>PK3-045_00001 Chromosomal replication initiator protein DnaA
MKNITDLWNNALSTIETKISKPSFDTWLKPTKANSLQGDLLVVTAPNEFARDWLEERYSQ
LIAEILYEITGEELLVKFIIPQNQKEEEFDQQISTKQKKKEEEVTEQTILNSKYTFDTFV
IGSGNRFAHAASLAVAEAPAKAYNPLFIYGGVGLGKTHLMHAIGHYVLDHNPSAKVVYLS
SEKFTNEFINSIRDNKGAEFRDKYRNVDVLLIDDIQFLAGKESTQEEFFHTFNTLHEESK
QIIISSDRPPKEIPTLEDRLRSRFEWGLITDITPPDLETRIAILRKKAKADGLDIPNEVM
LYIANQIDSNIRELEGALIRVVAYSSLINKDINADLAAEALKDIVPSSKPRVITIHDIQK
VVGEHFHIKLEDFKAKKRTKSIAFPRQIAMYLSRELTDFSLPKIGEEFGGRDHTTVIHAH
EKISKLLLTDSLLQKQLKEINELLKV
>PK3-045_00002 Ribonuclease P protein component
MKKEFRIKKNKEFQSVFKKGQSFANRQFVIYKLKKEEQVHFRIGLSVSKKIGNAVKRNQI
KRYVRQAFLELDDMLENKYDYVIIVRKPVADMSFEEVKKSLIHILKIAKVLSKKN
>PK3-045_00003 Membrane protein insertase MisCA
MNKKFLLIVGLLFLMTILTGCTEFNQPITSESEGIWNEYIVYPLSQLIIKTAAFAGGSYG
ISIIIVTILVRLVILPLMIKQTRNSKAMQAIQPQMKELQQKYSSKDQKTQQKLQEETMKL
FQENKVNPLAGCFPLIIQMPILIGFYHAISRTREIASHDFLWFSLGQPDPIYLLPIIAGV
TTFIQTRLSMAGAPPNPQMQMMVWIMPVMILVFAINFPAALSLYWVVGNIFTIVQTYFIK
GPEIKTAGQTSKAGGAKK
>PK3-045_00004 hypothetical protein
MKEVTAVGQTVDAAVESALAQLKTTKNQVEIIVVEEGKKGFLGFGSRTAKVIVKKKVNPV
ELVEEFLKDVCEKMGVPVKIQVKQNGRNILYELSGEKIALLIGKRGQTLNSIQYLAQLVI
NRESKEYLKVLLDAEGYRERRKQALIQLAERIAYKAVKIGKEIPLEPMPADERKTIHTAL
VSFKGIKTYSSGEDAKRHIIIAPIKMKNR
>PK3-045_00005 tRNA modification GTPase MnmE
MELDTIAAISTPMGEGAIAIVRLSGPDSIKIADKLFKSIGNKKLSEVATHTIHYGHIMDP
ATNEVVEEVMVSLMRGPKTFTKEDVVEINCHGGLASVNRLLQLTTSHGARIAEPGEFTKR
AFLNGRIDLSQAEAVMDLIRAKTDRAMNVALGQMEGRLSKLIKHLRQEILETLAQVEVNI
DYPEYDDVEEMTQQVMFEKSKYIKTEIEKLLQTSQQGKILREGLATVIVGRPNVGKSSLL
NSLVQENKAIVTDIPGTTRDVIEEYVNVRGVPLRLLDTAGIRETEDIVERIGVEKSRKVL
READLILLVLNYADDLTEEDKNIFKATEGMDFIVIVNKTDLPQKIDLEKVKELAGNRKVI
TTSLVEENGVDQLEEAISSLFFEGSIEASDMTYVSNSRHISLLNQALNAISDAIVGAETG
TPIDIVQIDLTRTWEILGEIIGESVHESLINQLFSQFCLGK
>PK3-045_00006 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG
MQYEAGNYDVIVIGAGHAGCEAGLAAARLGAKTLMLTINLDMVAFMPCNPSVGGPAKGIV
VREIDALGGEMGKNIDKTYIQMRMLNTGKGPAVRALRAQADKYMYQHEMKKTLENEPNLT
LIQGMVEELIVEDQAAKGVITKTGATYRAKTIVVTTGTYLRGEIILGELKYSSGPNNQQP
SIRLSEHLQELGFDLVRFKTGTPPRVNSHTIDYSKTEIQPGDDVPRAFSYETTKFITEQL
PCWLTYTNETTHQIIDANLHRSPMYSGMIKGTGPRYCPSIEDKVVRFNDKPRHQIFLEPE
GKNTQEVYVQGLSTSLPEDVQQEILRTIPGLENVQMMRAGYAIEYDAIVPTQLWPTLETK
KIKNLYTAGQINGTSGYEEAAGQGLMAGINAGLNALEKEEVILSRSDAYIGVLIDDLVTK
GTNEPYRLLTSRAEYRLLLRHDNADLRLTDIGYRIGLISEERYAKFSEKKQLIEKEKQRL
SEVMLKPNEQVQNVIKEQGGSELKDGIRAGDLLKRPEMNYSHIEGLAPSEIELTEDIKEQ
VEIQIKYEGYIEKSLQQVERLKKMENKKIPENIDYDAISSLATEAVQKLKKVRPLSIAQA
SRISGVNPADISILLVYLEQGKIARV
>PK3-045_00007 Ribosomal RNA small subunit methyltransferase G
MNTEEFIQMLSDKGITLSEKQINQFELYYETLVEWNEKMNLTAITEKSDVYLKHFYDSIT
AGFYYEGFHHPAQLCDVGAGAGFPSIPLKIVFPDLKVTIVDSLKKRIHFLEHLASVLELE
EVNFIHDRAETFGQNKEYRETFDIVTARAVARLSVLSELCLPLVKVGGTFVAMKAASAKE
ELEAGKKAVNLLGGKVNATHAFLLPIEESERNIITIAKEKPTPKKYPRKPGTPNKEPIE
>PK3-045_00008 Nucleoid occlusion protein
MKPSFSRFFGLGEKGDPIEDASQLGADATQEEIENMGNSEEVRKIPIHQIVPNRFQPRTV
FDDEKIEELARTIHTHGIIQPIVIREYEQDKFEIIAGERRWRAMKKLGWEEAPAIIKNLS
DTETASVALIENLQREELSPIEEAIAYGKLLELHNLTQEALAQRLGKGQSTVANKLRLLK
LPEEIQEALLNKEISERHARSMIPLKEREKQIQLLQEIIEKGLNVKQTEERVVRMLEQTK
QKPKPKRKAFSKDMRIAVNTIRQSLNMVSDSGINLNAQEEEFEDFYQFTIKIPKKK
>PK3-045_00009 Sporulation initiation inhibitor protein Soj
MGKIITVANQKGGVGKTTTSVNLGSCLAYIGKSVLLVDIDPQGNATSGVGIEKADVDHCI
YDVLVDDLEASMVIKQTNVENLDVIPATIQLAGAEIELVSTISREVRLKRALDEVKHNYD
YVLIDCPPSLGLLTINALTASDAVLIPVQCEYYALEGLSQLLNTVRLVQKHLNHDLAIEG
VLLTMLDARTNLGLQVIEEVKKYFQDKVYKTIIPRNIRLSEAPSHGEPIIIYDPKSRGAE
VYLDLAKEVVTSG
>PK3-045_00010 Stage 0 sporulation protein J
MAKGLGKGLDAFFPKIDVEKEENVQEISLNELRPNPYQPRKFFDEEAIEELKLSILEHGI
LQPIIVRKSIKGYEIVVGERRYRAAKEAKLETVPAVVRQLTEQQMMELAVLENLQREDLS
PIEEGHAYQTLMKKLKLTQEELAKRLGKSRPHIANHVRLLTLPKAVQNYISDGKISMGHG
RTLLGLKNKDKLPAIVDKIIKDGLNVRQLEQLIQQLNENVPRETKKEKAPVKNVFLKEQE
SFLRERFGTTVHIKQKKNKGKIEIEFFSEDDLARILQLFELENEK
>PK3-045_00011 hypothetical protein
MTLYSSLFEKNELPVRIAYDEQLAAFKIADSLAKHLPSISINQPIVFICIGTDRSTGDSL
GPLIGTLLSEKNISPFHVYGTLDDPIHALNLEEKLKEVHEKHKNPYIIGIDACLGRMKSV
GIVQIGDGPVKPGSGVNKELPPVGNIHITGIVNISGFMEFLVLQNTRLSLVLNMAKIISK
GIYHTSLRYMHTREYQVKEEPV
>PK3-045_00012 Small-conductance mechanosensitive channel
MDKNIKEGIDSLMNENLWRDVGFGALKLVLIFLISGIIIRIGKAAVRNIFKVRTHSALRV
SERREATLIKLLENTITYVVYFIAIMMALSVFHIDVKALLAGAGIVGLAIGFGAQSLVKD
IITGFFIIFEDQFSVGDQVRIGTYEGVVEEIGLRTTKIKGFTGEVNIIPNGSIVDVTNFS
INNSKAIVDVSIAYQGDINRAEKVIQELIEKLPEQYEDIVGVPELLGVQNIQAAEVTIRV
VAETLPTKHHAIARILRKEIKNVLDENGIESPVPKLVMYSQPQ
>PK3-045_00013 hypothetical protein
MEQKEFALNDVVEMKKAHPCGTNRWKIIRLGMDIRIKCEGCGHSVLIPRREFARKMKKVL
VKHEQE
>PK3-045_00014 Ribosome-binding ATPase YchF
MALTAGIVGLPNVGKSTLFNAITQAGAESANYPFCTIDPNVGIVEVPDHRLTKLTELVQP
KKTVPTTFEFTDIAGIVKGASKGEGLGNKFLSHIREVDAICQVVRCFADDNITHVSGKVD
PISDIETINLELILADLESVEKRIARVGKMAKQKDKEAVAELEVLELLKAAFEEEKPART
VEFTEEQAKIAKGLHLLTIKPVLYVANVGEDEIADAANNEYVKRVKEFAANENAEVIIIC
AKIEEEIAELEGEEKEMFLQELGIEESGLDQLIRAAYHLLGLATYFTAGVQEVRAWTFVQ
GMKAPQCAGIIHSDFERGFIRAETVSYEDLLASGNMVAAKEAGKVRLEGKEYVVRDGDII
HFRFNV
>PK3-045_00015 GDP-mannose-dependent alpha-mannosyltransferase
MKIAIFSDTYFPQVNGVAQTLKRLTNHFDNRQIAYQVYSPENKTSTTYPNINQFPSLPFF
LYPECRTVITNPKKIENSLKKFQPDLIHLATPYMMGLYGLFAAKKLNIPVVSSYHTNFDQ
YLKYYHASLLEPFLWKYLKWFHQATEKIFVPSKETQRKLESLHFDGLKVWGRGIDSKLFA
PNHDAKEQLRKKYHIKEKYILLYVGRLAPEKDLDTLNKIIHFPSDIKDSVHWLIVGDGPN
KVAWREKERVQKNITLTGYIKGEELARIYAGADLFVFPSFTETFGNVVLEAMSSGTPAVV
ANAGGVKEFVINDVNGRICEQQNAESFVHAISELLEDETMRLRMGVEARNYALTQSWDTI
FDGLISDYYEVLQSSRNINQKYA
>PK3-045_00016 30S ribosomal protein S6
MKKYEIMYIIRPNIEDEAKKALVERFNSILTDNGAELAESKEWGKRRLAYEINDFRDGYY
QLVKVNAAPVAVEEFSRLAKINEDIIRHIVVKDEAK
>PK3-045_00017 Single-stranded DNA-binding protein A
MMNRVVLVGRLTKDPDLRYTPSGVAVASFTLAVNRTFTNQQGEREADFINCVIWRKPAEN
VANFLKKGSLAGVDGRIQTRSYDGQDGKRVYVTEVLAESVQFLEPRNSSGNNRSDNMNYG
APREQDNPFGGSNNYQNQRPQTNRNNQDYTKVDEDPFANSGQIDISDDDLPF
>PK3-045_00018 30S ribosomal protein S18
MAMGGRRGGRAKRRKVCYFTANGITHIDYKDVDLLKKFISERGKILPRRVTGTSAKYQRK
LTIAIKRARTMALLPYVSGE
>PK3-045_00019 Cyclic-di-AMP phosphodiesterase GdpP
MPTFLEKGSIRYPLISLIGITIIMLGILSFYNWFFSLIGLFLFVIPFYFILRIDSRQRKE
TEEYITTLSYRVKKVGEEALMEMPIGIMLINDDYYIEWTNPFLASCFTEDTLVGRSLYDV
SPSIIPLIKQEVETEIITLHERKFRVIHKVEERLLYFFDVTEQTEIEKLYEDERTAIAII
FLDNYDDLTQGMDDQTRSSINNTVTAILNKWATDNGVLLKRISSDRFIAIFNEHILQNLE
KGKFTILDDVRELTTKQNVPLTLSIGVGSGVSSLPELGNIAQSSLDLALGRGGDQVAIKQ
PNGKVKFFGGKTNPVEKRTRVRARVISHALKELVLESDKVIIMGHKNPDMDAIGAAIGIH
KVAQMNQKEAYIVINFQEIDTAVRRLMEEIKKQETLFTKFITPDQALEMATGDTLLVVVD
THKPSLVIEEHLLNKIEDVVVIDHHRRGEEFIENPILVYMEPYASSTAELVTELLEYQPK
TVKIEMLEATALLAGIIVDTKSFTLRTGARTFDAASYLRGQGADTVLVQKFLKEDIENYV
KRARIIENVQFYKEGIAIAIAKEEEAVDGVLIAQTADTLLTMDGIIASFVIAPRGETMIG
ISARSLGEINVQIIMESLHGGGHLTNAATQLSNMPMEEVEARLKLAIDEYFEGRRKE
>PK3-045_00020 50S ribosomal protein L9
MKVIFLKDVKGKGKKGEVKNVADGYAHNFLLKQGLAVEANASAVSTLNAQKKKEEKEAIE
ELNRAKELKEKLEKVTVELHAKSGEGGRLFGSITSKQIAEELNKKHQIKIDKRKIELNDA
IRSLGVTKVPVKLHHEVSATLNVHVKELS
>PK3-045_00021 Replicative DNA helicase
MSEMLNDRMPPQNIEAEQAVLGAIFLEPQSLTLASEILIPEDFYRGAHQRIYSTMLKLND
EGKAVDLITVTSELAATNNLEDTGGVSYLSELAASVPTAANIEYYAKIVEEKSLLRRLIR
TATNIAQDGYSREDEVEALLSEAEKNILEVAQRKNAGAFHNIKDVLVRTYDNIEEMHNRK
GDITGIATGFAELDKMTAGFQRNDLIIVGARPSVGKTAFALNIAQNVAVKTGENVAIFSL
EMGAEQLVMRMLCAEGNIDAQRLRTGSLTDEDWGKLTMAMGSLSNAGIFIDDTPGVKITD
IRAKCRRLKQEHGLGMILIDYLQLILGSGRAGENRQQEVSEISRSLKQLARELQVPVIAL
SQLSRGVEQRQDKRPMMSDIRESGSIEQDADIVAFLYRDDYYDKESESKNIIEIIIAKQR
NGPTGTVQLAFVKEYNKFVNLERRFEDGAMPTGA
>PK3-045_00022 hypothetical protein
MTKSILRGEKIPKDLLKQFGKLGKKSISVTKVKIRKNHNHLNFLG
>PK3-045_00023 hypothetical protein
MKQMELLNPIFNSSNRPKEIPSIKENVQKRSITKEEGRQTRSDKKKDVKIPLSEEERQMV
KRVARRRGGA
>PK3-045_00024 Lon protease
MSSINNKIAKLSPKKLKVRNRLKNKSIKDYEFPPVSRLILLYLTSLIFYFFNIISGFIFV
IALLFLFIFLIIHYSNLRKRSNSNRVFVMPFLLPFLIVLYEFPIIFFDEYKFLVTSFNQP
EEIISGTNIFFLSVKEDTVSNIQNEKEVRNIYATNHQEIYEIVPVTNFIRYTSKNQFIYE
LVGLKNPEFEQYYQDISAYIGSDNTLIKEFLSRKNSQGNSAGLALVLSSYLIEQNFQNDI
LIGVTGSVNKSGKVEEVGYIKEKILSAERSGLTFIIVPNKNIIEANEIKDDLNLSINIIG
VSKIDEAIQLIEDLHNGKN
>PK3-045_00025 Adenylosuccinate synthetase
MSSVVVVGTQWGDEGKGKITDFLSENAEVIARYQGGNNAGHTIKFNGETYKLHLIPSGIF
YKEKISVVGNGMVVDPKAIIEELKYLHDRNINTDNLRISNRAHVILPYHLKLDEVEEESK
GANKIGTTKKGIGPAYMDKAARTGIRIADLLDKEVFEEKLARNLIEKNRLLERIYETEGF
KLEDILDEYYEYGQQIKKYVCDTSVVLNDALDEGRRVLFEGAQGVMLDIDQGTYPFVTSS
NPVAGGVTIGSGVGPTKIKHVVGVSKAYTSRVGDGPFPTELNDEIGHHIREVGREYGTTT
GRPRRVGWFDSVVVRHARRVSGITDLSLNSIDVLTGIETVKICVAYKYKGEVMEEFPASL
KVLADCEPVYEELPGWSEDITGCKTLSELPENARHYLERVSQLTGIPLSMFSVGPDRTQT
NVIHSPWRQI
>PK3-045_00030 Transcriptional regulatory protein WalR
MNKKILVVDDEKPIADILQFNLKKEGFEVYCAYDGNEALEKVEELQPDLVLLDIMLPQRD
GMEVCREVRKKYEMPIIMLTAKDSEIDKVLGLELGADDYVTKPFSTRELIARVKANLRRH
QQVSSAAEEEKETNEIEVGSLIIHPDAYIVSKRGEMIELTHREFELLYYLAKHIGQVMTR
EHLLQTVWGYDYYGDVRTVDVTVRRLREKIEDNPSHPTWIVTRRGVGYYLRNPEQE
>PK3-045_00031 Sensor histidine kinase WalK
MKKVSFFRSIHLKLVVVIVLLILISIQIIGVYFVKTLQTTLLDSFKVSIQEKVNILSIYL
EEQLVKERVVENGDSTLEDDIRRILSDNNSSDIKEIRVVNSNGIIVGTSDPENQNLVGQR
MVDYSVRRVLSNSSQPDNPIKQKNGEKIYELITPIKTNGDEIVGAIYLVGKIENVYKQID
KINQIFQKGTIITLVVTAILGVLLARTITKPISDMQKHAFALSKGNFSRKVKVYGFDEIG
QLAITFNNLTKKLQESQATTESERRKLSSVLAYMTDGVIATDRKGRIILINEPAAKMLDV
SRETVLSEPIVNLLDLNGKYTFEELLEERESVILDYSTHYEPYVLRANFSVIQKETGFVN
GLITVLHDITEQEKIDMERKEFVANVSHELRTPLTTMRSYVEALYDGAWKDDELAPKFLN
VTQTETERMIRLVNDLLQLSKLDSRDYQLNKELVDFIVFYNRIIDRFELTKEQNVIFIRK
LPKKAAFVEIDEDKLTQVLDNIISNALKYSPEGGKITFSIKEQEQQIIVSVSDNGVGIPK
ENIDKIFDRFYRVDKARTRKLGGTGLGLAIAKEMVEAHGGRIWASSKEGKGTKISFTLPY
IQSEEDDWG
>PK3-045_00032 Two-component system WalR/WalK regulatory protein YycH
MKYENVKSGILILLVALSVLLYYLLWTDQGAEFDAMDTSGSTMKQEALGAKKEVSEVIKP
DEIYQHIDGQHYGTISKEEVDHILNRLKEFDYGNFRNISSTIPSIATFLEKQNNGLEIRF
PGQVPFRIYKDILRIDQDNSFDFDTILFSYKDGNVYFLSKETGKVYETSINTTYIEQLNK
LKENVYAEKTVYSTYFSYKPNDQYLIYLPNGKQEVNKYKYFTRQIESIRLSRALFEEPSI
AQKEILTNWEEYTDDSGLLRIYKDTHIVSFFKPAGISNEMTQNHIINNSIELINERGGWI
NDYLYVGRDEDRKVTFRLYNTNGMPVFNLNTELSDIRLYWEDNKAKRLLTSNLIIINTTT
PFDFSKETVSSGEDVLKYLKSNKKLKMEKLQKIVLGYDMQVDSQSIVSLQPTWFYQYDHK
WYSLYSEGTGGSLDGLE
>PK3-045_00033 Two-component system WalR/WalK regulatory protein YycI
MDWSKIKTIFIIAFLLLDVYLIYEYVKIKEYQRADDLPTEPPTHTLSRLGIDYDKEKLPV
NNVKDQYLSAKSKKFTDDEIKKLEKGLLSGQEITVRDSIYLQAVLEKPISIDKEFDPDEL
SDFLLNSVLNGAEYRFLEKKGNTIKFYQQHAGKTLYRNPKAELTFNVNEENKIVSYNQTY
LENIKEMDKEEVIMQPPDAILNLFKNNFIESGSYVSHIELGYYTQLDTSAQLLAPTWKVT
VNEEDFYVNALDGQVIQPETEEMKVE
>PK3-045_00034 Putative metallo-hydrolase YycJ
MRFSVLASGSTGNAIFVESGEHSFLVDAGLSGKQMEGLFQGIERKMSDLTGILVTHEHSD
HIKGVGIVARKYKLPIYANEKTWKAMDPLIGEIPVEQKFHFDMETVKTFGNVSIESFGVS
HDAAEPMFYVFHEGEKKLVLITDTGYVSDRMKGIISNADSYVFESNHDVQMLRMGKYPWN
IKRRILSDVGHVCNEDAAIAMSEVIGDRTKHIYLAHLSLDNNMKDLARMSVGQTLESRGV
GLGEQVHLFDTDPRIPTKLMAI
>PK3-045_00035 Serine protease Do-like HtrB
MEYDYGNRGDGPKRGSRRGYFFSGFIGAVIGALLVLLLSPRLTDLAIFQNGNENEQIVTN
SDGIKTQNISLNVETDITKAVDKAADSVVGITNLQSSNFWADETTAQEAGTGSGVIYKKS
GGKAFIVTNNHVVQGATELEVTLSDGKKINAKLIGADIWTDLAVVEVAAKEITKVAEFGN
SDSLKTGEPVIAIGNPLGLTFSGSVTQGIISGLQRTIPVDINEDGTPDWQSEVIQTDAAI
NPGNSGGALVNIEGQLIGINSMKIAESAVEGIGLAIPINSAIPIIEDLEQHGEVQRPYMG
VELQSVSDIPGYYQQEALKLPNDVTTGVAVKDVSRNSPAQKAGLKELDVIVELDGEEIVD
LIALRKHLYTEKKIGDKMEVKYYRNGKLETTELTLSEEEM
>PK3-045_00036 hypothetical protein
MIYSCAEHVDIAIDSVVNEYETFPILEQISEEKKLSTTCEYCKNNAIYMVANK
>PK3-045_00037 Ribosomal RNA large subunit methyltransferase H
MNISIITVGKLKEKYLKLGIEEYTKRLSSYSKIEIMEVPDEKAPEILSDAEMLQVKKKEG
ERILAKVQADAHVIALAIEGKQKSSEELADTLDKLGTYGKSKVTFIIGGSLGLSDEVLRR
ADDKLSFSKMTFPHQLMRLILVEQVYRAFRIMRGEPYHK
>PK3-045_00038 Heme oxygenase (staphylobilin-producing)
MIIVTNRHKTKLGFAEKMAPMFTKPGPLQKMDGFIKVEVLITKNLTEYDELNVNMYWNTI
EDFTLWKNSTAFKEAHTGPTNTEQESPILGSEIIISQVASTSEPNA
>PK3-045_00039 Putative hemin import ATP-binding protein HrtA
MSGIQFKNVSKLYQQGENQVLALDDVSLTVEQGEFIAVIGPSGSGKSTFLAIAGALLHPT
KGEVIVNSKNLNELKSKDLVRMRLDEIGFILQTSNLVPYLNVLEQLLVVKRMAGKPVKQD
KEYAKELLHSLGLAAKLEKLPEQLSGGERQRTAIARAFINNPSIILADEPTASLDSKRAH
EVVQLIAKETKTRNKAAIMVTHDERMLEYCDKVYRMEDGRFQHDDSFSLEK
>PK3-045_00040 putative ABC transporter permease
MFLAIRELKHGKLRFLMIGVITVLIAWLVFILSGLGNGLSTLSAATFKNMDADYVTFEEG
ARASMSRSLLNESLAEKLESQPNVSAASVMGATMGTVIINSDLNESEKVDIAMLGINPGS
FLEPKVIEGKSLHTNLPLEVIANDTLKKKGFKIGDTLKIEGSLEKIKIVGFVKNETYNHL
PAIFTTLDKWRSIQFAAPGSDKGIKKPVNAIMLQGKKIDSAELNHLFKNTETVTKATAIQ
GMPGYKEENGTITMMLAFLLAISAFVLGVFFYVLTLQKSNQFGILKAIGASNRFLGRAIV
SQVFLLSFISIVLAILLTYGTALILPDEMPFSLDLKLVVLYALLLLIISILSSLASVRKI
AKIDPLQAIGRIE
>PK3-045_00041 hypothetical protein
MEHRSLILLGLLMGQSQHGYQINEFIERNLSTVTDMKKPTAYASLDKLNQKGYIDIHLVQ
EGNRPTRKVYSINESGRVYFYQLLLDNLSSAESVNYQGDIGLMFIDFLPMNQVIPALNER
LKKNKKLIDLFKQTPEHGIRTGVNLAVKHKITMLEAEISFLENTIQHLIQSN
>PK3-045_00042 hypothetical protein
MAYIVDFKNVSTIGLESSPVAEALAGLRANEARYFMNKYKHEFTVVPANESCETLDYVNR
ILKEERGIEFAAKPLETSTFQVENIKWTYVFYEDGLAINVLYTVDNPKKRAVGFKLSDGM
EVPKELEGKFKFARQKSKLAGTIRGSFFVIKGEY
>PK3-045_00043 hypothetical protein
MAGYMLEEKDSFIVLGIGTELKSDYTDYAGIAKEKADFWQVVKQEGKLDALKAIATNDYI
FIVNEAVNNKMMHYVGVMTEQSLPEADRMIQFPKGEYLVVKGESKTADELQNMLTGIAFG
QVLPEAKNFAYVGGPNTVVEMGQQNGLLLGEMWIPVVRK
>PK3-045_00044 hypothetical protein
MKKVERINTIMRYINNRANFTISEIMREFNISRSTAIRDIREIEAMGMPLVAEVGRDGGY
FVMNNSVLPTVRFTDNEIKALFIAFMATRNQQLPYLKSRQSLAEKLLGLISETQQDDLVL
LNRILLFEGTNPNNPDLLDLSDLPHPMLEKLIQLLIMDRYLLITIREEKVIKSYPIYLLN
LYREKSLWLIEGFDLKEEKKRILPVDNLTDVEPCTINNRLSRKKILEKLSKQEEVINLVL
ELGPKAIAQYKKYHPLRMSLSYTNPYQTTAILKTFINVNHSEELTEITSWLLFLGEDIKV
REMPVEILEGLQKRLLLYCP
>PK3-045_00045 hypothetical protein
MSSIRIETFILKFSEIGSVFDLIPIHSPHAKEEAKKHLNFHYQIDLLGLVKITIDDEVGF
GEDETTEDIFITWNSLDSARKNQLKEHCQDIILLDNVEDVYLERQDKKAQFCYRI
>PK3-045_00046 ECF RNA polymerase sigma factor SigH
MDQTSLHQSDASIDNIAEFKQLFSDYKKYVFAIALSILRDFELSEDVLQEVYIKLFQHMK
HNEITNVKAWLTSVSRNTALDMYRKKKRELTGFDNDYFDHVQYLSGDPLEKMILSKYLEL
LDCEERQIVILKDISGMKHREIAKIVEMPLGTVLWKYSLALKKLRKGIE
>PK3-045_00047 hypothetical protein
MKKEKILKHLDKAIEKQVPDVWDEIETQIHKAEELGDGEKVVRLSNVSTQNKKVSFYKRI
SLAAVVCLIVAITFTFTPVLATIQEVYEKIFSSKHIDDTGVRTAVNLGNGQAVDQTFYDE
KHDITVHFDRLMTDEKETKLLLTYQSDKTDLKNFYIDLFEGESSINLIVGNERKKLASVG
WGSRYYDSKKNKVAEALSFASIKEYEGQDIRLEIENLSIYDNEKETRMIQTIWPIDFKLS
KSAISDREIVEVNKQFTFRQETYKIKQVEFSPLETRVVVIIPPNPDAVQDKDGSTARVMS
KLEHKFLDARKIDKEYGYIVDKQKSGVFLKSAGERVDPIFSKGEVEGTEDEYIMIFAPVK
NPQDCILEIGDDIKIPLIGSGTATIEKQSENSEKQIIDAVLAENGYAAEPLSHDEMKEMD
LYLKKYQSEFPIDRTAIGKLKGHENSKLIEVAISQTSEILTEIQAGSPEEAEKARKEDGL
SFIPIYLTN
>PK3-045_00048 hypothetical protein
MNQFLQMGGNTALSSPKGYVSISYEIANSIDISLTAFLLTDSDKVQGDSGIIFYNQPKSS
SGVATLIPSEKVGNTKVHKINFDMSKSPEGITKIAITLTEDNHTGFSNVKNLKAEICTDN
NKIQLTPASFTTENGIVVVELYLRNGQTKARSIWRGFASGLEGLCENFGVEVEPEEHNKA
SESKVFQKQNHKVEVSVGDETHTMNQHSTQISLEKVKGKISLDKSQKPVIIEKTPEITAT
VSWKTGTDYDIYALVYTKNGEQIDVAMFGAEGKPPLRSFGNGAVEHMGDVRRESQATKTE
VIKLRLNNDILAVVPVVYSAQSNGTGSFHRYKVSMSIDNNNGTSVTIFAKNANNNDRIYS
CVPGILHNTKDGVMISPLELYSKPNSEFRPKLRMGASNLVEVIMDEGPKNDYK
>PK3-045_00049 Cellobiose 2-epimerase
MWLDRHQSEPWMQETAEKLFAKGWEQGWDVKYGGIYFALSPSLEVIDTDKNYWVMSEAIA
AAALLAAKTKNQQYWDYYNQLFTYSAQYFMDHEHGGWYTLLNRENEKYSNVKTSPPKTDY
HPVSACYQSILALP
>PK3-045_00050 Sulfoquinovose isomerase
MEGSSYIQFDHYQDKGELKKHIFKTLHFYYPACIDEEKGGYINGFLDDGTINDTDTKHLV
ATSRYIYIFSIGAILDGPDWCLKAARHGIQFLHEHHLDKQYNGYYFEMKGTDVKDAAKMA
YGHAFALLASSIAYQAGIKEAKEVMKNVFNVVENHFWDPKHGYYKDQWDAGWTTLSSYRG
QNPNMHMCEAMLTAYEATNEAKYLKKAYQLAEGVTQELADRASGMIWENYTPDWLPDYQF
NKNNTR
>PK3-045_00051 General stress protein 39
MSKLDEQTILSNGVNPQKQSEQPGVEKEMDPIPIYELETHVGSGKLKGKVALITGGDSGI
GKAVAIGYAKEGADIAIAYLNEQEDAENTKKRIEQEGVKCTLHAGDVADEAFCNQLVEDV
IQQHGKLNILVNNAARQEVKNSVLEISAEQLKRTFDVNFFSMVYLTKAAIPHLSVGDSLI
YTASINAYVGNKALIDYTSTKGAIVSFTRSIAQELSSKGIRVNGVAPGPIWTPLIPATMT
TDLQESFGVSTPIGRPGQPADLVEPYILLASEGSAYMTGQFIHVNGGQYMSS
>PK3-045_00052 hypothetical protein
MKRLALLFSGVLLVVLLISCSKNTPTIKETEQHDEEQTQEEKSSGEKKAIKEENPPPAYK
PLEPTEGASSLDKKVADEEIEKMPSAEARGEDPTRMVPLGETLVKDAVDQTDGPLKNHRL
IAYYGHPNSTKMGILGEMEPDELMAKLKEQTQAYSDADPSRPAVPMIELISTVAQRDPGT
DGKYYHPTSPEQIDEYSTLAEENDALLMLDVQLGTDSVLNQVKLLEKWLKLPHVHLAIDT
EFHVKEGQTPGVNLGQVDGAEVQEAVQYLTEMVKENNLPDKIVLVHQFMDEALTNKEAIK
PTENVEVALNYDGWGDSNTKMALYRKFVRNEAVQYGGFKIFYNKDKPVLSPEEVLKLDPS
PAIINYQ
>PK3-045_00053 Cyclic pyranopterin monophosphate synthase
MTNFTHFNQQGRAKMVDITDKQESSRTAISQSSIIVNELIYKKIMNHEFAKGDVLAVAQV
AGIMAAKQTSSIIPMCHPLSLSGVDMQFNWKQNEDKWELIIRVEVKTKGSTGVEMEALTA
AAVTSLTIYDMCKAVDKGMVIGPTFLVEKSGGKSGDYKREEM
>PK3-045_00054 Molybdate-binding protein ModA
MYKWKGLIIICICFFLLAGCSSEKREVKLTVSAAASLTDAMEELVEAFESREPNIAISLN
LASSGALQQQISQGAPVDIFLSAAEEPFDYLNKQGLLDKSHQELLLRNQLVLIKRKDTFS
QFHEFKDLLDEQVQEIAIGTPESVPAGIYAKQALKHVGIFHSLESKLVYAKDVRQVLQYV
ESGSVDFGFVYATDVIAAKQVEVEQVVDEEWHDPIQYPIGILKDTKHKEEAVAFYNFLRS
AKADTIFAKYGFTTVNK
>PK3-045_00055 Molybdenum transport system permease protein ModB
MKSSFWQPIELSLLIAISATLFVIILGIVTAWFMTKKKFPGKVIIEVILLLPIVLPPTVI
GFLLIMLFGKKGVIGKAIDFLFGQSLMFTVSGAILAAVVVAFPLMYQSVKNGFTSMNPLI
EDAARVDGANSWRLFRHISLPLCSPFLVTGTILSFARALGEFGATIMFAGNIPGQTQTLP
LAIYVAFESNKLALAWSWVMMMVIISFVMLLFIQKRAHRS
>PK3-045_00056 Respiratory nitrate reductase 1 alpha chain
MKKKPSPLWQRLNYLKPKETYSNNHSQLQEGDRDWENVYRRRWQHDKVIRSTHGVNCTGS
CSWNIFVKDGIVTWEGQNVDYPTTGPDMPEFEPRGCPRGASFSWYLYSPLRVKYPYIRKK
LLYLWREAIAEHKKPLDAWKSIVEDKEKANQYKSVRGKGGLVRADWEEVTQIIAAAVLYT
TVKYGSDRNVGFSPIPAMSMVSHAAGSRFMSLIGGPMLSFYDWYADLPPASPQIWGDQTD
VPESSDWFNAGYIMTWGSNVPLTRTPDAHFLAEARYKGTKVVSVSPDYAESTKFSDDWMA
VKQGTDGAVAMAMGHVILNEFYHKKQIPYFESYAKQYTDFPFAVRLKKVGSSYQADRFLH
AKDLGLSGEHNEWKPAMYNERTGNFAIPQGTIGSRWDKKGKWNLHLVDEYTGEAIDPKLS
FLGLEDEVMEIQLPYFDAEKRSVMNRAVPVKAVELNGQTEYITTVYDLMLANYGIDRGIG
GEVAQSYDDMAPFTPAWQESISNVDRNLVIKIAKEFAQNAIDTKGRSMIIMGAGINHWFH
SDTIYRAIINLILMVGAQGVNGGGWAHYVGQEKLRPAEGWNTLATAKDWQAPPKLQNGTS
FFYFATDQWRYEETSVNEITAATVEKARYDHHGDYNVLAARLGWLPSYPTFNKNGIAIYK
EAVAKGCQTQEEIAQYVAKELMNKSLQFAIEDPDNPVNFPRTLFVWRANLISSSGKGHEY
FLKHLLGTTHGLLNDDQSSIRPAEIKWREEAPEGKLDLLIDLDFRMAGTGLYSDIILPAA
TWYEKFDLSSTDMHPFVHPFNPAVATPWESKSDWDIFKKLAKGVSELAEQIDMDVIKEVV
ATPLQHDTPQEMAQPFGEIKDWSKGDCEAVPGRTMPNIHVVERDYKQVYKKMTSLGPNVA
KNPYGGKGISWSMEKEYEQVKHAIGVVEEEGISKGLPNIESARDACQAILMMSSTTNGKI
AVKAWESLEQQTSLELKDLAAEREEDLFTLEQINAQPKTVITSPAFTGSEKGGRRYSPFT
TNIERMIPFHTLTGRQSFYLDHEMMKEFGEEMATFKPMLHHTPFQQDRPKVEGKEITLNY
LTPHNKWSIHSMYYDAQPMLTLFRGGPTIWMNKEDAKEVDIEDNDWIECFNRNGVVVARA
VVSHRIPRSVAFMYHAQDRHIHVPGTNLTKNRGGTHNSPTRIHVKPTHMIGGYGQLSYGF
NYYGPTGNQRDLHVVIRKMKEVEWLED
>PK3-045_00057 Respiratory nitrate reductase 2 beta chain
MKIKAQIGMVMNLDKCIGCHTCSVTCKNTWTNRPGAEYMYFNNVETKPGIGYPKQWEDQE
KYKGGWELDKKGELKLKSGSKVNRLFSLFYNPNQPEIDDYYEPWNYDYETLTNSPERKHQ
PIARAKSAITGEFMNLEWGPNWEDDLAGGHITGLRDPNVVQMEESIKTEFEDVFMMYLPR
ICEHCINAPCVSSCPSGAMYKRDEDGIVLVDQNACRAWRQCVSSCPYKKVYFNWKTSKAE
KCTLCYPRIENGQPTICSETCVGRIRYIGVMLYDADKVLEAASVKKEKELYQAQLDIFLD
PNDPEVVKEAKKEGIPMDWIEAAQQSPLYKMIIDWKIALPLHPEYRTMPMVWYIPPLSPV
MNMIEGKGSQADTEDIFPAIDEMRIPIEYLANLLTAGDTAHIRTVLKKMAVMRSYMRAEQ
TGKSFDVSIIEELGLEENDIKKMYRLLAIAKYNDRFVIPKSHKEDIADLYYDQGACGLDF
AGGPGACGVLS
>PK3-045_00058 hypothetical protein
MKQTELYQMLAFLLRYPNEEFRQILLGLTAEIQEVGDTRIRQKLFQFIELVEQTPLDDWI
NHYVSQFDFDRKTNLYVTYFKNGEQKERGLELLKLKKFYQAAGFDIVETELPDYIPLMLE
FSAQVSADIRQELWKMHEQAIWEIRETLLSIKSFYGLLFDVLIQLFEQDGLEHHLTAEKQ
TPIPNLEDQAILAKMRDQLIKNQLG
>PK3-045_00059 Nitrate reductase-like protein NarX
MNSLNLLLWGVFPYIVLTIFIGGLIYRYQKDQFGWTTKSSEIFEKKRLRIGSLMFHWGLF
FVLGGHIAGLIVPVSFYNAFGISEHFYHRIALIFGLPAGIVAFIGILLLAHRRFSVKRIK
ATSSIGDWVALILVIIVIFTGLLATSMNVDSQGFDYRTTIAPWLRGLFVFRMQPELMAEV
PIWFKIHIYTTFALYVSWPFTRLVHAFSFPLRYLSRNYVIYKRRVQRKAG
>PK3-045_00060 hypothetical protein
MNHQDILLLGAELDKTLQENNMAQAKDIVSQLEPHYEARSQAFSVSNQLTIALSLAKYFR
KRNQYDKSAHYSRQAIQQAKIGKLGLTRPLVDAYLNYAKLEKDYNQIDNARKLLATLLMQ
LEKNKVEDNYIFGLVYHLLAQIGFQDLAFDTAVEQFKEALTCFRKAIPEEHPIIYQTINE
LTETYIRMEHYQDALYLQEKTLQDYQKTDDKLTQALILLRMGEIYFYLDLKKARKAISQS
LALLKALEQPLLLYQAKANLLLAELEENLANAPRSINYYKRSLKQLEQVHEQEHFMVIYA
YSKIGTLLMKVNQLEDAKYYLEKGLPLTKGHPRIQMQFLYALGKIYSKEQSYEQARNLYQ
AFLDQLEKANKKQSKAYADTLQAIGFNFIQQNDMEKAFICYQEAIDIYQGLRPVSKDSLG
FASIRLAYCYEQKAEKDIAKASEWYQYGVEQIEKLKDKALSEEALAAVIDFYQRHDFPKQ
QSYYENKLVKLQVNS
>PK3-045_00061 GTP 3',8-cyclase
MLQDRLGRPLQDLRISVIDRCNFRCTYCMPREIFGKDFSFLPKDQLLSFEEIERLAKLFV
QLGVRKIRLTGGEPLLRRDIATLIEKLAAIDGLEDIGLTTNGMLLGKMAKSLKQAGLERV
NVSLDALDDKVFQSINDSGIPTKKILDSIEQARKAGLSVKVNMVVKKGMNDQQVIPMAKY
FKEQEIPLRYIEFMDVGQTNGWDFSQVITKKQLFEQLSQHFELEPVDSAYIGEVAKRYRY
VGTNAEVGFITSVSESFCSTCTRARLAADGKFYTCLFASGGLDLRTLLRSNADDQTILQS
IVPTWKNRNDRYSDERTEESAKYRKKMEMSYIGG
>PK3-045_00062 hypothetical protein
MNNRYSRQIRFQPIGEHGQEQMAKKHVLIVGCGALGSANAEALVRAGVGEVSIVDRDYVE
ESNLQRQHLFTEKDVEQQLPKAIAAQQHLREINQCIKIHAHVMDVTGETLEPLIKDVDLV
MDATDNFDTRFILNDALHQHRIPWIFGACVGATGMSYTVIPNETPCLRCLLDAIPVAGVT
CDAVGIIGPAVQMVVAHQTAEALKLLTGAADKQRATYLTFDLWNNLYQTIRVEGVKRDEC
LTCGMTPTYPALAYQNQLKTEVLCGRDTVQLRASTSHSLAALAARFQVFTSVKQNEYLVS
ITYQSYRIVFFLDGRTLIHGTNSVTEAKKIYYQLVG
>PK3-045_00063 Molybdopterin molybdenumtransferase
MERREPIKVTEAIERVMQYGAAGDIEHIVLEQSMDRVLAEDVLADHDVPPFDRSPYDGYA
IRSSDTCRASTENPITLSVIGHIGAGEVFANTVRENQAVRIMTGGPIPVGCDAVIMLELV
EEVSEHKICIKRKVKPNDNISFQGEDTTKNDAIVRKGTRINPGIVALLATFGYKQVPVAK
KPTVGVIATGSELLEVDEPLVLGKIRNSNAYMIMAQLERAGAKAIYFGQFIDDLEVCYNQ
VNTAIEQVDFLITTGGVSVGDYDYLPEIYRRMGANVLFNKVGMRPGSVTTVAELAGKLLF
GLSGNPSACYVGFELFVRPVLQFFLGNPLAYNKAIQARLGSDFAKPNPFDRFVRGKLYFT
EAQPVVTPIGLDKSNVVSSLGEADVLIVLPGGTRGYEQGSSVVALLLEYAEGDAEFLNNY
QLKERQHGH
>PK3-045_00064 Molybdopterin synthase catalytic subunit
MDTKRYKIVDQPIAIDELIDKVTRPEAGAITTFIGTVREWTKGKRTIYLQYEAYIPMAIK
MLEQIGHEITEKWPNTEVAITHRIGRLEITDIAVVIAVSSPHREAAYQANQYAIERIKQI
VPIWKKEHWENGETWIGDQLEQIPYHDPWSTNEGGI
>PK3-045_00065 Molybdopterin synthase sulfur carrier subunit
MKILVFAHLQEQLGTSELELDWEAQTVQTFKEAFQQSYGIDSLDQVMIAVNEEFARGQAM
IQKDDVVALIPPVSGG
>PK3-045_00066 Molybdopterin-guanine dinucleotide biosynthesis adapter protein
MQCVQIIGYKNRGKTTLVEHLIGYFSKYHYQVAAIKHHGHGGPPLGWEKTDNAKHLQAGA
DFAGVQGENLLQIATNKEWNLDVIIQLYTLLNVDILFIEGYKHEPKPKIVLIGEQEDIHL
INKVSNLKAVVSSIPLEEISVPIFKPNQLEKLACWLLEQYTQNLLH
>PK3-045_00067 Anaerobic regulatory protein
MKIPIQESKNRMISPELRHLLVSIGTKKKIYKDHYLFREGEEAKEVYLLESGLVQISKLT
AEGNELLLRLCKQDDIVGELTLFADNPKFLLSCKTLQTGEVYVIKRSKLEKELMANSALT
FEFMRWVSDHMRKFQSKLRDLLLNGKKGAVYSTLIRLSNSYGVPVDDGILIDMTLTNQEL
GRFCATTRESVNRMLGDLRKNNIISLNTQGKIILHDIEYLRQAIGCENCPLEMCNID
>PK3-045_00068 putative molybdenum cofactor guanylyltransferase
MQQSIVGILLAGGKSSRFGSPKMFAEHNGKTFYHHSLDAITPFVKRVYLVTQAHYVDQIK
SAEADVSILIDLPSIKEKGPLAGMYSVMQEKSSTWYLVIPTDVPFMTEATIHLIVKEIQP
GYQAIIPSCKGRLQPLVGVYHATVAPIIEEMLQAGDYAVYQLLQKLKVKTVEVEDEEPFY
NLNYQRDYDYLIKK
>PK3-045_00069 Protoheme IX farnesyltransferase 2
MNINKDTKQQLQKPLYKWTVHDLLLLIKCKVLLANVLPVLTSFLLALNILREGFLDYWME
FIFVLLGSTLVMGGALVLNNWYDVDIDSIMERTQKRPTVTGNVPLQTVLILGIGFTIAGF
IFLLMVNMKTTLFAFIGWFTYVFLYTMWSKRRYAFNTLIGSLSGAVTPLMGWAAVGSILH
KIPLALFLLLFIWQMPHTYAIAIKKFQEYADAKVAMLPVVSGITKTKYHMVFYIACLLPI
PFLLASFGKVFVIVTFAFTMGWLILALSGFLVKDQWKWAHWNFLYSVNYLMIIFIYMTIL
TLCFKVK
>PK3-045_00070 hypothetical protein
MKKQTIQLNLQTFNLVIGFMVWVILSSLMPSIREDISLTASQVSLVTALPVILGSILRIP
IGFYTNRYGARLLFSISFFILLFPVYFISIANSFSDLVIGGLFLGVGGAVFSIGVTSLPK
YYPKEKHGFINGIYGVGNIGTAVTSFGAPVIAAMLGWNKAVQMYLILLLLFIALTVFLGD
KQESKEHVALSKQFKAVYKNATLWALSLFYFITFGAFVAFTVYLPNFLSTHFELSTVDAG
MRTAGFIALATFLRPVGGWLADKFNPYIILMLTFIGITASGIILSFSPTLTLYTIGTLSV
AVTAGIGNGTIFKLVPLHFPKQAGIVNGIVSAIGGLGGFFPPLILTAVEQMTGQYSIGFM
ALSQFALVSFVIVVWMYYQDEKNIEKQIIENTAEAIMLTDKKRVIKRVNSAFSRITGYTT
EEALGNTPVLLQSGKHDKSFYQEMWKSIDQHDFWEGEIWNKRKDGSFYLQWLTISAIKNN
VGEVRYYVGIFNDLSTAKRKINA
>PK3-045_00071 hypothetical protein
MFKVGSIFIPVTDIKKSTDWYVKFLGVKIIDSWEDGAGFYLPAGTTQLALVKVESPQPTE
FIIKGDQKNSYFNFVVDNIEAAHQQFRNNGIVTTEIDDFGGMKFFDFFDLDGNPFSVVNE
VSNSPFHSENVREMQERDKTKK
>PK3-045_00072 hypothetical protein
MVFEDIEVVIKKLYKYCLRLSGSPWTAEDLVQETILKVYKIKKAEPKREFTFSYLCTVAK
NQFIDENRKYKESILFNEDIFGEAYDFIDYDGLIEILLTTLPLKQAMLVTLKDVFGYTSK
EMASMLRISNEAIKTALHRSRKKLKLQNNNMKIPSSNQEIIIALTKAIREAKPMQIFYLY
RLLESQNFKVRRGSIHSRFYVIDPDGNILEITS
>PK3-045_00073 hypothetical protein
MLSFEEKLNIIEEFPQLERKNVSLKRVNFHYAESGSDKKNVVYHLHPNGNGFVYADKLNE
YETDEKGMVNIRDFSKEELKEIIEKSIQSLRPNIQEEETVEEETVEEETWIDTENNTLLL
LQEEGFWNIYAGVNLENSFSSYEEACEYLKEEGFNKSSI
>PK3-045_00074 hypothetical protein
MSQNRLVPNTFLYTFNYAEEEEQLCKLEVRSLFRADLHAFVLESSINRDPSRSPFIKEKI
AVLFTGDTLEELKQRVEAMPSLPSTYKVIGINYRDIDPLDKMEFNDRKGITRQIGCLVPG
AASLHNPEIVFAITKLKGKWYFGYYSENQGMWLIHQQKPHNYSTALTTRMARALVNIAVP
ELRGVKVIDPCCGIGTVLVEALSMGVNITGSDYNPLVMKGIRNNLAHFGLSGPVFLRDIR
DITEMYDVAIIDMPYNLCSVVSDEEKFAMLQSARRFAKKMVIVTTEDIDGILGEAGFEIV
DRCEVPKGKFIRQTIVCC
>PK3-045_00075 putative inner membrane transporter YedA
MPYKLNIRIVVANCLIIFLWGSAFTGIRVGLQSYTPEHLALFRMLVGSILLIGIAIIFKM
KLPEFKDIPIIFLFGFLGFTVYHLALNIGEKTVSSGIASLLVSTTPIICAFLAGWFLQEK
FGISKWIGSIISFFGVALISLGTWGFGTGSGILFILIASISESFYFVFQTHYIKKYGFFA
FTVYTIIAGTICMLFLLPGLVGEITNSSLASTLSVIYLGIFPTIIPYIILAYLTLRVGSS
VATSSLYLTPALSFVIGWFWLGEKPTQVSLLGGLLILAGVSFIHLNLEKLQIRFNLRRRG
FQK
>PK3-045_00076 HTH-type transcriptional regulator NorG
MVLKIKTPKYQQIIDFIKEKISNGEWPIGSKIPSQRVLAKRFEVNRSTIITALEELMADG
LIEAKIGLGTYVANNTWTLLATNPPPDWDEHVKSGLLRPSQSTVQEINLAESNADLIQLS
KGELSKDLFPLETMKSVLRRVSDQLEAFGYEEPKGFLPLREALSDYLKTIGIQASPSSIL
IVSGALQALQLISVGLLHRGSSVLLEQPSYLYSLRVFQSAGMKLTGLPIDEDGLIPNSIS
ITNKQRNRAILYSIPCFHNPTGILMPDKRRQELLSICKKEQLPMIEDDIYRELWLDEIPP
SPIKANDKHGHVLYLGSLSKSLSPGLRIGWIVGPEPVIERLSDIKMQTDYGSSSISQRVA
AEWFKSGLYEQHLGLVREELKKRRTVMLETLEYYLSDIASWYTPKGGFFIWLKITSKISM
KELYVKALDRGILLNPGSIYGQDSNRYLRLSYSYASIADLKKGIYQLSKIIRELVGS
>PK3-045_00077 hypothetical protein
MTISLSLVFVIGFIFIHFFSKTMKFIKDSPRSRFLSIAGGIAVSYVFIHLMPELSKHQRV
LEQLGDKGIFHLFENHAYLIALLGLTIFYGLEKMVKKSKKESGMKKSKTGVFWIHITSFF
VYNALIGYLLIRETYRSNWGMLFYFLAMAVHFVTNDHSLRKDHKEIYDHFGRWLLTLAIL
FGWMVGLFTELKEIYISMLTAFLAGGIILNVLKEELPEERESSFIAFFLGLVSYSVLLLL
V
>PK3-045_00078 L-cystine-binding protein FliY
MLLNKKILLFFSLIGLCLLSACAEKEKLADGSELINKNQFVFAASGEFKPFSYINNDLTM
SGFDVEVGEALAKEMGLEPVQKRIKFKGIVEGVKTGRADAAVASHTINPQRSKHVAFSTP
YYYSGPQIFTRPDSSIKTVDDLKGKEVAVAKGSTYADTASKYTDKIKTYDSDITALQALS
SGRHDAVITDFVTGKSAAQEGFKIKAQQLIDRSEQAIVLPQDNPKLLKRVNQALEKLRED
GTLTRISMKYFGEDITTKPE
>PK3-045_00079 L-cystine transport system permease protein TcyB
MPSFSHFFNILAETKGVFLKAMLLTLELTAVSIVLGIVIGLIFALLKISKIKVLEFISDA
YVYLVRGTPLIVQIFILYFGISGIFLLPDFWAASLALAFHNGAYISEILRGAIQAVDKGQ
LEAGRSLGMTKALTLRRIILPQAFRRALPPLGNQFIISLKDSSLAAFISMNELFNVATTL
GSNNFDEMTYLLIVAVYYLVLVALLTFVVNRIELKLAVSDR
>PK3-045_00080 Arginine transport ATP-binding protein ArtM
MDKKEMIRINQLNKSFGDLHVLKNIDLTVYESDVVCLIGSSGSGKSTLLRCLNFLEKKDN
GSIIIEGNEVNPSTDNLNKIREKVGMVFQNFNLFPHKTVLENIIEAPIMVKGVDKDKAIS
KAKQLLQKVDLEDKADVYPSKLSGGQKQRVAIARALAMEPDIMLFDEPTSALDPELVGEV
LTTMKDLAEEGMTMVVVTHEMGFAKEVADSIVYMHDGKIIEHGTAEQFFNNPKEERTQEF
LKATMLK
>PK3-045_00081 putative protein
MNKMKEFKELHFSEDLLFLGNAWDLLSALTLEKAGFKAIGTTSWGIANSLGYSDGELIDF
DRHLAIIKTITENVKIPVSADIEAGYSEDLDKIINNVLRTAEIGVAGINIEDSLKKSNEL
REITQHCKLMEKMRAALDRNGYKDFYINARTDTYLKRKNPLLETMERAHAYVESGASGIF
VPGLREDKEIKEITKNVSAPLNLLSLPGLTNCNMLKELGVRRFSFGNALSDSVIVHLEKK
VGELLEFKDTSSLYEKEALG
>PK3-045_00082 Bifunctional transcriptional activator/DNA repair enzyme AdaA
MSTNLNLSFEEMWEKIINCDRKYDGIFFTAVKTTKIYCRPSCRSRKPKKKNVEFYYDRNE
VEKAGYRPCKRCQPEVEHSPHIELVRNIITFLVNHYKQNLILKDIAAHVGLSPFYLERLF
KKETAETPRAYLEKIRIDKAAYLLKSTAMTNLEICYEVGFQSSSNFYKVFRSIKNCSPSE
YRKGYQHELD
>PK3-045_00083 DNA-3-methyladenine glycosylase
MNWIDYESYIEIYPPKEFNFEECLVFLGRSNQEVLHRIEEGFLYKLIKVNESLILCKVGS
IDHAIKVEFPLNPASNDIHKKVAEYIWEWFDLDQDLESFYQVADKDKVLRQLTHKYHGLR
IMCIPDLFEAAVWAIMGQQINLTFAYTLKKRFVEKYGESLTFQEETLWLFPSFEKIASIH
VDDLRELQFTTRKAEYIIGIAKDMQSGKLTKELLLMKQDNYQVKKSLLLIRGIGAWTAEY
VMMKCLHYTSSFPVSDVGLHNALKNVLKLKSKPTIEKTKELAEGWKGWQAYATFYLWRSL
YDKNI
>PK3-045_00084 Methylated-DNA--protein-cysteine methyltransferase, constitutive
MTKIYKLDYESPIGMIEIIGTHEAIISILFSEENDKSVNLLQPETPLVLIECYNQLDEYF
KGKRHEFSIPYQLEGTDFQSAVWNALIKIPYAETGSYKDIAMSIGNARAIRAVGSANGKN
KLSIVIPCHRVIGSNGTLTGYAGGLWRKEWLLQHEKTYHK
>PK3-045_00085 2-aminoadipate transaminase
MSTKYKKIVEEIKNQLTNGTLVAGSKLPSVRQLSETFSCSKNTVIKAYSELEKEHLVYAI
PQSGYYIVNEFALSAEDSTIVDFLSAGPDNHLIPYLEFQHCLNQAIEIYKKDIFTYSDHQ
GFYSLRTEIVKNLQDSQVFTDPDRVVIVSGSQQAIHLLTALPFPNGKKNILIEQPTYFGM
IESLQIHQVSTFGIELSMNGIDLDRLEYIFKHNDIKFFYIIPRFHNPLGHSYTNNEKKKI
VELANKYDVYIVEDDFLGELDRNKKSDPLFSYDTSGRVIYIKSFSKVFLPGLRIAGVVLP
KIMINNFLRYKFSSDFNSSVLSQGALEIYLKSGMYKSHIKKIKEVYFHRMQLLKSACEEL
LPEGTHYTQPDSGFYLSIYLPENVSAKRLAFLLSEKLILIDDADRMFLTNYKKDNLIRLC
ISQVQDHQIKWGVKMIAETITLLSNKRNYYYSLL
>PK3-045_00086 hypothetical protein
MEKEKLGLLLGLVGVICFSLTLPATSISVEYFGTTVVGLGRTVLAAIIAGIVLVVGKERV
PNRQQFKSILIVAMGAVLGFPLLTSWAMQALPVSHGAVEVALLPLATAGIAMLRAGEKPS
VRFWIASLIGAGAVIFYAVNLGFGKLQFADLALLTAVIILGFSYAEGGKLSKEIGSWQVI
AWAIVIGAPFFVIPVVMDFSVEMLTAPFQAWVSLIYLAIVSQFLAYIVWYGGMALGGVAR
VSQLQYIQPFIMIIFATIFLDESITLVTIVTAIIVVVSVIVGKNTPISKKTSP
>PK3-045_00087 hypothetical protein
MIFEMTTQVRVANIEEGQKWYETLLNKKPDFTPHEGFAEWELIPGCWLQVAEGTLTEGNG
PLRLGVTNIEAERDRLIDELKIDSFEIHSRPEVPVKWGTFTDPWGNRLGFFEYLDKGEEQ
ERIKTIIGTIEI
>PK3-045_00088 Adaptive-response sensory-kinase SasA
MRKRSITVKLFAVTSIFFLVFYVMIMIFQLVFFDRFYQHHKTKEAAKHIHQLAEGYEQNS
WSEAELTKQTLSYIKKTKSPLTIVDTEGYQLVQDPFNIMLDTEDGKIVEVSLSLLITDYG
KQVQALNIAKGDTVIVQGETDALVSSVIYPSIITKNSSSVGESQAENEVTIKGKVKSISL
PKGKVASRGLGILYDALLEWFPLQEKQIKQLSRGESLKLDWVESWSGKHYLVLMEPIKKD
GEMQIMFSVTSLQEIRDTNESLRIFYVYIGIAGFILILLLSLFFSRLVSRPLIKLNEMAK
KMVHLDFSSLKPIKQKDELGSLANNMLVMAQNLDVALNGLKEANGKLKEDMEKRLQMEKE
QREFFEHASHELKTPLSIVKSFAEGLQDGVSPDKQDHYIEVIIEESEKMEVLIKNMLDLA
KLENGVIKLRKTSFLLSEMIEDLANKLFCIAREKNVEIEIMPKNEQHILADYEWMERVMK
NLLINAIRHSEPDSVIRICIELDQDNGNSVFQIENTGPQIPEEQLDKIWKRFYRAESSRS
RMTGGTGLGLAIVQQILSLHGFHYGAENIPGGVRFYIHFR
>PK3-045_00089 Transcriptional regulatory protein SrrA
MGKKVLLVEDEVRIREVVADYFKKDGWEVYETDNGSSAIDWFDAIYPDLVILDIMMPQMD
GFAVTKQVRMSSGVPIILLTAKSSDDDKIHGFELGADDYVTKPFSPKVLVARANSLMKRA
KEHYLPTGHMISFGEAIVNTKSHQLQLAGQQVELTPKEYELLVFLLQHKNNVLSRETILN
HVWGFDFDGDSRVVDTHIKKLRAKLSFESHHIRTVIGTGYKFE
>PK3-045_00090 hypothetical protein
MNKLKQLYRHTGVRFALQTCFYLAILITLFLLYGFHTANTGNYIYNDF
>PK3-045_00091 D-alanine--D-alanyl carrier protein ligase
MKLLTRIAQHAVKKSEQIAYRTEDQMLTYGLLWDKSRRLASLLHAIKLKRQTPIVVYGHM
GIDMPVSFLACVQAGHPYIPVDTSIPIERVRLIVEKSGAGVVINTTTSKLDFEGVIVLQM
LEMNLEQVEHIGEEYWVQSDEVFYIIYTSGSTGNPKGVQITAANLQSFTDWMTGDFPLGE
GKVFLNQAPFSFDLSVMDFYPALQSGGTIHTLEKEVSNKPKLLFENLSHSSIQIWTSTPS
FVQMCFPNPDFNQKMLPELELFLFCGEVLPLAVATELKERFPKARIFNTYGPTEATVAVT
SIEITEELLAEEKALPVGYPKSDMRVFVLDELDNPLPEGEKGELILAGPSVSKGYLGEPQ
LTEKAFGMINGMNAYRTGDAGFIQDGVVYCQGRMDYQIKLHGYRMELEEIEFHLNQSEYI
KTAIIIPYTPNEEIEYLIAAVVPENHDFDKEFKLTAAIRKDLALRLPAYMIPRKFTYHSS
IPMTINGKVDRKKMKEEVLA
>PK3-045_00092 hypothetical protein
MTPYSSFLFFIILGILLLPTIILGIKGKNLRFYNVFVSIVVLAIIFSSGNAGFFSLVVFT
ILQVILVKGYIHYRQEKNSSLIFYVISFLSILPLILSKVLPILAVDNWASFLGISYLTFR
AVQIIIETRDGLIKNQLSIFQLVNFMLFYPTISSGPIDRFRRFEKDENKRWTPEEYRELL
YKGINKIFLGFLYKFIIGYCINAYFIMNLTYISDGKLSYHLLYMYSYSLYLFFDFAGYTA
FAVGVSYIMGIRSPENFNKPFMSRNIKDFWNRWHMSLSFWFRDYVFMRFVFLIKKKKWIK
NNMLVSNLGYILLFLLMGVWHGLEIQYIIYGAYHALMMSGFNFFETWNKKHKRWPTGKAM
TVVSIIITFHVVCFGFYLFSGKPFQ
>PK3-045_00093 D-alanyl carrier protein
MNFKEKVLQVIAEVCQDDVVKEELDLDLFDSGLIDSFGTVELLVKFEEQLEINVPITEFD
RDTWNTPNAIVERLNELK
>PK3-045_00094 Protein DltD
MKKKYLFGPIILALVLFAGVVFIPTSWLAKLVPADRLEESAISLEPNMFQGTYLQNEMLK
RSTYVPIYGSSELSRWDPFHPSNYFEVNSAPFTPYLIGKGGMTSIIHDLNFATHAAQLKN
KQMVIIVSPQWFVKHGTDEQHFAPNYSALQAYQLPFNKDVDEQVKRKLMERLMTYSAVKN
DTILYQLYDAYLKDKKTMFNMLSVPAKGYISILKKKDLYFTLLKDKPTNRHQSAKVKDKT
WEELRAQADAYGKKRTQHSQFYIDDKVYKHKNDYMKSMKGKNKGHSYAESLEYDDFQLML
DILKKAEAEPLFVIIPVNGAYYDYTGFPKKGRQDYYNRIKKQISDNGFTYADYSGHEHDP
YFMRDTIHIGWKGWVYLNEDMQKFLE
>PK3-045_00095 ATP-dependent RNA helicase DbpA
MSEKGFHAFNLSNQIVKALDSLEYKNPTEVQNKVIPLVLEKIDLVVKSQTGSGKTASYGI
PICELVEWEENKPQALILTPTRELAVQVKDDFIDIGRLKRIKATAVYGKQPFAIQKTELK
QKTHVVVGTPGRVLDHIERGTLTLEKVNYLVIDEADEMLNMGFIEQVEAIIKALPKKRVT
MLFSATLPEAVKELSQRYMKTPIDIEIKANGLTTDKIDHTLIKVDEKEKFSLLQAVTIVQ
NPDSCIIFCRTKDRVDMLSDQLTDLGYNCDQIHGGMVQEDRLDVMNDFKRGEFRYLIATD
VAARGIDIDNITHVINYDIPLEKESYVHRTGRTGRAGKKGRAITFMTPFEEKFLQEIEEY
IGFKIPIMAVPTEEEIADKRSDFEVKKNIEPAIKKAKNEKLNKHIMKLYFNGGKKKKLRA
VDFVGTIAKIDGVSAEDIGIITIMDTFSYVEILNDKGRIVLEKMKNTPIKGKSLKVYEAK
KD
>PK3-045_00096 hypothetical protein
MEQRQQWGSRYGFIMAAVGSAVGLGNIWRFPAVAYENGGGAFFLPYLFAILTAGIPILIL
EFTIGQKFRGSAPLSLFRLNKKAEWLGWWQLLIAFVICTYYSVIVAWAIKFTIYSFGTQW
GSNPESFFFNDVLKRADTAGTIGGLVPGIVIPVLFVWVVALFVLYRGVSKGIEKLNRIFL
PVLIVMFLIIVIRALTLDGAAQGLNAFFKPNWDMILDGKVWIAAYGQIFFSLSIGFAIMI
TYSSYLPKKSDINNNAFITAFANSGFELLAGIGVFAALGFMANQQGVAVQDVVSSGIGLA
FVVFPSIINEFPSMNGLFGVLFFLSLVFAGLTSMISIVETFIAGVQEKFNVSRTKAVLTS
GIAATVISLLFATNGGLYLLDVVDYFINNFGIVTAGFVEVILIAWFFRGLNGLQSHTNAI
SDLRIGAWWKFCLSVITPIVLGYMMFDNIRQNLRENYGGYPTELILSAGVLVVALSIIIG
VLLSRKKWNAKIALDKNKEVA
>PK3-045_00097 hypothetical protein
MSASAITMMIVGMIILWGGLAASIFNVVRVSKKAK
>PK3-045_00098 putative 3-phenylpropionic acid transporter
MNTQRWMSTRFFSFFMTWGIFLPYWSGWLIYTKGISVSQASFIMSLGLIARGLSTLFAFP
YLSEKFSSKSLLNIMGVGTFVSICGYMLTDSFSGLLLVTVILHLFYPTLMPALDSAASVL
VQNKQLKHYGRSRQWGSIGFVSVGVILTIFTGKFGDEIIFWALLLGIIGFVGLSFMNAPA
ILAKKPQIKPTEKIGLSQLFRIKHFILVLVIVILLQAAHATYYNYGYIFLQDIHAPIYLI
GVIINIAVIAEIVFFSIADKHFSKFSVGTLLAVAAAGSSLRWIFIFAFPNVIVFCLAQTL
HAFSFAMGHYAFMKYLISNISQAQIPKAQGIYSALALSWSTAVFTILGGFLYEIEPRYAF
LGMLACSLPAMIVALIYQRLEQRKQVRISN
>PK3-045_00099 Regulatory protein YeiL
MQIYKEDKKQQFLTRTSIADLFSFQVEEYIEIHEYQRDEWIIKEGMRPDYLFFVMEGKAK
IYVTHQNGKVSLINFINANDYIGEMELLHDVYYTKGIQASTKVICFALPFYYYRTKLLED
AKFLRELTRFLSEKATVMAAKYSQTLAFPLENRLADFILQTADDGIYKEKHVIVCDYLGV
SYRHLLYMLTKFCEKQYLQKDGRNYQIKEYQSLRKLAEALKNK
>PK3-045_00101 putative histidine-binding protein
MRNKLLMMMVLMVSAILLLAGCGTSDKSASGSSDDNTFRVGLEAGYAPFNWTQNNDSNGA
VKIKGSSEYASGYDVEIAKKVAEGLGKELVIVKTEWDGLVPALVSGKIDAIIAGMSPTAE
RKETVDFSDSYYKSNLVMVVKKGSKYEKATSIQDFKGAKVTAQLNTFHYSVIDQIEGVEK
KTAMDNFPAMRVALESGVIDGYVSERPEAVSASTANDKFAMVEFKEGFKTSEEDTSIAVG
LQKDSDLTEKINKILADIPEVERTSLMDNAIKNQPAAE
>PK3-045_00102 L-cystine transport system permease protein YecS
MSLEWIVKIISENWPMFLRGAGLTLIIALIGTIIGAAIGLIAGVIRTIPTPERGIKKFIL
KVINIILSIYIEFFRGTPMIVQAMVIYYGSALAFGIDMNVFAAAIIVVSINTGAYMAEIV
RGGIISVDKGQFEAAHAIGMNHVQTMWNVVLPQVIRNILPATGNQFVINIKDTSVLNVIS
VTELYFVTKSISGNNFKYFESFFVACLIYFVMTFIVTRILLYMERKLEGSDSYTVIGTDA
QPLRAKLK
>PK3-045_00103 Arginine transport ATP-binding protein ArtM
MDNKIIDIKHLNKSYGKHEVLRDIDFSVNKGEVVSIIGSSGSGKSTLLRCINLLEKPSGG
EILYHGENILDEKHDVAVYRKNLGMVFQQFNLFNNHNVLNNCVVGQIKVLKRSKEEAEKV
AMHYLNVVGMDKYINAKPKQLSGGQKQRVAIARALSMNPDVMLFDEPTSALDPEMVGEVL
KVMKELAHSGLTMIVVTHEMEFAKEVSDRVIFMDKGVIVEEGSPEQIFHHPSQERTKEFL
KRTIVQPQVSL
>PK3-045_00104 hypothetical protein
MKQLYMKQKIFSLNEKFTVKDQEEKDVYYVEGSFFKIPKTFSIKDTNNNEIALITKKVFS
LLPKFYIEINGENVLTINKELSFFKARYTIDAAGIEVSGNWWDMDFRVFQNEEEVGRVSK
EWFTWGDSYKVQILKEETEAILIALVVAIDCVKADQAAASSASVD
>PK3-045_00105 hypothetical protein
MSTLPNCPKCESEYTYEDGTFLVCPECAHEWTFNSNIEANDDSKVIKDANGNVLNDGDTV
TVIKDLKVKGSSSVLKQGTKVKSIRLVDGDHDIDCKIAGFGAMKLKSEFVKKI
>PK3-045_00106 Daunorubicin/doxorubicin resistance ATP-binding protein DrrA
MNQVTNNKKIIDSRELAVEAEGLVKVFGDNRAVDGVDLQVRTGSIYGVLGPNGAGKTTTI
RMLATLLKADAGSAKIFGYDIGKEPQQVRQLIGVTGQYASVDESLSATENLIIFSRLLGL
GRIESKRKAMELLEEFGLTEAAKRPLKNFSGGMRRRLDLAASLIAQPPLIFLDEPTTGLD
PRTRNQMWETIRKLVKGGSTVLLTTQYLQEADELADRVAVIDHGKVVAEGTVNELKGSIG
TSSLHLSIQNEQNMQEARLIVERVLNVQSAVSAEGGKITAPMADADKVTDLLMTLKTAGI
PLAELSVQKPTLDEVFLAITGSNANVDKSSKGEGLV
>PK3-045_00107 Daunorubicin/doxorubicin resistance ABC transporter permease protein DrrB
MSSTTLKPTREQKVYRNSTFRQAVRNSLTMAYRGLLKIKRTPEQLSDVTLQPILFTLMFT
YIFGGAISGNVQNYLPVIIPGILVQTVITTSVVTGVQLREDMDKGVFDRFKSLPIARIAP
LAGALLADTIRYTIATTLTFTMGYIMGYRPDGGIGFVILAGILVIVCSWAISWIFAFLGV
ISRTASSVQGISMIVLFPLTFLSNAFVPADTMPNFLQWFVKINPISHLVTAVRDLTNAGT
IGLDFTISLIGAAVIVAIFAPITVRAYMRRA
>PK3-045_00108 Heme response regulator HssR
MAKILVVDDDPHIRELIRVILTKEGFSIVEAEDGEAAMSILEQEKMDLIILDIMMPNMDG
WTLCREVRTYYTEIMPILMLTAKGETSQKVKGFELGADDYLVKPFAPAELVARVKVLLKR
YQINVSNQIKIGNVVINRDTYKISIGDDESTLPLKEFELLFKLATHQKKTFSREQLIEDI
WGYDYEGDERTVDVHIKRLRQRFAQEDCPFKITTVRGLGYRLEVK
>PK3-045_00109 Adaptive-response sensory-kinase SasA
MKFSQWMKRIAGFLAIIIFLMVCCSFSYWLTAWFYEAIQVTPSEFIRQLINCIAGFFLFG
CIIAVISKIPWIRSKQDKHLYPIIQAIKMIAEGNFNIDLSYYKNQFREGDNDHPYYQIVT
NISHMAEKLGEMEEMRQEFISNVSHEIQSPLTSISGFAHALKNDDLSPQERNHYLDIIEM
ESIRLSKLSENLLKLTSLESEHLPLEQKEYRLDRQLRRIILANEPQWTEKEIDMDISLAN
VTIMADEEMLDQVWINLLHNSIKFTPKGGTITVKAFKSENKIITVKIKDTGIGMEQDSLM
HIFERFYKADKSRSRNTGGNGLGLSIVKKIIDLHKGEIQVKSQIGKGTEITVKIGKQKDG
SIEIN
>PK3-045_00110 putative protein YkvR
MAKKVFLNDFALTVSNFKEAKVKSKKSEKLLTVVSFEFKVRGGEEYHVVTKFLYENVFDV
SIPDTSLKFRGEINQYSTSYTNFSDEYSTSDFFLELMEVE
>PK3-045_00111 hypothetical protein
MKLSILDQAPVLSGKSAQEALKESMKLAQLGEKLGYTRYWIAEHHDFPGLASSAPEVMLG
YIGANTEKIKIGAGAILLPHYKPYKVAETFNMLATLFPDRIDLGIGRAPGGSAEASIALS
GNFLENVRNMPNSIKDLLHFLYNNYPTDQMFSKITAHPFPDTPPVPWILGTSEKSAIQAA
SYGTAYAFGHFMSDKDGIEIVNTYRNAFRQSSGLQKPQAIITVSVICAETSELAEELALS
WFLSKIQTDKGEKNNGIPTLEEARNYSFTSDEKERIQEMRKKMMIGNPKEVKQQLAELQS
AYSVDEIMIVTITNSYDRRIKSYELIAKEVW
>PK3-045_00112 hypothetical protein
MKLSVLDQSVISKNGNASMTLANTIKLAKRTEELGYTRFWVAEHHNSNGIAGTSPEILIS
SIAAQTNRIRVGSGGVLLPQYSPFKIAEDFKVLEALYPNRIDLGIGRSPGGSTPTRLALT
DGIRKSLNEFPRQVTALQEFLIGSSPDYEVQAYPSVETQPEMWMLGVSQRGARLAAEKGT
AFTYGHFINPISGSIAMQHYRENFQPSSFLANPQANVCVFVVCAPTQEEAEEMALSQDLW
LLAIEKGQDTFLLSKEEAKNIVLSEEDKAIIRKNRKRAIIGTPGKVKEELLRLSKVYQTE
EMMIITNIYDFEEKMQSYTLLAEALL
>PK3-045_00113 hypothetical protein
MKYTNAMNVLPEKLILEIQKYIQGETLYIPKQENAHKKWGTSSGGRLMLDRRNNAIKAAF
ANGSSIQALAKEYHLSTETIKKIVYSHKNKE
>PK3-045_00114 hypothetical protein
MTEPFIKNEQLNFIKKQISNIKDSMNKSLPKPVLAAVIDLAQAKIFELFPQATSSQQELL
NISKWKTKDEYEQYIERLATYVLPFPKITEQQLKKLFPKQKKLRLPDFATMDLHKLTYLS
WIDGKSNRKYIIYEIDGKLVGMEGKMTPTNKKNICSFCNSFGEVAYFSTITKDKKPKNAD
YYKAIGNLICIDSSECNKNIANTAYLQEFLLTAEGRLY
>PK3-045_00115 HTH-type transcriptional regulator NorG
MAEMEWKPQKDSTVSLHQQITTYLKKKIIHGEWTIGMKLPSQRSLAEQFAVNRSTIVTAL
EELAADGLIETKMGSGTKVINNTWSLLASTPPPDWISYVKSSIHRPNISIIQKINKAEAN
PNIIRLGTGELSPKLLPKARMEEMFHQKGNLSLSLGYTEPKGSLALRQAVSSYLKKKGII
ATSESILIVSGGLQALQLLSLGLLKRGSAIFHETPSYLNSIHVFQSAGMHLLGLPLDEEG
ITCHSIGRLKRQHQAGLLYTIPNYHNPTGIVMSERRRKELIAISQKEAIPIIEDDVYGDL
WLETLPPKPLKALDTQGNVLYIGSMSKTLSPGLRIGWIVGPEPVIEHLADIKMQTDYGSS
SLSQFAVERWLQNGWYEDFLTEVRAELRLRRDFTNDLLKKYFSDIAEWTVPNGGFYIWLK
LKPMISSRKLFEISLKEGILINPGIVYDKADDRHLRISYSYASLEELEKGLITLAQLISR
VAKG
>PK3-045_00116 Arginine exporter protein ArgO
MEPLLHGMVLAFGLILPLGVQNIFIFNQGATHKKFSYVLPAIITASICDSLLIYLAVAGV
SVVVFTFEWVRTMLFTVGFFFLAYMGWSMWKTAAVVGNKQEQKLFSPRRQIAFAASVSLL
NPHAILDTIGVIGTSSLAYTGEEKIMFTAACIGVSWIWFCLLAIGGRKIGQITGRGKLIQ
HINQVSAVIIWAMALYLGLNLIILK
>PK3-045_00117 Methionine import ATP-binding protein MetN
MIQLRNVSKRFADDEVIKSISLAIHKGEIFGIIGASGAGKSTLLRLMNLLEVPETGKVLV
DGRELTSLNYKELRQARQSIGMIFQHFNLVANKTVYDNVLVSLELANYSRKDRRNRVIEC
LRFVGLESFMGKYPAQLSGGQKQRVAIARAIANNPPVLLCDEPTSSLDPKTTGEILHVLE
DVNKRLGVTIVIVSHEMEVIKSICSRVTVLEDGEIYDTVAIEPKGIQQINNTSKRLVEQL
KKDGEIDYA
>PK3-045_00118 D-methionine transport system permease protein MetI
MPEILIQYRLEIWQSIGETFVMVGMSILAAIIIGLPVGTLLFLSRKGKMLENQIIFSTLN
LIVNIIRSFPFLLLVVFLIPFTRIIIGTAMGTAAATVPLSIIAIAHYARLVEQSLLEVPK
GVIEAAISMGASVREVIFKFLYVEARSGLVLGLTTSIISFISYSTIMGVVGGGGIGDFAI
RYGYQQFKTDLMIYMIIIMVILVQAIQFTGTAIAKVIDKR
>PK3-045_00119 Methionine-binding lipoprotein MetQ
MKKILFLMIIGLFLLAACGKEKAETEKKQTNTKEKEEVTLKVASLIPPMTEILDLVKPTL
AEEGINLDVKVLSDNVQPNTALAAGEVDANFFQHVPYMEEFNRSNNAELVPVKAIYFANY
GVYSKQYDSMDDVPEGAVIAIANDVSNIDRSLALLAQHDVIKLKEKTGPYYTKADIIENP
KNYKFEEVDLLMLARMYDDADLVVMTPAYASPLGLTPKSDALLVEGVENDFAITLVARKD
NADWEPIQKLAEAMTSPEVRKFLEEKYDETAIPAF
>PK3-045_00120 putative malate:quinone oxidoreductase 1
MSRRETKTDVILIGAGIMSATLGTLLKELDPNLKITVFEKLASAGEESSNEWNNAGTGHA
ALCELNYTVEKPDGSVDISKAIEINEQFQVSLQFWSHLVNNQVLHNPQDFIRPLPHMSLV
LGEKNVAFLQKRFEAMVSNPLFNGMEFSKDPEKLNEWIPLIMQDRELKEPIAATKIDSGT
DVNFGALTRLLFADLLKKGVEINYKHSVNDLKRTNDGLWEAKVQNLNSGTVERHAAKFVF
IGGGGGSLHLLQKSGIPEGKHMGGFPVSGIFLVCKNQEIVEKHHAKVYGKAKVGAPPMSV
PHLDTRFIDNQKSLLFGPFAGFSPKFLKTGSMFDLITSVKPDNLLTMLAAGAKNMSLTSY
LIQQLMLSKEKRIEELREFIPNAKAEDWDLVVAGQRVQVIKDTEAGGKGTLQFGTEVVSA
ADGSIAALLGASPGASTAVHVMLKVIQKCFTEKMPEWQPKLKEMIPSYGLSLKENPQLLH
DVHTLTAETLQLSEKRPIHH
>PK3-045_00121 Beta-xylosidase
MKIINPVLKGFNPDPSICRVGEDYYIAVSTFEWFPGVQIHHSKDLVNWELVAHPLQRVSQ
LDMKGNPNSGGVWAPCLSYSDGKFWLIYTDVKVVDGAWKDCHNYLVTSETVDGDWGEPIK
LNSSGFDASLFHDVDGKKYLLNMLWDQRIDRHSFGGIVMQEYSTKQKKLINKPQIIFKGT
DIKLTEAPHLYHIGDYYYLLTAEGGTKYEHAATIARSKNIEGPYEVHPHNPLLTSWHNPR
NPLQKCGHASIVHTHTDEWYLAHLTGRPIHPDDDSIIQQRGYCPLGRETAIQKLEWRDGW
PYVVGGKEGSLEVEAPKIPETKFPPTYPVVDEFEQDNLNINFQTLRIPFTEQLGSLSERP
HHLRLFGQESLTSTFTQSFVARRWQSLQFEAETAVAFTPENIQQAAGLVNYYNTENWTAL
QVTYDENLGRILDLTVNDNFSFSQPLKEKIIVPTETEYIYLRVTVENEYYYYSYSFDKEE
WNKLDIVFESKKLSDDYIRGGGFFTGAFVGMQCQDTSGQNIPADFKYFRYQENE
>PK3-045_00122 PTS system oligo-beta-mannoside-specific EIIB component
MKRILLACSSGMSTSLLVSKMKDAAKEKGIEAEIWAVAQDKAQTDMERADVLLIGPQMRF
LKKKLATQAEAVGIPLDVIDPVAYGRIDGLAVLNKALELIENNK
>PK3-045_00123 PTS system oligo-beta-mannoside-specific EIIC component
MNKFMEVLENILLPIAEKLNNNRYLAALRDGFMVALPLIIFGSIFVVIANFPFLDKMISE
DAYAAYQNALGPASAATLSIMGLFVIMGIGYKLTQHYGLEAIYGAVVGVASFLILNPQEL
GEVTGVIPTVILGAQGMFLGIFTAFISAELYRFFVKKNWTIKMPPGVPDSVSRSFSALIP
ITLTLTFFLIIRILFSFTPFETVQNFIYTIIQEPLTALGSSLPATIVVVLLIQLFWFFGL
HGQIIMNSVLDPIWYALNDQNFTAFQAGTELPNVITKQFMDTFLVGMGGTGMTLGVVILI
FLIGKSRQTKELGKLGGPAGIFNVNEPIIFGLPIIMNPLVLIPWLLAPVVVTIITYLTMS
AGIVPKPAGIIVPWTTPIGISGFLATGNDWRGAALQIFNLLVVMVIWWPFLKVLDKNYYE
TEKKG
>PK3-045_00124 PTS system cellobiose-specific EIIA component
METDNKMTEIAFQIILFAGNGRSCAMEAIQEAKEGNFEEADRLLEESSTELGKAHGFQTK
LLQEEASGNGAGVNVILVHSQDHLMTAITVRDLATEIIEIYRNK
>PK3-045_00125 6-phospho-beta-glucosidase GmuD
MTVQYKFPKGFWWGSATSATQIEGAANEAGKGKNIWDHWYEAEPNRFFDNVGPETTSNFY
YQYKEDIQLMKEIGHNSFRLSISWSRLIPNGRGEVNPEAVTFYNNVIDELLANGIEPFVT
LYHFDMPLEMQKIGGWENREVVDAYQAYALQSFQLFGDRVKKWFTFNEPIVPVEGGYLYD
FHYPNIVDFKKAAQVAYHTVLAHAKAVQAFRGWNQDKDTKIGIVLNLTPSYPRSQNPYDL
KAANICDLFFNRSFLDPAVLGEYPEELVEILREHGQLPNSEQGDLELIKENTVDVLGVNY
YQPRRVKAKEHLPNPYSPFMPEWFFDSYEMPGRKMNPYRGWEIYEKGIYDIMMNLKENYG
NVESFISENGMGVQDEERFLKDGQIQDDYRIKFIEGHLQWLYRSIEEGCNVKGYHLWTFM
DNWSWSNAYKNRYGFISVDLKTQTRTPKKSAYWFKNVAANNGF
>PK3-045_00126 putative licABCH operon regulator
MLSSRMKQVLSELLVADTPVTGEYLATVNHVTARTTREDIKNLDAILNNHGAKIISVISK
GYTLEIWDKAVFQQYLHSIFVENSLSHTGIPKTPEDRVTYIIIRFLLNDQYFKLDDLADE
LFVSKSTIQQDIKHVKEILQKYDIILEARPNYGLKAVGDEIKVRFCLSEYVLDRKKQTIS
TIDSPHPSIFNEEKMDNIQEIILRQIKKYQITLSDIAINNLLIHIVIAQKRIVSGHYVAI
FHADMDEIEQQREYHVANEIVKEVEDLYQIKFPQAEIAYIAMHLLGTKLVTQKKGHIDHV
IEDDILQLVHFVLSKIEEKLDLGIEKDEELIFGMSMHLKPAVNRIKYGMNIRNPMLQEIK
NNYPLAYEAGIIAGMAIKEYTGIEMDENEVGYLALHIGAAMERTKLRSGPKRCLVVCASG
LGTAQLIYYRLKSYFGSNLDVVGTTEYYMLDQYNLNEVDFIVSSIPFKESFDIPVIEVNA
ILKESDLKAIEKFILTQSSHQPIESFFRQDLIFLKKIFHSQEEVLTFLHTQLMEKGLVGK
PFLDAVYEREKVAPTAYGNLVAIPHPITPQTEKTFVCVCTLEKPIDWNNNSVQIIFLLCV
KKNSQEDLQEMYDVLGKFIEDHTSVHKILKASMYEEFIRIMKEA
>PK3-045_00127 Dipeptide-binding protein DppE
MKRKNWLLLLMFAFVLSVLAACSGDKTDVSTDSKDKDGKSDEKVLNFINPEAIPSMDPAL
ATDESSFVYLGATMEGLYRLDKDTQPSPGIATDHKVSDDGLTWTFTLRQDAKWSNGDPVT
ANDFVYAWQRAVNPDTKSEYGPYMMNGVIKNAAAISSGELAVDQLGVKADGDYTLVVELE
NPTPYFETLTTFGTFLPLNQKFVEEKGDKFATSSENLLANGPYSITDWDSTGNSWVLANN
NSYWDASTVKMDKLTFEVVKDPQTALSLYEKGTVDRMDLTSDLVDQYSTDENYVVSADTF
LYFLKFNQTKSEALANKNIRLALSRAFDKDALVNEILNNGSIVANGLVPADFTPMPETGE
DFRKVSGDLVTYDLQAAKDYWAKGLKELGTDKVSLEFLADDDATTKTLVEYVANQLSTNL
EGLNIKIKQVPKKQRLDLDTSMDYELQLSRWGPDFLDPFTYLNLWITDGGNNKTGYSNKE
YDQLVGDTATKLATDNVARYDNFLKAEKLLFEDAPIAPVYQASRAQLISPKVKNVFVNPF
GATYEYKWADIGE
>PK3-045_00128 hypothetical protein
MGISDLIPGVSGGTIAVILGIYDRLLDAISGFFSRNWKKQLGFLIPLAVGMGAALLLLSR
LIEFLLENYHEPTQFFFIGLIIGVIPLMLKEARPKKNFGSGHYIILTIAAIIIASMAFMH
PVKSIEPITSLTVWSVLGLFLSGWLASMAMLLPGISGSFILLLLGVYSTAINALSTWNIP
VIIVLGLGAIIGFIGSSKGIKYALSHFPHITYAIIIGLIIGSLFVVFPGMVSGATSIILC
IITFGLGLSVTTLFGLKK
>PK3-045_00129 hypothetical protein
MDYRKATIKDINMLIELRKNQLIDEGVSADKDINDELEDFFQRKLAEGSLIQWLVMEKNE
IIATGAIVIYEFPPTYTNKSGKKAYVTNMYTKNAHRGKGIATTLLTKLVEEAKNLGIKKM
WLGASKLGRPVYKKFGFKETDEWMELELK
>PK3-045_00130 hypothetical protein
MWADLFFIGKSDRELIWPMRYSGMAADEGDIVRNCGISAKVEEESARAERKSAKAERNQP
KRRGNQPKWGRNQPKRRRNQPKRRGNQPKRRGNQPKRRGNQPKRRGISQSGGGISQSGGE
ISQSGEEISQSRGGISQSGEEISQSGGEISQSPKYLPNSITSPLHTLNITKKEPPQKGSS
FSKSINYGSDNQMHLMKQLHQNPWK
>PK3-045_00131 NADH dehydrogenase
MLLDNEIKGQLNQYLQMMEGDVVLKVSTGSDEVSRDMLALVDELATMSSHIKVETAELER
TPSFSVNRVGEDTGITFAGIPLGHEFTSLVLALLQVSGRAPKVDQKVIDQIKAIKGEFHF
ESYISLTCHNCPDVVQALNVMSLINPGITHTMIDGAAFKEEVESKDIMAVPTVFLNGESF
GSGRMSLEEILAKMGSAADASEFADKDPFDVLVVGGGPAGASAAIYAARKGIRTGIVAER
FGGQIMDTLAIENFISVKQTEGPKLAASLEEHVKEYNIDVMNLQRAKRLEKKDLIEIELE
NGAVLKSKSVILSTGARWRNVGVPGEAEFKNKGVAYCPHCDGPLFTGKDVAVIGGGNSGI
EAAIDLAGIVKHVTVLEFMSELKADSVLQERLNSLPNVTVLKNVQTKEITGTDKVNGITY
VERETGEEKHIELAGVFVQIGLVPNTDWLEGSVERNRMGEILVDKHGATSLPGVFAAGDC
TDSAYKQIIISMGSGATASLGAFDYLIRN
>PK3-045_00132 Alkyl hydroperoxide reductase C
MSIIGKEVSPFTAQAFHNGEFIEVTEENLKGKWSIFCFYPADFTFVCPTELEDLQNEYAT
LKDLGVEVYSVSTDTHFTHKAWHDHSDAIGKIEYIMIGDPTQRISRDFDILNEEAGLADR
GTFLIDPDGKIQAVEINADGIGRDASTLVNKIKAAQYVRNNPGEVCPAKWQEGSTTLKPS
LDLVGKI
>PK3-045_00133 Cardiolipin synthase C
MIHKSMKTILVLVGCYLLYIVVFCVIVPFFYKPKENSSWNPAVNLSQNEERVVSSDKVVL
LQDREDSGLARLQLIKNAKKSIDLSTYAIQKGTYSDLFFASLFEAADRGVKVRILLDGMV
NRFNKDLRLYSYAIYQHPNMELKYYEPLHLGKPWTWNNRFHDKLFIIDEELALVGGRNIG
DKYFSSQGAKGASNDRDVLVFTEKPKTSVLKQMDGYYQYVWKHPFTKISVKKLSPRKEKL
GEQKRKKALHLLKHAKDVYPLSIDKMINWKKDAYPTKKVHFLFNPHQRFNKDPLIWKEIV
SLSEQAKSIYLESPYIVPTRKMLAYVDKKKIAVDHWKVLTNSVASTPNLVAFSGYWASRK
DIIQFADELYEYQPKTESLHGKTYIFDGRISLIGSYNLDARSTFLNTETMVLIDSEEFAH
FLQEELNKTVNNQSLQVLEDGTYKSDEKVKETEAGFWKKLTIRALSLVVKLVDFLV
>PK3-045_00134 hypothetical protein
MKLFSILQAEMAKSHKHNFHNKLIYFSLLLWPALLFITSYYSFKPFNLTESSPLSAYMDV
DQITMFLLTGYLGYIFFWSLVQSAWNMSYERQAGTLELIFLTPANRLTIMFARAAGNLLE
AVWLFTTFILLVLIVTGQAAEIYWANVPLALFLLCISAIVWGGFLNIVFLFSRDAGILFT
IFEEPMQFFSGVRIPILAFPIWGKAIAYLFPLTYVLGIFRDLVLNGKDFTQMIGQYLLLV
SIILMLAVTSVFLLKKAETHAKNTGNMVLY
>PK3-045_00135 Vitamin B12 import ATP-binding protein BtuD
MIEAKGISKYYTVKKRKNFFRSEKQVVCAVKDLNISIKEGEIVGLLGLNGAGKTTTIKML
STLLNPTDGQITIDGFDAVKEAMKVKKHINMIAGGERMLYWRLTGSENLRYFGKLYQLSG
LELEKRIAYLLDQVGLKEAKDIPVELYSKGMKQRLQIARGLINNPKYLFLDEPTLGLDAP
VAKQLRGLVKNLAKQENKGILLTSHYLEEVEELCDRIYIIEKGSIILDGTPEKIISSVVK
SYHLRMETSSLSASAQNKLKQALVDCSIQFNWLTDSTVILVDAPYDPTSFLINICMNESV
SILKLELKRPRLEDAILTLAKEKSA
>PK3-045_00136 hypothetical protein
MWLSISATFWRNYLVMKRAFPWSFFLGHILSAIYIIIFAYLTYFFVFKGELSSSFSAYAG
TDDYLSYCILGGLLYSFSVSLLMITSRTLITELREGTLESLLLTPSTRKGYFLGYVAQGL
IRIMLEFLVIIAAGSLFGLHLQGINWLHLLIVLVVLILSTFSMALVLGSFMLYFRDTYIT
QNTLFVLMGLVCSITFPSDFLPAAVRWISQVMPLTYGIDALRMVWIEGTPLNELLAPLLK
MATLGLIYLPTGSYLMKKMEKYVLEKHFG
>PK3-045_00137 hypothetical protein
MDKVNIWIKKHVRVIYSPFRELLTSLHVLHNPAHHLTRLEWAEKTKEAISKPHWKMIQFF
GEISNEWLNFLDLDDYLLLEEKHVEEAIERLRLLPEQQFLAFLLGKSDFTDANTNQQKVL
KKPNYYRNLLCDLLYDYQQNYFARELYRMEPWLIKSVHELKKAIAANPYEAINAIHPRFR
LDPKSIRFYKANTWIFAYEEIETLTIYPSSFIAPHLLVGLEVPAIIVYLHVSFPNQLGTS
QDIVPIDLLSTLAALGDKTRLQLLRQMSRHPICTLQLSESTGLAKATISKHLKILEKACL
IKGERHGHFVFYETDLQKLDQLKVDLNQFFDQPSLGQKEDT
>PK3-045_00138 hypothetical protein
MLYVLYTVRIFESLHSVFNGRNGSLFIFSNHLIIFIWPPTCFLLWEYFKEKVRLNRLSLS
GKLLYKLRKEKFERSFTESKELHGLRYCRLRGLHNASEQVLLTAACQNMKKIATHLAKLG
VNVTILVFYIKMMEGSERNKY
>PK3-045_00139 hypothetical protein
MKSKNTSISFYCFLASIVVFILGNIMGKIYYETGFTLGIGSGWLGYVFLASIFIIPLVGV
IFGFNGEKSRLKYVSIAANLLVCLTVGALSVALIVYDFVPQ
>PK3-045_00142 ADP-ribosylarginine hydrolase Tri1
MLLKSAVYGFIIGDALGVPHEFKIRGTYACETMTNGGVWNQPVGTWSDDTSMLLATLDSI
NHENGINIKDMRNRFLDWMHHAKYTARNETFDIGLTTQQALMDGIGKSDVRSNGNGSLMR
ILPLAFIDCDDKKVKEVSSITHAHDISKKACLIYVDIVRRLIKNENLKDILNNQTHEEPF
TRLNSLHELAESEIKSTGYVVDTLEAALWCVLQSHSYKETVLKAINLGGDTDTIAAIAGG
LAGIIYGYDAIPKEWIDTLHNKELITAILLKQKLE
>PK3-045_00143 hypothetical protein
MFTLSDLDKFAWAFFVVLPIVNLIHAAGHQLFVWIFGLKGDLTIGRGKRLFSIGCMHIHV
LYFVDAACHYKGIEKKKRWQQTLIHGGGILFNLLSILVVNSLIIQEVLPKSSFLYQFVYF
SFYFIFFAVLPFDYGEDSPNDGKSILMIWKQRK
>PK3-045_00144 General stress protein 30
MLNQARKEELNMVKGIAPNVDKEALFNNKRKVFLFGSPSYTNIGDQAIAYAEEKFIKNCF
PYYEYIEIMDYATEEGIELVKKIINKDDIVCFTGGGNLGSLYVDIEEDRRKVVSSFKDYK
TIVFPQSAFFEDTEQGREEKRKSQEAYNQNPNLTLVARENQTLDILKETFQANVIYTPDM
VLSLSIEPRELERDGVLFVLRADKEKVTEESFVSDLMDLFGKTESVERTDTVLSEVDVID
YADREKYFLKTLDKIGSKKLIITDRLHAMIFSIITKTPCLVFGNSYGKAKHSYNDWLHEL
SFIEYTDNKELNDIPAIVERLQKAEPNKIDVKEDFQVLKDFFKG
>PK3-045_00145 Diacetylchitobiose binding protein DasA
MNFKKKFALLGTTALLAVGLMAGCSDSKNDASDSEVLTVWGMGDEVKQLPKMAEEFTKET
GIEVKIQAIPWASAHDKLLTAVASKEGPDVLQMGTTWMPEFQAAGALADMGPFIDKNDHL
KPENFFEGSVETTKFDDKYYGIPWAAETRVLFYRTDILESVGYKEAPKTWEELEDAAKKL
SERGDNMYGLNVDSKEQTLGFMFARQNGSELLSDKEEAQFNQAPFVEAVTFLNDMIQKGY
APKQDLGMDVSQTFSGDAIVPMFISGPWMVKTVNDTVPDIEGKWATAVLPAGKDNNDSSL
GGSNLTIFEHSKKKDQAAQFIDFMVSKENQLKWLELTNAMPTVKEAWKDEKLAGDPLYEV
FGEQMENSHPMPLIPEFEEIAQNYLKHFEKIYLGGADVQAEMDAFNAETEKVLSK
>PK3-045_00146 Lactose transport system permease protein LacF
MRNFTSKRAPYLFISPALLLLMLFSLIPIVVAFFISFTDISLVGLADWSQINFVGLSNYK
EILTDPVFLKSIGNTLFYVVIGVPLVIACSLGIAVMINFGENKIFQFFRLIFYTPSITNV
VAVAVVWSYLYNPSFGFLNYLLSLINVSPVPWLQDPTMAKVSLIILALWRAIGTNMIIFL
AALQGIPKEYYEAASLDGANRRQQLFQITIPMLKFATFFVTITTMIGWLQFFEEPFIMTN
GGPLDSTTSVALFIYRNGFQFSKFGYAAAGSFILFIAIIIVTLIQFRIQRKSDEESL
>PK3-045_00147 L-arabinose transport system permease protein AraQ
MHTSQKQMRTSKWIVGIILTVGGFFMVLPFIWMLLSSLKTDAEIMQFPPTIWPQEITFAN
FKELFLAFNFAVYLKNTLIIVLCSFGGLILNAMAGYGFAKYNFKGKNILFYLVLATMMIP
GQVTMIPVYLILNAMGLTNTMAGIVLPGLVGAFAIFLFRQFMSTISNELLEAARLDGASE
WKIFWKIIMPVSRPVIAVQGILTFIGAWNSFLWPLIMANDEKYYTLSVGLQLLKGQYASN
YALQMAGSTFMIIPIIIVFMIFQKYILQGFNVSGLK
>PK3-045_00148 Beta-xylosidase
MRHEDLVKLVDEMTVEEKVDQLLQLSADFYTKKSEEMTGPLTDLGLTEENIKQAGSTLGL
SGAEEAIRIQKEYMKKHRLGIPTLMMADIIHGFRTIFPIPLGLGSSWSLEAAEKMARISA
LEASVSGLHVTFSPMVDLVRDPRWGRVMESTGEDAHLNGEFAKALVRGYQGEDLKSDTER
LAACVKHFAAYGAPLGGRDYNTVDMSERQLRESYLPSYKAAIDAGAKLVMTSFNTVDGIP
ATGNEWLFRKILRDQFGFDGVVISDWGAVKELIAHGVAGNEKKAAELAIKAGVDIEMMTT
CYAHYLKELVEEEVVDEKLLNEAVLRILELKNDLGLFENPHRGADADREKEVILSQSHRN
ASREIAAKSIVLLENNGVLPLSADQKVAVVGPGADSQDILGAWSWQGKMDEAVSLLEGMQ
EKSANILSAEVPCDYFELSEDMISNALKAASHAEVVVLALGEQEWMSGEAASRSDICLPK
EQIKLFKQLKNTGKPIIVTLYNGRPLDISELDGAAAIVEAWFPGTEGGNALSDILYGDVN
PSGRLSMSFPENVGQVPVYYNGDNTGRPYEENPDEKYVSKYLDVSNYARYPFGYGLSYSE
VVYSNLQLDKETISEIEAVTITVEVENRGVYPVTETVQLYIRDLVGEVVRPVKELKDFKQ
VQLKNGEKQVVTFKISEEQLRYTHRNMQFLSDDGDFEVMVGPNSIELQSKSFELKKIRG
>PK3-045_00149 1,2-beta-oligoglucan phosphorylase
MNTQTVTLNGNNTTFSFLPSGDIYEIRHKDIMVNQLIGNLLDGSANQIYLRVFKKGTILS
TPLLGIQSDSKLAVGERALIWSGTFEGVSYEVKFIVTSHDVWFWEVSLQGNQTVDLLYGQ
DIGIAAKGAVQSNEAYVSQYIDHYIDTQHGYTICSRQNQPQDGKFPYLQQGCLQKTIGFS
TDGYQFFGMSYKETNIPEALQRESLSTEVYQYEMAYAALQTDKRNVQEKQSVVFYGSILE
NHPTAVEKPFFTTQQIEEIWVEANKLEQVTKPVNKMTRIVNQVIKTESLTPEEIDELFGI
QLEKEIVDQKLLSFFTDNQHHVVLKEKEVQMERPHGHILLSGTDLVVDKPVMATTVYMYG
IFNSQIVLGNTSMNKMMSNNRNSLNIMKKSGQRIYMKINNQWQLLAMPSAFEMGFNVAKW
YYKLADDLIIVTNYTSVEDHEIKLSIESKRGKKYDFVISNHILMNDGEDSVPFKWEQSNQ
VITFNGTPSSTVDQGYPELTYHIHVEQPFTLKDETVFVSLKEGSDFPLVMLELLQEHTVN
LTIQGNLHRGNYQHHQKSEGIETESYERYLDGLLNGFQMKHENPLIQEEVERMNLLSRWY
SHNMLVHYLSPHGLEQYGGAAWGTRDVSQGPVEYFFAVNRPEIVREILKKVYANQFENDG
NWPQWFMFDRFEKIKADESHGDVIVWPLKVVGDYLTFTGDTSILAESIPFTNRDTFAKTE
EFYPLMEHVKKQIHYIETNFLPNTFLSCYGDGDWDDTLQPYDSRLKKNMASSWTVALTYQ
TIRNLARALESYDNLYAAYLFDLAKNIKADFNRFILSTDTIPGFVYMEDSDHVELMIHPD
DEKTNIQYRLLPMTRSMIAQLITPEIAEHHYQIIKENLYFPDGVRLMNRPASYKGGVSTN
FKRAEQAANFGREIGLQYVHAHIRFTEAMAKLGKAEETWKGLNTINPIGLKDRVENAAIR
QSNVYFSSSDGDFKTRYEAQENFGKLKNGGVPVKGGWRIYSSGPGIYINQLISNVLGIRQ
TAAEVIIDPVLPQSLNGLTVTFQLLDKPVEIKYTLGSKDKKAIFNGNVLENRLEDNLYRQ
GGICLNKEAMKKVLQQENILEVYC
>PK3-045_00150 putative HTH-type transcriptional repressor ExuR
MVGIKDIAKAAGVSISTVSYALNGSPKVTEATRARITAIANELNYIPNMAARTLKKQETK
IIAVYLADYGGSFYGELLEGIKRGLAYYNYDMIVCSGQKSHLFLPERMVDGGIILDWSFS
TEEIIQFANRGHSLVVLDREISCPNVRKVLLDNKGGATLAVEKIISSNLGKVYLVTGPEE
AFDSRQRLEASERELARYGVEYEVIPSAFTEESGYAAAEIIHSKMTCSPITIFSFNDEMA
VGIYKYFKDKDRKIGTDISLIGFDNIEIGSFLNPSLATISYSKHRWGMVAAEKVVQLINN
EEVEDEWIITSFVEGKSFISNKK
>PK3-045_00151 hypothetical protein
MAVSKVNFRSEVLGKATSMNIYLPDKGNSALIPVIYLLHGWSDDDEAWLTATSLERYASE
YEFAIVMPQVDLSYYADMVNGNRYWTFLSEELPALVRKWFRISDQKEASFVAGLSMGGYG
ATKLALTFPDRFNSFASLSGAMDVVELWKRDRDRDKAFADIFGSIQQLAGSENDLFHLLE
KLKEDSHVKMLQICGTEDFLYQDNLKFREKAQKKIRDYHYIEMPGDHNWAFWDKTIQIVL
KWFDENYKEANN
>PK3-045_00152 Copper homeostasis protein CutC
MIKEVCVENFTLVPSAIQKGADRIELCDNLSVGGTTVSYGVAAKTISYCRNTDTKVMAII
RPRGGNFMYNEHEIDIMCQDIRLFKELGINGAVIGCLDKANWIDEEALEKCLDAAAGMEI
TFHMAFDEIAPQLKWQAIDWLASHGVHRILTHGGPLSTRIENNLPALKSYIEYASEKIII
IPGGGITSANLPLLSSELGMKEAHGTRILGDL
>PK3-045_00153 Histidine--tRNA ligase
MKKMNYQNVKGTLDYLPEEEGIRRAIRRTMEDVFIQYGCMPIETPILNYQSLLASKYAGG
AEILEEMYTLSDRGKRELALRYDLTIPFAKVVAMNPTLKMPFKRYEIGKVFRDGPIKTGR
YREFTQCDVDIVGVQSQVAEAELMMMALDVFKKLKMDVTIQYNNRKLLVGFLRQLNITGQ
MVNRVILILDKIEKISKDKIKEELREVGLEQGAIDAIEAFLQKDLDGIVEQYRQLAEKEE
IIKQGLEEWNELQVYLKRLELEPYCVFNPFLARGLEIYTGTIYEIFLTDKSVKSSIGSGG
RYDNAIGGLVGSEETYATVGISFGLDAILAALSLENHFSEAERLDYYIIPVGRPIEAILT
AKALRDQGFKVELELGKKKLAKALEKANKEGVKKVIMIGEKEVDRNTYKVRDMETGEEWL
EIFQY
>PK3-045_00154 Tyrosine recombinase XerC
MEYVDPIKEIESINAIKVVLRKQSQRDLLLFVLGINTGIRVSDLLALKVRDVRDASGIKE
FLYLRDSDEVKAYYLNSKVHIELEKYLQEHEFEEDEFLFKSQKNNQPITRQQAYRIINKA
AKLVGISGKIGMHTLRKTFGYHAYRKGIAISLLMHVYNHTSRSETLKYIGIEKHEKRLVK
VDVNL
>PK3-045_00155 hypothetical protein
MINGKERMDESILVCVYYGPNGERLIQRGCKLANMLDCPLYILTVDSKPFDELDAEKSNY
ITRWKELAERHSADAFIIKDKESRPISKVIAEVAREKNITQIVLGQTAQSRWEQIAKGSI
INSLLREIPFVDLHIISVARFLKNPEGQYEKGVRAYLVKEQNGYRLIFNHTKQVMYEGIF
FKEHGTDFNNGVFKFMKDQETLQVQVHEDIVNELTNVDIDTNASNDDDYL
>PK3-045_00156 Na(+)/H(+) antiporter subunit A
MTWVHFMILFPFMFALIVPFIYKRLTPRIHTGWFVLFVPFLIFIYLLTYIPKVAKGEVFT
STVKWIPAYGINFITYLDGLSLVFGLLIAGIGSLVILYSIFYLSKHREALHNFYVYLLLF
MGAMLGLVLSDNYYVLYVFWEITSVSSFLLIAYWYERDRSRYGAQKAMLITVFGGLAMLA
GLIMLSIMADTTSIRETLLQLDLIQGHALFIPAMILILLGAFTKSAQFPFSIWLPDAMEA
PTPISAYLHSATMVKAGIYLVARLTPIFGGTMEWFWIVVGIGIFTLLYGSFNAVKQTDLK
ALLAYSTISQLGLIMSLLGLGSAAMYKGVAVEEAELYATAIFAAIFHLVNHSTFKGSLFM
VVGIIDHETGTRDLRRLGGLIHLMPVSFTLTVIGGFSMAGLPPFNGFLSKEMFFTAVVQA
SEMEIFNLQHIGIFIPIIAWIASVLTFVYCMVLIFKTFRGKNKAPKLDKVVHEAPIGLLL
SPIILGALVILFFFIPNVVSKFLLKPAFTAVLPTLAYTVESKKISAFHGFNTELWMTIGV
VVLGTVLYLFLRKWYKIYRLYPQAITLSNLYNLGLEYLEILSKSITNFYMTGFLRDYLVY
IFGFIILIIGGSLFLFNGFTFDMSHDSPITIFDMGIVIAMIVSSVTVLFSKSRITSIVAV
GALGFLVSFFFVLFRAPDLALTQLVVETVTTVLFLLCFYHLPQLKKEISRVPFKVVNAII
SIGVGLVVTLIALSANGTHLFASISSYYENSYKLAGAKNIVNAILVDFRGIDTMLEILVL
TVAGLGVYTLIKVRLVGGDKNEGTK
>PK3-045_00157 Na(+)/H(+) antiporter subunit B
MKEPNDIIIRSVAKVAVVIILTFAINLFVSGHHFPGGGFIGGLTFAAAIILLFLTFDIES
VRKNLPVDFKVLAGVGVLIAVLTGVGGMVFGEAFLTQAFGYFDLPIFGKTELATAVIFDV
GVALAVIGTAITIIMTIGDDR
>PK3-045_00158 Na(+)/H(+) antiporter subunit C
MSILVGILFSIGIYLILTKTLLRIILGTSILGHGVNLLIITMGGLNKGGPPLLGITDHTF
ADSLPQALLLTAIVINFATTALFLVLSYRAYKVLGTDDTDLLRGNEDE
>PK3-045_00159 Na(+)/H(+) antiporter subunit D
MNNIVILPIILPIVFAMIMVIFRDKVILHRILSLVAVISVFIVAYVLIGQIKTDGIQSIQ
LGGWDAPFGVSMVADMFAAILVLVTSIIGFCCLLYAFHSIGEQLEKYYFYPLFLVLITGV
NGSFLTGDIFNLFVCFEVMLVASYVLISLGGTRVQLRESIKYILINIISSFLFLVAIAYL
YAITGTLNFAHLSVRIAEVGQGGLMTTVAILFLIVFSLKAGLFLFFWLPGSYSAPPTAIS
AIFAALLTKVGMYAIIRVFTLIFYHEVHITHLLIGILAAITMTLGAIGAVAYRDIYKVMT
YNVVIGVGFILAGVATYSTVGMTGSIYYFMHDMVIKALIFLLGGTIIHLTGTSKLDEMSG
LIRLHPQLGWMFFVAALSLSGIPPLSGFLGKIFITEGTFNAGYYWLGAFGLISSLFVLYS
IMKVFMAVFWGYTDLTLEQEKGTTKGLMLPMAFLTFLTIALGIGTEGIHEYVDLAVEGLM
DPNYYVKAVLSNN
>PK3-045_00160 Na(+)/H(+) antiporter subunit E
MPMQILINLLIGIIWMFLQDTWNVLTFFTGYLFGILVLFILRRYLSTKFYLETFFAVVKL
FFVFIEQLFTSSVVVIRQITRPRLNISPGIFSLETELEGELEVSLLALLMNLTPGSVVVE
VTSDNKKFFIHAMDIPAQKESIFRSKEKFEKAIKRVTRYD
>PK3-045_00161 Na(+)/H(+) antiporter subunit F1
MIDQLLVGSLILLIISILATIYRLIKGPSAPDRIQALDSLGINLIAGVAIFSVLLRNTGF
FEVILLIGILSFIGTIAFARYMERGVVIERKQSD
>PK3-045_00162 Na(+)/H(+) antiporter subunit G
MSENNLIELISVLLIFCGAIFCFLSSLGLIRLPDVYTRSHAASKGSTMGVLFTLVGTFVF
FIIEGVFSIRLFLGIFFVFLTSPVASHVIVRSAYRSKVKLADITVQDDLNAEMDKEGIET
VEVLHK
>PK3-045_00163 NADPH-dependent 7-cyano-7-deazaguanine reductase
MSGRKNEEGLTDLTLLGNQNTQYKSDYAPEVLESVDNLHSDRDYFVKFNCPEFTSLCPIT
GQPDFATMYISYIPNKKIVESKSLKLYLFSFRNHGDFHEDCVNIIMNDLIKLLDPRYIEV
WGKFTPRGGISIDPWCNYGKPGTKFEEMAAHRLMNHDMYPEKVDNR
>PK3-045_00164 Oxidoreductase YdhF
MRTIKLGSSNLEVPVVAVGCMRINSLEKKEAERFVQTALEHGANFFDHADIYGKGACEEI
FAEAINMSPSVRENIILQSKCGIRTGMFDFSKEHILQSVDGILQRLNTEYLDSLLLHRPD
ALVEPEEVAEAFDILEQTGKVRHFGVSNQNPMQIQLLQKYVKQPIVANQLQLSITNANMI
SNGINVNMENDSAINRDGSILDFCRLHDITIQPWSPFQFGFFEGVFLGNDKFPELNQQID
EIAGKYQVSNTTIAIAWLLRHPANMQPVIGTMNVDRLIDCIKASDVYLTREEWYSIYRAA
GNILP
>PK3-045_00165 Acetyl-coenzyme A synthetase
MKLEAFPPVKGKHNLENYEEQYQHFKWDQAEKDFSWHQTGKINLAYEAIDRHAENYRANK
VALHYFHPSRKETYTFKDLKKFSNKAGNVLKEIGNVNKGDRVFIFMPRSPELYFALLGVI
KLGAIVGPLFEAFMEDAVKDRLYDSEAKVIITTPELVNRIPHTELPALETIFIVGEDIQE
DDKTKDFLHYFQTASTELDIEWVDRKDGLILHYTSGSTGKPKGVLHVHNAMIQHYQTAKW
VLDLQEEDVYWCTADPGWVTGTSYGIFGPWLTGSTNVVAGGRFSPDIWYKTIETFGVTVW
YSAPTSFRMLMAAGEEVTEKYTLSSLRHILSVGEPLNPEVIRWGYDVFGHRIHDTWWMTE
TGAQLICNLPCMDIKLGSMGKPLPGIEAVILDDNGNILPPNQMGNLAIKKGWPSMMHTIW
NNQEKFNSYFQHDEWYVSGDSAYMDEEGYFWFQGRVDDVIMTAGERVGPFEVESKLIEFP
AVAEAGVIGKPDPIRGEIIKAFIALVDGYEQTDELKEQIRLFVKTGLAAHAAPREIEFCE
KLPKTRSGKIMRRVLKAWELGLPTGDLSTMED
>PK3-045_00166 Dipeptide-binding protein DppE
MKRKFTWLLSLTLVLSVFLAACSGDDKGSKGSDKSAENKDLKQELNLINGDAIPSMDPSK
ATDEYGFQFLGATMEGLYRLGKDAKIEKGIAETHEVSKDGLTWTFKLRQDAKWSNGDPVT
ANDFVYAWQRAVNPETGSEYGPYMMGGVIKNATEISKGEKKIEELGVKAEDDYTLVVELA
HPIAYFESLTTFGTFLPLNQKFVEEKGDKFATSSDTLLSNGPFVLENWESASQKWNLAKN
DTYWDADTVKLEKINFVVVKDNQTMVDLYQKGEVDRAGLSSDYVDQFSSDPDYVTQPDNS
VFYFKMNQTRNEVLKNKNLRLAISRAFDKEALVNTILNNGSSVANGLVPADFTPMPDGSG
DFRKVSGDLVTYDVKAAQEYFEKAKKELGKDTIEVELLGDDSESSTTMNEYLANQLQTNL
PGLKVNFKKVPFKQRIALDTAMDYDLQVAGWGPDYLDPYTFLSLWITDGGNNQMGYSNKE
YDKLLADTATTLATDNDARYKNFLEAEKLLFEDGAIAPIFQRGRAFLSSPKIQNMIVNPF
GPTYEWKWTSVGSGK
>PK3-045_00167 Oligopeptide transport system permease protein OppB
MTRYLLRRIWYMFLTLFIIATVSFFLMKFLPGSPLKAEDKLSEEQKAIVLEKYGLDDPIP
VQYVRYLGNLVQGDLGVSFAYDNTPVMDILMSKIGPSALLGAQALVIGTIVGILLGLISS
IFRNGPIDFISTIIAVLGTSIPSFVFAGLLQYYFAVQWDLLPVALWDGYEYTILPTIALA
ITPLAISARFIRTEMIEVLHSQYITTARAKGVAESGIIFKHGLRNALIPLITVIGPMAVN
LMTGSLVIEKIFAIPGIGEQFVSSVTVNDYQTIMGTTLLYAFAFVVIILIIDLLYGLIDP
RIRIAGGKK
>PK3-045_00168 hypothetical protein
MDKNNLKNIDKNLFKPLKQEESISERITAPSRTFGQDARRTLFKNKPAIISIFVILLIIV
LSIFGPYFTGYDSNGQDLSRAKLPPRVPVLEKVSWLGLDGTLSGTYKGVSVEDATNKAYA
RYKSDKEFIDIKVLDEGNGERNSASVKATFHIYEQKKLDDTYFWFGTDTLGRDQWTRLWE
GTRVSLIIAFVAAALDLLIGVAYGGISGFYGGRVDNVLQRIAEVLVGIPNLVIILLMMLI
LKPGIISIVVALTITGWIGMSRVVRGEVMKLTNQEFVLAAKTLGTSNGTIIRKHLIPNIS
GIIIVNTMFSIPGAIFFEAFLSFIGLGIVPPDASLGALIELGFANLRLYPYLLVFPAVVL
SVLMIAFNILGDGLRDAFDPKMHK
>PK3-045_00169 Oligopeptide transport ATP-binding protein OppD
MSKLLEVKDLRVSFNTYNGEVQAVRGVSFDLNKGETLAIVGESGSGKSVTSNAIMRLLPE
PQSVIKTGEILFEGEDLVKKSKKEMQKIRGKDISMVFQDPMSSLNPTMKIGNQIMEGLIK
HQNMNKSDAKKRALELLELVGIPQPEVRINQFPHQFSGGMRQRVVVAIALACNPKILIAD
EPTTALDVTIQAQILELMKDIQKKTDSAIIFITHDLGVVANVADRVAVMYAGKIVEIGTV
DDIFYNPKHPYTWGLIGSMPTLDSDDEELFAIPGSPPNMLKPPVGDAFASRNKYALEIDK
VMEPPMFKVSDTHYAATWLLHEDAPHMEPPESVKQRMLGFSQTGKKDGGKR
>PK3-045_00170 Oligopeptide transport ATP-binding protein OppF
MTREKLLEVKNLQKHFSAGRDRVIKAVDGVSFDIFKGETFGLVGESGCGKSTTGRTIIRL
YDATGGEVKFEGEDVHGKKSKAELRKFNQKMQMIFQDPHSSLNPRMTVLDIIAEGIDNHN
LAKTPEERRQRVEELLEVVGLNKEHATRFPHEFSGGQRQRIGIARALAVEPDFIICDEPI
SALDVSIQAQVVNLLKKLQKERGLTYLFIAHDLSMVKYISDRIGVMYMGNMVELAEADEL
YENPIHPYTKSLLSAIPLPDPRYERERKRIAYDPSVHDTNEPAELREVTPGHYVRCTEKE
LEKYKRELSLKKN
>PK3-045_00171 hypothetical protein
MINPILKPQYDKAIQQTKSHIMNDVNKYLEKQDRLPTFEQYMDDRKVFIEQIWLNTWLNT
ATSHIKYAEKKQYLTNKGLDINDLNKKVINRLFRSEIREVEVFCYEEWLRKNLGDNKEEW
EKRYKERRENYLQTVEEQKNLEAKRKYKMKFSYYIEQLMEKHYEELFLYVRYLTGSNIAL
EIERNGIVLSSMELTFEEYLSNEMNMPYNQFYFLEDRTEAYENLIFQHLIDFFPTWLKDK
LPTRIKEEYEDIFDHSLSNSFLLEVSTPLLEEITEEFLEDLFSEYVIDLEKLLDIPFDVE
IHKEIMEKDRQRKEQKEAEDREEQRRRKEEEARMIEDIFGREYYPPTNIDVKYILHTGET
NTGKTFQAIKRMMEASSGLYLAPLRLLALEIYEKLNQQGIPCSLKTGEEEKLVLEAQHQS
STVEMFHEKDFYEVVVIDEAQMIADRERGFSWYRAITKTNAQEVHIIASLHAKNMILQLL
GDIDVEVHEYRRETPLQVENELFQLSHTRKGDALVCFSRRSVLETASELQRKGWQVSIIY
GSMPPEARKKQMERFIKGETKVIVSTDAIGMGLNLPIRRIVFLENDKFDGIRRRMLTSQE
VKQIAGRAGRKGIYDIGRVAFTSDRKRMKYLLEKRDEDLYGFTIAPTSAVLERFQKYSNN
LGLFFYLWGHFKSPEGTRKASLAEEMQLYEMIMDTMVEARMSLHDLFSFLKLPFATSEAS
LRAQWKANMEAIVENRDLPEPKIKQDSLEELELGYKAIGLHLLFLYRLERRTEAYYWEKV
RQELSDQINDQLKTGFKGKKRTKQCKKCGKELSAKFKFAVCNECFYQT
>PK3-045_00172 Sensor histidine kinase RcsC
MDSKFKFGIRSKIILGYIVIILCLLVSVILLNNQIRSLQQERNSIINYDSRIHELTSSIE
KSVLDMETGQRGYIITGNQSYLIPYNDGKENWKEQFEELYQLMSNKPAQQRNLLEIKENI
LNWINTAGEPTIQYKAQNNTEALEEFFKEDNGRDYINEITEKFTNLRDTEKDASAKQATK
LDKQNNGLTVGLFGVLVLISLVAISLAGQTSKSIVRTIKEVTGSIKTIAASKGNVSTRIH
VRTNDEIRELAEATNSLLDTVEQREWLQSNVADIVMKFQGIPSIESLTSVFITEIALKTN
ASFGAFYVKDAQQKKETYIKMATFAESGDTIGRETFQIGEGLIGQSAKEQRVLHYQEIPS
DYRLIATGLGDVSPRSIIIVPVMFEGEAIAVLELATMTEFTTLQQNLITGIVETFGLTIN
SIMGRMEIVRLLNESRAMTEELQVQSEELQTQSEELQSQSEELQMQKEELMATNEQLEDR
TREAEAKTRDLEKAKEELEEKTELVIQNSNYKSEFLANMSHELRTPLNSILILSEMLAEN
DSNHLSEEEMEFANVIHSSGKDLLSLINDILDLSKVEAGKLDVHFGEVSIHDITSQLERS
FAPIANQKEVEFLVNKQEGLQDIVFTDEKRFQQIIKNLLSNAFKFTENGTVSLNIKKRNQ
ISRSMRELSSEWLEISVTDTGIGIPKDKHKLIFETFQQADGATVRKYGGTGLGLSICREF
ARLLGGWISLKSEEGKGSTFTLIIPSLPNGIADTQLNISEMNVAATMEVKKQEARQEIDK
EEQKQEEERKTEIVISKDENEDVFKGKKVLIVDDDNRNIFALKTTLEKRGMDVLVAYNGK
ECLDILDRTIDLDVILMDIMMPNMNGYETMTIIRQTLNLTEIPIIALTAKAMKNDREKCL
EAGASDYISKPLDLDQLYSVLRVWLA
>PK3-045_00173 Chemotaxis protein methyltransferase
MDHLFLNNDQEVENQDHADIEVDLLLEGIFRLSGFDFRQYNRSSITRRIYYRMKMDNIPT
ITRLLERVIHEEAFLEQLLNDFSINVTEMFRNPSFFRSFRAQIIPYLRKLEEIRIWHAGC
ATGEEVFSMAILLEEEGLKDKAVIYATDMNETVLEKASKGAFPLHKMQAYTKNYMLAGGT
NAFSEYYKTDHQYAYFHSDLLKNIIFAQHNLVTDQSFNEFHVIICRNVLIYFNPMLQNQV
HHLFYESLSKEGFLGLGDKETLSFVEVMPKYRELNGGERLYQKLY
>PK3-045_00174 Protein-glutamate methylesterase/protein-glutamine glutaminase
MTILLVDDNTVNLFVMEKILKNAGYDDCVSLTSANELFHYLQLDAPNSTGNSVDLILLDI
MMPEIDGIEACKRIKKVENLKDIQIIFVTALEDKNKLAEALDIGGVDYITKPLNKIELLA
RIRVALRLKAELDWHTQHEKKIQYELDLATHVQRSLLSSPLQDEHMHIEVSYLPSFNLAG
DMYYWHKIDEDKYAIILLDMMGHGISASLVCMFISSVLRESVKQLVEPDLVIKELNRYMT
LLKNDKEGLPFYFTAIYLVIDTKEKTVKYVNAGHPYGYMLVDENDVVALEQSTCAVGFFD
EMEINTKEISFEKDVQIILYTDGVLEAIGPCEFEAEKQIRSISSKRWEHTSSVMDYLLTK
EQQSNQPDDMCVLMIQAKASN
>PK3-045_00175 hypothetical protein
MKSFSFHTNHRKREKSPETRIKLIPLTGTQSRSEILKKIEISSQFNMRYRGLYEYYGDDL
IAYKKENPTDYFRNEFLRTFSSYLTDYLEDNMPASWHKCKKSFIELLLLIHLPNALKISK
ERNSMQHFISEFKNFSIWLDHKEKTMWTKMLASYEQTFHELKLCEELLNRLYLQMYPRFF
ASDWDYQKDLSRVSQLLEKCTEVEDNFFQINTIDGRDTVYFSNLHTKKQFQVNNFPIEEK
FLGLILHGSIGRLEGHSSWSLLLTAGVYPM
>PK3-045_00176 GMP reductase
MDNVFDYEDIQLIPAKCIVDSRSECDTTVTLGGHTFKLPVVPANMQTIIDEKIAVYLAEN
GYFYIMHRFQPETRKAFIRDMQSRELIASISVGVKTEEYDFILQLAEENLVPEFITIDIA
HGHSNAVIAMIKHIKRHLPKSFVIAGNVGTPEAVRELEHAGADATKVGIGPGKVCITKIK
TGFGTGGWQLAALRWCAKAASKPIIADGGIRTHGDIAKSVRFGATMVMIGSLFAGHEESP
GETIEKDGKLYKEYFGSASEFQKGEKKNVEGKKMYVEHKGHLQDTLTEMEQDLQSSISYA
GGNKLDAIRNVDYVIVKNSIFNGDKVY
>PK3-045_00177 hypothetical protein
MYQPSSFLPPKRSLTVYGNSKLSLEPNICKITLGINTESKNVTTAQQENARLHQQVITAI
LGLGIPSSNIQTIDYTIFPQYDFAENQQVFKNYRVTHLLAILVETIQLAGTVIDTAVQNG
ANQVMSIHFDVSNRSEHYERALQGAIKDALSKARAIAETLRITIDPIPVKVIEIPSGSSI
PMPLAKMSFAEIGGVSTNLEPGQLTIDATVEVKFSY
>PK3-045_00178 hypothetical protein
MNEEQFFQKVITFTASVYQLKHALTNDLRPNDLTPIQYSILEYVSINQPVILSEISNCLQ
ISLPNTSRELKKLTEKNLIRKFTNERDRRKQYMSLSDEGKKVMNHVFVEIENKLKKRIDH
LSAEELEEINTAMALLQGKVFF
>PK3-045_00179 FMN-dependent NADH-azoreductase
MNVLIVFTHPNKESLNGAFLKNVVKGCKENGLIKDIQLLDLYEENFNPILYFDEKNKRRH
MHKNPVFAKYRELLLWADKVVFIYPIWWGRPPAMLLGYFDQVFSAHFAYKNTGKYTAKGL
LKGKSVICISTMKGPRMYPFFLLHNVHKNLMKKAVFQFVGMKKVKFFEFGNMEASGQAKK
LERIYRYFRKMNS
>PK3-045_00180 Catalase HPII
MENKKIDQLKKYTIDNEQNAGLTTNQGLKMAEDEFSLKAGLRGPTLMEDFHFREKMTHFD
HERIPERIVHARGVGAHSVFQLYESLEAYTKADFLNDTNKTTPVFVRFSTVQGSRGSSDT
VRDVRGFAVKFYTDEGNYDLVGNNIPVFFIQDAIKFPDFVHAVKPEPHNEIPQGASAHDT
FWDFIGQNHESAHMVMWAMSDRAIPRSLRMMEGFGVHTFRLINKEGQAHFVKFHWKPKLG
IHSQVWDEAQKAAGKNPDFHRQDLYEAIDKGDYPEWELGLQLIPEEDEFAFDFDILDPTK
IWPEEEVPVKIVGKLTLNRNVDNFFAETEQVAFHPGHVVPGIDFSNDPLLQGRLFSYTDT
QLSRLGGPNFHQIPINQPVCPFHNNQRDGMHQMTIHHGQTSYHKNALNNNQPEPVSVEQG
GYEHYQEKVDGRKVRGRSESFLDFYSQAKLFYNSLAPFEQQHLKDAFSFELGKCKSEAVK
NNAVALLNRIDRSIAEEVAKNIGAALPQENLEVKSAKKSPALSMANTIKKPDTRCVAILL
NGEPDNAQLLQWVQTLAANKVNFSIVDKNLRTIDGELKVTDTYDTADASLFDAALLISTS
TKLETKAIEFIEMTFNHYKPLGISLNNYAVLEKSRITIHEPGIFDLAKNTINDFITGIAE
ARFWNRTI
>PK3-045_00181 FAD-dependent urate hydroxylase
MLLFVFLVNIFFKRIDQNILENLDILSIQNAKEHVNILAWYVDVRNPYINCERGKECKMS
LDDLNKRVQTDLAYLNYGGENWVRPKIHAEGHVFDVVIVGGGQSGLGIAFGLLRERVSNI
LVIDENKEGWEGPWETYARMVTLRTPKHLTSIDLGIPSLTFRSWWEAQFGREGWEKIDKI
PRREWMNYLRWYRNILQLPVQNEVKLTLIEPLEKGIHRLHIKRKGTISSSLLARKIILAT
GIQGGGEWHVPAMISDNLPSSLYTHTSSSIDFSSLKGKKIAILGGGASAFDNANFALSQG
VAQAHVYVRRHKMQRINPIRQMEASGMIEHFPALADDEKYAGMAHFFQHNQPPTNDTFNR
ASSWPGFHLHLGSPWLKVAQKGEQAEVTTPKGRFLFDYLIISTGLLTDPKLRPELRLIEK
HIARWKDRYKAPEAIASPMLDAHPYLSYGFSFISRDTEGEALLHGIYSFNYAALISCGLS
ASALSGMRYGIPRIVKAVTDELFLDDRDMNLKDFFEYDTEEFTGEWPVNQKDPSKVI
>PK3-045_00182 hypothetical protein
MIIVGTFQPSIEIERALSEMEALGVPPEEMMVLYMNEFPPISRKKKASADIHVSSFEIGI
AFATGMAVIGASIGFKLILGPIFSGLLAAIIGFFCGYSLYYLFHRKKKNKLSQSLPEIIV
LIQSTKEVAPLIKEILWKHKALSVGMRKRL
>PK3-045_00183 hypothetical protein
MSATLTFPKAKYSTAGITYLMYQKPSIVAWWSAVFPGFGHYLLNQYARATLLTVLEVIIN
TGANINEAMVYSFCGEIELARSVIHLDWMIGYIVIYLITIGDSYRSAVQLNKYIELSTPD
LASVEIFPFEIQYLQNKSPLLGVFYSLFFPGLGQLYNHRIFLGFYAIFWWWIYILLSHAH
KAIILTITGDFAYSTAILHPHWLLFMPSVLGGAVYHSYITCVQHNILAKESQQKRLTDRY
VGSKFSIRGVKG
>PK3-045_00184 hypothetical protein
MKKILSAILTLGLVLSPVSIVFQDSVTTVEAKSYKSGKRSFNNNNNSNTNSFFQKKNNTN
DTSKSNQSTTAKKSGGFFSGGGLMRGLMVGGLAGLLFGSLFANMGAFGSILGLFINVLAI
VLVFNLIKRIFTFYRNKKREEANNWRN
>PK3-045_00185 hypothetical protein
MEKLIIPEQDIINAICVYVARKKQVRPEEVEVELMYDDDYGFSAEAYVHDRKQVLITQNM
IEALRLWLDEYLNMDPYMGLKLVLDDEEGIIAIAK
>PK3-045_00186 hypothetical protein
MKEFFSKLLNGMSIGIVVSLIPNALLGEILKLFIPFFPPLQHVLDITAFIMSLLPVLIGV
MVGISFKLSSIQTASIGIAAMVGSGVVQKTAEGLFTLNGIGVVLNTGITAALAVLFVRFI
GDRLKAYSILLLPTLCILIPGMAGYLLLPYMKSSTGLIGIAIENVTNLQPILMGIIIAVL
FCLIILSPISTVGVATVISLSGVGSGAANLGIVAAGIGLAIASYKANSLGTALAHVLGSP
KIQMGNFFMKPKIVIPMIITAAVLGGLAGYLNIQGTPYSAGFGLSGLVGPMNFMRLADGG
WTSKNITIMVSTFLIIPFLLNVFLLYIFSKKLKMIKSDDYKLNFD
>PK3-045_00187 Major myo-inositol transporter IolT
MSDQLNPDSRNTNTNKKNNLKIIAIISTFGGLLFGFDTGVINGALPYMARPDQLNLNAVT
EGLVTSSLLFGAAFGAMFSGKLADSYGRRKVILYLAAIFLITTLGCTFAPNVPIMITFRF
LLGIAVGGASVAVPTFLAEMSPAEQRGQMVTQNELMIVSGQLLAYITNAIIGNTMDGAGN
SWRYMLVIATLPAIVLWIGMLVVPESPRWYASKGRFKDAFRVLLHIRKEKRAKAELQQIK
KAVETEAHVEQVGFKDLAVPWVRRIVFLGIGIAIVQQITGVNTIMFYGTQILESTGFSTE
VALIANIANGVISVLATFLGIWLLGRVGRKPMLIIGLIGTTTTLLLIGIFSFTLNGTTIL
PFAVLSMTVTFLAFQQGAISPVTWLMLAEIFPLKLRGLGMGVSVFCLWITNFIIGLVFPI
LLDKIGLSNSFFLFAVLGVFAITFVSKFLPETKGKTLEQLEQYFRNFDKNSRGVQKTTIG
EKQLHS
>PK3-045_00188 hypothetical protein
MKGESAKAKGESAKEEGESAKVRRESAKAKGESAKAERESAKARRKSAKAKGESAKAERK
SAKVGRESAKAKGESAKAERESAKAEGESAKVKGESAKAKGESAKAERESAKAEGNQPKR
RGISQSGEGISQSEGGISQSGEGISQSGGGISQSGGGISQSGEGISQSGGGISQSGGGIS
QSEEEISQSEGRISQSGGGISQSEEGISQSEGRISQSGEGISQSEGGISQSEGRITQSGE
ETAKVRRKSAKAERKSAKVKGESAKTEEEIS
>PK3-045_00189 Rhamnogalacturonan acetylesterase RhgT
MPDKITIFIAGDSTAAEKTPDKRPETGWGEKLSTFFTDQIVIDNRAVNGRSTKSFINEGR
LSAIEEAIHPGDYLFIQFGHNDQKDDPARGTDPYGDYQTNLHTFIHTANKHNAHPVLLTS
VSRRHFRNQLIDHMSLGEYPQAMRELAKTSKVALLDIHKKSIDFFQSLGPDLSRNFFLHL
EAYESSNYPIGVKDDTHFNNQGAEAVAKLICNAIKESDLPLKRILKY
>PK3-045_00190 Acetylxylan esterase
MLKIINDNYNQISKENQHMTLHLSLLDNKKRPFILVCPGGGYHHLSEKEAQPIVKWLHSI
GYHAGILHYPVGTINHASIIKELEEVFSQLRNNAKDWNLLENKIGVLGFSAGGHLASLAC
TKINNRANALVLCYPVITFTEPYGHSGSREHFLGKNPPNHLVEAYSIEHLVDENMPPTFI
WHTADDQSVPVQNTIMLAESLAKFNIPFEYHIFPSGKHGLALAEESPYVHRWLSLAEAWL
KTILS
>PK3-045_00191 Uronate isomerase
MFLNDQFLLKNDIAQKLFHDHAKQMPIIDYHCHLDPKEIYENKNFKNLTEAWLAGDHYKW
RLMRANGIPETHITGDASDYDKFLAWARTVPKTIGNPLYTWTHLELKRFFGIDLLLNEEN
APLIWDLANEKLATADFKRRNIIIHSNVKVVCTTDDPTDDLHYHERLKNEERHFQVLPSF
RPDKALNIDQDGFIEWVEKLSIQSHVTINSYQELIEALKARVDYFHQMGGKLSDHALDIL
TYEEADEKTLESIFQKRFKNEALSPYEISAYRTETLTRLICFYHEHNWTMQLHIHAYRNT
NSAMFDQLGPDTGYDGMNDLPLTIPLQRLLDRAEKEGKLPKTILYSLNPNDFFVLATLMG
SFQKHTPGKLQLGSGWWYNDTRAGMRHQLTVLSDTGLLSTFVGMLTDSRSFLSYTRHEYF
RRVLCEFIGEIVERGEAPEDEDLLGSLVKDISYHNAKQYFGFERSYVENHQ
>PK3-045_00192 Altronate oxidoreductase
MEKLSKQLKPNLSIFPEKVIQFGSGNFMRGFLNWQLQQMNNQHLFNGSAVLVKPTKHVSK
PTLEEQDYLYTVVLEGFYQGQMVQTSEIITTANRLINPYEDWENYLQLAEQEELTFIISN
TTEAGIQFDERDCSIDQPSTSFPGKLTALLFKRFQLKKPGFTIIPCELIDRNGDQLKEIV
LQYASLWNLEEEFISWIHAENIFCCSLVDRIVPGYPRDTANLLNEEHGYIDNLMVKAEPY
LLWVIEGPQELKESFPLERAGLNVLVTDDMTPYRERKVHLLNGPHTAMVPLGLLAGLETV
EDVMKDADFAVFINQLMQQEIIPLLPLPLDDLKAYANSIIERFKNPFIRHELSSIALNSV
SKYKARLLPLLIKYQEKQQQLPPYMTASLAALFLTYRGTQYKPKDSDEVLEAFSNAWENP
ETIAFTILNDKNLWDTDLTSIPNLVEEVTAYIHMLRKDGARAVLQKLNNEKQPPSLLKLN
ERDNVAVALRPINAAETVYLDGISITAKADIPQGHKIALTDIQKSSNVIKYGYPIGHTLT
EITRGDWLHTHNVKTNLDGELEYTYEQDIHQVKYPKKELTFQGYRRANGKVGIRNDLYIV
PTVGCVNGTAEYMLKEFEALHPGLGTFDNITILKHPYGCSQLGEDHENTRSILIDAVSHP
NAGGVLVFGLGCENNVVAEFRELLGDYDGNRVKFLVAQEVGNEIEAGLELLEEIYEAARN
DHREPIPIAELNVGLKCGGSDGFSGITANPLLGAFSDFLISQGGSTILTEVPEMFGAEQM
LMARAENEKVFEDIVHLINDFKHYFHSYGEPVYENPSPGNKAGGITTLEDKSLGCTQKAG
TAPVVDVLQYGEKISKKGLSLLQAPGNDLVASSALAAADCHLVLFTTGRGTPFGSFVPTV
KVATNSTIYEHKKHWMDFNAGPLLERPMNEVLEEFIGKVIAVASGEKTRNEANGVREIAI
FKTGVTL
>PK3-045_00193 putative HTH-type transcriptional repressor ExuR
MVTIKDIAKLAGVSHTTVSRALNDSPLIKPATKDKIKKIATELHYVPNFNAKSLVNQKSY
TIGVFFSSISHGTSSSFLVDVIKGVNSVLDENYSIAVNGIDTLVHFDKIISKRFDGIIVL
SQSDTDNAFIYYIQQTGIPLVVLNRRLDDPSIPNVSANDQQGVEQAIDKAISLGHKELAY
INGKSSFRSSAERKQGFINSLSKHQLPIQPEFMVNGDYSMESGFEKMKQLLDLPTPPSLV
FCANDDMAIGALKACFLKERKVPHDISIIGFDDTAFAQYSTPALTTIHKPIDKISEIGMQ
MLIALMNSDTLEETQILVDTFLVKRESLSYPTKQS
>PK3-045_00194 HTH-type transcriptional regulator YesS
MKKLRLFYKLFFPFFLLGISIVVGFSVFIYNSTYHSVEEEFLKDKQNYTKQILNNVEQKV
RTIEYGYTAYSSTATFETIFKKPLSGKDFDTYRDIKKEISYIEMMGIEGSQHNLISLAEN
WGIIDGSLKKLSEEEIAGYKEKYVEEATQSLFWRPTSIGIEMIMTLPVYQRDKFALGISN
IPRSSIDEIVDNEQDSLVEIYNSKNELLYSSRKKERILSHENYEKMINEGENIKIVDTDG
KKFVYAQSDYNRWIYVVQINPKEISNMINNTRIGLLIVSTLLIILVGIISYMLANSFSRP
IRKLQEKLAIDHLSGQKNELSLVADSVDKIIGQNETLMASLTMQKPQLETLFVLSLFRNR
ITTNEAKHRLKQFGYFFNDRHHFYTGLIQIDNMDSQKIVEKDLYLLALNNIVEEIVPAKE
RLIPIVLNDEMQATIFITDVNDHDSSRRIMKYYEEIQSAAKEYLNITISIGISPVYQTLI
SSKKAVDLAKEALHYRVNVGPESIIFYDDIAPLLNDASISKYPVELQNELLNTIRSGNEE
EVQETVDTLINEIFRMNKNPVSLEVTLIRLINEIIQLGQLLGAEAKIFDSIKPLYYEAIN
AYYPARIKQMLIEHLITPIIISTQDKTDKEFRSLSDKIVQIIQTEYDQEISLDIIADRLH
YNPNYLSSVFKKEYGENFVDYLMGFRLQKAKSLLEETNIPIKEIAEKLQYRNSQNFIRFF
KKKVGMTPGDYRKQYNY
>PK3-045_00195 L-arabinose transport system permease protein AraQ
MEKTHKNRKITKGGKVFSIINGTILIIIALICFLPFVNVIASSFASTQEVVAKRFILIPE
TFSLDAYRYILSTPTLFKSLAVSVGVTGVGTLVSMVLTSLMAYGLSRKYLHGRGFLNFLV
VFSMLFSGGMIPTFLVVKAFGLIDSYWSLILPVAINAFNLIIMRNFFQALPDSLEESAKM
DGCTDLGVFWKIMLPLALPSIATISLFYAVTYWNTYMTAILYINDSTKWPIQVLLRQIVI
VSSGMQAEGSSVDVIPPAQTIKMAVIVIATVPMLIAYPFVQKYFVKGALVGSVKG
>PK3-045_00196 putative multiple-sugar transport system permease YteP
MESIIKPSDQTLPELTMKQRKKIRRQKTWANMRKNKLLYLMIFPGFLYFIIFKYLPMGGL
IIAFQDYQPFLGILGSPWVGMKHFIRLFTEPTFFMLLSNTLILFALNIFIFFPMPIILAL
MLNEVKNKYFKSGIQTLIYIPHFMSWVIIVSITYVFLNVDGGLINEMLAAMGFNKVSFLT
SPDWTRTVYIAQVIWKELGWSTIIYIAAITAVDTQLYEAAEMDGAGRLRKTWHVTLPAIR
PVIITLLILKIGSTLDLGFEHMYLLLNSLNRSVAEIFDTYIYTAGLKNGQLSFSTAVGLF
KGLVGLVLVMLSNKLAKKFGEDGVY
>PK3-045_00197 putative protein YesV
MLKSVEKINHIFITILNLVYVNFLWWLFTLLGLGIFGAGPATYALVSIIRQWMRGNTSVP
IFSSYWKYYKESFKESMVTSWIYLLLGYVLVIDLLHVTNWNLKVCLMIIFSLYFLSAVYI
YPLMAHYNWKGIFFRIKMSFIFGFSCLQYSLLLFVVIGATYWTAITLFPGILTFFGISFL
FYMITWTANQVFTRMELQNTEEVEDTTVYPTLNGQ
>PK3-045_00198 Lipoprotein LipO
MKKLSKLASVSLAGMLLLAGCSGGKEQSSGTYDENSKAEITWLNILHTASPPTDTILDKI
EEKTNAEIKFSWIPDASKEERINTALASDSLADIVTLTILDNSSVRNALKSGMFWNVEDY
LDEFPNLKEISQDVRVSASIEGKLYGIPFQKDLARNGVVLRKDWLDNLGLKVPKTVDELM
EVSKAFTEGDPDGNGKNDTTGFVDRNDLIYGAFKTLSSYFGTPNVWEMDENGDFIPEFET
DGYVKTMDYMKELYSNGWINKDFAVTAKTDQQQSFAQGKAGIYIGALFDAKNLQTMAAGI
QDNMELALVNDMVSDSNPERAIWAANNGIGGLLAFPRSEVKDEAELKRILKFVNDLLDPE
IYTLMTYGLEDVHYKLTDDGAYEITNQDLWTQEVQPFAASRPKESGYDLKDPNPIKALAD
EMIADNANYAVLNPAYSLESATNTSQGSELQKIITDATYQYILGEIDLDGFKQAVKTWGD
SGGNTIKEEYKAAYEQTK
>PK3-045_00199 Unsaturated rhamnogalacturonyl hydrolase YteR
MAEMSWSERTAQSIMERLPRLYEDRGYNGKWSYDYGVVLKGFENLWKRTGKKKYLHFIKE
NLDYFVQPDGTIKGFEVSEFNIDHINNGKLLFQLFKQTGEEKYRQAADLLKSQLELHPRT
SEGVFWHKQIYPYQIWLDGLYMGAPFYAQYQMEYRDGEGLDDILHQFKISYQHLLDEKTG
LLYHAWDEKKVQPWANKETGLSENFWGRAMGWYVMALVDTLEIIPKDTPDRPFLEKILKN
TLAALLNYQDKEKGVWYQVVDKQGEKGNYLEASASSMYVCSIAKGIRLGVLEKQEWLHPL
KKSYQGLLDEFVLLTKEGWVNLNKNCQVAGLGGADKRDGTYTYYISEPIICNDQKGLGAF
LQALVEVEEVINE
>PK3-045_00200 hypothetical protein
MSDYIITEFGAENDGSICTESIQKAIDKAYENGGGRIVIPPGEFLTGALFLKDHIELHLA
AGAVLKFSNQQADYFVVTSRWEGVVREVYASCLYAENSQHIAITGFGTIDGNGEKWWQLF
RNEREKLLYPRPKLISLDGCENISIKDVTLINSPSWTVNPICSNNITIDNIKIHNPQDSP
NTDGIDPESCMNVRISNCHIDVGDDCIAIKAGTEDTAERIACENITITNCTMVHGHGGVV
LGSEMSGNIRNVTISNCVFQDTDRGIRLKSRRGRGGVVEDIRVSNIVMEGVMCPFILNLY
YFCGPKGKDKYVWDKNPYPVTNETPMFRRIHFANITARNVQAAAGFIYGLAEQYISELTF
NQVDISLAVDAIPGKPAMMAGIEDMNNRGFYVGFAKDILFNRVTIENHEGPAFFLENCED
IELINCKSKNTKKEEALLKEVKA
>PK3-045_00201 hypothetical protein
MEKQRKRLIELLGDYPHAKDRKVQLIRREEKDNYVLESLMLQLNEEESVPAYVAKPLNKE
GPLPIVLFNHSHGGNFDQGKEELLISNSYLQSPSFVEAITTLGYAVGSIDMWGFNERKGK
LESELVKEMLLDGRSLWGMRIFDNIAFLDYLVDRPDIDQNRVATIGMSMGGLMSWWMAAL
DERIKVTVDIAAQVHIETLRQKRGLDHHGFYYYVPGFLKQFSTLAVQSLIVPRPRLSLVG
KDDRMCPLEGVMLLDEELGKIYGKYDAKNQWNSQIVTGGHQETKEMRKQWENFLQKHL
>PK3-045_00202 Pectinesterase A
MGKLFAEAFMKNELQFVIGKGNDCDFTSIQEAIMHCSNIERPVTFIILGGDYYENILLYQ
SNRKLFGIGTVRIIGNKYARQLDEFGCEIGTFQTATLFINGENIWIENIEIINNSGPGEI
VGQAVALYNEGNKVSFKNCSIKGYQDTVCLGPLPDVQKDGTPFTTPEIKNNFQNNITTFI
HCSIEGTVDYIFGGGEAKFEECELKSLKRPNNLPGYITAASTATGKNGFLFSRCYLTADK
DVTNVFLGRPWRPYANVTFSQCRIGTHIHSDKWDDWGKNENRETVTFREIENYYR
>PK3-045_00203 hypothetical protein
MKRKWEVIIGMAGMVLCVLFLGGFSLTMTSMDTETYKETVFPILQEGVSFGEMQDSLEAM
NVLAIWFGITLVLVLAFVIVATAFIWRNRHPRWAGVLYLVAGFSTLIGTQFIAFPIAFLF
FLAGTLCLLRKGVNVSQKGEGYVSNHC
>PK3-045_00204 Beta-xylosidase
MYRTTVKNPILRGFNPDPNILRVDDTYYIAVSSFEWLPGVRIYQSNDLVNWEHETDIITN
QVDLRGNPQNGSIWAPQISYSEGLFYLIYTDVKSTKRPFKDCHNYLITAPNINGPWSSPV
YLNSSGFDPSLFHDKDGRKWLLNEIWDYRMITGNKSAGIVMQEYDAKNQALIGSVYKLFD
GTELAKTEAPHLYQYGGYYYLITAEGGTGKGHSVTVCRSKAITGPYELDPEYPMLTASDK
PESSLQCSGHGSIVQTPLGNWYMVYLCTRPLQNKAAILGRETAIEEVYWTEDGWLRLSSG
TNGPSLVTEIVTHEQVIFQNNTDFEDDFAGPLKKEWNTLRILADDSWCDLTSRSNYLRMF
AGESIQSMFEHHILAIRQKDFHFQAETSVAFHPTTFNQMAGLMLYLNDSNYLYAYVTFDE
EKGQVLRFMRCEDGQFQLDPAIITITAGEVQLKVIGNGARGTFYFRSDEEHSWQEITSSQ
DILFLAGGFTGNFIGIAVHDMDKKASTYADFAYFRYEGLDNN
>PK3-045_00205 hypothetical protein
MKKLKLSFLMFLLFTLLIGCSSQNQNTGGSESGDSKTVTFGVTPWTSTIPPTKVAKLLLE
DMDYTVKEKNADAGGVYTGLSRGDLDVFMDAWLPDMHANYMSRYKNQLEDLAVSYKEGEL
GWVIPSNIEGIDSIEDLKGKEDLFGGKVYGIEEGAGMTVTSKEMIEEYGLDLEYVASSEG
GMLAQASKFIKSGDPVLFLGWRPHPMFVDYDLKVLKDPKGFFKTSEVHVVVNNGLKEKSP
EVYEFLSHWSMPVEDIEEMIVKIEDGADEEEVAQEWIDNNKDKVNAMLGK
>PK3-045_00206 Glycine betaine transport system permease protein OpuAB
MNYFFFPLEEWTNQFVDNWLLPVLGDFFDSFSGVLSVFINAVTNLFTFIPAEIIAILLAL
LAWRLAGKGIALFTIIGALYLGSVGLWTGAMQTLSIVIVATFFSIVVGVPLGIFTAKNRT
LDHIIRPLLDFMQTLPSFVYLIPAILLFGLGEVPAVISTFVFATPPAVRMTSLAIKQVPA
DIVEAAKAFGSTSWQLLVKVQLPNAIPTIMAGINQTIMLALSMAVIASMIGSPGLGNTVL
SGISSVNVGLGLTGGLGIVVLAIILDRITQGLGKKA
>PK3-045_00207 Glycine betaine/carnitine transport ATP-binding protein GbuA
MPKIEVKNLTKIFGGNPKEGLKRLKAGEDKTKILKETGMTIGVDNASFQVKQGEFFVIMG
LSGSGKSTLIRLINRLIEPTSGEVLIDGKNITTMNKKELIDIRRKKLSMVFQNFALFPNR
TVQENVEYGLEIQGHPQSDRSKKALKAIHDVGLKGYEASFPNQLSGGMQQRVGLARALAN
DSDILLMDEAFSALDPLIRKEMQDELIRLQNKLGKTIIFITHDLDEALKLGDRIAIMKNG
LIVQLGTAEEILENPANDYVSTFVEDVDRSKVLVAGQIMKQPDLITTWKDGPRMAVRKME
EAGLSSIFVVDKDKQLKGILTIDAAINAYKENKWVEDVLEHDFHSTTYDTPLNDLIGVAA
ESKFPIAVTENNRLLGIIVRVSILSGLILGKEQKEAII
>PK3-045_00208 Ferredoxin--NADP reductase
MEHTELFDVTIIGGGPAGLYSAFYSGLREMKTKIIEFLPQLGGKLHLYPEKMIWDVGGIT
PMPGERLREQLVQQGLTFNPEVVTNTKIHSISKNEEGIFLLETDSGEVHYSKTVIVAVGS
GIVTPQKLKIEGAERFEVANLNYTVKSLMHFRDKVVVLSGGGNSAVDWALELEPIAKKVY
LTCRKDTLAGHEAKARELLESNVECLFHTSITKLIANENHDRIDSVELTNTQSEEVKTLK
VDEVVINHGYEMDSSLLKNSKLKIDMLEDFYIAGNVNSETSVPGIFAAGDILKHEGKVHL
IAGAFQDAANAVNKAKLYIQPEASNSAMVSSHNELFEEKNKELIKNMIQCDDCSVMKIRA
>PK3-045_00209 hypothetical protein
MKKILFSSLFIFSLIAGGCSNGPAESQSKLPTTEKADAAGQANTKTEQTTEKSPSNNEQM
KEIRSMLKMQGNKLPMKFPITDSEYVGAKINKNETDQYSISFYRTQEPVSINDKSLDTND
NLLATFKAETFHDKNNQEELFPETSLDSIPDEMKVDLGHKITGMKEGAAGSSYLLWKEGR
WVVQIKSISADKLDTTDIARKMVDYLEENALPVPQENGRIEVNYPENADKVESMARWEEG
NIVYTLETGEVPINALMMTVSTE
>PK3-045_00210 Leucine-specific-binding protein
MKKKLSLLITASTLVAGMLAGCSAGGKNASKEDEFKVGVNLELSGAVASYGQSLESGIDL
AIKEINADGGIDGKKIVPIKVDNKSDLTEATNGALKLIDQDKVSAIIGAATSGDTVAQVQ
IANDKQTVLLTPSGTAPNVTVNEDGKLNEYAFRTSFIDPFQGNVAANFAINDLKIKNAAI
YADSASDYAKGLAAAFKETFTAAGGKIVSEESYVAKDTDFSATLTRIKGKNPEFVFIPGY
YEEVGLIIKQAREMGITAPFMGADGWDSPKLIDLAGAENLNNTFITNHYSSEDPDEKIQK
FVSAFKDEYGKSPDAFNALGYDSVYLLKDAAERAGSTDSDKIKEELAKTKDLSLITGIVT
IDENHNPIKSATVLEYQDGKQVFKTKVDPK
>PK3-045_00211 High-affinity branched-chain amino acid transport system permease protein LivH
MEWIQQLVNGISLGSIYALIALGYTMVYGIIKLINFAHGDVFMVGAFIGFYAITGWGLSF
FPALIVSMIACAIFGIIIERIAYKRLRNATRIAALITAIGVSLLIEYIFIYFRGAGLETY
PSVLPTKTFDVFGAQITSKSLIILGTSVGLMLILQFIVHKTKTGKAMRAVSHDIDAARLM
GINVDRTISATFAIGSALAGAAGVIFGAYYTKIEPLMGVIPGLKAFVAAVLGGIGIIPGA
MIGGLILGVVETVVSALGFSLWRDAAAFIILILILIFKPSGILGKNTKEKV
>PK3-045_00212 hypothetical protein
MTGRVKNSKAFWIFLILSALIYGVIQFLMTGGWIDTLYSNMIILMAINIMLAVSLHLVIG
ITGQFSIGHAGFLAVGAYVSAIATMKFQMPFPIAILAGGIVAALAGLLVGIPTLRLRGDY
LAIATLGFAEIIRIFFLNIDYVGGAAGMQITHLTTWTSTFICLFITILVIVNFTNSRHGR
AAIAIRENEIAADAMGINTTYYKVAAFALGSLFAGVAGALQAHNFYIINPTNFGFLKSFD
ILIYVVLGGLGSLSGSVIAASFLTIISTYLQDYPETRMIIYSLVLVIVMLYRPKGLMGTK
EITDLFKRKGGNSND
>PK3-045_00213 Lipopolysaccharide export system ATP-binding protein LptB
MTKKEPLLQMKNVGISFGGLKAVSTIDVELSQGELIGLIGPNGAGKTTTFNMLTGVYAPT
EGEILFDGKSLKGLQPFQVTRRGISRTFQNIRLFEELSVLDNVKVAYHSLAKHSMLSSIL
RLPSHFKGEKEMEEKSIEFLKIFQLDRYMEEKAKNLPYGQQRRLEIARALAAGPKLLLLD
EPAAGMNPQETHELMELIAFIRKKFQLTILLIEHDMPLVMGICERIYVLDHGQLIAEGTP
EVIRNHPKVIEAYLGEEVAE
>PK3-045_00214 High-affinity branched-chain amino acid transport ATP-binding protein LivF
MLHIKDLNVYYGNIQALKGVTLDIKEGEIVTLIGANGAGKSTLLKTLSGLIKPKKGSIEY
LGKSIAGKPAQSIVKAGMSHVPEGRRVFSNMTVEENLELGAFLRKDKQEIQKNLQKVYEI
FPRLFERKKQLAGTLSGGEQQMLAMGRAIMAKPKLLLLDEPSMGLAPIIVRTIFQVIQEI
NEEGTTVLLVEQNAHMALSIAHRGYVIETGKVVLSGSAQELQESDELKQAYLGGH
>PK3-045_00215 DNA base-flipping protein
MTPFTKKAVEIIADIPEGKVMTYGQIAAVAGSPRAARQVVRVLHTLSEKYQLPWHRVLNS
KGCIGLSGEHGQLQRRLLEAEGIVFQQNGSINLREYGYEPLNFIDERI
>PK3-045_00216 L-lactate dehydrogenase 1
MKQQNINRVVLIGTGAVGCSYAYSLINQGVTEELVLIDVNKERAEGEAMDLNHGIPFAPA
PTKVWAGDYSDCGEADLIVITAGLPQKPGETRLDLVAKNTAIFKSIVKEITASGFDGIYL
IATNPVDILTYVVWKESGLPKERVIGSGTTLDSARFRYMLGEYFDVDTRNIHAAIIGEHG
DTELPVWSSTTIGLESIETKLAKNDKYSQKDLDELFINVRDAAYHIIERKGATYYGIGMS
LVRITKAILGNENSILPVSAYLDGEYGHKDIYIGVPAIINRQGIREVLELELNEKETEQF
NHSIEILQQTMKSALN
>PK3-045_00218 Aminopyrimidine aminohydrolase
MSFSQELRAQAEPIFQAIMEHPFVQGIAKGDLKKEQLIHYVKQDFEYLNAFMKIYGLAIS
KSTNRQDMELFNNQISFVLHSEIHPHNNFCEVAGVKYEDLQGFPVAPAAHHYIRHMLTVA
HQGGIADIIAVLLPCPWTYVEIGKKLLEEVNPDSTHPFYDWIHFYGDGPMTVTTPLCQRL
DELAETLNEEQKEKLKEYFLLSCQLEYKFWDMAYQVEEWPVKTFEVSI
>PK3-045_00219 Putative HMP/thiamine permease protein YkoE
MNWKVKEVVLLVVIAVACGVLYMGWSTLWLPISALVGPVGANFMFGIWVIASPIVAFILQ
KPGAALIAEVVAASVELLIGSHFGLSALLIGVFQGVGAEIAFAIFRYKKYHVSVLMLSGG
LAACGSMLYSLLANGFSYYTTTTLLLTFVIQVISGLILGGLLAKAIVEGLGKTGVLNGYA
ISKVNRKKESNDEFIVRM
>PK3-045_00220 Putative HMP/thiamine import ATP-binding protein YkoD
MSSLLGCNHLSVRFLEDREPVLQEVTLHINQGEKVLILGPSGSGKSTILSVLAGIIPEHI
EAYVSGEVIRRKGTGVLFQNPDTQFCMQHVDEEIAFSLENRKVPREEMDAIIFELLEKVG
LTIEPHTPIANLSGGMKQRLALACLLALEPEVLFLDEPTAQLDPAGRKEVFEVMKDTAAG
AGQTMIMVEHVLDGCIEWMDRVILFNKKGQIIADGAPAMVVKQYKAEMREAGIWLPQVFP
YKWEDIIQNENHSRRRELIKAYERKRTMALEIKPDPILEVNNLTAAYLKENILENIELTV
NKGEWIAVIGNNGAGKSTFLKLIAHLKKSQKGDICFHGKDLKKWKDRELYQHLGFVFQNP
ELQFITQTVFDEISFSGIQYQWEKAAIHKRTTELLQEFGLEPYKNQHPFTLSFGQKRRLS
VATMLLLDQDILLLDEPTFGQDAKSSHDLLQVLEKRKKEGTSIIMVTHDMDIVDQYADKV
VVLQQKNLVFADQPYSLFSNQELCKRLAIIPPIHYQLIADLKEAEDNQKQRVLSITT
>PK3-045_00221 Putative HMP/thiamine permease protein YkoC
MVILMTIQSAFSTVAIWLYVLILGLTLGGWKGKFLGKVLLPYSIFFVLTFWMLAAFGKGE
TVVWKWAWFQVTEESINSGLLIAMRMLAFVTIGLLFTTTTNLYELMMSLIHQWKLSPKWA
YGMMAGFRCIPMFQSDLAQLKEAHRIRGYKHSGTWKAFLRYAVPLLTQAIRRSEQMAMAM
EVRGFTGEKDRTYFQKTSITLFDYLYFSMMIVIAICIAVFI
>PK3-045_00222 PTS system trehalose-specific EIIBC component
MGKYTEQAKELLEHVGGSGNISVVTHCATRMRFVLNDPSKADIDSIEKIKLVKGTFTQAG
QFQVIIGNEVSSFYNEFIAIAGVSDTSKDEAKKAAKQNMNFLQRMIAHLADIFTPLIPAI
VVGGLILGFRNVIGEIKLVEGGTKKLVEVSQFWAGTNDFLWLIGEAIFHFLPVGITWAVA
RKMGATPILGIVLGITLVSPQLLNAYAVAGAEEIPFWDFGFAQVDMIGYQAQVIPAILAG
LLLSFLELRLRKIIPNAISMIFVPFLALVPTVLIAHTVLGPIGWTIGSAISDVVYSGLTS
SVGWLFAAIFGFAYAPLVITGLHHMTNAIDLQLMSVFDGTNLWPMIALSNIAQGSAVLAM
IYLNRKDEQEKQVSVPAAISCYLGVTEPAMFGINLKYGFPFLAAMIGSMVAAVISVGSGV
MAHSIGVGGLPGFLSIKAEHMPTFLIAMVIAIIIPFILTMVFSKLNMGKVSLKRVRG
>PK3-045_00223 Maltodextrin-binding protein MdxE
MKSYKKLLMSGVALLTAFSLTACGGNDTKESSKGGSSDGKQTLTVSVDGDGYKKYIDSIK
GDFESKNNAEVKVVVMAMTDQADALALDGPAGTGPDVFIAPYDRVGSMGSQGHLAEVTAQ
PEGITETEEKLVTFDGKQYGTPFVIETLVGFYNKDLIKEMPKDFSEVEALTKDSKYAFEA
ESGKNTAFLAKWTDFYFSYGLVAGYGGYAFGSEGTDPTDIGLNNQGTIDAIKYAKTWYDQ
WPKGMQDVTGSGDFITEMFTTGKTAVIIDGPWMAATFKDAGVNYGVGAIPTLPNGEKFAA
FGGGKAWVASSYAKDPELAAKWLEYVGNADNSTKFFEATNEIPANTIARKAVPADNELAQ
AVIANFENASPMPNIQQMAEVWDGGQYLMFDAVSGAKTPEQSAEDTVKNIKESIDQKYK
>PK3-045_00224 hypothetical protein
MSRNETNHKKKASLLSIIPGLGQFYNKQAFKGIVFFALFLVFAIEMALTGFQALEGLITL
GSIPRDDHSLFLMIKGTLQLILTVIFLFFYILNIYDARKIGALRDRGEKINTKTVDILKN
LWEQGFPYIFTFPSYILMAFIIIFPVLVTLFIAFTNYDFQHIPPFKLIDWIGFENFTNIF
FLSSYRATFMKILVWTLIWTFGATTLQIVLGVVAAVVLHQKHVKGKAFFRILFLLPWAVP
AFISIMGFSNMFNDSIGAINAQVIPLINHLPFIDIPAISWKTDATWTKTALIMIQGWLGF
PYIFVMVTGVLQSISDDLYEAANLDGATALQQFRNITLPMILFATAPVMITQYTFNFNNF
SIIYLFNEGGPGSIGWNAGSTDILISWIYKLTTGQAPQYAVAAAVTLIISAIVIAVSLIT
FKKTNAFGNEEMM
>PK3-045_00225 L-arabinose transport system permease protein AraQ
MSMKASRLINRILTYGFLGILSIIIIYPLLVTASSAFQATNMAAFTLKLDANWGLDNFQR
LFSETNYLSWYKNTIIIAVAVMVVQVTLVTLSGYVFSRYRFVGRKYSLIFFLVIQMVPTM
AALTAYYVLATVLGAIDSYWLLSLIYIGGGIPMNVWLMKGYFDTIPREFDESARIDGAGH
LRIFVQINLPLVRPMLAVQALWAFMTPFNDFLLSKFLLRSNELLTLAVGLQTLISNPREQ
KVALFAAGAVLAALPIVVLFFFLQKNFVSGLTSGGSKG
>PK3-045_00226 hypothetical protein
MKKSEPFLMQYFKSIITPTNVFKGKNLLTWPKMIFLFIFLIACMMMPTSIQMAKLTNFPF
EFLFPQTAELITDDFAKSLSSKQVKNGKLVGIDSQYAEETGGKVIAIDKDNKYQMTGEDQ
TIGIKGYANAVVFKEDYAVIAEENGFGFQLYYPMNEEKYPFKIENKEDVLQYIGTLWYVQ
NKAYLLPILLLLLAGVYTAMNVVQFLFMSLVLWLTKKSNITDIRTFKEAATIVLNAAGLP
TILAVIYGFIQFDVATFIMIQGLGTVLMIAFAFFRTGFKEKRLKIDSDKA
>PK3-045_00227 Maltose phosphorylase
MTNKRLFEINSWKLISNKLEKKEKRLQESLTSIGNGYMGMRGNFEEGYSGDFHQGTYIAG
VWFPDKTRVGWWKNGYPQYFGKVINALNFIGVDIYVDGTKVDLYKENIIDFHLELDMKEG
VLRRSFILQKGESQIKFEFERFLSIVAKEVCAIDIKVTTLTGAHKIELVPYLDGDVTNED
SNYEEKFWEETGRKVEANAANLIMKTVDNPFGTPRFAVSASMANTINHLEVTSYNEKPMY
VANAYNNKLKQGDTIHLQKYVAVSTSRDWEEERLGAVSDLLAKQAKEKGYDSLKEEHIAA
WAARWEKADVQIDGDEEAQQGIRFNIFQLFSTYYGDDARLNVGPKGFTGEKYGGATYWDT
EAYIVPMYLAVAEPKVTEQLLRYRRQQLPGAEHNAKQQGLKGALYPMVTFTGVECHNEWE
ITFEEIHRNGAIAHAIFNYTTYTGDETYALNEGLDVLVGISRFWADRVHYSKKNDQYMIH
GVTGPNEYENNVNNNWYTNKIATWTLRYTLELLEKTTSKRKIDLNIGKSELAKWQEIIDK
MYFPVDEELGIFVQHDTFLDKDLRTVDTLLKEERPLNQNWSWDKILRSCFIKQADVLQGM
YFLNHEFSLEEKKRNFDFYEPMTVHESSLSPCVHSILAAEIGLEEKAYEMYQRTARLDLD
NYNNDTEDGLHITSMSGSWLAIVHGFAGMRTAAGTLSFAPFVPKGWNSYTFTINYRNRLI
RVTTTSEEVKLELLSGSSLKMQLYGKDILLEKEFVGKK
>PK3-045_00228 Beta-phosphoglucomutase
MLKGIIFDLDGVITDTAEYHYLAWKKTAEAIGVPFDREFNEELKGVSRMDSLYKILDHGG
IRGQFSEAQVEELAHDKNTYYQELIKEITPHDLLPGIKDFLVECKEAGLQLGLASASKNG
PVILDRLEVTNFFDTIVDPGKLKKGKPDPEIFVKAAEQLQLQVRECVGVEDAEAGIQAIK
GANMFAVGVGTPDRMKLADWQVGSTAEITLERLREKLGE
>PK3-045_00229 hypothetical protein
MLCSFLLAGESAVLGRGDKSSILREMKARKRGRVGKSGVHVSDKSQKK
>PK3-045_00230 Neopullulanase
MLKEAIYHRPGNNFSYIYKDDLVHIRLQTKKAEMESVQLIFGDPYIFVNQAWQYEKAPMK
KSGSTELYDYWFIEIKPEYRRLRYGFELSSEKETLIYTEKGFYEAIPTDDTAYYFCIPFV
HKEDSFHAPDWVRDTVWYQIFPERFANGNPMLNPADTLEWGSTEPTPTNFFGGDFQGVID
HVDHLVDLGVNGVYFTPIFKAYSNHKYDTIDYMEIDPQFGDKQTFQKMVDVLHDHGIRIM
LDAVFNHSGYFFPQWQDVMEKGQESIYKDWFHIREFPIQTAPIPNYDTFAFTPFMPKLNT
SHPEVKEYLLEVGRYWVREFAIDGWRLDVANEVDHPFWRDFRTEVKALKPDVYILGEIWH
DSMPWLQGDQFDAVMNYPFTTGAVNFFAKDSITSTEFKHTITNVLHMYPNSVNEVSFNLL
DSHDTPRILTLANNRKDRVKLLYLFLLSFTGTPCIYYGDEIGMDGPQDPGCRKCMVWEKE
KQDLDLFAHIQKLISLRKNHPAFGNKGSFIFLDSNNNNITMYQKTYKEEHIIFSINNTDQ
EQTFTIPVEYIDNKNVQDLYHDKEIIWDLEKELTLSPGAFSILQFKVKS
>PK3-045_00231 HTH-type transcriptional regulator DegA
MATLSDVAKKANVSKMTVSRVLNHPEQVTDELKQLVYKAMEELNYVPNYAARALVNNRTQ
VIKLLILEEMDTVEPYYMNLLTGMSRELDKNHYSLQLVTRTSLNIGKCDGIIVTGMRESD
YAFIEKLTIPVVLFGENLHGFDFVDVDNKKGTYVTTKHILDQGYKQLIFIGIDEKEPFGQ
LREAGYLDAISENAIEGKIIRVANSSRAAEAKVSEFLSKNDGKFGFVCASDRIATGVIRA
IQKKGKSVPEDYAVTGFDGVFLDRISSPKITTIKQPLMEMGEACARMLLKKINERNKNQG
KHIFEPKLIVRGSTILEE
>PK3-045_00232 3-hexulose-6-phosphate isomerase
MSKLTAIQQEIQDVLSQVDENLLIDTAALIREKRRIFVVGEGRSGLMAKSFAMRLMHLGA
TVYVVGETITPSISSEDILVAISGSGKTKSVIWTAETAHKLGCTVLVLTTDPSSPLVEEA
THTICIPASTKYRQANEMKSIQPLGSLFDQCAHIVFDTICLNFAELNEIGFEEAFKRHSN
ME
>PK3-045_00233 3-hexulose-6-phosphate synthase
MIIQLALDRLTISEAIRIAQLVEADIDWIEVGTSLIKEFGIDSVRQMRKAFPHKKILADT
KTMDNAKYEAEISFAAGADIITVMGTAPKVTIETCMEVAKKKQKKVMIDLLNTSREQMIS
LATIKDAIFCYHISKDEQELNGKSEWETGTAYLTPIAAAGGITIDSIPQLQTNGIDIAII
GSAITKAADPAKAARQFNQEVLSNE
>PK3-045_00234 HTH-type transcriptional regulator KdgR
MAKVTMADVAKYAGVSKSTVSQYINKRYEYMGEDTREKIKSAIEQLGYHPNYIARSLKQK
KTSMIGIIVADIVHRFSTEICRSIEDYCFEHDYQAIICNADNNPKKERTYIETLRAKQVD
GLIIFPTGQNTDIYAKMIEEDYPVVFMDRDIPEINASFILSTNIESSYHAIKLFLENGHK
NIAILTQPLTISTRKERIEGYKKALLENSIDICEDYIISSEIENVKTELHHLFQKKNPPT
AILAGNDLVFLETLAFLQEKKLRIPEDVSLIVFDNFPFAHLSNPPMTMIAQPAFEMGKKA
TEILLKQVNKEHFKVEKIIYPCELIVRPSSIKKI
>PK3-045_00235 Quinolone resistance transporter
MNTLSKKRWIRLIPIVFITYSLAYLDRANYSFGAAGGLAEDLNITAATSSLLGALFFLGY
FFFQIPGAHYAENKSAKKLVFWALILWGFLATATGLISNVNVLFVIRFSLGVVESAVMPA
MLVFLSHWFTKAERSRANTFLILGNPATVLWMSIVSGYILESLGWRWMFILEGLPAVIWA
FLWWKLVNDHPKDAKWLNSDEKAAIHQSLLDEQKELKPVKDYREAFKSKTVILLSLQYAL
WSIGVYGFVMWLPTIINSAPNASIVTTGWLASIPYVLACVLMLAVSYFSDKFQNRKLFVY
PFLLIGAICFYGSYLIGTSNFWLSFILLSIAGGAMYAPYGPFFAIIPEILPRNVSGGAMA
LINSMGALGSFAGAYIVGYLNDLTGGFGASYNFMAISLLLSAILTIIATKKEKKVLGKLA
QQPLHE
>PK3-045_00236 2-dehydro-3-deoxygluconokinase
MHSIDVITFGEAMAMFIADSCGPLHEVQHYTMELAGAETNVAIGLAKLGYKASFVSKVGA
DAFGKFIMENLQKNQVDVEKIMTDAYFPTGFQLKSRVTKGDPEVQYFRKGSAASHLAIAD
LDEDYFQKAKHLHMTGIPLALSLETRDFAQHALSFFKKQCKKVSFDPNLRPKLWNSEKEM
VDTINFFAKQANYVLPGVEEGIKLTGYQTPADIASYYLDAGVELVIIKLGARGAYYKSPT
EEGTIYGYPVAKVIDTVGAGDGFAVGVISGFLEGLPVEESVQRGNAIGALAVQSLGDNTG
YPDKQELRQFINNHSQRSVRI
>PK3-045_00237 hypothetical protein
MSTIYIPLNSFFDEKIATKDLLQAISIIEKSNASGIEIRRELLHEEELLTTLQHIQPILQ
QANLFTVYSAPIPIWNNAGAVNEQALHTILEESEILSAKWVKLPLGHYLENKSDLHDLWK
IIHNYPSLSLLVENDQTREGGKIQPLASFFENASNLRMPIKMTFDIGNWTIQEEDALAAF
QIFQPYIFYFHLKHVFKQGKHFFTEPLPLDPNADWRKMDHLIPAAIPRALEFSLERSMVE
INKFIDIVHSNQRREKLHALN
>PK3-045_00238 putative FMN/FAD exporter YeeO
MSVSTNKIQNQSLFNISWPLFIELALHMGMGVTATLMLSHYSDSAAAGVGVANQLLGIFI
LVFNVTSIAAMILIGQKLGANELNLARRFARSAVGLNFWFGIIIAALVVIFGEHLLQLFD
IRGEVLEYGLIFVRICGASLFLESLSLALSAILRSHGFTKESMIVSVLMNVISVTGYAIS
ILGVFGLPITGVIGVSWTIVIARTFAVLVLLYLVYKRIALTFSIKDFIKVNKQDIRDMLY
IGIPSAGENLSYQFSQLMITAMVASLGDASLAARVYISNISMICYLFTLAIAEGTQLLVA
RYIGGKQFDRALKRGIKTLRLAMVVSLAAALVMALIGQPILELFTDNYEIIAIGLPILWA
VVFTEPGRAMNIVLMSSLKSSGDVRFPVIIGIISMWGIAVTLSYALGITLGLGLLGIWLA
QGIDEWFRGIFAFRRWKTKPWERVKVNRSIA
>PK3-045_00239 Putative niacin/nicotinamide transporter NaiP
MKKEISQRKILGIAGLGWMFDAMDVGMLSFIITALQADWGLSGKEMGWIGSMNSIGMAVG
ALVFGLMADRIGRKHVFMITLLLFSIGSGLSAFTTSLTIFLILRFFIGMGLGGELPVAST
LVSESVPKEKRGRVVVLLESFWAFGWLLAAVISYFVIPKYGWQAALIISVLPAFYAIYLR
LHLPDSPKFLKVEKEKKLTIKESLQAVWSKENRKQTATLWILWFCVVFSYYGMFLWLPSV
MVSQGFSMIKSFEYVLIMTLAQLPGYALAAYLIEKAGRKFVLVLFLIGTAGSAFMFGLAG
STAMLLTAGILLSFFNLGAWGALYAYTPEQYSTKVRGTGAGMAAAIGRVGGILGPLLVPY
LTAQNVSIPSIFTIFCIAVLIGAAVVLFFGKETKNTEII
>PK3-045_00240 hypothetical protein
MMKTKEYFMERMYKASAGMSNAVLVTLGMGLLLESIGKAFGWDVLVQIGGVAKVLLAPAF
GAGIAYQLGGNTLVIFSAMVCSTIGGNALHATDAGMVLVSGQPISAVLAAVVATYVGKRV
NGKTILDMVAIPAAAILVGGIAGVGLAAVTTPMLEWISAQITSSVQGSPLVAPMVISLVW
SILLMTPASSAALAIALQMDPVSSAAALIGCTVQFVGFTAMSLRQNDLGGFLAQSIITPK
VQFPNLVKNPLLIIPPFVAAVICAPIATLGFGFTATYELAGLGLNSLIAPISIMATQGLQ
GFLIYVAVGMVLPIVITLPLYFVILRVGWAKTGDLAMRVQ
>PK3-045_00241 Purine catabolism regulatory protein
MNQSGITVNDLLRLPVLKEAKVISGREGLNRNVQNIDIMEVPDIDGWLRGGELLLTTAYS
IRHDLSLLTKLVEKLAQANAAALAIKPERYLHEMPKEMMEVSNKYNLPIIQLPVGVPYID
ITNAVMEQIVNKHAALLRRSEEIYKKLTTLVLENSGIQTVADNVSQMIEAPIILLDKDGK
KIICSPKEGWMNEFTHIKQWDITVDKERVGKFLIEKEQLDEMDKICVEQARLVFSLELMR
RKTAMDTENHLRGNFIEELLAGIFLPQEEVVNKGRQLGLDPEIMWEIIVMESATLMEEGS
SLLHDLSSIIESINLSHANKIYTQKQGSRLVILSAVPYQPIITKETNQLWMDKLLPLIKK
YTDFQVGFGGRALLWEIHLSYLEARNSLLIGSSLNKGKRMYLYEDIELFKLLLDSSDYVN
MDPVIERKIGKLIQYDKENDSDLVKTLFYYLTFNGSLKDTANQLYIHRNSVKYRMDRIKE
IADIKLDTFQEKVLYYCCIFFHNFKGS
>PK3-045_00242 Glutamate racemase
MIGVIRVFTTENKAVLDHHGKIITELFGLPTVNQCIPDQALGIYDNASEKEAIPKIVELG
KKMEREGARILAISCAADPGIEELRKAVSIPVIGAGSAAALTAFSLGKPVGILGITQDVP
EVMKKILGELLVGFKVPEGVENTTDLLKEEGKAKGLKAAKDLLDQGAKVIVFACTGFSTI
GLADQLRNELKVPVIDAVEAEGQFAAQLY
>PK3-045_00243 hypothetical protein
MKQVEPVKKHPRLFEPVSLIFTIITAVFGAIIGMQIIVSLGVTPNTSIIGALLAMLIARI
PVTIFKRYKSIHRQNLMQTSISAATFGAANSLLIPIGIPFLIGEPDLIVPMLIGAALAMF
ADAAILYKLFDSKLFPASGTWAPGVATAQAIVAGDKGGKRAGLLGIGTLIGVIGSILHIP
MSAFGVAFIGNIWALTMFGIGLLFRQYSIPVFGVDVNALYIPHGIMIGAGIVALVQVTLL
IFGKDKRKQKGKNQEVAAAMENDVDDSNYTTPISVARKTLGIGFIVYIAIALIIALTGGL
ITDMSFGMLIGFLIFAAFAAFVHELIVGIAAMHSGWFPAFAVAFITLLIGMMIGFPPLAL
ALLAGFSAATGPAFADMGYDFKTGHILRGNGADKEYEIDGRKQQYMTSLVAFGVALLTVL
ITYKGYFANNLVPPIDAVYVSTIQAGTSMEVARQLLIWAIPGAILQILGGSSRQLGVMFA
TGLLILTPYAGIAVLVGIAIRLMWVKKKGKEAETPMSILAAGFIAGDALYSFFNSVFKLG
K
>PK3-045_00244 hypothetical protein
MTIKLDEQIVEFAVYGGAILGGGGGGKIEDGLQIGRLALEVGQPILKTAEEMADEDLLVT
VSLVGAPAAKEQYVKPVHYIKAMELLASKLDRPLQGIITNENGAGTTVNGWFQSAMTGLP
VVDLPCNGRAHPTGTMGSLNLTEMPTYISYQAAVGGKGDKYVEMLITGSLDITAKAVRQL
SVDAGGLVAVARNPITVGYAKQNGANGAISQAITVGKALLFNKGESAIEAVVSELGGSVV
TEGTVTACTLETIGGFDVGKVTIEDCYDMTFWNEYMTIEKDGVRFGTFPDLIMTLDTKTA
RPIVTAEMAKGQQVAVITVPKEKLRLSSTMSNQKLIQPIEKIINKEILTYL
>PK3-045_00245 hypothetical protein
MVLKQTLVALETLDNAFVTGEIVADLFKEYPNVQTDVVKVTGEKGSTDFIKITIPGAKGK
SAGGTVPTLGIIGRLGGIGARPSRIGLVSDADGAVAAIASALKLADMQVKGDVLAGDVIV
STHICPDAPTRPHEPVDFMDSPVDILTMNKHEVIPEMDSIISIDTTKGNRVINHKGIALS
PTVKEGYILRVSEDLLRIMEMTTGKFPVTFPVTSQDITPYGNDLYHINSILQPSVATDAP
VIGLAITAQSIVPGCGTGASHETDIADAVRFSIEVAKETANGTCEFYDKDEFNRITTLYG
SMKVLQTMGKAASPQS
>PK3-045_00246 hypothetical protein
MKKLGMITIGQAPRTDVAPIVEKYVNKAELVQVGVLDGMSKDYIETNLYPEEGDYVLTSR
LVTNESVVMSREKIKPILQEKIYYLENMGISQILLLCTGVFPGLQTRKAYLIEPDHIIPP
TINALVGNRRLGVIVPLKEQIKTSLPKYAPLGLKPIFSVASPYNMSRETFKNAAQELKKE
ADIILLDCMGYTENAREMVAEIANKPVILSNAIMAKLVSEMI
>PK3-045_00247 hypothetical protein
MNEKMIETSKNVLANCLGIKEGESFLVVTDEAKREIAESIYEAGKALRAETMFIVMQDRE
KSGQEPPATVAAAMKAADVAVCVTAHSLTHTQARKEAVETGTRLATMPGITKDMFLEGAI
SADYEQVRILTEEITDQLTKGKHVKIEKDGYCLALDITERKGIPSTGMYLYPGESGNLPS
GEAYIAPVEGTATGTIVVDGSVAGIGKLSNPLKLTIKEGRLVEAEGEEGEQLLKILGNGE
GRMLAEFGIGTNDKARITGVVLEDEKVYGTIHVAFGSNATFGGIVSAGVHIDGVVTQPTV
YIDDALLMEKGVLIK
>PK3-045_00248 hypothetical protein
MREYTKRETRIELEGLSKEEHLLNETIEVLTAHESVRAFQSKDIPANILQTIITAARSAP
TSSNLQAYSIIVIKDEERRSRLATLSGEQSFIHEAPVFLVFCADIYRLKYVTESQGYSFL
ANTLEMFLLSSMDATLALQNAVVASESLGLGCVPVGSIRNHPDAVAEELGLPAGVFAVSG
LSIGFEKEGTRRGVKPRLPEKVMVHQEKYTIENLDELLEQYDHTMISRKTYDGRRVSLAG
EPEKQGKDYGWREHTARRCTRPETIAASASLRENLKKVLESRGFSF
>PK3-045_00249 Albonoursin synthase
MDVLEAIKTRRSSRAFAERGGLPLEIVDSIAQSILHSPSGSNAQESHFLIVQNEEQIKRI
KRFSPGLSGDPEAIIVLCSNPAEALHKGGKDSEEVLRFVNLGIAAAYILLSTHSLGIGNC
PVRSFHKEAIKKLLELPHEMEPELLISLGYSKESPRKKKNREKEEVISFDRYGNTQK
>PK3-045_00250 hypothetical protein
MTDMETRKNEKLVELVRDYSGYILTSAKGLYREPAHYGPLRMVGALERTLVLLTELGIED
KEMEEALSFIRKEGWRALSDPLGYEEALDQSIDQLVELTVQNKA
>PK3-045_00251 NADH oxidase
MKVVVIGCTHAGTAAVKTLANVNKNIDITVYEKNNNVSFLSCGIALYVGGVAKDASQLFY
SSPEELKALGATMHMEHEVLEIDTENKQVHVKDLQTGKEKIDPYDKLVMTTGSWPIIPPI
EGINLDNILLSKNYNQANEIIERSKNVRNVTVIGAGYIGVELVEAFALNGKNVTLIDSED
RILNKYLDKEFTDVVEAEFAERNIHLALQQTVTKFAGDERGKVTKVYTTKGEYETDLVIL
CVGFRPNTNLLKGKVDLLPNGAIKINEYMQSSNPDIYAAGDSCAVNYNPTGEKMYIPLAT
NAVRMGTLVGYNIAGRPLKYMGTQGTSGLHIFGLNMASTGLTEVTAKFNNIPYEVAEVID
NDRPEFMPTFHEIRLKVLFHQETREILGAQLISKADVTQMMNTLSVCIQTKMTIDELGFI
DFFFQPHFNKPWNTLNQAGLAAIAKQKELVKH
>PK3-045_00252 Putative 3-methyladenine DNA glycosylase
MIDYINQSTEEIAQLLLGKKLIHKTPAYTYSGYIVETEAYVGIEDMACHSYAGRRTPRLE
SMYKSGGTIYIYTMHTHHMLNIVTKEEGNPQAVLIRAIEPFEGIEEMEKNRKTNGINVCN
GPGKLTKAMEITKALNGVFINEESLWIVDGKVPSQIIESPRIGIPNKEEWTLKPLRYYVK
GHPYVSGMKKGEVLSAADYWHYG
>PK3-045_00253 putative licABCH operon regulator
MLPIRQQKILHQLMQSKSPLSSDYLANALDVTTRTIRSDMKALIDTLKDNGAEIVLTRGK
GYELVIGNYHYFKPFLTKIMNENNVSTPLPTEPEERVDYILKRLLLAEEYLKIEQFAEEL
FVSESSIKNDLKEVRRLLKDFNLNLDKKPNYGLKIMGQEAKLRYCLAAYVFDQDETDWIL
PNKKLEEIRKIIIEQAEKASIFLSDIGVNNLATHIAIACIRIQNDNYVSMPLKEMEPLKE
KREFAIANQIVFFLEKTLYVTFPESEIAYITIHLLGAKMVVYQSDSRENMLEMIEEDILA
LTKAMLQEVEQELDLEIAYDEELIYGLCLHLKPAINRYKYDLTIKNPLLAEIKKNYQMSF
DAAVIMGKYLSKHKRMDINEDEIGYLALHIGAALERKKAKGSVKRCLIVCATGVASAQLL
YHKLQSTFGNKLEIVGTANMFTIDNYDLSTLDFIVSTIPINRELTIPVIDVHTILREEDI
SKLEHMVVDRVETTLQYFYPDLGFFQQEYQTKEEVLAFLAREIIQKGIAPDHFFELIMER
EEIAPTSYGNSIAIPHPLKPITDSTFLSICTLKKPIQWGENKVQLIFLLSVQKKYKKDIQ
KLYQLLVKISGNAYMVNQLLKVKSFDEFKECILAIGQ
>PK3-045_00254 Lichenan permease IIC component
MSFKDKATETLGNVAYKITNQKYIMAIKKAFVTLMPVIITGAFAVLIANMVMGTESGLAH
FKAFAFLADYQPIMKAIQYATLNFLTIGAVFLIGIELGRINGHQSLFPGILALMSYVSVV
PTTLELLVNEKNQLVVDVLARQFSDPKSLFLGMIIAIVSVEIYCKLSKVDKLQIKMPDSV
PSNVATSFSALIPSILTVTIVATFGFLFFKVTGIYLYEAVYNIVQRPLESVMQGLPGILI
LMFVAQFFWVIGIHGNQMVKPIREPLLLASITVNMTAFQEGKEIPNIITMPFWDVYMNIG
GSGVTIGLLIAIFMVSKREEMRSIAKLSAGPGVFNINEPVIFGLPVMLNPVMAIPFIITP
LITGTIGYIATVTGFAAKAVVMVPWTTPPIINAYLSTAGSIGAVITQIICIVVSVLIYLP
FVLIANKAPAVPEEE
>PK3-045_00255 6-phospho-beta-glucosidase GmuD
MEQMKVTIPDHFILGAASSAWQTEGWAGKKDSQDSYMDIWYKNNKNVWHNGYGPGIATDF
YHRYKEDISIMQEIGLTHYRTSINWSRFLVDYENAVVDEEYARYVDNVINELIDKGVEPM
ICLEHYELPAALFEKYGGWNDRHVVDLFVKYAEKVFERYGRKVKHWFTFNEPIVVQTRVY
LDAIRYPFEQNTQKWMQWNYHKALATAKVVALFKEKQLHGTGAKIGVVLNPEVTYARSSA
PHDQDAARIYDLFFNRVFLDPSIKGEYPAELMDLLHKHDILFEHTEEDLTVIRNNTVDYV
GINLYYPHRVKARTTAWNENTPFHPAYYYEMFDMPGKKMNPFRGWEIYPQIMFDMATRLK
EDYGNIEWFVAENGMGVENEFKYKDESEVIQDDYRIEFISEHLKWLLKAVEQGANCKGYM
LWAFTDNVSPMNAFKNRYGLVEINLEENRNRKMKKSAYWYKEIIKSREITVKNDDFIK
>PK3-045_00256 PTS system oligo-beta-mannoside-specific EIIB component
MKRIILACAAGMSTSIVVSKMKAAIKARGEEIDVYAIPEGAIADELATSSEGVMAILLGP
QVRFMKQAAESAAKPFGIPVDVIDTRLYGTANGEKILDHALSLAKN
>PK3-045_00257 PTS system oligo-beta-mannoside-specific EIIA component
MNTLEEMQTAAFQIISFAGEARSCYVEAIQIARNGKMDEAKQKIEEGVQFYNEIHKVHAS
LIQREAAGEQLPFSLILMHAEDQMLTTETLKIMASEMIEMCAMIIEKKS
>PK3-045_00258 hypothetical protein
MLEKINAFLGKWMPLLTPISVLIGVLLSDILHHVSFLVPWIFAVMTFIGSLTSNLKSVKY
TITHPFSLLLTLAILHILTPLWAFWIGHLFFQNDPYTITGLTLAVVIPTGITSVIWVSLY
KGNIALTLAIILLDTLLSPFLVPLSINLFVGETVQLEVWGMMKGLLGMIVLPSIFGMVIN
QFSVEKAKKWNHTLSPFSKIGLALVVSINSSVVAPYLRNIDKKFLQVALTVFVIALSGYF
FAWILGVVTKRSKEETIAMIYSGGMRNISAGAVLAVSFFPPAVAVPVVIGMLFQQILAAL
YGYFIKLVYEKPVIGKIKEGKIS
>PK3-045_00259 Taurine import ATP-binding protein TauB
MYKLEVKDSSKVFRKNGKEFFALKDTNLQIPEGKFVSIIGPSGCGKSTLFNIIAGLIKPS
TGHVLLDGRDIVGKSGHVGYMLQKDLLLPWRNILHNVILGLEVKGVPKKEAIQRALPLLE
RYGLEGFEKHFPEELSGGMRQRAALLRTLLYDQDVILLDEPFGALDAQTRLFMQEWLLQI
WGDFKKTILFITHDIDEAIFLSDEIYILTPRPGTIKEKVSIQLPRPRNEQTLLDSKFIQL
KEYVLQALKSTEEKE
>PK3-045_00260 Riboflavin transport system permease protein RibX
MESQDKTKVLYIEDDEAIAKRRKKFTRIGQWSFGLIFLLAWELLSKWKIIDSYYWSSPFT
IWKTGYVAWTEGTLWSDLLYTSGATIFGFGLGTFFGALLGLSFWWSYYYSRISEPYLIAF
NAVPKLALAPVLVILLGIGFSSKVVLAFMMTIITTALAAYSGVKAVDKDLEKLMYSLGAK
RWHVFTKVVVPTTMPWIVSSLKINIALALAGTIVGEFISSRQGIGRMILYAGQIMNINLV
WVGVAVLSILSIVMYFATVWIERLLLRGRNVE
>PK3-045_00261 hypothetical protein
MCFSFVLILAGCSSKEEKGTKDGLRKIVISEPVHLIGYLPLYVAIEEGYFKEEGLEVEVI
TATGGAHVTSVVSGDAWGVMGGPDSVQMANLGSSDPIQSVVNVVNRANVYLMGNSDETID
STNDEELANYLKGKVIAAGRYGGSPNLLTRWLLMELGLDPEKDVKLEEPADASAVVSLVE
SGNADIANGGEPQITEGMKKGAWKEPFYSFASLGDYPYSVVSVKKSTIEKEPKVVESFVK
AVLKGLKKVDEDPDLAMKVLKAEFPTTSDEILQASLDRAYADELWSKDGYISEEAVAKPM
DVVEKTGVYTEGYKYEELIDMQFVDKLSKKQ
>PK3-045_00263 hypothetical protein
MKRIKLLVIMAMFTAIGTYGSTLVWFPAGIAKAYPVQHALNVIAGAILGPVPAVIIAFAT
SLLRNLLGTGSLLAFPGSMIGALLAGYLFHKTAKPIFAALGEFIGTGVIASLVAVPYASF
FLGTKTGALFYLPSFAVSSFAGSIIGVILVSRLVKIKSIQMLTQN
>PK3-045_00264 HTH-type transcriptional repressor GamR
MEETNKDAALHSIVKESIIDMIKSGEYQPNTKLPTEAEFCNTFGVSRTTIRTALQQLTVE
GYVYRVQGKGTFVAENKIKQSLTSTVEQFSEQITLQGKAPSIKVLQLKVIEATDFLAKQF
NQNIGDPVNCLERMRYVNDAPLQYEISYLPWHKAPGLDSAACEKSLYKMLETKYNIKIRK
TIEHLELVLADDTISKKLEIPAGSPCFLLETFAYAEDETAIEYSKTIFRGDRAHFVIERN
Y
>PK3-045_00265 Lichenan-specific phosphotransferase enzyme IIB component
MNILLCCSAGMSTSLLVSKMEQSARNQGIDCKIWAIAASEVNNEIEKADVILLGPQVRFL
LPQVKKAGDQRGIPVATINPQDYGLCNGEKVLEHATALIKGE
>PK3-045_00266 Lichenan permease IIC component
MMGFIEKYIMPFALKLGNQRHLLAIRDTLIGMIAITIVGSFAVLFNNLGQIIPPYGKMME
AIFGANWSTLGGDIWFGTFAFLSVFAVFGISYKLARSYGDEGFEAMLISAACFFLLLPQT
ASVTLPIDEAATETVAGGVWGLVSVNYFNATALFTAIIVAIIATEIFLRLSKIKALIIKM
PDGVPPAVSKSFAKLVPGMGTIFLVGVFGVIFRMITDGKVLNDWLNTVIVSPLTNAVDSL
PFAVLIVLLVHLFWMVGLHGPNILGGITTPLFEKTGAENIDLAQSGIQALGEYHILAGSF
LDAFVYLGGSGATLGLIIAMIIAGRKRYKQMIGLGGAPGVFQINEPILFGLPIVLNPIWF
IPFVIGPVITTVISYLAVQYGIVPPVTAKIPWVTPPIIGGYLATGGSFWGAGLAALNLVI
STVVYLPFVYAQVKIDSKNKTELTKDSDSVSL
>PK3-045_00267 PTS system cellobiose-specific EIIA component
MNKEELYQLSFQLILHSGNARSFAMEAIQDAKKKDFAEAKKKITESEAELSEAHKIQTKL
LHLEAGGDQFMIPIILIHAQDHLMNAMTLKDLAVEIIDLRQECMQQTTRKGSVE
>PK3-045_00268 putative 6-phospho-beta-glucosidase
MSRGLKIVTIGGGSSYTPELIEGFIKYHNELPVKEIWLVDIEEGKEKLEIVGELARRMVK
KAGVSIDIFLTLDRKKALEGADFVTTQLRVGQLAARALDEKIPLKYGVIGQETNGPGGLF
KAFRTIPVILEIAKEMEELCPNAWLINFTNPAGMVTEAVLRHSRITKVAGLCNVPIGMER
GVADLLAVDPARVRIDFAGLNHMVYGLDVYIDGKSVKEQVIKLITDPKKAITMQNIHAMG
WEPSFLRGLNLFPCPYHNYYYKTGDVLAQELKEAEKGETRAEVVQKLEEGLFELYKDPEL
AIKPPQLEKRGGAYYSDAAVRLICSIYTDKCDIQAVNTANHGAITGIPYESAVEVSCIIT
KDGPKPITVGELPVAVQGLVTQIKSFERVAIEAAISGDYDKALLAMTINPLVPSDRIAKL
ILDEMLEAHKEYLPQFFTEKESIRM
>PK3-045_00269 Chitooligosaccharide deacetylase ChbG
MTKIIINADDFGFSRGVNYGIVDSHLKGIVTSATMMMNATATKHAITLAKETPSLKVGVH
LVLTWGRPLLHDVPTLVDESGNFKKQPFVYGDPESISLDDLEREWTAQIEKCLNAGLAPS
HLDSHHHMHGIKEFYPVIKKLSEKYKLPVRNGGTHFTDIPTLTDVFLDDFYGEGITENYF
EKLGERVKPGTSIEVMTHPAYIDETLMQESSYNMQRIKETRILMEASLKNG
>PK3-045_00270 Proline-responsive transcriptional activator PutR
MTAEPRNPFRRDMYDSLESFVDHVSELLGCPITLEDPHHRVLVYSSHDEETDMVRISTII
SRRVPERVINRLWKDGVIPQLLQSKKPIRIKEKKEIGLGNRVAVSIWRGEEVIGYIWAIE
MGTSLTEEKMGFLENAASVARHLLSRFATSKTPTLQDNQEFFWRMLTGYVKETDIDEKLK
EMGMSAAACFTVMIFPFSKMITKEIEKHILYLLKVSQDVKISFSTIEDNELIILATPLED
NGDSIACYKKFIKSFQKNLEERFSIKEVRGSFGGIYKQHRDIPKSFREARTVLEVREKFP
QEAGAFVHYQELGIYQFLDILLEKRRQDGSENVAIRNLKKYDSTHHTELLATLEAYLDES
ENIQKTAARLHIHPNTLTYRLKRMVEIMEVDLSVPSQKFMIYLDLKLMHWQKE
>PK3-045_00271 Alanine dehydrogenase
MIIGIPKEIKNNENRVAITPSGVSYLKNGGHEILVEQNAGIGSGFTDEEYTAAGAQIIDS
AARVWNTAEMIIKVKEPLASEYQYFRKGLILFTYLHLAAEQELAKALTENGVTGIAYETI
EVNGKLPLLTPMSEVAGRMAVQIGAQFLEKPHGGKGILLAGVPGVKKGNVTIIGGGVVGM
NAAKIAIGLGANVTLLDLNPERLRELDNQFGASLSTVISNPVNIEEAVVNADLVIGAVLI
PGAKAPKLVTEAMVKKMAPGSVIVDVAIDQGGIFETVDHITTHDNPTYVKHGVVHYAVAN
MPGAVPRTSTIALTNVTMPYALQIANLGAVAAIETNYAIKQGVNTFAGKITSAPVAKDLG
YEYKSVQELINNLSTTTV
>PK3-045_00272 Bacitracin transport ATP-binding protein BcrA
MSLNALEVTNLTKRIKGRNIVDNVSFSVEKGEIFGLLGPNGAGKTTIIRMIVNLINRTNG
KVIIDSYNVDDNFSEAMSSLGAIVENPEFYKYMSGYKNLKHYARMAKEPISEERFNEVIK
LVGLENAIHQKVKTYSLGMRQRLGVAQALLHKPALLILDEPTNGLDPQGIREFRDYLHLL
ASEGISVLVSSHLLSEMQLMCHRFAIIEKGKLIHISNMDETVSDEEVSVREVTFELDSPE
KAVELLRNSEYEVAESSVKGRELMAKLPKETIPLVNKLFVENNVAVYGIYVVKATLEDRF
LEITNQKREEETK
>PK3-045_00273 hypothetical protein
MIGLVQNELIKIWEKKNSWIFPIILLFALIGGSFLETKITPQYKGDDWRAKVQAEINELE
QKLPTAETEDTLMKSGKDFDWDDTKESIETKIQDYQNNLKQDVSPYSNTWSNMNGIVIGM
KSLVTLFVVIICAGSVSSEFSDGTIKQLLIRPYKRWAILLSKYIALLIYTAILIAFLMGV
GYLVSIVFFGVGNFEDKVLVFGTVDQIVASGGPFFLKSILYYLPGLLFVLTLSFMLSTLF
KNQAIAVGVGVFILFVSSTIGQLIQSLAEKYAWLKLLVFPHLDQTVFLFKDKIIETITMP
MSLGILFIYYAIIMIITFWFFKKKDVSI
>PK3-045_00274 hypothetical protein
MITKEAVDLAKKIVELDLLRDEIWEHLAEVAGEHAHELLRIVQNS
>PK3-045_00275 HTH-type transcriptional regulator TnrA
MDHEPSYKKRKVITIGVVSELTGLTERQIRYYEQRKLIFPERPERGNRKYSFSDVERLIE
IANKREEGVRTHEIRQEIMKKNKEEEERKVKKQMLRGQINARFGIQND
>PK3-045_00276 Inner membrane protein YjjP
MTYISVEKTYDIMEICILAGSIMLQNGAETHRVEDTMTRIATAYGVTDSDCFVTPTGIIL
SLEGEEPTKTKLNRIIERTTNLEKVARVNDISRKISTGTVSMKEAYHLLKDVEDEKCTYS
DSFQVIAAAIASGCFLIMFNGVWGDFIPALLAGGLGFLCSLYFHKALQIKFFAELSAAFV
IGLVAFFSVSIGFGQEVDKIIIGSVMPLVPGLLITNAVRDLIAGHLVSGISKGAEAFLTA
TAIGSGIAVAFFIF
>PK3-045_00277 hypothetical protein
MNEFLAQAITSFVATFGFGIIFHIPRKLLIQCGFAGTIGWMAYWTIVHFHQNEVIAALSG
SFLVAVISQVFARIYKSPVIIFSVAGIIPLVPGGAAYNAMRNFVENNYYVAVSLAAKVCL
ISGSIAMGLMLSEVINQLIFRASTRKKSLDKG
>PK3-045_00278 putative 6-phospho-beta-glucosidase
MGKGIKIVTIGGGSSYTPELVEGFIKRYDSLPVRELWLVDIPEGQEKLNIVGNLAKRMVK
KAGLPIEIHLTLDRREALKDADFVTTQFRVGLLAARAKDERIPLKYNVIGQETNGPGGLF
KGLRTIPIILDIVKDMEELCPNAWLINFTNPAGMVTEAVLRHSNWKKIVGLCNVPISIQM
GIAKLLEVESSRVHVDFAGLNHMVFGLNVYLDGENITPEFLEKMSKHKSDTMRNIAAIDW
EPDFIKALGVIPCGYHRYYYKQSEMLQNELEEAAEQGTRAEVVQQLEKELFELYKDENLD
IKPPQLEKRGGAYYSDAACSLIDSMYNDRRDIQPVNTINNGAIASIPDESAVEISSIITK
DGPKPIAIGDLPVAVRGLVQQIKSFERVAAEAAVTGNYHTALLAMTINPLLPSDKVAKQI
LDEMLEAHKEHLPQFFKEEVVSS
>PK3-045_00279 Thioredoxin reductase
MAEVLDCIIIGGGIAGLQAAIQLGRYNHDVLIIDAEDGRSTICKSYHNILGYPDGISGSE
LRSLGRKQAENLGVEFLKSTVTSLKKEEGHFTAATAKGLFQSRKILLATGVMDNIPPFTE
LYPCLGISVYLCPDCDGYEVKDKKTIVIGNGSVGANMALTLLYWTSDITYINHGGEAICE
KLGRQLSDSGISVFTERIDRVLADDSQIKGYVLGNGKMLETSHSFIAFGGNKVKSDLAVP
LGVEIMENNHIIVNARTKMTNIDGVWAAGDVVAHSEQVTIAMGEGSQAAIWIHKALLKDS
>PK3-045_00280 2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial
MKPTYQDALAYFGVSGAHPGGLTLTKFLLEQEKITSHTTLLDGGCGTGQTSAYIKKNYPC
AVTSIDYHPTMVKRAKERFKKEKLSIQLVQGSLEKMPFPSNSFDIILIESVLIFTNCKNS
LAEIKRVLKPGGILLLLEMTAERSLHAIEQQNMCEVYGIEKVYTEKEWIYLMTEAGFPKV
EIKLGHSVFSHMMTGMEKEDEAIDRTVPTNVQLEGKLMDHSYILYTYGDIIGYRVYRASL
>PK3-045_00281 Cys-tRNA(Pro)/Cys-tRNA(Cys) deacylase YbaK
MYIAMAITKTNAMRILDAEKIPYSVHTYENKDGKIDGISVAGKIGKETEMVYKTLVVKDT
GNGIYVFVIPVEAELDLKKAAKVVNAKKLEMIAVKDIQKTTGYIRGGCSPIGMKKKYETI
LDESVNKQSSIIVSGGKIGVQIEMEVNNLIQVTEARVEDVIH
>PK3-045_00282 putative ABC transporter ATP-binding/permease protein
MNENKWISPFLKANSGRIVLILLLSVLALLTAAMLTFTSGYLISKSAIPVENILMVYVPI
VGVRTFGISRAVLSYLEKLAGHHTVLRILSKMRIKLYQILEPQALFLKSRFKVGDMLGIL
SDDIEKLQNIYLRTIFPTFATSVLYILVVCAIGILDIPFAILMAIYLGLLLFVFPILSLV
LMRENQREFKQKRNGLYQKLTDSILGISDWVISGRSKSFIEEYEKEEAIVAQINYKLVQF
TRWRNFASQAVAALIILSLVFWSSKQYIDGAIPVTLIAAIILVALPILDAFLVVSDAFEK
LPAYQDSLARLNKLNVPEQKNERVRPILDTDIVNIQVDQISYQYEKEQTLSLSNVSLDIP
QGKKIAIIGRSGAGKSTLLKLIQGVIQPTTGRVTYNGETSASFHAETSSIISVLNQTPHL
FATTLRNNILLGVEEASDEELIKAIKAAQLEELISSLPNGLDTFMEETGQRFSGGERQRV
ALARILLQKTPIVIMDEPNASLDPKTEKALLKTIFTTLEGKTIIWITHHLVGVEEMDEII
FMDQGEIVLRGSHQELLATSSRYQQLYALDHPE
>PK3-045_00283 ATP-binding/permease protein CydD
MDKNLLKLTGIKPILATIGILTIVEGAAIILQAKWLAEIIASLYNGEAYQEQYVKIILFL
LAFLGRHFLHTIQQNIATAFAEKTSKELRLQLMQKLFELGPKFTKKQGSGNIATLVLEGI
SQYKTYLELFLPRMLATGIVPGMIILYVYWNDWLSGVILTVTTPILIGFLILVGMAASSQ
MNRQLATYKILSNHFLDSLRGLETLKFLGRSKQHSGNIEKVSEQYRGATMKTLRLAFLSS
FSLDFFTSLSVAVVAVNLGLRLINGDLVLLPALMILILAPEFFLPVRMVGADYHATLDGK
EAGDAIQTIIQTQKSTKMTGQSISLGNNPFLTFDHVTFQHHPKEKATLKNLSFTIDGYKK
IGVVGESGAGKSTLIDLLSGFSQHCAGSISVNGVSLPSLMTEEWRQLTTYIPQAPYIFSM
TLRENIAFYHPDATDEEIIQALKATGLYDIYTTFPNGLDEILGDGGRNLSGGQEQRIALA
RAFLTNRKIMLLDEPTSHLDIETEFELKEMMLPLFNEKLVFLATHRLHWMKEMDSIIVMD
QGTIVETGTHEELVAAKGFYYKLLQQ
>PK3-045_00284 Cytochrome bd-I ubiquinol oxidase subunit 2
MLELNVLWFILVAVLFIGFFFLEGFDFGVGMSTKLLARNDMEKRILINSIGPYWDANEVW
LITAGGAMFAAFPHWYATMFSGFYTPLVVVLLALIVRATGFEFRAKDSHPAWKKAWDLCI
FLGSFLPPLLFGVVFACFMQGLPIDKNMELKAGFFDVVNYYTLTGGLTVLVLCLVHGLVF
TTLRTVGDLRERARNLAQKLLPLLGILLTLFSALTYIQTDIFQERGLILSFIFSLGVIAF
VVGGFFISRKMDGWAFGMTGAVITLSFASIFIGLFPRVMVSSISDAFSLTIHNAASGHYS
LKVMTIVALTLLPFVLGYQIWSYIVFRKRITEKSHLEY
>PK3-045_00285 Cytochrome bd ubiquinol oxidase subunit 1
MDMIFLSRLQFASTTIFHFLFVPISIGLVFIIAIMESFYVKTGNEEYKKMAKFWGKLFLI
NFVIGIVTGILQEFQFGMNWSNYSRFVGDVFGAPLAIEALLAFFMESTFIGLWIFGWDRL
SKKVHLACIWLTAFGTTISAFWILAANSFMQRPVGFEINNGRAEMNDFFALITNGQVLVE
FPHTVFGALATGAFLVCGISAVKLLGKKDVDFFKKSFQIGITVALSATFLTLVAGHAQAQ
FLVETQPMKMAASEGLWDESEDPAPWTVFANIDVENKQNSGEVKIPYLLSILSYNTLDGS
VKGMNDLQAEYVQKYGDGNYIPPVKTTFWSFRIMVAAGVAMILLGIYGVFLAWKKKLVTK
PNKWFYRFMVAGISLPFIANTSGWIMTEIGRQPWTVFGLMTTADSISPSVSAGQVLFSII
AFCTIYAILGAIMVYLYVKVIKKGPYLMEKEDTKVTNDPFAKEGFHA
>PK3-045_00286 Phosphatase YwpJ
MIKCIAIDMDGTLLTSTQEITKENREAIKEAQDKGVEVVIATGRAYEEAGDLLKEAGIIT
PMICANGAEIRTNEHIIVDTNPLSKDLARQMAEILHKYQVYYEVYTNRGTYTLDKTVARS
LIMDIFTVSGHVKDMEEIKKAAEERLKEIHQLDSYEELFEDDDQVIYKLLAFHFDPIVLG
NVREELTKLEGAAISASGKENLEITSVDAQKGIALEKFVKARDISLSDTMAIGDNYNDVS
MFQMAGRAVAMGNAVEDIQRQCHFVTGTNEESGVAQAIRKALEE
>PK3-045_00287 hypothetical protein
MADFHASVIICEPIEEVFAYFADMANASAYMNKVISAEKLTEEPIGVGTKYKEIRNVRGN
RVYAEIEYLTFDKNKAFTRRSSSNGLMVDYAYRFSEIPEGTQVEFEGTVHVKGLKMLLMR
KFLVKMVKSEDNDHVQNAKEVLEERVENL
>PK3-045_00288 Acetyl esterase
MNNKNEIVLEEAAKKFTEDTADPPYLFELEPAEGRVAVDEVQSSEIDKLPVIENEFFIKG
GPTNQVSIKIVRPENSSTTKLPVILYTHGAGWVFGNAHTHDRLIRELAVGSNAAVVFTNY
SLSPEVRYPVAIEEIYTVLEWIAAKGEEYAFDINKISVAGDSVGGNMSAAITLMAKERKG
PAIQKQLLFYPVTDASFETDSYKQFAEGYFLRRDGMQWFWDQYTVDPKVRAEITASPLRA
TKDQLVGLPDALIITAEADVLRDEGEAYANKLREAGVKVTSVRFGGIIHDFVMLNALAHT
EAAKGALLLANAWLKA
>PK3-045_00289 putative N-acetyl-alpha-D-glucosaminyl L-malate deacetylase 2
METERQVLVIFPHPDDEAFGVSGTISKFLHEGVPVTYACLTLGQMGRNLGNPPFATRESL
PEIRRNELEEAARAMGLEDLRMLGYRDKTIEFIKEEILVDEFTALLDELNPSLVITFYPG
YSVHPDHDATGAAVVKAIAKREASKRPKLYCVAFSKNTEEDLGQPDIEIDVENFADQKIK
TIAAHLSQTQQYVAVLQEGIKNQDPEVLARLYTEKYWTYKF
>PK3-045_00290 putative protein YojF
MEFVQLEKVQNEIDRFSGKEIYIHLETTNGAYANHNDETFFNSGAYIRNAQLTYEYGKIT
GNGPYRIGLKTAIGWIYAEGITHYEIDDKNRLLLAGLDFTGKLAVALEISETPFE
>PK3-045_00291 Pyridoxine kinase
MKKVLTLAGSDTSGGAGIQADLKTFQELGVYGMTALTTIVTMDPKNHWHHNVFPQNINTV
NAQLETVLSVGIDAMKTGMLGSVEIIEAAAKLIDENNIKNVVIDPVMICKGEDEVLHPET
ADALRKLLVPRATVVTPNLFEAWQLAQTDKPIKTVEDLKEAAVKIHELGPKYVLIKGGSK
LGHEKAIDLLYDGKEFTLFESELIDTTYTHGAGCTNSAAITAELAKGATVEEAVQTAKDF
ITAAIRNGFKLNEYVGPTMHGAYRNEKEKLSAK
>PK3-045_00292 Molybdopterin synthase catalytic subunit
MRFEITDRPINLQEVIDKVVRRNAGAITTFIGTVREMTAGKKTLFLTYEAYVPMAAKKLA
QIGEEVKEKWGDIDIAITHRIGKLEISDVAVVIAVSTPHRKDAYEANQYAIERIKEIVPI
WKREHWESGEEWIGNQKGTKRYEDGTPSEEELN
>PK3-045_00293 Molybdopterin synthase sulfur carrier subunit
MIQLLFFAGVKEIIGKEAMELEWQGQTIAQLKEYLLNAFPSLSLQGVMVAVNEEFALEED
TVEENDTIAFIPPVSGG
>PK3-045_00294 hypothetical protein
MDQSRYSRQVLFSSIGKEGQRIIGRKHVLIIGAGALGSSVAEMLCRSGIGSLTIIDRDYV
EKSNLQRQQLYTEKDADEKIPKAFAAENRLKEINRDCTVKGIIGEATAALLEQLVENIDL
IIDATDNMEIRMIVNDMAVKHRIPWIYGACVGSSGMSYTIIPGETPCLHCLLKTMPMTGL
TCDTVGIIAPAVQMVVSHQVTEALKLLIEDKAALRGTFLTFDLWNNEYHNVKVSRAKRSD
CPTCGEKRTYPFLEKENQTRVAVLCGRETVQIRPSIPKNIPFQRLTESFQKKGYKVRQNP
FLLSVQLERNRVVFFKDGRALIHETNDAVYAKKLYDQLLG
>PK3-045_00295 General stress protein 17M
MYKVEVVENGVQATNIINALENQGYKKENIYIFAHDKDRSEDLTNATETGNVSMKEQGLL
DSISNVFRKRGDELRSKLQSVGLTDAEAAKYEEVLDTGKLVIVGSQE
>PK3-045_00296 hypothetical protein
MVSKKEKERINRELSAGKREQASTAMELNNRRGIRFPFFGLYRLRNRLNKKIMLFLSVLI
ILLIAGIVGLWKVAFPKESVLKTTAYLEQMKDLSTLATSQAFVKTILEKEDNEIFGKEIE
TDFPGTKRKILLVVPGTLTAGVDLSRVTENQLKVNEDEKSIHIELPKADFLQDPSIDFDN
VETYSVAGIFRGDVKWEEAYSLMDEAKETMKEEAVDQGILVKAEENAQKTLKEFYGRLGY
TLEVSFAGE
>PK3-045_00297 Uracil-DNA glycosylase
MAASWEQLLEQERQKEYFIQLETFLETEYRESTIYPKREDIFNSLTYTPYDRVKVVILGQ
DPYHGPNQAHGLSFSVKPDVKVPPSLKNIYKELHADLGCSIPNHGYLKSWADQGVLLLNT
VLTVRAGEANSHRGKGWEVFTDKVIKMLNDREEPVIFVLWGNPAQKKLAIIDQEKHGTIL
STHPSPLSAHRGFLGSRPFSTINRMLENNGQSPINWCIDDFL
>PK3-045_00298 hypothetical protein
MEKKKVNCYKCKFYYVTWDSQFPKGCKAFQFKGRMMPSVEVKRASGQECLRFQAKEG
>PK3-045_00299 putative protein YwdI
MNISIQQLLAKIEDQLTEAKASNSDARIRERVYAIKSLCELVLEQERKEGITYQQPVQQP
SFQAVQAPISIPKQTIQTQTNKIKMDEGNGDSLFDF
>PK3-045_00300 hypothetical protein
MKAFIIIGAINALLSVALGAFGAHGLEGKITNKYLEVWKTGVTYQMFHSTGLILIGLLLG
KFPESGLLNWAGWLMFIGIILFAGSLYILAVTQIKVLGAITPLGGVAFIVAWLLVIIAAW
KWM
>PK3-045_00301 hypothetical protein
MSQSNYGNYGYPQGYRNFSGQIPTYGNQQGFQQQVPIQQGMPMPTQAPTPTPPATPTTLP
GQLPIEASYIENILRLNKGKIATVYATFENNREWNAKIFKGIIEAAGRDHVILSDPQSGI
RYLILMLYIDYVTFDEEIEYEYPFAAGMPGLATSPPR
>PK3-045_00302 Putative heme-dependent peroxidase
MSEAAKTLDGWYCLHDFRTVDWTTWKMLPDEERQEAITEFLGLLEKWNTVQENNSGSHAL
YTIVGQKADFMMMILRPTMEELQQLETEFNKTKLAEFTVPAHSYVSVVELSNYLPSDSDK
DPYENPYVKSRLYPILPESSYVCFYPMDKRRQGEDNWYMLPMEDRRSLMHSHGMIGRQYA
GKVKQIITGSVGFDDYEWGVTLFSDDVLQFKKLVYEMRFDEVSARYGEFGSFFVGTLLKQ
EAITKYLHVN
>PK3-045_00303 Phosphate acetyltransferase
MSDLFTGLKEKVTGQNVKIVFPEALDERILKAAGRLAEDKVLIPVLIGDIEEIQTKADNL
GVSLENAEIYDPKKYAQFDALVASFVERRKGKVTEEDARKILLDENYFGTMLVYANQANG
LVSGAIHSTADTVRPALQIIKTKQGVKKTSGVFIMVREDEKYVFADCAINITPDSQDLAE
IAVESAKTARMFDIDPRVAMLSFSTKGSAKSPETEKVEGALAEAKLRDPLLVIDGEFQFD
AAFVPSVAKQKAPDSPIQGDANVFVFPSLEAGNIGYKIAQRLGNFEAVGPILQGLNAPVN
DLSRGCNEEDVYKLALITAGQSLTK
>PK3-045_00304 Octanoyl-[GcvH]:protein N-octanoyltransferase
MVGNTSLLKQEKWRIIDQSTTGLHVSALTSFGMDDTLCSSVGSGMAPATARTWVHDRTIV
LGIQDTRLPRLKEALTFLKEQGYHYIVRNSGGLAVVLDKDVLNISLILPEQEKRIDINSG
YDTMFELIKYMFREYGKTIEAKEIVGSYCPGSYDLSIDGKKFAGISQRRLRNGVAVQIYL
CVNGSGQDRAGIIKQFYSSGLQGETTKFEYPEIDPEVMASLAELLGVSLTVDQVMTKLLL
ALKDHAEFLFADQLQGEELSLFESYYDRVVERNEKIMQPFR
>PK3-045_00306 Prespore-specific transcriptional regulator RsfA
MKVRQDAWSEENDLLLAETVLRHVREGSTQLNAFEEVGDKLNRTSAACGFRWNAVVRHQY
EKALQLAKKQRKQRQRMLGKDQGGKKKLLYSPPVPTVDDFEALTVSTSLEMGSMDLDAME
TFITAETLDTNVNSPQEEELANYQSEEDEQPLPAYEAKQAPVYSSVNHSQAGTLNFDMVL
SYLQNFRNATIQMEILKSENERLKREMTSIKSRNKELEDKLHQIENNSETMQEDYETLMK
IMNRARKLVLLEEDERPTKFKMDRNGNLEKVAE
>PK3-045_00307 Multidrug resistance protein 3
MNKSRILVMCSIVLAMLIASIDTTIMNTTMPIIAEELGGTELYAWSFAAYMIASTILSPI
AGRLSDLFGRKKLFAFGIIVFLIGSLLCGISSTMTQLVIFRALQGMGAGFMMPFPAIIAG
DLFSIEKRGKIQALFTGMWALSAILAPTLGSLFVEFMSWRWIFYINLPVCIIALLTLIPY
KEVYQAKKAQVDYIGAMLFGIGITCLLLVTVLESYLYLYAIIGVLLLITFYFFEKRQTSP
IVPLSIFKNKTITWMFINGFVGTLALFGTSSYIPLFLQNQAGLSVLWSGVSLLGLSVGWM
AMSVPAGKWILKYGYRILLIIGNSLLLLSGILLVLLNESNGFWYVFILMVVQGLAFGLLS
TVGVIGAQALVGNHEKGISTSFFMFCRNMGTAIGVTIMGSLLNSGTTFMDGIHHLFLFGF
IVSIFAFLSAFFIRNEEALVEKNV
>PK3-045_00308 hypothetical protein
MANEFRVCDDCQAVNLKTLIPRLKQIDPDAKIDIGCQSYCGPGRKKTFAFVNNRPLAALT
EEELMDKINAKLKK
>PK3-045_00309 hypothetical protein
MPYSTDKLNEEKVFKDPVHRYIHVRDRVIWDLIGTKEFQRLRRIKQLGTTYLTFHGAEHS
RFNHSLGVYEIVRRIIDDVFEGREEWNNDQRLLSLCAALLHDLGHGPFSHSFEKVFDLDH
EEFTRRIILGKTEVNKVLTKVEKDFPKKVAEIIAKTSKEKLVVSLISSQIDADRMDYLLR
DAYFTGVSYGNFDMERILRVMRPREDQAVIKKSGMHAVEDYIMSRYQMYWQVYFHPVTRS
AEVILTKILHRAKYLHEQFYSFKYHPIHFYSIFEDETSLEDYLKLDEAIILYYFQMWQEE
DDAVLKDLCRRFMNRNLFKYVEFDPAKEYKKLQELSGLFQKVGLDPEYYLVVDSSSDLPY
DFYRPGEEEERLPIHLLMKNGEIRELSRESEIVDSISGKRRTDHKLYFPKDILKDDSSKG
EIKKQIRQLLDIQ
>PK3-045_00310 hypothetical protein
MLKDHAKVMKAIAASGEIIGRKKLQKMIYIAKKLDFPFHEKYQFHFFGPYSEELTLRIEE
LCNMGFLNEVKEKKGGYFQYRYTLTDNGKEFLDLNEVEMPDLSPCLEDMNGQNSRFLELV
STVLFFDSLPKEEVKEKVFTLKAKQKYTEEEIEIAYAYIESLREKRNH
>PK3-045_00311 2-hydroxymuconate tautomerase
MPYVTVKMLEGRTEEQKKNLVEKVTEAVVETTGASKEKVVVFIEEMPTNHYAVAGKRLSD
Q
>PK3-045_00312 hypothetical protein
MLFSQNLADLPYIIISIVIGFTFHEFAHAFVAYKFGDPTAQKQGRLTLNPIAHIDLIGAI
FILIAGFGWAKPVPVNRHYFKRPKLAGVLVTLAGPVSNLILAFLGFIILAILIKLQVPMG
SNFDLYPFFEIFVYMNLLLFAFNLLPLPPLDGYRIIEDLVSSRVRAAMSKYEVYGSILFI
VLIVTGLSSYTIFPWIEVIRYFFLSLFNQLLF
>PK3-045_00313 hypothetical protein
MEEKKKKTIGFNIIKNDPTDGHKGFGIGSLSLENVSPVIIDVEEGEAIVDIGAMHARSAV
ERGIKFLKTKEEVPNGKPYWLVWVTIDRKPEGPYYAGVTACEMTVDRSIRRGYKSLPEHV
NKMDKSMKRHIMVDHMDEKSKKVLADFLKKHDQRLWDNSVEQLKQDLLG
>PK3-045_00314 Endonuclease MutS2
MNQQAFEVLGFYKILEEIESYAKTNLAKETIRKLRPLQDKRKMEQSIKEIEEAMKIIEIS
SSVPIHTLDEMSIYLSQAKKGIYIRADQFPFVISFLEHCTKLKQFMRDKEYAAPNVSLYV
QSIPDVSELTEEIARCIRHSNVDDYASSDLAYLRRQLSILTDRVKEKASQLVKSKKYASY
LQDKIVSERNGHLTLSVKREYRTKIQGSVLDTSASGATVFIEPIELADMQAEIETMKLAE
ESEVERILYELTEKLLAEEEAINLAIETMHYYDVLFAKAKYSRVIAAKPPFLSEDYTIYL
KEARHPMLGDKAVPLTLSFGEEHRALVITGPNTGGKTVTLKTIGLLTMMAQSGLLIPAKA
GSKIAIFQHIFVDIGDGQSIEQNLSTFSSRLVNIIDILRTTNDRSLVLLDELGSGTDPGE
GMALAIVILEQLYQKGATLFATTHYSEMKEFADQTEGFLNGTMEFDINTLRPTYKLLLGQ
SGRSQAFEIASKLGLHPKLIEKAHQITYKTYRNFHHDQNLKELDFQQQIVVNKYARKSVE
KKTINPTPSREPIFEKGDNVILTETDEMGIVYQGPDVQGRYIVQVRQEKRTVNQKRLKLY
IKGTELYPEDYDFDIIFKSKEYRKINKQQKRKHVEDVWLEEE
>PK3-045_00315 hypothetical protein
MFRCDRVKLSSSSKWYQRAFLCCLSSLFFLQTGTEGLSLFPFLSLLPSNGNGGSLSVPFS
LSSSSKRERRAFLCSLFPLFFLQTGTESLSLFPFPSLLSSNGNGGSLSVPFSLSSSSKRE
QRAFLCSLFSLFFLQTGTESLSLLPFSSLLSSNGNGGSLSVPFSLSSSSKRERRAFLCLS
SSSKRERRLSLCSLFSLFFLQTGTEALSLFPFLLPPIPKGLRQRVSPPIPPPTTHLLHAF
FFAACLFSDILSI
>PK3-045_00316 Penicillin-binding protein 2D
MEVIVNKLKNSGKYLRLLIILGLLFMITASIIFIGIYVYARTLGPPPLAVSQSTIYYSDD
GSIIGESSNGQKRYWVSIDDISPYLVDATVSIEDKNFYSHHGFDYKRIGGAILADIKAMA
KVQGASTITQQYARNLFLEHEKTWKRKIAEAFYTLRLEIFYTKDEILEGYINTIYYGHGA
YGAEAASQYYFGKKASELTLGEATMLAGIPKGPSIYSPFSSMENAKKRQGIILNSLIENG
YITKEDKKLAAKEKLSLVGKFPNASVETAPYFQDTVKNILKNQLHLDDKTIQLGGLRVYT
TLNTEQQKIAEETINQTINKASNIQIGFVAMDPTTGNVKAMVGGKDYEESPFNRAIQATR
QPGSTIKPLLYYAALEHGFTPATMMSSEQTTFRFDDGRDPYTPHNFNNQYADGNITMAQA
LAVSDNVYAVKTHLFLGQDTLVKTGKKFGITTDLQEVPSLALGTSNVRVIDMANAYSIFA
NGGNRVSPVFITKIETNDGQLLYEHKPKPEKILDTDLTLVMNQMMTGMFDPTLNGYASVT
GSTIKDDITRIYAGKSGSTESDSWMIGYTPQLVSAVWTGYDQGEPITLAADKTYAKKVWV
QFMEQSLKKEPIKGFTPTKGTVGVYIDPKSGKLASAACNTKRMMYFTKDTVPTEYCADLP
KEDSSEKPANKEKGKEKVPWYKRILPW
>PK3-045_00317 Polyamine aminopropyltransferase
MGIWFTEKQTDDFGITMKIKRTLHTEQTPFQKLDMVETEEWGNMLLLDDMVMTSVRDEFV
YHEMVAHIPLFTHPNPEYVLVVGGGDGGVIREVLKHPSVKKATLVDIDGKVIEYSKKFLP
EIAGKLDDPRVDVQVGDGFMHIAKSEQEYDVIMVDSTEPVGPAVNLFTKGFYAGIAKALK
DDGLFVAQSDNPWFKGELIRSVQRDVKEIFPITRLYIANIPTYPSGMWAFTIGSKQYDPL
NVPESRFHSIETKYYTKELHKAAFILPKFVQDLCEGDSNKASE
>PK3-045_00318 Agmatinase
MRFDESYSGNVFIKSFPNYEESQVVLYGMPMDWTVSFRPGSRFGPARIREVSVGLEEYSP
YLDRELDEVKYFDAGDIPLPFGNPQRSLDMIEEFVDKVLDDNKFPLGMGGEHLVSWGVFQ
AMYKKYPDLAIIHMDAHTDLRDEYEGEPLSHSTPIKKAANLIGPKNVYSFGIRSGMKEEF
QWAKEVGMHISKFEVLEPLKEILPTLAGRPVYVTIDIDVLDPAHAPGTGTVDAGGITSKE
LLASIHEIARSNVQVVGADLVEVAPIYDPSEQTANTASKLIREMILGFVK
>PK3-045_00319 hypothetical protein
MGKRIFVLLVGVMVLFAGFHSVNTAQAASKKTKYVTASTLNIRSGAGTSYKIVTTVKKNQ
AVIVTQTKGSWDKVTVGKKTGWASNKYLTTKKPAAKATTSTKTMYVTASMLNVRSGAGTN
YKVVTTVKKNQSLKVSQTKGSWSMVTVGSKTGWASSKYLTTKKPASPKNLAAGLKTVGKN
KQLILVTSNGYNTSSADIRTFEKNKKGEWIPVLTTTGHIGKYGFTSNMSEGGKKSPIGKF
TIGTAFGTQKNPGTKLPYRKITKDDVWVDDPKSKLYNTWQSKKKTKGQWKSAENMNVPAY
KYGFVIDYNTKRIPNKGSAIFFHIANSYTLGCTATTEANVVKILKWLDPSKNPVIIQTPI
KELSNY
>PK3-045_00320 putative beta-barrel protein YwiB
MSQPSGQQVPVKLHVTTHIYNGKNKESIEWIGFGQYLEKDTSKYIKYEEIIEEGTIKTII
KITEKEGLILRSGAVKMRLPFLINKQKIGSYESPYGVFQLVTDTKRLALEVEQQATTGSL
DILYDLKMQGSNNGTYHMTISFKEETE
>PK3-045_00321 Arginine--tRNA ligase
MNIVDQIKDKLKEEIKQSVIKAGLAAEEQIPEVILELPKDKAHGDYSTNMAMQLARVAKK
APRMIAEAIIENFDQTKASIKKVEIAGPGFINFYMDNSYLTDLIPTILQAGEQYGQTTVG
NNEKVQVEFVSANPTGDLHLGHARGAAVGDSLCNILDKAGYEVSREYYINDAGNQINNLA
LSVEARYFQALGMEKEMPQDGYHGEDIIGIGKKLAEEYGDKYVHVSEQERFDFFREYGLK
YEMAKLKQDLEDFRVKFDVWFSETSLYQNGKIDIALNKLKENGYIFEQDGATWLRSTDFE
DDKDRVLIKNDGSYTYLLPDIAYHKDKLDRGFEKLINIWGADHHGYIPRMKAAIQALGYN
KEALEVEIIQLVHLYKNGEKMKMSKRTGKAVTMRDLVEEVGLDATRYFFAMRSADTHLDF
DLDLAVSQSNENPVYYAQYAHARISSILRQGKEQGIEPKDELNAALITAEKEFDLLKKLG
EFPQAVGEAALKRMPHRITNYIYDLASTFHSFYNAEKVLDADNLERTKARLALIQATQIT
LRNALALIGVSAPEKM
>PK3-045_00322 Sensor histidine kinase RcsC
MGLWVQMGINHKGQKTLLRELIKYIAALCISLIVLALLYLFMNTIAMNMGFSHPANYNER
EAEKLMPKLEHVDKITADMIPDTMSFALLDKETKQKTAGTIKVKDLKLVKKKIEKKPYVN
YKQKGYLVIERKNEYCILQYSLRADFSSPLLRKYLPNYELTSISILIVLLIIDISIITTY
FANRLRIHFETLNVITRYIKEQNLQFTPEFTHIKEFDDVIDSLIEMRDALRSSLEAQWRL
EKNKKEQIGALAHDIKIPITIIKGNAELLSLSIQNEEQAEYTKYILGAGNQIEQYISQLI
YLSKTEESLTIHLEKAFIDKLTETLQKDISAYKGNKKITISFKKENLKKEAEIDWQLLHR
ALLNILTNAVDYTPEDGTVSVHAECDSDTLYFIVKDTGNGFSESGLKKATELFYMDDKAR
QSKGHYGMGLTFAKNAVNLHNGELTLGNTIEGGGEVRVKIPLYRNH
>PK3-045_00323 Response regulator SaeR
MAKILAVDDEKDILALIQNILRRDQHKVDTLDRVKGQPPDLFQGYDLILLDVMMPDIDGF
ELCKQIRPLVDCPILFLTAKTEEEAIINGLITGGDDYITKPFGVRELSARVNAHLRRERR
DKHQSKRVISGFLFHFDSKEVFINNQKLNLTKNEYKIFEFLAQHKGRTFSREQIYEEIYG
LEGNALYSTITEFIRTIRRKCNEHNADPIKTVWGFGYKWE
>PK3-045_00324 hypothetical protein
MWLHFIIPIVCSVVLILYYYGRDQSQFHLYKSFMEAIAIALPLLIGVLCGMTASLEEQAG
KFQVLLGGTSPKIIAYASKMLMLLLMELCSIGIALFLYIMGLTFILNVPDLSYDIFITGA
AWLVAGSVILYVIYFFISCMFGMGASVLIGGAGLLMTALMNTGLGDAIWKYNPWAWSIRL
SGLNGVLHFIEKDNYSLLMHEINSGVFIVIFGTICIIIAGLIWFNRWEGRKTFE
>PK3-045_00325 hypothetical protein
MINYMKAENLKFKRTFSRKMIIFVPLLNIGFSFLMNNQFFVSGTFNWWSIIFMPVMIALL
CSLSHQKEKKASNYTGTYSLPIDLGRLWYSKIVIIMIYSLLSQIVFLVFMLLMGFVIADF
TIVTLSTVAASLLLWVTSLWQVPLCLFVAKKWGLTIAVMLNLIGTFILGIMPASRSFWWF
IPWSWPIRMMCPTIGIHPNGLLLEKNNPLLSWMVVLPAILISVLLFLIMAFLTSRSFASS
IDYRIKKQGAM
>PK3-045_00326 Bacitracin transport ATP-binding protein BcrA
MSTALLETKSLTKKFGKETAVSDVSLTVQKNSIYGLLGPNGAGKSTTLKILTGILRKTSG
EVFFDGHKWKRSDLQNIGSLIEAPPLYDNLTAFENVKVHATLLGLSEERIHSVLKTVDMQ
HAGKKRAGQFSMGMRQRLGIAIALLNHPKLLILDEPTNGLDPIGIQELRDLIRSFPQEGI
TVILSSHILSEVEQIADHIGIIIGGHLGYQGEINKIDDLEHLFMEVVKASREKEGVKK
>PK3-045_00327 hypothetical protein
MFLKRCINISGCIIVLFMLSACQSLTKFKDKTMEETKKTMHFTEGNENETAETMERLIDK
GKLDQVVYNEKLYQLKEKVDEDKKGKVIGAIGKTFFVDSDGKRWSEEELKEPYLSLDPDE
IKEKKPLRYGKVYSANEDSNAEDEIIVEFNREYYRAVLIKNEKE
>PK3-045_00328 ABC transporter permease protein NatB
MLFKLFLKELKDSFRDRRTLLLTVFLPIIMMTGLTLFYEKLVSSDEGDTYQLAIPTNINE
EMQANLAVYTNIELVDADNPEKMVKDGDAQAAILIENDFSEKLSKGENTNIVLIGDSFSE
KSSTLLSIVMNALNEYEKTVVTERLNEAGVESTVVQPFSIEQQEISAEDPTINLVAMLIP
LILSLALGIGASPAAADLFAGEKEKKTMEALLMTPVKRSTLVISKWLTITTIGVLTGLIT
LLVVVLEIAFFTENLKNAVPVHNNFALIIVFALVMTIIYSMLIASLLMITSIIGKTIKEA
QSYSTPILLLTIFPMMLLSTTGINELTTNHFIIPFVNVFSTLKELIFGEIIYQHLLLTLG
SNLVFIIISFLIGRMLFLKDKWVIN
>PK3-045_00329 ABC transporter ATP-binding protein NatA
MIAIQTVTKKFQDKKTSVTALKHVSFSIQKGETIALLGENGAGKTTLLRSIATLIQPTEG
TITVDQYDTKKNPNEIKQKIGVLFGGETGLYERLTARENLEYFANLYGLGKHETKVRIDE
LSRMFGMRDYLDRKVGGFSKGMRQKVAIARTIIHDPEIILFDEPTTGLDITASNVFRQLV
HQLKREGKTILFSSHIMEEVAMLCDSVAMIHKGELVYHGKLDDLYKAEGSKDLNYIFMSK
LVRGGNTYAI
>PK3-045_00330 Transcriptional regulatory protein NatR
MRVGLVDDRMIDLDKLIGIVSGIPDVEIIFSTISAEEAYTEIKKESIDLLIADIEMPGLS
GYELADIIHSHALNILVIFVTGTSGYAVHAFELNVHDYIMKPYNKERLTQSVQRALEKTK
STEIAGRLYIKQKSEIHIIQKKDIVFIERSGRSTTIYTKAEAIKTYQTLNELEGELRERD
FIRSHRSFIINIHYVKNFSLYAKNSYAVAFEGLEEKAMITKEKVDFLQENYF
>PK3-045_00331 hypothetical protein
MINNNHFYWLLIAVYSTIHSKRVIDHVSFSVQAYWIFAFFVGICFVLSKYLHADKAVITS
RIEVLFWLVQSLVLLLHIQVAFTYWNILFLLLFVLIEIVRFMIGAKIFSLQQAKESYEKE
ISQYNELFQVVRSERHDFLKHISAVHFMLEKEGSSHAKSYLDELVEGYEETNLSIKGESG
SVASVLHRVYKQAVQENIALKYDFDIPLSTLPMKEKDIVGLVGNLLSNSLEASREWQQKY
RREPHIIIRLSKRSGLYLLTCKNDCLPIPVSILDSLYKKFGKSTKKGKERGYGTRIILDI
VKKHHGYLDYTYKEESFFVKIKIPVIKNSNDD
>PK3-045_00332 Minor cardiolipin synthase ClsB
MKTFLIILSIIAILIFLLYLDFQLGKRAQQKKSNRKNHPFRYSDFHIYSDGTELFPALFQ
AIEEAAEHVHILFYTIKTDSISNEFLNLLKTKAHEGVEVRLILDWLGSYKIRKKVRAKLK
KAGVQFAFCQLPIFPYLFYSLQVRNHRKIAIIDGKVGFMGGFNIGKDYIHANYKLSPWRD
YHLKLIGEGVDDLQREFLMDWLKASKINLLQNRVYFPLQKKGESRHQIIPTQGVYLEEIV
CHVIKNCKSSLLITTPYFIPSKQITKELLRALHRNISITILIPDKADHLLVKEASFPYLR
TLIAHGASVYQYMNGFFHGKLINIDNEIIIIGSANFDRRSIFLNHELNCCIYDKGFIERM
NKITTEDLQQAKELSLEGLDTITIRSKLKEWIARLFAPFL
>PK3-045_00333 DNA-directed RNA polymerase subunit delta
MSIDKYTQEELKEMSLIDVAHEIMNGGKTPYAFNELMDQVAKLVGLSEEEVNEKIAQLYT
DVNIDGRFLSLGDNRWGLRLWYPVDKSEEDVVTVTKPKKKKAKKAVDDDFDDFDSLDEDD
DFDDFDADLDDEELLDEDEDLDEEDDDLLDDDLSEEDDDFDEDYEIDDDELDEDEEEEDD
EFDDEDEDK
>PK3-045_00334 CTP synthase
MTKYIFVTGGVVSSLGKGITAASLGRLLKNRGVSVTIQKFDPYINVDPGTMSPYQHGEVF
VTDDGAETDLDLGHYERFIDINLTKYNNVTTGKIYSTVLRKERRGDYLGGTVQVIPHITN
EIKERVFRAGRETNADVVITEIGGTVGDIESLPFLEAIRQIKSDIGRDNVMYIHCTLVPY
IKAAGEMKTKPTQHSVKELRSLGIQPNVIVVRTEKPISEDMKDKIALFCDIDNKSVIECR
DADTLYTIPLALQEQNLDQIVCDHLKLKCQEADMTEWIELVDRVRHLSKTTKIALVGKYV
ELQDAYISVVEALKHAGYAYDADIEIDWINAEQVTKENVQEILQDADGILVPGGFGDRGV
EGKILATQYAREQKVPFFGICLGMQVASIEFARNVLGWNDAHSSEINEATTHPVIDLLPE
QKDVEDLGGTLRLGLYPCKLKEDTRAYEAYQDEVIYERHRHRYEFNNQYRQEMENAGFVF
SGTSPDGRLVEIVELKDHPWFVASQFHPEFISRPTRPQPLFREFVGASIRLAEK
>PK3-045_00335 hypothetical protein
MLKMFSTQLSGLFKRLHEKEEEAIEDSSRLLAQAIVSDGKVYIYATNEMAGVIAEATTGM
EPMLNTEKWANASLESITSNDRFILFARTNEEEEINTFAKQLYDAQVPFISICSITNPDI
ESLVDFADVSIDLRLSKGLLPDDEGKRYGYPSLIVALFIYHGIKFTTDEILKEYDL
>PK3-045_00336 Sporulation initiation phosphotransferase F
MKGKILIVDDQFGIRILLNEVFQKEGYKTFQAANGNQALEIVTRESPDLVLLDMKIPGMD
GIEILKRMKKLNQDIRVIIMTAYGELDMIQEAKDLGALTHFAKPFDIDDLREAVKKYINY
>PK3-045_00337 putative fructose-bisphosphate aldolase
MPLVSMKDMLNKAKAEGYAVGQFNLNNLEFTQAILQAAEEEKSPVILGVSEGAGRYMGGF
KTVVKMVEGLMEDYNITVPVAIHLDHGSSFEKCKEAIDAGFTSVMIDASHHPFDENVEIT
SKVVEYAHAKGVSVEAELGTVGGQEDDVVAEGVIYADANECVELVKRTGIDTLAPALGSV
HGPYKGEPNLGFKEMEEIGNLTGLPLVLHGGTGIPTKDITKAISLGTAKINVNTENQIAS
AKAVRETLAAKPEEYDPRKYLGPARDAIKATVIGKIKEFGSSNKA
>PK3-045_00338 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2
MEKLMIAGGSPLKGTVRVSGAKNSAVALIPATILAESPVTIEGLPDISDVQILKEIMEEL
GGTVSISESDITIDPSSMISMPMPNGKVKKLRASYYLMGAMLGRFKKAVIGLPGGCHLGP
RPIDQHIKGFEALGAQVTNEQGAIYLRADELRGARIYLDVVSVGATINIMLAAVRAKGKT
IIENAAKEPEIIDVATLLTNMGAKIKGAGTDVIRIEGVDHLHGCRHTIIPDRIEAGTYII
IGAAVGDGVLVDNVIPQHLESLIAKLREMGVSIESSDEQVFISSNNSLKPVDIKTLVYPG
FPTDLQQPFTSLLTKTNGTSMVTDTIYGARFKHIDELRRMNATIKVEGRSAIINGPVHLQ
GAKVKASDLRAGASLVIAGLMADGVTEITGLEHIDRGYSHIVEKLTGLGATIWREKMTEE
EYEQINNG
>PK3-045_00339 Transcription termination factor Rho
MGLNISSLENMKLKELYELAREYKVAYYSKLTKKELIFSILKARAEQEGYFFMEGVLEII
QSEGFGFLRPINYSPSSQDIYISASQIRRFDLRNGDKVSGKVRPPKENERYFGLLQVEAV
NGDDPESAKERVHFPALTPLYPNRQIHLETTQRNVSTRIMDVLAPVGFGQRGLIVAPPKA
GKTMLIKEIANSITTNHPEAELIVLLIDERPEEVTDIERSVSGDVVSSTFDEVPENHIKV
AELVLERAMRLVEHKRDVIILMDSITRLARAYNLVIPPSGRTLSGGIDPGAFHRPKRFFG
AARNIEEGGSLTILATALVDTGSRMDDVIYEEFKGTGNMELHLDRALAERRIFPAIDIRR
SGTRKEELLIPKEHLDKLWAIRKSMSDSPDFAEKFLRKLRQTKSNEDFFAILGEQMKAGT
AKRS
>PK3-045_00340 50S ribosomal protein L31
MKTGIHPTYNEITVKCACGNEFKTGSVKKEIKVETCSECHPFYTGRQKFAEAGGRVDRFN
KKYGLK
>PK3-045_00341 Thymidine kinase
MYVMKHHGWVEVICGSMFSGKSEELIRRVRRAQFAKQKFIVFKPSIDNRYSEKSVVSHNG
TATNAIPISKSADIFEYVTSDIEIVAIDEVQFFDDEIIGVIQHLANSGHRVICAGLDQDF
RGEPFGKMPELMAIAELVTKLQAVCAVCGSPASRTQRLINGAPANYEDPVILVGASESYE
PRCRHHHEVPRSTEKANKDNTSTAL
>PK3-045_00342 hypothetical protein
MRIGQVAKLSGLSTRTIDYYTSNKLLPVTRSDSNYRLYSEDVLYTLERIKLLKKQRMSIG
EIRNVIHSMEDQEIEPIMDEVQDEIACLHKKLASLEERLKDAPQEEKKKVYRTLETKLLD
VMKLLSLM
>PK3-045_00343 hypothetical protein
MDIITIINLFLLVLLLALTAFFVGAEFAVVKIRMSRIDQLIAEGNKKAIMAKKVASELDY
YLSACQLGITVTALGLGALGKPAIEQLLYPIFNLLNASPSVASVASYAIAFALVTFLHVV
VGEMAPKTLAIQFAEKLTLLLAPPLYWFGKVMKPFIWALNGSAQVVLRLMGIKPAKHEQA
YSEEELKIVMTQSYQGGEIDQTELEYMENVFSFDERVAKDIMVPRTELVTLNKDMSYEEI
VKVLDEHNYTRYPVTEDGDKDHIIGVVNVKKMLTQMAWGRNRQLDEFVRDLPVVLEVTRL
QDALLKMQQERVHMLLVIDEYGGTSGILAMEDILEELVGEIRDEFDADEVADIRESGKDK
YFINGRVLLDELEERFGIPFEEREELDTIAGWIQYQLLDTAKIGDQVEQGDRLWTVTDMD
NYQIKEVSLIQNAFKTI
>PK3-045_00344 putative protein
MDSIILLNLFLVAVFIMLTAFFVGAEFAILKVRTSRLDQLIAEGNKKAITAKKVAHDLDY
YLSACQLGITITALVLGALGEPTVEKILHPLFERFDVPNALSTVLSYAIALSVVSFLHVV
VGELAPKTLAIQYAEKMTLMLAPGLYWFGRITKPIIHALNGSSRAILGWFGIKPTGHEIA
HSEEELKLIVTQSYESGEINQTELAYLKNIFAFDNRILKEIMIPREQIVNVEIEMSLEEM
LTVLDKQEYTRYPVTKNGTKLVGYVNTKEMLTNVVAGRETKMEEFIHEMPIFLQTSPIKN
VLLKMQQERVHMALVKNERGVIVGLVTMEDILEEIVGEIRDEFVGEEILNKGF
>PK3-045_00345 RsbT co-antagonist protein RsbRC
MSLTNHSIYEYVMDKAPSITKTWFAIKDGEPGSIYSKNSSPAVEKLLKKQHAFTIQTVIS
AFLEDESIFANNLEVWANEVAKSRVELATPVHEVLEALSITRKAIWNTIEQFILEHKEVS
TALVLQWSSKYQSTFDQLTNQFTSMYHAFTKEKIHSQEELIQQLSVPVIPITESIGVLPL
IGDIDSLRAKLILETVPVRCKEEGIEHLFIDLSGISSIDTMVLHELMKLTKILSFIGIES
TISGLSPDTAQMIAALGIKLGKVSTFSTLKQALSLQGKSLEVAASSINALPFRKA
>PK3-045_00346 Peptide chain release factor 1
MDKNEVNSVFDRLQAVEDRYDKLNELLSDPEIVNDTKKLRDYSKEQSDIQETVEVYREYK
EVKEQHLEAKAMLEEKLDPEMREMVKEELDETAARIEELEARLKILLIPKDPNDDKNVIM
EIRGAAGGDEAALFAGDLFRMYSRFAEAQGWKMEVIDASSTGVGGYKEIIFMINGKGAYS
KLKFENGAHRVQRVPETESGGRIHTSTATVACLPEAEEVEIEIHEKDIRVDTFASSGPGG
QSVNTTMSAVRLTHLPTGTVVSCQDEKSQIKNKEKAMKVLRARVYDKFQQEAQAEYDQQR
KSAVGTGDRSERIRTYNFPQNRVTDHRIGLTIQKLDQILQGKMDDIIDALIFEEQSSRLE
SASDV
>PK3-045_00347 Release factor glutamine methyltransferase
MPSFLKNNLVVWKVLLMCKVFEALKWASSYLKEHNREEYAAELLLRHSLQVSRSELLIKF
REDIDDEQFKDFQKLVSLHAEGQPVQYIIGQEDFYGRAFKVNKEVLIPRPETEELVQSAL
TRIDRLFGEGADLKLIDVGTGSGAIAVTMKLECPSLQVIASDLYEVSLAVAKQNAANLGA
EPIDFVQGDLLQPFIAQGKSFDVVLSNPPYIPEGDVVTMSDVVTEHEPHRALFAGEDGLL
LYKRLCEELPQVVKEKAIIGFEVGAGQSDAVAKLLEAAFPQAKVEVQYDINGKDRMVFAE
VGF
>PK3-045_00348 hypothetical protein
MKNKPMATIYLFVLILSTMMSLYIPKNEVTANNEVIIPNDAIRLRILANSDKEDDQELKR
KVRDAVNEEITNWVSELTSKEVAKDLLKEKLPEIQQIAERVVEDENANQAVNVTFDKVDF
PTKLYGEFLYPAGQYDAILITLGEGEGANWWCVLFPPLCFLDFSNGVAVSDGFEEGEAEK
KEGKADKPDKPAKEEKKEQTKAEEKQDPVFVEGEKEEEVEVKFFLVELWEKIFG
>PK3-045_00349 Manganese-binding lipoprotein MntA
MWKLILTGLLMSFVFLTGCSAESTGSKEDGKLTIVTTIAQIAEPMSVIGGDKVEVQSLMG
PGVDPHLYTATQGDIQKMDGADIVFYSGLHLEANMVKVFAEISKTKPVLAIGDVIAEEKL
LKDEEGAIDPHIWFDVDLWKEALDAATTELKKASPDNSDYFEQNKQEYFAKLDSLKEEAK
TQMESLPEDKRVLVTAHDAFGYFGRMLDIEVVGLQGLSTEAEIGLSDIEDTIALLVEHQV
PAVFVESSINPASVNAVVEGAKKQGLDIELGGELFSDAMGDAKSKEGTYIGMYEHNVATI
YQALSRGVE
>PK3-045_00350 Manganese transport system ATP-binding protein MntB
METILTVENVSAAYRKNEVLSDVSFQVEKGTLTSIVGPNGAGKSTLLKVILELHHAISGE
VNFFGETYQTAKSRIGYVPQRGSVDWDFPTNALDVVTMGLYGKIGLLKWPKKEHKQKAMA
ALKEMKMEDYADRQISQLSGGQQQRVFLARALAQDADLYFLDEPLAGVDATTEKAIMETL
KMLKERGKTVMVVHHDLQTVEEYFDHVLLLNKTVIAHGPTSETFTKENIRKAYGGTLHWM
GEKR
>PK3-045_00351 Manganese transport system membrane protein MntC
MFSILSYNAQSVLFSTFLLGMAAGVIGSFAYWKRQSLMSDALSHAALPGVVLGFILLGEK
NLFVMIIGAAITALLGAFLIQWIRSSSRVKEDAAMGIVLSVFFGLGIMLLSFANRMPGGN
QSGLDSFIFGQAASMVSRDVWTMMMVAIIVLFLTVILFKEWKIFLFDPSFAKGIGISITG
MNALYMAILVLVIVVGIQAVGVILMAALLIIPSVSARYWTESFKVMVILSALFGGASGMM
GTFLSTIGKGWPTGPFIVVTAAAIFFISLFLGSKKGLAVVFFQQKRQRKGMELVKMTREV
EQ
>PK3-045_00352 Manganese transport system membrane protein MntD
MSYTGWILLTASLVGLSCGLIGVLLILRRMAMMADAISHTVLLGIVCAYLITRELTGIHM
LIGAVIAGLVTAVVIQWLHTHGVQQEASIGIVFTTLFAIGVILIATKVGNAHLDVKHTLM
GEITFIPWERVEVPILGRVPEAVVLLSAVLFVVLLVIIAFYKEWKITSFDPALAASLGIP
VIFMHYLFMSLVSLTTVAAFDAVGAIMVVAMLITPAAAAYLWTDRLSFLFLLSSGFGILA
AFIGYYMAVWLDTSISGAMAFSTGIIFMISFLCSPKYGVLAKRMTRRKHNARTYKIS
>PK3-045_00353 Proline dehydrogenase 2
MEVALRNMFQSLAKNKSANKLARKYGLRFGAKRFVSGETIAEAISKVSELNKSGRVVTLD
HLGEFVYTKEEADESTRMSLKTLDEIHASGVHSHLSVKMTSLGLDIDKDLCLNNMRKIVS
RASQYGNFVRIDMEDYAHCQVTIDIYEELRKEYDNVGLVIQAYLYRTEEDMKRLNELNAN
LRLVKGAYKEPPDVAFPEKKDVDENYKKIIEMHMLNGNYTAVASHDEKIIQFTKELAANQ
GIAKDKFEFQMLYGICEDLQNKLVREGYKVRVYVPYGKDWFGYFMRRLAERPANVWFILK
NLFK
>PK3-045_00354 1-pyrroline-5-carboxylate dehydrogenase
MTNLTSIPPYKNEPFTDFTQIENQHAMEAAIQKVKRELGKTFPLVIGKAKIMTEEKTVSI
NPANVDEVIGEVSKGNKEYAEKAMQEALHTFETWKKVKPAERAEYLFKAAQLMRERKHEF
SAYLILESGKNWVEADADTAEAIDFLEFYGREMIRLSETSIHQPLYPTAGEVDNKITYIP
LGVGIVISPFNFPLAIMAGTTVAGVVSGNTVILKPSDNTPVIAAKFVELMEEVGLPSGVI
NYLPGDSLEVGEYLVEHPKTRFISFTGSRAVGCRIYERASVVQPGQIWLKRIVAEMGGKD
GIVVDETADLDAAAEAIVAAAFGFQGQKCSAGSRAMIVESVYDKVVEKVLTRTKNLAIGL
PETNAAVGPVIDEKALNKILGYIEIGKNEGKLAIGGSRAEGNGYYIEPTIFIDVPADARI
MKEEIFGPVLAICKVPDWKKGIEVYNDTEYGLTGSFFSSQEDRIEYALENQHCGNLYINK
KCTGALVGVHPFGGFNMSGTDSKAGGFDYLLLFTQAKLSTKKVV
>PK3-045_00355 Anaerobic nitric oxide reductase transcription regulator NorR
MFTDSQMKIETSFTILSDNEKISTLTEVLADYSYVIIESEQLFTIGNEEQYLLAAVRNNQ
TIKDWLEVSNILPSEVIAVQDIKRENLSWLRPVIIKTQNEFQGIVTAEARIQALQKENKY
LATYFETLAETMNDAVTAVDSDGTVFYWNSVAEDTYQITKAAIIGKKIGEHFETDSIQLH
RILKEGNPIRGTYHRPNEHTHVLINASPVLVDNKIIGGISTEHDITKLIHLNQELDSTTS
IYVQKDEPFSSILSSSKEVKRAVEMAQKIASAEIPVLISGETGTGKEQLAQAIHYGGSKR
KNQFLSLNCSTVPKDLVEMELFGYQKMTFNAGDPEEIEGKIEQAESGTLFIEEVDKMPLA
VQEKLLHYMTERSFTRVGGEQQKKPATRLILSSTQPLGELVRKGEFNEKLYYQISVVHIE
IPPLRNRKEDIPHLVNSFIKMYNEKYQKNIIKINEQAMHIVCSYDWPGNIKELKNVIEHS
VLVCEGNRELTLEHIPAEIVEKYKVSIRGERGNREDNEMERIEEALKKTYGNKSAAATLL
GISRGTLYNKIKEFGLK
>PK3-045_00356 hypothetical protein
MHIIRQAEIGDLERIAAFLTNAEVTVEGLQEWLDYFLLMEAEADQTLIGTIGIEPFGKTG
LLRSMVLSKGNVEDILFLIQQALKLAKDKDLDAIYCKVHNPHSMQLFRLLGFQAIEEENI
PAAMKESNTVKNVYTVDKSHFMYIPMNIVDK
>PK3-045_00357 Threonylcarbamoyl-AMP synthase
MKTNYWSVDKNVDKEESYSQIKQAADLLRKNEVVAFPTETVYGLGGNAKEDSAISKIFAA
KGRPSDNPLIIHIAKREQLDELVEKVPETAEKLMDAFWPGPLTIIFEKKNGVLSELSTAG
LSTVGIRMPNHPVALQIIEQSALPIAAPSANRSGKPSPTKAIHVKEDLDTYIAGIVDGGS
TGVGVESTVVDCTDEKVMILRPGGITKEQLESVVGEVKVDQALTDTEIKPKSPGMKYTHY
APNAPLFLVDGSKEKIQLLIEEEKQKGHRVGVLTTEENKVFYQADFIYACGERQDLSTVA
ADLYDGLRSFDHQQVDIIFGEIFPTEGVGQAVMNRLMKAASHQVIK
>PK3-045_00358 putative manganese efflux pump MntP
MSAVVGELFTLILMAFALGMDAFSVGLGMGMFQLRLKQIAKIGFIIGVFHVIMPLLGMIT
GKFLSENFSEIAGYIGGALLVILGIQMIWTGFKEVETSRITPAGLGLLLFAVSVSLDSFS
VGLSLGIYQARTVVVLLCFGISAMVLTWLGLLIGRKVQGWLGSYGEMLGGGILLIFGIKL
LISL
>PK3-045_00359 Protein-arginine-phosphatase
MIRILFVCTGNTCRSPMAEAILKHKFSADVEVKSAGVYAVDGSAASLQAQEVLSEKGIQH
NHFSTMVTKELIDWANYIFTMTKGHKNMLVSAYPSSIEKTFTIKEYAEDDLNGDVSDPFG
GTVSMYRDTYEELEILIDKIMEKITKSEW
>PK3-045_00360 Methyl-accepting chemotaxis protein McpA
MGTKGQYKFSLRKKLALFITILAIITYSTSAFFMYILYPVIESKIAISSVIFNIVTLVLG
IFWSGFLGFLAAGFIIKPLKRLEQSALKAAHGDISQDAEVSKSDDEIKSLGLAFNHMLFN
LRDMVQSIENNFNKTNETVKRISAESDNALEQTLAISNSVGEIAGGAEMSAQSVQASAES
VEESMNIALSVEEKANMSKSISGQMSEKLMETNTVVRSLVDGMMELAVENTHSLKSVQNL
EIHSKEIEEVLKLVGEIASQTNLLALNASIEAARAGEHGAGFSVVAEEVRRLADESGKAV
EGIAEIIRNMQTEVKNVVTQITNQVENAQEKAETGKKTNLIFNEMNETTNKMIDATADIT
ELIHKQKQQIYETTQQSQEVAAIAEETAAGAQQVTNIADNQTALIRKVDGLALELQAHAE
ELQQTICRFQIKE
>PK3-045_00361 hypothetical protein
MNEETLKLKEQLQTILTEYQEQAQLKEQQLFVIGCSTSEVIGQKIGTAGTVDVASLIFEE
CQKFQQQAGISLAFQCCEHLNRALVVERKVMLARNLPEVSVVPVRHAGGAMATFAFQQME
DPVVVEFIQADGGIDIGDTFIGMHLKHVAVPIRTSLKELGNAHVTLAKSRPKLIGGPRAV
YENTKENLSC
>PK3-045_00362 Serine hydroxymethyltransferase
MKHLAEQDELVFKAIQQELGRQRAKIELIASENFVSEAVMEAQGSVLTNKYAEGYPAKRY
YGGCEYVDIVEDIARDRAKEIFGAEHVNVQPHSGAQANMAVYFTILEHGDTVLGMNLSHG
GHLTHGSPVNFSGVQYNFVEYGVDKETHYINYEDVREKALAHKPKLIVAGASAYPREIDF
AKFREIADEVGAYLMVDMAHIAGLVAAGLHQNPVPYADFVTTTTHKTLRGPRGGMILCKE
EYAKKIDKSIFPGIQGGPLMHVIAAKAVAFGEALQADFKDYAENIIANAKRLASGLQKEG
LNLVSNGTDNHLLLVDLQSLGLSGKVAEHVLDEVGITVNKNTIPYDPASPFVTSGIRIGT
AAVTSRGFSLEDMDEIASIIGFTLKNHEDAEKLAEAAKRVTALTSKFELYKEL
>PK3-045_00363 Uracil phosphoribosyltransferase
MAKVYVFDHPLIQHKLTYIREKQTGTKEFRELVDEVATLMAFEITRDMPLEEIEIDTPVA
RTKSKVLSGKKLGIVPILRAGIGMVDGVLKLIPAAKVGHIGLYRDPKTLKPVEYYVKLPS
DVEERDFIVVDPMLATGGSAIEAIHSLKNRGGKNIKFMCLIAAPEGVEALKEAHPDVDIY
IAALDEKLNEKGYIIPGLGDAGDRLFGTK
>PK3-045_00364 Minor extracellular protease vpr
MLQKTLGILLFIPLLLSHLTMAASLKTPNLPSQNSNEVQIAIVYTKKNYAEQEIDRLLSR
YPDLKRRYIFTEVFSGFSVEGPVYELEKLKQSESVNQVSKVQTYMAEAEDPVEIIGADEI
RNYLGKSLDHISGKGIKIGVIDTGIDYQHPDLDKNYRGGYDFVDKDKDPMETKGLGNKDT
FHGTHVAGIIAANGKIKGVAPNATIYAYRALGPGGSGTTEQILAAIDRAVRDKVDIINLS
LGSDVNGPDLPISLALNEVVKKGIIAVAAAGNAGPAEWTVGSPGTAAKAISVGATTPNIH
TPFFTINDKKIALTNMENSKEWKGMASIPLASGGIGKKQQLTNAKGKLVLIERGELTFTE
KVQNAYEAGAVGVLIFNNLPGAFQGMLEKEVPIPVAGITKEEGEFIKKTIQKKKIYVTIE
KKWEKDILADFSSRGPVTSTWEIKPDVLAPGVVINSTVPDGYMALQGTSMAAPFVAGACA
LLLEVHPDWGPEEVKAALMNTAKSVKNRQNVTYKVYEQGAGRIQVDQAVDANILIMPGSI
RFGKYKLVKEKNQYKAYITIKNAGKRKEKISFDFPKGKRGISWKLPLSFTIKPGEKKNIP
IIMNIDDNLFNRKLQDGIIRVRAGGKLIELPYLYVLEEPDYPRIMGFDFHKKNGESCYEY
ETYLPTGAEEFGIALFREDTLQFVRFLDWKKEVKRGRLKGEFALTKVEEAGTYRMKIFAK
KAGKEDMLEKILKIK
>PK3-045_00365 hypothetical protein
MEQLFEIYMRVKKYLYFFLSFCAFAWALTPYQSVFLGLFVGTSASVFNLTLLVRRAKVFD
KAIEEQGKVYGLGTISRMATAVIVCLIAVEYPQKVHLISVVIGLMTAYIVIMADYLVRYF
ILHKNGEKRGE
>PK3-045_00366 ATP synthase subunit a
MHHEAPIHEHFGLYFNYSNVLMIVVSSLIVFLIAFFLTRNLQMKPTGRQNLMEWIMDFVR
NIIKNNMDWKDGGRFHVLGITLLMYIFISNMLGLPFAITVDHQLWWKSPTADPGVTLTLA
IMVVGLTHYYGVKMRGTKGYFKEFVQPVGFLLPLKIVEEFSNTLTLGLRLYGNIYAGEVL
LNLLVNGLAKANYIGTVAAFPLTMVWQGFSIFIGSIQAFIFTLLTMVYMAHKVSQDH
>PK3-045_00367 ATP synthase subunit c
MGSLAAAIAIGLAALGAGLGNGLIVSRTVEGIARQPEARGMLQSTMFIGVAFVEAIPIMA
VVIAFMVL
>PK3-045_00368 ATP synthase subunit b
MFTNGLVLGAVMNFAGGDVIVQLLSFLLLLWAIKKFAWGPLMKMMKDREEFVANEIDNAE
KSRQEAAKLLEEQRALLKEARNDAQELIDKAKQQADAQRETIIDDARKDAERIKNSALVE
IEQQKEKAVATIRDQVTSLSVLIASKVIEKELNEQDQEKLIHDYIQEVGEKR
>PK3-045_00369 ATP synthase subunit delta
MMDTGVAKRYALALFQIAKENGQIDQLDEEVRVVRSLVTSSPDIHTFLQSPNIALEKKKE
MVKVAFASASEYIQNLLMLLIDRHREEMITSICDQFIALVNEAKGIADAKVYSIKPLTMD
EKRAISATFAAKVGKISLNIENIIDSNLLGGIKVRIGNQIYDGSLQGKLNRLQRQLLG
>PK3-045_00370 ATP synthase subunit alpha
MSIKAEEISALIKKQIESYQSEVQVSEVGTVINIGDGIARVHGLDNCMAGELVEFSNGVM
GLAQNLEESNVGIIILGPYTDIREGDEVRRTGRIMEVPVGDALIGRVVNPLGQPVDGLGA
INTTKTRPIEYLAPGVMDRKSVSEPLQTGIKAIDALVPIGRGQRELIIGDRQTGKTSVAI
DTILNQADQDMVCIYVAIGQKESTVRNAVETLRKNGALDYTIVVTASASQPAPLLYLAPY
AGVAMGEEFMYNGKHVLIVYDDLTKQASAYRELSLLLRRPPGREAYPGDVFYLHSRLLER
AAKLSDAKGGGSITALPFIETQAGDVSAYIPTNVISITDGQIFLQSDLFFSGVRPAINAG
LSVSRVGGSAQIKAMKKVAGTLRLDLASFRELESFAQFGSDLDKATQDKLNRGARTVEVL
KQDLNKPLKVEKQVAILYALTRGHLDDIPVVDIKRFEEEFLNWLDHNHTNVVEHIVKTKD
LPSDDDMNAAINDFKKTFVASE
>PK3-045_00371 ATP synthase gamma chain
MASLRDIKARIDSTKKTSQITKAMQMVYSAKMNRAVINVKAFIPYMSKMEEVTHSVALGS
SGVSHPMLQTRPVKKTGYLVITSERGLAGAYNSNVLRKLNQTIKERHQSKDEYAIIVIGR
IGRDFLLKQGHNVILDVVGIPDLPDFLDIRDVTSKAVGMYDDGTFDELYVYYSHYVSAIQ
QDVIEKKVLPLTEMDASNKTLTSYEFEPSAEEILDVLLPQYAESLLYGALLDSKASEHSA
RMTAMKNSTDNAKELIDNLSLQYNRARQAAITQEITEIVGGAAALE
>PK3-045_00372 ATP synthase subunit beta
MSTGRVLQVMGPVVDVKFDGGSLPDLNNALRIVQGPNSSSNIELTLEVALHLGDNTVRAI
AMSSTDGVTRGAEVLDTGKSISVPVGDVTLGRVFNVLGETIDLDSEIPASARRDSIHREA
PKFEQLSTQVEILETGIKVVDLLAPYIKGGKIGLFGGAGVGKTVLIQELINNIAQEHGGI
SVFAGVGERTREGNDLYHEMTDSGVIKKTAMVFGQMNEPPGARMRVALTGLTMAEYFRDE
QGQDVLFFIDNIFRFTQAGSEVSALLGRMPSAVGYQPTLATEMGKLQERITSTNVGSVTS
IQAIYVPADDYTDPAPATTFAHLDATTNLERKLTEMGIYPAVDPLASTSRALSPEIVGEE
HYNVARNVQSTLQRYRELQDIISILGMDELSDEDKLVVHRARRIQFFLSQNFHVAEQFTG
QKGSYVPVKETVKGFKDILDGKYDHLPEDAFRLVGRIEEAIEKAKSMGVEV
>PK3-045_00373 ATP synthase epsilon chain
MKTIKVNVVTPDGPVHESDVEMVIAKAESGELGILAGHIPMVAPLKIGAVHLKNGSDSEY
IAVNGGILEVRPDQVTVLAQSAELAEEIDYDRALRAKERAEQRLHAQKSEHVDFRRAELA
LQRAMNRISIVEKKY
>PK3-045_00374 hypothetical protein
MVEAFGQQALLSILIHIVFIALSWWALQSLNFEKFLRKNRVFQARVLYVLLAIIMGSVVS
NFLLDYLVWSQQLPLILK
>PK3-045_00375 putative protein YwmB
MKINKTLIIITILIGLACLTIGNNITIARTKSDLITINEILQKQENVTINEWSLHARERL
ENVTSIEDAKAYQSELKTVFPNGDWVETKNHQSWQAKMVLKSSGQTEESIILTTSLTTDN
VQSYIMYEVRGKKLADKEMKRLDMEINKKISDIFRGKPTIFSCIKGEFSDKMNETLPYKV
NHLLDAFQAKKVEALEEDDFISTSAYTPLFEERIDNSEKEMNVQIGLRTQDMGGKTTFVV
GTPIITIEY
>PK3-045_00376 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1
MDKIIVRGGKRLNGTVKVEGAKNAVLPVIAATLLASDGKSIIKSVPTLSDVYTINEVLRY
LNAEVHFENGEVTVDASSDLSVEAPFEYVRKMRASVLVMGSLLARNGHARVALPGGCAIG
SRPIDQHLKGFEAMGAKVQVGNGFIEASVDGRLKGAKIYLDFPSVGATENIMMAASLAEG
TTIIENVAKEPEIVDLANFLNKMGATVRGAGTGTIRIEGVEVLHGTEHTIIPDRIEAGTF
LIAAAITNGNVLVQGAVPEHLSSLIAKMEEMGVVFKEEEDGIRVISAENLKAVDIKTMPH
PGFPTDMQSQMMALLLRAKGTSMITETVFENRFMHVEEFRRMNGDVKIEGRSVVMNGPTN
LQGAEVAATDLRAAAALILSGLVADGITRVTELKHLDRGYVNFHEKLAALGADIERITEE
SELTLTASYVADLNA
>PK3-045_00377 putative protein
MIKIKPFIVLGVILFVITLLVPTILVLPSIQDKKEEVKSHIPPAEKPEPAIEVAVYRENK
QEVEKLDLEEYVVGVVASEMPAKFEKEALKAQALTARTYIVKRMMNQEKTNLPEGALVGD
TINYQVYNNRDELKKIWENDGLDWKKNMAKIEEAVAATKGQILTYEGTPIDATFFSTSNG
YTENSDDVWANSISYLQSVKSPWDVNSPKFKGEVTIPVKDLEKSLGVTLTSDREVLEDVK
YTKGKRIASAKINGKKISGTDIREKLKLKSTDFTMERKGNTVYITTKGYGHGVGMSQYGA
NGMAANGKNYKEIVKYYYKGVDVTASDDMLAKYTAQK
>PK3-045_00378 hypothetical protein
MGESAKVAEESAKVAEESAKAAEKSAKVAEESAKVAEESAKVAEESAKVAEESAKVAGKS
AKAAEESAKVAEESAKVAEESAKVAEESAKVAGKSAKAAEESAKVVGESAKAAEKSAKAL
ITDSSYSLIP
>PK3-045_00379 Stage II sporulation protein Q
MREEENKRTSPKSKVKSFFKKRWAFPAIYIASAAIILTGVLWYQNSASETDKYKYDNADM
PTKQTDEPAEPVAKEFENFAWPVVDEESFITQKEFYDNTASKEKQAESLVFYNNQYQPNT
GIDLKMEDDSEFEVVAALSGTVTKVAEDSLLGNTIEIDHDNGIKTYYQSVKDFQVEEGAE
VKKGQPLATAGKSKLNQEAGVHVHFEVRKDNVAVNPIDYFGKPLSALQSDDTSGATSENG
SAVEESSNSDEEMPTDNNLKNGTNANQDEDSEGSTSTDPNA
>PK3-045_00380 hypothetical protein
MYGFTSVIFGEISVVFTVWRLNISREICHFPLVSDNFSFVSLTYS
>PK3-045_00381 hypothetical protein
MKNFDEAKSESHFTLLTSNLGRASGVHDYIKERTIKIGKYIVETRKTVRVIAKEFGVSKS
TVHKDLTERLPEINPDLANEVKEILDYHKSIRHLRGGEATKMKYKKEELEGETVQ
>PK3-045_00382 Cell shape-determining protein Mbl
MFARDIGIDLGTANVLIHVKGKGIVLNEPSVVALDRNTGRVLAVGEEARRMVGRTPGNIV
AIRPLKDGVIADFDVTEAMLKHFINKLNVKGFLSKPRILICCPTNITSVEQKAIKEAAEK
SGGKKIYLEEEPKVAAIGAGMDIFQPSGNMVVDIGGGTTDVAVLSMGDIVTSSSIKMAGD
KFDNEILQYIKRRYKLLIGERTAENIKINIGTVFPGSRKEEMDIRGRDMVSGLPRTITVH
SEEIEQALRESVSIIVQAAKSVLERTPPELSADIIDRGVILTGGGALLHGIDLLLADELK
VPVLVAENPMDCVAIGTGIMLDNIDRLPKRKLG
>PK3-045_00383 Flagellar basal-body rod protein FlgG
MFKGFYTAASGMLAQQRKTEMLSNNMANSTTPGFKADKSSMRAFPELLQQSVRKNAVGAI
EKQQVGYLATGVYMQEAIPKFTQGDLNQTGLKTDLAILNANVPGNGTNAGGGLFFTVQND
NGVAYSRNGNFTLDGQGYLTTSSGAYVLDENNERIQLTSTDFSVTSDGVLTSSNGEAYRL
GISYTDSPEQLVKEGDGLYRAQDGATLQSAYANNQVTFQINQGFLENSNVDTAQTMTDMM
TAYRAFEANQKILQAYDKSMDQAANEIGKL
>PK3-045_00384 Flagellar basal-body rod protein FlgG
MNRTMITASNTLTQLQKQMDLISNNMANVDTTGYKRQNGTFTDMLYQQFNNQKDETQEVN
RQTPNGIRQGVGAKMAQTQLVMTQGTIKATDRVLDTALTKEGQLYRILVQDGGTSEMRYT
RDGAMYLSPVSNNENMLVTKEGHAILDENNNPILLNNNVKEYAFSPTGSLTVKLDNGGQE
TFNLGISYANNPQSLEKTGENLYRLSDTADENQVMVDLNGGRRNEIAMKQNALEQSNVDI
SKEMVNLIATQRSYQFQSRSISLADQMMGLVNGIR
>PK3-045_00385 hypothetical protein
MALNSSSQEMVKTREQVKEDQKEKNNPEEKTSPKQKIRVRLFPIWLRIVVILLVLAVSVL
AGAVVGYSVMGNGKATDTFKKETWTHIVNLINEE
>PK3-045_00386 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ
MLDINQIKEIIPHRYPFLLVDRILEVEEGKKAVGIKNVSANEEYFNGHFPEYPVMPGVLI
VEALAQVGAVAMLIKEENKGRLAFFAGVDNCRFKKQVFPGDQLRLEVEMTRLRGNFGKGK
CVATVDGEIACEAEIMFALGDKKEA
>PK3-045_00387 hypothetical protein
MTKWMKLLGVSALSAMLLTACGNNDDNQSPPPDDDTTVEDKDLDTNDVVPDRGTDLDNDN
ESDVPDENRDDDLDPTKDDNDPGEDMIEDKDDMNDKDDLDR
>PK3-045_00388 hypothetical protein
MKVRYNKRNEEFAWGGIIVKTFKLISLQILTKEKLIPIKLIDGLIINKEDDFNHWLIEVY
TELAAIAFLDEAFQKKEELLVQAVISKKENDPAPFEVTILSIQNFGDKASILLEGTLKRD
RKDYAELLLQYLIEEGYEGKKLSNKFTELMQSKPQTFLEKKL
>PK3-045_00389 hypothetical protein
MKLRKVFFLVIMLFMLFSNSVLAATVPDKEISKKGEENKQNIQTIKADELETAYKKTDTV
RVVVEMNTEPTVQYAQAQAKQVKELPKSTKEKLKSEKLAEQKTVKEKVKAKKVKFKELEN
FTTIFNGFSGEMKYGDIEKIEELPEVAKVHIATAYERPEEEADMIYSKELVQAQDAWRDY
GFKGEGMIVGVIDTGIDPNHKDMVLSDETEEELSKAEIAQFKKENGLQGKFYSEKVPYGY
NYMDENDIIQDIAEGASMHGMHVAGTVGANGDEDNNGIKGVAPEAQLLALKVFGNDPTVS
TTWGDIYIKAIDDAIVLGADVLNMSLGSPAGFVAADAPEQQAVERAVENGIMMSISAGNS
AHFGNGFANPSSSNPDIGVSGSPGVAYDSLQVASIENSFIDIDALSYQYDGQTEQAGFLS
ASSVHPNSVAEKTFKIVYAGLGTPEELAAVDVQDNYALIQRGEIGFVDKAINAQKAGAAG
VIIYNNTDGFVSMATDASIKIPQLFLLKTDGDKLAAALQSGENISITFDGKKITSANPEA
GKMSSFSSWGLTNNLDFKPEITAPGGQIYSTLENNQYGMKSGTSMAAPHVSGGSALVLER
VDNEFDVSGFDRVNIAKNLLMNTAKPVTDIGTVNSAFDWEVPYSPRRQGAGLMQLHAALQ
SPVIVTEKKTKEGKVALKEVGNTFTFTLEAKNYSDKKVKYDVAANIQTDFAAYGELGYTA
DLLEAQKILDAKIKVNDKDETTISIPANKSKKIKVSVDLTNAKVIDPSQTGSWETPVAID
RVFENGYFVEGYVTLTDPQEKNATLTVPYVGFKGDWNKAPILDGMKYDETSFYGMAGAVT
KEGEDFLYLGYDPITSKFIKEGIAISPNNDGVQEEIIPILSFLRNAKKVQFSIVDSKGKT
VRTLRTQEEIRKNFYDGGKGTKYVLDSNWAWDGKVNGKLVEGQYFYRVSATLDYKGAKPQ
IVDIPVIVDTVSPTVEVDLAEGNKVLEIAASDDENGSGISYLDILVDGKSVVTTPVSGET
TEFTLPNEVKTGTSVTVVAYDYAGNKQEANVVAEEEKKDTTIPVISLTTPEALEVYGEKE
VAFSGTIKDDSDLKEFTIGGQKVDADYNKEKEEYTFNTVIPYENGVHSVEIKATDSADNT
AVFKRSFIVDAEAPVISFKGLSGNRIVNSNGKNPTVHVTVKDNFDDIQLALNGSELYYQT
FKEPYAMRSLEKTVKKVELDLENGLNEFEFTATDLAGHKTTKTVYFYKMTKQEKRKDIKV
PEDK
>PK3-045_00390 ATP-dependent RNA helicase DbpA
MLKTNYLKINVHYYDNRGFFLTGEIENRYLYPNYWKKLLFQQHQESYYGTILDTVTIDEI
EGVLLSGWQLVTLLATEGFNRYVDWDWNDTAQVCLAAAPSILEAIKHKEWIPDFSQWEAG
NFQWSLPNRVMDEFDPSFWEMELHDELAGQTNRDFIQQWFQHSLNHYLEDHQETKQNFHE
QIQTLKNANIPSEQLAAYFTEDKWQEWMGLKETDYPFTLGIRLEEPTEIDTTWDLDLFLR
SKENPDLVVDIHDESNMPKKWLNYTSYIEEEQQRWLLLFPWLKGKSGITNQLTEEEAWLF
LSEASETFLALGVDILLPSWWQAMKSANLKVKAKVSSASHRPSFVGLQAMLDYNWRFSMN
GVTLSEDEFNKLVEEKRRLVFIKGRWIKLDPAFIRQIQDLMKKAEKEGLHVRDIIEQELM
QAEEQQNDELENPKTFAKIQIELNRQWRTMIHQLKEVKNLPLEDVPHSFLGDLRAYQVLG
MSWLLFLRKYGFGAILADDMGLGKTVQLISYLLKVKEIEAELTTPALIICPTSVLGNWQK
ELERFAPDLNVYLHYGANRLKDEAFSKRAHESDVVLTSYGLTHIDKQNFEELTWSTIAID
EAQNIKNAQTKQSRAVRKLKGAHYIALSGTPMENRLNELWSIFDFTNHGYLGSLGQFQKR
FVIPIEKENKTEQIQQLQTLIRPFLLRRTKKDEEVALNLPDKLEQKEYCPLTTEQAALYE
QLVTDTFVQIEQLSGFERKGLVLQMLSKLKQLCNHPALYLKEQAPTSLIDRSVKMEKLAE
LTDTILERGESCLIFTQYIEMGHMIQEMMKKKFSIDVPFLNGSMSKQQRDRLIEQFQAGE
FPIFLLSLKAGGTGLNLTAANHVIHYDRWWNPAVENQATDRAYRIGQTRFVHVHKLICTG
TLEEKIDAMLEKKQSLNDQIIQNENWMTELTTDELKDLVSLNENPAAL
>PK3-045_00391 hypothetical protein
MLLEKYLEPVNFCAENLMDLLDANDPQMKKIVEKGLLLYRQSFVYQVKFSNELVTGMIQD
VTPVRATLDLDYVQQSSCTCHAEGFCRHQLALFFYLLAQVGKVSTWLENWRKPIENAEML
KNLGIMRASDLLKEKEDKEPNYTDWIETFEKSFQSLIETNHTKPYMIAETYYIYIRKIKA
ATPLQTEWKLLYLVIAHVFTFKQLLILSKKLDHNTQTINRYYRHLFHDLMNSIEDNLYKL
SNFTFPFAFDNFLISLKGDIRTILTIQPILAFECIQLYRLMWTDLFATKRWRQDELAQLS
ASTKPSFSEKIAIIHLEILLQKDENALKIIQSLDTQVTSYMLYWIDYLSSRKSWKRMDLY
IPAFIQELKNYICTDDDDDYCYEFTQMAIRAILPYCLAMNKEDLLEKAYIHTLPYSYRKY
EDFLYEKKQFDKWMDLFTMMGYGLDHLHKEQIKTLQEYDQSLLLSLYHRSIQEHIEGKNR
EHYRIAVRQLKKLRTLYKKLKKQTEFEQFLLVILERTKRLRAFHEECRKGKLIHAEN
>PK3-045_00392 D-gamma-glutamyl-meso-diaminopimelic acid endopeptidase CwlS
MKKKVTVLATTAILSTTFAANASASTYVVKKGDTLGQIAKKFNTTVNDIKSQNNLSSDLI
LINQKLSIGDDSKSSSDTTKASKSSTKTSSSAKTYKVVSGDSLIKIANKHSISLGELQQW
NNLSSSLIYPGDILYVSKPGNSNSNPSSNSGSSSSNSNTAVKETTTASTGTYTIKSGDTL
SKIASSYKMSVSQLKQLNNLKSDLIFPGQKLKVTASEKATDTGNSNSNPSSNSGNNSNTA
VKENTAASTGTYTVVSGDSLSKIASSYKMSVSQLKQLNNLKSDLIFPGQKLKITASEKVT
NTGNSNSSSSKPTLISNGNNGQSYASKVVSVSKSLVGIPYVWAGSTTAGFDCSGFVYYVL
NQSGKSIGRYSAEGYYDRSYYVDVPAVGDIVYFKNTYKQGISHLGIYIGNNEFIHADSSG
VRVTSLDNSYYKEHFDSFKRLY
>PK3-045_00393 hypothetical protein
MDFSAVGEKIKELRKQMGLSQKELSHNICTQAQISKIEKGEVLPLSSTLYLISKRLGVDV
NYFFDIGTTPRLDYVEETFRQLKAARRNTDYHTIKQIVKAEEKNPLFTHHKKNYQLLLWH
KAIYVFEIDRDFNRAVKIINEAIKLTFDTVFTEREIEIFISKGIFHYEEGFIDDSLTIYE
QAFKAINQLPYLQDDTIKSRLYFNIAKSLTDQSRYDASITYCKEGIDWAIQQDNLYLLAH
FHYHIGYNYELQKNFDLAIPYMQDALMIFQLVKDHRYTDYIEGKIRSWQT
>PK3-045_00394 hypothetical protein
MIVLFDGVCNLCNKSVQFIIKRDPVNQFSFASLQSETGKDLLKKYHLSEVDSVILLKDDK
YYTESDAALEICSHLTGGWKLLAIFKVIPPFIRDPLYRIIARNRYKWFGKQDSCMLPTEE
MKKRFFE
>PK3-045_00395 Beta-lactam-inducible penicillin-binding protein
MKKRWMLLLIFVLIAVVTGCNKNDPTPDERLSQYIKLWNDEKFKEMYAFLSTEAKKNVSE
EEFVSRYEKIYKDLGIKDLEVTYKKPSEDEKFDKVEKAEIPFSVKMNSMAGEISFDNKAK
LVKEERDKDENWYINWDTTYIFSELGPDDKISVNTIPAERGSIVDKNENPMAMNGVIYEI
GLVPEQMGDNPDAVVSNLAKLLDIKKETIEKAIKADWVQPSFFVPIKKVATGDRAYLDKL
FKLPGVQKQDTKGRIYPFGESAAHLIGYIGSITAEELEENKGKGYSSSDVIGKRGLEQVL
EERLKGTNGEEISIKKADGSTVSLAKKDVKNGENIKLTIDADLQKKIYEKMDGEAGAATA
INPQTGETLALVSSPAFDPNKMIVGLTTSDKEAYENNKLDPFTNRFKNKYAPGSVMKPLV
AAAALTEGVITPEQERKITTKKWQKDKSWGGYYVTRVHTSSEPVNLADALIYSDNIYFAQ
TALDLGKDKFAAELKKFGFEEPFNYAYPIETSTYGKLDTEPLLADSGYGQGHVEMSVIHL
ATAYTPFVNGGNLITPVLLDSEEKSKVWKEKIMDESVANTISDDLQQVIESPHGTARAGK
ISGKTFAGKTGTAELKEKQGEKGTENGWYVTYDKGNKNLLIAMMMESVQDKGSSGYVVKK
VKEIIE
>PK3-045_00396 hypothetical protein
MFRGNAPFFGIKVERGTVKGKRRDESGKVRGTTAYKRTYAEGKLKKQSG
>PK3-045_00397 hypothetical protein
MNEVEQKELEYAIEEITEIATGFGLDFYPMRYEICPADIIYTFGAYGMPTRFSHWSFGKQ
FHKMKLHYDLGLSKIYELVINSNPCYAFLLDSNSLINNKLIVAHVLAHCDFFKNNVRFQN
TKREMVESMAATADRIRQYEIKYGKQEVETFLDAVLAIDEHIDPSLMRPKLAWSMDDVEF
VEEEEPASTPYDELWGLDDRNKPKKPKKKVAKKFPPQPEKDLLLFIENFSRELTDWQRDI
LTMMREEMLYFWPQLETKIMNEGWASYWHQRIVRELDLTSAEAIEFAKLNAGVVQPSKTG
INPYYLGLKIFEDIEERYNNPTEEMKQRGVKPGSGREKMFEVREIESDISFLRNYLTKDL
VMREDMYLFQKQGRDYKIVDKAWEQVRDQLVSMRVNGGFPYITVNDGDYNKNGELYLKHG
FEGIELDLKYLEKVLPYIHQLWGRGVHMETVVEDKPLLYSYDGKALHRKYL
>PK3-045_00398 putative anti-sigma-M factor YhdL
MSEEYKKRLEAYKNGELSKEEAEEIERDLEKMEQYFQVFEEAEIGNPHQAAPLLIDSKKQ
RRIVRRGKWIARLQTALTALGLIILFTILSSIFTAVYYAWGTPDRTDVYRNIIDLTLTVT
DPYGQYSGTSTATKPYFGLETTTDIEKRVGDEIYKTGEYKTNFFFSLMGVPEKKTQGVIS
QQQASFSFLPKESSPSEWKRLEKVKNGTVASVYLSFSELLSTNKVFDYLKDRNVEIIWFA
VDTGVENRDEFGIDPIGFPNTPIWHDDDMITDSTEKEGNFWFSIESSSSSSPEYTEGDAE
ILHKQFLKTLAFLEPYEKKAENFYFGHLELNKRIAYMKKHGINHYGVVITGPTEEILKLK
KENWIRAIHIDEIGFWNWDE
>PK3-045_00399 ECF RNA polymerase sigma factor SigM
MKDSIDTIYQTYFNDIYYFLLSLCHNHHSAEDLVQETFFRAHLYLETFQGKNVKAWLFTV
AYHVFIDQFRKNKRLVVKENDFFQEKMENAQRIEETVLLKEEIQRVKTILKVLPEKQRMA
VLLADFQELTTEEGAMVMNISPTYFKVLLFRGRQTIRQRGKQIRE
>PK3-045_00400 hypothetical protein
MKQKKIIITGYGTVGKEFIELLYRKKEVYIKQYQTELIVTGVVGSVGMIYEPQGLDLTIL
NQLPTGSIGISQYASMKDLVLESPVIQGDILVECTPTNLETGEPALSYIKKALEAKMDIV
SISKGALVHSLPELLAIAKGKGCHIKYSGATAAALPTLDIGEFSLAGSTIQSIKGILNGT
SNFILTSMSEGNLTFEKALQLAQENGIAEKNPDLDIKGLDSACKILLLANGLLHTNLTLE
DVDIDGIDKITKADIQRAKINSCEWKLIATAKKQRDKFILQVKPEMIPPENPLIHVKGTN
KGILFETEEMGAICCVGGASHPRGAAAAAMKDMINLIRQE
>PK3-045_00401 hypothetical protein
MLMVLSRMNIENVCELMDTIDSLKIQLLKYGIEKGLNDPNTIQISELLDTYIVMYQKKMA
QK
>PK3-045_00402 hypothetical protein
MMKLQTNTAMTDFIDKDKFELESYLEYLFNLASEK
>PK3-045_00403 hypothetical protein
MKGWYGHLYDDFPFELFSVSHLIMIGILIIGGIFLVIFRNCIQMIRGIFQSVFFVLLLGF
EVMYHYWMYKDGLWDASFMLPFHLCSISLVLCLLLLITKWEFVFQVVYFFGMIGALMAIV
TPELFIGYPHFRYFHFFVTHILIIWTCLYFVLVHQYKPTKKGMVLSFVFLNSSAVLAWIV
NVYTGGNYMFLAYKPENGSLLDYLGPYPYYILVLEAVAFFLFFVLLMPFRWKKGKKG
>PK3-045_00404 3'-5' exonuclease DinG
MDFIAIDFEIANADMASACSIGLAYVENNALIKEQYFLIKPPSLSFDPKFIAVHGITEKD
VENAKSFPEVWELIKEDISSHTIIAHNAQFDMSVLYSCLEKYQLAKPDFSYICSIPISNR
ATRGAKIGQSLKDRTSYFGISMQEHHHAGSDARACAELVIACIQSRKKNSLSHYCASYPT
LPIKQFSELKPQRTFGRATNFSNKKPFKKFSSVSISDITPTTDSFDVDHPLYEKNLVFTG
DLRTLERKDAMQQVVNVGGIIKSGVSSKTDYLVVGDQDQKLVGSEGISSKEKKAYDLQAK
GKPIEIINEQEFLALLKRERVNH
>PK3-045_00405 hypothetical protein
MKKVLVMSLLSFGLLFSGIFNAHEASAASKKSVVTVAKKYIGTPYKYGGTSPKGFDCSGF
VGYSYKKVGKSLPRTTASMYKKGKKVKKSNLKKGDLIFFKTYKKGASHVGIYIGSNQFIH
SSSSKGVKVDKLSNSYWKTKYYGAKRI
>PK3-045_00406 hypothetical protein
MSAAMKFALSMAIFGSVGYFSAKTNLPSIELVFIRCICACVVLSLVYLFSNKKKETVEKK
EIGFSVLCGVFLVVNWVFFFRSFEHMSVTVAVSIYHLAPVLVVLLGSFLYREKITLKVML
TVITCFIGTLLVGGMQDYLSLESLMSAGLPWAFGAALFYALTTLMGKKISKLNPILTTII
QTGVGVLMLLPFVQWDYFSQLTGENWFYILLTGIVHTGYVYYLFFSSLPKLSSGTIAILV
FIDPAVAIFMDIVLTAYRPDFLQIIGILLIFWGQAHAALKRKVSESGN
>PK3-045_00407 hypothetical protein
MRYEFNPKVKLLLQKHSNETVYMTYINHKWTMPKITLRPPYFKRPVYELHFPKI
>PK3-045_00408 General stress protein 39
MSIYVNDPRDPMYQVPKAYYELVETRNHQSEKLLGLKEVQELFADNKQTDPYPLYPNYGR
ITKYEEIPINFPENRQLRQPGLESYMVPRPIIENDHYIGSGKLKGKVALITGGDSGIGAA
VAIAFAKEGADVAIAYLDEHEDANRTKKRIEELGQQCLLLPGDLRKKKQCIDIVEKTVKV
FGKLDILCNHVGIQFQQARLTDITDEQFDNTFKVNIYSHFYTTRAALPHLKPGSSIINTA
SVVAYAGEPLLIDYVATKAANVGFTRALARSVIKDGIRVNAVAPGRIWTPLIPASFSSDQ
VAIFGSENPMQRAAQPFELAPTFVYLASDDSRFVTGQVLHVNGGEAVSS
>PK3-045_00409 Tyrosine--tRNA ligase
MSPFIEQLTSDQEKEMKRQLDVYRQGVQDIIPTEELAEKIAKSLVTNTPLKVKLGLDPSA
PDVHLGHTVVLNKLRQFQENGHTIQLIIGDFTGKIGDPTGKSSARKQLTDEEVKENAKTY
FEQFGKVLDMEKVELHYNSKWLSSLSFEDVIGLAGKITVARLLERDDFEERLAYGKSISL
HEFFYPLMQGYDSVMLEADIELGGTDQHFNILMGRHYQEKFGKEKQIAILMPLLEGLDGV
EKMSKSKHNYIGIDENPNEMYGKAMSIPDPLMSKYYELITDLEPAEITQIKKELHTGTLH
PRDAKMLLAKTIVRMYHGKEASEKAEQQFIAVFQKGSLPEDIPTAKWTGKNPESLVQLLV
DLHLLTSKSEARRMIQNGGVRINGEKVEEMDLEVSINKDLIIQVGKRKFVKLLSE
>PK3-045_00412 Tryptophan--tRNA ligase
MEQIVLTGIKPTGQIHLGNYIGAIKPALKLAENNDYQAAYFIADYHGLTKIHDQEEFRTL
TYGVAATWLALGLDPEKTIFYRQSNVPEIFELSWILSCFSPKGLLNRAHAYKGIVDSNKQ
AGKEVDDGVNMGLFTYPILMAADILAFQANMVPVGKDQIQHVEIARDIADSFNHQYGETF
VLPEYIVDEETSILPGLDGRKMSKSYHNTIPLFEEPAKLQKLINKIKTDSLPPEAPKDTE
SSILFTLYKEFASVEEIAQMRKKYESGIGWGEVKKELFAVMNRFLEEPRKKYQELMANPE
KIDLILQKGAEKARARTLPFLEEVRKRIGVLR
>PK3-045_00413 hypothetical protein
MAHKMEALLDYIRTRFDSEPKPLLHIGEAMGCWTYHAAIADEIPVLEMALNTTTDNVLIK
LVHEAKELATEQRRTLEEFMIKEGVPLSNSAESKPKSDPNAVPLGAKSTDMEIANLLAAK
VTSNIVMCSTNITQSVRSDVGLMWIRFHTEKSIFGMELKTRMREHGWIKMPPSFYPPGAP
HQ
>PK3-045_00414 hypothetical protein
MEEFLLGGDIMFTVVRLFIFLVFAIILFNVLKGIFQWGKNNQQPRLTSAAKVIGKRTSIH
GGGNTHAYNHYFATFEFPNGDRTEFQLKDEEYGMLAEGDSGELQFQGTRYLGFTRNKRTG
ENSG
>PK3-045_00415 hypothetical protein
MNYTIQKMTEEVAREILSWTYPAPYDLYNGEVTEESLQEFAENPYYAIEQEGNLVGFYCT
GFVAQVPIGYLFQAYPEGYLDIGLGMRPDLTGQGRGMGFMQFIIDSIETKQPLRLTVAAF
NKRANALYEKFGFRKVSAFMNANDVEFFVMTREEGNKPCSG
>PK3-045_00416 Linearmycin resistance ATP-binding protein LnrL
METIVELRHVTKEFQGKKAVQDISFSIKRGEMVAILGANGAGKTTAMRMMLGLIKPTRGT
ISLFHKNPRQKEVLEKVGGMLQEVSVMDSLKVKELIQLVQSYYQSPLALSTLLELTGLQE
EVWNQRTEKLSGGQKRRLNFALALAGNPDLLFLDEPTVGMDVTSREQFWQKIKELNRQGK
TILFTTHYLQEADEVAERIIMINKGEVVGDGTPEQLKEKLTKPRVMFQEKTLYSLNFYRE
LPYVVDVQKEKEKVTLIATNSDQLLQELFERQLDIQHIEVKLGQLEEVFSQLMEDTKGVN
ENEIFLDAK
>PK3-045_00417 hypothetical protein
MKSFWMQSKAEIVRTLRNKYYIFWSLLIPVLFYFLFTNIFTAPRDDEALWNVHYLMSMTT
FSIMGSSIMTLGIKIVQEKAEGWTIFLHITPLSQFAYFGAKMVAQTVIHLFSILVIFTAG
VLINGVHLSFSQWMFCGIWILFGSLPFLALGTIIGNIKKVETASGISNLLYMSMAITGGM
WMPIDVFPTFMQQVAKWVPSYHFANGAWEIIRDQYPSFLNYLMIIGYLLLFMVLSIYIGK
KQEAV
>PK3-045_00418 Sensor histidine kinase DesK
MDTKKRFELFPKRYGFFPYIFLVYVLLPIIQVMQEKGIKQLIGILLVLVFLLAYRQLYCH
MEESIFNYWLVVQILIVMFFSIFYDPNLLFMGYFPANFIGYYSGKKYFYYFYSLFAISLV
IPIIFSWKGVNPQSLFFLVPFFIIMLISPFGIRSMNRRMDLERQLDIANEQISHLVKREE
RMRIARDLHDTLGHTLSLLTLKSQLVAKMVPAQPDSAIQEAKEMESISRSALKQVRELVS
DMRAITIREAIVEIQTALQAAEIESELTIELEDEKVPLLTQNIISLCLKEAVTNIIRHSA
ATISKVLIQQRLGEIELIVQDNGKGVKAEETQGNGLKGMRERLELVDGKWSMTSDSGTTI
HIIVPIIQKEGREEEIL
>PK3-045_00419 Transcriptional regulatory protein DesR
MIRIIISEDQRMLRGALGTLLNFEEDMEVVGQAENGEQALELIKKYNPDVCLLDIEMPIK
SGLDVAEELQRQKSPCKVIILTTFARPGYFERALNANVHGYLLKDGPSEELAEAIRKIMN
GKREFASELIFGSIGKENPLSKREREILVLIEEGKSVKELAAMLYLSSGTIRNYISEAIS
KLGAKNRMEAIAEAKRNGWL
>PK3-045_00420 hypothetical protein
MVDSQNFRRGMGYAFIKLAGAGFAATLFFSYIFLSSFDLYLFSHEIENPYFWIGFFGFGI
LISIVIDWVSNYFPKLELLLYIVVGVCLFLPIMWNVLPILAIVSGFSAILFYIGIKIAAK
VSWFKWIFACTPILFLLLTIPDFTVKKEWNTVRGEQSYEAYFAYFNGEDEVPIKAKKGER
VTVHIDFTNRNGGGFGYYLIDEKNRRIGISNEEKKVLTFDAKKTETYKLIVTGDGLQGGF
EVNWEKE
>PK3-045_00421 putative protein YpbG
MNIVKKRVLLLAILIGICIFFSYYQNNHLSTSSFTLSSPKITKPIKIVQLSDLHSKQFGK
EQQRLIQQVKKLKPDLIVFTGDLVDSKKYDEQKSMTLMERLVKLAPTYYVTGNHEYWSGE
FPSLEANLKHAGVFVLRNEQTLVEVGGETINIMGVDDPTFLSREDELVEIIGGLKDEEHF
NLLLSHRPELFSLYEKIDLVLTGHAHGGQVRLPFIGGVVAPDQGFMPEYTAGMYKKADTA
MIVNRGLGNSIIPQRIFNRPEIIEVVLEKE
>PK3-045_00422 Phosphoglycolate phosphatase
MNILWDFDGTLFDTYPAYTNIIYKVLGEKVDKALIYKELKVSFSHAMEYFNISDQQRSEI
KLMNKGIAADEVKPFTGVEEILKAAKTNVIMTHKSYNGVVHFLRHYGWELYFAEIVTLEN
GFPRKPAVDAYHYLHTKYSIDLAIGDRELDLIPARELGIQTCIFQNQCEFADFQLSNFAD
FFKVYPMKA
>PK3-045_00423 hypothetical protein
MKESREEKKGVHSADENQKGEQGREKRRS
>PK3-045_00424 hypothetical protein
MVFIAQMKTKKESREEKKGVHSADENQKGEQGRERWCS
>PK3-045_00425 hypothetical protein
MVFITLMKTKKESREEKDGVHSADENQKGEQGREKRCS
>PK3-045_00426 hypothetical protein
MNVSSYFQNATIDELKKGYIENSDSYLCLLCGEEIEKGVIYPEGGRLYEAEKYMKRHIED
VHQSVFHYLLSLDKKLTGLTEHQTKLLELFYQGKRDEEVKEELKIGSASTIRHHRFALKE
KERQAKNFLAIMELLKEKDHHAPSFVPVHPTAVMVDDRYNITEEEQEKIVAKYFNNGILS
KFPIKQKQKLGVLREIAKYLDAQESYTEKQLNQHLKTIYDDYVLIRRYLIEYGFLDRKAD
GSLYWLKK
>PK3-045_00427 hypothetical protein
MDRKKELKMQYKEIPVEAGIYTITNKKNGKVCVVSTRNFKTINGVKFSLENGGYANKKLV
DEWKQYGKEAFSFEIVEVLKQRKDDPYYNEKEELTKLEEKWLEKLQPFGDSGYNSRKE
>PK3-045_00428 L-methionine sulfoximine/L-methionine sulfone acetyltransferase
MIREMKETDLEEVLEIYNDAILHTTAVYDYRAHSLEDRKAWYNQKLEGGYPLFVFEEAGR
VLGFATYGPFRAWPAYKYSIEHSVYVHKEARKKGIGTHLLKALIERAEEEGYATLIAGID
STNKGSIFIHEKLGFTYSGTIKKAGYKFEKWLDLAFYQLELIGPKSPVEE
>PK3-045_00429 hypothetical protein
MIRPAICDYPEHYRGYVGLVPEGDIIAIINAQIEETVAYIKKNEDRRDFRYAEGKWSLIE
VIGHMIDTERIQAYRLMRIARGDKTPLAGYDDEGYVENARFSTRTIEDLLEELVAVRKST
VSLLRGLSEDTWENRGFANNGEFTVLALAYIIAGHELHHLKLIKERYMV
>PK3-045_00430 Sodium, potassium, lithium and rubidium/H(+) antiporter
MELLITIILLLFCLLISNIVSHYIPSIPTALTQIAFGVVMALLFSDFELELEAEWFLLLF
VAPLLYNDGRHFPREELWKMRTSILGNAIILVLLTTIVGGYFVHWLIPSIPLAAAFALAA
ILSPTDPVAVNGIAKRIHIPASVLNLVRGESLINDASGLVAFNYAVAAVVTGYFSITEAL
TDFTYTFFIGAVAGLVLSLLIIIIRFILRKQGIQDVTFHSLLQVLTPFLIFIIAEEMLHA
SGVIAVVVGGIIHSLVSERTETMLAEEQVLTENIWSIVIFILNGIVFLLLGLNIPSSIVD
TVEDPSLSNWLIIGYVMLIGMVILGIRFFWSYLFSIYEYKMNKKREIEKPSIKHTLLVSL
TGVRGAVTMAGVLSIPFVIHTGQGFPERSLILFLAAGVIMFTLLAATIFLPFLSKSSGET
EINDEDLVIRAKKKIMLSTIDKLYLEMNEENTAAAYELIDEYKRRIKQLNYQVARTEEEE
NNYSALVEIRLRALKEERNYVHQLVKKEKISEEVFAIFEKSLDYREEILCTNVQTGTRFL
FGKAMRGWKRFVRKHRGNKSDRREQIRISKEVLLNSMKSALFYLEQWKETAEHKQQVESV
ILEYRRMVDRWEKPTASFNERLQEQIEELRLGIVDQQRAAIQKMYEKGEVNREQAKELRR
FVHYIESVTLYEYEE
>PK3-045_00431 Adaptive-response sensory-kinase SasA
MAVYTPQTRFHPEVALTNLSDMTSGAHILYLMNDEDKYITNAASFLKTGLLLEQIVIFVD
QKKIWPLIIKKLEANGLHTKLIDKINFINSEDVYFKNGELCLENMLEASKDLVDPTLFFN
KEITIRYWGKIIPRVLSEKSNIDKLLQYEDEVDEYIRNYHNYTVCVYDGMELSASNYIRL
KKYHPYVMTDTEFTLSSVYEKEILPPSPVRNGKYEETIANLQLAQTYYSRLVEDMLDAVF
ITSNNIIMYVNKAAAKLLDAEDLVGKSAYEIMEPDFLENYLDKKRNIWREEISTPYEMQL
ITSKGKKVEVEVLAYPFLFEDLSSTIIIIARDISVRKENQQLQIKNEKLGIAGQLAASIA
HEIRNPLTAIKGFLKLAYQGAMKLDDIYPILDLEINRIETIASELMFLGKPARSEIKETN
IGKILLDVYTLMQSQANLDNVVINLDTYGDHLITLCNVDQIKQVFINLVKNAIEAMDNGG
TINMEAKLDGKWVVVTINDNGKGIPDEVKNKLGEPFYTTKEKGTGLGLVICYNIIAEHKG
KIDFVSEDGMGTTFTIQLPLANK
>PK3-045_00432 putative protein YdhK
MAAIFAVLLLFYGCSSGEKNSDGENQSTQTQHEHKETGSSDIPDDLEPASDPTYKEGSQV
ILKADHMEGMDGAEATVLNAFNTIAYEVTYTPTTVGKPVKHHKWVIQEEIKDAGNEMLEK
GTEVTLEADHMEGMKGAKATIESAENTTVYMVDYQPTTGGERVTNHKWVTEEEVYPE
>PK3-045_00433 UTP--glucose-1-phosphate uridylyltransferase
MKKVRKAIIPAAGLGTRFLPATKAMPKEMLPIVDKPTIQYIVEEAIASGIEDIIIVTGKG
KRAIEDHFDYAHELEQNLRDKEKFELLEKVQYSSNLADIHYIRQKEPKGLGHAVWCAKSF
IGDEPFAVLLGDDIVQSDTPCLKQLIDQYEETHASVIGVQTVPDNETHRYGIVDPGESEG
RRYQVNNFIEKPAPGTAPSNLAIMGRYVLTPEIFMYLENQKTGAGGEIQLTDAIQQLNQI
QRVFAYDFEGDRYDVGETLGFVKTTLEFALQRDEMREEIIEYMKTVLDKADLDKIKVL
>PK3-045_00434 hypothetical protein
MPFCGNPSNFGGDLELLARNTETRAKLNEEILGYQPFFSTYQPNLSTYQPFFRFISQTSD
LSAKPQIYQPNLSTYQPFFRFISQTSDLSAKPQYLSAKLQIYQPFFSTYQPNHQQLPTPS
HSHHKFQIKTPLTCRLSTSKRRSLITIL
>PK3-045_00435 tRNA 2-selenouridine synthase
MFQDITIERLFELREKKEFSLVDVRSPSEFNEHTIPGSINIPLFTDEERAEVGTLYKQVS
VEAAKARGLEIVSAKLPAFIQSFQELSRDVVVFCWRGGMRSKTAATVIDLMGVHSYRLQG
GFRTYRQWVIHQLDTMEMAQEAIVLNGYTGSNKTVILQHLKQEGLPVLDLEGMANHRGSI
FGQIGLKPHNQKTFDSLLVGEIEKLPASPYFLMEGESKRIGKVLMPNFLLKKKEAGLQLF
IHMPIEERVQHILADYSPADHHDECVEAFQLIKRRIHTPAAAKIEEALQTRNYAEAVELL
LTYYYDPLYERTALQYKDEQTIDLYVQNTEDAIIKVKEFWQKKSRTSAKSEVN
>PK3-045_00436 Selenide, water dikinase
MTQSYSVKLTSLSSKGGCGCKIGPADLSEVIRTLPPAEKNPNLLVGLDTSDDAGVYKLTD
ELAIVQTVDFFTPIVDDPYSFGQIAAANALSDIYAMGGKPLTALNIVAFPISVLEKEILA
DIMRGAGDKVKEAGATLVGGHSIDDKEPKFGLAVTGTIHPDKVRTNAGAKPTDKLILTKP
IGVGILTTSIKRGLLSAEEIDRVTKVMATLNKKAAEVMEAYNVHACTDVTGFGLLGHASE
MAKGSNTTIHIKRDQVPVLPRVKELAEQGVIPGGTKNNFAHLEGDVTFASDLDELDQLIL
CDAVTSGGLLISVEGEQADALLQELVDAGVEAAIIGEVTEESPGHIFVG
>PK3-045_00437 hypothetical protein
MSTLAEEQSSKKRTFWFAFLFVLVAVIGLTYVKWWPYYHKAILSFQTNSIGDSILQDQIS
GTFTWSAAVDYTVTYFQSVWKAAILGILLGSLVQVLLPTGWLLKVLGKTSFGSTAAAGLA
SIPGMMCTCCAAPVAVGLRKKNASVGASLAFWIGNPTINPATLIFMTFVLSWKFTLLRLI
VGLVLTFGISYFANRFVKNPTPVSVDKLIEDAEVDKRPFLNRWLTSLGSMVLYVVPAYVL
SVLILGAARFWLFPQLSDSMSNSLLAILLFAVAGMLFVIPTAAEIPIIQTLMAMGLGAGP
AAALLITLPSISLPSLLMVAKSFPRKVLVFVSISVVVLGIISGLIGKLIF
>PK3-045_00438 Arabinose metabolism transcriptional repressor
MGRHSKKVMVMESVKDWVINGRVKPGDRIYSEYELSKLFDVSRHTVRLAIGELVDEGWLY
REQGVGTFCGEPFASRKGKKIANGKNIGVMTTYLSDYIFPSIIRGMETYLTEKGYTLTLV
CTENDHAKERLCIRKLLDLNMDGLILEPTKSSHFNPNLDYYLELEERHIPYVMINQYYSQ
LSPFYLIMDDVKGGYMATNHLIQLGHEQLLGLFQSDDLQGVHRMQGFLQALRNEKLPIAP
ELVVTFTTEELHAGLEEKILNTLTNRKNIPTAIVCYNDNIAVIVQKVLQKLHLSIPEDIS
LVGFDDTALADSPNLPLTTIAHPKSHMGRDAARRIIAAIEGKEYTLFLKDPIIYEPELVI
RSSTNIVKKNRSAVY
>PK3-045_00439 Cephalosporin-C deacetylase
MKKEQVINEYREYKGSGRKPADYDAYWDKAIQELAEQSLDYELERVEIPSKTAEFFNLYF
TGVKGARIRCQYIRPKKIEGKVPGMLMFHGYHGDSGDFGDKLSWVTEGFAVLAMDCRGQG
GESEDKTTAKGTTLKGLIIRGVEEGPESLYYRSVFLDTAHAARILMSMEEVDEEAISVQG
ASQGGALSLVCAALEPRVKKVVVQYPFLSDYRKVFELDINSSAYEELAYWFRFRDPMHDR
EEEFLDTLEYIDLQHLAPRIKAEVKWAIALEDGVCPPATQFAVYNQISSPKEMIFFPEYG
HEYLPKLGDRVRGFLLNHE
>PK3-045_00440 hypothetical protein
MSKMIILKEETLEFYLSNGLIGYLFRVIGKNTPARASLFLVKANRQLDNSQYILEREIRP
SINQIEGNHPFTLEHIRKQ
>PK3-045_00441 6-phospho-beta-glucosidase GmuD
MKKFPENFWWGAATSGPQSEGRFNKQHANVFDYWYETEPEVFHNHVGPDTASNFYNSYVE
DIALMKEINLNSVRTSIQWTRLIDDFETASLNEDGVRFYNNVIDEFIKQGITPVMNLHHF
DLPVELYHQYGGWESKHVVDLFAKFARRCFELFGDRVKHWFTFNEPMVIVDGQYLYQFHY
PKVVDGKKAVQVAYNLNLASAKAIKEFRDLKMNEKGAKIGTILNLTPSYPASDKPEDVEA
GRIADLWRNEMFLHTAVYGEFPPALVELLTKDKVIWEATEEELAILKENTIDTLGVNFYH
PSRVKAPDVAPNSVGDWMPDRYYDHYAMPGRRMNLDKGWEIFPKALYDIAINIRDNYKNI
EWFVSENGMGVSREERFLNEEGVIEDDYRIEFIQEHLEWIHKGIEEGSNCYGYHLWTPID
CWSWMNAYRNRYGFISNNIHTQVKTIKKSGYWIKEVSAKNGIE
>PK3-045_00442 Beta-glucoside kinase
MSLLVMDIGGSSVKFAVWEKEKLVDKGSFITPKMWDEMKQEMMQLKEKMDAKYTIEGIAI
SAPGAVNQRKGVIEGASAVPYIHHFPVIFELEELFGCPVSMENDANCAGLAEVWKGAARG
MQNVLFVVIGSGIGGAVIVDGKIRHGKHLFGGEFGYMLLKEDKTFSDLGTAVNMAKRYSK
RMGLETPLSGKEVFELAEQGDKAAKEEVETFYHYLATGIYNLQYSFDPEKIIIGGGVSAK
EGLLDELNVHLARVVESTKIAPFIPDVAICDFQNDANLIGAVYNYELVFGK
>PK3-045_00443 hypothetical protein
MESAESQVSVRKAQAKCAKSQVSMRKEQVKCGEPQGNSQELQINGQNPQVI
>PK3-045_00444 L-glyceraldehyde 3-phosphate reductase
MYMANDNRYEKMIYNRVGKSGLKLSALSLGLWHNFGGVDLFENSRALVRKAFDLGITHFD
LANNYGPPAGSAEENFARILEKDLQPYRDELIISTKAGYGMWAGPYGDGGSKKYLVASLD
QSLKRMGLDYVDIYYHHRPDEETPLEETAEALDLLVRQGKALYVGVSNYSSEQTREIARI
FEEKKTPFIIHQPSYSMFNRWIEDGLKDVLVEKQLGAIAFSPLAQGLLTDRYLNGIPEDS
RANRETGLWLHKENVDQTIDKVRALNNIAKERGQTLAEMAVAWILRDGIVTSVLIGASKV
SQIEDNVKALDNIRFSAEELAAIDKVLKG
>PK3-045_00445 Cellobiose 2-epimerase
MKKVEFMEELENRILPFWLNLMDKENGGFYGVVDYHLKIHPESHKGGVLGARNLWTFSAA
YQYKQDPAYLEAANHAYDFLKTKLWDHDNGGIYWLVDYKGKPVISSKHVYAQSFALYGLS
EYYKVSKDVEVLALAQKLFYLIEDVCYSEALNGYLEEFNADWTKKENVLLNEGADAAFTT
NSHLHIIEAYTNLYQIWPDERLLRKIDNLLILFHTHIFDHQKHYCQAAFDQNWNSIKDPF
SFGHDMETSWLLTEALNVTKLDRPDIVEMNKLLALEVAREGLAEDGSLMDYKANGIIHAT
RVWWGQAEAVIGFHNAYEITDIPNYLMYSEDVWKYIQATIQDKREGGEWYSRIDADGEVI
SSLRDEKYQTQENIVDSWKCPYHNARMCLEMIKRLAN
>PK3-045_00446 hypothetical protein
MKKTNWQLFRFTFVFFNSQATVFLISALTSSSNYQGWLGIVLGSLLSIIIILCLVFIDKY
SRHTPWIQFGKHVFGKWIHFFFITLLLLWCIYYASYDIQSFVLFFGVNYLRETPFWFLQL
IISLAILFIIRLGISTIIYIADGMFILIFITLFLLFYLFTFDINLDMIPAFYHYHDPKLI
FTDSLTVLSWVGEWVVFLFILPEIQMKKGIFKNLFIGQITISCMVFFGWLLTLLNFGPEL
AKSFQIPYLEMIRSIDTNNLLAKIDPLLIGVWTSSMLIHSSCLLFAAYKCILYLSKNKGN
NFIPFFVVALSNVIALYYVKHITTYQEHFYSFNLVLVWLIVELIPLYYLLGMVLKRKKLF
IKSRKKETS
>PK3-045_00447 Spore germination protein B3
MKRIRTILLLLLAIPFLTSCWSKHELNELVFVTGIFIDNGKDPNTVEVTISTPLPNRVMT
VNSPGSSEGSSYSLLSKTGSNIPEALQTIQKDLSRKLLLSETKIIVLGREYAEDGINELL
EWIQRNANIRISSSILVAPNTAKEVSQLTPIYEQFPTDVLSAFVTKEHLVNTNIKECLLA
NANHSAFVTPYLSYGEVPSVEEDSKKIPWSGIGGSALFTDNKLTRIVNVKESRAIAWAKK
KVTAPLYTVNIEGQGHATVIFNKTSNEKSFKITENGPEFTITLNGSASLIYLNVKDKEVK
SLHRDIIRAVEKEIHTDLKEGLRKSQEVKADILHLGSLIVWNDPENWKKLQKNWSDVYAE
TTINIKTNFNIIDTGKET
>PK3-045_00448 Spore germination protein A1
MTQSYINLIKIQFKDISDIVYKSFHIYNHSCVIAYIPSIVDNDVLRDYITRNLVNEKTSN
WSNFVISLNKGEAFNIPYEQVKSANEAASLITCGNVILIFDDHPTMYAFNIVRYSTRTVT
ESQNEMVIIGPQEAFIEDIQINLSLLRHRIKHTDLKVKEYQVGKYTKSKIYIIFVEGLYK
PEVLEDIEQRIKHIKIDGIFGVTYLVEFLNTKNFPFPILQYTEKPDILAASLLEGRIGIM
MDGSPTSIITPVTLISLLQSAEDYYQNYFTASWIRIIRFLFSILSIFLPAIYVALTTFHP
QVIPSDLLVTITAARENIPFTSLTEAFIMEITFEALREAGMRIPKPIGQTVSIIGGIVIG
QAAVQAGIVSAPMVIVVSVTGVASYIIPHLELNLIFRLLRFPLLLLGGIMGLIGVYIGGF
LLFAYMVSLKSFGTPYLQPIAPLVLADWKDGLFRFPHRSSKRKTDAFARKRSLWKEKDK
>PK3-045_00449 hypothetical protein
MNNYLERVRKLSNLEPKTLEQMALKLSEEAGEVSQAVLSYSNASGSDYKQLNKEDIKEEC
VDTLLVALSLFYKLSNQEEELYDLLDKKMNKWENKIS
>PK3-045_00450 hypothetical protein
MSKKEKIIEAAKQLFRTKGYHDTAIQDILEQAKVSKSTFYNYFSTKSQLILSIIQKVDEK
VDEQQDTLLLEGSPYDKQLFHSQLRVKHSIYGTEKISELYNISLGENDEELQSYMQERHY
KELNWLSKRLIDVYGKEIEKSAMDLSTHFIGSLGYQFRYSDQIKLNISSSDILDYNILRL
ENNIEITKQTNQVLFPYKSANSADDQESAIREIRKLLDKCISWDELSQEQKELISFILEE
TQSSYTRWGVCEGAIRQLQTLSSSTDLSYQNILKELFDIIHTQKDIYQ
>PK3-045_00451 putative carboxylesterase nap
MNHLKSDDPKSTYIQSYDNVLKALWPTQFSSYFVETSYGKTYIIESGDKLSPPLLLLHGA
KMSSTMWYPNVAEWSKHYRVICIDILGDTNKSIAEKPFSNRLSYASWLNEVLDSLKIAKT
NIVGLSYGALHTVNFLTFFPDKVNKAVIMSPAATYIPFQPEFYSYAIGLVSNEAGVNNFL
NWIFGNRYTVDPLIKQQLIAGMKDTVSSPPKATQVKQAFPYVFEDEELAQIQTQLLLLLG
EEEVMYDPVEAFNRAKNSSPHIMTEIIKGVGHLMSMEKPEQINNRVLNFFNK
>PK3-045_00452 Multidrug export protein EmrB
MTNIRTHPIDINGNPFSRAGFVIVLMIGTFLTIINQTLLVTALPKIMVDLDISAINAQWL
ITAFMLISGIMIPTSAFLLNTINNRTLYMTAMVSFVIGTVICALSPTYNILLLGRIIQAV
GSGLIIPLMQTLMFLVYPVERRGEAMGLVGIVIAFAPAIAPTLSGWIVDYFNWRYLFYII
LPIAVINMLLACFYLKNVINLNKPKIDILSIILSSLGLGSLLYGISVAGNIGWQNKITGF
SCIAGLLIIILFSHRQFKLTQPFLELQVFKSRTFTLSTMIVSIIFMTMIGFEILLPIYTQ
TIKSFSALQSGLILLPGAIVLGIISPISGKLFDKYGVKKISIMGMFILAAATFPFLYLSN
NTATWWIVCLYSFRMLGMGFVMMPLATAGINALSNDLISHGSAINNTVRQVFASLGSAVM
VGVMSATVTKYSSYYEDSSFIPLLNGLKNAFISGLILIVIAFILCFFIKSPSNKAE
>PK3-045_00453 hypothetical protein
MTIGFDCATKLTAKMAKDLYGAGFRYAARYLGDSWKSFNKKEAEVIQKAGIKLISIFQKS
ANKISYFTEKQGTVDGKDAEKWAKAVGQPAGTAIYFAVDCEVTGKQMAQIQAYFAAVKKE
LKSYKIGVYGSYGVMHAMKGEVDYLWQTYAWSRGEVAPFIHMYQHENNIILEGVNIDRNQ
IMQSPGHWGADKMQANKYTVQQETGAFLTAADAKAGQNKKGIVKPGTYSIFNKSQGMINV
TKIAGKPGSWINPQQETVHIVSSGETLTKIANIYGTSLSSIQAKNPQIKNVDLIYPGQAI
KI
>PK3-045_00454 Oxidoreductase P35
MKKIEKEVRWGIIGCGDVTEVKSGPGFQLAENSKLVAVMRRNGELAKDYAERHHVSKWYD
DGEALINDPDVDAIYVATPPAFHKEYALLAAKAGKPVYVEKPMARNYQECLEMIEACKQA
DVPLYVAYYRRALPRFLKIKEIVDSGVLGDIRFVRTIQYQPPLKDDQAWRVQPELAGGGL
FLDLASHTLDILDFLLGPIKEAEGFATNQNGSYEAEDMVTGNYLFESGVHGTGTWCFGAY
DHMDENEIVGSKGKLTFATFGNGPITLTTSEGTEEWVIENPRHIQQHMIQLMVDELTGKG
TSPSTGVSGARTNWVMDQLIKGYYGEKASR
>PK3-045_00455 Multidrug export protein EmrB
MTTYITSYIIGSILLLLIINLLLRKKKTVAEPNRVMEDAKKENDTASSLTKSEMVKQEEP
SKKEDGVAEAMETNEGISDEEERLANAVESNEIADEEEPAAVAKESKTAKAPYKPLEMGE
EINRGKVIVALMLGAFVAILNQTLLNVAIPHIMNDLNVSTSTVQWLSTGYMLTNGVFIPI
TPFLINKLGTRKLLISAISAFTIGSIVCATSVGFSMLLIGRIIQAAGAGLLMPLLMTVFL
IIFPPEKRGTAMGIMGVVMIFAPAIGPTLSGWLIGHYSWRVLFELVIPIGILDLIIAILW
MKDVTKVSNPVFDTIGFITCTVGLGSLLYGFSEAGNNGWDSRVVVLSLVIGVIFLCLFVW
RELTTEAPMVDLRVFKYSIFTLTTLVSMIVNMAMFAAMLLLPIYLQNIRGFTALDSGLLM
LPGAIVMGIMSPISGKLFDRFGARPLAIIGLVITVLTTWGFTQLTMQTSYSHLMMLYIFR
MFGMSFIMMTVMTEGMNQLPLSLTSHGTAVSNTARTVAGSIGTAFLITVMTNRTAFHLDN
YNNIISSANPYIAEKLAQLGQGLAGLTGLPTGAGQTLAISTIYGKATQASTISGINDAFI
VATIIASVALVLSFFIRRATASSK
>PK3-045_00456 hypothetical protein
MNSKRMILLNIILLIVLVGGGFAGYYFYDQSVSYIKTDNAQIAGQQISIASPATGKLTDW
KGEAGTSFNKNQKIGTVEVVTESGTNKMDITVPEDSTIVQSSAVPNTFVAAGTSLAKSYD
LENLWVTANVDETDINKVKVGQEVDLYVDAFPETVLTGKVDSLGLATAGTFSLLPSNNSS
GNYTKETQVVPVTISIDNYGGLKLIPGMNVSVRIHK
>PK3-045_00457 hypothetical protein
MNGSLNNELIRSYSRINKAYNHLVHLDAKTLDLTAVQLKTLYRIYFCPNIGIGELATKLS
LTKSTVSGVIDRLSQRQLIERTIPENNRRSVNIQLTAEGQHVMQQYFAGTSILAGKVREV
MQLPEEDINKLLELNEKILTILNEIEEEQP
>PK3-045_00458 hypothetical protein
MHHRIWNNPAYFRYLFFILFIISIILNRYILQNHDNYFILYILCSIFLGLGFYNSSLWKI
VLLTFLVVICRFFFIPDPHTSSMLTFITYLLTYLLITFISVAFMSRVQRVMEDNLALTKV
LSNALDSRDSYTMHHSKNVAKYAMQIAKKMKLPHHLCEVIHIGGLLHDIGKIGIPESLLT
KPGKLTEEEYELIKTHTTKGYEIIKHVKQYKNSGILDIVLYHHERFDGKGYPRQLKEEEI
PLLARIVAVADTFDAMSSGRVYRKELPLAEILHEIRLNKGKQFDPNVVDAFLALFEEENK
PFTAD
>PK3-045_00459 hypothetical protein
MNDQQRSFFDRLVSIQEKYTKEAQEYWSLYSSIDSWQFWVVLLMLVVPLIVLYFTIDRKR
IFIIGFFGFAVHMLFFYADAIGIRFGLWAYPYQMLPFLPSFSLDGSIIPVAVMLVFQWTL
KHGKNFYLYAVILAAIFGFGFKPLLTSIGLFEPYKWVNFFHIFLIYLLLYIGGYLVTKLF
MKWQEDE
>PK3-045_00460 hypothetical protein
MLVLILIVLLFNTLAYSIPKRLTPIEMLTTTLFAMLIQLLTDIYLSLKYNIYGYFEKGPD
WESFIYILGIYPAVNIIFLNCFPYKKRLRNKIVYVFVLVVLAMIFETIFIWSGTFYLNGW
KQSYSIFTYPVLYVTLLLFHQFTVKLLKRSRRESDH
>PK3-045_00461 hypothetical protein
MTILLFIIAGIAEIGGGYLIWQWLREGNPYYWGIFGGISLVLYGVIATFQSFMSFGRVYA
AYGGIFIILSVLWGWGIDRKTPDIYDWIGAGICLIGVMIMVFAPRH
>PK3-045_00462 hypothetical protein
MIDIKITFHAFLNNMTLIIAFMFLALQLKEYLVLRYKNILKYMWVTPIVVSLLSIAAMWE
PLIYGEVRLDLRGVPIFYISYLLGWKCGLISTILPALYRYQLGGTVVMEGIFQAIILPFI
IGAFFQNKKSHNPPYSIVNMKHMLSAFFCYQILRLFLILQTTHVSFMTVIVLIVFEFIAV
LSIFFMQNGVSRKQLLRKELEYYSRHDSMTDLYNLRFFRTNVEKLMQHNVPIVIAMMDVD
YFKKYNDTHGHPAGDAVLRTIAQLLNDTMRQEDVFARYGGEEFIMCFTKITNMQTAATIA
ERFRKNVEEYRFFGEETQPNGKVTVSVGIGGLSAGKSLDELIKESDQMLYKAKKLGRNVV
VCSSS
>PK3-045_00463 Transition state regulatory protein AbrB
MKSTGIVRKVDELGRIVIPRELRRTLGIEIKDPLEIFVEGEKIVFQKYKAFEECAITGEV
SPDNITVGNGKLVLSKEGAALLMKELETVFASESQK
>PK3-045_00464 2,5-diketo-D-gluconic acid reductase B
MHTTIPQITLNDGLVIPAIGLGTYNLRGATGVQAMTSAIDMGYRLLDSAFNYENEGAVGE
AVRRSTVSRQQLFITSKLPGRHHQYDKAIYTIQESLYRTKLDYYDLFLIHWPNPKTDLYV
EAWQALIDAQKWGLIRSIGVCNFLPEHLDRLKKETGVLPSINQVELHPFFSQKEQLAYDK
ANGIVTESWSPLGRANNVLENETIKQIAEAHGKTISQVILRWHTQLGALPIPKSSSPQRQ
QENLEIFDFKLNEDEMNKISSLTRADGRIADQDPAVYEEF
>PK3-045_00465 hypothetical protein
MGWILLKQARKSADISRSWAGISQSAGDISQSRVGISQSEGGISQTRKISAEIRVESAKQ
RKYQPTPIPLPTKKRIFKQTNRINEIEKGSGKLFINEIGKSNRLKTTEILIKRLKETYKL
RPNVMEDLRKLLAGYRGEKDMKYYFQFLPDKDCLIIHNLRLYDGKTYFQMDYLILTQKFA
LIVECKNYYGEVEIDSNFNQMIRKVDEKVEGYSNPISQAKRHQRQLQKYFQLHNLPPIPI
EFIIIFSSSSTILKGSPAIRDKVIHSHSFLEKWDNLSQKYKVTVVEGKLLRKVSKNLLKN
NTPESIDLLRKYGIPQSDLITGVQCPACEKFAMIRQKRKWFCPHCHTYDKNAHHQTVNDY
FLLIKATITNKEFRQFANISSRETAAKMLVRMNLQSIGENRGRKYQNP
>PK3-045_00466 PTS system oligo-beta-mannoside-specific EIIC component
MFDKMMGNIEKVMGPVADWASSNRYLKAIMTGILATLTLTIVGALGVIIGKPPIPEVVFD
SESIFAKMLVGWANWGDNHLWIRGINDISTGIIGIAFTMGLTYNLAKHYKLNELGALITS
LMIYFFIVGEPTSILINDVATLQVNMSAFGATGIFSGIIISIIVVEIIRLFHVKDIGIKF
PDSVPIYVKTSFNAILPGIVTVLVFILINGILTALFGVKLPELITTIFSPLVNNFDNVFL
VGLFMLIINLFWFMGIHGGSIIMPIILPIELQNIVENLNNYSAGLPYDKVFTTPVHFGFI
LIGGAGIFALAFLNFFSKSKGLKQIGRIGFIPSVFNISEPTMFGTPIPFNTKLFIPFVTV
PVINTIITYAAFDWFHFINYPILNVPAQTPVILIAMAASASVKAGLVALIIILVDIAIYY
PFHKSFEKDMMKEEQEEEQMTARSNDQESGISVQ
>PK3-045_00467 PTS system oligo-beta-mannoside-specific EIIA component
MEETKMNLEQLCMEIILYSGNARAYILESMDYIKPKKKDKINELMLLAKEELNQAHKKQT
TLLAAEAGGDGVQISVLLIHAQDHLMTTITMRDLIEKLTEVL
>PK3-045_00468 Lichenan-specific phosphotransferase enzyme IIB component
MNILLVCAGGISTSILEKSIRDSFGPEKADWTVEAHPVDQLENLIDRFDVVLLGPQIRHK
LRTVKKVADANGKPCEVIDSRDYAMAKGSKVLKRIEELIQ
>PK3-045_00469 Multifunctional alkaline phosphatase superfamily protein PehA
MTRKIIFLVAGMKRPNIVMIVADQWRADSISYTGNTTTVTPNIDSLVEDGVGFSNAYCQL
PVCVPSRSSFLSGWYPHTKGFRTMHHLMGEEDPNILKTLKKEGYHVYWGGRNDFLRADVD
VAEYCSTRDNQYAEFFRKMREAQPKKKESKDFDYSHFKGVKESPAKLDWEQINNAIEFLQ
EERYEENPFCVYLALSLPHPPYQVDQKWYEQIKKEDIPNPIRLTEEEWKLKPSILRGIRE
NQKLYNWSDEQLREMKHVYYAMGTELDHYIGELIATLKDKKLYDDTLFIFFSDHGDYTGD
YEIAEKNQNTFEDMLTNVPLVIKPAKGMEVKQRVTAALTELIDIQATILDIAGITPDYTH
FGKSLKPVLEGKEEHREVVFSEGGRLEGESHCMDAGHDPSNEYWARTIEQTKMPQHTKAM
MIRDQSYKYIYRLYEQDEFYVLTEDPYETCNKINDEKYAPVIQRFKEKMLKHFFETGDVV
PQRYDKRT
>PK3-045_00470 putative licABCH operon regulator
MNLIEKDMKLLEEFLREEQYIPIKNLMFAFGVSEKTIRNSIGSINVFLEKFNSKIVAKRG
EGYYLRTSNREEILKSITRVSDTPFFSSSDLLENVFKRLIEEVKYVKLEELCDEYYVSRS
KMSSIISKLKKEIQTYGLVLKSKPHYGFKISGTELGKRLAIANMLRPKIYLDGTPKLFFI
EDFIVKEWKIRDINCSDIVLQNIIYHIKIMIRRVLAGHPIDIPTENMTEGSLEHEVSQSI
IEKVENVFTMKMSDAEIVYVYSHISGQIFQNDSQAGMHISDARINMIIDSFLEKIESMYD
ISLWKDQKLRSGLLIHLRPLIGRIMKDIHLRNPILHDIKKQFAFAFNLAVLLAEKVNSIF
KCQLTDDDIAYLTMHIGLALERDFKKFDDKNFNRIAIICTTGQGTAQLLKFKIEQTFPKA
HMIKNFSLYHQEDVIAFNPDIIFSTVPVDINNIPIEVISPFFTEEEKRKLLEEKSKVKTE
YILDKYFSKDLFQSNLDCNDQKEAITKMCDLIGKTGITPPNFEELCLIRESLASTAFGNQ
IALVHPIELCSEVTKIGIGILKKPIDWSGLPVKIIFTIAQAKSSEVRDLLLFIQELVHNK
ELMIQLCEVNSFDEWKETIISYSENL
>PK3-045_00471 PTS system glucose-specific EIIA component
MVLGKLFGNNKAKQERLKAPITGKVIPIEEVPDPVFAEKMMGDGIAFVPAEGKVVAPIEA
TVKQVFPTKHAIGLESNNGLEILIHIGLDTVNMKGEGFIVHVKEGDQVSIGDILVEFDLE
KVEENAASTITPMVILNRDNVKSLEKKYKEQGNAGIEEVLIASL
>PK3-045_00472 Levansucrase and sucrase synthesis operon antiterminator
MLRINKILNNNAVVIIEEGTEKIVLGAGIAFQKGKNDLIQESKIEKIFILKNETKQFQEL
LESLPESYITIAEEIISYAEEFLEVELNSHIHIALTDHLAFAIDRMKKGIAIRNRLLSEV
KILYPKEYEIGVWAINQVEKKLGIQLPSDEAGYIGLHIHTGTMNSNNVDVPLKRTMILQD
LLDIVASQLNMEIDKDSLTYHRFLTHLEFVISRMEKNEAFHEMDDEMLDIVKSKYKRAYE
CSEVLAVFLNQEYQYEVPESEVGFLTLHIQRLWDKSNK
>PK3-045_00473 PTS system glucose-specific EIICBA component
MDFQQICANIMRHLGGIENIKYAEACATKLRLGLVREDQVRLEELKSLQGVYAALFREDE
LHILLGKDSTYQLYLEMNKQLKNRESQQNRGQCERREKNMFNKLFGKFQMFGKAIMLPIA
VLPAAGLLLGIGGAFSNPNTIALYPFLDHTILQAIFTIMSSAGNIIFGNLPLIFAIGIAV
GLAKSDKGVAGLASVLSYLVMNASLNAMLQITNKLATENLAGVGQGMTLGIQTLQTGVFG
GIIAGLVTYMLHSRFNKVQLPQFLGFFSGSRFIPIITSVVSIFLGIAMYIVWPPIQEGIA
QLGGLVDKTGYFGTFLFGFVVKLLGPLGLHHIFYLPFWQTGLGGTLEVAGNVVQGAQNIF
FAQLADPNVEQYYIGTARFMSGKYFPMMFGLIGAALAMYHTAKPENKKKIFGLLATGALT
SFLTGITEPLEFAFLFVAPVLFVVHAAFWGLSYMIAHIFHITVGMTFSAGLIDLTLFGIL
QGNDKTNWILIPLIGIVFFVVYYVVFRFLIVKFNYKTPGREDEELAEDAAAATDGSSRAA
TIISGLGGKDNLSEVDNCATRLRVTVKDSSKVSEAVLKGTGAKGVMLRGNGVQVIYGPHV
SIIKTEIEEIVGE
>PK3-045_00474 Ulvan-active sulfatase
MNKPNIVFMISHDTGRHLGCYGKAVESPEIDRLAAEGVRFDQFFCPAPQCSPSRGSILTG
LYPHNNGLIGLAHYEFGIEESIDTMPTKFSEAGYESALIGFSHETVGHTERGTWTSSYKL
GYDRYEKIEGSRAPQVADSAVKYLQEKKEDGKPFFANIGFWETHRTFDEYEPFADEISAV
EVPEYLPDTEAIRKEIALMNGSVKVLDAAIKRIMDTLEETGLIDNTIVIYTTDHGIAFPR
AKGTLKEAGLETALIFYNPKLFGKNVVSTELLCNIDIMPTLLDLAGLPIPDDLDGKSFAP
LLLKQSNEKIREDFFCELTWHDNYHPMRGVRTEKYKYVKNFEDGPKIYMPMDIHSSPSGA
EVRKEYYVPNEAEELYDLEKDPLEYKNLIHDPAYSEVARQLREKVANWMNETKDPLLKGA
VPGIASARWSEEAKIGRAYTKRQK
>PK3-045_00475 hypothetical protein
MKKFFSTLGMALIGGVFGGALMLTLLSQEWTITNILLGVVCFLAFYIIHIILHEGGHLIF
GKLTGYSLVSFRVFSWMVVATKDGLKWKKLHVPGTLGQCLMAPPEYVKGKYPFKLYLCGG
VIINFLSSLVVGGIALIVYGNAFPIPVTLFVLLGLFIGVTNIIPYGFNDGMTLKMAWSNE
KKQWQLFSQFYINAQTSNGISYQELPEELFALPDGDDGKDYFSQWGLCMQQVRAMDRLDF
EEAKRINDLLWARKDELISLFRVEVAKERLFLLTVLEGDKEEVQSIYKNKEVKRFLAIKQ
MSNKRIAAAYELHVNGDRQKATALCEEGAQLEKHNPNMTDIVLEKRLMKTLLAG
>PK3-045_00476 hypothetical protein
MKTEQQYFEEGTTIQTYMENMSTLKEESHEVYENFSLPQDGFTEELKKHKLHFLTITEDW
CGDAMVINPVLRKIVEAADLPMHVALRDADTDLIDRHLTNGGRAIPMVLILNEQGELIGK
WGPRAPEVQEIVNEGRAKLPAKEDPTFAEKQKDFYESLQKRYRTEPAIWTYVYKSFKSRV
QEIIK
>PK3-045_00477 putative ABC transporter ATP-binding protein
MINIFKNFQKKDWMFISCALVFIILQVWLDLKLPDYMSEITRLVQTEGSELSDVLAQGGF
MMLCAIGSMVASIITVFFAAKVAAGFSNRLRKKVFDKTLSFSMEELSGFSTASLITRSTN
DIMQVQMLIILSLQIVIKAPIIAVWGILKITGKSWEWTAATGVAIAVLLVLIATIVLVAL
PKFKVIQKLTDNLNMVTREHLNGIRVVHAYNAANYHEEKFEKANKELTDTNLFTSRIMAL
MMPTISLIMSGMTLAIYWIGAVLINNAAMADRLPIFSDMVVFSSYAMQIIMAFMMVSITF
VLLPRAAVSIKRINEVLNTDVKIKSGSKTNGDKVGEIEFRDVSFKYPGASDYILRNISFT
ASKGETVAIIGSTGSGKSTLLNLIPRFMEATEGEILVDGLNVKNYKLEALRDKIGYVSQK
AVMFSGSVSSNITFGEEDKDSVEQTKIQRAVEIAQGKDFIEKMDLQYEATISQGGTNLSG
GQKQRLSIARAIYKDPEVYLFDDSFSALDYKTDRVLRSKLKEEIQDATNIIVAQRIGTIK
DADRILVLDKGEVVGMGTHDELMVTCDVYQEIALSQLSKEELEIG
>PK3-045_00478 putative ABC transporter ATP-binding protein
MAKKNEVKEEKNPTQNEELGNQPAKSIPPRAKGMNFSSLKQLVIYCKAYFPIIIFALILA
MTAAIFSIIGPDQLSKMTDYITAGLMGDIDLDAVYDVAILLVFLYGLGFIFNYVQGYIMA
TVTQRISKQLRRDISVKINRLPLKYFDNTTTGDVLSRVTNDVDMVGQTMNQSISSLITAI
TMFVGSLIMMFYTNWIMAIAAILSTFIGFAFMFFIISKSQKYFAQQQQELGKLNGHIEEI
YSGHNVVKAYNAEQQAKDDFFAINTRLYESAWKSQFMSGLMMPLMMFIGNFGYVVVCIVG
AALAVNGHISFGVIVAFMLYIRLFTQPLQQIAQAATNLQSTAAASGRVFEFLSEEELAVE
EEKTAKLANIKGDVEFKHVRFGYSEDKTIIEDFSVQVAAGQKVAIVGPTGAGKTTLINLL
MRFYEINGGEITIDGIPTNEMTREALHELFCMVLQDTWIFEGSIRDNIVYSREGVSDEEV
EAACKAVGLHHFIKTLPNGYDTILDDKTSLSAGQKQLITIARAMVKMAPLLILDEATSSV
DTRTELLIQTAMDKLTEGKTSFVIAHRLSTIKNADLILVMKDGDIIEAGTHKELIEKNGF
YAELYNSQFEEAS
>PK3-045_00479 hypothetical protein
MLDRPTYIWESIDFLNRFIMKSRQRYAEEHGLTAPQARLILEVFLHKKISVKELTQNLRI
TQSTVSDIVERLTEKGILIKKPNPNDKRSVQIMLTERMVKRIEEKSPKPNQQIMGSVLDH
LQPSEQAKVEEGMRLLVAAVGKKLEADGIDDLEDFEVLFLPKEKKCK
>PK3-045_00480 hypothetical protein
MQIKKSGLGPDFFAWNVFLRLKSLYLLKKEDASRNREKFSELLDESSPS
>PK3-045_00481 Multidrug-efflux transporter 1 regulator
MEEKLYSIGEVAKVANITIKALRHYDKIGLFKPAYVDPQTNYRYYRDTQLYRLDIIKLLI
SIGTPLGQIKEIQETDNLDFVAFLEKQEELISEKIASLLETQQSIRELREELQRQEYPFG
EIILMEKEEQAIIQTSVKNIGPQNILNPSYSNLKKATKEEFRNNGYGSIIPFKQYEKVEE
ITYSYLYTPVPLRKQLSSLSNEAERAVIPKGTYVCIKLKSSIFTEYFQTLQKLLHYVQEQ
NLTVTSDIYETFSVGLYHKKEEYISEFSVRVAEDESRKNNVG
>PK3-045_00482 Tetracycline resistance protein, class B
MLRQNITLSILLINLFIAFLGIGLVIPVTPTIMNELHLSGAIVGYMVAAFAIAQLVVSPI
AGRWADQFGRKRMIVIGLLIFGASELLFGLGKTVSILFLSRVLGGISAAFIMPAVTAFIA
DITTMEARPKALGYMSAAISTGFIIGPGIGGFLAEIGTRMPFYFAGILGFTAAILSFFAL
REPERRTEENQANAEKVGWQRIFVPIYFISFLIIFISSFGLSSFESLFSLFVDHKFGFTP
KDIAIIITGGATVGVIAQVALFEKLTKWMGEILLIRYSLLFSTILVLLLTIVHSYSLILL
VTIIVFVGFDLMRPAVTTYLSRIAGDEQGFVGGMNSMFTSIGNVFGPIIGGILFDIDLNY
PFYFAAVFLAIGIALTLIWRQKSLAKS
>PK3-045_00483 IS1595 family transposase ISBce21
MRPNLTKDISIDSFKDFYWLKEELQSFCREIGISVSGSKIEISDRIETFLRTGEIKKPIR
KVKINSKSEIQADLSLDTIISENHRCSQNVRAFFKTVIPNFHFSTYIQNYFKNNIGKTYR
DAVDAWYKEEERKKDPSYKKIIAPQFEYNQFIRDFFADINNQEKSREEAIEAWNNIKKLP
GSNKYTSNN
>PK3-045_00484 HTH-type transcriptional activator RhaR
MLSNNPLTTYRTYFFRFPEKQQQRIAGIYTLGWEKRNSASYYWDGLKRSEKGKIIFQYTL
QGEGEIIIQDQKVRLKPGYAFFVNIPSDHTYYLPKDSQEWEFIHITLYGEEVWRSYHEIV
KEHGNILRLDDNAYPNQLIFKLFDKAVHEEIKDAFESSSLAYTFIMELKRYLMHTSHSNK
TIPESISNAVRYIQHNYANPIILDDIVEASGLSKYHFSRLFQSIMQITPMNFLTRIRLNK
AIELMKQQDLTIEEIALRVGYSNGNYFTKVFRSIIGVSPGKYRNSENFVPFDEVIGPSSL
FAYKEGTKILC
>PK3-045_00485 Alpha-galactosidase
MSKITFLGAGSTIFAKNLLGDCMQVEALQGFEFALFDIDLERLNDSFMMLHQLKENLDAN
IAIHLYTDRKEALRGAKYVINAIQVGGYRPSTVIDFDIPKKYGLRQTIGDTVGIGGIFRS
LRTVPVMFEFANDMEEVCPDAWLLNYTNPMAVLTGAMLRNTAIKTVGLCHSVQVCADRLL
DALGMAKENVQWKIAGINHMAWLLEITQHGKDLYPEIKERAREKQKVLHSDKVRFELMER
FGYYVTESSEHNAEYHPYFIKKNYPELIDYYHIPLDEYLRRCEKQIEGWEKRKAELVGNK
HVTHKRTHEYGSYIIEAIETDNSIKIGGNVLNTGRLISNLPEKACVEVPCLVDASGILPT
YVGDLPEQLAALNRTNINTQLLTIEAAITKKKEYIYQAALLDPHTASELSIDEIVQLCDE
LIEAHGDWLPAYS
>PK3-045_00486 putative multiple-sugar transport system permease YteP
MDSSSAIEKAAQMKIARKSEKKKIVRKIRKNWDLYLLIIPIIAYFIIFKYIPMYGLQIAF
KDFIAVDGIFNSPWVGLEHFERFFQSFYFERLLSNTLLIGLYELAVGFPIPIILALMINE
VKNKYFKSFIQTITYAPHFLSVVVVVGILYLFLSPQTGIINQLIVILGGEPIYFMAEPAW
FKTIFVFSGVWQNMGWSSIIYLAALSAIDPQLQEAAKIDGASRLQRIWHINLPSIKPTII
IMLILQCGSILGVGFEKVFLMQNSLNMSASDVISTHIYRTGILGADYSYSTAIGLFESFV
NLIILLLVNYTARKVNKVSLW
>PK3-045_00487 L-arabinose transport system permease protein AraQ
MLKRESVRDKVFVVVNYTLLAIIACLMIYPLIYVLSASFSNPARTVLGDIWLFPKELTVD
LYVKVFQNEKILIGYRNTIIYTVFGTFINLLFSVMIAYPLSRKDFYGRNMITVFIMITMF
FSGGMIPTYLLVKDLGMLDTIWAIVLPGAVSVYNVIIMRTFFQSIPNELHEAASIDGCGN
ISFLLKIVMPLSMPIIAVMTLFYGVGHWNAYFDSLIYLNDESKFPLQLYLRQMLIQEDMS
GMSSASDNAISEHLMQIEGLKYAVVIVASLPMLVLYPFLQKYFVKGVMIGSIKG
>PK3-045_00488 Lipoprotein LipO
MVKFKRRKFITVTTALVMSASLLAGCQKSASSDKKENKVTTESVDNVNKEGFPIVKEPID
LTFFTGKYEPNLDDYEETLVFKKYQEKSGVNVTFNEVPFATLTEKRNLALASGEYPDVFY
SSRIPSADLYKYGKQGIFMPLNDLIEEYAPNIKAAMDKHPDIKKGLTMPDGNIYSLPSYY
SPEFLPMLIGKPIWIKGEWLEKLGMDEPKTIDEFYQYLKAVKETDLNGNGKKDEIPLSAT
SIAQIMDSIKGSWGVGTRGLGHKFVDVDPETNELRFFRTDDRFKEVLEFIHKLNKEGLID
GEIYTMDDNKLNAKGSQGILGTAIVPNPETVFTNQKDYIGLGGLKGPHGDTLYSHVKSPL
VHVGAFAITDKNKNPQATIRWIDYFFGEEGATLQFMGVEGETYEKNGDGKPQFTEKITNN
PDGLTFDQALTPYVTWMGGSYPGYVQEKYFGGSEALPSSVAVGDKVQPDAPKEIWNGFNY
TDDELKFKLATGTDLETFINETEAAFIAGDKDFSEWDQYVEQVKQMGQDQYLEVEKAAHD
RYQAN
>PK3-045_00489 putative protein YesV
MDGLFARVYHGSQIVAKLMYVNALWVGGIILGGGIFGLFPATIALFSVVRKWIMGDKDLP
IIATFWRYYKSDFKRANILGYALSLIGFFLYFDLRFFQTEMNPGYGIISLIFLSLLFWFC
VVLLYIFPVYVHYDFSLVQYVKHAIILSFARPLQTMAMLVGIIAVYLLFQYIPGLVFFIG
GSLLAYILMFLASFSFARG
>PK3-045_00490 hypothetical protein
MLWNSAKKIIWLLFASTILSSILSTSLIIISMKIYKDVISLRRKLSNTGDNGIRFQKYRQ
P
>PK3-045_00491 hypothetical protein
MGNLQVWSQSERFITAFQRFNWIDLGIALLIFLVFLGFRKLFTKYIYKLILALVKKLPVD
IVSKIFLAYERPLRWFWVILGTYLALTYLPFPITTFNFVQQVFRSFIIALIGWGIFNYFS
DQSNPFERMISRTKLDADSMLIPFLGRVFRMLVVIFTAVSILDTWHIQIGAFVAGLGVAG
LAFSLAAQDTVANFFGGVVIITEKPFAKGDWIQTPSVEGTVEDISFRSTQIRTFADTIVT
VPNSKLSNEAITNWSKMSKRRIDYELAISYRTPNEKLKTALKEIEAMLHAHPGVHPDTIM
VRFTDFRDYSLGVFVYFFTKTTVWAEYLAVKEDTNLQILSILEKHGIEIALPSQQIYLPE
KEDGKKLMTGE
>PK3-045_00492 putative capsular polysaccharide biosynthesis protein YwqC
MEGIKSVKEILAILKKRMLLIMMVSIGAGIVSGLYTNYKITPLYQSSSQLLVNKNIEKVV
DVSELDVRSNMDLIDTYIVIIRNPVILNDVVEKLQLPITAEQLSSQIQVAKQDSTQVLNV
TTTDTNPERAAKITNTTITTFLEKLPSLMKVNNVQIMNEAIVNEKPISPSITVNIGIAVA
LGAIMGVGLVLLFAFLDTTVRSKSDLEKLNIKVVGTLSAISEKDRIPQSLMESLKAERRS
LNVTTTETEI
>PK3-045_00493 Tyrosine-protein kinase YwqD
MSPLPKRKSKLERVSNLLSHLRPKSPIREQYHAIRASIQLAINENQIKTLAIVSGEESEG
KSTFSANLAIAFAEVGKRVLLVDSNFRHPTLHTSFEENNEIGLSTILVNRDRLEECVIET
PIDHLDLLTSGPVPPNPSELLGSPAMEVLVSNVSHQYDMVIFDTPSLVSVADSLLLSNIS
DGVLMVVRSNKNNIETVEFTRDMLSNSKAIFLGAVLNDERVSKRQRKKVRIN
>PK3-045_00495 UDP-glucose 6-dehydrogenase YwqF
MNITVVGTGYVGLVTGVSLSAIGHSVICLDVDKEKIEKMRLGISPIYEPGLSELMVENME
RNRLFFTTSQYEAFLKADLIYIAVGTPEKEDGSADLSFIDEAAYSIAENIIKDTIVVIKS
TVPVGTNRKVKERILQNLVHDVQVEMVANPEFLKEGTAIHDSFHGDRIVIGTDNERTARI
MEKVNEAFGIPVYKTSIESAEMIKYASNAFLATKISFINEISNICEKVQANIDEVAFGMG
LDTRIGSQFLNAGIGYGGSCFPKDTKALIQIAGNVHYDFELLKGVVNVNKKQQVLLLNKL
KDIYPNLTGKRIGVLGLAFKPNTDDMREAPSLLVIKELVENGAEVYAYDPIAVDNAKLLL
PPQVIYTVSVTEAIQSADAVLILTEWDEIKQIDISLFYKMSNPIVIDGRNCFSLERMKKS
DIEYHSVGRPSINEKIEELL
>PK3-045_00496 putative sugar transferase EpsL
MLIKEQKAYLLFKRVFDILCAIIGLLILSVLFFIIGLLIKLEDKQGSVFFKQTRIGKDGK
PFEMYKFRSMVSNAEDLKASLMDKNEATGPVFKIKDDPRVTRIGKFIRKTSIDELPQLIN
VIKGEMSLVGPRPSLPQEVAAYSSYERQRLKVVPGITCYWQVGGRSNLSFSEWVELDLKY
IRERNLFIDFKLIIKTFFVLFGSKNAY
>PK3-045_00497 hypothetical protein
METSVIIPTYKRTNDLKRCLEGLSRQLHKPDEVIVIVRDTDDQTASFLKDYQTIISIKQA
IVTRPGQVAALNKGLQQASGEFICILDDDTVPHTHWLQKIIDLFKSSEQIGGVGGRDWVV
HGNHKEEGRKDPVGKVQWFGRVIGNHHLGYGEARDVDVLKGANMSFRRKAIAGLSFDERL
LGQGAQVHNDLAFSLSVRKRGWRLVYDPEVAVDHYPAPRFDLDQRGRFNKEAYYHSVYNE
TIIMTDFMETKIRKLTFILWCLVIGTSEKPGLLQMIRLLMKKNSIEKFFINVSTRVRIKR
EVTAISK
>PK3-045_00498 hypothetical protein
MIEGANNLNRVIGYPNKSIKQFYYLLVILLLLTVGVGIVTPRFSVILLTQIILILAMAVF
GMFLSYFRSRLFIIYLLIIWSSMPGIRRVSDWIMGEYQSISLLSIAPLLLTATIIFSLMH
KKATYNNEQKKIIYCFIGAFIYAFAIGIISNRGSALYEMANYVIPFLLFIYSASLSKHEM
KYRDIWISSLSTIAVFISIYGWIQYFYLPEWDKLWMENVEMNSIGIAEPMNFRIFSTVNS
PGPFALFLSIAIVPMIVEKKWRGIFGWVGVFIVLSALAISLVRSSWIFTIVAIMVYILFS
RSIWRKVKYLGLITIVVIILINLVNLIPGAAQINERFSTLGNLEEDTSFNARLYFAIETS
KKILKNPLGNGFGSSGVSTKLSNNGNLGESGNFDNGILNVFYTFGWGGGFLFFTGLFLLF
QMLRRKLVKIPSHQSYYQLGIAMIIALLISLLSFNSIPGMGGFLIWFIISMSFVEEEGGK
>PK3-045_00499 D-inositol-3-phosphate glycosyltransferase
MKICIVTHKLIKGDGQGRVNYEIVKTALEYGLSVIIVSTEIDESLLKNNNITWHKVRASI
LPTNLLKYQHFALLSTYMIKKINPDFLILNGFITWVKSDMNIVHFVHSSWVDSIYHPFRE
KKTIKTFYQFLYSFINSKLEKLSLRSTKKIVAVSNKVKQELLKIGMPEAKIVVINNGVDI
DEFTPNREGKPPFLHNNYYKRTMLFAGDIKSSRKNLDTVLKAMLMVPDIYLLVAGSKEGS
VYPEIAEKMGLKERVIFLGYRNDIATLMSQVDLFVFPTRYDPFSLVVLEAMATGTAVITT
KEAGVSTLLESKEYPAGIVLEDPNDENELADAINKFIFNEKLLNEFGVNGRLIAEENSWS
KVSKKYVKEMFTLNENRVRV
>PK3-045_00500 hypothetical protein
MRIIHVLNHVRNTGNGIVNATIDLACSQKQMGEEVAVALSGGEFIKLLEQYGIPYYQLKQ
EK
>PK3-045_00501 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MPISLDGRSIVTVAGMNKRKGIMELIKAFEIVGSKHTDANLYLVGDGPDRPFFEEIASNS
INSNRIHFIGFEPEPQKYLLSADIFVLFSYRESCPLVLFEAREAGCAIIASDVDGIPEVL
NNESGILIKPGDIIELAEKIHLLFSNTMELTRLKLEAKKDLEKLSVNRVCEETLNIYKEL
AV
>PK3-045_00502 D-inositol-3-phosphate glycosyltransferase
MKVLSTGMGWIESTPGGLNRYFSDYLKAMQINGHEVRGLITGNGAELDIPDYMIDISKGA
SAHVINRANLFRNSIKNLISTFQPDIINPHFALYFSLVNQNLIPDHTPIVTHFHGPWAQE
STVETTRNLIMNVKNKSKKSLEKITYRRSDSFIVLSEYFKNILMKDYGIDESKINIIPGA
VNTEYFQPAEDREEIRRRKGINITDKVLFCARRLVRRMGIDNLVKAMGKVVTDYPHTKLY
IAGQGYLRQELESLIRNLRLENNVYLLGKIPNDELLNWYQIADLSIVPTITLEGFGLVTV
ESLACGTPVLGTPYGGTKEILQKLDEQLLFRDSSDQAIASKLEDILSGQLKLPNREHCRK
FVMENYTWDRVVDAVCTVFDNSMNRKTIDIYN
>PK3-045_00503 GDP-mannose 4,6-dehydratase
MKSALITGITGQDGAYLAQLLLNKGYKVFGLLARRSTDTLWRLEYLQIKEEVVLVDGDMT
DLSSLIRALQLAKPDEVYNLAAQSFVGTSWEQPVLTGNITGIGTVNILEAIRLTNPGIKF
YQASTSEMFGLVQEEIQTEKTPFHPRSPYGAAKLYAHWMTINYRESYKMHTSCGILFNHE
SPLRGIEFVSRKITDAAARIKMGIQKELRLGNIEAKRDWGYAADYVEAMWLMLQQESGDD
YVISSGRTTTVRRLCEIAFSYLDLNYQDYVVIDPQYYRPAEVDVLLGDSSKARRKLNWRA
KTELEQMVKVMVDADVQRIRKELNSYPSLFPKLANL
>PK3-045_00504 hypothetical protein
MKQVGKIKVLFLVHTAIIGGGERSLIDILTYINKERFQPTLVCFEDGPLVERVSEISGVE
VAVIPFSEKVLKYNRDEKSTLRFLSIFSLFVPMVRLFSFMYKNEAKIVYSNSMKAHFIGL
VVGKLAFKKVIWHVRDIIDGGINKKLFVLLSKFADEIICISKSVSSQFGKTEKTKIVYNG
ILPIEEVRSREEI
>PK3-045_00505 D-inositol-3-phosphate glycosyltransferase
MRKFKVAIVGQIARWKGQDVFIKAAKLLHPKYPEIKFLIIGDVLFAKEEELQYKNHLIEL
AQDCNYIQFLGHRENVLELLKDIDILVHASTRAEPFGRVIIEGMASRKLVIAAGIGGPLE
IIEDGVTGILYQPGNAGELASKLDRLIKDEELYQSISNKGYETYQQKFNVLNTVSKVEEF
IELVSNK
>PK3-045_00506 hypothetical protein
MIEGGLVELISICICTRNRVDDLKSAIHSIYQSTYKNFEIIISDDSTNDESEKMVTEEFP
KVKYIQGPQKGLCFNRNNALKLVSGSRVMFMDDDVIMSYDFLEKIINGLMKIEPAKRNRA
IMTGIEINNGSEVYPNKIDFLGFQTKAYKKKEPLNTIVINSTIFPLQMFKKIQFDQQLVY
GYDEVDIAARALALNYKIYLCKDAINNHYPSAINRDYYLPYKESSRIYVTFKKYYKLERS
IAKALFYLGFCYVHMLGYQVKKNNIKAFSSTSNIMKRAIEYIRNLESEIAFYKEKEKENE
I
>PK3-045_00507 hypothetical protein
MKSKNRFLSNFILTFQSEFILIIITLISGIIIARVLGPAGRGEYLAITIWGNLLMWYFHL
NIYQTVIYYWHKMKNNREDLLKTLAVASLFLGVVATLVGEFIIIPYVMPSLDSEVLIAAR
LFLIGIIPGIISEVILGALAAEEKFLFANMMRIINPTISTTFLIIIYYMGLLEVSSALYI
LLGTNTIIAIATFFIGYKNNYFSGDFHWELMKILWYGMKAQGGTVAGATSANATQLVLSA
MLPPAALGFYSASESSVKPLSTISTALQRVSFPRLAGLSADLTHQRTLRIWTNSFIANSI
TALPFALLLPLLIPIVYGKEYIPSIIPAEILIIYTFVRGQSMIIRNSINGYGKTFINTTT
EIISTIFIFITLSFTVKHWGVIGASVIAVLSSILKLILYLVEYNKHIHQLKLVYLIPSLA
DFKAVIMAAFSIVRKGVRKRGRINSKMEREVSK
>PK3-045_00508 hypothetical protein
MIRIAFILLVHQNPDQIIRLVNKLDSPHTDLYIHIDSRAGKTFILKLKEKLENKKNVYFI
KNYKCYWGDFSLVRATLEGLRNAATATIKYDHYILLSGQDYPIYPIEDILNFLEKNREKS
FIEYTKFSEINWYEGGYARTKYWFFRRLQRKKGNPSFLNKAVSKTWSIVRKKLPARRFPN
DFQLYGGSQWWCLTNEAVQFILEYLREYPRFEKFFHHVEIPDEIIFQTLVLNSPYKDKVI
NDNLRFMIWRDTTSSPSILIDKDYYSIVNSASLFARKFDIKKDTKILKLIDDFHFDIQNL
DRERSKL
>PK3-045_00509 Putative pyruvyl transferase EpsI
MIAKMKERIPLNWKINYKYYKSATKFVIPYGKKDLKIFVTIASDYGNLGDIAITQTQIAY
LQTVYPSYNIISVYASETYSAMKEMKKKCSEKDIITIIGGGNMGDLYKSYEEYRRTIIKY
FPKNKIISFPQTIDFSETESGRKALLKTQEIYSRHRNLHLLAREPISYEIMKRLFPYNKV
YLVPDIVLSRNEAEPILSREHILVCLRNDMEINLEESFKRTLITLLEGEVEPLVYYDTHI
GDGEITMSKGKEELEKIFHAFKKSKIVITDRLHGMIFCAITKTPCIVFQNSNHKIEGTYN
QWLKGIEYIKLLDPTDMDTIRRAIKELKEIDLDKCDIYNFELEFQPLLDALNN
>PK3-045_00510 hypothetical protein
MLEELLKLFPDADLYSTVEHLEAKDRHFIQNKQVKTTFIQNLPFSKRKYRNYLPLMPLAI
EQLDLSKYDLIISSSHAVAKGVITGPDQLHISYVYSPIRYAWDLQHQYLRESGLEKGIKS
WITRFILHYVRNWDYRTANGVDFFMCVSDFIGRRIWKTYRREAKTVYPPVDVSAFTLREE
KEDFYLTASRMVPYKKIDTIVESFSLLPDKKLVVIGDGPDFKKIKAKAGSNVMLMGYQPF
DVLKDYMQRAKGFIFAAEEDFGIAPLEAQACGTPVIAYGKGGSRETVRGYNESTSPTGLF
FYEQNVEAIAAAVQKFEQIQIDSIDCRNHSLYFSNERFQKEFKAFIDTKINEWRIEKALA
SEKEATSEHWLHKRKKA
>PK3-045_00511 hypothetical protein
MKTAIIHDWLVVYNGAEKVLEEILKIYPDADLYSTVDYLDEKDRHFIQHKKVNTTFIQKL
PFSKRKYRAYLPLMPLAIEQLDLSKYDLIISSSYAVAKGVITGPDQLHISYVHSPIRYAW
DLQHQYLKEAGMDKGIKGYLTRFLLHQIRNWDYRTANGVDFFMSNSDFIGRRIWKVYKRE
SQTVYPPVDVSKFSFYPDKEDFYLTASRMVPYKKIDTIVEAFSLMPDKKLIVIGDGPDFK
KIKAKAGSNVHLMGYQSFEVLKDHMQRAKGFIFAAEEDFGITPLEAQACGTPVIAYGKGG
SLETVKGYNESPHPTGYFFYDQTPEAIRRAVEQFERLPFNPVHCREHALNFSPERFRTEF
KQFIEEKIALKQQIWEKTTKINVVKSYIISDVHWTKKQSIS
>PK3-045_00512 hypothetical protein
MLLNEELARDCFYQVNKENTWKELNSQMYIWNEQKNTYYKIGEIGTVIWEYCKYPISEQQ
IVAMLMEDYEVSKEECEQQVEYFLAELLADNLLIKVDLKACLE
>PK3-045_00513 hypothetical protein
MIRKVKKFIEMDFKLKCLMMEAFIFLARGRFLKLLPFAKVAPSLGEESMETEVQVNGNEK
MIKDVSLAIETMSKYTFWESACLVQAIAATRMLNRRKIPTTLYLGIARDQAGKMEAHAWV
RSGSHYVTGARGKQRFTVVNTFAGGMSKRGEKNEGIRRN
>PK3-045_00514 hypothetical protein
MKGSEEIDLRSCANELQLLLRLLNEEEDSIKLIEEFHKKVDWKEFLQLIYFHKVYPSIYL
RLSSIDSPYLPNNVVKIVEGLYKDNTIKMLQLIKELDNISTALTKNEIRMLTLKGPILSY
YLYGDLSSRTSNDLDILISFQDLKSTIEILQAKGYEMEYEPPRKLKDWQKRNHHLEFLHK
EKNCKVEVHWRLHPGPSKEPSFEDLWNNRITVSIGTTTFYTLEEETLFYYLVTHGARHGW
FRIRWLEDIVQLLRREEDINSYPMVFMENQACHLYQQALYLVENLQLSPKRYQRKIKKQS
KGLAQKAFLFMRERINFFHPPDKIWDKEGKKYLFMMKPFKQKAAYIIRKFYANSWDAEVL
PLPKSLHFLYLPLRPILWLWRVILKQKVSLRRL
>PK3-045_00515 Heterocyst differentiation ATP-binding protein HepA
MRNLIVFFKKLQAVTGTKMYLNIFLSILISALEGISIYLLIPMLSVIGLLNMQINDLFPI
TLIVAAMEKLPFQLNLTTVLMIYLLLIGGQALLQRSQTILNTDIQQNFIKQLRIETYESL
IKVKWEYMLRKRKSDFNYILTTEISRVGVGTHSIIQLISIVFFTIVQIMLAFLLSPSLTS
IVLISGGLLSVFMRKFVRNSKTIGKETTELMNDYFGGITEQFSGMKDMKSNMLEPSFFDW
FQSKSHLIHHNVMNLVRLNAKSVFIYRLMAGFLIVLFVSISFSFLKLPPEKLMVIILIFS
RLWPRFSSLQSNVEQIVSMFPALDHVLRVQAESNKSQEWSTFRTREWEPFILEQAIECDH
VYFRYQASQEDWILTNVNIHFPLKKTTAIVGPSGAGKTTLVDLVMGLLQPEKGRLLVNGK
SLTEDELLLYRNSISYVAQEPFLFHSSIRENLLMVAPKATELELWQALSFAAAEHFVKQM
PEGLDTVIGDRGIRLSGGERQRLVLARAILRKPAILILDEATSALDSENEQKIQQAIDQL
KGKMTIIVIAHRLSTIRNADKVLVLESGKVIQEGEYKQLAQTKGALRKMLVSQELAGNQT
LA
>PK3-045_00516 Alginate biosynthesis protein AlgA
MKLVLLSGGSGKRLWPLSNDARSKQFLKVLTDEEGNKESMVQRVWGQLEKNDLAKDSLIA
TSKSQVEMIQIQVGTQVPIVVEPTRRDTFPAIALAAVYLYSVKGCSPQEVIAILPVDPFV
ENHFFSKVKELEKTLKESNAELALIGVQPTYPSEKYGYIVPYEEEKRNYMRVSAFKEKPR
REEAERLTESGGLWNSGVFAFRIEYLLNILLERGYPIQYEQLVSQYHLLPQNSFDYEVAE
KAEQVIALSYTGYWKDLGTWNTLTEEMQNPISGKGFVSKGITNSHIVNELDIPITLIGLD
DVVVAASPDGILVTNKEDSLQVKEILKDLIERPMFEERRWGWYKVLEHTKYLEGNEVLTK
RICVETGKNLSYQVHYKRSEVWTVVKGEGVLVLDDQLQHIRSGDVIHIPLGTKHALRATS
TMEIIEVQTGSELVEEDIYRFSLEWKQIMNGITFKNIAINL
>PK3-045_00517 Asparagine synthetase [glutamine-hydrolyzing] 3
MSGIAGILYENQANIATDHAGKIMNGFQGFPSDDIQVYSRMNIFLGCHARWITPESMGER
NPYYDKTSGVVITSDSIIDNRMELFQSLQVDRSLQQTISDTQLILLAYLKWGEETPKYLI
GDFAFFLWDERQQKLFGARDFSGSRTLYYVYKDRQFYFSTIIESLLKLPNVKQRLNEEWL
AEYLAIAGVVDTVDSSITPFVGIEQVPPSHSITIEKGRKKVKRYSHISSEIKPIHLPTNN
DYVEAFQEIYQSAVQARLRTHKKVGSQLSGGLDSGSVVSLAAKHLPEDAGLHTFSYIPPK
DFIPFGPKNLVANESSFVHKTVNYIGRLQDHYLDFEGKDSYKQIDEFLEIMEMPYKFFEN
SFWIKGIFEEAQKRDIGILLNGNRGNLSISWGGVQDYFPLLLKQCRLLKLYKEVEAYSKN
IARPRKRVAAMVLRETFPFLNQQRKKYTTGGPPPLINPEFAAKTSIYTKLAEAGMDATGW
FSELNAFEQRRRHFDDLFHWNASNTFMTKLSLKYGLISRDPTNDIRVIRFCLSIPEDQYV
QKGMDRALIRRSMEGYLPDEIRLNQQIRGAQGTDWLYRVIPHWKSLLQEAREVSKDPVIL
SYINYNCLKRGLDKLGKGAISEYAVDPDVRALFRSIIVYRFLKKLKLAG
>PK3-045_00518 hypothetical protein
MNKLEWKEPNLEVLDVKETMAGPFNNNKLDATYETGTPFPDLGWS
>PK3-045_00519 hypothetical protein
MITKSAFRYYAFGCHVYSEFMLPELCKEEKVEAIPELVIKEKDLREYWNAKAKTKANNYF
VIERDMVLFHVPNIAIFLIEKGESISITLLSANKMDEMRLYLLGTCMGILLMQKRILPLH
GSGIVIEGKVYAIVGDCGAGKSTLARAFLQKGYKLISDDIIPVQLNKDGKPIVIPTYPYQ
KLWLESLHEFEMTNRSFKPIAYREEKFSVPIEQQFETNCLPLAGIFELTKKDGEKIEIKE
KRNLEQLQILYKHTFRNSFLQPLGLLEWHLITTSKFLESTSIYQIERPKSRFTVNELVEL
ILTKQKGEEDK
>PK3-045_00520 hypothetical protein
MRKTQTQIDKQTIVVQTLGHIVSDMNGEKVMLSIANSKYYNLGHIGGDIWELIKEPISID
RVVATLMEKYDVTQRKCEQHVCSFLETLKEEGLITIKST
>PK3-045_00521 HTH-type transcriptional regulator SinR
MIGERIRYLRQRKGYSLSRLAKEAEVSKTYLSNIDRGLQNNPSLHFLEKVAAKLGTSVEY
LISDDFEKDMLNNASSKGTIK
>PK3-045_00522 hypothetical protein
MKAIILSILSIILVVILVIGNIHWNNREDTPLSNTHPTKAANGEVENKKNKDQYFSLDDY
MSFAKSWPESAQKVFEEKLTEKQPFHILLVGSDEIGDQELGLITPLQEALASKYDKYVTL
DSITYEETSSDYVNNNEYESIIEQKPDMIIWEPFLLNDNGVVDISTTLLNVNQVINETKD
VLPDVTFVLMPAHPLYNAGLYPMQVSDLKKFAESKEIPYWNHWEAWPESNDLKLKDYYVQ
LGDRSQANEQGFKVWSSYLSKKLISE
>PK3-045_00523 putative capsular polysaccharide biosynthesis protein YwqC
MEETISLKELFDTLKKRVSLIVSITLVAMIVSAVVSYFIITPEYKSSTQILVNQAKDDSS
ALINSGEVQANVQLINTYSVILKSAAILNSVKDELNLNMSVSTLNSKITVESSQGSQVMT
VSVTDSNPTVALQIANKTAEVFEKEIKNIMSIDNVTVLPLAEDQENQAPVSPNPPLNIAI
AAVVGLIIGVGLAFLLEYLDNTVKTEQDIEKLLELPVLGAITKIDESFDAKQRGTQKGRS
RGDLLGSK
>PK3-045_00524 Tyrosine-protein kinase YwqD
MAASKRAKKGGLGLNNRRKLIAKYDPKSPISEQYRNIRTNILYSSIDEEIRSILVTSSGP
GEGKSTTTANLAIVFAQQGKTVLLVDADLRKPTVHYTFNMNNTAGLTSILTNQMELMEAV
HEYDEKNLYILPSGPIPPNPSELLGSKAMNYFLEKALEEFDIVLFDTPPVLAVTDAQVLA
NLCHGSILVVSSGKTDKEAVLKTKEQLASSTGKILGVVLNNKKNDKNSNYYYYGTN
>PK3-045_00525 Tyrosine-protein phosphatase YwqE
MIDIHCHILPNIDDGAQTLENSLEMAKTAINEGITTIIATPHHKNNQYINEKSSILEKVN
DLNAVLKQENLPLNILPGQEVRIYGEVLEDYNKGEILTLNHTKYLFIEFPSSSVPRYAER
LLYELQTEGVIPIIVHPERNKELQEKPDLLYKFVKNGALTQVTASSVVGYFGKNVKKFSE
QMIEHNLTHFIASDAHNIHNRTFKMTESLEMIKENFGMDYIYLFKENAELLIEDKNIIKE
IPERIQRKKFLGIF
>PK3-045_00526 putative sugar transferase EpsL
MSEFYKDQSLYLEKKKNISVNTARSYLVMKRTIDIIGSFLGLVVLSILFVFIAALIKLED
PKGKVFFKQIRVGKDGKEFYMYKFRSMASDAEERLKELLALNEVSGAMFKMKEDPRVTKV
GKFIRRTSIDELPQLINVLKGEMSLVGPRPPLPREVEEYTNYDKQRLLVTPGCTGLWQVS
GRSNIGFEEMVELDLQYIKNQSIYIDVIIILKTVKVLFGTKDAY
>PK3-045_00527 hypothetical protein
MTTISVLIPTYNAEKDIGNLLNMLENQKLSVQDQLEIVIIDSSSTDNTKEIVENQYPQVI
YETIKNSDFDHGGTRNILASKASGEYLLFMTQDAIPYDEYLIKNLLGNFENKKVVISYAR
QIPKDNATDLEKFARNFNYPNKSVFKTKNSLKELGIKTFFNSNVCSMYKKSFFDSVEGFP
EKIILNEDMIVASKAILSGNIVAYSASAKVYHSHNYSLIQQFKRYFDIGMAFNQTEYLLR
FASNEAEGKKMIVTQCKYLVGKRLFHLIPLAIVEAIFKYVGYILGKNHSLFSNGIKRKLS
AYMK
>PK3-045_00528 hypothetical protein
MFNPYYLYIYGFFLSIIIYQLGWSILFPKITIEMYIFLLFTLICAFFLGKFTESKKIISF
YKVRKIENTWLVIIFIFFGYLLEFLYSKNIPFLSLVVNNYNNVYKEFGIPIFHVFLVTFN
SFVSIYIFHIFLSNKNRKYMILFLLLLIPPLLIVNRGMIVMILISCGFLFLIKIKTLTIK
QIVNIVLILLVGLYLFGLFGNLRVNDSYGRDSDIFDTTVLFSVGGASEEFKDSPIPDPFF
WSYIYIASPLANFQETTNEFTNNKITFSNTIQFINSEIFPDFISKRINDLMGWNYPTISK
ISPELTVGTIYARAYAQLGWLGSLLIYLFLIVSSLFYMFLLRNFNKDYYLTGIAILATLF
LMSTFSNMISFSGLSFQLIYPIALTYFPIFRKRITK
>PK3-045_00529 hypothetical protein
METVSILMAVYKPNINFFIEQLKSINNQDYENLKVFIVDDSDDISWHNNIVEIVEQNLTR
KTFEIFKNQENLGSNRSFELLTRISTGRYYAYCDQDDIWENNKISKLVKLIKDENALIAY
SDLSIIDKSNNNIARSLKDISKRLVHHHGDKLYKIFLRRNSITGCTMLIDSKVARESLPF
PEHNEYIHDHWLALFASCNGKIAYTSEPLVKYRIHANNQIGAKLLDGIEDKKKYVDIKIK
NEEEKINYLLKRNIQLINNDISKEVEDYLIFVKRRKAYLCHFNFKNLIGLLKEGHKDISL
IIFEFMLGVMPNRFTKYLISTVKK
>PK3-045_00530 Glucose-1-phosphate thymidylyltransferase
MKGIILAGGSGTRLYPLTLVTSKQLLPINDKPMIYYPLSTLMLAGIKDILIISTPEDTPR
FESLLGDGSQFGITLQYKVQPKPEGLAQAFIIGEEFIGDDSVAMILGDNIYYGSGMRKIL
QRAAQKEHGATVFGYHVQDPERFGVVEFNDDGKVLSVEEKPEVPKSNYAITGLYFYDNRV
VDIAKNVQPSHRGELEITSINEAYLNLGELEVELLGRGYTWLDTGTHQSLLEASNFVQTI
EDHQGIKIAAPEEIGYINGWITNDSLIEQGNLYSKTGYGQYLLKVAKGDIKY
>PK3-045_00531 dTDP-4-dehydrorhamnose 3,5-epimerase
MQITETFIQGLKVVEPKVFGDHRGWFMETYNEEIFQKAGIDIRFVQDNQSFSATKGTLRG
LHYQLNPKAQTKLVRCTKGAIFDVAVDIRKGSPTFGKWFGIELSAENKKQLLIPQGFAHG
FMTITDDVEVQYKVDNLYAPDCDRGISWNDPEIGIEWPLEITPVLSEKDEKAPLLKDADN
NFTYGENK
>PK3-045_00532 dTDP-4-dehydrorhamnose reductase
MKIIVTGYSGQLGYDVVLEGKKRGFNMIGVGHKELDITQEEQVRNYIHTVKPDVIIHCAA
YTAVDNAEDNKDVCFDVNVNGTKYLAASAKSVDAKFIYISTDYVFEGTGTEPFTEEDAAN
PVGYYGITKYEGEKAVQSLLDKYFIVRISWVFGINGNNFIKTMLRLVETRKELNVVGDQY
GSPTYTFDLAKLLLDMTETEKYGVYHASNEGFTTWADFAKEIFQVAGKAVKVKSITTEEY
PTKAVRPKNSRMSKDKLEKNGFTRLPAWQDALTRYIAELQEEVN
>PK3-045_00533 dTDP-glucose 4,6-dehydratase 2
MARKKVLVTGGAGFIGGNFVQYMVNKYPDYDIYNLDLLTYAGDLTKHKEIEAKDNYHFVK
ADIADRDAIFALFEKENFDYVTHFAAESHVDRSITNPEIFVVTNVLGTQVLLDASKAIGV
TKFVHVSTDEVYGELDFDPTTFFTEDTPLQPNSPYSASKASSDMLVRAYHETFGLPINIT
RCSNNYGPYHFPEKLIPLTISRVLNEQKIPVYGDGKNIRDWLHVLDHCAAIDLVLHEGIN
GEVYNVGGHNERTNLDVVRTIINTLGKSENLIEFVKDRLGHDKRYAIDPTKLEELGWKPT
YTFESGIAQTIKWYIENQDWWERIISGKYIDYFENQYQI
>PK3-045_00534 Teichoic acid poly(glycerol phosphate) polymerase
MVTRFKKAIKLVGNLFLLYFSILIPKDKKLWVFGSWFGKKYTDNSRYLFEYVLEKEPDIR
AVWLTHDRIIYQNLKKKCIPVYYINSLKGYWICCRSSIAFFSQGTWDVNRLGLFRTIKVQ
LWHGYPNKKNATKVNLSERNSILKKLKLSLLKPHHWYDFTISSNGSAGEIRANSFDMEKD
QVILSGYPRTDIILSKSKGGNYIKKKKVIGFFPTYRPYDFKLFENDTLDNLRKVLKKYNM
SLIVKLHPADNKIFNFVSDEDIIFLEDTIDVNDILADIDILLTDYSSIYFDYLILNRPII
FTSFDQKEYISRTGGFWDNFNERAGKHCVNWREVIQEIELLNEGGDYYEQKRLESINKIY
KHVDTENRKRLVDFFKSS
>PK3-045_00535 Bifunctional ribulose 5-phosphate reductase/CDP-ribitol pyrophosphorylase Bcs1
MVKVFAIILAGGIGSRSKSSTPKQLLNINGSSLLELTIKKFDSNINIHEIIVVVNKEFST
WNLVESLKDKYHKVNSIVIGGNSRRESTFNGLKEISVDDSVVLIHDAVRPFVSHRTINNC
VKSLVDYDAVYPAVSSADTIIEIDEEGLVKNIPLRKNMLRGQTPQGFKTSLIKKAHYYSL
EDEKVDKEVTNDCGLITRYNLGKIKVVEGNRENIKITFPEDILLVERLYKNELN
>PK3-045_00536 hypothetical protein
MEGLYKKISGTFLYKIFGLGLAFVFEIILGRTLNPVLYGQYAMVLTYTNVLSIFAIFGMD
KNLIKEVARVADDKLKVKSLFKFSLQISGAIFILLALIILFFHEEIITTPRELIYFLLII
FLLKVIIAILDGLLQGLGFIVKVTKLNILINTVLKIIIFFLLFFMNVNGIKAALLSFIIS
EILTICFRIKIILSLWGSKNSSKIVLKKSEKKIFLRYSLTVGLIAGIGILLQNIDKIMIS
NLLNLESVGIYRVAQNYVTLIGVFITPFIAFWPIISKLFAENRLEEIDFQMKKIVKLISF
LVIPMFSIFLFINEEFLSVFGNAFVTNEGKYILIILAFAYLFDAISGPIGSILTMTKYAR
FVLMNNILALLLNLVLNYYFIRKFGVIGAAYGTGICIIVNNLLAIIEVKVLLGIFSYDKT
NILQIISLSIYNYLICKYLRPIIVIENNLLFIIIFVTAVYIANILLLIILYRKQINAILQ
KLTKR
>PK3-045_00537 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase
MIKRIYNKVQRMFTTFIQKRKKGLILKGYVGFSGYPLIRLKGGKIIIHNNVILNSKNRDY
HINMYSPVKIYTSLPQAKIEIGENTRIHGSCIHAYGSIEIGKNCLIAANCQIFDSNRHEL
SFDDPQLRLTTSTRSKPIKIGDNVWIGANSIILPGVTIGNGSVIAAGSIVNKDVLPYTLV
GGNPAKTIKTYSQ
>PK3-045_00538 hypothetical protein
MIYIKIKIWIIFFFIVLTFILFLKFSEDRITYMINVNEVGIEGNGKDITQDLQNLLNSVN
TSKIKEIYFPEGTYTISFPIKIDKPITLKGNNAVFKLSDRFKSNKYGQGFFYSESIDGIT
FKNLIFNGNNKSLQKNLKNNFVLFMKNSSYINVINCEVYNLNGHGRNLNSAFSFVGNSNH
ILVKENRITNSNGGAIFFQGAYSMAIDNNAYNLKDVAYVTNGIGSKNVIFKNNKAISVSS
GSIGIENGASKITVEDNYIENFTNGYGIGVLKLKDESESLSKDIVINNNEINVNKGTNPS
NGIAIVQGKNIIVYDNIVKGVDQANQYNNSIYLGPKTENVLVYNNVLSNSDAALFVNNSK
GNNITIYDNILGNN
>PK3-045_00539 hypothetical protein
MEEQNFLKGLYFAIFVSFPLWIALLGWIKLLF
>PK3-045_00540 hypothetical protein
MNKKLIKLVLVTIISTASIIPISVFAETESKANNDISTGAALNDPNYIQNEDYYNSLEEK
RDKQTEREEQAFQKKQAMSKLAAKTNEHYTISVKYNKQQYSNFCGVAAGRQSLSFHKLKS
GSSEKLPSQKHFGNTIGTLPNGGGTKSTFLADGLNKYKYVYKFSGNPYIVGNIAKYSKPA
VKLETRVKTTLRNKKTAPILLTRTDFIEQYRGTKYRHYVTVSGYDKNADEFRLVDPNHHT
EFTKGGTYWSKLKTTVSKKGVARAVYEADKETKGSNPVMVW
>PK3-045_00541 hypothetical protein
MTRKNTFILITILVLIFIVFYGNHLLQTKKTSATNSKSLEKTQIYDKDFDVNVNLPYKEI
SSYAAYKDNVYMSAADNSPSGMANKIIEYNRKTNKVETLFTTKFDSSSIQGLKANDKWVT
WVDSDDFGDQKNIYIMNTKTREIEPITKENDKSIKNEFPVLADNYLAWIYFDQNKNQSYV
MIRDLKTQRNKTVFNLKTHTLDNAFLSVQDGKILFTDIREGKSYCYLYNISTHKLEEFQS
PHKKIGWGELLNDHQIVYLAFFTESFADNKLVLFDTQTKKAKEFSSKYMEVNGLRVDGSN
HVFVGTGVSNYFQKYQIDNGNIKKIGEIEDNDIFDMTANNGVYLMKIETKNKDEKLIITS
KLPE
>PK3-045_00542 hypothetical protein
MKNKQVNAIESQLEKYREGKELTAEYIVEGIGTVKVYGVLDFEALVKRLLQTKYINC
>PK3-045_00543 hypothetical protein
MTKVNPKYFETLLNETIINGVELIYKLYRYNKVLNQLLRLNSDKLGRSLRAFTGKE
>PK3-045_00544 hypothetical protein
MLDQRAAALLQLLKNYGPQRIKRLEKELGCTRRQITYDVKKINNWLIDQGMPPIKNDRSR
GLIFPNQWKEQEEGKIPVVKTNTYIASPTERKGLILLKIFTNTEYVSVNHFIDLLKVSKN
TVLTSIKEASKLAEQYHVIIKYTRRHGYELVGEEGNIRFLMMLCISEFIRYEEGSELLKD
LYNQENGQGAYEHSHKKISAIIAEMEKQLGIKYVEEKVQEVIVFLLFLLLRIQKGGSIFY
PDDRREIIANLNEYKVISEKVTKLGISKETDEHLYITSVLIGLQCKDSHLNEASFLMERQ
LYALTQVIIQEFELLACVSISNQKELAHSLYYHIRPAYYRMLFHIPIVNPLLKQIKEEFP
DLFVLVKKALKPLEEFVNRPISEEEAGYITLHFGSYVDAANIQVDLRKKAVIVCPNGMGT
SNMLKYQIEKLVPEVEILAIYSLSDYDYQREDEFDLLFSTIPFQTTKPIIMVNPILTALD
KARILQEFDFRVLRKKDLKGVSVNQIMEVIKPFTTIHNENGLYEALCDLVMGHTAAHFRG
YKPVISDLLKRELIQIKDKVDSWQEAIRVASSPLLDIQAIEPRYIDAMITNIEKLGSYVV
LAPHVAIPHARPEEGVKKLGMSLLKLHEPISFSPDDPEKNVHLIFVLAAVDNHSHLKALS
QLTELLEEEENIDQMIEMTATESFLELIQSYSEL
>PK3-045_00545 Ascorbate-specific PTS system EIIB component
MITIVTVCGNGIGSSLMLKMKIEEICAELGIPAQVESSDFNGAKGRNCDLVVTIDELAKQ
FDSTAQRVCVVRSYINKKKIKADVQEVLQEVASNKK
>PK3-045_00546 Ascorbate-specific PTS system EIIC component
MGFLTNVLEFLKDILSEPALLIGLIAFIGLVALRKPFHKVLTGTLGPILGYIMLSAGASF
IVANLEPLGAMIEKGFHIQGVVPNNEAVVATAQKMLGVETMSILLLGLILNIVIARFTKY
KYVFLTGHHSFFMACLLSAVLGASGLSGALLIMNGGFILGAWSAISPAIGQKYTLKVTDG
DDIAMGHFGSIGYYLSAWVGKFVGSPKDSTEKINIPEQWSFLRNTTLSTALTMCVIYLIA
AIAAGSEFVNTLSDGVSPYLFAIMSALKFAIGVTIVYNGVRMILADLIPSFQGIATRIIP
NAVPAVDCAVFFPYAQTAVIIGFICSFAGGIIGMLILGFAGGVLIIPGLVPHFFCGATAG
VYGNATGGRKGAMLGSFVNGLALTFLPALLLPVLGDLGFANSTFGDVDFALIGILLGQAG
NLFTTAGIYAIVFLLVLILIIPNFIKTKTVTINHVDEDTNM
>PK3-045_00547 Transaldolase
MDKLIDQLNVKIYADGAVLADMLAAYKSGIIRGFTTNPSLMKKAGIQDYEAFAVEALRHI
PDLPISFEVFSDDFAIMEKEAEKINSWGENVYIKIPITNSIGESSIPLIQKLSSKGMQLN
ITAILTLDQVEETVQAFKSGTKNIVSVFAGRIADSGIDPIPTMKEAAKICSKKEGTELLW
ASSRELLNIMQADACGCSIITCSPDILNKLANVGRDLKTISLDTVKMFNKDIQELGYSII
>PK3-045_00548 Orotate phosphoribosyltransferase
METYSLTVAGVKRELPIIPISNDLKIASFVILGDTEIVVAAASLLAEQLKDIDYLVTAEA
KGIPLVHELSKQLNMSEYIVARKSVKPYMDEPLINQVVSITTQKEQLLCLDGKDAAKIKG
KRIAIIDDVISTGESIRVLEELVTKAGGIIVSKAAILAEGDAAERDDIVYLEKLPVF
>PK3-045_00549 hypothetical protein
MEDILKDILAALSVVLNGLPQGLLALSFGFASVPTALAFLVGAAGNSLTSNVAVISFQAE
TITVAGTMGKNMRERLSSIFFGAFLLVIIGVFGLMEQIVAWIGPVITNGMMAGVGFMLAK
VAWDMAKNDRLIGVTSFASALLTYIISKDLVYTITVSVLLSSIVYHFTKKESATVTNMLT
EDKFKLQKFILNPSVIRGALALVCLNIGANIAFGKINGEIAGANVNIDTLTIISSLADMV
SSLFGGGPVEIIISATASAPHAVWAGVLTMAIMAAILFFKLLPKIGKYVPSSSIAGFLFV
LGAIVTLPGNATAALTGTEASSPIVGAITIIVTAIADPFLGLLAGVVMEFLLGLFGV
>PK3-045_00551 PTS system galactitol-specific EIIC component
MFLEKLNDAFNGFINLGGSAMMFIIITILSLIVGVSISKAIEGGLRMAIALTGMGAIISL
LTTAFSPALNSFVESTGVALSVTDLGWAPLAVITWGSVYTLYFAFICLLVNVFMLIAKKT
TTLNVDLFNIWNLSVIGLLTMYYSNDNLILTTLFVAFIYALMLINADVMKPTINELLGYD
QNNITTTAHPSLLIAPLVMVLNKFIDICLPFIDKFDFNAEALNKKIGFWGSNFAIGAYLG
IFIGILGQLSVAEIFTLAFTGAVALELFALVGSWFGPAIGPLSEGITSKMSKRFKGRKLL
IGIDWPILATRAELWAVANILAPILLLVAIFLPGNTVLPLGGILLTVLAPALLIVTKGRV
VRMTIIGTILIPLFLWGATFIAKFVTETSKAMGNFPNGLAADALFSSVDSDPIEKMLAIL
FGKAVDTWDIKLIGFSVLALAAYILLFGWYFKQMRKENKKMELKQNTDKKVS
>PK3-045_00552 Ribose operon repressor
MITIKDVAKEAGVSVATVSRVLNNKGGAKPETITHVENVIKKLNYKPNKIAKSLSEGSSN
LIALLVPTLNNPFFPELVREIEKVANENGYNVYLCNSDDDRMKVEYYLESMIDHYVSGAI
INSLHVDASDLAELEKRGIRTITIDRANFEHPYSAITVDHTLGAQLAVTHLIRDEKCNNI
VFISGPKNEKSAIDRLTGFTLALNEARHPVKTHICYGDFGTASGYENTKALIEKGRSFDS
IFCANDAMAIGAMRACHEFGIKVPSEVKIVGYDNISLASYMYPTLSSVDQCKEDIGRLAV
NELIQLIKNPKNKQKQYQLEPKLVIRNSSTINGGSINE
>PK3-045_00553 Ribulose-phosphate 3-epimerase
MNKIGPSLMCADLGNLEQNIKELDKAGVDFYHIDIMDGKFVPNFTLGPDFVKTVRRLTTT
PLDIHLMVEEPERHIDLFAECGADMISVHQESTNALHSVLMKIKEKGIKAGVAINPGTSL
EFLDQVYDLIDYVVVMTVNPGFAGQKFIPSMYEKIAKLNGKIKQYNREIEIQVDGNIGES
TIPTCQENGASMYVLGTSAVFNSNHSLEENVRLTREIFN
>PK3-045_00554 Ribokinase
MNYDIVVVGSINMDIIVEAPKYPAYGDTMFCDSIKMLPGGKGANQAVSVAKLGKKTCLVG
SVGKDSAGNQLIENLQAKNVDTSYIVKSEESGTGTFVAIVDSSGENTMVGTKGANDSLSK
EDIEKIFAQIDAKILLVQLETSKESIIAAMQAAKERGMYVILDPAPADGIFEEAFQYADL
VTPNKQETKRITGIDVINKETALEAAKKLNEKGISDVIVKMGEHGSLVYKNGEATVVDAI
KVKAVDTVGAGDCFAGALASAYLDTNDLVKAANFASVAAGIKVSRSGGQEAIPTLNEVEG
YLVK
>PK3-045_00555 PTS system glucose-specific EIICBA component
MKKMLSFEFWQKFGKALMVVVAVMPAAGIMISLGKLIAMIDASVFITIGSVVENIGWGII
GNLHILFALAIGGSWAKEKAGGAFAAGIAFLLINRITGSIFGVTNEMLSEDGAFTHTLFG
TKILVEGYFTSVLEAPALNMGVFVGIISGFIGAIVYNKYYNFRKLPDALAFFNGKRFVPF
VVILWSVIVSLILAVIWPTIQTGINHFGLWIATSSESAPILAPFIYGTAERLLIPFGLHH
MLTIPINYTSLGGTYTIMSGVMAGKEVFGQDPLWLAWASDLVNLQNAGDTAAYNQLLSSV
TPARFKVGQMIGATAILMGVAVAIYRNVDMDKKKKYKSMIFSAAIAVFLTGVTEPLEFMF
MFAAPVLYVVYAILQGLAFASADIVHLRLHSFGNLELITRLPIAFKAGLGGDVLNFVIVC
IVFFIVSYFIANFMIKKFNFSTPGRNGNYENDADSNTTEAGNAGPTNSQVLEIVDLLGGK
ANITDVDACMTRLRVSVKELDKVGDESSWKAAGAMGLIKKDGGVQAIYGPKADILKSDIN
DYLEQSE
>PK3-045_00556 Maltose 6'-phosphate phosphatase
MKLLTLNTHSWIEERPLEKLKAIKEQLLADSYDVISLQEVNQSMDAEEAEVDSFFIATNQ
DTVIKKDNFAFLLQQELKKEGLEFYWSWVPSHIGYDQYDEGIAILTRFKVTNARGILLSC
KDDYTDYHTRKSLEVRFQANKKNYLVYGLHLSWWQDETGSYPFLYEWNKLVEAWEVEARA
GGYILLMGDFNNPAHIEEEGYSVVSKHPYIKDAFLDATLKNGSHTVEKRIDGWENNSDLL
RIDYIFVSSNLSVYSYETVFDGRTTPVVSDHFGVKVEIG
>PK3-045_00557 Guanine deaminase
MSNYTHIFQGTAFSSESPKKVTILKDYLFFIDTNGMIKKMVGPEQSEYSTLLETYEGQAN
FHRLAEGQYFLPGFVDLHVHAPQWAQSGTALDIPLYDWLHTYTFPLEAKYADLSFATTVY
EDLVSTLLANGTTTVLYFATVHKEASLLLAKICAEKGQRGLVGKVVMDDPEQNPSYYRDA
DTKTALADTESFILAVKELAKETKQGVYPVVTPRFIPSCSDEALKGLGKLAAKYDTHIQS
HCSESDWAHDYVKERLGKHDAFALHDFGLLGNKSVMAHCNFLDDNDAALFAETGTAISHC
PLSNAYFANSVLPIKRFQSMGIDIGLGTDISAGATPSLYDNAKQAVVSSRMLEDGVNPTL
PAEERGVPDSRISIHEAFYLATAGGGESLSLPIGRLQENYTWDVQIIDTKAPTAKLPIFS
EAEDLDDIFQKILYLVRPDNISEVWVQGEKVHSRS
>PK3-045_00559 Uric acid permease PucK
MEKMAKDLEAKGKIQEGKEEITVGKSIFLGVQQILAMDLFIPPIILAGLLSFSVQDSSLL
IQMTFIACGIATIIQAGFAMKLPVMQGPSFVPLSALAAIGTTSGIGAMIGSLIPGALIIA
LLGYPLKLYSKVVRKVIPPIVAGTVIVVVGISLMPSAINSIYTAEGSFGENILVATVTAA
VLIFCMYVGEKAKSKWKYIKVVSVILALGLGSLVASFFGLVSFASLENASWFQMPSLFAF
GAPQFNVHAILVMIVVYLIVTIETTGTWFTVSNVTGEELNDKRLNGGAFGEGLGCFVGSF
FGGTPVTGYSSNAGIIAITGVKSRKPIIMGGIMLVILGMMPKLTSLIACIPSVVINSVFA
ILCVIIMMNGFKVVKGLEFTERNMIVIGVPIMLALFAVLMPANVLNGLPEIVTYFVSSGT
AIGAIAALILNLVLPQKQGERVNTNKPTVNVN
>PK3-045_00560 Methylxanthine N1-demethylase NdmA
MQQDRLWNEWHPVCKAEELLDDPKQVFVLGERVAIFRNEKGVHAFKDLCIHRGAALSLGK
VKNGNLVCAYHAWEYDCAGACVKIPALPNGRAIPRKAKATVYHCEEYLGLIWVNLGDDPA
PLISYPEYSTEGYRTAICGPYEVKANAPRIIENFLDVSHLMFVHEGLLGDEDHAEVVDYK
VDFIDNRFITSKIPVYQPNPDGRSKGGYANYVYEILNPTTARFTKTTDGSEDALTILLVV
NQEDNEQSKAFMLLTRNYDLDKPDEPFIEFQDKIFYQDLDIVQSQKPELLPLDLQAELHL
KSDALTISYRRWLQELGVENGTIPGDRHHKKTKS
>PK3-045_00561 hypothetical protein
MPRKKRVWYPGASYHITSRGIRRTSLFFDEEDRKKYLRLLTEVMEEKPFILQTYCLMTNH
IHLQIKTLQHSPSDIIRTLHFNYAIYFNKKYDFTGHVFESRYGSELITSAQYELEVNRYI
HLNPIRAGIVERLEEYPWSSYFDYIETKEESMVNSERIFAYFPDPKPEQYLQFLHARGKE
SDQYPI
>PK3-045_00562 hypothetical protein
MKKKLFLTFALTILLIGGCYYFFIYFPYPPSKDFYDFPVPRSAEMIRETETSKTYKWSNA
SEEHGIPFGYVKAIKSNGWKKGEQAGASTYYSNGVHQIILTSTTDIIAIEKVK
>PK3-045_00563 hypothetical protein
MENSGNFTIIVPNEFNFLLYLYNWIDKKEFPHFEVRVENLDINEIKKNIIEQWNLYFEQL
LNNGEYIQYIEVENSLAEEVLVGLDSKQKENIVNQYNSWWYHQSSIGYYQIIEKAISYHN
KINLIRSILNIETYPYLLITYDSIPKEFSVNNSDFYFISQNSILTL
>PK3-045_00564 putative NAD-dependent malic enzyme 2
MAIGTISKQDVIQTNLKGKQLLLNPFLNKGVAFSKEERQELGLNGLLPTQILTLEEQAKR
IYEQFSAQTSDLRKNGLLYDLYNRNVVLFYKVLQDNLNEMLPIIYTPTVGEVIQKYSHEY
HIPGGLYLSIDNMENMEEAFNNLNIPSDGIDLIVVTDSESILGIGDQGVGGINIAIGKLA
VYTAAAGIDPSRVLPIVLDVGTNNEALIQDPLYLGNKFSRVRGKSYDQFIERFVENALKT
FPDVLLHWEDLGNVNARAIMEKYSDKILTFNDDIQGTGAVTLAAIMSALKVTKESLSDQR
VVIFGPGAAGIGNADQMVETMVLEGVSREEAYNRFWPIDFRGLLTDETADVVAFQQPYVR
SAKEVADWERNEENIIPLLEVIRKVKPTILIGTSGQAGAFSEEVVKEMAKHVERPIIMPM
SNPTPLAEATPEDIIKWTDGKALIATGSPFKDVEYNGVTYEIGQSNNAFVFPGLGLGAII
AKAAIISKGMFAASANAVASLADSSSLGASILPSIDKLQEVSKAVAIAVAEAAIKEGIAQ
AKIEDIEQALNDYMWKPEYKAITLK
>PK3-045_00565 hypothetical protein
MSLGHIFLVLIPIFFTIILGYLGGYLNIFNADSSKGLNTLVTKFALPAHLFIGITTTSKQ
TLIDQWPFFLNMFIGIIGFYVILLLISKFVFKYDVTKASMFSLNSTQPAFAFMGISVLGS
LFGQQEVAIPIAITGIVVNAILDPLATIVGNIGESNKGKAKDEKGSTIGIILHGLSEPLA
CIPLLAVVLTLCGFHSPEIIQSALDQIGSVTSGVALFAVGVTVGIRKINFQGVAFGISLL
KVIVLPLFMILVAHLVGLNHADTVKAILLVAFPGSAVAAMISTRFDSLTTETASSFVIST
ILSLITLPIFITWLI
>PK3-045_00566 hypothetical protein
MFFLKDDGFEYSKTQLKTEVIDIHNLEDGFTQLQLRFTFDFNSGAFSHEVTWSNYDIESS
SVQIGKSHPFWRHHSH
>PK3-045_00567 Putative metabolite transport protein YjhB
MNIKAYENSEVPEKKITGYQWKTLWSSTVGYAMDGLDMMILAYTLPLIIAFFGINQAQAG
SLSTITLLGAVIGGIVFGVMADKFGRVRVFTWTILIFSVFTGLCALAPNLETFAIFRFLA
GLGLGGEFGIGMTLVSETWPKKYRSRATSVVAVGFQLGIVLATLTVLFIAPKFGWHGVFL
AGVVPAIFAFWSRKNLKEPEIWTKLKEENKNKIAIGQLFASKETTKITIGLIIATSVQNF
GFYGIMTWMPTMLASELGYNFNKTTLWTVTTIVGMILGILIFGYLADKIGRRPSYITFLI
AAAIIVWVYFQVTSTAALLLLGGVLGFFVNGMMGGYGALLAEHYNTEVRSTAENIIFNVG
RAIAGFAPFIIGYISLNHSLSYALSLLSGVYILSALAFIFLIPESKDKEIV
>PK3-045_00568 Pca operon regulatory protein
MEWLNRFTDVMDCLSSNANIGMGVSELARETDLSKGTIHRMLTSMCEHQLVVQDKTTKQY
YLGPKTMLWGSQFLRLQDPIKLLGRYGEKLSIETNLYTFICRYHGGDVYCVYTHQPSDLR
NKYFVHVGQRMPIHSAAAAKVILAYQEEAIVERMVHETPFEATTPYTKTNPLDIKKELKE
IYHSQLAFCIEELEMGVSAISAPIFYDDKKTNVSISIVGESDYIAMQQATLVKQINEVAK
EASEHMKSMHLLSSIRL
>PK3-045_00569 putative hydrolase
MAHNQGDRKMDRKRRYEELLNNMNQYNSGTKGITRVAFTNEEQACSHAFMRLCKNEGLEI
RMDYCGNIIARREGKHKDLPPVVIGSHLDTVYQGGKYDGVVGVTAGLEVIKRLNEQNLET
EHPIEIISFACEESSRFGVSTVGSKAMAGTLQKEKYQHLKDKDGITFEKALSLCALRFDQ
LDLASRATERFQAFFELHIEQGPILMNTNKKIGIVTGIAAPVRFIIEVKGAASHSGTTPM
NMRKDALLGASELALALEEAAKEEQHNGTVATIGVLSIPMGAMNVVPGTVEMKVDIRSTS
TASRNKVLTALLKKMEDVQERRGLTITSQEISKEEPVQLSKELTLQIEKICLEKKLPYQW
MQSGAGHDAMNMTSFGPVGLIFIPSLNGISHHPDEHTDLDDILIGIDVLEAAVLQQAIAV
Y
>PK3-045_00570 Dihydroorotate dehydrogenase B (NAD(+)), electron transfer subunit
MAVKAEIIFNKQVSKRYFHLKVKVPNQQLFPVQAGQFFHIKCCEGPKPLLRRPLSIFRIN
EAESTLEFLYLVKGVGTKALAERKSEETLDILGPLGKGFSIAEGSENILIVARGVGIATL
SALAFKLKSKNISCFAIVSARTKEDYLVEAELKAAGVEAVFVNDEAGTSDPSCVKLLAET
WISEKKIDSIYTCGSRRLSKLMKELAYEHRLFAEIALEENMGCGIGSCYGCVCQIEEEER
IRPVRICMEGPVFPLEKVVFA
>PK3-045_00571 Dihydroorotate dehydrogenase B (NAD(+)), catalytic subunit
MSGLEVILGNLHLKNPVMPASGTFAEQMTNYIDSNQIGAIIPKSITKNRRTGNSTPRICE
TKAGGMINSIGIQSEGLTYFKEKTIPFYAAFSTPLIPSVSADSIEEFVEVSAELGAMDEV
DAIELNISCPNLKNNGMAFGMDPSISHELVSKVRKTTNKPLIPKLSPNVTSIVEIAKACE
AAGADILTVSNTFLAMSIDVHTRKPKISNVMGGYSGPAILPLVVRMVYQVYQATSLPIIG
CGGVMNGEDAIELMLAGASAVQIGTASFVDPEAMITIRDEMEAYMQAHGIKDIQEIIGGV
VVR
>PK3-045_00572 L-hydantoinase
MADKQGVLADTSQGLADKQGVLADTSQGLADKQGVLADTSQGLADIFAALVDQSIFSYKK
GVESMLWDHVIKNGYLYTGNGFEKGHLYIKDGKIAAITQDELAGEVLEVTDGEGLYVCPG
FMDTHIHSRDPGPTYKEDFYYSTQAAAAGGITTVFEMPNTNPPINNVENFEKQKKNLTAK
AHVDFAIWGICLGDANREDIVPLHQAGVIGFKFFWGYAINKETYQLMYNYKDGDKGVIPP
LSDGEVYSIFREVQKTGQILAIHAENNQIIQRLTEEVEASGKRDYEALLQGRPNLAEEMT
IQSGIALAKNLGTRLHILHVSTGEGVKLIRQAQTDGYTNITSETCPHYLFLSNEDYERVG
PQMKVYPPIKYKKDQEELWRGIQDGTVTVVCSDHAPHTEEEKDGSLWDIPAGMCGVETLA
PLLLNAVSEEKISLVDACKLLSENPAKQYGIYPQKGSLQVGTDADITIVDMKKKHTIKRE
ELHSKSKVTAYNQTPITGMPVATIVRGTKVMENGQIISQPIGRIVVPGENERDGSPFELK
SIGDL
>PK3-045_00573 hypothetical protein
MNKKEKLDSFIKLYDLINFYYENRDRPADREFDFFEEVKVNCETLEIDYDSFIKELRLQR
L
>PK3-045_00574 hypothetical protein
MKKIERLISIVMILLQKEVVSASEFSRLFHVTKRTIQRDMEALSYANIPIYAKYGAEGGY
ALMDEYKFDKRLLSQNDIENILVALGGFEQLITNQEIQTTILKIKGMTSANISPKLDVTF
YDWKGRSQIDEDVLLIKQAMENNWLVKFEYVDSIGNITSRVVEPYKMHLREMHWYLFGYS
LERKDYRTFKLTRMTNINKGGFFIPRITDKVLEAEKQHNEKQDLVNVQLLIDVAVRDQFI
ERYGKNAVNKGNSESYLATIELPMNPFAYQFLAGFGNKVKIIKPKAFIAEYLHFLEDTVK
LYK
>PK3-045_00575 hypothetical protein
MKAISYLQFGGKAEKALDFYEKALHATNVKKVRFAAFVQDSNAPLTKEEQNMIMESRIEF
SGNILMISDVPPFMQAMTGEIIKGNTVLISIIDADKDRNQQIFEKLAEGGTVIMPLASTP
WSASFGMVVDKYGVTWKFNSEASKFLDSFK
>PK3-045_00576 Sortase D
MKVIGNCLIAAGICLLIFFGYQYYHNEHAQNIAFVEAKELIENNKNIKIDRSDKKKDPFS
QVTFDYGQSIGILKIPKLERSLAIVEGTDPDSLSKGVGHLSESVLPGQGEQIILSGHRDT
VFRDFGDLTIGDQFIVEMPYGKYHYEIKETEIVPEDDTSVIRKMGKEVLVVTTCYPFYFI
GNAPERFIIYAYPVEKKGL
>PK3-045_00577 hypothetical protein
MFTTLTSSFQEALEKIYHYIKETEIYAELNTEKECILFLSVGFKNKRADVINVTHQNFEW
AWKTLVKQAIKYFGEAKDFCNIKVDWVNDRKTYSIIDFIEMITHTKKNYFRKGISFDSSF
TYAFLEQELNSNSMIKLDGKTNRGYLDEVNIQHYISRHRMGLNKLDFNKVTAVTTFSTQG
FYCDQYSCYTLKSDEYDNGRRDTKLDANELKQMIQSAQKQLINMCKPNGKFVYGYFSCFD
KEIKFYNMLRHASTLYAMTESYELFPDPILKESIERGLDYLIDKAMYKDGQKAYIIDRIK
EDTFEIKLGANAAAILALSKYLEIFGLNQHYLLAAQQLAKGIVELQQPDGKFIHVLHYPS
LNVKEAYRIVYYDGEAAFALMRLYKLDKNPKWIECVEHAFNYFIANNYWKNHDHWLSYCT
NELIKYKPEKKYFEFGLKNTNDKLDFIYHRKTTYPTFLELTMATYHMIQYLKKTNHASLL
TSFDEKKLIDTIHRRAEYQRNGYFYPELAMYYKNPNRIKGGFFIRHHSFRMRIDDIEHYL
SGYCQYFHTFLAN
>PK3-045_00578 hypothetical protein
MKEFDYKKSLRNHQKRKRVQTKKILVSTVVASTLVVSSLPSIPIGNLLIKPQYTVSAASL
GEVQLLTDVDVTAELTENTDNYNLALGLSGVGLVDAELFNPDRVAVFYAPDLAGKLEVTE
PANVRVEILPITMDNLPALSNGIDLLMGSVNNVFSTLVSSVGDLVNNPITGRLVSVEGLD
ELESSIEALNNINDALEDLLAYEDQVDVTVNPDGSLVVNFSDGLGNHLETAVKDVVLKLL
NDLTDSINALEISGIAGSLIDPILTPVQALTTPIQDLSNQLLNGSIDIANDLAGVQVIGE
TTVSLNATVPKPAGVEGSVTIQGAGVSTTTIDAQLLSNLEDSDTVVFNEEGDADADADAD
ADADADADADADADADADADADADADADADADADADADADADADADADADADADADADAD
ADADADADADADADADADADADADADADADADADADADADADADADADADADADADADAD
ADADADADADADADADADADADADADADADADADADADADADADADADADADADADADAD
ADADADADADADADADADADADADADADADADADADADADADADADADADADADADADAD
ADADSDADADADADADADADADADADADADADADADADADADADADADADADSDADADAD
ADADADADADADADADADADADADADADADADADADADADADADADADADADADADADAD
ADADADADADADADSDADADADADADADADADADADADADADADADADADADADADADAD
ADADADADADADADADADADADADADADADADSDADADADADADADADADADADADADAD
ADADADADADADADADADADADADADADADADADADADSDADADSDADANSDTNNNKEYI
LNTNNGAQKLPNTATAMWSYGLAGIGALLSGIASRIFGRRKRQ
>PK3-045_00579 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MQGFSSKELATILEGYYIKEVDNFHIFNFEIDPKRLESEKCDHTCFISLSKKRWELVHKK
ETQWRDGNREILDHYLKCAIIITEEPIKELIDEKPQLIVKDSYKTIAKLAKAARLKMNNP
VIAITGSVGKSSTRLLLEHLLKGDGTIVATRGNHNTQVGVPLYGSKLSSNPDYGIIEISL
NALNNRGNHSLTIQPDICLVTSIGEAHLSTLHSTENIAKFKARIFKGMQQNGIAIINHDI
GKKEFDILYHAAKEKTEKIYTYSLSNKNADLYLKKYKQRKYDTLVTFHYQNQDYCFSMKL
PSNGMIANAFGAILCLAKMGHPFTSYLEKLQSFKSLDKIMDLKTYHTADGRLIDVIDDTH
NAAIPSMINAIQTFKEKQCFYSGNKILVLGQVADLGSQAQELHDKLLKYILSSGADYIFG
HGLYMRKVIKSLPAEKVGGWFDNAKDLAERIPYYCSNDSIVLLKGSVSGSDFRMTSHYLP
NQLKRSKMQLYQYDPQIVANAIQPSWGVEVWDANTKEINFVRGRQSTRSLEGLGHLLLLD
SFNLSTVNLNDVITLEKWPTNIGYSTNKKPFQKGTKFTILELINEFILTQHPSVIYQLGT
YFYGDVQKAMRVVNKNGRELNLKPSSCYNLTGRYRVKEQQTYNLTDLRKLGYSIYKKRDI
INFSPTLGRINGNEIKGLCFGELKLSCIAFYENYIISVSGVNTYSELINILSSSLQTFER
KLQTTNQE
>PK3-045_00580 hypothetical protein
MDSPNKEIPNIEEINKEIEEELQQLQLQNNETKESINEPRSFLKQAFDFLIILALILIII
ANFVILIFKLL
>PK3-045_00581 hypothetical protein
MYKLRNQIEQVREEMEKLALVEGFSSPNTIKKSIELDELIYKYQQTKQCKKVIVGSY
>PK3-045_00582 hypothetical protein
MPKDFSIIGFDNHPICLTTSPVLSSIQNQTEWMIEDLINCLLDRLAGKEFPAIRKVYTGD
LVIRGT
>PK3-045_00583 hypothetical protein
MGNYKQVQKSLEVVLFNIEEALNLIENNDYKDISEAGFDLFRKDSKDFKLWDFWLAVMRG
KSNKRECSKVRLLSTLFIFLVYFNSVIKKHKLWITYHFT
>PK3-045_00584 hypothetical protein
MGSLFADYSKFFNNILMEVQETQEEAIIEGANLISQAVKSGGRFYVFGSGHSHMIAEEIY
NRAGGLALVTAILPPELMLHERPNKSTYLERIEGLAKSYLNLHEVSDKDVIMIVSNSGRN
TVPVEMAIEARKKGAKVIAMTSIKHSQSVTSRHQSGKKLYELADVVLDNGAVIGDAGFRI
SNSDIYSGATSDAVGCFLAQALIVESLQLLIEAGFTPPVFKSSNVDGADQFNDEIFSNYV
KW
>PK3-045_00585 Bifunctional protein GlmU
MKTAIILAAGKGKKMWPYNDYWPKAALPVANQGNIVHLVNHLKSLSFDRIIIVTSYLGRR
IKSLVCDFEGVETIELSVTEGTADSLEKVVSLVNDEHLLIMYGDIFITLERLTSFVDAYK
KELNTVDTLILSKPITNEFAPDWFGISKGTGNSVQNIYGHPRPHYVQERLIGVFALSTKA
LKRMLHHNPGFMKNVPTGVMPQHEMEFEQSLQWLVEEGYTVSSYPVTDGVIDIDKPWHLM
QANQLALSVMTNKLQHNDIPETCNIHPTADIQGCIKLGEHVEIGKYVTIKGNAIIGDHTK
IENGVTIEGNVVIGSHCRIENFCRIGPDSVIGSKNRIGHCAEFSGITFDNVSFIHFGEVF
GIIGESTDIAAGVTVGITRFDDLPQTQKVNGRREIPEKFGNAVYFGDFTRTGILSLYMPG
TKVGSNCVIGSGVTVEKDIPSKTLLYAQQTLIEKGWDTHRYGW
>PK3-045_00586 HTH-type transcriptional repressor NagR
MNNKKTPLYKQLKKEIIQKIERGELKPGDVLPSERELAELFEMSRMTVRQAISELVNEYI
LIRRHGSGTYVAESKIPQGRRLKSFSEDMSARGLLPGSKVLEKTIIVEPPANMIADLKSE
GKILMLKRLRLADLYPLAIETIILPIEKFNNLESRNFENESLYRILEDEYSIKITKAQQK
IEVRMPTPQESELLEINYSVPVFHFKQITFDQNNEIFEVAHSVYRGDRYEINTEIYS
>PK3-045_00587 Glucokinase
MSGLYGLVDIGGTKTLIGIATNEKIIGTRQLMSKTIESPQMLIDILMKEFDSLIAETDHK
YGRLISVGISVPGPLNRQNGVIHFTGNLKWSNFKIVEELRKRLNDIPIIIDDDANAAGIA
EAIYGAGKGYKNQIYLTVSTGIGGAIIIDEKLYYGKQDLAGEIGHMTVSPDGPPCSCGNF
GCLEALASGTSIAKKGEQLLIQEQSQVLLELAGKNSVTAEMVFEAVRLGDQACFSIIQQT
CRYLGIGLANIIQIFNPDAIILGGGIMNNQSKLLIPLIESEMNQRLFKIHRGHMDLKLAA
LSGQSGLWGAWHLAKNIPSSAERNSSCHI
>PK3-045_00588 Carbohydrate deacetylase
MPYLIVNADDFGLSKGVNYGIIDAHVSGIVTSTTLMVNMPAAKHASSLAKKYPSLGVGVH
LNLTAGKPIHQNVPSLVNQKGYFHSKKEVLNKANVIEIEKELRAQINDFYTLGLNPTHID
THHNLHGTEPVSSIVKVLAEEYRLPIRQLNKEDPAINTLEFCSKFHDDNASYETLLDIFE
RASVTPLEMMCHPGFVDQQLLNHSSYNIQRIKELDILTDPLTITAIQKARIQLKSYKELR
W
>PK3-045_00589 hypothetical protein
MISFGLILVSHGGLSKGLLSSVEMIMGPRSAKNAETKIDKKYLEVFSGDCNYFRIHGTTN
ECKR
>PK3-045_00590 hypothetical protein
MNIYCGSAKVDITPTESKLLAGYMATRQSKGIHDPIYARIVAIRSQQTFIILVSLDLICI
DQNYTVELRKKISDQTNVSKECIFLHATHTHSGPGGTIHETSPIWRAFPDLWMPYDRILV
NEQHKKIVEAVKLALENLEECKVSICEGKASGIAANRISSEIEYSSILKVIEFEYCSTNK
KVIVYHFACHPTIMNRDNLLISADFPGVTSSNLENENNVEIALFINGPSGDISTRFTRKE
ASFYEVRRVGTVLSAAVLELLTHKKQIKVDTITSKIEKVELGLRNIEDSAQLQHKLHELK
QKHKIQRVTAGNNCAYLRKIESEIEGVSALIKKSGALENSLTISTEIQVLKLGEILFVSI
PGEIFNETGTEITNNYNGVPVFIAGNTNDYIGYIVPEGYYASDSYEAYMTLLEKGSSEKI
RDTILYMMDQV
>PK3-045_00591 hypothetical protein
MKYIKSKKTGSVLRWQYPFNCAGCISSKGIVTTLFKTKHAIGSTSDNGAEILIHIGMDTV
QLEGKYFIAHVKQGGKVSAGDLLLEFDREKNREEGYNLITPVIITNSADVKQIDTTRERT
VSEK
>PK3-045_00592 hypothetical protein
MKIDLIDKKIIDELNQSSRLSMSELGRRINLFSPSVTERDNLLFTYCPFPCRIDLFNIST
VCNNNRSNQIVSFFSIFFPIKF
>PK3-045_00593 hypothetical protein
MARINESKNGETPFQRLLGYNVDVLNGWNQLGDVLEKDLNLSSHLKEQVRRTLAQSNGCE
YCKAKGKPEPHLFDEKTSIAVGFAEAFLKQKGDISDAQFNILKEYLSEAEISELIAFITF
TTASQYFGAIMKLEPVTI
>PK3-045_00594 hypothetical protein
MKINKVEKHYDVIVVGGGMSGVIAAIASARNGAKTLIIDQNGYFGGTLTANGVGPMMTFF
AGDKQVILGIGEEMVSRLKRKGYSPGHVLDTTNYISYVTPFSAEGLKIVLDEMTTEAGAD
ILFHSYLIDLKRNNNLIESILIANKDGITKFTSDVFIDATGDADLAVMADVPFQLGRETD
NAMQPLTMNLKVYGVDTNELRRTVIEDPKKFPRLNRDLNVMKNTEILSFVGFDEEFNRAK
KEGKLNIPREDILFFETSTPGEFILNTSRIINESGVSAEGLTRAEIIGRKQCEELYKFLV
ESIPGFKNAKVAYTGPSVGVRGTRQIKGLYTLTNQDVLENRHFKSTIAHSGYPIDIHNPK
GEGTLSVHVSQSKEIAHNQFDKSVFDNYYRIPFEIMVTNEIDNLIVTGRCVSASFEAQAA
IRTTPTMTALGQAAGTAAWIASKQKESVKAIDIKMLQETLISQGSYIEI
>PK3-045_00595 hypothetical protein
MVTLQLIGILIVFFTMVGLMMTRKLPTILALPIMAIAISLIAGIQIISKDPEQFTLVKDV
LEAGSMRMSTAISGLIFGSLFGKILSKVGITETIIKKAAEMAGDKALPIALSFLLVCSVI
FAASNGLGMVILVGTIIIPIMISAGLSPMVSGMILLLANGIGVTFSVSTLAVYIDVLGLN
LSEVTSYSWMVGIPLIVVSVLMVVYYIKFNGKRRKAWAMPTKKNKGGQVRSIALISPIVP
VVLVFAFQVPLVASIIIGIIAALILSTPKNPIHVVSSAFVEGIQEVAGAAGLMIGIGFLL
NAVMSAEVSAILQPAISLMIPKNQLMFILIFGLLSPLAIYRGPLNVWGLGSGILSLLVAG
GMSPVAAMVALRLNSNVQAVCDPTNSHNVWVSDFTKTDVNEILKKTILWISISTFIGLVF
ASFFLY
>PK3-045_00596 hypothetical protein
MTRKVRIGIDVGGTFTDAVAVDNETYDVIAKLKIPTTHEDGVARGIVKIIQKLLSENNID
PEDVIFIAHGTTQATNALLEGDVAKVGIIGMGTGMDARTAKKETDIKQIELAPNKYLASE
HTFIDSSRISKEEIEKSIQELVNKDCQVIVASEAYSVDDSENEQTVIETAQNQKLYATGG
HEISQLYGLKMRTRTAVVNASLIPKMMQTANMTETAVLDTNIQTNLMIMRCDGGVMSINE
VRQRPILTMLSGLAAGVAGALMYEKVSDGIFFEVGGTSVDISVIKNGKVMIKYAQVGGHK
TYLRSLDVRTLAVAGGSMIRVKENKIVDVGPRSAHIAGLEYECFCDKDNLANPSITFVSP
REGDPNEYVIIESASGHKYSYTLAGAANLLGYVPNGDYAFAKEESNKIAWDTLGEYLGIT
GKEAAEQVLKLAIDKLDPVINQLIDEYEMDRNFITLVGGGGSGAIVVPALAKYFNYKWKL
AKNAPYISTIGVALAMVREQIERSITNPDDQDIKKIRADVMEKIIKSGAKEETVEVNIEI
DSQRNIVRAVATGATELRQKNLGATDVTENDLKRITSEAMGIEPTNVRYIANVGRWNLMD
AIVIKKRFFFKAKQTNVCLIDREGVIRFKHSNAHYLKFQKSQSDTDFLTFIDEHTIYSDA
NATIPKVFLFYKEKMLDLTGMQTIEQLTSIMELETENLTPNDEIIAVAYK
>PK3-045_00597 hypothetical protein
MDYFTDEFLAFLELKQDMLFHKIPEKKIPYYVRESLKIGKVMSGKFKGNMINSLYSTSNI
LIQMEENDGAFFKVQLRAQFETDRKGNNLVLLYRKSIEELARVNGLSYDEMVEIVLAHEF
FHFLEGKQIKHVAEQLETIDSYTLLNLVRKAHVQRASEIAANAFAKEFLGLKYLPNFYDY
QYLLETNKMNPQELEEEYQEYLRVFKTTERHSVEENYPINPF
>PK3-045_00598 putative HTH-type transcriptional regulator YbbH
MQSAVLLKIKSLESTFTASEYDIGQFVIENPDYVITNTITNLAKKTNTSEASINRFCKKI
GYKGFNKFKISLAQSNTQIEKLKEEEINESNLLEYITLDYQKMLTNTCALLNTKDVEDAA
SLLTLSRKIFILSVYNTSFISEEFAFKLKQIGLDVTILKENLEAQLAIENMNSDSILIAV
VPSVISKDIIPFLTKIKKKDVKVILITSNDNPKTNDLINIKFITPDPVTSNNSLVITNSP
MISLVFDIIYATILRDNRGLRQRKLSSDMIINSFQSADSAIYEW
>PK3-045_00599 hypothetical protein
MKKGVVILLAIVVFAMILIYGFMHMTGQTEHKRIESKIKQGQGTGNQSIYVSPTGNDRND
GSKEHPFQTLKKATDKAVAGTTVYIREGIYKEPLTVKHSGKKELPIVFQAYDQEEVIISG
VEMEEKEEETSLITIQNKNYVSIKGLIMEDLSTSLADETVMGIYIEGSSSHIVIENNAVR
KISTMNEDGNAHGIAVYGTEGIKNIVIRNNVVQDLKLGASEALVLNGNIDGFIIEGNTVR
NNDNIGIDLIGYEGTGKKDDFTRNGMIRNNIVYNNSSFGNPAYGDDYSAAGIYVDGGKNI
KVKANTIYLNDLGIEATSEHRKKYADNIEITHNIVYENVYTGISIGGYDEERGGTTNTII
AKNILYQNDTKGLEGGQLLLQYDTKKNTIQQNIMTSSSSQLFIVNEFQKNVDNRLVKNIY
HKEENKQGRWIWKEEEYTDFIDFKEASNSDKQSMYIDPKYKNPLKHDFDLKPNSPVYDIL
SE
>PK3-045_00600 hypothetical protein
MNYGSDLEHERIDTLVKEMLMAFRNLGYDKINKNIPKNPDVKLIIDTFDINKEKHIENLY
YLEEFYITDKQFERFKEEFTKFNGQHLYCRPNHRGHYYIHINNIEYTARSFVTIDNKEII
LIDDESTDNEKLRRKVYHLPENFQSLEISLDKVPNYEDREKIVQKWISKIINF
>PK3-045_00601 hypothetical protein
MNVTEFQQWVKDYYEGRGWSDLDIFIRIGFLAEETGEVARAIRALEIGRDRPDEVVGSYE
ENKQELTEELGDVLGNLIVIANKYNIPLEEVFQSHKKKLSDRYSKA
>PK3-045_00602 Catabolite control protein A
MATILDIARLSGVSKSTVSRVINNHPYVSEDSRRRVMEAIEKLSFVRNAQGVNLRKQSTK
TIGVTIPDLDHPYFSPLVSMITAKCRKASYKIVVFQTFYSIEEEYDIYDKLAENELDAVI
ITHTLLDEKKIRQRTREKLLLICNEPLQTTYLDVFSLDEREAIYSATQLLLKEGRRNLLF
CADKEETPLQRQRWDGFQQAHLDLNKTCGIHQKVSGHSTIEEGIRLGDEMFSCSFDYDGI
LAGSDFLAAGLLSAAKKHGVSVPKDFSIIGFDNHPICLTTSPVLSSIQNQTERMIEDLIN
CLLDRLAGKEFPAIRKVYTGDLVIRGT
>PK3-045_00603 Kanosamine-6-phosphate phosphatase
MVEELINELKQVYGIQLKARTQFGQKQCKMNYYYFIEDSARVKYDLPIIKQLAQNNGMSI
NINRCNP
>PK3-045_00604 Transcription antiterminator LicT
MKVIKVFNNNIISVINNQNKELMIMGRGIGFQVKPGDLVNKKKIEKIYTLDSKEVSEKFK
TLLREVPIEVMEVCEEIILYAKTVYHKKLNDIIYVALTDHINFAIQRKKDGYEIKNALMW
ETKKLYKDEFAIGVEAIKMIKERLGIELPEDEAGFIALHILNAELNDDITNIMSITKVIQ
ELLTIVKYHFKIDFDEESLNYFRFITHLKFFAQRMLTRTYMDNDDDDLFNIVKEKHPKAF
SCSVKINDYLKKEYHYVPTNEELLYLTIHIERVCQR
>PK3-045_00605 PTS system beta-glucoside-specific EIIBCA component
MKYEQLAKDIIQNVGGKENVKSVTHCITRLRFKLKDESKANTEVLKDMDGIVTVIKSGGQ
YQVVIGNHVPDVYKDVVAAGGFSSSAPVDPEDENQEKQSLFNRFIDIISNIFSPVLGLLA
ATGIIKGFNALFVAFGWISNVPVNAQTGAVESTYGIYALLNAIGDGFFVFLPIFLGYTAM
KKFGGTPMLGMAIATALVHPTLVDIKALDPIMTVFQGTLFESPIQIEFLGIPVVLMTYTS
SVIPIILATYFAAKVEKWLAKVMPAVVKSFFVPLFTLLLIVPLTFLIIGPVSTWASNLLG
QGTLWIYETVPAIAGLVMGGFWQVFVIFGLHWGFAPIGYNNYPVLGYDNFLIMAFAASFA
QIGAVLAVMLLTKNKKVKSLSVPAFISGIFGVTEPAIYGVTLPLKKPFIISCIGASIGGA
IIAVMNAKSYSPGPLGIFKIPTLINPENGVDSSFWGAMIAIGVAFVLSFVLTLLFGGINK
QAKEVVSEGKELMKGVRNEEIVSPISGELISLKEIPDQVFASESMGKGVGIIPSAGRAVS
PVNGIVTTLFKTKHAIGITSDNGAEILIHIGMDTVQLEGKYFTAHVKQGDKVSAGDLLLE
FDMEKMREEGYNLITPVIITNSADYKQIDTIKERTVSEKQVVITAV
>PK3-045_00606 HTH-type transcriptional regulator LrpC
MKIDSIDKKIIDELNQNSRLSMSELGRRINLSSPSVTERVRQMESFGIIKRYTLEVDYSK
LGLPIQCIIEATVKNGDYNSFKRYIEEQPNVEFCYRIAGNACYMLKMQFDTFAKAEQFIE
DVNPFAHTVTHFIFSKVDTNLKIDSD
>PK3-045_00607 hypothetical protein
MARINESKNGETPFQRLLGYNLDVLNGWNQLGDVLEKDLNLSSYLKEQVRRTLAQSNGCE
YCKAKGKPEPHLFDEKTSIAVGFAEAFLKQKRDISDAQFNIVKEYLSEAEISELIAFITF
TTASQYFGAIMKLEPKTT
>PK3-045_00608 putative protein YjfB
MDIAALSIGMKQASLSQNVGIALTKKAMDTAEQNNDQLLKMLEAPHPTLGKSIDLSV
>PK3-045_00609 Transcriptional repressor IclR
MSVKSAERVLRIFELLAHYPDGLSIKEISEKLSFPQSSTSNLVATLLEQNYLSIDVLKRF
KLGAKLVHIGTLAMENMDISIQAKPYLQKLMENVQETVFMATLAENELVYVQKINSNRSI
RTTAQTGYRKPLYSTGLGKTFLANMSEEERKRILDQIELVPITEKTVTDRAELEKELYQY
SMIGYTIDDEEGEDGLYCVAAPVFGPGRKLEVAISVAGPRERMLKQKEEVVERVLWTAKK
ISESMGYILSHT
>PK3-045_00610 2-dehydro-3-deoxygluconokinase
MDVISIGETMVLFTPNTLGKIRYANQYTSRIAGAETNTLIGLAKLGHQAGWISRLGRDEF
GEMILNTVRGEGVDVSKVVIDEKAPTGILFKEILNQDAVNIYYYRKDSAASRLAPADLDR
NYIANAKYLYLSGITPALSLSCRKAVFESINIAKDNGLKIVFDPNIRKKLWDDEEAREVI
LEIGAKSDIVLPGISECEFLFGTREYEKAIRSFHEMGVETVIIKLGEKGAYYSTTDSKGY
IDSYPVKTVIDPVGAGDGFAAGVLSGLLDKLTISEAVKRGCAIGAMVCSTNGDIEGLPSK
RELNQFFQSDLVDEVNR
>PK3-045_00611 KHG/KDPG aldolase
MSTLQKIFDHKLIAIIRGADPEDTLKIVKSLYEGGIRVVEITMNSPKALTAIERAADEFG
DRMAVGAGTVLDAESARSALLAGARFILSPTYKEETIRMTKRYGAVSIPAAFTPTEILEA
YESGGDIIKVFPATAVGPKFIKDIHGPLPQIPLLPTGGVDLTNVKEYLEAGAAGLGIGSS
LVDTRKEITEQYLRELTEKSNKFTLLAQNYSL
>PK3-045_00612 D-galactonate dehydratase
MKITGYELFTVQPRWLFLKIETDEGIVGWGEPVIEGKAATVKGAVEELMTHLIGKDPLRI
EDHWNVMYRGGFYRGGPILMSAIAGIDQALWDIKGKYYDAPVYQLLGGACRDSIKVYSWI
GGDRPSDTARAAKECVDKGFQAIKMNASEEMQYIDSYEKVNKVLENVAAIRAAVGKNIGI
GIDFHGRVHKPMAKVLAKALEEFNPMFIEEPVLPENNEALREIALLTAIPIATGERMFSR
WDFKSLLRDGYVDIIQPDLSHAGGITECKKIISMAEAYDVAAAPHCPLGPIALAACLQVD
ATAHNAVIQEQSLGIHYNQGSDLLDYLKDPTVFSYEDGYVKIPQGPGLGIEVDEDVVREM
AKTGHQWQNPVWRHRDGSVAEW
>PK3-045_00613 D-galactonate transporter
MKNKATKVRYSVVFMLFITVIINYMDRSNISIAAPFITEELGLSSVTMGLIFSAFGWTYC
LLQIPGGWMLDKLGNRNTHAIGIAGFSLMTLLQGFASGFLGLFILRVGLGVFEAPAFPTN
SKVAASWFPENERARAISIYTSGQFIGLAFLTPTLIFFQQTFGWRGLFIVTGIIGLVWAV
LWFILYRDPSKSKKVNKAELDYIQAGDGFVDAAADKADKPKIGKKDFATVLTSRKLWGIY
IGQFAVSSTLWFFLTWFPTYLVEYRGLSFIKTGFLASLPFIAAFIGVLSAGFLSDFLVKK
GVSSNKARKTPIIAGLILSTSIIGANYVDSPTLIVLFMSIAFFGNGFASITWVFVSLLAP
KRLIGIAGGVFNFIGGTASIIIPIVIGFLVKGGSFAPALTFIACIALVGALSYIFLVGKV
ERVPERTDNDKIINIS
>PK3-045_00614 Creatinine amidohydrolase
MLHRRYSGHAFEKRFLPRLTSKEIKELDKENALVILPIGAVEQHGPHLPVYTDTLIGEGL
LVEALNLIPDEDVWVLPSLPYGKSTEHLGMSGTITLSADTLQAVIRDIAKSIRESGFKKL
LLFNTHGGNHDLLNMMAREVRIETGMNVFRLNPDYSVIHSLISDKEQKYGIHGGEVETSM
VLALKEAWVDMELSPTEFVHLPEDTQHLYLKGNSYFAWVMKDISETGIAGDAASATIEKG
EQILQLVSESFAGAIKEMIRFDLRTVKSTI
>PK3-045_00615 Aliphatic sulfonates import ATP-binding protein SsuB
MQNTNVMEGKKLHPLNETIVHLQNVNKVYPNGKTAVQNVSLDIEQGEFVSFVGPSGCGKS
TIFKMISGLIEHTDGELTILGKSPHQAQKQSTDVSFVFQDATLLPWRNVMDNILLPLEFQ
QIPKKRKEEMAEKVLELVGLKDFRKALPRELSGGMKMRVSIARALVAKPKLLLMDEPFGA
LDEITRQNLQTELLKIWGKEKMTVLFITHNVFEAVYLSTKIAVMTPSPGKIENTVEVDLP
FPRNAELRTSHHFSDIAAKVSHYLQF
>PK3-045_00616 hypothetical protein
MWLDKLIELVGEEKVIVSDNLRERLSKDYYWYSPVLFEELKDKVADCVVKPTSIEEIRGL
VTFAVENKVPVTIRGAGTGNYGQAIPLKGGIVLDLTKMDKLLELKDDTVKVQAGMRLGAL
EKNLRKQGKELRIYPSTFMTATVGGFLCGGSGGIGSIRWGNLWDGNILSVTVMTFEGEPR
VFEVVGEEIEDYIHNYGTTGIVLEAILPVEEKQEWTQHIISFPTFKEAVKFGDELAHKEE
IIKRLVSVCEWPIPSHFHSLKDVLHEGKSITMLEIEESCLDALQSLVDKYKGSTDLMIPA
NNYHKGLKVSDFTWNHATLWAHKHGENMTYLQARFKVDRIFEQMDTLRAEFGEEIQFHFE
YIKIKGKITPASLPVILYQSKERLYEIIDFCRTIEVEINDPHTYLLGFGGYNLKMEKILM
KKRENDPFDLLNPGKIPVKQESEII
>PK3-045_00617 Riboflavin transport system permease protein RibX
MEQASQKVTEVQIIGIKTDKKWTKAFSVWIPPLIVFVLFMLLWQYGTVLFQIPPYLLPKP
TDILQASLENWENLRNAVTKTITASIIGFIFSVIGGVIAAILMASSKMLERSLYPYAILL
QTIPIVAIAPIIVIWFGSGTNAIVIIAFTIGFFPMLSNTLVGLNATDRGMINLLTLYQAS
KWKIMWKVRIPFALPYIMAGLKISCTLAVVGAIVGEYIAGIGGGDGGLGYAITVASSRME
TAYLFACGISASILGIVFFLLVNLLSKWVLGSWHESEMKRDN
>PK3-045_00618 Riboflavin-binding protein RibY
MRKIKSSKKIGVFITAMSMLLLTACGDAKESGGSSKDGELMKAKLVTNWFAQPEHGGNYA
ALKQDFYKEEGLDMTIEPGGPQISSTQIVASGKAQFGYTQAEDVLIARDKGIPLVAIGAI
FQKSPQVLIGHEGALKDFKDLDGKTVYTAPGSGYWEYIKKANDLEVKDMAYTGSLATFID
DPNAVTQGYVTSEPYVLEQDGVKTDYLFIHDSGFETYANVIFTTEDVIKDNPELVQSFMK
ATTKGWEYYRDHSDEINPFLKEKNPDLSMELMDYGAKAEEELIFGGDAKERGFGYMSDER
WTMLQDELLDLGIIKKKEDVSKIFTNKYLGE
>PK3-045_00619 Cytosine deaminase
MKDIQLINVSLPLLNIEKLYTIVIQNGMYTKVEPQTQKRNGNFSVFKDIWSSKEDHQPII
DMGGRILLPSFIDIHTHLDKAFSLETVPNKSGTLIEAIRNYSGKAASFSKEEIKQRVMKG
ALQALSHGTTHIRTHVNFEWNISNELALSHLQAVLEARDLLKSYVSIQVVPMFSDLSVKS
ERERDVLKEAISYGIDGIGGAPHLSPNATKDIDQLFELAAKYDKFVDLHVDEQDNPEVCT
IERIIDNTKKWDFQGRVTTGHLCSLSAMTEEKSDRIIEEMALQHIYAVTLPGANMYLQGR
GDKGIVRRGITRVREMLQKKVGLATASDNVSDPFHPFGRFDLLQIGLLTAYTAHLASEEE
LIAVLNMITQTPAAIFGKKAHGMKEGGIAEFVLFDATNIYDLFANLSPARYVYKNGDWIS
SSQFEHRFGEGGLSRLVELG
>PK3-045_00620 Cytosine deaminase
MMLDLVLKNAQLPFKENPTNIGIKDGKIHSISSSNLMGKEEMDLEGNVLLPPFVEMHTHL
DTVLTAGEPRFNQSGTLGEAIDIWSVRKQLLTKEDVKNRAFKALKMLMEYGVLYVRAAVD
ISDSDLTALHAIMELREELKSFLSLQIIAFPQNGIISCLENQERLEKAILLGADAVSAVP
HLENTREEGIQSLEFAFSLAKKYEKEIHIFCDEVDDEHSRFLEVVASLTMQGEMEGKVTA
SHANALLYYSDTYANKVMSLVKKAQVTIVCCPLVNTTMQGRTDAHPKGRGITRLKELAEY
GVNVCIAHDDIQTPFYPFGNGNILQAAHMALHLAHMTGREELKQIVNMITINGARAYSIK
DKYGIEVGKEANFACFSVKDVYEIFFKQPKCRYLFRKGALVVETVPERTSWK
>PK3-045_00621 Ferredoxin
MAKYVMVDKDTCIACGACGAAAPEIFDYDEEGLSEVMIDHNTGTVALADELYDDLLDAVD
GCPTGSILVENCPFGEES
>PK3-045_00622 hypothetical protein
MTKTKWLLALLAAMDITLLIMHYTGYYFIFLLPTGYILPFCLNILILVIMGFRSTRRRFF
WGIIILMLSIPILLLYALMNSLLENNYTTIDSPYNRQSLVIEHRNFTLGETTYSYEFYKT
KFGLIGKHLEGQSIKVMVRSSDMGDEGDESAIGWKNAQWITKDMVRFPTLEGEKDVYLNP
TSIRNNPLQNKKEENQSFSSEMKEKIETFMKMAEKKEDGQAIEINGNRLEVRYDKSANES
WIEVENDKESGAIPRQQCSRIVRNEENGYYMLEECTHRWEYRLYPLENGEERIYR
>PK3-045_00623 Transcriptional regulator ManR
MSLDKRSTAILMQLIHADSYMSVEELTEKLNVSRRTIYYDIEKINDWLESLGIDKVKKVR
SAGFILADQVKKLIPTNIKRVQAWHYEYSQDERKAWIAIYILMGGKRYFLEDLMEKTRVS
RTTTIEDIKSLKADIRSFHLHLDFERKQGYTISGDETEVRRAIGYYLSIAIPVQNHHSLV
AALQIQLSDAKNSEQLLTLLKQVYHLLFQSEKELNIKFTDNMLYSLSLRFMLFSMRIAQE
QYIKMDEVEKEVLRNTKAFLVAKQICRELQRIFQTTFPEDEQIYLTTYLLGARVNYSEED
LNDNILSEELMKVAKIMTNQFQILACTLFDDQETLVKNLVLHLKPAFYRVKYGLDVEKNI
VDSVKSQFEEVYFLTQKVIEPFEKLIGKQLPENEIAYISFHFGGCLRRAGTTLISRKKAL
VVCANGIGTSQILKQQLEGLFSTIDITDSVSVRDYEEKNYHVDLIFSTTAIQKKDTPVFI
VSSILSDAEKESLLKKVNAIFNSTQKQHLATNRIIDVVERYATIHQKDELMKELRQYLNS
PDMTITEAYKPNLFDVLKEEHIQTTLNVPNWKSAIKLAARSLIEGEYITEAYRDAMISKI
EEYGPYIVISPKVAIPHAKPEDGVKKLGISLLKLEEAVSFSNDEKHDVSLIITLAPLDQE
SHLRALSQLTGLFSKKDTVNRLIKLQTAQDIYQYMKQSLIDQQLVN
>PK3-045_00624 Ascorbate-specific PTS system EIIA component
MKFLEKSLIALDVEAGSPEEAIISTGKLLMNSKLVEETYIHAMVRSFQTNGPYFVLAPNI
ALPHARPEDGVKEACVSFVRLKTPVKFGHSFNDPVRLVFALGASSSTEHVTVLQKLTALL
SDQENVEKLLNAQSYEEIKPLIGGQI
>PK3-045_00625 hypothetical protein
MKILCVCGLGQGTSLILRINVENVLRQMGIDADVENTDVSSASAERPDFIITSNELSQSL
AGHSSKIIIVNNYFDTTEIKAALEANIV
>PK3-045_00626 Ascorbate-specific PTS system EIIC component
MEVIQWLASNFFGIPAILLGFIVLLGLILQKKNTSQIISGTFKAMIGFLIINAGAGVITG
SLGVFEPMWSEVFGIEGAEFSSFMGQEAFNAKYGSAVTLAMFIGFVINVLLARFTRFKYI
YLTGHMMFWTTMIFAGVLIDTTTNIPFAALVLILSVFMGIYWTFQPAIVQPYMRKITGHD
QIALGHTSALVALLASWFGKWFGNKENDAEKIKLPKGLEFLRDSNVITALTMSILFVIGA
VILSLKDTPAADALVAQAGDQNFIMYAIIQSFTFAAGIAVVLFGVKMFIGEIVPAFNGIA
TKLVPGARPALDAPIVFTYAPNAVILGFLGAFAGGIIWLIILGQTVGYVFVPTMIVLFFH
GATAGVFGNATGGVRGALMGGFITATVVAWGQYLMVKTLIASTIPDTAMWAADSDMFILG
PLFRLIGMLFN
>PK3-045_00627 Phospho-furanose lactonase
MSFIRTLRGDIQPKELGFTYSHEHIVCRPAYWAERDADDLLLDDKEKSKKDVADFKRHGG
QAIVDATAVDYGRDVQAVKEIADELDLHIIGTAGFNKSFLWDGKIKEELKPLIGNYDTYA
EWIDQTSINKLTDFVIREVEEGLEGTPFKAGQVKFGTGYNRITPLEEKTLRAVARAHHET
KAPIHSHTEVGTMALEQIELLKSENVNLEFLSLGHMDRNPDPSYHEKIAKTGALLSFDGI
AKIKYAPESLRIECILHLVEKGYENQILISGDTARKSYYKHYDYGLGLEYIIAKWVPRFI
EEANQKGFNGEQLVHKFFVENPARCFTFKK
>PK3-045_00628 Creatinine amidohydrolase
MQFQYENSFEVKEKIIDKKVAILPIGAVEAHGPHLPLGTDNLLAERLSAKLAEQVNGFVL
PTLPYGQVWSLKNFPGSINVSNESLISMLFDIGESLYRQGFQIFAMVNGHLGNAFAMKEA
ARKLYEIYPELIVLYLFYPGTSKVIAEVRETPASHGTYFHADEIETSYMLYLAPEFVAME
KALNDMPAIPMIADVTPTPWEEFTETAVLSDATLARSDKGEKIIKVALQNMVQIIEKMKE
GR
>PK3-045_00629 2-dehydro-3-deoxy-phosphogluconate aldolase
MLKEKLFDFVLFNFLAKDKENVQDIMEAGKGFVVPGIVASDFSNRQEGASKVKELKEVVD
IVSIGLGGGGDPMYAKRVLDIAAISNPGHINQPFESAVYAKGFLEGNGASPQLVNALVKP
SGTVGTVKLASGMEVKVEEFVEIALALGVESIKFMPLSGEVHLEELVYLTKVAAQKGIRG
IEPAGGISAFNIKTIIDAVKKIEIEFFMPHIFGSTIDQATGKTIPTEVAQILNKLGA
>PK3-045_00630 hypothetical protein
MLTNYFEKVGNLLQLVLEKEKVHLQLAAEKVADSIENDGIIQLFGCGHSHILTEEVFYRA
GGLVPLKPILFEPLMLHEGAMRSSQLERKNDYAQNFIEEYEIKPNDIVFVLSTSGRNPVP
VDVAQYAKEKGAFVIGITSLEYSQSQPSRHKSGNHLFNSVDLVINNHSAKGDAILSYDKV
KVPFAPTSTVIGATILNSIFAEAIKIMADHDFEPPVFLSGNIEGSDDHNEALVKKYEKRI
PLLTLNVE
>PK3-045_00631 hypothetical protein
MGITKRRKQFLEEIVKIYQDTLLPVHYETIANSIGVSKWTAYDVMKVLEKDGYLERTYVK
NESDTGRSIVVFIPTKEVIDLYVNAQNQSSLKEENLDNKESININMASMEKYVDKKILNR
IANKFGNRKLTTDTKFCCYYLSKLIYFLNKGGEETKGITDFSISASNNPYVQISIFVGLS
LAIIMPAENKRSDLSTNELSSQFFECLDRLEADELKMLVFFLSEI
>PK3-045_00632 hypothetical protein
MKNLDSETLLGVYHKAIELNLNKAYIDMIKRELIKRKVIVDKSDNNRNSEGLYFFK
>PK3-045_00633 N-acetylglucosamine repressor
MKNKVAAHHDLIKKINRSLILEEIKTEKLISRAQIAKKLSLSKSTVSSIVEELLEKKLVI
EMGEQSPVKGGGRPALMLGYNTDSAYGIGLDIDRVRILIIITNLVGKIIFKKKVKLTNQV
EEIIGIVKESIKESAIPEEKILGMGIGVPGRANSEIVFRAKALNWTNLNLHEIFKPHFPF
PTFINNDVNCAGLGEMWLDPSGIKNLLFIEIGQSIGSAVINEGNLVYGHDYQAGEIAYQI
SRSDFENGKFNLMGKPGVFESKISGIALAESGYSPEVLFQKYSHGEQQVISIVDSFVIEL
SVFISNATNLINPERVIIGGDVSESMDIVINQISELVTNLTPIKTEISLARLGGDAGALG
AIAFMFKQIENQ
>PK3-045_00634 PTS system mannose-specific EIIAB component
MRIIIATHGELAKSLIETAELIIGTNHQMSCFCMTKSKSGEVGKQELTELIFSDTLTDLV
IFTDVYGGSVNNICSEILLSLPENETFHLVSGVNLPMILTTIMTSYNEDSVEAILTESIK
EGRHGIKYINELVKGVV
>PK3-045_00635 PTS system sorbose-specific EIIB component
MISLFRIDDRLLHGQVAFGWSPSVGANVILVVNDEAKNDKVKAMALDLAKPNNVKLYIRG
VAESGEIISKFAEAKKSNVLVLVRNTDDALEVAKNSQGAISEINVGGLRYEEGKKKLTDL
VAVSEKDINNLKQIEQLGINLDFRILPRDKKQLFSDLLK
>PK3-045_00636 PTS system sorbose-specific EIIC component
MLYEAILLGLIAGIGILDSRLFGVLMLERPLVLGALVGLVLGDFKTGIIIGAQLELIWMG
IAGIGSSTPPDVVTGGVLGTAFAIISGKGPEVALALAVPIAVLAQSLGVLVRVINTYFVH
KADHYAQKADFKKVTLMMWIPISLFFLSVFVPTFLAILLGADKVSYLINSVPKVILEGMT
IAGNLLPAIGFALLMDMLFSKKMAVFFFIGFLSASYLELDVMAIALMGVCLAILLNFFIN
NNDAGKKKDESNNLTEGEINFE
>PK3-045_00637 PTS system mannose-specific EIID component
MSEGKKLSKKDLQSVFWRSFALQGAFNYERMQNLGFCYTMIPVIKRLYEKEEEQAQALKR
HLEIFNTTPVVSPTIAGISAAMEEQNANNKDFDTSSINAVKTALMGPLAGIGDSLFWGTL
RIIAAGIGISFAEHGNLIGPILFLLLYNVPNILVRVFGLKFGYSVGVNSLERIQKEGLMD
KIMAMATTVGLLVVGAMVATMLKITTPLKFSVNGAEVVIQDILNQILPNLLPILVTFVVF
WMIRKKVSISKMTIATVFIGIIIHWIGIL
>PK3-045_00638 hypothetical protein
MNITDYLKETPAKMKEIIALSSELFSTVKKEEINRIIITGSGTSYHSGAQVQQKMRELTG
LSVEAYYPFQITEELLTKDTKNTLFIGISQGGSSYSTFNSMKLAKESGCIIASMAGTDNA
LIDEIADYVLTVQCGEEKSGAKTKGFYCTKLNLLLLALYIGEENGKLSSEETKQVIEILN
KTSDAFIDIYYSAEEWVQKNSEKLKNAKEIRIVGTDELYGDTLESALKLLETMRVPVTGY
EFEEFIHGIYNAINEDSTIIFLHTGEEPRVNKLISVLSDWTDNIYIIGSKVEGFEDKNLV
IENGDNYLYHSFVYPIAVQLICAIVPALKGINPSIPKDPKFHMKLESKKLSGKI
>PK3-045_00639 hypothetical protein
MRADRLISILLLLQNRGKMTTKELAKELEVTERTIHRDMDALSTAGIPIVAERGKMGGWT
LLDQYRTNLTGLKYDEMLSLLISPSVQLLSDLGLAKEWHDARQKMVAALPNAFRQRSLDV
WNRIHIDTTAWKQPAKKTVSFKIIQEAIWKEKVLHIQYERADGNVIFRMVNPLGLVAKGN
TWYLIASSDEKIRNYRASRLLSLVMTEEAFTRPLDFNLEKYWLESTQTFISSLPEFKVEV
EASPSIIHRMKFTTRFVQIERIGTPTAEGWFPVSLRSDTEQEAIAYILGFGDQIRVISPS
PLKQEIYQMAKKIVDFYNR
>PK3-045_00640 IS1595 family transposase ISCac2
MKKQRNIVLFTATSLDGYIAAKDESLEWLFKVEGEGDNGFSAFYETIDTILMGRKTYDWI
INHTNDFSYKNKECYVFSRQEHKDTDEVTFIKDDIIEFANKLKKQEGKNIWMVGGGELLH
SFLKEKLIDEFILTIAPAIIGEGIPLFKEADYQLELILKGTKCYNQFVEVHYERRR
>PK3-045_00641 Transcriptional regulatory protein WalR
MQKTILLVEDDLAISDMVKRYLHNEGFKVECVFDGKTAGQMFKEKRYDLILLDIMLPELS
GMDVLQSIRTTSYIPVIIMSAKDTEIDKALGLGFGADDYITKPFSMIELAARVKAAIRRS
TQYADKSREESKPSRMKVYELELDKENHRVWKNGLEINLTATEWKILLLFFSNQRKVFTK
EQIYRSVWSDDYFGDDNVINVHMRRLREKIEDNPSDPIYIKTIWGIGYKLGEFE
>PK3-045_00642 Adaptive-response sensory-kinase SasA
MIIWISIILVLLIFNVYQYRQRKNRDQHITYISNKLKKILHMQTNERILVVSNDQQLRDL
LISINQVLDDRHEKSREFIKMEHSMKRMLANISHDLKTPLTVIAGYIEMFQKDFPITETE
RVQLLSQVHDKTMELIQLMNTFFDLAKLESGDKEIPLEIVNLSELCKKNILTFHDWIRAK
GLEVMIDIPDESVFALGNEEAVNRVLHNLLSNAIRYGLDGKVIGLSLHFDEQHVYIEVFD
RGKGIDEADQANIFERLFTLDDSRNKAFQGSGLGLTITKRLVEEMNGEISVHSIPYEKTS
FYITFRRMNG
>PK3-045_00643 Bacitracin transport ATP-binding protein BcrA
MDYAVRTKDLTKTIQGREVVSQVSLHIKQGEVYGFLGPNGAGKSTIMKMLTNMIKPTQGS
ITIFGKPLLPNSFDYLTRIGSMIEYPIFYEKMTALENLELHCEYMGYHNKKAIKEALEWV
GLENVEAMKPKDFSLGMRQRLCVARAIITKPELLILDEPINGLDPAGIKSMRRLFNILNK
EYGMTILVSSHIIGEIEQIADTIGVIKNGKLIEEATMDSIKAKNTDYLELVTNNQRKAAF
VLHNKLNMNNLKVIDDDVIRIYDTAILPSQITKTLIVEDIDVESITKKQTSLEEYFIKKV
GLEKINH
>PK3-045_00644 hypothetical protein
MFHLIKLELRKHKLGWFIKGAIIANIVILGLLCMITFEQIMEGEESFQSFADYSMVAGTM
VRGVFVVFASVLISKVIIDEFKNRTALVLFSYPIDRKKIMSAKIVLIFIMTFVTLIISNL
FVVLSFLGLNQVLHLTVEMNITINQFLSELLNILMFNVATAGASLVPLYFGMRNYSTPAT
IGSSLLIVMIMCSSIGTDFSLANIIYIPIALTIVAIGIVNMTIRKMDSIDLQ
>PK3-045_00645 tRNA (cytidine(34)-2'-O)-methyltransferase
MAIHVVLYQPEIPANTANIARTCAGTNTALHLIRPLGFSTDEKMIKQAGLDFWENVNITY
YDSLDDFFVKNQGEFYYIETFAEKTYTAYDFTDQSKDYYFIFGKETTGLPKDLLETHKDH
FLRIPMTEHIRSLNLSNTAAILVFEALRQQGYSQIK
>PK3-045_00646 hypothetical protein
MEGKNYEQLVEEFTPMIHHMIKKLLIYKDKQEFFQIGLISIWETMSHFKEEKGKYSNYLY
RHMQGRFLDELKRRTREAERNAYPSEEFWALMESPILYREEEDYIKDLCKELSERETTWV
IATFVHQMTVEEIAQNERVSPSAVKWWRKGAKEKLKRILEF
>PK3-045_00647 hypothetical protein
MNLEPYINASPDIIIIKDKEGRWMEANRKTLKLFNIEEYLGKTNEELGELYPHFAEYVPA
IVKSDLQAWKTGKQIEVKESIFFYNQERIYEVIKVPIFDSAGNRQNLIVFGRDITKLEKS
EQTYKSLFLHDPDGVYTLDKKGNFLDVNKVAVEISGYTKEELTRLNFRDLIVPEQLPKVL
QRFDKVCCGMTQGIESQIIRKDGEIRDIKLTTIPLKLNDQVIGIHGIAQDITEKKNMEEL
QKKQKAILSRIAVGEPLEQIIEYITESVEELLKGICSIMYYEEEHNWLRFGYGPKLDSTF
IEKIDKFPVGENFASCGHSAYTKELKIVADIETDSSWSNWKEIALAEGLRSCWSLPIISS
KDSLLGTFAIYYKEPVEPKDSDIEMLKDFSHLTGIALERHFHEEKIKYLANYDSLTNLPN
LRYLKEIFSQRLQETNHLAVMFLDLDNLKPHNDTFGHSSGDRLIQEVGKRIQDTIGENNV
VARMGGDEFVILISKYTSKSSLCALAAEILQAIEEPIIIDGQEFSTHGSIGISLSGEHGQ
TFEELMKNADIAMYSMKKVGGNAFNLYDPKMNENAVRAFQLKSNLKKALKENEFVLYYQP
KVNIETGNFIGVEALIRWISPEKGVISPAAFISLAEESDFILLLGEWILNKACAQIKEWE
KLNIKIPIAINVSIKQLLKQDFAALVSKKLREYKISSEYLEIEITESVLSNHESLVRDMV
SILRSMGIKVSIDDFGTGYASFMYLKQFQADTIKIDKSFISHLPASQEDAAIVSAIIILA
SELGMNVIAEGVETQEQSDFLKSKGCTNLQGYLYSKPLPPSEILSFLTEAEGRFL
>PK3-045_00648 hypothetical protein
MKTRGEKSCIDYKLLKERRLQKKLTQFELADETGLHYAHLGQIERGQKEPKVSTLYKICE
VLDLQLDAVLIKETMEELD
>PK3-045_00649 Competence transcription factor
MKKECILNKYIANERTMTIMPIEAIECDAVVKEVDRTVYVKETPFDIIKENLLIGGSDFD
GRRRSITYKLGMQKRLPMPINPQRNIYAFPTHAPRQFHCQWIFTEHIDHIHPVKHNEKFK
SAIIFKNGEKIFTEVSPYILETQMIKSWRVRKSMEDRKDIR
>PK3-045_00650 hypothetical protein
MKKIEHIGERIKLLREKHGLSQAAFGKRIGVSSGNVGDWESEKKKSLPGAKAIYTIAKEF
EVSADWLLAGEEFLGDSSLKSGNIVIQDDKPSISTSIIKERESINELALDETLTEEAKEL
VSIFNNLNERDAAELLMIARMKRDFESR
>PK3-045_00651 6-phosphogluconate dehydrogenase, NAD(+)-dependent, decarboxylating
MQIGMIGLGKMGYNLALNLANNHHSVYGFDKSSDARNRANENGIHIVESIDQMLINMQSP
RVVWVMVPAGKPSEIVIEKLLGKMKADDIVIDGGNANYKDSIRRAAVAEEKGIHFLDVGT
SGGILGANQGACLMIGGRQEIFERIEPIFKSVSTQDGYLYAGESGSGHFLKMVHNGIEYG
FMQAIGEGFQVLNQSQYDFDLAKVAAVWNNGSVIRSWLMELMESSFQKDARLENIRGMVA
SSGEAKWTVETALDLEVPVPIIALSLMMRNRSLEEDSFSAKVVAALRNEFGGHRVIRK
>PK3-045_00652 hypothetical protein
MATLSIGQALIIAIWVAIVMSRGIGYATLTLRFSPLMTGLVVGIVTGHITEAMIITAAIQ
LVYMGAVAPGGALPSEPAIAAAIAVTVAVLGDFTPEKAVAIAVPVGILGSYAYQFRFFLN
TFALRVLDKYAADVNDRGIFTSVIIIPIVISFILYVPLVFIALYYGAPVVADFVNSISDG
PIIHVLEVVGGGLAALGIAVIMHVIGKKELLLFFFLAYFMSVALKDLQINTVTYAIFGAI
LAGLYVLFTRGKEAA
>PK3-045_00653 hypothetical protein
MSAEEKKQSPENYPEPITKKDLLKAWARWWWANEIPHTFDRMVAPSFLFGMTPILKKLYK
DKKDLSEAYQRHLLFFNTQAIWGGGTLTGITASLEESRAKALAEGKEEEAPSPDMINNTK
VGLMGALAGIGDAIDSGTVQYIFIAIALPWAMAGSPLGALFPFLGFTLVTFLYGYYFVRM
GYGLGRNAAKEILAGSRIKTMIDALSVLGLFMMGILAGSYVKVSSSLSFTLSEKQFVLQE
ILDSILPGLLPLLTVLGVYLYFDKKGFNITKGLLWLTGTLIVLGAIKVL
>PK3-045_00654 PTS system mannose-specific EIIAB component
MENRAILVITHGEFGIELIKSAEMIMGPQRNLRALALRPGESVDDLREDASKIVQENEKN
GLETILLVDLLGGSPSNVSLSLLSKYDLHILTGINMPMLIELLTFYQTEEDANNLIQTVQ
GTGTSGIHHLNRNFLKK
>PK3-045_00655 PTS system mannose-specific EIIAB component
MGKINLVRVDDRLIHGQVMTKWSKGLGTNALYVIDNETASDEFMKDIYINTNSSSGLKIQ
VYSNQEVVEKWNSDQFGKDNVVLLFKYIASVKEVVEQGLPVTRLNIGGVSKKGEAQFVIP
TVALTETDVDNLKSLDAKGIEIFFQTVPDSKKVSLTDGLKTIKK
>PK3-045_00656 Formate dehydrogenase, mitochondrial
MANKIAIVNSSSFGERFPDQIERLASIGEIKRFIFPVNISGKELAEKLQGFTIIISSVTP
FFTREFFEQKDETLIISRHGIGYNNIDIEAATEKGTIVIIVSALVERDAVAENAVTNLLA
VVRKTYPAATAAREGRWADRAQFVGHQINGKTVGVIGLGNIGSRVGEIFKDGFNARLLAY
DPYQTKEELEQKGAESVSLEELLKQSDIISLNAFVNEGSYHLLSDHEFSLMKEGVYITNT
ARGELWAQDAVLRALESGKIAGLATDVLEGEPVDKTHPFFQYENVLVTPHTSAYTMECLR
GMGEKVVSDIERTLKKERPDNVVNVELFQG
>PK3-045_00657 Phosphorylated carbohydrates phosphatase
MGIPSLVIFDMDGLMFDTEKLAYRAWQMAAAHYGFSFERTLFEQLIGITNQDIIRKMADY
YGPDQPVQEWRAYMRLKKHELEYLFIREPHFKKAGLDELLSFLKSQGIKIAVASSSAREV
IHRFLTVSDTLAFIDLYVSGEEVPNGKPSPDIFLEVCTRLKVNPKEALVLEDSPAGIQAA
YLAGIPAFFIPDFVKETDIIRKLKPKIFRDLAEVEQYLRFV
>PK3-045_00658 Hydroxypyruvate reductase
MPKVLITPRSFGKHSEEASRILTAHGFEVVTNPYGRIMTEEEMKKEIVDVDAVIVGVDPL
NADVLAEAKRLKVISKYGVGTDNIDIDYCKANNIPVTITRNANADSVADFTFALMLAIAR
RIVEIDQSCRVMDWSKKTSIGIYGKTLGVIGTGAIGKGVIKRAHGFDMDILAYDVCPDNE
FAKEYKVTYVDLEHLVKESDFITLHLPATPETNNLFSEKEFSMMKETAVLVNTARGELID
EDALYNVLRNKKIWGAGIDVFKKEPPEKKELLELDNMIIGSHAAASSVDAVNKMSLMAVE
NILANFK
>PK3-045_00659 KHG/KDPG aldolase
MDKIEVLAKMKEEKIVAVIRAQNIEQGLRVSEAIRQGGIKFLELTMTIPGALDVIKKLAD
KYAGEDVIVGAGTVLDPETARLAILAGAKFIVGPNLSPEVITMCHRYRVAVMPGVMSPTE
ALTAIELGADVIKVFPGGAFGPSIVKDFKGPLPQGNFMPSGGVTVENAAEWIKNGAYAIG
TGSSLTKGAATGDYEAVSREAEKFVAIVK
>PK3-045_00660 hypothetical protein
MNKLSQWFKDLKYRRKILVICLLSSLLPVTALGSYCYFQIQKLLINREKEVLEETLHQAI
LSLDYKINSYNDAMNQIVWNQNIKSGLTANYDNNFDMYTMYRDHLKPLIFNVKNSQTDIN
RITVYSNNHTLFPHGTFLRPLTDVEKLEWFPEVIKNASAHLLVSSDKNSFEMASKIFDYN
GNNINIVYMDIHYQSFFNPLSNLFENSYGLIILDEKKQPVYNHQNFNKNKQSYTLSVDEL
LNKINNGSLKNEYVFKSAKFQSNEWTAYLFRPFDIVSQSTSPIMTWVIIVIILCIFTLYL
SIFFLSKVVVRPLELLAANMKQIEKGDLTVTVTHSSQDEIGDVIGQFGDMVHNLQEMINE
VYKSKIAQQEYEMKALQAQINPHFFYNSLSLINSKAILVGQEDISEMAQLLSTFYRTTLN
KGKNMITVKDEIENTISYMKIQQMMHSNSFDLSIIVDDQILGHTMINLLLQPLVENAINH
GIDHKEDRERGIVTIIGKQADNDLLFTISDNGIGMEPEILETILTTKTTGYGVQNVHHRI
KLAYGESYGLSYTSKLGKGTTVEVRIPKIL
>PK3-045_00661 HTH-type transcriptional activator RhaR
MYRILIADDEKDERSVIRFLLDKFHFQLDIVEAANGKDAIHLLEKESIDILFTDVKMPFV
NGIDLAKVAKSINPNIQLIFFSGHDDFDFVKNALSLRAVDYILKPVNPNELKQTIASVIK
NMEQRNQELKKEKSNIAFLKNHLLYRLLNGTSIDALKNEYPFIDMDYLYAYSRMILMQFE
EPFFDKLLKEETSLLFAQIKQCMEGLSFDYLHLNPYQLLLLIKKPIEHTEIRLIAKNIHQ
QIHSALGIHGYFSISEEVEAPEKIPERFKQIEYYLEDRFFYKDNYLYPIECGKFEQEEYL
EQDENLLLSIQNAIQYVDTFSFRLSLDALFQKYQSKKQISHIYVRYLFSRLLQILCNALP
EYKETILNKKISAIYKCTHFSEIEQIIEEVKRSVLSFLEKKEKSPKHVIHIVMQYIHEHY
AEDLSLNILADKVYLSPRYLSDVFIQETGSGINKYIKQVRMDAAKNLLIHTNMKINDICK
QVGYQNISYFVRTFRESFGLSPEKFRQSNGNTKEKTN
>PK3-045_00662 hypothetical protein
MKYKTFCKRAAFGLMATSLTLSLAACMDNSSSGESMTEDGKTIIKMGRVTAANSKLPEGD
TYENNAYTRLVEKKLNAKIVDQFEAEGEDYNRQVALAIASGELPDMMRVDSREELKELVE
NDLIADLTEVYDKNASDFIEEVYGTYDNKTLEAATFDGKLMAIPGTIGDSAPNIVWIRKD
WMEKLDIKLDADGDRQITLDELESTAKAFVDNDPGDTGKPVGIPFASWLNAGDYGGSGMN
MTSIAGVFNAHPRMWLEDNKGNIVNGSTTEETKQALGVMADWFKKGIIDPQFGTRTWDDI
MALVTNGQTGIVTGPWHIPDWGLSTVRGMDKNAEFAAYGIEGENGKVNVFHSNPTGQFIV
VRKDYEHPELAIKILNLFYDEIVNADDLQKDYPEIYKYGELAVDGSTRPFNIEVYKSTNI
IDEYKYIQEAVEGKISIDDIPTAGLKIDTKSIMAYQKEPEGAGTSEWAKYHSRMLGMSLI
DKFTKEEQFNWTTPVFFGNTPTMEKKGANLLKLEEEDFIKIVTGNKPLDYFDTFVANWKK
QGGDEIAAEIKEELADK
>PK3-045_00663 putative multiple-sugar transport system permease YteP
MFQQPHLKIENGKNSLPSAKRKKSKRIVTKEELFYHSMLLPGMIFLIIFTFVPMFGVIMA
FQNYVPAKGIMASEFVGFEHFKYMFSLPDIGKLFRNTIVIAIGKIVLGSLLAIVFAILLN
EVRLKLLKKSIQTIVYLPHFLSWVVLASVVVNMFSLDGTINQLLAFFGMDKQNFLGSNKL
FQPLLIGTDVWKEFGFNSIVYLAALTAIDPGLHEAASIDGANWWKRIWNITLPGMLPIIL
LLAVLSLPNVLNAGFDQVYNLYSPMVYESGDILDTYVYRVGLIGREYSFGTAVGLFKSVI
GIILILSANNAAKKYTDRKLF
>PK3-045_00664 Diacetylchitobiose uptake system permease protein DasC
MIENKSFSAKCGRLTIYAIVIFLALTCLLPLWNIVAISFSGGDAVASNKVGLTPINTTLE
AYKMIMDDSQFWRSFGISIQRVILSLVINMVLIVTMAYPLSKTKREFRGRGIYMNLLIFA
MLFNGGMIPTYLVVKNLDMLNTIWALVLPGAVQVFSIILVMNFFIGVPKSLEEAAIMDGA
NPLQVLIKVYIPISMPALATVALFSIVGNWNDFFSGLIYMTKVTNYPLMTYIQSLTISIE
EMLKAGATSSDLANAGEVSNKNLNAAKIVVSCVPLLLIYPILQKYFITGIVVGSVKE
>PK3-045_00665 hypothetical protein
MNNIFEWNGPVYRFLEKIVNLLLLNALFLLFCLPIVTIGSALTAMYSITIKMAKNEDVSI
VKAYVATFHKNFKQSTIIWLILLAAGIILYMDYYYLNQYKGNLVFLVKVSLGLFSFAYII
LFSFIFPYVARFKNSVKDSIINTWKIALVHPFKTISVLMVTGIPIIALGISVYSLFFLLY
FSLFIGFSFFAYINTLIILHIYEGYEK
>PK3-045_00666 putative histidine-binding protein
MGKLVEKLSLVGLSSLLALSLTACGSAKETSSKAGLEGLREKGKIVVGTMAATPPYEYHL
VENGEDKIVGSDIKLLEEVAKDLKVDYEIKDMDFDGLLVAMQSGKVDMIISAMSPTEERE
KNADFSNVYYKGRNVMMVRKSNLNKYTTPESLADKKIGAIKTSVQQSILESELPNATLKL
LGKSTELSLDLANNKVDAVLVDIPTATLLAKGNPDIVASEVYYEDPSAGAAIALPKGTDK
EIMDVINATIDRVKPDYEQWLKEAMDGVELEE
>PK3-045_00667 Arginine transport system permease protein ArtQ
MLSFSFLEQYYPYFLTGIYITILLAVIAVVLGTILGIALTLLRRSRFKVVKIIGDIYVEF
IRGTPLLAQIYIIYIGIPLIFKGWDIPDLMVGAIALSLNAAAYISETIRSGIEAVSKGQM
EAARSLGMNQRQAMFDIVLPQAFKNILPALGNQFIGSIKDSSIVSIIGVAELMYKTTIVR
GNTALGLEPILVASLGYLIMTFTLTQLLGVVERRLKASDRR
>PK3-045_00668 Arginine transport ATP-binding protein ArtM
MIDVKGLHKSYGNHEVLKGIDVKINKGEVVVVIGPSGSGKSTFLRCLNLLELPTSGSIKV
EEQEITARKVNIDKVRERMGMVFQQFNLFPHKTVAQNICHAPIKVKGMKQTEAQNLAKDL
LKKVGLLEKYDAYPSSLSGGQQQRIAIARALAMKPEVMLFDEPTSALDPEMVGEVLAVMK
NLAQEGMTMVVVTHEMGFAKEVGDRILFMDQGYIMEENNPKQFFGNPTHPRTIDFLSKVL
>PK3-045_00669 Fructoselysine 3-epimerase
MALITREQIAGMNIHYMRYSLDYFLQAQVKAGIQSIEFWTGVPHYYLDPTTYSDCKALKK
KIDSYHLEMKVFTPENCMYQFQFASLKPEIFEKSLHYFTNGIKAAAELGCKIMQCNSGWG
YLDEDREEAWKRSREMLSKLADTAKSEGVTLALESLRPEESNLVTTLQDTKRMIEEINHA
NVKVLVDTTAMGVAGETLQEWFDVFGSKIIHTHFVDGNPYGHLVWGDGKHDLEQFLITLK
QNGYEGYLGQEITDSRYFMDPAAHDCRNMKEFEKYM
>PK3-045_00670 Fructosamine kinase FrlD
MKVIGLGDNVVDKYEHIQTMYPGGNALNFAVFAKKLGAEAAFLGAFGSDLESQHVQESIT
EIGIDISHCKLYKGENGCARVTLKDGDRVFLGSNRCGVLRQFGLNLTEEDYSYLTSFDLV
HTGLYGFAETELPKIKQLGIPIGFDFSSDFTMEQVRRISKVIDYAYFSCSHMKLDDILNL
CLNVTHIGCQLVLCTLGEKGAILFDGNKFYMQESFFVKPKDTMGAGDSFITCFIYHYGKE
IKDGKTDTESIIKESLKKAAAFSSEQCLVEGSFGFGKKYT
>PK3-045_00671 Fructosamine deglycase FrlB
MELNQIIGSIKERQPNIKSVFFVGCGASKAELYPAKYFLEANAKTLRVSLYTANEFNYAT
PISVDDTSIVITCSLGGATPESVEATTKAKELGAHVIAVTHVEGSALTKDAGYIVYHGFE
ANYAAKMEKMTKVLGLATEILHQYEGYENYDKMIDGFGKIYELIEKAASTVLPDAKAFAE
AYKDDEVIYVMSSGATHEVAYSFSICLLMEMQWINSGTFHDGEFFHGPFEVVEKDVPFLL
LMNDGRTRPMDARALEFLQRFDAKTTVVDAKDFGLGSVIASEVVDYFNPMLISGVLRVYA
EQLSYVRNHPLTKRRYMWKLEY
>PK3-045_00672 putative HTH-type transcriptional regulator YurK
MLNSNSSTPLYIQLKQAIADDINDGIYTHGEKLPTEPELCEKYKVSRITVRKAVLDLVNE
GYLIKKQGKGTFVNHVKIKRELVAVNGYSEYMNSTGKMPNPKIISYEVKEVNKEIAEKLK
IDTNSPVLELKRLLHLDNEPLLHETSTYSLELFPELDRYVEENKSMHKILNEIYGRIPAF
NNKILNVILANSELAGYLQCNISDPLYQLEKVAYNKDKDPLYHSLLYYNVNKVSFTITSE
FESTD
>PK3-045_00673 NAD/NADP-dependent betaine aldehyde dehydrogenase
MNQQTVVLKEKVGKFLSGKKKLFINGEFVESQTQKTFDSYNPATDEVLASVYEAGPEDID
LAVKAARKAFDEGPWSKMSASERSRLMYILADLMEKNSAELAQLETLDNGKPIRETTNAD
IPLAIEHMRYYAGWCTKITGQTIPVNGPYFNYTRHEAVGVVGQIIPWNFPLLMAMWKLGA
ALATGCTVVLKPAEQTPLSALYLAELIQEAGFPEGVVNIVPGFGETAGQPLVDHPLVDKI
AFTGSTEVGKMIMANASKTLKRVTLELGGKSPNIILPDADLTKAIPGAFNGVMFNQGQVC
CAGSRVFIQKKHFDNVVADMADQAKKMKQGAGIHADTEIGPLVSAEQQQRVLGYIERGLN
EGAQLVAGGFNPREEGYFVSPTVFADVRDEMTIAKEEIFGPVISAMPYDDLDELINRANN
SEYGLAAGVWTRDIANAHYIASKLRAGTVWVNCYNTFDAASPFGGYKQSGIGREMGSYAL
NNYTEVKSVWVSMQ
>PK3-045_00674 hypothetical protein
MKNILLIVALALTIFVIYLITMHPNPTKTVYIPPTSSLEERVCEEVSAQFGDCKQILLLD
AQSRIVFAENSSGVVPVLTNKEFTDFQKIIYPILEFQEFQEEKQERGSITWQANNKLEKD
LSIIYGFAEDNAKTIIITSEGNVQPNKFFLQDNLWVWYATFTKDNVKLPVEVDIYE
>PK3-045_00675 Methyl-accepting chemotaxis protein McpA
MKKGKDRSIKTKFILYFLLIGLIPVIIASSIIYYVSSNNALNNEEEWLGNQTANTVENME
EWIQKRLDELTLISKSDTIINGDLAARSKQINIVKEQDSTYESVVVIGKNGMVEAHTDPS
LVGKLDLSKRDYFIKGIKGEQSVSNVLKSNATGNRVLAIATPIINAHKEVVGVVSATVNF
ETLIQDFLQNETSQNKSTYPVLVDSNNIVQFHPNADLIGKTIEEAGFSKNIGTIFEKGRT
TSGTKETELDGEKQLVTYAPLKSAGLGIYLFTSLDDILEITSSIKNITTIILAVFSVLII
GVAIWIANGMTKPIRNIVAQLRLVAAGDLTSKDVAIQSKDEIGQLAENTNSMKHSLRELI
KQLKESSVHTAETSAQLAVSADQSNQTSVVITESIQAVAEGAADQAEMVTESTEALDEVA
QGVQQIAEASATISEKASSTLNKAQTGKESVEKNITQMNTIQQSVQNSDELTKSLIVRSQ
DIVKILEVITSIADQTNLLALNAAIEAARAGEHGKGFAVVADEVRKLAEESQRSSQEIAG
IVTKIQGEIKQTSESMNAVMDEVQSGVLIANNSRELFKEILELTYEVSDNITNMSATSEE
ISAGAEEVSASFNQISTITKNTKSSTQEVAAASEEQLAGIEEISSAAQSLKNLAAELEKT
ITKFTI
>PK3-045_00676 hypothetical protein
MNRKSFEKLLWSIALPGFGQLLNKKYIKGIIFILLELVVNIQANFNTAIILSFHGQTSAS
LEEVNLKWLMFYPCLYFFAMWDAVRDADEKGENSPLLFLPFVFAAYFVTVGLIYSSEVFL
FGHLIGPIFLPMLFVLPGVIIGLVIRKVIYIFTN
>PK3-045_00677 hypothetical protein
MSILQSGTPTYLKIISKRKGLQEIIEGDNLYSKNKFGKKIEAE
>PK3-045_00678 hypothetical protein
MKKKVKRRQQKGRKPVHLLFAKEYKYTIGIDIGGTTTEIAIMDLENLFCTVK
>PK3-045_00679 hypothetical protein
MLVDQVNSILEEQNNSHTKVLSLTIGAPGMTDSENFICSPFTPFRERSEAI
>PK3-045_00680 Argininosuccinate lyase
MPDSRSQVYVNHILEPIYDFTKQHYLPYLLEINIAHATMLAHQKILTKEDTQKIIKANQA
LLAKGYPQHYNPLYEDLFFMLEEDLKKEIGEVLVGNMHIAFSRNDMDATMYRMVSREKLL
QFLTLLVELKKVLLRLAKEHELTIMPAYTHNQQAQPTTLAHYLLAIDSSLQRDLERGFAL
LRRINESPMGAAALGTSGFPIDRSFVAIQLAFDKPMENSYDSISAADYMLEIASVIKISL
STLSRFTHDLLFFTTNEVEAIRLDKSLVQTSSIMPQKRNPSSLEHTKSLISRTIGEVNAA
FMMSHNTPFGDIVDIGDDIQPILINGFSHSYQIIELLTEILKTMEVNVDKLLTRCSEGFS
TVTELADVLVRECQLSFRDAHQIVSILVQRLASTGKKIKDGSAELVKQISQEILGTHLPL
TEEQYRTAINPFHFVMVRSAFGGPNPKETERQRIRSSQKLADFSKEAAIYRNKFTSYKQL
LRNNNKLV
>PK3-045_00681 Multiple sugar-binding protein
MKKFLSVFLFLAIAMVIVGCSKGKDSGGEADGTVTIEYWQYAYKAKVDLMDELIKEFEDK
NPGIKVKQTTFPYEQYNEKVATLVPAGRGPDVINLYYGWLPKYIDSGYLQPLPEDAFPVD
KIESEYFSLVNAAKLDDKYWAIPTAVRTLALFYNKDLFEKAGLDPNSPPKTWDELVDYAK
KLTVRENGKLVTEGMAYEIGAQLNNWFYDALVYQAGGQGLSEDRKQVLWDDTPAGLEAFT
YLVEFGSKHKVGESGFYTDDVTAFKTGNAAMNIDGSFRLGTLATDAPDLNYGVAPLPSYK
EKATQSSFWANGITAKVEGEKLEASKKFLAFLTSDEVMERWIDEVGELPAKEAVATQDKY
VNDPLYGPFIEQLPYANAQFYVDETAQRQYVIDAVNEVLLNGVSIEDTYNDFAAKSQKLY
DDYWSNK
>PK3-045_00682 hypothetical protein
MSGKNHSAVPKKTARFTLKQQKYIFVYTCLLIPLLFFISIRFLPTLYTFNIGFREWDILS
EDKPFVGMDNYVALFKDEVFRKSLINTFIYVVFGVVGQLMCGLGVALLLQRINKFVGVFR
AIYFIPYVTSIVAVSWVFKWILMNNGVVNDILMKFGLEAQLFLKSPDQAIYIIILTMIWQ
GLGFQMIIFLAGLENIPKIFYEAAEIDGADGWKKFIHITLPLLNPTIVFSAVIGSISFLQ
TFTQVQNMTQGGPLHSTISVVLYIYELAFQHFDMGLASAATVILFLIILVITIIQMKVLT
KKFEY
>PK3-045_00683 L-arabinose transport system permease protein AraQ
MKKRRYLKKSIVYILLTVGAIFMLFPFIWMVSTSFKPPTEVYGLKLLADHPTLENYRKIM
VDTLFSKWFLNSFIVAVITTISVALFDTLVGYVIAKFSFVGKSIIFLFILSSLMIPTEML
IIPWYIMSTDLGWVDTYWGIMFPGVISAFGIFLMKQFMESIPDDLLDAARIDGLNEFKIF
FKIAIPQVYPALAALCIFTFLGNWNAYLWPLIVIETEEMRTLPVGLAFFSGENQTYWEIV
MAGATIAVVPLIIVFLIFQRHIIKGITLTGLK
>PK3-045_00684 Multidrug efflux protein YfmO
MSSSQSVSADSTKNNLNTKTEASLLKQPKAVWAVFFAGIIAFMGLGLVDPILPAIAEKLH
ASQSQVTLLFTSYNAVMAVAMLVTGMISSRLGIKWTLILGIVIIAIFSCLGGLSNGIWAL
VGLRGGWGLGNALFVATALAAIVSLSNSGTAKAIILYEAAIGLGISVGPLLGGWLGAMSW
RGPFLGVAVLMIIAFFGIFILMPKNTSMNTTNTVKSKTSLADPFRALKHRSLLVLGIAAA
LYNFGFFTLLAYAPFVMGLDEHGLGFVFLGWGILLAVTSVFMAPRLQERFGTVKSMCAML
TLFAVVLVAMGIWTTTQWVIIAAVIFAGALLGNNNTLITTAVMNAAPVERSTASAAYSFL
RFIGGAIAPYTAGKLAEIFNPSVPFLVGAGFVLVSVLFIWINSKHVHHVDAMGSGH
>PK3-045_00685 hypothetical protein
MLAHDIMVSRVYKVKEGDTVRSVIEKFIQYKISGLPIVNDRNEIVGFISDGDVLRYIGKH
DDHIIDSIYYTVVIKGDDEDFEHRLQSLLHLNVMKIAKKRVIKVSWDENLEKIAALLGKK
QIKKVPVEKNGVLVGIISRGDVIRNSFKELI
>PK3-045_00686 hypothetical protein
MDEQSLEELEVELSILIRRVTHTSSHKKTSSLDRSAYLLLHEIVTAGPAGVKALAIEFQL
DVSTVSRQAAALEQKGYLLRIPDETDGRAYTLQITETGLEEFQKEKKFRKSRVAEVTKVW
TEEERETFAKLLKKYNQSAMNVHL
>PK3-045_00687 Pre-pro-metalloprotease PrtV
MVKKKLKKTALAAVLGISTLSLGLYSPPEKAAAEAAYKEVVSSYGGAPIDLGIANDERII
EMLKKEGKLAKHASTGETEKALQKYLQGKAEGAKKETKDKLPKALSKLETKGENETSNHS
LQKGKGNKLGQAKKNIVESVKEEAYEGEVREDKVLVLAIDFPDYKKSSITKDETDMFYED
YTHEHFQNMIFGEDGYEGPNGENLVSMKQFYEEQSGGSYSVEGEVAGWYTADHEAAYYGG
NYPGADDSDARPRELVYEALSKAAQDPNVDLSEYDVWDRDDYDGDGVYNEPDGIIDHLMV
IHAGVGEEAGGGALGGDAIWSHRWNLGNLVAVPGATSNSDRFGGLLGAYDYTIEPEDGAA
GVFAHEYGHDLGLPDEYDTQYTGGGEAVAYWSIMASGSWAGDVPGTEPSGFSAYAKEYLQ
GAHGGNWLSGTTLNANEITSKGTELLLDEAVTKGTNNDAVRINLPDKTTDVNTPASGKYE
YFSGSGNNIDHSMKTAVDLTNATSAELTFKTWYDIEAEWDYASIKVNGETIKGNITTTEN
PNDQNPGNGITGSTNGEWVDGVFDLSAYAGQKVEIEFNYWTDVAVANPGFYVDDIKVTAN
GTEVLTDDAEGDSFFALEGFKKDEGKFYSKHYYLLEWRSQNGVDEGLAHIRRGASLMSYD
PGLVVWYVDESYSDNWTGAHPGDGYLGVVDADQHTNYWSDGTVGATRYQLNDAAFSLAKS
NKMFLDYAAINGTTLKDNFTKRTPLFDDSADYSNQGNLEAGRNIPSTGLKIRIVGESKDG
TVGKVLLYK
>PK3-045_00688 HTH-type transcriptional activator RhaR
MPQIDRYKKRIVNIDFFAIENFKELPYQNRFTIVFVTSGSIKGMLNNLPIAISAPGIICL
SQTDEIQVFEREKVSAQSFSFDPDFLSTIPISKTEDYFMPNLKIHTGLSLFQRDSTHTGV
PFITTKAFPKLLDWFFIIGTEVFAQSDSLWVCRIKKNLIQMLSLIESLNSENGQSPVDTV
LEYIHTNYANKITLDDLTQCAHLNRVSLNKLFHKRCNCTAMSYLLSYRLKVAEELLTHTG
MSLTEIARSTGFEYDTYFIKQFTSKKGMSPTSFRNTSRKLASYL
>PK3-045_00689 Glyceraldehyde-3-phosphate dehydrogenase
MAVKVAINGFGRIGRLAFRQMFSAEGYEVVAINDLTSPQMLAHLLKYDSAQGRYALADKV
EAKESSIVVAGKEIEIYAQKDPKNLPWSKHDVDVVLECTGFFTSKEKASAHIEAGAKKVV
ISAPAGNDLPTIVYGVNENVLNKNDTVISAASCTTNCLALMVDVLDELAPIEKGFMTTIH
AYTGDQMTLDGPHAKGDLRRARAAALNIVPTSSGAAKAIGLVIPKLEGKLDGVSQRVPVP
AGSVTELVAVVNKTVKKDDINTAMKAASSDSFGYTEEQLVSSDIIGITYGSLFDATQTKV
TSLPDGKSLVKVVAWYDNENSYTSQMVRTIKYFAEL
>PK3-045_00690 hypothetical protein
MNGQNRKDITPGTPVEIVLKQDQRTGKRTAGIVKDILTKSPSHPHGIKVRLEDGQVGRVQ
LIKEK
>PK3-045_00691 hypothetical protein
MSDMNDKQTREQEGKKKISLQEAMKQQLANKAQQGQGGKASLSGNQKMQKMKSQLTKKPN
NQRKRMGV
>PK3-045_00692 hypothetical protein
MDLPVILAGPLVRRVEETSAYLWIALSGKYQLNANLYAIHFNQTTKEFEYQPFDIQSDIQ
VCRLGKNLYIYLIKLQPISQNFPTQTLLGYNLVFKKGETSYDLSDFGLLAADSPVSICYG
NLQYPTFFIPATAEKNILYGSCRKLHGIGKDALSLGDAKLQEEYFQLEKRPSALFLIGDQ
IYADDVPAPAAPILFALGKLLMGKEEPIKELCETEDDKNTAFDITISQINGRREIIKEYC
QFTSRKADNHLLSMGEYAAMYILSWNTEIWDMATGAGYLKDFDDYLEDNQIHIQIGADQA
KEYERKISSLKRAYSQQQKDITSFQQSLPKVRRLLANIPTYMIFDDHDVTDDWNITKEWQ
EKVACSPLGNHVIANALTAYWAFQGWGNNPAAFPASFFRKISKYTKRLTVNTQTYTEWLH
MMLTFRAWSFVAPTNPRSLVLDTRTKRAYPQERTYVVGSMLKQRTNGPNLIRKKEWDYLS
ELLLSSGWQQQTPLVIISATPLYGVHLIESFLKNVIMPLTAVLPSLQKSLDLEWWKFNGR
GFSFFHQQIAEWNPSECLILSGDAHMASAIEVEVYFQQEQKRILHQFTSSPIKNQSFEGL
SGFTLKRILEFRQSRTKEKKISRYCGHDYLIQEKEADVPFLWKEIIAHQVLSNGSLIDTK
NNLGWLAFDKNGFNHRFLRK
>PK3-045_00693 Hydroxycarboxylate dehydrogenase A
MIDLVHSFGPQNYYHYSGVINTLPKFLEDNHLQFPLVIHGEKSWQAVQPYWPETEFQHPY
KKILFAGECSYEEIDRIGSEVIHHQHDAIIGVGGGKLLDTVKAVASKAKIPCILIPTLPS
NCASFTPISIVYSAEGDHLGTIRHSQSNYMVMVEPELLVNAPIEHLTSGIGDTLAKWYES
KIRFNKLTSEEISILLELSHTAAKQCRDNILKWGEAAVQAAEAKKSNADFSRMIDTIYAV
AGLVGGLGGKFGQSVGAHAFNYGYVSLGKKGHLHGSLVAYGILFQLSLEENYEEIKQLVP
LYKKLKLPICWRDLHLSPEKGDLDKMADQILRPSSRIYALPMELTKQSVIDGLQKLEAFI
TENEVGLNVF
>PK3-045_00694 LL-diaminopimelate aminotransferase
MYFDCSERLGKLKPKYLVVQNKRIKELQQSAKQVINLGRGNPDQPTFPRIVECLQEAIHD
KKNHGYPPYGGKQVFKEAIVAFYRKEYGANLSPNQVAIMNGSTIALSGLAQSLLNPGDIA
LVPDPGFFGYQAAVELAGGEPFFVPISEKNNFLVDYSSIPEEVSQRAKILFLNYPNNPTG
ANATRKFFEETITYANKYGIAVIHDFAYADIYYTDEKPISFLSIPGAVEVGVEIYTFSKT
FNMAGWRSGFTVGNESLIKHLSAYLQNAVGGVFGGIQDASVFALLHQQAERNALRELYHE
RQLLVESFLKTLDWEYVAPQGTFFLWAKVPLPINSIEFADQLLEEALVAVVPGSIYGKNG
EGWIRISLVTSLEQLKESFERIKRFLLRKRGY
>PK3-045_00695 putative amino-acid-binding protein YxeM
MKNFLKLNALLIFVISINLLAACSNSTNSQEESTKTASKSETSDEKVIRVGATGQSFPNS
YQEDGKLIGFDVEVLETIANNLGYKVQWTLAGFEGLVGQLGVGKLDTIANAFEYTEERAE
QYNYSTTYSYTSTGIAVLKDSPYDSVKDLNGQTVAGVLGSNKINVLEDYVKKNGLDIEVR
QYETRDGPQSDTIKGAVAGYVQGKPILQATINKSKLPLKILEDDLKKSEIGFPFAKTEQG
DALRKVFNAEIEKLRADGTLAEISEKYYADDITSED
>PK3-045_00696 3-carboxy-cis,cis-muconate cycloisomerase
MGSHVVALKMLQNNFSTEEMRSVWDDENRLQKILDVEAALALAESELGIIPKEAGRAIKD
AAKIENFDIEEIAKESAKLKHSLMATVNHLQKLSGDYGEYVHYGVTTQDVTDTAMILQLK
EADEIIRRDTKKVAELLIGLASKYKKTPMPARTHGMQGLPTTFGFKLAVVLSEFERHLDR
LKSVQSRIFTGVLAGGVGTYAALGSIGPKIEERALEILELNAPKICWHSSRDRISEYGSA
LGLISGSLGKLGNEFYNLMRTEIDEVEEPFSAGNVGSTTMPHKRNPAIFEGIASLTKPIL
HSVALLHESLVMEHERDAMSWRSEWIALPEICLYLSSQLKSMITVLEGLVVKPENMLKNL
ERLGGLILSERVMFALSEKIGKQTAHHLIYEIAMESAEHKIPFKKLLGQNEKVAAVLTED
QINQLLDPSQYIGLASEKVDEVIASIRNGGLLSE
>PK3-045_00697 S-(2-succino)cysteine N-acetyltransferase
MSNLSFHQATSKDIPELLDLSLRGYASIRELGIHFAAATADVELVEKNIKENICFYLRDE
GKMVATASVRMPWSGHPGPFEIPHIWWVAVAPEEKRKGYASKILHYVEESFLRDTLHCPS
VSLGTAKEHPWLREMYEKRGYKKVGETDLGKGHITIYLEKLLLAKSYKKR
>PK3-045_00698 putative amino-acid-binding protein YxeM
MFKKITVIMSIAFLLLLSACSGTDNKTENGESSKEQKTLRVGSTAQSYPNGYEENGKLVG
FDIEVLEKIAENLGYQVEWVRSDFAGLMGQLETKKIDTVANFVAVTDERREKYQFSEPYA
YAGATIVTNKDNAYDSLEDLKGKTVSGVLGSNNVKNLENFDPDIIPKTYENRDGAMNDAI
NKRVDGYVNSKSSLIAEIEKGNLPLKFVGEPFVYEDVAFPFLKNKDGEALAEAFNAEIKK
LREDGTLTEISKKYFADEDITVKE
>PK3-045_00699 putative amino-acid permease protein YxeN
MNLDLDFPYLVDILPELLEFIPLTLFLAVLSMVFAIIGGLILAVISRSNIPVLKQLAAVY
ISFFRAIPTLVQLFLIYYGLPQIFPALSAMTAITAAILGLSLKQAAFLAEIFRAALNSVD
KGQVEACLSVGMTKVQAFRRIVLPQATRNAIPATSNIFIGLIKETSLAFTLGVVELFAQG
KIIAASSLKFFETYLALALLYWVLIILVTFVQRAIEKRMEKPYLS
>PK3-045_00700 putative amino-acid import ATP-binding protein YxeO
MIAVTNLKKRFGENIVLDGVNLQVNRGEVLAIIGPSGSGKSTLLRCLNLLEMPDEGTIHI
GETNVNVQKMGRKDIHQLRQETAMVFQNYNLFKNKTALQNVTESLIVAKKMNKQDAEKLG
KELLVKVGLEDKFHQYPATLSGGQQQRVGIARALAVKPYAILFDEPTSALDPEWVSEVLQ
VIKDIAQQNTTMIIVTHEMKFAEEVADRVIFMADGNIIEENEPKELFHHPQNIRTKQFLK
TLERDE
>PK3-045_00701 N-acetylcysteine deacetylase
MNMSPELLNDLIVKRRYLHEHPELAFEEFHTTELIKKWLTEQGIAIVELGLETGVVAEIK
GAFAGPTIAIRADIDALPIIEETDVAFKSKNEGKMHACGHDFHTTAILGAAILINSQKDK
LHGNVRFIFQAAEEIAQGAKKFVEKGAIEGVEAIFGMHNKPDLPVGTIGVKSGGLMASVD
KFSLRFIGVGGHAGIPHRAIDPIVMASQYVTAVQSIVARRMDLFDNVVVSITSIHGGNTW
NVIPDEVKLEGTVRTFQPKAREAVPTIMKKLAESIAEGNGGSVEFVWDDYLPVVNNHQDY
EDIVRTTVLDAGYNVVDAVPSAGGEDFAFYQNYIPGFFVWMGVDGPQEWHHPKFDLKEDA
IKVAAEFFAKLAENILKND
>PK3-045_00702 hypothetical protein
MTDLTKAIVDLIQSSPSYQELTNETKENLKKGVFDYFLSCFASVRFDMNFSTVLHTAIYP
TEEGAAVVGTDLKVHPFDACLINGYSAHALDLDDVHSEIRGHPSAIILSLLHALIEKKRD
RDRFYEAYLIGIETMKCFAQLLGAQHYEKGFHTTATAGIYGAVAAGAHYLHFDTEKFSQA
INLCVSKLSGSRSQFGTMVKPLHAGLTAQSAWQILHFVDKGIVGSANTIQAKNGVLSMYV
EQSGNPFEVFEKWGEPWTIDKPGLWFKLYPCCSANAHAIEAIQNIQAQRNFTVEEVTSVD
LYFPPNGDAALVYTSPTNGEQGRFSVEYCAALLLKGEALSIENFSVNQIADEIQAGIKKI
HRKYDPAIPVKEISYPKGRYCIAKVMLKDGQQLVSRVDAPTGSPGKPLKMQDLASKANTL
LGEQANTLNKYFAAGIEGW
>PK3-045_00703 Sensor histidine kinase RcsC
MKKSIGVIIACCIFILSIISIVYSSWSNHTRDAKISDGQINLASVSFDNKDIIHLNGEWE
FYKNQLITPIPNRNIFDSYERELRYVPGLWSDNKSKAPFIAGTYRITITVPKDGLYGIKV
NAVNHASKLFINGIEAGESGNPSKDKSDYRPYIRKYIGIGRSENHKLEIVIQAASHKQPL
RGGVIQPIEFGSATQILTSRESDRTIETLLFGGYLVLGIFYLFTFFYRMRDIHQLYFSLF
CILQGVYIAFINEKIIELVIPSISVYLLSNIQLLLFHSALLFFLWFIHGCFKEFSSQKVI
LAISILLMIDGLLYGVPGVSANLLGFLPIFEKQIMIVLLVAPAYVYIGLVLIKALVNKSE
GSQYLIIIVSSFISYGLVLGVNFLFATEIGRIPLILFLFMTIGLALYMGLRFYQAYIKIE
KLSESLQVQDKLKDEFLIKTSHELRTPLNGILNLSRLMLEGKEGPLSIKHQESLALIHNV
GKRLANLVEDLLNASDIKTNNIALFPKSLNLKIIDEVIKEMYLLVPVNKNITISNKINAH
LPNVYVDEVRLIQIFYNLISNAIKYTDNGEITIMADVINNKMEITVTDTGMGIKEEELEY
IFTTFYQSERTINRGTDGLGLGLAITKQLVLNSGGEIFVKSKVGQGSQFSFTLPLADTRE
NLSETLVRPEESIIKFQENKEKLQLQLPLIENGKSPYTILVVDDEHANLKVVVNLLKLLN
HSIIAVDNGKMALEIIKERKIDLLVADLMMPEINGYDLCNIIREEYHLVELPILILTASG
QIADLTKSFIRGANDFLRKPIQPEELNARVTSLLTMKNAAEQAINNELNYFYAQIKPHFL
FNTLNSIIGLSYRDMERAREGLYHLSTYFRGKLDLYRKPTLISIQEEMELVQAYLAIEQL
RFGEDLQVKFDIEEDIRLEIPALTIQPLVENAVQHGFSYKKKGEISIVIKRVEPKVVNII
ISDNGKGMNEESRNRLLQGKGNGMGFSNALKKLKLLKNSKLLLETTEHQGTKIIIILPEV
RRNEGHNN
>PK3-045_00704 Protein-glutamate methylesterase/protein-glutamine glutaminase
MRVIIIDDEKWAIEVLVRQLNRLTNINIVKTFTNPLEAYQELPNLNVDVVFLDIEMGEVD
GLEFAAKLLSLPTHMDIIFVTAYNQYALDAFEVNAIDYLIKPVTITRLEKTFNKLRIYGR
ADLQVLNDKKQRSLYANVMGGFQLLDQDGNVVKWRTKKVKELFIYLWQHKGILVHKTKII
DNLWTDIPVDKSLTLLHTSIYQLRKTLKTLGLENPIVYLNDHYKFDCLIESDIDRLSEIF
AKKVVSEEMIEEVLSLYKGDYLEEENFEWAIGRQQQIKSQFVNFLDQYIEREIDHAKKSS
SIIKSLEKLVELEPYNEKYLAYAIRYLGEQESKQELIHFFEYFQEKWSSDLELPLPKELF
DLYQQYIVKL
>PK3-045_00705 hypothetical protein
MNNKVMAYRKQNGYSQDKFAEILGVSRQTIISIEKGKYNPSLPLALFIAKIFNTSVEDIF
SLDEEDLRKFLDK
>PK3-045_00706 hypothetical protein
MASQKNYFIVGILLTFIFVIRLILFFMTDNKESAVYFVELLNWGSIAIMAFCYSYLYPQF
KEKDERTQSIRQKGIYYSMFLVIISLIAMMLLIQYGVIALSTILVVRIMISLIIIIMSLS
WVILSKQM
>PK3-045_00707 hypothetical protein
MKRISISFLLFVFIMQTVMSSILLPSSVLAIELDDNPLIDVNLLDEQGNAVNLANKVTLD
SKLDLKYQWSLADIDVSEGKALSFQIPSELTVTEEKQGPLVTSDNQSVGEYSITTQGIVT
LHINAEEETTEAYNGLLSVPVKLNAEKIKGDEESLSIPFTLREGSKVMEVGLESIQSQED
NDSSGQEKAPETEETLKEEQPSDSNQQEKDITDLSVENERKEVNIRESNSSSIEENILSK
AELTYEDENGNNLETPNKNSYIGVDYTWKLKNGHGYKAGATFTFTLPEELEVYNKVDQEE
IRFNNQVIGHFSVAENGTATIVFNEFIEQYSNIEGTLKVWTKLSEELVVNEEKTVTITPI
KDGDSMDVPIEYTPSGPTVTKSGLANKAYNANSISWTVDFNKSLESLENAVLSDPIQTGQ
ELKPDSVKLFHIITKLNGQMSLGDEVDPSLYEIGKTGDSKDFTIKFKNKIGTAYRLVYET
TITDENKKKFDNKAILLSGDSQKGEAAASVSVNRGSHLEKSSTGYDADKQSISWEIKYNY
NEKAIKKDQAILKDLFTNSQSLMKESLKIYNVTIDEDGKESVGEEIPASSYTLQEINEDN
KNGFKLSFNNDIKTAYKIVYQTKAIDRVFEGETIKNTVISPNETKEASRNIAQRILFKSH
GTPNYKDKSIDWTITFNHDQYEMNSVNLDDIFVNEGLTLDKESLVIKSGENTLELGTDYK
LVETSDAKFSIEFLHKIDRMTTIKYKTTFDYETRLEKTHYYLENKGILTWIDENGEEANK
EVVSRFTPDSFTQSNGFKNGNYDAVTKEITWNVGINYNEKLLRNAVVEDYILGNQRLVDG
SIEVHKMNLTGGSNGTEKGELVSSDDYSISYPKDEKENKGFRIEFKEEIQSAYYITYKTS
LKDLALVNSKYDNRATLYDGGTKETELSASVSIPHGGTYITKDGTQSGKLIDWKVNINFA
QSRIVDAIIEDIPSPNQMLLKDSFHLYSTNVDSKGNVTRGEELVRGEDYSLQLKEEPSSF
KIVFTKEINEPYILEYQSFIQANVNDTVSNDVHITGKQITPGDITSTKKAVIVKRTAGMG
DGTGVLAKLKVVKIDASSQEKLQGATFSLVDKQSGVTLKTAVTDDKGEILFDKLLFGDYV
LTEDKAPEGYLVGINGEQSITIEKENSEITVQNQKIIRAVQLTKVDMASTDITLAGANFK
LLKKVDDKFVELETLTTDGEGKLSKDNLEPGEYQFIETKAPNGYELNEEPIAFTIKADQT
KVIELVAKNKKLGSVELMKLDKDDKQTQLANAVFQLWKDGELITSNLKTDAKGSVFVENL
KPGSYQFIETIAPDYYKLDPKPIDFTIEDGKTDPVKVTAYNELVEGSVELTKVNQADSKE
ALAGAEFELRNEAGELIAEKLVTDKSGKITVDQLKPGKYQFIEVKAPADFQLNSEPISFT
ISKSKTAADAEQVKVTAANTLIPGSVKLTKVEKDDHSIVLADAEFELQDKEGNTIKSDLK
TDEEGKILIENLAPDTYQFIEKQAPFGYMLEKEPVIFEIERGQTEVLSIKVENELILGAI
ELLKVDADNDMMPLKDAEFELQDQEGNSIKSGLITNEEGKIFIDGLKPGNYQFVETKPPF
GYKKVESPISFVIVKGQEKPLLKVVTNELTLGSVELTKIDADNHNQVLEGAEFELQDKDG
KTLQEGLKTNEEGKIRIDGLKPGSYQLVETKAPVYYQLNEKPIIFTIEKGQERALEVTAE
NSLINGSVELTKLDADQQDQYLSEAEFVLQDDNGHILFEKLVTNKEGKIVVENLKPGNYQ
FVEVKAPKDYILNKKPVAFTISKRETAADVKVVTVSAFNELTPGSVELTKVDADDENLVL
EGAEFELQDTEGKTLQEGLKTDKDGKIYIDGLKPGKYQLVEAKAPTYYQLSKKPIVFTIE
RGQTKALEITAENSLITGSVELTKVDADDKNLCLENAEFSLQDIEGNTILGNLKTNKDGK
LLIEGIKPGKYQLVETKAPVYYQLNNNPIVFTIEKGQQQLLEVKAENSLITGSVELTKVD
ADDKNLVLEGAEFELQDTKGKVLQKGLKTDEDGKIRIEGLKPGKYQLVETKAPADYQLNG
NPIVFTIEKGQTKPLEVVAENSLIPGSVEITKVDANNKNLVLEGAEFSLRDKEGKVLQEG
LKTDKDGKIRIEGLKPGKYQLVETKAPAYYQLNSDPLVFTIEKGQEKQLEITAENSLITS
SVELTKVDADQQEQYLTGAEFVLQDDKGNILFENLVTNESGKILVENLKPGNYQFVEVKA
PKNYHLNKKPVPFTISKSSTAAEVKKVTVIATNELTPGAVEITKVDADKNDLVIEGAEFV
LQDLEGKTLLEGLKTDKDGKIHIDGLKPGKYQLVETKAPAYYQLNSDPLVFTIEKGQVKA
LKVKAENSLITGSVELTKVDADQQNLPLSNAEFVLKDSQGNVLIEGLVTNKAGKILVENL
KPGDYQFVEVKAPKNYDLNKQPIPFTISKSKTLADVKMVPITATNELTAGAVKLTKVDAD
DKKLVLEGAEFELQDTEGKVLQEGLKTDKDGKIRIEGLKPGKYQMVETKAPAYYQLNSEP
ITFTIEKGQAKALEVVAENSLIPGSVELTKVDADDKKLVLEGAEFVLQDTEGKVLQEGLK
TDEDGKILIEGLKPGKYQMVETKAPAYYQLNGKPITFAIEKGQEKVLKVTAENSLITGSV
ELTKVDADNKNLVLEGAEFVLQDTEGKVLQEGLKTDEDGKIHIEGLKPGKYQMVETKAPS
YYQLNGKPITFAIEKGQEKVLKVTAENSLITGSVELTKVDADNKNLVLEGAEFVLQDTEG
KVLQEGLKTDEDGKIHIEGLKPGKYQMVETKAPSYYQLNSDPIVFTIEKGQMKMLELMVT
NKLMLGSAIVKKVDETTNQPLENAHFKVTDKQGNIIIEEGISGRDGSLELIDLLPGEYFL
FETKAPNGYKKLSEPIMFEITKGQQEPIVVKVANEKVISEEQKPTPESDDESGTKGEDSS
GSKNNSGKTLPDTATSYFNYILAGMLLIGFSVLIRIRNRGN
>PK3-045_00708 hypothetical protein
MAKWNYALIVFLGGCCYGILSTFVKLAYAAGFSAAEVTGAQYLFGTAITWILVLFTKKYK
VTRMQAIKLLLSGIPFGMTGIFYYQSLQTINASLAIILLFQFVWIGTLFEMVIYKKKPTK
EKVISIIILLFGSVLAGGISLEGGMDISWQGAGWGLLSAFTFATFIFLSGSVGKNTAPLL
KSGLLSLGGLFVVFLVFPPVYLMDFSTLIGVAPYGLLLGVFGAVLPPLLYSIGMPQIGPG
LGTILTASELPVAVSMSALVLREQVGMLQWIGVALILGGIAFSNVRLSKAKIASY
>PK3-045_00709 hypothetical protein
MEMSSDYQAFFGVDGIVNDFHVNRVHNTNFYGVGGDYSNGVHLQVQLSPNQYSNLLKYGY
SGKKHNVYFAVRSNNHAHLYAASTEDINKLLEVISN
>PK3-045_00710 hypothetical protein
MKAKAILDPKDSVQKIIDIAISTYNKMIAIQKNIGKHAITASDVAEWLNMTPRNARRILT
NLEEQGLAKIIGEEVPLTRGRPRKIYQIGI
>PK3-045_00711 Succinyl-diaminopimelate desuccinylase
MTNIEHKTEGLTEKVGQVYKLLAENEQVQKALKFLEEDNEATTKEQIELTEIEAPTFEEK
EKGEWYKKRLESLGVQKVTTDEVGNVFGVLTGSGNGPSLVVCAHLDTVFPKGTNVKAVHE
DGLIYAPGICDDGRGLAVVLTIIRALAVAGIKTEGDLIIGATVGEEGLGDLRGVKSLFEN
RQDIDGFISIEPGDPSRITYLGTGSKRFNVLFKGPGGHSFGNFGIPSPIHALGRAIAKIS
DLATPVEPKTTFNVGMIKGGTSVNTIAETAEMLVDLRSNSQEELEIIESKFLHLMEQAKE
EENARWNVEAQVSLQIEKVGDRPAGSQDKNSVIVQAARCATVALGFEPILDQASSTDSNV
PIHLGIPALTLGGGGEGGGFHTLQEYYNPTDAHIGAQKILLTILGLVGLEQVTAPLLEKG
K
>PK3-045_00712 hypothetical protein
MIFLWLFAPVVIVMGIVLFFAKKSGMTAPDENKQADKLGEVVHYNRVNSSSGPGGMS
>PK3-045_00713 L-arabinose isomerase
MSTNKVFWFVVGSQHLYGEEALKEVKAHAQTMTDTLNESGLLPYPLVLQDLAVSADTITK
MMKEVNYRDEVAGVITWMHTFSPAKMWIRGTKLLQKPLLHLATQYNESIPWDTIDMDFMN
LNQAAHGDREYGFINARLKKQNKVVVGHWQRAKVQQQIADWMDVAVAYNESFQIKVARFG
DNMRNVGVTEGDKIEAQIKFGWTVDYFGIGDLVQYVNEVSENEINDLFAQYEKLYDFDYG
SYSKEDWEASVKVQASYEIAIKRFLDEGGYNAFTTNFEDLYGMKQLPGLAVQRLMAQGYG
FAGEGDWKTAALDRLLKVMSHNESTGFMEDYTYELAVGQEAALQSHMLEVDPTLASNKPK
IIVSPLGIGNREDPARLVFDGKAGDGVVVSMADFGTHYKLLINEVSAFEPTVPAPNLPVA
RVLWNIKPNFQEGVKAWIENGGGHHTVVSLNLTTDQIITYAKLVDLEYVVIK
>PK3-045_00714 L-ribulose-5-phosphate 4-epimerase AraD
MLEKLKEEVFLANLELPKQGLVKYTWGNASAIDRESGLFVIKPSGVDYETMQPSDMVVID
LEGNVVEGTLNPSSDTATHAVLYKHYHEIGGIVHTHSTWATIWAQSGLDLPALGTTHADT
FYGAVPCARFLTQEEIDRGYEAETGKVIIETFEERGLDILAIPGVLLHGHGPFTWGKDAK
SAVMNSVVLDEVAKMNLFTRELNHFSKELPQRILDKHYLRKHGKNAYYGQK
>PK3-045_00715 Xylulose kinase
MKNNRANAKQDIVEGATSLGIEFGSTRIKAVLINNRFETIATGSYEWENLLEDGYWTYNL
VDIITGLQTAYSEMKQEVERNYGVTIRTVGSIGFSAMMHGYLAFDHTGELLVPFRTWRNT
TTSTAAKKLTDVFQFNIPERWSIAHLYQAIWNNEQHIPRIDHITTLSGYIHWLLTGQKVI
GIGDASGMFPIDETTQDYNESMIEQFDALIAAKEYPWKLKDILPKVAIAGEQAGKLTEIG
AKILDRSRNLQPGIPLCPPEGDAGTGMVATNSVKKRTGNVSVGTSVFAMIVLEKDLSAVY
PEIDIVTTPDGSPVAMVHANNCTSDLNAWMRLFREFSEAMGQKVEMDKLFHVLLNASLKA
DADGGGLLSYGYFSGENITGLESGRPLFVRSPESNFNLANFMRVHLFTAFGALKIGMDIL
TQQENVAIDSILGHGGLFKTPVVGQKIVAAAMNTPVSVMDTAGDGGAWGIAILASYMLNN
NENDSLEEYLDKRVFKEVDKQTIYPDRFDVEGFEEFIERYKKGLAIEKAAIENLIH
>PK3-045_00716 Arabinose metabolism transcriptional repressor
MKLKYQIIIDDIKSKILSGDYQVGEQIPTESILQEMYKVSRHTVRKAILELSNDGFLRSE
KGSGTYVSNYYQLKGNGKSKRKTIGVITTYISDYIFPSIIRGIESRLNAEDYSLLLASTN
NDVDQEKKALEMMLAFGVDGLIVEPTKSNLYNPNIAYYLAFKEQDVPFIMVNAYYEELEV
PFFCLDDVKSSYLATNELIAKGHTKIGLIAKMDDLQGKFRMKGYIKALGEAKLRFQAEHV
YSFTTETKPDLKVKLKEFLHENMDGMTAIVCYNDEVALEVVNVCRKLNIAIPDQLSVIGQ
DNSYMAKNANIKLTTLTHPQEKMGHDAAEWIIRKLQGKKDLKNENYYQPELIQGETVKDL
TEDAEGRFW
>PK3-045_00717 hypothetical protein
MGFKDELKHEMRNLTKDIEKEVQKSWTVHYKGHVIEVINQMKEELLIIDGITVAQNKRKS
ILSHIIPYTKLSGVLTLEGGKKHKVSVKIGGYVSLNCSIKIDNETILQESEKLEFLPWDH
KEKIVPFIQRQVLENNRIVENTLPDDTYFFGEDNPPLEPGLFDIIVNEPKTPFFVSKLMK
LFKEQLEHPTIKTRKATYDQIIFDHIAIYRDELLDQLGQAELDEQMAQQEALWLLEHAAH
RDVVKFAILVLGFTNCEEYQELLYTIGLHDEFTPYAIFAIRSGGKGVNDQIWKLVQSVRG
IGKMTAIELVEAKTPEMKYWLLTKGCENRKFADFLAHRCAVKGELDVALYEVNISKELYT
GAAMIIEGLLDDENQDGMDQYPYASAVMTRFLHHATTHCESLEDFYPIMKISEFVHAEDD
IWEERLNGQWKQHEPKAIQEAVQPFIDNPKWSQLALDVLQSSEKVDFRAMEIARFYQLDI
TALLFEKLKKEPTNSILYGAIMETRDLQSIQDLCAFAETHFSLSSLSLEEQYCLEYIIQD
LHEFEGIGAPLVYASLETKNESLRWLGLSVLAEWSPTFRQLSEIQHALKTIMSTTKDKEE
RRLAKQLLK
>PK3-045_00718 hypothetical protein
MKLYQVRKGQFVYFNNELHRVYSVKPVYKKSVHLIKLKDLTQHLTIASKIEKYKPKQLDS
FIFNHKAYTLHKDKKAEEGDYILITNPNPDYMDSYSLNEIEIVSSVEPDGVITTKHNGVK
HNEYLLMIPGRDNDSNSIDYFNKNLANSDILSDDSDQPEKSTQGDMPSIGDVYKKIGGDH
PLQTMVVAINGEKIFLGNNLEVSLNELNDKEIWEFQYSLLETDLK
>PK3-045_00719 Putative ring-cleaving dioxygenase MhqA
MNELKGLHHITAITSSAEKIYEFFTYVLGLRLVKKTVNQDDIQTYHLYFTDDVGSPGTDM
TFFDFPGIPKGVHGTNEISKTSFRVPTDAALEYWVKRFDKYEVKHKGIQEQFGKKTLSFV
DFDDQQYQLISDEKNAGVASGTPWQNGPVPLEFAITGLGPIFVRTAYLEYFQEVLEKVFL
MKEVSQEGSFHLFEMGEGGNGAQVIVEFNTILPQARQGFGTVHHAAFRVEDRGELDQWQE
RLSSFKLPNSGFVERYYFGSLYSNVAPQILFELATDGPGFMGDEPYETLGEKLSLPPFFE
PNREKIEKLVRPINTVRSNIEIDKEYL
>PK3-045_00720 hypothetical protein
MYVHFLLGVMLFSHPVLLSGDIIKATESISQPKDKKEEIFLWKSPGLPVIHTDEFNKVME
EIDKKVYIAPKDAAVNKYGGIVPEEVGYRLHRVKFIEQMYAHYFNDISSNKGYPLEVIYP
KVDSELLESIRRKKIGRYITSFNMRNKERSMNISLATEAINNSVIFPNEKFSFNQIVGKR
TVEKGYLQAPVIINGKFSEDIGGGICQVSSTLFNAVDNAGLNIIQRYSHSRKISYVPPKR
DATVSWDGPDFVFENNYEHPVLIQAKMLGHHLLIELYSAETISYQPRKVPYL
>PK3-045_00721 hypothetical protein
MNSIINYLDNVFASLPKTLEMETLKQEMLSNMEDKYNELKKAGKLEHEAIGIVISEFGNM
DELLSELDLPLTEETALEHQLTEEEVTTFLQKTTKAMNFIGIGVMLCILGSALLILFLQL
YNQGLLNGITENTATLIGVGQLLLLVAIAVSLFIYSGQLLEKYKFMEKAANFELSTPLKK
KITAEKDAYQPIFFRSVIIGVALCILSPIAILITSGMSDQAAVYGVCLLLVFIAIAVYLF
IISGGKKDAYEKLLKVEDYSFEKRTEDKVIGAFAAVIWPLAVVIFLITGFVYGNWHINWI
IFPIAGLIMAMFSGAYTIIKKDR
>PK3-045_00722 hypothetical protein
MVKYNYYDSHSMTDKVFERGDFLISSDIIRGYNDTIILFLLLEKDSYGYEISKDIRTLTN
EKYIIKETTLYSAFNRLIKNNYIHSYYKEGEFGKRRTYYTITLEGRKYYQEKCQEWFVTQ
EVINLFIKEGYNE
>PK3-045_00723 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MTLKKRITKRAFVIFVMGVFFFSTYFPIFPGLTMYAAEPTGKKVEENPPNTAENNTVEAP
ETTTDKEKGEIAEEEKAEEKNQHENESSSISKEKKSAPTAEQKEESVIKEEDKPQETEEK
EPAKEEITNETNQNQEKAEKKQESFDYKKLPPLLITELAPDSKGTDNFEFIEVYNNTNQP
IDLNSYYFYYQYIGGNTADKIMSMPEAILAPQETIVLWFNVKGLSVEDFNKHFSTSLTEQ
QVISIKGDFSGFANGGNRGVLIKNLAGQEVVSANYLPGETDNTGADVHYAFPTEGTEMVK
QEVKAAPTPGALSDGQVPAEQVPVNPITKDTEAPVITHEAKTTMKAGEAISIEATIVDDR
KNPTATLYYQGETDTELKALEMKQDSAQPQKFTASIPKEAALGKVVYYLEASDGMNMSKT
SEYTIELEKEPEKEPEKEPAQDTYSDRPLLITELAPNSMGGGTDYYEYFELYNNSNQTLN
TASYSFYYVYTDNSREPILFPLPATEIKSKERLVFWFNNGNKTLADFNKEYGTNLTSNEV
VMFTDQTFPGFANGGNRALEIKDAEGNITISASYLGSENDNNGKVIHYQFPQTGTEMVKY
KVLADPTPGKIEADQIPTKIVDLPDVPKDTEPPAISHQAMKTAKAFTAVTVEAKVTDNET
ANPIVTLHYKKAPDENFKSVSLLKDTQGKYSATIPAADIDGDIIYYLVASDGINESKTEE
YTISVEKTDIDFTKVPKLLITEIVPDSANVGTADGYEYIEIYNNTDKAINFKDYKIQYRY
NADPNTDVVWPSVPDDTIIEPQGTLVFWVINSQNGDKTVADFNANYGTNLVENKDIVRIK
SDGMANGSMRGLVIATNTKEEINVAYYNDEAAQLDTAMNMGVLYKFPEDGSTQSVKISSK
TKLGTPGSIEPSQVPNEPVHVEDDTVPPTLINATNVQEIQQMNDLTIRAKATDDKGIKSV
LLYYRTNDQTDYEKILLTVDASDSEYYATILSAANFIAKEKIEYYFVATDGQNEVTSEKY
VITIKNEINNAPIYLNVKDDDILTGKAILKAASKETAARDVELFIDGKKVEESTYSTLET
QAYLAVDISGLNMYFKNAITMGEEIIHLLDKDNNSDWKTFTIPIDPNKLAVGENIITVRS
GNKASPFQLEESEENRDDYNLRNVRLILADGTVIRDPQKADPSQVFDMGDDGTYRPFEDF
TFTITEEQSKAKTYVWDTTTVSDGAYSIKATDSERESTATIKVDNTAPVIKTNIEAEKEY
KGVFTIEASAVDTIAGVESLEVTLDEEEIKVPFDTASSKLAPGKHTLKMVAIDKAGNKAE
ADISFSVSNENPNKPELIAPANNTAAPVDGDPKLKVKVTDPTNDSMDVTYYKGYKYEASD
SKVKSFENASDTEPPVELAPAGEKALTAKDVSAISSLDGKYLTTNSSTKFPYHRFEVALD
PSISNQDKVELVWNGKSLQGRKVSMYAWSMQENKWKLLTYKIAGPEDFTLKADVDVRAFA
DKTNKVNVLIQDEIPSTPDEYDYTFVWMSDTQYYAESYPYIYKRQTEWIAEKQEEMKIKY
VMHTGDVVDEFDDEKQWVYADEYMRTLEENKIPYGVLAGNHDVNQLSNDYKEFSKWFGED
RFKDKPFYGESYKNNRGHYDLISAGGNDFIMVYMGWGVNDEDMKWINDVLKQYPDRKAIL
NFHEYLLVSGNRSPIGEEIFQKVVEKNENVFLVLSGHYHDSETLISEVDDDQDGKVDRKV
YQMLGDYQGGPEGGQGYMKLLHFDQKNNRILINTYSPYLDDYNFYDPIEYPLKDELAIDL
DLTVKEKQVATDYFAVNVYTKEEIGKQENVASGEIAEIAWKNLKEGQVYDWYVVASDDYT
GSVTSDIWSFAKGQTTPETPTEPGDGGSEKPTEPNPGGDDGGSEEPTEPNPGGDDGGSEE
PTEPNPGGDDGGSEEPTEPNPGGDDGGSEEPTEPNPGGDDGGSEEPTEPNPGGDDGGSEK
PTEPNPGGDDGGSEKPTEPNLGGNDGGSEKPTQPNPSVINQSEPKNNQSTILPNTATENY
TIMLVGLVLLIGGMVVAYWRRIRREI
>PK3-045_00724 N-acetylglucosamine repressor
MQRTGDLKLIQELNRSIILDTIRKKGPISRSQVAKEIKISPTTVTSAVNDLIRKGMVIED
GVGHSSGGRKPVLLRFNPSKHSIIAVSITNSYIKMADMDLEGKILRKNVHPVNQLQGNEI
ILLLIDLLEQFVAGNDRLEFCEGISIITPGIVDSNNGMIGYNTKLKLYDVPLTELIEEKF
NLPTFLDNDVNAFAVGEYYFGSFNSYKDIMYLTIGDGVGSGLMINGTIYRGFKGSSGEIG
HTTVVPGGSKCECGNNGCLENYVNWPAIYSNIVSSILTKGRDTLIKNLIENDIRKLTPEI
FIDAIKRNDKLSIEILDEIISYLAIAISNTIHLLNPEIIIISGEVVQDNPLFIKKIREKL
SEMVIPILKEDINIQSTSLGSDFDLLGAAAVILQGKFRFQL
>PK3-045_00725 hypothetical protein
MKKLLSLCIFVLISIMLVACSGKSSGDGKKTIEVALWDENVSDAVDASIESFKKEHPDVN
VKVTYTPFAEYWTKLRTSLGGGSGPDVFWMNGPNFYQYVTSDLIKDLEPFLQGDEEFAKE
NYYPAVVDLYSYEDKLYAAPYFVDSIGLFYNKRLFDEAGVDYPDETWTWEDIEAVGEKLT
KPDEGVFGYLNQVVRNQSGYYNLMHQAGGYVISEDKTKSGFDTPEAKEAFAFLNRLIEKK
ISPTVKAQIETDADQWFMSQKVAMTPEISVHAAEYEEVLGEDLGVAPLPKGKVDTSIVHG
IGWAMNSKTKNEDLAWELIKSLSNKEGTTVMAKTGFATPAHMEISKVWLDSLPNVELQIF
LDALEKAVPYPVSEKTSEWQNIETTEIQGAFLGQKSIDEALEKIAAEMNAILEEEQKD
>PK3-045_00726 Melibiose/raffinose/stachyose import permease protein MelD
METMVVNKKSPETVARKRKKKKFNREAIAAYLFIAPTMIGLFMFYIFPALASFALSFTKW
NGISIPEYVGVENLIQLFTDSSFLRSIVNTAVFTFVSVPFTVIIAIFIAVMLNQKIKGII
FYRTLYFLPVVTMPVAVGMVWKWLYNTDYGLINYILGIFHLPQPSWLFDPKISLISVIIV
YIWMSVGNNIILILAGLQGIEKTYYEAADIDGASRIRKFFSITLPLLTPTIFFVFITGMI
SSLQVFDLLFVMIGNSTALLEPLRTIVYGVYESGFKYGEMGIASAQAFILFLAILLMTII
QFIFQKKWVYYDS
>PK3-045_00727 L-arabinose transport system permease protein AraQ
MKRVSRHLLLIIGAFIMIVPFLWMISTSLKSFGESMQVPPTIIPKEWHFENYGNVFEAVD
FLKYYLNTIILTLGRTIGQLVLCSLAAFAFARLNFPGKNVLFILMLSVLMVPAQVILIPN
YATLTQLGWIDTFFALIVPGVFSAYGTFLLRQFFMGIPKELDEAAKIDGCSYFGIYWRII
LPNSTPALTALGIFTILAAWNDFLWPLVMTNSESMRVLSVGISTFSGQYSTDYPLLMAGA
VLSTIPMLLMFIFLQKHLLAGIALGGVRR
>PK3-045_00728 Myo-inositol 2-dehydrogenase
MLKALVIGAGTMGSTHSFAYSTMDDVQLVGIVDRTLEKAEELARKLGAQAFASYEEAIES
LGAVDVVSVCVPTPFHKEYVKKVADDCFQVVCEKPLARNLKDAKEMIDYCKKKGVKLFVG
HVVRFFPEYQRAKQMIEEGKIGKPGVVNTKRGGGFPSASRDWYADYNSSGGLVLDLMIHD
FDYLRWCFGEVERVYAKSAQGRAMAKLDYALVTLRFESGVIAHLEGTWAHQNFATKFEIA
GKEGVIHYDSSKATPLVKGINHNNTGSAGVAVPESPLKENPYITELKHFISCIKNKEEPI
VTPLDAYKAMEIALAAIESLKEGKVVELRKQEMEVKR
>PK3-045_00729 Myo-inositol 2-dehydrogenase
MRVGIISFAHGHAYAYAEALKKSKGVELVGIADDQEIRGAEAAKKYSTNYYSNYEDLLDQ
DIDAVIITSENYKHHEHVLAAAKKGKHVLCEKPIATNRKDALEMMEVCKENNVFLQIAFP
VRFSTPIVKAKHIIETGELGSIIAIKGTNRGTNPGGWFVDKEKSGGGAVMDHTVHLVDIM
RWYMNSDVKEVYAEVDNLFSDYEIDDCGIVTMEFENNVFASIDCSWSRNKTFPTWGDVTL
EIIGTKGTLSVDAFAQKSELYSAEGAKWDYWGDDMNQALVEDFVTNVQKGIAPTITGEDG
LKAMEVALAGYESAQSKRPVLIEKIESNNQ
>PK3-045_00730 L-ribulose-5-phosphate 3-epimerase UlaE
MLKGINQWCYPDDTPLEMVFKYSRDAGFDAIELNVSIDGIGLTMNTSREEAKRIRKMAEH
YRLRLSSISTNLLWKFPLSHYDEKVREQGRKVIEKQIELAGYIGADTVLVVPGVVNEETS
YLDCYRRSQDELRKVLPLAEKHNIHVGIENVWNKFLLSPLEMARYIDEFHSDYIGAYYDV
GNALQYGYPEQWISILGERIRKVHVKDFKLNVGNITGFVPLLAGDVNWEKVYQALKNIGY
KDTVTAEIPAYAFGPEYLAQDTSKHLDVVLNLKKVSP
>PK3-045_00731 Myo-inositol 2-dehydrogenase
MRKVRVGFIGVGGIGSVHLKNIALIEQAEMAAVCDISEDQATAVGKKYQIPAYTDVDKMM
EETALDALFICVPPFAHGDIEEKAAKKGIHIMVEKPVGLNLDNVKRKSAVIKASGIICAT
GYCLRYLDTVAKAKEYLQGKQIAMVNSYYLTKFVPTPWYREQSKSGGQLVEQATHILDLI
RYLAGDIDKIYANMNLLVSKDIPHIDIPDVTSVNFTLRNGAIGQLGCSFIQPDHRMGLEI
LGKNFRVAFNGSNITITDEFSTTTYRPKLNYYEAQDRAFIKAIAANQPELILSSYENGVQ
TLAATLAANDSHENGEPISLSNYYSL
>PK3-045_00732 hypothetical protein
MQKVMEGINYWIKRLPEEFNSMSENSSSHRPLPNKWSKKEILGHLCDSAINNIERFIKIQ
YEEPVYAIQSYGQNHWVKMQNYQDRPLDEMINLFQTLNKQIIHIVKNIPVEKLSNLCDIG
NNQHKTLEWLIQDYHEHMEHHIHSQILIEKSY
>PK3-045_00733 4-hydroxyphenylacetate 3-monooxygenase oxygenase component
MGIVNGKTYLSRISSLSTEIWLDGEKVQDLSNHPAFKGILHSKASLYDLQCHPNLKEEMT
FLSPLSGDSIGMSYLQPKTKEDLRKRRRMIERWAKETAGMMGRSPDYLNTVIMSFATSAS
LLEGKENCYPKHIQSLYESAREKDLSFTHTFITPQVNRSSMYLEYSNEPISAQIIEKNNK
GLIIKGARLLATQGGLTDELLVFGAPRFAKEEAFAFAIPSDTKGVKFLCRESYVGGESTI
DYPLSSRFEEMDSIVVFDNVLVPWERVFFHEDLETASMFLTQSSFNSFAYHQVITRQIVK
TEFILGLAENMINTIDVGEYQHIQEKMAEIIIGLETLKALLEKAENDALLNDQGFMIPNK
TILLVASNIFPKIYPRFSEILQLIGASGLVSLPTEKMFHSEVGKDLNQYLQATCRSADER
NKIFRLAWDLTMSSFGTRQTQYERYFFGDPVRLSGFLYNNYPKSNYVERINEFLTD
>PK3-045_00734 HTH-type transcriptional regulator GmuR
MSQLPKYMEIYTDIRDKINNNEYEINEKLPDGDTLADYYQCSKLTVKKALDILVKEGMVV
RRRGSGTYVKGVSTNGGAIALGPSEGLSNIVGKENISSKIILFSIEKPSLEIAKKLEIDD
EYIYRIIRTRHINNKPYSLEHTYMPLSIITGLEPKHLEGSIYNYIREELKLKTHSTHVWI
RGDKANSEDTSLLKIPDNSFMMEIEKLAQLEDGRIFEYSITRHLHESFVFETVFVHN
>PK3-045_00735 6-phospho-beta-glucosidase GmuD
MKEMLTFPSGFWWGTAWSAEQAEGRGNTGKAETVWEHWFKTEPSRFYQGIGPEVTTDHIN
RYKEDIQLMKETGHNSFRISISWARMFPDGGVGERNPKAISFYRNLLTEMNENGIKPFAN
LYHFDMPYVLQEKGGWESREVVEAYVNYAAACFEEFGDLVYHWFTFNEPLGPILGSYLED
FHYPNLVDFKRGAQAAFNTILAHAKAIQSFKEKQLPSKIGVILNLSPTYPRSQNEFDVEA
AEIADAFYTRSFLDPMVKGTFPKKLVKILQEYNQMPLYEENDLKVIAENTSQILGLNYYE
PRRVKARLTEINKKSPFLPEWFFELHNMPGKKMNVYRGWEIYEKGIYDLCIDIRDNYGNI
EAFISENGMGVANEERFLNEHGQIIDDYRIEFIKDHLAYAHKAIQAGCHIKGYHLWTFID
CWSWINAYKNRYGLVSLNLETQERTIKKSGEFYKKMSKDNGFEYETSKLG
>PK3-045_00736 Lichenan permease IIC component
MNNSTKQGIADRFAFVAQKLGAQIHLRSLRDAFASIMPFMILAGFMTLINYVILEPTGFM
GNLVNPDTLTTWQSIGVSIANGTLNIMTLLVAVAISYHLCVNRGYKNVIAPILVVLSTMI
VVTPLTTTFSPEGSTESFLVSNVIPVSYTSASGMFVGIIVGLLATDLFIKLSSNKKMQIN
ISGNIPPAVIKSFNVLIPIMVNVIIFAVASFLLNQLFNMDFNTLISTIITKPLSYVTTSL
PGFLLITSIANLFFGFGIHQAVISGALLDPFLLQNMQDNMLAYANHQEIPHIINMAFKDT
FAVMGGSGNTISLLIAIFIFSRRKDYRDISKMSLTPSIFNISEPIIFGLPIVFNPMLIIP
FVLAPIFSLSVAYFATAVGLINHVVVQTPWTTPPIISGFLATGGDWRASILQLLIIIITV
FMYLPFLKIDERVSAMQNK
>PK3-045_00737 PTS system cellobiose-specific EIIB component
MKNILLVCNQGMSTSFLVEKMKQAAKDQSMKVNIWAVSDAELHENWEKADIILLGPQVGY
LKSNTEKVVGNSIPVTVIDFVDYGRVNGAAVLETALEMIEK
>PK3-045_00738 PTS system lactose-specific EIIA component
MEGIELIAFQIIGNVGMAKTKFIEALAQAKNGDFSSAASLMKEGSDLLVEGHKIHGELIK
NEAAGNKTEFSILLMHAEDQFMSTETIKLLIAEMIEWRKELSIAN
>PK3-045_00739 hypothetical protein
MNREIIFEEDAAVLKIRGLMMLFTFKHKVKLPYRMIKSVFVDYFDPPKWMIRMPGTSISP
LNIYEGSYKYQDEWYFLSYEGRIPVVIIELDNHEKYRYVIFQIENPTEVAAELRRKMAEA
EGRYY
>PK3-045_00740 Protein ElaA
MKWHIKKFNELTNVELYTLLKERTAVFVVEQNCPYSEVDGKDLESYHLFAEKQGEIVAYL
RILPPGVSYPEASLGRIFVKKEYRGQGFAEELVSRGIDYTKQELKEERIKIQAQDYLRNF
YQSFGFQAISEVYLEDNIPHIDMLLNGRMAQIK
>PK3-045_00741 hypothetical protein
MFYIEIIVAILLILAFMKYLWTKKENEYQTALLANHIESSDELKKTLAMGLYLRFCKEEE
DKDYSSIYLKQDPLQFERFAAEIMEKTRGGSTWVTPPTGDFGVDFEHETEKGLFLGQVKC
YQEDLPFDSIALIHSNIIKRGAQGGYVITTGSFTPAAYEYAKGLNVELIDGVKFVESWLS
SLSKAEKEMKELLLV
>PK3-045_00742 hypothetical protein
MRKFTYAFLAVCMILLVACSADKDKKENTDNNKQADEQKMNVDKGLSNVEITLPASLFEG
EDIDSVIADVEKEGIKVTKNEDGSLTYKMSKAKHKEMMKEMEASLEESIKEIKESDDYVS
IKDITHNKAFSEFTLVVDKKKYEDSMDSFAIFTLGIRGMMYQVYSGVDPDDYQVKILTKD
EATKDVLDETIYPDDLEEDSK
>PK3-045_00743 hypothetical protein
MKKNLPNTFKLCLTSLFIITILGGCGQDTKDVKMKESDEAQEEVQKKKSDKKEEAKSKLG
SRTNPVPFKKTVTVEDELYNDKGESFPIKFDLTVLEVTRGEDAYQKLKSMNEFNEPAPDG
YEWLLAKTKVKFTESATKDLSLYIDGIMNFEMVSENGDIYSGDILGTTDPEFSYEMYVGN
EKEGYISGLVKKGEKAQLRYEEMLGGNVFLNLQ
>PK3-045_00744 hypothetical protein
MFVWLDDSFISEKRPRPVDYWSGNNWSWHLWNLGTTKCHSNTISTILHRNKLHLGISRI
>PK3-045_00745 hypothetical protein
MQTTIALNKKQATFHLWTMTFSNFISSFGSQIYSFIVSFSILQLTGSASSFAMNLLCGVL
PRIITAPFAGSFTDRFSRKKIVIFSYIATSLTIFIMLISFLTLGLNLPFLYLGTALFSLT
ATFSDIGFNASISGLIDKERIQRSVSLNSSVDSIAAIISPVLGGVLYQFIPIYTFLVIYM
ITTVIVIILQLSMNFNLYSIEKAIKETGKKETIWQNMHAGLLYVKTKPVIISIVSFSMVA
NLLGGAFGIGYSFVLINNLSMSSQVFGLIESAFAVGMLITSIYLSIRPEINYPLLVTKFG
ANLMGLILIIFALPILFHLSSIFLLIYYFILMLLLGVIQIFVNTPINVMLQTEVEEEYKG
RVFSIIRTGAQSLVPIGAILFGFLFDWLPAYWVFGISGLFLILTSLYFARPTIVRQVYPD
YVGRGKQENSTTVNNSKLFYVKKRD
>PK3-045_00746 hypothetical protein
MEKQEMEIAKVFFDEKKRSILHSIEYEAKAIKHIAEEMKEKQSRLYYHMKKLEELGLVEV
VKEEKLGNIIQKYYKAAEWTRKVINLSPEDLHNNPDMLNNLYSYINRAIDALKQTVEDPS
KDRKGVANLITEVAIPKTEWNNLNEEIRQVFLKYIDAHKNNEEKVNLSYLIMSYIEETE
>PK3-045_00747 hypothetical protein
MKIKNTFSVLACMSFLMLAGCNNNDHEASDMNMDRYNDSTISSLKTNVNSKKYPHTQPVK
IQNAKYEFRTIVGTYDSNNPNATNKQQVQKATPQQQQPQATEQQQANQGAQPGAQSAPQT
TPNNTAKKEPSNFVSEVIDLTNAERKKQGLPALQAYPELNNVADMKAKDMNDKGYFSHTS
PTYGSPFDMMRDFGITYESAGENIAQGQRSPEEVVNAWMNSEGHRANILNDKYTHIGVGF
DEGGYEWVQMFVKK
>PK3-045_00748 Polyisoprenyl-teichoic acid--peptidoglycan teichoic acid transferase TagU
MRTRKSKKKKIWITLGVIIGILVIGLGSYVFYLYHSVEETANKMYNPLEGDSNLEKKARE
EKLDNTKPISILLMGVDERKGDVGRSDTLIVMTLNPNKDKMQMVSIPRDTKTEIIGDGRV
TKINSAYAYGGVKMAKDTVENFTGVKMDYYIQVNMEALSDLVDAIGGITVQNDLDWIDEG
YYKKGYHYKKGTLTLDGPQTLGFVRMRHLDPNGDFGRNDRQREVITAIIDKATGISTVAH
FDEILDALGVNVKTNITFDQMMTIQKNYRDVRKSVEQYEVKGQGTPPGQTYYLNVPEEEK
TKVHDMLSENLQ
>PK3-045_00749 dTDP-glucose 4,6-dehydratase 2
MARKKVLVTGGAGFIGGNFVQYMVNKYPDYEIYNLDLLTYAGDLIKHKTIEGKKNYHFIK
ADIVDRDTILALFEKERFDYVTHFAAESHVDRSITNPEIFVRTNVLGTQVLLDAAKTIGV
TKFLHVSTDEVYGELDFDFTSFFTEDSPIQPNSPYSASKASSDMLVRAFHHTYGLPINIT
RCSNNYGPYQFPEKLIPLTISRVLNDQKIPIYGDGKNIRDWLHVFDHCAAIDLVLHKGEN
GEVYNIGGHNERTNLEVVRTIINILGKSEDLIEFVPDRLGHDKRYAIDPTKITALGWQPT
FTFQTGIAQTIQWYK
>PK3-045_00750 hypothetical protein
MANLNIPISVLNLAPIREGQTSKEAIESMVDLAQATEKMGYKRYWIAEHHNTSTLVSSAT
AILIKHTLEHTDSIIVGSGGVMLPNHSPLVVAEQFGTMATIYPNRVDLGLGRAPGTDMLT
ASALRRSQKDSVYTFPEDVNALLTYFGPEEDQGYVKAHPGVGTNVPIYILGSSTDSAYLA
ASLGLPYVFASHFAPRYMADAIKIYRERFKPSKYLDKPYMVVCLNLIAAETDEEAAVLQT
STHQFFLNVVRGTQMPLQPPVDSLDGLWNPQEEEMAKSMSSVTLLGSKDSVRNQLTAFQE
RFNVDEIMAVSYIYDPEKQKRSYEILREVVEGK
>PK3-045_00751 hypothetical protein
MVKNEDLKNKTVDRDFKITEEQKEKQQEKKKEDKEK
>PK3-045_00752 Transcriptional regulator ManR
MKERTKQVLKRLLTANTYLTLEDLSNEYHISQRTLRNELMIINEFLQSNNYSLVTTKRGK
GMQLTLAHRDAQTLLERMNAEGTKEYYHPDERFLVLLLDIADTSKTTLLYEMEGRLQVSK
STVDEDMRKIRQYLKKYGIQVVSLSKQGVVLQGDERSIRSMLFDVINNRTDFDYITLSSR
MPKEINFETRLVLNYLERERIKIIAQLYNQQLKQLNPDVNPLYHNQVILFLAIWIRRIHD
GNTISDTVKGKRELTEGQIRDFIDHICERFKLYPSLSEMKYIAFTIESFDSKDMSNSLDW
VTAQLLTIQLITHVEKVTLIPFSLEEEDLYEGLYKHITGLLSRARNDIKVFNPLKETIKE
SYSWIYQAVAGFSNHIESYIKKPLSEDEIGFLTIYFSTSTSRMKQEEQYIYQAVVVCNHG
ISTGRLLAANLKEQFNIEIVTVLSSYELSFIDKLDVDIIFSTIPIEYSKKPSLLLNPILR
ESDKKEIDAFLEQNKEKRRLVSNERDATKMLQDILTLMEACGAKITAESYLNLVDTFKQH
RLKFNTREIQPMLQDILRDKNIILHQECEDWKEVIERVSLPLVKEQVIEARYIEAMIHSV
EEYGPYIVIGKNLALAHARPEDGVNELGISVMTLKEPIMFGNEENDPVKIIFCLAAVDSY
SHLNIMKSLVDLINDKQKVERLIHADNLAIFKQELFEKNSCNKNGLC
>PK3-045_00753 hypothetical protein
MKKLNILFVCGAGLGSSFACQMAAEDVLNKLKVNAKLDHSDISSSAAAKPDIIITAQNFQ
TQFEKFTIDPAKTHIIYLKNIVSKQEIEEKLTPILREKGVLS
>PK3-045_00754 Ascorbate-specific PTS system EIIC component
MSVINFIIQNILTQASITVALIAMLGLILQKKSTGQIISGSLKTLLGFMVLSAGSSIIVG
SLLYFGEIFTEGFHMQGIIPSIEAINGQAMNELGLGRDIALTFLAIFVFNILIARFTRWK
YIFLTGQAILWMATMTTVFGYFAGLRGLALILVGGLIGGIFAVAMPAIAQPFVRKITGMD
EIALGHFCTIGYVFEAGVAKVFGEKGEKKKSVEDIKLPSQLEFLQDTYLSLMTVMVPLFI
ITAIFAGEEFASTFSGSTNYIMYAFLQSIQFVVGVYVLLSGVRLLLGEIVPAFRGIAMRV
VPNAKPALDCPVLFPYSPNAVIVGFITTVIGSIIAMFVLPVFGLAMILPGILTAFFAGGT
AGIFGNLTGGRRGAIIGGIFHGFFITLLPALLVTIFNSMGFVNATATDVDTVTVALLYAW
LIGPLMKAF
>PK3-045_00755 hypothetical protein
MWFKRKSEINKNENTISKKKLTEDQKEELLGFISRKSIEVQSLNIENQARVFEEIGLAYY
ELGDEENAIASLEKSLQLKKTIGESFKTLLKLYNKKRAEAAKSNDVDNLQTFLNKIDLLM
QISKDVTRGVK
>PK3-045_00756 D-tagatose-1,6-bisphosphate aldolase subunit GatY
MYTTLKEVTRKAEALNYTVGAFNAHNLEMLPEMIRAAKEMGAPIIIQTSIDTAKYIGHEN
IVAVCKSMATKEMVDVVLHLDHARDFNDIKEAIDKGFTSVMFDGSHLPFKENIMKTSVVV
EYAHQHGVSVEGELGTIGGTEEGIHVEESDKIYTDPQDALKFVKATGVDALAIAIGTNHG
QYKSKTDVNIPLLKEINRLVDVPLVIHGGTGVKENDIHELINNGIRKFNVGTELLVTWTK
TAKKYFDETKENKSLRHNIIPCNEAVKEIVKHKIEIFMNKEGAINNV
>PK3-045_00757 hypothetical protein
MNGVLILLAGYPGTGKTFLSNIIKKKLGGLVRISPDDIKEDYFDRYGFRNIKEKQQIERI
AWEKYYEIMEKQMKRDNGIISDYPFSNKQKTYLEKLSGNYNYKVITIRLIADLDILYMRQ
QKRDLDPTRHLSHIVNSYKKGDYLTNREKADNLLTYEEFIERCKTRGYNTFNLGRLFEVD
VTDYTNVNYTDLIDNVETYLSLE
>PK3-045_00758 30S ribosomal protein S14
MAKQALINKQKRTAKYKVQEYTRCEQCGRPHSVYRKFKLCRICLRELAYKGQIPGLKKAS
W
>PK3-045_00759 hypothetical protein
MAENKGKSTSNKTQLNMDNPEQYPTENESLFDKFEIEQTVDPIPMEDLKEEQREEKEKHA
TKNTSSSEKKYKTGM
>PK3-045_00760 NADPH dehydrogenase
MKDLFSPFSYKGLELKNRVVMPPMCQYSVEKKDGIATDWHYVHYVSRAIGGAGLIIIEMT
DVEPDGRITDNDLGLWSDEQIAPLKRIVDACHQYGAKVGIQIAHAGRKAEDAPQPVSASA
IPFDDKSKTPRELTTEEVKEMVEKFRQTAARAIKAGFDTIEIHGAHGYLIHQFQSAYTNK
RTDEYGQDLTKFGVEVIKAVKAEMPTDMPLIMRVSGKEYVEGGYDIEDSVAFSKKYEEAG
VDIFHVSAGGEGPIAAAGRPGTHVAYQVPLARAFKQELNVPVIAVGRLDSAELANSVIGN
EDADLVAVGRGMLRNPYWTIEAATQLRKETEMPKQYAVAFPKR
>PK3-045_00761 putative metallo-hydrolase YflN
MRIIHHNYLYQLTFLPRIFPVNCYLVEEGEELTLIDTALPFSYKKILAFAEKLNKPITKI
ILTHAHGDHIGSLDALKERLPDVKVYISVRDARILGGDHTIDKQEEPFVLKGGLPKNIKT
NPDVLIKEGDQIGSLISISLPGHTPGSFGFLDKRDTSLITGDAFHTRGGFAISGQFRSFF
PFPAMATWNKEKAIESAKKVMSLNVSLLATGHGDLLENPQPLIESLLQKERG
>PK3-045_00762 hypothetical protein
MTPRAGITHNDIIVTAIEIANTEGLKEVTIANLAKRLRVKSPSLYNHIKGLPDIMNLLTL
RALESLYQLLKKAIMEGEKAETIHNLSFAYLTYAREQPGLYMLTIESASKKGEEIQTAAN
QIIQLLIEVLKPYDLNEEETIHAIRGLRSILHGFASIENQQGFGMPIEVDKSFHYLVSTF
IEGLEKHS
>PK3-045_00763 Transcriptional regulatory protein YpdB
MLIRVMIADKDKRVIARIRYYLKDYKDIKIIVMCDNGNDLVYQYKKWKPDLIITEVDLPS
MNGLEVMKQCYQLGDQIHFIFLAEDEKHALAALELDAIDFLVKPFRSFRLSKAIEKAKRV
IASKRERYSFNNLPVKYNKGVYYIKKEEIYFIEKIGKKCVIYTDAEIVETRENIGELLPQ
LDDTFFLSHRSYIINLEKVTEISPYKETYIAYFDGVNRQAKISKLKINEVKERVSLFL
>PK3-045_00764 Cyclic di-GMP phosphodiesterase PdeF
MDIITRLKSKKFYHVYQPIWNIKEWKIIGYESLLRISQEPDISLEAFFADARKENYLSEL
DTFLINDTIEHYQILSSRRKKPLFINIFPSTIIHESFESLILSLLEKFPAMNGKIIFELN
ETVLEEELWNSPLFKEKIAFLKDNQFQIALDDFGKGIANFEKILEIAPSYLKLDRYFSNN
LAFSAEKQKLVHLLLDFADEKMKVILEGIEEETDLAMTKALKVPFGQGFLLGKPEMLV
>PK3-045_00765 Transcriptional regulatory protein YpdB
METLTIAVACIDSPINSSIHHLIAIHSSFKIIGEAKTGEELLELIYRAKPNIIIVDYDLP
SIHSTIFNSAYKDYLPDFQLILVGKDKRMAIEAFNYSAVGYLQKPIMESSFLSLLYKIKD
SYSKSRRQIHTGKGKRILIKLSNRFVYIPIEEILYIEIIARKTMVHTIKKSYETSETFLS
FVDRLPWYFYRTHRSFLVNLKKIVRIELFGESYLAYFSGTDKRANISKLKIREVHSLLIQ
>PK3-045_00766 Iron-uptake system permease protein FeuC
MSSLKLANKKIYIVSTTLLTALVLVFILSLNMGTIKISPMEMIEAFTGKGTVQNFNILYN
FRLPRSVIAVLIGMSMAIAGAILQGVSRNSLADPGIIGINSGAGFAVILYIFFIQGSAFQ
AGPLSVYIMPFFALAGALMAAALIYIIAWKDGVTPVRLVLVGIGINAAFGALIIIFQLMM
DPRDFTQATIWLSGSIWSASWSYVLALLPWILILVPIAISKFQSINLLQLGDNLAKGLGV
SIERERGLLLLLAVGLSGACVSVGGGISFLGLLAPHLARMLVGPKHQRLLPIAALIGALL
LLTSDIIAKSLMVGSEIPVGLVLSCLGAPYFIYLLIKE
>PK3-045_00767 Iron-uptake system permease protein FeuB
MSKSNSIENDQAAIFRPKAATLVLIIGLIMLFFSICMSIILGVADINLSTVIQGLFHFDN
TSTAHQIVYRLRLPRALAATFIGASLAVSGAIMQGMTRNALASPSIMGVTSGAMFAVSIA
FAFLSAVSNMTIMLFAFIGAGLGAALVFLIGALSKRGLTPMKLALAGTAISAFLGSISTG
IALRFDVAKDISFWYAGGVAGVQWINVKLLIPVAILGLILAFFISKSITILSLGEDIAAG
LGQKVGLVKLLGTIVVLLLTGAAVAVGGTIGFVGLVVPHIVRFIVGSDYRLIIPCSAVVG
ALLLVLSDIVARLIHPPFETPLGAITAVIGVPFFLYLARREGRGL
>PK3-045_00768 putative siderophore-binding lipoprotein YfiY
MNNRKMKSVLFICLLLVFTVLAACGNNSKENNNKENGASQETKERTLTDAIGNEVKVPAE
PKRIIGSYLEDDLVSLGVTPVAQWSIREGKGVQAYLQDSLKDVPTIDSSLPYEAVSSFAP
DLVLMSSGAQVEGAKYDQYAKLAPTYVVSKENNNDWRKRLQTIGEVIGKKDEAEKVLADY
DQKAEDAKGKIQASIKDESAAAIWLVSNKLFIVGENVSSGAVLYGDLGLKVPEVVKEISA
TATGNWSAISLEKLAQLDADHLFLINSDGEGAEVLKDSLWSNIPAVKKGNIYEYGPDTSW
LYSGPIANTQIIDDVVESLVK
>PK3-045_00769 Beta-galactosidase BoGH2A
MRNYKISNWLFFQGDDSNAWQKDYEDKSWQPVTVPHDWSITMPFSKNNSSGTGYLPGGIG
WYRCHIPLTDFTNIDNSVVQLTFDGVYKNAQVWINGYNHGIRPSGYSSFTFDLTEILPYT
PDNELVIAVRVDHSDIADSRWYNGSGITRNVWLEIHDYIYIPKYGTTFSTLETKTDVSNI
RIQHLITNTYPAASDVRVVNELVSIDGEQTYCFEKKVKLNPQETSNITFNEKLDNPKLWT
TDEPNLYMLHTHLYYEADDNKVHSAYTNHVGIRTSQFDVNKGYFLNNQNMKLKGVCLHED
AGCFGTAVPVSVWVRRLSKLKEMGCNAIRMAHNPHAPELYTLCDILGFLVIDEAFDEWEN
PKNKWWQGHNVYPPKIEGYAHHFPNWHQDDLKNMIIRNRNHPSIIAWSIGNEIDYPNDPY
ANPLFEEMTGNNDANKPAQERIYNPNRPDTTRLTTIANRLIKTVKSIDDTRPVTLAAAFP
ELSSQTGLLTEVDLIGYNYKEHLYEEHHKMFPNQPIIGSENGHGYSQWKIVRDTSYISGQ
FLWTGIDYLGEAHGWPIHGSAAGVLDLAGNEKTLYFLRKSWWTEEPMIYLVTRPLETNTN
NHSQIKELSKKWDYCIGEKVEVICFSNCEQVEVELNGNRIPLKFDEDFGYFVTYVAATES
PIKALGYIGDKVVAEELAPVLSPAQLKLDIWEIPEIYKNVLQSVFPNITQDVIQIECSLL
DRSGKLSDYSQKVAVSVQNGRLLGIENGKLDDVTDYTEPFRTSNHGKLVIYVQKNGDSET
QVKVETDGIRNTLFTLKTIN
>PK3-045_00770 Unsaturated glucuronyl hydrolase
MDKWIKEASAFIERKTTKNAIDIGASFPHATKQGKYDKESPQWWTAGFWPGILWNVYHAT
NEYAFKNLAIQLEHKMDYLLNNPNKVDHDIGFMWTLTSLARYQITADETAKNTALLAANM
LLARFNSAGHFFKAWNNWHGTNDNSGIVIIDSMMNMGLLFWASEETGDPRFMVAAKAHCD
MVLKHFIRNDGSVHQMVRFNSLTGELIEKLGGQGYSKNSSWSRGCSWAIFGFAIAYHYTK
EERYLSSAMKVTNHFALHLQHDPIPLWDFRIPSHTDGTKYDYRDSSASAIAACGTLLISQ
YAPLEEKRFYLAFGRDLLKRLYEHAATIEDDQNQALIIHGTSHWPEKKNLDTGLIYGDYF
FTQGIYALNGINNNFWLGDSWNVL
>PK3-045_00771 hypothetical protein
MLKLSISDKYGNIKKGRNDYEEESHNLESAGDTMCYIASQDFIFEEGDEINIFVAQKNQY
LMVKLDESLDSTIVFIPSHSWTYRINMEQTAKEAMPDHRFKSKRHYLGVRYATNEEIRRY
QNWALNPHDQKEFSGAYPHASANVETRNDATFFACNAINGIYANNSHGSYPYQSWGINRQ
SDATLTIDFGRLVEVDKIGITIRADFPHDSYWTEVTLLFSDASSETFSLQKNTSPQFFYF
KKRAVTYVQLTNLVKAEDESPFPALTEFEVYGINKL
>PK3-045_00772 HTH-type transcriptional repressor MelR
MATITDIAEKAGVSISTVSRVLNQDKNLSVTEDTKRKIFEIAEELNYTKYKQKKKKSAEQ
KAKQKSIAIIQWRIGEQELDDIYYMSIRIGAERKAQELGYYLMKYSDLNDSLSNVDGVLC
IGKFDKITIDKILSKNDNVVFVGTNFPLNNFDTVNSDFSYAAELALQHLLELGHKRIAFI
GAEESNNLYGYRTYRTPVTNTYIDMMKHLGYYDEKYFFVATNTYLSAETGTDLARQALAK
WGGNLPTAILAGNDAMAIGIMNVLTANNIKIPADISIIGINDLAFSQYTNPPLSTVRIFT
EEMGEIGMETLNQRISAPKIDRRIILTTELIKRASTAKPRE
>PK3-045_00773 hypothetical protein
MTRRKWLEAMDKIAYPVIKALSEEKLHQELPTDFHPDRKSYGMLEAFGRTMTGIAPWLEL
DSISESSERKMQKRYRQMVLLCLDKSTNPYSKDYMNFTDPGQPLVDAAFLAHSIIRAPKQ
IGDALPKYVRENIILALKSTRRTMPPNMNWNLFSAMVEGALYVLGEKEYDLLRVIYAIRL
LDDWYVGDGVYGDGPVFHWDYYNSFVIQPMAIDLLNLFYHQSKELENYREKMLPRFIRYA
AIQERMIGPDGTYPVIGRSSTYRFGAFQALAQSALQHALPATVTPAQVRCGLTAIMEKGM
QAPGTFDEKGWLLPGVYGHQPALAESYIGIGSLYLCSAVFLPLGLSEEDAFWNDQDEEWS
SKKIWQGKEGAIDQSI
>PK3-045_00774 hypothetical protein
MKITLSEESLPILEAIASSVRIKIIKLLSTKRMNVKELAHELGLSNPVVAKHIKILEESG
VIKTEKIPGKAGLQKQSILKVDLIEIEFPKKIFQAFEFYETSIPIGQYVDYLITPTCGIA
SIEHLIGEYDEPKYFMDTDRFNAAILWFTTGFLEYKIINPLKNTDKLEMVDINLEISSEF
PGGNNVWPSDITFSLNNVEIGTWTSPGDFVDTKGKYNPDWWSPKLNQYGTNLKIRITDYG
VWINGKQLTWISFNRLALEKSVWSLRIEVKEDAENVGGCTLFGKGFGNYNQNIDFKFYYT
DKEEPF
>PK3-045_00775 Putative ABC transporter substrate-binding protein YesO
MKKWKKLGFSVLLASTTLLSTACAGAANSDADSGDGKTTIEFMHWGGDETFEGVYQERIE
NFEKENPDIKVKTITVADDYDTKLQTMIAGKQAPDVAQVAENGSGFASKNAFIDLTDKIK
EANIDIAATWGSAIDLYTLDNKIFGIPDRGGSSLLYYNKVLFDEAGIEYPNENWTIDDYY
KAAETLTKDTNGDGEIDQWGSTAGDYQLIWGNFLRANGGAVIEDGKVVIDSAENQATIKA
YDEAFKKWSVSYQIAEDKVNRFQAGLVGMNMTGFWDMNSNAKVIGDKFDYGIAPMPIGTE
KTSWSTGSALTISTQSSEKEQEASWKFIEYMASEEAQQLVGKGLYDCPANLKTLNSDEFL
NQKVEGHEIDLSAIPVAQERVVIDELLTGPWYSEATTEARAKIKEMLLGNLTPEETLSTL
QKNLTDIVAKY
>PK3-045_00776 Diacetylchitobiose uptake system permease protein NgcF
MEVKLAESTMSKISSKEHRVKMNRRWFFIFISPWLIGFLGLTVGPMIYSFIMSFTDWDML
TKMEFVGLENYINLFKDQIFLLSVKNTFIYALMSVPVSLLVSLGMAYLLSFKLKGMRFFR
TLYYLPAIVPIVASSILFTNILAANGLLNKVLGYIGIDGPAWLLEKGAVLYGFVLLALWG
VGGTMVLLLSAINSIGDEMYEAAMMEGASRLKMFRSITIPLISPVIFFNLITGIIGSLQT
FTQVYLLTDGGPDNASSMIVPYLYKNAFSYYRMGYASAMAWVLFAIILVLSLIVLRSSKM
WVFYEEEVK
>PK3-045_00777 L-arabinose transport system permease protein AraQ
MLDRHLNLPKKIVVYLVLCFFGFILFAPFLYMVSISLASPETNIIQNFTFFPKEFYWRNF
IELFSNIFGGSRPIGLWFLNTMFVVILSIIGQIFSSSLVAYGFAQMKYKHKNKYFLLLLA
TMMLPAQITLIPVFVIFRNLGLYNTLWPLIIPQFFASAYNVFFTRQFMTAIPGSLYEAAE
MDGLNNFGIYRKIVLPLIMPALAAIAIFTFNHAWGDVMGPLIYISDSSKFTLALGAANLS
ASTNPTGTLNTSLVMCLSLLLSIPQILLYFFGQKYLFQLKLGVGSSGTK
>PK3-045_00778 hypothetical protein
MKKDEWLYRLYHYSSYFNYIIWLFEMNMLFLLMNLPFAVLIFILDIRLGTLPILYLSSVT
LVPSTYAVIRTLKDVTTEPKVMKNFFIHLKIGYKRLLKLSLILLFFLWIMVGNIFITAQL
PRLQVLFWLNILFLLVLITFTINFLIVMANWKQTIKETAILTIKLAIVKSIRSNLNFLIL
IGTFILLKLFPIYLLMFGASVAILLCMINFKPVIDFVNREIEEAA
>PK3-045_00779 Alpha-galactosidase A
MTFLYFAKTPPMGWNSWDCYGASVREEEVREHALFMSKHLKSYGWEYIVVDIQWAEPAAK
STRYNQFFPLNMDDYSRLIPAENRFPSSSNGQGFKALGEYIHQLGLKFGIHIMRGIPRQA
VHQNTAIKGTDKRARDIALNNICPWNSDMYGVNVDLPEGQLYYDSLIELYASWGVDFIKV
DDIAYSRLYDDAHKKEIAAIRKAIDKTKRPIVLSLSPGPAQLKNGTFLQDHANMWRLTDD
FWDHWDALYRMFDRAAEWVSYVRPGNWPDCDMLPLGHIGIRAVDGGGGDNWTRFTKNEQY
LLMTLWTIFQSPLMYGGTLPDIDDFTLSLFTNEEVLDMYRTLTYRRQAYRDDNWIVWEGR
SEHNEYIALFNVGDSNLEIPSELSNRFIGANKVVRDLWGNKDTCLEKQIVNAHGAILIRK
>PK3-045_00780 Beta-galactosidase
MKRFEIKDDFYLDNQPFKIISGAIHYFRVVPEYWLDRLEKLKALGCNTVETYVPWNLHEP
HQGIYDFEKRLDVRKFIQLAGDLGLYVILRPAPYICAEWEFGGLPYWLIKDPSVKVRFEN
PKFMEKISSYFAHLFPQVVDLQITNGGPIILMQVENEYGGYANDKNYMERMADMMKSHGV
NVPFVTSDGPWGDMLENGSIPETALPTINCGSKVKEHFKRLRAFHGTKKPLMVMEFWIGW
FDAWGDVIHHTTDAEESAHELADILEEGSVNIYMFHGGTNFGFTSGANYYEKLAPDVTSY
DYDALLTEWGDITPKYRKFQEVIAKFTTIPEVRFSTEIEKIAYGELKVRAKTSLFHNLDK
LSKRFHHNYPLTMEELNQGTGYIYYQSQIGKARPIEDFRLIECMDRAQIFINENHIATQY
DLEIGQKLEFELTEPKNQLGILVENMGRVNYSVKMNHQEKGIRDGVIINGAFQSEWDIYS
LPMDNLNKLDFEATWQSGQPAFYQFTFNASTIGDTFIDLEGWGKGFITVNGFNIGRFWEK
GPQQRLYIPGPLLKQGINEIIVFESEGKVGESITLTDLPKLSKD
>PK3-045_00781 hypothetical protein
MIINSNNLMKIAALTFITLFSQYFIGQEVLAKENSIDDALIASFHFDDPVNGIVGSGAKA
EVQGNPVYVDAPRGKAAKLSETFWLQVKKKNGKPLLKSKDEITISYNSKPEGGNGWVFYA
SSDEKTQSYQQERYLGIMDKTSDVIVERYYNKGARPGNNLSAPSSTSWKHIDLVVNKNRT
TIFVDGIQQDTKESTYKLKDILSETGGIIQLGKANWGNGEYFQGLIDDVKIYSRALTEEE
IETSYLASVKESLAEIYNEYKDTEKGTFTVSTWNNITRALTNAEALLAQEQITIQDINRA
KAQIEQAFQYAAHVRETVDYSELGIPVGDTWLDTEGNHIQAHGGGFLQQTAPDGKPIYYW
VGENKIHNSANFFAVSLYSSRDLVNWQNEGNILDQFSETVPGAELGLQYSKVERPKLLYN
EKTKKYVLWGHWEDGSGYSSSQIMVATADKPEGPYVFQGHWRPGGTERNWRNNNGWYTDE
EYFKAGDREQIPVSEQNDPQKYGYVSRDFTVFQEGDTAYLISSEGHSMRIHRLNDRFDDV
DFTTYPFSSSDSKDPVFESYNFYEGVGREAPAIVHVENDGYYLVTSGQSGWLPNQSTVGY
TNDITNPDGWTPLKGSDGLILEHAALGNNSTYYSQSTNIMTITKQDGTKQYVYMGDRWNS
KQLGDSRYVWLPLTIDRENHTASMKYATGWKVNVEDGNISLPEGISLVSQGKTAYGSNEE
DLERPIELANDGYDFNLRTSGDNTHWYRPGNAPFDYTVDLEEAYDLSRIDIAFRLYNGSE
MYYQYKVYGSNNNENWVEIADESQNTWAGFKSTPLKGKFRYVRLSVSAIKRVNDNSNGNW
ANGLVEVQVYAKNDKENVTKAE
>PK3-045_00782 hypothetical protein
MDTITHTLFGIGIYKSVNKEKMTRKEKYALLVTSIGASQIPDIDVISQLWDTTGQYQMWH
RGITHSIFLAPIWALIFYMISRFAFKIKGFQSFYIALLAVFIHNTSDVFNAWGTGYLEPF
SSVRLTFGTVPIVDLVIWFIFLLTFIGSKVYPKVNPHVLFRIGWILIALHVAIQSLQGAI
LFQNYKTDYQDVALSASFIPWHFTIIGKNADTVDIINDSLLTKAKFVDRLTSSDEVDLDY
LFAENPAAATLYRWSPFVVVVDDDNRIGIYDPRFYRNGESFLGEYLDK
>PK3-045_00783 hypothetical protein
MNRILWATFIFVVLFAGLAIGSSLEVLNPTTINGIFSILLSVFIMFLLDSFLHLLSNSET
SWKKKHYKSLLEWVDDGGNGGRRLEQNLLKDIKPKYNLLDNLELIKQAFTKLEKEKRELL
LAYFKAQRNSVSLPATIMAIFSTLFAGILLYFIQHPGIFRIEISVNADFAFIVQLFTWIF
FFIIVMYHLVKMNKRASTKNELFIEILEKLKD
>PK3-045_00784 Adenine deaminase
MQVDTLVLNGIVFNSYFKQFRKENIAIKDGKFFYIGKKGREFFQAKETVDADGNYIIPGL
IDIHLHIESTMVTPATFSYGLIKNGVTTIVPEPHEMANVFGIAGVKEMIKASKNEVVDMF
YGIPSSVPATAMETTGGAIEIEDIEELLQTESIKCLGEIMNYYDVLTKPDCKTNQILDFV
RSNYPELIIEGHVPKLLDDELQGIAFAGVGSDHTHQTVEGMMERIAIGMFLEIQEKSMTK
EVIDYLSANPVKEHFCFVTDDVMADSFQRRGHLNVLLKKAIAMGMSMEDAIYACTYTPAQ
RMRMYDRGVIAPSKIADFVMVSNVADFSIDAVYKIGQKVFDRDLPYVQRAVSKQFPASFY
ESVKLAPLKAEDFEVPIETKKKRVTVRTIHVQNGSTFTEERQDTLAVEEGKLQWMNSAYC
LVKTFERYGKNNNQAHGLIGGDILKKGAVATTYSHDNHNLLVVGKNKADMQLAANEVIKN
QGGICCVYNGKILSMVPLPVGGILSEEPLEVIASQVEELTDALKSLGYEHYNVIMSLSTL
SLPVSPALKITDHGLIAVNEGKVVSFEV
>PK3-045_00785 Vitamin B12 import ATP-binding protein BtuD
MALFTLENVSVAYEKKNILEDFNLSIEKGQLVSLLGPSGCGKTTTLRLIAGFLEASKGKF
IFEGKDYTKVPVNKRNFGFVFQNYALFPHLSIFDNIAFGLRLRKINKKEIEKRVLNMLEI
VNLRGFEQRFPSELSGGQRQRVAIARALVIEPDILLFDEPLSNLDANLRVNMRVEIRRIQ
QELGITTVYVSHDQEECFSISDQVAIMNKGVIEQLSDPATIYQYPETKFVADFIGFKNFI
SFDKRTDHKDHIELEKAGLIFKVDRHAHMDNRNKKVGAIRPDDFMMEPSIDAIPTNGMKG
IIKITTFLGRSYQYVVETALGDFTINKEMVQPFKNGQEVTVIIPQNQMVLVE
>PK3-045_00786 Inner membrane ABC transporter permease protein YdcV
MQEKHRGLALFTILVFIFLLGPLVIISITSFESGSILKFPPEEFSLRWYENIFKVEMFLS
TFKTSIIVSIAGNILALLLGVPAAYALSRFNFAGKGIINAIFVSPILIPGIVLGFSFLRY
IVVTYNLPIYLSLFIGHTVIMLPFIIRVISSSLANFDFSIEEAALSLGANRIGTFFRVVL
PNIKSGIIAAVMIAFLESFNNVDISVYMTGPGVSTFPIQMLLYVENYFDPTVAAISVLLM
FLTAIFMFVVERLMGLSYFTKR
>PK3-045_00787 Spermidine/putrescine transport system permease protein PotB
MKKRYLYLLLLPGVLFLTIFLVIPILSMMGTTFNDGGSFSLQGYIDFFKDKYFIDILLTT
LRVSLLTTFICILIGFPVSYYIAKLPSKRKAVLLLFTIFPLLTSPVVRSFSWMIIIGKNG
VLNKTLLSLGLIQEPLNILYTPNAIIIGLVHLFLPLIIVTLVGVMENIDNDLLRAAESLG
ASKMASFMKIIVPLCVPGLVIGSILVFVGSFTAYTTPALLGGKQRVISTFLYQNAITLND
WKLASIVATIMIICTFIIISIMNGVAKKLNPKG
>PK3-045_00788 Pyrimidine-specific ribonucleoside hydrolase RihB
MKEKLILDVDTGIDDAIGILLAVKSKAFDILGITTVNGNVSLDQATTNTCKILDLVKADH
IPVIKGAATPLVRAPFFEHRIHGEDGLGGALKETAVTHPVSDGFAPDFLINSILSFSGEV
TLVFTGPLTNLALAVKKCPQITNHVKEVIFMGGVVKGPGNVTPTAEFNSYVDPEAVKIVL
HAGFPAITQVGLDVTRKALLTKDHLHLITDKSLQDYIAQSTNDYQQKYFNRYGVHACAMH
DPLAVGIALNKGLVQTEKYFVDVETRSELCDGQLVCDFQNRLQREANLHISLQVDADAFF
QMFIDILNGHFEERE
>PK3-045_00789 hypothetical protein
MKMKKLVSAVAASSFLLLAACSSDDTSNSKEKKEKLVVSTWGFNEDFFRSEIYAPFEKEN
NVEIVLDTGNNADRLNKVRQGNSDVDVIFLSDYYAQQGIEDKVFETIDRSKLTNLDNIYE
TAKAPLGEEYGPAYTIAQFGIAYNPDEVAKPVTSWKDLWSADLKGKITIPSITSTTGPMM
VDVASLVSGEQTFSEDKAFKQLKSLMPSVVKEYGQTSEYVNMFAQGEIAAGPIMEMYFAD
LKEAVPNAEFITPAEGGYAVMNTVNIVKGSDQKELSEKFINYILGKEAQEKSAKNKVDSP
VNTQVKLTEEEAQGLTYGEKVITSLHTLDMKFINDNLKGWIDRWNRELVQ
>PK3-045_00790 hypothetical protein
MKRFLSQVYNKISKDLFGAGTTLLKVTIDQNVITLQAKHPRAPRSAALEGEVPSLKQEVD
FHLSLLFKKKLKEQLEETTNWNIEAILRDYDSFTQLAFTNIVLTKH
>PK3-045_00791 High-affinity gluconate transporter
MAAGLEISWIGALCGLALAIILILFKLAPTYSLILGAIVGAFIGGANFSETITILVSGTQ
SVQGTVIRIIAAGVFAGVMMESGAAETIAKFIVDKLGGTKAMLSLALATMIITAVGVFIP
VAVLIVAPIALSVANKMGYSKIAVLVALSGGGKAGNIISPNPNTIAAAGGFELHVNQVMI
GGLIPAIFGVIVTVVLASLIKYKGTKVTDKEAEELENANTSNLPSLSKALITPIIAIVLL
MISPIGALLGIDVLTKLNIDSLFILPFAAVVGTLALGKKEKLLDYCTAGLNRMTPTILII
IGAGAIGGLITASDLPSQVVALVESSGISGTFLAPIAGTLMAAATASTSTGVILATGSFS
EAILNTGVAPIAAAVMTHTGATVIDHLPHGTYFHVTRNAMNMSMADRMKVAGYESIVGLT
MTIVAIILYGFIL
>PK3-045_00792 Glycerate 2-kinase
MGKTFLLAPDSFKESMTAKEVCVAMEAGIKRAIPDAECIHVPMADGGEGTVQSLVDATGG
TLVIKEVTGPLHTPVLAQYGILGDGKTAVIEMASASGIHHVNKETKNPLITTTFGTGELI
RECIEQGITDIILGIGGSATNDGGTGMAAALGYKFLDKDGNELLFGGGYLNELNTIDCSH
VNPQLKNVHILVASDVTNPLCGENGASVVFGPQKGATPEMVQILDRNLRHYANKVKEYLR
IDIVDTPGAGAAGGLGAGLLAFTHSTMKKGIDIVIEYTNLKEKLKAVDYCFTGEGGIDFQ
TKFGKAPYGVSQAAKSVNRDIKVIALAGCIGQDVEVLYEEGFDAIFGIVPGADSIDTLLA
QGKENVARTAESIARLLK
>PK3-045_00793 Carbohydrate diacid regulator
MYELTPKQAQKIVNKMMKDIPYNINIMDKTGIIIGSGNKERIGTLHHGAVAAIKQKRIVP
IEKDEEFVKKGINLPIEWNESILGVVGISGEIKETSPFGKLVKSTVLLLIEQSIASEKEN
RRKNVKQEFFNLLIDPNTIYTKDLIDQASSYNVQLNKPSQLVYIEFQKNVDETIVKDFPF
FQPYQNTLCVVVQEPNNMEELRDNLAKYQDIFVSVSKINDKIAEGFLQTKLALKVLKGLF
LHQKIIFYADCEFIADLSYSLQKIKKTALQSDLLETNDELIKTLQAYLNCNMNMNETASQ
LIVHRNTLNYRLNRIYKITGKDPKNILDLLELIFMLISRIK
>PK3-045_00794 hypothetical protein
MLVINELPIEVTKIYPSSSFKGLEILFRIENHDYHLEY
>PK3-045_00795 hypothetical protein
MLEVKVTKNDNKLQIKWQLCTIEIPLSDITAVANDETYAGKEITGIRIGFPYGNTDRVLI
HTKTDHYIIFTSSGNLKDKITDLIKEE
>PK3-045_00796 hypothetical protein
MKNVFTIYRNDWIRIFKAPIAALLIVALMVLPSLYAWFNLAASWDPYSNTSGIKIAVTSE
DDGAVIRDSSVNIGDEIISSLKKNDKLGWEFVSKEKAKEGVTKGEYYASLYIPHDFSAKI
ATILEDKQVKPEIDYSVNEKLNAIAPKMTSTGASTIVQQVKENFIHTVSESVLGVFNDAG
IKLEEELPTIRNIEEKIFALEKEVPKINELGEKVVTLEGKLPEINKQAQKILTLEAAFPD
INEASKNILLLEEKLPELDKVGEGILVLQEKAPEIQKLADGVIELDAHFADISEMVTKAL
SNVEDMQSFLETASGSLEKIQQGINNGKQLADTLPAFIDANGEALDAVGPVYKQNLLLHQ
KTADAVHQFAGLVQNGNLTEEETKTNAVALQAQVQTSIDSLTRSIALFTTLNSATPNGDE
ALLSEIKNLQALQTNFQQEKELLQTIQAEDKEKASSLLALSQEAIELSTTLVNRYDKQTE
PAIHRALEGIKDSAQNAMNDLESAQANIPKLEEILKNTDESLAFAQEELTKLHSDLPTIE
KKIHETTNLIQKNMDKVLARINDAAEFYQKSFPSLKEKIHAAASFVRNDLPVAEKDISKV
AAFIKTDLPRVEEAVHKAADMVQNELPNLEATLTKTADSIRNFEDEYDLGEIISLLKNDI
QQESDFISDPIVLNENSLFPIPNYGSANSPFYTTLSLWVGALLLISLLRVDVRDPEGIYT
PNQIYFGRWLTFVTIGLCQSLIVTLGDMFILKAYVAEPVAFVLFSMFISLVFMTIVYTLV
SVFGNLGKGLAIIFLVLQLSGSGGTFPIQVAPPFFQKINPYLPFTHAINLLRETVGGMVK
EKVLFSISMLIIFSVIALIIALFLKKPLANGTRKMTEKAKASEIIH
>PK3-045_00797 PTS system trehalose-specific EIIBC component
MSIDKQQVSNIIDAIGGKENISAATHCVTRLRFALADEGKVDKEKLESIDLVKGSFSANG
QFQVVIGPGTVEKVYKELINQTGASEGSKDDVKKASEQNLNPLQRAVKMLADIFIPILPA
IVTAGLLMGINNVLTGEGIFFEQSVVQAYPQWADFASIINLIANTAFTFLPGLIGWSAMT
RFGGSPLLGIVLGLMLVHPDLLNAWGYGSAKEIPTWNIFGLEVEKVGYQGQVLPVLLASY
VLAKLEIFLRNRIPDSFQMLFVAPIALLVTGFVSFIAIGPITFFIGNLITDGVVAIFDFA
PILGGLIYGGLYAPLVITGMHHTFLAVDLQLIGSTGGTFLWPMVALSNIAQGSAALAMLF
ILKDEKLKSLSVTSAISAYLGVTEPALFGVNLRFRFAFISAIIGSAIAGAFISIQAVKAP
SIGVGGLPGFLSIFPNNWGAFFIGMAIVIIVPFLLTILFGKVRKAQ
>PK3-045_00798 hypothetical protein
MVSSLITISLASLVIFGGLFVYYYYSINQEITEERERITNQYKSITSYLDENLEMYSETI
FARYVDGKLTDRDLYEEYYHLLSRKERNIRIRLLLLDKNKNLLFDSEKKEDIRLIYFLNT
VVDNNPLEEKVIRRIFMTPQREHTLLSLKKIKEDSYTIGYAAFLMNGNDFLQNSSGNGTQ
YLLYDNYHNVFSSSSFEFLKGSLEKVSSEVRDGNFQSEEENYYSKHRLLESNMNLIVYKK
LESLNILWRFSFSIVMILVFFLLLFSRYSSKKIAYNNARYVEFISNEMKKVTNNKNYRFK
IESKDEFQFLSENINQMLDELEELNQNNISLLKENVISERKMLEAQFNPHFLYNTLETIR
VATYYDTELANKLILNLNTILRYSISKMNEVAAIKTDMLYIKNYLEICKERFERFTFDIT
IEEQTEEFLIPKLLILPIVENSMKYGFRDRRDLHLSINIVRTGESLTIQISDNGGGIDDS
TLVKVNSNVFKKSGNHHGLYNAKRRLLLMYPNSYFKVKSPGEHTTVIMKIRE
>PK3-045_00799 putative response regulatory protein
MYRVLIIEDEKLIRKWLRYGFDYESVNCVVIGEASDGEEGIELINELKPDIVITDINMPR
KNAFQMLEETKYLIFSKIIVSGYNDFPNAKKAISYDAVEFIVKPINESELKEAIRKAGTM
VDILKLEQKEKQKIDDMIKGLAHSSFEGHYDHLVKQMIQYIEKNYAKKFTFNAVSNELGY
SSSLLYKKFKEETKQTFNEYLNQYRIKKSIEEVQRGEYKIYQIAEKVGFTDYKYFNQVFK
KYTGYTCTEFLERK
>PK3-045_00800 hypothetical protein
MKRYWKMLILVVVGVLALTACSSEEKAGEGASDKLVIYTPNSEGLINATIPAFEEKYGIK
VELIQAGTGELFKKLESEKDSPVADVMFGGTYTTYALHGELFEEYVSAENENVIEEYRNT
NGYSTPFTLDGSVLVVNKDLTKGMDIKGYADLLNPELKGKISTADPVNSSSAFSQLTNIL
LAKGGYDSDDAWNYVEDLFTNIDGKINSSSSNVYKTVADGEMAVGLSYEDPTVKLLNDGA
NVEIIYPEEGTVFLPANSAVVKNAKNMDNAKKFLDFIISKDVQEVLAKSTTNRPVRDDVE
IGENMKPLADIKTLTEDYEYVIQHKDEIVQHYNEIFVDIQSK
>PK3-045_00801 Maltose/maltodextrin import ATP-binding protein MalK
MSFINIEHAKKEYGGVAVIPDLTLNIKDGSLFTLLGPSGCGKTTLLRMIAGFNSIEGGNF
YFNENRINDKEPSKRNIGMVFQNYAIFPHLTVRENVEFGLKQRKLTKEEIQKRTTQYLKL
MQIEQYSERKPEKLSGGQQQRVALARALAINPDVLLMDEPLSNLDAKLRLDMRQAIRDIQ
REVGITTVYVTHDQEEAMAISDQIAVMNNGVIQQIGSPKELYHRPANEFVATFIGRTNIQ
EAKLVSTGDSATIEFENGFNLSFDELASEHSQRVRVSIRPEEYVRTKQNPDTIRGVITDS
VYLGMNTEYFIHLDTGENIQVSEESTFEEDLKAGDEVWLEINKQKINIFTDDGSRNLLGV
>PK3-045_00802 hypothetical protein
MRNKFKFNIWTGSSLFILLTYTVFLIYPVLMILIQALFINGSFSLKYFVEFFSKSYYSET
LINSFKVSISAMFFALVIGITLAYLFSMFQFKGKKVLQVLIIIASMSAPFIGAYSWILLL
GRNGVITKFLVEYLHFPPFDIYGFSGITLVFTLQLFPLIFLYVTGAFKSIDNSILEAAES
MGCTGIARFFKVLLPLLIPTILAGALLVFMRAFSDFGTPMLIGEGYRTFPVLIYTQFISE
VGGNAAFAASLAIIAIVIALVIFLIQKYVSNKNSFSMSSLHPVQPKSMKGFKKLFVYIVV
YGIVFIAMLPQFYLMYTSFLNTKGMVFQEGYSFNSYIEAWDRMGSAIINTIRIPFLALVI
VVIFAIFISYLAVRKRNLFTSLIDSLSMIPYIVPGTVLGIALLASFNTGIGGSGIIAITG
TAFIMVISLSIRRLPYTIRSSVASLQQIPPSIEEAAESLGSSRLNTFIKITVPMMLPGII
SGAILSWITMLSELSTSILLYTVNTKTMTVAIYTEVIRGNYGIAAALSTILTIITVLSLL
IFMKVSKNDSITL
>PK3-045_00803 hypothetical protein
MIGLGLIGLLLMVFALIYFVIYLLKKVRGRNPILSKKIFYFSLIGGFLLMILSASFLDTG
TQGQLQEVEGKNSKLESEVKALKTKAKELEDKVVELESDKEKLSTELSDTEAKLSDSKDQ
DKEFAEYKKSQEEKIANLESEKKELEEKVNNLEDKVAAANTPSSSSTKASNSGSTASSKN
NNATASTVNSGNNNFANCTELRSVYPNGVPSSHPAYQSKMDRDKDGYACER
>PK3-045_00804 PTS system beta-glucoside-specific EIIBCA component
MREKDTISKIIEYVGGKSNIKKVWHCMTRLRFDLYDQSLIKREQIKQLDGVIGEQLQSDQ
YQIIIGTHVQKFYTAIIDELGLDEDKQEAQEGDKKKGVFGRLLDVVSGVFGPIVPAIAGA
GMIKGILAGLIALNILSKESETVTILDLVASGVFYFLPFFLAASAAKIFKTNQYLAIAIA
GGLMYPTLLDAAKLGEISQFQFIGLPIPVINYSGTVIPVILSVWALSHIHKWVDRFMPNV
LRTVFTPTLALFIAIPFSLIVTGPLGGYVGKALAYVIELLFDISPIVAGVVMGGARPIEI
VFGVHHAITPIALQNFADKGYDMLMPMMFMTNMAIAGATFAMFFKAKNKMEKSIIISATI
SALLGITEPALFGVLIKNKKAFIACTIGSAIAATFFAAAGVRIYGYILSSIVSLVAYVGP
YFPYAIAGIIIAIGSAFLIAYFTIKKADTNDVNEPVSDTQKL
>PK3-045_00805 D-galactonate dehydratase family member
MEPTIITDIKSFVTNPQRHNLVVVKVETNKGIYGYGCATFQQRPLAVQSILEEYLKPLLL
NKDANHIEDLWQMMMVNSYWRNGPVINNAIAGIDMALWDIKAKLANMPLYQLLGGKSKNA
IAAYTHADGLTLDELFANVDELIQKGYRHIRCQLGKYGGKNQKMHLTNELSEGEYFDPDI
YMTDVITMFKALREKYGYSIHFLHDVHERLFPNQALQLAKELEPYKLYFLEDILPPDQNE
WLSQLKVQCTTPIATGELFNNPMEWRNLIVNRQIDYIRCHVSQIGGITPALKLAALCENF
GVRIAWHGPSDMTPIGVAVNTHLNIHLHSAAIQEIQEPDETTMKMFPHAIKVHEGYIYPI
EREGIGVEFDEEMAKNYPVIYRKHEWTQARIPNGAIHTP
>PK3-045_00806 Mannosyl-D-glycerate transport/metabolism system repressor MngR
MMKKRDFIAEDILSKIYQNKYKAGEKIPTERELARHYDVSRYTIREALKKLVNIGCVKVI
QGSGIFVNETRYKSPLIYNSLTERKFKDIQSKIIYFKKIEADHALEKIFDLSGKKTKVWE
YKRVRIVDFQKMQIETTRLPCVYFPDLEEEAVKNSVHEYVQQCGYQISHFITTYSAINVS
KEDAELLNCKKGTAAMKIFNRGILQNGTVFEYSEMINLDYSVSYFTPFNPYSHQYRKN
>PK3-045_00807 hypothetical protein
MKKIISVLSLFLIGLLVLSGCESDKETSSNVDENGIKTFTAFMAVPGKELPDDNRMMNKI
AEKIGAKADVTWLTGQTASERIGVMIAGGEYPDFIDGSDGTAALINAGALIPLEDYLDDY
PNIKNLYTDAQWNQIRHEDGHIYIIPQFGVVKGQNMAVNHSDEAFWIQKRILEWADYPEI
TTLDEYFDLIESYLKENPTSEDGQKNIGFSILSDDWRYFCLENPPQFLAGYPNDGAAVID
PVTKEAKVYDQIPEAKEYYKILSEKFAKGIVDPETFTMSYDQYIAKISSGRVLGMVDQYW
QFQDAETSLKSQGLDHLTYVPLDLVLDKNVTPQYFSPPTLNVANGLGISISNKDVEGSLK
FLNDLLDPEVMVMRTWGEKGVDYEVDDKGLFYRTEEQRKNAKNQNYVTNNFSDYNYFPTY
TGMLEDGINAVSPGEQPDEFYATLSDLDRKILDAYGYKKWTDFLTPVKENAPWYPIYSAT
NGWTASTPEGISKEKMTEVKQQWLPKVIMTSPDKFESAWDDYMDAYNSQVDVKAYEDALT
KEVQRRIEVSESNN
>PK3-045_00808 putative multiple-sugar transport system permease YteP
MLETVVQPSPKKVGSLKKLFKKCKEQKELVLLSIPFVIYALIFYYAPLSGWLMAFQNYRP
GRGIFEQEWVGLNNFKFLFSDPTFINVVRNTLAMSMINLVLGFIFSIGFALLLNEVRNKT
VKKFMQTVSYLPHFLSWIIVTGIVMEVLSPETGIINQLLLVFGIIDTPINFFADPKYFWW
IVGFANVWKSTGWGSIIYLAAMASINEELYEAASIDGANRLRKIWHVTLPGIKPTIFILL
LINIGNILNAGFEVQYLLGNGLVQGVSQTIDIFVLKYGISLNNYSLATAAGIFNGIISLT
LIFIANHLAKAAGEERLF
>PK3-045_00809 L-arabinose transport system permease protein AraQ
MKKVYYSDVLFDIFKWIFLLFFILATLYPILNTLAVSFNDGLDSIKGGIYLFPRELTLEN
YITVLKKDTLIQASIITVARTVIATIVQLFLTALLAYILSRKEFVFRKSITLLYIFTMYL
NAGLIPNYLLMSKLGLLNSFWVYIIPGMISAFNMLVIRTYINGLPESLVESAKMDGASHF
RIFISIIMPLCKPVLATVALFIAVYQWNSWFDAMLYNGFNDRLTTLQYELMKLLSSVTNQ
GANADSMKNSSSMVTPTSIRAATTIITALPIVCLYPFLQKYFMSGLTIGGVKE
>PK3-045_00810 Reducing end xylose-releasing exo-oligoxylanase
MVKAFQTGEYTNLFKKYGYQEEEINNRLALIWQTLFFGKEEERIYYETDNQMGYVVDTGN
NDVRTEGMSYAMMLSVQLDQKEVFDRLWKWTKTYMWMDSGVHANYFSWSVSPEGVKNSYG
PAPDGEEFFAMALFFASHRWGDGDGIFEYSKEAKDILHYCIHKGENNDGFPMWNPENKLI
KFIPEVEYSDPSYHLPHFYELFSLWANEEDRDFWKGAAEASRSYLLKACHPVTGLTAEYA
DYDGNPYYDSEHFYFYSDSYRVAANIGLDYEWFGKDEELRNCVAKIQKFFCETVKGEEDY
VYAIDGTKVEQNVLHPVGLLATNAMGSLATEGKFDYAKDCVEKFWNTPLRTGERRYYDNF
LYSFAFLSLSGNYRIW
>PK3-045_00811 Non-reducing end alpha-L-arabinofuranosidase BoGH43A
MQTFKNPILKGFSPDPSICVVGDDYYLVTSTFSYFPGVPIYHSKDLVNWELIGNILDRKS
QLPLSDVTHSQGIFAPSIRYNKGIFYMITTNVPNGGNFIVTATDPTGPWSDPYYLEGAAG
IDPSLFFDTDGKSYYVGTRPNPKGVRYNGDWEVWLQEIDLKSMKLIGVSTKLWKGALREA
IWPEGPHLYKRNGYYYLMIAEGGTSFEHCVTIARSEKIDGPYIGNPCNPILTHRHLGRDY
PVCNVGHGDLVETADGQWYMTCLASRIFAGYSNLGRETFLAEVVWESDWPVINPGLGRLA
REQMHRLPLFPTETVNPRILFEQPLDKRLLFLRNPDIEKYVFDERDGWLRMYASPHTIAD
IASPSYIGIRQQSMWYTLKTRLDFTPQQNGDEAGLVILQNDRYSIRFVSGLFDGKRELRV
ITNYNGEEKLEERIVEDSRNLTLKIKGDCQKLHFYYSQEDGEEIEVVKNIDAHILSTEVA
GGFVGCTMGVYVTSKSDLTNSCYADFQWLEQVNEEVELHVTEKVKQYE
>PK3-045_00812 hypothetical protein
MNRLMNGIYMRRLTKVANLLYLSILWTVFSLPIITIGASTAALYYAAHHAIREEEGYIFQ
QFWKAMKSSFKQATITWVFFVAAISVFYYNSLFLGAQTNGSVVSIIGQTIFLLLIPLVCC
CFIYAISYIARFQSPLKIVWKNAAILAISHLPKSLFLLILLVFFIVSIWLLPILVVIIPA
FFSYIISRYMETIFSSYLKEK
>PK3-045_00813 hypothetical protein
MEGWEKNLLALLLNNIKIKKKMVLIYLLAVVIPIVLTNLVIIHSIRENEDIQKNKSMEIT
IERLKYHLNESFNEITEVSNYISRDLKINEFLQKKYKDNVDYYSDYISLVQENIINNFYV
SQALESIEIYTTNPTIINGGVFWNLRAVEQTNWYRIYKENNHNMILYPYYEENKQFPPKL
ESNRTISFIRELPNRSNGYKSIVKININYYRLLANIKNEDTSNNIVIAYNDQVIFSNQGS
EKKNTIFRKLKSKEKSRFNLSDSFLAINDRWDIYISNNQINIFDLIENKKTILLVLIIFN
FLFPTLVILLINKSFQDRIALTEQHLLKVEKGIFERININEGKDEIGDLIRSYNFMVVKI
DELLGEVYKKEREQQKIELAKTKAELNALQSQVNPHFLYNTLDSIRMRNLLNGDRESATV
INELAQLFRRMTKWSDSYFVTVEEELAYVQRYLNIQKYRFVDRLNFSIYVEEECKEHYIP
KMLIVTFVENACIHGIEKKKNGGEISIIVSTQENAIYIEILDSGVGMDAKRLRKIREDLE
KNDVTTSNWEESTGILNAYLRLKMHYQEEGELEIESQNYTGTEVYIKLPII
>PK3-045_00814 Protein-glutamate methylesterase/protein-glutamine glutaminase
MLKVLIVDDEPYIREGIKVMIDWGNYGFELCYEAGNGEDALQIIRDYEVDIVFTDIKMPV
MDGLELIKQVKQSMDKEIRFVILSGYYEFKYAKKAIQYRVTDYLLKPIQEKELIDLLETI
NKRFIVLKRKEKEEEKKNKAINDYHLKNILYDKFTLKDIEFIKDRYGDFKNYTFINMDVV
QETRQERVTTDEKKEWRNKLYKVIEKMVQEENFLILYDIENTNMEYSVSLVWQCNRSEVY
RANYIEKLQRRLISEVPFRVKMYIGNTVQKIEELTDSYNKVVLGKEYEYFYCADKSIIYC
DNTPVFSLEQYHLSPKRINQYMDSISENNEQKITVIVKEIYDEFQRKCLHPQLIKNNLTL
LIYQLTDLWNKNNKPNFSNDESSLFIHDQKNILSGKISMDEFLTYSLHFANYLYSIRNYS
SKDILIKIERDIEERYMEKLSLRKLGDKYNINSVYLGQLFSKKYGVAFKDYLNEYRIEKA
CQLLEETDDRIYQIATNIGFQNPDYFIKKFLQVKHVTPRKYRLISRSIKEA
>PK3-045_00815 Putative NAD(P)H nitroreductase YfkO
MRNKEELKQEILAAYHFRHATKEFDPEKKIPESDMKFILETARLSPSSFGTEPWKFLVIE
NPELLNKIKQSSWGASTKIPAASHFVILLARTKLDTAYNSTYLKEQFTNVSKLPAGVIPK
MIERIKEFQKEDFRLDTDRALFDWASKQTYIALGNMMTAAAQIGIDSCPIEGFHMEKMNQ
LLDEEGLLEDGHLGISVMVAFGYRAKDPYPKTRREFDDVVTWV
>PK3-045_00816 putative HTH-type transcriptional regulator YxaF
MKKGNNKKEAILTTATKLFQLQGFHATGLNQIIDESGAPKGSLYYHFPNGKEEIALEAIK
RMRELVVEKMKADLYSGETPVAAFQQHVNSIANEFDQMGCSALEGLQISLIASETALTHE
TLRLACDATFTDWQALYTNRLEDFGFAEPLAKELGITLNAMIEGGCMLALTNKSSNPLRC
ISNQIAVLLKQ
>PK3-045_00817 Riboflavin transporter RibZ
MTMDIPAKGETIGKTEFKTVPIIASFLIAGFIGLFSETALNMALRTIITDFSINETTVQW
LTTGYLLTLGILVPVSGLILQWFTTRQLFITSLIFSISGTLIGAIAPTFTILMVARVVQA
IGTALLLPLMFNTILVLIPPHKRGKVMGMMGLVISFAPAVGPTISGLILRSLTWHWIFWV
SLPLLVVALVFGSIFMQNVTTLTKPKIDILSIILSTIGFGGIVYGFSNAGEGGGWGSLEV
IISIAIGLIALILFAIRQVKSEQPMMNLGAFKYPMFVIGLVLVIMIMMVMLSSMILLPLY
LQNVLALSTFTAGLLLLPGGLINGLLSPIMGSLFDKFGPKWLVIPGLALATLALFGFSTI
DIDTSSGFIIALLIVLMIGVSMVMMPAQTNGLNQLPPELYPHGTAIMNTLQQVGGAIGTA
IAISLLASGSAEYIDSAATDLTNPLSPLLAFTAGVQKSFSFAIIVAIIGLVLSFFIKRVK
VDHPSH
>PK3-045_00818 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKHLQDKVAIITGSSRGIGATIAEELAQLGAKVIINYSSSSEKAKEVVASIVNKGGEAIA
VQADVSKVKEVERLFIETLQHFGKIDILVNNAGIMHTIPLKAVTEEEFDLHFSINVKGTY
FACQQALQHMVADGRIINFSTSVAGMMFPGYSLYAATKGAVEQITRQLAKEFGPKKITIN
TISPGPTNTELFMDGKSPEQLENLKKLNAFGRFGETDDIAKVVAFLASEDARWITGQTLR
VNGGMV
>PK3-045_00819 Regulatory protein PchR
MVNNKNELTDLVEKHFKTDGTHATEINHLSIVRASTLTEPLHSIAEPSVCFIIQGSKIVM
LGEEIFRYDSSQYLVISVHLPIRGKITEAMKEKPYLCIRLGFTTEQILEAVANHKEVVSD
PPKRAMLVNKTTSEMSDALLRLIRLLDTPKDIPVLAPLYQKEILYRILQKEDGDQIKQFA
ILGTHAQAIKETIKLINQAYAQPLRVEELAKAVNMSLSSFHHNFKLITGMSPLQFQKMIR
LQEARRLLIAEGLEAAEAAFQVGYESPSQFSREYSRMFGLPPKSDVKKLQDNWK
>PK3-045_00820 putative multiple-sugar transport system permease YteP
MAMLRNLWRNKAFLLMALPGTIWLILFFYIPVFGNVVAFKDFHYSSGGFFQSLRESPWVG
FDNFKFLFSSNNAYLITRNTVLYNVAFIVLGLIFAVFLAIVLSELRSKRMIKIYQTSMLF
PYFLSWVIISYFVFAFLSPDKGLMNSILTLFGGEEINWYNEQKYWPFILIVLGIWKGVGY
NSVIYFASIMGINSDYYEAAMVDGASKWQQIKNITIPQLVPLISILSILSVGNIFRADFG
LFYQIPRNSGALYEVTSVLDTYIYNGLTSTGDIGMTAAAGLYQSVVGCILVVLANFIVRK
FDEESALF
>PK3-045_00821 L-arabinose transport system permease protein AraQ
MRKGGPNHTVKKKKIEHVRVRTFNRKTNIFFNIMVGLFAFSCIFPFLFVIIISFTSETAL
ITNGYALWPSEWSIQGYTYLADLKTQIIQSLFITVFVTVVGTFINVAFTSTYAYAISRPN
FRYKRFFTIFALITMLFSPGMVPSYIVMTNMLQLKDTVWALILPMALSPFNIIVMRTFFR
RQVPESIIESSRIDGASEMRIFTQIVLPLAVPGIATISLFAALGYWNDWFNALLYIQSDN
LIPLQYLLMKIQSNIDFMTQNAGLSGNLSGGLAAIPKEATRMAMVVISTLPIACSYPFFQ
RYFVSGLTIGGVKE
>PK3-045_00822 hypothetical protein
MKMKKKVPFLLVLMLLIGTVLAGCSLKGNSTADTSSKEGVTTLLMYQIGDKPENFDVLME
NVNKKTEKEIGVRVNLQYIGWGDYEKKMSVIVSSGENYDIAYANNYVTNAQKGAYADLTE
LLPKYAKEAYDMLDPAYIEGNTVNGKLYAFPVNGNVYAQTMFSFNKQYIDKYNLDISDVK
GYKDLEPLLKVIKENEKDVMPFSVGQGFRVLPNMDFVLGNGMPFAVDLNGDTAKIINQYE
NDQMQENLRIMHDYYYKGYIAKDAATSNTEYPLNSGTWFVRQETQGPYDYGDTLLSTVAE
QPIVSMPITDPIKSTAQAQMANFVVSSNSKNKEKAVEFLGLLNSDPELLNGLIYGEEGKA
WEKAGENKVKLLDGYKSNNHMAAWNTGNNKIVYVQDSITDEQIKERDENIANATSSPILG
FTFNTDSVKTEITNISNVMSQYLDGLNTGTLDPDKAIPELNEKLEGAGYEKVREEMQKQF
DAFQASKN
>PK3-045_00823 hypothetical protein
MIASFLTTFFNRFYVVVKLNLYFWLLTIMGGIIFGIGPALLTIVKLSLECRWDHQELTWK
NVFSTFKTSYKRGNFSFYGFLLLGVILSYNLYFSLQINHLLFLIIDFLLIFALFLMAISF
LFSLFIEAQYEAAIKDVWKLSFLLFFMDFWTLLKLGGLLAGISVLTYFNPALILFGSISL
FIILASFISNKLFIRLSQKLVYVS
>PK3-045_00824 hypothetical protein
MGSKYFINSLLKTYSIILISAVTLFALLVSYNTSQDKQRTAIDSVERVANQLENIVTDNE
KKLDKVVANLMASSEMITSMYQYFELEPAAYLQKSLSEQKNNAFLYLPRIVTEMYYVDDD
IESVTISLNDYKEVYYSTKENKGGKKYFHTPIRNNQVVYQKAIKDPNTLSQIGIVSIVFN
DKELERILDNDKEKTSLQAAIISDTKKLVYYQGQYRQDSVLQQKIAANLEESSVISLKDL
EKQYYIKSVHTSNDFEVLAFISKKEVINESMKSLFFFLFVSAILDGILLFGLRKTFKRYV
IQVEDIQKGTNQVSNGNMEVRIEEKTKQGELKDISHSINQMLDSINRNIEDIYNLEIKQK
DANMRALQSQIDPHFLYNTLEYIRMYAVSEGADELSNVVYVFGSLLRNSITQEKVVTIRH
ELEFCEKYAYLYQMRYRDRIAYGFQIEKELGEISIPKFSIQPLVENFFIHGIDHTRKNNT
ISVKVSKQDGYTCILIKDNGTGVHEDKLKKINELLKTPSSENQLESSIGIHNVNARLRSF
FGDTYSMRLKTNPLGGLTIEILF
>PK3-045_00825 Regulator of RpoS
MYKVLLVDDEYMIVRGLQKLIPWENLGFEIVGTAGNGQEAFEFVKRQKVDIVITDVTMPI
LSGIDFLKQAQEASIFFRFIVLSGYQEFEYVKESLQMGAENYLIKPINKEELIETLKKCI
KEFEEEKLRIQGEKYLFAHLLKRWVHDDIDYMDLKKMLAAFDISTEMKRYQVLIFTYKKK
LHDQVHQLLHTNKDLYFFHHYEEDQWVVIYFGGRSGLESLMKSIQLLYCQNKVTFGIGEE
VKKMADVSLSYEHAKSSLYLCSFYERQQQFMDTATANVLNENVPNISFTAFKKALGIRNI
ETIQTEIKQIFAELMESAASPAYTRYIIFLVFMDIYRELEVQDEFIYEEMVEKINKACSF
KELQMIIKDLLDNLKYKKFRREYSMNVQNVLKIIQEEYHEDLTLKAIAERLHLNVMYVGQ
IFKKETNKSFSQYLNHYRIKLAQNLLLNSELNINEISEKIGYMSPGYFYKNFKKYCGISP
KEFRDSYQQLFEPIDE
>PK3-045_00826 hypothetical protein
MLELIDTRQGTENQHSYSNGNTLPYTGFPFGMNFFVPQTKHTNGSWFFHPRDRVFQGFRL
THQPSPWMGDFSHLLLTPLSGAVHHDDIYHTQSSYRPESSVYQPHYLQITQARYRIKNEL
VPTTYGSILRSAYRDLKLPGLSLHLPGKGNVSLDIEKNKLTGYVSNFAGCEDSDFKMYFV
MTFSHPIDQVNTGFFQENKMFTSALSATGEDQHFLMRFLLTEDKPLETRLATSFISSAQA
EWNLSQELSPFSFNALKERAEEAWEHYLNKIEVKNKDFSTVKTFYHCMYRMFLFPQKFYE
INQQGEPIHYDTTSKSVKPGVLYTNNGFWDTFRTVYPFYSLLIPEEYEEMLRGFLNSYKE
TGFLPKWLSPDERGLMPGTLIDAVIADASQKGIALDIIPELFEAMVKTASTVSSKRTYGR
QGIEDYDTYGYIPSSHHESVNHTLDYAYSDFCISRVAKKLGQDDLRKTFEKRAYNYRNIF
HKETGFMRAKDKQGKVEEPFNSFSWGQDYAEGSAWQSSFAVFHDFAGLINAYGGKEPFRN
KLVDLCNQEPIFDTKGYRLEIHEMSEMAAIDFGQVAISNQPSFHLPYLFTYAGDPASSQV
LLKQLMTQLFSSSPTGYPGDEDNGSMSGWFIFSSMGFYPICPGTGEYVIGMPIFDEVTIH
LPNDKKIEISTAFNLPQFNFVHQVTVNNEIYNKLFLKHDVLIKGCTIDFQLGIVPPNKDY
AETDLPYSLSTDSASLL
>PK3-045_00827 Arabinose metabolism transcriptional repressor
MKKEPLYQKIVTDILAQIQAGHLKPGDQVPTELEISKQYNVSRITSKRALTELENKELIE
RIQGRGSFVAEQKPSPSHVILFILPFPNNPGLGDYAQGISRFIANTPYTVQIQTNAYLSQ
LDAKKISSMYAGLLLYPEAGTSHLDILYTLYLEKFPVVVLDKKIESIPFPFITSDNMQGG
YLAAQHLINQGHKKIVFYATQNLERSSTIRERYLGYLKAIHEANIAYHGSKVVLSAEDNS
AFIHQLKEEEITGLIAENDINAIHLMKEIKRYGYQVPKDFSIIGFDNIQAAELVDPALTT
IAQSFEEIGYQAAEQLIQLIENKEAIHSVVIPIEMIIRESTN
>PK3-045_00828 hypothetical protein
MSYQKTTMSSVKEFMKRITEKCGDEHADWAVNFNTCFANTLETTVEKLEDGTTFLLTGDI
PAMWLRDSTAQVRPYLVLAERDEEMANMIAGLIERQCQYICLDPYANAFNKEANGAGHQT
DLTTMNPWIWERKYEIDSLCYPIQLSYLFWKATGRTDHFNQSFQEAVQKIIEVWMIEQDH
TNSSYTFERVTDRQEDTLINKGRGAEVVPTGMTWSGFRPSDDACTYGYLVPSNMFASVVL
GYLIEIYEDVLKITEQVPAFQKLKEEIEKGIEEFAVVRNQNGEEIYAYEVDGKGNFTIMD
DSNIPNLLSAPYLGYVEENDERYRATRQTILSEENPYFYKGKYAEGIGSSHTPENYIWPI
ALAMEGLTTEDKKEKERILDLLVACDGGTHLMHEGFDVDNPTQYTREWFSWANMMFCELV
MDYFDIRVKKK
>PK3-045_00829 Mannosylglycerate hydrolase
MKKVYIVSHSHWDREWYLPFEQHRMRLVQLIDDLLELFDTDPHFNSFHLDGQTIILDDYL
EIKPQNEWKLKKYIQEGKLKIGPFYILQDDFLISSEANVRNILIGLQECQKWGAPVKLGY
FPDTFGNMGQAPQILKQSGMDVAAFGRGVKPTGFNNIVINDDQYSSPYSEMWWEGPDKST
ILGILFANWYSNGNEIPVDEVEAKQFWDQKLKDALQYASTDHLLFMNGCDHQPVQKNITA
AIEAANNLYPDITFIHSSFDEYMKIIKQDIPENLHTVKGELTSQETDGWYTLANTASSRV
YLKQRNTDVSRLLENIAEPLAAMAYQKDGKYPHEMFQFAWKQLMQNHPHDSICGCSVDEV
HREMMTRFHKAEEVGQFIKTEALTMLAEQIDTSEFPAGSRPFIVFNTAGSTKTGLVEIEI
EWKRLPFSSGRPDELYRKLKAEEFPAMKVIDKEGVEVPARVIYTDIRFGYDLPEDRFRQP
FIGAYVTVELPLNEMSPLSWQTYALIEGESQQQEHKKIVQQQGHLLENNHLKVQIEQNGT
LTVLDKGTNSIYTNFLTFENTGDVGNEYIYKMPKGDQPILSSAGKAEVEVIGDTFAYGEV
LLTQTMLIPKSADERLLEEQKGLIEFRGRHAGRSNKLETLELKTKIRLERNSNQLLFETS
FANQMKDHRIRVLFPTGIHVEEHEADSIFEVVKRANKVSSNWENPTNPQHQHAFVNLHDE
NRGVTVANYGLNEYEIMEDTIAITLLRAVGELGDWGYFPTPEAQCQGNQAVKFAVGFHDS
TNKLESYHAAINFQIPFSSVQTDIHKGAYPSIYEFIQLDGKAFRLTAFKRRENSKEIVLR
GYNLTDEKQPLTVKYNGKYPRKSNLLEEMNGEMFDSNQMNEAEICTFIWE
>PK3-045_00830 hypothetical protein
MNTKTNFLIFLLAVSCGAVVANIYYTQPIIQFISTDLHIASNISGLLTTLTQIGYGAGLF
FLVPLADLYKSKRIIVLLIGLTILSLIGALFSTNGMIFLFVVTFIGIGASAAQMLVPLTM
KIVPKEQAGNYIGKVMSGLFIGIMVARPFSIAVTDWLGWRMVFLFSCLILVTILLLLLKF
LPDFELESNLGITYPALLRSMLSVLKETQPLQQRAFYHACIFATFSLYWTVLPILLRSES
LHFTNNEIALFGFVAIAGALLTPYIGKLGDKGYIYSMTNVSMVLVVVSIFLLFFVKDHSI
LSIALIVISGIILDIGVSGNMLLGQKVIFSLNPAIRNRLNGLYMTIFFLGGAFGSWIGSY
SYYQFSPNTALLLAIAFPMLALLVHLKKGKKILSEAMG
>PK3-045_00831 hypothetical protein
MSSKEREYDKKVLHLESLKELKDRKFQKLDDSTGKWTLKEINEQVIVITGASSGIGLVTA
RMAASKGAKLVLAARNENALEKLTAELKEQGASVVYVKADVGKEQDVKKIAETAQETFGG
FDTWVNNAGVTIYGYAMDVSIEDMKRMHDTNYWGVVYGTRIAINHFKERGNAGALINIGS
LFGDRGTLIQSTYAPSKFAVHGWTESIRMEAEKEQIPVSITLIHPGRIDTPYAEHARSYL
DKQPTHKGMIYPPDAVAEAILYAAENQMRDMYVGSQAKLLNLLGTLLPRFTDKLMEKWIP
PTQYKDQPSNNRENSNLYQPGYGLHERGTNQGWIRSRSMYVKMSKHPILTAAAAVSIGII
FLTKGKKSK
>PK3-045_00832 Fatty-acid peroxygenase
MPTNSIVPSEKGLDKTISLLKEGYLFINNRMDKFNSDIFTVRLLGQDVICIRGEEAVKIF
YDSEKFQRNGAAPNRIQQTLFGKNAVQTMDDEKHLHRKLLFMSLLTPEHQQKLANLTTVY
LEEAIKQWEQRDQIVLFDKIKNILCKVACQWAGVPLAEEEISERADDFIAMVYAFGTLGP
EHWKGRIARNRAERWIKQVIEVVREGKLETEQGTALHEMAFYKKIDGARLDPEMAAIELI
NVLRPIVAIATFITFSALAFHEYKEEREKLRTADDRHLDMFVHEVRRYYPFGPFLGARVR
TNFMWKNQEFKEGTLVLLDIYGTNHDARLWENPNQFNPSRFENWQGGLYDFIPHGGGDPA
KGHRCPGEGVTVELMKVVLRTLATKMDYNVPNQDLHYDLSEMPTLPKSGFIMSNIKKR
>PK3-045_00833 hypothetical protein
MVGERIRQLRIHKQLTQKELTEGICSITYLSRIENGQINPSAEFLRKVSKRLGYDLTELS
SPNRDEKILQIVENYKQSEKISDEDLSYLLVQTYELNSTKINLHLYGVLLRYYTAKGEIE
QARSIFNLSKRFISGEISDGLEGEYFYYFLACGNYFYYFQDFERANHYYSKAESLLIDRD
NLDAAKLYYNLSLVKQRTYDNQEVSLYYSQKAYEIFKKYGEKKYIITVLITLGVQYQLNN
ELDTSMDCLKKAEAIIVEDKESEKFVNYIAMIQHNMGRIFERKRDYQGAVTYYLKSIEIF
ENHSSEQQNVYPLKRLVEIYIELKDWVLVDKYLEKAIFISEKHRLKYDYILLNIIKFSVK
KLQGNESSYEKGMQKLLDTAMQLNQGALIRRITKELGSHFYEKKAYKKAADLLMKAIDYE
N
>PK3-045_00834 hypothetical protein
MKKVVFAILALVILTLGTNLDKAFAEAEAQPGPLSIIKVTTE
>PK3-045_00835 hypothetical protein
MVEMNNQLMQRIFVTYQDQMNRDYLQPSTSHIVACSIEKHQKEKLNTINSLFHKNTLAQV
LFEVFDKFEPEFINDISPLIIKLNPDVVTGIPHNGVYKLDAENEIFVQLDQLADNQYQEI
EVHQKQLGIKSDLGISYKLLRKDKETLDKLIKVMKKLNYFLSLHGGVESTIAIAELLSEH
QERKLLLPPYIFVQWLYATDSFRDSLIS
>PK3-045_00836 hypothetical protein
MKTKFGIALFLIIVLMITVTTKIGHSENNLTMEELNQPDFLHDKEAVVYFSTTTNQDRNN
EGISYAVFIDDKGKASGFQMGGLEFGSMALNNHQLLLEDKNTIRLIGEKNAVIDLKYQQN
GERTGYLEKQDVFFSIYRSSNDKERDISHIYWGNQKGFKGGNLPYSIMASGYTKDEILIL
TNDEEEKEYVLRKASLENNQLEINDIKGLELEKGYEYSALAPILSDELHYYVLLSEITKD
KSQNTVLFLLNKVTLEQTKVELNSGYVANDPAADSMNSKNAAYLWRDVFFYVNGLGEVVA
VSKDGKEQNKFLLEDFPQNGACHNEEVYFAGDYLFALRYDGSQKEKYYLESYSLENGEKV
EEKTIAGLDDILSSVKGTSIYSYDFKILK
>PK3-045_00837 Undecaprenyl-diphosphatase
MDLHDFLLMVKYFILGAIQGITEPIPISSSGHLIIGQRLLGIEQRGLSFEIITNTASLIA
IVFIYRKDIKQLITHSFLYLKTRKERYRADFRFSLYVIIGTIPAGVIGVLFGDYIADYFT
SFYTVSITLLITGIALWIIRNMRGVKRDGDLSWRDALIVGCAQVIALIPGISRSGSTVIA
SIALGMKQSTALRFSFMLYIPVSVGGAILGVTDMINSPDMKTLAWPYFIAFMTSLVFTYF
SMKWLMGIMEKGNLKYFAYYCFIVGTILLVVTYLL
>PK3-045_00838 Transcriptional regulator ManR
MSQVINERHQMILTILRREKRYVTAAELAQSLKVSKKTIYRDIQQIVDSNSMPFRIIKKE
NFGYYFQNHKEPLEKETIIFDYPDERRLNLLLYLLAIAPGKTSIQKISEKYIVSQSSILN
DFKHIEKELRSYHLRLLRTKEGTFIKGDKLSIYRLMAVIIENYLTQMGDPFSQYDIPDSI
KKVKVKNNHLIKIKRLLHDIQVKHDLSLDQPYYLTLFCSLLSIIEKHNNKLSLDEEEVVY
EEIDGNSAIYCICKDMIEEIENQFSLSLKQYDIYSLYYILKAYKLNSRFLLNQGTELYQN
AQVVLLTKRLIARVTENSGYRFDTDDELLERITLHMHAMLYRLSHRIYIVNPIIKSIATN
FSHIFGLVKTSIQQLVEEGHYEKYITDEEIGYITLYFQISYDDHFANQIPILIECTSGIG
TSHLLSEKIRRTFPDIHIKKIIAQQRIKQTDYEDVELVISTVKTHSIIDKPTILVSPILN
QEDKFKIDQFIKDYYNQQSIIGEKIER
>PK3-045_00839 PTS system mannose-specific EIIBCA component
MDMKIEELDFHKVVTEDLIELNLQGTTKEEVLNELTDLLYENGCISNKEGFIKDVMYREE
EGITGLEKGVAIPHGKSKHVQKTSIAIGRTKSFVEWESLDGNPINIIILFAVKDTDKTTI
HIKLLQKVAVLLADEETISKFQTLQTKKEFLKLLTKND
>PK3-045_00840 PTS system mannose-specific EIIBCA component
MMNIVGISACTSGIAHTYIAKEKLIKAGQELGHKVRIETQGTIGIEDELTTKEIEEADLV
IIAADIKVSGKERFAGKKIVEIPTHIAIKAPKQLYQKIDAELNKQ
>PK3-045_00841 PTS system fructose-specific EIIB'BC component
MLKKMQVKKHALTAISYMLPLVVASGLLIAIGNLTGGSVIEDYKASFDIPSALVSLGVLG
MGLLAPVISGAIAYSIADRPGIAPGLLMGLIANAIGAGFLGGMLGGFIVGYFVLFLRKNL
KVPKWAEGLMPMMIIPLISSLVIGLLMFFVLGLPIVWATEGLTSFLTSMQGSMRFVFGAI
LGGMAAFDFGGPVNKVASLFADGLLLEGIYEPEAVKILASMVPPFGVAISWGLSKLFQKK
RYTKSEEDNIKIALPMGICMITEGVIPIAAVDIVRVVASCTIGAAVGGGFSMMWGVGSPV
PSGGMFIVPAMTHPILFCVALLIGSLITGVMLFLWKKEPAAEIEETSSEEEEVDLSDVKI
TF
>PK3-045_00842 D-tagatose-1,6-bisphosphate aldolase subunit GatY
MYVSMKGMLARANQGKYAVMAINCFNLETAKAVIEAAQELRAPIIVDLLQDHLMQHFGSK
LLTRPIIEMANAASVEVAINLDHGQDVGFVKRCLRDGFSSVMMDASRYPIDENIRITKEM
VEFAQSYDASVEGEIGNIGSVSRNQMTDDEMYTNPDLSIRYAKETGIDALAISYGSSHGD
YPDGYIPAFRFDILEKIKGETGIPLVLHGGSGCGEENIRKSISLGINKINVGSDFFKAQI
NSIKKTMVGNEIDYFDVIHQTIKAGKDLVKYYIELAGSEGKSL
>PK3-045_00843 D-tagatose-1,6-bisphosphate aldolase subunit KbaY
MLLNMKQLLEVAQKHQFAVGAFNVADSNFLRVVVEEAESNNSPAIIAVHPTELDFVKDDF
FSYVLTRIKNSHVPFVLHLDHGGNMADIMRAIHVGFSSVMIDGSLLSLEENIQLTKQIVE
VSHSLGVSVEGELGTIGNTGTSVEGGVSEVIYTRPEDAQEFVEKTGVDTLAIAIGTCHGI
YPKDMEPKLRMDILKEIKETVDIPLVLHGGSANPDEEIAEAVQIGIQKVNISSDYKYAFY
KKCREILAETELWDPNAIYPACIEAAKEIVKYKMNLFQSIGKAEIYREENVTAWRREWL
>PK3-045_00844 hypothetical protein
MNVQFKKGVLELCVLVLLDKKDRYGYELVQKISNQIEISEGSVYPLLRRLTKEEYFTTYL
QESTEGPSRKYYKLTDKGRTYLNELITEWNEFSNGVNQLIKEGVNND
>PK3-045_00845 hypothetical protein
MTKEQFLKQLQAGLKKLPQEERKDIIHDYEEHFFIGKEDGKTEEEIAKSLGSPQQITKEL
IASYHLEKVEKNRTTGNILRAVWAVIGLGFFNLVIVLGPFVTIAALILSGWIVGVSFILS
PLLVLVDSVFHPGSFAFFKLFMTILLVGLGIFLVIAMYYITRISSKGFINYLKFNAKLVK
GGQKHD
>PK3-045_00846 hypothetical protein
MISLKKLMVIGLVLVLIGGIGAFLTFRDNSLDIHEEKIFKENNITGIEVDSNNAGIEIIP
TAEKETKVVLQGKGSSETKGSFTAKVVGKKLVVNWNEKQISFFQMNFIDESLTLKILVPV
KEYKSLRINNDNGKIDLADLMVEQVQAESNNGRIHLQNIQSNSIKVISDNGRVSLDHVSG
SVKGETNNGRISMKTATLDQAIQLETDNGSIEIVTEKEPTNVTFDVQVDNGSINILDKYK
GSTVIGNGENKVKLKTNNGKIRVGN
>PK3-045_00847 Putative methyl-accepting chemotaxis protein YoaH
MKIKYQLAIIFFILIISLLGIGGFSNMSLQSLIANSKELTEAKEIQRLVTHLQYRIAGIS
NDERAFLLTGNKEYSDGINEKESDIHDTLKTMETLSNYYEYKEDIQTFQSSLQTYLATSD
KVPGAYAEDPSAAKKLHFGDLRTLRKEVLDPAVNELVEHINQDVIQIEEQNQKNNKMTKT
VLIVIITVAALLSIVLGFLLLKSILRPLNKINNQLQSIASGEGDLTQRVNVNGKNEFGQL
AHSFNTFVDSLQIMIKSVGQTSKNVAQASDELASSMEQSTVAVEQVADAVQTIAENGNKQ
DSLTQNSLIEVNNSLKNIKHMAHTANEVANESLLIKEKAKEGELALTEMQMQMESIHASV
DLAGDGLKSLVLSTNEINEVLASIQDISNQTNLLALNASIEAARAGEHGKGFAIVAEEVR
KLSEMTGTSVNQIHDLISSIHDHSSTTEKNMSFVKENVDGGTKLSDTTNEHIKEILNRVE
SIADHIKKMAETTQEITAEVQEVQDSVEEIAQTSRETLERTESVAAATEEQTASFQEITS
SSMALSKMAEELQELVHRFKI
>PK3-045_00848 hypothetical protein
MLMELKDAFLFLMDIFKGKLPLHDLYLLVFIIVVTSIAETIQEKRKQSSRSKNTIFIYLK
WIPISFLASSIYLTSFYFITNLFTKFLFTAELFHQEQNVRSIAIMSLAMTSIVSLIIAIW
KLYAFFTVKKALLTLISNSLLIAMGVYFINMFWYEAIIMPIWCYGIIGLVNTIFISFLLL
KERENLQSNSSPINAVDQ
>PK3-045_00849 putative HTH-type transcriptional regulator YydK
MLKYQQIAEEIEKYIEEYGLKQGSKLPVIETLMKQFEVSKSTITKTLELLEKRGIIFQVR
GSGIFVRRQNRKGYISLLSNQGFKKDLEDYSLTSKIIELEIQKPTEEIALNLNMEPHEEV
YYVKRIRYINGQTLCLEESWYNKTFITYLNKEIVAESIFHYITEGLGLKVGFSDVYLHVG
KLTAEEAAYLGLEKDDPKLLVESIFHLTNGQPFDFSKVTYNYEQSQFFIQANSHFF
>PK3-045_00850 Aryl-phospho-beta-D-glucosidase BglA
MSKMPKDFLWGGALAAHQFEGGWNQGGKGPSVVDVMTAGAHGVPRKITDLIEEEQFYPNH
EAIDFYHRYKEDIALFAEMGLKCLRTSIGWSRIFPKGDELEPNEEGLRFYDQVFDELLKY
GIQPVITLSHFEMPLHLAREYGGFRNRKVVDCFVRFAEACFHRYKDKVKYWMTFNEINNQ
MDVSNPLFLWTNSGVTVKEGENAKEVMYQTAHHELVASALAVSIGKKINPDFQIGAMVSH
IPIYPFSSNPEDVMLAEEEMRQRYFFPDVQVRGYYPSYALKEFEREGYSITMEPEDAEIL
HNGTVDYLGFSYYMSTTVKSDVKNNNTGDIVNGALPNAVENPYIKASDWGWSIDPTGLRY
VLNRLYDRYQIPLFIVENGFGAIDTVEADGSIHDKERIAYLKAHIEALEKAVMYDGVDLI
GYTPWGIIDIVSFTTGEMKKRYGMIYVDRDNQGKGTMSRSKKASFYWYQEVIKSNGEKL
>PK3-045_00851 Oligoendopeptidase F, plasmid
MNKEMEKTLYRSEVPFEQTWNLRDLFESEADWKREVEAIEEDIPTVTQFKGKLHQNAKIL
LDCLKARDALDERLVSVLTYANLKQSADGSNPSNQENDAIVSSLYAKVSSSLSFINSEIL
TLANDKINTYLNEEEELQLFSKTLTDLMDLKPHMLTPEAEEVLAAFGEIQRSPYMIYQRS
KTSDMEFSSFITSDGTEYPLTFNSFEKYEESANKEVRRKAYEAFSASLNRYKNTYAATYG
TEVKKQIIESRLRNYESVTDMLLQEQQVTKEMYHNQLDTILTELAPHMRRFAKLKERVLG
LEKIHYCDLKAPLDTSYDPKITYEEASKLILEALNIMGPEYMEIMEKGLNDRWVDLADNY
GKRSGAFCSSPYGVHPYILMTWHNSMRNTFTLAHELGHAGHFALAGKNQIISNTRPSRYF
IEAPSTMNEMLLSKYIIKQSSNNQIRRWVILQSLGTYYHNFVTHILEGALQRKIYELAEQ
GTPITAKVLCEQNIDVLKSFWGDSVEIDEAAGLTWMRQPHYYMGLYPYTYSAGLTASTAV
SAMIEEEGQPAVERWLKVLKAGGTLKPFDLMKLANVDMSTPEPIRKAVAYVGSLIDELEA
SY
>PK3-045_00852 hypothetical protein
MPLKFSRKKRFYLLFFICIVSMVIIFMFSHMPYEEQDIKPFLRDKIDLTNIPFPSITFEY
DGQIISSDSDPYGFIEFLFRKAGHVIGYCLLTLLLFLTLMQTKIKRPWVYLLSGALSIAY
ALTDEWHQSFVPGRTGHWQDAIIIDGTGVILGLVIGFIGTIFFKKRKTKGRF
>PK3-045_00853 hypothetical protein
MKPIVQIWIFISAALLVLGYFHSSIIISTIALITAIIAYRQYKHV
>PK3-045_00854 5-deoxy-D-ribulose 1-phosphate aldolase
MLYRKEREDLCKVVKTMFDRFETNAAGGNVSVRMNEDHIIMTPTLMSQDKHCDLKPEEIL
VVDMQEQKIEGDGKITREINMHMACYRERSDIGCVLHAHPKESMVFATIGMDLPNLTEAT
QKLGQIPVLPFAPATSMELALIVQEYVSSLKEESIPKTMLLNKHGILVLDKTLRKAYDIL
ERVEYNAYVAAKALIFETLNIKKIDKNSEYQYNLEE
>PK3-045_00855 Tagatose-6-phosphate kinase
MIYTITLNPAIDRLIKVKGTLSKKRTNRVQQIEYDLGGKGLHVSHVLTKFKIENKALGYI
GKTNQPLMENILARKNICHHLLAEDGASTRECIVVLDDTHAGSLMITENGFSVSEENHFK
LINFLNQFLTEKDIVIIAGSMPPNYTIAQLLEIINTIKHKKCFIACDLSGEALAAVVDKG
INFIKPNQYEVEVLFQNKQTTLIQKMKELTRQIDYVVVSLGKDGSYVAHKDFLYQVTSPI
VKEQNDTGAGDVFVGTFIAQLVQGKNLETIMKYATGCSASKVTKQNSTDFDVKEAESYFS
SISIKKLGSDDYVIS
>PK3-045_00856 PTS system galactitol-specific EIIC component
MDVIQSFFQYILDFGAAVFVPLLMIIVGVSARMKFREALSSGIILGVAFIGMGIVIGFML
DALTPAAQALVEKTGIQLTIIDGGWTSLATLAWAWPLAFLMFPLQMFVNAVLLLVNKTKT
LNVDLWNVWGKILTAVLIIGVSGNVVLAFIVAAIQMVVELLLADVNQKQIEKITGIPGIT
CSHSMMIFAVFLLPFNWLLSKIPFLDKHVDADTLKDKLGIFAENHVMGFIIGGLLGIFAG
YSLQQILMLAVQAAAALTLFPMVAKLFMQALSPLSEAISDFMKRKFENRELFIGLDWPIL
AGSNEAWVAMILMVPITLIYAIILPGNNILPFAGIINISLAVPALIITGGNLLRMILLGI
ISTPVFLYVATGFASTITKLANDTGAVSVPKGQLISWSTLEYPVFRYIFASASGGNIIGI
ILVAVWLALFITYYKMMKKRTEKFEKEEQNSAA
>PK3-045_00857 PTS system galactitol-specific EIIB component
MKKVIVACGSGVATSQTVASKVKKILEKNGVRANVEAVDIKSLDLHVKSSDVYIAITKAK
KQYDIPTLNGIAFLTGMGLKEETEKLISLLK
>PK3-045_00858 hypothetical protein
MLKTGLIREELIFTNLEAKTSQELFSFLGNKLLSLGYVQPTFTEALIDREKEYPTGLALE
EFNVAIPHTDPVYIKQPFIAVAKNKYKLPFIHMGTEDHVINIDCFFILGIIDPNGQITLL
QTLMERFNTPPFVEKLKSYEGKELFTFLLTSL
>PK3-045_00859 hypothetical protein
MKSELNEIIFHLLVNQSTSLARIEMDLQDKKISPKEQIHFINKYLITNKIPPISIDFDGR
VKLENKTREYLYHILKSSKFINLDYLSPEVRMSLVILLLLTSSSYYSLQDLADFVDVSKN
TLLKDIKIIKERVKGLSVQVEYSRTKGYKIIGTEYNLRKLLVTELKTLLLRDFAIPLLEK
KKFIIPNELFLLEQRLIKVEKVLKISFTDEQIEHLPIILTLLTKRIKAFNREWVSEIKKF
DLENTKELDILKNIFWDLTDLSEKDKLYLALQVLSSNMLESALDLSRGEDLQFAVDEFLD
VVEQNLAIELIRKKEIKEKLLIHLRPAIYRSWMRLNIQNAIIEQFIKEYSSLFIVISKSV
YPLENFAGKPFSKEEIVYLAMHIQAWLYETQEEKEYVFSAIVVCRNGTSVSKFLLETLKG
MFPNFRFLGAFAERSFKKYENEVDFIFATVPLNTPKKLVIVKPILNKEDRLELKKQIRIT
IEKDINKKAKELVHYIKKYLNTDDYEKVSTKIVDFYQETTAEPVIEEHLHDTEQIYRFTP
ENILFTKAEMDWQDALNFALKSMRKRGSITKKYAKRVIELFANDSSRMMIGPSVYLPHAK
PSEGVLKEDFSLLICKHSVYMPDGELAKMIVVIAPEDNNQHVPTLLTLNELFLDEQKSKL
LFQATDINEILNLLNESIPT
>PK3-045_00860 Spermidine N(1)-acetyltransferase
MYQDKELTVRPIKEEDLYQLWTLAFKEENPEWKKWDAPYYAHKALSYEGFLKTQKERFLE
RDDYWAIIVGEELIGTVGYYWEHEPSKWLEMGIVIYNPNYWSGGYGTRVLKLWIDHLFKT
LPLVRVGYTTWSGNERMIKVGEKLGMTMEGRMRKCRYYNGVYYDSIRMGLLKEEWEAFID
GNKTSAGNINK
>PK3-045_00861 hypothetical protein
MKKEVGYVFFCQHCGLPQSIPAFVLKTYLCDDMVKQFYCNNCSRENLIPSYIKKLKAEL
>PK3-045_00862 hypothetical protein
MNYQEYWEKINEINGQLHSLYSSYWDKYSDFTTWQFWIILLSLLVPLIILYFVVDRRRLF
EILFFGYTVHLLWAYIDHALSSGNYLIHTHFLSPVLPSGLNITGSFLPVGFMLVYQYATN
RKKNFYILTVLLSAVYTFICANIEKSMGMVTFHRGVNVIHLFLLDLFIVFVAYWFTRLLL
KFRILKKDEQQ
>PK3-045_00863 hypothetical protein
MVFINKMKAKTERRSEKSGVHKQDESQNGKEKRKKVAFINKMKAKMERRSEQSGVHKQDE
SQNGKEK
>PK3-045_00864 hypothetical protein
MAFINKMKAKTERRSEKSGVHKQDESQNGREKRKKVAFINKMKAKMERRSEQSGVHKQDE
SQNGKEK
>PK3-045_00865 Phosphatase YwpJ
MPMKNVKGGIILLQKPKAIFLDMDGTILNHQNQVSVKTKEIIDDLRKDGLFVFIATGRSF
DEIESVVPEGFEVDGYVSSNGMAGYIGKEPIFQHTLPLELVDTIIKKARENKVYYELFPY
GDSRMTLSQDKEYVIQEIRDPKPESVGINEWLSRKEAISRKIAWKNTVEGKEFSKFYFFA
RTKEHINQWKQVLEDLRKEIDFTASTSSAHNVEVMVANVNKATGIKEMLERFNLSVEETM
GIGDSDNDIQMLQFVSMPVAMQNAPDHIKELAAEVTELSCDEDGVCHFLTSRFK
>PK3-045_00866 hypothetical protein
MVIILLFISLLFSAVLSIFTLTKTQKKWVALFVAFCGNSVVLAGLTWFIYISNEELRLFG
FGHSPLSLLPLFIPVITWINYFILELIKKFSKWSDSSWMDSNK
>PK3-045_00867 UDP-glucose 6-dehydrogenase YwqF
MNITVAGTGYVGLVTGVCLAEVGHKVTCVDQEQEKIVLLNLGISPIYEPELDTLIEKNLQ
AGKLTFTTDYNKAYAQSDVIFIGVGTPENEDGSANLNYVFQVAKQIAISVRRDCLIVIKS
TVPIGTNDRVETYIKNHLKHKVSIEVASNPEFLAQGSAIKDTLHASRIVIGVESEKAKKI
LTSIYEPFQQPILTMNRRSAEMVKYASNDFLALKISFINDIANLCESVGANIEDVTSGMS
YDERIGKKFLNPGIGYGGSCFPKDTKALHWLAEEEGYVLRTVKAAIEVNEKQKFKLISKA
RNEFSSFNGLKVAVLGLTFKPGTDDLREAPSIPNVRLLLNEGAKVHVYDPVGGENFKKLF
PTEVVYEQTPEKALEGADICFIYTEWAEIKAIDLTIFKEKMNVPFLFDGRNCFSLEEASK
AGINYFSIGRPEVRMIELEPIRRAAGR
>PK3-045_00868 hypothetical protein
MFWTEKKLDARIKELEKYRYRESISLDSFSMQLDEEGEIGARPPENGEWATIHVGDHWAG
RDHYAWLKTEVAIPVSWKGKQVLGYFDFGITDGGTNSGFESLLYVNKKIYQGVDANHREV
FLKEEHCGTNVSLIFRLWSGLEGGGKPFIQEHKIKKAEIAWLDEATDDLYYTAKAMIQTI
HILDENRPEYQTILTALNRAFYEIDWTEPESDLFYESINKANNYLNATLEKMDKHAAVTI
HAIGHTHIDVAWLWRLKHTREKAARSFSTVLRLMEKYPEYLFMQSQPQLYAYLKEDYPEI
YAQLKDRVAEGRWEPEGGMWLEPDCNLPSGESFVRQLLHGTRFLKEEFGVTSKYLWLPDV
FGYSWALPQILKQAGIETFMTTKISWNQYNRMPHDTFQWRGIDGTEILTHFVTTPYPNSR
GWAYDYNGEMQADVVQGAWDNYKDKNITQDLLMSYGYGDGGGGVNRDMLEMRRRFDRIPG
LPAVKSTKAGDYFDALHEKVKTTDEYVHTWDGELYLEFHRGTYTSQAYNKRSNRKQELLY
RETELLSVLVGVLASDWTIYPQEELHKGWTILLRNQFHDIIPGSSIREVYEDSLLEYEEA
EGLANKAQKQVLTRIIDSDVSDQFTVINDSSWIRSGLVEVPVKLGLEEGEWSSENGKVLQ
VEKVNGKWLILVENVPSHGLANLLFKSSENQGANKQSAFVINNNGIETPFYQILWNEKGQ
LTRIFDKKAQRNVLKENQAGNVLQVFEDKPLRWEAWDIDIFYQEKHQEISTLEKIEIIEN
NSLRAVIKFVWTYHHSKVEQEVILYAENPRIDFKTSVDWHEQHQLLKVAFPVEIRSTQAT
YDIQFGNVQRPTHWNTSWDYAKFETVGHQWADLSEQGYGISLLNDCKYGYDIKDSVMRLS
LIKAGTYPDYLQDQGAHTFIYSLLPHQGDWREGRTVQEAWDLNQPLKSLVGKLQSQDFSL
FQIASDHCFIDAVKKAEDEDKVIVRLHEFMGKRGTVELTSDAPIKGWQECNLLEGKNGEK
QENEIITFAIKPYEVKTFLVEI
>PK3-045_00869 hypothetical protein
MSSNNKWKEIQKLLNQCHSDLKEIQKDLIKLENALKIRKKALH
>PK3-045_00870 Amino-acid carrier protein AlsT
MNIIEKLIASGNTVLWGYVLIAVLLGLGIYFTIGSKFAQIRHVKEMFRLLKVKEKPPEHT
EKKQISSLQAFFVGAGTRIGTGNLAGVAIALAIGGPGAVFWMWMVAILGSASSFVENTLA
QIYKAKDNGRFKGGPAYYMKKQLNKKWMSALFAVMMILSYGTTFNAVQSNTIAVALENSF
GISPVIAGIALVILTSLVVFGGIKRIADISSLIVPFMALGYILLAVFVVITNITEIPHVL
VLIFKSAFGIEQVVGGGIAAAIMNGVKRGLFSNGAGIGGDPIAAATASVSHPAKQGFIQA
LGVFFDTLLVCSATAFIILTSDAYGSGLTGIELSQAAMAEHFGAWGGVFLGIAIFLFAFT
SIIGCYYYGEANLSFISKSKGFLIFYRVIALGMVMFGAVASLQIVWDLADFTMAIMALIN
LVAIAILGPIAFKALDHYMKQRKLGKEPVFFRDDIKGLRGVEAWPLRKKKSIKQVI
>PK3-045_00871 Putative NAD(P)H nitroreductase YodC
MSHLEEIMKSRKSVRIYDSAHKIEKKELEEILALATSAPSSSNLQSWRFIVIQDQELKKE
LREIGNNQAQIEDSSAIIAVLGDTDAYRNVEEIYEKNVSLGYMDQSIADRTINNTLSLYP
NQPKQILAQIASYDAGLISMQILLLAKERGYDTVIMGGFDKDAFAKRFELPENQFPITLI
AIGKAAAPAFNTSRMPIEKIAKFY
>PK3-045_00872 Thiamine thiazole synthase
MKRSSSIAFVLLAIFMLIIAGCSNNTNTEEKAKFKAGTYEGISTGHGGEIKATVTVSKDK
IEKIEISADGETGSISDGATTQLTNDIISSQSLAVDVVSGASESSNGIIEAVTKALEKSG
ADMKALKDAANKVIVEEQKQEDLDVDVAIVGAGGAGLAAAVKASEAGKSVVILEQMPIIG
GNTNKATGGMNVAGTKYQEADGIKDDKQTWFDDTMKGGKNLNDPKLLQTLVDNAPDALKW
LNDMGAGLTKVTLSGGQTNPRIHQPADGSPVGPVIVEVLSNKLKKLNTPILLNTTADSLI
KKDGAIVGVKATDKNKNSFTVNAKSVILATGGFGANAEMVIKYNKDLEGFSTTNHAGATG
SGIAMAEKAGADLVDMDQIQIHPTTDPETGYLFTEGLRGDGAILVNKEGKRFTNELLTRD
VVSKNILAQTDKVAYLVVNQEMADENASLAGYIKDGYAIKGETIEALGKAAGIDSSTIAS
TLKNYTKYVKNKKDEEFDRVHLTQTLEEGPYYIIPVTPGIHHTMGGLKIDTKTHVLDKQG
NIIKGLYAAGEVTGGVHGGNRIGGNAVADIIVFGRIAGETSAIEIK
>PK3-045_00873 putative oxidoreductase/MSMEI_2347
MNVVTLNNGLKMPQLGFGVWQVPDEEAAVAVSTAFKVGYTSIDTAMVYQNEAGVGKAIKE
SSIPREELFITTKVWNSDQGYENTLRAFDESLERLGLDYVDLYLIHWPTPQFDEYVDTYR
ALEKLYKDGRVKAIGVCNFEIEHLERILNECEVKPVLNQVECHPYLAQNELKEFCAKHDI
FVEAWSPLDQGGEVLQDEVITQIAETKEKSPAQVVLRWHLQNNTIVIPKSVTPSRIEENF
HVFDFELTEEEMKQINELNRNRRKGPHPNDMNNR
>PK3-045_00874 putative oxidoreductase
MAQSLKGKVAFITGAGRGIGKAVAVALANEGVNIGLLARTEGALQEVAKEVEALGVKAAY
ATVDVSSLEEVEQAISTLTNELGKADILINNAGIGKFQSLLDMDPEEWKQIIDVNLMGPY
YVTKAVLPQLIEKNGGDIINISSTNGLNGAATSSAYSASKFGLIGMTESLAQEVRRNNIR
VTSLTPSTVATELAVKTDLIKGDAEKYMQPEDIAELIVSQLKLHPRIYVKTATVLGTNPF
>PK3-045_00875 PTS system maltose-specific EIICB component
MMQKLQRFGGAMFTPVLLFAFSGIVLAITIMLNNPQIVGSIADEGTTWNSILTILEDGAW
TVFNQMELLFVIGIALGLAKTANARAVMEAVVVYLTFNYFLSGILEFFGPTFGVDFSQEV
GSTSGMKLIAGIKTLDTGIIGAILISSITVWLHNKYFEKKLPEWLGIFQGSTYVVILGYF
IMIPIAVVVAWIWPIIQSGIGSLQGFLASSGTFGVWFYHLFERALIPTGLHHFIYTPFMF
GPAVVEDGIVKYWMGNLGDFAQSAESLKTLFPAGGFGLYGNSKMFAAPGIALAIYFTAKK
EKRKKVAALLIPATLTAVLAGITEPLEFTFLFVAPVLFAVHAVLAATLSATLYTFGVVGD
MGGGLIEIMSKNWIPLFGNHWDVYVAQIVIGLIFSGIYFLVFRFLILKFNFATPGRETDD
KEVKLYRKKDYQEKQKGRDKKDEVAVTVVENSYREKAAIFLHALGGTENIETINNCATRL
RISVKDPNLVMPDIAFREGGAHGVVRNNKGIQIIVGLSVPQVREEFEKLKNEE
>PK3-045_00876 Maltose-6'-phosphate glucosidase MalH
MKKFSITVAGGGSTFTPGIILMLLENLDKFPIRQINFYDNDKERQQQIADACEIIIKEKD
PEITFLATTEPEEAFVDIDFVMAHIRVGKYAMREKDEKIPLKYGVVGQETCGPGGIAYGM
RSIGGVLEILDYMEKYSPNAWMLNYSNPAAIVAEATRKLRPNSKILNICDMPIGIENLMA
KILGLPSRKDMTIRYYGLNHFGWWTDIRDKEGNDLMPKLKEHVKDYGYDLAKNEGQHADE
SWQSTFRKAKDVYAVDPDTLPNTYLKYYFYPQDEVEHTDPNYTRANQVMDGREKFIFSQC
NRIAELGSTEGSELEIDEHASYIVDLARAIAYDTQERMLLIVENNGAIQNFDPTAMVEVP
CIVGVNGPEPLVQGTIPRFQKGLMEQQVAVEKLVVEAWEEHSYQKLWQAITLSRTVPNAR
VAKQILDDLMEANKEYWPELN
>PK3-045_00877 HTH-type transcriptional regulator GlvR
MLKDLMNKYYDQLSENDLYVINYVLNHIEECKKMSILELSEACTISKSSILRMTQKIGFS
GYSEFKYFLKNEPKSFEPNLDFFTMQMKEIEMTRKLYKNIDTEAIYNQIRNADTIYGFAS
GWGQRNALEEMARQFISNNKKIYIIPAETEFDFLLAKMKPTDLVIVISLSGDVKNIVGQL
RQLAVKSIPTLSITSFNNNHLATLSTYNIYYESFMLGKHYEIEHRSLLGLFTVIDSVYRG
YLDYSVRKNESKD
>PK3-045_00878 hypothetical protein
MVKTIVDKLNLKKYKKMAILNQPKELNYFGELEAYDTELQDKYDAIFAFVLDMAAMRETI
DKIMQSNSLNKKGYIFLAYPKKGNKVYSTFIHRDELFKGLDTDSDGYVGTNTIKFSRMVG
LDEVFTVIGLKEEEKRTTKDASSKASQRVNDYIEKIQAIEDDLINTPELLAFYQSLTPGY
QKEWARYVYSAKQEATREKRKAEMKMILQSGYKSRDTYRKERG
>PK3-045_00879 hypothetical protein
MRFARLADRFWDGITLTNVNHKGIIYPDFAFMITAFLFELFLIVLIGVSIYYFYQWKYYP
DVLFYIGCCILFLLLILTTISIKSIYLKIK
>PK3-045_00880 hypothetical protein
MNRLNAFSKKHSKINYSVLLAIIFGGFLIFGLSENVKGPAIPIIQADFLLSESQIGFLLA
INSLGYLIACTFTAALANKIGIKWTGIVAFAAMALSGICLYFSEIYFTLSSSYFLLYIGN
GMLEIGLGIMAARIFTKNTGFMMNLAHFFYGLSSMVAPIIASWMMKWTIAGEELSWRGMY
FIVLLLAILPIIPSIFGKFPEEETSDDESVSYRFLLRDPVAWLIVMILSFGVVSELAVGG
WLVNFLIKAYSWNVETASGMLSMFFLFFMLSRLILGPLTDKIGYTLSIMIFAAFSGICSF
AGIIIGEKGAILFAIAGIGIAPIYPTVMALLAKRYPKGTGTAITFTVTLMGIASVFGNLL
IGVIIDGINRLFYTSNGVIGQQAGYGFIALLSLLCSICCIILYYYLRKRQEVI
>PK3-045_00881 hypothetical protein
MVDFFKIIAEIVNILHDIIMDAAAILGWQATDKDLHLWIIGLIGIIAFFIVQFIFKRLAA
WSIKSISFIYTFTLILVLVFAIEIQQGITGRGNMEFADAVAGINGFLLFFGIYLVITLLF
KGIKKILHKKSNHVDTNNHSNEDSNLPSRQSRYHK
>PK3-045_00882 Sporulation kinase A
MLLWNRNRQIKSWGQITLVTISILFTTYQFVIKHEPFFNIDFFLFTVLAWIVGWRYDLSK
YYEKKAKDSEESYRLLMDSLPESIFIHSLRKKKLVYVNHAAVRMMGASSGQELINRSFGE
FVTADYMERWKMRLNIALEKKKPLSPIEYKMKRVAGNDFFYEASCLAIKLNGEDVILSIG
KDITASKEQTMHLLQKSEKLAILGEMSAGIAHEIRNPLTSIKGFIQLAKAENPQNKYFEI
VLSEIERINGIVGELLFLAKPTADVFLVKDIRNIIKDVVTLIHTQLSLHNIQIKEVYEWD
IPMILCEEKRLKQVFINLLQNAIEAMPKGGYISIKGTSLQDGNISIEIMDQGVGIPDERL
GTLGEPFFTTKEKGTGLGLMTCFKIIESHNGNLSFQSELNKGTKATIIFPAATQDTLLGT
VSKA
>PK3-045_00883 Cystathionine beta-lyase PatB
MINNFDEVVNRRNTYSIKWDGGKIIKEMGLTERYDEETIPLFTADMDLPVPQALVDALHK
TVDNRIYGYSIFPDEYYEAIQLWFKKRHNWEIDRESIVYSPGTVHAINMAVRAFTEAGDG
VIIQRPVYPPFTSAIEGNGRVVRNNALLQDEAGYYTIDFADFEEKAKEESTKLFILCNPH
NPTGRIFTVEELTRLNEICVKHNVLIIADEIHGDLIRRTQKFTPIAMVADNQDHLITCTA
INKTFNVAGLHCTNLIIPNVKLRNAFNKEMGHQLASPFTISALIAVYKEGEEWLEELKEY
IDGTMEWVKAYIDENMPKVKVTIPEGTYIMWMDFSGYGITPEEVHERIYHKANVLLEDGS
MFGEEGINHQRICIPSPRPIIKEAIERIAREFADLK
>PK3-045_00884 hypothetical protein
MIFIVIQQAVQTELIKKYWEMYESKKERTYIVKPSMPIMYFGNSKKYFESPIRIITVGLN
PSRRDFPDPDPFQRFQSMKRDHHYQFNQQYITALDQYFEKDPYKAWYEPSFEPLLNGMNA
SFYGNKENTALHTDICSPLATNPTWDSLSKEAKKDLQAEGVKLWHELIEYLQPDVILISV
AGEHLSKIQLETESDWETVYTVPNSRYLINSKKVKLAAKTADVYYGRSAEIPFGQVSPEN
KVKLGEYIKAITEKKDQPIDFKAFHHAILESEQRDNELFGWNQEAN
>PK3-045_00885 Bacitracin export permease protein BceB
MTVSNLVIRNLKKNIKYYYLYIFALVFSVSLYFSFVTLQYDPSMDVVENSVKGGAAIKAA
SILLIAIVAIFLLYANTIFIKRRGKEIGLFQLIGMTKSRIFRLLTLENFILYFLSIVIGI
FIGVSFSKITIMILFKVTGVQGIAKLHFSPEALVQTVIVFCAIYVLIMLMNYIFIKGQTI
LSLFRVTSSTEARVKKMSVWEMIIGATGIIFIISGYYISSQLFNGNFQSMNELFFAMISI
LALVIIGTYLFYKGSVSFLFNLIRKSKNGYININQVLSLSSIMFRMKSNAILLTIITTVS
ALALGFLCLSYISYYSAEKNAEQNVPADFTFDNVQDAEAFTSRLKEQKIAYKENRIPVIQ
TIFDIKGVLANIPEGFAQDTSEMQLPVISEDYVDDVHLSKEEVLFDGYSSTLEKFIQLKS
TGSITMELKGQSIPLSYLGMKEMNILPFNFSSGGLMTVIVDSSVFDLVEKNRDKSLQSPS
TLYIAININKDQDIIDADKIYQKLTFESQKTLSRYETSQSQKEFMGLAMFIVGFLGLTFL
ITSGCILYFKQMDEGEEEKYNYTILRKLGYTQNDLVNGIKSKQLFNFGIPLLIGLLHSYF
AVKSGWFFFGSELWAPMFIVMGLYAVLYSIFGILSVIYYKKIISEAL
>PK3-045_00886 Bacitracin export ATP-binding protein BceA
MDILVASKVHKSYGNKANRQEVLKGVNLNVQKGEFVSIMGASGSGKTTLLNVLSSIDQAS
GGTIRIVEKEITRLKEKQLAEFRKNHLGFIFQDYNLLDTLTVKENILLPLSITKTPKKEA
HQRFDTLAKELGIYEIKDKYPNEISGGQKQRTSAARAFIHEPSIIFADEPTGALDSKSAS
DLLNKLSHLNQTRSATILMVTHDPVAASYCNRVVFIKDGQIYTQLYKGDQDRQRFFQDII
KTQGILGGVQNDRK
>PK3-045_00887 Sensor histidine kinase GraS
MIRKFLVEKRSWILFILFLQLFQLFMSIIDETISFYSMIYICFISILLFVIFCFIRYQKE
TTFYKSLSAREDDLDLTTLASAKTPFEKIIADSFTTQTSMLKIERYQNLQQLELEKDELL
SWIHEVKTPLTALRLLIDAIENQEMKTSLTFEWLRIHHLLDQQLYQKRFSFIQNDLYIEN
VDIEMILFEEIKTLQSWCMQKGIGFDIELQKKMILTDGKWLSFIIRQLLSNAVKYSNESD
IIIRSYENDGYNCLEITDNGIGISPQDLPRIFAKGFTSTSKHQNNYATGMGLYLSKKIAD
VLKINIAVHSKLNRGTTFTLTFPKNNEFNQIHI
>PK3-045_00888 Response regulator protein GraR
MFKILLIEDDQTLFQAIKERLEQWSYEAIGIHDFNNVMQEFTEKKPDLVIIDIQLPKYDG
FHWCRLIRSHSNIPIIFLSSRDHPTDMVMSMQLGADDFVQKPFHFDVLIAKIQATLRRVY
NYNIEQSSLKTWCGATIDFEKNTVTSVNGEIELTKNEMFILKILLDKKNKIVSRDDLINE
LWNDKRFVSDNTLTVNVNRLRKKLDELSLGSNIETKVGQGYMAIEEDTL
>PK3-045_00889 Putative sensory transducer protein YfmS
MEEVCYYSKVILTDWSAASVIKQVESLEDIIPIVPIIKAAIPADLSIAICDKEKFIAYFP
GEIINLHIKTNQPLQSDEPLREAIQLKKTLKQEVPADFYGFEFIGTASPILNKKGEVIGG
IAVQLKRQTEIRNIVDQITKSLTQSQKHIDHIADGSHSLVDFSKILLEQSSVAEENIRKT
NEVVSIIKKVADQTNLLGLNAAIEAARAGEKGRGFEVVANEIRKFSKETVSFTQTISQTM
EQIKQTTQSINESIGKIAAIGEKQADSIEHTSVFMEEILEMAKKLNDYSNKL
>PK3-045_00891 Xanthine phosphoribosyltransferase
MELLKKKIEKEGIVLSDHVLKVDSFINHQMDPQLMKEIGLEFARLFKDAGITRILTIESS
GIAPAIMAGLALDVPVIFARKRKSLTLTSDLYTATVYSFTKQESNEITVSKKYMHSDDHV
LVIDDFLANGQAALGLANIVEQAGATVSGIGILIEKSFQQGADDLIAKGYRVESLARIAS
LKGGKVTFAEQRIHDGIYAGGY
>PK3-045_00892 Nucleobase transporter PlUacP
MEKMSVKTWSVGLQHVLAMYAGAVLVPLIVGGALKLTPEQLTYLISIDLLTCGVATLLQV
WKNKFFGIGLPVMLGCTFTAVGPMIAIGSKHGITAIYGAIIVSGIIVVLISSIFSKLVKF
FPPVVTGSVVTIIGLTLIPVAFNDMAGGEGSADFGNIKNLVLAFGVLAIIILLNRFTTGF
IKTISILLGIIIGTVIAAFMGMVHFSEVGEAKWIHGITPFYFGTPTFDLTSIITMTLVAI
VSLIESTGVYLALGDITNKKVSEKDLAQGYRAEGIASVIGGIFNSFPYTAYSQNVGLVQL
TGVKTKNVIYAAGTILVILGFIPKIAAITTLIPTAVLGGASLAMFGMVVSYGIKMLGQVD
FNQQGNLLILACSIGMGLGVTVVPEIFMKFPESIRILFQSGIVAGGLTAIILNILFNIIP
GSRAKTVQMEEKTAA
>PK3-045_00894 Methionine import ATP-binding protein MetN
MIEFQKVAKTFKLGSREVNAVKDVSISIAQGEIFGIIGFSGAGKSTLLRLVNLLETPTNG
NIQVQGVDVASLSPKEIRKLRRRIGMIFQSFNLFTSRTVAGNIAYPLKLAGVSKKEIKER
VAELLQFVGLSDKADDYPEQLSGGQKQRVGIARALATSPDILICDEATSALDPDTTGEIL
RLLKKVNKDLGITILLITHEMHVIQEICDRVAVMENGEVIENGSVFEVFTNPQHSTTQRF
IQSVQQDRPSASLLAEWRNKGGDKLYRVIFKGEIASDPVLSKVTRKFNVDVNIVYGSVRE
LQEKFYGNLLVSFEGSKENIKAVLHELEALVTVEEVLV
>PK3-045_00895 D-methionine transport system permease protein MetI
MKVDWSTFWPRIVESTGETILMVITTLILGSILGITIGLLLFVTRKGNILENKLVFRLLN
ILINIIRPIPFIIFLVAISPLTRAVVGTTIGTWAAIFPMTIAASFGIARVVENNLVSIDP
GVIEAAKAMGASPLQIIFTVLIPEALGPLILGLTFVTISLIDFSAMAGTVGGGGLGHVAM
TYGYQRFDGSVMLVTVIILIILVQIAQWIGNTLSRKIMRR
>PK3-045_00896 D-methionine-binding lipoprotein MetQ
MKKYFAILLLLTTIWALAACTSDSASSKDKTVKVKIGVTGSDGEVWPTLKKKAKAEGIEI
ELVEFSDYTLPNQALENGDIDINSFQHIAFLSQFNEENKTDLTPIGTTVIAPMGIYSEKV
KDVSEIKEGDKIAIPDDPSNQARALKLLESAGLITLADDFGLFGDPSKIVENPKKLDILP
VVAQQTPRVLPDVAASVINNGVAGQAGFDPVKDPIYLEDAEDKNVLPYVNIFAARTKDAN
NETYQKIVELYHEEEVVKAVEADTNGGSIVVDIAKDELAKQFKGL
>PK3-045_00897 N-acetyldiaminopimelate deacetylase
MSNTLSSLDLINESIQTNKELYIETSQLIHANPEIGNQEFFASKKHVDILTNAGFKVEIA
VAGHETSFYAVKDSGISGPTIAFLAEYDALPGLGHACGHNIIGTTSVAAGIALSQVLSET
GGKVVVLGTPAEEGGPNGSAKGSFVKHGYLKDVDVALMIHPSGQTSLTSETLAVDPLDFH
FYGKAAHASGSPEKGINALDAVIQLFVGINALRQQLPDDIRIHGIITNGGDAPNIIPEYA
SARFYIRAETWKKTEEVAAKVRAIAEGAALATGATVKVERFQNEVKDFVLNPILDGILKE
ELEAVGETVVTERSRGKGSTDAGNISYEVPTAHPHIKIGPDDLITHTNEFREAAKSATGD
AALVKGAQVLAKTGYRLLSDSVLLNRVNKAFEAAKKEKVNSI
>PK3-045_00898 Nucleoside permease NupC
MSILVGILGIIVTIAIAFLLSNDKKRINFRAILVLFVLEFIVALIMFKTTVGLKIVEATS
NGVSKVLNYGYEGVNFVTGGLVPEGGSVFFINVLMIIIFTSTLLSLLTHIKVLPLAIKYI
GGALAKITGLSKVVTFNSINSIFFGQSEALLAIKGHLDTINANKLFIVCTSAMGSVSASI
MGAYMEMIPPQYVLAAMILNALSALIIATLLAPISKDEDESINVKDVSNTNSVFGAISAG
ALDGGRVALIVAAMLVAYVGLLALIDGFFTSIFGIGFTGILGYIFAPIAWIMGIPGSEIV
TAGSVMGTKLAANEFVAMLQLQPLLGELSNKTVGIVSTFLVSFANFSSIGIIAGSIQAIN
AKKADIVAKFGLKMLLAATLASILTATIVGLFL
>PK3-045_00899 hypothetical protein
MAESKEKLEKELAVAGKHYSEKKFWSKIAKFGKKAGSSVVYAVLLLYYTLQKPNVPKKVK
ATIIGALGYFILPLDLIPDFLVGIGYTDDLGALGLALFQVAMYIDDDIKSKARLKLTEWF
GNKVDTTEIDKKINK
>PK3-045_00901 hypothetical protein
MRTRKLFTAPQMGYLHRVIQKLERGIVMYFQPYSAHYGQQSFLPQYRMVSLLKGGESRMT
PPSIGGGAVPPSPPSGGGILPPFPGGEQPPPPVGGSPAYPDAPPIGGGTDPGSPQLNQSQ
ASTSTVESMSIRPCIFRFTYIWLENGKGFWFFPTLIGRHSIAGYRWQKKYWIYYRTDTNR
IRSFQCI
>PK3-045_00902 DNA gyrase inhibitor
MNITIEEIPKSRIAFFRNVGEYGEKQNKELMESFKKWAKSNGIFDNSIILGIPQDNPEIT
PKEECRYDVCIVVENDFNVAKPAQVGEFSGGKYAVFLLDHTKEAVSEFWGNIISEIERNN
LSLKEQPIIERYTSQMIEDHLCEILVPIQ
>PK3-045_00903 CRP-like cAMP-activated global transcriptional regulator
MKQKMVSPCPKRVPIFYSLSDSEIKKITDIVHHRLFKKGEMIIEEGDISTSLYIIHSGKV
KLSKLTIQGKEQIVHLLTTGDFFGESNLFHDDMVMNLSCHALEDTKICVLNKQDFDHIML
SNPDISFKLLKTITKRLSHTEDLARTLATKDPEVRIADMLIEFCEKFGTEHQNTVLITLP
ITREEISSYVGLTRETISRKLAKLADKDILTLIGNKQILIHNKGKLQSIGG
>PK3-045_00904 Iron-sulfur cluster repair protein YtfE
MNAIFTEETKTGDIIIKFPAASKLFKEYKIDFCCGGNRPIGEAIKSLHLEDKDLVKVLNI
MYEQMQTTEEIDWMNMPLTDLVRYIIDHYHANTRDLLEELDGFVSKVYRVHGERDLHLKD
VYTQFYLLKDELEQHLLGEEQRIFPQVIEYEASKEAESLEAARAEISILEEEHEGAGGIL
KKIRQATNDYELPLHACNTYRLTYLKLEELESLTFDHIHLENNVLFRRL
>PK3-045_00905 2-hydroxy-3-oxopropionate reductase
MKIGWIGLGNMGIPMALNLIKAGYELTFYNRTPDKGKELIAVGAKQAESLTELVDNSNLI
FTMVSDDNAVKSIYLENGILSHAKAGKVFIDMSTVSPQTSQFIYNTALENGVKFLDAPVS
GSVQPAKEGNLLVLVGGEEEVYEQVKAVLEPMSKLSIYLGPSGAGSNAKLAINLLLGITV
QGIAESVLFAENQGIKKEDMLTIINESAVGTAISKMKSSSILKDEFPAAFALKHMAKDLR
LASETAELNAIGASAHKTYQSALENGLGEFDVMAVLKELKGDGSTSL
>PK3-045_00906 Hydroxycarboxylate dehydrogenase A
MQIQPEDIVRSGPNQYICKEGILKVLDNLLSPFQAPAIITGYKSFEAYSQYVSSIPEHWQ
IIQHAGYSSQQAIEEIAPSCGAADVIIGIGGGIILDTAKAVADKLNIEVVLIPTVAGTCA
ASTPLSVIYSPDGEFERVAYHRRSSYLTVVDPAFLIHAPIDYLKSGIGDTLTKWYEAEAI
IRNANDERAHSLFVQAALSQSVFIRDILLKDSIKAVQSSEAGKVTASFTKTVEAVITLAG
TVGGFGGRYGRMSGSHAIHNGLSFIEETHTILHGQKVAYGILVQLALENRIDEIDALLPY
YQQLGFPTNLADLHIVDNQAIALQKVAEHAVNPKESLQLMGSYRADEVIAAMNVLESLTT
SKSV
>PK3-045_00907 Tunicamycin resistance protein
MIIWINGTFGSGKTTTAYELEKRLENAFVFDPERFGYVLMKNIPPALQKDDFQDFPLWRE
TNYSLLKQITSDYDGIIIVPMTITNEAYFHEIISRLQNDQIIVKHVTLMASKATIKKRLR
SRLEGEDSWAYNQAESRLKQLELPIFKEQVDTNGLNIEEVIEKVAQVIGLKLKDDKRNPF
RKRTDRLWNKLKEISLFK
>PK3-045_00908 Putative quinone oxidoreductase YhfP
MENNFQAVVVDNKDSNFSVETKRVSVEDLSAGEVVIKVHYSGVNYKDGLASTPDGKIVRT
YPHIPGIDMAGIVVSSEDSRFKEGDPVIATSYEIGVSHSGGYSEYARIPADWIVPLPEGL
SLKEAMIIGTAGFTAALSVQRLQDNGLKPENGSVLVTGATGGVGSFGVAMLSQLGFNVIA
SSGKKEAEGYLKSIGASHIIGREDVYNGKIKALDKQEWAGAIDPVGGESLAAIISKIIYG
GSVAVSGLTGGGAVPTSVFPFILRGVNLLGIDSVYCPMVSRQKIWGRIATDLKPKNLSSF
VYKEVSLQQLPEELPQILEGGITGRIIVAVE
>PK3-045_00909 hypothetical protein
MAFFNKKEGMKQISMLYKPRTFSPEILVLQSLDQRMELDLNKKQYLAHLKKGLAGEKLFD
SFTETFLSDCYIINDLLLQINNTTFQIDSTIINSDEIHLFEIKNYEGDYYYQNDRIYTMK
HKEISNPLNQIRRNESLFQQLLQKHGWENKSITSSVVFVNPEFTLYQAPLSLPFIFPTQV
QRYLKRMGHPSKKLNKFQKQLAEKLTALHIDKSPFSKIPIYEYKELQKGIFCKTCHSFKV
VEIGMKVVCEECRQEETVEAAVLRNVEELKLLFPNEKITTPLLYDWCRIIHSKKRIRRIL
VKHFKLAGVNRWSYFE
>PK3-045_00910 hypothetical protein
MPKSRRQKGKGEQRGALCAQKQETERKKETERSALCPKARDRKKKGNREERSVPKSKRQK
EKRKQRGALCAQKQETERKRGTKRKALCPKAREKRAKGNREERSVPKSKRQKEKRKQRGA
LCAQKQEIEGKKGTERSALCPKARDRKEKGNRKERSVPKSKRQKGKGEQRGALNYQKQET
KKKKDTDSRTFLE
>PK3-045_00911 hypothetical protein
MGKSLIQQQIVTRDSKGLFLTGDESDTIAVSPNVEESFIKKYLIPISTYHMPSELKKSSD
NEIENYPPQFTLMQPDTGELVIGKSSFAPAESPKRKNRLFVHNYIIPVSRKEEWIHKPSQ
IFHIEHFYSLEDIDNLGEKLEEIEYVSYTKENIFTKKQELFHVLQLDEKKFKELLFACIT
AVAEKKRVYISFQSSPHLQHKYAMWLLELLFIYMPYETRRLFGATTFHNEPEILENIHVM
FVEQGSIRLRKRAVENQFTFDLSQDKRNGLNFKEEDHDYLHFAFEALETATELDEFFVYC
ERALKGLDKQKKLALQSYNDLFLLFYMEKLDYYFYDNDKVATLKMLYTFLQKNHREKLEL
VHIFKQVLHREERMKDASIVRDYLRFVLEIQKVVEHVDVVEFIVKTIAYYEGEDICQSLW
EILGKYPETYQQVLSYMSDIFSYSEIIEDYLKHEFSFQHSLSQILINIKNLLHVNSSFEH
NATFLKSTKNRLVYEVKKSSHPMAIVFEIIVYFQRSIPFESYKRMVLPDVKAQLLVQLQL
EKVDLADVKQFGEIFLQGKEERSFEIKGWEKEKFEVLELLYTYFYLSQEQTQHVFRMASE
PIKAKASDLAQEITKDNGLFKPYERFLLLFPGGMEGVEHRQVFSYIAIYGSEDEMLDYIE
WSLKKFGTSPRFNYALKDYLITDRNSIWKKKERKRELASIRSQSLKKLLKEVREQTANPG
VKFFRKYGILLIVLIILGVIGYFYVN
>PK3-045_00912 Succinate-semialdehyde dehydrogenase [NADP(+)] GabD
MQYINGEWRHSASGKTYSVYNPATAKVIEEVARGGKEDGHLAIDAAQNALPLWAKKTAKE
RSIYLKTVADKLREQIEDLAAIITTEMGKPVAEAKGEVNLAADYLEWYAEEGKRIYGDTI
PASSETKRIIVLRQPVGVVGAITPWNFPIAMLARKIAPALAAGCTVVLKPAEATPLTAIE
VMKIFHEVGLPKGVLNLVHGDAAPIGDAMMERQEVRKITFTGSTKVGKELAAKASATMKK
ISMELGGHAPFIIFADADLEKAAEGVIASKFRNAGQTCICTNRIYVQKTIAERFSDILVT
KMKNLVVGNGLHPEVTIGPLINEAAVAKTEEHIQDAIQKGAKVIYGGKKPAGEEYDNGHF
YEPTVLLHATHEMKIATEETFGPVAPIFEFETEEEALHLANDTSYGLAAYFYTKDISRVF
RMSEGLEYGIIGINDPVPTTEQAPFGGVKESGVGREGGKYGLEDYLEYKFLSLELDI
>PK3-045_00913 hypothetical protein
MGVIIILVDQLPRTLGELKQSIMKENNLVNQLIFKVGLTEQQISLIDNKIIIIAKHKRIP
VLEIIESSSDNLAEIIDRLLIDKYKEMLLRNLEEKLHFKVQLILKDYDSMREISGTIIML
DKKIESYLAG
>PK3-045_00914 Aliphatic sulfonates import ATP-binding protein SsuB
MYKLEVRHTNKIFKKEGKEVVALRDANLKIQEGKFISLIGPSGCGKSTLFNIIAGLMKPT
TGEVILDGKNIVGKNGYVGYMLQKDLLLPWRSILQNVILGLEIKGVSKKEAVARAKPLLQ
KYGLGGFEHHYPDELSGGMRQRAALLRTLLYDQDIILLDEPFGALDAQTRLLMQTWLLDI
WADFKKTILFVTHDIDEAIYLSDEIYVLSPRPGRLKEKVDVSLARPRNQDTLLHPDFIAL
KKYLFALLKEEVVLAK
>PK3-045_00915 Riboflavin transport system permease protein RibX
MRDNSEQIILPHKVKMQEVDTLPIIEDEELKERRKKRITLIGQVLIGILFFILWELFTKW
KIIDSYYWSSPTIIWETGVIAFTEGTLWSDLLYTSGATIIGFLFGTFFGALLGLSFWWSY
FYSRIAEPYLIAFNAIPKLALAPVLVILFGIGFSSKVVLAFMMTVIVTAIAAHSGVKSVD
ADLERMLFSLGAKKHHIFTKVVIPSAMPWIVSSLKINIALALAGTIVGEFISSRQGIGRM
ILYAGQIMNINLVWVGVVVLSILSVLMYIGTVWLEKRLLRGKGLRE
>PK3-045_00916 hypothetical protein
MKKNRYFHFGIYLILLLIIFSGCSSTKGTSSKKESENGTKKLVIAEPVHLIGYLPLYAAI
REGFFEEEGLEVEIITATGGAHVTSVVSGDAWGNIGGPESNQMANTGNADPIVSVVNVVN
RANVYLMADTEQTIANTSKEKLADYLKGKTIAAGRFGGSPNLLTRWLLMDVGLDPEKDVK
LEEPADASAVVSLVESGQADIANGAEPQITEGINKGVWAEPFYSFASLGDYPYSVLSVKK
STIEEEPETVKSFVSAVMKGLKTIDEDHELAMEILKQEFPSTAEESLQASLDRAYADSLW
SKDGFISEEALAKPMEVVEKTGVYTNGYQYDKLIDMQFVDELSK
>PK3-045_00917 Peroxyureidoacrylate/ureidoacrylate amidohydrolase RutB
MNQLEWNPKHTALLIVDVQNDYCHKEGSLAQQDLDVSMVDEMMPNLKDMIASMKDINVPI
IYIQTIHEDSTDSETWIKRLKGKNQKGLCRKDTWGAEFYQLEPEKNDVIVIKHRYSAFIN
TRLDSVLRALKIETLLMAGVSTNICVESTARDGFMLDYDVIFLSDCTAAFSKEAHEMTLQ
TINQFFGTVATSKEVVKSIHALQ
>PK3-045_00918 Riboflavin transporter RibZ
MTKNKLSFLEVRKEASASSQKFQSILLLLSVCTGAFLSHFSAGFVNIALTDISIDFSAKL
SVTQWIVNGYLLAIMLFLPLMGKLADQFGKKRIHNLGYLVFAAGACGSALSFNIPMLIIA
RVIQGSGAAMLQAVNMAIVTDVYPEKHRGKALGIISTSVGIGALLGPSVGGFFIESFSWH
ILFWTVVPISIGAYFLAQKFVPIDRHFEHSSFDYKGSIYFGIGIVSFVFVLNSIGEGAYK
IYLLGIACVSVACFLFFFFHSKKEEHPFIQPSIFSSPIVKAGGLILMTSYCAAFASTVIL
PFYLRGVLGFSAEQSGLLLMCYPLLLAVLGPISGSLADRFGGEKVVLVGLGLLCITMLGL
SFLSPGTSLPTLIILLCLLGFSMGILTSPNYSIMMLYVPLQFLGMMSSTIALLRNIGMVI
GTALAITFMNMWLDGTITDWMNDTRRSEFEAVMLGFHYLFLLLFVLLVLIAIYFVYSVWR
KKKEE
>PK3-045_00919 hypothetical protein
MKISIRYKLLASFLIVSILFMILSYYSYKSTKETVETYDYVIETVTELRSISEQIQTNAA
REISNLRGYFVYRTDAYKNRVNGASTNIDTLVNTGIEISTEAETVKRLKDIQTLNKELTH
KANALMNSNNPSPSALDEITTLSDSLSDQTEAFNIWLTHDILNPEVERAHTDSEQRMVLV
LIFSVLVTLLSIVMGFLQSALIMKPIQYLKTNMQKVAKGNLHTAKSPIKSRDEIYQLNEA
FEQMKENLAKMIVNMTESSNLVAASAEQLNASAEQSSNASAAIASSIQAIAASNEHAIVK
ISGNTLALDSILTGVEAIKDRSLHVSALSQAAFTNAEKGTKQIEDNLTQMKFIYDSVQRS
NTIIASLADRSQEIGKMIELISNIAEQTNLLALNAAIEAARAGENGKGFAIVADEVRKLA
EQSQASAQDISQSLHGIQQDTSDAVTMLNETMDRAKNGVTISTNTVESFSTIVSNTQKVA
PEIEEVAQTVATITIQIKDVVEVANEITLLAKENGNSTEEVAASTEEQSASMEEIKASAE
SLSSMADELMKIVSQFNSEN
>PK3-045_00920 hypothetical protein
MGNPDITMYYFEQNRYIPNHPYLPALHYKRAMENKEDEMEKVFQQNNWKNTWSGGVFSYH
HYHSNAHEVLGIKTGSALLQIGGEGGSKLIVKSGDVLLLPAGTGHKKLSASPEFEVIGAY
PNGEDYNIKTDVEKDLDGVQEEIESAFFPAADPVYGENGPLSKMWRQK
>PK3-045_00921 Phosphoglucomutase
MAYKEIVEKWTSFAGLEANLKTQLTELQTSDKLLEDSFYKHLEFGTGGMRGELGPGINRM
NIYTVRKAAEGLGKYIVEQGEEAMKRGVAVAYDSRHQSPEFALEVAKVVGKLGVKSYVFE
ELRPTPALSFAVRYLNTFAGVVITASHNPPEYNGFKAYGEDGGQLPPEAADIIIKYVNEV
EDELTIEVLEEKELLEKGLLTYIGAEVDAAYVEQLKTIQLNRLPEAKDLKIVYTPLHGTG
NKPVRAGLEAFGFENVTVVKEQELPDANFSTVKSPNPEEHAAFEIAIRYGKEIDADVLLA
TDPDADRLGVAVKDTSGEYTVLTGNQLGALMLEYLLSEKKAKGMLPENGVVIKTIVTSEI
GRTIAKSYGIPTIDTLTGFKFIGEKIKEFEQTHEHTFLFGYEESYGYLIGDFVRDKDAVQ
SAIFAAEVAAYYKAKGLTLHEGLLEIFKKYGFYQEGLESLTLKGKDGAEQIAYIMDTFRK
APIKEVKGLNVVAVEDYLTSKRSEGLTETLIDLPKSNVIKYYLEDGSWFCLRPSGTEPKA
KFYFSVNSSSLEESTSKLEALKLGVMEQVNAVIDGYNK
>PK3-045_00922 Single-stranded DNA-binding protein B
MINQVTLVGRLTKDPELRVTQEGTSIVHVTVAVNRNYKNQAGDYDADFVQCTFWNKVAEN
TAQYCHKGSLVGVVGRIQTRNYENQERKKVYVTEVIAESVRFLDPKKLEQTIP
>PK3-045_00923 hypothetical protein
MNNVPDLMVTLIKMQAKTNEKLEQCNVRIKQLEHIIQMETITRTSPTS
>PK3-045_00924 hypothetical protein
MINLFPTEIQTESNLDSEWLSLISEAKKQGLTQEEVRAMLTILENSNE
>PK3-045_00926 N-acetylglucosaminyldiphosphoundecaprenol N-acetyl-beta-D-mannosaminyltransferase
MDKKWLGNLKVNVISSKEAITYIKEKLDKRIATDVFFLNDHGYNIAQKDTEYREMLNNAD
LLLNDGIGIEMGAKLFGFSFKENLNGTDFIPALFVSLNEEKRNQPYRVFLLGAKPGVAQK
AQERLQQTYQNILFVGNQDGYFPKENTENIISQINESKADILLVGFGMPLQEQWINEYRS
KLESTITMAVGAFIDFSSGEVTRAPKIFRDLRLEWLYRMGKEPRRLWKRNVVGHASFFYS
IYKQRKIN
>PK3-045_00927 1,4-alpha-glucan branching enzyme GlgB
MKTKKHPYLALCLISLLIFTSCGGYLPSKKAKADNLLDSPIVNADKSVQFSYDNASAQEV
KVAGNFTDWQNGALSMKKDTDNRWSLSISNLAAGVYQYKFIVDNEWITDPANETMEDGNS
RFVVPGLNLDSIPGKVEKSKSYPLEATLVNKDGSTQKETELTWSVKEKVEGIDIVDGRLT
IQDNAKTNESFILLVEKDGEKVEKKIDIVGNMYSYTINYYRLDEDYTKWDLWIFNSGIPD
NGFPFTEEVPNNYTFTSGNYSFPENEITIIPRKGNWEAQDIQNSIKIADGKQAAEAWIIE
GVETVFYAQDDAIKAIKDLKGGDYVRRHIQFMYDRPDLDYKDWNIWVWGTGVKDDQIDFD
RNLHGMATAAINVSEAAQSVGFILRKGENWDTAIKEGNGDRYIPLNTSDLITKVYVTSGQ
EELYIVPEVTGPVLENGNATFYYRDKDLYAKNEMNKIEKVELQFNGKRYNMTNEAKNERF
SYTIENIPEGKHPYSFFVTIDGIETEVTDPYNTENGASMLVYEKADFDLLTDITPKEVTY
NDNAVLSVDWQTNKNTAIREVYADLRAIGGKEKVAIDPKLKELTIAIDQNTTTGAKEIPV
YITDLYGNTHTDQAKITVKARQSVGKDDFDWDEARIYFMLTDRFFDGNSANNDPYGIGYD
PSKPGTYHGGDFKGITKKLDYLENLGINTIWINPIVENIQYDVRYEKPDTPYYAYHGYWA
SNFEKLNPHFGTMEDFHELIDAAHERGIKIMVDVVVNHTGYGLKASDAVNDGKIANFPTA
EDRNRFAGMFRDGGTDTVQGELSGLPDFLTEDPDVRKQIVDWQTSWIEKSKTAKGNTIDY
FRVDTVKHVENTTWSSFKNELTKVLPTFKLIGEAWGAQVNDDQGYLNSGMMDSLLDFDFK
NLARDFANGHIERVQSALEERNNKLSNTGTLGQFLGSHDEDGFLESVDGDIGKLKLAAAL
QITSKGQPVIYYGEELGLSGANNYPYYDNRYDMDWNLTKNNDVLEHYTKLLNVRKKYSSI
FSKGTRTHLAGSDAEGYSVFKREYTNQQIFVALNTKETATDATFEVPFMKEAVDLYSGKT
YSISENKITLTIPSREDGGTVLLVDAGQAKPPHPTEPEVPSTPGETDSETPPTSNDNGGN
QPGSDGSNNQGSKQAAEPSTTPNKGNGIAALPNTATDSYNIILIGLGLLVIGTVIFIRRK
KHTANE
>PK3-045_00928 UDP-glucose 4-epimerase
MILVVGGAGYIGSHLVKELVEKEEVVVLDNLATGHKEAVDSRAVFVKGDLGNVEDLESIF
SKYPIKAVMHFAAYSLVGESVQDPYKYYENNVANTLTLLNVMLKHNVKNFIFSSTAATYG
IPKEEIIVEKSETAPINPYGRSKLMVEQILADFHTAYGLHYVVLRYFNAAGAHVSGEIGE
NHDPETHLIPIILQQLLGERESISVFGTDYPTEDGTCIRDYIHVTDLANAHIAALDVLLN
ETKKAETYNLGNGVGYSVKQVIEMCEKVTGTKANVILGDRRSGDPARLVASSEKIFSELG
WKAERGLETIIESAWKWHNK
>PK3-045_00929 hypothetical protein
MFNINKVHHIAIICSNYEVSKHFYVELLGFKPINEVYREERDSYKLDLLVNNIYQIELFS
FPNPRERPSYPEAAGLRHIAFEVNNIEETVQYLQSNNITVEDIRIDPFTNKKFTFFADPD
GLPIELYEA
>PK3-045_00930 hypothetical protein
MKIKAGSWRLLSSQDKQFILQTVCTLSQYKGKAHSN
>PK3-045_00931 Teichoic acid glycerol-phosphate primase
MVRELAIYLYLKLFSFLFEIAKLFPLQKKIVFCVSFVENTTHLYDELKKNNPNIPCILLA
DYKTYRFFNDKMITDPVLLFSPKYPLSFLKGIFHLATSQVIVLDNYYGFLSSVSFKENVK
KLQIWHANGAIKTFGWNDLSVKDRSKNAKGRFAAVYKQFDYIISGSDKMSAIFCEAFSAS
SQQILNTGIPRTDIFFDKDHREKIKTSFYKKYPNLKNKKIILYAPTFRENEEESANQIRL
DFSYLKDRLESDYIFLVRLHPSITNQMDFSEYNGFVYNFSDYPILNDLLFITDILITDYS
SIPFEFSFLQKPMIFYPYDLDEYRKTRGFWVPYHELVPGPIAYSTEEIVQFIYHSSFKME
KIANFHQEWNTYSIGNSSKNVVQTINSWLTKQ
>PK3-045_00932 Glycerol-3-phosphate cytidylyltransferase
MKKVITYGTFDLLHWGHINILKRAKELGDHLTVALSSDEFNAIKNKQAYHSYDNRKMILE
AIRYVDEVIPEHNWDQKIRDVVDHNIDVFVMGDDWEGKFDFLKDYCEVVYLPRTVGISTT
KIKKDLFKVNG
>PK3-045_00933 Teichoic acid poly(glycerol phosphate) polymerase
MKKELPHIILSSLKVIETVLTISFDINLHFLDGNKLLLQFNKRNNQEKKLIFPVNIKKIN
NTHALMEAAIDLEKNKKFFSEIDIFDIYIIINNGVSELKYRLKSKNVPLEFNLYIYDSLG
KTLYPYTTNKYNLSFKTIQNGIIARVKKVNLNKKGLLSFSGHVINTQQNKVVNSKKYLVI
TNHNSKLLGEKPLTILDKKQQQKEYSYYYYSVEVFLPNYIQTGGLEFFRFYIKEAYEEDS
KIIESYSPRVQVFPFNDINQEVLVNIKGFKRKILVKQTKSKKFLSTKIYVYNRRREWNSQ
IKNKLKKWKNKKMLKKMYKVLFKLTSMLPVKKNTVIFESFLGKQYSDNPRALYEYMKENY
PDYKLYWSVDKRFLHNFEGKNVEVIKRFSVKWLFVMARANYWVSNSRLPLWIPKPRNTKY
IQTWHGTPLKKLASDMDEVHMPGTDTVKYKENFLKESSKWDYLISPNAYSSEIFERAFNF
KKKMVESGYPRNDVLYTDNSSEKIKELKVQFKLPLDKKIILYAPTWRDNQFYGRGKYKFN
LELDLSLMREQLGEEYIVVLRMHYLVAENFDLTPYKGFVYDFSNYEDIRELYLISDVLVT
DYSSVFFDYANLRKPMIFYVYDIEEYRDKLRGFYFDFEKKAPGPLVKTTKEVIGAIKIAE
LEGLSTDFEDFYKRFCYLECGKSSERVWKEVLKDDITY
>PK3-045_00934 UTP--glucose-1-phosphate uridylyltransferase
MSKVKKAIIPAAGLGTRFLPATKAMPKEMLPIVDKPTIQYIVEEAVASGIEDIIIVTGKG
KRAIEDHFDNSLELEENLIVKEKFALLAKVKESANVDIHYIRQKQPKGLGHAVWCARNFI
GEEPFAVLLGDDIVDSKKPCLGQLIEQYDETLSSVIGVQSVPESETHRYGIIEPASQVGR
RYQVSRFVEKPKQGTSPSNLAIIGRYIFTPQIFRFLEMQEVGAGGEVQLTDAIEKLNQIQ
RVFAYQFEGNRYDVGEQLGFIQTTIELALKREDISEPLKDYLIQLTHKLAGK
>PK3-045_00935 UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase GtfA subunit
MEKITGYEINVTDPNGKSRKKTKFNTLIKKEMIEKKELIVRQNRDISNNTEKMYFTNKSF
SQIVDYTNYYEILEIRDKTIFYESFHGKNMTCNPYAIFKTLIKDPRFSDFHHVWALNNLN
DCPKEYLNLPNVEFVRVNSQEYLQYLASCKYLINNTSFPPYFIKKEGQIYVNTWHGTPLK
TLGKDMEGSLGQHKNLMRNFLHTDYLVSPNKFTIDKIIDSHDLRGIYNGQIIESGYPRID
LVNKDNHVLTDKLKIKTDKKVILYAPTWRGEVGNVSGEINKIIRDMRKLKSVLGNEFVIL
LKVHTLMQKYIKQNKLDFDVVPDKIDSNELFSDVDILITDYSSIFFDFLATKKPVIFYAY
DREEYERDRGFYLNLDDMPGPICSTIESVIKEIKNASNYQNVYKEKLERCINEFLYLEDG
ASTQRVIDTVFFEDNQHTYSVKNDKKTIVMYCGGFLNNGVTTSAVNLMNNIDYERYNVIV
ADKSEFDEESSKNFMKLNEHVKKFYRVGSMNVLLNELESQNHLFTYAAEQFYKKGPTNYL
EENIITMYKREFKRMFGTVEIDIAIDFSGYVKFWSMLFAANDIPKKVIFQHNDMMEEYDK
IVDNEYKHKENLNVIFPLYNNFDHIIAVSKHTRDKNKAGLSHLVVNSDQKMVYVHNSINY
QYVLNAVSSVEKVQVNNKEYYIEKNGDINQILDGHAVKVPDKSKFKFVTMGRMSPEKDQI
KLIKAFAEFQKEFKDTELYIIGTGELEEEIKSAIKSFGLKDQIHLVGQLDNPFPLIQDCD
CFVLPSNHEGQPMVLLECLILNKPIVATDIPGNRSVLENGYGELVENSIEGLVQGLKKMR
EVKPTYKQFDYVEYNKSAMEMFYSYI
>PK3-045_00936 hypothetical protein
MKKRIISFTMVKNEADIIEVFVRYNLQFIDHMYISVNLPNDSTREILEALKREGLPITIW
EDNEPSFEQNIKTTNAYHQIAENDNFDIILFIDSDEFVYGNIQELSQKCIPGKVYNLDRL
EYVYLEENPFEKNILKAMTYRRKKLQSAKSLICHDSKNYKHYKIGNGNHHVYYNGSSVPT
EKLNLLLGHFPYRSVSQFTNKNVLNWLALIFNNPSLMNTEKTIGQHWRNAYKYLQKNNLN
IDSTMLLKYLYKVDESNINQFKEDLIFEPFPLNGIELKYSDTIDNKSLSYMLTKEYEFAL
EKLNTINYNDSNNNINVNEKNTFAYDTGYLYKEIKLMNGATSYATDTIPRIRRIGNLVEL
SGAVKGIPKGKSNVYLSFPKSLAPDRNFQYQSVTSQKNTASWQIQPDGYVKLLNTTFTSA
DEKSWYPFHIKWFI
>PK3-045_00937 hypothetical protein
MALKKLFSKIFTLIELIRLPYIKRATDREFRMINTYTDYFKKKAMLNKTILYQSHNGIGM
NDSPLAIFKELISNPNYKDYTHIWVLNNLNNPLVNQYRSISNVKFVKLHSDEYLKYLASA
KYLINNHSFPSYFQKREEQIYVNTWNNTPHLYDEDSNYGRIRANTQRNFLQVDFLLTDSL
QHAQNLLEAYDLNGIFNGKVLEEGHPRIDLVLNSDSNLVKQQLSNNIPSYDSKQQLIVVS
ATWKNKCFSGQNGETNLIDFLLQLKQNIPSGFQLLLKIEGLSSDSISDKLKDNIIPSHMD
INEILSITDLLISDNMDIIKDFSFTNRPILFISNEEVESLDISVKVCSDLNVVSELIKNM
SSTITSNKKPIAKMSKITPTIIDSILTDNSSSKIYSLANNKTNLIFYCGGFLNNGITTSA
INLINNIDYKRFNVIIVDNIRTEKTSIENFKKLNPNAKKLIRVGPMNITVNEWYIHHYIT
KKGLINNQLEKFLPINLYKREAKRILGNINYDVAIDFSGYVPFWSFLFAFGGFRKKVIYQ
HNDMHAEYYKKINNKFKHKQKMNLIFPIYKYFDKIIAVSRNTRDENIKNLHQYMEENKVV
YVHNCIDPQKIKQQIEIKEEMVIEETTYLLSNKDISEGNLQIRGIMKPSENKINFVTMGR
LSPEKDHEKLLRAFKEIYTKKKDSMLYIIGEGILETHLKELTYNLGLQENVIFTGQLTNP
YSLIYQCDCFILSSNHEGQPMVLLENLIIGMPIIATDIPGNRSILQEDYGLIVENSINGL
IGGMEQYIKDSMVPTRKFDYKKYNMTAIEMFYKEVL
>PK3-045_00938 Teichoic acid translocation permease protein TagG
MSSIINVIKEQIDNFHLIRRLSTYELKATNRNNYLGILWEFINPGIQIAIYWFVFGYVQK
RPYVEGTNGQDIPFFIWMLAGIVLWFFIYPAITQGSKSIYTRLRMVSRMNFPLSAIPSYV
MLSLLYPQLLLMVAVMVIFQFIGYPISIYYIQLPYFLFATIIFLFALSLITSTIATIVRD
FQMLLQSLMRVLLYITPILWPVHKLGDTFKFIMKLNPVYYLIEGYRYALLGQGWFIIEHP
AITIYFWVVVLLLLMIGSYMHVRFRRHFIDFL
>PK3-045_00939 Teichoic acids export ATP-binding protein TagH
MDKSVVVKNLTKRYKLYNSKSEKLKDVFFPKEYGEPFYALRNVSFEADHGDVIGFVGVNG
SGKSTLSNIIAGIVPPTTGEVLIDGQASLIAVAAGVNNELTGRENIELKCLMLGFTKEQI
KELEPQIIEFSELGKFIDQPVKSYSSGMKSRLGFGISVHTDPDVLIIDEALSVGDKAFAD
KCLKKMEEFKERGKTMFFVSHSIGQMKQFCQKGIWIEHGKVKMIGSIQEVLSSYEEFLKT
YNKMTPEEKQAFREKGFEK
>PK3-045_00940 Poly(glycerol-phosphate) alpha-glucosyltransferase
MEVNYTPVFIFKSLNIVRGGLTKAILTRANTLIKYYKQVYIFTLSFQPDFEDILQELYNT
GRLDKRVQVLNCFHDLSAKIINNNSAEKGPEPPTIKEEGFYEFIDKANELPSYRYYKNGI
YVKYKRFDKEGRLLFVDYMSESRNRTRRDEYNREGILVCSQFMDPINNRPRLKSYYAKNG
ECYMTVWIDDHTKKEGRSLLYEPTSHEFKSLYKLFTFWAQTKLEDIKNPVVFSDSRFSDG
LVLDLKVDNIKRIAVLHNNHYSWPYNAKADVKKTWKSFLNRIHEFDKVIFLTNDQKKDIG
TLVGNLPSFDVIPHAVPEMKGAIVEKYDPKLVVYLARFESQKRIDEAIKAFKYVIKKVPD
ARLHIYGFGPQQGKLKELITLLKLDKNVKMKGFTTSASEVYQSAACSILTSDYEGFGMVI
TESMSVGTPVVAYNCKYGPNDIIRDGIDGFLVPCRNKRKLAEKIVKILSDENRRNQLSKN
AFEVNERFNYKNYEENWIKAINS
>PK3-045_00941 putative undecaprenyl-phosphate N-acetylglucosaminyl 1-phosphate transferase
MIYIMLVVCFIASILLTPLVKKLAFRVGAMDKPEQRKVHQKIMPRMGGLAIYISFVIGAL
IVNPSKDYHYPILIGSVIIVLTGVLDDIYNLSAKIKFLAQTIAAIIVVVWGGVQVEFINL
PFGGQLEFGFLDIPITVLWIVGITNAINLIDGLDGLASGVSCIALFTITGMAMIMGNGYV
IAISSIVLASTLGFLLFNFYPAKIFLGDTGALFLGYIIAVMSLLGFKNVTLISFVIPVII
LGVPISDTFFAIIRRLVNKQPLMAPDKSHLHHCLLNIGFTHRQTVIIIYAMASFFGLVAV
IFSMAKIWGAILLIIMVLLIIELIVEKIGLVGKNYKPILKFINDIRYSTDKNR
>PK3-045_00942 Polyisoprenyl-teichoic acid--peptidoglycan teichoic acid transferase TagU
MSRNKPKKKKTWLKVTGIVLLLLIIGIGIYLYTVWNSLSTAVNNMHEPIDRQTTKRTDTL
NLGSKEPFSVLMLGVDERDGDSGRSDTMIVLTVNPDKKSVKMLSIPRDTRTEIVGHGTTD
KINHAYAFGGVAMSMDTVENFLDVPIDYFMQINMEGFKDIVDSVGGVTVDNDLDFTYEGV
HFAKGPINLDGEKALKFSRMRYDDPRGDFGRQLRQRMIIQAVIKEGASLSSLTNFDSIFD
ALSKNIKTNITFDEMIDIQSKYKAAAGNIEQLTIKGTGQTIDKVWYLIVDDAEKTKIQNE
LKEHLDVR
>PK3-045_00943 UTP--glucose-1-phosphate uridylyltransferase
MSKVKKAIIPAAGLGTRFLPATKAMPKEMLPIVDKPTIQYIVEEAIASGIEDILIVTGKG
KRAIEDHFDNALELEENLIAKEKFALLAKVQESSNVDIHYIRQKEPKGLGHAVWCARNFI
GDEPFAVLLGDDIVDNDKPCLKQLMDQYDQTLSSVIGVQVVPDSETHRYGIIDPLPDAKR
RYQVKKFVEKPEQGTSPSNLAIIGRYIFTPQLFHFLESQEVGTGGEIQLTDAIEKLNKIQ
RVFAYEFEGNRYDVGEQFGFIQTTIELGLKRNDINSQLRSYILELAERLKEQEMNKLSK
>PK3-045_00944 hypothetical protein
MFLCFLLLLMAPQTNIKAAENTWSSNFYNNKNLSETPVSKSYNNIRFNWGKNEPIAGINK
DNFSASFEKNITISESQKDYFLHTYADDGVRMYLDNQKKIDRWTSSSGNYLGVPITNVSA
GKHTIKTEYYEGTGNAVLFADMLPFGSWIGYFYNNEKLSGNPEDALVFTPDKNGDLSFDY
QYGKPNAKGIGYNHFSAEFFTYKKLPAGNYIMQTKHDDDTRIYIDGKLVLDSDRVSQDTR
LIKIENNQGKDVHEIRIEYIEKTGKSYLQFSLKPVQEVLSSSTWFASYFNNTNVSGNAFV
STGIKDIKYNWGKSAPNASTNKDNFSASFYKLLNKGDYFVYTFADDGVRAKINNSILFDR
WTGSSGKANKALITNLNQNNNVFQLDYLEKTGKAFVNADVLPLGQWLGYYYANTSLKGAP
ANKTLIKGDGKGAFSFNYGKNAPMSGIPKDNFSASFTTALRLKQGEYVIRSVADDGIRIY
VDDKLVINRWTSANAKEDAIKIKISDRKEESDSSKRNIHWIRVEYLEKTGNAKLNFDIKP
INQLVTGQEWMNIFYPNPSLSGNGTVIGGLNSKNKVSSIQYHWKKDAPVVGMPKDNFSAS
FLRKVSGSNDYFVSTFADDGIRVKLDNKTVIDRWKNSSGTFDNAIIKGIGKGEHIIQTDY
MEKTGNAYVFADIQPLGNWIAYYYNNKNLSGAPVTSNVINNSNSNTLTKDYGINAPVSKI
NKDNFSAKFVTAKRLNAGEYVIRGLSDDGVRVYIDGKLIVDNWKNGSYREKATKVQLENV
NGDNIHWIEVRYYDNKSTAKFQVSMQPYNEKNMLDGTWYAEYYPEVINKNQLPSYKVTDS
KRNVVIGGKESLNKIYNINFNWKKGSPDSAIPSNNFSAVYKKVLNVTENSNYNFKLKADN
GAVLEVDGKVLIDAWSGNSDKQKEVIGYYLPKGKHTFVIKYYEGSGDAHLSFDMEKSKVV
TKTYNDLKTSLNDAVNIQLSKNAQTDKRYKAYMREDAFEYVSSKNDYGFVKSGTWNVRGG
TNKNSWIIGTFKGDYKVTILSKTAKKDSDGMYWYEVDFYKYSVPVGKVKPDITPKYTVKY
NTWVNASPTDIKYYMNPSNFENDNKQKLQFLLLSSSANLNSKEVNDKILKNRGILAGKGS
SFNKAGEKYGINEIYLISHALLETGNGTSSLATGIKVSSVDGKKVTPKKVYNMYGIGAVD
GSAVKSGSEYAYKMGWDTPEKAIIGGAEFIGKNYINNATYKQDTLYKMRWNPSKPGVHQY
ATDIGWASKQVSSMYNLYNMLTSYRMDLEVPKYK
>PK3-045_00945 hypothetical protein
MKKTFSLLLSFILCISLLPTFGQPTYAASGSEPQVHVMLKNYLGNKTQISIAPSGTYKTT
DGKISLNNTTAYTLKIEQAKLKLYKGSTFLYEADSLTFAPSNPDDYLTINNRKYKGSFTF
MMETINGSNYVRPVNTLGMEEYLKGVVPSEMPASWNIEALKAQAVAARTYSWNYGGKTIT
DTISHQVYGGLNDSHPNSDQAVEATTGQVLKFNNRLIDAVFSASNGGVMDSAKNVWGNDF
AYLVNAQDSFDTSYTWSFNVQKAQINMQDYDVANPDAWWNKVSEKDSTITTNIKKWLNDN
GYKDKDIKIVAVPTLSFDNPSTTKRVSTGSISIQFYVKNQRDSKGALLLQEIKQANVTAS
KVRAIIGINNVKSYLITKSSSTVDTHSIAGRGYGHGVGLSQYGANNRASAGQKYNTILAF
YYPGTQLVTEYSKTAAITVPELKEGKAEFNQANNTVKVGFTLTKAASTVVTIKDNDGNSV
ATLLNNGALQAGSYDYTTNASSWNNGSYTAEITATDIANNKVTTNIAFQVAKIEVPTISI
SSIKTAYDQKGNTINASFAINQPSKVTVTISDSKNKVMKTLASNKSLSAGTSSYKWDVRS
VKDGTYTLTIKAVNNIGKEKTEKQNFTLKKAVAPTIKDVKTSYDTAGNKIKTSFNINQSA
TSTVKILNSKGKVVKTLASNKSLKTGIHSFTWSVGKAADGSYTVSVESVNGSKLKSTVTK
KFTLYKVKTGTVKASNLNIRQKASTSSKKVGSIPNNKKVTIYAKSGSWYKIKYGKVTGYV
SAQYVKNVK
>PK3-045_00946 Polyisoprenyl-teichoic acid--peptidoglycan teichoic acid transferase TagT
MANNTRETLIKDTKKKKRKKIKLFIFVPLLVIILAGIGYGATLYSKAKSVADDSYEPIDR
DSKRDTKVDPNIDDVSILFIGVDDSKKRSSKSGTTRSRSDALMLATLNEKEKSVKLLSIP
RDSYVYIPERGYSDKITHAHYFGGVSSTLDTVEELLDIPVDYYVKMNFDAFMDVVDALGG
IDVDVPVTFTEQNSKDKAGAIHLEKGYQELDGEQALALARTRKIDNDIERGKRQQLIMQA
IMKKAVSIEGITKYSKVMEAIGSNMTTDLSFSDMQSLIAYATADNGLQVETLTLAGTDGR
VDNKYIYQLDETALAETKSILQQHLGITKSLQSDSNSTTDTDTTVDTESNTNTNTSTTTD
TSTLN
>PK3-045_00947 IMPACT family member YigZ
MLPSYLTVPSYGEYELIIQKSRFIAHIARTETEEAAQAFIGEIKKKHKEATHNCSAYLIG
EHDQIQKANDDGEPSGTAGVPILEVLKKKGLKDTTVVVTRYFGGIKLGAGGLIRAYGKTT
SEGLANIGIIERKLKQIISVSIEYPLLGKIENELRSKNYEIKDIHYLENVEIDVFVDSDE
VETYKDWITDLTNGQGIIKEKATLYAETLI
>PK3-045_00948 Signal transduction histidine-protein kinase/phosphatase DegS
MLIRKFDTKTLDYIVEQMIKTVGSSKDEIFRIGEQCRQDYETLTEELKEMKVLVLETIEK
GDKLEIQSRFARKRLSEVSKHFNEYSEAEVREAYERAHTLQMDLSMNRHLEKQYRERRDD
LERRLLGLDETIKRAEHLVTQISVVMNYLVSDLKQVGEVIEDAKQKQDFGLKIIGAQEEE
KKRLSREIHDGPAQMMANVMMRSDLVERIYKEHGAKEAFEEIRNLKVMVRSALYEVRRII
YDLRPMALDDLGLIPTLKKYLKTTEEYHESIKIEFATIGKETRLPSKYEVAIFRLVQESV
QNALKHAEASKISVKVELRVEQVIVLVKDNGKGFDKNEKKEESFGLIGMKERVELLDGEL
TIDSKLGVGTIIMINVPIR
>PK3-045_00949 Transcriptional regulatory protein DegU
MTTKIVIIDDHQLFREGVKRILDFESSFEVVAEGDDGTQAIQLIEEYQPDVTIMDINMPT
INGVEATRQLLEKFPETKVIILSIHDDENYVTHALKTGASGYLLKEMDADALVEAVKVVA
DGGSYLHPKVTHNLVNEYRRLALENANSDEHHVQVVEIRRPLHLLTRRECEVLQLLADGK
SNRGIGEALFISEKTVKNHVSNILQKMNVNDRTQAVVVAIKNGWVEVR
>PK3-045_00950 Protein DegV
MKTAIVTDSTAYIPKEVREKYNIYMIPLTVFLGSEVYEEERELTASEFYEAVRKMDLPTT
SQPAIGKFVELFEELSKNYDEVISVHLSSGISGTYQGAITAGDMVEGIEVFAFDTEISCM
VQGFYAIEAAKLVQQGKTAAEIIPILDELKQTSNAYFMVDDLSNLQRGGRLSSAQAIIGS
LLQVKPLLHFKDKIIVPFEKIRTKKRAMRRIVELLREETNGGSYYAAIIHGNREEEAIEW
KAELEQEFPNIEFSLSYFGAVIGTHLGEGSMGLGWIKKR
>PK3-045_00951 hypothetical protein
MQINLLFEGAVKEQFKQQVSTNTDVLTGQPLGGKKEIEVERDGKAFTLRFSDEIKHLKAA
TDEEIAQMFAQQVEDPSDIFSYRPRDQWLIFSQYLNDNGIFDGKNAKDIEEIENLLVDIT
DGLDNLDIATPKGRDIKSGSKPITQQLTSAEAQLELASSTAALQLFSEKYVTGDAKEGFH
QLIEQYTKRNEKRVLSYKSIEEKFYQGRAKIYETRHMDASSLNAKQKNNLSITNKLGKIT
YTEAEISKMIEGYKEKFGMLQNKSDVDVLIAKLQDELSKFVTKGISKQDKDYEAANNFVK
EKTAKTFERIADYWKKLL
>PK3-045_00952 ComF operon protein 1
MRFYQKDNILLPTKSNSPHSFRISNASQNQLITPSLNRAYPFNPQLQATLQGKALLLAEL
PFSEQEIQTHYENGYCSYRKGVEKKARNKYICMRCGNENQELFATFPCARCQEHCTYCRN
CIMMGRISECTPLITWHGPERDQETSKITLQWSGRLSQGQQVASEKMEHIIEVQSELLIW
AVCGAGKTEILFKGIEKALRDNQRVCIATPRTDVVLELAPRLQEVFPEIKVLPVYGGSEE
RHQYSPLTISTTHQLFRFHQAFDLIILDEMDAFPYSVDKSLQYAVQKARKEQSTLIYLTA
TPNKGWQEKCKHNKIHSVTIPARFHQYPLPVPDFQWCGNWEKGLKKDKLPVMLVDWIRKR
VPHNKPMLLFVPKIYYMEKVKKLLQPIVDTIETVHAEDPDRKEKVLKMRNKEVNLLVTTT
ILERGVTFPNVDVAVLGAENRIFTESALVQIAGRVGRKKEFPDGTITFFHYGKTNNMVLA
RKQIKSSNQEAREKGMLLL
>PK3-045_00953 Putative ribose-phosphate pyrophosphokinase
MICVICLAPVIPEFNWTYLFSKEPECYLCASCKEKLAVIKGDTCRTCGRSLQLLESVHIK
DGMCHDCQKWEGVEEWKGILQSNQSLFLYNDFLKETIARFKYRGDYQIAAAFVSFLPKDF
GKNKVVMPIPLSDERLYERGFNQVEAVLFYAKVPYVNGLVRTHSEKQSKKTRKQRLQIEN
IFKIEQKEAVIAQDIVLVDDIYTTGATLRNAAKVLKEAGAKSITSFTIAR
>PK3-045_00954 hypothetical protein
MAELGNCPNCGDIYVLNNIRDVCLKCYKQEEADYEKVYQYIRKKQNRTAQMDDVVEATGV
ERTLIYKFIKKGRIKLAQFPNLGYPCAKCGTIIREGKLCHSCLSGIQNDLNVMEKEEERK
REIEERNKSAYRVLDKR
>PK3-045_00955 hypothetical protein
MQISNKTQLSNVTTNEKQLELLKNETYNAQIKSRISETEAVVQIKGKDFNVKFEETIPKE
NRVSVQISDMDGGEIKVKTNTTKTPDLPSNPSSEKMIEDMSISEKSKNELRMATAILGKK
TTINRDILVQLNAFLEDETGTIEEKLVSIRALASKNLEISAVNLRSIHAAVNGEPLNDII
TKIANAIDPNFQKNLSENQVEHHNTVYALKNETSSKPNNALSKLISELSSSIETEADIQK
GIELLRTKISENPRISKEHIKSITQAIQDSEKLQSIAKTKIMDVLTNIKTGNLQESATEL
NKVKDQIKQEPNLQKAIQTVKETIVNNPKMPPEVVKQVEQAVREATISQRLGQESAGREK
LVQALTRAEQEVTAQQAKPIATDKAVQNQLTQTKDQIKQEPNLQKAIQTVKETIVNNPKM
PPEVVKQVEQAVREATISQRLGQESAGREKLVQAITKAEQEVTAQQTKPISTDQGKAVQD
QLNQTKEQIKQEPNLQKAIQTVKETIVNNPKMPPEVVKQVEQAVREAAISQRLGQESAGR
EKLVQALTRAEQEVTAQQAKPIATDKAVQDQLTQTKDQIKQEPNLQKAIQTVKETITNNP
KMPPEVVKQVEQAVREATISQRLGQESAGREKLVQALTRAEQEVTAQPSKPIDQGKAVQD
QLNQTKEQIKQEPNLQKAIQTVKETIVNNPKMPPEVVKQVEQAVREATISQRLGQESAGR
EKLVQAITKAEQEVTAQQTKPISTDQSKAVQDQLNQTKDQIKQEPNLQKAIQTVKETIIN
NPKMPPEVVKQVEQAVREATISQRLGQESAGREKLVQAITKAEQEVTAQPSKPISTDQSK
AVQDQLNQTKDQIKQEPNLQKAIQTVKETIVNNPKMPPEVVKQVEQAVREATISQRLGQE
SAGREKLVQAVTKAEQEITAQPSKPIDQGKAVQDQLNQTKDQIKQEPNLQKAIQTVKETI
VNNPKMPPEVVKQVEQAVREATISQRLGQESAGREKLVQAITKAEQEVTAQQTKPISTDQ
SKAVQDQLNQTKEQIKQEPNLQKAIQTVKETIINNPKMPPEVVKQVEQAVREATISQRLG
QENAGREKLVQALTKAEQEITAQQTKPISTDQSKAVQDQLNQTKDQIKQEPNLQKAIQTV
KETITNNPKMPPEVVKQVEQILNQADQLNVASKERIKTALNQVIDMDNAKIPNEKSPVQQ
NESNREAARANATTQLQLDSIKQAVKQIQKEPILEKALHDLKSELGKNENLSPDKKEKIE
KAINTSLELSSKGREMASRQNISKALQEVETAIQQENKNYVEDSSPKQVEMEEKRWDSQL
QAMGISSKDILVTKISQKLAEATHEFRDIKREIYRNLDNAQKLMEKYKDSSIPQASKIIE
STIAKLDQTILKSDLMLYADMRTEKRLLQASSQLAEAKKYLSNGNTAKATEIVSEVKKMV
ESIQYKPSEQKIVHYVSKNSALLEEVSPLKSLVKQSEDMGRNYILEGEEPSSRQMYEKIR
SFGLNRESDVANKLVSSHTPTKEQEDNLKTTLLKLASSENLGDETVSRQAEQALNNINGQ
QLLNKQDSSSQLQSMFFNLPMLLGEKNENIQVFINSKSKGEQVDWENCNLYFLLETKKLG
DVGILLNATDRNLSITVKNDSADFEKKMSPLSKIAVDRLQEIGYQVQNIQFTHLTNPSAE
AIEKKENKRLASVNEFIQEKGVNLQI
>PK3-045_00956 hypothetical protein
MSMTRYYNQKNRFERNGPVAAVLKYDDKSTAPSVVAQGKGAVAQQIIELAQKNNIHMQED
SSLVANLLDMDLGDSIPPQLYSVIAEILLLIEEMNKKY
>PK3-045_00957 hypothetical protein
MANLITEEVLYQKSPQELTALLYEACLNNLEEAIENIENKDYILANVKLKKANDIVWRLG
AGINYEAGIIADQLDMLYNYIAGKLIDANLKKDISIIQEVKTIVEELLAAWTASMKEKTP
KINTGLRQKTLAYEKNIMTYDKN
>PK3-045_00958 Flagellin
MKINHNIQALNAYRNLYQNQFNTSKNLERLSSGLRINRAADDAAGLAISEKMRSQIKGLS
MAERNSLDGVSLMQVAEGAMNEVHSMLQRMRELSVQAANDTNTDSDRNSIQQEIDQLLKE
IDSVAAKTEFNTRKLLDGSSAVDTQFLDGEQAKTNLKQVPTVVDPTLATGKYEVAVSGTP
QFVNTLNQPGAGISSSDVLTMDPDSDLALGEYSVVVTGYQDDGTKRSANIEIFDPSGFSI
GQLAAVVGEDGKTETIGTETGKKIKIDTAQITGNGTAKVQIESKVTLSVSKVNGDDSTTP
ITFSKELITRNGEVEHGGLKLSFGANVKEGSSQFDLTNKALTFQIGANTNQNLNIDIPQL
STVKLGINNLNILSNDDASKSIFKIDQAINQISSIRAKLGATQNRLEHTISNLQVTNENL
TSAESRIRDTDMAQEMTEFTKNNILNQSAQAMLAQANQLPNGVLQLLQS
>PK3-045_00959 hypothetical protein
MEVQRVSRTSTDKIKSKDNLPAESISFQEVISKNRQQAVYDKLTKLVEEIEGQGKKLSEH
RTVDDLRRYKKMVKDFMDEAVNNALKLEEQSGFNRRGRTKVYKIVKEVDKKLVDLTNTLL
DKEKNGLDILQSVGEIQGLLINIYT
>PK3-045_00960 hypothetical protein
MKINNYNPVNMNPYKKQMEKNATAQNIKKEDKVEISKAALELQGTQDEVRLEKIQELKKQ
ISEGTYQVDSKEVAEKILSFWKKS
>PK3-045_00961 putative protein YvyG
MQTEKIEASLKDILSLHEDLLQLSFEKKDILIKGDTDQLRVITGKEQKYIKAIQKKDQEL
QLNCNNFLGNESTQTTLNDVIKMVDDQTKEILMEIKQKLVEVLGLIKTQNDTNQQLINQS
LQFIEVSLDLLKPDIDTYNYNRSETKNPYQKEGFSIFESKI
>PK3-045_00962 hypothetical protein
MVSTFMGLETAKRALTTQQSAIATAGHNIANANTLGYTRQRVSLAATQGFPTVGQNSPVM
PGHLGTGVQADQVERIRDSFVDMQYRKESSKLGYWDSKAQMLSQMENVMDELSGTGISNS
MDQFWNSLQDLATEPENEGARRVVRERGSALADTFKYMYSSLKAIQKDNRNELENTEDNI
NSVLKQINQLNQQIGAVEPNGYLPNDLYDERDRLLDSLSTMMNIKVEAKSSGGLARASAE
GLYDVYMATPEGDILTDSNGQPIKLIDASTRTANGIHIQFDSREELDSPVTSFKFFKLND
DPTAKSKFDGIETDADADAANGVYTLNDFKALNSQGKLKGVIEGYGYMEGGEIKGTYNAM
FDDLDEMVYTFVTAFNEVHRSGYSLNEIEDGTAKDIDFFSFTDSNITADNPKGAAGSIVL
SKEILEDVDNIAAATESSAGNGTNALNLSKVKDSILDFGGNKTNVQAFYQGVIGKLGEQA
SEANRMEKTSGILKTSVEQSRMSVSGVSIDEEMVDLIKYQQAYNSAARMITIVDEMLDKV
INGMGVGGR
>PK3-045_00963 hypothetical protein
MRVTQSMLTNNNMKYISNSYKDLQRLSDQITTGKKITRPSDDPVIAMKGMRYRTQVSEIK
QYQRNLNEGYNWMENADTALDSSNQILKKIRELTVQASNDTYDETARKNIVDEITTLQEQ
LVTLAETKVGDKYIFNGTDTASSPMNLNQIDMEFEGFQAGLADGSINPSEYVINYQGNKY
TYDSTDNMFKNKNGSSIEIDGNTGEITYTYQEELPYKDGETVAAEKKIDSGSIVISKDTA
VSTNSNQVLLEVSKGISIPVNITSSNAFSLDMFGGIEAIKKMILDPDATGKEITKSLDAI
DGYITDVVSTQSQLGAQLNRAEMVESRLKKQEVVANQTLSENENMDFEEAVMGYLTQQLV
HNASLQVGAQIMQRSLVDFLR
>PK3-045_00964 Flagellar assembly factor FliW
MEIKTKFHGNVAIEKEKIIRFEQGLPGFEEEKEFYILPLEGGADLFVLQSVATPLLAFVM
IDPFLYFKEYAVKISDEVKELLKIQDTKEVVIFSLLTIKEELKSITANLQGPIVINDRLK
RGKQVILVDSDYQTKHELFLFKEQKEGSK
>PK3-045_00965 Translational regulator CsrA
MLVLKRKVNQSIKIANDIEITILAIEGEQIKIGIEAPKHIEIHRKEVYVAIQNENNEAGI
ASVDFVKNLTNQLGKNN
>PK3-045_00966 Flagellin
MIINHNLSAMNTYRQMGSNQVNASKSMEKLSSGLRINRAGDDAAGLAISEKMRGQISGLN
QAQRNSQDGISLIQTAEGALNETHSILQRMRELATQAANDTNTDQDRQELQKELNQLTSE
INRIGNNTEFNQKKLLNGSQSLSSGSRVATAGNTASGNGLHLQVGANSQQNFTVDIFDMR
AEALGIAGSKGTSAQIGKADLAGQKNKWDDTIGTEKYTSASGASTTGNKVLTENGTTIGA
ELVAKSEDAKFASGAANKLTDAGNATGAEVYALDISDHKKATSAISTIDAAINQVSAERS
KLGAFQNRLEHTISNLGNSSENLQSAESRVRDVDMAKEMMEMTKSNILSQASQSMLAQAN
QRPQAVLQLLG
>PK3-045_00967 hypothetical protein
MELHLSSEMLIYENSVKNIDILIQKINEDLEKNKLYFSHLIINGKEVYSDFEEQIMEQIN
TIEKIELVTKTIDEFINDLTVSLNQYSNRAIPIIKQLTEQFYQSPTEEAWGLLQDLLEGL
NWVYSTIKSMGNTELNEYKENLLNVANHFEVELPNLLDAIENHDYILIGDIISYEILPQF
ESIESITEKTFQVINK
>PK3-045_00968 UDP-N-acetylglucosamine 4,6-dehydratase (inverting)
MDNNLYYRKKILIIGGTGTIGKQLLIELLKCEPEVVRIFSRDEYKQFELQQEMGNKSNIR
YLIGDVRDQQRLLMAMEDIDFVFHLAAMKHVPACEYNPFEAVKTNVIGTQNVIQASLDAG
VKRVLFTSTDKAIAPTNAYGATKLTAERLISAANYQKGPKNTIFSSVRFGNVMGSRGSVI
PLFKKQIIEKGYVTVTNKEMLRYMMTPKQAISLMLKANAIASGGEVFVLKMPVIRLQDLV
EIIVDEMEQQYSSHRVDIKEIGLRPGEKMYEELMTEDEGRVALETEDMYIIRPPYGATGE
NYPNLITPTFQKVHPHEEAVISKDILKTWILEENLL
>PK3-045_00969 hypothetical protein
MGENQTLLMNMFPYLRSSLNTLNNETDEEKLEILHTKVENTPTLSVMIENRNYYLHSKYD
PRKEAEVLIERYKDEFEKYDHVLFYGVGLGYHVETLLKRYPNMNYSLFEPVPSVFYQFLE
SNRLDNLDLSRLKNVFIDTVDTDPKDFLINLTGNIQERIMLIALPSYERIFERKFQQFTE
DFKEAVAAKYESHYIDNKYSARWTLNSLINLPTTLSTPNILNGFDHIFKDKPLIIVSAGP
SLQEEYENLKKIKRDKTAYIFAVGSANKALIANGIIPDAVCTYDPQEVNHTVFTKMLEKN
IINVPMIYGSSVGFETLKYYPGPKLNMLISQDTVSPYYFESKENMRVINDAPTIAAIALQ
LAAELGCNPVILVGQNLAFKGNKKYSTEIEEEKKINELAQKEKGEIIVEDVYGNKIKSTK
GFINMKSFLEYYISMFSQLKVINTTKGGAKIIGAEYQPLEQLIEKELTKKVVKENWHNKQ
FEQLPAKNTIKKLKQMEQSLQHFDKLYGQLQDSLTEMEKITVKKKQENKLSVLINKINDK
MFRLTTNDFYQVFIQPINRTQYQALLLNITKIKKVENNLIHKAQLIINSFSPYLNRCKMI
ANQIAGTFYQVHEQIRQEMEKSNMLFYPFDCGVFNFSNNWIIKDYSSHRDVKFPVRTITN
EKNLATMKFRIRGEILRIYGVKRNGKVRIRIGEYVEDIQFKSSSKMREHPEKIYQLIYEK
KISLKEIETVEITMCNDQIEITGIEIDGNGEIHHIDEVKSLEDLTVGKRIRMHYSAKYNK
IGGFSKAKSFNQLFLPTFSSATPDGDFYFICVAQDENGKKLIADRNIQHSISWESIENEI
KIYNNKCLNISWDIPTCGIYQGSSDNTESNDWQRYITSWSDKDWLVDLNFHVTQLSSWCK
DMPQVNKEFYWIDGKTVEKTNKDSRMRAGRYKVNHKMIADKKATVNYIGFRPIWIID
>PK3-045_00970 hypothetical protein
MGSNKDSSHNLIDKDKLVNLINRYLLNFVDVAEKMEIKKVYPETLITSNRIDVVAKYCYA
NSRIKGTSNEFIEDLYINHLQVLNGFNEGDYSIKKTKEHFIESFNELIDSMQLNGFNKDI
SIIPVNEKNEIIDGAHRLGTALALNKEVYTVKFKNAHSLLYNTDYFRNQLLQEEYLDYLI
HEYSKIKKQIYVVVLFPSANDKFNQTKKTLGKYGNILLEKSLKLTERGKKNLIISLYRNE
PWVGNYDDGFYGADNKVNPCFTLDTPLKVYFFEKENDSISMVKIKEEIRTIFNIGKHSVH
INDTYEETLELCELFLNKNSLHHLNNSMNWYNKKFGILFHKYKEFLSGENLNKDNFCIEL
SGVLGVYGLREPNDIDYITLYDYGINIESEETINKTTQFYSLNKNELIYNPRNYFYYNSY
KFLSLETVKTMKMKRGEQRDIKDIVLIENLIGNNIITENHIIQKLETVLDNLKKKKIIFF
GSGSYAESLMKEFKFDISYIIDNNRDIQYKSRFGKIVYGPEQLFYEDFNKIVVIIASSYS
HEIITQLESMGLVNYENFYSGKYIENVILNTGSAINNINFYGMNLYYDKGNKDVKYFNHR
LEKAFIKINEELNETANIGILDIGAKIGLFTFYFATHLSAYKLYSIEPNQNLFNLLKKNI
TINNLNDNIKIFNSEIEGVDIGCYNKSLKKKKYGINNYSLDRWWENNHKPLIKLVHLNAD
GKEIFLLKGGMKFIEKVKPLLVFLYSPIKTNKYFYDLRDFKVFFTEIGYSLKMITSFENS
NGENYYIAFPKEYSESEA
>PK3-045_00971 hypothetical protein
MEQVDSPKVSVIMPVYNAEFYLSEAIDSILNQSFKDFEFIIIDDGSVDKSLTIIKSYKDA
RIKIVTNEQNMGIVDSLNKALNISKGTYIARMDADDVCHKDRLLIQVRFMDNNQNIGCCG
SFIQILNTNKIVKHEPNPDKLHSKLLFESDISHPAAMIRKSVLIENNIKYNRFYEHAEDY
RLWCEIAAKSKVANIDKVLLYYRLHSKSVSHMHIDAQKKSAYLIQNNLLEKLGLGETDGI
SIHNNISLQKYIYTTDYLKSIINWLELLKSQNSVYKIFPIKSFQEVINGKIKKIKDHFQI
VMSLIETIKKNNNSVYIWGAGELGKRELDTLKHSDIKVSGFIDSNTMVQGRKLDNLSIYS
PDYIFNKVENKFIFISSLYYKQIESILIENSFKKFENFLSLLELKEAHDNILTTEMAVEN
K
>PK3-045_00972 hypothetical protein
MNVIITACDNNYAIQLGVMLQSLIHNSKNRRSLFVNIIDGGIDYTNKLNLENILKENNIK
YQFLYTDAKDIVHLKIDKHLSLATYYRLLIPQLLDNNIEKVLYLDSDIIVNNEIVELCKK
DIANYSIAAVETPLFDRHKELFMDIGAKYFNAGVLLINLRYWRENNISNNIIDFIRKNPE
RVLYHDQDGMNSILYNNWLPLDVTWNMTSQLLYLVEANQVEIPNIIHYTEASKPWQLLNN
HPFKKEYEKYLAMTPWKDDIPPENAIIHKLLMDKRIIIFGSGGSGLRLLERVMELNGTVS
YFLDNNKELFGKEVNGKKIHTPNVLADENIDEIFIIIASMYYVDIEKQLTELGLKRLKHF
VSLGYENELLKEW
>PK3-045_00973 hypothetical protein
MNLTKEYEVFKNKYIVQQRREHDYAINRYYAHVIDPFFTKIVYDLKLTPNMVTIIAGFLG
IVASVFFIFDYWITGAILLQLHHFMDGADGNLARLTNNCSALGAKLDKLFDQLVRIVLFL
TLAIIIDVPLWAKILFIVTIYWDLFIVHYYILPFMRRNKMKRAKWKEWFLSKGIIPGFDH
FTIFFLISLGAIFQRLDVVIYIVIILKNIDWLYRVWECLKTQYRK
>PK3-045_00974 Phosphoglycolate phosphatase
MFNHKAYIFDLDDTLYCEHDYVKSGFYSVASFLAKVNPFLDVEELAEHFIMEWKQNGRGK
VFNHVCDRYGIQVDVKQLVDVYRKHEPSIHLYEDAVLCLKRLTEKKIPIGIITDGNSSMQ
WNKLKALGLDKQIPSIIVTDDLGGSEFWKPHPLAFQRMSDCLKVDMKDCVYIGDNPNKDF
VTAKKLGLHTIRIVREIGDHMQTKLDQGYEADKKIYSLMEIR
>PK3-045_00975 8-amino-3,8-dideoxy-manno-octulosonate cytidylyltransferase
MKVIAILQARMGSTRLPGKVLLPFGHTNVLDYAVSRCQAAKGIDQVIVATSEKEADNQIV
EWCNQNAIEVFQGSEEDVLSRYFECAKQYKADYVIRALGDCPFFHYELADEVIEEIKRVQ
GDIVIYKEPIPLGLGVEIISSSALTYIYNHGKKDYHREHVTYYAYENRELFKQVNVEIPK
YVLDKDVRLTLDTQEDYQLLSVIATHFADNKFISTEDILNYLEGNKELTMINQHIEQKKV
K
>PK3-045_00976 NADH-specific methylglyoxal reductase
MNHTQKKLALGTVQLGQVYGIANRIGQPDKQKAAEILNYAVKHGIMTFDTAPGYGQSEEI
IGSFLKEEMDESLNIITKIPSMNENNIEEIEKSIKASQNKLGIEKLYGVLFHDANVLEKL
TNKDREWIENLKEKYHINKMGISIYSPEQVKRVIELGIFDIIQVPMNVFDLRLINEGLLQ
ELSNNKIEIHVRSVYLQGLLFLEEQELPNSLKAASPYLLKLKKIAAREKLKISELAFLFI
RDNSYVDKMIVGCESLDQLRENIRISELPTLSSSIMDEINISFRDIPENIINPSKWRD
>PK3-045_00977 Gluconate 5-dehydrogenase
MKSLKELFSLKHKTALITGASGHLGSAISESLAESGANVILAGRNQENNKLLAEKLMNQY
GVICLPIYLDVSNRDSITNCVEVALKEFEKIDILINNASYGSTGKIESMTDKMWEMGIDG
TINQAFRLTNSILPYMVAQGSGNIINISSMYGVVSPNPEIYGDSGQNNPPNYGAGKAAII
QFTKYIASHYGKEGIRANSISPGPFPKLEVLKNGEFVEQLARKNPLNRVGRPEELKGAVA
YLASDASSFVTGHNLCVDGGWTAW
>PK3-045_00978 hypothetical protein
MVSKSYQYKCLKENILEQDNYHIEPLRQEDMMKIKEYRNKQMDVLRQKQPITDEGQVLYY
QKVVIPLFGEEEPKQLLFSYFYNKELIGYGGLTNIDWEAKRAEVSFLVNPNRVKNNQLYE
KDFQYFLNFLKRIAKQQLKFNRLFTETYDIRPFHVGILEANGFEFEGRMKQHVVIKNEFV
DSLLHGCLLSKEC
>PK3-045_00979 ADP-L-glycero-D-manno-heptose-6-epimerase
MLNGKRVFVSGGAGVIGRELVSKLHQLGAEILVGDLKSKPAEWSENIKYWQGDLNYITKE
ELDAFDPEYFFHLAATFERSVETYEFWSENDQHNVKLGHHLMDCLKDNPNLKRVVFASSY
LIYNPDLYQFNQPASVPTLLKESDPIYPRNLTGVAKLMHEIELRFLEGFNQVSFSSVNAR
IYRVYGKNSRDIISRWIRALLNKEPIKVYRKEGMFDYIYAGEVAEGLLRLAVSDASGIVN
LGNGNARKVSDVVAVLKQHFPDMNYSEEESDILYEASQADVTKLKQYTGWMPEKQVEDMI
PELIAFEKKQVEKQKEDTGAFGNILITSASKKIPLIEAVRKAVQKLGWDSKIISADGNEN
SMAAYFTDDFWHMPLLSDLTVDELLRYCKENTIKYIIPTRDGELLWFARNKDQLAAAGVH
VMVSDEKGIAASLDKLTFAKELESFNLPVIPTALSIDQVKASSYVVKERFGAGSQNIGIN
LNEENAKLHAEKLMEPIYQPYIEGKEISIDLYVGKNGKAKGVICRTRDLVVNGESQITTT
IQDQRLEELAKGLVEKLNLYGHVVLQVIKDEKENYHIIECNARFGGASTLSINAGLDSFR
WFLLESEGMNINDYSFVPAKTGVKMVRFVSDTFVK
>PK3-045_00980 Pseudaminic acid synthase
MKEIRIGNRLIGENHPPFIIAEMSGNHNQSLERALQIVEKAAEAGVDAIKLQTYTADTMT
LDIDEGEFFIENDNNLWKGSSLYKLYKEAYTPWEWHEQIFKKCEELGILAFSSPFDESAV
DFLETLNVPAYKIASFENVDIPLIKKVASTGKPVIISTGMASIAEIDEAVRAAREAGCED
LILLKCTSTYPSSPENTNIRTIPHMKELFKCEVGLSDHTLGVGVSVASVALGATVIEKHF
TTLRSDGGVDSTFSMEPQEMKVLVEDSKRAWQSLGKVTYGTTKDESASLEHRRSLYIVKD
VEEGELVTTENVRSIRPGKGLSPKYFERTLGMKFQKSFKKGTPLSWDCFK
>PK3-045_00981 UDP-glucose 4-epimerase
MKNILLTGGAGFIGRAVAKKLLADGHKVWILDDLSNGSEKNIEEFKDQLEEFIIGDIKDE
ALLEKLFAKTSFDICYHLGASINVQDSIDDPRTTFNNDTIGTFYVLEQCRKTNTKVVFMS
TCMVYDQCTDETGITEQHAIKPASPYAGSKIAAENMVLSYYHAYGLPTVVIRPFNTYGPF
QKTGGEGGVVAIFLKKKIAGEQLHIYGEGTQTRDLLYVEDCAEFVVNAGYSDAVNGEIVN
AGLGRDVSINELALKIVGDSDRIKHIEHIHPQSEIQKLLCNYDKAKQLLNWSPKYTLEAG
LRETEEWIKSHLM
>PK3-045_00982 UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate aminotransferase
MELALYGGQPVRQEFLSYGQQWITEEDVQAVVETLQSPYLTQGPKIDQFEQAIAEYVGTK
YAVAFINGTAALHGACYAAGIDDGDEVITTPMTFAASANCVLYMGGKPVFADIDKQTYNI
DPINIEKLITSKTKAIIAVDYTGQPADLDGIKALCKKHHLVFIEDGAHSIGASYKGEKVG
SQADMTMFSFHPVKHITTGEGGIIVTNSEEYAKKLRLFRSHGITKDTLKGDEGPWSYEMV
DLGMNYRMTDIQASLGCSQLKRLDSFVKRRREIANQYTVAFHNIPNVVVPFQEAAGESSW
HLYMLRLRLESLRVDRKTIFEALRAENIGVHVHYIPVHTLAYYRNLGYKKGICPNAELYY
EEAITLPLFPKMTEEDVQSVIKAVQKVIGYFSKER
>PK3-045_00983 putative protein YvyC
MKLEMNQQQSTISNLVNSTRNDNEISLNNRDYTKLVDTLSEESTNILKKEKAEEIVTSIN
EFLKPHYTSINFKVHDETERYYIEVVDKATEKVIREIPSKELLDIYAKMTEFIGIFIDKK
L
>PK3-045_00984 hypothetical protein
MSVNSIKFTGLASGLDTQSIVDSLMKVQRMPLDKLKQQKQILEWQRDNYRTMNAKLKEFD
TFIFEGISKQSNMMKRTAVSSNKDIVSVSAKANAGNVSYNISDVVMAKSAKVQSANKISN
STLDPTKSLLSQQSKLSDDSGIQWKGESFSQTLTGQGDEIYLGGTSLSGFPDSITVTGGT
DKTFKVQLIEGDAPEKGTRAADTVYVNPATGKMTFGEILPENSTVTVSGDNLKKNSYIEF
DIQTTNEDGTKNKQSFKIDGSTSLNSMFSKINSSNVGISMFYDTGTDKVVAQRTDTGILN
NGAEEIEFLGKDAEFFTKTLNLTEKTAGSDAEFTINGLKTTRKSNTFTMNDVTFNLNKNT
TAGESVNVNIQTDTDSIFDTIKSFVDKYNETIGAVNTELTAQRYSAFQPLTEEQKAAMGE
KEIEQWEEKAKSGLLKRDPLLTSGLNKMRNSLYASVTVNDKTKTIEKYNQLAEIGITTSK
DYLERGKLEINEDKLKAAIEDNPEAVYQLFMADGPTTDQQGLARRLRTDISDTMKQIEEK
AGNTFKTEYNYTIGKDMLRIDDNIESMEYRLKQIEDRYWAQYNAMEKAIQKLNNQSSQLT
GFFAQNG
>PK3-045_00985 Flagellar secretion chaperone FliS
MAVNQPYQTYKQNAVNTSSPGDLTLMLYNGCLKFITLAKRAIEDKNIEKRNENLGKAQNI
INELMITLNLEIDISKNMLQMYDYIYRRLVEANTKNDINILNEVEGYVIEFRDTWKEVIK
IAKKDIGPSNGLA
>PK3-045_00986 hypothetical protein
MSLLTDYKECTKKLLGLLTIEEGTIEEREAVIKEINDLLEKREELLNQLPLWPKINEADK
KEMIASEKLLNDKMVSLQGKIKTDLKQQQVRKKRINQYNDPYGGNISIDGMFYDKKK
>PK3-045_00987 Glucose-1-phosphate adenylyltransferase
MNKKCIAMLLAGGRGTRLKKLTEELAKPAVPFGGKYRIVDFTLSNCRNSGIDTVGVLTQY
QPHVLQNYIKDGKDWDLDSRDGGLSILPPYQCGTEERWYDGTAHAIYQNISYIDQYNPDY
VLVISGDHIYKMDYNLMLQQHIKTGADATISVTEVPWEEANRFGIMNTDGTNNRIVDFEE
KPSNPKSNLASMGVYIFKWKTLKSYLQKEEKNELSSKDFGKDIIPAMLTDNRKLHAYTFK
GYWKDVGTIDSFWEANMDLLSKESNIFLNDKDWTVFTHEQCYAPSYIESSATVNRSIISE
GCEIYGTVENSVIFNDVIIGKGAIVKDSVLLPGTVIGENAVIEKSVTACNVTVGDHSIIA
PKDADSEIILIGESIENKQTRVGLSRVI
>PK3-045_00988 hypothetical protein
MSEAILQNQPELELKEMEEEEYYYKLWEDDRL
>PK3-045_00989 Ribosome hibernation promotion factor
MNFNIRGENIEVTPAIREYVEKKISKLERYFSESPDAQVNVNLKTYNDKTSKVEVTIPMS
QLLLRAEEDHMDMYAAIDLISDKLERQIRKHKTKVNRKHREKGNLNELFGSYESTPNVEE
EEQELEIVRQKRFNLKPMDSEEAILQMDLLGHNFFVYTDAETNNTNIVYKRKDGKYGLIE
AQ
>PK3-045_00990 HTH-type transcriptional regulator LrpC
MKLDAIDKKILELLTANGRLSYVEIGKELQLSRVAIRERVSQLIENGVIEKFSAVINSEK
VGKTVSAFFEVDCEPASLIQVAQTLAENPVVASCYQMTGPSTLHMHVLVEDFEALESFTN
NELYSLEGITRVESHILLRRFKSRNGLKI
>PK3-045_00991 hypothetical protein
MENKINTPKKYSIISYIALAIGIICVFIVFVTPTRIANNGNAVGDYITFILTGTGILLSI
IAMMKKTEKKVIPIISFIFSCSLFIFWIIIFILLFTGQIDFAP
>PK3-045_00992 Glutathione hydrolase-like YwrD proenzyme
MKLDYLYHPYPSQRNTVFAKRGMVATSQPLAAQAGLEILQKGGNAIDAAIATAAALTVVE
PTSNGIGGDSFALVWFKDKLHGLNASGPAPSSISIDSLKAKGLEKIPTYGVIPVTVPGVP
SAWASLSEKFGKLPLKEALAPAIRLAEEGYPVSPTLGKYWNLAYNRFKESFQGDEYTPWF
DTFTPNRKAPQIGEIWSSPGHASTLRSIAETNAESFYRGELADKIAQFMKEHNGYLQKED
LERYYPEWVEPISVSYKGYDVWEIPPNGQGLVALMALNIAKGFKLTEKDTVDTYHKHIEA
MKLAFTDGKAFITDEKEMPHTVKELLSEEYAALRRKKIGDQAITPEPLSPPKGGTVYLAA
ADEEGNMISYIQSNYMGFGSGIVIPGTGISMQNRGHDFSLDPAHPNALKPGKRTYHTIIP
GFLTKDNKPIGPFGVMGGYMQPQGHFQIVTNTIDFHLNPQAALDAPRWQWTEGKKILVEP
HFPNYLAQALARRGHEIQTATEFGHFGRGQIIWRDEETGVLIGGTESRTDGTIASW
>PK3-045_00993 hypothetical protein
MTHWHLFLAFFRVGILGYGGGPSSIPLVKNEVVDKYKWMTDDEFSDVLALGNALPGPIAT
KMAGYIGWQVKGVFGMINAIIASVVPTILLMIVLLTFLNSFKDKPWVLGMTKAVVPVVGV
MLGVLTVDFLKKVNSHFRLKMTIGLMAASLILLVLLQIHPAIVIGVIIVVSLLSKKQKEE
VKEVKAS
>PK3-045_00994 Chromate transport protein
MIFWHIFLAFFLPGILGYGGGPASIPLVEKEVVDRYGWVTENEFSEILAMGNALPGPIAT
KMAGYIGYQEGGIIGASIGVFATVAPSLLLMIALLRLLMNFKDSPKVSLLTNLVRPVIAV
LLAMMTISFFQNSYHGIGILQTVFLGAVSLILLEKVKVHPAYVIAGSLVYGAIFLA
>PK3-045_00995 HTH-type transcriptional repressor RspR
MSIIVSIWKKENISTRDFVYESLKNRITELELKPGLKISEQEIASELNVSRTPVREAFLK
LSQEDLLGIYPQIGTIVSLIDLELVEEARFVRENMEKAVVKEVCQVFKQEQLFKLESNIA
MQELCLKNQSYHQLLELDDQFHRLLFEGCNKLRTWKMIRKMNSHFDRLRVLRVESNLEWD
MLVSQHKDIFQFIKEKKASEAEKLIGIHLNLVNFEKEELKKTYPDYFR
>PK3-045_00996 Xylan alpha-(1->2)-glucuronosidase
MEKMVDKENQQFVTNSYHCWLQYRKIENAHQYSNIASMIGIAEDTPIINSAARELQNAIK
SMLDVNPTLQPYTSKKSSIILGTYESVNLNDYGISSTLFDDLNEEGYLLKTTEDNKQMLL
IGKTDRGALYAAFHFLRILQQEEPLIGLEIKEAPQNQLRMMNQWDNMNGSIERGYSGKSI
FFNDNDFNEDLTRVKDYARLLSSVGVNAISINNVNVWKVETKLLTKEFLPKVKEVANILR
SYGITTYLSINFASPIELGNLATADPLDKEVEKWWARKAEEIYRYIPDFGGFVVKADSEG
RPGPFSYGRGHVEGANVLARALQPFNGKVVWRCFVYNCLQDWRDRKTDRARAAYDHFKPL
DGQFLDNVILQIKNGPMDFQVREPISPLIGAMKETNQVVEFQIAQEYTGQQKDVCYLVPQ
WKEVLDFDTYSDGEGSTVKSIVAGTLYNYSHSGIAAVSNIGNDINWTGNTLAQANLYGFG
RLTWNPDLTTETITNEWIQLTFGENPKVASVVKEILLSSWNTYENYTAPLGVGWMVNPDH
HYGPNVDGYEYSKWGTYHFADRDGIGVDRTMETGTGYAGQYFGPNAQRYNSLEDCPDELL
LFFHHVPYLHKLNSGETVIQHIYNTHFQGVEEVVMFIKKWHELEGKVEDWIFKNVQERLQ
LQLENAKEWCDRINTYFYRKSGIADEKNRMIY
>PK3-045_00997 hypothetical protein
MKKHRWLFLTIIMTISLLLSACGGAEKSSGGKNGKITLTIYSAAGGDEYYKDIVIPMFEE
ATDGKYNVEYGRGTPQEVINKIKTQGKNGTIDLVVTGLDGLPLGIKEGLWEKILPEYSEE
THSAEWNEIGQEYIDKFEGYGAPVTTGSGGPILMYNTKTVKNPPKTYEELRKWIKENPGK
FTYPAVPSSGPARGFFFGLIQAMGEDLNNPSSLDKTWDYLEEIGETIEYYPAKTSDSFDL
LYEGAVDIVPHIPFWYADNKAIKTIPPHIEAVKLEDAKQVIDSQFYVMVKDLPEDRKNAA
LEFLKFATSKEIQAQGYVRGFLPANSLATPDMLEPKYQKSYETLVESVMPEFKEGDKMKV
PDGEWILFPDLEETNELYGLWEEKIQALK
>PK3-045_00998 Vitamin B12 import ATP-binding protein BtuD
MEQSVLANTESAASKAIKNTTSTKVEIKNLTKQFGESTAVNNANLTIESGEFMTFLGPSG
CGKTTILSMVLGTLEPTSGDILFNGSPINHIAMNRRDIGMVFQNYALFPHMTVSQNIAFG
LDMRKVEKKEKKRRVQEAVEMVQLNGLENRFIKELSGGQQQRVALARALVIRPKVLLLDE
PLSNLDAKLRKDMRIQIKKIHDELAITTIYVTHDQEEALSLSTKIAVMSKGEIQQLGTPK
EIFGKPKNHFVANFLGYANFIKGKIVSKNNDHFIFESDAKLRLEIKGDGRHQVGDSVLLT
IKPEMIEIVSNDRIGANVIEGEILVGDYVGSTTGYEIKTKDGSILKTSVLGLDPYKAHQK
VKLYLNPAKIIILDEG
>PK3-045_00999 Putrescine transport system permease protein PotH
MNHQAKPKKSDYLMLLPSLLPVLLIFVYPLIRGIMMTFQENGTSHFTMGNYIEFFTNPDY
YQTIFRTLALVIPAAFLELFIAFAITYYIRGKMKGKGIIAGLIIFPLTLGSLIIDMAIIS
FFKPTGWFNTILLQIGLIDEPVRLVYNYTGAFIACVILGVAFLATNFIGMMDSIDPNLEK
ASRSLGASEWVTFRRVFYPLIRGGVLRVFALNIIMQIGVYTSAVIVGNPASATRTFAVVA
FEEAMRNFNYSMANTVAVVMAITQLVILAIVFALRKRGFVGSASTFK
>PK3-045_01000 hypothetical protein
MRIVENTIKGGINNPTEASVPKNSKVAGLLKLLYKFLTWLLIIVCITSIIGMTIAVLLTA
FGTEWYGTFLPAGYTVDWFVQAWQVYEIGHFYKITLQIVVTATIISLLLSIPTAYVLGRK
SFPFKEGLISFFQMPFTLPELVYAIPVASIFYSTGLAETIPGLILVNLIVGIPFSVFILL
PFMESLDPRLEWAAESLGATKFKLFSRIVIPQLVPGLTASAINIFIRMFSTFTIILLISG
PKTQTLSVMVFSVLQGAGSQPQPMLNSLALTLMFPLLLFAFISLWISSFTQRRLGKK
>PK3-045_01001 Glucose--fructose oxidoreductase
MLNVAIIGSGAISSAHIEAYQQFPERCRIVALCDLYPEKAKKQAEEFHLNATVYEDYQMM
LERTDIDLVSVCTPPYTHAKIAIDFLDAGKNVLVEKPMASSLEECDAMNAAAERNDKLLS
VISQNRFQSPMMKLKSVLDTKMMGPIVHTQVDSFWWRGHSYYDLWWRGTWEKEGGGCTLN
HAVHHIDIFKWMNGMPSEVTAVMSNASHDNAEVEDISVAICRYDDGSLAQITSSVIHHGE
EQQLIFQGKNARVSVPWKVKASKSKGNGFPVADTELEEKIQRYYEQLDDIPYEGHPGQID
DVLTALEQGTAVLVDGEQGRQTLELISAIYESASTGKTIKLPLTKDNLFYTREGTQTNAI
HFYEKKTAVENFEDNDITVGGKYE
>PK3-045_01002 hypothetical protein
MSNMKEEKNVNKNDGMNYAPKGQVNKVVEEGEFLFAAIGLDHGHIYGMCNGLIEAGGTLV
AVYDPGATRF
>PK3-045_01005 hypothetical protein
MASKVYLSLYAEKVQKFIQIYPQARAAASEEEILQDKTIQLVASANIPVQRGPLGLRVLD
AGKHYFVDKPAFTTMAQVEQAKQKVAETGLRWGIYYSERLHVESAVFAGQLIEEGAIGRV
ISVMGTGPHRANVNSRPDWFFDPEQYGGILTDIGSHQIEQFLHYANAKSAKVLHSTVANY
HYKQYPEFQDYGDATLVADNGATFYFRVDWFTPDGLGTWGDGRVTIIGTEGYIEVRKYID
IARSKEGNHLFLVNGEGEKYYQLSGKVGYPFFGQFILDCINGTENAMTQEHAFTAAALCI
EAQEKAIKIE
>PK3-045_01006 Protein translocase subunit SecA
MLGILNKVFDQNKRDIKKLTKIADKIELLADETAALSDEQLKGKTEEFKARFQKGETLDD
LLVEAFAVVREAAKRVLGLYPYPVQLMGGASLHEGNISEMKTGEGKTLTATMPVYLNALS
GKGVHVVTVNEYLATRDAAEMGQLYNFLGLTVGLNLNGLSREDKQAAYNADITYGTNNEF
GFDYLRDNMVLYNEQKVQKPLYYAVIDEVDSILIDEARTPLIISGSAQKSTQLYVRANIF
VSSLKPEKDYTYDEKTKGVQLTEEGMSKAERVFQIENLFDVSNVAINHHITQALKAHASM
HKDVDYVVQDGEIVIVDQFTGRLMKGRRYSDGLHQAIEAKENLEIQNESMTLATITFQNY
FRMYEKLAGMTGTAKTEEEEFRNIYNMNVVVIPTNREIVRDDRADLIYASMDGKFRAVVE
DIAERHKKGQPVLVGTVAIETSEIISKYLTKKGIPHNVLNAKNHEREAEIIATAGEQGSV
TIATNMAGRGTDIKLGEGVKELGGLAVIGTERHESRRIDNQLRGRSGRQGDPGVTQFYLS
MEDELMRRFGSDNMKNMMTRLGMDDSQPIQSKMVSRAVESAQKRVEGNNFDSRKQLLQYD
DVLRQQREIIYSQRNEVLTSENLRSIVENMIKSSLERNIQAHTPDNADRESWDLQAIVDY
VSGNLLNEGEVEVSDLRGKEGDEIVEFIFAKVLQSYNEKEEKLSPEQMREFEKVIVLRAV
DSKWIDHIDQMDQLRQGIHLRAYGQIDPLREYQSEGFAMFEAMVIAIEEDVAKYIMKAEI
RNNLEREEVAKGQAVNPKEEGGDKKPKKKPAVKQLDIGRNAPCFCGSGKKYKNCHGANL
>PK3-045_01007 Peptide chain release factor 2
MLEDDMLHPDFWNDQQAAQTVISESNALKDQVHEFYKLVETFENLELTYELVKEEDDAEL
RAELEEELTELVGRLSQFELNLLLSGPYDKNNAILELHPGAGGTESQDWGSMLLRMYTRY
AEKKGFKVETLDYLPGDEAGIKSVTLAIKGHNAYGYLKAEKGVHRLVRISPFDSSGRRHT
SFVSCDVMPEFNDEIEIEVRTEDLKIDTYRASGAGGQHINTTDSAVRITHIPTGVVVSCQ
TERSQIKNRETAMKMLKAKLYQRKIEEQEEKLAEIRGEQKEIGWGSQIRSYVFHPYSMVK
DHRTNTEVGNTQSVMDGDLDIFINAYLRSKINA
>PK3-045_01008 putative glycosyltransferase YkoT
MQKTILTIAVPCFNEEEVFEQTMGNLRTVLRDLMEENLISEQSQLLFIDDGSKDATWEKI
ENATLFDPLVSGIKLSRNFGHQRALLAGLEEAVKFSDCVISIDADLQDDTGVIRDFIIEY
LKGNEIVYGVRSKRETDTFFKRNTAQGFYRLMEKMGLSLVYNHADYRLLSKRAIEEMLRF
KESNLFLRGIVPLLGFKSTKVYYERKERAAGESKYPFRKMIAFALDGITSFSVKPIRLIT
ILGFLFSVISVFAGVYAIVQKFMGHTESGWTSIMISVWLLGGLMLMSIGLIGEYIGKIYE
EVKQRPRYIIESNLCKKIEKRSKVQS
>PK3-045_01009 hypothetical protein
MKDKSFLIFLVVGLMNTFIGLTMIYLCLTAFHFDYWAATFIGNAVGACVSYFLNKRFTFK
SNAALGSSGLRFIAVILASYLLAYKAGLVLVEMLLGEWNIFASYTDEIAVLFGSGFYTLL
NYAGQKYFVFPKRYQQNSRSVK
>PK3-045_01010 hypothetical protein
MNYLKRERKFFYIAIAIIFVWVLPYFVLNEDAHMRVHDNLDSNLGWYEVMKDNGVAFSPL
HTPVEQIMNGEFSRDTYYSEYYAMVFLFQFLPPVIAYGLCQAITHFVAFIGMYLLLKKYV
MKEEHNKAYILTIGVALAFSLTPYWPSGMLSILGMPLALWSMLNIYKGERSWKDLAVLTL
LPFFSTFVIGFFYFLAVMGLFWLYDFVRNKKSNWALFFAILYMTMVYLAIDYRLVASMIA
PISDELTNRDVFYQSKLDFVQTLKLVGKNYVISHNQDRTIHQYIILPVTIIGLLFVLLKK
QWRENKLYIGLHLLNIVLSTWYAFWFFEGWQPLKEKFGILTSFNFARFHYLRPMIIYVLF
ALTLKMLWKNRNMGRKLVYVLIIGQLLVLVPTNEQIMYKNQPSYKAYFATDQFTDIKKYI
GKPLDQYRVVSIGIHPNIAQYNGLYTLDSYSNIYPLDYKLQFRKIIEPELDKNKALRTYY
DDWGGRCYIFVDELGKNYQYSKRSNKEINHLQLNVEALKEMGGQYVLSAVPINNAAETNL
TFMKDFESKNSNWHIYLYKVM
>PK3-045_01011 Undecaprenyl-diphosphatase
MEIIIAIILGIVEGLTEFAPVSSTGHLILVAHLLEFTGEKAKTFEIIIQLGSILAVVFVF
WRRILSILGMKKWQTEEDVGTLSIFHLAIGIIPFGVGGILFYDFIKEVLFGSGTVVITLI
IGGLLMLAAEKWKPRKPTAETLDEVTYRQAFTVGMFQCFALVPGFSRSGATLSGGVLAGM
SHKAASEFTFIMAIPIMAAATGKDLFESWNYLSPQDLPLFLTGFITAFVVALLAIKFFLK
LINKIKLAPFAYYRFVLAFLFWIFIL
>PK3-045_01012 hypothetical protein
MKWREYIYVLIGSAFVALSFNLFLLPNNIASGGVSGISTITKAVFHWEPAYVQWALNIPL
FVLGVVLLGRNFGVKTLIGTVFLPFVVYLSRGLEPWTNEPLLAAIYGGIGIGLGIGIVFR
GKASTGGTDLAAQIINKYTGISLGKCVAMIDGVIVITASIVFSIEQGLYALIALFVTSKT
IDFVQVGFGSSKMTLIITDKQEEVREGILNKIDRGVTRLTAHGGYTDSERPVLMCVVDQS
QFIKLKQLVQSIDETAFVVVTDASEVLGRGFK
>PK3-045_01013 Cell division ATP-binding protein FtsE
MIEMKNVMKKYANGVIAANGINVRINQGEFVYVVGPSGAGKSTFIKMMYREEKPTQGSIR
INGINLEKLKDKKVPLLRRNMGVVFQDFKLLPTLTVFENVAFALEVIEENPKNIKKKVMD
TLELVGLKHKARMLPTELSGGEQQRVSLARSIVNSPKLVIADEPTGNLDPETSWDIMNIF
ETINNRGTTIVMATHNREIVNTIKHRVIAIEGGRIVRDETRGEYGYEG
>PK3-045_01014 Cell division protein FtsX
MKARTVARHTRESFKSLLRNGWMTFASVSAVTITLILVGVFFVIMMNLNHVATSLEENVE
IRVHIDVAATKEEKNALEEEIKAIPEVGSVIFSPKGEELNNLITSLGEDGDAFKLFEQDN
PLNDVFVVKTKDPEDTLAVVKKIEKFEHVAKVRYGQGTVEKLFSAINMSRNVGIVLIIGL
LFTAMFLISNTIKITIVARRKEIEIMRLVGATNWFIRWPFFLEGMWLGLLGSIIPIAAVS
AIYYYAYQFLKAKLAGSYIKILDYTPFVFQVSTLLLVMGAVIGIWGSVMSIRKFLRV
>PK3-045_01015 hypothetical protein
MKKKLAKLTLVSTLSVSSMIAYTSITASPVSAQGSLSELNKEKSNLENKHSNVKKKLDDS
SNKLGDIHSQQDSVETEIKRINTSISSTQVKITEKKEQISTTKEEVKKLEKQIEEVKARI
EKRNELLKERARSYQQTGGMVNYLDVLMGSQSISDFIDRVGAVATIVEADQTIIKEQEAD
KKLLEQSKAELKSKLSSLETMLADLESLSSQLNAEKKEKDKLMAQLEKEENHVHAEMLSL
EEEEQLLKDQQVAMEKAIKLEKERQAELARQAAEAEKQRKAEEAKAAAERAAAQKQAANN
TKATSKAVSKTTASSNGGSNSPASKPKTSVSSGSFTRPAGAGYLSSGLGHRWGTFHAGVD
IAATGTVPIYAAADGVVIRSYPSTSYGQVIFISHYINGQQYTTVYAHMREGSRLVNAGDV
VSKGQQIGTMGNTGDSTGQHLHFELHKGPWNQAKSNAINPVGIVPL
>PK3-045_01016 HTH-type transcriptional repressor CzrA
MSEFNEKKESMNPINKSELDEETLFIVSQTFKALSDPTRIKILHLLSKKQHSVNEIAESL
SMLQSTVSHQLRFLKNLRLVKYKREGTTMIYSCDDEHVMGVLKQMIDHARHH
>PK3-045_01017 Cadmium, zinc and cobalt-transporting ATPase
MEEEKQLRKKEFILEGLDCANCAMKIENGIASINGVRECTVNFATQTLQLQVDEIEEKSI
LAKAEKTISRLEPHVKMVEKRKKATSPSPDHSHHHEHGHGHEHSHDHGTENIKRLVGRLV
AGTFVAAIGFFAPLTGIMEFALFFLAYLIVGGDILFRAIKNILRGQIFDEHFLMSIATLG
AFAIQEYPEGVAVMLFYQIGELFQGIAVNRSRKSITSLMDIRPDYANVKDGSELKKLSPE
QVNIGDIIIVKPGEKIPLDGRVIEGSSSVDTSALTGESIPRDIEIGNEVLSGYINNHGLL
TIEVTKDFGESTVTKILELVQNASNRKAPTENFITKFARYYTPVVVITAALLAIVPPLLI
SGATFSDWLYRALVFLVISCPCALVVSIPLGFFGGIGAASKKGILVKGSNYLEALNDVKY
VVFDKTGTLTKGVFEVDSIHPAPRITEEEVLEYAAYAEVHSNHPIAESIRKAYQGQIIEE
RIGEYQELSGHGILVELDGKKVLAGNQKLMIKENINYLPNEEVGTVIYVAADKEFIGSIV
ISDQIKEDAEKAIQLLKEQGIKKTVMLTGDAQKVGAKIGSLLKIDEVHAELLPQHKVEEI
EKLDQHKQAKEKILFIGDGINDTPVLARADVGMAMGGLGADAAIEAADIVLMTDEPSKIA
TALSVAKRTRRIVWQNIIFALGVKAIFLLLGAFGIATMWEAVFSDVGVTVLAVLNAMRVL
QVKGI
>PK3-045_01018 putative manganese catalase
MFFHIKELAYEAKPERPDPVFAKKIQELIGGQFGEMSVMNQYLFQAWGTRKNDKYRDLLL
DTGTEEIGHIELLSTMVARLLDDAPVTELETAAATNPAMAAIIGGMNPQHAIVSGLAAMP
KDSVGVPWNGGYVAASGNLLADMRANLNAESQGRLQAVRLFEQTDDRGIKDMLSFLIARD
TMHQNQWLAAIYELEQKEGVVVPSTFPRHLEKTEVSYLFLNHSMGDESSKGRWASGPSMD
GMGTFQYVRDVPPFGSAPKLKPAPPAEHNTPPNLK
>PK3-045_01019 Carboxy-terminal processing protease CtpB
MNRKWLAIYMAGSLLAGSGMTYIGINMLEKRQEEQLNNQTMEAGSLDKLDKAYQIILQNY
VENVDKQKLEDGAIRGMLATLEDPYSVYMDQEAAKQFEQALDSSFEGIGAEISIEEDKMI
IVSPIKGSPAEKAGIKAQDQIISVNGENVEGKDLNDVIGQIRGEKGSKVELEIKRATVDK
PLKMEIVRDEVPQITVYSDIKKDGGEKIGYIEITSFSKDTASEFEKELNKLEKNGISSLI
LDVRGNPGGLLTSVNAIVEQFLTNKKPYVQVENRNGDREQFYSDLKKQKEYPVVVLIDNG
SASASEILAAALKEGAGYPLIGENSFGKGTVQQPILMDDGSEIKLTVSKWLTPDGNWIHK
QGIKPTIDVEQTDLYHTHPLQIVDSLKLEDNDEQVQYAQEILTSLGFTTDRQDGYYSPQT
EVAVRAFQSKNALEVTGVIDGKTAAKLEEAVRTEKQKDENDIQLQTAIRYLVH
>PK3-045_01020 putative HTH-type transcriptional regulator YtcD
MENKKYNISVEATLEVIGGKWKCVILCHLTHGKKRTSELKRLMPNITQKMLTQQLRELEE
DGVINRIIYQQIPPKVEYELSDYGKSLEPILNALCEWGDTHITKIYGDKNLMLEDSVLNK
>PK3-045_01021 Inner membrane transport protein YdhP
MKQNMNTFALIALAVSAFAIGTTEFISVGLLPLIADDFRVGITTAGLTVSIYALGVTFGA
PVLTAITSNISRKSLLLWIMIVFIIGNSMAAIAPNITILLIARIVSAFAHGIFMSIGSTI
AADLVAKEKRASAISIMFSGLTVATVTGVPFGTFIGQHFGWRLAFITIVIIGIIAFIANS
LLVPSNLSKGGRATFKDQLQLVTNPRLLMLFLITALGYGGTFVVFTYLSPLLHEVTGFQQ
NTVAGILLLYGVAIAIGNMIGGKLSNKNPLRALFFMFIIQAIILFVLSFTLPFKVIGLIS
ILFMGLLAFMNVPGLQVYVVMLAERYVPSAVDVASAVNIAAFNAGIAIGSYLGGIVTNSL
GLIHTSWVGGIMVIAAIILTGFSLILEKNSLQKGVITR
>PK3-045_01022 putative oxidoreductase YtbE
MKNLQDTIQLTNGIKMPWLGLGVFKVEEGQVLVDAVSSAIKNGYRSIDTATIYANEAGVG
EGIKRGMKEAGITRDDLFITSKVWTDDLGYEETIKAYEVSLEKLGLDYLDLYLIHWPKEG
KYKDAWKALETLYKQGRVKAIGVSNFQIHHLEDLMKDAEMKPMINQIELHPRLTQKELIA
YCQEQGIQVEAWSPLMQGQLFDQPELVEIAAKHQKSVAQVIIRWDLQNGIITIPKSVKEH
RIIENGNVFDFTLSKEEMAQIDALNLDQRVGPDPDNFDF
>PK3-045_01023 hypothetical protein
MKLWWIANVFWVVVFSILSIIIATRQIDGSGAVQTPEIRIITFIILAVPFVFILIVQLIW
FYFIHKRTRHS
>PK3-045_01024 Putative sugar phosphate isomerase YwlF
MKIAIASDHGGYQLKEAVKAHLRNAGMEVEDFGCHSRENVDFPDYAKSVGASIVNGENQL
GILCCGTGIGMSIAANKITGIRAAVVGDVFSAKATREHNDSNILCLGERVTGEGLACLIV
DTWLNAEFLGGRHEKRISGIKELESYYC
>PK3-045_01025 ATP-dependent 6-phosphofructokinase
MKVGVIVLGCLPSGVKQILHRLYEELSSKHQLFGMEIDRKSGEVNYTEIKEVSDSPYLSH
TILKVSAAPVNNLWEQTFAPMDMTVVLGDAQAKEIWQTSIADKEALRTLFVPVSVYNNIK
GNDWTLGYDTALNSITQNVLKVQDTIHSLKYDKPRLFGFSIEGNPSTNMLQDISLAVDGN
YLAVDYEEEEITTLCDAIKKSYTYTKTSNVLIYSQALQEVIENSVISKLEVDWKYTEIDE
ALCMGVNPTAIDRILANELADEVLRWIKNNCLTGELTVQKDGIQFK
>PK3-045_01026 Transketolase
MSNQVKTDIEQLAINTIRTLSIDAIEKSNSGHPGMPMGAAPMAYTLWAKEMNHNPANPNW
FNRDRFVLSAGHGSMLLYSLLHLFNYGVTVDDLKNFRQWGSKTPGHPEFGHTPGVEATTG
PLGQGIAMAVGMAMAERHLAETYNKENYPVVDHYTYSICGDGDLMEGVSAEAASLAGHLK
LGRLVVLYDSNDISLDGDLNLSFSESVQKRFEAYGWEVIRVEDGNDLAEIQAAIAQAKKS
DIPTLIEVKTVIGYGSPNKGGKSASHGAPLGASETQLAKQTYGWAYEEAFHVPAEVSEHY
AALAQAGAEKEKAWNELYENYKAAYPELATQLETAIKGELPADLQEKLPEFNAGDSMATR
DSSGKTIQAIASAVPAFFGGSADLAGSNKTLMTSEKNFAIDGYAGRNIWFGVREFAMGAA
LNGLALHGGVKVFGATFFVFSDYLRPAIRLAALMKLPVTYVFTHDSIAVGEDGPTHEPVE
QLASLRAMPGLSIIRPADAKETAAAWQLAIESTDTPTALVLTRQNLPTLDLTKAEAYEGV
KKGAYTVVAGKEAAQALILASGSEVSLAIKAQAALAEEGISVNVVSMPSWDRFEKQSLEY
KESVLPESVQARVAIEAGASLGWREYIGSKGEHITIDHFGASAPADKLFQEYGFTVENVV
AKVKSSIAKAK
>PK3-045_01027 hypothetical protein
MYLDERSNILLKEVLSNPDTSNIKLEKKFQLSRRQVSYSFQKINDWLESNNYPAIKRTNG
GKFIISPVIMELFAEKTDEQVDKHYIPSETERAQFILLYIISSNEELSLLHFTTALGVSK
NTVLRDMKNVQQMIEPYELEVSYSRMKGYELKGKEWDVRKLLVEVLENILSIYNGEVYIQ
KFIDISKDNLTTIKERLAEVESSLHLQFIDERINLLPYILAVILKRIQQGKVIQDFYHID
YRSLSDTKEFIAAEILIKDMKAIPKEEHLFLTLQLLTSKILSAQFLADHQIPELTRALEQ
FLHTFEYKACIAFKDKAALLERLVLHMKPAYYRMKYNLTTNYTMMEKVSEEFETIHFIVK
DSISPVEEYIGCPIPESELMFITIFIGGHLISSGETIQKKKKAVVVCPNGVSISRLMEST
LRELFPEFYFYHALSIREFQQLNYQVDIIFSPVPLQTDTKQFVINRILTDFEKVQLRQRV
LREIFDLNTSVINIEQLMGKIEKYASIKDKESLRSTLQEHFSITPANDSQEPMAKTDLSL
SSLLAPKMITVVKRIEGWQQGIQLAAEKLLKNGSITENYIAEMVKQYPTMVQHILLRNVI
AIPHAGPEDGVNNVGMSLLKIEEGIPFNDNVCVHFIVVLASTDKHKHLYALRQLMKLSKN
EEDISNLKNSNDSNQLYEIIKKYS
>PK3-045_01028 hypothetical protein
MAVASFIKESLINIGLKVENQDELFHAMFEKAYEQGFVKETFLPKIKERESIFPTGLSVN
NYSIAIPHTDPEHVVEQFIAVSVLEKPVSFHLMEDNTKTTEVQAVLMLGLNQPHSQIEVL
QELMQVIQVEEHLEKLIHAKDKSDITLLFESIKIS
>PK3-045_01029 PTS system galactitol-specific EIIB component
MNKPIVLVACGAGIATSTVVLDHLEELFRRENLKVELVQCKIAEVASLQDDAFLIISTTI
LPTKYKVPAISATAYISGLGIEKLDKEILSYFERTSKTI
>PK3-045_01030 PTS system galactitol-specific EIIB component
MKIYKILVACGAGIATSTVVCNRVENLVKDNNINAEVIQCKIAEVASKQSEADIIVSTTI
LPTTYQIPAIIATAYITGIGMESLDKKILDHLK
>PK3-045_01031 PTS system galactitol-specific EIIC component
MQKLLDGVQYVLNLGPTVILPIAIILLGLAFKTGFKKALKAGITIGIGFVGINLVIDLLV
STLGPAAQQMVERFGLNLTVIDTGWPSAAALSWASPVAAILIPICLFANIFFLLTKMTKT
LDIDIWNYWHFIAAGATGYIVTDSWWFAILCAIIYQYAVLFVADKTAPMVQKFYGLDGIS
LPTGSTAAFGPIGILVGWAIAKIPGINKLNADPETIQKRFGIFGEPMMMGIILGALIGLL
AGYDIGKILQTGISMGAVMLLMPRMVKILMEGLIPISESARSFLQKRYGDREIYIGLDAA
VSVGHPSVMATALILVPITLFLAVILPGNKVLPFGDLATIPFYIAFVVGSRKGNIIHSVL
AGIVMVALSLYMATNFAEVHTQMISGAQFTLPEGATQISSLDLGGNLFNWLILKFSEAVA
FLFGK
>PK3-045_01032 Galactitol 1-phosphate 5-dehydrogenase
MKAAVLHAENKIIYEDIELESCKATEVKVKVMAAGICGSDTHKMTSVWKYPLPAIMGHEF
SGIVTEIGSKVTNVKVGERVVVIPFIPCNECEYCLKGQFSLCENHGMIGSQSYGGFAEYC
NVPATNILSIGEMDFEEAAMIEPLAVALHGVLNIKPHLGDVVAVFGAGTIGMLVIQWLKI
AGVKEIIAIDISDEKLAEARAFGCEKTINAKKEDLYQKIDEYTNGLGVDIALECAGSKIT
QEQCLLITRKKGKIGYLGIAYSDVTLSQKAFENIFRRELTLKGFWNSYSAPFPGEEWTKS
ITFLQKGQIKLKDLISHRFPLEDTQAAFNLIINREENYGKVLILPNGSEN
>PK3-045_01033 D-arabitol-phosphate dehydrogenase
MKAVTKLKSGYDEMELIEIDEPSAYDDKVKIKVAYTGICGSDIHTFKGEYNSKNTPVVLG
HEFSGVVVEVGKDVTRVKVGDRVTSETTFTTCGECIYCQEKDYNLCPNRTGLGTQVNGSM
AEYVIAREESVHVLNEKVSLEAAALTEPLACCVHAALEKTTIAETDTVLVFGPGPIGLLL
SQVVKAQGAFVILAGITKDRKRLDLAKELGIDVVVDLLQEDLSKMVYQYTDGYGADKVFD
CSGAVPAVNQGLALTKKKGTFVQVGLFAKKANEIDQESIIQREINYIGCRSQKPSSWDIA
LKLLEDGKIDTDKMITKIVSLAEWRNGFEKVMAGDEIKVLIES
>PK3-045_01034 Putative sugar phosphate isomerase YwlF
MKLAIACDHGGFLLKEAVKKYLLEQEVEVEDFGCHSRGSVDFPDYAKKVGESIVRGQNDL
GILCCGTGIGMSIAANKINGIRAAVVGDVFSAKATREHNNSNVLCLGERVTGEGLALLIV
ETWLQAEFLGGRHERRVGAIGELEKYLC
>PK3-045_01035 ATP-dependent 6-phosphofructokinase
MKIGIIIAGLLPAGVKQIIHKMFNEWTPTHQLFGIEVNKETGKADYLEFIVNNDSPYLSD
SVLNPSPLVDNIRWEEICSPMDSIIFIGDEQAKERWTQTFAASETIHSLYVPVSIYNNIK
GSDWSLGYDTAINSITQMVLKVKDTIHSLKYDKPRLFGFAINGFPSNHMLQDISMAVDGH
FLANTDELEEVELLCNKIDNSFNSLQTSSVLVYSHLNKASVEKNLIRSLNVDWKYTEIDE
ALCMGTNPTTIDRILANEIAEIISLWIKNDSPTGEIAVKKEGVLYLNKNYEGMIV
>PK3-045_01036 Transketolase
MTNTVVANVEKLAVNTIRTLSIDAIEKSNSGHPGMPMGAAPMAYTLWAKEMNHNPANPNW
FNRDRFVLSAGHGSMLLYSLLHLFQYDVTVDDLENFRQWGSKTPGHPEFGHTPGVEATTG
PLGQGIAMAVGMAMAERHLAETYNKENYPVVDHYTYSICGDGDLMEGVSAEAASLAGHLK
LGRLVVLYDSNDISLDGDLHLSFSESVPKRFEAYGWEVIRVEDGNNIEEIHKAIIKAKQS
DIPSLIEVKTVIGYGSPNKGGKSASHGAPLGASETQLAKQTYGWAYEEAFYIPAEVSEHY
AALAQAGADKEKAWNELYENYKAAYPELAAQLESAIKGKLPADLQAKLPEFTAGESMATR
ESSGKTIQAAAKELPFLFGGSADLAGSNKTLMTAEKNFAIDGYAGRNIWFGVREFAMGAA
LNGLALHGGVKVFGATFFVFSDYLRPAIRLAALMKLPVTYVFTHDSIAVGEDGPTHEPIE
QLASLRAMPGLSIIRPADAKETAAAWQLALESTDTPTALVLTRQNLPTLDLTKGEAYEGV
KKGAYIVSPAQGEAQALILATGSEVSLAINAQAALAEEGISVNVVSMPSWDLFEKQSPEY
KESILPESVQARVAIEAGASLGWREYVGAKGECITIDHFGASAPADKLFQEYGFSVENVV
AKVKASMARN
>PK3-045_01037 Cell division topological determinant MinJ
MWQDWLLELLKGFGKLFLNPVFYLSFLFAAFLGVSRVKKERRNFTVRAQDAYFELRQLLP
RGIIVGLCVSILSIGLVLVVPMEFIIFTGIFTIIFALIGKTRILSPVYTAGLGIIASSVS
VFLGLDYFLFSKSNLQPSEYIFPTAIILLGLLIISEGIFVRGNGVKGTSPRLKKSKRGQV
IGVHLLERAWLMPVFLFIPSGVLTIPFEWWPMFTIANQTYSLIFVPFLIGAKLEVQGEHP
IVAIRNVGRNLIILGSFVIVGGAATYLYPLASLGLVFVAIIGREWITSKQRNKEKNRSFY
FSRKNNGVVILGIVPDSPADKMGLRIGEMISKVNSIPVQDKIQLYKALQKNSAHCKLEVF
DSHGEIRFVQRALFEGDHHELGLLLIPDEKVHGNEAV
>PK3-045_01038 Putative cytochrome bd menaquinol oxidase subunit I
MEFDTVTISRMITAMTLIFHIIFATLGVGVPLFISIAEFIGIRKKDKHYELLAKRWSRGF
VITVAIGVVTGTAIALQLSLVWPNFMQLAGNVIALPLFMEVFAFFFEAIFLGIYLYTWDR
FKGKYTHWLLTLPVVIGAGMSAVFITTVNSFMNSPNGFTMVDGEFVAVNPLKAMLNPSSP
TRIFHVLGGSYLTVAAILATIAAIALLRNKGAREYHKKALKMTVIAMFIFSVITALAGDV
SAKYLAKHQTEKLAAAEWLFESEENADLLLFGWLNDENEVVGAIRVPGFLSFLAHGDFTS
EVTGLEATPEGERPPLVIHYLFDSMVSIGFFLLGISFLYIVLARFKRWNQHNRLMLWLIA
ISGPLAMLAVELGWVFAELGRQPWIVRGYMTVDEAATSSPYILQMFFLFLALYIVLGTLF
TITLRKLFKDNPAELELEKNYPEWKEGIEK
>PK3-045_01039 Putative cytochrome bd menaquinol oxidase subunit II
MSYEVIGITVLWLFLYGYLIVASIDFGAGFFAYYAKITKQDHIINQIISRYLSPVWEVTN
VFLVFFFVGIVGFFPSSAYYYGSALLVPASFAIVLLAIRGSFYAFENYGSKQSNVYMFLY
GATGLFIPASLSVALTISEGGYISEHNGQVSLKYFELFTSPLAWSIVALAIVSVLFISAS
FITYYASRAKDLAALQLVRKWALFWATPTIIMALTTMIALSQRNQVNYENMLDLWWVFGL
SMGFFIIGIGLLYIGRNYGIAFIAIMLQFLFAFFGYGMAKYPYLLYPYINIEDSATNPSM
AMALIIAFIGGLLLLIPSLILLMRLFLFDADYAKGKK
>PK3-045_01040 ATP-binding/permease protein CydD
MQNIKKTVWMHKKKIYCLFGLTLILGFAIVAQAYVMTSIVDGVFLKEQSFSAIIPWLLLL
LIILFVRSSTDYISKRIGVSIASKVKGETRKNLLKKYVANSVQLNEKGQTGEKVSMLLDG
VDEMDSFYSQFIPQVMQSTFVPILMLLVILTQHVNSGIILIVSAPFIPIYMIVIGIKTQK
KSEEKLEKLASFSGKFLETLQGLVTLKLFAQTNRQKGELEKSSLSFRDTTLEILKIAFTQ
SFALELISMLSIGIVALELAIQLIIYESISFFTAFLILILVPEFYTSLKELGVTFHNGRS
SMGAAKKVLEVFEEEDEPTLWGKQTFPKWKVPPTIQLHQVDFAYTNTNFRLQSITATFLP
KQQIAIVGASGAGKTTLLHLLAGMITPEKGTIYINHEALTKYTEAAWLERISYISQTPYI
FSGTIGENIAMGTTEEVGMQAIETAAQLAGIAPLVNSLEHGFDTRIGEAGRGLSSGEKQR
VSIARAFLKKPHIVLLDEPTRGLDLATEKILQQSIQKLKETATVITVAHRLHTIKNADQI
LFLENGRLQAVGTHESLLEISPAYKEIVMIQKGRAQ
>PK3-045_01041 putative ABC transporter ATP-binding protein
MSALQKIMRLMLIEKKDIIIAVVCGFIAGISSVGLFAASGYLISKSALIPPFYTLIILTS
TVKLLGLVKAGAKYGERLSSHRATFTILSNLRVAFFEKLTPLIPQIFHKYRSGDLLARVV
GDVESLQNFFLRVFYPPLVLLLVFVSTILFTSFYSITIALILLLGFFLTTIIIPALFSLK
QVNIKGKVRHARGDLSTHITEVMYGFRELKLFHQLPYKQQQLLNRSESYINEQKRENLNK
VSSQSFNGFITLVTSWTVIGVGAYLVANGMLEGIFLAMLVMISLTVFESAAPMAVFPIYM
QESRDASSRLYEVVEDPSYKKNHSDSAINKLSSLPPSLEFKDVQFTYMGDWRSTIPNISF
TIPARSKTAIVGASGSGKSTVLQLILKLQEVDAGNIYWGEVDITSVSGEAIWEQTKVVLQ
ENYYFYGTIRENLQLAASELSDTQMEAVLAKVQLEYFSLDHRVLEKGENLSGGEKQRLAI
ARAFLKKGHLWLLDEPTSSLDAQTEQTIYKEIFKDADQDTFIIVSHRLNGLESMDQIIVM
DHGEIIECGSYKDLMDKQGYFYQMKVLEESLL
>PK3-045_01042 hypothetical protein
MKLDEFIIGQTFQTKTLSLTKEEIIKFAVEFDPQYLHVNETKAKEGRFNGIIASGIHTLA
ISFKLWVEEEKYGEDVIAGTGMNNVQFIKPVYPGDKLYTIVKVLEKKANKSATGILTVLL
KTFNDKEEEVFTGELSVLIKR
>PK3-045_01043 Fumarate reductase flavoprotein subunit
MKKRITSMLILVFSLVLVLAGCGNDKASNTQKQEKKDKGAETVSGASKTSYTPYEELKDS
YDIIIVGAGGAGMTAALEAKAKGLNPVILEKMPVAGGNTTKASSGMNASETKFQKEQGIK
DSNDNFYEETLKGGHGTNNKEMLRFFVDHSASAIDWLDSIGIRLNNLTITGGMSEKRTHR
PEDGSAVGQYIVDGLLKNVQEKDIPLFVNADVKEITVKDGNVNGVHVLFNQTDEKEIAAK
AVVVTTGGFGANMEMIKEVRSDLGDYVTTNQAGSTGDGIKMIEKLGGTTVDLDQIQVHPT
VQQDESYLIGEAVRGEGAIMVSAEGKRFTNELDTRDKVTAAINELPEKAAFLVFDAGVKS
RVKAIEQYKKMGFVLEGETVEALAEKMNVSADELTATLETWNSAVKNKDDQAFGRTTGID
NDLSKAPFYAIKIAPGIHYTMGGVKINTNTEVLNKEGAPIPGLFAAGEVTGGLHGENRIG
GNSVAEIIIFGRQAGVKSADYVKAK
>PK3-045_01044 hypothetical protein
MKDNRGKEVMIVVLEFSQMKRFLMMDMGIGTLSYYLIKMINGNLLIDLIGSTIITEGVKR
VFKGINNKK
>PK3-045_01045 Zinc transporter ZupT
MPENLLIAFGLTLLAGLATGIGSVLAFFTSTTNTKFLSWMLGFSAGVMIYVSMIEIFVKA
KDALVGSLGIQTGNWLTVAGFFGGILLIALIDKFVPEQGNPHELKKVEEINKSNLKRTDH
SLLKMGSFTALAIAIHNFPEGIATFTAALQDPGLGVAITVAIAIHNIPEGIAVAVPIYFA
TGDRKKAFKLSFLSGLAEPVGALVAFLILMPFLNDVMFGLIFAAVAGIMVFISLDELLPA
AKKYDEGHLSIYGLIAGMAVMAVSLLLFI
>PK3-045_01046 hypothetical protein
MIIIVIVIAIFLSSLAGIITDHLEKRAKLNKAMLKDQLELERLKHENFLLETEKLKLEVE
KMEKENNLLEKK
>PK3-045_01047 Ribose-5-phosphate isomerase A
MERQDEKVLVGEAAVIQFVKDGMTVGLGTGSTAYYVIKKMGEMIKKGVELKGVATSKATE
KLASECGIQLIDINEVEQLDIAIDGADEIDDNFFAIKGGGGALLREKIIASAAKTFIVVA
DGSKKVQSLGKFPLPIEVVPFGYKHTEKAIRKFGCKTAIRQKDGKLFVTDNGNYIIDCSF
PTIQNPTQLHQDLNNIVGVVENGLFINMVDVLISINEQDQISVEHKNR
>PK3-045_01048 NAD-dependent malic enzyme
MSLREDALHMHQVKQGKLEIHAKVEVKNAQDLSLAYSPGVAEPCKEIFENPETVYDFTMK
GNMVGLITNGTSVLGLGNIGAEASLPVMEGKAILLKSFAGVDAFPIVLNSTDVDKIVDAV
KLMAPTFGAIHLEDIAAPQCFEIEERLNQELAIPVYHDDQHGTAIVALAGLLNALKIVKK
EMKDLKIVINGAGASGIAITKLFNSYGVTNMIICDTKGAIFAGRTAGMNPAKESVAAYTN
VKLTRGTLRDVLVGADVFIGVSVANTLTKEMVQTMNKDAIIFALANPVPEISPAQAKEAG
AVIVGTGRSDFPNQVNNVLAFPGIFRGALDVRATTINEEMKKAAAEAIAGLVADAELNED
YVIPSPFDPRVAPAVASAVAKAAMETKVARIQVNPEAVRLKTMKMTTFDKE
>PK3-045_01049 Nucleobase transporter PlUacP
MPQNNKKGVRIFSLGLQHVLAMYAGAILVPLLVGRALNLTSEQLAYLVAIDLLTCGIATL
LQAWKNKYLGIGLPVVLGSSFVAVTPMISIGTNYGVTAIYGAIIITGIFMFICAPFFSKI
TKLFPPVVIGTVVTIIGLSLIPSGIKNMGGGATSEDFGSIENLLLAFGVLLFILLLNRFT
KGFMQSLAVLIGIIAGTIIAAILGKVNLTPVKEASWFHFPELFYFGIPSFEFGPILTMLI
VGLVIVIESTGVFFALSKITETPLSEKDLTRGYRAEGLAITLGGLFNAFPYNTFAQNVGL
VQLSKVKTVNVVIAAGGILVFLGFIPKVAAFATIIPTPVLGGATVVMFGMVVASGIRMLS
KVDFTNQANLLIMACSISIGLGATAVPNLFDQLPSALRIIVSDGIITGSLAAILLNLLFN
VKTSKKSSNVSLLSKQVGETNTL
>PK3-045_01050 Purine catabolism regulatory protein
MKLAEILQKPAFAEVQVIAGHGGLNKEIKHITMMDAPDIVDFLNPNDLLVTTAYHLKDNP
GVLLSLIKSMHKRDCTALGIKSKRFLGHIPQEAIQFANEIGFPLLEIPLETSLGEIVNAS
LNYMLSQRTAELTTAFETHRKFTQHILKGKGIKRLIDDLSQMINKPIFLLDAHFQIHTSS
HNRTSTDNFLSSLHAKGFEFLLANSPYSCFSSRNTEEIFTIFPIYTHMRKPAFLVVLGEI
PMEDHSLLLTIEQATNVLSFELMRENTVKQYTRRARNDFFAHFMEGKFSFAEEIESRAKE
FFLKKEQASIAIIGKLDSGDQYKSFTQHSVEVDYVFEFIETEIKKAPFASQLFLIEDHCI
IIMEVTDSSYELDKTILPYLQNIQTHLVNTFKTSISFGISNVYQRLLNLPNAYQEALSAL
HTGQLSGNTPFIQIHRPKDAFEMLRIIPTKDLQEFYDHIFQPFSNNHQQEDEQILLHTLS
VYLETHCQISETAKRLYVHRNTVIYRLEKCEDLLGKSLKDPETTFHLRFAFRIKSILKMN
ERKKQSQI
>PK3-045_01051 Allantoate amidohydrolase
MKTTIDIETKEVGDWIEWLARFGKTKNGGVTRLLYDENWRLAQHSLFQKMKENGLNPYFD
GVGNLFGRLAGVDQEEKAILTGSHIDTVIDGGKYDGAFGIMASFIAVNYLKQHYGKPKKT
IEVVSLCEEEGSRFPLAFWGSGSVTGKFTKSDCEGLADARNISFAHAMTSAGLQPVEKQV
KREDIECFIEIHIEQGAVLEKEQKSIGIVSHIVGQRRFTIKVTGESNHAGTTPMPYRKDS
IHLAAELITYAIKQVTEMDAHLVATVGKIQAMPNIPNVIAKEVTFTLDVRHHQEKVLDYY
CEKIFAHFKERCKTAGMEVGWNQWLDVKAVAMDDKLTQLSERIVEEIDIPYQKMISGAGH
DAQIFGTYCPTALLFVPSVNGISHSPKEHTNLEDLKNGVVVLIELLHRLAY
>PK3-045_01052 hypothetical protein
MEFMGLMKVKKKRGKREVVFMGLMKAKKKRGKREVVFMGLMKAEK
>PK3-045_01053 (S)-ureidoglycine--glyoxylate transaminase
MTFLELNTPLRTIMTPGPVEVDPRVLRALSTPILGQFDPAFTSIMNDVMRMIQQVFQTKN
QWAYPVDGTSRSGLEAVLASVIEPGDKVLIPIYGRFGHLLTEISERYGAEIHLLQCKWGE
VFDPEVIIAEMKRVRPKVVALVHGETSTGCMQPLEEVGKACREQDILFIVDAVATIGGAN
VQTDNWYIDAVIGGNQKCLSVPSGNAPITYNDRVEKVLNARKKVERGIATEVELAEIKAH
APIRSNYLDLAQLQDYWSPRRLNHHTEATTMLYALHEGLRIVLEEGLEKRFARHQYHEQA
LMEGIKGMGLELFGDKRWKLPTVTCINVPKGIDAESVRSMMLEQFGVEIASSFGPLHGKI
WRIGTMGYSCRKENVLFVLASLEACLISHGVKLPAGQALQAALNFYLRG
>PK3-045_01055 Proline--tRNA ligase
MAKDFVKSITSMEDDFAQWYTDVVTKAELIDYSSVRGSMIIRPYGTAIWENIKEALDKRI
KETGHENVYMPLFIPESLLQREKDHIEGFAPEVAWVTHGGDEKLAERLCVRPTSEVLFAE
HYKNIIHSYRDLPKLYNQWANVVRWEKTTRPFLRTLEFLWQEGHTCHETEEDADRETIQM
LQVYAEICEKYLALPVIKGRKTEKEKFAGAKYTYTIESLMHDGKALQSGTSHNLGDGFAK
SFGIQFSDRDGNLQHVQQTSWGFTTRIIGAMIMVHGDDRGLVVPPMIAPTQVMIVPIAQH
KEGVLDFAYDLQKKLRNSIRVGIDASDKKPGWKFNEYEMKGIPLRLEVGPKDIEKNQVVL
VRRDTGEKQFVSMDGLEETITQLLTDIQDNLLKKATDHREENTHTAVNFDEFKQLTAKEK
PGFIKAMWCEDQACEDKIKEETSATSRCMPFEQEKIADTCVCCGKKANKLVYWAKAY
>PK3-045_01056 hypothetical protein
MTTTLIKIIALIFMLIDHIGEFIPGTPVYLRWGGRIAAPIFIYFVIIGMTHTSNKHRYLF
RLYIASVIMACINVIINQNYNTGVGLTNNFFATLFTVALLIYVIDKRSWRYFSIYLIWQM
ISTVLSTLITEIFILNTALRYPFYGAIFGNVIYVEGGILFVLLGVVFYLFRNKKQLVISY
SIYCLFIFLVYEKWGGSLNPFSQFLLPFADFQWMMILALPLLYFYNGEKGVGYFLTLYTA
IKKSKGQN
>PK3-045_01057 Manganese efflux system protein MneS
MDKKYADLKLGERAAILSIITYIILASVKLIIGNSTESQALKADGWNNFTDIIASVAVLI
GLRLSQKPADKDHPYGHWKAETVASLIASFIMMSVGLQVLYQAISSFFTHSRQAPDLVAA
YTAIACGAVMFFVYRINLRLGKKINSQAVKAAAKDNFSDSMVSFGTAVGIFGAQLNLGFL
DPLAACIVGLLICKTAWGIFRETTHYLTDGFDVLLIDKYKKTILHTDGVKSVKEIKARNY
GNNPVVDVVITVNQQLDITHAHDISSAVENALINEFNVLEVHVHIEPDEETQ
>PK3-045_01058 Anti-sigma-V factor RsiV
MDRKLEKMKKDYLNIPLPNELEKQTHRSIKRYRTLRRISKNAIFLAASILLFITTVNISP
AAASTLSDIPFLNKVIKVVTITEWKETKKNSELDIKTPEVTGLENKTLSQTLNQQYVQES
KELYSKFMQETANDNGNYSLESGYIVKTDDDLLLSLGRYTIETKASAAESIRYDTIDKQN
ELLITLPSLFKDDSYIDAISSYILHEMNKQMKADIGSYFVKSDTDPEGFDKIDPYQNFYI
NKQHQLVICFNEYEVAPGYMGTVEFPIPSDVIKDYLVSDLYIR
>PK3-045_01059 RNA polymerase sigma factor SigV
MLNKNKKETELITFIMDHKESFYRFAYSYVRNQEDALDIVQDSIHKALRKQHQLKDTAMM
KSWFYRIVATTSLDFLRKKKRWYVADDDSLEVLASSSVDTYKNLDLEQAMNQLPPSYKTI
VILRFFEDLKLEEIASVLDENINTVKTKLYKALKILRIEMK
>PK3-045_01060 Apo-petrobactin exporter
MKHYIQQYFTAVTSKKGKWITLIAWLLLVGIVSMFLPQASSQKNDLARNIPTTALSQQAE
EKMKEEFPNEQGTPALIAWYRSTGLSDQDLQQIQELTKQLTEKPLIHQEMIIPYHQLPIE
AVKRQISEDGTTFVLPLLFENNLATSELKTGIQELETAASDLWGENPFNTSIKDETKLHA
RTTGPVGISIDATELFSQGDLSLLIGTVMIVLICLLVIYRSPVLALIPLIGVGIAYGVIS
PLLGFLGKSGWIEFDSQSIAIMTVLLFGAGTDYCLFIISRYRTLLTQESVKEIAMQKALK
RSGGAVAMSGLTVFFSLIALLLAQYGAVHRFAIPFSISILIMMIASLSIVPAILAIIGRL
SFYPFVPRTEELLAKKGIKKTAKKRKSLGTAIGKVVTKHPWKVTILTTILLGIFALFSLK
TEYTYDLLSSFLDDMPSREGYTLIEDHFNAGELAPVSVIINTEGEAVKVEESLKQLDFIA
KVSESEAGKKNPDLIKYSVELQTNPYSNEAMDKLPIIRETLEETLQENGIKNANDNVWIA
GITAEQYDTRELTNDDAQMIIPVILAMIAILLLIYLRSITATIYLIATVLLSYFSALGLG
WIILHYGFGVEAIQGLIPLYSFVFIVALGEDYNIFMISSIWKKSKEKPLLQAVKEGVAES
GGVITSAGVILAATFMVLTTLPMQVLVHFGTITAIGIVLDTFIVRPFLVPGITSLLGNAA
FWPSKKLHVKEKE
>PK3-045_01061 hypothetical protein
MNKKIVRSSTNHDTYQFIIHVSYQLFMELGYRKVSTRMIAEHCGITQPALYHHFKNKQDI
YKEVINASIKQTEQALLNITKKFENLQECLYQIAIYFLENYQEDLMQMFHDLQHEMPADV
QTHLRIRWQEGFLNPIIQVFDQEEKNNANISYNKIESNSQEIALMFLQYIQTAMQPSYMK
ELSSNQQKKEIQRKAKLIVHLFLFGLVDR
>PK3-045_01062 Aldehyde-alcohol dehydrogenase
MSVVEKEVKGKNEQVDVQAVIDEMAVKGKRALKEFMSLDQEQVDEIVKAMALAGLDKHMY
LAKLAVEETGRGIYEDKITKNIFSTEYIYHNIKYDRTVGVINEDQQTGIVEIADPVGVIA
GVTPVTNPTSTTMFKAIIAIKTRNPIIFAFHPSAQKCSSEAARILRDAAVKAGAPENCIQ
WVEKPSIETTKALMNHNDIALILATGGPGMVKSAYSCGKPALGVGAGNVPCYIEKTAKVK
RAVTDLILSKTFDNGMICASEQAVIIDKEIYEEVKDLLVRNSCYFLNKEELAKVEKLVIN
ENTCAVNPDIVGKSAHYIAGLAGVKVPEDTKILLAELEGVGPNYPLSREKLSPVLACYKV
ESTEEGIKRAEEMLEFGGLGHSAVIHSEDPKVIESFALRMKACRIINNAPSSQGAIGDIY
NAFMPSLTLGCGSYGKNSVSTNVTDIHLLNVKKLAKRNVNMQWFKVPSKIYFEKNSVQYL
QKMKDISRVFIVTDPYMVKFGYVDKLLYNLRKRSNLVQVEVFSDVEPDPSIETVVRGTEM
MAKFQPDCIIALGGGSPMDAAKGMWLFYEHPDEEFFGLKQKFLDIRKRVYKYPSLGGKAK
FVAIPTTSGTGSEVTSFAVITDKEQNIKYPLADYELTPDVAIIDPQFVMTVPPSVTADTG
MDVLTHAVEAYVSNMANDYTDALAVKAVQLIFEYLPRAYRNGNDEEAREKVHNASTIAGM
AFANAFLGINHSLAHKLGAEFHIAHGRSNAILLPHVIRYNAEKPKKFMSFPKYEYFKADE
RYADLARILGLPANTVEQGVDNFVKAVIRLGKELNIPMSIAAQGVDAKEFEAKVDYLADR
AFEDQCTTANPKLPLVTELADIYRKAYKGV
>PK3-045_01063 hypothetical protein
MGKGTMDIVGYRIKKDVYSNSIEGLLLLKKDSILTKKHVELLTKHQVNPFDVIEPTDETA
TSSDNKEFTNLLDEVKETFHRIMEQDNSTVEKLLTGFKDIIDSSLQELAILEILHKEVSP
NDYIYQHSINVGILSAIIGKILGLPKKQCHLLSQMGLFHDIGMLKLDSSILEASARLTQT
EYKEMQKHTIYGKSILFQVPQLDILISRTALLHHEKINGRGYPSQRTEKDIPFLIQIVSV
ADKFNSMCTANTYKDKKTYIEAIDELMSESYGNALNPAIVIPFTNFIMRKQLFKKVMLSN
NETAEIIFIHQNEPHLPLIRLKDSYIDLRRTSSLKITGLAN
>PK3-045_01064 hypothetical protein
MKRSRVNKNTYSLHKEKKYQHHINFIHNELRNYRTIDIPNRTIIIKNQDLEDWIVEELSP
EELDEIIVLLEQAKKRASSVKPIFQVIATSLLKIT
>PK3-045_01065 RsbT co-antagonist protein RsbRD
MEPCMQSLYTYLNDHLVDMRKEWLSMIENSDSSFYSVHKSAENMAELITAHQTLLENVIK
VFIEEEEVYSANISEWALKVAEKRAKDLVPILESIEQLNTVKGILLSYVEKFSAETTAHL
TIPTLFEWIRLIHYAFDLFVNIFIGSYDKYKFQQLTAQQETIYELSSPVIPITEGIGVIP
LIGDIDTKRAQLIMENTLKECNEKRFNHLFIDLSGVPLIDTMVAHQIFQVIHALRLIGVK
GYLSGLRPEVAQTAIQLGVDFSQIPIFNNLASALGKFGLTVNEVKFVK
>PK3-045_01066 hypothetical protein
MGKYIAALFFPCLLVILFSKATYYPIIGLVLTVALIAASVYRGYTDTFLLIVVDAFSMTI
GYMISRNWKERLASKDT
>PK3-045_01067 UvrABC system protein B
MSHDFELVSKYTPQGDQPEAIKKLVSGIQAGEKIQTLLGATGTGKTFTISNVIKEVKKPT
LIIAHNKTLAGQLYSEFKEFFPNNAVEYFVSYYDYYQPEAYVPQTDTFIEKDASINDEID
KLRHSATSSLFERDDVIIIASVSCIYGLGSPEEYREMVVSLRTGMELERNQLLRKLVDIQ
YDRNDIDFKRGTFRVRGDVVEIFPASRDEHCIRVEFFGDEIDRIREVDALTGEILGERNH
IAIFPASHFVTREEKMKIAIENIEKELEERLEQLRADNKLLEAQRLEQRSRYDLEMMREM
GFCSGIENYSRHLTLRPPGSTPYTLLDYFPKDFLLVIDESHVTLPQIRGMYNGDQARKNV
LVEHGFRLPSALDNRPLTFGEFEKHINQMICVSATPGPYEIEHTPVMIEQIIRPTGLLDP
TIDVRPIEGQIDDLIAEIHERMKRNERVLVTTLTKKMSEDLTDYLKEIGIKVQYLHSEVK
TLERIEIIRELRLGKYDVLIGINLLREGLDIPEVSLVTILDADKEGFLRSERSLIQTIGR
AARNSNGHVIMYADKITHSMEVAISETKRRREIQEKYNEEHGITPQTIQKGIRDTIRATQ
AAEEPEEYGTTTKLDKLTKKEKEAMIAQMENEMKEAAKALNFERAAELRDLLLELKAEG
>PK3-045_01068 UvrABC system protein A
MAKDKLIVKGARANNLKNIDITIPRDQLVVITGLSGSGKSSLAFDTIYAEGQRRYVESLS
AYARQFLGQMDKPDVDSIEGLSPAISIDQKTTSRNPRSTVGTVTEIYDYLRLLFARVGRP
TCPEHGIEISSQTIEQMVDRILEYPERTRLQVLAPVVSGRKGTHVKVLEDVKKQGYVRLR
IDGEMFEIGDDISLEKNKKHNIEVVIDRLVVKEGITARLADSLESALQFGNGKVIIDVMG
QEELLFSEHHACPICGFSISELEPRLFSFNSPFGACPDCDGLGNKLVVDVDLVIPDWNLT
LKENAIAPWESISSQYYPQLLESVCNHYGIDMNIPVKNIPKNLMDKILYGSGKEYIHFRY
ENDFGQVRENDIQFEGVMKNVERRYKETSSDYIREQMQKYMAEQPCRTCKGYRLKKEALA
VLINGQHIGKITEKSVVECYEFMEKVDLTDKEKQIANLILREIKERVGFLINVGLDYLTL
SRAAGTLSGGEAQRIRLATQIGSRLTGVLYILDEPSIGLHQRDNDKLIDTLRQMRDIGNT
LIVVEHDEDTMMAADYLIDVGPGAGVHGGEIISVGTPKEVMNDPQSITGQYLSGKKFIPL
PLERKQSDGRYIEITGAKENNLKNVNVKIPLGMFIAVTGVSGSGKSTLINEILHKGLAQK
LNRAKAKPGAHKEIKGIEQLEKVIDIDQSPIGRTPRSNPATYTGVFDDIRDVFATTNEAK
VRGYKKGRFSFNVKGGRCEACRGDGIIKIEMHFLPDVYVPCEVCHGKRYNRETLEVKYKG
KNISDVLEMTVEDGVSFFENIPKIHRKLQTIVDVGLGYIKLGQPATTLSGGEAQRVKLAS
ELHRRSTGKSFYILDEPTTGLHVDDISRLLIVLQRLVENGDTVLVIEHNLDVIKTADYII
DLGPEGGDKGGTILGTGTPEDIANLKGSYTGKYLKPILDRERQRMKNSIEEAEKIATT
>PK3-045_01069 hypothetical protein
MAEEKKRILELVESGKLTVDEALKLMEKVDEVNEKKSLNEEEKIILEDFQKESKFHEKKK
ETSSNYGFNFQAAKDKLFDIVDTTIKKVKEVDLDLNFGHFEEVSHIFQFNNIAPKKLDID
IPNGEVELIPWDQEEVSIECKAKVYRVNSLEEAKRVFLKEVDVIVDNERLVVKTNHKWMK
VKAQVYIPQISYESAIIRLFNGPITTFDVKAEKLYAKTANGKITLKAGENKKVEADAANG
SIKVEKGKMDKLDAETINGSITVEGYFNKVDLQAFNGSISCVNHSETCEILELQGTTGSI
EVSLPETLAVSGELKTNFGGFNVELEGIQIIEEKNEVLQKTLQFKSIQSSEHHTKIEANT
KTGSIKVKKIEKSN
>PK3-045_01070 hypothetical protein
MRWIIGILINAIFFVALAGLFQEQFYLSGIGAAIGASVILSLLNIIVKPILILLTLPVTV
LSLGLFLFVINAITLSLTDRLMGDSFEISSFGMCLFFSVLLSLCNIIVQNTVLRGKE
>PK3-045_01071 HPr kinase/phosphorylase
MAAKVLIKDVIEEFDLEIVSGEEGINRPITVSDISRPGLEMAGYFNYYPAERVQLLGKTE
LSFAERLSEEDRANRLTKLCSDTTPGIIITRNMEVPPQLIEASEELAVPVLRSKHKTSLF
SSRLTNFLERKLAPTTAVHGVLVDIYGVGVLITGKSGVGKSETALELVKRGHRLVADDCV
EIRQEDENLIVGSSPELIEHLLEIRGLGIINVMTLFGAGAVRTHKKISLVMSLELWEQNK
QYDRLGLDEEKMKIIDTEVTKLTIPVRPGRNLAVIIEVAAMNFRLKRMGVNAAEQFTNKL
NNVISDERK
>PK3-045_01072 Phosphatidylglycerol--prolipoprotein diacylglyceryl transferase
MEDIQPIDPIAFSLGPFDVRWYGLIIGFGLILALVIAMREGNRRGLGKDDFPDLMLWAIP
ISIICARIYYVIFEWSYYKDHLGDIPKIWNGGIAIHGALIGAIVTTYIFTKKKGISFWKI
ADIAAPSLILGQAIGRWGNFMNQEAHGEEVTRSFLEGLHLPNFIIDQMYINGTYYHPTFL
YESLWNIVGFVILLVLRKVNLRRGEIFLTYVIWYSVGRFFIEGMRTDSLMIGDLRMAQLI
SLALIVISIICIAYRRKTGLASERYLDANG
>PK3-045_01073 Pyrophosphatase PpaX
MFRLTGKINTALFDLDGTLINTNELIISSYLHTLNHYYPGKYKRVDVIPFMGPPLLETFE
SIDKMRAPEMIAMYRSYNIANHDKIVTIFDGVYDAIKELKQRGFKLAIVSTKLSDVVEMG
LKLTKLDEFFDVVVALDHVTNAKPDPEPVLLALEKLKASPGDAIMVGDNKHDILSGKNAG
TLTAGVAWTLKGKEFLQAYNPDYIFENMKDILSIPEVQQT
>PK3-045_01074 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase
MRKTTRYPVSGPNSLWHVYKTVPFLKVIKNFIVIQTARYMPFLKVKNWMYRKLLKMQVGD
QTSFALMVMLDIMFPEKIKVGKNTVIGYNTTILAHEYLIEEYRLGEIEIGDEVMIGANST
ILPGVTIGDRAIVSAGTLVHKNVPAGSFVGGNPMQIIYTAEQMEERKRNEPSYVLDE
>PK3-045_01075 ATP phosphoribosyltransferase regulatory subunit
MSSLFMFEKPLGMRDTLPAIYERKYKVKQKIDTEIKKWGYQFIETPTLEYYETVGTASAI
LDQQLFKLLDQQGHTLVLRPDMTAPIARVAASKLLSEDLPLRLAYNASVFRAQQREGGRP
AEFEQIGVEYIGDKTISTDGEGISLLISSLQQAGVKNYQVSVGHIGFVQSFFQQILGTKD
RVDSLTKYLYEKNYVGYRQHVEQLALSSIDKQRLNDFLTLRGKEEVIDLAYQLMEGDQGK
KAIDDLKQLRDILVDYEVADRVTFDLSLVSHMSYYTGIVYEVYAEGVGFPIGSGGRYDLL
LEKFGKNTGATGFAIRVDRLLEALGTVAKTNMIECILFSSERRKEAFLLAQEKRQAGIHV
ITQDINGVKDVDACTKQYSEIILLVGKKGAEVAK
>PK3-045_01076 ATP phosphoribosyltransferase
MNDMLTIAMPKGRIFEEAADLLRDAGFRLPAEFDDSRKLIIEVEEENFRFILAKPMDVPT
YVEHGVADLGIAGKDVMLEEERDVYELLDLHISACYLAVAGLPHTELNEIAPRIATKYPN
VAAAYFREQGSQVEIIKLNGSIELAPIIGLTDRIVDIVSTGKTLAENGLIEYERIVDITS
RLIVNPASYRLKDRRISELVVRLQPVVKSKLSVK
>PK3-045_01077 Histidinol dehydrogenase
MRIVTDIENISLKRSVDAGTEEQRKAVREIMGQVKRSGDQALIEYTKKWDGAELTSLRVK
KEELAAAYNYVDKEMVSIIKEAAANIKEYHQKQLKTSWDFTQENGSVLGQRILPLDSVGV
YVPGGTAAYPSSVLMNVIPALVAGVQRIVMVSPPNENGILPSAVLVAADIAGVKEIYKVG
GAQAIAALAYGTESIEKVDKIVGPGNIFVALAKREVFGDVAIDMIAGPSEIAIIADETAS
AKEIAADLLSQAEHDERASSVLVTTSILLAEEVSREVKQQLNDLPRKEIAEKSIDQYGLI
VVVETLDKAVAVINTIAPEHLEIITKNPYVLLDHIRHAGSIFIGRYSSEPVGDYFAGTNH
VLPTNGTARFSNPLNVDDFQKKSSITHYSEAAFKENAHKIAKFARLEGLEAHARAIEARY
DDLE
>PK3-045_01078 Imidazoleglycerol-phosphate dehydratase
MARTAAISRKTGETNIQLSFNVDGEGVSELDTGVPFMNHMLDLFTKHGQFNLTVQANGDI
EVDDHHTTEDIGICLGLAIKEALGDKRGIKRYGNSFVPMDETLAQVVIDLSNRPHLEFRA
EFPNDKVGTFDTELVHEFLWKLALEARMNLHVILHYGKNTHHMIEAIFKAMARALDEATT
IDPRIKGIPSTKGML
>PK3-045_01079 Imidazole glycerol phosphate synthase subunit HisH
MIGIIDYGMGNLFSVSKALERLGAPYFISEDKDKLLQADALILPGVGAFKDAMEKLKKTG
LSEMISVFVDSGRPLLGICLGMQLLFESSEEHGYSEGLNLLPGKVVRFPGITESGAAYKV
PHMGWNKLHFKRESLVTSDLEDDFVYFVHSYYADTNEGVIIASCSYDKEVPAVVGRNNVF
GMQFHPEKSSKLGMQLLSNFANLIQKG
>PK3-045_01080 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase
MTFTLYPAIDMRGGKCVRLQQGNYEKETIYGDSPFGMAKSFVDHGAKWIHMVDLDGAKDG
KKVNDQFVIDTATKLGVKVQIGGGIRKEEDIVHYLENGITRVIIGSIAVSQPDFAMEMIR
KYGKGIVIGIDAKNGFVATHGWLSTSEVKAVELGKRFADAGAETFIFTDIATDGMLSGPN
VKAIEEMALITKKEVIASGGISSIKDLNQLKKSDSRGAIIGKALYEKRFTLREALEQLNG
K
>PK3-045_01081 Imidazole glycerol phosphate synthase subunit HisF
MLTKRIIPCLDVKEGRVVKGIQFVQLRDAGDPVELARFYDEQGADELVFLDISASHEGRK
TMVEVVKEVASELAIPFTVGGGINSLEDMKKILRAGADKVSLNTAAVLNPALIEEGANFF
GSQCIVVAIDAKYDSELATWRVYTHGGRKPVNKDVITWAKEAVALGAGEILLTSMDTDGE
KNGFNLALTKSVSEAVSVPVIASGGAGNAAHFEEAFKMGKADAALAASIFHYKETSVLEV
KSYLKEKGVLVR
>PK3-045_01082 Histidine biosynthesis bifunctional protein HisIE
MKLDELKFDEKGLIPAVVQDVVTKEVLTLAYMNKESLEKSIRTGETWFYSRSRQELWHKG
GTSGNTQSIVEIKYDCDQDALVVLIQPNGPACHNGTTSCFVDRMYQNKARDVISADYQIL
ANLEKVIEERDIKRPEGTYTTYLFEKGVDKILKKVGEEAAEVIIAAKNRDAEELKWEASD
LLYHLFVLLREQKLPFSEILQVLEARHEEKTGK
>PK3-045_01083 Beta-barrel assembly-enhancing protease
MNKNSDRVQPVGKLITFNPTGEFYFNKGIKAYHQRDYYKSLKYLQRALALEPGEPMIACQ
LAVVYADIGEYQKSNELLHVIIEELDEDMVECYYFLANNYAHLGFFKDAYYHAKLYLSLD
KDGEFVEDTEDLMEVLSLESEELEEEEANEEEDLITRQEQARALLESGNFAQAVEALTKI
IQDYPEYWSAYNNLALAHFYLGQSEKASEILEHVLTNNIGNLHALCNKLVFAYYQNNDRH
VKEMAAILRKINPISIDHQFKLGTTFALIGEYDTAYFWLKKIYKQGFQGDGSFYYWLSYA
AYYTGNKQTAKKAWKKVMDIHPEKEGQEPWNNSEYTINGFEEHVSSILKRFESSHAEERM
FATFLTSISSQKDKILSSSVFQQENAFTQIEKKYRDFVKNGTEIEDPFLYVAHHTAEQIY
TNYHPIGTEETSLYLLWFSAIMEMQTEGALFKNCIASAAAIDYLWSQSREKKKTQQEIAN
NYGLSTSTLQKYIKSMKNFMQPIYN
>PK3-045_01084 hypothetical protein
MKIGEFVALLNTTKDTVRHYEELNLLKPNWQNNKKEYSDKEILDFQVVNELKKYGFSLKD
IQKISSLKEAVDYGDKQLIGQVHQILTGQLEKLLQEENEIRERRLILENEAKKLKNLL
>PK3-045_01085 Thioredoxin reductase
MTEEKIYDVIIIGAGPAGMTAAVYTSRANLSTLMIERGIPGGQMANTEDVENFPGFESIL
GPDLSNKMFNHAKKFGAEYAYGDIKEIVDGKEYKTVKAGSKEFKARSIIISTGAEYKKVG
VPGEKELGGRGVSYCAVCDGAFFKNKRLFVIGGGDSAVEEGVYLTRFASQVTIVHRRDEL
RAQKILQKRAFDNEKVDFIWNHTIKSINEKDGKVGSVTLVSTVDQSEQELEADGVFIYIG
MVPLSKPFESLGITNENGYIETNDQMETKVPGIFAAGDIREKTLRQIVTATGDGSIAAQS
AQHYVEELAEELKQQA
>PK3-045_01086 hypothetical protein
MTRAFAKSPNSRNKHHTPDHTNLLKKYNLSKEDIITGVHCTAFDKKPLIKAVKDYFLLIK
PSITSKEFREFVHISSKDTANRLLVSMNYLIQVKIEGKFITLQKIFGNE
>PK3-045_01087 hypothetical protein
MYVNPVKKDLKVRKLEALLKRGDKHSSIKKDVSIYLRGYKGEKHLTYYLDFIPEKECFII
HNLRLYDGKSYFQIDYLLLTHCFFIIIDCKNYLGTLLFDTTLNQFTRIRNNQEEGYLDPI
SQMKRLKRQLESFLQKRHFPIPPIKPIVIISKPSTIIKAIPR
>PK3-045_01088 8-oxo-dGTP diphosphatase
MTNCLLLKDNKVLLLQKPRRGWWVAPGGKMEPGESVRDSCIREYREETGIYLRNPNIKGI
FTFIIKEGDKIISEWMMFTFFSTNADGVNVDESAEGKIVWHDLDDVKNLPMAEGDYHILD
YMIHGNGIIYGTFTYTPDFELISYRLDPS
>PK3-045_01089 Nucleotide-binding protein YvcJ
MEPQVVIITGMSGAGKTVVIQSFEDLGFFCVDNLPPTLLPKFLELMKESENKMNKVALGM
DLRGREFFDDLFTALDDLATSWVVPKILFLDADDSALVRRYKETRRVHPLAPAGLPLEGI
KLERELLEELKGRAQIIYNTSQSSPRELREKILKEFSVNKQSIFTVNVMSFGFKHGLPID
ADLVFDVRFLPNPHYVEHMRPKTGLDVEVSSYVLKWTETGQFLEKVIDLLTFMLPQYKRE
GKSQLVIAIGCTGGQHRSVALAEYIGHHFEKEYNIAIAHRDMERRKDQQA
>PK3-045_01090 Gluconeogenesis factor
MSEKEQPRIVIIGGGTGLSVLLRGLKKYPVDITAIVTVADDGGSSGRLREDLDIPAPGDV
RNVLAALSDVEPLVEEMFQHRFTNSKDLDGHSLGNLILAAMTSITGNFTYAIQEMSKVLN
VRGKVLPATSHSVILNAVMEDGSIVIGESNIPEAGKKIKKVFLTPEDSEPLPETIHAIEQ
ADLIVMGPGSLYTSILPNLVVPEIKAAVREAKAKKVYVCNIMTQAGETSDYTASDHVKAL
YEHVEKPFIDTIIVNKTNIPASIQQRYDEEKAKPVVFDINRLERMDLDVIAGDIIKLDQG
VIRHNTLEVAKILYTIID
>PK3-045_01091 putative cell division protein WhiA
MSFASETKKELTTIEAKNCCGKAELSALIQMNGTLSFSNQRLVVNIQTENAAIARRIYTL
IKRYFDIPVELLVRKKMRLKKNNVYIVRISNQGKEVLEELSILKEGFVFTHEISPDLIKK
KCCKRSYLRGAFLAGGSVNNPETSSYHLEIASLYKEHIIALSDLMNTFGLKSKTLERKKG
FIAYLKEAEKITEFLNIIGAHGALLRFEDIRIVRDMRNSVNRLVNCETANLNKTIGAALR
QVENIRYIDKTVGLQILPDKLREIAELRVAYQDVTLKELGEMVSSGNISKSGINHRLRKI
DEIADALRRGEKVN
>PK3-045_01092 HPr-like protein Crh
MVEQEITVDLKSGLQARPAALFVQEASNYLSEVFIEKDGRRVNAKSIMGIMGLAIHSGAT
IKLIVDGSDEVEALQNLTGLLK
>PK3-045_01093 ATP-dependent Clp protease proteolytic subunit
MNLIPTVIEQTNRGERAYDIYSRLLKDRIIMLGSAIDDNVANSIVSQLLFLETENPEKDV
SIYINSPGGSITAGMAIYDTMQYIKPDVQTICIGMAASMGAFLLAAGAKGKRYALPNSEV
MIHQPLGGAQGQATEIEIAAKRILFLRDKLNGILSERTGQPMEVIARDTERDNFMTAERA
KEYGLVDHVISRNSLEDKKN
>PK3-045_01095 hypothetical protein
MTKKSQMLLNIIMIIVSWLSIPLLGKQTIKRFFPATIFSIIMCSLDLQIGKRLKWWSFYN
IPHSTLQNEIPFLIGPMLLMALCTLKWAYGSFVKFLLLNAFGGVIFTFPLTMLFSKLKLY
RLVKINHTQFFLYFFYKAFFLYGFQYLYEKSKITKAY
>PK3-045_01096 Central glycolytic genes regulator
MVSFIEIQKRLLPDLLTVMQKRYYILQYIKNMQPVGRRSLAVSLGLTERVLRSEVEFLKE
QQLIHISNIGMTVTSIGEEVLESLSSVMREVTGINEMEQLLQRKLGINRVIIVAGDSDHS
PWVKKELGLATANCMKSLLKGNNIIAVTGGTTMSSVAEALTPNIADGELLFVPARGGIGE
DVKNQANTICSMMADHTASKHRVLYAPDEVSEEMYKSISTDPRISEVLKLIRSANLLVHG
IGEALTMANRRNTSKSDLEKIKNAEAVGEAFGYYFNEEGEVVHKVQTIGLRLEDLSTVPN
IIAVAGGASKSKAIRAYLKEAPTSTILITDEGAAKKLI
>PK3-045_01097 Glyceraldehyde-3-phosphate dehydrogenase
MTVKVGINGFGRIGRLAFRKIMENPELEVVAINDLTDTKMLAHLLKYDSSQGTFQGEIEV
HEGYFLVNGQKVVTTAERNPADLKWGELGVDTVIESTGFFTTKEKAEAHIQAGAKNVVIS
APATGEMKTVVYNVNHDVLDGTETVISGASCTTNCLAPMAQVLQNKYGIVSGLMTTIHAY
TGDQNTLDAPHPKGDFRRARAAAENIIPNSTGAAKAIGLVLPELQGKLDGAAQRVPVKTG
SLTELVTVLDKKVTVEEINAAMKEAANESFGYTEEELVSSDIIGISYGSLFDATQTKVIT
VGDQQLVKTVAWYDNEMSYTNQLVRTVKHFAQLATK
>PK3-045_01098 Phosphoglycerate kinase
MNKKTIRDIDLKGKKVFVRVDFNVPMKDQQITDETRIQAALPTIKELVESGAIVILASHL
GRPKGEVVEELRLTPVAKRLSELLGKEVAKADESYGEAVKAQISKLAEGDVILLENVRFN
AGEEKNDAELAKQYAELADVFVNDAFGAAHRAHASTEGIAHHIPAVSGLLMQKELDVLGK
ALSNPDRPFTAIIGGAKVKDKIGVIENLLDKVDNLIIGGGLAYTFVKSLGHEIGKSLLEE
DKIDLAKSYMEKAKEKGVKFYMPVDVIVADDFSNDANIKAVSIEEIPADWEALDIGPKTR
EIYADVIKNSKLVIWNGPMGVFELDAFANGTKAVAEALAESQDTYSVIGGGDSAAAVEKF
DLADKMSHISTGGGASLEFMEGKELPGVVALNDK
>PK3-045_01099 Triosephosphate isomerase
MRKPIIAGNWKMNKTLPEAVEFIQEVKASVPSSEKVDTVVCAPALFLGQLVELTDGTDVK
IGAQNMHFEKNGAFTGEISPVALENIGAKYVVLGHSERREFFNETDESVNKKTIAAFENG
LTPIVCCGETLEQRENGETNDFVATQVTKALNGLTPEQAKATVVAYEPIWAIGTGKSSTS
ADANEVCAHIRKVVSEQFSPEVAEEIRIQYGGSVKPENIKEYMAQPDIDGALVGGASLEA
QSFLALLEAGKNE
>PK3-045_01100 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MSKSPVALIILDGFALRSERMGNAVAQANKPNFDKYWNSYPHATLVASGEAVGLPEGQMG
NSEVGHLNIGAGRIVYQSLTRVNLSIREGEFYKNETFVNAIKHVKEKGKNLHLFGLLSDG
GVHSHIEHMFALLRLAKEEGVENVYIHGILDGRDVGQKTAEKYIKATQEKIAEYGVGEFA
TISGRYYSMDRDKRWDRVEKSYRAMVYGEGPAYSDPLQVVEDNYNNGIFDEFVLPSVITK
ENGEPVATIEDEDAVIFYNFRPDRAIQISNTFTNEDFRSFDRGEKHPKNLYFVCLTHFSE
TVNGYVAFKPTNLDNTLGEVLAQNGLTQLRIAETEKYPHVTFFMSGGREAEFPGEKRILI
NSPKVATYDLKPEMSAYEVTDALLKEIEADNFDAIILNFANPDMVGHSGMLEPTIKAIET
VDECLGKIITLIEQKGGKAIITADHGNSDEVVTLEGKPMTAHTTNPVPVIVTDKNAELRT
DGILGDLAPTMLDLLGVEKPAEMTGTSIIKK
>PK3-045_01101 Enolase
MPYIQQVYAREVLDSRGNPTVEVEVLTESGFFGRALVPSGASTGEYEAVELRDGDKSRYL
GKGVLKAVENVNEVIAEAIIGMDVTDQVGIDRTMIELDGTENKGKLGANAILGVSMAVAH
AAAEVVGLPLYRYLGGFNAKQLPTPMMNIINGGSHADNNVDFQEFMILPVGAPTFKEALR
TGAEVFHALKAVLHAKGLNTAVGDEGGFAPNLGSNREALEVIIEAIKKAGYEPGKDVFLG
MDVASSEFYNKETGKYDLAGEGRTGLTSEELVSFYEELVNEFPIISIEDGLDENDWEGHK
LLTDRIGSKVQLVGDDLFVTNTKKLAEGIEKGIANSILIKVNQIGTLTETFDAIEMAKRA
GYTAVVSHRSGETEDATIADIAVATNAGQIKTGSLSRTDRIAKYNQLLRIEDELGELAVY
DGLKSFYNLKK
>PK3-045_01102 hypothetical protein
MIEKPLKQDICCSLCLRVETMAFCSLLQLFFLFAGTENGSLFPFSAFLLVCGHRQWLSVP
FFSFSSCLWAQRMALCSLLQLFFLFAGTENGSLFSSSAFLLVCGHRERLSVPFFSFSSCL
WAQTMALCSLFQLFFLFVGTDNGSLFPFSGIPASLCH
>PK3-045_01103 putative protein-export membrane protein SecG
MIHTVLITLLIIVAIALIVVVLLQNGKSAGLSGAISGGAEQLFGKQKARGLELILHNATI
VLAILFFVLTIAVSYFDL
>PK3-045_01104 Carboxylesterase
MKIVEQKPLTFKGDNKRAVLLLHGFTGNTSDVRLLGRYLNTKGYTCYVPLYKGHGVPPEE
LVEYGPKDWWKDVTEAYQHLKEMGFEEIAVGGLSLGGVFSLKLGYTVPVKGIVTMCAPMY
IKSEDVMYEGVLEYARNYKQREKKSEEVIEQEMAQFKPMNTLKELQNLIKEVRESIDLIY
SPVFVIQARHDQMIDTNSANIIYEEVESIQKDIKWYENSGHVITHDKEKEQVFEDFYQFL
EKLDWNQ
>PK3-045_01105 Ribonuclease R
MEDIIKENVEKLLTYMKDEAYKPLTVQELEEAFGIEDSSHFKDFVKALVQMEEKGLVVRT
RSNRYGLPEKMNLIRGKLAGHAKGFAFVIPEEQGMDDIFIPPNEVKTALNGDIVLARVTS
ESSGQRREGTIVRIIERGVQQIVGTYSESKHFGFVIPDDKKIATDIFIPKGSTKGAIEGH
KVVVKLTSYPEGRKNAEGEVVKILGHKNDPGVDILSVIHKHGLPLAFPDNVLEQANNAPD
TIDEEEIANRRDLRNETIVTIDGADAKDLDDAVTVTMLENGNYKLGVHIADVSYYVTENS
PIDVEAEERGTSVYLVDRVIPMIPHRLSNGICSLNPKVDRLTLSCEMEITSDGEVVSHEI
FQSVIKTTERMTYADVNSILHDKDEELRAKYEGLVPMFERMEDLAAILRKKRMTRGAIDF
DFKESKVIVDEDGKPQDVILRERSVAEKLIEEFMLVANETVAEHFHWMQVPFIYRIHEDP
KEEKLRRFFEFITNFGYIVKGTANSVHPRALQEIIESVQGTPEEMVISTVMLRSMQQAKY
YPESLGHFGLSTEFYTHFTSPIRRYPDLIVHRLIRTYLIEGDISSATQEKWNSRLTEIAE
HSSSMERRSVEAERETDELKKSEYMLDKIGEEYDGIISSVTNFGMFVELTNTIEGLVHVS
YMTDDYYRYDERHFAMIGERTGKVFRIGDEITVRVVNVNKEERAIDFEIVGMKGTRRRDP
KKEGKVFSTGSVSRAPRKGKSDRDTDRKGKTGESRRKGKNDRKHFENAPKAKRKKKKR
>PK3-045_01106 SsrA-binding protein
MPKGEGKLVAQNKKANHDYFIEETYEAGIVLQGTEIKAIRAGRVNLKESYARIINGEVFL
LGMHISPYEQGNRYNHDPLRTRKLLLHRKQINKLIGDTKEAGYALVPLKLYFKNGYAKVL
IGLGKGKKNYDKRETLKRKEANRSIERALRERQKM
>PK3-045_01108 putative licABCH operon regulator
MRDRYTKLLHILQNSDGFVTGNDISEQLNISSRTVRNDIKDLNDNYLIGARIISNKRQGY
QLEGELVGFKQRHHIEFEERAFYIVKALLDTKEWTTYEQLSQMIYFSPQTIRSDIQRISQ
MITSQKRNLSVEALVFQGIRLEGDEFDKRLLLESLVEKNFMTIKELYKELLVRFGGWVLE
EELNLLSTVVIENLNKYIHDIPTGKLSSLLVHLIIAIYRIRHGYEIREVKEVEQSLDYEE
FELASKILEDVQEIFQIDIGNQEKMYFSLHLISQRIIVSFYNNETNIPQELKQELEKSLV
DLGKQYDFRFNEDRLLVSGLLFHLAKAQYPLQYQLYVENPYISHIKMEYLLAYHIAVLLA
HRLEKHLTFVVPESEIGYIALHIAAHIERTKRKKVRVAIVSGSGIGASMILKQKIQRHFL
DIEIAGEYTLQMLDQIEENISLIISTMDVKKNGIPIIHVNEFLDEQDLKKIAVAINQGFL
DRTLSENRFILLDENNKHDFLLRLTEKVKMEYLLDGILTREEMSSTEVGNYVAMPHPIAR
TENEETMIYIAINHKPIPWGKTNVQLVFLILPSEVDRENHYKVFKQLYQLVKSKDKVQEL
IQTKDFQSFMEVLHTN
>PK3-045_01109 PTS system galactitol-specific EIIA component
MVLDLVKVKLKVNSSEEVIKILGEMLLESGYVTDTYIDAVLQREMSLPTGLQIGRINVAI
PHTDSTHVKESTIALATLEEPVNFQLMADPAQKVDVKLVFLLAVKEPKKQVKLLKQLMAI
FQNEELLNRMEKAEDSRVISDILSSALA
>PK3-045_01110 hypothetical protein
MKSYNILSVCGSGTVTSSMVAEKLKEEMETRGFRVRTTEAKPTEALNYAQSGNYDLITHT
SPLPVADYGIPTISASSCLTGIGEDEFYEEVEKVLKALNK
>PK3-045_01111 PTS system galactitol-specific EIIC component
MFLETLKEVFDTFGAPIIVPIIIFIIALLLKVSMKKAFISALYAGIGLQGFTMVLGAFTP
IISPVIQNMVDITGMELTGFDVGWQATAIVGFSTEPGMIFLAVGLILQTVLFLVKWTDVF
QPSDLWNNYSYVIWGSMVYLVTDNMILSIGCMIVLNLYSLLNAELMARRWSKYYNYPNAT
IIAMHNIEPTIFGVLMDPLLNKLGFHKIKLNPATLQKRLGFLGEPITLGLFLGIFIGVLG
NLTTLNSLDAWGSIALVGIATSAVMAIFPRVAGLFAQAFSPITEAARKNTVKKEKGSNRE
WYLAVNDAAGFGEQATLMTGVLLIPVMVFLAMVLPGNKVLPVVDLLAIPFMVQGLVAISN
GNIAKIMVNGAIWFGLGLYMCTYTAPLFTEIAKDVGIALPAGALLITSFNILGKPLMGLI
FLAFLSQNPIFIGLTIVAYFILWFFFRKNKMAIYDYLDRQAEKNSQDKETSSAA
>PK3-045_01112 Galactitol 1-phosphate 5-dehydrogenase
MQQKMQAAVLYSLGNIQTELIDIPQINEDEVLIKVVYCGICGSDVPRSMISGARTYPLIL
GHEFTGKVAEIGRNVTNVKQGDRVVVAPLVPCGECKFCQASDYALCENYNIIGTGSNGAF
AEYVKVPQRHVLQIDDRLNYETAAGVEPATIGYHGLQKAQIQPGETVVVMGCGPIGQLTI
QWAKIFGASTVIAVDIFEEKLELARDLGADIVINAKVSDVVQQIRKFTDGGADVVAETAG
SKITQQQSILAAKKKGRVVFLGIAHSNLPLEEEAIEHVLRGEIKIQGTWNSYTAPYPGIA
WKATLDFMTKGTLKFKPMISHKITVDEVGAYLKKMADRTLKYNKVLVSFGDN
>PK3-045_01113 L-ribulose-5-phosphate 4-epimerase AraD
MLEKLKEQVLEANLGLPQHHLVTFTWGNVSGIDRDSGLVVIKPSGVEYEDLKVGDLVVVD
LEGKVVEGHLKPSSDTSTHIVLYKNFKDIGGIVHTHSPWATIWSQATKELPALGTTQADT
FYGSVPCTRSLTEEEIKGDYERETGNVIVETFYKNGINPNEIPSVLVSSHGPFAWGKNAK
EALHHAVILEEVCKMAYHTLNLNPTISSMDQHLLDKHYLRKHGAYAYYGQN
>PK3-045_01114 Glutarate-semialdehyde dehydrogenase
MQTEPITIHAIINGEKVPTEKQAPRENPTHPDEIVGYAPLNTQEETVLAIDAAYDALKGW
AWTDVDERIERMERAIQKLKDATPEIATLLSREHGKALYDSKGEIAISIMWMEFACKNVK
KVVAPQEKEHENGRTIITFDPVGVVSAISPWNYPISLSTIKIAPALLTGNTMVVKPSPFA
PLAVSKVVEIIAEEFPPGVLNLVHGDAEVGVELTSNPKVAKIAFTGGTKTAKSIMKAASE
TIKKMTLELGGNDAAIVLEDFDVNDEKAMRRMVISNFLTAGQICMIAKRIYVHRSIYDAF
VEKYIEAANKWIRVGDPFHPDVTVGPVNNKNQVKYVKSLVEDAKSKGAKVIPLGEILNPE
LMDNGYFLQPTLVLDADFHDPIVVEEQFGPTVPILPFDDEEQVIELHNESIYGLTSSVWG
EEEHAIKVARRIEAGTTMINTAAVQGLDVRFPFGGVKQSGVGREYGEEGLKSYVETHVIN
IPKTLELPYIPE
>PK3-045_01115 hypothetical protein
MVNIEENTSVGAIYKKGGFLLNKKNNNQTTKVAGRMFDPSDYEKKDQLSSGLATTHEQAT
DTYTEGEIGAVIDDVDGEDIEIGKKRTK
>PK3-045_01116 putative arabinose-binding protein
MGLPKKGFSYFVILLMAVLVVGCSNSSGGKGSDKKEVEAEVTTVGPEDGAKLDMWLFVDL
HQKFYTEMLNKWNETNPDKQIQIKFTVYPYADMHTKLTLSVQSGEGIPDLADVEIGQFPN
YLDGEVPWLALNSYVEPYKADLVTSRLDAYEKDGNYYGVPTHVGATVMYYNTEILEKHGI
DYTKIKTWDDFAAAGEKLKEATNGEVYMTSVDTGGADWLTLAMSEHGESWVKDPSNANVK
LDSLNNMLTMQQGWLESGIAEVTPGGQIDTEQGYATVAKGEVAAFPKAIWYMSRFTDYMP
EMSGKFAIAPAPVFEEGQKRSNGAGGTGTVVYKDSENAELAAEFMTWAKLTEEGGEQIWN
ILGFDPVNTKVWTNKDITHNPDNEYVKYFVNNPFDTLLEIQDEVNLIKTVPITTTINEVF
NLTTLNEVLENGANVKQALEDAQAEVDFEQE
>PK3-045_01117 L-arabinose transport system permease protein AraP
MKKIQAFLFSQKIAPYVFILPFIVSLSFFWIYPMYSTIEMSFHNIGNGYSEFVGLANYEK
LLGDKVFHIAVRNSVIYTILTLIILIPIPMLCAFLLNSKSVVGKRVYKSIIYLPALVSVV
VAGILFRYMFSEMDSGLMNQILHFFGLESKQWLKNWGTGMFALLLLATWRWMGVNTLYFE
AGLSSIDEVLYESAKVDGANAWQRFWHITLPLLKPTRIYVTTISIYAGLAMFLESFMIYG
SNNSPKNIGLTIVGYLYRRGIEKNDLGYASAVGLVLLIVALSISMVYLLSSGMFKKEAK
>PK3-045_01118 L-arabinose transport system permease protein AraQ
MGKNNHLASSSLEIKKGKKEGKNPLVKVLINGFFIIMCASVAIPFISGLFASFRPGQMLI
RNGLNLNLDFENWSFINYSYLFDGSTGYLDWYKNSLIITIVSVVLTLIICYFVAYGFAMY
HFKFKNLLFFLVIATMMVPFEILMLPLYKQMISFGLIDTYAGVILPGLVHASTIFFFRQY
LSGIPKELLDAGRIDGSSEYGICVRIVMPISKPAFSAMAILSSMGAWNSMLWPLIVLRSA
EKFTLPIGLNTLLTPYGNNYDVLVAGSIFSILPLFILYLIFNKYFVEGMTAGAVKG
>PK3-045_01119 hypothetical protein
MKIKYDSPFWERMGKLYSIIALNFFWILFSLPLITIGPSTVALHRCMFSLITGKETNVFT
EFYQSFKTNFVRNMMAGLIVVGFGMLLLSVRNFYFEMAANTSLTIYYFYILLVFLFGLFF
VTVFPVLLTFDGTVLELLRTAFFIAIKNLPMSILMVVVACLIIYFCQMLIPLALIGVSLI
VFINSHIYWRKIDNNLVIDEDNF
>PK3-045_01120 Intracellular exo-alpha-(1->5)-L-arabinofuranosidase
MTENIKTAKMVIDKSFKISEIDSRIYGSFIEHLGRAVYGGIYEPGHPSADKNGFRQDVIE
LVKQLQVPIVRYPGGNMVSAYNWEDGVGPKEKRPRKLELAWNSIETNEVGTNEFFEWAKQ
VNSEVMMAVNLGTRGIDAARNLLEYCNLPGGTYWSDLRKEHGYKDPHNIKVWCLGNEMDG
PWQIGHKTAYEYGRLAAETAKAMKIVDPSIELVSCGSSNTAMPTFPEWEATSLDQTYDYV
EYVSLHTYYGNRDNDTANFLAKSLDMDDFIKTVIATCDYIKAKKRSKKKLHLSFDEWNVW
FHSNDQDKQIEPWSVAPPLLEDVYNFEDALLVGSLLNSLINHSDRVKIACLAQLVNVIAP
IMTETGGGSWKQTIFYPYYYTSVYGRGTAIQAIVDSPKYDSTDFTDVPYLDQSIVYNEEK
EELVIFAVNRSLDNQLNVEVDIRSFEGYSIVEHIVLANDDPKAINTLHQEAVKPVAFQES
YMENGNLILILPKMSWNVIRLGRK
>PK3-045_01121 Arginine transport ATP-binding protein ArtM
MAIIEIENIKKSYDKVEVLKEITFNVNNNDVVAVIGPSGSGKSTMLRCLVDLEKIDGGTI
RVSGDELVKDGIYAPQQKVKQITARMGMVFQHFNLFPHLTVKDNIQLAPKLVKKEAASSL
QERSMTILEKIGLSNFANVYPAKLSGGQKQRVAIARALMMEPEILLFDEPTSALDPELTG
EVLEVMKDLAKEKMTMVVVTHEMGFAKEVANKVIFMDNGVIEESGPPINLFTNPQSPRTK
AFLSRNLK
>PK3-045_01122 L-cystine transport system permease protein YecS
MSVDYIISILKPMLEGAQATVLLFLIAIVVSIPLGFLLTLAIRSSIKPIAWLASCYIYIM
RGTPLLLQLLFICFGLPMIPGIGEYLVLDRFVAASLGFILNYAAYFAEIFRGGLLAIDKG
QYEASQVLGLSKWQTTTRVVLPQMFRIALPAVANESVTLVKDTALLYAVAVPELLHFAQT
AVNRDFTIMPFFIAGIIYLIMTLLLTALFKWLERRFKFE
>PK3-045_01123 L-cystine-binding protein FliY
MKRLAINLVILASVFFVFTACSNNSKDKKEDTLVIGIDDKFAPMGFRDDNNEIVGFDIDY
AKAAAKKMNMSVEFQPIDWKTKESELSSGRIDLIWNGYTITDERKEKVLFTKPYLKNTQV
VVTLADSKITKLDDLKGKVVGLQSLSSASDALNSSPIKSKIKEVTEFSDNVLALNDLKSG
RLDAVVIDEVVIDYYMTKEQDSFKILDESLAPEEYGIGVKKGNEALLEKLQKALDEMNED
GTAAEVSEKWFGENKVLN
>PK3-045_01124 hypothetical protein
MENKKKQFLEGKERLHVLFLYTSMRNYMEEVLPFIYAGIEAREYVILIDNDRNFKRIFEQ
LKTKLTSTQLKQVHYVNSLDFYFSSGSYHPSAITDYFNKMVQPYLDQSIPFRSWAHVEWA
TMEEPFHLIGNFEKKVDNAFNHISFPLICAYEEWKIPNALETILHETHPYILKGDKLMSS
KKYITDTPFYKKPTIELD
>PK3-045_01125 hypothetical protein
MVYYDKSKTVKNILIQKIVCSSGLSSEMLQNLSIPELKETLNKVYPSTHPHNGCGSLKWK
KVR
>PK3-045_01126 Phosphoglycolate phosphatase
MGDYQIILFDLDGTISDPKEGITKSIQYALQKLGKEESDLRKLERFIGPPLQESFMEYYG
YTQTITDQAISYYRERFTQLGMYENELYPEIIPLLESLRAKGCIMIVATSKPTIFAEKIL
KYFQIETYFTHIIGSNLDGTRSSKTEIIQYILDLYPAYKPEEFVMIGDREHDIIGANNAG
IDSIGVTYGYGSYDELNKVQATFIAGSISSLKGILIDRKRKERIRLVTEEDAPIVHRLML
EAFEDYRYSEVPSSALTEPADKFLYALKNGTEQAIICWIDDVPLGSSRLQLQDDSLYFSR
LSVIPSARGKGIAKKLLAWIEEYAIQNGKQKVVCKVRANVLKNIQLYEKIGFVITKEETA
PNPNGLSVKAVTMEKRITKITPSKI
>PK3-045_01127 2-aminoadipate transaminase
MNYKFANRIERVKPSAIRELLRLGGDPAIISFGGGYPDPEIFPIEKLRKVYDQVLQEDGK
LALQYTETEGLTSLREKLVSRVKKIGISCSVDNLFIIQGGQQGLDLAAKAFIDRGDIIIT
ENPTFLGALAAFNPYEPEYVGVSMDENGMRMDELEAALQKHPNAKLIYTVPEFQNPTGVT
MSLERRKALLSLANKYNVVIVEDSPYRELRYEGKDLPAIKSFDTEGRVIHIGSFSKILSP
GLRLGWLIANRDLVEKLSLLKMASDTQNSTLNMYAVNRFMDMYDLDEHIVHIRETYKEKK
EVMFQTLHETFPPSIIYTNPQGGLFTWLTFPEHIDTKILMQEHSLPIAKVAYVPGESFFP
NKQEKNHCRINYSYMSEEKIIKGITNLGEIVRGIC
>PK3-045_01128 hypothetical protein
MKIGIILGSTRQGRVSPQVGAWVKEIADKRGDAEYEIVDIAEFNLPFLGAAEGQENVAAW
NEKLASLDGFVFVVAEYNHSISGALKNALDSAREAWNNKAAGIVSYGSTGGARAAEHLRG
ILGELHIADVRVHPTLSLFTDFENFTTFKPAPLHLENMNAMLDQVVAWSTALKTIRG
>PK3-045_01129 hypothetical protein
MSAFLEAIKNRRSYYGISKEAVVSDEKIQEIVNEAVLHTPSSFNSQSSRVVILLQEQHDK
LWDMTASELEKIVPAENFSSTKEKINSFKAGYGTILFFEDQEVIEGLQKQFALYAENFPV
WANQTNAMHQLVIWTALEEVGFGASLQHYNPLIDEAVQGEWSIPPSWKLVAQMPFGKPLA
EPGEKEFKPLEDRVKIYK
>PK3-045_01130 hypothetical protein
MKIEVWSDFVCPFCYIGKRRLEIALEQFPYKDQVEVEFKSFELDPNAEVYTGKSIHEALA
GKYRMSIEEAKNANNNVGSQAASTGLKYDFDNMKPTNTFDAHRLTKYAKTLGKDKELTEQ
LLHAYFTEGKLISDPDTLVEIGKSVGLEEEAQRQVLADSTSFANDVRIDEALASQIGVSG
VPFFVINQKYSVSGAQPTETFERVLEQVWQEDHPVPKFQDLSGTDAEGAICTDDGCEIPK
K
>PK3-045_01131 HTH-type transcriptional regulator GmuR
MNKYEAIAVEVKRRIKENYYPLDHPIPDEISLSKEFSCSRMTMKRALDKLVMEGLLYRKR
GHGTFIVQSALHTSRVNVLTNEITGLSKLLDGEKIDSKIIKFEVHFPSEEVAAHLAIDIK
TPVYYIIRLRSVNNEPYVLEITYMPTTVITGLNDDVLYGSVYEHITKRLGLTIAGSHRKI
RACKSIELDHEHLECELNDPILEVEHVGYLNNGVPFEYSFSRHRYDKFEVTTVNLKR
>PK3-045_01132 HTH-type transcriptional activator mta
MEYTVQALGKLAGVSTRTLRYYDEIDLLKPARINSSGYRIYGQKEVDRLQQILFYRELDV
PLETIKKMMASPSFDVKEALKEHHEKLLAKQKQLIQLIGNVEKTMKTLEGRMTMSDKEKF
EGFKSKLVSDNEAKYGTEIREKYGDEIIDQSNAKLMNMTEEDYRHMIEIENKLFSTLKEA
LKEGNPAGKNAQNAADLHRQWLTFNWPEYKKEAHAGLADMYIADERFTAYYDKVQVGATA
FLREAILIYTGMAFD
>PK3-045_01133 Riboflavin transporter RibZ
MHASVTENKNEGHQRRWLIFIVLNIFTFMGTLDASIVNIALPTISKELGLAFANSQWIVI
SYLLTICTVILFFGKMGDVFGKIKVFKWGSVLFIIGSFLCGLSGSLAFLVFSRIIQAIGS
AMTMANSQGIVTEIFPVKERGKALGLIGTFVSLGSITGPSLGGIIISSLGWEYIFWINIP
IGIIAISLAWKTLPKDMTLTKTKIDVAGSILFSLAIILLIGGLLLGQQYGYNNWMIIASI
LIGLIAFISFVMVEYRRESPMLELSIFKNPLFSISIFCAFIVFIANFCFNILSPFYTQDI
LGMSALHSGYILMLFPITMAIVAPISGSLSDKISGQAITFAGLLVMIVAQIGLTFLHEGS
SITNLALWIIMLGASSGLFQSPNNSLIMSTVERKQLGIAGSINSLVRNLGMVVGISLATS
ILFSVMSMKAGYRVTALIPGRPDIFLSGMHVVFLVSSSLCFIGLLLTGWRYTASRKADEK
KVRNAS
>PK3-045_01134 Multiple antibiotic resistance protein MarR
MSDIPIGRIISMIHRQNQKFLSKELKPYEIGNGGQQAFLKTIIAKPGINQDELSTVLKFD
KATTARAVKHLESVGYIVRHTDDNDRRANNLYPTTKAMNIFPEIQKVLERLNKEMTKHLT
EEEEQQLLSLLMKIYPELRSNMVTTKKEKNVEKEGE
>PK3-045_01135 HTH-type transcriptional repressor RspR
MKSIRQIPRQSLRDQVYEQLKSAIIHLELTPGEKINDKALAEQFGVSRTPVREAIKKLED
EGLIVTSPGSETIVSLIEVDQAMHALTVVAALHALAAKLASITLSSTEVEKMKVINNEFS
EALKSEDKYKAIQKDDQFHAVILEASQNPEIVIALERLLPKIRRLELLKFNTIDGKKSIE
QHQEIIACIEKGNTSLLPTLIENNWLSLVEYLAEQ
>PK3-045_01136 Copper-sensing transcriptional repressor CsoR
MEKNEQGMDNCHITSDRKSHHSDKVKQNLVTRLNRIEGQIRGIKGLIEKDTYCDDVITQI
SATQSALNSVAKILLEGHLKNCVVERIQEGDMEVVDEVLTTIQKLMKK
>PK3-045_01137 Copper chaperone CopZ
MENVTLTVEGMSCNHCVKAVEGSVGELSGVSAVKVHLKEGLVDVSYNENEVTLDTIKETI
DEQGYDVK
>PK3-045_01138 Copper-exporting P-type ATPase
MAEQSVMKSKEQVKEQTFEITGMTCAACATRIEKGLNKMQGVENATVNLALEKATVKYRE
DELSPSEIKEKVEGLGYGIVTEKIELDISGMTCAACATRIEKGLNKMAGVNKATVNLALE
NATIEYNPATVVPDELIGKVTKLGYGATKKESKQASINQKEAEFKRQKRKFIFSMILSLP
LLWTMVGHFSFTSFLYVPDLLMNPWVQMALATPIQFFVGKQFYVGAYKALKNKSANMDVL
VALGTSAAYFYSVYLSFETLGHSGHPVGLYFETSAILITLILLGKLFETKAKGRSSEAIK
KLMGLQAKTAVVIRNGEQMEILLEEVVAGEMLLVKPGEKIPVDGEIIEGQSAIDESMLTG
ESIPVDKQAGDTVIGATINKNGFLKIKATKVGKETALAQIIKVVEEAQGSKAPIQRLADH
ISGIFVPIVVSLALITFLFWYFIITPGDFAESLEKLIAVLVIACPCALGLATPTSIMAGS
GRAAEYGILFKGGEHLEMTHKIDTILLDKTGTVTNGKPILTDIVTEWQEEELLSLVGAAE
SKSEHPLAEAIVKGITERGIVLRETADFEAIPGYGIRANVDGRELLIGTRRLMDRYRINV
GKILPMMKDLESQGKTAMLVSVNGKYAGLLAVADTIKQTSKNAIKRLKQMNIDVMMITGD
NQQTAEAIGRQAGIDHIIAEVLPDGKAEAVKKLQQQGKKVAMVGDGINDAPALALADIGM
AIGTGTDIAMEAADITLIRGDLQAIADSILISRKTITNIKQNLFWAFGYNTLGIPIAAIG
LLAPWLAGAAMAFSSVSVVLNALRLQRLKL
>PK3-045_01139 hypothetical protein
MAKQKKSEVNNQWATANTEVTNKKQHKTATDNQWASTNKKQ
>PK3-045_01140 hypothetical protein
MMLNPDEEKKQKLKEIDRQLPWYLRSGWSIFFGLIFPPLLYIFIYLNLKKLDKETLEDRL
IWATLILSIWFLKLLPRDNVFSIILIFIAFAFSALLIVIKFSGGHLKDKK
>PK3-045_01141 HTH-type transcriptional activator RhaR
MINSGSLYQISSSKGYHPKVTAYYFKEWDGFYMAYHTHSSMEIMYVISGECRVEVERQDF
QMKKHQFIFIDSDVPHRLIVEKNKPCRMLNLEFALTEMNCTFPPINELAEESKELQELLV
MKEAYHFLKDRNGVFHSLRNLVLELDSQMNDTSDNYLMVHILFTQLLLLIARNVVQAKNE
STQLSNPYLKKVIEYLHENYDYDIRIEQLSAITHLHPNYIHRIFKKAMGCTIIDYLTKIR
IEKAKMLITQTDIPITKVASFIGMNSSQYFSKVFKKHIGITPSALRKKGIID
>PK3-045_01142 Alpha-galactosidase
MAFKVTFIGAGSIGFTRGLLRDLLSVPEFRNMEVSFTDINQDNLAMVTQLCQRDINENGL
KITIHSTTNRREALLGAKYIFNVVRIGGLSAFQKDIEIPLKYGIDQCVGDTLSAGGIMYG
QRGIAEMLEICKDIKEVAEEDCLLLNYANPMAMITWACNKYGGIRTIGLCHGVQGGHRQI
ANVLGIDKNDLDIICAGINHQTWYIKVSYKGQDQTSKLLTAFENHPEYSQTEKVRIDMLR
RFGYYSTESNGHLSEYVPWYRKRPEEIREWIDLGSWINGETGGYLRVCTEGRTWFKTDFP
NWLKDPALEYKQENRSEEHGSYILEGLETGRVYRGHFNMVNNGVISNLPDDAIIEAPGYV
DRNGINMPLVGELPLGCAAVCNVSISVQRLAVEAAVSGDDQLLRQAMMMDPLIGAVCNPK
EIWQMVDELLVAQEEWLSQYSEAIAEAKIRLKSGNLLPTKEYRGAARLKVKTIEEMEKDR
EAANKNAGEADKAKERPVSKQIKEL
>PK3-045_01143 hypothetical protein
MKISNPIKSGIWILLVMFIVIGCSNNSTSSGKTSSGNGKSIQLTMQAWGNPAELKVYQKA
IDGFMDKNPNIKVKLVPVSSDQYDQKLMTSLQGSKGPDVFYAHEPTMPQMIEADVVQPLD
DFFNSEASYVNLKEFPEGLFGPARQDGITYGVAPDANPMVIYYNKTIFKEAGLKTPQEYY
EEGNWNWDTFIEVTSKIKESGKEGLIMENWQGHWYSWIWSNGGRIFDQKGNFVLPENEKA
KETFHFLHDLVSNGNAVYAGSLPQGQGVDAMFMSNQVGMVAGGRWFTPQFDQNPSLDYDY
IYFPSNTKEKQEMVSVPVAYMSVNKKSEHLEEAMKFVSYYVGKEGQEARTGKGGNALPSL
PAADENALEGNSEKHMEYLFDGRNNGFTHGSNFARDAQFAGLTTEISETIDLMFLGKEDA
DTTIDKVIKIINQYVDK
>PK3-045_01144 L-arabinose transport system permease protein AraP
MARKNANLWGFLFISPQLLGLLFFSLVPLIYAFYLSFTDWSGFGSSSFIGISNYINQINN
PDFWKAMVNTIYYMFLVVPIGIALALILAVALNKVKGKAIYRVFFFMPVVTSSVSVGIIF
MWILNGDFGILNELLSYIGITGPHWLTDTKWVIPSIALLSIWWGLGYNMVIFLAGLQGIS
RSYYEAAEMDGANAIQKFRHITLPLLTPTTFFVTIMTIISSFQVFDQAFVMTNGGPAKAS
YTIVFHIYDQAFVDFTMGKSAAASMILFVIILIFTLIQFKFQKRWVFYGE
>PK3-045_01145 L-arabinose transport system permease protein AraQ
MENKYELNTGTNFDIPKARKRRTFMPKLVLHFVLGFGALVMIFPFIWTILSSLKDMSQIF
VIPPKWIPDPFVWSNFLNSLQAMPFNLAYFNSFYITVIIVGFTLFTASMAAYAFAKINFK
GANLLFILFLATMMIPKQVTMIPLYLVMDKLGWLDTHLTLIVPGALFNAFAVFLLRQFVM
GIPKELEEAAIMDGAGYVRIYWNIILPLLRPALAAIGIFTFMQSWNNFLDPLIYLNSPEN
FTVPLLLNSFKGLYTADWSLMMAGTVISIIPVLIVYIIAQRHIIEGISITGMKG
>PK3-045_01146 Glyoxal reductase
MELSINSTKKLSNGVEIPYLGFGVFLVKDPKECEESVLTAIKNGYRSIDTATRYENEEFV
GNAIKAAGVSREELFITTKVWVTDFGYEETKKAFHESLKKLQLDYLDLYLIHWAAPGFEE
TWRAMEDLYEEGLVRAIGVCNFQIHHLEKLAETARITPMLNQVETHPLFQQVELRNYLAQ
HNIAHEAWAPLGQGKNGLFNLPALTEIAKKHNKTVAQVILRWHLERDTIIIPKSVHEHRI
IENADLFGFALDSEDIKTITSLDTNERSFGNPDDIERFKAMQEAASK
>PK3-045_01147 hypothetical protein
MDRLYDGKSQAKSGKSQAKGSESQAKSGKSQARSSESQVKSGKSQARVRNHKQNAETRNY
MPKAASIKANAAMKIIPTK
>PK3-045_01148 Vegetative catalase
MSNNRLTTSWGAPVGDNQNSITAGHRGPTLIQDVHLLEKLAHFNRERVPERVVHAKGAGA
HGYFEVTNDLTKYTKANFLSEVGKRTPMFIRFSTVAGELGSADTVRDPRGFAVKFYTEEG
NYDIVGNNTPVFFIRDAIKFPDFIHTQKRDPKTHLKNPTAVWDFWSHSPESLHQVTILMS
DRGIPATLRHMHGFGSHTFKWVNEEGEGVWVKYHFKTEQGVKNLDVNLAAKLAGENPDYH
TEDLFNAIEKGDFPAWTLYVQIMPLEDADTYRFDPFDVTKVWSQKDYPLIEVGRMVLDRN
PENYFAEVEQATFSPGTLVPGVEVSPDKMLQGRLFAYSDAHRYRVGANHNALPINRPRNE
VNNYQRDGQMRFDGNGGGSVYYEPNSFSGPKETPENKTTPFAVSGVAESAAYDHNDHYTQ
AGDLYRLMTTEERERLVANIVGAMKPVALEEIKLRQIGHFYKADPEYGTKVAEGLGLSVP
ETVK
>PK3-045_01149 Shikimate kinase
MLQNESMKEKSIFLIGFMGVGKTTIGKELAKKLQREFADVDHQIEEKYNMTIPEIFSHYG
EAFFRKKEKELIKALSEQKGKVISLGGGAFLQEDIRNVCLEKGIVIYIDMSFEAWKKRIP
FIIDSRPVLQGKTEDEIKVLFNARKEIYRNHHLKVTTDGNKVEETVDTIIDSLDIT
>PK3-045_01150 3-dehydroquinate dehydratase
MVSKSIKVREVIIGEGIPKICVSLIGRTKEELREEAAALKELRIDILEWRADYFTEINNK
KRVIEMLQQVREIIGNIPLLFTFRTAKEGGERQIEEQEYFSLYKSVLETGLIDLLDIELF
MEAEAIKEVVNMAHSKQIAVVVSNHDFDKTPSKEEIVSRLQMARQLGADIPKIAVMPKSV
KDVIALLDATVTMKEEAPNQPIVTMSMGGKGAVSRMAGEVFGSAITFAAANKASAPGQIP
LEELRTILNVLHKSL
>PK3-045_01151 4,4'-diaponeurosporen-aldehyde dehydrogenase
MEVNQRLEQTNSFFSTQATLPLAFRIEQLEKLKNAILEKEPLLIKALQKDLGKHPFESYA
SEIGFVLQSIRHTKRHLKRWMKPQKAKSTWSLFPSRGKTVYEPYGTVLIIGPFNYPFQLL
IEPLIGAIAAGNCAILKPSELVPTVSAVVTDMINNIFEPAYISAVEGGIETNQALIQANF
DYIFFTGSTKVGKIVMEAASQHLTPVTLELGGKSPVIIDETANLNIAAKRIIWGKTLNAG
QTCVAPDYIMVHESVKEPLIAEMKKTLGNYFGEEIEDKEDFGRIVSDRHFQRLIAMLEAD
RKTILFGGKNNRDTRFIEPTLLDATWDSATMQEEIFGPLLPILTYTNLDEAMKSIRKLDK
PLALYLFTNNKETEAKVIRCLSSGGVCINDVLTHIVPPSLPFGGVGASGMGAYHGKYSFK
TFSHQKSILRKSTKVDIPFLFPPYTKRKEKVIRKVLK
>PK3-045_01152 hypothetical protein
MKFWTWTIIILLSVTAIGVSSYFIFQSLFDSKSPMQKENDRPVVKQASSETEESFDKEQV
NTPVNEEVVVLADGTSGHTFISKWHNFYNETLGWGRLETTNYDKQKEAALAILEAIKNIK
VNNEQIKQDISDISTNAQIVAEKDDRVAMRNLHRYFHDLDIYFNGYNYEQTFGITEFRGN
>PK3-045_01153 Diadenylate cyclase CdaS
MEGDNHLPNEFNQEMHQLLEDLEAELSELKNTLDEKDCCILNDFEEVNKLFKSIHHRAAT
FYLQLYLKPYTKNLEILTASAQALSDKRHGALIAIKRKDSLDRLILPR
>PK3-045_01154 hypothetical protein
MARRTEEERLVDLEEKIRKIQLEKQRLANQVRQKERKERTRRLIQVGGLMEKHFEIEGEE
EAIKLIASFKEVVEKNKEKMLAMDIDHARKILQIHTDK
>PK3-045_01155 hypothetical protein
MSVNMITILIPIYYALILILLILGIIILAKIIRTYFKNSKLTELKFKVESEDIKEIKERL
NKIENILKDID
>PK3-045_01156 hypothetical protein
MIHMNKIKNINQLLLIGKAFGNPIRLKILIILSKNGYYVSELARKLEISRAVLYLHLKKL
EEGNLVYSDIKISSDGKALKYFYINSFEFLIDNTLIEELTKINIDNEEF
>PK3-045_01157 hypothetical protein
MDQIQTLSERKLSSEKKEHEYLKIIKDAPKEEQEEYFEEVIQIVEDGLKNIDVNIKDGEQ
VNVDLGSNISLELDSDDTSESSLPKTPVLMSANGYDLSNGNIMAKNYGNRRFSCTVSVKS
LGVTIGKLVLVNHYSVGTYGLKFREATTVGTSGVEPLIIISKSSAKVDDSKAEKVGYDLN
ARGNYSWKIGIKGIYKSFTSEIYSTIKLRSWDKKRKV
>PK3-045_01158 hypothetical protein
MNIKKTLVGTVVAASLFGTGNFVSANEINSVEENEVLSSLTEQQIADYNSLIADGYIVTV
DVDPTTGYSSISGSKPAEKSPFSTRAVIGSDTFTVKSYVYYVKKYVDTISGKITVQYTGK
TSTKVTSDTVTVRDGNNVSKSRTTSGSSAKLVLKFTEWVNASLTSAVNVPFTCTYTITNS
GKISFFNDRAY
>PK3-045_01159 hypothetical protein
MFFWVPLVGGVIAFGAWIWYYASLGKRISAEEKEAGRDLTYEINPFTGSAKSISSKKL
>PK3-045_01160 hypothetical protein
MFKNKLIQLLKNGEYLYVNYDSDSLISYFISPDTKDKYTHYLYLDHKTELIYEYEKKTQK
SQHVSVHHVQHILESLEKEQTEVSNFLNHINNTSIKK
>PK3-045_01161 hypothetical protein
MPSVFTDEIRLSKSELEETIQRVVKVAIEEERENMFKAFEYKMNDVVEKRDRLLTMQLQQ
SLEEKKLEIAAAKEEENAKPWWKKLFN
>PK3-045_01162 Diadenylate cyclase CdaS
MHDGGVLIEEDSIISAGNIFPTASKFNGKDKLGTRHRAAIGLSEISDALVIVVSEETGRI
SFTLDGVLYPIQPGEINIT
>PK3-045_01163 hypothetical protein
MNTIMYIKDELKNFINENGNTFNQKLLTEATNVSIKITDILNKGNIDLLKNAKKLIFYTV
DQQEADLISFAKVEGIAWAKHSLTLELKLEWVQAIRRTLWHFIRMIDEDKDIIHNREDYY
GMEKLFNEKIDQFLNNFFLSYTHYKDEMLNKQRKMVEHLSVPIIPIKQSISVLPLIGTID
SYRIKVIEEKVLNDISDSKIQTLVIDLSGTAKMEMDVIDYFEKVLAGISMMGCNAILTGL
RPELVKKMVHAGIHFEKNAETRGTLQETLKNIL
>PK3-045_01164 Spore coat protein F
MSFMDKLKATGKMSDELIATELLVSAKATVRTYAVALTETASPQVREILKKQLNEAIDNH
AKIANYMIKNNMYYAYDVDKQLEHDKEKLDQSLELVK
>PK3-045_01165 hypothetical protein
MASTKLAIHETLELHEVLTLKQSCLVKSYALQSLVEDDTLKAILDNDVSSSEKAIKELQQ
ILKQ
>PK3-045_01166 putative protein YesV
MVHSLTNGVYKFCEWVTRLAYVNLLWIFFTVLGLGFFGWMPASIALFSITKKWVNGENDI
RIFPLFWASYKQDWWKGNILGMIFMLIFLLLYLDFWIIGILDGPTTLLLFFIFGLFLFFS
TTFLYLLPVYTYYDLKLLQCIKYAFVIGFLRPAHTVGIFMAVFSIAFLASLHITLLLFFS
ISTLAFVITWLACKAFGSIDHRLKKVTQQRIG
>PK3-045_01167 hypothetical protein
MKHFILSILNKYRQLKIKKKLTLTILFIMVGSLSFLLIGFQYAFHVYDQLYYQKTTEALH
MSSKQLEKELKSIEEVSFSLMTDNKIQTILSEIKLDSNPYQRYQLENQLWDLLTEYVGSS
KYIHSIHIFDANGREYRAGGYTSSIISNKKEKWIEIGERKKGANQWVTETDSNKIFAIRK
IRTHQNLSLDNLGTLLIQVNVDKIVEDSVSENNKVTSNMMISGEDNQFFYKGIFKEIENI
PYLPNQKVGYEIQSIGGQKYFITHTSSSYVNWVYWNIVSFDSIIAKVQTTKYTMLAIFFL
LNLVVLFMAIVFSSKLTKPIEQLVSAMKNVQKGDLSIKNTLQPMQAKDEIGILTDHFILM
IERINTLIKENYEKQLLIKDTEFKALQAQINPHFLYNTLESINWQAKMNRQTDISSMVES
LGYLLRNAISAKNDAVLLEEEIFIVDHYIRIQKYRYGDRLIFHKMIPPETKNCYIPKLMI
QPLVENAIHYALEQMIEPCKITVHAVLRENNLHITVEDNGPGMEEELLAKVRKQEVRTRG
TGIGLYNIDSRIKLLYGEEFGLIIKSKRGTGTQVHLIIPNKWR
>PK3-045_01168 Protein-glutamate methylesterase/protein-glutamine glutaminase
MYRVILVDDEKIILDGISSIIDWDMLHTRLVGKAANGIEAYQLIKNLQPHIVISDIKMPG
LNGIELVSKIKKEYPSIHFILLSGFSEFHFAKKAMEYGVKHYLLKPCNEKQIMEAIQQTI
SEIRIKEKRKRYLLEMKKKMDTVQPFVKKQLLTELVTSKKSEKNVLAYYQRIFHTRLEDK
KVCVVLFHLEGDFNYEHLFMLENVGSDIFGSPIFSSNIGEYILFLVDENNGQEELQERIE
EIRKNFYAVYEMDMTVAVSGAGPITLTRKLYQEALECLSHRFYLGEGSIITKKDIQQEQE
INNLEFGDLPLFLEIKSGNWNKVKQEMDDIFQQIAVKRDPIHLTRTYVIQLFLTMIQACC
AKSLSDYMGKITYLLEVDSIQAMKEFLLHHTKEITFIYYEKHKSSQSHIIEQMKEIINSE
LSNPALSLKWVAKQVYMNADYLGKLFKQETGEKFSTYVTKMRVNKAMEEIQKTDDVKILT
LAEMIGFGDNPQYFSQVFKKHTGYTPSEYKNAR
>PK3-045_01169 Putative ABC transporter substrate-binding protein YesO
MRKILILALSLFVVTAFSGCSASSSNESDGKNGSDKITIRFAWWGGQPRHDYTTKVIEMY
EKENPNVNIEPEFANWDDYWKKLAPQAAANQLPDVIQMDMAYLSQYGEKGQLEDLTPYLE
NGTIDTANIPENNISGGKIDDSLYGLPAGVNVLSVISNDRLLKEAGIEFDSQTWSWDDYE
KTALQLQEKLGIYGSNGMHPPDVFFPYYLRTQGERFYKEDGTGLAYKDDQLFIDYFERQL
RLIEADASPTPDEQAQIKGMEDDFIVKGATGFTWNYSNQYLAFSQLTDDSLTINFPPAQE
SALFLKPSMLFSIPKSSKVKEEAAKFIDYFVNNVEANKLIKGERGVPVSTEVSEAIKPEL
SESETKIVEYVEAAAQHATEADPPDPIGSAEVIKSLKDVSDQILFKQIKPAEGAKKFREQ
ANEILGRNK
>PK3-045_01170 Lactose transport system permease protein LacF
MKSRALKDNLSGYAFISPFIIGFTTFTVVPMLISLYLSFTNYDLFTTPTWIGLGNYKEMF
FGDEKFWKSLSVTFYYVLAGVPLRLMFALFVAMLLNQNMKGIGIYRVLFYLPSIIGGSVA
VAIMWRNIFGNEGVINALLFFMGIDKKILWYQDPTSALWTLILLAVWQFGSSMLIFLAGL
KNIPPTYYEAASVDGANAIRKFFKITLPLLSPIIFFNLVMQTISAFMTFTPAYIISKGEG
GPLDGTLLYPLYLFQKAFNFFQMGYASAMAWVMLIIVGLTTLILFKTSSLWVYYESKED
>PK3-045_01171 L-arabinose transport system permease protein AraQ
METIKQATNNVIEPDIRPTIEKKRKKIRPKKILFHLITSIIAIIMLYPVIWLIVSSFKES
SSIFVTAHSLIPEKFIWTNYADGWQGIAGQSFGTFIKNSLIIVGLSTIGAVVSSALIAYG
FARIQFKGKSFWFACMMVTMMLPHEVLMIPQYIIFAKIGWINSFKPIVVPQFFGHAFFIF
LIVQFIRTIPVELDEAARIDGCGRFSIFFRIILPLITPALATSAIFSFYWKWEDLINPVL
YLNKAELYPVSLALKLFLDTESASNWGAMFAMSVVSLLPVILIFFLFQKYIVEGISTSGL
K
>PK3-045_01172 Unsaturated rhamnogalacturonyl hydrolase YesR
MVDTGLLLEKQKVVGSIEKLMENLASIKDQTGEYLLHFDGVVVDDKSWEVWNWPQGVGLY
GIYNYWKISNDQKAKQIITEWYYRRLKEGVPPKNVNTMAPLLTLAYLYEDTRDQTYLPYL
EKWADWVLYEMPRTKEDGLQHMTYGPENKNQLWDDTLMMTVLPLAKIGKLLRNQMYIEEA
KKQFLIHTKYLCDRKTGLWFHGWTFEEDHHFAEALWARGNCWITIAIPEIIDLLELPKGD
FFREYLLETLTRQIETLKEYQHETGMWHTLITDRSSYLEASATAGFAYGILKAVHKRYIG
SEYKEIALKAVQAIIQEINEQGALQKVSVGTGMGETLEFYRQIPMTTMPYGQSLAILCLS
EFLYTYC
>PK3-045_01173 Beta-galactosidase YesZ
MQKLYHGAAFYPELWDQKIIEEDIQLMKEVGINVVRIGEFIWSFIEKEEGNVNVSFLKEV
IKKLKDNGIDTILCTPTATPPIWMSYQHPERMHIDKNGTIMSHGARQHVCTNNGYFREKA
AIITETLAKELGELPGIIAWQLDNEFKCHVGECFCDTCKSEWHRWLKQKYETIENLNVAW
GTQIWSQYYQTFEQIPQPKQTPFLHNASLSTMYKLFTHEKIAEFATEQAAIIRQHSNAPI
THNATVFFDLDQALLFETLDFASFDTYAVQENASSFMMLCDLYRNIKKDRPFWLMETSTS
FSASLERYANPHLDGYLQAEAAYAYAAGAEGFCYWLWRQQRSGCEISHSSVISAWGKPTI
GYKNVLEVERIRKELEPLLLRTKPKQAEVAICYSDRAKAYFQTEPFNGVQYKQMLTSFYE
RFLSLGIQRDLIMEKTDLDDYKILFTPFIPYLSTEYIKRAETFVEKGGIWIVGPLTGGRT
GEHTIHTNCALGELEKAAGTEALFTNPLDGTNTIGEAFGITAELGLWSTIFNTEKGGNIG
LIKEGLGAGRAFIKETKRGKGKIVMLGSLPLGKSGEEMLEALIQHYAETAAIKREIKATP
GMVLIPRVGGNATYWFAINMDGGTGEITVPENSWEWESKKKLEEGTYKIPAYSYKIIKS
>PK3-045_01174 Putative oxidoreductase YteT
MKKKTYALVGTGGRAEFFYGAIARDFRDTADLVGFCDLNQTRMAYANHLLESKYNYKKVP
TYTAVQFEQMLKDQTPDYCIVTTMDRTHHTYIIKAMELGCDVITEKPLTIDEEKAQSILD
AVKRTNRKLRVTFNYRYAPHNTKIRELIEDGVIGDVHAVHFEWLLNTEHGADYFRRWHRD
KRNSGGLLVHKSTHHFDLVNFWLQSYPDTVLAMGDLMFYGRENAEKRGETKFYQRAYGSK
YAISDHFALHLEKNEHLKEMYLNAEKEDGYQRDQSVFGDGISTEDTLGLIAKFKNKAILT
YSLHAYAPWEGFNVAFNGTKGRIEMKVIEKSYVNSGGNKEEEGALSSMSITVHPMLGKPY
EVEINEGEGGHGGGDPVLLRDIFGEPIEDRFHRAATHIDGVKSILTGIAGNISIKTGMPV
KLDSLVRF
>PK3-045_01175 Catabolite control protein A
MSVTIKDIAKSAGVSYSTVSKALRDSPLVKKPTKDLIMAVAKELGYQPNIAARSLVSKKS
FTIGVVWPTIEQTVLSKLITTINKELEELSYTTLISINEVESALKIFSRYQVDAILAFDT
SQSIVSSHSAVPIVMHGLANKQTPYPVIDVNRQKATYHAVQYLHKIGHHYISYIGDVESD
ELQKEKVKGFEEAILELELPTFSFQKIRVNNFDQYDGYEAAKQLLTLPKRPTAILTGSYD
LARGALQAISESKLSIPNDISIISYDNFPALEHFDMPLSTVGVPLDKISKKTIEILMKVI
NDEEVETKIFMEPELKITNSCTNYPR
>PK3-045_01176 hypothetical protein
MLSSTVLVQGYMMESLYINRAKFAIVVVNGISVPFFKQLNSKLKR
>PK3-045_01177 Energy-dependent translational throttle protein EttA
MIICSVNKIAKMYGGNTIFEDISIEIKDKEKVGLVGRNGSGKTTLFRLLAGKETPDAGQI
HWKKGMKIGYLEQIPEFKPEWMAKDVLKQAFSNLVIIEEKMKQMEQEMAKDNSPSQLQLL
IEEYGKLQEFFTNAGGYEMDAKIEKIVNGLNIQHLVNKKYGDLSGGERTKIGLAMILLEE
PDFLLLDEPTNHLDLMAVEWLGRFLQDYSGTILLISHDRYFLDEVIQKVIDLEDGEVTTY
HTNFTNFTKEKEERLLREFQAYEEQQKKIKKMREAIKRLREWANRANPPNEGLHKRARNM
ERALERMEKLARPIINRKKMNFEMESSDRSGKDVIQLRNVSKSFGGKILFKDVQIKISYK
DRAAIIGENGTGKSTLLKMILQQIKADEGEIKIGSNVKIGYLSQHTLTEMEGETVIEAFR
NAVSVTEGEARHILAQFLFYGYSVFRKTANLSGGERMRLRLAQLMHQEINLLVLDEPTNH
LDIDSREVLEDALENFDGTILAVSHDRYFLNKLFQKIYWIESQEIQCYEGNYTYAREKSQ
ERKRTQVHIDETITSKKKMQPIKKSQRTESAVNLVDLANELEELEKEISEVERRIETETE
WESLAQFLSEKEGLERRWEELYSLMNSK
>PK3-045_01178 hypothetical protein
MIDKLKPIPSLSSNSVFLAALLGMVGGFLDAYTFISRDGVFANAQTGNIVLFAVNAATGE
WRESLHYIPPLIAFVLGVLVSEIVKIPSLREILYSYRRSILILECIVLIIVGFLPASVPN
IIVTTSISFVSSLQISTFNKLDKWAYNSTMTTGNLRTATQAAYAAFIKQSQEARTQFKEF
SLIIGSFIFGALLGTFTTSQFGTKAIWISAIILIIALVLYHKDKGYIRKRCAK
>PK3-045_01179 hypothetical protein
MEINYQEMIFQFLGGLGVFLFGIKYMGDGLQNAAGDRLQEILDRFTTNPFMGVLAGIFVT
VLIQSSSGTTAITVGLVSAGFMTLRQAIGVIMGANIGTTVTAFIIGIDIGAYALPIIAAG
AVLLFFFKNTKITSLGQVVFGFGALFYGLELMSTGMKPLRSLEAFHELTVNMSNNPILGV
VVGTVLTLIVQSSSATIGILQELFATDAISLKASLPVLFGDNIGTTITAILAAIGASIAA
KRAAMVHVLFNIIGTVIFVIILVPFTHFISYLQGVLGLNEPMTIAFAHGIFNVSNTIIQF
PFIFALAWLVTKLIPGDDGAIITKPQHLNTTFIEHSPSIALGQAKEELERMKEFSIKGLE
ETFKYLQTGEKKYKEKALQYEQGINNLDKEITKYLVELSSKALTPHESEEFSILVDSIRD
IERIGDHMENIVELVEYKINKKVEFSADAKVELEEMYDFTVETLKTSYESFFANDKELAK
KAITNEEEIDKMEKRYRKKHISRLNERKCSGDAGIVFVDIISNLERVGDHAANIAEAIAV
SK
>PK3-045_01180 Sortase D
MKWTRWLSLLLILGGVLFIGYGVWNIMDTKAQTKNSLSEAKAAINKGNEKWVDKESKRFI
PSIGDAVGLLKIDKIDGELPIVEGTDPDDLEKGVGHYKGSFYPDENGQIVLSGHRDTVFR
RAGELEIGDELKIVLPYGEFSYQITATKIVEADDQSIITLDDTQEELILTTCYPFRFVGN
APQRYIIYAKRIE
>PK3-045_01181 hypothetical protein
MAWLLLLTVIMIWIILFLRTRLTFKFGASPKVLEIQPIKGLKKLSDDLEQSLTRSYMENV
EERVRRENKLRENEYEWRLLDLKRYFVLTSLLKESPMFSVKVDELWHQMLMFTREYKDFS
HKYLGSTLHHSPNVKGKSNPDLRGFFDWVYEELFLIRKENIYLYKGFFRYPVHPTIIEDF
KNLSEDELFNRYFKTDTKYHTTIYALITAMKKSVKKVRDYQKKYHL
>PK3-045_01182 3-hexulose-6-phosphate isomerase
MKTSDYLDQVIQELTEAGALIANEDLEKLVERILQSKKVFVYGAGRSGFMLKSFAMRMMH
MGIDAYVVGETVTATYEKDDLLIVGTGSGETKSIITIVEKAKSIGGNITALTISPDSTIG
KLVDQVIKMPGSPKDRENNEAKSIQPMGSLFEQLLLIVLDSVILKYMEIKELDSSKMYGK
HANLE
>PK3-045_01183 3-hexulose-6-phosphate synthase
MKLQLALDLVNIPQAIEVVSQVEQYVDIVEIGTPVVINEGLHAVKQLKEAFPNLSVLADL
KIMDAAGYEVSQAVNAGADLVTILAVAEDESIKGAVAEAKKLGKEILVDMIAVKDIKTRA
QQLDEFGVDYICVHTGYDLQAVGKNSFEDLKAIKSVVKNAKTAVAGGIKLETLPEVIAAQ
PDLVIVGGGITSQENLSEAASKFKELIAQG
>PK3-045_01184 HTH-type transcriptional activator HxlR
MERMAGKEFNCEKELTLSIIGGKWKMLILWHLGKEGTKRFGELKALIPGITQRMLVNQLR
ELENDYIVKRVVYPVVPPKVEYSLTDEGKSLMPILDAMYSWGRNYMDTVLENPPMIKELE
SIDK
>PK3-045_01185 HTH-type transcriptional regulator MalR
MAVTIKDVGKLANVSPSTVSRVLANHPKISDETKRKVREAMEELGYHPNLQARSLVVKST
KTIGIVMPHSTERVLENPFFPEVLRGISLEARKSQFGIYLTTGASEEEILQEVIEMVQGK
RVDGIILLYSKTNDKIMDYLLLNKFPFTVIGRPYQNAERITFVDNDNVFITKQITEYLIQ
LGHQKIAFIGANMEMVFTIDRLKGFKQALKENGIAYQKELIIYDKELVDRTKEKLMEILN
LESRPTAFVVSDDFIAIELISYAEELSISIPEDLSIVAFNNISTGKYMKPSLTSVDINIF
QLGVEATKCLLDDIKYPNAVTKRITVPAKMVERNSCCRVAE
>PK3-045_01186 Oligo-1,6-glucosidase
MTQKWWKEAVAYQIYPRSFMDSNGDGIGDLKGIITKLDYLKELGIDCIWICPMYKSPNDD
NGYDISDYQDIMDEFGTMDDFDLLLYEVHQRGMKLIIDLVINHTSDEHEWFVESRSSLNN
PKRDWYIWRDGVDGKEPNNWESIFGGSAWKLDEATGQYFMHIFSTKQPDLNWENEEVRKA
LYNMINWWLDKGIDGFRIDAISHIKKEEGLKDMDNPLGLDYVPSFDKHMNVEGIQPFLEE
LKNETFAKYDIMTVGEANGVKVEEAELWVGETKGKFNMVFQFEHLDLWDNEKNYGVDVME
LKQVLNKWQKGLENKGWNALFIENHDKARSVSTWGNDKEYWKESAKALGMMYFFMQGTPF
IYQGQEIGMTNVQFPTIEEYDDVATKNLYKLKREEGFSHKEVMEIIWSTSRDNSRTPMQW
SSDEYAGFSDHTPWMGMNPNYLDINVESQKQDPDSIYHFYKKMIELKKSGPILTYGTFDL
VDEENKQVFAYTRTLDDKKMVIISNLSAEEAVFENRVVELEHENLLLANYPVEEHEPTTS
ISLKPYEARLYTCK
>PK3-045_01187 hypothetical protein
MKKSAKEREESAKRKRESAKEPKYQPKGRENQPKSRNISQKEERISQTPEISAKEREESA
KEPKYQPKGRENQPNSRNISQREGGISQRAEITAKRKRESAKLPKYQPKGRENQPNSRNI
SQREWGISQSAEISAKRKRESAKLPKYQPKGGRNQPNSRNISQRQGEISQTPEISAKGGR
NQPKSRNISQKEGGISQRAEISAKRKRESAKLPKYQPKRGRNQPKSRNISQRQGEISQPP
TNIN
>PK3-045_01188 Putative esterase
MFTNISMKNTLMESLGINIVEVKNGVCIATMPVDERTKQPFGYLHGGASVALAETAASIG
AASLIDPKKQAVFGQEINANHIRSVKEGLVTATATVIHQGKSSMVYEIKLANDKKELICI
SRCTLAVISLEK
>PK3-045_01189 hypothetical protein
MNIINRAEINQIIDRYVSINFSVNRKFDQLIRQEIGDVLTTEQHFTMRHINNVEVCTSTE
LAIVFGVKKSAITPIINRLVEKGWVERTRDEKDRRVIYLTLTPAGKVIFGEMEKKIQSVI
VSVISQFDQAEIQNFIDTYAKLDRLIEEK
>PK3-045_01190 Chromosome partition protein Smc
MNAILKGKWFILGAWIIAIVGLFIIAPNMGDLVKEKGQITIPDEYSSSEAGKILDEIQNQ
KNAGEQSTVALVFHNDKKLTEKDIAEAKKAVDALEANKKKLGITDILSSFEKEELKDQLV
SDDGKTILTSLTISWNDREAEEVSDALYKTIEKYDVDHYYTSNWMIDQDLVNSSQEGLKK
TEGITVVFILAVLLIVFRSVVAPFIPLITVGLTYLASQSIVSILVDKFNFPLSTYTQIFL
VAVLFGIGTDYCILLLSRFKEEMMRRESIWESIVETYKNAGRTVFFSGVAVMIGFAAIGF
SKFVLYQSASAVAVGVAILLIALFTVVPIFMLLLGKKLFWPSKGSAEHGDSKIWEIAGNF
SIKRPLLSLLVVACICVPFLVTYDGDISFNSLEEIGDDYSSIKAFNAIADSFGPGESMTT
TVILKNDDELDTIEYLSLADTITNELAKVDLVDKVRSVTRPMGDSIEDLYISNQAKSLEE
GLGQGKEGIDQISKGLHSAGDELQKSGPQLNDAADGINGLIKGTNDVKSGLGEIQTNLEK
IEQGIRQGSAGSDQIKSGLQQAKTGAEALLNEHNKLQAGYKEAEKGLSAILGEYQKISSG
LEQLAQGLNKVPKESFGSLEGTYAGIADNPAYKGIKAGFLGAQQQLPVISAGIDQLNSEL
AKLQTGISKANAGYTEILKNQANISTGLQQLLDGIDQQQKGLDKLADGQGQIVNNMPKLT
NGLSSINDGQKQLLDGFNNIGGQIGQLTDGLSQSAEGLDQVSDGLGSATDYLSGLSKNET
NSFYIPDEVLASDEFKGALDTYLSPNRKIMTFDVVFSDNPYSNEAIDQIDRIKDRVDQVT
KGTKLENAEVAVSGITSTNADLRTMSNADYTNTVIWMMIGISIVLIFLFRSIIMPAYIIG
SLILTFYTTLGINEAIYVNLLGYSGISWAVPFFGFVILVALGVDYSIFLMDRFNEYKNLT
IKDAMLEAMKKMGTVIISAAIILGGTFAAMMPSGMLSLLQIASIVLVGLFLYAFIILPLL
IPVLVKNFGEANWWPFKRVKD
>PK3-045_01191 hypothetical protein
MEMLLHFFQKKAVKRFLILFLIGLILYFVRSMVNLILFTFIFSYLMDRLVQFFTSKFAIK
RTIAVILLYFTVLFLLIYGISTYLPVVIQQISILVIQITDFYMQPHDNAVLNFIVNTINN
LSVTTYLHQGFTFIFKYFTNIWGNLLQVFMAIVLSLFFLLEKERLRVFATRFHTSKIASI
YFECKYFCKKFVATFGKVIEAQFIIALINCVLTTTALYFLGFPQLFGLGIMIFLLGLIPV
AGVIISSIPLCIIGYTVGGISHVISIVILIVVIHALEAYILNPKLMSSKTDLPVFFTFIV
LIFSEHFFGVWGLIVGIPIFIFLLDILEVKSEKQRKESIKKNRWT
>PK3-045_01192 Undecaprenyl-diphosphatase
MLDNLWDLIVAFILGIVEGLTEFAPVSSTGHMILVDDLWLKSGEIFSPEVANTFKVVIQL
GSILAVVIIFKDRFLNILGLKKTINGEKVVGHKLSLIQVIIGLIPAAVLGLLFNDYIDEH
LFNFKTVIYALIVGAILMIIADFTQKKKKPTTTSLDQITNKQAFFIGLFQCIALWPGFSR
SGSTISGGVLMGLSHRVAADFTFIMAVPIMAGASFISLLKNWEYITSAALPFFIVGFISA
FIFALISIRFFLKLIDRIKLTPFAIYRIVLAIIIIVVFI
>PK3-045_01193 Fructokinase
MERKGILSLGDAFIDYVSQSSDNNCFERSLGGASVNVAVHISRFAIPSFYLTKLGSGEDS
QFVEKEMLKEKINLKDSVRTPTKQISKVYVHLDASGEREFHKYENETPNEVVLESDLKES
SFENKSIFYFGSGTLFHPSARVATKKAIEIAKKKGLIIAFDANIRIKRWNNEEECRQVIM
EFLSFVDILKMSKEELLFLLEIQSVEKGLANLEKFQIPFKLITLGEKGAIGQLYEEKVQM
AGKVIKAIDTNGSGDAFMATILACIYEKGFPACKKEMESYIDQANRLGAIVATKVGSLPI
LPDYQMIMGRAESPLLNENEV
>PK3-045_01194 hypothetical protein
MTERNVYIILTDTGTLFTRCIKFFTRKPHNHASISFDPQLNEVYSFGRRKPSNPFIGGFV
KENVQHSFFRNSRCIIYSISVTQTQYEKMKNKIEQMEKEQSNYRYNLLGLLFILLKIPYN
RKNAYFCSQFVASILHDSGVLFFNKPPCLMTPYDLLDEYKMQKVYEGKLHQYPLVFQIAV
A
>PK3-045_01195 RNA polymerase sigma-54 factor
MQIGFDLSQSQTLKLKLTPELKQAIDILQYSSQELVDFIQLKTIENPILEISESSIENIF
NCHHTPSNYSYNKDTEYDPFDFYSDTRISLEEYLIEQIMLLKNLSPLQIKIFKFLIGNLN
TDGYLEINSADASYYLSVSENEVNRIINLLQTLEPIGVGARNLMDCLLIQMRANKQNQSL
AYSIVENHLEDLAAKRYPKLAKILHVSVNEIQNAADYIATLDPKPCRQFFECKNLTQYVI
PDIIIENVNGKSIIKINDTFLPTVSINEYYKNSLNNHESSEYLKKKYQDAMLLLNSLTHR
KQTLFQVSNAIIEIQNEFFQFGLGRLRPMKLKDIAEKTGFHESTISRVTSNKFIKTNHGL
YLLKNLFTTGIDGLNSESESSFDIKKKMEKLIREENKQKPFSDQQIVRLLENEGILLARR
TVTKYRVEMGIPSSSKRKRY
>PK3-045_01196 L-methionine gamma-lyase
MNWKDCTTLIHGQPDHKKTGPIVTKIIPAVGYSFPDTETAIATVSGEIKGTYYGRYGNPT
TNNLQKKIASLERGEAALGVSSGMAAISSTLLAFLQCGDHVICTKDVYGGSYKFLRTLAP
RFGIETDFVDCTNLREVEQAIKINTKVLFIETPSNPCLTILNIRELADLAHSYNIKVIID
NTFMTPYLQQPLKMGADLVVHSATKYLNGHGDVIAGFIIGDLESIQFIHQNIVGDLGQVL
NSWDSFLIDRGLKTLGVRMKQHCQSAMMIAKFLETHPSIEKVYYPGLTSHPQHTLAKAQM
KDMGGMLSFEVKGGYCAAKKFIDSLQLALISFSLGDPETLVQHPASMTHASMPQMEKLKC
NITDGLIRLSTGLEETEDIISDLHQALSQI
>PK3-045_01197 Anaerobic nitric oxide reductase transcription regulator NorR
MKLERLSHLINIVKNVEYEVRHEMGFDEMVQKFSESLKFDVVVHDENGEIISGTGRYQNS
FGDGRNNVVVQRVLNNLEPYVIYDSKISELGCKNCKYNNECVGYGAIAYPIKDQDSVIGV
ISIIGFSNEHKEKIRLNLENYMCELIDFSKELATKLNMLQAPYHNRLINSDEVNFRSIIG
NETGLKNLIQKAKKVSNSLSTVLIRGESGTGKELIARAIHNESYRKNHQFIAINCAAIPE
TLLESELFGYEGGSFTGSKKEGKKGKFELADKGTIFLDEIGDMPISLQPKLLRVLQERKI
ERIGGKSSIPIDVRVIAATHRNLEGMLQEGRFREDLYYRLNVIPLYTMPLRERQSDITLF
CKYFIRKHCQLLNKEQMKLDPNLEKWFLQYEWPGNIRQLENAIEYMVNMAESDIIGFHDL
PDYLQETAGMQNVRLSLEQMIAQYEKKILQSYFVLEDYKKDKGKVAEELQISLATLYRKL
DKYDFCFDDSK
>PK3-045_01198 hypothetical protein
MFRSKIIKVEDFRTIEIFDLPTQALEVKNKIIQSLSKVVNKYSEYEEVADYVKKGDLVTL
NLASATEKFNKKSLPVVVGSNLFNSSFEEQIVNMIPNQMELIKLNGDIIETIVTKIERKK
IPELTDELIREENIDGVLTVEDYKDYLFDTIVSQQVSEVAEKVIDRVMEISEFEISKEDI
NRLFEGDVSKMTFLSQEEGKVLEEMTEMEIGQRIGEPSLAAFEVEYKNNRYPNYLKRALI
GLSIAQDDNVTFNESTYESSFESSEYYKNYSLSESKKLFPYFNYLTYSYSAYAHEKIAGF
FKEAFEQNKLLIK
>PK3-045_01199 Thioredoxin
MAIRKGNNNNFDQLTSEGFALVDFYSDTCNPCKILAVILEEVDKDLPFINTVKVNITDEK
EMSEKFGIMAVPTIVFMKDGKEVERHIGVLREEEIKEKISKYYY
>PK3-045_01200 Multidrug resistance ABC transporter ATP-binding/permease protein BmrA
MSVPLKTNKKMAIVTGEKPGNLDKGIWKRFIKLIWKSHLPYVWILAYILIMMFAVKIGIM
VPSYTAELFNGNVSVTLVTSLVSATILSSLIGQLSSIAQGIAEAKIDMNLRKMLWKKMLC
LPVEFFDKSKPREMVSRITTDTGIISSLVMQTLIGEITTLYLTYETAKQLANYDIKLMYS
ILVVIPILIIISIVFGRLQFKTKRKEQYRVSRLTQVLAELVSNVPLIKSFAKENKENERG
KAAIDQLYKASISNGMIGILFTPALSLVTLGQTVLIVVIGITLLNNGEITTTMWTAYFLY
VGNLTTIINSKAGIWTQIKTAQGATDRISRLLEQAEEEYYTGKDDDLLQGDIMLHNVSFN
FGEQQVLKDISCNFKAGNITALVGLSGCGKTTILNLIDRFYAPLEGEITLGNQNINSFSL
KHYRQSIAYVSQDSGIMSGTIRENLLYGIKREIREEEIIQAAKLGNAYEFIERLESGLDT
EVGTMGNNLSGGQKQRLAIARAILKDPKYLLLDEATANLDANTADQVLTGLKNLMKGRTV
IMVTHDSKSLQVADEIIVLESGRVSAFGTHEELIEANAYYRAMMEKHGEE
>PK3-045_01201 Multidrug resistance ABC transporter ATP-binding/permease protein BmrA
MSSSKTTLKMKWKPFLKIFAKIKIPWILYILSFLSGLSLTWIALKLAPIQTKIQIGKFFE
DNAIYVFVGLTIATILARMVQSGAELFGNEKVNRSLRFVLLNKILKTTMKVVNEKKQGGL
VSRITNDAATASDATSIVTRIFASLYSFLGALVGMYSLNPTLTFTYALMIPLVFFIFWLI
GRLQFNIQYKIFHTYGVMTDYFSEHLINMKHIKAQATEDEELNDGIEAIKTRYRADLYKT
FMGGIQAVVGNLITTFSMIIIFAVGAYYVRNGTFKTSDLVTFNNLSMIMLPGLYELLSQF
QTIKGAQGATANIANLMEAEEEQVKRKIAIGPSEEDIIFKNVAFGYNEHQILHDVSFTVP
KGKVTAILGGNGAGKSTIFNLITRYYEPTAGSIMFGSQDVKDIHLDEWRRTMVYVSQSSP
ILSGTIRDNILYGARREVSEKELIRAATLANAYEFIQSCPSGFDTDVGEAGSRLSGGQKQ
RIAIARALILNPDYLLLDEATSNLDTKSERYINEALANLMDGKTIIKIAHNLQSVQGADN
IVIIDNGHVVAEGTHNDLCEKNAYYKGFVDLHK
>PK3-045_01202 hypothetical protein
MEEYNGFRIEQKEYIQEINGNVYIMTHVGTGAKVIWVNNDDEHQGFSIGFRTPAMDDTGV
FHILEHCVLSGSKKYPVKEPIVELMKGSMKTYLNASTYPDKTLFSLASVNKKDFSNMMDV
FLDAVFFPKLHEQKEIFLQEGWHLAYSEETNELIYKGIVYNEMKGTLSSPQQRFIHSLFK
ALYPSFPHANFSGGDPKEITNLTYEKLLEAHRDYYHPSNSLLYLYGAMDIEERLQQLNEV
LGQFERKENKPLALDKIFEGERKEFTSEYPISEKEIEEENTFLAFACKVEEKADENLGIT
LNVLNKILLEGNSAILRKKLLEEKLGKDAFGLVDSSLKYPLFAICCSNGDAENKDMFIKI
VQDTLRELVEKGIDKKLIEAAILSTEFELREADYGTFPEGLFHGINAASNWAAGKPLIKA
FQYEDSLETVKSALSEPYFERFIENYLLNGKQSAIVVCKPSKQLSNIEYLQEQVKLKRIK
DGMKEADLQALIQENAELNKFQSISDSDEAKETLPTLLLSDIDPKPADLPLQEIECNGSK
VLFHDIYTKKVVYYNLYFDAINGKDDISYYRLFTELLGKLGTSEYTSEALASEIAMKIGI
VSFENYLYSSSVDTCLHKVAVKVRTMEKNMEKSLKLVHHILTETEFDNKKKVKELIGNLV
SNMKIQLNSNGNMFAAIRVNSSLTALGYINEYLRGISFYQFLVKLEKDFEQRYDSFIQKM
KGIANNLFCRKNLVVGLTGDLDAMKVFSNAFLNFDLPDGNKVETFEFQINNDISKEAFTN
SNSILYVVQGGNLKKMGYEFSGQMLVLAKILNLTYLWRNLRVLGGAYGGGINIYMNGNIF
FYSYRDPNLLETVDIYNTTSDFIMDLDLPRSELQRYIIGTIADLDNPMNARIKGEQAETN
YFINNTYEQRLKVRQEVINTTIDDLRSLSEMFKALLGKQSLCVVGNERKIAENNQLFDYS
YPLFS
>PK3-045_01203 hypothetical protein
MKRKKKFNLTFLVFCLILVLAACSSQNKAGSNTTDKAPVAKDKSTEEVTKDNVSDPASID
SESNGKDAQTKPLADMTLDDLTEYFKKVNLIKENSETSKLCCIGSDTINYKDVGVEVYWY
DLKNMNETLQKEYEGAKKDGYVTLGNSQVLVQVHGPFAVNASASTKAEEFVNAVKELK
>PK3-045_01204 hypothetical protein
MKFEVGIISLGVFLCDFSVRNCRGCVKGIPIKMIQKLIQASISNNNALNGDNNSPPIYLA
GGIKQKMIALLLYYAI
>PK3-045_01205 L-cystine-binding protein TcyA
MRKFSILLSLLVSLTIVLAACGSNSDKGSKDSADKKADNNTDLLAQIKDKGTLIVGTEGT
YPPFTFHDNSGKLTGFDVEISQEVAKRLGVKAEFKETQWDAMFAGLDAKRFDMIANQVGI
NDERKAKYAFSDPYISSAAVLITREDSDVKSFKDMKGLKSAQSLTSNYAEIAKTNGAELV
GVDGFNQAIELLNAKRVDVTVNDKLSFLDFKKQKPDVKVKIVDTADDVAHSGLMFRQGND
TLVEAVNKALKEMVGDGTYKSISEKWFGEDVLK
>PK3-045_01206 L-cystine transport system permease protein TcyB
MYLNSIFTDPEAFQRYYDIAVSSLLPLVKGAILYTIPLSIISFIIGIILAVLTALARLSS
IKIFKVIAGIYVSIIRGTPLLVQLFIIFYGLPNVGITLEPFVAAIIGFSLSVGAYGSEIV
RGSILSIPNGQWEAGYSIGMSYVQNLKRIILPQAARVSIPPLSNTFISLIKDSSLAALIL
VTEMFRKAQEIASTNYEFLLLYSEVALLYWLICFPLSIIQQGLENRFGRHLSK
>PK3-045_01207 L-cystine import ATP-binding protein TcyC
MISIKGLSKHFGDLQVLKDINLEVEKGKVIVVIGPSGSGKTTMLRCLNILEIPTSGHITI
ENKQLDFSTKVTKKAITDFRKLTGMVFQSYNLFPHKTAIENVMEGPITVKKQSKEKTRMK
AADLLNKVGLGDKIDFYPFQLSGGQQQRVGIARALAMEPKVMLFDEPTSALDPELVGEVL
KVIKQLANEGMTMIIVTHEMKFAKEVADEVIFMDGGYIVEKGSPHEIFSEPKEARTRQFL
QLIQ
>PK3-045_01208 hypothetical protein
MKNTLYVNSIIHCCLLTVFATTLFYILTGLSVFTIASLISGVLVAFISLLEEEVIHKKIH
DEH
>PK3-045_01209 Methyl-accepting chemotaxis protein McpA
MKKRSIFRSLRTKMIVIIFFATLFSTMISFKLNEMILEAGVFPQEFSIFVNTVINLIFVT
VIVALFTRRIIISPLKKLLYSIKKITEGELEIEIHKTSNDEIGQLTDAFILMKEFIRNLV
QKVNETSEHINASAEKLTANTVETNHVSEQISAAIQSVAAGSEEQTKGMDFIVDSVAVVN
NEIKDIAKNTEDMVKSTHNTVLKAKEGQAVVDNTVTQMSLIQNSVQESNDSIVLLQERSQ
EIGQFLNVITEIANQTNLLALNAAIEAARAGEAGKGFAVVAEEVRKLAEQSNQSAKQIAV
LVSEIQKDTLSSVKTMKRVTEEVKDGINITNDTKEKFTIISESMLSMSQQMESILEAAHN
ISTNIVEVAGSVDQVSGIAKENSQNSMNVSEASQEQLAAMEEITSSTKSLAKIADDLVEL
TKTIHVEA
>PK3-045_01210 Peptidoglycan glycosyltransferase RodA
MSPKNSSKIDYTLVLILMLLCLTSLIAIYGANSSYVLKQVMYYVVGIGIIIGVIRLDSDQ
LKKLTWYLYAFGLFLLVLLILAPPSIAREINGAKSWFTLPGFSLQPSEFVKVFLVLALSR
IIVDHQEKYIVKTIQSDFFLLFKIGAVTAFPLLLVMKQPDLGTSLVFLAIMLGMIFISGI
SWKILTPIFSSFAVIATAVLYLVIWHPDWITMYFGVKEYQMGRIYSWLDPYTYQSTTGYH
LTQSLLAIGSGQTTGKGVGTSEVVLPENHTDFIFSVVGEEFGFIGASIIISLFFLLIYHI
TKVALETKNTFYTCMSVGIISMLCFHVFQNIGMTVGILPITGIPLPFISYGGSSLMGNML
SMGLIFSIRYHYKKYMFSSDE
>PK3-045_01211 hypothetical protein
MDEKFQEEFDSLLSNYTELLLGEENEELKEKVQVWMLYTYMSKNMPGLVKHWNAKFPDGK
QTIVQIVSEIKKMNEIRKQNQK
>PK3-045_01212 hypothetical protein
MDQQKPIQNPESQVPKTPQMNDRDFTNDMLSTEKYMTDAYSTALNEASNETFYQDLLSIF
TETQNMQRELYDLMFQKGWYKLEAAEQQKIQQSYQQFKGYSNQFPYGNTTIQ
>PK3-045_01213 hypothetical protein
MQQQQNNMTQPNGMMMKPPVMVTVKDSLYLTDMLSWNLLAMKKAHFFAQHAQDPTIKSQL
EKCGQMHQHHYERILSHLDANSQPMAQQQQ
>PK3-045_01214 hypothetical protein
MARLKKNPSKAGVSAASVKGNAGPTVETDGGGKVNSQNNQYKKQ
>PK3-045_01215 putative 3-hydroxyacyl-CoA dehydrogenase
MVKEIKSAAVIGSGVMGAAIAAQFLNAGISTVLLDIVPTKLLSEEIEAGLTLKDEVVRNR
FGRLAIERMKLESPSPLTSLNNLAQLTIGNLEDDFDLLRESDWIVEAIIEDMQIKKELFK
KIDQYRKKGSIISSNTSGISINQMKENLSPDFQAHFLGTHFFNPPRYIKLLEIIPTKVTA
PNVVKTISQFAEEELGKVVVKANDTPNFIANRIGSFAFLNIVKEMIKEDLTIEEVDQLTG
PLIGRPKSATFHTLDMVGLDTFYQVIHNMQGKMNDTEEIEMYQIPALLEEMLKKKMLGRK
VQKGFYRKTEEGLQVLDYHTWTYKNLTGTKKKADHRSLPLFLEEKNPKAQFLWKGIAPFL
LYSAKMVGEISDSIYEIDQAVQSGFNWRNGPFRLWDELALKATVERMEKDSREIPGWIKE
MLDQGFESFYKVINGVEHYYHQGKYLPIPKSVDQICIQEWKKQRGVLLSNDGASLMDIGD
GVLLLELHSSNMSIGMDILVMIDKAIEKVELEAYKGLVIGSEKKNFSLGANLALMLLEAQ
NEDNVELQIAVRRFQQAMKRIKYCQKPVVAAPYQRTLGGGAEICLAANKVQASLETYLGL
VETGVGLIPGGGGTTALYCNKWKENQQLLPEEMLQLTAEVFQTILTAKVATSAVQAKELG
FLTERDGITNNDRFLLRDAKKAVLQLADEKFQAAKKEKIMVTGKLGYDFLMQEVDKLKKI
GFISEYDAEIASNLAIVLTGGSVEFGALVEEDYLLNLEREAFIQLIQQQETQKRMLYLLQ
TGKPLTTKKE
>PK3-045_01216 putative acyl-CoA dehydrogenase
MQKGGSFLTEQVTADAIFTPEDFTEEHEMIAEMTSEFVQKKVLPHLAEMENHQFTITKQL
MEEAGELGLLSSDIPEPYGGLGLDKISTAIISEKMSVAGGFSVTHGAHIGIGSLPIVLFG
NKKQKEKYLPDLAVGKKIASYALTEPSAGSDALSIKTTAVLNKEGTHYSLTGEKQWITNS
GIADIFIVYAKVNTEHFTAFIVEKDFPGVSIGKEENKLGIKSSSTCAVRFDQVEVPVENV
LGEIGKGHLIALNILNIGRYKLGLGAIGASKEALKKTIAYTDKRVQFSVPLSHFPLTLEK
YATMASYIYAAESTVYRTAGLLSTAMDEVDADIEWTIMAKIINEYVIECSLNKIFASEVL
DMVVDECVQLHGGNGFMEDFDIARMYRDSRINRIFEGTNEINRLLIPPTLAKKSVKGEIP
LLALAKMTEKEMLSFLPEEPDDKLLSQEKMLLSNTRKISYLLFGMMLKKYKEKLEEQQEI
MVNLANIFNAVFAMDSCILRTEKAMGKNEQEEKQKILYTEIYCQEAFQQVITEAIDTLAY
MLSGDELRLALSVLKKYTRYTPKPIIARKREAAKHLLTAGEYLG
>PK3-045_01217 Regulatory protein MgsR
MGDGMKVTFYWYPKCSTCRKAKKWLDENHVSYEEVHIVDNPPSRALLEDLYKKSGLEIKK
FFNTSGQKYRDLGLKDKIKEASDEELLDLLASDGMLIKRPLTTDGNKVTLGFKEEMFKES
WA
>PK3-045_01218 Glycine cleavage system H protein
MAVPKDLRYSKEHEWVKVEGDNARVGITYFAQSELGDIVFVELPEVGDEVTANEPFGSVE
SVKTVSELYAPISGKVVEVNEELSDNPEFVNESPYEKAWMVVIEPSDKADIEELMSAEQY
EEMTNEG
>PK3-045_01219 Ribonuclease M5
MKKVIIVEGKSDKQKVEKIVREPVDIICTNGTIGVSKLDELLDELMDKDVYILVDADKSG
DKIRKQFKRELPEAEFLYIDRKYKEVAASPECHLATLLLQADIEIEAKYLDTRMNGL
>PK3-045_01220 hypothetical protein
MIDWNLDQWEKQVKDTDAAFLYLYTPLCGTCMVASKMLTVLHTMKPELNLGKMDLNYAPG
LAAKYEVESVPCLVIMEKGELKEKVYRFESVPHLVEVIQNYIK
>PK3-045_01221 hypothetical protein
MQDWMKCFVEKLNRKESLKPLLRNASLSLVLTCQNESYYMELKNNRFSWRRMKGEDNPDI
WLTGDMTSISLVMEGEILLREAKKNGSIQLEGSLRKILLLESVFFLSHSRSVPHTG
>PK3-045_01223 Methionine import ATP-binding protein MetN
MINVNSVKKIYSSRSGKVTAVDHVDLTIDSGEIFGIIGYSGAGKSTLIRMLNGLEIPTAG
SVSVAGHEVSTIKGSKLRKARQEISMIFQHFNLLWSRTVKENIAFPLEIAGVKKSARDKK
VLELIKLVGLEGREDAYPSQLSGGQKQRVGIARALASDPKVLLCDEATSALDPQTTDAIL
DLLVDINKRLGLTIVLITHEMHVIRKICHRVAVMEDGKVVETGPVIDVFKQPKKEITKRF
VQQVIEPEEAKDTIEHLIAQYKTGSIVMLGFVGESAEQPVITNLIRTFAVSVNIIQGKIS
PTQHGSYGTLYIHLDGEKQEIEKAIQYLHAQEISVEVIEG
>PK3-045_01224 Methionine import system permease protein MetP
MMERLLPNVDWEIMWNATKETLFMTGFSIIFTFILGIILGITLFLTDKGNMWNNVFFNRI
ISAVVNIFRSIPFIILLVLLIPLTTLLIGTMIGPKAALPSLIIGAAPFYARLVEIGLREV
DKGVIEAAKSMGAKPTTIIFKVLLPESMPALVSGITVTTIALVGSTAMAGIIGAGGLGNL
AYLQGFQRGNGDVTLISTVIILIIVFIIQFIGDFITKKIDKR
>PK3-045_01225 Methionine-binding lipoprotein MetQ
MKKLWSLLIALTFIFVLAACGSSNDDSKENGGSNTDKGSTKLVVGASNVPHAEILEKAKP
ILKEKGIDLEIKTFQDYVLPNKALESKEIDANYFQHIPYLNQQIKENGYDFVNAGGIHIE
PMAVFSKKYKSLDELPDGATIIFSNSVAEHGRVLSLLEKGGLIKLKDGIDKVNAKIEDIA
ENPKNVKLKADYEPALLPQIFNNNEGDAVVINANYALDAGLNPVKDSIEIEGSESPYANI
ITVRKGDEKREDIKTLVEVLHSKEIQDFINKEYKGAVVPVSK
>PK3-045_01226 Vegetative protein 296
MSQPKLVINDLHVSIEEKEIIKGLNLEIKGGEIHAIMGPNGTGKSTLSSAIMGHPKYEVT
SGDVSLDDEDVLEMEVDERARAGLFLAMQYPSEISGVTNADFLRSALNSRLGEGNEISLM
KFIRKMDDNMEYLEMDPDMAQRYLNEGFSGGEKKRNEILQLMMLNPKIAILDEIDSGLDI
DALKVVSKGINKMREERKEEFGCLIITHYQRLLNYITPDYVHVMMQGRIVKSGGPELAQR
LEAEGYDWIKKELGIEDETVEQEA
>PK3-045_01227 hypothetical protein
MTTDIKLPFDQEYLSSFSKDMNEPSWLTELRVNALQQADALPMPRPDKTNIKNWNFTQFE
KHIVSSEDFSDVSDLPEQVKALIDLEKNKTLYIQRNNRPTFLAVSNELKESGVIFTDIFT
AAREYSDLLQKYFMKDAVKIDEHKLTALHAALLNGGVFLYVPKNVVVEEPIQSIFLHDDK
EANLFNHVIVVAEDNSSVVYVENYVSTVDPEEAVFNIVTEVIANANAKVQYGAVDNLAHG
VTTYVNRRGVAGRDAKIEWALGFMNDGNTISDNTTYLMGDGSYGDTKSVVVGRGDQKQNF
TTKVVHYGKSSEGYILKHGVMKDKASSIFNGIGKIEHGATKANAEQESRVLMLSEKARGD
ANPILLIDEDDVTAGHAASVGRVDPLQLYYLMSRGIPQHEAERLVIHGFLAPVVEQLPIE
GVKKQLVEVIERKVR
>PK3-045_01228 Cysteine desulfurase SufS
MDSKHIRSYFPILNQEVNGHPLVYLDSAATSQKPVQVIETIENYYREYNSNVHRGVHTLG
TRATDAYEGAREKVRKFISASSIEEIIFTRGTTTALNTVAQSYAMENVKEGDEIVITPME
HHSNIIPWQQVAKKTGATLKYLPLQADGTIALVDVENTITPATKVVSIAYVSNVLGVINP
IKEIAAIAHKNGAVLVVDAAQGAPHVKIDVQDLDCDFLGFSGHKMCGPTGIGVLYGKKQL
LENMEPIEFGGEMIDFVGLYESTWKELPWKFEAGTPIIAGAIGLGAAIDFLEEIGLENIT
EHEHKLAAYAMEKMSSINGLTIYGPQNANNRAGVITFNIEDVHPHDVATVLDAEGIAVRA
GHHCAQPLMKWLNVSATARASFYLYNSEEDVDKLVEGIGKTKEYFSDVF
>PK3-045_01229 Zinc-dependent sulfurtransferase SufU
MSFNNLDSLYRSVIMDHYKNPRNKGVLEGSLTVNMNNPTCGDRILLTMKIEDGIVADTKF
DGEGCSISMSSASMMTQAIKGKTVEQALKMSESFSEMIQGKDYPDDMDLGDIEALQGVSK
FPARIKCATLAWKAMEKGVNEGLDS
>PK3-045_01230 hypothetical protein
MAKKMPEIGDYKYGFSDKDVSIFRSKRGLTKEIVEEISKMKAEPQWMLDFRLKALEHFYK
MPMPQWGGDLSALNFDEITYYVKPSEKTERSWDEVPDEIKQTFDKLGIPEAEQKYLAGVS
AQYESEVVYHNMQEDLEKMGIVFKDTDSALRENEDIFREHWATVIPPTDNKFAALNSAVW
SGGSFIYVPKGIKVDTPLQAYFRINSENMGQFERTLIIVDEGASVHYVEGCTAPVYTTNS
LHSAVVEIIIKKDAYCRYTTIQNWANNVYNLVTKRAVCDANATMEWIDGNIGSKLTMKYP
AVILRGEGARGMTLSIALAGKGQHQDAGAKMLHLAPNTSSTIVSKSISKQGGKVTYRGIV
HFGRKADGARSNIECDTLIMDNKSTSDTIPYNEILNDNISLEHEAKVSKVSEEQLFYLMS
RGISEEEATEMIVMGFIEPFTKELPMEYAVEMNRLIKFEMEGSIG
>PK3-045_01231 hypothetical protein
MDATPKSMKIIIQQNIRQFLLANGSATKVELSDKLGISFPTISKFTAQMEEDGELLSAGL
DDSSGGRRAKRYTYNPEYMLGLAIFLEKTETNYIVFNCLGEEKETGKISSALKDDNVKLL
IEYVEALQMQYPKISSISIGVPGSVDNGRIIYSPDYEYLHDFDLKGYLENYFSIPVVIEN
DMNAAVLGYQDQQEKKNDKSLVYLYSGQNGPGAGIIVNGKIVRGSTNFAGEVSFVPQYNN
RNFGQTFTNGKVFFSKEDEVDAISRLIASFVAIINPHAVIFCDDEVTQTTINHIKQQSST
YIPAEHLPEFRMSDWKQDYLYGLQRLGLDLIITGISSKTNE
>PK3-045_01232 hypothetical protein
MATFFLVIIYLAFISLGLPDSLLGVSWSLMQVEFKAPLETAGVLFMTIAGGTIISSFISG
TVLKKFGTGMVTFVSCFMTAGALLGFHFAPSIVWLFIFAIPLGLGAGAVDTGLNNYVASH
YKAHHMSWLHCFWGVGATLGPIIVAQFISRDNSWRSGYFAIASIQFILVVILLFTLPLWK
KIEKVPKQVHENKIEESTSTLDEAYLENQKPWQIRGVKLALLAFLFYCGAEAAVGLWGSS
FLVNVKNLSIDVAAKWVSVFYAGITIGRFITGFITLKMSNQRLIRWGQIIALVGAILLFL
PFPVLFSLAGFIMIGLGLAPIFPCMLHETPLRFGQKHSQTIMGYQMAIAYTGSTFLPPIL
GYAAAKSTIGIFPFVIAGFIAMMLWGSERLNGVLHIREIKKDTASVS
>PK3-045_01233 hypothetical protein
MKIEHVAIWVKDLEGMKTFYTTYFEGTANSKYQNIEKKFESYFISFKEGARLELMRKAGI
DKSDSDDRVGWAHIAISLGSKEAVNQLTERLQKDGFLLVNGPRLTGDGYYESVIEDPEGN
LIELTV
>PK3-045_01234 Maltose O-acetyltransferase
MRIEGNKKVKTEKEKMVNGDFYNPADPELMKDRNNARKLTRIFNESIETEDNIRSVLLKQ
LFGSTGTNIFIEPTFRCDYGYNIHVGENFFANFDCVFLDVCEIRIGDNCFIAPGVHIYTA
THPLNAQERIAGIEYGKPVNIGNNVWMGGRAVINPGVSIGNNVVVASGAVVTKDVPDNVV
IGGNPARILKKIVE
>PK3-045_01235 Sugar phosphatase YbiV
MIKLVLTDMDGTFLNNNGDFDPELFKEVKNLMKEKGVAFAPVTGKQCERVEELFGEDAKD
MWILGDSATRIKHNGKFVYESLISNELGQAIIQLLEEISLNHTIIACTRSGAVIKDSVIP
EEVAIVRKSYTQVRKVSDFKEITEDFVKITIHDSELKCFETIEKLSSFFESAYIVASEAA
WIDIANVNVHKGTTVEHLQQLLNVTPEETMAFGDSYNDIELMSRSIYSFAVRNAVKELKE
TANFITRSNEEDGVMRTIIQLLSLL
>PK3-045_01236 Transcriptional regulator KdgR
MEKTKPYGTVLLRAAKIMDYLSENPNQTLQNIAQNTEMTTSTTLKILDTLLLIGFVSRDK
NKNYRLGSKLIRYANQGVDQLDLVELTLPYLEKLQKLIDETIHLGVLVDNEILYVNKLEA
KHQTIRMSSRVGITRPLYSSAMGKAVLAELEEEEYLNYLKTTPLVPFTEHTITNSLKLAS
ELQKVGETGIAFDDEEMEKDIFCIGASLKKDGKIIGAFSVSMPKYRLTEELKKQIIKAIV
ETKNEIMQVVTH
>PK3-045_01237 KHG/KDPG aldolase
MKRVETLRRLKSAGVIAVVRGNSKEEAVKASNAVVQGGMKGIELTFTVPNADKAISELVE
LYQNDSNIVIGAGTVLDVVTARLAIMAGAEYIVSPNFDRETAELCNLYQTPYLPGCLTIT
EMKEALKAGVDIIKLFPGSAYGPSIVSAFKAPMPQVNIMPTGGVSLENMEDWFKAGVVAV
GVGGNLLAPVAKGDFTKVTEIASQYMEKFHQIKGA
>PK3-045_01238 2-dehydro-3-deoxygluconokinase
MGRVVTLGEIMLRLSTDSGVRIAQADNFCAHYGGGEANVAISLANFGHDVYFASKIPDNG
LGEGVVKHLNRYGVHTNFLLKGGSRLGTYYVEAGIGERAANVIYDRAGSSFAEMTESEWE
KEELFNNVDIFHISGITPALSSSWKKTTISLIEAAKEAGCKISFDINYRGKLWSQKEAGE
TISEILPLVDYCSAGKLDALYLLGIPEATEQENELVYYYQEIQKKFPAISVLYSTKRTVV
SASCNELIGTLWMDDHYYESQNHVINPIVDRVGAGDAFSGGVLHGILAQKSPQEMIDFAT
AASALKHTIHGDCNQFSEPEVNSFLLAGSGKINR
>PK3-045_01239 4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase 1
MQNMETRYTHSPEDIRHYSTEQLRKEFLVEKVFVPGEISLTYTHNDRMIFGGVTPTDKSL
EIILDKQLGVEYFLERRELGVINIGGPGYIEIDGEKEEMKKQDGYYIGKETRHVVFSSED
PNNPAKFYISSVPAHHKYPNVKISIDHIKPMETGEALTLNQRKIYQYIHPNVCESCQLQM
GYTILEPGSAWNTMPSHTHERRMEAYVYFDMEEDTRIFHMMGKPDETKHLVMSSEQAAIS
PSWSIHSGVGTSNYSFIWAMCGENITYTDMDMIPMDKLK
>PK3-045_01240 2-dehydro-3-deoxy-D-gluconate 5-dehydrogenase
MAFTMDKFRIDGKVALVTGAIYGIGFEIASALSKAGAKIVFNSLNQESVDQALQTYQEAG
IEAKGYVFDVTDEQAVQAAVVQIKEEVGPIDILVNNAGIIKRVPMVEMSVEDFRQVVDVD
LNGPFIVSKAVIPGMIQNGGGKIINICSMMSELGRETVSAYAAAKGGLKMLTKNIASEYG
EYNIQCNGIGPGYIATPQTAPLREKQADGSRHPFDQFIIGKTPAARWGNPEDLAGSAVFL
ASEASNFVNGHILYVDGGILAYIGKQP
>PK3-045_01241 hypothetical protein
MIHIGLTGWGDHPSLYGKNTSSQNKLMEYAGYFPTVEVDASFYAVQPVRNAESWVKKTPD
SFQFIVKAFQGMTGHNRGDIPFSSNGEMFAAFIDSLVPYRKSGKLAMVLFQFPPWFDCTK
DNVQYLRACRKRMEDIPCALEFRHQSWFDSKYRASTLQFMKEENWIHSICDEPQVMPVSI
PTVLEAVGEDKVLIRLHGRNYYGWQQNNNPNWREVRYLYRYNTAELSEWAENIRLLEKQC
KNIYVLFNNNSGGDAADNAREMIDLLKIEYTDLAPRQLDLF
>PK3-045_01242 Mannosylglucosyl-3-phosphoglycerate phosphatase
MEVIHIYHTNDLHSHFENWPRIYELLRERKKWHKEAGEAVYLFDIGDHLDLSHPYTEATK
GRINTQLLNEEHYDAVTIGNNEGITLSYEGLDHLYDEAKFDVIVANLYKHNGERPDWAIP
LQIFKTAKGTKIGVIGITAYFEKLYELLGWKLTDPIEELSKQLEKVRGKVDIIVLLSHLG
INDDEMIAANYPEIDVILGAHTHHIFHQGKIINNNLQGAAGKYGYYLGHIELKVNASKKI
IDKKAILYETSKLPIANKEEAIVENYYQQGKLALSEKAATIDEYLSREALAEMLCEKLIS
WCQSDCAIVNEGLILDGLQAGDITFFDLLSICPHPINPCNVTLTGAELKEIILEMRSDKW
ETMPVKGLGFRGTLMGKMIAAGITHEIIGEREQYYINAKEIQADQNYVVTVPDMFTFGNF
FPAIYRATKKDYFLPEFMRNILADTLQNRIKA
>PK3-045_01243 hypothetical protein
MIDVYPVDINGHTFIAVSVLLPKTTLLAVKNDKGYIMCGALDVALLNDKLKDRKIIAGRA
VGVKTIEQLLNAPLESVTMEAEAYGIHKGMIGREALLKMV
>PK3-045_01244 hypothetical protein
MRLVGTKNIKEGAILAKPILNDRGRVLINSGIRLEKKMIKRLLDFGISYVYLEDKHTKDI
KVNDAISEQVKMEAMQTIEKSFDMIKSADADDISMVMEKNTPIFKKLVEKVLLELKNHEH
LSSVMSDVYLYDNYIFSHSLNVTIYTLALGLELKLPPKQMEILGLGAILHDIGKMKVPLE
ILLKPGSLTAEEFEIIKSHAEAGFEMLRKVETLPLLVSHCAYQHHERLNGSGYPRGIEAK
DIHLFGKIIAVADVFDAITSNRVYHDALLPHEALEILYTGSGYLYDAKIVEAFRRAIVLY
PNGLSVMLSNGEKGIVCKQNKGMNERPIVRIVEREGKEIPPYDLNLKEDLSIVITQCDSL
QNPL
>PK3-045_01245 L-Ala--D-Glu endopeptidase
MHRLIFIIIILMFLLPNTVTFANEKMTDPYTKRMELYKKIEALYQIPWYYIAAVDQYERN
IRSSRKDIPKAKGYTGIYFTKEEWAGIINPNPEDNNPLTIPLFGGLGADGDGDGKADRFN
DEDILSAFSNYISQYGIDEDNFKIGLWNYYKRDKTVSIIMGKAAIYNHFGRLNLDDHAFP
LPLRSDHSYRSTWGDARGWGGKRIHEGTDIFADYGVPVKATSYGIVEMKGWNNYGGWRIG
IRDINNNYHYFAHLNGFSKEIQAGMVVEPGMIIGGVGSSGYGPPGTSGKFPPHLHYGIYK
DNGYTEWSYDPYAHLRLWERQEKIKSRKKK
>PK3-045_01246 Lipoyl synthase
MVSEKKQEYLRKPEWLKIKLNTNENYTGLKKMMKEKQLHTVCEEAKCPNIHECWAVRRTA
TFMILGAICTRACRFCAVKTGLPTELDWQEPERVADSVFAMNLKHVVITAVARDDLKDGG
AAVFAETVRAIRRKNPFTSIEVLPSDMGGVEENLRLLMDAKPDILNHNIETVERLTPRVR
ARAKYHRSLEFLRRAKEMQPNIPTKSSIMVGLGETKEEIIATMDDLRANNVDIMTIGQYL
QPTVKHLKVQKYYHPDEFKELKEIALSKGFSHCEAGPLVRSSYHADEQVNEAKKNQQMAE
HAKEA
>PK3-045_01247 putative protein YutD
MVCINNHCYELIEERKSGFNEEAFKNRYSDILTKYDYIVGDWGYGQLRLRGFFDDHNQKS
SFDTKISTLTEYLYEYCNFGCAYFVVKKTK
>PK3-045_01248 hypothetical protein
MKYQENICSRLFNWGKLLLPTELIKYFPPSFVIRDPIIHQVQKAMIRGYEVAVIVLDISN
LHRIKQQLKANDFLQYIRLLKKSFGKTIQLKASNEIIAIHDYNPNGLTMFMKWEQGSECL
PVLDGLIKDIIHNVENDFRKIGSIPPVFSTGYMFIENKYTYLSDAIQTAYELALAMAHKR
SDPEFNKLVYTLGNIVANKSIRLLAQPIMDVETNKIHACEMLTRGPEGTPLENPLQLFSL
ARQTKFLYDLEMIVLEKAFEQIQQTKWRHNIFINFTPVTIGNQRFIKDIKSVIRRYKEIS
PKKITIEITERDSFEGLEHFANNLKVLRMLGFLIAVDDTGAGYASLNSISEIMPDIIKID
RSVIQNIDKNSVKESMLQGLLLIAKEVGSVVVAEGIENAEEASILSKNKVDLAQGYFYAK
PTSLSNHLQIS
>PK3-045_01249 hypothetical protein
MYFVDREKIEEQLNYYHELINQFETQETWNTFLEKVALERLTHMMIEVILDVGNSMIDGF
IMRDPGSYDDIVDILIDEKVITMEIGNDIKELILWRKQLVHQYTNIDHKGLIAVFEAKLL
SIKAFAPSVKEYLIHELGPVSAFRN
>PK3-045_01250 Acid sugar phosphatase
MKAYKGYLIDLDGTMYRGTEVIEEAAEFVKRLIAAQIPYLYVTNNSTKTPEQVAQKLREF
QIPAKASEVFTSAMASANYIAEKSPGANVFMIGEKGLQQALEEKDLKLAEDSENVDYVVA
GLDQQITYEKLTVACLAVRNGSQFVITNGDTALPSERGLLPGNGALTSVISVSTQRQPVV
VGKPESIIVNQAIKLLDLPKKDVLMVGDNYQTDIMAGINAKMDTLLVHTGVTTKEQLSGY
SVKPTYTVDSLSDWDIKK
>PK3-045_01251 putative protein YpjQ
MSLKDLTEKTARKWLHERGVDIEDIAKLVYLLQEKYHKDLQMEDCIHNVERVLSKREVQN
AVITGIQLDVLAEKKLLESPLQEIVETDEGLYGVDEVLAFSIVNVYGSIGFTNYGYVDKL
KPGILQRLNDKSTGECHTFLDDIVGAIAAAASSRLAHRAKGEE
>PK3-045_01252 hypothetical protein
MIKKILSTKYGIDVEEETRVGHYEACISKGKLYTIVPVGNIEEEELTERDQIAAHIYQIG
DKHVSMLLESKEGNKHTEMNEQLYCVLLNDRLRPFQSRKLGRKLGKFHFRGRTVPFGVQK
ISRMGQWKSMWEQRLGQLEGFWNSMLYKQPESEFDQLFLESFPYYMGIAENAIQYLVDTE
LDDDPTAVDSGTICYNRFTKDTWAGEYYIKNPFDWVFDHCGRDLAEWTRDRYFRNIKTYH
REVKTFYEEYQSVMPLSSFAWRLIYARLLFPIHYVECIENYYSAIQEADRLFLEERLKKM
LSQSRDLELFLKEFFDNTEVAVKTLKIPIVSWL
>PK3-045_01253 Homoserine dehydrogenase
MEAISIGLLGLGTVGSGVVKIIENHQDKIMHQVGCPVKVKKILVKNVKKEREVEITDDIH
LTVEANDILDDPEIDVVIEVMGGIEETRNILLKALKNKKQVVTANKDLMAVHGAELLQAA
SQNNCDLFYEASVAGGIPILRGLVDGLASDRIIKLMGIVNGTTNFILTKMSQQQRPYEDV
LLEAQALGFAESDPTSDVEGLDAARKMTILATLGFSMNIGLEDVKVQGITNVTDDDIQYG
KQLGYTMKLIGIAQRQEEKVEVSVQPTFIVDSHPLAAVNNEYNAVYVYGEAVGETMFYGP
GAGSLPTATAVVSDLVNVLKNMRLGVNGKGAIAPQFKKKLKEPDEMFSKYFLRLQVVDEV
GVFAEITSIFSQHGVSFEKILQLPVKEKGLAEIVLVTHHASLLNYENILLELRDLSSVRT
VKSSYRVEGGTK
>PK3-045_01254 Threonine synthase
MRWKGLLEEYKEYLPINESTPMLTLNEGNTPLIKLEKLSEEWGVELFVKTEGTNPTGSFK
DRGMVMAVAKAKEEGNSTVICASTGNTSAAAAAYATRAGMRCIVVIPEGKIAMGKLAQAV
MYGAEIIAIEGNFDQALQMVRKISETEPVALVNSVNPYRLEGQKTAAFEVCDQLGEAPDI
LAIPVGNAGNISSYWKGFKEYHEKKQTGLPKIHGFEAAGAAAIVHNRVFENPETIATAIR
IGNPASWQLAVQAQEESKGIIDEVTDEEIIAAYRTIAAKEGVFAEPGSCASIAGVYKHIQ
NGKIPKGSRIVAILTGNGLKDPNTAIDVSPIKPVVLPNDEKAVANHIKGVVHI
>PK3-045_01255 Homoserine kinase
MNEGEMLLIKVPASTANLGPGFDSIGLALNLYLSLEVVQSDCWEVIPLTEELKEFPSDES
NFIIKTAIEVAESFHTILPPCQIKVDSNIPLARGLGSSASAIVAGIELADQVGNLQLTKQ
QKFAIASKMEGHPDNVGASIFGGLVVGCQLGEEVDAEIIHSIDLEVLAVIPEEELLTKSS
RGVLPNSLSFAEAVSAGAISNLLVAALLTGNSKLAGKMMKKDKYHQPYRKELVPHLEIME
EHACDLGAYGVALSGAGPTVLCFVEPGKMNTLIDGLAVKLPDMRFLPLEIDKKGSTCSGA
LATEVK
>PK3-045_01256 Fe/S biogenesis protein NfuA
MQEVEMKEQVQEVLDKLRPFLLRDGGDCELVDVEDGIVKLRLLGACGSCPSSTITLKAGI
ERALLEEVPGVYEVEQVF
>PK3-045_01257 hypothetical protein
MKKEIEVSIYGAEQICASCVNLPSSKDTYEWLQAALSRKFPEQTFQIKYYDIFQANYTED
KNKFCQKIIEEDLFYPVVVIEGEIVGEGNPKLKKIYAEFEKYGYTSA
>PK3-045_01258 NADH dehydrogenase-like protein YjlD
MKKLIILGGGYGGMRVLSSIIPHLPYNFMVILIDKVPFHFLKTEYYALAAGTVLDKSLQI
PFPKHPQVSMIQAEVEKIDLENNKVWLAGRNPIDYDDLIIGLGCEDNYHQVEGAKENTHS
IQTINKSKRTHKHLHSLPQGAKVAIIGGGLSGVELAAELAESSSLQITLLDRGNTILSSY
PKKVRNYVERWFTDKKVNLIKNSNITCIKKNTVYNHGSPHHYDCIIWTAGIQPNKIVREL
DVEKDKKGRIILSKHHHLPDNEHVFVVGDCASLSHPPSAQLAEGQAEQIAFVLISRWQGK
VLPNYMPPIKLKGVLGSLGKKAGFGLIAKTALTGRIPRLIKHGVLWKDKNNKNKLITSKR
K
>PK3-045_01259 hypothetical protein
MFKPLIEFCASNLASGAYEAKECLEQDDSLDVIDYGCLSYCGQCGDSLFALIDGEVVKGK
DTKELVENIYQHLKENPS
>PK3-045_01260 hypothetical protein
MNKIEPLFDKQCTCLLCQTKFTTKKLRSRFVKLKHLDTDFFPVYAEHNPLLYYINVCPAC
GFSFSDDTVSYFSPESKKILIEKVCSHWIPHSFGEERNIEDSIKTYKLAAYCASLRKDKH
IILAGLHLRIAWHYRMLNNQEQEKRFISLALAEYETSYSVGDYQGTPVSELRTIYLIADL
SKRTDNLEKATKFYSKVIEQQSRTVETQIVKLAKESWQELRDSQKTFI
>PK3-045_01261 Protein
MTEEIVHITEAAALQIKEMMKANDEEGSYLRVAVKGGGCSGLSYGMGFSPDKEENDQLFE
QYGIRVLVDQNDGPILKGTKIDYKQSLMGGGFTIDNPNAIASCGCGSSFRTAKVAGTPEE
C
>PK3-045_01262 Ferredoxin--NADP reductase 2
MEENQTIYDITVIGGGPVGMFTAFYGGMRQATVKIIESLPTLGGQLTALYPEKYIYDIAG
FPKIRAQELVDNLEEQMKKFEQSIVLEQAVQTVEKQGDGIFKITTDKEVHYSKTIIITAG
NGAFQPRKLELEQAKEYEGKNLHYFINDLNQFAGKRVMVFGGGDSAVDWALMLEPIADTV
YLAHRRDKFRAHEHSVENLKNSKVNIKTPYIPSELVGDEEIKQVILENVTTQEKEIIDVD
AVIVNYGFVSSLGPIKEWGFDIQKNSIVVNSKMETNIPGIYAAGDICTYDGKVKLIATGF
GEAPTAVNNAKTYMDPKARVQPLHSTSLFK
>PK3-045_01263 putative protein YuiC
MNFYKKFFRRVGMVLLFMAALLTTFQSISGVKASSINLGTNEHAQVSKNPDHIDHTIKQM
SVALKSFKKALAEKTQISSSKEVAGKPPSLENMKDWSQYPTKRVIATGYTAGYESTGKNP
GHPQFGITYSGVKVKRDLYSTIAADTSVFPIGTILFIPDYGFGVVADTGSAINGNRLDLY
YETVQDVYSQWGKKTIDVYIVEMGKGKLTEETLSALNEEESMQVFRQQYTKAENK
>PK3-045_01264 hypothetical protein
MELLANFPLLASLAAIFFAQFVKVPITYFVTKKIDWSLLTSTGGMPSSHSAAVTALSTGV
ALQTGFDSPIFAVAAIFAIITMFDATGVRRQAGEQAIVLNRLVNDFNKFLNEAKGWQNKP
EQEKRKELKELLGHKPIEVFFGGLTGIVLTLVLHMLIY
>PK3-045_01265 putative cytosol aminopeptidase
MFSYQKEWDFQNNHESIIIGLFDKSIKLEGQLQLLDEQFEGELTSLVKDGDISAKKKSVT
VIHTFGKIGAKRIIFVGLGKKKELSFDELKAIFGATFKRITSEKWVETAVYLDSFISEEN
DAQDVAHACSEAFGLATYEFSGYKQKSNEPEKKITEITVYSHAEQEEVLSSLTVGYVYGQ
ATNSARTLVNLPGNMLKAADLANYALELAEKYGFEAEILEREDMLKLGMGAMLAVNQGST
EPPKMIVLKYQGKDNWEDVIGLVGKGITFDTGGYSIKPKTGIVGMKTDMGGAAAVLGAME
IIGELRPEQNVVAVIPSTDNMISGNAFKPDDVITSMSGKTIEVLNTDAEGRLVLADAVTY
AKHHGADYLVDVATLTGGVITALGMETTGAMTNNESLFEQVLEASYEAGEQMWRLPIFES
HKKLVRNSPIADLNNSPGAAGHAIMGGAFIGEFAEETPWVHLDIAGTSTQSNPTDLGQPG
GTGAMTRTLALFVERFESTK
>PK3-045_01266 Poly(3-hydroxyalkanoate) polymerase subunit PhaC
MAKKSIAKFIHTLSYDPAVGQSEKYAIWKKNKATLWYYPSKERKYKESIFLIYSIVNKPY
ILDLGPSMSLIEAFNNAGYDTYLIDFGIPAYEDRHLTIDDYITKYIQPGFKRAMRHANSD
SFTVIGFCLGGTLASIFAALDNRYIKNLILAVSPINFSDFPDYDKWLNALRENELHLEEL
IDKMGIVPPESVKYGTRLLVAPLSFSHYLALLNRSGEDKYSEKWARMNKWTLDHIPVAGA
TFKQLMNDYVRDNKMIEGGLTINGEEVDLANIHSNLLVFSTKNDPLVPSSLCEPIMDLVS
SQDKSFVLFEGGHAGLVASSHMPEPMEKWLQAHSTPL
>PK3-045_01267 hypothetical protein
MAHVTIDFYELLKKGGTLLQYQLNNRIKKSLNQMSIIDFTTSKTNPLTNKIDRIQTYTEQ
LSNYMNLPTKTDLANATQLILQSEEKIDNLDDQLFELTTMMKEVKQLIEQLNMNPSDDYS
NQLTTIITEQEQRISTLQNELTQAKQQLDSQKDELSFSTFSNQAI
>PK3-045_01268 5-keto-D-gluconate 5-reductase
MNSLFDFTNKTAIISGGSRGLGEQMAKTLGEAGANIVICSRNLEQCTKTAAKLQDKGIKV
LALPCDVSKKEDIDHVISQTIAKFQTIDILINNSGTSWMAPFLDYPEEKWDKVLDVNLKG
SFLFSQAAAKKMVEQKKGKIINISSVTAFNGTPPHLLDAIAYNTSKGALITLTKELAIKL
ARYNIQVNAIAPGFFPTSITTSLEDYKKQITAGIPARRLGELSDLDGIILLLAGESSNYI
TGQTIAIDGGLSSSL
>PK3-045_01269 hypothetical protein
MTRIHNLELRKKREQRISDYKSSGQSQVKCCEDNGISYQQFGYWKKKIKDQSTEKINNSW
VPVIIEEPRTSPTRDISSSLL
>PK3-045_01270 hypothetical protein
MNEILYLALFLSFFIISLVSIIFLVVLFVKMVKWKKGKYLFPRKTFFYTLSFLVVTGILY
YNQYYNLDYLPSGEMNTNIVSPNGKYSIKTYHFTGIYGENAKAVLVDLNKNKEKTIYFNR
FDYDPYVEWVTNDQVVIGEEKLNIHKDTYDYRHDPNALRGLTRQRLEH
>PK3-045_01271 hypothetical protein
MKKIALALALMFGFLLLSTPALANNSNEVKTIEELHNMLLNKELISLNDDKKLIISQDAN
NLEIDSSLFDDYKKRIESANFAVGEGIAWYDENLQITFLPDEEITEKVYQNYQIEKSLGL
FGPISTMATVLDVKTMMDKNYRAVNSINTVGRVTIARAYWVGKVREGGAWDYKVVKGFSP
WYKTFSMVLPNGSTETHNSKWLGNYNYGYTGRVVFNKTVLLIGGDLVGLGKNQKPDDAQA
KDAIRRGYDHANSFQKK
>PK3-045_01272 hypothetical protein
MNKRIYLSIPYSEKEEVKSNGAKWDPKLKSWYIPEGVNLNDFQKWYLTINDIKANEYFIA
ETVIDCWKCKKRIPVFSIFLNEYYSLDTEDLERDWVWDKIEQPSFVSYIRFIDKQAAKHM
ENISEGYVNMDYSKMVGNGYLMNHCPFCEMKQGDFSLFEDNPGVGFCVSTLEQLNKMKFY
QIKESITLSGQTYMSF
>PK3-045_01273 hypothetical protein
MMRKLKIYMKNGEFVIEHVNSFGHSTKRFLSEEGTM
>PK3-045_01274 LexA repressor
MFLDKNTITEILRYIYDYSCTNGYPPTQKEIGDQIGVLAPSSVHKHLNYLIKHEFIKKNP
SKMRTIISRNLAI
>PK3-045_01275 hypothetical protein
MYGYPYQYQYPQQDSRAWFAAPFVGGLLGGVIGGALVRPRPFYGPVPYGPVPFGPAPFAP
GPYGPYPYY
>PK3-045_01276 hypothetical protein
MYHARYYHRKIPTLAAFHPYLHYPLYFRELPEANPSKLIDSAKDTLSLLPDVETCLKKLA
NSPDFSKNLMNAAQLSKTETVEQLIKSIGVKETPTVAYTPDGITLNFDHKNKPPYCCFLS
VQLRWR
>PK3-045_01277 hypothetical protein
MKNIREGLIPTVLGTAVTTAGIAMKKNRKVDSMISNTVFGFGLAHVVLGTIDLIEHRNKF
>PK3-045_01278 Na(+)/H(+) antiporter subunit G
MTETIISIIIAILILLGSLLSLVASIGVLRLPDVYTRSHAASKSATLGVMFILLGACLYF
FQSEQIFNSRLILAIAFIFLTSPVAGQLIIRSAYNRKIPMADETIRDDLKEARDAAAKSK
>PK3-045_01279 Na(+)/H(+) antiporter subunit F
MFQTIMHISLFIVSISTILFIYRVVKGPSTPDRVVALDAIGINLVAITAILSIVLKTSAF
LEVILLIGILAFIGTVAFSKYLEKGVIIENDRDNH
>PK3-045_01280 Na(+)/H(+) antiporter subunit E
MAFQLLLNFVISFIWMFLKGSFAPDTFLIGFIIGLILIFITRRFFSDKFYLYRVVSILKL
LGIFLRELVLSNIAVLKIILRPRLKVTPGIFALETDLRKDWEITILCNLITLTPGTLVVD
ISEDNKILYIHAMDISDKEAAISSIKNSFEKAIQEVSI
>PK3-045_01281 Na(+)/H(+) antiporter subunit D
MSNLILFPILIPLLTGIILIFFYKKTILQRIISLLSTSVSIIIVLFMIDKIKNEGIQTVN
LSNWDAPFGITIVADMVSALLVLTTNIIAFCCILYSFKGIDRERENYFYYAMIQFLLVGV
IGAFSTGDIFNLFVFFEVMLMASYVLLVLGNTKIQLRETVKYIIVNVVASALFVIAVAYF
YSVVGTLNMASISERISEVGGSGILTVIAVLFLIVFGLKGALFPLFFWLPGSYYAAPIPI
LALFGALLTKVGVYSIARTYSLFFYEDSYVFTLLGILSLLTIILGAIGAIAYNDVKKIII
YNIVTAIGVILYGFSIFNSTSLNGAIFYLLHDMIIKGALFLLIGIMIYITGTSNLKYMSG
LMKKYPLLTWTFFLAALSLAGIPPLSGFIGKLLIIQGAFEERNYMGSFIVVLSSLLVLLS
VIKIFVKGFWGEESDNITIKSIKTLLLPGCILVLLSCLIGIGTEMISPYISLAVESLLQP
ENYIHAVLKE
>PK3-045_01282 Na(+)/H(+) antiporter subunit C
MEFLMAFIIGILFMCATYLILSKSLLRIIIGTGLLSHGVHLLILTMGGLKKGAAPLLGQH
ADSYSDPLPQALILTAIVISFGVTSFLLVLAYRTYQELGTDNLEKLRGKKHE
>PK3-045_01283 Na(+)/H(+) antiporter subunit B
MKINNLVLQTITKVIVFLILLYAVDLFFAGHYTPGGGFIGGLMASGAIVLLLIAYDLKLV
KKIFPVNFIYVTAIGLLISTLTGMIGVLNDKPFLTHFFNKHAHLPLLGETSLHTAALFDL
GVFLVVVGVTMTIIQTIGEDD
>PK3-045_01284 Na(+)/H(+) antiporter subunit A
MSILHWVVLAPFLYTLLIPITFKFMKKIHTGWFVLPLPLLLFIYFCRNIGTTSNLHTKVE
SIPWIPSLGIDFAVKLDGLGMLFALLITGIGSLVILYSIYYLDKNKEKVNHFYVYLLLFM
GAMLGVVLSDNLIVLYMFWEITSISSFLLIGFWNNRSNSRYGAIKSMVVTVFGGLSLLAG
IVLLYLMTGSFTISEIITSVQQDSIMSHPLFILGMICILLGAFTKSAQFPFHIWLPDAME
APTPVSSYLHSATMVKAGIYLVARLSPVFAVSGYWLWIVSLVGIVTLIYGSFMAIKQVDL
KGLLAYSTISQLGMIMSLLGIGAAGVHYDNESVYYIATAAAIFHLVNHATFKGSLFMMVG
IVDHETGTRDIRRLGGLMKIMPITFAIALIGSLSMAGIPPFNGFLSKEMFFASMLNILDF
QMFNLDTWGVLLPVIAWVGSIFTFVYCMILVFKTFTGKYQPEKLSAKPHEAPMGMLISPI
ILVSLVVIFGLFPGLLTNTILSPAITSIYGGGVYDLHIYHWHGFEPELFMTIGVIVFGII
LYLTVGKWSVIYQAIPVIWNRIYDWLFGETENGFNKLTNRYMTGSLRTYLIYIFSFFILI
LSYTLFIKDGFTINTSRLAPIGGYEVVLSLVLVISTIAILFAKSRLTSIILLGAVGYTVS
LFYVVFRAPDLALTQLVIETVSVALFLLCFYHLPRNARKKESIPFKLSNAIISVLVGLVV
MIIAIASYSTKLFDSISQFYVENTYTKAAGENMVNVILVDFRGFDTLFEITVLAIAAIGI
YSMITLRMGGKKNENK
>PK3-045_01285 hypothetical protein
MHLKTKVYISICLFSLGLFVGILLDNFQKREFYSLEELLFIEEANSPFFDETMIPFQPRE
YIRIIAEE
>PK3-045_01286 DNA polymerase III PolC-type
MEKQQYLFIDFEFTMPEKSSKFKGFYPEIIEVGIVAVVGDTIREQFSSYVVPRKFSTLSR
RCKSFLHISQEQVNNGISLYDLMKKLEAICNGYQNIIVTWGNMDMKVLKDNCHKAQLPFI
LSCKEVDLSMEYKRFFGDKNQTGLWKAVREYGREGTGKHHRALDDALTTYHIFKLVEQDK
KYLGKSNQPTIGDLIDMSKLFNKFA
>PK3-045_01287 Kinase-associated lipoprotein B
MSELAIGSIVTAFYKTGKYIGEITEIRPQSYLVRVLAVLKHPMQGDLHQPKEAIVDIFHE
RKALSYREQMNAPKKMVKLYKEDSIPSYNDSLQTAIEKMRKELQEDDSAFAIQSLKNLEI
LNAEYYKIV
>PK3-045_01288 Superoxide dismutase-like protein YojM
MKKLSLLVLITIFLTGCAEGEVTKAEVEMFNDVGDSLGTIKLQEQADGVKLSLNLKGLTP
GIHGIHIHETNKCDAPDFQSAGNHFNPDNKEHGLLHPEGAHAGDLPNILVKEDGTAKAEL
MAPQVTLRDGKNSLFSKKGTSIVITEQQDDGMTQPAGDSGERIACGPIKKK
>PK3-045_01289 Divalent metal cation transporter MntH
MDRNRSLEKNHSKSAKSVFSEEVKGWKRILPFLGPAFIAAIAYIDPGNFATNIAAGSKYG
YLLLWVILFSNIMALIIQSLSAKLGIATGKNLAEVAREEFPKPVSIGLWIQGELVIMATD
LAEFIGAALGIYLLFGIPLLEASLIAAVGSFAILELQRRGYRSLEAGITGMLFIVVLSFI
VQMFFAKPDVPSLLHGLFTPQFDGLDSVILAAGILGATVMPHAIYLHSALTQNRIVGETD
KEKKQIFRFEFIDILIAMLIAGFINGAMLIVSSALFHKNGLFVEDLDVAFNYFGQLVNPI
SATLFGLGLLIAGLSSSSVGTMSGDVIMQGFIHFRIPLYVRRFITMVPPIAVIALGINPT
TALVISQVILSFGIGFALIPLIMFTSSKRIMGNLVNTKWITVISWVMAILIVALNIFILV
QTFQ
>PK3-045_01290 hypothetical protein
MKITPKVLLASILAGALLTACGNTDTEPKKEEKKAEQSADVVTTASIVNEADPLVKALSA
DGTWIVATLQDLKVDSDILVAGEFHDKNDAANPIYRKLALYTQDEDHNIIDSFTLTAPKM
TVQSENFKIQGGTFVGDVYVEANGFTVDATAKVDGNVYYKSDAFKSSAVIDGEVTGAQEV
K
>PK3-045_01291 Methionine-binding lipoprotein MetQ
MKKILIGILLLLSFTVLSACGQDKNNADTGEKKEINIGATSGPYADMVKKAIKPILEEKG
YKVEVTEFTDYVQPNKALADGSIDANLFQHKIYMESFAQQNNIKLSELISVPTAPMGIYS
NKFKSLEEIADGSTIAIPNDPTNAARAFLILEEAGLIEIDQAADPLTVSEKNVTKNIKNL
KFETIEAAQLPRAVDSVDLSAVPGNFALAAKMNLLDALKLENMLDQYRNRVVVNTKDIDA
PFAKDIKAAVESAEFEKVIDKEFKGFGKPEWMN
>PK3-045_01292 Methionine import system permease protein MetP
MPLSLDWNYLIELLPDLNSAFFETLYMVGISIVVAIIVGLPIGILLFVTDKGLFLENTLL
KNTVGFVVNMVRSIPFIILLIALLPLAKWITNTTIGPTAASVSLSVAAIPFFARIVEQAF
REIDKGVIEASVAIGASPWMIIWQVLIPEARPGIIQGITITIINLIAYSAMAGIVGGGGV
GDLAIQYGYYRYDNTVMITTVVVLICLVQIIQFFGDKISKTLDKR
>PK3-045_01293 Methionine import ATP-binding protein MetN
MIQVNDLVKIYKTKKEQVIGVDHVSLSIKKGEIFGIVGYSGAGKSSLLRCLNLLEKPTSG
EIIIDNISLTKLNQKQLRAARLKIGMIFQHFYLVSSKTVYENIAFALKAANLPSKKIHKR
VLELLDMVGLADKKDVFPAQLSGGQKQRVGIARALANNPTVLLCDEATSALDPTTTKSIL
ALLKKINKELGLTIVLITHEMEVVKDICDRMAVMEAGKVVEEGSVYDMFANPKQELTKNF
VNSILQFELPNHLLEERKGKIIKVTFQGAIAEEGIISDAFQHYQVKGNILHGKIEYIQNN
PLGIFIMELTGEENEIVKAIQYIKDRTQNVEVIYHAS
>PK3-045_01295 hypothetical protein
MNSQEINFECVRLLNEWDPFSIGEGNYDTEIADILQAMHDVDLEDDLAASIQAIFEFSFE
EKLPLEDCMAISRKLLSLKRNSSCSF
>PK3-045_01296 hypothetical protein
MKLTNKEIEIAEILEKDARISDEDIAKMIGEDLEKTKEMIAKLEEVNVVVRYTSIVDWSK
VEGHEGVTAMIDVKVTPKRGVGFDEVAQRIYRFKEVKSLYLMSGAYDLSVIIEGKSMNEV
ARFVSEKLSTLDSVISTTTHFILKQYKHDGTIFEPSDEDKRIVVSP
>PK3-045_01297 putative N-acetyl-LL-diaminopimelate aminotransferase
MKQTKSYIAQKVEEMKPSGIRRFFDLASGMEGVISLGVGEPDFVTSWSTREAAILSLEQG
YTSYTANPGLIELREEISHYMQKRFAVSYKPSSEIIVTVGASQAIDIALRAILNQGEEVI
VVEPCFVSYAPLVTLAGGVPIAVQSLKENDFKIKPFQLEEVITERTKAIMICSPNNPTGS
TLSQEELAAIVAVAEKHDLLILSDEIYAELCYDDEYTSTAAIEGAWKRTILLSGFSKGFA
MTGWRLGFVCGPEELIQAMLKIHQYSLMCAPTMAQYAGLEALRSGENDVEEMKKSYRRRR
NFIVQSLNDMGLTCHIPGGAFYAFPNITATKMNAETFAERLLMEEKVAVVPGSVFGESGE
GHVRCSYATSLQQLQEAMKRMKRFVEKYSK
>PK3-045_01298 General stress protein 13
MSDKIEVGSVIKGKVTGIQPYGAFVSLDENTQGLVHISEVTHGYVKDINEFLKVGDEVNV
KVLSIDENAGKIGLSIRATEEAPAQPEAAKAKKPRPKRQTAAVVETENVQGFNTLKDKLQ
EWIDQSNRDDLIKK
>PK3-045_01299 Ornithine aminotransferase
MVHEVNKSISLMEQSEKYGAKNYNPLPIVISEAEGVWITDPEGNKYMDMLSAYSALNQGH
RHPKIIQALKRQADRVTLTSRAFHHDQLGPWYEKISSLTKKEMILPMNTGAEAVETAIKA
ARRWGYDRKGIEKDKAELIVCEGNFHGRTLGAVSLSSDEEYKRGFGPLLPGVKTIPYGDI
DQLQEAITVNTAAFIVEPIQGEAGIIIPPQGFMEEAYQLCKANNVLFIADEIQTGLSRTG
KLFASEWYGIVPDMYILGKALGGGVFPISGVVADKDVLGVFNPGSHGSTFGGNPMACAVS
IAAIDVIIEEDLTNRSAQLGEYFLQKLSEVTNPIIKEIRGRGLFIGVELKVEARAYCEKL
KEVGLLCKETHDSVIRFAPPLTITKEELDWAIERIKQVLNEDSPGLN
>PK3-045_01300 hypothetical protein
MSVIQRIALILTIIGAINWGLIGFFQFDLVATLFGGQGSVISRIIYGLVGIAGLINLGLL
FKPFSAAERESMPKTAR
>PK3-045_01301 Long-chain-alcohol dehydrogenase 2
MENFIFYNPTKLIFGKGQLAQLKDQLASYGKKILLVYGGGSIKRNGLYDNVMTILKENGK
EVFELSGVEPNPRLTTVQRGVDICKTEGIDFILAVGGGSVIDCTKAIAAGAKFDGNPWEF
ITKKAAPKAALPFGTVLTLAATGSEMNSGSVITNWETQEKVGWGSPFTFPVFSILDPENT
YTVPKDQTIYGIVDMMSHVFEHYFHLEEHTELQDYMCESVLKTVIEFGPKLVNDLENYEY
RAAILYCGTMALNGMLNMGYRGDWATHNIEHAVSAVYDIPHGGGLAILFPNWMKHNLAVK
PERFKQLAVRVFGVDPEGKTAEEAGLEGIEKLRAFWNELGAPSRLADYDIDDSKLELMVE
KAMTNGGFGQFKMLDAEDVLAIYKASL
>PK3-045_01302 Glucose-6-phosphate isomerase
MTHVRFDYSKALSFFGEHEITYLEDAVKVAHHSLHEKTGQGSDFLGWIDLPVDYDKEEFA
RIQKAAEKIKSDSEVLLVIGIGGSYLGARAAIEMLNHSFYNSLSKEKRQTPQIIFIGKDI
SSTYMSDVIDFLGDKDFSINVISKSGTTTEPAIAFRIFRKLLEQKYGVEEARKRIYATTD
KARGALKTLATEEGYESFIIPDDVGGRYSVLTPVGLLPIAVSGADITAMMEGAAAARTDF
GTSELKNNIAYQYAAVRNVLYNKGKTIEMLINYEPGLQYFSEWWKQLFGESEGKDQKGIY
PSSANFSTDLHSLGQYVQEGRRDIFETIVKVDKPRHELVIEAEENDLDGLNYLAGQTVDF
VNNKAFEGTLLAHTDGGVPNLVVTIPEMNEYTFGYLVYFFEKACAISGYLLGVNPFDQPG
VEAYKVNMFALLGKPGFEEKKAELESRL
>PK3-045_01303 putative cysteine-rich protein YhjQ
MLVEKEQLLIKSLQECMIVCNHCLNECLAEERVAPMLDCIHMNRECIQFCSYLEQAIIRK
SPYAKEFAEICLSVCEDCANECKKHDHRHCHYCAEICKECIEACKIFLES
>PK3-045_01304 hypothetical protein
MPNSILSRFLRLPLSIRVLSISLTIIILFGCFITLVEPETFPTLFEGIWWAIITTSTVGY
GDYAPITVIGRITGMLLILTGVGFLSTYLVTLATAAVAKQNAYLEGKTTYRGQNHLIIVG
WNERSKLIIHSIIKDREKIPITLIDESLATNPVPETIHFVKGNSNLDHVLLKANIMTASK
VILTADQTKEELQADMHSILTLLAIKGLNAKVPCIVEILTAEQIQNAKRAGADEIIETNS
LTSFVMHNSLNSQDTMIAFLELLHQLKDKKLQFIPLKNIQEELVDYLTLNNFLLAEGKLL
LGVKRGGTSYLNPKPSFEFEEKDELIIIT
>PK3-045_01305 hypothetical protein
MKEKEKIIIDSAIKFFAQKGFSSTSVQEIASDCGISKGAFYLYFKSKDSLLYTIMQYYYD
ELITAMEEISQKRIPAREKYMDQLTFMFNHALKHKEFIIMQSKEQAIPLNNSIKDLLVKM
QSELQSYNLKGLHSIYGEEKKQYLLDLLMIQDGLIHSFLKLVILEPINVSTRDISIYLLK
RLDSIITDMDKNNENPLFSTSFLKYIIKKPKINFMEHGHQDILDAIASIQRKSEHVANKQ
EIEITLEVLMTEIHADEPRLPIIKGMLSNLNDYKNFEEEQKTIASFYHIQL
>PK3-045_01306 Riboflavin biosynthesis protein
MDQNVIDLLQNKMEIIAFNEEQNLSLVGPVKLPVQLDDQVVTFQWYTWLPIKKDETKEEV
LRSLPNLHLADYQQSSVLVYGDFKNAENALIRMHSICHTGDIFGSKRCDCGYQLKESMRM
IVENGNGALFYLANHEGRGIGLFTKSLAYLLQENGLDTVEANLALDFPDDLRSYEAPIKV
LQALRQKPVKLITNNPKKLDALKKLGLTAEENIPLWGDVSSYNENYLNTKVNKSGHIPLK
NTVTI
>PK3-045_01307 Riboflavin biosynthesis protein RibD
MKHDQDYMRLALDLAASALGKTNPNPVVGAVIVKDGVIVGTGLHRKAGEPHAEVHAFKMA
GDHAKDATLYVTLEPCSHYGKTPPCALLVKDSGVKRVVVATEDPNSQVAGRGINILREAG
IDVEVGVLKKEAQQLNERFIHNMIHEKPFVISKVAMTLDGKIATHTGHSQWITGEEARKE
VHFLRNEVDAILVGVGTVLADNPKLTTRLEGPAKNPIRIILDANLRTPLEANITDCREAK
TIIATSATLQSEKAAALKEKGVELFTVPSIQGKLDLEIVLKEIYKRGITDILLEGGSEVN
ASFMRQRLIQKYLVYIAPKIVGGANSYTPFKGEDIDTVDEAVPLRFEKTEWVGKDMKITA
YPDIIN
>PK3-045_01308 hypothetical protein
MKFGFDIDDTLINLRQHAFELYNHKLQKNIALENFHALKTVEIHEPFGLNATEGKQLWNT
LREEIYFTNCPPFPDSIEVLNELVSNGHDVYYITARKKQFAEKTKDWMKKVGFPVIDSHF
FCGMEDHEKVCIIQELQLNYYFDDKPAVLETLQGSPTRLYVKDHPYNQHLELNRIKDWKQ
LRALYESK
>PK3-045_01309 putative chromate transport protein
MIFVSIFLSFLVANLLGYGGGPASIPLMYEEIVNRYNWLSNIEFSNMLAFANALPGPIAT
KIAAYVGFGVGGWAGFIVALLATILPSAVALIFLLKLMKKHQNSKIVKGMTLLVQPVITA
LMLVLTYEMFQDSYHSIGIIQSVCIAVIAFLLLQKWKVHPALVIIIAFLYGGFIAPHIS
>PK3-045_01310 Chromate transport protein
MYKDLILGMLRAGIFGFGGGPSVIPLFRHEAVTKYKWMANDEFGDALAIANTLPGPIATK
LAAYIGYHQKGIIGAIVSVIAHILPTCLAMVFLFSFISILSHSPIITSMIGAVVPVIAVM
LGLMAYEFGEKAVKGLGIYAGIGLTLVCLLLLQVFAIHPGIVVLIFLIYGAFHFKLKDKL
LHKKERGI
>PK3-045_01311 Adenine deaminase
MRAKLEKRIRIAAKKEPADIVITNGKIVNVFTGELMDGDVAIADDRIAGIGSYQGKQIID
AEGKYIVPGLIDGHVHIESSMLTPQEFTKILLLHGVTTVITDPHEIANVAGAAGIQYMLD
ASEDLPIDIRVMLPSCVPAVPEDSNGATLYAKDLAPFYSHDRVLGLAEIMDFPSVYETQS
DMIDKFILTKKHNRLMDGHAAGIEREKLNVYSAAEIRNDHEATTLQEAKDRLDLGMYLMI
REGTVAKDLKALLPAITLRNSRRCLFVTDDKLVDDLVEEGSVNYSVRLAIEEGLDPIIAI
QMATINAAECFQLDSIGAVSPGYRADLLLLDNLEEFSIHSVYRNGQCVVEKGKLRREVQH
FKSSYLDTNLPTINCAKLSSADLKLPLTSESCHIIEIIPNSIVTKEVIEKVQMVDGYFQP
SLEKDQLKLVVVERHHQTGNIGKAIVKGFGFKKGAIATTISHDSHNIVAVGTNDQDLLSA
IHELQEIKGGIVVVSEGKVVAALPLPIAGLISDQDYLTVYEQLKILNHKVQILQGYDTFN
PFLTLSFLSLTVIPALKLTDKGLFDFQSFSYKDVSLNL
>PK3-045_01312 hypothetical protein
MEEQTNFFNGLKWGVIISIPLWVSFFGWLKLLINFT
>PK3-045_01313 hypothetical protein
MKKLVWSLLAVVLIVSFQVKPAQAAYLPEYDKYIEVSYDQARQIADALGLKNVPLGEQTA
QISFDVQEKVIAKIEKILGKEIDRYYIWLTVDGEKVLGIDPPLPQA
>PK3-045_01314 hypothetical protein
MGIMNAGEFIETVYFKGLQISLMAAGDGTEVIYHRLQPGSSWAMTPEDNWDGFEYFYILS
GKLSHRTDENIIEMKAGQAFFESPIQKYSIFTAEEITEFIYITSQPVFHYYSQCSKDLME
LAISIEEKDGYTVDHCERIKNYSMLVGEALNLNRKQITRLNLASFFHDVGKVRVPLEILQ
KPTKLTEEEWEIMKKHTTFGRDLLEETKIPVLCEVGLIVEQHHERYDGKGYPKGLKEDEI
TIESAIISVVDSFDAMTTDRVYKKGKSAEEAFQEILNNRGTMYHPKVVDTFIALKEEIIK
YEKGESL
>PK3-045_01315 Glucose starvation-inducible protein B
MADNKMSREEAGRKGGEATSKNHDKDFYQEIGQKGGQATSENHDKEFYQEIGKKGGETTS
ENHDKEFYQEIGKKGGETTSENHDKEFYQEIGKKGGEATSENHDKEFYQEIGRKGGNSRN
DNN
>PK3-045_01316 hypothetical protein
MKVTREKFMNVVKVAEELGCKVAYDSTKKISFNTNMYITVPYQFSLENIYALAHEIGHVI
DYVNGDLDHDKWLHDWSYRVNAEMSAWVHAYKILEKNAVPLHHWQTHVNAKLANYFILPE
VI
>PK3-045_01317 FMN reductase [NAD(P)H]
MNEIIQHLKKHRSYRKYQDKEISLETLHSIIEAAQSAPSWTNGQHVTAIFVRDGDRKRHL
AELCGNQKHVENAPVFLIFCADFYRAKLASEMEGRAFKAIEDVDTLLIGATDVGLAMQNA
ITAAESLGLGTVPIGGIRRNSLQVIDFLQLPSYVIPIAGLCLGYPDGDPGLKPRLPLEAV
LHEEKYDRNQQELLEKYNETYSEYLKNRGETPAGWTNRIANFYDKSYYPSNAKMIKQQGF
LAKDMQDNN
>PK3-045_01318 Levodione reductase
MNDLENKVAIITGAASGIGKAAAISLANKGMKVALVDLNADDLEEVKATINKKGQEAISL
EANVAEPPSIQQAIEETVKKWNRIDTVFINAGINGAVSSIEDLTPSEWDTTIETNLKSTF
LTVKYSIPHMKTHGGSIIITSSINGNRIFKNFGMSAYSTSKAGQVAFGKMAALELAQYKI
RVNMICPGAIDTNIEKNTFKDEEHLKEITIPVEYPDGNQPLAQQSGSAQQVADLVYFLSS
DLSNHITGTEVYIDGAESLL
>PK3-045_01319 hypothetical protein
MKAMIIEAFGDSTVFKLKEIETLDLLPDQVRIKVKATSVNPIDLKVRGGAVPGVSPAFPA
ILHGDVAGVIEEVGEAVPSFQIGDEVYGCAGGFKGMQGALAEYMIADIDS
>PK3-045_01320 2-haloacrylate reductase
MEEAAAIPLVGITAWESLFTKGCLKKGDKILVHGGAGGVGHIAIQLAKWVGAVVSTTVST
MEKQAIVKKIGADHIINYREVSVKEYVDKYTAGKGYPLIFDTVGGRNLDHSFEAAALNGS
VLTIAARSTHDLTPLHSKGLSLHVTFMLLKMLNEDSRIEHGNILRNITKIVEENKLKPFL
DKKTFSFEEISKAHEYLESGNAIGKVVLVNKW
>PK3-045_01321 Small, acid-soluble spore protein Tlp
MSYQKPNPDNRSDNVEKLQDMVQNTLENIDKAEETLVNASSDEKEMIQQKNKRREAAVQS
FREEIQDEASDRENGYQ
>PK3-045_01322 3-oxoacyl-[acyl-carrier-protein] synthase 2
MKAVITGMGIIGAGFSNIVEFMTVLQSNKSMLKQEKYEGKYIYTGRVKEEQINKVHKRQE
KMSKPVRMILHACKEAIEQANISVRDYRTAVIVGSSAGGLAEISKATFSLEKGKRLSPYT
IGNMNANSLSSSISAYLQLNGIALSLANSCTSGIDALNLARILIESNQIDVCIVGASDES
ICDPIIKGFLPHRVLQAGNKPQPSFGPFSGGKGFSISEGAGVLIVENEQVAIQRHASILG
KVEATSVTQDAISPFQSDSTGLLMEKAVAECLQENMPTYINSQALGIMENDHIEIGVYKR
FFEGSKIPITSIKGTVGHAMGVSPLFQIIASLISIKKSFIPATISQEINDYYRDYPIVTQ
LITEDVDRVLVTAHGYGGNNGCAMITKGGA
>PK3-045_01323 Sensor histidine kinase RcsC
MEAILLLMVSLVPLIISVTIIFYSQSQLTKALSLFLCMLSFWQMDIAVLYAGDFLSQGTI
ELLFKIFRLGTICIMPVMYYFSYYLVSEHKEFKRFRVLFNKPFLYVLILYSLFAYFINFT
SLGVKDFIIMDGNLLSSKYILPIYGKWNVLFILNIVLLYLNTIILLVISFKIRDPIYKSF
YIKFVIAVLIIYINGVFSGFIFIPLFFSSFNSLIAAVILFLSFFQMQSTHLNNMNAELSR
QSELLEAIMDINPNYLLVKNKKEQIVKMNPSFLELLSLENNNWLGRPFSYIEKRINMETD
EPHRFVDSSGKNYFITWGKKELIHSTGEEYHIYFGHDITDQKHNEQLMISSEKLKVVGEM
AASVAHEIRNPLTTIRGFIQLLKEKNDASGYETILLDEIDRINEVLKELLILSKPEAKAN
DNNALPSTKVFLELKNLKVLFHALANEQNKEIILENRENKELIASIDNSQFKQVLLNILK
NSIEAVAPQTGKVKAILDQKDDFCRIRIIDNGDGISKERLARIGEPYYTSKEKGTGIGLT
ICLKLLKQNKGDMVVKSKEGWGTAVTIVLPCFL
>PK3-045_01324 Carboxynorspermidine/carboxyspermidine decarboxylase
MKKIDFTQAPSPSYVVDERLLTRNLEILQSVQERTGAKILLALKGFSMHSVFPLVGKYLA
GVTSSSLFEARLGYEKMGKEVHAYAPAYAESEFDELLQYTDHIVFNSHSQWNRFKDKVQN
AEKKIDVGLRINPEYSEIETQLYNPCAPYSRFGITLDNFNPEELDGIDGLHFHTMCEQNS
DTLKRTIKVVDEKFGEYIKKMKWINFGGGHHITRPDYDIETLVESILFIKEKYNVDVYLE
PGEAIALNTGYLVSTVLDIVHNGMDIAILDTSATCHMPDVLEMPYRPNIIDAGEPGENEY
TYRLGGMTCLAGDVIGDYSFKEPLKPGDKIVFCDMAHYTMVKNHMFNGVNLPSIASYNEE
EGLKVIRQFVFEDYSNRLS
>PK3-045_01325 Carboxynorspermidine synthase
MLGKALIIGAGGVASVVAHKCCQVPDVFEEICIASRTLSKCEAIKDKIDGGKTKVSVAQV
DADKTEEVIELINSFKPEIVINVALPYQDLTIMDACLATGVHYLDTANYEPPETAKFEYK
WQWEYKQKFEEAGLTALLGSGFDPGVTGVFTAYAQKHHFDEINYIDIVDANGGDHGYPFA
TNFNPEINIREITANGRYWENGKWIETPPLSEKREYDLDQIGPKNIYLLYHEELESLAVN
IKGLKRIRFWMTFSDNYLNHLKVLENVGMTSIEPINYEGKEIIPLQFLKEILPDPASLGP
RTKGKTNIGCIIQGTKDGKPKTYYVYNICDHQECYREVGSQAISYTTGVPAMIGAMLIMK
GQWKRPGVYNVEEFDPDPFMDALNKYGLPWQENFSPTLID
>PK3-045_01327 Protein SapB
MDINIDFLLKIGISAGLGLIIGLEREIKRKPVGLKTSLVISIVSCLLTIISIEAAYKFPG
SDQVNIQMDPLRLPAQIVSGIGFLGAGVILRRGNDSISGLTTAALIWGAGGIGIAVGAGY
YVEALIGVALLLISVKFIPIFMSMIGPRQLREKEIKVKLKADQKENVSTIIKAIRNLRTG
IKHIRIKDLETGEHSIYLIIIVDQKREITDVYRDISEIHGVKEIEIESLN
>PK3-045_01352 1,4-alpha-glucan branching enzyme GlgB
METVYPTEFQLHLFHEGNLFESYRLFGSHIHHKNGEIYTSFCVWAPNALSIQLVGDFNNW
NGEGYSLEKINKEGVWLLNVERDLTGVMYKYKITAPDGRVFLKADPYAFLSEVRPNTASI
VYSLEGYKWNDTKWKQKKTKKNYLNEPLAIYEVHLGSWKIHEDGDLYTYRELADELIPYV
VEQGFTHLEVLPLVEHPLDISWGYQGTGYYSATSRFGEPKDLMYFIDQCHQHGLGVILDW
VPGHFCKDEHGLYQFDGTSQYDYKNPVDRENYVWGTANFDLGKNEVQSFLISNAIFWMEY
FHVDGFRVDAVSNIIYWPNSNENSVNQFGIDFLQKLNQTVCQYDPTVLMFAEDSTDWPQV
TAPVHYGGIGFHYKWNMGWMNDILTYMETDSVNRKQVHDKVSFSLHYAFSENFVLPFSHD
EVVHGKKSLVDKMPGDYWQKFAQFRLLLGYMMAHPGKKLLFMGNEFAHFAEWKDKEQLDW
MLLDYEMHQKANEYMKELLKIYKRSKPLYQLDHINDGFDWIDVNNREQSIFSFIRKAEKE
EDYLVVICNFTYHTYENYRVGVPLNNSFREILNSDTDRFGGANYINKKVIKAEKVEFHGK
PYSVQLTIPAFSIIILRPVQHRKGRKGNGKETVRRNAISRRKGE
>PK3-045_01353 Glucose-1-phosphate adenylyltransferase
MGKKRCVAMLLAGGKGSRLYSLTKSLAKPAIPFGGKYRIIDFTLSNCSNSGIETVGVLTQ
YQPLVLNSYIGIGSAWDLDRVNGGVTVLPPYSESSEVKWYTGTASAIYQNQNYLSQYDPE
YVLILSGDHIYKMNYEEMLEYHIDKKADASISVIQVPWEEASRFGIMNTNKEMNIVEFEE
KPKHPKNNLASMGIYIFKWRVLKELLVEDNLNKNSSHDFGKDIIPLLIEKQKKVVAYPFK
GYWKDVGTVQSLWEANMDLLDDNCELNISDYNWRIYTVNPNHPPQYISSDAHVKESMVNE
GCIISGNLEKTIVFQGVTVGEGTIIRSSVIMPDAKIGNNVYIEKAIVPSDITIPDGMVIK
PKKDSNEVVLVTEEMVNEVIS
>PK3-045_01354 Glycogen biosynthesis protein GlgD
MIRSMLGIIDATTHKEDLEELTSHRTLAALPIGGRYRLIDFVLSNMVNSGIGSVAIFPKY
QYRSLMDHLGSGKNWDLDRKRDGLFFFPASLTETNTDGIGSFNHFAANMDYFQRSKQEYA
LVANCFTVFNMNFNPVLERHLSSGCDITEITNNGSSLEIYLIKKSKLIDLIETRAVTGYT
CMNDVVLDMNNQLKICEYEYNGYAEKIDSISSYFHVSKDILKAKVWNQLFIKERPIFTKV
KDEPPTRYTSTGEVKNSMIANGCFIEGDITNSVISRAVKVGKGSSLKNCIIMQKCTIGEN
CDLDSVILDKDVVVESGTVMIGTASSPFVVRKGTVQGALMNS
>PK3-045_01355 Glycogen synthase
MRVLFAVSECVPFIKSGGLADVAGSLPKELKKQGTDVAVIMPKYQDIPAHLLANVKKRCY
FFVQVGWRNQYCGIEELEVDGITFYFIDNEWYFKRSGLYGYGDDGERFAFFNRAVLESLP
YLADYPDIIHCHDWHTAMIPFLLDVDYKWKKEYSNIKTVFTIHNLQFQGILPREVLGDLF
NLNDYYFTTNNLEFYGNVNLMKGGLIAADKITTVSPTYKNEIQTEYYGEKLNNVLKQREP
DLYGIINGIDEETYNPETDPVIAANYTVTSLDKKQENKRFIQQKFGLKEDLEIPIICMIT
RLTSQKGLELVRHIFHEIMEEDVQFLVLGTGDPEFENFFREMEYTYSDKCKAYIGFDENL
AHQLYAGADLFLMPSKFEPCGLGQLIALRYGNIPIVRETGGLNDTVFSYNEWTEEGNGFS
FTNFNAHDMLYTIRRGIHFYKEEKEVWHKLMKNAMSMDNSWAQSAFKYNQLYAELISRSE
SHVF
>PK3-045_01356 Glycogen phosphorylase
MFSNKERFKRYFLQRLEMTYGKTFEDTTSSDHFQTLGHMIREYVSSNWIQTNEQSRNNNG
KQVYYLSIEFLLGRLLHNNLINLGIDQVVIEGLGDLGINFFEVEDMEHDAGLGNGGLGRL
AACFLDSLATLDLPGHGMGIRYKHGLFEQRIVDGYQLELPEQWLKQGQVWEVRKEDLAVD
IYFWGNIDMYEKNGKLQFRHLNAETVTAVPHDVPVIGYHTTTVNTLRLWNAEPSSLVAKD
VKDIMRYKRETESISGFLYPDDSNDEGKILRLKQQYFLVSASLQSIIRNYKQQYKNISEM
HHYISIHVNDTHPVLAIPELMRILMDEEGLGWDEAWKITTNTISYTNHTTLSEALEQWPI
YIFQPLLPRIYMIIDEINERFCMELWKKYPGDFLKIEKMAIIAHGMIKMAHLALVGSYSV
NGVAEIHTEILKKREMADFFTFYPEKFNNKTNGITHRRWLIKANPKLTNLISNTIGDKWV
DQPELLRELLNYQEDANLQENLAVIKQSNKERLAKIIKEKNGILVDPSSIFDVQVKRLHA
YKRQLLNILHIMFLYNKLREDPSIDMEPRTFIFGAKASPGYYYAKKIIKLINTVAHKVNN
DKRIQNKLKVVFIENYRVSLAEHIFPAADVSEQISTASKEASGTGNMKFMMNGALTLGTM
DGANIEMHELVGDDNIFIFGMNADQVLELYQNGGYSSREYFYHDDRIHEVVNQLKNGFYD
HPVGEFDPIFDSLLIENDQFFVLKDFNSYASIHEKVNQTFKNKRGWLRKSIVNIAMSGHF
SSDRTIKEYAEDIWRIKPYS
>PK3-045_01357 RNA polymerase-binding transcription factor DksA
MLSTEQINHLKKELEDRKATLLDRTNGYASEENALESVGELSSYDNHPADLGTELYEREK
DSALEQHDQSELQKINSALKAIEDGSYGICKVSGKEIPYERLEAIPTALTLKEYSDEQTI
PNDRPIEEDILELAHGNEFRHYDTGDVRDYDDSFQEVARYGTSETPSDLRGDFEDYDSLY
DRENDDDTFPEDYENFTATNIDGTERAVYPSKDQEKYEQALDEEGIEAPFGDVPYHKSDG
YIEEDTEDEEE
>PK3-045_01358 Salicylate biosynthesis isochorismate synthase
MNDSKGIMVQTIIKESDSPTILVSEVKKLEKKIDILEFFSNYSSYKGKRFFWKDPSEKNM
LVGIGICEGIEYSLGENSYSFVEKKWRQLLDDAIVFNKYNEIGIGPVLLGGFSFDPLKEK
THVWDGFGEAHFYVPQFMLSEINGSQFITTNIMIPSDKQDHAKAELKKHSIVYRRAEASP
PSLPLIEMITEIDQETWKNKVNKVINELNEDLKKVVLARASQVHFSNDVETEFVLKNLIQ
QQSNGYIFALEAKNKCFIGASPERLVKKEGPTVFSTCLAGSIARGKNKEEDDALAQALLS
DSKNREEHNYVVKMIKNAMEEVCSTVEMPLNPQILKMRDIQHLYTPVSGKVKETESLISF
IRLLHPTPALGGFPREEALKVIREVEGLDRGMYGAPIGWLDYQGNGEFAVSIRSGLIDGN
VATIIAGCGIVADSDPESEYIETAIKFKPMLTALGGK
>PK3-045_01359 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase
MSHQQQLTAYLDALISELVKNGVEHAVISPGSRSTPISLLLAEEEDIKLHVHIDERSAAF
FALGIAKASKKPTVLVCTSGTAAANYFPAIVEAKISRIPLIVLTADRPHELRDVGAPQAI
DQLDLYGKHVKWFMEMSTPDNSPGMIRYAKTVGARAVAMAKQHPSGPVHVNIPLREPLIP
DLDNLEHYRREDQESRSIQIKTGEFTIDDSYFHDLAASLEAKGERKGIIICGEMDKENFS
LKILQLAEKTGFPIIADPLSQLRSKSADMEVVIDTYDTFLRNERIKSLLKPDIVIRFGSM
PISKPLTIFLRENERAKQIVIDGGSGYRDPNQLTTEMVYCEEGYFCEKLTSFVSPCSINH
YLNKWIEINEITKKELTKTAEIQEMSEAKLFHCLGEMIPNDAVLFVGNSMPIRDLDTFFH
KQNKKVTIIANRGANGIDGTISTALGVGVIKQPLFLIVGDLTFFHDLNGLILSELYQLPI
TVILINNNGGGIFSFLPQVELPRHFELLFGTPLNIDFKHAVEMYKGQYKLVNSWDNLQTL
FQDSDFTKGLRVWEIQTNRENNLLEHRQMTNRILKVLDQLD
>PK3-045_01360 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase
MFIKLKDISYHVTVEGEGEPLLLLHGFTGDSGTWIPFILLWKKKYTVITVDIIGHGKTDS
PEEIEKYTMQESVTHLKALIDHLQLATVHLLGYSMGGRLALAYCMNYPETVKKLILESSS
PGLRTDIERKQRRIQDEKLGDSILEQGIINFVNKWEEIPLFKSQKILSEDAKQAIRKQRL
ANNPVGLANSLRGMGTGAQNSYWSSLSRLSIETLLITGELDQKFCQIAEEMVDCNKKIKH
LTINDAGHAIHVEKPEIFGTIVLEFLRS
>PK3-045_01361 1,4-dihydroxy-2-naphthoyl-CoA synthase
MTVEWVAGRQYEEIIYETYNGIAKITINRPHVHNAFTPRTVSELIDAFAMARDDSNVGVI
ILTGAGDKAFCSGGDQKVRGHGGYVGEDQIPRLNVLDLQRLIRVIPKPVIAMVKGYAIGG
GHVLHIVCDLTIAADNAIFGQTGPKVGSFDAGYGSGYLARIVGHKKAREIWFLCRQYNAQ
EALDMGLVNTVVPLEKVEEETIKWCEEILEKSPTALRFLKAAFNADTDGLAGIQQFAGDA
TLLYYTTDEAKEGRDSFKEKRKPDFGQFPRFP
>PK3-045_01362 2-succinylbenzoate--CoA ligase
MTEILPNFIKNRAHLTPDREAIVFKEERLTFKELYEKAYYRAGIWSAIGVKDTDYVGFLV
KSDLETVLHLFAMQIIGAKAVLLNNRLTAKEMAYQINDAKVSYLISEEAFKEKVAVLEEE
KELTVFYKENITESTYIEPIEKDQVSLEDTCTIMYTSGTTGLPKGVIQSYGNHWWSAVGN
TLNAGLYEKDTWLCTVPLFHISGYSILMRSIIYGMKVVLHDSFDVKRVLEDLWKEKVTII
SVVTTMLERIEKAAHDKFPPYFRYMLLGGGPASVELLTRCMNKGISVYYSYGMTETASQI
VTLSPEDSIRKIGSAGKPLFPAQLQIVNQAGHCLGSNEIGEIKVCGPNVSKGYLNKENHL
QDGWFFTGDIGYIDSEGFLYVLDRRSDLIISGGENVYPAEVEAVLTEMNGIKEAAVIGVP
DEKWGQVPIAFIVTDERIQENTIIEQCTNVLAKYKIPKRVFFISEVPRNASGKIVRRELR
KWIEEKSDFSL
>PK3-045_01363 Gamma-glutamylputrescine oxidoreductase
MSLYHGSLYWPTTVQERPVYPKLNNHVTCDVLIIGAGMSGALLTYMLAKESLQVILVDKG
SVGNGSSAANTGLLQYSNDKMLHSFAESIGEEDAVRFYKLCFNGMEELKSIASSLHEDVQ
FVNRQSLYYASTDADVLSLRKEYEMLQKYKFPVEFLEKDMIYKVYGFNKHAAIKTSGDAE
VNPERFVISLIKEAAQKSNVQVFENTEVSKPQNKDGCWLFNNGDSSIQAKHVVYATGYDL
DNFAIDIPTKINRTFAIVTNPVSSFPHWEDRCLIWETKRPYFYMRTTPNGRIIAGGLDEE
AREAPRDEQILQLYADRLLVRIKEHFPHLQLKADYVYGATFGESKDGIPFIGEHPQHKNL
YYCLGFGGNGTVYSAFGSNILKDLIIKGKHPDADLVQLDR
>PK3-045_01364 hypothetical protein
MAKDVLCEVRNCTFWEKGNRCGADQIYVVSNVGKHADTSYETDCKTFEPENSLS
>PK3-045_01365 Carbon disulfide hydrolase
MSLLQDMLVYNEEFVREQKYEKFITGKFPNKKMVILTCMDTRLLELLPQALNLSNGDVKI
IKNAGAVVVHPFGSIMRSILVAVYELQADEVMVIGHHDCGMSALHSDSMVEKMKERGISD
ETFATLQHSGINLEKWLTGFDSVSDSVTHSVEMIKRHPLLPSGVPVHGLVIDPKTGKLDL
VIDGY
>PK3-045_01366 Putative membrane protein insertion efficiency factor
MKHIFLFIIQFYRKVISPIKPPTCRFYPTCSSYGLEAIQRFGAFKGGYLTIKRILKCHPF
HPGGLDPVPEDWHCRNHHHSSKEKH
>PK3-045_01367 S-ribosylhomocysteine lyase
MPSVESFELDHTAVKAPYVRHCGVHKVGSDGVVNKYDIRFCQPNKQAMKPDVIHTLEHLL
AFNLRAHVEKYNHFDIIDISPMGCQTGYYLVVSGEPTVEEIIDLLEATMKTAIEITEIPA
ANETQCGQAKLHDLEGAKKLMNFWLSKDKEELKQVFA
>PK3-045_01368 Major cardiolipin synthase ClsA
MHIYSIVLSVIIILNIIFAFLVIFFERKDPIATWAWLMVLTFIPILGFILYLLFGQNLRN
RKLFQWDGRKKLGIEPILASQLLQISSNQLRTTNEVIRKNQDLIYMNLFNNDAVLTENNA
VQIFTDGHKKFDQLFEDIRNAKKSIHLQYYILKNDGIGSDLISLLVEKAKEGVEVRLLYD
ELGSRTLRKKVFKELRAAGGFVEVFFPSKFHLINLRLNYRNHRKLGIIDGKIGYIGGFNV
GDEYLGLHPKFGYWRDTHLRIVGTAVYAIQTRFILDWNQASHLHEIQYSPEYFPGKIEEI
IGNIGMQIVSSGPDSEWEQIKNGYIKMITSAKESVYIQTPYFIPDASLLDTLRIAALSGI
DVKIMIPNKPDHMFVYWATYSYIGEMLKAGAKIYIYENGFIHAKTILVDRKIASVGTANI
DMRSFRLNFEVNAFIYSEQIANELTEDFLKDMDLSTNLTADQYSKRSLWIRFKESFSRLL
SPLL
>PK3-045_01369 putative membrane transporter protein YfcA
MEELHLGMLLFLIGAGFIAAFIDSVVGGGGLISLPALLFTGLPPQIALGTNKLASTMGSL
TSSLSFIRNGKTDKKLLSKLLPLSIIGSAIGVYVVQKIPSESLKPLILAVLIMVTIYTLT
KKEWGLHSTYNGMTKKKLLFALFIVPLIGFYDGFLGGGTGSFFLFSFLLMGFDFVESAGN
AKVLNFGSNLTALIVFLCYDSVYYLYGIVMGIAMIFGAYIGSKVAIAKGSKYVKILFVLV
SATLIGKNIFDYITNP
>PK3-045_01370 hypothetical protein
MKIVDELYNLYKNKLTGDEEDIDMLAFAFLEEMSREDLLHIIQELNEQELYDLMGLYLIE
SLKGKFASEDYRKPNNPIFTHRNLH
>PK3-045_01371 Putative 8-oxo-dGTP diphosphatase YtkD
MEIFYDQNNNLVKLSFVKNEWNEESRHVLVICQYKDQWLLTKHKERGLEFPGGKREMGET
TIQAAHREVMEETGGIIKSMKWIATYQVFGEVPFLKDVFFARISHLTSKEDYLETDGPVL
ITGNIITKRWNESFSFIMKDEVIQFCIAYIENELLSK
>PK3-045_01372 hypothetical protein
MQNGDMIEKIRFPSPNPSIDLFLVTYYVDGLRVKGMLASPNDGKTYDGFLYLRGGIKNVG
KVRPGRIIQFASEGFVVFAPFYRGNQGGDGNEDFAGEDRNDAIAAFTLLKNLSNVQDVHV
FGFSRGGVMALFVGIYCPVKSIVTWGGVSDMFLTYEERKDLRRMMKRVIGGTPSKYPDRY
EERTPLYQLEKINAPTLIIHGKLDKNVSINHSLKLEDRLKQLGKEVDSWYFPELTHYFPP
ATNRKVVTSLTSWMKKQTERMVK
>PK3-045_01373 putative protein YtmB
MGMPLELNTMIVTKGKEIRLEENLFLLEKEDYRLYPMNIPLEVRRTKTAEISGIATIEKL
QWEKTKTSITYKLISLNSTN
>PK3-045_01375 S-adenosylmethionine synthase
MSTKRRLFTSESVTEGHPDKICDQISDAILDAILAKDANARVAAETSVTTGLVLVAGEIT
TSTYVDIPKIVRETIKEIGYTRAKYGFDAETSAVLTSIDEQSADIALGVDQALEAREGKM
TDEEIEAIGAGDQGLMFGFACNETKELMPLPISLAHKLSRRLAEVRKEEILPYLRPDGKT
QVTVEYDENNKPVRIDTIVISTQHHPEVTLEQIQRNIKEYVINPVVPAELIDENTKYFIN
PTGRFVIGGPQGDAGLTGRKIIVDTYGGYARHGGGAFSGKDPTKVDRSAAYAARYVAKNI
VAAGLADKVEVQLAYAIGVAQPVSISVDTFGTGIVSEDKLVEAVRENFDLRPAGIIKMLD
LRKPIYRQTAAYGHFGRTDIDLPWERTDRAELVKKAVEA
>PK3-045_01376 Asparagine synthetase [glutamine-hydrolyzing] 1
MCGFVGCVHEKAQNFQEEQKELFAGMNRVITHRGPDDEGYYYDNHIQFGFRRLSIIDIES
GHQPLTYENERYWIIFNGEVYNYLEIREELVKAGLTFQTNSDTEVIIALYSHEKEKAVEK
LRGMFSFIIWDKQEETLYGARDPFGIKPFFYFDDGEKTYFASEKKSISLALESDVIDYRS
LQHYLTYQFVPEPYTMSEGIKKLEPGHYFTKKIGEPMEIKRYWRASFKPVVKQEDEYTKE
IKDVLFDSVKMHMRSDVPVGSFLSGGIDSSIIASIAKEFHPNIKTFSVGFEHNGFSEIDV
AKETADKLGLENISYIISPQEYMNEIPRIMWHMDDPLADPACVPLYFVAREARKHVTVVL
SGEGADELFGGYNIYREPQSLEVFNKIPNVGKKLLRAVANILPEGVKGKSFIERGVTPME
ERYIGNAKMFSELEKEKLLSVYNNGLHYRDITNPLYEESRGYDPVDRMQFIDIHTWMRGD
ILLKADKMTMAHSLELRVPFLDKEVFKVASKIPTSLKTADGTTKYILRKAAESFVPEHVL
NRKKLGFPVPIRHWLKDEMNEWAKNIIKESDTDHLLNKSVVLQLLEDHCQGKADNSRKIW
TVLMFMVWHSIYIEKKYSFEKEYLKEGKVAIKN
>PK3-045_01377 hypothetical protein
MESNTIIVISLITLFFLLYLLVRNKLSIFVKSLYLFTIFAMIAISFLLINRDGYQAIVYA
KEFATQNTRKALLSIKEETNLIKESVLLDAPIINQLPELPRGCEVTSLAMLLQYVDVDVD
KMTLAKQIKKDTTPYTRANGKIYYGHPNDGFIGDIYSLNGPGLGVYHKPIAALAEKYLPD
SIVDFTGSDFEEIKNHLSNNRPVWVITNSTFKKLPESQFRTWNTPSGTVKITYSEHSVLI
TGYDETSIYFNDPLTGEKNKKAPIKDFEESWVQMGSQAITINS
>PK3-045_01378 Phospholipase YtpA
MWKWEAEGNAKAVIVIVHGAMEHHGRYGWLIEMFRLAGFHVVMGDLPGQGMTTRSDRGHI
DSFDEYTIEIKDWIQAAYQFDLPIFLLGHSMGGLASIRLLQQEKLKIAGLILSSPCLGLI
NYPSKLMSLVSLLLNKVAPKLRVNSGLTIDMATRNAEVREIDSNDTLYITKVSIRWYREL
INATKKAFEDIANTQDLPLLLMQGGGDLVVDKKMVKTWFNMIPLSEKRYKEWPEFYHEIF
NEPERDEVFEYTKDFINSQLKAIGYIV
>PK3-045_01379 Tetraprenyl-beta-curcumene synthase
MSVPKMPITLMSKVYLKVFPVVHQELSYWAQRAESIPNLELRKQALASIENKTFHCEGGS
IMALIAMSKYKEVIKFIVAYQTISDYLDNLCDRSTSLDPKDFSALHESMEHALTVGAKPS
NYYRYREDQDDGGYLYDLAKTCRDTLAKLQNYGSIKEQLLELCRYYCDLQIHKHVIMEER
IPRLKFWFEKNKNHVPKMEWYEFSACSGSTLGIFCLVSYAFRDDFDDSYPALIRDGYFPY
IQGLHILLDYFIDQEEDKIGGDLNFCFYYKNEEELFNRLKHFVTEADRHTNKLPHQKFHK
LINRGLLGVYLSDEKVNKQRNIRKLAKNMIRTSGPIGYFFYLNGRAYRKFQKVIPSGALR
ALSK
>PK3-045_01380 hypothetical protein
MKLDRVIPFAHQLLEKAISKGDIAIDATMGNGHDTVFLANLVGNKGKVFSFDIQEAALLA
TKDKLINQALQEAASLHLCGHEHIMDVIPSQYHGKVTGAVFNLGYLPGGDKSIVTKAETT
IAAIEQLLQILSKEGIIVLVIYHGHPEGAIERDKLITYVENINQQEAHVLRYQFINGINN
PPFIIAIEKR
>PK3-045_01381 Biotin synthase
MNQNNPFPFASDNKRYHTWNYHLRNEFGHKVFKIALDGGFDCPNRDGTVAHGGCTFCSAA
GSGDFAGNRVDSLEKQFHDIKNKMHTKWKDGKYMAYFQAYTNTHAPVDVLREKYEVVLKQ
ENVVGLSIATRPDCLPDDVVEYLAELNERTYLWVELGLQTVHEKTANLINRAHDFQTYVE
GVNKLRKHNIRICSHIINGLPMETNEMMMETAKSVSELDVQGIKIHLLHLLKGTPMVKQY
EKGLLKFLTFDQYISLVCDQLEILPPEMIIHRITGDGPIELMVGPMWSVNKWEVLNKIDA
ELKSRNSWQGKFYQANKKVTQ
>PK3-045_01382 hypothetical protein
MATRDSMSDLLQRCNDVINFAEQQYEAARRQEHFNDTEYTDAQMQLENIYNDLHTMDRSA
NQQQREELHRMRLLIEQMQNQMTLRLH
>PK3-045_01383 hypothetical protein
MDKRSKKNNPEQKTRNGINNQDIELGKDVDLIKAAKKKYENSGGQPAKSKSRQE
>PK3-045_01384 Na(+), Li(+), K(+)/H(+) antiporter
MPRSLWLLVIGMAVNVTGSSLLWPLNSIYIHEHLGKTLTVAGFILMLNSGASVIGNLIGG
ILYDKLGGYLSILLGISLTAFSLLGLTLFHNWEAYCTFFTLSGFGSGIIYPSMYAMAGNV
WPEGGRKAFNSIYVAQNVGVALGSAIGGFIASYSFQLIFLSNTLMYGVFFLIAFFSYKNI
QVKTDVLPSTTGTVSKRKGRHLLKGSPAMYSLGILGLGYLLCWICYVQWQATISTHTQEL
GIPLTQYSLLWAVNGGLIVFGQPLISFFTKKVCTSIKKQMLIGIGIFIVSFLIVGKAEYF
TGFLAAMIILTIGEMLIWPAVPTIADKLAPKGKEGFFQGIVNSTATGGRMIGPLVGGMLV
DSSGMTLLVPILVVLLVISLFTAFFYDYPTKEASKLTPKTN
>PK3-045_01385 Phosphoserine phosphatase 1
MTKICLIRHGETDWNALGRIQGKTDIPLNENGKKQAEQCRDYLKHSDWDVIVTSPLKRAK
QTALIINEALQLEVVEMDEFMERSFGDAEGKTREERAILYPDHHYPNQESREALVKRLTG
GLEKILCRFPNEKVLLVAHGAVIHTLLTIVSEESLKIEKYLSNACISNIQYKEKRWEVKN
YNLVDHLVEIHE
>PK3-045_01386 2-amino-5-chloromuconic acid deaminase
MSDFGAYIDKNISLKPMKRGNLDGLTFAVKDVFAIKDYLSSAGNPDWLSSHPPAKETAPV
ITSLLNNGARLQGITITDELMYSLNGENFHYGTPVNPKAPNRIPGGSSSGSAVTVAAKRT
DFSLGTDTGGSIRIPSSYCGIYGIRPSHGAVNIEGVIPLAKSFDTVGWMANDAEILNEVG
KVLLPAQRDGSFTRFIMGSDAWALADQEVHKAFAPLLEKLKQSVPNYTTTVIAEEGLQEW
SEVFRMLQGKEIWQEHGEWIQKVKPTFGPGIAERFKWASTIKDEDLAPYHQLRRKIQQRM
EELLKDDAVLIIPTAPGIAPLLNLPVYELEERRKQTFQLCCIAGLTGFPQVNIPLTTSNG
VPVGLSLIVSRNQDRNLLRLVAEWVKKW
>PK3-045_01387 Putative N-acetylmannosamine-6-phosphate 2-epimerase
MIEKLKGGLIVSCQALDSEPLHGSEFMAAMALAAKIGGAVGIRANGYSDIKRIKEKVDLP
IIGILKKHYPGYDAFITTTKADAQLVADAGADIIAIDATDRSRAEDLQELIDFIKDNLNK
KVMADVSTLEEGIRAETMGCDFVGTTLAGYTVKTQHLKNGPAFELLDNLVKAVNVPIIAE
GRIETPEDARKALELGAFFVVVGGAITRPQEITKRFVKGMNS
>PK3-045_01388 hypothetical protein
MKRIPLSMVIKDLSHIPQYPLPAEFRIRLFEKGDEHHWAFVEASVDEFESEEAALAHFYK
EFGPYIDEMTNRCLFIENKNGEVIGTTTAWYGDLKGDGEITGRIHWVGIVPAYQGQKLSK
PLLSAAMNILAKYHSKAYLTSQTTSYQAVNMYLNYGFKPFITAPSCHEAWSLLEDTLERK
ILK
>PK3-045_01390 Leucine--tRNA ligase
MSFNHQKIEQKWQKFWEENKTFKTSEEKSKKKFYALDMFPYPSGAGLHVGHPEGYTATDI
LSRMKRMQDFNVLHPMGWDAFGLPAEQYALDTGNHPAEFTQKNIDTFRRQIKSLGFSYDW
DREINTTDPEYYKWTQWIFLKLYEMGLAYVDEVAVNWCPALGTVLANEEVIDGKSERGGH
PVERRPMRQWVLRITAYADRLLEDLDEVDWPESIKEMQRNWIGRSEGAEVTFRIDNHDES
FTVFTTRPDTLFGATYAVLAPEHALVEKITTSEQKADVEAYLEKVKSKSDLERTDLAKEK
TGVFTGAYAINPANGEKMPIWIADYVLVSYGTGSIMAVPAHDERDYEFAKTFGLPIKEVV
AGGNVETEAYTGDGEHVNSDFLNGLNKEEAIIKMINWLEEKEIGTKKITYRLRDWLFSRQ
RYWGEPIPIIHWEDGTMTGVPEEELPLTLPETSEIKPSGTGESPLANISEWVNVVDPVTG
KKGRRETNTMPQWAGSSWYYLRYIDPKNNKQIADPEKIKEWLPVDMYIGGVEHAVLHLLY
ARFWHKVLYDLGVVPTKEPFQKLYNQGMILGENNEKMSKSKGNVVNPDEIVASHGADTLR
LYEMFMGPLDAAIAWSTNGLDGSRRFLDRIWRLLVDDNGELTSKVQDIEEMKALDKIYHQ
TVKKVTEDFEALRFNTAISQMMVFINECYKADRIPKKYVEGFVKLLSPICPHITEELWQI
ITGSNQSIAYEAWPAYDEAKLVDDEVEIVIQINGKVKAKLMVPADANKDALEQIAMEDSQ
VKEQIDGKQVRKVIAVPGKLVNIVAN
>PK3-045_01391 Sulfurtransferase
MDTIKTITTEELEEKLTNEEKLELVDVREDEEVAEGIIPGAKHIPMNSIPENLDYFSKDK
EYIMICRSGRRSENVCYYLQDQGFKVVNMEGGMLNWHGKTV
>PK3-045_01392 Sporulation protein cse60
MIKVKLFDQEHEKDLELQMNKFLQKIDEKKLIDIKYNVAAMQEDEEDQIYCFSSMIIYRT
>PK3-045_01393 putative protein
MQYDVIVIGGGPSGLMAAIGAAEQQAKVLLIDKGNKLGRKLAISGGGRCNVTNRLPIEEI
IKHIPGNGRFLYSGFSEFNNEDIIAFFEKLGIALKEEDHGRMFPVSNKAQSVVDALLSEL
DRLGVTIQTNSPVKTVNYHENKTKTVILQNGETKTCKSLIIAVGGKSVPHTGSTGDGYAW
AKKAGHTITDLFPTEVPITSKEAFIQNKTLQGVSLRDVALSVLNPKGKPIITHQMDMIFT
HFGISGPAVLRCSQFVVKAKKKWNLGEVKVSIDSFPDKKEEELFQDTMTLLKTESKKAIK
NTLKGLLIERYLLYLLELANIDPAAPCATISQDKIRVFVGLCKAFTFDVNGTLPIEKAFV
TGGGVSIKEIAPKTMESKMTEGLFFCGEILDIHGYTGGYNITSAFVTGRLAGVNAALVAK
SE
>PK3-045_01394 Lipid II flippase MurJ
MSSKLLKGTFILTLGTIISKALGLFYVIPFNMIVGKQGTVLYQYSYVAYTIVISIATAGI
PLAVSKFISKYNAMGEYKVGRRLFKSGLVIMLASGVLSFLALYAAAPFLAGLIISDDDLT
STVGQVTTVIRAVSFALIVVPFMSLIRGFFQGYDAMAPSAVSTVIEQIVRIVFLLGGSAI
VLFILKGKLITAVSISVFAAFVGAIGGLAVLLLYWRKSKDEYDNLLLYDKGMQTDIRLRS
MYKEILLSAAPFVFVGVANPLFQAIDTVTFNRAMSSIGLSSISETALNIFNYQTHKIIII
PVSLATGFSMALIPMITRAFIKEDHTDLATNLNQTFQVLLFITLPACIGLSVLAEPVYRL
FYGTEDLLMGAEVLRLYAPVAILFSLYPVTASILQGLNEQRFTILSLLVGILIKLSLNIP
FIERWETNGAILATSLGYTVSILINLGVIKAYANYSYKIVIRRSILIIGFSVMMYIVTNI
VYSLLRLFLSTESVVASLLMVVIVAIFGVLMYVYLAYRSKLIYRIFGEQANKIKQKLRLP
F
>PK3-045_01395 Ribosomal small subunit pseudouridine synthase A
MRIDKMLANLGYGSRKEVKMLLKNKAVKVNDVIIKDAKHQVDPEKDEVSLNNEIVEYKEF
IYLMMNKPPGIISATEDTREETVVDILQIEDSVYNPFPVGRLDKDTEGLLLLTNDGKLAH
RLLSPKKHVPKTYFAVISGKVGEEDIEAFKKGVVLDDGYLTKPGHLVILKAGETSDIELT
ISEGKFHQVKRMFESVGKKVVYLKRISMGPLELDETLELGEYRELTEEEIELLRNYEVNN
>PK3-045_01396 putative HTH-type transcriptional regulator YtzE
MKPSTNRMLNRIKSVYMFISKRGTVTTQELVEEFGITPRTIQRDLNVLAYNDLVQSPSRG
KWTTTRKKVKMTS
>PK3-045_01397 NADH pyrophosphatase
MGYVEDLRKLVGKMPIILVGAVVILFDKDQKVLLQERKHPKHVWGLPGGLMELGESTEET
AKREVFEETGLQITNLQLLSVYSGKDYFAVAANGDPFYTVTTAYCTSEYEGKLKNDQEEA
FSLRYFNLDELPEKMVGSHRRMIEDFKKNLKRI
>PK3-045_01398 Putative dipeptidase
MSSIDWLNEVHNRKDSFIKDLQGLLQIKSVLDEENATEDAPFGKGVKEALTYMLSLGEKD
GFVSKNVKNVAGHLLYGEGTESVGVLCHVDVVPEGDGWTSDPYKAEIRDGKIFARGALDD
KGPTMAAYYAMKIVKELHLPLTKEVRMIIGTDEESDWRCVETYFQEESMPTIGFAPDADF
PIIYAEKGISDFDIVQKYTEASSDSGEVKILCFSSGRRYNMVPDFAQAVLEVKEGEQTEI
IQRYQNYLKLENIPGRYLVDNGDLVLELEGVSAHGLEPNNGINAGLKLADFLVELELDEK
ADHYFQFVRNFFVNDSRGKKLGIDFEDEITGELTLNAGILDYQSDHGGKIGQTVRYPVTN
DMDQTKEKLIKLLAEHNFSLENFTDSKPHYVEKDSELIQTLSKVYEEQTGEKAKLLSIGG
GTYARSLEKGVAFGPLFPGREDIAHKKDEYMYIEDLLKATAIYAQAIYELAK
>PK3-045_01399 D-alanine aminotransferase
MRMVLMNGEFIPREQAKVDIEDRGYQFGDGIYEVIRVYNGKMFMAKEHLERLSASSEKIG
IAISYSISELTNLLEELIAKNSLSTGILYMQFTRGVSPRNHSYPTEAVTPTFVAYTKTLN
RPLDNLENGVSTITVEDIRWSRCDIKSLNLLGNVMAKQKAAEADCYESIQYRELSVTEGS
SSNIWIVNGEKIQTHEANQFILNGITRQKIIQICGENGIEVEEKAFSIEDLIDADEVFLS
STTSEVTPIVSVNNVPVKEGEVGEMTKKLQNLFVDAIISECGQISN
>PK3-045_01400 RNA 2',3'-cyclic phosphodiesterase
MKTTIPHYFIGIKPDVQVINEIEKIQKELQLKFPFKKWVHPLDYHITLAFLGSASDEQKE
KLHVLLNQSSPLSTNFQIHIDHLGVFGQRQNPRIFWAGMKEEQKLVELRNQVFAVSSKAG
FQLETRPFHPHLTLARKWKEDTIFSERELNEFSMPKNFISNVDSIHLFQTHMDKIPKYEI
INSYSFHNYKQ
>PK3-045_01401 hypothetical protein
MAQLIKLQDYVSRYEQNIVLYPSRFVRLKKQQWTGLKRAFDTKDRSLFYIENPIEDNWLM
EKPTLLERVKKTILNRNKLEDAETAKINESEKKEEDEEELDFDYDAKKYKHPQSIDELKQ
QFLNQLFEFQLKWASSTLTEMSKVKKTLYYDDLLKYFLQRFPDTFLVLYQPLFQLKNAPV
ELDTIIVTPTDVWCIHVLEAENSAVFVGSNDKFWLKKKGDKEKKILSPVISINRTEKIVK
GILEKYDITLPVQKVILTRNGYVDFPAPPYDLKIIEKRNYEEWFHKMRNNHSPIKAIQLK
AAESLLHYGLTNAKRRYEWDTEES
>PK3-045_01402 Pullulanase
MLSIRRSFFAYLDEMSLITVLLPYSYFQGESTSFILRGTNQATNLVIESKEKMQHFVKYK
CRTHNKIQIGQKYEVEDGNKGVTDLQIGAVIRTPLFDEEFYYDGPLGVHYASDQCTFYLW
APTAQQVKLVLQSPDPSSKERRIVEMERQEKGVWKTTYLADLEGYYYSYLVLINLEWKEA
IDPYAVAVSVNGETGVIVDLNKTKRQKPALPPLEQDVDSIIYEAHIRDLTIHPDSGIQQK
GKYVGVAELNTQTPQNNLSGLTYIKDLGVTHIEFLPVHDFEEIDELEVLKKYNWGYNPSH
YNVPEGSYSTNPMDPYVRINELKEMIHAVQEQGIRVILDVVYNHVYKKEDSSFEKIVPGY
YFRYDKHGMPANGTGVGNDIASERSMVRRFIVDSVRFWIEEYQIDGLRFDLMGILDCQTM
NEVRTICDNVDKSILIIGEGWDLATPINHDKKAIIANQQSLPRIGQFNDQFRDKIKGSTF
DKYDRGYALGNKQYKGEIAELLAGSVGIYKEGGMFFEPGQSVNYVESHDNHTLWDKIDIC
FPDASDEEKSKKHRLATSLVLLSQGIPFLHSGQEFFRTKFGVENSYQSPDEINQLDWNRK
DQFLRNVDYIKGLISLRKNNRAFRLRSVEEIQKHVTINQQANEVIQYCLNDLQQFGEWKT
IIVLINGNDSAEKGFCPENEWKILVEDGIVYEEDYPTIHGDSLIVNPSSVTILAK
>PK3-045_01403 hypothetical protein
MEHLLGQDWEITPAGGETGEAFFAQNNGQKLFLKRNSSPFLAVLSAEGIVPKLVWTKRFE
NGDVFTAQQWLIGREFSHSDMTDERVTMLLKKIHTSKPLLEMLKRLGKTSFHPEMILSVI
KAEIDDELKDNEDIIRYIQFLEDNLPFIKTTEHVVCHCDVNHNNWLLSEDNQLYLIDWDG
AMIADPAIDLGMLLYWYIPKEDWKNWLHTYGYELTDHLSLRMKWYVIAQTINSIRWYKKK
GRFSEMQKWMQFLHDID
>PK3-045_01404 hypothetical protein
MPINHEHQLALLADILSNQQTDCCGSVAECEQIERLITSLRTNDQIDQNILPILEEVHLY
SKQGVNASNLDNHIHSHQDQLSQWVDGINNLS
>PK3-045_01405 tRNA (guanine-N(7)-)-methyltransferase
MRLRHKPWAKDKLSAYPQYVIQTPEDWKGKWDQAFSQKGPIHIEIGTGKGRFITEMAKAN
PSINYIGVELQESVIVSALDRLIEAEVPNLKLMNINAEKLKDYFEKGEIARVYLNFSDPW
PKTRHEKRRLTYKTFLDSYQSVLIDKGEVHFKTDNQGLFEYSLKSFSEYGMLLKYVSLDL
HNSDYEGNIMTEYEEKFSNRGNRIYRCEVQFK
>PK3-045_01406 hypothetical protein
MNWKHIIGGVVAGLAASYIVKEVIVKNSSLSGDQVLSLAKTAFKEKGPINGSWINMEKEI
LHTQASSLTVYRGGITRMNGDTQEVYEFISDSETGRILDVNQLT
>PK3-045_01407 Putative aminopeptidase YsdC
MEQQTLDMFRTLTELPGVAGNEHQVRKFMKEQLSLYTNEIVQDNLGSIFGVKRGTENGPT
VMVAGHMDEVGFMVTAITDNGMIRFQPIGGWWSQVLLAQRVQIITNKGPVTGVIGSIPPH
LLDEALRSKPMDIKNMLIDIGADDKEDALKIGIKPGQMIVPICPFTPLANEKKIMAKAWD
NRYGCGLAIELLKNLQGEEIPNILYSGATVQEEVGLRGARTAANMIKPDVFYALDASPAN
DASGDKNQFGQLGKGALLRIYDATMVMHKGMREFILDTAESNNIAYQYFISPGGTDAGQV
HISNNGVPSAVIGICSRYIHTSASIIHIDDYAAAKELVTKLVKTTDHTTIETLRANQ
>PK3-045_01408 Inosine/xanthosine triphosphatase
MKVCIGTNNKAKVKAVKNCLEKDTAIEFATFNVSSGVSEQPFSDEETIKGAVNRAKAALQ
EGAGEIGIGLEGGVHRTNDTLFLTNWGALVWKDGTTYIASGARIPLPKEIETKLVAGREL
GPVMDEYVQKENVRSTEGAIGIFTNGRINRTAMFEHVVELLLGQMEYQRK
>PK3-045_01409 Thioredoxin-like protein YtpP
MKGAFTLKHLQSAEEFAELKNSPEKHIFLFSAEWCGDCRFIEPFMPEVEAKYDQYTFIHI
DRDKFIDTCIELDVFGIPSFIAFEGGKELGRFVSKDRKTQEEIEKFIESL
>PK3-045_01410 hypothetical protein
MKMTSKKMKDMLIQRISNEDRTFSFDSKKDQVRIESKATGKGVTVSLPEIIAKWETKKEK
AVDEIVYYIEQGLGAIEKDGEIEGKEKKIFPVIRSTSFPQQSNEEIPFITDEHTAETRIY
YALDMGNTYRLIDEKLMEKENWSATSIKEMALFNVRSLSTNVKADSVAGNVFYFLNSNDG
YDASRILNDAFLKDMYEQREGTMTVAVPHQDVLIIGDIRNETGYDILAQMTMSFFASGRV
PITALSFLYEDGELEPIFILGKNKKRER
>PK3-045_01411 hypothetical protein
MNWFKKVFKQFASEEEELNQVEESVEVEQQPKMESTAWKKEIDSKIIYQYPKGNFRFPLI
PDEEKDDKKETDRRKRREPRQAFHENRRENDQPYKPPYVEQTKSDQKEDKVSNTYSTNRP
FKPTEVVSPIYGYNRPERKETRTTESRPIIEKKVGISKEANSNQKEQKEIRVNEELLTFA
GMNDELAESQEAKRNLEAAELQEAERVVESPELQEAESNIESLEPQESGQQHANEETVEL
HKAETAVAQETVTVDSIMEQDSSLSIKAEEYFHEEISSKADSALEVENIASLSIFASEAE
MEVNEQEESLIDVQELNDDQLLLKFEEVEVVEEAYQENDEAIVEEKKEEVSQGKIEEKKT
SSRKGPLPFNVLMLNKDRKRLANQKVEKKIYEEPESQSKAEVVVPSMIEKEDEEQNDLPY
YVFPEENLLNPPILQIEKDGWIEEQTMLLNDTFTNFNVHAKVVNVTQGPSVTRYEVQPEP
GVKVSKITNLSDDLKLSLAAKDIRIEAPIPGKHTVGIEVPNQKSRPVLIREILESEEFKS
STSPLTVAMGLDISGKPIVTDLRKMPHGLIAGATGSGKSVCINTMLVSLLYKAKPEELKL
LLVDPKMVELAPYNYVPHLASPVITDVKTATAALKWAVEEMERRYELLAHAGVRDITKYN
QLAEEHKRYSEKLPYLVIVIDELADLMMMAPADVEEAISRIAQKARACGIHLLIATQRPS
VDVITGLIKANVPTRIAFSVSSQIDSRTVIDISGAEKLLGKGDMLFLENGTSKPVRLQGT
FVSDEEIDQVVAHVRKERKPEYLFEQEELLKKVQMSEEEDELFYEACEFIIEQGGASTSS
LQRNFKIGYNRAARLIDMMEKQGFISEARGTKPRDVLITESELLLLQENE
>PK3-045_01412 UDP-N-acetylmuramate--L-alanine ligase
MTIYHFVGIKGSGMSALAQILHDMGFEVQGSDVDKRFFTQIALEQAGIKILPFQRENIQP
GMNVIVGNAFPDTHEEVEEAVKLGLPVIRYHRFLGDFMKQFTSIAVTGAHGKTSTTGLLS
HVMKGAKPTAYLIGDGTGKGVTGAEYFAFEACEYRRHFLSYFPDYALMTNIDFDHPDYFA
NVDDVFSAFQEMAWQVKKGIFACGDDEHLQKIQAKVPVVFYGFGDENDFQARNVEKTTEG
TTFEVYVRNTYYNTFSIPTFGDHNILNALAVITLSHYEELDAEIVKERLMTFEGVKRRFT
EKTIGTQVIIDDYAHHPTEIKATVEAARQKYPDREIVAVFQPHTFSRTQAFLQEFADSLN
LADSTYLCDIFGSARENHGKLSITDLADKVPGSKIISEETVSSLKEHDNSVILFMGAGDI
QKYQSAYEKTLG
>PK3-045_01413 Aminopeptidase T
MKDPRIDQLAKNLINYSIRLQKGEKVLIENFGLQKELVKALVREAYAAGGYPFVSLKDND
INRSLLLGAQTEQYEMMAQFEANVMSNMDAYIGLRAGDNINELADVPAEQMKIEGATIGK
KVHREIRVPNTKWVVLRYPSPSMAQLARMSTDAFEDFYFNVCNLDYGKMDKAMDNLVELM
NRTDKVRLTGPGTDLTFSIKDIPSIKCSGQMNIPDGEVYTAPVRDSINGVLTYNTPSPYQ
GFTFENVSLKFENGKIIEATSNDSERLNKILDTDEGARYIGEFAIGVNPYILHPMQDILF
DEKIDGSFHFTPGQAYDDAYNGNDSNIHWDMVNIQRPDYGGGEIYFDDVLIRKDGKFVIP
ELEVLNPENLK
>PK3-045_01414 hypothetical protein
MINLLYLSVALIAIAFTVLVIYVARTLKSLHTTLDSVSKTLVGLERQLDGVTRETTILLQ
KTNDLAADIQQKSESLNSVVDAVKDVGTSVQGFNQSVQTITNNVENTLVKNQDKIAQIVQ
YSKVFMNIRDQWRAKKAEQNRTRVRSN
>PK3-045_01415 hypothetical protein
MKREQEIIHANESSSSKDFLLGALVGGVVGAATALFLAPKPGRELLHDLNGQAGILKEKG
IELTDTVKEKGSEFISIAKDKTDQLSNAVTKTSAEIMDKVKKTKGQENMSARFDELKEEA
SDLSSSLKNAEFDEIQQKLEETKRAFDETESKYNH
>PK3-045_01416 hypothetical protein
MEIIKTIEKIEELVQNKDAFWLVKHSVTCPISARAFDEYKQYASGNNAVDTYYLTVQDAR
DVSNYIAEKYEVRHESPQALLFVHNNIVWHASHGQITAASLQKASEENKL
>PK3-045_01417 Cell division protein FtsA
MQKHEKLFALDIGTRSVVGIILEKKEDNYHVADLLSIEHTERAMLDGQIHDVLAVSKIIK
EIKDQLEIKHGPLERVSVAAAGRALKTERAAYEMNIERKPLITKEDILHMELTAVQQAQS
TVAEKNERDKSQFYYCVGYSVLHYSLDDQAMGSLIDQQGSIAKVEIIATFLPKVVVESLI
AALHRANLEMQALTLEPIAAINVLIPPSMRRLNVALVDIGAGTSDIAITDIGTVIAYGMV
PVAGDEITEAISDAYLLDFPLAEKAKRELSQKDQISISDILGFTTKLHKEEVIKEIEPAL
DKLADTICREILSLNNHKSPKAVMLVGGGSQTPALQQKMAEMLNLPSNRVAIRGIDAITH
LTFEENFHLGPELVTPVGIAIAAEKSPVQYKTVYINEQPVRLFEVNKLTVGDCILASGIR
MNQLYGKPGNAMIVTINNQKITIPGSHGEGPTILRKDVPCSLEDTVEDGETLTVYRGRDG
EQAMVQIKDLLDAESDKEIKINNKSYTLHTKILCNGNPVSPEHLIADKDIIEYKADTTIQ
EALEGLHLTNLIEELRPFQLLINGKETVLPAFSGKVVKNGLPCRLNQLLSHKDEVILEKR
KTPTVQELAERKQILMYQVLPVYFNDKKITLTKQLAQIQRRGQLLQMEDLLFSGDYIRIE
QKPFEGFLFQDLFAFVDINMPQSGGGSFQLLRNGEQATFLTPIKKGDKLSIVWPAKTKSP
SMNN
>PK3-045_01418 Protein AroA(G)
MIVSNKELEELRNRVDELNLEILEKINERASLVQKIAQTKVTHGAHRYDPVRERKMLDHI
LNKNDGPFDNGTISHLFKQIFKMGLQLQQEDDSKALLVSRKKKAEDTIVDIKGTKIGDGT
PKFVFGPCSVESYEQVAQVAASVQAKGLKLLRGGAFKPRTSPYDFQGLGVEGLKILKRVA
DEYDLAVISEIVSTEHIETALDYIDVIQIGARNMQNFELLKAAGSVKKPILLKRGLAATI
EEFINAAEYIMSQGNDQIILCERGIRTYERATRNTLDISAVPILKQETHLPVFVDVTHST
GRKDLLLPCAKAALAIGADGVMAEVHPDPAVALSDSAQQMDIDQFDEFYRALQATPYVNA
>PK3-045_01419 Catabolite control protein A
MNITIYDVAREASVSMATVSRVVNGNPNVKPTTRKKVLEVIDRLGYRPNAVARGLASKKT
TTVGVIIPDISSTFYAELARGIEDIATMYKYNIILSNSDQNKDKELHLLNTMLGKQVDGI
VFMGGNITEEHVTEFEKSPVPIVLAASIEESKKISSVNIDYAQATYDVVTSFVEKGHKSI
GIVLGSLEEPINKNEKLGGYKKALEAAGIEFNESLVVEGDYSYESGMEAFDKLIEGNNKP
TAIFVGSDEMALGVIHGAEDKGYKVPEDFEIVTSDNTKLTLMVRPQLTTVVQPLYDIGAV
AMRLLTKYMNKETVEDHIVTLPHRIESRKSTK
>PK3-045_01420 Biosynthetic peptidoglycan transglycosylase
MNERPKWKNALNHFKNFFTNKRTLKGARLTYEVTWNIALLFIIITVVGGAFGLGIGAGYF
ASLVKDEPIRPYTTMQKDIYNYEETSELFFANNEYLGKVPTDLEREEVKIKDVSPYLKDA
VIATEDENFYNHNGVVPKAIFRALFQEVANSSTQSGGSTLTQQLIKNQILTNEVSFERKA
KEILLALRLEKFFEKDEILEAYLNVSTLGRNSSGRNIAGVQAAANGIFGVDAKDLTLPQA
AFIAGLPQSPFGYTPFTQEGKLKKNLEPGLNRLKTVLNRMYDQKKISKQEYDTAMKYDIT
KDFIGPQKSPIEDYPAVTIEIQQRSIEIIAELLAKEDGYTKEDLQEDDVLAEQYTTLADR
QIHQNGYKIHSTINKKIYDIQQKAVKNFSLFGPDKKQQVIDPETKEKVTIMEPVETGAIL
IENKTGAILSFVGGRDYNREATNHATRSVRSNGSTMKPLLVYGPAIELGTLSPGSVLPDV
PLRLNPSKPGSIWPNNYDSRFHGLVTARYALQQSYNVPAVKAYIDILPQKPIKFLEKMGV
SSLTPADASNRATAIGGLEDGITVEENTNAFSTFANSGKFIDSYMIDKIEDKDGNVIYQH
EVKPVDVFSPQTAYLTLDMMRDVMNRGTAAAVNSRLKFNSDWAGKTGTAQDFTDSWLVAT
NPNVTFGVWTGYDTPKSLQTGSLPSYSNRTNYLWADLLNAAYDVAPDLVAPSKSFKMPGG
IVRQSVCSISGLLPSEGCSKAGLVTTDLFKSGTVPSKRDDSLVAGKYVKIGDKKYMALDS
TPSEFAEPGLMLNPDYIEKLFGIRISDPSILSENNQKLKNLIIPSNKIEDNGKAPSALKV
NLKGDTIKWSKHSEKDVIGYRVYKNGKKVKSLKAANTLSFKGGNGKYIVKAVDIAGKESK
ASNEVVIGNSQEKQESQTKKESQEKKTSTKEQTANKPKDNKEKNSKPNNDKPKDDKPPEN
NQQNNKEQTEKPDKKTENN
>PK3-045_01422 Tyrosine--tRNA ligase
MNLLEDLQWRGIIYQQTDEAGLKEQLEKGMTSLYCGVDPTADSMHIGHLLPFLTLRRFQN
AGHRPIVLVGGATGLIGDPSGKSEERKLQTLDVIGYNVKCLQGQLERIFDFDGTNGAIMV
NNYDWAGKMDIVTFLRDYGKHIGINYMLAKDTIANRLETGISFTEFTYTILQALDFLHLY
EHHDCKLQIGGSDQWGNITTGLELIRKNMPEGAKAYGLTIPLVTKADGTKFGKTESGAVW
LDPEKTTPYEFYQFWINTADADVIKYLKFFTFLSKEEIEELEKSVQEEAHLRKAQKTLAE
EMTKLIHGESALEQAQKITAALFSGDIKNLTAEEIKQGFKDVPTYEHTEGEALLVDLLVA
AGIVSSKRQAREDITNGAVYINGERKQELDYALTEEDRIEGQFTVIRRGKKKYYLIKF
>PK3-045_01423 hypothetical protein
MKLNSEVLNVPSPFLEYIVMRMFMMKYYEKDHYSIAFQYPLSRFESSYVIPEFQMLFDKV
KWKNNIVTLINLRANIYEQILLQVNQCDSRSSYMAIIDYLNQQTKVEDRMDCFPTILTGD
LVSPEWSVDFQKDGIIELFKNQEILGDKICLTSREEKGKEKWEFQQIINQVVHEYWLVYE
QKREKTVIQISLPNVKYTRDIEMRIKDLFFPFFHQVQVATFFYEEGLFINNILVKRPKKK
EKANWEELLFPLGGKGNCD
>PK3-045_01424 30S ribosomal protein S4
MARYTGPSWKLSRRLGISLSGTGKELDKRPYAPGQHGPNQRKKLSEYGLQLQEKQKLRHM
YGVNERQFRNLFDIAGKMTGKHGENFMILLETRLDNVVYRLGLARTRRQARQLVNHGHIL
VDGKRLDIPSYRVKAGQTITLREKSRNLEVVKEAVEVNNFVPDFLTFDADKLEGTFTRLP
ERSELPAEINEALIVEFYSR
>PK3-045_01425 hypothetical protein
MDFLGHQKILMLKSRFFDLYNTKVIHENIGIITQAALEAIREVFGAVEVTLYTNEEWDVN
WKIVSSTVLKNCEDKAVCLNEDISFLCEYKFSRTSIKDDLAHDYMLLALNNKKKEKVDYI
LAIKMKKEILDDPNEESFLLEMAGKEVGSFFANMQNIADAMKEKKKYKQLFKVTEKFHSS
MMMEDVLREVIFTLKEVYPFYHYFLLLSHDNNSPTDLPVKDLEYDGENMAAMEAYVTAEL
QFENLKEEKSSVIYAPLKGKQGVYGVLQIIVPNAISFPKNEVEFISLLANTAGGALENAQ
LYQQSKKLVTDLQLINEASHQLNSNLRLNEIMTYICERISASFDAQEVGFILFSLENNST
KVLSGSSSFFFNQESQQYIKYVKEKIQIEKDSLFLGDFSMQLEGARYKSIMAVPMMQTGV
LKGVAIVMHPSAYHFSFDTFKLLQSLIHHSTLALTNSLLREELEKMVVTDHLTKLYSRNY
LDEKIQMSLREDKEGTFILIDIDDFKLINDTYGHQIGDDIIIQVANIIKDNIRSSDIGSR
WGGEELAIYLPRVPLSLGVTIAERLVKKVRGNSKPAVTISCGVSYWNKQSNDTYNTLFKR
ADKALYTAKETGKDKVIIQNTLLI
>PK3-045_01426 Free methionine-R-sulfoxide reductase
MIYMFSVETYNGNREQQYQLVEKQLRALLEGEHNAIANLSNASALLNQFLQNINWVGFYL
VEENELVLGPFQGLPACVRIPFGRGVCGTAAHNKETVRVEDVHQFPGHIACDAASQSEIV
IPLVKEDGTLIGVLDIDSPEKNRFDELDQKYLELFASTLVKYL
>PK3-045_01427 putative HTH-type transcriptional regulator YttP
MKEISTRDAIVEAAVSLFNRKGYHGTSIRDIAGLAKVNIANISYYFNGKQGLLEYCYMNF
FETYLELLEQVFLQSDSPTEKLKKMVDCIITYQCKNPQLTRFVLREVSIDSQVVREIMST
YYVKERYIFTQILEKGIERKEFRKQSISYSIIQLKGLLSMPFIHSYYVTEVLHIFLNEDY
FKRKYLEEIHRWIHDVVCLNEKELLIIP
>PK3-045_01428 Histidinol-phosphatase
MVITMKKDGHIHTPFCPHGTKDSLRQYVEQAIMLGFTEMTFTEHAPLPKSFIDTTPTQDS
SITLEALPFYIKEVQHIKKEYKERIKINIGLEIDYIEGFELEIKDFLAEWGHFLDDSILS
VHFLKNPLSNRYDCVDYSPEYFGHMVEQYGGVSQLYDCYYQTLLKSIKADLGPAKPKRLG
HITLIHKFQQLYPQEQNFQTIIFTILDEVKIHGYELDYNGAGVNKPYCKEPYPPKWIVQE
AINRDIPLVYGSDAHQAKDLGQGWDVMLWNNQ
>PK3-045_01429 Septation ring formation regulator EzrA
MNYIIGGIGIVICLFVAGYFIKRKYYNGVDELENWKINIMNRPVLEELAKVKQLNMIGQT
EELFERWRKEWDDIVTAELPEIEELLFDTESYIDKYNFPKAKKTQDIIRMKMESVDKRID
TLLEELNNLVGSEEKNRTEMEELKESYRVSKKNLLAHRHTFGDTEKKIETMLQEIAELFI
TYDEKTNNGDYLEAREIVYKIQDRLSTITYLIEKIPPLLIECQTKLPEQLDELKDGYADM
IEQGYILEHLQMEEEIASLTNELASTETDLKEGNVEAVEKVVSEIQDKLDLLYDLLEKEV
LAKNYCHINMNATKEILADVQQGNAQLQVEVGLLQKNYNLDNEDIELQFKLEKKLNFLFK
QYEVLEHKLLTESAAHTLLGEELKVLKEQLENASLEQKALFEKLHALRKDEVSAHNRLRE
LSKQVADAVRRVTNSNLPGVTEEYNQLMQEAKESIDQAKRMLEHTPLNMVEAKKIIDVTE
EKVTMLVNVTIELVETVYLAEKIIQYGNRYRRKYQKVHQGLLEAEAHFRNYRYKEALQYA
AATIEEIEPGSMSKIEAWSNEWKENQH
>PK3-045_01430 Cysteine desulfurase IscS
MIYIDNSATTKPFSEVLESYTTVSQKFFGNPSSIHRIGMEAEKLLIQAREQIAELLEVKS
NEIYFTSGGTEGNNTVLKGIARTFKGKGNHIITTTIEHDSIHKVMEQLAEDGFTITYVPV
NKYGQVSAEDIIKHIRKETILVSVMHVNNEVGSIQPIEEIGKCLSNYPNVFFHVDGVQGI
GKQPISLKKANVDAYTISAHKFHGLKGNGVLYIKEGKRIQPLLAGGGQENTFRSGTENVA
GAVATAKALRMQLQNQKEKMSVLTQINLYLREQLARIDGVSIHSPALGKSVAHILNFSIE
GIKAEVFVHALEERDIYISTTSACSSKTNKVSKTLLGMGVPEQIAENSFRISLSYANTME
EMEKVMAAIQDIKEWLRGVMK
>PK3-045_01431 putative tRNA sulfurtransferase
MKYDRILIRYGELSTKGRNRKQFVDKLRRTIAKSLEAFPTVSIEAKRERMYVLLNGEDVD
GISKVLKNIFGIQSFSPAIKLERDIEIIKAAALEIVTSLYEEGSTFKISARRADKGFELD
TNEINQTIGGHLLKNIPGLKVDVKNPDINVQIEVRTEAIYLSCENIAGAGGLPSGTSGKA
MLMLSGGLDSPVAGYLSMKRGLEVEGVHFFSPPFTSERAKQKVIDISEKLASFNGHFVLH
IVPFTTIQQLIHKQIPENYTMTATRRIMLRITDEIRKRQEALAIITGESLGQVASQTLES
MYAINDVTNTPILRPLITTDKTEIIEWAKKIDTHDISIRPYEDCCTVFVPSSPKTKPKKE
KIQYYESFTDFEPLIEEAVKNVETIILKREESNKVNTETDSLF
>PK3-045_01432 Small, acid-soluble spore protein 1
MASSNNSNQLLVPGVSQALDQMKYEIATEFGVNLGAETTSRANGSVGGEITKRLVQMAEQ
QLGGGFSK
>PK3-045_01433 Acetyl-coenzyme A synthetase
MKTEDLIAPKQYNFVSEIEKFAQNQDRLALKWENEEGETKEVTYSSLMKAANRIGNVFKD
EGLQKGDVVLVIVPRIIEAYQVYLAALKLGLTILPSSEMLRAKDLQYRIKHGDVKAVVSY
YPFIGELELVEDIHMIKRFVLGEEKEGWMHLDARAQDVSDELQLAPTLKTDTAFISYTSG
TTGNPKGVVHTHGWAYAHLRTAAPNWLCIEEGDLVWATAGPGWQKWVWSPLLSVLGSGAI
GLVYHGRFNPEKYLQLLEKYEVNVFCCTPTEYRLMAKVEDIHKYQLNQLRSAVSAGEPLN
REVIDVFKEHFHLDVRDGYGQTENTLLVGITKGVELRPGSMGKPTPGNLVEIINEDGEIC
SVGEVGDIAVHKDTPALFKEYLKEPERTQNQFRGDYYVTGDRARKDEDGYYWFEGRRDDI
IISSGYTIGPFEVEDALVKHKAVKECAVVASPDPIRGNVVKAFVVLRDGIEGNEELTKEL
QSHVKKLTAPYKYPRKIEFMNELPKTTSGKIRRVELRENEKNSKY
>PK3-045_01434 N-substituted formamide deformylase
MKKLIYGGKIYTLKEDGDLIEAILTDGQYIVDYGDKEYLQEKHGGTIEGEIDLKGDVLLP
GFVDSHMHLIGHGEKLLRLNLSACTSKEEALQMLASYARDIKEGQWIIGDGWNENMWPEQ
KVLTAKDIDQHVSNHPVLLNRICKHAIAVNSYALKIANITNDTPVPFGGVMEKDELGNPN
GVFKDQAQELITSVLPKVTDEYVENALRAGIKDAYRLGLTGAHTEDLNYYHGYKGTYQSF
KKVIEEEGNLFRAHLLVHHEVFEEMIEDGGKYLGGSEWVEFGSMKIFADGAFGGRTAFLS
RPYHDDPSTNGVSIFTQERLNDLVAMAREKECPIAVHAIGDAAFEMVLNAIEKYPLQGFG
RDRLIHATMLRKDLIERLKGLPLILDIQPSFVVSDFPWVIDRLGEENLAYCYAWKTLLEE
GLHCAGGSDAPIENVNPLVGIQAAVTRSNQEDKQGKGYIPKEALTIYEAVCLYTKGSAYA
ICHEEDRGKIEKGYVADFTILNKDIFHVNPHEIEKIKVMKTIVGNEIMYERN
>PK3-045_01435 Protein RarD
MEKNNVRIGAIFAGISYLIWGLFPIYWKHLQGVGADEILANRIVWSFIFMCILLTITWKW
TLFFQTLRSFKYQKKQGIMLFIASVLVSCNWFIYIWAVNANKIIETSLGYYINPLVSVLL
GIFVMKEKLSKIQYVSVLLAAIGVCIITFAHGAFPWIAISLAMTFGLYGLAKKLIKVDSD
VGLTLETMFITPFALLYIGYLFAKGDHAFLAISTSLDFLLIISGVLTAVPLLFFAKGAQR
IPLSMLGFIQYLTPTLTLILGVFVYHEPFTTAHLLAFIFIWSALTIYSLSRTKLFSSAKK
KEAKGIA
>PK3-045_01436 hypothetical protein
MRSKIINIEVGFSETFLLVGRIENRTNIRGF
>PK3-045_01437 Putative signal peptide peptidase SppA
MNGKRWAALGIAGVIFAFSIITSLVSIAFTTDVEELFGQFLGEGKAPYVEEYIEDGNIAK
KIAVLEVSGTIQDTGDADSLFSAAGYNHTSFMEKLDYIKEDPSVKGVILKVNSPGGGVVE
SAQIHDKIVEIQKEAKIPVYVSMGSMAASGGYYISAPADKIFASPETLTGSLGVIMSGYN
FEGLAEKYGVEFVTIKSGKYKDIMSSTREMTEEEREILQRLIDNSYAGFVKVIADGRGMK
EAEVKKIADGRIYDGRQAKELNLIDDFGYFDDVVEKMKADYKLNDAAVVKYTDNTGFGSL
FGMTAKKLITSEDKELANILKIVTNANSPRLMYLYAE
>PK3-045_01438 hypothetical protein
MSNEHEKLETENSLKEETVSETTFSYNEIVDRNEQTPIVPKEKKLPLGEVSYVYAGFWMR
FWAYLADLIIVSSVNRILIYPILRIADVPLYESGIFSTVNICTAITFYLYFVLMTKFLKQ
TLGKMIFGLKVVPINKEKLTWDTILFREWIGRFISSSFFILYALVAFLPKKQGIHDLFAD
TAVVHDR
>PK3-045_01439 hypothetical protein
MKVLFILAIIIGAFLLLLLFSFFLKLTIHIRYYHKKDNDDLKIEVRALFGIIRYKKTIPL
IKIDEDSPTLVIEEETEITGKKEKIEDTKQFSGSDLLNFLSNSQELLNHVVHFHRIVRSF
LAKLTIKNIEWSSIVGLGDAAHTGMISGAIWSVKGSIIGMISNYMKLHDMPKINIYPQFQ
GVASETLFSCMIQFRLGHAMMAGIKLVKYWKDGFPNFKTKETSIQSKQ
>PK3-045_01440 putative spore protein YtfJ
MSDHPIQGLMTTAMENLKEMIDVNTIIGDPVETPDGSVILTVSKVGFGFAAGGSEFTLEN
HSLNDSLTKHPFGGGSGGGVSITPIAFLIVNAQGVKMVHLDESTHLYEKILDIAPQAVDK
IQQMFAKKDSSSDSNSSEGQSQQQKEDIEF
>PK3-045_01441 Thiol peroxidase
MANVTFKHNPVTLIGNEIKVGDKAPDFTVLANDMSEVSLASSKGKIRLFSVVPSVDTGVC
DAQTRKFNEEASKLENVEVITVSVDLPFAQRRWCAASGLDNVITVSDHRDLSFGEAYGVV
MKELRLLARAVFVVDASDTVTYVEYVSEGSNHPNYEAAIKAVKEAN
>PK3-045_01442 hypothetical protein
MNISPVEELFTVFNETALIIQEELEYTYLESLALTGENIFQEAILQEELSELSKKRLKKS
YESIHLAKYSKEEIRKAFQLVILKGMKENTQPNHQMTPDSIGILFGYLVQKFYTKEELRL
LDLAVGTGNLLTTVMNHQIGKNIAAYGVDIDDLLLQLALVNANLQEQPIEFFNQDSLEHL
FIDPVDVVVSDLPVGYYPNDIRANEFKVKAEDGHTYAHHLFIEQSLNYVKPGGYAFFVIP
NNLFESEQAAKLHDYIKEEVHIQAIMQLPETLFKSKQSAKSILILQKKGNNIVAPKQVLL
AKVPSFSNMRAMEKVLSELDTWIQANK
>PK3-045_01443 Acetate kinase
MAKIIAINAGSSSLKFQLFEMPSEEVITKGLIERIGLTDAVFNISVNGEKIKEVTEIPDH
DVAVKILLGKLTELGIIASLDEIEGIGHRVVHGGEEFADSALITDDVIGKIDTLSELAPL
HNPANLTGIRAFQHVLPNVPAVAVFDTAFHQTMPEKSYLYSLPYEYYEQYGIRKYGFHGT
SHKYVSQRAAELLGRPIDQLRLISCHLGNGASIAAIEGGKSVDTSMGFTPLAGVTMGTRS
GNIDPALIPFIMEKTDQSADEVLQVLNKKSGLLGISGFSSDLRDITEQAKEGNDRAELAL
RIFADNIHKYIGSYASGMNGVDAIIFTAGIGENSEIVRARVLQGLEFMGVYWDPTLNKIS
GEESFVNYPHSPVKVMVIPTNEEVMIARDVCRLAGI
>PK3-045_01444 hypothetical protein
MLTKAEAYYLDKIEQWEKERKSERPIKILHLYSDYIDTGLSYLPEWQKQKIVRSLDNILF
HLHAILFNSTFQRNTAQKIMQQARVHNESIFTLRDMTKLSIDQLQSIAEKQMAHYRMLAS
VQGALASKHTGFFMGDFLSMLIINLRSVQVLASLYGRPADSPNEIMTALKVFCAGCLPHE
QRKEAWNELMDELEQEQQGFFYDGKDEIVQEKMLHSLLNELIKLSFILFLKRKYSKAGTI
IGAAANYHFTKRMTEMANHFYQKSYLLSKQDRIYPTLR
>PK3-045_01445 DNA helicase IV
MEKGETMEDFSIDEWEQEKKRLEYTKNYMNDVLHEAQINQGTLQENVRESISNEEALDSS
LSYINYLTNSKFLQLATTELSILKRILDAPYFARIDYQMKGKSQKNVYYLGKTSLFEKDT
QKPIIVDWRSPIANVYYDGRLGEVSYEVNEETIDGHLSLKRQFKIEKGELLHYQDIDLTT
TDELLQQSLAGKADQRLTEIISTIQAEQNEIIRADLNRPIIVQGAAGSGKTTIALHRISY
FIYNYAKYFQPEQLMIIAPNNMFIGYIAQALPDLGVEKIRQTTFLDYVLLCIGKKMKVIQ
SNKKLLTFINHTNKQEELVKWLSRYKGSLEYKKVMDKYLVDICNEMSPKEDFRVEKFPLY
GAKKLERLFKKEYDYLPLIKRKEKIKGILQADLKRKKKIILSKLEDKYEDALDRALKIKE
DTKRKEKVVYFLDTKAERLATVKKEASTAVRRYMKTMETTDLYGYYSRLFADKELLRKYT
EDSLTEKQLDYLIAFQRKILKQKKVEIEDLGALFYLQYKIFGIDKEYRAKNIVIDEVQDY
SEFQLYALKAGLETDMFTLVGDLAQGIHSYRGLQNWQTLQQTIFSRANYMTLQKSYRTTI
EIMFLANEILHLVNEDLPKVKPVVRHGEKPTVHLYEQKQELVDRMIQVADRLHNDGYHSI
AIIGKTEEECKAILKEMQKRKVPNVQFLQENEDLEKNYLIIVPSYLSKGLEFDAVLLFTL
NESFSQEEIDLKLLYVAMTRPMHRLHLFTRDKASLLLDKTYEAYFTVEKENERKSGER
>PK3-045_01446 Molybdenum cofactor biosynthesis protein B
MNKQIHTKHQYLQVGCKIITVSDTRSEENDKSGKLMIDLLEQENHSIQKYVIVKDEKEQI
VQEIITGVQSAEIDCILLNGGTGISPRDVTIEAIKPLLTKELDGFGELFRMLSYTEDIGS
SAILTRAIAGTINNTVIFCTPGSTGAVRLAMNKLILPELSHVVSELHK
>PK3-045_01447 Argininosuccinate synthase
MANPKVVLAYSGGLDTSVAIKWLQDQGYDVVACCLDVGEGKDLNFIQQKALSVGAVQSYV
IDAKEEFAQDFALTAMQAHTLYEGKYPLVSALSRPLISKKLVEVAEKENAIAVAHGCTGK
GNDQVRFEVSIQALNPNLKVLAPVREWGWSREEEIAYAKEKNIPIPVNLDSPFSIDQNLW
GRSNECGILEDPWAAPPEEAYDLTVSLENTPDQADIIEIEFKEGVPVSIDGITYSLSALI
LELNKIAGKHGVGRIDHVENRLVGIKSREVYECPGALTLMKAHKELEDITLVKEVAHFKP
VIEKKITEVIYEGLWFSPITKALQAFLQETQKNVTGTVRVKLFKGHAIVEGRKSPYSLYD
EKLATYTSDDEFDHAAAVGFIKLWGLPTKVQSIVENDKKVSV
>PK3-045_01448 Argininosuccinate lyase
MKKLWGGRFTKSAEEWVDEFGASISFDQELVLEDIEGSIAHVAMLSKTGILSVEEAEKIK
NGLLTLKKQAEKDELTFSVKLEDIHLNLESKLTDLIGPIGGKLHTGRSRNDQVATDMHLY
LRTQVKQIIQLLNELQSALLEKAEHHIETVMPGYTHLQRAQPISFAHHLMAYFWMFERDK
QRYQENVTRINVSPLGAGALAGTTFPIDRSYSADLLGFDSIYENSMDAVSDRDFILEFLS
TSSILMMHLSRFSEEIILWSSQEFKFIELDDSFSTGSSIMPQKKNPDMAELIRGKTGRVY
GNLMGLLTVLKGLPLAYNKDMQEDKEGMFDTVKTVVGSLRIFAGMIQTMKVNEQGMENAT
KNDFSNATELADYLSEKGMPFREAHEVVGKLVLYCVNKKCYLQDLSITELQEASSLFEQD
IYHVLNPRTAVERRNSAGGTGFTQIKQAIEKAKLCVWEKEEVK
>PK3-045_01449 Putative universal stress protein
MNVNYQNIIVAVDGSDEADNAIKKAISIAKENNARLVIAHVIDTRSFATVAAYDQSIAAK
SDEFANELLDKYIVQATAAGVQNVVKAIEFGSPRAVVPREIATKYKADLIVCGATGLNAV
ERFIIGSVSEGITRNAPCDVLIVRSSDQ
>PK3-045_01450 hypothetical protein
MHKQNERIQNDFEFDEKGSEEVTAQVMDSYNDGAVDAFLDKEQKQIKD
>PK3-045_01451 hypothetical protein
MVKYVDYTDSKVQYHFDVNKSNFFTRDSHNYINVLGEQQLNSLENVSLLDIYLSKDIVVE
PHIHQNAAELVYCISGSATVSLLNPFTKKVLNYTITPGQVANVPQGWWHYEIANTNKTHL
LAIFNAPTPEAIFGSDLLRLTPPDLMAHTYSLDLNKWKSTISPINKTTILGPAISRNSPS
QNYYADANYPQPIYQPYYIPRNY
>PK3-045_01452 putative peptidase
MEKKIASLANWMKQEEIDFTFLTSTDNIFYFSGFYSDPHERLLALIVFPENDPILVCPAM
ETNDAKDAGWNYDIIGYSDTENPWETIQSMVQSRTSRTRKVALEMDHMNVARYQALQTSF
PNIEGYVSAEEKINTLRMIKTSDELAKIKEACKWADFAIEVGCNEIVEGKSEMEILAAIE
YELKKQGIGKMSFSTMVLTGVNGASPHGNPGETKIKKGDLVLFDLGVVVDGYCSDITRTV
AFGDINEKQKDIYDTVLKAQLTAIEASKPGVSCATVDLAARNTIREAGYGEFFPHRLGHG
LGISVHEFPSLTETNSLVLQEGMVYTIEPGIYVPNVAGVRIEDDVYVTKDGVEILTKFPK
ELQIIQ
>PK3-045_01453 hypothetical protein
MNKNRYLLCILLCGVLLYYGMPRLSPFSDGVEGIFSITWLAFALMVVAGNLTALLYTPKK
PRTAKRSYSKVQKKKKIYYYQ
>PK3-045_01454 Inosine-5'-monophosphate dehydrogenase
MLFLKEGGNLATKHEQILNYIDELQVGEKISVRQIAKALNVSEGTAYRAIKEAENKGYVS
TIERVGTIRIERKKKENIEKLTYAEVVNIVDGQVLGGRAGLHKTLNRFVIGAMKLDAMMR
YTGPGNLLIIGNRVRAHEHVLKAGAAVLITGGFDTEEHVKRLADDLQLPIISTSYDTFTV
ATMINRAIYDQLIKKEIVLVEDILTPLKDTIYLKTTDDVALWHKYNKETLHGRFPVVDQS
LKVQGMITSKDVIGKSMDMTIDKVMTKHPMTVSGKTSVASCSHMMVWEGIEVLPVVDEAN
KLEGIISRQDVLKALQMNQRQPQIGETIDDIVTKHVLLTKGKNKGETSFSCEVTPQMTNH
LGTISYGVFTTVVSEAANRVLRGFKKGDLVVENMTIYFIKPVQMDSVIEIVPKILEVGRK
FGKVDVEVFNHGILVGKAMMMCQLIDRH
>PK3-045_01455 Bifunctional oligoribonuclease and PAP phosphatase NrnA
MKQKILDAIKAFNTIIIHRHVRPDPDAYGSQGGLAEIIKTSFPDKNVYTVGKEEASLNFL
RRLDVIDDSTYADALVIVCDTANQERVCDQRYLTGKMLIKIDHHPNDDAYGDIVWVETTA
SSTSELIYEFYLYGKDQGLKMSDESARLLYAGIVGDTGRFLYPSTSEKTFHYAGELIKYS
FSRTEMYDQMYELDPHIVKLSGYVMQNFQVHANGVASMKLNKEILAQFQATPAEASLLVS
SLGSVKGLKAWVFFIEEADQIRVRLRSKGPVINGIAKNYNGGGHPMASGATIYQWDDAGK
VVKDLEEVCR
>PK3-045_01456 Sporulation membrane protein YtrI
MRIPPYYKNQAVQRFFAGMVIGGVISWCIFVFIFGVWQERYSSEIKTQKATIEDLEREKK
IWQEEFAAQNKTTEEKLTVEDIVVKISNADKEKYDIKPFNALEMEDAIKEDLSTIIAKDL
DMVYKSRALLKKSIENKVVVSDKKRYKFKVTELIIYTTVHVELRVTFGD
>PK3-045_01457 Sporulation membrane protein YtrH
MNQQPFFPTFIESYFIALGVILGGALLGGLAAFLTGKPLLTEIIRISGIIKIWAIVTAIG
GTFDAIDTIEKGIYDAGTKDLFKQILLIVSAFGGAHTGITIIKWITQEYI
>PK3-045_01458 DNA polymerase III subunit alpha
MSFIHLQVSSAYSLLSSTLSIKELVTNAKKYGYRSIALTDRNVMYGAASFYKESLKQGIK
PIIGLTVDVISEWEEDKAYPLVLLARTSLGFKNLLKITSAVQTKNPQGIPVKWLKHYAKG
LIAISPGFEGEIEQNLLKDDSESARNTLMLWKSIFEPGQCFLSIQRHGIAIEDALNEKLS
RLASEEKVKLVATNNVFYLEEEDHFAYECLKAIKNGEKLSDIEQDEWSSNQHYLKDKEEM
ITLFNDQPDILENTWKVGESCQIEMNGILATLPKYTVPAGKNALSYLRELCMAGLNDRYS
HPSPEHTARLEYELDIIGRMNYSDYFLIVWDFMKFARENGILTGPGRGSAAGSIVAYVLH
ITDVDPIKYQLLFERFLNPERISMPDIDIDFPDNKREKVISYVKNKYGELHVAQIITFGT
LAAKAALRDVGRAFGLSVKELDELSRMIPSKLGINLKQSYQESIRLQQFVESSPRNQKLF
DTACKIEGLPRHTSTHAAGVVLSQQPLVDIIPIQGSHDDIYLTQYSMEYLEELGLLKMDF
LGLRNLSFIEAILDMLYKATKKRIDIRKIPIDDQNVFKLLSRGETTGIFQLESEGMRNVL
KRLQPTDFEDIVAVNALYRPGPMENIPHYINRKHGKESINYYHPDLEEILKSTYGVIVYQ
EQIMQIASKMAGFSLGEADLLRRAVSKKQKEILEKERIHFVKGAERKGYHEKTANEIYEL
IVRFANYGFNRSHAVAYSLIAYQLAYLKANYPLYFMAALLTSSLGNTGKIIQYIQELKQM
DIELTPPSINQSNYFFRVEKNKIRYSLAGIKGIGGNVLREILKARSQKKFEDLFDFCIRV
SPKTVNRRVLEMLIYSGSFDEFGVDRAILLASIDVAIQHAQLVHPEDEEQNDLFSEDDFF
FKPKYVEVEPLRVEDKLALEKDALGFYLSDHPVSIYKPYQATLQTFAINEMEVGKKHKSI
VYVTEINIIRTKKGEPMAFIQLSDQSGEMQGVIFPTIFKKYQSLLNSGEIVYLEGKCEER
NGNKQFVIQLVESMRTIVQSLSKKEHKLFIKVMNEKHMMNQRLELLAVMRKFPGTTPVII
HYEETGKNIVLNEEYKISPSKECIAELSTLLGANRVFLSE
>PK3-045_01459 hypothetical protein
MNESSSKESKLYVDIVNHLREMINQNGLKPGDKLPSERVLSDTLHAGRSSIREALRALEL
LGLIETRKGEGTFLRDFQGHKLVELISTFILQNDKAKQDVLETKNYIQLNALYIAMEKIT
EDELAHLKQLVNEREISESEFFFQIIKIADNFLVHRLWTILNDYYHSLTIPAKEWKREDY
LLLLDSLKQKNQMQLWSVFSNYNNFN
>PK3-045_01460 Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta
MIKGIFSKSKKLKYATLPSELSKNEVPEGIMTKCSNCKKIMYTRELQKNHKVCLNCGYHL
PMKAYERMNCILDEATFVELNAEMRTGNPLQFPGYEDKIAGDIKKTNMNEAVVTGTGEIN
GKKVVIAVMDSSFRMGSMGSVVGEKITLAVEKADELSLPFIIFTASGGARMQEGVLSLMQ
MAKTSIALKRFSDNGGLYITIMTHPTTGGVSASFASLGDYNFAEPGALIGFAGRRIIEQT
IGEELPEDFQTAEFLLKHGQLDAVIPRLELKEKLSLVLEMHQTGGELEW
>PK3-045_01461 Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha
MVGLDFDKPINELKDKIQELKDFSENANVDLSTEIEKLEIRLKKLEKDVYDNMKPWDRVQ
IARHPNRPTTLDYIPHLFTDFIELHGDRGFGDDEAIVGGIAKYKGLPVTIVGHQRGKDTK
ENIRRNFGMPHPEGYRKALRLMKQADKFNRPIICFIDTKGAYPGKAAEERGQSEAIAKNL
FEMASMEVPIVCIVIGEGGSGGALALGVGNHIHMLENSTYSVITPEGAASILWKDAGQAK
QAAEKMRITAPDLKELSIIDSIIKEVKGGAHHNIKEQAEQIDEVLYTSLKELKEMTKEEL
VNHRYAKFKNMGAYLNH
>PK3-045_01462 ATP-dependent 6-phosphofructokinase
MTVKRIGVLTSGGDAPGMNAAIRAVVRKAIFHGVEVYGVVGGYAGLISGNFRKLEVGSVG
DIIHRGGTFLFSARCEEFKTKEGQQKGIEQLKKHNIDGLVVIGGDGSYMGAKALTEQGYP
CVGVPGTIDNDIPGTEFTIGFDTALNTVIDAIDKIRDTATSHERTFIIEVMGRNAGDIAL
WAGLAGGAETILIPEEGFNLEEIVGRLKKGQERGKKHSIIVVAEGVASGVEIGKLIEENT
DFDTRVSVLGHMQRGGSPTAQDRVLASRLGAYAVELLVEGKGGRAVGIEKNQLVDYDIIE
ALARKHTIDNNLYHLSKELSI
>PK3-045_01463 Pyruvate kinase
MRKTKIVCTIGPASESVEKLTQLMEAGMNVSRLNFSHGDFEEHGARIKNIREAAEITGNN
IAILLDTKGPEIRTNNMKDGSIELVAGNDIIVSMTEVEGTTEKFSVTYEGLIDDVEPGSK
ILLDDGLIGLEVTKIDKAAGEIHTKILNSGTLKNKKGVNVPGVAVNLPGITEKDANDILF
GIEQGIDFIAASFVRRASDVLEIKQLLEDNNASHIHIIPKIENQEGVDNIDEILEVSDGL
MVARGDLGVEIPAEEVPLVQKMLIKKCNTLGKPVITATQMLDSMQRNPRPTRAEASDVAN
AIFDGTDAIMLSGETAAGLYPVEAVQTMNNIAARAEEALNYKEILSKRSKDSEHSITDSI
GQSVAHTALNLEVKAVITPTGSGHTARMISKYRPEAPIIAVTYDAKIQRQLALVWGVYPR
LSQKSESTDEMLDVAVQEGVNSSIVTHGDLVVITAGLPVGEAGTTNIMKIHVIGDVLAKG
QGIGRKTAFGKAVIATSAKEALDKVNFGSILVTNATDRDMVPALEKCSALIVEEGGLTSH
AAVVGLNIGIPVIVGVENATSILKDGLDITVDSRSGYVYSGHASVL
>PK3-045_01464 hypothetical protein
MRNFMISLLLLPLIELVIFLIAGNIIGIPETLIIAIGTGILGGILLKKQGLKAIRNVQVQ
INQGIMPGDAILDSFCILIGGLLLLFPGFLTDIAGVLILFPPTRRIGKNLFIRNIQRKLQ
KRNRVTIIHSYK
>PK3-045_01465 hypothetical protein
MFSLLRKWNTLRNQILFVFLSVMLVVLLFVSILIFNQVSTLLEKNAEKQIQQVAVEASGR
IETLYEQLNMASKLAATNDKVQKLLTREYEHKKATFYEKQELMGTVNTVTANSDGIFSFQ
LFTREQERILPLDDAKIMTDLHADWVEKADQAKGSLVWIGEDPNDSNYFLAIRRVNLINR
SFTNGGYLLFSIYANYFQFANQTLTDKTDQYFILLDELNKPIITNYQQSSEFILQTKKKT
VPINERDYMITKNSSYMTGWTVLILTPYNTLTEGITVVRTSILLAGIIGLMIFFVCSFFL
SNMITRPIIRLTNTMRFASEGSLPLTPKIPSVNEINELNSTYNQLVKETNHLITMVYQKE
ITRNRSELRALQAQINPHFLFNTLDALHWSLEENDEEELAELVVTMSNLFRYTISRSTED
EWVRIKEEIAHIEDYMEIMKMRFGELLKWQIQLPKAFEEVKIPKFLIQPLVENAVLHGAE
NKVGQCTVDVIVQQGEMDNNIKVIVRDDGIGISESKLKKIKESMEKEGISSATGKGMAIS
NVYKRLTLYYQERQQKGLMIESIENKGTFISFEIPKDGGM
>PK3-045_01466 putative response regulatory protein
MYAKTILIVDDEPRSREGIKKVLENWSSGQYQILISENAESAIDIMQKQKINILLTDIRM
PKITGIKMLKTIRDQKHLPVVIVISAYSEFEYAQEALRLGVINYLLKPISKKKLIEAVED
ALKIDRDKDRNDIISKVVDNKLIDARVTKESVREPIQKALQYIDSHLNEELTQRDVAAHV
YLNPSYFSVLFKEEIRLTFSEYITRRRIQHAKNLLISTKLSIADIAEESGYKTAKYFIKI
FKDLEGITPSGYRKINNENNERAF
>PK3-045_01467 Multiple sugar-binding protein
MFHRKVLSACLSVALLLVLVLAGCSSSTSSNNESASKNGDKTVIKFMHLWPEGSSKAQFT
IVNDIIKQYEKDHPDVKIQTEILGNEQYKDKIKVLSASNELPDIGVTWAAGYMQPFVKGE
MFAPLDDVIDSNFKDQFVAGTTEAFAMDGKTYGLPLELNITPVYYNKEIFEKYNLEVPAT
YDEFLNVVKTLADNGVTPITLGNKDRWTGSMWYMYLADRIGGPEVLTNAINRTGSFEDPA
LVQAAEEVKKLVDMGGFVKGFNGLSNDEAKGYFMNEQAAMYLMATWELPNYTTSPDVTQE
FKDKVGYFKFPTYVGGKGDINSFVGGPGVGLFVSEKSKVKDEAKEFVAYLVKEWGKNSVK
DAGVIPATVVDTANIELDQMYIDILNDLGNASNLTLYADVQMSSSVAQVHLDMIQSLFGG
QATPKEFTAKQEQALAEEE
>PK3-045_01468 Diacetylchitobiose uptake system permease protein NgcF
MKNVMSNKWVITLYVLPALLLILVLIYIPIVLTGYYGLMDWDGIGAKTFIGLDNYIQLMK
DKMFWSSTYHSVLLAVFSAISLIAYLVISLILASKIKGAGILRKIYLIPMLLSSVAIAQL
WLKIFDPTNGMLNKLLTMFGVENTPLWLADPNLVLYSIFIPIVWQYAGFYIIIYYAALKG
VADEIIEAAKIDGATPLQIAYRIKIPLIAPVIKVTIVLAIVGSLKYFDLIYVMTGGGPNG
ASEVMASYMYKEAFKTYDFGYGSAIGFALLIICLVMTWVIQKLTASKEDAQY
>PK3-045_01469 Diacetylchitobiose uptake system permease protein NgcG
MSEVILKKQNKTELSTSPKTKGSLGSKIGYGLLYLVLGVIAIFQIYPLVWLFFFSLKTNQ
EVFGLSPFALPQDPQWGNYVKVWTQGNISLYFFNSVWITVVAVVLTVILASFVTFAITRM
HWKLSKLVLGLFMVGIMIPLHSTLIPLFSFFNNLELIDNPISILLSYTAFNLPLTIMILL
GFYQALPRELEEAAVMDGCSIHRIFFQITLPMTTPVMATVVIINMIYNWNEFVFVNTFIS
SDQWKTLTVGVNNFVGQYLTDWGAIGATLMISIIPILIAFILLSNKIVEGLAAGSVKG
>PK3-045_01470 putative protein YesV
MTTKPMGKLYIICEWIMKLASVNLLWIMFTASGLFLFGFMPATVALFTIVRKWFRKETEV
PIWKTYLSVYKSEFTKSNTFGFIFILAGLILYVDYYLILHLDGFMRIVSISILLLITCLY
AITLLFFFPVYVHYQLRFIDYFKYSLFLGILNIHITLLILLGLAADIFLLLYIPGLLPFF
SGISAACILMSSSILLFQRLQKQNMNKAIIE
>PK3-045_01471 hypothetical protein
MTTIQEVIDKLMEPAKMVDSTTDVLIKGSADTEVKRIVIAFTVTQQVLEKAISIGANMII
SHEGPFYSHENWKELYEKDPVYMTKLQLIEDAAINIFRFHDYYHRYNPDGVMVGLIQKLE
WENYIEKHQSIATTIVTPKKTVADIATYVKVKLDAPFVRVVGELSMECQRIGLLAGYRGG
GEVVIPLFQNQNLDLIIAGEGPEWESPEYVRDAVQQGKKKALILIGHAVSEEPGMEYLTT
ILANDFPHIPVHYIKEKPLFQII
>PK3-045_01472 putative multiple-sugar transport system permease YteP
METEVVHSHVNKTMKAKRSKFKTTLTAIRKDWQLYSLLVLPLIYLIIFKYGPMLGNVIAF
RRYMPGGKIYGEQWVGLYYFNMFINDPVFWNVFKNTFILGGITLLFCFPMPIIFALLLNE
VKSKKFKKFVQTASYLPHFLSIVIIAGMILQLTALNGSINGIVEFFTGEKISFIQSPEWF
RTIYVTSEVWQGMGWGAILYLAALTTIDDSLYEAAKIDGANRWKQTLHITIPGILPTIVT
LLILNIGSFLAIGFEKILLIYNPLTYETSDVISTYLYRVGLESNNFSYAAAIGLFESIIG
LVLVLTANSISRKLTERSLW
>PK3-045_01473 L-arabinose transport system permease protein AraQ
MKESKQYKVFKVFNVCILLIIIFCTLYPFINVVAQSFSSESYINSGQVNLIPKGFNVDTY
EKVLSDTMFWINYKNTVVYTVVGTIISMFLTTMFAYALSKRRLVGRRFLTVFAVFTMFFN
GGLIPNYVLINSLGFGNTMWAIVIPGAISIYNMLIMKSFFENMPEELEEAASIDGLSTYG
ILLKIVLPLSKAVMATMVLFYAVAYWNSWFSAFIYMDKKELFPVTIYLRNMIAGTTGGMS
AGATSADNLTQISANIKSVTMVLTILPILTVYPFVQKYFVSGVMLGSIK
>PK3-045_01474 hypothetical protein
MKESWKKVGLFLGLIVFVMIAVACSKNDSASKEVEVATKGAMESYSAGDTFKATEPFDLS
ILYMDQPTYPYKKDWLLWDKIKEITNVTLKPTIVPLSDYTQKRSLLISSGEAPIVIPKTY
PGEEAAFVASGAALPVSDYIDKMPHFKEKIEKWDMGPELDTLRQNDGKFYVLPGLHEEVW
PDYTLIVRTDIFEENNIAIPTTWDELYTAMKKLKEIYPDSIPFSDRFTFNSTLNIAATSF
GTKAGWGFGNGLSYDQDADEFVYAATTNNYKEMLTYFHKLVEEGLLDEESFTQSDDQAVQ
KFVTGKSFIINGNSQTINLHRVDMDKTLGKGKYSISKITVPGGPAGQLMSGSRLENGVMI
TSKIKESENFEAILQFIDWLYYSDEGQEFTKWGVEGTTFTREDGVRKLMEDINYNGLNPN
GTKDLRVDYGFSGGVFSYGGTTDLLHSMMSEEEIKFQNDMKAVKTPIPTDPLIPYSIEDR
EKATLQSTPLKDYTNQNTLKFILGTRDLSEFDAFVKELQSQGLEQYVDTANQTYQEYKKN
NK
>PK3-045_01475 hypothetical protein
MKQQREFGQGVLYTFCNYVYWVLLTNIYFVVTNLIFIFFFMTLTPSFSNILIYALALIPS
GPAISGLLYSMEKLVRTKELSPTTDFFYGYRSNLKGTFFLWIIILAVFFVLFIDLQYLQI
TITPVNQIIFIVVLALTLIWTMLSINMLIINAKYTFRIRDLIKLSAYYLFIKWKETIGNI
LILFFTAVATVITNDFLIVFIASLLAWIMVFNSRELLKHIDRNFLKKSPSNNISEKYDAP
PLQGS
>PK3-045_01476 putative oxidoreductase UxuB
MLPLMKNLSGKVAVITGGGGVLCGCMAKELGRQGVKVAILNRTYEKAQKVAEEINNEGGM
AIAIACDVVDVNSVKEAEKIVLDTFGNCDILINGAGGNHPKGITSEEILRLEDLDKEGIT
SFFDLTMEGFSFVFNLNIIGTLIPTQIFSKQMVGKSGTIINISSMSAPSPMTKVPAYSAA
KAGIENLTKWLAVHMAETGIRVNAIAPGFFLTKQNEGLLKNSDGTYTERTKKILAHTPVK
RLGKPEDLLGTLLWLVNEETSGFVTGISVPVDGGFMAYSGV
>PK3-045_01477 N-acetylglucosamine repressor
MHITWNQQLVKKENKSLCLNLIKNNAPISRADIAQQTGLTKGTVSSLVSELINEQLIYES
GHGESSGGRRPVMLLFNEKAGYSIGIDLGVNYLLGILTDLQGNIIYRINEKYVNLSYEDT
LQIIKKIITLLIDTAPNSVYGVIGIGIGAPGITNMDGDILFAPNLDWNNVSLKSHLEEEF
HLPVLVENEANAGAYGEKKFGVGQTYQNLIYVSAAIGIGAGIIINGELYKGNLGYSGEIG
HMIIQKDGLECRCGNKGCWELYASEQYLLNKAVELKLGIKGQVYLNDLIELADQGNTQAI
HLFNEVGNHLGAGIINIIHIFNPEQIIIGNRLTLAKKWIEPQVKKIIDNYTLPFHQSQLA
IHFSDINFASSALGAAAFSTENFLKFMLHPE
>PK3-045_01478 Aldo-keto reductase YhdN
MEMNYRNLGDTGLKTSEVSFGTWAIGGSWGKVDDTEALKSLHMAMDKGVNFFDTADVYGD
GHSEELLAKATKGKENQIHIATKFCRGGDIFANENYSEERIRQYCENSLKRLNRETIDLY
QIHCPPIEILKDGRVFEVLDNLQEEGKIRHYGVSVETVEEGLICLQNPNVKALQIIFNIF
RQKPLELLIPEAARKGVGILVRLPLASGLLTGKFTKEHTFAEDDHRKFNENGEAFNVGET
FAGLGFEKGVELAEDLAWIGENRQSMAAAALRWILDQPGISCVIPGFKNRQQINENLKAL
VEKPFNNEELQRLRAFYEKKVKNAIRGPY
>PK3-045_01479 Sodium-lithium/proton antiporter
MNLTYLNRTIRFIIVIAATILLFVSFFYLSKVTYPFIIGFLIAFLMNPLVNFLQFKCKLP
RAFAVVLSILLILSIFAGLVSLLIAEIVAGAAYLGEVVPKHIDIIIRYIEDLFAAQIIPL
YNKISQTFNNLGTGQQDTIMTNIDKVGEQVGTVMGDFLQSFFLNIPIFLSWFPNAASVLI
FSLLATFFISKDWARLSLKFGKFFPSKWLNSGKTVFFELKKALFGFLKAQLTLVSITTVI
ILIGLLILRVDYAITIALLTGIVDIIPYLGTGLIFVPWIIYEIITGQIVLAIGLSVLYII
VLVQRQIMEPKILSSNIGLDPLATLIALFVGFKLFGFIGLIIGPVSLVIVTSLHRAKVFH
DIWRFIKGDSEIPK
>PK3-045_01480 hypothetical protein
MFLFSQPYLFLYLLLAIALIAKNNSLIIAVVFLLVLKLIGVDSKLFSLIQSKGINWGVTI
ITIAVLVPIATGDIGFKDLTATFKSPYAWIALISGIMVALLAKGGVSLLADSPEITTALV
LGTILSVSVFNGVAVGPLIGAGIAYAAIKVVEWIT
>PK3-045_01481 Citrate synthase 2
MAVTKGLEGIIATTSSISSIIDDSLAYVGYDIDVLAEHSSFEEVVFLLWHQKLPTDTELA
MLKQELADNAELPVSLIEQMKLMPLNKVHPMAVLRSTVSLLGAYDEQADAMDTEANYLKA
VRLQAKIPTIVTAFSRLRKGLDPISPRKDLGFAANFLYMLNGKEPEAIAIEAFNKALVLH
ADHELNASTFTARVCVATLSDVYSGITSAIGALKGPLHGGANEAVMKMLKEIGSIDNVEP
YIREKMANKEKIMGFGHRVYRKGDPRAKHLKEMARKLTQLTGEPELYDMSVKIETLLKEE
KNLVPNVDFFSASVYHSLGIDHDLFTPIFAVSRVSGWLAHILEQYDNNRLIRPRADYIGP
ERLEYIPVQER
>PK3-045_01482 Isocitrate dehydrogenase [NADP]
MQGEKITVVDGVLNVPANPIVPYIEGDGIGPDIWAASSRVLDAAVEKAYNGEKKIVWKEV
LAGEKAFNETGEWLPSETLDVIREYLIAIKGPLTTPVGGGIRSLNVALRQELDLFVCLRP
VRWFEGVPSPVKRPQDTDMVIFRENTEDIYAGIEYEKGSEAASKLINFLQQEMGVNKIRF
PETSGIGIKPISEEGTSRLVRAAINYAIKEGRKSVTLVHKGNIMKYTEGAFKNWGYELAE
QEFGDKVFTWAQYDRIKEEQGSDAANKAQSQAEAEGKIIIKDSIADIFLQQILTRPKEFD
VVATMNLNGDYISDALAAQVGGIGIAPGANINYETGHAIFEATHGTAPKYAGLDKVNPSS
VILSGVLLLEHLGWTEAAQLVIQSVEKTIASKVVTYDFARLMDGATEVKCSEFGDELIKN
MN
>PK3-045_01483 Malate dehydrogenase
MVKRKKISIIGGGFTGATTAFLLAQKELGDIVLLDVPRNENSTKGKALDMFEASPVQGFD
ANITGTSDYKDTADSDIVVITAGMARKPGMSRDDLVQTNQAIMKSVTKEIVQYSPNCVII
VLTNPVDAMTYTVYKESGFPKNRVIGQSGVLDTARFRSFVAMELNLSVKDITGFVLGGHG
DDMVPLIRYSYAGGIPLEALIPKHRLDEIIERTRIGGAEIVNLLGNGSAYYAPAASVVDM
CEAIIKSQRRILPTIAYLEGEYGYNDLYLGVPTILGGNGIEQIIELELTEEEKAALDKSV
HSVRSVLTVLN
>PK3-045_01484 Alkaline phosphatase synthesis transcriptional regulatory protein PhoP
MKKKVLVVDDEQSIVTLLKYNLQQAGYDVLTAMDGEEGLNLALTANPDVILLDLMLPKKD
GMDVCKELRQQKVLTPILMLTAKDDEFDKVLGLELGADDYMTKPFSPREVIARIKAVLRR
IQMQVPAASDEVDEEEDDGIKIGELRVLPNYYEAYFKGELLELTPKEFELLLYLVKNKGR
VLTRDQLLSAVWNYDFVGDTRIVDVHISHLREKIEENTKKPIYIKTIRGLGYKLEEPK
>PK3-045_01485 Alkaline phosphatase synthesis sensor protein PhoR
MKSFKSRLMASVLFTIFIVFLFVAIFIESYNKKTFMDSFDSRLKREGTLIAKQIMKNGDG
LDINNSLLKEYSEALDIQITVIDETGEILFNEGELQTDTEYENRMQRLLSNEKAKAVSIN
GNPNFHFYQQQLTGEEGRLGYLLIGAKIEEIEKAYQHINWIIFASFFLSLLVIYLIGYKL
IYRYTRPIESATKVAVDLANGNYHARTYEDRVDETGVLSSSLNKVAKDMQEMVKAQEIQE
DRLGTLIESIGSGLLLIDSRGYINLINKSYKDMFFVRSADYLYKQYYKVIPYRQVTDLAE
EIFMTEHKVIRDMTLEIKNEKKSFQVYGVPIIGTNDRWMGILLVFNDITELKKLEQIRKD
FVANVSHELKTPITSIKGFSETLLDGAMEDKETLEEFLRIILKESHRLQTLIQDLLDLSK
LEQHHFALNKEEFNLMEILNKATKMLEGRAEAKNIKLLFPQANEIVQIEGDRSRLTQVFL
NLITNAVIYTPNDGEITVYVVEKKKKIEIRIQDTGIGIEQEEIPRIFERFYRVDKARSRN
SGGTGLGLAIVKHLVELHRGTIQVESEMGEGTTFTVILHKEFPF
>PK3-045_01486 DNA polymerase I
MKKKLILIDGNSIAYRAFFALPLLNNDKGVHTNAVYGFTMMLMKIIEEEKPTHALVAFDA
GKTTFRHKTFSEYKGGRQKTPPELSEQFPYIRELLKSYGIHHYELENYEADDIIGTLSLQ
GEKDGFEVVVISGDKDLTQLSSDKTTVYITRKGITDMESYTPDHIQAKYGLTPDRIIDMK
GLMGDSSDNIPGVPGVGEKTAIKLLKEFDSLENLVQSIDKVSGKKLKEKLEEFKDQALMS
KELATIFREAPLTITLEDTEFPGMQIEKLKEIFKELGFNSLLEKLGDAPEKEELVLEDIE
FKTVENITDDIFSDRNIMYVEVLEDNYHYAPILGISLLNDNGAYFLPIDHALKSSAFKNW
AEDEKKEKIVYDAKRSEVSLRHQGIHLKGITFDILIAAYLADPSATIEDVASVAKKYDFT
NLQSDEVFYGKGAKRKVPEQEILADHLVRKAFALKAIQETMEDELKKNDQEALFYDLEMP
LSLVLADMESTGVKVDVSRLKAMGQELSERLKEIEGRIYELAGETFNINSPKQLGVILFE
KLGLPVVKKTKTGYSTSADVLEQLASSHEVIREILEYRQLGKLQSTYIEGLQKVVHNGRI
HTRFNQVLTQTGRLSSIDPNLQNIPIRLEEGRKIRQAFVPTEEDWVIFAADYSQIELRVL
AHIANDEKLIEAFREDHDIHTETAMSVFHVEADEVTSNMRRHAKAVNFGIVYGISDYGLS
QSLHITRKEAAKFIERYLESYPGVRNYMEEIVADAKQKGYVSTLLQRRRYLADITSRNFN
LRGFAERTAMNTPIQGSAADIIKKAMIDMAKRLEVEGLKAKLLLQVHDELIFEAPKDEIE
KLKEIVPDVMEHAVELSVPLKVDYSYGPTWYDAK
>PK3-045_01487 Formamidopyrimidine-DNA glycosylase
MPELPEVETVRKTLKQLTQNKVIKEVVVSWAKMIKKPENVEEFSDALVGQTILDVKRRGK
FILIETNDFTIVSHLRMEGKYGVFQAQEPVDKHTHVIFFFEDGSELRYKDVRKFGTMHLF
KKGEESNAMPLSQLGPEPFAADFTIANFSERLSKTNRSIKTALLDQKIVVGLGNIYVDES
LFRSGIHPERTANSLDVKEIEKLYKEIIATLSEAVEKGGSTIRSYVNTQGQIGMFQLELY
VYGRKGQECKVCGHTLERIIVGGRGTVFCPNCQKK
>PK3-045_01488 putative sporulation protein YtaF
MVQVFSLLLLAIAVSIDSFSVGFTYGLRKMKMPLNSILIIACCSGLTLLIAMLVGHVISR
IFSPSFAESIGGIILILLGGWILYQYFKPSKEKEILTEEKNIINFEIKSLGIVINILKKP
LTADFDKSGTITGLEAVVLGFALSLDAFGAGIGASMLGFPPLFLTLAVIFMSTSFVSLGI
YLGRFLSEKSYMDKFSFIPGIILIIIGIFKL
>PK3-045_01489 Dephospho-CoA kinase
MTLIVGLTGGIASGKSTISSYYQSLNIPIIDADIESRLAVEKGEPAYLKIASHFGKGVLH
SDGTLNRQKLGEIIFSNEEERRVLNSIVHPDVRRRMDEKQKKAVESGEKVVILDIPLLFE
NKLNHTVDRTILVYVDQDTQITRLMKRNDLSYEQALKRINAQMPLQEKLALADEVINNNG
SMEESIQQANRILKKWNVSPR
>PK3-045_01490 Transcriptional repressor NrdR
MRCPTCQHNNTRVLDSRPVDEYKSIRRRRECEACGNRFTTFEKVEEIPLIVVKKEGTREE
FSRDKILRGLIRACEKRPVALKQLEEITAEVEKELRSNAASEIKSEAIGEMVMDRLAKID
EVAYVRFASVYRQFKDINVFIDELKELIKKDY
>PK3-045_01491 Replication initiation and membrane attachment protein
MSQHWQDLLPVDRYRVAVNGLLSDYDRKTITFLYQPLIGTKCLALYMTLWAEVEENRLWS
LTNTHHSLMNFMSCGLNDIYEARLKLEGIGLLKTYLKKEDGNRSFIYELQPPLSPAQYFL
DGMLNVYLYRKIGKAQYSRLKKFFSDEKIADPSFQPITKAFQEVFMSDHSGAVRAIHELE
EEETTDQTYVGREEQPGIQITKSDFDFELLYAGIHDSLLSKKAFTKKVKEAIQNLAFIYG
IDPIQMKNIVISAINQQDEIDIEELRIAARDWYQFQHNDLLPMLVDRKQPQKDYSSTDAP
KSQEEELIYYLDHASPRQVLKDVSGGAEPSKTDLQIIEEIMFSQKLLPGVINVLIQYVML
KTDMKLTKGYIEKIAGQWVRKNIRTVKEAMDLAKKEHKQYMEWAQGKKNPQSKSTRKAIR
TEKIPEWFGQNQDNEGTKKTEENTSSKEANDQDLEQKKRELEERIKKL
>PK3-045_01492 Primosomal protein DnaI
MERINDTLKKFGAGNNFQERYRAMKQEVLAHPDVRAFLREHEDELTSNAVDVGMIKLYEY
ANQSKACNKCPSLQGCVNMMQGYHPSLVIVRGNIEIQYDRCPRKLTEDNQKKKEKLIKSL
YVPKDILEASFNTIDLDGERMEAVEAAIRFVEDYKPGERHKGIYFYGEFGVGKSYILGAI
ANKLSQKQISSMIVYVPELFREMKSSIADSTLNDKIESIKREPILMLDDIGAETMSSWIR
DEVLGPILQFRMLENLPTLFTSNFDFSGLEHHLTYSQRGEEEKMKAMRVMERIRYLSTPI
RVKGKNKRT
>PK3-045_01493 hypothetical protein
MTEISNAEKLVIKRYNQFLFFVSMTILLLLIPFFLSFYSPGIYKIILALLVFGLTYTYIT
KNRRLLAYIRTRCEKRSISFQKLYSGYIILYALVLGAILLFL
>PK3-045_01494 hypothetical protein
MIEIQFHDQKDALRFLRILKKQVKYAESFDRMDDDNKCIIVKTDGSSKEIKKCLTAFILH
IKTDDWAREILKNRYFYMDELEQRSILEILHSLVEEEREGLTTLTKEINIKSCLTECMNN
FIIEQHKEFSFDSFVTFRLKSFIGKLIKYIELSIDEYKMEQEYQVFIHTLRNSLSKKAAK
VNHIHVLIDLEIQFFDTEYREIPQQELMMLYDQKNVVSSTHYIDPYSLGPLLALAPKTIF
LYTEDRELPIVRTIVNIFEERVQLLEKEQFFLRISTQTEMK
>PK3-045_01495 Threonine--tRNA ligase 1
MSELIKITFPDGAVKEFPEGTTTEDIAGSISPGLRKKALAGKINGSLYDLKRPILEDASF
EIITPDSPDALEILRHSSAHLMAQAIKRIYGKVKLGVGPVIENGFYYDIDLDQSLTPEDL
PAIEKEMKKIINENLEIIRKEVSRAEAIELFKEMDDEYKLELIEAIPEDETVTLYQQGEF
IDLCRGVHVPSTGKLKEFKLLNIAGAYWRGNSDNKMLQRIYGTAFFKKNELEEHLRFLEE
AKERDHRKIGKELDLFMTSQKVGQGLPLWLPKGATIRRIVERYIVDKEERLGYNHVYTPI
MGSVDLYKTSGHWDHYQEDMFPVMEMDNEQLVLRPMNCPHHMVVYKNDIHSYRELPIRIA
ELGTMHRYEMSGALSGLQRVRGMTLNDAHIFVRPDQIKDEFKRVVNLVLEVYKDFNITDY
SFRLSYRDPADTEKYFDDDAMWNKAQSMLKEAMDDLGLDYFEAEGEAAFYGPKLDVQVKT
ALGKDETLSTVQLDFLLPERFDLTYVGEDGKQHRPVVIHRGVVSTMERFIAFLIEEYKGA
FPTWLSPVQVQVIPVSPSVHFEYAKEVQENLQRHGFRVELDERDEKIGYKIREAQMKKIP
YMLVVGDNEVEDKAVNVRKYGEQKSETVSYVDFLEKLTQEVKLSN
>PK3-045_01497 Translation initiation factor IF-3
MILNEGIRAREVRLIDQNGEQLGIKTKFEALEIATRVNLDVVLVAPNAKPPVARIMDYGK
YKFEQQKKEKEARKNQKIINIKEVRLSPTIDEHDFNTKLRNAIKFLEKGDKVKASIRFKG
RAITHKEIGQRVLVRFAEACAEVATVESHPKMDGRSMFMTLAPKNDK
>PK3-045_01498 50S ribosomal protein L35
MPKMKTHRGAAKRFKKTGSGKLKRSKAYTSHLFANKSTKQKRKLRKAGLVSKGDFKRIRH
LLDNIK
>PK3-045_01499 50S ribosomal protein L20
MPRVKGGTVTRKRRKKVLKLAKGYYGSKHTLYKVANQQVMKSLMYAYRDRRQKKRDFRKL
WITRINAAARINGLSYSRLMHGLKLAGIEVNRKMLAELAVSDEKAFAELATVAKQNLK
>PK3-045_01500 hypothetical protein
MITYVLIYLAVVNIFAYFLMGIDKKRAIKHQYRISERTLWITAILFGALGLFIGMQKFRH
KTKHASFKYGLPLLTLLDAGIVLYILNV
>PK3-045_01501 hypothetical protein
MEEQLSVLFVMVEVSGILAPIIFILFHTLRQFLFIPPILVCIAGGILFGVTLGTIYSIIG
LTINCLLFYAVIHRLPKTHNKLSHLKKRWFGEYRNLTLGQISILRLIPVFHYHLLNFCLL
EKRKSLKEYSKTSFISNIPLAFFYTIFGQFISQFSLTMVVIIMFALAILVYILREKITII
KWREFFKEAHE
>PK3-045_01502 Sigma-w pathway protein YsdB
MKWLLLFVLLAFLIYGLFRLTSFLTNPQRRLTFAQKRGTFYLFDKKDNIRMNLLLTYKGH
LLEGEKYAAAEEVDHILLFPTNPYNTKLSTQDKAYIEQSLLSIYPKARIEWTRFKKS
>PK3-045_01503 Putative aminopeptidase YsdC
MAKLDETLTMLKDLTDAKGIPGNEKEPREIMKKYIAEYADEVTTDNLGSLIAKKVGQANG
PKIMVAGHLDEVGFMITRIDDKGFLYFQTVGGWWSQVMLAQRVTIVTSKGEITGITGSKP
PHVLSPEARKKPIDLKDIFIDIGASSKEEAMEWGVKPGDMVVPYFEFTVMNNEKMLLAKA
WDNRIGCAIAIDVLKNLKDSNHPNIVYGVGTVQEEVGLRGAKTAANFIEPDIGFGVDVGI
AGDTPGVTEKEALSKMGKGPQIILYDASMVSHKGLRDLVTDTADELKIPYQFDSVPAGGT
DSGSIHLTHNGVPALSITIATRYIHSHAAMLHRDDYENAVKLIVEVIKKLDRETVNSLTF
A
>PK3-045_01504 Putative transport protein
MTKKKFHYWLLQVLIIVAIVYLCTKISFLFKPVAVLFSTLFVPIIITGFLYFLLNPIVKF
LQKNKIPKTLSIIILYVGVIGILILVIGSIVPMISKEFSELFKNIPKYADEAVQYFQYLN
DTKQYKWIMNQEYVKIEDITENLKAYAQTIPSNITNGIGKIISTMTNITITIVTVPFLLF
YCLKDGSKFPEALSKFFPASYRKEGLHIIKDTSETIAAYIQGQVIVALFVGTLALIGYLI
IGLDYALVMALLVAVTNMIPYVGPLIGGAPAVIIAIFTSPTQALLVIIVITIAQQIEGNI
LSPLILGKRLDTHPATIIVLLLVAGNLAGILGMILAVPTYAAVKTIVININRLLKARKAA
ILNTKIPPLE
>PK3-045_01505 N-acetylglucosamine repressor
MVTDKYVIREQNASLVMEQIVQHAPISRATLSANIGLNKATVSDITKKLLEEKLIEEIGI
GESSHSGGRKPILLQLNKKAGLSIAIELGYDFISTMVTYLDGEVVFYNKERGTFIKKENV
LTHISDIIEKYAKISNLTTYGIVGIGIAIHGIVNKNNILFTPYYDLDKIELYEELTKLYQ
YPIHIENEANLTAIGESTFSTEFNNLISLSIHSGIGAGIIIDGQLFTGLDGRAGEVGHSI
LYPDGRTCPCGNKGCLEQYCSDKVLLEQFKELKQLSNVTPDLLAEHYYDNDSAIQELIQQ
HCYNLSKGLNNIMTFFAPKIIYMNSSVIRRIPDILSIIHNNLESSFNKDIAIENSRLGSK
ASLFGATALNIRNFLNISHLKIINVE
>PK3-045_01506 Xylose isomerase
MEFFPMIKKVKYEGPKTENIYAYRHYNPEEVVLGKTMKEHLRFSMAWWHTLTQDGSDPFG
AAINNRNWFGETPMETAKNRVEAGFELMEKMGFEYFCFHDVDIAPEGDTLQEFFDNLDVI
TDLIKEKMDQTGIKLLWNTANMFTNPRFVHGAASSSNAEVFAYAAAQVKKGLEISKKLGG
KNYVFWGGREGYESLLNTDLQLEQDNMARFFHMAVDYAKELNHEVQFLIEPKPMEPSKHQ
YDFDAATAMAFLQKYDLDKYFKLNLEANHATLAGHTFEHEMAVARSYNALGSLDANQGDI
MLGWDTDEFPTNIYDTTLAMYQVLENGGIAPGGINFDAKVRRSSFSMEDLVLAHIAGMDT
FARGLKSAAKLKEDGFFDKEIERRYKSYTTGIGKSIVEGKENLKTLTEYALQHDQIENEP
NHLEFLKSRLNDYLV
>PK3-045_01507 Xylulose kinase
MSYVIGIDLGTSSLKGLLVDKEGKVLITKSSEYELLTPQPKYSEQNPNVWIEALDIVLKE
IIEAFPEAASKTEGISFSGQMHSLVLLDANGRALRNAILWNDVRTSKQCQEIMDRAGQEV
ISITKNKALEGFTLPKLLWVKENEPTIWEQAKHFLLPKDFLGFYLTGNKQMEYSDAAGTL
MLNVEKKVWSESIAELFDLPLGIFPKLVESSDKIGVMKAELAKKYGFTNDIAVFSGGADN
ACAAVGAGIVKEGMGLASIGTSGVFLSYEKDGKEDYAGKVHYFNHAIKDSFYSMGVTLSA
GYSLNWFKNTFASEKSYDELLSNIENIPIGSGGLVFTPYIMGERTPYTDSQIRGSFIGMD
ARHTIDNFARAVVEGITFSLNDSKILMEEKANKQFTRIVSVGGGAKNSKWLQIQADIFNT
PVVNLTVEQGPGLGAAMVAAVGLGWFATMNECVEKFVQYKEEFHPIPENVKKYEQVYNIY
KEVYAETKETSHKLQALNELKQN
>PK3-045_01508 Small, acid-soluble spore protein I
MNLNLRNAIIHNVSGNSQDELKDTIVDAIQNGEEKMLPGLGVLFEVIWKNSSEEDKVEML
QTLENGLK
>PK3-045_01509 23S rRNA (guanosine-2'-O-)-methyltransferase RlmB
MKHILSVKNPQIKEWKKRLTKKERDKTGTFLVEGFHLVEEAFKADSIIDLIVSEDIDVPA
WDYGDTPITIVTKEIIKELSDTETPQGILALCKQQSHPEILPTAQTFIAIDQVQDPGNLG
TIIRTADAAGIDAVIIGEGTVDIYNPKVVRSGQGSHFHLPIIKANLASFMDELKERNIPI
YGTALENGRDYREVEKTATFCLIVGNEGNGVRKEVLSKTDTNLYIPIYGKSESLNVAVAA
GILMYYFK
>PK3-045_01511 Phenylalanine--tRNA ligase alpha subunit
MEDKLKELQAEALTRIESSIDMKELNEIRIAYLGKKGPITEVLKGMGKLSAEERPKMGAL
VNVIRDEITSRIEAKQKALEEALVQEKIASETIDITLPGRPVSTGNHHPLTRVVEEIEDL
FIGMGYTVEEGPEVENDYYNFEALNLPKDHPARDMQDSFYITEETLLRTQTSPMQARTLE
KHKGKGPVKIICPGKVYRRDNDDATHSHQFMQIEGLVVDENIRMSDLIGTLEVFAKKMFG
EDREIRLRPSFFPFTEPSVEVDISCFICKGAGCSVCKKTGWIEILGAGMVHPNVLEMSGF
DSKKYSGFAFGMGPERIAMLKYGIDDIRHFYTNDVRFLKQFSVPEY
>PK3-045_01512 Phenylalanine--tRNA ligase beta subunit
MLVSYNWLNEYVDLNGISPDELAEKITKSGIEVEGVEVLDEGIKNVVIGYVVEREQHPNA
DKLNKCLVDVGEGDPIQIICGAPNVDKGQKVAVAKVGAVLPGNFKIKKAKLRGEESNGMI
CSLQELGIEGKIVAKDYAQGIFVFPSDVEVGKNALEYLQRNDAVLELGLTPNRADCLSML
GVAYEVAAILEKEVKLPNTEYPTINEKASDYIKVSVEENADVPLYTARVIKNIKIAPSPL
WMQGKLMAAGIRPHNNVVDITNFILLEYGQPLHAFDYDKIGSKEILVRRAQSGEKITTLD
ETDRTLSEDNLLITNGKEGIAVAGVMGGANSEVQAGTTTVLLESAYFDSKVIRRSSKVIG
LRSEASARYEKGIDPNRVREAADRACQLLQLYAGGEVLEGEVAVDTLTAEPKVVSITLEK
INQTLGTTLETNAVTAIFNSLQFATQMEGDTFIVTVPTRRNDIVIEADLIEEVARLYGYD
NLPKTLPIGAATPGSLTAYQKKRRMARRYLESAGLYQAITYSLTNEAKVHSFALEKRNPI
NLAMPMSEERALLRQSIVPQLLEVLKYNAARQNENIAVYETGVVFLANGEQELPEEKEHL
AGAVTGIWSMHPWQGEKKTVDFFVVKGVLEGLFQKLGVMEQITFARANLDGMHPGRTAEI
VLNGEIIGFVGQVHPQMQNDLDLKETYCFELDLSKLFAVEVEALHYTSIPRFPYVTRDIA
LVVEKDVLAGTLQEVIIEAGGKLLKDVQVFDLYEGEKMEAGKKSIAFSLTYFDPEQTLTD
EMISKTHDKVLAAVEEKAGASLRG
>PK3-045_01513 putative arabinose-binding protein
MKRMKKFAAIGLSSLLALSLAACSGNDTSSKTSGKDEKITLDFWTFGSTGYEDLAKEYEK
ENPNIKIKVKASETADHHDALFTALSAGSGAPDITMLEIDQFDRFKVAQDRFENLYDLGA
KDVKDQYLEWKWKSGENQDGDFLFGLPTDIGPKGLYYRTDVFEKAGLPTDPQEVANLINS
PEAFEKAGLQVKEKTKLPFVDSIEMAYRAYLDSAKTAYLTPDNKLNLGADSEVKKAYDYA
IRLNELGIIGKYDMWTPEWANAVNKGEFAAELGAGWLKGWMEGNAPDAVGKWRVATLPTE
FAANWGGSYIAVPSETKHSQEAYDFIEWLVSPENQLKSFQSHGLFPSAQSVYDMEEFKTN
ADEFFGGQATAPVFAEAAKDISGIGYKGEKYASIHSEVLNALKNVQNKGADPEKEWKAAV
KRAEDLLSR
>PK3-045_01514 Lactose transport system permease protein LacF
MYHAPSNMKRGGEMNPSSNKETVNTVSKKQPIHKKQKKFRSEQKKDMLSGYLYIAPFFII
FAVIGLYPMLFSIYLAFQKWNGLSPMTFNGLANFETVLTDPLFWKSVYNTIIIGIMGTAP
QLVVGLILAYLLNMAFLKFKSFFRVTIFMPYLTSMVAVALIFSVLFSNHESSLANYVLTH
FFGLDPIQWAASEWGTKIAISIMVFWRWVGYNTIIYLAGIQGIPNDLYEAATIDGANKFH
QLFYITIPMMKPFIILTVFTSTVGAMQLFSEPTVFLGTGAFTRDEAMTIVMYLYRDAFKL
QSFGTASATAIILLVIISLFAVINLSLTQGFRKKKRGVDQ
>PK3-045_01515 L-arabinose transport system permease protein AraQ
MRKHDKRNRRKFSIGRLSVYLFLFIAAIVSLFPFYWMFVMATRPSAAYNSIPPTLTPGNM
LVENFKKVLSQIDFFGGMWNSFILCFVVTIIVLLISSLAGFAFAKFRFPGRNIFFIAILV
TMIIPPQLGLIPQYFLISKIGLLDTLQGVMIVSFLNPLGIFLMRQYISEGVPDELIEAAK
LDGCSNFRIYWGIVLPIILPAFATLGIIVFTAVWGEFLWQFTVLRDPEMYTIQVALAQLG
NTHNIDFGMILSGVFWATVPLLVIFLLFNRLFISSITEGSVK
>PK3-045_01516 putative HTH-type transcriptional repressor ExuR
MSLTIKDIAQLAGVSPSTVSKVLNNYGEISEMTRKKVMTVINEKGYAPNFSARSLATKKS
NLIGLVYAGKINVDMTHPYFNEVISTFKKNIGLLGYDILMFSNEQFQGSYLARCKHFNLD
GCLIIAGEEVEDATFELAESGFPCIGIDIELVGPKASYVMTDNVNLSRKVVEHFYLNSLR
KIGYIGGMSESVISNLRLKGFKDAMNQFGLEIREEWIQYGDYHEESGYIAMKRILELKDY
PEAIFAASDLMALGALRAIKEAGLHTPRNIRIVGCDDIAASRYSDPKLTTVKQDKEKIGK
LSAFMLNDLIEGKSKLKPVYTDSKIIVRETCGTNKAFR
>PK3-045_01517 Beta-glucoside kinase
MNYYAVFDVGGSAIKFSLMNELGNFVEKSSVPTPKDGIDSFVDTIETVVKNFQEKNEIIG
IALSMPGAVDVETGFIKGTSALPYIHGPNIRDVIQERTKLLVELENDANCAGLAEGWMGA
AKNVDDYICIVIGSGIGGSIFLDKKIRHGSHLFGAEFGYMILEDYLNQPLGESWSSLAAT
GGLIKQVAKRKNLDPITLDGQIVFNMSDEGDWEVQEEIEKFIKRLAVGIYNLQYIIDPEK
ILIGGAISKREGLIEQINEKLKIMKPTEECLNIQVQPCQFGNDSNLIGALYHFLQRTSSP
LSGVSKGK
>PK3-045_01518 Cell division protein ZapA
MSNTPKNRTNVDIYGTQYTIIGKEPSNHVRLVASIVDEKMREIHVLNPSLDTNKLAVLTA
VNIVNDYVKLEDRVKELEEELKRREKD
>PK3-045_01519 hypothetical protein
MLDIILVILLLFGLLRGLKRGFIMQIIHLTGFIVAFIVANKYYIPLSQKLTLWIPYPNIG
ENSLLQSFIQTANMEDVFYRGFSFVVIFFVVKIIWQIIGSMIDFVASIPILKQLNTWAGA
VLGFVETYLLLFLLLFISILIPVDFIQSQLNESSVAAWMIENTPYFSEKIKDLWFDYMAS
>PK3-045_01520 DNA polymerase/3'-5' exonuclease PolX
MITNKDIIRLLEQIAIYMELKGENPFKISAFRKAANTIETSELNLTEITDLTELPGIGKG
TAAVIEEYLKEGKSSVLQELKDEVPKGLIPLLQLPGLGGKKIAKLYKELSVENAEDLKNA
CLKGEVQALKGFGKKTEEKIMEALQNAGSRPERLPIAFMIPIAVSIEEHLAKMAGVVQYS
RAGSLRRVRETIKDLDFIIATKDPNQVKEQLIQLPSIKEVIGAGLTKVSVILGLDYDVSI
DFRLVKPEEFATTLHHFTGSKEHNVRMRQLAKERGEKISEYGVENNETGEIKTFKTEEAF
YHYFELPFIPPEIREDGKEVENYSDDSELISLEDIKGDLHMHTTASDGAHSLEEMIEANR
KLGYQYMAITDHSQYLKVANGLTPDRVRKQIKEIKRLNAKYEDITILAGAEMDILPDGTL
DYDDELLKELDIVIASIHSAFSQSKDKIMNRLKAAMENKYVNIIAHPTGRKIGKRDGYDI
DMEMLIQLAKETNTILELNSNPNRLDLNAAHVKMAQDAGVKIVINTDAHYKHELNNMAIG
VSTAKKGWIKKSTVLNAMSKEELLAFLYKG
>PK3-045_01521 Endonuclease MutS2
MQERVFKTLEFDKIKDQLIEHASSSLGRYKVEELVPSTDYNEVVRWQEETDEAAKVYRMR
GSIPLDGIYDIRAHVKRSSIGGMLSPSELNQIASTVHASRQMKRFIEEFHEEEPIPILFT
LTDSIMVLAEVEEEIKMAIDEQGAVMDSASDALRTLRNQLRRNESKVREKLESMIRSSSA
QKMLSDSIITIRNDRYVIPVKQEYRGNYGGIVHDQSASGQTLFIEPQSVVTLNNELQAIR
VKEQQEIDRILTQLTALVAQYEEELLHIVTVLAEIDFMFAKAKYAHRLKASKPKINNEGK
IVLHKAKHPLIPPEVVVANDIILGDSYTSIVITGPNTGGKTVTLKTVGLCTLMAQAGLQI
PVLDGSEMGVFKSVYADIGDEQSIEQSLSTFSSHMVNIVSILEKVDHKSLVLFDELGAGT
DPQEGAALAISILDEVNKRGARVIATTHYPELKAYGYNREGVVNASVEFDIETLSPTYRL
LIGVPGRSNAFEISKRLGLKEDVINTARSHVSEDSNKIENMIASLENSRKQAEREHEEAK
DLLKQAEMLHRDLQKQVMEYYEKKETLQEKAKREAKEIIENAKKEAEAVIGDLRKMQLEK
RAEVKEHELIDARKRLDDATPQIERQKQPAASKTNHVYQPGDEVKVLTFNQKGQLLEKVS
DKEWQVQIGIMKMKVKEKDLEFIKAPKVVETKPLTTIKGKDYHVSLELDLRGERFENALA
RVEKYIDDSLLAGYPRVSIIHGKGTGALRSGVQEYLKNHRAVKRIRFGEAGEGGSGVTVV
EFK
>PK3-045_01522 hypothetical protein
MAQFWENEYVKTAGDYSVVILSLVVFLAIFELVTKYNNWDEIKNGNLAVAMATGGKIFGI
ANIFSHSIMQNDSLLKMIIWGVYGFVLLLIGYFIFEFLTPKFNIDDEIKNDNRAVGFISM
IISVGLSFVIGAGIS
>PK3-045_01523 Long-chain-fatty-acid--CoA ligase
METEKRWLKLYPEQIAKNVYYRADTLPQLLKYAANEYPKHKAIHFMGKEMTFKTLYKKTL
QFAAYLQHLGVKKGDRVAVMLPNIPQTVISFYAILQAGAIAVPVNPLYQEREIEFIMKDS
GAKVIITLDMLYNRVERVMKQTDLEQIIVTSIKDYLPFPKNIVYPFIQAKEQGKPPTISS
SNSTHLFIQTLKSKESVLKEVPINFEEDIAILQYTGGTTGFPKGVILTHQNLVANTSMCR
QWLYKMEKGKEKMLAVMPLFHVYGLMTVLVLSVMEVYKMILVPKFDASGLLKTIHKQKPT
VFPGAPTIYIGLMNHPDISQYDLSSIKGAISGSAPLPVEVIEKFEEKTGGKIVEGYGLTE
TSPVTHVNFLWDNEIVKGSIGVPWPGTDAAIFSLESGEILPVGEVGELAIKGPQVMKGYW
NNEEETNKVLKDGWLLTGDIAYMDEKGYFYIVDRKKDIIIAGGFNIYPREIEEVLYEHPA
VMEASVVGVKDSYRGETVKAFIVLREGMTVTEEELNQFMRRKLASFKVPRIYEFREELPK
TAVGKVLRRQLKKESEEENE
>PK3-045_01524 Electron transfer flavoprotein subunit beta
MQIVVLLSRTVSPEASLVLEAEQPLVEEKEFIINPPDAISLEEALQLKEKYGGRITVLMV
SKKEGEKQLRTALAMGADQAVLIESNPNEDHPAHIAKKIQEYLQNIDYDVLLAGDFSTDG
ATSQVGPRVAALLDIPYFVKAIRIEQEEKHARIIRNADGDIETYRVPFPFLATIPQSLHV
PRLPSLAGIMKAKKKPFRIIQLKDSRAKKTLSHYSYPQLNRKQIMLQGEIKDQVASLSKL
LKS
>PK3-045_01525 Electron transfer flavoprotein subunit alpha
MKGKIVVLGEHQEGKLASITLECISAAKELQTEAETILLLMGEDMRKNASEWDETDVDQI
IIVEHPLLARFSNESYIKALLSVWEQLEPSILLCGHNDIGRSIFPYLSEKWNLSLFSNIE
SFVFHDNKLSITRSAYSGKLTERTEVEDSSFLMTIKPKKWMTLPKKEKTKPNVRSLKVNI
EKPVATLIGLEQKREKAAGLVDAKIIVGAGRGIQNEEGFALVKKLADTLGGTVGVSRGAV
ELGVCDASIQLGQTGKTVAPDIYIACGISGAIQHLVGVTSAKTIIAINKDPNAPIFEVAD
YGIVGDIFEIIPSLLKEWE
>PK3-045_01526 Thioredoxin
MAITHATDQTFQEETGSGVVLVDFWAPWCGPCKMIAPVLEELDGEMGDSVKIVKVDVDEN
QGSASKFGVMSIPTLLVLKDGEVVDKVVGFQPKEALSELLAKHV
>PK3-045_01527 UvrABC system protein C
MFVYKVCELGGKIVNNIIKNKLMILPDQPGCYLMKDRQGTIIYVGKAKVLKNRVRSYFTG
SHDGKTLRLVNEIEDFEYIITSSNIEALILEINLIKKHDPKYNIMLKDDKSYPFIKLTAE
RHPRLITTRNVKKDKGKYFGPYPNVQAANETKKLLDRIYPLRKCNVLPDRVCLYYHLGQC
LAPCVNEVTEQEYKKMTDDIIKFLNGGYKDIKKELSEKMMAASEELDFERAKEYRDQIAH
IEATMEKQKMMMTDLVDRDIFGYSYDKGWMCVQVFFVRQGKLIERDVSTFPIYQEPEEEM
LTYLGQFYEKANHFKPKEIYLPDEIQGDIVEELLNVKVIKPQRGQKKELVLLANKNAKNA
LTEKFALIERDEERTIKAVENLGRQMGIYTPLRIEAFDNSNIQGTNPVSAMIVFIDGKPA
KREYRKYKIKSVKGPDDYESMREVVRRRYQRVLKEGLPLPDLLLIDGGKGHLEAVREVLL
DELSLDIPVAGLVKDDKHRTSQLLFGNPLEIIPLERNSQEFYLLQRIQDEVHRFAITFHR
QLRGKNAFQSLLDDIPGIGEKRRKLLLKTFGSVKKMKEATIEEFVKAGIPANVAEQLLAK
LKE
>PK3-045_01529 Aspartokinase
MGLVVQKFGGTSVGSAERILHVAERVIEERNRGNDVVVVVSAMGKTTDSLVTLASEINPK
PSKREMDVLLSTGEQITISLLSMALQAKGVDAISYTGWQAGIETENVHGNARIVNIQTEK
VQEQIQQGRVVVVAGFQGVTDAGDITTLGRGGSDTTAVAIAAALKADKCDIYTDVTGVFT
TDPRFVQSARKLLAISYDEMLELANLGAGVLHPRAVEYAKNYQVPLVVRSSMEQEEGTII
EEEVSMEQNLVVRGVAFEDNITSVTVFGLRNPLTSLSTIFTTLASHHINVDIIIQSLTND
QLTNLSFSIKDSDLEETLNVLEENKAELGYDKVTSEQGLAKVSIVGSGMISNPGVAADMF
KVLSQEKIIIKMVSTSEIKVSTVIEKEKMVKAVEILHDAFELSKLPVHA
>PK3-045_01530 putative protein YslB
MSDLTSLEEKTQVESDPLTVPAYGYELIREILIPELLGRDTPDLLYWAGKRIARLFPLNT
VEEAYAFFQKVGWGNLEVVKQTKNEIIYQLSSELIEKRLKEKGKCTFQLEAGYLAQQYEQ
TKKVIAEAFEDPKRKEKKVTITVRWDSKDPVEG
>PK3-045_01531 Succinate dehydrogenase cytochrome b558 subunit
MAANREFLFRRLHSLLGVIPVGVFLIQHLVVNHFATRGPEAFNKAAGFMEHLPFRYFLEI
FVIFLPILYHAIYGIYIAFTAKNNTKNYSFFRNWMFYIQRVTGIFTLIFIVWHVWETRVA
AQLGQEVNYDMMSENLANPGMLAFYLVGVISTIFHFSNGLWSFCVSWGITVSPKSQRINT
YVTLGIFVALSIVGVRAILAFV
>PK3-045_01532 Fumarate reductase flavoprotein subunit
MKKGKVIIVGGGLAGLMAAIKVAETGTPLELFSLVPVKRSHSVCAQGGINGAVNTKGEGD
SPWEHFDDTVYGGDFLANQPPVKAMAEAAPGIIHLMDRMGVMFNRTPEGLLDFRRFGGTQ
YHRTAFAGATTGQQLLYALDEQVRRYEVDGLVVKYEGWEFLGIITDDEGVCRGIKAQDLK
TMEIKSFPADAVIMATGGPGIIFGKSTNSIINTGSAASVVYQQGAYYANGEFIQIHPTAI
PGDDKLRLMSESARGEGGRIWTYKDGKPWYFLEEKYPAYGNLVPRDIATREIFHVCVDQK
LGINGENMVYLDLSHKNPKELDIKLGGIIEIYEKFTGEDPRKLPMKIFPAVHYSMGGLWV
DYDQMTNIPGLFAAGECDYSQHGANRLGANSLLSAIYGGMVVGPNAVKYISGLSKSAEDL
SSSIYDSAIKAEEAKWQGILKMDGTENAYVLHKELGEWMTDNVTVVRYNDKLLATDDKIQ
ELLERYKKININDTAKWSNQGGVFTRQLENMLQLARVITLGAYNRNESRGAHYKPEFPER
NDEDFLKTTMAKFVGANEAPDFHYQEVDTSLIKPRKRDYSKQKEGVK
>PK3-045_01533 Fumarate reductase iron-sulfur subunit
MGEQKTVTLQIERQDDPNSPSYVEEFSLPYRPNMNIISALMEIRRNPVTSDGKKTSPVAW
DMNCLEEVCGACSMVINGKPRQSCTALIDQLEQPIRLEPMRTFPVVRDLQVDRSRMFDSL
KKVKAWIPIDGTYDLGPGPRMPEKKRQWAYELSKCMTCGVCLEACPNVNSKSNFIGPAPL
SQVRLFNSHPTGEMNKEERLQEIMGDGGLANCGNSQNCVQSCPKGIPLTTSIAALNRETT
FQAFKEFFGSDH
>PK3-045_01534 hypothetical protein
MDLNIELLANLHIEILQDMYFDYEENSTTYIDMVTIMGSLFYFEQQTKKARKNNRLIVPV
FNLSLWEKNKAILTELIDWIMDEPVYLTFQQNEAELFAPSFYLPNHQEVTLFLDDIASLV
GVAKNNCIDPPITSDYIRLKNMDNEQSKQEKLATFLRSSVSDAGEIIHLGSAICKKIRRN
RSAASICLLVSIAAAKTYFNGKGTVYVYQNSKINKDVSIDGDVLLKATHPKTFNLINALY
SSLELDLTIQTPILYRPFHRVINEIPKEYKLQIKNTAECLRIRGDGYISAKVPCGICLPC
LQRKMVLSASNNELYDTLYEYDYGQKTADIKNEEDKRILTENLQTLEHAIEYLKTNVSRL
ASEEQTIAEEFIFTYHQFMEKY
>PK3-045_01535 Spore germination protein GerE
MKENEFTHKPLLTKREREVFELLVQDKTTKEIASDLFISEKTVRNHISNAMQKLGVKGRS
QAVVELLRMGELEL
>PK3-045_01536 hypothetical protein
MMTEEKDVKEYLENIATIEKDMRYISGIIKQKGREILSNYTMTPPQFVALQWLFEEGDMT
IGELSNKMFLAFSTTTDLVDRMEKNQLVQRVKDPNDRRVVRIHMLEEGKRLIDEVIKKRQ
GYLQEVLNEYSTEDIEELKKNFMRLHQVMREK
>PK3-045_01537 Glutamate racemase
MERAIGVIDSGVGGLTVAKEIMRQLPFENIVYLGDTARCPYGPRTGEEVKKFTWEMTRFL
LKKNIKMLVIACNTATAVALEEIREQLSIPVIGVIVPGARTAIKVTKNNYIGMIGTLGTV
RSRAYETALKKINNRVRTISLACPKFVPLVESGEYDGPVARKIVKETLWPLKNKEIDTLI
LGCTHYPLLAKVIQEEMGKKVKVISSGAETAREVSTILNHHDELASGENQVEHYFYTTGS
KEMFARIASNWLNQEIHAVETVKLT
>PK3-045_01538 Spore germination protein GerM
MSKNNKLTIVSAVIISSVLISGCSLLGDKEKVDPPQTTSYKEDAVKKDADKETTGEVAKE
DAMPVELYLMDKNGYVVPQTLNLPKTNSIAKESLEYLVKGGKVSELLPNDFQAVIPQDTK
ISINVDKDKVATVDFSKEFKEYEAKDEEKILQSITWTLTQFDSIDSVKLSLNGHELTEMP
VNKTPIQGALTRADGININTDDVTDITNTRPLTVYYIGGELDSYYYVPVTKRISNGEENN
VAAAVGELIEGPGMGGGAALTSLLPNDVKLLDDPIVEDGKVTLNFNENIYSSGLNGEEKV
LADEVLNSLVLSLTEQEGIESVAVTVNGEADLVNAEGKSLTKPVTRPENVNTGSF
>PK3-045_01539 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase
MSLHYQEYGDKSAPLMLFIHGGGVSDWMWDKQIQYFTHYHCVVPLLPEHGLNNDKVKFTI
KGSAQALIKLVEDKARGKKVILIGFSLGSQVIVEMISMKPDIMNFAIINSASVRPILWAK
KVIKPTIALTYPLIQNKTFSKLQARTLYISDDYFEKYYEESCQISSDTLVRVLEENMSYQ
LPKNFAEATGKILVTVGEKEKAMMKKSAKDIVAANSNGIGVIIPNIGHGVSFAMPDFFNH
MVETWIQKGVLLNECKVIS
>PK3-045_01540 dITP/XTP pyrophosphatase
MKEIIIATKNTGKAKEFVQMFSPLGYEVKTLLDFPDVQDVEETGTTFEENALLKAETISK
LLNRVVISDDSGLVIDALNGRPGVYSARYAGEQKNDQDNMDKVLYELEGVPLEKRTARFC
CTLAVAIPNEDSLTFTGTCEGVILEERRGEYGFGYDPIFYVEAEEKAMAELPPEKKNKIS
HRANALKKLKEQLPTVFKEGK
>PK3-045_01541 Putative metallophosphoesterase MG207 
MKILIVSDSHGLVSELGALKKRHEEDVELFLHCGDSELSASEEVMKGYITVQGNCDYEDK
FPTETTQEIADKKIFLTHGHLYGVKSSLNNLLYKAKEVGANIACFGHSHFLGMEVVDDVL
FINPGSLRLPRGRKEQTYVILTIEMDRFVTEVYDFHSGLLPELTSEFPF
>PK3-045_01544 hypothetical protein
MTKSVVGIYDSPEATVNAIEELLSKGYSPNHISVITRSEQTALIEQETNVDTASGIDEVE
PTSFLDRLKTFFSDTDTEPYEKELQEGKYIVLLDNDTESEEEKLNKLNFDNNEVDVIPSQ
TMNTTVERKKI
>PK3-045_01545 hypothetical protein
MILKELGRSRLIVINYYKNGLLETIKGQVQKLNLNDQTIDLKDDKENTYQIRLSWIQDIC
AVS
>PK3-045_01547 Acetolactate synthase large subunit
MLQETAFENTKAQVKPLTGADLLLQALEKENVEFIFGYPGGAVLPIYDKIYDSKIFHVLP
RHEQGGIHAAEGYARISGKPGVVIATSGPGATNIVTGLADAMMDSLPLVVFTGQVATGVI
GTDAFQEADILGITTPITKYNCQVRNLEDIPRIIKEAFYIATSGRPGPVLIDIPKDIAAT
ISDVPAEQDIELPGYQPKTQPNYLQIRKLTEAVSAAKKPVILAGAGVNFAKASAELLEYA
EQQQIPVVHTLLGLGGFPADNKLFVGMGGMHGCYAANMALYEADLLINVGARFDDRLTGN
LVHFAPNAIKAHIDIDPAEIGKIVPTKIPIVADAKEALTMLIKQKGLQSNHNAWLEKIEN
WKNEYPYYYKESNLLKPQQVLEMLFEKTKGEAIVTTDVGQHQMWAAQYYHFKESNRWVTS
GGLGTMGFGLPSSIGAQLADPKATVLAISGDGGFQMCSQELALIRELNLPIKIIIFNNRA
LGMVRQWQEIFYESRFSHSKESYQPSFVALAEAYGIKGYQISSVDEAANILDEVLAIREP
VLLDFRIDPDENVYPMIAPGKGLHEMVGMKP
>PK3-045_01548 Acetolactate synthase small subunit
MKKIISLTVMNKSGVLNRITNLFSKRNYNIESISVGHTEHEGISRITCVVHVESDGIIEQ
ITKQLNKQIDILKVVDITDQAIVQRELALIKVLATPQTRHELYSVIEPFRGSVIDVSKES
LVIQITGESSKIEAFIELLRPYGIKELARTGTTAFPRGSQKIANHKSNYSIV
>PK3-045_01549 Ketol-acid reductoisomerase (NADP(+))
MAKMYYNGDANLGYFNGKTVAVIGYGSQGHAHALNMKDSGVSVIIGLRKGNSWNKAVEDG
FDVFPVGEATAKADIVMILLPDELQTKVYNEEIKPNLTNQALMFAHGFNIHFNQIVPPSE
SDVLLVAPKGPGHLVRRTYEQEAGVPALFAIYQDVTGEARELALAYAKAIGALRAGALET
TFKEETETDLFGEQAVLCGGLTALVKAGFETLVEAGYQPELAYFECLHELKLIVDLMYED
GMAGMRYSISDTAQWGDFVTGPRIVTDEVKKEMKAVLTDIQEGKFAKGWILENQANRPVF
NAINDRESEHLIEKVGKELRAMMPFVKSSRKKEVVGSGKN
>PK3-045_01550 2-isopropylmalate synthase
MAKIKIFDTTLRDGEQSPGVNLNLAEKLVIAEQLEKLNVDIIEAGFPAASKGDFQSVQQI
ARTIKNSSVTGLARAVTSDIDAAWEALKDGAEPRIHVFLATSPIHREYKLKLSKEQVIER
AVSAVKYAAERFPVIQWSAEDACRTELPFLAEIIEEVIQAGARIINIPDTVGYITPNEYG
EVFQYLKNNVPSIDKVSLSTHCHDDLGMATANSLAAIENGATQVECTINGIGERAGNASM
EEIVVALHIRNDHYQEKTRINLKEISRTSSLVSELTGMLVPGNKAIVGRNAFAHESGIHQ
DGVLKEKTTYEIISPELVGYVNNNNMVLGKHSGSHAFKTKLNELGLRVNDEDVKDLFMAF
KDLADHKKEISDEDIIAIVLEKKLAKEEKYYELVDVKVQHKNDNEADATVKLFGPKNELI
IQHGTGSGSVEALYNTLEMSISGQVKLQDYRIQSLGAGRDALAQVFVRVQYDEKESTGRG
LDQDVLIASAKAYINAINRGILAKEQFLEKV
>PK3-045_01551 3-isopropylmalate dehydrogenase
MKKRIAVLPGDGIGPEIVAGAMKILQLIETLFSHQFEVTYADIGGCATDKTGTPLPNETI
TICKNSDAILLGAVGGPKWDALPVEKRPEQGLLKIRKELNLFANIRPTTCYESLAEASPL
KADIIEGVDLVVVRELTGGIYFGKPSERTIIDGKPGAVDTLLYKNEEIERVIEKAFEIAR
TRSKKVTSVDKANVLETSRVWREIASKIAEKYPDVMLEHMLVDNAAMQLVRNPKQFDVIV
TENMFGDILSDEASVLTGSLGMLASSSMSANGPYLYEPIHGSAPDIAGENIANPLATILS
VSMMLRLSFQMEKEASIIEEAVNNVLNQGYRTRDILSPNCKIVSTTAMVEAVEKEIHQLA
KVTQVL
>PK3-045_01552 3-isopropylmalate dehydratase large subunit
MGKSIIDKIWEKHVVYREEGKPDLLYIDLHLVHEVTSPQAFSGLRMKNRKVRRPDRTFAT
MDHNVPTINRFKIDDEIALNQMTTLEKNCVEFDIPLAGLQSPEQGIVHVIGPELGLTQPG
KTIVCGDSHTSTHGAFGALAFGIGTSEVEHVLATQTLWQTRPKTLKVEVNGKLAFGVNAK
DVILYVLSKHGVNFGTGHVIEYTGEVIRNLSMEERMTICNMSIEGGARAGLICPDETTFA
YLKGRKHAPENWDEAVQEWRNLASDKDAIYDKVITIDGNDIAPMVSWGTNPSMTAKVDEK
IPTADSYQEETDRRALHSALQYMGLKEGMAITDIAIQHVFIGSCTNSRIEDLRQAASVIK
GQKVFPGVRALVVPGSQQVKKQAEAEGLDKLFVEAGFEWRDAGCSMCLSMNNDVVPSGEH
CASTSNRNFEGRQGAGARTHLVSPAMAAVAALNGRFVDIRKVNTELQATV
>PK3-045_01553 3-isopropylmalate dehydratase small subunit 1
MSGFKKLYEKAVAMDRVNVDTDQIIPKQFLKRIEKTGFGRFAFFDWRYLKNGEPNPEFEL
NQPENQGASILIANKNFGCGSSREHAPWALQDFGFSVVIAPSFADIFYQNCLKNGMLPIQ
LQTDEVEYLLKAAQSQPYFLHIDLEKERVEDDQGFSTSFSIHPYWKKMLINGWDEIEITL
QYSDKIAEYENRAVSK
>PK3-045_01554 hypothetical protein
MKKREQEKKDNVVFFPDLDKRLLQKGLDAIQEKQYKEAISFLEEAKERNPFHRDINIGLI
LAYYELGLLEQAKHLAKETLKQDDGDYIHVLELYIMILVQLHEYEEIVTTIEGLLEEHQI
PANKIEHFSKMLLFSRKMAESASLSQADDYREEESEETTESLMNLEDPQEEMLLIAKMSS
KNIRAYIEEVKQYLLDVEKNPFLKTMLINILREQEYEKEVEIEKFDRKIVIQPTALKDMK
EQEQYKKIITILIDYVESNNPILFENIKMLIDRQMFLLYPFALAEYKDETWAAAYHAVVN
QYFGQEDEEEIFVLYEVDETEFEQAKTFIYQLEQISYPNI
>PK3-045_01555 Trigger factor
MSAKWEVLEGNRGVLTIELDAEKLNEGLDLAFKKVVKQVNIPGFRKGRIPRGMFEQRFGV
ESLYQDAIDILLPEAYANAIDETGIEPVDRPEIDVEQIEKGKSLIFKATVTVKPEVTLGE
YKGLEVPAVETTVTDEEVEAEIKALQEKQAELVVKEEGTAELGDTVVIDFEGFQDGVAFE
GGTAENFSLELGSGQFIPGFEEKLVGVATGESTEVEVTFPEEYHAEDLAGKPATFKVTVH
EIKGKELPELDDEFAKDVDEEAETLAELKEKIKTRLENDKKHQAEHTVRDTVVEKASENA
KMDIPSAMIDTEIDRMMSEFEQRLQMQGMNLELYFQFSGQDEAALKDQMKEDAEKRVRSN
LTLEAIVAAENIEVTEEEVNAELENMSQMYNMPVDAIKQALGGVENLQMDIKMRKAIDFL
VENSKTVA
>PK3-045_01556 ATP-dependent Clp protease ATP-binding subunit ClpX
MFKFNDEKGQLKCSFCGKTQDQVRKLVAGPGVYICDECIELCTEIVEEELGTEEEVEFKD
VPKPAEIRDILNEYVIGQDQAKKALSVAVYNHYKRINSNSKIDDVELSKSNIALIGPTGS
GKTLLAQTLARILNVPFAIADATSLTEAGYVGEDVENILLKLIQSADYDVEKAEKGIIYI
DEIDKVARKSENPSITRDVSGEGVQQALLKILEGTVASVPPQGGRKHPHQEFIQIDTTNI
LFICGGAFDGIEPIIKRRLGQKVIGFGSDGKQAEIEDKDLLSKVLPEDLLRFGLIPEFIG
RLPVIASLGQLDEEALMEILTKPKNALVKQFKKMMELDDVELEFEEEALKEIAKKAIERK
TGARGLRSIIEGIMLDVMFDLPSREDIVKCVITKETVTDNASPKLVLEDGTVVDKETKTS
A
>PK3-045_01557 Lon protease 2
MSWAEIALFVQLFFGIIIGLYFWNLLKSQRSQKVSIDRESKKEMDQLRKMRAISLTEPLS
EKVRPTSFSDIVGQEDGIKALRAALCGPNPQHVIIYGPPGVGKTAAARLVLEEAKKNQKS
PFKPNSVFVELDATTARFDERGIADPLIGSVHDPIYQGAGAMGQAGIPQPKQGAVTNAHG
GVLFIDEIGELHSTQMNKLLKVLEDRKVFLESAYYNEENTQIPSHIHDIFKNGLPADFRL
IGATTRTPNEIPPAIRSRCMEVFFRELTKEEVIQIGKKAADKVKMRISEKALDTLSEYAR
NGREAVNMVQISAGLAIGEDRDFIKDDEVEWVIHSSQLSPRMERKINNHSVIGAVNGLAV
YGANIGALLEIEVTVIPAKDGKGSINITGIVEEESIGGQGKSIRRKSMAKGSIENVITVL
RSMDVPADQFDIHVNFPGGIPIDGPSAGISMATGIYSAIYKQPVDRQVAMTGEISIHGKV
KPIGGVVAKVKAAKAAGVQKVIIPQENMQAILDEIKDITIIPVKTLNEVLENALLKEEWK
EEAIPASTIALTKKESI
>PK3-045_01558 Lon protease 1
MEENKKTIVPLLPLRGLLVYPTMVLHLDVGRDKSVQALEKAMVEDHLIFLTMQKDMDIDE
PEEEDLYKMGTLTKVKQMLKLPNGTIRVLVEGVQRAELEELMEEDGYFAARLRLFEEETT
KDVEDEALMRTMLQYFEQYIKISKKISHETYAAVSDMEEPGRMADIIASHLPIKLKEKQQ
ILETLNNKQRMNYVIDIIQNEKEVLNLEKKIGQRVKKSMERTQKEYYLREQMKAIQKELG
DKDGKTGEVSTLLEKIEEAGMPDHVKVTALKELDRYEKIPSTSAESSVIRNYIDWLLALP
WTNATEDDLDLIKAEKILNDDHHGLEKVKERVLEYLAVQKLTNSLKGPILCLAGPPGVGK
TSLARSIARSLNRNFVRISLGGVRDESEIRGHRRTYVGAMPGRIIQGMKKAETINPVFLL
DEIDKMSNDFRGDPSSAMLEVLDPEQNHNFSDHYIEETYDLSKVMFIATANNLATIPGPL
RDRMEIISIAGYTEIEKIHIAKDHLLPKQIKEHGLSKAQLQIREDGLQKIVRLYTREAGV
RTLERQLATICRKTARMIVTAEKKKVVITAKNVEDFLGKPIFHYGQAEEEDQVGVATGLA
YTTVGGDTLQIEVSLAPGKGKLVLTGKLGDVMKESAQAAFSYIRSKSEELGIDANFHEKY
DIHIHVPEGAVPKDGPSAGITMVTALVSALSGKPIKKEVGMTGEVTLRGRVLPIGGLKEK
SLGAHRAGLKTIIIPKDNAKDIDDVPESVREELDFILVSHVDEVLKHALNGSVNL
>PK3-045_01559 putative GTP-binding protein EngB
MKVNQAEIVISAVKPNQYPEGNLPEFALAGRSNVGKSSFINRMLGRKALARISSKPGKTQ
TLNFYLINEIMHFVDVPGYGYAKVSKKEREAWGKMLETYFTSREQLKAVVLITDLRHPPT
ADDILMYDFLKHYGIPCVVIATKADKISKSQWQKHLKVTKETLGLSADDYLILFSSETGE
GKDKVWSLLEHLANK
>PK3-045_01560 hypothetical protein
MKTQKWFSGIVLIGFGFYFILKEFDITILPNLYTWPTLLIIIGIAFLFQGYGGKDYGVIL
PGVILTGFGLHFHLVNKLAIWPDHTGTFILIIALGFILQNQKTGQGLLNGLLFLLLAVLL
LFYQEILGSLTFLKISPHTLNNLIPILFIILGGYYLVSKKRK
>PK3-045_01561 Glutamyl-tRNA reductase
MHIVAVGLNFKTAPVEIRERLTFDSEQIGEAMNQLQHKKSILENVIISTCNRTEIYAVVD
QLHTGRYYIKQFLAEWFQLEQEEFVPYLFVYEQDGALNHLFQVTCGLNSMVVGETQILGQ
IRTSFLTAQSIKSTGSVFNQLFKQAITFAKKAHTETDIGANAVSVSYAAVELAKKIFGTL
LNKNVLILGAGKMGELAIQNLYSNGAKNVTVINRTFEKAEVLAHRFEGQAKPMNELQCAL
IDADIVISSTGSNAFVITKAMMKGVEKIRKGNPLFMVDIAVPRDLDPEIAELDSVFLYDI
DDLEGIVEANLQERQKVAEKIMIMIEAEIIEFNQWLHLLGVVPVISALREKALAIQSETM
KSLDRKLPNLTERERKILNKHTKSIVNQMLKDPILQAKELAAQPNADQSMQLFMKIFNLE
ADAPKEASDIGKKEEKEAFSPIAQPSIQV
>PK3-045_01562 Cytochrome c biogenesis protein CcsA
MTRLHEFTIILYALSVLLYFFDFMHNNQRANRVAFWLLLFVWILQSSFLIIYIVEMNRFP
ILTIMEGLYFYSWVLVTFSLVINKWLEIDFIVFFTNVVGFIVMAIHTFAPARDSARIHVE
QVVSELLFIHVTAALLAYGMFTISFILSVLYCIQYDLLKQKKWGRRVMRIADLAKLEHIS
YLLSVFGVPLLLIGLILGVQWAIIQKPDFLWYDPKIISSFIVLLVYSSFLYLRVSRKMRG
KNIALLNIASFLIMLINFLLVGNFSTFHY
>PK3-045_01563 Porphobilinogen deaminase
MRKIIVGSRKSKLAITQTNWVINQLKKLDSSFEFEVKEVVTKGDVVLDVTLSKVGGKGLF
VKEIEQSMLDKEIDIAVHSMKDMPAELPKGLTIGCIPEREDYRDALISKNHIPLKDLREG
AVIGTSSLRRGAQLLAVRPDLEIKWIRGNIDTRLNKLETEEYDAIILAAAGLARMGWTSD
VVTEFLEPEVCLPAVGQGALAIECREDDKEVLELLSKLSNQDTTRTVYAERAFLQRMEGG
CQVPIAGFAQVEKDEVSLTALVISPDGKQIYKEEVSGKNPVEVGEQAAAILTDKGAKALI
DRLKEENVIDG
>PK3-045_01564 hypothetical protein
MANLLLGKKILVPRSKKQASVLSKQIIDLGGIPVEVPLIAFREKQLPDGVIASLKNKAYD
WLVFTSRNGVDAFFKEMNRLELTLVAPIAVIGEKTTAAIAGYGYQADFMPTDFVAEQFAK
EFAAILEKQQRILIIKGNRSREFLAEQLKKACLQVDEAILYETYFPLESEELLVNEVKEN
DIEVLLFTSSSTAHHFMQIIQKHQLIDRVERCIVISIGPITTETLHSYGMHVTITAKPYT
TDSILEHLVQYLTN
>PK3-045_01565 Delta-aminolevulinic acid dehydratase
MVEFKRHRRLRQSANMRALVKETYVHLDDLIYPIFITEEENSKTEISSMPGIYQFSIDRL
KEEMDEVQELGIKSVLLFGIPKEKDECGTQAFHDHGIVQEGIKYIKANYPEMIVVADTCL
CEYTSHGHCGVIEAGRVLNDESLELLVKAAVSQAEAGADIIAPSNMMDGFVAAIRKGLDE
AGFIDIPIMSYAVKYASAFYGPFREAADSTPQFGDRKAYQMDPANRLEAFREAESDVAEG
ADFLIVKPGLPYLDIVRDMKNEWNLPIVTYNVSGEYSMVKAAAQNGWIEEDRIIMETMIS
MKRAGADLIITYFAKDVARMLKEQ
>PK3-045_01566 Glutamate-1-semialdehyde 2,1-aminomutase
MRSYQKSEAAYKEAVELMPGGVNSPVRAFKSVKRNPVFMEAGKGSKIYDIDGNEYIDYVL
SWGPLILGHADDRVVEGIKKVAEKGTSFGAPTLIENELAALVKERVPSIEIVRMVSSGTE
ATMSAIRLARGYTGRNKILKFEGCYHGHGDSLLIKAGSGVATLGLPDSPGVPESVAANTI
TVAYNDLESVKYAFSMYGEDIAAIIAEPVAGNMGVVPPKPGFLQGLRDVTTEYGALLIFD
EVMTGFRVDYGCAQGYFGITPDITCLGKVIGGGLPVGAYGGKAEIMNQIAPSGPIYQAGT
LSGNPLAMTAGFETISQLTKDTYKEFIRKADRLEEGLKEAAAKYEIPFTVNRAGSMIGFF
FTNEDVKDYESAKTSNLDYFAAFYNSMLEQGVFLPPSQFEGMFLSTALTDEDIEHTIRAA
EQAFSTLKA
>PK3-045_01567 Vitamin B12 import ATP-binding protein BtuD
MMQLLIGQEGIFMDSFIKMQDVSFTYDHTTILHKINLDLEKGKSYALIGKSGVGKSTLLH
LLAGFLSPTEGEVLMDGKKIQHPQKDIGFMFQDLGLFPWLKVFDSISMPLKLDKRKAKQE
IKESVTALIREVGLSGMENKYPTELSGGQQQRVALARTLINKPDLLLMDEPTSTLDEMTK
EQIQQLIAEQVEKRQTTLLFVTHNIEEAVLLGEYILLLQDNGDIEMIENPLFGVERAKEN
LSFYKACIEVRKRLAVVEV
>PK3-045_01568 hypothetical protein
MKNIIKKIIVNQLFLGFISVGLFWYIVYFLLQSHTIPSPLLTVTYMWHDKYILLLHSGAS
LLRIFIALFISLVIGIPMGIILGKNKRVNTWLSPFLYYIYPIPKVAFLPIFMILYGLGNE
SKIMLIIWIIIFQIILSVRDGVLQIPASYFKVMNGYRAAIFQQFIYLIFPSILPAIFTGI
RISIGISLATLFFAENYATTYGIGYYIISAWTKMNYEEMFAGIVALGCIGLLLFILLDKL
ELKMTPWNYK
>PK3-045_01569 hypothetical protein
MKKIWTLSFILVFVLVAAACGKTTATKTNDQKNNTTEKPSGEELTIGILPAESAIPIILA
KENGYFDKEGLKVSIKSFSAPTDRNVAIQANEVDGTIADVMTAAAFMENGIKMKITSDIS
EDFKILSSPNSGVTEMKELDGKNVSLVPNFILEYIMDDFAAKEDFTYNIVEIPSFSGRAE
ALMADKVDGVVFTEPQASMLVSQGAHLLGSSTDAGIKGGTILFSDELISSKPADIKAFYK
AYNKAIDYMNNTKAKEYADILTKYQFPDAMSNYLSTKESFPYASVVPKNSFDSIVQWTKE
KGQIKESYTYEDLTDFTLLPN
>PK3-045_01570 Poly-beta-1,6-N-acetyl-D-glucosamine N-deacetylase
MAFSVLMYHEIRKEEDFQAAEQHPIDVKQAYKDFLPSPLFITLEKFEQQMEYLFHNGFHT
LSLEEVKAYYERGNPLPEKSILLTFDDCFQSIKEYAYPILKKYQFHATAFVVTGWLHDNK
RIFVKDKSVCLSARDLEEMKDVFEYANHTHHMHIRTSESESLLMTSRKETFAKDLDECNN
HILINHKNVFAYPFGLFNESNVLTLKEKEFKLAFTCENGHNDMQTNPLLLKRNAIPYLID
LEAFKKIITI
>PK3-045_01571 hypothetical protein
MSQENSSILRFSLEESVWFQKGQEVADLLSISLDPNITIQENDQYIIIQGSLELSGEYKR
YNEGEQEEEEVFKAPKLVHSVMEREEGVCEFLHHFPVDITIPLERVTSLDDVEIEIDTFD
YVFPERSCLNLTADLTISGLASEEVEEDIAEEEREEELEVARHTQEEEEVVELIRDHSKE
EEEVLTDSIEEPVEIAVSPFQNVSPLLEELREEKETEDDLYSSFELEVRKTPEEDDEWST
NEHTKIPYFSEEVRKEEEAAPAEPEMKVSILRSEEKVFTAEEVFQKPDHESSSEAKQEEV
VMEEEELEESSSSPNEEPKKKKGLFNKTKSLTFTEFFARKEEEKHTKVKVCIVQQGDTLE
KLSDRYNVNIHALLKENRMEANQDIYEGQVLYIPGNFVEK
>PK3-045_01572 hypothetical protein
MAVSLYEKVWADMNEQNILKKYTPILKPYAVEPNFVEEFGKVAKIYSNKGTFALKRMDPH
HGADFTRHIRMLYQKGYNRIVPIYPAVDGRYAIFYDNKLFYLMPWLPNEERENYSRKHQQ
MFRELARLHILSSKEVKIEKEDRQEHFENTQLDIEKEQEFLNGFIELCENKEYMSPFELM
FCLYYHDIRQALIYSETKLKEWYEETKEDEKARVSIIHGKLSPEHFLYDDRGYGYFTNFE
KAKYGTASHDLLPFLARSLKTGPKQNDECIEWLYTYFKHNPLKYDEMLLFLSYLAHPGPI
IRVCEKYMKANKKDINERKYVQKLLKQYWLLKNTEYVVMRVDEIERQKKAQQDAAEQAET
QD
>PK3-045_01574 hypothetical protein
MKVVSKRGNQQLRDFYSTHWKVALELLLRTVCLLVKDGQYPISSFKEPIPILYWKKGGTA
NKLHSSF
>PK3-045_01575 Valine--tRNA ligase
MEMKEISMPTKYDPASIEKGRYDWWLEGKFFEAKPDEGKKPYTIVIPPPNVTGKLHLGHA
WDTTLQDILTRMKRMQGYDVLWLPGMDHAGIATQAKVEEKLRAQNISRYDLGREKFVEET
WKWKEEYASHIRAQWSKLGLGLDYSRERFTLDEGLSKAVREVFVSLYKKGLIYRGEYIIN
WDPATKTALSDIEVIYKDVQGAFYHMKYPLADGSGYIEIATTRPETMLGDSGVAVHPKDE
RYQHLIGKKVVLPIVGREIPIVADDYVEMDFGSGAVKMTPAHDPNDFEVGNRHNLERILV
MNEDGTMNERAGKYEGMDRFECRKQIVKDLQKMGVLFKIEEHMHSVGHSERSGAVVEPYL
STQWFVKMQPLADKAIALQDKDAEKVNFVPNRFENTYMRWMENIRDWCISRQLWWGHRIP
AWYHKETGEIYVNHEAPADIENWTQDTDVLDTWFSSALWPFSTLNWPNTEAEDYKRYYPT
AALVTGYDIIFFWVSRMIFQGIEFTGERPFKDVLIHGLVRDEQGRKMSKSLGNGVDPMDV
IAKYGADSLRYFLSTGSSPGQDLRFSIEKVESTWNFANKIWNASRFALMNMDGLTYDEID
LSGEKSVADKWILTRLNETIETVTRLSDRYEFGEVGRVLYNFIWDDFCDWYIEMAKLPLY
GDDEAAKLTTRSILAYVLDNTMRLLHPFMPFITEEIWQNLPHAGESITVADWPEVNPAFT
DDKAANDMKLLVEIIRSIRNSRAEVNTPMSKKISILLKAKDEEVKATLLENKSFIERFCN
PETLSIDTDIAVPDKAMTAVVTGAEIILPLEGLINMEEEIARLNKELEKWNKEVERVQKK
LSNEGFVKKAPEKVINEEKAKEKDYLEKRAAVEARINELKG
>PK3-045_01576 Folylpolyglutamate synthase
MFHNYEEALNWIHSRLRFGIKPGLTRMEMMMEKLNHPEKQIKTVHIGGTNGKGSTVTYLR
NILQQAGLTVGTFTSPYIEQFNERISVNGIPISDEEILALANKLLPIVEEMDQMEIGGPT
EFEIITAMSFYYFAYINKMDIVIYEVGLGGRFDSTNIISPLLSIITSIGLDHTAILGDTY
EKIAFEKAGIIKTETPIIAAVKQKGAQKVIVNQAMERKAPIYLLDKDFMIDKYHSTPSSE
SFELKSMFFKWEDLQITMFGKHQVENASLAVMGAHLLQDTFESINEDSIRKGLYQSKWPG
RLEILSGNPFVVVDGAHNEEGIDALVDVLVNRYKDKKKHIIFAALSDKKTDKMIAKLDQV
ATSITFVTFDYPRAASSKTLYEESNHPSKEQNSDWQKAILTQLEKIRVDDLFLITGSLYF
ISEVKEFWRNYLK
>PK3-045_01577 hypothetical protein
MINPSYKKIIWTVWTLLLPLGLWFSYTLYPPQIYDKGWELVAFLLFMTIVASMPMIINGT
PVFFLQWATLSVFLIFGLVTEIILVQISLLAVLYQAKLDRKSLFRLPMNSIMFFLVSFFS
GIIYYSFGGGHGFDIALNFKSFYLITVYLISYLLLNTLGIFFIVRFIYKRKQRFVTKDLI
WEIITTIITYPVGIVLYLMYEYIGLAALILIGVPFISLSLILKLYHSSQTANDYLRKTAE
IGHQLSQNLYVNETIDFFIEKLYELFKVDFVFIHQVNTNEELEMISRVEQQEKLPLLPEI
MKENEGICGKVLASKKAEVYHSKQDWQKVNKGYMPDGVQSILCMPLIKNNKVIGVLLLGS
RQKKAFANIKLMVLDLLCSQFAIALENAKYFETTKENSERCALTKLYNYRYFDKILSEQF
TELNEKNLDNLVLIMLDIDHFKAINDQYGHQAGNEILIGFAKRIQNLIGDHGLVARYGGE
EFVILLSNIEKKEAFDLAEFIRKRIASSPFVIKQNIDDRHQVKNVNITASLGLAYAPVDA
DEPLALIRHADRALYVGAKRAGRNRVAGYVK
>PK3-045_01578 hypothetical protein
MRRTKLASKFFTVLLILVFILPVQTNASTTTPSVSFSVTPSQNIIVKPSGGVAQGNLDVR
LTPEGKVTSSNRSPIDLAFVFDKSGSMDELGYNPYKFQSAKNAITQAVNYFSEDPNVYDR
FAFIPFSTDVEKEKMVYFPIYAYNSADNVRNNLKTINNVANRLVATGGTNYTQSFQTAGS
MLASGNNNANKYIVFLTDGEPTSSMMEETFTDKVCTNYYFWQSCSNKQVKDTVTYTIYTN
NTARAVRSNGTIVSTSLSYVEKAIKSHIETEVNNLAANNYKLYSIGFGTNKDVDMSYLNK
LSETTGVTAQQASEQSIAKIFETISEKVNTPTISATIKINIAKFGNKVKLSDNANVTTDS
VGDIIIKKDILFPVNQEPSGSIDMALPLTFSETGTYVFDDITLQYKDLDGNNQTKKTSAT
IQVKEDAPASFSSTMMLEKEVNELNDLIKTSNSSDKTNHFNVKYTLNPIGLVNNTVSGTL
SNLVIEQPLPDSVSIVTTDSVKEVTKDGSRYAIITLPNEIHYSTGSFTPSTINRTVEYKI
NYAVNNISMPRADLYFKDSRFQPINATTISPSAQTMNMKVQLKEFTMIKYTGDAAGIIEK
REQETNKKVANTEYPNDYNLANKPVKEMVFAQESENQTIEITYSDNSKAYLHFLPDFELI
GQDTKKRYKSGSTSTEFIDTVLTQKVPGQNVTYAYKIDNGSESTGWKTFKPEDNISIETS
GENTLSIKAAGGFANNTEIIKTIKIAWPITSITIEPNPIEMNVDGTKSFTIKVEPNHATN
KTLDIAVANPSISSLIPGQNTLIGNAAGMTELIVKTTDGSNLVQRVPVHVIEPYVKLEDI
SFTKPVYTIERSAETNDKLIAVDDLLIFNPANATDKEIEQVLSNAPDTVEVIKQDGQYYL
KAADVGYAEITAIAEKQKDGTQPKDSTLFKVVKEKEGNNGSGEDRDGRW
>PK3-045_01579 hypothetical protein
MFNWNQKGNALITVLLISLVFTTIGLAIVASSISSTKRVETRESDISITYESKKVLEEIT
YEMANALQSLPLDYKQIDNQYIVSDSFDTQLASNVIMPTLNKILANQPYNEAISCLSVVD
LSAATKVEIPSHKACSKNTYDSDSTYSIDRGLDFTRVLEIILVTNNPNETEGAITRTLKK
RVILSPLPSFLKYALGSYSEQDDEGLFINGSPNVNGNIYANQLQINDHAKYQLKNGSRQE
KSSLPPSITGNIYSSSANLLPVLKDKNFYKGEVPSLNHDSQFINIDYNRTFIQRMDTMLR
TDDNLNSIAIGGISETANFPSLLQHKVASMVNDQPNSAALIENVPEQEAPSSVLGDSLKR
LSNSFQIKSDNHPLDFKNKVSINGDTVINSSNYPITFDKDLVVNGDLYLVSNNQLKLADN
IYVSGDLHLINFDGEMDLQGNLFVAGDLNIESAADNKSNPHNGISINGDILTGKSIHIRP
LNTTISLNSNMISLDSFTINGDEKGEESGENDIVKINSVVYTLNESFVSNINILGLPYID
NRTGANQVGQLILLAKEKLTITRMNEFNHFHPMKETGFPYLPEEETIIQPLKAFFYTEKN
AELYGVGSLFYIKGGVFARDSLEINAIRANREFSSISDIPNSREGMLSRFIVDYDQDVLL
RGIDALPIVDRLQIIPDDFVIE
>PK3-045_01580 hypothetical protein
MRIFDEKGITLYELLATITILAIVLPVIYGVFQSGLSLYNKIQIEGQIRDDADYAISMMM
NSFNSIPYDYVTIEGDSKISFYDTEKTVFEKNTKENSSFYTYEKEKITPENAKVRSIEFV
DQQLKSETITAVSINNQILEGSGDFTGSKIRLSCSKTAQEDKNRCLHGLIYITFVIDQAR
LNRPLTLESQFGF
>PK3-045_01581 hypothetical protein
MKISKLISSSKGLTLIEVLLSLTILSIIILGIMNFFTQAYSYTNLNQKKTAGINVARNAL
TYMEQTTQEDSFISIKNRIDHNKEATGELFICNNEYKVIWNKDNQASCTPIKINNIDYHV
TIKPVLDKNYSNFFIPLTVTVTWNVNKKEYNTSMEGAIKSEDLR
>PK3-045_01582 hypothetical protein
MSVYILALLSLIFVVPILYILPLGLSNQGKFTIIGLAFCISAIGLLSRELFSFWQSILIM
LLFLISASYLLLKNWSTVLFVMPEEVEESVIEKRQEPREIKPIKTTQSDVKQEGDIITYV
PEVNREGILTNEEDIIQEETVESIDINLDVMEQLEVVELDEEFSLSIEEEVIDKEIDKEP
AETNYLAEIEKMLEENDPSTGNEANEEIAEEDQIEEISFSINEDAEVAVSVEKMEQEQIW
NNIEDNDLTEEEKTILSEEMTAISEHIEESQEFSAIEMLGEQAEVSQNQSQENQIGSDDD
KHENVVSGLAHKIINNTLTQLVMLKNSMDMEEFETVLTLCLKKPIPLNEYFAYSALLIDA
YFQNNEKDKLESLIYSLREKFMEQPIVLEQIKFMEEKYLKNR
>PK3-045_01583 hypothetical protein
MKISTQFKGLPIISISNGQQEGNVQSLIINPEKGFVDFLTLEQEEWQESIQAIPFKKVIG
VGEYAVTIESANSIIDLTQIPIASELASKKIAIIDTNVITRKGDLVGKVTEYQMNEETGE
IIGLVLEEQESVISSEAVITYGKDIIIVKEEVATPNFVQEEAVSSNDHLIQALEEVEREN
EAGLNGLKEKQRELLLNKQVTKDIYAADGELIVAKGSILALEDIEKAQNAGPSVVIDLSM
SVNA
>PK3-045_01584 hypothetical protein
MKNVQAVKLFIAIAITTAFIFSFSHFGVKAYERIFSTKQGYEEGTTVGGIDISGMSLEEA
LKALKDSQEEWIQAVSIKLNYKEKTIDFATDLFTFQFQESLEKIHQGTDNALIVSLNQDD
LIGLLYSISPYLVEEDVFYVNKWSDSLIAIASQLDKGNHELALQDYLVSQKEEEVILVDT
TLDVQENKKNVAKWVKQFPSIEVGQEATVSLLDIMGKQTDSYSDTTLSMVATALHQLVLA
TNFTITERFISNQLPNYAPLGYEAKINQSKKMDYRFYNPNAAAYQLQFKMSGNKLYASVV
GVPFLFKYDVVLSNQEAFKPKTVIQFDSLLEFNEYRTITEGTDGLLIKVYRLAKNEDGVE
VKKDLMSEDFYPPINKVVASGLIKEQETVIDTDNVEDLTDLNDPSDSGENIKEEEKDSNN
QTTENPSQTESNNQDLKENKEETPQAEIEK
>PK3-045_01585 hypothetical protein
MKQIRKRLGDLLVEAGLLTEDQLQQALKDKHPDQRLGDSLLQKGYITEQQLIEVLEFQLG
IPHVSLYRYPFDPKLFTIVSKETAKRQLIIPLKKEGEKLYVAMADPMDFYTIDDLRLSTG
FQIETAIATKDDILRAINKYYDMDEGFEELLSDNGAVGEDVSDSMVEQQDTPIVRLVNQI
LSNAATLKASDIHVDPQETKVVIRYRIDGVLRIERVLPKHMQSVLIARLKIMANLDITEH
RIPQDGRMKFNLDFHPIDLRVSTLPTIFGEKVVMRILDLGSTLNDLDKLGFNKVNLARFT
KLIEKPTGIILITGPTGSGKSSTLYAALNRLNSEEVNIITVEDPVEYQLEGINQIQVNTN
VGMTFAKGLRAILRQDPNVIMVGEIRDKETAEIAVRASLTGHLVLSTLHTNDSLGSVTRL
LDMGVEPFLVASSVTGIVAQRLVRKVCRDCGQVHSATVREKEIFAKRGLTIEKVVRGKGC
ASCNMTGYKGRVAIHEVLVINEEMRKVIMNGESFSRLRDLAMKAKTIFLIDDGLLKVKQG
ITTTEEVLRVAIPD
>PK3-045_01586 Twitching mobility protein
MNHSIDYLLRVGFELKASDIHLTVGVPPVMRINGDLKRYGKNNLEPNDTEIMARTMVPEK
LWEVFQDRGELDFSYSLKGVSRFRVNVYKQRACIALAIRVVPTSIPSLDDLKLPAIIKKI
AERPQGLILITGPTGSGKSTTLAAMIAYMNETMRKHIITLEDPIEYLHKHGKCIIDQREV
GFDTNNFANGLRASLRQDPDVILVGEMRDLETIQTAITAAETGHLVLGTLHTSSAPATIN
RIIDVFPPTQQDQIRIQLASVLVSIVAQRLFPTPDKSGRVSATEILVNNSAVANLIRNEK
IHQILNIMQTSKAAGMHTLESNVKELVHAGAVLREAALPYLQEKEQ
>PK3-045_01587 Type II secretion system protein F
MARYKYTGRDRKGTKKGIVTASSKREAIVQLKEKGIKITEINEVPETLLTKEITFGSPVK
LQDFVIYLRQFATLIKAGISVVDATAILAEQTESKALRKALLVVEQDLKDGNPLSTAAAK
HRKVFSSMFVNMIRAGEATGSMDETLERLANHFEKQHYTKQKIISALTYPIAIAVIAFIV
VIFLLVSVVPTFVDMFADFDSELPAITQFVLSASSFMQKFWWLVSLLLIAFIIAIMVIRN
NKASKYYLDYFLLRVPIFGKILQKAAIARMTRTLSSLFSSSVPILQAISIVERVIENEVM
AKVLVQSRGALEQGQSLTVPMKAHWVFPPLVTQMIAIGEETGSLDDMLAKVADFYEKEVD
TATDRLKSLIEPIMIVFLASIVGTIVSSILIPMFEIFNHVQ
>PK3-045_01588 hypothetical protein
MRQLIKQRIKNEKGLTLIELLAVIVILGIIAAIAVPSIAGIIQNSKEDAVKADAITVLNA
AKNYVAANDIPKNGKIDQADLKSYVSGLKTTFGDYVVTSADGINFTLTTTNKVVAGKKFI
KFTSASIDDINNDNSDTVIVTDN
>PK3-045_01589 Type 4 prepilin-like proteins leader peptide-processing enzyme
MIYLLIFLYGITLGSFYNVVGLRVPLNVSIVRPRSHCSSCGRTLSAMELVPVLSYVLLRG
KSKCCKASISPFYPIFELLTGILFVVSPLLLGWSSELFVSWTLISLFIIITVSDLKYMII
PDKVLLFFSIVFMIERFFILLHPWWSSLLGAAVGFTLLLVIAIVSKGGMGGGDIKLFAVI
GFVLGTKLVLVSLFLSTFLGTIGGIVGMAIGKSKKKQPIPFGPYIALGTLITYYFGNQII
QWYLSIFL
>PK3-045_01590 hypothetical protein
MALNFNFGKNKVVNLTIKDHVIRFVEMKNSQDAVVQNFGERYLPPGLIHDGVIQDVENFL
WILEECVDEWKLSKKQVRFLVPDSSIVIRKLPIPEDVSEDEIKGYLYMELGTSIHLPFED
PVFDYYLLKAKEKNKQQIILFASPEESVAQYADLLEEAKLSPQSADISALALYRYFYRSE
KVEDNDIIMLVEIDIKTVNASIFEEHYPLLMRHLLQEMEEDHWTVTTDELLLQEKLTFTG
DHTEVWNGLEDVYNELEKVMSFYRYTLNKGDKLVTKLVVTGDHPWLSAIIENMVNRFEIP
VFELKVNQSVSNKPIPSSFLLNIGLGLKEV
>PK3-045_01591 hypothetical protein
MLVEINLLPKKEPKRKSQLLWIILAFLITFLLIGLFIWQYMTKKAELTATENSLKMTTNL
VDTYNQKLERYKSSQSVQSLESAINWANNQSVDYVLFLQELTKNLPERGFIQELKVSDDH
KTNMIVQFDTKSDAAYYLNSLLEISWIDEALLTEGKSTDALENKISEQVNQAIDILKQSE
VEPRYFASYEFVLNKAKLRDEMEKQKDKNEKGEDSP
>PK3-045_01592 hypothetical protein
MKLSDHKPMIWFAFSIIFLALGAIYSYYFYLMPLNNELAMKKTELQMTEQQADILESKLK
STGSETSTNTIELQKKVPVKRLLEQALLEIEKAEIISDSNILEISVNGSDVDENVTDGEV
STADEAIDDANKQENRETDEKKNTEEINLPSGIHQTTINMIGEATTYFELEKFLEKIQSS
QRIMTVDSLNITGPKEIIAVEESDQQIDFELTVSVYYYPTLTDLMEDLPQLDPPKVSERK
NPFDTGTLENSKDQ
>PK3-045_01593 hypothetical protein
MLKTRLNNKGLTLMELLAVIVILGIIAAIAIPSVLKVIGDMRDRAFIANAWNMKEATDFY
IKEATTSGADAKERITYFELVESGYMGTFHDPDTDRELVPSDKSYVTIQNNIAIAVCLKG
ENRKLCTEEEGVDQAIQYNDLSPSQIVSNNN
>PK3-045_01594 hypothetical protein
MEMGVGRVNEKPENRKTITIKINGNDRPFQNKDNDDMVERSEPSVFYKDQNSEGKEQDIF
KEESAAGQEAEFEESFDWILPASEEIPAKNKEKSIFSFQSSVNKKDKQPFTKGKKEKEGK
KKRLPKEVIASIFFAVFFAVILGTSFGFILLNMVSNDQSNTTNGKIAALANDSSDKPKSG
QAVSTTESATKPDITTYVLQKGVFSNVERAKSEQQKLTDAGKKSQILPIDKQQFLLVGVV
SNLENAKAWQKQVKDTYAKEMVFSGNEVKNVSKEEKEIIEGSSAIYSAILQMVTSVQFDQ
SIATEDKNKLEKALSLVDEKKTAKFTNEKVKKMAAYLLEGGELTIKLKEKSSENEIAEVH
QKLLDYLAVYVSL
>PK3-045_01595 dTTP/UTP pyrophosphatase
MLKQTLILASSSPRRKELLEELQIPFVISSSNVDESFDPSLSPNEIVMELARRKVEAIYA
DEQYPYILGADTIVYLNGAILGKPASHGEAFRMLRELSGKTHSVYTGVAIMANGICSTFY
EKTDVLFWELTDEEIHDYLDTGEPFDKAGAYGIQGVGRTLVKEIKGDYFTVVGLPISRTV
RELKAKGFNMPK
>PK3-045_01596 hypothetical protein
MDSLLIRDFPNDERPRERFMKQGPKSLANHELLAILIQTGSKNESVLTLANKLLVHFDGL
RLLKDASLDELKEMKGIGTAKAIQLMAAIELGRRVSNLEFTDRYCIRSPEDAAKYMMNEM
RFLTQEHFVCLYLNTKNQVMHKQVIFIGSLNASIVHPREVYKEAFRRSAASIICLHNHPS
GDPSPSREDIEVTKRLVECGKIIGIDLLDHIIIGENKFISLKEKGYV
>PK3-045_01597 Cell shape-determining protein MreB
MLGFGTRDLGIDLGTANTLVYVKGKGIVLREPSVVALQTDTKSIVAVGNDAKNMIGRTPG
NVVALRPMKDGVIADYETTATMMKYYIKQATKNKGYFSGKPYVMVCVPSGITAVEERAVI
DATRQAGARDAYTIEEPFAAAIGANLPVWEPTGSMVVDIGGGTTEVAIISLGGIVTSQSI
RIAGDEMDDAIVNYIRKTYNLMIGERTSESIKVEIGSAGNPDQIENMDIRGRDLLTGLPK
TIKITADEISKALKDTVAAIVDAVKVTLEKTPPELAADIMDRGIVLTGGGALLRNLDKVI
SEETKMPVVIAEDPLDCVAIGTGKALDHIHLFKNKAKDSR
>PK3-045_01598 Cell shape-determining protein MreC
MPQFFMNKRLIILLVSIIILVALIGFSLSNRNKLTWPEQFVKDTTGWVQTLVSRPAHYVV
GFVDNVQSLQDTYKENKELKAKLEENAQLKYQVQGLKKDVQALQETLEEKESLSDYTLMK
ATVIRRNPSQWTELVTINRGDNDGVEKNMAVITSAGLIGKIKSVAPNTATVQLLSSEDPA
NRISAFIQSKDDGKKKKEKSEVFGIIADYDKETKQLIMTWEEVPNGLKVKKGQLVTTSGM
GGVFPKGLAIGTVDKVEPDENGLQKKVYIKPAADFYDIEHVMVVDRAALSPKEEEQ
>PK3-045_01599 Rod shape-determining protein MreD
MRKVLIGCLISFMFILESVFLELLPTDPFGKNWIFVPYFLLITILFFSVYGNRNVGVIYG
FVFGLLFDIVYTEILGIYFFTFPFIIYIFNKLMKIFHSNIVVVSVMNLLAVSALEMIVYQ
MIKVINLTTIDFASFLHLRLLPSLGLNLIFIIIVAYPYKRLFEKYAAELKE
>PK3-045_01600 Septum site-determining protein MinC
MKKRQLVTIKGTKNGLGLHLYDNCSYEDLLKELQYKLNESSSLHNENRDIKVTVELGNRY
VTDEQKETIIHLIQEKQNLTVQAINSNLVTKKEAENWLKQNELKSITSIVRSGQVLEVPG
DLLLIGDVNPGGKVIAGGNIYIMGQLKGIAHAGYNGKDDAVIAASVMKPTQIRISRFIER
ELGNTSSEKTREMECAYVNDSVIKIDRLQVLPHLRPNLLKLEGGY
>PK3-045_01601 Septum site-determining protein MinD
MGEAIVITSGKGGVGKTTTSANIGTALALQGKKVCLIDTDIGLRNLDVVMGLENRIIYDL
VDVVEERCKIHQALVKDKRFDDLLYLLPAAQTSDKTAVRPNQMRELVLRLKQDYDYIIID
CPAGIEQGYQNAVAGADKAIVVTTPEISSVRDADRVIGLLEKEEQMEPPMLVINRIRNHM
VKNGDMLDIDEVTSHLSIDLLGIVADDDAVIRASNNGEPIALNPNSKSAIAYRNIARRIL
GETVPLQQLEEESKGVFAKIKTFFGAR
>PK3-045_01602 Stage IV sporulation protein FA
MGSRNDEVRKKIERRRKERARIEKNIDNRVLWSDEEDNFDYTFSSKEENYPPKIHPLFRK
DLFMLKILGAAILFLAVAIIVDHPSTKIAKVENAIRQAMSTEFNFMVVTDWYEEKFGKPL
AFLPEQKGKEQDTEQLQQYALSASGKVLEEFQKNGQRIAIETGVDTTVQSFNEGQITFIG
EKEGFGKTVVIKHSDQSESWYGNLEEVDVKLYENIKKGTKVGNASRYEGDETLGLFFFAI
KQNDDFIDPLQVIEIE
>PK3-045_01603 Stage IV sporulation protein FB
MNRFLSVFKYLHIHPLLWVVIAIGVMTAHFYELCLLFMIIFIHELGHAFAAAFFSWRIKK
ISLLPFGGVAEMDEHGNRPLREEAIVIISGPIQHIWLVGLGFLLWQWGIFTESLYHTFIQ
YNFMILFFNLLPIWPLDGGKLMFLLFSLKNSFPKSHKYTLYFSIVGTLIFLLMVLIMMPK
NVNAWIIISFLVFSIYFEWKQRRFLFMRFLLERYYGKSTELRKLLPLEVQEDDSLLDVLE
RFHRGCKHPIIVRSKRKENTILDENELLHVYFKEKNVTAKIKEILCVL
>PK3-045_01604 Ribonuclease G
MLNQVIINIKTRENRFAYLKDGKVEKIYVQQPQYKTTVGNIYLGQVTKVIPGMNAAFVEI
GEGKGAYLPREKMASFVRSDGTLEEKKKKSVSSYIKQGERVLVQVIKDAAGPKGAKITGI
IEINGEHLVYMPYGRYVAVSKKIHSHTAQKELRSIGSRIKTDKEGLIFRTSAANCSEETV
KEELEALRQEYKRLEQKASQKKIMLVYENDEFTKQLNVLFKQMKEGEVIVDSLEEQKKWQ
AMYPHLTVSFHQGNENLFSYYHVEREIDKALKRVVWLTNGSYLIVDQAEAATIIDVNTGK
YEGKHQLEQTVFQTNILAAKEAARQIKLRDLSGIILIDFIDMKSEEEKKVLDILEKELQS
DNRQSKVIGFTTLGILQLTRKKTMKSLSETLQSKCVICEGTGLVNSASSMAFQLERELWE
YRHMDIELVEVIVSQDVHTLFTGVGNKHKKRLEEVLGFMIKMEIAEFPKPDYFIRMVK
>PK3-045_01606 50S ribosomal protein L21
MYAIIETGGKQIKVEEGQAIYIEKLNGEAGDTVTFDKVLFVGGENVKVGSPVVEGATVTA
KVEKQGRQKKIIVFKYKAKKNYHKKQGHRQPYTKVVIEKINA
>PK3-045_01607 hypothetical protein
MIEITINKSNDGLIHSFTISGHALFANSGDDIVCAGVSAVSFGSINAVISLTGITPIIKQ
GKDGGFISCTIPGNIPAETRDKIQLLLEGMIVSLETIERDYGKYVTITYN
>PK3-045_01608 50S ribosomal protein L27
MLRLDLQFFASKKGVGSTKNGRDSISKRLGAKRADGQLVTGGSILYRQRGTKIYPGVNVG
RGGDDTLFAKVDGIVKFERLGRDRKQVSVYPVAQEA
>PK3-045_01609 Sporulation initiation phosphotransferase B
MNKDWNTIEFLRHVRHDWLNKIQLIKGNLDLNKPDRVKEIINDIITETKQEAKLSNLDIP
QFATKLLIANWENYYFRLEYEVLAEEKCQGTEDEILAKWTTLFFQTLNQYSKPFADNHLY
ISIHSMVEGFRLYVDFNGELLDSESMFQFLHQPFSHLKLENIEMRKEELLFEVWMDREQT
GK
>PK3-045_01610 GTPase Obg
MFVDQVKIYVKGGDGGNGMVAFRREKFVPKGGPAGGDGGKGADVIFQVEEGLRTLMDFRY
QRHFKAPRGEHGMSKNQHGRNAKDMIVKVPPGTIVADANTKEVIADLTEHGQQAVIARGG
RGGRGNSRFASPSNPAPELSENGEPGQERDVTLELKVLADVGLVGFPSVGKSTLLSVVSA
AKPKIADYHFTTIAPNLGMVETEDNRSFVMADLPGLIEGAHSGIGLGHQFLRHIERTRVI
VHVIDMAAIEGRDPYEDYVTINNELQEYNMRLLERPQIIVANKMDMPDAEENLKVFKEKL
EEDYPIFPVSALTRSGLRELLFAIADKLENTPEFPLEEVEEEAGIHRVVYKHEVDERQFY
ITRDPDGSFVLSGEGIEKLFKMTDFSRDESVRRFSRQMRGMGIDEALRQRGAKDGDTVKL
MEYEFEFID
>PK3-045_01611 hypothetical protein
MKQSKIDHKFFIVREDVLSEAMRKTLDAKELLERGKAESVHEAVKKVDLSRSAFYKYRDT
IFPFHTIVKERLITLFFYIEDRSGTLSKLLSVVASAGCNVLTIHQTIPLQGRANVTLSLN
TAEMEISIDMLLERLRMLEFVEKVDVLSTGA
>PK3-045_01612 Bifunctional chorismate mutase/prephenate dehydratase
MKVGYLGPKATFTNMAVNQQFPGVESIPFLTIPNCLDAVMEDKVDVALVPVENTLEGSVN
ITLDYLIHEVFLPIHGEVTVPIKQHIMVHPFREDTWREIEVVYSHSHAIAQCHKFLHTEL
NGIACEYMTSTAAAAQFVKENPHINGAAIGNLLTAEEYGLKIVKHNIHDSMNNHTRFLIL
SKNPVHYSATTSQLVGHKTSLMVTLPADRSGALHQVLSAFAWRKLNLVKIESRPTKTGLG
NYFFLIDLDRKMDDVLIPGAIAELEAIGCEVKILGSYPYYMTE
>PK3-045_01613 Transcription repressor NadR
MTESKKMLGEERRAYILTLLKEKNRPYTGSELSKLTNVSRQIIVGDITLLKAKNEPILAT
SQGYLYLQESKPMLYERIIACNHPPEKTEEELNILVDNGVTVKDVTIEHPVYGDLTASIL
VSNRKEVKQFMKKIKHTNAAYLSELTAGIHLHTITAPSLDTLLEAEEALRKADFLMEEEA
>PK3-045_01614 hypothetical protein
MKIHIVQKGDTLWEIAKKYGVNFEELKSLNSQLTNTDMIMPGMKIKVPTLGGSIKKEAPQ
MGSKKEMPITMEPIVKEAPKKEMPVKETPKKEAPKKEMPKKEIPKEKPFTPKMPAPIIPE
IDITNYYSMNMTNVDVDIDVEMKEKPAPVKPTPVKPAPVKPAPVKPAPVKPAPAKPAPVK
PMPAKPAPTKPEPTQLAPVLPNQEPVQKDVCPPIVPYQPYCYEVSPMMPGSGFPPGVCPP
EGVPVEQVASQVYPTFPGVEFTEKHHWEESSSSYSAFINQAPSHVNQIPQENSQKPWAQF
SQMPIENEPTSHVAGAAQKPNVAHKPNAPTHTAVHPTITLPVKEDCGCGPSFPTASNFQV
DGMMQGATSGKGGMPQGFDPQMGGHPMGGGFDPGMGGMPQGFDPQMGGHPMGGGFDPGMG
GMPQGFGPEMGGYLMGGGFNPGIGGMPQGFDPQMGGHPMGGGFDPGMGGMPQGFDPQMGG
HPMGGGFDPGMGGMPQGFGPEMGGHPMGGGFNPGMGGMPQGFGPEMGGHPMSGGFNPGMG
GMPQGFGPEMGGHPMGGGFNPGMGGMPQGFGPEMGGHPMGGGFNPGMDMRGVPQGFGLEL
GGYPMAGGFTSGMEMGGHPIGYQPSINQSPYPQDAVGNTPISYTTENYGADQEAPSYEGS
SMAQPVSTDVTSPVYGPGGNAPVFTPPYNPTIGQPPFMNPYGMNQGTPFGMPRYQEDESS
DL
>PK3-045_01615 hypothetical protein
MIYDFYHRGDDTFFYRLLSLLEKKIPIQIIELNRIRNDVYLIKTKQYWIILKGYNSYQKL
KVQVAFTRALKQEGFTQTYQFYDFDDEPIIIDNKVYGLIEYLPPHRDTFSYHSKRNRREA
LQLLEHYYSVTERLVEIYKYILPTFHLIKKFEQRLEEFRGNLLIIEQYIKKDIAEEIMEW
ADYSFGLIKKQMDYLDTTPNVIIHGDVAHHNFLRVKNNELYLIDFDLISIGPRIADYLQF
ANRILPDIGWSLQDLQKMQVYADLFKDKWFLTALIYPTDILREWNRIIRNKDVNNDFLLD
QVQLLTTNQYKRRKKFYQKLQQLVGT
>PK3-045_01616 Sporulation cortex protein CoxA
MRKVKLVAPVLLTLSFGLTGCGVNEDETADRNRLNNTRPIGYYSNEQHEGNNGVGNTDND
GPITEMMDHTFGDEGNRNGSNVRNVNNRNGTNVRNINNRNNDHDNVNTNDRDERVSYDTE
LAEKISDRVTKMDNVKNARTLVYRENVLVALEVENTKNIAKTKAQVKDKLNDLLNGRDIS
VVTDRGVFNSIEDINRSIRNGQPRQTINNNIENIFQDLNPARDNR
>PK3-045_01617 dTDP-4-dehydro-6-deoxyglucose reductase
MVRVLIVGGQENKIRYALMQELSNKQIYHIVADQANDNSILTSLVQHQVHTFLNTMELAG
LMAKYQIDCVIDLSNEPIISNKMKDSFEQSEKNIGRTIEVLEACVEAKVEKIIFPSTIAV
YGDLEGVITEDMTLQPVLFEGLSKKIVEKYIQNYHTLYGLSYTILRFPILYGEYSFHNQN
DNIVETTIKNVLENRPSNCFKDGEHKKHFLYISDAVRAFVSSLNKGGNEIFNICPMEKYS
MKEVVSIIQSSIKEDSLPHEGLKEGEKSRISIKKAQVHLGWQAQVPFLKGIRLAIDNIKI
GTKKEK
>PK3-045_01618 Protein BofC
MKTRFLLFSTVLLVSILTVFLSNGQVYGKTGSGVSQNENPKKLEVVLQRIYLDGEMSEET
IEETVWSMEDFWSKYDKWQLVDMTSRELVFKQEVDDISPLLKTNGYFGINEEGILTIYNG
KPAEENIIQSFFQIDLKKLESKQHEDLQKGIPIKSRDRYVKVLETFKNLTTIETTN
>PK3-045_01619 Holliday junction ATP-dependent DNA helicase RuvA
MYEYIKGNVEFVGPEYIVVENNEIGYQIKTPNPFSFSAFSGSKITVYTYHYVREDNISLY
GFRSQDEKALFTKLLNVSGIGPKGALAILASGEPSQVISAIEAEDEAFLVKFPGVGKKTA
RQMILDLKGKLAEFMPDFSPDLFTVDKHVAKAESDSAMDEAMLALTALGYSEKEVKKIIP
HLKKEQLTTDGYIKLALKLLLKR
>PK3-045_01620 Holliday junction ATP-dependent DNA helicase RuvB
MDDRIISSEADNQDLSFEKSLRPIQLQEYIGQDKVKENLKVFIEAAKYREEALDHVLLYG
PPGLGKTTLATIIANEMGVNIRTTAGPAIERPGDLAAILTALEPGDVLFIDEIHRLPRAI
EEVLYPAMEDYCLDIVIGKGPSARSVRLDLPPFTLVGATTRAGSVSAPLRDRFGVLSRLE
YYEVDQLKDIVSRTADVLQIGIEDLAAWEIARRSRGTPRIANRLLRRVRDFAQVKGDGMI
TKELADHSLELLQVDRLGLDHIDHKLLLGMIYKFKGGPVGLETIAATIGEEAHTIEDVYE
PYLLQIGFLQRTPRGRSVTHLVYEHLNIKLD
>PK3-045_01621 hypothetical protein
MNDIPKYIMTIGVIVFLIGLVMQLVPIGKLPGDILIKKEHSTFYFPITTCIVISIILSLV
FYFIGKFR
>PK3-045_01622 S-adenosylmethionine:tRNA ribosyltransferase-isomerase
MKVDLFDFHLPEELIAQTPLEDRTSSRLMIVNKETGDLEHRKFKDIYEYINPGDCLVLND
TRVLPARLHGEKEDTGAHIEVLLLKQQKDDMWETLVKPAKRVKEGTVISFGDGTLKAVCV
KELEHGGRILDFQYEGIFYEILDQLGEMPLPPYIKEKLDDQDRYQTVYAKERGSAAAPTA
GLHFTTELLDALKKKGVHIAFITLHVGLGTFRPVNVEDVDKHEMHAEFYQLNKETAALLN
KVRGQGGRIISVGTTSTRTLETIAAANNGEFVESSGWTSIFIYPGYEFKGIDGMITNFHL
PKSTLIMLVSALAGRENVLHAYETAVKERYRFFSFGDAMFIQ
>PK3-045_01623 Queuine tRNA-ribosyltransferase
MTAIRYEFIKTCKQTGARLGIVHTPHGSFETPAFMPVGTLATVKTMAPEDLKTMGANIIL
SNTYHLWLRPGHDIVKEAGGLHKFMNWDKAILTDSGGFQVFSLSDFRKIEEEGVHFRNHL
NGDKLFLSPEKAMEIQNALGSDIMMAFDECPPYPAEYDYMKKSVERTSRWAERCLKAHNR
PEDQGLFGIIQGGEYEELRKQSARDLVSLDLPGYAVGGLSVGEPKDVMNRVLEFTTPLMP
DNKPRYLMGVGSPDSLIDGAIRGIDMFDCVLPTRIARNGTVMTSEGRLVVKNAKYARDFG
PLDPDCDCYTCKNYSRAYIRHLIRCDETFGIRLTSYHNLYFLLNLMENVRDAIRNDRLGD
FKEEFFERYGFNKPNAKNF
>PK3-045_01624 hypothetical protein
MGNLAGLLPFILMFVLFYFLLIRPQQKRQRAVRDMQSSLKKGDKIVTIGGMHATIDAIDE
GTVVLKAKDGSRLTFDRNAIREVVESSAAVASPTLEKTEQ
>PK3-045_01625 hypothetical protein
MDQYLIILFRTILIYFLIVLIFRMMGKREIGELSILDLVVFIMIAEIAVVAIEDYKDPIL
PTLFPMFILLAIQVLLAFFSLKSKKMRDFIEGEPTLIIKNGKIDEKAMRSQRYNYDDLLI
QLREKNIRNIADVEFAILETSGKLSVFEKEENKSSITIPLIMDGIIQESNLDRIGKTNLW
LRQQLKDRGYVNIKNISFCSYQEGEFYIDLIDH
>PK3-045_01626 Stage V sporulation protein B
MSKFLKGTMILLIAGFITRVLGFINRIVIARFIGDDGVGLYMMVYPTMILVVTITQLGLP
VAISKNVAEAEAAGNLRKVKSILIISLSTTLGLTVIFTPALFLLAPYLSQTLFTDERTLL
PLLAITPIIPIIAVSSVLRGYFQGRQNMKPAAISQVIEQIVRIALIATLTKAFLPLGVEY
AAAGAMLASVLGELASLFYLLASFKWKKKFHLRKKFFQYVHNGKNTFQELMTIALPTTGS
RMIGSIAWFIEPIVVAHSLSLAGLSAINATKQYGVLTGFALPLLMLPSFFTQSLSTSLVP
AISEAKANNQLKLIEHLLQQALKFTFMTGGLAIVVLYVLAEPLMTIMYGSTRGTSFIQLM
APFFILNYYQGPLQATLQALNFARAAMINSFIGAAVKTALIFILASRPEFGIFGVAIALI
VGFVLVTILHFATILKTISFSIIVKDYVKMLLVIMLTAYLGSLLVKSITFPSILIQIISI
TSLICIFYIVLLFLFRLMNKRDLAKIPWIGPFFS
>PK3-045_01627 Post-transcriptional regulator ComN
MSSTSTHIYDQYRSQVKPVLNSKIEEFHLLGYETIKEDELWVFLTNKKWRKPAQEIRISE
LVQDILNVKVADYMNFATIEAYKTADLFSVLSEEEKKELLK
>PK3-045_01628 Protein translocase subunit SecDF
MVKRSRIVAFLLIIVLAAGLMGGTTNKILDNIKLGLDLQGGFEVLYKVEPLEKGKAKIDE
AALKSTAQALDKRINVLGVSEPVIQIEGKDRIRVQLAGITDQNEAREMLSTEANLTFRDI
HDKKLLDGSDLVQGGASQEFDQYGKPSVSLKLKDANKFKEVTQSVLGSPLVIWLDFEEGD
SYNAEAAKEEPKYLSAPMVSEVINSDTVSITGNFTVDEATRLAELLNAGALPVKLTEEYS
TSVGAQFGDQALKDTVYAGIIGVGLVFLFMLLYYRLPGLVAIITLSIYVYLNLLVLDLMQ
GVLTLPGIAALILGVGMAVDANIITYERIKDELRVGKSLRAAFHAGNKNSIGTILDANLT
TIIASIVLFIYGTSSVKGFATLLIVSILVSFITAVYGSRLLLGLLVKSKLFDKKITWFGV
NRKDIKHISENYDTLTLPTKFDRLDFVKYKNIFFTISSVLIVAGIVIMFIFKLNLGIDFA
SGSRIEVMADKALTTAEIEDHLDKLNVKADDIIISGDKQETAAIRIKGDLSQTKINTIKS
EFNKTYGHDPNVSSVSPTIGKELAKNAFKAIIFASIGIIIYVAIRFEVYMGLAAVIALLH
DAFFIIVIFSLTRLEVDITFIAAVLTIVGYSINDTIVTFDRIRENLAKKKRIKTPQEIKD
IINRSIRQTFARSINTVITVVICVVALLIFGSSAITNFSLALLIGLIGGAYSSIFIASQL
WYVWKKRELKRKGVLITYKEKRPISDEPQV
>PK3-045_01629 Lipopolysaccharide assembly protein A
MKFQWNMLLGIIFALIVAVFAVINVEPVSVNYLFGEGDWPLILVILISVLLGGLIIGSAG
IIRIYSLQRKIKTLEKEKKALEQKTDDKKEKEKVLTDLK
>PK3-045_01630 hypothetical protein
MLRSKKRWIQEETSNQETISLLAEELKLAPIVASLLMKRGYHTSEEAKAFLFDDNNDFHD
PFLLLGMDIAVDRIQKAITNKELILIFGDYDADGVTSTTVMMKTLEGLGANVQFYIPNRF
TEGYGPNERAFRYAKSIGVQLIITVDTGIAAVHEAEVAKELEIDLIITDHHEPGPILPEA
LAIIHPKIEGSEYPFRELAGVGVSFKLSHALYGKVPHHLLPFAAIGTIADLVSLTGENRL
LAKKGIRALQETDNIGLNALYRQMNIDKNTINEETIGFMLAPRINAIGRLGDADPAVDLL
LTDDPEIAKELALEMEETNKERQAIVNQITVEAMEQVDELYPLNENRVLIVGKEGWNPGV
VGIVASRLVEKYYRPTIVLSYDKETGIAKGSARSIEGFDLYKNLSTCRDILPHFGGHPMA
AGMSLKIEDVDVLRDSLNRLAFEQLTDENLIPLTKVDGSFSISDISIKSIEEMQMLAPFG
VDNPKPKLTFCDLEIDNMRKIGSNQNHLKIVLKDNEFELDGIGFGIGDLCDHISPSAKVS
VLGELSINEWNNRKKPQIFIQDMEVPHWQLFDYRSLRKVNQLYEVVPKNAQWIFFHQDSV
PKDMDEQVSYQVIESIEQAAFLESMNNTMVLADYPPSLDMLKTLLSNNAPERIYAVFYKQ
QSDFFSTMPTRDHFKWFYAFLAKQGNFHLQKFGGELARRKGWSKETVDFMSKVFFELNFV
TMKDGFISLNKNVPKRDLTESISFQQKQAQFELENELIYSSYEQLKNWFDLILKKSVNNE
EEVKEWI
>PK3-045_01631 Adenine phosphoribosyltransferase
MDLKQYVTIVEDWPKEGIRFKDITTLMDNGDAYRYATDQIVTYAKEKEIDLVVGPEARGF
IIGCPVAYSLGVGFAPVRKEGKLPRETIKVEYGLEYGKDVLTIHKDAIKPGQRVLITDDL
LATGGTIEATIKLVEELGGVVAGIAFLIELSYLEGRKNLDGYDILTLMEY
>PK3-045_01632 GTP pyrophosphokinase
MANDQVLTAEQVIDKTRGYLNEEHVAFIEKAYDYAREAHREQYRKSGEPYIIHPIQVAGI
LADLEMDPATVAAGFLHDVVEDTEITLQDISKVFNSEVAMLVDGVTKLGKIKYKSHEEQQ
AENHRKMFVAMAQDIRVILIKLADRLHNMRTLKHLPAEKQRRISNETLEIFAPLAHRLGI
STIKWELEDTALRYMNPQQYYRIVNLMKKKRAEREQYLDEVVTEIREGTAEVKIQADISG
RPKHIYSIYRKMVLQNKQFNEIYDLLAVRIVVNSIKDCYAILGIIHTRWKPMPGRFKDYI
AMPKANMYQSLHTTVIGPKGDPLEVQIRTQDMHRIAEYGIAAHWAYKEGKSVNEGSSLEE
KLTWFREILEFQDDIVNAEEFMESLKIDLFSDMVFVFTPKGDVFELPSGSVPIDFAYRIH
SEIGNKTIGAKVNGKMVTLDYKLKTGDIVEIHTSKHSYGPSQDWLKIAQTSQAKNKIRQF
FKKQRREENVEKGKELVEKEIRNMEFDLKEILTPENVKAVIEKFNFMTEEDMYAAVGYNG
ITALQVANRLTEKWRKKRDAEQISTISNAVAELKSFSNNKKSASGVRVTGIDNLLIRLSR
CCNPVPGDEIVGFITKGRGVSVHRADCTNIDTEDAKARLIPVEWETNLNNRKEYNVEIEI
SGYDRRGLLNEVLQAVNESKTNISAVSGKSDRNKVATINMSIMILNVNHLQKVVDRIKQI
PDVYSVRRIMN
>PK3-045_01633 D-aminoacyl-tRNA deacylase
MRVVLQRSKEAKVEVDGEIVGAIEKGFVLLVGITHSDTLEEAKYLADKIIHLRVFEDENG
KMNHSILDREGAVLSISQFTLYGDTRKGRRPNFMDAAKPEQAKVLYDQFNTLLRSHGLTV
ETGIFGAMMDVQLINDGPVTLILDSK
>PK3-045_01634 hypothetical protein
MKNIRWMLLLLVSIFFIPTQYQHVSAENQSTVQANTVVNVRENPGLDQNVIGKMEIGKAY
PLIKEEKDWIEIQYTSSSTGWVAAYLVTKNGQSTTDDQMEKEEEAITSHSNKATITENGL
RLRKGPGTNYEVITTLGKGIEVTVLSVNYDWYQIRTALGTGWVHNDYLLFEDSSNHTETG
VQKKSKQEIATVAEDQINLRSNPSTSAEIIGKISIGTVITIIEEESNWAKIQYSGNIGWV
HKDLLKSSDIESRKGKTIDKKVKLLYDRTNIRSDATVNSKILLVADSGETFQAVEIIDDW
YKIKLADGEFGYIAEWLVEDSASNDLQITNATATKDLKGKTIVIDPGHGGKDSGTIGIIG
TLEKTLNLRTAKLLANKLEASGAKVILTRKNDFFIPLQTRVDISHFYHADAFISLHYDSI
SDRSVNGVTSYYYTSNQKKLATSLHKSIIEATDRKDRGVKQNSYVVLKQNRQPASLLELG
YLSSPAEEQTLLSNKYQETITTAIHNGLENYFSY
>PK3-045_01635 hypothetical protein
MRFGEKSSSTSEIDSKLLGVDFHDFIQREGNSNAVELASEFGLSLGEVKKLKKQLGKL
>PK3-045_01637 Histidine--tRNA ligase
MHINIPRGTQDILPGTVEKWQYIEGKIKQLCDRYQYSEIRTPIFEHTELFLRSVGDTTDI
VTKEMYTFEDRGKRSLTLRPEGTAAVVRSFVENKMHGYASQPIKLFYLGQMFRYERPQAG
RFRQFVQFGVEAIGSKDPAIDAEVIALAYSVYQTMGLSKLKVVVNSLGDKESRQAHREAL
IAHFQPSIGEFCHDCQTRLEKNPMRILDCKKDHDHPLMKSAPSILEYLNEESKTYFTKVQ
KYLTALNIPFVVDSNLVRGLDYYNHTAFEIMSEAEGFGAITTLCGGGRYNGLTEELGGPE
APGIGFAMSLERLLSALEAEKIELPIEKKVDCYLVSLGEEAKDYTVGLVNELRQAGFSAE
RDYLDRKVKAQFKAADRLHAKYVAVLGENELQNNKINLKLLETGEQKEIPLTELVSALKD
FSAF
>PK3-045_01638 Aspartate--tRNA ligase
MFGRTYFCGEVTEKSIGESIVLKGWVQKRRDLGGLIFIDLRDRTGIVQVVFNPEINKEAI
EIADKVRNEFVLDIKGKVVARQEGTVNENLKTGKIEIIADEIKIINEAKTPPFVISDQTD
VTEDVRLKYRYLDVRRPVMFETLKMRHQVTKVMRDFLDSEGFLDIETPILTKSTPEGARD
YLVPSRVHPGEFYALPQSPQIFKQLLMVGGVERYYQIARCFRDEDLRADRQPEFTQLDLE
TSFMSQEDIMSMMEAMMAKIMKEVKNIDVTLPFPRMPYDEAMSRYGSDKPDTRFEMELVD
LSEIVKDSSFKVFASAVETGGQVKAINVKNASGNYSRKDIDALTEFVKVYGAKGLAWLKA
EEDGLKGPISKFISETEQKGFEQALNIEAGDLLLFVADKKNVVADALGALRLKLAKELDL
IDQSKFNFLWVTDWPLFEYDEEEGRFYAAHHPFTMPQRADLELLDTNPEAVKAQAYDIVL
NGYELGGGSLRIFEKEIQEKMFSLLGFTKEEAYAQFGFLLEAFEYGTPPHGGIAIGLDRL
IMLLSGRTNLRDTIAFPKTASASCLLTNAPSEVSENQLTDLHLSLKLNK
>PK3-045_01639 tRNA threonylcarbamoyladenosine dehydratase
MLHQFSRNELAIGKEGLETMKNSTVAVLGIGGVGSFAAEALARSGVGKLILIDKDDVDIT
NVNRQVIALLSTVGRPKVDIMKERIADINPDCEVIALKMFYTEETYEEIFAYGLDFIIDA
SDTIAYKIHLMKECLNRNIPIISSMGAANKMDPTRFQIADISKTHTDPIAKVIRTRLRKE
GIRKGINVVFSDESPIVIREDVRKVVGKDNAPIRKAKMPPSSNAFVPSVAGLIMASHVVK
ELLKEIKITRVKDEK
>PK3-045_01640 hypothetical protein
MNSFNGLLKKDLKLGLPFLYTSIIIVSLGLITSIVLSSYYKTIMLVAIFAITFCFAHVFY
LPSFLLTSLNIEGKTQLWLHNPNSSIKLLLSKWIAGILYSIISLFLMFSVAVISMNVGEL
KLAFNQTNLFFMCLILLGISIYLSSWVFFSWTLYHSMKKIVWLNKIRWVVLILLWNIWNI
AVYWFNRIPVIDALKRKSVISVDNTLAFEARRNFFKASIETTEISILSLCGYILTLFFLF
LIASWLLEKKVEV
>PK3-045_01641 HTH-type transcriptional repressor YtrA
MADEFESSRPIYMQIVEKITQQIARYERMPGDKLPSVREMAIASGVNPNTIQRTYGELER
MKIVETRRGQGTFITESEDIIEELRTKLQHDLLEQFIRNMQELGIKREEMVQLLEIYLQE
KKGEK
>PK3-045_01642 Multidrug efflux system ATP-binding protein
MIQFRNVTKRYGREYAVENVNLTLEEGKIYGLLGTNGSGKSTTLKMIAGLVQPTNGEVLV
NGKNATRRIAEDVSYLTELDRFYESFTIQEMIRYTASQFHDFQLGKAQELLDFMQLEQNK
KIKNLSKGNRGRLKLVLCLARTAPILLLDEPFSGLDPLVRESIVKGLLNYIDFEKQTVVI
ATHEIVEVESILDNIVVLNNGNVIANLSVEDLREEKGQSIIEWMKANINK
>PK3-045_01643 Vitamin B12 import ATP-binding protein BtuD
MTSVVELKNVSKIINGRKIIDSLSFQVKAGEVFGFLGPNGAGKTTTIRMIVGLINMSDGD
ITICKESVRDQFEKAIQHVGAIVENPEMYKFLSGYENLLHYARMVKGISKQKIMETVELV
GLKDRIHDKVRTYSLGMRQRLGLAQSLLHDPKVLILDEPTNGLDPAGIREIRDHLRMLAR
ERNMAVIVSSHLLAEMEMMCDRIGIIQEGKLVDVQLVKDFVAVEQVFEMELYPVDKAISH
IQGMMPEVQVMPREQGVHITVTKEQIPGIIKALALQDVQIFGIKEVSKTLEDRFLELTNH
REDLN
>PK3-045_01644 hypothetical protein
MQLIRNEWMKIWKRPATLVMIVLLLIAVLLLGAFNKYQSSGFSVPDNENWKHGLELENKR
YNEQLEDEHLPEETRNYYTKEIAINEYRITHNFSTNVEYSAWDFVADSIQLLSLAGLFTI
IIAAGIVANEFNWGTIKLLLIRPLSRIKILLSKYLTVLLFGLLTIFIIFAFSFILGAILF
GLPKEVYPYLFYYNGVVKEQSILMHLISYYGLNSISLFMLTTMAFMISSVFRNSSLAIGI
SIFLMFMGNTVTLLLAKWFDWAKYLLFANTDLTQYLEGTPLVSGMTLSFSITMLVIYFVV
FIGLAFWVFRKRDVAA
>PK3-045_01645 putative AAA domain-containing protein
MNGEPLAYRMRPTNLDEVVGQKDIIGKTTSLYKMIKNGHVPSMLLYGEPGIGKTSIAFAI
AGTTKLPFIALNATTSGKKDVEAVVDEARLTGKVILFLDEIHRFNKAQQDYLLPHVERGD
IVLIGATTENPYHDVNPAIRSRCGQIKQLKRLTDDDIEELLHRALQDEKGLANLSIQISK
EQIAKIAKGTNGDARKSLTLLESIVYSSDKEDDVFIIKDDTIDQMIEKVGVFGDKKGSHF
YNLLSSLQKSIRGSDVDAALYYLAHLLETGDLVAVNRRLLVIAYEDVGLANTSVGNNVLA
AVTASERLGLPEARIPLSVAVVEMCLSSKSNAAYKALDAAIADVRNGRVGDIPMHLRDGH
YEGSKKLGHVGYIYPHDYPIGTFGGWVDQEYFPEKLKGTQYYHPTEAGEEKKLGAIYDRL
KGFKKNK
>PK3-045_01646 hypothetical protein
MKKSIKKVLLLLLCFPFLLIGCSSESNSTSDDGKVDGKTQIKITWRDVGEHDKLKKYLTN
TFIPEFEKENPDIKIVLSPITASEGDYFSKVALSMQSESTAPDVVAEDSFMLNSDANAGY
LLPLDDYVRDWDQWKYYTENLKSGSIGEDGKLYAIPGTSDSRGLWYNKNVFKKAGLPEDW
QPKNWDEIIEAAEKIKDSAKDVIPLSMGVAKANGESVSMQTFEMLLYGTDDVLFDADTKK
WHVNTKGIEESLQFIDQVYNQKKLGPPLSIAINSNYSSVLFQEKFPNDEAGIILDGFWNT
GNYTETGAVPMDNVTERFGFAAMPTQNGQEPGTTTMSGGWTWAIPSKAKNPDASWKVIQA
LGGKEQQAARAVAEGNLTVRDDSAEVPAYKEQNFISEATEYLKNAHFRPANDKYPNVSVE
IQTMVEAVATGSKTPKQAAEDYASNVIRIVGEGNVVK
>PK3-045_01647 Melibiose/raffinose/stachyose import permease protein MelD
MEAVLGKKPKRKGKSDHVKAAIFLAPTWLLLLIFFIGPMLLTLLFSFTNLALTGAEASQL
RFVGFENFTRMFQDPDFRVSVWNTIVFVFFSAVLGQCFFGFLIAFLMKEKNKTFRRIVGL
IIIAAWVTPEVVVAFCWVAFLGESGTANWLLSLFDMKPIAWLFTFPMVSVVIANMWRGTA
FSMMVFQAALDDIPKDVEEAAIMDGARRFQVIRYITIPMVKGTIATNMMLVTLQTLGVFA
LIYTMTGGGPGVSTATLPVFMYKQAFVSYQLGYGTAISFVLLVLGAIASFIYMKTLKVKV
>PK3-045_01648 Trehalose transport system permease protein SugB
MVQKGYKVEKLIHYLILSILAILFLLPLLWMLFASVDPGAIQALKMPEKITLDNFKSILS
EAAILRSFFIGIGISTSQALLVVILCVLAAYPLSRYTLKYKNSFMMTILFMTSLPMTAVI
VPVFQLFLYLKFQDSLIAMTLFLIASSLPYGIWMMKNFMDSIPLDLEESAWVDGASIFQG
IKKIVAPLMLPGIFTVAIFTFTGSWGNYFVPYILIQSPEKLPASVTIFQFFGNFGMVNYG
RLAAFSVMYTLPVVILYTISQNFMSKGFSLGGATKG
>PK3-045_01649 hypothetical protein
MFYIIEKLEARMKELNPYRYMERQSLNNWKAKESIEGAEKYPPSITTDWQDFSLGDIWEG
RDYYLWIQTTFKVPKSDGRIVLLLDFGRTGGGYNSGFESLLFVDGQPYQGVDSNHKEVFL
DPGYYGKEVTLSLKLWSGLEGGGPEQIQSHTFKMAEYTILNEECDDLYFTADCVLKTIKQ
LKEDDSKRYELLPLLEKTMKYIDWSYPGSPAFYKSIKLANDNLQKGIDALDKRELVTITA
IGHTHIDVAWLWRLKHTREKAARSFSTVLQLMKQYPDYIFLQTQPQLYQYIKEDYPEIYE
QIKNRIEEGRWEIDGAMWLEADCNIPSGESLTRQILHGTQFIKKEFHKDVHYLWLPDVFG
YSWALPQILKKSGIDTFMTTKISWNQYNRMPHDTFVWRGIDGSEVLTHFITTPEPGKDIV
DNQWASRWFYTYNGQLEPETVLGSYKAYRNKDVNKQLLISYGYGDGGGGVTRDMLENRRR
MDKIPGLPHVKTGRADEFFHQLHDTIDSTENYVHTWDGELYLEYHRGTYTSQAFVKKMNR
RLELTLRELEILYTAVQDSKGVHYPKEEIMSIWEVLLRNQFHDIIPGSSIKEVYQDHKVE
IGEAMESSTQLLARLDEATINQWTIFNSAGWVRKELVIIDKKESGKFITDSGEELEAVPC
EAGYLVQTPNIPAFGTCILKFEPMEAKRLEAPFMKAIENGIDTNYYLIRWNEKGQLISIY
DKQYHREVLKENGLGNRLQLFEDKPMNFNAWDIDIFYQEKYNELAAESIIIKEQNNLYAK
VEFVYSFGTSRIIQYMQVYKHSRRIDFITKTDWKEREQLLKAGFDVDIRNTVATYDIQYG
NVQRPTHWNTSWDMAKFETVAHQWVDYSQRDYGVSILNDCKYGHDIKDQTMRITLLKGGI
YPDPTADIGMHEFTYSLLPHKGDFVNGRTVEEAWALNQPLSVLQGKRVNQRLFKLHTAES
VYIDAVKAAENGQGIILRLHDHLGSNRVLTLEPLFDCRQWNETNLLEEDMEPPVDIEGNI
TLELSPYEIKTIRIV
>PK3-045_01650 HTH-type transcriptional activator RhaR
MFRKTIFKKLFLSFSVVIIIYTSIILFVTISQEYSQNRLEINKLNEMFLERESNIIDYRL
DVSLNVVKLLSQQDVIAEFLKENQFNYSVYSKMFNELTGNHFSNDQLGFNLAVLKDYGTD
VTSSDGYFLFKDYMKFIHMDENITELEAFMDLKGNNDLQCYDAKDKLVIVNKIYYQQEKQ
YLYFFIVWEKKDLLMSNLPDANSILAMVDSSVLASTTIMGENVLASFLPVKKTNENQIVY
RSVNKYDGYQKRSNAIPTIHYLYITNVHTGIGLPIHTLTSIGVILIVLLLLGFVLTTTLS
RKSYSPIEEIIKNIKSGEEKNSSDSYIKNELDYIISKIHIINKTNQNLVQLQQSSLVDLQ
ENFLKNIIYENYDKQNMERRLKLLQLDPFSQGGILAIITMQGISEWESNLSEGNILTLRK
KVLALCNEKETNQKFISFPIDYKHFCLFFAEKNQHLILDVLHRMIGRIEQELGVEITFTL
SQAFPSLSELPKIFKSSFQLMEQKYSFIDTKSLCSSHIPLSSGKDYSYSVETESILINFM
QKRELKHAKKLINEIVETNFREESMDIYNIYDFRNALINTIKRILNKCNLSFSDFLKNNK
ALFFHLNSSDIEILKNTFIDIFNELMLLLEEKHSIKLSTVESVLRYIQENYTSDLSLGEV
ADHFQLSESYVSKLIKDHLKSSFKNYVNQLKVEKSKILLESGKYMVSEVGEMVGCKNVNT
FIRIFKQQEGITPGKYVINKMAK
>PK3-045_01651 o-succinylbenzoate synthase
MVKIDKIEVQHVKMPLVSPFKTSFGELLEKDFLIIKIYSGEHIGYGESVALPDPTYSEET
TGTVIYMLNEFLIPLLFKDEITHPDEVSKRFAPIRRNNMAKAALEGAIWDLYSKQQGISL
SKALGGIQTSIDVGVSIGIEPTTDMLLTKVERFLNEGYKKIKVKIKPGYDLEPLAKIRQT
FGYDIPLMADANSAYTLADIERIKELDPLKLMMIEQPLAYDDIIDHSILQSELATPICLD
ESIHSVEDARKAIELGSCKIINIKIGRVGGLTEAKKIHDVCKKHDIPVWCGGMLEGGIGR
AHNIAITSLPAFTIAGDTSASNRYWKKDIICPEVTLSTPGKIEVPKGAGIGFDLNEAVIN
QHLISKKEYANPFI
>PK3-045_01652 hypothetical protein
MDPYIIREVTEKAEIQLVVSLQDSIWGRTNTTPYPFLVASIHNGGMIIGAFLKEELVGFC
YSFPGFHQKEIYLVSHMMAVKAKDRNAGLGFKMKVKQKEMALKRGYSKIIWTFDPLESRN
ANLNIAKLGGVVKTYYPNHYGSMEDELNGGLPSDRFLLEWDIGKLSVNPHPAGEQIPSLV
TWKTIKEIPIPLSFELLSKKADTYKVPVPKNIHTIKEKDFATAEKWRMMLRNVFTHLFSR
GYIIHSYHKTNELVNYYIVSLNKENE
>PK3-045_01653 N-acetylcysteine deacetylase
MHEQIDSWVDGKKEEIIAMYQFLHNHAEISWEEVETTKFIKNELEKLSIPYQLFDDQTGI
VGEWGKGNNPVIGLRADMDALWQQVNGEWKANHSCGHDAHTTILLFTLRCLKELGVEPNG
KIKCLFQPAEETGAGAISFINKGLLDDIDYLLGLHVRPIQEMRMGECSPAIYHGAAASFK
GKLYGMQAHAARPHLGINVIDSLTAINMAIRSIPLNPIIPASAKMTFVQAGGKNFNIIPD
YAEFGIDVRAQTNEEMEQLISRLESQVKLAGEANGARVELELLSDMPAATPNKLMEEIAA
ESIKEILGAKGLVKPPVTPGGEDFHYYAKVKEQLQTTMIGLGTDLQPGLHHPDMYFQLES
LLHGIKIMALSAVKLMEEKQ
>PK3-045_01654 hypothetical protein
MKSLIGQDKPVQRLFIFIIGLLIMSLGIVLIITANLGSAPWDVLNIGLHIQFGLTIGSWA
IIVGFLILLIAAILSKKLPPFGALLNMVLVGVFIDFFLLLPFMNTPSTLYQKWIMFLIGL
IIMGYGMGFYISAKLGAGPRDSLMIVLSEKFGGGIARTRLLMEAIVLIIGWILGGPVSWG
TIIYAALIGRVAGWSIPQCTKWTNYILDRNKRTVNNIHQHNMEREAK
>PK3-045_01655 HTH-type transcriptional regulator CymR
MKISTKGRYGLTIMMELAKKHGEGPISLKSIAQTNNLSEHYLEQLVAPLRNAGYVRSIRG
AYGGYVLGDEPNKITAGDIIRILEGPISPVEGIEDEEPAKKALWMKIRDAVKDVLDSTTI
EDLANHQEDDNSDGYMFYI
>PK3-045_01656 Cysteine desulfurase IscS
MDHAATSPMHPKVIDRMYEVMKDQFGNPSSIHAYGRQARNILDNARAVVASSIGAHENEI
IFTSGGTEADNYAIFGIAEGKEAKGKHIITTEIEHHAVLYACQELEKKGYEVTYLSVNEY
GLIDLNEFKAALREDTILVTIMYGNNEVGAIQPIKEIGLLLKDHPAVFHTDAVQAYGLED
IDVKEQHIDLLSVSSHKINGPKGMGFLYVKNGIKLNPQLFGGEQEKKRRAGTENVPSLAG
FQLAVEISQQDRLQKREQFKKYKEILIGILKDNNISFKQNGLVDNTLPHVLNLSFPGTNV
EAMLVNLDLAGIAASSGSACTAGSIEPSHVLVSMFGKESERTKNSIRFSFGLNNTEQQIE
KVGHELVKIINRLTK
>PK3-045_01657 tRNA-specific 2-thiouridylase MnmA
MEKAPKDTRVVVGMSGGVDSSVAALLLKEQGYDVIGIFMKNWDDTDEFGVCTATEDYEDV
IRVCNQLEIPYYAVNFEKQYWDKVFTYFLDEYKAGRTPNPDVMCNKEIKFKAFLEHAMSL
GADYLATGHYAQVVREDGQVRMLRGKDDNKDQTYFLNQLTEEQLSKVMFPIGGMEKSKVR
ELAAKANLATATKKDSTGICFIGERNFKEFLSGYLPAQKGNMETMDGEVIGRHDGLMYYT
IGQRHGLGIGGSGEPWFVIGKDLKRNVLYVGQGFHHELLYSDSIIATNVSWVSKDRIGTS
FECTAKFRYRQPDNKVTVEVIDENTVKVIFHEPIRAVTPGQAVVFYQGEECLGGGTIDKV
FRDNERLTYVG
>PK3-045_01658 TPR repeat-containing protein YrrB
MDNSQLGIQYMQEGKWEEAAKIFMEEIEKNPNNAVSYVNFGNVLSALGDDTRALSFYQKA
IEIDDTTAAAYYSAGTVYYEKENLESAKNMFELALEKGLESSDNFFMLGLTYVGLDKGKL
AIPYFQRAVELNSQDAEAFFQLGLCLAQNEYIEEAITQFQSCLALDATHADAYYNLGVAY
GFKEETAKAVEMFNKALEIQPDHLLAGYGKQIIEEK
>PK3-045_01659 ATP-dependent RecD-like DNA helicase
MNEQNSLDLFEKEKKYVKGRHLVTIFHNEQNLYSVIRIRVDETNHDYDDKEAVITGYLPK
MNEEETYTYFGDFKEHPRFGLQLQATSFRKEMPQTKQGVIAYLSSNLFKGIGEKTAENIV
DTLGEEAISKIMNQPSILETVPKLASDKAKILYDTLMKNQGLEQAMVSLNQYGFGPQLSM
KIYQVYKENTLEIVQTNPYKLVEDIEGIGFGKADDLGSQIGITGNHPDRLKAGCLYILEL
SSNQEGHVYLHAEFLLEKVKALLEENQKEEIEFSQIADQVIQLEEEGKIIVEDKKIYLPS
LFFSEKGLVRNIKRVMEQSEYKDQFPESEFLLALGNLEDRIGVQYAPSQREAIQTALMSP
MLILTGGPGTGKTTVIKGIVELYGELHGCSLEPNDYKKDEPYPFILAAPTGRAAKRMAES
TGLPAVTIHRLLGWNGTGTFERDEDHPLEGKILIVDETSMVDIWLAHQLFKALPEHIQVI
IVGDEDQLPSVGPGQVLKDLLDSACIPTVKLKDIYRQAEGSSIIELAHEMKKGQLPANLL
VPQGDRSFIKCSSSQIPQAIEKIVLNAKNKGFAPMDIQVLAPMYRGPAGIDRLNAILQEI
LNPNPDGTRKELKFGDVTYRIGDKVLQLVNQPESNVFNGDMGEIVSIFYAKENTEKQDMV
IVSFDGIEATYTRQDLNQITLAYCCSVHKSQGSEFPIVIMPVVKSYYRMLRRNLIYTGIT
RSKQFLILCGEVEAMELGVSRNDELNRQTTLKEKIKEAFADVYQPDETMEITKENSFDLL
YEGKINQIDPMIGMENISPYDFMEASES
>PK3-045_01660 hypothetical protein
MLGGIFHETNEDEVFPMLKCPNCQSKDIGKIGINQYYCWNCFIELSLTKGIIHTHQVEED
GSLSSLDDLFDEEERRLS
>PK3-045_01661 hypothetical protein
MGKAINTAIAIGAGVVALSYMQKNNMMSQKQLKKVQRKVMKMF
>PK3-045_01662 Putative transport protein
MDIRIKWYYRLGFTLLLFIVLFIFIKLSPIWLPILSLITKVITPFIIGAFFTYLLHPIVE
LLHKKGLHRGLSVAFIYILFFGGIGYAIYKGIPILIEQLEELTVSAPKLAERYKDLIDSI
QNKMESWPLNLQEKVDRGIDIFERKMESLLNKVINGAMGIVNYSIIIMLIPFISFYMLKD
INAVRKGFNGLIPNKWRNSARLFLEDVNESLGSYIRGQLLVCTIIGVISMLLFLIFHMKF
ALVLGMIIGITNVIPYFGPVIGAVPALIVASTVSVKMIIIVVIIIIILQFLEGNILSPYI
VGKSTHMHPLFIMFALLLGEEIGGMIGMIVAVPLLSIVKVAIIHMKTHFGKKEREIKRI
>PK3-045_01664 Alanine--tRNA ligase
MKNLTGAEIRSKFLEFFQGKGHAIEPSASLVPHDDPSLLWINSGVATLKKYFDGRVIPEN
PRITNAQKSIRTNDIENVGKTARHHTFFEMLGNFSIGDYFKEEAIEWAWEFLTDEKWIGF
DKEKLSVTIHPEDEEAYVLWRDKIGIPENRIIRLEGNFWDIGEGPSGPNTEIFYDRGPEY
GNDINDPELYPGGENDRYLEVWNLVFSEFNHNPDGTYTPLPKKNIDTGMGLERMASVVQN
VPTNFDTDLFMPIIRATEQLADVRYGKDSLSDEAFKVIADHIRTVAFAIGDGALPSNEGR
GYVLRRLLRRAVRYAKKININRPFMFELVPVVAEIMVDYYPTVKEKTEFIQKVMKSEEER
FHETLNEGLAILSEVMEKAKDNGVIAGEDIFRLYDTYGFPVELTEEYAEEQGLAIDHEGF
EKEMESQRDRARKARQEVDSMQVQSGVLGNIKVESEFIGYDQWSNEAQIVALLRNGQEVE
TAEAGDEIQFILDKTPFYAESGGQIADKGTLKSDHVTISVEDVQKAPNGQNLHKGIIETG
AVRVNDRLAAKVDSKNRSKIIKNHTATHLLHQALKDVLGTHVNQAGSLVQPDRLRFDFSH
FGQITAEELDEIERIVNEKIWESIAVQIDYKDIDEAKAMGAMALFGEKYGKVVRVVQVGE
YSLELCGGCHVDNTSAIGLFKIVSEAGIGAGTRRIEAVTGQAAYQQLTDQIHLLKEAANK
LKTSPKDVVTRVDSLLTEVKQLQRENESLAAKLSNIEAGNLVDQVKLVNEVPVLAASIPN
VDMNNLRTMADELKQKIDSVVLVLGSVNEGKVNIIAGVTKDLMDKGFHAGKIVKEVASIC
GGGGGGRPDMAQAGGKDPSKLNEALEFVQEYVKSV
>PK3-045_01665 hypothetical protein
MFKMSSFDKTMRFNFPEEPYEHDVKEVLYQVYDALQEKGYNPINQIVGYLLSGDPAYIPR
HMDARNIIRKLERDEIIEELVKFYLKQQREE
>PK3-045_01666 Putative pre-16S rRNA nuclease
MRLMGLDVGSKTVGVAVSDALGWTAQGIETIKIDEEKEQFGLDRIASLIVEYDIGKIVVG
LPKNMNGSIGFRGEASQMYGQLLEERFELPVVFWDERLTTMAAERILLEADVSRKKRKKV
IDKMAASIILQGYLDSQK
>PK3-045_01667 hypothetical protein
MEHGETNTITVVDEQGNEQLCEILFTFESDEFGKSYVLYYPLGDESDDEEIDIHASSFIP
NEETGDGELSPIETEEEWDLVEEMLNTFLAEQEEE
>PK3-045_01668 Endolytic murein transglycosylase
MTNNKDENNTINSKKELFIANLNQRQQEAKLVRRVVVIVALVLIMIVAVVGTSGYFYIKS
ALKPVNPDSDKDIVVEIPIGSGVSTISQLLEDKGLVKNAKVFKYYVKFKNESNFMAGEYH
MNPSMSIQEIIDSLKTGKIMQEPVFTMTIPEGRQLKEISAIIAKKTNQKEEEVWKQLNDE
AFIKGLMAKYPDLLTTEIWAKNIKYPLEGYLFPATYSYYEEKPTLEAIISVMLDKTESVV
KAYETEIERDKLTVHQFLTMSSLIEEEATKNVDRKKIASVFYNRIEQGMPLQTDPTVLYA
LGEHKDRVYYKDLEVDSPYNTYQNVGLPPGPIANAGTVSMEAALHPDDTDYLYFLASKDG
KVYFSKSLNEHNELKAKYITEND
>PK3-045_01669 tRNA 5-hydroxyuridine methyltransferase
MQNKQILEYIENLIPERNNQISEMEHYAKQNEVPIMELIGIETLLQLLRIQQPKKILEVG
TAIGYSAIRMAEALPSSQIVTLERDEQRYLVAKENVEKFKLEAQIVLLQGDALELGSIVE
QYGPFDAIFIDAAKGQYQKFFDLYSPLLSNDGIVYTDNILFHGLVAAEEIDSRNLRQLVR
KIRNYNQWLMGNQDYHTAILPVGDGIAISKKRG
>PK3-045_01670 23S rRNA 5-hydroxycytidine synthase
MKKPELLVTPTSINDIEPLIDNGADAFVIGEQKFGLRLAGEFNRDDVKKAIEIAHQRGKK
VYVAVNAIFHNDKIEDVTEYLRFLVAVNADAIYYGDPAVLMIAREVAPNMKLHWSTETTG
TNWYTCNYWGRKGAKRAVLAREISMDAIIETKENAEVEIEIQVHGMTTMFQSKRTLLEHY
FQYQGKEVELEASKSDKNFFLHDKERENKYPIFQDENGTHIMSPNDICIIDELADLLDAG
IDSFKIDGLLKEPSYIIAVTGLYYQAITLYLNDPDRYEEEKDHLLAEIEKIQPPNRPLDT
GFFFKETVY
>PK3-045_01671 hypothetical protein
MTLVKDPISEIRDGKRVIVKKPELLAPAGNLEKLKIAVTYGADAVFIGGQEYGLRSNAGN
FTFEEMKEGVEFAKKYQAKIYVTTNIFAHNENIDGLEEYLLGLKSAGVHGIIVADPLIIE
TCRRVAPEIEVHLSTQQSLSNWKAVQYWKDEGLERVVLARETSAEEIKEMKEKVDIEIET
FIHGAMCIAYSGRCTLSNHMTARDSNRGGCCQSCRWDYDLYKLDGAEEKPLFSEGDAPFA
MSPKDLKLIESIPRMIELGIDSLKIEGRMKSIHYIATVVSVYRKVIDAYCADPDHFVIQE
EWLKELDKCANRDTAPAFFEGQPGYKEQMFGNHSKKTTFDFAGLVLDYNEETKIVTLQQR
NFFKQGQEVEFFGPEIDNFTMVVDKIWDADGKEIDAARHPLQIVKFKVDHPVYPNNMMRK
EL
>PK3-045_01672 Uridine kinase
MQPKPVVIGVAGGSGSGKTSVTKAIFDHFKGHSILMIEQDYYYKDQSHLPFEERLKTNYD
HPLAFDTELLIDHIQKLLNYEAVEKPVYNYAMHTRSDETILVEPKDVIIVEGILILEDES
LRDLMDMKLFVDTDADLRIIRRLMRDIKERGRTIDSVIEQYVNVVRPMHNQFIEPTKRYA
DIIIPEGGHNHVAIDLMVTKIQTILEQKSLL
>PK3-045_01673 Transcription elongation factor GreA
MAIEKEFPMTLAGKEKLEQELEQLKTVKRKEVVERIKIARSFGDLSENSEYDSAKEEQAF
VEGRITTIENMIRNAKIISEDELDRDTVSLGSSVTFVELPDGEEETYTIVGSAEADPFEG
KISNDSPIAKSLIGKKVGDKVIVQTPGGEMNVQIVTIK
>PK3-045_01674 Penicillin-binding protein 4B
MWRKRIVGIGILFLFALCILLGRLIQVQLIETNHFTKHNINLVEASVKQRSQEMLLDNGR
GTFLDKNGNSLTHQTKAVLILFPFLKKMDWDSKKVADIIGTSEYNVKNSIIDAKDPVVFG
GKKPLELTSRQMSAINQLKIPGVFAAEKKFHINNSIAEQLLGITGQNEEQLGKRYPDRKL
GGSTLIGLTGLERSFDEFLLPDGESKLVYHVDAKGGPLFGLNVKYVEPANPFYPVNVRTT
IDTDLQQMAEDLVDEQGIKKGGLVLLDLEDNSIAAMVSRPKINAKDPYQTDGVNNYMLKQ
QIVGSVFKTVIAAAAIDNKLDDNNKQYDCSKKINGEEDLTYQHGMLNFTDSFAVSCNNTF
GTIAKKLSDIDENLIEEYAAKLSLTSLVGWRGSVFHSPDFKQFSGEEMGRVFLNEEAKKD
KNYVALTGIGQHEVRVTPLEVANMMATIARGGEKESVRVVSDIQYKNGTTFYSFDKQELD
GGKISPYTASRLQKLLREVVTNNKGTGRWFQDLPYEIAGKSGTAETGVYKEEKQLHNKWF
AGYFPYEKPKYALVTVNLDVYSDEGGVNQLFAEVVKGIDKKQQNAAR
>PK3-045_01675 hypothetical protein
MSNEINNEGKTRYAQRSKRKKTNLILNGLIVAVILLIVFVSYSIFHTNDEKNTAKNKENE
PKSGQEVSDENKTAASTTKSDNKEENTTSEEEKESDGEEIVTEGGSDSNVIKTIENPSWK
PVGTSQTGEHVATYSEGADWNEQIKALSYATGLDSGNMTVWFLGNNNHDPQKSIGTVSSK
DKSEKYRVYIEWVDGSGWKPTKVEEIKDLNIR
>PK3-045_01676 hypothetical protein
MNIQLEMIEDKVEFFEGESLKAIEKKINEQVEVNKAILLSVHSVSHQVTLLENGRPYYTA
VVHFKMKKQF
>PK3-045_01677 putative methyltransferase
MGKEFLEIFEQWADSYDDSLTNNKEYEAVFHKYDYILKMVAERATGHVVEFGPGTGNLTV
KLIEKGLTVTAIEPSPAMRKLAKEKINAKATIIDGDFLHFKLDQQPDTFVSTYAFHHLTD
QEKEEAIKQYSNLLPLGGKIVFADTMYVTKDAYDEAIKNAKEKEHHHLAEDLQREYYTTI
PFLTEILEKYGFSAYFKKLNDFVWMMEGEKISERGK
>PK3-045_01678 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase
MKIAIIGAMEEEVTLLREKIANKKEQTIVGFQFIEGELFGKEVVLLRSGIGKVNAAMSTT
ILMQTFKPDYLINTGSAGGLNPTLEVGDVVISSEVRHHDVDATIFGYEYGQVPQMPASFK
ATERLIAAAEQSAKEIGNHSVVTGLITTGDSFINQPEKAAFIKSKFENLQAVEMEAAAIA
QVAYQHNIPFVIIRSLSDIAGKESHLSFDQYLEKAAVHSANLVLGIVERI
>PK3-045_01679 O-acetylserine dependent cystathionine beta-synthase
MVWSLNVYRNVHELIGHTPMLELTHFSLPKNVHLYAKLEFCNPGGSIKDRLGYELIQEAL
KSGKLTKGGTIIEPTAGNTGIGLALAALNTGIKVIVCVPEKFSIEKQEIMKALGAEIIHT
PTSLGMQGAIEKAKELQRNIPNAYVPGQFENEANPNTYYKTLGPEIWEQLNYQVDVFVAG
AGTGGTFMGTARYLKEQNPAVKAVVVEPEGSILNGGKSGPHKTEGIGMEFIPAYMDTSYI
DQISTVSDADAFEYVKLAAQKEGLLVGSSSGAALYAAVQEAQKAESGSNIVVVFPDSSDR
YMSKKIFDGGI
>PK3-045_01680 Cystathionine gamma-lyase
MKRKTKLIHGGIPGDPHTGAVNIPIYQVSTYKQDGIGNHKGFEYSRTGNPTRHALEELIK
DLEEGKRGFAFSSGMAAITAVMMLFKKGDHILLTDDVYGGTFRVMTKVLNKFGIEATFID
TSDINNIQEAIKENTVALYIETPTNPLLKITDIEAVSRIAKEKGLLTIVDNTFSTPYWQT
PLTLGADIVLHSATKYLGGHSDVVSGLVVVKDEKLGEELHFVQNSTGGVLGPHDSWLLIR
GMKTLGIRMEEHESNTRQIVSFLEKHPAIAKIYYPGLPTHPNHEISKKQAHGFGGMVSFD
VGSAENADKLLNKVKYFTLAESLGAVESLISVPARMTHASIPPERRAELGITDGLVRISV
GLEDVEDLVEDLKQALQ
>PK3-045_01681 hypothetical protein
MEKKIKILTDKISDYQQFGTVLLAVGAFFYIGVIIPKMDKVTGYNEGMLITSIVFLSVSI
LFFAKAKKLKKLLDEWKES
>PK3-045_01682 hypothetical protein
MLDNEMPAKATPELIGSVETSYNCLGFLFV
>PK3-045_01683 hypothetical protein
MNRPALTRLQDDIETGLIHKVICYDPDRLSRKLLVELMITETLQKNSVELQCVRSDSKND
TEGQL
>PK3-045_01684 Uridine kinase
MIKEKTPFVIAISAVSGGGKTTITKLLNQELHNSKVLFFDEYDFNGPDDIINWIDNGGDA
NDWDLNPLIKDLQVLLTESLDYIILDFPFSYKHGQVSKFIDFSIFIDTPLDIALARRVTR
DFCNSSTEDILSDMKNYTSRGRRGYLNMLETIKPDADFVVDGTLQAAEVINVILDNIKN
>PK3-045_01685 HTH-type transcriptional activator RhaR
MLIYEAHHFNLIANYQTVDLNFPSHLHRCFEVLFLLEGEMEVIISQKNYHVSAGQFLLIL
PYEIHSFITKSHSRANICVFSPEYVPTFYKMIENSSLKNPIFNLSLAANTLFTKALFNDN
ANLLEQKASLYLLLSELMGQTSLIQGEKQDQELLHKLLTYIQNHFTEAISLKSIASNLGY
NYNYLSKYFNNNVNMSFVDFLNGTRVNHASYLLIYSEKNISEIAFLCGYESIRSFNRNFL
KIKQCTPKEYRERHPRPFSDLDPFLTI
>PK3-045_01686 Inositol 2-dehydrogenase/D-chiro-inositol 3-dehydrogenase
MEKLRIGMVGYKFMGKAHSHAYRDLPPFFPNTVHPEMKVICGRDQNGVTVAAKQFGWEEY
TTDWKSLLERDDIDLIDINAPSNVHKEITIAAAKAGKHVFCEKPLALTLKDSREMLDLVE
AAGIKHMVGFNYRFAPAVMLAKKLIEEGRLGEIYHFRAWYLQDWLVDPNFPLAWRLQKEI
AGSGSHGDLGAHLIDLSHFLIGDITEVIGMNETFIKERPIPSQMMGLSAKGSDSDKKGKV
TVDDATLFLARFANGALGSFEATRFATGHRSTNSFEINGSKGSVIFDFERMNELQVYFTD
DKDDVQGFRRVLATDPSHAFAENWWPPGHTIGYEHTFIHEMVELMEAFQQDRQPVPNFRD
GVKCQEVLEAVDVSIKNRQWIRISDV
>PK3-045_01687 hypothetical protein
MYPLKIVNGYEFLTFKKVKGAAYTMKKNALIVWGGWDGHQPEQIAEIFKRILEEENFQVK
VSNSLDSYADKEKLKSLDLIVPHWTMGEIEKKYILNISEAVASGVGLAGCHGGMCDSFRN
NVDWQFMTGGNWVAHPGNDGVEYMVNIKHTSSPLLEGLSDFKVTSEQYYLHYDPAVEVLA
TTRFPVIHGPHSANKAVDMPVVWTKRWGFGNVFYNSLGHQANIVAMPEVSLIMRRGFLWA
AEGKKRIENVDTASSYENVRNYTGMGDSQ
>PK3-045_01688 Inositol 2-dehydrogenase/D-chiro-inositol 3-dehydrogenase
MRKLKIGIIGCGNISSVYMENCPKLPYLELVACADLDTGRARTQAKKFGIPLAYSVAELL
SDPEIELVINLTIPKAHASVTIQALEAGKHVYTEKPLAVTREEGQLILEAAKKHNLLVGS
APDTFLGAGIQTAVNLIEQGEIGVPIGASAFMIGRGHEHWHPDPAFYYDTGGGPMFDMGP
YYLTALVALLGPIKRISGSTRISYPERTILSTPKAGTKLKVSIPTHISGVIDFASGVIGS
ITTSFDAFGGTSLPPIEVYGSEGTLLVPDPNTFSGPVKIRKCDEKEFKEVPLTYGYTQNN
RGLGVADMARAIIEGGKYRANSDLAYHVLEAMYGFHDSSDNGQHYLMKSTCDRPKSLPLE
GQEKEFD
>PK3-045_01689 hypothetical protein
MKPKVEPLLDDVARKQLENNEGSFEEPNPYLFPSAFNKEEEMFIGKAMDELIRSKVYLNQ
QDNSN
>PK3-045_01690 hypothetical protein
MSIEKNYSIGEFAKLTGVTERTLRHYDQMELLKPSGYTEHEHRIYNNNSIAQLQKILLLK
FLDLSLGEISEYLKQPEQNLAMTLVNYAQILEEKRKQIGNGFTSHYPRSKYRFRTRTRQS
RFVACTHSCFEK
>PK3-045_01691 hypothetical protein
MKTKQFTIGYNWVVTIHEEYSLFKDLANEFKYSVVDSDNETITIFTVSNSHVDFEHTSYN
LHPVVGFDDQRTIEIKHKPYEEEE
>PK3-045_01692 hypothetical protein
MNRYKNSIIFYFIMIVFFVVYVKLVGYVFNRWIPLSPTADLFTIIIIGLIVIPVSAISAH
HLIKLIQK
>PK3-045_01693 hypothetical protein
MIRILPELNNVVLIEYLTYTNSTASEWDYLS
>PK3-045_01694 hypothetical protein
MTLNLIFLTVTFKKKQYTNAEFLQEIEMEKRIEENRRKLHEMGYRL
>PK3-045_01695 hypothetical protein
MTLNIFFITITINRKRPTEEEQNHLQEIEQIFEETKTKQIRSGYFSNFHY
>PK3-045_01696 hypothetical protein
MIINMLFFTITVHPKKMTAEEITHQQMIEEIMEENRRKQYSIIRF
>PK3-045_01697 Fructose-1,6-bisphosphatase class 3
MDTKYLDLLTEKYDSEEKVVTEIINLDAILNLPKGTEHFVSDLHGEFHAFQHVLRNGSGN
VKEKIRDLFKDELSSAEIDEFATLVYYPEEKLKRIVNSFIHTKELDKWYADTIERMIRLV
SYASSKYTNSKVRKALPQQFVYIIEELLYEKNELNNKTDYYSSIINRIISLGQANKLIIG
LSYTIQRLVVDHLHVVGDIYDRGPYPDKIIDTLMDYHSVDIQWGNHDVLWIGAYAGSKVC
LANIIRICARYDNLDIIEDAYGINLRPLLNLANKYYKDNKAFRPKMNAKENTDENILQIT
KIHQAISIIQFKLEIPIIKRQPDFQMHHRLLLEKIDYEHNTIDLNGKIYSLENTCFNTID
PKDPSLLLEEEEQVINKLLFSIQHSEKLAKHIHFLINKGSLYLRYNSNLLIHGCIPLNED
GSMKSMRIDGKDYRGKELFDLFEYYLRYSFNHPEITDDFATDLVWYLWTGENSSLFGKKD
MTTFERYFIKEKETHKEKKNPYYSLRENEEVCRHILEEFNLNPDQGHIINGHTPVAEING
ENPIKANGKMIVIDGGFSKAYQSKTGIAGYTLLYNSYGMQLVAHKRFTSKEDVLENGTDV
LSVKRVVDRELKRKKVLETNVGQKLLEQMNDLNRLLEYRYLKK
>PK3-045_01698 RNA polymerase sigma-28 factor
MSGILLSIGALLKELVFLVSYVKNNAFPQPLSASDEKKYLRLMAEGDSHARNMLIEHNLR
LVAHIVKKFENTGEDSEDLISIGTIGLIKGIESFSEGKGTKLATYAARCIENEILMHLRA
LKKTKKDVSLHDPIGQDKEGNEISLIDVLKSESEDVVNTIQLNMELEKVKEYIDVLDERE
KEVIIGRFGLDLKKEKTQREIAKELGISRSYVSRIEKRALMKMFHEFYRAEKEKKRKNE
>PK3-045_01699 hypothetical protein
MKKISLISIIILLGFIAYIETPTAKINKNNVLFYGAIKEEQEVSSNGDEIFGAPDLEYKL
EETKEEDGFIVEVYREYEIYKNRQGEVVKTVATDNTESLHYAKNKR
>PK3-045_01700 hypothetical protein
MFMRHILFITLLISLINNFWPIPNIDDLQDVTYQEGDEISISELKDAVRSMQKKADINSY
FTMKHAVVSGELYNNEVWRFDLGLNTPYQFTAENDSIDIAGLQKGLVKFIVFFSFGENEN
SIISKSIYYCDENDSIHEVKFIENTERESIIFS
>PK3-045_01701 Sporulation-specific N-acetylmuramoyl-L-alanine amidase
MVKIFIDPGHGGSDSGAVGNGLQEKNITLSIAQQIRRFLLNEYEDVEIRMSRNNDSAVSL
SARVNAANNWNADFYLSIHVNAGGGNGFESYIYPGVGAPTTTYQNDIHKEVIDETGFNDR
GKKNANFHVLRETTMPALLTENGFIDTVADVNQLKDSNFITKIAKGHVQGLERAFSLQKK
KNQPPIYRVQIGAYKEKENAEKKAMEAAEKGFDTAILFRNNLFKVQIGAFSNRKNAERLA
DRAKEAGFHAFISPK
>PK3-045_01702 hypothetical protein
MAGYGYPNQVPAAVPLGGFGPAPFGYGGAPYPAYGGVYGGAGGFWYAFLIILFIVIILFW
GFWAFGGFYR
>PK3-045_01703 hypothetical protein
MKIEEYQATWDLEGLFPGGSNSQEFREHLALSMDEIDKLSAYVHKYEPLQETDKDSLQQI
VNQFEVVVKKVRQAGAFVSCLEAQNMEDKGASALRGRVTELSAAFQNVLTVLDGKLSLYS
DMEWDSLFKGSNLEELYFVLSERRAAAKEKLSEEEETLINKLSVDGYYGWGQMYDTIVGK
IQIPFDEEYLSVGQAANKFSNPERAVRKKVFKEWEKAWDANGEILAKTLNHLAGFRLNVY
GMRGWTSFLKEPLAINRMQEETLQAMWNAISKKKQPFVQFLNRKAKLLGLEKLSWYDLDA
PLGKIETKMSYQEGAEFIIKHFEQFGTKMSGFAKKAFEERWIEAEDRKGKRPGGFHTYFP
ESAQSRIFMTYSGTPSNVSTLAHELGHGFHTYAMRDMHTLNRNYAMNVAETASTFAEMIV
SDAALKAAKSEDEKLVLLEDKIQRSIALLMNIHARFLFETRFYEERQNGLISKEQLNTLM
LNAQKEAYGDALEEYHPSFWGSKLHFYITGVPFYNFPYTFGFLFSLGIYAKALEEGKGYE
EKYIALLRDTASMTVEELAFKHLQIDLTKEDFWNSAIDLCIKDVEEFLALTNE
>PK3-045_01704 hypothetical protein
MFLHGVLEQTIKKIKTQLANVLTLTNISLGAFAIIYSLKGHLQLSLLLIFIAALADRLDG
MTARKFNIESELGKQLDSMSDIISFGVAPALLVYQGILFELGAPGSFFTVLYIVCGAFRL
ARFNITESHGFFTGLPITAAGCILTFSCLFFTFIPSHIYLFLMLILSILMIGSFKWKKI
>PK3-045_01705 Phosphatidylserine decarboxylase proenzyme
MKETIYRLCIELTNGRWSSYMIKKFAYSRWSRYLIPSFAKVYKINIEEMDKQLKEYGSLH
EFFVRKLKANCRNIHADHREIISPVDAVIEDIGEVREDSSILVKGKTYSIHEMLGDEKTV
DKYIGGTYLIFYLSPSHYHRIHCPVTGTVTNRWTLGNKSYPVNKYGLKWGKSTLSKNYRS
ITELKTEEGNGICIVKVGAMFINSIVLNHKKDRVVQGEEIAYFSFGSTVVLLFEKNTFKQ
KGFHSIPYPVKIGEVIGESFEKRNEYKN
>PK3-045_01706 Sporulation inhibitor sda
MRKLSDELLIESYHKARELNLSPEFIRLIETEIHRRSLSNKIKVSS
>PK3-045_01707 hypothetical protein
MLNQFLPNQFVKNIFEISPDDLKKKGIKGIITDLDNTLVEWDRPLATPQIIEWFAEMKRN
DIKVTIVSNNKEARVKSFSDPLHIPFIFAARKPLGRAFKKAIMQMNTKKEETVVIGDQLL
TDVLGGNRSGFHTILVVPVAQTDGFMTRINRRIERRILNWFRRNGKLTWED
>PK3-045_01708 putative protein YqeH
MTERIHCIGCGVVIQTENKNELGYAPSSSLEKEEVICQRCFRLKHYNEVQDVSLTDDDFL
KILNEIGKSDSLIVKLVDIFDFNGSWLPGLHRFTGNNKVILIGNKVDLLPKSVKHQKVIN
WMKKEAKDLGLRPEDVYLVSAEKGKNIKEVLDAIEYHRNGKDVYVVGCTNVGKSTFINRI
LKEVSGEENVITTSHFPGTTLDIIEIPLSDGKYLVDTPGIINHHQMAHFVDKKDLKIITP
KKEIKSRIFQLNDQQTLFFGGLARFDFVKGERSSFVCYFSNEITIHRTKLEKADELYEKH
AGELLTPPNREHLEAFPELVRHDFSIKEPKTDIVFSGLGWITINEPNIQVSVYVPKGVHA
LLRKSLI
>PK3-045_01709 Shikimate dehydrogenase (NADP(+))
MKNYAVIGDPIQHSMSPVMHNDLFHFYGLDAEMKKMHIKTERLEMGLKSLRDSNIDGFNV
TVPHKQAIIPFLDELDPLSEAIGAVNTVVCKNGKWVGYNTDGEGYLRSLLDQLSNLKQKK
TLIIGSGGAARAIYFSLANYGVHHIDICNRTLSNAERLKEACPFSVVTNILEVASVDKNL
EEYDLIIQTTSIGMSPKIDVSPIQVSNLKQGTFVSDIIYNPLETKILKDAKAKGAVTQNG
IDMFVYQGALAFEKWQGIFPDTARMRQNVLTQLGGSSC
>PK3-045_01710 RNA-binding protein
MLRGKQKRFLRAKAHHLSPIFQVGKGGVNDNMIKQISEALEVRELLKISILQNCDEDKDT
VASELVNGTKSELVQIIGNTIVLYKESKENKTINLPS
>PK3-045_01711 Nicotinate-nucleotide adenylyltransferase
MKKVGILGGTFDPPHIGHLIIANEVLHAKKLDEIWFMPNQEPPHKIKTGTVTNTQRVEML
QLSIESTSSFRIETMELDREGKSYTYDTMKLLNEAYPDNDFYFIIGADMVEYLPKWYKIQ
ELMEIVQFISVNRPKYQLETAYPVQYVKVPDINISSSLIRERVKEGETISFLVRDEVKRY
IEENRLYES
>PK3-045_01712 hypothetical protein
MNREEALQIVKEQITEKRYIHTIGVMETAIKLANKYGGDARKAEIAAIFHDYAKFRPKDE
MKKIIIQQNMDPNLLLFHSELWHAPVGAFLVEKEVGIKDREILDAIRYHTSGRPEMSMLE
KIVYLADYIEPGRAFPGVDEVRELAEVSLERAFLQAVKNTIMFLIRNNRAVFPLSFETYN
SYCIKMEVD
>PK3-045_01713 Ribosomal silencing factor RsfS
MDERTLLWTAVKAADDKRAENIVALNMKGISLVADYFVICHGNSDKQVQAIANEIKEKSG
ELGITVKRFEGYNEAKWILVDLGDIIVHVFHRDERTYYNLERLWGDAPVENVESVISQ
>PK3-045_01714 Ubiquinone biosynthesis O-methyltransferase, mitochondrial
MSYEQFAYLYDRLMNDVPYEKWIQLIKKAAADYKVKGANLLDLACGTGELSIRLAQTGYN
VTGIDLSEDMLSVAQAKTMEAGESVFYIEQDMSQLEGLPVFDLICICCDSINYLRTEEEV
INTFESVYAHLDEKGLFIFDVHSLYKMNQLFINQTYTVNDEDLSLIWQCYEGEYPNSVEH
DLSFFELDAASGMYRRYDELHFQRTYSVDQYSEWLEQTGFTLLKVEADFSQDILDEKAER
IFFYCKKK
>PK3-045_01715 Pyrroline-5-carboxylate reductase
MKIGMIGTGNMGKILIESMIDGKAVSPEDLFIFNRTRNKALEIKEEYPTINICDSDIEIA
KKAELIFLCVKPHDMYEVAHTISPVLTEEKCVISITSPISPDQLDSLFRCSVARIIPSIT
NRALAGVSLFSFGSNCTEEWKKQLESLYEKFSTPLEIEDDITRVASDIVSCGPAFFSYLT
QRFIEGAVDETEIDTETATKLASEMLIGLGELLKKGYYTLPTLQEKVCVKGGITGEGINV
LERQIGDTFNQLFQATQAKYEDDKQSLKNLVTWHKNI
>PK3-045_01716 ComE operon protein 1
MDWLRKNKKIIFFGLGGIVLLLLYRFYPILISSSEEEQIPHENLFAERNLEEKPEEALEE
EPPVTVMLVDVKGAVKNPGVYEANEGERVNDVIEKAGGILKDGEKNAVNFAMRVTDEMII
NVPYIGEEGEAANGNAVGNETSVPSNEGTVNINKASETELLELPGVGPSKAAAIVEYREQ
NGGFSTKEDLKNISGIGEKTYEKLESFISIK
>PK3-045_01717 tRNA-specific adenosine deaminase
MKVERISWDEYFMAQSELLALRSTCTRLAVGATIVRDKRIIAGGYNGSIAGGVHCIDEGC
YVIDNHCVRTIHAEMNAILQCAKFGVPTAGADIYVTHFPCLQCCKAIVQAGIKTVYYELD
YKNHPYALELFEQANIETVQVERKELEKKEEKKALVEALVKQLKENNADSVEAKALEKRA
AELFSIIPTAKTSI
>PK3-045_01718 ComE operon protein 3
MIQTKLLYFAVSALFGLLCAYTQQVLVYIFYFLFIGWLLFMKKGRWKLAAFLLCTFLLFL
VRGGYDDHGNSSKIREDTSSFFVTFIEPAEIDGDRWRVVGREKQTKEKLLLSYKIETKEE
KAFLKAKRVIGKTCSIKGSLSLPSSQRNENGFNYQQYLENNSIYWLVSVGNLDLSSCVTE
RNIILSLKQLREKGTIWIENHFSETTIPIAEALIFGDRSMMEEDLQKAFQRIGIIHLLAI
SGSHVVVLIGIVYFLLIRVGLTRERASTILLLLLPIYAVLTGLSPSVIRAVFSAFILLAI
NKFYTSSSLPMIDIISIVFTVCLFIQPRMLFSVGFLLSFIVCFFLIVSSSLIKEYHSSTI
KMYFFLTFISEYAVIPVILYYFFEIPTLSLLANLIFIPFYTVIVLPYLLVLYVLSFVFPP
FISFFSFPLDAVILLSDKLVLKLSNFPFSTIILGRPSFFFMCAYSLSLPIFFYLYENLAK
TVRKWLYCLPLLLLSVQFLNNIYPPKGEITFIDVGQGDSILIQLPYNKGTYLIDTGGTVN
FPKEDWQKRKDPYEVGAKTVVPFLKSKGIRTIDKLILTHGDLDHIGGSTAIIEQLRVKEI
MYPNVKGDWSVEEEHLLKLVEKKRIPIRFMQAGQKWSTGKESFMVLAPIEKENLTKNNSS
IVIFAKIAGITWLFTGDLEKEGELALMNKYPDLREINVLKVGHHGSKTSSTSVFIEQLRP
KIAVISVGINNRYHHPSMDVLTILEDYKVKVFRTDENGGISFYFSEKGGTFQLQIP
>PK3-045_01719 putative protein YqeN
MIEELWKKIKNRDFSFVYLLYGLESFLINETKYLLLQSLLNEEDEDFNLSTYDLEETPIE
VAIEDAETIPFFGERKVVVLNNPFFLTAEKSKSKVEHNVKKLEEYLKEPSPFTIMIFIGS
YEKLDERKKITKQLKTTASILEAKKLNEQELKKWLKQRAAYNHVEINEDGLDTILSLAGT
NLSLLTTEIDKMALYVQDSKLITKEIVEELVAKSLEQNIFSLVDKVISKKIDEALRIYYD
LLKQNEEPLKILSIITNQFRLIYQVKGLAQKGYGQQQIASVLKVHPFRVKLAAGQANRFT
EEELTKCIRLFAEGDYQLKTGTMPKNMVIEMILFQIGRGV
>PK3-045_01720 hypothetical protein
MSKKDYLPDSLFLFIKLVQTDSTKHELNREKPEQFHTVVQVKKFYRHHTQDTYRNERQSY
LI
>PK3-045_01721 30S ribosomal protein S20
MPNIKSAIKRVKTSEARNAQNTTVKSAMRTAVKKTEAAIALNDTTAANESFVDAASKLDK
AAAKGLIHKNAAARKKSRLAKRKNALNA
>PK3-045_01722 Germination protease
MEEKLDLSMYSVRTDLAIEAKDLALHNQGLVQNEQDQSHLDGVIIKEKEENGIKMSYVEV
TKKGEELIGKKQGKYLTIEVLGIRQQDTKLQEKVEQVFAKEFSQFLKQSDIKEDASCLLV
GLGNWNVTPDALGPQVCENILVTRHLYELQPESVEEGYRPVSSLAPGVMGLTGIETSDII
KGVVEKTNPDFVIVIDALASRSIDRVNSTIQVSDTGIHPGSGVGNKRKELSKETLGRPVI
AIGVPTVVDAVSITSDTIDYILKHFGKELREGNKPSRALAPAGLTFGEQRKLTDEDLPEE
QHRKTFLGIVGTLPEEEKRKLIYEVLSPIGHNLMVTPKEVDVFIEDMANLLANGLNAALH
SAINQENVGYNTH
>PK3-045_01723 hypothetical protein
MKLYTLGAVGIVLLMFICVLFGMQQANSGIHKMKGYEDEGFQSAVAINKENGNLEASVLG
ENITSHDLDEKKQQLEEMKAFNLLSSIGKGVADTISSVAEKGVNLVGDIMEEKEK
>PK3-045_01724 Elongation factor 4
MNREEMLKRQSKIRNFSIIAHIDHGKSTLADRILEKTNALTAREMKDQLLDSMDLERERG
ITIKLNSVQLKYQAKDGEIYTLHLIDTPGHVDFTYEVSRSLAACEGAVLVVDAAQGIEAQ
TLANVYLAIDNDLEIVPVINKIDLPSADPERVRNEIEDVIGLDASEAVLASAKAGIGIED
ILEQVVEKVPAPQGDPEAPLKALIFDSLYDAYRGVVTYIRVVDGTVKPGDKIKMMATGKE
FEVIEVGVFTPKAVNTDHLSVGDVGFLTAAIKNVGDTRVGDTITNAKNGATEALPGYRKL
NPMVYCGLYPIDSAKFNDLREALEKLELNDSALQFEPETSQALGFGFRCGFLGLLHMEII
QERIEREFKIDLITTAPSVIYDVILTDGTEIKVDNPSAMPDPQKIDRIEEPYVKATMMAP
NEYVGAIMELCQQKRGVFIDMQYMDETRVKITYEIPLSEIVYDFFDQLKSNTRGYASFDY
ELIGYKTSTLVKMDILLNAEQVDALSFIVHKDFAYERGKVIVEKLKELIPRQQFEVPIQA
AIGQKIVARSTIKAMRKNVLAKCYGGDISRKRKLLEKQKEGKKRMKQVGSVEVPQEAFMA
VLRMDDNNTKK
>PK3-045_01725 Heme chaperone HemW
MIQAAYIHIPFCEHICHYCDFNKVFLKGQPVDEYLDSLEKEMKLTIEKYGQQELSTIFVG
GGTPTSLSASQLERLCGMVNKELKLRPEQEYTFEANPGDLTEDKLKALYEGGVNRLSFGV
QSFNNELLKRIGRTHKAEDVFSSIEAAKKIGFNNISVDLIYSLPGQTLEDFQETLKTAFT
LDIQHYSGYSLIIEPKTVFYNLMRKGKLPTPGEDVEAGMYSVLMDEMARHGFQQYEISNF
AKPGFESRHNLTYWNNEEYFGFGAGSHGYVHGNRYSNYGPLKKYMQPLEQGEFPIMHEHK
VTVIEQMEEELFLGLRENKGVSLSSFEQKYNENVLELFDKEINKLISRELIEIESDYLKL
THKGRFLGNEVFQSFIGVLE
>PK3-045_01726 Heat-inducible transcription repressor HrcA
MLTDRQLLILQVIIDDFISTAQPVGSRSLSKKENITFSSATIRNEMADLEESGFIEKTHS
SSGRVPSEKGYRFYVDHLLSPQKLKRSEILRINSLFAEKIYELENIVQKSAKILSDLTNY
TTIVLGPAVKENKLKKIQIVPLNNHTAIAIIVTDSGHVENRMFHLPDSVHAGEIEKLVNI
LNDRLTGVPIDKLHNKIYKEVATLLKQHISNYEYFINSLSETVKIDTHEKLFFGGKTNIL
RQPEFHDITKIRNLLNMIEKEDGIPELIRNNSSDISIKIGRENNNTAMENCSIISASYRI
GNEQIGSIAILGPTRMEYSRVVSLLNILSNDLTKVLTNLYQK
>PK3-045_01727 Protein GrpE
MAEEKATNNAEMEQQAAQEDVKVEETVEEVFEEAEASPSNEGNVAEELKAANDKIAELEA
KLEEESNRYLRLQADFDNSRRRSRLDMEAAQTYRAQSLVMDLLPSIDNLERALKIEAVDE
QTQSLYTGVEMVYRGILDALKKEGVEAIEAVGKEFDPHLHQAVMQEEVEGTDSNIVVDEF
QKGYKLKDRVIRPAMVKVSQ
>PK3-045_01728 Chaperone protein DnaK
MSKIIGIDLGTTNSCVAVLEGGEPKVIPNPEGNRTSPSVVAFKNGERQVGEVAKRQSITN
PNTIMSIKRHMGTDYKVEVEGKNYSPQEVSAIILQYLKGYAEEYLGEKVTKAVITVPAYF
NDAERQATKDAGKIAGLEVERIINEPTAAALAYGLDKTDEDQTILVYDLGGGTFDVSILE
LGDGVFEVKSTAGDNRLGGDDFDQVIIDYLVEQFKKENGIDLSKDKMALQRLKDAAEKAK
KDLSGVASTQISLPFITAGEAGPLHLEVTLSRAKFEEISASLVERTMGPTRQALKDAGLN
ASEIDKVILVGGSTRIPAVQEAIKKEIGKEPHRGVNPDEVVAMGAAIQGGVITGDVKDVV
LLDVTPLSLGIETMGGVFTKLIERNTTIPTSKSQVFSTAADNQTAVDIHVLQGERPMAAD
NKTLGRFQLADIPPAPRGIPQIEVSFDIDKNGIVNVRAKDLGTNKEQTITIKSSTGLSDE
EIDKMVREAEENAEADKKRKEEVELRNEADQLVFTTEKTLKDLEGKVDESEVAKANEAKD
ALKAAIEKNELEEIRAKKDALQEIVQALSMKLYEEAAQAAQAAQGADGGASDKDDNVVDA
EFEEVKDDK
>PK3-045_01729 Chaperone protein DnaJ
MDKRDYYEVLGVSKGASKDEIKKAYRKLSKKYHPDINKEADANEKFKEVKEAYEVLSDDQ
KRAHYDQFGHTDPNQGFGGGGDFGGFGGFEDIFSTFFGGGGSRRRDPNAPRQGADLQYTM
TLSFEEAAFGKETEIEIPREENCETCNGTGAKPGTKPVTCKHCSGTGQLNVEQNTPFGRI
VNRRTCNYCNGTGKEIKHKCSTCGGTGKVKKRRKISVKIPAGIDDGQQLRVSGQGEPGIN
GGPAGDLYVVFHIRRHDFFERDGEDVYCEMPITFVQAALGDEVEVPTIHGKVKLKVPAGT
QTGTKFRLKGKGIPNVRGYGQGDQHVIIRLITPTKLSDKQKQLLQEFAEVSGDTPRGEEE
DSFFSKVKKAFKGE
>PK3-045_01730 Ribosomal protein L11 methyltransferase
MKWSEITIHTTNEAIEPISNILHEAGASGVVIEDPFELIKEREDQFGEIYQLNPDDYPEE
GVLVKAYLPINSFLGETVEAIKENINNLVLFNIDIGLNKVSIMEVNEEEWATAWKKYYHP
VKISEKFTIVPTWEDYTPVHTDELIIELDPGMAFGTGTHPTTVLCIQALERIVKKGDMVI
DVGTGSGVLSIAAAMLGAKSVLALDLDEVAVRSAKLNIKLNKVHEKTSVRQNNLLNGIEE
QAEVIVANILAEVIVRFTDDVYRLLQKDGYFIASGIILQKKEEVKDAIIASGLEIIETVQ
MEDWVSITAQKKS
>PK3-045_01731 Ribosomal RNA small subunit methyltransferase E
MQRYFAKNEEDTFFIQEDDYHHIVRVMRMDIDDEIYCVNSLQQAARCRIEKISENEVIAK
VVQWLEGEIELPVSVSIVSGLPKGDKLEWIIQKGTELGAFKFIPFIAARSVVKWDEKKGG
KKLVRWNKIAKEAAEQSHRTMIPEVSSPISIKELIKLSEGYNVKLIAYEEEAREGESSVL
TKSLQSMTKGQSILALFGPEGGLTESEVALLKEHGFMTCGLGPRILRTETAPLYLLSAVS
YHFELME
>PK3-045_01732 Threonylcarbamoyladenosine tRNA methylthiotransferase MtaB
MPTVAFHTLGCKVNHYETEAIWQLFKQQGYERVEYENISDVYVINTCTVTNTGDKKSRQV
IRRAVRKNPDAVICVTGCYAQTSPAEIMAIPGVDIVVGTQDRVKMLEYITQYKEERQPIN
AVGNIMKNRVYEEMDVPAFTDRTRASLKIQEGCNNFCTFCIIPWARGLMRSRDPQEVIKQ
AQQLVNAGYKEIVLTGIHTGGYGSDMKDYNLANLLRDLESQVKGLKRLRISSIEASQITD
EVIEVLDKSKIIVNHLHIPIQSGSDTVLKRMRRKYTMEFFAERITRLKEALPGLAITSDV
IVGFPGETEEEFMETYNFIKEHKFSELHVFPYSKRTGTPAARMDNQIEEDVKNERVHRLI
SLSDQLAKEYASNYEGEVVEVIPEEVYKEDGNGKLYVGYTDNYLKVVFPATEEMVGKIVK
VKITKAGYPVNEGQFVRVLEEVEDQAAIVS
>PK3-045_01733 Deoxyribose-phosphate aldolase
MNIAKMIDHTLLKADATKEQIVTLCEEAKQYKFASVCVNPTWVKAASELLNGTEVKVCTV
IGFPLGASTSATKAFETEDAIKNGATEVDMVINIGALKDKNFDLVKEDIKAVVDAAKGKA
LSKVIIETSLLTNEEKEIACKLAVEAGADFVKTSTGFSTGGATVEDITLMRKTVGPDIGV
KASGGVRSSEDTEKMIAAGATRIGASSGVAIVNGLTSNSDY
>PK3-045_01734 HTH-type transcriptional activator RhaS
MLYYQSNYFGQNGDFDRISAFNPTNLPHFHRSLELVMVDKGTLELTIQDKSYTLHEGENA
LILSNQIHSLQSNQKNHAWIYVFSPELVNQFYQLSKNKDLIHPIFQLQAATREMIKEIFS
NNNSSMFAKKGVLYLICAELLNQTSFKEETRRDDYLLHDLLNYIQNHFTEELSLKDLSQK
FGYDYSYLSRFFTKILHIPFVDFVNGHRVTLASQLLKTTDSKITEIADMVGYRNIRSFNR
NFEKIMNTTPTNYRKIYMESY
>PK3-045_01735 Putative multidrug export ATP-binding/permease protein
MNNYQWIWSYVKKNKKKVIVASLILLANSFFVLIIPILSGRLIDEVIENNQVQLLVPILL
AMIGATLIRTVTRYIYQMLYEYVGQDAQFDIRQDMYKKLQELDFDFFNHNRVGDIMARMT
GDMDAIRHFVSWVCYNIAECVIWFVVAIIVMMNIDWKLTLALLAVTPFIFIFTQKMSKAA
HPVFLEIRESFSRLNSMVEENISGNRVVKAFSREEYEIEKFNHFNDDYRKRNLDSANVSK
KYLPWLDGFAGVLAVITLLLGGLFVIQGNMSIGDLVAFNGFMWLLNMPMRMSGWLINDVQ
RFNASCVKIRNLLITEPQIMVEDKKKGKQIAGYVTFKDVSFAFSDDPETPILKNVSFTVR
PGQTVGILGETGSGKSTLVNLIARFYDPTEGEVLIDQINAKEWPVRKLRDQISMVMQDIF
LFSNTIEENISFGKPYLNMEQIQRVAAIADAHNFIVKMPEGYDTIVGERGVGLSGGQKQR
ISLARALAKDPSILILDDTTSAVDMETESKIQKELNQLTQDKTTFIIAHRISSVRDADFI
LVLDKGEVKEQGTHTELVAKKGMYYDVYRRQLGLVEQEEGGAAIGP
>PK3-045_01736 putative ABC transporter ATP-binding protein
MARNKFNVDEELETEFNWSHYKRIGAYIKPYKKALFITLLIILTANVAGMLGPFFTKIAI
DEIIPDKNIPLLIGISILFVLSLFVIGICMRYRIQWITQIGQNILKDMRLDIFQHLQKLP
FSYFDNRPHGKILIRVVNYINTLSDLLSNGLINLISDIISVIITLMFMFAIDAKLTLYSL
ALLPILGVLVWVIKNMQRKAYQVLSNKQSNMNAYIHESIAGIKITQSFAREEENFEIFDE
VSNETRTSWLKAVSIQFLLWPGVQNISVLTTSLIYFVGIRQIGVDVSTGTLVAFIGYVNN
FWNPVINMGNFYNALITASAYLERIFETLDVEPDIKDQPKAIPMPAIKGNVTFERVTFRY
EEGKNILSDVSFHINAGQSIALVGPTGAGKSTIINLLSRFYDVNEGSVKIDGVDVRDVTL
KSLRSQMGVMLQDTFVFSGTVLDNIRYGKLDATEEEVITAAKIVRAHDFIKDLKDGYHTV
VEERGSTLSAGQRQLISFARALLANPKILILDEATSSIDTKTEELLQEGITELLKGRTSF
IIAHRLSTIKNSSQIFYVDGGRVAEKGTHDELMAQKGLYYHLYQSQYDLLKVM
>PK3-045_01737 hypothetical protein
MIYLILFIILILLFIYGMTLLRTGLFNLSSQSLKNSLEKLTDKPWKGLLVSIIITALLQS
SAAVMVLTIGLISARVLTFPQSIGIILGTNIGTTFTTEFITFNMNNYLLPLAILGVLLII
INKYQLRSIGFILFGISIVFTTMRGFKYFAGMMEHHPALNSFFLSLADRPFIALIVGIII
TALIQSSTATIGIIMGFLSAGLLPIEIAIAIMLGSNIGSCITSFLASIGTEKSAKLCAYA
HIWLNIGGVILFYPFINDLAAIVKNMTAEMDVQLAHASLLFNVLSSLLVLPFAERFGKLI
MRLHS
>PK3-045_01738 30S ribosomal protein S21
MSKTVVRKNESLEDALRRFKRSVSKTGTLQEARKREFYEKPSVKRKKKSEAARKRKF
>PK3-045_01739 putative protein YqeY
MSLLERLNNDMKQAMKNKEKDKLVVIRMIKAAIQNESIKLGRDLSEEDELSVLSREVKQR
KDSLHEFEKAGREDLVDKIRAELKHVEIYMPEQLSEEELAEIVKQAIVDTGASSKKEMGK
VMAALMPKVKGKADGSLVNKLVQQHLS
>PK3-045_01740 hypothetical protein
MRRQKKIWMIPLLFIFFLSFIPSIIYANNEEKVYVVPIKDTVEKGLSQFIDRAITEAEEN
QASAIVFDMHTPGGDVSAAIEIGKRIAETDIKTVTFINQDAISAGSYIALNTDEIYMVEG
GRIGSSGVIDGQGNAAEEKAQSYWISAMKGAAEKTGRDPLYAMAMADKSISIPGMKEAGK
FLTLTSSEAKEINYSNGTVNSLDDVLNHLGLQNAKIEKVDESFAEKMARFVTNPIIIPIL
LSIGSLGLIIELYSPGFGLPGIAGISALLLFFYGHLVAGLAGYESLILFVIGILLIILEF
FVVGGIAGAIGIVAVIASMFLASGDIAVIGISLAIAIGVSIIASILLVKVFGRKMKFFKK
IILTDSTNTESGYVSNQNRNDLVEKTGVTLTALRPAGVILIEDERIDVVSDGSFIDKGKK
VKVVKAEGSRIVVREILTIDIQKEDE
>PK3-045_01741 hypothetical protein
MLVGGFEIFWIIVVVLAIILLGVLLTFVPVMLWISALAAGVRISIFTLVGMRLRRVIPSR
VVNPLIKAHKAGLNVTINQLESHYLAGGNVDRVVNALIAAHRANIELTFERCAAIDLAGR
DVLEAVQMSVNPKVIETPFIAGVAMDGIEVKAKARITVRANIERLVGGAGEETIVARVGE
GIVSTIGSSDNHKKVLENPDMISQTVLSKGLDAGTAFEILSIDIADVDIGKNIGAELQTE
QAEADKKIAQAKAEERRAMAVAQEQEMKAKVQEMRAKVVEAEAEVPMAMSDALRSGNMGV
MDYMNLQNITADTEMRGSIGKLTDDQKNKDDE
>PK3-045_01742 hypothetical protein
MEILPIIIAVVVFLFSSVFDNSKKKQVPKPKSPQVPKQVNAEVERERQVMTAPVRPKKVV
QEEKPLSELERLQRENASLQKKIKMMEKQRNRVVSGPTLNKNQFPKESEGLFTKDNIVQA
VVFSEVLASPRSRNPHRASMQHRVTNRK
>PK3-045_01743 hypothetical protein
MMIVSVRKRTVYPENLIKERKGGSFFMAKKWGHNLRNWMIKNLELPQDVMMDLPRITMIG
QIHIYVENHRGLITFSDKELRLLLKQGQLLIKGKGFVIKTILPEEILLEGKIDQVLYINE
>PK3-045_01744 hypothetical protein
MKNHWIEYLTGIITVKATGKGLERFLNKLLKNGMSVWNVKKHGPQAVTFQISLKNIHSLR
HLVRGSGIKIEFQRRAGAPFLYKRMWKNSGFVLGLFLFLGLVLTLSNMVWGIEIKGANPA
TEYQIRKQLDKMDIKIGKSQFFAKELDEIQAELTNNIDAITWIGVELKGTTYHFQVVEKN
EPKKKKEAGPQNLIAMKKATIVTDFVESGTKRYAINEVVRKGQLLVAGKIGNEDHAKSVS
AKGKVWGEVWYTTEVTVPLKTTFQVFNGAEKQKIYMKLGKWSIPVWGFGKIEYKEYEEEE
NESNVKFFKWELPIKIVNKTYREKEIVTRGYSEKEAIEKGKEDARKDIMKRIGEDGKIKE
EKILQQDIKNGKVKLNIAFTTIENIAKAQPLTQGDTE
>PK3-045_01745 PhoH-like protein
MTEDLKTMNVKLKDPNEAIALLGNGDSNLQVLEKELDCNIVTRGETLLVSSENPDSIELV
GDIVDKLLQVIRKGVSISQRDVVYAISLAKKGTLEYFGSLYDEEIAKTIKGKSIRVKTIG
QSEYIRTIRRNDLVFGIGPAGTGKTYLAVVMAVNALKSGKVNRIILTRPAVEAGESLGFL
PGDLKEKVDPYLRPLYDALHDVLGMEHTARLIERNTIEVAPLAYMRGRTLDDAFVILDEA
QNTTHAQMKMFLTRLGFGSKMVITGDKTQIDLPKGVKSGLVVAEQILQNVNGIGFVHLEE
SDVVRHPLVGKIIHAYGKQVM
>PK3-045_01746 Cyclic-di-AMP phosphodiesterase PgpH
MNVWQRMRNNLIKLMNITFFKIILFVLLGVILFFTLYGNVKPEKLNVQLFSVADQTIRSP
ITVEDKESTEKKKEEAKNQVQDVYVVNKEIAQNRVDLISSIFDSVTEVNNDVEKQLEEKR
KKAEEEEKNKESIKEPSVDEKLELLKGKLTNEVTNEIMDRSLKSLIPYSEDQLEIAKDIT
VTAIHTVMNGKIPSDEVENAKKRVEDILKVNDGLTSDLKSASIDLGRFAIIQNEFYDPTA
TEEMRQQAVDGVEPIRVLQGQVLVEEGQLISREIHRQLELVGLLDSDNSIQPFIGLGLII
LAMLAALYFYTLKRTSKEKENNIQFYLMFFLIISVTIVLMKTISAFQQFEYTEIGYIFPA
AMAVMLIKILMEEKSALLVTIMLAVCGMIMFNEGVAGTFNVGMGIYIITSGLASILFLNK
RNQRTNILYAGFFISFINIVTILAILYLQNGHYGAKEYGVFLLLAVISGISSAVLTIGFL
PFLETGFGVLSTIKLIELSNPNHPLLRKILTEAPGTYHHSVMVANLAESACEAIGANGLL
ARVGCYYHDIGKTKRPHFFIENQMNMGNPHDRIPPQASKNIIIAHATDGAELLRKYKLPK
EIVDIAEQHHGTSLLKYFYFKAKEKGGEVKESDYRYPGPKAQTREVAIIGIADSVEAAVR
SLNAPTTEQIDSLIKNIISDRLQDGQLDECDLTLKELDIVRNTLSETLKGIFHSRIEYPE
MKK
>PK3-045_01747 Endoribonuclease YbeY
MNLEIDFIDETEKVKESEIAKIEEVLQFAAEKLNLQGEIELSITFVHNEQIQQINKEYRE
KDQPTDVISFALEELGEGEMELVGEGLPRMLGDIVISIDKAEEQANDYGHSYMRELGFLS
VHGFLHLLGYDHMTEEDEKVMFTLQKDILDEFGLQR
>PK3-045_01748 Undecaprenol kinase
MSSDYKDKRIRKNSQLSSFRLAILGILTAIKQERNVKIHLVITILVIILGLLNDLSKQEW
MFIAFCIGLVISLELINTAIERVVDLVTSEYHPLAKEAKDIAAGAVFIAAILSIVIGGII
FIPKIWSAITG
>PK3-045_01749 Cytidine deaminase
MKKELLMEEAKLAREKAYVPYSKFKVGAALLSEKGVVYRGCNIENAAYSMTNCAERTALF
KAVSEGDTTFKKLVVVADTEGPISPCGACRQVISELCPKDMEVILTNLKGDVQTLTVAEL
LPGAFSPEDLNEH
>PK3-045_01750 GTPase Era
MNINNQTEHKSGFISIIGRPNVGKSTFLNRVIGQKIAIMSDKPQTTRNKVQGVLTTDDAQ
LIFIDTPGIHKPKHRLGDFMMKVAQNTLKEVDLILFMVNAEEGFGKGEEFILEKFQSVKT
PIFLVINKIDTIHPDQLFAIIESYKEKYPFKEIVPISALEGNNVETLLTQIKKYLPEGPQ
FYPADQVTDHPERFIVSELIREKALHLTREEIPHSLAVVIEKMERKSNDVINVMATIIVE
RDSQKGIIIGKQGSMLKEIGKRARTDIENLLGNKVYLELWVKVQKDWRNKMTQLRDFGFR
EDEY
>PK3-045_01751 hypothetical protein
MLDFTWKVFSQTGNIDTYLLFKELEKHNHEIPGMQEEELAELDYPIS
>PK3-045_01752 DNA repair protein RecO
MVMLEKCEGIVIRSIDYGESNKIVTLYTREWGKVGVMARGAKKPNSRLSAVTQPFVYGYF
LVQRSSGLGLLQQGDIISSMRSLKEDIFLTAYASYIVELTDKCTDEKKPNPYHFELLYQT
LNYMNEEYDSEILVNIYELKMLNSLGLYPVLDRCVFCGATEGHFSFSIREGGLICHQCLE
KDPYHYKISQATVKLLRVFYYMDISRLGSISVKDSTKKELSMIIDAYYEEYSGLYLKSKK
FIQSMKNLGDSFT
>PK3-045_01753 Glycine--tRNA ligase alpha subunit
MNIQNMILTLQKHWSDYGCILMQAYDVEKGAGTMSPYTFLRAIGPEPWNVAYVEPSRRPA
DGRYGENPNRLYQHHQFQVIMKPSPDNIQELYLDSLRALGINPLEHDIRFVEDNWENPSL
GCAGLGWEVWLDGMEITQFTYFQQVGGIECKPVSVEITYGIERLASYIQDKENVFDLEWT
DGFTIKDIFYQPEFEHSKYTFETSDTDMLFNLFSIYEKEAHRQMDEGLVHPAYDYVLKCS
HVFNLLDAKGAISVTERTGYIGRCRNLARKVAKTFYEEREKLGFPILKSKEGKSHE
>PK3-045_01754 Glycine--tRNA ligase beta subunit
MNKRDLLLEIGLEEMPARFISASIQSLKEKMEAWLAEKQLGYASVQAFSSPRRLALLVTG
LDESQHDMEEEAKGPAKRIALNEAGEWSKAAAGFTRGQGLAVEDIYFKEINGVEYAHVKK
FIKGKQTSELLSELKELILSLTFPKNMRWANNELRYIRPIKWLIALFGEEVIPFSITNVE
TSNQSRGHRFLGGEIVFQSSSDYEKKMLAQYVMVNAAERKEAIVSQINKLEEENNWIIPI
DEDLLEEVTNLVEYPTALYGTFDESYLELPTEVLITSMKEHQRYFPVKSKEGKLLPYFVT
VRNGDHQHLDKVARGNEKVLRARLADAAFFYKEDQKLAIDDLLKKLEAIVYHEEIGTLAE
KVARVRLLASKLADELQLTSEEKQDVDRAAQIAKFDLVTNMVYEFPELQGLMGERYALQK
GEKASVANAINEHYMPRHADDETAPSNVGAVLALAEKLDTIVSFFSIGLVPTGSQDPYAL
RRQATGIVQTLIDKNWNISIEQLVELSIQAIENTSKVSGQELVDSVLSFFKLRVKYILQE
QGIRYDMIDAVLAEKIGGAASVLRKAKVLELHKDDANFKEGIEALSRIINISNKAVTVSA
VDPSLFENEYESDLYNRFTAVKEKINTKVEEKEYFELLFSLQETISAYFDHTMVMADNEK
IKENRLNLMAEMASYIKGFASVNEIIVK
>PK3-045_01755 Transcriptional repressor CcpN
MAGFLDARPRVGYFYTGKNSERLVIDNIRNILVKDYYSHPVVVHENSSVYDAIVIMFTED
VGTIFVIDEASTLTGVVSRKDLLRASIGKQELNSLPVAIIMTRMPNVTYCFKEEILVDVG
CKLMDHEIDALPVVEKNENGLLVIGRVSKTNITRAFVDLSNNRKGIVEEHND
>PK3-045_01756 Putative pyruvate, phosphate dikinase regulatory protein
MTERQIIYVVSDSVGETAELVTKAAISQFSGHNVNVLIKRFPFVEDKSNIHEVVMQAKME
HGMIAYTLVKPEVRNYMSELARQEGVYACDIIGPIIDQFQVLWGKTPLYEPGLVRKLDED
YFKKVEAIEFAVKYDDGRDPRGLEKADIILIGVSRTSKTPLSQFLAHKRVKVANVPIVPE
VDPPKELFQVPASKCFGLKISPTKLNNIRKERLISLGLSDQASYAQIERIQEELTYFDDI
VNRIGCPVIDVTNKAVEETANIIHNLYYRSKYNADN
>PK3-045_01757 hypothetical protein
MIYVDADSCPVKEDIVEIASYYHYELQFVASYAHMKRENDGQNWKYVDSDKEAVDLFIMN
ATKKQDIVVTQDIGLASTLLLKQVTVLSPRGVMYEEETINTALDMRYLSAKARRKGVYGK
GPKPFTEEDRQKFRRNFIRILSKNEGESIGHVE
>PK3-045_01758 DNA primase
MVARIPEEKLNEIKQATDIVEVIGEHVSLTRQGRNFIGLCPFHGEKTPSFTVSPDKQIFH
CFGCHAGGNVFTFLMDLEGTSFVEVATSLADRASIDLGIEINELEKKPAIPNDLQQMIDA
HELLSKFYHHLLVNTKDGQHALEYLTNRGFTLPIIEKFQIGYTLNSWDLAVKFLGKRKFD
VSLLEKAGLIVKSERDEKYFDRFRDRIIFPISDRNGNTIAFSGRALGDNNPKYLNSPETP
IFNKSNTLYNFHKARPIIRKLQQAVLFEGFADVIAANRAGVENSVATMGTSLTEEHIAIL
KRNARNITICYDSDSAGIEAAFRAGQLLTKANCIVKVVMLPDGMDPDDYVNKFGEDKLQQ
EILHGSIPFMGFKMLYYRRGKNLQNEGDKLAYIEEVIGEIAKLDKAVEKDLYLRQLADEF
SLSLEALKQQEMQMEQSSPNEYVDEKTVVPVKQYTVKKRATGLLPAYHTAEKRLLAHMFK
SEDIAYKVQSSLQGRAFNIDEHQAIFTYLLAFYEKGLGTDTSSFMNFIDDPDLQRIVAEI
EMMEVNEEVSELEISDYMKQVTNYEKLLEIKEKKQQLKEAERQNDYIKAAQIGMEVLLLE
KTLK
>PK3-045_01759 RNA polymerase sigma factor SigA
MAEKSARSKEIETELTLDQVKEQLTEVGKKTGVLAYDDIAEKLSSFELDSHQMDEFYEFL
GDQGVELIGDGEEEAPNVQELAKGEEEFDLNDLSVPPGVKINDPVRMYLKEIGRVDLLSA
EEEINLAKRILQGDEEAKRRLAEANLRLVVSIAKRYVGRGMQFLDLIQEGNMGLIKAVEK
FDYEKGFKFSTYATWWIRQAITRAIADQARTIRIPVHMVETINKLIRVQRQLLQDLGREP
SPEEIGEDMDLSPDKVREILKIAQEPVSLETPIGEEDDSHLGDFIEDQDATSPSEHAAYE
LLKEQLEDVLDTLTDREENVLRLRFGLDDGRTRTLEEVGKVFGVTRERIRQIEAKALRKL
RHPSRSKRLKDFLE
>PK3-045_01760 hypothetical protein
MQDQRKTIIVKEIAYWKENKMLPEHYCDYLLTLYTEGNGVEENTISKKRSGFLLSSLLFF
SFIPITIFLLYFTELSFILQMAISLIFLIFCFVGIFLYNKKQLNVDIPATVAAIIFLLFS
VAFVLYFFVNKIIFLYIILFLNCLFWYICGKRFKLLYFTISAYIGACLLVILVVSKYMFN
>PK3-045_01761 tRNA (adenine(22)-N(1))-methyltransferase
MNTDRLSKRLETVAKYIPRNSKFADIGSDHAYLPCYMIKRKEVQSAIAGEVVEGPYQSAV
KQVKQEGLTSKISVRKGNGLEVIEGNEVDCITIAGMGGTLIASILENGKEKLHSVQRLVL
QPNISAFSIREWLLKNNWTLVAEEILEEDGKIYEVLVAEKGESPSLNEESALLFGPFLMK
EKDAAFVKKWELEKKNWQRILTQLESAPDSVENTQKRTELQHKIKLVDEVINDEEY
>PK3-045_01762 GTP cyclohydrolase 1 type 2 
MKNINGYEIISLFEQFSPKVYAMEGDKIGLQVGDLSRPVKRVMIALDVLDEVVEEAISKK
VDLIIAHHPPIFRSLSKITMDNPSGKLMHKLIKNDITVYAAHTNLDVAKGGVNDLLSDAL
GIQDAEVLVPTYEDKLKKLVVYVPKEHVEQVKKSIGDAGAGSIGNYSHCVFSTEGIGEFQ
PLEGAVPYIGSVNKLEQVEEVKIESVYLASKEKKIVKAMVKAHPYEEVAYDIYDLKIKGE
QLGLGRIGRVEETTLGKFADHVKKVLEVDRVRVVGNLDSPVKKVAVLGGDGNKYYSHALM
KGADVYITGDMYYHVAHDAQAVGLNIIDPGHNVEKVMKNGVTKVLKRMCEEKGYEVEIFP
SVTHTDPFTFV
>PK3-045_01763 4-hydroxy-3-methylbut-2-enyl diphosphate reductase
MKVIKIAPRGYCYGVVDAMVIARNAALDKTLPRPIYILGMIVHNKHVTDAFEEEGIITLD
GQNRKEILDKVDSGTIIFTAHGVSPEVRRIAKEKGLVTLDATCPDVTKTHDLISEKVKEG
YYIIYIGKKGHPEPEGAVGVAPHAVSLVETLEDLSGLEINHEKILVTNQTTMSQWDVADL
MESIKEKFPQAEFHKEICLATQVRQEAVAKQAGEADVLIVVGDPKSNNSNRLAQVSEEIA
HTTAYRIADISELKLEWLKGASSVAVTAGASTPTPITKEVINFLDQYDPEDENTWQFEKK
VPLNKILPKVKAK
>PK3-045_01764 hypothetical protein
MMPPRQRGPFQGPPMGGRMPGMRGPSNFPGGPMGRGAMPSRGNGGGGGLLSRLLGGGNNT
AGAATNAGARSAASGGGGLLKTLTNPSSINGFLANSQKFLNTASQIGPMINQYGPMVKNI
PAIWKMYRGLTSSNKETEETEVTEQKTSKEINDKTTSKPQTKKKVKKTETDHHDFETESF
SENPSGASKPKLYV
>PK3-045_01765 DEAD-box ATP-dependent RNA helicase CshB
MSNNLFNQYELKPFIIDAIDELGFYEPTEIQQKVIPLVLKGESAIGQSQTGTGKTHSYVL
PIIEKINPEKQAVQAVITAPTRELANQIHQEIQKITKHSAQPISSRLFIGGTDKQRSIEK
LKTQPQIVVGTPGRINDLVNEQALFVHTAKILIVDEADLMLDMGFIEDVDQIAAKMPKDL
SMFVFSATIPEKLKPFLKKYLENPTFIHIEPKQLTAAKIEHILIPSRHRDKITTVYEALV
SFNPYLAIVFTNTKQMCDEVANGLSSKGLKVARIHGGLTPRERKKVMKQILDLEFQYIVA
TDLAARGIDIKGISHVINYELPSDLDFYVHRVGRTARAGYSGIALTIYEPSDEDKLNQLE
KLGVEFKHMDLKKGEWIELDDRNRRKNRKKQVDEIDLKAKSLVKKPKKVKPGYKKKMQQQ
VETIKKREKRIKSRRK
>PK3-045_01766 putative endonuclease 4
MLKIGSHVSMSGKKMLLGASEEAASYGANTFMVYTGAPQNTRRKKIEDLNIAAGQLHMEQ
NGIDDIIVHAPYIINIANTTNPATFELGVNFLRSEIERTEALGAKQIVLHPGAHVGAGAD
VGIKKIIEGLNEVLTGNENLQIALETMAGKGSECGRTFEELAMIMEGVTHNDKLSVCFDT
CHTHDAGYNIVEDFDGVLEEFNRIVGIDKLKVLHINDSKNIVGARKDRHENIGYGQIGFD
ALMKIVHHSELADVPKILETPYVGIDKTNKKAPYKHEIEMIKKKTFNENLLQEILES
>PK3-045_01767 hypothetical protein
MKIFENIINHKINNITSTELLKYSKQFKIKITNEEAVKLANHLNGRKVNIFKPNERAQLI
REVAKLTSPATAKELNDLFNLFAEQ
>PK3-045_01768 Zinc-specific metallo-regulatory protein
MNVQTALDILKEKGYKHTDKREDILALFSNENKYLTAKDVLESLKDDYPGLSFDTIYRNL
SLFEELEIFEMTELNGEKHFRFTCSHQHHHHHFICLDCGKTKEIITCPMEELSESLKGYD
VSGHKFEIYGKCPECRN
>PK3-045_01769 Nucleotidase
MKKLRFGIDIDGTVTSPAAFIPFLNESFQLNITLEDVVQYEFYPLVNVSNEEFDKWFIEN
EARIYTASPLAEGANVVLQEWAEQHELIFISARGEGMLELTKEWFLNQGISFNHIELIGS
HHKIAAAKKNKVDIFFEDKHDNAVMLHEELGIPVILFDTPYNRKPIPNGVKRVTSWSEAK
KWVDEWANSSVK
>PK3-045_01770 hypothetical protein
MADQNSNEGYGHDFQDRERTESPVDYLEETSAEITPPMTYNATPPMTSTGTRPVTSDAEG
DRGVVGGKGIGITAIVISILSLFVMPIILGIVGIVLGFVARSKGASSLGTWAIALGAISI
IIGIFIAPFF
>PK3-045_01771 IS200/IS605 family transposase ISAac3
MSSDNSLSHTRWNCKYHIVFIPKYRRKVVYGKLRKDIGAILRKLCEMKDVEIMEAHAMPD
HIHMLVKIPPKMSVSYFMGYLKGKSSLMIHDRHANLKYNHGNRTFWAKGYYVSTVGLNEK
TIAKYIREQEAEDRLRDNMSKREYVDPFKDK
>PK3-045_01772 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase (flavodoxin)
MSEIIHRTKTRPIKVGNITIGGSNELFIQSMTTTKTHDVEATVAQIKRLEEAGCQVVRVA
CPDERAANAISEIKKQINIPLVVDIHFDYRLALKAIEGGADKIRINPGNIGKREKVEAVV
KAAKAKGIPIRIGVNAGSLEKKILEKYGYPTADGMVESALHHIKILEDLDFHDIIVSMKA
SDVNLAIEAYEKAAKAFDYPLHLGITESGTLFAGTVKSAAGLGAILSKGIGNTLRISLSA
DPVEEVKVARELLKSFGLSSNAATLISCPTCGRIEIDLISIANEVEDYISTIKAPIKVAV
LGCAVNGPGEAREADIGIAGARGEGLLFRKGKIVRKVPEDTMVEELKKEIDAIAAEYFAK
KAAEEKEMDTISVQP
>PK3-045_01773 hypothetical protein
MKRFFITFVVLVTIYVIYIDLNEGTLSSRKEQEPTIETQGTPQDSASSFEQKVKSGDTVL
SIVEQYSTGGLSVSLETVVNDFQKLNNGLKPEDIQIGKTYLFPIYK
>PK3-045_01774 hypothetical protein
MNKTKDRKKEKEKLSIQNRLFLFILPLFIITILILTFISINSSTKMMIKMMHERLEKEAN
TIYVMAQNTMLMYVGQEEKFQTKMEQIIRDQDASFAQEGLNASFFVLTEKEVKPFKVSQT
SDFTWENSFIQKIHDLESGVLETKWNGKTYTVAFQQIQELKGIYLLVVPQEEYLHNVKQL
KNSLLLFSALSIIIIAMVIRFFVKTMVSPLLKLREIMRIARNGHLNEVTSIKTSIPEINS
LINSYNLLIKRLKLVLSEMQATSAHLSKTNDILHTEAVQMIGSGKSLTEMINTVKNGAEQ
TAISSEHNISVFQEMKALSEQIEKSSQKIKDHTEAMNLAAIHGEENMNNLFASQHMLQDK
VKVIYSNNDLLNNHALSIKKVVEDIKGLAEQTKLLALNATLEATRAGSQGKGFAVVANEV
KKLAVLSSKSAEDIKSFTLDMDLIIQKSSSDLEDIQMNFTKSEGLVQKATVSINQLLQGI
SLVNTGLKENHYLLNELQAFFPKMEHSTLHVTSISQQTLASSDEMKRIGDIQQESIQVNA
EISARLTTLVAALEENIKMEEQTAPKDGSE
>PK3-045_01775 hypothetical protein
MNIFKQFYRSLYSPKDIASFRFQGIGKTIIYLLLLTIIASLPNLYYLNKGINEAIHTFSV
TMEDEVPSFTISDNILHTDNDEEPTIIEKPDLTIIVDSSGTYDHAKVSSYGNTVALLKNE
FVIVTSGQAQTFAYSSFGNFTMTSEELIDFIQGMDSLSYVFIIILVVIYILFMLLYKVLQ
TLVLAMFGSFFARIFGKGLTYAQCWKITVYSITIPVIFFAIMDCLQTVVPNGYLLNWFIS
LFLVCLAIKEIQTEKPLQP
>PK3-045_01776 hypothetical protein
MDIIYWTIISILFIIAFIGLIYPIIPSVIFILAGYLLYGLFFSFEELSILFWIIQGMFVI
LLFFADSVSNWIGVKKFGGSKAGIWGSTIGLLIGPFVIPVVGILLGPFIGAVLAELVVSK
TNWKNALKIGVGSLIGFLSSVVTKGIIQAIMIIYFLFKI
>PK3-045_01777 Anaerobic regulatory protein
MNEVQLSLYSLLIQHFFEIEKIEHIKKGTLLFQEKDPVQKIYILLNGTISLGRVHEKGKE
FVIKILHDEELLVEYQLFKHSPKYYFFAKSMTDCDVLAIDRTEFEQLALKDPVLLTSITS
WLSTGYLKAHMKCQDLIMNGKKGGLYSILIRLCHSFGIKNNEGILIDIPITHQELANLTF
GTREVIQRILKDLREREVIDYSNQKITVKNLAYLKRAVDCQNCPVDICGLN
>PK3-045_01778 Superoxide dismutase [Mn]
MAYSLPQLPYAYDALEPHIDKETMNIHHTKHHNTYVTNLNNALEGNDELLSKTVEELVSN
LDAVPESARTAVRNNGGGHANHSLFWEVISPNGGGQPTGDLAAAIDSKFGSFENFKEEFS
KAATTRFGSGWAWLVVNNGELEVTSTPNQDNPLMEGKTPVLGLDVWEHAYYLNYQNRRPE
YINAFFNVINWDEVAKRFAAAK
>PK3-045_01779 hypothetical protein
MKIGKLIGDVELTKDLKILLLTGGLYSLSVALSNTFVNVFLWKQSGEFRDLGLYNLAIIL
LQLFTFTLAGRWAKKIDRVIVFRIGVAFLTIFYLTVLLIGDKASTFLLVLGAILGIGNGF
YWLAYNVLTFEVTEPDTRDFFNGFLGLLNSVAGMIGPMIAGYIISQLTKSTGYMIVFGMS
LGLFLLAVVSSFFLKRRPAEGKYFFKRIVKERKHNYNWKLITNAHFFQGLREGVFAFIIT
VFVYIATDSELALGKFGLINSGISFIAYYVVSRTVKNKNRNKSILIGGIMLFLSMFIIVF
DFSYTKLLIYAGIIAIAYPLILVPYTSLTFDVIGKGWKAGEMRIEYIVVRELFLNLGRLL
SVILFIIGVSVFNPNKVIPILLFILGSGHSLIYFFARKIRWKTA
>PK3-045_01780 Penicillin-binding protein H
MGSIVGEKKKKKRNPIPLRVNIIFFAVFLLFSALILRLGFVQIVYGDEYKKQVEKKEDIT
ISTSVPRGEIYDRTGKSIVSNVGKNAITYTNWKKYKPNEMRDTAEELAKIIKMDSEKDLK
KISERDKKDYWILIHPKEAKKKISKKENEKLQQQHKDDNKEYQKAYDELLRERITEADLN
TLTDLDMETLAIYREFQSGYYYTPHIVKNEGVTDKEIAIISENLDKLPGVDTVRDWDRKY
DFGSTLKTVLGNVSTSQRGVPAEEKDSYIAKGYSMNDRVGLSYLEKQYEDILKGQKKKVK
FIKDKKDEIVNSEVIANGAAGNDLVLTINMKLQLEVEKIIEEELKKTKYGYAGTQYLDRA
FVVLIDPHTGEVLTMAGKQLGKDEKTGKQVVQDFALGNITTSYNVGSVVKGAMVLTGYKE
GVISPGTQIYDATMQIKGSPPFKSWKPMGRISDLKALQDSSNVYMAQTAIMIGKGHYGYM
QPLNIDLEAYPKIRNSFSEFGLGIRTGIDLPNETAGLRGVVDPNQPANLMFLSIGQYDTY
TNMQLAQYVSTIANGGYRIQPHLVKEIRETSKEEGKLGPIVQEIQPKVLNKLELKPGWME
QIHRGFRLVMTSGTGAKAFAGSSYSPAGKTGTAEAFYDGPLRKNKDGEPPQVMNVSLITY
APSENPEVAMAVMVPWVYTTNNGPSPNLTIGKRVMDKYFELKKEKE
>PK3-045_01781 Penicillin-binding protein H
MGKKKKKKTIPVRLNIIFFFVFLLFSALILRLGFVQIVYGEDYKRELEKTEDVTVNTSVP
RGKMYDATGKVIVDNVAEKAITYTNSGAKQEDMLKTAELLSKYIMKDTKKVTEREKKDYW
IIKNKKEAEKKVTEKEKKALAEKYPDQEEYNKQVYQLQLDRITEEDIKTLTNHDLEVLAI
YREFISGYKLTPQMVKNKEVSDKEFAVVSENLEALPGVGTTTDWERSYSFGDTLKSVLGN
VSSAERGLPAEKLDYYVSRGYSRNDRVGTSYLELQYEDVLKGQKEKIRNKTDKKGNIVST
DVITEGKRGNDLVLSIDMELQLKIEKIIEEELKKAKTFAGTKLLDRAYVVLMNPNTGDVL
SMAGKRLVRNDKTGKMEVQDDALGNITTTYNVGSVVKGATVLTGYKTGAISPGTVWNDTP
VKIGNTTKKSWTTMGPISDLTALQRSSNVYMFRTVMKMAGANYVYGKPLSVSLADFSLVR
NEFAQYGLGIRTGIDLPNEQVGFKGQDTLPGFLLDLSIGQYDTYSNMQLAQYVSTIANGG
NRMEPHIVKEIREPVADDSTLGPVVETVKPKVLNKVDVKPEWIKRVQQGFKMVAQTPKGT
AYSNLGGKDYSPAAKTGTAEAFYDGPSRSEYGKEPPQVMNLSLISYAPSDNPEVAMAVMV
PWAYQGSVDNGSNKKIGERVLDAYFDLKKERQKEEKKDK
>PK3-045_01782 Protein SphX
MKSLKTVGLTAMIGTMLALSACGGNNDASSSKSSDSSKDNGTEQLSGQIKLDGSSTVYPI
MEAIVEEYQAEQPNVKVSVASSGTGGGFKAFIAGETDFSNASRPIKDEEKSELESKGIDY
TELRLAYDGLSVVVNKDNTWVDHLTLDELKKIWLEDGTTKKWSDIREGWPEEEIKYYSPG
TDSGTFDYFDEVILEEQPIAKAATLSEDDNILVQGVTGDKNAIGYFGYAYYAENKDKLKV
VPIDGGNGPVEPTNETVESGEYSPLSRPLFTYVKNESVKKDEVADFVEFMIENAADLSED
VGYVKLPDEEYKKDLELIEGLK
>PK3-045_01783 hypothetical protein
MIKQTTNVNARSVQELIAEKKQKNNLSKLLEKIMPKVLLITAIFSVLTTLGILFTLVMET
FTFFERVNIKEFLTSKSWYPFSDPGSFGIMPLVSGTLKVTLIAGIVAVPIGLASAIFLSE
YASDRTRRIIKPILEVLAGIPTIVYGFFALTFITPLLRSVIPSLEMFNALSPGIVIGIMI
TPMIASLSEDAMSAVPRAMREGALAMGSTKLEVALKVVLPAAVSGIVSSIVLALSRAIGE
TMIVAVAGGSTPNLSFNVTESIQTMTAYIVQVSQGDAGYGTTIYYSIYAVGFTLFLFTFL
MNLLAQYISRRFREEY
>PK3-045_01784 Phosphate transport system permease protein PstA 1
MKLVNHSEVIKRMKPRLMKNIIMKGLFFSATLFGLIVLGVLFYRVLTQGIGYLDFQFLTS
LPSRKPENAGVYTALIGTVWLMAVVAPVSLLIGVGTAIYLEEYASKNRFTNFIQINISNL
AGVPSIVFGLLGLTLFVRALTLGTSVLAAGLTMSLLVLPIIIVAAQEAIRSVPSELREAS
LGMGATKWQTIVRVVMPAAIPGILTGGILALSRAIGETAPLVVLGLPLFLAFLPRTVFDM
FTVLPMQIYNWTGRPQEEFQSLAAAGIIVLLVLLILMNSIAVLIRNKFQKRY
>PK3-045_01785 Phosphate import ATP-binding protein PstB 3
MSTVFADKIKKAVEINATDSRVKNSVYKTNQLNLWYGDNHALKNIDLDIIENEVTSIIGP
SGCGKSTYIKTLNRMIELVPSVKTSGEINYRGRNIFDKDYGVEELRTKVGMVFQKPNPFP
KSIYENVAYGPKIHGIRDKKILNEIVEKSLRGAAIWDEVKDRLNQNAYGLSGGQQQRLCI
ARCLAIEPDVILMDEPTSALDPISTLKVEELVQELKENYSIIIVTHNMQQAARISDKTAF
FLNGEVIEFDVTDKIFSNPKDKRTEDYITGRFG
>PK3-045_01786 Phosphate-specific transport system accessory protein PhoU 
MPVREKFEAGLKELQEKLTELGEFSIQALERSLEALETQNIEMALEIIDDDQKADHLYEE
INDFAILLIAKQAPVAIDLRRIIVGIKIATDIERIADFAVNIAKATIRIGNQELVKPMIH
VKKMLGITNEMLRLSLNAYNKEDTKLARKIAEMDDEVDALNKQAFVELLEISKNKPEYLQ
QISQLTFVCRYLERAADHTTNIAENIFYLVKGRQYDW
>PK3-045_01787 Endolytic murein transglycosylase
MKKHSLRSFAIGMLLSASIIGSFYYYLENKSQEQATISVSEATSYLQTKGFTVLAEDEYN
NLQKQIAEKKQEQAKSAANEKEKTQEEPTEEQQDNIAYTLKVKSGMSISEIAELLYKEKI
VKDQEEFETYLIDNGYHTKIQVGSFPLTSDMSHKKIAETLTK
>PK3-045_01788 hypothetical protein
MLIVMLVIIGISLFLLILSLFLRDPIKDLREEIDQLSIQQVQELYKIKKKLKLLEEELMI
GEEDFSLKPSSTLKKPSAMERDKPQPIHAIIKNQVWTLAASGVPIEQIASQSSLSITQVQ
QIIKERVEK
>PK3-045_01789 hypothetical protein
MIEQIVNLRRKGLSFRKIAIELNSTVGKVQYQWKKYVKEQEQDGNVGQAEEQKKAIQMQK
QESYITESFWTSVDLLAKKNGMEAWLTSEDTALIFWRIPEGKWQLISTYYDIDPETCSLA
VKINDITSIIYNGRNAHNSRILPVENRQESVVLQDLSPNRSFCFEIGVLDVYQSFLPILQ
SNPLHTPRTAHNQTGQLAKDLQEWENGDVSVPNWIEHVSTYSYYELEEQEDVKKK
>PK3-045_01790 D-inositol-3-phosphate glycosyltransferase
MNGSYFQLIVINKIPFMNYFSKDKQKKKELYTQTINFIKFLFETEKNQLPYTIQIVVPPI
FLELLDVQSFREEITEFLEKYCCDDELYSFWIEKEKNLLKVLKSLLQEKRIELLASPASF
SPLSNVSTSTGIQLQIEIGLSIIDDYLDYRPTGFWFPEGNFSPGLDLYLNKENFSYSYLN
SKTINHSDPLPSGTGIAVESPHNIVFFPVEEKLYQLFKGENVTKQIWDKWLLDLLESYPP
YINESILSLSIDLADYVKITDELNKSIRYLNDEGYVVHIMPETYIKQFSQGMDRVHLCAS
FLERRGGEAVVTHSSFYAALAFLERELHEWRQISLPPATNRVQKQLEKEWLLLSALLYQD
NWTSEEVTNHLEAAKKLSGFWIGPIDKDWLSLREREQPILNTTIQNHKTVRSQKEPTNKK
SILILSWEYPPNLVGGLGAHVVGLTNSLIKNGYEVHLVTAQAMNKNPEDVEEKAGLFVYR
VKPIYSKEQNFIHWIGGLNLAMWEKAIEIGKNTTFELVQAHDWLVGAAAISLKNQLNIPL
IATIHATEHGRNGGIYTEMQKFIHRQERQLIDTADSLIVCSEYMQNEIMTIFDVEQTKIN
IIPNGVEMLKKEAVSAAPVDNFSRDNKKVVFAMGRMVKEKGFGTLLEAARKLHKKRNDLC
FVIAGIGPMYDEYQQFIERHQLAESVHLIGYLQEEQKNALYAQADIVVIPSSYEPFGIVA
LESLVFAIPTIVSQTGGLKGIIKDGETGLYMETNNAENLVKNIEYLLENPVVGKEIGKKG
QILVSQLFSWNRIGEETKRVFDELIVQAKVKESISN
>PK3-045_01791 hypothetical protein
MKIEANLQKDYQSVQRKLLVKKITTTPGIWVDGKTYWIQNGYEKLIPEHSISVHVKQIHK
HSKIQYNEIFVRNHSQEPQKMKILVLNYFSKAFHNHLSFVSPTENVIYHSIDDQLYLVNG
EHNSNSMEQRTVQPLWNVHTDHIWSNNQNGVLKYQPMAKGSSVSIFSLNMEVMPQSTGIS
RAWSIMGTEKKDILDMNHILMQTSTSIS
>PK3-045_01792 50S ribosomal protein L33 1
MRVNITLACTECGDRNYISKKNKRNNPDRLELKKYCSREKRTTVHRETK
>PK3-045_01793 putative protein YqgN
MQEKKHFRSEMIKQLQSINKPLYEHMSYQIASRLYNDAAFISASHIGITISKFPEVDTYQ
IIRTAWKLGKKVSVPKCIPATRQMSFRELEQFNQLESVYSNLFEPVIEKTKQTDSKQIDL
LLVPGLAFSPKGYRLGFGGGYYDRFLQNYDGQTISLAFSMQIQQQIPIENHDLAVQKIIT
NEGIICANE
>PK3-045_01794 hypothetical protein
MYAVVILFVSYLAYKRRSLTKSGAIAAFFVGSGIALGFGSKGLVVLGVFFVSSSMFSKYK
SKTKQTMEDKTKKGSRRDAWQVMANGGFAAIVGIIYFFTKESVWIIVFAILLAAANSDTW
ASEIGSLSKKKPISVRTFKQAATGTSGAVSVLGTIAAFAGSLLIALTANFLFALEPGSFV
VILVFGFLGNIVDTLLGAFVQVEYKCPVCGRIVESKVECHTTLVKTKGFALFNNDMVNVL
SGFLAALVYVFFF
>PK3-045_01795 hypothetical protein
MSKVFSVLLIVLGGYYLFQKRYRVINTVLRSPFIRKYAVRILMNIPSVKRMTMNSVFGRS
QNTIYQ
>PK3-045_01796 hypothetical protein
MYVTITDFIREWKWEAELTQKVLEGLTDESLQQKVYPEGRTLGRIVWHFTTNIPEYLAHF
GLKINELDNAKIIPATAKEIAATFKLLSSTAIKVIEEQWTDESLKDVQTAFGREETNAQI
LMGLIKHIVHHRGQVTILMRQAGIKPFGVYGPSKEDWIRIGVDNPPL
>PK3-045_01797 Rhomboid protease GluP
MELEHYKYWRIIHILVNEYQYKIIYLTEDQQEIWLEAQENKSKSPVIRLFQFDINWSNWL
SRDIERTALNAERIRSSLHSRSLKVVSIYISAYPPVDSYEHIINPVFLSPNKKVQIESIL
LDRSVQDWKIGEHKIAELQRMPETEAERETHIQEYKEAIFTSLRQKEKEERQLFNFGKPF
ITYLFIAIQVIVFFLMELSGGSTNSETLIKWGAKVNYLIANGEWWRFITPVFLHIGILHL
LMNSIALYYVGPLIERIFGSCRFLFIYLFAGFSGVFASYLLSPSLSAGASGAIFGCFGAL
LYFAWRFPQLFFRVMGWNVIIVIIINLIFGFTIQGIDNAGHIGGLLGGFLATAIVHFPKK
KNWKIQLGAAFVTILLLGIGVLYTFHQDVLQRQDQSAYKLVHEYIQDEKLQQAELALEKL
EPKDNEVYYFLLSYIQLKKRNLHDAEKNLQKTIAINPEFHEAYYNLAVVSLYNKKLEEAR
EYIQAALALDKNNPEYLLLWDKIKE
>PK3-045_01798 hypothetical protein
MKKDFIRLSLSLIILISIFYIFQQKQIAKESITYFPIDPTVTFPKANTTLTFSKKRFDEY
SILWESHSSINKVAYLRQDMSFLYANGKLINKMGEWKQNTLELSEKKTIVERESNFLQTI
TFHYAEIHDNSERIFSSQKTSADSLYIINSKFENAPLNFHTPSNLTEKDWAKALEKETLN
YVEYAYLQALKKFHISPEQYQTKLLLTDLINYNDAPLPNFSKEQSAKIIGQLTEGLYKNY
FLGVIKEDGTIADPIGSSIPVLLINDNHLLILFTTADGEAIVLRQQISTL
>PK3-045_01799 putative protein YqgQ
MQTIYDVQQFLKKYGTIIYVGDRVGDLQLMKSEIKELYQSQLIKEQEFDSAMRLLNQEIQ
YLEDKRNRGNV
>PK3-045_01800 Glucokinase
MQEKWVAGIDLGGTTVKIAFLSLNGDLIDHWEIPTDNSEEGKNITSDIAKSIDAKLKELG
HSKDDVLGAGMGAPGPFDYETGIIFNTVNLGWPDNFPLKARLEADLGLPVTIDNDANCAA
LGEMWKGAGEGAKDLVCVTLGTGVGGGVIINGDIVQGVKGAAGEIGHLTAIVENGAPCNC
GKTGCLETIASATGIVRLTKERLAERHTLSELHSLLDQEGAITAKDVFDAAKKGDELANE
IVQFVAFHLGLVLANIANTLNPEKIVIGGGVSKAGDVLLDPVKENFMKFSFKSVAESTVI
DVATLGNTAGVIGAAWLAKN
>PK3-045_01801 Lipoteichoic acid synthase 1
MFKNKLEWSKLSLITIATVLLWIKTNIAYITSFDIKIENWIQQFILIINPLSSILFILGI
SMFFSEKNQKRYIFISSLILSFVLYANVVFYRVYTDFLTLPLLFQTSNMSDLGSSIRELI
HVTDILFFVDIILLVVIMKKKPAFVKIPQYTRVHKSIFYLLTISLAFFNLSLAETQRTQL
LTRTFDRELLVKNIGTYNYQLYDIFLQTKTSAQRAFADGSELTDMVNYNQANYIEPNKDM
FGIAKGKNVIMISLESTQSFTINREVNGEEISPFLNDFIKESFYFENFYHQTGQGKTSDS
EFIVENSMYPLSRGAVFFTHSGNEYQAAPEILNENGYYTASLHANNKSFWNRDIMYQSIG
YQRFYEINDYDVKEENSVGWGLKDIDFFEQSIAHLKEMPQPFYSKFITLTNHFPFELDEE
DKFIEPLTTGSRTLNNYIPTVRYQDEALKIFIEKLKEEGLYDNSIIVLYGDHNGISENHN
KAMSELLGEEVTPFVSTQLQRVPFVIHIPGMEGKTLSTVSGQVDIKPTLLHLLGIETKND
IQFGSDLFSDNNDPFVVLRDGSFITDDYVYTKEVCYDRATGEAVDGDRCEPYIEQANLEL
QYSDSIIYGDLLRFYDKEKGMLDIVEEANKKE
>PK3-045_01802 Gamma-D-glutamyl-L-diamino acid endopeptidase 1
MEIKLRPGDTLWYYSQLFMVPLNLILDSNPHVNPNKLAASETIQIPGFELQVHQIKSGET
LWKLAGVRNISVDSILLLNQHLNPNNLQVGDEIYIPNRIIGRIVQGKKKYDYQSLQVDLT
RLKKLFPFIQVKTIGKSVLGHNIEEIRIGKGTKKVHINASFHANEWITTPILMVFLNDFL
LSLTNGTNIHCVHTMPLYQSIDLSIVPMVNPDGVNLVLNGPPEEEKEKLISINEGSTDFT
SWKANIRGVDLNNQFPANWEIEKERKEPKAPAPRDYPGDAPLSEPEAQVMAKLAYKENFD
CLLALHTQGKEFYWGYEGLEPAESQTIANEFFRVSGYKAIQNVDSHAGYKDWFIQEFRKP
GFTLELGKGINPLPLSQFTEIYHDTSTIFLASLYL
>PK3-045_01803 hypothetical protein
MFPLGKRNTLGIVLLFTFFTLILSGCVPRQNNSASENEAKNKNIHNNTMLPPISPIEGDF
EQVYGWIKNDTICYSAKVEGVNKIYTYNIYTGKHSPLYKSVTELSNVIINKNQLLIYNAL
SDEEGEIHIIDMKGNEVLTRKLQSYETDFVWNPYNENELLITTFTKDWESKVSVLDIQEN
ELSDFPVSTPFPQWQSKEKVMYLDWDQSSPSFYAPLKLFNMETKEEKEWDVPDIYFIEEK
NGYLLTLSGSSKEEEAIYTFYDSELKEQGSVRLPRLSKFSNWLIPNYTFYENKFLTFVPK
NSGNAETYQDGFDLVEINMETGESQKVDTEMELEDQPIQISSDGKYILFGYYYENMLDMK
TGEISSLFSTTIHNS
>PK3-045_01804 hypothetical protein
MAIVDVTVIPVGTQTPSVSAYVADIQKVLMHYEEKGQIRFQLTPMNTIIEGELPVLFEVI
QAMHEVPFEKGLVRVCTNIRIDDRRDISRKMEDKVERVVSQLESK
>PK3-045_01805 Hydroxyacylglutathione hydrolase GloC
MEYKQIPLGPIQTNCYLIWNENKDCLVIDPGANGEKLIKIIQELGLSPIAILLTHAHFDH
IGAVEDVRTEYSVPVYVHIKEEEWLINPKLNGSEAFRLPNPIVTRPAEHFLDENPSMTIG
DFTFQVMETPGHSPGSVTFYFKKENWAFVGDALFYESIGRTDLVGGNQRTLLTSIHEKLL
NLPEDTLVLSGHGRKTTIEHEMDHNPYINGF
>PK3-045_01806 hypothetical protein
MENTLKVTNVLSDPTRFYIYQYITKRHQDVTVQEIADEFSIHPNVARLHLSKLEDVRMLR
SETKKTGKGGRPSRLYRLSDEVIQFSFPFRDYQLLSSILLKTFESLGADGSKALYETGKT
FGKEMMEQEIARITNNTALLSNEDKLRLLQNASLMTGQLPALEWNDDQTSLYFEIYNCPF
KEVAIEHKNKVCTMHQSFFTGMFEALFKDVQLIEKQNIISGCDQCAYKTMVQ
>PK3-045_01807 putative oxidoreductase CzcO
MDYDVIIIGGGQAGLAMGYFLKKSGLSFLIVEKETSIGESWRKRYDTLTLFTPRFYSSLP
GLPLNGDLDGYPTKEEIADYLFDYATTFSLPV
>PK3-045_01808 putative oxidoreductase CzcO
MIIATGSFQKPLIPSFASTLSKNVVQLHTSQYHNPKQIKEGPVLIVGAGNSGAQVAAELS
DKYLVYLSVGHKIRFLPQNIGNKSIFWWFEKMRIYKASTNSKIGQWLRKKPDPLFGFDLR
AKIKSGAITVFPRTERIVDDTFEFLDKRTLKVNTVIWATGFYHDYSWSTIPQVVNVKGDP
IHKKGITNIAGLYFLGLPWQRNRASSLLQGVGDDAAYIYQHVRRNME
>PK3-045_01809 Cadmium, cobalt and zinc/H(+)-K(+) antiporter
MGHSHGHDHSHHGHHHGFSEIREGNKKGLLIALIITAGIMMLEFFGGLLTNSLALLSDSG
HMLSDASSLFLSFLAIWFATRPASSNKTYGYYRFEILAALFNGVTLFVIAFFIILEAIER
FSQPPTVSSGTMMIIAVIGLLANMISALALMRKGDVEGNINLRSAYLHILGDALGSVGAI
IAGCLMLFFKWYIADPIISVVVALLILKSGWGVIKTSIHILMEGTPTTINQEEVKKELEG
IAGVIDVHDLHIWTITSGLDSLSCHLLIDDKSDSQVILQNAIDRLKTKFKMEHTTIQIEK
SQIQHEDMNV
>PK3-045_01811 ComG operon protein 1
MLSIEALANRIICEAVEQNATDIHITPKQKESVLQFRIANHLINHLVISANECDKLISHF
KFTASMDIGERRKPQNGSISTTVKGQYIGLRLSTLPSHPHESLVIRILSDQNMLPIYHIS
LFPNISRKLISLLKHAHGLIILTGPTGSGKTTTLYSLLNENAHLYQRNVISLEDPIEKTQ
ENVLQIQVNEKAGITYSTGLKAILRHDPDIIMVGEIRDKETAHIAIRASLTGHLVLSTMH
TRDAKGAIHRLLEFGIKETEIEQTLIAITAQRLVEMVCPFCDKDCSPNCYRLDNRLKRST
VFEMITGRMISDILYNRTETKRANYKSLGDIICKGIALGYIKKGEYERWIYDEK
>PK3-045_01812 hypothetical protein
MKNNHAWSNIEQAKFLKCIGELLDRGYSMAEAVQSSRYYMPDRRMEDINACYGSLKGGES
FFENLVRFNFDYQVISFVYFAEKHGGFASAFQDASRMIQNKQDTIRKLRKILTYPLFLLC
FTFVLFFFVQSILIPKFNSIFLTMNINKNFFLLFLQFIGHIIPFLLVFLSLCFISALLYY
YFSFRKLDVIKQINALASIPMIGIFVRRYFSYLLSVQLSYLLSSGFSIYECMQFFLENKE
QKLYSQIGEITISQLKKGVRLEQAFASFDFLEKELLQIIQHGQENGKLDQEFYYFGNYCL
TQIEENLQKTLKVLQPTLYTAVGILIISIYLSVLMPMFQLLDGF
>PK3-045_01813 ComG operon protein 3
MKNEQGFTLIEMMIVLVVISILLIITIPNITKHNSKINNTGCEALTKMVQAEVQSYYIEH
KAYPENLAKLEEENYITADQKKCPNGKALIIKNGVITTSGSDSP
>PK3-045_01814 hypothetical protein
MEMFVAMSLLVVLSSLSIFLVTSQQTSLNETHFLTQLEGDLYYAQAYALENQMPIQVRIY
PTLHYYYMRADANTGNIVERYYADDIIFSTNATLSFNINSNGNFSKFGTYEFRIGKQPYK
LTVLIGKGRFYATKL
>PK3-045_01815 hypothetical protein
MRLNCKGFMLPDYLLSFTIWLLIALTWMPVYVHVLKQLEDSEHSKLVNELFYNHLIELKL
GEVERGNTTIENEGTSYSIVWEKDSIVCLQYKNVFQKNKKICEVWKE
>PK3-045_01816 hypothetical protein
MIKRILLNNKGYVLAEMLLSFFIFTIILTLLLTPLRLMLDKHFSEKELQEMEWEVFILEL
KKETKMSQGISVSNNKLVLYVDGRVVTYEKYGSSIRRRVDSTGHEVALQAINKVEFIMQK
NGFRVKVVDRFGREKESSIRSYLTFLE
>PK3-045_01817 hypothetical protein
MIKNNKGFIYPLSLCVYILFIHFLFILYGIYVNKKGIDAGVKNSNIQEYYFLSSLKEIEH
ELSTNEHPDLSGTKNFSHGNVFYTMEKNSRTTVKIDYQLKMQGAIKPIYAISYFDIEQNK
MTKWVE
>PK3-045_01818 hypothetical protein
MNTNDYVKYLTQTFVQYMDQPKEERKKLKAERKGLKEPFMLRWFGILPYLILFSFKRRKL
KK
>PK3-045_01819 hypothetical protein
MKQQEIHQFLERFFVANDCEIVENKPGYLLVQLTIEMDKELMNRPFYWHYLEKTGGVPNP
ASLTLITDPKLAPEDLKGELIHFGSPRLHQLFASAKNLSKYIRLYENKITHGKQQTALQP
WLALNVKISYQCDRKRDVFQSIGLQLINGQIATDFQAKVEKMNLSAKIPDYAFTLSPLIM
PISGITRIENMIKQSLLAEDHTWADEAKKRWKKDLDLLEHFYEDMEGMEEGQETLETERL
ALQEQYEPKINISIINGGLFYLASEAVS
>PK3-045_01820 RNA polymerase-associated protein RapA
MTLQINFDDSWNNQLLKRISDDGPWANWELYKLAVEVEQHNIIPEFEGLQAPKYLSDLSP
LPHQLEVAKKVIEDMNGKAILADEVGLGKTIEAGLILKEYMIRGLVKKVLILVPASLVTQ
WAYELNSKFYIPAMVQRKSYVWEQCDIVVSSIDTAKRQPHRDIINNLDYDLVIIDEAHKL
KNNKTKNYEFVQNLKKKFCLLLTATPIQNRISEIFNLVSLLKPGHLGSESSFYEKYKKDA
RSIDDDENLKALVNKVMIRNRRHDTGIEWTKRIVEAVPIEFTKEERALYEGLVDLKTETN
LSSNIENSRSPFSMITLQREACSSREAVYYTLQNMVRKVENPTPQFQQRIQELIKKVEAV
QQNSKANKALELIKKINDKVIIFTEYRATQLYLQWFLKQHGITSVPFRGGFKRGKKDWMR
DLFQNHAQVLIATEAGGEGINLQFCHHIINFDLPWNPMRLEQRIGRIHRLGQKEDVKIYN
FAVKDTVEDHILKLLYEKIHLFEKVIGELDDILTKLDFGNMDDYMIDIFSHSKSEGEMKI
KMDNLTSMIEFAQSMKEDQPYEAAGNSSIS
>PK3-045_01822 Aminomethyltransferase
MTLLKQTPLYEVYKQYGGKTIDFGGWDLPVQFSGIKQEHEAVRTKAGLFDVSHMGEIEVK
GNDSLAFLQKMLTNDIEKIKNGAAQYSAMCYENGGTVDDLLTYKLADNHYLLVVNASNIE
KDFEWLQKHASGDVILSNLSEDFAQLALQGPLAEEVLRKITPSIDYASIKYFHFQNKVNI
AGKEVLLSRTGYTGEDGFEIYCQSEDAIDLWREILTTGEPLGVLPCGLGARDTLRFEATL
ALYGQELSADISPLEAGIGFAVKVNKEADFIGKAALTKQKEEGLIRKLAGIEMVDRGIPR
HGYKVYANGLCIGEVTTGTQSPTLKKNIGLALIQSDYTAIDTEVEVEIRGKYLKAKVTKI
PFYKRK
>PK3-045_01823 putative glycine dehydrogenase (decarboxylating) subunit 1
MKHRYLPMTEQDQKEMLAAIGVSSVEDLFSDIPEKVRFQGNYSIKRAKSESALLKELTKL
AQKNADAKANVSFLGAGVYDHYSPVIVDHVLSRSEFYTAYTPYQPEISQGELQAIFEFQT
MICELTGMDVANSSMYDGATALAEAGMLSAGTTKRKKILLSSAVHPEAKEVVKTYAKGQY
IEVQEIPHKDGITDIEALEDMVDDTVAAVMIQYPNFFGRVEPLKDLEAIIHAHKSLFVVS
SNPLALGALTPPGNFQADIVVGDAQPFGIPMGFGGPHCGYFAVTSKLMRKVPGRLVGQTV
DDNGQRGFVLTLQAREQHIRRDKATSNICSNQALNALAASVAMTALGKHGVKEMAIANIQ
KAHYAKTKLKEAGFEIVYEGPSFNEFIIKCNSSISAVNRALLEKGMIGGYDLGRDFKQLE
NHMLIAVTELRTKEEIDEFVAEMEDYHV
>PK3-045_01824 putative glycine dehydrogenase (decarboxylating) subunit 2
MSNKNQPLIFESSTPGRIGYSLPEMDIPAADLTELLPNDYIREENPELPEVSELDIMRHY
TALSKRNHGLDSGFYPLGSCTMKYNPKINENVARFNGFAHIHPLQEVSAVQGALELMYDL
QQHLVEITGMDEVTLQPAAGAHGEWTGLMLIRAYHEANGDMHRTKVIVPDSAHGTNPASA
TVAGLETITVKSNEHGLVDLEDLKRVVGEDTAALMLTNPNTLGLFEENILEMAEIVHNAG
GKLYYDGANLNAVLSKARPGDMGFDVVHLNLHKTFTGPHGGGGPGSGPVGVKADLIPFLP
KPVLTKVGEEFVLDYNRPQSIGRVKPFYGNFGINVRAYTYIRSMGPDGLKAVTENAVLNA
NYMMRRLAEYYDLPFDRHCKHEFVLSGRRQKKLGVRTLDIAKRLLDFGYHPPTIYFPLNV
EECIMIEPTETESKETLDSFIDAMIQIAKEAEETPEIVQEAPHTTVIGRLDETLAARKPV
LRYTK
>PK3-045_01825 Thiosulfate sulfurtransferase GlpE
MTMIYTLLIILVAFLVYSLVMWLYQRRIVKTVNQDEFRQGYRKAQLIDVREPNEYEAGHV
LGARNIPLSQLKMRKSEIRPDKPVYLYCQNGMRSGRAAQFLYRKGYKDLTQLEGGFKKWT
GKIKAKK
>PK3-045_01826 Octanoyltransferase LipM
MVKETWRFIDSGNHSPSFNMALDEALLEWHSKGVFPPVIRFYGWNPATLSIGYFQKVEKE
IDLDAVKELGLGFVRRPTGGRGVLHEHELTYSVIVSEEHPNMPKTVTEAYRVISEGILKG
FHFLDLDAYFAVPKTEEQRNNLKSPRSAVCFDAPSWYELVVEGRKVAGSAQTRQQGVILQ
HGSILLDLDEDKLFRLFKYPNERVKERMQKAFKSKAVAINELTTRNITIEMAKEAFKKGF
EEGLQIQLENYQLTDEEVEYVEKIAKEKYENDEWNFRR
>PK3-045_01827 hypothetical protein
MSVLLSQGIKLNVEKLNKDIALFPEVHPITPDMKLTYKGVSRLVMLDRYTYKDTEKITLT
AGDFVVLTIKEDPKFPARGLGFIQEIDHVLNTATVLVEEDYRGVLEGKEAETGVVIRSLE
VIEKPLELYYEQIAKRNATGLASVEKTEEKRKEWFEKFYHELVNLNFIPAGRVLYGAGAG
TDVTYFNCYVMPFVPDSREGISEHRKQVMEIMSRGGGVGTNGSTLRPRNTLAKGVNGKSS
GSVSWLDDIAKLTHLVEQGGSRRGAQMIMLADWHPDIIEFIISKMQNPRILRFLIDNTQD
QTIKKYAQDKLKFTPLTEKERAMYRGILNYKNIPGQGGFNEEIFRDAEEKLSIGGTYSVH
QTEFLTGANISVCLTNEFMEAVEKDEEYALRFPDVESYDEEQMQHYNEEWHKVGDVREWE
AKGNRVRIYRKMKAKELWNLINICATYSAEPGIFYIDNANEMTNATSYGQKVVATNPCGE
QPLAPYSVCNLAAVNLAEMADKENKTVNFEKLKKTVEVGVRLQDNVIDATPYFLEENKNQ
ALGERRVGLGVMGLHDLLIYCETEYGSEEGNVLVDRVFETIATTAYRTSIDLAKEKGSFP
FLQAETEEEEAGLRNAFIHTGYMKKMPEDIRDNILQYGIRNSHLLTVAPTGSTGTMVGVS
TGLEPYFSFSYFRSGRLGKFIEVKADIVQEYLDAHPEADSDNLPNWFVAAMDLAPEAHAD
VQCIIQRWIDSSISKTVNAPKGYSVEQVQKVYERLYRGGAKGGTVYVDGSRDSQVLTLKA
EENTFEDILLQKQEKTHVVLVDTINELQSTNVTIGSEIGDTCPVCRQGVVEEIGGCNTCT
NCNTQLKCGL
>PK3-045_01828 Transcriptional regulatory protein WalR
MKTISILIADDEEEIADLVAIHLEKEGYNCVKVLNGQDAILAIQTRSIDLVILDIMMPIM
DGYDVTRLIREKYNMPIIFLSAKTSDFDKVHGLVIGADDYMTKPFTPIELVARVNAQLRR
FMKLNNPIASTNKTILEFGEIVISLEQRTVLLQGETIELTPKEFDILHLLASHPKKVYSV
ENIFQKVWGDAYFEGANTVMVHIRTLRKKLGEDKRKNKIIKTVWGVGYAFNG
>PK3-045_01829 Adaptive-response sensory-kinase SasA
MLSMAKFMRSFRARITALFAASMFLTGIITYFIYKVLQLYYHTMVQYGDSLVLLRQFIKS
IGDFAFFFILFFCLSLLFFYILTKPYSNYFKDISNGIHYLSHGNFKHKVIINSNDEFGDI
GQAINLASEKLEDAIQRGDFSESSKEQLVVNLAHDLRTPLTSILGYLDLILKDEKLTKEQ
RRHFLTIAYTKSQRLERLIDELFEITRMNYGMLPIDKKEINISDLLLQLKEELYPVFEKN
DLIARINILPRLLIWGDGELLARVFENLLTNAIRYGYDGRYVDINGFVEENVVVVQIVNY
GDSIPAEEHPFLFDMFYTGDKARTQQENSTGLGLFIAKNIVEQHNGTIKAESNLIRTVFE
VRLPQENAPIEIL
>PK3-045_01830 D-alanyl-D-alanine carboxypeptidase
MKKWGCLLLLLIGVFFFFVYKESPLSDKIVIQKNSGYLDNRANDEGLRKIKISREMVFQG
NLLLINKEFPVHQESIKSDVVELFRHKEWTQGFVLFDNKIKLSKEVLHKFSEMIAAAKKE
GVNHFLISSGFRDFEEQNVLYHDMGADYALPAGYSEHNLGLSLDVGSTQMKMEAAPEGKW
LENNAWRYGFILRYPKDKTEVTGIQYEPWHIRYVGLPHSAIMAEKDLVLEEYLAYLKEER
NISITLNEKKYDVSYYPLAKTTDIHVPDNLHYELSGNNIDGVIVTVFNGETNPSQMDR
>PK3-045_01831 hypothetical protein
MDIKDVPNWILTLEIEDLEFIKKFILTSGSLKEIAKIYEVSYPTVRLKLDRLIDKIKMND
VLENEEFIKFIKGLSIDDRISVEDAKLIIEKYKKERNEK
>PK3-045_01832 hypothetical protein
MDIDFYGVFITAGILAVQFFFSTRNSIYWGAVLPLLYIGFVTWMLATDRIESFIAYILIL
LLGSLFLLAEWSGGRKYLHEKRRKELDKMKSHDMK
>PK3-045_01833 hypothetical protein
MQNQYIYTNDLRRIRPGFGRPGFGRPGFGFGRPGFGRPGFGFGLGLLGGFATGALLSPAF
VGGWGYPPFGFGFGVPPFGFY
>PK3-045_01834 hypothetical protein
MYIDGVFSGGGIKGLALVGAYEVVEQRGFQFARLAGTSAGSIIAALIAAGYTSREIAKLL
EELDLNSFLDERKLFIPFPLAKWFFLYWKLGLYKGEELEKWIEEKLAAKGLRTFADIPHQ
TLRFVASDITNGVLMILPDDLPKYGINPQTFSIAKAIRMSCSLPYFFEPVIIGNKANKNV
VVDGGVLSNFPMWLFDQENVLKTRPVLGIKLSHNITEHPKHKITNAIDLFAAMFETMKDA
HDSRYISRKHEKNIIFVPTEGVLATEFALTKEDQAKLIQLGRDCAMKFFKSWAY
>PK3-045_01835 hypothetical protein
MKNRFSLILFGSIIFLAFIGLTVNLIKNPSGFFLNIVVMVAVGGIIWFIYRHLSTSSPQK
REQKAFLKAAKQSKKRLQTKDRSSSGQQQSTKTSSIKANKHKRSKSTAHLTVIEGKKSKK
KNRASL
>PK3-045_01836 hypothetical protein
MSSEQKPLYGGQAVVEGVMFGGKHHYVTAIRRKDQSVDYFHLPRTYNEKLTRLKKIPFLR
GLIAIIESSGNGTKHLNFSTDRFDLDPSEDYKLEEQEPSKLSMILGVAVLGVLSFLFGKF
IFTLIPTFLAALFMPIISGHVAQILLESLFKLILLLGYIYFVSLTPIIKRVFQYHGAEHK
VINAYENGKDLTVQNVQAASRLHYRCGSSFILFTVIVGLFLYLFFYPENLLERVLIRIAL
IPVVIGISFEVLQITNKLRDVPVLKYLGLPGLWLQLLTTKEPSDDQVEVAILSFNELKRR
EEETEAQLSTTND
>PK3-045_01837 hypothetical protein
MGNQQDSHEKERPMSFISLVIWTGMFGGIFWTFIGYIGYIFNFTELRPNFILEPWAIGSW
KYGWLGTIISFIAIGFFSTGAAFAYYLILKKFKTIYIGMGYGIALFVCVFVILNPLFPSM
APFLELKRDTIISSVCLYVLYGVFVGTSISYEESEIQLKKYKDKKAVTNMTGNEGD
>PK3-045_01838 Aminopeptidase YpdF
MEKLKRIREALTEVGAEGILITSTYNRRYVSNFTGSAGAVLISGEKALFITDFRYVEQAG
NQCIGFEIVQHKGAILQEVATQAEKLGIKKLAFEQDYTTFTQYKELETVVKGELVPVSGI
IEKLRLIKTNEEIKILKEAAKIADAAFTHILDFIKVGKTELEVSNELEFFMRKLGATSSS
FDTIVASGKRSALPHGVASDKVIEAGDFITLDYGAYYNGYVSDITRTIAVGNPDEKLKEI
YDIVLKAQLKGMEGIKPGMTGVEADALTRDYITEKGYGEYFGHTTGHGIGLEVHEGPNLS
FRNSAPLEPGMVVTVEPGIYIPGLGGVRIEDDTIITEDHNEALTHSTKELIIL
>PK3-045_01839 Elongation factor P
MISVNDFKTGLTIEVDGGIWRVLDFQHVKPGKGAAFVRSKLKNLRTGAVQEKTFRAGEKV
AKAQIDNRKMQYLYANGDQHVFMDVESYDQIELPEAVIEYELKFLKENMEVHIMMYQSET
LGVELPNTVELEVTETEPGIKGDTASGGTKPAVMETGLTVQVPFFVNQGDRLIINTSEAS
YVSRA
>PK3-045_01841 hypothetical protein
MMTKLINRTIADRWEDGLLIGNGKIGLALYGNPQITYLDFTVQDLFLKGNQMQKLPYLAP
YLEELRSIIDMQGYREGIRYFYERAQEQGYKGLTMSDPFIPAARFLIEIKQASIENYQRI
TDFQNGMIQVTYDSSIGGKVEETLFASKKENCIFGKIKSEKPLTGSIIPVNWKEIKMEEK
ITVAANGKLKWEHRYQDQTGYDVIWSIDSTDGRIISKRDSLMFHDSTTIYFTIQCVEKNR
EERQVRCYEKAVIEHKKSFSKKFNAVKLLLTDEQGTIYLEEVLSEMRTRKQITPVFMQLF
YQASRYIIQSMANGIPTLQGIWSGTLHPAWSGDYTFDTNVQLAISSLASSGYFAEYRSFF
ERLKKYYPDFRENAQSYYGCHGFLVPAHASTTAKHVHWNEEWPLIFWISGAGWLAYFYHE
YWHYTKDAAFLKHECIPFYEEVLAFYLDFAQCKEGKLRLSPSYSAENGMGDNTTMDIAIV
KSVLKYYIEAKTCLGEEVAKIYKQFYKQIPPYRLLEDGGIAEWLDPRTVENDNHRHFSNL
YPLFQTKEINQDTPELWESAKIAFRKRMDSWLNNIEGDTTSSHGRIHAAMCAISLEQTKE
VTESLEALVLENAFMDSLATAHYRDKNIFNVDANGSLPKVIHDCLIYSEHEDSVTILKTV
PYFLSRGKATGICLPDNFYVQALEWDIEKGDVSITLEQKENRFPNLNLGNQYHVKKETTH
LKQLNKNMWQYTWTCTFDTWEKR
>PK3-045_01842 hypothetical protein
MRSKFIPIKRRLMLMFLSVVIPIFIVGIYLTINIRQDMIKSRERDILVETERVRKGLEDN
FTSIIQISDWIYQDEGLEELVTKRYANPKEMIEGYNEFTLFDYFLRYHSNLANIRFFVNN
KSFMTNSNFVFADEQIKEMNWYEMALEGKGKIYWCNLVDPVTEKPFLALVRSVYNLENQF
LGILAIYVDELSLMDILNSATIDNALLLDKELTNFQYTNHTPKNYLTKQLQNKMKNHPIN
VGETYSIEMKETKPFIFYGQMLDLPKSITNHFQVVTVMNNQEILNEVNKIMIKSYTIISL
VMLLVLFVIKRYTSSMDRRILQLKVSMHKVANGDFDIPITIDGNDEIRDIYIQLYTTMES
LRDLLHKNYQHQLQEKSWQLQQKESEFKLLASQINPHFLYNTLEMIRMRALKNKDKEVSE
SVKILSKLLRRSLENNQQKYVKLSEEIDFLLLYLRIQQLRFGNRIRYEITSDVNTAQYNI
LPLILQPIVENAFVHGIEEKVESGLILINIVQMEEAIHIFIQDDGKGISKEKLIEIQQIL
HKEKIGNRIGLNNVNERIKRMYGKKYGLTITSTEGKGTIVKVTIPIKA
>PK3-045_01843 Regulator of RpoS
MKKVLIVDDEPVIREGLPYIIDWQEYGFEIVGAAQNGKEGIKLINEYQPDLVITDIRMPE
MDGLEMIQTAQKRGETFYSIILSGYSEFTYAQKAIRLGTVSYLLKPIDEDELTDILLGIR
KEVDKQKGTNNDIYNLLRKNIFEGDFKPCTLEYRLACLIRFPNQSIAREFQTRIRENKNV
LCYLFTHDDYTYALTLILDDFDLDTVEKELLSIASQEGEVILQSSWQNKSSHLKQLYKEI
RKLKDITFSYANLGVISNERIKSLQAKTHFTGNIPEQLLKDILYDGDLANSLFKYKENFR
YHPLHENEIKWNVSKELQSVVNNVIDTINPTDRERLQEVANTAERSIARSRTMEQLMKEM
ENSYRVLQQIVNESFNRINTIQEIERYTQKHYKEDLNLKIISEHFNYNNAYIGKKFKKET
GKSYSQYLDEIRMGKAKQLLKDSNLMIYEIAERTGYANLDYFYKKFKRHCGMSPNEYRKL
QGNG
>PK3-045_01844 hypothetical protein
MNTENYKAMGEAMNSRQLYHILNYISTFFLLNLCFVFSNILFFTALLLFPFSLENIMLFY
ISLLPMGASLTALFSTNGRLLREGGITPVRDFFMDYKTNFKLSFIYWFIQLTILFILFID
FFYMLQKNNLILACVVAILLAIVFITISIGLSVLSRFESNMKTLLKAGPFILLRFPGKAF
LHLSTSVILIVFFYYVPAVSFLFAFSLFGFILMYYTNPVLYQLEKELKK
>PK3-045_01845 hypothetical protein
MKTSPKNYLYIFILFVMCLLVSCNQESEHASPKQSSINLKNIEQASELHIKQQDSSIKLS
KEGSDWTVKEQTFQDDMANQFVLAFSNMRGDKVKEQNEMDLLFEVAADQSQMKLYKKKNQ
YYLVRQNQTYQLYNVPNLVKYYSPVIFSEKKAFPLEADQIKKIEFRGERDHYSLSKQTDY
SSVEKAPFISGWFLHDYYSHDYSVEYKKMDEILSTLTHLKVSDPSNEIDQSKLINWKEII
IQEEGKEYTLKLLKDENNQYYATVNKEKNLFVVPKGQIENLVNRPFSIIDKFLCLIMADA
LNKWTIEGKQSEQITAIHRLNSTSDKIISTFQLNNSNIDEADFRNLYQYIAVLSANKEYK
GEALEKKPYLKMAYEFASDGREHSRKLEFYPLKTNNNMFAIKENGNIDFVIKKDQLVTML
KQVNEFD
>PK3-045_01846 putative multiple-sugar transport system permease YteP
MEIAPLVKQEKKPQKEKKITWKKLKDQKVLIIMALPLVIWLIIFCYLPLFGWIMAFQDYK
PALGVLESPWVGLKHFKALFEDELFYRALINTLGMGGLGIVFGTASSIALALLLNELRFT
RFKKFTQTVSYLPHFVSWVIVANIVTTMLSTNGALNELLLSLHIIDTPIQFMSDPNKFWY
IVTFSDVWKEMGWNAIIYLAAMVSIDKEMYEAAWVDGASRFKQMIHITLPSIKPIILILL
ILSIGNLINIGFEKQMLLGNNIVADKALVLDKYALDYGIGMFRYSYGTAIGIFKSVVSII
LIFIFNNIAKKSGNGGLM
>PK3-045_01847 L-arabinose transport system permease protein AraQ
MTNLFRKKKSINRPTGFDLVIGAIMIIIIIATLYPFLNVLAISLNDSVDTAKGGLRILPR
EFTFANYIEIFSNNDQLLLAFTNSVLRTVIGTIAGVLCTCVMAYVISRKDFIFRKHLTTL
LIVTMYVSGGLIPGYILIRNLGLINSFAVYIIPALLSAFNVIVIRSFIDSLPDALEESAK
IDGANDFVIFYKIIMPLCIPAIATIALFIAVGQWNSWFDTYLYARGNVNLTTLQYELMKI
LDNASAQSTGNVSNSAMEQLNAGKTTPESIKMAITIIATVPILLVYPFLQKYFVSGLTLG
AVKN
>PK3-045_01848 hypothetical protein
MKWKKMIMAGSVLSASLLLAACNKAVDSEKEKDGDITTLTFFSADLTKDDKFDNPVAKEI
TKKTGVKLEISHPVGGDTQAVPLMIASGDYPDLIFGKGDLNKLIDAGAVIPLDELIEDKG
DNLKALYGDQLVRLKNNTEDPQIYHVGTGGMTNTVLNPSGTFKIQLEVLKELGYPEIKTL
EDYENALKAYKEKYPQINGQDTIGLSLLGSDWRWLITVGNPAGYASGYQDDGQWLVDEST
GETRYKFQDEKVKEYFKWLNHMYDEGLVDPESFTQKYDTYIAKISSGRVIGLADQNWDIN
DGIAALKADGQSWRTYAPLPVTLEEGILQPDTKDYGYTGTVGVSISSTSKQQEKAFGFLD
WMASEEAQILVNWGIEGENYEIKDGKRVATDIKESQTDPNYSLKTGVGNYIYPFPQWGTG
AVDSTGQPISRSDTKELAMSNYTEEEKEVISSYGHEVWADFFPSPDELGQTKHGRAYEIA
IPASSDLTVIQQKADDYTTQAITDIIISPPSEFEQKWSEMQTKLKEMGIDKASSDMTGLV
KDRMELWEN
>PK3-045_01849 Beta-glucoside kinase
MAVISFDVGGTFVKYGLIERSNIVQKGKFKTDRHDKESFLSSLTAKIVDLSLLASIKGIG
ISFPGFIDSVNGVPLLAGAITSINGVDIVNELKKRLTIDCPIYIENDANCAALAEKYNGA
AIDNNDFILLTLGTGVGGAIYYQNQTIKGHSYRAGELGMMLTDYGRFPNKTLHELASTSA
LISLYKEKYGLPPEAEIAGEEIFSLATDHKVKEIIREWCKYVAVAIFNSVVIFNPEKVLI
GGGVSQNPALYPYINEALNTIPYWQDFMVPVQICKHYNDSGLWGAYILVENHLKQGECER
NEIS
>PK3-045_01850 Alpha-xylosidase
MKFLNGGWLVKDGFEVNYATHVYSTRQSKNILTLYAPFSYINHKGATLDGGMMTVELFTP
HPDIIGVRMYHYKGTKKLEPHFVINKKEIVPDISESESTYSFVAGDLSAIVTKGETFTIT
FKYKGRILTESNPRSKGYIKDPQGDYHISEQLSIGVGENIYGLGERFTHFVKNGQTVDIW
NADGGTGTEQAYKNIPFYVSNNRYGVFVNTPGKASFEIGSEKVSKVQFSVPGEMMEYYVI
GGGDLKQVLENYTDLTGKPSMPPAWSFGLWLSTSFLTDYDEKTVTSFVDGMAEHDIPLEV
FHFDCLWMKEYEWCNFTWDQDIFPEPEKMLARLKAKGLKICVWINPYIGQKSPLFDEGMA
KGYFLTKANGDIWQWDKWQAGMAIVDFTNPAAVKWYQSQLTSLLDMGVDSFKTDFGERIP
IDCVYYDGSDPERMHNYYAYLYNEVVYNLLVEVRGKEEAVVFARSASVGSQKFPVHWGGD
NTSDYPSMAETLRAGLSFGLGGFGYWSHDISGFEAGATPDIYKRWTQFGLLSSHSRYHGS
WEYKVPWMYGEEAVEVTRTFTKLKLSLMPYLIAQSIYTAEKGIPMMRPMVLEFPDDISTH
TLDRQYMLGDNLLVAPIFREDGKVNFYVPEIKGVWTNYLTGELYEGGHWYEQSYDYFTLP
LLVRPNSIIIEGSCKEQAVYDYTEKPKIHVFDLHENQLLSAAIYSKDGEKQANVMVSKKH
GRYEIEVTGINKYEIILHGVTDIPPAPEVKVENNSTRIISSKQKWTLG
>PK3-045_01851 Aryl-phospho-beta-D-glucosidase BglC
MYHKQLDDFPADFLWGAASAAYQIEGAWNVDGKGPSIWDTFSKIKGKTYEGTTGDVAVDH
YHLYKDDVRLMVEMGLKAYRFSISWSRVIPDGDGQVNEAGLLFYERLVDELLVNKIEPVI
TLYHWDLPLSLQERYNGWESRETIKAFKKYCEVLYRRLGKKVTYWVSMNEQNVFTTLGYR
WAIHPPAVTDLKRMYEANHIINLANAEAIKLFHELVPNGKIGPSFGYGPMYPLNADPANV
LAAENGEAFNNDWWLDVYCKGTYPKFVKKQLERLGIAPTVLKEDEILLKSAKPDFLGINY
YHGGTAQQNRLELADKNGEKEFSGTDPYLMQPKSGQAVSPEIPMFNAVDNPYLQKTDWGW
EIDPIGFRIALRRVQARYDLPIFITENGLGAIDTIAEDGRIKDHYRIDYLKKHIIEMKKA
ITDGVDIIGYCAWSFTDLLSWLNGYKKRYGFVFVNRTEHEEKDLRRIPKESYYWYKQLIL
ENGVSIK
>PK3-045_01852 hypothetical protein
MFSKPTSVTYISNEFRATGKNMHFGIDFAHNGVNAIKACADGIVSRSYYSASYGECIMIL
HKISGQEYETVYAHLKRGSRKVKVGDYVKKGQVIGIMGSTGESTGQHLHFELHIGRWNIN
KSNAVNPLPYFESDSNTTPSRNTEYIVKKGDTLYQISRKYETTIKVLRAFNQIENQDIIN
VGQKIKIPSQKAVYYVVKKGDTVSRIAKNFHTNAGKIKEWNQLKNVDKIYPGQKLRVG
>PK3-045_01853 Alkaline phosphatase 4
MKKLLLVFISISLSFVLVLSMQPRTEKPAFSKEQKRKPKNVILLIGDGMGVGQMEIARLF
EHGANGRLFIETLPHTAIVHTSSSNNRVTDSAAGGTALAIGRKTNNGMIGITAEGKNVDS
ILDKFKRDGKKTAIITTNSVTDATPASFTASVNNRWADQEEIAKQQLSNKVDIIMGGGKK
YFTHKDKRGTDLIDAYKKAGYDFLTTAEELEKTKSQKWLGLFGDAHLNFQLDRSHIKTTE
PTLEEMTKKALDVLSSEQKGFFAMIEGGRIDHASHASDITGIWKETVAFDEVVKYCVEWA
KKRNDTLVVVAADHETMGISATEALDISGLKKVSASPHYMAQQLIKKKTNNGYTTKSIKK
VFKDYAGIDLRKDELLQLQINPKVNNGQVYREQQMDWKIGTIIANHYHAGIVDSLTQQLS
STGGHTSNMIVVFAVGTGAEEFHGVLDNTDIPRKIAAIMGYAF
>PK3-045_01854 hypothetical protein
MSKSFIEQVHYIRIPVKDLELSARWYRDVLGLQLLNNTGELAILKVNEGPFLLILVPTND
ETFAHFTIDNEEEFSIGFTSPQLSEFHQHLMDNQVKVEDIKEDNGHFFFHFYDPNGNKLQ
VHW
>PK3-045_01855 hypothetical protein
MNTIYSFLPKAIENLILTIPPSERLGMEEIRVRIGRPLEVFINGRSIFFPFIVSKEDGNQ
LLNKISQYSVYTMEEELKRGYITVQGGHRIGLAGKVILQDSKVKAIRDVASFNIRIAKEQ
IGIANPFIPYLYDKGKWRHTMIIGPPQTGKTTLLRDIARLISSDADNSLIKPAKVGIVDE
RSEIAGCLDGIPQMTFGPRVDVLDACPKAEGMMMMIRSMSPDVLIVDEVGRKEDEEAILE
AVNAGIQLIMTTHGSSLEEVKKRPMLSSMIKMGIFERYIELNRRKGPGTVTAIKNGQGQL
LMDEMKVK
>PK3-045_01856 Stage III sporulation protein AB
MIKIIGAILILASTSWGGMEFSKLLSQRPKQIRALKSALQSLEAEIMYGHTPLHEASRRL
AEQLNEPLHSFFAGFAERLLKEDTTVKEAWTASLREIWKKTAMKDSELEIMKQFGETLGR
HDRFSQQKQIMLTLTHLEREEEEAREIQGKYEKMIRSLGFLSGLLIVILLM
>PK3-045_01857 hypothetical protein
MGLEVDIIFKIAGVGIVVAFLHTILDQVGKKEYAQWVTLFGFIYILFMVANIVNDLFQKI
KAVFLFQG
>PK3-045_01858 hypothetical protein
MNAKVNTVYVETILKIIGIAYIAEFAVQITKDAGQGSIASKIELAGKILILAMAVPILTV
LVETILNMIPN
>PK3-045_01859 Stage III sporulation protein AE
MKTKLKVVLLVMAALFFLYQPIVQASPHESQDSLEAEAAEEIKEEGMDPTKIVESQLESL
DLNELTTFWDSIKTEYGGFLPESQKGSLYDFMTGDKSFDLQGFFHGILQFAFHEIIVNGK
LLGSLILLTIFSVMLQMLQNSFEKSSISKVAYAIVFMVLIILALNSFHVAITYASDAISK
MTHFILAFVPLLLALMAASGGAISAAFFHPVILFLMNTSGMLIEYIVLPLLFLSTLLHVV
SSLSEQYKVTQLANLLRNISIGILGIFLTIFLGVISVQGASSAITDGITIKTAKFVTGNF
IPVIGRMFTDATDTVINASLLLKNTVGIAGVVILLLLVAFPAIKILMISFIYKFAAAILQ
PIGGGPVIKCLDVISKSVIYVFAALAIVSLMFFLSITVIIVASNLTMMVR
>PK3-045_01860 Stage III sporulation protein AF
MNFITEWVTNIILFILLATVVDMLLPNSTFQKYAKMVAGLLLITVILTPVFKLISSDFEA
VFSASAMGEPEQKNMNNSIELKKREIQASLDEYTLNKMAVQLKEDANEELIANYGMEINS
IQLSIDKEKEGGFPANLTEMVIHMKESQDPNNVVEAVSPVRIDTQQPLLDKKETKQMDTE
SIISFLSEKWEVRNDAIVIMYEGGEEGKNG
>PK3-045_01861 hypothetical protein
MDKKDKGPLSWLKNILSNDGNEKKQGKTTYIVIVVLFGVAIMLLSNMFFKDNNKAQEVAA
YNNEASSEEAEETFGQKANSSNLTIADYEEQYKKEIKEAISAIAGVKDAIVYVNIEGSEK
KVYEKNQSQTIQKTEEKDTQGGNRNVEETSNEETVVLVPNGDKQVPIVVETMKPKIAGVL
VVAKGAGDIKVKTMIVEAVTRALDVPSHRVSVQPKQN
>PK3-045_01862 Stage III sporulation protein AH
MLLKKQTVWLLTMLSLVVVLSVYYITSPESRLNEFAATEEDNNKAKSNDAEEAAKDSKGE
STVTTTDSEAVFEQMRLDLMEQRDKMKEELVTIQGSKDKTAEEKNEATEKINELQEMTDN
EKIMESLIKAENYDDVLVQTADDGTVKVTVKAEELSADAANEIVQLVRKNMDAPNANVAV
KIDPK
>PK3-045_01863 Biotin carboxyl carrier protein of acetyl-CoA carboxylase
MLKISEIKELIKLIDESTISNFLYEQDGVKVEIQKNVGEIVAQAPVVTKTIQQQEAKATK
EVAVESVVADTPVKSSDDNLHKITSPMVGTFYQSASPDSPSFVKVGDKVTKDSVVCIVEA
MKLFNEITAEVDGEIVEILVKDGELVEYGEPLFLVKA
>PK3-045_01864 Biotin carboxylase
MIKKLLIANRGEIAVRIIRACRELDIQTVAIYSEADREALHVQIADEAYCVGPKASKDSY
LNFTNIISVATLTGCDAIHPGYGFLAENADFAELCRDCKITFVGPSPEAINKMGTKDVAR
ETMRQAGVPIVPGSQGIIKDVEEGMELAKEIGYPVIIKATAGGGGKGIRVAKTEEELIKG
INITQQEALTAFGNAGVYLEKYIEDFRHVEVQVLADNYGNVIHLGERDCSIQRRLQKLLE
ETPSPVLTEEMRAKMGDAAVKAAAAVNYTGAGTVEFIFDYQNQAFYFMEMNTRIQVEHPV
TEMVTGIDLIKEQILVASGKPLEHNQKDVTFTGWAIECRINAENPAKNFMPSPGKIKMYL
PPGGLGVRIDSAAYPGYTIPPYYDSMIAKVIAYGSTRQEAISRMKRALSEFVIEGVDTTI
PFHLNLLNHEKFVAGNFNTKFLEMYDLMKSED
>PK3-045_01865 putative protein
MSETTSLEMNQEYTGLGKVEIAPEVIEVIASIAASEVEGVAQMRSNFASGVVEKFGKKLH
NKGIKVDLSEEGIKVEVFCVMNFGVSIPHVAQQIQDNIRQTLINMTGLETEEVNIHIVGV
QFETAKQEPELQQEM
>PK3-045_01866 Transcription antitermination protein NusB
MKRRTAREKALQALFQIDISDIDKETAIEHVLEGEKSDPYLTKLVDGVLNNQVSIDETIK
QYLENWTLERIANVDRNILRLATYEMIYGQADDVPVNVAIDEAVEIAKLYGDDQSGRFVN
GLLSKIKENQ
>PK3-045_01867 Exodeoxyribonuclease 7 large subunit
MESRYLTVHALTKYIKRKFDADPHLQQVMVKGEISNFKQHSSGHMYFTLKDEKARILAVM
FARNNQQMKFTPENGMKVLIKASVTVYESSGQYQMYVVDMQPDGIGQLYLAYEQLKAKLE
QEGLFLADHKQAIPKYPKTIGVITSPTGAAIRDIITTIKRRYPIANIQIYPALVQGEAAA
PSIVKAIQRANEQESPAIDVLIVGRGGGSIEELWAFNEEIVARAIFTSRIPIISAVGHET
DFTIADFVADMRAPTPTGAAELAVPHIDELVERILSRQSRLIRGIKEKVELQKLRLNRIQ
RSYAFRYPKVLYDQKMEQLDKQTELLIRNVQRVFEQKNNQHQLIQKQLVRNHPHHYVMKA
QQDLANLQKNMIRNTELILQTKKQSFLSTIGKMDALSPLKIMERGYNVAYDQNGKLIASI
KQVKPKEHIELNLADGTVQAEIMEIKER
>PK3-045_01868 Exodeoxyribonuclease 7 small subunit
MATNRENKPTFEEAMEELERIVEKLEEGDVPLEEAINTYKKGMELSKYCHEKLKNVEEQL
AEVVLENGKKQPFSIAEEE
>PK3-045_01869 Farnesyl diphosphate synthase
MNKISLSAFTKDYKEVLEKELKKNVEKLNAPSSLKDSMLYSLNAGGKRIRPLLLFATLKA
FGRDPLEGLLPATAIEMIHTYSLIHDDLPSMDDDDLRRGLPTNHKVYGEATAILAGDALL
TYSFQIMTYMTNQNIPSDKILASIGFLAKAAGAEGMVGGQVADIEGESKTLNQSDLEHIH
LHKTGKLLEVSIIIGALLADATSTELETLKRFAYHLGLAFQIRDDILDLEGDEEVIGKPI
GSDTDNHKSTYPKILTMDGAKKELELHIKQAKDLLSGLNFDRFLLEEITDLIGYRNN
>PK3-045_01870 1-deoxy-D-xylulose-5-phosphate synthase
MKWLNGRKIYQLVSIFHRFIGYILNESELLQMDLMSIENPAFLKGLSNEELNSLSEDIRH
FLINRLSQTGGHIGPNLGVVELTIALHKCFDSPKDKFLWDVGHQSYVHKILTGRAKDFDT
LRQYKGLSGFPKMNESEHDVWETGHSSTSLSAAMGMAVARDLKKEDSYIIPIIGDGALTG
GMALEALNHIGDEKKNIIVILNDNEMSIAPNVGALHQVLGRLRTAGKYQWVKDELEMLLK
KIPAVGGKMAATAERIKDSLKYLLVSGVFFEELGFTYLGPVDGHDYDDLFEQLNYAKKTS
GPVLLHVITKKGKGFSPAEKDKIGTWHGTGPYKIETGDFVKPAITAPAWSKLVSDTVLKL
ARQDDRIVAVTPAMPVGSKLESFAKEFPSRMLDVGIAEQHAVTLAAGLATQKMKPFLAIY
STFLQRAYDQMLHDVCRQKLNVFIGIDRAGLVGADGETHQGIYDIAFLRHMPNLVLMMPK
DENEGQHMVNTAIQYNDGPIAMRFPRGNGIGVELDSTLKTIPIGTWEVLREGSDAAILTF
GTTIEMAMEAANQLELQGIHVKVVNARFIKPLDEKMLSDLLKKQIPILTIEEAILQGGFG
SYCIEYAHDHGFGANVIDRMGIPDEFIEHGDVNSLLEEINLTKEEVVKRISAIARKKQKR
A
>PK3-045_01871 Hemolysin A
MKKERIDVLLVEQGLFETREKAKRAVMAGIVYCEENRLDKPGEKINADSKLSVKGKTLQY
VSRGGLKLEKALKIFDVDMKDKVLLDIGSSTGGFTDCALQNGAKQSYALDVGYNQLAWKL
RQDERVIVMERTNFRYVTPVDLKGEMPNIASIDVSFISLKLILPVLKTLLVSGSDVIALV
KPQFEAGREQVGKKGIVRDRKVHESVLEKIIDFSIKEGYIVKNLSFSPITGGDGNIEFLL
HLYWDECAEEKTHYYQIKETVEAAHSELKAKKETEE
>PK3-045_01872 Arginine repressor
MNKGQRHIKIREIITNNDIETQDELVDELKSAGYNVTQATVSRDIKELHLVKVPLQDGRY
KYSLPADQRFNPLQKLKRMLMDSFVKIDSAENLLVLKSLPGNAQAIGALIDNLDWDEILG
TICGDDTCLIICRTADDGKKISDRFLDML
>PK3-045_01873 DNA repair protein RecN
MLSELSIKNFAIIESLSISFKKGLTVLTGETGAGKSIIIDAINLLVGGRGSAEFVRHGEE
KAEIEGLFYIEDGHPCFQKMNEFGIDIDEGAIVLRRDIALSGKSVCRINGKLITIAVLRE
IGSTLIDIHGQHEHQELMDETKHLQLLDTFAMGELAPVLEEYEEIYRSYTQTQKKLMNLT
ENEQQMAQRLDLLQFQFNEIEGAHLKINEDDELLEERKKLSNFEKIYDSIQTGYTALRGE
QKGLDWLGEVMGNMEEAASLNTEYKEMAESVSNSYYILEDIARQMRSALDYLEYDPERLN
EIETRLNEINTLKRKYGKTVAEILEYAAKIEEELETLQNKETHIDLLERELASLKKDLLV
EAKELTALRKRAALRLTDSIHQELKELYMEKTVFEVRIHADENNVTKKGIDEVEFYISTN
PGEPLKPLSKIVSGGELSRMMLALKSIFSKHQGVTSIIFDEVDTGVSGRVAQAIAEKIHH
VSVDSQVLCISHLPQVAAMADTHLFIAKKIEDGRTSTSVTPLVQQDKVKEIGRMISGAEI
TELTKKHAKELLKLAQKAKNKI
>PK3-045_01874 SpoIVB peptidase
MKSDILRKIIGGILLVSLISLVCNQSFQEYLHIPKSITLFEGQSMEINNSEAISVTANVA
DEDSVVALSQEKGKFSLQGKVSGKDEMMLELAGIPIKKVDVNVLKDFKVIPGGQSIGVKL
NTVGVLVVGHHQVNTEEGKQSPGEKAGIKVGDMIVEINGMKIEKMADVAPFVQKAGEGNK
PLDLVVKREKEEFKTKLMPLKEKGDNTYKLGLYIRDSAAGIGTMTFYHPDSMKYGALGHV
ISDMDTKKPIVVDDGEVLRSTVTSIEKGSNGNPGEKLARFSEDKEIIGDIKTNSPFGIFG
VLNKQIKNGIMDKPMPITLSDQVKEGPAQILTVVDNDQVKLFDIEVVSSVPQKYPATKGL
VIKVTDKELLSKTGGIVQGMSGSPIIQDGKVIGAVTHVFVNDPTSGYGVHIEWMLNEAGI
DIYEKEQKAS
>PK3-045_01875 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MENVTKENNTYKILWKLTRPHTLTASFVPVSIGTVLSFPHASTKWGLFFAMMFACLIIQI
ATNLFNEYYDYVRGIDTADSVGIGGAIVHHGMKPKLVLNMAISLYIIALLLGIYICSNTS
WWIALVGILGMAIGYLYTGGPLPIAYTPFGEVFSGICMGCIFILISFFIQAGHISEESIL
ISVPIAILIGAINLSNNIRDIEEDTLGGRKTIAILIGFNKAVNLLAALFILSYLWIIIFV
ALGFFSPWLLIVLLSFKKPLDAIRGFKGDRSQTPIAMKNTGLTNTMFGLFITVGYLLDFI
MQNA
>PK3-045_01876 Stage 0 sporulation protein A
MKKIKVCIVDDNRELVGLLEEYIDAQDDMEVIGVAHNGQECLELVEQLEPEVMVLDIIMP
HLDGLAVLERMRQMNKPMPNVIMLTAFGQEDVTKKAVELGASYFILKPFDMEYLASHIRQ
VSGKTTGFVRKSSSSFKTQEPKTKNLDASITSIIHEIGVPAHIKGYLYLREAISMVYNDI
ELLGSITKVLYPDIAKKFNTTASRVERAIRHAIEVAWSRGNIDSISSLFGYTVSMSKAKP
TNSEFIAIVADKLRLEHKAS
>PK3-045_01877 Tyrosine recombinase XerD
MKLTELEFYLEDFLLACQSKNLSPKTLSSYEQSLKLFLAYLKGEHDIEDVQRVKAGHIRQ
YVAYLQERGKYTVVNREVSKTMNHPHNRRDFKKTVSNVTINNYVRNIKVFFNWLQQEGEL
HKNPVENIKQIKTERRQKAGINQEEFNRLLSQFDYTKFHGYRNKVIVMILQDTGMRIGEC
LSLEVESIDFKHRMILVTKTKGNKERYVYFSQIMARELKQYLKFKDRYTETQLLFPTTRN
TLLTIQSFEKQLKQAGEQIGLNIHPHQIRNNFARHYLLNGGDFYTLSRILGHSSVTVTEQ
AYMDLTREEIGKKYQQHSPLSKWRIKH
>PK3-045_01878 hypothetical protein
MENQFYQETKKCSKCKKILPRSKDYFYVDSSAKSGFKSRCKSCEGNTYVFNNRYGLFDIK
WKELDTLCGIYKIECKGNGKIYIGSAVNICQRWSTHLFELRKNQHGNSYMQYSYNKFGES
TFVFTIIESVTQKGFLLEREQFWLDSLKSYDRNIGFNVLKVAGNCLGNKLRDSTKEKLKR
VLNKQVIQYDFEGNIIEIHLSAKEAHRRYGYSAAQIYNCANRKKQHYKGYIWIYKEDENS
LEERIQYINMSKRTILQFDLEGNLIKEWNCSISKLAKELDDKTYINIPNCCNGNQATLGG
YIWRYSIGGKIQNPINHLD
>PK3-045_01879 hypothetical protein
MIDEQHLEQMKEKLSNTIKGIDYIPEMFQVFAWEAGLGKSTHVNNSVAAYFDEFALKDNT
KRFLIVKKFKSDVYETVERLNQCEALKMYGGYSVIGLTSENVSNYSDDKIKGCMVLVITH
QRYIKACDRELIHTFGDRDTLIIDEQVQFPITKFGRSEYNGMRKDIHLFEGQLLFDRCFS
PLLRRLDEIYKEEDYNNIVTFKDTFEKDTLKDFKNWVKDKSKGDKRKKRYNEIIQSLDLL
QSDTREGLIHNDTLFLIDKSIRFRKLKNNIILDASADITPLYRIKDQFTIVENRLCINHS
KSNVGFLKINTSKSSLKKNLDDIIRDVQNRLKNIKDKKRALLVCHKENSSEIIAGIKKVL
GDNVYIPKGEEEIEATQSHAAVDWYGNIVGKNTYKDYDICLIIGTHNMPLPVYLLQFVQY
NPKIDVSGFPQKMELKSGKFDDEKLEEFRKAFLAADFYQAARRIQRNQEPKASYILYTFD
EDVVQTFVKKFNQLTNVFVLNSDNVVKPTLSTKDEKVIRILEFIRDDCAVGDVVPKKNIS
EALDIESSNLSRYLKHELITNLVEQRHIEIRHKDVVKKTDFTLE
>PK3-045_01880 hypothetical protein
MLRCITVDKETLIASNSEKETIKNLSKNKQLFCPNCHSAVIFKSGKVKRPHFAHYQSDCV
VTNYEPETASHLQGKQVLYEWLKRQFPTADIEYEVYIPETNQIADVFVEHTDKGMEGLRW
AFEFQHSSLSSTDWETRHELYKSEGIQDFWIFDKAKYMKFSKAQDVTDARKRNELEKTIY
NKIGLCYFLDLESLELTIDVNFTTSWLTTIVRGVKRQNLYTYHSPLNHSTHIDQVRVRLN
DEFKHGVLVYSEIEGQMEERLSRILGMLRGERARKAVQELQEKAKKKRVFAQEKYGEGKA
EIIWRFMELNIEELSDYELNLSEKENIKELTNDVRQLSEEDFFTKYESLFERLQLDIEEY
KALKDSEDLVKRLIESLTYEKDFFSLKFLIEQGSCSLEEYLKNIQQEKIDLVTYVYEKYK
EDLEKLATMNFRAIKRDLENIKPNITPWESNPTAIDYAIRYKRLETKEAADEHMKQVKKQ
IINYNPFANMEDW
>PK3-045_01881 DNA-invertase hin
MKYGYARVSTVAQDLEIQIQALQAEGCEVIYKEKFTGTKTDRPEFNKVLEILQEGDTLVV
TKLDRFARSAVEGIQTVKALFARGVKVHILNMGLVENTPTGRLIFNILSSFAEFERDMIV
ERTQEGKALAKQRDDFREGRPRKHSKQQVLHALELLKTHTYKEVEAMTGIKKRTLINRKN
ELEAKQL
>PK3-045_01882 IS200/IS605 family transposase ISAac3
MSSDNSLSHTRWNCKYHIVFIPKYRRKVVYGKLRKDIGAILRKLCEMKDVEIMEAHAMPD
HIHMLVKIPPKMSVSYFMGYLKGKSSLMIHDRHANLKYNHGNRTFWAKGYYVSTVGLNEK
TIAKYIREQEAEDRLRDNMSKREYVDPFKDK
>PK3-045_01883 hypothetical protein
MYTHPHVTENPKRIRKFILSAEEPLQTEYCREAISSYKWNMLTIA
>PK3-045_01884 hypothetical protein
MKTFSPLRPWLNRIHPLPSFKYLQEASPIIELGASVIFDDYVPLYKLHRQEAQSLSISWE
EQRNYVELALDIINSDEGGWLDREEVQMIHDELGPPPDSCYPIYMFTAKRGEFEEVLYIG
KTSSKFSRFSGGHTAAIKLHHPKYDGFEKRVYFGCVTFLDEENSIPLEWIHPKKFSLELL
DSIESQLIHSLKPELNTHKKKNYKALHPTSIHIQNTCPDSMYLNDYMISPH
>PK3-045_01885 hypothetical protein
MRIKEFTVRNFKNIGNAEPCTITFPRVDGEGASDFITIIGENNIGKSSLLEALKLFLPET
DSPNTPTIDMFPFKREPTTPSMNMEILVVFDDFNHADRNNRFIKPYIFNEEMRIRRIWTA
PNLKDSDVPFEVYIPKRYISEIDMEGTWNTRMFSSVSDALIEQYENYCSEQTITTGTIPK
AKKDDFVQYVYLNNPNLIYEGEVDWMKNPNGFASNIRSVMPKVIYVPAVKLIDEEADANK
NKSAANQITAALFEHHLNQTQEIQEFRASLASLKNIFNEGTRHTEVHNLENKLSRKLKRL
MDIEANVDFNVPEVMEKLHLNSNIYLKHNNLITLPSQQGNGVQRMLILSLLELMAEQLTQ
NNLEEDEAANTEVWKRSFLFLVEEPEIYLHPHLQRKMRDSLVQISKHPLAQVICTSHSEN
FIDLAGRHQGIVVMQRDEELFTRVKQVTDDIYIGQSAREKRNRMRMLLNFNTTTLEAFFA
KRVILVEGDCEVASITAIKNKLQELRPVIADNLESVLKEISIIPCNGKLTQKAYYEVLCY
FGIQPYLIHDLDDENLDTGSNLNILNTIGHEAFRLTHQPNFEGDIFEQTCTYDKPWKATR
LIEDEFSTYQDKLLRFFKFVIGEVNFNELQLDNLLQTV
>PK3-045_01886 hypothetical protein
MVSIFEAYYIDGNEKLLLTVEDVTPEQYSNKYWGKLFCTEPDCTAKLSYVNKPGNKSLFR
KWRDSPHSRSCMYFSDRVEGRLGNRQSAVQSGIISPEQIIRAQREAFALEMMSEDERIKR
READREKRKNRNNKKVTNIEEKPAIKVVVDPAKKSQTDEQVKGRLYKRDVDGLKEKDLGE
TRTITGRVVKVETANKHALVRVVKNGTFVNIVYGQAFFANVPQYEGLFHYIDRFAKENNN
AIFSGTGEVRKNEQTDEFELFVFDRDGLMIQGKSLPALAAYYSITAPDTNNIDE
>PK3-045_01887 hypothetical protein
MFKNLIYFDAVKVAEYSAVLEGKKHIAIKNVKVNSGKSLSAKVAVLSGGINGSNEMEGEI
VDNLILDCNEFEELLENKSQDNFFDLKQEECDSETIPRTSIIRFDGNFKIPSEFDMMDLI
NKFKPMLTSNLNLQNAQEEEIFNKIFNKESTKIPAFLECSDFVDRIGFAKLNSNSLCYEL
EHLEDFEDEEVTIIAKVLSRKNVSDKPIVLFDIMKDLFSLSRGIRRQMGGSEIEGLQNIK
SEESVIIFEVLAIYQ
>PK3-045_01888 hypothetical protein
MSRIDEIEDAEILYYVYNLNWLLPKENQEIAIDFLINLPPDKADMIIPKYGKECWENSVR
VIKKIGYPNNKKALPKLARLLQDRNWPGSLEAIELFRELGKAIATPLEQEYISACKQKDL
DWLENLFFACNSLNYSENDFKHKDSYRFMKKKC
>PK3-045_01889 Cold shock-like protein CspD
MATGKVKWFNAEKGFGFIETEEGQDVFVHFSAIQTEGFKTLDEGQEVSFDIEEGQRGPQA
ANVVKN
>PK3-045_01890 Glycerophosphodiester phosphodiesterase
MTKIFAHRGFSAHYPENTMKAFIEAEKAEADGIEIDIQMSKDGEIVIIHDEKVDRTTDAS
GYVQAFSYKDLRSFNAGHRFKQAENEPIPTLIELFDWMQDNDIICNIEMKNNKIAYEGME
EKTIALIRKYGFEKRIIFSSFNHYSLVHTYRIAPEIETAPLLSDGIYQPWIYANAINAKG
FHPNYKRINPEIIKTSEKNNIKVRAYTVNNPKTMQALMDAGISAIITDEPIIARTVLT
>PK3-045_01891 Anaerobic nitric oxide reductase transcription regulator NorR
MGSVRMIDRMIQSTSYTLFDEIKEGIIIVDNCGVISYFNKSAQSLMQNQYSLQKDQHILS
VIPNSGMMRVLHTKRIEEQKKFAVSETDYLLISRYPLIGKDNSIIGAVAVLQEESQKRHW
IDKDNLQMLLTLLLQKSAEAYVVVDEFGHIVMQNSSYKELAVLLDQQNNHQLMKKNREEV
IQTRRDAEIIIQTGTLCLTVKSTPIIVDGKLKGCLQILHNETETARLKKELQQTKAIIRG
LEQSFQFDDFKYQSPSMNFAIEQAKLAAGSKQVIFIRGEEGTGKFMLANAIHNWGGNKFH
LFRRIHPQKHREQLRAFLNKKNLLSKGTVYLENITCLSMAEQTLLLKRLKELELEEKQLS
SFRLIVSSPIKLEKALMAGDFLEELYDELMKSNIYLPPLRERKEDIYLLAKHFLIELNED
SGRWITDIDPEAQTALKNYGYTRNILELKAILQLSMIQAKEEDTVLKLEHLAPPQVIKKQ
QAEFQEEANADNQTLSDLVEKYEKVIIEQTLRKLDGNKTLTAKTLGLSVRNLYYKLDKYH
LN
>PK3-045_01892 Butyrate kinase 2
MVINPRAAETEIALYENEVPIIVDDLHHDSNKLLEFPSIVAQYKYRSDEVLSYLVNKGIN
LSKLAAVCGRGGLLKPIDGGTYSINAAMREELFAQTRGEHPSNLGALIAYDIAEHLEIPS
YIVDPVVVDEMDDIAKVSGYPSITRKSVFHALNHKATGRRAAMELGKKYEEAHLIIAHLG
DGITIGAHAKGKVIDVNNGLNGEGPFSLERSGTLPHGDLVDLCYSGKFTYEEMKHQLLYH
SGVKSYLNKVPEGSFDIEEELGKRDNPNILIYEALAYQIAKEIGSASTVLFGKVDAIILT
GELAFSNRFVKLIMERVNWIADIMVYPGENERQSLAEGVLRVLRKEERPKEYGEREE
>PK3-045_01893 Dihydrolipoyl dehydrogenase
MAKEYDLVILGGGTGGYVAAIRASQLGLKTAVVEKGKLGGTCLHNGCIPSKALLRSAEVY
ATAKKSEEFGIITSDIRLDFNRVQERKSTIISQLHSGVQYLMKKGKIDVYEGNGRIMGPS
IFSPMPGTISVEMNNGEENEMLLPKHVIIATGSRPKSLPGLEIDGSTVISSEEALQMEKL
PSSIIIVGGGVIGAEWASMLADFDVKVTILEYSDRLVPTEDKEISKELQRILKKKGIQIV
TGAKVLPETLQKNVDKVIIQAEKNGETKSFEGEKLLVSVGRIGNVEGIGLENTDIAVVQN
QIQTNEYYQTKESHIYAIGDCIGGLQLAHVASHEGIIAVEHIAGEKPHPLDYKTVSKCIY
TSPEISSVGYTEEEAIELGFTIKKGKFSFKAIGKALIFGEQDGFVKIITDQETDDLLGVH
IIGAHATDLIGEAALAKVLDATAWEIGNTIHPHPTLTEAIGEAALAVEGKAIHG
>PK3-045_01894 2-oxoisovalerate dehydrogenase subunit alpha
MNQLGGNSMTMVHNRHLEAGLTDDQVLEMYEQMLLARRIDERMWLLNRAGKIPFVISCQG
QEAAQVGAAFAFDREKDYMLPYYRDLGVVLTFGMTPKEIMLSGFAKAEDPNSGGRQMPGH
FGQKKNRIVTGSSPVTTQVPHAVGVALAGKIEKKDFVTFVSFGEGSSNQGDFHEGANFAG
VHKLPVIFLCENNKYAISVPIEKQLGCANVSDRAIGYGMPGYTVDGNDPIEVYRVTKEAV
DRARRGEGPTLIETISYRLTPHSSDDDDSSYRAREEVTEAKAKDPLFTFKAYLLSTGILT
EEMDQELNKKLADVINEATDYAEKAPYAQPEDTLKYVYGN
>PK3-045_01895 2-oxoisovalerate dehydrogenase subunit beta
MPVISYIDAVTQAIREEMEKDDKVFILGEDVGVKGGVFKATTGLYDQFGAERVIDAPLAE
SAIAGVGIGAAMYGLKPIAEMQFADFIMPAVNQIVSEAAKIRYRSNNDWTCPIVIRAPYG
GGIHGALYHSQSVEAMFANTPGLKIVMPSTPYDVKGLLKAAIQDPDPVLFFEHKRAYRLI
KGFVPEEDYVLPIGKADVKREGEDITVITYGLCVHFALQAAEKLAEDGISAHILDLRTVY
PLDKEAIIEAASKTGKVLLVTEDNKEGSVISEVAAIIAENCLFDLDAPIMRLAAEDVPAM
PYAPTMEKFFLVTPEKVETEMRKLAEF
>PK3-045_01896 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MPIEKITMPKLGESVTEGTISNWIVAVGDVVNKYDPLAEVMTDKVNAEIPSSFSGTIKEL
LAEEGQTLEVGEVICTIEVEGDDTQVEKEVKAESKEKTEAPLADAATSQKARYSPAVLRL
SQEAGIDLTLLTGTGAGGRITRKDVQKAIQEGIPQVKTEEKSSVNGTVEHAPQRETIVHN
VPTSAGDKEFPITGLRKAIANNMVKSKHEIPHAWTMIEVDVTKLVQYRNKVKDSFKKEEG
YNLTFFAFFVKAVARALKEFPQINSTWAGDKIIQKKEINISIAVATEDALFVPVIKNADE
KSIKGIAREITELANKARSGKLTVDEMQGGTFTVNNTGSFGSIQSMGIINHPQAAILQVE
SIVKRPVIKDNMIAISDMVNLCMSLDHRVLDGLICGRFLQRIKEILETTSEETTPIY
>PK3-045_01897 hypothetical protein
MNIDFNLFMNDVVRQARQEIVEAGYEELTTKEAVDEALSQKGTTLVMVNSVCGCAGGIAR
PAAGYSLHYKKRPDQLVTVFAGQDKEATEQARSYFTGFPPSSPSFALMKDGELVKMVERH
EIEGHDPMQVVEKLQNAFEEYCTEVK
>PK3-045_01898 Arginine-binding extracellular protein ArtP
MKKLLALMLLSIVVILSACGASTDEKGSNSGSGSADKKVLVMGTSADYAPFEYIDTAKSD
EIIGFDIDLAKALSEKLGYQIQVKDMDFSGLISALQSGKVDLVLSGMSPTPERAENVDFS
DVYFTAKDLVVTTKDSNIKTVQDLDGKKVGVQLGSIQEDAAKEIAKTVKVTVENRDRIPQ
LIQEIKAGRFDAAIIEDVVAKGYLNKEDTLTSFPAKEANEDAGSAIAFPKGSDLTEKFNA
ELKKMKDSGEIDKLVVKWFGN
>PK3-045_01899 Arginine transport system permease protein ArtQ
MGLDFQQFIPSLPYLLKGITVTLQIVVVAGIIGFVLGIILSIFKLSKLPVLSWIAAIYTS
VFRGTPLVLQLMIIYFGVPQLTGIQIEPAIAAILSFGLNSAAYISEIIRAGILAVDRGQK
EAAMALGVSPRQAMFDLILPQALKNIFPALINEAVSLTKESAVVTVIGVTDIMRRAYIMG
GEKYAYLEPMILAGLIYYVLVMILTTLAKAVERRMRRSD
>PK3-045_01900 Arginine transport ATP-binding protein ArtM
MINVENLHKSYGSLQVLKGINTQVEKGEVVTIIGPSGSGKSTFLRCINLLEVPTKGKVII
DGTDITDKNTNIKRIRENVGMVFQHFHLFPHKTVLQNVTYAPIKVKGLSKSEAEKMGQEL
LAKVGLADKAHVYPSRLSGGQKQRVAIARALAMNPDVILFDEPTSALDPEMVKEVLEVMK
SLANTGITMLIVTHEMGFAREAANRVLFLDGGVVVEDAPPAEFFTNPKTDRAKEFLEKML
>PK3-045_01901 hypothetical protein
MLKLVLSILLTISPVWPLGINPLPGDPFLIINKKTNQLTLIDENRVQTTISVSTGKKEDL
TPEGLFTITVKATNPYYRKKDIMGGDEENPLGTRWIGFDANNTDGRMYGIHGTNNPGSIG
KYVSQGCVRMQNEAVESIYDFIPLGTKVLITNSDKSFPELAKEYGAIE
>PK3-045_01902 hypothetical protein
MKKKKNRLQKIVVYLMIFVMLASTLLIGIGMLF
>PK3-045_01903 Peptidase T
MINQERLLNQFLELVQIDSETKYEKEISIVLKKKFEELGLEVIEDDTTAITGHGAGNLIC
TLPATKENVEPIYFTSHMDTVVPGVGVKPSIKDGYIVTDGTTILGADDKTGLSVMLEILT
VIKENNIPHGTIQFIITVGEESGLLGAKALDPKLIQAKYGYALDSDGKVGNIVVAAPTQA
KVKATILGKTAHAGVAPEKGVSAITIASKAIAKMPLGRIDKETTANIGSFAGGKQTNIVC
DHVDILAEARSLVEDKMLAQVAKMKEAFESAASEMGGQAIVEVDVMYPGFKFGEGDHVVE
VAKKAAAKIGRSCELQQSGGGSDANVICGFGIPTVNLAVGYEEIHTTNEKMPIEELNKLA
EMVLAIIDEVTGQ
>PK3-045_01904 Chemotaxis protein CheW
MEEKKVVIFKVANGEYSVDVSYVISIEKEEQITPVPQLPSFVRGIRKVRDELIPVIDLQM
VLYNQKTEENENNKLIVARTEDISFAMIVNDAKEILDIKDEVIKEVGISAYQKTEYITGV
LNLENRLVLMLDPTILLETLEGVKEIKDYMKNQPA
>PK3-045_01905 DNA polymerase IV
MKEFYPKKGRVILHVDMNSFYASVEMAYDPQLKGKPLAIAGNEKERRGIIVTCSYEARKF
GVKTTMPLWEAKKKCPDLIVLPPNFDRYRTASLAMFQILHEFSDIVEPVSIDEGYVDITH
CHELGTPIYIARTIQKRIFERLDLPCSIGIAPNKFLAKTASDLKKPMGITILRKRDIPKI
LWPMQVEEMHGIGKKTGEKLRAIGIETIKDLAMAQSILLKATLGINGIRLKEKANGEDNR
PVDPEAANEFKSIGNSTTLPRDIKNQQDLFQVLASLANKVATRMKRKHVHANHLSVTIRY
GNRKNYSKSKKLANPIKSEEEIFQQSKEIFTTAWDGNPVRLLGITAGDLIDNNIVVKQLD
LFSFEKEAEKEPLWTAIDKLKEKYGASIIEPASERNNISKKEEDIGTKTSFNKDFLQGNK
F
>PK3-045_01906 6-phosphogluconate dehydrogenase, NADP(+)-dependent, decarboxylating
MTKQQFGVIGLAVMGKNLAMNIESRGYTVSVFNRSKEKTEEMLKESEGKNIVGTYTLEEF
VQSLEVPRKIMLMVKAGPATDATIEQLKPLLDKGDIVIDGGNTFFKDTQRRNKELSELGI
HFIGTGVSGGEEGALKGPSIMPGGQKEAYELVAPIFRDISAKVNDEPCTTYIGPDGAGHY
VKMVHNGIEYGDMQLICEAYFIMKHVLGLEAQELHEVFAEWNKGELDSYLIEITADIFTK
VDEETGKPLVDLILDTAGQKGTGKWTSQSALDLGVPLPMITESVFARFISAMKDERVKAS
KVLSGPEIKPFTGDKAAFIESVRKALYLSKIVSYAQGFAQMREASEEYDWNLNYGEIAMI
FRGGCIIRAQFLQKIKDAYDRDPELKNLLLDPYFSEITENYQSALREVISGAVLNGIPVP
SFAAALSYFDSYRTATLPANLLQAQRDYFGAHTYERLDKEGIFHTNWMEK
>PK3-045_01907 hypothetical protein
MNENHNEERKAEKRRSSAILEPTKKEKGSKVTFIHKFYVSKEFKQLQNLQTNYNEKTKKY
AAITSSTII
>PK3-045_01908 hypothetical protein
MKKIKLILSVILVFLLYNLLVFYLGWNGYVWLDSLNLLTYPSIYIGAAILFSYSYIVSHF
LKSITIFKVLGAYWLAIFEYGIILFPLANLGWLLLNLSIPSEDATKIVGSAAAVILLFLL
IYGTFNAYSPVIRTYKLTVDKKQAKRDSLRIAMASDMHFGTLSGKSHLNRLVTKINGLEP
DLILLPGDIIDDDPIPFLKKDMGEQLKQLQAPLGIFGVLGNHEYYGKMIPTFLEEMNRIG
IRILMDEKVTIDETIRLIGRKDKTDQERLSIPSLLESESNHLPILMMDHQPDELEAAMND
GIDIILSGHTHRGQMAPNHLITKRVFELDWGYKKKKQLHAIVSSGFGFWGPPIRIGSRSE
IVYIDITFKE
>PK3-045_01909 Glucose-6-phosphate 1-dehydrogenase
MNEKQTSNALIMIFGATGDLANRKLFPSLYRLYKKGKLANFAVVGVGRRTLTQEQFKQNV
VNSVSEAIASSKNDDLETFASYFCYHSHDVTDSSSYVELKNIADELDVKHNLNGNRVFYL
AMAPEFFGPIAIHLKQDGLTEVKGYKRLIIEKPFGHDLESAKELNEQIRTAFSEDEVYRI
DHYLGKAMVQNIETIRFSNAIFENLWNNRYISNIQITSSEVLGVEERGRYYETSGALRDM
VQNHMLQMVALLAMEPPIKLTPDEIRSEKVKVFRAMRSVEVDEVDKYFVRGQYGKGLVED
VEVPSYREEQMVDPNSNTETFVAGKVMIDNFRWAGVPFYIRTGKRLESKSTKIVVQFKDI
PMNLYNRPNQEITPNLLVIHIQPEEGITLHLNAKKAGQNMEATPIKLSYANTGIAGINTP
EAYEKLIDDSLHGDATNFTHWDEVALSWSYVDKISQAWEQTPATQFPNYASGTMGPKEAD
ELLEKDGFFWWPVNQFEVDVC
>PK3-045_01910 Ribonuclease Z
MKLQFLGTGAGIPAKARNVTAIALKLLEEKGSIWLFDCGEATQHQILHTNIKPRRIDKIF
ITHLHGDHLYGLPGFLASRSFQGGETPLTIYGPKGIKEYVQVSLAVSKTFLKYALNIVEI
DEGIILEEQDFIVEAKILEHGVTSYGYRIIEKDRPGKLDTDKLKQYGIMPGPIYKKIKEG
EDLVLDDGTIVGSQTFLGPNIKGRIITILGDTRTCASAEILAKEAKILVHEATFSEKESS
IATEYYHSTTAQAAKTAKKANVDCLILTHISARYDYALTEQLLQEARTIFPNTYIAEDFS
EYEI
>PK3-045_01911 Pyrroline-5-carboxylate reductase
MKKIAIIGAGSMSEALISGIVSSKLQESTEITVTNRGNTERLIELQNRYGVKYSFDIEKL
VGEADAIILAMKPKDLKEATVQWKNYITKETLLISVLAGVNMDSLQRLIGLEVPIARAMP
NTSATVGKSATGIAFNSFVEEAQKTFVLDMFETVGLVTFVQEEQLDAITGLSGSGPAYIY
YLVEAMEKGAVKIGLNREVANELIVQTILGAAEMIASSPKSALELRKNVTSPGGTTEAGI
NILEQYDVQKAFISCMEEATAQSKRMGKALTEELKLSK
>PK3-045_01913 hypothetical protein
MKNRIKGSYLYFLIDDNLIYCYKLESHTYITLDDLKKTKHSALYNIKNRQEFQSFEHENS
EAVQGLGLFLDEESLNEIVTCINKAIENNRRKDRET
>PK3-045_01914 3-phenylpropionate-dihydrodiol/cinnamic acid-dihydrodiol dehydrogenase
MKELNGKNIVITGASSGIGEKIAIKAAHLGARPILLARSEDKLAAICKKINNQFPGQALY
FTLDVSNLEQVKKVFAKIYQEVEFIDILINNAGFGIFDMVHEAKMEDINRLFQVNVMGLI
ACTKEVLPSMLKNNEGHIINVASQAGKLATAKSSAYAATKHAVLGFTNSLRMEVANSNIK
ISAVNPGPIETNFFHIADKTGNYVKNVQKFMLSADTVADKIIKLMLHPKRELNLPVWMNW
GSVLYNLFPGIADKLVGGILNKK
>PK3-045_01915 hypothetical protein
MNTLLIKKMIQKSLNQYHLEPDSLSLHDYERLAVHIIALKKQHPVHDLYDLVQDVVYSYI
TNSL
>PK3-045_01916 HTH-type transcriptional regulator PchR
MDKNTEALEALEQFIKEREAVDKMRKQMKISQEESIISDWTLTQLHIVATIKESGRANNT
TLSESLNVSKPAITKAVRKLLEHHILEKVQDEDNKKEIYYLLTKSGEMLALIHAQLHKQA
RERYLRILNEFKPAELEIIIRFLNAITESIKSQ
>PK3-045_01917 sugar efflux transporter
MSRKMSQTKMLSLYLLSISSFFVSLNQNIYTPVIPLIRDSFNVSISWVNFTVSSFIFIIA
LIQIILGTMIDTKNQKHLLILSFIFIAISTIACSFVTNFILFMIFRIVQAIGAGIVPLVA
INMISHLFEGEKRGSAMGTYQILLTLAPAVAPILGGILGEHFGYPGIFLFLFIVAIVLLL
FIIYTLPDSGEKVYSQRISPNFIQTYRAIFSNQVGFITITVSFFIFFIYFAIIVFLPILL
NDHYHISLQNIGLLYLPLTVSMILGSMLFKKLQIRISWRKLFTIVLFLMPLLIIIFGLLH
TKSIIGLSILLFMYGITVGFASPLFSTVISNEYNENRGAALGLFNFIRYSGMAVGGMFIG
LSRILPSSYIFIFLGVLLLLLSLFQYSSLKKTWKQR
>PK3-045_01918 Peptide methionine sulfoxide reductase MsrA
MEKATFAGGCFWCMVSPFEEQPGIGGIVSGYSGGHVENPTYEQVKTGTTGHFEVVEITYD
PEVFPYERLLELYWQQIDPTDPDGQFHDRGPQYRTAIFYHNDKQKELAEKSKQAMAASGK
FSKPIVTLIEPAAIFYPAEDYHQDYHKKNKQHYKEDREKSGRDVFIKEHW
>PK3-045_01919 hypothetical protein
MKFLQNINISKKILIIIMFSTIGLVLIGLFGMYGIKEMAKSSKEMYEENLLPNTYIAKIQ
NYRRTNDSLVIELMITEDKKRNEELLETIKKNSEESDKYVKKLDAISLSKKEEDEYKIFK
DAYTGFRSLQDEVISLANNNLNDSAYNLYTKNLESKRNIINSQLDELQTANEENAEQISN
ENNKYYMKMIYISWGVIFVAVVLAVLLGLYISAMIVSPIKRLQILMERGGQGDFSARSSY
KAKDEVGSLSDSYNRMADGMKGLIEMLSETSHHLASSSEQLSSSSEESSKASEHISETIQ
QLAEGSETQMRLMESSSAGIRNVNETTGHITVRAKKVAETAEQTADVSHEGAKRISEVTT
QMKSINNNVVTLAESIATLETRINQIGDITMVISDISSQTNLLALNAAIEAARAGEQGKG
FAVVADEVRKLAEQTAGSAEQITGLISQIQIDSKNTSLSMTTAANDVDAGITIVQDAGES
FHRIEHSVQELVILVEEVSQSLDQLKEHTNTINGSILEVNSMASEAAASTENVSAATEEQ
VASMQEIAASSTSLAQLASDLQDKIKQFKI
>PK3-045_01920 hypothetical protein
MEISTVYDGISLGNFSILSHFDLENNLALVQKELSPLSEEIDIYASNKDCAVRVKEDKVD
ILGEVYLISHSNIKKLEETL
>PK3-045_01921 hypothetical protein
MEVKLLTLQTNNIKEMKSFYVETLGFPLIKEDSHSFCIKAGSSKLKFTSENVLGNPYYHF
AFNIFANKFAEAKSWVKERVALNVNDEGEDEVYFSNFQAHSLYFYDPSGNIVEFISRNSI
SEQDEAPFSSESVINISEIGVTVSDVAAAGKRLMEVGINERDNQPLDLTSINFMGNKSKG
IFLILNKPGREWFFSNKISAVFPLEIITSQHHTIVVDVEGNLEVS
>PK3-045_01922 Transcriptional regulatory protein SrrA
MDGDLLIDGGVAELTFNNILIVDDHEEIILLMTDFLEIENYQVYSAKNTNEASDILHQTK
IDCILLDVMMPGMDGFSFCKNIRKESDIPILFLSAYETDTDKIRGLTLGADDYIVKSASP
SEIVARIKAVERRMSLTRERGLGEKKILSIGNLILNKNTRSVTVGTQEVDLTAIEFNLLE
YFMENEGIVLSYEQIIARIWHDEFTGYHSVRVHVANLREKLAVFSSIPEIKTIRSVGYLL
QKG
>PK3-045_01923 Sensor histidine kinase RcsC
MHKISFKLLIFISFLVIFFVPVSITKLIFHKVIDNHSQFDDITYERNEWIEKNVLDMDGR
VFLEEDWREQLIHKAEEDNVELFIINREGEITYTKGIVESRNALIDKKDDQTTGVRYEQY
DFGGFDQYNIYAEDSLIASVYISYPISDQAVINNHPNYDLAILTGIITIVAGLIIIFFHK
NLIKPLSALNRSSQQISNENYHVTLPASRIKEVNNSTEAFMKMAHKLELAKQKNKQLEEE
RKLFVSSIVHDLRTPIFSLRGFLEGLQKGIITKEKKKIQYVEMCLKQADHLNELVSSLAD
YSKIEGQIKLEKITTFTMLDIISDVKELLYYSLAQKNIIVEVNNVTNKQISGDFSLLKRA
FENILANSIRHSPENGTIEVIIKEDKGYVETVIVDNGEGFVESELDYVFKPLYRGESARS
GPNQRMGLGLTITHVIIQKHEGIIKATNDKKKGAKVIVRIPINGSA
>PK3-045_01924 ABC transporter ATP-binding protein YxdL
MKVLEVNRLSKKYGHGLSEIRALEQINLEVEKGEFVAIMGTSGSGKSTLLNMISGLDTYD
EGEVLISGENIKGYSDYQLTRLRSEKIGFIFQFFHLIPVLSVLENVTLPGMLKQHKKGDI
EKKAIDILQLVGLGSFIHSKPTLLSGGQQQRVAIARALINEPDLILADEPTGSLDSKTSK
EMMAILQRFSHTLHHTIVLVTHDPTVAAYADRVVFMSDGKIADVLSLANTNLECQEKIRI
ISSKVEGLGV
>PK3-045_01925 hypothetical protein
MKQLCKAAGKFLLFHKTRHLFLIIGVTLGVALIIAIQVLIASIEASNEIAIKEQYGDYDL
VVGYQTAEKSVSAGEIEEMKNLESVEKTTRFLYPYLDKESEMNMLGEPIYAGFENEELAF
EYPVVSLAKGAFPQKEEVLVSSQYAKQHQLEIGSTVEMKFPPNGTKEVTISGFTVDNQAL
SNMAIFDYEWLQEATSKKNHTTAVIIQLDNHENKQMVINQLRQINPEFFIDSRSEIDKER
ENIGGIGPVIQGLNIAIYLVSALIIISTMRMSVQEKQKELATLRILGFERKHIYFLVLIE
SLILGFISLVAGLIIGILLPAGALDFFIERMNVGRGVITFPWSDLLMNLGIFSLVILFSS
LVPAYQASLAPPVVAYRGSSKVQALSKRYTVISIAISLVTAVAYLINVYFIQSKSMFVIN
GVLFIVCAFTSIPLMFAFSVTLLDWIAKFIRIPVEFLLAARNLLRQLNRNVQLSAIFTIG
IVITVIGMVILTTIKDETTDMIKENNPNDLRVISVASELAEGFPYSFYEKVEKDPDLEAF
YYTNEVVFLIENLPPNKRELSEVVLGISGTDLQHSFDSGSIKTDGLSTPEEMSENGVMLT
EQTAEEYGFNIGDTIIVNVSEDFNELDEKEFVVEGIITDTEHIGDADYHFFTTRENMKAM
FGIDTLYQVEMNILHGDKKEKVKLIQSLLQDPAYSNTILYSRAKELAELEQQFLQRVFLL
YLAVAMMIIFTVIGLMNSTASSIKERLKELSMLRVLGSTKKRLLSLLLMEGALLTTTAGV
LAIGLSTLSAYCFIQGLDANTFAVLPKLLLGLFLLSPLIGLGAVLIPALWATRLDLMKGM
RE
>PK3-045_01926 hypothetical protein
MRNKILNRFIGVYDDRDEYQLYEIHKELAFSGIMLWYLTTLLMIISLIIDTIHHTLSFAT
PSLFIVNMIYAILTLIKIRKKQLDETDCASIEEYEEKKKQLKKSSFLAGIQWGLSMLILM
EYVFPYLSTGELNLEWWNVLIWLLGGMLFGMIMYLFSKSKLQKHF
>PK3-045_01927 hypothetical protein
MRINKLVKSWKYPSILLSSIGISSIGEWVYFIALNLIVLDRMGVLAVSGLYILRALSAFF
TNFWSGSLIDRLNKKHLMVLLNIFQAVFIALLPSLSSLSAIYTIVFFINVASSMYEQTSV
PYITKLIPPDQRKRFNSLRSLIDSGAFVIGPAIAGMLFMIGTPNFAIYSNAIALFISALI
TLILPNIERNDFIETEDKKISLKILRQDWRLVVDFSRNHLYIIIIYLLFSTIMVLATAVD
SLEAAFSREVLLLSERDYGFLVSIAGAGIIVGALVNIIIVKKVATSWLIGLGSLMVSVGY
MIYAFSANFLIAAIGFFVLSFSMAFLNTGFNTFYQKNIPVHVMGRVGSVYRCIEAFFIII
STILFGIMAEMISIKSVIILGSIIMFAVTIILFIFNTRPSKAAFYMEE
>PK3-045_01928 hypothetical protein
MGDGVTDAPVIELGYMYVLHTVPTKDNMVTYCQTGVAPRRAATRPQD
>PK3-045_01930 Transcriptional activator HlyU
MYDSFMIIEQKNKDQIKVQIFKALADESRLEIIRILRDQKTELSCGEVGEKINITKSTAS
YHFKTLREAGLTSTRKETRNKYVKLNLDTFEKYLPGFLDSL
>PK3-045_01931 Tetracycline resistance protein, class B
MNKKISITFFLIMFVIGTDTFLISPLIPTLQSAYHIPISWSGWLVSSYALGYAIFALIAG
PISDGANRKKIMIVGLAGFSISTFMCGLAANFWTMISFRLLAGISAAFVTPQVWASIPIL
SRQQDIIKIMGYATGGLAFSQLIGIPIGSLLATFSWHTPFYIISFFSIFLIVVVFYFMPT
IKAIKDSEKQSVFKRYRGIFKTENSIKYFTAYFIFQVGNFAVFSYIGTWFSNRFSLNVSE
IGLAMMVLGLGNIIGSFFGSGLVKKLGEPKSLLAALVMLILFYSALPFVPNLFIGELFFF
FIFLINGTLFPVFMSILQSLTHSARGTVSSLANAAMYAGTTIGGVIGGILFSRIFGFTAI
TFFTVIMYLTSILLYKSSGLFKNRQDELSKKAIL
>PK3-045_01932 hypothetical protein
MRKLFRYLFSVLLFITSIGLYCSNRLMYMKKKDNDFIVNREKEAGRLDPVSYENLTKQEI
TIPSPYGYDLKAILVEPFDTKKYIIISHGVTENKTSSIKYMNLFLERGFNGIIYDHRRHG
ESGGKNTSFGYYEKFDLKQIVDWLKREKGKDILLGIHGESMGAATMILYAGGIEDGADFY
IADCPFSDFKELLNYVIKQEIKLPGKVFIPIANLFLRARARYSIKDISPISVIDKIKSPM
LFIHSKKDDFILPEMTQKLFDKKKGPKKLFFAVNGTHAQSYNENKEAYEKAVDDFLKEYV
QS
>PK3-045_01933 hypothetical protein
MMTQKRDKGYSQAGKPNADTVKQTIAAEELEKAIHPTNRQNSKQ
>PK3-045_01934 hypothetical protein
MAEHHFYLKADWPGYRNDIGTIESGNLKTKISIPKEMEGPGVGTNPDEMLLGAAATCFII
TLAAMMERSRLEKESLTLESEAVVDVTNGVFTYQKIIHRPKIVLKKDAAEKDIKLAAKLA
HKAEASCMITRAIKGNVEVELEETIELAL
>PK3-045_01935 hypothetical protein
MAKQRRHVPKTKQEDKPVTLGDLLNEQLADQLKNKKQELKQQEEAKQKAEEERKREERRQ
REKNKSFEELLNENAMNWKDFK
>PK3-045_01936 hypothetical protein
MYVKVYEYHMPTDKIKEYFYIQEKASNIYRKYINSTTTYLQSNDDPTKWLEITTYQTEQD
YDANIALINEQTEIVVLFQEFQALLSLENSQIKEENFTKKTEIK
>PK3-045_01937 hypothetical protein
MVNLQLKGRENIVERKIRYDSTIEEYQCKLLQSDKRKITLLHQVEKSFEMRKGKQKLVIP
KGTYTFAYYWLDQPYNLYFWRDTTGKYLGAYFNIVRKNWFQNDMVIYEDLIIDIVIKPNQ
MYYILDQEELPQPIETFEKGFVQKALQQLLKRKDGILTEVSRETADFFRS
>PK3-045_01938 hypothetical protein
MAITHEFGIIQNFNKRHVYNHYTPDLYDCIPVNDHFIQELIKPLAMMKTYFHTYERPANG
LAYYGITLIPPESLPIFLDIVADKKSGELIDLARKITAAQEAEKYMIHYGI
>PK3-045_01939 hypothetical protein
MNNFFSRLTLFLYIIFFLLTGIAFYFIYKDFTTTFPFYFIIGYIIFLFCFIFYLLWMAVF
TWKKNFSWSLLAKKVSQCICLFLLFSLVNYLFSYFFHPNQKTFAFSFTSLGLAIGLTFLD
IPYFQSKSKK
>PK3-045_01940 hypothetical protein
MKKIKDERLIMKNLQNIKVAYIIQTLGIIGILAYDLITKGLAGMRDNPLWYVFIITSIIS
AYLSMNISVDHENSKKDPKKGLSLSITIVTLLSVLIGILIILSDRERIVNGVLIGGIVFI
CGIIPVLYTYYLRNKKGRDLDDEDEV
>PK3-045_01941 hypothetical protein
MKNHIKIARIQADLTQQQLADKIGVTRQTISLIEKGKYNPTLKLCLELCYSLNRTLDELF
WVDKEEEK
>PK3-045_01942 Ribokinase
MKDLKILNFGSLNIDKVYSVPHFVSAGETLSSTNYDEFPGGKGLNQSIALAKAGAQVYHG
GNIGKDGLFLKEVLAEANVNVDWIDENGNTTGHAIIQVSASGENCILLLGGANKEITIDH
INQVLANFSQNDLLLLQNEINDLAYIVETAHKRGLKIALNPSPIDETITTLDFSKIDYLI
LNEIEAKAITNEHTNDKIFQKLLSLNKQLKIVLTLGKEGVIYKDSVEEHRQAAFKVDAVD
TTAAGDTFLGYFLSQISQQEEIKSALQMAAKAAAIAVTRKGASSSIPSSQEVMAFTKK
>PK3-045_01943 hypothetical protein
MKHALIIGGTGMLFDVSGWLAEQEDCRLSIVGRKAAPINSLIDILDDKTKITPLLVDYTN
HTAFREKLEWTIQQNGPIDLVVAWVHSIGKNALNIVKDELSESGQKWRLFHITGSSSDLS
KIKKELTIPPNCSYHQIQLGFIVENSASRWLTHKEISAGVIDAIQNNWQRKIVGVVEPWE
KRP
>PK3-045_01944 hypothetical protein
MTEDFYCDEVLSGKTKVRKVMETENVLAYYHTKPFYPVHIVAIPKKHIASLITLEEGDNH
LLLELLGVVKQVAASVTKEYGACRVITNLGKYQDSKHLHWHIVHGKPLR
>PK3-045_01945 hypothetical protein
MRKKVRLFIAIILLVSLFVPYGSNSKIKAASNAISINFQADDAVIDPNRPYIYMVEIGKP
LLQRVNYLTGEIKKINLKYPAEKVEVYKDKVYVTQHLMKHSYYTEKGLKGAIAEVDAGNF
TLLDTFPISTDPWDIAIDQNGYLYITPGSNQWETIKVYSLNTKKEVAENAGDDNTSIYME
SSISYNEKLHRLYTLDSETSPIDAYAYLIDNGKIINHYDSPYHGDYHLSSEMVLSPDGQY
MYNMNGVVFRLSTVQEEDMTFDFEYRMAYDEENNEYETFNDIAFDDSGSRTYIASSFGGI
DVYGYGSADYYYSLKEDYFVHSLFYQNGLIAIYEDENGNNYVEYMKNTEPSSFELTDSLF
YDVKNDEWASLRQDSSNLEIDSELLFFFNQGIRWKDRNGITLMEGDKKIPIQIESDDNYL
HILPELLTKGKKYKLTINKNAITGYAGKSLDRDIVITFGTIVEPVSEVFLEKDSSQSPKM
YTFIGGTTGGSNPLYEFYIKEGNSWKKVQSYSRNNKLEWHPASTGTFQFKVYAKSSGSRN
LYDSVREFSQKVTDTIKPSITITQKTKKPTNRDIELEITAKDNFRIRYIQLPDGKKVNNE
NVKYMVKKNGTYTFTVVDLGGNKQVKSITIKNIDKTPPNEPQIKEVTDKSTTVSGKGEVN
AKVVVLAGKKELGKSTVQKDGRFQIKISKQKAGTKLVIKIIDAAGNSTSKAIKVIDKTPP
AMPKITTNVTSKTTLIAGKAEANATITIYNGKKFVQKTTADAKGSFKMTIKKQKKNTSLL
IYAQDKAKNKSQATKIKVK
>PK3-045_01946 hypothetical protein
MNKIELIELTSENIQANGCYCLRSKQKSTGYQAKKAWLMDQFGQGLKYIQLMENDKLAGF
IEYTPIEHSSRVVYGENYYIIHCLWVNITGKGYATQLIEKVIQDAKDHKKNGVIVVTNPT
TSWTPSKEVFLKNDFTELEYAPYGFELLVYKINEAANPYFPNDWEERLTRHNNQLTILRT
AQCPYIDIAIDNVIEAASKLQIKAEIHHLQTREDLLKLSPTPYGVYGVIFKNQLVAYHRL
TVHSAMKRIKEFI
>PK3-045_01947 ECF RNA polymerase sigma factor SigX
MVENEKDKIILEWYEKFGEAIFKYIFIMIQDYQQAEDLTNDTFLKAFIHLDTFKRDASEK
TWLYRIAHNLTVDMIRKKKPVILLKEAFLFNKDKNPLPEEMLQIREQSLEIYKALSTLKS
TYREIIILRKLKEFSIEETAGILGWSEAKVKSTLFRAMKALEKELKKEGELNGKII
>PK3-045_01948 hypothetical protein
MEKLYKEQLDEELRDLEADIYWDKERKNALHLKLKEQMKNNRKTKNALQPFPFVAIIGAA
VILFLFTHMEMESLPFEKGGAKNAAFDMEADQDERVVFTVEEQNKIENKTTVYLSEEATL
PYNLNTNNLSSIVVVGEPKLSVRKEKSSILVNVDYPLKNGQNFSIRTEKKPNNMRGNGIN
SVVKKEYEITINNQEAVLVDMEKKPKLILKTDRYQYTISGVKDVRDLIKIAEMIEFY
>PK3-045_01949 RNA pyrophosphohydrolase
MRNRGSVVISQGNKVCLIKRVRDNSVYFVFPGGGIEADETPEQAAKREAFEELGVTVELK
ECLVELEKQGIPYFFLADIIHGMIGSGQGEEFTNSNRDRGTYLPMWVDIDDLTVMDVKPN
IVAKKVQEYFARKHSS
>PK3-045_01950 hypothetical protein
MKIEIRTSREKPIKACEVIELYKNAGWWKERTEQDIEKMLSQTFAIGAWEKNKLIGFARA
IWERKEIHLSISPKLYRSCNCRYVKWLLESKV
>PK3-045_01951 Fatty acid metabolism regulator protein
MGLNSIDKKNIVNSVYEQLKEHIINGTWQPGSKIPSETQLQKLFNVSRVSIRSAIQRLRD
LGIVVTYQGKGTFVSDDINGKSINDFVPVMHLSEEEFFDMMVFRQTIEFKCLELAVQNAT
KEDIDNIEEILNDMFRYRDDYKKYSEIDFNFHLAIAKASNNIVFYRVMHSIRDFYYYYLE
ELNRVIGITLDSIEAHLQIFRAIQNRDAESAKTSLSKSMESNIEIIKKIKSSRK
>PK3-045_01952 D-galactonate dehydratase family member
MNHLEIRDVKVILTAPGGIDLVVVKVETNEPELYGLGCATFTQRIFAVKSAVEDYLKPFL
IGKDPRRIEDIWQSANVSGYWRNGPIMNNALSGVDMALWDIKGKLANLPVYQLLGGKCRD
GIPLYRHADGPDEVAVEENIIAIMEEGYQYARCQMGMYGGSGTTDTRLIATVYEKSNKIV
PKRSPKTSLAGCYFDPEAYSKSIEKLFDHLRSKIGYNMEFIHDIHERLPAIEAVRLAKKL
EPYHLFFLEDPVAPENIEWLKMIRQQTSTPIAMGELFTNVNEWKSLIANQQIDFIRCHVS
SIGGITPAKKLATFSELYGVRTAWHGPGDISPVGVAANLHLDLSTPNLGIQEWTPFNNAL
EEVFPGCPQEENGFAYVNEKPGLGIDIDEEKAKKFPVAGGIPSWTLARIPDGTAVRP
>PK3-045_01953 L-threonine 3-dehydrogenase
MKVGAYVNSMQVEMIEREIPTPKEGEALIRVSYAGICGTDMMIYHGLHPRAKAPLILGHE
FSGVVEEVVENEQIKKGDKVTVEPLLSCGKCAACTNGQMHVCEKLRYIGIDQDGGFAEYT
TIPINRLRVLPDGVTEKEAAMLEPLAVAIHTVRRSNMKVGDTIAILGAGPIGLLIALIAE
RAGAGKIFISDVSTMRLKIARDMGYEGIDAKNMDIVQIVKDSTNGVGADVVFEVAGNQIT
ANQMIDCIKYQGEITVVSVYKKPPTINLASMHFREISLKTTRCYSSDDFTKAIELLGQRN
IDLNPLVSHVLSLEDIKLGFDLMEKPDESLKILFKP
>PK3-045_01954 2-dehydro-3-deoxy-D-gluconate 5-dehydrogenase
MTQAFDLSGKVAVVSGATRGIGQGIAIGLAEAGADIVLLQRSDDTSTEEKIKALGVRCKI
IQCDLMNLNEVKQAIPRAIETMGSVDILVNNAGIQRRSPAVDFSEQDWDDVLNVNLKAVW
ILCQQAGRHMVEKNSGKIINIASLASFQGGLFVPAYASAKGAVGQLTKALANEWSSQGVN
VNAIVPGYIATEMNTALINDPVRSRQITERIPAGRWGNPEDFKGPAVFLASDAADYVHGH
LLAVDGGWLGR
>PK3-045_01955 putative glucarate transporter
MSLERNNSIKDFIPVPAMKKTNIRWMIVSMCFLVTTINYADRATISIAASPLQSDLGISA
ITMGYIFSAFSWAYALGQIPGGWILDKFGTKKVLFWSLFLWSTFTLLQGFVGFFNASTAI
VMLFILRFIVGLTEAPSFPGNSQVAASWFPDNERATASAIFSASAFLAIIIFNPFMSWIT
QSFGWEYVFIIMGALGIMIALVWLKVIHNPKNHPLVNQAELNYIEQGGGILEMMEKGANK
EASGINWSHIKQLLKSRMLVGVYIGQYCISTLTYFFMTWFPVYLIQERGMSILEAGFVAT
LPGLSGFLGGILGGVYSDYLLRKGKSLTFARKTPIIIGMILSASMIICNYTDAEWLVVGI
MALAFFGKGFGQLGWAVMADCSPKEIGGISGGLFNTFGNISGITTPIIIGYIIAATGSYN
GALVFVGINAIVAMISYLFIVGEIKRVELSNSAK
>PK3-045_01956 hypothetical protein
MKKAQLVIEAQNGMFQEGDVVHNSKNRESNSVDN
>PK3-045_01957 hypothetical protein
MFIIVRIENQIQLIIESKQYVFDVLYDEELGWIVQTSYCQIGGCIVNYIPCQSKISAIEL
SARMTFRDETC
>PK3-045_01958 hypothetical protein
MMEIEWKKESIIFETLRESEVWADSIANEIHGRTINGYITPDYKIAYALSFFLASNPDYV
VHTEKSFNIRPGLKVEDSFIYKVWVTFNSK
>PK3-045_01959 hypothetical protein
MKIIKSGILAVLLLLFTNTGIGNAEEYQGGGFSENEIIKEGSNEIISDLEVEDRPNNLSS
PDAAISLGPPSCNRTHSHNVATVTMQVKNLTGSYRSLMWGFHLTSSARSFLGPIVVVKMP
SAAVNGKAINTPYEPHSEGASYNFHGSMKNYQIKGQSYPLKKGDIVNLSWHITGTNPERY
GYRYLTCKMP
>PK3-045_01960 hypothetical protein
MRELWLVQYLDMMESIPRAITSAVIKIAIWVTPVIFLVKVMEKHNPLSYLGLRYNFKKGL
KWVCWVSLVFISYFVILNFIVLKSNIDFQMGLHEWLNIVLLVGITEEIVFRGFLLRKLMD
SYKFWIANTITALLFVSIHFPIWFYKDLFEFSYLLNGITTTFVLGIILGFIYKKSNSLWS
VIIVHSLYNLLVSLFY
>PK3-045_01961 hypothetical protein
MFIMKLTNNFFIRLLICSVSSAFFLAFFLFYFINSVPFSFFDSFDLASFMLFFTIFSLIY
LVIGAPIQFFFRKSLNNSYIKNFVLFFIVGFIVNLIFFPIATDLNPKFYLDQNFYYMIIS
SSVIFWLNDLIFLRINHEKLKF
>PK3-045_01962 hypothetical protein
MQVKRKFGNHKNWKRIVEKQYAQTFMKTEEFTGYLALFHSIKVVESVTKRYDQKAVCILD
DGYMWLHQFPLYKHHSVTTMFNANGDIVQWYIDICLEIGIEKNVPWMDDLFLDIVMLPSN
EIYLLDEEELENAYKENSITKQQYNLAWEEANGIIEQLKLDQFTLLALAKVQKKQMERLL
K
>PK3-045_01963 hypothetical protein
MHQNIREKQSNKSSFLGVLSILFPIVLGLLIVNFFTDIIPLEKIQGLPVLMPLFVCPIGA
VIGFLGYKRSRDTLSLVGIIANVVLFLFPVFYHILGTLIMGN
>PK3-045_01964 hypothetical protein
MLISDKLYGNFEIEKVLIELIESKPIQRLKGIHQGGASYLVNENWNVTRYEHSIGVMLLI
RKLGGSIEEQIAGLLHDVSHTAFSHIIDFVLDKQNENYHEEIFLSVIKDSEIPIILEKFH
YDYEKIIGDDSKWTILEQPAPKLCADRVDYTLRDMYTYGKISLKEVEGFLENIVIVEGKM
CLQHVDSAEWFVETYYKEVIDFFMHPLNIYGYDQLTKVLKAALAHSILQFSDFLGEDKEL
IHKISTAKNVELQMLWNKLHPSVKVVEDEEDFDIHLKNKVRLIDPLIFCRNKLISASSLS
QKIQGMNHAALQKASKGAYVKVIEA
>PK3-045_01965 Metallothiol transferase FosB
MIKGLNHFLFSVSNLEKSILFYQQVFDAKLLVKGRSTAYFDLGGIWLALNEEKDIPRNEI
HHSYTHIAFSIEEADYDKTLKKLEHLNVSLLDGRERDEKDKKSIYFTDPDGHKFEFHTGT
LSDRIHYYKTEKQHMTFFERD
>PK3-045_01966 hypothetical protein
MLNDQLLIKELTSEAEWEKAFPVMKQLRTQLNLDTYLTLVSESVKKEDYRLIALYNQNEI
VALCGFMPMITLYNGKFIWVCELITDSKQRSKGYGKVLLNYVHEWAVANDYPIVSLSSGL
QRIDAHRFYEEKMEYDKVSYVYLKKI
>PK3-045_01967 HTH-type transcriptional regulatory protein GabR
MLELTPILQKDSGNPLYMQLADFIKQEIMNKHISPNEKLPSKRKLAEHLQISLNTVQSAY
DQLCAEGYVESIPRRGLFVLTIDEEFRSRLDTEENKEMQKVEQANPVKIDFNSGNVDSSY
FPYNTWRKLSMQSIYEDQNFWFSNGDPQGEFNLREEIAKHLYATRGVNCHPDHIILGAGT
QMLIGLIGLLIGRDKTYALENPGYHRIRVVLQDMGINVLPISVDDNGMNVSQLNKSKANI
AYVTPSHQFPYGMIMPITRRLELLKWAEKKGGYIIEDDYDGEYRYKGKPIPALQGLDKNN
RIIYLGTFSKSLIPSLRISFAVLPKSLYSTYRKHFTVYKQTVSRMHQDTLYRFIKEGHWN
SHLNKMRTLYRKKRQVLLQTIQHYLGGFVKVIGENAGLHIVLEVYTEWTETQLIEKALAC
GVKVYPLSMYYFEKRYTGNPKVILGYGGLTDAEMDEGIGLLRSAWEI
>PK3-045_01968 hypothetical protein
MNQALLIIDVQQELVEGNAEAKGVYNKQGLLETINLVIKKAIESGIEIIFVRDKDVAGGK
GPGFDIHPDINVPREVKIFDKYATNAFYGTGLLEYLQEKEMRHLVIMGCETPYCIDTAVR
TATVNHMDVTLVGDGHSTTDSSILSAETIIKHHNTILHGHYNVDHFSIVRNAAEDLFTPT
HDTYR
>PK3-045_01969 hypothetical protein
MKYIEFGIGNKWLIRTETELEDGTEFEEKGIKRPIKFQSLYTRIWIGKTVLIIDSKEGFK
QATKNGKSFKLILGIKSL
>PK3-045_01970 hypothetical protein
MFISKMKTTIQKTELEKGVHKQDENHYSRDRARKGVHKQDENHYSRDRARKGVHKQDENH
YSRDRARKGVHKQDENHYSRDRARKGVHKQDENHYSIDRAQKKVFISKMKTTFQKTVLKT
SVQNQDELRPPTKTISKIGIHPS
>PK3-045_01971 Aldo-keto reductase IolS
MQKSQLGNSNLFVSKLGLGCMSLGTEEKTAFPILEAALEEGINYFDTADLYDQGKNEQLL
GQFFKNNREDVILATKVGNKWEEGKEGWVWDASKAYIKEQVKQSLKRLGTDYIDLYQLHG
GTMADPIEETIEAFEELKEEGFIHYYGISSIRPNVIREYVKRSSIVSVMMQYSILDRRPE
EEALPLLAENNISVVTRGPVAKGLLSPKYREKLSEKGYLDYSGEELTEVLHTLEQKFLDN
RTLTEAAVQYNLAQPAVASIIAGASSAEQLRANAKAVNSAPLSADEIAFIKKISKASVYE
AHR
>PK3-045_01972 Cell division inhibitor MciZ
MKVYIQEKGIILSGKAWEIRYILKKYQTEFTYVKDWINANADSSQK
>PK3-045_01973 Methanol dehydrogenase activator
MSTLEEKTLKTEHIYSGRIIQVQVDEVELPNGKTSTRELVKHPGAVAVIAITDDNKLVMV
EQYRKPLEKVIVEIPAGKLEKDEEPALCARRELEEETGYECESLELVSSFYTSPGFADEI
IHVYVAKGLKQKENAAGLDEDEFVNVLEITLDEALEFIKEKRIFDAKTIFGVQYLQIANL
KE
>PK3-045_01974 hypothetical protein
MNSYYTDLHIHIGRTKSRKPVKITASRNLTLTAIIEYASKQKGLDMIGIIDCHSPEVISE
MEELIAQGKMLELADGGVRMEGITIILGSELEIYDSFCKGPIHVLCYLPTLAKMKEFSNW
ISHHMKNVTLSSQRLYISGKELQYKVKELNGLFVPAHVFTPFKSLYGSGVNRSFKEVLDE
KMIDGIELGLSSDTEMADQIRELHSFSFITNSDAHSLEKMAREYQVMEMEDASFAEFAKV
LHQEEGRKIIANYGLDPKLGKYHETVCMKCYSPFSEATGICTECGSHKWVKGVAARISDL
KDAASAPSRPPYIHQIPLEYIPGLGKKTLQKLLDYFSTEMQIIHEAPYEKLVEVVPKKVA
DYIVAARTGMVDLQVGGGGKYGKVRVDKL
>PK3-045_01975 Putative ribosomal N-acetyltransferase YdaF
MKPILIDLPETIETDRLVIRPCMPGDGKDVYESIQRSKEDFKPWMSFANQEQTLEEVEAG
VRESYAKYILREDIRLHIYLKATNEFIGSTGLHSIDWKVRVFEIGYWCDSAHTGKGYITE
STKALIQFAQSTLEANRIEIRVDSTNMKSRAIPEKLGFSLDGILKNETLSADTAELRDIC
LYSLT
>PK3-045_01976 Stage II sporulation protein M
MKKKKYQNILVNHIREHSSIYLFIIVLFLMGVIFGAIVVNSLSLSQKEDLYYYLTQFFGQ
VSNGQVADSKDLFFQSFSHNSKYIGFIWLLGISIIGLPIILILLFIKGMVVGFTVGFLVN
QMGWHGFLLSFVSVLPQNLIVIPIFIISATLSVAFSFKMIRQQFMKKKGEPMLPLFARYT
ILLIMAFIVIGIAAAVEAYISPLLMKAVINMVQSIIITIPFG
>PK3-045_01977 Ferric uptake regulation protein
MESRIDRIKKLLHSSSYKLTPQREATVRVLLENEEDHLSAEDVYLLVKEKSPEIGLATVY
RTLELLTELKIVDKINFGDGVSRYDLRQEGAAHFHHHLVCIECGAVDEIQEDLLGDVEKL
VERDWNFKIKDHRLTFHGICHRCTEKSEDVSSAE
>PK3-045_01978 hypothetical protein
MRWTKAIINTLKVFLLFTGCTILFYYAIVWFNQEYQQLHRYDEPSGSAIKVNADNTLETE
KYSWRDRIFLFYLNGE
>PK3-045_01979 Tyrosine recombinase XerD
MEDQLKDFIHYLLVEKGLASNTLVSYERDLKSYIKYMKNVEQCNLKEIQRSHIIRFLGFL
KDQGKSSKTIARHIASIRAFHQFLFRDRVLEEDPTVHIETPQAERTLPKVLSMEEVEALL
DFPHKNDHYGLRDKAMLELLYATGIRVSELINLNMDDVHLTMGFIRCIGKGNKERIIPIG
GAATRALEDYLHQGRPTFLNQKKSTEHSLFLNHHGNRLTRQGFWKILKRLGKEAHIEKEI
TPHTLRHSFATHLLENGADLRAVQEMLGHADISTTQIYTHVTKTRLKDVYSQFHPRA
>PK3-045_01980 hypothetical protein
MNDRKQLKALAMKKIARLMDSLSDESKDKYRTAIHAFADLYLEDELVFRELYFAYKQGLR
SYDIKSTNQEAIYYRKEDKEHVIQFRQSHYRLQDHLFFPFVTSCIEIMREVLPLGSVVEL
NPLYFLPEQQTSSAAKIVITKRYTVPTGYQTFFPYGGVVYPVGEMKKDAILYFTEPLITN
VLHMGFKDEMEEAFELLMKEELVVEKKMTSIEFSAQDMQSLQVEMERAGER
>PK3-045_01981 hypothetical protein
MANYTSSFSSSLVSNMISFLEDAKEGIQKNFEQMDLENASVEEEMREKIEEMIRELNRLI
VAIESVPFR
>PK3-045_01982 hypothetical protein
MGTAQIKMDIRELQATLQTLQSSIDEFSSYTDTFRTGTRNQLKNFHSDFIDKVDAILDHM
NNDVNKELVKNMHAVYTAGKSILEEMTKADEEIGKDIRSGQS
>PK3-045_01983 hypothetical protein
MKRDLKINYGILDQIIEQLHTYKRALHQMQTSLHTIAGYTERNAGKSLEAWEDLMQESKK
NIQSYQTQIEDLLTLFENYVADTTAYITPISRNSMMRVDRNDIWGNLTQIEWGVTYRLSR
AIQETYRSPSLLFSLFDDTDLEERERSRYNKQQLESIRNNMESVQSRLKNKMEELWDLYE
SKVKKYENTDDEYANKASQVKDRYTTFSEKVSDVISVTAEGAWDFVKGLAVAIYEIAKGL
ITLVIDAGIVAASGIIPDSIEPDFLKKASTKRIESATETLDAIIHDPANVLESMAQSITD
TAEKEGIMYVSGSAATSFIPYVGQAKYLKLLKGEKSKNKANGIRSAISQKTTESLQRIDG
SKKENSLWPNGIKNSGKQYVQEVTHFFRQNFMPNPSFQLSTANQAPVNVWSRATIENRMD
SIVPVSLRKVEGKGTTKGTDKDTPAAFRQTEFASSYEERLNQTPSLINQKVGFEGTRGES
KCTLKPPPDPQLKKILDEAGVDGIQYKNAVPDFSPVAKAEFDIDYMLGGNGNRGTNARRA
NFAQADQKLADQLNSSPNLARNFGMKAGGIKARDIERYRERNKLTWHELNDVKTIQLVPS
KINKTFGHLGGVGEINAGAFEPGGFAKK
>PK3-045_01984 hypothetical protein
MKINDTVFGELEYEYGWSRYTTIEFCGKEAEVALMIKGEEDGKFDEEQYIAYNSLMQKWE
QIQYSILQPILNYYKQTRHELGYDIDHNENYPEIETTDQILEMINLVGIVVPYGDIYDER
DIGITFDCTWDIENGLGLRLLNEQVNEVGYQDVAI
>PK3-045_01985 hypothetical protein
MRVDWNDIGGNLTQIEWGVTYRLSRAIQERYRAPSLLFSLFDDTDMEEKERSRYNKQQLE
SIRNVVINDPTIVLESMAQSITDTAEKEGIMYVSGSAATSFLPYVGQAKYLKLLKGEKSI
NKASGTRSVVSRKTTESLQRIDGSKKENSLWRNSIKNSGKQYVQEVTHFFRQNFMPNPSF
QLSTANQAPVNVWSRATIENRMDSIVPASLRKVEGKGTTKGTGNNRQIDFTRGFDVDPKY
SSYEQRVKTTPVNKGEWSNERAESLFISDKTGEIKKYLDEAGVDGVEYKNGMPDFSPFSK
GEIKLENMTNDRKSNFSTADEELAKKWSTPEQKWTAEDIADWREDNKYTWHELNDLETIQ
LVPSKINSVFKHLGGVGEYNIKVKLGE
>PK3-045_01986 hypothetical protein
MAIINDELFGKLEYKNNFWRGKTIIRMFDLEREILLSVDAHENADFSNVQKEAFINFNQE
MKNIIHEAEKQVYDYYIENYEEYREMLGNESEADKFAPKVDSISDLKGIVKPVELIVRRV
RKNGKRRLGLLCDVSWDIDNGMGIKIEDEMVEEVGYQDIVL
>PK3-045_01987 hypothetical protein
MNVVGYIRVLTQGQARDGYSLKYQEDEIKAYCEENNLNLIHIFRDEGISGAKLNEEALEI
DRVGLQEMLAHLSSVQIDYVVVLNTSRLWRSDIVKVLIQRELKKYGCDIKTIEQPFYSIH
KKDPNDFLVNGLMELLDQYQRLEIALKLTKGRNKKAKEGGYAAGRATFGYTKQKGEKELK
IDNGHAEVVKRLFELKHLHRKWSLSKLAEALNEEGYQTTQGKAFTKVQVKRILDLESFYQ
GIYTYGQIQANGKHEAII
>PK3-045_01988 IS110 family transposase ISCth6
MHEKQKHIYVGVDLHKHHHVAVIINCWQEKLDEIKFENKPSAFSTFLLDIDKHTEEGLTP
VFGLEDVGGYGRELAQYLTDHGQVVKEVNPALSYAERKSHVTVQKSDSWDAECVARILGR
QLSQLPDAKPHDLFWSIQQLVTRRNALEKAQGALKNQLHIQLSHHYPSYKKFFSEVDGKT
ALAF
>PK3-045_01989 hypothetical protein
MTTFLLEVSHNTCSVKKANEILKLVIEDGNTTKEYQETRNFLVECIVRHILFEKQEIGKV
ERELKELMSLLDFQLDSMPGIDLVTDSALIAEIDDVFLMPTN
>PK3-045_01990 hypothetical protein
MQVVKGSKLPRNPVFYAYYQKKLKEGKTKGQALVCIMRRLVNIIYGMMKHKTAYKLPIVH
EKEVV
>PK3-045_01991 hypothetical protein
MKDQEKGMNELTVDEYLKNREKYIEQGRAIEGNAAQQATREKALNKKIEELFESGMSWEE
AEIKANSWLKTQAALHNPDQISGGNPLNIGGMGDKRINSSIGSQWKYRIDIVDEQIGELA
KLMTPEQRKSTYLNVKLTH
>PK3-045_01992 hypothetical protein
MSLFKDFKKVSEVKECTINKYKNILPEALIEAWKTYGYGTFMNGYLKIINPDEFSSLVND
SYLRSKGTIPIFSTSMGDVILFEKDENQESYLVMINYRKGKTKVVASKYSLFLRFLEEEA
FRQKALDWLPYPEAIEKYKEPEHDECFGYTPLLGLGGAEKVENLKKVKLKEHILIITEFM
GPVQ
>PK3-045_01993 Phosphopentomutase
MSTYKYNRVFLIVMDSVGIGEAPDAKKFNDEGAHTLGHIAQRMNGLHMPNMAKLGLSNIE
EIAGVERADNPLAYYTKMQEASNGKDTMTGHWEIMGLNIATPFRVFPEGFPDELLNEIEK
KSGRKIIGNKPASGTEILDELGEEHMKTGALIVYTSADSVLQIAAHEDIVPLDELYRICE
LARELTLDEKYMVGRIIARPFIGEPGNFKRTANRHDYALKPFDRTVMNELKDNQIESIAI
GKISDIYDGEGVTKSLRTVSNMDGMDKLVDTLKMDFTGLSFLNLVDFDALFGHRRDPIGY
GKALEEYDARLPEVLELLKEDDLLIITADHGNDPIHHGTDHTREYVPLLVYSKSLKEPKE
LPLRKTFADIGATVADNFSVKMPKHGTSFLNDLI
>PK3-045_01994 Purine nucleoside phosphorylase 1
MNYTMIKQSADFLKQKYAKTPKIGLILGSGLGVLAEEIENPVKIPYEEIPEFPVSTVEGH
AGQLVFGTIKGIEVVAMQGRFHFYEGYTFDKVTFPVRVMKELGVEKLIVTNAAGGVNENF
APGDLMLISDHINNMGTNPLIGPNDSKLGVRFPDMSEAYCKSLRETARKVASSIGLSIQE
GVYVGNTGPSYETPAEVRMLRVLGGDAVGMSTVPEVIVARHAGLKVLGISCISNMAAGIL
DQPLNHEEVIETTEKVKANFLQYVKELIKHIGA
>PK3-045_01995 Pyrimidine-nucleoside phosphorylase
MAFRMVDLIEKKRNGLELSKEEISFIIKGYTDGTIPDYQMSAFSMAVFFQDMTAAERAEL
TMAMVHSGDVIDLSAIEGIKVDKHSTGGVGDTTTLVLGPLVASVGVPVAKMSGRGLGHTG
GTIDKLESVKGFHVEIEKEAFIDLVNKNKLAVIGQSGNLTPADKKLYALRDVTATVNSIP
LIASSIMSKKIAAGADAICLDVKTGAGAFMKTLDASRELAEAMVQIGNNVGRKTMAVISD
MSQPLGYAIGNALEVKEAIDTLKGHGPEDLTELCLTLGSHMVYLAGKAESTDRAREMLQE
VIDNGKALETFKIFLSSQGGDASVVDQTDLLPKAKFITELPARESGYVAEITADSIGTAA
MLLGAGRATKESEIDLAVGLVLRKKIGDKVEAGESLVTIYSNTEEVDDVIKKLVENIKLS
PNEVKAPTLIYEIITE
>PK3-045_01996 hypothetical protein
MKSLEDKLLEEKKKIAEIKAPPELEQRLSKALFDKKTNSPNLKRWYPLSAAAIILLIFMT
YQSSALAYYGKKLLGFDTIMNQSLKDLNENGFGQNIEKSYLLENGTVLTINGLMSDENRL
VVYITLENDKGLPDDLDHIFSPRNITGFFTNAKMNSSVFEKNDDKTKITGILNFDPINAF
SKKLQLHYVYWKDDETMEGTTDISFPYNHKEALQTKMKQSINKKWNVDKGTIHFKRIIAT
PTQTVIEGSFHVDNYDRLNYGFNGVELVANGKPLSQEGYTTSSSINKNNTFSIEYDGLPE
DIHSLEIHMKDFIGYKSINKSIALTEKEENRVIPLENDELTIKNIQLNDMLSISISTSDS
VLFDKVSIINEEQKRIPLKTTTNHQLITNKDGTINNERSLLFDTKSRPLELHIGGLHYVK
KYNKTLAIPLQ
>PK3-045_01997 RNA polymerase sigma factor SigV
MNDEQLVQKAKKRNKKALLQLVMQQKDDYYRLAYSYMGNSHDAMDAMEEMIVILYEKIAQ
LEKIESFYSWSKTILVNICKGKLKKERREIVMDDLEQHNLLHTTDPYKYSVETLDIIQLL
TKLTPVQAEAIKLKYFHDFDNETIASIMKVSTGTVKSRIHNGLKRLKKMYGGEDK
>PK3-045_01998 Methionine aminopeptidase 1
MIHLKTPEQIEKMRKAGEILADCHKEIKKLIKPGITTEEIDVFAENFILQRGATPEQKGY
QGYPFATCASINDVICHGFPSKNPLKDGDIVTVDMVVNLDGWLADSAWSYPVGNISEEAK
NLLKTTEEALYIGIEQAVVGNKVGDISHAIQMFAEAKGYGVVRDFVGHAIGREMHELPQI
PHYGPPHVGTPLKEGMVITIEPMLNIGMYHAKVDLDGWTARTVDGSLSAQYEHTLAITAN
GPVILTKQ
>PK3-045_01999 D-alanyl-D-alanine carboxypeptidase DacF
MKRIISLLIITCFMTSILAPGTLAAEKKQELVENVKSAILIDRDTGTIMYEKNSEEKLPP
ASMTKIMTMLLIMEAIDQGKLKLDEKIRTSEHAASMGGSQIFLEPGEEMTTEQMLKGIAI
GSGNDAAVAVAERLAGSEEEFVQLMNEKAKELGLESTKFQNVTGLPVTDHYSSAKDMALM
AKELLKYEDITKFTGTYEDYLREDTEKKFWLVNTNRLVKFYPGVDGLKTGFTAEAKYCLT
ATAMKNGMRVIAVVFGAPTSKERNAQVTKMLDYAFSQYETHPLHKREEAIGKVKVSKGSE
KEVTAVTSEPISILTKKGEQIDKLQKEITMNKKLKAPIEKGQEIGKITYKQDGKTLVTSP
LVAQKEVKSAKWWTLFKRSAGMFTKTE
>PK3-045_02000 Anti-sigma F factor antagonist
MSLNIELEIKNNVLCIRLSGELDHHYAEELRTKATTAIESYSIRHIVLNLEHLTFMDSSG
LGVILGRYKQIKQLGGEMVICAISPSVQRLFDMSGMFKIMKLETNEEFALQRLGVA
>PK3-045_02001 Anti-sigma F factor
MRNEMHIQFSALSQNESFARVTVAAFITQLDPTMDELTEIKTVVSEAVTNCIIHGYENDP
NGIVYISVILEDSYIDLTIRDEGKGIFDVEEARQPLFTTKPELERSGMGFTIMENFMDEI
EIQSSPDSGTEIRLRKHLMKSKMLSN
>PK3-045_02002 RNA polymerase sigma-F factor
MDVEVKKDKKETYLKDHEVKDLIKRSQDGDQSARDTIVQKNMRLVWSVVQRFLNRGYDPD
DLFQIGCIGLLKSVDKFDLSYDVKFSTYAVPMIIGEIQRFIRDDGTVKVSRSLKELSNKI
RKAKDELSKQYGRTPTVGELSEFLEIPPEDIVLAQEAARTPSSIHETVYENDGDPITLLD
QIDDGNEGKWFDKIALQEAIRELDERERLIVYLRYYKDQTQSEVATRLGISQVQVSRLEK
KILIQMKEQMDL
>PK3-045_02003 hypothetical protein
MAETIYIRMRHRIQKKSNERIFLKDLAQIIATDELLSTLKDVCLYHITEQDKNIIIIDST
LVIREIKKIDKEVEIQLIGPAQTIIEVVFKKRKVTLPLFILVWLLLFIGSGLTIMNFHED
VSMQSVHQRVYKMITGKEVEKPLIFQIPYSVGLGLGMVIFFNHVFKKRLNEEPSPLEVEV
FNYQQSLDQYMIMHENKESIKKSDDH
>PK3-045_02004 hypothetical protein
MIINILFVIFVGLAWGITVGAGYVAFLTVFGIIPRLTQLTKTFSKIYAYEWAAVLGAVSG
TLAFLREPSFSLPSFLLIIIGIAGGIYIGMIAAALTEVLDVFPLLAKRIGIADKLLVLMM
ALVFGKIFGSLFHWIYFIP
>PK3-045_02005 hypothetical protein
MENRRKVILITDGDEYARRAVEMVAKDVGGRCISTSFGNPSNHSGEEILTFIKQAKNDPV
LVMFDDSGFVGEGNGESALKYIATHPDLEVLGVLAVASRTRREEWTKIDVAIDQDGELTP
YGVDKYGIPEMELGRVNGDTVYILDELNLPLVVGIGDIGKMGKKDSYEKGAPITRKAVEY
ILERSGFYEQQDRKEDPDIRRTR
>PK3-045_02006 Spore germination protein B1
MSSKTEKKIQIYEELDKIEKYMKDRVGLGTSFDLGVRKFKVMRKEVNLYYVNGLCDSALI
AELLEQLLFLNDTDRKSQARDTFEIIQNQLVHQSVQVIEKMDELVDQVLSGLVAVVIEGY
DHGLIIDVRSYPGRMPEEPDTEKVVRGSRDGFVENIIVNTAITRRRIRDERLRFEIMRVG
ERSKTDIAVGYIDGVADPDLIEIVKKEMKSLKTDGLTMADKTIEEFLLKQGYNPYPLVRY
TERADVAATHLLEGHVIIYVDTSPSVIITPATFFHHLQHAEEYRQSPMVGTFVRWIRFLG
IIASIFFLPFWFLAVLEPSLLPERLAFIGPNETTNIPIVVQIFIADLGLEFLRIAAIHTP
TPLSTAMGLIAAVLIGQIAIDVGLFVPEVILYVSVAAIGNFATPSYELGIANKIVRLALL
IVVAIFHTPGFVIGMTLYLLFLIRTTTLNVPYLWPFIPFHPIALSQILIRRAVPGNKIRP
SHLHPRDRVKR
>PK3-045_02007 Diaminopimelate decarboxylase
MHYYGTSKVNDAGHLEIGGVDTLELVEKFGTPVYVYDVELIRERAKGFKQTFDQLGVKAQ
VAYASKAFSTIAMVQLANEEGLSLDVVSGGELYTAIAADFPVERIHFHGNNKSKEELIMA
IDKQIGCIVVDNFYELEMLTQLCEEKNRKMSILLRVTPGIEAHTHDYILTGQEDSKFGFD
LQNGQAEKALLEAIKSPYIEVLGLHCHIGSQIFDTTGFVLAAQKIMAQLSEWKANHHFES
RVLNLGGGFGIRYTEEDQPIQPAEYVDVIIKEVKEQVNNLEMQMPEIWIEPGRSLVGDAG
TTLYKIGSRKEVPNVRNYLAIDGGMSDNIRPALYQAKYEAVLANKPLQAPDETVSIAGKC
CESGDMLIWDLPLPKAGDHDVLAVFCTGAYGYSMANNYNRIPRPPVVFVENGEARLVVKR
ESFEDLLRLDLPLKETASLKK
>PK3-045_02008 putative protein YpuA
MKKNKWIWMVLAFLLLIPIPAYADVAVGDMIVTLGENLTPEQKQLLLTEMKAPEDAEIIT
VSNKEEHQYLGKYISKSLIGTRAISSSAITIGDKGTGIQVTTKNINWVTDEMYINALITA
GVKDAKIYITAPIEVSGTAALTGIIKAYEVSTDTVIPEDVKQAANEEMVETANLGEDIGQ
EEATALMAKVKEQIAEQKPKTVEEVQTIIQDSAKELNISLTDEQLQSLISFFNKLKELNI
DWNQVGNQLSEAKDKLTGYLESEEGKGFLAKIKEVFTSIVEAIKSFFS
>PK3-045_02009 Protein RibT
MIIRYKKAFEKIAMGLLSFMPAEKDLKVLQQTIKQYESEENWQLFLWKDEEDIIGLIGVI
FEDESSITIQHITVNPSHRHQGVGKAMVQAVKGLYPNRTLKSNELIVNFLSKCNDGVQVD
K
>PK3-045_02010 hypothetical protein
MYPNEYIEFLVHFHCDQDYFECHEILEEYWKKVDPGNKDSIWVGFILLAVSAYHHRRKNF
KGAEKTLIKSKQLLEKKQDIIKKLGLDNSKLLLLLKIQEEHIKQHHAFCTYHLPIKDHNL
EMNCIDSAHIKGLKWKTREPVPFEIIHRHISRDRSMVIKERENALLQRKQKDKHF
>PK3-045_02011 Segregation and condensation protein A
MRIMQYNVKIDSFEGPLDLLLHLINKLEIDIYDINVAEITEQYLDYVHAMQVLQLDVASE
FLVMAATLLAIKSKMLLPKHEEELLDDDLMYEPEEDSREELIERLVEYRKFKEAADDLKE
MELERGLIFTRPPSDLSDFNVSNEESIKQELDVSLYDMLAAFQKLLKRKKLQSPLATKIT
RQEIPIESRMEEIVGFLRTRRERTSFAELFPVATKSHIVVTFLAILELLKRRQIFVEQEG
NFADIFVMGKEVE
>PK3-045_02012 Segregation and condensation protein B
MNNRLKVNDWKAIVESLLFAAGDEGLTVKQLMHVLDMEQLEVEQLIDELIKNYRKDKTRG
ISIIEIAGTYQFATKKQHSDYLKKLVESPHASTLSQAALETLAIIAYKQPITRAEIEEIR
GVKTERPLHTLSAKALIKEVGRAEGAGRAILYGTTKEFLDHFGLKNIGELPPLTEKEEEF
NQEEADLFFESFQQIEE
>PK3-045_02013 hypothetical protein
MSSYNEYVRNVLIWNQELKQLLESEEVQKEESIWKRLDKFTQLMEGVQRKPIETEELIRI
QHEAEELHEQMESYFAQRQQLGTIFIKEPTIAAGEHQLPQLAYAYDALEPYISKEIMELH
HQKHHQSYVTGLNKAEEKLKEARKNNDFALVKHWSRELAFHGSGHYLHTIFWNNMSPKGG
GKPKGALLEEIRSYFGSFKAFKNHFSEAAKAVEGVGWALLVWSPRARRLEVLQSERHMLL
TQWDTIPLLVLDVWEHAYYLQYKNNRGDYVDNWWNIVNWKDVENRFLKASELKWRPY
>PK3-045_02014 D-alanyl-D-alanine carboxypeptidase DacB
MKLRKLIILTIITSILFLAIPQKSSAQMYVSAQSAILMEQDSGRVIFEKDAHTKRRIASI
TKIMTALLAVESGKLEETVTVSSNAIRTEGSSIYLQEGEKIKLEDLVYGLMLRSGNDAAV
AIAETVGGSLDGFVYLMNQKAEEIGMKNTHFANPHGLDDHEDHYSTAYDMALLTRYAMNN
DTYKKIAGTKSYRSESTNNEWDRVWRNKNKLLTSLYEHSTGGKTGYTKRAKRTLVSTAEK
DGVEYIAVTLNDPDDWDDHINMFETAFKTYKKVQVIEEGKIKTVKDKFYKNKVYIKSDIE
YPVTEKEEDLFKVEYSLTKVKKNWKKNQEEVPEIVGEAKIYLDSKLVDSVPIHFKHIKAK
ESKSFLDYFKNMFTAMTGVGQDG
>PK3-045_02015 Spore maturation protein A
MVNYIWAALAIIGIVFAAVNGTMDEVNKAIFSGAKEAVTICIGLISVLVFWLGMMKIAEQ
AGLLQKLTNLFRPIVAKLFPEVPKNHPAMGYILSNMIANIFGLGNAATPLGIKAMEELKR
LNGGKNSASNSMITFLALNTSCITLIPTTVIAIRMNYHSDSPTDIVGPTIIATIFSCIGG
ILIDRYFYHKRMRKG
>PK3-045_02016 Spore maturation protein B
MMEIVSLISLWMIPSLIGFILLYGTFKKVPTYESFVEGGKEGIQIAFSIIPYLVGMLVSI
SIFRASGALEFFMSFLKPVLDFIGVPSEVAPLAIIRPISGNAALGMTSDLIATYGPDSFI
GRLASVIQGSTDTTLYVLTVYFGAVGIKKMGDALKVGLLADLIGFIAAIVVVTLMFGK
>PK3-045_02017 Ribosomal large subunit pseudouridine synthase B
MERLQKVIAHAGIASRRKAEELILEGKVKVNGKTVKELGVKVGSNDKIEVSGIPVEREEP
VYFILYKPRGVISSVNDDKGRKVVTDYFSEIEARIYPIGRLDYDTSGIILLTNDGEFANL
MMHPKGEIEKVYVAKVKGIPAREKVKQLERGIMLEDGKTAPAKAKILSVDKKKGTSIVEL
KIHEGRNRQVRRMFEAIGTPVMKLKRERYSFLNLNGLQPGDARELTAHEVKLLRAEAQKK
KG
>PK3-045_02018 Transcriptional regulatory protein SrrA
MEKEIKILVVDDEERIRRLLKMYLEREEFIVEEAEDGMSALSKALNTDYDVILLDLMMPG
KDGMEVCKELREKKTTPVIMLTAKGEEVNRVQGFEVGTDDYIVKPFSPREVVLRVKAILR
RSTKTTFEQSDSSSKDVIIFPALTIDHDAHRVLASGKEVSLTPKEYELLYFLAKSPDKVF
DRELLLKEVWHYEFFGDLRTVDTHVKRLREKLNRVSEEAASMIVTVWGVGYKFEVNNG
>PK3-045_02019 Sensor histidine kinase ResE
MKFWRSVVFKLWITFLLLVSVVLTILTIMLLEYFEQYYTEQTETELTNTATKISEIMKEH
NNQIGLEIVGELLDHSTGAIIVSSPDQVYYYPENGLQELSYSFIQGNEDLNKVMTSNKTA
VVRTELTNKDNKPEQVAIVGSPLHVNGEDGAVFIYQSLQSMNESKQSTAKFIVLAAVIAI
ILTTIFAFFLLTRITAPLRKMREAAFEVAQGNFATKVPIMAQDEIGELSIAFNEMAKRLN
FNMNALSQEKEQLDNILSGMADGVLTLNRNGSLLLTNPPAEKFLQHWYYEKGELSDMHAQ
IPEELRKLFQLAVHTGNEQIDEITLQGRNWVMIVSPLYDKKDIRGAIVVIRDMTEERKLD
KLRIDFIANISHELRTPISMLQGYSEAIVDNIAESEEEKREMARIIYDESLRMGRLVNEF
LDLARMETGYLELRKEAIDLYPFINRVARKFNAIAKEKEITFTVSISEDMGEYELDPDRI
EQVLTNIMDNSMRHTPSGGTVFLRGRSDDYGVYLEVEDTGSGIPEEDLPYVFERFYKADK
ARTRGNAGTGLGLAIVKNIIDSHGGDISVYSKYGRGTTFFIFLPRNKEEN
>PK3-045_02020 ECF RNA polymerase sigma factor SigX
MNSVFDEIYNKYHHDVFQFLFYMVNHKETAEDLMQEVYIRVLKSYHRFEGKSSEKTWLFS
IARNVAIDHFRKQKNWKDRIMDKFDWSKQQVKADGFLPEEITLQSEEVKGVYHALQYCTV
DQRMVIVFRYIQELSIAETAKALGWTESKVKTTQHRALKALRSILEEYDGEEDSYAETKV
E
>PK3-045_02021 Anti-sigma-X factor RsiX
MPKQKWNDDKIKLVLKQMPYIKDERSPEFIYHTIQMKRKRERKSRRLMPVLATVCTVMLL
FIISQSFFDSNREDSFKGESKMADNSAEMKNKSYDTAETAESENYDMADEQEERRTTSLI
PSAIYENEVGKQELLTYPIPDKNVQVIVPVSILVENPNQLSRFDLYVENVKKVIGVNKQL
SSNFPISPELFAYDLRDDYIEVNVKQDFANFGSHSEDFFNTMVQQQLQTIGAKKMEFYTD
GKLGAVLGNREETSIDYKPLENRAYFLLENDESDDQPLYVPWEKPYDTIENAFDAMEDNM
ETHGLAASIPDTIDIDKVSKDENKGELVVHLSNESKMEEDQKTLHAIESILLTAKDFKYS
TVKFENTNVKEVGGFELTKELDVPVAANKVDIEQ
>PK3-045_02022 hypothetical protein
MKKNIKRRSGNLIFVSVIAGGVAGWVVHTGLSIISTTDMTHLYGISIFLGVIVGLLWDIT
DKLNND
>PK3-045_02023 hypothetical protein
MGDYIRRILIAAIMLLFISLLFLGGKHSQAQSFSLAERTKTWTWPSEGIITDTFNTRNGA
HKGIDIAGNLGEDVYAVDEGIVTRSYYSQSYGNVIFVKHKNDLETVYAHLNKRFAKEKQL
VKKGEVIGEMGNTGQSSGVHLHFEIHNKEWTIAKENAINPILVLGEVEVGQTVKIAVEEE
SEAAITERSENLPHRPHANLVHEEEKKLEKEYIRRSIKEMEINIEEDNSELSTIPYKKAS
IYLKSSKYLLF
>PK3-045_02025 Riboflavin transporter FmnP
MKKKMNVRKYVLIGMMSSLAYVLMMLKFPIPPFPSYLKVDFSDIPALVAALILGPGAGIL
VELIKNILDYLITGSDTGIPVGHFANFIAGISFILPTYFMYNAIKSKKGMAIGLALSIII
MTGLLSLFNYFIMLPFYNTLMKIPTDTTLLKQTVLSAIIPFNLLKGVIISIIFALVFSKM
GVWINKQIPSRNV
>PK3-045_02026 Ferredoxin
MAKYTIVDKDTCIACGACGAAAPDIYDYDDEGIAFVMLDDNQGTVEVPEVLLDDMLDAFE
GCPTDSIKVSDESFDGDPLKFE
>PK3-045_02027 hypothetical protein
MSFFKMIILKCLYKMNGERTIYSILHILNGKKSSQTIQDIHIFQLTSLFQSFPLLTREQL
DQIIYTLHKEEWLEKTGENHYFVKNDRKLELEVLLKENPFPRYLKGWRYHSVTGPYWQRL
SLFVQVTSHLSKKSNHYMPIQRNPATQLWLKDTLYTMSSIDRSKMNHYLYQEIVNCLEES
ELDPLLLIIRLTGSDRIGLTSEQAAIELELDPYYYQLSFLAILHYMIEKILSDKGEFPLL
SQMIKEGKKPFTLTESTAKTFNLIQKGLSIEQIVRVRNLKQSTIEDHIIEILLNVPNFPM
ANLVSSENITKIKACMEQSPSKSLKVIKQQLADVSYFEIRAVMAGYGDFS
>PK3-045_02028 ATP-dependent RNA helicase DbpA
MNLEAILKKYYQLSAFRGGQKETIESILNKRHTLAMLPTGTGKSLCYQLAGKLLEGTVII
ISPLLSLMQDQVEQMKMKGEKRVVALNSFLNPTEKNKVLRQIKQYKYIFISPEMISLPHI
IDQLQKMEISLFVIDEAHCISQWGYDFRPDYQKLGEIRQKLNNPLTLALTATATEAVRED
IIKSLHLEMVEEIIYSVDRANIAINIEEVSHVQEKVDKLLEYIQRLDGQGIVYFSSKKLA
EQTVAFLKEKSSKRIMAYHGGMTQEDRILVQQQFLAGQLDVICATSAFGMGINKEDIRFI
IHYHLPTQLESYLQEIGRAGRDGNPSVSIILYTPGDEWIAYQLIESELADELQINQWKAR
LKNFPSFEAWQKKEGYQLEMLFTETQWRVLESYIEPNNKTISELLHSLKLYNDFRENRVN
EKRRKVQDLMEWLHSISCRRRYILEYFGEKYESKENENCCDRCGIELSNFYHKKSMEDDE
VLVDWKSQLAFILNIKK
>PK3-045_02029 hypothetical protein
MNKAKYTALINQLSDRDLIKNVYITQFILLIVAFILYTFIFQSKPPLTTVFKYEQTDFII
GLIAGLAITGIDIFLMIRFSKHYHDDGGVNKRVFQNRNPFHIAFIALMVAFSEEILFRGV
IQTNLGLLLSCLLFAMMHYRYLFNPFLFMNVILVSFVIGILFEVTENLWVTVIMHFLIDF
LLGCIIRFKLFQKS
>PK3-045_02030 hypothetical protein
MKKEDPYRVQAELQKQRLKKVTSDEEVPVTEEREESSLPSRSTVHKNKKKKIKIPIISLL
AFLFILLPVALLLILNGKDISNLLSTENTSGVFENVNIQKGYSPNNKTTPDDSDNNQDEL
VIESNSTVKKEEIPADKFKEKADENVKEKEKKKEAEKQKEQKEQKEQKEEKQRSEKKVEN
EPKQKEEESSQTNPNEKIVYHTVAKGENLYRIALKYYPNGDGMGKIKAANNMTTDQVQLG
QTLKIIMEP
>PK3-045_02031 hypothetical protein
MERSIFPERYDLDGTTKKVLLKIIEKKKKYDKLKNRHLFIMWFTIFASFCYFIWLYKHIA
IPYSHSFAVMFSVYVEESANLYLLFLLIGAFGYMNVMRQKRDKAEKEYHDLRCEFIDKSK
DLFGNSETWNVRHEIYNTIKESYDINLFHQAK
>PK3-045_02032 Manganese catalase
MWIYEKKLQYPVKVSTCNPMLARFLIEQYGGADGELAAALRYLNQRYSIPDRVIGLLTDI
GTEEFAHLEMIATMIYKLTKDATPDQLKAAGLGDHYVNHDHALFYHDAAGNPWTATYIQA
KGDPIADLYEDIAAEEKARATYQWIINMSDDTDLNDSLRFLRQREIVHSQRFREAVEIIK
EDRAQRKIF
>PK3-045_02033 hypothetical protein
MKQLPPEYYQLLEQLQAVDFVLVELTLYLDTHHYDQDAINQFNHYVKEREKFKKIYENNF
GPLLQFGNSPSGSPWDWDAAPWPWQV
>PK3-045_02034 hypothetical protein
MSSFYREYHPYISPFDPCPPIKTKVFSTPPNLFLGFQPPHLPQFSPMEALKAGTLWKAFY
DPYFSPYEKTKRE
>PK3-045_02035 hypothetical protein
MGSEYRKIFLKMVFHVRDVLKYKHYPYSDGES
>PK3-045_02036 putative protein YpbG
MIYVLVGFVLLVLVGIALILHMRKMANENHVKYEMFYFPNFPASFREITLFFISDIHRRS
IDDSVINEAVNVAEIVIIGGDLLEKGVKLEKTRDNLRKLKKIGPVYFVWGNNDYEIDRDV
LETLLIDEGIILLNNKAITFQSADGESWSLVGIEDYSLEYDDLEKALEEVEDSDFKILVS
HNPKIVEKMEENEQISLVLSGHTHGGQIRILGFGPYELGGTKVIGNTTIFVSNGYGTTSI
PLRLGAHPETHIIKIQHKQMDK
>PK3-045_02037 Adapter protein MecA 2
MRLERLNSNRIKIHLTTDDLYERGLTKEDIWKDSIKWQYFFHEMLEEANDIFDMEIHGSV
AVEIFSMKAQGMVMILTISENELDTEELLSEGFLEMQVTVEETVDILYEFTDIEYVIDAV
KQLEQNNFKGGSLYNLNERYYLCFVDISSFKEEQIIAILSEFGEASLKSIYVIEEYGNVI
KKDNAIETLVHFF
>PK3-045_02038 Cryptic catabolic NAD-specific glutamate dehydrogenase GudB
MVANKSNEKNHVEEQHDVLKSTQTVIHKALNKLGYSDEVYELLKEPIRMMTVKIPVRMDD
GTVKIFTGYRAQHNDAVGPTKGGIRFHPNVTETEVKALSIWMSLKCGIVDLPYGGGKGGI
ICDPRDMSFRELERLSRGYVRAISQIVGPTKDIPAPDVFTNSQIMAWMMDEYSRIDEFNS
PGFITGKPLVLGGSQGRETATAKGVTICIREAAKRRGIEIEGARVVVQGFGNAGSFLAKF
MHDAGAKVIGISDAYGALHDPEGLDIDYLLDRRDSFGTVTNLFNNTISNKELLELDCDIL
VPAAIENQITEHNADNIKASIVVEAANGPTTLEATRILTERGILLVPDVLASAGGVTVSY
FEWVQNNQGYYWTEEEVEERLEKVMSKSFKNIYDTAKIRRVDMRLAAYMVGVRKMAEASR
FRGWI
>PK3-045_02039 Thioredoxin reductase
MLKREEAIIIGAGPCGLAAGIALKEININPLIIEKGNVVNAIHGYPTHQTFFSTSEKLEI
GDVAFLTEQYKPNRNQALVYYREVVKRKDLRIHAYEEVLDVQRTDGQEFIVKTKKEEYIA
PYVIVATGYYDHPNYMNVPGEDMDKVMHYFKEAHPYFNHDVAVIGGKNSSVDAAIELVKA
GARVTVLYRGSEYSTSIKPWILPEFESLVRKGIIKMEFHANVVEIKEGSLLYEVNGKLHE
IKNDFVFAMTGYHPDHAFLKKMGIEIEKETGRPVFDSETMETNVEGIFIAGVIAAGNNAN
EIFIENGRFHGAQIAKAIQEKNK
>PK3-045_02040 Protease PrsW
MLAIFSAGLAPGLALLSYFYLKDQYGSEPISLVMRSFITGALLVFPIMFIQYVIQAENVI
PEGIWSSLLTTSLLEEFFKWFIVFYTAVKHADFDEPYDGIVYGVAVSLGFATMENILYLV
ANGLEYAIGRALLPVSSHALFGVIMGYYFGKGKFIVPRGKWLVYSLLVPFLLHAIYDYIV
SLEKNWLIFITPFMFYLWWLGLRKVKSARELSSEPIRKMTGT
>PK3-045_02041 Spore cortex-lytic enzyme
MNKKFLLTKISISLFVMSGLLVFPFAEQKVHAFSNQVIQHGAVGDDVIELQSRLQYVGYY
NGKIDGVFGWQTYWALRNFQYEYGLPIDGLAGTKTKNKLASATKYNEQFVKEQINRGKKF
SHYGGVDLEKQKMPSSNKSKAKKQNDTAQKKTNNNDQASKQKNAAGNNNTTNKSSNQGAT
NNDNAPQNTTNTNGGENTTGKKPTAANVPNGFSQNDIQLMANAVYGEARGEPYVGQVAVA
SVILNRVNSSTFPNTVSGVIFEPRAFTAVADGQIWLTPNEQAKEAVLDAINGWDPTGNAL
YYFNPDTATSGWIWGRPQIKQIGKHIFCK
>PK3-045_02042 Sporulation protein YpeB
MLRGILIGVLTLGVAGVAFWGYQEHKEKNAVLLNAENNYQRAFHDLTYQVDLLHDQIGTT
LAMNSQESLSPALAEVWRITSEAHSDVGQLPLTLLPFNKTEEFLANIGDFSYRTAVRDLN
KEPLSDEESKTLTKLYKDAADIQDELRNVQHLVLENNLRWMDVEMALATDKQLDNTIIDG
LKTVEDKVEGYQETSFGVTNVNMEKKDENFKNLKGKTITEKEAKEIAKEFADFKNPVDVK
VTGNGKGSNYGFYSVSLKEKGTNVEASMDITKKGGYPIWSIVSREVKKDKISLNEASNQA
VEFLKEHKFKNLALFESMQYENIGVFNFVTEIDGVKIYPDSVKMKVALDNGNIIGFAAED
YLKANKEREIKDPVISKQDARKKINKQVKIMDDGLAIILNDMNEEVLCYEFIGTLGEDTY
RIYINADNGVEEKVEKLKNAEPVYEEVV
>PK3-045_02043 putative protein YpfA
MISIGDTLVIEPIHGETKVEQYKSRILGVEEKSISIEYPIHLETNKLVFLMNGAQLRINF
VTNEGNAYLFHSEVIGRKKENNVPLLILSLPPDDQMIKIQRRQFVRIETSVDMAIHPFEK
ENNLEPFTTVSLDFSAGGAAVIVPKHIKLQQNSKIKVSVVLPLQNGEYNYLHLSAKIKKI
FEYNEQNYKMAIEFLDVDPVDRQSMLRFSFDRQLSLKKKGLEI
>PK3-045_02044 hypothetical protein
MKTVERILLKIIALQIVFFIIGQMLHTWDFIPEIRTITQYEGVMDSNFVSFLETFGR
>PK3-045_02045 Cytidylate kinase
MEKKISIAIDGPAAAGKSTVAKIVAEQLGYIYIDTGAMYRALTFKAINHHLNLEDEKSLI
NMLNETVIELFPGEHGQLIFLDNNDVTKEIRSSEVTNSVSIVSKHKLVREEMVRRQQMFA
VNGGVVMDGRDIGTHVIPTAEVKVFLLASVDERAIRRHKENVSKGYHSDLEQLKREIAAR
DKLDSEREIAPLKKADDAIELDTTSLSINEVVEKIMELTREKISN
>PK3-045_02046 30S ribosomal protein S1 
MSEELNDVVVNNYTVGDVVSGQITKVEEKQVIVAISDSKLDGIIPISELSSLHIEKASDV
VAEGDKLELEVIKVEEDALVLSKRKVDAEKAWDQLEEKFNSGEVFEAEVKDVVKGGLVVD
LGVRGFVPASLVEAHYVEDFSDYKGKIISFKIVELEKDKSRLILSHRAVVEEEKNKQKQN
LLDSIEVGETLTGTVQRITDFGAFVDLGGIDGLVHISQLSHDHISSPTDVVQEGQEVKVK
VLSVDRNNDRISLSIKETQPGPWADIAARAEKGSVLDGTVKRIVSYGAFVEVFPGVEGLV
HISQIAHKHIGTPHEVLKEGQEVQVKVLDVNEEEQRLSLSIKELTEKEIDEEEVYELPEE
SKGFQLGDMIGEQLKKLKN
>PK3-045_02047 hypothetical protein
MGKDRQEKKLKNSNRVESDRDQALHYNGSTRLQSPEEGRLLNDNK
>PK3-045_02048 hypothetical protein
MEGSIFLFCTWCIWIITTFFMDKNNPKRTKYSIYILTAIILSPYQWEWQGKSCSILLLVV
LIMSFFYTGTLRWKNCIYTIVSSFFMMLAYVTYELMAIIDPFWVFIPGVWLKTSILFTFL
ILVHKNISCQILVLLIGSINGEIVLSFLLRSYQMDYSIGSMAFFDFLTLGLLGLISLYYL
KITLVRWENYVFLLEKERQKNL
>PK3-045_02049 hypothetical protein
MSNFVYPILFGVIVGTLLRMFMLRTDYRQYPTYLHGKIIHIALGFIAAGLGSVAIPSILN
KDFTAVTFLTVAASQFREVRNMERNTLTELDSFEMVPRGKTYIEGIAIAFESRNYLVMFA
GLVSTFGYIVFNIWTGILAAIISVVIAKKLMSGGQLKDIVDIEYVQPTFKGAGLHIDTIY
IMNIGLPERQKEVLKYGMGFILTPKNFNARTTIANLGQRQAILYDVTTALGVYRDSGTPA
LVPLAKRDLEDGRVAVFVLPQIHNEKKAIRIIGAVPTLENAIRMPSKREEREDELE
>PK3-045_02050 hypothetical protein
MTLEKYILASITTNPNKVAPGTGVFYCQDTKELETVATNLEAILDGIAHKISEEVFIIVK
H
>PK3-045_02051 GTPase Der
MAKPVIAIVGRPNVGKSTIFNRIVGERISIVEDIPGVTRDRIYSSAEWLNHDFNLIDTGG
IDIGDEPFLDQIRMQAEIAIEEADVIIFITNGREGVTSADEEVAKILYKAKKPVVLAVNK
VDNPDMREQIYDFYSLGFGEPFPISGSHGLGLGDLLDEAAKHFPKRDTKDYDDDVIKFSL
IGRPNVGKSSLVNAMLGEDRVIVSNVAGTTRDAIDSQVTVNGEEFVIIDTAGMRKKGKVY
ESTEKYSVLRALRAIERSDVVLVVIDGEEGIIEQDKKIAGYAHEAGRAVIIVVNKWDAVE
KDEKTMKTFEQNIREHFLFLDYAPIVFLSAKTKKRIHTLIPMIKVASENHTRRVETSVLN
DVIMDAVAMNPTPTDKGKRLKIYYTTQVAVGPPTFVVFVNDPELLHFSYERFLENRIRDA
FGFEGTPIKIFARERK
>PK3-045_02052 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
MKDKKSVAMIGAGSWGTALSLVLGDNGHTIHIWGKDEKNIAEINNLHQNSKYLPGITLPN
EVKGTTSLEESVHDVDIIVLAVPTKAMREVIPQLLPYIKEPKTFVHVSKGIEPGTLLRIS
EIMEEEIPESIRKSIVVLSGPSHAEEVSLRHPTTVTVSSKNMKEAELVQDLFINHNFRVY
TNPDLIGVEIGGALKNIIAVCAGIADGLGFGDNAKAALITRGLAEMARLGTRMGANPLTF
AGLTGIGDLIVTCTSVHSRNWRAGNMLGKGHALEEVLEQMGMVVEGIRTTKAAHQLSEKY
DVTMPITNALFEILFNGQDAKAAVESLMARGKTNEMEDLINILASQYIE
>PK3-045_02053 Stage IV sporulation protein A
MEKVNIFKDIAERTGGDIYLGVVGAVRTGKSTFIKKFMELVVIPNMDNEGDRARTKDELP
QSAAGKTIMTTEPKFVPNQAASIKVDEGLEVNIRLVDCVGYTVPGAQGYEDENGPRMINT
PWYEEPIPFHEAAEIGTRKVIQEHSTIGVVITTDGTIGDIPRSNYLEAENRVIEELKEVG
KPFIMIINSAQPYHPNTDALKQELSEKYDIPVIAMSVESMRETDVLNVMREALFEFPVLE
VNVNLPSWVMVLRENHWLRDNYQEAVKETVKDIKRLRDVDRVVSQFSEYEFIENAGLAGI
EMGQGIAEIDLFAPDELYDDILKEIVGVEIRGKDHLLELMQDFAHAKTEYDQISDALKMV
KQTGYGIAAPSLVDMSLDEPEIIRQGSRFGVRLKAVAPSIHMIKVDVESEFAPIIGSEKQ
SEELVRYLMQDFEDDPLSIWNSDIFGRSLSSIVREGIQAKLSLMPENARYKLKETLERII
NEGSGGLIAIIL
>PK3-045_02054 DNA-binding protein HU 1
MNKTELINAVAEASELSKKDATKAVDAVFDTILNALKDGDKVQLIGFGNFEVRERAARKG
RNPQTGEEIEIAASKVPAFKPGKALKDAVK
>PK3-045_02055 hypothetical protein
MGNKGDVMVMQELIESVKKRVIERTSNHYLQKHIPNPVIDEHKILLIISVLLEANIQKQE
IITYATTITLIQIALDTHELVTNEKMHKGNERNRQLTVLAGDLYSGQYYKILAEIEDLKM
LKFLAEGIKEVNENKIFFYHQNAKTIEQVIESLKNIEGALIKKLVDFYQLDGWKSLVEEY
LFLYRIQKEKELYDRTQGSIVVETFYKYENKNNLLSISAKTAVLDKYLKETSSRLEEMLE
NLPELQAVFRENTYQLLNAINKQQLYVEEG
>PK3-045_02056 Demethylmenaquinone methyltransferase
MQEQQSKEEKVHNVFEKIYSNYDKMNSVISFQQHKLWRKDTMKRMNVPKGAACLDVCCGT
ADWTISLAEQVGPNGKVVGLDFSENMLSIGKQKTMGYENIELIHGNAMELPFDDNQFDFV
TIGFGLRNVPDYLTVLKEMRRVVKPGGLVVCLETSQPTMPIFRQGYYFYFRYIMPVFGKL
FAKSYKEYSWLQESARDFPGMKELALMFQEAGLKKVTYKPYFGGVAAVHIGYK
>PK3-045_02057 Heptaprenyl diphosphate synthase component 2
MKLKMMYSFLNSDIDKIEKALEETVQANSSILRESSLHLLQAGGKRIRPIFVLLAGQFGN
YDIQVIKKAAISLELIHMASLVHDDVIDDSDLRRGQPTIKAKWDNKVAMYTGDYIFARSI
EIMSEIDKPAAHKVLANTIVEVCIGEIQQIKDKYRFDQNIRDYFRRIKRKTALLISASSL
VGAIVSDVEEDYQQKLYRFGYYVGMSYQIIDDVLDFVGTEEELGKPAGGDLLQGNITLPV
LFAMEQEKVRDKVITVHEAMPKKELMEIISMIKNTDAIDRSLQVSDLYLKKALQTIHDLP
NGKAKSALNNIAKYLGKRKF
>PK3-045_02058 Nucleoside diphosphate kinase
MERTFLMVKPDGVQRNLIGKIVTRFEEKGFQLVGAKLIHITENLAEQHYAEHKGKPFFTQ
LVDFITSGPVFAMVWQGEEVIAKARLMMGKTDPLEALPGTVRGDFGVVKHKNIIHGSDGI
ESAQREIALFFKEEEIVEYKKLLDSWIY
>PK3-045_02059 Chemotaxis protein methyltransferase
MEKDFQDFIKNFYKLSGIDLSLYKEAQMKRRLTSLYEKRGFTSFEDYFKAIHKDKNLLDE
LLDRMTINVSEFYRNYKRWEVLEKKILPSLLQSKAQLKVWSAACSTGEEPYTLSMLLSNE
MKLRDFQILATDIDINALDRAKKGIYLERALNEVPSAQKDKYFEKDGAMFKIKEEVKRNV
TFKKQNLLSDSFGGPFDLIVCRNVLIYFTEDAKDLLYHKFSQALKPGGIFFVGSTEQIFT
PAKYGFETADTFFYRKI
>PK3-045_02060 Chorismate synthase
MRYLTSGESHGPKLITIIEGLPAGMPLLAEDINKELARRQKGHGRGRRMQIETDTVEIGG
GIRHGYTLGSPVSLIVENNDWKHWTKVMGQDPIDEAEANEIKRKISRPRPGHADLNGAIK
YGHRDMRNVLERSSARETTVRVAAGAVAKKLLDLLGIKVASHVVEIGGIKSNITNYESIE
KLREITENSPVRCLDEEAGLKMMNAIDEAKANGDSIGGVVEVIVEGMPIGVGSYVHYDRK
LDAKLAAAIMSINAFKGVEIGIGFEAARKPGSEVHDEIIWDQENGYSRRTNRLGGLEGGM
TNGMPIVVRGVMKPIPTLYKPLKSVDIDTKEEFTASIERSDSCAVPAASVVAEHAVAWEL
AAAIVDQFYADRFEGLVANIAEHNRHAREF
>PK3-045_02061 3-dehydroquinate synthase
MQTVSIQTMSKHYDVWIGENVIAELSAFLQKEFADVTKILIITDESVEKLHLKTVEKKLS
SFPVVSYTVPAGEKAKTFDVFYACLTYMLEQHLDRKSLVLALGGGAVGDLAGYVAASFMR
GIPFIQIPTTILAHDSAVGGKVAINHPLGKNMIGVFNQPEAVFYDTTFLSTLPLQELRSG
FGEVIKHALISDISFYHELRSKISDLSQVKIAYWSEILEKGILVKQAIVEEDEKETSVRA
FLNFGHTLGHAIEAEMGYGKFTHGEAVVIGMIFAIRLSKRKYDIAFSLEEYIKWLKQLGY
TCDIPNDLEIERLIDRMRQDKKSINGTIRFVLLQEIGSPVLVEVNEAVIREELGLFKGGK
>PK3-045_02062 Chorismate mutase AroH
MIRGVRGAITVEHNIEAEILSATERLFKEMINANNIKACDVASVFLSVTDDINAAFPAKI
IRMQEDWTYVPVMCMKEIAVPHSLEKCIRIMMHWNTELPQEEIQHTYLEKAIQLRPDLTK
Q
>PK3-045_02063 Histidinol-phosphate aminotransferase
MKWKQQLLGLKAYQPGRTIDEVKKQFKLEHIVKLASNENPFGSSPKVLEALKKVDGSYAL
YPDGYATNLRYALADFLKVKPEELVLGNGSDEIILMISRALLRPGLNTVMASHTFGQYKH
NAVVDGAEVREVPLTEKAEHDLPAMLKAIDDNTSVVWLCSPNNPTGTYIPEQDLLAFLEK
VPEDVLVVLDEAYYEYVVAEDYYEAISLTRQFNNLIVLRTFSKIYGLASFRVGYGVANAS
LLNTLDPVREPFNVNTLGQIATEEALKDQEFVESCRQKNREGLEQLYRFCEENNLSYFPS
QTNFVLVDFKIDGDEVFQYLMSKGYIVRSGVPLNYPTSVRITIGSKEENDGLIEAMKQFL
AEKKVAQ
>PK3-045_02064 hypothetical protein
MNGRVFIIGLGLIGGSLALCIKKEHPESIITGFDISEDNLKLASMMGVIDNLSTTIEEGA
KTADLIILSTPVKETEKIIEILSKIELKENVIITDVGSTKSVITEKSQVLLDKNVTFIGG
HPMAGSHKSGVSASKVLLFENAFYLLTPHEKIKDQHVQCLLKWLQGTNAKFLVISPEEHD
LLAGAISHMPHIVAASLVHQADQISEKHKLVTRLAAGGFRDITRIASSSPSMWRDILIHN
KNVLIELMNEWKKEMDRVLTLIENERAEELYDYFSRAKKVRDGLPQDQKGAIPAFYDLFV
DVPDYPGVISEITGYLAQEKISITNIRIMETREEIFGILAISFQTEEDRIRAQKCIATYS
NYDTTIG
>PK3-045_02065 3-phosphoshikimate 1-carboxyvinyltransferase 1
MDLITLKTKNRGLKGEIAVPGDKSISHRSIMFGSIANGTTTVTNFLLGDDCLSTIACFRK
LGVLIEQNEKEVVIHGKGMEALQEPKDILDVGNSGTTIRLLTGILSGLPFHSTLIGDSSI
GKRPMTRVVAPLREMGAKIDGREDGKYTPLSVRGGNLQSITYRLPVASAQVKSAILFAGL
NADGVTKIIEPVPTRDHTERMIQRFGGEISRKDKEIFVEGAQKLSGTNIHVPGDISSAAF
FLVAGCIVPNSKISLNNVGLNPTRTGILEVLHNMGACMEIHKNDTDVFEPTGTITVSTSD
LKGTTIEGEIIPKLIDEIPIIALLATQAEGVTVIKDAHELKVKETNRIDTVVTELKKLGA
DIQATEDGMIIRGGKKLIGTKVDSHGDHRIGMMLAIAAQICEGELTLENAKAISVSYPSF
FEHLNELSNRK
>PK3-045_02066 hypothetical protein
MRYIIENIHLLKRQRVKKTSILIEDNRVELMRDTFNSYQYMRMDGSPYMMAPTTVMLDNH
VTRILSYTQQKQYIEENLIKKGCTTLLFYLEVNRERELPLQVKKMKTPLLNCAIDFVAGV
KIPLKLLTPSFIRGCKREKIPVIFIEVEDVKALYRVPWGWIKEALFPYNAPLVPIFLTKD
QQEKKIAQNMWSSLMRDVKIPSIPHEIKEGIAIAYPDLVKMGIYPFKGNIYQGGEVTYNL
FAMDDAIINIEENDLFHYHYDRIQMTIHKGKCIRAGHKVFYRPGFGELLEVKVPSFLTV
>PK3-045_02067 Beta-barrel assembly-enhancing protease
MERVNEIISLLEDGQQDKALKYYQDVLKSGNNEERFVLGEELFQLGFLEEAKDLFLVLLE
GYPEEGELLVLVAEVEMELGNEEAAISYLEQLNPNDPSFPQALLLLADLYQMDGLYEVSE
QKLKEAQKILPDEVIIDFALGELYAEQGKITEAIKSYQKVLPKEENIAGVNINGRIADNL
SAGGAFEDAIPYYEKALEEKVEINTLFNLALTASQAGLYTIAINRFEEVKGLDPSYHSLY
LYLARSYEQEEMLNEAYNTVIEGIKQDEFNKDLYLYGGKLALKRGDEQKAEEHFREALAI
DPEFTEAVLLLNKLFLTQDRFDDVLELIEMMDNQEIEEPQLHWDAAKAFHGIEKYSEALN
KYQLAYTFFKELPDFLYDYGYFLLEEGKRKDAAEIFNMLLQTDPSNEEYIEILQRLMDNE
>PK3-045_02068 hypothetical protein
MKTPVSVNEKKDFIRWFLNHYQLKRRECVWILNYLMSHDQLMEKVHFVENAEKCPRGLIM
STHCVDEVPFRFYKENVMTTDAEKSFHDIRLNRDEDIYIQLNFYASNQVHQYAAVLVENP
FMPKKLQITEKDKMIAEQFLVKSIEKFQKEKLLQLIDEALDNGDKEMFITLTNQLKFFQN
K
>PK3-045_02069 hypothetical protein
MRSIYMILSNRSFIGLLLAINLFGTVYGYYWYRYQLAETPAKFLLFVPDSPTASLFFVLV
LIAFLWRKNWPLIEALALVTLFKYGIWAVVMNFLVYFETGTIGIDSWMLIISHGAMAIQG
LLYIPFYRFKWGHIILVAIWTLHNDVIDYVFKMMPKYSVLDQYMANIGYFTFWLSVLSLL
IAYYAYKKSEELQWRIQ
>PK3-045_02070 hypothetical protein
MKAKLVMLLMILILLLPISFSVYADQKTPAKELDELDTLSDEVLQLVRSERYEDAKKILD
YFSNQFSSVSVNGSPFTVDERRILTGTHDEAVEAITNQSIKNDERINSVTKFRLAVDAVS
SGEQPLWTQMEEPVMSTYREMKDAILLDDKEKFDEKLDSFLSLYQIIYPSLKLDVSAAQF
QELNSLVEFMNTYRLQVFNQQGDLEEVTQLESELQDVFNQLYEDEADPSLWWVIISTGSI
IILTLSYVGWRKYLGDKAEKRKTKQKRDNI
>PK3-045_02071 hypothetical protein
MIFIYFILIILIPIWAQMKVKSAYKKYSKVASSSHMSGREVARRILDSNGLYDVSVEETR
GVLSDHYDPRSKVVRLSTDNYHGHSVAAAAIAAHEVGHAIQDQQEYSFLRFRSTLVPVAN
FGSNASWIFILIGMFARLPEMMLLGIILMAAGVLFQFVTLPVEFNASNRAMDQVVSLGII
RNDEERETKKVLNAAALTYVAAAAVAVLELVRLLLIYTGMLRDE
>PK3-045_02072 Fosmidomycin resistance protein
MQTAEYVQGKKRQEMTIYRILFAISLGHFLNDCMQSVVPALFPVIQKSMELNYTQIGWIA
FALNITSSILQPVFGVLADKRPAPYLLPIAMFSSLIGMLGLSLAPNFYLVLLSVLFIGFG
SAIFHPEGSRVSYMAAGAKRGLAQSIYQVGGNAGQSLAPVFTAFIFVRTGQFGTIWFTLL
ATIGMIVLFQVSTWYKRELYIRNPQKKQQGKREFVVNKEIILAICLLIFLVFARSWYGAG
ISNFLHFYLIEKFSLSIENAQIFVFVFLLAGVIGTFLGGPLADRFGKRTILLFSLIGSAP
FALLLPHMPFWLIGPLLFIIGFILQSSFSVTVVYAQELLPGMIGLVSGLIVGLAFGMGAL
GGVIFGVIGDTFSLQAIMIICSLLPLLGILTYLLPTDKRVSEIHSTLK
>PK3-045_02073 hypothetical protein
MALTNLNVEERMKHYKIAGLSIAVIQDANLNCIKQYGVKEAGKTDIVNEQTRFHSASISK
FVTAMLVLKLVETGLLDLDEDVNVKLSSWRLTANKWIKGKKVTLRDLLSHQSGIIDPEGS
FREWKENEEVPPMIDILEGTSVFNRQKIQISCEPMSAFHYSDAGFCIIQQLIEDTLQKSF
HIVLKEFLLQPLHMNQSCIDIRGVENISSGHDNKGQIIYGNYPFYPYPAACDIWTTPADL
AILVLELMNALEGRSQLGLSRQNAKEIISPQGNINWIGLSVFLDSSNKEVEISALGWGIG
FQSMLVAYPLLKKGAIIMTNTDLGVHQMKGIIGEIYHSIFGNDY
>PK3-045_02074 hypothetical protein
MFKSIKVKNILFILLGSAIFSFGIVHFNMQNNLAEGGFTGITLLLYAEWNLDPSITNLLL
NIPLFFIGWKLLGKNVFIYTIIGTVAVSIFLWFFQLPEIELHIPLTEDLTLAALFAGTFI
GVGLGIIFRYGGTTGGVDIIARLGFKYFGWSMGKTMFFFDFCVITLSLITYLSYREAMYT
LVAVFVGARVIDFIQEGAYAARGAMIISDDNEKIANKIMSEMDRGVTVLKGHGSFTKQDR
EVLYCVVAKTEIVRLKSIITSIDPHAFVSVSIVHDVMGEGFTLDEYKQPLDK
>PK3-045_02075 putative protein YpjD
MNQDKTVKDIQREVDEYIGQFKEGYFSPLAMLARLTEELGELAREVNHYYGEKPKKETET
EKEITDEIGDMLFVLTCLANSLNIDLEEAHNRVMHKFNTRDKDRWTRKDQ
>PK3-045_02076 4-hydroxy-tetrahydrodipicolinate reductase
MNKVKIVIAGPRGRMGTEAVYLMGRTENFELVAVLDHKNEGKSLKEIEGFASYDVPIYTD
IEKCLQTEKPDVLIDLTTPEFGMHHAKTALSYGVRPVVGTTGFTKENLAELEKLCEEMDR
GCIIAPNFALGAVLMMKFSKMAARYFADVEIMEMHHDQKLDAPSGTAVKTAELIAEVRES
KKQGHPDEKETIPGARGADFDGMRIHSTRLPGLIAHQQVMFGSDGESLTIRHDSYNRASF
MSGVKFAVEEVLKVNVLIYGLENIME
>PK3-045_02077 Methylglyoxal synthase
MNIALIAHDKKKNDMVAFVVAYKNIFAKHTLYATGTTGGRIQEATGLDVHRFHSGPLGGD
QEIGSYIANNDMDMVFFFRDPLTAQPHEPDVTALIRLCDVYSVPLATNMGTGEVLIRGLE
QGDIDWRKIVHGKTEPVAKKFTEKLNEN
>PK3-045_02078 N-acetyl-alpha-D-glucosaminyl L-malate deacetylase 1
MERQNQWQKNSQKNSMKTDEVDILAFGAHADDVEIGMGATIAKYAAQGKKIIICDLTESN
LSSNGTVKRRKQEAEKAGEVLGIAERMTLQIPDRGLYLEEKAIKKVVEVIRTYKPKIVFS
PYWEDRHPDHGNCTKIVNEAVFSAGIKNYQVGNTSAHKVQNQYYYMINGFHKPDFVIDIS
DYMEQKQASLNCYQSQFVKGENSVETPLTNGYIDTIEAREKLFGKEVGVIYAEGFIKSKP
ILLNQDLLGGDK
>PK3-045_02079 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKKLKIGITCYPTVGGSGVIATELGKMLAERGHEIHFISSSIPFRLNKMYPNIYYHQVEV
NQYAVFQYPPYDLALSSKMAEVINREELDLLHVHYAIPHAVCAILAKQMSNRDVKIVTTL
HGTDITVLGYDPSLAAGIRFGIEKSDLVTAVSNSLIAQTYEVIEPNKEILPVYNFIDERI
YRKVDASHLKKELAISDTEKVVIHVSNFRGVKRVTDVVQAFHQIANQIPAKLLLVGDGPE
MSKVTKLVDELQLRQKVLFLGKQENLEELYSLSDLMLLLSEKESFGLVALEAMACGVPVI
GTNVGGIPEVIVPNETGYICELGDIEDIAKHSIKLLTDEKKHAQFSQHSISRVRDYFRAD
IIVDQYIEIYKSILETGEMNDKSV
>PK3-045_02080 CCA-adding enzyme
MINPFEEALPIINKIEKAGYEAYFVGGAVRDHLLNKQIHDIDIATSATPEEIKSIFPHTI
DVGIAHGTVMVIWDQHTYEITTFRTESAYRDYRRPEQVHFVRELKEDLKRRDFTINAMAM
DKNGRVIDYFNGKESLEKKEIKTVGNPNERFQEDALRIMRGIRFVSTLGFHLEKDTLNGI
RNNQQLLSKIAVERITAEFEKLLQGSWCLEALKIMVETKIYQFLPMLSSEEKGVSMFAKL
PLTKLGLLEKWAVLILCLGMKEKQQIELFLRAWKLSVKQIKTIQKIIYWMLQREQMTNWS
NQALYFATLSVAVSAEKMYQLLKNCEVNIDIVHLEEKYEKLPIKSMEELKIGGNDLLSWT
EKRPGPWIKDVLSLVERNVVEEKLSNDKQLIKEWLKRCHQI
>PK3-045_02081 Bifunctional ligase/repressor BirA
MSSDIRKGLIEAFTNNPDQYLSGESLAELLGCSRTAIWKHIESLRKDGFILEAVRKKGYR
IISSPEKIVPDKIFFGLNTMYMGRNIHFEDSVDSTQTIAQKLALEGAEEGTLVIAEEQLG
GRGRLERKWQSPKYKGIWMSLILKPNIPIMRAPQLTLLTAVAVVQGIQEVTGVQADIKWP
NDLLLHGKKLTGILTEMQADSDRVHSLIIGIGINVNQQLEDFEKDIQSSATSIYLETQKS
WDRAELIQGIMLQLEKLYQLYLEKGFYPIKLLWESYSVSLGQKVTANTLNGSIAGLAKGI
TEDGVLLLEDEQGAMHSIYSADILLET
>PK3-045_02083 3-methyl-2-oxobutanoate hydroxymethyltransferase
MKATTDFIKMKQKGEKITMITAYDYPSAKLVEQAGTDLILVGDSLGMVVLGYDSTVPVTM
DDMIHHGKAVKRGAENTFIVIDMPFMSYHLSRRDTLLNAARLIQETGANAVKIEGADDVI
EQINCLTNAGIPVMAHLGLTPQSVGVLGGYKVQGKSSDEAKRLMDSALKCQAAGAFAIVL
ECVPMQVAKEVSKRLDIPTIGIGAGSETDGQVLVYHDLITYGVDRVAKFVKQYANVNEAI
SLAIDQYISEVKMGAFPEMKHSFQMKAEEIKSLYGGNTQ
>PK3-045_02084 Pantothenate synthetase
MNIVTNPKQLQDITTSLQKNKVTIGFVPTMGYLHEGHRALLKAAREQNEIVIMSVFVNPL
QFGPNEDLASYPKDFEHDKQVAMEEGVDYLFHPSVEEMYPGQMSVTVKVERRTNCLCGKS
RPGHFDGVATVLTKLFHLVQPTNVYFGKKDAQQVAVVDGLIEDFHFPINLVAVNTVREED
GLAKSSRNVRLTPIERREAGILYKSLSIARSELIKGTADIEALKKSIITFVEKESSGKVD
YFEILSYPQLETLKELNGKMVIAIAVHFSKARLIDNIIFELDHASR
>PK3-045_02085 Aspartate 1-decarboxylase
MFRIMMNGKIHRATVTEANLNYVGSITIDEDILDAVGMVANEKVQIVNNNNGARLETYII
PGERGTGTICLNGAAARLVQVGDIVIIISYCYVSNEELTQHQPKVAIMDENNRITTILQQ
EPEKTVL
>PK3-045_02086 3'-5' exonuclease DinG
MSNKFVVVDLETNGNSPRKGDRIIQFAAVVIENGNIVEEYSSLLNPLQPITPFIEELTGI
TDEMVESAPIFEEIADKIVHLLEDAYFVAHNVLFDLSFLNEELEQAGCRQFYGPILDTVE
LARILYPTADSYKLTDLAAQEGIVHTRPHQADSDAYVTAELLLLLLAKLNELPQVTTKQL
EFLSSSLKSDLDIYLQSLLQEKQSKVEYIPESWEVYRGLTLKKLPSNLISNQSKDYTDSF
DVNTVEKRMKDTLSFYQKREGQIEMMNAVHQALTSNQHGLIEAGTGVGKSLGYLVPAAYF
SIENKEQVIISTFTTQLQEQLFHKDLPLLKRILPFPITYTLLKGRNHYISLDKFEVSLKE
QEDNYDIILTKMQILIWLTETETGDKDELNLTSGGINYWEKIKNDGNFSLPISKEWAQKD
FYRRTRNAAQKANMIITNHALLVKDLTTDQHLLPSYHYAIIDEGHHFEKTATKHFGFRFS
YVAVRLSINAIGTTDQKQLMYHLEHMLGDLSLTDKIEFNQFILSLHEELDELFRAVLRYV
KKTNQSSKEGKGSYRIKKTDTGDWNAVKSVAERMVFLWKDGRNALREKVLRLKEQNRKFS
SSQMLVVERIESTLNDWQIYINHLREMFLREGDNIAWLEADKKNFPNNAVLYTQPSSVAE
PLQNRFFNQKQSIVFTSATITVNNSFDYYVKVLGLGKNQLEVQIDSPFNYEKQVQLLIPT
DVPEVNTVSLNEYVSTIGEQIINIAQATKGRMLILFTANEMLKKTYDYMKESGCLEEYAI
LAQGITNGSRMRLTRNFQRYDKAILLGTNSFWEGIDIPGEDLTCLIIVRLPFSSPEDPLT
EAKNERIKNEGGNPFLENSLPEAVLRFKQGFGRLIRTEEDKGFIIVFDRRIVSTSYGETF
LKSIPAVPIKQLNNTEMVKFIEKWLK
>PK3-045_02087 putative protein YpmB
MKKWIWIIVVVVLIGLAVSINTYVQAMKPVKSAREVAENIAKKEADLKEVDSFQLYNGKE
AYYILEGKNDDNKDIIVWINEKSHKVTEKLKKDGLTKQEALNILLSKQTPEKVNHVCLGM
YDGIPVWEIYSHTDKDSINYHWIDFETGEILLTIENY
>PK3-045_02088 Aspartate aminotransferase
MKIQLAQRVNALTPSTTLAITAKAASLKADGHDVIGLGAGEPDFNTPQNIIDAAVRSMNE
GHTKYTPASGLQVLKKEIAAKLKRDQKLDYETNQIIVTNGAKHGLYTLFQVILDKGDEVI
IPTPYWVSYPEQVKLAEGEPVFIEGYESNEFKITPEQLKEAITSKTKAIIINSPSNPTGM
IYTEEELKAIGEICLEHKILIISDEIYEKLVYGDSKHVSIASLSPELKEATIIINGVSKS
HSMTGWRIGYAAGSKEIITAMTNLASHSTSNPTTPSQYATIEAYAGPQESVEEMRQAFNK
RLDIIHEKLNNIPGFSCLKPKGAFYLFPNVQKAVELTGFKSVDEFSTALLEEALVAVVPG
SGFGADSYIRLSYATSLEKLEAAVTRMEQFVEKKMVVNQ
>PK3-045_02089 Asparagine--tRNA ligase
MIKATIAELPKYVDKEVKVGAWIANKRSSGKIAFLQLRDGSGFVQGVIVKSDVAEEVFQT
AKSITQESSVYVTGTVQKDERSPFGYELLVTNIELIHTSTDYPITPKEHGTEFLMDNRHL
WLRSKRQHAVMKVRNEIIRATYEFFNENGFVKVDPPILTGSAPEGTTELFATKYFEEDAY
LSQSGQLYMEAAAMALGKVFSFGPTFRAEKSKTRRHLIEFWMIEPEMAFVEFDENLEVQE
QYVSYVVQSVLKNCQLELNTLGRDVSKLEKITAPFPRISYDDAITFLHEKGFDDIEWGDD
FGSPHETAIAESFDKPVFITHYPTKIKPFYMQPDHEREDVVLCADLIAPEGYGEIIGGSE
RIHDMELLNKRVKEHQLDPETYKWYLELREYGSVPHSGFGLGLERTVAWITGVEHVRETI
PFPRLLNRLYP
>PK3-045_02090 DNA replication protein DnaD
MNKTIFLKWLQEGNVNIPSTLLTHYKHLKINEKELVLLLQVHYYLERGKDFPTPAEIAAQ
MTIDINECHELLSQLIRKGFIDILDGNSDTGIRFERYSLEPLWNKLIEQFLLNNKKEEEA
LIEKEESDLYTCFEREFGRPLSPFEIETLNMWVDDDQHEIAIIKAALREAVISGKLNFRY
IDRILFEWKKNGIKTIEQAKSHGKKFRQHQSVGYKAEQSEESSNKKTVPFYNWLDQ
>PK3-045_02091 Endonuclease III
MLKKDEIRYCLDTMGEMFPEAHCELVHSNPFELVIAVSLSAQCTDALVNKVTKNLFQKYK
TPEDYLSVPLEELQNDIRSIGLYRNKAKNIQKLCQMVLEKYNGEIPMDRDELINLPGVGR
KTANVVVSVAYNIPAIAVDTHVERVSKRLGICRWKDSVLEVEKTLMKKVPKEEWSVTHHR
MIFFGRYHCKAQNPQCEVCPLLALCREGKKRMKTKGVV
>PK3-045_02092 hypothetical protein
MANNQLDAPLELIYGPFPVIKQFPFIAADSFELMPAFLHEANYYHNKVVYQPWNKENFPE
CVKLVFDKWRQLKQEIQLFVKERDSNRLQQGLTIGAEYFLECLYWVNEKPVTFKNGLVDP
SLEVKPFNLEDRLQFILKRLNGYHSFKQLDELYKELEKQFAIKLVKLKRSN
>PK3-045_02093 Penicillin-binding protein 1A/1B
MTDKYQTREERRKQLEASKKKAPKKGKKKSGMNLFKRVLLILLTIGIIGIIAGGVAFAIM
VKDAPELNPETLKDPISSTIYDKNNEEIAKVGAVNRDYVNYEDIPDLVKDAFIATEDSRF
FKHHGIDPIRLGGAVIANFRDGFGSEGASTITQQVVKNFFFNQPQKTLSRKAQEAWLALE
LERKYSKEEIFEMYVNKIFMSENMSGVKTAAKVYFDKPLDELTLPEAALLAGMPQAPNAY
NPFNNPERAEKRRNIVLSLMHQHGYISKAEMEKAQKTSVEDTLVKKEKRKSNDLPFDPFI
KQVIAEIEKKYPDVNVFTDGLEIYTTMDMKAQEYVDKLMYEGEIVPFPDKDFQAGITLLD
TKTGGILALGGDRDPKVKLGTNYATDMKRPPGSTAKPVLDYGPAIEHLKWGTYQTIVDER
STYSDGTPINNWDNKYKGSMTMRKALEMSRNIPALKAFQAVGAEKAIDFAVNLGIPLDKQ
YESYAIGSFEASTLEMAGAYSAFGNEGVYNAPHAVRSFKLKDGTKINMEPKSKVVMQDYT
AFLISDMLKGVLTSSNGTGTLANIPGLPVAGKTGTTNYTEEERTKWGITDSSSVPDAWFA
GYTTNFTMAVWTGYTERKNPIKPGPDQKVAQKIFKAVMGHISEDVETPDFKKPDSVETVK
IEKGTYPARLASSYTPSSQIQTEYAVKGNILNEVSQKYNKPDAPNGVKASYNENSDEIDL
SWNYGKKDGIKFDVSVSVDGGASEQLTVTSDTSLKIAKPTPGSTYNFAVKVIKGDQESDP
ASASITVPEKIEEQPPQDPNETIDDEEKPDDSNGEDSDDNQDDGDNGDSDNGDENQNNQD
NNNGNNGGNGNNGENNNGNNNNGNNNGPNNHPNPNDTNPNPNQNQNRNREQNQNDSQ
>PK3-045_02094 Holliday junction resolvase RecU
MKIHYPNGKRYTPLKNVHTKSQKKVSYSNRGMTLEDDLNETNKYYLEFGKAVIHKKPTPV
QIVQVDYPKRSAAVIKEAYFKQASTTDYNGVYRGKYIDFEAKETKHTTSFPLNNFHEHQI
RHMRLVCEQQGICFVIISFSETNEIFYLDAEKLFIFWERMINGGRKSITKQELASNGHSI
SLGYRPRIDYIKVIDTIYGFN
>PK3-045_02095 hypothetical protein
MIGKKSYFSSLEEEKLINRIRLITDMRNFDNISRTKAYLHYYNKHKEIQWAFLASQVSRN
AGWNMCDLNGTWLPQVVSQEKRQQIYLTYEKANWLIFQDAYPQLLLYEYSTKNNLPMFHL
LKFFQVSSFMEEEWNHYWKEKDKKRLMNSLIINEQNVIHQPVMENKRIKHHVFHYLPYLF
QDLFHFNAVLFPTTQGTLYGASVSNFTSLSARIKLGNTLASLLFKPNLYQEFYDFARKNE
HTGSRRDYEKYIYPNLANTTPVLRAAYPVVRHQHILREDWFKKHIKKKWRNLSEQKEPFH
ITDWYLRKQRQLHELIRQENKWFN
>PK3-045_02096 hypothetical protein
MENAYTKEKLLNMLEEIQEELDTLDEVLLNSGKQNMQLVKEHITSLTDIERGIAAMEKKI
AGSKLNIRTDGPRQRMPLYLNLAK
>PK3-045_02097 putative protein YppE
MTENHQLMEHTAKLLEAVEYAVDTFYKVKESGVNEDFYEVVRPFANQIKELNDKWKEMAT
EWVQKSKPDYLNTIQINTAADHIEIISIQAFFTQTSKKRFLDSAKSVKYILQTLLDALKN
ETK
>PK3-045_02098 hypothetical protein
MHKASNQQSWNIPSYHTAYTHPVSFDNRQYHPYLNQGQWNGAGMNGQNFYNIPPMQPNYQ
NNQSSYYHPQNAYKNNTQDIFQNPLHYMENSEQNQYTTNYMNQNQGFMNPYPKQSFIPKK
QGNMKSIMNSFKSQDGSLDFNKMMDTAGMMMNAMNQVTGLVKGVGGIFKV
>PK3-045_02099 hypothetical protein
MSSNFPIDPNKKEKTPQPFNGFMRSMNQFFQEKPVKNFLQQMDEFFSNPFPNMAFPLSVN
ETEGATIIKAELPGVNKEQIQLDIYDHYLTISINHQEILTEENSQTKTFHTSKTYKRNSR
SIAFPHPIDERKVTASYQNGLLTIKVPKQKGKKIMIEDRN
>PK3-045_02100 2-(acetamidomethylene)succinate hydrolase
MNHIVVDNEQLSYIEEGKGETVILIHGFCGSVDYWEYIIPLLSENFHVIAVDLRGHGSST
YRGESFEIEDLAKDINKLLEKLEIDKVYMFGHSLGGYVTLAFAELFAEHLKGFGLVHSTA
YPDTEEGKEGRLKAIRKIQDLGIKEFVNGLIPNLFADESLRDLPNEIEKAKKIGYQTDGI
AAMETQAAMRKRPDRNGVIEQANVPVLLIKGTKDKVVSLDRVTSASNPKVSEVQLETGHM
SMQEAPQKLANAIYSFISSNSK
>PK3-045_02101 ATP-dependent RNA helicase DbpA
MKVRKNLQEIIRDLKTKDEYKERISFWHTIEAKEAVTVPLPDDLIPNLKDALQKRGVTRL
YTHQHSSYQAIREGKSIVAVTPTASGKTLCYNLPVIQSIAEDKNARALYMFPTKALAQDQ
KSELNELIESAELQINSYTYDGDTPASIRQKVRKAGHIVITNPDMLHSAILPHHTKWVSL
FENLKYVIIDELHIYRGVFGSHVANVIRRLKRICAFYGSNPIFICTSATIANPKELAENL
TEQRVQLINNNGAPSGKKHFVFYNPPIVNIPLNIRRSATLEVRQLAGELLKNKIQTIIFA
KSRVRVEILLTYLQELVKFQLGPKSIRGYRGGYLPTERREIEQGLRQGNIYGVVSTNALE
LGVDIGQLQACVMTGYPGTIASSWQQAGRAGRRHDESLVIMVASSSPLDQYMVANPDYFF
SRNPETARINPDNLIILIDHMKCAAYELPFKEGDTFGNCEITEILEFLTDERILFQNGDK
WYWMNDSFPAHNISLRSASQENIVIIDISDVSKSRVIGESDRFSAMTLLHEEAIYMHQGI
QYQVEKLDWEEKKAYVREVSVDYYTDANLAVSLKVLEEDNKSNYQKAETGFGDVSIVAMS
TIFKKIKFETHENIGSGPITLPEEELHTNAAWISFQPSDLEWEQEQTEQGLLGAAHALKH
IAPLLVMADPQDLHVVPQVKAEHNEKATIFFYDQYPGGIGLSKKIYEEMPAVLKEAKKMV
GNCSCEYGCPSCIGTESHAHNSKRDVMKILSLLENSEISI
>PK3-045_02102 hypothetical protein
MSIKNKLNRMKTHLKKEEQTLPVKNPEAKKGTIPFMKEWEQENVSPYWLDSEYCLIREVR
YPLDYKHGNYTFRDFCGVVDEWNKASYDHPLSAKGHQPKDLFFFDTETTGLGGGAGNTIF
ILGYAQLQQEEIVLKQHVLPHPGAEVPLFNSFLENVDYTTLVTYNGKAFDWPQVKTRHTL
IKEHVPKLPEFGHFDLYHASRRMWKHRLERTKLSIVEEEILGVKRKDDIPGFLAPMIYFD
FVERKNPEGMLGILKHNEIDILSLITLYTHLSSQLLRKDQEISARETLEVGKWYAIIGQT
DVAKQNLESIKDQDKEVLLEAAFLLAKEYKREKKFEDALSLWQKITETYTWETNQIIVIQ
SLIELAKFAEHKEKNPQKALQLTKKAQNLLYEQETLPKMEQELQKRYERLIRKLHTI
>PK3-045_02103 hypothetical protein
MHCKPNNILPAVVHPTKCCVNNTFTNNIVPHIHPTHTTTVNHVNYEHQHFFPHTQSSETV
VTNTQANMGPAPAPFPTAPTAPAFPQMGGTPFTATGQFFPGQAGMSGMPGGFPFRKR
>PK3-045_02104 hypothetical protein
MKIAVISGYKPFEIGIFKRDELAAEYIKIAIRKNLLAMLEEGLEWVLISGQLGTELWAAE
VVYDLQMEEYPDLKLGVITPFLEQEQNWKEANQEWYEEIIMQADFVDSVSKKPYESPQQL
KDKNIFLLKKSDALLLFYDEEKPGSPKYLYELALKYQEQNTYEIRKIQFSDLQDIVEEIR
FQDEY
>PK3-045_02105 Cell cycle protein GpsB
MLSDKMKLTAKDILEKEFKTGVRGYKPEEVDKFLDLIIKDYETLHQEIEELQQENLRLKK
LAEEASRRQPAPTTAGTTNFDILKRLSNLEKHVFGSKLYD
>PK3-045_02107 Ribosomal RNA large subunit methyltransferase K/L
MRNFDLIATAAMGLEAIVAKEVRELGYECTVDNGKVLFKGDEKAIAKSNMWLRTADRVKI
KVAEFKATTFDELFEKTKAIRWEEYLPVNAQFPVSGKSVKSKLFSVSDCQAIVKKAIVNR
ISTHYKKTGWLEENGALFKIEVAILKDIVTLTIDTSGQGLHKRGYRAGQGEAPLKETLAA
ALILLTNWTADRPFVDPFCGSGTIPIEAALIGQNIAPGFNRDFISETWDWMPSEVWEEVR
QEAEEIANYDQPLEIIGTDIDHRMIQIAQENAFEAGLGDLITFKQMQVRDFTTMKENGVI
VGNPPYGERLGDKPSVQKMYQEMGQAFAPLETWSIYMLTSDEEFETHYGRKATKKRKLFN
GFIRTDYYQYWGKRKRD
>PK3-045_02108 hypothetical protein
MKDSNIDYTKIIGALNSSVNLIEEEGIADQAVLQQLSTAQQMVQQAMTYSLSRDRG
>PK3-045_02109 putative ATP-dependent DNA helicase YoaA
MQNSMPFEVSKTESFYEKLGEWIGDVFYDILPEAGYELRDEQVYMAYQLEKAFKERKTIF
AEAGVGTGKTFVYLLYSICYARYVNKPAIIACSDETLIEQLVKKEGDIAKLEEALGLNID
VRLAKSRNQYLCLTKLDQKITFEDTYNTIYDSLPDFVHGTGSLQSFSPYGDRKDYPDLND
KEWEGVAWDSMQDCFTCDKRHRCGQTLHRDYYRNAKDLIICSHDFYMEHIWTKEARKREG
QLPLLPDSACVVFDEGHLLEYAAQSALTYRLTEQNLENLLTRLMANDVREKTLNIIEETI
YQNEQFFRELTDASYKTEGSDKQEIKKTDRVIQAGKKLAGYISELEEELVFESEMYVINE
YDLKVVEEYLEQISHSLGLFLKEMNGITWFEENNGERTLVIMPRLVQDIMQEEVFSQQKP
IVFSSATLSENKSFEYMAKSIGAADYLSFSVDSPFDYEENMAVYIKSFNQNEDKEKQAYC
YEELIKADGRSLVLFNSKEDLARFKDNLPQEFSLPIYFEGEREISTLVSKFQNEEQSILC
AVNLWEGLDVPGRSLENVFIYSLPFPPNDPVYKSKRENVENPFLEVDLPYMVLRLRQGVG
RLIRTHEDKGTIHLCMDTNVADLVKNAVIEALPVTAM
>PK3-045_02110 Carboxypeptidase 1
MSINQKEMEEQFLNYVKKIGAYNEALALIYWDLRTGAPKKGVDQRTEVIGVLSSELFELS
TSEELEAYLTVLSEESIQDQLSPITRKTVEEMKKEFDRNKKIPADEHKEYVMLQSKAESV
WEEAKEKADFSLFQPYLEKLVEMNKRFIEYWGYKENKYDVLLDMYEPGMTVAILDEVFSN
VKDKIIPLVHKIAASKNSPTTDFLFQPFPAENQEAFSLDVLKQVGYDFDAGRLDKTVHPF
ATGINPGDVRITTKYDESDFRVAVFGTIHEAGHALYEQNISKELIGTPLCTGTSMGIHES
QSLFYENFVGRNLAFWKHNYEALKSFANGQFDEVTVEDFYRAINESKPSLIRIEADELTY
PLHIMIRYEMEKGLFDGDFEVKDLPAIWNEKYKTYLGVVPENDGEGVLQDVHWAGGSFGY
FPSYALGYMYAAQLKQVMVKDIPDFDALLEQGNLLPIKEWLNEKIHRFGKMKKPLEILKD
VTGEGLNAQYLIDYLYKKYSDVYQLEL
>PK3-045_02111 CheY-P phosphatase CheX
MTLTKSTTEILNATIEAVKGVIPCELQIEKPSLTVSPFILQSLGVLIGLTGDFRGRIIID
GNEQVFGKIGESMYGMFLEGPMLESFSGELGNMLAGNLSTFVSQSGIEIDITPPTVLAGQ
TKLSGFDKALTLPISLQNIGQLNIVLILEI
>PK3-045_02112 GTPase Der
MLSTNIDTLHKWAAYYQYFLAYDDQQTAQRLQELIKKATRQEFIATFCGHYSAGKSSMIN
NLVGTTVLPTSPIPTTANIIRVKKGGKQLKVLYHSNQADVYKEVLDIKTVLQATERVEDI
KELEVQLDTELLIKNAILMDTPGIDSTDQAHQLATESSIHLADIIFYVVDYNHVQSEINF
DFTKELVDSGKKFVLIVNQMDKHREVEISFADFKQSVYDSFLSYGIKPEKIFFTTLIETN
YFYQGLAELKTYIIRKMEEQELILPYSMEESFQKLYKDHISFIETKNAEIIAPFEDQLSE
LTEEEYHSLEASLESTKKAIQTMDETENKTVMSLENEWHSIIKNAYIMPYNLRELAKSYL
ESEQKNFKIGLFGSKSKTQKEREDRLLTFYTELEKLVQIQLITPLSQFFEKQGKAEFFSL
IKGLTSILSIQTLKALVNKNAQLSENYVLVYCETVENDLKQSFRKEITQLFNRWKEERKQ
QLQIEKENLLKEQKKWQAFVNCKVKKEEVETKWQVWKEELEHLCEAQNVDESILRSLLDT
SEEEITYRSLSSSKTKNVQKNLKPAEVQKQNERKEMDTDLLLKQLRFLSSRLQQVKGFAH
IAKNLFHKAAIIENRTYTICLFGAFSAGKSSFANALLDYPILPVSPNPTTATINRILPID
EEHPHKTVIVKWKSESEMLREINDYLQLVKEEANSLEAAQKIINTLAANPMERYANEFRY
LQAFLKGYSDHRHYLGSETNIELEELSNYVAIEETSCFVASIDVYFDCQITRKGITLVDT
PGGDSINSRHTELSFEFMKKADCIFYVSYYNHAFSKADRAFLMQLGRLKDAFEKDKIFFV
INAIDLAKDQEEQAAVEEYLQEQLQLYGIRSPRILPVSSLYYKHDVYGKWMQKAEEQMYD
FIEHEWLSMMLQSAQKDYVETIDLLKKLVESTFAKKEVAEQELSRLKEEKWTILSQIESK
DFQHALEKFKMEVEEQLFYIKQRVMFRLHEIMKEAYHPSILRGDNKKREISLATTSFLIQ
LNFEFEQELRAVNVRLDQLFYKQKIEGYEEVRHLIQSINKEIRLQEEIERELDSNIIFHA
PFKELDTILNKIGIKYYKNPKSFFEKNERKNMGVEMEQLVDEHGNKYIKEQTNSFFAFYK
ELFAQHIDILLVNLKEQVAEYYDGKTALLTEHENIEKLEWIIKESVQTEFAQQTN
>PK3-045_02113 3-mercaptopyruvate sulfurtransferase
MEIVKSVDWLNKNIDQDTIRVIDCRCDLKNPDAGIEWYKKGHIPNSVYFHLEKDLSAPIS
NHGGRHPLPNIEEFVHKLENIGVAKDTIVIAYDNGDGASSGRLWWLMNYIGHSKTYILDG
GYKEWLKKDYPTSQEVPAFSKSNFSPLIQSHMIATYEEVSELVKTKDQDKILIDSREHKR
YTGEIEPIDKKKGHIPGAINFVWTEGIENGFFLAEREQKSRFSSLDANKEYIVYCGSGIT
ATPNFISLKMAGLDKVKLYPGSFSDWISYEENEVETCLPIDLKDEKEENSL
>PK3-045_02114 hypothetical protein
MNTFRGPFRLMMREMSMTFYINVCITFVLFVFYNILGYIGVAESGSFILFGPLFVVFLLF
PFINFTSYQYILSLGGTRKQFVLAFYLSAVIYSVLSGVILNLFYLFTTLLTSGNYLFHFA
KFIHTTNWLIYFWIDFSWIFFLFSLGMLAKTVWFNYGTAFLLAASTLLLILGTIAVIFGD
MSIFITTFFEHHLKFVAILFGLSIVFLLLSYSLMKNAPLEKGGRLNFKQFKRNNVVIHR
>PK3-045_02115 Vitamin B12 import ATP-binding protein BtuD
MIKLENVSFSYGNTPALRNVSIEESEPIIMGLWGRNGSGKTTFMKLLAGMEDIDAGTINV
SGITPYNNTETMNNITYIQENHPFSILWNVEDALHYGALFNKNWDAELAEHLVSLFELPR
KKKIKNFSKGMQTMLQIILGLGSKSPVTIMDEPTNGLDAHMRKQFYDALLNTYEEDPRLI
ILSTHHIDEMEALCEKIAVINEQTIVRFEETEELKSRGVHLSGLASAIEPLIEGYPILEK
RKLGKQMTVMMDDIYSDNWISKAKDAGVTIEKAKLQDYLVNYTTRKEGQKI
>PK3-045_02116 hypothetical protein
MKAVFDDSKPIFQQISDMIANEIVEGELLEGDQIPSTTEISKFYQVNRATVQKGLAALVE
AGYVYKQRGVGMFVSKNAKQKLLEKRKEEFYNDYLKPMFEEAKRLELKKEELLKIIKEDY
KHD
>PK3-045_02117 5'-3' exonuclease
MNKEKQANLMLVDGMALLFRAFFATAVTGQFMVNTKGIPTNAIHGFVKHFFTAIEHFNPS
HVAVCWDMGSTTFRTEMYPSYKANRSEAPVELIPQFDLVKEVVESFNVPNIGVAGFEADD
CIGTIAKQMKGEANVTILTGDQDILQLLDDHISVALLKKGYGNYMLYTPSSFQEEKGITP
KQMIDLKGLMGDTSDNYPGVKGIGEKTALKLLQVHENVEGILANLSLLTKGQRTKIEADL
EMLHLSRQLAEIKCDVPVSCLLEDSYLNINPETAVKKFEELEFKRFHHYVEKKEALTLF
>PK3-045_02118 hypothetical protein
MSKNHGNRGKTAGGVNPQGYGQDADITPSPKSKLENAAKKKNTK
>PK3-045_02119 hypothetical protein
MNKGIYVALISIGMAQFLKIPIQFLKTKKWDKGLFFQTGGMPSSHSAGVSSLTTFIALKR
GLPTIDFAMSLIFGLIVMYDAQGIRRQTGELTLKVNDLGELVDKINKDKNIAFKEQQPKK
LKEMLGHQPQEVLGGALLGVLVGFLGHVFTKKKRSLLRW
>PK3-045_02120 hypothetical protein
MLFLESKGFSFGEDVIGFIYFGKAYTNATDELVITAIECTLKIQKKFDGSFFVSLLEMFN
DNELKTKKEVIGFIKRNHLFPL
>PK3-045_02121 14.7 kDa ribonuclease H-like protein
MIEVYIDGASAGNPGPSGAGIFIKGHGSAEKYSFPLGSMSNHEAEYHALIKALEICIHNK
YLSVSFRTDSELVSRAVEKEFAKNKKFAPLLEQALKLISQLELFFIKWIPSNENKTADEL
ARIAIRKNK
>PK3-045_02122 hypothetical protein
MKYKLEYKFQMKKKKDFIYFTSDWIQSSLALEAGDELEKRNDVADILFYDEKGTSWTLKE
LRKLNEEIEEEPHDFTIYFDGGYHKETKTAGIGVVLFFHQGKKKFRVRANELFHDILSNN
EAEYAALCHALNLLEELEVKGVTCEVKGDSQVVLKQLEGEWPCYEDDLNNWLDRIEAKIK
TLRLSMVYTSISRNDNKEADKLATQALEGKRIYSKMQLL
>PK3-045_02123 hypothetical protein
MQRKKWMKEADELMQDYCKDCFLYRQNKVEYGKRGAHRFCISQCTVGNKLKEYGEKLSSS
K
>PK3-045_02124 Cold shock protein CspD
MQNGKVKWFNNEKGFGFIEVEGGDDVFVHFTAIQGEGFKSLEEGQEVSFEIVEGNRGPQA
ANVVKL
>PK3-045_02125 hypothetical protein
MYRFSMEKENWILRFTPNIVLEEDSKEAIVKSILQLGSVLPSFSHGESFVIMVKKIGLIV
FNVEKIPSLILTVSNIIEKENWYIQTDSKIRKYFM
>PK3-045_02126 hypothetical protein
MIETIVKSSQSPYYEISREDQMILSPFEGTVSEILMKEKAYFYEWEPILTIRTLAGEIKD
VSVPFSGSVVELLVKPGDKIAINTRLASLQDDLLVTGCD
>PK3-045_02127 hypothetical protein
MMQMHSALRNLKKYKIGYRTFKTAVAVSIGITIAQFFHLDFYVSSAIITILCVQNSKKKS
LHSAFSRFIACMLAIPFSYIFFEGMAYEPYIIGLLLLLFIPTTVLLKVNEGVVTSTVIIL
HIYSTNHMTWDVVLNEWALIVIGIGAALLVNSYMPSLDKEMKVHQKDIESYFKALLMDMV
VYLRTNEITEEYASKLKRASDIVQCAKSVAYRDVENHFTRKENYYYHYFTIREKQLEIIS
RLFDRILSVETLDNQRELVADFLEELSLCVHSGNTAVLFLSKLQRVEELIKHDKLPADWD
SFEEQAHVFFVLKELEQYLQIKKSLKVAY
>PK3-045_02128 IS1380 family transposase ISBha1
MKSVQETSLHFNKRVKINFDGGDLSSDSGLLLYKEFDEKLDITKMIKEKINISDSSSHHT
HSNHDVIMQKVYQHLAGYHTDNAADDLQVEPTMLRVFSKERLASQPTISRLNSKVDEETV
NQFQQTIQCLFDRVQLVKPSDGYIFDIDSANFETTGNQENTAYNAHYRTMGFHPLFLFDG
LTGDCIKAVLRSGNVYTSNGVVEFLEPVLIHFKELYPHCPIIIRGDSGFASPGLYELCEK
YDVHFVIRLKANAKLNGFAQELEAQITKNLEITSKPCVFYQEMNYKAASWHTERRVIIKL
EKPTDELLFTYTFIVTSLSANAKNIVKTYQNRGTMENFIKEGKNGFAFDWLSSHSQKTNA
MRLQMSVLAYNFHNWFRRICLPNKVRNQTMETLRSQLIKIAGKVIRSSRYITFKLCSSCL
YKDAFWQTLRNIQRLQVKIE
>PK3-045_02129 hypothetical protein
MKINDKASFHAYTQLSLVSRFKKHMETGNKYGNNTVEEMKNRMGFSTFNEAIKDNKIINK
DLARDTSSFHKGILEDRLKHSGNTFYSGQVSEIVNKAFKLGLVGNNEYLISKYKESI
>PK3-045_02130 SPbeta prophage-derived uncharacterized protein YolA
MKKILGIIAVAVLSFSFVFSVTPTKTLAGPATPLTNLQIIGITSDGNDFLWEDIEFNQLS
ASIPLKGEYVYLAIYVEGTERQGWLRINSGGTDITAQTIKALPDEPLVGSDNIVYGWIKY
YEIPKNLLSSGAINISALNYYDNTTFYDNISFLIE
>PK3-045_02131 hypothetical protein
MKSVLETNLSFNKRVKVNFEGGDLTSDSGLLLYKEFDEKLGITEMINIREYPKPAGQNRV
VS
>PK3-045_02132 DNA topoisomerase 3
MKLILAEKPSVSKNIADALKIKNRQDGYFEGNGYIVTWAFGHLLQLNDAKDYDEKMSTWK
LENFPFIPPKFQYKVKSDPKDRDKPDRGAEKQLKIIHRLMKRQDVDSIISACDYDREGQL
IGDSIIYNLKTEKEVYRLLLNEWTPNEVLNGLNNLRSNKELRPLQDAGVSRQWADWLIGI
NLTSVATLKYQKGKGKALNIGRVLLPTLKIIYDRDKEIENFVPENYYKLQATFLTENGSS
YTGTYLENKEEKFKEELYLKEIEEQIKGKTAVVIDKKVQKKKEYPPFLFNLSNLQGYITS
KYKGWTADKVLKVAQSLYEKKYITYPRTASIALEESLIAKTEKVVNLLAADLPFKNEVKF
VPSKRIFDNKKVESHSAIIPTYVLPKKLSQEEEQVYVAIKNRLLMQFMPVAEVEETRIIT
SVNQVELKGRFVTKGKVQLVEGWKKIENIQSKDVMLPLVNLQEEVLTQKASTSIHTTQPP
KEHTEKTLLRLMETCGKNFDADTEEDVLSILSGFSIGTPATRAETIKKLKDIGYIEAKNK
SLVCTELGRRMVEIFPIKDLFNLDFTGRLEKTLYDIEKGQFSKQQFLQIISSFTTNAVET
IKKEEDIIIQEVTYTKGKTEVLGKCPLCGHAVIEGKKGFGCSNWKNGCKYVIWKNDKFLG
TMKKKPTKTMVKALLKNGKAPVKGLISKKGNKFDAIMKYEKNQDNEYFSWKMEFPE
>PK3-045_02133 HTH-type transcriptional regulator MntR
MPTPSMEDYIERIYNLIEDKGYARVSDIAEGLSVHPSSVTKMVQKLDKDEYLVYEKYRGL
VLTPKGKKIGKRLVYRHELLEQLLRIIGVKEENIYDDVEGIEHHLSWDSIDRIGDLVQFF
EENPKHVEELKIIQQKNDSIE
>PK3-045_02134 hypothetical protein
MEKIVAVERNYMGDIISFKTSNGRVISYRKALLDIETGIIDGVEIMENEREQEDLPYSII
DNFDNYPPIF
>PK3-045_02135 hypothetical protein
MGRYDLEEFLAKTEQQDKNEGIFELETERMLEINLTNKIWAKAGSMVSYRGNIRFTREGI
LEHGIGKMFKKALTGEGASLMKAEGTGKLYLADQGKKISILRLNGDSIFVNGNDLLAFEP
SIKWDIKLMKRIAGMLSGGLFNINLSGSGIVAITSHYEPLTLRVTPNNPVFTDPNATVAW
SGSLQPEFVTDITLKSFFGRGSGESIQMKFSGEGFVVIQPYEEVYFSNSGSNNS
>PK3-045_02136 Homoserine O-acetyltransferase
MPIRIPQLLPAREILEDENIFVMEEGRARTQDIRPLNILILNLMPQKEKTEVQILRLLGN
TPLQVNISFLRTASYESKNTSSYHLEQFYRDFEAIKTNKYDGMIITGAPVELMSFEEVDY
WDELTKIMEWSKTNVTSTLHICWGAQAALFHHFGINKYELEQKCYGIYSHHVLNPADKLM
RGFDDSYLAPHSRHTNVSIEEIKAHPKLELLSASDEAGAFIISGNKGKQIMVTGHLEYDS
STLAEEYKRDKEKGLNIHLPLGYFPENDPNKKPLNSWRSHAHLLFSNWLNYYVYQETPYE
WK
>PK3-045_02137 Formate--tetrahydrofolate ligase 1
MKSDIEIAQQAVMKPIIHIAEKLGLSDDDLELYGKYKAKITASTLNKLKNNKSGKLILVT
AINPTPAGEGKSTVTVGLGDALNKLQRKTVIAMREPSLGPTMGIKGGAAGGGKAQVLPME
DINLHFTGDLHAITTANNALAALVDNHIHQGNECRIDQRRIVWKRAVDLNDRALRKVVIG
LGGPLQGVPREDGFDITVASEIMAVLCLAADINDLKVRLARMVVAYNVDREPVTVGDLKV
EGALTLLLKDAIKPNLVQTIEHSPAIIHGGPFANIAHGCNSVIATTAAVKLGDYVVTEAG
FGADLGAEKFLNIKARNKEIDPEIVVIVATIRALKMHGGVEKKELGVENIEALRAGFANL
QKHVESIKEFGLPFVVAINKFVTDTELEISVLKELCEQAQIPVALTEVWEKGGDGGIELA
QKILAILEKKEQSFRHLYSLNTTIEEKVLAIATKIYGANRVEYSSKAKKQIADFEKFGWG
HLPICMAKTQYSLSDDPSLIGRPEGFSITIREFKPSIGAGFLVALTGEVMTMPGLPKTPA
ALNMDVDEDGKAVGLF
>PK3-045_02138 hypothetical protein
MFDPTAFENMRTVMEGLIYDKDLDGDIIVLDRNDVFNSSKLSRNYTITFRLKNQQNAKLM
FELSADLQNLSAELLASVKKEKWIGATVYIHLFLRHKQDKTLYPLIQQLVEEIWGKDLKI
RQEISYQPLEAEQTILNHITIDFNRLITEEQIDDMITMMEFMEKTLTALQSIDSLLTV
>PK3-045_02139 Hydroperoxy fatty acid reductase gpx1
MSIYDFKVKTMDGKMQALSTFKGDILLIVNTASKCGFTPQFKELQELYQMYKEEGFVVLG
FPSNQFMSQDPGTNEEIKSFCEVNYGVTFPMFAKIDVNGKEADPLYQYLTKEAPGALGVK
AIKWNFTKFLIDRNGNVVDRYAPSTSPSEIKADIEKLIR
>PK3-045_02140 hypothetical protein
MLSVQKKELTIKEENSKLLSVKEAAEYINEGPGVVRNWLRELKTLIPVIIGENGYRYFDQ
KSLDILVKVKQMRNEKQMSLRQIEDELTRPLPASIPIATEATEKILQDLQTIKEELELQK
NFNQVLVQQLKKQQEHIEFQQEHIASQERKITLLENPIVLKEKEEQYYAKSRKKKLADLN
ERETKEKKSGFIRLFSYR
>PK3-045_02141 hypothetical protein
MEKTIKGLEEIKIVSYHDDLAGKVADMWTKSKDSWGGTGKTEEQVRDQQQSSDNIDTFLA
VIGEEVVGYCGFSVYKEDAGALYVPLLNVRPDYHGKKIGKLLLLHALNAATELKWPRLDL
YTWAGNLKAVPLYKRCGFFWEDNDQYTHLMNFIPTVRNDAVINSYLKNMDWYADLKRNLE
IKPDGVFERGFTHYEYVWQKETETIVVKFEKTSRGICSLETKDFQIELTMDNHKCIEEIE
HKVYLKIKNKTASPISLEVLADNQDRIQCSFQRSQEIKGNQEITISSSFVIEKGEEPVNG
KTFPALKVAVRINGLETGLQLGVFPQAPISIEGKEIEAILAKGMNTYLDLEIRNNLEKDI
YGYFTIPKNDRLHFEGDKYSFDLAKKAKKWIRIPVQVKSCGSFKEKIIGEIVENEQGILT
FEKEIALAFKGIGEQFVVEQEKSWQVYNGPHQLTVSKMDLTTEIAHTDFALFAPSIGKPY
SNELSKQKPYEVRTEKTGNSIKLELFFKSNAFPYLDIMLTNQLFAEGLIKRWITIANNSL
EEKEISVQETFFDIWQNLYFPLNGEVVSFNEWNLVQPFELNSKDITGNWYFSSPNSSPFG
VAWAKEARVKMDNWKVHIESTRMLGKNESVAFSPLRVNIGAYRNWQQWELAAEGLQKEHA
STVISGFKVEFNEENLIIDRDNDLKVRIKNYSNQAIQGEMTITMNERQGDSQRIDTEASE
VYQIQPQRDLQLGLNTVKTTISLPTKIIDTEDLLFVPSSKNMTTEVIIEEGVTIYHVSNG
IISFKASPDYYPGVYSLVVNGKEWLDHAFPKPIAKSWWNPWCGGIKNGPPDLNVFSVLKE
ETACAFTSLKDIHHNEWTGVKLVTTIRHHEKWNGLKYEQYFLTMPGIPLLITFVEIIDDA
GRRMAEEEWHTNLFITCNEEEKAVLHIQDNKVSTKQYMVASEEQEVNIKGHSYLSLEQEK
CYYIASDKSKGIDFYSNKDVIQLISYAKCRRTENRLFTEPTYLLFTEGELQSSLVNKVRQ
IAFSEREYVDENN
>PK3-045_02142 hypothetical protein
MKIIDAHIHYSNIGSFKETARDLSFVDYSYKGLKEEMRKADIVLAIGMGVTETPEMGFPD
YKAQTPMGLDLDLLVPDNVVCCAGINPYDMDLSAQERLEQEIQKPHVVGIKIYLGYYPFY
AYDEVYEPVYRLAEKYQLPVVFHTGDTYSERGYLKYSHPLAIDEVAVKHRNVNFMMAHFG
DPWTLTGAEIIYKNSNVYADLSGLIVGTKKELEEAHEGIFLDHLRHALVFAQSYDKLLFG
TDWPLAPFEPYIEFIKKLIPETYHEDVFYRTALKVFPKIKPFLSKK
>PK3-045_02143 putative protein YedJ
MKLITKVENIIEQEMENDASGHDWYHVDRVRKIALLLSEKEGIEYSHIIELSALLHDISD
EKLNKSKSEGQRRLANILMQIPIENQEKEQIKAIIETVGFKGGNGITPKSLEAKIVQDAD
RLDAIGALGIARTFAYGGSIGSPIYDPHSAIREKMTEEEYRKNNSSSIHHFYEKLLKIKD
LLHTESAKKMAVERHQFMESFLKEFYKEWNVQNEEYFN
>PK3-045_02144 Energy-dependent translational throttle protein EttA
MKSISIENVTKTYGEKKLFENISFSISEKERVGLIGINGTGKSSLLKIVAGIDIPDEGDI
IAPKDFRFAYSAQSPELNPDLTVLNQVYAGDAPVLALVKDYEAMLMEINHDPEDNKLHEK
LFDLQKRMDALNGWEVHTNAKTVLMKLGITNFNKKIGELSGGQKKRVALAQVLIQEPDLL
ILDEPTNHLDFEAVKWLEDYLSRYTGALLLVTHDRYFLDRVTNRMFELDGGNLYSYKGNY
GDFLQAKAIREENEAATLDKQKNLFRRELEWIRRGAKARSTKQKARIQRFDALDDKLANV
KAKDKLDISLKGSRLGKQVFELVGANKRFHDKIILNNYNLLVKPGDRIGIIGKNGTGKST
FLNILAGKASLDSGERIIGQTVKVAYYTQENEDMDTSKRMIEYLKETAEVIEASDGKVIT
AAQMLERFLFPLHTHGTIIGKLSGGERRRLYLLKILMGEPNVLLLDEPTNDLDTQTLMVL
EDYLEDFNGVVITVSHDRYFLDKVAEQLLILKGNGIIDTYYGNYSEYLEVERKEEQQIKE
KTEIPLPKKEPKEKKVRLSYNEQREWATIDEDIEKVEVRLATIETELAETGSDFEKAAEL
MSEQEQLNNQLEHLIERWSYLSEIADKS
>PK3-045_02145 hypothetical protein
MRIISIEPTPSPNTMKINLDQELPMGKSNNYKLDNSAEAPELIQNILSIEGIKGVYHVAD
FLAVERNARYDWKELLSKVRNVFGEDEATEVSKEINEHYGEINVQVQMYKGIPMQIKLSD
GNEERRFGLPDTFIQAVSEVRTPEDNVVMTRKWKDSGVRYGEFEEIGHVMVEELVAAYPQ
ERINAIIEHAKNPQTEANDKQVRVRTKLSFADLENQDWKVRYQKLEQSEDPTVDDIPVLT
KALDDEKPSIRRLATVYLGMIEDTAVLPSLYKALKDKTVTVRRTAGDCLSDLGFPEAMEE
MIHALDDKSKIVRWRAAMFLYEVGDERALAALKAHEDDPEFEVSLQIKLAIERIELGEEA
KGSVWKQMTEARK
>PK3-045_02146 hypothetical protein
MSMAYDEYMKQVVKPMRAELTQAGFEELLTEDAVEQFIETNKGTSLVVVNSVCGCAAGLA
RPAATQAVLASEKKPDQLVTVFAGQDKEATAKMREFFGDIEPSSPSMALIKDNKVVHFIH
RYDIEGNSMEAIMENLVSAFEQYC
>PK3-045_02147 Ribosomal RNA small subunit methyltransferase J
MIVTTASRTNKDMQILADRIAKDFNCRYVRREKVSIQHLKEQYQSDILIIGKNRFEFCSL
NTEEPFFFHPNSAVFRIKRLMNKENDPFIVATNLAKGKSFLDCTLGLASDSIVASYVVGS
SGNVEGLEANQVIAFLVKTGLKEWETSNPAIDEAMRRVTVKHINALEALARKEDNSIDCV
YFDPMFEETISSAGINPLKQLAHYEEVSVELINQAKRVAKERVVWKDHFRSSRFNRFQFE
QVKRKTAKFHYGIWLKKE
>PK3-045_02148 hypothetical protein
MPNWLRKSLVVFVSILTFGLVSPSPATFLNNNNNDKKPIDEREVPFARESIEDEAIFVDS
TEGNFSREDFISKMMKEAEAQSYLKFGPKIKPVIEDEFRLVVLPNMEKAINEVTHIFPEE
ELSYLTVTEFPAAGTSERIFHITRDNEDIIRFHVRRDRPPQEGYYFNFHYHTYHDQFQTH
YALGEIYWDKNTPPKWMS
>PK3-045_02149 General stress protein 16U
MAISLSKGQKVDLTKGNPGLSKVIIGLGWDLNKYDGGTDFDLDASVFLLGENGKVTNDAD
FVFYNNPTGGNGSIVHSGDNRTGAGDGDDEQIIVDLKSIPANIQRVTFTITIHDGEARNQ
NFGQVSNSFVRIVNEESNEELIRYDLGEDFSIETALVVGELYRHNNEWKFSAIGSGYQGG
LAALATDFGLQIG
>PK3-045_02150 hypothetical protein
MGIFETIMDTYAQFFNWQMWGEVLTDPVSWGYIGTLVILEGLLSADNALVLAVMVKHLPP
EQRRKALFYGLLGAYIFRFIAIGIGVYLIEFSWVKILGAAYLAYLSIKYFVDRKKAANQA
EDGEEENKGINKNGILIRTFGLFWGTVISVELMDIAFSVDSVLAAFGVSNQVWVLLLGGI
LGVLMMRGVAGVFLKLIDKIPELEATAYILILIIAAKMLLGVFDIHIEHIYFFGLLVIAF
GATFIVHFRNKKKAEQQGEA
>PK3-045_02151 hypothetical protein
MKLFSDLNEKQLERLFFQLPEEVFSTSEKEVLSYALASTLYMPATRPNIYQDLLRKKHPA
LTSMVICLEDSIGDHEVDLAERKLVEELTDINQAIQNGLLLKSELPLIFIRIRSIAQFLS
LMDILGDKIALLTGIVIPKFEAEAGEIILKELQKYNKLGYCLYALPILETKKIIEKETRM
NELLSIKNVLDHYKHLILNVRIGATDFCGLYGIRRSPETTIYDIAIIRDCISDIINIFTR
ADSAYVVSGPVWEYFTTKERILIPQLRETPFRKRYGKAGMNMRTQLIDKHMDGLIREVMM
DITNGLTGKTIIHPTHIKPVQALNVVPYEEYLDALNIMDSNNGEIGVVKSSFSNKMNEIK
PHLYWAQKIILKSKVYGVFHEGVTYIDLLKQENFITNH
>PK3-045_02152 hypothetical protein
MTYLNKKISLPIIDHLQMDINVEENPFQLPIEDFFKMAARINKRRAFLFVSKLLGKHLPI
EPKKGLLTGFMLAARYEEIMTGKHSPQRERLLEIYHDTSLPFVDKPFIQKEVSNPIIIGF
AETATALGHSFFQAFKQASFFHTTREKINGLDPIISFEEEHSHATSHRCYVKKDILDNNR
EIILVDDELTTGKTAINIIRDLHRKYPRDKYTVASILDWRSNKWQLEMKALEEELQITVH
SVCLLKGCFELVGEQINLPPIMESLVTNDGTPSVEYISLENYVKARIIPLISTNLAGERN
DFQYLKDTGRFGIYTEEGTDEWIKQAAKVLKKKRVGTSLCVGTGEFMYIPMKLASFMGED
ISYQSTTRSPIYPNDEEYYGAQTAYCFANPEDLEIVNYLYNIKPNQYDDIFLFFERNVKE
DSLKELLTALKAVQVKKINVVYFSGR
>PK3-045_02153 Cysteine protease StiP
MHLNINQQAKFGSYNSEDVIFLLKNLNGILLEGSTEEREKKIQSGAHYSETLPIEYNPPE
HYLQLFWKTLHVYKNKVALSTAVVAEQIYRKHGKQTVLVSLARAGTPIGILIKRYIKEKY
HVSLPHYSISIIRDRGIDENAIKYILKSHKESAIQFIDGWTGKGAISIELTKACESYLNK
YHVQLDDTLAVLADPGYCTTLYGTREDFLIPSACLNSTVSGLVSRTVLNERYIQMDDFHG
AKYYQELEPYDVSNIYLDEITEALQKINPKQVVERMNENLLDQSVDFRGMKEVLAIKDEF
QIESTHYVKPGVGETTRVLLRRIPWKILMKDPDSPYVQHIVMLAKERGVEIIPYPHMSYT
CCGLIKKVVQKG
>PK3-045_02154 hypothetical protein
MKLFASDLDRTLIYSKRALEEMETPWNQSMIGVEEKNGKYVSYMTKVSYNLLKEIASRYL
FIPVTTRTYEQYKRIFIFEREVPVSYCVTSNGARIHYNGEIMTEWEERLKGKLGVECSEK
EEILAMLQAYSLPGDLKIADNLFFYYVLNTTIAADLKIELSKIAAKNGWNISLQGRKLYF
MPSPVCKGEAIKYIKEREGIEQSIGAGDSLLDLPFLNICQTAFIPRHGELIGGGASRFSH
KATSQKGAFAGEEIIRKVHKEFII
>PK3-045_02155 hypothetical protein
MRSFFRKYTYHEIETDLNYVQNVLSSNMYVFVDLIFISLIISFFMAIFFESILFGIIIFV
CSYLFFVAIYCLLLKLIKDSPDDL
>PK3-045_02156 hypothetical protein
MNKDFYTVNNIILPLSEENWFNILLKPIKERPLYDTTNRIFTFGQAVVKLLGISLDEDEY
YNQLFNWIYKDNTGLHLLTDETLDRTIDNQHFQSIQKVFNRMNEQNLSINRFVAFLDGEN
VLIKSSVPAIHRKLRESFIKVIQHFVEIEENGIKNKDLRRLVVDIVKWSINHLQPALQET
VLSENMPKFLWYGDANKSQSYFIYYLLTIGCDIVMVHPNGEDILEKVKLDKELFFQHQYP
QRKEPESFPTEERKRTATVAYRASKEIESILHHEGSNLYKPWQFRDYIPFSVTLKTTYDE
IFLLEKELAMIRPNFEVKNGEVHIPAIFAKIFGVSKNRKEYWDRIHEIVNRDETLLIKEF
PFTRAIISDYRYHYRGALGRNGLLDPEKLMSAHYWNYKQLPLGLQKGIAAAISRVCSNPV
LIKQSNESNEDVAIFLFSQCLLIPDELLKMLQKFDYSQEVPSIVLFKTEKNGVFTREDAA
MLVLMNALGLDIIIYNPAGHVDMENFMQDNLFDTHWLEDVVFDMEYKEPSFLKRGLFGGF
LKSRKGDNG
>PK3-045_02157 TelA-like protein
MNMQPSNINNADNQVAELLTEEKVSEIKLALRNEPEVQKLAQSIDEKDQIQILEFGKEPA
TQISKFSDKILNNMRTTKVEDSGELLKQLGRIMDKFDKKDFEDTSKGFFGKLFKKSEKIM
EKLFGKYQSMGQEIDKVYVEISKYQNEMVDSTSMLDEMYEQNYQYYLTLEKYAVAGAMKS
EELKTQVLPQIEAKATAGDQLAGMQLDSLRNAIELLDQRVYDLEMAKMVALQTAPQIRLL
QRGNTKLIGKINSAFVTTIPIFKNGLIQAVAAKRQKLVADSMSELDRRTNEMLVKNAQNI
SQQSVDIARLAGSPSIKIETIEESWNIIIKGMQETKTIEEENKRLREEGTKKLEELQNNF
KQMKLQG
>PK3-045_02158 Stress response protein SCP2
MAINLQKGQRVDLTKGNPGLSKILIGLGWDPVQQNKGGGLFGSLFGGGQAASIDCDASVI
MVNEQGKVQANSDVIYFGNLKSRDGSVIHSGDNLTGDGDGDDEQIRVDLSKVPAHIQKLI
FVVNIYDAVKRRQDFGMIQNAFIRIINPLTNQSLIHYNLSDDYAGKTSLIAGELYRHGQD
WKFAAVGTGTNAGSLGDVVKSFS
>PK3-045_02159 General stress protein 16U
MSINLSKGQRIDLTKTNPGLTRAIIGLGWDINQYDGGAGFDLDASAFMADDNGKVINDVD
FIFYNNLVHPSGGVEHTGDNRTGEGDGDDEQIIIDFTKIPAHVSKIGIAVTIHDAEARRQ
NFGQVSNAFVRVVNEDNNMEILRFDLGEDFSVETAVIVCELYKHGGEWKFNAVGSGFSGG
LAALCRNYGLEV
>PK3-045_02160 Pro-Pro endopeptidase
MRWLKRLAPVGMIAATSILMGNSQLPNNEICLKNLSDLTVIKAHLSTEAKENLGNIILLP
DAHFDQAEAATIIERLNKLPPTLLNKIQSSGIKVKLFTGKLTDNKTAQKFAGIIPRGYNS
QKTWDDVPGIGGGKVVLVKIGASEKGKGHSSVNLEYHELAHSIDYKILKNASKSERYKAI
WNEEKRSLFPTRQYFLQYAEEYFAETFAMFYVGGTDKEKLFESAPKTYHYIASIK
>PK3-045_02161 Thymidylate synthase 2
MRQYLDLCEHILTNGVKKEDRTGTGTISTFGYQMRFNLSEGFPLITTKKLHLRSIIHELL
WFLKGDTNVKYLQDNNVRIWNEWADEKGNLGPVYGHQWRSWTTREGNTIDQISELIHAIK
TNPDSRRLIVSAWNVGDIEKMALPPCHCLFQFYVADGKLSCQLYQRSADVFLGVPFNIAS
YALLTHMIAQVCDLEVGDFVHSFGDVHIYTNHIEQVKLQLTRDPKPLPQLKINRNVKDIF
SFEFDDFEIINYEAHPHIKGAVSV
>PK3-045_02162 IS1595 family transposase ISSsu9
MISLIVAMDRNNVIGVNNQLPWHLPNDLKYFKRVTTGHPIVMGRKTRDSIGRNLPNRENV
IITRNPAYQCEDCTILHSVQEFYEWSKEKQAEEIFIIGGAELFAETIKKTDRLYITQIDH
NFAGDTFFPALNWQEWKLVSEKKGEVDEQNIYPHTFLVYERV
>PK3-045_02163 HTH-type transcriptional repressor NagR
MENLNITSSKPLYHQLAETIRKDIYEGKFKQDERIPSEFELSEMYEISRSTVRKAISILV
EEDLLVKIHGKGTFVAAPMLEQNNRVFMSFTSNVETLGKTLTTKTQKVYYRKATEQEIEF
FNLTEPEDILIIERLRIVDNLPIGIETVFFTKKFDSLKDENLNGSLYAVLEDKYSITPYT
GSKTIEICYATLEESNLLDIPRGSALMLVKDKVYDTHNNPLHISKQVLRGDKFKYAIKKD
N
>PK3-045_02164 Fructosamine deglycase FrlB
MNVNEILVEILEKKKENGGIKNVVWIAAGGSNGGFYPAQYFMDRESTTIRSQMFSSNEFV
YAPPKFCGQDTLAVLCSMRGTPETIEAARVAKELGATTIGLYVEPSGLTETCEYNIQYES
IAIDSSKTERVNSSFGLQIAITLLHLLENYEGYDDAMEGFEIVDTIYRDAVEYTTPLAKA
WAEQNKNEQSIHVMASGPAMGSAYIFSICNLMEMVQKDSPTVNSCEFFHGPFETIDKNTS
VFLLASEGRVRSADERVIKFLKRYGGEKVYVLDAKELGINRIKDSVSEYFNHILFSPILN
NVYLRQLSYATKNDYMTRRYMWKVEY
>PK3-045_02165 PTS system mannose-specific EIIAB component
MRRFLLASHANFAEGIYGSLRLIMGDQPNVEFLCAYMTEDFDLNKEISFILENLKPEDEL
IVVTDLLGGSVNNEFMNYVNRMDKKVFVVSGLNLGLLITLLSRQFEEKDTGQIIVESIDE
SKESICLCNKILEDSQNIDDEF
>PK3-045_02166 putative phosphotransferase enzyme IIB component
MILLTRVDHRLLHGQVAVSWTSMLGADCILIANDELMKNDLKKTTMKLAKPANVKLVIKN
IEDSIKAIQSGATDKYKLFIVVESIADAAKLSEAIPEIKQINLGGIKAKEGSRNVSKAIN
VLPEEEQLLKEMLMRNVEIEIRQIPNDKKILAKNVL
>PK3-045_02167 N-acetylgalactosamine permease IIC component 1
MVLEVILIFLIACFGYSDYFTGKTLQTRPIVLGPLVGLALGNLEAGCIIGATLELAFMGA
VGVGAALPPEVVSGSVLGTAFAIIGDKDAGMAVALGLPIAMLVMMLRNFLFIAIVPLFAN
KADKYAAAGDLKGVSRMHWYGGIFGMYLPLAILTTLSFYLGSNVMENVLNMIPTFIQDGL
SISAGILPALGFAILLRMILNKKIVPFLFIGLILTAYLNLPVLAVAILAVCIVFIMSKTS
EKQMAVGNNEMEVEDDDF
>PK3-045_02168 PTS system mannose-specific EIID component
MMTSNRSNVSNKGLGEKTGLETTTITKSDLRKVFWRSLPFEISWNYVRQGHMGFASSMIP
IIEKLYKNNKEEKAKALQRHMEFFNITVYFSTLVLGIITAMEEKRARDPKNFDIDSINNV
KVSLMGPLSGIGDSIFLGTLRIIAAGIGASLALNGSLLGAILFLLIYNIPALGMRYFGMM
KGYELGAGLLDKIQKSGLMERITNSTAILGLMTIGSMIATMVVVKVPLKFGTGDAVTKVQ
DILDGIMPSLLPIGVTFLIYWLLGKKIKTTWLLMGIIIVSIIFAWLGILAP
>PK3-045_02169 hypothetical protein
MNFSIKDFSLKEEIANSITHGIGFLLSIPALVMLIINAVETDNPWRIVSFSIFGATMIIL
YLCSTLLHSITHEKVKDFFEILDHSSIYLLIAGTYTPFVLVAIRGGLGWTLFGIVWALAI
IGIVFKCYYVKKYIVTSTILYVIMGWLIVMAIVPLYHAIGTTGFMLLVGGGLLYTIGSIF
YVMQKIPYFHAIWHLFVLAGSALMYFCVYLYV
>PK3-045_02170 L-threonine dehydratase biosynthetic IlvA
MEQNVMKKWVQLEDIIIAYQGIKDIVAHTPLQKNYRLSEKYDCNIYLKREDLQHVRSFKL
RGAFYSMKMLEKEKMKNGVVCASAGNHAQGVAYSCRYLNVHGKIFMPATTPKQKVTQVKM
FGKENVEIVLTGDTFDDSYVEAVACAEAEERAFIHPFNDENVIAGQGTMAIEMMNDIDVP
IDFVFASIGGGGLMAGLSTYMKSVSPATKMIGVEPAGAPSMKEALIRNKVVTLNKIDKFV
DGAAVKSVGQKNFEICRDYVDDIVLVPEGKVCTSILSLYNEHAIVAEPAGALPVAALDLY
KEKIKGKNVVVVISGGNNDIDRMQDIKERSLLYEGLLYHFIVNFPQRAGALREFLDDVLG
PDDDIVRFEYVKKNNKESGPAFVGLELKNRDDYRELIERMDKKGFPYTEVNRDSNLFHLL
V
>PK3-045_02171 DegV domain-containing protein
MRKIKIVTDSTVDLSQEILEKYEIEVVSLSIYIDNKSYLDRVDISPAEFIDKMIEADELP
KTSQPSVGTFVEKYDELADEGYDIISIHMTGGMSGTVESAKSASQLTKGTVFVVDSEFIS
KGLSFQVLEAAEMVKNGHNAAEILQRLNHVKKHTKLFVVVDTLENLMKGGRIGKGKAFLG
SLLNIKPIATLEEGVYTPVAKVRSRSQAVKFLASAFTEDSIGKKIKGVGITHAGSLDVAL
KLKEAIEKATGFNRVDIDYTTPIISTHTGPGAIGFSYYME
>PK3-045_02172 Sensor histidine kinase RcsC
MIKKFYTIPFVNKYQVVSFFLPFFLLMLFVTFVFYCQYKEWKTNFEKDGEEILTLLSNNA
SLQMREAKRTDSKQLLQNMINSSDFNKNNSEIKKLMYISVLAENEKQNHIAVISQQNQKI
GIHYVDTIADKIMPTYKRTITMHEIQHSNIYKLNKDHYMSSFIPINDKKGQLMGVVGMER
KLNDQFYFLKELALQTIFFLLISFIFLFIYIRKWLNKILHPINKMMVGLNEISGGNFDVK
MDINDNKELQGLMKNYNEVVDNLASLFYRLTNTAKELGTISKDFQLTTMEEALRQMDNIV
DFLKINKELQKAEKMNAVGQLAASVAHEIRNPMTVVKGFLQIFYAKEHMSEEERTYIKLM
IEEMNRAETIINDYLSLAKPDVEQSQKVNGRDLANKVIDLMHSYAMMSKGIHFKKNIQQV
YIEANNNELKQVLINILKNAIEAMKNGGTITINLYPAKEYGVFEIEDTGIGMTEEEINRL
GTAFYSLKEKGTGMGLMVCYQMVEQMKGYIEVQSEKGRGTLFRIFIPLYLSE
>PK3-045_02173 hypothetical protein
MKKPFTFLVLLFSLLMLVSCSNQTLYNTEKDMVVMNKKDIPVSFLPKDLSIVSVGDSLTQ
GVGDSTGKGGYVPYLQTLLEETKGVNKADFLNYGVRGNRSDQLLKRIKTEEVSESIKKAD
GVIITIGGNDIMKVVRNNITNLQMDSFLAQLSEYEENLNNVLASIREYNPKAVVILVGVY
NPFIKMFSDIKEMNQIVADWNSTSEGVLAKYKHTYFVSIENIFENPTSDLLYEDYFHPND
KGYQLIAEAIYEKMLTAPLADILENLQTEN
>PK3-045_02174 hypothetical protein
MFKNKWKLAFLTLAGALVLGIIYIAIMIFKPVEKTPIIKQQGEEVPFAVTTNREDLTKLI
NHFLEKEGLNGPIHYEINIADQVELYGTMPIFHTDIQMKLTFEPIALENGDLLLKQKEIS
IGHLPLPVSYVMNFIENQYNFPDWVDIQPNEEEIYVHLTKMDLKNGMLVEAKTFDLEKNI
IQFNLLLPTE
>PK3-045_02175 hypothetical protein
MTRDHFHSIQEAGMYNVLSDYYKYTNPELHVYYYHKHLQSLNHALKKESKSAIVSDIQRQ
NEYGKVRFLQATNNLPTVDIYMNGKCLLKEVSFKTMSNELTLPTGKYQLDIYETGKQIDP
LSSQILKIDSNVYHTFAFAGNERNLTIQLFPEFPIVPANETKLRIIQLAENLPTIDIAVQ
KGDIVFPSIPYKGASSYLGLFPMTVYLEARNAETKEVLKKFPALQLEADKTYSGFLVEGT
DEKTCELLIFSC
>PK3-045_02176 Small ribosomal subunit biogenesis GTPase RsgA
MELTQIGLNENIKEAFEMVAKENQIIGRISLEHKRMYRVWTEYGELLCEVSGKLAYVAKS
REELPAVGDWVIVSPRIPEEKGTITNILPRVSKFSRKIAGNSTEEQIVAANVDTIFLVNS
LNEDLNIRRIERYLTLTWESGASPVVVLTKADLADDINEKVTLVESVAFGVPIIAVSIVN
NIGLETLKTFLSPGKTVALLGSSGVGKSTLTNYLCGFKKQEVQGIRETDAKGRHTTTNRE
MVLLPNRAVLIDTPGMRELQLWNSEEGIANSFSEIEAFAAYCKFRDCQHEKEIGCAVKLA
IENGKIEEERLRSYKKLLRELAFLERRQDKKAQSDQKKIWKKRNNQFKIK
>PK3-045_02177 Peptide methionine sulfoxide reductase MsrA
MDENVKVATFAGGCFWCMVKPFDQEPGIIKVVSGYTGGHKENPTYKEVCSETTGHYEAVQ
ITYDPHVFSYEKLLSIYWQQIDPTDAGGQFYDRGQSYQTAIFYHSEDQKQAAEKSKQQLE
ASGRFSKPIVTKILPASTFYPAEDYHQDYYRKNPEHYNRYHIGSGRAAYIDENWSDQ
>PK3-045_02178 Peptide methionine sulfoxide reductase MsrB
MEKDKLKEKLTPIQYEVTQNNGTEPPFRNEYWDEFGDGIYVDIVSGKPLFSSLDKYDAGC
GWPSFTKPIDEEELTEKKDTSHGMIRTEVRSKEADSHLGHVFNDGPQPTGLRYCMNSAAM
KFIPKEELEEKGYGKYLSLFR
>PK3-045_02179 hypothetical protein
MKKGLKYFIYSLIFIVIISMTYVLVHSEQPKRNVYDKIIDGKQVNYLIVGDSIGRSSGAS
NNHRKWFHLVERSLTKKYGGSFKKQLVVQSGATAFEGLYKLKNSLSNNIDLVFIVFGEND
RKYMDDKQFYFFYQSLLEEVVYRYPDAELITITESSLDNEDFVNVIKKLSKNFYATNIDM
RLPFRESRLSPERLTNDLVHPNDYGYYLYAQEIVDTLQKAIHDKKTVLTSTIPVNEVSSL
EMKTSYPIESIDPSFRKKDGYYTSSKIGANIEYHFTGPFLGVNVIRSEKGGMMDVFIDNN
YVTTISTWWPFKKERSLYVTSGLKNTDHKVTFQISAHKSRYNITDQHLIQVSSIITN
>PK3-045_02180 hypothetical protein
MTKSFYHFLMKFRHPEPNDQISEFANEAYLDHDFPKNSFDYDEISDYLELNGHYLPSMRI
FDEAWEKYLFQEEKKNYSY
>PK3-045_02181 hypothetical protein
MANRKKPKFKIGDTVVITIYGTVGKITDVKYLDHMHVYEVNKSEGLYLESSLQMLSEYDG
EIMDSEKIDIEYRFFIGDLVKVKGYGSNLFKIMGFRTEIWRYKNDAWEDVIYELSRVSDG
EWLEAGEDELTLVADADSADSFIQKLGLLYILDKKQKSIELKKSNSSFQQTEKELLERSK
EKKELIDGLLDIYNDYSILYSLFKDIEYEQVMKLTLRKLKLVSSRSDKDNETKI
>PK3-045_02182 hypothetical protein
MNKIQYLFEEIKIDLNEENSEILTIFHSLLQKLFALLVISSIPMFIYLLF
>PK3-045_02183 hypothetical protein
MKEIDVIIDTEEIAEFFFRELLKRGFVPSEGEIEELADITFEYLLDKCIIDEEIDE
>PK3-045_02184 hypothetical protein
MGKKHRNRINSPKKNNHIPKEAIIAEQEAHGKEYSATGRKR
>PK3-045_02185 Purine nucleoside phosphorylase DeoD-type
MSVHIGAKEQEIAETVLLPGDPLRAKYIAENFLEDAVCYNEVRNMFGYTGTYKGKRISVQ
GTGMGVPSISIYINELISSYNVQNLIRVGTCGAIQKDVKVRDVILAMSASTDSQMNRLTF
GGVDYAPTADFDLLKKAYDSGLDKGLSLKVGNVFTADMFYNDNSELEKWAKYQILAIEME
TAALYTIAAKFNRKALSVLTVSDHILTGEETTAHERQTTFNEMIEVALEAAIK
>PK3-045_02186 Putative carboxypeptidase YodJ
MKKSVAISSLALAIAMLTGCEKVDLKSIQDKVSFWDKNEKEQEVEQPVNKEDQVKDEEQQ
APEKVSEEEKKPWTLESVFFNDIKEVDGRKVIQNPTNIVSLVNKEFGLPDGYAPEDLVRP
KVEFSFGNQDIEKSYMRKEAAKALEDMFNGAKKSGITLYAVSGYRSYNRQTEVYDAEVSR
VGEEKAVQAVAYPGNSEHQTGLAMDISSESADFLLTEGFGETKEGKWLKENAHLYGFILR
YPKGKEKITQYKFEPWHFRYVGKKSAKDIYENDWTLEEYFKVVRKI
>PK3-045_02187 Carboxy-terminal processing protease CtpA
MVKHLDNGNNNTEKEIEQESEQGYIKIKKFYFVMLLFVVVIAAAGITTIAFSFGDEPAVK
VNNQREEFNKLYTAYDTLMDNYYKDLNSVDLVNGAIDGMFTALDDPYSDYMNEEEAGNFQ
QSISSSFEGIGAEIQQLNDSIVVVSPIKGSPAEKAGIKPNDKILTVDGKSLQGMSSSEAV
LLIRGEKGTNVELEIERSGASEPLKMTITRDTIPIETVYGEMGKDKIAKIQITSFSEHTA
TELVDILNKYQEDGMKGIVLDLRHNPGGLLEEVKKIAGLFVPDGEIIYQIEHKDGTVEKV
TSQNSSNMDIPLVVLIDGGSASASEILAGAVNQSANVPLVGVKSFGKGTVQQAKSFTDGS
NIKFTVDKWLTPNGSWIHEKGIEPTYKVELPSYASLTMINPESKLKKGSNSEEVKTAQEM
LKALGYDVDNTNGYFDDSTEKTVKEFQKKEKLKEDGIITGKTTTELMNKLREKLQKSDTQ
MKKAIEVLKDEMKK
>PK3-045_02188 Putative metal chaperone YciC
MKQTDIYVLSGFLGSGKTTLLKEILKKEQELGRKVAVLMNELGRISIDSNEIDGDIPLKE
LLGGCVCCTIQDEVEAQIQTLLVEEKPDVIYFETTGAAHPVETIDGILSPLFANRLRFKG
IITVIDGRQWLERSALNAPIQQLILEQARHASILIINKEDQLTEAEKAKISFELQSINPH
AFSVLTNFSKFPFEKLLQMASHVYKDIEKTSIHSLHLSTFVYTFQKSIGADQFEDFLRAL
PDTIYRIKGYVQFHQAKHPDLFQYSYGMPLFMREDMKMPLNMVFIGENVDWKKIEAALDQ
L
>PK3-045_02189 hypothetical protein
MNKKNFLLLFLCYILIIPVPLVKGAEENIYSPISFDIQLLSWNVINEMIPKYSKFTILDI
ETGNQFKVQRRAGSQHADVQPLTVKDTKIMKEIYEGKWSWRRRAILIMVNDQWFAASMHG
MPHGAGALANNFPGHFCVHFLGSTTHKTEKMDFSHKLMVYKAAGQLRQYLEQMNPNDAVK
AFIAGIKEKDATILSYITTKQDWSSELALIENIKINRLNEVKPKVYEQALQVTLAIECNV
YMKNARTRNIKKDLVLVRTSPLEGWKVKVEDSSI
>PK3-045_02190 hypothetical protein
MNKPYCCPNCKTNRSRFNIIQQVPQSVKVDPQTGQVLEEYSSENLSPFHMGYSGPDYRVQ
CAACGLVEDEKTFIKFGEMKG
>PK3-045_02191 hypothetical protein
MKKKNLILSVAAASTLLMATPLANKAEASTVQPQEAKTIYQAHNLSEEQLNKIFHNIASN
YHIDIDKVLNELIGSMDKQQASYPVTKQKDMQKEVQKETVKPKETAKSKETAKPKETQKE
TAKPKETNNVQQQSNSKPNTTTQQNTTSESTKNNSANASSSVSAFEKQVVDLTNKERAKN
GLPALTLDNELSKVAKAKSQDMSANNYFDHTSPTYGSPFDMMKQFGVTYKAAGENIAKGQ
RTPEEVVNAWMNSEGHRANILSNKFTHIGVGYVENGNYWTQQFIGK
>PK3-045_02192 hypothetical protein
MEIRQGHIDDLASIMEIVKKALVIMQEEGNDQWSHKYPNEASFLADIENNNLFVAIMDDK
VVGSITIDQIGGKSYEKINWSYDNKEYMVIHRLVVDSDIRGGGIASNLLAFAEVYAIEQD
IFYLKTDTYSLNDKAQNLFVKNGYNKVGSTFFEGKDKPFYCYDKLFL
>PK3-045_02193 hypothetical protein
MSFDNLKKIYQFSENSHKKDYWKDMFEPNEKEWFSHPAASIKNSDAFPACDFYLFHSRYY
IDIELPGIDMNQLSIHLNNNQLRIEGHYQTIIPDCAYLSKERQNKHFIKNIKIPAYVKEK
EINKKYENGILQLSFPCKEMRKEGM
>PK3-045_02194 Spore germination protein GerT
MFPWNLFPFNKDAKSRMDQMNPQDIQKYVQEMMDKLMPESLQKMEPEKMFQSFSKEANFR
KDNINHAEKFNYIVFETHHHVYVRIPILDSSWLEHIKIFYTSNQLIIQHIPLFEDKHTIT
LPAIVRKKGSVALYKDDILEIRILKNIDIHYSEIDVTEMN
>PK3-045_02195 hypothetical protein
MNDKMGEQFQIKKEKLDLPERGLGQKNFT
>PK3-045_02196 Multidrug resistance protein NorM
MKQTYSIKQKLSQMIIILFPVLVTQVGIFALSFFDTTMSGHYSPVDLAGVAVGSSLWTPI
YTGLSGILLALPPIVSQLMGKNEQKGVSFSVIQAAYLSFTMAIALLIIGYFCLDSILANL
GLEQDVYRVAYHYLIALSTGIIPIFLYFVLRSFIDSLGQTQISMFITLIAIPINILLNYA
LINGIWIFPELGGVGTGYATSITYWVMLFIAVYIVHKKHPFVAFQLFSHFPTISWSKWKE
ILTIGVPIGFSVFFETSIFSAVTILMSNYDTNTIAAHQSAINFASLLYMVPLSISTALTI
LVGYEVGARRMKDAKTYSWLGVGLAISIAFISGMILLTFRTNIAGIYTNDWEVLQLTAHF
LIYAIFFQLSDAIQAPIQGALRGYKDVNVTLLMSFLSYWVIGLPSGYLLAAYTNLGPFGY
WIGLIIGLATGAIFLTSRLFKIQKHKFSDKQYGN
>PK3-045_02197 HTH-type transcriptional repressor AseR
MSNKDQSLNVLSLKETADVLKLLGDKTRLSIVSLLSEQACCVCELVEIYNMSQPAISQHL
RKMRDLGIVKEQKKGQWVFYSLNKASQYDGLINELLQHIPSQHGKMTRLKEKGIKILCN
>PK3-045_02198 Arsenical pump membrane protein
MLHTFLAIIIFLLTLTFVIWQPKNLSIGWSACGGAILALLVGVVDFHDVADVTGIVWNAT
LAFIAIIIISLILDEIGFFEWAALHMARMANGSGLKMFFYVSLLGALVAALFANDGAALI
LTPIVLSMVRALKLEERMVLPFIMASGFIADTTSLPLVVSNLVNIVSADFFGIGFVEYAS
RMIIPNLFSLLASMLVLYLYFHKRIPKIYDLNHLRLPAEAIKDRQMFRISWIILAFLLIG
YLGSEVLAIPVSAVVGGIALVFLIFARRSKAVSIRNVIKGAPWSIVFFSIGMYVVIYGLR
NVGLTGLLSSLIQVAADQGLLIATIGMGFIAAVISSIMNNMPTVLIDALAIADTNATGVI
KEGLIYANIIGSDLGPKITPIGSLATLLWLHVLSQKGVKISWGTYFKTGIILTIPTLLIT
LIGLYLWLSIIS
>PK3-045_02199 Coenzyme A disulfide reductase
MKIVIIGSVAAGTSVAAKARRNDEQAEITLYNADYDISYSGCGIPYFLGGEVDEIESLTP
RNPAWFKKRYNVDIFVRHEVIAIDVNRRKIQVKNLDTDEVIEDIYDVLVFATGASPLTPP
IEGVEKKHVFHIRTIQDTSAIDRFIKKKEPRRAAIIGAGYIGLEMAEQLTNRGLEVTLVQ
RSNHILSHMDQDIVTYVEEHLVKKGINLLLNEEVSEITTNEIRTKSGNVIETDLVILATG
VRPNVHLAESIGVNIGHSGAIAVNNRMQTNLPDVYAVGDVAESYSLITGKSLYRPLGSTA
NKMGRIAGDVITGGALEHRGILGTAILRVFDLAVGQTGMNETEALEEGYDIEVLHNIKPA
RAEYLGGKQLVIKAIADRKTGRILGVQIVGEEGVDKRIDVFVTAITFKAKAEDLFHLDLA
YAPPFSTAKDPVMYTGMALQNAIEKKNQLITPKDLSEKIEKREAIQVIDTRSAKQFNASC
VDTAINIPLGDLREKCKELDPNLLTVTYCNSGVTGNAAQNVLRNLGFMNIYNLSGGNKNY
QSYKKKR
>PK3-045_02200 hypothetical protein
MLKKRDLEECQALYPLMMHPDVFPFVRQKAYSYEEYLFLTKQTIEAEERGELISRTILDE
WQNPIGTINLYDINENIGFLGTWLGKPYHGMGYNQIAKELFFAEAFFELNIESILMRIRS
NNIRSLKAAEKLPYAVSANETRSNLLQILNTSGIPYQLFEIPKDLFTLYTLRQNTEETTN
DCREA
>PK3-045_02201 hypothetical protein
MDLNKDRSSNDDRVFAMLIYVSSFFTTFIGPLVIWLVKKDSPFVDYHGKEYFNFLISYAI
YSFIAWILVFLLIGFIILPIIGIMAFVFTIIAAIKAYEGQDYHIPLTIRFIK
>PK3-045_02202 hypothetical protein
MNIEKYYKYTAISSLNASLISCIPLFLFIGIFLLNHSSITFLYLLVPFAMYSVICFCQFY
LHKQRLEKMDNFFSVGQARSILKSNTVVLSFLPAPSLRMIVFDREGQEIGEIKDEKFSVI
RWYLPFLFDRFYTKSYGFYNTQGDLQYVFTLKRDRIDIQNKDKKIISRILEIKTEKRLVN
QFLYGEDTIIMKKTFGHMEYQFEQEDGHKLAQLRKGWMPKEWAKRFQDPNLPLLTIDHHA
SDKEVIHLYAILTKLFAYTNH
>PK3-045_02203 Nucleobase transporter PlAzg2
MKDYIFSFFQLKESQTSIKQEVLAGIIGFFTVVYIVVVNSLILAEAGIPLEAAIIATILT
SVVGCFLMGLYGNVPVLLVPGMGINALFSYTIVNSMALTWQEALAVVFVSGILFMIVAFT
KLARIVSDSIPVSLKESISVGLGLFLMLIGLEKGGIVERGTNSIIALGSFNDLHVLATVL
TFLISIILFLRNVKGNFLITIIVGTFIAWLFGLINVNAGSSQSIHLQEYRSVFGHLSFDK
LVTIPFWIAVFSLTMVLVFENIGLVNNHVQFINKPKRFQKAFRATSISVFLSSLFGTSPT
VATVESSASMTAGGKTGLTAVTTGFLFICSAFFIPVIKLIPDSAIAPILIIIGGLMLQNI
RNLDLKDLSESFPSFFIIAMIPFTYSIADGMAIGFILYPILKIALGKAKEVSLPLYFISS
LFLINFVLQYTH
>PK3-045_02204 Cyclic di-GMP phosphodiesterase CdgJ
MEVFVARQPLFNRIEEVYGYELLYRHNNINSFPNVNGDQATTDVIINSFLNIGIDKLSDG
KPCFINFTENLLELKLPTYFHPRDIVIEILETVVPSQKIIDICLELKQLGYKLALDDFIF
EKSNPYSYSLLRLADMIKVDFQNTTKEVRAEIEDVAKKHHLELIAEKLETSSEYKQARNR
GYHYFQGYYFSRPFIMSSHDVPTYMPTYYKILELLHDENPDINRISKLIEQDISLSYKLL
KLINTLEYGVKQKVTSIKHAIIYIGLRELRKWIYILTVREKDWKNGISLEVMHNCLIRSK
MCESVAKLVPGRIEYGSFFLTGMFSLMDTIMNRDMDSILSDLPLDETIVQALSGQKNVQQ
DVLQLVIAAETADWPGIALGCKELNIQEKELFKVYAESISWAKKLLDDDYLYG
>PK3-045_02205 Diaminopimelate epimerase
MNIKITKCHGSGNDFLIIDEISDAYQFSEEERTEIAKTLCNRGSSLGADGILFVMPSQVA
DARMRVFNADGSEASMCGNGIRCVARYVCELLQVEEAVIETMKANLEVKNEADIYPNIPT
YLVEISPVSFQTKDLPLQVESTTLINGKIPGLNNDLLFTALAVPNPHLITLVDKAVLDSD
IQETLSKYVNGPNEYFPDGVNVSFVSILEKGNIYVRTYERGVGFTNACGTAMSASTLVSI
LNGFNQENTYVDVYNNGGKVRCYVHHRNDQYRIDLIGNATYVYRADVSFKWDAMESFSVS
NKSYFEEEAVQYKKLQQEAKQYVENHLK
>PK3-045_02206 Multifunctional non-homologous end joining DNA repair protein LigD
MKPIKPFEPLLTEAIPKGDQWIAQVKWDGTRILSYYDGENTKLFNRKKNERTQQYPELLK
TSSFVQAKNCILDGEVIALQDGKPSFYEVMKRDRVRNLERLSGLQEEIPITYMVFDILFL
DGQWLVDKPLLERQKILHEKIAETKVVRLVENFADMQGLFTVCQQHQLEGIVCKDLGSSY
VLGGKDARWLKRKKEQDLIAIVGGVTIKHKTVHSLHLGLFDESGQLVYIGSAGSSKLTAN
DWAAVSKAIEPIIIKESSFVNLKEAKDGVWLRPALTVKISFLEWTEGKTLRHPVIESFVT
IPIEECTLE
>PK3-045_02207 Bifunctional non-homologous end joining protein LigD
MHKAAFFISNYHKKTDSFGVSVIGNENIIPVGSFQNGLKRAEKTALLQIIKEHAIKEDDN
FYFLDPGICVELQFSSFQQHRLNNPVFIQFLYNKDWKDCTLENVIATESTPITHADKPLF
PNTKITKLDYILYLKEVSPYLLPFLENRLLTTIRFPHGLFGESFYQKQCPDYAPSYVETY
KNEDIEYIVCNNVETLMWLGNQLAFEFHIPFETIYSNSMPSEIVFDLDPPSVEHFYMAIK
AAKVLQQILERLQLLSFVKISGNKGIQVYLPLPERTFTYEKVRLFTEFIANYMIEENPEL
FTIERLKKNRRNRLYIDYIQHSEGKTIIAPYSIRGNKGGYVACPIAWDELTEDLHPSQFS
MDVVLQRLQNGIHSFAGYFEAKEKQPFQQVLDVLTNIQNEEGTGKHLNR
>PK3-045_02208 Non-homologous end joining protein Ku
MHTMWKGNISFGLVSIPIKLHSAIEDKDIKLRTLHKACHAPIKYEKKCSACGNEVAPEEI
VKAYEYAKGKYVVLDEEDLGNLRKENEDKAVEIIDFVKMEEIDPIYFEKCYYMSSGEGGN
KAYALLRQALLETGKVGIAKIIIRSKEQLAIIRVYENTLVMETIHFPDEVRKVDDVPNVP
EVNQLEKKELETAILLIDQLTTEFTPEKYTDEYRTALLELIEAKKAGKEVVTGTDKPRES
NVMDLMAALQASIDNTKPKKTEEKKKKTTRKKVVKEA
>PK3-045_02209 hypothetical protein
MEKRITSKYIGIMLAIILIFSGLFYIIARHVKSSDIISFDETIIHFTQSFISEDLTIWVE
RITFLGSSLFIAAAILVITVLLLWKKKYALVIFFISTNSFGALLNTLLKWFFKRERPDIL
PVIIEKGYSFPSGHSMGSLIFFSSCAYLCIHLLKSTGKKVLAYIIACFFILLIGTSRVYL
GVHYPTDVVGGYSIGIAYSAVCILAFRLYEFKSKR
>PK3-045_02210 Glycerol uptake operon antiterminator regulatory protein
MNQHIIPASSNMKEFEAFLKSDYEIGVFLEVHVSQLKHISLLAKKANKKMIYHVDLIQGL
KSDDFGTEFICQEFKPYGLISTKSSVILKAKQKNVIAIQRVFLLDSHAIAKSVKLVQRTH
PDYIEVLPGTMPWMIKEIKESLNVPILAGGLIRSDKDISNAIEAGATSITTSKKELWQKI
K
>PK3-045_02211 Glycerol uptake facilitator protein
MSAFMGEVVGTMILIIFGGGVVAGANLKKAFSNGGGWIVITLAWGLAVTMGAFAVGSISG
AHLNPAVTIALAITGDFAWNQVLPYILAQMIGAFLGACIVYLHYLPHWGATKDAEAKLAV
FSTGPAIPHTFGNILSELIGTFMLVLGLLFIGANSFAEGLNPLAVGLLIVVIGMSLGGTT
GYAINPARDLGPRIAHFVLPIAGKGSSNFRYAWIPVVGPILGGSLAAVFYTYIFKGVVLS
SFWIVIAITVIVLLLAFFKTKGESKSIGKKVA
>PK3-045_02212 Glycerol kinase
MEKFILSLDQGTTSSRAIIFNKKGDIVHVAQKEFTQIFPKPGWVEHNANEIWGSILAVIA
TVLSESDIKPEQIEGIGITNQRETAVVWDKNTGAPVYNAIVWQSRQTNEICEELKAQGYN
QLFRDKTGLLIDAYFAGTKVKWILDHVDGARQKAENGDLLFGTIDTWLIWKLSGGKAHVT
DYTNASRTLMFNIYDLKWDDELLEILTVPKSMLPEVKGSSEIYAHTVEGHFFGNRIPIAG
VAGDQQAALFGQACFEAGMAKNTYGTGCFMLMNTGEKAVKSDHGLLTTIAWGIDGKVNYA
LEGSIFVAGSAIQWLRDGLRMIKDAKDSEDYASRVDSTDGVYIVPAFVGLGTPYWDSDVR
GAMFGVTRGTTKEHFIRATLESLAYQTKDVLGAMETDSNIQVKTLRADGGAVRNNFLMQF
QGDILNVPVERPVINETTALGAAYLAGLAVGFWKDQKEIAEQWSLDRSYEPKMEEETREA
LYTGWKKAVKATMAFK
>PK3-045_02213 Aerobic glycerol-3-phosphate dehydrogenase
MQKKPSSREKMQQQLMNNKFDVLVIGGGITGAGIALDAAARGMEVALVEMQDFSAGTSSR
STKLVHGGLRYLKQFEVKMVAEVGKEREVVYENGPHVTTPEWMLLPLHQGGTFGKFSTNI
GLRVYDFLAGVKKTERRKMLSKEETLAKEPLIKKDGLKGGGYYVEYRTDDSRLTVEVMKK
AVDCGATAINYTKVENFLYDKNGKIEGVEVRNLISNAVYPIYANVVVNATGPWVDTLRTI
DGSRKGKTLQLTKGVHLVIDQSVFPLKQAIYFDTPDKRMVFAIPRDGKTYVGTTDTFYSE
DPIHPSMSKEDRDYLLEAIKFMFPSISVSAEDVESSWAGVRPLILEDGKDPSEISRKDEI
WESDSKLITIAGGKLTGYRKMAETVVNLVSARLQEKTGKSFKQCMTKTMPISGGDVGGSK
GFSAYIQDILTKGMNGGLLKEEAEKIARLYGSNAPILYELAKDLSGKHEELSPVLLARIH
YAMEYEFAMTPTDVLLRRTGMLLFDIAKVKEVKDAVIEYMAEYYDWSVERTNTLTAELEK
EIHKATVPFAG
>PK3-045_02216 Bifunctional protein FolD protein
MSEKLILDGNVVANAVKDELKGRISALKEKGITPCLATILVGDDPSSATYVRMKGNACAK
LGIDSRKIHLDKQTTTEELLATIHSLNNDEKVHGILLQHPVPSHIDERKAFEAIAIEKDV
DGVTSFGYGQTALGFGKYPSCTPAAIMKIMEHYNIEVNGKHAVVVGRSPILGKPVSALLL
NKDATVTTCHSRTVHLEDHVKQADIVIAAVGKPNFIQGEWIKPGAVILDAGYNKGNIGDV
DYEACLEKASAITPVPGGVGPVTISMLLKHTVDSAEAAIE
>PK3-045_02217 Cold shock-like protein CspD
MNTGKVKWFNAEKGFGFIESSEGQDVFVHFSAIQTEGFKTLEEGQDVTFEIVEGNRGPQA
SNVTKA
>PK3-045_02218 DEAD-box ATP-dependent RNA helicase CshA
MTTFSDFKLSSSLEKALSNMGFEEPTPIQAQAIPIALSGKDMIGQAQTGTGKTTAFGVPL
LEKIEVGKAVQGLVIAPTRELAVQVAEELNRIGSVKGIRTLPIYGGQDINRQIRGLKKKP
EIIAATPGRLIDHIERKTIRLQDLKMIVLDEADEMLNMGFIDDIERILSETPDSRQTLLF
SATMPKRIQSLAERFMVEPQVVRVKAKEMTVTNIEQHYIEVQERQKFDVLCSLLDIQSPE
LAIVFGRTKRRVDEVVEGLIKRGYSAEGIHGDIPQGKRDQVIRRFKEQSIDIMVATDVAA
RGLDISGVSHVYNFDIPQDPESYVHRIGRTGRAGKKGLAVTFVSPRELDHLRIIENVTKK
SMTKKPIPSLTDVLAGNQQATISKIAKTIEENDYAEYKRVAEGLLEETDSVTLLAAALKL
LTKEPDATPVKLTAVEPLRSKKKDNRSGGGNRRRRSDRGGERGSYDRKRPNSSGDRRPRS
RNRSK
>PK3-045_02219 Cold shock-like protein CspD
MATGKVKWFNSEKGFGFIEVDGGEDVFVHYSAIQTEGFKTLDEGQEVNFDIEEGSRGPQA
VNVTKL
>PK3-045_02220 hypothetical protein
MKEFTVNFHVEDGVDQMIVQKLSEDDFNRVTSGGTRQLFELDTNIGFFIYFDAEDEQGKE
SYLVLQYEEEKEEPTACFSFQLKDFYQFVALHLNDLQYEEGEEEEEEDFGPIHYLAHLMH
HIVEDGKLVEV
>PK3-045_02221 hypothetical protein
MNIKEYTVEEIKDPTGILAGQRFEFFLTVEFDEEDELADEDHLQIKILFSVDDNGSHILN
YHFYDSLENKYLDYGLEEDELAEIQAFCKQHYLED
>PK3-045_02222 hypothetical protein
MAMGFGRRNNEEIVKEEVVVWDCTSDTCKCWIRDNFKSSETPKCPICGSDMVKTTRELQV
VNNNSIYSK
>PK3-045_02223 Inner membrane protein YohK
MIKIIILTIITYVLYRIAKACYKKYNMPLFHPLLVTPILLILFITVFHIPATTYMESAQP
LTHLLGPATIAFAVPIYKNLHLLKKHFSIIIVSVTTGTLVAIFSSYLLSILIRLNNDFIM
SILPRSITTPIAIVVSEEIGGLPTLTTIFVIITGVLGGIIGPYAIKWLSLRSPIAKGLAL
GMGAHGVGTSKAMEFGEQEATFSTLAMILAAWITVLWGTSLIPLMLNLTV
>PK3-045_02224 hypothetical protein
MKNIAIIAGQIIFLHVFLFIGMGIKMIVTIPIPASMIGLIILFIGLKLKLVKVEWVEKGA
AWLLAELLLFFIPSAVGIVNYNEILNIKGIETVLLIAISTFFVMGATGFTAEKIYNRKRR
FSK
>PK3-045_02225 HTH-type transcriptional regulator CynR
MEIRQLHYFVEVVKQKNMTKASDKLHISQPALSKAIKSLEAEIGLTLIHRSNKTHELTDA
GSVVYEYGQKIIAQVEEMSSTLHDMTNLTRGNINIGLPPIIGSLFFPKIIAAFHKAYPNI
QINIKEYGAAKVVKSVEEGEFEMGVAVLPLADEAFNIFPLVKEEMKLIVPVSHRFANRQK
VQMKELKEEEFIFYSEEFALYEIMRKKFIQEGFEPNIIFKSSQWDFMVEIVAANLGISIL
PESICNRANNNQVRFVDLEPITNWELVIITKKDRYLSVASRRFIDFVLNNE
>PK3-045_02226 hypothetical protein
MTKFGWVLTLVGFLAILSSILYPLDVISKQTVLILLFGGAGTMFVGSMIRNLSLLKKIPK
>PK3-045_02227 hypothetical protein
MSIFHELKEKIVFPRNWKDNLIAHKKYEKLYKKNPTELIYSNIYRIQSREQIEKK
>PK3-045_02228 hypothetical protein
MEIFSIQELEKVIRHVEIEGQGGIFQEETGKQPKDYPKEFLGRIVNYITDNQLIKKIQKL
TDDEALHLFVKSVYVVCIKDLHSADDIQEQDLVQKVFSDYLKETSMA
>PK3-045_02229 hypothetical protein
MDNNTMYHMVKKFHEAFGHEVATEPTAIAEKTAVNRAVWTGEELVEFLYATAEGDESKFK
ALYEQFLMGLNKAADKILTEKKPVDDKLVAQMDALTDVEYFNQGSFVIAGVEPFSLFQIV
QEANMGKLFEDGKPRFREEDGKIIKPPNWEKDFAPEGRLQAEIERQRKNKDK
>PK3-045_02230 hypothetical protein
MKRQTYILVPFIIMLILITFVQPISTVAIKSPNVVMTKQYKNIEKLKYPFLVSAPNNKAQ
NSVNKILLQHIKASYNQYIKLMKEMEKLKKESICKESASACQFEYITNYQVKYNQNNKLS
ILFSDYQFTGGAHGNTVITTYNFDLKSGKLLTLDDFLPSKEHYGKVTTYAIAYMKKHPEI
FFADPEEFTDFKVTNETNFYLADNGIVLIFQQYEVAPYASGNPSIFIPASVLSK
>PK3-045_02231 hypothetical protein
MSVLLLLLPTLLLYIFIPALLIFILVQFLKRKEARAIERLKVEKDSLSIHKQQMTIINDL
NKQLYSIEKMLKDVE
>PK3-045_02232 hypothetical protein
MQVFSVINLFIVSIPILIVLGFIFYIARYMKRAETRADEKLNLEKENIAYQKEQIEALNK
VKERIVNIEKLLNETN
>PK3-045_02233 hypothetical protein
MKHIKNGDKLLLILESLSNPYRLKIIAILKNEKKYVSQLARELGISRPLLYLHLQKLENA
ELIKGHHEISEDGKAMKYYALIPFSLPLSEELIADLADSVTIKKRKE
>PK3-045_02234 hypothetical protein
MGFLNGLMGNASETDVKELEKELSNVIGSNETIELAYKLVRDLIVFTDLRLIFVDKQGLT
GKKVEYLSVPYKSISRFSIETAGHFDLDAELKIWISGAELPAISKQFKKDNSIYDVQKAL
ASYVAKA
>PK3-045_02235 2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial
MNSKAKFSGKSTLYDRYRPGYPKRFFKELISEYSGSNDHFVIADVGAGTGIFTELVANIG
TYIFAIEPNDEMRSILKARMEDFKQVTCLDASAENTGIADNSVDLITVAQAFHWFDANVF
KKECKRILKENGQVMLIWNSRDHTSQLNSETAKISKRYCPNFQGFSGGINIERLGLQHFF
TNGYEHYAVSNPLKMNKEHFIGRNLSASYSPQKDDPFYDEFVEELGFLFDKYSKDGNILV
PNDLHVYVGAVI
>PK3-045_02237 Methionine--tRNA ligase
MSIFIGGAWTYANGSLHLGHVAALLPGDILARYFRQKGEEVLYVSGSDCNGTPISIRAHQ
ENSSVQEIADRYHKEFSQCFAKLGFSYDLYTRTDAKHHHASVQEIFLTLLKKGYLSRKTV
EQATAKRTINFCQIDL
>PK3-045_02238 Methionine--tRNA ligase
MPDRFVEGICPHCKQKARGDQCDHCSTILDPLELKDKRCKICGEEPVIKKTEHFYFTFSD
FQKELENYVKQAEDNQLWNENAISLTKRYLREGLPDRAVTRDLPNGIDVPLEGFEGKKIY
VWIEAVAGYLTASMEACKEKGLHMDDYWGSETISYYVHGKDNIPFHTVIWPSILLGLGRK
SLPTHIVSSEYLTLEKRKLSTSQNWAVWVPYILQKYDPDSIRYFLTINAPEARDTDFSWR
EFIYSHNSELLGAYGNFVNRTLKFIQKAYNSKVPDKQVSQKIIASTEDVYQSAGNWIKRG
KSKKALEEIFSYIRSANRYFDQQKPWEQVKINKEAGEMTLANCTFMIVNLAHLLEPFLPF
SARKIRAMLGITNIEWHIQYTLPKEIIYVAPLFERLDLGLIEEELNQLIMGQKHS
>PK3-045_02239 hypothetical protein
MKWSEFVSPGTNRVLPVIVEVYGKKYPPYASKLYPICYTSFNDLGILFTPCGLFRRKKKR
NLRTIRYKDIVSVEFNVQRVPTVYLYLLGSSLHVNMIIQLKDQSILHLESEDISILPEVF
QLLKKHKVVRKDPQKLQTILKEKDTMEKFYSYVDKHLQADMHYSKKEPKIK
>PK3-045_02240 hypothetical protein
MTLKRKQIHNPNRRHMSVPAMHFSVSIYNKQALAILEAIEKSKR
>PK3-045_02241 hypothetical protein
MAEKKKTAIASTPAPFNKPKNQTKKSMNPNRRKMTVAVSETFEDIHDMNKKALNLLAKRA
>PK3-045_02242 hypothetical protein
MAAIYFVFITAMILLIVLSLIYFWWRTDKYVENLQAIRKSYYVLFFLLVCLGILTKQLQM
SDWTMILSLASAAVFIDIAVFQTPDILKIWNTEFQHSNYIRKTIRKNEEVLGYNAKKVQN
FTEVISKTADHFIERNLPQHWRQYKDELRTYLNLYADTFQFHIAIFPFAISASGDDLKQN
LESAFNSVEICYNISFLDREVKENIIQDLLAGKSIPLKDQENNINNEDLVKNVFIVAYYG
ESYNMLIGISSQFVEVDGIDASHILNLAQIFDWYMV
>PK3-045_02243 IS1595 family transposase ISSpgl1
MFPILETERLLLREIKKEDAGDLFAYFSNEEVMQYYGQEAFTSMEQVEALIGHFANNFEN
QRGIRWGMQIKGTTRLIGTLGLNNLVLSHKRAEIGYEINPEYGRSGYTSEAVQKVVSYAL
EELHLNRVGAMIYLENEASNKLIQKLGFQHEGILRKYYEQNAKAFDINVYSILKDE
>PK3-045_02244 hypothetical protein
MKSRTTIYFVRHAHSVYSADELERPLSEKGLSAAKQVAKRMEKEAIDIVLSSPYKRAIQT
IEGVAEYFQTDIKLIHDFRERKLAKGSIPDFNTAIEKVWREETFFWDGGESNLIAQKRGV
QALFHILKQYENKRIVIGTHGNIMVLMMNYFSKEYDYTFWKNLEMPDIYKLIFEGKQILT
VERIWEDNNE
>PK3-045_02245 IS1595 family transposase ISOpi1
MNRHLFLFGGGPPFTYKMARKFSELVSVRTGKISFLIIDRPNWKKYMAKYTKKLIENGIT
EFQFIPLLTISEKDAVELLKNSAGIIIGGGNTEQYAKYIVETSLSRILQEQFSAGVPIAG
FSAGALISMEHCIISANDNEDQVFKWQTGLGLLKNTVIAVHFSEWMDENHLRKAVIKFQP
HVHFGIDEGTGMYFYNNRLMAVEGNNVYQINNNRLEKMEKINFL
>PK3-045_02246 [Ribosomal protein S5]-alanine N-acetyltransferase
MVQTTDPIYIRLLEEKDAEGLWNLELRNRDFFKDYSTARKEEFYTLHFQEQLINTWKENA
KQDSDYHFGIFLQESNELIGSVNLYMVRREPAHNAIVGYVLDKDSNGKGYMTLAVKKLVD
YAFHTLSLHRLEAGVMPHNVGSIRVLEKAGFHKEGIAKSNVKINGEWKDHQILAIINPND
>PK3-045_02247 hypothetical protein
MIADVQILQQQLKKNETIQGSLRCSLEVFIYKKIVRPGMLAATEKRLIFCADSIPGNELI
ESFDYANLEAIQLKRNLMNQYITIKYKKDTVKFKQIISEDIEDFMTKIKTYK
>PK3-045_02248 hypothetical protein
MKLITIGKGKSIEQYNSVSASYCKIMKTDEATNIGIITLGPKGILGNHQAPVPQLFHVVE
GEGWVRDIDDRKLLIKKGEAVFWEQGEWHETGSDTGLTAFVIQASNLKEPF
>PK3-045_02249 hypothetical protein
MDYSLILLFCFAITLHNIEEAIWLPKWSQQSSKFQKPVTSREFNFAVIFVTILAYLSAIS
FLYRPESVLSKWIFVGFLGSMILNAIFPHLIATVWLKKYAPGLLTGLLLNLPINSFVIYQ
MLSINLIRWHELVISTFTVGITLVALIPFLFKIGGKITLSKDSALD
>PK3-045_02250 putative membrane protein
MENWIIETMENFGYFGILLLIMLENIFPPIPSEVILTFGGAMTVKTSMTITGVVTVSTSG
SVLGAIILYFIGSLLDIRRLEKIIEKWGHILRLKKADLYKADRWFDKFGYWTVFFCRFIP
LIRSLISLPAGMAKMNFGIFLFLTTIGTFTWNFVLIRIGATVGDSWEDIVHYMDMYSNVA
YVILAVIGLAVIGLYIYKRVIKQK
>PK3-045_02251 hypothetical protein
MFDYWIPNALSTSIMTIIGWGILIGAVCYLYRKQTEKPVIWKMVIIIYIGLFCFNFSFIV
SETPVKIAILPLGVWILILVFGKRKERWKVYRPFAWLGFFGNYIFLITTLLSSLVQSLLY
PTDKVETFLAELNNPGILLIHPSGKQADLNKELFIESLSSWGIGKMDTQQWYYESFPEIK
EEELEEEGQMPHQTMERFPYILIGATPKWGIGYESTIYMERDGKGLLISTEKGQYYFRSS
ESVLKGGTE
>PK3-045_02252 hypothetical protein
MKFNRVWYLLVVVMIAISLFIFLFLKEAESSPSDLPNETSIRKMIEDTGEISINIVFDQR
ALDEKHVFIPHLSSDKQYGYSLLEWIDNKWEVTYVTTTGEPLLWRIKAGNQSESYFLWNL
DSKNKIETLTFYLIRDRHFTSGWSGEWYEPAIQIEEDVSISGKPYGIYKVPDKWGAIWNA
AQIKIENQEEDFISSNGEGLYYGIKGFDKKNNYIVPLNSYENGGNTISGATIENITIMDE
WEGEQW
>PK3-045_02253 hypothetical protein
MNSIYIGISLQLFLSVIVPIILMVYLQRKKMMSWKSLLVGIVIFIVFSQILEKIVHFIVL
SPTGTELKWSSNPYLFALYGGLAAGIFEEFGRYFAFTVWLKNNHQFNDGLSYGLGHGGIE
AIFIGGMSALNSLLISSMIKTGNLETLLGPAAKPEDINNIKEQFEQANVMLFASGGLERV
FALALHLALSILVLYAIRQQKFIYVIYAILIHAAVNFFPALYQAGTITNLLIIEVFLGII
AVLSILFIVKMKPKFEK
>PK3-045_02254 RNA-splicing ligase RtcB
MIELTGKYNRAKVFTDQLEEVAEAQIKELCDQEFAKNSKIRIMPDTHAGVGCTIGTTMTI
QDKIVPNLVGVDIGCGMAVAKLTVDRANLNFDELDETIRKFIPSGFSIRDKAHSYKEQID
LDEVKAPINKKRAEHSIGTLGGGNHFIELNEAADGSVYIVIHSGSRNLGAQVAEYYQTLA
YDNLVNIDGIKKEMIVKLKKEGRHAEIQESLKNMKLPKINKELAYLESQGFKDYMHDMKI
AQKYAYLNRLAMIDVIVTKMNWAVLDQFTTIHNYIDMENMILRKGAISARKGERVIIPLN
MRDGSIIAFGKGNDDWNQSAPHGAGRLMSRTKARKTVSLKDFETSMKDVWSTSVKNSTLD
ESPFAYKPMEEIIKHTAETIDIAEIIKPLYNFKAN
>PK3-045_02255 hypothetical protein
MRLTAIRGYAGFASEEEVAILMNRMLEILTKRPESTPYNYQEYEILRSAFLLPYLLEIYP
YDCFKKFNEQLEKQYDAMPDVFKGMFTCNDKGEHIQLVPPAVVQKRIAAFQRG
>PK3-045_02256 hypothetical protein
MEEKNKKMETYFNTKDIAKRNALLKQLVFDLPDDGKDFF
>PK3-045_02257 hypothetical protein
MIQAIGVVDFHYKPMRTTKYKENVTKRINAKTNKFDDSFEVLTISEPYDMDGDIYVRVSC
SFTIYMYEKAYIRNPEEYVGSVFPTLKERITPHIIATKVYSLTKRR
>PK3-045_02258 IS1595 family transposase ISBsp6
MGRLTNEQLDKAIGHKLSNASVLRTDSWHAFKTYAAEKGMDIFQFKSDGKVRTKRLYHIQ
NVNYYHRRLKGGIQRSNGVVTKYLNNYLAWF
>PK3-045_02259 hypothetical protein
MTTTTNDKTIIKDVTINAPLNLVWFAWTISERVSEWFAPETVVEAKEGGAYELYFIPGNK
EGMNTKDCKITKLINEKELLFTWKGPDQFETLMNNKNELTNVNVSFKSINEDSTKVIVKH
IGFKDNEDWTEAINWHQMAWSGVLDSLKSALENGEGNLCCQP
>PK3-045_02260 hypothetical protein
MRECKNIEEVRECVNMDFEKTSEVIGNLENQVERLDKEVYNLNSKIELLENLLMKIIEDQ
TISSDLLSDINYIVLKKELSGEEKAQIPFLLLKIQKEHMREGKIPTLEEFHDELLQVLGV
NQNEKTNYPIQISNQLLQKHMQLGEFPVAKEILAKR
>PK3-045_02261 Sodium/proton-dependent alanine carrier protein
MEEIVTFINGILWSTPVIYIVLVIGLIFTFVSKFLQIRHIKEMIVLMFHGKSSEAGVSSF
QALSIALSGRVGTGNIAGVATAIAFGGPGAVFWMWFMAFIGASTAFIESTLAQIYKVKQD
GQYRGGPAYYIEKGIGSKWFAFLFAGAAIISMSILMPGVQSNSIAVGMKNAFNMPTYITG
LLVVLLLGFIIFGGVKRIANVAQVIVPIMALGYILLSIVIVLMNIKELPGVFTLIFKSAF
NLEATFGGMMGMAIAWGVKRGIYSNEAGQGTGPHPSAAAEVSHPVKQGLVQAFSVYIDTL
LVCSATAFMILFTGMYNTKAPNGTMIINNVEGVEAGPGFTQAAIDSQIPGFGSGFVAISL
FLFAFTTIMAYYYIAETNLTYLLRNRNNRFFSDLLKLVLLFATFYGSTKTASLAWALGDI
GLGLMVWLNMIAIVILAKPAFIALKDYEKQKKQGLDPVFNPETLGIKNADFWVKEEKDKD
KAV
>PK3-045_02262 HTH-type transcriptional activator RhaR
MDLLKNMNDAMGYIEENLTNEIDFKIVARIAHCSEYHFKRMFSFLAGITLSEYIRRRRLS
LAAFELTNSILKIIDIAVKYGYNSPDSFTRAFQNFHGVTPSEARNNGQQLKAFPPMTFQL
SIRGGNEMNYRIEQKKAFNIVGMMKRVPIIFEGENPEITANVEIFDYGKNRSIKKTL
>PK3-045_02263 hypothetical protein
MEKIDQLKKLSNAEPKGMIQASTNFSDGRMEEKGELDQYIGVATTEECPENFSKLEVPAL
TWAIFESTGAFPSTLQETWGRIFSEWFPSSNYQVTEGPEILSIKTKDLTSPFVKSEIWIP
VLKK
>PK3-045_02264 Isonitrile hydratase
MKELIVGIFIYNEVEVLDVAGPFEVFSLAGGENKLFHVYTISEKGGTILARNGLRIEADF
SFENHPVLDILIVPGGYGAEEIEIYNPVSIKWIKKQSRKVEFMTSVCTGAFLLAKAELLD
NLKATTHWMDIDRLEQEFPKVQIVRKVKFVDEGKILTSGGISAGINMSFHIVEKLYGEEV
GRETAKRMEYDR
>PK3-045_02265 putative isomerase YddE
MKKITVLHYDAFTDQPNKGNPAGIVLAGEQYTEIEMQKIAKEVGFNETAFVLPSECADLN
IRYFTPGHEVNLCGHATIATVFALKTMGLLSDKELYSIETKAGVLPIKINHRDQSKPAIT
MKQVTPQFKEFKGSRLALAEAIGLKESDLDTNFPILYGNTGLWTLLIPIKELRVFSKMAV
KNDLFPAILAEIPHASIHPFCLETYDINAIMHGRHFSSPYSGTTEDPVTGTASGVMGAYY
IKYVDEAWKNKTIVIEQGQEIGHDGRVSVIVSERNGQLDVEISGTAVFVKELIITID
>PK3-045_02266 hypothetical protein
MERLEPVEAARLFIDTYYANCNAAVLAGSVVRGQATATSDLDIVIFDEKIVSSYRESMME
FGWPIEVFVHNLSSYKDFFLMDYNIAKPSMQRMVTEGIILRGDGALEAIKQEAKQMLAEG
PKEWSEETIRTKRYFITDVLDDLIGADNKQEEIFIASTLSFLLHEFVLRVNKQWIGTSKW
MVRALRQYDSLFADEFIEAFDCFYRTREKDKIIEITEKVLKPYGGKLFAGFSLGKET
>PK3-045_02267 hypothetical protein
MTIIGVHHVQITIPKGMEQKAKDFYCGELGIKEIAKPASLQGRGGFWLSLGNMDVHVGTE
EGFDRYSTKSHLAYQVDSMLDWKNKLSDLGVEITDSIPIEGYERFEFRDPFGNRVEIIEK
KISE
>PK3-045_02268 Proline iminopeptidase
MKEGYIEVTGGKVWYIIHNETAEGTPLLILHGGPGSSSYSLQGLKDLATDRPVILYDQLG
CGKSDRPDDDSLWTLDRFVEEVAQVRKGLELKKVHILGHSWGTTLAAASYFNNPEGISSI
IFSSPCLSAPLWEKDQKKNLALLPLEVQETIRSCEENGTTDTPAFQQAIEVFNDHFVCRL
KPYPEHLEQGKHFRNPHVYQIMWGPSEFTVQGNLKTFDCTEQLSEISIPTLYTCGRYDEA
TPASTEYYSSRTPHASFYVFEESAHMAYIEEPEQYRQVMNEFLAPLDKL
>PK3-045_02269 hypothetical protein
MEKKSSRKLARYSLLIMGLGFILTFPFQDNSWIHLIHGGFEAGLVGGLADWFAVTALFRH
PLGLPIPHTGLLPKNRDRMVNGLVTVLKKDWLSKESIQDKVKNIPFTEKITAAIKTRIET
EPVKKAMIKATQQAIRNIDVEKITPFVRKQMSAALSDVQISNILQLLTKQLISEEVDKKA
LDHVLVKTEAWLRKEETALKLGSVSMNVLNNVEASGMLQFALKTLQNILTEEKLGQIVQN
LCLSGMRSLQKDGEQNREALVHYIRKEIESLPENEKVLAGIYTWKDKVLDSLESNHTILT
SLKQAQEKAIELLENEEFMETKALPFILQLVGKIEENGEKIDPWIIHQISHFIEKNHDQI
GNLVKENLDKLDNETLVDMIENNVGKDLQWIRVNGAVCGFIIGLFLSGIQLVANIL
>PK3-045_02270 hypothetical protein
MCVLQKFALMLIVIGAVNGGLIGLFQYVLDVVIFGGQHTGFSRIIYSIGGIAGLLSLSLF
FSSESLSKPNFQKRPPY
>PK3-045_02271 hypothetical protein
MVLHRGKPRTGGKSLGSSLREVKEETGITKLALYSSNTFDQIYSPGENSLYITPVFVSFV
EENQGVRLNNEHSGYKWLSFEEAKEFVTLPGNRGSYLYRKELY
>PK3-045_02272 hypothetical protein
MWESKMITYIYMVRHGESPKAQGTERTRGLTEKGKEDSERISKMLQKEEIDLFVSSPYNV
LS
>PK3-045_02273 hypothetical protein
MEDLKEKVFSLDTVPLTNNELYPFLSKSFSNPDYALAGAESNRVCQKRAIKVLKQLLTTY
AGKKIAIGTHGVVMTLMMSYYDRRFDLEFLLHTTKPDIYRMKFMKNELVEVERLWE
>PK3-045_02274 hypothetical protein
MNEQSATNKAAWEYRAYEFWIKRDGHPKEKAKEIRKDPRASLKKHQALLENVEGKKIANL
CGSNGRKAVPLALLGADVTVFDISKENEQYANELAYYANTSINYVVGDVYDIDLQTYGET
FDILYLEGGVLHYFHDLDQLMSLLFSILKKDGTMILSDYHPLLKCLNKDFSAKHTYFDTE
IHSGDIAYKHFFPEEEQDGFPDVSLRFYTLSEILNAVITARFTLDRFEEHPGWKKENIPW
EFTIIARK
>PK3-045_02275 hypothetical protein
MINALKSDCQNCFGLCCVALPYGESADFPFNKESGIPCRNLCSDNACSIHDKLRKTGFRG
CVSYECFGAGQHVSQTIYKGKDWRSGKHAEEMFLIFPLVQQLHEMLWYLNQALTLKETAS
FRDKLQLIYDETVELTERTPQEILTIDLNSHRRKVNELLIAASINYRGSRTNKGKKRLKN
KSDLIGADLKGLDLQGENFRGKLMIAANLSNSDLRGADFIGADLRDADLRVANLEAALFL
TQSQINSAIGDVHTKIPNYLERPKHWIEREIL
>PK3-045_02276 hypothetical protein
MVRLNTLYQHKVKGWQSKQVIYQIPPSIGETIVIEKAYYKIVNIIHYSEEGSLEVIADTE
>PK3-045_02277 hypothetical protein
MKTKAKIKGVKYSTDYKFPRYKVKLETPEGKVLIIAFDHTLASKTKGYVPLNVNYDGEDM
GNKLSWYSKKIENMTINDFLRILAGKIDKFYKVS
>PK3-045_02278 hypothetical protein
MASKMKLARIEKGLTQEQLAKRVNATRQTIGLIEKGEYNPSLNLCIAIAKELNTTLDDLF
WEVELS
>PK3-045_02279 hypothetical protein
MRSWISFLLPNDEYKEKRILYFFSEGAIILLLILAGMLILNNYVNLDAKTSLLLPIAIFL
LYVLGRYILSGIEYADIATEDSYKKELRSIVMKTSSFVILFFLFYVIFLGLPANINEWME
TIVLIVFAGLLWFFVNYISLKRSYNKNKDLL
>PK3-045_02280 dITP/XTP pyrophosphatase
MKEIIFVTTNKGKVASAEKELKNIKVTPIQEELSEPRTDDIKEIAKQKVLQAYEIVKRPC
IALDSGFFIEELNGFPRAYVNHMLDTIGITGILKLLKEENNRACEFRSCLAYYDGEQITY
FASKSQGTIAEEIRGLDNNNKWSDLWYIFIPNHFNKTLAEFTEDDFHIYEEKKEESCIRK
FGKWFEAL
>PK3-045_02281 hypothetical protein
MNPIVVMIIIGLAVLIDYFWLDRNKSRWGWMKNWSSFGKGLFFSVFIIISILIYVGLSAV
YF
>PK3-045_02282 Intracellular iron chaperone frataxin
MEVFAEFLAGIDNPEHRDRTEEVLHWVMKKFPSLVPKIAWNQPMFTDHETFIIGFSIAKQ
HLAVAPERAGIIQFSDEIVQAGYDHTKQLVRIKWSNSVNFSLLEKMIDFNITDKADCKTF
WRKE
>PK3-045_02283 hypothetical protein
MANRKLNPQVEEFLSKDSQWQEEYVKLRQLALECEELTEEFKWMHPCYTYKNKNIVLIHG
FKEYCALLFHKGALLKDPQGILVQQTENVQAARQIRFKNLQEIMKRESAIKEYILEAIAV
EKSGLEVMVKEHKEYSIPEELERKFEEIPSLKTAFEGLTPGRQRAYILHFSQPKQAKTKV
TRIEKAMERILNGKGLNDCICGLSQKMPNCDGSHKFAGKK
>PK3-045_02284 hypothetical protein
MDQISCISYILHQSREENIQKIAIDLLIGDISLKEAEKISPKVKKELKKAEALYKSHRVD
LKAVSVFVQDFMFVTG
>PK3-045_02285 hypothetical protein
MKQVSTLFLKIAVILIGVPILALCIFLVPEIGNFAAELYPNNAYLKYLIMFDFYAAAIPF
YYALYQAFKLLNYIDKNEAFSELSVNALKKIKNCALSISAIFVLGLPLFYLLAERDDAPG
IILIGLVLIFASMVIAVFAAVLQKLLKEAIDIKSENDLIV
>PK3-045_02286 hypothetical protein
MAIIINIDVMLAKRKMSVTELSEKVGITMANLSILKNGKAKAIRISTLEAICKALDCQPG
DILEYRNEEEI
>PK3-045_02287 hypothetical protein
MIRALKQLICFGWQQALACVFPVAIFASLAMTKMIELPLLPRYDWLLLICLFMQWVMVRT
GLETIDELKVITVFHLIGLALELFKVHMGSWSYPEAGFTKIFGVPLYSGFMYASVASFLC
QAWRRLKVELVNWPSFLVVVPLAAAIYLNFFTHHFWIDIRWYLSGLVIIVFWKSWVFYKV
NGIKYRMPLALSFVLIGFFIWIAENIATYFSAWEYPNQKDAWSLVHVGKVSSWLLLVIVS
FLIVATLKLVKGKKTSLNNDGK
>PK3-045_02288 hypothetical protein
MRAAYSVLREIHKGIALPTAKDYDMQQRQFENFILFLENEGFIERVLRIDTFFSLKPARL
TKKGQAFLEKYNYLEETYPDKQNMMKWIRVGKEVYSNEADEED
>PK3-045_02289 hypothetical protein
MNDRKQLKALAMKKIAQLMDSLSDESKDKYRTAIHAFADLYLEDELVFRELYFAYKQGLR
SYDIKSTNQEAIYYRKEDKEHVIQFRQSHYRLQDHLFFPFVTSCIEIMREVLPLGSVVEL
NPLYFLPEQQTSSAAKIVITKRYTVPTGYQTFFPYGGVVYPVGEMKKDAILYFTEPLITN
VIHKGFKDEMEEAFELLMKEELVVEKKMTSIEFSAQDMQSLQVEMERAGER
>PK3-045_02290 hypothetical protein
MANYTSSFSSSLVSNMISFLEDAKEGIQKNFEQMDLENASVEEEMREKIEEMIRELNRLI
VAIESVPFR
>PK3-045_02291 hypothetical protein
MGTAQIKMDIRELQATLQTLQSSIDEFSSYTDTFRTGTRNQLKNFHSDFIDKVDAILDHM
NNDVNKELVKNMHAVYTAGKSILEEMTKADEEISKDIRSGQS
>PK3-045_02292 hypothetical protein
MKRDLKINYGILDQIIEQLHTYKRALHQMQTSLNTIAGYTERNAGKSLEAWEDLMQESKK
NIQSYQTQIEDLLTLFENYVADTTAYITPISRNSMMRVDRNDIWGNLTQIEWGVTYRLSR
AIQETYRSPSLLFSLFDDTDLEERERSRYNKQQLESIRNNMESVQSRLKNKMEELWDLYE
SKVKKYENTDDEYANKASQVKDRYTTFSEKVSDVISVTAEGAWDFVKGLAVAIYEIAKGL
ITLVIDAGIVAASGIIPDSIEPDFLKKASTKRIESATETLDAIIHDPAIVLESMAQSITD
TAEKEGIMYVSGSAATSFLPYVGQAKYLKLLKGEKSKNKADGIRSAISRKTTETLQRIDG
SKKENSLWPNGIKNSGKQYVQEVTHFFRQNFMPHPSFQLSTANQAPINVWSRATIENRMD
SIVPASLRKVEGKGTTKGTGNTSKAFDNVVKDGSHFLDEFKLKPNVKYETNGYLYQTDEL
GRIERASGELTLEMGERNSKHQLAAGGEDRVKAPSTQGDHGGHLIGTQFNGSPLIDNIVA
MNGNVNVSAYKKLEFAWAKALRDKREVIVDIRPVYEGDSVRPVSFNIKYRIDGEKFKASL
KNVYGGK
>PK3-045_02293 putative antitoxin YezG
MNTENMESIYQKVAIQLNNIIPEPWEKVMVYSEVDEYSDSTVFFYYPKNKQEPIYSLDIE
DMEGIDEDETDRQLNLLDSIFRELWEEFKRNKQEPWTNLTFELYSTGKFDIEFDYTLLEE
ENNYNHYERLIIWKYKKLGIFPDEKRESDVKLIREYINTQK
>PK3-045_02294 hypothetical protein
MLAHLSSVQIDYVVVLNTSSDIVKVLIQREMKKYGCDIKSFKLTKGRNKKSRKVLPLFPE
TVMRVDRHDIWGNLTQIEWGVSYILSRVVRETYRAPSLLFSLFDDPDLEERERSRYNNSS
WKAFEI
>PK3-045_02295 hypothetical protein
MAQSITDTAEKEGIMYVSGSAATSFLPYVGQAKYLKLLKGEKSKNKANGIRSAISQKTTE
SLQRIDGSKKENSLWPNGIKNSGKQYVQEVTHFFRQNFMPNPSFQLSTANQAPVNVWSRA
TIENRMDSIVPASLRKVEGKGTTKGTDNTSKIVNEANLNNIDEFINGTKKFDDVIDDYVK
LYIEKIISNKTWSWNKSLHGGANLTARQKRMIKEKAVTDGLVPDVKVIKADGMRYGFADF
KSAGLVLETKQLPERLWLLSDEEQFKWLDNAIGGRPEGMTWHHTEVPGKMELVPFGIHNI
TIHNGGRSAGMWADAPR
>PK3-045_02296 hypothetical protein
MKIIQDTIVKPLPSEELIKKHENFWRLKLPGSFLDFIKVYNGAEVEGATFVCDNRSYAIE
RFLCMLDDIENNPKGIYDIDVVFSQIEERLTDNEDLLGAEVLPIASIFAGDFVCLDFREN
KENPSVCVWSHEESGEFEPVFYKIVDNFTEFLEVLQ
>PK3-045_02297 Putative ribonuclease YeeF
METEWANALKEVPPKKVSVSIEPIYSNNSIRPDSFMVELKLKANFQ
>PK3-045_02298 Type VII secretion system protein EsaG
MSFETELNELYKEIAQQVNDMIPTEWDNFYFNGEVKEGEGGVFFFFTPKGEEQHIFSHYI
PKLYSVDKKAYNKELHKLFQLTVELQKVFTDNDQEPWFSVTLILNDTGKLNVHFDYTNWH
ESEFGPTDRIKYFEYKYISQNKEQLDFDLLERMKEFVEK
>PK3-045_02299 hypothetical protein
MLGIYGFQRMGQAKEGYSLRYPEDEIKAYCEEQSFKLIHIFRDEGISGAKLNEEALEIDR
VGLQEMLAHLSSVQVDFVVVLNTSRL
>PK3-045_02300 hypothetical protein
MYVSGSAATSLLPYVGQAKYLKLLKVEKSKNKANGIRSAISQKTTESLQRIDGSKKENSL
WPNGIKNSGKQYVQEVTHFFRQNFMPHPSFQLSTANQAPVNVWSRATIENRMDSIVPASL
RKVEGKGTTKGTGKETYQHLKDYKNNKYFTRSVEYNAGKDGTGFTYKVYQRGDINWDMVR
TKGAKKGRGLTNAEASAKYGLAPILDEAGSVATLHHSQQKGVGPLYEASTRYHNIANAKR
APLHPYKGKLNPFYPMDETTRGAFQKVDSINYWKIRGEEALGGR
>PK3-045_02301 hypothetical protein
MRILPERLDEVLGEEIYKREDSNLVQDALVRLGVNASDTFQEFYIQYAGPFWEEHVPFEL
LDIADEENNIESYTLISRKEHGFPKQYLVLSETSANAVLVLDTITDKVYIVNFEGGDELL
IKGELKESWSSFFDFLKAYFNC
>PK3-045_02302 IS110 family transposase ISCth6
MHEKQKHIYVGVDLHKQYHVAVIINCWQEKLTELTVENKPSAFSTFLLDIDKLMEEGLTP
VFGLEDVGGYGRSLAQFLTDHGKVVKEVNPALSYAERKSHMTTQKSDSWDAECVARILLN
KLNHLPDAKPHDLFWSIQQLVTRRNALVKAQGALKKQLHNQLSHHYPSYKKFFSEVDGKT
ALAFWERYPSPSCLEGVSIKQLTTFLLEVSHNTCSVKKAIEILKLVKEDGNTTKEHQETR
NFLVESMVRHILFGKQEIGKVERELKELMSLLDFQLDSMPGIDLVTASALIAEIGDVRRF
PNANKLARFAGIAPVYFGFGGKGKEQKSKQGNRALHALFYNLAVQQVQVAKGSKLPRNAV
FYAYYQRKLKEGKTKGQALVCIMRRLVNIIYGMMKHRTAYELPIIKEKEVV
>PK3-045_02303 hypothetical protein
MAVGILVDCFYYELGHSDFVHSFFSTISYHLEKEGWSTKYPLMMNELYNDKLNWNDVSVV
KANLIEIEQELSKFSPEQVIWDIDDLSQKPPWGDKISPKVTSLANYFATTDGKTFFEVLR
TAIDVAEEDKCDLKIHKL
>PK3-045_02304 IS1182 family transposase IS663
MFKDYTMNQIVLPLDLEVKLQNNDIAFHVHHLVESIPQEAFEPFLRNEGCPAYHPRMMLK
IILCAYTQSVFSGRKMEALLKDSIRMMWLAQGYEPSYRTINRFRVQPEVKDLIRQCFIQF
RCQLIEEKLIDQEAIFIDGTKIEANANKFTFVWKKAIEKFHQSLIDKSNQLYNELLENEI
IPQIERESDEQLSFGELTQIVQKVDEVVTEYDKQIEESSDVTERKALRSERKYPKQVRKQ
LIDFVLRKRKYQQDFTIFGPRNSYSKTDLDATFMRMKDDYMKNGQLKAGYNVQIATEGQY
ALAYSLFPNPTDTRTLIPFLDEIEQHYFELPKHIVADAGYGSEQNFSDILSNRNREALIT
YNMFLKEQKKKYKQNTFNPDNWVYDQETDTYTCPNQKRLEFQYHSVRTDATGFQRSFKIY
ECEDCSGCPFRSSCTKAKEGNNRKLMVNKKWEQQKEYVRAKLSEEKTGAIYRKRKTDVEP
VFGFLKANLRFTRFSVRGKSKVENEMGLALIAVNLRKFTAIN
>PK3-045_02305 hypothetical protein
MPITIKLKEILKERDLSQRELARMTGLRPNTISHLCSNNVDRVYLSTLETVCKVLDIDIQ
ELIEVE
>PK3-045_02306 hypothetical protein
MKVIGYIRVSTQGQARDGYSLAYQEDEIKTYCQTHGYTLLRLFRDEGISGDKVDEEALEV
DRLGFQEMLEYLTHQKVDYVVTLNTSRLWRSDIVKVLVHRELKKYGVDIRSIEQPQYSIH
KKDPSDFLINGLIELLDQYQRLEISLKLGRGRNKKSQQGGYSGGNVALGYKVEKGKKILV
IDDRQAKIVQRVFDLKEQYPSWSLTQLAEQLNEEGHQTKQEKLFTKVQVKRILDRKAFYS
GLYHYGDITADGKHQAIL
>PK3-045_02307 hypothetical protein
MRRDKYIYIGLDLHKFQHTAVILDCWNEKLGEMTFQNKPAIFLSEFTRVCE
>PK3-045_02308 IS110 family transposase ISCth6
MNRYLTEGLTPVFGLEDVGGYGRDLALYLIEQGYIVKFVNSSLSNSERNSYAMTQKNDSW
DAQCVANVLIQQLPHLPDASPSDIHWVIGQLVGRRNAIIKAQTALKNQLHIQLNYHYPSY
KDFFSEVDGKTALAFWESYPSPSHLEGKTVDELRTFLLEASSNACSTRKAEQILSLVQSD
GEVKRDYQTSRDFIIQSMVRDIRFKKQEIKKVDKELKVTI
>PK3-045_02309 Putative ribonuclease YeeF
MPKGTGKNSEITEITGENFGEHIIKGKNGRKELAPNVRYITEENYKYTTDELGRIVDVNA
EELILQKGTRNRGMQVVAGREYRLVDDDGGHLIGTQFRGSGDIDNLLAQNRQINRSGGEW
YKMETEWANALKEIPPKKVSVKIKPVFVGTSLRPDSYKVIYEIEGKGIFKKTIENRAGG
>PK3-045_02310 putative antitoxin YezG
MEKEMNRLYREIAETVNEMIPEDWNKFYFYAQISENGGGTYFFYNTLENKQYKYSVEIPF
KYQIDEGEFERKEDVLYKLSKELRKVFKDNEQELWYSFTMSLESSGKFKLHYDYTNWFDT
EYSFSDQMIIWKNKYLGEVPNDENYKKLIDKYYSEFPNNPI
>PK3-045_02311 hypothetical protein
MLAHLSSVQIDYVVVLNTSSDIVKVLIQREMKKYGCDIKSFKLTKGRNKKSRKVLPLFPE
TVMRVDRHDIWGNLTQIEWGVSYILSRVVRETYRAPSLLFSLFDDPDLEERERSRYNNSS
WKAFEI
>PK3-045_02312 hypothetical protein
MAQSITDTAEKEGIMYVSGSAATSFLPYVGQAKYLKLLKGEKSKNKANGIRSAISQKTTE
SLQRIDGSKKENSLWPNGIKNSGKQYVQEVTHFFRQNFMPNPSFQLSTANQAPVNVWSRA
TIENRMDSIVPVSLRKVEGKGTTKGIGKGEQVLDKVKTYEQARNKALDLVGDLGPNSQPY
TGTLKSSVGYGQVVGRQSADGKVRWRLDYDPNKGTHINIEDFRNGKGANARKIAIPFEGN
ESTFKSLLKQLNR
>PK3-045_02313 hypothetical protein
MSLFDECIEALDEDVHVLSDNNREQILSNFESSFPFAEWGRIEWEKVSNHAAVDTVDEII
SFLHQNIDEYSNVVYIIWDEGTLPIIQSTLDKVFKVIDDVTAVSFDTWIFSPSAGYVIEI
FHDGEVKVGLK
>PK3-045_02314 hypothetical protein
MPITIKLKEILKERDLSQRELARMTGLRPNTISHLCSNNVDRVYLSTLETVCKVLDIDIQ
ELIEVE
>PK3-045_02315 hypothetical protein
MKVIGYIRVSTQGQARDGYSLAYQEDEIKTYCQTHGYTLLRLFRDEGISGAKVDEEELEV
DRLGFQEMLEYLTHQKVDYVVTLNTSRLWRSDIVKVLVHRELKKYGVDIRSIEQPQYSIH
KKDPSDFLINGLMELLDQYQRLEISLKLGRGRNKKAQQGGYSGGNVALGYKVEKGKKILV
IDDRQAKTVQRVFDLKEQYPSWSLTQLAEQLNEEGHRTKQEKLFTKVQVKRILDRKAFYS
GLYHYGDITADGKHQAIL
>PK3-045_02316 IS110 family transposase ISCth6
MRRDKYIYIGLDLHKFQHTAVILDCWNEKLGEMTFQNKPAIFPSLLEYVNRYLTEDLTPI
FGLEDVGGYGRDLALYLLEQGYIVKFVNSSLSNAERNSYAMTQKNDSWDAQCVARVLIRD
LPYLPEATPFDIHWIIAQLVGRRNALVKTQTSLKNQLHMQLNYHYPSYKDFFSEVDGKTA
LAFWESYPSPSHLEGETVEDLRKFLLEVSNNACSTRKAEQILTLVQADGEVKREYQTSRD
FIIQSIVRDISFKKREIKKVDRELKVTIQKLGMQLETMPGIDTVTSSALIAEIGDIHRFA
NSDKLARYAGIAPIKMGSGGKETMKKTKQGNRKLYDVFYNLAVQQVQVSKGNKIPRNPVF
YAYYNQKQSEGKSKSQALLCIMRRLVRIVYGMMKNKTAYILPRMPETKAS
>PK3-045_02317 Ribonuclease YxiD
MKLHKSQIERLKGTLRENKYEKMTPLETLKHRNKFNSVKNKLIKEWEENTGQTWPRYTEE
IYDKKGRLARDIGQPYDAHHIIENNIGGPHEWWNIHPAKFPDEHQAGIHGKGSPSNKLFP
RR
>PK3-045_02318 Antitoxin YxxD
MATFDFVKNDKHKFIRLQENELLDAEERLGFELPNELRDFYLEVGYGFIKGSDGNAINRI
MDPDTIADITLREGIYEFDPDLEGIYEDDDKLVFYEVNEGVYLTLDLNTPQQTPVYFFET
QIAGSLEEFIRKVDEDAEYFRDMVD
>PK3-045_02319 hypothetical protein
MLGIIRVSTQGQAKDGYSLKYQEDEIKGYCKEQGWNLIHIFREEGISGAKLNEEALEIDR
VGLQEERERSRYNNSSWKAFEM
>PK3-045_02320 hypothetical protein
MWSRATIENRMDSIVPTSLRKVEGKGTTKGTGNVKHLVDVPRIKEVEVNFKRNDKHDSEE
FARQLKDQEKDMNELTVDEYLKNREKYIEQGRAIEGNAAQQAAREEAYVQKINELQREGL
TLSKAKKQAKEWLDTQAALHNPDQIAEGKAEVIGGLGDKRINSSIGSQWRYRIDIVDEQI
KELAKSMTPEQLKNTYLNVKLTH
>PK3-045_02321 hypothetical protein
MEKYLKDFKLHNKVPSEIIEKYMQLVPNEIIDLWSNYGFGTFMQGYFKSVNPEEFKEILG
ESSQRYKDSVVLFATGMGDLVIWSDGYVRLLNYRYGVVKTIMFTFEFFFQNINDLEFKDE
DLSWQPYPEALKQYSELDYDECFGYTPLLGLGGAEKVENLKKVKLKEHILIITEFMGPVQ
>PK3-045_02322 hypothetical protein
MMRVDRNDIWGNLTQIEWGVTYRLSRAIQETYRSLSLLFSLFDDTDLEERERSRYNKQQL
ESIRNVVINDPTIVLESMAQSITDTAEKEGIMYVSGSAATSFLPYVGQAKYLKLLKGEKS
INKASGTRSVVSRKTTESLQRIDGSKKENSLWPNGIKNSGKQYVQEVTHFFRQNFMPNPS
FQLSTANQAPVNVWSRATIENRMDSIVPVSLRKVEGKGTTKGTDKLNSTKDIYKVSPKDI
YQALEGYEQTHKFKAHFRGFEVKAQRSLSHMSDKQLIYSFKKGYSPKDGANDTIVLHHHE
QKVEGPIIEMPSRYHDLGNKKQHPFGNSGGVGSGEARIEFNKWRKEYWKARYANEMIKRG
IIE
>PK3-045_02323 hypothetical protein
MKIEILNAIDEEFEMCPEAFGGPLNIEEVNQAEDELKVKLPEDFKEFLLRYGSGAVGEAI
ILGLKEAEFVATPSFVEKSLHFRKALPQGYENFTAIGIDGAGNPVGFNSPNTEIITFDFN
FGGKEIIAESFEEYLEKAIREELNIHF
>PK3-045_02324 Putative ribonuclease YeeF
MAQSITDTAEKEGIMYVSGSAATSFIPYVGQAKYLKLLKGEKSKNKANGIRSAISQKTTE
SLQRIDGSKKENSLWPNGIKNSGKQYVQEVTHFFRQNFMPNPSFQLSTANQSPVNVWSRA
TIENRMDSIVPVSLRKVEGKGTTKGIDNGTRQVSGDIIKDGSHLVKGGKLKPNVKYQAGE
YNYQYKTDGLGRLTDFNADDLKLTKRNNRLSHKSNTPGKEPGDHAGHLAADRFGGSPDLD
NLVSQSSSVNLSKYKKLENQWAKAIEEGRDVSVNVKVNYEGNSLRPSSFDIEYEIDGRMR
FTSLEN
>PK3-045_02325 hypothetical protein
MKLFEDYFSELQTDMVAICLEYVDNKADEIFIYCSYEPKMYVFDFFYKINGKVVHKHQLN
EASKELDSQQNRVYDVSKERQKAALRIGNQNLKLIHKKCEEFNKDMPTEMKLHYNVKKNS
LKGKYRYDLVYSIDDELLPDDIFDLWFEEVKENNL
>PK3-045_02326 hypothetical protein
MKVIGYIRVSTQGQARDGYSLAYQEEEIKAYCQAQGYTLLRLFKDEGISGAKVDEEALEV
DRMLLGDVGVSLPQ
>PK3-045_02327 hypothetical protein
MRWDYVVTLNTSRLWRSDIVKVLVHRELKKYGVDIRSIEQPQYSIHKKDPSDFLINGLME
FFGKAILRHLIWRGKR
>PK3-045_02328 hypothetical protein
MEGKTVDELRTFLLEASSNVCSTRKAEQILSLVQSDGEVKRDYQTSRDFIIQSMVRDIRF
KKQEIKKVDKELKVTIQTLGMKLETMPGIDVVTSSALIAEIGDIHRFANSDKLARYAGIA
PIKMGSGGKETMKKTKQGNRKLYDIFYNLAVQQVQVCKGSKIPRNPVFYAYYNQKLNGGK
SKSPAQLCIMRRLVRIIYGMMKNKMAYIMPETKVS
>PK3-045_02329 hypothetical protein
MNGNLNKGEWKKLENTWTDALKHGDEVKVKITPNYKANSQRPESFNIKYKIGEDEWEIRR
FDNVSGGRKLDE
>PK3-045_02330 putative antitoxin YezG
MNEEQLDRLYQQIAEVVVETIPEEWSKVYLYGEVVEGSQTAYFYYYPEGSNKPIYSHEIT
ELFTVSELEYTEKWHQLVDFIQELWRAFKDNDQEPWTNFTMVFDKIGKFNIDFNYDVLSK
IDSHERKTIWKYEHLGIIPKSNSGKRHLEKYLSTLE
>PK3-045_02331 hypothetical protein
MYVSGSAATSFLPYVGQAKYLKLLKGEKSKNKANGIRSAISQKTTESLQRIDGSKKENSL
WPNGIKNSGKQYVQEVTHFFRQNFMPNPSFQLSTANQAPVNVWSRATIENRMDSIVPASL
RKVEGKGTTKGTVKDKGVSETTLRNIDDFINGNKKFDEVIEDYAKVYKEHVDLNKPWSWD
DTIPGGDCLSSAQKRKIKEMAIEKGHIPEIKVTKADGMRYGFADFASAGVVEETVQLPER
FWKLSDKEQFKWLDEQIGGTRKGMTWHHTEVPGKMELVPFGIHNITPHNGGRTKGMWADA
PR
>PK3-045_02332 hypothetical protein
MEFKDGSIIYPLPDDTLLSEKEGKWRINLPETYKEFIKKYNGGTPIKDSFKCNSHIYAID
RFLCILKVTGERDDEYYDIGVVRTQLDERIVFDENLVGTELLPIAVLFAGDFVCLDYRNN
VEEPIVCVWNHEESSDLNPITYIVSNSFEEFLNMLTE
>PK3-045_02333 hypothetical protein
MNDEAFEIDRVGLQEMLAHLSSVQVDYVVVLNTRRLWGSDIVKVLIQRELKKYDCDIKSL
KLTKGRNKKAKEGIPLYFQKQHDESRSERYLGESHPN
>PK3-045_02334 Putative ribonuclease YeeF
MMRVDRNDIWGNLTQIEWGVTYRLSRAIQETYRSPSLLFSLFDDTDLEERERSRYNKQQL
ESIRNDMESVQSRLKNKMEELWDLYESKVKKYENTDDEYANKASQVKDRYTTFSEKVSDV
ISVTAEGAWDFVKGLAVAIYEIAKGLITLVIDAGIVAASGIIPDSIEPDFLKKASTKRIE
SATETLDAIIHDPAIVLESMAQSITDTAEKEGIMYVSGSAATSFLPYVGQAKYLKLLKGE
KSINKANGIRSAVSRKTTESLQRIDGSKKENSLWPNGIKNSGKQYVQEVTHFFRQNFMPN
PSFQLSTANQAPVNVWSRATIENRMDSIVPASLRKVEGKGTTKGTGNASNKVNFGEQYTK
VNGKKALKPNIEYKTKEGYHYKTDSEGRISNVEATLQLGKADRNNYAQRTVGREDRLPND
DGGHLIASIFKGSGEIDNLVPMNATLNRKEYKALETSWKKALESGKTVEVKIEPIYKGNS
SRPSKFEVEYKINGKKYEVNLSNYNGGS
>PK3-045_02335 putative antitoxin YezG
METKQMEAIYQKVANILVEMIPEEWEKILLYAEVREGFSQVFFYYYPVNQEQPVYSLDIV
DMFNIDKPLHRKLKQELYDCFEELWNEFMVQDQELWTSLTYILDNMGRMKLNYGYDDVSE
ISPDEKQDKWEAEYLK
>PK3-045_02336 hypothetical protein
MNVAGYIRVSTQGQARDGYSLKYQEDEIKGYCKEQGWNLIHIFREEGISGAKLNEEALEI
DRVGLQEMLAHLSSVQIDYVVVLNTSRLWRSDIVKVLIQRELKKYSCDIKSIEQPKFSIH
KKDPNDFLVNGLMELLDQYQRLEIALKLTKGRNKKAKEGGYAGGRATFGYQKQKGEKELR
IHNGHAEVVKRLFELKQLHRKWSLSRLAEALNEEGYQTTQGKTFTKVQVKRILDRESFYQ
GIYTYGQIQANGKHEAII
>PK3-045_02337 IS110 family transposase ISCth6
MHEKQKHLYVGVDLHKQHHVAVIINCWQEKLDEIKVENKPSAFSTFLLDIDKLIDDGLTP
VFGLEDVGGYGRSLAQFLTDHGQVVKEVNPALSYAERKSHVTVQKSDSWDAECVALILLN
KLNDLPDAKPHDLYWSIQQLVTRRNALVKVQGALKNQLHIQLSHHYPSYKKFFSQVDGKT
ALAFWERYPSPSCIEGVSIKQLTTFLLEVSHNTCSVKKANEVWKLVKEDGHTTKEHQETR
DFLVRSIVRDISFKKQEMSYVEGELKQLMSLLDFQLDSMPGIDLVTASALIADIGDVRRF
PNANKLARFAGIAPVYFGSGGKGKEQKSKQGNRALHALFYNLAVQQVQVAKGSKLPRNPV
FHAYYQRKLKEGKTKGQALVCIMRRLVNIVYGMMKHKTAYELPIEQEKK
>PK3-045_02338 hypothetical protein
MTVTDILGGYRKGAKSNSPYTSFTNNKNVIGNYGENAIELDISALRKDIQSGKVKDVVIL
SPKQIQKLIERDVISSDFWKNRAINWTKRDNEYLIKGEVPSQYIKVSPKE
>PK3-045_02339 hypothetical protein
MKLYFLNEFLGDIRNINVDGMWINAEITPSKNIDKFNDFFAAIVDEENDFEETNYNEEWL
DDSNWYIIDDENRRKGIYIPAVYPDREINWRWR
>PK3-045_02340 hypothetical protein
MPITIKLKEILKERDLSQRELARMTGLRPNTISHLCSDNVDRVYLSTLETVCKVLDIDIQ
ELIEVE
>PK3-045_02341 hypothetical protein
MKVIGYIRVSTQGQARDGYSLAYQEDEIKTYCQTHGYTLLRLFRDEGISGAKVAKKR
>PK3-045_02342 hypothetical protein
MLEYLTHQKVDYVVTLNTSRLWRSDIVKVLVHRELKKYGVDIRSIEQPQYSIHKKDPSDF
LINGLIELLDQYQRLEISLKLGRGRNKKAQQGGYSGGNVALGYKVEKGKKILVIDDRQAK
TVQRVFDLKEQYPLWTLTQLAERLNEEGHRTKQGKLFTKVQVKRILDRRNFYSGKYQYGD
IIANGKHQAIL
>PK3-045_02343 IS110 family transposase ISCth6
MKRDEFIYVGVDLHKFQHTAVIVNCWGEKLNEITFLNKPSLFPDFIRFVEEQAEKGITPV
YGLEDVNGYGRSLAVYLLERGYIVKSVNPSLSYAERKSHAMTKKSDSWDAECIAEILARK
ITQLPDAAPSDIYWTISTLVGRRDTLVKQLGSLKNQLHLQLSHHYPSYRQFFSQVEGKTA
LAFWEKYPSPHHLEGVTMDELRLFLLNASNNSLSTKKSKTILSLVKFDGETKRDYQSQRD
FIIQSLVRDIRFKQEEIKRVEKELNGLVKSLGMQLATMTGIDTVTASALISEIGDIHRFS
HSNKLARYAGIAPVLFGSGGKETYQKSQQVNRNLHHIFYNLAVQQVQVSKGSKTPRNPVF
YGYYQKKLSQGKTNKQALICIMRRLVNIIYGMMKNKTAYIMPEQVEKKAS
>PK3-045_02344 hypothetical protein
MNSKEILSIRCLIFLYNLKIQCLKATEAVGKEGESYLRNTDTEYKILNDIASRLGENTQA
TGKIKLFTELDTCDSCSKVIAEFATKYKNIELEVIHNNGNRIIP
>PK3-045_02345 hypothetical protein
MKDWEYNELFGAIQETYEELLDEDRGYRYAIAKLADEFDNLGKIEDVIVDTAIGEIAIGH
EKVFIGRIEGIIKILSMFNPQEAGDELTLEEIKDLSRRINKVIEGLKNVEVDYNPSAE
>PK3-045_02346 hypothetical protein
MIHIFRDEGISGAKLNEEALEIDRGGLQEMLAHLSSVQIDYVVVLNTSSDIVKVLIQREM
KKYGCDIKSFKLTKGRNKKSRKVLPLFPETVMRVDRHDIWGNLTQIEWGVSYILSRAVRE
TYRAPSLLFSLFDDPDLEERERSRYNNSSWKAFEM
>PK3-045_02347 hypothetical protein
MAQSITDTAEKEGIMYVSGSAATSFLPYVGQAKYLKLLKGEKSKNKANGIRSAISQKTTE
SLQRIDGSKKENSLWPNGIKNSGKQYVQEVTHFFRQNFMPHPSFQLSTANQAPINVWSRA
TIENRMDSIVPASLRKVEGKGTTKGIDNANRLISGTPGVVTGGNSNKLGKNMLEDMGLKR
STKWSGYQAQHVIPSEMAKNPVIQKIGMNFDDSTNGIFLRVPDNDISTLSRHRGYHSVYN
EVVERALNRMDIKQNVDNLQKQVYELQSNLRKLQEKGLPLYPSQGATVELWERKLKQLEK
>PK3-045_02348 hypothetical protein
MDEKDIIFLEQLLYNTDKDYVVSQLKNIDDPLLLHYFAANYNWNSGFDVPTVIFENEACD
LGTGLLMFHYADGYRLLESSDEISSSSLEEWKVFLRKIYNKLLSLDFKSQDISFDPELTK
IQKYKLKKNNPDLPDVLISKSPGKEIDIPKI
>PK3-045_02349 hypothetical protein
MPITIKLKEILKERDLSQRELARMTGLRPNTISHLCSDNVDRVYLSTLETVCKVLDIDIQ
ELIEVE
>PK3-045_02350 hypothetical protein
MKVIGYIRVSTQGQARDGYSLAYQEEEIKAYCQAQGYTLLRLFKDEGISGAKVDEEALEV
DRMLLGDVGVSLPQ
>PK3-045_02351 hypothetical protein
MRWDYVVTLNTSRLWRSDIVKVLVHRELKKYGVDIRSIEQPQYSIHKKDPSDFLINGLIE
LLDQYQRLEISLKLGRGRNKKSQQGGYSGGNVALGYKVEKGKKILVIDDRQAKIVQRVFD
LKEQYPSWSLTQLAEQLNEEGHQTKQEKLFTKVQVKRILDRKAFYSGLYHYGDITADGKH
QAIL
>PK3-045_02352 hypothetical protein
MRRDKYIYIGLDLHKFQHTAVILDCWNEKLGEMTFQNKPAIFLSEFTRVCE
>PK3-045_02353 hypothetical protein
MNRYLTEGLTPVFGLEDVGGYGRDLALYLIEQGYIVKFVNSSLSNAERNSYAMTQKNDSW
DAQCVARVLIRDLPYLSEATPSDIHWIIAQLVGRRNALIKTKQGNRKLYDVFYNLAVQQV
QVSKGNKIPRNPVFYAYYNQKQSEGKSKSQALLCIMRRLVRIVYGMMKNKTAYILPRMPE
TKAS
>PK3-045_02354 hypothetical protein
MTMKIYYCDEWSDIKKKPWNILDVRTAYTYHQKQEPYTAVLLEDEKPKYIVNVTNEWVSL
GFYDDLIRKYLNYDFEVMSDGKIFLRTAVYWEYDDETDMEVSTLILGFREDGFIAMEKRD
LKTGSVEERETSDILERNWDVFPEFGHYNYLCKEER
>PK3-045_02355 hypothetical protein
MENANFSSLTEDGKVIFFLGLSEKVLSVFSRKEDQMLAQEVIYKCWEWLKGKENIGVILY
ELLDNEENGITIIQEMSDNETDFIAWNCVIDAVAYTSRKAFEREGVKYYPEPIALVDDTL
VDHFMDRFGKCVENADSYIQRIIFLLDNYKNGNIANDWRTEILKKLQLYN
>PK3-045_02356 hypothetical protein
MDTFENFLKHNTVDERIILKYKDKLPGELIEVWYKYGFGTLLNGFLKLINPDEYLDILER
CYRRYEQAIPIFTTSMGDIIVWEKDKYVNLLNFRKGLVHIVSSGFNFFFDDLKDNDFIND
ELMWEPYPKAYSKYGRPDYEECFGYTPLLGLGGSEKVENLKKVKIREHILIITEFMGPIE
>PK3-045_02357 Putative antitoxin YwqK
MENDSKYTKDFVLKNGVNFDDLWFTSYSDEILDNPEDEGGKPFTGLAFELYENGNLIYFC
FYKDGLAHGLNREFYESGKIKCEEYFKYGLVNGKSICWHENGNVKSTSEVELSIELNYKE
WDANGKLIMEKELEQDKENAQYAILLTRREINRNLGR
>PK3-045_02358 hypothetical protein
MVFSLLLKPEYAQNIIVGVKTSSQFSWYLTERDVWILDIVKYKKLYERNGFSFEMDFALS
LRNNISVVNEKNYRLYLQEYTDYLVPSSELKKLVEHHNYGSTILELRPSLFIDFNQKKLL
SLYPELLPFENYVPNNWSGIREDFTSDIPEEDRYWIFDNINYIDKLFNEKERE
>PK3-045_02359 Antitoxin YxxD
MSYEFIKTNQENSFYPVAENKIKEAEKALNLKFPKELVHFYREVGYGFIKGSEFNINRIM
GPYSVRDFRLRVNDFEFYPDIEIYEEFENNKLIFFEGSESALMSIELNDNNRNPVYYYDV
QIATSLEEFLRKMEENDNYYLELLPD
>PK3-045_02360 hypothetical protein
MVMTPEEFINKWDYIKNGPLNKFKEADLMNTYFSEEVKRFLSIGGLPETPPPYLEFTTSQ
FRPITDVFDMPEEFQKYWFLGSTGSGNPICITEKDENIVSLTNGDNYKVIFVNSSLNQFA
ECILAYVSMIDKAIEINGEDAYIDNDIPKVVMEWLKGELEKIDSKCMEAGFFWSTEFENL
FE
>PK3-045_02361 hypothetical protein
MSEKLSKDELVELVKKICNPKQSDEKVSEYIEILEENVPHPAPSDLIFWNDEDLSPEEVV
EIALAYKEEN
>PK3-045_02362 hypothetical protein
MKLSENTQLVEEVMDFIRHNKMFNMNNFHVNNLEVINNFKEAQNLAWSQDSSEVDTVWEN
VKSQEAGSIVQQVYDLDLVTEQDDLYDFFNDYNNYSNDFLPFDYIDINEEVEGDLMMCAL
NRLVNGKTDNFYEKIFEIYKQGGWPCGWKG
>PK3-045_02363 hypothetical protein
MWVEGVRVDFEKGGIKVMNYGVFNNLVEEVIRFSKIFQSELTNNITNKIVIINDIKKAEY
LAYDEIFGEDEYNWKDIRELEMSEVWETYYAMSEKEKPKGLEELLEVIAGNVSKSSCKYS
MFYNDVVADLTNCAINRAVNGKNNTFFEDLFEIYQLGAFPCGWNGAYPEGKIIAYTLD
>PK3-045_02364 hypothetical protein
MEKQGCVSVWLGNINDEDSIGEYVDLTYDEDGESVPSQFFIDFKIDVDETDEDTIEKEVY
KNSSSDIAALLEGCSYEEIVIPKIQKSINLKKSYNAVILIYNFQYQNEISSTDDFDFIAA
TNYE
>PK3-045_02365 hypothetical protein
MKILISQPKMENSLQQLIKEIERFPEVDFILFPEGYFTADYIEEVCNLAIKHHTYIVTGY
KDKNKKDRAFIANRAGKIIIERAKTPENEILYTPSKQKDENVSFGYLLCREIFQGVAGLE
NGKVEIIFNPIGVGMFSEKQYEEWTSEARKIAMKENAIVVGTSHADGSYRNGGFSIPIAY
CFDQEGNDLLLSKDDIRTRIFDTETNSIKIAE
>PK3-045_02366 Putative metal chaperone YciC
MTTIYLLGVRALNNKKIPVTVLSGYLGSGKTTLLNHILSNRESLKVAVIVNDMSEVNIDA
SLVKQGGFSRTDEKLVEMQNGCICCTLREDLIIEVEKLVQLGDIDFIVIESSGISEPIPV
AQTFTYVDESVGIDLSRFCQLDTMVTVLDAHRFWHDYASGESLLDRKQAVGEMDEREIAD
LLIDQIEFANVILLNKTDLVSDSKLQELKAVIQKFNPEAKIIESEYSRIPLNQVLNTQLF
DFDAASQGAGWIKELNEEHIPETEEYGISSFVYRSNKPFHPVRLMQWLQDWPVEVVRAKG
FIWVATRNDIAGLLSQAGPSLTIQGAGNWIATYSESEQKEVLEEDPDLQKRWDPLYGDRI
TELVFIGIGMNQQQMEDELDACLLTDMEMKKDWTKFIDPLPAFFVE
>PK3-045_02367 50S ribosomal protein L33 2
MRVKITLACTETGDRNYITTKNKRNNPDRIELMKYCPRLKKRTLHRETK
>PK3-045_02368 Alternate 30S ribosomal protein S14
MAKKSKVVKEKKRQAMVEKYAALRMELKEKGDLEALRKLPRDSSPTRLKNRCEVTGRPRG
YLRKFKMSRIAFREYAHKGQIPGVKKSSW
>PK3-045_02369 hypothetical protein
MNSVNPVLVQIFYRSAIANLPEKKREIYRYITSKEEELEKIAVSEKQFMELMVNHSPFKE
ASNYFSLSMSTIKEIMGEAQAEIDLMIMTRINQMRWINYSKTDRKARKNKKWTFVFVS
>PK3-045_02370 Catabolite control protein B
MTNIKDLAKMAGVSVTTVSRVLNNHPYVSKEKRNAVLAAIKESNYEQNINAVHLSKGKTQ
MIGVVLPFSDHPYFALLLKGIAKQALENNYKLVLFQTDYMVSRELEALQMLKQKQIDSLI
ICSRTCEWSVIQEYLSYGTIVLCEDTKGKEVSSTFVNQYKIFKEALAFLHKKGHQKIGYC
IGRKTGPSSQLRANAYQEFLLEHQLPYCEEYIIDHCNYFEDAKKVMDHLLQMDNPPSALI
VTSDQVAAGIVIYCQKQGIKIPEELAIIGYHNESIARLMEISTMEIPLLEMGKNLFQQAI
SKEISKEEMFFRFIERTTV
>PK3-045_02371 hypothetical protein
MLSKHSSIQRKLALDHPRPKQVIKKFMQKEKRGMRWTTLWGLKKLSMQAMLNP
>PK3-045_02372 hypothetical protein
MIGISFYLKDPLAEERITRAGKLGVKRAFTSLHIPEESGELATRAKALMTLAAESGIEVF
ADVSLRTPSHLGLNSLMELKKLGVIGLRLDDGFDNEMILTLSQDFKLALNASAFQEEDLS
ALIKAGLNANQLIAWHNFYPRQETGLSFSFFQSQNKIFQRFGIPISAYIPGDEEKRGPLF
DGLPTLENHRHLEPYHGALELFLAGVEDVYIGDPGVSEALLHKLIDFDQHHYVSIRIQDY
QEGEFQLRPDLSRDVLRFLGTRSLENIYPENTEARPAGTITRDNDLYGRYRGEIQITLCD
LPADERVNVIGKVIDADIPLLSLLKPSQKIKLVPFSF
>PK3-045_02373 PTS system EIIBC component
MAGENNKILAEKILEQLGGPENIVSYTHCMTRLRVTPKNSSLINKEELKKVDGVLGVVVE
ETLQIILGPGKVNKVTEAFSRLIEDAGGINLKEKAASTKAEINKKNATPFKLFLRKIASI
FIPLIPALVASGLITGITKAIVQSGVLAEESQLAIILSVIGSGLFGYLGILVGTNAAKEF
GGSPALGAIAGILIINPAVAGIHLFGADLLPGRGGLIGVLFAAIFIALVEKQVRKYVPTS
LDLFITPTVALLLTGILTYLIFMPLGGLISDVITKGLTSLLEMGGVVAGFVLGATFLPLV
VTGLHQGLTPIHLELINTIDNDPLLPILAMGGAAQVGAAFAIYFKTKKTRLKRAIAGGLP
AGILGIGEPLIFGVTLPLGRPFLTACLGAGIGGAFQAAFGVATVAIGVSGIPLAFLVVTG
QVFLYLAGVLIAYAAGFVFTYLFGFKDEMAGEFE
>PK3-045_02374 putative HTH-type transcriptional regulator YbbH
MVAGGLKIIQSMLEQLPASERKIAAFILENPNMLLNSTVHEIGAHAGTSGAAVIRLCKSL
GLNGFQDLKVRIAGDLVKPLEQGYRDIEPDESFYSIVQKTTSNSIQSIRDSEEIINYEEL
ERAVHTISAAKNVHFFGIGASNIIAKDAQQKLLRIHKNATAFTDIHLVATLIGNAGKDDI
VFGISHSGETPEVIKVMSLAKKHGVKTISLTKYGQSSVASLSDIKLFTSYSAEAPFRSAA
TSSRLAQLYIMDILFLSMATVQYEDTITSIDKTREAIQFIKEGK
>PK3-045_02375 N-acetylmuramic acid 6-phosphate etherase
MEEKLELLTTESRNEQTMQIDTAEPMEILRLMNEQDQLVALAVKEVLSDIEVAVQYVFES
FQKGGRLIYVGAGTSGRLGVLDAVECPPTFGTDPEMVQGLIAGGETAFFKAVEGAEDQPE
LGIKDLKAISLSKNDTVIGIAASGRTPYVIGALQYARAVGAKTIALSCNKNAAISKEAEQ
AIEVIVGPEVLTGSTRLKSGTAHKMILNMISTSSMILLGKAYENLMVDVHVSNEKLKERA
IAIICKIADVSYEQALETLEEANLQVKTAIVMLKTNSSKQEAEQLLANANGYVKKAIQK
>PK3-045_02376 hypothetical protein
MIFRSKVDRFFIIMLLVVIFSIGLVTLGPLFIEKERTILPSIIMSTIFILCTSFFAWITF
GIKYVFTDEYLLVKGGPFHSKIRYENITKVAKTTDIFTGFRLLTSKSAIEIFYMTASLGS
VKISPQNAELFLIELENRISKRGKNNN
>PK3-045_02377 hypothetical protein
MKKIILVGTFHFAENADMIKRKDEEIEELVQLLAEWRPSKIALEWDKKDEQLLIEKFHQE
SNQYSSDEIEQIGFRLANKLHHDKVYGVNWEGELGQEDVQNLFNEIKENYQELSEKMESL
NKASPVLSATSSLIEAFRRLNENAYIHRLEDLYLSFVLVENKQGVKIGIPFLDKWMKREL
YIFNNVLEITKDNDQDCILLLIGSDHLWLLRKFFEGIGWEVINPFSYTNKI
>PK3-045_02378 Proline iminopeptidase
MAIHYLNINNKELYVEMHGKMTGKAILYLHGGPGEGCFDFSMNQTHRLNNFFRLVVIDQR
GVCRSEEIFKEESFGINHLIEDCEELRIQLGISKWSIIGHSFGGYLAVLYANRYPYAIEK
LIFECPTFDFELTAKSLLKRTASLFARYNMIPLQKQVNRLIAKAVSPKELVEGYLQLSSY
LQEKRMEIYSLHSINLETSIYTDEQWDRFYDKSEIHFVRLRNEGKIFESVLPLLKKIQVP
SLLIVGEYDPVTCEKQIDFFDKNVRQGEIQIIEQCGHTPHNESPEWFSKMVTEFILWENH
>PK3-045_02379 Putative aminoacrylate hydrolase RutD
MYVKTRDGLLVYYEMSGNGDPCLYLHGGPGYWSKPFQLFAHGLLEKDLQMIYLDQRGCGR
SEHSLSHDYSLNRLIMDLEELRISLGINKWYIMGHSFGGILAVNYAARFPEHTIGLILAN
VTLNMYESFEYQINRGLEILQEQRNIFPSDPLEDYIELFYSTLFKLIENGRYDHFQYTDI
DKKKEVDMIDKELRTDAYFQKKIFSLKEYFDDFTELLREIQKPTLIIAGKSDHAVGPNHH
LTFPCENAVIHYINGGHHPYIENQDAFKEAVLSFVNDKKTV
>PK3-045_02380 hypothetical protein
MLASLQAIQEVRQGNKEVLRQQKWLQYLYITKEKNVNLEQVPSLEGLESNPVLSYVEKTL
LILDNCTSLNDPEKQIIEQVLIWSDVAKCGSPSQRKYWRERGFQLGIHNIGSAQIYAEEI
RKTTNGERNLVLEELIFTLIYTHGLIGQFIRGEVRYCQLEPLILSMNKNIVVDQNDRYRL
LYVLNQCIIEAVSPQIWKEVQKEVKEVISSILEGKREQELPLKERIKRLRKAAIQNGENF
DEEYSRFLKESKRNEMLQLFFHKTDMWYVESALHDFSLEEFLKIFLLIYQKVDPLTIRQI
SFEPFMKDIYYDYKGKKTINLYKKRIIEAFLKEQTIDDLIAGTKCANEHVELVIIPLDSL
NENISVTFVYSKAGEKLIEFCQEAEKSPLYERAIILLYDFFGFRKDGFDRMQNEQNYLAD
MNNAEDHKKMIADYAIGNKLLDIGAGGGIMLDILSDRHPQATVIGIDISTNVIEALEKRK
IREKKTWLVKQADALQLKETFAVNSMDTIVFSSILHEMYSYIPYKGMKFNPEVILDSLTS
AFEVLKPGGRIIIRDGIMTEPKEEWRQIEFKQPNGLDFFKRYVNDFKGRQIEFEQINEST
VKLPINDAMEFLYTYTWGEEAYPHEVQEQFGYFTPAEYKDVIKRVIGNKGKVLLFDHYIQ
DGYAEHLLPKVKLMDSSQNVVKLPDSTCFIVIEKHLR
>PK3-045_02381 Small, acid-soluble spore protein H
MDINRAKQILSSSAEIEVKYNGASVWLEDIKEKDATAIVHLVGGSQEQTEVDIASLEEA
>PK3-045_02382 hypothetical protein
MQISLKVYGEHARMVSHLIAKNPHNLYERKEKGGLVRIVFTKNEEHEVQILFFVTVDNME
LTKNQTNFSSITHYINDRESAVSSIFCSVLRKAVGTALNGKPKDEFKEWVNYSFPLEITF
GPLSTKLTNHELAELFEPLGYELTIENGKVLLPKSFAKKSSAKFITLKAKQTIQDCFRHL
FVLIPVMDQYKHYYIDEKEVDKLKRYGEGWLSSHPKRNEIIKESLVFSDLIEKSRLIESK
PSEEKQAPLTKKKSLNQWRYEKIIETVKKLPHNSRIVDMGAGEGKLTAQLGFISGIEELI
AVDPSEREQLKAKKRIEALVDKPDFLLPTFKWGSLFYYDSELEKKDIFILCEVIEHIDEN
RLGKVFDTIFTKYKPYHVIVTTPNQDYNAVYDMNEAKRHSDHRFEWTQQQFEEWTKYWES
HANYKVQIDGIGEYIEGYGYPTQMAIFSQKRGG
>PK3-045_02383 Bis(5'-nucleosyl)-tetraphosphatase, symmetrical
MKTIRIPYNSIVLLIGPSNSGKSTTLENWINKGFLQAEEVISSDHFRKLVSNIDFVDWTN
QPKEVAANLMEEYSQISTAAFEMMKQMISARATLNKRSYIDATHLKEAEREKYRLLGKKY
HVPVVVIVFDLSLSVLLERDEKRTHPRGKGKVKRQFEIMRQEIRKIQRESYHAIYYIRDR
DESVSIETEEASYYLNADNGLDIIGDIHGCMDECYELLERLGYIKHDDGLYRHPEGRKFV
SVGDIMSRGPKSAEALFFFSAHLNHNLAYMIDSNHGWKIARWLDGKKVTLNHGDEWIKET
FTSFSLTYTDEQIEKIREDWKTMLLQSPSHYVLTRNGVKTAVVAHAGIKDHYIGKQSNTI
SDFTRYGETLGMDTDGKPIRGDWYRNHLSKELIIWGHDPKPEPLFVNNTINIDQGVVFGG
KLTAFRYPEREFISVKAQKDYAQIEDNPLKKWQETRLSLPNVQRFINGYSVWTDTFGEIS
CPQNNVKAAMDKVSHFTIPMEELIYIPPTMSPPPQTSTIEGYLEHPIDAYHYYKDNGIDQ
MVVEKKHMGSRGILLLFKNPEAAEKYVGKRSLGTIYTRTGRAFFSIELEEKILTKLHYDL
TTVNYFDKNQTDWVLLDAEILPWNLKAKDLIIQQYAHVAEMSVMDRDKIYEQLLCAQQNG
MAVNGWVEEFAQKRQNAQSFSEVYNQYCWEIQQLEDIKIAPFHILAHSNESYFHQTHQWH
MEQNEYFSTISSLFMKTDYLIVNDDESLKKAVSWWEEITTDGHEGVIFKPYQFLAKNPKG
KLLQPAIKVRGRKYLQIIYGMDYLEKDQLRRLKDRKTAKKQRNALKELALGIEGINRFIQ
LESVERIHECVLATLALEEDPIDARL
>PK3-045_02384 hypothetical protein
MKDETIKIVIGAGEYRNNPGWIHTQEDELNLLDDSTWLKFVKCSIDAILAEHVWEHLTFE
EGVQAASLCYQYLNPGGYIRCAVPDGFFPDESYQRIVQIGGPGPKNHPAFTHKIVHNYQT
LSKMFELAGFEVHLLEYCDEEGVFHENEWHGKDGVIFRSKKYDQRNNGEKLLFPSLIIDA
WKR
>PK3-045_02385 Methyl-accepting chemotaxis protein McpB
MKKFLIKKRKGIPLKKKLIISFLAMLLIPSILIGAFSFLYANKQMEKDFISNASTNLNML
DKSITNLMSEKIYDVSALTETMTKKLLEKDPETLQKTIEQYSQVHPEVSSIYIGTNDGKL
FQKSMEENNDHMDPRLRDWYKAAVNKPGEAVIMDPYLSPVSKKMVITIGKTIADNAGVMA
VTMNLDYLAELAGEITFGKEGYVILLDQKKRFIVHPDEKQGGVVKASYYETLYNRQAGTL
DYSADKISRKMVFQTNKLTGWKLAGTMEKSEIVNHSKDLLYAVTGILAVSIIIGGIMMMV
IVSSIIKPIKKLKEQAITVSKGNLTTDINITAKDEIGDVAAAFHTMQNNLRQLISNIEQS
SENVAASAGQLTASANEVTIASEHVTNTIQQVASGAEIQTKGLDNNVDSLKSVLNGTNQI
VIFSKEVSDLSTGTIEKAYAGGNSIQATLEQMHVINGTVAESNKMIKELVEQSKHIEKIT
ESITTISEQTNLLALNAAIEAARAGETGKGFAVVANEVRKLAEQSGQFASNISQLITDVQ
KTTENTVQRMAEVSRAVQTGLEVTDESHIRFQEIVHSMKEMTPHIQKVTDTSNEMATTLK
EVSITAGELAQIASDNSASSEEVVSLTEEQLAAIEEISGSAKNLLNMAEQLKRNLHQFTY
>PK3-045_02386 Putative metal chaperone YciC
MEKIKVYLINGFLGSGKTTTLLKCMEYFKGKNKKYAIILNELGETNIEKHLFKEESLYEL
LNGCVCCSIKEDLRSTLNDLTVTLHKENIEIVLLEGTGVANPCEIMETFSEQRYRDNFEV
VERICLIDSLHFTEYTSIFSSSKEVRQLQKEQIENGTVLVLNKIDQLSSKLAVEKVEKRI
RKINPDAPLLHSNYGHGVTAYLEKQEGTKIKDQSISHHHHHHHIKAMKIVQTTPMTKSEL
RDFLKNNQDKLLRAKGTIKNSDDHSWYHFQYASGLLEWQKVKEYLPDRKGEIILIGEKLP
EKVIL
>PK3-045_02387 Putative two-component membrane permease complex subunit SMU_747c
MSIPTRMKDIFIFCLFIALMYLFFFGDLYVAKQWSFALPDQIKTIFVLFLGILLEALPFL
LLGAIASSIINIYISEEYIARIMPKNPIAAIGAALIAAVITPVCECAIIPVVRRLIQKGI
PVHIGVVLLMGAPILNFIVFGSTYYAFQHNLSIAYGRFIICVLAAIIVSLIIYFFFSKQK
VLKTQREDLMAAVPINENKGDSKWKGILHHTCHEFFTIGKYFIVGAVFASVAQVYLKDSF
IMQAGESPIEGTAVMMGLAYVLSLCSEADAFVAASFSKMFTPEAIIGFLVFGPILDFKNT
FVMMASFRVKFVFVFITIVTMIVFLLSLASRFILFS
>PK3-045_02388 Putative two-component membrane permease complex subunit SMU_746c
MVKIKWSPTWQLANELQGIVLIGFSLLIFKLLVTGDVGQLVAPKMVPLLGITMTLMFLLG
FFRLLNSNLKGADCDCDVCDENASFLNLTFSYLLFFSPLMLFFTLQDMSIDKSMLPNIQF
EQGQTFSVSEGQLKTSEKEDMITMEDDNYLQTMDMIHTNLDDMAGKEVMITGFIHREESF
SDNQAVIARYVMTHCIADLGLFGYMLEGEVGGLQSDQWYVITGKLDKKEYEGQIMPIIKL
EKAEETIAPDEDYIYALD
>PK3-045_02390 Hydroxyethylthiazole kinase
MNEKVDMVIPAILTKLRKHVPLVHNITNVVVTNFTANGLLALGASPVMAYAKEEVAEMAA
VADALVLNIGTLTAENVESMIIAGKAANQANTPVILDPVGAGATSYRTESVHRIMKEVKI
SLLRGNAAEVANVAGIKAKMRGVDSVGEHNNQGIALEAAKLLQVPVIITGEQDIVAVDGK
LAIIHNGHSMLTKVTGTGCLLSSILGAFIAVEKDIFLASIAGLVAYGVASEHAFEKTSEE
GPGSFQIELLNQLSKIKEENVKEAMRVEIKRG
>PK3-045_02391 Hydroxymethylpyrimidine/phosphomethylpyrimidine kinase
MATAKALTIAGSDSGGGAGIQADLKTFQELKVYGMSAITAITAQNTRGVDGVYPMTLEAI
EKQLESIAVDLRPDALKTGMLFNSEIIELVAEKIKEYHWKNLVIDPVMIAKGGANLLQKE
AAESMKRKLLPLATVLTPNIPEAEVLTGMDIRNIEERKEAAKRLNAMGVAYVVIKGGHGA
EKEAIDLLFDGSDFSSLVAERIPTKNTHGTGCTFSAAITAALANGYSINEAFRLGKDFIH
QAIKNDLHIGSGHGPTNHWAYQESKR
>PK3-045_02392 Thiamine-phosphate synthase
MTTYTKERIKQLLKIYFITGSNNSTSDPKVILEEALKGGISIFQFREKGNGALRGEDKIQ
LAKRLQELCKQYHVPFIVNDDIELALAIDADGVHIGQDDENAIKVRNMLGNKLLGVSAHS
IEEIKAAIEAGADYIGIGPIYPTSTKKDAKAVQGTSLIEKVRQENISIPIVGIGGITTEN
APPVIQAGADGVAVISEISLAENPYKQTINLRKAVFDQA
>PK3-045_02393 hypothetical protein
MYGYGGYGCGYGTGAVGGVGYGGGFALIVVLFILLIIVGATFIC
>PK3-045_02394 Ammonium transporter
MTLDGNITYIKGEGNLMENLEFLMNSLWTMIAAILVIFMLGGFILLEAGSTRMKNAGHIA
GKTIFTFGIASLVFWAVGYGFIFGDNANFFVGMSEFFYNGGSVGQIDGDGLQTTVFFVFQ
LAFAGISLTIALGGFAERAKLSVYLIFSVLFGILVYPIIAHWIWGGGWLAEHGKQDFAGS
TVVHLTGAAAALAATMLLKPRIGKYNADGSANPIFGHNQVYTALSVLILWVGWFGFNAGS
TVSVADGFFGYVALNTNLAAAAGAVAALLISWIVLGKSDITTMLNGALAGLVAITASCAF
VEPWAAVVIGLIAGVLVFYSVRFFENRKIDDPIFALSVHGTAGIWGTLSNGLFATAELAE
YTGVGKAGLFYNGGFGQLGVQALGVITCGLFAFAISYVILFVIKKVSGLRVTEEEEIMGL
DISEHGSYGYPEAFLSKDETKSL
>PK3-045_02395 hypothetical protein
MCSKNHRLNEWKREKELFLQTTTYQNTQLNDFYDELFMELFQFILFEYKKNYGEPPCSFV
WFVTGSAGRKEQGIFSDQDHGIIYESNDENSNQYFIHFGEWLSDALNEIGYPYCEGKVMS
SNPIWCKSVEEWKHQLQQWMEKENWESIRFLQIFYDSRQLFGEENYVQELRSYIHQYCVL
HPMLLKRFMNNVMRIKKGVGIFGQFFVERTGSHRGSIHLKHTMYLPYVNSIRLLSIKEKI
QQTSTLERIQTLRTMETYDNWLKPYESSFRRILDYRINSFKEAKTYEDVHYLNIKELTKE
QRQEIKGLMRHGIKLYHQVQRIIEKGC
>PK3-045_02396 DNA polymerase III PolC-type
MGVESFLQYMRDLYGKVNSSVLHATSSGSNSQQIAFMRQLQKDLKVEAASRLPLNNLKAV
VFDIETTGFLPDKGDQIISIGAIKVEGSDILDEQFYTLVNARVEIPEEISRLTGIKTEDL
LDAPSLSDVLVRFFGFVKDDTLIAHHSSHEKSFMQSACWRSFKTPFKHRIVDTSFLFKIV
EPQQRILTLEEWCEFSDIPVINRHHALGDAKLTAVLWCQYLQRAEQLGCRTLQDIYERLA
CR
>PK3-045_02397 hypothetical protein
MDVFETKRLLLRGWKEADYKDLYEYAQKEEVGPFAGWSPHKSEQESKDVIRYFLQNENSY
AIVWKEENKVIGSIGFHERMPDVKLSHLAQREVGFALNPRYWGRGVVPEAVNHLLEYGFE
KLCLDLIWCGHFDFNTKSRRVNEKCGFRYKFQKTNHYKLFDNQLITSVYYCMTKEEYFKK
IREASVGVSHTNQVRST
>PK3-045_02398 hypothetical protein
MKRISYYYLDFVKILFSAVLLFAIFGTVNDTIIKLITGYSFPNVEFLKGKQSLTGLFILQ
YIGFALIYFVLYKNTLSFIGFTKNRERKKLSSMWTKYLILFGIGFILLFYIVLLIVS
>PK3-045_02399 Lactose phosphotransferase system repressor
MLTPERHELILQLLKQHSVVKIQDLIDVLNTSESTIRRDLTQLEQEGFLKRVHGGAARLQ
RKITEQSMSEKAFKNLQEKKMIAAYAAKLVEDGDSIYLDAGSTIKEMIPFLKNRDIVVVT
NGLTHMTSLLEARIQTYITGGYVKEKTNALVGRGALLSLDNYRFDKCFMGVNGIHPEYGY
TTADQEEAMVKSKALSLSREAFFVADDSKFSEVYFAKIADLHNASIITNYLDEEVNDLYS
RKTSIKVVKE
>PK3-045_02400 Tagatose-6-phosphate kinase
MIYTLTLNPSVDYIIEVAEVHLGELNRLEKTSKFAGGKGINVSRVLKKMGVQSKALGFVG
GFTGSFIETQLLSEMIETDFVKVEEDTRINVKLKSDTETELNANGPAISEVKFQELKEKI
AALTSEDLLVLAGSVPSTLPKTTYEELVKICHANNVSFVVDAEGELLKAVLPYQPFLIKP
NHHELGELFGVTISTPEEAIPYGKKLLEMGAQNVIVSLAGDGAVLITQHEEIISTVPKGQ
VKSSVGAGDSMVAGFLSKYEETQDIKESFRYSIASGSATAFSIGLCTKEKVEELLPQVQV
QS
>PK3-045_02401 PTS system fructose-specific EIIABC component
MKITELLTQETILLNIEGNGKLDAINQLVDILHSAGKLTDRETYKQAILNREEQSTTGIG
EGIAIPHAKTSAVKTAAIAFGRSSSGVDYESLDGQPANLFFMIAAPDGANNTHLEALSRL
STLLLKEEVRSKLLTATTKQDVISIIDSYDVEEETVDENIADKKNFIVAVTACPTGIAHT
YMAADSLKAKAAEMGVDIKVETNGSGGAKNVLTAEEIDKATAVIVAADTKVQMERFNGKH
VVETPVADGIRKPEELINRAINQQAPVYNGGSGSNSGEVNTGKKGIGSQIYKHLMNGVSN
MLPFVVGGGILIAISFMFGYNSADPNDPSYNAFAAVIKYIGGDNAFALLVPVLAGFIAMS
IADRPGFAPGMVAGFMAAQGGAGFLGGLIGGFLAGYLVIGLKKVLEVLPRSLEGIKTILL
YPLLGIFFTGLIMNYVIMEPVAAINTGMTNWLSNIGTGNAVFLGIILGAMMAIDMGGPIN
KSAYVFGTGLIANGVFEPMAAIMAGGMVPPLAIALATVLFKKKFTKQEKDAGLTNFIMGL
SFITEGAIPFAAGDPLRVIPSVAVGAAVTGGLSMFFHIGLRAPHGGVFVVGLVDGNPWLY
LLAIVIGAIISALLLGLVKKPVQQK
>PK3-045_02402 Bacillibactin exporter
MDHVNDDKNIVNLTNKAQKTAKKQNVKVSKMAIFSLSSIPLVMTLGNSMLIPVLPSIEKK
LDISSFQVSMIITVYSVLAIILIPVAGYLSDRIGRKRVIIPSLIIAGVGGVISGLAAWLM
DNSYWIILIGRALQGVGAAGAFPIVLPLVGDLFKDEEQVSSTLGVIETANTFGKVLSPIL
GAFLAGFIWFIPFMSIPVFCLVSIVLILIFVKSPKSKEKPAPFKEFIQHTKETMHKDKKW
LYAIFFIGVIVMFVLFAEMFYLSDILEKKYHIKNVKKGLYLAIPLGALCLTSYITGKKIK
KDKNLMRWITFIGLLAIIIGTIALNFSDNMWFIILFLTVAGIGIGASLPPLDALITEGIE
KKERGTITSIYSSMRFIGVAAGPPIMAILMKHIDHLQFYLLSAITLIAAIAAFFRLKYVD
GQEEKKENKINQ
>PK3-045_02403 Protein YiiM
MGKIITLSIGKEKTFIWKNKSISSAIGKEKVSEVSLTFDGFVGDGVANPAFHGGKERAVC
YYPFEHYKKWEDEFKTKINPPALGENICGTEFTEKNTYIGDIFSLGNAIVQVTQGRVPCS
TISKYNQIDPFLSRIVETCYTGYFLKVLEEGVVSEHSTMELIERPQNKISVWDATKVMLL
DRTNKEAMLSILQIDELAEDWKNRYRKALQKVK
>PK3-045_02406 Anthranilate synthase component 1
MENSILLIDEIQGDTLTPISIYQRLSGKKKFLLESSLKHEDSGRFSIIGCDPTFEVIGKG
LETTIVEGEKREQRKGRALDFINEFLPENKATLPFQLPVNAGAFGYVGYDNIRLYENIGP
EAKDEIGIPDVHLMFFEDLVIFDHSELKVYLIASPLKHTTTEKELKFRLQIRKLEITAPY
KEDSPEVKVTPFQASISKEQFMEKVKKAKQYILEGDIFQVVPSQRMTAEIEGSPFSYYRK
LRIKNQSPYMYFFDFEDYAVLGSSPESLIKAVNGKVITNPIAGTRPRGKTKEEDSQLEQD
LLLDEKELAEHKMLVDLARNDVGKVSNFGSISIDKYIKVEKFKHVMHLVSEVSGELKKDY
SCVDALISCLPAGTVSGAPKIRAMQIINELEGTKRGIYSGAVGYFSQNGNMDFALAIRTM
VIKGKKAFIQAGAGIVHDSIPEKEYEETIHKLKLFLEGQHDFISR
>PK3-045_02407 Aminodeoxychorismate/anthranilate synthase component 2
MILLVDNYDSFTYNLFQYLGELGEEIKVVRNDEITVEEIRTLNPHGIVLSPGPGRPENAG
ILIELIQSLYQEYPILGICLGHQAIGYAFGSEIVKAVNVMHGKTSTLRVTGHPFFHAMEE
PIEVMRYHSLVIKKGTLTKEFEVLASSTDDHEIMAIKHKDYPLYGYQFHPESIGTESGKQ
FLQNFINETREEVQR
>PK3-045_02408 Anthranilate phosphoribosyltransferase 2
MKQYVEKIMANESLTETEMEGAADLLFSDDITDTEIAAFMTSLKMKGETVEEIVGIVKAV
RKQTLSFAEPVSGCIDNCGTGGDKSQSFNISSTSAFVLAGAGIPVAKHGNRSISSKTGSA
DVLEELGIKLNITPEQNMQQLEEVGITFLFAQHVQPKMGRIMKVRRELRLPTIFNLIGPL
TNPISLESQVLGIYRSDLLLTFAESLRKLGRKRAVVLNGAGGMDEASLQGDNQLVILQNG
RIEKIVLTPDDVNLPYYTNQQIRGGDAKENAAILLKVLKGEKGAYRDTILLNAGIGIYTA
GRAESIGEGVHIAKESIDSGAALYKLNQLVEVSKELEGAGI
>PK3-045_02409 Indole-3-glycerol phosphate synthase
MTTILDKIITKKRETIADLYERKEVLHTKKHSFKKRSFTEKLKDAEKLAIIAEFKRASPS
KGDINIDKDPKEQTKMYEIYGADAISVLTDTPFFKGTYEDLAEVRETVNLPILCKDFIVD
KIQIDFAKYYGADIILLIAAALKDNELHELYTYATEIGLEVLLEVHNEEELERALKTKAQ
LIGVNNRNLKTFEVTLDTTEKLAGKIKESGRYMISESGISTYTDIQKVSASGANAILVGE
SFMKAADLETKMKEMKVSIRAEIE
>PK3-045_02410 N-(5'-phosphoribosyl)anthranilate isomerase
MNVKICGITTIEAAACAVSYGASAIGFVFANSKRKISEEEAKDIIATLPKDLMKVGVFVN
ESKENIMKIVNVTGINVIQLHGDETAEFAASFSLPIIKAFSISTPEDLKQVAAYPCDYAL
LDSPRGKYHGGNGIAFDWNLIKDYDFGNKKVILAGGLNENNLTEAIETTHPFMVDVSSGV
ETDGEKDLEKIRVFLELAKTVQI
>PK3-045_02411 Tryptophan synthase beta chain
MTETYVYPDNRGHFGRYGGRYVPETLMLAVTELEAEYKKAQEDPAFHKELNNLLKDYVGR
ETPLYYAENLTKYAGGAKIYLKREDLNHTGAHKINNSLGQALLAKRMGKKKVVAETGAGQ
HGVATATACALLNLECTIFMGEEDIRRQKLNVFRMELLGAKVVSVTSGSATLKDACNEAL
RYWVTNVIDTHYILGSVMGPHPFPMMVRDFQSVIGKEAKKQYIEKIGRLPEAIVACIGGG
SNAMGIFYPFIEEESVALHGVEASGHGLDTDKHAASLSKGKPGVLHGSYMYLLQNEDGQI
QEAHSISAGLDYPGIGPEHSFLHDIGRANYESVTDDEAFEALQLLCKIEGIIPALESAHA
ISYAVKLAAKMDKEEGIIVCLSGRGDKDVNTVMERMGE
>PK3-045_02412 Tryptophan synthase alpha chain
MITIEAAFKATLDKGDKAFVPYIMAGDGGLETLKEKVLFLEEAGATAIELGIPFSDPVAD
GPIIQAAGIRSLQAGTTLKGVLETIQSFRELTNIPLVIMTYLNPILAYGVENFFQDCEKA
AINGLIVPDLPVEEEALLEEVAAKHCVEIIRLVTLTSPLDRIENIAKKGNGFLYAVTVTG
ITGSRTSFQAHLGTHLLKVKEVSPIPVLAGFGISSPEHVVSMTEYCDGVIVGSKIVQLFS
ENKLEEIKALIAASKKGNTLPAI
>PK3-045_02413 HTH-type transcriptional regulator CysL
MDYHLLTFVTVAEKLNFTRAAESLHITQSAVTLSIKALERKYNITFLDRTNKYVKLTKAG
ELFYFHAKKILSEYKEVNNLIEHLSEKESRPLTIGSSFTFGEYLLPKIMANNVRINNNQE
KPMISIRNSNRIVDQLLRGEIDLGIIDSPLKAHPHLSITPFKEDELVIIVSKNHRFAHQT
FVELSDLYEETWILREEGSGTRQIINQFFQNQAFSPPMIRSFGSIQIIKESIEADLGISI
LSKYAIQKEFSMGSLKILRIKNRPITRYFSYITPEFSFKQHAVSPLIKELTKENKRLYRN
INLGE
>PK3-045_02414 Putative multidrug export ATP-binding/permease protein
MIKRFFSYYKPHKKLFTLDFSSAIVVALLELAFPLAVSWYIDELLPEGNWSSILSVGVGL
LLLYGISTFLQYIVNFWGHKLGINIETDMRGQLFTHVQRQSFSFFDNTKTGHIMSRITND
LFDIGELAHHGPEDLFIAIMTFVGAFWIMLTINIKLALIVIFIVPILVWLITYCNRSMNK
AWGQMYGDIADVNARVEDSVSGVRVVQSFTNEEFEISRFTVNNRRFRKAKIGAYKVMSIT
SSSVYMLMRFFTLVVLVFGAWLTFNNQMKIGELVSFILFVNILQKPIDKISAILELYPKG
MAGFKRFLELLDTEPKIQDRDDAIEVESLKGNIHLNDVSFGYDKNPVLKNINLSISAGET
IAFVGPSGAGKTTICSLIPRFYDVNSGSIKVDGIDIRDMTMSSLRSQIGIVQQDVFLFTG
TLKENIAYGNLHATDEEIHEAVRRAHLEELVLKLPEGYETQIGERGLKLSGGQKQRIAIA
RMFLKNPPILILDEATSALDTETELIIQNSLNELAKNRTTLIIAHRLATIRNADRIVVVT
ENGIEEEGKHDELLERNGIFANLHRVQYQR
>PK3-045_02415 hypothetical protein
MRPIILGIFSALFFAFTFVLNQSMEIGGGSWIWSASLRYFFMVPLLLLIVGWRRNLTAVW
KELRDNPVTWIFWSSVGFGLFYGGICFAGAYGPGWLVAGTWQLTIISGTLLAPFFYEQKM
DGNGRIQKIRRKIPFKSLTFSMLIVLGIIIMQLEFAVSISLKNALFCLIPILIASFAYPL
GNRKMMEVCDGRLDVFQRVLGMTVASIPFWVLLSGVGAFTLGLPGKQQVFQSAIVAIFSG
IIATILFFAATDLVKDNLIKLGAVEATQSLEVLFALIGEVLFLSAPLPSHLSFFGICLVM
FGMVLHSVYSSKKLHINRSMEASS
>PK3-045_02416 5-amino-6-(5-phospho-D-ribitylamino)uracil phosphatase YcsE
MTKRLEDKEIKLIALDMDGTLLDEKGEIPEENKKAIKEAHDQGLHVVLSTGRTIATCRDH
AKSLLLNSYLITVNGSEIWDMNGNLIERNLVDASNIQWMWELAQQHKAKMWAASCEKVWV
DEMPEDINKSEWLKFGYHIEDDKVREQVLTSLNEKKCFEISNSSPVNIEVNALGINKAKG
LKKVCELLDITMDQVLAAGDSLNDISMIKEAGIGVAMGNAQDIVKQTADVVTLTNNDNGV
AYAIRKWALKKEMAGIKE
>PK3-045_02418 Glutamate 5-kinase 1
MEKKRIVVKIGSSSLTNTKGAIDQSKLSDHIASIAKLREYGHEVLLVSSGAVAAGFGKLG
YPSRPVTLKGKQAAAAVGQSLLIQSYNEQLSKFGIVPAQVLLTRNDFSKRDRYRNAYSTL
TELLERNILPIINENDTVSVEELTFGDNDMLSALVSGLVHADQLIILTDINGLYDKNPKE
DASAKRIDYLPEITVEWKDAAKGSGSKVGTGGMKSKLIAAETANSLGVKVFIGKGEGEKK
LIDIIEGKGDGTYIGSDALSSINSNRQWISLHSTVEGSLYVDEGAEMALLNKGGSLLPAG
IYKVEGLFEKGNVVEVYGEKGVIGKGEVLYSSEELKAIITQRAEEKTMIKHPKIEVIHRD
KWVKL
>PK3-045_02419 Gamma-glutamyl phosphate reductase
MGEVYQKGKLAKNASYQLLNKTTEQKNAALSFISKQLIEDQELIIKANKIDLENGKENGL
SSSVLDRIMLDEKRINNMALALKELIKLNDPVGVVVEEIEKENGLKIIKKTVPIGVMGMI
YEARPNVTIDAASLALKTGNSIVLRGSSSAKQSNLALVDTIHRALEKSAIPKEAVQLIED
TSRETAKELFHLKEFLDVLIPRGGKGLIDTVVNEATVPVIETGAGNCHLFIDETAELTMA
LAISLNGKTQRPSVCNALETILIETKWFAQHGLALLEALHHNGVEIYGDETVCTTFSFAK
KATEEDWYTEYSALKVSIKTVDGVTEAINHINTYGTKHSEAIITENIENAETFLSGVDAA
AVYHNASTRFTDGFEFGYGAEIGISTQKLHARGPMGLKALTSFKYFIYGEGQVRN
>PK3-045_02420 hypothetical protein
MEKVKLEINCWQFTPGYVIVHEDWMMLLEYLSILLPIFFIFSVGFIGQKMLHIDIKSVSA
VSVYLMTPLLSFSVFYETTFTIDYLYMTLYALTLVLSIVAIVYIIGFFRGYSVRKTCGMI
LSSAFMNNGNYGTPLVLFVFGEPGLHYAVILMVIQQLIMVTIGVYYAAKGSVDDGNGKDT
LKKVLKVPVMYGAILGAVLHSLHLPIGATMLEAIKLVGNAAIPTVMLVLGIQLANVRLKN
ISYRPLSVSLLLKLIVSPVIAWLLTLVLPVDEILKQIMILLAGMPAAANTTLYAVQYGTE
PDFVSSATFFSTLASLITLPVILSLI
>PK3-045_02421 hypothetical protein
MFNRELVKGSTSLILLQLLAEKEMYGYELVKEMEKRSDYSLQVKEGTLYPALHKLEKQEY
VESFWKESEKGPARKYYRITDTGQQILEQKTAEWKNFVQTIDKVIGRKGI
>PK3-045_02422 hypothetical protein
MISSKESYMKQLRDLLKDHEQSEEICMEYELHLIDILEEIAFEKQCSEEEALIMAIQRLG
TPLEVVAMYQEELNMTAKKTQWNFFFANLFFFVGGIGLTIIYHRLSNPTISKLWSLLTSI
PFFLIVLYLFFWLLLGYEVGKEFGLGGKKLLLKTFCISLVPNLLLMCSVVFKIIPLTLFD
PLLTPEFVLICISFTIMLYPICYLAFRYGTTRSV
>PK3-045_02423 hypothetical protein
MNKKNFIYFISCFLLAIIAEITLFTETIGISLSIFVVVFYVFYFYLTRKQTHTHRLIGIY
LFVCIWLLSLSFVFIANPSFYFFNFIVIFSLIGFHTTLLTSPSFLSWCNTDVFFYLRKKV
SSFFKLGKYLTFLVWKSVNVRSDERNYIAIKRIVLGMVIVMPILMLLIFLLSSSDQHFNN
MMVTIITRLFSFHIDGISTLLRIGLIFVFLLLFMKTISKRSIIIPSERKGKQGRWEQTTL
LTILLFINGLYIFYTIVQFQYFFNDVLLNGFTYATYARRGFFELIIVTVINISIILLVNS
FAKKRTLFLKIFLSCLIAFSFIILLSAHLRLSLYEQAYGYTYLRLFSHSFILLLAVFFSF
TLIKIWMKKIQLMRFFLLFSLLYYCSLNVMDIDRIIVSKNLQRFEETNLIDFLYIDSLSY
SAIPVLVDYYEKNPDMESVKQLLLAKKERLQQTDQKWQSYNIVEDRARKLLNAMELPKKV
PENHEENKYRLEE
>PK3-045_02424 hypothetical protein
MRMEMQNIKNLYQKLDSYCRYLSLDKWEREDLIQEALLKAMENYQDKDITPALLKKIADN
QWIDKIRKKQDIIGIQVKEPRAEEKNLTSMMLAEFLSEKLTFKQGIVYLLVEGFQFRLKE
VGELLNITETAVKSVLFRARNQVKKEAMIVKNQHDEDKENMQRMYYEVLKREDPAILINS
IYKNILLAKEDKKYLSQQPMLIAA
>PK3-045_02425 ATP-dependent Clp protease proteolytic subunit
MSTIPYVIEQSANGERSYDIYSRLLKDRIIMLGDEINDQVANNIVAQLLFLAAEDPEKDI
SIYINSPGGSTSAGFAIYDTMHYIKPDVRTICTGMAGSFGALLLLAGTKGKRYALPNSEI
MIHQPLGGTRGQATEIEISAKRILKLKEHINRIMAEKTGQSFEKIANDTERDYFMSAEEA
KEYGIVDEIISVK
>PK3-045_02426 hypothetical protein
MNIKTNALDNGPFFHGTKAELKIGDLLEPNHLSNYQDKKSNHIYFTATINAAKWGAELAR
STSKERIYIVEPLGEFENDPNVTDKRFPGNPTRSYRSKSPLKIIAELGAWERHSDEEINH
MLESLKKLSEAGKNVIYD
>PK3-045_02427 Ribosomal RNA large subunit methyltransferase I
MEIVTVQIETPFEKNLLNGNPLIYKEAIKANISLEEGQIIDVVTKKNKFIGRGYYAIQNK
GIGWILTRERNIPIDDSFFENRLKKAIDKRAAYFKDPETTAFRIFNGEGDGIGGFSVDLY
QNYLLIQWYSIGIYKYKSWIVESLQRLLEIDGIYEKKRFDDNGTYMEDDDFVVGKKADFP
LTILENGIKYAVNLNEGAMTGIFLDQKDVRKTIRDQYAKGKNVLNTFSYTGAFSVAAAVG
GSLSTTSVDLANRSKQKTADNFLLNDIDLSSQKIIVEDVFHYFKYAVKKQLSFDMVILDP
PSFARSKKHTFRAAKDYTNLLKEAIAITNNGGIIVASTNCATFDIKKFKGFIDAAFHHQK
ETYQIVEQFGLPADFANIKEVTESNYLKVVFIKKLK
>PK3-045_02428 Pyrophosphatase PpaX
MTIKAIIFDLDDTLLWDKKSVQEAFFKTCKLAEEKYKISPVRLEEAVRKEARALYEGYDT
YEFTKMIGINPFEGLWGEFLEEHASFPIMREIIPVYRKDAWTKGLLALGIDDPEFGEELA
EAFPENRKTSPYVYEETFSVLNQLKGKYSLLLLTNGSPHLQNTKLSITPEISPYFDHIVI
SGDFGKGKPDPSIFEHAVSLIGVDKTECLMVGDNLMTDILGANRAGIKSVWINREKAAKQ
DVLPTYEIHHLEELFALLD
>PK3-045_02429 HTH-type transcriptional regulator LrpC
MDKVDIQLLKILQEDARITVSDLSKKLALSRPSVSERLLRLQEKGIILEFSARISPAKLG
RETLLYIQISELKEEPHAFEEFIKTEADIIECHRVTGTVSYIIKAAVSGIDGMRNLVDRL
IPYGTINTSVILASPVPFRHILPNEQSQ
>PK3-045_02430 hypothetical protein
MRKIIVMMFGCLITSFGLFLLKGSAIVTGGTAGLALSISYLLPISFSILFTLINIPFYIL
SYFKMGKKFTLSTILAVSLVTLFSYLLSIILPPLALYSLLGSIIGGFIIGIGTIILFMNG
SSLGGAQILSITLQKQLNWNMGKTNFIFDSIVILIGLYSVGLIRGLYSIVSVFIISFMMS
TFKEKIAKRNTSNANIEKVNSVVETQSV
>PK3-045_02431 hypothetical protein
MKNDFIVLAPFQYMIECTCPRPEHTFILDLHKGDIITITEEKKYVDSLGWLLLVMVNDYS
FFMFIDEIEEFIANKKITSLMDMELRMNYLEYKVNESLDGLNKEQFELFAKELNDLKSIQ
NELALI
>PK3-045_02432 hypothetical protein
MKVKINRHAVKVLNQMLEKAEEGEMIRVYITENHGNHAHYDLKLDKKTEHDEVVQSDKDI
PILLDTRDADFLDGVWIQYFHVPQPGFTIYNPSKEQHHH
>PK3-045_02433 Phosphoenolpyruvate carboxylase
MTTTIKGNESSLPLRKDVKHLGNILGEVLIHHGGQELLDKVEIIRKLAKELRETNNEHTY
NQLKFEMERLDKPVRRQVIRAFSKYFHLVNVAELNHRIRRRREYQLSQEKGVQPYSIDRA
IMAFKQKNLSEETIQEVLNTLSLELIITAHPTESTKRTILESQKRIANILKQLDNPMLTK
KERQHLNDDLFEEITIMWQTDELRQERPTVMDEVRNGLYYFEQTLFDVLPEIHQEVQDAL
DENYPNFEWKVPNFLWFGSWIGGDRDGNPNVTPDVTWQTLHKQNELVIQKYIHAVDELMK
RFSHSTNRVKVSSKLIQTIMEEEQLYLTPEKKWPVEKEVYRRKFSIILERLKEYGKSEKG
YVKAEELLEDLYLIQESFALHQPKAHQQKDLQKLIRQVQLFGFHLATLDIRNHSGEHEAA
IDEILRKVGITDNYKNLPENEKIRILESVLNDPRPILLLNEDYSNETQEMISTFNMIREA
HKKFGERAINVYLISMTQSPSDILEVLVLAKEAGIYRLHADGTVESHLNVAPLLETIDDL
IAGPKIIETLFRMPVYREHLRQHNDQQEIMLGYSDGSKDGGTLTANWKLFKAQREIHEMA
SNYQIGLKFFHGRGGSLGRGGGPLNKSILSQPGETLGDGVKITEQGEVLSSRYLLEDIAF
RSLEQATSTLLMAIAHISKDISEHKEERNLWEDCMEEISAIALAKYQSLVFNDPDFMTYF
KEATPLNEIGNLKIGSRPMSRKNTTTFENLRAIPWVFAWTQSRQLLPAWYAAGTGLTEFA
QQKPANIEILKQMYAKWPFFHSTIDNLQMALMKADLTTAREYSSLVENEAIGNRIYQNIK
EEYDKTRAILLEITGIEELLDHTPSIQESVYRRNPYVDPLNFFQVDLIKQLREQEVLDKE
LLNQVLLTINGIAAGLRNTG
>PK3-045_02434 Thioredoxin-like protein YdbP
MNEIKTVETFEEIINNGDTNIVKFFTTWCPDCTRMDMFIGEIMEANNDKKWYSLNKDELP
EIAEKYDVMGIPSLLVFKDGEKIGHLHSANAKTPEQVEEFLASYK
>PK3-045_02435 hypothetical protein
MSSTKINISPVENTYIRLILAIENMDKEKLVDLGDSYLLKVNKKNKSGNELHFSMLFNKK
LINKVARSTNPTVNITKNKHLISLEITIMLDLTEPIKEENFFWIKKEFASTPAFEISYKM
NEEYFDKKILQHLNKEANEESTEV
>PK3-045_02436 5-amino-6-(5-phospho-D-ribitylamino)uracil phosphatase YitU
MSITYKVLFLDIDGTILTPEDTIQDSTKKAVQLMKEKGLEVFLATGRPLHEISHIGETLA
IESFIGYNGAYAIHNGKDVFRQPMSPDLVTKYLDIANEKGNELILYTNTHNLLSHPEGKM
TKQFSAKFHLKQNRAFTLDEKANILGITIINLREEDISLYEDFPDIHLSQVNIDGFRHSY
DVISDKVNKGFAVSLILKRLGIEKEASIAFGDGLNDKEMLQVVGEGFAMGNAHELLFSYA
KHTTTSVTDSGIYNGLKWLGLIEE
>PK3-045_02437 hypothetical protein
MKAYTIGEASKKLTTTPTMLKQWEKEFQGIIVIPRTKTGARIYTEKEITLLHEVKNLYKE
KRKTAEVKETLTMLLNRPKKEKIVEIKEKSENTIIELLPKKGALEPVETAKSQITEQNFR
LLLSSLENYKQDFLEEVKDEIRNGIKTEVLETISKEIKAGHEETISHITNTVKETQTQTS
EHLDEFSELLHKNAETTTTKYEEIQTKIKKLSQISKAERKTYSKQWTSNVSSAKEIKSMI
EHLSKSNEELNKTVEQLNENDQYFMETLQLEREQLNKEIKQRERSFQELVQTFRHAAAAQ
EKRRSWWKIFK
>PK3-045_02438 2',3'-cyclic-nucleotide 2'-phosphodiesterase/3'-nucleotidase
MKKKFFVSICITFILFIHANPLLTKASDENHKESIFPLRILETTDIHSYLLDYNYEEKKK
TIEYGYNRVASLILQAKKEQRNTMLFDVGDVIKGSPLAEYVASSPMFYSSDIHPAYKSMN
LMGYDAATVGNHEFNFGLDFLLNTLIGADFPYTNANIYVDDHNGYEQDDIHFFQPFLLLD
KILVNDQGKTENIKVGVIGLITPITGVWDKEHLEDKLIIKNMQKTAEEIVPQMKKAGADI
IVALVHAGLYSDQYWPKQGNNVRDISKVKGIDVILYGHSHGIFPVKGEKGPKGVNHEKGI
INGKPTVQAGNWGNHLGIIDLTLKKKKGKWAIVDSKSTAKPIIRIIKNKKIPIVSPMPQL
EYILSRYHQDTLEYINSKQLLNHFD
>PK3-045_02439 hypothetical protein
MGKTLQEIKYSVLDLAPIREGSNAAESFKNSLELIQHAEQWGYNRYWVAEHHSMPGIASS
ATSVLVGYLAGGTSKIRVGAGGIMLPNHSPLVIAEQFGTLESMYPNRIDLGLGRAPGSDQ
LTARALRRYHQSDGSDFPELLEELRTYFKPYEETNLPVRAIPGEGVTIPIWLLGSSDFSA
RLAGQLGLPFAFASHFSPDYTIPALNTYYQSFCPSEILTKPYVMVGVNIIAADTDEKAAY
LASSSQQQFLSLIRNKPTQLQPPVSNMEEMWSTYEKAIVHKQLKASIIGSKDTVTQKLQT
FLEETQADEIIINTQVYSQSERLRSYEIVKNILK
>PK3-045_02440 hypothetical protein
MKTTMKLVNQEKIKQILKQMVDDAYANIKGEEVLLCMECCDVDLYVAAESCEPFIEAVKV
NFELDDLGEIMDREAYHILMRELDEYYVDLHVKSGYYDYFPAGTYKVDGREEESETNVLA
PKGVFYAPFEDAVIK
>PK3-045_02441 Magnetosome protein MamM
MKEFLLLLKNGNRSALLAALVNTVISLLKGVAYFLTGNVAMFAETMHSLGDAANQFFVFI
GSALSKKAPTKRFPGGFGRLVNVVLLFAVLIVGIMAYETIREGLDHVFKPQESTGFLLII
IILSISVCLEFTVLIKAMKEIVATAGLKTRGLQLFSASIAYLKSAKPATKLVFLEDSVAT
AGGILAIAAVIVSEYTNFKQAEGVVSIIIGIFMFIVVGRVFLDNAAGAIGEADLEMQDTI
GNIAIKDPDVRDIQDLAVYKEGEDFHVELSIEIDSKLTVEQVDKIRQRIEKQILSEKGVS
DVIIEFDKDDGILKWPHFISELDKHKKMAEKHTN
>PK3-045_02442 hypothetical protein
MDISMNADEVLLAIQQLRSNGMNMNKKKIKQSHPDLMRHALHYFPDWNSAVEKSESA
>PK3-045_02443 Copper transport protein YcnJ
MNSKKLLMILPFVVLMFSLLGINNVSAHAYITNSNPSENEILESAPERVYIEFNEKIQTG
FKILNVLNSSGERVDKKNVVINPDTEKSMEVDLKSDLPNDIYTVEWRVVSADGHSVSGMI
PFSIGELPDGADFPTQQDSGNLVSFISTMINKGFLYIGFSVFMGLLLFYTFWYRNNKLSA
KLVKRTKRISIIAVLLLAISIISALVIQTQSYAGVSLLASLKPSNLMETLTSTKEGIIWI
VQMILLAILFLGQRFIWAKEAYLDRKHWIIPGLAFIGIMLSKAFLGHPSSSPYETVAIVL
DFFHLIAASIWLGGMIVIILFLREGIFAKEGEGHDLYWGTMEKYSLWALFTVAVLAISGA
VNASLLIPDFQSLVSTAYGKVLLIKIGLLVLMLIFGAYHLVSRLLLRKKDFYKKSIKVEI
TLGILILIVTTAFTQIQTPTLPIDLPFYEEAELGYNENISLSITPKKTGVQNQYEVFVFD
NNRKPIDPVEQITISLKQGDKEMAFPLTKEKEGHYFAENLQLNQPGKWDVEIHVLTDKLE
SLDYSYSIDIR
>PK3-045_02444 hypothetical protein
MKQWKPIDITMIALFVAFMAVGANVTSFLIIGGVPVTLQTFFSILAGLILGKRLGGVAMF
VYMLVGLIGIPIFAGISGGLMVITRPSFGFILAFIMTAFLVGSLIEKKQTVPFYIFSAFI
GLLINYIIGTSWMYMSYKLWYAAPEGFTYQLMWSWMALPLIKDIILTFIAGIIGHRLYYS
VIKKSSFRVH
>PK3-045_02445 hypothetical protein
MKKLKYPFISIFLVSLFLMQLNGPLHTGAEELPSYVKWGRIAITKTQEKYPNSEVTDYLH
VGKEDKKGTSVEKFKLIVNKDQKEIGVFVHLTFDTRTERLLSVDMQETKP
>PK3-045_02446 hypothetical protein
MIGNIQKIMRYPIKSFTGESLEKARIMSYGIYGDRSHAFIDKANNKHLTITQYPKMVTYR
AGFSGEESIEKFPDLTITANDGSEYIWGETALLERLEQETNRTLDSITYAPTFVPFPAIE
EDNLLLISTKALSELSTSFGESIDERRFRGNIVYDLQESGINEQDLLGKKIKIGSDVILK
INKFCERCMIITVDPETGIRQPKLLKQIVKERNNHFGLYASVIHTGIIHIGDEIAIL
>PK3-045_02447 hypothetical protein
MGFTLVRKQKASTFLEKYWVSSISVFVLSQIFFFTSEATGWILKYRDMDGTIFGRLLDSY
IITEWFNFYETPQYNLLTVFFVVFFLVPGIISAIIKIFTRGK
>PK3-045_02448 hypothetical protein
MKIKTRKRNSFFKEVLFEVVGEVVWNIVLFIPRMVFRLISSIW
>PK3-045_02449 Transcriptional regulator SlyA
MNTTHDLFHSIQQLARQLTKQLNTALEPFDIYSSEWAILYVLKKNGPLTQKEIADYLSIE
PPPVTRTIKKLVEKKYVLQIKGEDKRTNRVFLTDFAIQQYAKWEAAVLQANQELLEQLPI
ESRKTLQHIIFEWTHSLTIKEEKN
>PK3-045_02450 Staphylopine export protein
MNKEPLWTKGFIQIWISNFFLFMTFYFLLVSLPIYAIRELNGKQSTAGLIVTVFIITAIL
IRPVAGNLMQKFGKKAIFVTSLLIFLVAAVFYLFTDSITSLLIVRAIHGIGFGMATTATG
TIVADILPSSRRGEGMGYYSMSMNLAMVVGPFIGLQAINSWGTSTLFTLALIFAFFAILT
GGFMKLESDIETERVDKEAEAKKGFQFDRIIESTAVKISIVAAIFGIVYSSILSFVSVYA
EKKGFISVSGYFFVVYAIFMLIARPFAGKWFDRYGANKIVYPCIILFSIGMIILGTAQTE
WMFLLSAALIGLGYGSMFPCLQTIAIQKAAPHRRGLATATFLSIFDIGIGFGSYIVGIIG
DAIGLNSFYSLSSIYILIGIAVYYYLHGKTIRNETTVAKEEQLNTSA
>PK3-045_02451 Cell wall-associated protease
MYKKRKWKTLFALLLTVTLVLSAMPSKEILASEGEISADTLSIGKELSSSFQPDEYVKWF
KIDPKSVVTKATHLEVELNSTEEMNISVYSSKDNAMSDNTFDRYNAVSFMDNKGVIYFPI
AWEGPYYIKVEYYSNTDDEEYIEEEEVPEPNSQFSLKVTDTKQAPTVETEEACPVELSTK
ETKDNQPLLTQLRTIRDTILSSTANGKKLSSLYYQVSPFLSAKMIFNKQLRQDVLTNLNT
LKPIFANLLDNGTSSTYKIGKNEAKAINNLYEIALEASPTALQTKISTLANKVELSNIEG
KTLDDIFTLLGASSSSITNKEINNKYIVKMKAGKTVSSLKNRLGKASAQTIKGLEGSEKI
ADGMFTLELKEGKYTTKSANTLINKIQKAKEVEYIEPVQQYTLLSLPSDVSAPYQWSLKN
TAQTNGKNGADIQFEKLYRLQQSTDVKQMKIAVLDTGVDASLADLKNKITAGYNFINESD
NVYDDNNHGTHVSGIIAAGINNGYSMSGIHTNAKIMPVKILDASGSGDTEQIAKGIKYAV
DHGAKVINMSLGGGYSRVIESMLQYANSKNVTIIAASGNNGYEGLDYPGSSKYVTAVGAS
NDLDIVADYSSYGKELKLVAPGSNIPSLVPNGNLVLYSGTSMATPHVSAVAGLLLSLNGK
LKPKEVEKYLIETTTSIVFKENDNPENEFSEEYPEDLPASSNPIGFDKVSGWGRLNAFSA
FSALKLNAKINPVYNSTRLLTGTAEQGSKVSVKLGSKTYSSSADKNGKFTVEIPLQKPDK
LMYIQLSSKNGNASTSLRTTVQRDTKAPNLPTIQKLGDNDSLMKGTSEPFAYINAKVKGK
LIGKGNADKNGKFAIKIKKQKANTIVSVTAADGAKNTSKPATVKVVDNTPPPMPTITGTI
SNKSDKITGKAEANSTVTAKAGKKKLGSAVADKKGKYTIKIKKQKENTKISVTATDKAKN
ISKAKTITVVDKIAPAKPKVNTITTKTTKVTGTSEKNATIIIKRNNKVLAEGKTNKKGAF
SIKIKKQKEKTSLTITAKDTSGNVSKPVKKVVTKAK
>PK3-045_02452 Mannose-6-phosphate isomerase ManA
MNEPLFFKPVFKERIWGGTALRSFGYDIPSEVTGECWAFSAHPHGQSMVKNGSLAGKNLE
ELWENHRELFGNMEGDRFPLLTKILDANQDLSVQVHPNDDYAKVHENGELGKTECWYIID
CQDGAEIIFGHHANTKDELTTMIAENKWDELLNKVPVKKGDFFFVPSGTIHAIGEGIIIL
ETQQNSDTTYRVYDYDRTDSEGNKRELHIEQSINVTTVPHQLAATTPLVKQQGNMEITKF
VTCDYFTVEKWVLDGQSTREQDQAFLLCSVIEGDGSLQKDGKEFTFQKGDHFILPYKFGE
FELAGKAELIVSYI
>PK3-045_02453 Histidinol-phosphatase
MYYIDYHHHSNHSFDSKAIMMDICENAISKGVNEICFTEHFSVNPNAPTYGHMIWPTYLE
DINKCRIRYQDQLIIKLGIELCEPHLLREQYKAVLAPIPFDYILGSVHNLHGLTLRKYMN
THPDEDIYLTYFKEVLELVTYADIDVLAHFDLMKRYAHPIRGIYHFPDYQEIITTILTTA
IKRNIGLEINTSGWRTSLNESLPSIEVLALYKKLGGEILTIGSDSHRKDDVGAGFMQALN
LAKKAGFTAYYKYEKRKPIRIDM
>PK3-045_02454 hypothetical protein
MTEVRTINWKDDTIVLSVDYPKKIQSEYKVVIMCHGLIGSRIGVDRLFVKASNVLTELGY
LVIRFDYRGCGESSGEYGSTQLSDLIEQTEAIIQFAYDGFSITELILLGHSLGGAVAVLT
AIKDSRVSRLIQWAAVGDPAVDIKRIFGKARLSELAEREVVDFYGYSFFQTYFDSLTDYQ
PLTSCHKFSGDVLLVHGTADEDIPYHYLNKYKNEYLTRNTGTVDSILIEDGVHTFSSGRQ
FLKLINGTVDWLERK
>PK3-045_02455 HTH-type transcriptional repressor GlcR
MAQEQRLVEIIQHLNEHEKITVEEICSLFHVSRDTARRDLVKLEEEQAIIRTRGGALLPK
THRKVDNYHNRLKAVSEEKKAIGKLAASFVRENDHIILDASTTVQAIGSFINQECTVITN
SINLADILSDKQLPKIHLLGGVMQKEHRYLYGNSVIQRLDKYYVDKVFIGIVGISEKGLT
IVDEEDGDVKKKMMQQAKQVIVVADNSKIGITDFYQFANLFDIDLFITDKEPEEWFIQLL
KENGVELLVADRKDGEG
>PK3-045_02456 Phosphatase YwpJ
MITCIVTDLDGTLLNHESKISPENAASLKSAQEKGIEVIVATGRNYPDVMEIFKETGLKT
WVIGANGATIHDPEGKLFDHLPMDKTKAMNLLQWLDERDYYYEVFSNDYLYSPQRGRQLI
AIELDRLCTANPQISREELEKHATIQFAQTGFSYIDSYKEIENPAIDVYNILAFSFDKEK
LDTGWKTFEDDSSITIVTSGTYNFEFEHKDASKGNALAKLANHLGIHLKDVLAMGDSMND
LSMLTKVGYPVAMGNARQDVIEASLEVAETNDQDGVANTIKRLVLSSITV
>PK3-045_02457 hypothetical protein
MDIRLRIKYKPKQLYGEAIRISYDRLGFFIIWINKGCGHSLITNLFEN
>PK3-045_02458 1-acyl-sn-glycerol-3-phosphate acyltransferase
MYAFTSRFANVVLKIFGRTRVINKDKLPQDTGYVVACSHIGWVDVVALGTSLLPNEIHFM
AKKELFNKPNAAKFLHSINAFPVDRENPGPSSIKTPVKLLKEKKIVGIFPSGTRTSEDVP
LKKGAATIANLARVPIVPAAYSGPTDLKGLLRGRKIRVIFGDPIFLKNEDGTKKDPADIT
RELSDVMAQLQNELDKRGGKQ
>PK3-045_02459 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ
MMNLQKVKDILSRYPLPLVDEILELKEGKMAVGVKQINKEDTFATGQNPNNPIMPGVLII
EAIAQVTAVAIHSEEKHRNKFALLAGINHSKIRKPVFPGDELCMEVMVEKVKNSFAKASG
KATVAGELICEAEFLFSFQ
>PK3-045_02460 hypothetical protein
MQTSKTRTLIQYLNTTILGIILMFILIAGITTSIFSFKLTSDNVANILKSVNTTEIYTEI
FHSENHLFPKSDGKGLSIGNILFQIATNIRLDDTRTLLGRELPALTFFHTEIVVAEEGTS
LANLPFESTPSKELMKNPKEVDEEKVEKEDKPSENKAPVTTPKNKTVLVYNTHNLEAYLP
LLKNANENEAVSSDERANVVGLSNKLSSILQDEGIGVQLDKTNINQKLLDRGWNFFSSYA
VSKEVVETAVSENKHLNYLIDIHRDSARKKTTSATIDGKSYAKLLFIIGNANKGYEKNQE
FAKKLHAELQKKYPGISRGVFLKGKEEGNGVYNQNFSDRAILLEVGGIDNTQGELNRSIE
AFADVFSKVYWEENDATQQ
>PK3-045_02461 Tyrosine recombinase XerC
MMITLPDYALDYMENLNQSGRSKLTLKQYESDLKKFFSWLSTYKENTKFETIKALGADDI
RAYFHYLKEKQLSQATIRRLASVLSRLLMYHQCVCAHEIHKLAEAAPLRSLTTKDFITSE
ESNKLLQNLLTKDFEGTKKSARNYLLARNWTIVTLLKTFGLTPLDIHSIKMKDVNFAQGE
LTLHREESGFLLTIPNDILTKLRAYYFSIPEVLRPKYYSNDPVFVAFNNISYSFQYDYDR
QKPKALSVRAIQEMIKDEVKRAGLRKISAVNFRNAAILKELALGVSDEKVMHQFHLTSEA
ALRRYKQYLQNKINR
>PK3-045_02462 Cysteine desulfurase
MIRIKVGESVYQYHTKLEQYFSKIKHNIIGNNLTFSTPYGTQQLLYADWTASGRLYKTIE
EKIIHKLGPYVANTHTESNITGTYMTKAYKEAKRIIKKHVHADENDIILFDGFGMTGVVN
KLQRIIGLKNGCACAKKEKIAVIFVTHMEHHSNYLSWLETNADVIMIKPNDSGDVSMEHL
KSLLEQYKDIPLKIGAFTACSNVTGRKTNYHELAKIMHKYKGYCFVDFAASAPYVEMNMH
PDDKEERLDAIYFSPHKFLGGPGTSGVLVMSKKLIYSSIPDQPGGGTVDFTNEWGDILYK
KEEEEREDGGTPGFLQAIKIALCIQLKEEMGIERIAAREKELIQLAMTELKKINRVRILE
SENEDRLGIISIICEDIHYDLVVLLLNDRFGIQVRGGCSCAGPYGHYLLPITKAYSKEIS
KEIQEGNFSHKPGWVRISLHPTMSNAEVYYIVDAIKKILNYQDEWKKDYVTKPFSCEYHS
IRRDKLQMKDLFTI
>PK3-045_02463 HTH-type transcriptional regulator BetI
MAKPRSEQKKEDIYQAALKLFSHNGFSKTTIKDIAAEAGVSFGTVFTYYENKETLFTECV
NRPLQLFKEIINETKNELTDLTEEKLKYIIRKHLNLFMESEKELRIVQYVIGQPDRFAEI
HALDEFVELFLVYIQEIVHIGMEKGFLPKSNSKEVGYGYLAFLMGARLTYSDHAHAMFTS
TFTNQAYRLFGMEGEYADENI
>PK3-045_02464 Na(+), Li(+), K(+)/H(+) antiporter
MPMKTFSQLHISLRIRMYLQFVTSLTSSAIIPYISVYFSSLIGTTVTGVIVIIVILSGIV
GALIGGYLADRIGRRKMMIIAEAGIGITYLFIAVFNSPRINLPYISAGLFMINLFFNGMF
FPASTAMIHDLVLAEQRKFVFTAMYWLANLATALGTITGAFFFIDYHFYFFLSVGIVSLG
SSLVTYLFIKESLMKNKFLRSDNKSKFTIWSNYLHVWKDRTFMIYLLSCFLIFSLESHLT
NYIAIHLRDTMQDTNLFGILPVNGINMVGILHAENTILVVFCVGIVTWMMKKISDNKQYF
IGMCLFVVSYCILTYISSPLWLIMMMLFISIGELMYVPINQSILADLVNENYRSSYLALN
GLIGQGQMIVAGLAITISTQISALTMSLGLFSFGILGLLLMGYVVKKETNSKKQMNITQT
V
>PK3-045_02466 Thiamine transporter ThiT
MRNMKLVVMIEVAIMAAVALILDLLPSIPIFNTSISFAMVPIFIVAFRWGFKASASAGFL
WGLLQIVFDLQALTFWQVILEYLVAFACIGFAGLFASSIQKALKTEQKGIATGLIILAVV
VGGFTRYIWHFIAGVTIWASYAPKGMSPFINSLIVNGGSYVGATILCSIILVLLLVSAPR
IVLDRPVNGASKN
>PK3-045_02467 hypothetical protein
MINLKNGLGIQIRPYKEDDFQSIHELNKREQWTNLVEKKEDTKSAWNHSNAAYVATLNDQ
LIGYIRGITDRSITLFICELLIAPDYRGIGLGEKLLYYVHSKYPSTRVEMLASSTSNTYY
ESKGFRSFYGFRKTFLEYN
>PK3-045_02468 hypothetical protein
MNNKSNFIFILLFLFFPLIFLISSFGWRYILQQKELMVVATDCFAILGIYYVISSVFFSF
TFKKINLKDL
>PK3-045_02469 hypothetical protein
MTEIKYSFQKKPTKRKLIGGIIIAALLVVISFIMLMFYPFANKDKVEYFKGKNPVLLNGE
QVGNAIIDKGTVYLPLNIWQEKIDESITYDENSNSVIVTTKDKVIQFPSDSVSYYVNNKN
TKLSFHPLRDENGTVYLALDPLASFYPIQYSIVEDNHVVLLEENGQERASGIFTTKKVKN
DFTRLRSEAALRSPYTGELVPGEHVTIEKEVDGFYFVRKANGIAGFVKKKYVDKGKSEVV
EVELEQKEPKLKKINGPIQLTWEAVYSRNPDTSKISKMHGVNVVSPTWFKLKGTDGNVSN
LGSKAYVEWAHKQDYQVWGLFSNAFDPDKTHEVFKDYQKRQTVIRQLLVYSEMYDLDGIN
IDIENVREEDGKYITQFVREATPYLHDAGLTVSMDITFIAGGNYSAFLQRDHLAEIVDYL
VVMAYDEHWATSPNPGSVASFPWVEANLETLLDIVPSDKLVLGVPLYARLWEEKENGELS
SKSLSMESVEEWLKEHKVTPTYDEASGQNYGEYYDEKTKSTFKIWLEDELSLTKRAELVE
KYNLAGLASWSRTFANEAAWSALSLEKKEQ
>PK3-045_02470 hypothetical protein
MKLLKNLNITRKLFIIILVSALSLGTIGYTGLHYIKDMAKDSQEMYEKSLIPISNLMQMR
INTRASNGYTLELLLTTESAKNKELNDQLTATSQETDHLLSEFLKDNITTEEKELVTVYN
EEMQKLNDARKDVISLALQNKNEDAYRIFTTDVEEYRVKVNDTLTSLQNLKASSAEATYK
KNIESVQTVTIIVFIISVAALILLLFISLIISRMIVRPVKQIKDLLFKAEQGDFTVKGTY
QSKDEIGELTTSFNRMTEKLRNVFSTVQESSQHVASASEELSASAEQNSSASEHISLTIQ
ELATGSETQVMKVKESNQVITTISEHTNSIAAHTEKMSENVKHASDMSTEGNKAIQQVNK
QMNSIYSNVNSLSDAISILNERSAEIGQITDVITGISAQTNLLALNAAIEAARAGEHGKG
FAVVADEVRKLAEESTASTENIAKLIHMIQKDTEQTIETMKKASNEVQSGLDIVQIAGSS
FQKIEIAVKNVVGQIEEISNALVKFTEGTDIISHTIYEVSDVAIESANRTQNISAATQQQ
LASMEEISSSSLSLAKLAEELQTIVKLFKI
>PK3-045_02471 putative protein YccU
MVSEAMQKAGYEIIPVNPTVDEVLGVKAVKQLTDIKGHVDIVNVFRRSEFLPEVAAEFEK
IDADIFWAQLGLVHEETFHDLTEKGYTVIMDRCIKVEHAMTK
>PK3-045_02472 DNA topoisomerase 4 subunit B
MAKDQQAFEYNDDAIQVLEGLEAVRKRPGMYIGSTDSRGLHHLVYEIVDNAVDEALAGYG
DAIIVKIHRDNSISVKDRGRGMPTGMHKIGKPTPEVIFTILHAGGKFGQGGYKTSGGLHG
VGASVVNALSEWVVVKIKRDGFIYEQRFENGGKPVTTLEKVGKTNQTGTTIHFKPDPAIF
STTTYNYETLCERLRESAFLLKGLRIEIIDERNNEHGVFHYENGIEAFVEYLNEEKDTLH
PVVSLEGESNGIEVEYAFQFNDGYSENVLSFVNNVRTKDGGTHEAGAKTAMTRMFNEYAR
KVNLLKEKDKNLDGSDIREGLSAIVSVRVPEDLLQFEGQTKGKLGTSEARSAVDAVVSEH
LAYFFEENPEVSSLLIKKSIKAAQAREAARKAREEARSGKKRKRGEAVLSGKLTPAQSKN
PQRNELYLVEGDSAGGSAKQGRDRRFQAVLPLRGKVINTEKAKLADIFKNEEINTIIHAI
GAGVGADFKVEDSNYDKVIIMTDADTDGAHIQVLLLTFFYRYMKPLVEAGKVYIALPPLY
KVSKGSGKKEVIEYSWSDDDLQDTIKKVGKGYILQRYKGLGEMNADQLWETTMNPETRTL
IRVKIDDLARAERRVTTLMGDKVEPRRKWIESNVAFGLEEEGNILENENIMVTEEESPS
>PK3-045_02473 DNA topoisomerase 4 subunit A
MSSLEQYRDLPLEDVLGDRFGRYSKYIIQERALPDARDGLKPVQRRILYAMHEEGNTHDK
HFRKSAKTVGNVIGNYHPHGDSSVYDAMVRMSQEWKVRNVLIEMHGNNGSIDGDPPAAMR
YTEARLSAISAELLRDIEKRTVDFIPNFDDTSNEPTVLPAKFPNLLVNGSTGISAGYATD
IPPHHLGEVIDGVIERMDSPNCTVEDIMKHIKGPDFPTGGIIQGVEGIKKAYETGKGKII
VRGKTEIETLRGGKQQIVITEVPYELNKSNLVKKIDELRLDRKVEGIAEVRDETDRTGLR
IVIELKKEVDANGILNFLFKNTDLQITYSFNMVAIHNKRPKLMGIIALLDAYIEHQKETI
KRRTEFDLQKAKDREHIVDGLIKALSILDEVIATIRASKDKRDAKNNLMAAFQFTEPQAE
AIVSLQLYRLTNTDITALEAEAAELAQKIEEWTAILASEKKLLSVIKKELKDVKKRFVSE
RRTLIQDEIEEIKINLEVLIASEDVIVTVTKDGYIKRTSQRSYAASNGQDFGMKDTDRIL
AKIDVNTTEVLLLFTDKGNYLYLPVHELPDIRWKDLGQHISNIIPIDRDESIIKAMPIKD
FEQNQYLLFFTKNGMAKKTELINYKAQRYSKPLVAINLKGDDEVVDVFLTNGKQEVLIAT
HIGYALRFHEEEINIVGARAAGVKGINLKDNDYVVAGKVITNPLQESVVIVTQRGSIKKM
KLTEFEFSGRAKRGLIMLRELKANPHRIVGMTIAGAQDIIYLQTEKGDIESLKTADLRFN
DRYSNGSFVIDETEAGKIVELWEEKITDEQV
>PK3-045_02474 hypothetical protein
MKTTLEENVEEKGVHRVNENHFEGERRRK
>PK3-045_02475 hypothetical protein
MRREMLVALCAFFLMTLTAITGVYAMEKEDKTNKLILEEKIDITNDEQEETVQLKGDASD
QPENSNFFKEFFLKVTKGKDKSATLTVEGGFDPVLHIIDINDDHQKEILLTVSANERGSE
KNFYFFQLQGNHLIELQKPELASVESQFKDAYKAEIKINNEKTYIFDLYDRRNHYEKLGL
YHKARLNEPTELILSPFSELKVTRFNNQTAMKGKQRISGLATVDTIGYLETWWIWKKEEW
ILEKVKVKEISYKGSQHH
>PK3-045_02476 hypothetical protein
MSLLFLCLSAVFGGWLFQVCQLPLSWLLGPMFSTILYVRLAKNSPNLPFSFRDIGLLVIG
YLIGRQFTNQTLIDMGTHLPSMLLMTVVMLAFSFLLAFTTSKLTHSNLKSTVAGSIPGGL
SQMVAISSEIKGIDLTVVTVIQISRILSVMILVPLLVYSPILYGNQAVAAVTTTSGSPSY
HWMIFLILFFCSLIASKVKKWKFPAPFMIGPMIFVATISIAGMDVPEIPTSLACVAQTLI
GIDLGLQIKFGNIENKARFLSVVTVTSALLVLFSLVLGYILVRVDQDISLLTAFIGLAPG
GMAEMAVLGQSVHANLPIITTYQLFRLLFILFCVPIIMKWGFQRVEKRLAERKG
>PK3-045_02477 Acetylxylan esterase
MLADKIDHYEIINAGINGNNTVDALKRIQADVIQKQPDLVTILFGANDAAFHKMIDLPTY
RKNMKRIVQLIGPDKAILITPAPVDETLQFARTNEVLARYANAVKEVANETGANFIDFYT
EMLSLKDYQKKLKGIHNDGLHFGEAGYAILVDLLVKKIDKIW
>PK3-045_02478 Trans-aconitate 2-methyltransferase
MAYTGSSVYDQEQFFENYRARRNRETSPNNSIESPILSELLGKIDGKSILDLGCGDASFG
IELLEKGAASYTGIEGSKRMFDEASHILNGTTASVYHSTLEDWKFSNSKMDIVVSRLVFH
YIKDLQPIFQGVYDQLNDNGKFIFSVQHPLCLSTFDSSVSSKKRTNWIVDDYFSIGERIE
RWIDEEVVKYHRTIEEYFRLLKEAGFKITDLREGMPKRENFLRKEEYERRMRIPLFLIVS
CEK
>PK3-045_02479 Adenosylcobalamin/alpha-ribazole phosphatase
MKKELRLYFIRHGETQYNIEKRMQGFCDSPLTENGILQARSVGAGLTDIPFEAAYASDSQ
RVLDTAKFAIGNRNIQLTKDARLKEMNFGVLEAMLQTDIIAQHGDIVERLFSFTDMESKV
QDGESFTELLTRTRTAVDDIIAKHKDTGGNILVFSHGVTIGFFIKSLLNMADYPHHDNCC
VSVINVKDGVLMVEKVADPSFRDNGKLSLSLSID
>PK3-045_02480 hypothetical protein
MKATPNKIHIIGSVASGKTTLAKDLSMKLQIPYYELDNVVWKRSDRGDIRRSEEERKANL
QSITQTDRWIVEGVHSEEWVRGSFQQADVIVFLDTNYSKRTYRIIKRYVKQKLGQEKAHY
QPNLTIFFKMFKWNKHFEQVGRPSFFHTYKQYQNKIFVIKNENELSDLFKNND
>PK3-045_02482 hypothetical protein
METNCFICDKHKGIIKTAGIPIYENEYVYVGHIDRKGKGSYLGHLMIDLKRHIPTLAEMT
NDEAKAFGLIISRVSKALKETENAEHIYALVSGNSVPHLHLHLNARYPNTPERYWGPTEL
YDWPEAPIANAEEMSSLCKRIKNYLANEVFEEA
>PK3-045_02483 hypothetical protein
MEYKWVGSDKNYVDEINILHLRNNLVLGRFGGNSSAGQYKNEDGCFIWIEREWELVILLD
AHDSAQSAELVIKSIATKKEEIKTILQLPLKRVFQEITSFFLNHFASKEFLEQCKMIQGE
TACLIVVRKAHYLWWLSIGDCILALHHPELSRLGEYQQNHRSFYEWIGVNSTFHQEVPSY
NQGVKELRKGKTHIFLTTDGLIECPNTDYHRMEAIFQGFDTFSNQESVYYLLKEIKKKNV
RDSTTIISWIVHNNKEDTMPSDFLKGVR
>PK3-045_02484 Glyceraldehyde-3-phosphate dehydrogenase 2
MTISVAINGFGRIGRMVLRNAINDQSIHITAINASYPSETIAHLIKYDTIHGKFPGKVVA
KEHSIFINDQEILLVNNRNPEKLPWRELGIDIVVEATGKFNARDKAAMHLKAGAHKVVLT
APGVNADATIVMGVNDSILNIDKHHVISNASCTTNCLGPVAKVIDEHFTIKNGLMTTIHS
YTNDQNNIDNPHHDLRRARSCGQNIIPTSTGAAKALKQILPHLEGKLHGMALRVPTQNVS
LVDLVVDLEKNVTSEVVNQAFEEASNGKLKGILSITEEPLVSVDFNTTTESATIDALSTM
VIGQNKVKILAWYDNEWGYSNRVVELVKLVGSKLRVKMDSQAV
>PK3-045_02485 ABC-type transporter ATP-binding protein EcsA
MSLLEVKIQSAGYEQKKEIIREINFTIEKGELVGLIGPNGAGKSTTIKSLLGLIEHLEGT
VSYIDGITYSYLPERPIFYDELTLWEHLDFVAAVEGLEEKEYKQKANELLNVYKLAEHAH
ENPTKYSKGMQQKAMLILAMITNPSLYIIDEPFMGLDPNAMKLFLGSMEIEQKHGAGILM
STHVLDTAEKICDRFLMIHNGQLVAKGTLEEIRDQCQLPAGSLYDCFHLLAEDHGNE
>PK3-045_02486 hypothetical protein
MNSRKLFFSRLIRNWHYQWKVLRSIADWTVIVYILVPLGVFCVAIYRSWWLEIPVWIHKI
PFIVPFFCLYFLAWIGNIRTLIVEADKVFLVKQLHLIGRLKALSYFYSLFFQTMVLSAGF
LCLLPFLLHYYLLNWSVILGLFVYFTALQSCFMLWKYHIRKIGSMWAKSLLVVFLFLVFN
WFSQWIYHIVDMGMTIPVYALSLIILLLSIFFSLTALQKIASIDLHIELEQERKTSIVQA
IYLAAPEIEKPVIMRRKKPRIFKNSKRIFQNRTPVNGFIELFIKIVIRNSSYLYGYLMLI
NSTTGAMIIVPPLWLKILIFVGFSIIMNGWLTTLWNKVCHYHPLMKKYMESDAYFSARKK
AVRGMLSFALVLVLFLTCVFGFIIGR
>PK3-045_02487 hypothetical protein
MEPKWLQWAKQLQAIAQAGLTYSKDTFDLERFEDIRKISLEIMSEYTKVNETRIRDLFAN
ETGYATPKVEY
>PK3-045_02488 hypothetical protein
MVKEKTDNSWALPGGWGDIGLTPAEVAVKEVQEESGFKVKAVKLIAVMDKKCHPHPPSPY
HVYKMFIQCEIVGGEAQEGVETSSVVFFAKEDLPPLSIPRNTESQILLAFKHMANPLEPV
YFD
>PK3-045_02489 malonic semialdehyde reductase RutE
MKENEIHTFRQADHEIDPIFLNRWSPRSFLDKEVSEEVLMRLFEAARWAPSANNLQPWRF
IIARTVEERSLFHSFIFERNLEWCKNAPVLAVLISDKQNGMHAFDSGTTWGFLSLQAIKE
GLKTHAIGGFDKAKAREVLNIPEEFDIQVTIAIGYQGDKEALPEDFQAREIPSSRRPLEE
SILQGKYKK
>PK3-045_02490 Beta-peptidyl aminopeptidase BapA
MNGQKRLRDYGITIGKLETGKRNAITDVEGVTVGHATLNNRDTQTGVTAIMPHPGNIFKE
KVIAASHVINGFGKTMGLMQITELGTIETPILLTNTLSIGVTADALIEYMLEHNEDIGRT
TGTVNPIVCECNDMFLNDVRARKIKKDHVFGAIANASAEFDEGSVGAGRGMLCYSLKGGI
GTSSRIIHMEHGSYTIGVLALTNFGTLSDLVIAGNPIGQQLKKKLTQANEDKDKGSVIII
VATDLPVSERQLNRIIKRAVTGLSRTGSIITTGSGEVVIGFSTATKIPHENPYSSVPIST
IHEEDIDVAFRAVGEATEEAVLNSLITATHVIGRDGNERPALIDLLSEHNICLH
>PK3-045_02491 Isonitrile hydratase
MQTDQWKIGIFLFNDVEVLDFAGPFEVFSVTAREDGSKPFIVQTISETGQMIRARNGLKV
YPDYSFQTMPKFDLLIIPGGLGAREREVHNKTVINWIKEQMGEVQWMASVCTGALLLAEA
GLLDGLNATTHWASLTRLKEEYPQVNVVKKVKFVDEGRIITSGGISAGINMSFHLVKRLA
GVKIAKETAKRMEYDVELS
>PK3-045_02492 HTH-type transcriptional repressor GlcR
MNLDFNGKGNSMLAEERRKLILEIISRDGKVIAKDLASKFEMSLDSIRRDLTIMEEQGLL
QKTYGGAILSEPIPKVRTMPPSSIRYGTAAQHENAISKLAVSFIKENDTVFIGGAGIHYG
MVKYLPTDFPYTIVTNSLKIADLIRMKENISSYLIGGKLRGASSSSIIDCIAMEMMRKFS
LDICFLTGGGINAKGISTSTPEAAAFAQTVASVAQKVVCLAPHEKIGREMFMQSVPIEEI
DILLTDLGAPQKTIDEMKKKQLKIKFADLR
>PK3-045_02493 UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2
MRWMNIEGPSKLEGSLSVPGSKNSSLAILAAACLASEPVTLKNIPNIADFKVLRQIGEEI
GCIMERDSRGDVYIDPTKIYNPIIEPEKSRKFRTAYYFIGALLAKFGKVSLGYPGGDDFV
SRPIDQHIKAFEKMGATFTFHEDYYVVEAKKLKGATIYFDTITSGATINSMLAAVLAEGE
TILLNAARDPEVTDTALFLNKMGARIKGAGTDTIKIKGIKSLNGCSYTVIPDRLIAGAFL
ISSGITGGTITVSDIIPEHLTSCLTKLEEIGVGLEIKENNITSFLDGSLKASRVRTAMFP
GFPTDLQQPLTVLLTQAQGKSILRETVYPNRFNHVYQLNKMGASIEVSNGIAHIKGKSAL
HGALVHASDVRAGICLMLAGVIAEGTTTITGIEHIERGYDEAVAAFNSLGAKVSLHHSDE
ITNDLLMMQEFEKIMR
>PK3-045_02494 putative membrane transporter protein YfcA
MNLPMIKEESEQQIQIKRQKIFFCIILIILVSIGLTTAFLGRREGNYQLFTLMLIGLGAS
FIGTLAGGGGLITVPGMMLTGIPIQTSIATNKFSSGIAALSSVFYLIRNKQLSVHFLLIT
ILIAVLGGIGGALVTTNIQEETMNIIAFALLCFALIVTMKNKQWTATIQQDKKQKQQKTI
KKRLYIPFFIAAYDGGFGPGSATFSILFYLKSNFTYMKAVQMTRVIILGSCMGGFIIYYQ
NGFINWYYAICMAVGSIIGSQIGLLVLPKVSQKAAKTLLLIIISALMVQMIVKII
>PK3-045_02495 HTH-type transcriptional regulator CysL
MNLHALRIFITVASAKSVTDAARVLSISQPAVTMQIRNLEKETGLTLIESAGRGIKLTKE
GDFLYKQGERLFDLERDIEGKINKLKAGILDNIKIASTHLPANFLLPSLLAKLKIDNPLL
HIELYSGNSNEAIEKLLRYKVDLALVVKERWEQPELHVTHIMDVDFWFIVPRKHKFAGEE
VSFSQLVQEPFLVRENGSSTRDMLFSLCKIHGVNHPPIGLQFHGLNESIHSVIAGYGVML
APSLAVKEHVLRKEVGVVKVKGVEIKRPIFLCRRNENVELSPLVNQLLDTIRNMDYMK
>PK3-045_02496 Alpha-galactosidase AgaA
MPIFLEKDGKTLHLQNKKISYVLSIEKDKYVCHRYWGRRLESFNGSTQIQMIDRGFATNP
FPEERVFSLNALPLETSTQQSGDHRISNYTIRSHTNQTRTDFIFKKFDIITGKQPLEGLP
TLEGEDTNVTTLIITLYDDIQQLEMKLYYHLYEQLPVITRHVAFLNHGEQEVFLDNAGSL
QVDIAAATFDLLTLYGSHTNEANISRRKLHNGIQKIESTRGASSPQHQPFLALLNPNTDE
FSGEVRAFHLIYSGNFQAQVEVEQYGSSRVQLGINAEGFSWKLSPGGSFDTPEAVMVYSN
LGLNEMSHTFHTLYQQYLCPKSFRNQERPIVLNTWEANYFDISEEKSWKLAETAAQIGIE
MFVLDDGWFGNRNDDTSSLGDWIENKDKLPNGIAGLAEMVKNKGMKFGLWFEPEMTSPNS
ELFKAHPDWIIHTHGYKPIEGRRQLVLDLSNAEVQDFLISVLSEYLVTGKIDYIKWDMNR
HITDIGSTSFPIDQQGEISHRYILGLYRILDTLVNQFPNVLFENCSSGGGRFDPGMMRYM
AQTWTSDNTDALCRTKIQYGYSLLYPPIMMGAHVSSVPNHQVGRITSLETRGRVAMSGNL
GYELDLTEAEEEELLEIENQISFYKQQRKLFQFGKFYRLKAPGEYFESAWMFKNEKEAIV
VYFNGIARPAVPVNYLPVYYLEDLAIYKDVATGRLYSGSELNYAGVTIPRVKEDYKTLIY
HFEKVETQIN
>PK3-045_02497 hypothetical protein
MKHREVAERVAKALGEDNLIAATHCATRLRLVLKETKKIDQAALDDDPDLKGTFEANGQF
QIIVGPGDVNEVYKELISITGVGEATKDDLKEVTAQKETNPVMKLVKLLSDIFVPLIPAL
VAGGLLMALNNVLTGEGLFGPKSIVEMVPGIKGFAEIVNLMASAPFAFLPILIGFSATKR
FGGNPYLGAAAGMMLVMPELVNGYGVAEAVASGQMPHWDVFGLHIAQAGYQGQVLPVIGV
AWILATLEKFFHKHLNNAVDFTFTPLFSVIITGFVTFAFVGPLLRGVSNQLTDGLLWLID
TLGGVGYGLFGLGYSAVVLTGLHQSFPAIETQLLADIAKTGGSFLFPIASAANVAQGAAC
LAIFFLSKNQKQKGLASSASFSAMLGITEPALFGVNLKLKFPFFIGLVAAGVGAAFMGFT
GVRNVSLGPAGIIGFIAISPKAIPMFLIGVVVSFVLAFAATMLYGRKKLNVPSTNSQGTE
TTEKDSTINRQIALSEEIAAPVEGNAVDLTSVNDPVFASGTMGKGIAIIPRLGKIYAPID
GVVTVTSDSNHAYGIQSEKGAEILLHIGIDTVKMAGDGFKTYIKQGQKLKKGDLLGEFDM
AKIKEAGFDSTVMMIITNSSEYLEISSIKDTDIKVGEKALTLIQSERN
>PK3-045_02498 Sucrose-6-phosphate hydrolase
MTDIVSNWTRDLRYKPYSEWDIDYKNALNKSVENSKWRTGYHIEPKTGLLNDPNGFSFFN
GKWQLFFQYYPFGAVHGLKSWYHLESKDLVHWQENGIALQSDNNFDSHGVYSGSAYPIDE
DKLFLFYTGNVRDKDWNRYSFQNGAFMYKDGTIHKFPKPLINQPNETTDHFRDPQIFCYQ
DQLYMIIGAQKQSDKKGAIFLYKALENDIKNWTLVSELAFSDQELGFMIECPNLIFIEDV
PVLLFCPQGLSKKIQSYENIYPNMYTIGDTFDPVKAAITKTTNLQNLDEGFDVYATQAFN
APDGRALAISWIGLPEVNYPTDQEGYQGVLSLVKELTLQDGKLKQYPVIETKKLREMETS
FHESFDTKTNRFELEVIIPENEIVKILLFSNVDKTRYLAFTLDSVNGKVSVDREYAGERF
AQEYGFQREAYVSKNTDIKVNIFADTSVFECFVNEGERVITGRVFPDDSQTLIYLHSKRN
VSGTIWRLNNQKR
>PK3-045_02499 Ribose operon repressor
MVAKLTDVAKLAGVSPTTVSRVINKKGYLSEKTIAKVHDAMRELHYQPNNLARSLQGKST
KLVGLIFPALNNVFYAELIDHLERELFRAGYKTIQCNSEHNSDKEREYIQMLQANQVEGI
IAGAHNLNHDDYTNIKAPIISFDRFLAPNIPIVSSDNYQGGVLATRSLLNHGIQKIIMLT
GSNDVKSPTYLRTKGYIDEMNNAGLQPRVFSINGSFTPLRKSVEIAKILKTEQPEGIFCS
DDMKALLVINEAEKLGLTPPQDFKLVGYDGTSFIEDYFPKLTTVKQPLGELAKLCVELLI
QKIDGVNDQEDRYEIPVKLISGQTS
>PK3-045_02500 Thioredoxin reductase
MLDCIVIGGGPAGLNASLVLGRARMKTILFDDDKPRNSVTQESHGFITRDGIKPSQFKQL
GKEELKKYPDVFFKHQQVTEIKKVNKYFIIFTDQNESYQAKKIILSTGLIDILPDIAGLH
HFYGKSIYSCPFCDGWELKDRALAVLAENDHAFHLTKLLFNWSKNLIVCTNGKKILTKEQ
LDMLNNKNIKVIEHEIDRLYGDKGQLQKIIFKNGEEVDREGGFVTAELQQAVPFAEALGC
TLNKMGGVETDALGRTNIEGVYASGDNTLLTPPQLINAASQGSRAASGVIADLINEEF
>PK3-045_02501 Putative HTH-type transcriptional regulator
MKYSSATNYALHTMVYLTLATKGKTVGVDQLAKIQDLSPTYLSKILTKLVKAGLIESTPG
VNGGYRIIKQAEEISFLDVITAIEGKTSLFTCSLEHDDRKNGECLIENVMLEAETKMREH
LSQKYIRDIANQIEHNAK
>PK3-045_02502 hypothetical protein
MLYLVALSQSVFIVACSAPLPEDPVNLKQSHINPEQKNWQLSSDFITVLVEAAKKGMTDT
SSFNVFTSTIEQVISQWGEPDQTDQVGDGYYAIYKEKDTVFGYTAKGDIYDVRSNKKRLN
RLSLSDLKKKIGDPAEIRIGDGEQIIVYNLSEDIQLKFIILNKTNRVEHLSVYHKPRSIQ
EEYTLTIQGESNQLTNKQWEMMQNWRREIVKFQENKANVYLNGRNKKKISLTFDDGPDDS
ITPRIIEILQQYKVKGNFFFIGSEAEKHPQVVKNAYKNGNLVLSHSYHHVDLSVLDKEQQ
LEEITRAGSALQSLIGKEPAMIRPPYGETNETLMKNAELKGYSIIIWSIDTLDWSQMEAD
NIIRNVTNHLRNGDIILMHSDSEKTETAKALPKIIEAIQERDFQIVGLDELLGIEAYQ
>PK3-045_02503 Putative two-component membrane permease complex subunit SMU_747c
MNMETLLQLNTIFISIIIEALPFILIGVLISGIIEIFVSEELIAKMMPKNPILAILFASL
VGSIIPACECGIIPITRRLILKGVPVPASIAFMLTGPIINPVVMFSTYVAFGNSWRMVIL
RSVLALVCSILVGLALHKSVKQSPLKSHVIEHVHFHSFKDRIEAMFKHSIDEFFSVGKYL
VIGSFIAAAVQTLVKTSTLVSIGTGQASSHLVMMGLAYILSLCSQADAFVAASFRNSFSE
GSILAFLVFGPMLDIKNTLMMLSTFKAKFVILLTGLITVCVFLVTIFL
>PK3-045_02504 Putative two-component membrane permease complex subunit SMU_746c
MFRIFVLIGFTYLFLHLHATGDISKYINMKYAYISESAIYIFVLFTIICVYNYVKKDKHT
HDESCNHCGHDHAHEENSWWKRGLTIITLLIPILTGLILPVATLDSNIVEKKGLYFPAYD
EGDEYSQHQFLQPNTSSYYGKEGYAEVMDKGLDKIKNLPEIKLGEDNFLNDLETIYNYPG
QFMDRKITLTGFTYKEEDLTNNQLFLLRFGIIHCIADAGVFGMLLDIPDELKRENDQWLQ
VTGKLETVYYQPFKKTIPILKVTDWKSINQPDDPYVYRQY
>PK3-045_02505 hypothetical protein
MNISFKKIDNPTDQLVSCLNKWENDPRLIPFIHPCRDKEDAENRVLVTIEDITKRLTNYH
MYAIYLDDILVGEMNYTIDPVHLYKKEQGTAWIAITIGEEVARGKGIGSTSLIYLEEQIK
KQGFNRIELGVFEFNKNAYKLYKKLGYQEIGKNKFFTYYQDRMWDDIRMEKYI
>PK3-045_02506 hypothetical protein
MITVHYFENSTNVLTQLRQDIPNIDEPVKIKGRKGKILSVNQLKEEVYQVNVEFEKVVKK
AVLATDNKKRKR
>PK3-045_02507 L-lactate dehydrogenase 1
MLSNKVSRVALIGTGFVGSSYAFALMNQGIVDELLLIDLNKNKAFGDVMDLNHGKVFAPN
PISIKYGEYKDCAEMDLVVICAGANQKPGETRLDLVEKNLKIFKSIVEQVMASGFNGIFL
VATNPVDILTYATWRYSGLPKNQVIGSGTILDTARFRYLLGDYFKVAPTSVHAYIIGEHG
DSELPAYSSADVAGIPVYKLMKRAAHYKMEDLDNIFVNVRDAAYKIIEGKGATYYGIAMG
LVRITKAILSNENSVLTVSAYLDGQYGEKDVYIGVPAVINREGIREVVELELASDEQEKF
HQSAAVLKDILKPHFS
>PK3-045_02508 hypothetical protein
MDWKKYLLIAAATFLILFSGIVTVLLFQANKVEADKEKGNSVNSESNVTTESGQGNVNIS
VTNNIQNIVSGESKATIENKVKNDLEDKEATIDNSIENKTENEASVTINNAIENLLKGQV
NGTTNNNITNNILSSNKAELANNILNDLDLNVDVNVSNEVNTNGKKESSNNDNGDTNDNG
NNKEDNGKEENDGKETNGNEENKEKTSYLWGIDSASETTQDFLACVRDNFGNPKVIARYL
GTNEGVSHGLTADQVDLIHSNEADILLIYNGFTDATGYDNGVSEAKKAIELAKELGAPDG
VAIFADIEPNYPVDAAFIEGWYAEVSKSIYKPAIYGIFDKDEALTVSFNEAVKNKEEIKD
NTFLWSASPNIGITTEEDAPKFKVDAPEESLAYGWQYGINDQTCNIDTNLFDSKLTNVLW
KQ
>PK3-045_02509 hypothetical protein
MPKKRRKRNPIKLCLPGGYRYCGPGCSGPGAPINYVDSCCRRHDQCVETYGSCRYCDEKL
LHCVQSKSRERTQEGKTARLISDFMRFRLEINGGWRGRRL
>PK3-045_02510 Endolytic murein transglycosylase
MKPSIITSFAAGVLLATSVSGIVYFSTKDDTANAKTNNNVQKVDKVASDAANTPTVEEMK
DILTSSGYVVQTSDEAKKKEDDVKKQASKSNTSEEKKDDKDKKEEDKKKEEVKTVTVKVS
SGMTSYDVGSILHDEKIIKESALEFSQKVDKKGVAEYLKLGSFKIKSDMSTDEIISTIFK
KRS
>PK3-045_02511 hypothetical protein
MEWTLAILFIAAAILLITSVIKAKQTSKSEQREIDVIHLSVMEEIAQLQKQIRHLELDIE
ILEKQTGVQLASKDRMVLREVLDLHRRKYSVETIAAQKKLTQAEVEEMLAPYLTGKEERR
SVLQ
>PK3-045_02512 hypothetical protein
MNENDTPSLDFFRMLVEHVSDWIWQLNEHWQFTYSNSIVEDILGYSSAEILGQSLFSYIK
ADEIPTLKTIFSTAKEHSKILHNMDFTMIHRNGYDVLIETNAKPIINSQNKAIGYRGINR
DITLWKKNQERQQQLLDIIEASPDFIATADSKGNTTYLNPSARFFLGISESTEDLQSVNT
QLWTNKFVELNENGISNEKSIWQGENVLCNALGKQVPVSQTIVSHKATYQNVHFLSTIAR
DISERKAYEAIIKRQALYDTLTELPNRRYLYKTMTELIEVQNESHSFALLFIDIDDFKQI
NDSLGHKYGDRALKLIAARMKGSIRETDFLCRLGGDEFILLIKDMNTEHELENYAKRILA
IFNHPLRMDNKLYSISCSIGISIYPYHGKDIETLMQNADKIMYHMKKSGKNGYQITKQ
>PK3-045_02513 hypothetical protein
MDSILYYIALGLSLAAPIGPVNAAVINRGLRYGFHHAWVLSLGSLLGDVFFIILVYFGVA
KLANIPIVQTFLWLFGAFVLIYTGIEGVMTKTSTISSRGKDNNSMLRSFVTGLLMSIMNP
LSIIFWLGIYGSILASTIHNFSTSTVLLYTGCMLFGVAIWDITVSVLSSFFRNVVSEQLI
TFVSRISGLILVLFGGYFGIRGIQFFL
>PK3-045_02514 putative metallo-hydrolase YflN
MAELKGIEILTIEKNSFVIHPTLIWDEKQTLLIDTGMPGYMEDINLAMAKANKSLEDLTG
ILLTHQDIDHIGSLPEILTACTQHLTIYAHEGDIPFIEGDIPLLKANPDNFNEKEWKSLP
DSLKFIYLHPPKAKVTASLQNNQLLDIDGGIEIIHTPGHTPGHISLFHKRSGTLIAGDAL
IAANGRLQHPNPVHTPNMKLAIQSLKKFLAYPIKQVVCFHGGMVTENIQEQLEGLVQTKT
L
>PK3-045_02515 Chaperone protein HtpG
MIETKEFKAESKRLLEMMINSIYSQREVFLRELISNASDAIDKIYYKALTDDSINFEKDN
YFIKITANKENRTLTISDTGIGMTKEELEANLGTIAKSGSLAFKMENEAKDGHDIIGQFG
VGFYAAFMVADEVTVITKSLNSDTAYKWMSKGADGYTIEETEKSTIGTDIILTIKENAEE
EQYDEFLEDYRLKSIIKKYSDFIRYPIKMDVTTSKLKEGTENEYEEVSEEQVINSMVPIW
KKNKNELTEEDYQNFYEEKRYGYDKPLKHIHVSVDGAIRYNAILYIPEKTPFDYYSKEYE
KGLELYSNGVLIMEKCADLLPDYFSFVKGMVDSEDLSLNISREMLQHDRQLKRIEKNLTK
KIKSQLLSLLKDEREKYESFYESFGRQIKFGVYNDFGMNKEMLQDLLLFYSSKEKKLVSL
DEYVERMPEDQKFIYYAAGDSIDRIEKLPQTELVADKGYEILYLTDDIDEFAIKMIATYK
EKEFKSVSSGDLGLDQEEEKEEKEVTEENKALFDYMKEILSGKVKNVKVSTRLKSHPVCL
TAEGEVSIEMEKVLSMMPDNQNIKADKVLEINKNHEIFQSLKEAYEKDKDKVALYTNLLY
NQALLIEGLSIEDPVEFTNNICKLMK
>PK3-045_02516 Catalase
MTEKKDMNNKKGQDQDRETLTTRQGHPVLDNQNIRTIGNRGPATLENYHFIEKISHFDRE
EVPERVVHARGSGAFGYFETYGKVGNEPVEKYTRAKVFSGAGKKTPLMVRFSTVAGAKDS
PETARDPRGFAVKMYTEDGNWDLVGNNLKIFFIRDAMKFPDMIHAFKADPVSNVPNPQRM
FDFVSRTPEATHMITFLFSPWGIPATYRHMQGSGVNTYKWVNEQGEAVLVKYHWEPKQGI
RNLTQEEAESIQAKNVGHATQDLYEAIERGDYPEWELYVQIMEDDYHPELDFDPLDDTKL
WPEDKFPWLPVGRMVLDRNPVDFHTEIEQAAFGTGVLVDGMDFSDDKMLQGRTFSYSDTQ
RYRVGANYLKVPVNAPKAPVRTNQHRGQMDVRDPKESGDNPHINYEPSMLGGFKEAGKEE
RVPHQPTYNAAAMSAPIDRPNNYGQAGHTYRSFEDWEREELIKNLSEALAICDKKIQNAM
IEHFTQADEDYGRRVKEGIETKMKEMKEMAKENVPGREAGQSKYGQGTIDANEATKDAVK
KSHEADPY
>PK3-045_02517 hypothetical protein
MDYIITEELPPFIKFARLHEDSGLLKNKKGNYTREQLYKAAKNSWYSVSIYNDQKLIAFG
RMISDGVYQALICDVMVHPDEQGKGLGKQIIEKLVSKCQQSGIQSIQLFSAKGKHPFYKK
LGFIEREQDAPGMSLHL
>PK3-045_02518 hypothetical protein
MKLSKEAETFVENLYLYLLTTGKKEKEIKEIVEELTDHLQEAEANGKNISEITGDSPKAY
MESLAKEMQTDLIEWGKLLPHVFISLIAYTLIGKVILGENQISLLVGLGSLLISVVMLGM
YVVIFRFISSRNVSNKKAFAIIFPLQLLIIGMFIVLMFYGNNYGPVYMIDTVTKQLLFFL
IPFVYLCWFAWWSKSWVVFFPVILYLPNLLVKPLPMSEEMKTITSSVIFFVFLFGYFIWI
IWQGKKAQKST
>PK3-045_02519 hypothetical protein
MSKSQMLKGVLEGCLLAIISKGEIYGYEMIEKLEAYGFTMISEGSIYPVLLRMKKEELVT
VETKASPSGPKRKYYSLADKGTKVLDEFADTWTELATSVHWLLKDIREEK
>PK3-045_02520 hypothetical protein
MKKVIKILFLPFLFLITACSTDPVREDLLEYVNEDMKTAFELEVKAVSAYDSVSGINYTD
DWTMYDTIQTTVIPNYNEFIKELNSVQVETEELREIHEIYIEGADTQYNAFVKILTALET
QDIALIEEANAMLEEARKLIRQYMNELDKLAKEHEVEWDDNTVSESL
>PK3-045_02521 Arginine/ornithine antiporter
MNTKGKLGLGILISLVVGNMVGSGIFMLPRSLAEVASPAGVILAWLLTGFGVLVTALVFG
NLAIRKPKLTGGPQIYAKELFKRGSKKSTLSGFMSTWGYWIGNLAGNVAIITTFAGYLST
FFPILTSEAALINIGSFTLYVGNALTFLVCTILLWGTHWIILNGLENAGKLNILATSAKV
IGFMLFIIIALFAFETSNILPFAEPKVNASGHSVGLFGQINSAAITTLWAFIGVESAVVF
ASRAKKQSDVKKATIIGLLIALAIYIGISTLVMGILSQNELIASQKPLIDAIETVLGPIA
GKVLAAIGLISLFGSTIGWIMLSAEVPYAAAKQGIFIPAFLKENKKGIPTFSLVVTNILG
QLFIFSTVSKSISQAFDFIIYIATLSYLVPYLISSIFQLKLVMSGETYTSMKSRRVDFVI
GIIATIYSIWVIIAGTADIKTFSFGVLLLLSGIFFYNQLNKGTKPE
>PK3-045_02523 hypothetical protein
MKKKFLITGLVLFIVIFSSFYAYASTLSISGKSDNGMWKYTYKKNLDLSEPTGWQGKLKQ
LDKQKVEVKELTFTDNDEILAQTDSFVEGTDIDGSVTTLHPFATEFYLGNSPKRGHIYKM
AVKWQKEGETYEDTFTIH
>PK3-045_02524 Methionine aminopeptidase
MIVKSEQDINGLKEIGKIVSIIREELIKNTVPGVTTKELDNLAGKLFAEHGAVSAPQEMY
DFPGYTCISVNEEVAHGIPGDRVIQEGDLVNIDVSASKNGYFADTGKSIVVGNGDPKLIK
LCEVAQEAFEEGLKCFKPGAKKNRIGKFVYNTAKKNGFTVIKNLTGHGIGTSLHEKPDHI
LNYFDSWDTELLRDGMVIAFEPFISTGSEEVDEGNDGWTFTTKDKSYVAQYEHTVIITKE
KPIITTL
>PK3-045_02525 hypothetical protein
MFSMTILLSYILLGLTLAAPIGPVNSARIDKGIKNGFWHAWIVGFGSMLADGIFMIMVYI
GMVHFLEIEIIQIFLWLFGGFILIYTGMESIVGAQHLKLDSLRGKDSLFKCFLTGFIMSI
TSPLSILFWLGIYGSILAKTAQENGTSSLLIYSSMIFLGLTLWDLIVAALTNGFRRFLTL
RTLRGISIISGASLVIFGVYFGYQGMMKLFFSS
>PK3-045_02526 Glucan 1,4-alpha-maltohexaosidase
MENQTLMQFFEWHLDADGQHWNRLKEKAGELKEAGIDSIWIPPVTKAASNEDNGYGVYDV
YDLGEFDQKGSIRTKYGTKKELLEAIEACHNVGIQVYVDVVMNHKAAADEKETFKAIEVN
PENREEEISEPHDIEAWTKFTFPGRGDTYSSFKWNFQHFNGTDYDNKTKKEGVFRIVGDN
KMWNSNVDDEFGNYDYLMFANIDYNNELVQNEMISWGKWLYETLNCDGYRLDAIKHINHD
YIKKFATSLLKEKDDFYFVGEFWKADLQECQEFLEQMDYKIDLFDVPLHYKLHTASMEGS
NFDLTTIFEGTLVKENPLNCVTFVDNHDTQPNESLESWVEDWFKQIAYSLILLRKDGYPT
IFYGDYFGISGDEPIDGKKAAIDPLLYVRKKKAYGKQDDYFDNPNIIGWVRHGEAEMEKS
GCAVVISNKDDGNKKMFVGESRSGEEWIDFTNTRKDRVTIDEDGYGEFPVNAKSVSVWGL
AD
>PK3-045_02527 Methyl-accepting chemotaxis protein McpB
MRKILKRFHYSMTIKKKLYASFFVLLFIPTIFIGSFSYFNSKNQLEEEIMDNASQQVKRL
DENINSELSTKIKQVDKLRKDWGEESKPVSNEQILATLEDYYYFYDDIDSIFYATKQGQY
IQKPDRQMADNYDPTASEWFIKAEENPEEIYISDPYISASTNEMVVTIAGSTKDSDKVIG
LKIKLSAIQSIVSNVTIGKKGYAFLIDENNAYMAHPSEKIGEIGTENYIEQMNRKEYGTF
TYSLDNKEKKLTYLTNKLTGWKIAGSMYAKEVSEASSPILKASFWAIILFVFIGSILIYF
NTQSILKPLNQLKEKAGLVGKGDLTQKLIVKRKDEIGHLTSSFQKMQDSLRHIIIYMEKS
ISQVAASSENLTISSTSSTKVVEDLVSVTQEIASKADYQKQQIEANSTKLKEITERTGFI
RENSLSMSNLSTMTVEKAKEGERAIYQAEEQMQLIVESVNKSDKQIDDLNKRSKEVESII
QLISSIANQTNLLALNAAIEAARAGESGKGFSVVAEEIRTLAETTQHSATEIEHLIKGIQ
TDTHSTVDRMKSVHQQVDGGLSIMSSVKSAFHSISTSMNETTPIINRVTISSEEVYQHIK
LLSETFDTLLLFSKQNAELSEEISAASEEQLASFEEVSASAITLAETADHLKNLISQFHY
>PK3-045_02528 p-aminobenzoyl-glutamate hydrolase subunit B
MGIAAGIGLSKVLSETGGKVIVYGTPAEETKGGKVTMAEAGIFEELDVAMMVHPLDNYMT
SGDSLAMDAIQFEFFGKAAHAAASPHLGINALDAVLQTFNSINALRQHIKSDARIHGVIT
EGGKAANIVPDYAVAQFYVRAGKREEVNKLVEKVKQCAEGAALQTGATVKSSFYEFSYDD
MITNQTLSDLFTKQLVDLGVDASEIQEQRDGSGSLDMGNVSQVVPSIHPYVKICNEAYAC
HTHEFREAAMSDQGRDAMILGAKSMALTGLEILTNKELLAEIKAEFIKNKN
>PK3-045_02529 hypothetical protein
MNNIKGVKIGEETIVVNSYYGLLEPEEISLFSVTKEKGSASVLVTGYTADKSVIFKKYST
DVTVYYK
>PK3-045_02530 hypothetical protein
MGLFSKKSKDDKEKIINKLDLRLISGASLILNKKNASNDQYVCFRQLENDIIKVHLLLNK
SKAKKYYLTNVEWNFQEGRSGGKIAGGAIVGTLVAGPLGTMAGAGMGSGKKDQSVAQVTL
FDIDEKRELTIAVKCTVDEYSILSSMISIHHSEKQQKIDAASEIRKFKELLDDGIISAEE
FEDKKKQLLDL
>PK3-045_02531 hypothetical protein
MNEMTKECFACGNTNEEEIEFKTVIIDDGWKEVKKEAWACKDQVDCGKRMFGYKN
>PK3-045_02532 hypothetical protein
MTLTKPKKVKKPSRPSRDEFELEEIANTLTEALEDNAELRLTVWKREDPIRGKVVKMDGN
TKLIHIERFTETIKIPFIDILQVKRV
>PK3-045_02533 hypothetical protein
MKGLLKRAVMNGEVLEMIYLNTKGEISQRRIKVIKLNEESFSAYCFIRKQQRTFKISNIL
SVGPVRKVRRGA
>PK3-045_02534 hypothetical protein
MLRDRGTKKWVAMMLPEHVAGVKEVIESQNKIEQPELDEDKLNDIDILIHEGMEYNQLLK
YSLYNNGYINTLIGRTVYIDYLNNQLRIQDEKDQIHYVSFRKLVDVERA
>PK3-045_02535 hypothetical protein
MSRLSEEERDIFENAIYLPMLLTVLDRDYKVAETAPFKLNQVYINLIEHTMKKVQKDMRE
NKTKMYKCKWKLVKGENDGYFTEYNFYFNGYHEVHRYFNDNLRNNTEKLLNQYFLHRH
>PK3-045_02536 hypothetical protein
MTDYDLLLQLKEQYESAKDSTELKLLIETFLNNFPEDQ
>PK3-045_02537 hypothetical protein
MTKILGIDVSTHNGKPDWAKVKADGVKFAMLRMGIGSDISSQDDKEFERNVSECDRLGIP
WGAYLYSYALNVNDAKSEVEHAKRLLKGKKPTYPIAFDMEDADGYKKKNGMPSNSTLVDI
CETFLSALEKEGYKVTLYASLSWLNNQLNSSKLDKYDKWVAQWGPKCTYGGEYSLWQYTS
DGKVNGIDGRVDMNYSYKDFAAKSVSETKKETKKEVKTEVKSKTASVKTYQVTKQYNGYA
TAGDAKSKKNKKTTVPKGKYYVFNESQGMINVTTKKGVPGSWINPSETSAKATNPEYYVV
KNNDNLTKIAKKYKTSVAAIQKLNPSIKNPDLIYPKQEIRIK
>PK3-045_02538 hypothetical protein
MEQFQSQFFLLVAIAAILVALVVAVVHVLKTAFNISNRYAPLLSIAVGLIIGFVTYFLPA
IEFSLMQMVFAGFIAGLAACGAYDLSKVKK
>PK3-045_02539 hypothetical protein
MPTQEVPKTMEEKVENHEERIKALEDYQQKQEKLNNEIKSQLFATENTVLKESGKQQDLV
QKLLDHVLEEDKEDRKSSRDRKTYTQQQIWKALGIICGSGGILFLLIKSYFNL
>PK3-045_02540 hypothetical protein
MKELETRVMEDDFSGFLSDLVEYKRIDDSAHVGISTLVLDKGFESLSDKQKFVFIKFVVQ
PNYVSECDRCAIDIPWSEMLDALDEGDNYCGYCRHMEAKDI
>PK3-045_02541 putative poly-beta-1,6-N-acetyl-D-glucosamine export protein
MSKKIINEVYWLRAIACLAVVTIHSVNETIKNNKTIMSDYESTMLTTIKFIAFFGTPIFI
LISELLLSKSYPNGLPKGFFKKRIKYLLVPFLLMGIVHGLIISNGSPIPQIIRNIFLGGY
TGYFILIIFQFYILHKLLTNYLAKKSPILMIVSAFIINFTYLAFFNFTSPPEVTGAHYIW
FRGYWFPFIGWIFYFVIGYYIGINYEKVKSFVTKNSIKIYVLPLIFLVVLLISEYYNFIE
LESSKRIDNLLYTLSMVLLIMLIGSKFKKVPKIILIISNYSFQIYLIHKLILYLLPTNTL
IEPLLYFIVSFSISVFLSILLSKFLYRFKATSYFLGQNPDYKIKPTKI
>PK3-045_02542 hypothetical protein
MFDLTIDRVVIYNGEEYQVVESLESNHLLVVKLEEYEKGIYPMSTCIIPGS
>PK3-045_02543 hypothetical protein
MGSITKYLNEIITAVKGVDTRQAMHDAIKQVYDDAAQSGNANMEVTLARGTEPNLNARLN
KMDEVAETNTKQLATKVSRINYDADKSYLDARLNALTSQWGQPFQSFEDLKNALPSNDGK
LHPINDDDSWYFWLDGQGWTAGGKLNTALLADRSVTAKQTDFLNTVSRINYFNKNDILIN
KFYNYETGELSSSITASGSNLIPVKNGDIIRFKSLTAGNYQWVIFDSNKNFLGGGLVSDP
GIDVINTVNISKENAAYFSIAFRNSEIDQFMLVKNISFPAYYHEYYTDEEIDSFSAELKE
SVSLGKSMTQILSSIPSKGITAKMVSFLDSLEVVNLFDKNNIMVNSYYAYNTGEITTGIT
ASGSNLIPVKYGDIIRFKKFTEGNYQYVFLDENKNYIKGGYLTTLTVGQVATVNIDDENA
KYYAMAFRNTEIDQFMIVKNREFPDEYYEYVSEEDAAGYESKLSEEVSIENHLKEIKENM
KYWFSPWYGKTIVFNGDSITDPNYNASLTFRYPEVVRDTLGFTGFYNYGISGSTLAVNPN
APTERNPFVTRIEEMVVGDVNYFAFGSNDAKYSWTPIGDMDSRDVYTFYGALHLACQKLI
KKCKNKVIIFATPIMRRQDNLSSPTSVNDYGKTIKDYGDIIKEVCGYYGIPVLDMYHESG
LYPFDDEVALEYFLQQGSAGSYYYTHPNGNGQLMMGRRATGFIRQLA
>PK3-045_02544 hypothetical protein
MYIVSILNGEDSIVIHHPHLNELKVQDGTIKKGINTVDSFSFSILPQNPGYDRIFLRKTH
VNVYNTKTNKYEFKGRVLIPTNKMTVDGIFRKSFLCESKLGYLYDSRQRHGEYHNMTVEE
FLRVILDNHNKQVEPFKRIKLGIVTVTNSTDNVYRYLGYESTLDTIFDKLIDRLGGEIQL
REEDNGELYLDYLTEIGSVKNTEIRLGKNLKSIEVEADPSQIISRIVPLGATIESEDETA
TDASQARITIASVNNGLDYIDDQESIALVGIQEETVTWDDITNPSILKTRGQQYLKANNR
VKKQHIISALDLSLIGLDIDQFDIYNYYPVKTPILQDTLRIVGKTVFINEPEANDLTFGD
KLKKASEYQNEANKAQYKVVELQNTISQQTNRIGSISTQLTNTINELATTKQTLELTQKQ
LQNFETVTDGDISAISQSVSELLGAITEIEIAINNLSQVVSAEEISQMKTNIQSNSQNIT
NNTNAIDSINQSILLINQAIEDLTNRVVALEEGGQ
>PK3-045_02545 hypothetical protein
MSRFGITFNGKHSFNDFGLTVASKNIGNPSKIKRKERVPYSNQIYDFSNLYGGQEYEERP
LTYVFNLRSYDKIDLSFMKIEVLNWLMNTNGKVILKDDYIPDYYFMAEVEDAPDFNEMKY
GGTLTVNFTAYPFKIAELREGHDIWDEFNFLLDYAQDTSFTVNGSLDVTLYNPSAAVLYP
IINSSAPMQIIKDGITYNVQTGKTTSYDFFLPLGESKLKLVGNGSIEFEMYKELI
>PK3-045_02546 hypothetical protein
MAADGSVVIEITLDDTNVSDQISDIDHAFQQVGSSFPQTFNSHMQRIRQSLGQLRTNISN
TFSAAANSIRNVFSGGNPFLNMFTGLRNVASNTVSRMASGFSNGFTRIRTAASNSISRMR
QEFANLDRSVESPLKSMLKMAATITGITGLMNLMGRAISRVDTIDTATKSLTVLTGSAED
AKLVMNDLVDAIDGTPIALNDVALGAKKMVAAGMKAEKVKPVFKSIADAAYGVGDGAQSI
DQITSAIASMQSAGTVYADDINRLVDAGIPAWQMLANQTDQSVADIKKFTSKGLLESNDA
IDMLVNGIQNGTEGVAGSTAAMAGLAKTAGDTISGSFGNMRTAIVKIMANVADVLKGDII
NALKGLTSAFKAVASVTGSETFANGLRGMVDVLKLLSPALLGVVTALAVFSAYMGLTKSV
GLLRVAIGGLLTTITANPIVAIVAALAGLAVMLVTLYKTNETFRNAVQKTWSFITDIYEK
SVEGIKTALASIMPGLQAFGSWSADKLIAGFAWLGSVGVKAIGAISTGLAIAGDAISSFF
DYLANSAVGQAVLNALKLSFENITNVLLTLVPFLSRLALGFIGVTGPLGLVISLAITFAA
TLLKMGGFSAEGINKALKDIGKMLMGILDTALVLIPQFIKIGADLIVKLMEGIAQSIPKL
VSVAEQLMNMLNEAITTYLPMIIQAGLQIITAIADGIVQYLPMMINALISIVTFLVDTIA
QYLPTIISVGITILTNLLEGILTVLPEVINTAILIITSLLGILIDNLPQILSAGIDILNA
LIGGVIAALPALLTAALTIIISLATALLDNLPQILSAGIELLMALIDGIISILPMLIETA
LTLIITLATALINALPQIIAAGIKILNALVDGIIQLLPALIACALKLIITLAGAIIKNLP
QILSAGVKILKMLVQGILSIIGTLLKAGADLIIKLAKAIGDKLSSIKDKGKEITGKVVDG
ITSTISKMVSIGEDIVSGIVEGIGNGFGWVKDKISSLGGKITEWASGVLGINSPSRVMRD
EIGKWIPAGVAVGIDADASKVEKSMDKMLKIPTNYTAEAAVGINNVGLLDKLKATVNASS
IINNNYDDSKVTKLLKRIADKDSNVYLADDKVGSFTDKDLAMRTFKASRRLAT
>PK3-045_02547 hypothetical protein
MFSLARKLQNSIDYNGVTYELNLAFDNVLLVFDVLKDDSLNDLFKVDVVMDLLLTHPHEL
EDEQMVELYTLIMETVILQGKKQEVKRDLAGNVIDEDEDDKKLYSLEEDAQYIYASFLYD
YNINLFKEQGTLHWFEFNALLASLSDDTMFKRVIDIRQRKPNKHMTSEEKSNLMKLKQLY
ALKKSQEEIEFEAMDLAEKQAYIKQKMAERGE
>PK3-045_02548 hypothetical protein
MSININLSNQSIIPVRFGEFDFNVDISDAGKQKLMGLIEEFDNRNTDIGEVKDKESFAKV
VEETKSILKSIYDPLFGEGSFDKIYNKYPDVTLLSNSFIDVANGVMAEYEKRTRREQKDN
YVANLKK
>PK3-045_02549 hypothetical protein
MPFHLNYLTTYKIGETKEELLPLAAGISTVDPSNEESTEEYSYYDGAGGTETETTGLTSS
YAFSGNRKYADDPAQELIRNKLFTLGQGREVYFQVTEPDGRVIEGPATLQEITPHGGDAN
ARATFEFTVTFKGLPSDTKPGETQTTEE
>PK3-045_02550 hypothetical protein
MTMDFLERLVYLLDSQKYYSTVLSPVLGTGNSIAVTTLPSRTYQYYMDGSYSQGYAFQIS
TKHDQQLVAYNTCQLIVDFLKDRKSIPSENHSYEFEGIDIQTSPNLLMKDDKYYIFTAQL
SANLLVYKGD
>PK3-045_02551 hypothetical protein
MSVNIQTNLSGIALIIARAKERTQFALDNQVLKDNNEFIPADTWNLRDSSISHSVIGQGI
LKWSTPYARNLYYNPQYHFSLDKNPKAGGLWHERAKAAYGTDWTKLAQREMEDNL
>PK3-045_02552 hypothetical protein
MNIPPIPKKLLIHTIEYEEFVRDGSFGEEFAQTETISFVLVQPSSKLRRDGNGEEVQTLG
VIFLDAVNTPNFKPLKEKSKVRFKEKGYRVIECESLYALDPNTPHHYEVNLI
>PK3-045_02553 hypothetical protein
MNPEKQQELSNSVTEIYLAIEEQILINFARQLKQRKRLLKQDSIEKWAEYQLSQLEALSQ
QNIITIAKYSGLAIDEITNLLQEIGYAAVNQVDKDLQEAVRQGAIIKPPTEPRSTIQPIL
LSYQQQAIDKFNMVNTTMLEQAKQQYKDVLNKTVGKVLTGTITPQKALRETVSEWAEDGV
PALIDKANKEWTPEAYINTVVRSISNRVSNTIQDNRMDEYGVDLIEVSAHMGARPLCAPY
QGKIYSRSGKSKKYPPFSETSYEKHIAGLFGINCGHVKYPFIEGVSVKREIEINKEENDE
AYKLSQQQRYLERQIRHAKKQLNVLSAMGDDVGVQMAKQKVRERQANMRRFIDETGRTRR
RNREQLAYNNPRV
>PK3-045_02554 hypothetical protein
MRDKVLKIIKRRLKLDDESLDDLIMDYIEQAEWKIRNYCNLKVVPEGLLFTWASIAIDLF
KINHPNEEVVQSLTDDSFNSFTVGKFSATKKSSQNQGTTNSADNLLTSYTSELNAFRRLK
TI
>PK3-045_02555 hypothetical protein
MAKKETAEDKKVREAEEKKKAEESANLEENNQSEIEETVKVKLKANIKYNTERFKKGQKI
EIKKSDYDSFLKEGLIDER
>PK3-045_02556 hypothetical protein
MPTIFDLVNAPNIATYYQANPSNAVPYLGETLFPAKKQLGLDLSWIKGSKGLPIALMPSA
FDSKATLRDRIGFDKIQTEMPFFREAMRIGEKDRQELNRLSASNLDSMIMPLINNIYDDV
TNLVNGAMVQPERMIMQLLSTGKIAITANRLSYDYDYKMSSEHKETLTGSAVWSDYTGSD
PVNDIIEWQDKVEDDTGVRPTNAICTRKTWNYLMKNKSIRLDMNPIGGQNIIMTDAMLRS
YLSEKLGLSVAVYNKKFALQDGSTSLFYPDDHFTLLPDGNLGSTYFGTTPEESDLMTGQS
TADVSIINTGVAITTIKEPHPVNVETIVSMISLPSFETIDNIFIAKVN
>PK3-045_02557 hypothetical protein
MSKFETTSYTNKKEILKFPDHYVNVAVTVSDTGVTANDDGKKIVPAGTIVGGGFLADEAV
HAVKATTTEGESNAEGVLFNDVDVTYGPAPGAVLIHGFVAIDKLPAAPSSEEQEALKQIT
FLK
>PK3-045_02558 hypothetical protein
MFVKIGGKLVGVPLMSPDTGGAGAGGTQGTDHGTGQGQNNPNPDGDKGAIELPKSEEELK
KLLQSESDKRVTDALKTAQAKWEADYKQKLESEKAEAEKLAKMTAAEKEQALLDKQKKEI
EDRERAIQQKELKLETINILNEKKLPITFADLLLADDADKTKGNVDTFEKAFREAVDAAV
TERLKGNTPGSGSTNPNAVNYGQKAAEANKQNNASLEEARKSYFK
>PK3-045_02559 hypothetical protein
MLKIRVNKAVEITEELIRNIIAMWDSGKENERLLKLEKYYKGEHDILNRSVDVDKPNNKL
VINYAKLITDNATGYFMGIPVTYESDEKEFINKVFEILDDNSEEDINFELAKTMSKAGRA
YELIYADEEANVRFKEIDNKSVIPVYTDDIQERLLFAIRHYTSADISTGDKTNKAEVYTA
DEIIYYESTTNKLTEIARKEHHFGEVPINEYINNNEMMGDFEVVLSLIDDYNKSQSDSSN
DFEYFTDAYLKLVGMDATEWADVKEMKKNRVIIVPPEGDAGWLIKEVNDAATENYKNRLQ
NDIHRISQVPDLTDEKFAGNVSGEAMKYKLWGLEQIAAIKERKFKSPLIKRLRLITNFLN
KKGANYDYNKINLKFHRNIPKNLIELVEMVQDLGSTVSQKTKLSLLPFIDDVDAEINRIQ
EDGKRTIGEIYEGATKII
>PK3-045_02560 hypothetical protein
MVATQPKKIVKEFSFLTRAPKKKKPAPFKFKPFSIKQKQVLTWWRKDSPMKDKDGIICDG
SVRAGKTVVMSLSYVMWAMDTFHECNLGMSGKTIGSFRRNVITPLKRMLKARGYKVKDHR
ADNFMTITYKGKTNYFYIFGGKDEGSQDLIQGITLAGMFFDEVALMPQSFVNQATARCSV
DGAKFWFNCNPAGPFHWFKVEYLDQLKEKNMVHIHFTMDDNLSLTHKTKERYKRMYKGIF
YQRFILGLWVLAEGIIFDMFDKEKHVVATESRKYSKYYVSIDYGTQNPTTFGLWGLCGDV
WYKTKEYHYDGRQKSKQKTDQEYLEDLKEFVADISNFRGVIVDPSAASFIALLKKNGFKV
IKAKNDVLDGIRNMASALNNLMIKYNDCCKETFREFSSYIWDEKAADRGEDKPVKQNDHQ
MDGDRYFVNTILFNRNKLSTMDKKSFGL
>PK3-045_02561 hypothetical protein
MARARDPNRDKAYNLWKEHNGEITNREIANQLEIDEKKVAVWKSRDKWGQDNKSNVVQQK
KSKVKNVVQQKNNKQKKQQKKQNIEEQEPLIESDELTDKQRFFCMYYVKYFNATKSYQKA
YNCDYLTANANGSRLLVKASVKKEIDRLKKALIDGKMLDAQFVLQKYIDIAFADITDFAE
FGKKEVQAMGAFGPLEDEDGNPIMVEVNYVDFIDSSQVDGTIITEVKKGKDGVSVKLADK
MKALEKLSLYFDLFPDNFKRQVEEEKLKISHFKVHGKEDEDEYEDDGFEDALNAVTSEVW
SDGSDSTEEDS
>PK3-045_02562 hypothetical protein
MRKIILFILVIVIMLIAYIAEYAKENTPVKYLAWVHVHITGILPSKYMSHSFIGRDEKNY
QYWVDYWLIKMEE
>PK3-045_02563 hypothetical protein
MKLTIQINYHWYMHKIKSFIFGKYSTNAHPHLGKVVALSIIKGMNDYNKKTR
>PK3-045_02564 hypothetical protein
MTAGLIEQIGPLNTLKFYQDVCNQVEFYEEMVASIEYEWKIQYKLLSSNPTPNRNGGLVP
VPMDIVAGRMDKISDNYEQMKQTLEFSKKMKEKAEKILSTFEGIKHKIIYCYYVQGMTLK
EIAAETGYSYDYIKKLKSQIGRELDEEKLEQ
>PK3-045_02565 hypothetical protein
MELNEIRIEQLKLLGQKLADAFKRAKESFLAAWRILLNKIKTIPRIVEKRQDNSFNPPIQ
QTRTNYKMQHQVIENKPRYMIRKIIY
>PK3-045_02566 hypothetical protein
MQQSAQEEILSPKELKAAIKNELPKGASLAIATHNDILKSINAMEEHIDSLSPFQIAKLE
HYYNRAEREAWKIAGYYKSQYQFYFGRAATERGQSYVYERETNKRAINDSNYASRIVEGV
NLEKSGIYEGYFVTWRGIALSYQGMQNTLKDMLKAIMSEGGA
>PK3-045_02567 hypothetical protein
MMYVISFGVGALVGAVIVAMCTVKPYKKGYEDGLNNLYGEKY
>PK3-045_02568 hypothetical protein
MKNKYGNKKVVVDNVKFDSIAEAKYYEQLKWLLQAKQIKSFKCQPKFLLQEAFKKNGETF
RKIEYIADFEIHNLDGTIEIVDVKGAETKEFLIKKKLFLKKYDYPLKIVTLDKTLGWIEL
DKLKKLKSGRVKKL
>PK3-045_02569 hypothetical protein
MADKLRYYKVVETAGMSADELQKTLNKATDGFPEMQIDHVIGTKIILGYDSMLNEKGRAE
ARLLNKLNAATRSAAGKLGV
>PK3-045_02570 hypothetical protein
MNLQKLFETQKVLSDRIGYKGEDRFEKLILALQVEVGECANEWRGFKFWSKDQEPRTKVQ
WDYSLDDEPIFRNLLLEEYVDGLHFVLEIGLEHGYDIDLKNQETFPKASKRETITKQFTK
LFSIKWGRDIGYQNNYMQGLELYIGLGEMLGFTWEEIETAYFEKNKVNHIRQDTGY
>PK3-045_02571 hypothetical protein
MFIKLLGAQILSVNNNCIEVKKGDEVYKLEIISDDGDCCGYADFTTNLLYSPNDLRNPVI
TNVSREDGEYDNQDSSIITFFGESKPLATIESNAGSGSGWGYGACVSLHCKALGIDETLA
SW
>PK3-045_02572 hypothetical protein
MNNLQLSDNDILAMHMSLKLSMQGIERHCDYNIFALDEETKNMYIDMAELRERIEMMFFP
GLKE
>PK3-045_02573 hypothetical protein
MVSLIAKTELTTQLERQIYSATNKQGVFGCFEVTIGWFGKERVDYMTYDTKGIFRCYEIK
VSVSDFRSKAKKTFCGHYNYFVMTDELFQKVKEEIPSHIGVYVGATCVKRPKKQELLVDE
QILKDSLLRSLSREADKVFKSESPTFADAMRRRIAYYEREKDRYREQYQTLQREVQEKFG
TRWRYN
>PK3-045_02574 hypothetical protein
MSETDTINNDKKSLNLRKATLQQLYYLARYTEYRTAAQNELNRRVHGSGESYC
>PK3-045_02575 hypothetical protein
MCEEGIYDKYKVIKNSTKEEVAGAFVLLPESDPIAIAALKTYAELTDNVELANNIECWLE
TLEMIGKEMPPVCDYCEDIAKVKSTPFMADFGARMCKKCWDSTRREYRLSNGEEIGEF
>PK3-045_02576 Single-stranded DNA-binding protein A
MLNRVVLVGRLTKDPDLRYTQSGVATASFTLAVNRTFTNQQGEREADFINCVVWRKAAEN
VANYLRKGSLAGVDGRIQTRSYEGQDGKRVYVTEVIAESVQFLDTRNNDNQSNNWNQQSS
NQSSQQNNNRGGYVDDPFAPGSQIDISDDDLPF
>PK3-045_02577 hypothetical protein
MNKYIVYSPHIIPSKKKGELPNIAYQYIAVESDIGWHYDVTTFRERAYVFEEFELSFANE
IADFWGMKVEKLN
>PK3-045_02578 hypothetical protein
MTRRVVTHHAKSKDNEPLTVITIFEPGCNKVQAKKEIPWSKTHQVLVQRTGKYDFK
>PK3-045_02579 hypothetical protein
MSKDSWLKWQKQIIREEYVKDGAANDKTSSNTSREIKRQ
>PK3-045_02580 hypothetical protein
MNSEFNPYPKSKQLAGHQKEKDRPKFKVQKPKKKRKTKVNKNIEMFHNRKIPHWKKRGEV
NRKTANETLRFYGEACAICGNPNYQLHHIMHKGYGIGGRGVWRNLVPLCELHHTGSEGVH
TIKVLDQFWKDKHEKLFGPHYFKDAWDLWMEGHIENPTQELYEKFMKQEEERCQKIVGSN
GKNKLSEKSM
>PK3-045_02581 hypothetical protein
MSEAQAIGNIESTHLVKTRYGIRIAMERIPIDWIWSNKEVREFKKMWKENKPLKEIAFEL
DKDEFDCLPMVLELLYLEEIDPRENWHIW
>PK3-045_02582 hypothetical protein
MEQQTLTKEQLERYEIFHTAWKCFLAAGLVTKSFEQWLTPQAKRFILQAE
>PK3-045_02583 hypothetical protein
MSQYFYTNIQRDGVHAKEEIEKAIEDLTGRGFELVYGPECNLRHAKTFTQDESGRCVFKE
NIQSQLWRARLRKEKVIENGTTNIN
>PK3-045_02584 hypothetical protein
MNRKVEVITSEYLPTFEDLVNEILAIADNPKITYSTGIHNGKLLFIAFVECAV
>PK3-045_02585 DNA replication protein DnaC
MHEMKMPQHLKINMVWSSNYCYKHPIKRQHKEVENPIRMMIIDGEEICPRCKTEADTKEL
QQSIQQSYEEMEQQKKYNTFYKRSIISDPTLKESSFDNFIGKEQEEITNKNECLGIAKRY
KSGQIFNTFIQGLQGVGKSHLAYSILKDINESVEGIRCLFVSVEEMIRLIKDSFRNKESK
YTEQYFIELLSGVDFLVLDDLGAETGAIDTEKSATDFVQRVLYGVMTSRQDKVTIITTNL
SSEQLFKMYDKKLVSRMLKKPKYVLFQNTKDKRITDIPF
>PK3-045_02586 hypothetical protein
MHRSYYAIIPANVRYDKDLTPNAKLLYGEITALCNEKGYCWASNSYFSDLYSVSKTSISK
WINQLVAKGYIKSTIQYKEGTKEILNRYITIVYDPIEEKLNTPIEEKLKDNNTSFNNTFN
NTNNIYMPTKKKNTNSSSKKTKLAEFVSMTQEEYKKLIEQFGEENANERIETLNLYKGST
GKKYKSDYLTILNWARNEKKKIGGNRNNARNEDAAAFKNQYGLEF
>PK3-045_02587 hypothetical protein
MLKNELISTKQNDNGDIIISGRELHEFLQIKTEYKKWFDRMKEYGFVENVDFIVIVKNVD
DVTAFGGIRKITDHHLKLDMAKEISMIQRSEKGKQARQYFLQLEKMWNSPEMVMKRALEY
ADKKVLELQGMIDKDKPKVIFADSVSASKTSILVGELAKLIKQNGVNIGPNKLFEWMRSN
GYLIRRKGTDHNMPTQKSMDLGLFEIKETTITHASGEIRINKTPKVTGKGQLYFINKFVE
KEKSPVLPTLD
>PK3-045_02588 hypothetical protein
MKLEVKLLEMMARNNIRQIEELHHLTGISRTTIRLILEGKKNALYFETIATLCEKLNCRI
DELLVIKR
>PK3-045_02589 hypothetical protein
MVVKNNLRILMAKHKMSIQDVHEKTGLSRTTISKLYNETSAKIGFDTIVTLCKLFDCDIA
DLLYMEEDK
>PK3-045_02590 hypothetical protein
MKRGHYKQPNYKPTTSITLDEELFVMIDKFKHRNEIDSRSQAIEKLVRLGFKQLKQQRLS
RMQG
>PK3-045_02591 hypothetical protein
MGLDFSHTNVRWGYIGFNFFRKKLAKQIGMDLDAMEGFGGDIKFELFKDDIIPLLDHSDC
DGELTVEECKKVAPRLRELVSGWEDDDYDKQKALSLAEGMELAVSRGEPLEFW
>PK3-045_02592 hypothetical protein
MKTLDEHIYEVNQDSDWYKKKDKQFDDINNFYRIIKEKYGFEEGFVFYHSEYFGIEYGTP
DYEKFKDELLKNSNKDGIHIFKKKSKFNQIMKGLLDEVEEISPFKVHDTFGLNNTRGSQW
VNGRWFFSIEDPENINQFGEISSVEFKDYLKVVMDALEKEEQK
>PK3-045_02593 hypothetical protein
MRDIGETIIDCRNCSVRIIVNEAIISNDLLDWKDVDNYWLELTLNEIAQQINTPGTIYVW
EESGLEGSIYLFNNQGDCKWHKHGKTRGFA
>PK3-045_02594 hypothetical protein
MTAELSELEYKLEYLQKENDQLIEKLADIRSLFDESDQEAEGHGMEDMIASPYAVLCYAE
NKLKRLIEINTLYESNNKRLISQVSKLTKENNYIYGTLNTISDIVENGRKEIDRLGE
>PK3-045_02595 hypothetical protein
MTLGDWVRKYFPDATDKEVMFILWEKTPFPMCSAETTEKYLKAYKEEIEGKKVNI
>PK3-045_02596 hypothetical protein
MKLPNNFDLEIESGCCVAELNEKGNYLINENEYAPPYVRDKLKDRIWKLILPDEFEFINQ
MNNVCTAKKHNDKYLIGLKGQSSSIRIFYSEVYMYILEGKWSILDDPEEELDIINNPSHY
HKNEIDVNGYLEKHFPKEGEFTVSEGFYIGNALKYISRYKYKNGLEDLEKAAYYLGKLID
IEKGKLPS
>PK3-045_02597 hypothetical protein
MNKNQNILFQYLKELHFQNSVIEIDGDYESIPDNIYEAYYKLNYKEKLQVFKKVINYQLK
NKSQQVLLSDD
>PK3-045_02598 hypothetical protein
MNNKCDFCNQEFNKDYESKCPTCGETVDVKMDQYSAYSEAYEKVSNYIKKRGYSYTIAGI
LETYRNYYKKGFYVSYTAKDCIENFKSELSVLDELHR
>PK3-045_02599 hypothetical protein
MSKHVLEVCYSLKEAIMSIKDRLSHIDSKNNEMWNWYKEKMPKEIQGKTSMEDKYWSDAI
YLVYRNDYFIDECWLFDGNHEIECWLEEKWSDWNLWDYDNLNGFFEENLVVWKFHRNICN
EKWSHYKKYSKPFMEGWSRKRESAAFQAVPSFSVG
>PK3-045_02600 hypothetical protein
MNIDLVKTFMRLVQKHSPKCFINHNFELIVEPKNNIYFRLEDVETELELKCKVIAWLSRP
SCKGISDYWQKRIRSIVNEFLETDFNFEEMQEIYTYLGNDCNRKKTIRFIESNYDLSILT
E
>PK3-045_02601 hypothetical protein
MINMTLCLTCNGQGKIYAGKLHGRPKYRTCPGCHGIGEHEKEITRKPKEDRGRTGAELQA
YCPKCAKPVVTNQYFKATKYTSFTCSCGCNWRMLIEDAKQKIV
>PK3-045_02602 hypothetical protein
MKKVAIKVTLEREIWLSKEVWEKSFGEQLPQDMDDLDMIEDESLRRNTELKNAEFISEFE
LK
>PK3-045_02603 hypothetical protein
MKVPKEIKDSIRKSAKAFHTAREHEKIVRGWLDEQGLENDTVHDSWIDTIEMGSGNSKDF
IEFLKRVDE
>PK3-045_02604 hypothetical protein
MDEEKCPNCGNGNLKIYEQIAVGRTISAKTGKVLKNHGFLETTCWNYLCKCGWCGELNTH
>PK3-045_02605 hypothetical protein
MTPNDWVYDKEGNVFFVHQVVENLVKVGQFYRLHDEGQLFTSFNLERAEKYTVCELEGYS
EEEIDFLINLALDTNDREWFDELSERKKQLVKAM
>PK3-045_02606 hypothetical protein
MNELKFQAWSNKYKHMFRVNEISFCRNGDIHGTVDHESLDEYTPDLNHPYSWVGRIYFTK
PVDGNSFSLTQDPDDEPFYLRQYTGVNDLENKEIYSGDIVEIETTDSIGSSTIIGEVKMY
EGCWWVDNGETAAALWNEMHIPKILGNIYQNTELLEVQHDSK
>PK3-045_02607 hypothetical protein
MSALKQEVVTYIEEEQKTEVAKEHILLDSKHWIWPVVFWAIVLVIIILLGMGVVS
>PK3-045_02608 Putative metallo-hydrolase YycJ
MIEIKIISTGSKGNAYIVTDGITPLLLECGITYRDIQRAFDFKMSQVAGCLVSHEHGDHV
KSIKDILKAGIDVYMSAGTKDAIGIEHHRIQTVQSKKQFRVGSWTILPFDVQHDVSEPYG
FLLANQQGEKLLFATDTYYIKYRFTGLTHLMVECNYDIGILNENIANGRVPAVMKKRLMK
SHFSLDNVKEFLRSNDLSKVQEIWLLHLSDNNSDEAMFKREIAELTGKLIFVP
>PK3-045_02609 hypothetical protein
MSNQLAIIQKDITDSVNNKLAELQKEGLVVPHKYNASNALKSAFFKLQETKDKNGKPALE
VCTKDSIANGLLDMVVQGLSPAKTQCYFVVYGTQLKMERSYFGTQAVLKRLSEVKDIWAN
VIYKDDVFEYENYHGRERLISHKTAFENRDKDIVGCYAVVQTTEDEEILTVMTKKEIDMA
WSQSKTSQGVHKKFPQEMAKRTVINRAAKAFINTSDDSDLLIDAINRTTENEYENERVDV
TPEAEMQHQIDQNANKEVIDLDIDDTKIIDAEPIQEQKDEPKQETESDGPTW
>PK3-045_02610 hypothetical protein
MSNYNVQESVELQKRLCEEKGYPHFAPRSGVCWNCHNNIYEPIEQKRIMFFEDGKPEKTI
VTGITVDKAANQLVTGCPHCNRTYCD
>PK3-045_02611 hypothetical protein
MAQIVEVKVLSSEGWEGLRKERLEIDGVEVMHVGPLSECPEDAILERDLVGPSDFASLLE
SFLKEHNGKNVKFVYEEEEE
>PK3-045_02612 hypothetical protein
MSILLLNRLSLRNFKGCKSFELVVNGRNAKTYGDNATGKTTLFDAFSWLFFDKDSQNKSN
FQIKTLDESNKVIPGLEHEVEAEFNFNGEYLKLKKVFAEKWTKKRGQAIAEFTGHTTTYF
IDDVPVKKKEYEAKIESIMSEDIFKLLTSPTYFNEQLHWQKRREILLSIAGDITDNEVIS
SSSKLSALPSILNGKSIEDYRKIIASRRRKINEELEKIPVRIDEIRRNLPDTNGLDKAEL
EQQVTVLNNQIDELMTNINSIKNGKAISDIQQSIQQIEMELLEIKRNNESDSKEKIYQLK
SRIQEEASNISILKSKINNQKQLKSSKEYNINSLKEELNNLRQDWMQINKLEFTHEDACV
CPTCKQDLPAEQVEEAKNKALAAFNSDKSNRLEKIDKEGKSKKERVVMLENEIAKIDGEI
EKIEKQVSEKENFLKGLKEQLEQLESTVTDVLDNTTYVEKLKEKQSLEGQIKAIREDANK
QIQSIQMEILDKKEQRDQIQNKIGQLANIDAQNKRIEVLMQEERNLAAEFEELEGNLYLT
EEFIRLKVTMLEERINSKFKYARFKLFETQVNGGLQEVCETTFNGVPYSSGLNNAARINV
GLDIINTLSEHYDFMAPIFIDNAEAVTKLIDTKSQTIALIVSEQDKELRVEVEDDSDLIP
VNVKVV
>PK3-045_02613 hypothetical protein
MENEQILNYIQQSINSGASIILSMGNFNQETYEQAKKEANNVFGEMTETENLYEGLTVKC
LQSEKANLYFNVWQV
>PK3-045_02614 hypothetical protein
MKNYEAWDIENNVSIYNGGHINSLINELMDYIEYQIHIDEELISEEEIRNLDSKALKKVG
IKIFVNA
>PK3-045_02615 hypothetical protein
METQHDYYLNLLVDYPELMKAEDVGKFFDKKRRFGYELMKQTGFPTFKVGGLKYVTKKDF
AKWLENRPESKIS
>PK3-045_02616 hypothetical protein
MKGFGIRIRALRKGKGWTQEELAQRLGVTHTYVSKVESERTIPPIERLQEFAEILDVSIV
DLLEDKKEPPQELKEAGVKWMIVGKELEKKGITPEQALKYAEIIAMLERNEKNSDND
>PK3-045_02617 hypothetical protein
MKIVKVSDIPKDTILITETLIIVGTGKKESMKNEGICKETRQNVELYS
>PK3-045_02618 Putative prophage phiRv2 integrase
MKGYVRKRGKTWSYTVDVGRDPITNKRKQKTKSGFKTKKEAEKALNELNYELNNGLWIEP
SKITFAEFANEFLASHKPNIRQATYERYVSTIKRQLIPFFGNMRLQDLKPIHGQKFKDEA
IKKYKVSTIRKAVTFLKQILNHAVELEIINKNPFEKLSISSKRKNNLHVWTAEQLNKFLE
AAKEYDTFYYNLFTFAAYTGMRKGEVLGLARINVDFSNKVVTLKQSVTESQEGIELSLLK
NESSYRQIAINEVCIEVLKNQIERNQYFKKIFKNEYQDNGLIFCRENGSIFRPTNLNRPF
RRICKLAGVPEIRIHDLRHTHATILLELKVNPKLVADRLGHSSIKMTLDTYSHSSISMQS
NVAELFEKRVKEL
>PK3-045_02619 p-aminobenzoyl-glutamate hydrolase subunit B
MMKQIILDTINENEAKFKDISIYIGENPELGHEEFKACEILTDTLKQHGFNVEIGICDLP
TAFKATFDSGKAGPVIGYMAEYDALPELGHACGHNLIGIVDF
>PK3-045_02620 S-adenosylmethionine decarboxylase proenzyme
MSLTPQQRIELHGFNNLTKSLSFNMYDICYTRTKSEREAYLQYIDEQYNAERLTKILKNV
SDIIGAHVLNIAKQDYEPQGASVTLLVSEGPVADTSKEVFEESPGPLPGSVVMHLDKSHI
TVHTYPEYHPDEGISTFRADIDVSTCGEISPLKALNYLIHSFDTDIMIIDYRVRGFTRDI
HGHKLFIDHDINSIQNYIPEEAKSQFDMIDANIYQENIFHTKCKLKQFHLNNYLFACKEE
ELTEDDRMMITAKLTQEMNEIFYGKNIK
>PK3-045_02621 Glutaminase
MPCQSNEELESILLEAKQYTHNGKVANYIPALSKANPDDLSVAIYHSDGTCYSAGCIHEK
ITLQSISKVITLALALIESGEEYVFSKVGYEPTGDPFNSIVKLEMSNPSKPLNPMINAGA
LAVTHMIEGNTVDERFQKIIEFVKLLSGNSDIGYSAEVAKSEFDTSHLNRALCFFMKQHG
IINEDVEELLDLYTKQCSIEVNCLDLARIGIVFALDGKEPVTNKQLMPAHVARICKTFMV
TCGMYNASGEFAVRVGIPAKSGVSGGILGAVPSRFGIGISGPALDDKGNSVAGLKLLEIL
AKKYDLSMF
>PK3-045_02622 hypothetical protein
MDYKHSETKWMVAICFFVLLSVILNIFAASINKELFILLQLIITSGLLYVFYQLIKKFTY
VLGEFAQSNKKLQSIFDTLDIAIWFHDLKTNKLMVTAGIEAIYGYSAEAFYKNYNLWKDV
IHPADQEVLAERAELLTHQDVVVSTYRIIKPDGKIRWIKDRGIAVFDKTTGEMTEFTSVL
IDITDSKENEDKFSKLVDISPDIIAVVVNYKFQYINKAGTKMLGKDYSSLQGLAISDLLF
ADTYQNIVQQYKKSKKLNQNVAEMEIELTKELTKNVFLEINCMPILFGGQEAVLVVGRDI
TSRKQAELKIKELAFTDTLTKLPNRNSCMHHLNDRLYNQEVERMSILFLDLDQFKRINDT
KGHGIGDIILQEVSTILQSAIEKNDFVARLGGDEFLILLENKTKLETAETAQKIINHFSY
PIVVKDDEFFVTPSIGISMYPLDGKDQESLIKNADTAMYVAKDQGKNNFQFYSASIAEKG
ARKMELEMALRRAISNKELELYYQPQINIYTGSIFGVEALLRWKHPVYGYLSPDEFIPIA
EESNLILSIGEWVITEAFAQKKKWEREGKKDLKLAINISARQIQYTDFIPFLQKEITRLE
INPEKFELEITESIMQNIELAQIELANIKNLGFQISIDDFGKGYSSLSYLTSLPIDTIKI
DKTFIDDIGHPIHKGSLAKVIIDMGHNMNFFVIAEGVETENQIDFLIKHQCDIVQGYYFS
KPLTSSELEKYYL
>PK3-045_02623 Peptide transporter CstA
MNAVTIVIASACILMIAYRLYGTFMAVKVLKLNDKEKTPAHELNDGKDYVPTNKWVTFGH
HFAAIAAAGPLVGPILAAQFGYLPGLIWLLIGAVIGGAVHDAVVLFASMRKKGKSLSEVA
KEELGPVAGFCTGLAMLFIITITMAGLSMVVLHALERNPWGTFSVGITIPIAMGVGIFYK
KTGNLKLCTTIGFILLMIGVFVGPMIQDTVMGDWLTLDTKTLAIILPIYAFFAAALPVWL
LLAPRDYLSSFMKIGVFIALIIGVFIINPAIEFPAFTEFVNGGGPVIAGPVWPFISITIA
CGAISGFHAFVGSGTTPKMLDKWTDIKVVGFGAMLVECLVGIMALIAATALHPGDYFAIN
SSPEVFRTLGMSVSNLPELSREIGIDLEGRTGGAVTLAVGMSYIFTEISWFSHLASYFFQ
FVIMFEAVFILTAIDAGTRTARYLIQDFLGEFYKPLKRVDWLPGSIFASALACLMWGYLL
FSGDISSVWALFGVSNQLMATIGLIVGATVILKVADKRRYMLTCLIPMAYLFVTVNYAGV
WMVKNVYLNPEASGYNVLNAVLSIIMLILGVIIIIAATKKWFDTWNTPRVHVEAPNLN
>PK3-045_02624 Sensory transduction protein LytR
MIKALIVEDEPLARDELKYLLKRSSKIEIVAECDDLETALYIIDNQKIDVIFLDIQLGED
NGMNLAEQLKHTANRPEIVFATAYDEYALQAFDVNAVDYILKPFEEERINQTILKIQNQR
SETKEETHGKAPSKSSLQSNKLAVTANDKIKIIDLDKIVYISAQNGKTLLITEEEELVIT
FTLTQLEQKLVNSPIMKVHRSFLVNKEKICEIEPWFNSTYLLCMNNGEKVPLSRNYTKEI
KQLFGF
>PK3-045_02625 Sensor histidine kinase BtsS
MLQLLPLMIERVGILVIFAFLLSRIKIFRSIIHHESQWHDKLSLILIFGVFGIISNYTGV
EILKGSISTHTWQHELDVSSAIANTRIMGVAIGGMIGGPLVGLGVGLIAGLHRLTLGGFT
ALACGLSTIAAGLLTGLLGRKYSIKQDSACKAVIIGITMEIIQMLFILLIAAPFELAFEL
VKIIAFPMIVINGFGMLIFIYLIQNILLEEEKTKAAQTNIALNIAQSTLAYFRQGLNPES
SKQVAKIMLKATNADAVSITNRSIVLAHEGLGGDHHIPLEKTSTKLTEKVLREGNILIAK
KKDEIQCSNQACPLHAAILLPLKANNKTVGTLKLYFANPKNIQLVEYTLAEGLSKLFSLQ
LELAEAELQQKLWKDAEIKALQAQVHPHFLFNSMNTISALIRTDGEKARQMIQRLSTYFR
SNIQGAKNMLIPLSQELEHVHAFLALEEARFPNKFIIKESIEPELKKVLIPPFTLQPLVE
NSIRHGFSKGTVGTITICAYREKDRMVLITEDDGKGMSEDTLYMIGQKNISSSTGTGTAL
WNIQERVKKLYAEKGKFTIESEWNRGTKVMITLPSKEPSIWREVDD
>PK3-045_02626 Ribonuclease H
MAAKKYYVVWNGRKTGIFSTWAECEKQTKGFKGASFKSFPTLEEAEKAFKQDGNISKSAS
KSSSAQKQSNQTLAAIEENSISVDAACSGNPGMMEYQGVDTKTGEVLFHYGPVFGTNNIG
EFLGIVHALSLLQKQGKNTTIYSDSMTALAWVRNKKANTTLVRDKRTEELWQLIERAEKW
LKQNNYSNKILKWDTNKYGEIKADFGRK
>PK3-045_02627 Pyrimidine-specific ribonucleoside hydrolase RihB
MKKKVYFNHDAGIDDLVSLFLLLQMDEVDLIGVSVIPADGYLEPGISASRKIIDRFGQGP
VEVARSNSRGVNPFPKEWRMHTFYVDALPILNESGEINTPESELPAHEHLIKTVRGNPDK
TTLLFTGPLTDLARALEIAPDIQEKIEKLVWMGGTFLEVGNVQEPEHDGTAEWNAFWDPW
AVAAVWASDLQIEMVALESTNQVPLTLSVRNHWASLRKFTGIDFVGQCYAACPPLVHVET
NSTYYLWDVLTTATIGKKELVKMKEVKSIALTEAPSQGRTLISDNGRPVSVVYDVKRDDF
FAYITDLAKMAKNNL
>PK3-045_02628 D-alanyl-D-alanine carboxypeptidase DacC
MTLWKKGIIVVMLFSIFLSGSTPNTFSPKVFAAEDHKKATLSTALESLLNIEPELKGSLA
GISIREQETGKIVYEHMADLRLTPASNMKLLTSAAALNILGEDYQFITEIYGDGRVEDAH
LKGNLYIKGNGDTSLLASDLAKLSKEIKRKGISYIDGDIIGDDSWYDNIPFSSDLAWSDE
STYYGAPISALTLSPDKEYDAGTVLLEIKPGKKKNEPVIINTLPRTSEIKIVNNGITADK
ESAASLKVNREHNSKVVTITGSLPIDDSLKKEWVSVHDPTSYTLDVFQQALKKEGIQWKG
VVKKGRTPQIASILITHSSIPLRELLLPLLKLSNNTIAETLIKELGVVKKGEGSFAKGLE
ALEEELVAFHLDPTKMVIRDGSGISPIDFISANDLSLFLYEVQAQPWFPSFSQSLPVSGH
EEKMIGGTLRHRLNSENTKGKILAKTGTLTSVSSLSGYMESKTGKKYIFSILLNHLTDED
KGKKIEDKIMETLAEY
>PK3-045_02629 Formamidopyrimidine-DNA glycosylase
MPELPEMENYKILLNKLITTQPITSIAVNREKSINITKQSFENQLVNTTILRVERRAKHL
LFYLNNQKVLLLHLMLGGWMFFGTEKEKPNRTIQIQLTFGENHLYFIGLRLGYLHLLTLE
ECKERLNDLGPDPIEPHFTENSFQNIINSRKGTIKLKLVDQHFISGIGNCYSDEICFDAQ
ILPTRKLEDLKEMELNELYNSILKILRAATHMGGYMEHPLYIGDKKTGGYDKLCKVYDRE
GEICPRCQHKIVFIKVSSKKCFYCPGCQF
>PK3-045_02630 FMN-dependent NADH-azoreductase
MKTIVYAHPWEGSYNHAILNSITKDLEAKEETFQVIDLYKDGFNPVFTAEELAQFNSGET
PYELVKDYQKKLSQATELIFIFPVWWWDLPAILKGFIDKVMLSGFAFLEDKTTGALKGLL
TNIEKTTVISTSTTDKDYIESEGGNAIQGVFINRTLADLGVKNEYTKWIHFSRVNLTTDE
KRKQFLREITQEI
>PK3-045_02631 hypothetical protein
MENDSYLFEENLKDTGFGYTLSLIGGKYKMTVLYALYLNNNPIRYNQLKRRLGNISFKTL
TNTLKELESDQLINRKEYPQVPPKVEYSLSDKGLSLIPVLDAICYWGEEQLDKRKEVTMK
GNNN
>PK3-045_02632 IS1595 family transposase ISBsu3
MDIRKPNDIELKMVLSLSPQAIFDGTLGQVEPTKEKIDQLVKPLLEKGSYYLIATKNNKI
MGWIFIGTSKDQFTDRMIGFIYELFVIEEFRGKGISKLLMRAGIDHLKQDGYSEIRLSAF
AGNHAIKLYEKLGFNIRTITMSLQL
>PK3-045_02633 hypothetical protein
MKKISITLFIVFLLGITACSKSSIDASNNNKSEPNNTSSNTDTFNDSATDENSINNPEKE
DHIEPNNNSDKEFSTNSISEVKENEIKPETSTPDKMNKKREEVLDNIQKELTALPDKIEG
SRQEFLERLDSIQRELDSLPDKKYSDTGTTNAMKNYYGISDEKYDIALNRIYDLLKKELS
PKTMESLQMEEINWIEQKEAEADKERQKYAGKTHEWVAYYISSYELTKERCYELVNKFIT
D
>PK3-045_02634 hypothetical protein
MKLSLLERITLIILAICTVIFIYGFIVNQNIMSLVFLLIPIIYITRLVLTKNRKSKKLSG
TFLKLKESISVIMRSRVEEGKSLLIICNL
>PK3-045_02635 hypothetical protein
MSIIDIKILITGVTGTLGGEVAKRYLKEGAMVKGLVRDEKSYKEMKEIGIEPIIGELTNR
GSLVEAAKDIDIIIHCAAYLGEDLEKAMNSNVIGVENLASVAIELGIKRFVHISTLSVYG
EPTEGYFDENLPITESHPEVYIKTKAHSERILNKYKNNGLGLIILRPGAICAEKNSYWGD
RQVERMINTDIVNWVNPDDLIPWVHRDNLIEMIFVAILKGISGEIYNAIDGNYPDKEYRL
ELINAIGKKYILPERRLERPIYSNKKIKGLGYMPVKTLEETISNLKKLALEHNTYIN
>PK3-045_02636 hypothetical protein
MTLWITIGIIVLLSFMIGMGIYMFKKEINKEDPDYIFQFIKENAKSERVALSINYNKQKW
VKVNQNKQLPLASTVKIIIAMEYARQAAEGKIDPLQEVSLEELNSFYIPKTDGGAHEAWI
ANLNDGKETDKVHLSEVSKGMIAYSSNANTEYLIHVLGLENINTSLESLGISNHEPLYPI
VSALFIPTQLMKEQNITKQEMLEVMKSMDISEYRKRAMDIHNKWLNHPPAAEEKKQIVNT
LDMDVQRIWSNRLPRSTSEDYVYIMEKLNNKTYFDENTYKYLDPVMEQLMENPNNRKWLV
HAGQKGGSTAFIITTAMYATDKDGNQTELAFFANDLTSFEQTKLSRNLNGFKLKFLKDAE
FRALIQKELSALESRIP
>PK3-045_02637 hypothetical protein
MTKESNQKIQIKSSEFSWNSENGVFHFDGAPALLFWDNAFEIFLSTIMEISGPDASNAVF
ETTGFRMGLLVNDYYQNRFSIEEIIKKYSEIYSSAGWGNVTITSFNKDKQTVTVRLKNSW
EHRIFQSLNPSQSAVLLPSHWAGVFSGLFKEKMWYELTKSQTRGDEYDELNIFVSNHTPH
QSVHELVRGKETKYITELETIVEDRTKELSTLIRHLSTPVMPVMKGILAIPLIGKFNEER
FEDLLQKGLQEFSERRASYLLLDLTGISEFDQFIIFRLQELVKAIELIGGECILVGINPH
LSVQIIQSGVDLKYIHTFATLEQGIEYAIEALGYRIEKQP
>PK3-045_02638 hypothetical protein
MLKKEINKYIEECKSLNSGKVVLFEEEMNYVRKEGLADDHMVMEQTAERFSDLYMELANK
ETDEVVQENAQERILEDTVDYLERNIDIYLYVETKAFDIVSIDSMSIEVDSVFGTYEVLC
GLKSPKKTEKEIRAFMENQLIGDDTPYQLMFNGNDGVWDVNFPLEKINGFDKEMQIGDAL
KLAYLFLFSLNEKLSA
>PK3-045_02639 DEAD-box ATP-dependent RNA helicase CshE
MQSFTDIGLSSTIIEKLHKQGIKQPTPIQAKVIAPLLKGSDVIAQAQTGTGKTFAFILPI
LEKMIIDANHIQTLILTPTRELAIQITNEIMKMKQEAVNVLAVYGGQDVDKQLKVLQKDV
SIVVATPGRLIDHIKRGTIDLSKISYFVLDEADQMLHIGFLEEISYIMRRIPKSRQTMLF
SATISREVEKLAKKYTKNADYFTVEAKQGPAKTVKQVSIHTTDRAKQGTLMTLVKEANPY
MAVIFCRTKRRVTKLYEVLLANKFSCGQLHGDLSQTKREQVMKAFRDGKFQLLIATDVAA
RGLDIDGITHVYNYDIPQDAESYVHRIGRTGRAGTEGYAVTFYSSDDRPLLDSIENQLDI
KIEKIQQPKKTDSTKQSEESKPAKKPYKKQSHTKKKDEVIRSSQSDKKGSDNKRKSFSTN
NKHRGNSSQSPTKKWAKPKKRDGKR
>PK3-045_02640 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MKKIVFTGGGSAGHVTPNIAIINELNKQYWDISYIGSKAGIEKDLIAKIDIPYYSISSGK
LRRYLSKENIKDIFKVMKGCYDARKILKKIKPNVVFSKGGFVSVPVVIAARQLKIPVILH
ESDLTPGLANKLSVRFASKIFTSFEETLHYLPKEKSKAIGSPIRKEILTGSASKGKFFLG
FTSHKPILTIMGGSLGAKKINEIVRDNLDTLLQSYQIVHLCGKGNLSEDHAGINGYKQFE
YVYNELADILAATEFVITRGGSNSIFEFLALKIPMLIIPLTKQQSRGDQILNGKVFTENG
YSYMIEEEALTKEHFLHTLKQMQENKQGMAEKMEKNKSKNALEEIIKELNRY
>PK3-045_02642 5-amino-6-(5-phospho-D-ribitylamino)uracil phosphatase YwtE
MKCVSIDLDGTLLDDHHQISEANRMIIQKLKDQHIEVILNTGRQYADVIKVDGVKELELP
IFCLNGSMMYDEKGKLLYETQISIDLYQTLLKVLQNLEVGVLVYTNQGGFPGTLPMLRGK
SWDEIQTLFDQQDYEAILHLKDVKIYKLIAVVDETQLDKIDHVKEMLRKYEAISFSSSFP
NNCEITSTDAQKGKAIRRYENLRNLTFNEIYSFGDGGNDITQFEVSTRSFAMENAPEEIK
KRASDVTKSNNEDGFAYAIEKILKLV
>PK3-045_02643 Putative ring-cleaving dioxygenase MhqA
MNLKGIHHVSAMTAKAKENYSFYTNILGLRLIKKTVNQDNPSVYHLFYGDEQGSPGTELT
FFEIPHMALNREGVSSISATSLRVPSDKALEFWLKRFEEYNVKHGEILERAGRLTLEFRD
FETQRFFLVSDENDNGVKAGIPWEKSPIPAEFAITGLGPVQLTVRRPEATISVLTDLLGF
RLKTSYPSTMENQPPILVFETGEGGSGAEVHLEERNDLKVQRLGRGGVHHVALRADNEEE
LYYWIEKVNEARFQNSGYVDRFYFKSLYFRDPNGILFEIATDGPGFATDEDLKHLGESLA
LPPFLESKRSDIEAILEPLDTNRKEK
>PK3-045_02644 Exodeoxyribonuclease
MKLVTWNVNGIRACVKKGFLDFFQQIDADIFCLQETKLQEGQIKLELEGYHQFWNYAERK
GYSGTAVFTKEKPLSVQYGIGEDFEELEGRAITLEFKDFFLLNVYTPNSKRDLSRLSYRV
EWEKQLKNYILSLEAIKPVIYCGDLNVAHQEIDLKNPKPNIGNSGFTTEERNEMTSLLEL
GFVDSFRYLYPERTDVYTWWSYMAKVRERNIGWRIDYFIVSNQLKERIQDATIHCDIMGS
DHCPVQLDIEI
>PK3-045_02645 putative metallo-hydrolase YflN
MKITENVFGYRTAIANIAYIAGLGNRKEEWVLIDTGVPYSAPFILKNTDQLFKGKKPLAI
ILTHAHFDHIGALQTLVKKWNVPVYIHEQEIPYLESKKKYPPPTPLREKGMMSFLSPFYP
RDGIDFHSSIKPIPWDGSLPYLDDWKWIHTPGHTEGHISLFREKDRLLLAGDALITVKQE
SLFAVLTQKKKIHGPPAYFTPDINTSFQSIEKLLALDPQILYTGHGMPMYGAEIREGIRE
LLYQYNTENLVKEI
>PK3-045_02647 Riboflavin synthase
MFTGLVEELGVVKHSKKTGHTISITIQAEQILEDMKIGDSIAVNGVCLTVTAFRDCLFTV
DVMPNTFNDTTLRLLNSGTIVNLERAMAANGRFGGHFVSGHVDCTGMIISTKKIENSTLV
EIQMPEEQIHLVMDKGSITIDGTSLTVFQTTPTSIFVSLIPHTSKVSVIGNKRKGELVNI
EFDLLAKYFYSFMNRDKNPAIKKDSTLTASFLRENGF
>PK3-045_02648 Riboflavin biosynthesis protein RibBA
MFDSIEDALNDLKNGKVVIVCDDEDRENEGDFIGLADHVTPEMINFMAKEGRGLICVPIQ
QNLAEKLHLPAMVTNSTDPRSTAFTISIDHKETTTGISAYERAFTISKMVDSDAKADDFT
RPGHIFPLIAKDGGVLNRNGHTEAAVDLAILAGANPVGVIVEVLKEDGTMARVDDLKQIA
EEFALKMITIQDLIQYRQNLLQKVE
>PK3-045_02649 6,7-dimethyl-8-ribityllumazine synthase
MKQVFEGNLIGTDLKIGIVVSRFNEFITTRLLSGAEDALNRHGVNEDNISVMWVPGVYEI
PLAAKKMAASGNYDAIITLGTVIRGATPHFDYVSNEVAKGVANVSLSTEIPVIFGVLTTE
NIEQAIERAGTKAGNKGWEAAVNAIEMGNLYNQLTQA
>PK3-045_02650 putative chromate transport protein
MKKGQQLKNRTNFLEIFLISTKLGLTSFGGPVAHLGYFYDEYVSRRKWLDEKSYADLVAL
CQFLPGPASSQVGIGIGILRGGLLGGIISFLGFTFPSVIALIIFASMIDVLDIGNAGWIH
GLKIVATAIVAHAIFGMAKNLTPDLKRKTIALFALILTLLWQSVFSQVGVIILSAIIGYF
LYKQQVRQQNQVDISFPISKQVASVSLVLFFSLLFLLPIIREVFSYQWIAMFDSFYRSGS
LVFGGGHVVLPLLEREFVPGGWLSEASFLAGYGATQAVPGPLFTFAAYIGTVLNGWGGGL
LATFAIFLPAFLLIVGTLPFWNFVRKNPKIQGVLMGVNAAVVGILVSSFYQPIWTSSISD
ASDFAFAAILFSMLVYWKLSPWIVVITGALGGMLLPYL
>PK3-045_02651 hypothetical protein
MPSKKHSIIVHANAKKVWDFVRSMNNWAPLVPGYVNHEIINDTVSTWEFKIDMGLFKKKI
EMKVTILEWKEPTKVTFDLEGINDHFKGNGYFMVEVKDANYTKMTGYLEINSTGTFPTIT
NNLMEPKLEEIAEELTIAVSKAIEDLQ
>PK3-045_02652 Tyrosine recombinase XerC
MITKETLFSWYEEELTLFRTEMDNKDYSIFTIDNYLRDIYLFLEFITRKKEVYMDLNSVK
KLQVTLFMNELKTKRANSASSRNRRLTAIRSFYKCLVDYELVLKNPAIDLESAKEQKGKL
PSYLEKDELKSFFEMIGKVSQKQHQRRNKVILGLMAFAGLRVMEIHSLNLSSINQNRGIH
VLGKGNKTRYIPLPKKLMEELQLYIEENRIFPMKGQEDALFISRRGKRISRRRIQEITER
IIDQMRKEYPELKWKEKGISSHKLRHSFATHLVREGRDIRTVQELLGHTNLNTTQKYTHV
SDLQKEQAMDLEISEYI
>PK3-045_02653 hypothetical protein
MYHLIKKDILIQKRSIALSLLLICFFSVSLSSLGEVGLMVGILAITYQLLLGASALEDKN
NSDKVLISLPIKLSTIVLSKYVSIYVYAAFAAIGFYLIHVLVKLFHIPLDVPFSYIILIG
GAIMVTICFSISLPMIFKFGYLKAKMANFILLFVIVFGTTGIMKYFAKLDNQFIQETMIR
LSTLSKAELGLILIIPLLLLLLVSYFISLSFYSKREF
>PK3-045_02654 ABC transporter ATP-binding protein YtrB
MSTVENTLELINVSKSRQGFSLDTINITLKKGFIMGFIGPNGAGKSTTIKLIMNLIKKDS
GMIKVFGLDNEKHSMKIKERIGFVYDDNHFYEELTIKEMKNIIRPFYSQWEESTFNKYVK
DFSLPIDKKINELSKGMKMKFSLAIALSHQAELLIMDEPTSGLDPLVRTELLDVLQTLIQ
DENKAIFFSTHITSDLDKIADYITLINNGQIILSKTKDELLEEYTMVKGKDSTQIIHNKN
LIGLKSNDFGFEALCKNKEEVRKQFGNSYFYEKPTLEDIMVFYTRRSGGHVSSN
>PK3-045_02655 HTH-type transcriptional repressor YtrA
MNIFISNSSEEPIYLQIVKQIKEQIVAGELKETQSLPSIRSLAKELKISVITTKRAYDEL
EKDGFIVTVAGKGSYVAAINKEILRENKLTTIEEHLTEASSTAKLIGLTLEELQEILKII
YKG
>PK3-045_02656 hypothetical protein
MQEELNGEKINSRMNQFKQLDQSRESLIEEAIILCKTGETQINEVTERINELARHGVIQL
EKMLHKQWYVNL
>PK3-045_02657 Signal peptidase IB
MQPTYENQDRVIVSKVGQIKHFDTIVFHSPIEKEDYIKRVIGLPDDTIEIYDDTLYINGE
KYDEPYLQEKKKHLLPNQRLTENLKVTVPKGHLFVLGDNRQNSMDSRQLGCISEDAVVGK
AVFRFYPVMENY
>PK3-045_02658 L-amino acid N-acetyltransferase AaaT
MKSADQYLIRHAKLEDAEAIFAIQQSVIAEEDYLITTIEEFNQTLEDQQAWVAKILHHNE
RETILIAEETNKVIGFIVFQTKNRQRLNHTGSLGMMISKKHRSKGIGKLLIKALLAWAKE
NPLIEKVSLGVFSTNTRAISLYTCMGFIEEGRKIKEIKLSENEYIDDILMYKMVI
>PK3-045_02659 hypothetical protein
MKKFLIIFNWSLLFLLLLTGCSQNSEDKAADSRDYEKADSNVIDAQNEIGELPATDSKTV
KENNGQAISNNDRLVIYNGNLSLKVKDYHNVEKHIQSKAAELGGYIVESSIHDSGTDYIN
GTIIVKIPQKHFQTYLNDIEKKSIKVTEKSITGNDVTEEYVDLQSRLKAKEAVEKRLLAL
MEQAEKTEDLLKISNDLATVQAEKEQILGRMKYLKNNVDYSTVTIQLEEELVKVGSIQDK
ESLNTWEKAKSQFVSTINGLISFLSSVIVMIVGLSPILIPVVVIVIAWIIYRKKKNRSE
>PK3-045_02660 hypothetical protein
MELDRHMEMTFQNLQEKNMTFDIVFQRILAFMSRSPSGNYQLMIGTDSQVHSKHTKFITG
IVIMNKGKGAWACIRKVIIPRKILRLHEKISYETTLTEEVVSLFTEDRKNQLIDVVLPFV
YQGATFSIEGHIDIGAGRRNKTREFVNEMVARMESIGIEPKIKPDSFVASSYANKYTK
>PK3-045_02661 Putative membrane-bound redox modulator Alx
MDVLHQILSTYASFFDWKMWAEVLTDPVSWGLIGSLVILEGLLSADNALVLAVMVKHLPP
DKQKKALTYGLFGAYFFRFFFIGIGVYLIHFTWIKVIGAAYLAWIVIKHFWLGEEDEDAS
AMKKDSWTIRLFGVFWATVISVELMDLAFSVDSILASLAVSNEIWILLIGGMLGILMMRT
VAKLFLVLIEKVPELENTAFVLIGIIAVKMFASIFGYELDHYVFFGILIAAFIITFIIHF
INKNKKVSEEVASSKEK
>PK3-045_02662 Dihydroanticapsin 7-dehydrogenase
MYKDKVVIVTGASNGIGKAIAKAYLQEDAYVILADIDEEQGKHVLDSIEQKERAIFIKTD
VRNEADIIQMVETTQAKFGKIDILINNAGKGIFKSFYDLTIEEWDDVINTNLRSVFLCSR
EVAKIMRTQGAKGSIINMSSSRAYMSEPNTESYSASKGGIMAITHALANSLADAHITVNS
ISPGWIETKDYENLRESDHEQHLSQRVGKPEDIARACLFLTNPQNDFITGTNLMVDGGMT
VKMIYEE
>PK3-045_02663 Peptidyl-prolyl cis-trans isomerase B
MATKGYILMQNGEKIEFELYPNEAPGTVANFVELIKKGFYNGLTFHRVIPGFVSQGGDPN
GNGTGGPGYTIKCETEGNPHKHVEGALSMAHAGRDTGGSQFFIVHEPQPHLDGVHTVFGQ
VTSGIAAVKAMKNGDVMEKVEITEE
>PK3-045_02664 hypothetical protein
MSRKQRGGIVFFLSLVLLLLLSGCGTTKSEPSNEENTTQAKVISPDDYPIVTITMEDNST
ITLELYPDKAPNTVNNFVSLVNKGFYDGLIFHRIIPDFMIQGGDPNGNGTGGPGYSIKGE
FSENGFENDLKHERGVISMARSQLPDSAGSQFFIMVADAPHLDGEYAPFGKVIEGMDVVD
KIVSSKRDKNDKPVEEIKMKQVTVDTKGIDYEEPKKIKE
>PK3-045_02665 ATP-dependent RecD-like DNA helicase
MTNIITTIKQWQQALQIEINHLKKYGQSKVALYNGILLNTENDFTYYFESISNLKVPIGS
NVMIHWGSQAVRGRVLSADGKSLLIILEKEIGEDVSEAYLSHDPWELLEQLQIRFDTIKK
NKRKLSRIVKLMQPSEETKHPSEQLKNHVHELSLRCKYNPVSFVWGPPGTGKTYTLARVA
LQRYWKGKRILLLAQSNQAVDVLLTEITTTIKEKDRFKIGDILRYGGNSNNASLEQEKIT
TSSLLDKKDMDLAKQKQYFFEEKLKLKQDLSYSFTTRDSAQLLEMEEKLANVMEKIRKRE
LQFVQKAKIVGTTIVKAATDPAIYEDEYDLVIVDEASMAYIPQVAFSASLAKRIIICGDF
KQLPPIATSRHALVDKWLREDVFHATGVAKTVHSSSLHPQLLLLNEQRRMHPSISQFTNK
YIYHSLVGDHKRVERNRKAIAEKLPFQGDANILLDSSQFGAYATFERASKSRMNYIHLLL
ALQVINEALSEKGTTSIGYVTPYRAQAEIMEAMAAEFFPEAIMEKRLIVATVHRFQGSER
DIIIFDSVEGQAFLKPGMLLTGKESGRLINVAISRAKGKFIHIANRNYIKTKIDRKKTIR
QLVNHQESFNKVVTNQQIGEWIQKKNPKLFWTHAQRVELLEKDIKRSNHTIIASFPKQNE
ILKQQWKQLLNRGSIGSAPGIPFPFIIIDEKVIWFGLPSELVNGSTPPSLAVRIHSPYLA
SYLLKYIS
>PK3-045_02666 hypothetical protein
MRDVKLLDIYNHHIAQKYITRSGLAHALAVAYHAFEMAKESNVDVDNAAKAGFLHDMGHY
TWYKDGKWDYKLYRQNDIHPIKGAERAHKLLIRLGENPIKAKEIALAVLFHTDSFIPGGS
VILTPLQKIVKLADEKDEEPGGHHHYRTITKERAIKSLERLDAKIDEYIEQQTKNSKELE
G
>PK3-045_02667 Glutamate synthase [NADPH] small chain
MGKATGFIEYNREEAEERNPLSRLKDFKKYSAPFSDDVLQRQGARCMDCATPFCHIGMEI
AGSTSGCPIHNLIPEWNDLVYRGRWKEALDRLLKTNNFPEFTGSACPAPCEGSCTVAISD
PAVAIKNIERTIIDKGFEQGWIQPRIPAKRTGKKVAVIGSGPAGLASADQLNQAGHSVTV
YERADRPGGLLMYGIPNMKIEKKDVERRVKLLTQEGIDFITNTEVGKDITASELREQYDA
VILCTGAQKQRDLVMEGRDAEGVHFAMDYLSGVTKSLLDSNFQDKNFIDAAGKDVIVIGG
GDTGADCVATALRQNCKSVVQFGKHPKLGIMRSSENMWPAAPNVFTLEYAYEEAEQKFGE
DPRQYGIQTKRMVKDSDGKLKELHTVSMEKIKQADGTFIFREIPGTEKVWPAQLVFIAIG
FEGPEQPVLKHFGLETTSRKVAAVYGDFTTNLEGVFAAGDARRGQSLIVWAINEGREVAR
KVDEYLMGTSILPTVNA
>PK3-045_02668 Glutamate synthase [NADPH] large chain
MTYNQMEKAQGLYRPEFEHDACGIGLYAHIKGEATHDIVKKGLSMLCKLDHRGGQGSDPL
TGDGAGLMVQIPDTFFRKELKEFNLPESGKYAVGMIFFSKDDPHREIIEAKINEYIKEMG
QELIGWRTVPTDFRKIGKVAQESCPIVRQVFIQSSIENKDKLAFERKLYIIRKLAENWGR
AEEKEFYFASLSSSTIVYKGLLTSDQVESFYLDVQDPAFVSAFAIVHSRFSTNTFPSWER
AHPNRYLIHNGEINTLRGNFNWMKAREQQFVSEVFGEDLQKVLPILDANGSDSSVFDNAL
EFFILSGRTPAHAAMMMIPEPWTENPHISKAKRDFYEYHSSLMEPWDGPMAITFTDGKQI
GAILDRNGLRPARYYVTKDNYIVFSSEVGVVPVEEENILYKERLSPGKMLLIDLEEGRIV
SDEELKNTIASAHPYDDWLDEVIRLEENVEEKAEDFTDLLARQKAFGYTYEDVQKNLLPV
VLEGKDPIGSMGNDTPLAVLSNKPQSLFNYFKQLFAQVTNPPIDAIREHLVTSTLTWLGA
EGDLLHPDASNCHRIQLKTPILSNSDVEQLRSHTFTEFTARTLDSLFTDDLESSLNQLMQ
KAEEAIAQGVSLLILSDRAMKREEKAIPVLLAVSALHQDLIKKGLRTKASIIVESGEVRE
VHHFASLIGFGADAINPYLVYATYNQAIKDGMLSLSYEEAVTRYNTVITEGVVKVMSKMG
ISTVQSYRGAQIFEAVGIGEEVIDRYFTGTVSQLGGIGLDIIAEEATKRHEWGYQDGMDE
TLDSGSDFQWRKGGEHHAFNPKTIHTLQWACRKGDYSLFKQFSEAANEESMSFLRNLFAF
DSARQPIDMKEVESVESIVKRFKTGAMSFGSLSKEAHETLAIAMNRLGASSNSGEGGEDP
SRYMIDENGDNRRSNIKQIASGRFGVKSHYLINAKELQIKMAQGAKPGEGGQLPGNKVYP
WVAEVRGSTPGVGLISPPPHHDIYSIEDLAQLIHDLKNANRDARISVKLVSKGGIGTIAA
GVAKGAADVIVVSGYDGGTGASPKTSIKHTGLPWELGLAEAHQTLMLNGLRNRVVLETDG
KLMTGKDVVLAALMGAEEFGFATAPLIVMGCVMMRACHLDTCPVGIATQNPELRYKFAGD
PDHIVHFMRFVAEEVRELMAQLGFRTIEEMVGRTDVLKVSEQAQSHWKAKDLNLSKLLYQ
VDGPRTFETPQNHKIDESLDSQKILPAVQKAIVNKEALHLHYTIQNTNRVTGTIVGSEVS
KLYGEEGLPDNTINLHFTGSAGQSFGAFIPKGMSMYLTGDANDYIGKGLSGGRIVAKAPA
DNSFIAQDNVIIGNVAFYGATSGEAFINGKAGERFAVRNSGASVVVEGIGDHGLEYMTGG
EVIILGDVGKNFAAGMSGGVAYVLSKDADKFKAMCNKEMIIFEQLEEQAEIERIKGLIKK
HIELTGSLAGQQVLANWDKYVQQFVKVIPKDYKRMIANIQKGLENGLSEEDAAMEAFANN
SKQDKKKQANKISVLVQ
>PK3-045_02669 HTH-type transcriptional regulator GltC
MELRQLKYFIEVAEREHVSEAAEHLHVAQSAVSRQIANLEDELGVQLFEREGRNVKLTPI
GKIFLTHSQSILKSVDRAVEQVNAYLDPERGSIKIGFPTSLASHLLPTVISAFKEKHPHV
KFQLRQGSYHFLTEGVKNRDIDLAFLGPVPTDDFLLTGNILFTEKIFALLPSNHILSERK
SLRLRDLRNDEFVLFPEGYILQKIAIDACKQEGFLPNINAEGEDLDAIKGLVSAGMGVTL
LPESTFYDTVPKFTVKVPIEDPIISRTVGIIVPSNRELPPSVQTFRRFIIDFFTILEKYQ
>PK3-045_02670 Oligoendopeptidase F, plasmid
MQTYKTREEVADCEKWNLRDIYESEAAWDNDLEAVKEKITTLSGFNGKITNGTTLLAYLT
LSEEVSYLYRKVYAYGMLLLDLDTRNTHAQSLIEKARLVGQKYSSATAFFMPYLLSLDEQ
ELNTYIQEEEGLAYFEKDLLESFRYKKHVLSKEKEEVLSELGESLSVPSNVFGMINNADI
TFGEVTTDNGEKIELTRGMYAKRIEDEDRDVRKEAYLAYYKPYIGLKNTIAATFSAAVKN
NVKTAKLRNYPSALEKSLFGDQVPVEVYDNLISTTRKNLPYMDDYMNFRKKRLQLDELHA
YDLSVPLVGEAAKEEISYDDAFQIMLEALKPLGEEYLSVLKTFKEKRYIDVRETPGKRSG
AYNLGLYGVHPYILLNHRDDLDSLFTLAHECGHGMHSYFSSKHQPQISAGYSIFVAEVAS
TVNEVLLIRHLLKTEDDETKREHLLHHFIDSFKGTFFTQVMFGEFEKAVHEQAEKGLPLS
LDFFNQTYEELFKAYNGSALVIDEQVKYGWARIPHFYRPFYVYKYATGFASAINIADKLL
EGKKEDVENYLEFLKSGSSDYPLELLKKTGVDLTSPEPINHALTIFHSLVKEVLKK
>PK3-045_02672 hypothetical protein
MEKYLLNAPKQSVGNVVDSLFAEMVLEKALYDFQKAALKKQIDETLIAGDKELFYRLTKE
LNQLTAK
>PK3-045_02673 Sugar phosphatase YidA
MSYKMIVLDMDDTLLTDDHIISEATKTALMLAQEKGVKVVLASGRPTYAMLDAAKELRLA
EYGSFILSFNGAKITNCQTNEELFSSTLSPETVHQLFDLSQRENIWIHTYMNDEIITQEN
NPFTEIEGKLTGLPIKTVADFKQTVSSPVVKVLMVKEENYLKEVEARLQKELANDLSVMR
SKPYFLEFTELSVTKGTSLAILIEKLGISREEVIAIGDSYNDVAMIEFAGLGVAMGNAPD
DVKQLADYVTDTNNNDGIAKVIDMFILEPLVTKSV
>PK3-045_02674 hypothetical protein
MVNKSHTLNFGWNLIAHKDYKLFSNQNEYVLMDWDGDVVLCVSVQDHEIEILRSNWNLHF
KVNLAFKTIKVFNEPDEEE
>PK3-045_02675 Branched-chain-amino-acid aminotransferase 2
MTDQTITVTLAKDKKPKPDPSTLVFGKVFTDHMFMMDYTVDKGWHDAQILPYQPITLDPA
SVIFHYGQAVFEGMKAYLTEEGKVLLFRPKKNMERLNKSNDRLCIPEIDEEFALNALTQL
INIDREWIPKGEGTSLYIRPFIISTQPFLGVAASISYKFMIILSPVGSYYKEGVKPVKIF
VENEYVRAVAGGTGSAKTAGNYAASLKAQQIANERGYSQVLWLDGVEKKYIEEVGAMNVF
FKINGEVYTPELNGSILEGVTRSSVMELLKYWNIPVTERKITIAEIFEAHKNGQLEEAFG
TGTAAVISPIGEFFWNEEKIVLNNGETGELASKLYNTITDIQNGRQEDPFGWAVEVK
>PK3-045_02676 hypothetical protein
MHLIRTDIDEILTNTADLEQEISTWNLIDIEIDELLEDTKHWN
>PK3-045_02677 hypothetical protein
MIRLLKWVITILLIYGAYNFYLKDNGHNAEESKPSGSMENRINQDSITSFFQSFTDEFEK
IKSFFKDAEDMLPDWNFEENTEDTEEIDKPELVTPQDHPFSIHNISLGDDKKSVEKSLGS
PKRETINEYGISWYAYHQNYHNFVMVGYDEHNQVEALYTNQDLIASTNGIKKGTKKEVVL
KTLGKPLTEIRKGLVFYKMAEDRDYEVFALDDSYVTVFFDKHENNTVTALQIISSSLEEN
RKDFYVEGNEKLKEGFEYQLFDLTNASRVNNHLKPLTWNEAVRDTAQKHSLDMAENNYFS
HTNLEGESPFDRMLNDGIRYTIAGENLAYGQNSSIFAHEGLMNSSGHRENILQKDFASLG
VGVAFNNKSQPYYTENFLTE
>PK3-045_02678 hypothetical protein
MENFNTQFLYSVIIIGMGYFFKQRNIIKEKDGEGLARIIFNITLPCLIITTLHNVIIEKS
LLILVFLGLFYGVLISIIGLFLFRNEANKQKGMLGMLIPGFNIGIFAYPLVQGIWGAEGI
KYFGMFDIGNALVTFGISYLIGSYYSQEGSELSAKQVVGKLGRSIPLMTYVLIFFISIVG
IEIPHQIIDVTSTISKANMPLSLLLLGIYLNFSFEKSHWKGIGRVLGIRYGTGLFLGVLA
YFLWPAEDMFRYTILICLILPMASSVLPYSVEFKYNQRFVGTAANLSIVISFFLIWMIGN
LIV
>PK3-045_02679 L-lactate transporter
MKTKNRWLIALSAVGIHISIGSVYAWSVFTKPLESQYNWTLTSISWTFSIAILFLGLSAA
FLGHFVEKYGPRTSGMLSACMFGLGMAGAGFATSIESLPLLYITYGMFGGIGLGVGYITP
VSTLVKWFPDRRGLATGLAIMGFGFAAMISSPVMNHLINTVGISNTFYILAAVYFVIIFV
SAQYLEAPPKGYLPKGFQQSVEAGNVIVKEDLSQLTANEAVKTKRFWALWIMLFINITCG
IAILAVASPMGQELAGMSVAGAATLVGIMGVFNGVGRIAWATISDYIGRPNVYTLFFAVQ
VVAFFALPHLHHYIAFSIIIFIIMSCYGGGFASIPAYIGDIFGTKQLGAIHGYILTAWSA
AGVAGPSIVSWIRDTTGSYQGTLLVFSCMFIVSLAVSLLIRLDIRRLKELNKSVTESNSF
>PK3-045_02680 Formate-dependent phosphoribosylglycinamide formyltransferase
MNRRDFYDIMQNKGIINCLGGLAIVLGAPNTSQARKIMLLGSGELGKEVIIEAQRLGLET
IAVDRYEQAPASHVAHRAYTVDMLDVNQLKAIIEKEKPDYIVPEIEAIATSALMELEEEG
YSVVPTAKATYLTMDREGIRRLASETLNIPTAKYAFANNITELKDAVHNIGFPCVIKPVM
SSSGKGQSICRSIDEIEFSWKEAVDGGRGKKTRVIVEEFIEFESEITLLTVRSVNGTTFC
PPIGHTQKDGDYIESWQPHFMSAEQLDEAEMIAKKITDSLGGYGIFGVELFLTENDVYFS
EVSPRPHDTGMVTMITQDLSEFALHVRAILGYPVSGVKLHSPGASKTLKATEESNSYFIQ
GIEETLSFENTQIRIFGKPKTTKGRRMAVVLHTNETVDLALEGVRKASAPLSITYSS
>PK3-045_02681 Allantoinase
MVDLDLIIQNGILVNEETLYKADVGVKGGKIVLVGSEINGNNATKIFNADGLYLFPGVID
SHVHFNEPGRSDWEGLESGSKSLAAGGATLFFDMPLNSHPPTTTEYGFQQKERLAKEKSI
IDYRLWGGIVPGNYDEIEKLVKCGVIGFKAFMSNSGIEDFQSADDRTLYQAMQKIAALHS
ILAVHAESDTITEFLSKEIIHQQTNLGLAFSNARPIFSEVEAVQRIIAYAESTKCKLHIV
HISSSKVLEPIVSAKKRGLDISVETCPHYLSLTIDDLEELGAVAKCAPPLRSDKEVDDLW
KAIKREEIDMIGSDHSPSLPSMKNGNLLEAWGGIAGCQTTLSVLLEEGYWKRGISLPLIA
KITSTNPAKRFGLYPQKGSFANGSDADIAIVDLNETYTLQKEDLYYKHKISPYIGKTFRG
KVKATICKGEIVYSTLNG
>PK3-045_02682 5-hydroxyisourate hydrolase
MKMGITTHVLDLSKGKPGKGIKVELWRLLDSERIFLASGITNQDGRVDTILLEKVETGEF
ELVFHIQEYYRHLEEQHPFFTTIPIRFYTDETQPHYHIPLLLSGWGYQTYRGS
>PK3-045_02683 Uric acid degradation bifunctional protein PucL
MYTIAEINQMNRQEFIEKIGWVFEHSPWIANKTWNYRPFPSLNTLYQLMVQAVMEAPIGD
QLDLIRAHPDLGGKLKMTSSSSKEQKGAGLNQLSEQEYMQFAALNKTYSEKFGFPFILAV
KGHTKDSVYQSMKERVNHTKEEEFQTALTEIFSISKFRLEEIVKLETEGQGA
>PK3-045_02684 putative xanthine dehydrogenase subunit E
MDTNEITETTTFKVNGESLTLSLPPTFRLVDILREVLTFTGTKIACEAGRCGACSVIMNG
KLVNSCLVMAYQLENAEILTIESLAEKNLHPIQEAFLQAGALQCGYCTPGMVMALKSLLD
ENEHPSRAEVLTALSGNLCRCTGYEGILRAVTLLTNKRDEKG
>PK3-045_02685 putative xanthine dehydrogenase subunit D
MVLDIESAGSRWKIRRDGEPKVTGKLKYLTDLTFPNMLYGTVLRSEYPHAEIESINTKEA
EELAGVFAVITYKDVPGLNGFGIVIQDQPVFCEEKVRYVGDAIAAVAARTKEIAQKAISL
IKVKYQPLQTITDPDEALKDTAIRLHKEGNLLHHAAFKKGKSNIEEAFNKCEWIIEETYQ
TPRQMHAYMETEGGVAVPDEAGGITIYAPTQHGFKDQLQLSRILTLPLEKIRIISSPIGG
SFGGKDELNVQPYISLLALKTQRPVKIHQSRRISIKAGLKRHPMKIYMKTGADASGKIIA
HQVKITADTGAYATLGPAVLDFAVEHSTGPYIIENVDVNGYSVYTNNGVAGEFRGFGGNQ
ITFALETQIERLAEKAKIDSTKLRFTNLRKTEDFGPVDQPIVATTGAYAVLAEITKSAIL
QKNLDTNAMDGDGKIKGRGYSITMHGGGLGYGRADASGARLALNSAGKIEVSFGFEECGQ
GLISTIEMIMTDTFFCVSSDIEIIIGDTAKVPHSGSSTASRATNMVWLGISKLKAPFSEK
LLTLAEKQTKCSKESLYLGKNGIWKKEEENKGPALILSYKQLADSCEELPTVSASYHFPT
TPNSIDGGHFLYTFAGVAAEVEIDILTGIVAVTRMDHVISAGPVVNPMGYLGQIEGGANM
GLGFTIMEDAVMENGRYMNENFDTYLIPTILDIPIETTVTAIEELVPGDDYGPRGVGEIG
TVAVAPAIISAIHDATGIWLNQLPVRADILLQALEKQQGLLD
>PK3-045_02686 putative xanthine dehydrogenase subunit C
MHVSTLNYPTTVEIPTTLAAINKWNESDYAFISGGTILQVNWEAGHDKPNHLISTEKLIE
LKGISEVERNGQYFLQIGAGMSISDCLINPLVQKKAPLIVAACEKIAAPAIRNRGTIGGN
ICSKIGDCIPALLVLEAQLTFFNGKETYLVTLKDWLASQKSHSSELLTKVLIPIAAPKTE
TYSFFKKIGRRASFTAAIISIAGYLEFEEKNIRIIRIAIGGGSHIPTRLISTEREFTRSH
SAIDWSRIFKVIQEDFSSYTDPFISEAYRKKVAANVIVTNMKELLQ
>PK3-045_02687 Purine catabolism protein PucB
MIAALYLAAGNSKRMGEHKLSLPLRNEPVGNHALSVLLTSPFVDFVIVITQPDDDLNWIT
PVNKLLLNGKKGKVINCDESSLGQSYSLKKGFRAAIEQQAEKILVCLADQPFITHDMIDK
IVTTPLHPPYKYVASMHNGVYKPPILFHQSALSDVNQLEGDKGARKLLKDGILQGEKIEF
SEEEYFIDIDTKNDYEKVLKRRE
>PK3-045_02688 putative xanthine dehydrogenase subunit A
MSSDHYAVIDAVIAMEKNNYLATIVNVEGTAYRKEGTLMYITETGKEEGLLTGGCVEQDL
LARIEMQKEAKAFLMEYDLRSEDDLTWGQGVGCDGKIYIMVEPITPATSAVFQQLKSYMQ
KGESVKLIKSFHKINKFLVNTVIPLGKEETNPALTSFLDTGNNYIFTQVLSPQPRLIIYG
AGPDVRPVVYFASKAGFYVILSDWREANCSVDNFPDAKEYQIGSPTQVLDAINPSENDYL
LLMTHNFSKDQEFVHLLLERRVKFLGLLGSKKRSEKLLAEKIKPDWVHYPVGISIHSESP
EEIAISITAQLIKIKNSKNSVMGKIG
>PK3-045_02689 hypothetical protein
MNKEIIKFIRKNYEMTQRDFARVLNCSFALIALVEVGKRRVSKDLENKIRQTFNIDDQDI
ASITSIISEISKGIPPFM
>PK3-045_02690 hypothetical protein
MPINEHHSNSSKIYLPKLSAESLNNQSRYHHNYLQEYLFKQHKQNEQLMTLWNKFQEDSI
EKQKKHLQQFNEIDSKLELNDSATKELLTKFTALDNETSKIEEQLDTIILLAQEQKDLTE
EESLRQTALFDQLSFQEKDIAMISNKMEDFNQLATDVKTKITETETNYQHIAEKLDLQEI
FQQTLLESMKETTGSVNKISRQLDYLKEVIFERIHYLAEKIENNIKSISQPIQRFFVSSE
KDETIKK
>PK3-045_02691 Cell wall-binding protein YocH
MKKIFSILTCASILTTAAPFVGAEEMKVEKGDTLWSISQEKKVSVDDIKRWNDLDSDIIK
VDDTLTIKEVKKYKVKAGDNLWKISKKYNTTVDQLKDWNKLNSDTIHKDDVLIVSKEGSE
QKTSESKPVNKPVKADNTVKAESTNSAAKEITVTATAYTANCEGCSGVTATGINLKDNPD
KKVISVDPNVIPLGSKVYVEGYGTAIAGDTGGAIKGKKIDVFVPSQAKALEWGRKQVSVK
ILD
>PK3-045_02692 Adaptive-response sensory-kinase SasA
MYNSILIFISILIVYMACYSSFDLFQLVKNGEKNSRFLFLASTFTIGFGFWILSFIDMMI
KNVYATANYNIPITILSMVVGICFSGMAFYALLDKKKKKRRIYVSAFFFSLSLLSVSIIG
FYSIGSIVYYQIPQLFISFLLLFFVFFISIWLSFYPVNISAVLKKWIRPVCSLLMTGVCM
ISHFILLSDVSAPEVSVVRDSYQSSFIIYIALFVSVLVLGGLIGTSTLIGERMDVGAINV
RDMQHALDESAIVAFTDNNGMITYVNDKFVEVSKYSREELLGQNHRILNSGHHSPEFFRQ
LWNTIKKGEIWKGEILNKAKDGTLYWVDTVIVPFLNKEGAPYQYVAIRRDITEQKMVQHQ
LEESVREVSDITYALEQSSIIAFTDKRGIITNVNSKFCEISGYSRQELIGKTHRIVNSGY
HSKDFFRNVWQTIGKGEIWKGEIRNKRKDGSYYWVDTTIVPFLDKNNKPYQYLAIRNDIT
EKKRTEEVLHRQDKLAAIGQLAAGVAHEIRNPLTSIKGYAEFLSMDETEKDRQEYFEIIL
DEIERVNSIVEEFMLLSKPTVSVLEKKPLLPIIDNVLSILDYQLRKNKIQLNRYYEDSNP
FVECDENKLKQVFLNFIKNAVEAMPDGGSIDINVKKEKGNISILIKDSGIGMSKEQLKKI
GEPFFTTKKEGNGLGLMVSFKIIENLNGKVYVDSELNKGTSFHITLPSVH
>PK3-045_02693 hypothetical protein
MFFNRKGVEEKPEEVLMSMEVYACNSCNGWMRKDFATDDLLCPLCGDQTTAEMRELPQIS
N
>PK3-045_02694 hypothetical protein
MSTKLFYSTPYETKWTTTIKEVIETKNQIYVLLKETAFYPEGGGQPADTGFIDGIRVVDV
QMKDNQIYHLMERKPENKLVSCELDWDRRYDHMQQHTAQHMLSAVLEELYQIPTVSFHLG
KEYTTIDIDTADLTKEQMTQLEKSCNSYIMKNLEIKTHITTYEQVSKFPLRKLPKVTGDI
RIVEIDNWDFSACAGTHVGRTGELGVFKILKTEKHRGQTRIFFLSGWRAIRDYQTAQSIL
DNLGTFFKTNKLQLEDRVNKVELEKKALTKELETLKRENIAFLAEQILSTHTEKVIFLSF
ADKTIKDLSILAKYLLQKQSSSIILLSSETDKKILIQQNGDYPLHCGKFLKETIQGYEGK
GGGNVLQAQGTFSSVLQLNACLKELRQRLDESI
>PK3-045_02695 ATP-dependent DNA helicase RecQ
MMDKARSILKEYFGYDHFRKGQEDIIRLLLNGENVAGIMPTGGGKSICYQVPAMIFPGLT
IVISPLISLMKDQVDALTEVGIPATYINSTLHNEEVQERIYDIKNGHYKLLYIAPERLEA
DYFTDLLKEVSLSFIAVDEAHCISQWGHDFRPSYAKIGFLINKLAERPLVAALTATATPK
VHEDICQLLNIPWENTVKTGFARDNLSFSIIKGQDKGKFLESFLKKNKEESGIIYAATRQ
EVEKLYERLAKKGYSVAKYHGGMNDGQREAEQQAFIKDDVSIMIATNAFGMGIDKSNIRY
VIHYQLPKNMEGYYQEAGRAGRDGLQSKCILLYSAQDIRIQRFLIDQTISDPDKQKQDLD
KLQSMINFCHTEDCLQEYILHYFGEEYTEKCGQCSNCTDERTVIDVTVDAQKVLSCMIRM
GERFGKTMIAQVLTGSKNKKLMDFQLNQIKTYGLMKEQSAKEISDFIEFLISEQYIDVST
GTMPILKVSNKGKEVLLGKIRVVRKEQIETVKVSENNALFDYLRGVRKQLAEEENVPPFV
VFSDQTLRNISVLMPTSHEEFREIKGIGDHKLQKYGDVIIDHILAFQKEETYSADREDIH
SSEVRTKKDKRAKKQVENSHLHTFELWKSGLSIKEIAKERQLNVQTVENHLLRCGEEEIE
IDWTKFLKPEDKTKIVEAIQKVGMDKLKPIKEELPEEISYFMIKVAIMLEKRNQQIRN
>PK3-045_02696 hypothetical protein
MGYGGFGYDNCGCGYAAPVAAPVATGGGFGFGNGFVLIVVLFILLIIVGAAWL
>PK3-045_02697 hypothetical protein
MSGGHTAGFGGGFALLVVLFILLIIVGSCYVGF
>PK3-045_02698 hypothetical protein
MSAKNFYNQCSNGVGRCVRIRTHSGEVHTGIIERVTPNKVYIRPIGGNRRSHGGFGYGYR
RGNRPGWGWGWGWGFGAAAVGVSLGLIAALAFIPFF
>PK3-045_02699 hypothetical protein
MLVAAMWGAIASLSLLVGSIAGLFLMIPKRIIAYFMALGTGILIGASSFELLIKSVHKSG
IITTAITFLTGAGLFTLIEIFLYKKGGSNRKRSHKNPEGHSGLAIYIGTLMDAIPESMII
GLSLLITQKVDMLFLIAIFISNFPESLSSTVGLKKDYYSNKKILFLWSSVILISAISSSV
GYLFLENASAVMLSGIQSFGAGGLIAMVCSTMLPEAFEQGGPTVGFVACMGLIFSLSMSH
LG
>PK3-045_02700 Nitrite transporter NirC
MEIHPVDKAINYALKKKETIDDSFFRYFVKAILAGIYIGFALMLCYRLAQPFFDIHSPAT
YMMTSLFFGLALVLISYGGGELFTGNTMAFAMSTLSGATSWKDTIYNWVSTYFGNLVGAL
FFALLIYYSGLFSLVPKTTWLMDVANSKMSATTVELFVRGILCNWLVCLAIWIPMNVKGD
VGKIIATLLIVFAFMISGYEHSVANMALFSIALIVPHPETITLANALHNLIPVTIGNIVG
GAFFVGALNLYIFPKKKRKTNESSLRVTTPKSLAK
>PK3-045_02701 hypothetical protein
MMAKKQLVDLVNKMKKSGIKISFTKPRSQFSVAIQQNSKLSTTTQ
>PK3-045_02702 putative ABC transporter ATP-binding protein YbiT
MITVTNVGLRYGDRKLFEDVNIKFTPGNCYGLIGANGAGKSTFLKILSGEIEAQSGNVSL
GPGERLAVLKQNHFEYEEHEVLKVVIMGHARLYEVMQEKDAIYMKENFTDEDGMKAAELE
GEFAELNGWEAESEAAILLKGLGIGEELHYKTMAELNGSDKVKVLLAQALFGEPDVLLLD
EPTNHLDINAIKWLEEFLINFDNTVIVVSHDRHFLNKVCTHIADLDYSRIQIYVGNYDFW
YESSQLASRMANDANKKKEEKIKELQNFIARFSANASKSKQATSRKKLLDKISLDDIKPS
SRKYPYVAFTPEREIGNDLLRVENLTKTIDGVKVLDNVSFIMNKDDKIALVGPNEIAKTT
LFRILAGEMEPDSGTYKWGVTTSQSYFPAENSEYFNNDDETLVDWLRQYSPNDQTESFLR
GFLGRMLFSGEEVLKKPSVLSGGEKVRCMLSKMMLSGANVLLLDEPTNHLDLESITALNN
GLINFKGSLIFTSHDHQFVSTIANRILEITPQGLVDKQMNYDEYLEDEALQKNIANMYK
>PK3-045_02703 hypothetical protein
MKETTIVFCFVLLLFCFPAISNAKDNKEPELISEAAFLLDSDTGAVLYEKNGYKKMYPAS
LTKIATAIYAIEHGKLDDIVTVSENAYSAEGTRVYLEKGEQVTLRHLLDGMLINSGNDAA
IAIAEYLDGSISNFETNINKYLKEKVNVHSTHFKNPNGLFDKDHYTTANDLALITQYAMK
NETFREIFGTDELKWDGLSWDTTLVSHHQMVNGSRPYDKVTGGKTGFVDESKQTLATTAE
NGELSLIAIILKGTYKQDVYNDTEELMDYGFSQYMHKLVPGGKSFFAKGTTYETSDEVNI
TVPRTKGKEEVSSSGVLMIKNENDDIIQSVQLANAEPAEETFKKNISDEAGRDEKKSSFP
GIVFLIPFAIYFIYVIRKKAIKR
>PK3-045_02704 Phosphatidylglycerol lysyltransferase
MSIRKKEILINIAKILLPIVIFIIVLREIKNMIVSADINQLYEYLQTIPFHSLFYIAIGG
FMATLPMFFYDFFLVRHLKKRVPIVEVGKYSFISNSFSNLIGFGGLIGIALRNFFYKRYE
KDRKKLFKGIAVVTIFYLSGISLLSWIAILYSRRLNLMEDHFWIFAAIIIVGLIFPVLLV
SYQKAKQHNFVFDQNQIVGLIIVSLLEWIFLFAYLYSIARIIALPVSIGDFFLLFLVAAC
TGIISMIPGGMGSFELVFLWGIESLGIESEQMLIVLFLYRIGYYLLPFLLAAFLFIIEIG
KNIKKNAAAYLKAFSSE
>PK3-045_02705 Formate acetyltransferase
MEKVETTNYWEGFKNGSWQKEVNVRDFILKNFKPYYGDSAFLSGPTLETTQLWEQVMELS
KLERERGGVYDLDTDIVSTITSHGPGYLDKTKEKIVGVQTDEPFKRSFQPNGGIRMAVQA
CESYGYKADEELVKFFTEHRKTHNAGVFDAYTDEMRLARKAAIITGLPDAYGRGRIIGDY
RRVALYGVDFLINEKQKDKKATSSVMTEETIRLREELSEQIRALHELKELGASYGFDLSR
PAANAQEAFQWVYLAYLAAIKEQNGAAMSLGRVSTFLDIYVERDLENGTLTEKEVQEIVD
HFIMKLRLVKFARTPDYNELFSGDPTWVTESIGGMANDGRPLVTKNSFRFLHTLDNLGPA
PEPNLTVLWSTQLPDNFKKFCAQMSIQTSAIQYENDDIMKPQWGDDYGIACCVSAMEIGK
QMQFFGARANLAKCLLYAINGGKDEKLKIQVGPKFEPITSEYLDYKEVTEKFDNMMEWLA
GLYINTLNVIHYMHDKYSYERIEMALHDTEILRTMATGIAGLSVVTDSLSAIKHGKVKVI
RDENGLAVDFETEGDFPKYGNNDDAVDSIAVEIVESFMKKLRKHQTYRNSMHTMSILTIT
SNVVYGKKTGNTPDGRRAGEPFAPGANPMHGRDTKGTLASLSSVAKLPYDYSLDGISNTF
SIVPKALGKEEDIRANNLVSILDGYATKAGHHLNVNVFNRETLLDAMEHPELYPQLTIRV
SGYAVNFIKLTREQQQDVISRTFHESM
>PK3-045_02706 Pyruvate formate-lyase-activating enzyme
MNGNIHSIETFGTVDGPGIRYVVFTQGCLLRCQFCHNADTWEIGTGKQMSVMDIINDLKT
YLPFIEPSGGGITVSGGEPLLQIPFLIELFKECKKLGIHTTIDSSGGCYSKAPSFQAQLD
ELMQYTDLVLLDLKHIDRKKHIKLTGMGNDHILDFATYLSNKKIPIWVRHVLVPTINDTE
EDLTRLSDFIAKLENVEKIDILPYHKLGVYKWETLGLEYPLKDIEPPTQESVDFATAILN
RMM
>PK3-045_02707 hypothetical protein
MIKILGLDVEVTLLNIPISFESELSVGCKKKSCCPHKPPKPPYPPYPPYANRDA
>PK3-045_02708 NH(3)-dependent NAD(+) synthetase
MRDLQERIMKDLNVQPEINPKQEIEKRVQFLKDYAKKAKAKGFVLGISGGQDSSLAGRLA
QLAVEELRAEGYNATFVAVRLPYGVQADEVDAKRALEFIKADKEYVFNIKNPVDDVKTVY
DDMSDTPLADYHKGNVKARMRMIAQYAIGGQENLLVIGTDHAAEAVTGFFTKYGDGGADV
LPLTGLSKRQGKQLLKELNAEEALYLKVPTADLLDNKPGQADETELGITYDQLDDYLEGK
EVTQDVAEKIEARYLLTEHKRQVPASMFDDWWKE
>PK3-045_02709 Nicotinate phosphoribosyltransferase pncB2
MSFNFKDDSLMLHTDLYQINMAETYWEDGIAEKNAVFEVYFRKLPFNNGYAVFAGLERVI
QYLENLQFSEGDIEYLRQEGFKEDFLAYLKDLHFTGSLRSAAEGEVVFANEPLMRIEAPL
AQAQIVETAILNIVNYQTLIATKASRIKNVIGDGIVMEFGSRRAHELDAALWGTRAAFIG
GFNSTSNVRAGKLFGIPISGTHAHSMIQAYHDEYIAFHKYARRHKECVFLVDTYDTLRSG
VPNAIRVAKELGDSINFRGIRLDSGDLAYLSKEARKMLDEAGFYDTKIVASNDLDEYTII
NLKAQGAKIDIWGIGTKLITAYDQPALGGVYKLVSIEDEEGNMQDTIKISGNPEKVTTPG
LKRVYRIINDINGKSEGDYICLESEHPENEERLKMFHPTHTYISKFVTNFTAVDIHQDIF
KDGKLIYATPDIMSIQKYSEQSLEILWDEYKRSLNPEEYPVDLSPLCWENKMSHIEKVKV
SIQNRK
>PK3-045_02710 hypothetical protein
MKALINIDYTFDFVEGNLPCGEPGIAIENEIVKITKNFIDNDDLTVFAIDLHTLNDPYHP
ESRLFPPHNIAESRGRDLYGTLQKTYEDHKDLTNVYWMDKTRYSAFAGTDLHIKLQERSI
KDIYLVGVCTDICVLHTAVDAYNLGYNIHIYENAVASFNEIGHQWALEHFKNVLGATIL
>PK3-045_02711 hypothetical protein
MIDLLLDLTFFPSYQTVYYTFLVGLVLKYLWDWNIKTTVQQEFFATDQRLSLDVSITTIN
MNVQKYNTPILHWIVKNIRKRIESSHDDPEKPITSFVS
>PK3-045_02712 Membrane protein insertase MisCB
MKKLSKNTLLIMLLGLSTILLSACSSSASGNNDGFFHKIFVEPFTAIIHGTADVFAGSYG
LAIILITLVIRLVLMPLMLKQYKKQQLMKSKMDTIKPEMEAIQKKIKATKDQKEQQKLQM
EMMDLYKKNNINPLNIGCLPMLIQMPILMGFYYAIRGSQEIASHSFLWFNLGQSDLILTA
LAGIVYYLQFRVSQSTMTQEQQKQMSKIGLISPIMIVIVSLNAPAALPLYWTVGGTFLIF
QSLIGRKLYPPQPSNTKVATDK
>PK3-045_02713 Putative fluoride ion transporter CrcB
MVSNLLLIGVGGFIGAISRYFFINELKKIMEASIPIPTMIVNIGGSFLLGLIVGMDVTAS
VYFILAIGFLGAFTTFSTFAVEAVTLYREKRRMGLYIYILGTFLGGILFCFAGWNVGLHL
>PK3-045_02714 Putative fluoride ion transporter CrcB
MNYIFVGIGGVIGSILRYIVGQIPFVYDFPLQTLGINIAGSFMLGWFTSAIIKRQKLKSE
YAAAIGTGMIGSFTTLSTFSMDTVHLLIDGSDLLAICYVVGSAVIGISFAYVGMKIGERK
WSKSNG
>PK3-045_02715 hypothetical protein
MIHENWEKKPSVKKVKCIHTDANKYIVNRVLTVGKEYEVKNETEEFYFVVDNSGKIGGFY
KDYFQTI
>PK3-045_02716 hypothetical protein
MYIQEHKNFYVIKYNHTSYYALDFKRLDWINGKCYMTFLQVDTGKWFTFERNKIMWMEKE
LQNLVS
>PK3-045_02717 hypothetical protein
MFAINQKCSKRKLQEADEEHIETKIKYNVTLI
>PK3-045_02718 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MAEIKVPELAESITEGTVAQWLKKTGEYVEKGDYIVELETDKVNVEIISEESGIIQELKA
NEGDTVQVGETIAIVNAEGAAEEPQTAEEKKVEKVEPETPSAEEPKEQKEELVNKQHPIA
SPAARKLARERGIDLTAVQTNDPLGRVRAQDVAAHDQKAASSVSPQSAQTPKVEKEAPAV
ESDNRVERVRMTRRRQTIANRLLEVKQNTAMLTTFNEVDMTNIMALRNRRKDAFQKENDV
KLGFMSFFTKAVVAALKKAPLLNAEIQGDQIVLKKYYDIGIAVSTDEGLVVPVLRDADRK
NFAEIESEILDFASKARSNKLSLSDLQGGTFTITNGGVFGSLLSTPILNGPQVGILGMHK
IQLRPVAIDAEKMENRPMMYLALSYDHRIIDGKEAVTFLARIKDLLEDPESLLFEA
>PK3-045_02719 2-oxoglutarate dehydrogenase E1 component
MEKPSDGTVSYQPRFYGPNLGLVMELYEKYVQDPNSVDEEMKRHFDQWGPPIDNQEKTNT
NHLSLQSEVQVEKIIAAVTLVNKIRAYGHLAADIYPLKDHKREYELFDLARFDLTKEDLE
KIPARLICPDAPNHISNGYEAVQYLKEIYTKTIAFEYYHVNDIKEKNWLQSKVESGSLKP
ACHRELKRKLLKRVIEVEEFESFLHRTYVGQKRFSIEGLDTMVPMIDKIISESVVNGAQN
INIGMAHRGRLNVLAHVLEKPYEMIFAEFQHAPNKQLVPSEGSIGISFGWTGDVKYHLGL
DRQIKSNNVSNVRLTLANNPSHLEFVGAVVEGFTRASQDDRTKPGFPEEDSTKSLAILIH
GDAAFPGQGIVSETLNLTGLKGYRTGGTIHIIANNTIGFTTESSDSRSTRYASDLAKGFE
IPIIHVNADDPEACIKAAKLAIEYREKFKKDFLIDLIGYRRYGHNEMDEPMTTNPLMYKL
IHEHPTITKLYGEKLVAEDVIKEEEIQALKEEVTRKLKEAHDRVPKKNEDPVITNPPNSV
ERQLPNVNTAVPIDQLKHINNELLSYPSQFQVFDKLGKVLKRRNAALEGEGKIDWSLAET
LAFATILEDGTPIRLSGQDSERGTFAHRNIILHDYVTGNQYSPLHTLSKAKASFAVHNSP
LSEGSVLGFEYGYNVHAPETLVLWEAQFGDFANAAQVMFDQFIAAGRAKWGQKSGLVMLL
PHGYEGQGPEHSSARLERFLILAAENNWTVANLSSSAQYFHILRRQAAILNKEEVRPLVI
MTPKSLLRNADVASNGLEFSEGAFHSVLEVDNTGENDNVVTRLVLSTGKISIDLYQAHKK
LENGEAIHLARVEEIYPFPEERLTEIIQRYPNLKEVVWVQEEPKNMGAWSFMEPRIRKLI
SNSISLQYVGRRRRSSPAEGDPIVHRKDQARIINEALTME
>PK3-045_02720 Sensor histidine kinase RcsC
MKWIKKISLLPWKWKLTLGLSFSIFLTYSIFSFFEFHTVSSWLLNQEETDVKQTMNQVVK
QLNLQEKHPTDEEITANVTLLEKLNNDNQLIRILDKNGQAILADMNGDFPIIEPNQIYND
EQFHYISIGDHNSLVYSKEIKTKAFNGRVEIIRSLESLDKVREHLWFAMTMFAIAALIIS
ALIGYFISYLLLRPINSMTKTMKKIKNSGFKERMPVYPQKDEIADLSHIFNEMMDVIEQS
FQQQKQFIEDASHELRTPVSVLEGHLSMLNRWGKNNQDILEESLQTSTEEVARLKKLIIS
LLDLSKLEQNRMESDLTPERVKWIFEHTIRDFVMLHDDFTFEVKLDSLHLYEVSEQHLQQ
ITTILLDNAVKYSVHEKNIFLHTYETGNHFILEITDHGIGIPKEHLEKVFDRFYRVDKAR
SREQGGTGLGLAIAKQIVSLYNGSIEIKSKVGQGTKVIVRFNI
>PK3-045_02721 Response regulator ArlR
MKKILIIEDEKNLSRFIELELTYEGYKTEVCSDGRSGLQKALEEDWDIILLDLMLPELNG
IEVCRRLRQTKNTPILMITARDSVLDRVSGLDSGADDYLVKPFAIEELLARLRALFRRIE
PQTNTSNQIMTKLTYKDITLEVESHIAKKGEEILSLTKREYDLLYMFMTNINIVLSRDIL
LEKIWGYESEVETNVIDVYVRYLRNKLDPSGQEVYIETVRGIGYVMR
>PK3-045_02722 hypothetical protein
MHFLRIAMIVFSSITAASLFGFQFVEMAHAIMDSMFSKQN
>PK3-045_02723 Small, acid-soluble spore protein H
MNIGRAIEIMNAADMVDVSYQGEKIIIQNVNEKTKKATIYTKTNPDYELDVDVYQLIEEM
>PK3-045_02725 Cystathionine gamma-synthase/O-acetylhomoserine (thiol)-lyase
MYSLETKLAQIGNRSETTTGAVNPPVYFSTAYRHTGIGESTGYDYTRTGNPTREILENAI
AELEEGDRGFACSSGMAAIQTILSLFQSGDEWIISKDLYGGTYRLLEQGYKKWGLRCTYV
NTSDTDAVRAAISSKTKAIFLETPTNPLMEQTDISVIASIAKEHNILLIVDNTFYTPIIQ
QPIRLGADIVIHSATKYLGGHNDVLAGLIVAKGEELCNELALHHNSAGAVLSPFDSWLLM
RGMKTLALRMEKHEENAKILSTFLQKHEAVVDVLYPGRGGMISFRIQSESWVNPFLQSLT
LISFAESLGGVESFITYPATQTHADIPLEVRLETGVDNRLLRFSVGIENANDLIKDLDKA
FSIAKGIAQEVTI
>PK3-045_02726 Cystathionine beta-lyase MetC
MTTSYTFETKLLHNKHKFDPDTGAVSVPIQHASTFHQKDIDEFGKYDYSRSLNPTREALE
EVVAELEEGTHGFAFSSGMAAISTAFLLLSQGDHVVISEDVYGGTYRMVTTVLNRFGIDH
TFVDMTNLEEVEAAILPNTKVLYVETPSNPLLKVTDIEAISLLAKKYSALTFVDNTFLTP
ALQKPLTLGADVVLHSATKFLSGHSDVIAGVAVVKDAELAKQIGYLQNSFGAVLGVQDCW
LLLRGIKTLHVRMKHSSEGARVIAEHLQNHPLIKKVHYPGFEDHPQYAIQRKQALNPGAV
FSFELYSEEAMRTFVENVKLPVFAVSLGAVESILSYPAKMSHAAMNPLARAERGITDSLL
RLSVGLENPLDLINDFDIALKKTAELHFI
>PK3-045_02727 Bifunctional homocysteine S-methyltransferase/5,10-methylenetetrahydrofolate reductase
MNFLDRLKNEILIGDGAMGTLLYSYGKDTCFESLNLSHPEQIEQVHQAYIHAGADIIQTN
TYAANYLKLQRYGLEDNVKEINSAAVKIAKKAVENKNVNVLGTIGGNRGMKPQAISLEEL
KRSFREQLYCLLLEDVDGILLETFYDLEELETVLEITKKETDIPVLAQLSIHEIGILQNQ
ISLASAFDRLENLGADIIGLNCRLGPHHMIASLEQIPLPRNAYLSAFPNASLPSYIDGKF
EYKDNAEYFQRSAEEFRKQGVRLLGGCCGTTPEHIRNFAKVLKDASPITEKTIETNKAVV
DSILEHSPPPRDYTPLEEIVKTRASVIVELDPPRKLDTTRFFEGAKKLKEEGIDALTLAD
NSLASARISNTAIATLVKQNIGLRPLVHIACRDRNIIGLQSHLMGLHTLGIHDVLAITGD
PARVGDFPGASSVYDMTSFDLISMIKQLNEGLSFSGKNLGQKTTFSVSAAFNPNVRQVEK
AVKRLEKKIECGADYIITQPVYSEQKIIELYEATKHIDTPIYIGLMPLTSSNNAEFLHNE
VPGIKIDDSIRRTMAQFKDNPVQAAQQGLKITKSLIDTAANYFNGIYLITPFLRYELSVE
LARYTKLRTDALRRTTDATNFIS
>PK3-045_02728 Methionine synthase
MQQTSLAEQLKRKIIIMDGAMGTMLQRENLTAADFGGEELEGCNENLNLTRPDIITKIHE
SYLHAGADIIETNTFGATKIVLDEYHLGHIAYQLNVKAAKLAKEAVRKYSTPDWPRFIAG
AMGPTTKTLSVTGGTTFEELISSYEEQALGLIDGGVDLLLLETSQDMLNVKAGFLGIKQA
FTKTGKELPLMISGTIEPMGTTLAGQSIEAFYISVEHMHPIAIGLNCATGPEFMQDHIRS
LSSLSKFAVSCYPNAGLPDEEGNYHETASSLANKLVGFAEEGWLNIVGGCCGTTPEHIRA
IAEKMKEISPRKVAETNFHMVSGIEPFIYDDPTLRPIMVGERTNVIGSRKFKRLIKEGKY
EEASEIARAQVKGGAHVIDICLADPDRDEMQDMELFMKEVVKKVKVPLVIDSTDEQVIEK
ALSYSQGKAIINSINLEDGEERFQAIAPLIHKYGAAVVVGTIDEDGMGVTVEKKLQIAKR
SYDLLTKKYQINGQDIIFDPLVFPVGTGDEQYIGSALATVEGIKEIKQACPDVQTILGIS
NVSFGLPPVGREILNSVFLYHCTQAGLDYAIVNTEKLERFASISKEEIELAEKLLFETTD
ETLAIFTDFYRDKKKEKINSLENLTLDERLAYYVVEGTKEGLIADLAIALTTYSAPLDII
NGPLMDGMKEVGRLFNDNQLIVAEVLQSAEVMKTAVSFLEGYMDKNVSTSTKGKVILATV
KGDVHDIGKNLVDIILSNNGYEVIDLGIKVPPADLVSAIKKEQPNIVGLSGLLVKSAQQM
VLTAADMKQAGIEVPILVGGAALSRKFTDTKISREYDGLVLYAKDAMNGLSLANQLTNKD
EFDLLKQEHEKKKQLLSASPVKEYTKPVITGIKRKTVNTDAPVFVPQDIKRHILTTYTTS
HIKPYINKQMLLGHHLGVKGKIDVLLEKKDDKAVQLNNMIEQLLNEAEQNNWILPKAVYR
FFPAQSDGNKIYIYDSKDKTKIIETFDFPRQEREPFLCLADYLKSVDSGVMDYVAFFAVT
AGTGIREAGEQLKRDGRFLESHALQSLALETAEGLAELIHRQIRDRWGFPDPATFTMKDR
FTAKYQGQRFSFGYPACPELEDQKKLFSLLSPEDIGITLSEECMMEPEASVSAMVFAHPD
ARYFNVLSSNSY
>PK3-045_02729 hypothetical protein
MIRELTEQDHAEVMRFLLQDPSMNLFIIGDIEAFGYHSAFQKLWGEFHSGEIKAVLLKYF
ESYIFYAVDKDHFDVQAFAAIMETNTNPVTLSGRADLVDKFEKLPSLNLGKKKVTYFAQC
GKKREIKQIDMIKKATLDDIDRIVTLRNSIAEFTTTEDSKNMLKKAIESQTGRTYFLEND
KGEIISTVSTTAENSHSAMIVGVCTHKGYRNKGLASKLMTALVNDILDDKQFVCLFYDNP
DAGKIYKKIGFEDIGLWTMYR
>PK3-045_02730 hypothetical protein
MSTLYEKIIDVLQQKGPTTLSAIFNELNSYLGEEETPISMSSIKSVLSRKKDLFEVYDDI
VSIHPEKEITKLIVEYKVNQEHSFSIHIDFDLRNYLIQEWSQFPIVIPPVFNKIEPEEFD
ALRMELYRLKMWDWEEEMLGIETVKCTARLVTVTSTYTVDLVNMQSKEWRQLQKMISLFT
DLELLLK
>PK3-045_02731 hypothetical protein
MKIICFGDSLTRGVSFVKGRIRIIKDNYPALLGKLFALNNSDDTIVLNKGVFNDNSDLLL
KRLEKDVLSEEPNYVLLNVGGNDCNFQWQEVAEDPDSNHEPIVPINQYIENIAQMVTKMK
QSNITPILLTLPPLDPVRYYKSIAERYGTTISHWISCCGGIEHWHGLYNFHLNKLIEQLN
LPSIDVRSALKKAGNIADFISDDGIHLNAEGYKKMSYFIFEEMNRLTGRQHEQLS
>PK3-045_02732 Multidrug resistance protein 3
MEHLTHKKKLSIMIAIMAAMFFAAINQTIVSTAMPKIISILDGMDYYTWTINIYMLTSTI
ATVLVGKLSDMYGRKPFLLIGILLFMVGAFLTGTSNDVFQFIAYRGIQGIGAGIIQSSAF
TAVGDLFPPRERGKWMGLLTAVFGFSSVLGPLLGGYLVDHLDWHWLFWIFLPIGIIAFGM
IMALFPKVEGNGKQSIDYIGSLFMTVAIVPLLLAFSWAGTEYAWGSVQILGLIAASIVFA
IVFVLVEKKAKNPILPLHLFKNNIVTVSNIIGFIMNFGMMGAMIYLSFFVQGVLGISPTY
AGYVTMPMSIVMVISSTIIGQLISKTGKYKRFALIGVPTMIAGMAIMIFMNSVPMAILSM
IVFGLGLGIGMPVFSIATQNAVSHKELGVVTASTQLFRNLGGTIGIAVMGTVMANNLKTN
LQDTMQNSPVVKDLATLDPKVTEQMVGFANPQALMNKPLLEQTEANLPADVQPIFAQMIQ
GIRDALGDTLSTVFLTGTIVLVVAFLLVFFLKEIPLRTSNQAAPEEKKEENIVLDRQKS
>PK3-045_02733 Transcriptional regulator SlyA
MHNGEELFEVAAMFGNFIKNITSDFNKNSSDLNITQYKLLFHLDKEGSLNVSDLAKSVHI
TNAAVTTITDQLLAEDYITKDRSKTDRRVVNITITDKGRSIVNNMKKEQQNKMKEHFHKL
TEEDIQHLKRIFKLLNENF
>PK3-045_02734 hypothetical protein
MKIVIENTTEQYEKLFSMEDEKENYFRYSMMKPFEKMWNTINVPLKANQSNGYDVILATK
MLGYLDVTKTEIGKIALENLKKIQALQTAYDTLNHCVDFIQENNLKLNTDELKFGMYIAD
PKKLELQKGYCGFGGIPGFIQVAIFPNSYNIPKIPAVIAHEFHHNLRFSYFDWDHGNVTV
GDYLIIEGLAESFAKELYGEKHLGPWVTSFHKEDLEYSIEVIKDALNVKGFAEVSSYMFG
DTIAIEQGYQPVGLSPFAGYAVGYHAVQSFIRTNNVGIGEATLLSAEEILNNCEMFS
>PK3-045_02735 hypothetical protein
MIFSEFFLYDEEKPIRCTVRNYQEKDFNELMAIQAECFPAPFPEDLWWNDEQLANHLAYF
PQGAICVEVEGELAGSLTSLRTIYDPEHSQHTWGKITDNGYITTHDENGNALYVVDISIR
PKYRKLGLGKVLIQSAYYLVIHLGIERLLGGGRMPGYRKVADKLSPAKYLDYVMAGKLQD
PVLTFLLRCGRTPVTILSNYLDDEDSLNYAVLMEWKNPFQNI
>PK3-045_02736 Deaminated glutathione amidase
MKIRVSAVQYKLENIKSFEEFAKQCEHYVRTALEFGAEFVLFPEFFTTQLLSMGDENNAL
TINELPGFTEQYQELFRSFAVQTGMHIIGGTHVIRKEDKLYNVAHLFYPDGRIEEQAKLH
ITPTEEYEWNMEKGDSFRIFDTEKGKIAILTCYDIEFPEIVRMAKAAGADVIFCPSCTDD
RHGFHRVRYTCHARAIENQVYVVVTGTIGSLTNVDFMRANFGQAAVITPNDIPFPPQGIL
VEGELNNDMIVTADLDLSLLYEVREKGSVTTWRDRRTDLYPDWNSTVEG
>PK3-045_02737 Putative acyl-CoA dehydrogenase YdbM
MTGFFSLEKDLAQKINKLKEMSRGFSERAKEIDESASFPFDNVKELQESGYTSLTIPKEF
GGQEISLYEMVRLQEVIAQGDGSTALSIGWHMGIVRNIQEANWNKDTLREIYEKLLTGSL
INGAATEPQTGSPTRGGKPHTTAEKKGEDWVINGHKTFTTMSPVLDYFLVTASIKDTDNV
GNFLIPKECRGIRIENTWDSIALRGTGSNDVYFENVEIPARYFVEKLDSRKKINPWLLHI
PACYLGIAGAAQKEAVTFAKNYSPNSIKGTISDIPSVRSKIGDIELKMQTAKHFLYSVSK
KWDEANKEQQSHMQPELSAVKLVATNTAIEVVDMAMRIVGARSLSAKSPLQRYYRDVRAG
LHNPPMDDMTLDQLAQKSINEY
>PK3-045_02738 hypothetical protein
MNKKDILTSSELATLWMTYQEKTMFLRFVEYFHAVNEDKKEKNFYESHLTKLAKEIKKIE
AILTAEGAIIPHGFSDQDVNKQAPPLFQPTFALQIVRMLAEIGMGLHALHLARSYRKDII
RLYQDLSVTTQHCYEECTELLIDKGALSRPPQVAMPEQVEVVVSTEYLKGTNILGDKRVL
NTVEVSFLYQSIESNSIGQQLITGFAQVTKDPELKKFFTQGKELSKKIIAKLSKKLTDDD
IQVPLGWVGSPTLSTIAPFSDKLMLYCISLFCSFGLGSNAIGTTFSLRKDLSATFIPLIA
KIYDYGVQGAELMAEKGYTEEPPAMENRQNLINRK
>PK3-045_02739 hypothetical protein
MKRIFFLLFIIFIMFYSGTIYHHLKKPLPKGLSIEGVIHQVKDVELLIDITYKNNKKNRM
VQHEIINSMLKEVEKANEFIIIDMFLFNNDTNEDQQYPKIVEKFTEALIKKKQENPMINI
IFITDKINTVYDSYPSEEFKQLKENGVKVIETELNDLRDSNPLYSGFWRMFGQWVKTRGN
GHLPNFLAKSAPKVSAISYLELLNIKANHRKVMITENTAIISSGNIHNASGYHSNVAFKL
HGNILNELLKSEESAARLSEPIDLPRIKEQAETKNTNVKIQLLTEGKIGKHILQEIKNTQ
KSEVIWIGMLYLADQKVIKEIKAAAKRDVKIYIILDPNQNAFGNKKTGLPNIPVVAELRK
AKAANNIHIKWYNAGKEQFHPKLLYIERLKARESTIISGSANLTQRNLYDFNLETDIKII
ARQKEKIMRDTKRYFQKLWENEQADFTKEVDRQKNFPIFRYIIYRLQRMLGFTTY
>PK3-045_02740 Glycerol-3-phosphate acyltransferase
MIIGLLIILAYLIGSIPSGLIIGKSFYNIDIREHGSGNLGGTNTFRVLGKKAGFAVTISD
ILKGTIATVLPLLVTLIWNVEMDINPLIIGVFAVIGHMYPIFAGFKGGKAVATSAGILLG
HEPILFLIIVAVFFISLYLSKYVSLSSMVAGLAGLIYSFILWEDKLLIIILAILTIFVVY
RHRANIKRIINKTEPKVNWL
>PK3-045_02741 Sporulation kinase A
MTLPTTSFHEPEATFQCFINKWKRVEAKLQEQSATMEALTDSLQSLSLSTTYSENIAKMV
TSITHEVRNPLTTVSGFLQLIKQTNNVELIHQYTAIALGELARANELITNFLTLSKTQGD
DITPLSINELLLNLIPIFKCEANLKDINLITKFSRDELLCKGTKHHFTQVFVNIVKNAFE
ATEANLSSVPKEVAIVTRKQKNQLVIEIKDNGCGIPKAQLNNLFTPLQTTKKNGTGMGLY
VCKQLIEKYDGKMKVWSLQDKGTTMSICFPLYIS
>PK3-045_02742 hypothetical protein
MQKKTYLLFVFILLLFGIIGIILINTIDNSSSTYKEVRSNSGRDKGNLAKEESSEITLAA
IGDILIHDRVYNDAREGNRFNFDKMLDNIASELKKPDLLIANQETIVAGESIGLSGYPAF
NSPHEIADSLKKAGIDIVTTANNHALDRGVDAQKLSLDYLNQIGLPHVGTYLSKDDQDKV
VVLEKKGIKVAYLAYTYGLNGIPIPEGKEYIVNILDKKRMSNEIQKAKKEADVVVMMIHW
GNEYQRFPSNEQKELAQFFVDEGVHIIFGSHPHVLQPIEWVKGHNGHKGLVVYSLGNFLS
GQDEEYRDIGGMVTVTVKKKQLGKQTSITMEAPSFYPTFVSSKAEKDYKMYPLQDSQHAI
NKYSPSIYKEIMEHMQKEGQAD
>PK3-045_02743 hypothetical protein
MKIVISDKAAEWYKDEMMLKDGDYVRFFARYGGCSTVQQGFSLGISNEQPVNIGVETEKD
GIHYYIEEKDLWYFDDHDLFADFNEVANEPEYRHAH
>PK3-045_02744 hypothetical protein
MAFGLKKSELREWKRKIDNGEIAFLTHYWLDDRFPGCKTVTKVGCADLEKLKTWGKKYGL
KEEWIHYRHDGYSHFDLLGDTQKKILKEEGIDQPLR
>PK3-045_02745 1,4-dihydroxy-2-naphthoyl-CoA hydrolase
MLETVVYVSSRDIELYYADTDMMGVIYHANYLKFFERGRTGLIEDLGYSYLEMENKGYFA
PVYDVYAQYKKPLRYGDQAKVKTWVETNDGIKTVYGYQIINQDEEVCVEGTTTHIIVSKE
TFRPKSFKKMFPEWFNKYEEIKKQPSDK
>PK3-045_02746 hypothetical protein
MVINDVYLRRKNKLLLNKGNEKTPQKKYIATILLNIDNLGFTLSNDIIEILYTYSISQLN
SFYIALVKNLKELVGANKQYNPMYPNFPHQVMDADASELFINAIFHYWSFGSLLPNYNKE
ERLPLYDITTKKVIETGTEEEFESIFINLLSSKTSISETDKEDLSWFFNEYPDKVNNILP
KEIPSKENVALLSILLLHNNINTSVLFDYVKTATDVLRIAVAMSEGDISLATNTKFKSFK
RKQRRLLMSLLENCSNIEEDMKRYKNRWIRLGERLHPTEFKKYEKVKEAFTKLRNNQPIQ
TFNGVLTNALENNRMDQALSLLVKRPGEFARKLDHLIRLHTNPNVILNEFKNVADSVETT
VLLQVREHFKNRNNQKEKRTFFPKGNVAKLFVIDNNLPEIEENICNSIVQICENSLVNEY
KKRDYLGKVYLDESLKNYLVPFSQRSASKSLKSVVRGSKLDISDSTSTIRSFIYWKENNL
DRADIDLSAVMYDDNWDYLEHVSYTNLRSSKYKAFHSGDITSAPHGASEFIDLEIESVRK
FGGRYIVLSIQSFTGQTFSELPECFMGWMSRENPNSGEIYEPKTVENRMDVTSEARVSIP
MIIDLHENKVIWTDIALRNNPDYYNNVEGNKIGMVLMGKAMTTLIKPNLYELIELNIKAR
GEKCDNIEEADIVFSINQGVTPFDQDVIVSQYL
>PK3-045_02747 Holliday junction ATP-dependent DNA helicase RuvB
MNNEKIITNRKYPEIFLIEKEFEEHGFVQDEKKILDEIQKLTEGENGKEISQLLTIAALS
RMYTDKEDTIAVAWLNKAIELDEENKTALKYLSQFDWKNFSGLLDSLVFPNIRETDNRTA
KRKIAEQYINNCRSFLEQMDEEATHLQNQKKNASLYENRDAVAKYEAIEELLQKVMEKTS
QLLKSAEEYEESISGVFHTSIYYESVKELIEELTELKDEWTSLFVEDVEEDNKSLSSLEE
LEQMVGLDAVKKRVYDFYQFLHYQKSRKKLGYNIQDELSLNMIFTGNPGTGKTTLARLMA
KIYHELGVLPSAEVVETDRSQLIGGFMGQTEENVRSVVKQAVGGVLFIDEAYSLKREGQS
GNDYGQTAIDTLVSLMTGSEFGGKFAVILAGYPEEMRQFLDGNHGLRSRFPASNMIHLPD
YTPTELLVIGERIASANDYVMTEDGKKALLKRLEREQVDESFGNARAVRNIVLDAIFSKG
SRKANEQEIFKYTLLQEADFVCEEDDKQLDPAKELNKLIGLAKVKDEIKKIIALVKVQQL
RQTKAKKNLPIQLHAVFTGNPGTGKTTVAKLYAQFLKDCGILKRGHLVVTSRADFVAGYV
GQSAIKTRKKIREALGGVLFIDEAYSLLGNSGQDFGKEVVDTLVMEMTKHNENLVVILAG
YPNETNTLLQSNPGLTSRFKKFIHFEDYSAAELVEIMKLYADKYDYLLSTDAIQLLQNML
PTVSTDGNGRFATNLIDEAVQLQALRLSEQLEQGIDADVSTISAEDIESVLKEKRRIDE
>PK3-045_02748 Small, acid-soluble spore protein N
MSNPKKDSKHFVPSHIGTKSRSFGGNKGKQMQDKSGQHAQVIQTKGE
>PK3-045_02749 hypothetical protein
MRKPRKRSFQELVLENKMQLLKDREAIEKIEERLERKHLKKAR
>PK3-045_02750 Thiol-disulfide oxidoreductase ResA
MSLKKTIFIFLFFSSFFLIMSTNVEAKTGLNIGEEAPDFKLNDLNGKTVRLSDYRGKSVM
INFWATWCPPCKKEMLDIETFSKKMQDHWVVLAVNVDGGNERGVRQFVKERNLTFPVLID
NNDMVSNQYHILSIPTTFFLNEEGIIINKGFSMLTLQQMMKMTQD
>PK3-045_02751 Manganese-dependent inorganic pyrophosphatase
MEKVLIFGHKNPDTDTICSAIAYAELKKALGVEAEAVRLGDVSGETKFALDYFKTEAPRF
IEKAATEANSVILVDHNEFQQSVEDIKDVTILEVIDHHRIANFETSDPLYYRAEPVGCTA
TILNKMYKENNVEIKKEVAGLMLSAIISDSLLFKSPTCTEQDVQAAKELAEIAGVNAEQY
GLDMLKAGADLSDKTVDQLLSIDAKEFTMGTYKVEIAQVNAVDTNDVISKQAELETSIQA
IIDKKGLDLFLLVVTDILNNDSVAVALGNKAETVEKAFNVLLENNSALLKGVVSRKKQIV
PVLTETFEAL
>PK3-045_02752 Glutamine synthetase
MSEITLEKIESIVKEKNVELLHLQFVDIEGILKNITITAQQLDDAVEGKIMIDGSSIKGF
SPINKSDSYLLPDLNTFAVLPWTETEGYSEARFLCSVTNPDGSLFEGDTRNVLKKTVERA
AENGYSISVGPELEFFLFATDENGYPTTELGDRGGYFEPSPKDLGEKVRVEIFKTLRAMG
FTIEALHHEVAEGQHEINFKYADALTAADLATTYKWVVKTIASQYGLHATFMPKPVFGIN
GSGMHVNMSFFKDGENCFYDADDDLELSETAYSFIAGVLENVKSFVAVTNPLVNSYKRLV
PGYEAPCYLAWSASNRSALIRIPAKRGMATRVELRCPDPSSNPYLTFAVIAAAGLDGVEK
GLRAPAPINEDIFHMTDDRREELGIDSLPGGLEAAIAELEAGEIGLKTLGEHVFTEYVAA
KKEEWDSYRTTIHTWEIENYQYKF
>PK3-045_02753 2-aminoadipate transaminase
MQLLKPFSYSRRFPDIEVIGSAFAQNQENLIPLSFGFPAPESLPVDKMTAATEAAMQTQG
RHALAYSGGTGVNAVINWIKERLKLREIKATENEILITAGSSQAIDLVTRTLTDPGDEVW
VEAPTFFGALKTFQLAETKLASFPIDENGLRVDLVEQELSERVKNNLPLPKLMYVIPNYQ
NPGGVNLSVDRRKRLAELAYEYNFFIIEDDAYVELSFDGIYNPAIYSYGPERVVYLSTFS
KIIAPGLRLGWAIGLTEIIEKMRILKIDGLTSVYVQEVTKNLLDQIGMDEHICYLNSLYL
SRKNAMVSAIKQYFGNDVTFHEANGGFFLWITFPCHIDTSEFIDAAASAGVSYIAGKHFF
LKDEGYNHMRLCFTFCQEDIIEEAIKRLANTYYEYVNSKQMIKGVN
>PK3-045_02754 Glyoxylate/hydroxypyruvate reductase A
MINRKTIPKIYIRRTIPQKYLDKIKSSGAEYIVDPWQFGEPEPPIKQDISDCNIVLTLGL
TDSLAITEQAPYIKWVQSLSVGLDALLTEKMKKNDIIITNTKGCTSVPIAEHTIAMMTGL
ARGISYMIRNQLNRSWTSTPITDLSGATVAIIGYGEIGKQIAKRAKALDMFVIGCKKRPS
IRATADPADKIVGLEQLESVMAETDFLILTLPSTPETYHLINKEKLESMKKTSFLINIGR
GNTIVEEELINHLKEKKIAGAALDVFETEPLPPQHPIWQLENLIISPHNAYFSPNTLERY
MDVFLENIERFKEGKELLNVVDKQLGY
>PK3-045_02755 hypothetical protein
MALTFGKLVEEARKNVPGISSVEAKKKIEENPNTYIIDVQDAADAGACGLIPSSVNISLG
MLPIRADLELPEELRDPELADRNRPVIVTCGLGGQASLGAYLLKQMGFTDVAFIEGGTTA
WKKEGFETV
>PK3-045_02756 L-amino acid N-acetyltransferase AaaT
MKIIPVRYDVNKLPYIIRSAEESDAEQLASVRLQIDGETTFLDREPGEGLLTEKEFKHLI
RSDSEAPNHLFLLAEREDGQIIGFSRCEGSSLRRLKHKVEFGIAVLEEYWGYQIGTHLLE
ESINWGAENDITKMTLSVIELNEKAIKLYKRFGFEIEGVLKKDKRLTNGKYYSTILMSRF
FS
>PK3-045_02757 Aconitate/2-methylaconitate hydratase
MAKDFYNARQTFEVGGKRYHYYQLAALEKAGIGKVSKLPYSIKVLLESVLRQMDDFVIKQ
EHVENLAKWGTDEVKEIDVPFKPSRVILQDFTGVPAVVDLASLRKAMADLGGDPSKINPE
KPVDLVIDHSVQVDKYGTPDALKANMELEFERNAERYQFLSWAQKAFDNYRAVPPATGIV
HQVNLEYLANVVHVNETAEGEYETFPDTLVGTDSHTTMINGIGVLGWGVGGIEAEAGMLG
QPSYFPVPEVVGVKLVGEMPNGSTATDLALKVTQVLRAKGVVGKFVEFYGPGVPQLPLAD
RATIANMAPEYGATCGFFPVDKESLAYMRLTGRSEEQINVVEAYCKENGLFFDPNLEPVY
TDIVEIDLAEIEPNLSGPKRPQDLIPLSKLKEVFNESVTAPEGNQGFGLKADEFDKEVVV
NFANGDSTTMKTGSVAIAAITSCTNTSNPYVLVGAGLVAKKAVEKGMEVPKFVKTSLAPG
SKVVTGYLRDSGLLPYLEQIGFNLVGYGCTTCIGNSGPLREEIEKAIADSDLLVTSVLSG
NRNFEGRIHPLVKANYLASPPLVVAYALAGTVDIDLQKEPIGKDKDGNDVFFKDIWPSTE
EVNEVVHRTVTPELFNKEYERVFDDNERWNEIQTSSDSLYSFDDTSTYIQNPPFFEGLKP
DPEQVLPLKGLRVVGKFGDSVTTDHISPAGAIGVNTPAGKYLKDNGVQPRDFNSYGSRRG
NHEVMMRGTFANIRIRNQIAPGTEGGFTTHWPTGEVTSIYDACMKYKDEGTGLMVIAGKD
YGMGSSRDWAAKGTNLLGIKTVIAESFERIHRSNLVLMGVLPLQFKEGENAERLGLTGKE
TFNVYVDETVKPRDFLEVTATTEDGKKITFEALVRFDSEVEIDYYRHGGILPMVLRDKLK
N
>PK3-045_02758 hypothetical protein
MPYHSNKQEAFQDAQRNLFETQNLYQDIVKDSANYGHQLKHLKQEINETYQQIENALEVA
SEHQRQQLESFQRDLKSIVDEVNEI
>PK3-045_02759 Alpha-galactosidase
MSKITFLGAGSTVFAKNVLGDCMFVDALEGYEFALYDIDKQRLQDSEQMLTNLQESLGKN
IIVKAYTDRKESLRGAKYVINAIQVGGYKPSTVIDFEIPKKYGLRQTIADTVGIGGIFRN
LRTIPVMLDFAKDMEEVCPDALFLNYTNPMAVLTGVMNHFTPIKTIGLCHSVQICTKELF
EAVGMDRTGVKEKIAGINHMAWLLEVSKDGVDLYPEIKRRARELQNTKHGDMVRFELMDK
FGYYVTESSEHNAEYHPYFIKSRYPELIDRFNIPLDEYPRRCEKQINDWVAMREDLVNNK
ALEHVRSREYGSRIIEAIETDIPFKFGGNVLNTGRLISNLPEKACVEVPCIADRSGITPT
YVGDLPEQLAALNRTNINTQLLTIEAAMTLKKEYIYQAAMLDPHTASELSMDDIISLCDE
LIEAHGDWLPNFTTETSVGLAK
>PK3-045_02760 hypothetical protein
MNSIIEYFTGMDALTDQMIATDLLISAKSGIRNYSMAITETGHPEIKEILVRHLNEALDL
HEQLSSYMAEKGWYHAWDPKEQVNFNLQNIHTALNLPIL
>PK3-045_02761 hypothetical protein
MDYVLHEVLEVQELATFKTICITKAKTMRALVSDPQLKELMLQDVDISTRQLQEFSSILS
KAQEMPGIGGENG
>PK3-045_02762 putative zinc-binding alcohol dehydrogenase
MKAVTYQGIKNVEVKEVEDPKILKPDDMIIKVTSTAICGSDLHLIHGMMPNLQENYVIGH
EPMGIVEEVGPEVTKVKKGDRVIIPFNIACGECQYCKSNLESQCDNSNDNGDVGAYFGYS
GNAGGYPGGQAEYLRVPFANFTHFKIPETCEEPDEKLTVIADAMTTGYWSVDNAGVKDGD
TVIVFGCGPVGLFAQKFAWLKGAKRVIAVDYVDYRLQHAKRTNKVEIVNFEQVENVGAYL
KELTKGGADVVIDAVGMDGKMSDMEFLASGMKLQGGTMSALVMAAQAVRKCGTIQITGVY
GGRYNAFPLGDIMQRNVNIRTGQAPVIHYMPYMFELVSTGKIDPSDVVSHVLPLSEAKRG
YEIFDTKMDNCIKVVLKP
>PK3-045_02763 hypothetical protein
MNNDYLDPINALNMPELADMTFAVDFLIRAKEGVRNIATALTETASPDLRVLLRKQLNQA
IQMHQEITDLMVEKKWFHPHDLSQQYKLDQLSAKNTIMIGNMHLFTGETNRKGMFDRTPD
QH
>PK3-045_02764 hypothetical protein
MERKSFAPHESLDLHEVINFKTLCVAKSKLMQGLVFDEDLKKLMQKDVEQSIQALSELQE
AYKDVPFAAEIPQMRPTPIIGGEEGVIH
>PK3-045_02765 RNA polymerase-binding transcription factor DksA
MLNKQQMSHFQKVLTEQKRDLEVRFEHNDNLDLKDGHYHESLGELSSYDNHPGDEGTELY
EREKDIALAEHYHHEYMGVLNALKAIDEGTYGKCAECSQDIPIERLEVIPTTLYCKEHSP
DQKISEKRPVEEEILMPPFGKFDMDNKDESVVYDAEDSWQEVSSWGTSETPSDFAHPVYD
HYNDVYTESDENIGYVEDYENFVGVDIEGKNITVYPNEQHKRYEESLDEEGIMTTFGDLP
AYEHEPYVENDE
>PK3-045_02766 hypothetical protein
MNDDNWLSLMDEWLKNHFLDPLTSVLDETEFRIDVYETDKEFIVEALLTNCQKSSIYLSV
NKNVLTIKAMIHDSNLFEEKQRSIEFPVSIDQNPIHAVFANEILEIFIQKEQQQNKKLTS
IIDIQFL
>PK3-045_02767 hypothetical protein
MVSFGTFIIGVAVAIITFFVLDNFTPPLFLNIFICYVIVFVTMLMTTWYRIHTTRNIEKL
EKLFRKNKKHPYYSFVYALSLKEDKRVIISYRKLMKRKKYQAHYPLFTILFSLYFGKTLG
LREEAEKIKDSEMKSYYLALINIEERQFNAAWQWIERVNKKWMKEALLAEIALKKEEKDV
AKKHAKSALKHTKGIQYYILKKTYEREFAL
>PK3-045_02768 HTH-type transcriptional regulatory protein GabR
MNMAIHLHKDSTEPVYMQLYNYFKAEILTGKIEAGTKLPSIRYLANYMQISKNTVIDAYQ
QLWMEGYVESKEKSGYTVVSLPSYEYKDRQNQSEHKNNEKQMEPYSVNFHYGDIDQTNFP
TNAWKKTLKEIMEDKHNRWMNYGDKQGELKLREEVAGYLYRSRGIQTTADQLVITAGTEQ
LIRVVLSLLNDCPLHIGMEEPGYNDVRNVFQEKGLAISSIPVLETEGHDLSSLLNSSCNL
VYITPSHQFPTGKIMPISKRIELLEWAERENGYIVEDDYDSEFRFQGSPIPSMKAIDQHD
RVIYMGTFSKSFLPTLRISYMVLPNVLLEKWKTKRYNETQSSSPLLQLALGKFIQKGGFE
RHIKRMRKVYERKYTFLIQCIKQYMGDKVEIIGEKAGLHLLIRIAFKNEAILLSEAEKIG
IKVYSTKPYFAEERECYPLLLGFGGLEEKEIEEGIISLADAWFM
>PK3-045_02769 hypothetical protein
MNISQATKKDIEGVARLFNEYRMFYKREDDIVSAASYIKERIENRESVIFVVQDGDDYIG
FTQLYPTYSSLSMKKIWILNDLYVQKRARKKGIGKMLLQQAKEYAKNNGANSLSLSTAVD
NLTAQRLYEKNGYKKDTQFFHYELDLNN
>PK3-045_02770 hypothetical protein
MAKVERISRLKRKISAKMGRESAKGEKESAKMGRESAKGEKESAKVGRKSAKGEKESAKM
GRESAKGEKESAKVGRKSAKGEKESAKVGRKSAKAEKESAKAQIYQPKHNKYKTRKAGFV
YKKLFKLE
>PK3-045_02771 hypothetical protein
MKKVLFSFLLFWGLSLQASSVAASPSEKEIESLANNLGWTTEDLEEYLSFKGLKISDFDN
IRVLKKQLGTPITPANLDKLLVQNSMTQEELDILLAGFHESVDDFWFLEDLEVAIDFYKN
HEDKMLQLEKFLENIGFDDKEKQQFYGHLNKLDPAFLAAKVEDWKVKLSTFQAMDQEGGI
SKEGNHALTDFWKDFFTATALKPVIISIDDNGKRNELSLNDLKHKQMDTTVAIELYDHDQ
FLIGDAIVTSDMVSSVDAIDKVVELTEVTEGLANLYAAQLPNTASSLPIMLCIGYMLVLL
GLFVTFRKVPYEN
>PK3-045_02772 hypothetical protein
MKIRKKMGILSILIGLGMIFYTLSCYMKVETITKQPFLPKDSQVVFSPSVFLKEGEKMGV
ILVPKSEKTIPIYEGISTGILTKGAGHYPKSALPGENNNVVLSGHRDTFFRFLRDLKKND
SLIIQTMEKEYEYKITKFSIVSPNDRTILTPKSRPVLTLTTCYPFSFIGHAPKRYVVTAM
LTHSEEFGKNNRSE
>PK3-045_02773 hypothetical protein
MQKNMVIFFNRMVESLYSKEYITETSYTDIKSGFQKYLEDEAIKENGEIEEKVKVMEKQE
KKKQPSIQKKQHTPEQLRERNIGVLLYLGVFLLLIGGLVVATSNWDSMPGWLKAVSIFFV
SILFFGFAMLSKKIIKIDHTAFAFFLLGSLFLPIGFLSISFFQLAGDYLSIYGEGRFLLG
VIAGLVLFPIYAALAIYLKSRLYKILTIGTITGTIAFLLAFLPLALDGFFFFMIIYQFIT
IYVLLRYQHLKWINYFQKELTPIVQVQLILTALFMTFLFESSVINGFYYLIISSLFIMTV
ALTKRKHDHFYITTAIAFGLYRIFTYPILEDLLPIAFACFSIFLLSFVFILKGKIEWGKV
WEFTSFVIALATFFVTILFYWELFLAGSLYLVFAYLLLAVEFILLAKRLTYVIIRYLPVL
FINLALWNLALLIPLIKDLDSFFLVSYGINIGLLFLLGIFNNWYPLQDIRKPSAIYNIAW
MVLIAFLSTAIFLGKWYIPFMIAGIALSLYSGSRFIKNKRQQQLLAYIIPFTVFCVYFTT
AESISLIQKQGLPLSIALGSLVTILTGSIYEKIDKQMGRNGYFIGQIMYGFGLLLILEYF
ILNKWVATGIYLASIFIFYDLYRKIKNILIAWLIGIVSLISYFSLVGSIWNTDTIVFELL
MKYGWIGLFMLSLGLKNTSFKLPFLTLSHIYIIGSIIIDRLIIENNSFLPFIYLFIAYSI
SVYLVANKYVKMTFRYGSYLSSYFFIAAAFPFGFAGGNAYNIAFTVMSMALFGIYYLKKE
KKELVFFFLPFSSVGIIYWMFASPFTIITYTIILVYITLLLLIIHLEKLYLVSFIGIVFL
FMNNEVFMHDFLPIDRYLFTLVWGVIFMLISTIVYPFITKWQEEGEKWIDFYFLASFLTI
FSLYVIETNLKWDNVIPGVLLALLVFIQKNRVGKEIKWVPQLIGLVTLLLPYYSMLSIIS
IQEYIETELKVLPVLVVMVAAKKIVKHASGLLTKIEWGVVTISALLLAMDGYLSHTIYDA
IILGGLAVISILSGFYFRYKSYFFVGIGVLILNVLLQTRPYWGNFPWWVYLLIAGTILIT
IASMYEMQKQGKQPKIFTKILLWKNRIRKFLKTWK
>PK3-045_02774 Succinyl-diaminopimelate desuccinylase
MDVIQQYLKEKRKEHLEELFSFLSLESISALPEHQTDIERTAEWLVHALTKAGLENAAIH
QTSGNPVVYADWLHEEGKPTVLVYGHYDVQPVDPLELWESPPFTPEIRNEKLYARGASDD
KGQVFMHIKAIEAILKTTGSIPVNIKFCIEGEEEIGSPALPSFVEANKDLLSADVIVISD
TGMMEKGKPTICYGLRGLCGMEIYVKGPKSDLHSGLFGGAIQNPITALSHLLASFHDENG
VISVEGFYDRVTPLTKQEKDAFTALDITDESIIEQTGSPSLFGEKEFTTLERLWVRPTLE
INGVKGGFQGTGVKTVIPSEARAKITCRLVPAQDPDEIVALLKKHIEKHKPKGVDVTVQL
FDKGNPYVTPFDHKAIQAAGRAYEKVYQVSTSYTRGGGSIPIVAAFDQILQLPVVLMGFG
LPDENFHAPNEHFHLENYDKGLETICHYWFDLAEVW
>PK3-045_02775 DNA helicase IV
MNNKEQLEKDQEQKRIDFVRKQIEEKLTVLETDINHIGGDVSQLRSSFWEDVTVNLDEPD
DVIETFTSIKQQAELLGERERTYGQIHKQQKVLHKLKDSPYFGRIDFKEEGEETEPVYIG
IRSFMDKKNEEFYIYDWRAPISSVYYDYSPGPASYQTPGGKINGELLLKRQFIIRDGKLI
SLFDTGVTIGDELLLEVLGNNANSMMKSIVATIQKEQNQIIRNDKSKYLLVQGVAGSGKT
SAALQRVAYLLYKHRDTLKSDNIMLFSPNPLFNSYVSTVLPELGEENMRQSTFYEYLQSR
IGKSYQVEDSFSQLEYLLTETNKAKKAQRLISIQYKSSAAFKELIDEYLQHLQNDGIVFK
DIMFRKKVFISSEELTRKFYEMDSTITIPNRMQLLIEWAQKEMKKHAKAERNQPWVDEEI
QLLDKEEYLEAFHASETKNGKEQEFAYFEEEEKFLRKIIVNRYFKSIYAAVKKMRFIDFA
AIYKNIFHLACPKELSKEEWQTIGIQTIANLNQSFLVYEDGTPFAYLKDKLEGKKSTSGI
RQVFIDEAQDYSDFQINYLKELFPYSKMTLLGDINQAIYAHHHNEIVGNEESEEVERIEL
MKSYRSTKEIIEFTRGLTVNGDLIEPFNRHGEKPAVVNAANSEKKIKNIQKKIEEWMEKG
HKTIAIICKTIEESKEVYKRLKAKLDVRLIQKGTTSYEKGISVIPAYLAKGIEFDGVILY
NASSYEGELEKELFYTACTRAMHELTMYIENGKQNEYFEKIDHTTYVYEELEIN
>PK3-045_02776 Lipoteichoic acid synthase 2
MKGTVELFRKFLTKHSSFFLIAIFLFWMKTYIGYKVEFSIGVQGPMQEFLLFINPLSSAL
LFIGLALFVKGKAQPIYITIITALMSALLYANIVYYRFFTDFITVPVITQVKVNGGQLSD
SILSLLKPYDILYFLDVIILIVLLATKAYKPTVQKNRRAAKSVFALAILTFVINLGLAEA
DRPQLLSRSFDRNYLVKYLGAYNFTIYDIVQNARSESQRALADSSDITEVQNFISANYAE
PNDKYFGAAKGKNVIYVSLESLQSFIINYKLNGEEVTPFLNSLIKDDNTFYFDNFFHQTG
QGKTSDAEFMMENSLYGMSQGAVFVNKAQNTLQSAPAILKGEGYTSAAFHGNYKTFWNRN
EMYKTIGYDYFFDAEYYDMSEENTKNYGMKDIPFFEQSMPLLEGLKQPFYTKFITLSNHH
PFEMDEGDTDFPAGDFGDNAVNHYFQSAHYLDESIRLFFKELKESGLYDNSVIVMYGDHY
GISENHNKAMAKVLGEEEITPFMNTQLQRVPLFIHVPGVEGNVVSKYGGEVDVMPTLMHL
LGIDTKDYLQVGSDLLSKQHRETVPFRNGDFVSPTLTKIGDNYYDANGELVDAEKGKEQA
EAAAAELQASDSIVTKDLLRFHKPDGFKPINREDYNYIKGNTSKADSEESAEE
>PK3-045_02777 Putative aminopeptidase YsdC
MVQIDQKEYFDLLEQILNVTSPSGNTETIIQLMEKYLHSANISTYRNNKGGLIATIPGKI
SEKQRMLTAHVDTLGAMVKEIKANGRLRLDLIGGFTYNSIEGENCIIETSSGKTYTGTIL
LHQASVHVYKEARTAERNQANMEVRIDEIVKNQEDVKKLGISVGDFVSFYPRVEITPSGF
IKSRHLDDKASVAILLLLMKKITENNIELPYTTNFLLSNNEEIGYGGNSNIPIETIEYMA
VDMGAMGDGQSTDEYTVSICVKDGSGPYHYALRKNLVQLAEKHEIPYQLDIYPYYGSDAS
AAIRSGHDIKHALIGPGIDSSHAYERTHFSSIEATGQLIYHYLLSDLV
>PK3-045_02778 Peptidoglycan L-alanyl-D-glutamate endopeptidase CwlK
MRKKRKKHGRSLLIILIFFFILLLYWKLNQPDYRDVPMPVELNPVVNEKKDILVKKAGDI
GIRVVITEDFRSVEEQNRLYEQGRTREGSIVTNAKGGQSYHNYGLAIDFALMDINGVVIW
DMKYDGNGNGKSDWSEVVEIAKSLGFQWGGDWANFKDYPHFQMDFGLTIEELQKGKRPE
>PK3-045_02779 hypothetical protein
MRPLKLTMQAFGPYARKEVIDFTVLGNRTMFVISGKTGSGKTTIFDGISYAIYGKASGED
RNGPELRSQFAEDSLLTEVSFEFKLKENRYLITRAPQQEKKKERGDGYTTIGAKAELYTF
DADGNEQLVASSIRDVDEKVKEIMQIDSNQFRQILMIPQGEFRRLLTSDSKEKENILQRL
FHTEMYKRIEEKLKEQAQALKKEVEQKVLLRTNALSKITAVYHQDLITQLESDRDNDVAI
LPLLKEEIVLMGEEIEKLQKKLDRKNTDRDSLKQHLYEAESILKQIKLKEELSTRLKELN
NQQKEYAETENKINMAQKAALLAQQEEICHHLKKQIDERNLEEKMIQFKLEKLNSQLKEA
EKQLNQEVEKEVERKQLSDYLVDLKNMEKDVFRFAEVEGKLSIIKKDLDSLGAKEALLQN
QRKEKEVMIQNVKERLKQLDGIKEMLLENKDKLRNLQSILEKMNDYLEVLNRTMRQKVDA
ESKEKMLDNTLRRVEDAKKLVEELENKWLINQSYILASSLKPDEACPVCGSVHHPDPATN
RNHEDNATEEDRKNAKKDFEAIEKEKAKAEAAWLEANTQWKLLEEDAQNKLMKVKDIYPD
FTNEESTIAVNTIKSELHRINTEQKRLEEQLTERDKMEQSLVSAERRYHELQSELEKIAV
VMRETTIQYTEHNTTWKNMKDAIPAELRDLSRYKTVWKESSLQLEKLEAQLKLAQEKVQM
TKENWQKESVRFESVQKQIKQLTDSLQTEREIFLESMTKQGFPTYRSYSDSKLLEKEVEK
LKESVQAYREECRSVSDRLKDLENTLKDITIPNMEDLQNKLKTIIEEANKLQEEHTNMLI
KQKENKEIYNQVISINRQVKDLENQYKLVGHLYDISRGQNAQRITFERYVLASFLDEILL
QANSRLNKMTSGRYQLVRKSDRSKGNVQSGLELLVFDQYTGQERHVKTLSGGESFKASLA
LALGLCDVVQNFAGGISLETMFIDEGFGTLDPESLDQAIETLMDIQNSGRLVGVISHVPE
LKDRMEIRLEVIAGQTGSTTRFEYLR
>PK3-045_02780 Nuclease SbcCD subunit D
MKFIHTADWHLGKLVHGLYMTEDQRFMLKQFMDLVEKEKPDAVIIAGDLYDRSIPPTDAV
NLLDEVLYFINVELNTPILAISGNHDSAERLSFGSSWYQKNRFYLNGKIENSFTPISFSG
VNFYLVPYCEPVVVRKLLADDTILNHHDAMKAIISKIESNLNINEPNVFIGHSFVLGGKT
TDSERILSVGGSGCVGAELFAPFSYTALGHLHSPDAIHHPTVKYSGSLMKYSFSEAKQKK
SVSIIEIDEKGNFTQSYQTLMPKRDMREMEGYLEELLDVSYYQQQKVDDYLKITLLDEGA
ILDPIQKLRQVYPNVLHLERKIENKDRKEKSILQVQKEVQKNELELFASFYEEMTTADFT
QEKQEWMTTVINQVLREEGAK
>PK3-045_02781 Cold shock-like protein CspD
MKNGKVKWFNAEKGFGFIEAEDGNDVFVHYSAIQVEGFKSLEEGQDVSFEVVEGARGPQA
ANVTKI
>PK3-045_02782 hypothetical protein
MAKTLEITFETSNGKTSKLSLESPIEPVNSEEVLTVMQSIIASKVFTSNNGDLMAVKGIR
LVERMVTDYEI
>PK3-045_02783 hypothetical protein
MAQALWNEASLKLAFLNGMKENGEPNLVTKTFRNLNEMATPEQIFASAQGMASLVTYSLY
SVERNDTSEIVEA
>PK3-045_02784 hypothetical protein
MEWLQSFLLEHYYILVPVLWIIGYALKQTPIISDWLIIWILLLTSISLAAFAYGMTFEAI
TNGIIATGVSVFGHQLAKQTIFKDKSK
>PK3-045_02785 hypothetical protein
MKKVYIIRHCEAKGQPSEAQLTDKGFKQAIEISKFFAGIKIDRIISSPYKRAIQSIEPLA
TRLNLEIEINRKLIERVLSTESLSDWLDKLKATFEDFELTFEGGESSQEAMKRIVKIIED
VFNNEHENTIIVTHGNLMSLLLNFYNKNFGFDDWQNLSNPDIYLLKNVGNKVIYERLWKQ
>PK3-045_02786 hypothetical protein
MTSVIISTCIAVFMGVSVMVMRMKAAKKPVSPKKIILPPFFMSTGALMFIFPYFRISGQE
ILEAAIAGILFSFLLIKTTKFEIKDNDIYLINSKAFIYILFGLLAIRIVAKFILSSSIDV
GPLGGMFWMLAFCMIVPWRIAMFINYKKLTKNLSTTN
>PK3-045_02787 Chemotaxis protein CheY
MARILIVDDAKFMRLTLSNILTRSNHEVIGEGENGKEAIRLYRELDPDLVTMDITMPEMN
GLDAVKEIKKEFPQAKIIMCSAMGQQKMVVEAIEAGAKDFIVKPFDDTRVLDAINRVLK
>PK3-045_02788 hypothetical protein
MVDINFFLALGAGFLSFISPCCLPLYPAYLSYITGMSSGQLKEEKLLNNASLIHTILFLF
GFSIIFIALGFGSSLIGEYFKVYQEEIRKIGSLIIIFFGLTIIGLIKPQWLMKEYRFSFK
TRPTGYLGSILIGLSFAAGWTPCNGPILAAVLSLASLHPETSLLYLGAYIIGFALPFIFL
SFFISHWNKLKKYSVQWTKFGGFFMIVMGILLYVDGMKWLTRVISPIFGDFQGF
>PK3-045_02789 hypothetical protein
MLKKQLLTQIELKRTELIEIAMKHGFSSSSAIICSQELDVLLNKYNEINLKNKFPAFPKS
KKQWNI
>PK3-045_02790 putative multidrug resistance ABC transporter ATP-binding/permease protein YheH
MDKTIKLTSEQQRKVLFRLLGYIKPHKKAVMIAFCLLILSTLGELAGPYLIKVFIDDYLT
PRNLAVQPLTVLGITYIFIQIMNVVIMYFQLYKFQEIALYIIQQLRVDIFSKIHTLGLRY
FDKIPAGSIVSRVTNDTEAIKDMFVSVLATFIQSGFMIFGIIIAMFVLNVKLGAICLILL
PILGFIIYTYRKYSSSFYQDIRERLSQLNAKLSESLQGMNIIQVFRQERRLKNEFDDINT
KHYQAGMRNIKLEGLLLRPAIDLVYVLGLILVLSYFGISSFNNPIEIGVLYAFVSYLDRF
FEPVNNMMMRLSLYQQAIVSAFRVFTVLDEEDIEPSLVADSKSKIENGVIEFKDVTFSYD
GKQDVLKNISFTAKEGETVALVGHTGSGKSSIVNLLMRFYDFGKGEILIDGKSLKSFSKR
ELREKMGLVLQDPFLFYGTVTDNIRLYNKEVTEKEVIEAAKFVQANQFIEKLEDQYNHKV
VERGSAFSSGQRQLIAFARTILTNPKVLILDEATANIDTETEEAIQLALSKMRKGRTTIA
IAHRLSTIQDADLILVLHKGNIVEKGNHQQLLQQKGLYYKMYLLQNGAADSIEETVEHKV
ELT
>PK3-045_02791 putative multidrug resistance ABC transporter ATP-binding/permease protein YheI
MKVFLNLKWYFIQEKKAYLGGVFLLILVAILQLIPPKIVGIVVDHIQGKTLNWSNLLQWT
GVLVVSALAMYVLRYYWRVLIFGSAVKLGRLLRNQLYSHFTKMSQSFYQRNRTGDLMAHA
TNDIQAIQQTAGQGVLTLVDSLATGGFVIIAMATTISWKLTLICLLPMPLMAILTSYYGS
LIHKYFHQAQAAFSSLNDKTQESISGMKVLKTFGQEREDVEDFRRSSLDVVDKNIKVARV
DALYDPTISIIVSISFFLAIVFGSRYVINGELSLGQLVSFTTYLGLLIWPMLAFGWLFNI
MERGRASYDRVTALMETKVDIINKPAAITTPPAGDIVYDLKSFSYNHKIDVLKNIRFCLK
RGQTLGIVGKTGAGKTTLLKLLFREYDHYERKIMINGTEIKEMDLDALRVSIGYVPQEHF
LFSASIRDNIAFTNPNTSEEEIHKAAVLANIHDDILGFTDGYNTVVGERGVSLSGGQKQR
ISIARALLMNPEILILDDSLSAVDAKTEERILTALKENREGKTTIITSHRLSAIEHADLI
IVLDEGAIIQSGNHQQLVKESGWYKEMYHRQALEVMVSMGDTNG
>PK3-045_02792 hypothetical protein
MPWYAWLSIVVALIAGIVIGFFIARKYMMNYLKKNPPINEQMLKMMMMQMGMKPSQKKIN
QMMTAMNKQQGK
>PK3-045_02793 Sporulation inhibitor of replication protein SirA
MYLIKEKIAIHYNGRERLFYNLFSDHTKTDDGPLKEILQKQVDFITLPISRWMIENQLYS
ALQRNKSFRYKDGTFYIENGNLSSATLTIKDDSLFIEAKGYYDAESIFFEIIRKYEPSFL
AIDVENGRFGWLKPIKERNFV
>PK3-045_02794 Transketolase
MNTKLDHLSIASIRTLSIDTIEKAKSGHPGMPMGAAPMAYTLWTSFMNHNPKNPEWFNRD
RFVLSAGHGSALLYSLLHLSGYDLSLDDLKGFRQWGSKTPGHPEYGHTAGVDATTGPLGQ
GIAMAVGMALAEKHLAGVYNKNNYPIVDHFTYSICGDGDLMEGVSAEAASLAGHLQLGKL
VVLYDSNDISLDGDLDKSFSESVEQRFKAYGWQYIRVDDGNDTDQIAKAIEEAKKDQSKP
TLIEVKTIIGFGAPNKAGKSLVHGAPLGADELKLTKEAYNWTFDEDFYVPEEVYNHFKEK
VFMNGEKREQEWKELFANYEKEFPELAQQLKTALADTLPQGWDHQIPVYEEGSSLASRAS
SGEVINSISSELPFLVGGSADLAGSNNTMIKGGKDFTPETPDGRNIWFGVREFAMGAALN
GIALHGGLKIFGGTFFVFSDYLRPAIRLAALMGLPVTYVFTHDSIAVGEDGPTHEPVEQL
ASLRAMPNLSVIRPADGNETAAAWKIALESTNKPTALVLTRQNLPTIKGTKDNAYEGVSK
GGYIISPSKTETPDALLIAAGSEVGLAVDAQKELEKDGINVSVVSLPAWDRFEQQTKEYK
ETVIPKNIKKRLAIEMGSSLGWHKYVGDEGDVLSIETFGASAPGNKVLEEYGFTVSNVVK
RLKSLLES
>PK3-045_02795 hypothetical protein
MYPKNKLDRINELAKKKKETGLTLEEAKEQTKLRADYLKNFRSTMVNTIENVKILDPNGT
DVTPQKIKDIQNKKKLH
>PK3-045_02796 Resolvase YneB
MNKEKNAIIYCRVSTDKEEQTTSLERQEEELLQLASKMGFEVKEIISERASGYDLDREGL
LELLSRIKEKDISSILIQDETRLGRGNARIAILHCILKENVKVYSVSSSGELTLSEADEM
VLKIVSIVEEYQRKIHNLKIKRGMRRAVENGYRPDRNLKNLGDHSGRQKIDVPIEEVVKL
KQNGLTFAEITSTLKGLGYSFSKATIHRRYQDYIEQIKEK
>PK3-045_02797 Cell division suppressor protein YneA
MSKLWEKYSYTIILLICGFIACIIIVVNTGEADSSKYLSVTVKNGETVWEISNEYAGSYN
MSKKQFIKWVEQQNNISANNISAGKEILIPVREEDHQLMLASE
>PK3-045_02798 LexA repressor
MQKLSKRQLDILEYIKEEVKLKGYPPSVREIAEAVGLASSSTVHGHLARLESKGLIRRDP
TKPRAIEILDLEESNIPKYNIINVPVVGKVTAGMPITAIENVEEYFPLPERLAPSDEQIF
MLEVMGESMIEAGILDGDYVIVRQQHSANNGDIVVAMTEEDEATVKRFFKERDFIRLQPE
NSTMEPIILRNVSILGKVIGVYRHIQ
>PK3-045_02799 hypothetical protein
MSLENVQAYLSKWNKEKDIRLFTTSSATVLEAAETLGVEPQRIAKTLSFRKDNNAILIVT
AGDAKIDNKKFKQAFSEKPRMLSPEEVLEKTGHAIGGVCPFGLTEDLPVYMDESLKRFNT
VFPACGSSNSAIELTNEELYIYGNVEEWVDVCKGWE
>PK3-045_02800 hypothetical protein
MKKKWKKYKVYIIGLFYILFINALIAASYIIGFKEFKKLITF
>PK3-045_02801 hypothetical protein
MVTYMLSFILHYPSNIEIEQEKEKLTQLSIDHWLQHDFLSTNWWILFLATIIPYFIWWKL
VDKNRFFEIFSYGMVCATFCMILDVIGTEFMLWSYPDKIIPIISPLIPANLVIIPITAMI
VYQYFTNWKHFMLATLGWSILFSYIIEPLFMLRKMFILGEYWSHTRSFIGFIILGVILKS
IFEKIKKALPN
>PK3-045_02802 hypothetical protein
MKDPNVKNANFQDRLGLDEDEQEMNGLYGMAETKEEDVRHNSNSQLKQ
>PK3-045_02803 Nicotinate dehydrogenase subunit A
MVEKEPNLLTMKLRVNGENHLVVIPPYKTLLAVLREDLFLTGSKPGCFNGDCGACTIMVD
QMAMKSCLMLAIEAVGKEVITIEGLENSPLQQTFIEEFAFQCGYCTSGFIMNGHALLLNE
KNPDKEKIKEWLESNICRCTSYEEIETAMLKAIERKKI
>PK3-045_02804 hypothetical protein
MDFEFKKTSTIGQAFAQFAKTKTENRKPAYYAGGTEILTLQRVQQLNIDVAIDIKDIPAC
LVHQLTEDYLVYGSCLTLTEIEEHNHFPLLTDVCKEIADRTARNKITVGGNICGAIFYRE
AVLPFLLTDSILVLAGKNGLRTEYIHDVFHQQLQLPDGELFVQAFIEKRYITCAYIAIKV
RQQWETGYPLITIAALEIDGEIRMAFSGLCPYPFRSLILENIINNRVLSRQERINQIVNQ
LPGPILNDVEGSDEYRIFVLTDLLEKVIARLEGD
>PK3-045_02805 Putative xanthine dehydrogenase molybdenum-binding subunit XdhA
MTYIGKSVFRKESLEKVTGRARYTADYLASDALHVEMVKSSYAHANIRSIEIEEAQRLDG
VRAIILGDNLPLIGEEVIDRPALAVNKVRYYGEVIALVVAETIPIAKKAAQLIRIEYDPL
PIVNSPLQGLEENAPLLHENMLDYTKDEGIYPVEGTNIINHTKIRKGDIQAGLQEGEVKI
ESHFSIPLSDHAAMETRAALCEITESGIVRIVTSSQAPYMVKKIISRDFKVETGKVVVET
PFVGGGYGGKASVQLEIFAFIASRAVGGRKVRLFNTREEDIAVSPVHIGLEATIQLACTE
DGKLTAAKLKYVFDGGAYADKSPHLSTAGAVDCTGPYKIENVWCDALCIYTNHPYPAPYR
GFSHGEVHFAFERAMDMLAKKVRMDPLRFRRINAIRPGDTTPTQVLLTSSKVGNVEKCID
RLHEMMEWEKGQLEEISPNKVRVKGIACSWKNSTIGPGVSSGAVITFNSDGSINLMSGLV
EIGTGTKTVLAQILAEKMQMKVERIHVRMTVDTQTEPEHWKTVASRGTLMAGRAVMAAAD
DAIRQLKKMGAIVLRASEDDIEVANETVYLRDNPQKLVPFKDIVYGYTFPNGNSIGGQII
ANGSYTLTGLTKLDPETGAGNPGPEWAVAAQGVEIEIDIKTFRYKILKAITVVDIGEVLN
YKGVLGQIKGAMSMGIAWAGREAFYFDENGRILNLQLRTYRPLRFGEHPKYEVAIIKTPH
LEAPFGARGAGEHGLIGIPAAIANALSKAVNHELVRLPLTPESIWRQTKEEVHGL
>PK3-045_02806 Putative metal-dependent hydrolase YfiT
MDEKYPIGLFEWQSEITEEVLQQWLAELEEYPDKLAKAVVSLNEEQLDTPYRDGGWTIRQ
VVHHVADSHMNAYIRTKLTLTEKEPTIKPYEEAQWAELADSALPLSVSLQLLTSLHERWT
YLLRSILFTDDRKKEFLHPENGKQSIELLMGTYAWHGRHHLAHIINLCKKMGWD
>PK3-045_02807 hypothetical protein
MYLVQKFYDLEDFKNVMIPHLEKDEAVNGLPLGILMNANQDVKPSVMAGLYDNEQPVLML
LQTHPKQIIVAVFERILPNDLPLISKLVHESITDIPGLIGEKAIVEELAIHIASLRNLKV
VLGMDQRIYQLKELKKKADHTGIFRWANKSDQAITQQWVYDFAVSINEPMEMDQAAKRAE
ELIDSNRLAFWEVNNQVVSMANASRPTKNNITINFVYTPKEFRKRGYASNCVAELTQRLL
SSGFSSTSLYTDITNPTSNKIYMEIGYEPKIDSILLFLEK
>PK3-045_02808 Putative cytokinin riboside 5'-monophosphate phosphoribohydrolase
MKKIAVFCGSSTGASPIYTEEAIALGKELARRNLELVYGGSCVGLMGAIADSVVEAGGKV
IGVLPDFLQEKEIAHPALSELIIVKSMHERKAKMTELADGFITLPGGAGTMEEFFEIFTW
AQLGLHKKPLGILNINHYYDPLVGLINHMADAEFLQEQYRSIAIVDSNPKQLLDQFTTYT
PPAIKTFIEVSQS
>PK3-045_02809 hypothetical protein
MEEGKVLYKGRVFKVLFCYDTGYCEIRDIYNVFKVELVHNSQLTQLEDVCTQ
>PK3-045_02810 hypothetical protein
MSEYGGGFGSNFALIVVLFILLIIIGASYVGGY
>PK3-045_02811 hypothetical protein
MSDCYGGGGGYSSNFALIVVLFILLIIIGASYLGSY
>PK3-045_02812 hypothetical protein
MGRHNNNVGGSGNNKHCNKCSNRVSPVEDIIHPTKTVVRTTTNERRIRNIHPTEIINVNR
TVVRNENFFPVTERQVNETVVEDFDCGADINNSNNCRPRRRFF
>PK3-045_02813 hypothetical protein
MVKQLEKAWKEKRPIEIIYVKKDNTVSQRTILVYGVTDIYIMAYCLKKKQPRIFKLGSIL
AASFVKKRHPLYA
>PK3-045_02814 hypothetical protein
MNLAIPHRLEGYPFSSHSQWSQLSNSPHQKYFTPFNLPSYSYSLYRQPNQTSIRKNHLLS
QITKAINGEYTAISCYHTLKNIAPSKKEQTVITEIRKDEIRHYNTFSNLYTQLTGKKHTP
IMKEKCPTNYRKGIDAAFLDEQETVDMYLEIAYNTTNHQVKEAFLRAAHDEQNHAVWFLY
FMK
>PK3-045_02815 hypothetical protein
MIKLFRKRWMLFDQIVKTYKPFVTVDYGVISVSPNDIIGLSTPVNQVKNSDKMKELRNSL
EQKGWHDECPVDLHLYRLPNGKYTVATDGNHRTYLANQLEIPKIKAMVSLLIPETYIPEN
IKAKIEEYEQKEKTYRLEAEKLSKSLQSLGEKRKKAKDEFAYKNFCKLIDDMYSKRQYML
LGFARFLNLVPNETAD
>PK3-045_02816 hypothetical protein
MPFTIFGFDLTVTILNIPFNAEYSITIGKEHKGKHHHHHLPVKA
>PK3-045_02817 Acetyltransferase
MITELHTTRLLLRKMRDSDSTSLFPIWSDPEVTKFMNIDSFTEESQAKEMIFFLDELAKE
DKAIRYAIIERESNQIIGSCGFNFIDFDNAKAEIGYELSKLHWGQGYAKEAISCLIQSAF
TDLNLNRIEAKIEPDNFNSIRLIEKLSFTYEGTLRKAEKAKNRFIDLQLYSLLASD
>PK3-045_02818 Undecaprenyl-diphosphatase BcrC
MIFSEVNIHLFRYINDLGKQYTFLNIPMILIAEYMVYFLAIATLLLWFSSKKKNRMMVLC
AMVSFLFAEIGGKIAGLLHSNYQPFEELLNVNKLIEKAVDNSFPSDHTILFFSICLSFYL
FKRGIWLFWVILALIVGISRIWVGVHYPMDVFVGAFIATMSSILVYLTLPKLKLTNQFLA
YYEDLEQRLTRKVFSKNKGSKDI
>PK3-045_02819 hypothetical protein
MMELKTTGRNKYDMIMELLALHVKQADLFGEDVRPEEIEELFKKYSEIVNKI
>PK3-045_02820 hypothetical protein
MKKFFSIASFIIFFISLTGVIRFFFDASNFKREFAIFFMGVLPVIGLVLE
>PK3-045_02821 hypothetical protein
MSKNGLDLERIVFIGRTFEEYMEMFSLSLDELQGKKILDCPAGACSFTAIGKQKGLEVTA
CDIAYYHPGELLANKGRKDLEHAMESVEKAKEQYVFDYFKDVKDLAQHRTQALNDCAADM
KENPGCYIPVTLPSLPFESEQFDLILSAHFLFTYGDRLNKVFHLDVIAELLRIAKEEIRI
FPLVDLTGNRYEHLDEIVKILKNNGHDVEEVRVPYEFQRNANTMMKIRKRNKE
>PK3-045_02823 Glutamine synthetase
MAKNYTKEDIKRFASESDVKFIRLQFTDILGTIKNVEIPISQLDKALDNKMMFDGSSIEG
FVRIEESDMYLYPDLNTWVVFPWTAEKGKVARLICDIYNPDGTPFGGDPRNNLKRVLKEM
EDLGFTDFNLGPEPEFFLFKLDEKGAPSLELNDNGGYFDLAPTDLGENCRRDIVLELEEM
GFEIEASHHEVAPGQHEIDFKYADAITACDQIQTFKLVVKTIARKHGLHATFMPKPLFGV
NGSGMHCNLSLFKNGENVFYDPKGELELSETALQFIAGIGKHATSFTAITNPTVNSYKRL
VPGYEAPCYVAWSARNRSPLMRIPASRGLSTRVEVRSVDPAANPYLAMAALLKAGLDGIE
NQMTPPAPVDRNIYIMSKEERIAEGIVDLPSTLAQALDELKQNETMIDALGEHIFDHFVE
AKEIEWDMFRVQVHPWERDQYMEMY
>PK3-045_02824 HTH-type transcriptional regulator GlnR
MSGSQIRRSMPLFPISIVMQLTELSARQIRYYEEHELVAPARSDGNRRLFSLSDIDKLLE
IKDLIDQGVNLAGIKQIFSVQEKQVLTDEVKKEAEKARRELSDEDLRKLLRKELLNAGRF
NDTHRPSMRQGDMSRYFQK
>PK3-045_02825 hypothetical protein
MYKQLTYGTQLETLVMEVEEQIKEVHQSIDKRIDSNQFRVLASFQNHKVSESHFIPSTGY
GYDDIGRDTLESIYAEVFGGEAGLVRPQIISGTHAISTALFGILRPGDELLYITGKPYDT
LEEIVGIRGEGTGSLREFNIGYNSVNLLPDGQPDYEKIAASIHANTKMIGIQRSKGYATR
PSFSIKEIEKMIAFVKEIKSDVVVFVDNCYGEFVEDLEPCHVGADLMAGSLIKNPGGGIA
KTGGYIVGKEEFVKACSYRMTSPGIGAEAGASLYSLQEMYQGFFLAPHIVGQSLKGAIFT
AAMLEKLGMNSSPSWNAKRTDLIQSVQFDDKDKMIAFCQAIQYASPINSHVTAYPNYMPG
YEDDVIMAAGTFIQGASIELTADGPIRPPYVAYVQGGLTYSHVKIAICIAINQLLEQKLI
TI
>PK3-045_02826 GTPase HflX
MKETKIEKEKVILVGCETQNDADRFAYSMEELANLTKTANGEVVATLTQMRERIHPSTYI
GKGKVEELEMLAEELEADLIIFNDELSPSQVRNVSKNLDARIIDRTQLILDIFASRARSK
EGKLQVELAQLQYLLPRLGGQGLQLSRLGAGIGTRGPGETKLESDRRHIRRRIDDIKTQL
SVIVEHRDRYRERRKKNRAFQIALVGYTNAGKSTLFNRLSEADSFEEDILFATLDPMTRK
IILPSGFSALITDTVGFIQDLPTTLVAAFRSTLEEVREADLLLHVVDSSNEEYYQHEETV
HKLLEDLEIPAIPHLTVYNKKDLVHPKFVPTSKTESILISAFDKEDREQLKQTIEQMMME
NMEYYETTVESNNGKLLSQLKNETVLRSLIFDEETQNYLCKGYAFKEHAILNYKKSIEKE
EWEK
>PK3-045_02827 Stage V sporulation protein K
MEHPIRMKNNGQISVVINSQKKKVLPKEKPEAESIPRNVPSEHEALREIEAELGSLVGMD
EMKKMIKEIYAWIYVNKKREESGLKTGKQALHMMFKGNPGTGKTTVARLIGKLFQKMNVL
SKGHLIEAERADLVGEYIGHTAQKTRDLVKKAMGGILFIDEAYSLGRGGEKDFGKEAIDT
LVKHMEDKQHDFILILAGYSREMDFFLSLNPGLHSRFPLVIDFPDYTTDQLMEIADRMLK
EREYTLSHEAEKKLKEHLSYVRNVQHPKSFSNGRYIRNIIEKSIRAQAMRLLLESNYDKY
ELMTLRSNDLMLNSHEK
>PK3-045_02828 RNA-binding protein Hfq
MKQSVNIQDQFLNQLRKDGTNVTVFLLNGFQIRGFIKGFDNFTVLFESEGKQQLVYKHAI
STFAPQKNVQIDLEGTQVQ
>PK3-045_02829 tRNA dimethylallyltransferase
MTIKEKVVVLIGPTAVGKTNLSIELAKKYNGEIISGDSMQIYKGMDIATAKISPEEMQGV
PHHLIDIVEPDESFSVAQFQELVRKKITEITARGKLPFIVGGTGLYIQAVLYDYQFQETA
SDQAFRMKLEEMAQREGSLRIHDRLKEIDPEAAAAIHHHNVRRVIRALEVFHVTGRKMSE
IQKEQKQEPLYDTALIGLTMDREILYERINKRVDQMLENGLLEEVEHFYHQGIRDCQSIQ
AIGYKEIYKYYDGLLSLHESIEELKQNSRRYAKRQLTWFRNKMDVQWYDMTETVKTNDIT
KKIQEISSYLEGMLEIKSNT
>PK3-045_02830 hypothetical protein
MEYTLNRRHRQWKKQIQAYINEWYLLAFLLTGDRVTAEQLLNMAVEQVKDKWSYRHFERL
WAKPVIKEYIKFSRNNECNDKYLDFSTLLNRIGLLEGNARVAFLLKYYYGFSYKKIARNL
HISERKAKIIIYDALLLWTNNGKLIPIEQVEAAINKDINLAKNFLLDSFRFEKKNQYIET
RLKGKRKALFLIFTIVVLFAGGSINQKTLGKTRVSLGPDVYKIYKEGGVFQLGREIQQKG
YTDIYAYPEEENNILYVQFSTAESLENKEEVTMFIESYLKERDLDYEIRYEEMNQVIEAE
QTDEQTDEQTAENKQLEMEQEIYELLTSNTYYYMQNYVSDSSGESREILLSESIPKEEET
MIKEEIKNIMTKFDSEWNFSFGKVDAEVVEMEKAMWNIVPALLEAYMFGGDKYKVYDVYP
TYEDEQLKFDIYTELAFTTDEDRAKNIETAKELKRSIQFFFQHEDIQKLFNHAPYVIKIY
GNNRKEVEFDI
>PK3-045_02831 Quinolinate synthase A
MNLLEGLQASNTIPEKYLAMSNAELEERVVSVKNRLGKKLFIPGHHYQKDEVIQFSDATG
DSLKLAQVAAENTEAEFIVFCGVHFMAETADILTTEKQKVYLPDMRAGCSMADMADIYQT
NRAWIKLQELFGDTIIPLTYVNSTAAIKAFVGENGGATVTSSNAEKMVSWAFTKKERLLF
LPDQHLGRNTAYNLGVPLEQMAIWDPAKNELVYEGVIEDIKVILWKGHCSVHENFTVKNV
EQVRKQYPYMKIIVHPECSREVVAAADLAGSTNYIIDVIENAESGSAFAIGTEMNLVNRI
MKEHPDKEIISLNPYMCACLTMNRIDLPHLVWCLESIEDNFERNRINVEEPIASNAKIAL
DRMLELS
>PK3-045_02832 putative nicotinate-nucleotide pyrophosphorylase [carboxylating]
MNQLKLQKLLEAFFMEDIGERDVTTDAIFPKEQQGEIVFLSKDNGIFCGEEIIQVGFQVL
NPATEVTMRIHDGDRMEVGQKLATVRGKIRDLLKGERVILNLVQRMSGIATKTCEAVETL
NSGYTKISDTRKTTPGLRMLEKYAVTVGGGHNHRFGLYDAVLIKDNHIAFAGSIANAVKA
VKQSIGHMVKVEVETETKEQMFEALAAGADVIMFDNRKPEEIVEWITHVPETVTTEASGG
ITLENLASYRECGVDYISLGFLTHSVKAVDISVKVSFD
>PK3-045_02833 L-aspartate oxidase
MDTDVLIIGSGIASLQLAKKLSTDFNVIILTKSKIESSNSYLAQGGIAASMGDSDDYRKH
ALDTFEAGRFHNNPEVVTKITNAAPILINELRQGGCKFDEDMAGNLALGMEGAHSENRVV
HSGGDTTGKQLMQYLVETKTNNIKIIENVFVYELMVNTNTKQCFGAKGIFSDGTRTEFYS
AHTVIATGGCGNLYTYTSSASTITGDGIALAYLAGANISDMEFIQFHPTLLYVNGKTIGL
ISEAVRGEGARLVTAFGEYVMEHVHPYKDLAPRHIVSQTIYQYLSKGEPVYLDISMIANF
QERFPTITNMCLKAGIDLQKGLLPVAPGSHFLMGGIDIDLHGRTNIDNLYAIGEAACTGF
HGANRLASNSLLEGLYMGKNLATLLHKKQKIKTETIQWKNEEKNENFFPILPEKAEIQDR
MMEYVGIVRNGIHLRMHLEWLEGFRITNLEQISLENKSVEEIEKYFMLLTAFLITKSALE
RKESRGGHFRSDYPMEKNEWMKKKICMNREQTKENQNEPIKIAETAGSIFYGRYR
>PK3-045_02834 Putative cysteine desulfurase NifS
MKYFDYAATTSLDSDAASTYVEVACKYFGNSNSLHDMGDTATRIVENCREEWGRLINVDK
KGIYFTSGGTESNFLILQSLLKGTKKEGKHLITSIAEHASIHGTMHVLADKGYEITYLPL
SETGLIDTRLLEETIRPDTVLVSIQHVNSEIGTIQPIKEIGAICKKHHVLFHSDMVQSIG
KIEVKKVTPYVDALSLSSHKFYGPKGVGLAYINPNVPWIPIVLNGSHENGFRSGTVNTAG
IASMTVAAQKACSTISENETKHSKFRRLFTEMLPKETVTVFECTDQYPGIIGLRVKGIEG
QWLMLECNRRGFAISTGSACQVGKQAPSKTMKALGLADQEAKEFVRISMGKDNMEEDVRD
LANTIKQLALNSSLPK
>PK3-045_02835 hypothetical protein
MKKISHDVELTTAEIANLWTQYINDSLSICILTHSIEKAKDEDIKEVLYFSLSIAETHIT
KITDFFTQENLPIPKGFSVEEDVNLNAPSIFTDAFIIAYLHIMTLLGLTGYAGAVSTSSR
ADQLDYFIQCNKETMELHKRIVSIMLNKGFYSKTARINTPEQVKFVDNQSYLAGWFGKKR
PLNAIEISGMSFNMKKDVVKTVLELGFAQVCQTKDIQKYFERGKKICLNHFTTFNTILTK
EDLSSPKTWVSEVTNSTVSPFSDKLMLYHIVTLVSSAVGYYGAGLSVSQRRDIAAEYTKF
MAEVGLYAEDGCELLIKYGWLEQPPLADNRQTLANNKE
>PK3-045_02836 hypothetical protein
MFEILNVNAENVDEYGFFCMRSKPKSKGYQNKLAWMKKRFKEGLKVKILLEDGKQRGFIE
YIPSEFTWRAINAKKYMVIHCFWIVGKSKGKGYGSKLLEECIKDARELHLDGVAIVTSKK
SWLPDKTLFEKKGFNQVDKRGDFELMAYAFQNDRKPSFIDWSLIANEYDNGITVFKSDQC
PFTQDAVDNLQAAADEHGLKVTVLEMNDNEMVQHLSPTPFGVFTVIYNGEIITYHPETKN
KFLQLIERQDLKMSK
>PK3-045_02837 Aminoalkylphosphonate N-acetyltransferase
MTVSLEFRLATLQDLDQIVAMLADDMLGSKRERYEQPLPASYLQAFQAIAEDPNNELVVA
CFGNEVVGVQQITFSPYITHQGGWRATIEGVRTVSSVRGKGVGTQLINWAIERAKERGCH
LIQLTTDKQRPDAMRFYERLGFQATHEGLKMKL
>PK3-045_02838 Lipid II flippase Amj
MELITSKVIIISILLLVITMIETLAYSTRISGTRVKLIATAISLFSTMVIVSRFSTMFQQ
PLTAKLIAEVPKGADKLTFIAAQYRILIGVTSMGVLIGILLFPTFINIFSRAIVQLANER
GSMLALFSKLFKKNNLNKLLKCLKLPRLSYFKGITLNTVPKRLFVLNVIISAIFTTGVIS
SIYASMLVPAKVSQAALMSSGVINGIATIILTLFIDPKASVLADRVMKKQTDYIYLKSYS
LTMVSSKFIGTIVAQIIFLPAAYYVAWFAEWL
>PK3-045_02839 hypothetical protein
MGLLNIGSLVLGLIAWILPATNLMRDKKKVQRNGLMICFLSMGACAISISFQIFYSYYLV
KMEDWSAMMDTSGGVVVATAVLLSVTIF
>PK3-045_02840 hypothetical protein
MRTNEMLSQTFLTFAEKECKGSSVLYALLSKQIAMDKTLLNIAKCARVGQPVPNLLFGAV
HYLLLKGTNHSLKDYYPSITENPKTAKASFPIFKDFCLKYQKEITWILQTKLVQTNEVRR
CSYLYPAFCMIYNLAKKPLALTEIGTSAGFQLQWDKYAYSYGKEWYGNSESELPITATVI
GENMPFLLKTSPPVTIRIGFDLHTIDLHDKDEELWLKALIWPEHRERLFLFEKAADYRRE
GALNVVSGDGVSLLPYYAETIPEGSAICIFHTHVANQIPREGKELLLQGVEEIGKRREVF
HLYNNIQDRYLHLDYYMAGKKSENSIAETDGHGRWFKWLKNDTR
>PK3-045_02841 Lipid II flippase MurJ
MESSKLLRGTFLLTLGTIISKVLGMLYVIPFYHIVGEKGNALYSMAYIPYSIFISIATAG
LPLAVAKFVSKYNSLEEYAVGRKLFKSGLIMMSCTGIVAFVILYLFAPILAAASIPDNAD
VSVQDGTTVIRAVSFALVIVPFMSLIRGFFQGHQSMGPSAVSQVVEQIVRVIFMLSGAYI
ILNLLKGSLVTAVSVATFAAFIGAVGSLVVLLWYWYKRKPHLDKLLLEDKGVIDVSLKET
YKEIIVYAIPFIFVGLANPLFQFIDELTFKGAMESIGLKDQVVTAFGVLTLNTHKLVIIP
VSLATAFSLTLVPAITKAYTEKDHVSLVQQVNQTIQIVLFFTLPAVVGLSLLAEPIYTVF
YHHKELGTDILRIYAPVAILFSLFSITAAVLQGINKQKYTIISLLLGLMVKLCLNIPLIK
IFATSGAVIATSIGYLMAIIINFYVIKKFAGYSLRLVIKRVLQIGFFTLAMFIGTLFTYM
LLTLFLSAQAKVDACIIVIVCMVVGISIYFCLSVKSNLIIQLFGERAIRVIKKLNINKSF
>PK3-045_02842 hypothetical protein
MNQKNKKEFISIILTLFLFLASIAVFLFVRGSNLTLWIPISLYLLIDLGLLVSLIIGVQS
KNKNIKIFSILSNIILLIPITIWTYFLLLANGISEK
>PK3-045_02843 hypothetical protein
MYEDVKGLLINLLILLTQHHAGYLLKALHSCYHILAFGREVINSFRKTIEKLYPAGNMIG
>PK3-045_02844 2-hydroxymuconate semialdehyde hydrolase
MKKWTRKLLNTSRGKFEIFIKGQGEPLCITHHYAEFNETGDYFAESFVDTHKVFLINLRE
AGSSDKATQPYELGLLESIFDLEAIREALGFKKWNLAGHSTGGILGVIYGIYYSNSLNKL
VLVGAAAREYMTFSPDCIYNDKHPSFKKMQDLIEKLKRSDLTITEKMRITKERTKLSLYT
PENYEEYFSLPIQKKISSIRLNYFSREVQLFDVTRKLKLISTPTLIICGKFDVQCPLSYS
LEMNECIPHSKLLIFNQSNHYPFLEEASRFKDEIDAFMGEISCN
>PK3-045_02845 hypothetical protein
MQLKKIDIDMIAHSLLTSLITAICISTIYLINSSYFSLLGILIFSFIFFCFYLVIASPLQ
ILLNQRPKKFSIFYLAIYNVFSGVVTWIVAMFFDMEDPFHSSIFYFVCISFLES
>PK3-045_02846 hypothetical protein
MKNSLQIIAEASYSLNFLVYVQNIFLNQNDNKDNWKFPYPLTTCEFRKDFLLQYRDLWTK
VTKSISENRDIDQDIFYNEKHLFYHELCDVNVDNLTAFDQIYDSFFTWWTSLAGGFSIER
AMGETIEHIYHDISTILLEEKIIPKKPLHINFIYDNSIIEDLTSFSYFAVLSINDCILHY
KEAVARIKICVD
>PK3-045_02847 hypothetical protein
MNSAELWIVKNKLPIDDIVCASEYINGKPECAFIHNVTLFIEDNPTHALSIANSGIDVLL
LDKPYNQMCKHERITKVKDWEQVGRLLLSYGFYK
>PK3-045_02848 hypothetical protein
MNHIGIDFDDTLVDMRKSIVKLLNKIHNKNWDYEEMVEYGVSDLYGYSFEAFVDFFTINQ
KELHSAKPYPF
>PK3-045_02849 hypothetical protein
MKRDKEEKLQKQKMVQELYRERVKQKSKDKNDNRIGKLIVNLCIVVFFVCTIMAILFDWG
VKVPQFFGI
>PK3-045_02850 Validoxylamine A 7'-phosphate phosphatase
MIKAIIFDLDGTLLNRDASIEMFVDCQYDRLNIELGHIPKDTYTKRFIELDQRGYVWKDK
VYQQLAAEFELKEITWEELLQDYLSQFKNHCMAFPNLKKMLEGLKSQNLLLGMITNGFGQ
FQMDNMKSLQIEKYFDVILVSEWEGIKKPDPRIFNKALNILNVQPNEAIFVGDHPENDVL
AAKKVGMKGIWKKDLHWRNAEADYIVDDLGELPFIIEKLM
>PK3-045_02851 hypothetical protein
MLKRKVVSAILTLFLSTFVFTVFLPLDSFFTQPVIQDVDLKEDLISYTLFFSLGLLLYGL
PISILIEKITSKLPQGRLAFSFILYVFFGFLPFFFLWIFTIYSLSISIMFFLIDESIRRF
RQEKDRIINNVY
>PK3-045_02852 hypothetical protein
MKKKALIIFTTVTWLIILCPFAILGYINYQKHSLKNDVYAYLLEKYQEDDILEIDTTLTK
ASYHFTTFVTFRDEPDQKYEYIRVDKEIRQASPNPNEEEEHLYKHLDFNR
>PK3-045_02853 hypothetical protein
MRGIKYYLLIFTIFFLSSCQQNEVVEQEEKVKEGLTYSFQHPETGQAYNIIHVYKLYENF
EKRMKKDVNMSESQVFDEEVINPIYEACYQDAEYFTETVKAPENREEVNNIIQTMDVKAI
NSAIEESLIKSSNYIPSNQKTNICIYPTEATKSTTLMFTEGAGKISVLYNEFFNEETLKA
GIAHEYHHSVWTEKYFNNSHSHTVLDNLILEGKAVMFEKLVYPDITLTTVNYNFNKDDWN
QIEPDLFQEDSYRAAEIISGGNGLPYNYGYNVGYQMMRSYLDLHPDFTPQEWTALGAREI
YEEGKYNEHYQ
>PK3-045_02854 hypothetical protein
MTLESYGNYYDKRVESIDEKICELISQRKIISSDPGDPTSQHIAIWSKKYNLNGEFLNDV
FSHLLREDIYKPIEVPKGFLKNKPVLKSYEDNNVFYSVPFIRQYENASVVHLNIDKDVSE
EKPGDMHHFIFIELSINGTNIVYDCRNDHGGASGGHISFEFIVTPPLPDNMSNIKLIFKE
YNEPLKRKPTGLEFEFTLDK
>PK3-045_02855 RNA pyrophosphohydrolase
MAKTSGCFTIVINDKGQVLLTKRKDFPIWDLPGGRWEKGETLEDCAIRETEEETGYLIQI
KRKIGEYFQPQFNDMQYLFLGELKGGKPIEEGPETEKVAWVNIRHLPLHMVPNRRKQIKN
YLQNKNHVVKQSITVSPIIRILLKGYLKVFR
>PK3-045_02856 Adaptive-response sensory-kinase SasA
MIDNEFLPSIKLYRMIIGLFIILMSAGIVIVYIEDNRIISMSLILQFLFVVSISILLVIF
PKKDTLNFRATIIFLMSAYFFFMYLRFPDRFALILLICFIPVIPVLFLHIRLFYITLLGN
ITIMLCVIIYLMMNKSPGIHSYSYLDFIGVITNFLGTQLLLLFLFLLFQKRMKDQELYYV
QVKQAEKLRTTGQLAAAVAHEIRNPITVVKGFIQLHEKDKEIPEHIKKQYKLMLDELEAA
ETVITDFLSLAKPSETKTEIISVKLALHTVMDLLNSYAMNDTIHIELESETDYKIQCNIM
EFKQLFVNLLKNAIEASQPGDTIHVKLIGELDILKIVIIDKGTGMNEEQLEQIGTPFYSL
KAKGTGLGLMICYNIIEKYDGTIHFKSKEGNGTEVTVTFPIV
>PK3-045_02857 hypothetical protein
MIKVRKAEPKDVEGIAKVCRDGYWGTYEDLSSKEYITRIISTFYNRERIHKEVTETSREW
GGYFVAIDNDEVVGAIGGGMINDTASEVFVLYINPDRRNEGIGTKLLDVLTKQQKEEFAA
SEQWVSVAKGNQKGIPFYEAKGFIFKKEQDTYGNVEGESYTSLRYCRVI
>PK3-045_02858 hypothetical protein
MIEIKNIGRICRTDSRGNIINDSTINAIKPEFKCIIEAAVATYVSHLGEHLHSVYIRGSI
PRGLGIDNVSDLDTIAITNKNIDSIDLNWVDRAEEVLNENFKAVDGVELSFYFIEDILET
TNFSIIPFMIKTHSICVYGEDIRDFLPNYKADKTLANEHLVNLKSQIQQAKEELSGNEDV
EDVVDCCRWIMKIIIRAGLALVLVEENKYTRDLYPAYKLFSEHFPSKQSEMKQTLEYAVN
PITNSEVIINFLNVMGDWMISITEKWLQTHNPIMERNMKI
>PK3-045_02859 hypothetical protein
MKIIILGSTGFLGSSLFALASSIPDFSVYGTSRFANAHSHILQLDTNNKHQVTQLMNHIN
PDVVIWSLMDGENEKQLIEIGLHNILTVISPKTKLIYLSTDAVFVDGKGNYSETDLPGFL
PSGAPLSTYINAKHIGEDLLLTNHTNHLIIRTGPIYGKDANQEIEARTKRLVHEIKIHGY
AHAPANTFKTFVHIDDLSNAIIEIINMNLTGILHFGPIQKESYYSFYGKRLLQLGFATTN
LLPFSINKYEKPFHAFDTSLNTKKATSLLRTNFRNVDEPGGIKKIIETNNYESRWK
>PK3-045_02860 hypothetical protein
MYVYWFGQLFWLLTGGAFLVFLIGLRRISWEIVLISGILFFVPALYFLGANNWFRLLVIV
PLIPFWSAFRIKKSM
>PK3-045_02861 hypothetical protein
MRTSFLLLLLFTSLHPVVDVTTISEGIPQNLNSTLTESAFLRFLSPTILEIIEKHGDMQL
YMNEKIESITFNEHEDSYDVTLHVVGFEGAIILLIISFEWSFVSRGGKI
>PK3-045_02862 hypothetical protein
MNIEKRLYEEAVALIEKRYPVGWGGAAAMYTNEGEILTSVAPEIINASTELCIETGAVLE
AHKLAVRITHSICVVRENEKAAFTILTPCGICQERLFYWGSDVKVAITNPGNEIIFKTLT
EVQPYHWYEAYRER
>PK3-045_02863 hypothetical protein
MSRAKDVLQDQLLANANDPSWYVSFSESVVNLTEEEAFWKPNDESNSIAEIVQHLLYWNE
TWQTRYKESHVNAVAPINDNNESFVIPENITFADLKKSLLAVLLQWQDLLTQEKVDNDVI
GFPETAKWWEVLSNLTTHNAYHIGQIVYIRKLQKSWKTNLKGD
>PK3-045_02864 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MELMNKVVIITGAGTGVGRATAVKLASEGAKVVINYNQSEKEAHKVVNEIKQNGGIAIAY
KANVANEKEVKELVSQTVQTFGSIDGLVNNASITAQIAMDNLDALTDEIWDSLFSVNVKG
MFHCIKAVVPFMKKQHSGVIVNMGSVAGMTGIGSSIPYAATKSAIHTMTRSLAIALAPSI
RVNSISPGAVETRWWAGNEEKMYQLAGKLPLQRISTPEDIAEAIVFQLIQKSITGQVFTI
DNGQTL
>PK3-045_02865 HTH-type transcriptional regulator YofA
MESHELKIFKHVAELQSVSKAAEKLGYVQPNVSQRIKNLENELGVRLFMRNNRGVTLTEE
GEKLLDYTNEILQLIDEAKTAINPNKWRESLKIGASQTISAVKIPSLLSAFLKESNNLDV
KVRTSNNLMLEEMLFYGEVDGIFVNNSSKNTSDCEIVYSYLEKIILISPILNPFHINSNQ
TLIVNSDRNCIYRKQLLEWSKESNFHSSHIIEFDSLESIIQAVHDGLGISIIPADIAETR
KGTKEIIFTELPKKIKIDFLIKNKKQQTPGLKKFIRFLRENNERK
>PK3-045_02866 hypothetical protein
MTTIQKINQIGVPVKDINRAVKFYKALDLPLLFSTDTMAFFDCNGTRILLSLPEKEEFAH
PSSVLYFQVENIKETYEKFTNEEISFVDEPHIVAKMSGMETWMTFFKDTEGNTHAFISEV
EAK
>PK3-045_02867 hypothetical protein
MNIKLNKAIDLRKNGKLKESNELIGELVRDFPEDAIYNYQYAWSFDILGEEEKAVPYYEN
AIKIGLPSKDMEGAILGLGSTYRALGEYENSKDVFLKGMELFPDNHAIQVFYSMTLYNLK
EHSKAMELILKCLINTTNDTELLSYKRAINFYSDKLDETWK
>PK3-045_02868 hypothetical protein
MGSRIMHLVIANRIADALSIKDRRSFLLGGISADAVSPKDLSHFYKGDVKDYSRYIDYQE
FIDKYNFNKGCHFIQGYYTHLIADDIWLKGFYLPWLKNRMEADENILNRYHNDFRLLNGK
LLDYYGFTQQLCEELSKSGTIMETEEVKSHDIKEFLPFVLGDMDYGRDELVQPLTVFTLE
QIIGYIETSVDKGLIYIKSLYN
>PK3-045_02869 hypothetical protein
MLLKIFVALIMILNVIVLTFIVDNFLILLSIWLANGIAISFLLFSKDKKDVKEIENNY
>PK3-045_02870 Streptothricin hydrolase
MKKALLVIDVQNGMFQEGNVVYRGDRLLHNLKYLISQARFTKTPIFYIQHNGPVGKPLEV
STKGWEIHPEIAPNNLDTIIQKTTPDSFFNTTLDDELKKQEIEHLVITGIQTEACVDTTC
RRAFSLEYKVTLASDTHSTWDTKEITAQQIISHHNGVLRWFADVYPSRNIIFES
>PK3-045_02871 hypothetical protein
MRKFFSILSVISILLGFLLFISLYQNDEKLLTALTFGTKGYPFIILLNLYNIIGFLFAIF
AERNKYRILLFVFSISMILTSLFVTFVALYGFQEP
>PK3-045_02872 hypothetical protein
MITIRDMNRSSDIDSIREIAAVTWKNTYSEIILEEIQEKVLNDAYSDVEMEKRLNSSLAL
VAENNDKITGYAFFQESTLSLMVYKGNLIYHFMKRKDLELSRKMREISMAFNDFYCNDES
FKKS
>PK3-045_02873 hypothetical protein
MTKNGWLSLLMVGICIILSLFLNTKNAGIFFLLFPILSLSGIIFAIFSKKWSNIILGVLL
NGAAGVFFTLLAFAVGFGET
>PK3-045_02874 hypothetical protein
MKKEEIKKAAIKFFLQNGFEGASLSEIAEEAGIKKASIYSHFKGKDELFLEVLREAKAEE
IKRKAYFFEKKDSHNPETFLYEYLLYTKELFQENEMLKFWLRMGFFPPLHLYDVIQREVF
EAEQFQEELIGQKSSKWIKHSQIHVKDTNTFNLAFTGIIMAIMVEIVYFHSEKRVDDKLE
ALWEVFWKGVSS
>PK3-045_02875 putative guanidinium efflux system subunit GdnD
MAWLALIAAGCCEIIGVINIKRLTMKKWDAFLYLIIGFMCSFALLSYAMKTISMGTAYGV
WTGIGTVGSALLGMFVYGEPKDGKRILFISMILVAAVGLKLIS
>PK3-045_02876 putative guanidinium efflux system subunit GdnC
MNKYWMMVFSAGIVEVAWVSGLKHASNLWEWSGTIFAIAISFYLMIYTTRYLPIGTVYAV
FTGLGTAGTVIAEIVLFNEPINIAKIILMLVLLIGVIGLKIVTDEAANQEEA
>PK3-045_02877 hypothetical protein
MEDCLICNRIEMIKKGTNKYFVKELETGYIVIGDHQYFKGYTLFLCKEHKNELHELDSDF
KEKFLVEMSRVSEAVYKAFKPIKLNYELLGNGDSHMHWHIFPRSEQEPNPTHPVWWTPRD
QMYAENVKPNAEELSAMKKLLVSELDKIMTSY
>PK3-045_02878 hypothetical protein
MPTNKGNKHPKLENYLIYGMIFGLLAGSLLGTFAMISGHVFIAIGSYGAGAALGMLVGTL
LYTIKKGRS
>PK3-045_02879 hypothetical protein
MNKVAILIIVGILLLMTGIYVSAFLSANWVMIGTALTVVGGIMTGGSSYFLINTKK
>PK3-045_02880 hypothetical protein
MIENEEQTDIFNLAIKKLCKLNNISPRKPRFELIDNLVVINNKNHLKDGVDSDCFFILNW
VYQIIASLGIKFRQQLMLFPNSRRVASIAVSFKKKDYDTLNRNLREGNIPI
>PK3-045_02881 hypothetical protein
MIHKLKEYVENASEEEVRSLLFLILLQISVEEQPDEELAKNLRKTYQDYLQTKIDQLKLE
NKKDYKAVHIVFGESAAGSLRMALKEMGVQEEEKVIYFSDDFSFGPLWKIEEEIGFALRH
KWLINHINYDDEYLFSYKRKFHKTILEVKNIKEQAHIIIWAGENANEQTAQRFVLSLLQH
KTNDIFLINPLEYNKEIASKSDAEVHAIHTGEFTSEELQVIYQKNNWKQPLTKSARLKYI
NEWKKISQQNKNLRIWADKKIDSVGEDYYDNYIIKTAKLLHKEQNNADFIKSARLIGEII
GNLNQRIGDIYFEYRLIRLVLKGIFELEGVPKAMRYYSVKLQEGYR
>PK3-045_02882 hypothetical protein
MKRIIVPTVFILGVIGILVLFLPREGFDIEIENQANKDISGLYLTYENIKKDIEIPTIMA
GEKEEYQVSVKDNSSDNFEEAALKLVYEDNEGNQQTEYIIGYFEKGYYGEAKINILSVDE
KGKLEIEVTENTKLF
>PK3-045_02883 hypothetical protein
MGVVKVVESEKRKKKRSKWVNYSIGVVVLLAIMGGSLVIYKHFIVKTNNDSFVAETKEGE
ILDETGKESIDYSYWNEDRAISTLHKMTHQKVYASDKWGAVQMTNDRVNRLYEIVKNSSF
SNKDNLLGILEKWKVGDFSTVDKDHNYFWKYQGGNVGEATGIMTAEDEQSFIESTFKQTQ
NDAEE
>PK3-045_02884 hypothetical protein
MNWIVALLLIILAICILLIVTNLVSLPKLGDERANYIKMRAQSYTFVVVIGILLLEIMES
IYVTTWTNSHYEGMKPFSFLVTISVIYLISLLLSKRKYGG
>PK3-045_02885 hypothetical protein
MKNRIRELRKSAKLSQEELAKLCNVTRQTINAIENDKYDPTLQLAFSLAVALATTVDDLF
IYDTVIK
>PK3-045_02886 hypothetical protein
MKLTKGACEAEISKAITQWEKDFLGRGSLSVKTDILRDMIIVNLQGILTPAEYTVCETKE
GLLTIKKTRSELVESGVEELKKCILTITGEEVKSFHTDLSSRTGERVMVFKLYNNVENLF
A
>PK3-045_02887 hypothetical protein
MILDKTKKVLFLMDVRDGLESIIKEETNIQPENMLTIKCFGPVISNPFGDIMRSIIIAVF
QEKVEEIFVVGTSSEADRFISIDGQFKSRIQTLDYLFQNSMPEFTGETINEWLNGKQNTG
DNIKNCVKMICHHPLVPPTVKVRGLLINNQDGKSSVVEINTNKTA
>PK3-045_02888 hypothetical protein
MSITSVLTKASSNKKNIPDNFVESDISSYIEAASKVIAPLWPISTFAARHPWMGLEKQTF
DQVADWLKQTRDVDIYPSASMILSAKKKGEIKEVFVKQGLKQWLASNPFNIPQDVAERFC
HAALNLEPIPSSLLTSHELKKKAEEYRKHHTDFAHYSSVQPISSHLQSKDKERLINILDY
HVIKWCKLYLDESQAAWTMPHREEGFYRSWRRLICYDPALTKKQRESLKKWPEEAEIALN
KGLNALSIPEPEKQKYLEAHLLSLPGWAGMMLWRSKQSSEENNLLTEYLAVRISLEWVLI
NPQLPFIPKSYENNQSIDGLLAALIHWGSLSLEEWSQLSSAQQQEYLLFAAKFDEKLCRK
LWLEAWEQTHAEQLSQKISAKQFSTNDKATTLAQFVFCIDVRSEPFRRQLEKEGPFETIG
MAGFFGVPIATNKLGSEHSHPSLPIMQKPLHKIMESTDENELKAFQQRQQTVHSFSDTFK
SMKQNLLANLLLPELSGPWLSLQMAARSFVPKSVDRFIHNLRKNWLRKPNTKLVLNHVHQ
TENGIPIGFTEEEKVNYARQALKMMGITENFSPLVVICGHGSHSTNNPYASSLDCGACGG
ASGGFNARVLATLCNLPEVRRALSLEGIDIPKETVFAAAEHNTTVDELDWIYVPELSKSA
QEAFRRIKAILPKVSKQANTERLAKIPHFPSQRKNSQSEAYCLAEDWSVIRPEWGLAGNA
AFIIGQRDLTNGCDLEGRVFLHNYNWQKDESGEILDNIISGPGTVTQWINLEYYASTVAP
HYYGSGNKATQTVTAGLGVMQGNASDLLTGLPWQSVMQSDEAAFHSPLRLLIIIQAPKNY
VERLLQTNAAFQEKVQNGWVRLASVSPEGDWENW
>PK3-045_02889 NAD(P)H-quinone oxidoreductase subunit 2, chloroplastic
MFLLHSMPSLLLVFFMMIIVSMLSGLLFLHQKVPLSYVRIHIWIVSLPPLFALIALANPN
GAENAGPFHMDSLAWLMTFFVLVIGLIVQRFSIRYLMGDRSYRKYFTLFTFTTTAASIAW
LSGDLRWLVLFWGVTLAGLTLLIRLNNGWKVATEASKLSGYHFLIGWVSLLLAAVWLSHS
TDSWQLSTALSIENLAGISAWERTGINLLIVLAVIIPAAQWPFQRWLVESVVAPTPVSAI
MHAGIVNAGGIMLTRFSPLFNGDLASTILLLIFAGISVLVGTGISLVQVDYKRQLVGSTI
GQMGFMLIQCALGAYVAAIIHLILHGLFKATLFLQSGSAVRRKEEASYRKTQPAFLWTIA
GWILSFAVGLVFWLQAPREGYQIISALILVWSISISWRQLVAFGEGSIGRIAGLIFVGGT
AAIYSFIHHFFYDILQTAVFQGSQPPLAVVLIVGCLLLVGTVIGAIAARNRSSIFFTVLY
LWLVRLGEAKPKAVESHPSYLKQQLP
>PK3-045_02890 hypothetical protein
MLRIELICNEIKRLMADYYKCEDAQLKKQIHSDIKLLSNVLYLSDLPDEYHEAEQEKRET
I
>PK3-045_02891 2-methoxy-6-polyprenyl-1,4-benzoquinol methylase, mitochondrial
METNVFEQLAKRYDTEDRRELANVIVKEVRRELENSTSLSLMDYGSGTGLVSLELSDLVA
SILLVDSSEQMLEVAQAKIANRGIMNADILYSDFTQDTPKHKADVILMSLVLLHIPNTKK
ILQALFQILNQDGKLIIIDFEKNDKINHPKVHNGFTEEELNEILSEVGFRSSKRKTFYQG
NRIFMNQDASLFISSSIK
>PK3-045_02892 hypothetical protein
MRWKISVNEKDAMVDYRWKEYIVVINNDYAIGNYIKSTTSNNTLLY
>PK3-045_02893 Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)
MKLPFFSKKQAAVSDLFLNETIPEHVAIIMDGNGRWAKKRGMPRIAGHKEGISTVVKIVK
TAVKWKVKVLTLYTFSTENWKRPKTEVEFILRLPKEFLSIYLPDLIASNVRIELIGDIEK
LPAHTREAVEDAIERTRDNDGLLLNFALNYGSRQEILHAMKEIFLDINNDEFSLQELDEQ
KFSDYLYTAGMKEPDLLIRTGGEKRISNFLLWQLAYTEFWFTDVLWPDFSEKEFLYALED
FCKRKRRYGGL
>PK3-045_02894 hypothetical protein
MAIVINIDVMLAKRKMSVTELSEKVGITMANLSILKNGKAKAIRLSTLEGICKALECQPG
DILEYRKSQENE
>PK3-045_02895 hypothetical protein
MKRGTTLFLRVAVVLIGIPVLALGLWGMYGLAKNPVNPDYAHILYPLVLGIYLSAIPFYM
ALYQAFRLLGNIDRNEAFSEMSVKALSHIKKDAINISILYVLMTPFIFLLAQTDDAPGLI
LFGMIPIFASIVIAVFAAVLQKLLQQAIDIKSENELTV
>PK3-045_02896 hypothetical protein
MKKYMIEQIKNLMNFELDSLVEQSKEEGFRFVERLVTDYKNEVNTFSNFGEILFGVYDEE
DFQRVIFI
>PK3-045_02897 Bis(5'-nucleosyl)-tetraphosphatase, symmetrical
MYRIAIISDIHGNIYALKAVLKDMKEKSVDFIYCLGDMIGVGPYSNEVLHSLFELDNTEI
LTGNHDESVLAILNNEPYPKSRFHVIPHHQWIAERLNKEYIDKLKKLPRIINPTFHEQSF
HFIHYPMKQSIYNMHISKDPFDRIGIPSLENFSILDGLDFASLVCFGHYHCSHQFLSKNK
TFYNAGSLGCFNQPFARYGIIDIREREFNIMQQYVPYEFHTYIDKIRNANMPRKESILAM
YE
>PK3-045_02898 hypothetical protein
MELVRPSKKYSKQLMEYRSAFLQIEEQPYGGSSLQNYTDFHEWLNKVNSQEKGENLPPNR
VPATQFLSIKNGELMGLINIRHRLTPELLMESGHVGYSIHPAKRRKGYATEQLRLSLLEA
KKLGLNKVLVTCDKENTASAKTIQKVGGVLENEVISTDGKEIVQRYWIEIR
>PK3-045_02899 hypothetical protein
MVRTIKTHETQKNDADFSNDDEIFVPKEFAHLQKATGDQIGVTNYNINSFPKFVKISAYL
FVGLLCLFVLTSIIVMFAF
>PK3-045_02900 hypothetical protein
MKIDNGKQRKIQAKYRELQNEDNKKDNITEKIAIVFSLLFLLIMFLNVFIKSF
>PK3-045_02901 hypothetical protein
MIKYESLHHVSLTVTDLKKAKHFYEKILCLKELPRPNFDFPGAWYQIQDQQLHLIVYPNS
QTIRKDKSINSREGHFALRVENYYDTRSWLKKHNVEFLEKPYGISGFAQIFCADPDGNLI
ELNVDQKDL
>PK3-045_02902 hypothetical protein
MKVTITDAAVEKFRSYEVPEGAVYRLSTIFSGGCSYVYNFDLAVDFPQEEDKAFEDNGLT
IYLDPLTIKHINEDLKFDYVQGKGFRLIGPSEIYSFHLEVKQKAK
>PK3-045_02903 Dihydrolipoyl dehydrogenase
MKKYDVVVLGGGTGGYVAAIRASQKGKTVAVIEKDKLGGTCLHRGCIPSKALLRTAEVFT
TFKNAASFGVEVSGNIAVNFQKAQKRKEMIVRQLEAGIKGLMAKGKIDVYEGTGFFHSNS
ILKITDRAGKETSIEAKNTIIATGSKPRSLPGLTLDEKQVLSSDGALSLKELPKSIIIIG
GGVIGMEWASLLNDFGVKVTVLEYSPRIVPTEDEDISQELQKIYTKKKVQIVTNALVDAK
SCRLTEKGVQISAEVNGKKDIFSAEKLLVSVGRSPVVEGIGLENTAIKLEKGAIVVDENC
RTHDHKIFAIGDCIPTLQLAHVAMHEGILAVDTIVGEETYLIPYEQIPRCIYTAPEIASV
GISEATAKERGYEVKVGYFPFQAIGKALVHGEKEGFTKIIADKNTDDILGITIIGPHATD
LIGEAALGQMLEATPWEIAHTVHAHPTLSEVLGEAALAVDGLSLHM
>PK3-045_02904 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MSTAIVMPKLGMTMKEGTIVEWLKQPGESVTEGEGVAVISSEKLTSEVEAPSDGVLLKII
EDVDNEVEVGKPIGIIGNEKEAESESNHDVKEGKDSTLEEKEPAQQEAEVKVKDTNKRIR
ISPAARKLAQQLQVDTQKVTGTGPNNRITRRDIQAFADKRGEEKVPTKPKVEQETATVVQ
PTGVNGEKLSVMRQTIAKRMQQSLFTTAQLTLHRKAEINALLDFQKDIKKQIMESELDVR
LTLTVLIARAVTLSLRDKSFMNTHLIDDQLYLFDEVHLGIATSLDAGLVVPVVKNAERLP
LGELAKAISSVTEKARNGQLPGNELTGSTFTISNLGQQGIEYFTPVLNTPETGILGVGTF
IDELKLENGTVKTVKKLPLSLTFDHQVLDGAPAGDFLNRVVYYLEHPYLLVL
>PK3-045_02905 Acetoin:2,6-dichlorophenolindophenol oxidoreductase subunit beta
MGRKITFSQAINEAMDIAMERDNKVILIGEDVAGGATVDHLQDEEAWGGVFGVTKGLANK
YGRKRVIDMPIAEAGYMGAAVASAVTGLRPISELMFNDFIGSCLDEVLNQGAKMRYMFGG
KARVPLTIRTNHGAGASAAAQHSQTLYGMFTAIPGLKVVVPSNPYDAKGLLLSAIEDDDL
VVFFEDKTLYSMKGEVPEGYYTIPLGKAEVKRAGSDLTIVAIGKMVHVAMEAADILASKG
VEVEVIDPRSLSPLEEEPILDSVEKTGRLIIVDEANPRCSVATDIAALVANKGFDYLDAP
IKTITAPHTPVPFATNLEQLYIPNAEKVVNTAYELINELTLAR
>PK3-045_02906 Acetoin:2,6-dichlorophenolindophenol oxidoreductase subunit alpha
MKKETAYWAYTKMNEIRKFEDQVHKIFSTGAIPGFVHLYAGEEAIAVGVCAHLTNKDYIT
STHRGHGHCLAKGCDLNSMMAEIFGKETGICKGKGGSMHIADLDVGMLGANGIVGGGFPL
AAGAALTAYVEGTDSVTVCFSGDGSNNHGTFHEAINIASILKLPVVFVVENNGFGEATPY
HYSTSCKQIIDRAPGYSIPGVRVDGKDLVAVYNAAKDAVERARNGEGPTLIEAVTYRNYG
HFEGDAQKYKSETDREKWPVDEDCIEIFKSYAFANDLLTEKEVEQIENEVEKAVDNAVEF
AKNSKQPDPSMLLEDVYVNYK
>PK3-045_02907 Acetoin dehydrogenase operon transcriptional activator AcoR
MTGKIDTKEVWTRFIQEGSLEPANLTPEIEESWHLCRQKGLNPHDGITDCILTPEEFEER
LVENELLITLAKQNVKRLQKFLRGWRFVIILTDRDGYILYKEGESSINIAAETIRFKEGA
KWGEIEVGTNAIGLAARYKKPMMVRGYEHFSKASQQWNCSAAPIFNQHKEMIGVLNVSSL
YQSINQPYVLACVKLIADSISLDWKKKMHEDMEFLLRTTFQSTGQYIVCTIDKYICALPK
NLQQKYQKWIGTSLSRFAQETGAVSAVHIPIMHQHRLIGYRIPLRAETSFVLNGSRGVSE
SYKQVMESIKNVAPTDTTVHLIGETGVGKKFLASCIHENSPKSTSPFYKLHCSMLTKDIL
QRFLSTDLQRLTKKKHQVVEEATIFLEEIGELSISSQQMLLTILQEKEREYHKSYRFITS
STKDIRDLVEQGIIDQDLFYYIYAYPIYLTPLRERNEDINALIDYYCDKNNWHPEWRINW
KLLFSKGQWYGNVRELYNALDRCRILYKEVAPTEEQLYEQVMIAEKHMQKSYYRKDPKTK
FEIQAITNALKKHHGNVSEAIKELNMSRATLYRKIKKYQLKNFL
>PK3-045_02908 hypothetical protein
MFNLIRRDAILQKRQLLVFIPFIIFFIVMNLDSVYIFLVASIFIPFNAYAYDEKAETNIL
LNSLPYTRKEIIASRYIGAIVYMLASILLTSAALFLFNKPFTLTDIVVGSGFFLLFAAFT
FPLFYMLKPGYITTVVIISFLVLSAIGPRIVTFLGEHLTSITGFIINLSLPTLYTGATIF
ILVVYLASWGVATVIYQRKVF
>PK3-045_02909 Vitamin B12 import ATP-binding protein BtuD
MENVVELRNATKKFKGFSVNNINLEVKKGFITGFIGENGAGKSTTIKMMMNLLKPDAGQV
KLFGLDYQTHEKAIKERIGFVYDGNVFFEGLNLIDIKRIVGPAYKQWDDRLFYHYVEKFE
LPLKKAIKTFSKGMQMKASLAIALSHHAELIIMDEPTAGLDPIFRRELLNLLQELMVDGN
RTLFFSTHITTDLDRIADYIAFIQRGELIFNQSTLDITENYAVVKGGLDLLDRDTEKSFV
HLNRGPTGFVALTDDRKEVEQVFGESVVIEHATLEDIMYYTKGGMQYV
>PK3-045_02910 HTH-type transcriptional repressor YtrA
MQIIISNSSKEPIYEQITNQIKSSILAGELKEGTALPSIRNLAKDLQISVITTKRAYEEL
EKAGFIYSIVGKGSFVAEQNLDVIREKKLKVIEEQLSAVIANSKEIGLPYEDLLQLFNIL
YEE
>PK3-045_02911 hypothetical protein
MMEIVLSIVAVIILVISVISVIKQRKKAGVTGFKSMLTPISFFLISINCLLAIWFKYMGL
AVWLINVVLLLLAAYCTKYLPETKK
>PK3-045_02912 hypothetical protein
MINHIKYQWRVTKYNPAFRDENGYFTLTEEWTSPTQIGEIINGKKFTLDEYLQVENAYVE
AVMKFLEESGIHSLRILNLTKQEVSERDLTASLYEAAFDQLVLQEDMLIERNEIHLICKM
VLRNFLECQLYAKDKFFVHFGWDYYMYIGSYVNCPSAIDYATRNGLYVEAFQSPYYFSEE
ETIRQVQWYEINDPSMIIVGEEQLPAIPLAEYRSIFNLSSEHPIVGTFDINEGQLDFFQK
HLQHTMNINKYAYSLWAGY
>PK3-045_02913 Trans-aconitate 2-methyltransferase
MGSYQSETDNWNASLYDNKHSFVSKFGNNLVELLAPKQGEKILDLGCGTGDLTNTIHKYG
VEILGIDKSENMINQALNKYPSLTFMVRDATSLDYLNEFDAVFSNATLHWVHPPIQALKG
IYQCLKQGGRFVAEFGGKGNVETITNEVIQQIKQAGFPFSAEHFPWFYPSVGEYSNLMEK
VGFRVTFAQHFDRSTPLIGENGLRNWIDMFGSQLFHNIPTEAKNEIIAKVERNVKDTLYI
DGKWMADYKRIRIIGVKE
>PK3-045_02914 hypothetical protein
MIKVPIDQYSIIKKEIREAPTFAHSILDFMIEGTVYSDCTNYNSLLFQAASGLFFVTGSP
SNELFMEHLIDIFEKTVLKGNRFTLFSNEIVWEQAIEKFLNKRVRRIERIAYSFDLPTYI
NRTTIASPYDVYRINSCLIENSLEFNEKYYEEYWDSKENFLQNGIGFCVKDKNRIIGEAV
SIFKSNNYAEIDIITEPAYRGKGVASLVSQRFIDYCLSINIHPRWDCDVDNRASAYLANK
FGFTNPKKYAIYIKA
>PK3-045_02915 hypothetical protein
MYETRWATYNELNIVAECWYKMACEMGEIDRIPKPSLQRLEEVKNLFRKEFELGNLMFQV
ALDSDESIVACAGGLIRTEYAFPLAEEQSLFGWIIAVYTVKNHRKNGLASQLVEEICLWL
KQKGAKRARLWSSSSGRSVYEQLGFHNMMDLAKPLS
>PK3-045_02916 hypothetical protein
MFKVKTQCSNCGKHIERNEVVFVKMRYPERKGMTEIKAFIQNEGKLICEACFNTKQF
>PK3-045_02917 IS200/IS605 family transposase ISSep3
MSKENNSLVHTTCNCKYHIVFVPKYRRQVIYGKIKKDIRQILRTLCERKGMEIIEGTACK
DHC
>PK3-045_02918 hypothetical protein
MNVWNIEIDDYTLDYLVQDDIILAEKHFNVKLPKAYIDLLKIKNGGTLQYNALPIKQNHQ
EDDNYLIIEYLFGIKRGEGILQTKYFVEEWKIERENIIILSGDGHEWLALDYNESSSKPS
VIYIFSEENKFIHLFDSFDEMLDNLYIYEEEQEEEEGAIVFTLEEARKLVKSSDTTDVLN
GISAYEKLYGEDGKVLKEQLQNLLVLIKSENEIISNEAGRSAWYLITYELTDDKQFINEI
ARIFGESTNPVFKLFREEILEYIEDKK
>PK3-045_02919 hypothetical protein
MRLPEVYLVGELRLKNHEIYRIMHSKNDGLNYSIGFLLIEDCNRKTELSDYPFLIDVYKN
NPSKFEGGDNIFKVKAILSEPIDEQDESVLEHIGISLVEFKEKVDCIFSVIIRDDLDEWI
DMLDDKPYTAYTELLKYTEEKPNVENYSKEKLKRLHQE
>PK3-045_02920 hypothetical protein
MKAKHLDFKKVTHVVIAIDIFVAVVGVMLFAPIVIGAWAAVFLP
>PK3-045_02921 hypothetical protein
MRFERPYGSSATTYHTHVKGKVGKKVVEAKESLDGHSTHGKGNTMND
>PK3-045_02922 hypothetical protein
MVELNKQLDIIYSQLDDKGEASDESVNKLEEILNELGLIQAL
>PK3-045_02923 putative N-acetyltransferase YycN
MINLTLMNAGEYQGYLSSAIKTYAEEKVLAGNWKEEEALKKAEEEYTRLLPQGEKTESNF
LYTIRKGDEAVGIIWLAQKSEELGFIYDIYILEKYQGNGYAKEALKSIENVGQKLRLKKI
GLHVFGHNKVARGLYEKLGYETTNVLMEKDI
>PK3-045_02924 hypothetical protein
MKKEKDAPEIRREKMRQEELKHPSSSMHGSNLADLVGGLGWKGTGILILIIIVGVIIYAA
LFQ
>PK3-045_02925 hypothetical protein
MTKEFTAYHIVTNKKMKLGQIINFDEHQKNTLHHYFFEKEQLNNQNEDFMQILNNHFTET
GLHLDKENAEVVAQYAGHTMRAIREVIAEMVRLQDFPNHPSRLSCLYTAKSYEDVLKWKA
LFDSYNRKVLQIVKLHVSGNYFEGDGELLPNLEAVPFHKKMEQAREYWKGNAKNDLPELL
INGRIEVMEIIHEYLDESKS
>PK3-045_02926 hypothetical protein
MILEAVLLQVKEGMEAKYEESFREASKIISSMNGYISHELQQCLEVKGKYLLLVQWETLE
DHTVGFRQSNEYQEWKKQLHHFYDPFPTVEHFKKVKL
>PK3-045_02927 Beta sliding clamp
MEFLVDSEYFNRAITDVSKAVSQKTPFPILSGIKIMATKESLIVIGSNADIIIEQVIPME
IDGVQVLEVKEVGSVVLSAKYVSELVRKLPGKIHLTVNEKQIATLKADEIVTTLNGFHAE
EYPTLPSMEETTHIRMESTDLIEMINQTAFAVSKSEARAVLTGVNMLFEETKLTCVATNS
HRLAWRELPIESGVRGAFIVPSTSLHELTKLMQKTTGMIKIFATDRYIVFKTNSTTLYSR
LIEGNYPNVAGLFPNNARTKITVNTKQLLKGVDRACLFASEWKNNNIHMEIKDGSKLKIT
SNSSEIGKIEEIQPINKLAGETDLSISLDGSFLMDALKAIKEEEIKISFGGSMRPILMEP
VGNNSYMHLISPVRSY
>PK3-045_02928 hypothetical protein
MTWITIIALVFFCIIKILMTCLPTGVVDWLLDKYRLHLKLNNMETEIIYNEMKIDGENKE
AIIKIFNEAIVREKYSLYPGSEETYLNAKDAEYSLVIHTKKGNKNINLFLNSYQDHVDIV
KKYKNKMVAYSTYPLQLDVLTKK
>PK3-045_02929 HTH-type transcriptional regulator NorG
MKQHKNEIAVLYGDKIRKRSVDTMEWKPDRQVKKAIYKQLADYIENGIADGSFPLDKPLP
SERKLAKLLELNRSTVVAAYDELESNGLIERKRGSGTMISKDIWGITKKRVPSWNRYIEA
GSFLPNVPVMQRIRKEMAEHDLINLASGELSEDLFPLNSLRKITSDRAYIGSLGYDHPQG
SEVLRKTITNHMEKYRGLQTTPSSILITSGAQQALHLVIQCLLKPGDAVAMEDPSYHYSL
PLFESAGVKPYYLTADENGIKPEDLILLHRKHRIKMIFLNPAFQNPTGVSLGQKRRREIL
EISSQYGIPVVEDDPYSLTSFSGKPLLPLKSMDQNGNVLYISSLSKIVASGLRIGWIIGP
KPVIERLSDAKQQIDFGHSSYSQWLANDFLESPSFAVHLDNLVKQLENRRNQIIESLDTY
LKEEVEFLTPNGGIHLWCKIKNAVNENRLLEESLKNGVIYAPGSTMGSNANYVRFTYAKE
TESNIDEGIRRFAAALKSSRE
>PK3-045_02930 hypothetical protein
MKNNICPKCNSEEIKKGVMAATVGQVHMYPEKNLRKNSSTISAKYCGHCGYIVALYVDNP
ENLG
>PK3-045_02931 hypothetical protein
MKKIVIAFVSLFFLAGCTNIKEVQYQAYAVGLGIDYKDNQYIVTVQFLDFLNVAKSEQGK
GDQPSKVWLGNGTAKSIEDAIDQINKGIQLPLNFDQVKVIVFGKSLLKSKLKPTLNALDS
SYNIRLTGKVYGTNQAIEDIFTAKIPFYYPFNESQISYPDAMQHQSSTVPPLTLQKFMYQ
FNEKINTILLPSLEVNKEIIKEDQKDYVVPSINGAHLFKEKEWKGFLNTDDLSGYIRVNN
ETERTKLNINNDDNEMEIELIKPKLRQVVNKDKKKYSFGLKIRIDATVLSSNERTNANKM
KKQLKKQLVEEIYTSYEKSKEIGADIYQFENYLYRYHWDIWKSSEEDEFPTLDIDDIEIN
VKNFKSVPKLHSKYQP
>PK3-045_02932 Spore germination protein XA
MDYPLFTSEALKQLFNESSDIMVKEDKGELQIIMVYCVPLTDTSMIKTIHFPVLGAEESN
IYQYVQMESFNKKEFNREKIQEEVFSGKLLVIPPGEKLYLYDIKKFPSRQPDESVVEVSA
VGPKDGFVEDINTNIGLIRKRLRTSSLIIKEYTIGKRTNTKVGLLYMNDIVNNEILADIK
DRLSQVDIDVLTSSNILTEYLEPRKFSLIPTIHYSGRADFIVQALNQGRFAIVVDGSPTA
LIAPVDLSLLFKSAEDENSSFYYTSLQRTLRIIGIFTTILLPGFYTAIITHHVGQLPLPI
LATISVSRLGLPFSPLIESLLMVVMFELFFEAGSRLPKGIGQTVSVLGGLIIGDAAIRGG
ITSPSMLVIIGITALTSFTLVNRSLAGNLFYFRVFVLLISYFLGIYGFFLSFIFIILYIA
RLESFGVPMFSNITTPYGKDILFTFLRIPNNLLKKRNAGLSIKDEKRKGD
>PK3-045_02933 hypothetical protein
MQNTLRYISIVYLVLLSVGLFAHVEIIPGVLTIVKRDAWISVVIALIVVPLWVLLLHRIN
GIVHTDSFIKIVKRYTSTIQYYYFLLPLGLYMYISAFITAKDIVFWSQLTYMKDYNIFLL
GGTLLFLCLLCSNLGLFSMGILSTILCPIVIFLGFFISFANTENKNYELLLPVLENGFMP
VSKGLIYTLLPIIELFVILFLSSIVKKSITKKQLFVLNVLIIGLMIGPTIGAIVEFGPEL
ASQYRYPAYEQWRLIAIGKYISHTDFFAIYQWLSGGVVRISLFVLLTSFIFTKDEKNSKL
LTFLYIFLFIALLIPVDQSIFSEVVFLYFRPVSLVLLIIQIVSLTLFIGKRKKVTRS
>PK3-045_02934 putative protein YcnI
MIHKKKFISGLVALAAVFFIALPVSAHVTVNPSQSTTEAWETYTVRIPVEKDVDTTKVTI
KIPENVEYKMYEPVDGWKTTTTKDDNDKVATVTWEAESEETAIKAGQYRDFTFRAQNPKE
PGDIAWDAFQYYADGSIVEWTGDSDAELPHSITNIAQSNETVDSHGHSTKTDDAADDQQK
DKDAEHANEGTNVNTILSIIAIVLSLAAIVIIFIRKK
>PK3-045_02935 Arginine--tRNA ligase
MNIKSELANVLASKLHVELSPEAIEQLLEKPKYAHLGDLAFPCFTLAKKLRKAPVLIAEE
LSHKIESPLIDHVEVVGAYINFFLNQQLIASKVIKEVLEQKEHYGDLPKNKGVMTIDLSS
PNIAKPFSMGHLRSTVIGNALGLIAEKNGYTPIRINHLGDWGTQFGKLIVAYKRWGNEEE
VRKNPIKELLKLYVKFHEKAEEDPSLNEEGRKWFNYLEQGNEEAINLWKWFRKESLEEFN
KIYKLLGITFDSNDGEAFFNDKMERVVELLKEKQLLIESEGAQVVELEDFPPCLIKKSDG
ATLYATRDLAAAIYRQENYHFVKSLYVVGNEQTLHFKQLFQVLEKMGYDWAKGMAHIPFG
MMLKDGKKMSTRKGKVVLLEEVLQAAIQLAEKNIEEKNPSLENKEEVANQVGTGAIIFHD
LKHYRLTDIEFSLEDMLKFEGETGPYIQYTHARACSLLRKGNFVPPANLDNLQWDEVSFP
IVKLLMDFPTTLEKANEHYDPSEVAKYVIDLAKTFNKYYAHIQILEENSGKTARLSLVYA
VTVVLKEGLRLLGIAAPEAM
>PK3-045_02937 hypothetical protein
MNFQNRAFGGHIGAVGPIGAGGFAGVGHGAVGVGAIPLGAVTPTAGFTAGNPLIITPFHH
VPTTQQQHWNYGQTYPSYTQPYGYNPAYSTYGYYPFY
>PK3-045_02938 Right origin-binding protein
MNVTWLEGLQKALIYIENNLEEKLEIEAIARVANVSLFHFQRTFTILTEIPVGEYIRRRR
LSMAGQSLLHSREKIIDIALRYGYDTPEAFTKAYRRQHGVTPSETRRGIGSLKIYNPLVI
QVQLKGAEPMKVKVVEKEAFTIVGMKKSYTFKEDENLREIPKLWDEVNKNGTVNELLMLT
RGEIPGVLGVCVEESEAAGKDMDYWIAVATEDKSEKYDQLVIPASKWAVFEVNGPMPESM
QKVWKQIYSEWMPSSGYQQAGFISFERYTDDDPSSENCYSEIWIPVK
>PK3-045_02939 hypothetical protein
MKNHPIFNLLIALVFLILFIASKKLFANYLAALIIFGAFFCIYLGRSILSLIRYIDEKKT
KDISVKSKHK
>PK3-045_02940 hypothetical protein
MFMVVTIIAFIFACIWVLMDTIYFSKPPKPEVLWKNNRIPTTIGSNCWQGSLKGSCVDYV
YASPWDMGLQNGSVKVEPNSIITIDFNKKPLAGSLQVAEVFEDGEEEFIKVDKNKMTVPA
KKGTHVYMIYAKWDQGNPNYTFSIRVE
>PK3-045_02941 hypothetical protein
MFGIIMLVFVAIIVAQIFSRKEKTNNINSHNYLPIQGEIGDSSQASIFDGGNDCGSSFDS
GGSCGGE
>PK3-045_02942 hypothetical protein
MKKVICIKHFWKPFTFFVTVSLFIIFFRYTDIFQAIREGELNSVTSVFKENISYALIVSL
FLMIIQNSFTVIPLILVITLNFYSFGFIYGFLWSWFSSIIAAIIIFLAIRFWFQDFVIRK
VQNHQEMLDKIEQKGMRYVFYGRVFPFFPTSILNIIAGVSKISIRPFTIGTAIGNFFYFF
ILALIPYGVFSTDINPLALIVIILLITGIFYYFSKKKPAVMERVKKRA
>PK3-045_02943 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase
MPYCKVKNANIYYEEIGAGIPIIMLHGFTPDHRLMSGCMEPVFKENDGWKRIYLDLPGMG
KTMDYDLISNSDEMLKAVASFIDTKISNQPFLIIGESYGGYLTRGIIKLYKEQILGAGFI
CPMILPDKEKRTLPEHTIVYADDEFLSNLVEEERNDFKSNQVVLDEYNWKRYKHEILSGC
NIADTAFLDKIQKNYGFSFVIDDVLFQKPTVFLLGKQDSVVGYQDAFAILGNYPRATFAI
LDRAGHNLQIEQTKLFTAHMNEWLDRVEEEM
>PK3-045_02944 hypothetical protein
MNTYIGSALNQIEIALKTTIEMVETIEEADLQQRPDDNKRSIGELLEHIAVICKADLLIS
NGATQKEMDEYYSSVALLNMQDIKNAIADNYKTLKDIYMNLTEIELQERTTSYWGVTYSR
YEWLLEIVAHIYHHRAQLHTLLVYCCGKDLNISLFE
>PK3-045_02945 Peroxyureidoacrylate/ureidoacrylate amidohydrolase RutB
MKQALIIIDMQEIFFNHPKNYLYDRIQLVKNINILIKQAHEKNIQVIFIQHTDPNEQSAL
YEGKNDWKLHQNLLLSTTDKIIKKSKWDAFYKTELLEYLNSKAIEQLIFAGAQTEFCLDT
TIRAAYSLGFQQNLLYQNTHSTINGSILNADNIIDHHESIWNNRFLTIKKGELKL
>PK3-045_02946 Putative hydrolase YdeN
MNKLYLIDGYGGSPKINWLSDIKKEFKNSFHIQIVDYTDATIANVTQWDLDLDRAIKEPN
NVYFICHSLGCITFLRYLLRHNVQIKGAIFVSGFAEPIAAFPQFDPYMQELNLDKIKHLL
GASFFISSRTDKIIDWQISNSLANKLEIPFILLPSGGHFTSGEGIIEMPTVKHIIKAKWL
>PK3-045_02947 hypothetical protein
MSKAKAKGKGGTGRGTDKKGWNRWQASANKAKSNKPYKSKGVKNRKNTENTSNPATTEKK
N
>PK3-045_02948 hypothetical protein
MNSTAIFIIALAAIAVWSIQIYELLKPSKEQNNRKIVLLTSAGSLFTIILTVSFFQNIPF
FQ
>PK3-045_02949 hypothetical protein
MITLLEDIAQHGLKDTKLYIMKTTDSFVISIPKINWSTEISNEESPHDQFDHLLHSLTFH
MFEGDCSQLAESITTSISKYETS
>PK3-045_02950 hypothetical protein
MDLLFASERLGFRLLTIEDIDACEQFWGNEEVMKYCGGSTSSALLPQVIDFYQQCQKDFG
LSVYGVIDLTTNLVIGAAGFNIEESVDQAELIFHFSKANWNKGYATEAGIACLTFAKEQG
NTQKVIASASIENKASLDVLGKIGFQYMGIKYFEDTEQEEAYFAFVL
>PK3-045_02951 Pyrimidine 5'-nucleotidase YjjG
MMSSYKAVLFDLDDTLLDRDKAVEKLFFILLEKCYVDISDSLKREMLLEFKEQDKQSYGQ
KDKTKVLESFFAMFPPKYRIPHNDILAFWNKHFPYCFSVNQERINIVNKIKNKARVAIIT
NGTIHRQKAKIQNTNLHSYFDPIIISDEVGLSKPDKRIFELALNMLNVQPEEALFVGDDI
EIDINGCQNAHIKGVWFNPRKIKNPTEIKPFAEIHSFDSLLNYFS
>PK3-045_02952 Glucosyl-3-phosphoglycerate phosphatase
MTTIGLIRHGITEWNTLGKAQGISNIPLNRLGKQQAMAIANRLLQEEKWDILITSDLSRA
IETGEIIGQKINLPISHIEKRVREIDCGKIEGFKRIKKSV
>PK3-045_02953 hypothetical protein
MTQNTQPQYAPPKHIVSAASIVINEQKEILLIKGPKRGWEMPGGQVEEGESLKAAVIRET
KEESGIDIEVIKFCGIFQNVKRSICNTLFLAKPVGGEFATSPESLEVGFFPIEEALNMVK
YKNFRQRIEYCLDEKRQPFYVGF
>PK3-045_02954 hypothetical protein
MKRSMNKKQAAKLYALIFPITRNKKTATKIVMEMLQADDNLGEKELARKAVNRAIEMVRK
>PK3-045_02955 Adaptive-response sensory-kinase SasA
MATKSRSKGFFIVWTLLITLALSGIVSVDMWFNRYLHTDFYQTSIFQERMQYYKDLLSEN
ELYYVPIEEAKKKITVSAKEINEYRYYYGDLNEQIQNIKSQYEEQIQTAKETGSSEAEQL
YTEERDKKIADITKNFQSDEYVEDKIKKEKARQLDEYYQELQNREYEYKDWTDSFLFYFE
NNKTGKIVTNVDLAPGETIESKLKQKKTKFLSDIHIDPKDEWEQHYISINSPWYEFGDSD
DVAIEVSILNDIKKNIGSFEGVIAVPENLSAKSMLHTDMDNYKTQQKQVIYFSVISIISL
VASCILLLTKRRNLTQWEFPFYKKIPIDIGIIFLLISIAVAIISVWGVNDQIELALYNEG
SFWKEIILFGCLAWLFISLSFIQMSLLYKEIVKGDKSIWTKTFVGKCVKTIGKPMLLLFS
SRSPLTKLILCLMIVFALGFCLMAVIVEPFFVLFFLIAVIIIGIPAIHYLVKNAKSLGQL
VLYTKEIRSGRKVSDLDIKASSELSALAETINTLKNGVIYSQNAQEKSERLKTELITNVS
HDLRTPLTSIINYTELLKKKNLSEEEKEGYLGIIDRKSQRLKVLIDDLFEVSKMVSGNVE
LKKEKIDLVQLLQQALGEYDETIKATTLDFRVTNQEPSIYATVDGQKLWRVFDNLIGNIL
KYSLEHSRVYISIKLEKDQAILQFKNISKYELDDNLDELYERFKRGDTSRHTEGSGLGLA
IAKSIIDLHQGMMKIETDGDLFKVTLALNLSDL
>PK3-045_02956 Transcriptional regulatory protein SrrA
MENVNVLVVDDEKEIRDAIEIYLKNEGITVLKASDGIEALEILMGETVHLILMDIMMPNL
DGISATYKIREQKNIPIIMLTAKSEDTDKILGLQIGADDYITKPFNPMELVARVKSQLRR
YVTLGTFDGVKKKIDLHGLTLDQEAKEVAVNGESVKLTPIEYKIVVLLMKNAGRVFSIAE
IYESVWKEPGYNAENTVAVHIRKIREKIEVDPKNPRFLKVVWGIGYKIEK
>PK3-045_02957 hypothetical protein
MPRKDVEISEEVEKEQTNTKKKEGEEDKLNRMLAAVLEYISDDEVEEIDIDYILDQTEGL
RDWWNQYREKNRKRMEKEIKESLGELSLEELEKIREQIKAKQ
>PK3-045_02958 hypothetical protein
MKPRQEVLLKQLETYRKELLGTVELVTEEQAEIIPAGFRNNIRWNLGHLYVDQLLWIEAL
TKVPTAISKQFNQWFGFGTTPANFTVETPSFTELKVLLQSQPQAILEKYGAILEKEYPPI
DMGMHTIEQVLVRTIFHEGMHLQVINDIKKLI
>PK3-045_02959 sugar efflux transporter
MIKKTNFLIFILAISCGSLAANIYYAQPIVQFIAKDLNISSNLSGLLTTLTQIGYGLGLF
FIVPMADLFKSKKIITILIGLTVISLIGTLISSNGIVFLLLTIIIGIGACAAQILVPLTI
RIVPVGETGKYVGKVMSGLLIGIMIARPLSIGITEWYGWRMVFLFSLIILVAVLLIILKF
LPNYEVVSNSNMSYSNLIASMVKLLINTFPLQQRAFYHACLFAAFSLYWTVLPILLRSEP
LDFSNNEIALIGFVAIAGALLTPTIGKLADKGYIFAMTNVSMALVLLSIVLLFFVQDHSP
LSVILILISGISIDVGVSGNLLLGQKVIFSLNPEERNRLNGLYMTIFFLGGAFGSWIGSY
SYYKFNSEVPLLIGTALPLIALLVHLIKNNTINIAKNNSKNIS
>PK3-045_02960 HTH-type transcriptional repressor ComR
MGRRISFNKEQALNKAMYLFWEKGYDATYISDLIEKMGISRSTLYESFGDKDELFKLVLE
HYKNYGRQKRNLLFSGIDTKGSLKSFFYQHIEKCYSDDNPKSCIITNSSLLIGHIDPSIE
EILINDFNELEKVFKQVIEEGKKKGEISQEADSELVAYSLLSLNHSINLMSRYKKEKNLA
YNLVDKTIADL
>PK3-045_02961 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MQLDLKNKTALVTGSSRGIGKGIAIELAKEGVNVLINGRNYEEVEQTVNEIKLEFPDTFP
QNATVDIVDIQQREALFKKHPQIDILVNNMGIYEIMKYEDVNDEVWEKYIHTNVLAANGL
SKFYLPKMIKNNFGRIIFIASEEAVMPSGQMPQYCMTKTMLLSLSKSLSKLTIGKEVTVN
TIMPGPTLSENVHQIIEGMYPNEDMTFSEKEKKFMTTNLPQSEIQRFIRPTEIGRLAAFI
CSPYASAFKGSPIRMDGGMVPTIF
>PK3-045_02962 HTH-type transcriptional regulator VirS
MTLYASDRIKVPAGFWTGLSQLGIDALDVVRKAQLPLTIISDSVVTTAQYFAIWQAYAAL
IDDTAKGIIKLATSFETDHFPPTVLATYHARDYRDALKRMARYKQLCPPESLHITEEGEH
CTIEIKSLHSEQPGLTILIGITMAFLLELGRRGTGQHLTASFVEFSTHSIGDLQLLEAYF
GCRIQLGTNCNRLTIHRADLDRPFVSYNAELLEILTPVLEQSLNEQARGPSITETVKWIM
KRSLTGGRPDIQTIASELGVSDRTLQRRLMEEGTSFKHLLTKVRHEQAKEYLADPSLDIK
EVAFLIGYEDQSSFYRAFHLWEGATPLKWRTEYFGLNLIN
>PK3-045_02963 Purine efflux pump PbuE
MSNTFKIYILALISFLVGTSEYIISGVLDNIADSLGITLAAAGQLITIFSLVYAIFTPIL
MALTSSMDRRKLIIVSLGLFVIANILAFLLPGYTLFVFSRIIMALGAGMVVVTALTIAAK
IAPDGKQGSAIATVVMGFTASLIIGVPLGRIITDAFDWKAVFGGIALLGLLAMIIISFVI
PPTKGDEPVPLIQQLSLLKDRKVAIGLSITFFWLGGYSVAYTYLSPYLLNISGIHEKLLS
GVLLIFGVASLFGSKFGGYSTDKWGVSRTLIGSMLLHIVMLILLSLITHIYVGVVIILIL
WSFAAWTSAPAQQFNLATIKPESSGVLLGLNQSMMQLSMAAGAGIGGIFVEKVSLGSITW
VGVLGLAIAIFMVLKSSRGSYIKS
>PK3-045_02964 hypothetical protein
MKPIEIFKALSNESRLQILHWLKEPERHFVPHEGIDMRKTGVCVSQITEQLKMTQSTASQ
YLNILLRAGLIKTERIGKYTYYKRDEEAIKNIAAILEQEI
>PK3-045_02965 hypothetical protein
MKNILVLGGTRFFGRKLVEMLLKEGHRVTILTRGTVSHPFGNEVKHIIADRSRKEQLQHH
FAGQTYDIVYDNICYTPNEAKDFCEVFNGKIGKLVFTSSLSTYSVDGNEKREADFHPYNY
PIQLEKNEFVYDEGKRQAEAAFFHYADFPVVAVRFPIVLGEDDYTRRLHFHVERIQQDRM
IGFVNTEAEMSFILASEAAAFLKWAGFSEVEGPFNATANGKITMKKLIHIIEKVTGHTAK
ITLDGDEENFSPYAIPASWYMNTEKAEKAGFTFTNLDDWLPALIKKIAKDNKK
>PK3-045_02966 hypothetical protein
MPIYFTNQTIEVVNQLNKTGYLTGNAEFVDKDFLPAYKWMIEQMSKRLNHNGFYPIWVWT
TKPNLQREGHFNRGTKAVCLTVEIPKNQILFSDFYAWHCVLNNGFCPMTEEEDTLFDEGR
LTITKEQSWERIFDLAKLRSSEMWNNGDQVVQGVTPIIQKEQIVNIEYFIAK
>PK3-045_02967 hypothetical protein
MNKLHLLIKILITGLGLLLILTNIDTLWYNVFIAFVIVYLICDLLLNMFRKKDNDGRVQ
>PK3-045_02968 hypothetical protein
MNELKLPLKQLEKIIGSLPSISLVAEQGSTSTVYQVETRSGTYILKSAFEEKYRDWLQTE
ASVLEKLIGKEFIPVPYYYGFLKEQASSHLIMSYEQGITLTAALNQAKTDTEKCALVQSF
GRLLHKLHTTEILDPFHYANEWLSERLLKAEYYVKKGWTEGSIELLTLLKNNKPAPINQT
IIHGDCTTDNVLVVNGAATKFIDVAGMTVGDPRYDEALAIRSFVHNKKFKEAFYAGYKHY
QITIDEFRYFDEGLYEFF
>PK3-045_02969 Thiamine precursor transporter HmpT
MYTTKQNKTRILVLNALFITLTFLATMFINIRLPLMGNGGLIHLGNVPFLIAAFLFGKKS
GAIVGAFGMALFDIMSGWTLWAPFTFIIVGTMGYIAGLIAEKMPGKKSFVYILAVAVAMI
IKVVGYYFTEVILYGNWIQPFGSVPGNIMQLVIAGIIVVPLTKGFEQRILKSVH
>PK3-045_02970 HTH-type transcriptional regulatory protein GabR
MDMLMFELNKNTTKPLYEQLYMGIKSAILSQQIEVGTQLPSKKKLADFLNISQTTIEVAY
AQLVAEGFIVSKPRIGFFVEDINELPYIETEHDELPIEDTGKEVIRIDFHPGKIDTDSFP
FSQWRKYAKNLFDTPSKELLQIGEPQGEYTLRAEIAKYLYQSRGIVCKPEQIVIGSGTEQ
LFPMILRLLEKDSTIALENPGYSASPRIQLQNKTIPVPVDEDGLIVEQLEKTMANVVYIT
PSHQFPTGAILSATRRTQLMQWAAKSKTRYIIEDDYDSEFRYTGKPIPALHGMDQNDKVI
YLSTFTKSLMPSLRLAYFLLPSTLLKKYKETFSYYSATVPRFDQHIVASFMRDGYFSKHL
NRMRKIYRKKLDRLTHIFKTDYPEVIITGDQAGMHILISLPLQKSENELKAIAAKSHISI
YPLSDYLIKPIEYKYPTFLLGFGGIPLEKIEECIHQLMHSWEMAK
>PK3-045_02971 hypothetical protein
MFYFSKKKKIRGWKRHKRKIERWKQNAINLDMDYLRNYQRQYEKLWIHPFYKLERRNPPN
WYQSLLLDAMIEVYLEWHQKMKKEEEDFYLKLWLYDPHFINSQIVVAYRNCLDFYDETFK
RRQENKGFPFDKFHSLRDKLEQFEWNLHIESDYYDENDLNEWLEEGALTEKEVSRIKGKA
YDAVRIKDEDGSFLQYSLDKGDVWIGTLKR
>PK3-045_02972 hypothetical protein
MADEVETLEMLRKKLKLDKIHLFGESWSSILALLYATEYPENVNKLFLTAAIGISSSGYR
QFSKELLKRMSILDKIKLFIIHNRMKKGKSDDRNVESYRSLLCIFI
>PK3-045_02973 hypothetical protein
MIKSFLMLGQSNMAGRGFLHEVEPIYNEKIKMLRNGQWQMMTEPINYDRPVAGVSLAASF
AQAWSNANPDEEIGLIPCAEGGSSLNDWHPQGILFQHALSEARFALETSEICGILWHQGE
SDSNNSLHETYYEKLSLIMETLRKELNLQNVPLIIGELGDFLGKSGFGKYSSEFQEINDQ
LRRFAHEQQNCYFVSAKGLTANPDGIHLNAVSQRKFGYRYFEAFSKKCHILEPLSDENQS
LKINNNYSKTEQIYIHSMNLTLGIITYAEFEAQMTKVMRP
>PK3-045_02974 hypothetical protein
MIPLLILGLLIQNPGAHGYELLSLMEKRHYKYIVNFTKGSFYYNLQQLEEKGLIEQTHQI
SPNNGREMHPFKITSLGREEFDKLMVKYGTKSEYVNLQFYGSLLFADEFDKNKLLELIQS
QIDQTEARIALLDEYLAITKELPGKIDYFRRMNENSRSHHLVNLNWFKELKADIEEATV
>PK3-045_02975 hypothetical protein
MNNRVNEFWNQFCIDTQKEGVQYKDATQFGASADWLAELVVNGKKTATTSGYVFYEIEKE
AIPKVGEYYIILNGKENPVAIIEIESVQIVPMNEVTEEFALAEGEGDYQFWWDAHEKFFT
ELLKEYDIAFTQDMLVVCERFKKVYPK
>PK3-045_02976 putative protein YqjY
MKIRSVNSLDYYEISLLLNQWWGGRQMADKLPKLFFDHFTDTSFIAEKDGEIVGFLIGFL
SQSQPEEAYIHFVGVHPKYRKHNVGKTLYNKFFYVVKQKGASIIRCVTSPINKISISFHT
NMGFDIEQGNAVVDGVTVYKDYDGPNQDRVLFKKNLQ
>PK3-045_02977 hypothetical protein
MEIFDYGKNRSIKKLSNVELKGMIQASTYFSDGRMEEKGELDQYIGVAATEECPENFSKL
EVPALTWAIFESTGAFPSTLQETWGRIFSEWFPSSNYQVTEGPKSCRLKPKI
>PK3-045_02978 hypothetical protein
MAMHIYKGNIPALEAEIAAGWDIEEGIVLSKRISLSPLDLALVLQKKEVIKLLVEHGVNL
NVHHNPAFLRAVRYCGEDIVRYIAAQGAEMDKHYQTGSGAYSEAYYGNKKNIPLIHELGL
DIKLYGGAIIREAASDHDLKTLKYLLDHGVDINYNQPDMVYPYQATPLTVAARMGNMGMV
KFLIEHGADVTKAEKDGDRPYTIAVSNKDTVMANYLKSLEPAEFHDPANKKNELKKYKLP
DELVCFLTGNQLRIELAQNEYEIEYIDFFTLNDTIEMKIGRQKLLRLSADIDNYSDLQLV
WNPKNKGLIGCYDVEHQTYLDLCSFTEFLEQPELYLIKYLEGEL
>PK3-045_02979 hypothetical protein
MRKASMASFLKNYIGLAAIMLLAYLVLGPNEHTSLPFVLLMGIPITAFMLFTGLDEKLKK
IFP
>PK3-045_02980 hypothetical protein
MYEESFKIIAEYKYKLESLKGQTIEELWVSWDSINDEWFNDLPVILKFKTCQLELCAYKT
NQYAVTFDHIDLLQEINYFGRKLVWKKNKLVELNKFLKKEINTVEIIQWMEQLIGVGFET
NEGFFAICNGLDENEIVTRKHIDQDYKYITI
>PK3-045_02981 putative protein YizA
MFKILIKFFVYNWQVRDEWFDWCNQLTTEELLKNRIGGVGNILFTLFHIIDVEYSWIRGI
QGKEDVVFQFDDYHTLEKVKTLSDKLRNEIAEFLKNTDDLKEQSVSVPWDEKKYAVNDII
HHIIAHEIHHIGQLSVWSRELELQPPSSNFVGRELKFVHFS
>PK3-045_02982 hypothetical protein
MKKKMNYLILLLTAIFIVGCSNVEDVSNTDGNANSQEVTTKNSENEKTSTGKQVVEETVT
QSKNELFKGYKLIEVDGGDLSGHREPNVVVDVGYGDREYWAFTNKHGQLVRVVAEKIILQ
DDKNEPVTSSGRYYSDEAKVPGVERADLDEGHIIADSLGGVSNAYNITPQDSTLNRHGDQ
AYMEDAIRKAGGATNFEAIITYPNTETQIPSRYRYTYTIKGNVIKDEFDNMNPDEVNKSL
GLTGSKSSESTTSKEKEDISTVDTNGDGQVTIKEAKAAGYSMPITSDHWLYKYMRDNDND
GMVGE
>PK3-045_02983 hypothetical protein
MNSIRFYSFWFAKTSIALADVIYIMVITTYIYQKTDSALMSSLFPLFKALANLIAGLTSP
LIYRKFAFAKLMVKFQGLKALLLTFLLLGFLPITNHIYVLLLFILVISFMEGWGNPLLNS
VTPKIVPKENLVRANSSLSITTQSVQIAGYSFTGFAVINWGHNSTLAFNVVLLWLSVLAL
YITSKHFVSNMEVPVENKSKWALMNEGWKILWHNQTLRMVTLMDVIEGMAGSIWVGAITL
VYVKEALNQGEQWWGFINASYYVGAILGGIITIFIAKTIQKHLIFSMAIGSLVFSIFTLI
YGLTSSPILALLLCIAMGPAYQIRDVAQQTAFQINIQTIDLPKVFASQSILLSTVSGLSI
FLIGFIADFVGIRAVYIFASILIFISALLSFTLVKVNKKKFSTVDVK
>PK3-045_02984 hypothetical protein
MTGNIEQFVTLLPVNKNMLADFKQELHEAFLKGLKDSFPEHDNPTEIAPVPPEKDVDKML
TEPDAEIYHLVMNGEKLGGAVLKIDVDTQHNEVVFLYMNANAHGKGIGTKAWQAIEAAYP
ETKVWELYTPYFEKRNIHFYVNKCGFHIVEFLHRGNPGPDFEVDETKPDTEYEFFHFKKV
MKK
>PK3-045_02985 Uridine kinase
MQDHINAIAASIPTPAKGKRVVVGIDGLSRSGKTTIVKKLQACLHEKGFSVTVLHLDDYI
VQRNRRYHTSYEEWHEYYHLQWDVQALQESLFKKLKDKTVLQLCKYNPDSDTHQIEKISL
LHTDLIIMEGVFLQRKEWREFFDFILYLDCSKETRFARESKETQQNLNKFKNRYWKAEDY
YVNTEYPKERANMVFKV
>PK3-045_02986 Lysine--tRNA ligase
MSQEQTTRRIEKLAALRSQGVFVYPERFATNYELYEAALLEDGTEAVRVAGRIMGIRQFS
KFSFLTISDIQGSLQLLLKKEEVGEQSANNFANYLDVGDFIGVEGRMYSTKTKEKTLRIE
KYVLLGKALHPLPEKWHGLNNVETRYRQRYLDLMMTKETKERMLTRTRLVRAIRRFLEER
DFLEVETPVLQHTSSGALARPFRTYHHALDSELNLRIAPETYLKRLIVGGFTKIFEFAKC
FRNEGVSPQHLQEFTMVEGYAAYWSYEDTMALMRDLLLYVLNETFQTTVIPVQGKTIDFS
LDWKVVSFRELILQDTGIDIDLYPNVDDLYEETKRRNIYLEQDNIETLGRGNFIDLLYKK
MCRPQLIEPTFLINHPIDLSPLARANDHNPAITDRFQLVVNGVEIINAYSELVDPLEQRR
RLEAQAVLKSGGDLEAMEMDEDYLLAMEYGMPPISGWGFGIERLLMILTDSETIKDCALF
PLTKKV
>PK3-045_02988 hypothetical protein
MTLEYLENGSGETSYFMNDQTWKMERINTNPENQILFSIRNKQGKFAVAEQMFLKELLKS
GEEFTKFISELSQPNSITVLEPVIMKIKKLVY
>PK3-045_02989 hypothetical protein
MVVKLEVPLGVALGKCPYRAKIKPPVLPAGYLLWEERAINIHTYIFNSKREKIAITEEKA
ISIANDYQVRNNGYID
>PK3-045_02990 hypothetical protein
MNFRKRDYLISFLFLFFLFVSSIMPVGGMMMPFLKSIIASLLGSAVIGTLTNLLIKKRKT
SY
>PK3-045_02991 hypothetical protein
MKKVISIIVAIGLIFPVSINLASAKTNVIVKVNNDNLTSKEEELVKELKSNNVRTAAEIE
NILQEIVKTDEKGKHEIKEVIQNTEALPAVTEENVKDDTLNLDDYMQKNLDNGNFEGEEI
NDNVNIIFTNEDVFFVEILEAEKSEVIESEEEEVTFANIPIFGDIVEAIQPSKTSAATKY
TGKVSKKYVAYSWVGLPLWEVYTKGEFKYTGSKVTPYFYDGYVKKRAGGMIWQLDNYGEG
TTTNAKGTSATVFTRFNAHYGLEYSGVGIVVQYKDVRNQISCNQKGKISKSTIIR
>PK3-045_02992 hypothetical protein
MDEKDYQKIYDDYLQQASSEAQIEAAEEIDPNIEQIVAVRKNEDDDIIAFKTNSGRELDY
NTALDEAKAGKLAHVDVFHKYGRDIIRSEPDGIKENNLDNLPTF
>PK3-045_02993 hypothetical protein
MNTIIHRVGTIYLPVENPELASNWYQEKLGARENFRNEDKAILDFANQSFFLVKAKKGEK
AAFQDDAGNEHFFLTFEVDGIDQLKKLHYSLKEKGVTVDDIEDRGHPGNNFVFYDLDGNK
FDVWSQLSPSFKEKYLLNDSER
>PK3-045_02994 hypothetical protein
MCKTRNTRRNRSLYSSTYRDFYFGHTKWKGYFYFAESVSGIPVMNEMDKIIGIRFVNSKE
KINFPIELSSAIKTVLASNLVHDKITKWI
>PK3-045_02995 hypothetical protein
MEEKERFSKIKAREEAMVDIVNYKIWTVRNKSMEA
>PK3-045_02996 hypothetical protein
MEGILQSFLEVEISDQEFYDGIIDFIYNGNIRCGEYECNEFVIRKMDLLNFVVYVEYVID
DKREIHGSFSIAKNKLLQAINEYARKQGFAIRNFEGYPKHKGH
>PK3-045_02997 hypothetical protein
MKKIEKVVLKISFVFYLLALVYLLFLGTRAIFWSDISWIEYIKYSSNFVPFKTITTYILA
MFNGSMNMYIPIENLFGNFMMFMPMGIYLPYLFKHLNKFSKFIISMCSLLIVIEVVQVVT
RLGSFDIDDFILNMLGAWIGYGIWKTKVVQYVLK
>PK3-045_02998 hypothetical protein
MDKNNKFSIGEFSEKTGVSIPTLHYYDEIGILRPEKNPSSGHRIYNYQDIVTLQKILSLK
FLGYSLDNIANLLYESSFTTDLNESLSLQLQVLEKEQEQIEQSIKSIKRVIKLVKEEGEV
DSAVLFSLIHSMRTEYIQEEWMERHMLTDVVEELSKKSEEDKITLDKTYIQMSKKVKRLY
GKPVEDPEVQEMIKTYIEASLAFLGEDLMQKLADTNMEELDIQEIENMTPSPFTEEEQQW
INQAMEFYMKQEELE
>PK3-045_02999 hypothetical protein
MRVIYSVLREIDKGESLPTAEDYGFKQREFENFIFDLEKGGYVERVLRMDTFFSLKPARL
TKKGHDLVEEYKELEKSYPKNKEDIIKWIQVDKEMYSNDAEGEEY
>PK3-045_03000 hypothetical protein
MNGYLDDLILSSDDINASYELVSLEPSELQEIKNLNPKCKPTNGLHLNYTDLEDNIQQVK
YYLSTQLIEAPINSDVSLFAVDTIFDTASFT
>PK3-045_03001 putative transcriptional regulatory protein
MGRKWNNIKDKKASKDANTSRIYAKFGREIYVAAKQGEPDPESNQALKVVLERAKTYSVP
KHIIDRAIEKAKGGSEETYDELRYEGFGPNGSMVIVDALTNNVNRTASDVRAAFGKNGGN
MGVSGSVSYMFDATAVIGVEGKTEEEALELLMEADVDVRDIMEEEDSVIVYAEPDQFHAV
QEAFKQAGVTEFTVAELTMLAQNDVTLDPEAQAQFEKMIDAIEDLDDVQQVYHNVDLGE
>PK3-045_03002 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase
MYKSSNLGYPRIGEKREWKKALERYWKGECSEEELLQETKNLRLKNLQKQKLQGIDLIPV
GDFSFYDHVLDTAAMFGQVPARFAYDGGRVPLQTYFQIARGNPAAVAAAMKKWFNTNYHY
IVPELGERTPTLTENRPLFFYREAKAALGIEGKPVLLGPLTFVKLAKGYEEDKLAETVAS
YLPLYAQVLKELEAEGVQWLQIDEPYLVTDVTAREWEITQQIYQTLREAAPNLKIILQTY
FDSVTDYKTIVSLPVAGIGLDFVHDDGENLVSIQQYGFPQDKILAAGIIDGRNVWRANLE
EKWNLLTEIQKAIGSDKLIVQPSSSLLHVPVTVKEEQITPILKEALSFADEKLQELNALT
EGIRKGKAVIQAEINKSVEAIGQLNASSARNNQRLQEELKWLPDKVERSENAKIRQQAQQ
EAFKLPILPTTTIGSFPQTKEVRKERLRWRKGEITNEEYETFIQAEIKKWMEIQEDLGLD
VLVHGEFERTDMVEYFGEKLAGFQFTTFGWVQSYGSRCVKPPIIHGDVAYVNPMTVKETV
YAQSLTNKPVKGMLTGPITILNWSFVRDDISRAEVAKQIAFSLKNEVEELEKNDIRMIQV
DEPALREGLPLKKEKWQGYLNTAVYSFKLATTFVEKETQIHTHMCYSNFEDIIDAIDALD
VDVISIETSRSHGEFIQTFANKTYEKGIGLGVYDIHSPRVPTKEEIMQTIGNSLGVLDPQ
LFWINPDCGLKTRNEEETIRALEVMVEAAKETREKLFVQKQ
>PK3-045_03005 DNA polymerase IV
MFDYDQLPNRAILCVDMKSFYASIIAVTKGLDPLTCHLVVVGNTDQKGSVVLAASPAMKK
DFKIKTGSRLFEIPDDPRILVSNPKMELFIRVSTEITKLFFRYVPATAVHTYSVDESFLD
VSGMEKSLGTPFQIAQKIKADIMREFGLPSTIGIGPNMLIAKLCLDLEAKKANGGISRWA
YKDIPDKLWPISPLRDMWGIGKRTEKTLNNMGIFSVGQLAHYDLGLLEKKLGIMGNQLYH
HAWGIDLSEIGAPIMQGQISYGKSQILLRDYKEIDEIKSVLLEMCEDVAKRARSNHHAGR
TVTLGISYSKDEFGGGFQRSRTIENPTNVTMIIYQVCLELFHENHRGQTVRQISVSITKL
ENDDEMQLDLFDTGGWKKRKLGYVVDTIRNRYGSTALLRAVSYTSGGTALQRAQLLGGHK
K
>PK3-045_03006 DNA replication and repair protein RecF
MLKQIRLKKENIPSKSGYPFTIPAISHFSSLDFQNKVTFFVGENGSGKSTLLEAIAYQCQ
FNTAGGGRNNSYDIHASQSDLGEYLQLSWSPTKLTNGFFLRAESFYQFATHIDQLESEKK
YVSYGGKSLLQQSHGESFLSLFLHRFRGEAIYLLDEPEAALSPQRQLSFLRILHDLAETE
ECQFIIATHSPILLGYPSATILSFDGDQIEEIAYEDTEHYQITKYFLQYREKMLKDIFTE
EEM
>PK3-045_03007 hypothetical protein
MLGLLLSVFLFNLIAYKTNKKLTVNQILHIWIFTIAFQQLFDLYIDIGYHAYWYFSKTEV
DWESIIHILFLVPPVNIIFLNLYPMKKRILNKILFIFLWNFIIVGYEWLTLLPSPWGFFH
YGWWKLAYSFLINPFLLFILIKYYKLINKLEKKSFLA
>PK3-045_03009 hypothetical protein
MFYPTVVTDEKPCLRHVVKDKNYCMCGSKYKSYSTFKKSDFKRIEFKQLNDITCPYCQSI
IN
>PK3-045_03010 hypothetical protein
MSIVILRIFMVLISWGSLFFLPKSAIKKFLPVTFFSASVLLIETLLSLIFKWWKVKGGLK
SLVADALGFIFGPFAAINIWIFHFTYKRFLVYTLVNLIMDLIFAFPLNSFFQKAGFYKLK
KFTSIHLFLIAYGLSFLNYWFQKFIISDKKIRTAS
>PK3-045_03011 F420-dependent glucose-6-phosphate dehydrogenase
MEIGISTFVETTPDPHTGKVVSYAERIRQVVEEIILADKVGLDVFGVGEHHRKDYAASAP
ALILAAAATQTSKIRLTSAVTVLSSDDPVRVFQDFATLDGLSNGRAEIMAGRGSFIESFP
LFGYDLNDYNELFDEKLDLLLKLQASEKVTWSGKHRAAIQNRGVYPRPVQDPLPIWIGSG
GNSESVVRAGILGLPLVLAIIGGNPANFAPLVDLYYRAVEHAGHDPKKLTVACHSHGFVG
EDTLLAADAFFPSTQYAMNVLGKERGWEPYTRETFDAARSETGALYVGDPRTVADKIIAL
RKNVGITRFMLHVPVGSMPHDQVMRSIELLGTEVAPIVRKEIAEWENNN
>PK3-045_03012 Putative ribosomal N-acetyltransferase YdaF
MFEHTIDENLALRMFRLDDAEEFFQLTMKNKAYLKEWLGWLDYTRTVEDTKDNIRQRLQE
IIETGGYPKSTAILYKGKIAGTIGFNEINRTSKIGVIGYWLGEEYQGKGIMTKSCQAIIH
YGFTELKLNRIQIAAASENKKSRALPERLGFTEEGIIRQAEWLYDHYVDHVIYGLLREEW
ENSK
>PK3-045_03013 hypothetical protein
MFYKLTREQQKAMIADIQFFFSQEREEEISEFAAERVLDFVKDSLAPHFYNAGVKDARKI
VEERASSLEDELLTLERPIK
>PK3-045_03014 hypothetical protein
MIKDRGTKKWVAMMLPEHVAAVKEELLNEKKIKKPELDQEKLNDIDLLIHEGMEYHLFLQ
FSLFKNGFIETFIGRTVFIDYLKKELRIEDETNVIHYIPFHLLIDVERL
>PK3-045_03015 hypothetical protein
MNRLSKEDIKILEHLIYLPLLLTVLERDYQQAKTTPFKLNQVYLNLIEHTMKKVQDDLKG
FKEKMYRKKLKLIKGNMDKNFTEYHYYVANYHEVHRFANTELKANTEKLLSYYLFKENAV
F
>PK3-045_03016 hypothetical protein
MYFYKEDLINMIVPDKPDPNAAKVLQEALGGQFGEMRTLMQFSFQSANFRGKAKKYRDLI
RGVFLEELSHVELVQSTINQLLNDSGGSMPGNMASDGAPLDDVIKGGANPHHYIIGAKAS
LPVDAGGNPWNGSWVYDHGNLVANLLNNVMLESTGVLQKSRIYEMSDNKTLRETIAFLIV
RDNAHQNAFAKALETLGVDWGKILPVPNYDINKYPECRKYVEMGFHNAQFNFRLDDTRIG
EIFQGTTPSRNNGDLNVVPPPQGYPVPELPDMPNEHASGLMDLNN
>PK3-045_03017 hypothetical protein
MSKSGYIPDNTNIHSSSGTPNLIYNTRDNVFFERNPENIAYKVTSTQLPAMIGGAFVDLF
LTKGHMREPHWHPNAWELDVIVSGEAMISIVDPDTRKLHHYHAKVGDVVFIPMAWWHWIQ
PTTEKLHLHLFFNNDQFESAEGSDTLRLTPPEVFEAAYGVDSEKVANAFSALKESVVIGP
PDSHRLQTSSVSNLEQTKKEVPDKISIQINHKQIDY
>PK3-045_03018 hypothetical protein
MNMERWILVGIIAISILAIFLLVPKQKTRDAWVIFLSLQIITWPAGLLAVEWNMIDYPVQ
LFSSANEFNRSSFTFEFFLFPVTAIMFSLYFPKKFKKTGKFFYYFLFAGFFTCLEVVIER
YTELVDYLSWHGYYTLLSVMVTLYINHTYYSWFKKELKYNE
>PK3-045_03019 hypothetical protein
MNKELIILIVSWVVCLFLLIRFIPKERKRYFQIVFLFAHATAWIFTHIQVSMDLVRFPYR
EFSHATKMSFSLYYIVLPTFAVLFLLYYPEKKHRLKIFLYYLIFSNGIHLYMFLVEKNSN
LIHDLNWHWWLAVSIDFLVLYMTKTFAFWFRKGFS
>PK3-045_03020 hypothetical protein
MNLETVMQELEALGKERTKKIYMGNGAQEPVFGVATGAMKPLSRIIKKNQPLAEELYATG
NYDAMYFAGVICDPKSMTEEDFERWIDAAYFYMISDYIVAVSLAETDFAQAVADKWIESG
EEFRMSAGWSCYCWLLGNRKDEEFSETKLASMLEQVKNTIHQAPDIVKSSMNNFIATVAI
SYVPLHELAVATAKAVGPVEIKKGKKKSTTSIVADRIQKELDRGMLGFKRKYVRC
>PK3-045_03021 IS1595 family transposase ISSpgl1
MKQPFPIIETERLHLRQATNEDAKDMYIYLSDQEVVQHMGLEPYKSADDVLEEINWYKSI
WEKGTGIRWCITLKKENIVIGSCGFLNRQPKHYKAEIGYELSRSYWGQGIAGEALNAVLA
YGFQQLSLERVEALIEPANTASQKLVEKHGFLKEGLLRHYEYTRGKFDDLYMYSILKGDF
KKSPV
>PK3-045_03022 HTH-type transcriptional activator RhaS
MDWLDRMNNVLDYIEANLEGEIDYKELAKIAYCSEFHFSRMFASISGFTLSEYIRRRRLT
LAAFELQQSDRRIIEIAQLYGYESADSFSRAFKKLHGIKPSECRHQGTQLKAFPKISFQI
AMKGDTEMEYRIENIDFEVKIVGKSNPVQTSKAFKKIPTIWSKAKKDGFMQELIDLSWEN
PKCLLEGILGICGKEAAIMDEEFNYFTGVRYEGEAKNGMETILIPPATWAVFPNIVEAWK
RLYSEWVPTSGYELANLPCIECYYGPGHKPRHELWVPIIPKPSK
>PK3-045_03023 hypothetical protein
MKKSSIFFAATLFVLLLAGMSACSNASESDSANNTNNKQSETDQKAENKDVSSPSNESPA
DSTETAENSKDSQMDEPASEDKSQADDKVEGRKAEFIKKLDNIQKEVDAMPDKKDSDKGV
TNAMKNYYGVSYEKYDEALNEIYSILKAELAPEVMNNLKTEQMKWIEQKEAAAKEEREKY
SGGTFENVANYISLYESTKKRCYELVNEYMAD
>PK3-045_03024 Diacetyl reductase [(S)-acetoin forming]
MSKVAVITGSAGGLGRGIAERLLKDGFKVVIHDINQELLNATLEEMKSQNADVIGVVGDV
SKREDQFNLVQKAVDAFGRLDVFVNNAGIDAVKPFLEIEENELNRLFNINVNGVVFGTQA
AAKQFIAQGSKGKVINACSIAGHESFEMLGTYSATKHAVRSFTHSAAKELAKYQITVNAY
CPGIAKTKMWDRIDEEMVRYSNGALQPGEAFAQYSADIALQRYQTPRDVANLVSFLASDD
ADYITGQAILTDGGLVYR
>PK3-045_03025 Stress response protein CsbD
MAENKHSIADKVKSGVSKVKGEVKDQLGNAKGDTSMQADGKKDKLKGKMQEAAGKFKEDV
DRK
>PK3-045_03026 Extracellular esterase EstB
MKKTKLLLSLTMSIAIIISVMGMNPTVLKAQTTGHDPVIYVHGTGGNSTNFLAIKNYLLK
QGWSSDELFAIELIDKTGNSLTNAKQLESYVDKVLKETGKNKVDIIGHSAGGINTLKYIQ
NTGGTKVNDVITLGSPNKFITSKAPVGKDPNHKILYTSIYSKNDYLVPNMLSKLEGAKNV
QISGVGHLGLVVNSQVNELIKEGLNGGGKNTN
>PK3-045_03027 hypothetical protein
MGILSGNPKEEPLHYGEVFDIWASQLVGNSMTAGYQTMLNHAGDGDLKKLLVEVIETCKE
EKKQLEELLKENGVGLPPAAPEPPDACLEDIPVGARIPDPAIAATLSADIAAGLVTCSQI
IGKSIREDVAAMYGQFHTKKAALGAKVLRLNKEKGWLIPPPLHLNKHGDC
>PK3-045_03028 hypothetical protein
MQKGISVFLFTFMIISFVLPARNITAEETINENLIQNGGFETVTSNSSWANSEGPGKWST
WIPSGTPELRMDDSVFYEGEKSISIKATETSRADVLQDVSVKSGFTYQLSFWVKTENIEA
SGGGVFVRTQYLDSANKKISDGPSTEKLKGSQDWNTKRLGLTIPNNASKVRIELFFETAK
GQAWFDEVALKESDKTVTDFSLKQNAVKVGIGETVTLEPVFTPADVTDKTVTWTSSNPEI
ASVNSAGVVTGAESGAATIKATSKDGGFTAECLISVDSVEDIGYYDELRLSWFHKLTGNE
LYNPADQDAAAYMSGLEKKVTNKDGTGIWDMMNKMENRNSLWADNESTTNSAQITTSYQR
LKDMALAYSSKGSALFRNQALKTDIIIGLDWLHNNRYNADKEEYGNWWDWEIGIPQTLND
IMVLMYNDLSSLQINNYIKAIDRFVPDPAKRVSLGDPNFRETGANLLDKALVVSLRGIIE
KNSGKVLKGRDSISKEYIYVNSGDGVYRDGSLVQHFNVAYTGGYGATWVGRTADMLYLLK
DSPWEVKDSNVDNVFNWVSDSFEPLIYKGAMMDMVSGRGVSRQSTNDHATGRSTILSLLR
LADAAPQEHALSIKQMVKEWIQTDTTFSNYVNGLSIYQIHLVHTLVNDTTIEPRGELIKN
QVFAGMDRVVHLRPGFGFGISMFSDRISGFEYGNGENKKGWYTGAGATYLYNNDLKQFSN
DYWPTVDSYRLPGTTTDQSKGTLKDWESYYNPRSWVGGSNLDDLYGAAGMDFSLEKLTGS
SLKGKKSWFMFDDEIVALGAAIYSTGESEVETIVENRQLNANGNNKLLINGEEKIKELGD
SEVLNDVQWAHLEKNVQGSDIGYYFPNSPSLRGLRESRTGSWNEINSGGSTESITRNYLS
LAFDHGKQPVDETYSYVLLPNKDVEQTKNYSEKPDVTILANTASVQAVREETLKLTAANF
YQKDTVGFIKAGSAASVMVKEEKNGLTLSVSDPTQKQDKIRIEMNKTGLEVDKKDDKIKV
LQTSPTIQVEVNVANSIGKTHSIQFIDKESPTISAPKTDDIYRTDTVNLTFAMSDSYSDI
ASKEFYLDDVAVSNPIEIKPYSLSLGEHTIKVIATDQAGNVAEEIYQLNVIMDINHLREA
INYGRDKEWINNEIANNLHVKINHIIQKEKMNNKQIRNNLHAMTKLIQAQSGKKIDESFA
NLLLEDISNLLTLYQ
>PK3-045_03029 Beta-galactosidase
MTSFQIGKEFLLNGEEFKIISGAVHYFRIVPEYWEHSLFNLKALGCNTVETYIPWNLHEP
QEGIYNFDGIADVKEFIKTAERLGLYVIVRPSPYICAEWEFGGLPAWLLKDRTMRIRSRS
SNFLSKVDTYYQSLFDVIRPLQVTKGGPVIMMQVENEYGSFGNDKEYVKRIKDLMVKHGA
EVPLFTSDGTWHEALKAGSLLEDDILPTGNFGSKSGHNLKELAAFHQENNKAWPLMCMEF
WDGWFNRWGNEIIRRDPDELAGEVEELLQLGSINFYMFHGGTNFGFMNGCSSRNGIDLPQ
ITSYDYDALLTEWGEPTEKYFAVQKAIKKVVENCWQDQPRDLVRKDLGSVKLNRKVSLFS
TLPTLSQKITHSHTLTMEELDQNYGYILYQTKIDNREQIDNCQVVEANDRVQIFANEKWI
HTEYQETLGSSFVLPKETKELSILVENVGRVNYGGRLLSPTQRKGIRSGVMIDIHFHHYF
DHYPLTLDELSKVDFSRSWEKNQPGFYEYVFELEECVDTFLDCSGFGKGMAELNGFHLGR
FWNEGPTGSLYIPAPLLKKGMNRLIIFETEGIYSEEIHFADKPIYIK
>PK3-045_03030 Unsaturated chondroitin disaccharide hydrolase
MAELQSIKEKLLESGNLLTNDDIEKELDWICAKLKSNLARYQNKFPSAEATNGKYRLKDN
DDWTNGFWTGMLWIAYEYTQDAAFKNAALEQIKSFKIRLKENIVLDHHDLGFLYSLSVGA
GYRVTSTEDFIPLLKGAADKLLERYQPKGKFLQAWGALNNEKEYRLIIDSLINLPLLFDV
WRLSGEEKYYQKAVNHYHQVCNHIFREDYSTYHTYYFNHENGEPLSGATHQGYRDDSCWA
RGQAWAVLGLPLNSLYNPSLRNEFVYEKTVDYFLANLPDDIVPYWDFAFTKEDGQVRDSS
SLAIAACGLLSAKKVSLYPDADKLAAGMVKVLRDSYTSQNVEGNEGLLLHGVYAYQEGKG
VDEPNLWGDYFYMEALFRLLRPTWETYW
>PK3-045_03031 PTS system fructose-specific EIIB component
MEGIVHIRVDDRLIHGQVATRWATGLKVNRIMVIDDKVAANELEKSVLRMAAPSGVNTSI
LDVEKAVNNIKNGNYQGQRVLVVIKTPEVAVQLLKAGLNVKQVNIGNLSNRPNTLQIKKS
VSLSESERKAVDFLIEKGVEVTAQMVPDDPAANIISYL
>PK3-045_03032 PTS system mannose-specific EIID component
MSNNQKELNSVFWRWYFLGQAGWNYEKMQGLGYYYSIYPLLESVYGKQENKEELKEASLN
QLQFFNTNNTMAPMILGVNTAIESEEGIKAKEVVTSIKTGLMGPLAGIGDTLFFMIPTTI
IGSIASYLALKGNPAGLILWIVFGIVRLICMRLFVKAGHREGTKLISEIGNRLKKVTSAA
NILGITVVGALIPSVVKATFGYQFTQGEVKLNLQDIADQIMPGLAPALIVLLTYWVLGRK
KMNSTKVIFMLIAFGIIAYNLKIFA
>PK3-045_03033 PTS system sorbose-specific EIIC component
MAGIEWWQIILLTLYAAFAIYDGNNTTFGFVKPTMAGFFAGLILGDIQTGLIVGGTLNLL
VLGVGNFGGASIPDYMTGALLGTTFAVLSGEGAEFGATLAVPIGLLMVQLDVLARFTNTF
FQHRAEKLVKEGKTKKATYMNIWGIVPTSLSRMIPVFLALVLGSHFVQDVVDWIPTWLMK
GLSVSGGILPALGIAILLRYLPIKPNFAFLLIGFFLAAYLKVPVLGVAIVGVAFALIYLQ
FFAKAEKEEQVTPVGGMGDE
>PK3-045_03034 PTS system fructose-specific EIIA component
MKNIVILSHQGVASGLKRSAQMIVGEFNPLITIELTEMGVETFTNEVQQFLQNEVIDKQK
EYLAFVDLKGGTPYNQIVKETLRLNLADKVRIISGVNLPLILEAFYFEEDDLTILEKKGK
RAIEFCQLEMNVSNLDE
>PK3-045_03035 HTH-type transcriptional repressor NagR
MPKYLKIKNSLLERLTNGEFQPGDKFYSESELKKEFNVSSITVIKAITELVNDGYLVRYQ
GKGTFVSKARRGKIVKFTEKENIQYDEEDVKVIEVELMKDPRIAKELRIAEDKLFYSVKR
IRYSDGCAFILQNTFILPEFIGNEEIENLENFKSIYEMIKNKFGINLFQAEFTETTEIIF
PAPHEICAEIDLKEAAPVVFTKRHTYLANGRVVEYIESYKRWDYFNIRIDSV
>PK3-045_03036 hypothetical protein
MGKTNNASLTRIHTKKHRYTCVTRELSLYKNKILACFILKLNTPLKNQLPETAGFLLWRD
TTREGKYFTKKILFIFLIPLAIIR
>PK3-045_03037 hypothetical protein
MNKTDIEYKILELKNEYLQVQDNLEKLEYVNGNIRPLENRLTKIEEELKSLYNRLKTI
>PK3-045_03038 hypothetical protein
MKYVKAFAIKFLSTLVLLSLILMILFNLPFTNVFMITVVLGVLAYIIGDLLILPRTNNLV
ATISDFGLAFFVIWLMSENFTYRGNTVMMSLIASIGVLIFEYFFHKYLIQNFIQEAKSNP
RQEKLQFQTEMAEEFHPNSKTDNDES
>PK3-045_03039 Aspartate--ammonia ligase
MNESLIVPSIYQPNLNFIETQIAINKLKHHFENHFSKELNLTKISAPIILKAGSGINDNL
NGVERIVTFNAMDVEHSQIEIVQSLAKWKRMALGQYGFSYGEGLYTDMNAIRRDEVLDNL
HSMFVDQWDWEKVISFDERQLATLKLEVQKIYSAIKSSEDFLYTLYPRIEPTLPENIHFI
TTQDLEDIYPSLTPKQREDEIAKEFGAVFIMKIGGELLSGIKHDGRSPDYDDWNLNGDII
LWYPLLEKSIEISSMGIRVDEKTLLQQLKCSKNENRKDLEYHQGILNKRLPYTIGGGIGQ
SRLMMFLLKKAHIGEVQVSVWNDAIITACKESNIPLL
>PK3-045_03040 hypothetical protein
MRNNFQFIALQDNEFNDLFLMDEEELINIGAVKMIADKKPGFPCRVSLKDAEIGEEVILL
NYQYHFVNSPYKANGPIFIRKEATTAMLDVNEIPDIIYHRLLSLRGYNIDAMLVDARVTE
GVNVREMIDDVFDNEEVAYIHIHYAKPGCYSCLVKRM
>PK3-045_03041 HTH-type transcriptional activator Btr
MCRPDLSETIYDPNKDLVERVKELISNNYSKSFETKKIAPMLGVSNNHLVRLFKQYYGKT
ISEYLIELRLKEATRLLTRTDTEITKVAFEAGFQSMSNFYKIFKTRTGLTPKEYRMKCLY
GSYSI
>PK3-045_03042 Cytochrome b6-f complex iron-sulfur subunit
MAENANYKEKLPPNAESYWTNTIHLPEYPCLEDDMQVDVAIVGGGITGITSAYLLVNEGL
KVAIIEADKLLNGTTGHTTAKITAQHDLIYEELIRYAGKDTARLYYEANTDALEFIQETV
NKHQIDCDFTHQDAYVYSTTEEYARKLEKEAEAYEELHIEGKLVNKLPFDLEIYNALVME
DQAQFHPLKYLAHLTKIITEKGGYIFENTTAVNIDTGEHPAVLTRGGARITAKYVLACSH
FPFYEGAGLYSTRMHADRSYIIAAKAKTDYPGGMYISADEPKRSLRYAIINGEEMILISG
ESHKTGQGGETLKHYEALETFGQKVFGIENITYRWSAQDLTTLDKIPYIGEITSGQKNIL
IATGYRKWGMTNGTAAALLFRDTILGKKSKYQKLYTPSRFNLNPSLKNFLTQNANVVSHL
IKGKLEIPQNDINNLSHDEGAVIEINGHKKGAYRDKEGKLHIVDTTCTHMGCEVAWNDGE
RSWDCPCHGSRFSYTGEVLEGPAEKPLKKYDYKMTDNLTSEDSGY
>PK3-045_03043 hypothetical protein
MDEIEVILRNAHIDFLKRESFRYLIFHKETKEFIGTASLHGINWKIAKGEIGYWINTTYT
GNGYMTEAVRALINQGFQQLKFSRIGIRCESTNVKSRSIPEKLGFKLEGTLRNDDLSADG
SRLTDICIYSIIKENHP
>PK3-045_03044 hypothetical protein
MPEMNSYMMVGERLCMDFINTVSWRESDEKRRDWFTSYAKIVDWCIHADVLTEQQAKVLL
LKAEEKPSEAGEVLKQTIEMREVMYRIFKSVSKGTSPQPLDLECFNESVSKFYQTLRVIQ
EKDHYTLKFMDNEENLDTMLPPILQSAVDLLVSKNDLERVKKCEGDSCGWLFFDTSRNRS
RRWCSMADCGNRAKARRFYQKEK
>PK3-045_03045 hypothetical protein
MDNPMLVAVRTLLKETYDGPEKNASWYTEAKPGSGLFGTLEKISAEDASLPVNGTTIAAQ
TDHTRYYLWVANSYLNGEVPSKDWGASWKITTVDKITWAQFTDELQQEYTKLIKKIDSLR
SLDKQTSNGLLGALAHSAYHLGSIRQMIKSIKVPNQT
>PK3-045_03046 Regulatory protein BlaR1
MVVTRLLLSTLVVSLLILIILLIKRVFYNQLSQQSHYKIWYFLFAPIITCVIPWDFLRFQ
EIFQYMQNLLFNEKEITRGNQTFSGLDISQTSNHDFLNDFSISVNKTNTEFFQQFFFVIW
IIGIMVFIASAIYAIYQIRQIKKSSTSIKDQNINELLEECKEIVGVKRKIILRETALINS
PITLGLWKPYVFLPQKTKEEFSLSKIKYVFLHELCHQKSKDSFVNYLMWLVQIIYWFNPL
VWLALKKMRIDRELACDASVLSLLDESRYTEYGYTIIHFADKKFNRPYKQFSTGIGGTKE
QLKRRIQSIANYRVDSPLLKWKSKVIYALLAMVVLLFTSLSSALASSDDKYHFNEKNVTY
EDLSSYLNGYKGSFVLYDPIKKQYQIYNREMSEQRVSPNSTYKIYSALFALETNVISTTS
NEQLWDGTAYPFEKWNTNQNLSTALENSVNWYFQQLDREVGKKKLQSYFHKLNYGNENLS
GNIDNYWMESSLKISPIEQVQLLFALEENKLGFKEENIRSVNNAIFIDEQKQAQLYGKTG
TGTINGKEINGWFVGFVKKDGYSYYFSINIQNKTGKANGKKAANIAKRILHDKNIF
>PK3-045_03047 Penicillinase repressor
MKEIPQISEAEYEVMKVVWNYEPISTPEIVEKVLKNSDWKPNTIHTMLVRLVKKKVLQTR
KDGRAFIYTSLVKENEYVEQKSKSFLKQFFGGTLNSMVLNFIENEQLSKEDISELKSILA
ERDKKEGEK
>PK3-045_03048 Beta-lactam-inducible penicillin-binding protein
MSSRVERKKRRIRPYIILILISLAGIISLSLYMITNNSENSQGQKVANAFIQILVNKEYE
KLGEVLEKDSYDSLGYTLKEVIDKYDHIFNGINIDGIHASNMDLKKINRNEQELTYQLSL
TTPLGRLDKINYQARIIKSGDQYLIKWDPSLIFPNMEGKDKVAFHQWRAERGEIKDRLGN
GIAVNENFKEAGIVPKDLLKGNEKTKRLQNISKQLNISIEEIQQKLKQGWVKDNLFVPLK
IIEANNAEVIPGISYQNTNLRYYPLKEAAAHLIGYIGEVTREDLDKNSDLKEGDMIGKAG
LERALDKELRGKDGGEILIVDENGKTKQTIQKAEKIDGKDIKLTIDAYIQMEAYNHLKEN
PGSTVVMNPKEGGLYAVVSSPSYDPNKMVRGISQNEYDKYAKDENKPFLSRFASAYAPGS
TFKTITASIGLDAGVTYPEKRRIINGFSWQKDKSWGGYSVTRVSNVQHVDMRKALIYSDN
IYFAQETLELGEKTFRNGLDKFIFGEELDLPIAMNPAQISNHRTFNSDILLADTGYGQGE
LLLSPIQQAAMYSVFQNEGKIVYPRLLEDNSRPKTKSAITPSTANEMRTFLEAVVSNPNG
TAHLLYNQQYQLAAKTGTAELKMNQGEKGDENSFLLAFDTGNDQFLLLSLVEHYSKGGSA
TQLNKSFIDELYEYFQSF
>PK3-045_03049 Penicillin-binding protein H
MKKKKERTKPFVSSFRINILFLIVFLLFSLLILRLGIVQIVNGEDYKREVDRKENVTVKI
AMPRGEILDRNGKLIVGNKPSNAITFTRAQNSKTEEMLKIAEKLAIFIKKDSKEDLKAIT
ERDKKDYWIIKHPNEAEAKITVADKKKLKHDKHYDTKIYQLTLDRITSKEVNSFTKQELE
VLAIYREMSSGYPLTPQIIKKDATTKEVAMISENLDSLPGVDTTIDWDRYNLYKDTEGNE
TLDSVIGKVSSSKEGLPKDSIDYYLARGYSRNDRVGKSYIENQYEDVLQGQKEKIKNIID
KNGNILESEVVQEGKRGDDLILSIDIDLQREIEKIIEEKIGKARIGEPYLDRTFVTVMNP
YSGEVLSMAGKQFEQNKKTGKTEVNDFALGNITTSYEMGSVVKGATVLTGYQTGAIVPGE
VLNDRPLKFLGTNAKKSWNKTGFGPINDLYALKRSSNGYMFLTAMKLGGQQTYIPNGLLS
IDKVSAIETFRYNFSQFGLGVRTGIDLPGEHSGYGGGQIPPESGKVLDYAIGQYDTYTPL
QIVQYISTIANGGYRIQPHIAKEVREPNQANELGPIIQEMKPKVYNKIDMKEEWIKRVQL
GFKQVVNEPLGTGYGIKNKEYKIAGKTGTAQALYNGPLPHSQGLMLWNITFGGYAPYDHP
EIAVSVTVPWLRTDQSHVNLEIANDVFKAYFELKEKRYDSE
>PK3-045_03050 hypothetical protein
MKHKNWILYEDFADKSLNENLEWRCEPKKWFIDTESSQLVLETDQETDYWQKTHYGFEVD
NGHFLFTKTNKNFRMTTRVKAIPKSKYDQAGLMIRFSEEVWVKTSLEYIPDGLSKLGAVV
TNKGYSDWSTQYVDCEEVQIYYRISKIGQNCYVDFSWDGEVWNQIRIAHLDVAENSTILA
GVYACSPQGREQEVRFDFITIEELNNNPATAYL
>PK3-045_03051 putative oxidoreductase
MLENRKVIITGAASGIGKESVRKCLNEGASVIACDINKHSLHSLKQSMGDGYDLHTYHLD
ISNYEEVHKFFVYIDEEHSDIDGLVNNAGIYLAKNILDYQVNEIDKVLDVNVKGFIYFSQ
MFGKKLMASKSNGVIVNMSSVSGMEGSSDAIYGLSKAAIIGLTKSCAMNFSPYIRVNAVA
PTMVDTSMMDTIPNWRKDAYLSHQLIDKPVSPEDVANTVVFLLSDKAKHYTGATFDINNG
GYLR
>PK3-045_03052 Glutamate decarboxylase
MQHHRKAEIQNDADEGKESMPDNSQSLPRHMQMELPHELSVNPLFAREGESDVPRFHMAD
KGMLPETAYQIVHDEIALDGNARLNLATFVSTWMEPAAEHLYTKSFDKNMIDKDEYPQTA
EIEERCVRILANLWHSPNPLTTMGVSTTGSSEACMLAGLALKRRWQNIRKSKGKSVERPN
IVFSSAVQVVWEKFANYWEIEPRYVKVNPDHPLLDPQGVLAAVDENTIGVVPILGETYRG
LYEPVAAIAKALDDLQKRTGIDIPIHVDAASGGFIAPFLQPDLVWDFQLPRVKSINVSGH
KYGLVYPGLGWIIWREAADLPEDLIFRVSYLGGNMPTFALNFSRPGAQVLLQYYNYLRLG
KSGYYEVQRASQKVALFLSEAIQKMAPFELLSDGSDIPVFAWRLKDGYTLNWNLYDLSRQ
LRVFGWQVPAYPLPPDMEEVTIMRIVVRNGFSMDLAHLFMMNLKQAVAFLDSLDGPMPHD
SKSNNGFHH
>PK3-045_03053 Broad specificity amino-acid racemase RacX
MLSNKFCRIGILAGMGPRSTAPFIESVLDECERQYGAKNDIDFPHMIIYSLPTPFHPKEP
IIKEDMVKTLQIGIQSLTEANCDFIAVPCNVVHQFYEDMTKMTNVPILNIIQETINAIGV
QSSKVGLIGTRSTVENQLYQPYLLNNNKDIYWTERIQSQVDQLIYDVKQNREMEELIQQW
KNIELDLTENGVTDVVCVCTDLYFCGSYTSLNFFDSSKILAKSLVERYLAFK
>PK3-045_03054 rifamycin-inactivating phosphotransferase RphC
MSSLVLDLKEVGKTEYMLVGGKGVNLGELSKIHGIQVPDGFCVTTAGYQKSIEHNETFQT
LVENLICLKIENQKQISEISRKIRQIIMATDIPSDVVSEVVTYLVRFGEKHAYAVRSSAT
AEDLPHASFAGQQDTYLNIIGKEAILEHIKKCWASLFTDRAVVYRMQNGFDHQQVYLSVI
IQRMVFPQASGILFTADPLTSNRKTLSIDASFGLGEALVSGLVSADNYKIQENEIVHKKI
AAKKLAVTAVKDGGTKSQAINPEQQKTQSLTDKQILQLARIGRKIEDYFGCPQDIEWCLV
DDKFYMVQSRPITTLFPIPEANDQENHVYISVGHQQMMTDAIKPLGLSFFLLTTNAPMRK
AGGRLFVDVTQQLASPASRNMLLNGMGQHDPLLKDALMTILEREDFIERLPDNDQAPSQR
RGSTARQAQLENNNPSIVADFIKRSQISIEKLKHNIKTKSGSALFDFILEDIQELKRILF
DPQSTAVFMAAMNAATWLNEKMNEWLGEKNAADTISQSVSNNITSEMGLALLDVADVIRP
FPKVIDYLQSVKDDNFLNEMLKLHGGQKASDAIRAFLNKYGMRCAGEIDITRPRWSEKPL
TLIPMILGNIKNFEPHASQQLFEQGLHEAMQKEKELLERLKQLPDGEQKANETKQMIDLI
RNFIGYREYPKFGMISRYFIYKQAILNEATQLVQAGVIHEKEDIFYLTFEELHNVVRTNK
LDYQIISKRKEDYNIYEKLSPPRVITSDGEIIEGKYKRENLPEEAIAGLPVSSGIMEGRA
RVILNLEDADLEDGDILVTTFTDPSWTPLFVSIKGLITEVGGLMTHGAVIAREYGLPAVV
GVENATKLIKDGQRIRVNGTEGYVEIL
>PK3-045_03055 hypothetical protein
MINFEVDIIQIRDRSFHIGLKTAERILDRSIIKMWSEVFEQDIDYKNMHSIYSAYAPHLL
EELEGLAQGLGISSIRAASMFSGYQVPKIDAMGCTAILTDETYVRNYDFSPDLYDGIFSC
IQAEDALATAGYNLQILGRHDGVNEEGLVMGFHFVSYSGYTKGISPWAAIRMALDTCSSV
DDASALLKEIPHSACYNFSVGDKKGNIAVIEATPEKVCIRKDEKLLSCVNHFQTSELQDK
NRLAIDGSVKRNNYLQSFQGKKRTQQELFSIFAKKSSPLFFRNYDELFGTLHTFSYSFQE
SRILTSLAQGRAVLDFNFHDWTNGEDLVSKKMTGYIETIN
>PK3-045_03056 hypothetical protein
MLNFTWINESTIVEEDGRIKIYAPQETDFFCNNGAIGAEGITPQSLCNAPFYYTEVAGDF
IMKVKVSHDFKDTYDSASIMVMKDMTYWAKACFELTDFDTHAVVSVVTKEESDDANGCNI
DGNAVWLQVCRSGHSFAFHYSIDGENYYMMRFFSLPVDEIVKVGLLAQAPLGSGGMRIYE
NLSIEKKTVKNIRMGK
>PK3-045_03057 hypothetical protein
MSIQLQRLFNILMLVLSWFSLTLIGFRDIKRFFPATLLIGVIEILTARIGKKRRWWVFYN
KPNSYKFNEFPFNLGPFIFISLWTLKLAYGNFKKYLLINAIVNALFAFPFSSLAKNIKYY
SLVRFNHAQFFMYFFVKAPLLYFLQYYFENRKQLKLNKQR
>PK3-045_03058 hypothetical protein
MAISPDFSYVAKLMADSSRAAMLEALLGLDGLPANELARKANVTLQTASSHLSKMVEGKL
IRVEKHGRHRYYSLANTDVAKAIETLIVIAPPVGIRSLKDSSRAEKIKIARTCYDHLAGR
LGVKLTEAFIVKGYMIEDQDNFSITEEGETFFRDFGIDLDTLRNKRRHFARKCLDWSERR
YHLAGSLGHAVLLKLLELNWIEKLPDRAVKITIKGKEKLYSILGIEI
>PK3-045_03059 hypothetical protein
MGKTDLLILNFKEVRRRSIKVWKAIPPQLLNWKPDEKALSCAEMIRHVVEGEYLYHQMLI
NKGSIESNSFHNPFDQKEFTTVEEELKFSQPYREEFLTYIESISNYELENGMIDRSDIGY
IRTLEDMLLRIAYHESVHTGQLLGYMRTMGIERPQIWD
>PK3-045_03060 hypothetical protein
MNKENKFIISDEFLDQLAKEINRLNGDPEEEESKDDESEG
>PK3-045_03062 Potassium transporter KimA
MLGSIKRLLIGRPLKSYELGEQKLNKTKALAILSSDALSSVAYGPEQILIVLITISATAF
WYSIPIAIGVLILLSALILSYRQIIFAYPNGGGAYMVSKSNLGVTPGLIAGGSLLVDYIL
TVAVSVSAGTDAITSAFPALHGYNAEIAIAFVLLLTVLNLRGVTESASILAYPVYLFVLA
LFILIGVGIYNILTGNVSSELHTPIGTPVAGISLFIILKAFASGSSALTGVEAISNAIPN
FKKPAPNNAAKTLVMMGALLAVLFAGIVTLAYFYGITPKAEVTVVSQIAEGVFGRNFMYF
FIQVTTALILILAANTGYSAFPLLAVNLAKDKFVPRMFLIRGDRLGYSNGIIILGLASIL
LILVFNAKTEHLIPLYAVGVFLPFTLSQSGMMVKWLREKPKGWVPKFIINTIGAAISFIV
TMVFFITKFSQIWSILIFLPIIVFIFYKINKHYLAVGDQLRLTTSEPPLTIQGNVMIVPI
AGMTHVVENTLNYVKSLKPEQIIAVYVSFEREEEKVFEAKWNKWQPEIRLVTLHSYYRSI
INPLRKFVDTIEHKAKEGNYQVTVVIPQFIPKKGWHNILHNQSSLLIRTFLLYRRNVVIT
TVPYHLKK
>PK3-045_03063 hypothetical protein
MYRAFGEKVDGLDYQIRKGVYAVIFNDARDKVLTVQNSRGHYFLPGGGIENDESYQECLE
REMLEETGYRISIGTFIGDAKRYFQSSKNEPLINEGYFYLANLLEKIHEPIEADHFIKWI
GIESVKGQLFHEHHCWAVYQALSRVG
>PK3-045_03064 hypothetical protein
MLISEASQITNLTKKAIEYYIEQKLIIPNTLENGYRDFSEKDIECLKKIYVLRKLGLSTE
EIRSVLVDKTNNTLQRISIQKELTLQREQEKKSLLNELRICKDYTVISKKLRMIEQHETV
TEKILEAFPDYYGRFICLHFARFLKEPITTAVQQAAYEEIIAFLDNVPPPQLAEDLQLFL
MESTNNMDTESMQDMLAQTKQSIENPDKFLTERKEFIERYLEYKQSEEYKNSPIYKIQQI
FKAFNHTSGYDDVFIPAMKKLSASYAAYCKQLESANEKLLLQYPALDSLKE
>PK3-045_03065 hypothetical protein
MNELEGVLERTECRYEIVHHQKPILSREDGMNYFGIEAGQTAPTFILKTDKGYFVFIVSG
KRDKLDLKKIAILLDCSKVKLASPKEVKTVTGFEVGSVPMVGLDLPCVLDKSHFKYDFVY
GGTGKATCTLKIEPQALQELNHVVAILES
>PK3-045_03066 hypothetical protein
MYANVNAPPTFGANAAPQPNVSPEFFPSAPSFPTYTAPAFTAPAYGYCAPDCPKNDFVLI
VVLFILLIIVGAFICF
>PK3-045_03067 Protein-glutamine gamma-glutamyltransferase
MIQIAGTTFQLQENWPLDQIERSILQYMQDDHNIYSYSSLVELQFELTMRKNIINSARAM
NETQAQFTVFEQSRCNPAYWQLTSAGGFLLRPDVMPSDAIMDIYSNSSLYAFECATAAVI
IIYHATLQTIGKRAFDTHFRNLYLYSWHVDTDLGLVTFNSNSFLPGDIVYFENPDFDLAA
PWFRGLNAILLDDGRFFGHGFSIRTDQEIIQNLNEIRIPASNRSAFLSSLVTRPSFTHLS
RLTQQQTRSTTFKLQLPVVHHNRSSISTLRYQNYLVQLGYMYKG
>PK3-045_03068 hypothetical protein
MYNQEVYPTTNAYQQSERLNFLFPIAPGPIGTPGIPGPGVGGQGGIPGFPGPGFGGPTGI
PGLQPSQAPTAPPPPFIPQQAMASPFAIDPGAIRLCMFRNTFIWLSNGDGFWFFPVFTGP
RSVAGFRWNGRFWMIFGIDTRRIVSFTCF
>PK3-045_03069 Cell wall hydrolase CwlJ
MARIAYRDADIDLMARMMRAEAEGEGNQGMLYVGNVIVNRVVGDCLDFKDLRTVEQVIFH
VQGGNYSFEAVQKGNVFYQRARESERRLALQNVKYWRDHPAKFALWYFNPSGPCPTTWYD
QPFTGQFKQHCFYEPKAGTCESVYRG
>PK3-045_03070 hypothetical protein
MKEKQNRSNRRDEILSAAIEVFAQEGYYRATTMKVANKAEISQPYIFRFFSSKELLLEEA
LKLSWSRIQAAFTQVIQAASAENLEKELIQAYEGIMRNYENEILLQMQAQTIRETNIVTL
MQEEFLKVHSIVYTAFQTAGVSNPSEKTLLFLARGMLCNISLALNLPKLMEIDD
>PK3-045_03071 hypothetical protein
MKNVIVLGATGGTGAAITEELLNRGIKTIAFGRSMEKLRSLKEKLSNSNLLTLKAGNAFD
YNSIYEAAKDVDVIFQCAAVPYEEMHRSQIPLGEGVMTAANKLSKKIVFIDGIYPYGKAI
TPLVDEEHPKNPHTKKGKIKLELEKLIFSNEWTKAEPMIIRLPDYYGPTANFNSYLGMTL
VNIAKGKISAYIGSLSIPREYVYLPDAAKMIIELAMNNDAYGQNWNIPGKIITGKRLIQI
AQSSAGKSAPVIPLTRYMLKLIGIFSPVMKEMVEMSYLTETPVYLDGSKYQKTIGSLIQT
SFEVGLAETIRSIQKDTQ
>PK3-045_03072 HTH-type transcriptional activator RhaS
MYRKVAQDVICFLEDYLLEDWHLEDYASKIGYSKFHLSRIFKEETGLTISEYIRKRRLAT
AAMQLLYSDDSLIDIAFKLHFQSQEAFTRSFKELYTMPPGKYRRVMRILQGMEEKVMSDH
TIIKGWNLSGSNPALYEMRTDEQVFHTGTKSGLLISKADIGEGQFGTMMQSFSADNWKGK
RIKMSCFIKTEEVRKCGVWCRVDNALSDVIQFDNMDDRSIEGTTDWNFYTIVLDVPKESK
SIHFGVLLTGTGKVWADGFKFEEVNLSVPSTNMLIRDTLPLEPINLDFNEG
>PK3-045_03073 hypothetical protein
MLLDLKGDSQMDPIVGMLYSMVENNYQRLKSIVAGMDQEELEYKGPSKNDNSTAQLLRHL
MYVDLNWVYRIRGKLIPKELEDRYGPMLDKNNQLPQVTDISLDELLNEYDYVLSLLKSLC
CQLTDKDLLQTVEYEDGNDATIQWGIWHLADHNRYHQAHINQLRKWFSTYN
>PK3-045_03074 hypothetical protein
MENNLSKIEQVEKALYKSWSLESSSKWREDNPAKGHCGVTTLVVNDILGGEIKKTKLPDG
WHFYNVLDGKRYDFTASQFREAIVYMDFPSNREEAYMDTNEKQYNYLKQRVLKNLDIT
>PK3-045_03075 hypothetical protein
MKKNKSNAEHYLWGDNCDGWHLVKNQDLSIIHERMPAHTSEVRHYHQHARQFFYVLSGVA
TIEVDGKEITLKPHEGIEVPPLVPHQMFNKSNNEVEFLVTSQPTSKGDRVLVD
>PK3-045_03076 HTH-type transcriptional activator CmpR
MNLHALKLFHIVAEKGNVTRAAEELNISQPAVTAQIKKLEQEIGMTLLAPKGRGILLTEV
GIELAKHSKRVFSLEGEMEAYLDQYKNGSIGKLRIVATYLPANFLLPKWLAKYKRRYPEV
EVELTTTNSLKAMDQIINYQAEIAFIGGKRESHPFLNTSELFEDEMWFVVHKNHKFAAKK
VTLGQVMCEPFVFREKGSSAREKLVSLCTINSINQPTVGLQINGLNEAIRVVMEGYGVTF
VSSLEVKEYIARGDLAIVDVEGVELKNPISICRRREDELSMPAQHFIQMVMNDENN
>PK3-045_03077 hypothetical protein
MKFICIDCKKVFTSSEFAYHCSCGGLLDIVHDFQHYDADFLKHLFKERLSERMTPYASGV
WRYKELIFPELPDNFIVTKYEGNTGLYASELLQTYTGLKQVFVKAQSENPSGSFKDNGMT
VAVSHGNSLGYKKFTCTSTGNTSSSLAMYASIASANSYVFVPDKDISLNKVLQTVSYGAK
VFSFPGTYDDGIQFLEKYSHELELYVCNSINPFRIEGQKSIIYEIAQYLNWELPEWIIVP
GGALSNATALGKGLSDLYTLGLIKKMPRVAVVQAEGASPFHKMVSQQKKELIPEPVPYTR
ASALNIGNPPSWKKALHTLFQTQGVTISVTDEEILDAKAMIDKSGIGCEPASAATIAGLR
NLVSKQVIDKEESALCILTGNILKDTDVLKYYHHVENTNATYKNNIHHTNLSLSSISNSM
KSEK
>PK3-045_03078 hypothetical protein
MIDVQSKFGFEFRKFNRFYTDVLGFLNEHIYNSPFSLTETRILFEIYNTENCTAKNIQER
LDLDGGYVSRIVKKFEKEKMVYKQKCKDDGRNHLLYVTSHGELIYKELEKKANQQVEYIR
ESLNPEQQQKLIASMCTIQEILSASFNEKNEETVSIRSYYTLEDINNMIEHQWLFYNQVH
KWDNSFLAYLEETFRADIERIWIAEINREFAGCIGLVNDGNNIGQLRWFLVNPSFHKKGI
GTQLINALIQYCKEHDYEQIFLWTVSEMVTARPLYKKFGFEITEIQEEKSLWGADLIEER
WDLDLKKS
>PK3-045_03079 L-lactate transporter
MKRTFHYAWIIVFVTFLTFLAVQGVRLSFGAFVEPWETEFSMNRGTISLISTLSFIIYGL
SQPLIGRLVDKLGARLILSFSTFLVGISIFLTAFVTHPWQLFFLYGIMVSLGVGGASNVA
ATVVVTNWFNEKRGLAFGIMEAGFGAGQMLLVPGSLLLIHLLNWKMTVVILGAFLVLFVF
PIVLLFLRNHPKEKGLVPIGGEIAEDDSVPKKTLDTNTSIWNVFLKRQFWFLILPFAICG
FTTTGLMDTHLIPFSHDHGFSTSVTSAAVSILAGFNIIGILLSGIIADRWSSRKMLFLLY
GIRALSIAILLSSHNSTLLLIFAVIFGLVDFATVAPTQLLATQYFEEYSIGFILGWLFLS
HQIGSALGAYLPGFFYNETGSYTISFYFSIIILVGAAILNIFLPEPNKITQKEN
>PK3-045_03080 Glutamate racemase 2
MRIGFFDSGIGGMSVLHQAVRLLPNEDYIFYADTLHVPYGEKSKEEVRDYIFSAADFLAD
QGIKALVIACNTATSIAVDDLRQKYDFPILGIEPAVKPAIQSCEGKQKKVLVLATNLTLK
EEKFHNLVRSLDQHDIVDSLALPGLVQFAENFEFREEKVIPYLEEQLASFDLRKYGTIVL
GCTHFPYFENSLRAIFPGNTNIISGSIGTAKNLKRTLEEKNLINIEGTGDITFFQSDIKI
EAQETLAKYKKLLGILDKVIS
>PK3-045_03081 Oligopeptide transport ATP-binding protein OppF
MHEPTSGETLFQGIPVNRLTKKELKMLRRHMQIIFQDPYASLNPRFKVLDIIGQALDIHQ
LYKDPHLRLKRVEELLELVGLEASHAYRYPHEFSGGQRQRIGIARALAVEPSFIVCDEPL
SALDVSIQAQIVKLLEELQQKLGLTYLFIAHDLAMVKHICDRVAVMYAGKIVEIAESEEL
YSNPLHDYTKALLSAIPIPDPKIEKNKKIMNPIDNRQIKYEVENTQLKEVSTGHWVAMPV
>PK3-045_03082 Oligopeptide transport ATP-binding protein OppD
MEVVLKVDNLRVSFTSNEQELEAVRGVSFDIKKGETLGIVGESGSGKSVTARSIMRLLPS
PSSHLKSGDITFLGENLAEKTEKEMEGIRGKDIGMIFQDPMTSLNPTIKVGKQIAEGISK
HQRLSKSEAKNQAMELLRLVGIRHPEERFNQYPHEFSGGMRQRVVIAMALACRPTLLIAD
EPTTALDVTIQAQILALMKEMQQRFGTSIILITHDLGVVAGMCDRVVVMKEGEIVETGTT
EDIFEQPKHVYTKKLLNALPRLDEKKKVKRKVSITSEALVHPILEVNSLNKILILARGR
>PK3-045_03083 hypothetical protein
MEPVHVKSSKVKNRTRSVRTLVQESFIKLQKRPDYRWAIYILGLPVTLFALFLYLFKKQN
DPSKKFIEEIEEQLRKEGHWESLHKKFRLQLEKKIQFFNQAHTPSELDKVARKWANEQYQ
TDIMERSKEKMLALGNKKVTFSETFLAFITNKKIISLLFLPGLLMYVFLLICINPYLKFI
LERLIMSIFVIFGVTLLVFTILYFSPFDPAVNILGETATKDQIANFNHIYGLDQSYFHQL
IQAFKGIFTFDLGNSYTGNEEVVNSIARKFPITFTLAFISLIMAILIAIPIGIISATKPN
SIFDYSFMFIALIGLSIPNFWQGLIFILNFSIKLKWFPATYVPDNWISIIMPAVVLGTGL
TASIARMMRSSTLEIINEDYIITAKAKGLSKSTVIWRHAVTNAMIPVITVIGLLFGGMLG
GAAVTEKVFNISGIGSFIVDKQFIPDIPSILGGVVYIAITISLVNLLIDVLYAFFDPRIR
TKMKQY
>PK3-045_03084 hypothetical protein
MSNNTVDTPHYRRKQAQKVSLEYSQAVFSLIVSLILTVIFLINGFDYSSAAIKPFFFSAF
AAYLFVSIIQVLITWKIKQNLKQFGSIQKSTRKWGYIQLLSVLFGNVFTASSGLLLIKEK
KSIDYIFAVYMLLTQFFVIAVSALNLFKPYVADTFLLGMYILIAISFFYLYVFYFLSKKD
RSTLNATKIIVLSIILFLTGLSGNLFALFLGINFLRDLRKEKLSGKAGWNTTWRKITNNA
SAMLGLFFIIFLFALSICSYLTFDKDMAMENNYAAILQTPSLAYPLGTDDFGRDLFSRII
FGARISLTVGFLSTIIPLFIGGFLGALAGYYGNRADNVIMRLLDILYAIPGILLAIVIIA
AFGSNTITLIIALSVGSIPTYARTMRANILMITNLEYIESARALGANNFTILFRHAVPNS
LAPMIVKSTLTIGSAVIATSSLSYLGLGVEPHIPEWGNILKIGSAYLESHSYLAIYPGLC
IIALVLSFNFLGDGLRDALDPKLD
>PK3-045_03085 hypothetical protein
MKKSLLAFLLVFVLVAAGCVNTKSSVEEDKGNDGKSSAKPTIEILGSSTSESDINILRDQ
LIKNGFDVKLNLQPDYASFKAQQDAGNYDVAVSSWTTVTGNPDYAVRSLFKTGGDYSILA
DEEIDTLIDKASTQSPDEYKETYKELEQKLVYDKAYIAPLYISYKAQGVNKEVLNPATVR
LAKSRAIAWETIDFKDTSKRNTDPLIVQQAISTLTSLDPIKGNDGSINTLNTNMYVRLIN
LTDDDQVTSEGSLSHNYSIADGNSEYYFLLRDDINFAQIKDKKAVDTGERVGADDVIFSL
DRAKDKNSVPDHRTYSLHEHIKTTELVTDLAELNAQEAGSGTTIKAALEKNLDKEITELV
SDKKDANNKEGKYQVVKVITTEPFPQVLNYLAHQSAGIVSKKQVESINTYDVASFDINKD
IPYGDQNTVTEGDKYNNTLFASGPYILSYKNDYEAVFLKNPAYQKGTDVEPKISTVQVRF
IADADSALSSLRNGEIHLFNGVPETKYNLVEEDSKLTLQRQESNAVTYLLFNTKNREVAN
SDDLRKAVLYSINQDDFINYYQGNKIKAVSTVSPLVETGNELNADADKVKEYLKKYHEGK
>PK3-045_03086 Protein PsiE
MQSVRANLIKFFTQLPIFLQALLNSCLFLIGITLSFLLIKETWFIFSYVAFVTEDERDYY
LFTEELLTFFLYFEFIALIIKYFDSHFHFPLRYLIYIGITAIVRLIIVEHDAPINAFWWA
LAILILIISLLLTNLRILKRDY
>PK3-045_03087 hypothetical protein
MILQMIEAFKGLSYFGIMLALTFEFVPAELVLPLAGYWVYEGDMNLYMAIFAGSIGGVLG
PLTLYALGRYGGRAAILKFKNFFLLKDEHITKSDQFFEKYGGSIAFLGRFIPLVRTAISI
PCGMAKMNIWKFIIYTYLAMLPITVMYVYLGYKLGPQWKKAGEVFGQYTNYLLIPIAIFI
IIFLFTKRKKVKVQ
>PK3-045_03088 hypothetical protein
MYLNHTEASFFFSCNNRLSECSNTSMSPSLSRLLLKSEMENLPVIGFLFLPILLNGGGKD
EKRNSS
>PK3-045_03089 hypothetical protein
MKKEIPVEFTEKVLDQRNDLTGPDDSGKASYPKRPKHVSIQESKRK
>PK3-045_03090 hypothetical protein
MELLNKNKAMENQKLLRKKLKNIEKWEKNQKGLFFWEKIGRLPFVLLDKLTPTYIQEKIH
ILLDEIAVYIDNGGQYLVDNEKTLYKVKKELSLKEDVKLEDIKHFPIDSMEQTAETFIKN
RAKNAQIQGATTGFGGIFTLAVDIPLIFGITLKTIQEVAVAYGYDPSNKEERIFMIKCMQ
FTSSDIVGKRAILNELTNASKEEGFAQLQGWREVFASYRDNFGWKKLFQMIPVAGMIFGA
YMNKAAIKEVGEVANMLYQKRRILERIG
>PK3-045_03091 hypothetical protein
MIQTKVISEKNKKFEKHLNKALKELENHEVMDIKFAVNNDPITEEGIYTAVILYKA
>PK3-045_03092 hypothetical protein
MKRVKEVLDNKNDNYILPFFWLHGEDNDILRDYVKKIYESGIKAFIVESRPHPDFLGESW
WENMDTLMEEAKKLGMKVWLLDDSHFPTGYANGRVKNDYPQYIKKYLKIHQLDFVGPLED
ATILVNRGNTKQLFSKEKEYIPDKLLKIIAAKRTGNSSFDSTSFIDITNFEINGILNWSI
PEGQWRIFVLMETIDGGEPQTEGYLNPLESQATQILIDEVYQPHYKRYQSEFGKTFAGFF
SDEPRFGNMHGAEGSIGRKEMVYPWREGMLEEFFLDDYVFLPLLEPIESDGKEKEVRLKY
MDIVSKEYSNNFTGVLAEWCQKRNVEYIGHLIEDNNSHARLGYGAGHFFRAIKPQDMSGI
DVVLNQIMPGMDKNINKSITKMGWDGEFFHYGLAKMGASLGQLDRKKGGRTICEVFGAYG
WAEGLSLMKFIVDHMLVRGVNHFIPHAFSPKTFPDPDCPPHFYANGHDPEFRYMYILNNY
INRISHLFNGGKHIAKVGILYHAEAEWLGNYMLFQEPARVLMQHQIDFDIIPIDYVMESK
ITNNEFLINNNEFHTLIIPYAESLPLSFMEKVEAMSKNGINIYFVNNYPLYSEKNQRLDE
SFFSGTNKVNLESLGEELKIKGTELIVSEYQPYLRYYHYEHIDGNLYMFFNEDPYQEINT
VAELNSEKVLLKYDGFNNELLSYDQFNKEGKKQIPIQLQPNESLILVDSNKFEGMITKNV
NQLEGKETILQLKWKVEFCTALEYPTFGNLQELNNLININKLPGLENFSGNFKYTSTFNS
IDLTGDRFILDLGIVNEIAEVKLNGELVGIKICTPYSFEITDYLQKGINHLEIVVVDNLG
KQEQDFFSQFIPMKPSGLLGPVKVIEYKGNYS
>PK3-045_03093 Lichenan permease IIC component
MNNLEKILGPASNWINNNRIIQSISKGLMSLMSVLILGSFATIFQNLPIEAYQSFLTTSG
LGGIFTTLSNITINLLALYAAFSIAYTYVGNFSDYDSFTGGLLGLLAFLLVTPLTTTGEG
FMAITNLPLEWLGAKGIFVAMFCAIVSAIIYIKLSDKGLIVKLPDSVPEFVAKSFNGIIP
SVLIGILFGAITLGLSHTEFENFHNAVYTLIGSPLSVIGTSIWAGIIIYVLTGLCWFLGI
HGIAVVSVIMPVWIAADAENMAAVAAGQVGPNIITYNWINAVSSPGGAGATIGLVICVLL
FAKSSRYKIFGKVATIPSLFNINEPVVFGFPMMLNPILFIPFVFTPVLFIIIGYILTSMG
ILPMPTGAGGPGGTPLIIQGLMMGGWKYAVFQLIATIVSTLIYFPFFKVLDKKAVEEEMK
SNDVKISV
>PK3-045_03094 PTS system cellobiose-specific EIIB component
MRKIILLCSAGMSTSILTRNMRQEAEKMNYKCTIDAYALSEAVNVANDADFILLGPQVRY
QLNTIVQKFQHCPVEAINATDYGMVNGKKIMEYVKNVLGD
>PK3-045_03095 PTS system cellobiose-specific EIIB component
MKKILLVCAAGMSTSLLVRKMEQAAKEKNEEIIICATGQGEVKKNIRDTDILLLGPQVSY
KEDSFIKEYGGVKGIPVKVINTVDYGMMDGKKVLEWALSLINK
>PK3-045_03096 Lichenan-specific phosphotransferase enzyme IIA component
MENQEIIMGIIIYGGNARSCAMRAIVEAKNAHFEEAEKLMEEAREELNKAHRIQTDLIQA
EARGESSEVSLLMVHAQDHLMNAMTVRDLSIEIIELTKKTINL
>PK3-045_03097 putative licABCH operon regulator
MNARQQQILKALISEKKPISGEQIASIIQVSSRTIRNDLREIDNQLMNAGANIVSVRSRG
YQLEVCDECKFKQFISQFIEFEKNVPVEPEDRVHYLLKKFLLRQNYFKVEDLADELFVSK
STLKNDLKDVKVILQQFNLKLAQKAKYGLRLAGSERNIRFAISELLFRRPSIIEEKLKRQ
SWLLPEDSMELIRETALRELKAFDLNLSDIALHNLVVHIAIACQRIKSKQYVDSLNEVEE
NIQNKKEYIVSKRIIKSMEKMLNLEFPRGEIVYVTMHLLGNRLLLNKNQPELLNSFNYNI
IETVKRMISNVEEQMSLNIGNDKELLVAISLHLKPALHRVKYQMNIYNPMLEAIKVNYPI
AFEAAIIAGKVIEEDFDIVINENEIGYIALHFGAAIERSKLKIKPKRCLIVCTTGHGSSQ
LLLYKMRAKFGNKISIIGTTELYNLSMYEEDDIDFIVSTVQLPSTIKIPHVVVSTLLGTS
ELTEVEQMIGDTQESIINKYLVEELIYAHLSCKTPEEIITYLGEELIKKKMTEEGIVETI
MDREQVASTSYGNLVAIPHPLEAKSPHTFWTIATLEKPIDWGKHKVQLVCLLHVADDNKE
ELKPMYDTLFRFIDDRDIVQKIINALDSCTIMKLIKEM
>PK3-045_03098 hypothetical protein
MENNRDIMESSSSHHEHHHHHHKKDHDHYKHKFHPKCHKHLFEFIQIETRDGEVHQGILH
SYDDENVYLLVTGHNQSEDSRLIFPFRRFGLFAFPFFGIRRFGPFFPLWW
>PK3-045_03099 hypothetical protein
MNNCKLNYSKKVVIVLNKIIENLDIHAKGIWVPIVWAVLLLIMVLFMPKEKMNGLQIYCT
YGVISAITWIANSVFAIYLDWVNFGRGESTGIGELLTYALIPSSLAIWFLNKLHRDKRMK
RTLLFALLSLFIEWTCHISGFMEYKGWNLLYSIPVYIIIYYFFLPFHYRLIKDIKVS
>PK3-045_03100 DNA mismatch repair protein MutL
MAKIIQLDDALSNKIAAGEVVERPASVVKELVENSIDAKSTSIEIFIEEAGLQSIRILDN
GQGIDEEDVLTAFSRHATSKIKDENDLFRIRTLGFRGEALPSIASVSQVTLTTSTGEKGT
TVELKGGHLVKQEGAPGRRGTEIIVSDLFFNTPARLKYMKSIHTELGNITDIVNRLALAH
PDISFRLVHNDRKLLHTNGNGDVRQVLAGIYGLNIAKKMIPISASTLDFKLSGYMALPEI
TRASRNYISTMINGRFIKNYSLVRSIQEGYHTLLPIGRYPIVLLNVEMDPILVDVNVHPS
KMEVRFSKEQELYELVSNTIKSAFKKKELIPAGLIREKKPAPKEEQAAFSFDTIRESAMP
VSVPKMEPTFSNPTTEQVEKPSWSEPLEDTPSSWPSGESEEESTITDGTAFFFGQEGNSS
IPPATEEEIEETWEEEEIADVAEGPRVPPLYPIGQMHGTYIFAQNERGLYIIDQHAAQER
IKYEFFREKVGEVHKELQEMLIPLTLDYSLDEWMKIEENKAELEKVGVFLEPFGQQSYLV
RSHPQWFPKGEEKETIEEMIEQVLSMRKVDIKLLREEAAIMMSCKGSIKANRHLRNDEIQ
SLLDELRTTSDPFTCPHGRPIIVHYSTYEMEKMFKRVM
>PK3-045_03101 DNA mismatch repair protein MutS
MTTYTPMIQQYLQVKADYQDAFLFFRLGDFYEMFFDDAIKASQELEITLTSREGGGAERI
PMCGVPHHSAANYIEQLVERGYKVAICEQTEDPKQAKGVVKREVVQLITPGTMMEGKNLS
DKENNYIATISLFAEEQFGFAYSDLSTGESKATLLKGIDSLLNELSLSGAKEVVISDDFS
KEYQKRLQERGTLTLSIENELDEKDVHLPLLQGIQEQQLRNTVVRLFNYLYRTQKRSLDH
LQPVSTYVIDQFMKIDYFSKRNLELTETIRSKGKKGSLLWLLDETKTAMGGRLLKQWIDR
PLLNKEEIEYRQNLVETMIGHYFERQDLREKLKEVYDLERLAGRVAFGNVNARDLVQLKK
SLQQVPIIQQIVASFGSKEAIKLAEDLDPCEDITDLLERAIVENPPLSIKEGNIILDGYH
PELDSYRDASRNGKTWIAQLEREEREKTGIKSLKIGYNRVFGYYIEVTRANVHLLQEGQY
ERKQTLANAERYITPELKEKESLILQAEEKMVELEYEIFTTIRETIKEYIPRLQNLAKTV
STLDVLQCFATVSEDRRYVKPVFSNDRTLSVKNGRHPVVEKVMNAQSYVANDCTMHKDRE
LLLITGPNMSGKSTYMRQIALTSILAQIGCFVPADDAVLPLFDQVFTRIGAADDLISGQS
TFMVEMLEARNALLHATNNSLILFDEIGRGTSTYDGMALAQAIIEYIHHEVGAKTLFSTH
YHELTVLADELPSLSNVHVSAMEQNGKVVFLHKIKEGAADKSYGIHVAQLAELPEALIER
AQELLTSLEQKDQFAGETAVAVIEKPVVKAEIAEEEAQLSFFETEEKKPQKAISTKEKQI
VNKLKDLDILEMTPMQALNTLYELHKKVRNDR
>PK3-045_03102 hypothetical protein
MKRILSILLTIVLMVSFMPHSRAEAKTKVKTYKNCTALNKDYKGGVAKSKSTKNKGGKTK
YKPYVSKALYNANKKMDRDKDGIACER
>PK3-045_03103 Spore coat protein E
MGEYREIITKAVVAKGRKFTKSNHTICPDNSPSSILGCWIINHTYEAEKVGKTVEICGYF
DINVWYSYNDNTQTEVVTERVKYTDVIKLKYRDPDCLEDHDVIARVLQQPNCIEAVISPN
GNKIIVHVEKEFIVEVIGETKICVEVCTDECGNEDDDAWFKDEVEDEEFEELNPDFLVGG
EEE
>PK3-045_03104 hypothetical protein
MAGLFNKNDQFDFKFNVNGKEVTGEDRAKYAQELITKLSSEMGGLVQKLTKGVSENVAGT
TMDAMKEKVASTVDLDSIKEKVKPHLNPETLKSIVSEDTLSKLQEKLPVIDASNDDGNLK
LNVNGKPIFSLDLSDFIKK
>PK3-045_03105 hypothetical protein
MLSKCTSDCHKGNGSGVAGTDVTAKGKGIGNKGAELRGFTNATQGNGNLANQFSASGAAG
GAAVGVNLLNFFVGGILVNANVAGAATAVSFNQNSPEMVNEG
>PK3-045_03106 hypothetical protein
MAKDKNIGLTAEKLKELGVPEELIDKILETGGPSVNTHAEGGNGGSAVSLTYVDNYSVLF
LVYTFLLQTVNNGNAKDKETKQLNKALLSTLQTAMKEQQEYRKAFLRAINILNNQNK
>PK3-045_03107 putative protein YmcA
MAKFTREEIIERTEQLAKMIRETEEVEFYQRAEKQINQNQKVNDRIAQIKKLQKQAVNLQ
HYGKIAALKDTEAKIDVLQKEIDELPIVSEFKESQEIVNDMLQMVTKTIADTVETEILSS
VEKKKEQ
>PK3-045_03108 tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase
MNENQRLEGQQIGSNNSSDKKSEKDYSKYFETVYKAPSLKDAKRRGKEEVRYEKDFSISE
QFRGMGEGRKFYIRTYGCQMNEHDTEVMAGIFLALGYEATDSVDDANVILLNTCAIRENA
ENKVFGELGHLKHLKTEKPDLLIGVCGCMSQEESVVNKILKTYTQVDMIFGTHNIHRLPN
ILHEAYMSKEMVVEVWSKEGDVIENLPKVRNGKIKAWVNIMYGCDKFCTYCIVPYTRGKE
RSRRPEDIIQEVRHLAAQGYKEITLLGQNVNAYGKDFTDIDFRFGDLMEEMRKIDIPRVR
FTTSHPRDFDDHLIEVLAKGGNLVEHIHLPVQSGSSDVLKIMARKYTREQYLELVRKMKA
AIPNLTLTTDIIVGYPNETDEQFEETLSLYKEVGFEAAYTFIYSPREGTPAARMKDNVPM
EVKKERLQRLNALVNEYSANSMKNYQGQTVEVLVEGESKNNPDVLAGYTRKNKLVNFVGP
KSAIGKLVSVKITDAKTWSLNGEMIEVLEAEAVEAN
>PK3-045_03109 hypothetical protein
MSYFDGHCDVLYKMFIDKTINFQNSDKLHVTKSNLQKGGAKIQCFAIYVPESVHPDMRFE
AALSMATIFYDKILQPNADLKFIRSQKDIKELKNGEIGALLTLEGCDAIGGDLLKLKTLL
RLGVSAVGLTWNYANAVADGALEPRGAGLSLFGRETVKLLNKQAIWVDVSHLSENAFWDV
MEHAEYPYASHSNTYNLCPNPRNLRDDQIKAMIEADSVIGITFVPQFLSGTNTATITDIL
RHLDYICSLGGEDHVGFGSDFDGIDQTVKGLASAVDYPNLINELTRYYTSTQVEKFLYTN
MTKRFPK
>PK3-045_03110 Stage V sporulation protein S
MEILKVSAKSSPNSVAGALAGVLRERGGAEIQAIGAGALNQAVKAVAIARGFVAPSGVDL
ICIPAFTDIVIDGEERTAIKLIVEPR
>PK3-045_03111 2',3'-cyclic-nucleotide 2'-phosphodiesterase
MHILFVGDVVGSMGRDMIKEYVPKLKEKYRPQMTIINGENAAGGKGITEKIYRSFLEIGA
QAITMGNHTWDNREIFEFIDQAKYLVRPANFPENNPGKGMVFVKINDIEVAVINLQGRTF
MNPSDDPFIVIDGLVEEAKKRTDIIFVDFHGEATSEKQAMGWYLDGKVTAVVGTHTHVQT
ADNRILPNGTAFMADVGMTGPYDAILGMQKELVLNRFLTNLPTRFEPPKSGRAQLSGCLI
EVDKKTGKAKKIERILINDDHPFFS
>PK3-045_03112 Ribonuclease Y
MMDLIKIISILLILIVIAVVGFVVYFIRKSNANAKISNATLTAEQIMENAKREADALKKE
ALLEAKDEIHKLRSEAELEVRDRRNELQKQENRLLQKEENLDRKGEALDKRESVLEKRDD
SLNKRQQHMEEMESKVDEMVRKQQTELERISGLTREEAKSIILERTEQEVAHDIAIMIKE
SDTRAKEEADKKAKEILSLAIQRCAADHVAETTVSVVNLPNDEMKGRIIGREGRNIRTLE
TLTGIDLIIDDTPEAVILSGFDPIRRETARLALDKLVQDGRIHPARIEEMVDKARREVDE
HIREIGEQTTFEVGVHGLHPDLIKILGRLKFRTSYGQNVLKHSMEVAQLSGILAAELGED
QTLARRAGLLHDIGKAIDHEVEGSHVEIGVELATKYKEHPVVINSIASHHGDTEPTSIIA
VLVAAADALSAARPGARRETLENYIRRLEKLEEISESYDGVEKSFAIQAGREIRIMVKPD
LVDDLESHRLARDIRKKIEEELDYPGHIKVTVIRETRAVEYAK
>PK3-045_03113 Protein RecA
MSDRQAALEMALKQIEKQFGKGSIMKLGEQADRVISTSPSGSLALDAALGVGGYPRGRIV
EIYGPESSGKTTVALHAIAEVQANGGQAAFIDAEHALDPVYAQKLGVNIDELLLSQPDTG
EQALEIAEALVRSGAVDILVIDSVAALVPKAEIEGEMGDSHVGLQARLMSQALRKLSGAI
NKSKTIAIFINQIREKVGVMFGNPETTPGGRALKFYSSVRLEVRRAETLKQGTDMVGNKT
KIKVVKNKVAPPFKVAEVDIMYGEGISKEGEIIDLGSELDIVQKSGAWYSYNDERLGQGR
ENAKQFLKENPEMRLEIQKKIRDHYGLDKEVTLKPENDENEQFELID
>PK3-045_03114 Putative competence-damage inducible protein
MNAEIIAVGSELLLGQIANTNAQFISKHLADLGVNVYYHTVVGDNAARLEEAIKVAESRA
QLLIFSGGLGPTKDDLTKETIAKHIGKELVFDKTALDSIEDYFVKTKRTMTENNKKQALV
LEGSDVLPNDHGMAPGMFLKKDSRFYMLLPGPPKEIQPMFVKYGFPAIQKQMTSKDVIVS
RVLRFFGIGESLLETKIEDLIDAQTNPTIAPLAGDGEVTLRITCKHDSIEEADKLIVKTE
EEIFARVGEFFYGYEDTTLMNELSHILLKKNLTVAAAESLTGGLFQQEITGIPGAGNIFK
GGIVCYTNEVKHQILQVKESTIKEHGVVSEQCAKELAENVARLLKADIGISFTGVAGPNE
LEGNPVGTVYIGIAKSGEPTKVEKLALSGTRAGNRVRSVRYGQYFLLKMLEDK
>PK3-045_03115 CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase
MNLPNKITVARILLIPVFLVIMLVDFQWGELTFLGVTLPMTHFIGALIFILASTTDWIDG
HFARKYNLVTDLGKFLDPLADKLLVSSALIVLVGLQMAPAWITIVIISREFAVTGLRLIL
AGGGEVVAANMLGKIKTWAQIVAISALLLHNMIFELISLPFDILALWVALIFTIWSGWDY
FAKNKQAFVSSK
>PK3-045_03116 hypothetical protein
MSELGNRLKEAREAKGLTLEELQEITKIQVRYLVGIEEGNYSMMPGKFYTRAFIKQYAEA
VDLVPEEIFEEYKAEVPTTVNDELPQNLSRVNSRSAIDGATSKVFDILPTILIAILVLAV
AFLVWYFVYAKDSNPEKQSNSGAEQNSVYMKSDALNKKEKEKVTDKDANKEKEQVVEEEE
KKVEEEAPKQEITKKETVGKKTTYEVKNAEKFVVKLVATGKVWVDIQNGKNYSFFQGILE
KDGTESHEEDLSKETEARIVIGNSQVDVFVNDEKIDLGDSSSRQDLVIKNIKEE
>PK3-045_03117 hypothetical protein
MEQKEWYLEYEIQKNRPGLLGEISSLLGMLSINIITINGVDDGRRGLLMLAKNKEQIKRL
ESILYTMDTIKVIKLREPSLRDKLAVRHGRYIQRDADDKKTFRFVRYELGLLVDFMAELF
KTEGHKLIGIRGMPRVGKTESIVAASVCANKRWLLVSSTLLKQTIRHSLMQGEYNENNLF
IIDGIVSSKQINERHWAVVREVMRLPCIKVVEHPDAFVHNTEYTLDDFDYIIELRHEPDE
EILYDVHKKNTLALESEFEGFDF
>PK3-045_03118 putative protein YflH
MSILENWDQWKDFLADRLHHAENEGMNQEAIGDLAFQIGDYLSNQVQPKNEQEKILSDLW
SVADEKEQHAIANMMVKLVHNNGTK
>PK3-045_03119 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MGKWILITGASGGIGQAIAKQLAKEGYSLYLHYHQNEKAIKELLEVLAVNGGEYLPIQAD
LQQENDYQKILESIFTIDGIVHASGISTYGLFTDMEEGEMKALWNVHIHSLMCITKALLP
KMLSRQYGNIIVITSIWGQVGAAMEVAYSTVKGAQISFVKALSKEVAFNGIRVNAVAPGA
IETNMLQSFSPEEMQLMAEEIPMGRLGSPQEVAESVAFLLSEKSSYMTGQVLSLNGGWYV
>PK3-045_03120 hypothetical protein
MEKIEFAQLQEELYYEKLANGLKVYILPKKGFNKTFCTFTTNYGSVDNTFIPLEGSEFTQ
VPDGIAHFLEHKLFEKEDGDVFQDFSKQGASANAFTSFTRTAYLFSSTSNVANNLETLIN
FVQEPYFTEKTVEKEKGIIGQEITMYDDNPDWRLYFGLIENMYVHHPVKIDIAGTIESIS
HITKDMLYECYNTFYHPSNMLLFIVGPVDPEEYMAQIRENQSKKDYTNHSEIQRKFKEEP
AHVNKDKQVLKMNVHTSKCLVGIKGIDVEQSGKEMMKQEWSINLLLDFLFSESSENYQNL
FQEGLIDDTFSYDYTQEHGFGFAMIGGDTSDPDRLETAIKEILMKAKTTDFASETLERTK
KKKIGAFLRAINSPEYIANQFTRYAFNEMNLFDVVPAVEEITVEDIKNAANKLLAEERIT
SCQVVPK
>PK3-045_03121 hypothetical protein
MSVATEKITKYSGFQLHTVKTEKFKTNTIVMKWRTPITKENSTHRALLPYVMQNSTKKFP
TTAKLRSFIEELYGATFFIDLAKKGEYHIVSFSLEIANEKFLSDPAPLLKKGLEFLSEVI
FQPNVSESGFDQNVIDNEKRALKQRIQSIYDDKMRYSNQRVIDVMCENEPYALSVYGEKD
EVDSITPQSLYDYYTKALAEDQIDLYMVGDIKEEEVGAYIEELFPFKERTAQSIDRRKSY
ETKKVKEVREVQDIKQGKLNMGFRTNIVYGDPEYFALQVLNGIYGGFSHSKLFINVREKE
SLAYYAASRLESHKGLLLVMSGIDNNNYDKAVKIIKEQMELMKKGEFSDQEIMQTKAVIH
NQMLETLDTSRGMIELFYHNSVSDNYVEMGDWLQYMSKVSREEIIAAAKKIELDTIYFLT
GSEGNA
>PK3-045_03122 hypothetical protein
MGIKNLLILFSSVLLMLVIGLLWNNRPVYGNDEASITKLIMKSDLLQEKTNIKIIDIFDI
EKTRIAAFTNGEGQGIIKFEKDSKGNYTYLMELLPTLFR
>PK3-045_03123 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase
MPKLVLIRHGESLWNVENRFTGWTDIELSEKGLTEAREAGIILHHNGYTFDIAYTSYLKR
AIRTLWIILDEMDSMWIPIHKTWKLNERHYGALQGLNKKETADQYGLDQVQKWRRSMDIR
PPALNKDDPRYNIDDPRYQQLEEGDFPLTESLADTEKRVLTFWDQEIAPMLRNNKKIIIA
AHGNTIRAIIHYLDNVSPDGIASLNIPTSIPLVYELDDNSLNPMRHYYLDMNGEVPADVI
PKHIPIELLDKEFKTKAINTHEE
>PK3-045_03124 putative riboflavin import permease protein RfuD
MGLMDVLLIVIPSSLLFAAPLIFTALGGNFSERAGVVNIGLEGLMVMGAFSSIVFNLTFA
DSLGAWTPWVSLLVAMVVGALFSILHAVASITFRADQTVSGVAINLLAAGLAMFLVKLIY
DGKGQTGTIRYSFKKIDIPLLKDIPVIGDLFFSNTYWTSYLAIVVAIIVWFVMYKTPFGL
RLRSVGEHPMAADTMGINVTKMRYVAVILSGAFGGIGGGVFAQSITNDFTHATISGQGFM
ALAALIFGKWNPLGAMGAAIFFGFAQSLSIVGSSLPFLENIPSVYLLIAPYVLTIVALTG
FIGRADAPKASGVPYIKGSR
>PK3-045_03125 hypothetical protein
MSNTIKKISIPIIAVLLGVIVGTIIMFATGYNPADAYTALWNGAFGDIYFTGEVVRQITP
LILAGLAVAFAFRTGLFNIGVEGQLIVGWLAAVWVGISFDLPKIIHLPLAVLAAAAAGAL
WAFVPGFLKARFRVHEVIVSIMMNYVALHVSNYLIRNVLTDKADRTENIAPTASLRSGFL
ESLTDYSRMHWGILIAIGCAILMWIILEKTVKGYELKAVGFNQNASQYAGMNVNRNIILS
MVISGAFAGLAGAMEGLGTFEYVSNKGGFTGVGFDGIAVALLGANGPVGILLAACLFGFL
KVGALNMPLEAGVPNEMVDIIIALIVFFVASSYMIRLFLERLSKNKSKKGEK
>PK3-045_03126 Galactose/methyl galactoside import ATP-binding protein MglA
MEYVIEMLNIRKEFPGIVANNNITLQVKKGEIHALLGENGAGKSTLMNVLFGLYQPEKGE
IRARGKVVNISNPNIANDLGIGMVHQHFMLIDTFTVTENIILGKETVSKGKIDLKKAERE
VQEISERYGLAVDPKAKIANISVGMQQRVEILKTLYRGAEILIFDEPTAVLTPQEIAELI
GIFRKLIQEGKSIILITHKLKEIMEVCDRVTVIRKGEGIGTYNVKDTNPNELANLMVGRE
VSFKTEKKAPNPKETVLKISDLTVKDSRGVHVVNSLNLDVKAGEIVGIAGVDGNGQSELI
EAITGLMKKNSGSITLNGKEISVLSPRKITESGIGHIPQDRHKHGLVLDFSIGQNMALQT
YYKTPFSKYGFLNQGEIEKKASKLIEEFDVRTPSIHTPARALSGGNQQKAIIGREVDRDP
DLLIAAQPTRGLDVGAIEFIHRRLIEQRDKGKAVLLISFELDEILNVSDRIAVIFDGEII
ATVDPKTTTEQELGLLMAGSKAKKVGVENNV
>PK3-045_03127 Membrane lipoprotein TmpC
MKKRKFGLALSLVLAAGTVLSACGSNDKDNDKAADGNKEKDSFKVAMVTDVGGVDDKSFN
QSAWEGLQAFGKENGLSKGNGIDYQQSQSDSDYATNLNNLSRQGYNLVFGIGFLMEGAIS
EISQQQKDAHFAIVDAVVDQPNVASITFKEQEASFLAGVAAAHATESKKIGFIGGVEGDV
IGRFEAGFVDGVKAVDPNIKVDVQYAGAFDKPELGKTIASKMYSSGADVVFHASGGTGAG
LFSEARDLKEKDPSKYIWAIGVDSDQVAEGVVGDHNIVLTSALKGVSTAVQDISTKAKDG
KFPGGETTVYGLKEDGVGLAPINEEVKKKAEIDAAVKEWTAKIKNGEYTVPDTVK
>PK3-045_03128 HTH-type transcriptional repressor NagR
MLIKSDTRHLYLQVVDRLKKDIELGIYKEKEKFPSEFELAKTLGVSRATLREALRTLEEE
NVIVRRHGVGTFVNCKPLFNSGIEQLNSVTNMIKQAGMNPGTIFLSSNTMFATEEDSTRF
SASQGEEMLVIERVRTANGEPVVYCMDKLPQKILPERFSYDQESIFQFLESDSQRHITYA
VAQIEPIGYHDKVSPILQCEPETALLVLKQMHYDEKDEPILYSVNYFRSDKFSFQVLRKR
IYS
>PK3-045_03129 DNA translocase SpoIIIE
MAKRKKRKTRKKQHLKLTIQYELVALLLMALSFISILQLGAVGKTMVSFFRFFFGEWYML
CLIGLIVYSGYLMWKREKPYMFHTKLNGIYLIVSAILLLSHVTLFKLLASQGAFQNPSVI
LNTWELFWMEVKKEATNVDLGGGMIGAVLFALFHYLFDTVGTQIISFIVIIIGFILLTGK
TLSGAFKKVISSIWSFFQDQWEAFKQDMKDWKESIQKNKEKRKAEKQARRENQQSEENTN
ASIIVNTPPQEDEPYIQEPIINTFAERAYQEEAIQEDLMADSPEEQTDLGDVVPITFTEV
ENKDYELPPLKLLKLPRKADQSGEYEQIHANAAKLERTFHSFGVKARVTEVHLGPAVTKY
EVHPSEGVKVSKIVNLSDDLALALAAKDIRIEAPIPGKSAIGIEVPNSEVAVVSLREVLE
SSKNDKPDSKLMIAFGRDITGEAVCAELNKMPHLLVAGATGSGKSVCINGIITSILMRAK
PHEVKLMMIDPKMVELNVYNGVPHLLAPVVTNPKKASQALMKVVSEMERRYDLFSHTGTR
NIEGYNEYIKRINAEEQEKQPLLPFIVVIVDELADLMMVASSDVEDAITRLAQMARAAGI
HLIIATQRPSVDVITGVIKANIPSRIAFAVSSQTDSRTILDMGGAEKLLGRGDMLFFPYG
ASKPVRVQGAFLSDEEVEEVVDFVIGQQKAQYQEEMIPDEIVEVTGAVEDELYHEAVELI
VEMQTASVSMLQRRFRIGYTRAARLIDEMEARGVVGPYEGSKPRTVLVPKGSEEINMQ
>PK3-045_03130 hypothetical protein
MSGESAKVGRISAKLSGESAKVGRISAKLSGESAKVDRISAKLSGESAKVGRISAKLSGE
SAKVGRISAKLSGESAKVGRISAKLSGESAKVGRISAKLSGESAKVGRISAKLSGESAKV
DSKSAKRAKYQPKHTTNQPNQKAYLFL
>PK3-045_03131 hypothetical protein
MIMYTMMPEELIFPMSQDIYEKHQVIHYNGIPLLVARNESNEYEVIRILSTDPNHFLQTD
MQPGAKIPTL
>PK3-045_03132 Translocation-enhancing protein TepA
MVSVNNNNQPDEKPNEDKPSSLMEKIQQLGQTNVPQLSQDSKIHCLTIVGQIEGHLQLPP
QNKTTKYEHLIPQIVAIEQNPKIEGVLVILNTVGGDVEAGLAISEMLASLSKPTVSLVLG
GGHSIGVPIAVSCDYSYIAETATMTIHPIRLTGLVIGVPQTFEYLDKMQERVVNFVTKHS
KITEENFKDLMFAKGNLTRDIGTNVIGNDAVTSGLIDSVGGVGDAMKKLNELIDVNKEQN
EGIIQ
>PK3-045_03133 Ribonuclease J2
MKNDKIKLVALGGVGENGKNMFVVEVDEDIFVIDAGLMYPQNEMLGIDIVIPDIAYLKQN
KEKVKGIFLTHAHEDHIGGLSYILRDLDVPVYTTLLTAELTKEKMKEQDFKGQAQFEIVT
SKSVLTFASSKVSFFKTNHSIPDSIGIVIHTSEGAIVHTGDFKFDQTASDLYKPDYGEMA
KIGEEGVLALLSDSTNADKPGYSTTDFVVTQSLIEAFLHTKGRIIAACFATDLNRIQHII
DAAEKTNRKVAIIGKNLQRVLQIALKHNYLDVDEETIVTYNELQGYTQDQMVIITTGTKG
EPIEALQKMVKKNHKQVSIMEGDTVLFAASSFLGSEVFVGKTIDKLYRAGATLLAGYKTF
NSSNHGSQEELKFMINMMKPKFFLPIHGEYRVLKAHEKIAIECGVPPQNIYLPEQGEVLE
FKEDTLRVGGKIPAGNVLIDGSGVGDVGNIVLRDRKLLSQDGILTVVVTLNKAERKISAG
PEIITRGFVYVRESEKLLEEAADRVRDIVEKSISKDSFDWTGIKQDIRDTLNQFLYEKTR
RRPMILPIIMEVKPVRR
>PK3-045_03134 putative amino acid permease YvbW
MAKNQLQKNLLPRHISLMAMGGAIGTGIFKGSGETVSIAGPGVIFTYIFAGLLLLVVMGS
IAEMAIVYPNTNMKGFIGKAFGNQTAFVIGWMYCILWLAVCVIEVVVAGSFLQFWLPDVP
LWILSILCAVGLIVVNTMNVKNYGEFEFWFAGIKIGMIIIFIILGAAVLFELIPSGQTNY
LQNYTEHGGFFPNGWTSVFSALLIVMFSYGGSELIGVSVTETKNAEKVLPKVIKSFIFRI
VLFYTLPILIICGLIPWNELTEESSPFVQVLSISGLSGAAHIMNFVLIIAVLSAANSGIY
GCTRMMYSLSTEGEGPKAFSRVNHNGVPIYSLMVTGIILIAGSMIALFKQDQVFSLLMAF
PGFVVSVVWIMICLAQLKLRKQYPLQPSFKIWGYPYIPIFTVTCLGIISISFLFDEANRI
SILACLICFFAVIAISIFKFKSNKR
>PK3-045_03135 4-hydroxy-tetrahydrodipicolinate synthase
MGLFGRVSTAMITPFDAKGHIDFPKTTQLINHLLENGTDSLVVAGTTGESPTLSKQEKIA
LFKHVVKVVEKRVPIIAGTGSYNTYESIELTKQAELAGVDAVMVVGPYYNKPNQEGLYQH
IKAVAESTKLPVMIYNIPGRSVVNIEPETIIRLSEIDNIVAVKEASGNLNNITKIIASTP
ADFYVYSGDDSLTLPLLSVGATGVISVASHIIGKEMKEMVTSFLDGKVEEASKMHQQLLP
LMLILFKAPNPVPVKTALQLRGFDVGSVRLPLVPLTEEERIELAKFI
>PK3-045_03136 Aspartokinase 2
MKIMVQKFGGTSVRDEKSRIQAKDHIKDALNEGYKVVVIVSAMGRKGEPYATDTLLSLVG
GSESSISRRENDLLMSCGEIISSVVFTQLLLENQISATALTGAQAGFKTNNDFTNARIME
MDCSRVLEELKNHDVVVVAGFQGAAPNGDTTTLGRGGSDTSAAALGSALQAEYIDIFTDV
EGIMTADPRIAENARPLSVVTYSEVCNMAYQGAKVIHPRAVEIAMQAKVPIRIRSTYSKG
TGTLVTSSNAESRGSDIKERPVTGIAHVANVTQIKVFAKKDQYDLQSQVFKAMANEEISV
DFINISPNSVVYTVTNEMTNKAIAVLENMGYEPVIEKECAKVSVVGAGMAGVPGVTFKIV
TALSNKGIRILQSADSHATIWVLVKQDDLVSAVNVLHDAFELEKEIE
>PK3-045_03137 Aspartate-semialdehyde dehydrogenase
MEQLKGFNVAVVGATGAVGQQMIKTLESRDFPISTLTLLSSKRSAGTKVQYKDKEIVVQE
ATPESFKGIDIALFSAGGGVSKELAPHAVRHGAIVVDNTSAFRMDKDVPLVVPEVNEEDL
REHNGIIANPNCSTIQMVVALQPLKEKFGLSKVLVSTYQAVSGSGAAAVEELNSQTQAIL
NKEAFEPKILPVKSDKKHYQIAFNAVPQIDVFTDNGFTYEEMKMINETKKIMHADDLKVA
ATCVRIPVETGHSESVYFELDNDQVSVEEIKSLLADAPGIVLQDDPSNQVYPMPADCVGS
NDVFVGRIRQDLDVKNGFHMWVVSDNLLKGAAWNSVQIAESLIKLGLV
>PK3-045_03138 Dipicolinate synthase subunit B
MSLQGKRIGFGISGSHCTYEEVVPQVEKLVAQGAEVVPVVTGNVKNTDTRFGKGKDWVSK
IEEITGQKIIDSIVAAEPLGPKAPLDCMVIAPLTGNSMSKFANAMTDNAVLMAAKATLRN
QKPVVLGISTNDALGLNGINLMRLMATKNIFFIPFGQDDPEKKPNSMVARMSMLAETIEA
ALEYKQIQPVIVEKYLD
>PK3-045_03139 Dipicolinate synthase subunit A
MLKGMEIAIIGGDARQLEIVRKLTEQQAILSLIGFEQLDHAFTGATKEKIDNVDFSKIDA
IILPVRGTDLNGQVDTIFSNEKVFLTKKIVEKTPEHCIIYSGITNDYLNLLIKETNRSLV
QLFNRDDVAILNSIPTVEGTIMMAIQHTDTTIHGSNVIVLGLGRVGMSVARTFHALGAKV
KVAASQSEHIARIIEMGLIPVHLDDLQIAVDDIDICINTIPHLVVTSDVIEKMPLHTLVI
DLASKPGGTDFQYAEKRGVKALLAPSLPGIVAPKTAGNILADVLAQLLDEQ
>PK3-045_03140 putative zinc protease
MIKRYTCQNGVRIVLENIPTVRSVAIGVWIGTGSRKEDEKNNGVSHFLEHMFFKGTKTRS
AREIAESFDSIGGQVNAFTSKEYTCYYAKVLDTHADMALEVLADMYFNSTFDEEELKKEK
NVVCEEIKMYDDTPDDIVHDLLSQAIYDKHPLGYPILGTEETLATFNGDTLREYMFNHYT
PENTVISIAGNITEAFISEVEKYFGSFEAGKSEIELVKPSFHANNFSRKKETEQAHLCLG
FNGLQVGHDKMYTLVSLNNILGGSMSSRLFQDVREEKGLAYSVFSYHSAYQDSGIVTIYG
GTGAKQLDELFDTIQNTLALLKKEGITEKELLNSKEQLKGSLMLSLESTNSRMSRNGKNE
LLLGKHRSLDDIIADIDRVTKEEVDQMANDIFTDTFSVSLISPDGQLPKALQ
>PK3-045_03141 hypothetical protein
MKKTVSLIGILAISWFLVNNPWADTYVSTLQENAVSVTATNSLYTTISEKAKDYEKKPID
AKLDPVWKAIPGLNGVTVDIDASYKNMKKEKKFNEQRLVFKQVKPKITLNDLPPAPIYKG
NPEKEMVSFIINVAWGNEFLPDILSTLKKHHVKASFFLEGRWVQKNPDLAKMIAEAGHEL
GNHSYTHPDMSKISSSKIHEEIVKTNDVIEATTGKQVTLLAPPSGYFNNEVVKIAAQQKL
KTVIWSVDTIDWQKPSPDTLLKRVTGKIHNGALILMHPTEVTTNSLEHLIIEIKNKGYKI
DSVSDMLSEERESIKTKK
>PK3-045_03142 Polyribonucleotide nucleotidyltransferase
MGQDKHVYSIDWAGRKLTVEIGQLAKQANGAVLVRYGDTAVLSTATASKEPKNLDFFPLT
VNYEERLYAVGKIPGGFIKREGRPSERAILASRLIDRPIRPLFADGFRNEVQVVSLVMSV
DQDCTSEMAAMFGSSLALSVSDIPFGGPIAGVYVGRIDGKFVINPTVEQAEKSDINLAVA
GTKDAINMVEAGADEVPEEVMLEAIMFGHDEIKRLIAFQEKIAAEIGKEKMEVVLYELNK
DIEADVRALCESEMLDAIRVQEKHAREAAIKEVKDSVIAKYEAEEAEEEDLKQVKAILDK
LVKNEVRRLITEDKVRPDGRGLEEIRPLSSEVHLLPRTHGSGLFTRGQTQALSICTLGAL
GDVQILDGLGVEEEKRFMHHYNFPNFSVGETGPMRGPGRREIGHGALGERALEPIIPSEK
DFPYTIRLVSEVLESNGSTSQASICASTLAMMDAGVPIKAPVAGIAMGLIKSGEHYSILT
DIQGMEDHLGDMDFKVAGTSKGVTALQMDIKIDGLSREILEEALQQAKIGRMQILESMLA
TINTPRESLSSYAPKILMMSINPDKIRDVIGPSGKQINKIIEETGVKIDIEQDGTVFISS
VDDEMNNKAKQIIEDIVREVVVGQMYLGKVKRIEKFGAFVEIFNGKDGLVHISELAEERI
GKVEDVVAIGDEILVKVTEIDKQGRVNLSRKAVLKEQKEQAENAKN
>PK3-045_03143 30S ribosomal protein S15
MAITQERKNELINEYKTHENDTGSPEVQIAVLTESINNLNEHLRTHKKDHHSRRGLLKMV
GRRRNLLTYLRNKDVQRYRVLINKLGLRR
>PK3-045_03144 Bifunctional riboflavin kinase/FMN adenylyltransferase
MLSFTLKESLTTNEKKRNLLEKVSSTVKIVRINHSERNKEHDNPPISIALGSFDGVHLGH
QKVIGEAKRVADENGWSSAVMTFDPHPSIVLGGKTKKVDYLTSFEAKVEQLANLGIDYLF
IVDFTIEFASLPPQEFVDLYLIDLNVKHVVAGFDYTYGKKAQGTAETLSKHSRGKYETTI
IGKETFGGEKVSSTLIRSLINNGEMEKVPALLGRHYSVNGTVIHGDKRGRTIGFPTANVK
STSDVILPPLGVYAVRFFVNEKWYEGVCNLGTKPTFQPDEKKISIEVHIFDFHQDIYGHS
VIVEWHKRIRSEQKFNGIDELVAQIEKDKQTALQYFYEKAQ
>PK3-045_03145 tRNA pseudouridine synthase B
MEGILPLWKPKGLTSHDCVFRLRKILHMKRIGHTGTLDPDVTGVLPICLGRATKVAEYIT
HAGKEYVGEVTIGYSTTTEDRSGEKVEEKKVAEIITRDRIEAILRELTGEITQTPPMYSA
VKVNGKRLYEYARQGIEINRPSRQVNIYSLDLIDEWQVLQGDTVSFRFRVSCSKGTYIRT
LAVMIGEKLGYPAHMSDLCRTRSAAFTKQECVTFEELEKYVENGKLENYIYPLEDALLHL
PKYEINDTLAMKVRNGTVLETPAYLLDEQEPIVIQTTTGEALAIYVQHPTKQGLIKPSKI
LKILE
>PK3-045_03146 Ribosome-binding factor A
MSLRPNRVGEQMKKELGEIISRKIKDPRIGFVTVTDVNVTGDLQQATVYISVLGDQEQRE
NTLKGLAKAKGFIRSEIGQRIRLRKTPEITFEFDESIDYGNRIDTLLHQIAKENPSSDDE
RK
>PK3-045_03147 hypothetical protein
MIVGLMSVECIIYDAHSLKEKRAVLQRIMTRLKQKFNISISEVGYQDTWQRTKIAVVTVA
SARVSAEGVLQQTQQFIDSFPEIERTITDIEWL
>PK3-045_03148 Translation initiation factor IF-2
MSKVRVYEYAKKYNISSKDVIAKLKEMNIEVSNHMTTLEEDTVKKLDSIYNKKNEENKPK
APAAKVAAKNIADEYEKESDEMAEKGKVNQSVKNTKDNKPGFNKPKNNNNNNKNRNNNRK
GKQNTAPAAPPAPKKEKELPEKITFSESLTVAELAKKLHREPSEIIKKLFLLGVMATINQ
ELDKDAIELICTDYGVEVEEEIQIDTTDLEVYFADEEGVELVERPSVVTIMGHVDHGKTT
LLDSIRNTKVTAGEAGGITQHIGAYQIEENGKKITFLDTPGHAAFTTMRARGAKITDITI
LVVAADDGVMPQTIEAINHAKAAEVPIIVAVNKMDKPTANPDRVMQELTEHGLVPEAWGG
DTIFVPLSALTGEGIDSLLEMILLVGEVEEYKANPDRNAVGTVIEAQLDKGKGSVATLLV
QNGTLHIGDPIVVGNTFGRVRAMVNDLGRRVKTAGPSTPVEITGLNDVPQAGDRFVVFKD
EKTARQIGEARSTQAIQAQRSEKTRISLDNLFEHMKQGEMKDINIVLKADVQGSAEALAA
ALYKIEVEGVNVKIIHTGVGAINESDITLAAASNAIVIGFNVRPDVNAKRAADAEEVDVR
LHRIIYKVIEEIEAAMKGMLDPEFQEKIIGQAEIRQTFKVSKIGTIAGSYVTDGKITRDS
GIRLIRDGVVIFEGEIDALKRFKDDAKEVAQGYECGITIKNFNDVKEGDIIEAYVMEEIE
RK
>PK3-045_03149 putative ribosomal protein YlxQ
MNDNKWMSLLGLANRARKITSGEELTVKEIRSGNAKLILLSEDASQNTTKKITDKCRSYK
VPVKLVSNREILGKAIGKEQRVVVAVLDNGFAKKLLTLLD
>PK3-045_03150 hypothetical protein
MNKPRKVPMRKCVATGEMKPKKELVRIVRSKEGIVSVDLTGKKSGRGAYLSLDKEAVLLA
KKKNILSSQLEVTVDDTVYDELLELIDKEQRQSK
>PK3-045_03151 Transcription termination/antitermination protein NusA
MSSELVDALVLLEKEKGISREVIMDAMEAALISAYRRNFNQAQNVRIDLNLGAGSMRVFA
RKEVVDEVFDPRLEISLEDAQRINPNYEVEDVVELEVTPKDFGRIAAQTAKQVVTQRVRE
AERGIIYSEFIDREEDIMTGIVQRQDSKFIYVSLGKIEAILPTNEQMPNEHYKPHDRIKV
FLTKVEKTTKGPQIFVSRTHPGLLKRLFEMEVPEIYDGTVEIKSVAREAGDRSKISVHSE
NEEVDPVGSCVGPKGTRVQTIVNELKGEKIDIVKWSSDPTVFVANALSPSKVLEVIVNEE
DKATTVIVPDYQLSLAIGKRGQNARLAAKLTGWKIDIKSESEAREAGIYPTENSLIKFDD
EVEEDDFRLNTEDFE
>PK3-045_03152 Ribosome maturation factor RimP
MSKVTEIVEEMVHPILDELHLELVDVEYVKEGPNWFLRVYIDKDTGVDIDECAVVSEKLS
EKLDEVDPISENYFLEVSSPGAERPLKKDKDFEKAIGKNVYIKTYEPIEKEKTFEGVLTA
FDGKTVTVEVKIKTRKKTIEIPYEKVAKARLAVSFS
>PK3-045_03153 DNA polymerase III PolC-type
MSDIQGKVDRFQILLQQLQLTEDSYISHFRNASIEKIVVEKRSKKWHFHFLFDDIIPFQI
YQLFTAKLKSSFSHIATITYDIRVRNGIVTDVLIRDYWSACIEEMQGISPPLLKLLNEQV
PQLNGNKLTIQVRNEMEGLAIKRKYANLITDAYQYFGFPAMSLDTEIVAEKSNSEYEQFL
LAKQKEDEERGKQALLDIQKMEAEKEAGDSPIPSGPLTIGLTIKDDSDYRRMEEIVDEER
RVTVQGYVFFAETKELRSGRTLLTFKITDYTSSILVKMFSRDKEDAALFQLVKKGMWLRA
RGSIQNDTFVRDLVMIGNDLNEIKPVERKDTAKEDEKRVELHLHTPMSQMDAVSSVATLV
GQAKKWGHKAIAITDHAVAQSFPEAFGAGKKNDVKILYGVEMNLVDDGVPIAYNPKDIEL
EDATYVVFDVETTGLSAVYNTIIELAAVKIHNGEIIDRFESFANPHHRLSATTINLTGIT
DDMVESAPEIDIVLRKFADWTGDSILVAHNASFDVGFLNVGYQKAGLPKSTNAVIDTLEL
GRFLYPEMKNHRLNTLAKKFDIELTQHHRAIYDAEATGYLALKMLKDAAEKGITNHNQLN
DNMGQGNAYQRARPYHCTVLAQNEVGLKNLFKLVSIAHINYFYRVPRIPRSVLQKYREGL
LVGSACDKGEVFEAMMQKAPEEVEDIAPFYDYLEVMPKEVYAHLIEMELVQDEKALEEII
GNIVKLGDKLDIPVVATGNVHYQNPNDKIYREILVGSQGGANPLNRHKLPDVHFRTTNEM
LDCFSFLGKEKAKEIVVTNTNKIADMIDVIKPIKDDLYTPKIEGSEEEMREMSYGMARRI
YGDELPEIVEARLEKELKSIIGHGFAVIYLISHKLVKKSLDDGYLVGSRGSVGSSFVATM
TEITEVNPLPPHYICAECKYSEFFNDGSVGSGFDLPDKNCPNCGARLKKDGHDIPFETFL
GFKGDKVPDIDLNFSGEYQPKAHNYTKVLFGEEYVYRAGTIGTVADKTAYGYVKAYQNDN
NLQIRGAEIDRLASGCTGVKRTTGQHPGGIIVIPDYMDVYDFTPIQFPADDRNSEWKTTH
FDFHSIHDNVLKLDILGHDDPTVIRMLQDLSGIDPKTIPTDDPEVMKIFSGTESLGVTPE
QIYCKTGTFGIPEFGTKFVRQMLEDTKPTTFSELVQISGLSHGTDVWLGNAQELIHNNIC
NLSEVIGCRDDIMVYLIYQGLDPSFAFKIMESVRKGKGLTDEMEEEMRKNEVPEWYIDSC
KKIKYMFPKAHAAAYVLMAVRIAYFKVHHALLYYAAYFTVRADDFDIDAMVKGSHSIKAV
IDEITAKGLDASTKEKNLLTVMELAFEMVERGYTFKKVDLYKSSATEFIIEGNSLIPPFN
SIPGLGTNAAINIVEARKDGEFLSKEDLQQRGKVSKTIMQYLENHGCLADMPDQNQLSLF
>PK3-045_03154 Proline--tRNA ligase
MKQSKMLIPTLREVPADADIKSHQLLLRAGYIRQNASGIYSYLPLANKVIKKIEQIIREE
MDAAGGVELLMPALQQAELWQESGRWFTYGPELMRLKDRNSREFALGATHEEVITSLVRD
EVKSYKRLPLTLYQIQTKFRDEKRPRFGILRGREFIMKDAYSFHSTHESLGEVYDSIFQA
YCNIFERCGLNYRAVIADSGAMGGKDTHEFMVLSDVGEDTIAYSTESNYAANIEMAPVIN
SYDKSDEPAKKLEKVETKEQKTIEEVSSFLNVAAEKCIKSLLFKVDERFVLVLVRGDHEV
NDIKVKNLLEANVVELADQADTEQVLGSKVGSIGPINVKEVEVIADHAVKAIVNGVCGAN
EEHYHYVNVNPDRDFAVDQYADIRFIQEGDLSPDGKGTITFAKGIEVGHVFKLGTRYSEA
MGATYLDENGRSQALIMGCYGIGVSRTMAAIVEQFNDDRGIVWPNAVAPFDIHLITVNTK
DDTQNELSEKLYATLKANRFDVLVDDRAERAGVKFADSDLIGLPIRITVGKKAAEGIVEV
KVRSTGEMLEVHESELAATILRLTQVEG
>PK3-045_03155 Regulator of sigma-W protease RasP
MYTVIAFIIIFGALVFFHELGHFVLAKRAGILCREFAIGMGPKVLSLKKGETVYTIRLLP
IGGYVRMAGEDPEMVDIKPGHRIGLILNDKEEVTKIIINNKEKYPNARVINVEDADLEHK
LFVKGYVEEDNEDNLLVFPVKKDAVFVENGIETQIAPYDRQFASKSLWQRTLAIFAGPAM
NFVLAFLIFIVIALLQGIPSNEAKLGKLTDDGVAISAGLHEGDNVISIDGQSVGSWEEVV
TIIQKSPGENLEFLIDRNGKEMTIEVTPKESEVDGKTIGLVGVYSPMEKSPLKSIQFGAT
QTYNWTKEIFGAVGKLVTGQFSIDALGGPVAIYQSTDTVAQSGVYSLMNWAAVLSINLGI
MNLLPLPALDGGRLLFFAIEAVRGKPIDRQKEGIVHFIGFALLMLLMIVVTWNDIQRFFI
Q
>PK3-045_03156 1-deoxy-D-xylulose 5-phosphate reductoisomerase
MKYISLLGATGSIGMQTLDVIKSHSDRFELVAFSSGKNIELTKKIIQEFRPLLVSVAEKK
DYEQLKQNFPEIHFSYGMDGLIEVAVFDKADILVNAVIGSVGLHPTLQAIEAGKVIAIAN
KETLVTAGHIVMDAAAKYNVPVLPVDSEHSAIFQCLQGENPKNIERLIITASGGSFRDLS
RKELEQVTVDDALNHPNWSMGAKITIDSATMMNKGLEVIEAHWLFGLPYEKIDVLLHKES
IIHSMVEFHDSSVIAQLGTPDMRIPIQYALSFPERLPAANGKRLDLAAMGKLHFQHMDLE
RFRCLHLAFEAGKAGGTLPTVLNAANEVAVQKFLKQEISFLQIEDLIEKALNSHQNILNP
SLEVIQEIDLETRKRVSTLL
>PK3-045_03157 hypothetical protein
MKQRIITAIIAIAVFLPFVLIGKLPLVLFTFLLVGIGVFEMFRMRKISFFSIPGFISLVT
VWMIVLPNHYISSWNMNKIELGLIAVLFYLTYMVFSKNKFTFDDVAFTILAVIYIGTGFH
FFIEIRETDLAFLIYSLFIIWATDSGAYFIGRAIGKRKLWPEISPNKTVEGFIGGIVSAL
VVGVLFSVFGYIEWSIGFAFTTIILSIFGQIGDLTESALKRHYDVKDSGKLLPGHGGILD
RFDSLIFVWPLLYFIFERFLHLI
>PK3-045_03158 Isoprenyl transferase
MFNKIRLWKKKPVSSTFQDRISALKMRQIPEHVAIIMDGNGRWAKKRTLPRIAGHHEGMK
CVKRITAIANDLGIKVLTLYAFSTENWKRPKSEVDYILSLPEQFLSTFLPELIEKNVRVT
AIGYTEGLPESTLNALNRAVEQTKHNTGLHLNFALNYGSRAEIIDAVKNVVKDSQTGKIE
IDNLTEEVFSSYLMTEDIIEPDLLIRTSGEVRISNFMLWQIAYSELYFTNVLWPDFNELH
LFEAIEEFQNRQRRFGGV
>PK3-045_03159 Ribosome-recycling factor
MPKQVIANTKDRMDKAIQSYSRELASIRAGRANASLLDRITVDYYGAPTPVNQLAGISVP
EARLLVIQPYDKTVLGDIEKAILKSDIGLNPSNDGSVIRLSIPMLTEERRKELVKNVKKE
SEEAKIAIRNIRRDGNDDLKKLEKNGEITEDDLRGYNDDIQKLTDEYINKVDALTKEKEK
EILEV
>PK3-045_03160 Uridylate kinase
MFPIFQDITNKAEVSMSSNPKYKRVVLKLSGEALAGEAGFGINPSIIKNVAQQVKEVADL
GVEAAVVVGGGNIWRGKIGEEMGMDRANADYMGMLATVMNSLALQDSLEQMGIETRVQSS
IEMRQVAEPYIRRRAIRHLEKKRVVIFAAGTGNPYFSTDTTAALRAAEIEADVILMAKNN
VDGVYSADPKVDKTATKYEELTYFDVIKDGLAVMDSTASSLCMDNDIPLIVFSITENGNI
KRAVMGETIGTIVRGKNNA
>PK3-045_03161 Elongation factor Ts
MAVTAQMVKELREKTGAGMMDCKKALTETNGDLDKAIDFLREKGISSAAKKADRVAAEGS
TFIAVEGNEAVILEVNSETDFVAKNEGFQTLVKELASHLLATKPASVEEAHTSNITEGTT
VEAHINAAIAKIGEKLSLRRFEIKTKTDNDAFGAYLHMGGRIGVLTVLEGTTDESAAKDV
AMHIAALNPKYISRDQVSQEEVAHEREVLTQQALNEGKPANIVEKMVEGRLGKYFEDVCA
LDQSFVKNPDQKVRQFVESKGATLREFVRYEVGEGIEKREDNFAEEVMNQVNKK
>PK3-045_03162 30S ribosomal protein S2
MSVISMKQLLEAGVHFGHQTRRWNPKMKKYIFTERNGIYIIDLQKTVKKVEEAYNYVKEL
AGNGGTVLFVGTKKQAQDSVKEEAIRSGQYYVNQRWLGGTLTNFETIQKRIARLKDIERM
AEDGTFDVLPKKEVVQLNKELERLEKFLGGIKDMKKIPDCLFIVDPRKERIAVAEAHKLN
IPIVGIVDTNCDPDEIDVVIPANDDAIRAVKLLTAKMADAILEAKQGEEVTTA
>PK3-045_03163 hypothetical protein
MVNFLLFLSITLNLIAILCIVILYVRQNRFVNLEKDQRKNLEEMEEVISTFITEIKVENE
QFLNRLTSFDPNEDLLGKKVEDNKGKAESLEYKPREIKGNKAMLNAYKNVTDSIQENSLT
EDRLEKEDVNELLNLILPPEKKQKEKSIVEVAKEMQAEGKSIEDIAKALNKGKTEMELLL
KFRQNS
>PK3-045_03164 hypothetical protein
MSLKALEMQVALPRTYDAGKLQEQQDQKHQQMYTFAAQETGKEEERKRTTVIKGEGNGKV
TSKKKRDKQFFETEMRKDEKELDDLERIQTIHPYKGKSIDFSG
>PK3-045_03165 RNA polymerase sigma-D factor
MVMNTKILIFLLDLGDIDREEIYLYPFQVVTYIDRTSYMRVWGSLFIEEGNNLMAKESTT
EEKQAWEMWTSTRDQEAGNQLIKKYMPLVSFHVQRISIGLPKSVSRDELTSLGMMGLYDA
LQRFDPNRDLKFDTYASFRIRGSIIDGLRKEDWLSRGTREKSKKIEAAIEKLEQKLMRNI
TVQEIADELETSVDEVYATMNEHFFANILSIDEQMNEGEEKEAQSFSIRDDKTVIPEEKV
VKDELVQEMAAKIKELNEKEQLVISLFYKEELTLTEIGQVMNLSTSRISQIHSKAIFKLR
HSLEKVI
>PK3-045_03166 Chemoreceptor glutamine deamidase CheD
MVTDQITVIKVGIADMNVVESPNTIRTSGLGSCVGIVLYSSLKPIAGLAHIMLPEASISK
SGTLNKAKFADTAIVELVERLEGLGIKRSTLLAKIAGGAQMFQFTGTSDVMRIGPRNVEA
VKNTLQSLRIKLVSEDVGGNSGRTIEFCPATHELTIRTVNKGIHII
>PK3-045_03167 CheY-P phosphatase CheC
MGYINDINSLKLDVLREIGNIGAGHAATSLSKLLNKKIDMKVPDVQIVTFDEMMEMAGGA
DNIVAGVFLRIEGDVPGSMFFILPLEQATKLVQDMIGDPSVNLAKPPYDELSMSALQELG
NILSGSYLSSLSDFTKLSLYPSVPALAIDMVGAIVTYGLVEHSQVSDYAIVINTELNGEE
ITLADTVNGHFFLLPDPDSFAALFQSLGVKDGD
>PK3-045_03168 Chemotaxis protein CheW
MSDAVSTEEKLIIFELKGKEYAISVNEVMSIEKNMHITRIPNIAPFVKGVINLRGVVTPI
IDLRLRFNLEEIPYTDSTRIIIIMLEDMEVGIIVDSANDVVDVDTSLYEPAPETINGDEV
DYIKGVVKLDKRLLILVDLEKVFDRNILRNYANTKSDE
>PK3-045_03169 hypothetical protein
MLAQVALPWNKLIKQNYYLSEFVYKWGNNDLALYKLQIGYVRGMKRK
>PK3-045_03170 Chemotaxis protein CheA
MEMSQYLEVFIEESKEHLQACNEHLLELEKDPENLQIVNEIFRAAHTLKGMSATMGYEDL
ASLTHQMENVLDAIRNKKIIFSPEILDVIFLAVDDLDAMVESIASGGDGKRNVEAVVEKL
IQIEKGLPLNQNTAEAEVAVTAIEDAPAKQNQYDEFETTVLQQSSDQGFFTYEINITLKS
DCLLKAARVYMIFEALESLGEVVKSIPPVEELEEEKFDYDFMVTLISKEAADKIEASVMK
VSEVEKVAVREFFANSQSAKQQTIVETPVVEAVQAKMDNTSVTENSTPAETKQTEKQTGT
KVSNKTIRVNIERLDILMNLFEELVIDRGRLEQISSTLKDQELHETVERMSRVTGDLQNI
ILNMRMVPVETVFNRFPRMVRQLARDLNKKIDLQIVGAETELDRTVIDEIGDPLVHLIRN
ALDHGVETPEVRRANNKSEEGTVVLRAYHSGNHVFIELEDDGAGINKEKVLSKAINKGII
SKEVAKTLTNNQIAELIFASGFSTADQISDISGRGVGLDVVKNTIESLGGSITIESEEGK
GSLFSIQLPLTLSIISVMLVEIQAEKYAIPLSSIIETAIVNKNDLMHAHDQTVIDFRGKV
VPLLFLKDIFDVPSAGIESDYYSVVIVRKGDKLAGLVVDGFIGQQEVVLKSLGTYLSSAY
AISGATILGDGQVALIMDCNALIK
>PK3-045_03171 Protein-glutamate methylesterase/protein-glutamine glutaminase
MEKIKVLVIDDSAFMRKLITDFLSEDSRITVIGTARNGEDGIKKIKQLAPDVVTLDVEMP
VLDGLSALKRIMLEHPVRVLMLSSITKVGAESTIQAMQAGAIDFITKPSGSISLDLYKVK
QELVEKVILASKVKPKTLLNLSNEGKKTITSQSSYSKMEPREENERIVQKIESISNWMNS
MKKIVIIGTSTGGPRALQKVLTNLPSDIEAPILIVQHMPAGFTRSLANRLNTLSAITVKE
AEHGEIIRNGVAYIAPGGQHLKVKTVGVHTAIDLDQTAPINGHRPSVDIMFESVSDLKAY
AKIAVIMTGMGSDGTDGLIKLAKKGNVKAIAESQETCIVYGMPKTAIATNYIDEIQKVDH
IAETIMKYV
>PK3-045_03172 Flagellum site-determining protein YlxH
MNDQASILRKKIEQLNANKRDSNHKTLAIISGKGGVGKSNFSLNFALTLQKRGYRTLLID
MDIGMGNIDILMGTQSRFTIVDFFRNDINFEYIISKGFDGLDYIAGGSGLSDFVDMEEEK
LESFFQHFQRILNHYDYILFDMGAGISTDSLKFILSVDDCIVITTPEPTSITDAYAAMKF
IHTKNAVLPLYLVVNRTMEKKDGAETLQKLQQVVKKFLQRDLINLGYIPDDTNVAQAVRK
QIPFVFFNEKSEAAKALREIADRYGKQQFTEPYPANRHNFVSKLKRFLFER
>PK3-045_03173 Flagellar biosynthesis protein FlhF
MKIQKYVARDMPEAMKKIRAELGNDAVILHSKVIYTGGFLGLFKKRNIEVLAAIDPSISE
TTISKQTKKREMRSPVLIKEPAFRADADNSTNNISLKEGKRISDYPEIVKHLNEINQNVK
ANKSMTFSIPSPITNIVNQLDKQGIDEDIKTGLVKELVAKWYAAGEDVLESQVSEWARQF
LLAEISPYSFGEISLAKKYINVIGPTGVGKTTTLAKIAANIILRQQKSVGFITTDTYRIG
AIEQLKTYANILDVPLEVCYSLEDFEHATKKLEECDVILIDTAGRNFRNKKYVEDLMQVV
DYKREMETLLVLSMTAKQDDLEEIYQQFSAIKIDAFVFTKLDETSSYGAMINLIVACKKG
AAYITTGQNVPDDIVPATPEELVNKLFEVVEE
>PK3-045_03174 Flagellar biosynthesis protein FlhA
MARRDLIVVIGVILIIAMLIIPFPTWLLSVLILLNITLALLILLLTMNMSEALEFSIFPS
LLLLTTLFRLGLNVSTTRAILSKGDAGGVVHTFGTFVIGGNIVVGLVVFLILVIIQFIVI
TKGSERVSEVAARFTLDAMPGKQMSIDADLNAGIISEQEARQRREKVGREADFYGSMDGA
SKFVKGDAIAGIIIVFINLIFGIVIGMTQLGMAAGDAAQHFSLLSVGDGIVSQIPALLIS
TATGIVVTRAASEGNLGSDITSQLLSYPKMLYVAGGTIFLLGLFTPIDDFLTIPIAGLLI
FGAYYLSRKPKQNLEQMQELEEDIQTDELKSPESVVSLLSVDPIEFEFGYGLIPLADANQ
GGDLLDRVVMIRRQLAIELGLVIPVVRIRDNIQLQPNEYRLKIKGNERASGELLLDHYLA
MSPGMDDDSIEGIDTIEPSFGLPAKWITESTKEQAEIFGYTVVDPPSVVSTHITEVIKAN
AHELLGRQETKQLVDHVKESYPILIEEVTPSPLSIGEIQKVLAKLLRENVSIRNLPVIFE
TLADFGKMTADTDLLVEYVRQSLARQITTQYTNQNDSLKVVTLSGKVEKLIADNIQQTEH
GNFLALDPNISQSILESIAGQIEQLSVMEQMPILLCSPAVRMYVRQLTERYFPQVPVLSY
NELEANVEVQSVGVVNIE
>PK3-045_03175 Flagellar biosynthetic protein FlhB
MKLLSLDLQFFAGEKTEKATPKKRQDTRKKGQVAKSQDVNTALVLLVVFGVLSFTGEYLL
DGLLSLFTFTFSDFMGINLSINSIQGLFLDILKEVALLLSPILIAALAGGLIANYMQVGV
LFSPEAIKFKLEKINPISGFKRLFSLRSIVELLKSLLKITVIGIVVFSVLWGKMNEILIL
SHKSIGSIAVTIAKLTVQMGLYASIALLVIALMDYMYQRYDYEKNIRMSKQDIKDEYKNM
EGDPLIKSKIKQKQREMAMHRMMQDVPTADVVITNPTHYAICLKYDEDKYDAPYVVAKGV
DFVAQKIKLVAKENNVVMVENRPLARAMYSQVEIGDLVPEEFYKAVAEILAFVYQTRDK
>PK3-045_03176 Flagellar biosynthetic protein FliR
MMDELLSNFPAFLLILVRVTSFFLMLPLFSYRTIPTTFKVGLGFFLSLVMFWGMDVPTLT
IDTGYYFLILKEALVGLSIGFVAYMLFSAIQIAGGFIDFQMGFAIANVIDPQTGSQSPLT
GQYLTIIAMFFLLASNGHHLLLDGIYYSYQFIPLEQPWIKFGNGELAEFLIKTFSLMFMI
AFQMSIPVVGSIFLVDVGLGIVARTVPQLNIFVVGVPIKIIAGLIILFIVMGVLMTSVTH
LFSSIVTTMRGMMNIIGGVG
>PK3-045_03177 hypothetical protein
MSQEMVISIAEKGVLTVLIISGPLLIIALAVGLIISIFQATTQIQEQTLAFVPKIVAVLV
GLVFFGSWMLSHMLSYTKDIFSNLTRFIG
>PK3-045_03178 Flagellar biosynthetic protein FliP
MNEFMQFFNNNDPGNVSTSVQLLLLLTVLSLAPSIIILLTSFTRIVIVLSFVRTALATQQ
MPPNQVIVGLALFLTFFIMAPTFQEVNDKALTPLFNEEITLEEAYDNASLPLKEFMSKHT
RQKDLALFLNYSKAEAPESIEDIPLTTLVPAFAISELKTAFQIGFMIFIPFLVIDMVVAS
ILMSMGMMMLPPVMISLPFKILLFIMVDGWYLVVKSLLESF
>PK3-045_03179 hypothetical protein
MNKVNLLIRCSLLIIVLLGFGNQAYAEQIDKSVYDILQNESEKNKAQDDTKKEMTTEQNS
KNDNQTKEQSDLLLEETNSDEPRSIGVTIWDFVKMIFATIFVVFLIYFILRFINKRNHGY
KNSQIIENIGGTALGANRSIQLIKVGKRLLIVGVGDSIQLIKEIEDEQEYKEILAEYNQK
LDQLVQPSDIVTKVKNVISSSHSAPKTKESFSIRLSKELERISSERKEKLDVLEKKKKGS
SEKNE
>PK3-045_03180 Chemotaxis protein CheY
MAQKILIVDDAAFMRMMIKDILSKNGYEIVGEAADGMQAIEKYKETQPDLVTMDITMPEM
DGITALKEIKNINPNAKVIMCSAMGQQAMVIDAIQAGAKDFIVKPFQADRVLEAISKTLG
>PK3-045_03181 hypothetical protein
MVSKDMLSQDEIDALLRGDSDTNDSSEMDAEKYLSDIEKDTLGEIGNISFGSSATALSTL
LNQKVDITTPTVSVICKNMLADEFPQPYVAIRVNYTEGFSGMNLLVIEQADAAVIADLML
GGDGLNTNPEMLGEIQLSAVQEAMNQMMGSAATSMSTIFSKKVDISPPSIDILNIHDGEG
TESIPDEDVLAKISFRIKIGDLIDSKIMQVLQLSFAKKLVEGLINPNNREEEVSNIPEVD
YNSVYEPKEPMQESHATANYQTASNPMANNPVNTNSQPANVTQQQYFGSGNHTQGPPPNV
QPAGFSSFDTPTSTVTETKNLDMLLDIPLQVTVELGRTKRSVKEILELSSGSIIELDKLA
GEPVDILVNNRLVAQGEVVVIDENFGVRVTDIVSQKDRLKNLK
>PK3-045_03182 Flagellar motor switch protein FliM
MSADILSQNEIDALLSALSSGEMDADELKKEQLEKKVKVYDFKRALRFSKDQIRSLTRIH
ENYARLLTTFFSAQLRTYVQISVTSADQIPYEEFIRSIPKMTILNVFDVPPLEGRILMEV
NPNIAYAMMDRMMGGRGSSLNKVENLTEIETKIMSNTFESAFDHFREAMEDLVDIEPSLA
EFEVNPQFLQMVSPNETVVVISLSTTIGETSGMINICIPHVVLEPIIPKLSGHYWMQAEK
KERLPEFTARLEENIQQSIVPVVAELGTSDISIQDFLMLDIGDVIEMNQTIQQPLIIKVG
DIPKFIGQPGKLNKKMAVQVLGTLEEGKEDGE
>PK3-045_03183 hypothetical protein
MKNNKVIIIMLVLLLVITLAGAGAFIYIWKFTGEQKTNEPSIDEILESSVDIEEMTTNLA
SNNFIRISFKIQTDSKEAKEELEKRDFQVKNIIIQELSEKKSEELKGKNGQIKLENDLKD
KINELMQEGKVVQVYIVNSLLQ
>PK3-045_03184 hypothetical protein
MEGQGLFVRLAPNKKMIQLTRLNGKKFLLNALFIETVESFPDTTITLTNGNKFVVKESEE
DVLEKMNHFFQKVNLFGLPHVGEKDDEE
>PK3-045_03185 Flagellar basal-body rod protein FlgG
MLRSLYSGISGMKNFQTKLDVIGNNISNVNTYGFKKGRTTFSDLISQTVSGATAPANGNG
GTNSKQIGLGSQLASIDTVHTQGPTQYTGRGLDLAISGEGYFVVEDGEGNPFYTRAGNFY
FDEDRNIVTSSGLKVSGVGTIPASAKSYSIGTDGTITYVAENGETQNAGQIVLAKFNNPE
GLEKVGGNIFQVSNNSGDPILSTPGQAGTGSVNSSYLEMSNVDLSEEFTDMIVSQRGFQA
NTKIITTSDEILQELVNLKR
>PK3-045_03186 hypothetical protein
MDKPVYPSIKSHAAIKNGIEALKTKSTLHKAQNIPSFSTHLQQSISSLNTLNISKHANER
LQERGIKIDAAKWRAIEEKVTEAKKMGIKESLVLLNNAALIVSAKNNTVITAMDREEATN
QIFTNINGTIIMN
>PK3-045_03187 hypothetical protein
MANTINDPSLSLSEYQKSKSNTSTGSSSLGKDAFLKLLITQLQNQDPTSPMDDKEFIAQM
AQFSSLEQMQNLNTAMTNLISLQTQSNLISYGQFIGQEVNWSKVVTDKAGNDKTYSGTGK
VSSIAYSEDSVIFTLEDGTKIVPANISSMNKNASENNLVLASQLIGKNVSYLNENEDEVS
NKVLSVSLKNGQIQLTLGDDAETKITSGQIIKIE
>PK3-045_03188 hypothetical protein
MQLELINSLRKVEVASGNKGMLNEKLGGKFLLLINSLQTTNQQEKSSPKVAQDQQKEGLN
QLLALLSSSSKEIPNEEISMSLEKLWNTYYDISDQSGINDLEATDMEGIIAATFIKIENK
ITQVLIEGQNSRITPEMFNHTELPDLFSDLKLLEKTVKSLPDLTINEKIAETVEDLQGFI
LSLNNFLEQNMYSNESIAGTVQSAEQNVEPFVEGERERKKVAAYTMITSEAISGKENLVS
GASIVKEIENQKVVNNGILKNSTGNSLSEDIAKTKNIESVINHNMEDFPNVFSKFDTKLL
ALQNSLLQENKNIIGCEQKRTMQAYLNQEAETENHVIAATTELKTIISSILGKLDKQLVE
KNTILPKMVNPIMVSSLRKSGELLGSNTEIKGNVEVGEGDTDTKIFSSIPTTFLKQDPLM
LLSDSGEAIHSKRVEEQFVKILANSTFTKTSDMQKLTIRLAPDHLGSIRIEITQNEGNMI
ARIITANTEAKDVLEKQLTSLKHGLTAQNLQVDKVDIVVSPQPQDRLQRDQQQEQQHPHQ
QREKKDENDDENKQKASFIEELLNIEV
>PK3-045_03189 hypothetical protein
MENSWEEKKKPFNIFQRFLMVAVIPTIFAIIVLVLLLMYSGADVAEKGKELLNAIPFLSE
EKKSTDKLLENNKNTISSLQTKLKERDKEIKSLESQLENSENRFQSANSEKEKLQSELQS
LQSAQEETKKAMNEIVKTYETMSPKNAAAILSEMSEKEAMKILGELKPAKLASVLEKMEP
PVASKYTELLSKSAKASQ
>PK3-045_03190 Flagellar FliJ protein
MSYQFKFEKILTIREREKEEASSAYNQSVNRFEEAAENLYELLKRKEDLEAYQAEKMMSG
LSVQEIRHHQQFVGNLAKTIEHAQKMVQNARNSMVYFQEKMLEKNLEVKKFVKIKEKDHS
NYLAIARAEEAKQMDDISLQQYMQHEKVGG
>PK3-045_03191 putative ATP synthase YscN
MKALELLSSISSIDTYKQYGRVNKVVGLMIESQGPESSIGDVCNIHIGTKHKRIIKAEVV
GFNEGNIILMPYTTVQDISPGCLVEASSEPLEIKVGPGLIGTAVDALGMPLDGSMLPKGL
KSVPIDQEPPNPMTRPPISQSMEVGVRLIDGLLTVGTGQRLGIFAGSGVGKSTLLGMIAR
NTKADLNVIALIGERGREVREFIERDLGPEGLKRSIVVVATSDQPALMRIKGAYTATAIA
EYFRDKGLNVMLMMDSVTRVAMAQREVGLAIGEPPTTKGYTPSVFAILPKLLERTGTNEF
GSITAFYTVLVDGDDMNEPIADTVRGILDGHYVLDRELANKGQYPAVNVLKSVSRVMNHV
VSKEHVKAAERLRDLLSTYMNSEDLINIGAYKKGSSKEIDTAIRLYPSILSYIKQETDEK
VSIEESLHSLLTLVGTEG
>PK3-045_03192 hypothetical protein
MISLSRLIKSRYSKPEDANEKVISIKYIDTFNAEVDLSREVTQTEYNRIVESARKEADEM
KAQALEEAELIRAQLMEERQNWDIEKGNLIEEARKNGFQAGYEEGQNVGYNEMLSFIQQA
KDTVTASKEDYEKYLQSAETTILELAIEVAEKIMNNKIKEEEENFLYLVQNALKEVRKQK
EIQLHVSPIHYEMVIAEKEELLQLFPIKPNLFIFPDETIDENACIIETANGRLDASVDTQ
LLMIKNKLLEILESEEG
>PK3-045_03193 Flagellar motor switch protein FliG
MARKESNELSGKQKAAILLISLGPDVAASVYKHLSEEEIEKLSLEISGVRKVENTSKESV
LEEFHNIALAQDYISQGGIGYAKTVLEKALGTEQASIILNRLTSSLQVRPFDFARKADPN
QILNFIQNEHPQTIALILSYLDPTQAGLILSELPQEVQADIAKRIAVMDSTSPEIINEVE
QILERKLSSTVTQDYTQTGGIEAVVEVLNGVDRATERTILDALEIQDPELAEEIKKRMFV
FEDIVTLDNRAIQRIIRDCENEDLMLALKVSGDEVKEIVYGNMSTRMAESFKEEMEFMGP
VRLKDVEEAQSRIVGIIRRLEDAGEIVVARGGGDDIIV
>PK3-045_03194 Flagellar M-ring protein
MKENLNKIFNPLKEFWQSRSKKQKTVITGSGLLLILIAVFATYFFTRVTLVPLYSNLTPS
ETGAIKENLDSKGITSEISGGGTVISVPEEVVDTLKVQLAAEGIPKSGSIDYSFFSENAS
FGMTDNEFNVLKLDALQTEIANLIKGVDGINDANVVITLPEESVFVSDQGGEATASIVLN
TKPGYNFSENQIEGLYTLVSKSVPNLPTDNIVITNQNFEYFDLNSSDNSATDTFTAQNNV
KKQIERDIQRQVQTMLGTLMGQDKVVVSVTADIDFTQENREENLVTPVDEENMAGIEISA
QNITETYTGENAAGGVVQAEDDADVTTYNSETGSGNGNYEKVDQTVNREVNRIKKQIVES
PYKVRDLGIQVMVEPPDANDSTSLPQESIDDISNILGTIVRTSIDKTSTGGELTDEDIQS
KIAVSVQPFNGKKQAADVVQASIPWWVYAVGGGLLAVIILLIFFVMRARKKKQEEEIEEI
IQPVAPVADINEEQQESEGTIRRKQLEKMAKEKPEEFAKLLRTWITED
>PK3-045_03195 Flagellar hook-basal body complex protein FliE
MEPINFSSVSSALPLTNSATSNKTAVADTQKKFASFLKESINNVNQAQNESDMLTNKLAR
GENVDLSQVMIASQKASITMQATLEIRNKAVEAYQEMMRMSV
>PK3-045_03196 Flagellar basal-body rod protein FlgC
MTIFTSMNTTASALTAQRLRMDVISSNMANVDTTRGRLVNGEWEPYKRKQVVFQEQEGSF
ASHLNAARGNSANTAGGVKVSRIVEDDTPFEMVYDPENPEADETGYVRMPNVDPLRETVD
LMSASRSYEANVTVLNASKSMLMKTLEIGK
>PK3-045_03197 Flagellar basal body rod protein FlgB
MKLFSNTITTLENAINYSNQKQKVISQNIANVDTPNYKAKTVTFKDSLSSAMEANVTNSK
HIPFSAPNTASTSVITKNRVTYNNSGNSVDMEKEMTDLATNQIYYNALVDRISGKFSSLE
NVIRGGK
>PK3-045_03198 GTP-sensing transcriptional pleiotropic repressor CodY
MDLLTKTRKINAMLQRAAGKPVNFKEMSETLSDVIEANIFVVSRRGKLLGFAVHQQIEND
RMKKMFEDRQFPEEYTNSLFNIQSTSSNLEIESEYTAFPVENKELFAKGLTTIVPIIGGG
ERLGTLILARLQEQFQDDDLILAEYGATVVGMEILREKAEEIEEEARSKAVVQMAISSLS
YSELEAIEHIFEELNGSEGLLVASKIADRVGITRSVIVNALRKLESAGVIESRSLGMKGT
YIKVLNDKFLLELEKLKTNK
>PK3-045_03199 ATP-dependent protease ATPase subunit ClpY
MQKSASLTPRQIVERLDQYIVGQKDAKKAVAVALRNRFRRSLLDEKLRDEISPKNILMIG
PTGVGKTEIARRIAKIVNAPFVKVEATKFTEVGYVGRDVESMVRDLVETSVRLVKEEKMF
QVRERAEVAANNRLVELLVPSAAKKTSSYKNPLEMLFGGGGADTEEEEPTVEETSKSEKR
KIVKEKLALGELEDEVVSVEVEEQQPSMFDMLQGSGMEQMGMNMQDALSSFMPKKKKKRK
LTVREARTILTNEEAQKLIDMDEVTQEAVVRAEQMGMIFIDEIDKIASKSNSSSSADVSR
EGVQRDILPVVEGSTVVTKYGSVKTDHVLFIAAGAFHMSKPSDLIPELQGRFPIRVELTK
LTVDDFYRILVEPDNALIKQYQALLYTEGIEIEFSDEAIRKIAEVAYEVNQNTDNIGARR
LHTILEKLLEDLSFEAPEITMEKITITPKYVEEKLGAISRNKDLSQFIL
>PK3-045_03200 ATP-dependent protease subunit ClpQ
MSEMPQFHATTIFAVKHKGKSAMSGDGQVTLGNAVVMKHTARKVRKLFNGKVIAGFAGSV
ADAFTLFELFEGKLDEYNGNLQRASVELAKLWRSDKVLRKLEAMLIVMNETDLLLVSGTG
EVIEPDDGILAIGSGGNYALAAGRALKTYSGDNLSAYDIAKAALEIAGEICVYTNNNIIV
EEL
>PK3-045_03201 Tyrosine recombinase XerC
MKQELNNHVQAFIAYLQIEKNYSPYTIEFYTQDINQFFHFMKDQVIDKLEDVSPSDVRIY
LTELFSMQLARKTIARKISSLRSFYRFLLREKIVENNPFSAVSIPKLEKRLPDFFYEEEL
QQLFLSCDTNTPLGLRNKALLELLYATGIRVGECTKIQLSDIDFSVSTVLVRGKGQKERY
VPFGSFAHNALEAYIKAGRNQLMKNSTDHSYLFVNYRGGILTDNGVRDILNKMMNTSSSQ
GKIHPHKLRHSFATHLLANGADMRTVQELLGHAFLTSTQIYTHVTNEYLKKTYMSYHPRA
>PK3-045_03202 DNA topoisomerase 1
MSDFLVIVESPAKAKTIERYLGKKYKVKASMGHIRDLPKSQMGVDIEKQFEPKYITIRGK
GPVLKELKTAAKKAKKIYLAADPDREGEAIAWHLANSLNVDIESDCRVVFNEITKDAIKE
SFKHPRAINMDLVDSQQARRVLDRLVGYNISPLLWKKVKKGLSAGRVQSVAVRLIIEREQ
EIKEFVPEEYWSIEGSFIKGKNNFEASFYGINGKKVELHSEDEVKKITSQLKDNKFTVDK
VSKKERKRNPAVPFTTSSLQQEAARKLNFRAKKTMMLAQQLYEGIDLGKEGTVGLITYMR
TDSTRISEVAQSEAYDYINSHYGKEYTREEKKQEKKNPKVQDAHEAVRPTSIGREPSKMK
EYLSRDQFRLYKLVWERFIASQMAPAVMDTMSVDLSNGNVLFRANGSKIKFPGFMKVYVE
GTDDNVDEKDRQLPDLKEGDVVLNKDIDTKQHFTQPPPRYTEARLVRTLEELGIGRPSTF
APTLDTIQKRGYVALDNKRFIPTELGEIVLELILEFFPEILNIEFTANMEQDLDNIEAGK
VNWVKVIDDFYKTFEKRLEVAEQEMQTIEIKDEPAGEDCEECGHPMVFKMGRYGKFMACS
NFPECRNTKAIVKDIGVKCPKCHEGNIIERKSKKRRIFYGCDRFPECDFISWDKPLQRPC
PKCENMLVEKKLKKGVQVQCVNCDYKEEPQS
>PK3-045_03203 DNA processing protein DprA
MEIINKLLVKLHHCQGISWKMIDRLLKEDPTLQLEKIPSFISSISPTMEKEIVKTIHSHH
VEEQLIQYRYNQIHPITFFDPLYPPFLKEIYQPPWVLYAKGDLELLQSKRKLAIVGSRLA
TSYSTKVIKRLMKELVEEKITIVSGLAHGVDSIAHKLAIENGGKTIGVIAGGIFHIYPKE
SIQLAGDMMKHHLVISEYPPLTKPLKWQFPMRNRIISGLSNGTLVVEAKKKSGSLITANF
AVNEGRDVFAVPGNIFSPYSDGPNELIQQGAKPVLEAKDILEEWKHISE
>PK3-045_03204 Succinate--CoA ligase [ADP-forming] subunit alpha
MSVFINKDTKVLVQGITGATALFHTKQMLEYGTKIVGGVTPGKGGTTVEGVPVFNTVKDA
VDVTEANASVIYVPAPFAADAILEAVDAELDLVICITEHIPVLDMVKVKRYLEGKKTRLI
GPNCPGVITPEECKIGIMPGYIHKKGHVGVVSRSGTLTYEAVHQLSQAGIGQSTAVGIGG
DPVNGTDFIDTLKAFNEDEDTYAVIMIGEIGGTAEEEAARWVKENMTKPVVGFIGGRTAP
PGKRMGHAGAIISGGKGTADEKISVLTECGIKVAPTPSDMGATLIEVLKEQSIYEKCKTH
EVVAK
>PK3-045_03205 Succinate--CoA ligase [ADP-forming] subunit beta
MNIHEYQGKEILELNGVAVPKGKVAFTVEEAVRAAETLNSDVWVVKAQIHAGGRGKAGGV
KVAKSLDEVQTYASDILGSTLVTHQTGPEGKVVKRLLIEEGCRIKKEYYIGFVVDRATSR
IVLMASEEGGTEIEEIAEKYPEKIVKEVIDPVTGLTPFQARRVAFSINIPSKQVNKAVAF
MTGLYKVFVEKDCSIAEINPLVLTEDGNIIALDAKLNFDSNALYRHKDIVAYRDLDEENE
KELEASKYDLSYIALNGNIGCMVNGAGLAMATMDIVKHYGGEPANFLDVGGGATAEKVTE
AFKIILSDSNVKGIFVNIFGGIMKCDVIATGIVEAAKQVSLHVPLVVRLEGTNVELGKKI
LRESGVDIVAAESMADGAEKIVTLVEQGGNA
>PK3-045_03206 hypothetical protein
MNKHHSLKRKEAIALTYEQQKHAAPTVIAKGKGMIAEQILERAKKENIPIQEDPSLVELL
SKLNINEQIPEDLYMAVAEVFAFIYSLEKEATEKEGEKAN
>PK3-045_03207 hypothetical protein
MNVNHIVQTLFQENVMSNKSLELRDGQLVYGKLTKLFPQQMAEVQIGSQKMLANLTIPLT
LDRSYWFQVSITDNKPVLKVLPQSSEVPAEKGNINGLLQQLHLTETKENKLLLHFLLSNN
LPISKEAIRSIGEWLPKSIGKQELATIGLMMERQLPLTKEVFTSISALQSNKGVSVLLNE
LQQQLSTYHILEPKVADVLSEISQGGKLVQDNMLAALKAVLHKIGYSFEAGLLQHAQIEE
QTSQEILKPLLLGLMGKDIPDAVKETAGQLIDKVTGYQLISQQTGPMMQMVTEIPLRFFN
QQVDVTMQYNGRKTADGKVDSNYCRILFYLELANLKDTVIDIHIQNRIMNMIVLNDRSTE
IMPLIKQAEELLKEKLRELDYTLLSIHVKDLSKEHKPVWSSQQAVKGNAYKGVDIKI
>PK3-045_03208 Ribonuclease HII
MKLATMKDIKEALEAIREVNDPFILELEKDERKGAQKLLEAWKKRIEKEEKLHQHFLSMN
YYEQMIRKQGYTYIAGIDEVGRGPLAGPVVTAAVILPEDFYLPGIDDSKKLSEKKRELFY
EVIQKEAIAIGVGIISPAEIDRINIYQATKKGMLLAINELSQTPEYLLIDAMKLTTPYPS
QSLIKGDSKSVSIAAASIIAKVTRDRMMKELHQEYPDYHFATNMGYGTQEHVAALKEYGI
TIHHRKSFSPVKEMVETN
>PK3-045_03209 Ribosome biogenesis GTPase A
MTIQWFPGHMAKARRQVTEKLKLVDIIFELVDARIPQSSRNPMIDEIIQHKPRIVLLNKA
DMADKERTKEWIHYFQSKGIRALAINSQAGVGMKEITALAKEVLAEKFDRMKAKGIRPRA
IRAMIVGIPNAGKSTLINRLAKKNIAKTGNTPGVTKAQQWIKVGKELELLDTPGILWPKF
EDQEVGLKLALTGAIKDTILNLQDIAIFGLRFLEKEYPQRLKERYQLETIPEDTVELFDR
IGEIRGALSGGGIVNYDKVTELIIRDIRGEKFGPLTFEKADEM
>PK3-045_03210 Signal peptidase I T
MATEKKKKNEVWEWSKALIIAVLLAVVIRYFLFAPIVVDGESMQSTLLDQDRMIVNKINY
KVSEPKRFDIVVFHAPEGKDYIKRVIGLPGDTIEYRDDVLYVNGQAYEEPYLEHNKEGVM
GPLTEDFTATVPKGELFVMGDNRRNSKDSRHIGTIGFDKIIGTTSVIYWPIADWKIVE
>PK3-045_03211 50S ribosomal protein L19
MQKLIEEITKEQLRSDLPAFRPGDTVRVHVKVVEGTRERIQLFEGVVIKRRGGGISETFT
VRKVSYGVGVERTFPVHTPKIAKLEVIRRGKVRRAKLYYLRNLRGKKARIKEIR
>PK3-045_03213 tRNA (guanine-N(1)-)-methyltransferase
MKIDVLTLFPEMFEGVLHSSILKKAQEAEKVAYNIVNFRNYSDNKHQTVDDYPYGGGAGM
VLKPQPIFDAVDALKPKDNRKPRVILMCPQGERYSQAKAEELAQEEHLIFICGHYEGYDE
RIREHLVTDEISIGDYVLTGGELGAMVVIDSVVRLLPGVLGKEASHVNDSFSTGLLEHPH
YTRPADFRGMKVPDTLLSGNHAHIDEWRERESFRRTIERRPDLLENYPLTEKQKKLVKEL
TNQHHPS
>PK3-045_03214 Ribosome maturation factor RimM
MEKWFNVGKVVNTHGIRGEIRVISRTDFPEERYKIGNTIYFFQNDKANPLELIIKSHREH
KNFNLLTFEGYDNVNDVEFMKGGLLKVPESFLGELAENEYYFHEIIGCKVVTVEGEELGE
ITEILTPGANDVWVVKGKDKSEILIPYIEEVVMKVDVEEKVVVIEPMEGLLS
>PK3-045_03215 hypothetical protein
MKILQSVTVKQVLTETTKKSISDRYKQEIQQLEKEIQQLQFEERKQLKNNPSISEIKTFF
RKEVTNKLEKQKTIEFQLKQLHILPLGTEIKEQEVMGLVDVQVGQVWESANKTIVLKDGI
VVDIR
>PK3-045_03216 hypothetical protein
MKELIETIVKPLVDFPEEVAVTVTEEDNRITYLLSVNENDIGKVIGKQGRVARAIRTIVY
AAGSLQQKKIIVDIRD
>PK3-045_03217 30S ribosomal protein S16
MAVKIRLKRMGAKKSPFYRIVVADSRSPRDGRFIETVGTYNPVANPAIVEINEDKALQWL
QNGAKPSDTVRNLFSNQGIMEKFHNIKNGK
>PK3-045_03218 Signal recognition particle protein
MAFEGLADRLQNTMQKIRGKGKVNEADVKEMMREVRLALLEADVNFKVVKDFVKKVSERA
VGQEVLKSLTPGQQVIKVVKEELTELMGGEESKIGVSKRPPTVVMMVGLQGAGKTTTTGK
LANLLRKKHNRNPLLVAADIYRPAAIKQLQTLGKQLDFPVFSLGDQVSPVEIAKQAIEKA
KEDHHDYVLIDTAGRLHVDEALMDELKQIKELANPEEILLVVDAMTGQDAVNVAGSFNEQ
LGLTGVVLTKLDGDTRGGAALSIRSVTNTPIKFVGLGEKMDALEAFHPERMASRILGMGD
VLSLIEKAQINVDEEKARELEKKMKSDSFTFDDFLDSLSQVRSMGPLDELLKMMPGANKI
KGLNNMKVDEKQIAHVEAIIKSMTKQEKEHPEIINSGRRKRIAKGSGRTVPEVNRLLKQF
DDMKKMMKQMTNMGQKGKKKGKFKLPFNPF
>PK3-045_03219 hypothetical protein
MLEKTTRMNYLFDFYQSLLTPKQRSYMSLYYLDDYSLGEIAAEYNVSRQAVYDNIKRTEA
MLEEYENKLGLLQKFQERQVLFEKMKKMLEHDTLSISALREAVEELEKLD
>PK3-045_03220 hypothetical protein
MQIEFKYPFILLIFLPIIFLLYRYWKQSRTMSNRKERQVILFLRSLIFALLILALAIPQI
VLPQKENQVVFLMDRSASVQDAGEQQLEWLEKSLRYKKEKDLYSVLSFGEKTTIEQMMGK
EELRFSKWNEELGKDHTNIEGALNLASSVFSNNSGGRIILFTDGNETMGNLTEAAKLLKN
RSIELDTVLLEPSLYEDTAVTDVEVPSTLFEGEQANVSVTIESNKAKTGLLHFYENNHKI
VSKSIKVKEGTNVIPIQFPVKQTGLVTYKAEVDLMNDAYAENNKLQVVNMVKTIPKILVV
QNSPNESFVQALEAAGYKVEVRSSIQLPTVLSGYLNYQSIIFNNIAATDITEKQMSLIEK
SVKDFGVGFLMTGGENSFGLGGYFQTPIEKLLPVDMDIKGKKEMPSLALMIVLDRSGSMD
GSKFSLAKEAAARTVELLQETDTLGFIAFDDKPWVIVEPKPLKNKEEVVDKIRSVPVGGG
TEIYGSLLEAYEQISDLDVKRKHIILLTDGQSATNNNYEELINNGSKKNVTISTVALGAD
ADRNLLEKLAEMGAGRFYDVQDSSVIPSILSRETVMATKTYIEDNPFYPQIKSGYGWDSL
FSKGVPEMNAYIATTPKSESIVPIESTKKDPILAEWQYGLGKAIAFTSDVNGMWAGDWAR
WNQWSSFMTKMVAKTLPQYDSEAYSLSVEKAKDRTYLSITADHLSMLPIETTIISERGET
VEGNTKMLAPGKYEVDVGNDPGLYFIHVKQTDEDGNVTVYQSGFTVPYSDEYLITGANKE
KLAELLAITNGSQLEKESQAFRPLKEPVKQKQEITEILLLISFLLLFFEIAIRRLGLPVK
FFPVFEKRKRGKRQKSRIPSIEKKGVAPKERPVTFKKDVSSREPKQKQEKPREKIKTEKV
DSENHLEQLLEMKRKKKR
>PK3-045_03221 hypothetical protein
MHLAQPYYFLLLIFIGLFILIYFFRKKYTKQTIPSNLLWEEVLKEMRASSWFHKWQNNVL
FWLQLLCLLLLMFALVGPYFAKETMKGEQIIFLFDTSASMAANGSSSNRLEDSKKEALEM
MKGLQKNQAVTILEVNDRPQILLHNESERDKISAAIKGLELSYTHEDWQSATELTASLAK
EGKTAIHIFSDGVEKERIKNIDSFYVKVHNQEQEKAENISILSFGVSKNADKVAGVALVE
NQTDSHKTIPFQVESEKTVLYQQDIELKPKERKVIAINELPEKSYYDAKLNASDDFAVDN
MQTAVLNKQATTIYTDNEMNPFLVKGFEAIGLQVIQMENKEDFLTKKDSIFLLSGSALPE
HIEGPFVFFFTGGKKEEVQTVIEPSEDELLLHVDMKDVFIASAMKQTMKTMKPIVKSGEL
PLIQKGEWNNQPAIAIQFDLKDSDWPLHPSFPIFLYNMYQWLSFQSNYVGDFQPLESRTI
HLTSKETEWDIYNENDQLVRTFSLDDGFQAPKLPGVYQLTNGSEILYFSVNLDDREKTTA
TQKSFVLNEDKLIGNEMTKTQNDWFWYILCLLALIILCMEWEVYRRADRV
>PK3-045_03222 putative protein
MKNYHSLLARMNRKRLQVSTKGAGMQNGRRKSHIHGTSLDFADYKIYHPGDDIRQIDWNV
YGRTNKPYIKRFQDEKEISVSIFLDGTASMKQIPSKWELARELAASLAYITLSHEDRLSF
SVVSTKHSFHRKGSVHNKRTFYEIVDVKEQTINESFTQSLSNSIKAPTQMIILITDGLEA
LSLFEESFKRLKYRNQQIWLIQLLSESEIHPNLSGDIQLVDSENGKTVDVSLNSSIKTLY
RKRLDQHNQELEVLCATNGIRYCQISDKLDIQTIILRELAFAGLVQ
>PK3-045_03223 hypothetical protein
MEKELVEQDFIQAEALLKKVKEEIGKFIVGQEKITDEVLWCMLAGGHVLLEGLPGLGKTM
MIRTISEVLDLSFARIQFTPDLMPADITGTMVLQPDNKGKQQFHFHEGPLFKHIVLADEI
NRATPKTQSALLEAMGEKTVTIMGETKKLAAPFFVLATQNPLDMEGTYPLPEAQLDRFLC
KLHVTYPSKEELKAIIKKTTGTESTVLTRVASVEDILHLQSLVKQILVADDILDVAVNIV
SATHPGSEDATELGNKYIQAGSGPRGLQSLVTMAKARALASGRLHVSMADLRYAALPVFR
HRILLNFEGEIAGVTTDQIMEDILEKTLRIEVGKGR
>PK3-045_03224 hypothetical protein
MENLQQYKELLKPVRKSIARELLAKELCLLLALLGGGFLLLSIMAYLFILPFLLYYLFAV
FCVGVSIFLIRLWRKWPTEKQAVKLYNQFVADDYATTAFSYLHSEGAVEQVVVKQAIAQM
TEKQLAVLSRKKRYIYPKFILSGMVCFIICLLLQFFPSANMEAAKKKENEIKTIAKAEKE
LEKAIKKETDKQVRKELKQIQKQLEKKETVEKTFAELEKQAKELQLQKRKIQEKSKERQQ
IESMLNETGLKSLSKAISEKDKEAVQKELQKANEQYKRLTDQQKDALNQLTGANKQLSEE
QFQQLLKQMDELLSNEELLQQLETVQTELAQVGKKLEDESLANGITIPKSRTVAKGSSNN
DTTSSGETTTSGQQGKNDKGNSTNGNNDSSSSGNGSGNSNGSGSGSGNGSDSSSGSGSGS
GNGAGGSGNGNGSGAGFGSGSRELLTVPEKVVGKDNVEVDSGKLGNGKQGQMTEGEGPVL
KGNIRPYEQVFSEYEASYRESTSRYKLPNDLENIVKNYFTDIKPNEK
>PK3-045_03225 hypothetical protein
MKAYFMNPVLNKELKLRFRSGKTFVGILFYLLALTLLMVALMYVLRTSSPNGFFKPQESR
LMFMFLAFVQLGLVLFITPGLTGGVISSERERQTLSILLTTTQSSFTIILGKLLSSISYL
VLLILASLPIYSFVFLYGGISPTQLTQVFFFSLFTMLVIGSFGVLFSTLIRKTIVSMVTT
YSVALFIVAGTAVISLILFQIANIHAASTPAKVPSVYFSAMFNPGIVLADIFEPTVSEQI
IELTGIKFPIWAAHLITYCIVIALSLTISVRNLRANMKKGS
>PK3-045_03226 Linearmycin resistance ATP-binding protein LnrL
MIEIKGLSKKYGKFTALEPLDLQIEAGCVFGFVGQNGAGKSTTFSILATLLAPTSGTATI
NGADIIKQPKEVRKQLGYMPDFFGVYDQLKAEEYLDFYGASYGISAAQREKLIPQLLELV
NLSHKRKEYVDLLSRGMKQRLCLARSLIHDPAVLILDEPASGLDPRARIEMREILKELKN
MGKTILISSHILPELAEMCDVIGILDQGKLVAQGTVSAIQQQLQSEKIISVKTFDIQKTI
EFLEESPRISKIEVLEDGKVIQFLFKGGDKAQQELLKTAIQKEIPIISFSEMESNLEDVF
MEITKEVEFS
>PK3-045_03227 hypothetical protein
MRKVKKVIIICFILLLATTFIVKEANAASTDTIKITTEAGFAGKVMDGKGFQLKIILENS
GEDFKGDLLIPYSPSYEAGGQTLVSVDIPANSKKTYMTTIPGISSDTDYANKKMKLYRGS
WQNGDEVTFTGVKEVRVNLIPEQALGILTDQYDKFKDLRKLPSNSIYTTEMIKEEIPDQA
LALETISYLLVDQFSLSELTDEQQQAIKKWIENGGILITGAQPNGKQAYGHLETSMPLAL
GKKEAFSLAVLDTKNKQQAKIDGYQSTLIEGAEAIVLHNDQPIMAKKELGEGKIIQASFS
LSDPSFLGWSGFNSWIEKILLAESSQHANNSQYNSNPIGELYNSFVKANEYFESSTISTS
ILLIILAGYLLVIVPILYVVLKRIDKREHAWWIIPSVSILLSIAVFLTGAKDKIRNPQFN
EMGVYQYSNNYLSGYQATTLLSNKSGDFTLMYDKNLYTPIPFAGYGELQMKAVTKEKVKK
NEMIFPDVEYWSSRTMYGKSSIPVEGGFSHKFETTEKEITGSITNHFPYAFSNLFIWSGT
EKIELGSLAAGETKKIKVFRKHKYFSKPSDSNQGSYVYDYNGNDLDEYRELVASGLVLNT
EYFKTVTTGDPLLIGITNEDIIKVGLTSGKVTKNSTNLIMEPLTIANNFPGPFTLNEGDM
YQKLAVIKGTVYNQNFQENDFTLEDGEYLYTLGIPKSYEDSSIAFESITIQASGTPGVKY
SIYNKRTGNYEEVKNLYKLEKQKIADYLDENRKITLKVNKATNGDPYMQLPSVKVKGEIK
E
>PK3-045_03228 hypothetical protein
MIIQSVVLLILIGGVVLTVKGHLVQHHAYARLGDSLPAKKFTEAEGENLLTIEEENLFLS
SLSGLRMKIIGAILIAIPSSILILFHLN
>PK3-045_03229 Signal recognition particle receptor FtsY
MSFFKKLKEKMSQQTTTVTEKFKEGLSKTRNNFSEKVNELVSRYRKVDEDFFEELEEILI
GADVGFETVMELIDELKKEVKRKNIQDPKEVQDVISEKLVAIYQNGEDQSSTINMQAEGL
TVILFVGVNGVGKTTTIGKLAHKYKEEGKKVLLAAGDTFRAGAIEQLEVWGERVGVDVIK
HTEGSDPAAVMFDAVQAAKSRQADILLCDTAGRLQNKVNLMKELEKVKRVIEREVPGAPH
EVLLVLDATTGQNALVQAKTFKETTNVSGIVLTKLDGTAKGGIVLAIRNELHIPVKFVGL
GEKMDDLQSFDPEKYVYGLFSNLVEQSEE
>PK3-045_03230 Chromosome partition protein Smc
MFLKRLDVIGFKSFADRISVDFVPGVTAVVGPNGSGKSNITDAIRWVLGEQSAKSLRGSK
MEDVIFSGSDSRKAVNFAEVTLTLENEDHFLPLDFHEVSVTRRVYRSGDSEFLINKQSCR
LKDIIDLFMDSGLGREAFSIISQGKVEEILNSKAEDRRSIFEEAAGVLKYKTRKKKAEGK
LVETQDNLNRVNDILHELESQVEPLKIQSSMAKEYLHHRENLESIEVALMVHDIEEAHER
FEAISKQLETYKQEELKLSSMLQNKEAKMEEVKNEVAALDESIDDLQQVLLLVSEELEKL
EGRKEVLKERKKNATQNRDQLEKSKVELQERVETLVLQKEEQQKLVHELQAESKAIEETL
KANEKNLALFNENLEEKIEMLKSDYIEIVSNQAAAKNELNSVIQQLENYEKRTSQLDEEN
ANFTNERMHIQEKKTKFMEKLKELSDELEKWSKQWQEKQSHFQGIEAKVQQVEKALYQSY
QYAQQAKSRKEMLEELEDDYSGFFHGVKEVLKARGKSLQGIRGAVAELMQVPKEYSVSLE
IALGGSMQHIVVETEQNGREAIAFLKKNGFGRATFLPMNVIKGKTLADSQLRLIQGHPSF
IGVAADLINYDSQYREIIRSLLGNVVITKDLKGANEMAKILQYRSRFVTLEGEIVNPGGS
MTGGAMKQKQASIITRKGELEELKKKIFEMDKTSLKLEEQLKKGKAALQAEESSIEEARL
KVEDLRFQIQTWKDDLKEVEFEERAMNDKLSLYDRNKADSHQEQELLQQRRTVLQEKLEQ
QSKKLSELDKEIALVTEQKNKQTVSKESVVNTISDLRIQSAAKKEQLRHEKDKLAAIIQE
HESTEEKWELVKEDLRLLSSEMSNSHSGEATLEEAAEQKLQEKQETIQLISLRREERLQK
QMRLEELELETKEQRRLHRGIVQALKDEEVKLNRVDVELDTRLTNLREEYLLTYEGAKLD
YPLTLEVEEARKKVKLIKLAMEELGTVNLGAIEEYERISERYEFLLEQKTDLEEAKDTLY
QVIDEMDEEMKNRFEQTFEGIKAHFETVFQSLFGGGSADLVLTNPEDLLNTGVEIVAQPP
GKKLQNLSLLSGGERALTAIALLFSILKVRPVPFCILDEVEAALDEANVFRFSSYLKRYS
HETQFIVITHRKGTMEEADVLYGVTMQESGVSKLVSVRLSETKELVANG
>PK3-045_03231 Ribonuclease 3
MRGNRKDKRTVRPNEKKMKELQDKLGIHFTNEKLLKQAFTHSSYVNEHRRKPHEDNERLE
FLGDAVLELTVSKFLFNKFPMMSEGELTKLRAAIVCEPSLVSFANELSFGKYVLLGKGEE
MTGGRTRPALLADVFEAFIGALYLDQGLDSVVAFLEEVIFPKINNGAFSHVMDFKSQLQE
YVQRDAVGTIEYKILLEKGPAHNREFISQVFLNNRELGTGMGRSKKEAEQQAAQKSLLML
KAESEN
>PK3-045_03232 Acyl carrier protein
MADVLERVTKIVVDRLGVEESEVTLEASFKDDLGADSLDVVELVMELEDEFDMEISDDDA
EKISTVGDAVNYISNR
>PK3-045_03233 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKLAGKVAVVTGASRGIGKSIALELAKQGADVVVNYAGSVERANEVVKEIEALGRKAISI
QCDVSDSDAVNAMMKEVLEAFGSLDILVNNAGITRDNLLMRMKDSEWDDVINTNLKGVFL
CTKAVTRPMMKQRKGRIINITSIVGVTGNPGQANYVAAKAGVIGFTKTTAKELAQRNITV
NAIAPGFITTDMTDKLTEEVKNGMLTQIPLGQFGKPEDIANAVVFLASDESSYITGQTLH
IDGGMYM
>PK3-045_03234 Malonyl CoA-acyl carrier protein transacylase
MSKIAFVFPGQGSQVVGMGKDLFEQFEPAANVFKKADQKLNFSLTDLIFDGPKEELTLTH
NTQPALLTTSIAILEHFKQFNIQPDFVAGHSLGEYSALVAAGVLSFEEAVYAVRKRGEYM
QEAVPAGEGAMAAVLGLEREKLTAVTHEISDAGNSVQLANLNCPGQIVISGTTKGVELAG
ERAKEAGAKRAIPLEVSGPFHSELMKPAAEKFASVLDGLQLTDAKIPVIANVTAAPIQDH
AEIKTKLVEQLYSSVLWEDSVRNMLDLGVDTFIEIGPGKVLSGLIKKIDRKAKVYAVNDI
ETSSKVAEELKGDM
>PK3-045_03235 Phosphate acyltransferase
MMKIAMDAMGGDNAPKEIVIGAQKAIETFSDLEILLVGDEKQIQASLTNKERINILHTEE
QILATDEPVRAVRRKKTASMVLGATEVKEGRADAFISAGNTGALMATGLFVVGRMEGIDR
PALAPTLPTIGGEGFLLLDVGANVDAKPENLVQYAMMGSIYSEKVRGVAKPRVGLLNIGT
EEKKGNELTKKTFELLQNTNIHFIGNVEARDLLEGVCDVAVTDGFTGNMILKTVEGTAMS
MFKMIKAELMSSFTSKMAAAVLKPNLKQIKNKLDYSEYGGAALFGLNAPVIKAHGSSDSQ
AVFSAIRQTREFVQSGVVAQIKDAMENK
>PK3-045_03236 Transcription factor FapR
MKRNKRERQELLVETIKETPFITDEELAEKFSVSVQTIRLDRLELSIPELRERIKNVAKQ
SLEDEVKALPIEEVIGEIIDMELDSSAISIFEVKEEHVFKRNGIARGHHLFAQANSLAVA
LINDELALTAKASIHFTRSVKLGERIIAKAKVKHIDSITGRTTVEVNSYVNTELVFKGEF
DMYRAKR
>PK3-045_03237 ATP-dependent DNA helicase RecG
MSESLQLSVEHIKGVGPETKKQLEEMNIHKINDLLEYFPYRYEDYRLKNLEEIKHEEKVT
VEGKVHSEPSLIFYGRKKSRLTIKLLVEQYLITVVFFNQPYLKSKLAVQELITVTGKWDQ
HRQTITANHLQIGSNQKGHVFEPVYAVKGNMTVKSLRKYISSALNQYGELIEENFPPSML
TKYRLLPRKEALKIIHFPEKREDLTQARRRFVYEEFLLFQLKMSALRKYEREHSGGKSQQ
YSLEKLTTFIKELPFPLTNAQKRVVNEILTDMKADVRMNRLLQGDVGSGKTIVAAIVLYA
SILSGNQGALMAPTEILAEQHADSLHHIFSEFGVTCGLLTSSVKGKKRKELLAQLKEGKI
DILIGTHALIQDDVVFKSLGLVITDEQHRFGVEQRRVLREKGENPDVLFMTATPIPRTLA
ITVFGEMDVSIIDEMPAGRKNIETYWVKHDMLTRILQFMEKELQQGRQAYVICPLIEESE
KLDVQNAIDVHAMLSTFFQGRYNVGLMHGKLHPEEKDNMMKQFSQNEIQVLVSTTVVEVG
VNVPNATFMLVYDAERFGLSQLHQLRGRVGRGDAQSYCVLIADPKTDVGKERMKIMTETS
DGFVLSEKDLELRGPGDFFGKKQSGLPEFKMGDMIHDYRILETARNDAAILIESTAFWQN
DDYKALRDSLEETGVLNGEKLD
>PK3-045_03238 L-serine dehydratase, alpha chain
MFRNVAELVEIATTRSLPISEIMIEQEMQVTGKTRQEIIGQMETNLQVMEQAVERGLKGV
VSHSGLTGGDAVLLQNYIKKGQFLSGEIILDAVSKAVATNEVNAAMGMICATPTAGSAGV
VPGTLFAVQNKLNPTRKQMIAFLFTSGAFGFVVANNASISGAAGGCQAEVGSAAGMAAAA
IVEMAGGTPEQSAHAMAITLKNMLGLVCDPVAGLVEVPCVKRNAMGAANAMIAADMALAG
IKSRIPCDEVIDSMYRIGQAMPTALKETARGGLAATPTGRRLEAEIFGSAAAANK
>PK3-045_03239 L-serine dehydratase, beta chain
MKFKSVFDIIGPVMIGPSSSHTAGAARIGRVARNLFEREPKWINIHFYGSFAETYKGHGT
DVAIIGGILDFDTFDERIKESLEIAEQHGIQVKFHIEEAIPEHPNTAKIHLGDDDGEMEL
VGISIGGGKIEIIELNGFQLKLSGHHPAILVVHNDRFGAIAKVANVLAKHEINIGHMEVS
RKEKGKLALMTIEVDQNIEEAILKELEQLDSIEKVTTIVE
>PK3-045_03240 putative protein
MSITVLEGKRFAEMVIQGANHLSSNAKYVDALNVFPVPDGDTGTNMNLSMTSGAKEVQKN
IQSHIGKVGTSLSRGLLMGARGNSGVILSQLFRGFSKHIEQKETITGKEFANALQFGVET
AYKAVMKPVEGTILTVAKDAAKKAVQSAEKNDDIIVIMEDTVKEAKASLNRTPELLPVLK
EVGVVDSGGQGLVFVYEGFLAELKGEKLPDAVQNVVSMNELVNAEHHKSVHSYINTEDIE
FGYCTEFMVRLEQEKLGNKPFSEDDFRQALSKYGDSLLVIADDEIVKIHIHSNQPGEVLT
FGQKYGNLVKMKIENMREQHSSLVDAAEKEEVNNTHSVEEQKEYGVVTVSMGSGIADLFR
SIGAHYVIEGGQTMNPSTEDIVNAVRRINAKKVFILPNNKNIIMAAEQAADVLEQDVVVI
SSKTVPQGMSALLAFNPSSDLETNEKNMKAALEHVKTGQITYAVRDTSIDGLAIETGDFM
GLAEGKIIVKSKDKTESAMELLKSMIDEDTEIVTIIKGEEATEEEVETLVSFIEDNFEDV
EVEVHDGKQPLYSFIFSIE
>PK3-045_03241 putative protein
MSIELRTNFGQIDISTEVIATIAGGAAVDCYGIVGMASKNQIKDGLTDILRKENFTRGVI
VRKVEEEVHIDMYIIVSYGTKISEVAHNVQSKVKYTLNKTVGLAVDSVNIYVQGVRVTNP
>PK3-045_03242 50S ribosomal protein L28
MPRKCVITGRKTTTGNARSHAMNANKRTWGANLQKVRILVDGKPKRVWVSARALRSGKVE
RV
>PK3-045_03243 Thiamine pyrophosphokinase
MIVHIMAGGPKQYIPNLDNYSKDICWIGVDRGVMYLIERSLPIYAAFGDFDSISETELHA
MEEKTGIIKRFKPEKDETDMELALLWAIKEGATTIRLFGATGGRLDHTIANLQLLLREAL
DNKHIQLEIIDKQNSVSVVQAGAYTVKKLEEYKYISFFPYSTKIVGLSLEGFKYPLVRRN
LPASSTLCISNELIRETGTFSFEEGILMVIRSCD
>PK3-045_03244 Small ribosomal subunit biogenesis GTPase RsgA
MPKGKIIKALSGFYYVLSEGQLIQCRGRGVFRKNKITPLVGDEVVFQAENTTDGYILEVK
ERKNELVRPPIANVDQAILVFSSVEPDFSTALLDRFLVLIEYNRIDPVICMTKMDLASSE
VVEKMKEYAAQYEAVGYPVILTSSETETGIGQLLPYLKDKISVFAGQSGVGKSSLLNVIR
PDLDLKTNEISSSLGRGKHTTRHVELISIGDGLVADTPGFSSLEFLEIEGEDLNYCFPEI
EKTSENCKFRGCLHLSEPKCAVKEAVENNEIPTYRYEHYKDFLQEIRDRKPKY
>PK3-045_03245 Serine/threonine-protein kinase PrkC
MMIGKRISGRYKVLEMIGGGGMANVYLAHDMILDRDVAVKMLRLDYVNDEEFIKRFHREA
QSATSLAHPNVVNIYDVGEEGDIYYIVMEYVEGDTLKQYIHKNSPLSVETVIAIMQQITS
AIAHAHQNNIIHRDIKPHNILIDKEGKVKVTDFGIAMALSATSITQTNSVLGSVHYLSPE
QARGGMANKKSDIYSLGIVMFELLTGRLPFSGESAVSIALKHLQSETPSVRRWNEAIPQS
VENIVLKATAKDPFYRYNSMEEMSEDLQTALNLERLDEPKFAIPVDDEATKAIPVITNDG
LYKNFDETIIHTNEKEDQGKTLVKESPKKKEKKEKKKKAKKKGKKIAAIIISTFLALLLI
MGLVLFLLPDLLAPEDIVVPDVAGLELDKAKTTLEEKGFVVSDTITLNSDDVEKGHVIKT
SPSAGSARREGTEITIYESLGKETVVLSDYVGRKYDDVVKLLESEGFDFKDIEPIEVFDD
SEPGTILEQNIKPKEEVVPSETSLEFTISKGAQLISVKDLSDYTKKEVNDYVDDVGLTVT
FKEEYSDTVEKGLVISQTPEARTNLKKGAEITVVLSKGKKEVQPKEVMKEISIPYEPTEM
TADGKPVEQTVRIYIGDFNNSMTEPAETFKITENTKKTIYLQIPEGQKGYYRVQIDSVVI
IDEEVPYPN
>PK3-045_03246 Protein phosphatase PrpC
MSQIFMTDKGKVRQHNEDSGAIIRNKSGQRLAIVADGMGGHRAGDVASSLTVEKLTELWT
MVEEIKTADEAENWLESNILEVNQYVFDYASTHPECEGMGTTIIGVISTENFATIAHVGD
SRCYLYNEDGFKQITEDHSLVNELVRMGQISKEDAEHHPRKNVVLRALGTDAQLNIDVMT
IIFEEGDIIFICSDGLSNKVTDQQIKEILEKEITLEEKASTLIETANINGGEDNITVVIL
EYGDGHQAGEGQ
>PK3-045_03247 putative dual-specificity RNA methyltransferase RlmN
MEQVKTSSRRRQKAEPTIPSIYSMELQALKDWLTAHNEKAFRADQIFEWLYKKRVTSFED
MSNLSKNLRLMLQENFTITTLNTLIQQTSNDGTIKFLFELHDGYSIETVLMRHDYGNSVC
VTTQVGCRIGCTFCASTLGGLKRNLEAGEIVAQVVKVQQALDELGERVSSVVIMGIGEPF
DNFTSMLSFLKIINHEQALNIGARHITVSTSGIIPKIYEFADQNMQINFAVSLHAPNTEL
RSRLMPINRAYKLPDLIEAIRYYVDKTGRRVSFEYGLFGNVNDQVEHAEELAELVKGIKC
HVNLIPVNYVPERDYVRTPKDQIFLFEKTLKKHGVNVTIRREQGSDIDAACGQLRAKERK
EETR
>PK3-045_03248 Ribosomal RNA small subunit methyltransferase B
MKKTKKNVREAALDILEAIQKNQAYSNLLLNTTIKKNEIPSKDIGLLTEIVYGTLQRKMT
LEFYLRPFLNKGKKIEEWVYILLQMTVYQIVYLDRIPDHAAINEAVEIAKKRGHKGISGF
VNAVLRNMQRQGLPSFHEIQDEIERLSIETSHPTWLVKRWVEQLGVEEAKKMCEINLTAP
MQTARVNTTKVSVTECIELLTEEGFQVEASEVIPEGIKVLKGNIAHSSAYEKGLLTIQDE
SSMIVAYALDLDKPYSVLDACAAPGGKSTHIAEKMNKDGNILSIDLHDHKVKLIKQNADR
LNLPTIETKAMDSRKLDKSLEQESFDRILLDAPCSGFGVMRRKPDMKYTKTEADVDRLQK
IQLDLLASVSLLLKKGGILVYSTCTIDKAENEEVVEKFLAANTQFERDSTLADRLPQDVK
NYAEGNELQILPQYFGSDGFYIAALRKKVQ
>PK3-045_03249 Methionyl-tRNA formyltransferase
MTKVVFMGTPDFSVPVLQRLLEEKYEVIAVVTQPDRPVGRKKVLTPPPVKVEALKHDIPV
YQPEKIRQSDELKAIISLNPDIIVTAAFGQILPKELLDAPKFGCVNVHASLLPELRGGAP
IHYSILQGKEKTGITIMYMAEKLDAGDIISVAEVEIEEEDTVGTLHDKLSRVGSDLLAET
LPKLLAGEITPIPQNDEEATFAPNLKRSDEQIDWTVSGEEIYNKIRGLNPWPVAFTLYQG
KVMKVWAGKKVAKKKDAAPGTIVDITDQGPIVATGNDTYIQLTEVQPAGKKKMDISEFLR
GAGSKMQVNEILGVTNEEN
>PK3-045_03250 Peptide deformylase 1
MAVKQIVMYPDPVLEIPCAEVTVFDKKLAKLLNDMYDTMIEFDGVGLAAPQIGISKRIAV
VDIDDDMGTLELINPKLLEVNGSQVGPEGCLSFPGLFGDVERPLSITVEAQNRKGKKYII
EAEEYLARAILHEMDHLDGVLFTSKVIRYLEEDELEGVEAND
>PK3-045_03251 Beta-galactosidase
MTRQEYPRPQFVRDQWINLNGTWQFQFDDKNVGEQEQYFNKETLDKEIQVPFVYQSKLSG
IGERTIHEYVWYKKEVVIPKYADKRTILHFGAVDYYCKVYVNGKFVGDHEGGHTSFSFDI
SNYLLDENQSITVKVYDPIKDETIPRGKQFWEEEPRAIWYTNSTGIWQTVWVEQVNNDYL
EKVRFTPDLDRGVVWMDFDLNKEAEISKANYYVKYKISFKNILIAEDRIKMNNLAEKRAV
DIIQNKIFRTNFHDSGYTWSPEHPNVFNVSIELCDEKGIVLDKVQSYFGYRKVHTENGMV
YLNNKPYYQKLVLDQGYWPEGLLTAPKAEDYKKDIELAKEMGFNGCRKHQKTEDPLFMYY
ADTLGFLVWGECASAPVYTKEAATRLMKEWMEIVDRDYNHPSIVTWVPLNESWGIPDIHH
DKKQQHFSTTMYHMLHAIDGTRLVISNDGWEATVTDICAIHNYGHGNADEKAKYQYFKES
ISTVDNLLTHSHSKWEVYAENHSHQGEPILLTEFGGIAFKIGEQSGWGYTSVENAEDYIT
EYRKIMEAIFQSKGLWGYCYTQLTDVEQEINGILTYNRIPKCDLSKINELNNLFFPERLA
IKGKAANGGIN
>PK3-045_03252 Beta-galactosidase
MNVLHPNPQFHRVEWVSLDGKWKFAFDDKKVGDKERWYDSFPESQTINVPFTYETKASGV
NQQEHHETVWYERTIVIDDTKKHPIVHFEGVDYEAFIYVNGNLATIHQGGYHGFSVDVTD
FVTTGENKLTIKVKDSKDCAQPRGKQRWHDENFGCWYVQTTGIWKSVWLEYVNEFHLNHA
KITPLFDAQQVAIEVETKGIPLTADGYKIVASIQFDDKVINELTANIIDNAASLTGSVLE
RLDPWTMKVWSPESPKLYDLTLKLYHHDELLDEIHSYFGMRKISIEGNRILLNNRELYQR
LILDQGYWEESDLTPPSVAALEEDIDKILELGYNGVRKHQKVEDSRFLYLADKKGLLVWL
EVGSTYGFSDKAVRNFTHEWLEIVKQNYNHPSVITWVPFNESWGIGDIHHDKQQQAFTES
IYHLTKAYDRNRPVITNDGWEHTISDIITLHDYEEYGALLASRYKDSDKLMSNGIQFNKG
FYAFADGYPYKGQPIVISEFGGIAFQTEEGWGYGNQVKDEEAFFKRFEDIHHAVQDLEYV
CGYCYTQLTDVQQEVNGLLTIDRKPKVSVERVRQVNTRRL
>PK3-045_03253 hypothetical protein
MNRKLERNLVRIVGVWQIVDGLITILLYGTVKKVEGAKLVEDSAFVYIKAMESYVGSIYI
FIGMFGALLIGLGLINLVCAKKYMIDDQVHVKVAVWLFVCGALSYIIMDIISLVLCMSAG
ILVLAKNKSIRKINRTINKRVGGIN
>PK3-045_03254 L-arabinose transport system permease protein AraQ
MSSKRINPLPKIIGFAFLLIMAVIWIIPLLWGVVTSFKSEIELQTVGFKFLPIEWVLTNY
TTLLVDNTSTPLVRWFTNSVVISVSHTLLVLIVVTLSAFAFSRLNFRGKNGLFAFLMATM
MFPGVVNLIPLYKIIDILGWVNSPIAMIVPGAAGVFNIFLVRQFMNNIPLEFDEAARMDG
ASDFQILGKVILPLIKPVLLVVALFSFTGSWNDFLWPSIVFNDIEKMPITPGLQLLQGMY
QAQPTLLMAGALVAIIPTFILYLFAQKYFLESMSLSAGVKG
>PK3-045_03255 Lactose transport system permease protein LacF
METVPATKNVKQMKLKNSRSTSFAPWLFLAPHLIIFGVFFLIPIFFGIYISFTEWDLISS
PIFVGLDNYKELLLQPDSVFYEQLHNGLKNTFLFVLFTVPFCIIVPLLLAAALNTKPVLW
KVFQSLFYLPSLFAISAVIIIWGLMFNVTYGPINNIFNLETVWTGTQPYAWIALVAVTVW
WTIGGNMIIYQAALNGIPKDYYEAADIDGASPFQKFMKITLPSIRGQILYTVVITTIAQF
NVYGQPLMLTGGGPTDSTRVLLMDIQQNAFGSGQSIAGISSAMAVILGLCIMVVASLQFF
FLREKKN
>PK3-045_03256 hypothetical protein
MGAKSKLWKYVGVIGLSISILAGCGDSEASSSAKNEITFWNPFTGPDGKNMQAMVNEYNK
TNPEYKIKNVSLKEGDMYTKIPTIVNSKKNIPDLTIVHAERIKQFKDNDMLTSYNDLLAD
FPEIKADNYVAEAWKIGELDSERYSIPLDIHTFGLYYNKDLVDQYLPTALDDNIVTFDEI
KQVGEKAQKDKIRALGVTWLKPNFLSLYAQNGGELTEDGIQPTLVNQAAKDTFNLWRDYV
KAGYTTKDGEDPTQMFLTGKVVFLPEGIWMQNQIKESKVNWGLTNAPQLSDDLSKAVNWS
SSHQFVMLKDDSRTEEKEKAVVKFLDWVRDNSMEWAKSGQNPATLALLENEEYKAMPQSF
FLATPEQQATLKIFDYKYNGYVSELLDSKAGDVVFSKTETDKALEDMEKEISAKVEKDNS
N
>PK3-045_03257 hypothetical protein
MQIQISKDYFHIYQALASETRIEIIEILAKNNMNISDLAKQLGISAAIVTRHIQKLEEAG
IVKSERIPGKSGLQKIVYLAIDNIEIHFPRKIFKEYQLHETDLKIGHYTDFSVKPTCGIA
TEKEIIGKADDPKYFMDSQRVDAQLLWLSQGFVEYKIPNLLGPNEIPEMVEISLELASEF
PLSNNVWPSDITFYLNNVKLGTYTVPGNFSDVRGRYTPKWWNDKFSQYGLLKTIRVNKID
TGIDGEPFSSVTINELQLESSPFLTLRIAVEEESERVGGLTIFGEHFGNHKQNIQVGIYY
LEKENN
>PK3-045_03258 primosomal protein N'
MTVAKVIVDVPAKQTDRPFDYLIPEELEDVIQPGMRVIVPFGPRKVQGFVESIEETSSFK
SLKKIIEPMDLVPVLNKELLSLADWLSHSTLCYKISAFQAMLPPALKAKYERKVKKVSGE
EEKMAEGVAALFTKTGEVVWEEALKNVSLSSLQKEVKKGTIEVSYEVQSRGKKKKVKHIY
PLLNREELLHYEDSLNKNAKKQKELLVYFSEHPDPIEQKQLLTKLSISTAVIKGLVEKGL
LAEMEKEVYRDPYQEREFERTFALPLTDDQAKVVAPIHQAVEQNQHEVFLLYGVTGSGKT
EVYLQSIDKVLAKGEEAIVLVPEIALTPQMVNRFKGRFGDQVAVLHSGLSVGEKYDEWRK
IQRNEVKVVVGARSAIFAPFTNLGLIIIDEEHEMTYKQEENPRYHAKDVAIERGKKHGCP
IILGSATPSLESFARAQKGVYSLLSLPNRMNNQELPKVEIIDMREELRSGNRSMFSEVLL
EKLKDRLEKKEQTVLFLNKRGHSSFVMCRDCGYVVKCPNCDISLTYHRFQNQMKCHYCGY
ETYTPTTCPECSSEHIRYFGTGTQKVEEELTKILPEARVIRMDVDTTSRKGAHEKLLQKF
QEGEADILLGTQMIAKGLDFPRITLVGVLSADTMLHLPDFRSSEKTFQLLTQVSGRAGRH
ELQGEVIFQTYTPEHYSIELASEQDYDRFYETEMMIRRQHAYPPYYFLTMITISHEELMK
VVGVAEKITQIVRNRLSPQTVILGPVASPIARIKNKYRYQCLIKYKKEPNLEEVLKSILD
HYQTEISTNGLQISIDVNPFILM
>PK3-045_03259 Coenzyme A biosynthesis bifunctional protein CoaBC
MMLNGKKILLCVTGGIAVYKVCALTSKLTQKGADVKVIMSESAMEFVNPLTFKALSKNEV
YTDTFDEKDPKVIAHIDLADWADLILVAPATANVIGKIANGIADNMITTTLLAATSDVWI
APAMNVHMYDHPAVIKNINTLHDYGYRFINPGEGYLACGYVGKGRLEEPEMIVQHMEDYF
SDNNKNKILTGTTVLVTAGPTREKIDPVRFISNHSSGKMGYSIAKKAIAYGADVILVSGP
TNLAPPKGAQVISVESAEEMYNAVMTSREKADIIIKTAAVSDYKPTIVYDHKVKKQSGPE
TIEFTRTQDILSELGKRKEQQILIGFAAETQNMAEYAMDKLKRKNADMIVANNVNRQDSG
FGTDTNLVTMYKRDGTSIELPLLSKDEVAEKILEQAMLMKEAVQK
>PK3-045_03260 DNA-directed RNA polymerase subunit omega
MLYPSIDKLMTKIDSKYSLVSVAAKRARKLQTNAKPQLAKYVSHKNVGKALEEINKDQLT
YRVNTPNGASEE
>PK3-045_03261 Guanylate kinase
MVEKGLLIVLSGPSGVGKGTVRKEIFSQKNTSFEYSISMTTRSPRAGEVDGVDYFFKSRE
EFENLIEQGKLLEYAEFVGNYYGTPVDYVRETTLKGKDVFLEIEVEGAKQVREKFPDGLF
IFLSPPSLSELKNRIVTRGTESEEIINNRMNVAREEIEMMHLYDYVVENDTVENACEKIK
AIIVAEHCRRERVEPKYKKMLEAN
>PK3-045_03262 Extracellular matrix regulatory protein A
MSIKLINIGFGNIVSANRIISIVSPESAPIKRIIQDARDRGSLIDATYGRRTRAVIVMDS
DHVVLSAVQPETVAHRLNDRDEIIEEG
>PK3-045_03263 hypothetical protein
MKSMTGFGRATKQYHHSTLHIEIKSVNHRFSDQIIRMPKQFLYLEDQIKKIISNYIHRGR
IEVFVTLEDEDKKGQEIIVDWPLLDQYYQLLHQLKDKYSIKEPISLRDLLNQEECFQIVE
RELDMEELSEVLLATMEEAVVQLNRMRTIEGEELSKDLESNLKQIEKLVANLQSLAPEVI
AQYREKLKARIESYLTEPIDEARLITEVAIFADKADINEELVRLHSHIRQFYQIMEENNP
IGRKLDFLLQEMNREVNTIGSKANSADIGANVVEMKSCLEKMKEQIQNIE
>PK3-045_03264 Calcium-transporting ATPase
MNYHEMNEKEVEQTLNTDFSAGLSDEEAEKRRKNFGYNELEEGEKQSLLLIFFSQFKDFM
VLVLLAATLISGLLGEYIDAIAIIAIIILNSFLGFFQEIRAEKSLSALKELSQPHVQALR
NGEWVSLLSKELVPGDVIKFASGDRIGADVRIIESRSLEVEESALTGESVPVPKTVSAIK
NNNLALGDMENMGFMGTMVSRGSGVGVVIGTGMKTAMGQIADLLQNADSVTTPLQRRLEQ
LGKILIVTALLLTVLVVVIGVLQGNDLYTMVLAGVSLAVAAIPEGLPAIVTIALSLGVQK
MIRKNAIVRKLPAVETLGCASVICSDKTGTLTQNKMTVTKTWIGGKTYTVDGTGYEPQGQ
YYVGEQLVNPAKDKALQQLLTFGMLCNHAEILQKDDDYVLNGDPTEGAILVAGMKAGFTR
AQLLNQFAIVNEFPFDSTRKMMSVVVKDPTGRQFVVTKGAPDVLIGQSKSILFENRSQAL
GNKEKQVVQDAINGLASQALRTIAIGYKEISPNTLIMHEREAEKDLIFIGLQGIIDPPRP
EVKQAVKECKEAGIKTVMITGDHVITANAIAKQLGIANNHSKVMEGKELSDLSLKELEDI
VEDVAVFARVSPEHKLKIVQAFQNRGHVVAMTGDGVNDAPAIKKADIGIAMGITGTDVAK
EASSLVLMDDNFASIKSAIVEGRNIYENIRKFIRYLLASNVGEILVMLFAMLLALPLPLV
PIQILWVNLVTDGLPAMALGLDRPEDNVMKRGPRSPNEGVFSRGLGWKVISRGFLIGVST
ILAFMFAYNNNPENLEYAQTVAFITLVLAQLIHVFDCRSEKSILSRNPFGNMYLVWAVVS
SLVLALIVIYVPGLQEIFHTLPIAMKDWPMIIGFASVPTFLLAGSFLLSKSK
>PK3-045_03265 Rqc2 RqcH
MSFDGLFTRAMSLELKELLLGGRINKVQQPFTNEIILSIRANGKNQKLLLSAHPSYARIQ
ITEENYENPKEPPMFCMLLRKHLEGYFIEDIYQIDNERIIVLEIRGRNEIGDTSYKKLMI
EIMGRHSNIILVDRDKNTILDSIKHISYAVNSHRAILPGYEYLAPPKQEKQDPYTATEED
ILRAIDFNSGKLDKQLVQQFAGLSPLVAKEMVYQAGLANRETLPKAFLMVMEPIKNGNYA
PSIMDTPEKEYFYCLSMEHVKGNVKSFPTLSKMLDRYYFGKAERDRVKQQSNDLERFIVN
ERDKNKKKIKKLERSLSEAENAEQYQLLGELLTANLYAVKKGLSEVEVINYYDEESKTVK
IPLSPRLSPSENAQKYFTKYQKAKNSIDIIKEQIKLADQEYGYFETLYQQILAASPKDIQ
EIREELVEEGYLRERQKKQNKKPQNIKPVLDYYVSSDGTEIIVGKNNKQNDYLTNKVAAR
DEIWLHTKDIPGSHVVIRSKEPSEETIMQAAILAAYFSKARQSSSVPVDFTLVRHVKKPS
GAKPGFVIYDNQQTVYVTPDEETVIRLKKS
>PK3-045_03266 Orotate phosphoribosyltransferase
MKHEIAEQLLEIKAVFLQPNDPFTWSSGLKSPIYCDNRLTLSYPKVRKNIATGLADLIKE
NFPETEVVAGTATAGIPHAAWVSDILDLPMAYVRSKAKAHGKGNQIEGKVEKGQKVVVVE
DLISTGGSVITAVNSLREAGCEVLGVVAIFTYELPKGKELLGDAEITAYSLTDYSSLLDV
AQKQGYIQEGDLASLNAWKESPENWG
>PK3-045_03267 Orotidine 5'-phosphate decarboxylase
MNNSLIIALDFATKEEVHSFLSKFNGESLFLKVGMELFYKEGPSIIKELKEQNHQIFLDL
KLHDIPNTVGSAMKNIASLGVDLVNVHAAGGVDMMARAVEGLEAGTPSGMKRAKCIGVTQ
LTSTSEASMQKEQLISVPLVESVLHYATITKEAGLDGVVCSTLEAGAIREQLGESFLTVT
PGIRLQTDQVQDQVRVATPQVARENGVSAIVVGRSITRAENPYESYTLFKSEWEGIML
>PK3-045_03268 Dihydroorotate dehydrogenase B (NAD(+)), catalytic subunit
MNRLQVKLPGLELKNPIMPASGCFGFGREYSNLYDLSKLGAIMIKATTVEPRFGNPTPRV
AETTSGMLNAIGLQNPGLKKVVGEELPWLSQFDVPIIANVAGSVEEDYVEVAKEISKASN
VAALELNISCPNVKTGGIAFGTIPEVAKELTKKVKEVSEVPVYVKLSPNVTNIVEMAKAV
EAGGADGITMINTLVGMRLDLKTAQPILANKTGGLSGPAVKPVAIRMIYEVSQAVNLPII
GMGGVSSAEDVLEFFYAGASAVAVGTANFVDPFICPKIIEELPELLDKYGFEHISEVTGR
SWGKHEQFAYHRA
>PK3-045_03269 Dihydroorotate dehydrogenase B (NAD(+)), electron transfer subunit
MIKNEICTVVDQKEIAENIMELTLTGGLVSEMNEPGQFVHIKVSDHSAPLLRRPISICHI
DQERKTFTMIYRAEGAGTKLLAKKQAGEAIDILGPLGNGFPIEESKSGQTALLVGGGIGV
PPLYELANRLVAKGVKVVAVLGFQTESVAFYEEKFAKLGDTYIATVDGSYGTQGFVTDVI
FQEKLEFDVLYSCGPTPMLKNLEKTFPDKKVFISLEERMGCGIGACFACVCHTADDPTGF
SYKKVCTDGPVFRTGEVVL
>PK3-045_03270 Carbamoyl-phosphate synthase large chain
MSKLKSIKSILVIGSGPIIIGQAAEFDYAGAQACIALKEEGYRVILVNSNPATIMTDTEM
ADKVYIEPLTLEFVSRIIRKERPDAILPTLGGQTGLNLAVELSDAGVLKECGVEVLGTKL
SAIQQAEDRDLFRNLMNELGEPVPASDIIHNMEEAKAFVEKIGYPVIVRPAFTLGGTGGG
ICHNDEELEEIVTSGLKNSPVTQCLLEKSIAGFKEIEYEVMRDSNDNAIVVCNMENIDPV
GIHTGDSIVVAPSQTLSDREYQLLRNTSLKIIRALKIEGGCNVQLALDPDSFQYYIIEVN
PRVSRSSALASKATGYPIAKLAAKIAVGLTLDEMMNPVTGKTYASFEPALDYVVSKIPRF
PFDKFESAKRNLGTQMKATGEVMAIGRTFEESLLKAIRSLEAKVYHFSLNAADETSDELL
EKRIRVAGDERLFYIAEALNRGISIETIHEWSKIDLFFLFKLEGIIKFEKELVNHPFDEE
YVKEAKEKGFADIQLAKLWNTTELEIYNWRKKKGIVPVYKMVDTCAAEFESETPYYYGTY
EEENESIVTDKKSIVVLGSGPIRIGQGIEFDYATVHSVWAIKEAGYEAIIINNNPETVST
DFSISDKLYFEPLTIEDVMHIIDLEKPEGVVVQFGGQTAINLAGPLAERGIKILGTSLED
LDRAEDRDKFEQSLQDLGIPQPDGKTALTVEEAIVVAQSIGYPVLVRPSYVLGGRAMQIV
YKEEELVPYMENAVKASPGQPILIDRYLTGKEIEVDAICDGTDVVIPGIMEHIERAGVHS
GDSIAVYPPQSLSAEIKQTLVDYTTRLAKGLKIVGLLNIQYVVSKGEVFVLEVNPRSSRT
VPFLSKITNVPMAKIATKVILGTSLKEQGYQSGLVVEKSGVYVKVPVFSFAKLRRVDITL
GPEMKSTGEVMGKDITLEKALYKGLIASGMKIKTFGTVLMTIGDKDKEEALQLAKRFTNI
GYSLMATSGTAAFLESNDIPVKVVGKIGGEGHTLIDVIRNGEAQFVINTFSKGSQPARDG
FRIRRESVENGIPCLTSLDTAEAILRVVESMTFSTEAMEPSKKQSEAVLI
>PK3-045_03271 Carbamoyl-phosphate synthase small chain
MKKQLILEDGTVFIGKGFGADTEKFGEIVFNTGMTGYQEILSDPSYCGQIVTLTYPLVGN
YGINRDDFESITPAIHGFIVKEVCDFPSNWRNELSLDEYFKQKKIPGIAGIDTRKLTRII
RQYGTLKGAICSIEENAEEVIAKLKGITLSAEQVKQVSTKKPYPSPGRGSRVVLVDYGMK
HGILRELNKRDCDVIVVPYNTTAEDILNLSPDGVMLSNGPGDPKDVPESIEAIKGIIGKV
PLFGICLGHQLFALASGANTEKMKFGHRGSNHPVKDLLTGKVSLTSQNHGYTVEEESIKY
TNLEITHIALNDGTIEGLQHKEYPAFTVQYHPEASPGPEDANYLFDRFMEMIQSHKQEGA
AYVKA
>PK3-045_03272 Dihydroorotase
MNMSILIKNGQLLNTTGELEQNDILIENGAIKMIAKEINVTAEEVIDAAGKVVAPGFIDL
HVHLREPGGEKKETIATGTMAAARGGFTTIANMPNTRPVPDTVENLHNLNERIKKTANVN
VLPYASITIRQLGTELTDFKALKELGAFAFTDDGVGIQEAGQMLEAMKQAAALDMAIVAH
CEDNSLINKGCVHEGEFSKANGVNGIPSVCESVQIARDVLLAEATGCHYHVCHISTKESV
RVVRDAKKAGIRVTAEVSPHHLLLADTDIPSLDTNYKMNPPLRGTEDRAALIEGLLDGTI
DFIATDHAPHTAEEKAQSMQLAPFGIVGLETAFPLLYTNFVKTGVMTLQQLMDYLTVKPA
QSFKLDTGTLEAGKKADIVILDLEEKNKIDPETFLSKGRNTPFAGWECQGWPVTTIVSGK
IAWRKESVHA
>PK3-045_03273 Aspartate carbamoyltransferase
MENLLTTTELTVTEIQEILRDAQRFADGEIWRPANQCFIANLFFEASTRTKSSFEVAERK
LGLEVIPFETTTSSVVKGETLYDTVRTLESIGVNAVVIRHETDRYFDELVGKVNIPVLNA
GDGCGHHPTQSLLDLLTIQQEFQRFNGLKVSIIGDISHSRVARSNADALTRLGAEVVFSG
PREWFDETVLQDANYEDIDTAIETSDVVMLLRVQHERHGDERAVFDKESYHKLYGLTIER
ERKMKQGSIIMHPAPVNRDVEIADELVECERSRIFKQMENGVFIRMSVLKRSLENIGGRN
EHVNTYQKWPVA
>PK3-045_03274 Uracil permease
MNETKPLLGINDKPSALQWITLSLQHLFAMFGATVLVPFLIELSPAVALVSSGIGTLAFL
IITQFKVPAYLGSSFAFIAPVIAAKTMPGGGPGAAMIGTFIAGIVYGIVALTIKKAGYRW
IMNILPPIVVGPVIMVIGLALATTAVGQSMYMNNGAENQEYSLLYISVALVTLLATILFT
MFGKGVFSFIPILAGIVIGYVYALLVGVVNFQGVLDAKWFAMPDFIFPFVDYPVTINLAL
LTIFVPVAIVTLTEHIGHQLVLSKVVGKDYIKDPGLHRSILGDGTATIISALMGGPAKTT
YGENIGVLAITRVYSVYVLGGAAVLAIGFGFIGKIAALIQSIPTPVMGGVSILLFGIIAS
SGLRIIVEAKLDFNKNRNLVIASVILVTGIGGFSIHMGEHFKLEGMAFAAILGIILNLVL
PGREKAKEDLFEESIAVDETK
>PK3-045_03276 Bifunctional protein PyrR
MSKKALVLDDQAIRRALTRIAHEIIEKNKGIENCILVGIRTRGIYIANRLAEKIAQIEGK
PIEVGELDITLYRDDLTKKTKNEEPLVKGSDIPTDIQGLKVILVDDVLYTGRTVRAGMDA
LMDLGRPASIQLAVLVDRGHRELPIRADYVGKNIPTSSSEKIVVELDEVDGHDEVNIFEN
>PK3-045_03278 Ribosomal large subunit pseudouridine synthase D
MEKKEHIIQSEQVNERIDKIVSTINADWSRTQVQQWIKDGHVTVNGQTVKTKYKGVLNDI
VAIEVPEAVELDVEAEEMDLDIYYEDQDVIVVNKPKGMVVHPAPGHVTGTLVNGLMAHCK
DLSGINGVMRPGIVHRIDKDTSGLLMVAKNDAAHESLVNQLVAKTVTRKYKALVHGSIPH
DYGTIEAPIGRDTKDRQSMAVVDKGKHAVTHFHVLERIAEYTYIECQLETGRTHQIRVHM
KYIGYPLVGDPKYGPRKTLDIGGQALHAGLLGFEHPRTGEYLEFEAPLPKEYEQLLDTLR
NNR
>PK3-045_03279 Lipoprotein signal peptidase
MEETLVFYYIIAAIIIIIDQWTKWLVVKNMELGESIEVIKDFFYLTSHRNSGAAWGMLEN
QMVFFYIITVIVVIGLIYLIQTGTKGKMLYGVSLGLILGGALGNFIDRARHQYVVDFINT
YIFNYDFPIFNIADSSLVIGVILLILVMLREDRDAKKEKKHGEKGTYHSK
>PK3-045_03280 hypothetical protein
MNSTIEKLYTELRMTQIELVTTLRVKRDSKINKYIEDELKDVEETMQKLETGNFGMCEMS
GELLPFDLLEMIPTIRTKDDINSIQSYYRKSIH
>PK3-045_03281 Isoleucine--tRNA ligase
MEYKDTLLMPKTAFPMRGNLPNREPEIQAKWKEMNIYEKVQERTQGRPMFVLHDGPPYAN
GDIHIGHALNKILKDFIVRYKSMTGFQAPYVPGWDTHGLPIEQALTNKGVKRKEMTIAEF
RKLCEEYALGQIDSQREQFKRLGVRGDWENPYITLKPAYEAQQIKVFGEMAKKGYIYKGK
KPVYWSPTSESALAEAEIEYKDKKSASIYVGFKVKDGKGVLEEDVQIVIWTTTPWTIPAN
LGISVHPTLTYVVVEEKGSKYLVAQDLLESVKTEIGWEEAKVVQELKGKDLEYILAAHPI
YGRDSLVMLGEHVTTDAGTGCVHTAPGHGEDDFLVGQKYGLEVLCPVDDKGVMTEEAPGF
EGLFYDKANKPITEKLEDAGALLKLQFITHSYPHDWRTKKPVIFRATAQWFASIKDFRNE
LLDAVKETAWVPAWGETRLFNMIRDRGDWCISRQRAWGVPIPVFYAENGDSIITDETIEH
ISNLFRENGSNIWFEKSAKELLPEGFTHPGSPNGEFTKETDIMDVWFDSGSSHQAVLLER
DDLQRPADLYLEGSDQYRGWFNSSLSTSVAVTGKAPYKAVLSHGFVLDGEGRKMSKSLGN
VMVPAKVMNQLGADILRLWVASVDFQADVRVSDAILKQVTEGYRKIRNTFRFLLGNLADF
NPETDALSYDELREVDQFMLIKLNKLIKNVTESYDKYDFSTIYHNINNFCTLDLSAFYLD
FSKDVLYIEAANNKERRAIQTVLYESLISLTKLVAPILPHTADEVWDHISSAQEESVQLT
DFPAYTTFENSDVLEEKWNKFLVVRDDVLKALEEARNQKVIGKSLAAKVTLYVNEEVNSL
LNSIQENLQQLFIVSGFEIAGAYNSAPEDALKLENAAIVVTKADGETCERCWTVTTDVGK
VEAHPTLCERCAHVVEENY
>PK3-045_03283 Septum site-determining protein DivIVA
MPLTPLDIHNKEFAKGFRGYDEDEVNEFLDQVIKDYENIIREKKELEERLNELTDRIGHY
NNIEETLNKSIVVAQEAAEEVKRNAQKEAKLIIKEAEKNADRIVNESLSKARKIALEIEE
LKKQSKVFRTRFKMLIEAQLDMLNNDDWDHLLEYELDASELNSTK
>PK3-045_03284 hypothetical protein
MSIYQHFRPEEREFIDQVQNWRNYVADTYAPKLTDFLDPREQKVLRMIIGENQEVKYAFF
GGHEQAERKRAILYPEYYQPMEADFNLALLEVNYPKKFVTIEHPHVLGSLMSLGLNRSKF
GDIFVLDGDIQVVVAGEVEDYVRLQLDSIGKAKVTLAAVPLEKIILTEEHWTEMTTTITS
LRLDAILAAIYNFSREKAKNYITQGLVKVNFTLNENVAFMCEEGDVFSVRGEGRATIKSI
EGKTKKDKWRIVVGKLK
>PK3-045_03285 hypothetical protein
MTFIISILANALTIYSYALIVYILMSWIPNARETSIGVFLAKICEPYLEMFRRFIPPLGM
IDISPIVAIFVLNLAGRGIGQLFYWF
>PK3-045_03286 Cell division protein SepF
MSIKSKIKTFFFLEDEDYEEEQVNYQEEPSEPARNYKQPVQHTHSQHNHNHHIQQQQPKN
SQNVVSLQSVQKSSKVFLVEPRVYAEAQDIADQLKNRRAVVVNLQRIEKDQGKRIIDFLS
GTVYAIGGDIQKIGTDIFLCTPDNVEVSGNISQILQDAEYENTRW
>PK3-045_03287 Pyridoxal phosphate homeostasis protein
MLVKDNLNGIKQEIVAACKKVNRQPEEVTIIAVTKYVTIERAKEALDAGIVHLGENREEG
LLAKYDVLQDKPIWHFIGSLQTRKVKGIIDYVDYIHSLDRLSLAKEIHKRANRTIKCFVQ
VNVSNEESKHGMKPEEVIDFVKQLSEYPHIQVVGLMTMAPFTDDKEFLRECFQNLKSIQE
DVKGLQLPYAPCTELSMGMSNDYSIAIEEGATMIRIGTALVGSEN
>PK3-045_03288 Polyphenol oxidase
MEPFILRNKQFFNLDLWEQQFPNLIAGFTTKNGGKSKGDYASLNMAFHVNDQKDTVVANR
KELAQKLSFPLEQWVGAVQTHQVNIVEVTQAHLGMGASDYDSALKDTDGLFTFEKNILLT
LCFADCVPLYFIHPATKAVGIAHAGWQGTVKGIAGEMMKVFASHKIPREEVLAIVGPSIS
ERHYVVDDRVINEIEKAIQSEHKPFTTISPGQYRLNLQEANKQILLESGMLESNIHLTDY
CTYEDDAYFFSHRRDKGNTGRMMSYIGWREEDEN
>PK3-045_03289 RNA polymerase sigma-G factor
MTRNKVEICGVDTSKLPVLKNEEMRLLFKQMHEGDTSARESLVNGNLRLVLSVIQRFNNR
GEFVDDLFQVGCIGLMKSIDNFDLSQNVKFSTYAVPMIIGEIRRYLRDNNPIRVSRSLRD
IAYKALQVRERLMNKTSKEPTAEEIAKELDIPHEDIVFALDAIQDPVSLFEPIYNDGGDP
IYVMDQLSDEKNKDIQWVEELALKEGMRRLNDREKLILRKRFFQGKTQMEVADEIGISQA
QVSRLEKAAIKQMNKNIQS
>PK3-045_03290 RNA polymerase sigma-35 factor
MSKWKLRLSYYWYKLLIKLGLKTDEVFYIGGSEALPPPLTKEEEEILLEKLPKGDQAARS
MLIERNLRLVVYIARKFENTGINIEDLISIGTIGLIKAVNTFNPEKKIKLATYASRCIEN
EILMYLRRNNKIRSEVSFDEPLNIDWDGNELLLSDVMGTEDDIITKDLDASVDKKLLVKA
LHQLSNREKQIMELRFGLGTGEEKTQKDVADMLGISQSYISRLEKRIIKRLQKEFNKMV
>PK3-045_03291 Sporulation sigma-E factor-processing peptidase
MAIYLDVIWLLNFLFDSLLLYLTGILLKKKIIHWRILLGGLIGSLIILFSITPLSPYTNH
PISKLLFSIVMVAMAFGYKRFRTYIQALMIFYLATFLIGGTLIGAHYFIQFDFNLSSSVL
LASIKGFGDPISWLFVLLGFPIAWYFSRRNVEGMEVTKIQYEQIIDVIFQVGGKEFSIKG
LVDSGNQVYDPISRLPVMFVSLKNIEKDMPAEIIRLTDQPEAIIYGSQPIAPEWESKMRI
IPYKVVGKDHQLLIAVKPDSLFLKKEQEVIAVEKGLISFTNQVLSAEGIFDCIVHPKMLL
GKKSIEEKVS
>PK3-045_03292 Cell division protein FtsZ
MLEFDTNIDSLAVIKVIGVGGGGNNAVNRMIEHGLQGVEFIAVNTDAQALNLSKAEIKMQ
IGGKLTRGLGAGANPEVGKKAAEESKEQIEEALKGADMVFVTAGMGGGTGTGAAPVIAQI
AHDLGALTVGVVTRPFTFEGRKRSTHAASGITALKDAVDTLIVIPNDRLLEIVDKSTPML
EAFREADNVLRQGVQGISDLIATPGLINLDFADVKTIMVNKGSALMGIGVAAGENRAAEA
AKKAISSPLLETSIDGAQGILMNITGGTNLSLYEVQEAADIVASASDQDVNMIFGSIIND
DLKDEIVVTVIATGFNQDLSQLQPDRPGFGGLKPNNNNANTVNNPVNNREVKREEPHVQK
EQQQPRSNAQQPEDALDIPTFLRNRNRRR
>PK3-045_03293 Cell division protein FtsA
MNSNELYVSLDIGTSSIKVIIGEMINESLNIIGVGIVPSEGLKKGSIVDIDETVHSIRQA
IEQAERMVGMEIKQVVVGVSGNHVNLQTSRGVVAVSSENREITIEDVIRVKDAAQVVSIP
PEKEIIDIIPKQFIVDGLDEITDPRGMIGVRLEMEGTIITGSKTILHNTLRCVERAGLEI
QDISLQPLAAGSFALSKDEKNLGVALIDIGGGSTTIAVFENGFLKATSVIPVGGDHITKD
LSIGLRTTTEDAEKIKIKYGYAFYDHASEEEVFSVPIIGSDQHQQFNQLEISDIIEARLE
EIFELVGHELARLGVYDLPGGFVLTGGVASTKGILELAQDIFQSRVRIAIPDYIGVREPQ
YTTAVGLIKFSYKNSKLQGGNIHNPVAVPAETREKAQKTASQKQAYEKKQVEKEPSKFKK
FMGYFFD
>PK3-045_03294 hypothetical protein
MWLPIFGLIVGIVLGLLTDIKVPDEYANYLSIAVLAALDTLFGGIRAHLQNIFDEKVFVT
GFFFNIALAASLAFLGVHLGVDLYLAAIFAFGVRLFQNIAVIRSIILKKSNTHSLEKNEK
S
>PK3-045_03295 hypothetical protein
MTGITLIAGFMIAVQFQTIKEPVVRDTRDTWELREDLIHEKKLELKLIDEIRSTNGKIEE
YENETPRSKEAVLKETLAELKQEAGLTEVTGNGIVLKIESVSTEMLLGENPGVVTSELLQ
RLVNELNLYGAEEIAINDNRYVNTTVIREINNVLKMDGNPLNQLPIEIKVIAKDANTVEK
LFNYMKVSKSADEFFLSNLLLNVEMPKEPIKIPAYSNPINIHYMKPVSTSKGGDS
>PK3-045_03296 hypothetical protein
MKNNKRRRNVIFSLVFLVLGFMISFSYQNTKKDEGKAVSESQFERDLDLRNELIEQEEKN
NKLYKELKENQRDLLQLEKKLSNEAETYYNLAEDAEKYRIYLGKVAVKGEGVQIALEDGE
YNPKEDNVNNYLVHEHHVFKVINELYIAGAEAISINGQRLAHNSYILCNGPVIEIDGYQH
PAPFVITAIGDSDVLEGAININGGVKDLLVNDNVRFTLEKKRMIQMDPLNVN
>PK3-045_03297 Cell division protein DivIB
MEKGKVVSLEDRIPKLKEQRRRKANRRLIFLLLLFFLIIVCVIYFQSPLSHVKNIEITGN
HLFSFEDLEKMSGIDSKTNIWTIKKDKLTEKLKDSGGIKSAKISIVFPNTVHIDVKEYRK
IAYFEVKNEFIPLLENGEMLHDRAMTNSPYDAPIIKDIKSEDNKVIKKIGGELNKLSAEV
YNAISEVRYTPKNTDKWRVTVYMNDGNQVLASLSSFSDKLQHYPSIISQLNTDKKGVIDL
EVGSYFKAFDSEGEKKGEE
>PK3-045_03298 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MKIVVSGGGTGGHIYPALALIREIKREVKDAEFLYIGTEQGLESKLVRREDIPFKTIHIT
GFKRKLSPENVKTVWRFIAGVQKSKAILKEFKADVVIGTGGYVCGPVVYAAAKLGIPTII
HEQNSVPGLTNKFLSKYVDKVAICFEEAASFFPDKKVVMTGNPRASEVLNQDGIKGRLSV
GLKLKEPAVLIVGGSRGARPINDAVIAALPQLGEKAYQVLYVTGEVHYEAVKKEVERVGN
PENVIIKPFVHNMPEVLTSIDLTVARAGATTLSELTSLGIPSILVPSPYVTNNHQEKNAH
ALTSNGAARMLLEQDMNGQKLIEEMDAIMLNPVLLKEMKEASKKLGIPDAAMRLYNVMKE
VIDNKKK
>PK3-045_03299 putative peptidoglycan glycosyltransferase FtsW
MVPSKKTTPDIILMIITFTLLAIGLIMVYSASAVMAERNLGDSFFFAKRQMLFAGVGIAA
MLFIMNLDYWIWRSWAKPIIIVCFILLVVVLIPGVGLVRNGSQSWIGVGAFSIQPSEFMK
IAMILFLGKFLSENQKHITSFKKGLLPSLGLVFLAFGMIMLQPDLGTGTVMVGTSIVMIF
IAGARIRHFVILGLIGVAGFIGLVASAPYRIKRITSFLDPWSDPLGSGFQIIQSLYAIGP
GGLFGLGLGESRQKFFYLPEPQTDFIFAILSEELGFIGGSLILLLFALLLWRGIRIALGA
QDLFGSFVAVGIISMVAIQVMINIGVVTGLMPVTGITLPFLSYGGSSLTLMLIAIGILLN
VSRFSRY
>PK3-045_03300 UDP-N-acetylmuramoylalanine--D-glutamate ligase
MKQINDYHHKKILVLGLAKSGISAAQLLHNLGAFVTVNDSKPLDENPEAQGLLEQGITVI
CGSHPIELLEEGFQLIVKNPGIPYFNPMIKGAVERGIPVITEVELAYRVSEAPFLAITGS
NGKTTTTTLLFDMLEIDKKKPLIAGNIGTVASNVAQVAEEDNKIVIELSSFQLMGIEKFK
PKIAIITNIYEAHLDYHGTREEYAKAKGNITRNQDESDYLIVNVEQEIVMDIANRSNATI
IPFSAKRELEFGAYIKDNIIYFNDQKIMALSDITYLSALNLENILSSVAAAKLSGVTNES
IFAVLSTFKGVKHRLQFIKEINGRKFYNDSKATNILATQNALAAFNEPVILLAGGLDRGN
EFDELIPSLKNVKAMITFGQTAEKVEKAGKLAGIKTIKRVDNVDKAVPVAYDLSESGDVI
LLSPACASWDQYKTFEVRGDIFINAVHMLK
>PK3-045_03301 Phospho-N-acetylmuramoyl-pentapeptide-transferase
MQEKVIFFTILLGFLITVLISPFFIPFLRRLKFGQSIREEGPKSHQKKTGTPTMGGLMII
FSIVVTTLVMINKFSEPTIKTYLLLLVLVGFGLLGFLDDFIKVVMKRNLGLTSRQKLLGQ
IIISLIFYFVLRENEFSTAISIPFVDKPLELGWFYALFIIFWLVGFSNAVNLTDGLDGLV
SGTSAVAFGAFAVLAWSQSQFEISIFSVAIVGAVLGFLVFNAHPAKVFMGDTGSLALGGA
IAAIAILTKTEILLILIGGVFVIETLSVILQVISFKSTGRRIFRMSPLHHHYELVGWSEW
RVVVTFWTVGLLFAALGIYIEVWL
>PK3-045_03302 hypothetical protein
MTLSYNLVLQAIPEAKGFVKEDLLFQTVSFLAECEQPKGLFIPFYKDSSGDLSAAITNGA
IGAIWEEGMKLPSYTPNHFPIFYTKDLKEGILKMSKIYEQQLQAQEKTTKFIFLQENSLN
SQMETYDIAVIREHVLNTNNQMKGGN
>PK3-045_03303 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase
MQLKKLIESLQPYTPYTGEDVEIKSIENDNRKVSDGSLFICIKGYTVDGHDFAQKAYESG
AVAVIAERSLSLPIPVIVVKDTKRASSVLADVFYQKPTQKLQLIGITGTNGKTTTSHLID
AILKEANKKTGIIGTMYTKIGEEIQETKNTTPEAVTLQKVFHQMVEQKVDTAVMEVSSHA
LVEGRVFGCDYDIAVFTNLSQDHLDYHGTMEEYKKAKGLLFTRLGNAFSSEKPKFAILNK
DDAAANEYETITAAHILTYGIDKEADIMAKNIKITAAGTSFDLHTPLGIHSVQLKMVGKF
NVYNTLASIGAAIASNIPMEVTINALEKVAGVAGRFETVNAGQDFSVIVDYSHTPDSLQN
ALQTVKEFAKNKIYVIVGCGGDRDKTKRPLMAKIACEEASYAILTSDNPRSEDPLAILKD
MEEGVRAEQNYTIISDRKEAIAFAVDQAQPDDVILIAGKGHETYQIIGSKVLDFDDRLVA
KEAIEERKNDIVL
>PK3-045_03304 Stage V sporulation protein D
MRVSNVTVRKRLLIALVAGIVIFLIIDTRLAYVQFFLGDELTTKAKNLWSRQIAFEPQRG
EILDRNGIALATNVSAPTVYIVPRQIKDPADTAEKLAEVLEADKESVYKQIIQREMSVRL
KEGRKITHEKAKKVRALDIDGVYIGEDSKRSYPFGNYLSHVLGFAGIDNQGLIGLELEYD
DELKGKKGSVQYYSDAKGQRMNDMADAYEAPVNGNDLVLTIDTKIQTIVERELDIAQQTY
DPESIIALAMNPKTGEVLAMSSRPGFDPSDFQNVDSTVYNRNLPIWSSYEPGSTFKIITL
AAALEEGKVDLDKDTFYDKGYAEVGGAKLKCWKRGGHGSQTFLEVVQNSCNPGFVELGER
LGKDKLFQYIRDFGFGQKTGIDLQGESKGILFNMDRVGPVEQATTAFGQGVAVTPIQQVT
ALSAAINGGTLYTPYVAKELIDPSTGEVVMEKKPVAKRKVVSEETSKEVRRALENVVAKG
SGGKAFVEGYRVGGKTGTAQKASGGRYLENNYILSFIGFAPADDPELVVYVAVDNPKGTV
QFGSAVAAPIVGAIMGDSLRALGVEPRKDQIDKVYKYPENPLIEVPDLVGHTKKDISEMF
INLKIDSSGSGDTVIKQSPEPGTKVKEGSTILVQFN
>PK3-045_03305 hypothetical protein
MYKKRREPLELALLKSLNSRMELSDELKTKYLNQGKGWEGERKFDEHLRDLAPNSIVLND
LLLQSHQTTFQIDSLLIEGEALHLYEIKNYEGDFYYENDRFYKKNNKVEINNPITQLKRT
EFLLRQLIHQLGYSITIIPHVVFINPEFILYQAPLHLPYIYPNQLNRYVKLLEKNRSQVK
KQYALLAEKLIALHMEDSSYRRMPSYTYEELKKGILCEKCNSLFISTERAMIKCNVCGYT
ESLELAVLRSVKEFKLLFPERKITTKEIYDWCLISGGMRRIKRILDKHYRLIGIHQWAYY
E
>PK3-045_03306 Penicillin-binding protein 2B
MIRKQPNINFGAAILFILFCLLFFVLVIRFVYIQATGEVSGVELAAQAEKKHNTSRVLEA
SRGSILDRNGDVIAEDAVSYKLVAVTDKSLSKNLDKKVHVADPELTARELAKYIDLKESE
IYRILTKKGAKQVEFGEAGKDLSYETKKKIEDLKLPGIQIVEGKKRFYPNGIFASHVIGY
LEEDDGKETGRLGIEESLNKMLTGTNGSMQYSKDIWGYILPNSKDKIVPAQNGKDVYLTL
DKKIQSFLEDTMNKVNAEYDPVKMIAIVANPKTGEILAMSQRPSFDPETREGITASWHNE
AIETNYEPGSTMKIFTLAAAVEEGVFNPNEKYQSGRYEGIGDHNNGAGWGPISYLEGVQR
SSNVAFAKLAKEKIGFETFREYLTKFGLDQPTGIDLPKEANSSIVFNWPIEKITTAFGQG
TALTPIQQIQAATAIANDGKMVKPYVIEQIKDPNTGKIIKKGETKVAGTPISAKTAKEVR
DILETVITSKKGTGYKKFNIDGYDVAGKTGTAQIPKSGGGYLKSKNDYIFSFLGMAPKDD
PELIMYVAVQQPKLKETETGSEPVAEIFTSVMKSSLQYMDIVPTKEVISKPIEIPNLSGM
TAEEAKKILEDKGLNAVIIGDGKTVEEQLPVKGDTYLKGEKVILKTDGKETVPNMKGWSL
RDVLKIADLNKLKLESSGSGYVSSQSIKAGSKVKENDKLSVKLKEPE
>PK3-045_03307 Cell division protein FtsL
MSNLARKIQQDQYQQQEEKQSVKKVIKQTKSLLSPGEKILGIAFVAIICIGGVKIVSNQS
EIYQVNKDIQVAESSINSLEKSNKELDTQVKDLSSFERLREVAGKLGLDFSKDNVKVVH
>PK3-045_03308 Ribosomal RNA small subunit methyltransferase H
MFNHTTVLLNEAVDALDIKPDGIYVDCTLGGAGHSELILSKLSGSGRLIAFDQDEIAIKN
AQEKLAPYKDRLTIVKSNFRYLKEEIHNLGITHVDGILYDLGVSSPQLDTPERGFSYHHD
APLDMRMDNEADVTAYDVVNSWSYESLVKIFFRYGEEKFSKQIARKIEAARENRPIETTG
ELVELIKEAIPAPARRKGGHPAKRVFQAIRIAVNDELGVFEDSLEQAITLLNPGGRISVI
TFHSLEDRICKSTFKKMSDLPPLPPGLPVIPDEFKPELKLITRKPIVPSEEELEFNNRAR
SAKLRIAEKQ
>PK3-045_03309 Transcriptional regulator MraZ
MFMGEYHHNVDAKGRIIVPAKFRENLGETFILTRGLDRCLFGYPLNEWEIIEDKLKQLPL
TKKDARAFTRFFFSGATECEIDKQGRINIASPLFQYAQLEKECVILGVSNRIEIWDKQEW
ENYFSESEDSFAEIAENMIGFDI
>PK3-045_03310 Putative cysteine ligase BshC
MEMMNLSLPVANKFVTDYLEQKNSAEDFFHYSYLDNGSYEKRVKELETRTFMRNDLADYI
ADYMKKFPQGEKVRQSLSKLRKENSVVVIGGQQAGVLTGPLYSIHKVISIILLAKQKEEE
LGIPVVPVFWIAGEDHDYLEINHIYTPGKEKMKKIVFPQRVLDKRMASDILLEKEVCIEW
LETVVESYGETDHSKPLLELLHSAVHESTTIVDFFSYITMSLFQDYGLLLVDSGDKEIRK
LEKEIFLKQINEFQKLADSVSEQQKLVQEKGYSLVIEMAENPVNLFYYDEAEQERVLLQY
DEIENCFIGKDRTVSFTMEQLIEIASEFPQRLSNNVVTRPITQDLLFPTLAFIGGPGEIA
YWAELKKAFEHLGIKMPPVIPRLNITLLERSVEADIEELKLSIKDVLVNGTSEKCAEFLK
SVSNERIEQILSELTNIIKTKYDQVEEEMKAEYKGLLPLLEKNEDFLVSQVEFLQNKVDA
SVKLKHEVLVNKFNRIEQNLKPEGSPQERVWNITYFLNKYGMDFIQSVMELPMDFDGTHK
VIKL
>PK3-045_03311 hypothetical protein
MINLTSQLISFLVVFPIFTLFIVFVISKLITKKHRLSIHLALDISTIFFIVSVHFLIQSI
WHTSLLLYIVIFILLIGMLFVIIHWKFKEEIQYKKVFKGIWRVTFLLFFLLYIVLLVYGL
ILSIWRTLGMI
>PK3-045_03312 2-dehydropantoate 2-reductase
MKIAIIGAGAIGLLCAYQLKEKHDITLYVRSKKQYERILEEGIYYKVNDEKKNRTVHVRF
FEEWNGLEELTIVAVKQYQLSSIYEKMEKMGDKIKAMCFLQNGMGHIETIRNSRVANILI
GIVEHGAMKEDEQTVIHTGVGAIKIACLKGEMDDILTKLTTATNKDFLFIMEHNYEIMLQ
KKLVVNCLVNSLTSILQVPNGVLLENAYYSEVMTMFMNEVLDVLTINEADKEIYREYCLE
VIRKTALNKSSMLKDMEAGRPTEIDAILGYIIEEAKKKKQSVPIAKVVYRMIKGKERERE
VFIHD
>PK3-045_03313 Prespore-specific transcriptional regulator RsfA
MTTTRQDAWSKDEDILLAEIVLRHIREGGTQLQAFEEVGKLLSRTSAACGFRWNSYVRKQ
YKSGIELAKKQRKQLKKTNVAEEFSQEEVTGQPAISPTPIQNQFDEMMIYLKDLYDKATK
WEQENIDSSTVKEKTKELEEKLALLKKENEELQSELDSMEGAYKALVELMEKARQMVVFK
DEDKLPKV
>PK3-045_03314 hypothetical protein
MIVVSSCLAGLKVRYNGTDCLDANIEAFIKKESIRTVCPELLGGFSTPREPAEIVGGDGY
DVLDGRAFVKDAKGNDVTQMYIEGANKTLVFIKDLEAEMVVLKENSPSCGSGSIYSGSFD
GTRMDGVGVTTALLRRNGIKVVSEDELFS
>PK3-045_03315 50S ribosomal protein L32
MAVPFRRTSKTAKRKRRTHFKLQVPGMVECPNCGEMKLAHRVCSACGTYKGKEVVSN
>PK3-045_03316 hypothetical protein
MIYMKWTLSQLQKFRSKGLPIDETINMDEIKETDPTIRKVSPIHITGRTDIDSTKVTFHL
NIKGSLVLPCSRTLVDVDYPINVETTETFLLKVSEYETDEEEVHQVKGDVIDLKPIIAEI
LLLEVPMQVFCEDVTEEGAPQSGNDWEVIQEQDLQEKKVDPRLAGLAKFFENE
>PK3-045_03317 tRNA(Met) cytidine acetate ligase
MKAVGIVVEYNPFHNGHLYHIQKAKELTQADIVVAVMSGPFLQRGEPALVSKWARAEMAL
ESGVDLIVELPYAFATQHAAVFASGAVDILQSLSCNFLCFGSESGSIDAFHQIFTKLQEQ
KTEEDLLVKRFMKQGISYPKAKSLAIKELTNSDDHTTLNLSMPNNILGYEYYKAVHTNKY
PMEICTVARMKADYHDKTFTSDTIASATSIREELLHAKGDIKKIEPFLPASSYQILQQYK
ETYLAYHTWENYWHYLKFRLLQSTAEELATIYEMEEGLEYRFLKYVKTASSFQDFIRLVK
TKRYTWTRLQRICVHILTNTKKAEMQSSLKPSFIRLLGTTVNGRLYLKEKKKQFQLPIIS
KLSAFDKEKIALDIRASQIYALGVPNLVQHQLLEMDYTKPPIMK
>PK3-045_03318 hypothetical protein
MERPKIGLALGSGGARGFAHIGVIKILREENIPIDYIAGSSIGAIVGCLYGAGSDIERLY
TLSKFFKRKYYLDFTVPKMGFIAGNRVKELIHLFTYGKNLEELDIPVAIVATDLLTAEKV
VFTKGPIADAVRASISIPGIFVPEKIDGRLLVDGGVIDRVPVSVVKEMGADIVIAVDVAK
VNIHTDISNIYDVIMRSLDIMQMELVESREVASDVMIKPPVEMFNSKAFTDLEKIIKIGE
TETRRYIEGIKKEIRKKERRKKSN
>PK3-045_03319 Sporulation integral membrane protein YlbJ
MLRSKFKTIVLALSASLLALALISFPGVAVDASKNGLNTWWTIVFPSLLPFLILSEILIG
FGVVRFIGVLLEPIMRPLFKVPGVGGFVWAMGMVSGFPTGAKLTARMREEKQLTRTEAER
LVSFSNASNPMFIIGAVSASFFHSPKLGLLLAFSHYLANFTVGLFMRFHGKDTEIKKQEA
TEKASIKRALRELHHTRLKDKRPLGKLMGDAVTSSIQSLLMVGGFIILFSVINRLLFHLH
ITSFVAKLLESIFQLFTFSGELTIPFIAGIFEITLGSQLTSEVETSTLMHQAILTSCILG
FSGLSVQAQVASILAQTDIRFKPFFIARIMQAIFSGIYTFIAWDFFNKTFLAKDAPTIAI
PGLKQEGAFFQQIFENISTWGPIVTIISLTIYCFILVKRLSPREEV
>PK3-045_03320 Phosphopantetheine adenylyltransferase
MASIAVCPGSFDPITYGHIDIIKRSAKVFDHVYICVLNNSAKKPFFSVEERLALIREVTK
DIKNVSVSSYEGLLIDYAKSVNANAIIRGLRAVSDFEYEMQITSMNRVLSDDIETFFIMT
NNQYSFLSSSIVKEVSKYDGDISELVPKIVHDALREKFHKNRP
>PK3-045_03321 Ribosomal RNA small subunit methyltransferase D
MIEMRVVSGKNKGIPLKAVPGNSTRPTTDKVKEAIFNMIGPYFQGGEGLDLFAGSGGLGI
EALSRGLDLVIFVDKEGKAIHTIKENLSICKLDSQAEVYRNDADRALKALQKREKRFDYI
FLDPPYKKQQLEKMLTFIDEAGLLKEDGVIVCEHGSEISLPEAVSRLQQVKHEKYGIIAV
SIYSLQNGMED
>PK3-045_03323 hypothetical protein
MLGQRQGIIVWLFSLKQAKMLRRYGNVHFISKRLKYVVLYTNQSDVESIMEKINAHSFVK
KVEPSYKPFLKMEFENSRPDKAKEYDYKMGI
>PK3-045_03324 hypothetical protein
MLATTEILLIQEEAEEIAEMILESDVAEQYRICLANIQSNKETQRKIHSFNKMKELYEEV
QRFGKYHPEYKKVMMEIRQLKREMDLDDNVAAFKIAENGLQKLLDDVSVIIGRSVSTFIK
VPTGNPFFDELSGCSGGCGSGGSCSCSA
>PK3-045_03325 hypothetical protein
MLKKFGLICIPAFLLLTGCSHDIPDPKVKPHKEAVNGVISSNMAVQASTTYRDTEKMAVH
HLVKGNKVFVECRVKDYSFREDSQGKLGKIVLEVDGQKYEYSSAAFVIEGLKAGKHTINL
SVIDAASKETQYQKSFQVMIKS
>PK3-045_03326 hypothetical protein
MRQNIKEYIAQNTELQQFIREQPQWYRELSRNPNQLEVFEIASLHYYKKTIPDHVEKFSN
GVQMASMMVSMFQAMNAQS
>PK3-045_03327 hypothetical protein
MMADKKLHPSVEEFKAFVKANPKILKEARSGNVTLQELYEDWYLLGPNDTRWDGLLEGSA
ESTQKKEEASGNRTVWMSNIVDTLKNMDQNQIQGYLANLNQALGTLQGVISQFAPNSGSS
GTSAPTEQKPSGPFSFRKD
>PK3-045_03328 hypothetical protein
MPAPKEGLGSLIGKSTSELKKKYGKPARIDPSAYEYDWWIFNKDDSKYFQAGILDDKVVT
IYAIGSSVNVTPYKIGQEVGDIYTMTPIETNISFNYENSSYRFELSEDEINNRPLIQIGD
YYAQLYFDKFNGTLSSIRYMDARTLLHLRPYELVYRGELLETQSNVENNEAIQEGNERQI
LDMTNVLRKRFKLNTVEWDQPTAVVALGHSKDMFDTENFSHTSEKYGDLEDRLKAGDILY
QVAGENIAAGYSDAPAVMEGWLNSKGHRECLLNEKFTHLGVGVFDKYYTQNFIEKW
>PK3-045_03329 hypothetical protein
MEFTLPILPTISTTFIILSAIFVAIGWGLIKQKKRQQHQTVMLFAAIFAVIFFVIYASRT
IFIGNTSFGGPDDIKIYYTIFLIFHITLATIGAVLGIIMLYTGYKQQYAKHRKLGPITSI
IWFITAITGTAVYLLLYVFYHGGETTSVIKAILGF
>PK3-045_03330 hypothetical protein
MLAFVRKVEGVAWLTALNLRTSLIEKGILGVC
>PK3-045_03331 Protoheme IX farnesyltransferase 2
MANSRVYPEAKLTNQQSETSAWKDFLALIKIGIVNSNLITVFTGIWLAIVFTDAKFLEQI
DTVLYTLIGSGLIMAGSCVLNNFIDRDIDPLMERTKSRPTVTGKVKPAKVAVLGFGFLFI
GTLFLLLTTITATVIALIGAFSYVVVYTMWTKRRLVSNTVIGSFSGAFPPLIGWAAIDPG
LHVMAWSLFLIMFVWQPPHFYSLAIRRAEEYRAAGIPMLPVVKGFEVAKRHTYIWIIALF
PLPFLLYQIGIPFLILATLLNIGWVITGIRASKKEDEYKWATAMFIYSIQYLTILFVSMV
VFTLF
>PK3-045_03332 putative peptidoglycan glycosyltransferase FtsW
MIKKILKSYDYTLIIAMVLLILFGLIMIYSASMVSAVQYYGEDSSDFFYKRQLKYIIIAG
IAFVIVAIFPYKALLSNKILVPMVFGSIIFLSGIFLFGSVFGNAQSWYKVGTASLQPAEF
VKLGVIIYLSAIYSKKQAYINEFNRGVVPPLAYLVIVCALIILQPDFGTAAIIFMIGATV
ILCSGMNWKNLSKLMLIGLAFLLLLVLILQLAGKSIFTEKQMARIFVFLDSPFAEDVVQE
SGYHMSNSLIAIGSGGLKGVGLGQGVQKLGYLTDGHTDFIMAVIAEELGIFGVGFVVVGL
SYIVLRGIYTGLKCKDPFGSLLAIGISSMIGIQAFINIGGVSGLIPLTGVPLPFISYGGS
SLLQLSIGMGILVNVSMFVKYERVYKPKEENVSDIAVKKQPTSSFVRPNRHF
>PK3-045_03333 hypothetical protein
MTSEMIINHKEKANELLKADAEKILKLIKVQMDNLTMPQCPLYEEVLDTQMYGLSKEIDF
AIRLGLVEEQVGKKILDELEKELSILHEASIRK
>PK3-045_03334 hypothetical protein
MNSIIQVSGLVNFPITIDPTVWIFDDRKQTADTVFAPVEVKDELEAYTKEASKHWDQEIT
DGAKAPEQSTKTYKKVEMLTGTFYMALAPFIKNAEPQEEAKTLLITTEEEEYAIPLEEIG
SIFLLFCVKGKPLTEDGPVHIFDQTKGPEQTPIKNVRAFKIT
>PK3-045_03335 hypothetical protein
MSKIYVLDTNVLLQDPYSIFSFSDNDVVIPAVALEEVDSKKRYMDEIGRNARQISRLIDN
LRESGKLHDKIPLENGGTLRIELNHRSFHELQEIFVEKTNDNRILAVAKNLSIEESKKEN
GRTVILVSKDTLVRVKADAIGLKSEDFLSDRVVENEHLYTGFMDVQVTIDILNNFYENGQ
LPIAEIGNGNYYPNQFLILKDVLGSSSSALAIVDSSRKFVKKLVFDHEHIWGIRPRNVQQ
TMAIEMLLKKDMPLVTLIGKAGTGKTLLALASGLMQTEDFGDYKKLLVARPIVPMGKDLG
FLPGEKEEKLRPWMQPIFDNLEYLFNTKKPGELEAILAGMGSIEVEALTYIRGRSIPDQF
IIIDEAQNLTKHEVKTILTRVGEGSKIVLMGDPEQIDHPYLDAFNNGLSYVVERFKDQPI
AGHVKLVKGERSSLAQLAADLL
>PK3-045_03336 hypothetical protein
MKKWFFFIAVLFLLTGCTNNNAENSQQSENRENSPQVTNVKNSTNQRVDRKTGQDIAKRL
VALATSIDNVNDATAVVIGKYALVGVDVNADLDRSEVGSIKYAVAESLKNDPDGANAVVI
ADPDINARLKEIGEDIQNGKPIQGIFNELADISGRLIPEVPADMIRNEPDRDLKKSNEKL
NDKEEKELKNNQDEQSNNHIRD
>PK3-045_03337 hypothetical protein
MKVKCVICDKIEDIDENSFQAKRLRNRPIHTYMCNECDDRIAKNTKKRIDSGNFVLYQNK
TQEDDW
>PK3-045_03338 hypothetical protein
MKIFRFNKESGKQITQFNSCFIMNRILETKKEAYIGCMYLEENGIIGLHQAVIPQLLLIV
SGIGYVRGEKNEGFKLEVERRCIGIKRNGINENRY
>PK3-045_03339 hypothetical protein
MVFIEGMKATINMESAENGVHQGNESHFLHEDKEIRVKGHGDHLS
>PK3-045_03340 GTP-binding protein TypA/BipA
MKIREDIRNIAIIAHVDHGKTTLVDQLLKQSGTFRTNEHVEERAMDSNDLERERGITILA
KNTAIQYKDKRINILDTPGHADFGGEVERIMKMVDGVLLVVDAYEGCMPQTRFVLKKALE
QNLTPIVVVNKIDRDFARPAEVIDEVLDLFIELDATEEQLEFPVIYASAINGTASTNPEK
QDENMQSLYDAIVDHIPAPVDNREEPLQFQVALLDYNDYVGRIGIGRVFRGTMKVGQQVA
LMKLDGTVKQFRVTKIFGFFGLKRQEIEEAYAGDLIAVSGMEDINVGETVCPFEHQDALP
VLRIDEPTLQMTFLVNNSPFAGKEGKYLTSRKIEERLRAQLETDVSLRVENTDSPDAWTV
SGRGELHLSILIENMRREGYELQVSKPEVIVKTIDGVRCEPIERVQIDVPEEHTGSVMES
IGARKGEMLDMINNGNGQVRLIFNVPARGLIGYTTEFLTLTRGYGIINHTFDSYQPMASG
QVGGRRQGVLVSMESGKSSTYGIMQVEDRGIIFVEAGTEIYEGMIVGEHTRENDITVNIT
KVKQATNIRSANKDQTATMKKPRIMTLEESLEYLNDDEYCEVTPESIRLRKKILNKAERE
RAGKKKKSAE
>PK3-045_03341 hypothetical protein
MNFDNYPYFYYNVYGASSFISIGICILEKTLAGTLICFCLFCGIWFLKSHKKKKVLHVTE
N
>PK3-045_03342 Fructose-1,6-bisphosphatase/inositol-1-monophosphatase
MTNWLEIDKYAKEWIKEAGARIIKSFSSELIIQTKSNKNDLVTQIDKGTEEFLINKINKV
FPSHRILGEEGVCEALEDLKGIVWIIDPIDGTMNFVHMQRDFAISIGIYEDGVGKIGLIY
DVVADELYHVRKGNGVFMNDLKLLPLKDTAVDEAIIGLNATWVTKNKRIDPTILEPLVKA
SRGTRSFGSACLELAYIAAGRMDAYLTLRLSPWDYAAGKIMVEELGGKVTTLRNEPLDLL
TQQSFFASKPGLHEEILQKYLKDGNW
>PK3-045_03343 hypothetical protein
MRWVIAQNRSKLISFHIIYMKSTEMQVDERGVLSVKQLMNLAKKMEVEKEKKAVLRLEMD
YELATLFDAMNEKDEKQKKLSKQKLERIRQELLRLKAL
>PK3-045_03344 hypothetical protein
MAFTGFTQKDFDTFTIDGLDARMEAIQERIQPKFREIGTQLTEELSGKLGMEMFLHIAKH
ARRTVNPPKDTWLAIASNKRGYKQHPHFQVGLFDDHVFIWLAYIYELPKKKEIAEGFLAN
YEILQSTLPQDYVLSMDHMKKEAVKIGETNLEAALTRFRDVKKAEFLVGQKIAAGDSILS
NGEELLALIEKTYDTLLPIYKLSLEY
>PK3-045_03345 hypothetical protein
MDYQYPIDIDWSTDEIITVVKFFECIEKAYEKGVEKAELMEQYRAFKKIVPGKAQEKKVC
DEFEEVSGYSTYRTIKKAKEASDDSRIKMS
>PK3-045_03346 Arginine decarboxylase
MSQHETPLYHGLLEHVKRDPIQFHIPGHKKGNGMDPEFRNFIGENALSIDLINIGPLDDL
HYPKGMIKHAQQLAAEAFGADHTFFSVQGTSGAIMTMIMSVCGPGDKIIVPRNVHKSVMS
AIIFAGAIPIFIHPEVDKNLGISHGITVESVQHALDIHPDAKGLLVINPTYFGISADLKT
IVDLAHSYDIPVLVDEAHGVHIHFHEELPMSAMQAGADIAATSVHKLGGSMTQSSILNMR
GDLISYKRVQSILSMLTTTSTSYLLLASLDVARKRLATEGKELIDKTINLAQYIRRQIND
VEHLYCVGEEILESDSAFDYDPTKLIISVKDLGLTGHDAEEWLRKHYRIEVEMSDLYNIL
CIITPGDSEREANILIDALKALAVERKDKASKVEARVMLPNIPLLALTPRDAFYSETELI
DFDDSVGRVIAEFIMVYPPGIPIFIPGEIITEDNLAYIKRNMEAGLPVQGPEDYDFKKLR
VIKEHRAIR
>PK3-045_03347 hypothetical protein
MKKYIVIMIISLLISLVSPFIFKNYVAQKPEQLEQAFHFGGPIPFAEQKKLLPTSVEAYP
LEITFESPVQSKTIFHPIPFIFSFLVFFLLILAISTVFSSFFGKKSTKRRL
>PK3-045_03348 hypothetical protein
MFFLKVYTAILFQLIIWSGFSIIEWLSRYDLILYKVFMFGVFFYLAIIIGNTIIKSTRKT
MLATMISLSIYGSFHLIMTIISVV
>PK3-045_03349 Dihydrolipoyl dehydrogenase
MVVGDFPIETDTIVIGAGPGGYVAAIRAAQLGQKVTIVEKNVLGGVCLNVGCIPSKALIS
AGHRYEHAAHSADMGITTENVTVDFSKVQAWKDSVVKKLTGGVEGLLKGNKVDIVYGEAY
FVDANTLKVMDEKSSQTYTFKNAIIATGSRPIEIPTFKFSKRVLDSTGALALQEVPEKIV
VIGGGYVGTELGGAYANFGTQVTILEGADEILGGFEKQMSSLVTRNLKKKGAEIITKAMA
KGVEETDTGVVVKYEVKGEEKSVEADYVFVMVGRKPNTDELGLEQVGIELGERGIIKTDK
QCRTTVSNIFAIGDVISGPPLAHKASYEGKIAAEVIAGHNSEIDYLGIPAVVFSEPELAT
VGHTEASAKEAGIEVKAAKFPFAANGRALALNDAEGFLKLVTRKEDGLVIGAQIAGPSAS
DMIAELGLAIEAGMTAEDLAMTIHAHPTLGEVTMEAAEVAIGSPIHILR
>PK3-045_03350 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MAFQFRLPDIGEGIHEGEIVKWFVKPGDKVQEDDVLCEVQNDKAVVEIPSPVEGTVEEVK
VEEGTVAVVGDILITFDAPGYENLQFKGDHGDEAPAAEEAKPEAVEESKGQEAEVDPSRR
IIAMPSVRKYARDKGVEIQLVSGTGKNGRISKEDIDAYLNGGATPASQPAAEAAPAETAA
EAPKPLAIPEGDFPETREKMSGIRKAIAKAMVNSKHTAPHVTLMDEVEVSKLVAHRKKYK
EVAAAKGIKLTFLPYVVKALTSALKEFPALNTSLDDATSEIVHKHYYNIGIAADTEKGLL
VPVVKNADRKGIFNISNEINELAVKARDGKLAPAEMKGASCTISNIGSAGGQWFTPVINH
PEVAILGIGRIAEKAIVKDGEIVAAPVLALSLSFDHRMIDGATAQNAMNHIKRLLNDPEL
LLMEA
>PK3-045_03351 Pyruvate dehydrogenase E1 component subunit beta
MAQMTMIQAITDALRTELRNDPNVLVFGEDVGVNGGVFRATEGLQKEFSEDRVFDTPLAE
SGIGGLAIGLGLQGYRPVPEIQFFGFVYEVMDSISGQMARMRYRSGGRYNAPVTIRSPFG
GGVHTPELHADSLEGLMAQQPGLKVVIPSTPYDAKGLLISAIRDNDPVIFLEHMKLYRSF
RQEVPEEEYTIPLGKADVKREGKDLSIITYGAMVQESIKAAEELEKEGYSVEVVDLRTVS
PLDIETIIGSVEKTGRAVVVQEAQKQAGIAANVVAEINDRAILSLEAPVLRVTAPDTVFA
FTQAETVWLPNFKDIIETAKKVLTF
>PK3-045_03352 Pyruvate dehydrogenase E1 component subunit alpha
MASKTKKAQFDVQAQLEQVANQFQTLQILNEEGEVVNESAMPDLSDEQLQELMTRMVYTR
ILDQRSISLNRQGRLGFYAPTAGQEASQLASQFALEKEDFILPGYRDVPQIIWHGLPLSQ
AFLFSRGHFQGNQIPEGVNVISPQIIIGAQYIQTAGVALGMKKRGAKSVAITYTGDGGAS
QGDFYEGINFAGAFKAPAIFVVQNNRFAISTPVEKQSAAKTIAQKAVAAGIPGIQVDGMD
PLAVYAAVREARERAINGEGPTLIETLTYRYGPHTMAGDDPTRYRTADLDSEWEKKDPLV
RFRKFLENKGIWNEEKENAVIERAKEEIKEAIKIADEAPKQKVTDLMNIMYEELPVNLKE
QYEIYAAKESK
>PK3-045_03353 hypothetical protein
MKRSVLISTIMLFTIIAAGCNFNSPSEKMYDKLEEVVKIESGFEEQQDPLVKLEKKEQDI
YSKIISLGLEDMDEITKLSDEALESISKRKEYMDKEADSIKKSQEKFETITTDIEELEKK
EEKSLKDKADNLYQTMMARYKEHDKLYANYIEGLNSDKKLYEMFKDKDVNMDDLEKQVKK
INDTYEKVYENNKTFNELTKKYNDLKVDFYKEAGIKIKMNEEEEEK
>PK3-045_03354 Peptide deformylase 2
MITMTDIIRDGHPTLRQVASEVIMPPSEEEKNILKSMMEYLINSQNPELADKYGLRGGVG
LAAPQINVSKRMIAVHVKDENDKQYSYALFNPKIISHSIEKAYLTTGEGCLSVDETIPGF
VPRYARITLKGIDLEGKEVKLRLKGLPAIVFQHEIDHLNGVMFYDHINEKDPFLPIDNAI
PIER
>PK3-045_03355 hypothetical protein
MIFKVYFQDLKTEVPVRENTRTIFVKGSSERDVRTKLAEKPYNIEFITGVEGAFLEYEQQ
NEDFTVLEIE
>PK3-045_03356 Ribonuclease J1
MKFVKNDQTAVFALGGLGEIGKNTYGVQFQDEIILIDAGIKFPEDELLGIDYVIPDYTFL
EKNVDKIKGLFITHGHEDHIGGIPYLLRQVNIPLYGGKLALALVRNKLEEHGLLRQTTMH
EIQEDDIIKFRKTSVSFFRTTHSIPDSYGIVVKTPPGNIVHTGDFKFDFTPVGEPANLTK
MAEIGKEGVLCLLSDSTNSEVPNFTMSEKKVGKSIHDTFIKADGRLIFATFASNIYRLQQ
VTDAAVEFGRKIAVFGRSMEAAINIGLELGFIKAPKETFVDPQQINRLPANQVVILCTGS
QGEPMAALSRIANGTHRQIQIIPGDTVVFSSNPVPGNTLSVNKTINQLYRAGAEVIHGPL
NNIHTSGHGGQQEQMLMLRLIKPKFFMPIHGEFRMQKTHAQTAVDCGVKEENCFIMDNGE
VLALSSDSAQVAGKIPSGNVYIDGSGIGDIGNIVLRDRRILSEEGLVVVVVSINMTDFRI
AAGPDLISRGFVYMRESGDLINDAQTLISKHLNKVMERKTTQWSEIKNEIIDTISPFLYE
KTKRRPMILPIIMEV
>PK3-045_03357 Ktr system potassium uptake protein A
MKRAFAVIGLGRFGGSICKELTELGMDVMVIDKSEEKVNEYANLVSHAVVGNAVDETVLK
GLGIRNFDHVIVAIGEDIQASILTTLMLKELGVQNITVKAQNDYHEKVLSKIGADAVVHP
ERDMGKRIAHNIVSNNVLDYLELSDEHSIVEIKASHKLDGRSIIDLDIRARYGITIVAIK
RGKEIIVSPQASESIREKDILIVIGADSDINRFEKKVMS
>PK3-045_03358 Thiol-disulfide oxidoreductase YkuV
MKIGEQLPNWNTPTIWINGETKLTNEIGDKLILMHFWSVSCYFCKRAMPELNQYRELYQD
NLLIISVHFPRTERDLDIDLIKKTAKTYSMTQSIYVDHDFQLAKAFSNEYVPSYYLFDRE
RKLRYYQAGGTNLKMLNTRINRVINNQQ
>PK3-045_03359 putative MscS family protein YkuT
MIYVDKLKTYIQNIEWGDFLLESSLLALKIILILLSYIFIKKMAKKVINKLFETYIQKHS
ISRGRAFTLESLTNNLITYVLFFILIITILQLLGIDATAILAGAGIIGLAVGFGAQGLVS
DLVSGFFLLLEKQLDVGELVSIGDFSGTVEQVGLRTTQIRGADGTLHFIPNREITQLSNH
SRGEMQALVDIEISVHNNIPKTLEILKALCEHIAKENTVITDGPDVVGIQNMGPNTLTIR
ILAKTINMEQWGVERLIRQEVKIALDENGIKLPETPIIVDKKS
>PK3-045_03360 N-acetyldiaminopimelate deacetylase
MGNTIDLVTIRRQLHRIPELGFKEFKTQQYLLQMIQSVADERVEVKTWKTGIIVKVNGLN
PTKTIGYRADMDGLPIVEETSLSFVSEHPTEMHACGHDFHMTIALGVLTNIINNPINDDV
VFIFQPAEEGPGGAEPMLKSEELQAWKPDMIIALHVAPEYPVGTIAIKPGLLFANTSELF
IDLKGKGGHAAYPHLTNDMVVAACTLVSQLQSIVSRNINPLESAVVTIGKITGGTVQNVI
AETARLEGTMRTLSSEAMEKVKKRVQSLVKGTEIAYDCECTIDFGSGYYQVYNNELLTKE
FMDFIIEETEATLFECKEAMTGEDFGYMLKEIPGFMFWLGVDSTFGLHHSKLNPKEDALQ
LAVNVLTAYLTKKGN
>PK3-045_03361 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase
MKMMDANEIISFIQNSTKSTPVKVYVKGDLSAVEFGENIQTFISGNSGVIFGEWTDIQSV
IEANKDKVTDYVVENDRRNSAIPLLDLKNIKARIEPGAIIRDQVDIGDNAVIMMGAVINI
GAVIGEGTMIDMGVIMGGRATVGKNCHIGAGAVLAGVIEPPSAKPVIIEDDVLVGANAVI
VEGVTVGKGSVVAAGAIVLEDVPANTLVAGAPARVVKEIDDKTKSKTEIMQELRQL
>PK3-045_03362 HTH-type transcriptional regulator CysL
MSTISELQLLTVLSQEMNMRKAAERLFVTQPALSQRLQNIEKDWGTPLFIRSQRGLSLTA
AGELVTTFARETLKKEEEVKESIHAFKEEVYGTLKIAVASIVGQNWLPEVLKRFVERYPQ
AKVSLVTGWSSDMMKSVSEDNMHIGIIRGASDWKGIKMHLFDDPLYLVDREIAKLEDIAL
TDRPFIQFKSDSNYYEEIQVWWHQNLQMPPKNTIVVDQIETCKQLSFNGIGYSILPSIAL
RKADESLSRIPLFNDNNKPITRGTWLIGYEANFQLKQVQAFIEIVNEYLEEEKVEAINP
>PK3-045_03363 CBS domain-containing protein YkuL
MISMHSEEFLNITLQDLLIPSERVAHVQIGNSLEHALLVLTKSGYSAIPVLDAHYKLHGL
VSTPLIMDSILGLERIEFEKLEEIKVETIMNKVIPRVKSNSSVLHTIKYLVDHPFICVET
DDGYFDGILTRRSILMRLNIYLHQLNQNER
>PK3-045_03364 hypothetical protein
MMPTVICPECSQEEKLENVLTAQSNQNVIFRCPHCQLLVRNIKTSKG
>PK3-045_03365 putative protein YkuJ
MSQLQGILTRLKNLQEQATGGEPTQRFFEVNGERKCQVTFHPKTETFELEVYNDKEKPKR
YQFDNVDMITIEIFDLIQ
>PK3-045_03366 hypothetical protein
MHQITLFTQPDCPPCEYSKLFLKEHGFDFEMRDIQKDPHAKKDLIKKYQSFSTPTFVIDG
TVIYGFDLEKLKEALNLS
>PK3-045_03367 hypothetical protein
MKKSFFILLIISMWSVFPYSIDAASRLTSREEVFAFVEKAFRAQVSLSKEAREMEEIEEI
LTPYFSDKLIYLFLNENLKGEQGNFFTYGNEFGKYYLPFYQLSEQTFVEQEENSILLYEY
YEPIVIGEKVYEGSYEGILIRKLNNKWLITNMFSDKEVRSILKSKEKNYSTLVYMPLFSI
DNQVTYIKNENKNYNDVNTNHL
>PK3-045_03368 putative EAL-domain containing protein YkuI
MDALDILTDLENVIPYFQAIFSADEHRVIGYEVLGRYNGQDGAESLGDFFADEGIPDEYK
LEVDQVILTKALDKALSLDEDVLLFINRDAEMLMKDDGEAFLDTLLEYEGKGIKLNRIVL
ELSERNYQGQFDHLDHLLIYYRTYGIKIAIDKMGSDSSYLDRLSDLGPDILKIDLLALRS
TSTSHTYQDVLYSLSMLARKIGATLLFENIEMVYQLQFAWKNGGRFYQGYYLHYPEENFV
ERNSRKETLRNMFHEFILSEKKKLATIYDLTEEFQGQLQALLVKYKKYSSYEELLKLLSA
ELTEAAFRMYVCDEDGFQKSANIIKYENDWLIQPEYAHKNWSWRPYFLENIMKMRNEKKG
ILSDLYSDIETGETVRTYSYPLNSKEYLFIDLSYNYLDRMKLLLP
>PK3-045_03369 hypothetical protein
MQLLKLLLLLAPFFGSEQVWEYFHIDDHPRQKSEIVSQVSSSSNKILLDVPLVKQNPELR
YGCEVTSLTMVLNYAGVKVTKMDLFKDIEKDLDPLVRKNGNIIKWGDPSTGFVGDMTGKK
AGYAVFDRPMEDLVNKFLPERAVNLTNSSFHDLEKHVENGYPIVVWTTGDYRLPDRWESW
EHNGRTIKTPLDLHAVVLVGFSKEHVYLNDPLSGKKNVKVNKKNFIDSWHALKSRAISYR
>PK3-045_03370 hypothetical protein
MDKYNENSTSKKIIAQSKSNIENIIFEIIFMYIKDMVFIMKVEKGEIFRYIFVNEAAFLF
AKLPINFIGKKIQDVNSAYISARLQKEYSTVCKRKENHSYTDQIKLNDGELIYAESVLTP
IKDDKDEVKYIVSITRDITESIKEKLLLYESEQRYRSLVENNLDAVLTVNLDGVIQEVNP
AGLKLIGFSDEAKTIFSLYDLIDEENTLFYGSFKKCKLTKTSQSVDCKLISKNGNELSVH
SKFVPIIVNHTIKGIYVILRDISEKKKTAEKIQFMSFHDQLTGLYNRRALMEAINLEIKR
AETDQAAFALMTIDLDRFKYINDTFGHIVGDQILVKVAERLLEFNNYKCHVYRQGGDEFN
ILLSQTNRQEVASIAQQILSTFANSFYLDSQEYYISPSIGISMYPQDGEDIEILIKNADE
ALFRVKERGKAHYQFYRSDMTTALTNIVSVETKLRKAVQRNELKLYFQPQIDLNNYTFNS
FEALLRWESPSLGLVAPNDFIPLAEDTGLIISIGNWVIETACEQIKIWKSLYNLDVRIAV
NISPKQFQQPNFVEVIREAIKKYNIQPFLLEVEITEGVMENIKEAVPILRNLKELGVIIS
VDDFGTGYSSLSYIKQFPIDVLKIDQSFIKDAVTNAKDAAITTTIIHLGQNLGMEVIAEG
VENKDQEDFLKKANCQKAQGYYYSKPLTCEDAEQFLRQF
>PK3-045_03371 hypothetical protein
MNKQQQYPPPIQPTVVNLLQAISVVNRHAKTAPNPKFLYKLKHDSLHKLLAEGKAKKIGL
HFSNNPKYSQQQSDLLIACENYTFHLPPTKKDFEELPHLGSLNQSIRNPKSTLSLTQSKK
LLSTYTGLKEDTPPNHSIRKKKYQKPVFKKLGESY
>PK3-045_03372 hypothetical protein
MRKFGINYEYKQTEKKNGDRLISVRDIGENALLEVEKKGNMVEIITNWQNFKTTKYSLPV
ELFEKIHKDIMQNNNA
>PK3-045_03373 Chemotaxis protein CheV
MKNDKGILLETGTNELEIVEFSVGKNHFGINVIKVKEIINPVPITPIPHAHPYIEGIMEL
RGEVLTVVNLANVLGYPPSDTPEKDKYIVSEFNKTKIIFHVHNVTQIHRISWENIEKPSE
TYYGTDSQIIGVVKLKGEMILLLDFEKIVVDINPESGINVQQVKKLGDRKRSDKKLIVVE
DSALLRKLLEDTLNAAGFQEITFFENGREALAYLTKTIEDGHSVEEVAQLMITDIEMPQM
DGHHLTKVVKDNPNLATLPIVIFSSLITDDLRHKGQVVGANAQVSKPEINELIHIIDNII
L
>PK3-045_03374 hypothetical protein
MEPITNKTEMKKRGLALYFTLPIISWALYDAANTIFSSNINTIFFPLYLQDMVGSNEVTK
QIASTFITYANALASFLLVIFTPLFGVMMDRTGKKKKYIVILTLLTVLGTIAMGFFSFIP
STQQIFGIPISLALVILFFVLSKFTYHSSLVFYDTMISDLGTKEQIPLISGFGVAIGYIG
TLIGLTVYLFIDEGAYNQSFIPTGILFLLLSLPLFFFIKDTPKENIQKQSVLSGYREIIE
TFKQMKSYRKIFTFMLAYFFLNDALATTIATMSAYANAVIGLDTGKFIVLYLVSTLASII
GSFVFGYITKSVGAYRAVRYVGILLVIAIIIATLAKNEGLFWVAGSLFGVALGSMWVTTR
TYIVEITPEEKRGQFFGLFAFSGKVSSIIGPLIYGTITLVFAEYGNIASRFALSSLIILT
IIGLVIHARIKED
>PK3-045_03375 hypothetical protein
MVTTIQIEEKENHPQYAGFWIRFGAWAIDSIILGIPLLFFSNIIFALFISSMEIPNELLL
DPASINALSDSEILSLLGSIMTAFFGTMAVCMFISLFYYSLFHASKWQATIGKKLLGLKV
EDLKGNKLSFWRSLGRYIVSSLLSGILLIGFILAAFTEKKQALHDLIVGSIVVRK
>PK3-045_03376 hypothetical protein
MKGTAILFHDDLTVTFLENIDLEIWKKTDKMDNRKQPLENHLNQSNHEQLLLMEEDVDWD
YGY
>PK3-045_03377 putative N-acetyl-LL-diaminopimelate aminotransferase
MEHLINKKVKNIEISGIRKFANMVAGKKGMVSLTIGQPDFPTPLHIKEAAKTSIDENYTS
YTHNAGDLALREAASQFVNTKYNLSYDPSKEVIVTVGASEAIDVTFRTILDDGVEVILPG
PVYPGYEPIIRLCGAIPVHADIRHTSFRFTAEVIKKYITERTRCIVLPYPSNPTGVSLTK
EEIKEIAALIKGKDIFILADEIYSELLYDQEHVSIAQYLREQTIVINGLSKSHSMTGWRV
GLLFAPSYLCQQILKVHQYNVTCASSISQRAALEALTVGINDAAPMREDYQRRRKYVYDR
LSSIGLDVVMPDGAFYFFIKVPTTKLNSFDFCLDLVDKVNLAVVPGSAFSELGEGYFRIS
FAYSMETLEEACNRLEEYIKLHLAK
>PK3-045_03378 2-hydroxy-3-oxopropionate reductase
MLAKETTIIGFIGTGVMGKSMASHLLHAGYPVMVYNRTKAKADELVAAGAEWADSPYEIA
LKANVIITIIGYPKDVEEIYLGELGLINNAKENTYLIDMTTSTPSLAKKIYEEAKKKNIY
AVDAPVSGGDVGAREGKLSIMVGGEEAVFQQLLPLFEILGTNIVYQGSAGSGQHTKMCNQ
IAIASTMIGVSEAIVYAQKAGLDPEKVLQSISSGAAGSFSLSNLAPRMIKGDFEPGFYIK
HFIKDMRIALKEAEEMQMETPGLSLAETLYSRLSAKGEDESGTQALYKYWD
>PK3-045_03379 Calcium-transporting ATPase
MEFYQKDKEAVLKNLQSSEQGLSTDKVKEILENEGYNELQDKEKVPTWKLFLETFKDPMV
IVLLLVIIIQLIMGKFVESLIIFLVLLLNSVISVIQTKKAESSLDALRNMSAPEAKVRRD
NTNITIPARELVPGDIVFLEAGDFIPADGRILESGSLKVNEGMLTGESEAIEKQEKVIDE
EAALGDRINMVYSSSLVVYGRGIFVVTGTGEKTEIGKIADMLNKAEEKQTPLQQKLAEFS
KKLGVGILLLSILIFAIQALRIWLGDENVDVTTSILNALLFAVAVAVAAIPEALSSIVTI
VLSVGTNKMAKQSAIIRKLPAVETLGSTSVICTDKTGTLTQNKMTVTDYFIPEGEREHLP
PDPSQWNHSETFLLNIAVLCNDSYINKENREVGDPTEVALINFYNDGKRNYEQIRSRYPR
EAELPFDSDRKLMSTIHTIDNKRFMLVKGGPDVMFNRATKILVNEREEPFTNEWLKKLQE
ANEDFSNQALRVLAYGYKHVPNDKTIITEEDESELILVGLTAMMDPPREAVYGSIEQTKD
AGIRTVMITGDHKTTAQAIGRKIGLMEDNDIALTGQELDALSEEELNQKLEQISVYARVS
PENKIRIVRAWQKKNRIVAMTGDGVNDAPALKQADIGIAMGSGTDVAKDSADMILTDDNF
VSIVNAVGVGRTVFDNIKKSIGYLFAGNFGAIIAILFAVIAGWANPFTALQLLFINLVND
SLPAIALGMEKSEPGVMKRKPRDVKEGIFAGGTLRAVVVRGVLIGIAVIISHYIGLQHSD
ELGVAMAFTTLILSRSLQTFAARSSTQTIIGVGLFSNKYVLGAVGICFLLYLVTILPFAR
EVFAIPDSFGLNEWLIAAGLAIGAVIAMEIMKMLLVRVLRNK
>PK3-045_03380 Phosphoenolpyruvate-protein phosphotransferase
MSFLQGIAASSGIAIAKAYRLVEPDLSFEKTSVENAESEISRFQEALNKAKSELEAIREK
ANKELGADKAAIFEAHLLVLSDPELIAPIEDKIKTDLVNAEFALKETTDMFITMFESMDN
EYMQERAADIRDVTKRVMSHLLGVHLANPSMISEEVVVVAEDLTPSDTAQLNRQFVKGFT
TDIGGRTSHSAIMARSLEIPAVVGTKKATEEINNGDLVIVDGLKGEIHVNPTPEVVESYK
KVAEQYEQQKAEWAKLVNEQTVSSDGVHVELAANIGTPNDLEGVTNNGAEAVGLYRTEFL
YMGRDQLPTEDEQFESYKAVLEGMKGKPVVVRTLDIGGDKELPYLDLPKEMNPFLGFRAI
RLCLEEKDIFRTQLRALLRASSYGNLKIMFPMIATLNEFRAAKALLEEEKANLVSEGVKV
ADKIELGIMVEIPSTAVLADQFAKEVDFFSIGTNDLIQYTMAADRMNERVSYLYQPYNPS
ILRLVKMVIDAAHKEGKWAGMCGEMAGDETAIPLLLGLGLDEFSMSATSILKARSQILNL
SKAEMEELAEKALQMSTTEEVMEAVKAAAKLS
>PK3-045_03381 Phosphocarrier protein HPr
MVEKQFKVIADTGIHARPATLLVQAASKFDSDIQLEYKEKKVNLKSIMGVMSLGIAQGAD
IKIIAEGNDEQEAINGLQETLNKEGLAE
>PK3-045_03382 hypothetical protein
MRYNRKESFRYQLTDFIDATFTVKVDEATLSSKGHASINNISPNGLRFRTEYDLPADDTR
LLLQLQFPLNGREIVMPGHISWKKKIGNLYEYGFEGTGTPEAKQQIIRGLKELSRIENED
TPQ
>PK3-045_03383 hypothetical protein
MKWMNKEIIEEILDKLMKREIESYRVKKEDFLAFRSELVKREDFKHFKGIAEIGGDVTYK
YMDEPRS
>PK3-045_03384 hypothetical protein
MKIAEVGNIIEFRGLQGIVEKVNENSVIVDLTYMSNYRDLELEQRTVVNHKNYRIIK
>PK3-045_03386 hypothetical protein
MVQQRRAVVSVIGKDQIGIISKVTTILSNNHINILDISQTILQDFFTMMMLVDITDKENL
DNLTKQFDELSEQLHLKINIQLEEIFQSMHRV
>PK3-045_03387 hypothetical protein
MKIALNEMMETINMVQMENLDIRTVTMGISLYDCADSDFQKLNDSVYKKITTYASKLTEV
ANAVEKEYGIPIINKRISITPIAEILGNSTVEQAVTLAKTLDKAAKDLNVDFIGGYSALV
HKGISKGDQTLLDALPEALSVTERVCSSVSVATTRTGINMDAVKQMGEIIKKAAENTKDT
NGLACAKLVVFCNPVEDNPFMAGAFHGAGEGEVVINVGVSGPGVVLSALKKYPAADLGEV
SDIIKKTTFKITRAGELIGRVVAERLNVPFGIMDLSLAPTNAINDSVAEILEEIGLERVG
THGTIAALALMNDAVKKGGAMASSYVGGLSGAFIPVSEDNGMIKGILDNSLTLSKLEAMT
CVCSVGLDMIALTGDVTAATLSAIIADEAAIGMINKKTTAVRVIPVPGKKEGEIVEFGGL
LGRAPVMGVNPYSSDKLINRGGRIPSPLQALIN
>PK3-045_03388 hypothetical protein
MKNKWSAAIQLAAVYVGTVVGAGFATGREIVVFFSQYGFIGFLGILLSGIIFAYFGAKLM
RISVKIKASSYQEFTIYLFGNIVGNMINFLLLLMLLGVCAVMFSGAGAVFEEQLGLNKST
GVIFTIILSLLVMRVGTKGLFAVNTFVVPIMITFSFILFLLSISLPGFFGEIFQMENISW
KTISSPFSYTALNLALAIAVLVPAASEIGDEEVAKWGGILGGIALMLILISSHFSLIMLS
DVYRYSIPMAVIMKNLAPQLSWVYILVIYGEIFSSVIGNIYGLERQLRSFIPLPSMVIIG
GIILISYLISYVQYGTLLSFLYPIFGYISLVFLLFLWRKPIPK
>PK3-045_03389 ATP-dependent Clp protease ATP-binding subunit ClpE
MKCEMCQQNNATISLRFVFNNMESTMNLCHACYQKEKQKMTAQSGPMFFQPSPFDELFQS
FNQSNPLGGASTSKEAPFTNNHKKAGILDKHGKNLNQMANAGLIDPVIGRENEIERVIEI
LNRRNKNNPVLIGEPGVGKTAIAEGLALKIIEGNVPKKLQNKEIYLLDVASLVSNTGIRG
QFEEKMKQVIQEVQARKNVIVFIDEIHQLVGAGSAEGSMDAGNILKPALARGELHIIGAT
TLKEYRQIEKDAALERRFQPVQVSEPSVEATLSILNGIKDKYEKFHEVTYTEDAIKACAE
LSHRYIQDRFLPDKAIDLMDEAGSKMNLSSTYQNTEEIENRLAMIAKEKEQALKEENYEK
AAELRKEEQQLEKAINEPNIEEKPIVDVTLIQQLIEKKTGIPVGKLQEDEQQKMKFLSER
LAAKVIGQDEAVRKVAKAIKRSRAGLKSKTRPIGSFLFVGPTGVGKTELTKTLAEELFGN
KDSMIRLDMSEYMEKHSISKIIGSPPGYVGHEEAGQLTEKVRRNPYSIILLDEIEKAHPD
IQSIFLQILEDGRLTDSQGRTVSFKDSVIIMTSNASVGHKHKVVGFGNNDAIEESNLLQT
LGNFFKPEFLNRFDAIIEFKTLEKEHLLRITDLLIQELAQNLQEQNITLHVEDTAKEKIV
ELGTHPSFGARPLRRVIQEHLEDQLADVILDDPSVTELTAVLEDDQIKIKPVLSKKLS
>PK3-045_03390 hypothetical protein
MKFSEFTYKRPDINEFTIRMDELLVEFNQAEHLDQQMAAMEKINELRNDISTMFNLCYIR
HSVDTNDEFYQQEQDYIDEISPKVEGLITKYYQALVQSKFKPELEEKWGKQLFALAEAQL
KVFSEDIVELLQQENKLSTEYTKLVASAKILFEGEERTLAQLQPFTESKNRETRKAASEA
RFAFFREHEEQLDRIYDDMVKVRTEIANKLGYKNFVELGYDRMYRTDYNADMVAAFRKQV
EDYIVPLATKLKERQRERIGVDSLKFYDEPFEFVTGNAAPKGDSEWIVENGQKMYNELSK
ETGDFFSYMRETELMDLVAKKGKAGGGYCTFIENYKAPFIFSNFNGTSGDIDVLTHEAGH
AFQVYSSGGFAIPEYYWPTYEAAEIHSMSMEFFTWPWMDLFFKEDVEKYKFSHLSSALLF
LPYGVSVDEFQHWVYENPTATPSERKQAWRKIERKYSPHLDYDGNEYLENGGFWQKQGHI
YNSPFYYIDYTLAQICAFQFWKRSRENKEEAWEDYVKLCGLGGSMPFTELVKAANLISPF
EEGCVESVVGEIDEWLNSVDDRNL
>PK3-045_03391 HTH-type transcriptional regulator MhqR
MAKKDIDQSLKLYIVLSRAYRAINENVNKAITANGLNPTEFAVLELLYHKGDQPLQQIGG
KILLASGSITYVVDKLEEKGYLKRVACPTDRRVTFAQITDNGKGLIESIFPNHEQRIHEI
MSELTPDEKDTAIELIKRLGLSVGDK
>PK3-045_03392 Sporulation kinase D
MKINTHKKLLYFAIVVIPILITTILFFYYQVNREEAKNKAHAEWVASIHQRQWDSYINKI
VSSLNILSLSIQTNTDSAEEINNLLKKVFTNEHIYGGIFLLDSSGKTIAGVNDTYDSIDI
SEEDYIMEVINSKDLVISNREEVLSNGQKVIGIAMPIISDHNQLNSIITAYLRVDHLINI
TKMLSSEENIAIMNEQKERIFYINDGASINKKEVISMPIDRLPWTIIVELEKPHIWNIVK
SKIWVLLFFMVIFHFFYMLLILYYHRKIREEEAKQNEIQKLELVGNLAASSAHEIRNPLT
GIKGLIQLLSEKYHDQQDQFYFSIIQKEIVRINEIVSQFLILGKPTAQNKQKINLKLIIA
ELNPLIVSEANLYNVKYTEKISDQDIYILGIADQMKQVLLNLTKNALEAMEKGGQLELSI
RSVKSNVIITITDNGIGMSNQQLKKIFEPFNTSKETGTGLGLVVCKRIVESFDGEIHISS
REKKGTKVNIILPIME
>PK3-045_03393 hypothetical protein
MYCKKTELLFEIQDKREVMIKTAKERGTIDEETIRLSQELDKLIYEYQLVFRYESEKRKQ
IKRQYKNTRIFWSNANRYKRKNYSEVVYR
>PK3-045_03394 Transaminase BacF
MKKYDQSQLLKNLPEQFFASLVSKVNSYIEKGYDVINLGQGNPDQPTPSHIIKSLQMAAE
QPKNHKYSPFRGYKHLKEAISEFYKKEYDVDLDPESEVAILFGGKAGLVEIPICLLNPGE
TVMVPDPGYPDYLSGIALANAETVFMPLREENNFLPNYKEVRKEELEKAKLMFLNYPNNP
TGAIATKEFFAETISLSKQHDICVVHDFAYGAIGFDGKKPLSFLQVEGAKDIGVEIYTLS
KTFNMAGWRVAFAVGNQSVISAINLYQDHLYVSLFGAIQEAAYTALTESLACIRDMNQLY
EQRRNIFINGLKKIGWEVNAPEGSFFAWLKVPDGFTSQEFSDYLLETVHIAMAPGSGFGA
FGEGYVRVGLLTEEERLQEAVDRLKTLSIFK
>PK3-045_03395 Omega-amidase YafV
MKFQISLIQMDIAFGRPEENFKQVEKKIAACKDNSDIIVLPELWSTGYDLTRLAAIADKQ
AQNTISFLSKLASKYNVHIIGGSIANNKEKGVYNTLIVINKSGDVVHTYDKLHLFQLMDE
HLYLKSGTSNGLFSLEDRNFASMICYDIRFPEWIRAHTTKGAEAIFVVAEWPKPRLAHWR
SLLIARAIENQCYVIACNRVGNDPNNIFAGHSMIIDPWGEIIAEAGEKEEILTAAINLDK
VTEVRKTIPIFADRKPAYYT
>PK3-045_03396 hypothetical protein
MQLDKMVAFHKTMGDPTRIKIISLLANKPWNGQAIAEKLGLSAPTITHHLKKLRDINVVY
ERRDKNTIYFFLNKSVILQQNESLRKLTNGMEESIMTVTKEEQAKIIENFFTKEGRLKNI
PSQRKKKLIVLKYMLEGLVFGRKYEEKEINAYIQQYFDDYATIRREFIINHFMYRENSIY
ELNPEEMWAK
>PK3-045_03397 Sporulation kinase E
MDSISYSEEYRQLQNKLRELERENTLLKEELEENKLVWDRRFIAFQTINVGMVIFDNNGV
IRDINPCLCDYFNVNMNQVVDRNITHFVKQEERSVIREHMEAIKTKSGTFQSVFLLTING
RKRYFETQTSRLPDELGFITIIEKITEEFEREKEKEEAQKLYNDFFTEALDGIVLWKETG
QIIAANESALKIFESSEEKLLKSRISDFIYKKDKRYVDMITNLYYKKSNREELMFLMPNG
QKKILEFTTKLHSVEGLNMSIFRNITERYKMEEELRESKAMFENTFEEVFDGIIIWDQNY
QIIDMNKAAERLLHKSKEGLIGADLISFFPPAKTIGEDIKPKLLNVDKDGQNRGLYTVKF
PNNREYTQLEYRNKFNIYSGLSITTLRDVTENALLEEQLRKSSTLNVVGELAAGIAHEIR
NPMTALKGFIQLLEDGVASKENDMYFSVIKTELTRIESIINEFLLLAKPQAVQYVKRDIR
QIMNDTIELLYAQAVLQNVQIIKMYAEDMPIIYCEPNQMKQVFINIIKNAIEALEDGGEI
AVSIECKQDYFQIAIRDNGRGMGKEILARIGEPFYTTKEKGTGLGLLVSYQIIEEHQGKV
TVESELGVGTTFYIVLPVKLNE
>PK3-045_03398 hypothetical protein
MKQRDYYFDNAKFILIFFVVFGHFIQSFINDNQNIYTLYKVIYTFHMPAFILISGFFAKG
IAEKGYIKKYAKKLIIPYLIFQLVYSIFYYFLYGKSTFAIEPLTPHWSLWFLISLFFWNI
FLLVFVKLKPIHGILLSFVLGLAIGMVDWTSSYLSLTRTFVFFPLFLIGFYMKKEHFALV
KTRKATILAIVIFTIVFIGFHLFPTVNYQWLFGSKSYEALGEGYFIGMAIRLFFYLLSFL
MIFCFFACVPKKEYFFTKLGKSTLYVYLLHGFFIRLFRQSDLPAIFESPRSYVMIVIVSF
LITVLLSSNIIISFTQPIIELKSSKLKKLFSRVQRSLQTNR
>PK3-045_03399 hypothetical protein
MAKKIKKRQQTEASNVEFGQEFGDVNASKFYDTGALTKDKTKSATRRK
>PK3-045_03400 hypothetical protein
MAKRKAEVNSVEKYSKTPKKNTQETEFSAEFSRGENPIKGANRNAKHGREGQ
>PK3-045_03401 Ktr system potassium uptake protein B
MGKKFKLVLQNLTPAQMITSYYGLAVSISVLLLSLPGVHKEGVTVSFMDTLFTAVTAVSV
TGLTVINIAETYSTFGIIILMFVLQFGGIGVMAIGTFFWMILRKKIGLRERQLIMIDHNQ
SNLSGLVNLIREIIKIILIIEVLGAIILSMQFHNYYPTWGDSILHGTFASVSATTNGGLD
LTGESLTPFKDDYFVQLVNIILITLGAIGFPVLIEVKNYLFPKEGKNHLKFSLFTKLTTI
TFGFLLLFGTIMIIILEWGNYYAGMSWHQIFFNAFFHSTSTRSGGLATMELNEFSMTTLL
IFCFLMFIGASPSSVGGGIRTTTFALNVLFIYHYANGNRYIKIFKREIHEEDIIKSLVVT
IFAIGICLVAVIALSISEKASLIVILFEVCSAFGTTGLSLGLTPELSTFGKCVIMLLMFI
GRIGLTSFIYIIGGKEKKDNFHYPKERIIIG
>PK3-045_03402 Small, acid-soluble spore protein D
MASRNKLLVPGIEQYLDSVKYEIAQEFGVNLGSDTVSRANGSVGGEITKRLVQQAQAELS
GKTQ
>PK3-045_03403 hypothetical protein
MDASMLLEYGWVLLILVVLEGLLAADNAVVMAVMVKHLPVEQQKKALFYGLLGAFVFRFA
TLFMISYLVDVWQVQAIGALYLLFIAVHNIYGKYAKKNEADKDKKPKKQSGFWMTVFKVE
LADIAFAIDSMLAAVALAITLPKTNWFTLGGIDGGQFLVMFLGGLIGLIIMRFAANWFVK
LLHSRPSLETAAFLIVGWVGVKLAVFTLAHPSVGFLDEHFPESKLWKGIFWFVLVAIAVG
GYLFSNKEAVKAKESNA
>PK3-045_03405 hypothetical protein
MVIPMKGLSRLEAIMWSIALPGFSQLLLKKYWKGTLLVILEFIINAKSNFNLAIMLSFCG
NIQEAIEIIDFQWILFYPCLYMFAMWDAYKEVMETDNEYAFLPFVFCAYFVTVGVFYSTQ
MKLFGVLLGPVFLPMVFLIPGIISGFVVKYCLIYFRKKKHS
>PK3-045_03406 Glutamine transport ATP-binding protein GlnQ
MESVFGINKLSTPLDEREDIIKVTKLNKWYGDHHVLKDVDLTVKQGEVIVILGPSGSGKS
TFIRTINALEEFQKGHITVDNIALTDDLKNIEEIRKETGMVFQSFNLFPHMTILKNISLA
PIWVRKWKKAKAEQIAKELLERVGIPEQANKYPGQLSGGQQQRVAIARALAMQPKIMLFD
EPTSALDPEMVKEVLDVMKTLAESGMTMLVVTHEMGFARQVADRIILFDKGEIVETGKPE
ELFDHPKHERTKAFLSQIL
>PK3-045_03407 Inner membrane amino-acid ABC transporter permease protein YhdY
MDNIQLNTEPVMETKKLANQKKLQLWLKNNLFKDWKNAILTIVTLMFTIYLLTRIGKFLF
ASEWGVVTDNLRLLFVGQFPLEEIWRLWVSLLLLSVFLGTTWGAWRGIIGHVAISLSVLL
VILGVIPYTEMESKVYLFTSAAVIFLFYFIGKYVPKLKIPLLILWILYIPITLSIINGFG
VLEPVKTNIWGGFLLTLVIASVAIICSFPLGLLLAVGRRSKLPIIKYCCILYIELIRGMP
LIMVLFIAQLLLPMFLGGIELDNVVRAMIAFTLFSAAYLAENIRGGLQSIPRGQFEAAQA
LGLNNFKVMFFVILPQALKAVIPAMVGQFISIFKDTSLVAVIGLADFLGMGKKIAANPEY
LGKYMELYIVIAFIYFIFCFLMSHVSKHIEKSLGVGTR
>PK3-045_03408 hypothetical protein
MEMKKTTSTPLWRNRKVVPIISQIIFVLIVGIVIAFMVRNVISGLEQIGLVLGLDYLNLK
ASFPIAESIISYTPDDPYTRALLVGLLNTLKVSVFGIILATIIGVIVGVARLSNNWLVRK
VATVYVEIFRNTPLLVQIFIWNFAVFLPMPKIQDAISVGPFYFSNRGASIPWFTLQDNTL
IWLVILIFLIAGSIILFKKLTKVSIESGKSTYPFISSVGLIVIGTIIIYIILGNGPLGFS
VPVFNGNSFEGGTSLSIGFMSVLVALTIYTSTYISEIVRAGIMGVPKGQTEAAKALGFKS
HTALRLIIFPQAIRIIIPPLTSQYLNLIKNSSLAMAVAYQDIVGIGNTIINQTGHTLETL
LIVISVYLLFSLTTSLLMNIFNKKFQLVER
>PK3-045_03409 Putative amino-acid ABC transporter-binding protein YhdW
MKKSLSLTFSILLVLVLALAGCSSKSGSDGESTNGAKTSSSKSLLETIKERGTLKAGVND
ALPGFGYIGSDGKNTGFDVDFARAIAAGVLGDPSKIEFRPLSATDRFTAVQSGEVDVLIR
NTTWTTNRDAEVGLSFAPVTFYDGQGIMVPKDSGIKTLKDLEGKTIGVETGTTTELNLAD
QMKAAGVNYTAQTFDNADAVIAAYEQGSIDAWTTDKSGLVSRQSTLQDPDAHIILEETLS
KEPLAPAVKDGDEKWADAVSWIVFATIQAEEFGITSQNVDDFLTSENPEIKRLLGVEGNL
GEQLGLANDFAYQVIKQVGNYGEIYERNLGPDTVFKLERAQNALYTDGGLLYSIPFR
>PK3-045_03410 Peptide chain release factor 3
MSKNFKQDVLSRRTFAIISHPDAGKTTLTEKLLLFGGAIRDAGTVKGKKTGKYATSDWME
IEKQRGISVTSSVMQFDYKNARVNILDTPGHQDFSEDTYRTLTAVDSAVMIIDSAKGIEE
QTLKLFKVCKMRGIPIFTFINKLDRQGKPPLELLAELEEVMGIESYPMNWPIGMGKEFLG
IYDRFYNRIEQFRVEDKERYVDLNEGGEIEGDHPIKQDSLYDQTLEEIMLLNEAGNEFSE
EKINNGDLTPVFFGSALSNFGVQTFLETYLQFAPSPQARKSTIGEIDPLSEEFSGFIFKI
QANMNPAHRDRIAFLRICSGKFERGMMVNLPRTGKQVKLAQSTQFMADDRSTVNEAVSGD
IIGLYDPGFYQIGDTLTVSKNAYQYEKLPQFTPELFVKVTAKNVMKQKHFHKGIQQLVQE
GAIQLYKTVKTEDYLLGAVGQLQFEVFEHRMRNEYNVEVIMEHVGSKIARWLVDEEVNEN
LSSGRSLLVEDRYGKKAFLFENEFALRWFQDKNPEVKLYNPMDEQE
>PK3-045_03411 NAD-dependent protein deacylase
MDSLVSLIKSANYFVIFTGAGMSTESGLPDFRSANKGLWTAEKKQYLSSTSALNNHVQEF
IEFYRNRVQGIHEFKPHNGYYILSDWERKGYLKQIITQNVDGFHEEAGNEKVAELHGTLK
KVHCETCGKNYPSDEYLHDNYLCSCGGILRPSIVLFGEMLPEQPFFTAEEAAINSDVFLV
LGSSLSVSPANQFPLLAKQTGAKLIIINKEPTQMDGIADIVIHESIGKVLEEINLKL
>PK3-045_03412 hypothetical protein
MYGYGCGYPGYGSGYGGAGYGGGFALIVVLFILLIIVGAACFKW
>PK3-045_03413 hypothetical protein
MGEVGVGYGGGFALLVVLFILLVIIGASWGYGGF
>PK3-045_03414 HTH-type transcriptional repressor OpcR
MTDREQLNIARERVIDSVAQNMDLYGVTESIGRLYGMLLFQKNPMTLDEMKEELGMSKTS
MSTSVRTLLELKMVDKVWRKGVRKDLYRAEEDWYQTFIDYFTIKWRLAITENIYAIEKSM
NEIKVLMNKEGISEDVIKDATNDLEKMKYALDYYDWLERFVDSLESHEIFNFIPKNKE
>PK3-045_03415 Glycine betaine transport ATP-binding protein OpuAA
MESMAKLKVENVTKIFGKNAKKAIQLLNSGESKKDILKKTGATVGVNKASFEVNPGEIFV
IMGLSGSGKSTLVRMFNRLIDPTIGNIYIDGKDIVKMSKEDLRKVRREKISMVFQKFALL
PHRTILENAEYGLEIQGIDKASRKERALESLKLVGLSGYESQYPDQLSGGMQQRVGLARA
LANDPDILLMDEAFSALDPLIRKDMQDELLDLQSNMEKTIIFITHDLDEALRIGDRIALM
KDGTIVQVGTPEEILMNPSNDYVERFVEDVDLSKVLTANHIMKRAEAVTIEKGPRVALQM
MKKLGISSIYVVNKKRELLGAITADDARAAAENNEGIETILQKDVITVTGDTLLADLFDK
VSTAIIPVAVIDEQKRLKGILVRGAVIGALAGNNELINTPPTEESVLVGGNE
>PK3-045_03416 Glycine betaine transport system permease protein OpuAB
MNNLIPKLPVADWIDSFVAWLTTTFEVLFDGITAVLEFVVNILVGFFGFIPPILLIILLT
LLAWKLANKKIALFTLIGLLLVDNLGYWEPMIDTLALVLSAVFISIIIGVPLGIWASQNS
TVRNIVIPILDFMQTMPAFVYLIPAIFFFSIGVVPGVVASVIFAMPPTIRLTILGIQQVP
SDIREATESFGSTTSQKLLKVELPLAMPTILAGINQSIMLALSMVVIAAMVGAPGLGADV
YRAVTQIQIGRGFEAGISIVVLAIILDRITQNVGTKKKGAK
>PK3-045_03417 Glycine betaine-binding protein OpuAC
MKKMTSLLGAITLTLGLAACGSNSADDPNATIGEKVDYEIIGIDPGAGIMKAANKAISDY
DLKDWKLVEGSSAAMTATLKKAYDKKEPIIITGWTPHWMFTAYDLKYLEDPKGSFGENEN
IHSIARNGLKEDMPEAYQVLDNFHWTTDDMGVVMMDIYDGEDPEKAAEKWIKDNADKVSE
WTKGVSKVDGDKIKIGYVAWDSEIASTNVIGKVLTDLGYKVTLSQVEAGPMWTGVADGSL
DAHIAGWLPITHEDYANKFKGQFEDLGPNLEGTKLGLVVPSYMKDINSIEDLKEKE
>PK3-045_03418 Inner membrane protein YqiK
MAIEIYIVIGIVAFLLIALISIFMAKYKTAGPDEALIVTGSYLGSKNVHVDESGNKIKII
RGGGTFILPVFQQSEPLSLLSSKLDVSTPEVYTEQGVPVMADGTAIIKIGGSIGEIATAA
EQFLGKTKQDRENEAREVLEGHLRSILGSMTVEEIYKNRDKFSQEVQRVASHDLAKMGLV
IVSFTIKDVRDKNGYLESLGKPRIAQVKRDADIATAEADKETRIKKAEADKDAKKAELER
ATEIAEAEKENQMKIADYRREQDVAKARADQAYDLESARSKQEVTEQEMQIKIIERQKQI
ELEEKEILRREKQYDSEVKKKADADRYAMEQAAEANKRREIAEADANQYRIESQAKAEAE
KVRVDGLAKAEAEKAKGETEAEIIRLKGLAEAEAKRKIAEAYAQYGQAAILDMVLDMLPE
YAKQVASPLANIDKITVVDTGSDGSNGGANKVTGYATNLMSTMQESLKASAGIDVKELLE
NLSGKGNIRQSINELNDNLSNKTE
>PK3-045_03419 putative membrane protein YuaF
MELFGFDLPSIYLTVLIGSGICVILTLLLSDLFGGDVGVFNPTLILAFFTILSASGYLME
KYSSINSFIILSISAIIALIISSCLHFFVFIPLANAEESLVYSDESLKGRIGKVITAIPQ
DGYGEILIESISGNISKTAASFYNEEIGFGEETVIVEIKENVAYVVRKDGI
>PK3-045_03420 hypothetical protein
MKRTDKHEEIENKNRIGKKVMYFLGSILLLTTIFGGYIFSDRYFASESKTGTEEYGDKVV
ITLPNGKKVFTYENLIVEEDGKLLYKGERNTIDLSGGVVVYENWED
>PK3-045_03421 Putative bifunctional phosphatase/peptidyl-prolyl cis-trans isomerase
MAYKIVFIDIDGTLVNEEKQIPSDAKAAIKELKKRNIPIVLATGRAPYFFSHILEELGLS
SFISFNGSYVVHEKEEVYKKPIPMEILEMLENTALKNNHPIVFQGSKEGCANHKEHAHII
ESFQSLKLKAPSYRKDFWKEADIYQCLLFCEESEEKVYEEAFSNIHFVRWHPLSMDVIPT
GGSKAAGIAQILNILNIDPKEAVAFGDGLNDKEMLSYVGMGIAMGNAHKDIKPYAKFVTK
HVDDGGLAYGLQKISLL
>PK3-045_03422 putative ABC transporter ATP-binding protein YlmA
MVVKIEEVGLKRNGQWILKNINWEIKKGENWILYGLNGAGKTALLNMICAYYHPTVGKME
VLGKEFGKSELGGALRRKIGLVSNRLQQNLYASDSAFEIVLSGAYASIGLYESPTTEIRN
RAIEIIEKLGSLDYADRPYSSLSQGERQRVLIGRALMVNPELIILDEPATGLDFLAREQL
LDTISSLVSENSSIIYVTHHVEEILPVFSHTFLLKKGEEFISGYTKEVLTSKNMSSFFSL
PVEVIWNNERPLLARSSSLIKK
>PK3-045_03423 Phosphocarrier protein HPr
MSEKTFTVIDETGIHARPATLLVSTASKFKSDMQISFKGKSVNLKSIMGVMSLGVPKGGE
ITISATGEDEVEAVDGVEAVLKKEGLVG
>PK3-045_03424 Putative glutamine amidotransferase
MSKPVIGITGAYVFKNKFMEGTYVHHDYQKSVAVNGGLPVILPFVEEDLAREMVDLCDAV
ILSGGEDVDPSLFGEDPHQNIGDTIILRDKVEIQIIKRAMETNKPILAICRGIQILNVAL
GGTLIQDIPSQIKDSIKHTQSVNRNLDTHFISIEEKSKLANIIGETKTRVNSLHHQAIDD
LAAGLEIVATSSDGVIEAVEHKSYPNFLLGIQWHPESMASTNDKMNQIFREFIKSVKKQR
VMG
>PK3-045_03425 Trifunctional nucleotide phosphoesterase protein YfkN
MNLLNGGIKRSFDYTTLFVKIGNLDTGDEILNTEVTILLTSDVHGNVFPLNYGNNAPADV
GLGKIASIIRNERAKNVHTIVIDNGDLIQGTPLTYHYANFLADKKNPMITILNELKYDAA
VIGNHEFNYGLDILKSAVKESNFPWLSANIVDVKTKTPFLGIPYVIKRINGFKIAILGIT
THYIPNWENPQNIRGLQFNDAYDSAKEWVELIKKEEQPDVLVISYHGGFERDPETGEPSE
VLTRENQGYTICKQIDGVDVLLTGHQHRELTGNINGTEIIQPSNNGKYVGKITLLLDDKG
EVIEKSSELLSVAEVEADEDILLLVKENEEWTQEWLDTPIGYIDGEMLVTDPMQIRLKDS
ALIEFINKVQMDAAQVKISNTALFNNESPGFKPNVTMRDIVSNYIYPNTFKVLALTGKDI
RRALEQSAKYFALNDEGEPIVNPSFVYPKPQHYNYDMWEGIEYTLDLTKPIGQRVVQLDF
EGAPIDEEGVYEVVMNNYRAGGGGDFFMFKNKPVIREIQFDASELIANYIMERKVVPATC
NHNWKVIW
>PK3-045_03426 putative phosphite transport system-binding protein PtxB
MLKKFATLGLSLALTAGILSACGSEEKTTSNTDGYDPKELTVQFVPSSNADTLEAKAKPL
EGLLSKELGIPVKVSVSTNYNTIIEAMDSQKIDVGFLPPTAYVLAHDKGSADVILQAQRF
GINDDGSENDELVDFYKSLFIVKADSDIKTVADLKGKKIATQDVTSSAGYVWPVGKLMEN
DINVPGDVETVTVKGHDQAVIALLNGDVDAAVIFQDARNIVKADYPTVFEDTKVLEYTED
IPNDTISVRSDMSDKWRKKLQEAFIAIGKSEEGHQIIRDIYTHEGYVVSDDSKFDIVREY
NEKVAE
>PK3-045_03427 Glutamine transport ATP-binding protein GlnQ
MIEFKKVTKIYPNGTKGLNDINITINKGEFVVIVGLSGAGKSTFLRSINRLHEISAGNIV
INGQSITAAKGSELRKIRRNIGMIFQNFNLIKRSTVLRNVLSGRVGYHGTLRTILGFFPK
QDIDLCLLALDRVNILEKVYSRADELSGGQQQRVSIARALAQEAEIILADEPVASLDPLT
TKQVMDDLKRINVEDGITTIVNLHFIDLARQYATRIIGLRAGEVVFDGPVEEATDEVFKI
IYGREIKKDELLGESI
>PK3-045_03428 Phosphate-import permease protein PhnE
MNEKAIKQPLLNRPTPPAKNKLILTILLLLVLLWWSAYKTDASLTELIQGFPNIFDVLLQ
MVPPDWKYFQKIMEPLLVTIRMAVIGTTFGAIIAIPLAIFCASNIVRSAFIFYPFRMILN
LIRTIPDLLLASIFVAIFGIGSLPGIIALIIFSIGLIAKLLYEAIESIDSGPLEGMTAVG
ANKIQWIFFGIVPQVTASFTSYVLYTFEVNVRAAAILGLVGAGGIGEYYDRTLNFLQYDR
ASSIIILTLLVVLIIDYCSTKLREKLL
>PK3-045_03429 Phosphate-import permease protein PhnE
MSETIKTITKPKKKSFRNITLFVLLILIYIWAFSDIPVTSIKDSSAQISQAIFTGIFHPD
WEYVYLPDGEDLLRGLLDTLAIAILGTFISAFLCIPFAFWAANNMSKGKTIASTGKFVLS
FVRTFPEIIMAILFIKAVGPGSFAGILALGLHSIGMLGKLFSEEIENLDMGPTESLLAAG
GTRLQVLWFAVLPQVLPGFLSYTLYRFEINIRSAAILGVIGAGGIGTPLIFALSTRDWDR
VGIILLGIIVMVTIIDIISGFLRRKIA
>PK3-045_03430 Glyoxylate/hydroxypyruvate reductase B
MKKRKLLLTHSLHSSLLKKIQSTFSEWEIIQALKQDDWQKHLIDSEIILGWRSSFDLKTI
MDNDQLKWIQTWSAGVNSLPLEQLRKKNIVITSANGVHGYPISETIFALLLGLTRNIHTY
VRNQLKRKWDGTDIKLEAHKKTIGIIGLGAIGLETAKIAKAFDMHVIGVRNSRKPTDYVD
ALYTSEELNEVLPLCDYVVVTLPLTDDTYQLFQKEQFQHMKNSAFFINIGRGEIVKEDDL
VIALKNGEILGAGLDVFENEPLQQTSPLWDLENVIITPHTSGSTEHYNSRVIEDIFLLNA
KHYLKEKDLAINVVDYQKGY
>PK3-045_03431 High-affinity zinc uptake system membrane protein ZnuB
MFELEFMQRAFWAGGLIAIIAPIIGIYLVLRRQALMADTLSHISLAGVAIGFFFQTNVTI
SSLLVVMAGAIGIEYMRRAYHTYSEVSIAILMAAGLSFALFLMSLSSGGMTTSMDQYLFG
SIITISKQQVNILAIVTGIILLFFVFFTRQMYIMTFDQDTATTSGINTNMLSIAFSILTG
IAISVIIPTIGVLLVSALLVLPSAFSIKLVKGFKWVFFVAILVAAVSIFTGLFSSYHLGT
PPGATITLLLVVILLVGFLSQRIYMMVRRATSQKNYKKVG
>PK3-045_03432 High-affinity zinc uptake system ATP-binding protein ZnuC
MKLATVSKITFGYEHVPALEDVSFELEYGEFVGITGPNGASKSTLLKLLLGLLKPWSGEV
NISKLNASGKKLTVGYVPQQISSFNVGFPSTVIELVRSGRYQRKKWYERLKEVDHEAVKK
SLEMVGMWDYRNKKIGELSGGQKQKIVIARILASEPDLLVLDEPTTGMDADSRKGFYEFM
KHQVNEHNRTVVMVTHDQDEVEDYLDKIIHIEKGEKGGWRCLSLNSCKEHFGQVGSLQ
>PK3-045_03433 Peptidoglycan DL-endopeptidase CwlO
MLKKKLVVLNTTILLGLGTSLAVPGINAHANQSPSIVQQKESLQGQISDAQIKIVETQEE
LKKLEAQIKRVDKAIEENKALIEETKTKMETTEKEIATLEKKIKELEDRIEKRNDVLKER
ARTFQENGGNVDYIEVLFGAASFKEFVDRVGAVATIMEADQDLIASNEADKKDLETKQNE
VKEKYDELKNTKLDLEEMQKQNQDKQKKNEQAKNDLKAKEADNKERKAKLEEKYGSLQSV
EPQIKKMIQQKEQENLNQLVATTVGTSDNGSSNNSSSASSNKSKTSSDKTTSGSKKTVKA
SGSKSKAITAGYKYIGNSTYKFGGGRTASDVANGLFDCSGFVSWAYSQAGYSIPASTDAL
KNAGTRVSTSDMQPGDLVFFNTYKTDGHVGIYIGGGKFIGSQSSTGVAIASMDSGYWKTV
FNGRVVRF
>PK3-045_03434 Hydrogen cyanide synthase subunit HcnC
MKRIVVVGGGILGAATAFELAKRGAEVIVIDREDRGQATKAAAGIICPWNSQRRNKKWYL
LAREGAKYYPTLVNDLQNYHQLNTGYKKVGALSLHSDITKLEAMKERTLKRKIDAPEIGD
IDILSSSEAQSLFPLLASGYGALHISGAARVNGWSLRNALMEASKQLGARFIHSSCTLLK
EGHAIKGVTLRDNTSIYADEVVIAAGVWANELLEPLNLAFDVKAQKGQILHIQLKDIQCS
NWPVVMPPHDQYLLTLENNTIVIGATHENTTELSPDVTIEGIKEIIDKALLFAPGISEGI
WSEVKVGFRPFTNDFLPVFGKVKHYEGLTLANGLGASGLTMGPFIGQQLAKFLLHSESDI
DFSPYSIDSSIQER
>PK3-045_03435 hypothetical protein
MVKKVVVPGIFLAALSSPLFMDEAHAASVTKYVEVNKGSVLNVRVGPSISTSVVTTLKAG
EKVSVLSETNGWSKVDVDGKIGYVSSSYLTTKQESFVKYVSIDPSSTLNVRESASTKANV
VTKLKNNTKVEVISESNGWAKIKVNGINGYVSSQYIKAVQSEEKKTTNSSNKQQKVTKYV
NVDTGSSLNLRNSPSNSASIIVKLAKDVPVTVYSESNGWSKVEAYGKQGYVATQYLAEKK
GTSSTEKKDETKTSASKEATAKTTAKYVNVEKKSSLNVRKEASTNSSILTKLSRGTEVKV
LSSANGWDKVTVSGKTGYVSSSYLSEKKITEATTNNNKATEKNSGNTPTLVSKKVNVQAG
SNLNVRSTASTSGSIKGKLSAGTVVTVLSEKNGWSQIKTSKVEGYVSSEYLTSISTPDKG
TDKNEAKQPEKAPTGKEMKVNVQAGSNLNVRSTASTSGSIKGKLSAGTVVTVLSEKNGWS
KIKTSKVEGYVSSEYLTSISTPDKGTDKNEAKQPEKAPTGKEMKVNVQAGSNLNVRSTAS
TSGSIKGKLSAGTVVTVLSEKNGWSKIKTSKVEGYVSSEYLTSISTPDKGTDKNEAKQPE
KTPTGIEKIVNVQAGSSLNLRSTPSTSGKILSKLPAGTVVIVQAEGNGWSKVKVNNLEGY
VSTEYLSTKGNGSANATINKNYVNYNLTLEEMTNIQLSVNPQTDKKYDTYIREDAIAFKT
ADSTKGTVIGNGWRLRGGAGTDYSVVSTLTSGQVLTITSKIKGTDGYYWYKVNYSQSWVT
ASKEDTAYYLNPDNFINSDTQSLQFLKLSAKANVDDKEVDSKILAGKGILAGKASAFVTA
ANAYGINEIYLISHALLETGNGTSTLANGVKVNGKTVYNMYGIGAYDGSAISSGAQYAYN
AGWFTPEAAIIGGAKFIAQGYVNAGQDTLYKMRWNPDAAEKTGNATHQYASDIGWATKQV
GQIYNLYNLLSSYTLNYEIPTYKVNTK
>PK3-045_03436 L-asparaginase 1
MKKLLLLATGGTIASIEGNEGLVPGLSAEDLLQYFKNDILEVDVTCEIIMNRDSTNMQPE
HWVMMAETIAERYHEFDGFIITHGTDTLAYTSAALSYMLQGLEKPVVITGSQVPISFKQT
DAKKNVIDSIRFAKEEIGGVFVVFDGRVIIGTRAMKMRTKSYDAFASINHPYVATIEKDQ
IHFLWKPDKTTTDLLLNTSICPDVFLLKLHPGTKPEIFNFIKQHYKGVIIESFGNGGLPF
EERNLLPKIEEMVEEGIAVVITTQCLEEGQDLLLYEVGRKVAQYNIILSADMNTEAIVAK
LMWVLGNEASLNEIKNRMESQIAYDLSVDWEGERSNY
>PK3-045_03437 Bifunctional F420 biosynthesis protein FbiB
MNISELITGRRTVKKFKTKDVENSIILEWLQQAKFAPNHKMTEPWRILFVGEKTRAELKH
KTNFGGASKVIAVLSHKGRNQIERDENLASVSCFIQNFMLQAWDAGVGTFWSSVGSSALG
RKSLGVSEDYEVVGVLAIGYPEEIMEPKARTSIEEKITYLD
>PK3-045_03438 Spore germination protein B3
MKRCLLCISIVSILFLAGCWDHSELNQNSIVTGIAIDKGKEHKYKLSIESTSAAELNPRT
AQGLAPAIVYSIEGDTVGEITHKFNTAISTHLVFSHTRLLIIGEDIAREGILSFMDYFDR
DREIRDDFNIVVARDTEAVDFLRITNDYQKVSSLKIFPQLDNMLKEWGGTPGIKLNDFIR
TYSSPGQVPVLSAMKIDGEKEKGWNLDNIKTTVPGAIAKIDSLAIFKNGKLQGYLDLNDT
RMLVWIQSKLEQTSLSIPYEKNKFFGLRVMHSKTKIKARQVNGRPQFDIFIKAESILDGS
EKGIKAAKANAFEDFEDKTNRYLEKEFSKLIEKMQKEYVADIFGLGEIFRDQDYKHFKQY
EDNWDTGFKDAKINVHVNVEIKRSGFRNNSNNIK
>PK3-045_03439 NADH dehydrogenase-like protein YjlD
MSKHIVILGAGYGGLLAALNVRKFYSKAEATVTVINKYPTHQIITELHRLAAGNVSEKAV
AMPLEKLFKGKDIDLKIAAVDSFNVDTKEVALGDGTKLSYDALVVALGSVTAYFGIPGLE
ENSMVLKSADDANKIYNHVEERIREYAKSRKQEDATILIGGGGLTGVELVGELADILPGL
TRKYGVDFRDIKLLLVEAGPKILPVLPEDLIERATKSLENRGVTFLTGLPVTNVSGNVID
LKDGQQIVANTFVWTGGVQGNPLVGVSGLEVNRGRATVNDFLQSTSHPDVFVAGDSAVYF
PADGDGRPAPPTAQIAWQMGELIGYNLYAYLENKALDTFNPINSGTLASLGRKDGVAIVG
GSSTPLKGLPASLMKEASNIRYLSHIKGLFSLAY
>PK3-045_03440 putative protein YjlC
MSETTAQTNAEKQLTATNQDLLDQLLKPEVQESLTTLMEQLPKLTEMVNGLSKTYDVVQS
LSQDEVFKSDIVGATTEMFEPVIHSVKGMASAAIEAKDRADASNETIGVFGLMKMLKDPQ
AQKMFRFLQSYLQIMSERNNK
>PK3-045_03441 Sensor histidine kinase RcsC
MIRFDNYLFVLLLNVVPIFIYFYYFHKMKIKNTRLFTAFYCSTILILAMALSLEIAPGHI
YDLRTIPWLVAFFYGGLPAGLLTTMVMAIYRYMIGYNEGLMITIIIVLLTVPVLCYTIKM
YKQAKTYGKKIMIACSTSLIPISIDVIATSFFTNKLTIMFVIYLYLSHLVTLSIAIYLIE
SLSYQERKQEQMQQTERIRLIGEMAASVAHEIRNPLTVVKGYTHLLKEDSNITGKQQEML
LLISSELVRAEKIINDYLSLARPNQGKKEQIVLAKIIKKVEELMYPYALLNNVKIYNQVQ
TTCIIEAGHDEILQLFINMIKNAIEAIEDKGEVIISAKLSENHLRINIKDNGKGMSEDEL
QRLGTPFYSTKTQGTGVGMMVCFNIIHHLNGKIKINSKINKGTTCSVIFPLNHK
>PK3-045_03442 Phenylalanine-specific permease
MTNKKADSKSENLKWWQLSLIGVGCTIGTGYFLGSSLGIMETGPSIVFTFILAAIGTYIV
FNQLAKMTAEDPQEGSFCYYANKAFGPWAGFSCGWNYWFSNILIMGSQLTALSLLSQFWF
PKVPLWVFACIYAVLSLFVVFLGTKGFDRVENYLAIIKTAAIIMFIGLAAAAVFGWIHGG
NGAVSVPKSIDDLFPKGYKGFWISLLFAFYAYGGIEVIGLMAMQLKDKKDAPKAGTNMLI
ILVIIYVLSLGLATILAPLDQFSEKESPFVTALSEYHLTFFPHVFNGAIIIAGFSTMTAS
LFGVTSLLVTLAKDGDAPRIFQKKLKKFNELPLPSFILGGIGLFASVVAALLLPGKIFEY
ITTAAGILLLYNWTFILLSSFKILKGKLWDKLKSSFGILLIITAIAGTIIEKEVRIGFFV
SLAFVLIIASATFFMRHKLGKNKAGCAK
>PK3-045_03443 hypothetical protein
MNKRKKQVMDKAHELFIEKGFQQTSIQDILTASKISKGTFYNYFSSKNELLISIFKNIYT
ELEWQRKQLLMGQDETDSTLFIKQIEMLIRTNNQYKIISLFEEILFTKDEELKNYIKNRR
IHELSWIYNRLVDVCGAQNKTYLLDCSIMLMGMIHSSIFVHSLIYQDHANIHQIVQYCVN
RVLEMVNHLSKSNEVLIKPDTLYNWIALQSMSDEDVGKKEILCMIYAFKADLKKDKELLS
SQEKIEQLLTFIEEEIEIKYPRYFLMESALMSLMQEVKETPYAKKVQKLRDSIKKVYSKR
NQ
>PK3-045_03444 Multidrug export protein EmrB
MNTNATSNEKKPPYGIIVILMAGAFVAFLNSTLLNIALPSISADFKIDPSVGQWLVTGYM
LVNGIMIPTSAFLIQKYSTRRLFIIAMSLFTIGTLMAGMAHSFPVLLLSRMIQASGSSIM
MPVLMNFLLTSFPVEKRGSAMGVFGLIMTFAPAIGPTLSGYIVEHYEWRMLFYVVSPIAI
IVLISAIFKIKDKKEKVDIHIDLLSVILSSLGFGGLLYGFSSAGTKGWSNIHVYGTLIIG
VIALIFFVLRQLKMTTPMLEFRIFKYPLFSLSAVITVVVNIALFSAMLLMPMYIQTVRGI
SPFHSGLLLLPGAIIMGIMSPITGRLFDKYGARTLALVGLTLTAITTYMFSQLSMTTTIT
TLVLIYSLRMFGMSMVMMPIMTNGLNELPSRMNPHGTALNNTLSQVSGAIGSAVMITFMS
QRTKTHGEELAAKAMQEMSNTTTQPTPEAIATMKEQLGMQAMLEGINDAFLISVGIVIVA
LVLAAFVKRAVPPKDAEQQTSPAKMKEAVE
>PK3-045_03445 Sorbitol dehydrogenase
MVKMKALRWHNQKDIRLENIEEPQVAPGKVKLKVKWCGICGSDLHEYLGGPIFIPVDQPH
PLTNEVAPVTLGHEFSGEIVEIGEGVTDYQVGDRVVVEPIFATHGHQGAYNLDENMGFLG
LAGGGGGFSEYVSVDTELLHKLPDELSYEQGALVEPSAVALYAVRSSKIQAGDTAAVFGC
GPIGLLVIEALKAAGATDIYAVELSPERQAKAEELGAIVVNPADYEDVVAELVRRTNGGV
DVSFEVTGVPVVLRQAIQSTTISGETVIVSIWEKGAEILPNDIVIKERTIKGIIGYRDVF
PSVLNLMRKGYFSADKLVTKKIKLDEVVEEGFQSLISEKNQVKILVSAE
>PK3-045_03446 Hydrogen peroxide-inducible genes activator
MNIEQLKYIVEISHSSSLKTAATKLNISLPALSQSVTKLEKELNIEIFHRSRKGTYPTEE
GKILIQKANGVLEKLQEFLDEAESFVHILKGELKIATFPGPLDLLADQITLYKKEFPYIK
ASIEEDNSQHIIEKVKKEEVDIGFIIYTAEDIKKNSSLRFHKLYDGCMVVAVNKNSPLAN
NEYITEKMLINQPIILYNDHSILEFVQNLAIVENDMEILFTTNNVETIRYALERNTAINI
GYDYAFKTITGLANNDSYVTLPFVDTIINTYYFGYIYPIDKGISKVAKEFLNRLT
>PK3-045_03447 hypothetical protein
MIRMYLESMIIYILIGSPIYLLSRYLYVKYKTQQIVWMKETLLFLFVMFCIGVASQTIIP
HWYLIVEDGKQQLSIQWSEGLRSINLIPFATIISYFALENDQVSNWNEVSRVNLLGNIVI
FVPFGIFLPLLWKAFRKFSSLFWIAIGIPLLIEILQLFIGRSTDIDDIILNALGIMFGFS
LYKIFQNFFHKGKDSGVRKNSK
>PK3-045_03448 Peptidoglycan glycosyltransferase MrdB
MNNKHLFLDKVTEQVKSKEAKESIKLEMEYHIQLAKKGWMKKGWTENEAEEKAINEMGSP
SQLGRELSEIYRPTIDWAIVILTVSLLMIGILPALSSSFHFITLKLLMTFLGIAIVIGFM
YVDYRKFADFGYLFYSIGSLLLISIIFFGNLMINGMNYIKIGPIILQGIMAIPFFLLAWA
SFFSKKEFTYVSFLCLFFFSCVLFLFGFDSISTVFIYIFTVAIMLSWSRFSKRKVLITYG
IGTILLLGLLFLTRGSYQLNRLMAFLFPERYAEEAGYFYLYRQKMWADLKWVGSPDMEVL
TFINNTDTVFLQITYQFGYMMAVILVLLFGALILKMIANVKKIKHPYAKFLLIGSITLYS
VQVVYNLGMCVGLLPVISLSLPFISYGLVPTVINALLIGLILSIIRRKNFQ
>PK3-045_03449 hypothetical protein
MEKRLKNLQAGLKKTYFNHLSFTAEHRKEIMKKIQIKNKEEEILLAALQLLHTRKTGFEL
TELLRARGFQKFENQEGFIYTFLHRLEQRNIIASEWDNNKVKYYHIDRKGKKLEKKLAAE
GGRSKNIRELIDWVYVNE
>PK3-045_03450 RNA polymerase sigma-H factor
MEELSACWKEIDNKEEVFDEIMTTYGQELLHLVFSYVKNEGIAEELTQDIFVKVYYSIHK
YKGKSSFRTWIWRIAINHCKDYLKSWYTKNVIKVDDEYIYGEDSKENIEQTIVQKEEEQW
LVQAVMSLPILYREIIFLFYFEELTIKEIARIIGVNENTIKTRLRRAKQLLKKIGDEEKW
KND
>PK3-045_03451 Na(+), Li(+), K(+)/H(+) antiporter
MTMRLRDWDRNLKIRLAGESTVNVTFWMFFPFLAIYFTESFGKSIAGFLLILSQAFSVVA
NLLGGYYADKFGRKKMMVISSLAQGIAYLIFAFASSPWLDSPAISFICFTVISLFTSIYW
PASQAMVADVVKEKDRSSVFAIFYTSTNIAVVIGPILGGFFYKDYRFFLLLAAGLLNIIL
SMVLKIWIAETAPPYKELDNKKKNWAMALGAQLKDYQVIVRDRTFLLFILAGVLIGQTFM
QLDLLLPVYVDEMVATQNLFSLGNWSLEIQSTQAFGLILAENGLVVALFTIIVTRWMSKF
KEKNVFIISSFIYAIAVIMFSQTNLIWGLMFAMLLFSFAELMTAGIQQSFISEIAPEDQR
GKYFAAASLRFTFSKMIAPLSIPMSAWFGFKWTFFIIAILAIISAFIYQVMFKQFETKKR
KLNIVKPL
>PK3-045_03452 Acetylxylan esterase
MEANKRFLFIGDSITQAGRMEDREGIGYGYVRYIKDYFTINQPEVLPNIVNKGIDGNRIT
DLEQRWEADVLTLRPDLVSISIGINDVWRQLDQPQLEQVTPAKFSAIYERLLEKVKKHTN
ASIFLMEPTIIEEAIEAKGNILLKDYVTVIHHIAAKYDAVVVPTHQVFMEYLQKQNNQVL
TTDGVHMNSAGNMLMAQTWLQVYKKFKEDKSSFR
>PK3-045_03453 High-affinity zinc uptake system binding-protein ZnuA
MGKKFKLVTIMLLAILVIAACGKGENNDSNGANKEKLKIMTTFYPMYEFTKNIAGDKADV
TLLIPSNQEPHGWEPTPKDIANVQTSDLFVFNSIYMENFVDTIKSAVDNKETVFVEASKG
ITLKEGLTDEHDHEGEEADHDHESEEAEDGHSHEKDPHVWLSPALAIKEVETITESIIKV
DPDNKETYQKNSEKYIAKLTALDQRYSDDLSKVAKKEMITQHAAFGYLASEYGLTQVPIS
GISPDQEPNAQRLAELKDFAKEHDISVIYFEETASQKVADTLATEIGARTEVLSTLEALS
KKDEESGMDYIKVMERNLEKIVQAQQ
>PK3-045_03454 Myo-inositol 2-dehydrogenase
MSKLKVAIIGCGNIFPMHAQSIVSREDAELVAVCDVKPERAEEKAKIYGCAAYTDYKKMF
EQESLDVLHICLPHHLHAPVTIEAAKKQIHILTEKPMSIHYDDAVEMVETAKENKVTLGV
IFQNRYNPGSQLIKKMLDNGELGKIKSGKLSVTWDRSDEYYQKSDWKGTWEKEGGGVIID
QAIHTMDLMRWFVNADINYVDASISNRAHEIIEVEDAAEGVIAYKNGIVTAFHAINYYTY
DAPVEIELHCEKGIAKMVADRATVRLMDGREFIADNNPQETFHYENGVKGYWGVSHVKQI
NNFYDSLATGIPLDVTGEEALKTQKMICAVYESGKKKERVYFKSTVESIQ
>PK3-045_03455 hypothetical protein
MKLGVFTVLFADKSFEEMLDAVKEAGIQAVEIGTGGYPGNKHCNVDELLESEEKRKEYLE
KVTERDLIISAFSCHGNPISPEEAFAKESHETLLKTIKLASLMNVPVVNCFSGTAGDHDG
AKYPNWPVTPWPNEYSDVKKWQWQEKLIPYWKEVGHIAKESGVKIGLELHGGFLVHTPYT
LLKLREETCDAIGANLDPSHLWWQGINPVAAIKILAKEKAIHHFHAKDTYIDQDNVNMYG
LTDMQPYGEVQTRAWTFRSVGCGHSVSEWSDMMSALRTYGYDYVVSIEHEDPIMSIREGL
TRAVTNLKSILIEDAPSQMWWV
>PK3-045_03456 Glucose--fructose oxidoreductase
MASLKVGVIGCGSIAQHRHIPEYLLNKQVELVAVCDINEERATEIAEKYQAQAFTDYKEL
LKMDGIDAVSVCTPNYLHAPISIDALNAGKHVLCEKPMATSKEEAEQMIKAAKKSGKKLM
IGHNQRFVASHQKAHQLIKSGEIGKVYSFRTTFGHGGPEGWSVDGKESWFFKKEEAFIGA
MGDLGVHKADLLRFVLGEEFTEVGAFVETNAKDFSTVDDNAVCILKTDSGIIGTLTASWA
YRGKEDNSTVIYAEKAVIRLEDDPNYSLIIQYTNGEKVNYELGRIQSNSDGGQNKTGVID
HFVESVLEDKEPLISGEEGKKSLAIILAALESQATKTITKI
>PK3-045_03457 hypothetical protein
MITIWNENRHEKKNPTVAEIYPNGIHGAIAAFLEKEGYETHTATLDEPDHGLTEEVLNNT
DVLVWWGHLAHHEVEDEIVLKVKQRVLDGMGLIVLHSGHFSKIFKTLMGTTCNLKWREAD
DRERLWVVAPNHPIVEGINEYIELEKEEMYGEHFDIPAPDELIFTSWFEGGEVFRSGCTY
ARGNGKVFYFRPGHETYPTYHHQEIQQVIINAVKWAAPVKREKPVYGNAQPLETISDK
>PK3-045_03458 HTH-type transcriptional activator RhaS
MEMETKHTFKQPVNEKVIYQNPLLSLKVWEINDEREHVMTPVDDYPWHYHKEVELLAMID
GDLAVQTKERYLSITSGDVLIMGASQPHRTSKVKKGKLRYIVLQIDLHKHFDQSILPYFY
CFSELTHPLDKINYIFEDNKEIKQEVHSLINEIHRESQTKEKGYEIAINYSIKRLLLLCV
RNDTKNMLQYSEEQDLAKLKPVLDYIDSHLEERILVEDVSKLLNFSYHYFIKYFKKVMGL
SFVDYINIKRIKKAELLLLTTDKSILEISYEVGITNMAQFYKLFKRENQCSPKAFKNRML
NASVL
>PK3-045_03459 Dipicolinate synthase subunit A
MNENHVLLIIGGDSRQLEVIRLLAPKLNKIYLIGFKDASVSYKNVRKVNWQTAPLHEVDS
ILLPIPGIQEDGIAESLFSKEAIFLTKEMINKTKTNCTMYSGIITPYLKQLATETHRNLV
ALFARNDVAIHNSIPTAEGALMLAIKHTDITIHNSQVLVLGFGRVGKTVARLFSAVGAKV
TVLVRKKEDEARVIEMGLVAIFEPSLESEIPLQQIIINTVPALLLTSSLIKKLSSTALII
DLASKPGGIDFAAAKEHNIETLWALGLPAKVAPKTASTIIGKTLMELLEIS
>PK3-045_03460 hypothetical protein
MKEKNAFHFNGFIGVLLIAISLFLGVYFLVQEIPEAAIPFFLIAVLLGSGITIIQPNQAV
VVTFFGKYLGTIRSSGLFLTTPLTLRKTISLRVRNFNSKRLKVNDVDGNPIEIAAVIVFK
VIDSAKAIFDVDNYEEFVEIQSETAIRHVATKYPYDTFENVELTLRGNAEEVSNELTAEL
QARLDLAGVEVIEARLTHLAYSTEIAQAMLQRQQASAIISARQKIVEGAVGMAQMAINQL
EQDKIIELDDERKVQLVNNLLVAIVSENPTTPVINTGTLY
>PK3-045_03461 hypothetical protein
MTKKKSFPLRIDPELYEVLQKWAADDFRSINSHIEYLLREAAKKAKRYPKQKEN
>PK3-045_03462 RNA polymerase-associated protein RapA
MNTVITRKMILEMCGPVSLKRGEAFSKNHKVIFKEYRDNYCEAFVQASEDFAVMVAIDGE
EIKATCSCPKLASFQKECQHIAAVLVEIKKFQMNGKAPSTTDEKNMDVSGDFFALFNQSE
SLSTKQQRHFEKREVIPVEFMLKVIPIDSETNLFGIEIQLLSHPIKDIRLFLKRIKSGKA
YSFSSELEFNPKLHCVKEESEAILQELGKVIEDERIFLNHHQGVSNIWGDSILLIPPSSW
IPLRSHWKELGYYDPNKGTMVPLNVSNEVLPLRFHLYQREIGSYQLNVHGMESIQFLHQY
YAVLIEGNVRQLEAEDFKRLIEIKKMMEKVGESFIPIALNQLDFFLEKVAPSLKKLGEVQ
LERELSKKIGKTPLQAELYLDRVNNRLLASLEFRYDHIVINPVQERDKEVEAVLLRDWKK
EEQIKELMDSSSFAKTDSGYMLYNEELEFDFLYYVLPKLQKLVKVYATTAIRNRIFKEKT
WPRFSVKLKKDRINWLEFKFEMEGFPEREIKGLLAALEEKRKYYRLQDGSLFALQTREME
EVQRYLQSPQIKDKDFISGFELTLLESLSFIEEDRKIFALDESYQQLIDSFLHPEKLNIK
VPADLNNVLKTYQKDGYKWLKTLAQYQFGGILADDMGLGKTLQSIAFIQSELPVIRKAKQ
PVLVVCPSSLLYNWQREIMKFAPAIQCLILDGVKKERAALQKDLENIDVIITSYPLVRQD
ISWYEQQVFHTVLFDEAQYFKNPLSQTAKAVKKLKAVNRFALTGTPLENSIEELWSIFHI
VFPELFKGLKEFANLTNKQIAKKIRPFMLRRLKEDVLAELPEKREWSEIVELLPEQKRLY
AAYLAKLRHDALKHLNKETLRKNKIRILAGLTRLRQICCHPALFVDNYHGKSAKLDHLME
LIEEAQRSNRRVLIFSQFTSMLEIIGQELAKKGLAYFYLDGSTPSDERVELCHRYNLGER
DYFLISLKAGGTGLNLMTADTVILYDTWWNPAVEEQAADRAHRIGQENVVDVIKLFSKGT
IEEKIYELQEKKKNLVDEIIDSDDKVISSLTEEDLRELLS
>PK3-045_03463 Intracellular serine protease
MKKECRVIPYQVKEVMDVSAEIPKGIELIQASELWKKTKGKGITVAILDTGCDINHPDLQ
ERIIGGKNFTDDDNGDPAIYMDYNGHGTHVAGTIGASGKEDGLTGVAPEISLLIVKVLNG
QGSGQYEWIINGIYYAIEQGADIISMSLGGPEDVEELHEAVKKAVEAQILVVCAAGNEGD
GLDSTEELGYPAAYNEVISVGAVDLQRNSSRFSNSNREVDLVAPGEEILSTFLDGKYAKL
TGTSMAAPHVSGALALIKIISNEAFERNLTEPELYAQLIKRTIPLGNKPSLEGNGILYLT
APEALMEKLQSTVQLLVANSL
>PK3-045_03464 hypothetical protein
MKHYLNVKEGKNNWPRYLASILLAVGFMIAGSIVYFIVELIRIELDGNDATYIDLDTGMV
MGGNGTVSLLMTHIVYIFALVGIWIGVRFIHKRKFRSLITGDDRVNWKKIIWGFLIFAGL
FLLTSGLDFLFNADDYAWNNVSFSQFFFLFLVVLLFVPIQTTVEELLFRGLLLQWVGKKI
KNPILLALIVGVIFGSLHFSNPEMNDSAILVGLDYLLAGFALTFIAVKTGSLELSIGAHA
ANNMMIFLFFTYDDSVAGNIPSLFQILETSPQYSIIWSLLIFTAFYLLSIKKYGRKSIS
>PK3-045_03465 hypothetical protein
MKPIQVYRGQYLESSHSIHVAVVDKDGRLLYFYGDPERMTFPRSSLKPFQAIPLIETGAA
DSFSYDNVEIAIACASHAGELFHQETILRILERLGIQEDNLQCGTHTPWNLESYKELLRK
GKDVTPVFSNCSGKHAGMLAAAIHMKEDIATYREVEHPHQQRILEAIATICDFPKEKIKL
SVDGCGVPVHQLPLYNAALGYARLANPDSIKSVNRIDIVKRIRDSMVEFPEMVGGTNRFD
TDLMKAYKGRIVSKAGAEAVQCMGLIQEGIGIAIKVEDGGTRAVNVAAMEVLNQLGYKEV
NLFTNLDRYVHAPVLNARKEKIGEIRANFHLEEALSTEK
>PK3-045_03466 hypothetical protein
MINIMEKVTYKNIHKEGKRVKETSDWFHVHNEEMLLQYDSNYIQFKKMPTIQEFELVEDY
LKTFHQKTGQKHLKFVFPENEKFTKDLLEYIVQNLHYEVGMTELYAIAPCNFPVLYPSED
ILIQKVTEENFEDYLQLEYNQDLEYGVDYAKGKTEIYQKNFKNPLFLQVIAYYKGKAAGA
LEVIIADKTVEIDGIFVIEEYQRKGIAARMQRKIMDLFPNKTIILLADGEDTPREMYQRQ
NYQQQGFQYEALKENF
>PK3-045_03467 hypothetical protein
MSGLITYQTIVIHDHTEKEWKEKLNKEFRDLLDKDFLLSVGIGEAVNNAIEHGNYPVILE
LQYNQNILDMRIKDHGNGFDVKKKFRDIERYGTEKLMSDIVLEERGRGILMMMQIFQKVQ
YNEMGNEVFLWRETREDAKAI
>PK3-045_03469 hypothetical protein
MNQYNVKVKKNPLRTREDLERALYDLYEPLFMLGNEQKAGLLNLGTNGSVYGQKTRELEA
FLRPFWGWGPLFSVTPNKYPAIKRQLVKGIIEGTTPTSDSYWGITGEYDQRFVEMAALSC
TLIHCKADFWDILSTVQKENLANWLYQINENTIPNNNWLFFRVLVNVALKKCGRSYSLEK
LEADLQQLDQYYLKNGWYFDGYKNQIDYYIPFAMHYYGLIYAKVMEDEDPERAAIYKERA
IQFAQDFKEWFSSDGSSFPFGRSLTYRFAQSSFWAALAFADVEALPWGQIKRLVLNNLRY
WFKQSIFSLEGLLTIGYGYQNLNMAEGYNAPGSPYWSLKTFLLLALPESHPFWQAEEEPV
KFLEKSVQKSPRMIICHDSEGKEVQAFTSGQHSHEHAHADAKYEKFVYSTTFGFSVPKGN
VLLKQGAFDNCLALSECDNRYRSRSGCESYEIHDDYIVSTWKPWQDVTIDTYLIPLTPWH
VRIHRIHTNREIETAEGGFSAPATEGAAYVIKDENSLFYPSEVGTTGIMDIFGKRKTELI
IPEPNTNLLYSKTVLPTLTSRLAPGRHLLVSSILGTDRGVEEISFQPIVSLEQESVTIQY
RNRKYKIEIK
>PK3-045_03470 Unsaturated chondroitin disaccharide hydrolase
MSKKEQWVAEAWEFVVEKTARNNETIGANFPHASIDKKYVLESPEWWTAGFWPGVLWQVY
QDNKMEALRKTAEQCEEKLDYLLSDSEKLDHDMGFMWTLTSLANYKLTGNKESRRRGLLA
ANLLLGRFNAQGNYIRAWNAWSKKDDNRGVAIIDCMMNLPLLYWASAETGDPRFKIAAEK
HAETVLRHFIRPDGSVHHIVVFNPETGEVVDKLGGQGYAPDSAWSRGTAWALYGLTLSYL
HTNNSAFLHAAKSVSHFFLSNLRSNECPVWDFRIPEDGETKYHYPDSSAGSIAACGLLLL
GTLVADFEKPVYQEAGATLLKTLYITCATDADKEEEGLLGHGTSHFPEQKNVDVPLIYGD
YYFVEGLNILRQKGVLFWQ
>PK3-045_03471 Protein-glutamate methylesterase/protein-glutamine glutaminase
MYKVMLVDDDYPVLELLTKTIDWKSLGFEVMSTHENGVSALKKAEETMPDVLISDIGMPK
MNGIELTRKMKSINESLQVALLSCHTEFNYAREALKLQVSDYLVKDTFELEELYELLEKF
KIQLDTMLNNKQKEQKLQHILHKNIEKEKTAFIKRLINNGYYKKEAEWESDRKKFGLLAD
KGYIVTLLSIHHHPLDLFPEETLYFAVSNIVGELLGRLNPLAVHFLNHSNKVFIFFPRDL
GYQRNALSNAKETLKMIQLSIDKGLNMHSSSIIGETSESLLDYQNTVNRLLNNHQQLFYM
LPRTVSSIKECVKNTEELFAKYDEAATEMRMIVLNKKVERISNFIHKWTIYIMENQFPPE
IVKDWFWKLLLDLNVKLQALQYFSGEYSFESKHKEIFLMEYMYQLKDWLKHYFEKIIHYH
ETIDQTKRKEIIEAFKFVAMNLERKITLDEISSYLFLNPSYFSRLFKKEVGETFVEYVTR
MKINRAKELLEQTDESVGKICERLGYDNQSYFIKLFKTYAGITPMEYRSGKVG
>PK3-045_03472 hypothetical protein
MLIWLKNMWTPRSFRYKVILISIISLIIPAVISLLIYNYMTKNTVKEQALSNANRELNIA
SEYIEKLFSDMLYVANFVQLDPKMNTVLKGLAKSDADKDGYDQYLLENEINRTIENITLV
GEKSYVTILLKNGKYFTNYNVAEFDPRDLFKEKWYEDIEEAVGYESTWIESQPTIFELEK
KNNPYQISIVRTLRDEGIQIYGYVVVTIMENKLSEVFTKMDGYNDVMMLNPSGKILSHSD
DEKIGTVFTYRSNLFNRDGSEVLKMKDKEYIVTEHTLSFLNWKLVSFVPYEQSINKLNGI
FQKVFLIQVLSFMLFLLLLTYSMKTITKPLEYLAKLADKVQAGNLIVRSKIKGKDEIGRL
SKSINLMLDHINTKIEEITETEARKRKAEFAMLQAQINPHFLFNVLNSIRMKVMIRGDKE
SANMITSLTKLLRITIDKNKEIITFLEEIEILFDFVHIMNMRQNRKVSLEMDIDPDAYPF
EIPRFILQPIIENSIIHGFNQSDGLILIHAVIVNEMLIITIEDNGLGMNKEDLEQLKKKT
FQAASLENPKRKQQVKGFSSLGLANVYERLSITFGPAFNMDIISELGNGTKVILNLPMKG
GKKNV
>PK3-045_03473 Putative ABC transporter substrate-binding protein YesO
MQRKSWKLSIFVLILTLVMTACSSGASEKASGNEDGKVTIKFHTHGNEASYNWKKTIAAF
EEANPDINVDLVILSEKGDTQEAIKKLDLAAASGEQLDVLMFSDTASYAQRVSMGMVAPI
DEFIEKEGYTVTDEYKVDTKIGDKYYALPGKFNPWYVLLNKDHLDKAGLEVPTDWTWDEF
QTYAKELTTDDHYGTFFFGPQNGGWLEFMKLALASEAENTEFIKEDGSSNIENPLFKKTL
EIRYQMEKVDKSAVPYTDIMSQKLHYRNQFFNQDASTVLIGSWMNTELGGTDQFPLEFNV
AVAPYPKNTSDAEGGYTPVTTDFMAVANNSEHKEEAYKFIRWYTTEGQILQGKNIPSWNN
VSNDQFGEIIDNILTGTLNPEKVDKESLTNVLSNAKSSKLVSPVSYQAEIYKVVNEEYEK
LIFDEQDVDETIKVTNERVQELIDSNK
>PK3-045_03474 hypothetical protein
MKAEIGGWSGKVYDVCQWITRLAYINLLWLIFSAMGLFIGGLFPSTVAMVTIIRKWLQKE
TDIPVLRTYWQTFKQEFRKANKVGAVVFAFIAFLYIDWRIIASIQGSINVGLIGMLVGGV
FLFLLTLLYLFPVYVHYELKLFQYFKVAFLLACTHPLHTLSMIIGVFTMLFLGVVFSGAG
LLFIGSGLATILLYFSNPIFMKMAEIRITKLQEGKFQS
>PK3-045_03475 L-rhamnose mutarotase
MKRLASIMFIKPGYENEYKKRHDELWPEMEEALKQHGASNYSIYLHHESQVLFAYLEVED
EAAYDAISQTAICRKWWKYMAPIMETNEDYSPVSHKLEEVFHLD
>PK3-045_03476 hypothetical protein
MTFEELLEKLDGKYSLFFPNAEAKKAWWKSIQHNPDYADILKQVSETLEQLQQQKINNDE
LPYSLFQLFETTGTRIEYETAYFQKRRKLNTYAIMVLLEPEKEEFRKVLQDIIWSICNEF
SWCLPAHLINSPETDCGQLYSLTEKQDTTYTIDLFSAETAFALSEIYTLTKEYLDPLIGK
RIYEEVYNRTFIPFLEGNFKWETETHNWAAVCGGSIGSAAIHLIQDSTELALILEKVLPV
MESYLSGFAEDGICMEGYLYWQYGFGFYSYFADLLNQRSDGTINLFMQKKVHQVALFQQR
SFLEGDLVVNFSDAPPKAKVLIGMSHFLVNQYEDVIVPELPLYARYQDDHCSRWAPAIRA
LLWFDSSLSPSKWEEGTFISEDSQWLISRVQSNAGSFAFAAKGGSNNEPHNHNDIGHFIL
QANKTTLLQDLGSGLYTKDYFNENRYTYLCNSSKGHSVPIINHSYQEAGKASYARLVTAN
SDRKRDLFELEMTKAYRDPSLLNVSRKFTWIKTEFPKLIVEDIFKFSEEPKSIIERFILP
NVSVERCDGGISIKGESCIHIYFDSNYYEVSIQRDSFVNHFNKGEEVLLLDLSLKKLSRN
FRVYLEFEFSSEK
>PK3-045_03477 L-arabinose transport system permease protein AraQ
MLKSLSINKAIMTIVMLMISIMFLLPFVWMLSTSFKIEADVFKFPIQWIPERWNGFNNYK
EVWFGENPFYIYYWNTIKVTVFTTAISVTVSALAAYGFSKVNFRLGNFLFLIVLATYMVP
AQAILVPQFIIYRKIGLFDSHLGLILLGSFSVLGTFMLRQFFMGVSNELVEAAKIDGAGH
WKIFWRVVLPIVKPAIATYAILRFIWTWNDYQNPLIFLRSDHLLTIQLAMQKFTTINGEF
YSLIMAAAVSAILPLVIVFIIGQKQVIEGIALGGVKG
>PK3-045_03478 sn-glycerol-3-phosphate transport system permease protein UgpA
MSASTEVKTADIVKPTKKKRQSKHVKNENWAGIAFVSPMLIGVSILVLLPIVATFILSLS
DWSFITNISQLKWVGLQNFIDLFQDKIFIRSLMNNAIFMLTVPICMVISLFLAIAIDRNV
YFKSYFKVAFFMPYISSVVAIAVVWQVLFHPSLGPINQFLMSLGIDNPPKWIADPSFALV
SIMFIQIWISIGFNMIIYLAALQSIPRDLYEAADIDGASALVKFKNITLPMVSPTTFFLL
ITGIISTFKVFDLISVLTKGGPMHATSMIVWNLYDTAFVNLDIGHASAMAVILFFIVFAI
TLIQWLGQKKWVNY
>PK3-045_03479 Aldose 1-epimerase
MNYSQRSMGEINGADVTEFTFTNNSGMSFSSMNYGCIITKIIVPDKEGNKENVVLGFETL
EEYRENKGPYLGAIVGRVAGRIKEGKFELNGKEYRLNTNTPPNHLHGGNIGWSEVVFASS
IVEKDDAIGIRYTYHSPDGEEGYPGNFDLTVDYLLTNDNEIILSYSGKTDKETPVTVTNH
SYFNLSGNNKRDILEHELIADVDRFLELREDFIPTGKMIPTNNTPFDFAKGKLLKEGMDN
DFEQNRIVGNGYDHPLVFAEDGSHSAILRDRESGREMSLITNQPAVVLYTGNMLEDQYRF
NGVIAKKYLGVCLETQGLPDAINHSAFPSVVLKPGEIYQAETKLKFRVME
>PK3-045_03480 Oligo-1,6-glucosidase
MEKKWWQTSVVYQIYPRSFQDSNGDGIGDIRGIINRLDYLQKLGIDVIWLSPVYKSPNDD
NGYDISDYQDIMDEFGTMADMDELIAAANEKGIKIVMDLVVNHTSDEHKWFIEAKKGKDN
PYRDYYIWRDPVNGEAPNDLKSTFSGSAWEYDEESGQYFLHLFSKRQPDLNWENKKVREE
VWKMMNYWLDKGIGGFRMDVIDLVGKQPDLGITGNGPKLHEYIREMNEKSFGNYDVLTVG
ETWGATPEIAKLYSDPARKELSMVFQFEHIGLDKQEGKQKWDLKPLEINQLKTILAKWQT
SLGNEGWNSLFWNNHDLPRIVSRWGNDKEYRVESAKMFAILLHLMKGTPYIYQGEEIGMT
NCPITDISQVNDIESINMYHERLAKGYTKEEILHSINVKGRDNARTPLQWDDTENGGFTT
GTPWLHVNPNYTEINVKNNLEDPNSVFYCYQSLIQLRKDNPIIVWGDFELIKDTEEEIFA
YTRKFEGETWIVIANFSAQERSLIMPVFGESEDIIISNYHRQHADFSNLQLKPYETFAVR
VH
>PK3-045_03481 Catabolite control protein A
MTITIKDIANAAKVSTATVSRVLNGAGGYNEETKKKILHIAEELGYRRNEMARSLVKKSS
NLIGIIMPSVSTIFYADIVNGIEKLAQKHGFSVILSHAGVKGNRLIHCLKMLEERKVDGL
VIVSIPLMEDQIQAIESLSIPYVLLSTDTPNKQIPFIKVDDYEASYAATEYLIKHGHRKI
GLAGVDFSDRVAGIPRIEGYKKALKDHGLSFSANDIKAGDYSFTAGKEALYAFHTEKDGI
TAVFCVSDEVALGIISAAYELGIKIPEDLSVVGYDNTRVAEMAVPPLTTIEQPFRLMGEK
GCFKIIEAIQQKKAVKTEMLPFDIVERASVKHWEH
>PK3-045_03482 hypothetical protein
MKNSSSIIFGLATIIGFTILGLFILSAFGKESTTVENDNDDYRYELVPANENNIIIFDKK
TGEYWSKFIPSDEGPTNWEKGDFPANNSSK
>PK3-045_03483 hypothetical protein
MYEEEEQRLSRLKADLEKTTLPLEKAEEAILSGILKAKQEKNRAKKKQKRLIGLAIASII
IISFVTSIRISPTFANALSSIPGMEWLIGYIEQDKGYSAIIENDYYQKVDVSETKGDLTL
TIDGVIMDESGINIFYTLQSTKSLTGGKIKDVNLFNKEEFPEHAQSNNVFFPDDIENEFQ
SMVEYQFVKPFSFKDLKFNFEFITVIDNKEIKFLIPFELKENIKKQITYPINQVVEVENQ
KMTIEEMIVYPLRIGVKVAFDPANTKEILGFEDMRLENENGEVWSAIANGIVNTTLSKYE
KMYYLQSNYFEKPKDLYLRINKLMAIDKEEAMVIVNTETNTLINSPKDDRLKLGKTSKSQ
VEFSMDSNSEEDPKDLFSTAIAADGKELSISKIESRSSHKEISWILSFDNTMYKNPLKLE
LAAYPNYIKGDIKVKLK
>PK3-045_03484 RNA polymerase sigma factor SigV
MEELETSRKAIKGGDDAFLEVMQLHKESLLRAALAFLKDEDAAIEALQEVTYRAYKKIHT
VKEPAYLKTWLTRIMINYCQDQVKRKNRIISDKQLYDVSVHQNQSLIELKEALGMLSHED
QQLIYLKYFQNTKIKEIAAIENIPEGTVKSRLHKVLKTLRLYFKEKGASDHV
>PK3-045_03485 Putative aldehyde dehydrogenase AldA
MATSLNAATVLDSEYGLYIDGQWQKGSEGKLMASFNPSNGEKLADFVDATYTDVDQAVDA
ATEALKTWKKVSLLDRSNLLLKIADLIDENAEKLALVETLDNGKPLRETRNIDVPLSSDH
FRYFAGVIRSEEGTAQAFDEDTLSISIKEPIGVVGQIIPWNFPLLMAAWKIAPAIAAGNT
VVIHPSSSTSLSVLELAKILDQVLPKGVVNVITGRGSHSGDYMLKHEGFAKIAFTGSTEI
GQEVAVAAAKRLIPSTLELGGKSANIIFNDAPMERALEGVQLGILFNQGQVCCAGSRIFI
QEGIYDEFLAKMKLAFEDVKVGLPWEEDVVMGSQINERQLKQILEYVKIGEEEGARVVTG
GCRLINNGLENGAFMAPTILADATNDMRIAKEEIFGPVATVIKFKTEEEVIELANQSEFG
LGGAVFSRDINTALRVARSVETGRMWVNTYNQLPAGAPFGGYKKSGIGRETYKSILDGYT
QTKNIYIVTKEETEGLY
>PK3-045_03486 hypothetical protein
MSCLVLQVFKKREQKPFLAIGIVTKRSTTLLLDIPNIGFYNLTIC
>PK3-045_03487 Ubiquinone biosynthesis O-methyltransferase, mitochondrial
MKRDILQQNKESWDKVAHHFNGIDALPSYGPFSQTEEELRLFEEIENKKVLDIGCGSGHS
LLYMAEKGASELWGIDLSEQQIETAKETLKDLTSHLYCAAMEEEIDLPKVYYDIVYSIYA
IGWTTDLASTFKLIYSYLKPGGVFIFSWDHPLYAYMQSQNGQISLTGSYQEEGLTLYQRF
KGEEAPVVIPKRKMSTFINELIKAGFTIESVIESEVSKSLETVEAEISDRYYSLYKARKF
PTTMIIKARRT
>PK3-045_03488 hypothetical protein
MNIMNKLTLRNLKENKRRTLVTIIGVIISVSMLTAVATLGVSFIDLLKRDTIARGGEWHA
QFIGVNSEQAKELKKDSKIEKVILSNDLGYAEWKDSKNENKPYLFFKQYDEQGFEQFPIR
LKEGTYPKSSNEIIISDEMRKKGNSSYAIGKEIKVSIGERHVKSDGEDTILTQTDPLQRN
EEGEKTEEIQQAKAATFKIVGIMETPSWESSWAPGYTVISYLDQKELTTNSSVNASVVMK
KVKQSLFEDMESSAKKLSIAKVNFNDELLRYEGVSSHDNVLVTMYSLLGIIILVIVIGSV
ALIYNAFAISVSERARHLGMLSSVGATKKQKRNSVFFEGTVIGGISIPIGILAGLAGIGA
TFYFINKYFKEALNTTEGLNVVVTPYSILFSILISIVTIFISTYLPARKASKISAIDAIR
QTQDIKLSGKKVKTSKLVRKVFGLEAEIGLKNLKRNKRRYQTTVFSLVISILLFLTVAYF
TDNMKKSVGLSQKNIDYDIAVSGDSHTTEEEMQILANAPSVTKSNIIKSTYVNTYLPEDV
LSKNNREKVKKDKTILENGKLSFNVNFFVLSDTAMQKYAKTAGFNSQEYTNPNVPKGIVI
ENVSYLDPNEKKFVEEKVINAKPGDYMDLYRYNMDEEKDEKFNKIQIGAFTNETIMGIDA
NSYGTITMIISDEVAKELFKNENLVMNYTLYLNSENPEKAQEELEDLKTSSVYIYNVEKD
RKQSEQMIMMMSVFMYGFITLISLISIANIFNTISTSISLRKREFAMLRSVGMTPTGFNK
MIYFESIFYGIKALMYGLPISIGVIAIIYWSISNTFEYGFALPWMSILYVVIAIFIIVAS
AMLYSVSKIKKENIIDGLKQENI
>PK3-045_03489 Lipoprotein-releasing system ATP-binding protein LolD
MEILKIENLSKVYGKGETAVKALDNVSFSVNKGEFVAIIGPSGSGKSTLLHMLGGVDRPT
SGKVFVDNTDIYQLNETQLAIFRRRQIGLIYQFYNLIPILSVEENITLPLLLDNHKVDKE
QFNRIVSILGLQQRLDHLPNQLSGGQQQRVSIGRALISNPAIMLADEPTGNLDSKNSEEI
MELLKMFNKTYNQTLIVITHDERIALQADRVISVEDGKIAKNEVIRP
>PK3-045_03490 Adaptive-response sensory-kinase SasA
MLRNREWKVLILILAIISIVAIIYALTVFSFAVAAYLLSVISIIFISFFLFTRFRYKEIE
NLSSYLQRISNGDESLDIRDNVEGELSILKNNIYKVTLMLSEHSSLLRQEKLKLTDAISD
ISHQLKTPLTSMVVMTDLLSNPHLEESKRREFTNNISIQLERMEWLVSSLLKLSKMDAGT
IPFKKEKVVVKALIHKAVEPVLIPIDIKEQTLQITGDDSVTYIGDFNWTVEAIINILKNC
VEHTGEGGQIHISFAENVLFTEIVIYDNGKGIAKKDLPYIFKRFYKGENASEDSIGIGLA
MAYSIIKSQHGDIEVRSKIGKGTTFHIKFYKQVI
>PK3-045_03491 Transcriptional regulatory protein WalR
MKILIVEDDKTIASGLDYSLQSENYETIICHDAKGARKTIEAELNHIDLCLFDLSLPDGS
GYELCELVKSKSDKPVIFLTALDDEVNVVMGLDMGADDYITKPFRLRELLSRIKSVLRRY
NVQPQNTPFIEIDDIRINTLEGKIYKKDEEVVVTALEYRLFLIFANNLGQVLTRTQLLER
IWDVAGDFVNDNTLTVYIKRLREKLEDNPQKPTIIKTVRGLGYKVGD
>PK3-045_03492 hypothetical protein
MDARPKPLNIDLKQTDLSEKLTSAELGKLWATYMGNSMSKCFLHYFLQHVEDSDIKKLLK
NALKLSTEFLSISAEILSKENFPLPKGFSLEEDVNLHAPRLFEDEYYVHYLKYAAKAGIS
IYNVAIPLVFRKDVKEFFQYCMSSTVRLIEQIKEILMKKGFTRKPPIIPIPESQMFVQKD
FLNGYFGHVRSLHALEIAHLYDNIENNVASKALIMAFSQVVQQEEIRELFIRGKNFTDKH
VEQYMEKLHNDHLPTPSFLDHLITTSTVSPFSDKIMLFHKMDMFSMKIRSFGNSIAVNGR
HDIAFMYTRALTQIGLFTEDAAKIMIKNGWMEHPPFAVKRES
>PK3-045_03493 Peptidoglycan-N-acetylglucosamine deacetylase
MKKRWKILIGFLVLLLILFGAYQLMNARSFQLFGGLTDYVKTKEKVVALTFDDGPTKNVD
DILSLLDAYDAKATFFLIGNEIEKNPLLAEEIAEKGHQLGNHTYSHERMIFKSQAFIRNE
VEKTNQLIEKAGYTGEIDFRPPNGKKLVGLPYFLKQAEIDTILWNMEPDTYYQTAEDKIN
YVKESVKPGSIILMHPMYDKTGQERKALKGILKTLTEAGYTFVTVNELQEMADSNN
>PK3-045_03494 hypothetical protein
MNKDSNTNPAGKTHQPDEKKQKDEASKGLKETHDQANDSLTEGTIDKKKNKE
>PK3-045_03495 hypothetical protein
MRLYFQYLLLLFKSQMQYRTSFWLLSLGQFLVPFSAFAGLYFLFERFGQIKGWDFYEVGL
CFAVIHMAFALSECFARGFDNFSSLVASGDFDRLLVRPRTTFIQVLGSKFEFTRMGRLLQ
SVMVLGWALFNLAIDWNIMKCITLLLMILSGVFIFTGIFILAATLSFWTIQGLEIANIFT
DGGREMAQYPLNIYQKWVTRFFTFVIPFGAVNYLPLLYLLGKGGEAEWLYMLTPLAGILF
ILPCILVWIVGVRHYRSTGS
>PK3-045_03496 hypothetical protein
MRIIKPYVAVLRLRLLNGMQYRAAALAGVATQFFWGFIYIMIFQAFYAQTMGEQPISLEE
LVTYLWLQQSFLAFIMLWFRDNELFDLITTGNIAYELCRPIGIYEYWFSKLLAQRLASAL
LRCFPILLLAFLLPSAYRLMLPPDLKTFILFCISLLLGLFVLVSISMFIYISVFITLSPM
GSLLVFGVVGEFFAGMVIPIPLLPEWLQQIVYLLPFRLTADFPFRVYSGNIPNSEAVEGI
MIQLIWLVALVFLGKMALHKAMKKVIVQGG
>PK3-045_03497 Vitamin B12 import ATP-binding protein BtuD
MIKVKGINKSFKVAKRAAGLREGLKALVSREHTIVHALKDVSFTINPGEIVGYIGPNGAG
KSTTIKVMSGILVPDSGACEIMGYTPWQDRVEYVKNIGVVFGQRSQLWWDVPVIDSFALL
KDIYHVSDKDYKETLSLLMETLELKDIIHSPVRQLSLGQRMRCEIAASLIHNPQILFLDE
PTIGLDAVSKIAVRNFIKKINKQKNVTVILTTHDMFDIEALCDRVLLIGKGSLLYDGNLQ
ELRSRFGSHRTITADYKSSNAPIEIPGADILSWTEERAILSVDTSVISVSEVIMQLSHSL
DLVDVSVTSQPIEDIIVQLYKEYEI
>PK3-045_03498 D-serine/D-alanine/glycine transporter
MQQETLSRGLKNRHVQLIAIGGAIGTGLFLGAGKSIHLAGPSILFAYIITGIICFLIMRA
LGELLLSNLEYHSFVDFVNDYFGKKAAFVTGWTYWFCWISIAMADLTAIGLYTKLWFPHV
PQWLPGFIALIVLLIMNLATVKLFGEMEFWFALVKVIAIIALIIIGFIMIVKGFSTDAGP
SSFTNLWNHGGMFPNGMNGFILSFQMVVFAFVGIELVGLTAGETENPEKVIPKAINNIPI
RILIFYVGALLIIMSIYPWNAINPAESPFVQVFLAVGITAAAGIVNFVVLTSAASACNSA
IFSTSRMMFALAKEKNAPESLAKLTKNQVPSNALFFSVIVVLIAVILNYIMPEGVFTLIT
SISTVCFIFIWAITVLCHLKYRKSRPVLAAKNKFKMPLFPFANYLILLFLAFVLVVLALA
EDTRVALFVTPVWFILLLVIYQIKWKQSAN
>PK3-045_03499 Ribose-phosphate pyrophosphokinase
MPNTYQGTKLKVFALNSSLELAQEIVDHLGTELGKCTVKKFSDGEIQINIEESVRGCEVF
VIQSTCDPVNQSIMELLIMIDALKRASVNTINVVIPYYGYARQDRKAQPREPITAKLVAN
LIQKSGADRVITLDLHAPQTQGFFNIPVDQLVGIPLLADYLNTKEFSHDVVVVAPDHGSV
TRARELADRLKAPIAIIDKRGPKDFGPREVNVVGNIEGKTAIIIDDIVDTSYRITTAAKA
LLDNGAEDIYACCIHPVLSEPAIDMIQESQIKELIVTNSIPLTEEKRIDKITQLSIAELL
SDAISRVYEHKSVSVLFK
>PK3-045_03500 Erythronate-4-phosphate dehydrogenase
MSTTTVKEVKTIKTLNNIAASGLNVFKKGNFTMDDTCANPDAILLRSFNMHGLELGDNLK
AIARAGAGVNNIPVEQCTAKGIVVFNTPGANANAVKEMVLMSLMASSRNLFEGVSWAKTL
VTEGDQVPKLVEAGKKQFVGHEIKGKTLGVIGLGAIGALVANDALALDMDVIGYDPFLSV
DTAWNLSRNVKRAMTLDQLFAESDYITVHVPLTEDTKGMFNKKAFSLMKPGTQILNFSRG
ELVNEIDMAVALEDGKIGRYITDFPNENVLQMKNTIAIPHLGASTGESEENCAVMAARQV
KDFLETGNVKNAVNFPNASIPYAGKRRVTAFHLNVPNMVGQMTQVISTYQLNIADMINRS
RGEYAYTMIDIDNQVADEIVPLLSKQLKEIDGIVMLRVI
>PK3-045_03502 Nicotinate-nucleotide adenylyltransferase
MVRKIGVYGSSFDPITNVHLWTASTVAHRCKLDKVIFLPSSSKRRDKTMETADEHRIEMV
NMAIADNDKFAFDDYEMKQDGWEIYTYHTMNYFKKLLPEDEVYFIMGADLLVDIGQGKWT
KGEELVAENRFIVMARNGIDMLSTISRSPLLRNHDDGKTFHLLDKGLSMEISSTYIREEF
SMGGEPRYLLPEKCYQYIKKNKLYQ
>PK3-045_03503 Nicotinate phosphoribosyltransferase pncB2
MNYADDSLMLHTDLYQINMMETYWRDRVHERKAVFELYFRKLPFGNGFAVFAGLERILSY
IKNCRFTDSDIDYLRNEVGYKEDFLDYLKNVTFSGDIYCMQEGELVFANEPILRVEASLA
EAQLVETALLNIVNYQTLIATKAARMKQVIGSQTAMEFGTRRAQEMDAAIWGTRAAFIGG
FSATSNVRAGKIFGIPVSGTHAHALVQAYQDEYEAFKKYAEAHTDCVFLVDTYDTLRSGI
PNAIKIAKEFGDKIHFKGIRLDSGDLAYLSKKARAMLDEAGFYDAKIIASNDLDEYTIMN
LQAEGAKIDIWGIGTKLITAFDQAALGAVYKLVSIENESGEMRDTIKLSGNPEKISTPGQ
KRVYRIINKENGHAEGDYITLASEAITQEPLKMFHPVHPYLNKVVTNYQAIELHHPVIKN
GHIQITPPLLTDIQKKVEDNLELLWNEYKRTLNPEEYPVDLSKACWENKRNYIEKMKEKT
NPI
>PK3-045_03504 tRNA pseudouridine synthase A
MKNYKMLIQYDGGRYKGWQRLGNGDQSIQGKIENVLTEMVGEKIEIIGCSRTDAGVHALS
QVANFKMKKEMTEKEVMNYLNHYLPNDISISKVQIVPDRFHARYNAKDKTYLYKIWNKSY
THPFMRKYSMHVEKRLNLKKMEQAAVYFVGKHDFTAFSNAKSKKKSMVKEVYYVDIKEVD
GFIEIRVSGDGFLYNMVRKIVGTLIEVGLGKVEADTIPAILETKDRSLTGMMAEANGLFL
EKVKF
>PK3-045_03505 hypothetical protein
MIEIKTSPLSDGEFNRGVFATCDIKKGTLFHEAPVVPYPNEQHKYIERTVLEDYVYEYGI
NHSAVVLGYGMLFNHSYEPNATYEINFDKHTFDYYAYKDIKAGEEILINYNGEVDDYEPL
WFNKDKED
>PK3-045_03506 Glycine betaine transporter OpuD
MKFKNHLVFNVSVIILLVIVLVGVFAPETLEQTSASAQSFITDSFGWYYLIVVTFFVIIC
LYLLISPVGRIKLGKPEDKPEFSRIVWLAMLFSAGMGIGLVFYGTAEPLSHYAVSSPTNE
IGTEQGMKDAMRFTYFHWGIHAWAVYGIVALSLAYSTFRKGGKTLISSTLKPLLGNSMDG
RLGRIIDIIAVFATVTGIATTLGFGAVQINGGLSFLYGIPSSFLTQFIIIVIVTVLFLLS
ALTGLGKGIKILSNMNMILAFILLLFVFILGNTVFILNLFTDTLGTYLQNLVRMSFRISP
LNGENRQWINTWTIFYWAWWIAWSPFVGIFIARISKGRTIREFVTFVLFIPSIIGFLWFT
VFGGNAMFIEHKGLGTISTFATEETLFALLEHFPLSAVLSILAIVLIGVFFITSADSGTF
VLGMLSANGIQNPSNRIKVIWGLLLTSISLVLLYSGGLDGLQNMMIIAALPFSVIMILMT
VSLLKEVHREKAEYESKWKKKKGSM
>PK3-045_03507 Myo-inositol 2-dehydrogenase
MGVIRIGIIGVGGMAQSHIKGLQKVGTFKIEAICDPNRVRLKKVGEQLAIKTENQYQDFR
ELIDSQKVDAVVSVTPNNVHAPILEYCMESNMPILTEKPFTLDYEEAQQLAEKYKKHPIP
CMVGFSYRYTPAFRFVKELLEKGEIGQIRNFSIQYLQSWGAPPYQTPYVWRFDPAITGTG
VLGDLGSHMIDMAHYLFGPFQEVSAILESFITKRKLKHSNESKEFAIDDFASFQARMENG
IIGTFQTTRNAIGSGNQHEIAIFGDKGTIHASTKEEDSVYLIQVNKETGALVEKKMHVPK
SVYLTEWEDFAKMLYGEVRLGFPDFMTGVMNQQVLEAIRESSREPGKRIAP
>PK3-045_03508 hypothetical protein
MSSLFQIDGLIGRNLARMVDIFLLNLIFILFSLPVVTIGASLTALYTVSFKITNGEYPFV
WRSYIKAFKKNLKQSSFVWFLLIGVAVILFGDIYYLVYTTGIWKIIFMSLTLFFGFLYGT
LILYIFPYLSRFEDSIKTGMVNSLLMGGFHFPFLVLLFIINYLPIIFILSSFTGFMTGIY
FFTFGGFSIIAFVNTIIFKKIFSKYENKKGEK
>PK3-045_03509 hypothetical protein
MDPLKNKREGKEEMLKRSWKGLLSVALASSLMVGCSNTNTNTTEKEDGEYRIATVRWSDW
GDDFLKGFVEETEKEAGIKVNWDIYLNSEWGDKKSVLMAGGDLPDAFWGSLALSDGDIAQ
NQSLFIPLEDLIAENMPNLMAAFDKEPSLRALVTSPDGHIYSLPKKLPLRPLTGNQLFIN
QKWLDNLGLEMPDTYEDFYHVLQVFKEKDANGNGDLNDEIPYGGNIYGFVLPFGVTKGND
KAGLMTLKDGKPSYIPTQEEYKEGIAWMHQAYMDGLIDQELFTQDDSMAEAKRKDENDAL
VGVAFGWTPDAVFGPNAEEYVPLAPLKGPDGERYVISDTETYSRNELLITTQAKDPEKLL
QWADKFYTEDASIQTFYGSFGIGVEKKTDGTYQVLDAPEGESADIFAWTNSFRDFGPKYI
EDGFNEKVTLPTDSGDGLKLELDKKISEYAREQFPTVSFAAEEMQRLNTLNVDLTSYVNS
MQSKWVVEGGIEKDWDDYISQLKKMGYDEFMEIQNNAFNRYQESLK
>PK3-045_03510 hypothetical protein
MDGVLIQKFNKKFKRKKKWNDRLFVIAVYTIAILMILMIVYPLWFIIIASFSNPTDVTNG
NVWFWPKEWRLDGYIELFKQEIIWRSYVNTIIYTVAGTIIALIVNIPAGYALSRSDLFGK
KWLSIFILIPMFVSGGLVPTYLVVKGFGLLDTFWIMVLPFAVSSFHIIIARTFFKNSIPD
TLWEAAQIDGCGTIRYFLTIVLPLSKAILAVIGLWTAVGIWNSWFNALIYITNEDLQPLQ
LVLRRILISNESLLGTASGELASELRRLSEMMKYAAIVVSTAPIMCLYPFLQKYFNQGVM
VGSIKE
>PK3-045_03511 putative multiple-sugar transport system permease YteP
MKNTIATEKNMQVTPNIPNKIRHIKQIKKSLPLYVLLLPTLILLICFTYIPMYGIIMAFK
DYSPALGIWNSPWVGMKHFIQYFHSYQFGLTVKNTLYISLYSLLVGFPLPIALAILCNQM
RIGMFKKFFQVTTYLPHFISTMVMCGMILIFLSPSTGLIANILSLFGMEMPNLLSKPTLF
SSVYVWSDVWQHLGWDSIIFLAALSAIDPTYYEAATMDGASRIQKIIHIDLPLIMPTAMI
LLILRAGSLLSVGFEKVLLLQNSLNLTGSEVISTYVYKVGMQNFQYSLSTAIGLFNTVVN
VIILLLVNWLSKKLTKTSLL
>PK3-045_03512 hypothetical protein
MVRSTDKNPSRSINYYLKVLLIIMVIILLINMFISMLTISITRKQSIDTITNTVNLYVEN
VRTNLKAVDHFMIWTVVHEPLIEEMEENMMMDEFPRNLTNFRTRIIDFQYSTGKEFQFFL
GLKKESFFTNASPIKLPYQDYLQIKNYFFSKNDSLHTYENFSTWKALKINDAFYFYHLLS
YENRIFVCLVSAEDLLKPLENFNLGRNGSIVMKQEGRTILTVPQPTGNEATTSYDFFTSK
LRFQEKQTLLPFSLQINVDHFGAFKHVVITQFILILATIVISIILFFILVYIKNRLIFPI
QKFSKNLSELNNSTNMVDFESSSIVELEQANTQFKNLIQEIKKLKINIYEQELEKKRIEM
DFLRLQIKPHFYINCLSSIHSMAEMQMFAEIKKMSIATSRYFRYLFQTNLHFVSLKKELD
HIHDYLAIQQLLHGPTFQFETSFGLDVGEEQIPPLILQTFIENSIKHGFSAINDDNTLII
SLSISSVKAEQKMNITIKDNGPGYPSDILDKLQNQLPLSETNGRQIGINNVIQRLQMLYG
NSFSISFSNRIKSGTIVQIVIPKQLMEE
>PK3-045_03513 HTH-type transcriptional activator RhaS
MNVLVVDDDCFVVTLLKEKVNWEGLEIEQVYTARNIRQAKNIFKKQNIHLLISDIEMPLG
SGLELLAWVRQEGYTIQTIFLTNFADFHYAQKAIELQSFEYYLKPIEIDKLEFSILKAIK
KVKANQQSQQAIQVGQYWQQNKQKLVDHFWSTYLRNHEWLQADLEEQLLKNHLNYSTEDY
FLPILLNIFPYHISIKENSTPIFEIDKTSVSKLIIHLNSTFKEHSFALESIVALDINKES
YVLLLRQSDEQTSFVSLCENLIHTLREKLSIDSRFSIGFPAPLVKIQAEVKQLQKKCEDM
IEFRNSVQHFLSYELTVTSYTEPNLAVLEKYLQNGNKQSFLAKCRQYLIHLKESNALNLN
VLSNFRLDITQLLFTHLKKKEVLAHKLFNGYTNNFLQTQSLRSIDDMIIYITYLVDISLQ
YIDFIHSQKNVVNTICDYIDEHYHENITRDNIAKIVYLSPDYITRIFKKEKGLSLVNYII
KKRVDIAKELLIQTTLPVHIISDKVGYGNYSYFTKLFKKETNYTPFEYRRKEKSSAL
>PK3-045_03514 D-threonate 4-phosphate dehydrogenase
MSNVKPIVGITMGDAAGVGPEIILKSLGKEEMYTISRPLVIGDSKILNRAKQFVNSDLAI
QNISVEEINEITYDYGTVYCLDLNLLDETLPVGKVAPEAGNAAFQYLAKAIELAKEDKIH
AICTAPLNKEALHKGGHKYPGHTEILADLTGTQDFSMMLSAPNLKVIHVTTHVGILDAVK
MINPERVYHVIKLAHDTLQKAGISNPKIAVCGINPHAGENGLFGYGEEEEKVIPAVERAQ
KEGIEAVGPLPADTLFFRTVRGDFDIVVAMYHDQGHGPVKVLGLDAGVNITVGLPIIRTS
VDHGTAFDIAGKGIADEKSLMEAMRQAVELAPK
>PK3-045_03515 D-threonate kinase
MKNKMGIIADDLTGANDSGVQLAIKKLSTSVVFDYTNSSKEMASDVLIVDTDSRARAKED
AYKAVVEAATFLKRNGYKHIYKKVDSTLRGNLEAELAALESVYNPDMVVIAPAYPKMRRQ
TINGHHFVDGKIITETEFSNDPKTPVQESFLPKLLNSKNNRKITLLNKEVWHKSKEEINN
LIQSALVEGNKWFVCDAAAEEDLINIAKLFSEQNKSIIWAGSAGLIEYLPEMLHLIPSSV
NEQEDMEIQTTLIVSGSLSHVTKKQLFKVDRLQDSYFMQVDPVDLINGSYRLDEFMEIVQ
QNKEHHHFVLYVEADDDNRKRAIEAGKMLGLSKHDVSAAISNGLGTISTHIVKNVPFIKG
LVLTGGDTAKAVCRALGVTEMDLYMEIEPGLPFGKIRTETNSYWAVTKAGGFGQEDSLIK
ALEFLINNRRVIV
>PK3-045_03516 2-keto-3-deoxygluconate permease
MKIKETLDRIPGGMMVVPLLIAALLNTFAPNLLRIGNFTEALFVNGSSTLIALFLLCTGA
QINVKSFGVSVGKGATLLITKWVVGAAFGLLAYLFAGDNGLWLGLAPIAVIAAMTNSNGG
LFVALVGQYGSKEDRAAYSLLALNDGPFLTMVALSIFGAMGFVDGLFSFTSFISVLLPII
VGMVLGNLDDKMRDFLDSGSSMLIPFFAFSLGMGINFSAILEGGLAGIILGLLTVFVTGT
AGYYVFKLLKWNPIVGAAEGSTAGNAVATPAVIAAANASFASVVDIATVQVAASVVTTAI
LLPIYVGFLVKRLEKKGYKFEEQGIKM
>PK3-045_03517 Anaerobic nitric oxide reductase transcription regulator NorR
MGIKTLLIAPYPALEHVMEECIKLEPDLNMKIELANLQEAIPIAKEAEKHGVEVIISRGG
TAQLIEQEVNIPVVDIHVSGYDMLRVLTLANDYPGKKAIVGFSNITIGAKAITDLLEIPI
EVFTIEDAIEVDPLVNQLKMDGYQLIIGDVITRDAAAKYNLEGILIQSGREAIFEAIKEV
KSIYRMLRKQRFQMSIMQMIIERQFSDVIVMTRDGNIVYENWKRFRESPLSVKKMINIIQ
QKNDNKEELDIIETDQHKRVKQMVIPIKVEGELHYLFAFSFMKDLVPDNSLHIIDIQTPP
VILSKSDSMKRCIEKIQNNLSSYGWILIGKSGTGKKLISKWIHFQKNRGNGFLAVMSANA
FINMNQQLDPDIKTIYLNEIEMLSHEELRIFVGKVKRNYNNGITVIIAIETSDVNRYTAL
PYLEFIRVDLPILVERKEDIRPLATHFLTAFHAEFGTSAIKIKEDAWKVLESYSWPGNVE
ELYILIHDAVKEEKGFVIGKGLIQQLLGDRLSKMEMFDNEYLQGTLEEIEKRIIDAVMKE
ENYNQTKVAERLGINRTTLWRKLKQ
>PK3-045_03518 Extracellular exo-alpha-(1->5)-L-arabinofuranosidase
MTNVKTVHYNNPIVLQRADPWVYKHTDGYYYFTGSVPGYQKIEVRRARTLNGLKNGESAF
VWHAHSTGPLSSLIWAPEIHYIHGKWYIYFAAAEYDYPKNGIFQHRMFVLECADEDPLTG
RWIEKGQVKTAQESFSLDATVFELHDKLYYVWAQKEPAIPGNSNLYLSEMENPWTLKGKQ
LLLSVPEYAWEKIGFLVNEGPAVLIRNGKVIITYSASATDENYCMGMLWADINSDLLDGY
SWTKLDKPVFSSAPENQQYGPGHNSFTISEDGREDVLIYHARPYTEIEGDPLNNPDRHAR
AQVFTWDENGLPVFGKPSKD
>PK3-045_03519 hypothetical protein
MVWSNKVMIVLDRLLSVIILNLLWIMGSIIGLGIFGIFPATYALNVLIRREEFSNDFPSF
SRLAKEYFSAYKQNFLKMNGVGIIYFLVLYVLWIDLQLVRGMTVGAAIFYYPVLFFIIYV
LAALLYTFPIAIYTHGTFKEKAKLVLSLPLLLPLHTVFSLLFFLVLLAVAYKFSIIIPLF
LISTYFLCIDKFIAGDLVKKGIIRDFE
>PK3-045_03520 Extracellular endo-alpha-(1->5)-L-arabinanase
MKMKEETRKGLELIESYGWGTLGTHDPTIIKEDDFYYMFSTDTYIDNAPTEGAQIRKSKD
LIHWDYIGTALKAVPQEAKEWSKALGLWAPEVINYKGQYYMYYSASTFGSTISCIGLATA
DHLKGPWCDQGIVLQTNPEIATHNAIDANVVRDKYGKYWLCYGSFFGGIYLVGLNMETGM
PVAEDGYGTLLAIRPKEVEGAIEGAFIIYNSAFDYYYLFTSYDSLHDSYNIRVARSKEIT
GPYVDVNGKNMIDTEDEPHTIGVKLVGSYQFEDDIAWIGPGHNSIFTEMNKQFMVHHVRL
EEFSPYHYGFIREMFWLKSGWPVVSPEYYYHTEPPNYSVQDLLGDWEYISFDEDRRVKHS
KRFSLKENSLTEIDSLGNNQFAFADRNFEFVIFPVKDWRNNVETIAFSGLTKSGNAIFGK
RV
>PK3-045_03521 L-arabinose transport system permease protein AraQ
MKKHKKITDIFIYFILTIGSVFMIGPLLWMITTSLKDKTGVFALPPQWIPDPFQFDAYTK
LLQLDTLGYGLKNTIIVSLTVTIIGTITSSMAAFAFAKLRMPFKNTLFLILLASIMIPYP
IIMIPQFVMFSKMGWVDTLLPLIVPGLFGNITMIFFLRQYLTNVPYSLIEAAKVDGAGYL
QIFFKLIFPVIRPAVAAQFILWFMGVWNDYLAPLIYLNSPEKQTLQVVIANLKATYAIQT
DYPLIMAGSVVSLLPVLIVFLIFQKQIIESVALSGVKG
>PK3-045_03522 Lactose transport system permease protein LacF
MSSVIATNSEKNKNPKIKPKRKTSNLYKQEHRVALMFVAAPIIGFLLFSVYPFAYSVYAS
FTDWNGLNRMNFVGLDNFIKLFKDEYFYQTLYNTVFYMIGIPIGLGLALLLAMALSRGLK
GTTVFRTIYYIPVISSLAAISIMWAWAYNGDFGLINQFLDLFGIKGPNWLENTATVKPAI
ILMAVWKGLGYSMLLYLAAIQSVSKTYYEAADLDGANSFQKFKNITWPMVKPVTFFLVIT
NIIGGFQIFTEINIMTPTGGPSYSAASIVWYVWQKAFKYYQMGYGSAMSLILFIFIFIVT
VIQFYFNRKSDYSLD
>PK3-045_03523 hypothetical protein
MKKVKILLSSFVIFSMLLLGACSSSSSSNADGKKEITFMFRGGPDEKTAYTEAIKKFEES
HEDVKVKIINTDADQYATKLSAAVSGGNVPDVFYLDSGSIANYVDNGIIKDITEEVENAD
FDLDSIWKFGVDIYRYDGKTPGQGALYGLPKDIGPFALGYNKDMFEEAGIPLPDKDKAYT
WDEFLKISQELTKDTNGDGEVDQWASGFNATWTLQSFAYSNGASFLNDAGDTVTVDTPEF
ASSLQFLADLTNKYNTTPNASQAETLDTYQRWMNGELAFFPVGPWDMSTYAKLDFEYDLM
PWPSGTTGKSVAYVGSLGLVVSETTKYPDLATELAIYLSADENAQQTLLDAKVQIPNLID
MAEEWANDTETVPNNKKEFLDIVRDYGVPYPTFATYNSQWLDEFWSNITPVMQGKQTAAD
FVKEIQPKMQKLLDEANEQAKMSK
>PK3-045_03524 NAD(P)H-dependent FAD/FMN reductase
MKLVGVSGSLVGSKTAKAVNEVLVAAKALDPTIQVELIDLREYEIEFVNGVPLSYYNDDT
IKVVNTILSADALVIGTPVYQASISGVLKNLFDHLPVDAFKSKVTGMVITGGTDKHFLVM
EYQLKPILTYFKALVTVQNVFVHNDYFDEENEITDNDAKERMIKLAEEIIYLLR
>PK3-045_03525 Superoxide dismutase [Mn]
MTTYSLPALSYEFNALEPHIDQKTMEIHYGKHHQTYVSNLNAALEGQHALQAKSLEELLS
NLDEVPEQIRTAVRNNGGGHLNHSLFWEVIAPASGANTPSGELAEAMNKAFGSFDEFKQQ
FTAAATTRFGSGWAWLVVDKEGNLKVTSTPNQDNPIMDGERAILGLDVWEHAYYLNYQNR
RPEYISNFFSIVNWSVVADKFANNN
>PK3-045_03526 hypothetical protein
MVPTQKTTKDKILYLLKKEGSLTVNDFTDRLQITHMAVRKHLTILEKDSLIQSEFIKQPM
GRPIQSFTLAEKAEQFFPKSYEGISIDLLHDVKELYGKDSVQQLFNKREERLTKEYISRM
DDKDPAEKMQEMITIQNEKGYMADLTKVDDHTFEITEYNCPILEVAKEFKIACKCETEML
KKVLHAEDVTRTYCRTEGDNHCKFVVKFVSQHDSSLVVV
>PK3-045_03527 hypothetical protein
MGIVVVEICDGSLITSINLEEILESKYPEVAVIESSCLSFCGMCAKRPYAIVNGKRIFAK
TTEECLELIMKQIEAELAVFA
>PK3-045_03528 hypothetical protein
MNEQNGANIPDFGQINDHMMNADSDKTSVSIKTSLDPKNVLEDNPYFDKTKTYSKEELEK
FKKFFGG
>PK3-045_03529 Methylated-DNA--protein-cysteine methyltransferase, constitutive
MFVLDYQSPIGVIEITGTEKAIYSILFSEKESPENQIDDQTPQVLMTCYKQLDAYFNGNS
QDFSFPIAMDGTPFQRQVWNALTSIPYAATGSYKDIANSIGNEKAVRAVGSANGRNKLCI
VIPCHRIIGANGMLTGYAGGLWRKEWLLSHEQKWKTITI
>PK3-045_03530 L-cystine uptake protein TcyP
MNLYAILNIIILLILLSVLFYMQKKHISFSKRVFTALGLGVLFGAILQLFFEPTSEVITV
TNDWFGLVGNGYVKLLQMIVMPLVFISIVAAFTKLEKSANLGKISGLVIGTLLLTTAIAA
GIGIASAAGFDLKAIDVNAGDAEVLRGQQLEESLGEVQSTTVPQKILSFLPANPFQDLTG
ARPTSTIAVVIFAAFVGVAFLGIRRKNPEQAAFFQKIVESLHTIVMRIVTLVLRLTPYGI
LALMAKTVAGSNLDAIVKLGKFVIASYVALIAMFIIHLIILAIMGLSPKQYVKKVWPVLT
FAFTSRTSAGTMPLNIEAQRNKLGVPESIANFSASFGVSIGQNGCAGIYPAMLAVMIAPT
QGINPLSPSFIATLIIVVMISSFGVAGVGGGATFATLIVLSTLNLPVALAGVLISVEPLI
DMGRTALNVSGSMVSGVVTSKTLGELDTKQYQSNEIDTSENMA
>PK3-045_03531 GTP cyclohydrolase 1
MSKINTPQIEEAVRLLLEAVGEDPNREGLLDTPKRVAKMYEEVFSGLTIDPKEYFETIFH
EDHEELVLVKDIPFYSMCEHHLVPFYGKAHVAYIPKGGRVAGLSKLARAIEAVSKRPQLQ
ERITSTVADTMMETLEPHGVMVVVEAEHMCMTMRGVKKPGAKTVTSAVRGVFQTDSDKRT
EVFAMIK
>PK3-045_03532 7-carboxy-7-deazaguanine synthase
MSKVPVMEIFGPTIQGEGMVIGQKTMFVRTAGCDYSCAWCDSAFTWDGSGKELIKQMQAE
EIWEELVRLGGDGFSFVTLSGGNPALLKNLSFLVNLLKEKEIKIGLETQGSKWQDWFIDI
DELTISPKPPSSKMNTDFDMLDSIVQRLRNANRSTHISLKVVVFSDEDYNYAKKVHLRYP
DIPFFLQVGNEDNKTTDDTKLVEHLLAKYEWLIDKTMLDHQFKNVKVLPQLHTYIWGNKR
GV
>PK3-045_03533 hypothetical protein
MHDFRIVDRLQKFGEDISSKQLKYHCKRVMVSKEFTFDAAHHLHAYEGKCMNLHGHTYKV
VFGISGYLDNRGLMIDFGDIKKIWKNEIEIYLDHRYLNETLPPMNTTAENMVYWIFEKMA
EALNKDEIKQADNGARVEFVRLYETPTSYAEMRREWMESE
>PK3-045_03534 7-cyano-7-deazaguanine synthase
MKNEKAVVVFSGGQDSTTCLFWAIKNFKEVVAVTFDYNQRHITEIECAQKITEELGIKHH
ILDMSLLNQLAPNALTRDDIAVEDGKEGELPSTFVPGRNLLFMSFAGVLASQIQAKHIVT
GVCETDFSGYPDCRDIFVKSLNVTLNLSMDKQFVIHTPLMWLNKEETWRFADELGAFDFV
REKTLTCYNGIVADGCGECPACKLRKKGLNDYLAVRKGL
>PK3-045_03535 hypothetical protein
MFKNKLGKVRSGWIIVLALATTTIIQSLLMIPGTVLTVVLQMVTDPNSLNENVEDVIESS
PWFILFTQGIGLIGGIGMLFLLWKFVNKKKIKEMGFGHFTSDFFIGLILGAVSIIFIFLL
LLVTKNIELTNSISSPNFSAYTISYLLFFILVGFSEELTFRGYIMSTLTDNENSKWVVYI
VSSLIFGIAHLLNPHVAALGIINIFLVGLLFAYMYDKTKSLWMPIGYHITWNYFQGNVFG
FPVSGTTPHGLYGIDVSVGNDWLTGGSFGLEGGFLATIIIVLGFVITNLFTKKR
>PK3-045_03536 hypothetical protein
MIQFKSDMEFRKFLEEELVSTSQVTELLGCTRQYIHDCVKKGILEPLNVGNKERIYLKSD
IMAHIKRKRK
>PK3-045_03537 hypothetical protein
MYKVGIDVGGTNTDAVILDEGLNLIHQVKMPTSEDIESGIVSSLKRVLEEAGIDRKKVTH
AMLGTTQCTNAIVERKKLAKVGVIRLGYPATASVLPYTAWPKEMVSVLTGEYRLAGGGYE
YDGQVLSSFSEEEIRSILKGWKGKVEAIAVVGVFSSLKNDQELRVADLVAEVMGEETPVS
CSSLIGSVGLIERENATILNSALFKVIAATSNGFENALREEGITDAQVFLCQNDGTLMSI
EYARKFPILTIACGPTNSIRGASYLAGIKDAMVLDVGGTTSDIGVLTAGFPRESSLAVDV
GGVRTNFRMPDIVSIGLGGGSIVRNVNNEVTIGPDSVGYRITEEALVFGGETLTTTDIAV
RLGVAEIGNPELVKHIDEEFAQQAYAKIAAMTEETIDKMKTSNNDATVVLVGGGSIIIPR
QLKGVKEIIHNENGAVANAIGASISQISGQYEQIYIYSQTPRDEARKDAEERAKQQAILA
GAKVETIELVEIEEIPLAYHPGNATRLRVKVVGELT
>PK3-045_03538 hypothetical protein
MRYLDEEAIENIAVGAAFLGTGGGGDPYIGKMMALSAIKENGPVQLLSPEEVENDDFFIP
AAMMGAPSVLIEKFPKGDEFVRVFKKLGQYLNKEVKGTFPMEAGGVNSMIPIVVAAQLGL
PLIDCDGMGRAFPELQMVTFHLNGVSSTPMAITDEKGNIGIMETIDNKWTERIARVATVE
MGASSLVSIYPCTGEQLKKYSVKNIITLSETIGQIIRSNTKDELTKLHELLDTTSGYHLF
DGKIIDVERNTMGGFNRGCVTLDGLEQFTGEEVQVFFQNENLVAQKNGKPLAMTPDLICL
VDLETLNPVTTEALKYGKRVRLLALPSDPQWRTEKGIETVGPKYFGYDISYTPLEDLVRK
EV
>PK3-045_03539 hypothetical protein
MSDNRDGNQEAQSWQSLAFLWTGSMICIPSLLIGGTLVSGMPLWEAVLVGLLGYGIIVVL
MIFQGIQSSDIHKPTVSVASQVFGEQGSKKIISIILAVACLGWFGIQANVCGAAFSQFLS
VYGINLPVPLSSLIWGIIMLLSAIYGIKILNILNYVAVPILLAVCVYAVAVSLMGDGVAQ
IKNYLPAGSMSFLSGLSITIGSFALGAVIAGDYSQYVKSRKDVGKAAFIGILPSGVLMIT
VGAILTLTAGTADITSVFTELGLPVLGIIALILATWTTNAVNAFSGGIAIINVFNISKEK
ERIAVAIAGGVGTLLAVVGILDYFIPIMSVLSAMIPPVAGVMIASYWVIQKGDKSKWASK
AGINFLGVISWLVGAAIAGIPVIFSFFPSLPQLPNQPLIGMVISFVCYLVARNNIVQKQV
SINQ
>PK3-045_03540 hypothetical protein
MSIKLEELLKLPSLREAKVVAGKEGLTKLVSSISVLEYTDVASLKEDLFNNDEFYGSEIV
ISALIMIKDDVEAQCRTIEHLHKVGEIGLILYYVGVFLPKIDEKVIELADTLGFTLIVMP
EKQMSLRYSEVIYEVIEAIVKNEMASPSFVSEMVEQISGVPLPQRNMDTVLKILADRTRS
SLVLANKNNQVIHAVTWPRTSTMNIFETVEQYKELSVDQVLVKRNGDQPLYISKKVIAQE
GIPFLNLYILKEKDPLVLDTAVQLAEVVQVFINLWGKHYDEISTAELMKAIMNDESVKMR
RLANILNIDVTAIHMMWIVETNNMEEEQLLKKVKEYVRQNYHVSLVDFYNGFLIILVDDS
IIQEDPFQSANRLLALLDEKEQNFTITICQNMNNTTEVQQAYTNCNEYLRIAKIIYPYKK
IFTLQEMNFSLECFQIINSGELAIEKILQPISPIREHGNQAEELLSTLTVYLLEGNNRFQ
ETADILYLHKNTIKYRIQRIIEILKYPVTKSPEVFQLYKAVAVYRMLAQIKEQ
>PK3-045_03541 hypothetical protein
MNKEKIVTMQLLNQKHMEELLSLATIVGWDYDKQEIRTLLASGTVFGHVNDKHTVVSCAA
IIPYGSNLASIGMVIVHPDYRGIGLAKELLVTCMNQVSKDSALMLIATREGRPVYKKLGF
NDYSHVTKLLGEGQQCRQSLNGYTISPYQSKDFKEMLKLDKEAFGCERDLFLKNRFEQAK
EVIVIKKSNLIVGYAAAVKKPANLVIGPVVAQNDEQAMLLIQTIISNNRGMIRMDLVEGK
KEIIKALVELDFQEKDRPPVMVKNSEAFPERNGSLYVIAAQAYG
>PK3-045_03542 hypothetical protein
MKILITGANRGLGIHLTKTALKRGHTVLAGVRTVQETSPINLLKAKYPDQLHTYYLDVTQ
EESIIKAAELAAKDVGAIDGIINNAGVLTERGKKIEELDFEHVQFTMDVNVLGPMRVVKH
FLPLIHKGEDKAIINISSEAGSIQNAYGGDFPYGISKAALNMFSVQLSRYVKEKNITVYA
IHPGWIKTDMGGEDATGYPDDSAKGILDILEGKIVGTSELGFIDFRGREMKI
>PK3-045_03543 hypothetical protein
MTLSRVLVGIFKSFEETKEQPKVPELKTRYYKKSRDRLMETIKNVVERKLTNWDLKKVDM
ERGEIVLSKGSSLMIVTVYKLAGMQSAVDVYCSKEGTLGDFGSSYKHIQHFFKALHTEIQ
PEKG
>PK3-045_03544 Putative amidase AmiD
MEKENQNLFHIEETTIFEVQKALDLGQITSWELTKQYIERIKTFDSTLCSIREINPDALA
IAAELDKKRQEMDQIGPLYGIPVIIKDNIDTQDAMATTAGSIALANNFAKEDAFIVKKLR
EAGAIIIGKANLSEFANFITELNMPNGYSSLGGQVMNPYGPGVWDVGGSSSGTGASIAAN
FAVVGIGTETSGSILSPASNNSLVGIKPTLGLISRTGIIPLAHSQDTAGPMTRTVQDAAI
LLGIMAGVDERDEVTLTSMGQPRDYTAFLKADGLKGKRIGVDRSFLPEEEEEVTLFNKGL
EELTQQGAILIDMTIHREKFDSIVLYHEFKYGIDNYLRKCAEEVPVHSLKEVIEFNKNHL
DVVKYGQTILEYCETLNGDLADPTYKEHRDKDIRLSALEGIDAAIEKYELDGLVFAKYVG
CELPAKAGYPSITVPAGYTSKGKPMGLTFTGVAYSEPSLIEMAYSYEQATKHRVPPALAW
KGLK
>PK3-045_03545 Mycothiol acetyltransferase
MYSFQLITQEQAEEIAFNWHYDGKYAFYNMEADEEDLTEFLDRDKRADSVYAVTENNRLI
GFFSIHHEENETIDIGLGLRPDLTGQGLGYTFLATGITYIKERFSPAFITLAVAVFNDRA
IKLYKKAGFKEAATFLQYTNGGEYEFVKMIYPCKKSVDFN
>PK3-045_03546 putative protein
MKITFLGKYGGYPGKESPTSSFLLESAGFHLLVDCGSGVLAKVQSYVDLKDLDACILSHY
HHDHIADVGVLQYAMLVESILGNRAAAFPIYGHKQDSKFEELTNDIYTEGREISVGKTSN
IGPFTISFCETIHPAYCLAMKIQANGKTILYTADTEWKDELVVFAENADLLISEASIYKE
QFGVVKGHLTGEEAGKLAELAGVKQLLLTHLPHYGEQEKLVEEAKEIYSGSVQLVYPGME
IDFK
>PK3-045_03547 hypothetical protein
MDKKVKDKKKEEYRSAEDKAARYFESLQKQLVDKAYVSRLTNDFQTWKINHIHSPSILSY
FSRKKRKPRVKGYRPYIEWLNYAGKLDNYLHRSVSYLYMRDLGKTLSSPFTQERVNEVVG
KVKNYLLKKETKEDNFSASRIYKLAKKDAVEHTMIWVMEKLKRVTSHIPAGMSVEHAQRK
ILKIFAGVLMHELEERRTMDLSDEERQLRLEKAIKLGFYYGLTYPLIDDLLDAHILSPEE
EERYSALIRSALETGIVPHFGVWHGENKELISFIHKELKEAFEYMKKQHDNQTWELFLNQ
SYIFFHSQEVDRKKKLTVSTYSNEEIYIPVILKSSASRQIVRSLMNAPEDEGYNQRTFYY
GIYNQLADDLADMFEDKRDGAVTPYTYYLTYYQTRKDLLNPFEMYWTVISYLIHDVYHSD
SKTQEVLLDRAVNGLKRLKEKLGNEKYDDLMGILTKDFPVFNRLLQQMVEKSDDVDFFDK
LLRDHMISILKENHREQEAFSEMIQSTRVSIDNMLPITENAQLKKDIVTDAANYSLTGNG
KRLRPVITSFIGEKEWGLDNTQIAPLLRSVEYMHTASLIFDDLPSQDNAAIRRGRPTLHE
VYDTATAELTGLFLTQKAIEEQANLRDFDESRVLQLIQYTTKATADMCKGQIMDLESREK
QLSLQELNTLCFYKTGIGFEAALVMPAILAGVPEEVKDLLKKYAYHAGIAFQIKDDLLDE
EGSKEILGKESGMDKDNNTSTFVSVLGVEGAKKEMWEHYCIALDIVDAIPKKTNFLRYLV
DYMVNRNR
>PK3-045_03548 Enterobactin exporter EntS
MKEYSLEKRATYHLWTFVSSKLIATAGSQIYTFAISLYILHLTGSSMSFAVNMLCNILPR
TVVAPFAGSIIDRYPRKHIAITAQTASTVSIGGLLLYSVTMGLSLPAIYTTSCILSITSM
FASNAFTSSLTGLVDESRIQKASSMNQIAVSIAQIASPAIGGILFGLVSMSVFLTIFLIA
SLIAVVLDSTMNFTLFEKEKEKAEQQETVWRSLKAGLVYVKNQPLLVAMISISLIVNFIF
TAFNIGFPYVVNTKLHMPSVQFGMVEGAFAVGTLLLSIYLSLGKEFKQPFQVSKLGIIAL
GILMAAAAIPIFIPMSAASIFIFYLMLMFLFGSVNILVNIPMMVLMQKKIANEYKGRVFT
ILETFAMGMMPVGTLIFGVLYDYVPAQWILLIAGALLIISVFILARPSVMEKAAESGDTV
PVTKHRATSV
>PK3-045_03549 hypothetical protein
MLGERIRTLRKQKKMTLEALAGDRLTKGMLSQIENNKARPSMESLEYIAGRLGVDISELL
EKVSIVELRKVLEEAEKIHEEFRIYFKHSEETIEQCSKLTALIEPYISNLNESYESARLL
EIYSRSLFCLNKKEWALYCDKAALIYDSLNLTANRANIAFFRGINFYLEHRYQDALQCYL
EERHHIETTHIKIDPMTKVTMDYHIAALYSAIGDIKATSEAVESALEYSRKEKLYYKIDD
IYKLATVVALLVGDEEKFHYYLKKLKQYGEFVEDKIFEELCDVIYVEYLLHVKGEYHQAM
PIIDQYLTFDENTQKGSGDNWNMLQKGKAMYYVKVYKEALDILRTIYIPKHINHPVDQAI
YYTKDIFIALCYKELNNIDKAREHAKIAYDCYLPLPDSIFKTLCNETYKNICLS
>PK3-045_03550 Glycerophosphodiester phosphodiesterase
MSKFLNRSILLPILIVSLSACGNNQSVQTMVSPSVTEHEETPRVIAHRGANEWYNESTIT
AYQIAAQSGVDSLEMDLRMTKDGELVAMHDDTIDRTTNGKGKVSDYTLEELRAFQTIESD
NRKEIKEKIPTLKEIIETFQDTQKYYIETRLVDGKLAMEEKLINLLKEYGLLDKNLVTIQ
SFSEESLLKIKEMAPDTELALLFRKGSFSLEKASTVDFPIIGIESTDITKEVVDELHKKE
KEVHVYFTNKKTQKVEQERVHEFGVDGYFTDFIHFTKEILAI
>PK3-045_03551 Glycerophosphodiester phosphodiesterase
MNQTKVYGHRGAKGRFPENTLLSFQQAILQGVDGIELDVHLTKDGEVVVIHDEFLNRTTD
GTGFVKSYTLEELKEFSAGSKFSSLPDYEESWIAEKVPTLKEVLQLLAPYDIELNIELKT
YTFEYEGIEEKTLALVNEFGNGRKIVYSSFHLPTLLRIKGMDPSASIAWLLNQVISNPLD
YIKSLELEALHLHKEMVIDNLKDWQELRKHVRVWTVNKKEELTNLIEAKVESIITDYPEV
AIAIRQERAVSVE
>PK3-045_03552 sn-glycerol-3-phosphate-binding periplasmic protein UgpB
MKKTKQLFSIFMLSIVLFMVGCSNNAESSTSGEKQEGPTTVTFWHSMGGAAQEALNSIVE
EYNSSQDKVKIKAEYQGTYDEALTKFHTVAGTESAPTMMQVFEIGTKSMINSGFVEPIQT
LIDEDGYDMSGLEENITNYYKINDTFYSMPFNSSTPVMYYNKDAFKAAGLDPEKAPATFE
EVEEAGKAIAKANPKMKGFALQAYGWLYEQLLANQGALLMNNDNGRTDTPTEIGFTDEQG
KSIFQWVKRMIDDKTFANYGTNGDNMVAGFLAGDVAMFMQSSASARDVIDNASFDVGVAF
IPHPEAVERQGVVIGGASLWMMKDKSEEEKKAAWEFMKYLQTKEVQAKWHVGTGYFAINP
DAYSEQVVTEAYEKMPQLKVTVEQLQSTKSSYATQGALMDMIPEGRRISETALETVYNGG
DVEGTYSNMVKQFNEAIEKANRARK
>PK3-045_03553 L-arabinose transport system permease protein AraQ
MTLPIHKKTIFYILLIVSALLIFSPAIIAFLMSFMSSQDIMTGKIIPTGLTLDNYIKVFE
RFPLMQYLLNSFIVSLVIMLGQLILASLAAYAFVFLEFKGRDLIFFIFIATMMVPFEASI
IPNFQTIRNLNWLDHYNGLTIPFFATAFGTFLLRQNFKQIPKELKEASEIAGIGDLKFYL
TVVLPMAKTSLITLGVYGFVTSWNMYLWPLLETTNDSVRTVQIGLRQLQSQEQLNEWGVI
MAGAIIVVLPTLILLFLGQKKLQKGLTEGALK
>PK3-045_03554 sn-glycerol-3-phosphate transport system permease protein UgpA
MSEVVYRQEVEPSIDFIKEKKKQHLQYWLKGMLFLLPSILLFSVFLFYPLGRTIFLSFFL
TDNRGDPTVFVGLENYLEIFKSAIFLQSLKSTLFFALYTVPGTIIVSLFLAILANEKLRG
IGVFRTVFSSSMGISVAAASVFWMFLFHPTIGWLNRIVTTFGIEPIGWLTDPNWALFSVS
VSTIWMNVGFTFLILLGGLQSIDSYLYESADIDGAGYFYKLRRITIPMLSPTLFFVLTVT
LINAFQTFGQVDMLTRGGPQNETNLIVYSIYQEAFMNYQYGTASAQAIILFVIILVLTII
QFKLGERKVHYQ
>PK3-045_03555 Oligosaccharides import ATP-binding protein MsmX
MIGKFGYFVKFVWLNRDVIQLGRGLLVIAVELKDISKSYDRQKSVIDQISLSIEEGEFFV
LVGPSGSGKSTLLRMIAGLEEISGGILRMNNKIVNHLPPKERNLSMVFQNYALYPHLTVE
QNILFGLRAKKIDKLEQQKRLQETAEMMGLTDLLKRKPKELSGGQRQRVALARSVVSEAP
ICLMDEPLSNLDAKLRAHMRIEIRRLQKKLGLTMIYVTHDQVEAMTMGDRIMVLNDGKIQ
QVGEPITLYNQPANMFVASFIGSPKINLSKGNLIDYKLVLESGLQISMDKEEILPLLSYP
NLTMGIRAEHILPAAPEEKTHTLEVLNVEQLGNETLLTFEVGNELWTAKWLGQWRIQAGD
HVPVQLSSKNICFFDSESGALIRPAIAVKEQEVVGL
>PK3-045_03556 hypothetical protein
MDNTMKQEELETLRDLIKDVDTAMLTTISEEGLVSRPMKTQEVEFDGDLWFITKKDTDKY
EEILHENEVNISYAGKSYVSIRGRAEIVEDIAKKKELWSKAYEKIMKTSYDDPNVVLIKI
KAEAAEYWDTSFTKNIVYFYKRLAGKEAENTDINETIEL
>PK3-045_03557 putative membrane protein YdfK
MIGTLFNCFMILAGCMIGSFLKKGIKEEYQDILMQAMGLAATALGIHSIVQYMPDSKYSV
LFIVSLAIGGLIGERLDIENAFKRVVGKFSKGNLAEGLSTAILLFCAGTLSILGPIESAL
RGNHTYLFTNAILDGVTSIVLASTFGLGIAVSALVLFVWQGFFYVTAGLLANFLTPDLLA
EISIIGGILILSSGLSILGVKNFKTLNLLPALFIPAIWFIILKLF
>PK3-045_03558 Putrescine transporter PotE
MNQRKIGSLTLSGLIIGPLLGSGIILLPTIIYENIGNYAIFAWFIMSIIGICFAYVCGEL
MIQFPGEEGLGNAMEKAFGARIKNLSSVFLMIAALMGPVAVMMTAAEYIQTWLFPGKIKV
EWIAFILLIMNGLILLFRLNFLGKLSFIISTFAVLILVSGSVFSLINHPSDTWDFPVFHF
SSFGYSLLLLFWTIVGWEIVGNYSSEVKNPKTTIRRAIFFSAAVILVVNLVLSAAVQWTT
YTGTFTIRLTGIMYPLFGQLSIGLLAIVATGLCITTHLMVVGGVARLIASLSKPISSLHF
LTKKFSNGAPYKAIGLLVFIHLLFAFLVLLKLVTVEQLVSLANAFFIANALIGLCAAIKL
LKKPLLKGMAIMLSILFAILLLRSSIIALVIILVLTGLFSGWHKRELTGKKRVMYDKKMT
KM
>PK3-045_03559 HTH-type transcriptional regulator GltR
MEIRHLQTFKAIVEAGGFAKAATQLGYAQSSITSHIQALEMELEGPLFDRLGKSIALTEL
GKSFLPYANEMLRLHKGAKELHQSSSMKKGKITIGASESLTVYRLPTIIQAYKEKFPDVH
LSVRMGTCEELQHLVEIGDLDIALLLNLEFKKNPSLETIKMLDENMSIISSPSHMQPNSI
LYSESNCPYRTIFDKFIAEENITPTSFHEFWSIEAIKQCVQCGLGLALVPEITIQNELKD
GRLSARRLDKKHGQVASFLFYHKSRWVSPIVHYFIEEAKAYFKQEEEKRTAYVKEASY
>PK3-045_03560 hypothetical protein
MLDLLRNNKVVAGILAFIRIYLGYQFIHAGYEKLTSGAFDASGFLQGAIASSTGEHPAVQ
GWWATFLEHVALPNADIFTFLVQWGELLVGIALILGLFTSFATLMGMVMNFAFLFSGTVS
TNGQMILLAIFVIVAGANAGKFGLDRYAMPYIKNQINNRKNKHKKEAAVA
>PK3-045_03561 Beta-xylosidase
MSKIINPVLPGYHPDPSILRVGDDYYIAVSTFEWFPGVQIYHSKDMINWRLLTYPLTRES
QLNMIGNVNSGGVWAPCLSYSEGMFFLIYTDVKSRMGAFKDTHNYLVTAENIEGPWSEPI
YLNSSGFDPSLFHDEDGRKWLVNMIWDFRKGTNSFAGIALQEYSVEEKRLVGPVQNIFKG
SEIGLTEAPHIYKRNGYYYLVTAEGGTWYTHAVTVARSTSLFGPYEIDPTNPILTSDESK
KDQLQKAGHGSLVETQNGEWYMAHLCGRPVVDKKCILGRETAIQKCYWTEDDWLRVEGGP
NPSTIVEGPDLQLHPFEQESNFDDFQGHSLKKYWNSLRRIFMEDWISLTERPGYLTLKGG
ESMSSLHHQSLLARRLESFTVEVETAVEYTPENFQQMAGLIFYYDTDDYVYLRITTHETL
GKCIGIIESKHGVYDELLDQDIPLKSKGEVKVKAQVDQQWLQFAYAEEDEWKNIGSKIDI
SHLSDDDADYIRFTGTFVGICTQDLSGQKKPSYFSYFKYDEL
>PK3-045_03562 Isoprimeverose transporter
MSTNLQREEVTPAQSAPAGEKISLMERLGYGSGDLASNFIWQAMSIFIVYYFTDIIGIAA
GIIGSIMLFSRIFDGITDILMGYVIDKTKSKHGKARPWLLWLAIPFAISAVLLFTVPDVS
TVWQVVYITITYNLVCLVYTGLNVPYGTLNSLITQNQYQRSILNVFRMSFALIGSLIVSN
LTLPLANIFGGGQFGWIVTFLIFGSIGSSLFYFCFKSTTERVKPASKEQQKNPVKLKDSI
RTLGKNKYWALVTTFIFMTYIFNALNSGAVIYFAQYILDDTLLVGLVTTAYTVFILLGMV
IVAPITKRFGKRNAIIVGEVITLIGYLIMLIDITNIALIVAGTIIRGIGKAPINGSMFAM
LGDTIEYGEWKTGIRNEGMVYSGGSMGIKIGSGLGTAIIGWVLFIGGYVGGGGTQSSAAL
LSIQSLFIYIPMAITVFLIILMLFYRLDKIYPRIISDLKARSAN
>PK3-045_03563 D-xylonate dehydratase YagF
MTLPFIFENENKSLYEVKTNAKGPTGTLPLTAQMLEDSPSGDLFGLSQNVGMGWKPKDLL
GTEVLILGTKGGIRDHNGEPIALGYHTGHWEVDILMAEAAEEIRNHKGVPFAGFVSDPCD
GRSQGTLGMFDSFPYRNDAAIVYRRLIRSLPTREAVIGVATCDKGLPAMMIALSSMHDLP
TIIVPGGVTLPPAIGEDAGKIQTIGARFANKEISLKEAAELGCVACATPGGGCQFLGTAA
TSQVIAEALGIAVTHSALAPSGQKIWAEMARQSARAVLEMEKNQIKTKDIITDKAIENAM
VLHAAFGGSTNLLLHIPALAHAAKCKIPTVDDWARINRKTPRLVSVLPNGPDHHPTVRVF
LAGGVPEVMLHLRKLGLLHEDVLTVTGHTLGENLDWWEKSERRTQLRKRLLEADGVNPEQ
VIMDPATAKARGLTSTITFPKGNIAPEGSVIKSTSIDRTVVGEDGIYRHTGTAKVFTSEK
AAITAIKTGGIKAGDVMVVMGGGPSGTGMEETYQLTSALKYLPFGKYVSLITDARFSGVS
TGACIGHIGPEALSDGPIGRLRNGDLIDIMVDCENLIGTVDFIGTEDQRLSKEEATSVLK
AREAHPDLKPDPNLPDDTRLWAALQAVSGGTWRGSVYDVDRIIEVLEAGKKALAKEEGSF
IR
>PK3-045_03564 Putative 2-dehydro-3-deoxy-D-gluconate aldolase YagE
MTELNRFRGIIPPVSSILDKDGNLKEGEMALLIDKLIEEKVNGLFFLGTGGEFSQMFVKE
RKRIAEFAVKYVAKRVPVLIGIGSTNTREAILLGQHAEQIGADGIVAINPYYWNLTKENL
YTYFSDIAKSVKLPVLLYNFPTLTGQDLTPDFVIELVLNHQNIVGIKETIDSIGHIREMN
DKVKMINPDFSVFCGFDDHLFNTLLLGGDGAISASANFAPQLSVGLYNSFLAGDIEKAVS
LQKQLAILPQLYKIDSPFVNVVKEATKLCGLNITTEVLPPAKALNEEKKQQVKEILQQAN
LL
>PK3-045_03565 HTH-type transcriptional regulator XynR
MPIIQSVERALQILDLFNDHTVELKITEISEQMGLHKSTVHSLLKTLQQSRYIDQNSENG
KYRLGLKLVERGNLVINTLNIRQIANKYLVELALKTGQTCHLGILDGNAGVYIDKEEGAN
SVIRYSRIGRRIPLHCTAIGKLLLSYQPPDIIHSLLDNYLFTQATNRTITKKEDFLMELE
KVRYNEYAVDNQENELGVRCIAVPILNQHGQILAALSISTLVSSVSDDLLNDYLQLLKTT
GKELSEKMRYGITMK
>PK3-045_03566 hypothetical protein
MKKSNHRIIIIALFPFLLILFAGCTEKTVKDTDPYIQPVEAVLQNALNGPKDELIEIWNK
QKESKANGEEKQAALGEYEEAVFKDYFSNQKSYNDFITRYGTILMMESYKKDYSLKVKNI
EFERTDSKGKIYNFSISLAYHKKGMDEPKVKQVTGQANVNADYKIERMFIRVNDLWGSID
KRK
>PK3-045_03567 hypothetical protein
MKQLLFIAIIFTFISGSYIYIPSIANAETISKEETTTVATRKFAVDKKENVKASDESADI
TNNEKKLLARLVHAEAKGEPFAGKVAVADVVLNRLDDKQFPDTVESVIYEKNAFQPVQNS
SIDKAPDKESMEAVEEALNNGKENKELLYFYNPDTATSDWIFTRQVIKHIGNHAFSI
>PK3-045_03568 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MTTIEKETMIVDIKNVDEKGAGQAVVWRENELGNKKKLKLTIPQTLPGEKVKVTVDQPHR
RHRKAMPEEIIDAHAERIGPACPHFEKCGGCVWQHWDYNGQLQQKTNHVKRVIEEQGFDP
SLVKDTIGMDEPWRYRNKMEFTFAADGSLGLHEQGNFRKIISLETCLIAGKEMVEAALEI
ANWVKEHALKGYNKDTHEGLLRHLMVRQSFATGEMMLALFATEAPDGSLKDAVDTVVARI
TEKFPQVKSFMWLENTDWADRTQSEKSHTLVGRDFIYDEMDGYRFRVWFDTFFQTNPTQA
QKLVDLAVEMAEPKKSENMIDLFCGVGTFSLPFASRVGKLVGIEIVESSIESAKRNAGDN
GIDNTTFLAQDARTGLAQVLETFGRPELLLLDPPRSGAGGKVMRRIGRSQPERIVYVSCN
PDTFATDIKQLEPFGYTLKVVQPVDLFPHTVHVECCALLVRNN
>PK3-045_03569 Beta-galactosidase BgaA
MTKKWTEEKLTLGVCYYPEHWSEELWEGDFQRMKELGFTYVRMGEFSWTILEPEEGVYSF
ALFDRAIEKAHKFGLKIVLGTPTATPPAWLTHKYPDVLNVSQTGIPFQHGARRHYNYNSE
NYRRLSSAIVTEMAKHYSHNPGVVGWQIDNELNCEIDVFYSDADHLAFRRWAMEKYQTLD
QLNEAWGTVFWNQTYTCWDQVYLTRTTVPNSPNPHHMLDEKRFISDSAISYAKMQADIIR
KYTSNQWVTTNGMFKHLDNHKLTNEVLDFYAYDSYPNFGRVLEDKSDKPLRDRKWSWNLS
VVRSISPNFAIFEQQSGPGGWVTRLEQPSPNPGQLRLWTYQSIAHGADLVMYFRWRTATK
GTEIYWHGINDYHNLPNRRIKEVEQVSKEIQLIGEKIAGATYQAEIAIVTNYDNEWDAEF
DKWSGPFASLSKEAWFKVLQYNHIPVDAYNLNSNSNLDELKKYKVLVYPHAAIVSEQTAN
LLKKYVKQGGKLILGCRTGYKDETGQVYMKAFPGYLADLTGITVEDFTREAPFETTPIVI
YKEKTEIKTRGFYETLKIESKDTKVIGRFSDCYFEGKPGLVKHQYGEGACYYFGGVFTIE
LVENLLEEIQINNNNKFDLPESVELSIRKKEGKEFVFLLNYSHETQELEVKEGMTNILTG
EKVHQKIQLKGYDVLVLE
>PK3-045_03570 Lactose transport system permease protein LacG
MTKQKRIQKIFMHLFLLIGVVISIGPFYWMLVGATNPSGDVLTFPPKLIPGDYLLENLRN
LSNSIDIVKAVTNSSIIAIVFVIVSLFICSAAGYAFAKFKFKGSNLIFASFLLAMMIPYQ
ATIIPLFQIFGSLDWINTYQAIILPQICYPFAIFLIRQNMQGIPDSLIEAARIDGAGEFF
IFFKIALPTMKPALAAVGIFLFTHQWNNFMWPLIVMTTQENYTLPVALSTLAGLNSIDYG
QLMLGTAISVIPVMAVFLILQKHFISGILGGSIKE
>PK3-045_03571 Lactose transport system permease protein LacF
MSDNKMLETGTNSLTIKKKKQFITPKTVPYLFVGPALLLFIAFTVYPIIASFLLSFQTKV
AGVYTFSGLANYTRLFSDPLFYKALGNTFIILLVQVPIMLFLAVLLASVLNSSLLRMKGF
YRVAFFTPAVTSLVAASIIFVLLLNTDYGLINYLFTSIGLEKVHWLTDPFWAKVSLILVT
TWRWTGYNMVILLAGLQNIPNSLYEAASIDGASTIKKFFYITIPQLKPVLLFTFVMSTIG
SFQLFDEPYNLTNGGPNNATITITYYLYNQGFSFFNFGYASAIAYVIVLFIAVLSWIQFK
VVRND
>PK3-045_03572 Lactose-binding protein
MRKIYGFVLLFLFMIVLGACSNSSSTSTEDLTIPDNPEDIKGDVTVWAWALEANYLEKDV
LPAFNKKYPNVNVKVEHIGVDQVYQKVSAGLSSGGSGLPDVVQVENNRIHSFTDDFPDAF
TNLSSLGFDKHENEFSKSKIDGLKDKDGNIIAAPRDLGPVGVIYRTDIFEEAGVDPATIK
TWDDYIKAGKKVVEHTGKAFLGTDGDGLLRIMLQQQGSYYFTEDNKLDLTSDAAKKAIDI
LQKMKDAELIIYTNNWDGQVAAMKNGEVATQPGAVWWSGTMIEQMPELSGKWGMFQLPAF
EEGGGRASNDGGSALAIPSKSDNKVAAYVFAEFASTDVESQIKALTNRGLFPALLAAYEE
PVFSEEQEYFNNQTFFKDFADTVTDIPSVNHSSAELELRSIMTSQMEAFLLEDKPAAQIL
EDGKKQAEQQTGLESSK
>PK3-045_03573 HTH-type transcriptional activator RhaR
MGNRLNMKNLEYICNLMTDILNISITLLNNEGTIMAEKTANELINPLYPSKQSFYRQVIP
RNGKNSLSPAIIGTPFFENVSIIPIANLGTIILGPVLSKRPSRLLIDNLITAYRKKGLEE
ALSDYYYSLPVISNAKLGQICKLIYFLYNNKIYDKDIIIPKMQSPNHLTDDKTANKYILE
THQNSSFHHDPIAEKKLYQFIIDGQKEHLLAYWKAFKENTSFHFGKLSKKNEVRNQKNLT
IATITLATRAAITGGLHPEIAYSLGDRYIQDLEELQDIKDIHFFTENILYEFADKVAKTN
RENYSRPIFQCRNYIYKHIYEPLTLQSIAEHLSISPKYLSNLFKKEVGIPISEYIQQMKI
EEAKKLMTFAEHSLSDIHALLHFTDQSYFTKVFKKYTGITPKQFRKNTVNFL
>PK3-045_03574 Carnitine transport ATP-binding protein OpuCA
MIHFKEVTKTFQDGFKALKNITFEVKEGELLVLIGPSGSGKTTTMRMINRLIEPSSGSIT
IEGKDISTEDPVKLRRTIGYVIQQIGLLPHMTIKENVSLVPRLQKWKKEQYVDKINDLMK
MVGLDPDTFGDRYPSELSGGQQQRIGVIRALAADPKIILMDEPFSALDPLSREQLQDELV
RLQQDIKKTIVFVTHDMDEALKIADRICIMQDGEIVQLDRPENILRHPANEFVRNFIGED
RLQENISLPKLAKLMVPPVTAGESRGLAESLKLMRRKRVDSLVVVDKSNTFLGIANVWEV
QKRYREEELTLKDIMDTNIKTLHLEETTEKAFQLVSESQYGFIPVIDQHSKIIGIVNRAG
LVEYIADQIGE
>PK3-045_03575 hypothetical protein
MYLSLISIAIAIVISVPLGIYLTRHRKIADSIIGVAGVFQTIPSLALLVFLVPFIGTGKL
PAIIALTVYGLLPILRNTYLGIVGVEKSAIEAGVGMGMTNRQVLRMVELPLSLSVIMGGI
RTATVLIIGVATIAGLIGAGGLGDLIFRGLQTYNTGLILAGAIPSALLAIIFDYLLKLLE
TDVTPQGLQNKKVKKSKIRIWIVAGLIVLLPLSTVIANFSNGKSGKDSITITGKNFTEQE
IMVYIMGHLIEEHTDLKVNYESFLGGTAPAFEGVNTGNYDMYMEYTGTGLLSILKEDMVS
DPDEAYEIVKKRFKEDYNLVWLEPFGFNNTYTLTMRKEDAEKYQIKTISDLKKIAPDLTL
GSEPEFLEREDGYPGLIDTYGIQFKNTQAMDSGIMYSAIKNGDVDVIDAFSTDGRIPAFD
LQVLEDDQNFFPPYYATPVIRAETLEKYPELEEVLSMLVGKIDNEKMQELNAKVDIDKEQ
YEDVAVEFLKEEGLID
>PK3-045_03576 hypothetical protein
MNKNLWAGFILGIAVTIGIGLAIIFIGDYSVQKETKTGSQSITEEGNSKEEKSSKIDGNN
ESEGISYSIEPYALLLKKEDGSIESFNHDSASSEMKPVDYSPTRKKVLLTPQYGWEAGGA
LYVYSKEDGLKEIINVNATSGEQEYPSGAVWLDERYILYMNSNLYGTIPSGELKIYDTET
KRQLPLDLFKGDAATHLARLTSMGKTYIVIGGIQFTDDMLNDTKAFVEQHDLEEILKLAE
>PK3-045_03577 hypothetical protein
MFTLGFKFLCSRRKWTILIVLALCLIISSVLSIFTASEAIRAALMEKSYLQYGKNSGVLV
GIEKSKSEINKEVKNIGEFQLIDWIPLENSNSATIGWMDKGAVDLSKIKVMEGRLPIGKN
EVAIESAYLKLFNSSWAIGDMITLDGEEKQWKVKIVGIISNYSSKRYIPFQFQKELAFPN
IFISEQYKDKSSKRNYLINYEDGKNSTLKKTENLLAEYDDKGFVNEKLFLEGLRDYDTIR
NISIFYQTVILFISIFSISSLFAYFNKSQRRKIGVLKALGIKRMQLYFFYFSQTFILFFS
GLILAVPLNYVFKFLIINKSFKEGISTYQNQTYTFSICWILFLFFMVLFLSFWEIFRSRN
LSIKMLINGVEKIPIVNILINKNIKRFEIKQLTRQLFLFPKQFILTVAMISLSILILLFS
VIFQKETEGIWDIDEYYYLNSQEVYGFDTQDNLPILLRKGLTFSEQQVTNLKILPGVQYV
EKNPFMVDVIPLITSQQKTKDITQWLDNQGEIITYNQKWIVPNVKYEIIDKEEFSQLFPE
DDYKAFRGKIMIFVPNKDGRKDANLNNLKGETIEFIKQEKHEGKLQKIKEQFEVYSVNNE
TYVKQINNKNKISYDGFTIIFDKDTMQNSKLFNGYMELGIFLDTNITENELKKIDDYVNQ
MIATVPGSLLQNIPEFIQNDTKITSLLGFLAKFSFIITFLLTVTSMFIIVFSKYQLQKKE
WGIYLSLGMSKRKLYYFLTSEMVVYCLIAALMSFIIIFLYLMGAVLTFPLSYYLYYYLLV
IIYMSLLLIVGSFIIYKIVINQTVYNMLREVE
>PK3-045_03578 Lipoprotein-releasing system ATP-binding protein LolD
MVEILKVVNMTKKYSDDREIIKIKNFTVEKGTIHVIEGKSGSGKSTFLSIIGGLEFPTNG
KVYYNNESFYDLPEQRQAEIRGHKFGFVFQSFHLIPELTVRENIELPLKLLKKREKQLKY
SIDELSQELGIHFYLNKLPTFLSGGEQQRVAIARALITEPDILFADEPTGNLDQITTKSI
TSLLTKFNKERELSLIIVTHEKNLIQVPHFLYSMKNGVLEEMS
>PK3-045_03579 hypothetical protein
MEKKKSKLVLSGALILGLSFPAVASAYSSSYSFDVGYSLEGTKKYSLSNKTTKTTAKANT
YNSAGNVQSNKSNYRVSLYKSLLTNYSVSMPADGYSYTKSFGKVSKGSYTININKSDNTG
YGSRVKGSGTINQ
>PK3-045_03580 hypothetical protein
MKKLIVAAGLVLSISAFMLIDKADAATNRTIQSGDTYWKVAKGFGIPIGDLMKANNSKAL
ITGQNIILPNATVSPADKDLMARLVRAEAVGEPYAGKVAVAVVVLNRVKSNQFPNTIRDV
IYEKSNGYYAFTPVQNGEINKAADAESKRAVNEAIALDGKGNGSLYFFNPKTATSDWVFS
REATVTIGNHRFAR
>PK3-045_03581 hypothetical protein
MRFGCCAAIDQAEALDKAGYDFIECTVISLMPEEKEEVFKTILEKYQASPLPIEAFNILL
PSDLKIVGDKVDNQRVKDYLKSALERVCRIGADTIVFGSGGARSFPKGLSKEKGREQMAA
FLSTVSDMADQLSLTIVIEPLNKKESNIINSISEAVAWSKEFNQKSLKTLADFYHMEEEK
EPLTNLYEYKDFIQHIHVADTNRLAPGTGMYPYPEFVRNIHKANYDGRISIECNWRNFAE
EIGPALDFLKKQFSCH
>PK3-045_03582 hypothetical protein
MKLAFTTLGCPHWNLETIIQHAVENGYSGVDFRGLLGELDLYKLREFSANVKETVRLFKE
ASLEIPCFSSSVKLVTQSQEEYEKYVEELREYALLCKEFNTPYIRVFGGAIGKWKREEAM
EIAEKNIHDYLAIVEDINVKLLLETHDDWTDSRYVKELVQRVSSDYLQVLWDIHHPFRTI
GEKPDVTWENLGEWVAYTHWKDSYLKKEAERGYQLCLLGDGDIPLQDIYTLLKRNGYDGY
YTFEWEKKWYPELEEPEIAFKQFSKYMKNILV
>PK3-045_03583 scyllo-inositol 2-dehydrogenase (NAD(+))
MAKVKIGIIGIGNMGSSHAMYLNNGEIAGAELVAVCDSNPERLKWAKETLGEHIQQFDHV
DRFFEYADMDGVIIATPHYDHPPLAIQSLEQGFHVLVEKPVGVYTKKVRELNEAASKSDK
VFGIMFNQRTNPLYQKLRELVQSGEVGEIKRTNWIITDWYRSQSYYDSGGWRATWAGEGG
GVLLNQDPHQLDLWQWTSGLMPKRVRAFCGFGKFHDIEVEDDVTAYVEYENGATGVFVTS
TGDSPGTNRYEISGDRGKVVIEDGKLTFWRLRQSEREFNKEYKGGFGEPECWKIDIPIKG
EATQHKGITANWVNAIRNGTELLGPGVEGIKGLEISNAMHLSAWIDDWVELPINEDLFYA
KLQERIKTSTFKKNKHASITLDVKGSH
>PK3-045_03584 hypothetical protein
MHNQFAAQLFTVREELKRGITPVFKELKEMGWDGVQLSALPAGYDPHEVAKALQENNLGT
AGIHIPLDRLENDLDQVVEEVKLYNTKDIVCPFLPEDVRNQDGYERVKALLNEVAEKAPE
FRISYHNHAFEFDTDMDGKSALEYLLEPTSDNKIFAEIDVFWVKKAGKDPLQFLKPYANR
MPIIHLKDMTNDERQTFAEVGTGLIDFPPILNWCKKAGVEWYAVEQDICPGDPLDSLRIS
LENLKRLTRLLQ
>PK3-045_03585 Inositol 2-dehydrogenase/D-chiro-inositol 3-dehydrogenase
MLKIAVIGLGDISSIHLSAIQANPTAELVAVSDIDETRRESVQGVNFYTDYQEMLEKETL
DCVHICLPHYLHYPVTKACVDKGVHVLQEKPLALHTEEGLELLKLEEDNKQVKIAICFQN
RLNETVERLRQIIAENKYGKIVGIKGIVTWARSKSYYDNKPWRGKLDLAGGGVMINQAIH
TLDLMQLLGGEIATIRGTVDQLLDYGIETEDTAAARIIFKNGINGFFFATNANGNNSSVE
LQIVCENQKLTIKDNRLTILDENGKKIVIEEDTKLYGSKFYYGASHKKLIDGFYASILEN
RQDYIHVKDALPSLQMIDAIIQSSKLRREIRIDEVLVSNRCLGDM
>PK3-045_03586 hypothetical protein
MKKRLFSKTAAFALAWMMVISAVLAGCSSKSGGSSGSDKDGEWAGQQITVMMIGDFAMED
KTDPITGDSVKGVKVLKEEFEKQHPGATVKFVLMPWEGYTEKTQAMITSGEADVYQMPGV
ADFAPQGVLEPLQPWIDKDPEFDLDIFIDNQVEGWKALGPDSKELDIFGLPFLGDARFIS
YDKQLFDEWGVEYLSEYPTMEEVAEKAKQMTGKNPKTGEQNYGIWFRGDWSSAFTLVDLA
EGQNGQWGTGFAWDEVEFTFNSKEMLNGLNWLLDMQNYAPKGIVSNQGNEKWLTKENNIA
IMLNQGPGDTVKSAYAQGLGDRIAISQEFKNDDGQGGLFAGSPITIAKDSKNKELAWEWL
KFATSDFVQKYVYEELGLVPSVKSATEWDSVKDQPLMLPVFEAMSTPMTPRYPWGSSQPR
YILTSEIEAALTGKRSAEDALEKAQKESTEWVKNR
>PK3-045_03587 L-arabinose transport system permease protein AraQ
MKNTISMKKLERMTAIIKYIVLFVFGIVLMAPFVWMISVGFDRTANIVMPFPPRLIPEAI
SSFNYGIVFENGRLIQAYVNSAIVTVSSVFLSVSASLLAGYAFSKGKFKGKRVLFIIVLC
TLMIPMEPRLIPLYTFFNQLGLLNTFWPLILPSVISGMLIFLCKQFFDQLPDTLREAAQI
DGAGEFKIFFRVYLPLAGPIAATMVILSFIWSWNDFMWPLVVINDLNLQTIPLYLASFSL
ENGSSLGGLTMALATVSVLPIVIVYLFLQKYIIQSIALSGVKGE
>PK3-045_03588 Lactose transport system permease protein LacF
MEDNHVTATETSMYMEAAKKKKKRRTTQWTWYIFLIPSFLGILLFMVYPVIESFRLSFFK
SNGTIESFTGLDNFRTVLTSGPFWNAVWNTFFIGIFQVLITIPLGFIFATLINSVGKGKN
FFKVIYFLPNVTSIVAAAMIFQFVLHPEMGIVNFALDSMGLPTPGWFSEPSTSKWGVILL
AVWHWIGFVIIICLANLQAIPSEMYEAAKIDGASGVQQWLFITIPNMTGTFAFLLITGWI
GALQRFNEVYVIGGPNGSPARSIQTMGAFIYERGFTGFEFGIASAATYIMFIIILIFTFI
NLKISKMKI
>PK3-045_03589 HTH-type transcriptional activator RhaR
MTEKIIALYRLMDKVETYEDFSYHSHDRYEIYYFHGGECKYLIGDRIYRLQEDDLIIMNG
LTLHRAYPEPGAYYERSVIEFSSEWLRPLLNNLNVPELLSPFNQLSNTLFHIKDKEQSAE
VKALIKKLAEKVKRSKEENAGDVRFQVGELTAMLMQLLFKVYELSKQQLEHNIHAESDKN
LHVKKMIEWIDTHFCEPITLDDIAHHLNISKYYMSRIFKDVTGYTIMQYIMSCRINRAKY
LLEIHPDKSILEVSLESGFEDSSHFSRFFRKQMKLTPTEYRNSKAIRMKNTN
>PK3-045_03590 Transcriptional regulator ManR
MLDERSYLIIQKIMERPFIEKQNLQEQTKLTQRQIDYSLEKINSWLASHHKKPIEINSYN
QISVDYETRELLINEVSNTIPVDEYVLSSEERIQYMFLYLFINIEYLSINHFIDALKVGK
TTIMGDLKALAAKLQHRGISLGYNRKQGYHLVGTESEIRYLGLKLIVKELNTNNNTKLFG
YFLRENHLESYEQMKQIVLFYSNKHKIHFIENRLTEFIYSFLFLKTRLKTKESVNFIHEW
KSVKSTKEYQFAEELLSFYHLQKEDNICYLTAWVLGLTLGEADEYREDFPLIMDLVEHIR
MRFESFSGIRFEHPREVSKQIFRHFRSAYYRLLFHLPIVNPLYEKIIEEYNHLFTIVNET
MKPLSVLFKHPIPAEEVAYLTIHFASLSRNEKEGKVNKKVGVIVCPNGVGSSSITHTVLK
SIFPEFTFLAPIETQQLDKIDVDYDLLFSTVPDIRLFYTKKPVFIVSPVMDIAEKYRLIR
DVYTELGNSFFKLPSVELITQIVEKYAVVKEKEQMKRELYEYFAVNEKVELKKEQGPNLS
EIISPNLIQLHVLAKNWQDAISLSALPLLQERRITENYIQKMIENARKDGPYMVIMPNVA
LPHARPADGVNQLSISIAVLNEPVYFDKHTNKPVQFVFCLAAINQEFHLNALSQLVQLLE
KEEFYHILKTSNTSEEVFDYICYQEENNIKLVP
>PK3-045_03591 2-dehydro-3-deoxy-6-phosphogalactonate aldolase
MYKNNILNRIENTAIMAIVRVETLERAYEIADGCLAGGVDVLEISYTLPNAGEIIKGLNE
KYGARLLVGAGTVLDTETARLAILAGAKFIIAPNYKEEVSRICNRYQVPYAPGCTTISEM
VDAMESGASMIKAFPISNYYGSQLGTVFKTPIPYMPIMASGGVTIDNIIEWFENGIDCVG
IGSLLTKGTSSQIEQNARELVEKLREYRNKK
>PK3-045_03592 Putative 2-dehydro-3-deoxy-D-gluconate aldolase YagE
MRPSGIITAMVTPFDQEQKIDIQATRNLVNRLIRSKVAGLFILGTNGEFHVLSREEKVEF
ASLVINETNKRVPIFVGTGGNNTAEVISLSKEMEKLGADALSVITPYFLSLTEDELYHHY
KKIAESVSTPILLYNIPKNTGIHLSPPLVARLAKVDNIVGIKDSSGDIENIKNYISVTKE
EAFSVLSGSDSLILKALDEGATGAIAATSNLLTYIDVSIYKHWQKGERQEAEEAQQSLEE
LRRVLKLGSTPSILKKAMELAQIPVGPARYPILEPKSDVIEEINSVIAAYLQKYHQLSYE
GAAIHVQK
>PK3-045_03593 Arabinose 5-phosphate isomerase KdsD
MSEAKNYLEAIQAEMNQLINHISIANLEEAKSCIINAGKKGKRLHLTGIGKPSYVARYSA
SLLSSTGTPAYFLDGTEAIHGSSGQVVEGDVVIAISNSGETEELKKTIHTLRENGAIIIS
LTGNLQSSIARQSDFAIFAGVSKEGDGLNKPPRASVVAELLVLQTLSVLLQNEIGLDAQT
YVKWHPGGTLGQSIK
>PK3-045_03594 Ascorbate-specific PTS system EIIC component
MMQFIISLFSNPAIILALVALIGLLAQKKAMTEVMTGTFKTLIGFLIFGIGASTMTAALK
NFNVLFQDGFDLTGVVASPEAATALAQSEYGFVVSCTLILGFVMNLVFARITPMKNIFFT
GGHSLFFACVLSLIIKSYGYSNTISILVGGVILGFCSAALPQLCQPFMRKITGSNATAIG
HFNMLGYALSGSIGMLFSKHQEKSTESIKFPAWLSFFRDFLMGMAVIMLILFYVSALKAG
KDVTQELAGTTHWLVFPLIQAFMFTAGMSILMTGVRMFLAEITAAFVSISEKFIPNSRPA
LDVPTVFPFAPTAVIVGFLSAYVAGLLAVFIMVFFDFPVVIIPAAHIAFFSGGTAAVFGN
STGGWRGAVAGSFVVGLLLALLPTVLYPVFAGMNIEGSTFPNIDYNITGMLLNKFLSFFH
>PK3-045_03595 hypothetical protein
MYKALVACRAGVGSSLMLKIKVNEVVKENKLPIQVEHSSLDGVAGFDGEILITLVDVAQE
LSNKGIKQHIIGIANIVDKKEILEKLNAFLQQTEI
>PK3-045_03596 Ascorbate-specific PTS system EIIA component
MLSNILEEEFIQLNVRVDNWEEAIRKGTLPLVMKNKITKEYVNKIIEIAKTIGPYIVITK
HVALPHAPAEFGAKETAIGITTLEYPVRFGNEANDPVKYLFCLSATDSNSHLEALAELVK
LLENEEFFQLLDTSSSPKEIFSYISKI
>PK3-045_03597 hypothetical protein
MAKVLDLNLTILELTTTYPELVSVLKDLGFEKITDPRMMQTAGRIMTIPKGCRMRKISMN
TVKQTCIDHGFTIIEERRDTYE
>PK3-045_03598 hypothetical protein
MSELINNRTELKKAASERQQLLKEIMKDLHAGRSVEEVKAQFEKAVGNISVSEISQLEQA
LMEEEGIPVEEVQRLCSVHTAVFKGSIDDIHASSSQKAEEEAGHPIHTFKLENKEIDLLV
NFKLQLHYERFEKEDSPKNLQKLSEDIQLLVEIDKHYSRKENLLFPFLEKYGIYGPTQVM
WGVDDRIRAAIKLAKQQLEDYHGEKQDILNNIYFIIQEATEMIFKEENILFPMALSTLTE
DEWIKIAAESEEIGYCLIKPVEKWIPKRVSMQESSALDKIESGLIHFETGILSVKQLELM
LNHLPVDITFIDKDDVVRYFSHGKERIFARTKAVIGRTVQNCHPPKSVHVVEKLLNDFKS
GKKDSEDFWIKFKDKYVYIRYFAVRNEQSEYMGTLEFTQNIQPIQAIDGEKRILD
>PK3-045_03599 Fructose-bisphosphate aldolase class 1
MNSQLERMKTKKGFIAALDQSGGSTPKALLHYGVPESAYTNDEEMFDLVHKMRTRIITSP
AFNSEYILGAILFEQTMDSKIEGMYTADYLAQKKDILPFLKIDKGLADQANGVQLMKPIP
DLDKILRRANERNIFGTKMRSVIKEANRDGIKEVVEQQFEIGKQIIAAGLVPIIEPEVDI
YSQDREQSEAILKEELLKHLDDLNENENVMLKLSIPAIANTYKELTTHPRVVRVVALSGG
YSREEANQKLKENDNIIASFSRALSEELNVNQSEEEFNQSLKEAVTSIYEASTVKK
>PK3-045_03600 50S ribosomal protein L31 type B
MKKGIHPNYQEVVFMDVNSGFQFLSGSTKQSKEEIVWKDGKTYPLLKVEISSDTHPFYTG
RQKFSDRGGRVERFYEKYKQKKS
>PK3-045_03601 Alternate 30S ribosomal protein S14
MAKKSKVVKERKRREIVEKYAEIRRELKERGDFEALRKLPRDSSPTRLKNRCEVTGRPRG
YLRKFKMSRIAFREYAHKGQIPGVKKSSW
>PK3-045_03602 Putative metal chaperone YciC
MKKIPVTVLSGYLGAGKTTLLNHILHNRDGLKVAVIVNDMSEVNIDSELVQTVGGFSRTE
EKLVEMSNGCICCTLREDLLVEVERLAIEGDVDYILIESSGISEPIPVAQTFSYIDKEMG
IDLTKFCKLDTMVTVVDANRFWHDYESGDSLLDRKEAVGEEDDRNVADLLIDQIEFCDVL
ILNKCDLVKAEDLDKLEKVIRTLQPVARIIRTVNCAIDPHEILDTNLFDFDRASESAGWL
RELNLGPNMHTPETEEYGISSFVYSSKKPFHSERFNDWCHSMPLSIVRAKGIAWCATRND
LALLLSQAGPSVSIEPISYWVAALPEVRQEEILKVNPSLRGNWDPQFGDRHTKLVLIGMD
LNVELIKKELDECLLTEEEFLGEWQQLRDPFYWQLSAR
>PK3-045_03603 hypothetical protein
MGYGFRKSFKIAPGVRVNVGKKSVGISAGVKGLRYSVNSRTGSRVTASIPGTGLSYSTSG
SGSRSRKSPAYQRQTDINRRQREIAKLNELEQAKLAVEAYENTIERIHSIHIEADDSINW
IKVRGSEPPYQLPSGEMGEKEKAALQKLQNYKPSLFSKLFNREAAEQKLREEVIAASEQD
KQEYLAWERDVQVATKVLEGDIDTYFQVIEEFAPLDDLTEFGSGFEFGCEDPKVMEIEFE
VNTEDVVPKEHLSLTKTGKLSKKQMPKGRYFDIQQDYVCSCVIRIARDMFALLPLHTVYI
HAVDNRLNTATGYVEKITILSVKLEKGKLNRLNFANIDCSDALEAFKHKMHFKKTKGFEP
VARLAIN
>PK3-045_03604 hypothetical protein
MNGTSHAVIGSATGFIVAHTVQSTPSETLLFVSIGAVSGLIPDLDIDGKLRGKITLPHQM
IQLSAQVIGIMMILYSFFDRTALERWMGVGIGILILFIASLIKQKHMLTITGIAVLMGGI
SLEERWIILLGIYIMIASFTSHRSYTHSILGVIFFGIIAADLETSLGINGLFYTCIGGYI
SHLLADLKILPVNKRGVKLFLPLSSKEF
>PK3-045_03605 hypothetical protein
MFFRKMSNSEEANWRKGAIAGFYVYLLLLFVNYTSSLFFQKEPFSTTVIFWSGLLVAFGL
DFILNLLSRKNK
>PK3-045_03606 hypothetical protein
MQQLQFEASWDKQLAPQDRLNIENIFQETKDLTNLNILFSPIREAINHKEALLVSVLVHN
FTDSPLSFHDTKLAYSINGDIIAERTFTLPDFVIPAHTSMPWTFIFPKGSYQMTTSFKNG
TIKFS
>PK3-045_03607 Caffeate CoA-transferase
MSKVISSKHAALLIKDNDTIAASGFGLSCWAEEMGIAIEEAFLQNGHPRDLTVIHASAVG
NRKDKGMSHLAYQGLIKRWIGGIASASPGLAKLIEEDKCEAYNLPQGVITQLYREIAAKR
PGVITKVGLGTFVDPRLEGGKMSLSTKKEIVKVIDLEGEEWLYYKAFPIQVGLIRGTVAD
ENGNLTLEKEGLHMEVLPIAQAVRNSGGIVIAQVESIAKNGTLNPKDIKVPGILVDYIVV
SKPENHFQTENTYYNPAFSGHIKVPVKNIESIPLDERKIIARRSAKELTPNSILNLGVGI
PVCVSTIAAEEGVSELLTLTTEAGSIGGIPAGLKDFGHAYNSEAILDHDAQFDFYDGGGI
DLSVLGLAQTDEFGNVNVSKFGTRVAGCGGFINISQSAKKLVFAGTFTAAGLIIAINDGK
LKILQEGKVKKFIKKVQQVTFSGWYAAQTNQPVLYVTERAVFELIDGKVTLTEIAPGVDL
ERNILHQMEFTPVISPDLKEMDKEMFLEHWGELHSILNQKQLVRTI
>PK3-045_03608 L-lactate transporter
MHTNINRWSVLTASTLINICVGAVYAFSVFALPLTEKFHASMSTIMIAFTINAAISPIPM
IIGGKLVDKGGAKKAIIIGGLMFGFGFVFSGLATTPWVLYITYGLLAGIGQGIVYSATIG
NTVKLFPDKRGLGTGIVTAGYGGGTIIIAPIANALITTYDVQFALITIGISFLIIIMACS
FFFQVCPNNYLPDGWTIPGNKNENKKASVQINWREMIKKPIFYIIASMFMIGALSGMMVT
SNASVIAQSMFGLSAASAALFVSLYSLSNCFGRIFWGAISDKLGRTICLMLIYIVISSML
LTIALSTSVIGFAVAIIGIGLCFGGTMGIFPSIVGEKFGMKFYGVNYGVTFIGYSAAAFF
GPRIANTVAELNNGDFTNAFYIALIISLVGLILTFIYKSMENKQPKTITSSTKIV
>PK3-045_03609 NADH:quinone reductase
MSITKLLDIKYPIFQGGMAQIAFAPLAGAVSNAGGLGIIASGGLSADALREEIRKTKEIT
TNPFAVNLMLMMNNIPELIDVIIEEGVKIVTTGAGTPAPYMSLFKENGIKVIPVVPSVKI
AKKMEALGADAIVAEGTEAGGHVGETTTMALLPQVVSAVSIPVIGAGGIADGRGIVAAFA
LGAQGIQIGTRFLATYECPVHENVKKAVLDAIDTSTTVTGRSLGGPVRSIKNSMIDEYLK
LEQQHASRDELEKLSLGSLRKAVFEGDIDRGSVMAGQICGLCNELTTVEEMITTLFIEAE
EVQRKLTNLSFPAKETVNN
>PK3-045_03610 Anaerobic nitric oxide reductase transcription regulator NorR
MTEKTMQPFIDSPSSLFVTDGSGNILISNEFTALTLGMSLEELLQLNVQDLVKAGYYKHS
ITMEAIQTKQKVCKTIKTNRGFNIRSTATPLLYKSGEVQLVVTTSNNIKIENQQTFIEVD
SVNKMEEQEKKREQQKLVVESLAMKQIMKVCRKISHYNSKILIYGESGTGKEVIAKYIHQ
HSDRADGPFITINCAAIPHSLFEYELFGYEKGVLAGVFDEKKGMIEEANNGYLFLDEISE
IPLEMQAKLLRVLEENELRRIGGTKQIPINCRVITATNCDLWGLVQQNKFREDLYYRINV
IPIYIPPLRHRKPDLVGLLSYFLQNINDNYGTNYRFKAEEFEYMLHQEWPGNARELRNYI
ERLVLTEQTVMREKEEQVTDWFTLDYFIKSNMSKLSQLKDYTAITEGRYIQQMIEICNNN
STEAAKKLGIDRSVIYRKLKKMEKVLKDL
>PK3-045_03611 Nitrite transporter NirC
MKEVITAFSNTALMKSNALTASKKKYLVGSMLAGFFVGLGIILIFTIGGLLGATGFAGTK
IVMGVSFGIALSLVIMAGADLFTGNNMVMTIGMLEKKVTWKDTGKVWGYSYIGNFIGSIL
VALLFSYSGLAVGGVADFITNGAAAKMNAPFMELLIRGILCNILVCLAVWCSVKLKDETA
KLIMIFWCLFAFITSGFEHSVANMTLLSIALIIPHPETVSIGGLIANLLPVTIGNIIGGA
VFVGAAYWYHISEKTQAVVKSFKKEA
>PK3-045_03612 Sirohydrochlorin ferrochelatase
MDAVVYIGHGSRIIEGNKQFIAFIEAVKKEINIPVQEIAFLELTSPSIEETMEKVIWAGA
RDILVVPVLLFAAAHFKRDIPEELLAVKERFPDVRFSVSKPFDVHPKMLNLVMKRINEQG
WDYDGGILIVGRGSSDPEPIGKLKEISEHIQQKLACSVYPAFLTAGKPEFEEELQKLQLA
YNKIYIVPYLLFTGRLIKRIESTIESSDKEVILCQPLKYDQLMKEVLLERMEEQFMSLTI
>PK3-045_03613 Uroporphyrinogen-III C-methyltransferase
MDTNKGYVAFVGAGPGDIGLITTKGRECLKKADVVLYDRLANPRLLRFTSRDCVFIYCGK
LPNNHIMRQEKINETLVAEALKGKYVVRLKGGDPSVFGRVGEEAEAIAAYDIPFEIVPGV
TSSIAASAYAGIPVTHRDYSTSFTIRTGHACKKNEAVIHHKPKQEAIGDTLAYYMGVKGL
PGICESLIAQGKSSDTKVAVIEWATLGKQRVVEGTLETIVERVKEAKLGNPALTIIGDVV
QLRSSIAWFEKKSFYQKKLLIAKSSSEESVLERYFSKHGAEAYAFPTIKSNAHSYTEEEL
QLIVNAERLIFASVEGVELVFTQLFKANYDVRDLPRQIEHLSDKTRKELEKRGIHSLKAS
YDKRSAILIGNEQAIEKQAFSDNLLALPSHMIEIDERFQEVNERLLTEDQWETVIFPNKR
SVDLFLQEWRKFSTQNPMELSFAAIGQSVQEYVVKQGFNHIDEQVQQVLDNQEWKCES
>PK3-045_03614 Assimilatory nitrite reductase [NAD(P)H] small subunit
MMTATLEWNKIMKLADLPKQIGKEVHLKGKSIALFHLSNGEVRAIANNCPHQNGPLAEGI
VSGEFVFCPLHDWKISLVTGEVQKPDNGCVEVYETQIKDDYIYIMV
>PK3-045_03615 Nitrite reductase [NAD(P)H]
MKKRLVMIGNGMAGVRTIEEILKRNADLFDITIIGDEPYPNYNRIMLSNVLQGKTTVNDI
NINDWNWYQENHIHLLTGEKAIKIDREEKAVLTDKGKAIEYDELILATGSSAFILPIPGS
DLEGVIGFRTIDDTEKMLETAKTYKKAVVIGGGLLGLEAARGLIDRGMEVHVVHLLPTLM
EQQLDAAAANLLRKDLEAQGMKFLMEKQTAEIYGDKRVQGLKFTDGTTVDCDLVVMAVGI
RPNVAIAREAGLEVNRAIIVNDHMVTSDPSIFAVGECAEHNGIAYGLVAPLYEQGMALAD
YITGKEGKGYQGSILSTQLKVAGCDLFSGGKIHEDENTEAIIVHDQFAKVYKKILVTDNK
IVGIVLYGDASDGTRLFNMLKKQADISEYTSSSVLSKSGEDAEEDLVASMSADDTVCGCN
GVTKGTIVHSILEQGLTTFEEVKGCTKAGASCGKCKPLVEGILAHTLGDSFDASIQKTGM
CSCTTLTRDEVVAQIKEMQLKSPKEVRMVLGFASEEGCSKCRPALNYYMRMLFPEEYEDD
KASRFVNEKMEGNIQKDGTFSIIPRMYGGTTTAEDLVKIGEVAKKYNVPLVKITGASRIG
LYGVKKEDVPHVWEELGMRSGYAYSKSLRNVKSCVGSRFCRFGTQDSLGLGIKLEQELEM
VDTPHKMKMGVTGCPRNCAEVLTKDFGVICVENGYQLYIGGNGGTEVRECDSLTTVQTEE
EVITMAKAFVQYYRENANYGERTAPWVERMGIETVKETLLNARNMKQFVSRFERAKTTYE
EAWSTVLNDQMKREMYEVIKG
>PK3-045_03616 Aryl-phospho-beta-D-glucosidase BglC
MIHQSLKAFPSNFLWGAASAAYQVEGAWNVDGKGVSIWDTFVRIPGKTFKGTNGDVAVDH
YHRYKEDVQLMAEMGMKAYRFSVAWTRIFPNGKGEVNQAGIDFYNDLIDELIKYKIEPVL
TLYHWDLPQALQDEYGGWESRQIIEDFTNYSIELFKQFGDRVKYWVSLNEQNIFTGLGYR
MAVHPPGVTDEKRFYQVNHHANLANASVIKAFRQYVPSGKIGPSFAYSPAYALTSKPEDI
IAAENAEELNSHWWMDMYAWGRYPEAAWNYLEANGLTPEVEEGDFELLREGTPDFMGLNY
YQTTTFEKNPLEGGVGSAEMNTSGKKGTSQDSGIPGVFKTVENPNLERTDWDWNIDPQGL
RIALRRITNRYQLPILISENGLGAFDKLEEGDIINDDYRIDFIRSHINAMQEAITDGVDL
LGYCVWSFTDLLSWLNGFQKRYGFVYINQHEEGTHDLRRIKKKSFYWYKEVIESNGENR
>PK3-045_03617 N-acyl homoserine lactonase
MIERLYWLPTGKLTLDHSSLNQKLVPGKLLTLQIWSYLLETKEGPIIIDTGMPESFIENP
SYFDDTPYEGLFLPNMRKEDHILAVLDNIGYKPNDIQAIISSHLHMDHAGGNPLFPKTPI
FVQQAELDVAIGNENYAPPECTQDNLNYKAIQGDYELMPGIQLLFTPGHTPGHQSILVTT
KQSGPILLTIDLAYTRENYEDDIPFATFDQQLASESIRKIKRLMAEVCPSHIFYGHDLSQ
ATTQKTYPDFS
>PK3-045_03618 hypothetical protein
MKGAMKKFAKLIIYYLLGVIAILALSVLPQYFQMKMFSEGESYLSMFVSFLTDEFFQMDK
WVYSLKGAETPIFDVLLPAFIYSMKILGGAILLGFGIACILALFAFFLPNFLLQPMKRIL
DFAESVPDIIVATLLQAFVLFIFKTTGVEIFQVATYSEKAYLGPILTLSIVPAVSLFKIL
LLMMEEEYLKTYVTFAKSKGIHDLPILCKHIIRNIIPVSFHHMKIIIWGLLSSQFVIEQL
FNVHGLTYFLRANFTPITVTVSLLLIFTPFFIIFQIVDMFVIKKEEKAREVKRGSWKQKW
NIPNLRLSLKIRRMDLKESLQQFNWGKFSIIPPIKWLAQSIGLHMKNWKFALGSLFFVLT
IGYSLIYSVITNDYVEQQNLLYAEDGSTLLAAPPFAPTEPYFFGSDKSGESIFDQIVVGA
KYTLIFGLLIAFLRVIGGLLLGVVYSFYLKHSFQQFLAKMVDSIHFMPLSIIAFILLTPI
LLPGIDGTFTYSFTERVILETIILTLLVIPLTTILLGKEINRVLEYEFIESARVLGGGKF
KIFIRHILPHIGPRLTILFGQQFIQVMLIFMHLGMFDYFFGGTKSSMGMMFEDNPKSITY
EWSGLIGQVGREAIGAGRYWFLYILVPIIITIFAMQLIVQGVKEVQQVKVGVIFKRPSLS
KRKEKENPKEINLGVTKESFAQIGGKGN
>PK3-045_03619 Glutathione hydrolase-like YwrD proenzyme
MNKVIVGTESMIVSPHYLASQAGEQILQKGGNAFDAAVAVSACLAVVYPHMTGLGGDSFW
LTYKEKTGKVRTYNGSGKSGAAVTREMFKGKESIPFRGIESVLTVPGMVDSWDAILKEYG
SMTLAEVLQPAIEYAEKGFPLSNDQYENTIKNEELLRSIEETAAVFLPDGKVPEKFSRFV
QKNLANTLKQLGAKGRDDFYKGELAYRIISGLKKKGSYLTIADFAAHKGEWSEPLTSTYR
SYTMYQARPNSQGFVGLMILNILENFDFSSIPYESYEYYQLIIEAVKRSFQDRNEHLTDP
TFHKIPLEQLLSKKYSKEMADSISLEYTTGYSSRPVGSDTAHAAVVDKDGNAVSFIQSLY
FEFGSGVVAGDTGITMQNRGSFFSLDPDHVNTLEPNKRTFHTLMPAMAFKENKPYVLYGT
QGGEGQPQTQTLMITRMLDYGLDPQIAISEPRFVWGRTWGEKTEELKIENRVSANVLEKL
QKAGHIVNRVEAFDGIMGHANAILIDEQGFLYGGVDPRSDGAAIGK
>PK3-045_03620 putative sulfoacetate transporter SauU
MKKSHPVLVIFLFFLGWVFMYADRNILSPVMGSIGEEWNLNQTELGLMATVFFAAYAFMQ
IPTGFLADKFGRVKVLVIGFIVFGVGTYLSGASTTFAMFLIMRAITGLGEGTYYGSQYGI
SSTITPKKYRGLVSAIINSGMAFGISLGFMSSSYFTYTLNKGWQFPFYVFAIPTVLVAIL
IGIFVRDNSHKEKKVESEYEKVEMKKIFTKNHIFVYILIFCSLYGFFGMLTWLPYYLQTA
RGIEASQTGIISSLVPWASIPGAILFGFLSDRIKSKKPLIITLALAGAICQFAIPYTDNY
SLLIVGLCLYGLLGKLALDPVLISYMADITPKSMYSRVYGFFNFSGMLSSIFAPYITGYF
ADKTGSLEFGFYLAGGLLIIGAILFIFTSDKGKEDNKAAINVGLKEEIVS
>PK3-045_03621 NADP-specific glutamate dehydrogenase
MKVLDKKEEFQTQTVKDYINQLINQVKERNPHEKEFQQAVKEVLDSLVPVLEKNPTYVKH
AVLERMLEPDRLISFKVPWVDDNGNIKVNRGYRVQFNNAIGPYKGGLRFHSSVNASIIKF
LGFEQIFKNSLTGQPIGGGKGGSDFDPKGKSDFEIMRFCQSFMTELSKHIGPDIDVPAGD
IGVGAREIGYMFGQYKRLKGAYEAGVLTGKGIGYGGSLGRKEATGYGLVYFVEEMLKSQG
RGFEDNTVVVSGSGNVSIYAMEKAIQLGAKVVACSDSGGYVYDPNGINLDTVKQLKEVEN
KRIYEYVNTHPDAIYQEGYTGIWTIPCDIALPCATQNELNKESAEKLIANGVKAIGEGAN
MPSTLEAVDTFIEHKVLFAPAKAANAGGVAVSALEMAQNSARIAWTQEEVDKKLQAIMKD
IFSKSIQASEEYAEKGNLVAGANIAGFIKVADAMIEQGII
>PK3-045_03622 HTH-type transcriptional regulator GltC
MEIRQIQYFLEAAKREHITEAADALHVAQSSVSRQIFNLEAELGVELFIREGRSVKLTPL
GRVFFERMKQIWSMMEDAKREVEESLDPEKGTVRIAFPISMAAHTLPSIIYSFRTRYPEA
KFHMSNALYYDLIDGVINGEFNLAMIAPMPNREKEDKINGATLFTENIVALLPLHHPLSS
QKELQLKDLKNDPFCVLPEGFVFRDQVVKACHDAGFSPQIAFEGKDIDALKGLVSAGLGV
ALMPEMTLVDNTPRSTCVIPLSDINLTRTVGVIYPSHRKLLPTESLFYQFLLETYERLNE
FKK
>PK3-045_03623 hypothetical protein
MKSIQSRLFFMLLAFIILPYFLTVLIIYGYTKDSVEQHELQNSKEQLDKLSKELEQYFND
MIDLPYILYRNPDFFRIFTNGYEDSIYFNPIAMEENIETFFLMRSEIRQIRFYLDKNKES
FTIYNGMISARKPQKDFMKQDSMQKLFHSNSRYLIEPPHTIGNYNNAAIIPESDKTEVMT
IHHKILDPLSKEFLGVITIDMDLDKYAQICSSLLQEKGDSIYLLNEHDIVMYTNVHSLIG
KTADEKFLHASQDKSNDIILSKTLSKPLHQWKIVKVTPSDRLFYDARQTAYTNILVGIGV
GVLGLLMISILAYYISRPIKVLSQKVLSIKGGNLNIPFTDSREDEIGHLEKHMKEMLERI
NLHIDREYKLEIENRKNQLRALKSQVNPHFLFNALQSIGAVALQNNSPKIYQLVTSLSKM
MRYSIRADQWVLVREELDYIKAYLTLQRERFGSKLNYSIQISEAIQGIKIPSMILQPLVE
NYFKHCYEQGYFDSTLNITGEIKEDFLYLIVENDYSSLSAEELDTLRSNIYRAPYAGEFS
HEHIGLKNIHDRLLLNYESKAGLEIDTNEGHGFIVKLYIPMQN
>PK3-045_03624 HTH-type transcriptional activator RhaR
MKVLIIDDEINVRYVIRYIGEWKKHGITTILEASNGEEAIKIIQKQKPEIIFTDVKMPKM
DGIEIIEWLDSISYSGKVILITGFDDYTYMRKAIQCSSFDYLLKPIEAESLNNTLSEAVQ
SWITENKDAGVLEDAKRLRLNQLATQACMGEEFDLIELASSLPDAVEYELTLISFYQMHH
SEPYIQLLADQLIEKGIGNAFTLQHDHSLCLVITTSQQWLSVEEWIIQQFDIPIRIVNGM
SLLSLGKIHESYQSMQKAVEEQNYRTIHRLNDIDDAKRMQDIVSYVDTYYMEELSLEKLS
NRFFLSREHISRKFKQQTGMPLSKYIMKLRIDRAKFLLREKDENIYAIALLLGYQDEKYF
SKLFKKMVGLTPFEYRNCQKTLDAK
>PK3-045_03625 hypothetical protein
MKKWTFTWLIAGLLIVALSACQPKSEEDSSERKTADERITLTIRNPKVEISTQFEEMVMA
YEREHPNIDIQVHTVGGAADDLADLKAQIAAGNGPDIFTNTGYDNVKIWSDYLEDLSDQP
WISHAYKDTLKPVTMDGKVYGMPLNIEGYGFIYNKDLFHKAGIHTLPRTLSELQAAAQTL
EEAGITPFATGYYEEWKLGDHLLNIAFAQQDDPEAFIAQLNKGTTKITNNQKFLDIISLL
DTTIKYGNQNPLTTDYNTEVDLFASGKAAMIQQGNWIQPMIDQQSPNMNIGFLPIPINEE
PADAIVVNVSNYWVVNKQSSAERKKAAKNFLNWMVFSEQGKSFMTEQFKFIPAFDHIEAH
HLGPLAMEIMNYYQTGKTLRANWFSFPGSAREEFGLAMQLYVGKQLNRDQLLQEFQKSWE
KATASSSH
>PK3-045_03626 Levansucrase
MKLNKLAKQATVVSLSAAILLGGSGSLAFAKQKEKLDHKESYGISHITRFDMEKMTEQQN
DSKFKVPAFDESTIKNIPSAKGYDEKGNLIDLDVWDTWPLQNADGTVAEYNGYQIVFGLA
GDPDRGWDTFIYMFYKKIGDNSIDAWKNAGRVFKDSDKYATNDVILNNQAEEWSGSATFT
SDGKIRLFYTNRQGWDPDHGFFGKQTLTTAQVNVSKLDANTLKIDGVEDHKSIYDGGDGS
VYQTVDQAFSGGNYADNHTLRDPHYVEDNGHKYLVFEANTGTDYGYQGEESLFNKIYYGG
NTKFFRTEKEQLLQSPKKNLATLANGALGIIEINDDYTLKKEMKPLIASNTVTDEIERAN
IFEKDGKWYLFTSSRGSKMTIDGINDKDIYLLGYVANSITGPYKPLNKTGIVLHQNLDPN
DVTWNYAHFAIPQKNSDNVVVTSYMTNRGLFEDHQSTFAPSFLLKIKGNKTSVVKNSILE
QGQITIK
>PK3-045_03627 Levanbiose-producing levanase
MKKPAKHTQKVLFLLCLIILVGILLFWHQITKVFTETVDQQEKTVVSDGQSYRAKYHFTT
PDKWKNDPQKPIYLDGYYHYYYLYNGDYPDGNGTEWRHAISKDLVHWKDKGIAIPKYTNQ
NGDPWSGSVVVDKENTAGFGYGALIAIVTQPSANQQKQEQFLWYSLDNGNTFTSSSDTPI
MENPGTDDFRDPKIIWSKEYRKWIMLMAEGTKVGFYESSNLKDWTYLSDFFTNDIGIVEC
PDLYYMQTNDGSFKWVLGASANGKTKNQPNTYAYWIGHFDGKHFTADHPEPQWLDYGLDW
YAGVTFEDGSNSDDYKKRYAFAWMNNWNYADNTPTLQEGFNGMDSVVRQIQLKNNGENSY
YLASQPIEAYNNLAKTNDYLKEIEVNGQKQLEMTGEIYQLETDISWTELDNVGLRLRESS
DQTRYVNVGIFIKDNYSYVDRSFTEHPDQQNSHSESTAPFPAEQKQVHLKILVDKSSIEV
FVDDGKVVQSNLIFPHAVDQGITLYSDGGTAIFKNMTITHLD
>PK3-045_03628 Levanase
MRKRILTAVLSVTWLLTGCSINQMGKEEKNLDGLRPDNMEAATSDYYTELYRPQYHFSTP
SGNLADPNGLIYFAGEYHLFHQKNGNWAHAVSKDLLHWEHLPIALEHDQLGQALSGSAVV
DWNDSTGFFEGKAGLVAIYTNTEGGESQSIAYSKDNGRTWERYKGNPVIPNPGIKDFRDP
KVFWHESTKKWVMVVSTNQSVTFYRSDNLIDWEFQSQFGDKEGSHAAVWECPDLFELPVD
GDENKKKWVLQVSVGDNEETNGSTAQYFIGEFDGTKFINDNAPETILTTDFGQDFYAAQS
FSDIPEKDGRRIWLGWMANWRYPYQSPTEPWKGSMSIPRELYLKTVKDGNIKLFQEPVRE
LESLRVNHIAIDPMEVNGEQAIADFSGTTYEFEAVLEWENVEEFGIRVRQSEDENTVIGV
NTKENKLFLDRSRAGLETILDRNGNPFQFGNNHTTTYPIEEKRIKIRGFVDESSVEVFIN
DGEYVFTNLIYSQPTSNGIELYTKGGSMKVASLEFYPLYSTWRERPKEEEVERIVVSSEY
LTLKEGEIQTIKAILKPDWIKSSSPFSWDIAEQDIIDITESTDEGKGIFVKALKPGVTNI
QVKHPETELTKEVKIRVIK
>PK3-045_03629 Fructokinase
MSDVTALGEILIDFTPQGENEQGFSMFVANPGGAPGNVLVALSCLGLRTEFIGCIGKDHF
GELLVSTLQNKGVQTNGIVYSPIKTTLAFVHIDHQGDRSFDFYRQPGADMMLSKDDVDLS
LIADAKIFHVGSISMTNEPAREATLLALNYAKEQQKIISFDPNLRPLLWQSLEEAKEQIE
VVLHFADIVKVSEEELAFLTDTTDIFSGAKQLYKEFHLRLLFVTVGDKGSYAYGEDGLVF
VPGAAVKAIDTTGCGDAFLAGVLYELLKRDLLNFKISEDILKQILNFGNAMGAYVATNKG
GIPAMPTLHQIEDFIVVNKKEKK
>PK3-045_03630 Levanase
MKITKLEKYRPALHFSPKKNWMNDPNGLVFFKGEYHLFYQHNPHGSTWGPMHWGHAVSKD
LIVWEELEIALHPDENGTIFSGSIVVDWNNTTGFFNDEPGLVAIFTHHLEPVHGKEAVQT
QSLAYSLDKGRSWIKYDGNPVLAHPSKPDFRDPKVFWHKESQKWMMALATGQTISFYSAP
NLKDWKFESEFGENCGCHEGVWECPDLFELPIDNSNDKKWVLIVSIGDNPQYDEGSRTQY
FVGSFDGKEFMPEHEEIKWLDYGKDNYAGVSFSDIPEADGRRIYLGWMSNWRYANQVPTE
GWRSQMTLPRVLELREEKEEYYLVQHLVRELDTYFERKEERTDTIITAKESTVFEVDDEY
TEIILSLKNINANKYGLKIEHTDLQHTTITIDVNENVLSLSREKSGIVDFSDNFPKLQRV
YLEDSQSLDLRIIVDSASLELFINGGEQALTSLIFPDKVSKRVCLFAKDGEVNLVYGKVS
VPSKN
>PK3-045_03631 hypothetical protein
MGKINKLLSTFIVAGLVLTGCSGEKTSKSASTEDLKLTDVTFPLKEKATLRFMTQSSALA
PTDPNEKLIYQRLEEQTGVHIDWKNYTKDQFVEKRNLALASGELPDAILDAAFSDYDLLK
YAKDGTIIPVEDLIDQYMPNFKKVLEEAPEYKSMITAPDGHIYSFPWIEELGSGKSRIQV
VDCLPWINVEWLNNLGLEMPTTTEELKEVLLAFKTQDPNGNGEADEIPLSFIVNQGGEDP
AFLFASFGLGDNWDHTVVSNEGKVIFTAAEEGYKEALKFFNELNDLGLIDVEAYEQDWNK
YVAKGKDSKYGLYFTWDKGNISGMNDTYDVMPPLEGPSGEKNVAQTNGFGLDRGRMVITS
ANKNLELTAKWIDQLYEPLQSVQDNWGTYGDTKQQNIFEFDEKAGMLKHLPLEGAAPVEI
REKTNIAGPLAILDEYYGVYTTKPEDAAWRLNILEKNMVPHIKAENFYPPVFFSLEEADE
KAKIETDLFAYVNRKRAEWMSNGKIEEEWEDYLKELERLGLSTWLQIKQDGYDRTVN
>PK3-045_03632 hypothetical protein
MKNHSKTDKMLLFSNKIILILLVLIVLLPLLYILLASFLDPNVLLSKGFSLNPSNWSLEG
YKRILQDELMIKGFINSVIYSLGFTIVTIVITIFAAYPLSLDGFKGKNIIMVFFLITMFF
NGGLIPTYLIVKDLGMLNTIWSIILPGAISVWNIILARTFFKGLPKELFEAAKIDGASEL
KIFLKIVLPLSKPIIFVIALYAFVGQWNSYFDAMIYLEDQELHPLQLVLRSILIQNQVQP
GMINDQLAMAELSKLAEKIKYASIVISSLPLLIMYPFFQKYFEKGVMVGSLK
>PK3-045_03633 putative multiple-sugar transport system permease YteP
MSVSVPETKTTNKKTSHKVKGEFLPEHKKENFIQYFKKNYALYLFLVPAIILTIVFKYIP
MYGAIIAFKDFSPMKGIIGSDWVGLTHFKDFLTSPNFKEIFMNTLKLSFYGLILGFPVPI
ILALSLNQVRRAAIKKNIQLILYAPNFISVVVITGMLFIFMSPTGPINSLLSVFNDKPVS
FMTEPEYFRSIYILSGIWQAAGWSSIIYVAALANVDPQLHDAATIDGATLLQRIRHIDLP
TLKPIMAVLFILGAGGIMAIGFEKAYLMQTSMNLPTSEILPTYVYKVGLQAGDYAYSTAV
GLFNSVINVVLLVFVNFVVKKLNEGEGLY
>PK3-045_03634 HTH-type transcriptional regulator DegA
MKVKLEDVAELAGVSPTTVSRVLNNRGYISAKTREKVEQAIKDLNYYPNDIARSLFKKRT
NFIGLILPTINNPFFSELALYIENICSNHEFKVILCNSLGQVAKETSYAEMLIRHQVDGI
IVCSYNRGIEIYKNSNLPIVAIDHYLSPTIPVIGSDNYEGGKLAVQHLLNQGCKAIVHIN
GPSELETPTQNRRKAYEDQVANPITYELNSVFDEEATAETIKRIFIEHPETDGIFASDDL
IASTCLKVASELGIQIPNQLKVIGYDGTQSVRRLLPQLTTIKQPIEEIAQSAVLRLMDII
NEVNKDERMEVILPVQLLKSETA
>PK3-045_03635 Spore germination protein A1
MENISKKKVSSHLDENVGYLKEELGVGQNFDMIHLDVEYAGIRMAMFLVDGLVKDDILHL
LMKFLAKVKKEELRKDVLKKLLSTYIPYIEISTVDDLNKVVDNVLSGPTALLIDGIDEVL
LIDARTYPVRGPQEPDTERVVRGSRDGFVETIVFNTALTRRRIRDRTLRMEFMQVGRRSK
TDIVICYIGDIADPDMVEQLKKAMSHIDTDGLPMAEKTIEEFISGNNWNPFPKVRYTERP
DTTAIHLFEGHVCIFVDGSPSAMITPVTFWHHLQHAEEYRNNPLVGAYLRFVRYLGVFAS
LFLLPLWYLVSIEPSLLPGSLSFLGPNELGQVPLIVQFLLIEVGLDMLRMAAIHTPTSLA
TALGLVAALMIGQVAVEVGLFSNEVILYFSIAAIGTFATPSYELGLANRLVRIVLLISTA
IFKVPGYIVGVALFIIFLANMKSFGVPYLWPFIPFNYRAMRDILVRTPIPLKNRRPRILN
PNDPDR
>PK3-045_03636 Putative aliphatic sulfonates-binding protein
MKKRIRKKTVALILGCMLLLSTIFLSACSLPNPPGENSSHDEVFRIGYQKNGPLLILKEL
GTLEDRLEPLGYKVEWYEFQAGPALLEALNAGSIDFGRSGDSPPIFAQASNSALQYVAAG
KSKFEGSGILVKNDSSIKTLEDLKGKKIGFAKGSSSHYLLVKALEKAGLSYSDIEPAYLS
PGDARIAFEKKEIDAWVVWDPFTANTQLQADATLLVNGKGLTSDRDFFLASSDFLQENED
IIKVVMEEIQKSCQWANENPEDLTKMLSSILGIDEASMRMAVERRVYGVEEISDSIIKEQ
QEIADTFYNLQLIPKKVKVNENVYTIDLKDEEK
>PK3-045_03637 Putative aliphatic sulfonates transport permease protein SsuC
MKKTSLYFIKKILPWGIPILLLIGWQWIIKAGIISSRILPAPSDVYLAAINLFQTGELTH
HVWISLWRASIGFLIGGTIGFVLGLLNGLFRFTELLLDTSIQMLRNIPHLALIPLVILWF
GIGEEAKVFLVALGVLFPVYLNTYHGIKSVDKGLIEMGKMYGLNGFSLFLNVIFPGALSS
ILVGLRFSLGIMWITLIVAETISSTSGIGYMAMNAREFMRMDVIVLSILLYALLGKLSDV
IARFMETRWLKWHPSYQKHS
>PK3-045_03638 Aliphatic sulfonates import ATP-binding protein SsuB
MSKEKIYLEIKNLEKSYNETKVLKSLNLKINQGEFLAIVGKSGCGKSTLLRLLSGLEKPT
KGEILIDGKPLNSLNREACMMFQDGRLLPWKCVLDNVKLGVKGIRREEAIQVLRDVGLED
KKDEWPANLSGGQKQRVALARSLMHKPRLLLLDEPLGALDALTRLEMQSMIENIQMTHGF
TSLLVTHDVEEAVALADRVIVLQDGIIAQDIPITLEKSRQRNHAAFSSLVNDILKKILHP
TDEKSHRMIEEERNLALKTIPKLN
>PK3-045_03639 hypothetical protein
MRKKKPVTYSPYRFRRICRQYSFILLGAIIQGCAMGIFLFPNSIPSGGAGGLTVLFHYFF
NIPLSIILWIINSSMLLFALHFLGGSSAVGTLFGITITSIAVNLSQAYFSTPFSNVWIDM
LMGSLVLGTGIGILLRQGVSNGGIGVIALIISKYRNINPGRPLFWINGVIFVITAYIIDW
QIVIQALICQWLSTQIVAYLYNLRIRLPIPGPAFAWRKK
>PK3-045_03640 Bacillibactin exporter
MEKKNTKMTAVAIGSIPLIMTLGNSMLIPILPKMQTEINLSAFQASMTITVFSVVAAFFI
PILGYLSDRFTRKSVIIPALFLYGVGGILAGFAAAKFSHAYTWILVGRSLQGIGAAGTAP
IAMALTADLYKGAKESRILGLVEASNGFGKVLSPILGSAIALIVWYGVFFAFPMVVLISI
ILSWIFIREKEHSKKPPSPSKYIKGLVSVFKHEGKWLFTAYLAGATCLFTLFGILFYLSD
TLENTHKIDGIIKGLILAIPLLIMCTTSYITGSKIGKNQKLMKKLIVLGFIFVTASYATL
SLFKSLVPFIAVLAVSSVGTGLILPCINSFITGAVGQERRGFVTSLYGSVRFLGVAIGPP
IFGRLMDWSRIGMFLSIAGFTCLVGLLALLLIKVEDKKQPQGEKGKKDKKEADAKEVIPF
LEPIEGR
>PK3-045_03641 hypothetical protein
MKLFIEYILDEIEQIGLKKGFRTSLSSSKNEENYLRGTLQYFDKDFFIHFVLFFSYPEKK
PNLTYTFWILNHHGNEQLLKNVNGKESEEDGAENKKKKIDLIKEHCLSEINVNISKGEEI
QKLFRKIENVLSKEVIMS
>PK3-045_03642 hypothetical protein
MLSFIEKAVLGMVILRLLSGSIEITAALLMLKANEIEKALIINSSLAIVGPLVLIATTFI
GLWGLTDKISFVKMMWILLGVGLIIYGVKSE
>PK3-045_03643 hypothetical protein
MEDTGKFVEKLKDDQKKQEKNKKHGKGHPEAKLPNKQH
>PK3-045_03644 hypothetical protein
MFNGLSTLPILNNGRTRAINAENPTGEKGGGGKAASNLGPSRKGAPCLRDIKSGEVKVLA
EIDGPGVIEHIWITVPAKINDKNPFVLRDIIIRMYWDDEENPSVESPLGDFFCCGFGQGC
LVNSMPIAVNPNRGMNSYFSMPFHKKARITIENQCEEAIPAFFYQVDYCLYDTLPKEIAY
FHAQWRRQSITEKGQDYIILDGVKGKGQYVGTYMALSTLERYWWGEGEVKVFLDGDKDYP
TICGTGTEDYFGGAWSFATYDEHGKMDETTYSTPFLGFPFYAKQDNTVVNPYHNDDVPPM
RGFYRWHIMDPIRFEEEIKITVQQIGVSHRGLFERQDDVSTVAYWYQTLPHKPFPVFPLR
EERWPR
>PK3-045_03645 Trehalose transport system permease protein SugB
MNIRSTKSFYFFLRWGLTFVVAIIILLPLYWIFISSITPKGSLFQTPIDYFPKTITFQNY
QDLFIQLGIGEMAINTLLITGLSLVASIIFGTAAAYGFARYDYSRGVSWGYKLLLFSALI
PPVITARPLYDFMKSVQLVDTYLGLTILYTSSLLPFSVLILYNFVKQIPPSLEEAAQVDG
ANFLQVLFKVYFPLMKPAIATVSIINFIQCLNEFFTPLFFSYKIKVLSVGITTIPRTSNF
EVPWDLISSMGWFITLPIILFVMIFEKNIMEGIIAGGVKQ
>PK3-045_03646 Melibiose/raffinose/stachyose import permease protein MelD
MKTVLNKSFQNKLVIAWILILPVLIIRGFTIIYPIIVTFINSMFEINMFKGGVATFIGFQ
NFFAIFKDDKIITSLEFTLIFTIISMIFHVILGIFLAVLLNQKFKGRKFLRTIVLIPWAM
PMVVTGLAARWAFNDSYGLVNDLIRRIFTTFHFDWLIHPESTRIAVILVDLWKDVPFFAI
LVLAGLQFIPEEIYESAKMDGSNVVRTFFSITIPLIMKNLLTLCIFFTMWRIVSYDIVYA
MTTGGPGDSTSLLAYRIAVEAFTNLNIGYASAIAVLLFLMMIIISSISLLGIKKNDY
>PK3-045_03647 hypothetical protein
MQKSRKWYSIVLCLMIVTAIFLTGCVGVNNTSSNADQASGGEGKAEGETITLMTNDSTKA
GWSVYQKKIEEATGVKLNIIVTPTNPDDMVAKMTTILSSGDNTIDLMHVNDELITAFSRA
DYLEPLEKEVMTPEIVKNFSEQYIKDIPTYNGSIFSVPSYLEILAFWVNNELLKKTGMEA
PKSKEEFLEYAKAATKDGVYGYGGSWEKSYVFNEIGTFVNLFGGDYFDWTNPKTKEALQF
MYDLAHKEKVTPISQLADIYDPMNQKFIDGKYGMLFMYTGAIPTFEEAGKFSPEQLNIEP
MPTFETNDAFIASWHYVLNKSSEKKAASKKVLQYIASPDGQLAYSEMSGRLPARLDVIND
PNFTAKGLESVKEYISNSTLRGRPLVPQAMEFVNGIGAIFQKFISDEISLDEAVEQAQKE
IARLAK
>PK3-045_03648 hypothetical protein
MRLYFYLKKLFQRYFTSFQKKILWSFLLTSIIPLISLSVLSYFLSYNIAKNKIFDSISYS
SNQLNVILSNRFEQMKNASSLIQNYLYPLVIQPPQKLSDQLESYSTVRNNIIYLKEAYLL
DNITIYINPQFLFSDEGITFFPTSELHKRGINEQQLSINTNKLEWILSENINEPFVVNQS
YQKKRYLTCFITYQKKDTKTIDYAIFLDLDAQEVNQLLDESSTDSSINSYLIDQNGIILA
HNNSKLIGQQMKKKIFNKIATNEEPFKIKNNQYIFKRNEITGWYIVTEVPTSYIVKNTIV
LISILISAVILVIIISIVSSLFISKELSKKIRTIAKTIKSISLDNNNLISVKLPIDKEKE
FKDEFDSLAITFNNMTESINTNFNAILNFKIQEEKMKYQLEQSKINPHFLYNMLDSIKTC
QTLGRIDDANKMISQLAHFYRMILKKGDELILIKDELEIAQVYLQLEKLNKSMEFHWKIE
KEEGIENFLIPKFVLQPILENCIHHGINNVNTPLFIQISITYKNDAIQFTIQDNGRGITD
EKIETLCQVLNNNAFRTNHFGLSNVNYRLSLYSSEKPTIQISRLHPQGTLVSFTIHQMIS
EELFFEELGG
>PK3-045_03649 HTH-type transcriptional activator RhaR
MKKIIMIDDNTVCLEGIYKNIKWEDIGATVCGIYASGIEALKEIEKTQPDLVISDIQMPE
ITGIELAKSILTRFPFIKIIFISSYDDFVYAQEAIRLNICDYVEKPIDYDYLTTVIQKVL
RNIQQETETMEQLKHSQPILKEKFFLNLINAGPTYAEYMLQNQASYLNLQFTKKRYICIY
LEISKHIDYMNSLGVERYHLYTFQLIHAVEDYFASEDVYTINQGGRIIFIIGQKQYPHKL
STHVMKAFETIKKQFDFLTITIGIGHTVQSIWEISNSYRNAKKATEYKFIFGDNNIYSTE
EIHQAASPPLFLSRQDEELLINLISKKDKQGIKEFLAYIENNWSSVYYNKNGILSYIASI
LSKILRFLYEVEIKDTEIVEKITHTFSILDTFNTVEEVCENLEKICLLTSEKIQQSIHSK
HSQIAEQIIQYIENHYNDLTLNLNTISNHINMSPSYVGSIFKKIKNTSISKYITFLRINK
AKELLSFTSIPIMEISEKVGYSNQYYFSASFKKVTGLTPTEYRTHSTTV
>PK3-045_03650 Putative NAD(P)H-dependent FMN-containing oxidoreductase YwqN
MKKIAVIDGGTRPNGNTALLTEKVIEGIPVDTILLREYTILPIMDMRHTLEGFQEREDDY
NSIVDRILPHDILIFSTPIYWYSMSGLMKNFIDRWSHSLRDSSYPDFKAKMARKKAYVLS
VGGDNPTIKGIPMIQQFQHIFDFMGIEFGGYILGNGNKPGDILKDKNAIFAAAQLKKELL
>PK3-045_03651 Heme-based aerotactic transducer HemAT
MLFKKGVKEKENKIQQLIDQEINKVSIDIEKGSDYEMQLNVIGLEREDLALLKSIQPIVA
KHLPAIRTESFHFSHEGMSKIIDTSRIGISTEDSMKYFLSFFNGKIDREYVQRRAMLAQM
YVKIGVEIRWFLSVYHLLMTEIMIKVNQELQLNEKEATILFMAISKIFNLENQLVIDSMH
NAQKNMIAKKEQEAKIDIKNFVGGFVENLAAMTEETGASVEQIVEQSGHIATSAKKSLAS
SIEMEERSENGKLQLDKVIKNMQELKEDIQRIMKTIDELEDNSKKIGGIVNVITGIADQT
NLLALNAAIEAARAGEHGKGFAVVADEVRKLAEQTKDSSSSITELVQGTIAHIANVIEQI
STINKVVDTGNHEIKLTTDVFDNILGSSRDNNKMIKSTENDLQLLIQLLEEINQAVAKMA
VSTEELNETVAGF
>PK3-045_03652 putative 3-hydroxybutyryl-CoA dehydrogenase
MDIKQITVAGSGVLGSQIAFQAAYKGFQVAVYDINDEVLEKSKNRMKQLEAFYQRDLDAT
PEELQEVYNRLFYSTNLGKATEKADLVIEAIPEVVQIKRDFYQELAKVAPKHTIFATNSS
TLLPSQFAEATGRPEKFLALHFANEIWKNNTAEIMKHQTTEEQVFQTVIAFAKSIGMVAL
PIQKEQPGYVLNSLLVPLLESAEMLLVNEVAEIETIDKAWMIGTGAPLGPFAMLDVIGIT
TAYNIVKGKAEATGNPAYIKLSHLLKTNYIDHGKLGRSTGEGFYKYPNPSFIQPDFLKN
>PK3-045_03653 hypothetical protein
MQLFSTFEHSVFIEMALSTLEKKGIKKENIFVVPLDNRTEQRKIFDDLHRSDGTSLIDIG
VALATALSVVFASIGFKLAWGPIYWGLIGAAAGFLLGFVIRLFTEIIVKKKRRLLKGFQS
EIIVIVDCEESQGEMIENVLFSHYALGVAKVKAKQ
>PK3-045_03654 hypothetical protein
MDNYNNDNTARRYRAHVSTLGTTQIHLRNPYIIAWWSAAFPGFGHLLLSKYLRGFVLFIW
EVVVNVNSNLNLSMIYSFQGEIEKAKEILDTRWLLIYIPVYIFAIWDSYRTTVDLNKIFV
LAEREEHRFNSFSIGIMEINYLDKRNPLMAIIWSLFMPGLGQLYIHRVITAFFVIIWGVV
FFYLSHGLEALSLLFLGEIKQATDVINSEWLLFFPSIYGFAIFDSYINTVENNKLYDKEQ
RFYFREKYQSSSFQVLKGQKVN
>PK3-045_03655 Phosphoglycolate phosphatase
MSQAIIFDMDGTLFQTDKILEISLDDTFHYLRSIHQWDGETPIDKYREIMGVPLPIVWET
LLPNHSLSLREKIDAYFLERLVTNIKKGKGALYPNVKEVFSYLKENDISIYIASNGLTAY
LQAIVEYYQLDKWVTETCSIQDIESLNKSDLVCRIIKKHGITQAAVVGDRLSDIKAAKEN
DLLSVGCNFDFAKDDEMKQADMVIDDLIELTSILAASPAFQIKNNTIK
>PK3-045_03656 Linearmycin resistance ATP-binding protein LnrL
MSAIKAVKMTKKYNGVTVVNGIDLTMEEGELFGFLGRNGAGKSTFINMLTGIAKPTSGSF
SLLGGNIDHIEVKRKIGVLPDYSSFYESTTALEHLRFFSALSGETAQKSECLEVLEAVGL
ADHANKKLGKFSFGMKKKLGVAQAIIHDPELLFLDEPTSGMDAESAIQIQQLIKRLHGEG
KTIFLTSHNLDEVEKLCTRIAIMKEGRIVKIGTMNELRAFYRSNIIVNIKHSPIPVSELS
KFHQWIKDKGTEIHTKEESLTITVEEENRISEITRALTACNTNVYRVNVEEPTLEEIFLD
>PK3-045_03657 hypothetical protein
MLTIGKREFLQLFKGFKSILLILVFLVTSYYSAKFADGIAEAMELTAQEAGEAHLVGLLF
LVMFFGHLFVASLSHDSINKEIRERTMRFLVTKTTRFSIIVGKFLGIWMFWFVCLFLSFL
IIALTTEKIDVLVFAQTMSLLTLQISFILLMSVLINKPGATMFLGILGGILLPILGGWFV
LTSNPAISWLKYVSPFYYLDLNEYSFLVLLVVAAILIYLTNLLFKRREC
>PK3-045_03658 hypothetical protein
MKKVFSAIATVAAVIMLSRHIGNEFAAQNYSSLAIILMIGLIGQILFHFREKKVSD
>PK3-045_03659 Transcriptional regulatory protein WalR
MKKIRLLIVDDEQAIHQMLKIILQKEGFERIDTAETAEEALQLCAVNDYGLIFLDVMLPD
RSGFDICPFIREKTNATIFFLTARSTDLDKLSGFALGADDYITKPFNPLEVVARVKAHLR
RYTANTVKESTTYQYGDLFVNSSSGEVMVRGVKVSMPAQVYQLLLYFCKHPNQLFSKAQL
YENVWGENFLGEDNTIMVHIRKLREKIEVDPSQPQYIVTVRGLGYKLSVEGYK
>PK3-045_03660 Sensor histidine kinase RcsC
MNMTKRFILQFFFQLLFVFFLVSIIFLLFWAIIGFTVMKNELYSDLTQADSSNMEDWISV
KNSHISISNDLKDLVRKQNGWLAILAEDGNPIKTYNLPKGTSFSKIDFALLLSESEDDSY
HYYMWSIQQDTAEPLIVLYGKEVGSKSILNTIKVAVNWQKNQLNITDTQGKTITNKHGWV
QLVSKDGVVQDSYEADNQKDRYSFQELFQLTKNEQKDVSTYYNRETGQVLLTGTDQTNSL
QSDTEIMQDTGNKILFLFLLALLLLIMLNIWFGYKFGAPLVTIMKWIGDLGKENYEEGHN
KHSMMLTKKGKLQRKYKIYKELITTLIQLTTSLEQNKQLRRKANKARDEWISGLSHDLKT
PLASIGGYAEMLQSDQYSWTEEEVRTFSSTIKEKAHYMKQLLEDLTLTYQLRSEGFPIAK
EKVEINEQIRRTVIHYVNGPAGQQYEFVFQPSPKELIAAVDPKWFQRIMENLIENAIKYN
PPKTTVTITIGKLDHHLLVITIKDNGVGMDNETLNRLFERYYRGTNTSSSMNGTGLGMTI
TKKLIELHGGSIKVRTELEKGTTIRILLPLLDD
>PK3-045_03661 hypothetical protein
MDEKQKVVAVVNKKQLASVMNNTKWEQLQKFVIDTLPFTPPYQVKYVLEDAPYPETFIED
VWYWGDWEQGLRPFYSIEWLRIRPRYVKSRGRLIEPERFDITDEFIELLQKLNIPFVKED
SIICIYGYVKSTETFNC
>PK3-045_03662 hypothetical protein
MGYTILFSYYEIVGEEAHLIDEYKLPVKERKESLETLLIEQNYKFIGNVDLWGFRTSKFM
NIAEIIKN
>PK3-045_03663 Heme response regulator HssR
MFKILVVEDDTNTRKLMCAVLKHHGFQTYAAKDGIEALQIMEKEHVDLAVLDLMMPKMNG
YELTQHLRQTWENLPILMVTAKQEAADKRKGFLVGTDDYMTKPVDEEEMILRIKALLRRA
KIVNEHRLTIGKTVLDYDALTVSRENHVITLPPKEFFLLFKLLSYPNMIFTRIQLMDEIW
GMESETDDRTLNVHINRLRDKLRDFPEFEILTVRGLGYKAVKKG
>PK3-045_03664 Adaptive-response sensory-kinase SasA
MREFFTKRLSLAITLVMFVFGVMMATVLVVAVITFALQHLGIISDNSQLPVFPLIAFLGF
CILLGTSLTAFLSKKALNPIRTVIDATHKVASGDFSVQVNIKGIGELEELSHSFNKMTQE
LSGIETLRSDFVNNFSHEFKTPIVSLRGFAKLLKENNLTEEERQEYLDIIITESERLAAL
STNVLILSKYENLEIITEKTPFRLDEQIRKTIVLMEPKWSAKDIVIDVELDEVTYHGNED
LTQQIWLNLLDNAIKFSEIGGNITIHLTKFKEEVCFSIQDNGPGMDDQTKKRLFDKFYQG
DTSHSQSGNGLGLALVKRIVELCNGKIYVESEKGKGSIFMVRL
>PK3-045_03665 hypothetical protein
MYESEERQELVRAAEEAEQSLLTANIMDSGYVYQSFLDYCSLSIDHALHSENEFIRAFAM
VDRRIGKRRLSNIDRKTLNHPLISKFYQIRCQVEKMAKR
>PK3-045_03666 hypothetical protein
MQWSKLKTKMEGFISEKLKERMQIHITAYRKFHDSPRRIWITFDKND
>PK3-045_03667 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase
MTKTIIKAPFRADHVGSLLRPQSIHDARKKFADGVISAEELRAVETEEIKRIVDKQIEVG
LQAVTDGEFRRRFWHTDFMEHLTGVEGYVPDHGYKFNGVETEAYDVRVTGKVSFNPDHPH
LKDFKEFYEIVGDRAVAKMTIPSPNQFFNAGIRKEEIYPDIEDYANDIIQAYRDAVQAFY
EAGCRYLQFDDVYIAGLCAPKLPFAKSELERQELIDLALRVVNGVLEGKPEDLIVTTHLC
RGNYQSTWAFEGPYDKIAPSFFAKEKVDGFFLEYDDERSGGFRPLEFVPNGGPQVVLGVF
TSKTGELEDKEAIKARVEEASKYVALEQLCISPQCGFASTHHGNILSEEEQWNKLKYIVD
VAKEIWG
>PK3-045_03668 putative manganese catalase
MFRHQKELQFEVKVDRPDPMLARQIQEVLGGQFGEMTVMMQYLFQGFNCRGEEKYKDMLM
DIGTEEIGHVEMLCSLISQLLDGASPEDQAEAAKDPAVAAIMGGINPQHLLVSGLGGMPT
NSNGVPWNGSYIVASGNLLADMRSNLHAESQGRLQVARLYHMTTDEGVRATFRKMLARDR
YHQYQWLAAIEELEAKNGVVVPATFPPEAEKESQPEAYEFWNLSEGDASSEGLWATGSAQ
DGTGDFVYVKEPVPKGQVPLNPIPPESLHHDLNIKK
>PK3-045_03669 hypothetical protein
MSNLAKDAKKQSPPYDFVQIANSSKFKQLMSQKKKFLIPLTVFFLLFYFMLPILTSYTTI
LNKPAIGSITWTWVYAFAQFIMTWVLSMIYVRKAMKFDELAADIVEENQMEGANNK
>PK3-045_03670 Cation/acetate symporter ActP
MSPIALMLFVIIVLITLIITYWAAKRTNTTSEFYTAGGGLTGWQNGLAIAGDYLSAASFL
GIAGAIALTGFDGFFYSIGYLVAYLVVLYIVAEPLRNLGKYTIADMINARFDQKKVRGVA
ALSTITIVIFYMIAQLVGAGALIQLLLGIDYWLAVLIVGVMMTIYVLFGGMTATSWVQII
KAVLLMLGTVVISFLVLAKFNFNILTMFDEIKTLTPLGENYINPGVKYTNSLDTISMMAA
LVLGTAGLPHILMRFFTVKDAKTARNSVVTATWVIGIFYILTIFLGFGAAAFVGASDIVE
ANAAGNMAAPLLAHALGGDFLMSFVSAVAFATILAVVAGLVLSGASAFAHDIYGQIIKKG
KVTEKQQMKAARYASVAVALLSIILALFAQKMNVAFLVSLAFCVAASANLPVIIFTIYWK
RFNTAGAISGVVTGLLTALVLVAISPNVLNPVPGAAILTGTAIFPLTNPAIISIPAGFLG
AIIGTILSNKRDEKKYAEVIVKANTGMK
>PK3-045_03671 hypothetical protein
MGKTVMMLILLIPFLPSMVIAQTKIPILVYHSIEEFHGQGSKELYVTPANFEKQMIYLRD
HGFTPLTFEKWQDINKVRKPIFITLDDGYKNNVRVLGIFRKMKTDDFTPTATMFVIADFI
GNANRLSNQELKELASSGFLSIQSHTATHPDLVKTTDYKHELKDSKDKIEAITGKKVIAL
SYPYGNIDSKTMEEVKKHYSFGLTTTPEFYSAKGIKDELYLLPRKYVKYSTTLEEFADIV
EGQ
>PK3-045_03672 hypothetical protein
MLQNGQQVHQNLQTGQVPQAMNHGGHEMFDVHEVLVGAINTMNLYKLLGNHIQDPELRDI
QNRQYQFIQEDYNLTLECFQTGQPPAKRTEPYMMKENNDFIFGMTQMPPAKPIQNVTEMS
DQQAAVAMLSALKASASMKTMAAAETTNPVVRRVIAASIPNCLEMAYEVSLYQNKHHYYQ
VPQLAAQDMQNILNGFAPAQGAPMMQQQMNMNNNMH
>PK3-045_03673 hypothetical protein
MPRNQVQVNVDPNMDGPREGVMADADGDQLGISRDTEVETTAFHVKQLKKDPELTKFNQS
FKDK
>PK3-045_03674 hypothetical protein
MNSYLDTMVTKVKDSIIQAADSVRKGFFTLTGETSLSVNELAKYIKENKETKTESKYLLG
NYYYFSHLQENGIRYYLETNGDFILQLDASTKDHVLIAYRSYKDKLSINTPVKFPKIQ
>PK3-045_03675 Sulfurtransferase
MKEITTTELNSKLQSGEKVSIIDVREPAEVATGKIPEAINISLRLIEFRMHELDKQKEYF
MVCQSGGRSSQAAQILNKNGYRVVNVIGGMQSWEGKVE
>PK3-045_03676 Sulfur carrier protein DsrE2
MATKTTIVLFSGDYDKAMAAYIIANGAAAYDHEVTIFHTFWGLNALRKEENIKVNKGLLE
RLFGKMMPKGADRMGLSKMNFLGFGPMMIKHVSKQHQAMTLPQLIAMAQEQKVNLVACTM
TMDLLGLKEEELLKGIDYAGVAAYLAEAEDGNVNLFI
>PK3-045_03677 Copper-sensing transcriptional repressor RicR
MEYNDQLKNRVKRMEGQLRGILKMMEENKDCKEVITQLSAVRSAVDRTMGVIVSTNLVDC
VVEAQENGEKMDDVIKEAVNLLVKSR
>PK3-045_03678 Coenzyme A disulfide reductase
MRKKVIIIGGVAGGATAAARLRRISEEVEIILIERGEHISFANCGLPYYIGETIKDRSKL
LVQTVEGMSKRFLLDIRVQSEAISIDANNKKVTIKNLQTEEIYEETYDKLLLSPGARPII
PPILGIENHQSLFTLRNIPDTDRIKAFVDQNAPESAVIIGGGFIGVEMAENLVARGMKVT
IVEKGNQVLGPLDVEMAGPVQTHLKQNGITLILGNGVKQFKGNGNIIVLEDGTEVQTDIT
ILSIGVRPENELAKQAGLEIGEKGGIVVNHLLQTSNQDIYAVGDAIEVRDYINRKKTMIP
LAGPANRQGRIAANNMMGKKEKYEGTLGTSIVKVFDLTVATTGNNEKTLQKWEIPYEVVH
IHPNSHAGYYPESSPITFKLIFDKESGQIYGAQAIGREGVDKRIDVIATAIKGNLSVEDL
TNLELSYAPPYSSAKDPVNMAGYVASNIVDGELEQIQWHEVDQIVQDGGYLLDVRESVER
EFGYIEGSLNMSLGELRERMDELSKDQPIYVSCQVGLRGYLASRILKNNGFNVKNVDGGW
KTYSSAFAYTKKVERTEESNQTNEEIREDEGFQIETVLDVAGLTCPMPIVKLKQGMDQLE
SKQVLELQATDRGVLSDLPAWTKKVGHQILKMEQVGSTIKFWIKKK
>PK3-045_03679 Low specificity L-threonine aldolase
MYSFNNDYSEGAHPRILQALLESNLQQEIGYGQDSFTHKAVEILKEKLNCEEVDVHLLVG
GTQTNLIAISAFLRPHEAAIAAKSGHIFVHETGAIEATGHKVLTVDTENGKLTPSLIQKV
LDEHTDEHMVKPKLVYISNSTEIGTIYSKSELKQLSEFCQKNQLLFYMDGARLGSALCAK
DNDLTLSDLPQLLDAFYIGGTKNGALMGEALVLKKDSLKEDFRYHIKQKGAMLAKGRVLG
IQFYELFKDNLFFELAEHANRLAERLMTALAEKGYRFLTQSSTNQVFPIVSNDKIIELQK
NYHFIIWGKIDKEHSAIRLVTSWATKEEEVERFINHLK
>PK3-045_03680 hypothetical protein
MVTIGRKCLYQNNILARDYYLKLSDNPFICCDEIILLILVASWLLMLPLENPHSSQ
>PK3-045_03681 hypothetical protein
MQYRTSKNGLPALTENWELSRVARDKSMDMAQKKYFSHTSPTYGSPFDMMKAYGISYKAA
GENIAQGQTSA
>PK3-045_03682 hypothetical protein
MKKIIAMVIFFCLIALPTMVFADTYIVKNGDSMWEIAVKYQIGLTEIIAANPQISNPSLI
YPNQKLTIPNIDPIKTVEREVIRLCNIERQKMDFLL
>PK3-045_03683 Glycogen debranching enzyme
MNHWLRKLLIILTIFVLVFTTRGFSFNQMNVKAENTSGKDIPENTLRIHYQNEENKYQDL
GLWLWEDVESPTANWPQGAAAFEEENQDEYGTYIDIPLKEDARKVSFLVVNRTNGEKESG
DKSVTINNPSLNEIWIKEGSDSVHLFEPVELADNTVRIHYQRDDQNYDKLGVWLWEDVES
PTVNWPTDAVALEKNDRYGAYVDIKVKENAKKIGFLIVNRENGEKIAGDKGFALLEEYDH
LWIKNEDDQVYISPYWESPTDLVSGELLSDTTIQLTFSSTKGLVEEEIAQALSIVDKDKE
VIDFRAVKIINETTVEITGIYDAEKGPFTISYQGRSVTAKSGWKMLDENYFYEGNDLGAT
YHNKDATLKLWAPKASKVTAVFYDKNDAARKIGSLDLVQGDQGVWRIEAKASELGINDTR
GYYYQYEVTNDGKVSKVLDPYAKSMAAFTVNTEGKVGSDGDTVGKAAIVDLSQTNPANFS
GVNIDGYEKREDAIIWEAHIRDFTSDPTIETDLNGRFGTYKAFIDKLDYIKSLGVTHVQL
LPVNAWYWGDETRMGERELAYSAAGNEYNWGYDPHNYFSPDGAYSENPKDPELRIKELKE
LINAIHAAGMGVVLDVVYTHMSNASLLNDIVPDYYFFQDSNGKFVGGFGNNLATNHKMAE
KLMIDSVKYWFREFKIDGMRWDMMGDATYEAVQKAYDVAKGINPNALFIGEGWRTFSGHL
ADPSLAGKGADQDWMDKTDDVGVFSDEIRNELKSGFGSEGEPRFITGGARNIQTIFNNIK
AQPSNTPADDPGDMVQYIEAHDNLPLYDIIAKALKKDPAIPENDLEIHKRIRLGNSLILT
SQGTAFLHAGQEYGRTKQWLGEGIPEQKYDAFTDENGNVFGYFVHDSYDSSDAINMFDWS
KATNEEAYPINNETVEYTKGLIELRKSSNAFRLGEKSLVDSNVTMIDAQEIQEEDVIIAY
KNESTDNTGSYYVFMNGDTKARELTLSEDLTEFKVVVDNDEAGKDSVEEKSGFTLTAEKI
TLEPLTTIVIKNEKETGGNPDDGDKEPNDPENPVDSTDPEVPEKPDKEAPVNADKNPIDN
KGDKGDNGEKADNNGKSKNSLPNTATNNGTYLLIGIVILAAGVCLSIIVRRKKADAE
>PK3-045_03684 hypothetical protein
MKVFQAIIMTVFIGFIGFFATMLTTLFTASTFYLWFLPIITVLYIITVYLLIFEWWKKKA
VKKARLMILAISICGIAGYIIYEHYDKNLEVVSSQDTDLTEYMPFLEGTKAVSLKEESPF
KIEKNLPRLDGSTALYPVYAGFVQAVYPQKKYPLEESEVVSSQTSEAYNRLLNREADIIF
MPKPSEKQYKMAESQGVKLKLTPIGREAFIFFVHAKNPVGTLSIEQIQDIYSGKIRNWKE
VGGKHEKIRAFQRPEESGSQSALLRVMDGKPLMDPPTKDIVDAMEGIISETADYQNKSNA
IGFSFRHFSEDMVRNGKIRNIAVDGIPPTVETIKDGSYPFINEFYAITLEDNSSPQIDGF
LKWMVSEQGQQIVSETGYVAVE
>PK3-045_03685 hypothetical protein
MTKKQLIMEKSIELFAKQGFAATSVQQITEHCGISKGAFYLSFKSKDELIMALVDYFMEQ
FIVKLDYAVNHVDDILYHFYYEILYTFKENSSFAMLFIKEQALSFNEEFIRKFTYYDHLL
EKTIEHMIGEVYDSSKQAIKYDLVFSIKGFLNTYTHIVLNHNKYIDFDLHRLAKSLVEKT
DILASYTESPYFTESIYQLLHQSVKEESATKEDLLQLIKGKREEVDDHYVNESLSLLIEQ
LEEKTLNPVLLKGLIENIRHHRDCIWLSYLLFQYFQLHPSHQQ
>PK3-045_03686 Swarming motility protein SwrC
MKGLVNFVLGNKLAVWLLTIIITVSGIYSGTKMNMETIPNISIPYLTVMDVYPGATPEKI
MEEVSIPIEKVVENLEDVKAVYSNSYSNMANVQLEYEYGTDMDEAKRALQSALDNVTLPK
DAEEPTITAISMNMMPVVALSVSSTKEDITELTSTVEDIILPKIEKINGVASATITGQHI
EEVDLTYDKEKMAQLDLTEDTVKNMIQASNLAVSLGLYEFEEGEQAVAIDGKFMTEKELK
NMQIPVTPSQQNPSPFVKLSDIAKIKVVGKVESVSRTNGKDAIAIQIVKGQQANTVDVVN
SVKDLIKDEQKNIDGLVIDVSLDQGDPIEKSVLTMVEKAVFGCLIAVLIILLFLRDFKST
IISIISIPVSIFMALLLLNWMDITLNIMTLGAITVAIGRVIDDSIVVVENIYRRLHLKEE
KLTGRALIREATIEMFKPILSSTLVTVAVFAPLMFVGGMVGELFRPFALTMAFALGASLL
VAITIVPALSHFLFKKKLYSEKTESNHKEAGKLATWYKGILEKALNHKIITSVIAVILLA
GSVALTPLIGFSFLGSEEEKTMYITYTPETGELKDETLKNVTEVEEKMLDRKDIDIVQLS
INDTADAQSAMMGTGAGGALMYLIFDEDMKNFPEARDEIEEYITNLDQSGEWKSQDFSST
GMSTNEVSYTFYSEDLDKLNESVKKVEDMLKKNDGLEDVTTTAEDAYVEYTFKVNQQELL
QYGLTAGQLLATLSPNNSKDVLTTIEKDGQELDVIVQQEKSAQPKSIDDMLDTEIPTATG
QNMPLSKLVDVKKGTTQNTLSRSEGEYYATVSGKIIGDNVSKVTNEVDKEIDKIDLPKGV
TMGVAGVTADMNETFTQLGIAMIAAVAIVYFILVVTFREGVAPFSILFSLPFAVIGSFVG
LYLSGQTISVSVMMGLLMLIGIVVTNAIVLVDRIIHMERDGMNMREAILEAGSTRLRPIL
MTAIATIGALIPLAVGSGGSGLISKDLGITVIGGLISSTLLTLVIVPIVYEILSKLFKKN
RKDIDEN
>PK3-045_03687 N(G),N(G)-dimethylarginine dimethylaminohydrolase
MKIHCSNEYDPLKTVVLVSPEYMAIKVPINDIQKKHAKKNIDKKLAVKQHEMFIETLQKN
GVETLLLPSEEKYHEQVFTRDIGFTLGSQIFVAEMARDARHGEERVLIDYLKKKEITYTD
IKGNFIEGGDVIIDGKTIFVGISQRTNEAAVRHLQTLMPSYDVIAVPFTDTYLHLDCVFN
ILSPTEGLIFPGEFHKEKEKLLRERYEFIHVSAKEQETLGTNVLSIGNKKVISLPMNEGV
NKELQKRGYEVLEVDFSEIIKSGGSFRCCSMPLLRE
>PK3-045_03688 Inosose dehydratase
MKNIPIAIQMYTLRNECEEDFRGTLRKVADLGFQGVELAGYGGIPVAELKELLDELNLRV
AACHVPLTDLESDLSQVIQDQIVLGSKFLVCPYLLPDKRTEADYQSLISFLNMAGAECRK
AGISLCYHNHDFELDIMSDGRTALATIMEDTDPTLVFAEPDVYWLSKRDYDPAKWIDTYK
DRMKLIHLKDMTTDEEQFFAEVGTGSIDFQAILEKGEDIDIQWWIIEQDATRRTPLESIE
ISLRNLREMLAVR
>PK3-045_03689 hypothetical protein
MENHIRKVIEQTEKEFNIKVLYACESGSRAWGFPSKDSDYDVRFIYIHQPNWYLSIDRSR
DVIEIPNHDSLSIPVDPLLDMSGWELTKTLKLFRKSNPPLLEWLRSNMVYYQRFSTIDQM
KELEKEIFSPASIIYHYLNMAKGNFREYLQGDTVKIKKYFYVLRPILAAKWTQIYQTVPP
MEFETLVHELIPAGDLLTSISTLLERKKSGEELSLEPRINLINTFLESEIHELEAYAKGL
QKNSEDPTEQLNELFRFSLKEVWNY
>PK3-045_03690 Manganese efflux system protein MneP
MGSRELLAKRVAWISVISNIILTIGKIIVGWIGNSDAVFADGIHSAADVFASVLVLVVIK
IANKPADQEHPYGHGKAEIIVSGIVGMILLCVSIYLVYEVIIGLFHPITTPSMIAMWVAV
ISYISKVLLYRYSKRIAKEQSSKAIEAIAYDHKADIVASIAAAIGVLFSILGEKLNIHLF
LYGDKLATIIVAYLIFKIAKEMVSEAFDILLERNIDLAILAEYHDIISSFAEVKRIDRLR
AREHGHYILVDLRISIDYDKTIKEGHDLSRKIKKKLMAKHDNINEVLIHLNPYFKD
>PK3-045_03691 hypothetical protein
MVAVSVVIPLYNKVQYIERTIMSILSQTFQDFEIIIVDDGSTDGSVEKAETWIDERIKVL
KMEHKGASAARNKGILAATAELITFIDADDEWKPGFLEKIIYLKDKYPECGAYATSYEIV
LPTKKKIIPSIYQTPEKWEGVFTNYVEKTLKDLPIISSAIAVRKQVFDKIGLFKEGEPLG
EDQDMWLRIGMNYSIAYINESNAIYYRGLENSVCMDLTILNRYPIIYSLENLLHKEEIPY
IDLYLSKLKLDYSKRLLEANKLDSAWQELQNTKASVYKWQKIKLWLFYYWKKISNKYSFT
QKNIIKNARKL
>PK3-045_03692 hypothetical protein
MSKIILSGYYGEQNGGDDALLLVSSWGSRKFLSGDKIYGTCIQKPVLPLNAEIEALFVQE
EQERNENLLRLYRHCYESDLILFGGGSVFHSTDKMTRDSDLIDLNRGKGAAAIGVSFGPF
RDSAAEGACKKLIEKFNYIGCRDEESYELIRSFSSDVKVELTFDLAVLLPLVAGENFNGI
HTRKGLGISLCHYERYIGGDTSIEKTRLKKIVNVLNGLHQEEIEELVFIDFNGHPIFGDQ
DIHREVIDQLHTKIPIKHLSYDKDPMNTLRTIASLKGLIGMRLHSSVFGYITNTPTIILS
YHPKCDGWAKQIQADKEYIIPSHSFEDESIWHALKQIIAGQYRYPKLSIKDAQSLAMKNW
EGARWSLSQ
>PK3-045_03693 hypothetical protein
MTLKKKRKILFITKNWENGIERNTYYLTKELKKYVDIRTWEEDGNISETIQKMNFQPDFI
LVNDLRPTRSPKVTGLKDCNIPFGIIMHDLNYQMDQRRAFIKENNVKYIFTHYRDTFLEW
YPEFKDKMIWFPHYVNIDVFKDFKQPKTIDYLMMGAVHPTVYPLRQKILDQMKNLSNFTY
HAHPGYFHQQYDERSFKVASSFAQELNKAKMFFTCDSIYHYPVMKYYETLACNTLLLASC
TKEIKDLGFIPGVHFIEINEENFMRKAKYHLRNYETLGKKIALNGYKMVRKKHSVQVRAQ
QLLAHIEEILAKEGGNEQ
>PK3-045_03694 hypothetical protein
MRILYLGYLGVNNIGDEVCYEAFAQACERWLHEDYTLFSYPINSSKTLKELYGEKPFDIV
ILGGGSLFQGNFFIDLALEAIEMKLPLYCYGTGIDYMTEETIESFKRGKFQLSSTTFNNK
EINREKIKKVIEYSTFAGLRGPLTQKYIKTLTPSPTSNYQIIGDSGMLFTPQKDDYIRSK
YLQDHDKKIIAVNWGTTQNILFGYDEYKLKKQIIKACTNLLKKGYQIVIFPMWDLDVPHC
KELYESIKKKGKVTFIPEVCTASQIYSFLSLCHFSLNLKLHANVLSASSGTPFFQLAYRS
KGVDFAASVHQLPYTLLSNTEKLAETIENKEYYLTSNKNRKKLRQAKERIVARHKNFIFS
LKK
>PK3-045_03695 CDP-glucose 4,6-dehydratase
MTTDWRKIYKNKTVLITGHTGFKGSWLAIWLMKLGANVIGYSLDPIGEESLFKLTELNNK
VKDIRADIRDAAKLQAVFEEYQPEIVFHLAAQPLVKQSYRDPIYTYEVNVMGTMHVLEAI
RKSPSVKAGVMVTSDKCYDNKEWVWGYRETDPMGGYDPYSSSKGCCELLISSYQHSFFPI
ESYSKHGKLIASVRAGNVIGGGDWSENRIIPDSVRSLMSDQAIKLRSPHSVRPWQHVLEP
LSGYLKIGAYLYEGKTQYAESWNFGPESDSVTTVQQLVEKIVEHWNGGTWEVEPSYSAEH
EAKLLSLDINKAKYYLDWHPKWNIDQTVYYTMEWYRLYQKVDVYELCLKQINEYEK
>PK3-045_03696 UDP-glucose 4-epimerase
MKLKNKKVLVTGAYGFIGSHLIKRLVKENASVAVIIREHSNPWRVQEYLPHLKKYEANIQ
NRSDICRIIHEFQPDYIFHLAAYGTNPSNRNDLLAYETNIVGTMNILFAAKGTKCKKIIC
LGSSSEYGDKKEKIHEDMLLEPVDIYGSTKAASTIISHQLAQEYKLPIITLRAFNIFGEA
EDNHKLFSHIIEKVLRGDEVKLTSCDQYRDYSYVGNIVDGLILAATYEGSNNMILNIASG
NAYPLRYFVDLIYQHLGTKQVPLYGAIPKRENERNAPIPDITKIQKVLGWTPAVSIEEGI
KKTIAWYKSYYHFH
>PK3-045_03697 hypothetical protein
MKWLKRNIISDFLKALSSEEKQEKSATLNIQLFSKEISVKFHVDNLVDIINGARKNNKVL
ELPSPQAETSTPEIIDAQASVVNENAQETMGAIIQNAEVIDQEKARQEAEVKEKARQEAE
AKKARQEAEAKKARQEAEAKEKARQEAEAKKARQEAAAKEKARQEAAAKEKAKQEAAAKE
KARQEAAAKEKARQEAAAKEKARQEAAAKEKARQEAAAKEKAKQEAAAKEKAKQEAAAKE
KARQEAAAKEKAKQEAVAKEKARQEAAAKEKARQEAAAKEKAKQEALKEAKDQQIVLVNT
KEQTKLSPTEPIASTNQNFCVIAGKEYCIKIMAVYESLAKNSDNFNLWVCCTDAITHKFL
NEKNLKNMHLIRVEEIENDQLRAVKQERMINEYCWTLKSFLIEYILKNNDIEQVLYCDGD
IYFFSNPASIFNEWGSASIFLTPQRDLDWVEQKYGKYQAGIIGFRKDEIGLSAVQWWKER
CIEWCGVVESNGRFGDQKYLDQLPIMYDNVRISSNLGVNAAPWNIIYNNDFNVSLQGDKV
FINNDPLVAYHFSCITIYDSDKYDLWSMHQLNIQKEIMNYIYVPYLDLLENLIKNYQNSY
PGIIKATLSTKDFIQAKTKYQSTKLKKRMIQYNNYLLLTSIFSKEYLVKGLAMYHSLSRQ
IDNFHIWICTMDSETYDVLSNLNLKNATLIPVETFETPQLKEIKQQRTLQEYCWTIKATL
LEHLLSTHADIDHLFYCDSDLYFFSNPLSVIDDFSRYSVYLCRQRGTDTLEHFHGQYQAG
FIGFKNERNSRKILNWWKKKCLEECSEVYNDERKSWGDQLYLDRIPELFENIKVNQNPGI
NAAPWNLILNNTDQEVTMRENNVYIDSNPLIFFHFGSLLILNENEFDLWKLEKVDISSAT
LTYIYNPYLTKVRELLSSLSNNAQFFANLPSGYIAKNPYSIASL
>PK3-045_03698 Glucose-1-phosphate cytidylyltransferase
MKVVILCGGKGMRMRGLTENIPKALADVNGKPIIWHIMKHYSEYGHQDFVLPVGYKGEQI
KDYFVNSAWRNNDIQIDLANNQYNILEKTEPWTITCIDTGQDTMTGARIKQLEPYIDDDI
FLLTYGDGLSDIDLDKLIAFHKEKGKTVTLTGIKKNNQYGVLDIEDGIANRFAEKPILDD
WINGGFFVCNKEFFQYLSAQPDCVLEEEPLRKLIEKRELAVYLHEGIWVSIDTPKDLEDA
RKIWKKEQ
>PK3-045_03699 PTS system glucose-specific EIICBA component
MFKNLFKRNKEEKTNTTQTYIQPLEGKLLSITEVPDPVFAQKMMGDGIAVDPSNGVLVAP
ADGQIMNVFPTKHAVSMTDNNGKEILIHVGLDTVSLKGEGFTSFVKDGDKVKQGQKLMEI
DFDAIKSKVPSIITPMVFTNLEENEKVIVEGNEIRIG
>PK3-045_03700 Trehalose-6-phosphate hydrolase
MKQAWWQKAVVYQIYPKSFQDTTGNGVGDIQGIIKRLDYLKELGVDVLWLTPIYASPQKD
NGYDISDYYSIHHEYGTMEDFDQLLKEAHQKGLKVIMDIVVNHTSTEHEWFKQAASSKDN
PYRDFYIWKDGKEDGSEPTNWQSKFGGNAWQYDEKSGQYYLHLFDVTQADLNWENEHLRD
EVYKMMQFWFEKGVDGFRLDVINLISKNQNFPDDDGSVAPGDGRKFYTDGPRVHEFIHEM
NQEVFSKYDSMTVGEMSSTTLEHCVKYTKPERNELSMTFNFHHLKVDYPNGEKWEIGEMD
FHALKQILSKWQVGMNEGGGWNALFWCNHDQPRIVSRYGNDGEFHNESAKMLATTIHMMQ
GTPYIYQGEEFGMTDPKFTSIDQYRDVESLNMYNILQANGKSEEEILEILRRKSRDNSRT
PVQWNGKKNAGFTDGTPWIETARNYRELNAENALKDKDSIFYHYQKLIQLRKEYNIITDG
DYELIAPEDDKIFAYLRSTDKEKLLVVNNFYEEEVTFTLSEHIDWTGLTGTILLSNYPDS
DSMRESIKLRAYESIVYYIK
>PK3-045_03701 RsbT co-antagonist protein RsbRD
MKDELAYIGNKIIENQNILAENTNRLLSQFLQQQASDFSLPYPEEDMHKWNAKLFFILAE
ALKDKKNSEGIEYWSDKTGKAFVKNHIPLQSALRSLSIYRNVIWDVFTEELEQKSFAPIT
MLDVGKIIDPILDEISAYIGHIYEEHNTQIMKLAYTALEELSVPVVPIAKETAIIPLIGE
IDTQRSQLILEVALQESANLKIEYLILDISGVPIVDTMVADNLFKVVHALDLIGVKSIVS
GIRPEIAQTIISLGIDFSKITTCANLHTALASIGLKRVVE
>PK3-045_03702 hypothetical protein
MCAHVFYVPSTNLMGRGCLQEVLMTIYMFIPCNQHI
>PK3-045_03703 Rhamnulose-1-phosphate aldolase
MVAIMQKQNILDAPFIKEMSEATFNMWNMGWDERNGGNISYLLEEELVEQYLDTGKIIRS
IPLKFPVAELAGKYFIVTGSGKYFKNVKKDPANTLGVLKIDKSGEKVHILWGFEDGSNPT
SELPSHFMSHIARLRVDPNHRIIMHNHATNILAMTFMHDLDEASFTKTLWQMCTECIVVF
PDAIGILPWMVPGTDEIGEKTAAKMREHRLVVWPHHGIFGAGSTMDETFGLIETAEKAAQ
IYTIIGDASKIKQTITDQQLQDLADAFQVVPREGILHL
>PK3-045_03704 putative HTH-type transcriptional regulator YdjF
MLVAERRRKIVELVNERISIRVSELSEIFSVTEETIRRDLEKLEQDKLLMRSHGGAVSIE
KEPSDTPFMEREVTNAEQKRAIAREAVKRIQPGEQIILDGSTTAWYMASQLPDMPLTVIT
NSIKVALELSKKEQIRVISTGGMLLSKSLSYVGPLAERSLERYYVNKLFLSCKGVDMQSG
LSDANEWQALLKKQMMNISSEVTLLVDSSKFGVKTFAHIANLDQIQYVITDERIPEEYAN
WFQEKNISFQVVPS
>PK3-045_03705 Xylose transport system permease protein XylH
MQPQIKPNPVGSQKSKSLFHVNFRQYSMIIALVFIMVLFQIITDGLLLKPLNITNLILQN
SYILVLAVGMLLVIVTGHIDLSVGSIAAFVGAISAIMMVNYEMSPFLAIVISLVLGAVIG
AWQGFWIAYVRIPAFIVTLAGMLLFRGLTMIVLEGKSIAPFPESFQKISSGFIPDISGGS
LHLLTILIGAVLSIIIIFLQLKNRRNQLKHQFDVQPFGLFVSKLVGMILILNIFTFVLAT
YEGIPNILIVLGILIVIYTFVTNKTKAGRHIYAIGGNEKAALLSGIKTKKMTFMVFVNMG
VLSALSGLLFAARLNAATPKAGNLFELDAIAACFIGGASAYGGIGTIPGAIIGGLVMGIM
NNGMSLMGLGIDWQQGIKGLVLLAAVAFDIYNKNKAQ
>PK3-045_03706 Xylose import ATP-binding protein XylG
MANIILEMQNITKEFPGVKALDDVNLKVKQGEIHALCGENGAGKSTLMKVLSGVYPHGTY
SGDIFFHNEVCIFKDIKQSEELGIVIIHQELALVSELTIAENLFLGNEIVNKGVIDWNKT
ILRTRELLKKVGLSESPNTKVSDIGVGKQQLVEIAKALSKDVKLLILDEPTASLNENDSE
NLLNLLLDLKKQGMSAIIISHKLNEIEKVADSITILRDGKTIETLDVKNDQVDENRIIKG
MVGRDLTNRYPERIPHIGEVVFEVKDWNVYHPKHMDRKVIDNVSLTIRRGEIVGVAGLMG
AGRTELAMSLFGRAYGKNINGKIIKNGKEVQFKDVTAAINNGLAYVSEDRKGNGLILMED
IKQNITLATLDRISKHSVLDKNQEIKVAEEYRQKFRIKTPSIFQKAGNLSGGNQQKIVLS
KWVFSEPDILILDEPTRGIDVGSKYEIYTIINDLVNEGKSILMISSELPELLGMCDRIYV
MNEGRITGEVLKEEANQEKLMKYMTKSKVRG
>PK3-045_03707 Multiple sugar-binding periplasmic protein SbpA
MCKKVYTFIAVIVLTFITAACGVEKTSGESKGFIGISMPTKSSERWVNDGENMKKLFEEL
GFKTDLQYAEDVIENQTAQIENMITKGVDILVIAPIDDRSGLTGVLERAHKDGIKIISYD
RLIQHSEYVDYYATFDNFKVGELQGQYIEEKLGLKESEGPFNIEIFAGSPDDNNAYFFFD
GAMSVLQPYIDSGKLVVRSKQTKFSQGATLRWDGALAQARMDNLLSAHYSSERIDAVLSP
YDGISIGVISSLRGVGYGSKDKPMPIITGQDAELASIKAIINGRQTQTIFKDTRELAKKA
VEMARALLNGEEAEVNDTETYNNGKKVVPAYLLKPVSVDIENYEAELVDTNYYTKEQLGQ
>PK3-045_03708 Regulator of RpoS
MDKQIWNVLIADDEPIIREGIRNVIDWSALQMNVIAEAEDGEEAIELSLMHSVDILLIDI
NMPIANGLMVIKQVKAKLPDCQIIIITGYDEFKYAQEAVRLNVFDYLLKPIDPDHLMGLL
NKIKMELVEVNKKRALLDRTSEQFTKNLPTLQHNFFREWIGGKLTNEEIKEQLAFYYLNT
SIPKQLVVISCLEFLENKSILSEKEKGEIQASLKYHILLFLKHKEIGYFHDESGLIALII
WQTITNEVALQLEEYIRKELKMSIAIYINNNEVDYKQLFSLYKNCKEMIQKEMNISPIVR
RAKSIIDHQYADSSLSLEKVAITLQVSPVYLSRLMKQELKVSFVQLLTTKRMKQAIYLLQ
STDYPIITISQLVGYETQHYFSTAFKKIMGVSPNKYRRNIMEETNNIK
>PK3-045_03709 hypothetical protein
MFAKLRKVNDFSLRDKLIALFLLISIIPAIGLGLLVGVTVEKILGEQATKNTLQLINQVN
TTLESSITNVQNVSYLISMDAQIKTFFSSNRKEGNETDQSYSIRQTMQGFTSLYPEIAGI
LLINKQGKYISNELYAEDKVDLTKEEWYKEAVRNKGIFKIIGKPEKRHIISQINYRDEDV
VTVVRAIVDRDTQEITGVLLIDLKLRVIGEAMNNVHIGLSGFLTVIDENGKEIYSTSNSE
AIEIPETILLEGDWGAYKKVVDGEKMEFIYQRTPFSNWTTVGIFHSDESVAEVKEIQLYL
FFFVFFLCFAGITVSYYFSHSISNPIIELMTMMRKIEDGQMEIRYKGKRKDEIGRLGKTF
NHMITKINSLITLTEVQEKQKREAELRSLQAHIKPHFLYNTLDTINWMARKHGAKDVAEV
VASLSSFFRIGLSKGNDMIPLKDEMKHIQSYLMIQKARYQEKLSYEIIYDSNLTEVTILK
LVLQPIVENAIYHGIKERRGPGNIIISAIQENACLLLKVTDDGKGMEEEELHTLREKLNT
LVILKKERKEQINFGYGMMNVQARIKLTYGDAYGLTIDSEPDKGTTVTIKLPMNLEEKKE
>PK3-045_03710 hypothetical protein
MKRLLYVYMFVFILFGIYFYYSHLYNALDDNNGLKRERLQGVVNDEFVMVTFLAGMDYWK
SALKGFEDAANEWNVSVAYRGGTQYDLHEQITILEQVIAKKPAGIALSAINPNNLNATID
KAVEMGIPVVLFDSDAPLSKASAFLGTNNYEAGVKAADKLSSLINKKGKVAVITLPDQLN
HQERTKGFVETIKSNYPNIEVVQVQNGEGDQLKSEKIAKEIMKNYPDIKGIFVTEANGGV
GVADAAKENKKMDVKIISFDVDRKTLDNIENGTISATIAQGTWNMGYWSMQFLFKLHQKD
IISDPHGLPSYVDTGITIVTKDNVKEYYAEYTK
>PK3-045_03711 L-rhamnose isomerase
MSVKENFELAKKQYEQWGVNVEEALEKLKNIPISIHCWQGDDIAGFEVNQRELSGGIDVT
GNYPGKATNPEELRSDLEKALSLIPGRHRVNLHAIYAETNGLAVERDELEPKHFENWVQW
AKENGLGLDFNPTLFSHEKAADGLTLAHPDQEIRDFWIQHCIASRKIAEYFGKELGTPAL
TNIWIPDGYKDIPSDRLTPRKRLKDSLDKIYAVETDERYNLDAVESKVFGIGSESYVVGS
HEFYLGYALKNNKLCLMDTGHYHPTETVSNKISSMLLFSDKLALHVSRPVRWDSDHVVIL
DDELKEIAVEIVRNDALDKVIIGLDFFDASINRVAAWTIGTRNMIKALLNALLLPNDKLK
QLQEEGNFTERLALMEEFKTYPFGAIWDYYCEQMDVPVRESWLNEVKVYEEEVLSKR
>PK3-045_03712 Rhamnulokinase
MTRYTLAVDIGASSGRLILGSVSLEKLELKEIHRFENRMIKKGQHYCWDIEMIFSEIKKG
IKKCNDIGITPESIGIDTWAVDFVLLDEKGELLTDAVAYRDDRTDGMMEEVFQKIMKERL
YLETGIQFQKFNTIYQLYSLKKTQPEVFAQAKTFLMIPDYLHYLLSGIAVNEYTNATSTQ
LLNAFTKKWDKTILDTLEINKEIFQEIKKPNTILGNLRPELVEEFGFDMKVILPATHDTG
SAVISVPAFNDTIYISSGTWSLIGVENRFPICVTKALDYNFTNEGGIDYRYRFLKNIMGL
WMIQEVRRNYNNQYSFAKFVELAKEAQGFSSIVNVNDNRFLKPDNMVEEIQNYCLETGQQ
VPATPGEIAKCVYDSLVDSYVIAINEIEEIFEKTFPSINIIGGGCQNEMLNQLLAEASQK
EVYAGPIEATAIGNIVSQFIALGEIDSLSEARQMIKQSFEIKVYKAAEDAIK
>PK3-045_03713 Arabinose operon regulatory protein
MDHVLMEQLRKLTEEEICIVQQKQGVIKDIYTSQSNFIIESEKFLRNDKMIAVRKHTRFI
DFPKHKHNYIEINYVVNGQLKQKVGNDEIVLKRGELLFLNQHMEHEIEACDKEDIVVNFI
IQPPFFQFIFQYLHEENKLTDFLISSLFKHKESGQYLYYKVSEVIEIQDIIGKLLKEESN
NSILSESTMKLYMGLLMIELIKNTDKIQQNEGVTQDHYVVIEALSYIEEHYQLGTLNELA
GRLHQSMSSLSKNIKKATGYTFKELQQEKRLSEAKNLLETTDLPIKRIVEEVGYDNISYF
YRIFKEKYRMTPKAFRLKLAK
>PK3-045_03714 hypothetical protein
MKRIFYSMLILFLLSACSKGGGMETEEEIVDTNNVKVPSTIFYSDKQNSVIDEEEMKSSI
KTYLDTHEELSLASSPFQEIIDEEKELTKSDLEKLKQINRLTRENDENFLNYISQNTLPQ
GYQEESERISRYITSLNGMLDELDTVLDQLTDDLNEDVIPTVNMDSLYKSSKVVNGREQK
KIEEFLENKNIKTKAFRQEQ
>PK3-045_03715 3-phenylpropionate-dihydrodiol/cinnamic acid-dihydrodiol dehydrogenase
MVQNLWNNEKASQLNKGLEELVYRSNLIGTDRAVCNWGGGNTSMKTIEKDFRGRDIEVMW
VKGSGSDLATMKAHNFTGLKLEDIKPLMERKEMSDEEMVAYLSHCMIDRSHPRASIETLL
HAFLPYKHVDHTHPDAIISICCADNGKQIAEEIYGNRFVWVPYIRPGFTLSKMIAEGVKN
NPNAELVLMEKHGLVVWGETAEESYNKTISIINEAEKYIHNKIDEEQVFGGEQYPALNEE
EAEEILSQVMPVIRGAVSGEKQMLLTYDRGADVLQFVNSKDAKTLSQIGAACPDHLVHTK
RQPLYIEWNPTTKDIASLKEKIKSGVEEFKKEYTSYFDRNKETGDQISETAPRVILIPGI
GMVNTGKTLAMAAVSGALYHRAISVMKGTTTLGNFVSLNENESFKIEYWPLELYKLSLAP
KEAEFSRKVAFVTGGAGGIGSETCRLFAEQGAHVVIADLNIEGAEKVAAEINEKYGSMRA
LAVKMDVTKEDAVKEAYKKTALTFGGVDIIVNNAGLATSSPFDETSLQEWNLNLNVLGTG
YFLVAREAFKQMKEQGLGGSMVFIGSKNSVYAGKNVTAYSSVKAMEAHLARCIAAEGGEF
GIRVNTVLPDAVLQGSAIWGSKWREERAANYGIEPDQLEEHYKKRTTLLVNIFPKDIAEA
ICYFSSSKAEKTTGCMLTVDGGVPAAFTR
>PK3-045_03716 hypothetical protein
MKAQKTKTFGKRSVHEGNESQKEEGQREKWRSSKE
>PK3-045_03717 hypothetical protein
MKRKNRPIIIFSVIVVIIIICIAAIWTLKSKDNDAIEDIQKINASATFNQQEEEYIVYFW
QATCTYCKQIEKDVLSFSNNGDTPIYVVDMHDEKNESSWYDWEEHHKKYDQVIGKIEDGK
EVWNEGINIENFQNDKNTAWGIVANEENQIIATHNTAFGNEVPENAEEIEITGTPTMIKI
KDGKFAAYAVGVEETVEMLGK
>PK3-045_03718 Peptidase T
MKENIINRFVSYAVVDTQSNENNLECPSTPGQLTLANLLVEELKEIGMEEVTIDENGYLM
ATLPANTEKKVPTIGFLAHLDTATDFTGKNVRPQKVENYDGEDITLNEDLHIVLSPKDFP
ELKNYVGHTLLTTDGTTLLGADNKAGIAEIVTALIYLKENPAIKHGKIRVAFTPDEEIGR
GPHKFNVKAFNADFAYTVDGGPLGELQYESFNAAGAKITVKGTNVHPGTAKGKMVNSMKI
AMELQNRLPANEAPEYTEGYEGFYHLLSFEGDVEETKLAYIIRDFDRTSFEERKRILQTI
VAELNEKYGAETVKLELNDQYYNMREKIEPVKEIVDVAYQAMVNLGITPIVQPIRGGTDG
SQLSYMGLPTPNIFTGGENFHGKYEFISVDNMVKATNVIVEIVRLFEERG
>PK3-045_03719 hypothetical protein
MDTMSKMQEEVTQNTELHHYILETFGLQSKKKRVRKKLLKQVISQEKVLKKLVSEFKNTD
QEQPVVSRKEEVSTVSFEKLPVTTLLKIGKEFFKEEESVRFYYNKNKEPFYKNKEMLITC
ISTNYAAAPADIQKEIITKL
>PK3-045_03720 Ribulose-phosphate 3-epimerase
MIKIAPSILSADFAKLGDEVKDVERGGADYIHVDVMDGHFVPNITIGPLIVEAIRPVTTL
PLDVHLMIENPDAYIPAFAKAGADIITVHVEASRHLHRTIQLIKEQGVKAGVVLNPSTPV
EMIKHIIEDIDMVLLMTVNPGFGGQAFIPNVLPKIKEVRQLADLLNPTLDIEVDGGINTD
TAVLVKEAGANVLVAGSFIYNNPNREEAIKAIRG
>PK3-045_03721 hypothetical protein
MNIISVFDHSLKVELVLHELEKHHIRKEDIFVSSLNKKGVEKKYMDPFNADGFNMFFVAS
VSMIMMLLGTIYGFVLYLGPILWGLIGLIAGICITIPVDYLYKRWRNKEEIKPSKAELII
VIHCEETQVALIESLLYQHHTIGLVKI
>PK3-045_03722 hypothetical protein
MQQFNEQAYRHKNMNMSIIGTNYLSVSNPLMPLWWALAMPGTGHIMVGKLLIGVLLFIWE
FLINTQAHLNLAILYSCIGEFQLAAESLDIRWFFFYVGIYIFNAWDAYRITTDINQFSKL
AKEERYPLMPFVIHPLGINYLQRVNKWVPVFWSIITPGLGHLILRNFLTGSFLLASHLII
IYHSKALEGIYFTCRGLYGLATSIINIEWLLFLPSIYLFAACDTYYHAIEMNQLFRLEQS
HYLEQKYSFYLKRNFKIKDNNP
>PK3-045_03723 Di-/tripeptide transporter
MSDLNKQKIVDSVPQKGFFGHPKGLFTLFFTEFWERFSYYGMRAILVYYMYYEVSKGGLG
ISEGTAIAIVSIYGSLVYMSGIIGGWLADRIFGTSKAVFYGGIFIMLGHIVLAVPGSITM
FFISMILIVIGTGLLKPNVSSIVGEMYSPEDARRDAGFSIFYMGINLGGFLSPIIVGEIG
MNYSFHLGFGLAAIGMLCGLIVFMMTKKKNLGLAGTFVPNPLSKKEKKKVYSSIGISIVV
IAIILAILIPLKILTFESFVTIVGILGFLIPAIYFIVMYRSPKTTRDERSRLIAYIPLFL
AAVMFWAIQEQGSTILAAYADKRTQLEFGGFSLSPTIFQSINPLFIIIFAPVFAWIWVKL
GNRQPSVSKKFSIALLFAGLSFIIMMLPAYLSGVNTLVSPLWLVLSYFLVVVGELCISPV
GLSATTKLAPAAFSAQTMSLWFLSSAAAQALNAQIAPLFTKISEVAYFGILGGVAIFLSI
ILFLLSPMIQNKMKGIK
>PK3-045_03724 ECF RNA polymerase sigma factor SigX
MGSIEELYERYSQELIHFLIYLGVKKEEAEDLVQEVFIRLLKTKCLFKGESSERTWLYTI
AKNIAIDHFRKQKNSYTFDCEIPIHIKDEQALPDEVAMKKEQLDWIKHLLYCCTEDQKKV
IYCRYLKELSIGETALNLGWSESKVKTTQHRALKLLKKNLVGI
>PK3-045_03725 5-oxoprolinase subunit A
MSIDINCDLGESYGAYRIGNDETIIPYVTSVNIACGFHAGDPTIMRKTVNLALENKVAIG
AHPGFNDVLGFGRREINISPNEVYDIVIYQIGALEAFVKAEGGTLQHIKPHGALYNMAVK
DGRLADAIAKAIYKINPAYILFGLANSELIRAGKRYGLETANEVFADRTYQSDGSLTPRT
HKQALIDCPKQAAKQIIDMVKNKKVTSVQGEEIPIQADTICIHGDSTHGISIVKEVTSTL
LQSTITIRNFMEKT
>PK3-045_03726 HTH-type transcriptional repressor NagR
MIIKDSHIPIYYQLEMEIKEIIKELKPGDPISSEREFSEKYGISRMTVRQAINNLVAEGV
LVRQRGKGTFVAAQKVEQELSGLTSFSEDMHSRGLTPKTKILDFKIIPCPRGIASKLKIE
EGDQVYEVSRLRIADDIPMALETSYLPTLLIKELQEETLHGSIYEYVEQTLHQKISHATQ
TIESTLSHKNESASLGIKEGAPVLLMERFSYLANGTPFEYVKSIYRGDRYKFIIDMKRS
>PK3-045_03727 Glucosamine-6-phosphate deaminase 1
MKLIEVQNYDEMSKVAAKKIIEQIQTKPNSVIGLATGGTPVGTYQYLIKDFTENQTSYEK
VITVNLDEYVGLEEDNPQSYSYYMKEHLFNHINIPENQTHLPFAKNIDDKEAGKNYEKLI
DSFGGMDMQVLGIGENGHIGFNEPGTSFSSTTDVVQLADSTREANARYFTSMDEVPTHAI
SMGISTIMKSRKILLLVSGVKKASVLNQLFHSDIKEDLPASILKKHPDVTIIADQEALSI
LKENKGSVYS
>PK3-045_03728 N-acetylglucosamine-6-phosphate deacetylase
MITDEAKELILKNVCIYTETEVNPNGYVVVKEGKINSIGLMDSFLEKEWENAHILDFPKG
MNLIPGFIDIHIHGANNADAMDASQQALEIMAETLPKEGTTSFLATTMTQEVESIENALT
TIAQYVETADQSGKAEIIGIHLEGPFISEKRVGAQPVQSVKKPNVELFKKWQTLSNNQIK
LVTMAPEEDENFELVRYLKAENIVSSIGHSDAVYEQVLSSIQAGVNHVTHLFNGMRGLHH
RDPGVAGAALLHSELMAEMIVDGVHIHPEIVKLAFLQKGAEHIILITDSMRAKWLADGIS
SLGGQKVIVRDGKALLENGALAGSTLKMNDAINNMMKFTGCSLQDVVKMASYNPAKQIGV
LDKKGSIAKGKDADLVVLDENNQVALTICKGKIVYSNGGFSA
>PK3-045_03729 Catabolite control protein A
MTTISDIAKLAGVAKSTVSRYLNEGSVSEATKRKIQHIIKETGYTPNAFAQSLKAKKTNI
IGTIVPQLDSYAFSRTLIGIDEELKARNYQMLISHSNLDLEREIENIHSLVRQKVAGIIL
LATEVTNRHLMIIKQLGIPVLIVGQQHEEIPSLIHNDYEAAYELGKYILSQGHKRIAFLG
LQEKNVAIGIDRKEGFKKSIEETANIDVQFFEVKMDQETQSFSIVSEIIDRFHPSIIVCA
TDNIAMGTMKAIYSKGISIPCDLSITGFGGYEMTEMIYPGLTTAKFFYKDAGNLAARKML
SLINGDDTPMKTVSGYEIIYRESVRQM
>PK3-045_03730 hypothetical protein
MKNISSLRKNNKYKYELLQSANYLEQPIISVITPVFNNEKTIQKTIESVLQQSIMPQIEY
ILIDDGSKDQTRSILKKFVNEHPNIKLALLAKNTGTPGYPRNLGIELSSAPYLTFLDADD
WFEKTGLEKLYSVLNETDDDYIVGKTIKVTSKKNAIVGEHESWKERRSIPPASIPHIFHH
LGPRARLMKSSIIKQNQIQFPEMKYGEDKQFFMEVLTNCKKISTTEAVIYYLNRLDDNDE
SLTKQTNVLNKMHCNRKVINYFKEKEMDSELKRMVLNRLYEFDCFNRFINRYHTLRTENN
QTFKGKLDEFLKRKAYISTMKKMLRTTSSLDYEISDHFYHPYNKVCYQLFSQKRYKDIET
LFRWMNQEKIKKHVVKDDTAYWVSPLSSPYNFIRVPMYAELINCEYTNGFFRFDIRIAGD
HPKEIEHLLFRDRNNIHNQFMFSIEPYEGALKRIMVPEAFFTALGKSVYTIYLSYRDYHK
VQLHIPNPKLRLKKQQTDKQHFYKTIHNHLALKVL
>PK3-045_03731 Galactose-1-phosphate uridylyltransferase
MTTTIYQHVEQLLHYGIESNLITKWDIDVVRNKLLEILELDDFVPSEISAPVKIELRELL
DTILDWAAEHNLLVENTITYRDLLDTKLMACFVPLPSEINNRFAMLYKDKGAKSATSWFY
DFSKKVDYIRTDRIAKNEEWLAHTSYGDLEITINLSKPEKNPQEIAALKKVKQGFYPKCL
LCKENAGYAGRVNHPARQNHRIIPVTLEEEQWFLQFSPYVYYNEHAICFSERHEPMTISK
RTFTRLLEFVHQYPHYFMGANADLPIVGGSILAHEHFQGGYHEFPMAKAEIEAGFTLEQF
PAIHAGIVKWPMSVLRLNGTDKQQLVEASDYILKKWLDYSDESVDILAYTNGVRHNTITP
IARMRNGQYEMDLVLRNNRTSEEYPFGIFHPHEEVHAIKQENIGLIEVMGLAVLPGRLKV
EMSLLAENIVKADFEERIRLEPAIVKHLAWAKKVKENNPQMTKENVSTILQTEIGIVFET
ILHHAGVFKRDDDGTKAFYRFIETL
>PK3-045_03732 UDP-glucose 4-epimerase
MAILVCGGAGYIGSHMVSELLDLGEEVIVVDNLQTGHKAAVRAEATLYIGDLRNESFLEE
VFKNHTIEAVVHFAADSLVGESVTNPLKYYDNNVNGAMTLLKVMHANDVKRIVFSSTAAT
YGEAKNFPIQESDDTIPTNPYGETKLAIEKMLKWCEAAYGIHYVALRYFNVAGAHIDGRL
GEDHFPETHLIPIILQVALGKREVISIFGDDYETHDGSCIRDYIHVTDLANAHILALKKL
QKEETSGIYNLGSGTGFTVKEVIETARKVTGHPIPAEIAPRRAGDPARLVASSEKAQVEL
GWNPQYTSLETMIGSAWNWFQANPNGYKE
>PK3-045_03733 Galactokinase
MAKNLFATFTNIFNETETSIRTFFAPGRVNLIGEHTDYNGGHVFPCALSIGTTALVRKRS
DRVIQFYSTNFADLGIINVSLDDLSFNQADDWANYPKGVIVTLAQYGYQLDAGFDVLYEG
EIPNGAGLSSSASIEVVTAIMLNELYSFAIDQVSLVKMCQKAENEYIGVSCGIMDQFAIG
MGKEKHAILLDCDTLDYVYSPLDLDAASLIIANTNKRRGLADSKYNERRGECERALRDLQ
GELEIRSLGELTPEEFDSHAHLIKQDVDRMRAKHAVYENARTIEAVKKLQAGDIAGFGQL
MNASHISLRDDYEVTGKELDALVEAAWEQAGVIGSRMTGAGFGGCTISIVNNEHIDSFIE
TVGAKYEEQTGLKADFYVVQVGDGAKEIVE
>PK3-045_03734 HTH-type transcriptional activator RhaR
MSKKDNNVFAYRFTEKITKEVAQIWSIGWENQTSHLYNWKGKKRKEDSMYVFQYTISGIG
AIELGGKNHKLTAGKAFLIDISEEYRYYLPPTSEHWEFIFITLYGETVKKCWRSFTENEQ
PIIQLASDSRPIQHLLHIYQLAKDKQINNAFYASSLAYSFIMELYQYKKNIGDIQLPESI
LNATLFAQNHYHKPIGPDDMAEAAALSRFHFTRLFKKVLGITPIQYLTNIRIIKGAELLY
QTKYSIEDISVQVGFANANYFTKVFRKSTGITPGEFRKKNIRPSEDILL
>PK3-045_03735 hypothetical protein
MNNEIETTYEAIYNQILHFQLQLEALSIQAGSWQEEDQEQLIRMSIALQASKDILENMLT
PGKKLNFIYEKGMFSLEMFDEK
>PK3-045_03736 Xylulose kinase
MQLSSLYLGVDIGTTSTKSVLFAEAGKVLSMHHVEYPLHSPAPAIAEQDPEQIFQAVMET
MKTAIKKANVDTSKIKLVSFSSAMHSVIALDEKGKPITRCITWADSRSSSWAKKIKEEYN
GLEIYRRTGTPIHPMTPLSKLTWLRNDQPDIFTKAAKFIGIKEYIFYRLFNEFVIDYSIA
SATGLFNLEHLNWDQEALKVAGVTSEQLAKPVPTTHYLTGLKDNYAAELGIPAETPFVVG
ASDGVLSNLGVNAIDPGVVAVTIGTSGAIRTVTDKPVTDPKGRIFCYCLTEDHWVVGGPV
NNGGMTFRWVRDELASSEVETAKRLGIDPYEVLTKIASRVTPGADGLLFHPYLAGERAPL
WNANARGSFFGLGLHHKKEHMVRAVLEGVILNLYTVMLALQEVIGAPKQIQATGGFARSE
LWRQMMADIFDQEVVVPESFESSCLGAIVLGMYALGEIDDFSIMKQLVGSTHSHQPIQEN
VDIYQDLTAIYIRISRALEKEYDAIASFQNKWVK
>PK3-045_03737 hypothetical protein
MRTCQNCDQKWTWKQTLKSSFTLDNKLICPHCREKQYVTSRTRGITFMATILIITFTLLS
NLLFGPSFVFVVILISFILIFLGLYPFWVELSNKETGS
>PK3-045_03738 6-phosphogluconate dehydrogenase, NAD(+)-dependent, decarboxylating
MNIGLIGLGKMGFNLALNMVDHKYSVTAFDINESAVKEISNKNVTGVNTIEKLVRNLPAP
RVIWLMVPAGEVTENVLREVKKYVEAGDIIIDGGNSHYKDSKRRGLDLQELGIFYLDVGT
SGGVDGARHGACMMIGGNKGIFDKVEGLFKDLCVENGYTYTGVSGSGHFLKMVHNGIEYG
MMQSIAEGFELLEKSEYDFDNEGVAKVWNNGSVIRSWLMELAQNAFSKDSKLEGIKGVMH
SSGEGKWTLETALDLQTAMPVTALSLMMRYRSLEEDTFSGKVVASLRNEFGGHSVESK
>PK3-045_03739 putative HTH-type transcriptional regulator YbbH
MAQNCLGKIRSYYARLSEKEKKIADYILENPEKIIHSTINELAEDLGVADATVFRFCKRI
GFKGYQAMKIALASEVIEPIQQIHEEINENDSVKTVTEKVFKSNVRTLENTLEILNGHSI
QKAVEFLLQANRVEFYGTGGSAVIAMDAFHKFVRTGIKAFSFVDSHFQLMSSSQLSEKDV
AVIISHSGTNKDTINIMKTAKNNGAKTIGITGYPKSPIGQNTDVALFTSSEETEYRSEAL
SSRIGQLSLIDALYVNVMILNKNVANQSLERIRNAISDTRI
>PK3-045_03740 hypothetical protein
MKQVYSDFIQFRGSHYDFGYMQGELLKDSPILPNRIKHWTSKRKRYFTINEKKSIQLLNK
FIPGMLAEITGLADALQWRIEDALREFGGHYVEYGRSGCSILAGSQYLIRNYDSHPGSYE
GRYMIYQPTDTGYAVIGPSMQITGRIDGINEKGLAMGYNFINRVGSGDGFICNMIGRMIL
ETCANVEEAIDLLKEIPHRTSFSYVLLDPSGEAYVVEATPRSVIARKSNISTNHFEILKE
ENRYQMDESIQRKQNIEKQQGNHSNVYEAFRILNDRDKEIFSNKYNAWSGTLHTAAYLPN
ERKAWFALGSDRMPVIIDLESFLKGEKLNFKKIIGQLDYDTPFINMELL
>PK3-045_03741 hypothetical protein
MTKSMRGLALRFFKTNKFITWTSVFSTLLSVCLVIVMVSYATNAERSLREEVQKMYGEMD
LSVGYEAKLNKSVNQELINSFRSNKDIDMLSPVIITHLKVDTLQGEIYSVGVKNDNLAKS
RYHFKQNLQENSVIMNKSLAEVLRLEIGQKVSIEDNEFIVTEIIEDLNASGLTPDILLFT
KETVQKLVKQETGETKEATYVLIKANEQADTLLLASELRKYDNGLRIDIAEEDEFLKSNV
QSLKVFIFSLTFLLLIITALLIISNFELFLYKYKNQFAILRSMGATTKQLSKIILIQSSI
ITAAGTIGGFLLALISHQYMKPWLEAIFLFDVPKVSFNYIESLIVALVSGMIIQVFMLIP
AYKCSRLLPILIMQQNENRDFSYKKIRKIIGFALLFIALLLICIGKAMMGVASVLLGAII
LLISIYLLFPIYIGTILTWFLPVIKKTLGNVSYIAIKNLVPQVRKNTFVVLTVSAMMTIA
VFGSVMLKTIQQNEENYLKEQYPTSIVLTSRLGYDSNIEHEDLKKKVQTISGVIEVSSRS
TNNSAEIIDEEGTKAIDYSLVDLNKMEQQGIIPKMEDDIENLIIVSERFLKENGLKVGDS
IDMGLFSNQKQSTDFVDTLTIGAVINNLTDADAYIDWKNKKFKNDFTKFSAMYISSDNEK
QTVQALETLKREYPELQINVYQQSVEKANKMFLQRWSIFIGVMVVILICVMLGVFSTLGN
NIYSKRKEFAILRTISIDRQGIKKVILTQINLYLVIGLLLGIVAGLIFTTVILLIDSGQI
SIYYSLIIGIGVTVFLVGNSIFIPIATKLSRKKISLELTEDNK
>PK3-045_03742 ABC transporter ATP-binding protein YxdL
MVTNPVLVVSNLSKVYKGAGYEVQALKNVSFKLYEGEMIVIMGTSGSGKSTLLNVLAALD
VPDQGEIQLYGQSQKAIYKEPIATYYRRDNIGFIFQSFHLLKDLTVEENIALPLVLKGEK
KSHIDEKVKEMLQFIGLTNWKSHRPVQLSGGQQQRVAIGRALITAPPIVLADELTGNLDY
NTSKEILQVLVNMKETLKQSIVVVTHDPHVAVHADRVLFFHDGQIVNEYKSAGDQKIDDI
LEKFGKLLETRG
>PK3-045_03743 High-affinity gluconate transporter
MDAYLLIIALLSIVIVIVGVSLFKWHAFISLTVASLFLAVFSGLSFDKIVSAYETGVGGV
LGHLVGILALGTILGKMLSESGAGLRIANYFVNVFGEKKLPWAMFFSGVIIGIPVFFEVG
ILILLPLVISIQKATKKNILLIALPGIAGLSIVHGLVPPHPGAIAAIGIFDANLGTVLLY
SLIIAVPAGILGGPLFAKWINSRVFPKGESTLITAEPIAEDKLPSIGVSFLSILLPVILM
IIGTAAPYLTIFSQGVRNVLIFLGSPLLSLLIAVFFAFYFLGMRQGMDKESIKKFTEDCF
LPVGSILLIIGAGGAFKQVLIASGVGDTIGSMSESLSLSPLVLAFMIAGLIRIATGSATV
ALTTAAGIVSPIIAGMSGVNVELLVIATGAGSLMFSHVNDAGFWMVKEYLGLTVEETFKT
WTVLETILSFIAFAGVLILDLIV
>PK3-045_03744 Peptidoglycan-N-acetylmuramic acid deacetylase PdaC
MKRLKWRNIFILFICLTLLVFIFKFFDSEKKQAAEPSEKQPEVKIQYDQNYKTIEINSYT
KDEKHGGYWTSYPILPDEEITAALKKYITNKITEYDKHIQKANVPDTQETSLHISYTITH
YSKQTISILFETFEYTAGPKGNLTTESLTFDLQTHKQLSLKDIFQEKSNYLSLLSKISYG
ELIKDKDLATDKALVKQGTAPHEGNFQNFAVLNDSILFYFPPNQIAAEKLGVQELAIKKE
ILQDKLLAIYQEEEKNKNLLAEAKPKKLVTELPEVAKIDPSKKVIALTFDDGPSNKPTKK
ILKALKKYNGHATFFVLGERVQYYPNVLRQAIENGHEIGNHSWNHPLLTKMNNKKALKEF
QDTDNLIKKVTGVEPTLIRPPYGAIQLELKKELDKEIVLWNIDPEDWKHPSKKKIVDKVM
KAASDESIILMHDIYEKSADAAVEIIEKLTKEGYQLVTISQLRAVQEERNSN
>PK3-045_03745 hypothetical protein
MQPTIITGLDGVIYQNFPQPTYGAWNQQLLGKDNSYYYLIGGQMYYIAPRPQGTQAYYPY
LGPNVPLNRGPWY
>PK3-045_03747 FMN reductase (NADPH)
MTTVTIIAGGHKIDSRLTGILQFAVDYLGKKNVAVHIIQVHQLPSAALITADFMNKDIIA
ARQKVEQSNGVIVLSPVFQASYSGIIKTFLDLLPQKSLRNKAILPLMLGGSIAHLLVMDY
ALKPVLANLGATNLLTGAYVTDNQIAKKDNQNYVLDIDSETRITNQLEQLLEGIQ
>PK3-045_03748 hypothetical protein
MFMSFFRENKVAAGLLTIIRLVLGYSWFTSGFGKLTGGGFDASGFLTNAVTNPVTGPDGT
AVYGWYTSFVEGFALPNVGLFNVLVPIGEVLVGLGLILGCLTTAAAFFGVIMNFCFLLAG
TISHNPTDILMGMIIMFAGANAGYFGLDRWVLPYIRKTFFKKEDHNAEFTKKPRLT
>PK3-045_03749 Choline trimethylamine-lyase activating enzyme
MRVLSIVEDSIVDGPGLRTTIFFAGCTHYCRGCHNPESWKINGGTEMSIDEIMRKVKQNP
LNDITFSGGEPMLQITELKQLAKECKQLNKNIWCYTGYLWEELRATQSDEFAELSMYVDV
LVDGRFVLEQKDLSLLFKGSSNQRIIDCQKSLKEDKVCLFNECKREERDREISILN
>PK3-045_03750 Anaerobic ribonucleoside-triphosphate reductase
MSNEVQLLNQFAEIMNSNNQDFIQENANVDGMSPMSHMMQFAATASKYYTMEHLLSEKVK
QSHQEGYIHIHDLDFYSSGTTTCCQIPLAKILKDGFNTGHGYMREPKSIMSAMALTSIIL
QANQNQQHGGQSIPMLDYDLAPYIQKTYRKNKKRLKEVIQEKAELEKKAWEWTERETYQA
CEAFIHNCNSMHSRGGGQTPFVSVNLGTDQSVEGRMLTKNLLLATQAGLGAGETPIFPII
VFKVKDGINYQKNDPNYDLFRLAIETTSKRLFPNFVFIDAPFNLAYYNGTPQSEVATMGC
RTRVMGNIHGSEQTIGRGNLSFTSINLPLLALESTTIESFFHKLDETIDLVVDQLLERFH
YQGKKKVANFKFLYGQGVWQGGEELNVDDQLEELLKQGTLSIGFVGLAECLVSLLGVHHG
QSEKAYEIGLQIVQFMRQKADEALEKYQLNFSLLATPAESFAGKALRAARKKFGIIKGVT
DREYFTNSFHIPVYFPISIHEKIQREAPFHALTNAGHITYVELDGDASKNVEAIEIIVRT
MKEAGIGYGSINHPVDRCMTCGHKGIIDNECPNCGEKDENQIERIRRITGYLVGSLNRWN
NAKRAEERERVKHR
>PK3-045_03751 hypothetical protein
MTTKGTIKEETIFSKELGEEVTLLIYLPPAFSPLYKYHLLIAQDGKDYYQFGRIGRVADE
LHGNHQIADTIIVGIPYSSVQDRRRKYHPDGAQNKAYIRFLAHELVPYLDDQYPTFQMGM
GRGLIGDSLGATVSFMTALKYPHTFGKIMLQSPLVNEGVFDAVDKFDSFHLLEIDHIIGI
GETSVKTTINTTEDFLTPNRELSQVLQTTNADYSYEEFNGDHTWKYWQPYIAKMLIKMFP
S
>PK3-045_03752 Putative phosphoesterase YjcG
MKYGIAIFPGKDLQDLANSLRKRYDPKYALIPPHITLIGDFEASNEEIEEVSKKLATIAS
HYHSIPIKVTKVSSFKPVSNVVYLKIEPSTDLEHLHQELISTLGVSLEHPFVPHITLGQD
LSSDEHLDLYSNLRMQNYHFEETADRFHLLYELENGSWTVYETFRLGKE
>PK3-045_03753 putative N-acetyltransferase YjcF
MEVVIVKTDKELKDAFYVRQTVFVQEQKVPMEEEIDAYEEDSVHFVLYDDDNKPIGAGRY
RTFDEYGKVERICILSTNRKGGAGKAVMNKIEEYASNNGAPALKLNAQTQAIPFYSKLGY
EVISEEFLDAGIPHKTMIKHL
>PK3-045_03754 hypothetical protein
MEFTHIFSELIIGYFLLLLLTKVLGKTQITQITTFDFVSVLVLGELVGNAMYDTETGIKE
IMYSILIWGGLIYITEFITQKFRKTRQLLEGKPSIIINKGKIDFKELKKNHLDINQLQHL
LRAKDVFSIAECAYAILETDGTISVLKKSAFVNPTKKDMNLSLEATSLPISVILDGEIIK
ENLPRIGWNEEQLMQELKKRDVQSPKDILYAEWQEGSPLYVQSY
>PK3-045_03755 hypothetical protein
MGYILPITHYQAEQYAVRDIISKTKNYKKEEIYPAAKIVNSSTYLQIKYPSQTSYQKKQR
HEEVVPNEKLIAQLTGKGTYFHAQI
>PK3-045_03756 Putative ATP-dependent DNA helicase YjcD
MLTAFYYDRLISLNTIDRQELQKIYEAGKNGFLACSVCGEAVKLYLGLKSTPYFYHYSAK
QPCMTESSTIEQEQAAAADIDYEEKNGFRIPKSRNISKDNTEITPFRPPMSIKAITHTSD
VAASQTVTFPQESYLNTLKQNGYSLDITQSEAVAIDDGPILVLAGAGSGKTRVLTMRAAY
LIQEKKVDPSTIMLVTFTNKAANEMKERLLHYPMMNKGIVQKIVSGTFHSILYQILIFHE
REKWQRNKLLSSNWQRELLLKEIAREKQLDEKDFPFDAALQLIGAWKNSMLFPHEIEPDN
DWEKKVAQLYSGYETKKQQRNLYDFDDMLLGGYHFFLENPAILETYQKRFTHFLLDEFQD
INKVQYEWMKLMARSAHSVYAVGDDDQSIYSFRGSDPKYLLDFEKDYPNAKTIILDYNYR
SSQEIVSIAKSTISKNTKRRAKKMITGYSGQTPIAFYPYDEEEEATMILTDIQEKIKTGY
EPKDFAILFRTNTNSRAMFERLASSSLPFRLEQDTGSFYQRFIVKSMMAYLKLIHDPDNQ
QAVADILPTLFLKKTVLQDIKAISILEDCSFLDCLVFIKTGFAFQESRLKKIPEIVKRLI
RYSPLDAINYIEKELGFQEFIKKRGNEGNQWDKGSDDIRDLKVVARKFQSIKEFVQYTDH
MTAMNEELRKQYKNEENVITLSTIHRAKGLEYKTVYIVGTVDGSIPHDFALESFRNNNFM
PIEEERRLLYVAMTRAQQELYLSVPMYLRGKKAKTSRFLSPLSMVAIKAAEKERS
>PK3-045_03757 hypothetical protein
MNNNFFKNIESKTGVNMKDILELANSLQNANFKDEKTVRSVIRRVSQIAGKSVPKQTEDK
IVESIVKDGKQLDFNTLSKMINKK
>PK3-045_03758 hypothetical protein
MCYGGYGYGGGGYSGGGYGISSFALIVVLFILLVIVGASFYN
>PK3-045_03759 hypothetical protein
MLPMFFWAFVIGGIICVIGQLMFDVARLTPAHTLTTLVVVGAVLDGFGLYEPFADFAGAG
ATIPITSFGNALVHGAMQEAEKHGIIGVLTGMFEVTSSGISAAIVFGFIGALLFKPKG
>PK3-045_03760 Stage V sporulation protein AD
MLQGKQSWVFQNHPVIKSTGVSGGPFEANGRLAADFDVLHDDLWMGKTSYEQAHRILLEE
AAQTAMKKGELRLEDIQFFLAGDLINQITPSSFAARDLQIPYFGLFGACSTSMEGLALAS
FMVNYQGANNVLTGASSHNAAVEKQFRYPTEYGGQKPPTAQWTVTGAGVALVTKNQSEEQ
LPYTTSATIGKVVDMGLADPFNMGGAMAPAAADTIFAHFQDLHLDPSHYDLIVTGDLGKI
GRETAIGLLREKGLTIDENKMKDCGLLIYTNEQPVQSGGSGAGCSATVMYGHLLNEMKKG
MYKRILCVATGALLSPLTVQQGETIPCIAHAVSIEI
>PK3-045_03761 hypothetical protein
MADSKKKNKTPEQQQYEKFEQKFETKRPVLKNCIKAFFVGGFICMIGQFISYFYIYFFHF
TEQTSGNPTSATIIFLSMLLTGFGVYDRLGQFAGAGSAVPVSGFGNSIISAAIEHRTEGF
VLGVGGNIFKLAGSVILFGVFSAFVVALIKTLFIMMTGGF
>PK3-045_03762 hypothetical protein
MTNRRRASYLLIFSICVFLAGCAKETPNSRWSMLKRINPAPIALYTETDENQEKIVEGIK
EETNTISSIYDVAVIKGKKDTLVAYKVKQMARFKMKSIEKELTKKLEAKYPDERFTVSSD
FKIFLETIRLWDKIQEPDYSKEKADKRLKEIIQLNNELT
>PK3-045_03763 hypothetical protein
MDIHWMEFFLLILASFRVTRLIVFDQITEFFRKIFLEEVEEQNKDGQTEIYIVPKSGKIR
GFIGELISCYWCSGVWVAVFLTILYYFFPAICEPVVLIFAIAGGASLLEAILQRVFVE
>PK3-045_03764 Spore coat protein Y
MGCGKKEDIHGTSSCVCEVVRAIKDIQDNAEDNCECETNCFSEPLGSLVSPSKRKKADTR
VFVLSSADGSPFHAFFTGHDCNCVSIFFRVEDVFDNCCAVLRVLAPIGKDGETLDIVGHK
GIDLSKICELEGFQRTSSCITVDLSCFCAVQCIADVDLNVCD
>PK3-045_03765 hypothetical protein
MYSENNKPYLSQSGTKTMQGNMQVSYSAKISKQKQYKELMEKKQKEEALQEIKAKKDAAK
EGAEKLDTTNVQEQIQSYQEQQVEKTPRKPAFKRLKSFKEMGIVEKLEYLLHFPKQLPPV
PCLVVTEQETVRGFVVDLNADKVDIKLMDQTIVTLNIATIDEIKMIGI
>PK3-045_03766 Enoyl-[acyl-carrier-protein] reductase [NADH] FabI
MTFSLKGKTYVVMGVANKRSIAWGIATSLHKAGARLIFTYAGERLEKSVRDLVATLDSTD
SIVLPCDVTNDQEIATCFEAIKKEVGTIHGIAHCIAFAHKEELQGDYMNTTRDGFLLAHN
ISSYSLTAVAKEAKGLMTEGGSIVTLTYLGGERAIRNYNVMGVAKASLDASVRYLAADLG
KEGIRVNSISAGPIRTLSAKGISDFNSILKEIEERSPLRRTTTPEEVGDTALFLFSDLAR
GITGENIHVDSGFHIVG
>PK3-045_03767 Glutathione-regulated potassium-efflux system protein KefB
MAHGASFASLVIVVTVALLTPIILQRLKLNVIPVVVAEILMGLIIGKSGFNLVEQDMWLE
TLSTLGFIFLMFLSGLEIDFSAFSSKKKRETLPNGELEPKSFKTAIIIFVAILVLSIGLS
FLFVLAGFVDSTFLMTIIIATISLGVVVPTLKEANIMKSVIGQIILLVAVIADLVTMILL
AVFASIHESGGNTWLLLILFGAGLILYFVGRRIKNKKFMDTLSRGTVQIGTRAVFALIIF
LVALSESVGAEHILGAFLAGVLVSLLSPNEELVHQLDSFGYGFLIPIFFVMIGVEMDIWS
LFTDLKLLLFIPLLLVALLVSKLLPVYYLKKWYDTKTIVASGFLLTSTLSLVIAAATIGE
RLNIITTQMSGTFILVAIISCIITPVVFKKLFPKDAAREKVINVSIIGVNQVTMQVYQEL
KSTLYDVTFYHKKQEKHDFQIADSLFEIIELENYSEDILQQTDIYGADIVVVSTGDSYLN
AEMSLMIKRAGVDRVICRVENMEKEEELRREDIEVFSMLTSTKALLTALIQSPNIFALLG
NTETALHEITLRNKEFEGMSLRSFPFTGDVIFVRIFRGSDFVIPHGDTELQLNDHLLVTG
SHSYVTELKRQLEFNYK
>PK3-045_03768 Magnesium transporter MgtE
MAEKILTNEAQHAVILHSLQNENLQEFRKNFLDLHPYDQASFFKEMEIEERAQVFEYLAP
NEIAEMFENLQMDNWEYQTLFAKLLPDYVAETLANMSVDDAVDILNVLDKEQVESYLAIM
DQPTAARVKALMHYEESTAGSIMTVDYISLSAEQTVETAMEILKREAPNAETIYYVYVVN
EQKQLVGVVSLRSLIVSDNQMLIKEIMNDRIYSVSVSEDQEEVARKMQDYDFLALPVVDF
QKRLLGIITIDDIVDVMQEEASEDYSKFAAVSNMDFVDQHPFSAAKKRLPWLIILLFLGM
FTASLIGRFEKTLDQVAILAVFIPLIAGMAGNTGTQALAVAVRGIATGNIGKESSWKLIG
REAGTGLITGTICGLLVMMVVYIWKSDFFLGMLVGISILGTLIVATIAGAIIPLIMHKFK
IDPAVASGPFITTINDIISILIYFGMATMFMSYLTN
>PK3-045_03769 Bis(5'-nucleosyl)-tetraphosphatase PrpE [asymmetrical]
MKVDIIGDIHGCYEEFTLLTEKLGYTWDQGYPLHPAGRKLAFVGDLTDRGPASLAVIETV
YLLVKKGLAYYVPGNHCDKLYRFFLGRKVKIAHGLETTVCEWEQLNKKEQQRIKRMFKEL
YENAPLYHILDNQKIVIAHAGIREDYIGKYHNKVKTFVLYGDITGEVHEDGSPVRRDWAK
KYKGKPIVVYGHTPVRNVREMNRTYNIDTGAVFGGKLTALQYPELTVESVPSSMPLVEEK
FRTFDTETAKNL
>PK3-045_03770 Ribosomal large subunit pseudouridine synthase D
MSFTLKWVMQQEKSMTIKEFLKTQHISKAALTDIKFKGGKILVNEKEENVRYTLKEGDQL
VVSFPPELPSRGLIPEQISLNIVFEDEYLLIVQKESGMNTIPSREHPSGSLANALVGYYQ
KQGIEATTHIVTRLDRDTSGLVLIAKHRHIHHLLSEQQKGGDVKRKYLAFAEGQISPFTA
TINEPIGRCSDSIIKREVRKDGQTAITHYRVLAQDKHLSLIELSLETGRTHQIRVHLAYQ
GHPLLGDDLYGGKRDWINRQALHCFFLKFTHPVTKQSITFTVDLPDDMKGLEQKIKKSEE
SI
>PK3-045_03771 NAD kinase 1
MKFAVTSKGDSKSENLVQIIKQYLLDFELVYDEEEPDIVISVGGDGTLLYAFHRYSNRLD
KTAFVGMHTGHLGFYADWTPAELEKLVIAIAKTPYNIIEYPILEVIVRYQNEEKETRYLA
LNESTVKSMEGTFVMDVEMSGKHFERFRGDGLCVSTPSGSTAYNKALGGAIVHPSIEAIQ
LAEMASINNRVFRTVGSPLILPKHHTCVLKPVNEPNFQISIDHLNLLHKKVHSIQYRVAE
EKVRFARFRPFPFWKRVHDSFISE
>PK3-045_03772 GTP pyrophosphokinase YjbM
MKQWDQFLAPYKQAVDELKVKLKGMRRQFDHEDDHSPIEFVTGRVKPIASILDKANEKGI
PLDKLETEMQDIAGLRMMCPFVDDIIRVVELLRQRNDFDIVEERDYILHRKESGYRSYHV
VIVYPVQTINGEKKLLVEIQIRTLAMNFWATIEHSLNYKYKGQFPEDIKMRLQGAAEAAF
RLDKEMSLIRGEIQEAQAFFNRKKENDKNK
>PK3-045_03773 hypothetical protein
MKQKWQIKETIKRENELVFQLQEDVNLENAKACGQILVDSDALAFIYLLEKENEYVYLEI
PESVWKDCKQALESNSSFFIKDEKGHLLLENFKEELEYLIENIRGNGNYGEDMEKGVSSV
FL
>PK3-045_03775 Putative triphosphatase YjbK
MSKNQNIEIEFKNMLTKEEYELLLTHFQVSEEDLFEQENHYFDTSNFALKANHSALRIRK
KEAEYELTLKQPHPDGLLETNKTLSKTESDDIFSTGRISDEQISSLLRNMNIDPTSIIYF
GSLRTIRAEKKIGNGLLVLDHSFYLKKEDYELEYEVSNREEGKIYFQELLATLKIPVRKT
KNKVRRFYEEKYNQK
>PK3-045_03776 Membrane-bound lytic murein transglycosylase F
MKIDQFKVMLELQALQGLNSQNTGSASTLFQDFLSNMLSSETKLTNAIENNTLGAASIPL
GLANTSPLMPLSLTKLSSSSASTTSDFDEMIKTAAEKYNLPEKLISSVIKVESNFNPNAT
SYAGASGLMQLMPSTATSLGVQNIFNPLDNIMGGSKYLKQMLDKYNGNVELALAAYNAGP
GNVDKYGGIPPFKETQNYVAKVTQHYTA
>PK3-045_03777 Group 2 truncated hemoglobin YjbI
MVEKMSTPYEKIGEATLNKLVDSFYNRVGQHPDLAPIFPKDLTETARKQKQFLTQFLGGP
PLYSNEHGHPMLRARHLPFPITEKLALAWLSCMDEAMEEVDLDKEIREEIFSRLVLTAKH
MVNSEEIETKKGDNT
>PK3-045_03778 hypothetical protein
MEKDISISKPKTADDNCQDRKPLEIYMFIDPLCPECWALEPIMKKLQIEYGRYFSLKHVL
SGRLSSLNCSKKSKHANIAEFWEKTASRSGMSCDGSLWFDNPIVSPHLPSIALKAAELQG
RKSGMKFLRKLQELLFLEKKNIATFEVLKSCAKSVGIDVIEFVSDIHSNSAAKAFQCDLK
ITREMEVNEIPTLVFFNENIEEEGIKVTGYYPYEVYVQIIEEMLQIQPEKAAPPPLENFL
ECFKLVASKELSVVYNKSIQEIEKEMKKLQLRQLVEQIPAKYGVFWKYIG
>PK3-045_03780 Oligoendopeptidase F, plasmid
MSAETGVKKLPLRNEVPVEDTWRLEDIFASDEEWDKEFEEVKKLSQKATEYQGKLSESAE
VLYEALQYQDELLSRLGKLYTYAHMRYDQDTTNSFYQGVDGRIKSLYAQAASALAYMVPE
LLSIDEKVISAYLEENNELKLYKKALEEINLQRPHVLNADQEALLAQASEVLDSSSNTFG
MLNNADLEFPSIKDENGEEVEVTHGRYSRFLESANQRVRRDAFMAVYDTYGKFRNTFAST
LSGEVKSHTFNAKIRNYNSPRHAALAANNIPEQVYENLVETINKNLPLLHRYVKLRKKVL
GLEKLHMYDLYTPLVKDVKMEIPYEEAKELVIKGLAPLGEEYASILKEGFENRWVDVHEN
KGKRSGAYSSGSYGTNPYILMNWQDNVNNLFTLAHEFGHSVHSYYTRKSQPYPYGNYSIF
VAEVASTCNESLLNDHLLKTITDKQKRLYLLNHFLEGFRGTVFRQTMFAEFEQLIHEKAS
NNEPLTADLLTKEYYALNQKYFGEEDIIIDEEIGLEWSRIPHFYYNFYVYQYATGYSAAT
ALSKQILEEGTPAVERYIEFLKAGSSDYPIEVLKKAGVDMTSKTPIEEACQVFEEKLNEM
ESLLNEI
>PK3-045_03781 Competence protein CoiA
MFTAITEAGEIINLFTRKEKDDLKGLRQTPLYCPECKGRVLLKMGEKKITHFAHERKACC
SSNGEAESTYHLQGKLQLYQKLVELNLHPLLEPYYPEIKQRADISFVFRNKQYVIEYQCA
MISPQLIKKRTEGYRKVNIHPIWIIGFCHLKKWNPIKLKLSAFVYQFFILYRKQYLLPSY
CPYDRAFYLIQNPIPISISQSFVTTFCFPLVKIEGKQPFIPRKKWHFAYWREIIHRQKTK
DVHYQTKTNYQFLKELYAHGLHPHFLPPFIGIPLKEGFLLETPPLYWQATIFLDSFKEET
KIYPLQKIYVNFHKRIERGQIKIRDCPFISEVDWRETVKQYILLLVELKVIEEIKPCFYQ
MLYKKKIRNYEIQEQEEVMFYKQLKNLINKQ
>PK3-045_03782 putative cardiolipin synthase YwiE
MNHTARLGLFFIVAVLFVYVFNLFFSIQGGIYGQLSLVISLSVVFIGLVIFFENRHPTQT
LTWLIVLGSFPIIGFVFYLFFGRNYRKERIYRKKYFLDKEAFLKIEQAISSRREEKRKIL
DGHQRNLFHLAEKLGNTPISFGTSTEILTDGEETFSAILKELKKAKHHIHLEYYIVRDDA
IGQEIKDVLVEKARAGVQVRFLYDAVGSWKLSKKFCSEMKEAGIEVIAFGPVKMPFFNSK
FNFRNHRKIIIIDGNIGFVGGLNIGDEYLGRNPSIGYWRDTHLLVKGNAVRSLQLIFLQD
WYYMTNHSFLTEEYLTPISEENSHGGVQLIAGGPDNEWSVIKSIFFSMITTAKESIWIAT
PYFIPDEDIFSAIKIASLSGVDVRILVPSKPDKRIVFHASRSYFPELLESGVRVFEYNRG
FMHSKIIIVDGEIASIGTCNMDMRSFHLNFEVSAFLYKTRSTEKLVKDYLEDINQSIELE
EETFNKRHYGYRMLESTSRLLSPLL
>PK3-045_03783 Adapter protein MecA 1
MEIERINDHTVKFYISYIDIEERGFKREEIWYNRERSEELFWEMMDEVHQEEDFIFDGPL
WIQVQALEKGLEILVTKAQLSKDGQKFEISIPEDKLKDLPIDERFEDLMDQHFTIKEGEE
EYDESLEFLLTFNDFEDIISLSKMQGLEGIDTKLYNYNGKYYLFVQFLDEEIAEEEVENA
LSILLEYAQEDSKMTIHVLQEYGKVIIENEVFMELRKYFH
>PK3-045_03784 Regulatory protein Spx
MVTLYTSPSCTSCRKAKAWLEEHEIAYKERNIFSEPLSIEEIKEILRMTEDGTDEIISTR
SKTFQKLNVNLETMPLQDLFGIIQNNPGLLRRPIIIDEKRLQVGYNEDEIRRFLPRKVRT
FQLREAQRLVN
>PK3-045_03785 Putative acetyltransferase YjbC
MHWYDKLNQYFPVEEMKSQEHMEALLKDFPEYYHKDEGKYHVLMYVEAEDFVFVDYLFVS
DEARGQGLGHQLVEKLKKKGKPIILEVEPINYKDSDTKKRLKFYRREDFKHATSIGYRRL
SLATREVNAMEILYWAPNNEGEDVVYQALVRTYNKIHTYKDLQFYGESYEPVDEVVQLNL
EQKRKNLFDEI
>PK3-045_03786 hypothetical protein
MKKKLLSIGLSIYLLVPNVAFAKGEKVIPKQPTKQVEIMVKHLPASLPRMKTNLNFTYPD
AVRGIYVNSQSIEGNKWSQLIKLVKTTDLNAMVIDYKEDHGNLTFMPEADSPYREIGSQS
IKNMTGLLQELEKEKIYPIARIVVFKDSILAKEKPEWSFVQGEKVWTNGRGEAFVNPFEK
KVWDYNINIAIEAAKMGFQEIQFDYVRFPEGFENKGDILSYTKGDYHKLNKSEGEKRVEA
VTDFVQYAKEKLKPYNVKVSVDIFGYTATLEEAPGIGQNFSKISKHVDVISSMIYPSHWT
NYFGIEKPDLFPYELVREYMKVEKQKLNQLENPPISRPWLQDFTAAWLGKDNYQVYGKEE
VQKQIEALNDQGVNEFLLWNAGNNYTKNVDYTPKNKEDKGD
>PK3-045_03787 Oligopeptide transport ATP-binding protein OppF
MKEKLLEIKNLKQYFNVDTPNVVKAVDDITFDIFKGETLGLVGESGCGKSTTGRTIIRLY
DATDGQVLFNGEDVHGRKSRGELKKFNRKMQMIFQDPYASLNPRMTVADIIAEGIDIHGL
AKNKKERMEKVYELLHTVGLNKEHANRYPHEFSGGQRQRIGIARALAVDPDFIIADEPIS
ALDVSIQAQVVNLMKKLQKEKGLTYLFIAHDLSMVKYISDRIGVMYFGKLVEIAPADELY
NNPIHPYTQSLLSAIPLPDPETERTRKRTVYDPAVHQYQEGEELKMREIKPGHFVYCSES
EYKNYKTQ
>PK3-045_03788 Oligopeptide transport ATP-binding protein OppD
MEKLLEVKDLQVSFHTYGGEVQAVRGVSFDLYKGETLAIVGESGSGKSVTSQTLMKLIPM
PPGHIKGGQILFDGEDIVQKTDKEMESIRGKEMSMIFQDPMTSLNPTMRIGTQIMEVLIK
HQQMNKEKAKKKAIELLSLVGIPKPEKRVDQYPHEFSGGMRQRAMIAIALAANPHLLIAD
EPTTALDVTIQAQILDLMKDLQEKMNTSIIFITHDLGVVANVADRVAVMYAGQIVEMGTV
DEIFYDPRHPYTWGLLASMPSLDNDNEDELAAIPGTPPDLTNPPVGDAFAARNPYALAID
FEQEPPVYQVSETHFVKSWLLHPNAPTVEPPASVKERIRTLPSNFETPVLVKGDK
>PK3-045_03789 Oligopeptide transport system permease protein OppC
MQEISKDKFEIVGNSTIESEKISKASLSFWKDVFTRFKKNKLAVFGLVLLILLIVMSLIG
PLLTPYNYYENDYTKTNQPPSAEHYFGTDDLGRDMFARIWYGAKISLFIGVAAALIDLVI
GVIWGGIAGYKGGKTDEVMMRIADVLYGIPYLLLVILLMVVLGQGIWTMILAMSITGWIN
MARMVRGQVLSLKSQEYILASRTLGASVSRIMSKHLVPNAMGPILVTLTLTVPNAIFTEA
FLSYLGLGLTPPLASWGTMANDGIGALQYYPWRLFFPAMFICLTIFAFNVIGDGIRDALD
PRLRK
>PK3-045_03790 Oligopeptide transport system permease protein OppB
MIKYLTKRLLFMALSLWLIITATFFFMRMAPGNPFTSEKKMPPAIEANLNAHYGLDQPWY
VQYGEYLLRVVQWDFGPSFKYKSQTVNQLINEGFPVSLVLGVEAIFIALAIGVTLGVIAA
LRHNKWQDYLAMIVAVLGISVPSFIMAAFLQYILAMKLGIFPVARWGTFMQSVLPAIALA
AGPTAFIARLTRSSMLEVLSNDYIKTAKAKGISGFNITVKHAIRNAILPVVSYMGPLSAG
IVTGSFVIEKIFGIPGLGSQFVKSINNRDYTAIMGVTVFYSIILLVSVLLVDLLYGLIDP
RIKLSGGKKGA
>PK3-045_03791 Oligopeptide-binding protein OppA
MRKRMVVLMSLVLILSAFLAACGNNKGGSDKASQNLRLNIVSEPPTLHPALATDSTSGGV
LIQTFEGLTRIDKDGVPQPAMAEKIDISDDQLTYTFKIREDAKWTNGDPVTAADFEYAWK
WALNPQNQSQYAYQLYAIKGAEAANNGKGSLDDVAIKTVDEKTLEVTLVNPTPYFLQLLA
FYTYFPVNKNVAEANPDWYKNAGDDYVTNGPFKMTEWNHSESILLEKNEDYWDADKVKLE
TVEMTMVEDPTTELSMFDNDELDWAGLPFGALPTDSIKALKDKGDLNIKAIAGTYWYKFN
TNEKPFNNENIRKALTYAIDRKAIVEQITQGGQIPATAVVPPTMFSENEKGYFKDKDIKA
AKAALEKGLKEEGYASVKDLPKITLSYNTGEAHAKIAQAVQDMWKKNLGINVELDNEEWQ
VYLEKIDSGDYQVGRMSWSGDYNDAFNFLELYRDANGGNNDTGWENPEYKKLLDASQKET
DEVKRKQLLQDAETILMNELPIAPVYFYTNTWVQKDNLKDVVISGLGEAQLKWAHFE
>PK3-045_03792 Tryptophan--tRNA ligase
MKTIFSGIQPSGTITLGNYIGALSQFVELQDEYNCFFCIVDQHAITVPQDRMVLRNNIRS
LAALYLAVGIDPNKATLFIQSEVPAHAQGAWVMQCISYIGELERMTQFKDKSTGKDAVSA
ALLTYPPLMAADILLYSTDIVPVGEDQKQHLELTRDLAERFNKKYNDILTIPEVRIPKVG
ARIMSLQDPTKKMSKSDTNNKATITLLDEPAQITKKIKSAVTDSEGIVKFDRENKPGVSN
LLSIYSILSGESIQSLEEKYEGKGYGDFKSDLANVVVDALKPIQEKYNELMNSTELDDIL
DEGAAKANKVAGKMIKKMENAMGLGRKRR
>PK3-045_03793 hypothetical protein
MQYLHDVWVNWFEGEENGYNVCHFHEWRKDDGVELLDQVPLLKVDSCLYNYIENDLAEIP
RQLLEEIYQKAYLRKNHERIQLDYCFVVSDGIGLLVVDTIGYSVPIRKSRMIPRQEQLAY
ELLENQETIYYNFQNTEEKKEFHILSPDPHVMNGLTRKERQLKQLLFMALDQLHSSENVA
EVRYWYTEWSPERYFEIQHLDFEHAWNELYECTKYGWSKKHEQFCENIIKGQPFFEKLWE
MEHGPKVN
>PK3-045_03794 hypothetical protein
MGVIKTNKWLEDNFYEPTTICEHFQSAFDGDKPQNIYRYLMRFGMYKPSRHSRQAFEKMK
EQDTWSKVERIFFKYKKKWKGPEIPIYVFPFQSSWRGDENKSGVSFPDQLFLFIDDVENE
KELEALFIHEYHHVCRIHYQKKAIEDYTLLDSIIMEGLAELAVKENCGEAYNANWCHLYD
EEEIKQFWETELKEHLHVKKTEEKHDELLYGYRRYPRLIGYNTGFYLVNSLHSKQKILEK
DHFTINSEAFL
>PK3-045_03795 Peroxide operon regulator
MLSIERAKNLLKEKNIRLTPQRLELINILSKDNKHWTVDEIYHVLNENMPSVSITTVYNN
VHLFTELQLLKEIQFGEGLSKYEWKKEEHYHIVCSDCGEIVDIWYPTLREVEAFAKSISK
FHISSHSLQFYGTCEQCSKA
>PK3-045_03796 3-oxoacyl-[acyl-carrier-protein] synthase 2
MSTNKRVVVTGIGAVTPLGNDAITTWKNIVAGVSGIGPLTRINADEYPAKVAAEVKDFNP
EDFMDKKDARKMDRFTQYAVAASLMAVKDAELQITDENAPRVGVWIGSGIGGMETFENQY
ETFQKRGYKRVSPFFVPMLIPDMASGQVSITLGARGVNSCTVTACATGTNSIGDAFKVIQ
RGDADAMITGGAEAPITKMSVAGFCANTALSFNPDPKTASRPFDANRDGFVIGEGAGIVV
LEELEHALARGAKIYAEIVGYGSTGDAYHITSPAPGGEGGARAMKMAINDAGLTPEDVSY
INAHGTSTAYNDKFETMAVKEVFGDYAYKVPMSSTKSMTGHLLGAAGGIEAIFSVLAIKD
SIVPPTINFETADPDCDLDYVINTHRKQEVNVAMSNSLGFGGHNATIVFKKYQ
>PK3-045_03797 3-oxoacyl-[acyl-carrier-protein] synthase 3 protein 1
MGTGIIGIGRELPEKILTNFDLEKMVDTNDEWIRTRTGIEERRIADDNTDTSDIALAAAQ
KAIDDAGIHPEDIDMIMVATVTPDQSFPSVACMIQEKLGAKKAAAMDLSAACAGFMYGMI
TAKQFIDTGVYKYILVVGVEKLSKITNWEDRNTAVLFGDGAGAAVLGKVSEGRGILSFEL
GADGSGGKHLYLDEEDYIYMNGREVFKFAVRQMGESSENVLVKAGLSKEDVDFLIPHQAN
IRIMEASRQRLNLPEEKLSKTVHKYGNTSAASIPISLVEELEAGKIKDDDVLVMVGFGGG
LTWGAIAMRWGR
>PK3-045_03798 hypothetical protein
MEDFKDEFYDEKDKEKIEEEEIEIDHFSMFMFGTNRQSVRKKQQIEHSQHNDKEPSYNRR
EKGDDWILGRSGGNTKQVEEKDENVNIDAVANFLNQIDMELLIKNVDMFMTSANDLKPIF
KKITPFIKKWMD
>PK3-045_03799 5-amino-6-(5-phospho-D-ribitylamino)uracil phosphatase YcsE
MKTNKIVFFDLDGTLLTSELTVSDSSIAAIKKLMENEIEPIIATGRTLMEIGYILEATGI
NSVVAMNGQYVVYKGTTIYENPLEVSVVKELHLDTIKNRHEMAFYNAEKICVTNEGSTLI
RKNYERVGGKYPPINECLYNQEPVHLMLIFCEPDEEVYYQEKFPHFQFIRNSPYGCDIYP
KGKSKATGIKYLLTHLNCSVENTYAFGDGLNDLEMFELVKYPVAMGNAFDIVKKSASYVT
TSNDEDGIVNGLQLCGII
>PK3-045_03800 Fructose-6-phosphate aldolase 1
MRLYIDSANYEQIERINEYYPISGVTTNPSILVKEKKPYIQVLQDIRKIIGEEKELFIQV
IADNASEIVKEAEYFQTRISGKIIIKIPVTEEGIKAIKALTAKKIPTLATTIYTPFQALI
AAKAGAKYVAPYVNRIDDLSGDGIRVVSEIITLFTTHKISTEVLAASFKNVQQVYEACLT
GAHTITVAPEIIEKLIDFPATTRDVRVFQSQWKDTFGKGGNPLLK
>PK3-045_03801 hypothetical protein
MDYIVIKKEDNKTTNGGEWHLNMPVKMKTIYENTINSIGPLATSFVEEKMIILFGEGAPK
ELAEFCYGIEVVGVKDRIKTGQKVMINNESYEITSVGEIVEQNLTSMGHITLRFNGATTP
ELPGTLYIEDKDMPVLEIGTKIRIVSE
>PK3-045_03802 PTS system glucitol/sorbitol-specific EIIB component
MAHYRTIKIKKGNGGFGGPLIVTPTEQRNKIVYITGGGAKPDIVDKIVELTGVEAVNGFK
TSVPDEQIAIAIIDCGGTLRCGIYPQKRIPTINIMPTGKSGPLAKFITEDIYVSAVGLNQ
IELMENEAVLENASSVDKEDNIPKKEYKYSTDKKISQTLAENHKQGLLTKIGLGAGKVIS
TFYQAGREAVQTLINTIIPFMAFVSLLIGIIQGSGIGSVFANLMSPLAGNIIGLLLIGLI
CSLPFLSPLLGPGAVIAQIIGTLIGVEIGKGNIPPNLALPAVFAINTQCAADFIPVGLGL
AEAEAETVEVGVPSVLYSRFLIGVPRVFVAWLASFGLYSN
>PK3-045_03803 PTS system glucitol/sorbitol-specific EIIC component
MDYIIKFAEGFRNLFDTGAETFISWMTGIVPVVLLLLVAMNTIIQLIGENRINRLASASS
KNPLLRYLVLPLLGTFMLGNPMGLSLGRFLPEKYKPSYYASASYFCHTSNGLFPHINPGE
LFIFLGIAAGIEQLGFSTADLAVRYFLVGLVMNFFAGWITDFTTKMVEKQQGIKLNSEVN
LNH
>PK3-045_03804 hypothetical protein
MELIIIMLLIAGAFVIQMGLGFLQIKHFTKGYSELRRMGKVAIGKKPGRIKAGTIVLFAI
NKNGRILAAKKMQGVTVMAKFRDLPGFLDKNIRNLKEEDLKHCNKLLRDAILDASNNYKI
IMNGGVVPEKDSFFKRMMIRAENAVSFKK
>PK3-045_03805 putative licABCH operon regulator
MADLNSSSRIGKIIELTAKKMYCPLDYLAQQMGISARTVRLVIKQFNKELEGIAELINER
GKGFFLKIHNQEKLNRVIEQFNKLSQMVDSPQRRIATVIDMLLNDDGIITMDEMAFELNL
GRTTLVNELKKASVALETYNLAIKGKQNKGMYLKGREIDLRFFILDNLFPYLFTEDSLDK
DIKEAIIEVANHYDFEISTKDRLLHSIIIMLDRFLKGHSIKEMDDNYHKIVNSPDFNIAL
EIGKVLERKLSINLPRCEILFIALPIVGRRTPINSHSIEGIIVTKEITNLLDNSITYLGF
NLNKVKESGDFYKDLQYHLTFMINRLMFNIQLKNPLLEDIKGKYPLAYQMSEIVGESIFK
EYGMKVSEEELGYIALYFGIFIENNKDNLKKLEQVVVVCGTGRGTAKIVAMQLKKILDPH
TKIDIFSENELSKNTLDKYDIVFSTVNIPYAIQTPLVILNEIFDEKKVLQQIEHISYLDK
FKIKENSSTSFHSVIKLLLNKQKFFILDKSLSYSENLNWMVDQLTLNGYVDDGFKQRLQI
REEKGSMIFDKYIALPHTLNYQSDKIELAVGIFPETVWQDNHALKLVFLLALPEHTEYDA
SLLVKIYDEIINISSNTKLVNKLIQVKKYEDLCLYLEDGIEKDI
>PK3-045_03806 putative oxidoreductase
MNNSWLDLEGKVAIVTGGSSGIGFAIAKELVNNGAKVIISDLVGEEGQQADGSFLIKCDV
TNKESIDRMINKVVEQYGKIDILVNNAGVNLPRLLVDIKGEKPQYELNEKDFDFMVAVNQ
KGPYLCAQAAAKEMLKQGKGVIINVASEAGQEGSAGQSCYSATKGALISFSRAWAKELGT
YNIRVVAIAPGILEKTGLRTSAYNEALAYTRGVTVDDLSTDYSKSIPIGREGKLKEVGDL
VSYLASDRASYITGTTFNISGGKSRG
>PK3-045_03807 Purine-binding protein
MKSAWMNIRKSIIRGKLFFILPLMACVLFLFLFFNSSLEKQGKIEKVGLLVVGTVNDQAW
GTQGYKGLLNIHTKLGVDVFYKESIDSYTVAERAVKELQGKGVNLIFGHGGNFVQYFNIL
SHKFPSIHFVSLNGREPATQPNTSNIRLENYPMGFFGGMVAGHMTRTNKVGVIGAYEWQE
EATGFEAGVHYINKDVDVLKEFVNDWDNRERAMNLLDKEISQHVDVVYPVGDSFHVGILE
KMKENGLYAIGYISDQSTIGKYAVLTSTIQDIPKLYGQIAQAFDEGKLKSGNRSCGIRDD
TIFLGKYSPNVDKEFIERLEKDLDRYKNTGKLPDEIKLK
>PK3-045_03808 hypothetical protein
MKKAVIFGVYQFVGFHICSALLEEGEKIIGISYPEVSIEDLEDKKMEIGRNANFSEKSLD
KLPFILQDSNVQHIYFDLYTLKQISIYEKVQSLFSNFRDKEKSCGKKLIFLVNITSIESE
REFATFLKDNLVDHDIQVIHLPTLYGPWQPNDFLFQQIVEGKEKNDIQLNVREYTMDAIF
IEDAVREVVKMTTKGKNNDILLKSKEINHWQRCLEQLQWDIPKTNKTLQLSRNLQEVIIE
NKGTIEDNIEKQKRHYLFNRI
>PK3-045_03809 hypothetical protein
MENRNFLLDTEWNMIHYPHRPNGFGILIIGDERNYVTDSNSFWNQNEGKRNLIESLRDNG
YTIFYSNLYGKNWGSEKALQLAKRLYEHIIRTEILNQRIHIIAEGMGALTAIQLMMEMKD
NIRSVVLLNPILSLKEHLDREKEHKFFIKKLTNEISIAFNTNKQELFEMVKEKKEYQLDE
ADIPTKIIHILHNGRSYYQSNGLKKASVIWEEKDLPIFVSYVLPEKRSAIPKQIATFFKK
YEKSL
>PK3-045_03810 hypothetical protein
MRYIMTIFWTFLLAQMLVYVVGSMNGVPFNFSMGLILTAVFSVLVFILSAIIPDEPAHEK
GSH
>PK3-045_03811 Chaperone protein ClpB
MNVEQMTERVQLAITEAQSLARKESHQEIDDIHLFMAILHQQDNLMTAILNKLQKDPNRV
SDKLAEELKKKPQVSFSGSQQGTVYITAGLQQLLMKAEEEMREWEDEYLSVEHLILSAYK
VESSAIGRILKEEDISLAEIKKVIKEIRGTQRVTSKNPEATYEVLSKYGRDLVEEVKLGK
LDPVIGRDNEIRNVIRILSRKTKNNPVLIGEPGVGKTAIVEGLAQRIVRKDVPEGLKDKT
IFSLDMGALVAGAKFRGEFEERLKAVLQEVKNSDGRIILFIDELHTIVGAGKTDGAMDAG
NMLKPMLARGELHCIGATTLDEHRQYIEKDPALERRFQQVLVSEPTVEDTIAILRGLKER
FEIHHGVNIQDRSIIAAATLSDRYITERFLPDKAIDLIDEACAMIRTEIDSMPIEIDELT
RKIMQLEIEEAALHGEEDEQSKARLAVIAKELANHRERSNVLKAKWQQEKDALQSIHEKK
EQLERKKRELEDAENNYDLNKAAELRHGSIPKLEKEIKKMEEKIKQGQENRLLREEVTEE
EIANIVARWTGIPVSKLVEKEREKLLRLEAILQERVVGQAEAVQLVSDAVLRARAGIKDP
NRPIGSFLFLGPTGVGKTELAKTLAATLFDSEEQMIRIDMSEYMEKHAVSRLIGAPPGYI
GYEEGGQLTEAIRRKPYSVVLLDEVEKAHPEVFNILLQVLDDGRITDSRGRTVDFKNTVI
IMTSNIGSHLLLETGEAEEIPEVIREGVMNQLNGHFRPEFLNRIDEVILFKPLSLGNIKD
IVSKLVVQLQARLTDQHITIDMTEKAKEFVARNGFDPKFGARPLRRYLQKTIETLLAKDI
IAGKVKENDHVLIDEEEEQIILKHTL
>PK3-045_03812 hypothetical protein
MGQNRQFRPGQKAPNNGLYIEIGETGSNVNNPQMLKLKAGDRFPETSNHNRLWTYQRKP
>PK3-045_03813 Ornithine carbamoyltransferase
MMITSNLDLKGKDLLTLADYSKETILELLDKAKAIKESHLKGEIIAPLKGKTLGMIFEKS
STRTRVSFEAGMTQLGGHALYLNSRDLQIGRGETISDTAKVLSQYVDAIMIRTFSHDIVE
ELAEHATIPIINGLTDLYHPCQALADLLTLLEVKGSLEGLKLAYIGDGNNVAHSLLIACS
KVGVDISIATPPNYEVDKKVAELAYSFAKISGSKIVLTHNPIEAVREADAIYSDVWTSMG
QEAENEQRLKDFQGFQINAELVSHAKSDYIFLHCLPAHREEEVTSEIIDGSHSYVFQQAG
NRLHAQKALLVEILK
>PK3-045_03814 Carbamoyl-phosphate synthase arginine-specific large chain
MHMPKDTTIKTILVIGSGPIVIGQAAEFDYAGTQACMALKEEGYKVILVNNNPATIMTDE
TFADSIYFEPLTVDVLEKVIQKEKPDGILATLGGQTGLNLAFQLSEQGILEKYQVKLLGS
SIESIKKGEDREAFRELMYQLNEPVPESKIVHKVDEAIEFANEIGFPIIVRPAYTLGGTG
GGIAGDMEEFISLVSGGLKESAIGQCLVERSIAGFKEVEYEVMRDSMNTCITICNMENID
PVGIHTGDSIVIAPSQTLTDVEYQMLRSASIKIISALGIIGGCNIQFALDPNSKKYYLIE
VNPRVSRSSALASKATGYPIARMAAKLAVGYCLNELINPVTGDTFASFEPALDYVVVKIP
KWPFDKFPTVSRKLGTQMKATGEVMGIDRNLERALLKAIHSLEIKGNDLILRELKDMSVE
VLYEKMLEQTDERFFIILELIRKEEPIAKIHDLTKIDLFFLHRFKRLIEMEKEIFHTSLQ
TVTKESLLQWKEKGFSDAFLANAWNCFEKEVREKRKQLQVMPIYKMVDTCAAEFKAKTNY
YYSSYYGENEQNKSAKRKVLVIGSGPIRIGQGIEFDYCSVHGVFALKDEGLETILINNNP
ETVSTDFATADRLYFEPLSVEDIMNVIESEGIEDVIVQLGGQTALNVAKELESYGVHILG
TNSDTIDVLEDRDLFYKLLEEEDIPHIQGDNAENEQQIIASVKKIGYPVLIRPSYVIGGK
GMERINNEAELQSYLRTDVPYPVLVDQFMEASEAELDLATDGIDICVPTIMEHIEKTGVH
SGDSLSILPAKNLSVSVKEKMITYAKKIVQHTGYKGLMNIQYIINKEEVYVLEVNPRASR
TVPIVSKVTGVPLVQIATKILLGKYTLTEKEKTYSDDIEFTCIKYPVYSNYALKGLDSKL
GPEMRSTGEGIALAETVEDALRKVFHPTLKKMPKQEMKIVLKTTEDLADLYEKADQVQLS
VEIADSQTVESLLADKSTVAFYNPTNLQEDRQSRELATRNRIITFTQKESLEAFISSFKG
KDITVHSIQEWHTNIRKGVSTV
>PK3-045_03815 Carbamoyl-phosphate synthase arginine-specific small chain
MEGYLHLSNGVKYKGEFVTTSDAKEIKGEIVFFTGMTGYQEVLTDPSYKDQIIVFTYPLI
GNYGINKEDFESKKPHVAGVIVYESNSDAFHYQAEYSLQQYLNKWNIPMLAHVDTRSIVK
NIRQSGSMPAVITGEKEISIPAFSLKEDVKVAKVSEMNFQTYGQGEYHIVLVDFGKKESM
LTALLERECKVTVVPYNTPFTSIKSLQPDGILLSNGPGNPKELISILPTIKAMIKHYPTL
GICLGHQLAALALGAETTKLSFGHRGANHPVMDRKKKKVIMSSQNHSYVVKEESLSATGC
EARFYNLHDGSVEGLSHSIYPLQTVQFHPEANPGPSEGCYIFDEFIENVKANNGRVFAYA
>PK3-045_03816 Acetylornithine aminotransferase
MSHLFPTYSKWEIEPESAQGSYLYSKNGGVYLDFTSGIGVCNLGHCHPEVKDAVEQQLNK
FWHVSNLFPLEVQEKAAEILTKASGLDLVFFANSGAEANEAAIKLARKATGKTKILTFQQ
SFHGRTFATMSATGQDKIKQGYGPMLETFEYIPFNDLNALKEQLTEDVAAVMLEIVQGEG
GIYVGSQEFLQGVEAICKEKGVLLLIDEIQTGMGRTGKAFAFQHFGIKPDIISVAKGMAN
GIPTGAIVADGKLKEFFGPGSHGTTFGGNPLAMAAAVKTMEIIFEPAFLEEVKKKSEWVF
SLLKEKLAGNQHVKDIRGLGLMIGIELDIPVASILGELRREGLIVLNAGEKVIRLLPSLN
TSQEDFIKGMEIIQKSLNIHAKVTI
>PK3-045_03817 Acetylglutamate kinase
MKTIVIKCGGSVIDQLTSEFFTSLKRLKNKGYQLVFVHGGGPDINEMLDYFQVKAAFHNG
LRKTTKEALEIVEMVLSGKTNRKLVQLLREHDLNGIGLNGTDNNCINASLIDEEKLGLVG
EVSQVNIRLLSSLLEENLIPVLTPLGITEDGRKLNINADYVASAVAKYLHAEQCLFVTDV
AGILIDGELQARMAQEEITHYINTGQINGGMIPKVTSAIAALESGLNSVMIISGKKQFFD
GEELIGTKIVVKEGIVE
>PK3-045_03818 Arginine biosynthesis bifunctional protein ArgJ
MQIMNNIQSHIEEIKDGNIVSPIGYKAAGVHAGLRYNKKDIGAIVSAVPANCAAVYTASH
FQAAPLKVTQESIAKEKRIQAIVVNSACANACTGEKGLKDAYEMRKIMANYLQIKEEYVA
VSSTGVIGEYLQMDKMEKGINQLIFHSTPQNAEAFQEAILTTDTVMKKCCYSATIAGVTV
TMGGTAKGSGMIHPNMATMLGFITTDAAIPSEVLQAALSKVIPTTFNQITVDGDTSTNDT
VLVLANGMAKNEPLTEEHPDYPVFVELLSTTCESLAKQIAKDGEGATKLIEVKVSGSNND
EEARIIAKQIVGSNLVKTAIYGSDANWGRIITAIGQTKTAVNPSRVDIAIGDILMLKESE
PQSFSEQTAIEYLNQDFIQIFVDLHNGKGEGKAWGCDLSYDYVKINASYRT
>PK3-045_03819 N-acetyl-gamma-glutamyl-phosphate reductase
MKVSIIGTTGYGGAELIRILHSHPSFTIKSVHTTRDEVPVWNEYPHLFNIMDNKLEPINP
EKIAKECDIVFFATPTGVSGKLVQEFADKEIQMVDLSGDLRLRSTGDYQTWYKKEPVSTD
LIDSFVYGLSEWNKEKIATSTRISNPGCYPTATLLGLAPLVKENLILPNSIIVDAKSGIS
GAGRSPSRANMFAEMSENFKIYKVNEHQHIPEIEQQLADWNSESKAITFSTHLMPTSRGL
MATIYATLNKSVTNEQIHDLYTEIYANSPFVRVRPLFTYPSIKEVKGSNFCDIGINVDER
TSRITIVSVIDNLMKGAAGQAVQNANIMNGYEETAGLQFLPLYP
>PK3-045_03820 Lactate utilization protein C
MTGTIHNRDAFLETIASRLGRQRKIKLEKPKWNYCPQEEVLKDASKDELVEVLKSQCTLI
HTDLVITSQKELNHTLHHLIKEFGGGKIVTWKDPRYQQYGLEPLLKEKLPDENIDVFEWD
ASLGKENISKAEQANIGITISELTLAESGTVVVYSGKDRGRTVSFLPINSIVIVPKSTIV
PRMTQAAKVLREKVQNGEVLPSCINYITGPSNSADIEMDLVVGVHGPVKAAYIVVEDL
>PK3-045_03821 Lactate utilization protein B
MSMKTSSQKFKDRVSTELGNDFMRGAVSKAQQTIQTRKNNVTEAMGNWEDWRSHGEEIRQ
HVLENLDYYLYELSEQVAKRGGHVYFAKTAEEASAYIEQVARDKNVKKVVKAKSMVTEEI
SLNQKLEEAGCEVIETDLGEYILQVDDHDPPSHIVVPALHKNKEQIRDVFTKKLNYTNTE
KPEELAWHARQVLRNQYLTADMGITGCNFAVAETGSITLVTNEGNADLVAALPKTQVVVM
GMERIVPTFNEMEVLVGMLTRSAVGQKLTSYVTTLTGPKEAGDVDGPEDFHLVIVDNGRS
DILGGAFQSVLQCIRCAACVNVCPVYRQVGGHSYGSIYSGPIGAVLSPLLGGYEEYKELP
YASTLCAACTDACPVKIPLHELLHKHRQVIVEKEGKAPISEKMIFKAFGIGASSPKLYNI
GSKIAPAMTKPLVKGDKITKGIGMLKEWTDIRDLPAPNKERFRDWFKNREKEEEK
>PK3-045_03822 Lactate utilization protein A
MKVTLFATCLVDMFQSDVGKATVELLERLGCEIDFPATQICCGQPSYNSGYVKETKEVMK
AMMKSFQDAEYIVCPSGSCAYMFHEYQHIFKGDPVWEPLAKELAAKTFELTQFIVDVLKV
EDVGATFNGKVTYHTSCHMTRLLGVKEAPIKLLKNVKGVEYTELPLKENCCGFGGTFSVK
MGQISEQMVDEKVACVESTNAEYVVSADAGCLMNIGGRITRKGKPIKALHIAEILNSRA
>PK3-045_03823 HTH-type transcriptional regulator LutR
MEFKQIRPKKIYEEIAEALHEGIRSGALKPGEKLASVQQLAENFQVSRSAVREALSALKA
KGLIEMKQGEGTYVKRFEADQISFSFPTAILMKEKDLNHLLEVRRIMEVGAAAAAANKRT
NEDLQKMKQALEEMKQANGVEELGEKSDLNFHLGVAAASQNPLLVNLLLNVSDIMQEAMK
ETRRLWLFSKQTTTERLYEEHLTIYESILEKNAEKASEAMLYHLQKVEAVLQKYFAEKEQ
KV
>PK3-045_03824 L-lactate permease
MTFTQDFTAVGDNLALSAIAAVIPILYFFWALAIKRMKGHMAGITTLLLALLLSVTAFNM
PVGMSIMSASQGIVYGLLPIGWIIVTSVLLYKLTVKSGQFSIIRNFILSITEDRRLQALL
VAFSFGAFLEGAAGFGAPVAISAALLAGLGFNPLYAAGICLLANTAPVAFGAIGIPITAV
EGPTGIPAFEISKMVGRQLPFISVFIPFYLVIIMAGFKRVWEVLPAILVSGISFALTQYL
SSNFLGPELPDILSALVSLFALVILLKFWKPKTIFRFKGELETAASAEIKKAPDPTYSPG
QIFHAWSPFLVLTAFISLWGIPVIKNALTGHYEGTNFILKGINGLGERLTFLPEVPLLNN
KIINGTGEAVAAIFKLEVLGAAGTAILFSCIVTKYIARLSWKDVYATAKETLHELKFPIL
TISSVVGFAYVTNASGMSTTLGMTLAKTGALFPFFSPVLGWLGVFITGSDTSANLMFGNL
QKVTSMSVGMDPVLAIAANSSGGVTGKMISPQSIAVACAAVGLAGKESELLRFTLKHSVF
LLLIVCLITFLQHNVLSWMIP
>PK3-045_03825 Molybdopterin molybdenumtransferase
MTVENRVPILIEEAISRVMEHKREGEKEYVSIYHCNGRYLSEDIKAIHDVPKFNRSSYDG
FAIRAKDTKGASCEMPVEFEIIDEIGAGQVSTKKIGEYQAIRIMTGAMLPRDADAVVMLE
KTVERKKNGQTYIKIDHMLHKGENISFQGEDVKKGEVLLKKGTKINPGVVAVLATFGIEQ
VPVAKKPTIGLFATGTELLEVHEELEEGKIRNSNAYMILAQIERAGAVPRYFGKLPDVME
TSFEAIRQKIDSVDMLITTGGVSVGDYDLLPEIYRKLGAEVLFNKIAMRPGSVTTVANLN
GKLLFGLSGNPSACYVGFELFTNPIIKSLLFIENPRLPIVDAVLKENFPDANSFTRLIRS
KVSIVNGKIETRTSGMDKSNIVSSLASANGLTILPGGESGYKCGDIVKVILLEEVQNQLL
L
>PK3-045_03826 GTP 3',8-cyclase
MKDLLNRPLRDLRISVIDRCNLRCQYCMPKEIFGPDYPFLPPSELLTYDEIERIARIFVK
LGVEKIRLTGGEPLLRKDLPVLIARLIQLEGLEDIALTTNGIFLPKYARDLKQAGLKRVN
ISLDSINDELFGQMNGRNVGVAPVKKGIEAAQNAGLSIKINMVIKKGMNDSEIIPMATYC
KENELELRFIEYMDVGSTNGWKMKDVITKKEIYAKLQESFELEPVEADYFGEVAKKYKYK
DASVLVGFITSVSESFCSSCTRARLSANGQLYTCLFNGNGHNIRDFLREGADDPALEGFI
KNIWEQRRDRYSDERTEETVKQRKKVEMSYIGG
>PK3-045_03827 Fe-S protein maturation auxiliary factor SufT
MNEELKDSIMGALELVIDPELGIDIVNLGLVYDLELNDEGLLVVTMTLTAMGCPLAGVIV
DQVKAALTDIPEVKDTEVNIVWSPAWTKDRMSRYAKIALGVR
>PK3-045_03828 hypothetical protein
MILVEKLHIEEIPVLHIVKKDHYDQKRPYIQFTHGFTSAKEHNLHFAYHLAEKGFRVVLP
DCLYHGERDQGLSAMELNMHFWNIVMKTIEEIEVIKDYFSEKELIDEQYIGIVGTSMGGI
VTLGALRKYPWINTAVSLMGMPYYEKFAHYTISEVKKRGYELPLSDYEIEDLIKQLEELD
LSKAPEMLQKRPLMFWHGKKDEVVPYAYSHQFYEHIKPLYKDAPDRLKYLSEDNTGHKVS
RRAMLKTVEWFEKHLAEGLVKA
>PK3-045_03829 5-amino-6-(5-phospho-D-ribitylamino)uracil phosphatase YitU
MTEKHLIALDLDGTLLKDDKTISPLTKKVIQKAMEDGHEVMIATGRPFRASEAIYHELNL
HTPIVNFNGAFIHHPKDTDWGFYHSPLDIQTARDIVAACNDYSFHNIIAEVMDEVYYHYH
DEKLIDIFSLGNPKVTVGNLLEFLEAAPTSILIHAEEEHVAAIRKHLSEVHADLIEHRRW
ADPFHVIEIVKLGINKAIGLQKVSDYYQIPQRNIIAFGDEDNDFEMIEYAGKGVAMGNAI
DELKTLAKDVTLSNEEDGIAVYLNEALNLRVR
>PK3-045_03830 hypothetical protein
MGKRNKSKRFVQQGVDSVSKHSERIPYHMTYAEAESYKMSNERQSHGGLE
>PK3-045_03831 hypothetical protein
MGNRLFQEARQAVEAAKYGNGNDGLVDKAKNAISSAYANTTSAEQHQLAALQKELEQIQT
H
>PK3-045_03832 hypothetical protein
MKKTTVVFLCMLISSFLPFLTITAAANSGKEQVKIEDVTVSGTRGNYLVEGKATTTGTIF
YSVEDGHNEFIANQKLQVSNNQFSLQIHIEEKDLPTNGTIIIFFSEEGREPYSVVLETFS
>PK3-045_03833 hypothetical protein
MYWLLTKKLIVVIFGALLNAIAMNFFLIPADVYASGFAGVAQLISKITPISTGLLLFILN
VPIAIVGWIKVGKSFTFFSFLSVAFMSLFMEIIPETSYSHDILLNAVFGGVIAAVGVGLT
LKWGASTGGMDIIAMILSRVQDKPVGTYFFILNGAIIITAGAMFGWEKALYTLVNLYAAT
KVIDTIHTAHQKLTVMIITKKTAELKVAIHEKLVRGITILPARGAFSNEPKEMLMIVVTR
YELFDIERIIKEVDPQAFTNVVQTTAVLGFFRKA
>PK3-045_03834 hypothetical protein
MINNDNLFENALFFENKAYLFVVYKTFREKTNE
>PK3-045_03835 Fatty acid-binding protein
MTFKILADSASDLPLSYYEKNEVTLLPLKVNLDGKEYEDLKTIEPATVYNAIRSGQVPKT
SQVSPALFKDVFTTLAQNNEKGIYIAFSSQLSGTYQTAVMISEQVKEEYPDFALTIIDSK
CASLGAGLVVQEAVKLRDQGKDVSEIIPRLQFLCEHMEHLFTVEDLEYLAKGGRVSKASA
FLGGLLNIKPLLHVEDGKLVPLEKIRGKKKLLRRMIDLIAERGEKLDQQVFAISHADDEA
TAVEVKEMIMEKFQPKEVFISSIGASVGSHTGAGTIAIFFLNKLPE
>PK3-045_03836 hypothetical protein
MPHTSDNDKKAKDNNALRHEKNMMREKNRKKGKHQYSKKTDHL
>PK3-045_03837 Conserved virulence factor B
MSLRDYMGRVEILTVARIASFGYFLTIEEEDEDVLLHFSETDQKFEEGDEVRVFIYSDSQ
GRACSSTFIPSIAVGKYDWVKVTDRKEGIGCFFDIGLKKDMLLGEDDLPVHEEVWPEVGD
MLYITLKVNKNNYLYVKPATDPIIEEMAAKATREDFNKNIHGYIYRTAKVGSWIYTAEGF
KGFIHESERGKEPRLGEKVNGRIIDVKLDGTVNVSLLPRKEEALDKDSQLILDYLITRKG
AMPYGDKSMPEDIKERFNLSKGSFKRALGRLMKENKVYQEEGWTYLKEDNQNN
>PK3-045_03838 hypothetical protein
MAKESSFDIVSKVDFSEVTNAVQLAMKEIQNRYDFKGSKSNVTLDKEELVLISDDEYKLE
QLKDVLISKMFKRGIPIKNLDYGKIEGASGGTVRQRAKLVQGIDRDNAKIINSLIKNSDL
KVKTQQQDDQIRVTAKSRDDLQKIIAAVKDESKITIDVQFVNYR
>PK3-045_03839 General stress protein 39
MTNSNKEQLQQTFPPQHQDQQPGIQTEMNPIPKDVDPSYKGSEKLKGKTAIITGGDSGIG
RSVAIYYAKEGADITIVYLDEHDDAQKTKELVEAEGVKCLLLAGDIGDEGFCKEVVKKTV
SEFGKVNILVNNAAEQHPQSSILDITSEQLEKTFRTNIFSMFHLTKATLPHLQKGDAIIN
TTSITAYKGNETLIDYSATKGAITAFTRSLSGSLAEQGIRVNGVAPGPIWTPLIPSTFDS
EQVASFGGNTPFKRAGQPCELAPAYVYLASNDSTYVTGQVIHVNGGTIVNG
>PK3-045_03840 Neopullulanase
MIDLASIYHRSGDNYCYLQNKDTLHIRIRTKKANVTEIELIYGDQYEIVDYQWVSQRLSM
EKSGSDSLFDYWHCTITNKKRVRYGFILRDSEQQVTYTEKGFFPFIPEDAGFYFCLPYLH
LKDVFTPPSWVSQTIWYQIFPERFRNGDSSLNPVDTAQWGQEEPGLYNFFGGDFQGIMDS
LDYLTDLGITGIYLTPIFHAKSNHKYDTINYLEVDPQFGDREMLKYLVKECHNRGIRVML
DAVFNHCGDHFPPFQDVLKNEERSRYKDWFHIHKFPLKENDMLHYETFGFYEAMPKFNTA
NPEVKEYLLHVAKYWITECDIDGWRLDVANEIDHEFWRSFRSVVKSLKPDIFILGEIWHD
SLPWLRGDQFDSVMNYPLLTKALQFFAYDMISPQQFMEEMTTTLQAYPDTVNNVLFNIIG
SHDTPRILHECSYRKERVRLLFTFLFTYPGTPCIYYGDEIGLGGGSDPGCRKCMPWNTEE
HDTELKEFVKRLIQVRKQSSPLINNGTFYFLSQSDSCLAYYTKEEEEILLTVINKSDKEA
QFLLPFPLRGKKISLLLTEEEYAAESDDLAVILGPYECSILRFNMNYEYIHTR
>PK3-045_03841 hypothetical protein
MNQQTAPKSIGIPLLISIIAISFSAIFVKWSEAPATILSMYRMWLACLIMIPMVYIHRND
FKKLTKRDWAFLFFSGSFLALHFALWFSSLKFTTVASSTIILALQPIVSLLGGFIFFRER
TTSTAIMTMGIAIIGAMMIGWGDIGLDSNAIIGDVLSFLSVIAVVGYLLIGQNIIKKMTH
WIYTFTVFFFAACLLTVYNLLAGEALTGYSGREWGIFVLLAIVPTLAHVINNWLLNYVNA
TTISMSILGEPVGATLLAVLLLNEQLIFAQLLGGLLVLFGVFFFLLQKQPKSTITQEKPI
G
>PK3-045_03842 hypothetical protein
MLKENLSLSQLFAIIIGFNLGTTLVVVLGITAKEDAWITVLLSTIIGLIVSSFFLHINEL
VPSKNLFEIIEFGFNRFMAIPITLVYSLYFFYLAARTIRDFGELTSTFILPLTPIEIIVI
TLMLIIGYILYLGIEILGRTTEIFTPYSAVFLFLLIIFLFASGNLSITKIQPVLARGILP
VVKAIFPIEVSRPYGEMLVMTCIFPLITNVKWRKKSVLASVAVSGFLLAIATLIIILSLG
INTSSRATFPLLSTTRLISIGEFIERIDALAVFIIILGIVIKSSIFIYSGLKGLEYIFKQ
PYRFYVVPIICLISMFSIFISMEINDHVREGAVVVPYLLYIPLQFAFPCFLLFFLLIKKV
KSHNNP
>PK3-045_03843 Asparagine synthetase [glutamine-hydrolyzing] 3
MCGITGWVDYKKDLRNESEILSAMAETLAKRGPDDTNVWTALHAGFGHKRLVVVDPLNGI
QPMTKEKQEFHYTICYNGELYNTEDIRKELLIKGYSFQGHSDTEVLLTSYMEWGEDCLQY
LNGIFAFAVWDEKRNSLFIGRDRLGVKPLFYTEISTGFIFGSELKALLAHPNVKAELDRE
GLAEVFALGPSHTPGSGIFKGIKELRPGHALKFTQDGLKVWRYWNVKSEEHTDTFEETVE
KVRFLFKDAVTRQLVSDVPLSTFLSGGVDSSAITAIASMEYKRTGKGPLHTYSIDYEGND
KFFKANEFQPNSDGVYIKKMTDTFGTIHHNCIITQETLADFLHEAVTVRDVPGMADVDSS
LLWFCREIKKDFVVSLSGECADEIFGGYPWFRREADLQRGGFPWMRSIQERQNLLKDSWS
NKLQLEDYMMDKYNQTIAETPKLAGESKEDAKRRELFYLNQLWFMTTLLERKDRMSMGAS
LEVRVPFADHRLVEYVWNVPWEMKNYMGREKGLLRKALEGILPDEVLYRKKSPYPKTHNP
IYTKTVSDMLKSALADKSSVLYEFFDKESLTEIIETEGSAFKEPWFGQLMTGPQLLAHLV
QIHYWFKDYQINIVE
>PK3-045_03844 hypothetical protein
MNNQHRSKLIEFQTRAFTKGTVEYINNQWIFFDEETEEAAMLDEYLHQEIEIRSFNRWRK
GILLEDGKVNVSGTIHFLEHEDPIRIRKHLVFALEELLDDLSDDSFYQFITTLNSMKFSI
YDCIYCYNHLTFLKDEKRKNGVNMMIFDNEEGLCSVNHHFFYNEKSTDRFEFTLNTGKRM
IVEKLTS
>PK3-045_03845 hypothetical protein
MIIRKAKDEDAKRIAKVHVDSWRTTYKGIVPDLFLERLNYEEREEIWKKAIPTGSVFVAE
NETGEIIGFANGGKERSGQYPGYVGELYAIYLLEAFQGQGIGSLLVKKVMEYLKEIGLFP
MIILALADNPACKFYEANGGKRIGTEEVEIGGKKLTEVVFGWK
>PK3-045_03846 hypothetical protein
MKEERKFHRPFGVYGVNTENDKLLVIHKKRGPYANRFDLPGGSLEPEESLATAMRREFLE
ETGIKIAIEKQIGMADFLFPCIWREYTHIHHIAAFYTVRKVGGEISIPKQFEGQDSFGAE
WVSLNDLSIHNASPLVLKAIEWIQTGSIGLEVTWFEKWEVKKSLQIEGKKESTDDY
>PK3-045_03847 Non-reducing end beta-L-arabinofuranosidase
MLSEFALNKVHIKDTFWNYYVKNIKHKTIPFQYKVMDNDMDINIEREREDESLPAEKSNA
IENFRIAAGLKGGEHYGWFFQDSDVYKWLEAVSYSLQISPDKELEELADSVIDLIGKAQE
KDGYLQTFFQVKFPNRKYRELYYSHELYCAGHLIEAAIGYTEATGKRALLQIALKVVDNV
AKYFGYEEGKIQGADGHQEIELALAKLYEFTGEKKYLDLAAFFIDVRGKDPLFYDKQVEQ
NNKDGITNDHPKIDLKYLQAYIQPKKQTTAVGHAVRMLYMATGMARIAKHSNDEQLFMAC
KEIWRDVIKKKMYITAGVGSTVHGEAFTGEYDLPNDTMYCETCASIALIYFAYEMFKIEQ
KAEYIEIMERALYNGALSGASIDGEHFFYVNPLEVYPSISKNNPGQGHVKSQRPNWLGCA
CCPPNFARTIGSIQRYFYTWDEERQIIYSNLFVSSNLDFPGGTLEQMTEFPKQNRVKYRL
KTDGQLVTLKIRIPEWLKNPLLYVEGTTVEMNMIDGYMELKRMWNGEIVELAFETPVLAV
TANPNVVADVNRIAIQRGPFVYCAESIDNEEKLQTYHINPKNLEWAKVCYQPGVLNGITQ
LMVEADHELVDRSWQETLYQFNFRGNTEKKELTLIPYYSWGNRGECEMVVWLYK
>PK3-045_03848 HTH-type transcriptional activator RhaR
MQETYILSRLTGAVPFHSAGLFVSDVPWSHAPRKNPNEEIILCISGTLYLEVDNTAYELK
ENEFLFIPANTSFKGSKHSEKGLSFYWFHFYLPQGKKAVSNPYAQKSSSPEIYLPLYSSE
MNLSKTIILLNQLIASMKSSQTNNGFLDYLVTAILLELSEEARSVYEDSAEREPHNRFLY
YVKEWIRMNSNHPLTIEEIANHFGYNKAYLSHTFSKNIGTTISQFILQVRLEKAKSLLLN
TNDTVTKVAADCGFKDEKYFMRVFKQTENMTPTAFRSALRHIKLNNI
>PK3-045_03849 hypothetical protein
MQLGIDKSSLVVYEALASEVRMTIIQLLSKNKMNIKELAKELGISSAIVTKHVKKLEDAG
LIKTEKIPGKSGLQKISMLKVDHIEINFPKKIYHSFASYETSVPIGHYTDYDLKPTCGLA
SEKDFIGRVDEPKLFMDPKRVEAEILWFTQGFIQYTIPNFLKKEEKIQQFEISLEVCSEF
PFSNDNWPSDITFSLNGLELGTWRSPGDFADTRGKLTPEWWPHNLNQYGLLKTLRITNHG
TYIDGDPISAVTINELDDNCDRWTFRIEVKEDAEYVGGATIFGKKFGNHPQDIIFKVYYL
>PK3-045_03850 scyllo-inositol 2-dehydrogenase (NADP(+)) IolU
MKLGIVGAGKIVQDLLPMFKSIPQIDLMAIFGRPNKKGFLLDLQKEYLINKIYVDYKEML
ADTDIDVVYIALPNQLHYSYTKQALEARKHVICEKPFTSNLKELQELEKIAQRNDLYLIE
AITNQYRGNFLQIKELLPKLGDIKVVEANYSQYSSRYDAFKEGDILPAFNPEMSGGALMD
INSYNIHFVVGLFGKPMAVQYYPNLSRGIDTSGVLVLEYERFKAVCIGSKDSRGASFATI
QGDNGFLTVDGPVNSIDSFTISNASNVEEKINKNEHKHRMYEEFVAFEKIIREKNKSEML
KRLEHSLQVMEILTMARKKAGIIFAADKGINE
>PK3-045_03851 putative oxidoreductase YhhX
MLTIGYIGNGKSTNRYHLPFTLQRDHIKVKTIYRRNPARDTWKKYKHIHYTTDLNEILND
QEIQLIVVTTSHDSHYAFAKLALDHNKHVLVEKPFMMSVEEAEEIFLYAKEKGLVVQCYQ
NRRYDSDFLTTKKVIESGKLGDLLEVELNYDYYRPEVPESVQVYNNYRSFMYGHGTHTID
QVISYFGKPQHVHYDVRQLLGQGRMNDYFDLDFYYDQLKVSIKSSYFRLKERPSFVVYGK
KGSFIKHSKDRQEEHLKLFYMPDGESFGIDQPEHYGTLTYIDENGDYHEEKVVSKAGDYG
RVYDGMYNTIIHGEEKIIKDEETLLQLAILEAGMKGCK
>PK3-045_03852 putative HTH-type transcriptional regulator YbbH
MLKQIANRTDYTAAEKNIAKYILENANLIERMTIQELAQKTFTSHTSIIRFAQKLGMKGF
KDFKIMLVKSIEQKNHVLSEINPNIPFEDDASLMKISQDMMYLTQQAIKESYELLKEKSL
FKMTKYLYNSNRIFMYAVGDSQIRAESFQNKLLKINKYAIIATARNEFANNTVNIERNDC
AFFITYEAKSNEDFIAARILKERKVPILLLTAFPESKLAKMADVVLTIPALEKKETDKIA
TFASQVSIDYVLNVLFSSLYQINYTQNREHQRKSTELIDRFSF
>PK3-045_03853 hypothetical protein
MTDYKVLKLLDHFKAFFLKIGIDYEVLRAILQVKLIMDQRKLPTIFSQSIQKKEKKEDKY
AYIKSLWLYALMGLILIPFMAFGDNYLFQMSISFGIILFLVMTSMISDFSAVLLDVRDKH
IVHSKPVNRKTINAAKVLHIMIYLSQLTIAITLVPLMVSLIKQGIVFFLLTILLLVLANL
FIVVMTALLYLAILRFFDGEKLKDVINYVQIGLSIMIMIGYQIVIRSFEFVDLNIIYEVH
WWHLFIVPMWFAGPYEWVLNGNTEMMMILLATLAFVLPILAIIIYGRLVPVFEKSLEKLT
SQSKARKRKILKIKEWVLSLYIKSREEKAFYHFTEQMISQERDFKLKVYPSIGFSIVIPF
LFLYSGTNLEDIDFSTSSAYLTIYFTMINIPTIIFMLRFSGKYKGAWIFTILPVADFSAY
YKGSLKAVISKLYLPIYFLLSFVFLFLFGIRIIPDLLVVFLSAFFYAIVCNLLLDKQIPF
SLSFESGGNQQSWRLFLLLIPLPILAGIHYISSTFPYGVYIYALLLFFVNLLFWKKWKP
>PK3-045_03854 Daunorubicin/doxorubicin resistance ATP-binding protein DrrA
MAVEEIITIKGLWKNYGAKEVLKGIDLHVSRGEIIGYIGPNGAGKSTTVKILLGIETYVK
GEVKLFGKEINQNSIEYKRRIGYVPEIAEVYDNLTAYEYLTFIGQLYGMKVEFVDQKAQK
LMELFGIGEVYHSRISSYSKGMRQKLLIISSVLHNPDILFLDEPINGLDANSVMIFKEIL
AQLASSGKTIFYSSHIMDVVEKISSRIILLNDGKVVVDGSFKELQAQNQQGSLEGIFNQL
TGFYNHREIGESFVSVVQEVQT
>PK3-045_03855 hypothetical protein
MKDINFHRYLEEINEKFSGWDFSSIYDTGRIQNSMISWSYGSKVISAMQEATAVLDMGTG
GGEFLSLLKGYFPSTIYATEGYKPNVPIAKKKLEPLGVRVMEVVDDNELPFPDNHFDLII
NRHESYSEKEVKRILKPKGIFLTQQVGGLDCKEINDWFEVPLNPEFKEWKLSIALNQFPN
AEWEVLEHQEEFPVQRFYDLGALIYYLKAIPWQVPDFSVEKYQNELYRLHQYIEKNGFFD
ASQSRFYLKMRKK
>PK3-045_03856 hypothetical protein
MVLYFMFQRFHNLIFSPLFLLLISIKTIRSLSTTIKPYKSLMVSFVNQTRFPLGSKITEI
KNVKGRTTTYK
>PK3-045_03857 Linearmycin resistance permease protein LnrN
MNAILWGKCKKFIRQPGGFIITSFICIVFAYLVGISSFTKVEVPVYTEHSEKTTDILEFL
NQSESYSFVMYTEKEVKEQLGKGKTDMGVAINPDTYTMFRVADTSNVLMVQNYLQTYYAN
MLKEKALINEAADKEEAKRVLAHNKETPIIPVETEQTLTEKEASYNQSLQSLFGFALFFC
IFTVSFTVIEILRDKQNGIWDRFILSSTSKAQIYLGHLLFSFLIGYVQIIIIFLLFKYGL
NIDFNGNFHLVFVLIIPYLYAIVALTILLTGLVKTPSQFNAFIPLVSVSFAMLGGAYWPI
EIVTSKIMILLSKVVPITYGMELLKKGVIDSASWNDIMVPAGILCLMGTIMLGIGIQLIE
KRHV
>PK3-045_03858 Linearmycin resistance permease protein LnrM
MLWQMIKKELLLIWRRPRELVVLLLMPFVLITILGSALGALDNDSEVEVKAKLAVVVEDQ
EQQAQQEIIEKINQSPLSNQEKNAKIAHIQALQPIATFMKAVGESPDLKKFLSVTEYNDR
TKVKEKDFDGVLLIPEGFTSDFYTNFLEEETDLPSWIIKTKNQESLQATIIEDILANYQK
EWTYLKTAQDLQIDYSTLVSEKANGQIKNIEKKKEISAFAYYGVGMSVMFVFYISTTVAG
FAYQQKEELLYERILLANVPKIMFFAGIFISAFILSFLQQTILFSLIALIYGVVFSSMIN
QLIVILTVNLMAAAFATIATAISFAAKSRNVESIFSSLIVPILAFIGGSFFNVSAIGGFM
ETLGEYSPGGAALTAYLKAYQGYPLVDLWSHLKAILLFSLALLLISGITLKTRGGVRR
>PK3-045_03859 Linearmycin resistance ATP-binding protein LnrL
MLEIMNLSKSFKGKQVVNSVNLYLERGEIVGLLGPNGAGKSTTISMISSLVSPQEGDVRL
NNESILKTPQALRKVLGVVPQELAVYMDLSARENLLFFGKMHRIPKKILQKRVDEVLEII
GLKEREKDLVKTFSGGMKRRLNIGVALIHEPEIIIMDEPTVGIDPQSRNYILETVKRLNK
EKQMTVLYTSHYMEEVEFLCNRIYIMDHGEIIASGTKEDIKNILSAETAINIKVEIVKHE
FTEALRHLESIKNISIQQSVITVIVPREVNLLKDILRIAEEQKTNVLSVNIEAPTLEDVF
LHLTGRQLRD
>PK3-045_03860 hypothetical protein
MGILVLVILIALNAFFAAAEIALISLNDNKIKHMADTGHKKAIIVHKLLSEPSKFLATIQ
IGITLAGFLASAFAADSFSGHLTELFLRMGIPLSKGLLDSISVIIITLLLSYFTLVFGEL
VPKRVALKKAEGIAMFAASPLTMLSKITAPFVAFLTFSTNLVARLFGVRPDDEEEEVTEE
DIKMMIDVGNERGSIDEDERMMIHNIFELDNKDVTDIMTHRSNMVAIPSHYTLKEIATLV
NREMYTRYPVYEGNMDNIIGILHSKDLLAYMGKEETSFQLSKIIREPYFVLESKRIDELF
IQMQKNNVLFAIVVDEYGGTDGIVTMEDLVEEIVGNIFDEYDEPKPPEIKIIGEHTYLLQ
GTISLDDVQELLKITLPIEIYDTLSGFLISKIGYIPNENEKPTILFNNFEFQVEEIVDRR
ISQVKVTKIIEEQFPSNTSLET
>PK3-045_03861 hypothetical protein
MKKYGKDILVIIFGAFLFALAVNLFVIPNDLGEGGVTGLAIIAYYLFQWSPGIVNFALNT
ILLIIGYKFLNKQMIIYTIIAVFFNSLFLHLTETWSIHSDELFVNVIFGGVFAGVGIGLI
IRVGGTTAGSTILARLTNKYLGWSISYGLLFFDLLVVFASFFLIKAEGVMLTIIMLYVGT
KVMEFVIEGVNPKKAVTIISNHPAEIADQVNEQLNRGVTVLSGHGYYTKENKEILYIIIN
KQEVVKLKKIVKQTDEDAFITIHDVRDVFGEGFIHLSKA
>PK3-045_03862 Transcriptional regulatory protein LnrK
MIRVLIAEDQAIVRNGLKMIIEQEEDIKVVAEAENGKEVLLLLEKTIVDIVLMDIRMPIM
DGMEATKQIRQQFPHIKILILTTFNDEDYAIKAFQEGANGFLLKTTDNTTLVNSIKSCLS
GGMSIHDQVAAKLMPKLLKKENMPEKERDQTVVLTTREIEILKKIGQGKTNKEISRELLL
SVGTIKNHITQILAKLELRDRTQLAIYAVRNDYI
>PK3-045_03863 Sensor histidine kinase LnrJ
MKDFSIKIVVLIFLCLGALYQAYNIDAWHFAMHLFLFSIIIGFYFLVPVFKRKSIPFLAI
VVMLELILFTVGRELYSYLLLMLLYFIIVMSRYISTNLFRIVISLFLIINAATVIIISPY
LALIWISFLLLISYLLIHANELEEDYRQIRNTYESLLNDYRIQKRQSYYNEHAARVEERN
LIARQMHDSVGHKLTALMMQIEQFWIKEKKDQYLTLKNMTADSLEETRKAVRLLQVEEPR
GIASIITLIKKLESENNIHVHFTTKQGVLQANLSNKQSAVLYRSVQEGITNAMKYGSSKA
VHITLGVSPIGHLTFEIRNPYIHKHPFHYGFGLENMKKRIEERHGKLEVLQSNGEFILQG
NIPVGEE
>PK3-045_03864 hypothetical protein
MSSTDAHVLTWIIGLILFALSFGLHKAGKEKGSKIVHMVLRVVYILIIGSGIGLLAKTGM
DFMHTIKMLVGIWVIGMLEMVLIRTKKSENTKTLWILLVVSFALVLVIGYSI
>PK3-045_03865 putative protein YisK
MKFATVAIEERVLVGIVEKKGILSLNDVEEKRSGRRPYADDLVICLEQEDFLENVKGLIE
WVENQNNKDNLFIPIEKAKFLAPIPRPRKNIFCVGKNYEEHAIEMGSKADIPEHVMIFTK
APTTVIGHMGDIMEHKQVTEQLDYEGELAIIIGKKGKGIEKEKALDYIFGYTILNDITAR
DLQKKHKQFFIGKSLDTTAPIGPWIVTKDKISNPNELNIITKVNGEIRQQSNTKHFIFPI
EEIISVLSKGMTLEPGDIIATGTPAGVGKGFNPPRFLKAGDSIEISVEGIGTLINQVVAE
E
>PK3-045_03866 putative spore germination protein GerPA
MPAIVGVAQVISVGGSSIFNIGDVYKMMPISSAKTFSGSGSFNTGDGLNVTNYRSSTNTY
DNDGIDQPIAANA
>PK3-045_03867 putative spore germination protein GerPB
MNYFIQQSIVINTLKIGGISNSSVLQIGSAGIIKPASYLYNTGGFTESAPELSPSEPGLN
IAEEETVFTPAVPLQSPRK
>PK3-045_03868 putative spore germination protein GerPC
MSYDFYEYSEKMRHYLQQLEKRIIDLEKQVAALTNDLTAIKEKPTVHIERIDYSFDQLKV
ETLEGTLNIGLNPEDLSNIEELAINPSSPISQSHAPFYPPIDPKQMMNRSMDIEEEMNQF
IQLELPDIIRKKQLELNMSEEESYVTFIQDDISKQLPTRIQYYLQQGANRKQNGSILTNE
AIIKALKEEMENGVHLFLSNIPDNMKGSGKE
>PK3-045_03869 putative spore germination protein GerPD
MNFQVYNRELQVGNINIIGVASSSICLVGDAQTIQLASTFDTPAESLIIGPFVPLHPKI
>PK3-045_03870 hypothetical protein
MMFQRTSVVDSINISTVSFSSIVELGDATYHQALSRAIAVQRQKELFYGSESDYKDYDVF
KEPIPLIPVMENVECHFENLKPIIKVHHINITGISSASLLQIGNCRHIYTEARIKHIRQF
EQDMATEAGNNLIPLNEPGQLDMSASESSVSVTGTALSGSPISDVETSAPE
>PK3-045_03871 putative spore germination protein GerPF
MPAIVGPVQIVNVGEGIVQFGDSLFISPKGNSKATLGSGTSNTGAFIITNNGLNASNYID
TSLLDQPVVANN
>PK3-045_03872 putative spore germination protein GerPF
MPTIIGPIQIVNTGEGIVQFGDSLFISPKDNAKSTVGSGTGNNGAFVITNNAVNSSNYTD
SSGVDQPISGNN
>PK3-045_03873 ATP-dependent helicase/nuclease subunit A
MKEINIPDKPADVTWTDDQWKAIMSSGQDILVAAAAGSGKTAVLVERMIRKIVSDQPINV
DELLVVTFTNASAAEMKHRIGEVLEKEINANPASQHLKRQLVLLNKAHISTIHSFCLEVI
RKYYYLIDLDPGFRIADETEGQLLRDECLEDLFEEEYGKENNLAFFDLVDAFTNDRSDDA
LQRMIQEIYDFSRSNPFPSAYLQSLIEMYDRKEDADITELPFMKHLIDDVELQLEGVRKL
LEYGYELTKLPGGPAPRASNFLDDLELVSILEKAKAHSWETLYEAMQSLKFSRAKPCKGD
EYDPALVEEGQRIRDRAKKILQEMQSDLFTRKPQNFLKDMAAMKPHVETLVYLVEAFGQR
FQQIKMDKGLVDFADLEHFCLAILSQPEENNTELIPSEAAWFYRNQFKEVLIDEYQDVNL
VQESILKLVTKDSESEGNLFMVGDVKQSIYRFRLAEPNLFLAKYLRFQEREDAGYKIDLA
KNFRSRKEVLEGTNFLFKQIMGVKVGEIEYDESAELKLGASYPEETPYPIEVALVNQRDS
SEDMEMDGESTGLDAAELEQSQLEARVIAEKVKELFETNQEVYDAKQKAYRPIRYKDMVI
LLRSMTWAPQIMEELKQYNIPTYANLTTGYFESTEVDIMMSLLKIIDNPYQDIPLASVLR
SPIVGLTEEELSKLRIAKKQGAFYEAIQAFIQSNNQKEEALYAKIRPFFDKFADWRSEAR
RGALSELIWRLYRETYFYDFVGGLPAGNQRQANLRALYDRARQYEETSFRGLFRFLRFVE
RMRDRGNDLGAARALTEQEDVIRIMTIHSSKGLEFPFVFMAGLGRNFNTMDLRKNFLLDK
DLGFATKYIDAKKRISYPSLPQIAFAKKKKMELLAEEMRVLYVALTRAKEKLILIGAVKD
IEKAKQKWSQIAGHSNWLLNEFDRAQAKSYLDWIGPALVRHRDNKWIHLESWSEKEEISF
HPSNWEVKILQKEELLNRSVEEENKENEWLEKVSEGKRMDRSSVYKDDIKETFGWSYFSK
ESTSHRSKQSVSELKRQGELRDAQSGTDLAKKWKQTVWNRPKFMQEKKLSPAEIGTAMHM
VMQHVDVKAIVTEASLTQLLEDMVKKELLSSEQAEVIDIASILSFFQSPLGKRMQQAPKL
VREIPFNIAYPASRVYADWQGEEEPVLVQGIIDVFFEDDLGTVLLDYKTDTISGRYKSGY
EEAKPILESRYKVQIELYTEALEKILKRKIEEKYLFFFDGAHVLKL
>PK3-045_03874 ATP-dependent helicase/deoxyribonuclease subunit B
MTVRLLTGRSGTGKTTFCIEEIQAKLAENPEGNPIIYIVPDQMTFMSDQRLLSGSNVQGM
FRSQVYSFTRLAWRVLQETGGISRYHINSMGVSMLIRKIIEENKNELTLFKKVADKNGFI
DQVEQLVTEFRRYTVTPEELLATKAQLAGTKESTKALQDKISDLELIYEKFEERIIGNYI
DGEDYFRLLAEKISESSYLQKAEIYIDGFYSFTPQEYLIIQQLMHTCEKVTITNTLDPFS
SQNDDLSLFRMTTESFQTIQAMAKQLGVEVEVVKLAKFKKSSHPSLVHIESHFDSRPARA
FTEDATIKFAESVNPRAEIEGIAREIVKLVRHKNYRYREISLLSRNLSAYQNIIETVFRD
YHIPFFIDQKSRMHDHPLVELIRSSLEIFDTNWRYEPVFRSIKTELLFPLHERKNKIREK
VDRLENYCLAYGIKGNKWTSKERWKYRRIKGLEFEQGVQTDAEKEFEQELNELRLSLTAP
LIRLQNRLKRGKTGRAKCEALYLFLEELEVPVKMEYWKNELESKGELVKAGEHDQAWNSI
VDLLDQFVEILGEEEFSTKQFATVISAGLDTLKFSLVPPALDQVLIADLEQSRLNDIKVA
FVIGLNEGVFPSRFQDEGILADTDRESLQQKGMKLAPTSKTRLLDEEFLAYKAFTTPTDY
LYLTYPLANDEGKSILPSTYIKRMQDLFPKAETVYYMSDPKELSEEGQLDYVVHLQTTLS
YLTGQLYLKKREYPIYDFWWDVYNEYIEHPNWREPAKKVFSSLTYQNKTEKLSEQTSSEL
YGDTISASVSRMELFHACPFSHFATHGLKLRERQVYRLEAPAIGDLFHAALKYIAETVMH
QELMWSSLTREQCENLARDAVEMLAPKLQNEILLSTNRHHYIKRKLEQIISRASLILSEH
AKHSGFSPIDLELEFGPKGKLPSISFPLKNGTNMNLIGRIDRVDKAEVGDEVYLRVIDYK
SSGQELNMNEVYYGLSLQMLTYLDLIITNSTILVDKKASPAGVLYFHVHNPMISSKKILT
LDEIEEELLKKFKMNGLMLGEERVIQLMDETLEKGNSPIVPAGFKTDGTLTKASKVATRD
DFSKMQKFVRHKYKDSGNKIISGEVGIEPYRLNDKKPCTFCSFKSVCQFDEALETNQYRQ
LPAYSKDEVLQLIREEANTSERD
>PK3-045_03875 Signal peptidase IB
MKEAIKKESIEWLKAFAIGIIIFIIIRAFFFSNYVVEGESMMPTLQDGNKLVVNKVGYKM
TDFNHFDIIVFHANKNDDYVKRVIGIPGDKVEYRDDHLFINGKKYEEPFLDDYRKQVSSG
RLTGNFTLKEITGEATVPKGKLFVLGDNRLGSWDSRHFGFISIDQVVGKVSLRYWPFNEI
QFSF
>PK3-045_03876 hypothetical protein
MDMNLIKEWFTLERIMDLIDSYRSFGPLPGVLLPLIEAFFPFLPLFVFIMANVNAFGFWL
GFLYSWVGTILGALLVFSIIRKYGKKRMLRFLSNHKKVQKPMIWIERHGFGPLFLLLCFP
FTPSALVNIVAGLSRISTSQYILAVIAGKLVMISTISFIGYDLRSMIAQPLRTIPVAIAI
FILWFIGKRIEIKMNNVGIDEKERSH
>PK3-045_03877 Regulatory protein MsrR
MGREEYRKGKKRRRLRKGRVFFLVLILFILAVTIYSIFQYKQGEKQSLGKIGIDEVKYEF
NGEKDSNGGTNILLLGSDQRKGEKQSRTDTIMIAQYHPDKGTYKIISLMRDMYVDIPGYG
QGRINTAYTVDGPELLRQTIKQNFDIDLQYYAIVNFEGFEAVIDEAFPNGVEIDVEKQMS
KNIGVTLEPGLQHLNGKQLLGYVRFRHDAESDFGRVARQQKTLQAIADQVSAVQTFAKLP
KLAGVIMPYINTSMDTGDMLFIGKDLLTSKSHEVESLRVPVDGTFQDMKVNGAAVLSVDL
EANKAAIKEFLAQ
>PK3-045_03878 Dipeptidyl-peptidase 5
MKESKRINAEDLYELNSVVDPQVKGEECLYVVTSICQETDKYYSNIYYKDLNTLETMQWT
FGKHQNHSPRWSPTGEEIVFISNRSGKNQLFLLSKKGGEAEQLTYLVNGVSNPVWSPDGT
EIAFQCHFKKGETVEDKEMKTDEKEEKLSALEVTNMKYKSDGKGFWDGSYDHIAVLNIKN
KTIKQLTSGENNYYLQSWSPNGQYIAISADESKEKDFSFISDIYLYNRKEESWKKITEGN
GNYGKATWTPDSRRLGLIGSDREYENATLSQLWVYEVEADFLQCLTPEWDVNVGDYAIGD
FQQGTVTPGMLWGEDNESFTFLATDHGNTVVYFGNTSGAIYPSLIDNQHVYGLSTGGSLK
KAVVAISTPTHPGDLYTLNLETGETKQITNVNKVFVETRAFSEAEPLQFTSRDGWDLHGW
LMKPQGFKEGEKYPMVVEIHGGPHAMYANSYFHEFQTLTSNGFAVLFINPRGSHGYGQQF
VDAVRGDYGGKDYEDIMDAIDYAIETFDFIDASRLAVTGGSYGGFMTNWIVGHTDRFKAA
VTQRSISNWISFYGVSDIGYYFTDWQIKADLNDIETLWKHSPLAYVNNIQTPLLILHSEK
DYRCPIEQAEQLFIALKVQKKKTKFVRFPESNHELSRSGKPALRIERLNYINNWFLEYV
>PK3-045_03879 hypothetical protein
MTRIPEIERDVMEKAIYLPMLLTILNRDLQVIKISNLKLKQPYIDLLENAMKVVQSELKK
TKSYMYKHTMKIQEVNRDEAFTMFLFIYNGYEEYHNYFNPRLRNKVQELLEHYLYKRFTI
S
>PK3-045_03880 hypothetical protein
MEENYLIVEKYYINYHTLAVLPYIVANGDIYSKVYEHNNVFLCKRSPLMIVKATCGYLGS
SYEGRREGTRQLMTYYHKLPIVIDDFNSVYFFPTHSPRNNNCAWISLHHILDTKKIEASK
VRITFQNLQSVEIGVSLYTLRNQIMRTNSLKTLQRYNHEASINPKLTYKSLLVDKQKKLA
EAQGMYKKK
>PK3-045_03881 hypothetical protein
MNDKSYTEFTKLSGQKKNTNTYVKDLYIEMLLSEIQLKNEKANLMSLIDKAIDEHDRKTF
NELSNEFNLLCKRFGT
>PK3-045_03882 Protease HtpX
MTRKIGFYAVVAYVLYGLFFYWYLFQYTSPALPFEYQGSQADPSTFLNSRELVLSEEYSR
VRNFLFFISTPFEWLFYLFVLLFGFSKVFKKWGEASAKYKSMQTAIYLFWLNITAFIITF
PLSYISYSVSKTYHISTQSFPSWMKDQFIDFWVNYVILFLIVSVLYWLMNKSQKRWWLYA
WVLSIPFTLFLTFIQPVVIDPLYNDFTPLKDKELEAEILKLASASDIPADHVFEVNMSDK
TSALNAYVTGIGSNARIVLWDTSLKELENDEILFVMAHEMAHYVEKHIYIGIGISLFTSL
FGLYFIYKLLHWIVNRWGAALKIAKVEDIQSFPLILLLTSMLLFTVNPLTNVISRYEEKR
ADHYAVELTENPEAGIVTFQKLAKTGLSEVNPPLLVKIFRYSHPTMLERISKLEEESIRL
QNQKK
>PK3-045_03883 Lipoate-protein ligase LplJ
MLFIDNKGITDPRINLAIEEYALKNLDINETYLLFYINEPSIIIGKNQNTIEEINTDYVE
SNDIHVVRRLSGGGAVYHDLGNLSYSFITKDDGNSFHNFRKFTEPVVQALKSMGVNAELS
GRNDLLAEGRKISGNAQFSTRGRMFTHGTLLFDSEMDHIVSALKVKKDKIESKGIKSVRS
RVANITEFLPEKISIQEFRSLLLSYLFDGEENIQEYVLTAEDWEKIHQLSKERYQNWDWN
YGKSPKFNLQHSHRFPVGQIDVRFDVVKGIVKNCKIYGDFFGVGDVEDIEKRLIGVRYDR
SELEKALDDISIKHYFGNVTKEDFLQLIY
>PK3-045_03884 Chromosome partition protein Smc
MKQSLLKAELSSIFKNKMVLISVIAIVFVPILYAGIYLWAFWDPYGNLDKLPVAVVNEDT
GTEMNGKSLDIGKDLVENLKDSEDFNFKFVDKETGYKNLENQKYYMLIEIPKDFSNNATT
LLEDNPQKLDLKYVSNPGYNFISSQIGNSAIEKIKQGVSKEVTETYAESIFENITKMSDG
LKTASNGAKDLKDGTDKVKSGTEEVYKNLETLAEKSIQFSDGVNSANNGVKELANGADDL
NQGLTQLQSAQGKLNDAAQKLQGGDQAILDGVSQAKDGINTVKANIPSLIEGTNKLQTGS
NTLTQGLTDWSDKSAQLAAGANQLHEGATTLQETVNAIMPMLQGLPEENKQQLVAALKGL
VDGSSSIATNTKALSQAADQLAAGGTSLSNGITDLNKGQKQLQTGINQLSDGSSQLENGV
KQQVAGQEQFVAGMNKYASEFAKAVNGSTKLSTGANTLVSGMNTLATGSNALSDGTDLLK
DGSKKLVNGTSSLLDGSKELSSKLSDGAEEASSIHSDEKTYDMIAEPILVDQDKVSDVPN
YGTGLAPYFISLGLFVGALMLSIVFSFAEPEEQPKSGIRWFLSKTIILIGVGILQALVAC
FVLLVILGMEVESVPLFILFTILTSLVFFSIIQFLVTLFGNPGRFIIVIIMIFQLTTSAG
TFPLELIPNVLQHIHNLLPMSYSVAGLKAVISTGDMDFMWHNAEILGIYPLIFFAGTAAY
FIFKYKRYYTNKEVEVTVE
>PK3-045_03885 HTH-type transcriptional repressor KstR2
MAVDRRKLILEAATKSFSMFGYKATTMDHVAKIANVGKGTIYTFFKNKEELFFEIVNDLI
TEMKERADESFDSSSTFMENAHRAVMNMLEYRKEHHLTVKLFQEQREIGTLEVKEVISHL
ENAILNYMKTRVQEAVDKGEIHTQNPELTSFIIIKVYLALIFEWEKHHPPLTTEEIASSF
ELHLFHGIANPLNK
>PK3-045_03886 Ferrochelatase
MSRKKMGLLVMAYGTPYKEEDIERYYTDIRHGRKPTDEMLHDLKSRYEAIGGISPLAKIT
MEQAKGLEAHLNEIQDDIEFKMYIGLKHIEPFVEDAVKMMHEDGIKEAVSIVLAPHYSTF
SIKAYNNRAKEEAKKLGGLTIHSIESWYKEPKFISYWVNQLKETYAKMSQEERENAALIV
SAHSLPEKILQYGDPYPDQLKDTAELIAKGAGISTYYLGWQSAGNTPDPWLGPDVQDLTR
DLHAKYGYKAFVYVPVGFVAEHLEVLYDNDYECLVVTEEVGASYYRPKMPNAQPEFIDAL
ATVVLKEIAVPIKG
>PK3-045_03887 Uroporphyrinogen decarboxylase
MNKQMKDTFIKAAKGQPTEYVPVWYMRQAGRSQPEYRAIKEKYSLFEITHQPELCAYVTK
LPVDQYDVDAAVLYKDIMTPLPAIGVDVEIKSGIGPVIENPIRSMEDITRLGMLHPEQDI
KYVLDTIRLLTTEQLNVPLIGFSGAPFTLASYMIEGGPSKNYHKTKAFMYAKPDAWHALM
EKLGDMVVTYVKAQINAGASAIQIFDSWVGALNVEDYRLFIKPVMHRIFSELESENVPFI
MHGVGASHLALEWNELSLDVVGLDWRLPISDARKMGITKAVQGNLDPAVLLAPWSVIEER
AKQIIEQGIEQPGFIFNLGHGVFPDVDPAVLKKLTGFIHEYSGDLLSKRARK
>PK3-045_03888 Heme-degrading monooxygenase HmoB
MNIYLTSGTYDYLGKKYENKFSTETLLLMQEEASDRAILLHESQAPSFFQEPRSYDILFS
YGMLENKGFITMNHIPVSEENKPVFEHKMMKYFTSIANKAMTAIRFLRPAKGDTYILFCL
WEEKANYIKWKQQEANAEAPIGKSNEKSWNSSQHSIFNGKPYFVQLTIPDEEKA
>PK3-045_03889 Transcriptional regulatory protein LiaR
MIRVVVVDDHEMVRKGIISYLMTEPNIHIVGEANSGQTAVQLVLKEKPDIVLMDLLMDNG
NGIEATKDILKGYPSCKVIIITSFYDEAQVIPAIEAGAFSYLLKTASATEVVRAINKAYS
GEAVIEPKVANVMVKKLRATERKPHDDLTERELEVLMCIGEGMTNQAISEELYIGIKTVK
THVSNILSKLAVADRTQAAVYANRNGIIKTR
>PK3-045_03890 Sensor histidine kinase LiaS
MRQTISRYGYYRNIVLTSLSISLLLFISIYLFPNFVTSRIGNIIFAVNCFFLITLVGFYF
AFKWSGKIKKQLDEIFWFISSLRRGKIPQKMLLASSEYVYDVKEELNQLADYQQEQIHSL
QRLANEKTTLGQTAHNAAVIEERQRLARDLHDVVSQQLFALNMMSSAAYKIFDQDPALAK
QQLQEIVSIAGKAQGEMRALLLHLRPIELSNDTLCDGIIKLIQELKGKTMLHFSASIDEI
DGLSTAGQEHLFRIVQEALSNVLRHSHADKVRIILEERGEYASLHISDNGKGFDPTIERI
ASYGLKTMRERCEEIGGVMELRSKIGEGTYIDIRVPTKGWEND
>PK3-045_03891 Protein LiaF
MRKSISKIMFSISLLIVGVILLLVNIGVISLEIKKLFVIIYPFLLLVYGLLSLYQITLKQ
KSNLFFTLFILTFATLLLLDRFQVLEFRFIDFWKLWPLILILMALGLIKPKFTFEDDSGG
KSYTKKSNLMGDVKYNTDNWAVEPMEISHGLGDVYIDFSKAFIPEGETELFIHARIGDVK
IIVPDDLAIYVHAEVKIGEVRILQSVKEGIGNTLEHKSAYYEEAIKKIKLNILLDIGDIT
VQKV
>PK3-045_03892 hypothetical protein
MGIELTALHWIYVLFIVFIIGFMVIRRDTTFICIVGIFLLAITATGSLSTSISSIFNSFI
FAITELLPTIAVISIIVAMSRILTKTGINDVMISPFSKLIRSPGLAYWTIGIVMMLISFF
FWPSPAVALIGAVLLPVALRVGLPGIAVAMAMNLFGHGIALSGDFIIQAAPKLTADAAGI
PVEDVMHASIPLVIVMGVVTTITAFYFIKRDMKRGTLTFATGVTSINKSDILPQVNKLLL
SNTQKKLFAILIPILYILDVAAMFLLDLQGGDATALVGGTSIFILLLITLVSYKNKGLEK
TTTYLIEGFQFGFKVFGPVIPIAAFFYLGDSGFSTIIGDFLPKESHGIVNDLGVALASTV
PLTKEIGAVTLTAVGVITGLDGSGFSGISLAGSIAGLFAHAIGSGISTLTALGQIAAIWV
GGGTLVPWALIPAAAICNVDPFELARRNLLPVCIGLVVTTIFAMFLI
>PK3-045_03893 hypothetical protein
MDIRKSKMAWVLIIVSFLLFILLILAVNGQAILAFDTELAHFIHTLFPASFLLFWEGMSS
IADKIGIGIIAFLFILFLWWKKKDFVGIAAFVFCVGLGNELNKWVKDLVARPRPIAAAVL
ETDSYSFPSGHAMVGLLLYLFIAHILAKEIKGNAGKLILAAIAFMVILLIGISRIVLEAH
YPTDVIGGYLLGGIWLFVWVGLYETFYDRFHKQKGAGTKLSS
>PK3-045_03894 N-acetyldiaminopimelate deacetylase
MLQIIWEQLDNYYNEMVKIRRYLHQYPELSFKEVKTAQYIISFYEKLGIQVTGNVGGNGV
VAKISGGKPGKTVALRADFDALPIHDEKNVAYKSKVSGVMHACGHDGHTATLLILAKVIN
EFKEELAGNFVFIHQHAEESNPGGAKAMIEAGCLENVEAIFGTHLWATLPTGTISYKAGP
MMAAADEFKIKIQGQGGHGAQPHKTKDSLVTASQLVLNLQQIVSRKVNPIHHAVLTVGYL
ESGNAFNVIADTAILGGTVRTFDEETQLLIKEELERVIKGTCYTANSTYEYDYDDGYPAV
VNHPEETSLLAHCAEKVPGVIVLEGEPELTGEDFSYYLQHVKGTFFFTGAMPDTNGPTYP
HHHPKFDINEEAMLIAAKTLGSTAITYNISLSPAKARTNLNS
>PK3-045_03895 hypothetical protein
MNEYEQRALKEVEEWKWKIQKRSSILNRVSKKAQNKINSYIPAKVHQTLTEAIKQMIQAT
LAGSNIIKKKNPSIFRSLQGKDEELTKKISQFQKIAVVEGAGTGAGGILLGLADFPLLLS
IKMNFLMEAAATYGYDTDQVEERIYLLYIFQLAFSSEEKRREVLEIIENWEEEKHRVATL
NWQDLQQEYRDFIDFVKMLQLVPGIGAAVGAYANYNLMDQLGEAAKNVYRWRYFQEQNK
>PK3-045_03896 hypothetical protein
MFEFNEKQLWRERAGQTAKEYSQYLKYIFNGHVVIVLVFLLGTGAFYYQAWLKTISNDFP
VALIMSIILTLFMTNSPIYTFLKDADRIFLIAVETKMKRYFLQSLLVSFVLQGYLLVIIL
AALMPLYAQVHGGDFSRFWYLLIVLLISKGANLLIRWHIQYYVNVRYHHIDSVVRFLINL
AILYLLFADSSPLFILALLLIMAFLLIYFQKATSNKGVKWEYLIEQDEKRLASFYRFANM
FTEVPKLRNRIKRRRFLDVLFSRVSFARENVFTHLYWRTYVRAGDYLGLTVRLTLISGIF
IFFLSFGPGQVFISVLFVFLTGLQLLPLWNAYDNKLWITIYPVAASLREKSFKQILAAIL
SCQGIILSLIIALKGDWMYALISLVVNIVFIIFFTLFYINKKLKKG
>PK3-045_03897 ABC-type transporter ATP-binding protein EcsA
MALLEIKNVTGGYTRNPVLKDISFSIHANEMVGLIGLNGAGKSTTIRHIIGLMEPHKGEI
LINGKTFEGDKEAYRKEFTFVPETPILYDELTLEEHLRITAMAYGLSESDYQKRMEILLK
EFRMEKRLKWFPAHFSKGMKQKVMIMCAFLVEPSLYIVDEPFVGLDPLGIQSLLDQLKIM
KDRGAGILMSTHILATAERYCDRIIIIHEGQIKSQGTMEELRTAFNMPNATLDDIYIYLT
KEEEHV
>PK3-045_03898 Protein hit
MSDCIFCKIIAGEIPSKKVFENEHVMAFLDISQVTKGHTLVIPKRHVKDVYELTPEIASN
LFEVVPSIASAIKEVYEPIGLNLLNNNGEKAGQSVFHYHMHLIPRYGKGDGFGAVWKTNF
DGYSNEELTEIAEKINSKVR
>PK3-045_03899 Phosphoserine aminotransferase
MKRAYNFNAGPAALPEWVLHEAKEHWLNFNDTGMSLMELSHRSKDYEAVHNEAKELLKSL
LSIPDNYEILFLQGGASLQFTMIPMNLLPKSQTAYYALTGVWSEKAMKEASKLGNTAIST
SSKNDNYTYIPAHEQMNIPDDAAYLHITSNNTIFGTQWSSYPSNLSVPLIADMSSDILST
PIDVSQFGIIYAGAQKNLGPSGVTVVIIRKDLIKEDSTLPTMLSYHTHAKNNSLFNTPPT
LGIYLLSLVLKWVEKQGGVEGIANINNEKAKHLYEVIDQSNGFYRGHAEKTSRSKMNVTF
TLQTEDLTKDFLREAKEAGFVGLNGHRSVGGCRASIYNAVPLEHVVALSTFMRDFQLKYH
Q
>PK3-045_03900 hypothetical protein
MSAKSFLSGFLIGGIAAGITTLLTTPYSGKEVRKACSDNGKAFLQHIQELKLDLNEIKDS
IKTATVEGKTVFSTFIEDLKLSLEAWREEVKPHQEILQKELDGLQSTINELENDLK
>PK3-045_03901 HTH-type transcriptional regulator Hpr
MDESQISMKDALLFTQRIGQLSKALWKAIEKDWQNWIKPYDLNINEHHILWIAYQLNGAS
ISDVANFGVMHVSTAFNFSKKLEERGLLEFSKKENDKRNTYICLTDKGKKVFVQIMEEYN
PSNSSALSASLPIKNLYGKFPELLDIMTIVKHIYGDNFIEIFEKSFTNLDDILEEDEGHL
KQKEPVFTK
>PK3-045_03902 hypothetical protein
MNCWKTVNFHKKYGAQRLFILSTMTMIGCFLFLYVPIISYFAHNKLSDDYFLLFMAMFLL
MYPLHKLLHLLPMLHLGDKIKKTWTKHLQFLPILHIQVKEPIGKMQFLFALIIPFVIISG
VLFLSCFLFTSYVHYFLMLFAYHTGICVPDFIRIKNLWHSPRSCYVEENEDGFEILINNV
SELS
>PK3-045_03903 hypothetical protein
MMISIFIILAIFILYNINRLTNALCLQKEIPEEKQPKVFRTINVLITILLISSYVDILF
>PK3-045_03904 hypothetical protein
MRQNTTGTIKRGGIFMSGGGVYGGGFALLVVLFILLVIIGAAWL
>PK3-045_03905 hypothetical protein
MLGIPLWVIFVLGGIAISAFMAVKTGKEDRAAENEIIEREGEVYMKRLEEEKKRRDGEER
VYEN
>PK3-045_03906 3'-5' exoribonuclease YhaM
MEKKGVLQYEVGEQFESYLLIKNATKAIASNGKPFMTLIFQDKSGEIEAKLWDATEMDEQ
SYRPETIVKVNGDIQSYRGKLQLRIRQIKVATGEEGIRLADFLETAPLTTDEMLSKITHY
IFEMQNPNIQRITRHLVKKHQEAFLQYPAATKNHHEFVSGLAYHVVSMLDLAKAIASLYP
SLDKDLLYGGIILHDLGKVIELSGPISTSYTLEGNLLGHISIMINEIGKAADELGIRGEE
VVILQHLVLSHHGKPEWGSPKAPLIKEAEILHYIDNLDAKMNMLDRVLDRVKPGEFTERV
FPLENRSFYKPTFHK
>PK3-045_03907 putative protein YhaN
MELKKITIYGYGKLENITFSIHSPVHVFYGENEAGKSTIMSFIHSILFGFPTKQQTELRY
EPKLQHKYGGKLDIYFPKFGLTTIERVKGKATGDVTVTLADGRRGQEELLDELLAGIDKA
LYQSIFSFNLHGLQNVQQLRGEELGRFLFSTGAVGSDRLLKVENELQKELDVRYKPSGKK
PVLNEKLQVLRDKHSQLKSAEKDNNQYEQLLAKKRKIEQERQLTEAELKKEEHEKWLLEE
WIKIRGMVREQELLEQKLATCKDFNFPQNGLMRWEALKEKLLSVEAEIRHIEARMEETEQ
EIASIPIQEELLIAENNILLAVEKFPVYEQLQNRQTQVENQVKKIEEDIDSLKSKLHLPI
EEKMLLKESNTSIFLKEQCAQAASKQRRLKEQKEELDERLKAEQTALESLEEAVKENKQR
LLPKEERARLEERINADHQYSWNKEKADLLSREINQLEDQRKLEEKRMKHNTMITSVLTV
FLLLAGAGALFFEQWFITLICFVVCVVYVLFFLSGRKLAKNEISKKEKRLVLIKEERTKL
VESFEKGQGISRYEAQKFEEDTTRREKFTQLQFKLEQQNESYERVLEAFEKWEGDFLSHQ
KLLRQLANELNIPYELATQQIYDAFLLIEEWKGKDRERNSYHQELEEIHRESEEIISKIS
YFFRTFIGDEKDTIANMCYRLKTTLKEEKKKTDRKEALRTKQTELSEDLDKYQTEYNRYA
EEKAALFSFADVTDEEAFREKATLEMERAKYKERLAAINVQLEMTNIAKEHISLYQQILN
PELQLEEKKKRMDKLASRLQELVEEAAATNFTISRIEGGGTYTDLLHSFKQAQSEFKEDV
KEWAKFAIAKQLLAKTVEQYKQKQLPAMLQKAEENLAFLTEGKYIRIVPKEEGAGFLVES
QHHLFYEAKELSQGTTEQLYLSIRIALAQTFYKSFCFPFIIDDSFVNFDEKRTEKVIQLL
KNCKQNQLIFFTCHRHLLKYFPDESLHVLPVEERETSL
>PK3-045_03908 putative metallophosphoesterase YhaO
MEISFIHCADLHLDSPMVGLKNLPVTIHNKLKESTFTAFKKVIDAAISKKVDFIIIAGDI
YDGEDRSIKAQIRFRNEMLRLEENQIEVYLIHGNHDHLNGSWVQIELPPNVHVFPSMVTV
KKYVKNNLSVNLYGFSYETRHIKERRIVEYERSGEANFHVGILHGNLEGSTEHSAYAPFQ
VKDLLAKKMDYWALGHIHKREILESVPPIVYPGNIQGRHKKETEVKGCYYVELRDEDASL
EFIPTSEVIWETVKIDASFVHTFDDLYKLCRKEMDAVGDRKYSYLISLEIEKLRLQDSFL
ASDLLEILQQDEVDEDSFVWVNSIKVQENTEWLKENLLRESAFYEELFAVTKDFELVNEA
VAPLFQHPKAHRFLEELTAEEKQELAEEAEDLLLTMLVKRGGN
>PK3-045_03909 putative protein YhaP
MNSFWVILFHTFLSKFKTKSFLITTAITLIFVVALTNITTIIDTFSSDEGKTEVAVIDQS
NSLLPAIQEATETLNEDLKLVAYKDSEEAAKQEVEEGNYSGLLIVNMDESKLPIATYYTM
DIAETTVSDNITNSIQMVKSQLAANQLNLTNEQLTKLNEPVAFEKIALEKDAKTEEELNQ
ARGLVYVLLFLIYFAVILYANMIATEVATEKSSRVMEILISSVSPIKHMFAKILGIGLLS
LTQLAILMLVGYFSLTNNDSLGSMEGFFGFSEVPVSTIIYAAIFFILGYFLYATLAALLG
SLVSRIEDVQQMITPMTLLIVAGFMIAMFGLSAPDTTFVTITSYIPFFTPMLMFMRVGML
NLPVWEPILGIVVLVATIMILAIFGARVYKGGVLMYGKSNSYKDIKKALQLTKKE
>PK3-045_03910 Multidrug efflux system ATP-binding protein
MSLELRNVTKKFGSFTAVDDLSISIPENEMFGFLGGNGAGKTTTFRMILGILESTAGQIT
WDGKPINYSTSPYIGYLPEERGLYPKLKVRDQLIYLARLRGMEKKAALNELEYWLNRFKV
PEYMDKKVEELSKGNQQKIQFISAVLHKPKLLILDEPFSGLDPVNVEQLKSAVVDLKNNG
TSIVFSSHRMEHVEELCQHLCIMHKGKPVVHGSLKDIKRSFGKKNVTIHADFDLTHLIRY
PGVLKLKETAEGVSLQIEGEEVAERILNDIVGKGFIRKFALEEPSLNDIFIEKVGASLE
>PK3-045_03911 Guanine/hypoxanthine permease PbuO
MFKLKENNTTVKTELMAGFTTFLTMVYIVVVNPGILKEAGIPFDQVFLATIIAATIGTLW
MALLANYPIAIAPGMGLNAYFAFSVVGNNNVDYTVALSAVFVAGIIFVILSLTSFREKLI
QAIPDNLKHGITAGIGLFIAFIGLRQTGIIVANPENLVGLGDLQSPTVIIALIGLAITIV
LFSLNIKGALFIGMIVTSIIAYFSGYLSFENGIMASPHLPEGLIISNPISAFGDVIQHGL
YAVVFSFLLVTIFDTTGTMIGVAEQAGLIKNNKLPKARQALLADSLGTSVGAMFGTSPTT
AFIESTSGVAAGGRTGLTGVTIAVLFIISAFFAPLVSSISGLSAITAPALIIVGSLMMGA
ISDVKWSEFDEAFPAFIVILSMPLTSSIATGIALGFISYPLLKLVKGKGKTVHPLVYVFA
VLFLYQLVFLPH
>PK3-045_03912 Oxygen-independent coproporphyrinogen-III oxidase-like protein HemZ
MKQIYIQGLTDERYIRPLEHIGNLFFEDTKVLYRELEEKADLHVEFETEIIGHEFIVKGK
LKELKEETICNSHADLSQLTDKEIFKQMKKAISKSYLLLLQEYTGMVQKWGILTGIRPTK
LLHRHMQKQTPIEEAHQSLREEYLMSDEKIELMQKIIDRQLAVIPDLYDLKKEVSIYIGI
PFCPTKCAYCTFPAYAINGRQGSVSSFLGGLHYEMEKIGEWLKEKNINITTVYYGGGTPT
SISAEEMDMLYERMHASFPNVENIREITVEAGRPDTISPDKLEVLKKYNIDRISINPQSY
TQQTLKAIGRHHTVEETIEKYHLARKHGMNNINMDLIIGLPGEGVEEFQYSLDKTEELMP
ESLTVHTLSFKRASEMTRNKSRYKVADREEIQEMMKMAEEWTEKHDYVPYYLYRQKNILG
NLENVGYSKKNQESIYNIMMMEELQTVIGVGCGASSKFIHPVTGKITQFSNPKHPKTYNE
SFVEYTDKKIALLNEHFSLEASK
>PK3-045_03913 Stress response protein YhaX
MIYRLLALNIDGTLLQSNGRLTKATKEAIEYVQQKGIYVTLVTARSLPSAKKVAKALKLN
SYIVAHEGALVANNEDDTIFVKRIADDLTSDIVRFLEGFICQIRLVHEKFSLANKSKLHH
NMLAKTVLSSGDPVFYSHQFVDVLSDVLLEEPVSPPKMEVYFEEKKDCEDAKEVLGKMFD
NIHIVQHNELRLDILPAGVSKRSGLLFLGEKLGIKSSEMVAIGDGLDDLEVIEAVGLGVA
MGNAPNQLKIAADWVTRSNDQEGVAYMVKEHFRKQHPIEFLRKMNIIK
>PK3-045_03914 Small, acid-soluble spore protein 1
MANNNSNQLLVPGVSQALDQMKYEIASEFGVNLGAETTSRANGSVGGEITKRLVQMAEQQ
LGGSRF
>PK3-045_03915 hypothetical protein
MAVNLHDPANALEKAIRQSDEYTELKKMYDTVNGDPSAKAMFDNFRNIQLQLQQKQMSGQ
EITQEEVEQAQKTVALVQQHESISKLMEAEQRMSVLIGELNQIIMKPLEELYGPAQQQ
>PK3-045_03916 Endospore coat-associated protein YheD
MTLKFLQLTKKDDFQKTLKGLSIAISPSLLKFLHVDLHDDVYVCIAKMLIPVNVQTHSLE
KQDIVFSTDLEKNLPIPKEINTYLLPYYHKNQIIHLGPVIGILTEVNDDKEDISFPAIQH
LCKELTEELTQIGGFFYLFGLQHVQDDFVHGYFFANNTWSKQPLPYPNVVYNRLHSRKAE
ASTSFLQLKKILEDKEIPIFNSKFFSKDETYQLLVKNAEVTLHLPVTEPLTVENLHFMLK
NFPVLYVKPVHGSQGRNIIHIESFNNHYIATISSGKRKGKSQLFTEEKKLWKWLEHYSKG
RSYICQQGIDFQKWQGRSLDFRILCHKNYQGNWTITSTVARIAQKNAIVANLAQGAEMKP
AKAVLNELLHTENAEQKLEELKRLAIEIAILLHKNTDGYLGELGIDIGMDKQGHLWIIEV
NSKPSKKLEEHIEKTRPSTKALLEYFIALSFSPCLKELSDDE
>PK3-045_03917 hypothetical protein
MNNFGIMSLSLDHENHYIHQIAKYGRDFGFTIYHFVPSTYHPFTHTVKGKQYMPDSDSWI
EAEFPVPSILYDRCFYHDDSHSIQCKNIIQWLKKQPTITFLGNGLPNKWKLYQVLRESKL
SAYIPETFLLQSANQINFQNLNPVIIKPINGSQGNGLYFIKKQNKDILVRTDKKEKTIEK
IFSDQVTFNKWLNQLLKRNSYIMQVHLPLTNKEEQPFDIRALMQKNPKEEWNVIEKGIRI
GEKGRIISNLSAGASIIAFEDWFQTAPFPLKGFLKQEMEEILTLLPSILENSFSALFELG
VDIGISPNGSLWILDVNSKPGRKVIMTAYPHLCEKLYQAPILYAAKLADDKRRNRDEEAI
SYRNNL
>PK3-045_03918 Endospore coat-associated protein YheD
MKKLYPIEIISNSENTVYLPTDFEANKNLKIIAFGTVSKEATIKKHKKSKNIIGISSDLF
KELLLPSNSSNVHLFSDDETIYIGPLVGIFTSGFSTIKVRPIGDRSILFSKLLSVQKTVG
VIAFLFGEQHINWETGTINGLFYEDGWKSVEVPFPNVVYDRIPNRRIENLHRIQAVKTRL
QKEYSISWYNPGFFNKLDIYERLLQDDSISDYLPETHALTNFSVIERMLSNFGNVYIKPK
NGSLGKGIYQILFDKKDGCYYTRFKDEEQGNRLMKFDHLEALMNHLFENQNLSHYIVQQG
IHLIRSEKKSVDFRVHTNKNKDGQWEMTAMAAKIAGTGSVTTHLNNGGTVKAIEELTNTD
LHCEEISNKLSKASLQISKAMEKQMEGYIGEIGFDLGLDRKGRVWLFEANAKPGRSIFKH
PSLKKFDLETRRKSLEYAVFLMDQSIKNLEDIYQ
>PK3-045_03919 Endospore coat-associated protein YheD
MNIYYDSEKECWYTASRDTYLFGASNMCLANLMPAANHAAFPIVPHEDKVGPLIGIMIAR
NKHNKLIGNGELFKQLQEKLQQHAGGIIVIFPPENLQTEKLTGYIFCSSRNSWIKAITPL
PNIVYNRVPFRKTEKQEPFQTAVSFLKEQGIPFFNASFINKWELHQLFRDSPFLKEHLPK
TTLLKQKEDFADFLLTYKNIYLKPVEGFKGKNIYRIRLKQNDSIHVSTTEETKYYSSLNQ
VWEQYQQDWLQREYLLQEEIDGALYNGNRYDFRLLVTFENRYVLTGVGVRQSTQQNVTTH
IPSGGKLLSYQEVQQKEHDLFFKKIVDHCGILLTQKYGFTGEFSIDACVDKNGQYYLFEV
NAKPMLFDEKEIEEKRCQQLIKLFYSLTNFPFQNKSQEMTHPKT
>PK3-045_03920 hypothetical protein
MKKAKKDLAYEGKEKAYLDIDRIINEGLAGGTVINRENNTNMEEARELPEEEPPHLIE
>PK3-045_03921 hypothetical protein
MFLLAKGVLFCSHSIDFMILSANVEDFPAGFLFYQPNLWSFQPNFWFISQICTLFSQTFI
LSAKSALFSAKLLVYQPKHHTFQPNFLFISQNTTLFSQTSFLSAKTPYFSAKLPFYQPKH
HSFQPNSLFISQNTTLFSQTSDLSAKSALFSAKLPFYQPKHHSFQPNFLFISQNTILFSQ
TPFLSAKTPLFSAKLPHHKPSSSLAPFL
>PK3-045_03922 Leucine-rich protein
MKHKLLAYYKHSLEQAVPPSPSQLSDYYWFKVDFQDDWIGIQKQEIDDSQLELLKACYDF
FQPDETLKKEEYSWNQYLYFNGEQPSFKNMETLRFIQFHIKGDTTSIERKLIESAFDGFI
HENSLIIWNGSNEGVVIEQNAQYLEEEDFTALAQALQSDFFFSICFYMGKELKLNSSIPV
IFGQERNFFSKGLAFMPKSTVLSLETILPNLLISRLKEDELDLFKEWFSIFEEDKELLLT
IKTFIENNGHSTNTAKQLFIHRNTLQYRLDKFTEKTGLNLKNYHSYITTYLACLFHTSGK
>PK3-045_03923 Oligosaccharides import ATP-binding protein MsmX
MAELVLKNIYKIYDEKVEAVKDFNLHIQDKEFIVFVGPSGCGKSTTLRMIAGLEDISKGD
FYIDELRVNDVAPKDRDIAMVFQNYALYPHMTVYDNMAFGLKLRKFPKAEIEERVNNAAR
ILGLEEYLKRKPKALSGGQRQRVALGRAIVRDAKVFLMDEPLSNLDAKLRVQMRAEISKL
HQRLQTTTIYVTHDQTEAMTMASRLVVMKDGVIQQVGAPKEVYEKPENVFVGGFIGSPAM
NFFEGKVVDNKLVLGNNAFIIPEGKLKTLREQNYIGKEVIFGIRPEDIHDELVFLNSSEN
TSFDAKVEVFELTGAESLVYSTLSDKEFVARLDSRADLQAGQSVKLALDMNKGHFFDKET
ELRIR
>PK3-045_03924 hypothetical protein
MGSICPICNGLGNLESVCSNCGDRVEDKGRVMDYYDDYSAYMPIDQMKLENGYQDLSAHL
CPHLVLCPQCGQEEVLFIQE
>PK3-045_03925 Small, acid-soluble spore protein 1
MANNNSSNQLLVPGVSQALDQMKYEIASEFGVNLGAETTSRANGSVGGEITKRLVQMAEK
QLGGFQG
>PK3-045_03926 putative protein YbbA
MDSYRSRKRNIRGTVREVQIQTRTLSIYLPPSYNKLSSSFPVIYVHDGGNLFHPILHELE
ELFSLDRAEEVILVGIEPKERLHEYTPWYSPSLSPTFPPFKGEGKAYLSFVTQTIKPYID
TSFHTKADRQNTGMIGASLGGLISLYAMYEFTDYFSKFGLLSPSLWYPNSLSYVQKNEMQ
MENSVFLYVGEEEGKSKVNIQRYMVENVSLVNEVFFKKLPKEQYQFILGENADHNREHFI
KQFLYAIKWLYPK
>PK3-045_03927 Iron-uptake system permease protein FeuC
MDKERKRTYLSMYVLIALCLIVMFISLSKGEYILSFQEIGRSIFRYHPDANTDLVIFEFR
LPRIILAIFVGFGLGIAGSILQSITKNGLADPGILGINSGAGAAIVAYMFFFQGVLNLNK
DSLWFVLSMPLIGLVGGFIAAFVIFLLAKDRERLDSQKLILTGIAINSGFGSLAMYMSLK
MKAQDFEMATVWLTGSIYNANWLFILAMLPWFLLIIPFIIRKAYSLDLFQLQETVMIGLG
VKVEKEKWLLLLCAVGMIGACVSVSGSIGFIGLMSPHMARLLVGLKNRNSLIVCGLIGSF
FMLIADLIGRTIVAPAEISAGIILSIIGAPYFVYLLVKAKV
>PK3-045_03928 Iron-uptake system permease protein FeuB
MKGGSFDQVMSNLDKEKVRAYAIIYSAPFLCIAVILLSISLGTMNISLKEVFDAFFYFNA
ENVEHTIIRTARLPRAVGTLLIGGLLAMSGAMMQGMTRNYLASPSIMGVSDGAAFMITLA
FVFVPGLNSFQMVAFSFIGSALGVFLVLGLASIVKNGFSPLRLAIIGTVFGSFLSSLSSA
IASYFQVSQNMSFWYNARLHQLNNDLLLICFPLAIIGIVLALSLSKSIAILSLGKEIATS
LGQKTFIIQLLTMASVVMMTGISVSLAGKIGFVGLIIPHITRMMVGVDYRKIIPCSGIIG
AIFLVICDTLSRFINYPFESPIGIVTAFLGVPFYLYLIKTKGGGNTQRG
>PK3-045_03929 Iron-uptake system-binding protein
MKKNLFFIFLAAFLLLTACSQKGEKNTSSSIKDSKGDGQSTTQEVTYLGEKYEIPAKVET
IVTASQEAMEDAAMLGIKPAGAIATAGKFPAYLGDSMSEAEQIGEKMQPSVEKLLQLKPD
VILGTSKFQPEVADNLNKVAPMIPVSHISTNWKDNLLLLGQLTNETKKAETIITDYEKNV
TETKESIHDKLAGKKVVMLRLRGGSLYIYPETVYFNPVLYADLGLEVPEEVKKAKAQEMI
SLEKLAEMNPDYLFIQFEETENTDSPTALADLENNSIWKSLDAVKNNQVYENVVDPLAAG
GTAWSKTTFLKAFADLFK
>PK3-045_03930 HTH-type transcriptional activator Btr
MIYNWESIEINYGRIERLYAKKIERVLSTSYLFIYINSGEGMLSIDIDKFLFSKGDLLFI
PAESTYHLQFKNTCCVDYYLLPFQLYQTKAINRDTYTKVALKNENSIMKSFVFQSADTIQ
PMMEDLFKLEQDESINNHFLKKAKRSLIFHYFVTNQPQKIPKNTMIAIEETKRYMEKHYA
DTISTALLAKRAGVSPKYYSQLFKKEYGIGVQDFLTEIRIRRAKELLIKTSNSLRVIAAS
VGYADEFYLSRVFKKIVGIPPTNYRKKREVKIASYDFSTTGHLLALQIIPYAAPLHPKWT
SYYYQHFRDDIPIHLNTYKIHSEWENNIQKLSAEKPDKIIAKDDISAEEKQELEKIAPVY
YYSSKNSSWKSQLLEIATYINCEIDAENYLKRYEDKVKETRKLWKESLESEVVLVVSLFK
NTLVLNRSRTAIDLVYKDLGFTSAQPEEDIQLSEAITLSDLVSLNPTYLFVNIRQDMETI
SAWDKLKCSTEWNRIAAVKNKKVAFIHSDPWNEYSASSHLRVLDNLRELMIEKEKVQAY
>PK3-045_03931 Ferri-bacillibactin esterase BesA
MKWKESFYIPNTEIWTYSIDETKKYKIFVYIPNIPVPEDGFPVLYLLDGNANFGSYVEAV
RLQTRTREKTGLHPAVIIGIGYDTAEPYSEERYFDFTFHADQTQLPKNPTGSQWPPLGGG
KQFLSFIEQKLKPLVEQNIPINTKKQMIAGHSLGGLFVLFTLFTAPSSFQYYLASSPSIH
WNEEQLLKELDFFPKRLNPLDTNKLLLTVGEKEKSHFTQMHQKAITLSEKLQNYHSPFFQ
HIFHEFKEEDHLTVLLPLINKTIRFINDK
>PK3-045_03932 hypothetical protein
MPIKTNKMSINGANKIYTFCLDYGEFDSIRLDNTTMFKKK
>PK3-045_03933 putative multidrug resistance ABC transporter ATP-binding/permease protein YheH
MTTGKRLFQYALKFKGIIIAALIMLTIAVIADLAGPFVAKKVIDDHITGIESQWYQTEPT
KEAVKYKGNFYKKAEYLDSDKEKLAEVRILQVGRQFLFVEGKISFDGSREFHDGTLTIRK
GTDAKTYPATLLTNAEVFDFYKPEITPILKLLSFYFGLVIISAIFQYGQHYLLQKSANRI
IQKMREDVFAQIQRLPIKYFDNLPAGKVVARVTNDTEAIRELYVTVLSNFFSSGINIIGI
YIALFILNPPLAAICLILLPILYIWMIGYRKFASRYNHVIRAKISDINGMVNESIQGMHI
IQAFSKEKQTRKEFENLNNEHFRYQNKMLRLNSLTSHNLVNVLRNIVFVIFIWYVAGQSL
SVTAALSLGMLYAFVDYINRLFQPVQGIVNQLANLEQALVAGERVFELLDEDGIDVEDVT
LERYKGNVTFDQVNFAYKDNDYVLKNISFEAKQGETVALVGHTGSGKSSIMNLLFRFYDI
QSGKIKIDGKDIMSFSKQDLRKYMGIVLQDPFLFTGTIASNVTLNDPSISRETVEKALKD
VGADRVLKHLEKGYDEPVIEKGSTLSSGQRQLISFARALAFDPAILILDEATSSIDTETE
QIIQHAMEVLKEGRTTFIIAHRLSTIRNADQILVLDHGEIVEKGNHDELMARKGKYYQMY
QLQQGESLVS
>PK3-045_03934 putative multidrug resistance ABC transporter ATP-binding/permease protein YheI
MFSIFFKLKWFFKEHWKSYTIAIILLIFVGFIEVLPPRILGMFIDELTIGSLTSNKTLVY
ILGVAGITISTYIITYFWMYKLFGGANILELKLRSKFMNHLFKMTPTFFEKNKTGDLMAR
ATNDLKAVSVTAGFGILTLVDSTIFMLTILITMVITVSWKLTLAAILPLPIMAIIMQIYG
ERIHKRFMEAQDAFGDMNDSVLQSISGVRVIRAYVLEKEEQKQFHHFTEDVYKKNLHVAK
IDSLFDPTVRILVGLSYLIGLGYGAYLVFQQQLTIGQLVTFNVYLGMIVWPMFAVGELMN
IMQRGNASLDRVQETLSYKADVRNPENGKKEEVPEIIQFQDVQFQYPSSKQENLRDIYLT
IRRGETVGIVGKTGSGKTTMIKQLLREYPKGEGKLVINGNSIDSIDLHTLRGWIGYVPQD
HVLFSKTVRENILFGKEGAVEGELEEAIRLASFDQDIEMLPEGLETLVGEKGVALSGGQK
QRISIARALIRKPEILILDDSLSAVDAKTEQKIITNIKQERQAKTTIISTHRMTAVQHAD
HIIVMEDGHIAEHGTHEELMKQNGWYKEQYITQQTKVDADEVEVKA
>PK3-045_03935 hypothetical protein
MKKFAEIFKNASFTRLFIANVTSQMGSVIGLTAFMFYILDRFSDQPAYATVTELMFSLPT
LAVFFLVGVVADRMDRQKIAYYCEMIAAALSLCVLGAVLIGWMPLIFMMLFLRSAVQKFF
FPAEQGILQGVLKKDDFTTAAGLNQLVNSIFMLFGNAIGIFVYWTLGIYGAILVDVATLT
ISGLLIKSMKLDETVRKPNGSHTLKELNIRFIWSDFMIGLKYILTNKLLMALIYGFIAFG
VVNGGFSVMQVFILKYKLAPDNYEQVSIYFGIVFGAGVMIGSFLSSLLAQKVKLYKLIIT
GAFYIAIMTILASYSPNILVFLTICFFLALGLPLINIAIGGWMPTIIEPKMMGRVQGWIT
PLMMLSQSITLGLISIGYPQWFSIEIIYWFVGACFLVVGFYYSLVLPKLAKEKEAKDAIA
GKEEVQLNY
>PK3-045_03936 hypothetical protein
MTREEIIESVSEKMRLIRTEAGYTQDKMAEVIGLSKKTLVQIEKGRLYAGWSTVVAVCAL
FRETETVRFLFGNEPLEVLETVARDGMDYRKEKTLGGKVWWREVEKKNGFILQQNIISQH
FRIIDEDHFRIFSSFDEKESKDRFKELLGE
>PK3-045_03937 Methyl-accepting chemotaxis protein McpC
MKKKDSFKVKSLIGFNMLILITTCISAFSGFFIAKNENLQGLFSFTYSDYLIIVAAVIIL
TILSALVFNVLMMGKLKALSRLNDKVHRLAHGDLSVEFKDTSKDEIGQLNRSISQLQEKF
SFLVSSLKNVNETGISQASDVSVIAEETLASAEEIGRAMAEIAEGAVSQASELEEVKREI
DSLTNSIDNMEGKNQIIKKATENAQEASHNGQKTINTLKICNENASKSTNEVSIGISGLY
QKVLDISKITSTINRIAEQTNLLALNASIEAARAGEHGKGFSVVANEVRNLAEETNSATK
QIQDMIQNIEKEMESTVMSIYETTNQTAELDVAVKDTEKEFTAIARAVINSIEAVKEMTV
ELNRVVEQNNHISSSIAKVSEVSESVAAAVEQIASSTDEQTSAIGNVAKTAEIMKSSNEE
LKDSLTKYNLAK
>PK3-045_03938 Putative ribosomal N-acetyltransferase YdaF
MLFNIFVDQQIRLRLLERTDSHELFQLVNKNRNYLRKWLPWVDQITSPYQYQTIIPIWHQ
LFTEQTELNAGIFFNGKLVGMVTLQQIDWASRKASIGYFLAEDAQGHGIMTKCVVAILNY
AFYYLKLNRIEIQCGVKNGKSQAIPEKLSFKKEGIIRDGEFLYDHFHDLYSYSMLAREWA
AKY
>PK3-045_03939 hypothetical protein
MVMNEIMIGMQLLLIVILTAFSAFFVATEFSIVRVRPARIEQLVEEGHKNARTVKKIIEN
IDAYLSACQLGITITSLGLGWLGQPTILKLIQPLMNELAVPAALSQGLAFVLSFSIITYI
NVVIGELFPKSVAIILTEKVSLLVSKPLIWFYNIMYPFIWILNKSSRQVAKLWGITNPTT
NSDALSEEELQIVLKESYNNGEISLSEYNYVNRIFAFDNRLANEIMIPRTEMVTLSDHLS
IDEAINIIQKERYTRYPLTKNDDKDSIIGFIHIKQLLTDWLKNEGYENKSLSDYAQPIIH
IIETTPIQAVFLKMQKERTSIAILHDEFGGTAGLISAEDILEEIVGEIRDEFDEEETPLI
QKINDHHYILDSKLPLTEVNKVLSLSIDREDIHTLGGWILYQNPNLKKGETIEYNGCLFK
IDKMIRQHIFTFDVQKIPAHLTEEK
>PK3-045_03940 hypothetical protein
MDIFNLVIIAILIALTAFFVASEFAIIRVRSSRINQLIEEGRKNALSAKKVTSNLDEYLS
ACQLGITVTALGIGWIGEETVQHVLAPLLQIIHVPATVITVLSFSLAFAFITFLHVVVGE
LAPKTFAIHKAEQITLWVAKPLILFYKLLYPFIWTLNGSSRIITRMFGLKAVSEHELAHT
EEELRIIVSESYKNGEINQSEFKYVNNIFDFDDRIAKEIMVPRTEIASLEQSSTLEELLN
LIQKEQFTRYPITDGDKDHIIGMINVKEIMTELLKSRNLTTKTLKPYIRPVIRVIETYPI
QDLLLKMQKDRIHMAILMDEYGGTSGLVTVEDIIEEIVGDIWDEFDQEEVPTVRTIKENH
YILDAKVLINEVNALLQIDINDEVIDTLGGWILTSNYEASEGDTVMFESYAFKILEMEDH
HIKYVEVKKISDFPAQQTKHISVQQSIPSPSSEAEIVS
>PK3-045_03941 Transcriptional regulatory protein SrrA
MKILVIEDNESVCSMLEMFFLKEGYEGKFIHNGKEALDFFLENQDWDIIIIDWMLPGMEG
VTICRKIREVSSVPIIMLTAKDSESDQVLGLEMGADDYVTKPFSPLTLMARIKAVTRRYQ
KETMNQGDDKFLTTEHFKISKETREVIYNNKVMTNLTPKEFDLLYYLISNPKQVFTREQL
LDRVWGYQFYGDERTVDVHIKRLRNKIGTKEQPFIHTIWGVGYKFDESMVND
>PK3-045_03942 Cobalt/magnesium transport protein CorA
MIHSLAINKKKQLLTDHSVEDLVAGDYEWFWVDFDQPIDEEIEKLHHPFNFHPLSIEDCL
HNLQRPKIDYFETYTFFVTHCLNPKTVKKDELNIFLGKNFIVTFHHHASVEVNAVKEMLL
KEETAAWTQYTVLYQLLDHLVDNYFPIVYQIEDSLAEIDENPTNKTMEALLDELFSTRHQ
LLSLRHTVVPMKDLLHQMINTEKLAALLMKREYYSDIYDHLLKISELIESNRELTTDIRD
SYLSYNSHHSNRIMQILTVITTIFMPLSFLAGLYGMNFLNMPELHWKYGYFLLLFVMVSI
GVGMFILFKRKGWFK
>PK3-045_03943 hypothetical protein
MESSNFQTEAILEKPQHRIMPKRVLAKRIFFIIIGSILMGIGIEEFLVPNKILDGGIVGI
SIILSHLSGAKLGYFIFLLNIPFFYIGYKQIGKTFTLSTMLGITVLSLTTILLHDVPVFT
SDLLLATVFGGIILGIGVGIVLRFGGSLDGTEVLALLFSKKSPFSVGEIIMFFNVFIFIS
AGFVFSWNRAMYSLIAYFIAFKVIDIVIAGLDESKSVWIISDHSEIIGETILARLGRGVT
YLKGEGAYTGDTKKVIFCVINRLEEAKLKTIIEELDPAAFLAVANISEVRGGRFKKKDIH
>PK3-045_03944 hypothetical protein
MRKNITLSILIGSSIVCLLWLIGLGWVLIDYNNQPESSAKIASEEKIKEMEKDGIRLLAL
GDSLTRGTGDDTGKGYVGYLSDALEEKTEEEITITNYGIKGLTTDKLAEQVKEDEVQRQI
THADLLFITIGGNDLFQGGESLSELNEDSISKLMKAYSEQLQAVLSSIRSINKDAPIYLM
GLYNPFNDLDNSALTSQVVRTWNNATAEICAKYKQTIFVPTYDIFQQNVQQYLYSDHFHP
NKKGYQLMAERVASLISWEVNDNE
>PK3-045_03945 Linearmycin resistance ATP-binding protein LnrL
MSDITLSVSHLTKKIGKRAIIKGISFELKSGEVFGFLGPNGAGKTTTIRMLVGLIKPTSG
QISICGYDVKKDFSKAMERLGCIVENPELYPYLTGWENLKYFARMLTNADDKRITEVVEL
VGLTERIHDKVKTYSLGMRQRLGIGQALLSRPKVLILDEPTNGLDPSGIREMRQFIRFLA
KEEGLSVLVSSHLLSEIQLLCDRVSIILDGKIIHTESVHTLLTQKEKLIWRFTPLEKGIE
ILNKLAPSVTVQEEMVITPYIEEEVSKWSRSLMEANVAIKEMNRQIPSLEHLFLELTGGD
SVGE
>PK3-045_03946 hypothetical protein
MNKLIYNEMLKLVKSKRLLVVTIIIGIMIMMFTYAQHREMENVKKRIGDTDWRVTLQQSI
VDMQNRIGSSGISEEFRSQLKVRIDQSQYYLDHNINPQDPGAPTFLRVFLDNSIQLLLPL
MVMIISADMVSSEKSLGTIKLLLTRPVRRWKILLSKYITLILSVSFILLMFGLFSYLISG
LFFGYTGWTAPVLTGFTVEAGELNTANVHLVPQWQYILMIFGLGWFVSVVVGTLSFMFSV
LIKSTAAGMGAMLAFLISGTIISSIASSWESAKYFFMVNLRLTDYLQGNIPPIEGMSLPF
SLMVLSIWGLAGIIISFLVFTRRDVY
>PK3-045_03947 putative membrane protein YdfK
MIGTIVNTIAIIIGSAVGGFLKKGIKDEYQSALFTAMGFAAVALGITAVVQNMSNSEYPV
LFIVSLAIGGLVGTILEIDAHFQKLVNRFSQSDLSKGLSTGILLFCMGTLSILGPIESAL
HNNYTYLFTNATLDLVTSMALAVTYGFGIAFTAGVLFVWQMLIYLCAQYLESFLTNALMT
EISIVGGILILGSGLSILEIKETKSLNMLPALFIPVLWFVGLVLFK
>PK3-045_03948 hypothetical protein
MKDIFTIGEVSRLFQLKSSALRYYCDIGLLTPTYVDPVTGYRYFSTAHFERLNTIKYLQT
LGLSLQEIQTFVDNRDPVYLVNQLHAQREITHQKIKELQEIKQKIDNRIQQIEDALSQQD
IGVVKEQIFPIREMVVLRQTIPSGADLELFIRNLENSSKLQSAVFLGKIGMSIAKQKIEK
GQFDFYDAIFLLLENEAVDEAVQEEIPGGLYVTLRFQGTHAAASTYYEQLLQYIKQKHYE
IIGDSVEVTHIDYGLSNNTNKFVTEIQIPVITS
>PK3-045_03949 hypothetical protein
MSMNVTEFQEWVKDYYKSRGWSELDIFIRIGFLAEETGEVARAIRALEIGRDRPDEARGS
YEENKQELTEELGDVLGNLIVIANKYNIPLEEVFQSHKKKLSDRYSNV
>PK3-045_03950 hypothetical protein
MITMKKRFKLLIGIALILLVIIGCFLYENSYDMLEKEVTIKTEQGTLVGYLALPKTENKG
VVIFVHGDGAQNATQDGGYKPLMERFAKHGFASISWNKLGVGGSSGDWLNQSMDDRAREV
EEVIEWAKGQKTFNAEKIIIWGASQAGWVIPKVLKNREDITASILVAPAINWDRQGQYYT
MMKMKREDRTNQEISSELNKDIEESEMIKTGISYEEYKQKTGDSSMSKERYTFVQKNISS
DATEDLKNINSLIFLILAEKDENVDSEETEKIYRGLLSEKQLNVKTIPKVGHSMINPALA
NSELLINLSAIIAPKDTLISTEYLDYCESIVHRILNLK
>PK3-045_03951 hypothetical protein
MHSTMVNPKKDIQDIAVLLMEGFAGKFKTLNLPNREYEYLLHCLAEHILKKHSENLLIIK
NKNIQGILLMKPKKWYLGEFSNLLFKELSFKSFVKILLFFGALSHEKKENEIHIDFITVS
KEYRGTGIGTELIELVKNSADQSQFVTLYVSKNNNAARKLYERLGFRIVKEGTSIAGRHL
HGINQWYFMEWKGIDNNEKEI
>PK3-045_03952 hypothetical protein
MQYLTSGELAKLLNITKYLLRHYEEQQLIQPAFIDGNGYHMYGESEVYAMSHLLLLRELG
FSIKEIKSILDKEMNYEEALSDVLLKVENDIKHLNRLKENVQTVLELKQKETYKLNIEDK
EERCFTFLDDKFVDDSYNIKLKKLANWKDGSIKILDEISYLILEDGSKVKVMYESSKLEG
DYLFSAGTYYCKRICIENEQELLQEIEHFYDELAGRDAKYEDSLLLTEEVQLSAFYKEAM
VYSLEVRRNA
>PK3-045_03953 6-aminohexanoate-dimer hydrolase
MIYLTSMCQCEKIIMNNNPIYNLEDLIKKEYSNIACIIVKKDGSLVYEKYFDGYTKEDVL
HIASVTKSIISILIGIAIDKGYIKNIDQKVLEFFPDYTIRRGEKTIQNITIQNMLTMTAP
YKYKSEPYTKIYKSDDWVKAALDLLGGKGSIGEYKYSTVGTHILSGVLTNATGQSVLDFA
SETLFKPLGITAPINTTIQNKDDYFTFLKDKCVTGWIVDPTGVNTAGWGLTLTPRDMGKI
GELYLKGGVLNGKQILSSKWIEESTKEKSRWGELSYGYLWWILDDCYAALGDGGNVIFIN
PKKEMVVTIASRFMPRAKDRIELIRKYIMPLFE
>PK3-045_03954 hypothetical protein
MSSTKEVLKSFEFTVEKYLEELKKLNMEKLNRKLNEEDWSIGQMYVHLIQSAFIHLHNAE
QCLDGSESTLNPAMEKTEQGKAVFKIEQFPAVRIKVPASPNYTPQPPESMEYLVDGLHRV
VERMRNMESILHQSVVSNKMLHPAFGALNAQEWFLLIVMHYRHHFLQLDRLKTSLAVEE
>PK3-045_03955 hypothetical protein
MNKTERQLAITLELQRSKTLRAEDLASQFETSVRTIYRDIQALSEAGVPILGAPGLGYSL
MEGYFLPPVSFTAEEAVSLLMGADFIEQRLDTDYGIYAKAAKRKIEATLSESVRNQSTLV
RETMRLLHVGEPSTEDRVRTYLNQVRDAILKQCKISFVYIKNMPGTDGKRKNKRKVSPYG
LTLVHGNWILIAHCDLRQDIRHFRLSRMTELSVLEERFLLPNNFDLSSYRPPDNRDEKIL
IRATPEIADKIIEAVNFYIDTFEEREKEVIFQFRVRYPEEILHFLLGFGEDIEVIEPKSL
RHKIREVARKILEHY
>PK3-045_03956 hypothetical protein
MEPKHSVGLSSTEIAGLWGTYIYDSLSICLTKHFLHHSNYTDVNPLIQLTLDISNKHIEE
IESIFKSEGFPIPKGFSDDDLDLTAQPLFFDLFSVSYIYGMSRIGLMNYSIQLSNVARED
IRTFFSNCLTSSLDLYNKSVDLMLSKGIYDRPTMIPYPDSVEFVTKEGLLSKFIEPKRPL
NVLEISEMFFNIERNYFGLILLTGFIQVVKDKEIKNYLIKGKELAKKQIRFLNDALIKDD
LLGTIMINTEVSTSTISPFSEKLIMNLVTTLNTQGLTYIGHALSITSRIDLSTEYLKLIP
EILKFGKDGADILMDRGWMEEPPHAPNRKELGGY
>PK3-045_03957 hypothetical protein
MKYLKPFFLVTDIGFIIYWIITYFSLIPIEWAFKDYDNPIIIAWNWSFFPLDIFISATGL
YSLYLYKKTSAKWKPYALISLVLTFCSGLQAIAFWGFSLEFDISWWAVNLYLMIYPLFFI
PFFINSDKSTSKELPCKVDTV
>PK3-045_03958 Multidrug resistance protein EbrB
MAFRNIRKVINISWLYLCLAIVFEVAGTTSMKLSEGLTKLLPSILLIFFYLNSLVFLTLA
LKTIEISVAYAIWSGIGILIISIIGVYYFNESLSLVKITAIFLIIIGVVTLNFTVDHSEA
SDHKSQMSEKLY
>PK3-045_03959 hypothetical protein
MHNRIIDETIRLIQVKGFSFTVSELAANLGTSKRTIYQYFSSKDQIVDEIIEKLIHSIKQ
NEQEIVMDENTNVLDKIKLILCSTPEEFGIMDIRLLSDLKKHHFQQWEKLDIFLREEWST
VLTLMKQGIKQGNLRDINLDIFIELYLGAINQIYASQSSLTIKEKLEAVMDILLNGISKY
KEGD
>PK3-045_03960 HTH-type transcriptional regulator HdfR
MDLKELITFQTILRQGTFSKAAESLHYAQSTITNQIQRLEKELGISLFYRGWEAELTPAG
KIFAEEVDDLINHWKFVTEQAKAIQKEEVGTINIGIIDSITNIVPSILARFSREKPKIVC
NFVVGNTNSLAAALEKNEIDFAICAEIAGQFPYTFESLYEEKLAFIVSNIHPFANKSRMY
SLEELCDYPIVTGGKNCIYQLKLEKELLTISKKPFCYTISQLSIIPQFIISIDGAIGVIV
SSMPIPDNCKKLDVEINNSDIKIGIMRNLRYDNMTSSKQLLLNYLIESLSRVK
>PK3-045_03961 hypothetical protein
MPFIKISYLEEQYNKKELKFISTQIMNSLIKEFNVPYDDFFQVFDSHKKEQFHFNSHYLI
NAKRTKKLLYIQITCGIGRTIEQKRNLYHTLTDNLSEKNIVTKENVFIILNETPLENWSF
GMGEAQMVTNWNAATTIIKENHLSKKEIKSNIRSTLGDLAPAFVDYTESVLFGDLWKRKN
LSMRDRSLITLSSLITAGNIEQLPFHINLAMENKIKEDEIIELITHLAFYTGWPKAASAL
DAAKKVFSS
>PK3-045_03962 hypothetical protein
MGDVWKTCSSEVKDFVFHLNKSMKEIIKDNYLGFYIHGSLAMGGFNPKSSDVDALVITHQ
SLEVEDKRKLARFLLGYSNSPYPIEISFLNTDQLRHWQHPSAFDFHYSEFWRERFERDLL
NGTYQYLNSDIHSDADLAAHLTITYQRGICVEGKPIKEVFPLVPSADYISSILGDYYDCL
ENIEKDPIYCSLNLIRVFWFLKEGVVSSKQEAGNWGLKTFPKNVRTIIRKVVDSYKNGNG
TKTFEKDELISLRDYIADKVQKLLS
>PK3-045_03963 Guanine/hypoxanthine permease PbuG
MKDFFKFAERNTSYAQETLAGITTFLSIAYILVVNPIILSQSGMDSGAVFTATALTAIIG
TLLIGLLANFPIAIAPSMGLNSFFTFSVCIGMGIEWQVALTGVFVAGIIFMLLSLMKIRE
KIINIIPASLKHAIAAGIGFFITFIGLKNGGIIIGNPDTFVSIGDFTSPMTLLAIIGLVI
TIVMLVRGINGGIFYGMVITTIVGMIFGLIEVPSSVVGDIPSLKPTFGVVFSHLDEIFTP
EILTVIFTFLIVAFFDTAGALIALTSQAGMMKDNKIPNIGKGLLADSAAGAIGAILGTST
PATSVESSAGIAVGGRTGFTSVVIAACFVIALFFSPLVAVISVEVTAAALIVVGALMAME
IRRIDWTKLEIVIPSFLTIIMMPLTSSVAIGIGLGFVFYPICLVSQKRYKEVHPIMYVLC
LLFILYFAFIV
>PK3-045_03965 hypothetical protein
MKTKSLSVLIVTISVLVMAFMFPSHHLAVQELDYKKFGTVAMAVVKADYPEESVTDYKYL
GRKKISPQEEQDSFQFLVKEGGKEKTVIVTVNHSIKNDKFISLVVEEAKP
>PK3-045_03966 hypothetical protein
MKRRLIIILTAISVFLCVNTKESYAKSVVDTSEVYTYENFQDDVWILKSKYKKQLQVHAI
GKSEFGRKIYAIQIGTGKKSILLSGAHHGREWITSLLTMKMAEDIAGTIKNGDNFLGSYS
IWIVPMINPDGVTIQQGKINKFPFFSKRKIKKMNGGLNDFTRWKSNGLGVDLNRQYPAGW
EYIKDSKKEPFYKNYKGKAPFEAKEVQAIVELTEKIKPTIAVAYHSSGQEIFWQYNNGVN
EDRDRMIAEVLAKETGYKLGVPPKDAVGGGFTDWFITTYHLPAYTIEICPLVDERHPSLT
NFSKEWARNKTIPRTLIEEAKKIDAIHKKMLGDS
>PK3-045_03967 hypothetical protein
MNKTDYDRALYYTHRSEWDNLLILMVRTHDNFLSKKIEQFLHAYNFEHDYSVIEKHLYSL
LRYIDHANDLAEEEWIHTTTM
>PK3-045_03968 hypothetical protein
MPKLDLSKFEKKLIIRNTEFQDIDKIMKLQAECFPGMDPWTKDQLRSHIEIFQEGQFVAE
YDGEIIGSCSSLIINFDEYDARHTWDEVTDGGYITNHNPHGYNLYGIEVMVDPEYRRMKI
GHRLYEARKELVRQLNLQSIIIGGRIPNYYKYEDQMTAREYVQEVLHHKIYDPVLSFQLL
NGFTLMRINPNYLPDDAQSKSYATIMEWNNVEYMPKSKRFFKSSYPVRICVVQYKMRQIK
SFEDFANQVEYYTDVASNGESDFVVFPELLTSQLMSFMDERVPSTAIRKVTEYTEQYIEL
FTNLAIRYNINIIGGSHFVKEDDEEIYNIAYLFRRDGTIEKQYKLHITPNERKWWGIRRG
DAVRVFDTDCGKIAIQICYDIEFPELARIATDMGAKIIFTPFCTEDRQGYLRVRYCAQAR
AVENQVYTVIAGTVGNLPQTENMDIQYAQSAIFAPSDFEFARDGIVGETNPNIEMVMIGD
VDLEILRRQRQRGTVRQLKDRRFDVYRIEYKK
>PK3-045_03969 disulfide formation protein
MEEKTKQKDSRENILYLAWIAAVLSMFGSLYFSEIREFVPCTLCWYQRILMYPFVIILGI
AVIRKDYKISFYTMILSGIGACVSIYHYSIQKLASIFESSSACGPVSCTGEYINWLGFIT
IPFMALIGFIIIFTCSLIIWKKTKEMNE
>PK3-045_03970 hypothetical protein
MKKVLFFLVFIIILFAGVAFLSHMKKEKAVEGNIYKKADLEPATVELLENPNYQNIILPD
ELEEKLKNEEDVTVYFFSSECQYCLKTTPELMPLAKELNVSIDQYNLLEFEEGWDKYNIE
STPTIVQYKNGKEVSRINGYKEPAVFKQWLEEYSVKK
>PK3-045_03971 hypothetical protein
MKVVFASTPTQEERINELIQTFYSKVFPFYFSDEEINQFERLKVLAITPEKAQLLSTLKT
SYQVIASLQTLVNILEDPENKHKYKQVFAKNVHILEELDIFFPFHLDNFRSSSNGDSCNQ
VNFSMYAEANNSYLL
>PK3-045_03972 putative RNA pseudouridine synthase
MIYERKGDWLLLKIPVQWEGLSIEEFFSQVLLASKKQIHLFKMEKKVQLNNQNVPWNSML
KQEDILKINLFQQQPNNIIPIYMDLSILYEDDFLLVVNKPDSIDTHPHSPEDTSSLLNGV
AYHLLLSGEERQLKHIHRLDRDTTGCILFAKHDLVANMLDYLLRERKIKRTYIALIEGFL
AQKKGTINKPIGKDRHHSSRRRISETGQQAITHFKRIKRLPSEDLTLISCTLDTGRTHQI
RVHLNSIKHPLAGDKLYGGKPMFHRQALHAAKIQFTHPISQEQITVFAPPLDNPPIFPNE
DWEELLS
>PK3-045_03973 hypothetical protein
MGFLWSLIIGGIIGWLAGLITGKDIPGGVIGNIIAGFVGAWLGSLILGDWGPSIADFAII
PSIIGAVVLVFILSLIMRGMRKTT
>PK3-045_03974 Glyoxal reductase
MVNSIEQKVTLHNGVEIPQLGIGVFKVEEGDTVFQTVKTALDLGYRSIDTAAIYKNEEGV
GRAIKESAIQRDELFVTTKVWNDDQGYDSTLRAFETSLKKLDLDYLDLYLIHWPGKDKYV
ETWKALEKLYEEGLVRAIGVSNFHEHHLEHLLANANEKPTVNQIELHPRLSQESVREYCK
KKDIKVEAWSPIAKGRLVNEPTLNYIAKKHEKTPVQVILRWHLQHGNIIIPKSVHPERIK
ENAEIFDFQLSLVEMDQIDRLNMNERLGSNPDELLF
>PK3-045_03975 hypothetical protein
MAGKGEKVEKKVVLITGANSGFGKWMTIEFAKANYTVIASMRDRNKSRQLVEEATKMGII
SNIDIVSLDITSEQSVENLSLYVQRIGQVDLLINNAGYAGAGFSEEISIEEYQRQLDTNF
FGAIRVTQCVLPFMRKQRRGMIINISSISGEIGFPGLSPYVSSKFALEGWSEALRLELAP
FSIPVVLVEPGSFQTNIWTTGKQIAEKSTLSSSPYYSYMKQLDTYLHNSSKKNGDPRLVA
EKVVSIAKKKHPRLRYVVGKGTKGTIFFKHIVPWKWWEKIVLYILK
>PK3-045_03976 hypothetical protein
MMKLLLFEKDMAYRKRTESHKQVLYITMDITGTNNTIIEKKGDSLLGGED
>PK3-045_03977 hypothetical protein
MVFKKQDKFAVMLKNIASNLKEGADFFADYKLTNVSDLKTFSETMKEIETKGDTYVHEVI
TELNKAFITPIEREDILALTMSMDDVLDGLESTSALFEMYNIISADEYMLRFVEEIKNCA
VEIDKAVDLLTTKKLPKIREYAIRIKDHESKCDGILRQSIKNLFSVEKDPIRIIQYKEVY
ENLEDIADYCQSVANTLESIIMKNA
>PK3-045_03978 hypothetical protein
MNTLLILTILIVVFALAFDFINGFHDTANSIATAVSTKALKPKHAIIMAACMNFIGAMTF
TGVAKTITKGIVDPFQLTNGSLVILAALISAIIWNLVTWYFGIPSSSSHAIIGSIAGAAI
ASSGFSSLNYTGFIKIIEALILSPIIAFIVGFTIYSIFKFFFRDLNLTKTNRRFRYFQIF
TAALQSYTHGTNDAQKAMGIITMALLANNYVSTGEVPFWVQFACATAMGLGTSVGGWRII
KTVGGNIMKIRPVNGVAADLSGAMIIFGSTLIHLPVSTTHVISSSILGVGSAHRLKGVKW
GTAQRMIITWVITLPISASIAAICYYILHFFF
>PK3-045_03979 hypothetical protein
MIEKIAAIFVGSLLIGIGVNGFLVPHHLLDGGIIGIGLILHYHYEIPTGLSMILLSIPLY
IVVWFYNRKYFIYGIIGFLASSISIDFLSFLRDLFSLKLVLSAILGGVIIGIGIGVMLRF
ETSTGGTDLLAQVLSKILSIQVGFIIFLIDGIVLASGYKIVGPTTFLASFLTIFCVAVFT
TLLSKNSPIK
>PK3-045_03980 Sensor histidine kinase RcsC
MKIKDYFGKSISRQFVALLFFFSLLFLIGCAFLALSQKQLNNRYAEEREVILEKISITRE
LQDKLETALSEARGYFAFNNPEMRSSALKMDAKTNKLIQRLKAIATTDEDAVLVEELVNF
HSYYFQDILPKALNYFDEGEVDKVVKISDDGGTDRINHIKGSLNNYLHSMTNELNDKVNE
LNKNIIIFQICFLVYIIFIMMVIYFIGRAGFNKIGKPLADLSVAANEIAKGNDAQIKVDT
KRADEIGKLSVAFYQMYQSVQDKEQNLLAQNEELLAQQDELHAQQIELEEVLETVRANRE
SLKRRNKLINSISNSLDKNEVLESIITHLAAILQADRGIILLLKDQAYASYGIVEEGAEQ
FKNYVWQGVLDRLKKEKDPFIITREMVLAEKGYHLEKGFTHDLYIPVYNSEDEIAAVMML
SRFSDPFSVFDKEEFIALAKQISISLDKIELFEQTENDRVLNYDILNTIQEGIQVVCGIG
EIIFVNEKLEEMIGDTKEAIFYPGCGWDEWKHPLTAHFMDEEGLLQYIEASIKEKQTDSY
SAFMKDGRVVNIYAEELFRGNTKFGTILVYRDITKEYEVDRMKSEFVSTVSHELRTPLAS
ILGFTELMINRELKVDKQRKYLQTIYGEAKRLTSLINDFLDIQRMEAGKQTYEKKYIDLM
PIVERVKEKLSINTSSHRIEINQLIEETMIIGDKAKIEQVLTNLLSNAIKYSPDGGTIEI
NVYKENNQLRVSFKDEGLGIPEAEINKLFTKFYRVDNTDRRKIGGTGLGLSIVQEIMNAH
DGQVVVESDYGKGSTFILIFPLVHKMETSDEASKENKHTYSIMVIEDDISLGELIVHELQ
DNGFQVVYYKNGQEAIRMLEKNPPDALVLDIMLEDENFDGWNILNHIKKSEKLRNIPVIV
SSALDEKEKGLSLGALDYLVKPYQTSQLSKTIMQTLLKMGKVGQVLVPEQDKE
>PK3-045_03981 Sensor histidine kinase TodS
MKRILLAEDEEVLRMLIVDTLEDEYIVDEAQDGEEALQLIHENQYDLLILDYMMPIITGL
EVIEKVRADKEREHLKIMMLSAKSQASEQHEIKGAGADYFMAKPFSPLALLDTVGEILNE
D
>PK3-045_03982 hypothetical protein
MKWNKSIIFFLLILFVVGLLTSPFWLWQLKHSKELNVLIMDKTVSDSSYREHAGLIWVLN
NQKYVKTNHAPYSKQRDYVGFNPLKEKHKQLTHLPKDLSSYDVIYMTDQYGIDKKDASRI
NSKHMEGGLALEDVERVESALLQNTNKTLIAEFNTFADPTSDQAREKITNLLQLSWSGWI
GRYFSDMESEEIPIWVKERYERIYDDKWSFKGSGLILINSDDHLIVLSDQELNSGAVQFS
TTDKGKGLFNQPIISNYGYWFDIVAAKDKTDILATYTLPVNKKGKAVLSEYGLPRQFPAV
IQYKNKQYTSYYFAGDYADEAEVPAIYKTVGLDMWKSSITYRHSFYWNSYVPIMKGILKN
GLHAEDHASTNAEITTVNHLKINTKTDDTYIQVLKDNKWTNLLVKGVNMGIAKPGSFPGE
TAITKDEYFRWFKDIGAMHANAIRVYTLHPPAFYQALYEYNQLAEEPLYLFHGAWINEET
LLDKQDAYAKEVDNDFDRELKNMIDIIHGNASIAAAPGHASGEYTYDISKYVLGIMIGIE
WDPEVVKNTNEKHKRIASYDGTYFETKDASPFESWLAQKMDETVKYEVDKYDWQHTMSFT
NWVTTDLLKHRYEPNPKEDMAIVNPNHIKTTENFHAGFLASYHVYPYYPDFLNYEPAYKS
YINKQGKQSNYGAYLQELREAHDMPVLIAEFGVPAARGKTHENVNGMTQGFLSEQEQGNF
DKEMFQMIVDENYAGGLLFAWQDEWFKRTWNTMDYDNPDRRPYWSNLQTNEQHFGLLSFD
PGKYESPIYIDGKKKDWEKLGISPLYEDRMTQKGIKSIYVTSDEQQVNLRIDYQQPIDLQ
TDTTYLLLNTIEKQGQQTILLKNETIKSTFGADFLVKIANEHNSQILVDSYYDSFHYHYG
SILHMIREEAYAKKKDNGVFHPIRLTLNKELELPDTKIPFQSYITGQLLFGNGNPASKEF
NSLTDISVSKDKKTIEVRIPWALLNIKDPSRKEIMADLWQKGLEESVQAKGIQIAAVMER
EKEIISSFPKLNRYNEILAADTKWYTWEEWEMPAYHERLRASYYLLKDAFSEINLGD
>PK3-045_03983 hypothetical protein
MVYQWWSIAVQIFASFIAVYMIIIILFYSVILFISMLQLRKEYKLNREDTFDDVSNEWYT
KPVSIIVPAYNEEAGIIPSVRSLLSINYPQFEIIVVNDGSIDQTLQKMMEQYEMVHIEKV
VRKQLTTKPIKGIYQSKLLPKLYLIDKENGGKADALNAGLNFSHFPYICSLDGDSVLERD
AFLKVMKPIMDSDEEVIASSGSIRIANGCKIKNGQVLEIGLSRHPLVIMQIIEYLRAFLM
GRIGLSRHNLLLIISGAFGVFSKKWVLKAGGYQTNTVGEDMELVVRIHRLLKETKEKKKI
VYVPDPVCWTEVPEEIKYLRRQRRRWHRGLYESLWNHRKLTLNPKYGNIGLISFPYFWLI
EFFGPIIEFLGYVYTIIALFFGGVYLEFAILILLLSCIYGSIFSMAAVLLEEWSLRKYPK
VSHIISLFFYSLTESFWYRPLTVFWRCEGIWQLIRRDKSWGEMSRKGVSE
>PK3-045_03984 hypothetical protein
MEQEVRVLQIVSIILFATLLCLLTYLVIRKVIENRQNNHINERKKQLVGPIFSYLREGKE
RVKDIMQSRIDKQAIEQVLTDFSERIEGEQEEERLHELADFYLKDKYRKEIKSRYWSKRM
NVLYKIEDFHMKEMTHQVISRLSKRNCHKEEKIQIYRILAAFQYDNIWSLINKDEELTEK
NYRSILLRLKPESFRKLIQPFYYCREALQLATLDVISMKKKVEYIQFLEDVFAKYEEEIR
LRALKAIAAIGYVRNMEDYVLLAESEVWQERMMVAKLLGSRSSLDKYIPLLVKLLHDSSW
WVRSQAAESILSFKKGREILLEVINESEDKFAQDMAREWLNKGVY
>PK3-045_03985 Regulator of RpoS
MLDKYKAIFITRMTQQLNELLNKQATETIKNEEVYRLLHTIKGTSGTLDLDLLFHLVSGL
MAKVEEREGDWIQSELKNFLSELLDICEEYEHFHEEINKIPDFRDIDVPLIQLIDDDVSL
LIFLKEMLERKGWMVMANSNAEKAIEQFYRMQPDCIIIDINLPFKTGLDILDDIQMHTKH
SFVPKVICSIDTSREKRIAAYKKGADDYMEKPLDMEEFLIRIERHIERKKIFDQSVLIDE
LTEVYNRKFLKDSYTRFISDTVRTKTSGTIAIVDIDYFKRVNDTYGHVAGDKVLKAFAQF
LKINIRTTDTLFRFGGEEFVILFQRAGESEVIDVLNRMLKRFSGIEFEESGGKFSLTFSA
GVFEVISNDIPLNKALEKADEALYLAKEDGRACIRSTNKRKEAANKKLLNISIVDDDSFI
RSILKNILDSIEINNLTINVAEYEDGIQFLESKRLQENGMHFLILDGMMPVMDGLELLQI
VKKTSYQHNAHILMLTGRKSEQDIAEALRLGADDYVTKPFSIKELQARITRLIMRMI
>PK3-045_03986 Pyrroline-5-carboxylate reductase
MEKRKVGFIGCGKMAQAMVNGMLQSSFLSREDILASTKSVESAQMVRETFHIETTLDNKK
VASFADVLIVAVKPHLYGEVLQEILSYVKNETIIVTVAAGIEMAYIESQLSKNAKVIRSM
PNTPSLVGEGMTVFCANERVTEPEIAFIIEMFAAFGQVEVVEENLMDYIPAISGSSPAYV
YMFIEALADGGVRSGIPREKAYKLAAQSVLGAAKMVLETGKHPGILKDEVCTPGGATIEA
ITALEQNQFRGTILAAMESCDRKNRRMKKEN
>PK3-045_03987 hypothetical protein
MKEQIYVTEENLLLIKEALDFSIRNASRGILFILEMVKEKVTTSNDSSLKLDGMEMEIIL
VSLIEYGISLISFHADKGNLCMEEAIRIDQIKQYYQRKNGPKMMC
>PK3-045_03988 hypothetical protein
MHRNKLRIIRKQYGYTYQMMADKLGITKSYYWQIENGKRGLSYEQAVQISSIFSKTPDEI
FLPDYIKVKDCSR
>PK3-045_03989 hypothetical protein
MNFPERLRQLRKSANISQQTLGNAMNVTKVSISGYETGNRKPDTDTLQKLADYFDVSTDY
LLGRSEAKETRASYHSKVSDNSMTSEEAELLTQLQKYPTLYNHLISNPEKAVSQLYRLWR
FLEDEKQNK
>PK3-045_03990 hypothetical protein
MTNLLKTIPVPLVRTNQWTIFLSVLLSLVFQQYWIMLIPLIAGLCGLLFQWNPIMKAASI
FLKKPMKEYHQEDWDQQQFNQIIAVVCLAIGSLSFFLDWNVLGYIFSIIVGLSSIIAILG
FCIGCFIRFQWKKYQYKRSL
>PK3-045_03991 Threonine--tRNA ligase 2
MIKVVLADGSMKEYPKGSTVAEIAESISVSLKKKAVGAKINDEWFVDMSHQIEEDVHLAI
ITIDSDEGVSIMRHSSAHVMAQAIKRLYPNVQLAIGPVVEDGFYYDMKLAHSLTSHDLQA
IEKEMKKIIKENLPFTRKEVSFEEAQQLFEEKEEIFKLELLETIPSNESISLYQQGEFID
LCRGTHLPSTGFIKAFKLMRVSGAYWRGDSDKEVLQRVYGVAFSSQQQLADYLEMIEEAA
KRDHRKLGKQLELFMFSEEAPGMPFYLPKGQIIRNELEQFSRELQGEADYEEVRTPLMMN
ERMWKQSGHWDHYHENMYFSEVDEQKFALKPMNCPGHMLIFKNSLYSYRDLPIRLSEFGQ
VHRHEYSGALNGMLRVRTFCQDDAHLFVREDQIEAEIKSIFQLIDKVYRTFGFAYTVELS
TRPEDSLDGDDIWELAEGALRNVLEQLKIDYILNEGDGAFYGPKIDFHIKDALKRSHQCA
TIQLDFQMPKLFNLAYINENNEKVCPVVIHRAIYGSLDRFFGILIEHFAGAFPVWLAPVQ
VEIIPVSNVHLDYCLEVQAVLKEAGVRVKIDDSNEKLGYKIRAGQMQKIPYLLVLGDKEK
EQNAVNVRKYGEEQSKGFSLEAFKQMIEMQIIERSL
>PK3-045_03994 Fatty acid desaturase
MSANLIGTYLYYRYPLREGKLKMNIKNLKQLRTAVAPFEKSTVSISILQLANTILPFVLL
WFAAYKSLSISYLLTLVFAIAAAGFLVRIFIIFHDCCHFSFFKNRKANKVLGTITGILTL
FPYSKWQHSHSIHHATSSNLDKRGVGDLWMMTIEEYENASLMVKIQYRLYRNPFIMFILG
PIYEFLLANRFNRKGARSKERLNTYITNMAIVLLAVLLGSTLGWSSFLLVQLPIFLISGS
VGVWLFYVQHTFEDTYFEEDKNWDYVKAAVEGSSFYHLPKWMQWLTGNIGYHHVHHLSPR
VPNYNLEQVHKQTEPLQNVPTITFASSLRSLKFRLWDEKDKKFISFYEWKKQKKSLSMSA
RSEMP
>PK3-045_03995 Sensor histidine kinase DesK
MMKRLEVLKKSTGISPYIWTLLTILPFYFIFHASSAVDVISGIILTILFFIFYRIAYLSK
GWTIYLWPSLLIGISTFAIYTYSYVYFSFFLSYFIGNIKKRIPFFILYFIHLAVTTFAIY
FKIIIGDALLIKQLPFVLIIWFGVILLPLNIQNRKEKDQLQEQLEDANKRISHLVKLEER
QRIARDLHDTLGQKLSLIGLKSDLARKLIYKDPEQARIELKDIQHTSRSALNEVRKMVSE
MRGIRLKDELLLVKKILGAAEISLTCDIASNLRISSIAENIISMCLKEAVTNVVRHSNAT
ACSISINQNKKETIMEIKDNGSTPFQEENMHKGNGLAGMRERLDFINGTLEISAEEGTIV
KIAVPRDGKIIEKEELI
>PK3-045_03996 Transcriptional regulatory protein DesR
MIRIVIAEDQRLLLGALGSLLDLEDDITVVGKANNGEEAIQLVKEKNPDICIMDIEMPAK
TGLEAAEELMSHPCKVIILTTFARSGYFQRALKAGVSAYLLKDSPSDDLANSIRSVMEGK
RIYAPELVDDVYKEENPLTEREKEVLMLVANGKNTKEIAQELSIKTGTVRNYISMILDKL
EVKNRIEAITRFKEKGWFK
>PK3-045_03997 hypothetical protein
MQIYWTKINKIVEENPEVKTYLLDRPQDFTWEEGSHTHFALRGFNAGDKPNRSLIRHMSI
SSLPHENVIGITTRIREQCSEFKSILRNLEVGNEVAIFKTHSNLPLKRENKNVYLLSSGV
GLATFRPIVLDYLERADNVTRIHSLNIDSSKAFLFTDIFTSVPDKKFEAQFVVNRNDYYE
EVKNLAADKDGLFYVVGSDDFLMQNIEVLREQGIKPEQIMLDKREDQLPKFLAQ
>PK3-045_03998 hypothetical protein
MKNNESSLTSLVSAFSRAYHVKEDCPIIFNDYIAQDFLSPEEYQAIAANMSNGITFFSSE
MAEKFKGDQDAILKWVTQIQLSPTPLARAAYAENVVRNECQHGAEQYVIMGAGLDTFAWR
HDTLPNVTVYEVDHPSTQKFKIERLEQAGYEIPSHLKFVAMDFTKELSLEKLAAAGLDLS
KKTVFSLLGVSYYLTKDVLQQLLHAFFKDLSKGSSIIFDFADEGLFTEPGIFNRVQNMVQ
MAQAAGEPMKFAASLAELEDLLANEQLLIYEHLSPQEIQQQFFSDRDDNLQAFETIHYIH
AVKN
>PK3-045_03999 hypothetical protein
MRFNKVERENSNETIFSLLFNLEGNQLFKLRVAENKKCLETTNGEKFFYLADTVWSAFTN
AALEEWNDYLELRKTQGFNVLQINILQQWDASETELNMKPFEYKKDGSFDFSKRNEAYFE
RAEKMVQMAVEKGFVPALVLLWCNYVPETWGSEISSVNNMPLDVVEDYVTYVDGKFSKYN
PIYLVSGDTDFPTELTITYYSLALNTIKKLSPQCLTTLHVRGRLMEIPDELLYSDNLDFY
MFQSGHNIQFQSMSYQLAEEFSNKPVKRPSINSEPCYEQMGYSRNLYGRFTRFDVRKAAW
QSLLSGAEAGITYGAHGIWSWHKKGKGFGLVGEAFDKPFDWRDAVKFEGAWDYAFAKKIF
KLFSLHDLQPLDIVLKNTEEIRVASTAGLNKIAIYMPVNTTLKLNKLIENYEFTIIDLEQ
RRFAEAHVSFKDNITVIGMHNFEADVVIIGEKKPGS
>PK3-045_04000 PTS system beta-glucoside-specific EIIBCA component
MNYGALAKKIVQEVGGKENINSVIHCVTRLRFNLKDQSLANTEVIKDMDGVMTVVISGGQ
YQVVIGDQVPIVYAEVVNLIGGGTSQNVEATEESEEKKGLFSKFVSLISGIFMPVMGAMA
AAGILKGFLVALTVVGWIDEEMGVYKILFAASDAFFYFMPILLGFSAGKVFKTNSYITAT
IGAALVYPTMIEIYNAGEALSFLQIPVILMNYTQSVIPIILASFLTAKLEKVLLKVIPKS
LQLIFVPLFITVIIVPLSFIIIGPVSVYASELLAKGAMVVYSLSPVIAGLLLAGIWQIAV
MFGLHWAFIAIFINNITTLGFDPINALLYCTVFAQTGAALAVSLRTKETKMKSLSTTATI
SGFLGITEPAIYGVNLPLKKPFIMACIGGGVGGAIAGFFSAKMYGGFASGGVFGIPMFID
PDGISSEFYGFAVSLLAALVTAFVLTFLFGYSKKVSTKPAKEKSAVTSESNL
>PK3-045_04001 Glycerol kinase
MSDSYILAIDQSTSGTKALLVDEKGSIIAKETTSHKQLYPQSGWVEHDPIEIYDNVKKVI
NSIVDSNQSLMGKMKTLTITNQRETLVIWDKYTSEPVYNAIVWQCRRTTSICSSLKAKGC
EEKVHAKTGLKIDPYFSATKAKWILENVPGLKKRAEKGELLLGTIDSWLIWKLTNGRVHA
TDVTNASRTLLFNIHSLCWDDELLRIFEIPKEMLPEVNFSDRIFGMVEDSELLIHKVPIA
GVIGDSQAALFAQRCFNKGMAKATFGTGTSVMVYTNEYVQAKEGLVTSIAWGFNGNVHYA
LEGIINTTGDIIRWMKEDLTLFTTFEEAEILADTLDNNEGVYLVPAFVGLGAPYWSPNTK
AGITGMSRNTNKSHLVRAGLESIVYQVKDIIQLIYKETNVVVKELRVDGGATANEFLMQF
LSDLLGVKVIVSHVSELSALGSVYLGGLGMNMWKSVEEISQLNNEKRIYSPKMDRETSER
YYAEWMKAVHTLLI
>PK3-045_04002 Apulose-4-phosphate transketolase subunit B
MNNVILKKNTGNKIANRTVVSDTLLDLAMDNKDILVLTSDSRGSASMVPFADALPEQLVE
VGIAEQNLVGISAGLAASGKIPFVASPACFLSMRSIEQVKVDIAYSRTNVKLIGISGGIS
YGALGMSHHSVQDLAVTRAIPGLHVMMPADRHETKKMIEALVDYDTPVYMRIGRNPVEDS
YQSEEYDFQIGKSVTMHEGDDLTIIASGETVRVALDTAFLLKEEGISCRVLNMHTIKPLD
EEAIIKAAKETGYIITIEEHSVYGGLGSAVSEVTSNKCPVPVKIIGIPDEPAVAGTTKEV
FQHYGISPENISSITRELLGQ
>PK3-045_04003 Apulose-4-phosphate transketolase subunit A
MIDIKKLERKAAEIRMAVIDMVYEAGTGHTGSSLSNTDILTVLYYEVMKNDPANPNWEER
DRYIQSKGHAVESYWAVLADKGYFPKEELKTFSKFNTRLIGHPNNKVPGVEMNTGALGHG
LSISVGMALAAKMDHKDYRVFTLMGDGELAEGSVWEAAMAASQYKLDNLVGIVDRNRLQI
TGSTDDVMSNEPLDKKWESFGWDVIEVDGNDIAELVQVFHSIPKTEGKPTIILANTIKGK
GISFAENEAGWHHHVPSQEEYELAMKELSKRLEVLA
>PK3-045_04004 hypothetical protein
MEKFKLGFAPTRRFVFSKEDAYKYKELIKEKIRSFGLDMEIVDLEGINEEGLLYNRADEQ
AIIQRFKREDVDALFFPHCNFGTEDLVAKIAKAIDKPVLIWGPRDEAPLENGMRLRDTQC
GIFATGKVLRRFKIKFTYITNSSVDSEVFARGFKNFIGAANVVKHFRKLRILQISTRPSD
FWSVICNEGELLEKFGIQIYPITLDQIKQKTLKIEKEGGAELEQAVAYIKKSLDWSTVKE
EDVRRIAALKVGMKQYAEETGSSAIAIQCWSTLQDIIGIMPCLANAILTDEQIPVTCETD
IHGAITSIMVQAATLNTLPTFFADITIRHPENPNGELLFHCGNFPVSLSVEEKPQLNKHF
LFDDHSPGTHEGEIKGGEMTIARFDGDNGEYSIFLGKARGIEGPYSRGSYVWVEVNDWPL
WEEKLVKGPYIHHSTGIHANVIPIIYEACQYIPGLTPDPVDPTEEEIRAWLRGSDINY
>PK3-045_04005 HTH-type transcriptional repressor PurR
MKIDDIAQIAEVSKSAVSLALNGKPGVSQETREKILKIAKENGYNPRTFSKGKNTSPTKI
FRFVACTHTGIVTEQYQSQSFFMELINNIDQSISSKGYSLIISSINIDSLEQEITNLEMQ
QQSSGILLLGTNLTEEQIKTVSKLQPNLVVLDTCFETLDINFIVMNNIIGAYQAGEYLIE
LGHKVIGYAESVSRMYNFDARRKGFQKIMSENGLTIKPEHIFKMSPTDLSAQDDFKQNIM
ELKDNLPSAIFCECDYMAISIIKSLNELNIHVPEDISIIGFDNIVESQIVSPELTTIHVK
KDKIASLAVEKLIREIDENEEDKMKIFIDTELVKRKSCVKVSNHKTILT
>PK3-045_04006 putative oxidoreductase
MNIPLQVNLSNKVAVVTGGNGLLGSYFSKALARCGAKVAILGRNQDTADQVAREIIEEGG
EALGVAANVLQRDSLEKARELIENKLGACDILVNNAGGNHPLGTTDDEFFDREKARNHPE
YKTFFDLESEGVESVFELNFLGTFLPSQVFAKAMTEREGGCIINISSMNAYTPLTKIPAY
SGAKAAINNFTQWLSVYFAKAGIRVNAIAPGFFVTKQNESLLYKEDGSPSPRAENILHNT
PMDRFGEPEELVGGLLFLVSDKASSFITGMTLPIDGGFSSYSGV
>PK3-045_04007 Mannonate dehydratase
MEMSFRWYGKNDSIPLEYIRQIPGMKGIVTAIYDIPVGEVWSLEKIIELKNAVEKVGLYI
SVIESVPVHEDIKIGLPTRDQYIENYKETIRNIGKAGIEVVCYNFMPIFDWTRSSLDYVL
PDGSTALIFEEEVVEQMDPLIGELSLPGWDSSYKEDDLYKLFDHYKNVKEEKLWENLEYF
LKAIIPVAEEANVKMAIHPDDPPWNIFGLPRIITNKANLERLLSIVDSPFNGLTMCSGSL
GAEPANDFPQMLRYFGNKGRVHFVHARNIKLTGNRSFQESAHMTEYGSIDMYEVIHALKE
FNYSGPIRPDHGRMIWGETGKPGYGLYDRALGAAYLLGLWEAENKNRKI
>PK3-045_04008 Beta-glucoside kinase
MYLVIDIGGTFVKYALMNSAAQIIKKAKMTTPKTNLIDFENVLFTLIEEHDLSAIKGIAI
SCPGTIDTDTGIVYYGGSFPFLHEVNLKRRIEEKYGIKVSIENDAKCAALAELWLGSVKD
YEDSVVLVLGSGIGGGIIIDGKVHRGVHLSAGEISYVMNGLNPQTKEATYFGLICSAVEM
VKRIAVIKKIEDITDGVAVFNYINNKDPEAAAIFDEYCLHLATQILNLSYILDPEVVAIG
GGISAQPVLLQRIKWAIEEIKKMNPFHMATPKVVACKFQNDANLYGALYQFFISNEGENV
LSPNK
>PK3-045_04009 Beta-glucuronidase
MLYPIISETRNVIDLNGIWNFKLDLGAGFQEEWQKAELNNPISMAVPGSYNDMGVKAAIR
DHVGWVWYERELTVPNILMEERIVLRFGSATHLANVYVNGVLVIQHKGGFLPFEAEINSY
LQKGKNRLTVAVNNIVDETTLPVGFVTKKETALDRPIIRNQPNFDFFNYAGLHRPVKIYT
TPKTYVRDITILTELDGKVHYSIDMAGSSNIIAKVIDESGKVVGSSEGISNTILIPNVKL
WEPLNAYLYKLRIELQDQNEILDVYEQPFGVRTVEIKDGKFLINNKPFYFKGYGKHEDTP
IHGRGFDEASNVLDFNLMKWSGANSFRTAHYPYSEEVMRLADKEGFVVIDEVPAVGLHLN
MMVLHSGGNLRNTWKELKTFEHHKQVIKELIERDKNHPSVVMWNIANEPASEEEGAYEYF
KPLVDLTRDLDPQKRPITIVTQIESTPKKDKVAELVDILAFNRYYGWYVDGGDLLSAKEK
LRAELNGWLERCPNTPFMMTEYGADTVAGLHDVEPIMFTEEYQIEFYRANHEVFDEFAQF
IGEQVWNFADFATTQGIIRVQGNKKGIFTRDRKPKSIAHELRRRWTAIPNFHYKD
>PK3-045_04010 putative symporter YjmB
MRPFGIKDKFGYLFGDFGNDFFFALVGSFLMVYYTDVFHLNPAAVGGLFLIARLWDAIAD
ITWGRFIDTRKAGKHGKFKPWIYRMSFPLVISGVLMFIHIPGMSNGFYTAYAYVTYILWG
TLYSTVNIPYGSMASVITADPVERTTLSTWRSLGAALAQLIVGVAGPLILFVDNKADANQ
FLVGAIIFGILSISSYMACYKLSIERVVRNEDEQPNINLAKTLKGISKNRPLIVFLIGSL
LFLINLMLIGSVNTYLFKDYFGDAKLLSVFSMVQSATIFIGMPMAKPLVARFGKKEVASA
GFLLSTLAYLVLYFLPNVTATIFICILSVGLFGYALFNLISWAFITDLVDYHEYLTGLRE
DATIYSIYSFSRKVGQAVAGGIGGVAIAAAGYNPTLQVQTQETLDGIHRLATLIPALGLL
LVFICFAFLYPLNKKRTTQLVSDLERKRSEKNSSKPA
>PK3-045_04011 HTH-type transcriptional activator RhaR
MQSIKQITDLEYICHLAYSMFKIPTYFFNSVGELIHKAVDSNFHHNPIYQSNVDIIIELF
SKMEKQKAIPILKETAFLEKYVSLSIYSNNRFEGNIIVGPVINFRMTDETITSSLRDMDI
RVAKEEMLHYYSNLPILSNLKFIKLSMMIYYMIYQKQLNILDIVQTNKEIEKENLNIEPI
DNQIIESRQNKNVHTDISLEKKFLNYIKIGKKTGLLESFHAINKQGKKGILSKTSYLRSQ
KNIAISLITLATRAAVEGGLYQEIAYSLSDSYIIKLEELSNSRAVDQLIENALIDFAERV
ENSKKYKYSKPINICQTYIFNHLYENITLSELANLTGLNPNYLSNLFKKEVGISIKAFIQ
KTKIDEAKNLLSYSNYSLTEISTLLNFHDQSYFTRIFKQVTGITPKQYINKNC
>PK3-045_04012 hypothetical protein
MTTRKEIFSYAKEKYGTNPEYPWKKFQNYAVLRHVNQGKWYGLMMNVPKNKLGLSGEEVV
DVLNVKCEPELKNLLQKEEGILPAYHMNKEHWISIILDSPYPKADIYNLLDTSYYLTK
>PK3-045_04013 hypothetical protein
MANKMNFGHISAIITIMIWGTTYISTKILLTDFTPIEVLFFRFVIGIVALSIIYPYRLKM
KNRKHHYLFLLAGLCGVTLYYLLENIALTFTTASNVGVISAMVPFFTAILTYYYLKSEPL
RLNFFIGFILALIGIFLISFNGTANFKVNPLGDLLAVAATLIWAIYSVITKKISSYGYNT
IQATRQIFLYGILFMIPVLYLFDFKLGIERFAQPIYLFNIIFLGLGASAVCFVSWNLAIK
KLGAIKASVYIYLVPVITVITAMIVLKEPLTWMAALGTLLTLTGLFVSESKIITKKKKDL
VSSY
>PK3-045_04014 HTH-type transcriptional activator RhaS
MRREERKICFDEDLQIEAYRFHGIMQKFPNHFHEYYVIGFIESGQRKLTCRNKDYVINSG
DLIFFNPFDNHACEQMDDEPLDYRCLNITPEVMRKVVEEITGKDYLPSFKDPVVFRSEHA
ELLQRLHQMIMAELGDLEKEETFYFLMEQLIEEYSAIEKNIKLDKMTKEISKVCEFIERH
YVDPISLDDLVAVCNMNKYTLLRSFARIRGITPYRYLQTVRINKAKKLLEQGMKPTDVAA
QTGFVDQSHFSHYFMDFIGLTPGQYRNIYIDSVN
>PK3-045_04015 putative protein YqjZ
MNGIAKTPKLPYYAVIFSSQRTEGDKGYGKMAEKMVELASQQEGFLGVESARDEGLGITV
SYWDSLEAIKNWKENSVHLAAQKLGKKEWYQSFALRVCKVERDNFFEM
>PK3-045_04016 hypothetical protein
MWFNIDDELSYFIHWTVKHCGDDVFLSDFVKFTSTDNQSGSIYYPDLNVKLSRNEYTFQV
CQFAIEARDFFRSSKEKRIADDFDKNMYDEFWSEYNQLLNSNLPD
>PK3-045_04017 hypothetical protein
MQLFKINIKKQYWLGSTDSEEDLCSHGEIYLKVNDTVITQSGIDEEWGISESALALLRTL
DNDYLCAPEDDEGLILHGCGLILMTSCPISFIGQ
>PK3-045_04018 hypothetical protein
MEIFNELRKFIFAESEMNDEQKVFVSALKLLTEGKEDLSMDCLKKLYMESNDPSLQSSCA
KILFELYFINSEWKELEILGLLEEESIDKSNRVIAKALGQFEQATFSFSNDKICIPMKRS
ISGSPTIDVMINGRKKCFWLDTGAGMTVISDSIVKECGMALIENEDLEVGNSTNQNFNSD
LAIIDTIVIDNLTILNQSTLVLASDLLKIPIPHSAKVMEIDGIIGWDIIQYLHLEIDYRQ
EKVMIQKHRQKAGEKNNLFFCGYPIIKVKGKNQVPLYFGLDTGANKSHFGKTLLSKIDEL
KIDKTIKYSGGLGDVKEREIDTIETLSIYLDKNQSITLKNVRETLTDLAAFFKLDGVFGM
DIAHNGSLVIDYPNRHFELKY
>PK3-045_04019 putative protein YjdF
MKLTIYYDGQFYIGLIEIVSENKLKACRYIFGKEPKDQEVLDFVNRKLLRVIESNQQIGI
PICQKSQKKINPKRIQRKVSKELKQCSVSSKAQEAIKAEYKQRKKVKSAKNKQLREEKKT
YIRNCKVQKAKNKHKGR
>PK3-045_04021 Peroxyureidoacrylate/ureidoacrylate amidohydrolase RutB
MLGGKSMKDKKKALIIVDVQKAFDNKKWGERNNLNAEVNISKILKLWREKGWLVIHIQHT
SDNPDSVFHPNNEGFAIKEIVAPIDKEVIINKKVNSSFIGTNLEDLLIAKEVTTVVITGL
TTPHCVSTTTRMSGNLGFDTYLISDATAAFGMKDQDGTYYDAAAIHNISLATLHEEFATI
LTTDKLLNEFF
>PK3-045_04022 hypothetical protein
MNVTEFQQWVKDYYEGRGWSELDIFIRIGFLAEETGEVARAIRALEIGRDRPDEAKGSYE
ENKQELTEELGDVLGNLIVIANKYNIPLEEVFQSHKKKLSDRYSNV
>PK3-045_04023 Putative cytokinin riboside 5'-monophosphate phosphoribohydrolase
MKKLAVFCGSSNGVSDIYIEGAKKLGKELAKRNITLVYGGASVGIMGAVADSVLNEGGYV
IGVMPSFLDNREIAHKNLSELIIVDSMHERKAKMAELADGFIALPGGPGTMEEFFEVFTW
GQLGLHKKPCGLLNINNYFDLLINFFNQMNKQEFLQEKYLSMLMNDSEPASLIEQFQTYN
PPSVKTYIKANQT
>PK3-045_04024 Na(+), Li(+), K(+)/H(+) antiporter
MGKFIWDKNLKVRLIGEGLFNLLFWMYFPFITVYFGEILGFQIAGLLMALPPLLSIIGSL
LGGNFADSLGRRPVMLLGTFLQMLMFVMFALSTSPWIDYIAFIGIGLGSALYRPASSAMV
ADLVPERNLRQVFAAFMTVNNIGAVLGPVIGAIFFFHYRQELLWTCALVLFLYLLAIYYI
TYETLPNSKKELDLTSPLKHSFKERWNGYTIIFRDKIFMVYVVAGVFSLFPIMQLDLYLP
VYIINNIPTQPLFTWNSNSLLLSSNEIYGWLVGLNGLLFVLFILPVANWFKNWQERNIFI
LSSLLAGIGTFLVGINNNIWYLFFVTVIFTFGEIVRTPVTQSFVSHYAPEHARGQYLAAD
SLQNTLGKAMGPLTVFLASFTPPMGIFSLIVVFSIIGVLLYIKLFRMYSPKLKIMDED
>PK3-045_04025 hypothetical protein
MDIKYCHCVCTVPLKVVKPICKVYKILSFMYSDMVLINRLSLYDHGEKGEIATMPSNPML
NLRPLSLVWESTYGII
>PK3-045_04026 L-lactate transporter
MKTKTFANPWIIFIGCCLMSFVGFGLVVNTHGLYFAPLTEELGLNKTELSLTLTLQAIAC
AVTLIFSGRIMSKVNTQLLLTLCILMFGGGFILFAFFTSIVPFLIVWTLIGIAQAFALVV
AIPVLLGNWFEKKLGLVMGVALGVSGLGGAFFNPMISSIIINNGWRTATIVSGILILVCI
LPFTLFVFRSAPNAEKGELPYGRERNTLDNKKVIEEVVLGITAKEAYRTSSFYFYLITMF
SLSMVGGIVQHVSGHIVNEGFNLTVGASVVSAIMLGAAAGKFLIGILLDIFHANLVISLY
ALFGIVGWGGLIWFSSEVSLVGSGFLLGLGQGISLVAIPYFVRKTFGAKEYSQIYSIIAM
VGSFASAISATLGGVFFDKLGSYHLPISTNLVFYLIAALCILTAYAHKKKINSDTNEIRE
EKLV
>PK3-045_04027 Beta-glucoside kinase
MRLQKNYLAFDIGGTYLKYALINSAGTIIERNKIPTPKQGLEYFKLEVELIIQKYQEQIK
GIAFSCPGKIDQNNKTIHFGGSLPFLDGVQLTKALKIREDVPISIENDGKSAALAEMWLG
QLKDVSEGAAIVLGTGIGGGIIINGKLIQGSHFQAGELSFMLNDNASGNEKLFGYNSSAV
RMIQSISRELHLKNIDDGPAVFEAIKAGNPVAGKIFNDYCRNIAVLIFNIQSVIDLKRFV
ICGGISEQTLVVDQINSQYNQILDEIPLAKQTLTRPEICNSAFHNDANLYGALYRLLLDI
DNKNKLGSEQNEN
>PK3-045_04028 Cocaine esterase
MNEAEFYEKSKKSLPKGRYTYKNKVVEFVPMRDGVKLATTIYFPDKGEEWPVLFTRNPYP
NNKTVLEAIYTPLVEHGYCLVIQDCRGTGESEGEWEPFINEREDGIDSLGWLSKQLWMNG
NIGTFGRSYSGFTQWIVADCLPKEVKTMFIEVFGVDRYSQIYMNGMFREDIYTSWAFANS
GVKSELSIADLYKKALEILPANQRDKKLLGTELPFYQHYIKECSEDSSYWQDSIWKNLKE
IPSKIKIPIVITGGWADHHLDGTMYAYEQLNEEIKDRSKLIIGPWDHLSNTTGKLQYPMS
SKHGFMNIHAHLLWFDSQLKGEEAKLESEVYVIGMKKWEKLKTWPPKSHQTKLFFSADYG
LTDQLPKKGSVSFNYDPKNPVMTNGGSALLAWISPGFTNLPHGFTKQEDYEDRNDVLIFK
SEPIGEALTVMGKISVKLLVSSSAEDTAFTVKVCEEFANGDSYNITDGITSICSNENGTH
SNSYKKYEKVALDIDMWDIAWQFQVGSKIRIDVSSSNFPMYHIHSNTKKLWSTVGESNII
AKQTLYCDIDGCHLILPTVKEK
>PK3-045_04029 HTH-type transcriptional regulator KipR
MANGTNVTSKTLEILKAFVDKQTEWGVNELARYLNYPPSSLHRILKILKEEDILHMHPSN
KKYTIGNEWIRISSVVSSNASIKNVANPFLQKLSLELDQSVYLAIYHKQYKKLSFISRFQ
STSALQYLLELGTLQPIHVAASGKAILSYLDEKEIAEIFEQEKVSLEEQKHIWKDIEQIR
NQGFSFSLNERRNESIGIGAPLFDATNQVIGSIICAIPINLYKKERKDELISSVIEVAQN
ISSALGFQKENS
>PK3-045_04030 Glucose 1-dehydrogenase 4
MGKFEGKIALVTGGTSGIGLATAQKFVNEGAYVYITGRRQNELDKAVNQIGKNVTGVQGD
ISKLEDLDKLYDIIKQEKGKLDILFANAGIGNFLPLGEITEEQVDRTFDINVKGTIFTVQ
KALSLFPDKVGSIIVTGSTAGSIGNPAFSVYGASKAALRALVRNWILDLKGTEIRVNVVS
PGAILTPAYDELFGDALEEVMENSKNTVPAGKVGTPEEVANTVSFLASDESSYLTGVELF
VDGGLAQV
>PK3-045_04031 putative HTH-type transcriptional regulator YtcD
MKKFSCGFEVTKEVIGGKWKGLVLYFLMNGPKRTSELKRIIPNITQKMLIQTLRELEASG
LVSRKMYNQVPPKVEYSSTELGESLKPILQELCQWGSHYAEQEYAEGEYEIVQPEQVSYQ
DNIIS
>PK3-045_04032 hypothetical protein
MKIIVTSIFVQDQDKALKFYSETLGFVKKHDVPAGEFRWITLVSPEDEEGTELLLEPNNH
PAAKEYQKKLFTEGIPVTMFGVADIHKEYERLLENGVKFTMEPTKMGEVTIAVFDDTCGN
LIQIMQE
>PK3-045_04033 hypothetical protein
MNFNKLIPELSVKNIQQSKEFYLGILGFKLEYERKEDNFAFISLNGAQMMIEQYNGFWQT
GELNYPYGRGINFQIEVENIEEILHKIKKHNILLFKEVMINEYSEYIQKEFLVQDPDGYL
LRFSQNIRP
>PK3-045_04034 hypothetical protein
MNILVIGRGVISTQYAWIFKENGNNIDFYIRPESIDKYTPMLNLQLDDRRKRKSKKINVS
WETNLIYEIPQNHNYDLIFVSVNIEQISSVVKTLNNKVNNATVLFFNNFWEDPIKQTEIL
PQTQIIFGFPGAGGGTVGTNTIIGAFSSIIMIGDIGKASKERVQQVYTLFEQAEFSLKRQ
TNFKKFLLNHFLLNVAVEIEVLKEGSFIGLMDSIDALGNISINLRQLKPIMKERGMSYDA
LNTLLSTISPKIIGIIMSKFIFKSGSTARSLMEGNNIITGRSAKLILDEARRKNIHVNTL
ENISKLLT
>PK3-045_04035 hypothetical protein
MERRKRRTQKLIIDTFFLLLNEKPFDKITVNQITTLADINRGTFYLHYQDKYELLEKTIK
IYINQMDQYCLHNQEMTINSLTLAFDYLKENYNFIEPLLRNEGYQLFQHELKSSISSFIE
TSDLFDLRVVSILKRRAIISTILGTIEWWLAEDELNTDPSEIAAELKDIIFSIIT
>PK3-045_04036 hypothetical protein
MSLPTLSVFFGAGAEIGYGLPSGGKFALEIFRVSNEKDKETFRSQIQSLDSRSQIATQWL
PDNYASKRLNVFGKGEFEGLIASSLENRRSNILDYLDHFDENVSDLLNKWKFNETIIRDK
FTNETGEQIGDMRYNQAIRLNEKLASSVLLFESDYFSAFLRLLEKYPTDRYLKRIVRAFL
ELLVGAIGQSLVSQLNEELFTAAPDELNVFDDLSGVFSLNYQGVGQTGMEIVIEETSIDL
KEDTDGLTVFRELGRSILEEIYCQAMDYQALIDSHFRYLYNPKAQWAKFSRIAIFLHTVQ
RYITNKVHVDETRISDGPGYYHDLINLRNYFHIKAVGTTNYNNFVQQVLAGTELAETPVY
HLNGSVNEYYDPYKNEILTEPSSEERQGRILVPFMFTQSGVKPLTSVSMSRKYVNLYDHF
VESDIVCVIGYGFNGDDGHINGMFRSLVEIENKSLVILHYKSDNRTQQQLLKYYQQKLRL
SSSGNLRVVLVDNNRIFNGDIWYNALL
>PK3-045_04037 hypothetical protein
MKKLGTLYFFCGKMGAGKSTKSKQLAIDKHAVLFSEDEWLSSLYPNQIASFEDYLKFSAQ
LKPLVKKHVQNILSVGTDVVMDFPANTQKLRKWFFDMASEVNASHQLIFLNLNNEQCLRQ
IAQRRNEQPERSTFDTEAVFIHVTKFFEAPEASEGLNILEYSGKE
>PK3-045_04038 hypothetical protein
MKHTGRHTGAFLLLFLMEGDNYGGKLLQKCKEELPINPIDSAILYRTLKKLEEEGAIDSY
LDVSDQDKPVRMYKITTLGKRKLEEFQIDIQEKIKNLSFFLEKYKKMELRK
>PK3-045_04039 hypothetical protein
MVNGIVLYTIAAIYLSLSFIKDKYKTKVALLSSWKMFRNVLPDLLAIMLFVGLALSLLTP
SLISSIIGENSGLLGILYSTIIGSIAIVPSFIVFPLGHTLVQNGAALPQVAVLMSTLMSV
GLASLFMEQKTFGQSFAYARNISAIIMSLLFALIIWVVMT
>PK3-045_04040 hypothetical protein
MKKLKRYRFFLILLLGLLLIAFMNQTIAAKTVQLTGKNILDMLILLSPVFILVGLLDQWV
KKETLVRYMGEKSGIIGVLFTLLLATVAAGPLYIAFPIAVLLLRKGASIRYIVFFLGAWS
TVKLPVLVYEFTSFGPKFTLIHICFGLVFYYLTGILFEKMYSQQKLLKYDTTIGK
>PK3-045_04041 RNA pyrophosphohydrolase
MTTSSDYIRYIRGKVGQDLIFLNFAGGIVYNERNEILLQKRGDGNEWGFSGGAMELGESL
EETTKREILEETGLNVKVEHLIGVYSKYSAEFPNGDKAQTITHFFQCKPIDGELTADGIE
TLDLKYFPINKIPKLFTKQHEDALEDWLCKRKGVFK
>PK3-045_04042 2-isopropylmalate synthase
MSRKIWVFDTTLRDGEQVPGAKLNVYEKLEVAKQLKKLKVDMIEAGFPSSSIGDFNAVKE
IAKRIGNTDDVIITALARAVKSDIDDVYNSVKYAKNPLIHIVLGTSDIHVEKKFGKSKNQ
ILDIGVDAVKYAKTLLPEVQYSTEDASRADFEYLWKTIEAVVKAGATIINIPDTVGYAEP
QEFGELIYKINDRLKNLNDNVLLSVHCHNDLGMATANTLAAIKNGAEKVECTINGIGERA
GNASLEEVVMAVHTRSEIYQAFTNINTKEIMNTSRIVSGFMGLDVQVNKAITGENAFAHS
SGIHQDGLIKSRNTYEIIDPVTVGLDDMELILTARSGRHAIKTAFEKLGMNQFSNSEFEE
IFVDFLKLADAKKEVYNHDLYVMIENYYKKVKGNNQDISHYSNNFYELIDLQVISNTKFP
SASVELKKADQIIKGTAIGSGPIDALYSAIMNVCDLDMKLIQYDIRSVSRGKEALGKVKI
QVEFKGEVYIAKASDTDILKASAYAYINAINSIVVDHLLPVK
>PK3-045_04044 hypothetical protein
MVYRIQKVGVNINYQTINLNEKFSKFNERWSPKVIGEMNDYQFKVVKIEGDFVWHDHQDT
DEVFIVLTGEMFIDFRDGQVKVSQGEMFIVPKGTEHKPFATQECHIMLVEPRGIVNTGDT
KSALTAVNDIWI
>PK3-045_04045 hypothetical protein
MISKVNIQDKFLKINDYWNPRIGCELNDSYIKMVKIRGEFIWHHHDHEDEMFFVWRGKLV
IRLRNGEIVLNEGEFIVIPKGIEHQPIAEEEVHLLLIEPKTTLNTGNVVNQRTVLNPQEI
>PK3-045_04046 HTH-type transcriptional regulator GltR
MDIKSLEVFKAVAIEQSITKAAEKLNYVQSNVTARIQRLEQELGVPLLYRYHKKISLTPA
GRELLPYVNKLLFDFEEAIEAVKLSSTPRGSLHIGAMESTATTRLPIIFSRYHKEFPQVE
LSLYMAPTVDQVNAILNYKIDGAFVDGPILHPEIIEYPVLEEFLVLITSYSTETFHIESI
LHKPLLSSFAHCTYLAIWQKWLADNDFAPMRVMEYGTLEGVLKCVENGLGVTVLPISMVE
SRMQDKLNCHPLPDPHRTVPTVFIMRRDSYRTSALSKFMELAGITNL
>PK3-045_04047 Blasticidin-S deaminase
MKIFNTTKEDIELVEVATQKITMLYEDDKHHVGAAIRTKTGEIISAVHIEAYIGRVTVCA
EAIAIGSAISNGQKDFDTIVAVRHPYSDEVDRRIKVVSPCGMCRELISDYAPECFVLLEI
NGELIKTAISELIPLKYSRN
>PK3-045_04048 hypothetical protein
MEKFEVKYINNLLNFDLVSLVKQSKEDGFCFVERLLNEYQNGNNTFNHLGEGLFGVFNEE
GLLVAIGGLNKDPFSGAQNIGRLRRLYVYKEYRRNGIGSLLVKRIIEEAKRHYKILVLYT
DTEQADRFYSSIGFTRGNLYPNSSHFMEFKS
>PK3-045_04049 hypothetical protein
MESMNQISYKVNESIKAEELSEVFKTSGIKRPSDDLNRLQQMIDNSNVLITAWYNNQLIG
VARAITDYCYCCYLSDLAVNKNYQNRGIGKELVRLLKEHNGDEVALLLLSSPIAMEYYPK
IGFEKIENGFKIPRKK
>PK3-045_04050 Uridine kinase
MSFKSELKNFEQLVSFINLIPRKQSTLLIGIDGCGGSGKSTLAHKLKDECSDVTVVHMDD
FYLPSKQLQETIPENKAIGADFDWKRVLNQVLEPISQNKEGSYQRYDWETDDLAEWHTVP
IGGVVIIEGVYSIRNELASKYDFTIWVECPREKRLSRGLERDGEEARDMWENNWMISEDL
YVETQKPFERADLIVNGTK
>PK3-045_04051 hypothetical protein
MNTTHTILNQLKVIGVHSIISDEQIILEILDDNLKQKEKMDCLINNLLINTRISKLKKVL
LECPKIHLEHLNRTMEKMKIKGERVIYIKSLEEPINIGDIDYELWSINDEKSLTFLSEIM
DRNMLDIHKFIGSMRTELPSQVQKMFTIYKVNNEPVGVVFPHLEPDKDKEGRIFWIGIHP
KFRGKGLGKNLHLIGLYRLQNDFKAKSYVGATQINNYSMRKIMIYNGCVENKNTVISLVY
SSE
>PK3-045_04052 hypothetical protein
MKTLLITGGTSGIGKGLAEYYLTTGNRVIIVSRNKGDLPNATYLQADLSLASENYRIIEK
IQRSYGAIDGLILCAVLQRARKDALITQEGLEFTFALQYLSRYILSNQLAFNNDSFILNV
ATPGINGTVNFDNLEHRCKFNSVKANINANRLNDLLGAGFKRKGVRYILYNPMAVRTSGA
RSVFANPLMRIFLRVVHRLIGHEVDEIVNSIVNVLQESSSQSFSTYKLSKTVDVSMKTFD
SQKAKQLEEITKQVLLNV
>PK3-045_04053 putative HTH-type transcriptional regulator YybR
MDIPNLQELMAQKLNNQENCNPNFNPLDPVFNVFQGKWKNQVLFEIIALKNARFGQLNRA
IPKITNTMLSATLRELEKDGLITRKQYNEIPPRVEYTITEKGKDLLPVYYEMYKWGIKYQ
KE
>PK3-045_04054 23S rRNA (guanine(745)-N(1))-methyltransferase
MLKENKRIKSAKYVSNFENIFACPICRSSMQVIDFKSLICLNHHTFDFARQGYLNLMTHS
VNTKYSKALFEARRKLITKGEFFTLLSHAIAKFITEHLVKTKETISILDTGCGEGSHLSN
ICEIIRSNFFKNVLGVGIDISKEGIMVASKNYSDKIWAVADLANTPFKFKQFDVILNILS
PSNYAEFDRLLKPNGIVIKMVPQNSYLKELREHLFQKNEKQFYSNAETMERFKKSFQFVE
CSRLTYNMNLNKSSIEWLVQMTPLTWSTTEEQIKSFLIKDSAQITVDLDILIGKNTI
>PK3-045_04055 Beta-xylosidase
MQKNEVMALIDSLSVEEKIGQLVQLTGDFFTNETGETITGPIKKLGLNENYNIYHTGSIL
NITNAHEIIKIQEKYLENSSHKIPLLFMADIIYGFRTIFPIPLAQTCSWNFDLIEEAASI
SAKESYEEGLHVTFSPMVDIVRDPRWGRVMESPGEDTLMAELFAERVIKGLQGNSEQKIP
KNKIAGCVKHFAAYGAPIAGREYNAVDMSEHTLREIYLPGYLSAVKAKVKLVMTAFNTLN
GVPSTGNEWLNKMILRDEFKFAGVLISDYAAVEELITHGYANGPKEAAQLALKATVDIDM
KTSVFANELGAIVNNNEQMMDLLNKAVYRILSLKNDLGLFEDPYRGLKERSAENSSILCS
EHKKTALMLSEESIVLLKNNGVLPLEKGKKAAIIGPYHDEKSTLGMWAIKGDINDTITLK
DGINEIVGNNKNPFCRGSHLIEKETAHLLGKFEDKIPNERISNDELIEEAVNLAKDSEIV
ILALGESIFQSGEGGSRTEITLPKPQQKLFDAIKKLNKQIITIIYSGRPLILTDVEKHSD
ALIQAWFPGIMGGKALANILYGISNPSGKLSMSFPRSVGQIPIYYNELNTGRPDLPENAF
YRFASRYIDESNKPLFSFGYGLSYTTYQYNSVSLNKKLIRQNSNDELIVTVEVENTGDYD
GYEIVQLYIRDQFGSTARPVKVLKDFKKVCIKKGEVKTISFTITEEQLKIYRSDLSFASE
PGQFDVYIGSSSEDLPLKESFELIQS
>PK3-045_04056 PTS system trehalose-specific EIIBC component
MSNKNYKNIAQEVIRGIGGTDNIISMAHCATRLRLIVKDRDIIDDELIENIDFAKGFFFT
SGQYQIIFGTGTVNHVYDAMLQEGVSGTTKSELKEIASDKDDNIFLRMIRLFGDVFVPII
PALVATGLFMGVRGLILQPDILAVFGLTPDHISDNFIKFTQILTDTAFAFLPVLVCWSAF
KVFGGSQLLGILLGLMLVHPSLPTSWDVAQNVAEPLKFFGIIKVAGYQGSVLPAFIVGAL
GAKVEGFIRKRVPSALDLILSPFFTLLIMIVLAFFLIGPVFHEVELLLLHAVTYVLELPF
GIGGLIYGGINQVIVITGLHHPLNLIEIQMLADTGKNLVNPISTASICAQAGAAFAVAVK
SKNVKTKAIAYPSTMSALLGITEPAIFGVTLRYGKPFIMGLIGGAAGGFVAGLMHLSATG
MSITAIPGTLLFLNSQIFGYLLVSLIGFGVAFILTYLFGYKDNQQTK
>PK3-045_04057 HTH-type transcriptional activator RhaS
MGELYEYIEINQKKTIKFFSFKAKDTERIIPMHWHDSPELIYCVEGKLKVWYEGKIVTLG
KGDLLLINSNTPHSTQSITHNHVCIIQFPGNFLEEENKSIHLSTCENKYDAQVIDYTRKI
ITEIIEYHVSTNEYDYLLEQSKILHLKYLLVTNFSSGANGKCEDNNRKQLKLKQLEIVIR
HLKNNYKDNPSLKEIANACGYSEAYLSRLFHTITGQTFIDFKRNLCLEKAIELMNTTDKT
ITQIAYESGFSNVKSFRNYFRSTMNINPKYYKRSKNDP
>PK3-045_04058 hypothetical protein
MIEFFAIFGFYLLPVYCIIFCLNLVSLLKKIQEEDSTTKNTIWFTISFIFIIMTVASLIA
VN
>PK3-045_04059 Formylglycine-generating enzyme
MDKELQSKSCCSASRESMDFINFGREDATFTKNSSYSRKNMLLLQGGEFLMGTEDQDGFP
LDGEGPIRKVKISPFYMDKYAVTNEEFARFIEETNYKTDAEKFGWSFVFHLLLAKEDAAI
YTRAPRNTPWWRVVEGAYWKKPEGPNSSIEDRWNHPVVHISWNDAMAYCKWAGKRLPTEA
EWEYAARGGLEQNKYPWGNELNPNGKHMCNIWQGEFPTVNTIEDGYLGTAPVDSFEENGY
GFYNMAGNVWEWCSDWFHPTYHQKDSLQDPKGPPNGNTKSLRGGSYLCHDSYCNRYRVAA
RTSNTIDSSSGNLGFRCAADVDEVEVNQNRK
>PK3-045_04060 Chromate transport protein
MLVQLFLFFLLIGTVSFGGGYAMIPVIEQGVSARGWISTNEFTDIMAIAGMSPGPIATNS
ATLVGYQLAGVPGGIISSLAMTIPSLVIILLMAICFTKVNEYKLVKQSFYGLRPIVTSLI
VYAAWKFAYSNHVISLNVNMEMISLLLICLVSLYFLWRWKAHPLFVLLGAGIAGIFVF
>PK3-045_04061 hypothetical protein
MKLKVSLFQIFWVFCKMSPVTFGGGYAMIPIIEKEIVVRKKWMKMGEISDTLALAGTAPG
AIAVNASIFIGYRLGGILGALVAMLGALLPTFLIVLILGSLYLYFQDNVFVNAAFKGISG
AVVALIGYAAIKIGKTSIIDKSTAVLSIVMIVSMIIFNLHPIVVILLGALLGIMIAKVKE
KLGMAVKLEKEESQVHEADQAS
>PK3-045_04062 hypothetical protein
MRAVMIMFDTLSRNFLPNYNNNWVHAPNFKRLQDKTVTFDHFYGGSMPCMPARRELHTGN
YNFLHRQWGPLESFDRSVFEELQKNDVYTHLVTDHSHYFEDGGATYHNRYSTWEGFRGQE
GDRWIARGEALPNENNHKLNKQGLSVIQHFANRTRQQEEEEMSSVQTIAAGLDFLHTHKE
KDNWFLQIECFDPHEPFYVPEKYRKIYDCEDKKDIPYWPAYQQLNDGDYEEKDIEDMQKE
YAALISMCDYHLGKVLDYMDEHDLWKDTMLIVNTDHGFLLGEHNWVGKNIAPLYEEIIHI
PFFIHVPKITIGGTRCSALSQTIDIPVTLMDYFHVPYDNKLLLGNSLLPILEKEKEENHK
SILFGTHGSYVNIHDGRYTYMRASSQEENGPLYNHTLAVTAIRGFLDQEAINKAELKPGT
RFTNYSPYLKIPVKSYYNSYKTGSLLFDIQNDPKQEKPIVDKELEKEMSHKLVDLMQKSD
APEEQYIRLGLERR
>PK3-045_04063 Anaerobic sulfatase-maturating enzyme
MIHSPIAAPLTTVLLKTVSEACNLACDYCYYSKCENKSTIQTFDLDVLEKFIKEYSSYSN
GFMTFVWQGGEPLLAGLPFFEKVIELQKKYGKNGSIISNSLQTNATLITKEWADFFKEYN
FLIGVSIDGPKEIHNKRRPNRGGQGSFAQVMRGISHLKAAGVEFNILTVVHEDNVLKGQE
LMAFYKEEDFRYIQFIPCMDFQSQDIDAPGKFLITPKEYGKFLCDVFDVWFNDGSPETSI
RFFDEYLSVSLHQQAALCTHRKTCPKTLILESNGDAYPCDFYITEDLRLGNIGEDSLTDI
LSSPIYNTFLTKKEDLAERCLDCEFLSFCHGGCPRNRNWTEDANYDYFCESFKIIYQYSS
DRMNRLTRTIKSQWKQQLIREGHPLPDRNSLCFCGSGKKYKKCCALLTV
>PK3-045_04064 PTS system beta-glucoside-specific EIIBCA component
MKYEQLAKDIIKNVGGRENVNSVVHCVTRLRFKLKDESKANTDILKNMEDVITVMKSGGQ
YQVVIGNHVPEVYKAVVEVGNFQSNSSLVEEDSGEKQGLFNKFIDLISGIFAPTLGVLAA
TGMIKGVNALFVALGWYANTSGTYHILNAVGDSLFYFFPIFLGYTAMKKFGGNPFIGMAI
GAALVYPTLSGLTAGDPLYTLFAGTLFESPIHITFLGIPVILMSYSSSVIPIIIATYVGS
KLEKWFAQVIPAVVKTFLVPFLTLLISVPLTFIFIGPIATWLGKLLGELTLWVYDLSPII
TGIVVGGLWQVFVMFGLHWGLIPIAYNNIAVHGSDYILAFNSATSLATAGVVLGVLVRTK
QKKYKTLSIPAFISAIFGVSEPAIYGITLPLKRPFIITLITSAIGGCIMGIMGTKAYTMG
GLGIFGLPTKINPTDGFDMGFWGAVLAMTSNLIVGFILTYLFGIDKNKEKEELAKQEQAA
KEKESPNNPQGTASNEEIYSPLKGEVRMLADVEDAAFSSGTLGKGVAINPAEGKLISPVG
GTVTALFPTKHAIGITTDAGAEILIHIGMDTVQLGGNYFTAYVKDGDRVEKGQLLIEFDM
DKIQESGYSLITPVVVTNYDQYRDIIVAAGHKINFGGTLMALEA
>PK3-045_04065 Aryl-phospho-beta-D-glucosidase BglH
MSLPKDFLWGGAIAANQAEGAYQEGGKGRALVDILPAGKERWEALYNPKKALETKYDYYP
SHRAINFYHTYKEDIKLFAEMGFKVFRTSISWPRIFPNGDELEPNQEGLKFYDDLFSECH
KYGMEPLVTINHFDTPLYLVEKYGGWRNRKLIEYYERYAKVVFERYKDKVRYWLTFNEIN
MLLHIPFFGGGLIIDDDENADQIKFQAAHHQLVASSLATKAAREINGSNFKIGCMLAAGE
IYPYSCHPHDLLKSVKENQKQYFFIDVQSRGAYPSYTKRMFRELGVNLQMEADDERLLKE
YTVDFISFSYYSSRLTSADPAINAGNKSGNAFGSLRNPYLEVSEWGWQIDPIGLRVTMNN
LYDRYQKPLFIVENGLGAVDKLENETIEDDYRIDYMREHLKQMMEAVDDGVDLLGYTSWG
CIDLVSAGSGEMKKRYGFIYVDLDNEGNGTGKRYKKKSFDWYKKVIETNGGEL
>PK3-045_04066 HTH-type transcriptional regulator GlvR
MKLESLVNERYNSFSDGEMEIAKYILQNKEIIHTLSINQLANNSLSSKSSVLRFAQKLGF
SGFTELKNFMKWGNFFSDNPVVNSSLGEQIVNSVTTTIEHLKNMNMDEMFQAIDSSEHIY
IIGTGWAQQNQASELQRMFLGVGKEMQVLPFGHTSLYQVMIERMCDKDLLIVFSGSGNNP
ILKEALTTPILKNVKIVGITANSNNWLANHSTFNIYAYIDSPTSMKNIYSLYSPIHAIIE
MLVYSYAEYLNRKT
>PK3-045_04067 N-acetylglucosamine repressor
MLKEFLLDTSEKNNIKKQIYKYIHLHKRASKNEMLQVFHLPQTTLTRIIYELHDKGYIYN
DGKGEPTGGRPPTYYAVLPDAAYVIGIDISRTHVTCILTNIAFEELGKIQTKLETTDTPD
RLVPKLISDLRKLLEMHKIEEEYLLGIGIGSVGPLDREKGIILNPDSFAASAWNNVRIVD
ILKQEFPVPITLNNGANTAAYAEYYLNSLLDDSILYCINGYGVRTGFLERGIIGNNHEGD
SSAAGHIVIDINGRQCICGKKGCLATYTTYEALLEKIMEKKEVSFPKKEINAFEYIIEAI
EKNDPLVKELVLESAYYYGIGISNMVNILHPTKVFLHGKLIYQYPSYYQEVVKTIKNNVY
QKDTIIIQKSTIGEKSVALGGAIELYNTYFNMHN
>PK3-045_04068 1-deoxyxylulose-5-phosphate synthase YajO
MDYVKLGSTGLEVSRLCLGCMSYGEPDRGGHAWTLTENDSRPFIKKALELGINFFDTANV
YSDGSSEEIVGRALRDFANRDEVVLATKVHGRMRPGANGAGLSRKAIMSEIDNSLKRLGT
DYVDLYQIHRWDYETPIEETMEALHDVVKAGKARYIGASSMFAWQFLKANHVAEKNGWTR
FVSMQNYLNLLYREEEREMLPLCKEEGIGVIPWSPMARGRLTRDWEDTSTRKETDAFART
LYSQTEAADRQVVERVKAIAEKRGVPRAQVALAWVLQKEPVTAPIIGATKLHHLEDAVAA
LSLQLSHEEIASLEEPYVPHPVLGFK
>PK3-045_04069 hypothetical protein
MPNIWEPEYTITKEQASQLVEEQFPISVYSIREIGEGFDNTILLVNDCYTFRFPRREIAV
KLLTSEWELLRIIADQLPIPIPKPVYIGSASRVFPRIFIGYEHLPGNTPEGLTNKERIQM
AKPLARFLKKLHSFSTEQFKLVPYDEFDRLHIDKRKSRLIDSIKKLRMHEDIALFHLVEE
YAKKLTHIAVPTVHVLTHGDLHIRNMLINEKKELTGIIDWGDTHIGHPAVDLSIAYSLCP
SEGRKQFFTNYGEVDDTTLKLAQFKAIFTTVTLLIYSIDKKDWELYQEGKISLSFALMGE
N
>PK3-045_04070 hypothetical protein
MNKISQAEAVKLKSVLSKRIHELEEEMDRVAFVQVEAGKPIPKQKRTILDVEKELEEVRA
DYRLLDKLMYCANIENEISFENTNITIVEAIELATQLRAKARKYKEFAAAEKEEYVYSYS
ETVQLMKVATFEPEEYRLKSLECERKANRLSNLINSKNYQIELEFDGEKYF
>PK3-045_04071 Inner membrane protein YbaN
MKPIYRWIYIFLGTVFLVLGIIGAFLPLLPTTPFLLLTSFFYTRGSERINKWFRSTTFYR
DYVKGFRKGELTKKQKIKIIITCYICLAVSAILVDHFYTRIMLGCIAIVQAISMFIIKTK
KEEPEVIIKE
>PK3-045_04072 hypothetical protein
MTKIVNIILLINVIGIVLYAAGVLDTDIFRVEFLSSGVIMLLFGLRDVVRGAKRKRR
>PK3-045_04073 hypothetical protein
MEKNKMEKRFLNGLLIGNLLILLPILYRKPPIRDWIIVFVYNAITNGLLDMLLTSHKVIR
YPVRFLPKIFNIHILFDFLIYPTFTVFYNQLTKRDKPFAIFYKLIFFTLPFFIIELWAEN
KTKLIEWNKWWKWYYSFLSIILKSLITRFVIEMLRKMNFLTK
>PK3-045_04074 hypothetical protein
MDFPTIQTNFWDAVIAVPVVMIMTQLLKMMIKIPKKYVPTIALALGLLISVFISHRHSLV
AGLFMGWFYGYSAIGSYASMKTTILTFLEKRKKKAGK
>PK3-045_04075 hypothetical protein
MIRYSIGKPYLIVYSLFEDAWKVSLPFKLVTS
>PK3-045_04076 hypothetical protein
MTSHYFIATMRAIPEFHEGDNNYSFLSGEAYKEVLPFTLPYVYEVDEDDRELIIFLDDFM
QLGDVVEHYIYEEGRNGITLSENFPEEARTINLWKKTYKDQYGAYQLDPKRWREDLSSRT
IASKRSVTTFVKI
>PK3-045_04077 hypothetical protein
MNRFSLATILTIFILILFMMDMITDKLFVIAFIPLSIWMLFIGVSEFKKTLKNRSTVEED
ANKLK
>PK3-045_04078 hypothetical protein
MTEKQNKHQFVISQENWSLHRKGHDDQQRHQEKVQEAIKNNLPDLITEENIVMSNGREVV
KIPIRSLDEYKIRYNYDKNKHIGQGNGDSQVGDVVARDGSGNQKGPGKGQGAGDQAGEDY
FEAEVSLMELEEALFKQLELPNLKRKEQDQIVVENIEFNDIRKVGLMGNIDKKKTMISAF
KRNAMSGKPAFHPIYPEDLKFKTWNEVQKPESKAVVLAMMDTSGSMGLWEKYMARSFFFW
MTRFLRTKYETVEIEFIAHHTEAKVVSEEDFFSKGESGGTICSSVYRKALELINDKYDPG
RFNIYPFHFSDGDNLTSDNARCVKLVEELMEVSNMFGYGEVNQYNRHSTLMSAYKNIQDE
RFRYYLLRQKADVFNAMASFFRKEEEGQMYA
>PK3-045_04079 hypothetical protein
MSILKKIEMHRQEEELLKWEGTFEEYLEILKEKPWVGQSAHSRVYNMIKDAGIDEVNGKK
QYKFFSDQLFGLEEPLERLVEEYFHPAAKRLDVRKRILLLMGPVSGGKSTLVTMLKRGLE
AYTYTDRGAVYAIKGCPMHEDPLHMIPHSLRKDFYDEYGIRIEGNLSPLNMMRLQEEYNG
KIEDVIVERVFFSEDKRTGIGTFSPSDPKSQDIADLTGSIDFSTIAEYGSESDPRAYRFD
GELNKANRGMMEFQEMLKCDEKFLWHLLSLTQEGNFKAGRFALISADELIVAHTNETEYR
SFISNKKNEALHSRIIVMPVPYNLKASEEERIYEKMIRESDVADVHIAPHTLKIAAIFTI
LTRLKEPKKGDIDLVKKMRLYDGESVEGFSSADLKELQNEYGDEGMSGIDPRYVINRISS
TIIRKDVTSINALDVLLSIKEGLDQHSSITNELKEKYLNCISLARKEYDEIAKKEVQKAF
VYSYEESAKTLMDNYLDNVEAYCNKNKLRDPLTGEPINPDEKLMRSIEEQIGISENAKKS
FREEILIRISAYARKGKRFDYNSHDRLREAIQKKLFADLKDVVKITTSTKTPDEQQLKKV
NEVVARLIDEHGYNSTSANELLRYVGSLLNR
>PK3-045_04080 3-oxoacyl-[acyl-carrier-protein] synthase 3 protein 2
MVGARITAIGTYVPKRRLTNLELEQMVDTNNEWIIQRTGIEERRIARSDEFTSDLCISAV
KDLMQRYNKKVNDVDMIIVATSTPDFPFPSVASIIQNKLEISNTGTIDLSAACAGFVYAL
HTAHGYIASGLHKKILVIGADTLSKITDYNDRSTCILFGDGAGAVLVERDEKTSSFIGFH
LGSDGSGAQFVYRPGLTKKVNDIELIDTEYLVQNGREVFRWVVRNVPNNVKKILDKTHIS
MDKINWFIPHSANLRLIEPICDKLGYPMEKTLYSLTKFGNTSAASIPLALDLGIREGKVM
NGDKVLMYGFGSGLVHAGELLEINFDEANNETSTL
>PK3-045_04081 FMN reductase (NADPH)
MNQTIETILNHHSVRKFTDEELTQEQIRLLVEAAQSASTSSFVQAYSIIGVKDKEKKKKL
AVLAGNQQYVENNGHLFIFCADLYRHTVAAEMEGKKEAAQDSIESTEKFMVSLIDAALAS
QNMAIAAESLGLGICYIGGIRNNLVEVSQLLKTPDYVLPLFALVVGHPDQQTEKKPRAPF
HHIYHEDQYEQDEAQYKKGLQEYNEEIKAYYQERTNGARSDTWTAQMAANFEQKSRMYMK
EFVQQKKFDLK
>PK3-045_04082 tRNA (cytidine(34)-2'-O)-methyltransferase
MAIHIVLYQPQIPSNTGNIARTCAGTDTVLHLIRPFGFSMEDKALKRAGLDYWEFVKIYY
YDSLEEFYDKNEGGAFYYVTKAGETPYDSFDYSAINKEHYFIFGSETTGLPEEVIQNNVN
KTLRIPMTDDILSYNLSNTVAVLIYEALRQQNFAHLK
>PK3-045_04083 hypothetical protein
MRQQLMELIEKRIQQCVTKDREAIVDEKLERKRNSMYKRKAEIVHVKAKGKIEDMEKKAD
ETEELVYSVHLQYFIKQGELFLIEEEMENRKAVVYKGVIIEDTEVLPAYPEDYREVPLAE
EWRETKERESRYKYDRLKAVQYAEKWWNSYNPKYHQFEVDCTNYISQCVHEGRAPMRGYP
NRNKGWWMQNNNWSYSWAVANAFPRYLETSTAGLRAKRVDSAMELKLGDVICYDFEGDGK
YNHTTIVTGKDANGEPLVNAHTYNSRMRYWKYEDSTAYTPNIKYKFFTIIDG
>PK3-045_04084 Epoxyqueuosine reductase
MDYREFKKDIIAYSKTIGIDKIGFTSASTFEEMKVRLITQQELNYQSGFEEKDIEKRVNP
SLLLHQPKSIISIALAYPSKMKERVVSKKGERRGIFCRASWGTDYHVVLKDRLQKLEDYI
KERIPDALCKSMVDTGELVDRAVAQRAGIGWSGKNCAIITPEFGSYVYLGEMITNLPIEP
DTPMEDQCGTCNKCIDVCPTGALVQGGQLNAQRCIAFQTQTKGFLAEEFREKLGNRIYGC
DTCQTVCPKNKGIDFHNHPEMEPDPEIAKPLLQPLLFISNKEFKEKYGHISGSWRGKKPI
QRNAIIALAHFKEEGAIGDLITVMNKDPRPVIRGTAAWALGKIGGDESKTALESAKQQES
DHEVLKEMDDALQRLAK
>PK3-045_04085 hypothetical protein
MDISIAKEIKERIPNFKIGFIHYQGMQVMDTPQMIKGRMRLFQESIFFDLEDSNVTDIPS
IKEWREIFKKTGKDPNRYRHSAESLLRRIKKQNYLEPINSSIDINNFFSLQYGIPIGIYD
CANLQGKINIRIGKESEQYAGLNGRINSIENLIVSEDELGPFGSPFVDSDRAPVQSSTKN
AIQIIYLPPSIANEKAKQMVESLLKMFLQVHGGEATFSIVE
>PK3-045_04087 Putative multidrug resistance protein MdtD
MTSAYRISMLVNDQPGVLARISSLFGTHHVNIEDIKTKKYKREATTRIQISSSAEEKQVQ
NLILGLQGLMDVVEVDADAIHQSAFQQRLLQRTNTIQTLREQKTLSKKVSYWLVAFSLFL
TLFGTNIPASLYSLYRVEWGLTSGMITLVFAIYAFTVIPAIVIAGQLSDQIGKKKVLIPG
IFFSLIGTLCFTVANGLGMLLIGRLFQGLSVGILNGVAVAALTELDENKNTKKTALICAL
AVTLGNAFGPILSGLLGDFAPIPLRLSYYVHLLFIIPCFIFLFFLNENIKPGLKPVQLKK
PFVPKEIMKPFLLASFTSFVAWSIISMFMSLIPSNLSSFTTVTSLTISGVVVALGLIAAA
FNQILLKQLSLMKLMTIGYVFLALGLIFLVITIDTKSLTLLLISAVLIGGGNGPAYAGSL
ALVNEVAPSKTKGNIVSTFFVITYLGVSLPVIGLGYLSQSFGVAGAVTTYVLIMGVLLVG
IAGFAWKEGKSIFPK
>PK3-045_04088 Nitrite transporter NirC
MEGASLYEVEKLALKKLKIYKRSKFRFFMRAVVASMFIGFGVIVAFKTGNFFYAVESPFA
YPMAALVFGAAIILIAYGGGDLFTGNTFYYTYAALRKKIKWTDVFKVWGTSYAGNIVGAI
FFAVFILLTGLFKSPSVNDFLLHAAETKLQAPISELFFRGILCNWLVCLAFFIPMALKED
IAKITVMILFVFCFFISGYEHSIANMATFSISYVLDQNPAVTIPAIIRNLVPVTIGNLIG
GVGFMGVMYYYVNKPFMEDDEK
>PK3-045_04089 hypothetical protein
MRKYSKMIKPFDIIMVVLLLIISFVPMAVFAMNQGKEEEGNKVMAVITQDGKVIREVELT
GHTENEQFMIKGKGKQYNLIEVENEQIRIKEDNSPDQIGVKMGWKGIPGQTIICLPHKVL
IEIVAEKPEKTNEDGLILSH
>PK3-045_04090 putative zinc-binding alcohol dehydrogenase
MKAVTFQGTKDVQVKEVANAKLQKKDDIVVRITSTAICGSDLHIYQGALPAEKDYVIGHE
PMGIVEEVGPEVTRVKKGDRVVLPFNIACGHCYYCEHDMESQCDNANPNKDIADTGAYFG
FTERYGDYQGGQAELLRVPYGNFVPFVIPESCELEDEALLFMSDVLPTAYWSVENSGVKD
GDTVVVLGCGPVGLMTQKFAWMKGAKRVIAVDNIPYRLNHAQKMNQVEIVNFDNHGDTGN
YIKELTSGGADVVIDCVGMDGKKSPMEAIGQKLKIQGGTISAIEIGMNAVRKFGTMHLTG
VYGSKYNMFPLGNIFERNITVKTGQAPVIHYMPMLFDWITTGKIDPTEIITHRIALDDAS
NAYQMFNDHQDEVIKVVLKP
>PK3-045_04091 hypothetical protein
MLKNREDVIKLIQSDEKMMEIIKVAGSLNLPDWWICAGFVRSKIWDTLHGFIERTETPDV
DVIYFDNTKIDENFEKELENKLKSIMPNIPWSVKNEARMHVINNLPPYSSSEDAISKFPE
TATAIGVKIDKDNKLVLTSPCGIDDVINLELKPTPYFIETKELAAIYEERIIKKNWKAIW
PKIKVQTY
>PK3-045_04092 putative protein kinase UbiB
MGVSKRIRQMKRYRKITSILARNGIGFFSNKIGLEEKFFFHKEHPPKSTGRRIRLILEEL
GTTFIKLGQIASTRPDLIPPEIINELKELQDQVPPFTYGEAVQILEEELGDSVDHLFKHF
SETPLAAASIGQVHKAILKDGTQVAVKIQRPNIHAIIETDLEIIADLARIAENTWGWAKQ
YGLREIVDELAKGLLVELDYGIEARNMERFLEQNKSIGYVVIPSVYWDYSTKKVLTMDYI
EGIKLSDHKRLDEAGIDRELLAERLAYTIFYQILEVGHFHADPHPGNVLALQDGRIVLLD
FGMVGQLSSYTKKSFASFVVALRNKSTKGIIRAISDLGMIPENVDIKKLTADVEELRDKY
YDIPLKDVSVGEAINDLFIIAFRHNIRIPSELTLLGKSLMTMEGVVVALDPTFSVFDVAE
PFGRKLFLDKLKPWKIVKNIVDEIPEYFASLKDIPITAKQLMGILRKGKVQVEFTSPQLD
LLIKKIDRFSNQIAFSIVLLALSIVMVGLIIGVALSGVQTVLWKFPIIEIGFSIAMLMVA
WLIYSIFRSGRF
>PK3-045_04093 hypothetical protein
MRTTIEKALSLGLGLAIAGKEQVEKTVEELVKKGEVSKNESKDLINHLIQKGEEMKGQLE
AVAKEKVNAAYGELKLATLEDVKKLEKRIEALERKNLDE
>PK3-045_04094 hypothetical protein
MENKRSLYIELVWGSIGMLIISLVIANALLSSEHSFSVPTLILGFALINGYIFFLEKRAG
LSQKVIWTQSLILVCIIIIYIVSNSS
>PK3-045_04095 Protein DedA
MSTSIHFISQFGYIAIFALFALSGLGIPVPDEALLTFVGYLSSISIMNFLTADIICFIGA
LSAMVINYALGKKIGKPFLLTHGKWIKLTPSKLERVENWFDKYGPWTIVIANFIPGVRRL
TSYFSGISGMNLSKYMLFAAIGSFLWCLLFNIIGYYMGVLPF
>PK3-045_04096 putative HTH-type transcriptional regulator
MDKKYFTIRNISNMTELSVHTLRYYEKIGLLNNVKRDVNGYRQYTKSDISWINFLIRLKV
TGMPVSEMKKFSDLRSKGDSTISLRRKLLEDHQKSIQEQIKDLQNNLHKIEEKINYYKEL
E
>PK3-045_04097 hypothetical protein
MSNDRYQRGWEKLMEIDGEGGERVINSLKDIAPDLGKYVVEFAFGEIYTREGLNLKQRQL
ITIASLATQGGCEPQLNIHINAALNVGLTPIEVIEAITHCVPYTGFPKVLNAIFVAKQIF
KERNLQIKN
>PK3-045_04098 hypothetical protein
MSMADYKEKGNIQETPFGYTLSVIGGKWKMLILYLLSESQPVRFNDMKRRIGTITFKTLS
SQLKDLEADGMVIRKEYPQIPPKVEYSLTHKAESILPILEQLCEWGEKNRNI
>PK3-045_04099 Putative aminoacrylate peracid reductase RutC
MTTIKTYNHNLWDHGITQGYSVNGTIYISGQFSHDKDGMFVGKDNIEAQTRQTLENLDRV
LNEFGITKSNLAYVEIFLTNPQEHTEPVISLFKEYLEKHRPAGSLIGVTYLAFPEQLIEV
KAVAHSD
>PK3-045_04100 putative HTH-type transcriptional regulator
MYTIKKASALTRLSIDTIRYYEKIGLLPNIKRLPNKHRVFTQADIDRLQMITCMKKANLS
LEEVKLYLDIAETSKMTPEMIAGMLRQKEKVKNQMAQLQTVLDFIDEKLAEGTWLKRKV
>PK3-045_04101 hypothetical protein
MIISERKIALVTGANSGIGLELTKKLIENGWEIAALIRSEFPKEEQMLQQKIQTGEIRVY
HADIADFKQLKSALKLIKEEETKLDALFNNAGGSFSKLIFSPQGRELHYEIQTVVPFIIT
MELLDLLKKGKPSIVIQTSSDAFHFKKSFVPEELANPPKFQKLIGPYASTKLAITLWTYA
FAQELKREGVTIVSIDPGNNNTMRKGRNGGLPLIIQPFIRLFGPHPSVGADRLFAGLEKS
PHDAGLYFRKGKPAEFKFKQHAGQVLLQVQSVYEKEYLPL
>PK3-045_04102 hypothetical protein
MGILLELLNFAVYIPFFKVDEEDVCRNVKHLKKHQWFQNYLNVEEYRGLIIHDKDVRQCI
GKFKSSKLHNHSYQNKCQEKLYKALLKNGNIV
>PK3-045_04103 hypothetical protein
MICESGQLTDYLSEQKKVNYSNPIIKEQRKELFNSAQTEIEKTKVAFEFVRDEISHSWDI
QGKRVTCKASDVLKYKEGICYAKANLLAALLRSQHIPTGFCYQRLMLFDSPEKGYCLHAL
NAVYLKSLNKWIRLDARGNKAGIDAQFSLEEEKLAFTVNEKMDEKDYPVIYIQPNTKTIN
VLKGHNDALEMYKHHLPDSI
>PK3-045_04104 Cysteine synthase
MKLYDSVLELIGNTPTVRLNKIPNTTGAEVFIKLESFNPGGSVKDRAALNMIERAEKEGK
LIPGRSTIIEPTSGNTGIGIAMVAAVKGYRCIITMPDNATKERVQILKAYGAEVYLTPGN
RRMQGAIDEANRLATDIADSFIPMQFENAANADAHRGTTAVEIFEAFEGKLDALVLTAGT
GGTVTGVGEELKKMIPDIKIYVVEPFGSPVLSGGKPGPHKIPGTGPGFIPKILNRDIFDK
VLLIKDHDAEVMARRLAAEEGIFVGASGASSAHFAVQIASELPSSAKVLCIAPDTGERYL
SSDLFS
>PK3-045_04105 hypothetical protein
MKRRRKTTTNTIIVLILVIYFGYLFASTTIKQNKEQRLLKYLPEIATQLKKNELNAEELA
PVVLAIMDQESRGKGNDPMQSSESAGLKRNAIEDPAESIKQGVFHFAEVYKYGQKQGVDI
EAIIQSYNMGPGYIDFIVSNNQVEHSEESAKTYSEYMVERSPDIYTCNNDKLNFRYPYCY
GDFTYADKVTSKVDEMSNIIEKYARKL
>PK3-045_04106 Enterobactin exporter EntS
MSTVNNKENWYRNIVLFLSSQTISLFGSSLVQYAIMWHITLTTESGLMMTLYILCGFLPT
FLLSPVAGVWADRYNRKLLIMISDGLIAFATLILALLFLMGYDSIWLLFVMAAVRAFGTG
VQTPSVGAILPQIVPKDKLTKVNGVNGSIQAVIMFVSPMVSAALLTMGSIEAIFFIDVIT
AAIAIFTLLAFLKIPAHQKASLEQATSYFSDFKEGLKYVHHHAFLKKFFIYFSIFFVLMA
PAAFLTPLQVTRSFGDDVWRLTAIEIAFSIGMMVGGGVIAAWGGFENKVKTMTLASIIMG
VCTFALGMIPFFWIYLVFMALFGVAMPIFNTPTTVLLQEKIEEGFLGRVFGVMGMISTSM
MPIGMLIFGPLADFIKVEWLLLGTGIFIMILSIFLGKDKALIEAGKPSIEGV
>PK3-045_04107 D-xylose-proton symporter
MVATLGGLLFGYDTAVISGAEGSLQAYFTEGLGLSSLIHGLTVSSALIGCIIGGFISGYF
ATNFGRKYSLIIAAVLFLVSALGSAFPEFLFFTRGEPSYALLITFNIYRIIGGIGVGLAS
AISPMYIGEMAPPKIRGTLVSLNQFAIIFGMLVVYFVNWGIAKGQTLEWVNDIGWRYMFL
SEAIPAILFMVLLFTVPETPRYLVSKNEDEKAMNILSRIYEKTMAKATMFEIKASFKESN
KKAKLFTFGKKIVVVGILLSVFQQFVGINVALYYAPRIFESMGAARDASMFQTIIMGLVN
VVFTLIAIFTVDKFGRKPLLIIGSVGMTIGMFGVAAMAFSNKIGIATLIFIIIYTASFMM
SWGPVVWVLISEIFPNRIRAQAVAIAVAAQWAANYFISSTYPAMMEVSGGLTYSFYGIMS
LLSALFIWKFVPETKGRSLEELEKILVNSQKKDEDVA
>PK3-045_04108 Protein-glutamate methylesterase/protein-glutamine glutaminase
MLKVMLVDDEPIEREGLKLMLSRNRSNFEITAEAENGKDAVELAIAHKPDLVFMDIKMPE
LDGIEAIKRIYASAPMIKYIMVSAFDTFDYAREAMKFGIKEYLLKPSKVSEVLAAFDGMA
AEIEKEKREVRNRQEIHHRLERVSSVIENEFIVSLIMDYVHEFNQEEWDEWLDLEQKKGF
VTVFSFESEDQHPSKAVKGHWYRILKQALQAYDLPCIVGPLTGFQVPILVLLDENIPPDK
EGRDYFARKIIHDVQKQLEQCLLYAGVGTIVSNIHQFSDSYKEAIYALELVHSHPSAAYM
TYNDRVKQKRKQLIPFDVEKELLDAVKKGESQKGLQMFETYFQSIQQASDFQLRMIHKAM
ESFFIVLTRSLKELGFEEEIETSLGQFDHSMQIKEAAKSQLLSIMKRLGEWRSKGIRSLL
LEAKEYIDKYYDRAISLEEVADQIGISSYYLSKLFKERFQVTFIDYITNTRLEKAKELLL
IPNVSLKEIALTIGYKDPNYFSRVFKKEVGMSPSEYRTKYQQ
>PK3-045_04109 hypothetical protein
MIKIRTKLLIYFGVILLLLLLLFWIRETSNQQVKKLYDENMASFFLLNEMTKETNQAYQS
LQIYVHEPLPENLALYKVEIEKISRVEQQFRAMEKEGIPKKNLLNMINNFRKQTEKTVQG
IEKEDIQQYSTSLKEVEKISAYIHEKALDLIDEKLTKYQAASYFLDEKITQTKNMGTAIL
LSIILLSILFALWFSNGITITIGRLTKEAEEISTGRYDREDIVVSQKDELWFLTKTFNEM
KKNILESVKQIEEKAKLAQLLKEMELKSLQNQINPHFLFNTLNTISKTAYIEGADKTSDL
ISSVSALLRYNIGSLDRQTLLKDEVAIVKEYFFIQKTRFGGRVEFTEDIDPECLSTPIPC
LTLQPIIENAFIHGIERMAKGAKITLSIYEKEEKVLIEVIDNGVGMDQDTIDRLLDVSEE
TDQEVANKGAGHSTGIGMRNVIKRLRLFDKDSQVKIHSIVGEGTTVLISLNKLGKEDTLC
>PK3-045_04110 HTH-type transcriptional repressor PurR
MKRTLLYSFFLLSFLIAVAYSLYFYKQAHTFDKKMKEVLSDEVSLPTYHFALIGEEMDHD
YWRLVGAGAKKAAAENDVFVEYEGPKRSNPEEQLKLLDMAIQAKVDGIIVQALNDSFTPL
INKAVKEGIPVITIDTDAPDSLRLAYIGTDNYEAGRLAGQTLVKDTAGKAKIGIITGGVD
NAYKQHQLRVQGFKEAIEKIEGIKIIAIDESNLTRVQAEEKAYKMLKKHKDITAFYGTSS
LDGIGIAAAARSLNRQNDLYVISFDSLEENLDLLHKEEINAIVEQQPYEMGQKSIELMMH
LVKQKSVPQMHHMNAAIIHSKDLDSMVEKMGNGHD
>PK3-045_04111 hypothetical protein
MKELEGIVVIQRDIGSDVLVINNVPVSQYYMGCNGEEIKLTIVCAKGKTYTFEGTADIFY
FEGKQHYYRGTKYVDDFFIDDIDIRELLEQHDNEFVKIIVSS
>PK3-045_04112 NAD(P)H-dependent FAD/FMN reductase
MKIVGLSGSKVGSKTRTAMDYTMKAIADNYPDIEITLLDLADYDIQFSDGRNYLEYEGDT
GVVTKTLMEADAIIIGTPVFQASIPATLKNIFDLLPQNAFRDKVVSIIVTAGSSKHYLIA
EQQLKPILAYMKAQIVQTYVFIEEKDFQRKEITDDDVLFRIERLVEDTIVLTETYTEIRA
KKEAQYDF
>PK3-045_04113 hypothetical protein
MKKYGLDPSKGLEFGIYTLGDHLPNPLTGERISAEERVHEIIEYAKLADQAGLDFFSVGE
SHQEYFVTQAHSVVLSAIAQATKNIKIASSSTIISTSDPVRVYEDFATIDLISKGRAEII
AGRASRVGLFELLGYDLRNYEELFEEKFELLMKINEEEVVNWSGEFRAPLRNARVLPRPK
DSFIPIWRAVGGTPASAIRAGMAGAPMFMAHLGGPASVFKRTVDAYREAARNSGFDPAEL
PVATAGFFYAAESSQQALKDMYPHINEGMKKTNGAGFPKQHFAQGVDPHNIMNIGSPQQI
IEKILYQHEMFNHQRYIAQIDFGGMPFKNVMKNVEIIGTEILPAIRKYTKKSEA
>PK3-045_04114 hypothetical protein
MDNKKEGSSKKNAQFNILRNDPTKGDGGYGVGSISLENVTPIIIDRESQEVFIDIGAMHG
RSKVEQKVFFKNVTKEEVLDLDPHKYWVIWIALDRNEEGAYYSGAGACEILVAKKMKEGS
RKRFGYKAMPEHVNSLDRAIKRRFALNNMDYDSKQSLKKFLVDFNNEYWERSPEELKNSL
NNDE
>PK3-045_04115 hypothetical protein
MAKWTVDQSHSSVGFEVKHMMVSKVKGQFDSYTADVEAADLADLTTASIAFKFDVASINT
HSEDRDNHLKSADFFDTEKYPTIDFKSTSITKDGDDYKVTGDLTIKDVTKPVTFDVEYGG
KGTNPWGVEVYGFEGEAKINREDFGLTWNAVLESGGVLVGKDIKIKVELEVNPA
>PK3-045_04116 hypothetical protein
MKKAIPTILIGKGCFGVATSANVQSTQKIKSQKEQPKGLKAPQMPLIIGGLIVTAILLVY
LLMTQKSMQPILLVLGLLLGYTLFHARFGFTSAFRRLASVGNGQALRAHMLMLAVAVTLF
APILAYGVSFFGTGATGYVSPVGVSLVVGAFMFGIGMQLGGGCASGTLYAVGGGRSVAFV
TLLFFIIGSTIGAAHLSFWTEDLPSFAPISLATSTGLGYGGAWIVSIILFGVIAWITLVV
ERKRKAPKMAPLPTTTGWKRIFRGSWPLFAAAIVLAVLNALTLMTRGTPWGITSAFALWG
SKVAQFFGMDVASWGFWQGANAQALEASIFADSTTILNFGVILGAFLASAAGGLFKFSKV
TLGNVLASIIGGLLMGYGSRLAFGCNVGAYFGGIASFSVHGYVWGILALAGTFVALYLRP
LFGLSVPKSKDTFC
>PK3-045_04117 hypothetical protein
MLMIHDLYLMEILEIHRDILEDSFGKNLIDLRRKFSIYPDFKKQGYLYSYGEGIFLFLIT
KIKIYIDTN
>PK3-045_04118 NAD(P)H dehydrogenase (quinone)
MGFLNKLFGKSKEMENMANVKVAVIFYSMGGTNYQLAQWAAEGAKEAGAEVKVVKVQELA
PQSVIDSNEAWKATVDATKDVPVASSEDIEWADAIIFSVPTRFGTMPSQMKQFIDLQGGL
WANGKTVNKVVSAMTSAQNPHGGQEATLLSLYTSMMHWGAIIATPGYTDPVLFGAGGNPY
GTSVTVGQDGKMIEDVQGAVKHQAKRTVTVAEWVKKGNQ
>PK3-045_04119 Putative hydrolase MhqD
MKHIFNKGKDPKKPTLLMLHGTGGTELDLLPLAGMIDDEASVLSVRGNILENGMPRFFKR
LAEGVFDEEDLIFRTKELNEFLDEAAPKYEFDRDNIVAIGYSNGANIAASLLFHYQDALK
AAILHHPMVPRRGITLPDLTGKGVFITAGTNDPICSKEESNELQSMLVNANANVEMHWEN
RGHQLTAEEVEAAAKWYSALTNS
>PK3-045_04120 Putative ring-cleaving dioxygenase MhqO
MQKTAGIHHISAMVNDAQRNIDFYAGVLGLRLVKKTINFDRPEVYHLYFGNETGEPGTII
TFFPWEKQLKGRIGQGQVGVTSYVIPHGSSAFWKNRLLSYGVEVENASRFNEKYLQFVDP
DGLQIELVERNEGPLSNWQLGSIHPDVAIKGFGGATLLSAQPNKTAEVLEHILGLKCVGE
DAGYLRFIADAQIGNVIDIKLTPSVRGLMGAGTVHHIAWRAKDETELQQWRTLLQEKGYY
PTEVKDRNYFKALYFHEEGGILFELATDGPGFTVDQPVEQLGEKLMLPDWLEEKRDELTA
ALPKVEIRILEEEKG
>PK3-045_04121 hypothetical protein
MHSIDPKTISERENYKFLIGSIIPRPIAFVTSLSEEGVLNGAPFSYFNIVSSNPPMISLS
IQRSNGKPKDTARNILNKKEFVIHIVDEQNVDKINQTAASLASSESEIELAGLTPIDSSA
ISVPGIKEAKIRMECVLEHSLELGGTEPLPGCDFLIGRVVHYHIDPTLYENGRIDPRGLA
AVSRLAGNDYAKIGDMFTKVRPQ
>PK3-045_04122 Putative ring-cleaving dioxygenase MhqO
MTKSTSGIHHITAIVGHPQENVDFYAGVLGLRLVKQTVNFDDPGTYHLYFGDEGGNPGTI
ITFFPWAGARQGVIGDGQVGVTSYVVPIGALSFWEKRLAKFNISFTKTERFGEEYLAFSD
PHGLLLEIVERAEGKNNSWQFGEVTPENAIKGFGGATLLSKQPAQTAELLEKVMGFKKVG
EEGEYVRFRSFSDIGNVIDLKLTTGRSGEMGVGTVHHIAFRAVDDLDQLDWQKHVSQNGY
HVTAVKDRNYFNAIYFREHGEILFEIATDPPGFAIDESKETLGETLMLPSQYEQYREQLN
SRLIPIDVRNLD
>PK3-045_04123 HTH-type transcriptional regulator MhqR
MDNKEVSKYEEDLSLKVFVVLSRALQSIKKRVEEDIKCLGLNPTEFSVLELIYSKGDQPI
QKIGEKVLIASSSITYVVDKLENKKLIRRKPCPKDRRITYVVITEEGTELMDKVFPKHRA
AMNEICGGLDNKEKEILIEQLKKLGLHAQEM
>PK3-045_04124 hypothetical protein
MNTYLSKRNKGFLFIISVILFIGIIGYGVYWAFYDMNRLPKGEYITEETSPDGAYTLKAY
RTNGGATTSYAIRGELVFNKKGKKKNVYWNEGEETAKIVWSDKHTVVVNGHSLHVPTDKF
DYRNQ
>PK3-045_04125 hypothetical protein
MTNRKADPSTIGLGSNQPEGQGTTSKETGKTKEDSSRKKQKRS
>PK3-045_04126 hypothetical protein
MNNQTNTNSIISVTLGILSVLIPFIGLILGIISIIFSRKAVNEINKTDENGRGFATAGLI
WGIVGIILQLLVLLGIIAFLSLATFG
>PK3-045_04127 Adaptive-response sensory-kinase SasA
MKWKITTQFLFFMILSLLLSIFVFLLVNVFFFYSSYLGKERIFPYQNPTYYTLDFADNIR
YENDQVSIAKNKLDDLKEGQIWIQVLDENGTEIYSQFKPEKVPSHYTPAEIIRYHKFTGA
LENSTIYVGMLEKGNRSLSYIMGYPEKVIGKAYINYRTETLLRDVLLMIVSIVIVVTLIA
LIFGYFFSRRLAKPIVQLIEGIQKLAKGDFWRRNQVKGVYKTVFENLNELSDTLQSNEAE
RRKLEKMREEWITNITHDIKTPLSSIKGYSELLQDYELDANEKNRYVDIILNKSVYIEHL
IDDLNLTYKLKSNVFLLKKAEANLVDIIRESVIQILNHPLYEETNLDFSTETEQILFNCD
KTLIQRALMNLIYNAIVHNPPDTFIQVFIGQEKETIKVWIEDNGNGIEEGELEDLFSRYY
RGTNTGEAHKGSGLGLAIAKQIVEAHGGKIFVDSKLGEGTRITLIF
>PK3-045_04128 Transcriptional regulatory protein WalR
MSLTGLTEKKILLVDDEVDILNLLETVLRKEGFKRIEKATTGEKGIRLSETFNPDIIILD
IMLPDMEGYEVCQKMRKITFAPIIFLSAKSEEIDKLLGLGIGGDDYVTKPFSTKELVFRV
KAQLRRSQYMIQSQNIDEQITFGDIIISPNTGEVKKGEKSITLKAKELQLLVYLAEHPNQ
IFSKSKICEAVWGEDFIGLDNTIMVHIRRLREKIEEDPSNPKWIKTVKGLGYKLQVRGNE
G
>PK3-045_04129 hypothetical protein
MFTLLKVELYKLKRSKILLATTIFTFLALYQGWDSAKSGYAEGEGNVFKAFLFQGTATVY
SWIIFPLIITLVLVMMSRIEHSNNSWKYYLTLPVDRVKVYLAKLVIGGGIIFYSLVLLFA
GMILVANYLGLEAVPLLWLAKRFALLLLSSFAIIGIVFYLSYRFTHFAVPIAIGAGLAFP
AMFVANSEKFWIFYPWDYPIVASMTDVFEVSGKNTSMLVISISIFLLTIIIGLLRFRTKD
VL
>PK3-045_04130 hypothetical protein
MKLTTLILLESYKQKKGWLWLFLLVIPTGTTLAMFLDINERYNYLLDTASPGYNSWDVLL
LENHSVLGWGMFLPMFIGIIYSLIFQVEDSQNNWKQILSLPIKREAVYFSKFLAGLLCCI
ALIILNMLGLILVGYMMDFPEAVEWSSYLFYAGKQIVMILAVASLHNWLSSYFKNTIIPI
AIGFAGVIVSGIVKFQYPEAGKFFPYMYPYVTDGLVNKELAEFLPYSLVFTLLFLCFGIW
QFKRKDVL
>PK3-045_04131 Bacitracin transport ATP-binding protein BcrA
MSDYIIETSNLTKKFGKFLAVDQVNLLVPKGGIYGFLGPNGAGKSTTIRMLLGLIKETEG
EVKVFNKSIKDDRIAILSRIGSMVETPSYYGHLTAYENLEITRKILGAEKKEIERVLEIV
KLTEVRNKAVKKFSLGMKQRLGIAQALLGKPELLILDEPTNGLDPSGIIEIRELIKSLPK
DYGITILISSHILSEIELMATHVGIINKGRLLFQGSMNDLREKQKAVIQLEAEPRAEVEA
YLKNAEIPFKADKRYLYLEPNYQPAKVNRELIMNGYDVHQLMMKKNSLEEIFLSITGKES
VL
>PK3-045_04132 Pentapeptide repeat protein MfpA
MKIEEPKIPANLPSKNFHDILYEEELELEGCEVHHSMFEEEILNKVRLSKMVLKNCKFMH
TDFSGMELTDVIFESCDFSNAKLTSSSIHKCQFTNCKLLGVDFTDSRLRNVQFTDSLLRL
AAFGSSKLEKVRFQDSPVESADFYDCLFKKIEFKKCTMDGANFERTSLNGVDISTSTFQS
LLVSPPDLKGCKVSTYQAIQFSALLGLEIVD
>PK3-045_04133 hypothetical protein
MENASKRLQILIGDTLQILDHMKVDADKDPLLQQVKNDLQEQKNKMDNFPKSNEEIINTA
SSMTQSLDRINNMVQQLEASLMEDYQASTGGIDEYQHMSIDEQREQPESYHDKIDYLSAV
KIRENINRMNEVLLNIRS
>PK3-045_04134 Ferredoxin 7Fe
MPFVITSPCMHEQAGDCVDVCPVDCIAKGEDQFYIDPDICIDCGACEAVCPVSAIYHEEE
VPPEEQPYIQKAIDFYKSYEG
>PK3-045_04135 hypothetical protein
MKYLSLFMVAFLFLLAGCGNSAEEKKEEPVKKETNADQETKAKELTDEDKKFIALLEKGE
YQQIVDETIHLASDAQVNFYFLANAFKAVPDYSLSKTYLKKAKYIPAEIEDKVNKLKKDI
DANVEKEGA
>PK3-045_04136 Aryl-phospho-beta-D-glucosidase BglH
MKKNGFPEGFLWGGATAANQLEGAYNEGGKGLSIFDMVTFVPKEERGDDIEMDVKSKAEL
EALLAGKGGDNFPKRRGIDFYHRYKEDIALFAEMGFKTFRLSISWPRIFPNGDDLVPNEE
GLAFYDRVFDELAKYGIEPLVTLSHYEIPLNLVQKYNGWVDRRLVDFFVHYAETVFNRYK
DKVKYWLTFNEINISTLSPYIGSGILIDEVENKEQAIYQALHHQFVASSRAVKACHEIIP
DAQIGCMLARMEVYPETCNPDDVLAALEEDQKNLFFTDVQVRGYYPSFMLNYFEENNIQI
EMLPGDEELLLQHTVDFLSFSYYMSMVASGAPDKKKEKGNFFSGVKNPYLESSDWGWQID
PKGLRITLKKMYDRYQVPLFIVENGLGAHDKVEEDGSINDEYRIEYMRAHIEQMKEAIKE
GVDLIGYTSWGCIDLISASTSEMSKRYGFIYVDQDDYGNGTLKRTKKKSFDWYKNVIATN
GEEL
>PK3-045_04137 hypothetical protein
MEQLIYTLLAYINNSLEKDINYSIANSFLENIHHIEGYSLEMAAEVCNVAPSTINRFCKR
IGFRNFSNLRSSVAYHGGMYEEREKSLTTETFELKLKENIEIMERISRVQLDRIIKKIHE
SKRIVILGFEKHQIQAMELQKQLFLLGKLCECNTNFFKQLETVSHLTEEDMIITISIEGN
ILTEALAIKEKIKAASGKKLLITFSDSEKHEHIFDEILQCGKIDNSAVSSYTLLRLFDIL
IYHYQKRYPSF
>PK3-045_04138 putative HTH-type transcriptional regulator
MKYYYISDASAKFNIPESTIRYYEKQGLLPLLERDEAGRRLFSDNQMALLGTVICLKNTH
MSIKRIKQYIDWIIEGDSTIQLRLAMMENHKQDVIAEISLMKESLKGIDEKISRYLKRSR
KEYRK
>PK3-045_04139 NADP-dependent 3-hydroxy acid dehydrogenase YdfG
MKLSNNTILITGGNAGIGLAFAERFIDAGNTVVVCGRREEALQQAKEKYPSLITYVSDLS
VEAERVKLFEWVTAHYPEVNVLVNNAGIQQRFNVLKADAKNDWSYFNKEITINMEAAIQM
SMLFAPYFSEKENAAIINVTSGLAFTPMVIAPIYSATKAAMHSFTVSLRHQLSDTSIEVI
EVAPPAVNTDLGGAGLHTAGEPLNEFADGIFQGLKEGKVEIGYGSSVNRLRMSRDEVDKH
VENMYEAMKKMIE
>PK3-045_04140 Melibiose operon regulatory protein
MEYKYEFIKTDDNLPIKIIYHKSNEPSFVPSHWHDSIELSYVLSGKIEQIYIDGSVYCSK
QGDIVLINSNSIHAFSLDRGENRRALSLFIPYEFIKAIYNNIDQVSFDCISINETSEQKS
LYFNELRENLDAILKAYLNIKHNPLETIKITGLIYDLVYVLLKNFSSNKKIRGEIKTNKY
LDRLMKITNYIKNNYNHNLPIGLIAEKFDLSAEYLSRFFIKHMGMTVHHYINAIRLEKAY
RDLMNSDHTILQIALEHGFPNEKSFNRVFKAIYNKSPYQYRKEIKGKK
>PK3-045_04141 Acetyl esterase
MKYTEALDELKNKHAQDGYFVKYVPGLQEESGFLDPNAKKEIQMFQQENENINHQPTLQE
IRDSMGWRATKDIAVLPLKIEERVTDSNVKVRIYQKKALKEKVPALIFIHGGGFFGGSLN
NVENPCRALADKADIKVISVDYSLAPEKPYPNGLLDCYHAVKWVYENAAELSIDPRKIAI
AGDSAGGNLSFTTSLLDRALGTNFIKAEVLIYPATVLRSDINGELWDLKKWGMKADKALI
SEYIMNFASSCDNVDKMYAPYIQPDIPFIAPLFASQLADMPSTLFLIGEFDPLRIQGEKL
FNLMKEEGASVEYIRYNGMIHAFMDKIGDFPQAEDLINETVQFIMNTFTTV
>PK3-045_04142 Isoprimeverose transporter
MPIKQTTWKERISYGFSDTASNLVYSMITTYLMFFYTDVFGLSVASVGTLFLVARILDAI
DGPIFGILIDRTSTKWGKVRPYFLWFALPFGILAILAFTTPNFSDSGKLIYAYITYILLG
ICYSAINIPITAILPSLTSDPKERNILVSTRMVLATVGSTIVSIGTLPLVQVFGNGNQQK
GFMLTMTLFAVIGIILFLVTFFNVREKVGNTGSDQVVPFKLALKTLKGNTPWFILFFVSF
FTFISSIMKSSTTVYYLTYNLNRPDLIGIILALASLNIIAYFLMPLVANKMGKRNVMIYG
LILTIIGQFILYFAASTLSVSILIIGTIIGSIGGGFAMGVSFAMNADTVDYGEWKSGIRA
QGFLSATPAIGVKAGMGIGGALSAWILTVGKYVPNQEQIPSALRAIEINFIWAPTILSFI
SILLLLFYKLDKQEKQMISELNERRSNLSI
>PK3-045_04143 Bicyclomycin resistance protein
MNSLTKTKRLQIAFLLGSLSLLGPFTIDTYLPAFPTIVEQFHTNASLVQVSLTTCLLGLA
FGQLIIGPMSDVQGRRKPLLTFLGLYLLSSLICAIAPNIYMLIGARFIQGFAAAGGLVIS
RAVVRDLYSGRELTKFFATLMLIGNLGPIVAPIIGGAILSFASWKVVFLVLTCVGIILTL
VVAFKLEETLPVEKRVPSNIKKVVSNFGSLLKDREFAGYAFTQGFTTAGIFAYVSGISFV
YQNIYGVSPQVFSLLFGVNGVGLIIGTQIVGRLSRFSEKTFLKSGLALSMSASILLVIAI
LVHAPLVAVAIPIFLFVTSISIIGTSSFSLAMETKGHMAGSASALLGLLPFLLGSLTAPL
VGIGGEHTAVPMGVIIFASSLLAFLSYYILVRKSAVKMNTPKHITHN
>PK3-045_04144 5-oxoprolinase subunit C
MEYIKCLKPGLLTTIQDLGRPSYQSFGVSVSGAMDPLSLKLANIIVGNPPDYAALEITLL
GPEILFEGEGIIAITGADLSPTLNGKAIPMWKAIHIEGGAVLKFGKGKNGCRSYLAILGG
IDVPEVMGSKSTFIRGRYGGMEGRALQSNDYIPIGPFHPKWMNLVKNRRIPDCYIPNFSN
DVVRFVWGPHNREFEGESKELFVKRLYQVTNQSDRMGYRLDGDPLVHKKSADILSEFAAP
GTIQVPANGKPIILMADCQMSGGYTKIGMVIGTDIPLVAQKKPGDTIKFHPISILQAQEE
WKRQMKWLSILAANNLRLNRKTAI
>PK3-045_04145 5-oxoprolinase subunit B
MELIPPKTNRKIEFLPMGEQILIVQFEEILSIEQNQIVQRFAEVIKSLKIRGVKDIVKGM
CNFSILYDPLLINFEQLKDKLIRIDFTEVSGREKESRMVHIPVVFDEQYGLDLSELAKKL
GFSEEEIVEIITSNAYYVYMIGFIAGLPYMGNLDERIAVPRKSNPRVKVPKGAVAIANQM
TSIYTVESPGGWHIVGWTPMDIFDETKNPPNFITAGDYVKYEPISAEVAHKWNSQVQKDW
DQLWNI
>PK3-045_04146 Aryl-phospho-beta-D-glucosidase BglH
MGFRKDFLWGGATAANQCEGGFNEGGRGLANVDVIPTGPDRRSIITGKKKMYSFEEGYFY
PAKEAIDMYHRYKEDIALFGEMGFKTYRLSIAWSRIFPKGDETEPNEEGLQFYEDLFKEC
HKYGIEPLVTITHFDCPMHLIEHYGGWRNRKLIDFYKRLCTVLFTRYKGLVKYWLTFNEI
NMILHAPFLGAGLCFEEGENEEQVKYQAAHHELVASAEATRIAHEIDPENKIGCMLAAAS
YYPYSCRPEDVWEGKQKDRGNYFFIDVQSKGAYPAYALKELERKGIEVEMTAEDLEVLKN
HTVDFISFSYYASRVAAAEDSNVEKTAGNLFPTVKNPYLQSSEWGWQIDPLGLRITMNDL
YDRYQKPLFIVENGLGAVDTPDEFGYVEDDYRIEYLAAHIQAMKEAVDEDGVDLLGYTSW
GCIDLVSAGTGEMKKRYGFIYVDRDNEGNGTLNRAKKKSFHWYKKVIASNGEDLTNE
>PK3-045_04147 PTS system beta-glucoside-specific EIIBCA component
MNYQDLAKVIIDKVGGEENVKSLTHCATRLRFNLKDDQKPDEKTLKSTPGIMGVVNKGGQ
YQVIIGSDVGNVYKEIITQTNIANDEAKSQEEDKRSVFAKVIDTITGIFTPILPAITAAG
MLKAVLSILVVFKVLTTESQSYQIINFMADAAFYFLPILLAVSSAQKFKANPFLAMMVGG
ILLHPNFVAMVNIAKEGGEAIKLMGLPISAVSYSSSVIPIILSVWFMSYIEPLADKVSPK
AIKFFSKPMITIFIVGTASLVVLGPIGYLISDAISNGITALESVSPWIVPLLVGTFSPLL
VATGTHYGLVPIGINNRMTTGYDTVIYPGMLASNVSQGAAAIGVGVKSKDSSIKQLAYSA
GLTGLFGITEPALYGVNLRFKTPLYAAMIGGAAGGLFMGICRVRNFSGGSPGLLTLPSYI
GDNTLSFFYYACIGAAISIVVTFIATLILYKDPVAEEKEEANESTTKETPNLSIGGATIV
SPLQGNLHSLKHVDDGMFSEEILGQGVAIEPAEGTVLSPVNGIVSATFESKHAIGITSED
GVELLIHVGIDTVQLNGEGYEYFVEKGQEIQIGDKLIQFDLEGIKAKGYKVITPVVITNS
AEVGDILIANEGPIHFGEEVIKVMK
>PK3-045_04148 Transcription antiterminator LicT
MNVWKVINNNIVLSRNDDDQEVVIMGKGLGFKKKAGDAIDESKIENMYLSSKEWSVNKLT
QMLSSIPLEHIQVANEIISFAKVSLGKKLSENIFLTLTDHISYAIERYENGMEIKNALLW
EIKRFYNHEFLIGKEALSIVKNRLGVDLPEDEAGFIALHIVNAELDMGQVSKVSEMAKVI
QNILNIVKYHFKIDLDEYSLNYERFITHLKFFFQRMFSGVKLDDAGTSSFIFMLKEKYTD
EYACALKIREYIKKEFGRELEEDELIYLTIHIKRITSD
>PK3-045_04149 NADH oxidase
MNNKELLSSFTLPNGVTLKNRVVMAPMTNFSSNQDGTVTAEEVDYYAHRSTGVSMVITAC
TNVTRNGQGFPGEFAAYSDEFIPSLTKLASRIKEKGAKAVLQIFHGGRMCPPDLVNGDVV
SAGNIPAEGEGNATPRELSEAEVEAIIDAFGETTRRAIEAGYDGVEIHGANGYLIQQFFS
PHSNRREDRFGGNLEKRMTFPLAIIDKVKSVVAKHATSPFIVGYRFSPEEPETPGITMGD
TLALVDKLADKGLDYLHVSLQEFHSTPRRGVEDLSKTRIDYLLETINNRVPLIGVGSIYT
AEDAQKAFQTGVSLLALGRGLIIEPHWVQKLAEGKEDTIVTTLNKEKQKELVIPDPLWNA
IINAPGWFPGV
>PK3-045_04150 ABC transporter permease protein YxdM
MTFRQFAFNNVLRNKRLYIAYFLSSMFTVMVFFTFAIFAFHPAFSGPDVNSHALFGMGVA
GGIIYIFSFFFVLYSMSSFLQSRKKEFGLLMMLGASNRQIRLLVFLENILIGFFATVSGI
LAGLVFAKVILLIAENVLIITESLNFYFPTLAIVVTFISFLILFFFISIFVSFILRTNKL
IDLIKGDKKSKGEPKASLFLSILAGLLLLGGYVTAISVEGILVAYALVPVVLLVTLGTYL
LFTQLSVYFIRKIKGNKSIFWKKTNMLLFSDLSFRMKDNARTFFLVAIISTVAFSAIGTL
YGFQSYITKGVKEINRYTFTYSPLDKDSEEVIAKDKSKMNTLIENEKLDVISEETQLNYY
KLAGEKKNVLIARASDYNRFAELIGEKKIHPKEDEAIVVEQSDAVLKEGGQKPSKKLLET
AIPLKSGREVTPSRVIDAAVLTEISAYYVVNDKIYEQLDEPIKSKPSIVWQAKEGQEDKV
LAVGEQLDEELSYKAFSVDYAIYQINKAFGPVLFIGLFIGIVFFVSAGSFLYFRLFTDLE
EEKRKFQSIAKIGLMETELKRVVNRQIALLFFSPIIVALIHGSVALIALSNMFDFNITRE
AALVLGSFAFIQILYFLIVRYFYVKQVKRIIL
>PK3-045_04151 ABC transporter ATP-binding protein YxdL
MLKLTNVSKVYEGKVAYRALTDINFEIDKGEFVVIMGPSGSGKTTLLNIISTNDGPTTGA
VEIEGKMPHKLKKNALAKFRRNELGFIFQDFNLLHTLTVEENIVLPLTLDGSPVKEMKRK
AEEIAKELGITAILNKRTYEISGGQAQRVAIARAMIHEPKLLLADEPTGNLDSKAAKDVM
NMLVSINERKQTSLLMVTHDPQAASYSDRVVFIRDGKLHSEIHRGDSRQAFFQKIIDMLS
LMGGDGNDFSSVRV
>PK3-045_04152 Sensor histidine kinase GraS
MKLFIREHVLFIIIQLIQCLLIPFIFWLDGYRGKGVCLYAIFLSVVFLTVFLLYQYVSRR
KFYQRLEHSIGTLDGSLETTEAKPISEALDQLLMVQYRLYQEEIQKAEDRQDEHLLFMDR
WVHQMKTPLSIIELTAQTLDEPESSSIREETDRMRNGLNTVLYMARLRTIAEDFQIKPVV
LSKLIHEVNQENKRFYIRNEVYPQFNEEKQGITVETDEKWLFFLLTQLVHNAVKYSAGKA
NHLIISLYEQSGEAVLEVQDFGVGIPIVDQKRIFNKFYTGENGRKYRESTGMGLYLVKEV
AERLEHRLELESKVGLGTTIRIIFSDTQNLTSM
>PK3-045_04153 Response regulator protein GraR
MQKIMIIEDDVKIAEHLSAYIKKYQYEVITAIDFETIMATFRREKPDLILLDINLPSFDG
YYWCRQIRKESLCPVIFISARTGEMDQVMAIENGGDDFITKPFHPDIVMAKIRSQLRRAY
GEYALKQEERVLREGDLSLYPERFELRFKDKVTQLTKKETDIIESLLDRYPRVAGRQDLL
AKLWDDEAYVDENTLNVNITRVRKKFQELGIEEAVETVRGAGYRLRPTWKEGQA
>PK3-045_04154 putative protein YesV
MQMNGAIGGFYKLCDWIMKLAFVNLLWIAFSLLGLLIFGFFPATVAMFVIVRKLLMGNMD
IPVFKTFWESYKTEFIKSNLLGFIVSILGYFLYIDINLLKHTSGIMNVFYYPALLICLGF
LLTICYVFPTFVHFDLKIYQVIKNAFIIMLMNPIATIIMVIGITAIYLLMTTVPGMIPLF
CGSALAFIMMWSSFFAFTKIQRMEEAASKTE
>PK3-045_04155 Rhamnogalacturonan exolyase YesX
MAEKKKQEKRLRQMESLNRGLIAVKVKNGVYIGWRLFGTDPEEISFNLYRDGIKVNPAPI
TSSTNYLDESGVEASIYQVCSIVDGKEQPCSEKAEVWETSFLTIPLNKPEGGITPDGVAY
SYSANDASVGDVDGDGEYEIILKWDPSNSHDNAHKGYTGNVYLDAYKLNSTHLWRIDLGR
NIRAGAHYTQFMVYDLDGDGKAEVACKTADGTRDGEGKVIGDIGADYRNKDGFILQGPEY
LTIFDGMTGRELVTTDYDPPRGKGEDWGDDEGNRVDRFLACIAYLDGERPSLVMCRGYYT
RAVLAAYNWRDGELSKVWMFDSLAPGNEGYSGQGNHSVSVADVDDDGKDEIIYGSCVIDH
DGTGLYTTGLGHGDAIHVGNFNPARPGLEIFQVHETPQAMGTEIHDAKTGEILWGIPSTE
DVGRGMAADIDPRYEGAEVWSSTHWKTGGAGLYSSSGEKISDLNPQSFNFAIWWDGDLLR
ELLDHDYCEETGIGVGKIDKWDYENGRLVNILTADGTRSNNGTKGNPCLQADIFGDWREE
VIWRTDDSAALRIYTTTDLTDHRIYTLMHDPNYRLAIAWQNVAYNQPPHPGFFLGHNMEK
PPVPRIYEVKNQRDLEE
>PK3-045_04156 hypothetical protein
MTNFLQLKHEFNDPSAEYSIFPFWFLNGDLHKEELARQLRDFKDKGVHGIVAHPRIGIPE
DIDYLGTKFIERLRFIMEEAAELGMKVIIYDEGMYPSGSAHGKVVENNPEYAARGLRMTM
HPIKGPAKIKEQLEEYEEIVFAAALKMTGDRKIDPHSVVSLEVEQDNIVFDPKESGEWSI
VFLIATFSKGTIRGLHFGEDDGEPNAPLAGDLLNPDAMKKFIRVTHDVYYEQFSEYFGNT
ITALFTDEPSVLGRCVDPEKIKPWTEGFLDYYRQHGNEPKDLLALWFDVGTDTAIKRRNF
KKTVNKRLQETYYLPISEWCEKHGIQLTGHPEASDDIGFLQYFQLPGQDLVWRWVGPEDN
KGIQGHDSTLGKCSSDAARHRGLPRNANECFGCCGPNGHQWQLTAADMKWFVDWLFVRGV
NMLYPHAFYYSIEGERLNERAPDNGPHNAWWNYYRLFADYERRMSWLLSDCTNITEIAIL
CEEDHLPWKIAEPLYTNQIEFNYLEEDLFLHNCLIEEGQVKIQKQIYRVIVIENLEQLVS
NEMVQKLSLFLKNGGTVIIYNPEKKELPLRGNVVQLSNYNSVIGSLDRLQSRDVYLIPHN
PGLRVTHIVKEGIDFYVLVNEDDSSVEGELAVKCRGALEKWDAWSSNIETIEINEVDGEY
TKYNFSLQHRESIILCVNHQETPTFAAKSQKEEHSLDINVDHWTMTNPFRQKEVIKKLVS
LTEYEDLKYFSGKTIYQSKVTLDASKRKYKKAQLDLGEVCELAELRINGERVGVKMWSPY
HFDITPYINTDTLDIEVIVTNSKANEYAKELVKSGLIGPVRLKFYL
>PK3-045_04157 L-arabinose transport system permease protein AraQ
MAMPKMHNTRGGRIFDGFNVILLGIIGITMILPFLYIIAGSFATEAELTTRSFFIWPETF
TLDAYKYIFSTGTFTRSILVSVGITLVGTLICLFFTFTMAYPLSRKNLIGRSLLMNMIVF
SMLFSGGMIPTYIVVKSLGLLDSYWSLILPAAINPFNLIIVKTFFQGIPVELEEAAKMDG
CSEMGIFLRIILPLSKPVLATFALFYAVTIWNDYFHALLYISDSAKWPVQVLLQQIIILS
QGNLADTASQGVEYVAPPAQSLKLAVVVVATLPILIVYPFLQKHFAKGMLLGSVKG
>PK3-045_04158 putative multiple-sugar transport system permease YteP
MAKASTQVTEPETDIAHSMIGTTVQQKPNLSKFQRILRDKWLYILLLPGLAYFIVFKYLP
MWGIVIAFQDYSPFTGILGSKWVGFDNFIDFFKNPDFFRLLNNTAIFAVLNLVFFFPAPI
ILALLLNELRVNSYKRVVQTFIYVPHFMSWVIIASITYIFFTTSGGVVNDIVSQIYGKNI
DFLSSPDWFRPLIMMQIIWKETGWGTVIFLAALTAVDKEQYEAAIVDGAGRLRRLWHITL
PAIRSTIIVMLILQLGRFLDTGFQQIYLMSNSLNRGVADVFDTYVYFVGITQGAYSYSTA
VGLFKSVIGIILVLGSNKLAKKMGEEGIF
>PK3-045_04159 Lipoprotein LipO
MKKSKSIGKKVAIPVLSAIMLSSLVACSNSEESSAKSNGKSTITIMTTAYTTTPPSDDSP
ALKALEKYTEMDINAEFVPNSVYTDKLNVTLASGKLPMIIMIPGKIPSFVSAVRNDAFWD
LTPYLKEYPNLSQANEITLQNSAIDGKIYGIYRSRPLGRNGVFFRKDWLDNLGLSEPKTI
DDLYNVLKAFTTDDPDGNGKDDTYGMTISKWFGPFDIMQTWFGVPNKWSIEEDGTLQPDF
MSPEYMDALKFFKQLYDEGLINEDFAVMDTAKWNEPFQNGKSGVQISTLDDAHRNQEAME
KIDPKFKDVVDVIGAVSGPKGLFNLPTSGYNGILAIPKSSVKTEEELKKILSFLDKVNNE
PAQTIAYAGVEGRHYEIKDGEFIPLVTAQDPESTEYTDLNQFIPGIPGENFKHPEFTALR
LKENELMKKNEEIVVANPAESLLSTVYAQKGQQLDNIINDARIKYIVGQIDDKGIEDAIK
LWRSSGGDDYIEEINKLYKESQK
>PK3-045_04160 HTH-type transcriptional regulator YesS
MEWNSFLKRFRWNGNFHRNSFILILLITSIPGLITGIFIYWFAVGKVEDEIMLSNANQIV
QRANNMNEQFRYIEEYATHWAFEPRFGDSLKDIDFVKQFTETNDITKTLLLLQGSHNLIS
NAVLYLDFDKPILFEPSYNPLDEKKSDFYRGLQSKEAGLHWIEYDDNKNDDNKNLAFVSE
LPITSKQPFGSIIVTIDQMKLLELLRTLTPYDNGATFLLNEDNKVMLSSNSTNQSNFIDA
LRKELEKHKERNGSFPFEYNKIMYSVSFGDFARMNTNWKYVSAAPMSSITAPIVFISRII
LIISGSALILAFILSWFTSIRIYSPIRKLLQNLAGDETKTFKQYGKDEFSIIEHRWKEMS
HKSNLMQATLLKQLIELKNSFIYKLIQGYSFHYHEEDLRRKMETYGWDLQEQSFIALDLQ
LTGMADLKESFSDKDEELITFMTINIMEELGQAAFKQFNVIKFSDLSAGMLVIFPSDSSI
KKELYSFAKNVTDAVNKILNLQVTLTISHTTNSVKEIPYIFEEVRTGKRFRTFENINQMI
DLQEHKNSACEADFHYPFATEKEILKAIRMGHKEDIEKLINKFTQDLTKKEISEIYIQQA
VLQLFSSIQHEILHSGIHPNDLYEGRNMFRELSQMRDLIRINTWLIKDAITPYIERLEGR
KNLELKRIVEQVVSKLEENYMNDISLESCSDEVGTNPYSLSKAFKQIVGINFIDYLTQLR
MEKAKELLIHSDMKINDIAENVGYRHSYFNRIFKKQMGVPPSQFRKRNQESASL
>PK3-045_04161 putative rhamnogalacturonan acetylesterase YesY
MRAKQIRIFLASDSTVQKYEEEKYQGGWGEFLQDYFTKDVQIMNHAIGGRSSKTFVEEGR
LKRITEEMGADDYLLIQMGHNDSTKSRPERYTNPFTTYKEYLKLYIKSARMCQAEPVLIT
PVARLHQENGEFINDFPDYCQAMKEVAQEENVPLLDLMERSLSLFAKMGYAEVVSFFMVS
VNNTDHTHFTKKGANRMAKLVAEQIKEQISRLSPYILVDTYKG
>PK3-045_04162 HTH-type transcriptional activator RhaR
MSQRKALSHHMPANHFHSTFEIYYLISGKREFFIKDRTLVIHQGDIVIISPNILHRTTNT
EKPKHERFIVNIHEKHLAQISLSYLDIYQPLFENDYLIISCPLNELLTIDSLTQKVIEEI
EEQRPGCEIYAQTLILQMLIICCRHIKQHNMQPIESPSPMHERISEVVRYLNSHYMNKLS
LQSVAEKFYISPYYLSRFFKEATGFTFVEYLNSVRIKEAKKLLENSSMKVNLISKKAGFG
SVTHFGRVFKEVTGYVPLHYRKMKR
>PK3-045_04163 Unsaturated rhamnogalacturonyl hydrolase YteR
MTFSESSTYVKANETLTPIQWAEKACETIMTKFEPEQLPPERFHYHQGVFLSGMEKCWKE
TKKDKYFSYIKKWVDSHVLEDGSVTKLKTDELDDMQPGVLLFNLYEQTGDERYKKALYHI
VPLLKTLKCNPSGGFWHKEHYPNQMWLDGLYMGGPVAVQFAKTFGETEYADMITHQALLL
EKHTKDPETGLLYHGWDETKAAEWADPITGAAPEFWGRAIGWVPVALLEILDYLPEDHKD
KKALTSMLQDLLIALTKYQDSKSGLWYQVIDKGHLSDNWLENSCSSLFVHAIAKAVRLGY
LEDKYLPFAQKGYQGVIDTLKYDTNGNLIIGNICIGTGIGDYHHYIARPTSENDLHGAGA
FILMCVEMHHALGQ
>PK3-045_04164 Petrobactin import ATP-binding protein FpuD
MVLLETNSLTLSYGDTVIIDDLYMKIPKGEITVFIGSNGCGKSTLLRSLARLLKPQSGSI
LIEAQKISELSTKEIAKQLAILPQGPVAPEGLTVLQLVKQGRYPYQKWYRQWSEEDEQIV
HNALEATGMSALSDRLVDSLSGGQRQRAWVAMTLAQNTNIILLDEPTTYLDMTHQIEVLD
LLFELNEKENRTIVMVLHDLNLACRYANNLIAIKDRSVYVQGKPEEVITAKMVKDVFNLE
CEVTVDPLFGTPLCIPHGKGRNIKKLHREALINS
>PK3-045_04165 putative siderophore transport system permease protein YfhA
MKKYLSLRTANDKVSFLVDRRALFLTSIFFIILLVAFFISAGIGEDYISPWQIISILSGQ
GSDFDTLIVQSFRMPRILLAILAGMSLAVAGAIIQAVVRNPLASPDIIGITGGASVAIVL
FLALFSDMNHSLTISINWMPLAAFIGAAFVAFLLYVLAWKKGVSPVRLVLVGIGLWSLTK
ALTNLFMILGPIYQASQANIWLTGSVSTADWKKIQIAAPIILLLLILSFIMVRTLNIQVF
GEEIVIGLGSKVQQQRLFLLLISTALIGTAVAFAGGIGFVGLMAPHIARKLVGSSFGALL
PLSALIGAILVLIADTIGRTLFLPIEVPAGIFTAAIGAPYFIFLLYKQRKV
>PK3-045_04166 putative siderophore transport system permease protein YfiZ
MLLLNNRRRIIGLIIGLLLLCTIFIFSIVLGYADTSFKTAIQAFQQFNGSNEHIIIKEVR
LPRALIGTIVGSSLAITGALLQALTKNPLASPDILGINSGASFFVIIGLFFFSINSLQAF
AWLAFLGAAAAGFIVYFLGSLGNEGLTPIKLTLAGAAMAAMFSSFAHGFLVMNESALEEV
LFWMAGSVQGRSLEILFSVLPYMIIGTLLAFLISNKMNVYSMGEDVARGLGQRTGAVKLL
IGISVILLSGSSVAVAGPIGFIGIVVPHIVKWLVGNDYRWILPFCGITGGILLLLADIGA
RFIIMPQEVPVGIMTAIIGTPFFIYIARNGGKSS
>PK3-045_04167 putative siderophore-binding lipoprotein YfiY
MLTYFQQKRFTPMLVSLLVIIFVVLAGCGNNEKEVSGNKETSSDTNTSDNKPYTIEHAMG
KTEIKGTPKRVVVLTNEGTEALLALGIKPVGAVQSWLGNPWYDHIKKDMDGVEVVGVEHE
VNVEKIASLKPDLIIGTKIRQEAIYDKLRAIAPTVFSETLRGDWKDNFELYAKALNKEEE
GKKVLSAFADHVAEVKEKLGDKVNQEVSVVRFMAGTSRIYYTDSFSGVILDELGFKRAKQ
QKSLFTADNQLGNLAIEVGKEAIPKMDADILFYFTYAPQDDQKALDTAKEWTSDSLWKNL
DVVKKGNAYEVSDAVWNTAGGVIAANQMLDELEEIMLNK
>PK3-045_04168 hypothetical protein
MNEFYKALSFVKENFYEPNHFIIKSIQEEAQNSDYGAGIFQLNSKSVRFRVAKTTPNKVG
QFVAFWEKDDANKNQAFSCDKATDLLVINTFSSGNRLGQFVFPKEVLLKHNILKTATTKG
KMAMRVYPLWDKPTNKQAIKTQKWQLEYFFEINNSNNPHPDVLQLYS
>PK3-045_04169 hypothetical protein
MKHLNIYLMLLGFSVFTGATFNLAKYTVVYFSPSSAAAWRFGVAAAVMLIILIFTEGIKK
SQLQQNIVIYIVLGLIGIFGFNALFFIGLKYTSPVNGALIMGLNPLLTTIFARIILKDHI
TKKQVFGICFAFLGVLLVITQGSIETITTLSISIGDVIIFAGNVCWALYGVLGRKFIKNG
TPLSTTTYTMVIGAVSLIVVSLFTSNPVSIPNIPIEAWGAIAFMALFTSVLGYLWWNQGM
KEIGASKTSLFFNLVPVVTMTISFAFGTPIKVFQILGALLVILGVLTSSGVISLPKYKAE
KQSAA
>PK3-045_04170 hypothetical protein
MYSISKAAEESGISAYTLRYYENIGLLPSPKRNNGGRRLYTETDIQFMKFLKSLKDTGMS
LEDINEFVKDGCILEKISSNAEPTQLTPSINKRIEILTKHLEKMEIKKKELEEVTSITKL
KLDTYYSILKQNEGNK
>PK3-045_04171 hypothetical protein
MRKVEIFSYDEKWKQMFKEEAAKLQTIFGNEIVDIHHIGSTSVPGLKAKPIIDIMPVVRD
INTVNNYNIYMQEIGYEPKGENGIPKRRYFQKGGENRTHHVHIYQTGSYEIKRHLAFRDY
LILHTDYMKKYAYLKEKLAQQFPYDIESYIKGKNYLVKEIERKSLKWYEASQK
>PK3-045_04172 hypothetical protein
MEIDKTQDRSRSISNIIIDRSRLKRSQYILSLLQEGQRVGIITSQKSYQIQVEIMQVLQQ
LIRRYTQGKSTSVTAETAEGIMASLMYAMDAYALHFKDPEEAIAHINFENIKNIHAKGVE
LLRHYFEDAKQLYQEVKKMKLDVPVEAYNMTIDESIPVFMNHYNIIFEAQNTMASIDYPL
AIDDMRLQGVFYMKQYLERLRMETRFCHFFSHQDLMYVLTNFGKICRFNYRIELFNIFEL
LVNNAVFSLLSGGKATNVKISEVQFGQLSRMLIGCHTNQRTKLIHEAVDQLQETLQTDQT
LTRYINLYRDELIQKVNNAAEIGSFETLIIREVEEPEKTMVLMLSENDRMSDIQMRDLVD
RIMESDNTEKKVQLIRKHFVSLHDYLDLLNSGCLYGGEYDALFDTFDDIELAILAKIVFY
EKLRGGMRDFSNIVADGVETENEWETHYIGFMQQLEDKCIGAVGRLIYDIDYDDISFY
>PK3-045_04173 hypothetical protein
MNLTEILNSIQLSHMSKTVMELLSLNEKTKERGLVLTPNDVKTLVVFRNKVLRDHARVEL
DIGVLKELIEVFSTSPYMEREHYVETINELQEIFYYLRNETEDKIGDVKLIQRMNDFYNG
PCAGSLELLKSKMEELAENFRRDMMCRDSLFEGDD
>PK3-045_04174 hypothetical protein
MESLPCNGCKGMCCGPVPITKDELKKIKKKIKSMPKKTRLDLKHQRRYFGTCIFYDETND
RCGIHSVRPSICRAFGYYNNLICFRNPKLASRRNYTTNSHPIGILSVDFTWSDFI
>PK3-045_04175 hypothetical protein
MKKNWLLAIFLSVLMSVVLLGCQKGESSSDDKISVMTSFYPMYEFTQQVAGDRANVSLMV
SDGQDAHHYEPSAKDVAKVNKADVFVYSSEEMEYWVNSLLKSIDNDNLVIARTADGIDVE
GTNESGHSHEHGHGDTDEEAKHESDEKITIQGKADHYHTGDMIELTAKLDEKVDYDHWHW
YTRESADKEWVTVPNQGGPKFKYEAADESFEVRAVLYDDNHNEFAVSAPVEIVVNNHGHD
HGEEASHDHADGEEGHDHGHEADKDHDHEGDANAQKIEIVGLADHYHTGDVVSLVAELKE
KTDYDHWHWYTRSSEEEDWEVVSGQGSDHFEYKTTGKSFEVKAALFDEEHHTFAESEPVT
VFINDHNNHDPHIWLDPVLAQEQVKIIRDALIKADPDGKDIYDKNTAAFIKELQALGKEY
ETTLKDAKNRAFVVQHQAFGYLAKRYNLEQIAIGGLSTEVEPSPSRMAEIGTLVKEHNVP
VIYYQHGANSAIAKTVANETGTKTAILYDLEILSKELQEKDLGYLDAMRENLKALQLSIK
>PK3-045_04176 hypothetical protein
MKKLLFSISCLLLLSVFLAACQGTKEEKANKEEKDAAQLVHEAPESIKVEGIADHYHTGD
KIELTAVLDKETDADHWHWYSRESANDEWKVVSGQETATFTGEATVNGLEIKAGLFNSDD
KAVAQSVPVQIVIDDHHGHDEASKKIYQGYFDDNQVKDRELSDWEGDWQSVYPYLLSGDL
DEVFAHKAENGDMTKEEYKEYYTVGYKTDVNRITIKDNVVTFFEKDKEYSGEYKSDGYEI
LTYEKGNRGVRFIFKLVDGSKEMPQYIQFSDHNIFPVDSAHYHLYWGDDREKLLEEVTNW
PTYYPSELDADGLVRDMLAH
>PK3-045_04177 Multidrug export protein EmrB
MSKDKVRQSGLPKEMLAAAWALAIGGIAPMLDSTMVNIAVDTLLKDFHTTLNIVQWSITG
YVLALAMAVPVSGWLMNKYNGKKILIGAVIAFGVISVLAGISWSISVFIFFRLLQGFSAG
IITTLMSTLLVKTAGPENLGRVMAIVSTPMILGPILGPVIGGFIVHGKSWHWIFFINVFI
VLIAVPLMMKYVPDYNPFNKDSKLDIFGIIDLSLMSAALIYGITQAANHASFNNSETIVW
MGIGIVLAIIYVVYNRIQKNQCVLPLNLFSRKNFLVSSVGLFLANIAIMGPMLILPLYFQ
SIRQFSAFEAALALIPQGVGMLVTRPIIGIMIDKIGAKYVVIVSLALSVISSIPLIFITD
QTSMIWISAILFIRGTSFGGIMLPLTSDAYTDLNSNQLPEASVGINIIENLGSSFGTAII
ATVVATVALGVQPTIISGYHAGFLVSAIVLALIFIPSLFLTDKRMDTLKH
>PK3-045_04178 Tetracycline repressor protein class A from transposon 1721
MKGKKTKITKENIIAASWRLLDKVGIEEFSMRKLAVELNIQAPSIYWYFKNKQSIFQSLA
NEIAKESILSTKLDGDWKGKLTQFAVGIKDTLSKYPCSAQLIMRTIPTEPDYMILINELL
QVVDDLPMEDKDKFSSIMCLLNYVIFFELDKYEQKKTQLLILEEFGPKDVQTLFKRPFEQ
FPDDGVKVLKRLYNNDLFEEIGSDRMFENGLYIIISGIEQLIIKNSTNEE
>PK3-045_04179 hypothetical protein
MHIVTIVMQSFLIFMFLMASFRKLTGDKTAIEEFKTLRMPQWFRVFTGGYELVTAAALII
GYWNASWIAAGSLLTVIFAIVGTFAMIRVKEPFKNMTMIIVIAIFALILFLSNASNLANS
P
>PK3-045_04180 HTH-type transcriptional regulator PchR
MTKEEELIMNVRDLFNKMVWLNKSKMMKSLEGHSPSEVHCIESIEKSTNPNVTNLAESLY
MTRGAISKLTKKLIKKGLIESYQKPENKKEIYFKLTEQGEKIFKIHEELHNEFYERDKVI
FEQITEEQFDNMLSLVEKYSKHLNTEIKKQNLTIN
>PK3-045_04181 hypothetical protein
MDFVLDLLKDVAKIFFTTLAAGYANRFASKKKNKRKPTPRRRKHKGGSSK
>PK3-045_04182 Isopentenyl-diphosphate delta-isomerase
MTDSIDKRKAQHIELVLNEKVTGDNITTGLETYRFLHNALPEINFDDITLNTEFLGKKLK
TPFLVSSMTGGAAMAETINRNLAIAAEERGWAFALGSTRALIENEKYRESFQIRKYAPSI
PIIANLGAVQFNYGFGIDQCRQIIEMTDADMLVLHLNSIQEIVQQEGDRNFKDLLGKIEQ
VCTQLEIPVGAKEVGFGIDGTIAKKLTDVGISFIDVAGAGGTSWSQVEKLRSKEKIKKIA
AEAFSSWGIPTAECIVSVKEAINQPIIASGGIKNGMDAAKAIALGSDMVGFARSILKEAT
ESPEDLIELFETRELELQMTMFGIGAATVEELKGTDRIK
>PK3-045_04183 Phosphomevalonate kinase
MHEIKVPGKLFIAGEYAVLEPGYPAIVVAVDRFITVKVTFSEKQTLSLPKIGLPNVACRF
EHGQVVLEDTDARLEFIENTLAVVHQYLREKSVHTKAFSLSVTSELDDVSTGRKYGLGSS
AAVVVAVVSSILMLYQDQLTVTKKHIYKLAAIAHYQTQGSGSCADVAASTYGGWLHYAAF
KASWLKEKLADKGPVSELVEENWPYLQIEQLEAPKELVLAVGWTGSAAKTASLIKKIEPL
KQQDSHIYQGFLQKSRDAVSAMVEGFKQNDITMVMASLSANRSALLELSRETGGAIETTE
LEKLIQIADRFGAGKSSGAGGGDCGIAFTSMNKLERLHKEWQEAGVVPLDILPAAKYNET
GV
>PK3-045_04184 hypothetical protein
MEAIARAHTNIALIKYWGKRNTQLFLPTNSSLSITLDHFYTETKVQFSDRFEKDSLILDG
SQVSDREIGKITAFLDHVRNIAGTKAFAKVTSVNHVPTAAGFASSASGYAALAAAASKAL
QLGLTGTELSALARQGSGSASRSIFGGFVEWQKGEKTDGTDSFATQILDEKAWDLSVLSV
VVEAGTKSVSSRDGMQRTVETSPFYAGWLATVDEDLQQMKEAINARDFTKLGEIAEANAM
KMHATTLGAKPPFLYWQSATLDVMQQVMELRQQGLEAYFTIDAGPNVKVLCKPEQEHIIK
EKLAAVASVRDVVVCHPGPGIQYLSEWVG
>PK3-045_04185 Galactokinase
MLETPQKIAVGRAHSKLILIGEHSVVYGQPAIAFPFKQIEVKVTVKNIGGSSIQIESPFY
QGPIEQIPEKMEGIGDCIIQTLKVLEQQSSGLEIKISSTIPIGRGLGSSAAIAIALVRGL
FAFFNQKLSNSQLMILVERAEKFAHGTPSGIDMMTAASATPIWFQKQQEVEHVQIGAPFH
LVIADSGRVGDTFAAVKSIRDKYEIKPEQIEESITLLGILTQETRVALAAGDFQLVGDKL
NQAHQHLGLLGVSDSGLDDLVDTARSAGAVGAKLTGGGRGGCILALVENEQLGKKVADAL
LEAGAAQTWQYTIAEC
>PK3-045_04186 hypothetical protein
MDIVLIIEMIAAAVLAAVLYTIIGVAPGTDETAVLAPVTLAIVLAGVEPIVVLTFFMSAI
VANKVTDSIPVALAGIPGGVMATPMVEHALVLKKHGMPDISIRKMASGSVIGTLVSVPVS
LLMAQVLIPFSDVIKEYANPLFFIGAVLLALMTKNKLLSLLVILPFALLIEGLRHLYWGI
GVVPEGTNVFISFFLGITIGPVILTLFELLHKEKRASMPRHPKKTIHFAETNTSKGFPNP
FKILTKQETGTSMLASFIGSITFIMSPVGMTIFLGEVFSSRIKDPVKKASVAIASMEGLT
NATYISGTLIPLIALGIPLSPMAIGPANALFNAPPVFTPEHNLHHLLSNADFVWATLIGA
TIALVITYFVAVKYANQICAFVFRWVPHEAILGLFFGLVLLLAFMDAGWINIIGVLVIGL
FAGMLHRWGVNYGVQFMILYSAPWIISWF
>PK3-045_04187 hypothetical protein
MENKHNHEENDNIEVWEDLINIKDLVIALIICSITTMGAYFIAPNEAPKPLFFGLGGAII
GFIICSFIIKPKRNFERTGEK
>PK3-045_04188 hypothetical protein
MRLIIKKVNNLKSDEPTLNINVIHRFFAFEDVVSFKYRTIGVSEQIMVISFTICGITTMN
TYLISGIQLRIIFNGWNLVYNLRGEAEPNSMLINAH
>PK3-045_04189 Daunorubicin/doxorubicin resistance ABC transporter permease protein DrrB
MKSKTWVLLGRLMRNIMRSPDTIITVAITPIMMMLLFVYVFGGAIETGTDNYVNYLLPGI
LLMAIASGVAYTSLRLFTDVKSGLMARFVTMPIKRSSILWAHVLTSIISNMLTVVVVILA
ALLMGFRSNAAIIDWFAIAGILGLFTLALTWLAVIPGLRAGTMEGATAYSYPLIFLPFIS
SAFVPTETMPKLIRVFAENQPVTSIVNAIRALLYEGTVRNDIWIALGWCVGIMAIAYFFA
NKAFKRQLG
>PK3-045_04190 Daunorubicin/doxorubicin resistance ATP-binding protein DrrA
MSKTVISVKGLKKSFDDKEVLKGISFEVRRGEIFALLGSNGAGKTTIVNILSTLMKPDDG
KGSIRGFDIQRQPDNVRQSISLTGQFAALDGMLTGRENLIMVAKLRGVSNPVQAADHLLA
RFSLTDTANRRADQYSGGMKRRLDIAMSLIGKPSVIFLDEPTTGLDPEARMEVWDTVKEL
AGGGTTILLTTQYLEEAEQLADRIAILHGGKIITTGTLTELQEMFPPRKVEYIEKQPTLE
EIFLAIIGKKERI
>PK3-045_04191 hypothetical protein
MSIFEKIIGSLEEKREWKAMETRAKALPGEYSSAYKAIQKYIWNAGGGPTDWEGSSRIFN
GILDLFEAGAAEGKKVTDLTGEDVAAFCDELVKGEQTWNDKYRKKLNDTIGRG
>PK3-045_04192 hypothetical protein
MINGVGNMENITEMLKGVLEGCVLEIISRGETYGYEITQQLRELGFTDVVEGTVYTITMR
LEKNNLVDIEKKPSNMGPPRKFYTLNAAGQEQLKMFWEKWEFVSSKINELKTKKTKGIL
>PK3-045_04193 Alcohol dehydrogenase
MRAIISERYGTPDTLKLVEVDKPAPKDNEVLIKVYASSLNFGNLALLTGKPLPVRFVFGL
MKPKYRIPGGDIAGIVEAIGKDVTKIRIGDQVYGDLASSGWGAFAEYVVVDERVLAIMPS
NLSSIEMAGVPMAGTTALQAIRNVAKVKAGQKVMIHGASGGVGTFAVQIAKAFGAEVTAV
VSTRNVDLVKNLGADRVIDYKKDDFLNDSETFDVIFGVNGLQSIFTYKKKLKTNGVFIHI
GGANSQFYQILLLGPLLSLFGKRKFRSFLQRPNQQDLMVIKELIEEGKVKPVIDRRYSLS
EVPQALHYFEKGHSQGKVIITMEQDE
>PK3-045_04194 hypothetical protein
MKEILMKYMEKYTKLKREEQQAIIEAIVIKEFKKGTDLIKQGDYPTKNCFFVLKGCVRQY
HLEIDGKEVTTNFYTEEQAILLFQFEKANQVSKHSLNCLEDCVLVVANLESEQIMYKQYA
ELESMTRRMMESFLIQTQNEYGQFIRSSPEERYKAIIRNRADLLQRVPQHQLASYLGITP
ESLSRIKKRIQ
>PK3-045_04195 putative chaperone CsaA
MASIENFTALDIRVGTIKEAEFFEEAKIPAIKLKIDFGQEIGVKSSSAQITKRYKAKQIV
GRQIIGIVNFPPRRIAGFKSEVLVLGGVPEKGDVILLKPDTEIPNGTPIA
>PK3-045_04196 hypothetical protein
MNDTKNLYVTVLWEARAKVGREAEMKAFMAAAVTPSRNDLGNIDYEAHEVEGKPGTFIIY
ERWENRDALDRHLNAPRMQELVPKLLELMEGSIEEGIRLLQPFRPAQ
>PK3-045_04197 hypothetical protein
MIGVDGYRSIVRRYLNPDRPFADYAGTMSPITGVGFNNSLDDMVAIIDSLKL
>PK3-045_04198 hypothetical protein
MPFNTQELVVVTGTSSGIGRATAEQLAAEGFHVLAGVRRQEDADKIKRKNIEPVIVDVTK
IDTLKSLAERVERDPLGRPLRAVVNNAGIAVNAPLEMVPLDEFRRQIEVSVIGQVAVIQA
LTPALLNSGGRVVNIGSIGGKVSMPGFGIYSAAKYAMEAINDSLRREMSSFGLKVIMITP
GGVSTGLSEQGITTAARLAKLMTTDQHRRHDRLFDAVKVQAETWATDGISPEKVAAVVSR
AIHVSKPRTRYTVGRDSALLIRLVRILPDKLLDWMLRNQMKLQ
>PK3-045_04199 hypothetical protein
MGHRHRSSSWTYAYSIAIIDIMNTYDKILAAALRVLEEEGGTQFSTRAVTAIAQVSAPTL
YHHFGNADGLLSAAIVEAFKQLFKSKIAAVESTIPEVALRQGWDDYVSFAAARPRIYAAM
MGRLLEGAHIEAADQSYQTLVQNIQRVADEGKLAVSVQAAADLVWASANTASWLYVTAQI
RKAPPPQLNVVELIRESVMQIILIQKPDADSK
>PK3-045_04200 hypothetical protein
MDYTKIYSEELIALVQEKIKSVGDIKAVKFVREQTGMSLIQAKKFVDFCKE
>PK3-045_04201 RNA pyrophosphohydrolase
MTTTSDYVRYIRGKVGQDLRFLNFAGGIVYNERNEILLQKRGDGNEWGFPGGAMELGESL
EETTKREILEETGLNVKVEHLIGVYSKYSAEFPNGDKAQTITHFFQCKPIDGELTADGIE
ALDLKYFPINKIPKLFTEQHEDALEDWLSNRKGVYK
>PK3-045_04202 hypothetical protein
MCLSVFLHKYIPISSSFIKKSTTLMLLLRTTSLLIISISILVMTFSIFFQKETAGSWDKA
EEYYLTAQEGYGFDTINNLNVLVHQGQTFSVDEVKELEKTPGVTYIESSPFHD
>PK3-045_04203 hypothetical protein
MIDVHPLISQEVMTPAIREWINTYGPNTLYKDKKILPNIRYKIVDSKKFKEIHPTGDYSN
FIGKVMLFIPTTQVSDQEKEIIGKEISFVRSFEESEGLKTVENNMKVYDVINKPFTRKIS
EYQQIRYDEITIILDMQTANKSGLFQGYSELGIYIDSDLSSEDYNNIDEKVYHLIASIPG
SLIQNIPDLIKEDNAIYSFISILGILTFIIAIVLAVISIGFIVFSNYRIQKRTWGIYLSL
GMNKKQLIKYLTLEMLFYLVMSSIISLSIFTITFNNIHHIYSYWFYFKYVCFAILLTLVL
LLVSSSIVYIVIEKQPISSFLRRED
>PK3-045_04204 hypothetical protein
MKEDKLNQGVLSIGLSQENKYMIKDEKKYKNFKR
>PK3-045_04205 putative licABCH operon regulator
MALLSSRQKDILVLLSESKEPVTSDWMAKELGVSDRTIRKEIKLMQDTTESCGTIIDSIR
GKGYVLNIVNPALFSNTIHAHFNDKKKPVDDFADKNTRVLYILKRLFLEKGFIKLENFTD
ELFISMSTLNNDLKIVKEILDKYNLKLINRPHYGSKVQGDEYMKRLCLSNFLLSRNQETF
VKEDSLQLIDQNLLKKIKEVIIQKVVKYKIDISDISLENLATHIAIACRRIQEGFVIEEL
TDVLVEEYPFEKIVADEITSKVEEFTGLTFPNTEINYIIVHLLGTKLLHKRELVEFSKFD
EAGTIINEMIERLRTELNWDFRQDREFIQALTLHIRPAMNRLRNKMSIRNPLLNDIKRKY
PAAFEGAIIASKCIEEYLGMEVVEDEIAYISLHIGVALERLELEKKKRKKAIIVCASGVG
SAKLLYYRLQNRFEQELEIIDTINYYNLSSYDLTDIELIISTIPIREDFGIPVQVVNTFL
EDRDIRSIHDHLKAASYKVGNYLDASRIYLQLDLPDKESIIEFLSKELYQLNLVPADYMN
LVLEREAIAPTSYGNLVAVPHPLVPVTQETFWTVCTLKNPVQWNEQQMVQFVCLLNIKEG
THSELDGMFKKLISIIENKAIVQKIIKSKEVDELIELLN
>PK3-045_04206 6-phospho-beta-glucosidase BglA
MSKTALSENFLWGGAVAAHQLEGGWNKGGKGVSVADVMTAARHGVARQITDGVLEGYNYP
NHEAIDFYSRYKEDIKLFAEMGFKCFRTSIAWTRIFPNGDEAEPNEEGLQFYDDLFDELL
KHNIEPVITLSHFELPYHLVKKYGGFRNRKCIDFFVKYAETVLKRYKDKVKYWMTFNEIN
NQADTSMDFASFTNSGIKYEEGENREQTMYQASLYELIASAKVVKIGREINPDFKIGCML
AIVPVYPYSCHPDDVMYAAEAMHNRWFFGDVHVRGEIPNYTKKYWERNGFKMDITKEDEE
ILKEGTVDYIGFSYYMSKVVSSREVEGSESDGEFGHVIRNPYVEASDWGWQIDPVGLRYS
LNALYERYNIPLFIVENGLGARDTVEEDGSINDEYRIQYFRDHIAEMKKAVELDGVDLIG
YTPWGCIDLVSAGTGEMEKRYGFIYVDKDNEGKGSLARSKKKSFNWYKHVIETNGEEL
>PK3-045_04207 Lichenan permease IIC component
MSGENKVFALFEKYLMGPMGKVASFRFVRAVMAAGMASIPFTIVGSMFLVLNVLPQTLTF
LEGFFNSTFFKISDLYMLANKSTMGILALYFNLVIGYEYTKIIAEEDNLNLNPLNGALLS
MFAFFMTIPMLVIDGGKISLIHQIDDGTTIVNGWEMVGDGVSRLGTTGIFAAIILGIIAV
QLYRLCVKQNWVIKMPEAVPEGVSRSFTALIPAFLVAIVILVINGILVALGTDIFKVVAV
PFSFVVNLTNSWLGIMVIYFLIHALWIVGIHGANIIGAFLTPIVLSNMQSNLEGSNIPFA
GEFSNSFVIMGGSGATIGLVFFVAFLAKSQQLKILGKASLAPGIFNINEPLLFGLPIVYN
PYLAIPFFLAPMASASIGYWAIKLKFVDAIIAQVPWPSPIGIGAFIGTAGDYMAVIVAII
CGAVAFLVWFPFIKMYDNKLVIQEKGGESVL
>PK3-045_04208 hypothetical protein
MNYEQRALLEKQRKKQSIKTMYFNRYLLVRYVTALFFFTNLYWFISLVLSDSKLFFIPFV
LLLFMIASVVEQVKIYSSPSHHPKFTKYSFTALLAANVICIVPACFSSTFALLYPFLINQ
DESRMFILTILISGILLAAFMLKRLHKISLNEDKHYSRIKLYEKVIN
>PK3-045_04209 hypothetical protein
MKKALIICAAGMSSSLMAKKTTEFFKSKGQDIVLDAISANEGGKMIEKGEFDLYLVSPQT
KMYFNKLKETGDRVGKPVVNIPPQAYIPIPMGIEKLANVILQELPN
>PK3-045_04210 Lichenan-specific phosphotransferase enzyme IIA component
MNLEEISFQIILNGGNARGLAMEAINDAKSGDFSLAEQKLDEANEAMRVAHRFQTDLIQG
EARGEKFEIRLLLIHAQDHLMNAMTVVDMAKEFIELHKKLPN
>PK3-045_04211 hypothetical protein
MVVFNKYGEGIILKKLVKVLLCMSLWLSLPYAALAYSNPMDLPESWTWDSGEYYGEGDPF
ILKHNGIYYLYVSTVDDKSGVKAWTSEDLMNWTYAGLVTEEPTTKAAYAPEVVYWNGDFY
MYTSPGGNGHYVYKSSSPLGPFKKQTDNLGMGIDGHVFIDDDGKWYFYSTGSNRIDARSM
PTPSEFGKATDTGAKMNGWTEGATVLKRHGKYYMTYTGNHIWNKAYRIDYGVSDSPNVGF
TTNKEQNPLLLNTEGENVGLGHNTVVRGPDLDSDYIVYHSHANPGRNINFDRIAWNGEKM
LVLGPTTSEQSDPALPDFSDRFNRTELGADWKNVNGGKWSITKNTSNWLEQKKLGDAKWS
RQVSKVSTDKEYTAEFNLKMVEKGESENPRLGVVFSYKDEKNYGTAVLSSKHNRLETNFV
VDGEEQGWEYADLPEGYDYTKLHQLRVERSGDTFRIYVDGMQKQTREVLNIGAGSIGYTT
SDVHGAFSYTAFSNKVDGSNVFDAYKPLPGTIEAVHYNAGGEGVGYHDKTRKEAVNAYRQ
DYVDIADDSDGSYYIESNKKGEWLKYNVNIAEEGLYNLDLRVGESSKDAKIRILLDGKSD
ITGDVSIPPSTDWRTFSIEKLKLPKGKHTLTIEVVKGSFDFSSFKVQGYKAVDVLYDDFN
DGDAEGWDEVEGTWKVGPFEEQNIDFDEYKQVPGVINAAYYNTGGEGVAYHDTTPENIGG
VFRRDSVDIRTNPEGGGYAVGWNQTGEWLKYNVNVQEAGAYNLKLYAATTFTSAKARLWL
DDKIDLTGVFDVPATGGWNNWQAVIKNGIKLPKGNHTLKLEFVEGEFDFTKMELSSFDVH
RPLPGLIEAEDYNNGGQNVAYYDKSEGNSGGQYRNDDVDIRKTAAADYAVTSIETDEWLT
YDVNILEEGSYGLDFLVSSVKDGSKIKLLLDDKLDLTGEIDLPKTGSMDSWKTVSLEDIT
LPAGQHTLKIVAVEGGFELSKFMFHQFDQYKKLPGRIMAADYITGGEGVAYHDNTIENIG
GEYRQDAVDIRVNPEGGYNVGWNQTGEWLKYNVDIAEEGSYDLAINVATTYKDSQIRLWL
DDSIDLTGVIDVPSTGDWNNWQSVIKKKVSLPTGQHTIKVEIVKGEFDFYYFEILEEIEV
PEPQIIGEYNASSETFAKSVIGEKEWKDYIIEADVKVAEGSGDGGVIFRVNNPANGIEYS
QNNADFMQGYVAYINEDGVHLGKQNYNWEYLGGASITEPQAAWHHMKIEVIGTTIKVYVD
DMETPKINFTDNSRTAFTQGKVGVRSNYNNTKFDHFLVRPYQADHTSIQTLLDMYKESGE
LKDSLYKSLSNKLKQSKKHLEKGKNDQAIKFLQDIIKLLHNDKKEVLKAEIERLIERL
>PK3-045_04212 HTH-type transcriptional repressor PurR
MSTIKNEPLYQQIQNKIIERIKDGKWRVGDRVPSEKDLMDEFHVSQITTKNALAGLADQG
IVERIKGKGTFVIESSFTGSMARNQTSSGLIGLIIPTMKTKVEQDFVNFLEQYVTEQGYN
LVIKISRESQLKEAEAIETFRVIGVEGIIIFPAEKEMYNEAVLRLSLDKFPLVLIDRYMK
NISTYSVSSENTQGTFAAISYLLDKGYEQIGLISPLITNTVTEERAKGFEQAFFRKEITI
DKNLWLTLPFDKISVQETPAIIKQFLLENPKLTSLFTMNAELAQYAHRAILEVQKESYRQ
IELVTFDFPGIEGFTFVQQDIQQCSKETVKLLLQQMAGEYDPKRMFIPVNVVFAAGNEI
>PK3-045_04213 hypothetical protein
MFLDFLFKKKNIKKNKKEGPINVKNRNNSTTKIENNQSAVRKGELGEYKIDIQLSQLPKD
YMYLSDIFIKNPKSSTGYSQIDHVIIAPYGLFVIETKNYQGTIYGGKDRKTWLINGKFKM
MNPIMQNYGHIQALKSFIEAKYHPYLFQ
>PK3-045_04214 hypothetical protein
MRKISSTELVIYDVELTQFINRKVAVLKLQYPPPLFLKSEMEMIYNSLVNANITDAAIRK
QHIDIIEEKKNITDKKEKENTCIICQKPVSDKVKSFCLSNKKFQGKIYCYEHQKSL
>PK3-045_04215 hypothetical protein
MRYENGEVITDYIKRAKTDQSLKRIKKRLKESPEEAREIADKIIRNTYRTLMTRGQKGCY
IFCTDKKLEEYFRTRLTRESVYSEKTYGNIKIAEEKESY
>PK3-045_04216 Multidrug resistance ABC transporter ATP-binding/permease protein BmrA
MSNQEKFTNIRDRDNSLNKTGLRYLAKLLFSTEVPKLVLSIALILSIISSFVGLIVPIAT
GKIIDQFRLELINATTIIQLVFIFILQAVSSGFSYYLLAYVGNRMVNQLRKQLWEKMLHL
QMSFFDRYRSADLMSRIANDTNEIKSLITDHFINFISNLITVIGAVAMLFYLDWQMTLII
MLVLPISLGVMMPMGNKMYENSVRLQEHLAALSSTLSQIIGEMRLVKASNSERKELKNGE
VNMDDLFQSEMKEARVNAVLMPLMTLIMIVLLVVIIGYGGVRVSSGALTAGKLVAYILLL
FQIMMPVEQFGAFFSNLKKVMGSTERLRLILEQPLEADNKKDVIPDKHNILEFREVCFGY
ERDKQILLNASFTIPDRKVTAFVGPSGSGKTTIFSLIERFYDPETGNIYWGDTPIDSFSL
HDWRKKIGYVSQESSLISGTIRENIIYGREDEVSELEMMNVARLAYAHDFIDALPRKYET
EVGERGIQLSGGQRQRIAIARALLRQPDILLLDEATASLDSDSEHEVQKALHYLMQDRTT
IVIAHRLSTVVHADQIIVFEYGHVTGVGKHEELLQTHPSYAAWANKQFQGIQRL
>PK3-045_04217 hypothetical protein
MFIKNIPNLLTFVNLSLGVLSIVEVINQNYFVSAIYIIIAAFIDRYDGRIARRLDVCSEF
GKELDSLSDLVSFGIAPALLVYFKFNFDDLGMLRLVGIVALLLYVVSGSYRLARFNVKEF
EGIFSGIPITVAGFILSIYSVLAPSTINLTFISVISLFAFSYLMVSSIKFKKI
>PK3-045_04218 hypothetical protein
MGKKAEGKNSSIGDHVFAILIVILMCVFLISLPFLIFFGGFKLVSLVPDVSINTNGTFDS
IIVLFKFFVLTVVVVGIVDVLFSQLLLKKRGFFNFFIEAVFMFCVFYLYVLIYSMNSQEI
VIKNNGVFLVALFLFVLYLLINVVYIASKWIYGSMMKNIQKKNN
>PK3-045_04219 hypothetical protein
MNRLLMGKKLKIKLVLAVLISLAISLSVFGILQVVGEKVLNSYLSKSAFMENRQQDALER
FEEFVNSQNVSTRDREKLTEWINNERYLNLYIFAKEKLIFSSNKEVDPAINEELLTRFTP
SETPTTIHFADQDAQIYLVGLYEYQYYNLILFIGIFIAAIIFIISFLLIINKKTSYIGVL
EQEIKILEGGNLDYSITISGKDELSSLAQSIDEMRKSFAERLSSEERIRIANRELITAIS
HDLRTPLTILLGYMDIIELNKYKNHEDLLQYIHNSREKAYQIKALSDKLFEYFTVSSAAE
EEEVEFELYEGRALIDQLIDEQLVVMDNLDVQVQAVPYDEKFLLEINLVAIRRVFDNIFS
NIRKYADPMHPIHIQISLKQQWVDLRFENKILHETKKEDSNKIGLVSCQKIIQKHNGMLN
VSVRKDTFLLQVTLPVILNKTVQTFE
>PK3-045_04220 Transcriptional regulatory protein WalR
MDKLRVTYIISEEFLSRLYLLVVAQNAYYTDIRWGDQMNKQILIADDNSEIREIVRILLE
SENYEVVEAIDGQDAINKVNEETDLIILDMMMPNKSGLKACLEIREKTSAPILFLTAKTQ
DSDKQLAFSSGSDDFLSKPFSYTELVSRVKALLRRYYVYRGKEKTEETEHIIIKDLTIHQ
DAKTVFVGEREITLTEIEYQILLLLAKKRRKVFSAENIYESVWGQPYFYTCNNTVMVHIR
NLRSKLEDDPQNPKYVKTVWGKGYKIE
>PK3-045_04221 hypothetical protein
MPQLSKKTIVTILLGLTLILSIGLIYYSPTIIKIMSSMNNFRAFIHSTGHWGPVMFILFQ
ILQIVVAPIPGEVVQVAGGYIYGVTLGSLYTTIGLIIGSAIAFYFTRFIGRDYISKLLQK
KKYKWMSLIQDEKKFSIFLFIFFVIPGLPKDLLVFVAALTSMSSLRFFTILIVGRLPWII
ASAALGSTIHMQQYSIAIIISVIAIVGFILGYIYKDKMMDRFSNVKKTKKTNHSAKTKVN
LSINKKESLCTKKGE
>PK3-045_04222 hypothetical protein
MWKSYISNISKEYNFKAPASNSEISFIKEKLNVNLPKKLNDLYNETNGVFDNYGCPLIWS
TAQLVEDNLFFRNFDEYKDIFMPFDNLLFFSDAGNGDLFGYTILNGVIQKEDIYVWNHED
DSRMWVASSLEDFIKGWITGDISI
>PK3-045_04223 hypothetical protein
MWKVLYLVFLLIATIVFTGCATLDEDRLIVGTNAEYEPFEFMNGEGVLTGFDVEIMEEIG
LREFALLKQLIHLLIIE
>PK3-045_04224 Fructoselysine 3-epimerase
MVGIDQIAGMNIHYLYYSLESFLQYQQKIGITAIELWGGCPHVFMDSISYSDCAKIKKLA
NSCDQRIIAFTPESIIYPYNVASPEAMQWEKSKGYFSNAVKATAELGAKIMTINSGYGLE
NEDISESWKRSREMLSFLSEIADREEIDIALETLRPEESKIVTTLQDAQRMLSEVGSEQL
KPMIDCTALAVAGETLEDWFESFGDEIGHMHFIDATPKGGHLAWGDGELNLLESLLKLNK
YDYSGYLGQEITDLKYFEKPFQADQQVVESFKKTLKLLPR
>PK3-045_04225 hypothetical protein
MELTALKKKKKLEFPHSYTLIFILIVLSALLTWVVPSGQFDTAVETIDGVEKTVIVPGTY
QELDKFSASHDYRQGLFSILEAPSNGLVAAVEVVAFVLVLGGAFGIILKTGAIDRALGSL
AKYLGNKGILVIPISMILFSLGGATYGMSEEVIPLYAVFITLMFSLGFDSMTAILILFLG
TQTGYVGATINPFSVLIAQGVGGVQGNPLLWLRVIYWVIFTAVSIGFTMWYALKVKKNPK
SSLSYKTDLSLRKKYQNMTTSDSFSAKDKLIILGFIVCLGTMVWGIMIHGWYMIEIGALF
VALGLFAGIVAGFSQKEISESFVAGCADFVYAAVIIGLARGILVILENGMIIDTVLNALT
NLLSGLPDFLFTSILLVAQTIISFFVPSSSGAAALTMPVMAPLADLMNTSRDVVVMSNQF
GNGLINIISPTGGVLLAGLAISEINYSQWFKVAFKIFAILFVIAAVLLYIATLF
>PK3-045_04226 hypothetical protein
MKKIIRSNQIYDSIKEPFKGFIQIEDGKITNVQQGWDYEEFLDSNTELVIHDEDFVMYGI
HDNHVFFTGYLSMNAGIDFSLISDFESALDLIKREMGRLKDQTTPVYGSGWPRESVKMLT
EEELNHLNHLGPITIISQDRSYCSMNSQAKKRYGFTEEECSAEDRVLLLKEMLSNKELVN
QVYKKFENLLLSRGVVSIKEIIFDDCNYLNDLEKRIIRTNFYIQPVEKSLDFSLLKVYKE
AKFTPKVKFGGAKLMVDGVVANQTADIHGTYYSGTDKPMIDYPGISEMVSRLSSAGIPCC
LTAEGDKAIEGAARILGSNQKIDAIGYNSISDLEMITNVAALQMQKKEIVAEIYPQILGL
NSSIKEGYMDKVIVDQAGEDFFNYKCLVDNNVLLTSGTDLPLFITDVPDSLVRAKYRKFA
QTDEQWFLDKGISTEDLLKSWTVNGYRANRLEEYGTIESGKNACLAVFNKNLCTASEVEL
SDAEVIATYVDGECVYKKI
>PK3-045_04227 putative HTH-type transcriptional regulator YurK
MLDNNAQLPLYKQMKEIIKNKIASEEYKISDKIPTEPELRELFGVSRVTVRKAIEELVAE
GYLVKKQGKGTFVSHKKVSRKIEYVSGFTDSCLQNGFVPSSIVLECKVIPASEEIARQLQ
IAVGEDVIFTKRKRFADKTPILLENNYFSKKDYAFLVNENLEGSLYRLLSEKYNIIPENP
KETNLEIVVADEMLAMDMDVAIGTPFFYMETMIADQNHKLIHVGHQYYLGDYYKFSI
>PK3-045_04228 Fructosamine kinase FrlD
MRVLGLGDNVVDKYVNLKMMYPGGNALNFAVFAKKLKQDASFLGVFGSDEEAKHVLSVIK
ELGIDNSHSRNEIGENGCARVEIIDCDRVFLGSNEGGVTREFPITLNHDDMEYLKEFELI
HMGLYSHVNHLLPDLVKLSSEISYDFSDDFTQSDIDKAIEFVDYGFFSCSAFSTHEAKTF
LNQNFHPNNKILVVTRGSKSVIAYDGKEFYKANPAFIEPVDTMAAGDSFLTAFLVYLLDE
CSSIEDAMMRAHQFAAESCLVEGSFGFGKSY
>PK3-045_04229 Fructosamine deglycase FrlB
MDVSKVVKEVLKKNEGNLKEIYFVACGGSLVDMYVADYFVKSEATKLVSGWYTANEFVRA
TPKRLGSSSVVILCSHGGNTPETVKAGEVAQTLGAQTIGLSHNKKAELLNVSDFTFLYEW
GDETNVKNNPMAIILDLTVSLFNAVEQYEHYADFRDGVEKINTVISKAKKQVANRVKVFA
NKYGKEELFYILGSGPSFGHAYGFSICSLMEMQWLGAAAIHSGEYFHGPFEVTDRETPFI
LLMSEGRTRALDERAKVFLDQYAEKVEVVDSKELGLDTISDTVSEFFNPILFYSVLSEYR
EALAEIRQHPLDTRRYMGKVPY
>PK3-045_04230 Tyrosine recombinase XerD
MVTRRNENEKKQEKSKKGRRDELSHAELMILGDVIEVDYSYEELLKMFLDDCELRNLREH
SIKYYRSELTTFRNQLQKQNVKMNVREWNADTIKQHGIRYMKDKGLKTVTINTRLRAIRA
FFNFLEQQQLINKNPMKDIKLLRDRRRIVETFDKKQIKSLLNSCDLRTFTGLRDYTIMLL
LLETGVRANELIGIDITDIVWSQKVIRIRNTKGGYERFVPIQKHMIDVLKKYIAIRGSVE
TNSLFITQDNTSLSKKQMQDRVRECGVKAKIKNVRCSPHTFRHSFAKLSVMNGANAFQLQ
AILGHSTLEVTKVYVNLFSNEVQEGHSKFSPLENLF
>PK3-045_04249 hypothetical protein
MEDILRPIYQERASQTNTLGVLIIDKKQNEMTVTDTFDTVMLIIVKEAEQPVFIKHYTYA
DKKAALHIVTEKQLRSWILLGNNKRIFEWIYNGRVVFDRNEFIYRLKNELKEFPVNERKQ
KMALEFAKLIKRYMDGKAFFENKHYLDAYNDIVHSLHHLARLAVIENGFHPEVTVWSQVK
QMEPEIYKLYVELVNSDEPIEKRLELLFLASEFLIHSRMRTSTSYILDILKEKDAWTFNE
LLEKEELLIYAVDLGMLIEYLIDKHLIEVVNISTKSPGVYHRCYRVLEKK
>PK3-045_04250 Peroxide operon regulator
MGCMSVEHNELQEALDKLKETGVRITPQRHAILEYLISSMSHPTADEIYKALEGKFPNMS
VATVYNNLRVFREVNLVKELTYGDSSSRFDFITSHHYHIICKECGKIVDFHYPGLDEVEQ
FASHVSGFKISHHRLEIYGTCPDCAQKEAH
>PK3-045_04251 hypothetical protein
MGIERSTFLIDKEGKLAMEWRKVKVAGHVAEIKQALEKIEA
>PK3-045_04252 Putative peroxiredoxin bcp
MSVHIGETVPDFELEANNGEKIKLSDYRGKNVVLYFYPKDMTPG
>PK3-045_04253 hypothetical protein
MFYVLLALILFFIAMSLKTLFVPYQRKEKWVSFENFMYLIFVYITIMIGFGLIYTLFQMN
GIPVYNDGQAPSLNYDFFHTLHTSIYFSGVTLFSVGFGDLMPIGMGRMVVLIEALIGYTI
PAAFVARAVFDLNN
>PK3-045_04254 Glutamate-1-semialdehyde 2,1-aminomutase 1
MLHTNSERLHEEALEIIVGGVNSPSRSYKAVGGGSPIVMERGQGAYFFDVDGNQYIDYLA
AYGPIVTGHAHPHITKAVTRAAETGLLFGTPTPHEVKFAKMLQEAIPSMEKIRFMNSGTE
AVMTTIRVARAYTGRNKVIKFAGCYHGHSDPMLVAAGSGPSTLGTPDSAGVPAVIAADVI
TVPFNDLDAYKDALDKWGDQVAAVLVEPIVGNFGIVEPVEGFLQGINDLTHAAGALVIYD
EVITAFRFTYGGAQDLLGVYPDLTALGKVIGGGLPIGAYGGRKEIMDQVAPVGPAYQAGT
HAGNPASIQAGIACLEVLKQEGVYDHLDKLGALLENGILEAAAKYNVPITINRLKGALTV
FFTTEKVYNYKQAESTDSEMFGRFFKLLVEQGIMLAPSKYEAWFITIAHTEEDIEATLHA
VDQAFAALKEEYKF
>PK3-045_04255 hypothetical protein
MTLGARVLKTGIAIVLALFLAQLLNAPTPVFAGISAIFAIQPTVYRSYLSIIDQVRGNII
GAIIAVIFVLSFGNNVFIIGLAAIIVITINLKLNLEKTITLSVVTLIAIMESPTDDFITF
AIIRFSTVMLGILSASTVNLIFIPPKYENKLYNQISDLSEEITKWIRLNIRHASEHSLLK
NDIDKMSERLMRIDQLYILYKEERNYFKKTTLLKTRKLVIYRQMIATLKKSFQTLKKIHR
YENELLSLPEDFQNIIQQQLDCLIHHHEHVMLKFIGKVKPNVVFEEGSISLDRNILFQEL
MLYYKETEPSVLENEEELKQYHMMQIVSAIIEYDENVEHLDTLITSIQVHHQHEADVTIE
E
>PK3-045_04256 Putative multidrug export ATP-binding/permease protein
MDSIKRYMTFVKPYRWQIIGTIIIGIVKFAIPLLIPLLLKYVIDDIINNSALDQATKMSN
LWTIMIIMTIVFIVVRPPIEYYRQYFAQWTSNKILYDIRDQLFMHLQKLSLKYYSNTRAG
EVISRVINDVEQTKNFILTGLMNLWLDAVTILITIGIMFTMDVKLTFVSIILLPFYALSV
SYFFGNLRKLTRERSQALAGVQSFLHERVQGISVIKSFATEDHEQKHFQKYNNTFLEKAV
NHTKWNAKAFAVVNTITDISPLIVIAYSGYQVLNGDLSLGAMMAFFAYIERLYNPLRRLV
NSSTTLTQSIASMDRVFDLIDEKYDIQDKPNAVPCTNVKGDITFEEVDFAYETNDPKVLD
NISLHIKQGETVAFVGMSGGGKSSLISLIPRFFDVTGGRILLDGIDIRDVQARSLRDQIG
MVLQENILFSESIRENIMIGKPNATEEEVIAAAKAANAHDFITQLPEGYETKVGERGVKL
SGGQKQRVAIARVFLKNPPILILDEATSALDLESEQSIQESLEELAKDRTTLIVAHRLST
ITHADRIILIEHGKIMEDGTHEELMKLQGHYHDLFQIQQLGN
>PK3-045_04257 hypothetical protein
MGVPIEGEPIQIHSYKHNGHIHRIWDETTILKGTQNLIIGGNDRTIVTESDGRTWVTREP
AICYFHSQQWFNVIGMLREDGIHYYCNLSSPFIYDGEALKYIDYDLDIKIFPDMTFNLLD
EDEYERHRQEMKYPEVIDRILKTQVTQLIHWIRQRKGPFAPDFVDLWYERYLTYRS
>PK3-045_04258 hypothetical protein
MDVFNGLVGEQMRIMEKLLYLQGELERCEEIEEQLQILQKETELKEVQIEISNMKEELKK
IQKIFELQTEKVIKVYQENELKLSSSS
>PK3-045_04259 Small, acid-soluble spore protein gamma-type
MAKKAGATQSGTNIQEVKQQNAQAGQGQQFGTEFASETNASEVRKQNQQAESRKSQNTSK
>PK3-045_04260 Enoyl-[acyl-carrier-protein] reductase [NADPH] FabL
MTNKVALITGSSRGIGKATAIRLAKQGYDIVINYARSKKAAQETADEITALGRKVLLVKA
NVGDVDKIKAMFAEVKAEFGRLDVFINNAASGVLRPIMELEESHWNWTMNINSKALLFCA
QEAAKLMDKGGKIVSISSLGAIRYLENYTTVGVSKAAVEALTRYLAVELAPKNIVVNAVS
GGAVDTEALTHFPNREELLQAAAEKTPAGRMVEMEDLVNTVMFLVSDDASMIRGQTIIVD
GGISLLV
>PK3-045_04261 putative protein YfhS
MYVGRDITKLAMIAKSDWKDDELAYFHHSLQQMTPYLNSEGASIHRSIIEEIENRGGLKR
NEADYTHGTEVSYE
>PK3-045_04262 Adenine DNA glycosylase
MTDKQEIIKNQVDVERFREDLLNWFIEEQRELPWRQDQDPYKVWVSEIMLQQTKVDTVIP
YFNRFISQFPTIEALSKAEEEKVLKAWEGLGYYSRARNLHAAVKEVHEKYGGKVPDTPKE
IASLKGVGPYTAGAILSIAYGVPEPAVDGNVMRVLSRILSIWEDIAKPKTRKTFEEAVRV
LISHENPSFFNQALMELGALICTPTSPSCLLCPVREHCHAFEDGTVTELPVKTKTKKQKS
IQLAAVVLTDEEGRTLIHRRPNTGLLANLWEFPNMEIVQVLKSEKAQLEEKLLEDYQAKV
EVGEMITRIEHVFSHLIWNINVYSGKLIELKEEKEDIRRVNADEIAPFPFPVSHQKMLKF
LPEQVKKG
>PK3-045_04263 putative protein YfhP
MDTGTHIVMGVALGGLATLDPVVASDPATTTGVIIATIIGSQIPDIDTVLKLRNNAVYIR
NHRGVTHSIPAVLLWPLLILAVMYPLFPEANLFHLWLWTFIAVFLHVFVDIFNAYGTQAL
RPFTNKWVALGIINTFDPIIFSMHIVAILFWLFGADPGYTFLTLYIVLIGYYLLRVFTQR
QVKINVKKRIPDAKEIILSPTMRYNHWRIAVMTDDSFYVGRSHQHEIEIYDKFHRIPVPD
TPVLTAAQKDKNLSAFLSFSPVFRWEVIELDDQYQVRFIDLRYRSNGHYPFVAVVHLDLN
LNIITSYTGWIFSEDKLKKKLDILTN
>PK3-045_04264 hypothetical protein
MHEAQKKLVERLLELNSFISVGQAQTWVELLWEDFESTYAKAGRKYQGEEVTERVVSQWI
ENYGGKLHEFVAENPKYKEFLADDKKKLH
>PK3-045_04265 Small, acid-soluble spore protein K
MGNVDNTNDVKLEGEPRAKTEYASKRANGTINTHPQERMHASSHRKPKK
>PK3-045_04266 putative protein YfhH
MLTKRYSMMTEHELRMEISTLNDQAKKAEQLGMVNEYAVLERKAVLAKSYLLNPKDYKAN
EIYEIEGDPGVLFQIDYMNGVFAWGKRQVDGSQEEGIPIALLKKKA
>PK3-045_04267 Regulatory protein RecX
MIISKITRQKELNDRYNIFTLKQGKDVYAFSVDETVLIKYKLRKGMELDSLLLNEIQYTD
EIRKGYHMAVRYLSKVKRTEMEVRKHLSAKMENDALIAEVMTKLKEMKFIDDEDYAFSYV
RTQRNTTTKGAETIKRELREKGIQRELIERSMEELSYEDQMQAAKKIVAKFLAGKKKDSK
KIIIQKLEQTLVRKGYTSDIIQQVKRMPEIVEMDTDELETVRIHGEKARRKFAKFTGYEF
KQKMKQFLYRKGFSMDLIEQYLDEIENED
>PK3-045_04268 hypothetical protein
MEGKKKQKPKHTLSSMQAVTYQHEFKMADRAANRKDTK
>PK3-045_04269 hypothetical protein
MKCVIKKWLFFLLVIIVLFPWPYEKEKQVKAEGSQADSIEFQHVSVHDPSIIKGDNGSYY
VFGSHIAAAKSTDLMNWTSLVTSEYQTPENNPIYGNLSENLAESFKWAGENDADSTGGYS
VWAPDIFWNKDYAWDDGSKGAYMLYYSVSSTYIRSAIGIAVSKNIEGPYDYRDTIIYSGF
TNYETTDNKSVINKHWENTNIAELIADGTLDNVNPDWFTSEGNYNNALYTNAIDANILYD
ENGDLWMTYGSWSGGTFILPLDKKTGVPIYPRKDGKTSDGRIVDRYFGTKIAGGYGRSGE
GTYAVYDKETGYYYLYITYGGLASDGGYQMRQFRSKKIDGPYEDASGNAAVFPESFNLGP
GNFPSNDDHKEIGNKMMGNFLFKRDFGEEGSGIGTGYMSPGHNSFLIEEELGKEFIVTHA
RFPQQGELHQVRVHQTFKNKEKWPVPTPFQYAGETIETVSEKDIVGDYKYINHGKEITGK
LTESQWIKLNADKTVSGAVSGTWKLYDDYRVEVEIEGQIYDGVFIRQYDPATAKWVMTFS
AMSGEGVVIWGSRGDSKSNQEVVASVKAELIKAIPTEVIKDISLPTQAAQGTAIVWVSSQ
PEIISNDGIVTRPPFGSENADVKLTATITLGDAKESLSVMVHVLAEEEGRLTAYYDFNDG
FADRSGNQADAIVTGDRIHNTGGEVTFAKGIAGNAAKFNGESGLKLADGLIASNKYSLSL
WIKPEEITEFTTTFFGARTENNWISLVPNAQNVTKVWSHNGDQWYDAVSDSIIPKNEWTH
FGFTVNEGEAKVYINGEEKFSDGNFPDVFTTVNAQFSLGVNYWDMPFKGLMDEVRVYDGL
VLTETEIQSLFENPVEEELGTEEPGAEEPGAEEPGTEKPGTEEPGADKSGAEKPGTDKPS
AENPQTDNTGKALPNTATNEYNWIIGGLFLLAAGLSISLVKRKRAMKVK
>PK3-045_04270 6-phosphogluconolactonase
MTKFTGYIGTYTKKTSKGIYSFVLDTDAKKITDVSLVAEIENPTYLTVTNDNQHLFAVGK
EGSLGGVSAYTIDSDGSLALINSEYTEGASPCHVSVNADKTLVLSANYHKGTAESYPVHT
DGSLSSAASIIEHSGTGPNPARQEKPHMHFAGFSPNDQYAVSVDLGTDRVDTYKLVDGKL
EEVSSLSVKPGSGPRHIAFHPNGKFAYVMTELSNEVIALSFNAETGAFEELQYISTLPID
FTENSQGSAIHLSSDGNYVYAGNRGHNSIAIFQVNGETGQLTFIDRTSTEGNWPRDFVLD
PTEQFLLASNEQSDTLTLFERDTVTGKLTLLQSEIEAPEPVCVKFLNN
>PK3-045_04271 High-affinity branched-chain amino acid transport ATP-binding protein LivF
MLKGGSSMEKILELTDIEAWYGGIQALKGISLHVDKGEIVTLIGSNGAGKSTTLKSISGQ
VPIKKGSILFNGKDIANVAAHKTAVLGISQVPEGRRIFPKLSVRENLLIGAFAVKDKQLM
EARMQKVFEYFPRLKERVEQKGGTMSGGEQQMLAIGRALMMQPEVLMLDEPSMGLAPIIV
EQIFEIIKELNNQGMTILLVEQNAFQALQIASRGYVIQTGEIVLEGTGAELITNKQVQEA
YLA
>PK3-045_04272 Lipopolysaccharide export system ATP-binding protein LptB
MNILEVKGLTKKFGGLVANSNIDMSVERNSITAVIGPNGAGKTTFFNMITGVYKPTSGEI
LLDGKTIAGLKPHVVAKQGISRTFQNIRLFSDITVLENVMVGMHNHIKGSLVGTLLQLPK
AKQEEEKAMKEAYRLLEYVGLADLLNEAAANLSYGAQRRLEIARALATKPSVLLLDEPAA
GMNPKETSLLTGLIQDMCKKYDLTIILIEHDMKLVMEISNHIIVLDHGEKIAEGGPEEIR
SNPKVIEAYLGKGAVSLA
>PK3-045_04273 hypothetical protein
MANMIKTIQTNKVAQIILFFAYVLVTTAALAFSQKSVIAFLLLLLSLLLLYYMNLGNKMK
WGIALLILVIVLPISASQGPSYQAYMEVATMVGIYVCMALGLNIVVGLAGLLDLGFVAFF
AVGAYTYGVFATAQANNFMPFGTYPLSGNSFWFFIIIGLFVAALFGVLLGIPVLRVKGDY
LAIVTLGFGEIIRIVFNNLDKPVNITNGAMGLPSIQQPELFGITLSQPNQFYYIVLVMFI
IVIYAVTRMEHTKLGRSWKAVRENEIAAQAMGIPLVKTKLTAFAIGASFSGMMGVVFAAK
QMFVDPTSFTYLESTTILVMVILGGMGSVPGVILGAAVVTILNLQVLTELTGWLSQVTTI
PDALSPAKMQRFIFGALLIIMTLYRPQGLIPAKNKKVNAKKLKESIAEKQESTILLKEGH
K
>PK3-045_04274 High-affinity branched-chain amino acid transport system permease protein LivH
MLTEILQTLPQVLIDGLTLGAVYAVIALGYTMVYGILELINFAHGEIFMSGAFIGTAILI
TLTSLGWTSMLPAVLSLIVMLLITSLITGFLGMGIERVAYRPLRKAPKLIALISAIGISF
LLQDIVRFITELFKGNYIITSPNLFSDKINIGSVFGSHAASFKSSFLVVIIVAVILMVGL
DFFVNKTKWGMAMRAVAQDRDTASLMSINVNKVISVTFFVGSALGGATGVLFAVQYGTID
PYIGFILGLKAFTAAVLGGIGNIRGAMLGGMLIGLIEMFTAANLSVITGGIMGAEYKDVV
AFAILIIVLIFKPEGLFGKAVAEKV
>PK3-045_04275 Leu/Ile/Val-binding protein 
MLSKKVLSFAMTATLALGFMSGCASNTNSDSGDSGDKKVIKIVTQSPLSGGSATLGEAIK
LGAQLAIDQQKDKFAELGFELKLDAQDDQGDPKKGVANANLVVADKSVLGVVGHLNSGVS
IPASEVYEKNNLVSVSPASTATDYTDRGLKTVSRVVARDDFQGPAGAQYAVETLGAKKIF
VVQDKTAYGSGLADAFKEAAEDLGAEVVGYEGITVGEKDFNGVLNQVASKKPDLIYYGGL
YAEGGILVKQAREKGLDIPFMGGDGLDSSTFVEIAGDAVKNTFITSVAGDTTQSEEGTKF
AEDYKAAFSKNIESYSAYAYDSAAVLLAGIEKAIKENDNKLPTREEVTKAVRATQDYKGV
VTEVGFDEKGDNKFAKIFIYKFDEAKYPATLDGEISQ
>PK3-045_04276 hypothetical protein
MTVQEEKYCKESLVVKTSRIFPIDTNNHNSLFGGKLMSYIDDVASISASRHSRSDVVTAS
TDSVDFLFPIRPTDSVCLESYVTHTGKSSMEVFVKVIAENLKTGERKLAATSFLTFVALD
ENGKPRRVPKVIPQSEEETMLYNTAEQRVKIRKDRREHSKAFASVISTDMPWG
>PK3-045_04277 Sensor histidine kinase RcsC
MAKLKHYADWAINFIFRKNNKEKTPLLYYWTKRYLLTLCGGLLIIGIISILWIRHNALEN
RLELTKLVAQEIAEHANEMVEGRLKDIRLPFLQDRQKFINEGQPLDVFLKDAAGNIRSMN
QNFPPDSREKQQLIESLPLVSELTIKKVTLWNNQKASVVIAPIIKDGTPTGSVYIIQPHN
QLQHLNKEEYQLLGLLLLSLALLGWFVIYSLSKKMAKPVEEVANAAQQLMNGNYHITLNE
EVQEKELYQLMLSFNEMTKRLYALESLRTQLLAGVTHELKTPITSISALIQAVNDNVIPE
KKKSQFLSMSLKEAGRLQSMVEDLLDFNSFSAGSIKVNKEKLNVQATLKEIIYQWEIVHT
ESLSSAKLTFINPEKPIFTMLDSVRFQQIIVNLLNNSLHAIKGKQGGKITIRLTHDDQNI
IILVEDNGYGIPKEEQAYIFERFYRGKNKKDIERGLGLGLPYSLLLAKAQGGYLSLQNSD
GRSTIFLLQFPILT
>PK3-045_04278 Transcriptional regulatory protein SrrA
MRKILIVEDELAISMVLGAYLENAGYDVDYAYNGEEALRKLEEETPALILLDIMMPYVDG
WSVLSFIRKKSACPVIMLTALSDTEQKLKGFENGADDYITKPFVGEEVIARVQAVLRRSS
HYQEDERVKYYGDLKINYVSHQVFLNGIEVPFTPRDLSVFLFLASNPNQTFTRDQLLDHV
WGNDYDGSDRAVDLAIKRIRKLLNGWDPKDGEIKTLRGLGYQFYIQEKQ
>PK3-045_04279 Macrolide export ATP-binding/permease protein MacB
MKLGQAIKIAFKNIAMNKLRAVLTMLGIIIGVAAVIALTSLGMGASNSVSDDIAGLGTTT
VSVNLSGNSSEEEVVDYNELMAFAEFDEVKAVSPTVTTSSTLRNGTTSSSGVTVTGVTTS
YEEVQDITLKSGRNVMDIDLDNRNKVVVLGYNIATELFGFANPVDKTVQIDGTTFKVIGV
LAEKGEELTGSVDDSVLIPFTTAQRFIGQTYVTSATVLMTDEDSVEMGMAKMKQELYNQF
DGDETTYSVRNQSSVSEALDSVSNTMTLLLAGIASISLIVGGIGIMNIMLVSVTERTREI
GIRKAIGARKKDIMLQFLIEAIVLSALGGILGAAIGIASADILSSTLEMTSQITWWVVSG
SVSFSVLIGIIFGIFPANKASNLSPLEALRYQ
>PK3-045_04280 putative ABC transporter ATP-binding protein YknY
MIEKHAIVEIKNVKKEYTLGGETVTALDNVSFTVNKGDFIAIIGPSGSGKSTLMNIIGCL
DTPDSGEYYLDGQNAFSLKSKQLAEVRNHKIGFIFQSFNLLTKQSAFENVELPLVYRGIG
SKERKEIAMQALKKVGLLERAGHKPTELSGGQQQRVAIARALAGNPPILLADEPTGALDS
KTGVEVMNLMKDLNRQGHTIILITHDLEIAKQAKRVIRIQDGRLAETKEVVVS
>PK3-045_04281 hypothetical protein
MKKSIKKWIISGVTVLVIGTGIGSYYYFSNDNQTEVRAQARSQTATAEAGDVEIEVSGTG
SIAAINKETFTSEGNATVDEVLVEVGDEVEEGDELVTFENDTLDPIVATFSGEITALNVA
EDGNVSMGTEVVTVTDYDNLEMVVNVDELDISKVKAGQAVNVKVSALEDKEFTGKVTSVA
KEANSDSTSVAKYAVAVKITKPSGLLVGMTAEATITTDKAEDVVTVPVEAVQKENEEYYV
LVANGTTTNEDGTKETASTKQTVEVGLQNTEVAEIKSGLEEGTTVVLPTFESSSDSETQG
MFPGGGQMPNGEGRGQMPNGEFRGQGGGMPSGGFGGRNE
>PK3-045_04283 Queuosine precursor transporter QueT
MKTKTLAMNGLVAALYVAVTIAIAPIGFGSIQYRVSELFNHLVVFNKKYIYGIVVGVFLA
NLFLSTIKLYDLTFGVAHSIICLLITIGISKFIKSHLLRMIINTLVFTFNMFIIAYQLHL
ALGFPFLITWGTTAIGEFVVMAIGIPIMHFLNKRIPFGKLMD
>PK3-045_04284 putative isomerase YddE
MKLKVYTAHSFAKTLEGGNPAGVVLDSDALSDENMKKIAGDVGFSETAFVMKSESANFKV
RFFTPEEEVDLCGHATIATFYVLLNKGIIKPGVFLQETKAGILSVEVREDSTIMMEQNTP
RFYETVNEKEIADSLNINQYDLIDELPIQIVSTGLRDILVPVKNINIVNSITPNLKKVSQ
ICNKYNSVGYHVFTLETLIGSHSYCRNFAPLYGINEESATGTSNGALASYLFKYKNPEMG
CDYSYLMEQGYSMKKPSEIKVELMVEGKEVIDVKVGGKVMNLSELIVEI
>PK3-045_04285 TelA-like protein
MTDERQMKNITDDYFSDPLGESNNLFMQKGETAETVRLIDVLSPQNQKRAYELADKLDPT
NHRTMIAYGAAAQKKLLSFSHTMIEHVQRKDVGEVGDIVSDLMEKLNEINPDELRVEKKG
FFRRLFSKPSKSVHEVLSNYQKASAQIDRMSVRLERSKNVLTADIHLLEQLYEHNKTYFE
DLNVYIAAAEMKYEEMTKKLIPEQKKLAEESGDRMKLQEVNDLIHFAELLEKRIYDLKVS
REITIQTAPQIRLIQHTNRTVIDKIQSSIMTSIPLWRNQVSIALTLLRQRHAIETQAKLN
TSRMDANAKEMVQIAKENRPAMVEIDSLKETQHKLMSSLEETLHIQEEGKQKRNQAEQEI
TEREGNLKQALDTVDNRY
>PK3-045_04286 hypothetical protein
MNSFLMFLVRTGISFPVGALTWLISYVAFDQYFILSVLYGVAATGVSYFISDGVIKHQLM
VRQGLSRKEYKFIQTQLKEANEKISRLNRHVFAIRHFPSFKQRIDLMRVTKKIYRLTKEE
PRRFYKAEKFYYSHLDSLVEIAEKYALLSAQPKKNRALQATLNDTRRTLEQLSRTLEDDL
HGILSDDIDDLHFELDVVKHTSNKEKDTDLLDESRRTK
>PK3-045_04287 putative MFS-type transporter YhjX
MKERNGNRLLIVIGTIIVQMGLGTIYTWSLFNQPLVDKFGWDLSATAITFSITSFALAFA
TLFAGKIQDKWGLRRLIACAGIMLGGGLMVTSQVSSLWMLYLVAGVCVGFADGTAYITSL
SNLIKWFPEKKGLISGISVGAYGTGSLVFKYINTSLIAAYGVSTAFLIWGIIALAMVVGG
SFLLKEAQEVETTTNSLAPEQKNYTVKEMLKTKQAYLLFVIFFTACMSGLYLIGIVKDIG
VSLANLDVATAANAVALVAIFNTIGRIILGALSDKVGRIKVVSGTLVVTAVAVTVLNVVP
LSFPLFFACVAAIAFCFGGVITVYPAIIADFFGLKNQSKNYGVIYQGFGFGALAGAMIAA
VLGGFHATFTVITVLCVVSFIITLIIKPPHMKLQPKEPKQPQPRLANRLG
>PK3-045_04288 Transcriptional regulatory protein YpdB
MKAIIVEDEIPAKEELEYLIQTHSKIDIVATFEDGLDVLKFLQAEEVDAIFLDINIPSLD
GMLLASNISKFAKKPYIIFTTAYKEHAAQAFELEAFDYILKPYEEKRIAAMLAKLEASFK
KESGGEEEITTEVTRRINLRKNENIIVTDVNDIYYAEASEKVTLVYTKTDEYMMPMSISD
FHDKLPQDTFFRCHRSYTVNLSKIHEIVPWFNHTYLVRLKDIKAEIPVSRSKAKAFRQIM
HL
>PK3-045_04289 Sensor histidine kinase YpdA
MNSSLELQMLIQLFERAALLLITLFFMTRVPKFKETLQKDHHSPTELTLITIIFCAFALF
GTYSGIQVEGSIVNIRTIAIMSGGILFGPWVGIVTGIVSGLHRYLIDIGGVTSIPCLITS
ILAGIVSGYIHLRVKKSSRWIYGIVAGMLCEMLTMILILFMADPFDLGIDIVSIIALPMI
LGQGSIGLIVLMIASVEGEKERIAAQQAQLALNIANKTLPYFRSINGNSLRTICTIIKED
IQADAVAITDTKDVLAYVGFGEEKYKIGQEIISDLTKDTIRSGKITIRNNIADHHTPQIH
CLLIIPLEERGVVTGTLKIYYRKAYTITNTLQTMAIGLAQIISTLMEVSRVEQMKEEANK
AELKALQTKINPHFLFNALNAIASTTRRDPEKARELIINLSGYMRYNLEVGEELIDIQLA
LKQVRDYIQIEKARFGNRLQVNYEIDDIHIKLPSLLIQPLVENAVVHGILKRKGPGVVTI
SVKDLGETVRVSVRDTGEGIAQEVIDRLAKEEVSSKQIGLTNVHQRVKLMYGTGLNIRRL
EPGTEVYFDITKEIA
>PK3-045_04290 hypothetical protein
MDARIEKLINFTRRQWGLEDYYLGRHHLFRQLTLDGETVYFLNMEWFPNKYADWTDEEEN
PEGTASIDINIHTEEFESVIFVQGVTYAKNGVVFPHKDVKEVKKWLAEFAGINIEKDFIC
KRRDEREYYFEEQWNGIPLSPSSSITVEFNEDGELTFYSKDIMVLTNKNELEEEYTLSLA
DIEDIASDQVVLAKFPKEDGMLIVYGVEETYIRNDRKGSLPFMEEKFGLRKNINKEIIWQ
EGKEDDFERKFLDWDDEVSVEDAYLKVTHPDSLPITDEDTEKCIQEVTDFLRMKYPNDSG
KWMLKYLYRENFNLLARIEKIAPKSIFAGKILTFHDQEGKIVNFMDKKEFWDEILDKEEK
ELIKKEKEIKITKDEAYKKLKPYFTLTPYYVFDPADRKWVLCGKLDCNYCVDVESGEISN
LEDSFS
>PK3-045_04291 hypothetical protein
MTKNKNKNAKQAVQNDTARQYDHEFANEPLTAAEKLNNKKTKKRQ
>PK3-045_04292 Staphyloferrin B transporter
MEIWKRNLLVLWIGVFFTSASFNMVIPFLPIFLIELNVHENTEIWAGVLFSAAFFAGAFA
SPFWGRLADKYGRKPMIIRAGFVLFVVYTLAAFVTNPYQLLVLRILQGLLSGFIPGAIAL
IGTNTPSDKTGYALSMISTASASGGIMGPLIGGVISQLVGNRLSFASAGLLVFIATLLII
FWVKEDNFSPSKEKGSVRNDLRIAFANKPLMLVLLLTIVTSCSIMTIEPILPLYILEIGG
SMDKASLLAGIIFSLPGIASVIMAPYWGKWADKVGFNRVLFIGLLGGGLGTFSQIIFSNI
WGFSITRFIFGLFFCAVFPALNGLVVKSTAEDFRGRAFSLNQTANQLGGMFGPMIGGFLG
GVLPAQSVFIVTGILLIVATGIAYKKGNIFSPTMKQKVKIVTHGK
>PK3-045_04293 hypothetical protein
MKFKKIKITSLKKEKKSQKSIFSKLNIRKISRNGNLKRVNGRFTKLNNITIGWKYGITLL
FVFALLTITTVLVTTRLIHINNSIEQLNKTDEKALIITEMGSLTREKSLSILNYLDYQNP
TYVDEFQDISTKFNEYEEQIKKDLRNKDEKALFDEIINRNKQMNDLFLEQIIPAIEANDR
SAVNSLSLTNTTIRKRTITALNKMQEQVQDSRTEAAEDAIASGSVATKTLIISMIIALLI
GTALIIIISSRITRNLKKVVEVSDTIAQGDLTVEEVYYKGKDEIGQLAQSMNKMSNNLRM
VIQKISEVSITVNKQSENLSQSTNEVTAGSQQVATTMQELSSGAESQANTATDLASSMES
FSGTIGDAYNQGELIYQSSNKVLGMTNDGSRLMGNSIEQMNVINQIMIEAVEKVRGLDTQ
SHEISKLVSVIKGIADQTNLLALNAAIEAARAGEHGKGFAVVADEVRKLAEQVAFSVTDI
TDIVGSIQKESSVVTESLQGGYEEVMKGAEQIKMTGETFEGIKAAVNDMVNSIEVVSENL
ASILETSKEMNRSIEDIAAISEEAAAGIEQTSASVQQTSSSMQELSDSSHELSNLAVDLN
GLVKEFKIN
>PK3-045_04294 Mycothiol acetyltransferase
MEIRQLGPDDAEAYFALRLEALQTNTEAFGSSYEEEKDYPLSRTQSRLSDPASYVCGAFV
EKDLVGVVTIMRETKKKLSHRANIYAVYVTPKCRGKGVAKHLLKATIEKSRDLQGIEQVY
LAVVAENAAAKKVYQAFGFETYGIDRKAIKINGKYYDEELMVLFL
>PK3-045_04295 hypothetical protein
MRKFAKIIIYYLLGTITILALSVFPKYFQMRDFPEGEGYFFTLFSFLSKEFFQKEGWVYT
LNGVDQEPILDVLWPAFIYSIEILLCAILLGCFVAFILSLSSFFLPQFLLQPLKRFLDLI
ESIPDIIIATLLQALVVVIYKKTGVEIFTVASYSENAYLGPIITLSILPAISLFKILILM
MEEEYLKDYVTFARSKGIRNFPILWKHIIRNIIPVTFQHMKIIIWGLLSSQFIIERLFNV
HGFTYFLLENFTPITIAVSLLFIFTPFFILFQLVDILIHEEQEKARDVKKGLWRQRMSFS
YLLLSLKVFGSNLRDGGRRFSWKNFSMIRPLSWLGKIVALHMKNWKVAVGSLFFIVVIGY
SIIYSVTTNNHIDQMRLFYAEDGVTLISAMPFAPTEPFFFGSDRLGYSLFDQIVIGAKYT
LIFALLIAFLRVVGGLLLAVIYSFYLKHPAQQWIAKMVDSIHFMPLSLIAYILLTPILLP
GLEGFSYSFWERVFLETMILTLLVVPLTTILLGKEINRVSDYEFIASAKVIGGGKFQILI
RHILPHLGPRLTILFGQQFIQVLLIFMHLGIFDYFLGGTKLSMDQMFPDPPQSTTYEWSG
LIGQVGRGAIGSGQFWYLYILVPFVIAIFAMQLIVQGVKEVQQVKVGVVFKQPGLRKNKE
IKQSKEAAPTITKESFTQIGRDPNGNQAIRPR
>PK3-045_04296 Acetyltransferase
MEIIQQWVQEDSDYIRRKLVAYNMEQLPEKLKSAYENISFVVKDEEGIIKAGITGHMFWH
HMHIDFLWVDTSVRKKGYGSELLATMEQAAIEKACTFIYLDTFSFQAPAFYEKHGYEVFG
TLDNFSEGIKQYFLQKRLVDEKK
>PK3-045_04297 L-allo-threonine aldolase
MTNILRESYSKTTYKLGNHGKRNVQVLKEALQEIDENAESDIYGQGKIIEDFQQKMADLL
GKETAVFFPSGTMAQQIALRIWCDKKDLGKVAYHPLSHLEIHEQDGLKKLHKIETILLAD
ETRVIELDDIKEMERGVACVLLELPQREIGGQLPSFETLEQISSYCKEQGIKLHLDGARL
LEVLPYYQKTAAEVCALFDSVYLSFYKGIGGIAGAILAGSADFTSQSKVWKRRYGGDLIS
LYPYILSADYYYEKRASKMAEYYESAKELAVLFNGCEGVRTLPIVPVSNMFHVHFELGKE
EVEQILTAVHEKAGIGISGYVKEIDEKNASFEISLGDAYQEAPKEAVREMFSLFAEKIKK
RRG
>PK3-045_04298 Putative multidrug export ATP-binding/permease protein
MSKQKISNQKQMGDGKRVIRFLMPYKKWVIGDSIVIAISQVFSALIPTLALSWLIDTILP
SENHTWLWGLMWLLVLSAVLDLGMMIIDEYFCHITAKSVTNRQKLRLFGHLQVLPFSFYQ
NNSSGELLARTSDDPDTLHNFLAWEGSTFMASAQGVVIYSIVLLFIHPYLMITSVVLGIL
FYWASNYVGARTRAASADARAEASRYLERLRESVTGIHLSRVMGVSDSEVESVISIRDSF
VKHSLKELKARMQSVVVIASYNGFALGLVYFISTLLIWNNDLTSGQMLTAGGLVTIAANE
MQRLLRNWLSVRRTGPALDRSDILLSQPVSEAETKQGLKGTRAKGDVRLKDVSFVYPDKE
ENVLKGVSFTIKAGEKIALVGPSGSGKSTIIDLLFRLYDTTEGSIEVDGREIKEWDTDWL
RSQMAIVTQDVLMRSGTLADNLRIGKKEATEEELYEVLRASGLGELVDSLPDGLNTKVGE
RGSLLSGGQKQRLSLARAILKDAPILVLDEASSALDPITEAKINEAVLKTTKKQTIFIIS
HRLSTVLAADRIIVLDNGVIVEEGTHTELLQNNNGVYTRLFKRETDIGEATVNHTNAQLL
>PK3-045_04299 putative ABC transporter ATP-binding protein
MNLLRTTLQHFKPYWRKLLIALFFSLVGGAFTILPPILVGKLVDEVIGDKAIALILWIVF
GILAAFLGKALFESLQEFVQVKIGFDVITDMQIRAFKRLHRTPMSFFSNTPRGDMLYRLT
HDVESIQNLNNTVVPRILQQVISAVAAFITVFAIYWPAAIVMFAVFAIYIFPSFKLGKTM
RKMSAVQRDMSADMYQHLQESIESVRLVRTYQTQKDEMATQEQKLTNWKNYSIRAALIGK
VNWRLGNLFNIATPGVVMLIGGLAIWQGNITVGTLISCLNFIPIMFQPVRSLAENALTIQ
QAIPALQRIYEYFDLPEEHEQNLPNFGSVQGEIDLHNIWFSYPGSDKQVLKGVSVSVEKG
KHIGIVGTSGGGKSTLIQILLGLYEPEKGSVTIDGKDLFAYNRNSFRRQVGVVSQETFLL
NSTLRNNLLYGKPDATMEELEQAVEAAGLKELIDSLEDKYETIVGERGLKLSGGQRQRVA
LARAILRQPPVLIFDEATSSLDGETEEKVQESLEQLIPGRTTITIAHRLITVRKADTILL
LDQGMVAEQGTHEELLALKGQYYQLYRAQYSELEKEMIG
>PK3-045_04300 hypothetical protein
MVLKKQRIRSTKNTWTGLVSFLLSLVALTGINLGLIFEVDILPELVFTKIPFISLLLGII
GLFTKRRSRAFAIMGISLSVFIFVFFMMMFGLAWTINPKP
>PK3-045_04301 putative anti-sigma-M factor YhdL
MKKDGFKEKEEKDYLNKIQEAIDEFEAETPFTDKDQQLIVRRGKVEARLTNILYSLTILL
LIIPVATLGSYLYYGIGNKANDFIDIMEKTIYITKPNVSLEEMEIDSKIGFFNMDLSYDL
YKRVGKKDVRIGDSKAHFTFSTPSFPDTSFITEKPFTEYRDEDKEVLFHPHRAIPYMVKQ
DETVLKGLPDGTVAEAFVSFDQLYTEKELFSEFPKDLDLVWFAVDTGLEEKNLSADGDYI
SPIGYPAQEDPDNWSPFNSDEINSKQFMEILTYLSKNQETAETIAERPLALPERIEYLQK
NGIHIYGAVVTGPKESLVKLQDNDMVKGMKLGEVRLWNWY
>PK3-045_04302 ECF RNA polymerase sigma factor SigM
MELDDAYRMYVNELYRYLYSLSKDHHTAEDLVQDAFYRAYKQLDTYDILEIKPWLFKVAY
HAFIDYTRKRKRIVLKESFQEEINNSTPESKIVHKESFNQLLYYISQLSEKEANAIILCD
FHQFPYKEAAAVLNLKENTVKSHVFRGRKKLNRMVQKAEENSMGKKGR
>PK3-045_04303 Ribonucleoside-diphosphate reductase subunit beta
MTKYAVNWNQHEDDFTQMFYTQNTRQFWLPEEISLSSDKNTWVELSKEEQDTYKKVLGGL
TLLDTEQGGEGMPLIGMHIEGLQRKGVLSFMGMMEQIHAKSYSTIFTTLASEEEIDEVFN
WVHNHPQLQAKGKRISEYYQKLFSPKINKYDLYMAMVASVYLESFLFYSGFFYPLFLAGQ
GKLTASGEIINLIIRDESIHGVYVGLLAQELYAQLTPEEQEQATRERLELLESLYENELE
YTQDLYQQIGLVEEVNKFIRYNANKACMNLGYEPVYPSEPINPIVENGMKTDTKNHDFFS
VKGNGYVKATKVEPISDDDFVFDWK
>PK3-045_04304 Ribonucleoside-diphosphate reductase subunit alpha
MRHIELNNEVTQLNEKGFFRLEKDKEAVAEFLESEINPKLIRFDSIEQRFKYMVEEDFYY
PQVLEQYKISEIEEITKLVYAYEFKFQSYMAISKFYKDYALKTNDKKQYLETYEDRIIIV
ALFLGQGDFEKAKKNAIAMIEQRYQPATPTFLNAGRSRRGEMVSCFLLEMDDSLNSIFHN
INTSGQLSKIGGGVALNLSKLRARNEQIKGIDNAASGVVPVMKLLEDTFSYANQLGQRKG
AGAVYLNIFHWDIVEYLDTKKINADEKSRIQTLSIGLIVENKFFQLAKENKDLYVFAPFS
VYKEYGIHMDDMRMDEMYEELVANPNVKKRVIMSAREMLTKIAQIQLESGYPYFMNKSNA
NNGHALKDIGQIKMSNLCTEIFQLQETSEITDYGQEDIIRRDINCNLGSLNIPNVMKPGE
VFRDSVHVGIEALTTVSNISDIQNAPSVKKANEELHAVGLGAMNLHGYLAKNKISYESEE
AKDFTATFFMMMNFYSIEKSMLIAKEREETFKEFEKSEYAKGTYFEKYKQVSFAPKTDKV
KELFAGIYIPTCEDWAELAAQVQKHGMYNAYRLAVAPTQSIGYIQNATASVMPVVNQIES
RTYANSTTYYPMPYMDETNFWYYKSAFDMNQFKVMDLIAAAQEHVDQGISTILYVNSDVS
TKELARYYIYANEIGLKSLYYTRTRNLAIDECIACAV
>PK3-045_04305 Protein NrdI
MLIVYDSKTGNVRRFFNKLGLPANKGIEISAGLKVHEPYILLTYTTGMGQVPQTTLDFLK
INHPNLHAVVASGNKNWGQNFALSANKISTMYGVPILHKFEMSGMPEDVEIVRERVQSIS
YETYRTKQRSDTA
>PK3-045_04306 hypothetical protein
MACVGCELKEQVSQLDVDALVQEQLSFEVDLAREEIRDLRLSICVQCEHLNQHTCGKCGC
FVRFRASLDKKSCPDKKW
>PK3-045_04307 Intracellular exo-alpha-L-arabinofuranosidase 2
MQVKLLVDKQGPTISKYIYGQFAEHLGRCIYEGVWVGTDSDIPNENGIRKDVVNALKEIQ
IPVVRWPGGCFADEYHWKDGIGPIENRSTIVNTHWGGVTENNHFGTHEFFELVRQLDCEA
YINGNVGSGTVQEMQEWVEYMTMNGESPMANLRRQNGQEEAWKVEFFGVGNESWGCGGNM
RPEYYADLYRRYQTYVRKYGEHNIYKIACGASVDDYNWTEVLMKNAARFMDGISLHHYSI
PTRVWEDKGDAINFPEEQWYSVLEHAQYMDELITKHSTIMDKYDPEKRVGLIVDEWGAWY
NVEPGTNPGFLYQQNTIRDAMLAAITLNIFHKHADRVHMANIAQMVNVLQAMLLTEGEKM
IKTPTYHVFDLYKHHQDAELVDSYGDESNHVTYTASKKDGKLTVSLCNYDLTETREITLS
REEGEFEIVEAEYITADAMNAHNTFEEPEAVAKKEFTSYIVEKGTLKVTLPPMSVASIVT
KEN
>PK3-045_04308 hypothetical protein
MQLDISENSIPVYEVLSSPTRINIIKLLSKKKMNIGELAKELNISSAIVSRHITKMSDAG
LVKTETIPGKSGLQKIAILKVDRIEIQFPQKIYSAFETYKQAIPVGHYFNFEVYPTCGLA
TTAKAIGEYDDPKYFMDPEKNQAAILWFTKGFIEYRIPSILKEKDRLEMIDIVLEASSEF
PYSNNVWPSDITFSLNGKELCTWTSPGDFSDTRGRFTPDWWPNETNQYGILLTIRITKHG
VYADGKKLSDTTIDQFREEQSGMWDLKVAVKEDAENLGGVTLFGKGFGNYDQDINFITYY
SNLV
>PK3-045_04309 Beta-galactosidase BgaP
MAKKFFNRILYGGDYNPNQWPKEIWEEDMRIFKKAGINSATINVFSWAKIQPSEDEYYFE
ELDDIVEMLSRDKYDIILATSTASLPAWMVKKYPEVARTDYEGRHHKFGQRHNACPNSLV
YQKYASKLAGKLAERYGNNPYVTCWHINNEYGGECYCENCEKAFRVWLKKRYQTIEALNQ
AWNLEFWGHTIYEWDEIVLPNALSEGIGSDKTAFAGISIDYRRFNSDSMLENYKMERDAI
RRYDADTPITTNLMGTYKNLDYFKWAKEMDLVSWDNYPSYNTPLSYTAMCHDLMRGLKDG
QPFMLMEQTPSQQNWQPYNSLKRPGKMRAQSYQTIAHGADTIQFFQLRRSVGACEKFHGA
VIEHVGHENTRVFREVRELGNELQNLGDEFLGSTIDSKVGIIFDWENYWALEYTSGPNKD
LKYVDQIHQYYQYFYTKNIPVDMISVDSDLSKYDMVVAPVLYMMKAGLAERITAFVENGG
HFVTTFMSGIVNESDNVYLGGYPGPLREIAGIWVEEIDALAPEQKNGVEFADGNIYTCQL
LCDIIHLEGAETVAAYKKDFYGNTPAITKNTYGKGTVWYVGTQVEQTGLTHLLNQVIEGT
EAKPICSNGEGLEITKRDTDKASFYFVINQQVNKQQLPEELVGKVNLLTGEVVKEAVELK
QFDVLILK
>PK3-045_04310 Arabinose operon regulatory protein
MEVHFNLLDGSNPFSIESIGYQWEQEIIMRADGYPYYHWLQTEEGLGEVTIENEKIRLRP
SEGILITPFVSHYYQAISAKGWQTNFLTINGTFSPNIADILGTAPYYLANDCQDFSYSNW
TRKMLSHIKNENQNRQQQLSIDVYTFLLNIRDHGLHRTVHTNDLYQQYIWPSIQWIETNY
VEKCDIGDIAKRLYISPQYLNKLFRRFVGVSIYQYILAYRIKKAKEILVTNREIKIKDIT
FLTGFNDTSHFVATFKKETGFTPKEFRAFY
>PK3-045_04311 Cobalt/magnesium transport protein CorA
MRKIYISNEDGMLQETDKVVNGCWINLIAPTEQEITEIATGLDIPLAFMKDPLDEEERSR
IEKDGENILIIVNLPLVSFDEKKTQIYDTIPLGMIIAKNCFITVCLKDNPIFQQFSEGRM
KSFFTYKKTRFSLQILYSMATAYLKYLKQISKKTDSIEKELQQSMKNKELFSLLNIEKSL
VYFTTSLKSNNIVMQKMLKSNYLKMYEDDQELLEDVIIENQQAIEMAETHMSILSGMMDA
FASVISNNVNMVMKFLTSFTIILSLPTMVASFYGMNVHIPFQDMSYSFTIAIMISFLLSG
ITALVFWKKKFF
>PK3-045_04312 hypothetical protein
MSTRKCMEPEPEPTAMKEEVIYSPSFRSLNTDKDSTLFGREC
>PK3-045_04313 Multidrug export protein MepA
MEKENLYYFEKAPIAKAVAHFAIPMMLGMSMTVVYSILNAYFIGFLQDTAMLTAITLALP
VFALIMAFGNLIGMGGGTYISRLLGEKKYYRVKQVSSISIYSSILLGLLIIIITVPFIDS
IVSLLGSSLHSFDYTKQYVLMLIIGSPFIILFFTMEQLVRSEGAANVSMIGMILSVAINI
VLDLLFIFVLKLGIMGVAAATILSNIMACIYFSYYMGKKSKFLTLSFREFSFEKTIFKHI
LTIGVPVFLMNVFMGVTALFFNHFMMIYGDKAVAGYGISSRLQQFPEFFIMGVCEGVVPL
IAYSFTADRKRMKKVLAFTSKLILGMAVLFGLIIFFTSSNLIGLFTNDIELITVGSYILK
VTFLSMFLSGFTFLIIGMFQATGQGTAAFVMAFVQGLVLIPILFFANFTFGFHGVVWSLF
IADSITFIVAAAILYVLRNKLNSPSVEELLQGE
>PK3-045_04314 hypothetical protein
MKEREFEVNFQYLIRTINHKIKLSGDKRLEAHGITLEQARTMGFIDAHEEQGITHKDLES
RFNRKGSSISSIIHNLEKKDFIKRTIDPKDERRKLLSLSEKGKKIVGDFEAFFANAENML
VEGFSEEEKKQLFHFLERMNVNVDKQL
>PK3-045_04315 hypothetical protein
MSFFRNQFANVVEWEEFREDMIFYKWKNREIKKGSKLIIRPGQDAIFLNNGNIEGAFQEE
GEYDIESQIVPFLSTLKGFKFGFNSGMRVEVLFVNTKEFTVKWGTKNAINIPAAGLPGGM
PIRANGTFQFKVKDYIALIDKIAGIKNQYLVEDVKIRIISVLDQLLMKWIVTAGKDMFNL
QANSFEIAKGIQEDLNSQMMESGLAITGFQIMSFSYPQEVQEMINKNASHGMVGNIDKYQ
QISMIDGMANGKMSGGGAASDMAGMMMGMNMANQMMDKMNKQNQSQGQNQQQAPAQQPTP
EAASQNQEKKRPNFCPNCGTKTGEGNFCSNCGHKLV
>PK3-045_04316 hypothetical protein
MRKILRNYSSLLFIALAIFTLFSGSAVSAASENQTEYIFDDAQLLTDSEKTELESLAEEL
GEETETALLILTLDGTDGKDIEQYVDDYYDEEAPGYDQPHGNTAILAIDMEERDIYLAGF
KRAEDALDNATIDYIREEITPALSDGEYFEAFSTFMHESAYYLVDDPANLEDDYDYSGID
EARNEYNEENNASGMPAFFFHWGFQLIASLVIAGIIVSIMVFQSGGKVTVNGNTYMDNSK
IINRHDRFIRKTVTKQRKPQNNSGGGGGITGGGHSHSGSRGKF
>PK3-045_04317 hypothetical protein
MILHYKCPNCGGDMSFNADTGSLSCPSCGNEENIESYPENLMTASFEENEVKEYHCDNCG
AVLLTEADTTATNCSFCGAGVVIADRLAGALAPKKVIPFTISKEEAMAAFQKWCRKGLLT
PKGFMNADRIKSITGMYVPFWLYDLNSDVDVTALCTKVRTYTSGDYIYTETKYYEAYRKI
NLDYTKIPVDASEKMKDELMDKLEPFPYEQLKDFKTPYLAGFISEKYNYTDAELLPRAKD
KVSDYIDSFVHSTFIGYHTINYRDRNIDTKAVRSDYVLLPVWMVSYDYESQEHIFAMNGQ
TGKVVGKPPISKGKVALWFSGIACGTFLALKGISFLMGGGFF
>PK3-045_04318 Protein adenylyltransferase SelO
MSNKETKTDAGWNFDNSYARLPETFYSKMTVNPVSSPSLVKLNEDLAKTLGLNGEQLQRP
EIIQVLSGNEVPEGGFPLAQAYAGHQFGHPTMLGDGRAMLIGEQITPSGERFDIQLKGSG
RTPYSRGGDGRAALKPMLREYIISEAMHGLGIPTTRSLAVVDTGEKIVRETSLPGAILTR
VAASHLRVGTFQYAAALESKQELKALADYAMERHFPTIKKDGNPYVEMFREVMKRQAALI
AKWQLVGFIHGVMNTDNMTISGETIDYGPCAFMDSFHLDTVFSSIDVQGRYAYGNQPKIA
GWNLARFAESLLPLFHDDTEKAVELAQAQLDQFNPLYQQHWLDGMRGKLGLVAAEEEKDA
KLIEKLLGIMQNNRADYTDTFRALTIGEVERIELNKNQAFSEWHKAWKERIAGQEGGEVA
ARERMKKHNPVVIPRNHRVEAALDAAEGGDLSVMEELLQMLSNPYAYTQAQMEYGIAPVK
INPAYKTYCGT
>PK3-045_04319 hypothetical protein
MGILYFCCGVMIGIFFWKKNDKRKYNKWKAKVEKEDIMFRLVESSKDIVYRYEVKPQMRH
SYISPSADAVLGDGMVKEFYRNPYAPLEMIYPDDYHIMYKKLHGAIDYSQPLVQRMRCSD
GSYKWFEEYATPIYEHGELVAIHGIIRNIDEKVRLRENLEHQLIHDALTEVYNRFYFEQK
MEEFDTKIDEVIAIILCDLDELKQVNDKYGHKQGDDLIKAAGKLLNTFSSPYITVSRIGG
DEFVLLIQGMQQEEIEELYKRMTMGLSDKGKCVEENMVRMSIGYAFGQSSLGRMTALFTE
ADNHMYQNKVQKKKKNHNKVLAE
>PK3-045_04321 hypothetical protein
MKKTKLIIPIFITILFAVTILLIITQNNRYEKMDDSDIKQLVQDFSSGKKSAAAASITSD
TLTVNTLDNEEHLYRLPKEEFFVSVAPYLVDTHPCAIHNLAGCRGELANKEFAVLIEDDV
GNVYVDELITSQQNGFIDLWLPRNKDLKLTISYNGKTAKSDLATFKDDNTCITALPLI
>PK3-045_04322 Mycothiol acetyltransferase
MLSKEQIAEIRELKDICEKEEGFELKLNFDMLENRNGEKKEDFFYYVDGKLVGFLGSYYF
GKKVELCGMVHPHFRRNGIFTALLEEGLETARQREATSILLNAPAASQSAKVFLEKLPCS
YAFSEHQMKWHKEDLIEDAAISLRPYDYDQDKEIEIELDVLGFGIAEEDARDYVNTITEQ
AGDKRMIIEVDGKTAGKIRVSETDGEAWIYGFVVVPELRGKGIGRRALSKVVKMEKEKGL
SIFLEVEAKNARALKLYESCGFRSYHSQDYYEYK
>PK3-045_04323 UvrABC system protein C
MELKEKIKNLPASPGVYLMKDSSGQIIYVGKSKRLKNRVSSYFQHSKNRIGKIEKLVKHI
KDFDFIVTDTEFEALMLECKLIKEIQPMYNRMMKATKAYNYIIFRYQKGSYRMEIVNELE
KEDIHYYFGPFTSKRTVENAIKGIKSFYKIDCSNTTNSTSPCLNYTIGKCIGICFNPIAE
ETYQQIIHRLISLFKKQDTRILEEMSAEMNEASSNFEFEKAAEIRDTIAKIKTILQTETV
INFMVDNRLFLAVEYLDNGRIKLFLIRRNQILYRQIYEANHFDMQVVKRQICTYLSRKNL
FIGTLDKAEIDEAYIIYNYLNSGNCQYVVIEGEWQGNRECGNLENSLRKILPY
>PK3-045_04324 Microcin C7 self-immunity protein MccF
MRIPAKLQKGDEIRVIAPSRSAAILSEEGIEQAKKRLENLGFVVTFGKHIFESDLQFSST
IEHRVEDIHDAFRDQNVKGILTVIGGFNSNELLPYLDFDLIKANPKMLCGYSDITALATA
ITTKADFITYSGPHFSSFQMEKLQEYQTEYFRKCVMETSAFIIEPSDVWTDDAWYLDQEN
RQYEPGGWRVYQEGSAKGQLFGGNLCTLNLLQGTEYIPNLKDGILFVEDDELTIPETFAR
DLTSLLQTAGIIKALVIGRFQRASKMTEEQLLFILDKHPLLQQIPVLYDVDFGHIQPFFT
FPIGGEVEIDTKNYGIKMTTF
>PK3-045_04325 hypothetical protein
MFVFFFIIGIISIFIAVTMIGAWPDGRQHRNHHITETKEDRALNIKISMIAFLIGVVSLA
IAGIINYFTN
>PK3-045_04326 Nucleotide-binding protein ExpZ
MKELLKLINIGYEVLDTTIFTNINASVQQGEVIGIIGKNGAGKSTLLQLINKEIVPTDGH
IKWVKEDLSVKMVEQETENYDLEKETFLESKLLEKWQVPTKDFRVMSGGEKLKARLGKGF
AHDADLLLLDEPTNHLDEQSMALLHELITAYKGTIIIVSHDRYFLDKVTTKIWSLENKQL
IEHKGNYTSYMEAREQKRLTQQREYDKQQKKIKQVEGQMKELTSWSQKAHAQSTKQEFPK
EYYRTKAKRMDAQVKSKQKRLEKELEKNKVERLDEEYTVAFSIEANKKKGKRFLEIKDLS
KAFDSKMLFEKVNITIQHGEKVAIMGPNGSGKTTLLNIILGKEKANGEVWISPTATIGYL
TQEVFDLPLEETPEQLFFKETFKERGKVQTLMKHLGFMASQWKEPIKSMSMGERVKCKLM
AYILEEKDVLILDEPTNHLDLPSREQLEKTLSQYNGTLIIVSHDRYFLEQTTSSKLIIGN
GTVQRQWTESPKRDRDNKEELRLKLETERQEVLGKLSFMTPKDKEYAELDRKFLELTKQM
KEL
>PK3-045_04328 Membrane-bound lytic murein transglycosylase F
MKEKKRMSKLVLFFVVILTMLNIISPISKAEAKEKVYQIATDITFAPFEFQDVNGDFVGI
DMDLMAAIAKDQGFKYEMKPLGFNAAVQALESKQVDAVIAGMSITEERQMKFDFSEPYFD
SGIIMAVDSDNDKVSSYKDLKGQKVAVKTGTEGASFAESIKDKYGFSIVTFDDSANMYEE
VRTGNSVAVFDDYPVLAYGIKQGNGLKSVTDKEAGASYGFAVSKGQNTELLEMFNTGLAN
LKASGEYQEILDKYLETGSDEEAKSGFFGLLKESFPSLLSGLKMTLILTVVSLLIATVLG
IIFGLLRIAKSKVLRTIAGIYIDIFRGTPLIVQAFFIYFGIPAALDFRITAVAAGLITLS
LNAGAYMAEIVRGGIQSVDKGQMEAARSLGLPYGKAMRKVVLPQAIQLMIPAFINQFVIT
LKDTSILSIIGINELTQSGKIIIARNLESFQMWLIVGIMYFIVIMILTKVSNRLERRIKN
GQA
>PK3-045_04329 Glutamine transport ATP-binding protein GlnQ
MAKLNVTNLKKSYGNLEVLKSIDLQVTEGEVVCLIGPSGSGKSTLLRCLNMLEEVTSGEV
VVNDFKLTDKKNDINKIRENIGMVFQHFNLFPHLTVLENITLAPVDLKKATPQQAKEKAL
QLLDRVGLKDKANENPSKLSGGQKQRVAIARALAMNPDIMLFDEPTSALDPEMVGEVLNV
IKQLAQEGMTMVIVTHEMGFAREVADRVIFMDNGYIVEEGTPQEIFGNPQNERTKDFLNK
VL
>PK3-045_04330 HTH-type transcriptional activator HxlR
MARFFVQNESVSIDEEGFCPVTYTQNLTAGRWKIIILWHLSQGTKRFNELQRLLPGISKG
ILTRQLRELEADQMVHREVYKEVPPKVEYSLTEKGVSFIPILDLMGEWGKKHFKE
>PK3-045_04331 Quinone oxidoreductase 2
MKLLVTGATGKLGSKIANVLLAKVPADQLAVSVRNPEKAEDLRAKGVDVRHGDFDQPETL
AAAFKGIDRLLIISADGDTETRIRQHNNAVNAAKNAGVSFIAYTSIANAQKSTNFLAEVH
KATEIAIQKTGIPYSFLRNNWYLENELSTIQGVQGGAPWVTSAGSGKVGWALQQDYAEAA
AEVLAGEGHENTIYELSGKPLSQEEIAAAVSQVIGKEVPVQHVDDSKYAEIMTQAGIPDF
VVPMLVAIQKDIREGTLDIESNDFEKLLGRSETPVVDGVRKLIS
>PK3-045_04332 hypothetical protein
MKKITTLLNEQEDNYILPFLWMHGESEEVIREYVNKIYESGIKALCVEPRPHPDFVGEKW
WRDLKVVLEAAKEKTMKVWLFDDSHFPTGYANGAILKDFPKLRKKFLRINQVDYHGPQKD
AGIIVKWHVGGDRNSIMTVGTDKAKMQKVVDEYGEKIIAVIAGRVVDYETVDTSTLTDIT
KYLKDGVVYWDMPAGNWRIFTLVETFNGGESSTEGYLNPIDPLATQVLIDTVYQPHYEHF
SEYFGTTIAGFFTDEPRFGNIKGPNAIIGKTEMVLPWRADLLSVLETRLGKSAKTLLPLL
ITNGTTDQSLVRYVYMDIVSQAYADNFTGKLASWCNDHGVEYIGHLIEDNNAHGRLGYGA
GHYYRAIKGQSMSGIDVVLHQLLPGMDEDYFKTFTSTGWDGEFFHYGLAKMGASLGHLDP
KKMGRTMCEIYGAYGWSEGLNLMKWMTDHMLVRGVNHFVPHAFDMAPYPDSDCPPHFYAH
GNDAQYRYLPLLMNYTNRVSELLSDGVHVATSLILYHAEAEWSGEAMLFQKPAKELSRNQ
IDFDVISIEMLKEAKVLNNQIVLNGEKFQNLIIPFSEKLPLVFMKLLKKFIEQGATIIFI
EGYPVESSEGDILTDYYSLFEASKQVQIVSLEELAGYLHSIGSYEIILKKNSPTLRYYQY
RHGNDEVYMFFNESPNLEVDTKVTLKQKGYIYSYDAINNRLSYSADGKQNEISLKLSPQE
SCLFIVTEKALAAEKRLTPIRKSAVAIEGTWEVSFSTAQEYPRFEKKIQIERLENIAKPS
LYPNFSGTIRYEITFTLKDKESKYYYLDLGDVYEIAEVFVNEYKAGTKIAKPYKFDVTDY
LKEGINSLRVDVTNTLGTMQKDYLSQYRVLQPSGLLGNVSLQGYDIK
>PK3-045_04333 PTS system beta-glucoside-specific EIIBCA component
MDYTSLAEQIFTEVGGKDNIRNVTHCMTRLRFVLKDAKVPDTKAVKQIPGVLGVTISGGQ
YQVIIGTEVSKAYEKVCNILGIEKKEAQEEVEENKEKVGLFNRFFKLVSGIIFPVMGVMA
AVGIMKGLLAGLTSFNLLSTESGTYQILYALADGFFYFLPIILGVSAAIKFKSNPYIGAA
IGSALVYPDIVTLYNDGVSITFLKIPVILTSYGNSVFPIIAAVALAAFVEIRVKKVVPSS
VQLFLTPFVTLIITVPLTFLVIGPIMTFISDILATSTQAIYGFSPIITGIILGAFWQLVV
IFGLHYAFIPILINNITNMGEDPINAILNVTVFALAGAAIGFALKQKDKVKRSLGFSTGL
TGLFGVTEPIIYGIALPYKKPFVAAFIGGGIGGGITAAMNAKMFGFGGNALFAAPLFINP
EGIDVSFTAYVIASTVGFFVSLLLTYLFASRNDI
>PK3-045_04334 Melibiose operon regulatory protein
MLPSELKKFLFTMTASEKEHKKNAKLNSTLYKSFEKVYIDNKEVYVFKLDEQRKSINFGY
GNNSKFEIVKHSRYSLIPFHIHDYIEMNYVYSGSCTALVQDQIIHLKSGDICIMDTLVPH
TITDVEEKDIIINFLMSKSYFTASMLSRISSNSIISDFLLDAITQDRQHNRYILFHCQKS
DKFEYLVENLLCEYYNPSFCAKDIIDAYMILIFAELLFHYQRDTNTNSSISRQPYILEIL
QFIEENFQTCTLNSTAEHFSFHPNYLSRMIKKNTGKGFKQLLQEQRLNKASFLLANTEKT
VEEVLMEVGYQNHGFFNKIFKERYGLLPKEYKKNKGRK
>PK3-045_04335 hypothetical protein
MNRDIRLEALSEFLKTKRSKIQPQMVGLPAGTRRRTAGLRREEVAQLAGVSTTWYTWLEQ
GRDIKVSISVLEAVADALQLNSDERKYVYGLAFEEGNSFFPKEAEEDMMTPALERILKEL
RYCPTIITDRRSFIVGWNEAAKQVFLDFEKIPSEKRNLIELLFSRKELRALAVNWEDFVK
GFISIFRTYLGQYMADEWYQEFIEDMKKNYPDFNRMWNESEVSSAPEVLIEFRHSKAGKM
IYNLTSLQVHGANDLRCSIYTPVDGTGTEEKIKHLMK
>PK3-045_04336 3-oxoacyl-[acyl-carrier-protein] synthase 2
MKRVVVTGMGIISPLGNNVDEYWQNLLKGESGILSIDHLDVSNSKTRIAGVVTDFHPDER
WGAKEAKKLDRFSQFALAAAEEALTNSQLDLDSIDKERMGVYVGSGIGGLTTLIDNVNTL
NQRGPNRVSPNLVPMMISNAAAAQISIKLGAQGPSLSPVTACSIGNTSIGEAFHTIRNGD
ADVMVAGGAEAAITNLSLASFGNARALSTRNDEPASASRPFDKNRDGFVMSEGAAILVVE
DLEHAIKRNAPILAEIIGYGASSDAHHMVATHPEGRGAYLAMKRALTKANISPSDVDVIS
AHATSTPVGDLSETLAIKKLFEEDAYKIPVTANKSMLGHMLGAAGGAEAIALIQSLREGI
IPPTTNLETPDPDCDLDYVPEGARKADISIGLSNSFGFGGHNSAILLKKY
>PK3-045_04337 Enterobactin exporter EntS
MPNHQSTDQTKESGVHLNIFRNKSFTFMWIGNGISELAGAFGTFCNSLLIYEITGSTWAL
GSMWLLYFLPSLILQLFIGPYLDRWSRKWMMIFALWSRGIIFLFPLIGFVSDTLVPWHVY
IVQIIIGLITPIYSPANQAILPNLVSKEQLSSANAYVEGMARLMTFTAPVFAGIVIEYIG
IGSTLLFICTALMLSGCLLLGIMEVREEKVERKTWAVEFMEGVRYFFQQKTIVWLGIFLA
FVQFGVGVTMVINIPYIKTVLNGNNAMYGYFMAGFPLGYMFGTLLVGKIKFQSRRRLMLG
ALLIGGVTYINLGITSSLISAIATEIVAGITMAFFSIHNITLCQQTVPNHLMGKIISVRS
FIIRALMPLGVLVGGALSELWGIRPLYILIGAIITTVSLVGLLSPYFAFLDKESINKNKL
AA
>PK3-045_04338 hypothetical protein
MYISQKEKGISQTGEISAKGRRESAKGRRESAKLEGISAKGRGKSAKLEGISAKGRGKSA
KLEKYQPKRGENQPNWRNISQREEGISQTGKISAKGRGKSAKLGKYQPKGGENQPNWRNI
SQREKGISQTGKISAKGRRESAKLEKYQPKGGENQPNWRNISQREKGISQTGKISAKGRR
ESAKQGKYQPKWREIGQSI
>PK3-045_04339 hypothetical protein
MKVFSTTGRKQETYQVEMKYSLLWECALGIAAITNERLLDSLDQPKSYWENVRTNLSQNL
QAQLDYVEANNTWKALLQLLHQQDFLSLDVFTEYINKLTERQLIYQCIPFLSESYQPIRE
HAADGNKEAIEKLKEATKDNPFFPTYISFICQVDSQQLKQHLITVMSEWYEAVIEPDREK
LTSILQTDVSIKEKMRQKMDPEEFVEWATGGIRYTPEPSVHKVLLIPQYIYRPWNIKADI
EGTTVYYYPVSNESISPNDKYMPSNFLVLKHKALGDEVRLRMVKLLFEQSRTLQDITEKL
EMGKSTIHHHLKILRSAQLVGIEDGKYVLKSSAITSLAKELEQYIQQ
>PK3-045_04340 hypothetical protein
MKLNKNFTLLLNGQSFANIGDVLYMVSIINLIYTVKGSATAASFVPFTITTSMFVSSVLT
PLFVRKIRLNRLLAGSQIGKTGLLLLLGFILPGITEANYFIIFIVIGLIAFLDGCANPIT
RTLIPYYVRPEKLMKANGMVETVTQLIQAGMWFVGSMFLLFLSPQNLIWFVGCLFFISSC
LLCLLENVDGKTIESAGKLEQIKAGWKTLFHTPVLRKMALVECLESLAATVWIAAVLYVF
IQDALKVDQQWWGFMNGTFFLGLILGSLYCMNYSSFVERKLGVFLVAGSFISFLLTILFS
LNSIPMLALVLSFGVGIVTQIKNIPQQTVIQTSVPKEQLSTVYTSLGAIGTGIFGIGSLL
MGLLADLLGVRIVFLFSGVLLALVSMIIYKNKSLFRIQSHLEKE
>PK3-045_04341 3-oxoacyl-[acyl-carrier-protein] synthase 3 protein 2
MSTSKARITAIGSYVPERILTNNDLEKMVETNDEWIVKRTGIKERRIADEQEFTSDLSYK
AVLDLMERYDKTVDDVDLIIVCTMTPEYKTPSVASSLQAKLGIKNTGAMDLNAACAGFTY
GLYVANGLVTSGLNKKVLVVGAETLSKITDFTDRTTCILFGDGAGAVMVEYDETKPSFLS
SHIGSEGEGGQHLYCTSLATQMNGVDLQGNGCIVQNGREVYKWAVKTVTNGMKIVAERGN
RTLNEIDWFVPHSANLRMLESICEKSNFPIEQTLYSLVNYGNTSSGTIPLSLDIGVKEGK
LKQGDHVLLYGFGGGLAHAGLLIKWTI
>PK3-045_04342 Xylose transport system permease protein XylH
MNIQHQTVEESKKREISFKVDMQSYTLIIALLLIALIFGFFTGGEFLSSRNISNLFTQMS
VISVLAIGMTLIIVAGHIDLSVGALVGLTGGIAAILQVWYDWDTFLVVLCAVIVGALLGL
WQGWWVAYRAVPAFIVTLGGMLIFRGILIGISKGQTVAPMSDSFKKIGTSYFPYIPGYIL
ALVSIALLFLWTTKHRTKRKNMGLMIPAAKIDYGKTVAYSFFILLATYMLNRYLGIPIPI
LIVLAIAAIFIFISNKTPFGRYVYAIGGNQEAAALSGINIKWNTLWVFITMGGLAGVAGV
LLTSRLNAATVSAGNMYELDAIAACVIGGTSLIGGKGKIVGALIGALIMASIDNGMSMMN
IQTFWQYIVKGLILIVAVWIDISSKK
>PK3-045_04343 Xylose import ATP-binding protein XylG
MDTYALQMEGIVKEFPGVKALDNVTFSVKRGEIHALCGENGAGKSTLMKILSGVYPHGTY
EGDIIINGQTVQFKSIKESQEAGIGIIYQELALVGEMSVAENLFLGHELMRKRIINWNEI
YVEAQKWLDHIGLNIDPQTKVADLTVGKQQLVEIAKALTKKTSILILDEPTAALTESDVE
ILIHLLQDLRSQGVTCIYISHKLGEVMSLADSVTILRDGQTISTNSIEELSEDKIVTKMV
GRELTELFPYEEHAISKENILEVKDYTVYDEQGNKIINQVSFLLKKGEILGFSGLMGAGR
SELFISLFGGFKGKKEGKVIIDGKETNIQKPADAIKEGLAYVSEDRKRYGLVLGMDITKN
TTLAALNKVVKLNVIDQALEVKSATDITEKMKLKAPSLEARVGQLSGGNQQKVVLSKWLL
NNPKILVLDEPTRGIDVGAKYEIYKIINELVQQGVGIVIISSELPEVLGMSDRVLVMAEG
EISGEFLREEATQEKIMTCATGGKKNEYSTSNS
>PK3-045_04344 D-xylose-binding periplasmic protein
MKKRNSFLSLVLILSLMFIMAACGQDANGTPANEKGNKDEGGTEKEKITIGLSVSDLTLE
RWQHDRDFFVEKAEELGANVLVQSANGDEAKQLSQIQNMLSQGIDALVIIAINSDALSTV
VDQAKAEGIPVLAYDRLINGTDIDAYVSFDNVRVGEMQAEYLVEKVPSGKYFLMGGSPTD
NNAKMFREGQMNIIQPLVDKGDIEIVGDQWAKDWDANEALKIMENALTANKNDIDAVVAS
NDSTAGGAIQALEAQDLAGKVVISGQDADLAGVQRIAEGVQTMTVYKPIKAIATKSAEVA
VQLGKGEKVSSDSTVNNGKIDVPFIKLDPIKVGKENIVDTVVKDGFHSYDDIYKNVPENE
RPERP
>PK3-045_04345 HTH-type transcriptional activator RhaR
MFNLLVVEDEDMIRHKIINNTNWLSHGFQQVFEAENGSGAVKILAENHIDILITDIKMPE
MDGIQLTKHVKEFYPEIKVIIISGHADFDFARKSITLKVCDYMLKPFQSKNLLKLVLNVK
NDLIRDKGEQENIEKMKRQLQENKHSLREKLIQNLLTNSFVGDLDNNLKYMEMEHLKNAS
FFVAVLNIEQLQTDRSEMEENDKYLFNVSIYKRLSRLLEKEWGQFSERGQIEKGYILNYK
MDQIVLIVFEDIGIRHQLRKVIQKEDQEKGFTLIIGIGDKYNQLLDLHLSYEEACSAAAL
SRIHGSGDVYFYHNIISNHTYYSKQLHKIVNHKIYQDLKSGDFEEVKKDVAELLAELKNE
SIPYEAVATAINNIVFMSCKTINEQGYDVNEIFGETGLPIFNQENNFTYKEIEDCLYSFY
SAIHSFIESKRGNRIDRLIAEMKEYMNENFAENISLTSLSRKFNISPSYLSILFRDITSQ
HFSEYLTNLRIRKGKELLKNTDLRIKEIAAQIGYRDAYYFSSVFKKVTGVNPTQYRNE
>PK3-045_04346 hypothetical protein
MKKWLKWIDLYSIRTKMIVCFLALSLIPLLILGYLSYQYYINDLQNSINVYTNEVIQRVD
KNIETYILDIENILEIYDDYYTIQYLRLNEAGDIDGIQKYTVRLWETIELIRNMKSDLVD
IRIISHTGETISAQGVYWSDMNDPFFTNMRKIDEAQFAVKSPYMDMFNRNVFSIGKKILS
PSLSEPAYLIIDIDVNLLNRIVNDIKLGEKGYVYFTDRTGEVEFFPADTSHPMFIKELMN
NDRLLNSDKGSFEEAVKGKHYLVNFKQSEITGWNIIGVTYADELNEDINKIRQITLVIAV
GSLLVVVLISIYLTNILTNPIRDLRRTIKRFADDNLAIRAQVKTNDEIGQLASSFNELMN
RIQWLVQKTMDDQVKIRKIEMKALQELIKPHFVYNTLDSIIGLLEQERIEEALDLIEALG
MFFRTSLSHGKDIILIGAEIEHIRNYFTIQEFRFFNKFDTKVEVDEEILNYETVKLILQP
LVENAIYHGVRRMKTRGLIEIKGKEKEGAVVLEVIDNGVGMTAEKVNHINNVLTGIEKIE
DENEYFGIRNVNERIKLTYGMEYGIYFKSKPNAGTTVTVILPIVKI
>PK3-045_04347 hypothetical protein
MSRLGEESMKNKGYILFVILLIFVSACENKQATSIRIKNNPHEQAIYKEPLLNQDKEKII
SFVTKSLDNPVFIEAKEEAERVSSQLGVKMEWLAPMVVDSQEQAKIVESLIERKVDGIVI
SVLDTKKMTPLINKAVSQGIKVATFDSDAPVSNRAFYVGTNNYELGQESGKSLVKIVKEK
KLHQRHLRVLIMTGVKESVNMQERIEGFKDATEELDLEFVDMVESYDDINRASELLENYV
KKNPHFDLFFSAGAWPLFSPPEGMISYKRWKETGGIAVIVDTFYPIVFAANKGLADALVG
QDFQEMGRLSVENMYKLINGDKVKETMIYTGLEYGNADNYEELLKRKKPWEIK
>PK3-045_04348 Phosphate-specific transport system accessory protein PhoU 
MVIRENFEKKLGELKQKISEMGEMSITQLEEAFDALKAQDVEIALNVMEEDNDIDNLESE
INHFAIWLMAKEQPVARDLRVVIGVIKISSEIERVADFAVNIAKATIKIGKATSLLDLTH
LEKMKELSIEMLQKAVKSFIEEDIVLAKEVSKLEDKVDDYYLETYKKLTAYLSEHPEETN
QLVQLLFINRYLERTADHITNMAESTGYLIKGKIYDFNS
>PK3-045_04349 Phosphate import ATP-binding protein PstB 3
MTTTVTEKSQKKTGKAFLKVGQEDTTGASKISVSDLNLFYGEKQALFGVTLDIEEKKVTA
LIGPSGCGKSTFLRTLNRMNDLIDGVKIAGDIIIDGENIYSSNDVIKLRTRVGMVFQKPN
LFPMSIYDNVAYGPRMQGIKNKKELNKIVEESLRGAAIWDEVKDRLKTSALGLSGGQQQR
VCIARAIAMKPDIILMDEPTSALDPISTLKVEELITKMKKDYTIVIVTHNMQQAARISDK
TAFFLNGEVVEYDETNKIFSTPRDQRTEDYVTGRFG
>PK3-045_04350 Phosphate transport system permease protein PstA
MRKMKDNLLRGLLWFSAFLSVAVLVMIVGYIFYKGAHLLSFDFIFGDYSPSGGGGIWPMI
VTTIYTIVISLLIATPIGILAAVYLQEYAKQGRLVKIIRFATESLTGIPSIIYGLFGAVF
FVTTLKLGMSILAASLTLTIIVLPVIIRTTEESLKTVPPTYREGSLALGTTRLQTLYKVI
LPSAMPGILSGIILSIGRIVGESAAIFLTAGTVAAMPEGLLSSARTLTVHSFLVTQESGD
IELAAAVGIVLIVIILAINLIATFISKKLNKADY
>PK3-045_04351 hypothetical protein
MSIQTTEKQASAMGKANKRKYMFEKVSARVFLFCALLSVISLVLIIGFVFYKGAHPFIAE
GFNFFDFLFGVDWVPSEGEFGIWPMIVASLYATIGALIIGVPIGLFTAIFLAEIASKPIA
KIVSPAIQLLAGIPSVLYGVFGLAIIVPFLQNTLGLVKGQSLLAVILVLAIMMLPTIVTV
AETAIRAVPKTYREGSLALGVSEIGTIFKVVVPAAKSGIMTAIVLGLGRAIGETMAVILV
AGNSLIVPTSLTDSIRPLTTNIALEMGYAAGTHQEMLFATGIVLFSFILILNFVLAKISA
KGGK
>PK3-045_04352 Phosphate-binding protein PstS
MVIIKKLKIVLSLLSILLLLSACSSNEETEQSTNDSKPISISGSTSVGPLAEKLAAKYHE
HDQTKIEINQIGSSAGITNAMSGVSEIGMSSRDLKDEEKGKLKEVVIAYDGIVVVTHPSN
KVKELTLEQVKQIFTGKVTNWSQLGGDDMEIVVVSREDGSGSRDAFQEIVGYSSGELIRN
SIIASGNGNIKTTVANNKHAVGFISFEYIDDAISTIDIDGVAATAENVLEQKYKLSRPFL
FVYKDGNLTANGQKFIDFILSDEGQKIAAEAGAIPIK
>PK3-045_04353 NADH pyrophosphatase
MFIVNVEGAVRRADKWLIVERSRKEEHAGGMLSLVGGKVDLEGNSIDILERTVKREILEE
VGVTVRDKMEYVHSTSFVTESGKHVIDIVFLCEHEQGEAFVKSPDEVENIEWLTTEEVLD
HSHAPSYVKESIKRAAVLLQA
>PK3-045_04354 hypothetical protein
MSIEREYLQAVVNRFKEVKKLGDNTFEQIGEKEINWTYNSSSNSIAIIVKHMSGNMISRW
TDFLNTDGEKEYRNREEEFTDNISSKKELHTVWENGWKVLIDSLTNLKEEDLLKTIYIRG
EGHLVLEAIERQMAHYAYHVGQIVYIGKFIKDTEWKSLSIPKGKSEEYLIEMKEKHKKGI
VE
>PK3-045_04355 hypothetical protein
MKELTQVFQDRKAELASALFEHIQISFIALFFAVIIAIPLGIYITRHRKVAEGIVGITSV
IQTIPSLALLGILIPLFGIGRVPAIIALVAYALLPILRNTYTGIKEVDPSLIEAARAMGM
NTRRRLFKVEIPLAMPVIMAGIRTAMVLIVGTATLAALIGAGGLGDIILLGIDRNNTNLI
LLGAIPAALLALLFDYLLKKFEQLSYKKAFISIGVIALLSLVIILMPLIGQKDEEIVIGG
KLGSEPEILINMYKILIEEKTDLQVELKPGLGKTSFVFQALQTGSIDLYPEFTGTAISEF
LKETATSTNREEVYRQARDGMLEKYQMIMLEPMQYNNTYALAVSKNLADQFQLESISDLK
GIEEQIQAGFTLEFSDREDGYQGIQHLYGLTFPNLVTMEPKLRYVAVESGEINLVDAYST
DSELQQYQLKVLEDDQNLFPPYQGAPLMKEETAKEHPEMVEALNQLAGKISDDDMRKMNY
QVNVEGESPREVAEQYLENAGIVQ
>PK3-045_04356 Osmoprotectant import ATP-binding protein OsmV
MIKFENVSKRYTDGTAAVDSIEFEIKQGEFFVIIGPSGCGKTTTLKMINRLIPLSDGTIY
IKGKKISEYDIHELRWNIGYVLQQIALFPHMTIEENIAIVPELKQWERDRIKQRTEELLD
MVGLDHQTYANRKPSELSGGEQQRVGVIRALAADPEILLMDEPFSALDPLSREKLQDDML
DLKKNLKKTTVFVTHDMQEALKLADRICIMKKGKIVQIGTPQELITNPTNDFVKNFVGNK
HDSWSNDFQLKDLLEPIIEKEDKQINQVSAPITTTMQEIVDMLVKYEQVIIERDGTPIGL
VNRRSMMKYVSSRLLQKGV
>PK3-045_04357 hypothetical protein
MDKQGQEKFLAFILQRVQEGKEEEAKAILMDNFRKQDEGTFSKNDIEQFLPKMISLIKPE
RLEEIQAVVKQFSGSFGSK
>PK3-045_04358 hypothetical protein
MNGHFKEIFGSAINTIGTIQAAIGSTPSFHLSRETNYQLRLVGNILQGTGSALQADGQGT
ISLEKLGDEIQAIGNSTVVTGLLLYKWSNTPTEQKLIITGNWLQALGSFVGLTDEFFDHT
ADGRIENIIGGLLQGIGNSLQAISGTEQLHGISNHDQQNIGVLGSWIQAVGSAISLIGQV
KEELEEIALNINE
>PK3-045_04359 hypothetical protein
MNFVAWMIVASEIGFWIVIILGLLIRYVFKREKLGFFFLALTPVIDLLLLITTSLDMYRG
ATATTAHAIAAVYIGVSIAFGKDMIKWADERFRYYVAKQGTKPISLFGMAYAKHYLKSWG
KHVLAYAIGAGILLGLIFFIKDTARTEALDGVLKLWTVVLGIDLIIAISNFIWPKKKKG
>PK3-045_04360 hypothetical protein
MGRNIYRSRPFCSRYKFPLILTKKAASPQKLAWIAPFLTLILLGLGCAFIGIGWSDNVAA
SLDYFEKGAEEKVIILEEYKVDYPSGMYGGAIDYVYTGVDGEKLITNTDFNIQVFQNEKY
EIRYLPRTKYIMGISHIKEENF
>PK3-045_04361 Aryl-alcohol dehydrogenase
MKIKAAVTPGQGKDFLLEEVELAAPKANEVLVKIVATGVCHTDAVARDAAIAPLPAVLGH
EGAGIVEEVGSGVTRLAKGDHVVLSFAHCGHCENCLTGHPTVCETFNDLNFGGAHDDHTH
RLSKDGKPLSTFFGQSSFGTFAIAHERNVVKVDKEVDLALLGPLGCGIQTGAGTVLNKIK
PEFGATIAIYGAGAVGLSAIMAAKIVGCKTIIAVDIHDSRLGLAKELGATHTFNGTKVDV
VKEIKELTTGGTKYAVDTTGFPPVVRQCLQALRPLGVAAVVGVTPEMNIDVHNDIMAEGK
TMMGVIEGDSVPNVFIPQLVEYYKNGQFPFDKLVKFYDFDQINEAFEASKNGEVIKPILR
IS
>PK3-045_04362 HTH-type transcriptional regulator GltC
MQLLQLHYFLTVAKTEHMSQAALHLDISQSSLSKTIARLEEDLGVPLFNRNGKNIRLNNY
GKFYAKEVEHALRILEDAHETIQEMAEIEEDQVSVSVMSSTILPSIFKRFYERRPNVRIQ
QSILPDFIAKERLMRGEIELCVSNTPITGPDIEWLPILKERLDLIVPKNHRLAHLDEIDL
QDVKNERFIGYKSGLESTSMFEQCCIQAGFTPNIVFEGTELSIVLQLVDEGQGISFYPQY
SFLGKQLTNSKIIRLKNPHCYQMVGFAWLKNRHYSYVARQFRQHMIDSFKEINKKN
>PK3-045_04363 hypothetical protein
MLHTYLGETIRYEIKYKNRTSIGITMDGYGNIEILAPKKTPDEYVHQVLEQNWNQIQTRI
KEMQTRMAGPQKKVYENKERFLYLGNTYPIHIIQEMAVVQEQVKFEEDKLCIYIKEYDKK
KIKKLLKRYYYQQSKSLVEERVSFYQSNFKTKPRSIRITDSKTNWGTCDSNFQLTFNWRL
AMAPIEVIDYVVVHEMCHMVHLNHDRSFWRLVGKIMPNYKEKEKWLALSNWKMTV
>PK3-045_04364 hypothetical protein
MENNDILIRLRYALEIKNSEMEEIFKLGGKEVSVPEVVRILKKTDEEAENDDQIKLTNSM
LDSFLNGFIIYKRGKQEPKPGQPNTPESSIKNNTSVNNILLKKVKIALSLTTEDMIDIFK
KAGLNVSKGELGAFLRKEGHKNYKVCLDNFARNFLKGLAIKYRG
>PK3-045_04365 hypothetical protein
MIFFFMGITNKKGNKQMIGLFIAIIGVNIFAFKVNKYVTKAQMVSIWAFTVAFQAGFDIY
ISFKYHGYWYFDKDAIEWIGLLPHLALVPPVNIIFLNWYPFKKSFIKRLIYFACWTIGIL
IYEVITLLPEPWGYFHYGWWNVWISVMVDPVLLYILLLYYKWISKLDNLPN
>PK3-045_04366 Sensor histidine kinase RcsC
MKEFKNNVNRKIYYIIVWTVIAIIIAGLFINNPRLDDFGVAYVFQLIMAFCLSLCLLLYP
KNGTDSYRLIIILLGSTYFYTLCILYPETGSNFILLCFIPMLSILFFNSKLFYFSLFLNS
FFILLLFAYILFVNQKSQYSYIEQDVIGNLLSFLASQIIVYFIFYLTNVRMKRQHVYDEQ
IQHSERLKTSGQLAAAVAHEIRNPLTVVKGFLQFYKEDHSFTPNQKHHFALMIDELNMAE
EVISQFLTMAKPEQEKVTEIVDIKAVLQSVTDLLHSYGHLHDNQIELNVTDDCIVSANII
ELKQLFINIIKNAIEASKYGDLVRVTAKREQDFVVINVIDYGKGMSEEEIAFLGTPFYSL
KRKGTGLGLMICFNIVEKYNGELKFKSLKDYGTTTIIRFPYYLV
>PK3-045_04367 hypothetical protein
MKIMKYSKTLLILSMIVPWVTVPLLGKNTLKRYIAASTFIALMVRVTNIVAKRRKWWWWY
EKIHQILPGDIPFMLGSFFVGSIWILKWTYGKFFTYMGINMAFDSMFTYVIVPYLTKFGI
ASLVRISKMQLMYVFTVLALILYAFQFLYEKIPFNRWKLKHTE
>PK3-045_04368 hypothetical protein
MKRRNKRNLSVITIIAILFSLFSPVANLNVKAETVVATDLIISEYIEGSSFNKAIELYNG
TGADLDLSQYSLGIHTNGAEKISHKLSLNGTLKNGETYVIYHGQADEKIKAKGNLENSTV
INFNGNDPLVLLKGESIIDSLGQVGSNADFAKDVTLIRNSDVLSGDKNIKDSFDRNVEWT
NKGINSFDNLGIHTFGTAAPEEPTEPAEPEPAISIADARELGTGKTVTIEGIVTTNSGLW
GSETFYMQDSTAGMYVYASPKSVKPGEKIKITGVLKTYKNELEIEPESLDIVSSDNDLPE
AQSVTEVTDSTQGELLTLQNVTISEMTKDSYGTATFQAVFESGEKVRVIHDNRTGSTYDD
LIKQYKEGDKVHLTGIGSIDETGYHLKTTGLNSYDLVNKPAVYSTQTPGVVPAGTEVELN
SGLEDAAIYYTTDGSTPTEKSTKYTQPISLKTGETTIKAIAVTNGTVSDVFSFTFKILNT
ENLRIHDIQGKGHISEYNGSSVTDITGVVTHVFGSSSFVMQDVDGADTDIETSEAIEVYK
SSHGVSVGDKVSVNGTVTEYGGGANLSKTQITATSITKDGTAELPAPLIIGKDIFPPNKV
IDNDEMTSFDPDEDGIDFWESLEYMRVSFPNALVVGPPYSNDVPIIVESTTNNTLNNQGG
LNIAEDDYNPEKIFLDNVGSDFQPGDKFNGDVIGVVTYSSNGYQLSVNKNELPTLTKSNL
TQEVTHIVPAEDKLTVASYNIENFSNNKANTPDAKVAKIAKSFVENMKSPDIITLVEVQD
NDGETDSGNSDASESYQRLINAIVAAGGPAYKWIDVAPVNNTNGGAPGGNIRVGHLYNPE
RVTLVEGTKGKATEANGWTETGNLTLNPGVINPEAFTNTRKPLAAEFEFKGQRVVVIGNH
LNSKGGDQTLWGANQPPVLSSEAERIKLAQEVNNFIKEGLVKNPNLNVVVTGDMNDFEFT
PALKALKGEILTNMVEKVPAEDRFSYFFQGNNQVLDHILVTNRLANVTTADMIHINANFT
EATGQASDHDPVMVQLDLSNLPEVPDLTIMHTNDIHSALDNIPKTVTAVKEIRAANPDAL
LLHAGDQFTGTLYFNEFQGKADLAMLNLLGIDAMTFGNHEFDLGSSAEGHQALADFIKGA
NFPFVSANVDFSKDGKFTGLQNKSIESNSENGKIYNGIVKEVNGEKVGIFGLTTAETADI
SSPGSIAFENYLKEAEKAVEAFEEAGVNRIVALTHIGYDDNAAIDNDLILAEKVEGIDVI
VGGHSHTTLEKPVIVDEDETPTLIVQTGNSNSNLGVVNVTFDENDVVKTYDGHLVAIGAQ
EEDEEAVKVLEPFKEKINQVAKTEIGVSSPIALESPRTNGDDTKPSVRKNETILGNLITD
GMLEKSRTFTGKNIIMALQNGGGIRAAIDKGPITVGEIITVLPFNNTLATMDVTGAELKE
AFEISLGQYPTENGGFLHVAGGKVVYDETKLPGERIVSVSYLNEAGKYVEVQDDTMYTIA
TNAFTAKGGDGYDVFAKAYAEGRVTDLGLSDWENFRDHLVSIGSEGIPTEVEGRIIDVSQ
EPGEEPGEEPGEEPGQEPGEEPGKEPGQGPGEKPGNKPGEKPGNSNKVKEIKPKVIKDGS
KYKISDSALANIADNAVVVIKLDNKINATFTLTKEQVQALQKAGASIVVSNGNVEVQIPA
SVLPLAENVNINVKKMEVKGSIIAYDFTIEADGKTYHEFDDKVKLTFKVDPKQVKNPKNV
KVYYWNEKAGKWELIGGDYKNGKVSVYTDHFSTYGVFEGQPKSSNVPAHQANELPDTATN
NFNILVAGFMLLIVGIGLYFVKRRKTNF
>PK3-045_04369 hypothetical protein
MSGVILIFKIRIQFRAEFFNSAFFSRKLAYFIFIHVGSISKYLKEC
>PK3-045_04370 Cysteine/O-acetylserine efflux protein
MPFLSFLLFVLVSSFTPGPNNFMAMSFANKYGFKKTIKFSLGVSAGFFVLALMCSIFNLL
LISILPIIKLPLTILGVGYILYLAYKTLTSKSIHNNNEKNDETNKNLFLIGVLIQFINPK
GILYGITVVSTFILPYYTSYFSYFIFSLFLGIIGFLSSLCWSIFGSIFQKSLSKYQKPFN
IIMALLLIYSAISIVLH
>PK3-045_04371 Extracellular exo-alpha-(1->5)-L-arabinofuranosidase
MSKLTFYNPILEPGADPWVYKDNNTYYFMVTKRTRLDLWKSPTLSGIAKGSCKTIWSAPN
EGINCANIWAPEIHRINGKWFIYFTANDGIGDDQSRKIFVLENSAEDPFNGDWVEKGYVN
TEYPGLDGTIFEHKSRLYFIYAGYGNFPEYGSALYIAEMENPWTLTGPNVLLSKPEYDWE
KQGGMAINEGPVMLKRNNKLFLIYSASTTWSDDYSLGMLTISENEDVMNPEVWLKSTEPV
FKKSIENKVFAPGHNSFTQSPDGTEDWIVYHAISESEGGSQRRSTRIQKFNWNADGSPNF
GIPLCTSTPITIPSGE
>PK3-045_04372 putative ABC transporter ATP-binding protein YbiT
MSVLNVKNLSHGFGDRAIFNDVSFRLLKGEHVGLVGANGEGKSTFMNIVTGKLQPDEGKI
EWSRKVRVGYLDQHAVLQKGTTMREALSTAFQYLFDAETEINELYAKMGDEGADIDALLA
EVGELQETLDSNDFYQINAKVEEVARGLGLDDVGLDRDVADLSGGQRTKVLLAKLLLEKP
EILLLDEPTNYLDEQHIEWLKRYLQEYENAFILISHDIPFLNSVVNLIYHMENQELNRYA
GDYDNFLKIYEMKKQQLESAYKRQQQEIANLKDFVARNKASVATRNMAMSRQKKLDKMDI
IELGKEKPKPEFKFKEARAASRWIFETEDLVIGYNEPLSRPLNLKMERGQKIAFVGANGI
GKSTLLKSILGLINPLSGKVERGDYQHIGYFEQEVKESNYNTCIEEIWSEFPSMNQAEVR
AALAKCGLTTKHIESKIEVLSGGEKAKVRLCKILNTETNLLILDEPTNHLDVDAKEELKR
ALKEYRGSILMVSHEPDFYREIATDIWNCEDWTTKVF
>PK3-045_04373 hypothetical protein
MNRYSKHIFLSLILIVIMAIFSWLTEQTARADSMIDRLQPNEYESGRNQKNTDFLKESSQ
SSKTDGLTAEKRAISFDGSKANDHDKWKGQLFTQKVETGSSITRKAEELQLFTDDEENVH
YRVDSVGAENSTELSMALLIGILISICLLLLIFILFVFYRSNLKVMRKGNL
>PK3-045_04374 ESX secretion system protein YueB
MGKVKLWKMVIALVVIIGVPVLFFQLIGDHPFLEKPNTTKTIAIVNEDAGVDIAGEHRLL
GGDVSSILSNESSFQWTVVSRSAGENGLRNKKYDAVIYIPSNFSEQVMAYEEENPSKVTF
KYNVQSQLNAVNTEKVNLEIERATKRANERISSLYWNYVAKDMEMVRSEFEEILQKEIDF
QQTMLAFYKPSSKNLADEILEQEGVLKSMKSSIEQIGTQSDSQNQSMKSFSEDLSSLVDY
IKAYEEYQQQQKQKLTDLQTTALSTVQSATEASSPYFAEQSLFLSENNQQLMSNVNSVYE
KLDNSKRLLTLLKENRLLALDKQREAILDYQSRMLDYYKQLIDTESLNSFQEKIVKTKEK
LAEGEGSLLPEAPPENPESPNLPTSDEDKDTDDQTGEEFVLKSTQHTKGNSNTDNGANRE
TKSLSAEEQLAQMEELLKKLHEYIQADQQIPDESKSQFEIQLKDIQKNLQDVKQSLKTSD
EGNNQIIQQLKEKIAALLTDNETLANTIKELTENKNSLTEENRLLKEYIESLIEVNDELR
EQLTLLTNNMNSIIARIEEKEEAILASPALSGDRRLILETWFHKEFLTGDIMDLLYYYAY
LDQYETTLNNMLSENKAKSEVMKNEQFLTELTRIFQLTDAETTDWTNVEAEIPTIGDGLT
ALQDQFVVFLAKSKESLDTHHTELTQNLSEIKTEGEALLQQIQQGEQTTTHEPGSAKGTQ
LVTVHSQIIEQVNAIHSSIKDAGKHQQTVIDHTNELHDEVSFVQTDADALNNKWAVNVDS
TRKIKDDVFSVLQNAFIEGRSKGDVYNFLSSPLQLTAGASEVKQEKNIPPVVIMFIVLIS
SLLIGYTTYYFKRIPLWFRGTVFLLLNLIVGFVISLYGLNIYELSQASTMQWTVFTILLL
LVSSSIIAVSFAAQKLLGLFLTVGLIILYVTPLLALTTPNFSYDDPMSKVYMSIQYGTQS
LFAPAAIILLIGLLILIGVQILIERWKSNEIEDDSRNESI
>PK3-045_04375 ESX secretion system protein EccC
MYTLFVFHEQTYYSIKLTKNSSITIGPEFGDNITLPSFPSSILVKVGEDDRAIYRIDSTE
TVMGTEKFYQLSLESQSLTLFMTSRKKLEKTYYIGNQSEVVCMVEPVSKDEECHFEKKSI
YIKKAHMQHGAKGLSLIKNQKYWEIISRDSTVYLNGHMVLDKQKLEVGDILFWNGIYVTL
MDQDVIQIESFYEFESSLKEISLPQSEMMKRYPNYRRTPRMLYELPKEKVQLSFPGQESM
QSKRSLWLIILPPLVMMIVMGLVALLIPRGIFILISIVMFSMTIITSTIQYFKEKTSRKE
QEERRKRVYSNYLEEKRRELESLASKQRQVLEFHFPSFERMKYLTEQISDRIWERSIDSK
DFLQFRLGTGDVPASYQISVNSADLSNREMDELLERSKHLQKTYQHVKNLPITADLSKGS
IGLIGKMSVLKGELHQIIGQLAFFHSYHDVRFLFIFHEEEYKYWEWMKWLPHFQIPQSFA
KGFIYNEQTRDQLLSSIYELIRERDVEETDEKTRFAPHFVFIVTNQELLAEHVILEYLEG
SYSHLGISAIFAGEAKESFSNNIHTLIRYVNGRQGDILIQNKAAVQIPFNLDNHALNGNE
EYARMLKTLNHQVGVTNSIPETVSFMEMLKAKDVDEIPIKENWLTNESAKTLAAPIGLKG
KSDIVYLNLHEKAHGPHGLLAGTTGSGKSELLQTYILSLAVHYHPHEVAFLLIDYKGGGM
AQPFRNMPHLLGTITNIEGSRNFSNRALASIKSELKRRQRLFDKYEVNHINDYTSMYKRG
EIEEPLPHLFLISDEFAELKSEEPDFIKELVSAARIGRSLGVHLILATQKPGGVIDSQIW
SNARFRIALKVQNAEDSREILKNSDAASLTITGRGYLQVGNNEVYELFQSAWSGANYQED
TSQMEDEIAIVSDLGLIPLSELSVQEKTKVQASSEIDVIVGKIEELQKELQLTKLSSPWL
PPLSPRIYRPDYQPDENYRKINLAMIDDPEAQSQSIYPYTLLEDGNVGVFGTSGYGKTQS
LITLLMGIAENYSPEEVHFYLMDFGNGGLMPLKQLPHVGELFLMDEQQKINKFMAILQNE
INLRKQLFQQTEVSSISMYNQLNDETLPVWFIVIDNYDIVKDEMADLEAQINQFARDGQS
LGIYMFFGATRVSSIRPSLMNNLKTKIVHYLMDHTEAYSILGRIPYEPEPIPGRAIIKKE
GTYFTQILLSCIGDNDFDQLTELKASIQNLREKYESCRTPQRVPMLPKELTNISFKEYIK
EETSVGLLPIGLDEESVQPVFVDFHAMNHFMILGQAQKGKTNVIKLLINHAIQQGMEGIG
IWDSINRGLAYLAEDDRVQYLTDRGTVAKWLESTEAMLLERNRQYDKAILEGKALPIFTP
LLFVVDGYGRLLQEIDNRMQEMIVRLMKNYSHLGFQIVVSGSTNELTKGYDPLTLEIKQI
RQALLLMKKSEQSLYTLSYERKEPEIQPGYGYYVKNGLERKIQIPLVLMERKVYS
>PK3-045_04376 Type VII secretion system protein EssB
MSNEHVSYMEKKLDAVIQKEDQRIIFNFQIEKIKLNHLLEAAFLEDIDSQVKRTLNKHED
LLQIEVQLPKSFIYNQGIFSLKKKEQYIIAHQLLEKVRNHSLSRLHLFICPENIAVDQGL
APYFLHYGVKESIPPYEDNREEEWLQLKAMTAALIDNQYSFEQYIAYYETLKLSEAAVAI
MKANNYDDLQAVLDQAFLQEKKEYEQLVELPKNKWKQMKYAVWATSILLVPAIIYSIYTL
FFLQPKHNHIMDAQQHFLADAYSDVITSLESYDIDSLPTVAQYELATAYIYSADLSDKQR
DIVKNTVTLQSDSNYYEYWINIGRGDAEAALENARLLEDRSLIMYALLEYQAHVQRDDSL
TSEERQQQIDKIENELNKYEQDMKEESSQKDTLLKKDQTTKDQGQNPK
>PK3-045_04377 ESX secretion system protein YukD
MYIEVTVDLSKYNGEYLELRLSDYHTVKKLVDIAWKTTNRLDTPRNGYWIKVMNKKRVFS
GEKRLADIGIMTGDKIQIL
>PK3-045_04378 Protein YukE
MSGIIRVTPEELVGMADRYSSEGSQVGDQISRLDNMIQELETMWEGQSSRAFSEQYQSLR
PSFVDMQQLLEEISSQLKSTAKALEDADAQIANQIRG
>PK3-045_04379 hypothetical protein
MTKLLYSIITVVLMLVGCSNDSSTSEKQETKGNVNKEEISYKDKQGEIVDFINNDIQKII
AYETEANQQLATVSGDNYNSDKELYEVLTSKVIPTYEKAVNEARDLQVSTEELEPMKSKI
KEATSTYYEALILEKKALEKKDKGLIEESNKKGQEYIELINSYHEEMKKLASKYEIDYQK
N
>PK3-045_04380 hypothetical protein
MKKIVSFFGEPYHIIWSEFHYLANLKKDSGTNAKEKGRIAQLQVFNTLLLVIYSLFLVIF
FVYIILLFIVKLYALSGIIVGLLMMTIIKLVQKKKYLKRRNAFIKNDPTLIES
>PK3-045_04381 hypothetical protein
MSQEVNSLIIDKGTELLPIGTIVLLDIFSQPLMIYGRMQQQAEKNKIWQYVACPYPQGHI
SDETNVFFNHEQIKQVIFKGLESEGEKLMREKLNSFHLRDEK
>PK3-045_04382 hypothetical protein
MKVLEVASLEEYLDQTIKSFKEKVEQIHSLEQSVMELVGLDGSFHGKGAESIKFFYESSH
KPFLVKLKQVIQDYQEKISKCREAINSFEPNEDGFIRQSFLQEELSDRLTSVQNYTNDVI
ADGNSVMEKISDIISLASLDDSMFNSEIKNAKNKIAETINQLETIDRQNADSFNEIKSDL
AIMQSYLSELNTNVNLNPELIRHFSPYNLLTSTSHFLLVSSIKPSNSRFDSNPPYRNDSQ
KSIFLLDAYGQYPYRWLGLNYTSSSEKEEVDKEINEDGFLVGDKVTKGDFSAEGGLGKIE
NDWSGFDDFKNGSGQLGGASSFRGIHAGLEYDTTILDSSFSQDILFAEGQASVGGSSILP
IAKAGGSVYTAQVKSQIDKEVDFVGSTGLEAKGEILKANAFAGVDGSSVGFGAKASVAEG
EVSGIAPIPFTDYTIKGTVGASAVGIGGEAKVGKEIVLDLRLLLGVKIGISFEKEE
>PK3-045_04383 hypothetical protein
MGEIKFDYSGIESVLKKMDTNITAFQANLPENNAKNNKLDLLTELEEVNASFVKIMNEYK
TLLLKNANTVRDSVTLMRETDEALRDVISSEVLR
>PK3-045_04384 hypothetical protein
MSIFYYYGLLQEKEDQLRRLKNGKSDLKAIKHEMTSYSDNVVKPDLSASTWHGTLAVEFE
NIRTKGAFQQYQDIEIKQLPNRISEINEKINSLQSEMNSIRHTIHELEEEREKEMKRKQK
KK
>PK3-045_04385 Spore germination protein YndE
MVLKEKISLNQLFHIVIGFNLGSSLIIGIGINAKQDAWIAVLCSSIIGILIALFYYHFQE
ILPNKHFSEILEYILNRPISIFITYIYTLYFFYLAARVIRDFGELVTTFILPNTPIEVCS
LSFVIILTYIIYLGVEVLGRVTEVFTPYSILFIILVTILLFGNNDIKLERVTPILATGVK
PLLNTIFPYELIRPYGQLFALTFLFSHLPKQQYARHTLVYSVLSSGFWLTIGTFIVTTSL
GPYVASRSTFPFVSATRLISIGDFLQRLDAFAIFIIALGVVIKICIFSFAALKGLEYIFK
LPYRVLVIPMMCILTICSSLISINFSDHITESITVVPYFLSLPLFFLLPSLFMVLALIKK
KKDA
>PK3-045_04386 UDP-galactopyranose mutase
MMFDYLVVGSGLFGSTFAYEAAKKGKSVKVIERRNHIGGNIYTENIEGINVHKYGAHIFH
TNDKEIWNYVNQFAEFNRYTNSPIANYRGEIYNLPFNMNTFNRLWGVATPEEAKKKIEEQ
RKNANIGNPTNLEEQAISLVGTDIYEILIKGYTEKQWGRKATELPSFIIKRLPVRFTYDN
NYFNDRYQGIPIGGYTQIIEKMLSSKLIDVEVNQDFFTNKDEYVKSYSKIIYTGMIDQFF
DYQYGKLEYRSLHFESSILNQENYQGNAVVNYTDAETPFTRIIEHKHFEFGNQPNTVITK
EYPKGWEEGDEPYYPVNDNKNNEKYRKYQRLAEEHPNIIFGGRLGMYKYFDMHQVIASAL
AVVKKELS
>PK3-045_04387 hypothetical protein
MKVLSVVIPCYNSEEYMRYCIESLLPGGESVELLIVNDGSIDQTAVLADEYAAMYPTIIK
AIHQENGGHGEAVNAGIRHASGLYLKVVDSDDWVDTKAYLKILQKLNEFVAGNKLVDMVI
SNFVYEKEGAKYKKVMKYENVLPVGEIFTWDDIQPFRKGQYLLMHSLMYRTQLLKESGLE
LPKHTFYVDNLFVYVPLEHVKTMYYINVEFYRYYIGREDQSVHESIMIKRIDQQIKVNKL
MIDLVQLDEIANPNLRQYLLHHLEIVTVISAILLIRSGTAENLQKKKELWRYIKEKDLAL
YREIRYGMMGQLMNLPGRPGRSISVGAYKLSQKLVGFN
>PK3-045_04388 hypothetical protein
MSNLNTEKPKKLSGPIGFWKNYKKKHPNIAQFLVFFMLSNGITVLQLVFMPVFKSIFAKT
DLVSTSFQVLQFGHNFDGTPYYVFDYAAGSLASGGGGGLAYFLAVQITIAIAQILNFFAQ
RSITFKSNSNIWTAAFWYLLAYIVITIGAAAAQGFYKAPIYNLLMNTWEMGAVGETTADV
ITMIINSAISFWVFFPIFKIIFKQEK
>PK3-045_04389 Beta-hexosaminidase
MKYKDLIKKMTLEEKASLMSGKDFWQSMDIERLNIPNMFLADGPHGIRKQAEAADHLGLN
ESIPATCFPTAATVANSWNEELTEKIGDNLGQEAVAQKVNVLLGPGINMKRNPLAGRNFE
YFSEDPYLAGKMAASMIRGIQTHGISACVKHFAANNQEERRMSIDTIVDERTLREIYLTA
FEIAIKEGKTKTVMSAYNMLNGAYTNENLHLMRDILRDEWNYEGVVVTDWGGSNDRVAGL
IAGNELEMPTTAGETNQEIIQAIKDGTMSEEVLDECVNRLLDLIFTSNEAFSKPQKEFSV
DEHHMVAQQVAEESIVLLKNEENILPLSKDKKVAVIGDFAKNARYQGAGSSIVNPTILDQ
TLDYLEEAGITSIGFEPGFNRYGRKSQKKIDNACELAKNADVVLLYIGLDEVTEAEGLDR
QSMEIPENQINLLNSLYKVNPNIVAVLSCGAVVEMPWINKVKGLVHGYLAGQAGARAILR
VLSGEVNPSGKLAETYPLKYEDTPSYYHFPGKEVSVEYRESIFIGYRYYDIANVNVLFPF
GYGLSYTTFEYSDLKVNKDGVNFNLTNTGNRAGMEVVQLYVGCKSGAIFRANKELKGFKK
IFLHPGETKSVAIPFDDKTFRYFNVKTNKWEIEEANYEIMIGASSEDIRLVDIQFIKGTG
APLPYDRMKLPSYYTGKVNSVSVGEFENLLGHKVPLSQWNRSKPLGYNDTIAQCQYAKGR
FARFAFHVITFAHWFLRKIGKRSTANLIMMSIYHMPFRGVARMTGGIINMPMLDGILMIV
NGQFFKGLRHVLKERSRMLKADKTEKTIAGTAKEL
>PK3-045_04390 Beta-hexosaminidase
MAKKKMSKKKFRIVWSSILSFLIIIIVAANVALAQFSDVISAYFSTIDLESAEAVKAREN
SEIVVEQIADEGIVLLQNNENALPLSEGKKVNVFGWSFTNPIYGGTGSGASDASKAVTPK
DGLEGAGFKVNEELYKAYVDTGIERPLVGMDGQDWTIPEPKPSDFYTDELMQQAKGFSDV
AIIFLARSGGEGADLPRSMDGPDTFDPEGGAFGATGQKFGNEDDLDTSKHYLELSNREQG
MIDAVTENFDNVILVVNSANTFELGWVENYSQIKSILNVAGPGQNGFNALGRVLSGEVNP
SGRTVDLYTKDLLDAPAMANFGDFDYVFENNDGSYSQAVDSSNVLLKYVDYSEGIYVGYR
FYETAADLGFINYDEKVQYPFGYGLSYSNFEQEVVQDSLNWTDTEVTVDVNVTNTGSVEG
KEVVQLYFSAPYTGRIEKSSIDLIAFEKTDVIKPGESETVTLTFKVEDMASYDANKEYSK
TGSYVLEAGEYKLMLMSNSHDKIADVGSKELAEVVYDSGRSTDKQVAVNQFDDEVTGEGS
ITNYLTRADNFAGLAKMDKNKEFTVTTPEGEKKTVQGKIVDKEFVKLINSIRYDVPSDTH
DAAPTTGADNGKTLKDFVGVDFNDKSWNELLDQFTVDELVKLATLGGYRTLEIESVGKPA
TLDYDGPAAINNMNMAANGQSGTAFPAEIMIASTWNLELAKAMGEHIGAEAKAYGVTGWY
APGINVHRTAFAGRNFEYYSEDGLLSGKMAAAVTKGYQSEGGYVYIKHFALNDQETNRTL
GVLTWSNEQAIREIYLKPFEIAVKEGGAKAVMSSFNSVGNKWAGADDGLLKEVLRKEWGF
NGHVITDFYMNGSGLNTYPYMNVELAVRNGNDLMLTGAAPMGVPEVNTSSNDTLWALRDA
AHNILYTTANSSAIEGNLSAETPKWVVITIIVDILLVLGIATAFFFVFRNSKKRDEELEN
TRSA
>PK3-045_04391 hypothetical protein
MNDVLPDIPRILTALAEWLACLVYISILAKKLYGWRLVAFSSGALIIQSVFLVITKDLPI
VFWVPCMVVAMGMMFLLIYMCCDISMIEAGYFSVRAFVAAEFVASLEWQVRFFFWNAESS
DIFLELLLLLFVYAFLFLSLWLLEKRHIPTEGRLNIRKREFWSTIMTGIAVFAISNLSFV
TSRTPFSGQYAKEILNIRTLVDLGGLSILYAYHIQINDLRTRHELKAVQDILQNQYAQYQ
LSKESIEMINFKYHDLKNQLIALRAEENVDKRNEFLEKMENDIKFYEAQNKTGNHVLDTV
LTSKNLYCIKNGITLTCVADGTLLNDMDVVDITTIFGNALDNAIEHVQQIKEAEKRLIHV
SVFTQKKFLMIRIENYFEGDLKLEAGLPVTTKKDSFNHGYGLKSIRYTVQKYDGVVSVDQ
KGKWFELKIFMPILN
>PK3-045_04392 Transcriptional regulatory protein YpdB
MIRIAIVEDDVKYKEQLIEYIRRFEQEKGENIEMETFSDGDEIVENYHAQFDIILMDIQM
RFMDGMAAAEEIRKMDSEVVIIFITNMAQYAIKGYSVDALDYVLKPISYFAFSERLNRAI
ERMKKRESRFITIAVKGGVMRLKVSDIYYVESFGHKLNFSMNKEEIMTTGTMKELEKQLS
EFHFFRAHKGYLINLEHVDGMNDNCAIVKGKELLVSRNKRKAFMEALSHYWGEVIK
>PK3-045_04393 hypothetical protein
MLPYKDDFSKGGLVGVKLLCYSAKVPGGCNAKIGMMLKSIQFNMQSLKG
>PK3-045_04394 hypothetical protein
MMNNSNLENLIIIIDDLDRFSSERIIDTLEAIKLFLAVKKTTFIIAIDEDVVSCAMDRKY
LKIDDATLDIS
>PK3-045_04395 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MKDKQQNTMAKLKVGQTFPLTIKRLGINGEGVGYFKRQVVFVSGALPGEEVVVEATKVQP
KFSEGKVKKIRKASPFRVQAPCPFYEQCGGCQLQHLAYDQQLQEKRDIVIQSLERHTKLK
IDKLDIRPTIGMEDPWNYRNKSQFQVGQQKNGAVIAGLYGLDSHRLIPIQNCMVQHPLTN
KVSEEVRKILEEFQVPIYDERKQKGIVRTIVTRAGFESGEVQVVLITTQKEMPRKKLVMA
EIQKRLPEVKSLVQNINGNKTSLIFGEKTIHLSGEEVIQETLGDLNFELSARAFFQLNPV
QTVKLYDEVKKAAALTGKEKIADAYCGVGTIGLWLADGASEVRGMDTIEAAITDAQKNAD
RHGIENATYVTGTAEHWLPKWVEEGWRPDVVVVDPPRTGCDRKLLDAIKKVKPKKFVYVS
CNPSTLAKDIDYLSKDYKVEYLQPVDMFPHTAHVECVAQMVLRCN
>PK3-045_04396 hypothetical protein
MEKINSTSDRIIQAFIELFRDYGYKGTTTRAIAEKAGVNEVTIFRHFGNKKGIMEAAIQS
VSYHPMLEKVINEQMVWDLEQDLWVIAEGYLTYMEKVKDLIMIGMREAQMFPELNETIVN
IPKQLKEMMVLYFNEMNRRGKIVDTDIDFQAMNFIWLNFGYFLSKSRFGDSVISSSKKDF
IKHSVYLFARGLTP
>PK3-045_04397 hypothetical protein
MKTLKQFFKHPETIIGISTAVAFLLIFFCVWMTAYDGVNNRIDKLKIGLVNEDQQIGSMI
EKKVVKNVPFEVKMYQSIDSAKKDMNQSKLDMVMHIPAIFSSRLQENGKPEINYFINQGN
ATLAKQIMDGAAKNITQSINENVYNYKQQLILSNLQEQLGKNIPSNELAQEFSKGISQAL
ESLNIQSVQTTVEKTNNVDGFAPTMVPMMMVLASYVGSMIMSLNMNIVSSKIKSNYNKWS
IFLVRQIINIGASILLSGITLLLFAIFNIELHISIMESGIFQIFVYFSFLSLTQMFVILF
GPGGMLFNILALSLQLVTSGVIIPKTMLSSFYQTIGSYLPATYASNGYYSLIFGGMSLTT
EMMALLIVSAVTLFVALFRIALLKKSVSTNSVVSQ
>PK3-045_04398 hypothetical protein
MNFKKLTLGMMTALLFTGMLVGCSDQKDDQKEDTKTETPAENETKE
>PK3-045_04399 HTH-type transcriptional repressor NsrR
MRLTNYSDYSLRVLIYLATKETPKLTNIKEISEVYNISKNHLMKIIFNLGKLGYIETIRG
RSGGFRLAMDPAEINIGALIRQTEENFYLVECFEDKNACVITPVCSLKHVLNNALEQFFK
VLDQYTLADIAENQVMLKDYFALKNKASSEEE
>PK3-045_04400 Flavohemoprotein
MLSQKTIDIIKSTVPVLQVHGTQITTVFYKNMFAAHPELLNIFNHANQARGRQQTALANT
VLAAAQNIDQLETIIPVVKQIAHKHRSLMVKAEHYPIVGEFLLKAIKEVLGDAATDEIIQ
AWADAYGVIAQVFIDIEKEMYEDSASKNGGWADYKEFKVMKKIKESDVITSFYLAPADGS
SLPAYEAGQYITIRLSIPGEKFLFNRQYSLSCASNKEYFRISVKKEASVENPDGKVSNYL
HSDIDVDDLIEVTVPAGDFTLLKEESPIVFISGGVGITPFMSMVGTIAKEQPDREVHFIH
SARSGSVQAFKEELIQLKEKIANFYLSYIYENPSEEDKLNPFFQKAGYIDADWLKKNAIT
ADGHYYVCGPVPFLQAVVTGLKANGIDDSKIHYEFFGPSMKL
>PK3-045_04401 hypothetical protein
MEKKTQKKQKKLLKASRALLVIIGGIITGYGLEAVLIPNAVSDGGVTGLSIVGSQLMGFP
LGILIGILNIPFIFLGYKQIGKSFAIYSVIGILSLAISTSLMHHVPTIIEGDTLLITVVG
GIIIGFGMGLALRNGGALDGIDMLAVLLSRKLPFGTSDLILFLNLFVFIFVSTVFGLQGA
ILSAIAYFIASKVIHIVEEGLSGSKTFKIITDEPEIMVETIRDRLGRSATYTLAEGGYSN
EPFKEITCVVSRMEERKMKEIIHELDPTAFVAIYDVSEVKGGNFKKRDIH
>PK3-045_04402 DNA-3-methyladenine glycosylase
MHTIKIEGPYNFDLVLSRLALDPLHVLDKEARWVKVPLRIDNKPIVVKIQATGITEKPTF
RLEWEEIDSSLHDLIYKEIRRIFRWDESLLAIHEHFQATKLKPLFEEHYGTPIVLDFHPY
NSLVKCIIHQQLNLKFAFTLTQRFVTTYGFQKDGVWFYPAPETVAKLTVQELRELQFSTR
KAEYIIDLSNEIIKGNLDLASLEKKSDDEIMKELIRYRGIGQWTIQNLLLFGLGRNNLFP
IADIGIQNALKKLLQLDKKPTKEEMEALLPEWHPYLSYASLYLWRSIE
>PK3-045_04403 Peptidoglycan-N-acetylmuramic acid deacetylase PdaA
MKLAIKAFICFSAFCLFALPVVASVSNKPQSWGFKKAANEQPAEAGPELDALLEKYSAYY
KDTSEDKVLYLTFDNGYENGYTGKILDVLKKEKVPATFFITGHYLKSAPDLVKRMAAEGH
IIGNHSYHHPDFTQVSDEKLKQELDSVVKETEVLTGKKGMTYLRPPRGVFSERTLKLAQE
LGYTQVFWSLAFVDWKTDQQKGWKYSYDNIMKQVHPGCILLLHTVSKDNAEALEQAIKDL
KKRGYTFKSLDDLTLKKEMDEGIMH
>PK3-045_04404 hypothetical protein
MYFENLKKSIYDLIVETSTNLPKDVRRAIAKATASENAGTRSAMSLATITQNIGMADKEV
SPICQDTGLPTFKIKTPIAVNQLDIKAAIYEAMELATKNGKLRPNSVDSLTGENSGNNLG
AGTPVIKFEQWEKDYIDIRLILKGGGCENKNIQYSLPCELEGLGRAGRDLDGIRKCILHS
VYQAQGQGCSAGFIGVGIGGDRSAGYDLAKEQLFRSVDDTNDIPELAALEAYIMENANKL
GIGTMGFGGETTLLGCKIGVMNRIPASFFVSVAYNCWAFRRLAISVNPDTGEIKEWQYQE
GDKIDFKAETEDNEVAAAEEVITLQAPISEEEIRQLKVGDVVQINGMMYTGRDAIHKYLS
TNEAPIDLNGQIIYHCGPVMLKDEEGNWHVKAAGPTTSIREEPYQGDIMKKFGIRAVIGK
GGMGAKTLKALEEHGGVYLNAIGGAAQYYADCIKSVEGVDLMQFGIPEAMWHLKVEGFKA
VVTMDAHGNSLHQDIEMSSLEKLAQFKDRVYK
>PK3-045_04405 hypothetical protein
MGSSITDKNEQVTFLKTRLNMFMDVLDAIDPEEAELEDIDRLIEMIDEIESKCNEFKHRD
L
>PK3-045_04406 hypothetical protein
MPKFTKQEKEHIHRSLMEKGREIFIQYGLAKTTIDDIVQACGIAKGSFYKFFQSKEELYF
EILKNEEEVRETVLAELFREDLSSKELLTSFFHTSFTFVEENPFLQRVFQSDEHERLTRK
LPEQMEEFSRIHTQRGINAIKTLMDRGVLPKENPELTVGVIQAIMMIRLHKDEIGTELFP
QVMDRIIDYIATGLGKESFNK
>PK3-045_04407 Tyrosine-protein phosphatase
MKTLEKAFEFEKLYNFRDIGGMTTSDGRKMKAGVLFRSEELSKLSNKDLETFDKLNIKAI
CDLRTPNEQKSKVSRIPTGKRIQLLNVSIHDKSREFTRLEFFKFLVSKSNTIDFEKIMKE
MYEHMAFGCHKEIREILIFLSNQQNIPALIHCTGGKDRTGFISAIIQLLVGVPYEAVINE
YLVSNQLIAARMKKVENFIRWMSLFQVSPERLKPMLEVQRDYLEDVYSKIIEEYGNIETY
LLVACNIPQSNLDKLKQLLIE
>PK3-045_04408 hypothetical protein
MSNAANQGNKIVTGLVIGSVIGVTVSLIDPATRKRTMQKFENIKDGSTRIVQSYKDNPDE
FKKDWKERFHRSSDAMKAITNDTQRLYKQIQSTVRERSKDLKEITEDFKQLYFQTKRQYN
QITNRIATTKDQIIESSEMKEGTQLPAVREDMEVKEKGTVLQ
>PK3-045_04409 hypothetical protein
MITEKNIISPSIDPWEAYMDMEQHGKLTLSNIEFTTTTLCNMRCEHCAVGYTLQPKDPNA
LPIDLLLKKLDDIPHLRSLSITGGEPMMSRKSVENYVVPLFKYAHSRGVKTQLNSNLTLG
LDRYEPVIPYLDVLHISHNWGTEEEFAERGFAMMARKPTYEQRGKLFNNIITNSRALVEA
GVVVSAETMLNKRTLPYLEHIHRQIVEEMKCQRHEIHPMYPSDFASALETLSLDEIRDSI
NHLLDIRDENVWMLFGTLPFYPCNTKEEDLQLLNRLYSSKNVTVRNDPDGRSRLNVNIFT
GDVIVTDFGDTPALGNIQTDNLEDIFQKWLSTDLARSLNCHCPAVKCLGPNVLVKNSYYQ
DVDFTKRNAVISR
>PK3-045_04410 putative protein YfkD
MYKKIMIVLISFFLMLPMFTYAEKAKEKEKEENPRKSKIITIPNAVMNITKENTYPNPTQ
DVPKLQPSELTQQLINSSKVKIDNPDLIRMLNESTVNSTPFALGYKAIVYLGQWPLNYES
TETAPNWEYQKINTNFYDNRGGKSSYQIHYVQESQKKVRGGLTAKIPNAEQVKKMMLVKA
AQNSGLSLAFETVVGTGTKKDQVYNIPAKRLGYLYGYAPAVNEKGKVTYGEVYMMLKGSK
KSIIVKNVTSQGIGAWIPVQDHVSFEFSASEKPK
>PK3-045_04411 hypothetical protein
MNERKRMVGERGYTGMSSFFYRCLLYVVGLFILAFGATLTIKANLGAGPWDALNVGLSHL
VGLTIGSWIVIIGIILIFVNALLLRNKPNLLSLATVFILGFFVDFWMAHLVNRLHYFMFM
SQLLLLIAGLIIVGLGIALYLQSEFPLNPIDDFMVTIQERYGVNLMVAKLIGEILALLFA
FLVKGPIGLGTLIIAFGLGPAIQFFHPYCSKLTGKFVIK
>PK3-045_04412 Ca(2+)/H(+) antiporter ChaA
MVNKIFMIAAFIGVPLSIIGSLLHWSSILMFVIYCLTIIALSSFMGRATESLAIVAGPRI
GGLLNATFGNAVELIIAIFALREGLTEVVLASLTGSVLGNLLLVAGLSFFIGGLKYKRQQ
FNVFDARHNSGLLIFAVIVAFVIPEVFTMNMGEGKTLSLSIGIAIILIVLYLAALLFKLV
THRGVYQVEKSGDHGHAHEEIPEWSVKKSIAILAIATLAVAYVSENLVHTFEVVAESFGW
SELFIGIIIVAIVGNAAEHASAVVMAYKNKMDIAVEIAIGSTLQIAMFVAPLLVLISLFF
PSGMSLVFTLPELISMVTAVLLMVSISNDGETNWFEGATLLAAYAIMGIGFYLL
>PK3-045_04413 putative MFS-type transporter YcaD
MNSKKFAVLISIVSISGFSQGMLLPLIAVIFENDGLSSSLNGLNAVGLYIGILLISPFME
HPLRKYGYKPVIIFGGLVVIVALALFPAWKSFWFWFLLRLFIGIGDHSLHFATQTWITTA
SPKEKRGRNISLYGVFFGIGFAVGPLLTPLVKINESLPFILSSIMCFIAWIFILWIKNDF
PEQTVETNSFLDTMKRFSSAMKYAWIAFLPPLAYGFLESSLNSSFPVYGLRIELSVVQIS
LLLTAFSIGAIVFQLPLGMISDKFGRRQTLITILIIGTACFSFASLLEAYLIGLIICLFL
AGMAVGSTFSLGISYMTDLVPTNLLPTGNLLCGMAFSVGSLIGPYLGGLFIQYFQHISYF
VVIAAILFIVGLIIFLFGKKEVKNQYLAEAK
>PK3-045_04414 Zinc-transporting ATPase
MSTETELKTYIETKVEAKPTLFAKLSPHLELIAAGISGVFIVGGWILHHFHYSSMSILAY
LLAFVIGGYAKAKEGISETIENKELNVEMLMIFAAVGSAIIGYWAEGAILIFIFAVSGAL
ETYTMNKSNKEISALMKLQPEEAVRILPDGQEQVVPVSSLSISDIILIKPGERVPVDGKI
IKGTTAIDEAAITGESIPLSKGINDEVFAGTVNISGSITVTLTKHADETLFQKIITLIQS
AQSEKSPSQAFIEKFEGAYVKIVLTVVVLLMFLPHFLLGWSWNETFYRAMIFLVVASPCA
LVASIMPATLSAISNGARAGILFKGGVHLENLAHIRAIAFDKTGTLTKGKPVVTDVLVDR
HFSKKEIIQITASIESHSNHPLAKAIVQYAKHKYQETFPQPESIQDNSGWGVTALLNNSE
WRIGKAAFVGEKEAKAFQEGKYDQLSEEGKTTVFIKKDADVIALIALKDIVREESKEAIN
RLKENGIYTVMVTGDNEKTAKAIAQESYVEDYIAECLPEKKVTSIKELKERYEIVAMVGD
GINDAPALATANVGIAMGEGTDVALETADVVLMKNDLPKIADAIQLSKRMNRIIKQNIIF
SISVIMLLIISNFLQIVALPFGVIGHEGSTILVILNSLRLLKG
>PK3-045_04415 hypothetical protein
MTKHTKKDGGTKQKGKSKPKHKTSGSANGSNGYH
>PK3-045_04416 hypothetical protein
MGDVIPFIKVLIKKIQQDNVFDLAAQLSYYFLLSIFPLLIFVMTLLPYLPITKEDLLGLV
EGFAPGDIMNTIESNIDQVLSRNVSLLSFGIIATIWSASNGLNAIVKALNKAYDVEETRS
FIVARGMSILLTLGMIAVVVVALLLPVFGEQIGMFLFSQFNLTDEFLSLWNTLRFLASPI
ILFIVFLALYWIAPNKKLKCISAIPGAIFAAIGWVVASLAFSYYVGNFSNYSATYGSIGT
IIVLMIWFYITGIIIIIGGEINAYFTERKKEPC
>PK3-045_04417 hypothetical protein
MKMSITKGLFIGSLIGTAISLFDRHTRQHAVTTLQHAKDTVTDLDQMTSSLNLTSEKIKN
SALKISDDAAFVKKQLEELKGITPVVAGIIRDTKEAFTSGKMRNQERTLVSSIQYLPKPE
>PK3-045_04418 Low molecular weight protein-tyrosine-phosphatase YfkJ
MKIRVLFICLGNICRSPMAEAVFRDLVEKEGLQKTIICDSAGTGGWHTGNPPHQGTRDIL
KVNKIKDAGIFARQLADKDLEEFDYLIAMDNSNIANIKKLNEMLVGTKVRLLMDYTDHAA
GKEVPDPYYTGNFEEVFALVKDGCEGLLREIKQKYSL
>PK3-045_04419 hypothetical protein
MNLDNKTTENVNFMIEKIKEKLKVLNIGAIKSTHFDEDLYDDIKEIYDHVMKRDSFSPNE
MQALAEELGNLRKQ
>PK3-045_04420 Methionine aminopeptidase 1
MIVLKSKREIEQMKKAGEILVGCHKMIAKMIKPGITTLEIDQKVEAYLAEMGATPEQKGY
RDYPYATCASINDEICHGFPRNEPLKKGDIVTIDMVVNYNGALADSAWTYAVGEVSAELQ
KLMDVTKKALYIGIEQAKVGNRIGDIGFAIQQYVEEHGFSVVRDFIGHGIGKVIHEKPEV
PHFGLAGKGPRIKEGMVFTIEPMVNMGDYKMKMDNNGWTARTIDGKHSAQYEHTIAITKE
GPVILTDQDA
>PK3-045_04421 General stress protein 18
MSKRIATLITDMFEDSEYTEPAKAYKEAGHEVVTIELEAGKTVEGKQKEASVTIDKGIDE
VSPDEFDALFIPGGFSPDQLRVDDRVVAFTKAFMDEKKPVFAICHGPQLLITAKALEGRN
ATGYKSIKVDMEYAGVTFKDEEVVVCGDQLVTSRTPEDIPAFNRESLKLLNK
>PK3-045_04422 HTH-type transcriptional regulator TreR
MVTNNLKMLVNFMLNKYYMIFEELEAAIRNGKYPPDTILPSENELAEQYNTSRETIRKAL
NILSQKGYIQKLRGKGSLVLDLEKLQFPISGLVSFKELADKMGHSSVTIIESFTNKQPSS
LLQKEMQLNKDDSIWEVFRVREINQERIILDKDYIVEKYVPGLTEEICKNSIFDYIEKEL
NLKISFAKKEFTVEEPTEEDYNLLDLEGFHSIVVVKNYIYFENATLFQFTESRHRPDKFR
FVDFARRNEA
>PK3-045_04423 HTH-type transcriptional regulator SinR
MIGDRVKQLRLEKRMSLSELAEQAGVAKSYLSSLERNLQSNPSIQFLEKIAAVFNIPVDH
LINDQQNKDELDSEWLKIVKEAMDSGVSKKEFREFLEFNRWRLEQKK
>PK3-045_04424 hypothetical protein
MINSQLFTEELDSEWIQLINEAKNIGMNLQEVREFLRSEKDYLIQENPK
>PK3-045_04426 hypothetical protein
MYRKNCDICNRPSYSSSERGRWICPICQNDLTEYPFFDAITFEQIHINYSFKKVLKSYQT
QYYDRRQDK
>PK3-045_04427 HTH-type transcriptional regulator SinR
MLVGAKIKTLRIKKGFSINELSDKSGVSKSYLSYIERGIQKNPSLQVLTKLAHTLETNVE
ELLDNNHTVIEGIDEDWMSLVEEAIEEGITKEDFAGILEYVKFKKRQEN
>PK3-045_04428 Pseudouridine-5'-phosphate glycosidase
MKTEWLEFSKEVLEAKKNNLPIVALESTIISHGMPYPQNVETAKEVEDIIRKNGAVPATI
AIIEGKIKIGLSEDEIEFLAKSDNIEKASRRDLPYLIAGKKNGATTVAATMICAELAGIK
VFVTGGIGGVHREAEHTMDISADLQELAKTSVAVVCAGAKSILDIGLTLEYLETYGVPVV
GYGTKSLPAFYTRTSPFEVNFSVENPKEAADMIQTKWALGLDGGVVIANPIPENDALDEK
YITDIIEKALQEAKENHITGKKVTPFLLSRVKELTEGTSLVANIALVKNNAEVGSRIAVE
LNK
>PK3-045_04429 Pseudouridine kinase
MEVNDKEIFILQLIKENPFVTQNEIAEKMGLSRSAVAGYISSLTKEGKLLGRAYVLPKKK
EVICIGGANVDRKVQAEETIQYGTSNPASTSQSPGGVARNIAENLGRLGLETSLFTIVGD
DHEGEWLLENTKSYADITPSLLSNLYRTGTYTALLESDGELAVALADMSIYDTIDKDIID
KKWGYIATSELVILDTNFSAEVLEHIIIRCRQEQMALCITPVSAPKVRKLPEDLHGVTWL
IANRDEAEALAEMKIKEEGDFFKAAEIILEKGVEKVVITRGDKGLIYFTKLGEAGVILPP
EAEVVDVTGAGDSLVSGIMYSHIKGLNTEDACKIGITCSNITLQSNQTVNPLLNNKKLQE
LFGKYFR
>PK3-045_04430 Motility protein B
MSKKKKKKVHHEEHVDESWLVPYADILTLLLALFIVLYGMSSVDAKKFSEIAEAFNKELQ
GGTGIFEYPSPAPSMNSETTDVDLADQEKKEDKKDKKNLSEKELKELQKQKDKQELSEIQ
QKVNAYIAKNKLGNKLDTELTDEGLHVSIRDNVLFASGSAEVRNKDRKVVSEIANLLVMD
PPRSIIISGHTDNVPIRNSRYASNWELSVTRALNFMKLLLENKKLDPKSFSAKGYGEFQP
IASNDSSAGRAKNRRVDILIEPRVAKED
>PK3-045_04431 Chemotaxis protein PomA
MDKTSLIGIILAIIAVGVGMVFKGVSPAVLLNPAAILIILVGTVAAVVIAFPASEIKRVP
KLFGILFKEQKVQDTKELIRLFSEWAQLARKEGLLALEAKTDEIEDPFLRNGLSLSVDGQ
SAEYIRDVLTEEIEAMEERHRTGALIFTQAGTYAPTLGVLGAVIGLIAALGNMSDAEALG
HAISAAFVATLMGIFTGYVLWHPFANKLKRKSHMEASQKYLMIEGVLSILEGEAPRVIEQ
KLASYLPVSERRQFLEESESSVNTNE
>PK3-045_04432 hypothetical protein
MDFSILVSEDKIKKAYKDGEFNHLPGFGKPLPKDSLDSVPKELRMAYRVLKNAGYSLEED
KIRQELLSMEDLIRSCETEEEKVVLQRKYNEKLLRFRKMMKERTGESHSNPFSGYQKKVE
NKFFPK
>PK3-045_04433 hypothetical protein
MGNSELLLNINAEHIEDLFRTYRKIKGGKKEDGALFQWSRTPSIAWIYSSSSIRFLKASC
VTINSSSPGASSVCVCFLVSFGSGPGWCFFL
>PK3-045_04434 DNA topoisomerase 3
MKSLVLCEKPSVAREIARVLGCNKSTKNYLESDKYIVTWALGHLIELKMPEHYDPKFKNW
NLDDLPIIPQKMELKVMKQTSHQYKAIEQLAKRKDIKDCIIATDAGREGELVARWILEKI
RFTKPTKRLWISSQTDRAIKDGFKQLKPGKDYDRLYQSAVCRAQADWLIGLNVSRALTTK
FNDPLSAGRVQTPTLSMVLEREKEIQSFVPKEYWTITAQIDSLQAKYEKNQERRIFSKET
AEKIVANTKGKQAVVETLTVKEKTEHQPLPYDLTELQRDANRRFGFSAKKTLNVLQKLYE
QHKLVTYPRTDSRYLTTDMKNTMIDRIESISGAFKEEVQPILRNKGKVEANNVFNNNKVS
DHHAIIPTEQPVFLNRLDNEEVKIYDLIVKRFLTLFYPKYKYEIISTTLNINGASFVAQE
TNILELGFKALDSRKTDSSKNIQLQKGQQLKVQSVNLEQKFTEAPSRFTEADILGKMEKF
GLGTPATRAEIIERLLSSEVLERQNGKLHSTSKGKQLLNLVNDDLTTPDLTAKWEQELED
IAKGKANPHQFMEQIKEQTKRFVREIKQSEKSYKMQNLTGSKCPECGSFLKEKNTKNGKI
LVCSSMDCSFSKRKDPKLSNKRCPQCHKKMEIHNGVAGTYFQCRNCNVVEKATDRKKTIN
KREERKLVQKYSKDESFGNSLGDLLKAAMKKDD
>PK3-045_04435 Beta-phosphoglucomutase
MANRLQAVIFDFDGVIADTVPLYYKATKKMAVEIGASFTREDNLRYQGVPRKVLIDDLVA
QTDKIFTDREKEMLGNRKSEYYKALISEFTVENMLPGMYEFLKDLREMGIKFGIASSSSN
APFLLDRFGIRDWFECIVDPHSLKKGKPDPEIFLTAADCLGVDYHECAAIEDGQAGLSGI
LQTPMFSVGIGQGDVFAKADWQVASTRELSASTLLEKFNNR
>PK3-045_04436 Aminopeptidase 2
MSTFQENLQKYAELAVKVGVNIQKGQTLVINTSIESAEFVRLVVKEAYQIGASNVVVNWS
DDIVTRTKYELAPDEAFKEYPEFRAKETISLAEEGAAFMSVVSSSPDLLKGIDSERISNF
QKASGTALSQFRKYVQSDKVSWTVIAVPSKAWANLVFPDAPENSRVELLWDAIFKAIRVD
QANPIQAWKEHDKTLHTKVDYLNEKAYKQLHYTAPGTDLTIELPEGHLWCGAGSINEKGF
EFMANMPTEEVFTVPHKKGVNGTVSSTKPLSYGGNIINNFSVTFKDGRIIDVKAEEGEEI
LRQLVETDEGSHYLGEVALVPHRSPISQSNILYYNTLFDENASNHLAIGSAYAFCIEGGK
KMSSEELAEKGLNDSITHVDFMIGSDKMNIDGITVDGKVEAVFRNGDWAF
>PK3-045_04437 hypothetical protein
MKKNKYIWLIVVGVIIIAGILITSMVNSYLTEKHKNELDQKHMVIKKDLQWTKDNAYFEI
DINVKEKKYELYIIGEGERKYQQVEDTDLGEKDDTIVTGDFAFYLWTKEYGKKAVKQDLE
LPNPMTFNLSQKNIGTFLVNQQNIAAVYQGKEANEVMAYFYTIHDGKLVTLTDYGMRIYS
KNIKNIQQNYIQTLREKDTDQMEFDTWMLEQKSGKLVKIDGTSIKNKEIINKWLDDTEFY
YPYKNLSVTSSLKNLAEQGMLIGAQYPIGTNIKEIKKINSNYTIKDYNQKYSQLDFPEIT
YYYDKKTDLVTSISIPGIRLKESVQSIQDTIGKPDDFVTKEAGSIATYTAGNYKLIIQLD
LSQRIKSISLVK
>PK3-045_04438 Acylphosphatase
MKQLHLIINGRVQGVGFRYFVQMIAMENQITGWVRNKADGTVECRAVASSETLRAFVEKV
KRGNRFARVDHIEIQESEPEELFSSFKVIY
>PK3-045_04439 Large-conductance mechanosensitive channel
MWKDFKAFAIKGNVIDLAVGVIIGTAFSKIVSSLVDDLIMPLFAHFIVGVDFSTWSYSSI
NYGNFIQRIVDFFIISFSIFLVIRFLNRFKKKEEVQEEAVTVDTKEELLKEIRDLLKTEV
IRDKDGLN
>PK3-045_04440 putative protein YetJ
MYAYNPSNEYMPSVLRTFALSLGIAFIGTMIGNFVPANLFLPLSILEVVLLLIAIFARRG
KSLSYGFLFTFTFISGITTFPIVSYYVSTVGGNVVINALGTTTIVFAGVAIYATKTKRDF
SFLRGMLLASLIALIAIGIFNIFWPLATGGMLAYSFIGVLVFSGYVLYDFNRMKHYGITA
DQVPLMALNLYLDFLNLFISILRIFGILSERD
>PK3-045_04441 hypothetical protein
MKIFSLSYFVVTRKIDLNMEIIEEEKSLDLWSDRVTSAEQTFHLHTIHDISFKPSSNQYK
MLYLHTNRGVHSFVIKDNPEEMIRLIRRQIADYL
>PK3-045_04442 hypothetical protein
MEESKFCSESLVVKTSIVFPTDTNTYGTLFGGKLMAYIDDTAAISAMRHARRGIVTASTD
SVDFLYPIHEGNAVCLEAFVTYTGTSSMEVFVKVTAEDLISGERHLCALSFLTMVAIDEN
GKPTKVPKVIPQTEEEKSLYESAKERAEARKKRKKETEELAKKYRSY
>PK3-045_04443 Magnesium transport protein CorA
MKRYRLENWDWFQLLKEADIQKVSFEKGPLINTWFRDIKGNRSNYLHIDTSEEDQEVLSG
SLIYHREIDKREDYEIFHFFLSRDTLITYDYKDNSLHIDGNNLLKEIKHAQTPIEGFMVI
LGKVMTDILYHIDAYEQQLEQLIWDVKQRNSIKTLDKVYQSRHELLVWKNVMIPFLEIRY
SLEEAFGEEITKGKVYARVTKRIERGLILVEEYQKELNNLVDFEEVVSQHRGNEIMKTLT
VFTTICTPIMAWGALWGMNFEIMPELKWKFGYVFSLAIIIGSTVVVYFYLKSRGWMGDLL
KARKKNSFFR
>PK3-045_04444 hypothetical protein
MFGKNSMRTFAIVGAGLGSFFLFTSKGKDMFHRFKSKFNSTQQEDLLSKAGNPAPDDIGD
NNMVNEGAMYSVNYYNKQRNSN
>PK3-045_04445 ECF RNA polymerase sigma factor SigW
MESLINKTYTVGNQEELFEQVVKEYGKSIYIYILSLVKHKELAEDLYQEVLISAYTSFGS
FEDHHKVKSWLYKIALNKCRDYWRKEKTSKKFWEESVYTYARDTSVALEPEETLMSKCEK
EEMIDTLEELPNMYKEPLLLFYYHNQTLVEISNHTKTPLSTVKTRMKRAKDQLKPKVMNK
KIVHL
>PK3-045_04446 Sporulation protein YkvU
MSSFYKGTFLLIVTAFFGECIEFIINMVMARELGEHGLGLFMTILPTIFLIVLLATFELP
TSISKFIAEKDSKYHLSMLQQVLKWTIIFTIFLTTIASIIIPFIPIFYDYHPLLKWLVIL
LLPIISFTSIARGYFMGKQQMGKIAASNFLKKIIQLGLLVFLFQWFSFDLNTSVLIAFFT
IVGSDTVVLLYLLHMFFVQYQRIKKGKNESMNGKVIWKDLLSVSIPTTGLRIFHALTHAI
QPFLIKGALVASGITVANATEQYGMLAGIAMTIGFFPAFISHSFMTMLIPTVSKAYVQKD
YAKLQRLLQQVMIITAIYGTISVGIFYFYADTLTMTFFHSTQAAIIVQLLWPYFLLHYFT
IPMQAYLIGLGLLKDAVFHSVWATSFSYAAIYYLGSLSQLQMSGIAIGMNLGAVILASMH
YLTICKKIGVSMWLTPVNKFQ
>PK3-045_04447 Transcriptional regulatory protein LiaR
MIRVLLVDDHEMVRIGVSSYLSAQTDIEVVAEAENGRKAVELALQLKPDVILMDLVMDEM
DGIEATRQIIDAWQDAKIIIVTSFLDDEKVYPALQAGATSYMLKTSKASEIARAVRETYQ
GQIVLEPEVTDKMMTKMREKKSTPLHEELTTREMEILLLMAEGKSNQEIADQLFIALKTV
KTHVSNILSKLQVQDRTQAVIYAFKHSLVE
>PK3-045_04448 Sensor histidine kinase LiaS
MSIITRQILWGVSASLLLLVFFSISYLIVFPPSNWSALWEKEVMDVPFILFLISVDITLG
VLIGYLSGFSWKKQIRSMEETLHTMDKMEYYPVQPIGSTEELQSLSYRIIQLQNQLVEQT
KLSQKLVNEKAEDQEVKVQTVIIAERNRLARELHDSVSQQLFAASMLLSAINETRPKTND
HESRQLQLVEETIQQSQLEMRALLLHLRPIALKGKTLKAGIVELLHELQQKVSLEIEMKL
EDIDLDKGIEDHLFRILQESVSNTLRHAKANSLEVQLIQREAFVILRIIDDGVGFNVDKR
KAGSYGLQNMHERAAEIGGVLKLISLENKGTRLEVKVPILGRKEDLND
>PK3-045_04449 Protein LiaF
MFKQIKDNYANWVYIVGGFLLLEIFVFNPGLIFSLLVSIGMIYISKKSRNGGAGKILFWI
GSLLLIVSILNMVTVKIILFTLLAYYLFQLFQKKNTEDIIKPIIRDKETAIQTEETIIKK
KPLFMNSLFSRNITPDHVYEWDDINIQGGITNTTVDLSYTVLPEGETVMMIRNIVGDVKV
YIPYDMEVSIHHSSLFGSYQIFSEAEEKIWNQNISIRTAGFDQAETRVKIFTSLITGSLE
VKRI
>PK3-045_04450 Protein LiaH
MTNLLERIKNTVMADINHLLDKKEEKNPIALLNQYVRECEKETDKVKKMVERQYKLKEEF
MKELQQAEQMAEKRQRQAEVASKAGEEELSAYAKQEQTHYEERVARLTESLKNTEQQLHE
IETKYMDMKHKLKDMKIRQMELMAKENITKAHHTMNKVLEEKQANPTNPTRFSEMEQYIE
TLEEKINTEYYKQTMDEKLAALEKDMLKKEDDSISL
>PK3-045_04451 hypothetical protein
MKKFGLFLIGAVASIILLSQIGPILGLVISAAILYFAFKQYTKATSSSGKLWWGIAGVIM
LIITASNLPAIIGLAAAYVLYLVYKKWNNKQNIITNKTTDDPFVNFEKQWSELNK
>PK3-045_04452 Spore germination protein B3
MKKICVFLCILNCLFLLTGCWDRKELSEIKLVSGMAIDKGENAKYKLTVEALNAVELNTQ
TAAGNAPTIVEGIEGNTISEITHHLNEYYAQFLVFSHMKILVISEEIARSGMLDFIDFLE
RNREIRDDFKIIIAKDGKAEDILKVVAHYRKASSLKLSPQLDHLLEDWGGDPGMSIIEFI
SELNLEGKEPVLATVRLKGDVEKGNSMENIMKVTPDAIIVVDSLAIFKKGKLIDFLSMED
SRNYLWVRNELKTTSFTIKCRQGDYSAIRVTESQTETTSKWKNNKPVIHVGIKAEGYLEG
TQCYKSVDKLGTIEKYEKLVNKALSQEISNTISHVQSQYETDIFGFGEAMRRQDYDSFMK
IKDKWNQEFSKADIKVDVDFVLRRSGIRSKSFLTGTEK
>PK3-045_04453 Spore germination protein B1
MNYFKKLMSINSKKEIPSKVVPTEAKEIGIDELTFEALREVISLTFGNTADLQSDVIRVG
KSEGCIYYLETVVNTEMLKEMLGNTLENSADKDIVVDTIEDLQRLSKKSFGVSGYKLLKK
VNEIVSSLLEGRIVIAFRGVGQALSLNYLNSEGRSVAEPTTQTVVRGPKDSFVEDASTNI
NLIRKRIRNHQLRFEKFMIGNETRTNVYMGYMYSIANEKIVTEVRNRLNKIDISAVFESA
NVEELIVDKSLTVFPLAMNTERPDAVATYLMDAKIVIIIDGSPFVLIVPAVLTDFFTSPE
DNYQNYFMSSFVRLIRYLSFMIGLIMPSAYVGVLTFHPELLPTTLLLSVIAQREDVPFPA
VVEVFIMEITFEILREAGVRMPRAVGQTVSIVGALVIGQAAAEAGIISNIMVIIVAITAI
ANFVFPNYSFANASRLIRFVLIIVASILGLYGVLLILVFMVAHLSSLRSFGVPYLAPVAP
FIIEDQKDVFVRFPLWSINKRSSYLSPNVKNRQKPQGSPSPPKPESGKEK
>PK3-045_04454 Spore germination protein YndE
MLTEKLSLTQIFTMIINFLLGSSIVIGIGIDAKRDAWIVVLIGMIVGVIIISFYLYLMSL
LPGKNLYEMMEYCFSRKVAIVLALVYLSYFLYVSARVIRDFGELITSAILPVTPIEFTIL
ALMLVIGYILYLGIEVLGRTAEIFSPYMFLFIILLFIFLYAGEKINLTNVQPVLSNGMKP
IMKAAIPSIVAFPYGELIAFTVIFAHIGDFKATKKVALVSVVVASIILLSSVFIIIATLG
ENTAARANFPLLIAARLVSIGEFLERIDVLVVFIMMLGILIKGSVFLYGGLKGMEYIFRI
PYRYFAMPVACITTMFTIFISSDFSDHIVEGLNVDLFLIHVPLEFMVPILITFVLLMKKW
KEQRDEKRGLKI
>PK3-045_04455 hypothetical protein
MLKESISLTQLAAVVFNFQIGSTIVIGLGLKAKEDAWIVLLIALGLGIIISLFFIYMISL
APEKNLFEMFEYCFNRPIAMGLSLVYAAYFFYYSCRIIRDFGELIASTVLPLTPIEISTI
MLVFVMGYILYMGVEVLARTAEIFTPYAFIFILLLFIFLYAGKNLDFSNIKPVLAGGFKP
LWTAVFPYEIVRPYGQLLVLTFIMSNVSNAKYSKKIIIYSVLISSLLLLVTSVMIILSLG
HELGLRSNFPLLSSARLVSIGNFLQRIDAIVVFCMMLGTLVKGCIYIYGGLKAIEYIFDQ
SFRYFSIPMICIVGVFTTLIARNYTDHMEEGLQSNPFLLHIPLQFGLPALMVFIMLIKHW
NKFNSKKNVKSRGQNVF
>PK3-045_04456 hypothetical protein
MVTFAYLLIFTSMGILTVGLDIFVFHEGFMKCIKRIYEAEVGAGAITIVFTAILGFVWSV
VVDIRLWKNKKQSKQKTQG
>PK3-045_04457 putative ATP-dependent RNA helicase YfmL
MKEQLFWSTFKPFIQENWEKAHFKQATSIQEQSIPLILEGKDVIAESPTGTGKTLAYLLP
VLNNLDTESKNIQAICLASSQELVMQILGEVQKWGEGSGVRAASFIGGANVKRQLEKLKK
HPHLVICTPGRALELIKQKKLKMHAVKTVILDEADQLLVPEHLESVRQIIKATLKDRQVV
LFSATLPKQTENIAAELVQEAEIIRIKKDKVIEAAEVEHIYFQAEYRDKVKLLEPISRLK
NAKILVFVKDIGNLSVIHEKLAFKKIQTSILHSDLNKMERQKSLNDFRDGKRNMLLATDV
AARGLDIQNITHVVHYDLATDQTQYIHRSGRTGRFGAAGVVISLVTEREERELKQTAKKL
NLPLTRKSFYHGEVVDYKVRQKNNK
>PK3-045_04458 GTP pyrophosphokinase YwaC
MESVKQLKTYMEDNNFNLHELSNELNEWKNSLIIYNFALDEINTKLKILNEEFQFIHDHN
PIEHIKSRIKDPKGIMQKLHRKGHAITIENAKKYIHDIAGVRITCSFISDIYEIYNIIEK
QADIKVMQVKDYIKNPKPNGYKSLHLIISIPVFLSTGMQEVVVEIQIRTIAMDFWASLEH
KIYYKFDKDVPAHLLSELKEAADAAHELDVKMKRIKDGVDIVHTVGKNQLFI
>PK3-045_04459 putative ABC transporter ATP-binding protein
MQKELTDPFRYPKPKLRSDPTVVKKGKKPKNMGKTLYRLWSYLAQKKGLLFLVLVMVAMS
CALGLLGPYVLGMSIDRFIVNRNLDGFTGMLIALGGIYFFYSVALFLQSYWMVGISQTTV
FRLRADLFHQFHELPISYFDKKQHGELMSRVTNDIENVSSTLNSSVIQIFSSIITLVGTI
VVMFLLSPLLTVLTLTIVPVMFIGMKWITSRTSILFKEQQKNLGELNGFIEESISGQKIV
KTFSLEEKMIHDMKEKSDKLKNSAYWAQVYSGFIPKLMNMLNNASYAVIVGVGGLLALKS
GTVSIGVIIIFVEYSRQFTRPLNDLSNQFNTLLSAIAGAERVFEVLDEEREEVDEKEAAV
MKEMKGEVQFKHVSFSYEVNKEILKDIDFKANPGETIALVGPTGAGKTTIIQLIMRFYDA
TAGSILVDGQEITKVKRESLRSHMGFVLQDSYLFEGTIRENIRYGRLNASDEEVEYAAKQ
ANAHGFIEHLPEGYDTILSANGNGISQGQKQLLSISRAILADPSILILDEATSSIDTITE
VKIQDALKRLMKGKTSFVVAHRLNTIKHADLILVLDKGMIAEKGSHEELLKRKGFYYELH
QNQFSETVD
>PK3-045_04460 putative ABC transporter ATP-binding protein
MSKIFGRLRVYKLSITIALILMLTELAVELVQPLIMAKIIDDGLAHQDTKVVLIWGGFLI
LFSLVAFAAGIINTFYSSHVCQNFGYSLRNELYQIIQYFTFSSSNVFASSSLITRLTNDI
TQLQNTIFMGLRFLLRAPLLIVGGIIMSFLVNVKLAFILAITIPLIVVMFIWVIKVGRSL
FQSVQKKLDQVNSVMLENLTAVRLIRAYIRKQFERNRFMHTSEDLKKLTQKALRIMETTV
PLLLFAMNLCIIAILWIGSGQINTGEAQIGEVVAVINYTLRITTSISVVSMLVMVISRSK
ASADRIQEIIDKKEQDKDNPDESMDSKLKGKIKFQHVSFRYPSNRRNTIENLDFTIHSKE
TIAILGATGSGKTTLFQLIPRLYEPTEGSVLIDDKRVNSYSLYTLRKQIGYVPQESMLFT
GTIQENIRWGNPDATFDEVVQAAKDAQIHDTIMLMPNTYDTRIGQKGVNLSGGQKQRLSI
ARALVRKPSILLLDDSTSALDLKTEKKLLDAVADYQCTLLFITQKVSTAMKADRIMLIED
GKIVSFASHDELWKTNNLYQKIVESQLGEGEWENAKGTNRSISLS
>PK3-045_04461 Oligopeptide-binding protein AppA
MKKFKKIFGLFSIFILVLLSACSGVNNPASTGGGAKENTMYLGLVNAPVSFNPINSSDIA
ASWLEKFMFDTFLEMTGPLEFTPKLAESFETEDNQTFTIKINKDANWTDGTPVTSADVAF
TLNLVANPKTETAVGAYLTVLDGLTDNGKLPEGETEIPSITIVDEKTIQFKTKAPVDPNM
VKEQLGSKFMILPEHKLKNIAPENLQKDPFMMKPTVTNGPFKFVKYAKDQYVEYAKNDDY
YLGDVELDKLFVKIMPAANLVAQLQTGEIQMNAAGGIGKIAVQDFETVKGFDNVTTTTDK
TYGYQNMSFNMETITDKKVRQAIAYAIDRQKIVDQLLKGEGEIVDGPYTSISPYLDKELE
AYTYDPEKSKQLLEEAGWDFNKTIEFVVPIGNKVREQSANIIAENLKAVGLKLNTTTYDF
PTIMSKARAGDYDLMLMGFTNTIDPDLTTIYGSTGSSNYTNYNNPKVDELLVKGKQEPNT
EKRKEIYNELQAIWSDELPIFTLYSDYDFGAVSKDVAVGSPKVFGFHHELYKWSLAGVN
>PK3-045_04462 Glutathione transport system permease protein GsiD
MSIPNVKVDTELQVNVVIPVQNQLGNEESYLKLITKRFFKHKLAVVGLIIFSLMVLIAIF
APVIAPHNPYSVDGEFASAPSANNILGTDEVGRDLFSRLLYAARVSLSVGVGAVAIYVAI
GTILGAIAGYFGKWVDMVIMRITDVFMSFPYLMVILVLVSIMGPSLFNVILVLGLLGWPS
IARLVRGCVLTIKEMDYVKAGVALGYSTPKIVFQHILPNCIAPILVNATFGIASAIIMEA
SLSFLGMGVQPPTASWGNMLNEAQSITVLATQPWLWIPPGVMILLAVLSINFMGDGLRDA
MDPKSHK
>PK3-045_04463 Glutathione transport system permease protein GsiC
MFQYIIRRLLIAIPVLLGVTVFNFIIINLAPGNPVDMYINPDTIQADIDAKKEALGLNDP
IYIQYFRWLGNLLQGDFGFSYTTYEPVLDLVLNRVGPTLLLMSTALIIAYIIAIPIGILS
ATKQYSWIDYLTTTFSFLGVSIPNFFLGLGSIYVFALVLNILPTGGMFTLGSSGGFMDTL
FHLIMPAAILGTGIAGSTVRYVRSSMLEVMGQDYLRTARAKGLKEFIVTNKHGLKNALIP
IITIIGMEIPILIGGAVVTEQIFQWPGLGQLTIQSISSRDYPTLMAINFIAALAVLFSNL
LADILYAVVDPRIKYN
>PK3-045_04464 Oligopeptide transport ATP-binding protein OppF
MSVEILSKKDRIFKEQMQPLVEIQNLKKYYPIKKGILSKTVGHVKAVDGLDFSIYSGETI
SLVGESGCGKSTTGRAIVKLDPPTDGKVLFEGRDMAAIQNKELRKIRTDMQIIFQDPYSS
LNPRKRIGDLLAEPLIAHRLASKEEASKKVDRMLEIVGLTKFHKSRYPHEFSGGQRQRVG
IARALMLNPKLIVCDEPVSALDVSIQAQVLNLLKDLQKEFNLTYLFIAHGLGAVKYISDR
IAVMYLGKIVEIGKTEEIFRNPKHPYTQVLLSAYPIPNPHLRNRERIVVEGDVPSPANPP
NGCRFHTRCPMAQAMCKEKEPLLDGANHSVACHFPLS
>PK3-045_04465 Oligopeptide transport ATP-binding protein OppD
MVRNILEVEKLQTAFRTDKGEVISVEEVTFQLKPGETIGIVGESGCGKSVTSLSIMRLLG
KHGYIKKGTINLKGKELTTLTEAEMRKVRGNEISMIFQEPMTSLNPVFTIGNQMVELIRL
HMGLNAKKAKSYAVKMLKKVGIPRAEVIIDEYPHALSGGMRQRVMIAMALSCKPKLLIAD
EPTTALDVTIQAQILELMKSLKNESETAIMMITHDLGVIAEMADKVIVMYAGQVVEEADV
FTLFDEPKHPYTKGLIESIPHLEYDSQEKLYSIPGSVPTLQQMPKGCRFHTRCPHVTEKC
IAEKPPHISIDNQADHKVRCWLYETQQQGNMLEEEREVKI
>PK3-045_04467 N-acetyldiaminopimelate deacetylase
MLEKWYEEIEAMYEQMVEWRRYLHENPELSFQEINTSKMIGDLLESFGIEVRRNVGGNGI
VGKIYGAKPGKTIALRADFDALPIQDEKNVAFKSKVPGVMHACGHDGHTATLLAVAKVLQ
NNAEELAGNVVLLHQHAEESPPGGAIAMIEDGCLEDVDFVYGAHLASGSDLGSVLYRIGP
VSAASDAFELKIQGKGGHGASPHQTIDAVAVGVQIANQLKHIVSRRVNPQKPAVISIGSF
HAGNAGNVISDTAELTGTVRTFDEDVRSLIIEEMEQLIKGVCKAFHATYEFNYTKGYPST
VNTADETNILEKCLINTLPESKPVIIEKPGMGGEDFSYYLQNRPGCFFSVGARNEDIEAI
YPHHHPKFTFDERAMLHTAKIFLSLVDYYTNTERKEALVNSSTI
>PK3-045_04468 N-acetyldiaminopimelate deacetylase
MLKKWHSELAEMFDQMVEWRRHFHQYPELSFQEVETPRMIAEILEGFGIEVRRNVGGRGV
VGKIYGAKPGKTIALRADFDALPIQDGKDVPYKSKVPGVMHACGHDGHTATLLAVAKVLQ
DNRDSIAGNIVLLHQHAEELSPGGAKAMIEDDCLKDVDVVYGAHLSSLNELGKYYYKPGY
SQAAADAFEITIKGKGGHGSAPHETVDAIAVGTALVSQLQYIASRRVDPLNPVVLSVGSF
HGGKAQNVIADTAVMTGTVRTLDKDLRLFMEEEIKLMVNEICESMQATAEINYIKGYPAV
YNHEEEVEVFEKVIENSLDKNMLVRSVPIMGAEDFSYYLLEKPGMFFHTGAKVSEGKAYP
HHHPMFDFDERAMIYAGKAFLSIVDNYVSIQVKENLAEPVL
>PK3-045_04469 hypothetical protein
MFSYYSELCTELYDLTKPVGYSLNGDIEYYQERLKNCQGRILEAAVGSGRFIIPLLEAGY
IIDGIDYSPEMLNSCRKRCEERGLSPNLYEDKLQGLSLPFNYKAIIIPTGSFCLIEKRED
SLNALKCFYKHLVPGGRLIVDLLLPHDWKTGEISTSTFSLPNGDGITLENKSIELDWLNQ
FTISYLKYEKWRKGKLIQTELQRFALRWYGIEEFKLILENIGFSDITCSADYVYEKQPSN
ASQIITFEAVRKQ
>PK3-045_04470 Glutamine transport ATP-binding protein GlnQ
MIVVEKLKKSFGDNEVLKDISMTINQKEVVVIIGPSGSGKSTFLRCINLLESISDGTIHI
KGKNITDKSTNINEVRKDVGMVFQQFNLFPHKSVLQNIMLSPMKVRKVSKENARIKALEL
LKKVGLEDKANVYPDSLSGGQKQRVAIARALAMEPSIMLFDEPTSALDPEMVGEVLEVMK
ELAKEGMTMIVVTHEMGFAREVGDRVIFMDGGYVVEENTPVKLFTHPQEERTISFLSKIL
>PK3-045_04471 L-cystine transport system permease protein YecS
MDFNFTIILEYADLFKKGILVTIQLSLYAIVFGTVLGLLIGLGKIAKNQLVAFPFRCYIA
IFRGTPLFVQILIIHFGFIPLFLNTTNAMIAAIVALSLNAAAYIAEIFRAGIESIDRGQM
EAGRSLGMTHIQAMRYIVLPQSFKRMIPPLGNEFIVLIKDSSLAAVIAAPELMYYARLMM
GQYNRVWEPYLTVAVIYLVLTLTLSFFLTRLERRLKTE
>PK3-045_04472 Glutamine-binding periplasmic protein
MRKNGILFALFISIVLVLAACGTGSEKANSDGDGKKKLRVVTDAAYAPFEYMDKDKIIGF
DVDIFTAAAEEAGYDFEIVNVGWDPLFAELENGTADVGLSAITINDDRLKSYDFSVPYFE
STNKILAPEGTDIKKAADLTDKTVAVQSGTTGADAVDALLGNGNEKVKKFENNNLAILEM
KNQGAAAVVADNAVLEAYAKNNPQDNFIVIEDKEGFESEYYGFMFPKDSEMEADLSKGLN
AIFDNGKYAEIYKEWFGQDPDIENLKAQQ
>PK3-045_04473 Aspartokinase 3
MKVVKFGGSSLATGKQLEKVLQIVKADKERRIVVVSAPGKRYDSDTKVTDLLIQCAQAVV
NGSGYSSYLEEVLDRYASIAKELDLSSDIITNIKSDLLDLINTSSNIDAFMEAMKASGED
NNAKLVAHFFKARGLDAIYISPKEAGLIVSDDPGNAQVLSESYDRLYSLREEKRIIVFPG
FFGYSEAGDVVTFSRSGSDITGAILANGVKAELYENFTDVDAVYSVNPSIVTQPKEIKEL
TYREMRELSYAGFSVFHAEALIPAYRAGIPVQVRNTNNPSAQGTRIVASRNNTNGPVIGI
ANDKGFCSIYISKYLMNREVGFARKVLSILEDYHISYEHMPSGIDDLTIVLRQDQLTGKS
EQEILARISEELQVEEIKVEHDLALIMLVGEGMRRNIGTNARASKALAKAEVNIEMINQG
SSEVSMMFGVKETVVKKAVKALYEEFFVE
>PK3-045_04474 Staphyloferrin B transporter
MENQKYSKRNLGIMWFANFFISACMTMVLPFLSLYIESFGQYSPEFVQHWSGLCFSVTFV
AAFLFSPIWGKIGDKFGRKTILIILAIGLGISIFLMSFADSVWEVFILRFFTGFFTGFIP
MSQAFISTQTPKKVAGKVLGTLQTGSITGSLIGPLLGGVLADSFGYAATFRFTSLAIFIS
AILVFTTKEFVLPAQKGTKSSYTSKEVLAYILKNPVFITVLLISAFIQIAHFSIQPILSL
YVSKLHGPENIAFFAGLAFSAAGLGNLLMARKWGEMGDRSGHLKVLVILLFIAGIIYFPG
GFVNQYWQLLIIRFILGVAIGGMVPVRIAYIRQEVPIAMQGEVMGYETSLRFLGNIIGPA
LGGLIAGNFGFSMVFFSTSILLLASGIFLFTMMHRHPKLAKHSIS
>PK3-045_04475 hypothetical protein
MAKSKARKKRDKVLRENGFDTTMRRGSWGSIVPITKITKTKKERLTRNEKKYKQNHSSRY
DENGFYFLI
>PK3-045_04476 Inner membrane protein YgaZ
MESIKVVEQEQQHTLSYLDGVKDCIPTLLGYISIGLAMGVVGVSSGLSILHVFLLAAFVY
AGASQFIICAMIAAASPISAIILTTFIVNLRHLLLSSALAPKFTQYSIQKNIGIGSLVTD
ESFGVAITKIARKEPINDRWMNGLNLTAYLVWIAACTVGGYIGGWFPDPEQFGLDYALPA
MFIALLILQLQTIEPTKLKHYLLLITLMIVCMLIFSTFLSSSLSVIISTIVVATIGVVTD
K
>PK3-045_04477 hypothetical protein
MMSNMTFFLLLIGCTLVTFIPRVIPFLVARNFTISPSVEKWLSYLPVCIFTGLIVESLLE
TGGSNSISINWEALLATIPTLIVAFLSKSLLTTVLFGVVCIAVVRLVL
>PK3-045_04478 Glutamine--tRNA ligase
MEMGSNFIKNIMKEDLETGKHDTVITRFPPEPNGYLHIGHAKSIFINFGLADEFGGKTNL
RFDDTNPLKEDIEYVNSIKEDVEWLGYEWENLLFASDYFEEMYNRAVLLIKKGLAYVDDL
SADEIREYRGTLTEPGKESPYRNRAVEENLQLFEAMRNGEFGNGEKVLRAKIDMTSPNIN
LRDPVIYRIAHATHHNTGDKWCIYPMYAFAHPIEDAIEGVTHSLCTTEFEDQRPLYDWVV
RECEMESTPQQIEFGRLNITNTVMSKRKLKLLVDEKYVDGWDDPRMPTISGLRRKGVTPE
AIRNFCMELGISKGSGAVDSAMLDHFVREDLKLKAPRTMGVLNPLKVVITNYPEGQVEML
EAENNPENPEMGTRQIPFSREIYIEQEDFMENPPKKYFRLFPGNEVRLKHAYFIKCEEVI
KDEEGNVIELHCTYDKETKSGSGFTGRKVKGTLHWVEASQAIPAEFRLFEPLITDEDEEM
EEGKTFLDYVNPNSLEVIQGFIEPNMKDVKPQDKFQFFRHGYFNVDPKYSTPEKPVFNRI
VSLKSSFRL
>PK3-045_04479 hypothetical protein
MTLEKKLIEKTYYEGYLQDRDESPIEVLGQLYIAEQRKNVPDLTSIRFAQGELYFQYHDY
EAAIFKWENIGNELEPWAKKNLADAYLELEEYSTAESFYKSVVTDSELLQTEISLQLFSL
YFQKENHEMALGIINNLVLTNPDYANIPTIAKSYYEEQQNWEKAVELAVNEGKRTDGLKW
YEALIHYSNLGVIQQFEPAYFIESLKNLQELDFATFERLSISLWKNYEDTAYYLTWVTAF
NSIYEPVPCEGEEGLAHILESAYAHLIDGSYSIKEVEEIVPTLLSNYFLSSTGQQIVSAA
SAVLAWNEMYKHSMEQSVVSKAEMVINETTETNVSFQQFMNLFESIIEWADKHDIPLDKK
FTQKVHDFLPSDHYQLLMVGSAGSGVNAYINELVGETILAEDTNAILTIKDNDYLEINEV
TNSGLESIDTLTNFYKELLVQQESPRVFQLDTPSHYLNQNKWTVTTAPFVENASYADYAM
LADSLLFVINERSVFSYTEYEQLKQWKEKSPFLTLQFLIYIDDLDNEKVASKRLQKAMSA
IQHYFPDSKIFIYSKQEEREVQLDEISRYYYHHFAARKMNEERLQSCISIIQDLITNLLD
KRLDMEDSLKASLQLYEEMVSKLTGAKNQLIDMEASKSEIITKQFDEIKTETHEAIKKEI
PAILKGCKDFIKEDSDYSKMHISLNKEMNRRVNEYLNETLSPKIHRSIEDWIQAAHKQLE
DGQLFLNELSQGFNGIYNEHPIELSCDFVIIEDWKRDARRLSSGLRIEPLNIFNRFNASQ
VFLKSAGKLLGAIQQNNKMLQSRYQKYLETEDFSEVAASVSTAVLQHFDFYEKGLENDIK
MFFVRPKVTLEQFAEEKSKDIVEYKNLLERLKNNPELFHDPLKLFELRLLQYDWLANTTK
PATTWM
>PK3-045_04480 hypothetical protein
MEIDGGIGWAKSDYFPKSMFLYNLKVYCYFPLNNPHSVKCESELGKKTERINKKQGRKVR
WTLEDGGNNQ
>PK3-045_04481 Multidrug resistance ABC transporter ATP-binding/permease protein BmrA
MNAYKMLLLAINDTKKKILLFTIIIASILFTAATLFFPLLVKDIVDEFSMNEISLWMVGG
LVLFLVIKSIIEAVNQYIISKFGNMVIRDLQKNIYNKVIYFKVDFFDDYHSGELSSRIVN
DTEIVKDLITYHIPKLVTGIIMILGGLALTIILDWKLTVVVLIIAPFIFGIIFPLMRRME
NTGDRQQKETSVFISKTQETFKNIKMVKASTAEKQEKSLMYKCIDRLYNANLYESKVFAI
VAPLVNFLLILGLLIVVGYGAYRISVGTLTISTLIAFVIYAFQMMTPMSSISGFIGEYHK
ANGAIKSLNNIMNNNEVEFTGNIEYKFLHELSFNQITFGYKDKPMLSDISFTIKRGESLT
IVGPSGSGKTTLINLLEKFYHPESGSITIDNINISHLNTYELRKNIGIVSQGSSLISGTI
LDNLLYGLDEDQIDESKIREALKYANLQEFVDRQKDKLNTNIGESGDKLSGGEKQRLNIA
RLFLKNPDIILLDEPTSNLDIESRNLVLESINKLTKDKTVIKVTHNLEEVKPGDNVLFIE
DGEIVCEGSHERMSEMNKRYKEFISTAAV
>PK3-045_04482 hypothetical protein
MNKVLSLQKEAISKDVQLKAKSLASIQCKGSSNASWFFC
>PK3-045_04483 hypothetical protein
MNKVLSLQKEAVSKDVQLKAKSSKSIQCKGSSHASWFFC
>PK3-045_04484 hypothetical protein
MNKVLSLQKEAVSKDVQLKAKSSKSIQCKGSSHASWFFC
>PK3-045_04485 hypothetical protein
MNKVLSLQKEAVSKDVQLKAKSLASIQCKGSSNASWFFC
>PK3-045_04486 hypothetical protein
MNKVLSLQKEAVSKDVQLKAKSSKSIQCKGSSHASWFFC
>PK3-045_04487 hypothetical protein
MNKVLSLQKEAVSKDVQLKAKSLASIQCKGSSNASWFFC
>PK3-045_04488 hypothetical protein
MKNVLGLQKIDKKERKNGDILKSSVSLGCSPSSNTSWFFC
>PK3-045_04489 putative SapB synthase
MDNRYIKYINEGYYYNVASENNQRLLHLDCPPDNYIVIDGEHWINVLERNIKLPNQGWKI
HISTNMKEAQTTLDIVSKLMIERNISFKYVKSMTELLMKDSKYGDRGSSGKFITIYPVNT
NQFIELLSLLENSLSHLKPGPYILNDKRWYDSNVYFRYGAFAPRFTFIDGVKVDAIENLQ
GELIEDKRVPYYYLPDFVEEPPEIIAMDKAMDQNDTYSPLENYDIKEALHFSNGGGVYIC
ENKLKNNTKVILKEGRPHAAVDAQGRDAFSRIVNESEILDKLEKTTFPVKKISSFRAWEH
YFIEEEYIEGDSLSEWLVKNYPFSSTLKNESYTEACINIINQLIEAIHEIHEHNVGMGDL
QPANVIVTPEEKVRLIDFETASTTNDSLSGLMTPGYIGHQEMNKEQSDWFALLRIAKQLF
VPIGSVQDISWNLDTIHSKWVHVVFGEKATKIIDKVKSLCDFYQSRPMDELLSTNGQLKQ
DFDLSILKLKLRNSILKDVKMEDRLLPGDIRQYEMEAGIINVLTGGFGTAMALHRTGGIN
QTVKDWIEKQEINQLLHLENGLYTGKMGIAAVLWELGYQEKAKALFDSDIDIKNMEDISL
AAGLSGIGLAYLGLSYEYDNPRYLDICLSIGEILIDKLNSNAPIITFDYDVVDKGVMTSW
SGVSLYFTALYKKTKDQKWLELSEKALEKDLKLGVFDDDGLYHIDDDFRILPYLAGGGSG
LAIPIIELELNADIKKWDKEIDGICKISKSKCFYNAGLFQGTTGILAIANLLELYTNKNS
LVSSALFTLNLHLLENDDCIFVPGDSCFRLSGDIMSGSAGLLLVINDILENRNYSWLPIL
NLEKVFNSSILKGGNSQRKVELSFSGN
>PK3-045_04490 hypothetical protein
MSRTDVLSLQSLRYKKNDEPPIGSNVSVNCKTHSGLSLFFCVVPR
>PK3-045_04491 hypothetical protein
MFKLSMNENQIMNTGILKIKQNKTKFISNASLIMGWKYPLVCTAAHCVFDWYKQTNANEI
TFITYDNQEYEVEEVYVSKEWVQNGIVDYDTAFLTLKKPPLETDNIIKPIFNNTSKKQHA
LIPYIQKKFFRKNKIEIIKNITFEDHIHNSSLLGVKGKAGVGSSGSPWLLEKDREYFQFS
NTSLSFNSVKDIVWGPYWGEHIENLYLHANKKGNNLESIKTYKL
>PK3-045_04492 hypothetical protein
MKKIFLSILFLFILSACSNEENISTSENQIPDTKNVEIPSIIFSSDKQNSVIDEKEMKSS
IKTYLDTYEALQLASYPFQEMIEEEKELTKSELEKLDQIYRLTKENDENFSNYISQNTLP
EGYLEESERISRYITGVNEIIYEIDTMLNQLTDDIEKEVIPTVNFDSINKKSDVVNGREQ
KKIEEFLERKNIDTKAFGKNSQGKTE
>PK3-045_04493 hypothetical protein
MNKNNFLKLLKNSLKFMSEKEKKDILEEYSMHFTEGLSENKSEEEISKELGNPEEIAKEL
NAVYAINKVEEKKSIRSMLTAMMSIMGLSLMNCIIIIVSLFFMLLLTPFILAYVIGVPIM
ILSPIILIVMGFVDGSTIGIGEILESIKGVIIGAILAILGYYIGKSFIKLFIKYLKWNAS
IARGKNGL
>PK3-045_04494 hypothetical protein
MNAQFKKGVLELIVLIIINKEDEYGYSLIKKISNKIVISEGTVYPILRRLVKEKYVTTYH
EESKEGPFRKYYRITKEGIAKLESLKMEWNEFFLTINRFVEENDKLEQK
>PK3-045_04495 hypothetical protein
MIFIDFFGALFETIPMLLITLQLLNKFHFSKIQILYLFSISLGTAIFLTLSLSYPFIKLP
LAVVILAIFISKLYKVKFTFSILSLLLSMTLLLIVQLINIIIFDLLFAGSSTFNQIRFIS
GLVNGSLLTLLLLFLRAFRRSLIPNHDISQAKTPKFWWIFPLFVVLFMLIVIKVIQDDGI
SITSAYLIITSSIAFIYLTRYLVYLNTIKAEKKLLTEQEKSAKFYLRSIRAQRHDFIFQL
NTINSLVHLNRINDLKAYLSELTEEFQTTSETLPLHYMSIAGLLIQYKQVLKKDGINFNI
FISDTFELIPMPVYEFNNVIGNLISNAYEFIKSNETASREIVIKFYKNQYLIVEVLNEVN
PELLDLENIFQDGYSTKTTYENGLGLSNIMMTLERYNGYIYPELNNRTLSMFVLIPPKER
K
>PK3-045_04496 Accessory gene regulator protein B
MVNPNIISNEVTNFVIKHAPEYKDNKEYIRYGLEWIISLTIQISVILILSALFGVFIEAT
VSLFTGAFLRTFGGGAHFKSYLKCVVYSTILILILSIATKHFLALNMIAVLIIYLISMFI
YNKKAPVLHKTRALFNNNKKMLFKHISLFFITTLFILTILSPIGKSSIISSIWLSVLFQS
ISLTKWHHDMTDWLDKKTTRKVDYL
>PK3-045_04497 hypothetical protein
MNLFTKVLAKIIGKVGFMASKGTLASYWFTYEPELPSKDQKNDSK
>PK3-045_04498 Transcriptional regulatory protein YpdB
MSKLSIIAIDDDPIQLELYKDIFKESPYNLVYTSTNGDSLPIFLSENKVDIALLDIEIAS
QSGFKLAEHINQYYKNIKIVFISNHKSFALDAYNFYPLDYIVKPVDVFRLFQTLTRVNYV
NKDDLRVGVKTSTGYLLIKKDEINFIGKTIRKTTIHLTTGELIESNEKLEILEAKLAKHG
FYRIHKSYLVNLERVKKIQKDEFMNSYNLVLIDSKETLPVSKHRIKGLKDLIFSEFSF
>PK3-045_04499 hypothetical protein
MSEFFSGFFNILYGAFGVPLLLIVLIILVIVVSQRRRKKKMKQEDWMGHSSVEKIEKDNK
EK
>PK3-045_04500 putative protein YlbL
MNKSRKSIFSKKWLAILFGVLIILLFIPTPYYLNQPGSIEALASKVTVEDGTKSEKGSLN
LTTVYSIKVNNPYIYLYGLVAPHTEIRKEEEVKGNLSDEEYNKLMLHMMATSKQNAIVAS
LHAAGKKVEFTYNGIFVAQVLDNSKAKSIIKVGDIIKKVDGKSFAKSEKLIAYLKEKQAG
DIVHLEFLHGKEKKEADVEVIELDKRTGQVGIGIAPEDNMTIHPSVDVEINSENIGGPSA
GFMFSLEVYNQIVKEDLTRGYKIAGTGTMDAEGNVGQIGGIKHKIVAAHKEDVDIFFYPR
DITEYDTNEKEIKEQVKEEGYTDIKIVPVSTLQEAIDYLEKLPEKK
>PK3-045_04501 HTH-type transcriptional regulatory protein GabR
MIFITIDRSHSISLTQQIYEQVRNGILEKRLKEGDRLASSRELANSIGVSRNIVLEAYER
LIAEGYLEVKPKSGTFVASGTSLSFTENTRRKETPKKSDANKKMYIDFKAGNPAIDYFPR
KKWAQLTKEICLHSPEAVFGYGEASGMKELKNALVDYLKRVRGVQCSAEQIFITSGATQG
LKLITEMLGKGNKTIAVEDPVTDEMRNIFTFSNGQIIPVPVDENGIDPKELPTQSPSFVF
VIPSHQFPLGGILSIQRRLQLIEYAKKMDCYIVEDDYDSEFTYEGAPVPSIQGIAPNRVI
YVGTFSKILSPGLRIGYVILPEELISDFEQIKWFSDRHTSSLEQLVLARFIREGYLDRHV
RKMKKIYKEKRERLVLAIQQNFKHATIIGKSAGMHLVVEIPDTDFHSTFIHKIEEYGVKV
YPIEQYSLVKGKHKSRIVMGYGGLSLEQIEKGVQLLREILERDK
>PK3-045_04502 L-aspartate/glutamate-specific racemase
MKTIGLIGGLSWESTADYYRYINTFVKEQMGGLHSAKSLLYSFDFEEIVALQKAGHWNEA
TVLMINAAKTLEAGGADIVIICTNTMHKMAKEVQAAINIPLLHIADVTGNEIKKTALKKV
GLLGTMFTMEQSFYKDALFQQEIETIIPDKEDREAVHQIIFDELCKGIILPESKAIYLRI
IEKLQAQGAEGIILGCTEIPLLIKQEDSSIPLFDTTFLHAKAAVSYALGQNFVLK
>PK3-045_04503 Alkaline phosphatase 3
MNLKSWKKKLLPIAVISSLTVAGLATVLTGTDAEAKNKGNNNGKPKNVIFLIGDGMGVSY
TSAYRYLKDNPKTKTAESTYFDPYLVGQQMTYPEDPEQNVTDSASAATAMSAGIKTYNNA
IAVDNDHSEVKTVLEAAKEKGKSTGLVATSEITHATPASFGSHDINRKNMNAIADDYFDE
MINGKHKVDVLLGGGTDLFVRQDRDLTKEFKKAGYNYVKNRKDLLKNKDTQLLGLFAEAG
MPKMIDRDKDTPSLEEMTKTAINSLNKNKKGFFLMVEGSQIDWAGHDNDIVAAMSEMEDF
EKAYKAAIDFAKKDKNTLVVATADHSTGGFSIAANGDYNWYGEPIKAAKKTPDFMAELIV
NGANVESTLKDNIQLSLTSEEIQAVQKAADTKDLTSIDNAIEDIFNKRTNTGWTTGGHTG
EDVPVYAYGPSSNLFAGQKDNTDHAKIIFNLLNTKIKITDK
>PK3-045_04504 hypothetical protein
MKQIMIYLFIFLLLAGCSSKETNTSTNKHNLKKEAMSTENDDIRTVSTDIYAPNPQVIDD
ATLLTAGDFYRDRKGEATLKAIMKEAKNVQVDSIRLTIKDVKLIDYRPAYSLIDFYHTYT
HDEQFTFIKFFVEIENLSDERKKFSPVAFIQTNKDEMITWEKDIYLEELNGVLKPGERKK
GNIGFIVKDSAINKVQLTTSDAYTEQDKILGEAKTIDFHFK
>PK3-045_04505 RsbT co-antagonist protein RsbRC
MHYNQGVYQYFIDNTERLTAEWYKDLTKNDPKGVYATTDPYTIETMKKQNNDFHLRLAGL
FIKEREEFLEDIKEWIYQIATDQAHLDTPIHFIIREFIRTREQYFQLIEEYAVKHHVEQE
RVTEWSHSVVKVLDKIILKYTEEHHNYSNRQLIAQQEMINELSSPVISLSKTSALLPLVG
DIDTARAAFILENTIKQCAEKKVFRLFIDLSGVIIIDTMVAHQIFQLIHGLSLIGVNTTL
SGIRPEIATTAIQLGLSFADISIASTLSKAIEQDGNFEK
>PK3-045_04506 Catechol-2,3-dioxygenase
MTFHNESTIYAKSITLKVSNLEKSLLFYTKIIGFSVVSQDKMTASLRAGKGVPFLFLEEL
KEVEPKMVRTTGLYHFAILVPSREELGIILNHLLETGYPLQGASDHYVSEAIYLADPDGN
GIEIYRDRKATEWEWEDGLVKMDTAYMDTKGVLASAGNRPWKGLPEQTILGHIHLHVADL
TETVDFYVKGLGFDIVQKYGSQAFFLSTAQYHHHIGLNVWNGIGAPAPEKNHVGLAYFDL
KIPDHEKLEEIKHRIVQLGALVKEKEGKWYTWDPSGNAIHLTVT
>PK3-045_04507 HTH-type transcriptional regulator YodB
MNHSTICPRFEKAMSILSQRWTGLIIYQLLNGPQRFCSIESSIGISGRLLSERLKDLEQA
DIVVREVYPETPVRIEYSLTEKGRSLEPIMKEIENWSHSWLEV
>PK3-045_04508 hypothetical protein
MYLSVQETAELLSISEIKVKNLILQNQIRAIYDGTDYLINKEQFNTHFKQVEKYKTFVEE
VLSEPIPEDLDIKDED
>PK3-045_04509 hypothetical protein
MSFVLNSLFLVMIFCCFSFIFYQSFFAKTRKASAPISPTIKLENDSCKLENTGVFSKDIK
LSAE
>PK3-045_04510 putative signaling protein
MPSADSVTYLQVEYSIPIILLSILIACLASYTALSMNERIVYNSFFHRYIWLGLASITMG
FGIWSMHFIGMSASMLPVNMKYNIPLTILSIVPAILAAFLAFLLSSKARNSSRLIVFAGI
CMGIGISAMHYIGMKAMIIEANYAYHFGYFTLSVVIAMLASFASLFIFLKLQPYMSNFIV
KCITSLLMGITISSMHYTGMYAVRYYVDLERDLIHSHTNHLSIKSIILGVSISMAILFLF
SILSSLLDRYVDYRLNHFDALTKRPNRRQFEKVIDSAAYLSGIAILHIHNINKWNSKYGY
CFGDKIIIYIDELCRKLVGHNIELFRIEGNRFAFLSRTNEDLENLILELNQLTAIISSPV
IIDDQIIKIETAIALSVNEKKVSAKQIYINAVAVLAHYSLRYENEIIKYDSDKHKRTFAN
HLVNEIEDALIKKQLYLVYQPKVILQSKEVAGVEALLRWKHPRYGELSPGIFIPILEASE
KMWEVTDWIMEEICKQMARWQNQDRSLPVAFNIPGPYVTSPRLMRNLVAYIEKYRLSPSL
IELEITETSAVGNMEGAIQSVQAYRNAGFSVALDDFGTGVSSLSYLKRIPVNTLKIDKTF
IDEVPESQKDGEIIKAIIALASSLHLSIVIEGVEREEQIEYLSSINKWPIIQGYYYAKPM
NNLALEEWLYMFAEEKTG
>PK3-045_04511 hypothetical protein
MNYDKLLHIGTEEVQVGFHKSYHYHRYEPTPYEHLEQLFREFPLREADHIVDFGCGKGRL
NFYIHYVFQSTVKGVEINEDFYHQALHNLERYAKNRKKKKEKIHFYLGRAEDYLVQPEDN
YFYFFNPFSLPIFQKIISNIIYSLEESSRKVNIILYFPSDEYRFFMDNHALFKQQGEVKV
GNRTDKDTFIIYQSLY
>PK3-045_04512 HTH-type transcriptional activator RhaR
MKALIVDDERHVREGIKLLADWSGNEITDIYEASNGEDAIQIIEAANPEIIFSDMKMPKV
DGTQLLKWMDEHYAHGKTIVVTGYDDYHYMRKAMHYGSSDYLLKPINPEMLNDTLRRVVN
EWKQEEEERKRKLNRTKLINKMKLAYRDHQLTQMLNNDLFDKHVLEEFLLTKAQVYTIGL
LQVSNGIVEEFNGDKDLTLFTLLNVINEELSSNNKGIAFHYVTGKGEIVLLLIRRKEEAV
VIMREVHTTILKLLGISCTLSMGLEVTSINQLNLSYQHAKSIMMNRDVLDNQQGKIMIEK
KEHEIKSLMGYSSSIKMAIQTGEIHAFHSLIGQIQKDITNNPPLSLSQLLHLEHEYLMIS
TRWYKEFNLSIRIPSNIEERIYSFMDKEGIFQLEAYKARKKKEISLFLRRVKRQNTRRTQ
NVIHEIEKYIKANFHREIKLQEISEHFYISREYISRKFKQEYNINISEYLVTIRMKKAQE
LLKSSNLKVYDIANMIGYQDDKYFRKVFKKIIGVSPNEYREMEIR
>PK3-045_04513 hypothetical protein
MKWGIRKKLMIFLLLATILPFGSSIVLTYFQTIHHVNKESVAYNTELMKKGKEELGTYLE
DIALMSTVLYRYTPFMNVLTQGVGENNKENMEEVRRVLAYVYNSRSEIEQMHLYINKGRD
SVTNYHSRISGRGENKNIYFHPYYRRLEESETNYSLIEPPHTIYSYNGLSIIPNSEKSTV
LSLHNKIRNVPSNDILGFMSIDINLSIIDGIVNRLYNDKEGISIINENGTVIYSSNKAVI
GKKTKDKWFYKVQTNPQQNNMKWESKDFSGVIFYENIAVQDNSWYMVKSIPYSSLYQGAK
ATAFMNTMIALVALVIVLVITMIISFKITAPIKVLMENMKKVEKGIFVANFEAGGYDEIG
MLGRRFKSMVLQINRLIDKEYKLQIENKSAQLKVLQSQINPHFLYNSFQSIGTLALKMNA
VPVYTLLTSLSDMMRYSMDMREDVVPLTKELKHTQSYLSLQKQRFEEDLNIILTIEQSTL
EIPVPKMLLQPIIENCFKHGFSQKMEDAGITIRAYTEDGDLVIIVQDNGIGVSSERLKMI
HEELYDEERRKENKERESIGLINIYDRLQLYYEGQASFVIDSIEKKEFTVMIRIPIFLYE
GVIDDEGTNR
>PK3-045_04514 Melibiose/raffinose/stachyose import permease protein MelD
MNNPNNIEKVETPPIHQTSVTRKKSLSTKKKKNWKEAGLFSLFVGPVFIAFTIVVLVPFF
SGIYYSFTDWNGITGEIKWVGLDNFKYIFTDDKQFLQSFKLTAVYTVVAIILTNAIGFSL
ALLVTQKLKSSNLLRTVFFMPNLLGGLLLGFIWQFIFIRGFASIGELTGIPLFELAWLGD
KNTAFWGIVIVSVWQGAGYIMLIYIAALQNIPKELIEAAKMDGANRFQVLRNIKVPLVAP
AVTICLFLTTASSFKIFDANLSLTNGGPFKSTEMLALNIYTEAFVNNRYGIGEAKALIFF
IVVAAISILQVTITKRKEVES
>PK3-045_04515 Melibiose/raffinose/stachyose import permease protein MelC
MENRYTSKTFLMELLGIILGLLFLIPFYYVISNSLKPFSEILTNTSSLPSTFEFGNYLNA
FEKLNFLKVFSNSLLITIASNIVLVVFCSMAAYMLVRTKKKISTIIFMAFVAAMIIPFQS
IMIPLIKTASSLHLLNSIWGLVFMYLGFGSGMTIFLYHGFIKGIPVELEEAAIMDGCSRF
GVFWRIVFPLLKPITVTIIILNSLWIWNDYLLPSLVLQNPELRTIPLATFFFFGQYTKQW
DLALAALMIGIVPLLIFFFSMQKHIIQGITSGSIK
>PK3-045_04516 hypothetical protein
MKFNKMKRYSLLTGILSASLLFASACSNEGASSNTSSSKGDKVVVDLFNGKVEIADQLKA
LTDQYSKEHPDVTFNIETVGGGADGTAALKAKFASNTAPDIFGNGGYQEALTWLDKLEDL
SDQPWVKDAYESALVPMTVDGKIYGQPVNLEGYGFAYNKALFKKAGITEIPTTFSELEAA
AKKLKAAGITPFSIGYGEWWVLANHGLNVPFAYQEDADAFIKGLNDGSAKIEGNEHFDKY
FDLLDLTIDYGNKNPLTTDYNTQVTLFATGEAAMIQQGNWIQPMIDKISPNLEVGFIPMP
LSDEKEKSDKLMVDVPTNWVVHKDAPKKDKEAALDFLNWMVTSDFAKESIVKDFKYVPAF
ETITATAEDIGPLGAEIQNYSQEGKTYTWQFTKYPDGAGQEFGASLQAYVGGQKSREETM
KALDDTWAKLKK
>PK3-045_04517 hypothetical protein
MRSLKKLMAISLSSVIFLTSAIMVQAETSQETLNKAKNQLDQNQQLINEKEAEKQKTLKE
LEAVQEELKSIETVMQQNKDKIANLQVKIEETQQQIEKKKEEIVVLEDKVLARKDVMKDR
LVSLQNTDQTNVVLEVLFNSKDFADFLSRATAISMIFDGDKDILEQQQADLQKIEEEKAA
IDQQEEELTGQYDELAATQNELQQNVAQRQEAVTAVQKKYASVSKEVELAESQKKAVLDQ
IGAAESALKKEQEEAKKVVKVNSPAKKVASASTKSKPTTSKASSSKSSSRKDVIYVTSTA
YSHQDTKSDFTALGYNIKKNKNMKLIAVDPAVIPLGSKVWVEGYGEAVAGDTGGAIKGHK
IDVLMPSTSKAKAWGRKTVKIKILD
>PK3-045_04518 putative N-acetyltransferase YvbK
MKIRKLREGETPPFDLLLLADPSEHLIREYLKKGICYMAEDRDQTIGVYVLLPMEEETIE
LINLAVGESYQGIGLGKRLVMHAIEEARKLGYNRIEVGTGNSSISQLALYQKCGFRIDRI
EKDFFLQHYEEEIYENGIQCMDMIKLTQDI
>PK3-045_04519 Tetracycline resistance protein TetM from transposon TnFO1
MNKTIGILAHVDAGKTTFSEQLLYHTNSITKRGRVDHKDSFLDSHIIEKQRGITVFADQG
IIEHGDSTYYLIDTPGHIDFSPEMERAIQVMDFAIVIISAVEGIEGHTETVWNLLRKHQI
PTFFFINKTDRTGADVARVLKEIRSQFTTDVYDISSLDNSSMSDVQIEFIAERDEELLDY
YMDNGYQPTLWMEKIQEMIISSRLFPCGYGSALQDIGIKEFFDQFHQLTKTMYRKNQPFA
GRVFKIRYDQAGTRITFLKAITGTLHVRDELPYGNGMVEKITQIRKYTGKQFQQVNEAGA
GEIFAVTGLTEAIVGDGVGAMLEKAVYELVPTLRSKVVVEDGVNKKEVLKLFRILEAEDP
SLQITWEEKQQDIHLHVMGKIQLEVLQELVLERFSLNVHFGQPEILYKETIETATVGYGH
FEPLRHYAEVHLRIEPGKRNTGITFESRCHTDDLSLANQHLICQHLFERDHHGILTGSPL
TDIKVTLLTGRAHNKHTHGGDFREATFRALRQGLEKVQNRLLEPYYAFKIKVAIEQMGRV
LADIQMAHGVFDTPETIDNKAIITGKAPVATFMVYSTILASFTQGKGQLSFTFAGYYPCH
NEQEVIAGLDYDKNADPAYTSSSIFCAKGAGYTVPWQEAEKMMHCL
>PK3-045_04520 hypothetical protein
MYRLFYFVITILMMLLGLSSRKFSNHLPDFIAVHAGDMIWAMMVYFGFRFLFIRKSLLLA
GVLSILFSFGIEGSQLYQADWLNQLRDTTIGALILGKGFLFMDLIRYSSGILLACIVDTF
FVWRSKRD
>PK3-045_04521 hypothetical protein
MESKGCVKCGGTDIGTKDVAMTGTGLSKLMDIQHNTFTVVFCKKCGYSEFYNKQASKGSN
ILDLFLG
>PK3-045_04522 putative tRNA-dihydrouridine synthase
MKGTEFYMIDNFWRELPRPFFVLAPMEDVTDVVFRHVVSEAARPDVFFTEFTNTESYCHP
EGTQSVRGRLTFTEDEQPMVAHIWGDKPEYFRQMSIGMAKLGFKGIDINMGCPVPNVAAK
GKGSGLILRPEVAAEIVQAAKAGGLPVSVKTRLGYTEIEEWQDWLTHILEQDIANLSIHL
RTRKEMSQVDAHWELIPEIKKLRDRVAPNTLLTINGDIPDRQTGWELAEKYGVDGVMIGR
GIFKNPFAFEKEPKEHSSKELLDLLRLHLDLHDKYSQELETRSFKALHRFFKIYVKGFRG
ASELRNQLMSTQSSDDVRAMLDDFEAKNADETGIVG
>PK3-045_04523 hypothetical protein
MGKFTPHVATLEIPVSNLKNSLNWYLAIFDLKIHYQDSITAMLTFETKGVPTIYLVETKE
LNKLSFKNTITENVHSIIDFFTPSLAEFHSWLKEKNVVVGTLNIDPNHGFGRFSFKDPDG
NLLGVTNVLHPKQLHNKFSCHAIQLLKKSWIANFTILF
>PK3-045_04524 Crotonyl-CoA reductase
MKALIHDNLNKNGQLCIRKIPDSSPKKNEVKIKIKVAGLNRRDLFVMKNRDEEEGEFIPG
SDGAGVIVEVGSDIYSDVLNQEVIINPTLNWERSDDVPISPDILGGPTNGTFAEYVTVPF
KNVVQKPRQLSWEEAGTLGLSAVTAYRALFTKGKLKSDEIVLIPGIGGGVATFAMQFAKA
VGAKVIVTSRHSQTLKKAQRLGADITLNSNIDWKDALGDTKVDLILDSIGPATFSKYLEI
IKPNGRIVCFGASSGDSITLPLRSLFYPQIQLIGTSMGSTQEFEEMIHFVMKHSISTVTE
NVYPFEEAKIALEHLENGVHFGNIGLAMY
>PK3-045_04525 Purine efflux pump PbuE
MKKNINQVIIILLSLGAFVMGTAEFVVSGILEIISSDLGISISIAGQLITVYSLSYAMGA
LVLVVLTAKFERKKILLYSIITFIIGNIVAFFSYDYFLLILSRVIKAISGGLYIVVATNY
AAQIAITEKKGSAMATVITGFTVSLVLGVPIGTFLAAYLNWSYIFLIIAVFTVFLLLLLY
KLLPSIKGKKPIPFKQQIQIIKDRRVIMGLITTIFWILGYTMVFAYISPLLSNGANFSIE
MTSIALFVLGTFAFLGSRFGGYAVDKWGPNRTISISLLVHAISLFVLTVTQYSIIGVFIT
LAVWGGATWTTTSAKQFYLISLKPQSSETILSFNTALMNIGMMLGSALGGILIQHTNIIN
LTWIGGLFVILAFIFINYSFNLNKAKLRKVRI
>PK3-045_04526 HTH-type transcriptional regulator GltC
MSIVRLEIFSKVIELGSFTKAAKRLNMTQSAVSHAISSLETEWGVSLLIRDRRKGISLTE
IGKNTLPHIREVLNRMESINQEIALAKSIETGTIRIGTFASASSCLLPKLLVKFQKKHPN
IEFKFYEGTYEEITEWLLSGIIDIGFVVEKESNTNFELVPLIKDKMVVAFHAEHKFLHKD
TIDIRDIEKESFIMPTGMYQSHVEELFKQAQIKPFIRFEVHDCNTIANMVQEGLGITIGP
ELFLKTQQNIKIGNLNLTNYREVSLACSAISEASPAVKEFLKVANNVFTDSNKTTNK
>PK3-045_04527 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MSKTLPVQKNDILDIVFEDLTHEGSGVAKIDGYPLFIPNGLPGEKATVKVIKTNKNYGFG
RLLEIKERSPYRVEAPCLIYKECGGCQLQHLSYEGQLKTKHKHVKDVLERIGKINTIVHP
TLGMENPWRYRNKSQVPIGEQEGGLIGGFYQQRSHQIINMEQCLIQQEENDYVVNTVKDI
CSKYGVRAYDEARHKGDLRHIMVRRGLVTKEIMIVLITRTQDIPNRKAIVDEIVQKVPNI
KSIIHNVNNKKTNVIMGDTTRVLWGEETITDYIGDVRFAISARSFYQVNPEQTKVLYEKA
LEYADLSGEEKVIDAYCGIGTISLFLAKKARKVFGVEIVPQAIEDARNNAVLNDIHNVDF
AVGEAEVVIPNWYKEGNEADVLVVDPPRKGCDEALLQTILDMKPKKVVYVSCNPATLARD
LRILEDGGYKTEEVQPVDMFPQTMHVEAVARLTLNIV
>PK3-045_04528 Diacylglycerol kinase
MKRARIIYNPTSGREAFKRHLPEVLKRLEEAGYETSCHATTGPEDATYAARVAVERRFDL
VIAAGGDGTINEVVNGMAEQEYRPKLGIIPVGTTNDFARALHIPRDVIGAVDVIAKGDTI
PIDIGRMNDKYFINISGGGHLTEISYEVPSKLKTMLGQLAYYLKGIEMLPFIKASHVRIE
YDGKLFDGEAMLFLVGLTNSVGGFEKLAPGASINDGLFSLLILKKANLAEFIRIASLALR
GEHINDPNVIYTNANYIKVSSDEKVQVNLDGEFGGLLPAEFINLYRHFELFVPLDAIRDE
DRPDVKDYKEMLQIDNNKE
>PK3-045_04529 hypothetical protein
MRTWRVGTFSMGLSLVFLGVFLLFTQFFDWKIVTVLKVWWPIILVILGIEILLYLFSTKQ
EKPYLSFDLFSIIIVGIIGTAGIAMVFLQSSGIMDLVEQGLKREEVTSDLPEFNYAMKDD
IKRIVIESDNRQNPITIEGTNDDVLSLFGTYRAVQSKKEDVLKPEDYLLVSQKGDTLFIR
LKQLPYRVSEFYRDYASINTTILVPTSKKLDIIDLQNDITVNPRNLKNNWTINNVPQIDL
ILDETKNVKVSVDDTLINNQEQEDWEFPNKEKKHIEEITNAFLQKGKGGSSINIFDSGTL
NVTNH
>PK3-045_04530 hypothetical protein
MKNPIVATILAFFPGGGLFYIGKKLRGFFYGLAVFGLAFVSIVMLSAGSLNELTFIVVFI
GFIIYCISFIDTLITTSSYLKKRVSLAADSETGEAAPILAKTTESERFYTIVLSFFPGLG
HIQLGLVYRGITLLTTFLGLGIMIIFIAFLTYTNEFLLFLAILPVIWVYGFYDVSQQFNK
KLKGEALEDITIFQDFEKNREEGKKSKFIATFLSVFPGAGHLYLGLQQRGIQLMAAFLFS
IFILNELRLGLFLFVIPIIWFYSFFDGLQKASKVGEEELEDVPVIAYLINYQKWFGIGLL
VVGLYYLMINIILPIFSPIIQKEINIDLHFFFYQYFQTGIVCLVLIIGGIHLLKGTKKKK
I
>PK3-045_04531 hypothetical protein
MTAHYSKDYWMKYVKDELGEKERSLLEDHLYTCDQCLELYIDAVDKQEETLPSISDEAAF
MNDIMQKISYENMEIKTTEEKKRRIYQSSIFHYAIAASLTLILMSAGFFQSIVKHTETIQ
KTEVSFKNEPKSGGLVDKTFAWMDSFDGSKKEEVKK
>PK3-045_04532 ECF RNA polymerase sigma factor SigW
MAGKGGEAISDQVLIEKIKAGNDHAFRLLVEKHRDYLFRSIYSILKDQKEAEDATQEVFI
KIYTSLPKYENQGFKTWITRIAINHAIDMRRKKQRRKEEMAEELESHIGGSQTDDVELEV
LRRERQRLVQKRLEEVPANYRDVIYGFYIQEKSYQEMAAEQNVQVKTIETKLYRARLWIK
THWKEEEFL
>PK3-045_04533 hypothetical protein
MHYLFALLALTLNPFIWKSHFHKKIFLVFQITRLLAGILIIFCLDYFQLVDHSLQALFKF
GSIFLAFFLLLDLLFGKVKGYRITGILFLYFVLFSLYVQFIYPLTITGDKYQFVQEKATV
IDKEAVSTNEKHIVVVPESYARYRSEKKLGEVSHPSYYDLGTSTLQKINDHLYWVTPIEY
TGFFKWIKGDDVPGFIKMSAEDENEDAILVKSSMKYVPSAFFQEDLKRLVRSKHKDTILL
EASFEPDDNDKPYYVVPYGQYNKFREIVDIKGIYIIDPATGKIKDYGMDNIPDFIDHVIP
TSVAEDWNEWYGKYIHGFWNTLFAKEDMKLPTAWEDMNEVNGVFNEDLQLHWFTDFTRPK
TDSGSMVGYSMLNARTGALTFYTEANGSLNGKSAINVAEKTFRAQKYEAGTPLLYTIYGQ
FTWVVPLMDSNHVLREIMLINAKDEKVYSYHTEKTKLFNDYKYALVTLLKNDKTVPNNIA
DKKTITGTVDYVYKAEVENSTIVKFMLEGNKTIFQVSSNDFPYSIFLEKGMQLTVDYVDT
EEMIVTVEKLKISNQELNN
>PK3-045_04534 Glycerol-3-phosphate acyltransferase
MLILLLASYLIGSFPTALIIGKVFYGIDIRKHGSNNPGATNSIRVLGKKAGIAVLLLDVG
KGALAASLPYLLMVDVNPLYTGLIAVVGHCFPIFAGFRGGKAIATTAGTLLVANPALFLI
SYFAFFAIIIITKYVFLGSISVGITIFLYALFSPDIQHDWLFFLFLLLLIFLHRSNIINF
IHHKEPKVNDKNVKKDRINPKKIV
>PK3-045_04535 hypothetical protein
MSEEEISQSGEGISQSEWGISQSEWGISQSGEEISQSGEGINQSEEGISQSGEGISQSEE
GISQSGEGISQSEEEISQSEWGISQSGEGISQSGEEISQSGEEISQSGEGINQSEEGISQ
SGEGISQSEWGISQSEEGISLSWEEISQSGEGISQSEWGISQSEEGISQSGEGISQSEWG
ISQSEEEISQTEEYQPNHLIPASTPYHQKTTKIKELLSKEQLPDLISNHSTVFPRKSS
>PK3-045_04536 Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit B
MEFETVIGLEVHVELKTQSKIFSASPNHFGAAPNTNTTVVDLGYPGVLPVLNKKAVEYGM
KASMALNCEIATETKFDRKNYFYPDNPKAYQISQFDKPIGEHGWIEIEVDGYKKRIGITR
VHLEEDAGKLNHEKGYSLVDFNRQGTPLIEIVSEPDIRTPNEAYAYLEKLKSIIQYTGVS
DCKMEEGSLRCDANISIRPVGQAEFGTKTELKNLNSFNFVRKGLEYEEQRQREVVSSGGV
INQETRRFDEATSTTLLMRVKEGSDDYRYFPEPDLPDLYIDEDWKARIRAEIPELPDARQ
KRYMEEWGLPEYDAKVLTVTKEMADFFEGTVANGAEPKLASNWVMGDVSAYLNAEQKELA
EVKLTPENLAGMIKLIGNGTISSKIAKQVFKELIENGGDAEAIVKEKGLVQISDEGALLK
IIGEVLDNNPQSIEDFKNGKQKAIGFLVGQLMKATKGQANPQMVNKLLVQEMNKR
>PK3-045_04537 Glutamyl-tRNA(Gln) amidotransferase subunit A
MSLFDQKMTDLQELLHKKEISVSDLVKESYSRIKDVDEKVQAFLTLDEENALSKASELDS
KLVNGEHSGSLFGMPIGIKDNIVTKNLRTTCSSRILENFQPIYNATVIDKLQAAGAITIG
KLNMDEFAMGSSTENSYYQKTKNPWNLETVPGGSSGGSAASVAAGEVLFSLGSDTGGSIR
QPAAFCGVVGLKPTYGRISRFGLVAFASSLDQIGPITRTVEDNAFLLNAISGVDPMDSTS
ANVEVPDFTKGLTGDIKGMKIAVPKEYLAEGVSEVVRQSVLDALKVLEKLGATWEEVSLP
HSKYALATYYLLSSSEASANLSRFDGVRYGYRADNAETLIDLYKRSRAEGFGDEVKRRIM
LGTFALSSGYYDAYYKKAQKVRTLIKKDFEDVFEEYDVIVGPTTPTPAFKLGEKVDDPLT
MYANDILTIPVNLAGVPGISVPCGFSNGLPLGLQIIGKHFDEASVYKVAYAFEQATDYHK
QKPTL
>PK3-045_04538 Aspartyl/glutamyl-tRNA(Asn/Gln) amidotransferase subunit C
MSRITKEEVKHVANLARLEISEEEAELFQKQLDAIISFAEELNELDTEGIEPTSHVLDMK
NVLREDVPTKGLPVEEVLRNAPDHQDGQIKVPSIME
>PK3-045_04539 hypothetical protein
MDITALRPKKRSALRLYVGKKYYITKRYAQWIIARKQYAMKKQTALLPHSYFTHKTMLLR
ELKDVDMKLQYNKIVNLKIAVSKINQIVLEPGETFSYWRTIGRPTYKKGYVDGMVLFAGS
YRTGVGGGLCQLSNLIYWMALHTPLTVVERHRHSYDVFPDSNRTQPFGSGATCSYNYLDL
QIKNETDTSFQLCLEVTDSHLKGEWRGASPSLYRYDVFEKAHQITPAYFGGYIRHNQIYR
KKYNRRGVLLEEEYITENHAIMMYEPLLTSDEENTP
>PK3-045_04540 Organic hydroperoxide resistance transcriptional regulator
MNELDALKLENQLCFLLYASSRELTKKYKPLLEELDVTYPQYLVLLLLWEHKSLSVKEMG
HHLYLDSGTLTPMLKRMEQQQLLERKRSLEDERSVLITLTEKGASLQQKAECIPTEILKL
FEKSDKEINDLKQSLQLLLQNLTK
>PK3-045_04541 Organic hydroperoxide resistance protein OhrA
MSDTILTTSVTATGGREGRVESEDYVIQFDTAMPGTQRAKELEDATNPEQLFAAGYAACF
DGALQLMAQREKVNFESETTASVSLLKDETDQGFKLSVKLSVKGTGIEKTVLENLVHKAH
NFCPYSKATRGNIEVQLEVVTA
>PK3-045_04542 hypothetical protein
MSSNPNLDDYMQKGMYGAKETKPEERRKFLSTLRERVVIALQQSQVMEPSPYKEILDAMK
QNPGAKLYLNGHLDYSYLSKYIKEANEAHMEYTIVTNKEADSDIGLLIAYDHAINKEDIY
IGEPKTDLVAEESSKTDQKKGLLTTIGKWFSK
>PK3-045_04543 hypothetical protein
MKKHVLMVLVLVLVLSACAPNFNKEEKVKTEDVDSNTTETAILPNYKISDDYYKVVVPFK
PSEARGLVVNNLNTRYDIAEFETGLMRIAQNAYDPEEYFFQEGQYLDKDLITSWLGRKSE
KNPDGLNPAGKDNGKVPVYLAHILEHDYLVKTDDKSLKLGGISIGLAMNSVYTYEEKGAA
KELKIDRTKLEKEGKKIAAEVVKRIRGVEGLGQVPIIISLFEQKESSSVVPGNFFAYAKI
AGNSNSIGDWESINEKYVLFPSSDTKYKSEVDAFSYFKQDIEKYFPNFNGVVGRAFYVND
KMQNLSIEIPIQFYGEAEALGFTQFVAGKVMEHFPPNNSSSVQVSITSVYGPEALIVRDV
DAEEPYIHIYQ
>PK3-045_04544 DNA ligase
MEQNLAEKRVKELHNLLNQYGYEYYVLDNPSVPDSEYDALLNELIQLEEKFPSLKTNDSP
SQRIGGEVLDMFSKVQHQKPMLSLGNAFNEADLRDFDRKVRAVIGDDFSYVCELKIDGLA
VSLRYENGLFEQGATRGDGTTGEDITANLKTIRSIPLRLNQAVSLEVRGEAFMPKKSFEA
LNKAKDENGEEPFANPRNAAAGSLRQLDPRIAASRNLDIFLYAIGDAGQTGIQSHSEGLD
LLDTLGFKTNKERKRCATIEDVLHYIEGWQEKRPHLPYEIDGIVIKVDNLVHQEQLGTTV
KSPRWAIAYKFPAEEVMTKLLSIELNVGRTGVITPTAVLEPVKVAGTTVKRASLHNEDLI
REKDIKLGDMVVIKKAGDIIPEVVNVLVEKRTGEEEEFLMPTHCPECESELVRIEGEVAL
RCINPKCPAQIREGLIHFVSRNAMNIDGLGERVISQLFSEKLIEDVADLYTLQFDQLIQL
ERMGEKSVHNLLEAIEASKQNSLERLLFGLGIRHVGAKAAKTIAMEFKTMDQLMVATKED
LTAINEIGEKMADSIVTFFEQEEVIELITELKTYGVNMEYTGPLPIAVEESDSVFSGKTI
VLTGKLEQLSRNEAKEQIELLGGKITGSVSKKTDLVIAGEEAGSKLTKAEQLGIEVWDEE
RLMAELKNKGVFNE
>PK3-045_04545 ATP-dependent DNA helicase PcrA
MQFLTDTILNGLNPEQKEAVKATDGPLLIMAGAGSGKTRVLTQRIAYLMVEKGVNPYNIL
AITFTNKAAKEMRQRIAAVLGGASEEIWISTFHSMCVRILRKDIDRIGYNRNFTILDTTD
QQSVIKGILKDRNIDPKKYDPRAILASISSSKNELVTPEEFAKTAGDYFSQIVSDVYTEY
QRRLRKNQALDFDDLIMQTINLFQRVPEVLEYYQRKFQYIHVDEYQDTNRSQYMLVKLLA
SRFRNLCVVGDSDQSIYAWRGADISNILSFEKDYPNAKVVMLEQNYRSTKRILQAANQVI
ANNSSRKDKNLWTENEDGSKIYYYRADSEQGEAQFVIGKIQELRRESSLNLSDIAILYRT
NAQSRVMEEMLLKANIEYSIVGGIKFYDRKEIKDTLAYLRLIANPDDDISFQRVINVPKR
GIGSSSVDKIANFAAMHDMSMYQALEAVELIGLSPKITKAASEFRDLIQNYTRMQEYLSV
TELVEEVIDKSGYVDMLKAEKSIEAQSRLENIEEFMSVSKNFEEANDDKSLIAFLTDLAL
VADIDKLDDDGNQADSVVLMTLHSAKGLEFPIVFLIGLEEGVFPHSRSLMEETEMEEERR
LAYVGITRAEKQLYLTNAQMRTLFGRTNMNPPSRFVKEIPEDLLEGLNPVSNRQRMASPQ
NSSRSSYTQQQPTRKAVIRPAAVATGGEGIGWSIGDKAVHGKWGTGTVVSVKGEGDSKEL
DIAFPSPVGIKRLLAKFAPIQKG
>PK3-045_04546 Heptaprenylglyceryl phosphate synthase
MYDVREWRHVFKLDPNKEISDDTLESLCESGTDAIIIGGTDGITLDNVLNLMARVRRYTV
PCILEVSTIDSVSPGFDLYFIPTVLNSSDPKWITGLHHEAMKEYGELMDWDEFLIQGYCV
LNEDCKAAKLTSAKTNLSEEDIAAYALMAEKMFHLPIFYMEYSGSYGNPSFVKAAKSQLN
ETVLFYGGGIETVEQAEEMGRYADVIVVGNVIYKDLSAALHTIEIKKSKR
>PK3-045_04547 hypothetical protein
MQIDKLRGRELDQLFESILSLESLEECYQFFDDLCTVNEIQSLSQRLEVARMLREGNTYH
TIEKETGASTATISRVKRCLNYGNDAYELALSRIKKEEQTETEE
>PK3-045_04548 Putative lipoprotein YerB
MKKRWFVSLFLLFVLTACNSEPKDVGKHNGNQTGNGAKEEEGIKDLSTLYPLTGLPSNTE
STNRAVSVMINNHPKARPQTGLTEADIVYEVLAEGEVTRFLAIFQSSIPKLIGPVRSSRD
YYIELAKGYNSLYIAHGYSPEAKKLLTNGYIDNLNGMEYDGTLFKRSPDRVAPHNSYISF
ANIEKGANANNYSLKGAPESLLFLNTKELEEIEGEESSSININYGKNPNYNSQFLYDQDV
QKYIRFSNGEQTIDNETKATVAVDNVFIIETSHKVVDNKGRKDIDLLSGGNAYLLQHGRW
QEIDWKNINGRILPFKEDKQVGLIPGKTWINIIPSTPGLKSAVTLKK
>PK3-045_04549 Putative adenine deaminase YerA
MLAQRYRWKNKVLRDHVSILNGEKSPSIVLKNATYLNQVLRKWLLANIWIYQDRIIYVGN
DMPKQIDQAEIVDCTNLFLVPGYIEPHAHPFQIYNPLTLAQYTSQFGTTTHVNDNLVLAM
QLEKKKAFTFLNFMKDIPSTILWWSRYDAQTELQEEELIFSHGNVKSWLEHDAVIQGGEL
TGWPRLLDGDDMMLHWMQETKRLRKRIEGHFPGASEKTLAKLMLLGVDSDHEAMTGKEVL
NRLLQGYKVSLRYSSIRPDLPKLLKEIKELGIEQYDYFMLTTDGSPSSFYENGHIDQLIR
IAMNHGVPVIDAYNMATINIAKYHGMEHLHGNIATGRVANINFLKDKKNPTPVSVLAKGI
WVKKDGREMRDAYPIVDWKQFDLSPLDIKWNVNSLDMQFSMPFGISLENAVITKPYSISI
NVSDTILTEEHDECYFMLIDREGEWRINTLLKGFSNRIGGMASSYTGDGDIVLLGKSQKD
MITAFERLKEIGGGIVLVKDGKVDIEIPLPLRGMMASMSMEELIEKEKELFDYIKDRGYR
YEDPIYTIVFFTSTHLPYIRITQKGLYDVMNKTVLFPAIMR
>PK3-045_04550 hypothetical protein
MNPKQNISLINALIRITCGCAFLAWSTAKMAKKPYKQSYFLIALLAGMKIAEGIVRYCPV
VALYEKKDAIMPKSEHNHSKSQSSNIPSPDESKTNNSESSSKEVTEMMEQFSPEKIFSPD
DMKK
>PK3-045_04551 putative oxidoreductase YghA
MVNALTETNEGAGQMTKPKNPLDLYYNDDFPKQYQEPPGVQAKMDPQPDCGETSYQGSGK
LKNRKILVTGGDSGIGRAAAIAYAREGADVAINYLPEEQEDADEVQKLVEAEGQKAILIP
GDLSNESFCKDLVDKAYNELGGLDVLALVAGKQQAVDDIMELSTEQLRKTFEVNVFSLYW
VVKAALPYLPKGASIITTTSVQGYNPSPNLLDYAPSKFAINGFTRGLAKQLASKGIRVNS
VAPGPIWTALQITGGQPSEAIPTFGQQAPLKRAGQPVELSSIYVFLASDESSYVTAQIYG
ITGGIELA
>PK3-045_04552 Phosphoribosylamine--glycine ligase
MKVLVIGRGGREHAICTKVSESEKVETVFVAPGNVGMTDVAERIEIAETEVEKLVDFALT
QKIDLTIVGPEVPLLLGVVDAFQAAGLKVFGPNQRAAEIEGSKSFAKDLMKKYHIPTGEY
QTFSDYEAAKAYIEEMGAPIVIKADGLAAGKGVTVAMNMEEALESIQEMLVGEKFGSASA
TVVIEEFLAGEEFSLMSFVNGETVIPLEIAQDHKRAFDGDKGPNTGGMGAYSPVPHIDPA
IVQTAIETIVKPAAKAMIAEDRTFTGILYAGLIATDKGPKVIEFNARLGDPETQVILPRM
KSDLVEVILSILNGETPSIEWYEEDMLGVVIAAKGYPEAYEKGAVIQGLDKMEDVSIFHA
GTDLNEAGAFTTNGGRVLLVAAKSRTLKEAQDKVYKELKKLESDGIFYRKDIGFKAVK
>PK3-045_04553 Bifunctional purine biosynthesis protein PurH
MKKRALISVSDKTGITDFAKELHELGFELISTGGTKKAIQDSGIPVMSVSEVTGFPEILE
GRVKTLNPYIHGGLLAKFDEPSHAAQLEEHKIDPIQLVCVNLYPFQQTIAKPDVTVEDAI
ENIDIGGPTMLRASAKNHQYVTVVVDPVDYQTVISELKQGAEVSFETRRRLAAKVFRHTA
AYDAMIAEYMTELTEEETPEKLTVTYELKQPLRYGENPHQKAAFYRKPLGSEFSIANATQ
LHGKELSYNNINDADAAIQIVKEFTEPAAVAIKHSNPCGVGTGEDIFTAFSKAYEADPVS
IFGGIIALNREVDAETASKLHEIFLEIVIAPSYSQEALDILQAKKNIRLLTIPFGTGSSK
EMKFTSIEGGLLTQDFDRYSLEDAAITIPTEKKPTDEEWEALKFGWKIVKHVKSNAIVVN
NKEMTLGVGAGQMNRVGSAKIALEQAGEKAVGAVLASDAFFPMDDTVEAAAKAGVTAIIQ
TGGSIRDEDSIKKANEYGIAMVLTGVRHFKH
>PK3-045_04554 Phosphoribosylglycinamide formyltransferase
MKRIAVFASGNGSNFQAIINAVKRGELNASITLLVSDKPGAYVIDRAIKEEIPTFVFAAK
NYPEKADYEKEILMHLDKNKIDLIVLAGYMRLVGDTLLQAYAGKIINIHPSLLPSFPGKD
AIGQAIEARVEQTGITIHYVDAGMDTGPVIAQESIILTEEDTRESVQEKIQALEHQLYPK
VIQQLLHKAEAFH
>PK3-045_04555 Phosphoribosylformylglycinamidine cyclo-ligase
MAEAYKQAGVNIEAGYEAVTRMKKHVKKTIRPGVMGGLGGFGGMFDLSVLNLQNPVLVSG
TDGVGTKLMLAFMLDKHDTIGIDAVAMCVNDIVVQGAEPIYFLDYIACGKAEPGKIEAIV
KGIADGCEQAGCALVGGETAEMPGMYGEEEYDLAGFAVGACEKEKLITGEKIQAGDVLIG
LASNGIHSNGYSLVRKLFFEKASMSLSDYIEEFGCTLGEELIKPTRIYVKPVLSALAEFE
IKGLAHITGGGFIENIPRMLPEGLGMELDEANWEVPAVFEKMEGIGEIDRKEMYNIFNMG
TGMVLAVSKEDEEQIIDHFTRIGEKAYTIGKVTDDGEINIILK
>PK3-045_04556 Amidophosphoribosyltransferase
MLAEIRGLNEECGIFGVWGHEDASQLAYYGLHSLQHRGQEGTGIVATDGEKLKGIKGEGL
VSEIFTQEAIKELSGKAAIGHVRYATAGGGGYENVQPLLFHFQSGSMALAHNGNLVNATA
LKSQLEAQGSIFQTSSDTEVLAHLIRRGGFAAFKERVKNALTMIKGAYAFLILTETELMV
ALDPNGMRPLSLGKLGDAYVVASETCAFDVVGAEFVRDILPGELLIIDDNGFRSEMFSVA
SNIAMCTMEYVYFSRPDSNINGINVHTARKNLGKRLAIEAPIEADVVTGVPDSSISAAIG
YAEATGIPYELGLIKNRYVGRTFIQPSQSLREQGVKMKLSAVRGVVEGKRVIMVDDSIVR
GTTSRRIVTMLREAGATEVHVLISSPPIKNPCFYGIDTSTKEELIASKYSVEELREIIGA
DSLIFLSTEGMIDAIGRTDDGENRGHCLACFTGKYPTEIYPNADHPYEKV
>PK3-045_04557 Phosphoribosylformylglycinamidine synthase subunit PurL
MSLMLEPSPEHIKSEEIYKQMGVTDEEFAMVEGILGRLPNYTEIGLFSVMWSEHCSYKNS
KPVLRKFPTTGPQVLQGPGEGAGIVDIGDGQAVAFKIESHNHPSAIEPYQGAATGVGGII
RDVFSMGARPIAILNSLRFGELDNERTKYLFKEVVAGIAGYGNCIGIPTVGGEIAFDDSY
AGNPLVNAMCVGLINHEDIKKGQAHGVGNTVMYVGAKTGRDGIHGATFASEELTENSDEK
RPAVQVGDPFMEKLLLEACLELIQSDALVGIQDMGAAGLASSSAEMASKAGSGIEMNLDL
VPQRETGMTAYEMMLSESQERMLIVVKKGREQEIKDLFHKYDLEAVAIGVVTGDKMLRLL
HKGEVVANVPADALAEDAPVYHKPSSEPTYYREFQAMENYIPTVNNYGETLLNLLKQPTI
ASKEWVYDQYDYMVRTNTVVAPGSDAAVVRIRGTKKALAMTTDCNARYLYLDPETGGKIA
VAEAARNIVCSGAEPLAITDNLNFGNPEKPEIFWQIEKAADGISEACLALNAPVIGGNVS
LYNETNGTAIYPTPVIGMVGLIKDTKDITTQSFKSAGDLIYVLGETKAEFGGSELQKLLE
GTISGKAPSLDLELEKMYQQAVLEAIRAGVVESAHDLAEGGLAVAVAESLIHSKGLGAKV
KVTEDAVTALFSESQSRFLLSIKPENKETFEKLVPATLVGEVTDIAVLTISQGETILVNE
QVDSLTNAWRGAIPCLLK
>PK3-045_04558 Phosphoribosylformylglycinamidine synthase subunit PurQ
MKFAVIVFPGSNCDVDMFHAVKDELGEEVEYVWHDTDSLEGFDGILLPGGFSYGDYLRTG
AIARFSNVMREVIKAAEAGKPILGVCNGFQILLEAGLLPGAMRRNESLKFICKPVELQVV
NNNTMFSSAYKENEVITVPIAHGEGNYYCDEETLANLKANNQIIFTYNGTNPNGSLENIA
GIINEKGNVLGMMPHPERAVDELLGGADGLKIFKSIVSQWREANVVNA
>PK3-045_04559 Phosphoribosylformylglycinamidine synthase subunit PurS
MFKVKVYITLRESVLDPQGNAVKGSLHSLNYKEVEDVRIGKYLELTIDKSERNIDELVKE
MCEKLLANTVIEDYRYEVEEVVAQ
>PK3-045_04560 Phosphoribosylaminoimidazole-succinocarboxamide synthase
MEKRALLYEGKAKRVYETSDENIVWLEYKDSATAFNGEKKATITGKGRLNNEITSLLFLK
LKDFGIPSHFVERLSETEQLVKKVDIIPLEVVVRNLAAGSFSKRLGIEEGISLSKPLVEF
YYKDDALGDPMITEDHIEELKLASTDEVAILKKKALEVNEVLCRFFGELGINLVDFKLEF
GKDKEGNVLLADEISPDTCRLWDKETNAKLDKDVFRRDIGNLTDAYETILARLGGSQHV
>PK3-045_04561 Adenylosuccinate lyase
MIDRYTRPEMGNIWTEENRFKAWLEVEILACEAWVKLGEIPQEDVKKIRENASFDIERIK
EIEMDTRHDVVAFTRAVSETLGEERKWVHYGLTSTDVVDTALSYLIKQANEILLKDVENF
IDVLKNKAQEHKYTVMMGRTHGVHAEPTTFGLKLALWHEEMKRNLERFKAAAEGIEYGKI
SGAVGTYANIDPFVEQYVCKELGLKPAPISTQTLQRDRHADYMSTLALIATSIEKFAVEI
RGLQKSETREVEEFFAKGQKGSSAMPHKRNPIGSENMAGLARVIRGYMLTAYENVPLWHE
RDISHSSAERIIIPDATIALNYMLNRFSNIVKNLTVFPENMKRNMDRTLGLIYSQRVLLA
LIDKGLTREEAYDTVQPRAMESWEKQVPFRELVDSDAVISSKLTKEEIDDCFDYHFHIKH
VDTIFDRLGL
>PK3-045_04562 N5-carboxyaminoimidazole ribonucleotide synthase
MSLSNRVILPGQTIGIIGGGQLGRMMAIAAKAQGFRIAVLDPTEDSPCGQIADYKIVDAY
DSLSAIKKLAEISDVITYEFENIDAVCLEWLTNNAYVPQGSALLEITQDRVKEKKAIEQA
GINIAPYVVVEKARDIYNGLAELGYPAVLKTARGGYDGKGQYVIKESSQIAEAEKLLNNG
VCVLEKWISFNKEISVIITRSGKGEATVFPVSENIHLNNILHESIVPARISDLAKDLAIE
KASKLAENLNLVGTLAVEMFLTEDEEIYINELAPRPHNSGHYTIEACETSQFEQHIRAVC
NWPLASTRLLRPTVMVNILGQHQEKIIEQIPELQDWKIHLYGKQDPKENRKMGHATLLRS
SVEMALDEIENTHIWKVQKEKIGG
>PK3-045_04563 N5-carboxyaminoimidazole ribonucleotide mutase
MTASVGIIMGSKSDWETMKHACSILDQLEVDYEKKVVSAHRTPDLMFEYAESARDRGIKV
IIAGAGGAAHLPGMVAAKTTLPVIGVPVQSRALNGLDSLLSIVQMPGGVPVATVAIGKAG
ATNAGLLAAQILGASDLEIAERLFSMRERTKKEVMESSDELV
>PK3-045_04565 hypothetical protein
MSKKKRFEVQTNESIDDCLDRMKQEGYMPIKRMEKPVFKEVKVNGQMSYEPVSQQIIFEA
IQLEG
>PK3-045_04566 hypothetical protein
MLENSVTMILIILVINIVYVSFFTIRMILTLKGQRYLAAFISMIEVVIYVIGLGLVLDNL
DQIQNLVAYAIGYGIGVIVGMKIEEKLALGYITVNVITKEYDRDLPNSLRTQGYGVTTWT
AQGLEGDRMALQILTPRKYELKLYQTIKELDPKAFIIAYEPKTIYGGFWVKSVKKGKLFN
E
>PK3-045_04570 hypothetical protein
MTLSFREEGLVEALWREVGDRVLHITLANYKDIPVMSFIHKMGTFYKGKEKVRVDFQTIG
SFINTKTLFYSPTITEELLDLHFDHHRNFASFIDDEESVYLPGKWVPHCTLANRLSEEKL
KDAYNYCLKMDEKLKGEINRIGLIRIDSKKHAPLIYSESLI
>PK3-045_04571 hypothetical protein
MQFNERIGRDIKGEYQKIRRRVAVRAVMIEKQKILLMQTNKGDFKFPGGGTCRSVMERSR
>PK3-045_04575 Putative penicillin-binding protein PbpX
METSLENQIKITVNRNKFSGTILIKKAENNLFSASYGYANRSDNIKNTIDTRFGIASGCK
LFTSIAICQLVEKGKLSFESKLEDCLPITFPNFNKNITIHHLLTHTAGIPDYFDEEIMDD
FEELWIDLPMYHIRKLTDFLPLFQNKPMKSNAGEKFHYNNAGYILLGLVIEEVSKMSFTD
FIEENIFKKVGMQNSGYYELDALPKNTALGYIDLPNNKWRTNIYSLPAKGGADGGAFVTA
LDMSSLWNALLTNQLLSDEYTSKLLTPFIQTKKSTGFYGYGLWIEKKENAIFKYHIMGYD
PGVNFHSAFYPKSQIHTVICSNKSEGAFEVSKVIEDQLIIKME
>PK3-045_04579 PTS system glucose-specific EIICBA component
MFKKIFGVLQKVGKALMLPVAILPAAGILLAFGNALQNPTLVDIAPFLNNSGVEMVASVM
EDAGNIIFGNLSLLFAVGVAVGLAGGEGVAGLAAIIGFLIMNVTMGTVLGIDAKDLKGST
EYAAVLGIPTLQTGVFGGIIVGIVAASMYNRFFEIELPSYLGFFAGKRFVPIATAASAVI
LGLIMIIIWPPIQHGLNVFSENMLGANLTLSAFIFGLIERSLIPFGLHHIFYSPFWFEFG
SYTTKAGTIVKGDQAIFMSQIKDGVQNLTAGTFMVGKFPFMMFGLPAAALAIYHEARPEK
KAIVGGLMGSAALTSFLTGITEPLEFSFLFVAPILFGIHAVFAGLSFMTMHLLNVKVGMT
FSGGLIDYVLFGLINPQTNAWIIIPVGLVFAVIYYFGFRFAIRKFNLKTPGREDETEESD
SSSTGATSDLPYDVLEAMGGQNNIAHLDACITRLRVSVNDIKSVDKDRLKKLGAAGVLEV
GNNIQAIFGPRSETIKGQMRDIMSGKRPRPAAQPSMDKEVQEQIEEVNPSAMQSNITSED
SFVAPIKGELVPITDVPDAVFAGKMMGDGFAIIPSEGTVVSPVDGKIVNLFPTKHALGIL
ADNGREILIHFGIDTVKLKGEGFETLVTENDQVKQGQPLLKVNLDYIKENATATITPVVF
TNLAEGEAVQINKRGNVELKEEGVITITK
>PK3-045_04580 PtsGHI operon antiterminator
MPNLLIKKALNNNVLIGDHPTYGEVVLIGKGIGFNQKSGDYIDISVVEKLFVLKDEKEQS
NYLKLLPQVDNDLLDVIVSSIELIKNKTNAKLNEHIHIALTDHIMFASSRVSNGLVLNNP
FLIETKALYPFEYSIAEEVVKLIGEQSGLQLPVGEIGFIALHIHSAMMNKNLSEVNRHSQ
LVTHLVNLIEDQLETKIDKDSIDYMRLVRHLRFAIERVNTGEKVEEPEKITLLLKNEYPL
CYNLAWKLIKVMQQVLKRPVFDAEAVYLTMHLQRLQKKIK
>PK3-045_04581 Guanine/hypoxanthine permease PbuG
MKKFFKFEELGTNYRKEFLGGFTTFLAMAYILAVNPFTLSLGDVADLPDALRMDYGAVFV
ATALAAAVGSLIMGIFANYPISLAPGLGLNAYFAYTVVLTQGHPWEYALAAVFISSVFFL
LLTISGLREKLINAIPVELKLAVGAGIGLFITFIGLQNSKIIVDNSATLVHIGDLTNPST
LLAIFGIFITIILMVRGIHGGVFYGMIITAVVGMIFGVINTPSAVVSAVPSIKPTFGALF
SALGDPGFYTQSMLVVVLTFLFVDFFDNAGTLVAVANQAGLMKENKLPRAGKALFADSIA
SMVGSIFGTSTTTSFIESSAGVAAGARTGFAAVVTAGFFLLSLFFFPLLEVVTSAVTTPA
LVVVGILMVSSLGKIDWTKFEVAVPAFLTIVAMPLTYSIATGIAVGFIFYPIVMIVKGRI
KEINPIMYVFFVIFALYFIFLQ
>PK3-045_04583 Pyruvate, phosphate dikinase
MAKLIYFFEEGSSEDKGLLGGKGANLAEMTRLGLPVPAGFTITTESCMKYLGEPSFFESW
LKEDILEAVIKLETETKKSFTGEENILLVSVRSGAAFSMPGMMDTILNLGLNDLRVQSLA
QLTSIDFAFDCYRRLLQMFGDVVYGIHKDKFNIRLRKMEKQLSKTVAEFQEKDHLQLIES
FKELYMENNRVFPQNPIDQLFEATKAVFKSWNNHRAKVYRELHEIPHHLGTAVNIQSMVF
GNSGNESGTGVVFTRNPSTGENKLFGEFLLNAQGEDVVAGIRTPESIESLQQILPKAYAD
FKRYANILEQHYKDMQDIEFTIEKGELFILQTRNGKRTAKATLQIAVDLVKEGLITKSEA
LLRISPGTIDQLIHPIFDPQAIQNVELLAEGLPASPGAATGAIVFTSEKAKECHALGQKV
ILVRQETSPEDIEGMVVSEAIVTSRGGMTSHAAVVARGMGTCCITGCEGLTVNEELKTIT
CGERILTEGDLLSVDGTAGKLYLGEVPTVTAENDQNLQLLLSWADAYADLQVRANAETVH
DLKTAIEFGATGIGLARTEHMFFGEERVLEMRRLILAENKEEIRDALDKLQAFQQEDFYQ
MFQVVEDKRMVIRLLDPPMHEFLPRDLNEMKQLAAKLNKHPSIVEEQIKRLQETNPMLGH
RGCRLGITEPQIYQMQVRAIFHSAIQLTKEGYTVFPEIMIPLVAEKEELAYVKAFLKETI
ENIFVNHQMEPFPYEIGTMIELPRACIIADQLAQEADFFSFGTNDLTQMTYGFSRDDIGK
FINSYKEKNVMTNDPFQTLDQNGVGELIKLAVMKARQTKENLMIGICGEVGGDPKSIAFF
RNIGIDYVSCSPYRIPAARLAIAHASINK
>PK3-045_04584 Transcriptional repressor CcpN
MKLSERQEKIIKIVKEYQPVSGEKVSDLLDVSRATLRSDLSFLTLVGILQATPKIGYTYS
GSDLEKFFFFKTFNTKVNEIMMPPLMVNQDTSIRDAITTLFMYDVGSLYVTGEEKLLLGV
LSRKDLLRASLNTNIDQTPVAVCMTRVPHIKVCKKDMDILEAASILQDFEVDSLPVVDDE
NERKVIGKITKTRILNFIIQQARKAELNE
>PK3-045_04585 Putative pyruvate, phosphate dikinase regulatory protein
MKNEIIVYTISDSIGETSQKLLAAVTAQFPDLVFNNSYRFSFVNKEEELVDILNDALKDD
AVVVSTLVDNHLANVAKDFSKRTKLHYLDLMNPFFEIIKSKTGYTPIEEPGIVHKLDTEY
FNKIAAIEFAVKYDDGKNPQGFLQSDAVILGVSRTSKTPLSMYLANKGYKVSNLPLIPEV
PLPTILEKLEGQKIIGLICNPEKLSRIRSNRLDSLGLSHSSSYTNLERIYEELEYSKQVF
KKHNAYVIDVTDKSIEETAYLVEKHLKEVSIHW
>PK3-045_04586 hypothetical protein
MELSFLMFALIGVIIGILSSMFGFGGGFVVVPILFAFLPDSIPSEYLMHTAIGTSLAVMI
INSFNSTYNHAKKGNVTWSVFKLLVGYIAIGSLIGGMLAVYIDSDFLRFAFIGLLIYVLV
SNIFKKSFTREIDEQSFHMPKQSSASFIGIGIGFLSTLLGIGGSTMTIPYLRNRGMRMIH
SVALATPLGLPIAIVGALTYLITGIQIDTMPSSTLGFIYLPALIGFTIGGFVGVPIGRSW
AQKLSDKLFSKIYLILLFIVVIMMITS
>PK3-045_04588 GMP synthase [glutamine-hydrolyzing]
MIVVLDFGSQYNQLITRRIREFGVYSELHPHTITAEEIKELNPSGIIFSGGPNSVYDENA
FGVDEKIFDLELPIFGICYGMQLMTQHFAGKVEKAKHREYGKAAINIENNSKLFTDLPTE
QIVWMSHGDLVVEAPAGFTIDATSASCPIASMSNEEKGLYAVQFHPEVRHSVYGNELLKN
FVFGVCGCKGDWSMENFIEIEMEKIRQTVGDKKVLCALSGGVDSSVVAVLIHKAIGDQLT
CIFVDHGLLRKGEAEGVMKTFTEGFNMNVIKVDAKERFMSKLEGVSDPEKKRKIIGNEFI
YVFDDEAAKLEGIDFLAQGTLYTDIIESGTATAQTIKSHHNVGGLPEDMQFQLIEPLNTL
FKDEVRALGSELGIADDIVWRQPFPGPGLGIRVLGAITEEKLEIVRESDAILREEIKKAG
LERDVWQYFTVLPDIRSVGVMGDARTYDYTIGIRAVTSIDGMTSDWARLPWDVLEVISTR
IVNEVAHINRVVYDITSKPPATIEWE
>PK3-045_04590 hypothetical protein
MGTPYSKQHITIANFLLYILGFLLICEWLGPLEALTNTENVIVFHLFLALSLLLAFFRTP
SWVSGTLKTVYIIFILQYLYYEESFFTFQWIQPFAAEFIDNLALVFNTKWPEMTNMFKSS
LCFILLWLMAYLIDYWLIKRRKIFTFFLLTIIYITVLDTFTIYSADAAIIRTVIIGFTAM
GMLTFFRLSDKEGARNTNSSIVKWMIPLLLFVIGSAGIGYLSPKADPIWPDPVPFIQTMG
DKGGEEDGDIPGSGVHRVGYSVDDSRLGGDFIGDSSLVFVAEVEEPHYWKVETKDTYTGK
GWVQSEESLKLNRDNFEVLDQGGEIPFVSFVEGENVKRTESESTVQFTNGFSYLLYPLGV
KEVSAANSFMEIESGNERGVFNGYVESYSVKFDVPEYSLNALTTADMEDFIRNNPDMVKR
YLQLPDSLPQRVKDLAVDITKNDVNLFAKVRAIETYFSSNGFAYSQNNVAVPNEEEDYVD
QFLFETKLGYCDNYSTSMVTLLRSIGIPSRWVKGFTEGEFVEADGDIRRYEVTNNNAHSW
VEVYFPEVGWVSFEPTQGFSNANTYINDVESNRNTENNETQTPEEKAQQPKTPEQKPETP
EQTIEQASPSTEGWESYKTTAKENWQWVTIVLVIIITAGLAAYKFRYKWLPYYYIWKFRN
TTEEANFPKAYMVLLHLLEIAGLRKKEEITLREYAKQIDHIYSSEEMSQLTAKYEEYLYK
GYIQKETWEDVKELWENLIKKTTA
>PK3-045_04591 hypothetical protein
MKRSLQKLNRIWKLILLFLLIVMVFSYAMFQGGFVSWFLFYSFLPFALYGLFIAVYPMRD
WQVKRKILKYEYSAKEEMHVEIELTRNSFFPVFYMVVRDSFSSTVGQKIEEKRMLMPGLK
RRLRFNYTVKELPRGEHVFDQICLQLGDPLGLIEKEKVYIQVERILVYPPIEEMIYKPLE
NHYEQGMTSSKERVQRDTTMAVGVREYQPGDRFSWINWKASARRNNMMTKEFEQKQSHDI
MIVMDCQENKRMETTVSFTASIIRAILKKGAQVGLLSVDTDRKIFPIRGGESHQQYLLHH
LAKVRTTKEITLAEVLDNESSQLPPQATIMLITSQVTRELIDKAGWLASKRYNIVIFTIT
GQKEGLSNEERTLSAFAGKKGIRIIPVSKGRFKEALGEGVA
>PK3-045_04592 hypothetical protein
MAGNHSLVINRIIGNIEKVMIGKRDVAELSLIALLAQGHVLLEDVPGVGKTMMVRALAKS
VGANFRRIQFTPDLLPSDVTGVSIYNPKELEFQFVPGPIMGNIILADEINRTSPKTQSAL
LEAMEESSVTIDGVTHQLQKPFFVMATQNPIEYEGTYPLPEAQLDRFLLKMNMGYPTVEE
EIEVLTRVQVAAPIEKLESVVSLDELLTLQNEVRQVYVDETIKKYIVELATATRENASVY
LGVSPRGSIALMRASQSYAFIQGRDYVIPDDVQFLVKAVFAHRMILKSETKFDGITAEEI
INRIIGQVSVPVQRLVK
>PK3-045_04593 hypothetical protein
MGVMLSKGQKIDLTKSHPGLRNVVIGLGWDINQHGANYDLDASAFLLGDNHKVWSDNDFI
FYNNPTGPNGSVVYSGDNRSGHGRMDDEQIRVDLSQVPSTIQRIAFTITIHDAYNKGQNF
GQISNAYVRVFNEGDQVELLRFNLGRDYTVETAIVAAELYRHHGEWKFNAVGSGFQGGLA
ALCSNFGVTVDDEPQAPAYPNDSIQQAYQEPNRPYYQSFETQTYPASSSGAYQPNWQQSY
TNRNPKMYGQDAVNDAYSSDHMQCIRCRSTNVRTGEKGFGIGKAAIGGLILGPVGLLGGF
IGKGQLKITCNSCGYSWSPSQTDYAEWGRQQKQRARDLFMRYKNPDVLDAVVAACALVGM
ADGRLDHAEEQKMMEFIHQSEELRVFDTNKVIQQFNYFVRKIEYDQIIGRAESFRALGKV
RSKPEIARLVARYCIAIGYADGHFDQREKQVVTEICRELGLNPQEFLS
>PK3-045_04594 hypothetical protein
MLLGSLICKIRKYHKYNYYYSGICITCGEVRKEYEKVQEDTIEEQAEEKDITDRSITQ
>PK3-045_04595 Transcription antiterminator LicT
MKIEKVYNNNVIAAFNEQDEELVVMGRGIAFQKKPGDLVEEAKIEKVFALKNNDMSEKFK
TLLYEVPVEYIEITEEVIKIASSRLGRKLNDSFYISLTDHLHFAVQRIQKGFEIKNALLW
EIKRFYKEEFAIGLETIQLMKEKLGIELPEDEAGFIAMHLVNSDLSQEMPNIANITKVMQ
NILNIVKYHYKMEFDEDSLNYFRFLTHLKFFAQRLYSKTYMDDDDPYLFEMVKHKHREAF
RCTEKINEYIESQFNYSLTDNEKLYLAIHIQRVVNR
>PK3-045_04596 Aryl-phospho-beta-D-glucosidase BglH
MAFPKGFLWGGAIAANQAEGAYLEDGKGLTTVDLLPTGDKRFEIMMGKLPSYQPLEGEFY
PSHEAIDFYHRYKEDIALFAEMGFKALRLSISWARIFPNGDDAAPNEAGLKFYDNVFDEL
LKYGIEPVVTIAHFDVPINLVKNYGSWKNRKLVDFFEKYATTLFERYKDKVKYWMTFNEI
NMLLHLPFVGAGLVFEEGEDKLQVKYQAAHHQLVASSLAVKAGHEINPDMKIGCMLAAGQ
TYPYSCNPDDVLDAMEKDRDSFFFIDVQSRGKYPGYAKRFFRDKNLKIEMEEQDEALLEK
YTVDYIGFSYYASRTTSTNPEVNKQTSGNVFGSIENPYLEKSEWGWTIDPKGFRITANQL
YDRYQKPLFVVENGLGAVDIPSEDGEVKDDYRIDYLRKHVLEMSEAIEDGVEMIGYTSWG
PIDIVSASTGEMKKRYGYIYVDKDNEGNGTLERSKKKSFDWYKEVIASNGENV
>PK3-045_04597 PTS system beta-glucoside-specific EIIBCA component
MKYEQLAKDIIANVGGKENVSSVVHCITRLRFKLKDESKANTEVLKNMDDVVTVMKSGGQ
YQVVIGNHVPDVYKAVVSVGGFQNQQPVEEEEGPKGSLFNRFIDMISSIFTPVLGILAAS
GMIKGFNALFLSTKLLTESSGTYQILNATGDALFYFLPIFLGYTAIKKFGGTPFIGMAIG
AALVYPTLSTLTTGDPLYTLFGGTLFESPVHVTFLGIPVILMSYSSSVIPIILSTFFASK
VEKWLRSVIPDVVKTFIVPLFTLVIVVPVTFLVIGPIATWASTLIGQGSLYLYNLSPVIA
GLLLGGFWQVIVIFGLHWGLVPISINNVATLGYDTILSPVFAASFAQIGAVLAILIKTKN
QKLKTLSYPAFISGIFGVTEPAIYGITLPLKKPFIISCIAASIGGAIAGLTDIKGYIVGG
LGIFGLPSYITPEGINMNLWGAVISITVGFIVAFLLTLFFGGINKGQNSTGNTTASNQVA
ATKVEKEEVLSPLKGEVKPLSEVKDEAFASGALGHGIAIEPSEGKLYAPADGTVSALFPT
KHAIGITTDTGADILIHIGMDTVQLEGKHFIVHTTQGELVKKGQLLIEFDMDEIANSGKL
LTTPIVITNYREFHLEMTDKKQIQQGDSLFHLETK
>PK3-045_04598 Polyol:NADP oxidoreductase
MLLLLDKEAIQSKKDSFSRIGIKTPNYDYRGIWEETKKEPIWLHIGGGNLFRAFHSVLQQ
HLIEKQKTKKGIIVVSTMDDGLIEKIYHPYDNLSLNVVMKSNGTLDMEVIASVAESIAAY
SNNYSWQRLIEIFTTSSLQFITLSITEKGYELRDIKGNLQPTIIKELEQGLYQPKHTMVM
LTSLLNERYKAGKIPLALVSTDNFSHNGDKLKDAILTVAAYWQKRGVVDKGFIEYLTDQT
KIAFPWTMIDKITPLPSVAVKEKLSDLGYGSTELIKIRENAPTIAPFVNTEESEYLVMED
CFPNGRPSLEEVGVFFTNRDTVDQIERMKVCTCLNPLHTALAIFGCLLGYTSIADEMKDN
DLKSLVEKIGYEEGMKVVTDPGIIHPMQFIKEVIEVRFPNPNNPDTPQRIAADTSQKLAI
RFGETIKLYVKRDDLDVEDLHFIPLTIAAWCRYLMGINDGGKEMSLSPDPLLEELQKQIK
KIKFGIPGSVGNYLQPILSNERIFGSNLYAIGLGDKVELFFKQFIQGLGAVRKTLHNQIS
LKA
>PK3-045_04599 Uronate isomerase
MKGFMDKDFLLQTETAKKLFHDYAATMPIYDYHCHLEPKEIYENRRYENITELWLEGDHY
KWRAMRANGIDEFYITGDADDYSKFEKWAETVERLIGNPLYHWTHLELKQYFGVEAILKK
TSAKEIWEICNRKIQSPDFSARSLIERSNVALIGTTDDPIDDLVFHKLLQEDKTFSTTVL
PAFRPDHLMAIQSNYWAEYVGKLSNLTGVEITSYSTLMEAIDHRIEYFHGIGCKLSDHSL
EMVVYEPATMEELNMIVKKALTGEAITQKENNQFLTSLLVSLGKAYSQRGWVMQYHIGAL
RSANSRLFQSIGANIGCDSMQDSPIAIPLAKLLDELDRDDNLPKTILYGLNPNANEVLAT
MAGNFQEGGIPSKVQFGSGWWFNDHIEGMVAQMKTLGNQGLLSRFIGMLTDSRSFLSYSR
HDYFRRILCNLIGNWVENGEYPNDIEWLGQIVQDISYYNAQRYFDFQLKMDY
>PK3-045_04600 putative symporter YjmB
MGKKQKDVTLARSIGYGLTDMMGGGAFTIIGAWLLFFYTSYAGLTPVEGASIIAIARIVD
AVVSLFMGSFSDNFLKFKLGRKFGRRRFFLLIGSPLMLVYVLLWTSGMNYLYYLLTYLAF
EIIAAMVLIPWETLPSEMTTDFNKRTKLSTARMFISGLGTFLATFIPGQLFSILGQDNSL
AFFINGAFFAVVFAICVYISFRSTWEREVSPEELQILMSQKKERKNGLKVVIQTFVDFAS
TFRVKSFRKHLLIYICSMTAKDAFNAVFVFFCVYALNSTSTVAANLLSFSIIGLPGAILY
GFLMIKIGPANLFKISYSTMILCLLGYGAVYLYHPSNLILVLGVISFFYQIGRSMLEFIP
WNVFPFIPDVDEMITRKRREGIFASVMTFFRKSSVALATFLVGAILEAGGFVQGSATQPQ
SAVHTIMSIMIIGVGLLLFISLITAFTFKLNKETHGVLVEEIERLKNNGLKKDVDPKTKK
VVESLTGYSYEKLWGGKTDEALTQVKIN
>PK3-045_04601 Mannonate dehydratase
MQMTFRWYGEGNDTITLKQIRQIPGVKGLVWALHDVPVGEVWPVERIAEVVNQAKEYGFH
TAVVESVNIHEDIKLGLNSRQQYIDAYKQTLKNLSQFGVKVVCYNFMPVFDWLRTDLFKE
TEDGSTALYFDATKVISLTPEQVVKNMEENTKELTLPGWEPERLKDLQHLFTLYKDVSEV
DLFDNLVYFLEEITPVAEQYGIKMAIHPDDPPFSIFGLPRIVKNREDIERILTSVDSPAN
CLTFCSGSLGANSSNDLVDIVKSFTKRIPFAHIRNVKRFEDGSFIETSHHVEDGSVPITE
IVNGLYENGFCGYVRPDHGRHIWDEVCRPGYGLYDRALGVMYLLGAWDTNKILTKEKMQK
I
>PK3-045_04602 HTH-type transcriptional repressor RspR
MSNNSAKVFAYNQLKDEILKLKLIPGTKISEKIMSDELQVSRTPIREAFIRLAQEELLTI
VPQSGTFVSLINLSLAEEARFVREIIETNIVGLCCENITDEISLKLEMNLKMQEMLASNE
VGKQEKVKFFDLDESFHKELFICCGKERTWKMIQDMAGHLNRFRLLRLKDIKDLDWEILI
SHHKEIYEAILEGNRTKAEQLMSDHMRLMLSEKGVLLQEFPEYFYPQQY
>PK3-045_04603 Fructoselysine 6-kinase
MAIGDNCVDIYLKEKTFYATGNAVDFAINLKKQGIDVSLITVFSNDIFGEFIKKTLQENG
VDISNSYNKDEPTAMAKMKLINNDRFHESFYENVLADFKLPGSISKIIENSSIIYSEKRS
KIYRYLDSIYDQNKIWIHDFSKRLDDELNDKILPYMNYSFFSYEKKDERIKEFLKITQSK
TKNGVVIAMLGEDGSLAYDGNSFTYEKAKTSHIVNTVGAGDSYISGFISGIYNDRSLQEC
MEIGTNIASETISKFEPY
>PK3-045_04604 hypothetical protein
MKTELLIKHLCSDMETQLIKITEEVKKAVSNSSIENGVVFIICSHTTCGITINESLECVE
TDILDFLDTIVPVDSPYTHAHFLMSYGTTSGNSPGHLKQMIVGNNCVLPIKNRKLVLGHA
QDIYFAEFDGIKNRKYFIQLLGE
>PK3-045_04605 hypothetical protein
MTIIDVHAHPSLYSPISESEERLNFRMKEMGLGLMSPSDLTVIDKQNDLAKISKTILLPL
DTTTTTGDTLISNDEIKKLVYLRPERFIGFASVDPNRADALEVLEHAFGTLGLSGLKLNP
AKQQFSPDHPDYYPIYEKCLQYDKPIMFHAGFSWDKNSISEFAHPFRFERIAIKYPKLRM
CLAHFGWPFVKETAILLVKYPNVYTDTSMLYMDSPELFFEQVFTRDMGKYWLDHNFPDKV
MFGSNTPRFRPIRILRGLEKVYMSEKTRSKVLYKNAMRFLGEKGDIDENRATD
>PK3-045_04606 Fructoselysine 3-epimerase
MKIDRIAPGNYHFKRYTIDYFLDSVSELGFKYIELWASGPHFHLDYFTLNDIKELKKKID
YRNLKVDCLTPEQAVYPISISHPDKQYRQNSIDFFKRHIEAATVLDCKKVLVTTGIAYLD
IPIIQQWEWCRQSLEAISKAAENEGVTLVLEAFTKYSTHVFNTSSHIVKMIEEVGSHALK
GLIDIDVVASTGEESIDSFIDTLGDNLHHVHFVDGNPGGHLVPGDGSLNMQHALEKIAST
SYQGCLGLEFLDRRYFLEPEKALIKTIKWLEDNNNEAKQ
>PK3-045_04607 Anaerobic C4-dicarboxylate transporter DcuA
MFWIQLILIIVLIYFGSRVGNVFMGLLGGVGVGIFVFVFGMQPASPPIDVMLIILGVVLA
ASALQSSKGLDYLVIIAEKILRKSPSNITIIAPIVAWIFTFLSGTGHVVYSLLPVMNELS
IDNRIRPERPISNSIISSQQAITCSPMSAATAAMIGFMATIDVSFSKLLMITIPATLIGV
IASSVLTIKKGKELHQDPEYIRRLEEGFIKKFERKEIKDIANSQKWSVLIFLLAVVSVIV
LGLFTGLRPSWVIEGKVTPLSMPYTIEIIMLTCAALIIIVCKPKIEEILSGSIFKAGALA
IVCAFGLAWMSNTFILAHQEFVEENVAQIVNRYPWLFAVVVFAVAALITSQGATTLIMIP
IAIGLNLPPAIIIGAWMAVNANYFLPVSAQTLAAISFDTAGTTKIGKYVLNHSFMVPGLI
NTIISVIVATILGSIIL
>PK3-045_04608 Fructosamine kinase FrlD
MRKYKVIGIGDNVVDKYVLEGKMYPGGNALNFSVYAKMNNIKSAYIGKFGDDDVAEYIKA
VLDELQIDYSYSKTYSGENGYAKVKLDKNERVFLGSNKGGVAKEKKWELTNQVISYISEF
SLIHTSLNSYIESELKTLKSLDIPISFDFSVRWSDEYLKEVCPYIDIAFLSCSHLTSSER
EREMKKAEELGADLIVGTVGENGSYALYKGDFIYQPAIIDEDVVDTMGAGDAYLTAFLIE
LLDQSNGSFRFKDDDLTFEVIQNAMKKGSKFAAEICKIEGAFGYGKQVRV
>PK3-045_04609 Fructosamine deglycase FrlB
MNIKEIIRKIISDKKEDGGVKEVYYVACGGSYAAFYPAKAFLEKESKEIKVGLYSSNEFV
HNLPKAFGKNSVLVVASHKGNTPETVKAAAIGKEKGVPVIALTWISDSPITKEADYIVDY
TFGPDKDIAEEKTMQALLTAVELLNQVEGYPYYEKFMDGRQKIDLIVKNARKHVEKRAKR
FADEHKDDNVIYTLASGASYGAAYLQSICIFMEMQWINSSTIHTGEFFHGPFEIADAEIP
FVIQVSEGSTRALDERALTFLKKYARRIEVLDAKELGLSTIDADVIDYFNHLLFNNVYPV
YNEALATVREHPLSTRRYMWKVEY
>PK3-045_04610 HTH-type transcriptional repressor NagR
MDINESIPKYEQLRMKILNDIERGILKKGDKIPTENELSKNNQISRVTVRKALDSLTEEG
YLIRIPGKGTFITENKLLKDIGNTIGFSENTRMQGKKPGARVIENKIIDLEEEEQNVFGT
LGNTKQISIVRVRTADDIPVSVEYSRFPMDFDYLLTEDLNNTSLYDIIKEKSNIKFGNSR
KAIQIVSASFEEAMYLNVKEGHPVLCIESLVKDIKGSTIHSSKQIMLGDKFTLIV
>PK3-045_04611 hypothetical protein
MDFKNACEKNELSELLKIGVLLLIYVLSTVALFFLIH
>PK3-045_04612 putative sugar epimerase YhfK
MKVLVVGANGQIGKQLVTLLHESNEFSVRALVRTSEQQKAFDKVGIETALGNLEETVEQL
ESAVKGCDAVVFTAGSGGKTGYDKTLLIDLDGAVKMMEATKNAGVERFVMVSALQAHHRE
NWNEQIKPYYVAKHYADRILMESGLTYTIIRPGGLTNEAGTGLVAAAENLERGVIPREDV
AATIMASIKEKNVFNKSFDLVSGETEMEKAVKNL
>PK3-045_04613 hypothetical protein
MTSQYIDLIDKDLLYDHIQVLTKYERLTGEEEAERAADYIIETLKQYEVSYNRYQFVGYF
SNPIHGEVYVGGAKKKVIIAKARSFGGHFPKGIKGNLLYDRYSETLRGINGPADRYEKMK
DKIIISWNYYEDYVKKIERAGAIGLIHIWPSKEIAIHEETVGTIWGTPTSENIDQLPKIP
VVGINYEDGVTLLDWIKENGSLEAVVKTKLENALKKTSLPVATLRGESEDYILISGHYDS
WHKGATDNATANALMLEMARIFSKKNSRRTIKLAWWAGHSNGRYAGSAWYCDQFWEEINE
NCVAHINIDFPGTKENVEVVPRSTAMENHELLINIIRKYTDREPSRIEYLPRGADQSFWG
TNIPIHLMLKYEPPHQKKSYQTPGGNWWWHTEEDLIDKVDSNLLVRDTGMHIELVDYLAN
ISLLPVNLIRFLSKSKAIINELDADSDEAFDFTMIHSIFEKVTTMVEKLLEKEVTDVDSY
NQLLKTVGGILNRLKFSSSSKYDYDNTDPFQPYPGLAKVKSVYWSNTSPEEFLFLSTLFV
RQRNRLVNEMKEVIKEIKRYLD
>PK3-045_04614 hypothetical protein
MKTNKVVSQMHSIKQSRPKRVKMPHTFVIILTMVLFAAVLTYILPAGEFDRVEDASSGNT
VVVQDSYHHVEQNPISLFNLPLAVVQGLVSASDTVFFIFIVGGVFQIINSTGTIEAIAGR
VGKTFMNRGLVIIPIFLTLFSFGGFTIGMSAEVMAFVPIGIAIARALGYDALTGTAMVML
GAAAGFTAGLLNPFNVGIAQSIAEIPMFSGMWLRAIILVVLLIATSYYIIRYAKKVKKNP
SSSIVAQLEAEESHNNVDISSLSSMKISHYLTIMVILAGFGLLIWGVSEKGWWMQELAAF
FLALGVIVGFLSKYGPSKIASEFVAGAKDITFGAFIVGLAKGIVIVLEDGHVIDSVVNGL
AIMVDHMPSYIQVLGMYFFQTIMNVFITSGTGLAATTMPIMVPLADLIDVTRQTAVLAYQ
LGDGLSNCILPTSAMLMGSLAVSKIKYQEWVKFFWPLLLVWLIIGGIFVIVADVIHYS
>PK3-045_04615 N-acetyldiaminopimelate deacetylase
MHNKSVQEKQTLIDKVDAMDMELRELSLKIHQNPEVSFQEYQAMNWLTEPLKKAGFMIET
GLANLETSFRATWEGEAGGPTIALLAEYDALAGLGHGCGHNIIGTSAVGAAIALKEAVPH
LQGKIVVLGTPAEELGGGKIMMVEDGIFDQVDVAMMCHPHKKSMVLRGGLACVDATFKYY
GKAAHAAASPELGISALDAVIHTFVAVNSLRQFFKDDVRIHGIITKGGEATNVVPAYCEA
EFLLRAENVEQLEIVREKVYAAARYSAEAVGAALEIEEGLIYAERNNNHALAKMFKENLE
YLDEEVSDPPKKGGIGSSDIGNVGQVTATIHPYIKITDSANTHTPEFVEAAGSEEGMQGL
NKAAKALAMTAYDVCSNREYLQAIRSEFEDWKSSKILK
>PK3-045_04616 HTH-type transcriptional regulator CynR
MNEKDCLLLIYLQKEQNITKAAEHLFMTQPALTYRIKQLEKEFQVEILSKNGKYIKMTPA
GEYLVEYAKRILNDLRKTKEFLLNIENELIGHLKIGVNSHFGLHTLPAILKEYRKNFPKV
QLNVDTGFSTEMMDLLVDGQIDVAIVRGDYNWPDAKYLLDEENVCVIANEPIAIHKLPQM
AMINRKEPKVLLKYKTSPYNPFEQSIEYWWNQRFSDPPLITMQVDSYETCKEMVKKGLGY
AIIPSVFLKKSDDLYSCPLVFKNGQEMKRRTWIYYREASMSLATVAAFVQYVMNID
>PK3-045_04617 hypothetical protein
MNKKDIANIRKQFKMNNDLLRITDMFNVYVMKESSDIFHYQSQPFGMLDQDQQELFLHNF
KKLLAGNLDEKLFELKFQREAENNSQLILHKGLLSSETEDWKEQMLLMVDKMLNSRQYDK
DIVITFIRGEYLKPKKRRSEESEESDRDTVFSHPFILCSINNTQEPKKELLFDYVEKEFK
YNIVVDPIINLNAPMGGFLFPSFTDNAADVNHILYAAGKIHEPNYQFIEEVLNGEEMMTA
QDDKIVFEEIIKDVTGDQLSTSTLSNVYEEINRMIVENEEEEVPKLDSKDVEQVLKMSGV
EDISPEKVEFAFKKIIDDDKYELKASNILPKFTSKSIKISTKIANIAISPPDLRYVKQIE
FSGKRYLMIEVEEDTVIEGFTMIPEAFGGNPEED
>PK3-045_04618 Na(+), Li(+), K(+)/H(+) antiporter
MKWKELPRNIKVRMITSFFNRAVSSAVMPFMALFFAQELNKIWAGLFLISTVVIGFLINL
VGGYISDRFPRKKVLMITSWLNALFFLIMTISLFPTNKIIVLFALAYVGFIITSSLGRPA
MHAIIIDSTTPENRKAIYALDYWLVNLSMAIGAALGGLLYLNHQKELFIMLTCTSTLIPI
AYGVWLQDKFTDQLQKKHKNVLVDLISNYKVAFKDTAFVKVVTGSTFIFAAEFSLNSYIG
IRLAETFEAVRIGSFEIVGVRMLSILNIENMLLVVCFTFIINRFTDKMNKKNALITGLII
YGIGYVTVTSANTWYMLVLFNLIATMGELIYSPIRNAEQANMIPSDKRGSYSAFSNLSFS
GADLIARASIIIGAFLIPTMMSVYIGFIVMVGTILIYTGLFAKTIKVNNLVNKGVSGD
>PK3-045_04619 HTH-type transcriptional regulator SgrR
MDNKLLTLWRYYPSGSIRMEEISETLQLSSKQTTRYLKKWMEEGWLSFTPGRGRGNISTL
LWKKEVETSYEEEVLKRIDLEPVEQTSKYLMYDWSTNSKMRLMNKFHTKLGFVQESNDKL
IVPKRYPFHSVHPLEAGDVFSAHLVANVFNRLVTHTEDGKVLPEIAHSWDSTPTTLRLYL
KKDIKFHDGSVLTAKDVAECLEKLRTHAYYKDLWTPVERIEVKSPLILDIIHPNGCSYIL
PMLSMMCASIYRETNEKILGTGYFILQQNSDKKTTLTAFQDHFRERPLIDVVEFIQVPED
FKGIYHSPMEKNTSSSFEVESDSGFGIIVMNSCRNSAIRQKEVRDYLHWIIVKNRHTIGD
LSPRLIPNDKSIIVGQNQQLTISEVERPIFSKPIVIRGARHTANTTQWLAEVFAKENIPI
DIQWFSFADILTKHPETLDVDLFIHGEVFEFNQDFSFYHFLMNGFSPLSQMIANNETLTN
LMDKYKEIPFEQWTALNLEIEKELINQSIMIPLYYQKRYIPFSTDISNIKISHFGYVDFS
KVWVRPKE
>PK3-045_04620 UV DNA damage endonuclease
MKIRFGYVANALGLWDASPSKALTFSRYSALPKQEATEKLLAVTAQNLKNTKRILYYNAA
NEIPLYRLSSSLVPLATHPDVDWDFITPFQEQWRELGQLVKQFKLRVSFHPNQFTLFTSP
REEVTINAIKDMTFHYKMLEAMDALDTSLINIHIGGAYGDKDTSLQRFQQNIQQLPMVIK
NQMTLENDDKTYNVRETLITCEQENIPMILDYHHHMANKEDIDLALYLERIFKTWKNHRM
VPKVHISSPKSTLAFRSHADFVSFDFVLPFLKMAKNLNQDFDVMIEAKQKNLAMFKLIED
IASIRGVKRVSGGTIEW
>PK3-045_04621 UV DNA damage endonuclease
MTIVRLGYVAMSMIVKNASPSKTMTFKQFQKIDDRDAGLRKLERIALQNLHNTLRLLKHT
AASDIHFYRLTSRLIPLANHEELLDWDYMKPLNEPLKEIGEFARKHQIRLDFHPDHFVLL
NSNQKHIWKNSIKTLRLHYLLLKGMGIDTTHRCVMHVGGNYKDTEKSLERFIDNWMLVPN
SIQDMIMLENDDTSFTLEDTLYLCEKLGIPLVFDYHHHLSHHHNPNWEDNWSRILQTWST
SPLPIKMHISSPKDEKHFRHHADYIDIDMFFYFLNRIKGSIPVIDCMIEAKKKDEALFKL
IEEVSIRNDVEMIDGSSFRLK
>PK3-045_04622 General stress protein 26
MTNQNLKNQVINIISGHRTGVLSSVENNKPHSRYMTFYHENLTLYSPTQMDTEKIDEIEK
NPHVSVLLGYEEKGQSDSYVEIAGTCSINNSETLKKQFWNESFQQWFEGPMDPNYVFLQV
QPDVIRILNRNGEPVQELTLGN
>PK3-045_04623 hypothetical protein
METSNSIESTLLSFKKGIGDFTQKMPEFASRYNAFTEACFEEGALTQKQKQLIALGISLH
AQDEYCIIYHTKGCLDQGCSEQEILEAVGVTAAFGGGATMSQGVTLVQECIQELNRLEQ
>PK3-045_04624 hypothetical protein
MELYNENHAYQAGDIVYVFYRNPHTQDVANIQAAAVVKNPDNSNELSLFLYENYYPLSNE
VAVYTTEAEAQEAYYYYYGDVSEGRLE
>PK3-045_04625 Spore photoproduct lyase
MIKPFTPKLVYFEPEALEYPLGKELLEKFKKMDVEIRYTTSHNQVRNLPGDNDFQRYRVA
KSTLVVGIRKTLKFDTSKPSAEYAIPFATGCMGHCHYCYLQTTMGSKPYIRTYVNVEEIL
EAADNYMKERAPEFTRFEASCTSDIVGIDHLTHTLKHAIEHFGESEYGKLRFVTKFHHVD
HLLDAKHNGKTRFRFSVNADYVIKNFEPGTSPLEKRIEAAGKVARAGYPLGFIVAPIYLH
EGWEEGYLHMFERLEAELPPEAKKDLTFEFIQHRFTKPAKRVIQKNYPMTKLELDEEKRR
YKWGKYGIGKYIYQKEEEADIKDHLHSYMKKFFPDAKLEYFT
>PK3-045_04626 5'-3' exoribonuclease
MDLHIHSIYSDGFWTPQEIVEDSIKKGLEIIAITDHDVLTGYEEALSYSKDALKVIPGIE
LNTDGPQGELHILGYQFDPHHPKLKDHVSWRVEDRIQWGKGIVEKLRNLGYDISFNNCLA
RVGKGVLVRTHIADELVSAGYFQNSKDAYEQLLKKGKPAFEERGSFSAEDAIKLIHEADG
LAFLAHPGIYKHEFQLQQLIDSGLDGIEVYHSKHSDKEQNYWGRMAEAFNLLVSGGSDFH
GPESRNPFPIGSVELPHTERITWISDAKVFTKK
>PK3-045_04627 Vitamin B12 import ATP-binding protein BtuD
MISIDGLKKNYGSFTALNNINLELLNGEFIAILGPSGCGKTTLLRLLAGFMKPTEGTITI
DNELAASSSKLVPPEKRNISMVFQSFALWPHMTVEDHIRFPLKHHRFGRTNGKEEQEIRI
GEALGMVGLTHLKTRYPAELSGGQKQRVALARAIVPKPSLLLMDEPLSALDAELRMEMRR
EISRIHQKLGTTIIYVTHDQGEALAMADRIVVMNNGRIEQIGTPESIYNNPQSVFVATFV
GKSNLIKGEWIGEDRFIPAEFPNVSWKDIGISKEIKSQNLYPVRPEQWKLGEAEQEEMTG
IIQFAQFQGNEIHYSVQVGEETINVYGSVFEKRFLPGDAVSLRIFSGVEERAVLTGSR
>PK3-045_04628 hypothetical protein
MNSSIQSAERKTEALFPLSFSYLSRKWWGILGFLLLIFVFLLPVWRLVWLSISSGEGISL
ELYQEVLVERATWKTIQNTVIITVSSTLLSLVLGVGLAFTMAYLNIRAKKWLQLLIFLPF
LIPSYISTLAWVQFFGGNGPIQFLFHQSVNLYSMGGIIFVLGLSHYPLVYLMSVEVFRRI
PRELKYAANTSGASGGVVFRKVIFPMALPGIASGGILAFLSNIDNFGIPAFLGIPANIRV
LSTYIYEQIIGYGPSAFARAAVLSVILGVIALIGTVLQWAIIRKSNVSETAARDIEPRYF
LPRGLRNAVEIVLWMFLLLTTLLPLVVMASTSFIKAYGLSLAWENLSLKNYSYLLFEDGK
TGAAIGNSVTLALVTMLICMVIGTVIAYLRFKKPSVLVKVSEIIVTIPYALPGTVFALAI
ILMWLQPVPGFQPGIYGTIWILLIAYITRFTVLQMRGSLTAFSQIDSSVEEAARISGAKA
LAKWRSILFPLLMPGILSGAALVFLTALTELTVSSLLWSSGSETIGVVIFSFEQAGYTTY
STAFSTLIVGSVLIMGILFVLLEKIWKKKVMKSD
>PK3-045_04629 hypothetical protein
MRKWMLVLMFGILMVFTAGCGSKESSEPSNASKDTGSSESKIEGSLHFYTSQPDADAAKL
VEGFQAKYPDVKVETFRSGTEEVISKIKAEKMAGKIQADVLLVADAVTFESLKEEDMLKA
YESKEAAEIPAELVDPDHTYYGTKVMATGLVVNTQKVKKLPTSWNVLTSKEAKGKIIMPS
PLYSGAAAYNLGVFTRQDKLGWDFYKNIAANDVTVTKGNGDVLKGVAGGEKDYGMVVDYL
VTRAKAEGSPVELIYPEEGVPVITEPIGIMKDADNVDAAQAFVDFVLSEEGQKLAAELGY
TPIRKGVEAPEGLKTIDEMKVLSTDVQELYRARDGDKKEFETVISE
>PK3-045_04630 5'/3'-nucleotidase SurE
MKVLVTNDDGIFAPGLQALVEVLQHFADVYVSCPDQERSAVSHSITLRVPLKAKPLPLFP
GVKGCWAVNGTPADCVKLGIEVLMKEPPDFVISGINLGPNLGRDLYYSGTMAGAVEGLLY
GIPAVAVSLNAFSDIDINYEKVKKLLYPIVEVLLQNKIPKGVFLNVNLPYLSREVYKGVR
IVPLDMDVARYSYVGLNDPHGQVYYWLKDQLHNMKDLKADSDYTLLRTGYVTISPIEFRT
FHRRKKEQIERWFAHLNIASTDEEEIDYA
>PK3-045_04631 endonuclease 4
MHFASTLAWAYPVDQVVQLAKQSGLSGLEIWAEHVWFHGTDPNKIREANWNQSINLTMHA
ASWDLNISSLEKEIREGSVKQIQNSIKLADEIGADSITFHPGRLTLPQIKQEIYESFMME
SILTLIETAKRYKKTLSIELMEVKAKEFVTTPETMNRLIASFLPELKTTFDVAHISEGTP
QQAFAQLINVDKIHISDNSRGQLHVPLGTGILDRNMLKEFISINDLPVVVEGFDASESLN
WWNHNLHYLKSLAMMKEVPQ
>PK3-045_04632 hypothetical protein
MVLITMFKSELVNLVLKFVCYVLFMLFILFSFVDYWLKIAFVFLIIPLWVITDVIQYRKK
KETHEF
>PK3-045_04633 putative NAD-dependent malic enzyme 2
MTVSDNVIITTLKGKEILSNPFLNKGVAFTKEEREDLGLDGLLPPQVLTLDEQVNRVYEQ
YLMRTTNLFKNGLLNDLYNRNVVLYYRLLKEHLAEMLPIVYTPTVGDAIQSYSHSYHRPE
GLYLSIDHLEGVEKAFRNLGKAKNDIDLIVVTDSESILGIGDQGVGGINIAIGKLAVYTA
AAGIDPSRVLPVVLDVGTNNQSLIDDPIYIGNKFARVRGDRYDQFIDLFIDTARRFFPEV
LLHWEDLGNVNARNILDKYGDKILTFNDDIQGTGAVTLAAIMSALKVTGGALKDQRIVVF
GPGAAGIGNADQMVDTMALEGLTKEEAYDRFFAIDYRGLLTDETPGVLKFQMPYVRKAEE
VKHWNRNEDGIISLMEVVKRVKPTILIGTSGQAGAFTEEIVKEMAKHVERPIIMPMSNPT
NLAEAMPENLIKWTDGKALIATGSPFADVEYNGVSYEIGQSNNAFVFPGLGLGAIVAKAQ
IISKGMFAAAANAVAEMCETNQPGASLLPSIEKLHDVSIYVAVEVAKAAIEEGIARAEIT
DVTKAVIDAVWQPEYKKIKSVGMWANV
>PK3-045_04634 2-keto-3-deoxygluconate permease
MHIPIKKTLDKIPGGMMVVPLFLGVLTNTFFPQFLEIGHFTTALFSKEASSTILALFMFL
IGSQINFKLAPKAIKKGAILLTGKFIVGAGIGIAVAMLFGPAGILGLSPLAILAALLNAN
GGLYASLASSYGDETDVGAYALFSLKDGPFFTLVALGASGLAAIPFQALVGVLIPILIGM
ILGNIDPDMRKFLGSSKLLLIPFFSFPLGAGMDLRTIVEAGGPGLLLGLIAAFTGIGAYL
LLKLFKENPIVGLATGSTAGNAVATPAVVAAADPTLSSIAPAATAQVAAACVVSAIICPI
IVSYVFKRSQRKKTKKSMASAA
>PK3-045_04635 Transcriptional regulatory protein DcuR
MINVMIVEDDPMVAEINKRYLSQINGFHLTATANSVDDAITLLKKEKIELILLDIFMPGK
IGLELLAYLRKNDLAIDVIVISAASDLERIKKALRHGVVDYLIKPFEFERFNTALTTYLE
QARITNKQASISQQELDTLLLHREESVTVEELPKGLTKDTLKQVWEAVQKLKEEPFSTDD
AANLVGISRVSARKYLNFLKDLGILEVKVIYGTIGRPVYQHEYNRLKEHRIKNFL
>PK3-045_04636 Sensor histidine kinase DcuS
MKKGKFSLQAIIIIFVCIVVAFSLGITDLIISNSITSSVEETQKEKALDVARMMAITPQV
IGVLEGRENEEDVQVFANQIKTQTNVNFVVVMDMNGNRLSHPEASKVGKHFSGGDEGPVL
NGKEYVSISKGTLGKSMRAFTPIKNAEEEQIGAVAVGISLKSVTEAVHKGRMGIGIGTLI
GILIGIIGAVVLARYFKKILLGLEPFAIAKLLEERSSMLQSVREGIIAIDQEGKITLVNK
AASKLFQKAGIGEDAIGRNIEDYLPETRLTRIIKSGEMDLDQEQNLHGVTILVNRVPVVV
ENQVVGAIATFRDKTEVQQLAEQLTGVRNYADALRAQAHEFMNKLHVILGLVRTEQYETL
ANYVSETVNHRETEVGFVTKKVQDPVLAGFLIGKLSFARESGVSLSFDCENILPKPADPE
ITNELITIIGNIFDNAIEAMVDSINKKIDLTLDYAEEILTIEVKDTGIGMTNALQNKVLD
KGFSTKGNNRGFGLYLLVMAIERLEGELIISSKPGKGTTFAVYIPYKAEDE
>PK3-045_04637 Histidine decarboxylase
MKEIQALFPSMDGNDFQREELLSYFKTILTKIDELKDPDKLTLGEMPEYTEDYYNRVIQN
ANVPQAGVSIDEVIKELLKLVEGHRYVNRNYVANAAPLPNIASIIGNLVMVLVNGNNLWD
VEGPAAAAAEVEITSMLSKLIGYDENLSAGYTTWGGQGAVFNSLRIAIARYAPSSNQMGI
PKNLYCFCSELSHYSLYKSVEAAGIGVENMVRVKVNQDHSMNLEDLKEKIEQVIAKGGVP
LYILATMGTTDTFGIDDIAGIKQLAEELERKHCLSPLYIHADSAMGGMYTFFNDYDFERN
ALQLEDDVKEVLQSYQQKFKQIKHADSMVFDFHKLGQTPYITSLFLIKNRESLKYVDLDE
EETPYVGNRGYGSYHTGYTLECSRMGSALAIYASLLAFGVEGYQMLLANYIRVNSKFRET
LTKEIPNVAITNEVSPITTFRFYPEEPKWKEERNGLLTAEEMIEINQFNDAFAEIIGAER
DTIFFGNTKKQCLVKAANSNKQIPVYAHKFFTISPYSTVEEIDRYVAFLKEHLSFFMKTT
STYDSISLL
>PK3-045_04638 hypothetical protein
MSQQEQWRSKIGFVLAAAGSAIGLGAIWKFPYVAGTGGGGAFLLLFLVFTLVLGMPLLLG
EFMIGRMGQSNAVRTYGKLASNPKWNFIGKLGVFTSFLLLSFYSVVGGWIILYIVKVLSG
GLAGLSQDQYGELFGEIISNPYSTISAQLVFMLITILVVAQGVQKGIELASKIMMPALVI
LFLILVIRSLSLDGAMEGVKFLLVPDFSKLTSESILFALGQAFFTLSLGVSVMLTYASYL
PKSQNLPRSAISIIILNIVIALLAGLAIFPGVFSFGMEPNAGPVLIFSVLPAVFAHMPFG
MVFFLAFLLLFLFAALTSAFSMIEIIVAAVTKNDTAKRKKATWIIGFLIFIVGIPSCLSY
GALSEIYLFNKTIFDLMDYLVSNILMPLGALLIAIFVSQKVSKADLFAELKRGSNVGYVF
FMICYVLLKYVVPIAIVIVFLDAAGLSDWIITLFK
>PK3-045_04640 Methyl-accepting chemotaxis protein 4
MEAILLGIIVILLVTTVYFAYRYFTLKHHPHINKEIMNGMKEIAAGSMSSKVEGSSSYHA
TFNQLIEFLERVRGKFFSFSKNVHKKGESLTEIGEYAMEKADIVRAAIDEVGRGLQKQLV
ATEESALSMEEMAQAIEDLSIRSNQISEQSNTTLELTQEGDEKLKDSLVQMEQFNQTINT
TFHAINNLGEKSKEIGTIVKVITGISEQINLLALNAAIEAARAGEHGKGFAVVADEVRKL
AEQSRQSSSEVSNIVKNIQEETNIVVKSMQQGTEEFKETNTNILEVGTMFEQILSTTKVI
AENNENSSASTEELSSASQQIMATIVQIASISRESVEMFEELIEISDDELQTIQGLVQEA
ENLLELKNDVDKLLSTWNQASEQKSHAEGDITVAV
>PK3-045_04641 hypothetical protein
MQKVEMSYKYEIITKEQTDLIEKAADCLASSFIGVDIAGKWVQEPMVGQLNIGYEDFYQF
TKDYIDATVEQGYCAVAIDNNQKVVGVLAGDTNAPEIIGEDVFEGTFLDMNVILHVLEDV
DKRFLDDYKQRTGKELQDGEILHLFMLGVTAELERHEIIKQLGNKLITKASEQGLKAVVG
EATNPKSMRVMEKYHNMKKYRDVKGNYIVHKYQENSRLKDIPATIADGTYIIMKEF
>PK3-045_04642 hypothetical protein
MIVVDKKKYKMEIDENSKEVRVQVHGLMREEDAEGYMVDLQDTISKVSKKDYTFVVDGTH
QTPVPSKVVPQLEQTMQFYSSLGFKDVLVIKPSSKIAQVQIRNALERIDFAGTFIDRASH
SK
>PK3-045_04644 putative xylitol oxidase
MGLKRNWAGNFQYSATNWHEPESVEEIQQLVLKLKKLRVIGTRHSFNSIADSEENIVSLQ
KLNKVIAINSEEKTVTVEAGMKYGDLCHVLQQHGYALHNLASLPHISIAGACATATHGSG
NSNQNLAAAVSAMEVVTADGCIITFSREKSEEELHGAVVGLGGIGIVTKLTLDIHPSHLM
RQDVYENLPFAQTAHYFDTISSSAYSVSLFTDWQDETFNQVWLKSKLTDDQTFSLGDDFY
GAKAAKENLHPVRGVAATNCTAQLGVPGDWLDRMPHFRMDFTPSKGQELQSEYIFPREHA
YNALCALSEIREYIAPLLFISEVRTIAKDELWLSPSYKQDSIAIHFTWQDKWKEVQQVLP
LIESKLEPFQAKPHWGKLFTTAPSKIQSLYEKMPAFQQLLIKYDPQGKFRNTFMNKYIFN
EHN
>PK3-045_04645 Ribonuclease J1
MKVDENALSFFALGGINEIGKNMYVVQYEDEIFVIDCGGKFPDESLLGIDLIIPDITYLE
ENQDKIKALIVTHGHEDHIGGIPYILRKLSIPIYATRFTLGLIELKINEHKLNGETKLIT
IDSSSKLEFGEVQVSFFKVSHSIPDCLGVVFHTPEGNIVHTGDFKFDLTPANNQYADIHK
MAEIGQQGVLALISESTNAERKGLTPSEQMVGSHLDEAFMKADGKIFISTFASNVNRIQQ
VVESAIKTNRKLALLGRSMVNVVNVAIERGYLHMPEGMLIDVSQVDQLPAEKVAILCTGS
QGEPMAALSRLASGNFRDVTIYPGDTVILAASPIPGNEKDVSKIIDNLFQLGAKVIYGSG
STTGMHVSGHGYQEDLKLMLTLMKPTYFIPIHGESRMLYHHRILAESVGVEKENTFIIKN
GEVVDIKNGVARQTRFVPAGDTYVDGMGVGDVGDIVLRDRKQLSEDGMLVVIITISKGDR
KIISGPDTITRGFVYARNSDELLKEVNRLVKKTVNDLQSENIHKWNVMKQNIKKSVGQYL
FNQTKRKPMILPIIIEI
>PK3-045_04646 putative oxidoreductase YhhX
MLTIGYIGNGKSTNRYHLPFVLQRENIKVKTIYQRNPKRESWDRIAGVNYTSDLNELLND
KDIQLIVICTRHDSHFEYTKLALEHNKHCLVEKPFMETAEQAREIFALAKEKNLIVQAYQ
NRRFDSDFLTVQKVIEEGKLGDLLEVEMHYDYYRPEVPESAQTFNPAESFLYGHGCHTLD
QVISYFGKPDHIHYDVRQLLGQGRMNDYFDLDLYYGKMKVSVKSSYFRLKERPSFVVHGK
KGCFVKETKDRQEEHLKLFYMPDNKDFGIDTIKHYGVLTYIDDEGTIHEETVKSVNGDYG
RVYDDLYKAIINGEDKTITDEQTLWQMEVLETGIKNLK
>PK3-045_04647 PTS system mannose-specific EIID component
MEKAFKLSKKDRISVWWRSTFIQGSWNYERMQNGGWAFAMIPAIKRLYKSKEDRAEALKR
HLEFFNTHPYVASPILGVTLALEEERANGAPVDDKAIQGVKVGMMGPLAGIGDPVFWFTV
KPILGALAASLALTGNILGPIIYFFAWNLIRMGFTWYTQEVGYKAGSKITDDLSGGLLQN
ITKGASILGMFILGALVNRWVSVKFTPVVSSVELDEGAYIDWDKLPAGAEGIKTALEQQA
AGLSLDPIKVTTLQSNLDSLIPGLAGLLLTLLCMWLLRKKVSPIVMILGLFVVGIVFHLI
HLM
>PK3-045_04648 PTS system sorbose-specific EIIC component
MDLNMIQILLVIIVAFLAGVEGILDEFHFHQPIIACTLIGLVTGELVPCLILGGTLQMIA
LGWANIGAAVAPDAALASVASAIILVLSGQGDAGVSSAIAIAVPLAVAGLLLTIIVRTIA
TGLVHLMDAAAKEGNIKKVELWHIFAIILQGLRIAIPAALIIAIGAGPVSDLLTAMPDWL
TNGLAIGGGMVVAVGYAMVINMMATKEVWPFFAIGFVLATVSQITLIGLGAIGVALALIY
LALSNKGGSGNGGNGNTGDPLGDIIDNY
>PK3-045_04649 PTS system mannose-specific EIIAB component
MVGIIIASHGEFASGILQSGAMIFGEQENVKAVTLMPSEGPADVKAKMQEAIASFDNQDE
VLFLVDLWGGTPFNQANSLFEEHNEKWAIVAGMNLPMLIEAYASRFTMNTAHEIAAHILG
TAKEGVKVRPEALEPAETAANTTAQPASAGAPGKFEYVLARIDSRLLHGQVATAWTKTTQ
PTRIIVVSDEVAKDELRKKLIQQAAPPGVKAHVVPVKKMIELAKDDQHFGGQRALLLFEN
PQDALRAVEGGVPLKTINVGSMAHSPGKVQPNKVLAFNQDDIDAFAKLKEAGLSFDVRKV
PNDSKGNMDEIIKKAQDELNRRK
>PK3-045_04650 hypothetical protein
MVQSINTKVDLVMNATSHTGISEYGKIMIGDKGFEFFNSRDARKFIQIPWEEVDYVIASI
MFKGKWIPRYSIQTKRNGTYTFSSKDPKKVLRTIREYVDPKRMVQSLSFFDVIKRGLKGK
SKK
>PK3-045_04651 Transketolase
MTTNQLIDQLAINTIRLLSIDAIEQANSGHPGIAMGAAPMAYTLWAKEMNINPANPKWLN
RDRFILSAGHGSALLYSMLHLFGYGLTIEDLKNFRQWGSKTPGHPEYGHTAGVEATTGPL
GQGIAMAVGMAMAESHLAERYNKEDFHIINHFTYSLCGDGDLMEGVSAEAASLAGHLKLG
RLVVLYDSNDISLDGNLNLSFSESVADRFKAYGWQVLRVEDGNDIEAIQKAVKEAKTDLE
RPTLIEVKTTIGFGSPNKSGSSASHGAPLGKEEIELTRAAYQWEAKEPFFVPEEVEKYFA
SIREKGKAVEQAWNDQFEEYKTAYPELAAQFESAVKGELPINWRKDLPIFESGLKIATRE
SSGRVLNAAANAIPQMIGGSADLAGSNKTLISSEKNFALDGYEARNIWFGVREFAMGAAL
NGMALHGGVKVFGATFFVFSDYLRPAIRLAALMKLPVTYVFTHDSIAVGEDGPTHQPIEH
LAALRAMPGISVIRPAEAKETAAAWRLALESQDHPTALVLTRQDLPTLKADQEQVYEGVK
RGAYVVSQAKGKVVGLLLATGSEVTLALEAQEVLEKEGIYVSVISMPSWDLFEQQPADYK
ERVIPSHITARVAIELGSSLGWREYIGHNGRMITIDHFGASAPANRLMEEYGFTVEHIVE
TFRSTL
>PK3-045_04652 D-allulose-6-phosphate 3-epimerase
MMKKVGFSPSLMTMDLDKFKEQITFLNQHVDSYHIDIMDGHYVPNITLSPWFIEEVRKIS
DLPMSAHLMVTNPSFWVQQLVDLKCEWICMHAEVLDGLAFRLIDQIHDAGLKAGVVLNPE
TPIETIFPYIELVDKITIMTVDPGFAGQRFIESTLDKIVALRELRDKKGYQYVIEMDGSS
SRKTFKRIDEAGPDIYIVGRSGLFGVNEDIEKSWEIMCQDYKDMTGKEVES
>PK3-045_04653 PTS system fructose-specific EIIB'BC component
MSGVKKLNLKGHLLTAISFLIPIVCGAGFLIAIGMAFGGTSQGTLVQGEFNIWDALATMG
GAGLGLLPAVIATGISYSIAGKPGIAPGFIIGLTANAIGAGFIGGILGGFLSGYLAIAII
KHFKVPSWAKGLMPTLIVPFFTSIIGGLIMVYIIGIPIAAFTSLLTDALNSLGTSSLLVF
GGIVGLLSGIDFGGPINKTVFAFVLTMQAEGINGPITALQLVNTATPIGFGLAYFIAKVF
KKNIYTRSEVETLKSAVPMGVVNIVEGVIPIVMNDIVRTVTAVAIGGAAGGAVTMVLGAD
ATVPFGGVFMLPTMSNPWAGVAAILVNVVVTGLALALIKKNVKEDEQVEVEEEDIDLDDI
QIL
>PK3-045_04654 PTS system mannose-specific EIIBCA component
MEVNNIVDINTIKTNMSAKSKEEAIQELAEVLLENKYIKDIEAFTKDIYAREAIGQTGIG
NYIAIPHGKSDSVEKIGVAIGITQEEIAWESLDGKGVKGIILFAVGNDDGAQSHLKLLSL
FARKLGNDEVIKKMLQSKNAEDVKEALCS
>PK3-045_04655 PTS system mannose-specific EIIBCA component
MKIVGVAACTVGIAHTYIAQEKLENAGKKAGHEIHIETQGTIGIENELSQQQIAEADIVI
LATDVKIAGRERFDGKRIIQVTTEIAVKSPNKLIEKAAEVVSQKK
>PK3-045_04656 hypothetical protein
MDINSIYQVYFNCELKTKEEVYSFISKIVSQDNPISKEEVIHQLNERDKIGSTLIAEHVI
LPHIESDQLKKSQILFIRLVNPIITWDQSKDICLVIIILLKKNESVNIKKRISSFIRSFA
DEEYLNRLLKSHEEEEFSEEIIGY
>PK3-045_04657 Transcriptional regulator ManR
MSSKSNYEQDLLLFLSKTQGYVTSKELLEVLNVSQKTVYRLVNKINDEYEDGPLIISERG
RGYKLDYEKFIHAQKSNYKDKKMQFSPQERRKRIMEQLLLSSPKPINVYHLFSDYYVGDS
VAFNDEQIMSEELKKYNLVLERKNRTLAILGDEVNIRKAIKDIIEIFHIIDIDDLKRNPK
LNFNQYDVLFILEQLRKMEEDLNITIPYPYNVNIFSHLYILLSRSRKVPIRLFTDEISSK
EMENMQRDILYPLAKMIVQNIEKYLNSPLPDMEVYFLYQYLVSSRMQGSHAITSTFSSEV
IRVTKAYIEGMSTSLGMDIDSQCQSIFVDLANHIKPMLNRLEHKIRVKNNLLSQIKLTYE
EVFMGVRKVSGSISEKFNLPAINDDENGFITLYFAKALETRQYQHPIKTLIMCTTGIGTS
ELLRAKVSKKFPELEIVDVVASRNTQILKEKYSDAELILSTVHMKEEVVIPYLLVSAMFT
MDDQKRLQGKIEEIYHGY
>PK3-045_04658 putative protein YcnL
MKTSTPCPNCNKSLTIEHFEDFPSPFNMKCPHCKAKLKETKMTPILILVAIIIIPLFILL
GVTVKNFLTNFFPIVEKIPTAIIFLAFCYPVYALYEAFNAVIIFKGNLQLKKRQ
>PK3-045_04659 hypothetical protein
MKKNLLKITMVFGLIFSVSSPVFGSDVKPMISDCGGSEHPVPCWAY
>PK3-045_04660 Tn3 family transposase ISAau4
MSKGLIHHIEIYVSNLKSSITFWGWFLEELGYESFQSWESGHSWKLGETYIVFVQAEERF
MDIPYHRCRVGLNHLAFHASSRQQIDDMTRKLEQKGVKILYTDKHPYAGGEKHYAVYFED
PDRIKVELVAP
>PK3-045_04661 hypothetical protein
MNIWNDDNSTYTLSSITSEDIKLAEEHFKVKLPDEYIDLLKIKNGGTLRYNALPFSLNGR
EEDDFILIEYIHGIKKDEGIMQTDYYLKEWEINKERVILLSGDGHEWLALDYSTSEEPKV
VYILTDEDEVIELYETFSKMLKALYIEGEEVEGNFEEDDDTITYIIEEARRLINSNNKIE
VLTGIEAFNNLSDDQEILAENLDNIRHFLKHSDKDIVEFAGESAWSLVYSDYEIDEEFIK
FVSSVYKGRTDIPIFPILLARMNNHLKLDKQ
>PK3-045_04662 hypothetical protein
MTNIEKRKVLEILDYWKTIELLNQVDIPQEIGDNKKVVKKITRGERIDSNLDKITIFTKI
KEPSIDLSHALKNDKEKFSLFPCEGTDLSFLFGRIKRNDLVDYLAKFVKNYDEQPNIAYP
KSSEIAWFSFRTDTEGIYQKNSFQLSPLLWAISVWNKKVNGFSLNSIDYDDETKKYDSWF
EEAEDLFAVLPSVFSDIYNTYVKIIKSELPADYIGHFIYDRYKNGEVKNKEENLEDYASL
GKSFFLADIVLLIDAIKSGKFGEGSDYERKVIDYILSAHNKAVGIIPENSISISPEEERQ
KMMDFFQNTLNIKNAPLGKWPAKFMPALMQQVAVNLAIDENANTEVFSVNGPPGTGKTTL
LKEIVSSNIVKRAELLAEAAHSDPDDAYERCSFTQGPLDNKGYFKYAPSYFKLKNDKINQ
YGMLVASCNNSAVENITADLPKSDDILKSLEPSKNDEESVVSGLNEVHNLFNVKKSEDIE
QIKISGEIKEERDIYFTRYANNLLNRKDCWGLISAPFGKRANINKYCVSVLKKFINDYNL
NNVREEHRKKYVEQRECFLRQLKIVKELEKELEILCHYAKSLPLTNESISEVDLDRKIKE
NYAYLMELEESRPRGLFGRWKKDTTRDNLIAEKKVEIEVLKKQKDRLSKITSYYNLLSKH
SEGAEKLTPIDSSFIARYVSDDEIESTQAQVTNPWFTERYNREREKLFFYACKLHKEFVI
SSKAFRQNIINLLIAWDMHEDCDVRMSEKDRIDAFPALIQNIFLITPVISTTFASAQTFL
RDIKHPGTLGTLIVDEAGQAQPQMAVGALMRCRRAIIVGDPKQIEPVVTEETDMIKSLIT
SDLLTPYQDKKISVQGFADYINSYGTFLGKDEEKEWVGCPLTVHRRCIDPMYSISNCLSY
DGTMKQQTEAPKEKVVKTFILEKSYWINVKGEEQSGNKNHYVPSQGQIVLKLLEEKFKKD
GSDIPKIFIITPFTSVKEGMSDALRKSDFYKRDSRVKKWLKDKNIGTVHTFQGQGTDEVI
FLLGCDKSSVKAANWVNKNIVNVAATRAKYRLYIIGDREVWSCKPVKVARDKVNNDISSD
NLIKMLSGCENTESILGPTIQTIEVKKVEYTTQEMKNEVATLLGNRSKVCPKCGKPLVEK
NGRYGVFYGCKGYPKCSYSESIKK
>PK3-045_04663 hypothetical protein
MQGRTIQIFLPFGSPRGIKIAEITNRTVQAIYIPRNQLENAAKRAEVTNVGVYFLFGQTD
VDALPQVYIGEAENCFVRLKEHNRDKDFWESAIVFVTNNNQNQFTKTDVKFLERLSYETT
KSVMRYKLNQTVPASSFVPEWRQFDLLDIFETMKVLVATLGFPLFDFVRKTIDTENKEEN
KDNLFFCKGKGLQAKGEYSEEGFVVFEGSRMAIEHSNSIHNYLVTKRESLVQDQVVELDS
GSYVFKKDYPFSSPSQAAAVILGRNANGWIEWKNIDGVTLDQIKRKNME
>PK3-045_04664 hypothetical protein
MAIRDAFHCYGHFYDLFLANQRIAECRSVLEIVRKSSNISINSVSNLRPNAIAIMMNPGK
SYPLRNTPERIDLESFDINFNSKLLVTAYPDDTQPRIMKLMNYKNWNHVRVINLSDIRER
NSNRLGHLIESFELITRTKVHSIFSNERQDERDYALSEDIVPILLAWGVKDFLEEPATQC
LCIVRSRETYGVPSIESEIYFHHPLTRRVSWYSKMIELLSNC
>PK3-045_04665 hypothetical protein
MGLISDWIWKKQMEFIEKHGSLPEYLQKKAENHKTIDANYQSKHSSLKFEPAYGALVYTE
LLFGFAEHSGIYIGNKQIINLDGKGRITKVSLNQFTENISTFNHEIYVPCYDGEGTSIGF
YRAGINAEEKLSQGRKYNLLFDNCHQFSAGCITGDFENSSNFLSFVKEDFKRALGGESIV
WRKWDWKNN
>PK3-045_04666 hypothetical protein
MNYIQSKEKQKNPLEKQNVKQAAKRVNIVSLKMVREHSIMYPKRNVRSPEDAFTLLQTFL
DDLDREHFVVVCLDTKNQPTAINVCHMGSLNASIVHPREVLKVAILSNSASILVAHNHPS
TDPSPSKEDIEVTKRLLEACEIIGIEILDHLIIGGKNYISLKEKGYI
>PK3-045_04667 hypothetical protein
MQVSKICKINNYRNLSGMKVDFNENVNFIVGKNNVGKSNLLELLNNLINTGKFYESDFLD
VKDPIEVEFQIRYSEVEVGYFEDNFDVEDNLQITILARQHSVDDRIEYFHKNSEAPISQK
KIKGLNFIYYSSLRIPSKELNFNRNLGTGKVLTYLMKESFKKESVLEVDLLKTSKINKVI
KVLNDQIKKLNGLSNEKIEAYINSDSENLINRIVEIGDDSRRNLDDLGDGVRYGFNIFLH
ILELLVHLKTTTKQENYEKLMISMPSGKKYLPLILGLDEPEIHQHPYRQRALIKSVQKII
NNANQEFAELLKELFGVDGFLGQLFVVTHSPNILLNEYKEIIRLHNQEGVVKATSGININ
FDAKIHKHLVRSFTYIKEAMFSESVILVEGDTEFGAVPVFASRMGHDIDEDGIGVIKLDG
ADSVKRCLQLYRAFEIPVSAIIDKDKLESYMDEEDVFFTNEIDFEEEVYSHYTLQEYMKY
LIEVDKVRSLIRIFKQEIDQFNVKEFLEDTKEYAIKSAVGDKIMRIIKEEQLQFLKNNKT
AINGALLATYVNGVPNCFKSVIEKALRGRLNE
>PK3-045_04668 ATP-dependent DNA helicase Rep
MNKEEIRAKFHEIHGKDQEQLDFILSEENKIIVTAPAGCGKTKAMISKIAHEIITNEYLN
QKRILALTFSVNAAAKIREDIKETLPLLLGKDNYEIDNKLDVSNYHGFANKIIRKHGYIL
HNNLKNINDFLRTSDNNGGLRKILVSQEIRILEEYDQSLKSLEFDKADRLQGSYIDIILN
KLVPQNIITYNGLLLLAIQILDKKTVSDFYKLYYQMVIIDEFQDTNYLALQFLKRIVKAN
KVILMGDDIQKIYGFLGAVPNIFKKMEADYNMFPMEFRTNYRFKDNKNMKQLDSYVRGIF
NNYKNINAYSESANIKFTLFKTDHGEANHIYRDLLKHIEAGNNVAILFRAKYLAGNLINI
LEKNKLMYFNGLFEDSDPEYIKFHKEALEIFVKESGVRKSVSRTVISNVKEKITAIKQSI
TNNEPMFSSLMRLLDALLETTKAKSISTEEKYERILFTLNNNSLKRLMNEINEQVTLTTI
HSSKGLEWDYVYLPNMTAYSFPTSNALCKSCNNINGRNEYEKHCEFKFLPELEESFSEEL
SVLYVGLTRGKQDVFLTANRGPNQFGYNKKVSCFITLPNLKRIKE
>PK3-045_04669 hypothetical protein
MIYITKNFYTAESTGKKGYFQVISIIKEEEDLSHF
>PK3-045_04670 hypothetical protein
MNKNITTISSRLSLRKPQRLSLEILSNVLEILELGNKEGASLEEQLDKVRSVYPSVTSFE
RDFPSLCFALATGVGKTRLMGAFISYLYKAKGLKNFFVLAPNLTIYNKLIEDFTPNTPKY
VFKGISEFIANPPIIITGDNYEEGIGVRKQSLFGEDEVHINIFNISKINSEVRGGRLPKI
KRLSEYIGESYFDYLATLPDLVLLMDESHRYRASAGVKVLNELNPILGIELTATPQVELK
NKTLPFKNIIYSFPLNKAIEDGFVKEPAVATRENFNPDNYSEDELERIKLEDGIKVHEET
KVELKVYAKQNKQPIVKPFVLVVAQDTTHAESLLEIIQSNSFFDGRYKDKVITVHSNLRG
EEKDENVQQLMKLEDPATNTEIVIHVNMLKEGWDVTNLYTIIPLRAANSKTLVEQSIGRG
LRLPYSKRTGVKPVDRLTIIAHDNFQSIVDEANKQDSIIRSGLFIGRDIAKDEKKPVVSK
PVIEDKVLEEVQNKLSTEECTDGAVAKFDSQEIKQVIQLVQSKVAKLEYLPNSRQLNNQD
VKSKMINEIQEDFNLNNLDLFTEERKQFVTHVVETYLEKNIQHSIDIPNIIVEPVGDLSW
GYNDFDLDTSNINLQPISENILIQHLRTHDRDILTRIESNQEGERLEDLLVSVLMEYPDI
SYEDQAELLYKLSRQLVSHLFSYLPNETTVKNVLLYNRNRLGELVYLQMKDHYFEHASSY
QAKVNKGFETLQPVNYTTSISTGQINFREPVLDKSRIKSMVFSGFIKCLYKTQKFDSDSE
RRFSVICENDISVEKWFKPSIGQLKIYYGQSKIYYPDFVVETKTQKLICEIKRSDDINDD
EVQKKANAVIKWCNYASDHEMESGGKVWRYLLIPHSDVNENMTIEGLMAKYLKH
>PK3-045_04671 hypothetical protein
MAAKTRLELNWIGKDLDIRPEPRILIENESLSYKSEHKSDIGGKLHNDNKIIYGDNLIAL
KALEQGFTGEIKCVYIDPPYNTGNAFDHYDDGVEHSIWLSLLKERLTIIHKLLRDDGSLW
ISIDDDEAHYLKVLCDEIFGRKNFVNTVIWQKKYSPSNDAKYLSDVHDYIFIYAKDKNMF
NRNLLPRTAEQDNRYKNPDNDPRGPWKPSDLSVKTPNPRDLYPITTPSGRVVTPPESRSW
VVSKERYEELLKDNRIWFGKSGNNVPSLKRFLSDVQEGVVPKTLWLREEVGDNQEAKKEI
KAFNNKDVFTTPKPERLIERILQIATNEGDWVLDSFAGSGTTGAVAHKMGRKWIMIELGE
HCHSHIIPRMKEVASGADQGGISKLHNWKGGGGFKYYSLAPSLLKKDKYGNWIVNERYDN
DMLSKAVSKINGFVYEENQQTYWKQGKSTEDDYIYVVNRLITREEVERINSELGEQESLL
IYCKAYNFDQDEYPNITVQKLIPSLLQNRYDYGIEDYGELITRGRN
>PK3-045_04672 hypothetical protein
MVPTQVYWQVSHQNILRAIYWATKKLKYSIDRPGMNKRTQSEALDDKIMGDIATIAVLEY
LASIGVTSVAYDHYRSDNFQRPDPGWDIAIGLQAQKWANSTSDLMRPSNLTTVSVKSSRL
PKGQNVNQAIQTRDFKIFKFTDSIGKDLNTDIELQVYYPLETTQLGKLEVTPQDVEAIKK
LNGFSQAECQIIHDKLNVTQRWGTCALVGYNNRENMVTQSPTLNPQSWSSFGKEMWCAPL
RLGKEMSTLIDFNI
>PK3-045_04673 Tyrosine recombinase XerC
MQGYFRKRGSSWSFTIDIGVDPQTGKRKQKTQSGFRTKKEAQLEAVKLQQEIGQGTFVNE
KETLFKEFIKDWLKQYENNVKISTVRVRDHESRKLLSYFEGLKVKQITRKMYQDVLYDLY
EKGYALNTISGIHSTGRMIFKKAIELEIIKNDPTQYAKLPRPIKTVEELESEEEIVKYLE
KEELALFLRTAKEHGLERDYEIFLTLAYSGLRVGELCALMWKDLSFKDYTVSVTKTYYNP
RNVIRDYQVLPPKTKNSKRTIELDPIVLKELERLKARQNELKMLNRSIYYDKDFVFAKTG
NHLGYPELIKTIQNRMIRLLKLSGLNPALTPHSLRHTHTSLLAEAGVGIHEIMERLGHIE
DDITKRVYLHVTKTMKTEASKKFGELMRNL
>PK3-045_04674 hypothetical protein
MTRNDYPLILQMKDVTRILGFSKSTVYSLIQDPDFPVLQVKNRKVVYRDDFFSWLDSKRK
VIS
>PK3-045_04675 hypothetical protein
MNYKEHPIVNINDIKLVEVENIKEIKQEKGDILVRKNKAIANSSDSYEQYKEDLLRNEVN
SIFEQEYIESEIDLSVKYYKDRESSDKRKSKNDLLENNSSIIEKEKQDTQSKQPIEYIAT
SKFLEKNIVKSFAGRVRIYDWQYGYFKELSEMELYIAIKDSLPEEIEMKLNRNKIMEVAH
RIKTSPKLQIEYEAFDCNSHLINFRDLVYDTNTCKTYPHSHEYLFSSYIDTDYRDYNNLI
KVYRPNSPFTGYGYYLDQLLQDCTGGDIDKAKSLQQVTGYIISNEWRAKKFFVLIGLPHT
GKSVWLSIWRALIGSDYTTSMSLNQIGSNRFMTAELYKSKLNITSELDENGKIQGTSVIK
AVTGGDLLTAERKGENPFHFYGRTKLVAAGNYMPPVNKLDGTSAFTDRLHFLMFSNPVPE
VKRDKELLTKLLKEEERTKIIHWALDGLKELKDQNYIFTESGEAKEFKKHYIGDLNNVPD
FIHDMCKVDINNHDLKVQRRHLYPTYIEYCKQNGVKALSKVEFYTEIKSLGVAEDKLRMY
GSNALRGFRGISLKIIKPEWFNDADNN
>PK3-045_04676 hypothetical protein
MKVIDKEKYRKYINKVFDKNKQMSLFYHQDERNSLIIEGKKVKFRAILFAYSRGDIQICF
GQIGEEHIFFSSDERYKDHFYIIIDQSKEKKRFHINYHDQFLTHSEEDSYKEQEFIFTYV
ENQNFAQLQVYNSLLKNNKLGEYFADTPSTIKSARSLGASQLVNIIPGINQVIPDFYESK
IEEKSL
>PK3-045_04677 hypothetical protein
MHNLNIGINENLKEQVYIYAGFEFSNTLLKDQELNYENIFKAIDPGIVFRKVCKDFELDT
EKAVDYIKKYILHLIIEEVRSSINFNQRSLMSIKNEEIKDQTIQDLLDEICFKTPKDLFN
SLNYINGYFTKEQIEAKLYNEYEYMDWNEKVLTPESNWKWMENSKKTGSFYHLYVKYATR
KSRVSKALVKKFNKITNFNQELLNKQEHFSRFNNSLEVAEVDPSLDVWLFEYNSFILMLQ
KISSYEEIRDLDEEYFPVIASFLIVGDIRLKLLLIDTFFKNFSWSFYKSKLDNLVLLSLV
IIPFFKEYTKNKLVALVNRSMLKSHCETLKHGTNEMQLDDLRKQLYMYQILKTENCYKGE
SLASEFNIDFNSNIQVTEEISRVWKNIEDVKNIINENFNNLFQNFLDHIAKYEEYEDFTF
KDWVEFGVYFVTKEYKETMGKSLNEPKVNSQESMLEIYSGQVNEDIINYYWSLDTEEQEI
QRDLEEKIRAELEQVDIDINKLKELCKKFNCSITVESENIIIKPFFNVGKETLRERT
>PK3-045_04678 60 kDa chaperonin
MAKDIKFSEEARRAMLRGVDALADAVKVTLGPKGRNVVLEKKYGSPLITNDGVTIAKEIE
LEDAFENMGAKLVAEVASKTNDVAGDGTTTATVLAQAMIREGLKNVTAGANPMGIRKGMD
RAISTAIEELKAISKPIEGKASIAQVAAISSADEEVGQLIAEAMERVGNDGVITIEESKG
FTTELDVVEGMQFDRGYVSPYMVTDSDKMEAVLENPYILITDKKITNIQEILPVLEQVVQ
QGKPLLIVAEDVEGEANATLVLNKLRGTFTAVAVKAPGFGDRRKAMLEDIAVLTGGQVIT
EDLGLELKTTSIESLGRAAKVVITKETTTIVEGAGSTEDIQARVNQIRVQLVETTSEFDR
EKLQERLAKLSGGVAVVKVGAATETELKERKLRIEDALNSTRAAVEEGIVAGGGTALLNV
YNKVAAIQAEGDEATGINIVLRAIEEPVRQIAFNAGLEGSVIVEKLKNEPVGTGFNAANG
EWVNMIEAGIVDPTKVTRSALQNAGSVAAMFLTTEAVVADKPEPAGQGAAMPDMGGMGGM
GGMM
>PK3-045_04679 10 kDa chaperonin
MLKPLGDRIIIELVETEEKTASGIVLPDSAKEKPQEGKVVAVGTGRVLDNGERAALEVSV
DDRIIFSKYSGTEVKYEGKEYLILRESDILAIIG
>PK3-045_04680 hypothetical protein
MKKEYWIIIIAYIAMQLSTFVGVPVILFIAGLLGYNPASKAIQFQSNIIWLIFSFVVTLI
ICLFLLRKEMRNPMRSDMMNIPSSIGWAIGGIFLSLFAQTFAGIIERLLGIEAGSENTEQ
IMQLINAAPLVIIVVSVIGPILEEIVFRKIIFGSLYKRFGFFISALISSLIFAVAHRDFT
HILLYASMGFTFAFLYVRTKRILVPIFAHVAMNSFVVIMQLNYDRIIEWQEKYSGVTHFI
GGFL
>PK3-045_04681 hypothetical protein
MRRSPLFSGIIYIIFGAFFIYFAVHDLQRNQEWGFYTYLLVILATFDIGSGIKLINFHFF
LKKNQRDTKKPKQ
>PK3-045_04682 Redox-sensing transcriptional repressor Rex
MHNEVMKIPQATAKRLPLYYRFLKNLHSSGKQRVSSAELSEAVKVDSATIRRDFSYFGAL
GKKGYGYNVNYLLSFFRKTLDQDELTKVALIGVGNLGVAFLKYNFLKNNNTKIEVGFDVI
EEKIGTLVNDVPIHHMDDLEKVLQENGVEVAILTVPASAAQVITDRLVESNIKGILNFTP
ARLNVPSNVRVHHIDLAVELQSLVYFLKHYPTPDAEVEVEVEETEE
>PK3-045_04683 Cyclic pyranopterin monophosphate synthase
MGEFTHFNHEGRAKMVDISEKSETVRIATAQSSIKVREEIYQKITNLEIKKGDVLAVGQV
AGIMAAKKTADIIPMCHPIMLKGVDISFRWEEEAGFFHLIISATVKTVGSTGVEMEALTA
ASVTALTIYDMCKSMDKGMVIGHTYLVEKSGGKSGNYKREQ
>PK3-045_04684 putative ABC transporter ATP-binding protein YheS
MILLQVNQLTKHFGAELILSNIKLEVQARDRIALVGRNGAGKSTLLKIIAGQLSYDSGEI
IKPKNVEIGYLAQNTGLESNLSIWDEMLTVFHELQIKEKHLRKLEQQMSDPGTIENPDAF
EKILKEYDNLQYEFKESGGYQYEADIRSVLHGLNFNTFDYSTKISSLSGGQKTRLALAKL
LLTTPDILILDEPTNHLDIETLSWLEQYLQGYKGAVLIVSHDRYFLDKVVTQVYEISRHH
IQKFLGNYSGYLEQKAENYEREMKLYEKQQDEIAKLETFIQKNLARASTTKRAQSRRKTL
DKMERMDRPDGNEKSASFGFEITKQTGNDVLKMDDLSIGYKDNTVSKHISFQIKRGDSVA
LVGPNGVGKSTLLKTIIEKLPKHAGSISLGSNVMLGYYDQEQAELTSNKRVLNELWDDFP
LTPEKDIRTVLGNFLFSGDDVLKTVNSLSGGEKARLALSKLMMEKPNVLILDEPTNHLDL
DSKEVLENALIDYPGTILFVSHDRYFINRIATKVIELSAEGSTEFLGDHDYYVEKKLEQA
EIKALEATASIQVERDNGTEEKTSYQMDKEAKKLERQRIRRIEEIETTIEELELKVSEQE
NLLCEPEIFQDHAKVLELNNSLEQLKGQIDRLMDEWTELSDK
>PK3-045_04685 tRNA N6-adenosine threonylcarbamoyltransferase
MKNNNVIIMGMETSCDETAVSIVKNGTEILSNIVSSQIESHKRFGGVVPEIASRHHVEQI
TIVIEEALSKAEISYEDIDAIAVTEGPGLVGALLIGVNAAKAISFAHDIPLVGVHHIAGH
IYANRLVDNLEFPLLALVVSGGHTELVLMKEHGHFEVIGETRDDAAGEAYDKVARTLQLP
YPGGPHIDRLAGEGNPKAVKLPRAWIEGTYDFSFSGLKSAVINTVHNAEQRGEVIRPEDL
AASFQESVVDVLVSKTLEAAKEYKVKQVVLAGGVAANKGLRTVLAEKFKQLDSVKLTIPP
LSLCTDNAAMIAAAGTVFFEKGQRAHLDLNGNPGLDITIHNE
>PK3-045_04686 [Ribosomal protein S18]-alanine N-acetyltransferase
MSTFEFRNMTVADIDNVFKIETISFSTPWSKEAFYNELTQNRFAKYIVIQYEDGLVGYCG
VWIVVDEAHITNIAILPDFRGKKLGEMLLTKIMEEARKLGATTMTLEVRVTNEVAQNLYR
KLGFQNGAIRKKYYTDNQEDALVMWVKL
>PK3-045_04687 tRNA threonylcarbamoyladenosine biosynthesis protein TsaB
MKILAIDTSNFVLGVALYENGKVIGEYITNLKKNHSIRAMPAIEQLMKDCDIKPKDLSKI
VVAKGPGSYTGVRIGVTIAKTLAWTLNIPLVGVSSLEVLAASVGRYFDGYVSPLFDARRG
QIYTGLYQFSRNDIEIVKNDQLILSTDWIEELVPLKQRILFVGNDLPIHQDILIEGLGEF
AQLTDAVDFNPRPSILAMLGEAREGEAIHTFTPNYIRLAEAEANWLKANKIEKKEDRG
>PK3-045_04688 tRNA threonylcarbamoyladenosine biosynthesis protein TsaE
MNNFEWKADNAEETIGFAERIAWLLQAGDVITLEGDLGAGKTTFTKGIAKGLGITKTVNS
PTFTIIKEYQGKLPLYHMDVYRLKDSDEDLGFDEYFEGAGVTVVEWAHLIEEQLPVDYLQ
INLYYDNTSGRKIVLSPKGSRYMQLCKELFS
>PK3-045_04704 Protein SprT-like protein
MSGTMTNEELQKLVEDISWDYFKRNFEHKAIFNPRLRTTGGRYLLSTHNIEINKTYYDLM
GLNELVGIIKHELCHYHLHLLNKGYQHKDADFKSLLKMVGGPRYCSPLPVGNKKGNSKRI
LIYSCVSCKQQYTRRKRMDIKKYVCGKCKGRLKLEEVIQIDK
>PK3-045_04705 Cortex morphogenetic protein A
MPNWLQNQIKKAFYEKNSYQVKLLNQCWYYYRRKNAAN
>PK3-045_04706 Protein YhgF
MEKVLEQEKGQNYLAIIAKEQSVSIKQVKSVITLIEDGNTVPFIARYRKEQTGALDEVQI
KDIIDRYTYIQNLAQRKEEVIRLIEEQGKLTEELHNNIIKAIKLQEVEDLYRPYKQKRRT
KATIAKEKGLEPFAEWLVSKEKKISLEEEADKYISEEKEVLSIEDAINGAKDILAEQISD
DAESRKWIRSKTMLTGKIQSTAKKVEKDEKNIYEMYYEYEEPINKIVPHRTLALNRGEKE
DVLKVAIVAPIEVITEYLEKKWLTNARSPEGLIIKEAIEDGYKRLIQPSIEREIRNELTE
KAEEQAIHIFSENLRNLLLQPPLKGKMVLGVDPAYRTGCKLAVVDETGKVLEIGVIYPHP
PVSKTVEAKAKFQEILDRYDIEMVAVGNGTASRETEQFVADMLKKQNKEIYYLIVNEAGA
SVYSASEIAREEFPDFQVEERSAVSIARRLQDPLAELVKIDPKSVGVGQYQHDVSQKKLA
ESLHFVVETAVNQVGVNVNTASSSLLQYVAGLSKAVANNIVKKREEEGKFISRKQLKKIP
RLGAKTYEQAIGFLRVLDGEEPLDRTGIHPEHYDEVKKLLSTLGFKTKDIGTTALREALT
KVNLKESAQELNIGELTLKDIIEALVRPSRDPRDDLAAPLLRKDVLKLEDLQTGMELQGT
VRNVVDFGAFIDIGVKQDGLVHISKLSNKFVKHPLDIVGVGDVVTVWVDSVDHNKGRVAL
TMLKPKEEK
>PK3-045_04707 Phosphoserine phosphatase RsbX
MNELKDNNVHVLSYQTSKKGKTLCGDSFFYTSTDEYFICVLADGLGSGEYANEASVAVTE
IIKENHAKSVDELMELSNNVLVKKRGAAVCVFKINYASKTIVYSCVGNIRFFLYSPSGEL
TYPLPVTGYLSGRPQHYHTQRFTFENHAKFLVFSDGFNIQGIKNLLKGYLPIRSIANDII
GKYNNSNDDSTFILGSLL
>PK3-045_04708 RNA polymerase sigma-B factor
MQKQSQPNRHLSKEEVNALIKDFQSTQNEKAQEALVINYRDLVEMLARKYSKGKMFHEDI
TQVGIIGLIGAIHRYDESFGKSFEAFAVPTIIGEIKRFLRDKTWSVHVPRRIKELGPKIK
KTVEQLTTDLQRSPKVDEIADYLDVSEEEVLEAMEMGRSYQALSVDHSIEADSEGGTVTL
LDIVGDVDQGFEKVNQKLVLEKVLHVLTEREKSIIQYTYLDNLSQKEAGEKLGISQMHVS
RLQRRAIKKLQEAIQAETSNSEFIL
>PK3-045_04709 Serine-protein kinase RsbW
MSHFEYIEMKIPSKPEYVGIIRLTLSGIASRMGFSYDEIEDLKIATSEACTNAVQHAYKN
KDAGEVLVGFRLYNDRLEVIVADNGKSFDFHSTTKDLGPYEQDESVEFLREGGLGLYLIE
TLMDEVKIHHNNGVTVFMTKYLEGEQVERDAETIST
>PK3-045_04710 Anti-sigma-B factor antagonist
MNIIIDVKEKELDVEVKVSGEIDAYTAPKLRERIYSFSEKEGMKMIIDLSDVNYMDSTGL
GVFVGIFKNVRANNGEFKLVGLSSRLIRLFEITGLADIIDINSKIEGGIQ
>PK3-045_04711 Phosphoserine phosphatase RsbU
MDFREMMESKYRDLLVNYIKDESEQALYQGQKFSRKSIEQKISPEDIISLHKSILMDLYP
DIPGYVTKSFDILLEVMIGYGFAYREHQSLRHVQQELRSEMEIAANVQQTLLSTDIPKVD
GLDIGAISVPAKMMNGDYYHFVHDDDQIINIAIADVIGKGIPAAMCMSMIKYAMDSLPEN
RNKPSNVLENLNRVVEQNVDPSMFITMFYGAYDVLSHVFHYASAGHEPGLYYQAETKQFS
ELKTKGLLLGVDKRTKYQQFEKQIYPGDMIVLMSDGVTECRTKEGFIEKETLLGYIRKHM
HLDAQNIVENVFKELEKIQDFQLRDDFTLIIFKREV
>PK3-045_04712 Serine/threonine-protein kinase RsbT
MGDQSCVKIINEWDIVAARQLGRNLAKELGFGTVDQARITTAISELARNIYLYAGQGQIC
IEKLFDNGKAGLKLIAMDSGPGIKDIRQVMQDGFSTSGGLGAGLPGVKRLMDEFDIKTSI
GDGTEIQAVKWLR
>PK3-045_04713 RsbT antagonist protein RsbS
MNRVRIPILKLYDYLLVSIQWELDDQTALQFQEDLLNKIHETSANGVVIDLTSIDFIDSF
IAKVLGDVIGMSKLMGAKVVLTGIQPAVAITLVELGISLNDVLTALDLEKGLEKLQQELE
D
>PK3-045_04714 Endoribonuclease EndoA
MIVKRGDVYFADLSPVVGSEQGGVRPVLVIQNDIGNRFSPTVIIAAITAQIQKAKLPTHV
EIDAKRYGFERDSVILLEQIRTIDKQRLTDKITHLDEEMMEKVDEALQISLGLIEF
>PK3-045_04715 Antitoxin EndoAI
MFVSESSTTTEIMIKLPKHLLTELDGFVKQENVNRSEFIYQATKMYLRERKKRHIRESMR
RGYMEMAKLNLSIASESFLAEYEAEHTVERLVSGG
>PK3-045_04716 Alanine racemase
MNQEDNFYRDTWVEIDLDAIAYNVGELRKKLHPKNKLIAVVKANGYGHGALQVARTALRS
GANYLAVAFLDEAISLRKQGITAPILVLGASRPKDVMTAIKYKVTLTVYYKDWLEEAVQF
LNKDDSLTIHLKLDTGMGRIGVRNEQEIQSIEELLVKHPNIVVEGIFTHFATADEKNSSY
FESQIQRFKELLSSFTKLPAIIHCSNSAASLLHPDLQYNAVRLGISMYGLTPSLEIEPDL
PYPLQEAFSLRTKLVQVKKLNKGDKVSYGATYEAKEEEWIGTLPIGYADGWLRKLQGQEV
LVEGIRAPIVGRICMDQCMIRLPFYLEPGTEITLIGKQRDAEISVNEIAAKLETINYEIT
CMISTRVPRVFKQYGNVTETVNFLI
>PK3-045_04717 Sporulation protein YdcC
MNKKIWLLFVGLTVMLLLTACGTKSKEDVLTDLKEKVETKGYKADAEMTLKMGTEPQTYE
VEVWHKDPSFYRVNLKNSAKNQSQMILKNEEGVYVLTPALNKSFKFQSEWPENSSQAYLY
ESLVKDIEEDKEVKFSATDKHYVFETKTRYQNNKMLPTQEIAFSKKDLSPVSVKVKDVEG
VALVTVKFSNVKFDVSFDKKDFDLQKSMTAAKMVIPVMGEIEDKDFAVKYPEEPLEGVSL
VEEKKMASENGNRVILTYDGEKSYTIIQEKAVVAPATAGPIVSKGDPVDLGFTIGEVTDS
KVSWTFEGVDYTIASSDLTRDELVTVARSVQGEAIK
>PK3-045_04718 Holo-[acyl-carrier-protein] synthase
MISGTGIDITEIERIESLLQSKPKFAKRILTDKEMEKFQQLSGHRKCEFLAGRFAAKEAF
SKALGTGIGANLSFLDIEIGYEEKGKPCILKPFSKGVHLSITHSKHYAFAQVIIEE
>PK3-045_04719 Rhomboid protease GlpG
MFTRRESFKEYITYYPVVSMILLIHLILYLLTNLPIFPNKYLLETMMGVNLYIVEGEWWR
LITPIFIHGGFAHLLFNSFSIFLFGPALERILGKFKFLLIYLVTGIAANIITLLIEPLTY
VHLGSSGAIFGLFGYYISLVVFRKDIISQSNAQIITTIAVLSLIMTFLQPNINIVAHIFG
FLTGVIVGSLSESKGKKIFSSYKEEWYYLRQQLRRTKKPEAKSIIIWIIIFGLAIIGFVS
Q
>PK3-045_04720 hypothetical protein
MFKQNRLHPVSIIYVILKRLREFIFPFIGIIVLGGKPTDWSLYTILGASLLLLIILISGF
LSWYFFTFYVVGNELRMEYGVFIKKKRYIPFERIQSIDFTEGIFHRPFSLVKVKIETAGG
AEAEGELTAISKKVAQELKRYIIQKKNEQIETDEMIEEVEPAQQEIYRITSKKLVILAST
SGGVGVIISAIFAFISQFDDLIPYKEIYKHVQQVITSGVALVSIVVFVLFVLLWILSWFI
TILKYANFTLSKTKDDLIITRGLIEKKQITIPLKRIQAIKITEAMLRQPFQLVGVSVISA
GGSFDDIEASDVVAVPLLKKKELPLLLKEMVPEYEWNEELHSPPKRSIWRYIIKNSWIAL
PVIIALIYFFHQWGALSLLLLLVLPLWGYWNYRSAGYRISGKQLTLSFRQFNKTTFLMRR
NRIQALYYTEGWWQRKGELASVQGVVLSGAGGATGVVTDLTKEDVEKVYEWYSLS
>PK3-045_04721 hypothetical protein
MITIPQNRLSKKGITVWRLTGIISSLIMMVIGGGLITFAILFDWHILISIGTVIYLLFHI
ALTIGIMPPLKWKRWRYEVRGDEIEIQQGVIVIKRTLIPMIRVQHVDMKQGPLLRKYELA
TVSISTAATVHEIPVLQVDEAEEIRQYISSKAKVAEEDV
>PK3-045_04722 DEAD-box ATP-dependent RNA helicase CshA
MVKFQDLGISPATMKALKRMGFEEATPIQAETIPLSLQNKDLIGQAQTGTGKTAAFGVPL
VDKIDVANEVIQGIIIAPTRELAIQVSEELYKIGYGKRTRVLSIFGGQDINRQIRALKKN
PHIIVGTPGRILDHINRKTLRLDNVQTVILDEADEMLNMGFIDDIEAILSKIPTERQTLL
FSATMPGPIRKMAERFMKDPEVVKVKAKEMTVPLIEQYYIETQEKTKFDILTRLLDIQSP
ELAIIFGRTKRRVDELSEALNLRGYTAEGIHGDLSQAKRMSVLRKFKEGTIDVLVATDVA
ARGLDISGVTHVYNFDIPQDPESYVHRIGRTGRAGKEGVAITFITYRERSYLQVVEKTTK
RKMEKMIPPTVDQAIEGQQKAVMEKISQIIEENNLESYRNTADELLEQKDASTVVAAVLK
MLTKEPDTTPVKLTEEKPLPMKRDRRPYDKNNDRGGRKNYNPRQRQGYGGNKRQGQSGNS
YNKSKSYR
>PK3-045_04723 Carboxylesterase
MTACLCIHGFTGSPMEVEPLAEYIQNYTNWECMVPTLPGHGDQLSLKGIIYNEWIQYAEE
ALKDLLKRHDTVYVVGFSMGGLIASYLAAKYPIKKLILLSAAAYYVNLVQLQKDIRIICA
DFFRGRIKDNEQFIRYMNKIKSTPLAAAIQFRKLVQCVKPLLANIQVPTLIAQGEKDGIV
PLKSAAYLYNTIRAENKKILYVEESKHLICHCEKRESLFQEIITFLKAPS
>PK3-045_04724 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MIKRTYAEIASMSSSTHFFEQYNEVLISGVTIDSRKIEAGQLFIPFKGERTDGHQYVADA
IKQGAAAAFWQKDVPNPPENLPLIFVDNSLTAIQMLAKSYLQQLKVKVVGITGSNGKTST
KDMTTSLLSLKYKVQKTEGNYNNHLGLPLTVLGLEEDTDIAVLEMGMSSRGEIDFLSRLA
EPDIAVITNIGESHMQDLGSREGIAEAKLEILNGLKEKGRFVYFGDEPLLSTRVKDRKLD
MKTFGMDPANDLYPHEIKALENGSVFHINKATEPFELPVLGNHNILNALAAMLVAEFFEI
PYEEMNKGLQSLKLTNMRMELVEGKLGVKVINDAYNASPTSMLAAIDVLKKLPGYKQKIA
VLGDMLELGDQEEAFHYEMGEHLEGVDYVLTYGKLGNFIAEGAKTVLPEDHVFSFQEKEP
LIETLLPFLNKETVILVKASRGMKLEEIVKAIQ
>PK3-045_04725 D-alanine--D-alanine ligase
MKKKLGLLYGGKSAEHKVSMQTAMAVIKALDTDKYDIHPIYISESGEWVRGPQLMGPVEN
VKELAFNTQEQIGSNALSTTLFQANDEASLDVIFPLLHGPNGEDGTVQGLLELLNLPYVG
NGVLASSAGMDKVIMKNIFEVAGLNQVKYNSFIRSDWQSDKDAAYERVEKELGFPCFVKP
ANLGSSVGISKCTTREELETAFIEAFQFDRKIIVEEGLTAREIEVGVLGNDHPEVSVAGE
IVPKKDFYDYKAKYEDGNTALIIPADVTEIEYAAIKEDAIKAFKALDCSGLVRADFFLTK
EGKVYINEVNTMPGFTPFSMFPLLWKHTGLEYDALINKLVDLAVERHTEKQNIKYTI
>PK3-045_04726 hypothetical protein
MRDVQVVSWNQKEELVISADNSGGIGQKEDDQVSVPYDIVSYFSFRVAVMECMAAGGVPF
SVILQNFCGDDAWDILLAGIYKGIEELELEREIGITGSTESNFSFRQSAIGLTVLGKRPA
DLKDTTIINGKMAIIGSPLVGEEVILQQEKVVPLAVFSRLTKVDKCRIQPVGSKGILYEL
GQLKGDLVQEEEVQCSVDLLKSAGPATCFIVEYEKEVEAEIKRLTSGFFLEVQVSSR
>PK3-045_04727 hypothetical protein
MNAKKINVLAIFIAISVIGAFIKIPSFIGSVALDSFPSLITGALLGGLAGGIVAALGHLV
SAYLGGLPLGMLHLFIAVEMFLLVFTFSKIYQTGNSIISILFFVLGNGVILPLPFLYLMG
KGFYISMVPVLLIGAVLNGIIAQLLMPRLTAFLKEWRVVKQ
>PK3-045_04728 Corrinoid adenosyltransferase
MRIYTKTGDTGETSIIGGRVSKDDIRVEAYGTVDELNSVVGLIVTQLTGEQFADIKEDLE
KIQHELFDCGGDLASISTRRQLKLTESAITYLEERIDKFMEETPDLERFILPGGTEAAAI
VHIARTVTRRAERLVVTLVRTTEDIPELPLKYLNRLSDYFFALARVINFRSNVADIEYIR
SAKVFRTSKKGERNEREEN
>PK3-045_04729 hypothetical protein
MHFITGGSFHGKKSWTVTFAREQGFTEGKVLRLFDEKEISMANNEKGSFYRIEGLEWMIK
NRLQEETLEQTIDYMEKLVEALLQWEREENNRCVFIIGSDITKGIVPIDRRDRLWRDATG
LIFQRIAAAADRVDVIWYGLNERLK
>PK3-045_04730 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase
MGDTMVIALFRHGLTAANERKAYIGWTDAPLSEKGRNMLYEKGRPVSKYDWISTSDLLRT
KETAAYWFPEQILYSVSGFREINFGDWEGKTYEQLKELPEYCKWLNAPFTNAPTNGESFA
ELVERVDRGWNHLIKQSTRNNRMAVVTHGGVIRYLLSKYGVTKRDFWDCAISPGEGIELI
WSNKESFRRKERCTLLQEVAFTEKKAGQ
>PK3-045_04731 Adenosylcobinamide-GDP ribazoletransferase
MKKWCIGFLVNIQFFTAIPVRKELPMEGEFLQKSIKTFPLLGLFQGFIYMGIFFLLNEYT
PFTALAIAFIVWISTILLTGGLHLDGWMDASDAYFSYQDAKKRLEIMKDPHVGAFGVLSV
ILLLSTKFLFIYEIVTHMQDFTYLFVMLLPFFSKAVMGWSLLFVPEAKRDGLGAYFKKSV
QGQRLFFYSGYIAAALLVFLLLFPKWLPLFFLFLSVSIGCYLLFSRFMKQAFGGLTGDLL
GASVEGTEIALWATLWLLHYFVMG
>PK3-045_04732 Cobyric acid synthase
MKGVMIQGTSSDVGKSLIVTALCRMLANEGIKVAPFKSQNMSNNSYVTVDGKEIGRAQGI
QAEAAKIEATVWMNPILLKPRSDLQSEVVLLGEASTTLSGRGYRERFYEEGIRVIQKSLH
YLQRNYEMVIMEGAGSPVEINLKDRELVNMKVAEMADIPVILVADIDRGGVFASIVGTLS
LFSEEERSRVKGIVINKFRGDVTLFEDGVQWLKEKTGIPVLGVLPFIHNHMIEGEDSLSI
REKRIATSKEVLDLAVVNNRYMSNFTDIEPFFLEEDVTIRLIDKGEDLGNPDAVIIPGTK
STIEDLREMKRNGLDAQLKRYYKEGGRIIGLCGGYQMLCSVLMDPYGADTGIAGEEIEGL
GLIPARTIFEQKKATIRMEGSYHPFTKLSSERIEGYEIHLGKTEYEDSAERCPFLFLNNR
DEGYYREDGKLIGTYMHHLFYNDMFRNTWLNQIRLQKGMAERKTLIMREQKDKRFDALAD
EMKRHLDWDKLLDILQAGDN
>PK3-045_04733 Bifunctional adenosylcobalamin biosynthesis protein CobP
METKSSLIFVTGGVRSGKSSFAEGLAIRYAQEERATLHYIATAVITDAEMEERIIRHQQN
REAQKVKWNTYEKPVDIGELAAVFTKKDVILLDCLTVLVNNELFFQDKQQEGIEGKLKKD
LIELSQSCRYLILVSNEVTYEPSLDPAVQKYCRILNRLHYFLVQHAYEAYLVENGIAQRK
KGGQE
>PK3-045_04734 Threonine-phosphate decarboxylase
MNWPMHGANPQYIYEKTNLEMPVGAIDFSANINPLGPPPVLLRKWFDLFQTVQLYPDPFA
SRLKEKISNQYGIPSKQLLIGNGAAEIISLLGRILAGKKVLLLQPAFSEYEEVCRINNCD
IYHHYLSEETGWELSLAKLEKDIRQVDAVFLCNPNNPTGIFYPKNLVEELLDICMQNDCS
VILDEAFYDFVVGYEDMLPLLKNYPNLIILRSLTKMYSIPGIRLGYVFASEELIAQLQHL
QSQWSINGIALKAGELLIEQEEFLNNTQSYIEGEKKKLFSFFKNKHFVYSNSAANYYLLK
DPRLTDQKEFLTFLLNNGIIARHTYNYPSLEGRWLRFAVKSKEQNQQLRGVLTKWKQNHP
SSL
>PK3-045_04735 Cobalamin biosynthesis protein CobD
MIGHLISITIAIILDKLIGDPPGWPHPVKGMGKLISYLDQRLNKGSNRQLKGLWMLMSVL
VLTFLLSCFLVYISYQLHWWIGVIIEALLIATTIAQKSLKDAAIEVYEPLQANDLVLARR
KLSYIVGRDTGQLEEKEIVRATVETVAENTSDGITAPLFWAFIGGAPFSLVYRAINTCDS
MVGYKNDKYREFGYYAAKCDDIVNYLPSRITAMLLLLVSRSPFHPKKEAWKLLFQDAKKH
PSPNSGWGEAVTAILLGIQLGGINYYRGQKSDRARMGTALQPLGTKHIIESTKIANKAVV
CFYLFLFIGGIGFELANAWS
>PK3-045_04736 Vitamin B12 import ATP-binding protein BtuD
MLNVRNLFFQYETKQILEDISFSVNKGEMIGILGPNGSGKTTLMKIISGILTPRVGQVEI
KGTSIDQYKTKELAKVVAVLSQHVNESFSYTVREIVSLGRYAHQSGLFQSWTSKDEEVIT
RVMKQTGVFVYQDKSIHALSGGEKQRVYLAQALAQEPEILLLDEPTNHLDLSYQKELLDS
LREWSREEGLTIVCIFHDLNLAGLYCDRLLLLHDGKVEVDAPPSDVLQEKRVKRIYKTNV
KSTFHPSRPASQIALVPRELKRKKVQIDTTAITITSERVEMKAPFPLYTLSSGVTGAGMG
WYKNFVNRHVDKTYCCEDYQKDMDNYLLQNGFSPQETVGMMTAVHTEDATYQLLERADFS
VMIVVTGGVGNAVDAAKTNEHSSSLNPGTINIWIFVNGKLSEQAFLQSAITATEAKAAVL
RDRKTKDMETGTIATGTSTDSISVAATQVGTYLEFAGTITALGKCIAEGVYHCLTTSLDK
RDRRLAAK
>PK3-045_04737 Hemin transport system permease protein HmuU
MPKRCIRMFLNKRKAAYVYAAFFLLFAIVMGIAIGTISVPILSVVKILASYIGPESILTN
VDPMHVNIVQNIRLPRVLLAGLVGASLSIAGAAFQGLLRNPLADPYTLGVSSGASVGAVI
TLFFHFTIPFLGGLTLPFMSVLFSFLTILFVVFFAKKMDPAMRVETIILTGIIIGSVLSA
FISLMIALTGNELRQIIGWLLGSVSMRGWEYIKIILPFFVVGSGLLLSQGKELNALAFGE
ERAQHLGIHVQRRKMVILLAGSMLTGAAVAVSGTIGFVGLVIPHFVRIIVGPDHRHLMGV
SLFAGSGFMILADLLARTIISPTELPIGVITAIVGAPVFAGLLLRRRKRSLK
>PK3-045_04738 Vitamin B12-binding protein
MKKLYSILLAMLLVVGVLAGCGETKTENKHNKEQATTEETSFPVTIKDGLDQEVVIEEKP
EKIVSLMPSNTEIVFALGLGKELVGVSDFDNYPKEATEKEKVGGMDFNVEKIISLNPDVV
LAHASSAHNSTEGLQQIRDAGIDVVVVNDATSFEDVYKSMVMIGQATGTEKEANKLVADM
KEKLGAIKEKAAAISDSDKKAVYIEVNAEPNLFTTGKKTFMQEMLDTIRANNIISEEGWI
QVDQEAVIGANPDVIITTYGAYSEKSPLEQISSRKGWEKINAVKEKQIIDVDSDMVTRSG
PRLVEGVEAVAKAVYPDVFK
>PK3-045_04740 Sugar fermentation stimulation protein A
MVSFPAALKKMTFVERPNRFILHCYDQETEEIEKVHLADPGRLIELLVEGAVIYVLPSMN
PNRKTKWTAVYVEANGLLVSINTTYPNKLVELMLKKAMIEELSAYHWVKSEYTYGSSRWD
FLLEDRKNNQLLLEVKSVTLASDGIGMFPDAVTKRGSKHVQELTAIASEGIIKTAILFVV
QREDVEIVTGAAAIDPVFAKSLEEAAHAGVQLLSYTCILSEQGIALGHAVPVDPFFKL
>PK3-045_04741 hypothetical protein
MKKGNNDIRDVVYIHLNEKERFVLSYGIEFREFYRILADTLASILLLKHQFEDGEFHIHT
QFEYVPNNKLAPLSMEDVYGYGDFVWVDFDETETLDILEGQTIAELLYLGHKLEPLKKPF
FQQLNNQYAYLAHDDGWFNKIYYKNMESFYQLFCEVIANKVTELKLEKALLGIKKKRLYP
PLPKEIVTELKRYMSEGMVLSIEKAYQTRLKLEIPIWVLGDFDNMDDMYEEYEKNAKQKS
DALLIFDKKLREWQLAIV
>PK3-045_04742 5-methylthioadenosine/S-adenosylhomocysteine deaminase
MGNMLIKNAQIVTMNQAEEIITGDIYIEGNIIKEIGENLKKNHVDKMIDATNRTVIPGFV
QTHIHLCQTLFRGKGDDLELMDWLKQRIWPLEAAHDEESIYYSAMLGIGELLESGTTTIV
DMETVHHTEHAFHALAESGIRAVSGKVMMDKGDEVPLALQELTAESIQQSVDLLEKWDGF
DNGRIQYAFSPRFVVSCTEELLKEVKILSDKYGVKVHTHASENKGEIQIVQKETGMRNVV
YLDHLGLANDRLILAHCIWLDEEEKRIIQEKGVHVSHCPGSNLKLASGIADTHHLTCNHV
SVSLGADGAPCNNNLDMFNEMRLAALIQKPIHGPTAMDARTVFRMATLGGAKAVGLEKEI
GSLEIGKRADLAILNLQNFHTFPSYDVDPISRIVYSATRADVETTIIDGRIVMENKIMKT
IDKSIVLKEADKSIKRLLSKTTIN
>PK3-045_04744 Magnesium transporter MgtE
MIHKMTENQITLHIIQTLKDNKKSEFESIVDELQPYDIAQIYESLPDKHRARFLLFLKVD
LLAHLLEELDKEEQLEVLNTLGMDKTGKVLDLMDNDDLASLLNELAPERIKELLSGMKKE
ESIIVQNLMNYPDETAGRLMTNRFVWIRDYYTTREAVDKLKSFADFAETLSYLYVIDQNR
KLVGVVSYRDLLIAEPQDKIRDIMYERVISVTVDQDQEEVAQTIQKYDFLAIPVVNEENI
LMGIVTVDDMIDVVFQEANEDIEKLSASGKSIDFDTKASVAAYRRLPWLILLLFIGVVSG
SIISNYEDVLTKVVALSFFMPMISGMTGNTGTQSLAVVVRGLISNTINKAVVTKLIFREL
LVGLIIGITCGVIITIIAYVWQSDLMLGLVVGLSLICTLIIGTLSGTIIPIILYKLNIDP
AVASGPLITTLNDIFSLFIYFGIAQIFLAHLM
>PK3-045_04745 Peptidoglycan glycosyltransferase RodA
MRTRNVFSERFDWTLCLLLMLFCLVSSIAIYSANAAYLQSQIMWYVIGAVVIAIIMYFDN
EQIQQITWILYGIGAVLLIGLLVAPETAFTPRRGGAQSWYVIPHIGSIQPSEYMKVFYIL
AIAKVINNHNVKTIHKSLRTDFILMGKLAIVAGVPIALVILQDFGTTLVLMAILIGMMLV
SGISWKLLIPLYGAAAAFGSIVLYLAIFGRELLEKYLGVDPYQFARVNSWLDPHNAGDDG
LQLVKSLMAIGSGLIGGKGLGKEEVYIPERHTDFIFTIIGEEYGFIGGSIVIILYFLLIF
HLVRTALQTANPYSIYISVGVISMITFHVFENIGMTIQLLPITGIPLPFISYGGSSLMCN
LMAMGLIFSIRYHHKSYMFSSKSLSF
>PK3-045_04746 Metalloregulation DNA-binding stress protein
MGLQTKVELQKELNVQIANWSVLYTKLHQHHWYVKGPFFFTLHEKFEELYDEAGEAVDEL
AERLLAIGGKPVSTLKEFIETSTLQESTEKRSANDMVKSLVEDYSHINTQLKALAAHADE
LEDVITNDLAIDLIGKIEKHLWMLTAYLSE
>PK3-045_04747 Ktr system potassium uptake protein A
MKKQFVVIGLGSFGGSLVEEFHKMGAEVLAIDQSLEKVEKYRPFATLCVQMTTLTEASLT
QIGIRNFDHAFVSFGDDVESSTLTTMLLKEMGLSKVWVKAADVYHKRVLEKIGADRVIHP
EQDMAKRIAHHVVSDSMIDYIELSKEHGIVEMVASPKIHNKSILDLDVRANYGCTIIGIQ
RAGETIVSPSANEVIHQGDILIMVGSNDCLYRFEEKALR
>PK3-045_04748 hypothetical protein
MYYNWNWNSFWDKLPDFILAVVVLIIGWIIAKIIEKALYKGLQKTNVDEKIFPDGKPKKY
SSEKIISKIVFYLLLVFVFTLFFNILNLTVITSPLVNLLSTILGAIPNILKAALILLIAW
VVASGLKYLIKKTGSTLKVHERLQKWNLAEKNNPQNIMDKVANIVFYLILLLFLPAILGA
LNLYGVSEPFANMLQNMLAFLPKLLAAALIVLVGWFVAKIVRTILTNFLQAIGTEALAKR
LGINKLLDNVSISSVIGNIVFIFILIPTVISALEKLDIQGISQPAINMLNDILTMIPNIA
TAIILILIGIWIGKWVKQMVVTLLVKLSLDTYVRKMGINANTSISNIIGTIVQILIVFLL
AVQALNIVGLEFLVTLSTAVIAYLPMVIAAIVIIGVGLWLGYLVQKLLSSVLQGGHFKVL
PVIAKYAIITLSVFMALDQLKVASSIVNAAFILILGGLALAFGLAFGLGGREFAKKRLDK
LDRKMEQTSIQKPNDDNTLNS
>PK3-045_04749 putative protein
MKKIICFFCFLTFPLGISAQEAAPSKNQVRKELAIVIDDFGNNMKGTEEMLNLPVPITVA
IMPFLSTSKEDAIRAHKKGHEVIVHLPLEPKKGKKSWLGPGAITTDLSDQEIRKRVKDAI
ESIPYAVGMNHHMGSKATEDKRVMRIILEECRNHSLYYLDSKTTSNSVIKELAEELNVPY
LENDLFFDHIYTSQYINKQASRLAKKLDTEQEFIAIGHVGVSGPAVVSVLKEYIPLYQKD
ADIVPLSTLVEGYELLDTDIP
>PK3-045_04750 hypothetical protein
MKIVVNKILKKLDSQESAIFNIFEVTPSLEKVISILKESNYTIIAQDIDSEKFSQIKISD
IFYLEYLERRIFLYTKNNSLTTRDSLSNFMKVLPKEFVQISKSTVVNSLYIKSFIAQKNG
NLLLETIEHEQLIVSRRYVQNVKKSLQSLCY
>PK3-045_04751 hypothetical protein
MEWRTKISSGLGTGSFIYLALIYFNGSTMVTTKTVTIVFLISIFVGVSAIIFEVEKISFL
LALMAHYTATTLFVCFLYIANYGSQSLVNLIVSISFIYLLTYIVIIVKNKLIVRDLNNHL
KKIKKN
>PK3-045_04752 Vitamin B12 import ATP-binding protein BtuD
MLKIKHLQVKYKDFTALDIHSEINIKENDFVGVIGANGAGKSTLIKALTDQVRYTGLIEK
PKNIAVHLQENSYPNVLTCQTIMEGLLKTTLKKDEKLKSLINFFNFQDILRKKVTQLSGG
QKQRLTLIMVLYQDAPLTCFDEMTAGLDFESRSRLMEKIQEWYSGKNATLLLVTHYFDEI
EKLANKLIIIDKGRLIEFGKTEDLFKKYIGYSTIIIEGDNENIVLQTGTKIISEKGKQAF
SFSNKIDQEEAVKELIMLGKKFSISNNNIELIYLNAINQSKECQEN
>PK3-045_04753 hypothetical protein
MKHYIKFELKNTFGYNIGMIVGGLLPLVLAIGGYHDTNDAAQNNIIAEKIFSMCLPMIPL
GLVLLPFTIAFAKDIESGISTRFSLFGYTKLNQMLAKFIAILSMVIGICIIYFFVLQIAL
PLPFPSTTTLILMICGIVILTISLYFLAFTIAWFFKGFNAVQGIAMIAYFGIAILTGTIG
DFEITGVMKKIADFIPFDSFRTELANKWATPSFDMSDVLMRLILFMIFTIFLFGIINVSI
AKKKHE
>PK3-045_04754 Spermidine/putrescine-binding periplasmic protein
MKSLIRGLIVIFALAFILLFIVHQLNSSRGYTSGKTLTVYNWGDYIDADLISKFEEETGI
KIIYETFDSNEAMMTKIQQGGTSYDIAIPSEYMIDKMKEEDLLIPIDHSKLPNLKNIDSR
FMDLSFDPDNKYSIPYFWGTVGIVYNPAMLDNKKITSWNDLWDKDLRNKIMLIDGAREIM
GMSLNSLHYSLNDKDHDHLREAKEKLDTLTPNVKAIVGDEIRMLIENEEASIGVLWSGMA
AEIMWENEDVEYVVPEEGSNLWFDNMVIPKTAKNIDGAHQFINFMLDAENAAQNTEYVGY
STPNKAAMKFLPEDITGDERFYPDEELTSKLEVYENLGHRSLAEYNDLFLEFKMHRK
>PK3-045_04755 Inner membrane ABC transporter permease protein YdcV
MKKLSKWSVLYLCIVFIILYAPIFYLIFYSFNSGGTMHDFDSFTLGWYKELFQDTRLLVI
VLNTIIIALLSAAVSTIIGVLGAISISIMRKKGLRNSILSLNNVLIVSPDVIIGASFLIF
FTIIGIKLGFFSVLLSHIAFSIPIVVIMVLPKLEEMSPTLVDAALDLGASWKDVLTKVII
PYISPGIFAGFFMALTYSLDDFAVTFFVTGNGFTTLSVEIYSLARRGISLNINALSTLLF
LFTLLLVIGYYFITQRVNKTPQAGVRK
>PK3-045_04756 Spermidine/putrescine transport system permease protein PotB
MKSSTKWYTVPYYLWIVLFVIAPVALVVYYSFFDIEGAFTFENYQKFFTPVYLKMTLSSF
WYAFLITFFSLIIAYPTAYLLTKTKHKQLWLLLIILPSWINLLLKAYAFLGIFGTHGAAN
QMLDFLGIGEQQILFTDFSFLFVSVYIFIPFMILPIFNALEKMNPSLVDASQDLGASSWT
TFKKIVFPLTLNGVKSGCQAVFIPALSLFMITRLIAGNRVITLGTAIEQHFLITQDWGMG
STIAVFLIISMIIIMVLTGNRKRGI
>PK3-045_04757 Spermidine/putrescine import ATP-binding protein PotA
MSEQHIIQFENVTKSYDQDTTVLENVSFEIERGKFYTLLGPSGCGKTTVLRLIAGFMEPT
EGNIYFNGKLINKIPANKRQVNTVFQDYALFPHLNVFENVAFGLRIKKWKKQVIEEKVKE
ALRFVNLEGYENREISEMSGGQRQRVAIARAIVNEPEIILLDEPLSALDLKLRTEMQYEL
RELQRRLGITFIFVTHDQEEALAMSDEIFVLNKGRIEQSGTPTDIYDEPINRFVADFIGE
SNIVPGTMKKDFVVHFGSKTFDCVDGGFDDNEAVEVVIRPEDLEITSLEAGKLKVKVDSQ
LFRGVHYEICGYDEDGNEWLVHSTKKATVGTEIGLYFEPEAIHVMRLGETEEEFDKRLEA
YEGAANEK
>PK3-045_04758 HTH-type transcriptional regulator PuuR
MEIGKKIKNLRLKKGLTQEELGERTDLSKGYISQLERDLSSPSIETFFDILEVLGCTPKE
FFDDEERKQKVVYTEDDITDFSDEEKGYRIQWLVPESNEKEMEPIRLFFSKNGEFKIFEP
SLSETFAYVVEGEILLKLGRQEYRAKKGESIYYHATEEHQLINLADGVTELILVATDSYL
>PK3-045_04759 hypothetical protein
MKQYSKLRITEKDQNIYNALCDLYKEKGGKVGIGPTEIGIRVGRDSYDASAYCNASLKKL
IHFEKIEKIDNGKYIPLEIGKEE
>PK3-045_04760 hypothetical protein
MKKIIMLLMLTTIALTGFCSLVSAAPSSEKREITQEDKQFLIEMAKSLGIKPEGKDPAAI
KKEIHEVLIKKEAQKLGIKTEGKDLQQIAMEVHTAHLKEEAKSLGISTEGKDAKTLMKEV
FEAKILKQAKELGIDTKEKTIQQLGKEVQEKMIMTEAKKLNIQTEGKDFKQIADEIRDTQ
IMKKAKELGIDTENKQPKELLKEMMIKHPKELKKLKLFPSYGEHFMFKKHHKLNREH
>PK3-045_04761 Peptide deformylase 2
MSKFTKEYIITMEDIVREGDPILREKTKEVSIPPTEEDIKELQCMLQYLKNSQDPILSKK
YQLRAGVGLSANQIGLNKRMFASYIRQENGEALEYMLINPKIISHSTAMTYIPESEGCLS
IDRSIVGYVPRYRRITVRAYNIHGEEVKIKLKDYEAIVFQHEIDHLNGILFYDHINSKNP
FELPANVDITPLY
>PK3-045_04762 Foldase protein PrsA 1
MKNKKVLIPILVVVLVALIIGAVYLTQRSKTVATVEKEKITQEQLNKELNKQYGATVLNM
MISNKVVDLEADKAKVKVTDKDVQAELDKMIKQYGGQETFNMLLAQNGMTEDLFKEQVEQ
NLKVTKILEPSIEITDDEIKTYFEDNKASFGTPEQVEASHILVKDEKTAKEVKKKLDNGE
DFAKLAKEYSTDTQTKDKGGELGYFTSGKMVEAFDKAAFSMKVDEISDPVKTDFGYHIIK
VTGKKEAKEATLEDSKAKIKEALLAQKVQEKAGTWLNEATSKYKIDNKLEKDQKDQKDQK
DKK
>PK3-045_04763 hypothetical protein
MSDLEKRNEWEKDRPEAEETNLGGEELVAEKEDQVISEDPVEKDEINKPEEAEYTAEKEQ
VHLDKEEEQENARKDTSKTKGFLSLLAAGVVGSALTFFTIPHTDLYNDSYDKLEKQVEEL
SNKVEGKQTGAITANTTSNTKTSDGTIAIADMVESSSKAIVGIVNMQKQSNPFSQNSSDV
ESGSGSGIIFKKDNQYAYIVTNNHVIEGANALEISLYNGDKTEAKLIGADALTDLAVVRI
DAKYASDIINFGDSSTLRPGDQVWAIGNPLGQELSRTVTQGIVSAVDRSITVNTSAGDWE
FNVIQTDAAINPGNSGGALINSSGEVIGINSLKISDSGVEGLGFAIPSNDLIPIVNEIIE
KGKVERPYLGVGLASLEEVPRMYLEDLPNKVSKGVMITNIDANSAAAKAGLKVQDVIVAI
DGKKVANSTDLRKYLYSEVKIGDKVKLEIYRDGKSQKVELTLTSNNTIN
>PK3-045_04764 Sensor histidine kinase RcsC
MRIKYIYQQLISHLSVILVALLVLSLVFSHYIEKLVFSMKAEELKGYGYNIVQDVQGADL
WSAATYSTLLRYSEELKGTGITIGIFNTQRNRIWSFGKDLDINITHAEWDEIKDGRSTVI
KPSTKRGDQEVALVAIPYSVNDVVVGGIILTSPLVESKEMIQEINRYLLYTLFLVFAIAL
LMSFIFSRVHVNRIKKLQEATSHVAQGDYTVKVSSSTFDEIGELGEDFNQMVDNLRESKE
AIDALENRRRQFMSDVSHELKTPLTTISGVIEGLNNNMIPENEREKGLKLISHEAKRLIR
LVNENLDYDKIRSNQIVLMKEFISLQEVLEIIDDQLSILAEENGVKIYVDVDSDAVIYAD
YDRLIQIIMNITKNSIQFTENGSIWLKGRTEASKTIIEVKDTGIGIDAHEIENIWKRFYK
ADISRTNNPYGEFGLGLSIVKQLVQFHEGDIKVSSEKGKGTTFTLFFPLPEEK
>PK3-045_04765 Putative fructokinase
MSLYGAIEAGGTKFVCAVGDAKGNIQERISIPTTIPEETMPEVIAFFKKFSVDAIGIGSF
GPIDVDKNNATYGNITTTPKLAWKDYPLLKTIEDEFSVPTGFNTDVNVAALGEAKLGAAK
GVDNCLYITIGTGIGAGAYINGELLQGLTHPEMGHILVRRHPKDSYKGRCPYHADCLEGL
AAGPAIEERWGEKAFHLSDKEEVWEMEGYYIAQALMQYILILSPKKIILGGGVMNQEHVL
THVHRYLTELLNGYVSYPEVQDKMNEYIVRPGLGDNAGITGGLLLAEKVFHEK
>PK3-045_04766 scyllo-inositol 2-dehydrogenase (NADP(+)) IolU
MTIKFGVIGTNWITESFIKAAGEIEDFQLNAVYSRTADKAKAFADKFNVEHTFTNLEEMA
KSDKIDAVYIASPNAYHAQQAILFLKNKKHVLTEKAMASNTAEVKEMITAAKENEVLLME
ALKSTFLPNFKVVQENLHKLGKIRRAFVSYCQYSSRYDAYKQGTILNAFKPELSNGALMD
IGVYCLYPMVLLFGKPEKVKANSFLLESGVDGEGSIILAYPDMDVILIYSKITNSHIPSE
IQGEDGNLIINQMNTPTKVEFIPRNGEGENLTLPQKEASMFYEAQEFIELIKAGKTESSI
NSFDISLAVMEVMDEVRRQTGIVFPADTKQ
>PK3-045_04767 Petrobactin-binding protein YclQ
MKKKLSLLLLTCILAVLAACGNTEKSNADTNKGSEKSAKIKVTHELGEDTVKVNPKTVVA
FDFGVLDTLDKLGIEVAGVPQANIPPYLSKYEDSKYTNVGSLKEPDFEAISELEPDVIFI
SGRQSAAYEELKKIAPTVYLGVDTTDYMNSFKHNMNIIGEIFEKKQEVSKELAKIDEDIA
ALNEKAKAVDGKSLILLVNDGSISAYGKNSRFGIIHDVFGLAPADENIEASTHGQKVTFE
YVAEKNPAYLFVVDRGAVVGGESSAEKVLDNKLVKGIAAAKNDHIVYLDPSYWYLSGGGL
LSTSEMVKEISEAISK
>PK3-045_04768 Petrobactin import ATP-binding protein YclP
MVEVKNITKQYGSKKVLDNVSLSVEKGKITSFIGPNGAGKSTLLSVISRLTKADSGDVFI
DGQHIDKSKSNDLAKKIAILKQANHINLRLTVRELVSFGRFPYSQGKLNDLDEKMVDEAI
KYMELEDMQHKYIDQLSGGQKQRAYIAMVIAQDTEYILLDEPLNNLDMKHSVQIMKVLRR
LVEELGKTVVIVIHDINFASVYSDNIVALKNGKIINDGPAKEIINQKVLKDIYEMDMQIE
EINNQRICVYFA
>PK3-045_04769 Petrobactin import system permease protein YclO
MMQPRVKLIILAILAVLLISIFMLIKVSSNNWEYVIPRRAIKIIAILLTGGCIAFTSMVF
QTITNNRILTPSILGLDSLYLFIQTVVVFVFGSSTMTVMNSNINFLLSVALMVFFSSILY
KLFFRREDQNILLLLLIGIVLGSFFSSLSSFMQVLIDPNEFLIIQDKMFASFNNVNTNIL
IISIIIVAIVSIYVTRYSKFFDVMSLGRDQAINLGIDYEKVVRSMLIVVSILVSVSTALV
GPITFLGLLVVNLAREFLKTYKHRTLITGSILLSIISLVGGLLIVERVFTFSTTISVIIN
FVGGVYFIYLLLKERKAW
>PK3-045_04770 Petrobactin import system permease protein YclN
MLIVLSIISLFVGVIDIHPQNIFHLTADQREILLISRFPRLVSIIIAGVSLSICGLIMQQ
ISRNKFVSPTTAGTMDWARLGILVALMLFTGESPIIKMLIAFVFALGGTFLFMRILNMIK
FKDAIFIPLIGLMLGNIVSSITTFFAMKYDLIQNMSSWLQGDFSLIMEGRYELLYISIPM
VIVAYLYANKFTIAGLGEDFSTNLGLNHKRVVNIGLIIVALVSSVVLLTVGMIPFLGLII
PNIVSLYRGDNLKNSLTHTALLGAVFVLFCDILGRVIIYPYEISIGVMVGVIGSGGFLYL
LVRRKSYDAT
>PK3-045_04771 Quinol oxidase subunit 4
MAKNHENEKFPISHIAGFIVSLLLTFAAVGAKLYTDLPMVTVMWIIGALAVIQAILQLFM
FMHLTEGEGQVQTINIIYAFFCAIVVAGGTIWVMTSGHVHY
>PK3-045_04772 Quinol oxidase subunit 3
MAKVDKSLPLEYQTEQSRLNILGFWIFLGAEVVLFATLFAAYGSLKDNFAGGPTPAELFK
LKDVMIETLLLLTSSFTCGIAIWYMRRQNLKGLLTWLIITLALGAGFVFVEVNEFIHYVH
EGATMQTSAFLSSFFVLLGTHGLHVSLGIGWAILIIIQLLKHGLTPTTARKTFIISLYWH
FLDVVWIFIFTFVYLARMKMGG
>PK3-045_04773 Quinol oxidase subunit 1
MHIKWDDIVITGDPLILSAQIGIILTMLAIVVGVTYFKKWQYLWDEWITTVDHKKIGIMY
IIVAVLMFFRGGVDGLMMKYQTAAPEMKFLDPQHYNEVFTTHGVIMILFMAMPALIGLMN
VVIPLQIGARDVAFPQLNALSFWLTFSGAMLFNISFVIGGSPDAGWTSYFPLAGKEFTPG
VGNNFYAIGLQIAGIGTLMTGINFIVTILKMRAKGMTLMKMPMFTWTSLITNVIIVFAFP
ILTVALALMTFDRLFGTHFFTISGGGNAMLWNNLFWLWGHPEVYIVILPAFGMFSEVIAT
FSKKRLYGYNSMIISIVGIALLSFLVWVHHFYTMGSGPVVNSVFSITTMLIAVPTGVKIF
NWLFTMRKGRIQFTTAMLWALAFIPTFTIGGVTGVMLAMAAADYQYHNTLFLVAHFHYVL
IPGVVYAVFAGFYYWWPKMFGYALNERLGKWHFWLFNIGFNVTFMPMFFLGLKGAVRRSY
TFSAESGFAPLFMLSAIGSLILAAGFAVLVYNIYYSTRYADRKISTDPWDARTLEWHTAS
PVQPYNFAITPEVKALDAFWYMKKNNEGLVLKEEELEEIHMPSNSGLPFYMCVVFGIVGF
FLIFEWFIPAAICSLGIFVGLIIRSFDYNEGYHIKLDVIKKTERAWRGEK
>PK3-045_04774 Quinol oxidase subunit 2
MKKGVLVSLLAIVPLFILSGCESMVVFDPQGPVARSITDLINWSIVLMAFVCLVVFALFG
YIVWKYRATKENADYEPEEHGSTKLEIVWTVIPFLIIIALTVPTVKTIFALEDVPKDYKD
RDPVVINVTSADWKWIFSYPEEGIETVNYVNIPAGVPVEFKLTSAGTMQSFWIPALAGQK
YTMYGAETDLYVVADNPGNYEGQNTSFNGKGYAEMKFDVEAKSVEDYDKWVDEVKETAPK
LTEEKYREIIKPTHLGRMTFSNTHLEWIDHGKGGDSNYYLNPELYRVHGYPGRTFEKNQE
SDGGEKDAH
>PK3-045_04775 Penicillin-binding protein 1F
MDRLKPYWEGFRRFWKKRHLTQIILLALLLFVLLAILYFTYLATQANVSSLKAGLSQATI
IYDKDGDEATRIRTERTEGIELKDVPKYVPDAVVSIEDERFYQHNGFDIKGISRAFFKNI
FAGRITGGGSTITQQLTKNALLTSEQTYKRKAEELFLAVEIEKHYKKDEILQMYLNHVYF
GSGAWGISQASLKYFNKDIKDVSISEAALLAGIVQAPSALDPYNNYDGAINRRNLVLKKM
VELKKITEEQYQQAVNEKIVLENGGGSFIERDYPYFVDAVIDEAISKYGLTQEEILKRGY
KIYTEMDQNLQSTLEKTFARDSLFPRSSDGTLVQGGAVLLDPETGGVRGLVGGRGEQVFR
GFNRATQIKVQPGSTMKPLAVYTPALEKGYKIDSMLEDKPFKKGDYEPKNFTKSYKGEVP
MYEALEDSLNVPAVWLLDKIGLENGLKSLDRFGIPYEKEDEYLGIALGGMYSGVSPLQMA
SAYSTFPNEGVRMESHLITKIVGPTGNVVAEYEPKSTRVTSKSVTNDMTSMLLDVIKSGT
GQGAKITGFQLAGKTGSTQLEDSSISGTKDQWFVGYTPNLVGSMWLGYDKTDKMHYLPSK
SSGDVIPIFKTIMDQAVQYVEPENFQVQSVSDRLANKDNKNVNKKVEKTKKVIKEKAEEL
ETTIKENSSKWSKVVDEIKEDAKKVNEKVKGKLQEILGN
>PK3-045_04776 Mannitol-1-phosphate 5-dehydrogenase
MNAIHFGAGNIGRGFIGLLLHQSNYAITFVDVNEQIIDEINRVGQYHVLLANEAKDQFTV
KNIKGINSKVNPEQVVEQFIHADIVTTAIGPNILKFIAPLIADGIKARMKSNQTPVNVIA
CENMIGGSSALKQFVLEHLNEEEAAWTEEYVGFPDSAVDRIVPNQKNENLLDVLVEPFHE
WVVDETAIKGPKPEIAEAHFVSNLQAYIERKLFTVNTGHAATAYLGNRKNYETISETIQH
EDVKEKVLHVLQETGKVLVAKYGFNAADHQKYIDKILGRFANVYIVDDVKRVGRSPLRKL
GGNDRLVAPALAYYNEFKEIPSYLVEVMASALHFYTAEDQESVELKNFIDAKGVQAAFSE
VSGLSEDHALVKEVVLTYNKINA
>PK3-045_04777 Mannitol-specific phosphotransferase enzyme IIA component
MSILKKENIILNSSLASKEEAIKKAGQILVEQGYVSEDYVPAMLQREEISSTYMGNFLAI
PHGTDEAKTAVLNSGLSVIQAPNGVDFGDGNIVKLIIGIAGKDGEHLELLSQIAIVCSEM
ENVEKLVAAKSEEEIIQILSEVE
>PK3-045_04778 Transcriptional regulator MtlR
MIISARERIILQILLENIEEEMTIKGIAEHVNVSERTIHRDLKNVEAILKDFHLKMNKKA
GVGVKIEGHPNDIYQLRVSILKQDYIEYTPDERIIVALCTLLDHQEPIKLFSLAKELGVT
TATVSNDLDKLEPIIAKYDLQLMRKRGYGIELVGTEEDKRKAIRSLISDRFDVPEFLKMV
KENIQKKSSNKIDSISERLLGLVQKEKLLRIENIIEDINEQLPYPLADSSYVGLVVHIAL
AMERIQRGENISFKEDYLGELSQTKEFDFARQIVSRLERTFDISIPIEEVGYITMHLRGA
KVRYDNKVGIEDENVEVAMLVRTLIANVEKLLHTTLADDSLFQGLLAHLQPTLYRLDQKM
SISNPLLEDIKEDYAELFEVVQQAVEKTLVDRDVPEEEIGYLVLHFGSALNDRKITKNIK
LLIICSSGIGTSKMLAAKIVNQIPSLSEVKTASVFELKNISIEDYDAILSTIPLEDISRD
YLLVNPILNDKDLEEVKTYLQKNIGHVIREEKGIEVPKQKCIDFQSFLLFSEQAQLLSSI
LNELDIWDERASLSASLNKGLRILKQQGSISSVEEVFAALEARAEIGGLAIPETNLALYH
TSNNQIEKPSFNIIDLPEMVSLRAMNGANEMVKRVLLLLAPLDANPNVMEVLSFLSASII
ESERSIHVFSNGKKEELLNFISSRFLKHHLRN
>PK3-045_04779 PTS system mannitol-specific EIICB component
MSDENKNGFRVKIQRFGSHLSGMIMPNIGAFIAWGLITALFIPTGWRPNAELAQLVDPMI
KYLLPLLIGYTGGKMVYAERGGVVGAIASMGVIVGADIPMFLGAMVMGPLGGFLIKKVDD
LFRGKIKAGFEMLVNNFSAGILGAIIAIIGFKYVGPVVEGLSTFLSSGVELIVDAKLLPL
ASIFIEPAKVLFLNNAINQGILGPIGVEQAKEVGKSILFLLESNPGPGFGVLLAYCIFGR
GTSRQTAPGAAIIHFLGGIHEIYFPYILMKPMMLLAVIAGGMGGVFTFTLFDAGLVATPS
PGSIIALMAMAPKGQHLGVIAGVVVATIISFVIAAIILKTSKDKEEDINAATEKMEALKG
KKSSVASAITETAETPDETSATEFDYKSVKKVIFACDAGMGSSAMGASIMRNKVKKAGIE
GVDVTNTSIANLPSDADLVITHKDLTDRAVEKLPNAHHVSVENFMNSPKYDEIIEKLK
>PK3-045_04780 hypothetical protein
MILFVILIAFTAFFVATEFAIVKVRSSRIDQLVAEGKKGALAAKKVTTHLDEYLSACQLG
ITVTALGLGWIGESTFAEILEPLFVHLSIGTALSHLIAFVISFLLVTFLHVVVGELAPKT
VAIQKAELITLAFATPIIWFYRLLYPFIWLLNGSARLLTSIFGLKPASEHELAHSEEELR
ILMSESYKSGEINKNELAYVNNIFEFDERIAKEIMVPRTEMVTISVDNTFDEIMAILEEE
NYTRYPLVNGDKDNVIGLINIREFLTATIQNREEIQLEEYMKPIIRVIETVPIRELLIKM
QKERTHMAILLDEYGGTSGIVTAEDILEEIVGDIRDEFDEDEISDIRKIKDNHYILNGKV
LISEVNDLLGTHLSEDEVDTIGGWFLTNNFEAVEGDILEEEGYIFKIKNIEEHHIHFIEV
TKDTSVVEA
>PK3-045_04781 hypothetical protein
MKLRIGDLAKATGVAKRTIDYYTNLGLLQAERSQTNYRYYSEEQN
>PK3-045_04782 hypothetical protein
METIINFLTSKSVKRFFIFAFMILGIYALRSMINLMLFTFILSFLMDRMEKIISKRIHVK
RNVIVSILYLITIGLLSYSFIKYLPMLVEEITALVRQLMDFYSRPHDNAVLNYIVSIIQE
RQINSYLEQGLGIIVKYFSSISSLSLQFILAIILSFFFLLEKPRLIKYKENFRTSKIAPF
YNEMEFFGKKFVLTFGKVLEAQVIIALVNCILTTIGLWILSFPQLLGLSLMVFVLGLIPV
AGVIISLIPLLTIGYTIGGYPYIIILIIFVCIIHAIEAYILNPKLMSSKTNLPVFFTFIV
LIFSEHFFGVWGLIIGIPVFVFLLDILQVQSMDPKRKTDLVKE
>PK3-045_04783 Dihydroxy-acid dehydratase
MTQLRSNMIKKGFDRAPHRSLLRAAGVKEEDFDKPFIAVVNSYIDIVPGHVHLQEFGKIV
KDAIREAGGVPFEMNTIGVDDGIAMGHIGMRYSLPSREIIADSIETVVAAHWFDGMVCIP
NCDKITPGMMMASLRLNIPTIFVSGGPMKAGVTSDGRKISLSSVFEGVGAFQSGKIDEGG
LRELEQFGCPTCGSCSGMFTANSMNCLAEALGLALPGNGTILAVAPERKEFVKKSAKQLM
NLIKEDIKPRDIVTEKAIDNAFALDMALGGSTNTVLHTLALAHEAGVEYPLERINEVASR
VPHLSKLAPSSDVHIEDLHEAGGVSAALYELSKKEGALHLDTLTVTGKTLGENIAGCKVK
DYQVIRPIDDPHTQTGGLAVLFGNLAPQGAIIKTGGVQNGIQRHEGPAIVFNSQDEVLEG
LVKGKVKEGHVVIIRYEGPKGGPGMPEMLAPTSQIVGMGLGPKVALVTDGRFSGASRGIS
IGHASPEAAEGGPLAFVKDGDHIVIDIENRTMDVVVPEEEWEQRKAEWKGFESKVKSGYL
ARYSKLVTSANTGAVLKY
>PK3-045_04784 Aldo-keto reductase IolS
MSSKVQIGQTAMHVTKLGYGANSVGGHNLFPNLNDETGKNVVRNALDAGIDFLDTAYVYG
LGRSEELIGEVLKERGNRQDIVLASKAAHKLVDGKIELDNSREFLRKAVEDSLKRLQTDY
IDLFYVHFPDGVTPMAEVAGTLKELKDEGKILAVGASNLDAEQIKEFNQDGYLEVFQAEY
SLFKRQAEEIYLPYCVENNISFIPYFPLASGLLTGKYSKDSIISGGKENNPLFQGEVFVR
NVEKVDQLKQMAESKGFDATHFALAWLLEQPAVDVIIPGAKSTEQLKNNLRTLDVSLTEE
EVKKISEIFA
>PK3-045_04785 hypothetical protein
MKGLRLSVHVLKSGIFVIIFLFLFITLWSISGVQLRLNFPFILILAVPLWVYFRLQRKNE
RNSVIFSKEILPNLFFFYLLTVAYVTLAPFHFTPPTITEGKMNITPYVQILYQYKYKPPF
FWMLYTLGNIILFIPFGFILPMLYKKHFQALITIGLAILCSLSIELIQFFFTVDRTADID
DFILNVFGAIIGYLLYLLMRLFLRKIDLK
>PK3-045_04786 UDP-N-acetylenolpyruvoylglucosamine reductase
MNKNILLKKFLEILPKESVKMDEALNKYTYTKIGGKADFLLFPLTYEQLQSAYKLALTQN
VPITILGNGSNVLIRDGGIRGVVFNLTKLEGISLAGNKVIAQSGAAIIETSRFALEHSLT
GLEFACGIPGSVGGALYMNAGAYGGEVADVLESAKVLTKTGEIQTVTKEELELGYRTSSI
EKNGWVALEGTFSLQTGEYAEIKAKMDELTFLRESKQPLEYPSCGSVFKRPPNHFAGKLI
QDSGLQGTKIGGAQVSTKHAGFIVNVEDATANDYLSLIKHVQKTVKENFNVELETEVRII
GEE
>PK3-045_04787 putative siderophore transport system ATP-binding protein YusV
MDILSTDQLKIGYEDKIIVDDLNLRVKEGEITTIIGPNGCGKSTILKTLARIHKAKAGFI
YLDGEMIHKIPTKKIAQRMAVLPQSPDAPNGLTIYDLVSYGRSPHQRGFGRLGEKDKEVI
NWALEVTGLTELKDQEVDTLSGGQRQRAWIAMAIAQETNLLLLDEPTTYLDMAHQLEVLK
LLKKLNEEENRTIVMVIHDLNHAARFSDHMIAMRNGKLMKEGTAEEVMTEEVLKEVFQID
AVVVKDPRTNKPACLSYDLLHQKERELVAFAK
>PK3-045_04788 hypothetical protein
MNMEKLSKRIDKIVQEYEGEGHLGIAIEWKEQSFLLNENDIFLSASLIKLPVLIEGFMQS
SSGILDLEDLVKVNSLQKTGGAGIVQYMSPQSRLSIRDLLTLMIIVSDNMATNYLIERLG
MDNVNRRCQQIGMSSTILQRKMMDREARERKIENYTSPQDILRCLKSIYNDKNQSGKTIL
DHQQLLDKLPYYHRENSGIRIANKTGELDKVEHDCAIIEYEDETIFIAVLTDQLTANQKG
KEIIQLIGASIFECLYDKKV
>PK3-045_04789 Oligopeptide transport ATP-binding protein OppF
MTQQVLLKVENVSKHFELEKNTTLQAVSNVSFSIKKGETFGIVGESGCGKSTLGRTIMGL
YKASNGQVLYNDINMGSMSEKDNFSFRRKMQMIFQDPYASLNPRSTVREILAEPLEIHGV
YRTKEEKNARIDELLESVGLNREHANRFSHEFSGGQRQRIGIARALALEPEFIIADEPIS
ALDVSVQAQVVNLLKRLQREKQLTYLFIAHDLSMVKQISDRIGVMYLGNLVELTDSKALY
SNPLHPYTQALLSAIPIPDPDIEDKRERIILKGELPSPVDPPSGCVFRTRCPHAMDICAN
EKPAWQERENGHFVACHLY
>PK3-045_04790 Gamma-D-glutamyl-L-lysine dipeptidyl-peptidase
MTKYDVRIVDVPVATLWTTEYSAREIDAGAIDNPCDIKSWIASLDYEKGLELCTENLVQS
QALYGQEVYVLDEKGDWAYVALPNQATRKNQLGYPGWIPKKQLVKKEGYSLQSGPIAVVE
AFAAELCNRNKDVILPLSFQTRLPLKKQEGEWVQVSTPSGEGWIRAADVVVYPSFQDVRK
GTGKDIVNQGERFLKLDYLWGGMSSFGYDCSGFSYSMCLANGYLIPRDASEQAEAGKKIP
LEEIEPGDLLFFAYEEGQGYIHHVGIYYGENKLLHSPKTGKTIEIIPLENTIYEKELCVA
RRYWE
>PK3-045_04791 L-Ala-D/L-Glu epimerase
MKITKIETFRVAVPLIKPFKTALRTVTIAESVYVKIICENGIVGWGEAPPTLVITGDSLK
SIEASIHEVFKPYLLSKSILQLELLLQGIQQILVGNVSAKAAIDMALYDCFSQYCKLPLY
QLLGGYNNTLETDYTVSVNDPVEMGEDAMSYVKQGFNVLKIKVGKDEIQTDINRIIEIRR
RVGSEIKLRLDANQGWSPKEAVVAIRKMEDLGLNVELVEQPVKADDIQGLKKVTDSVDTL
IMADEAVFTPQQAFEVLKTRSADLINIKLMKSGGIYRAQVINHLAEVSGMECMVGSMIET
KLGITAAAHFAASKKNITRYDFDAPLMLARDIVDGGVQYDGRNIILSKQFGLGINHILVH
EKENVG
>PK3-045_04792 putative murein peptide carboxypeptidase
MIKPERLKKGDTIAVIAPASPPSSDTLQKGIHYLEEELGLKVKVGQHVYDQYGYLAGEDE
ARLVDLENAFLDQEVKGIFCACGGYGTARLAGQINYSIIAQNPKIFWGYSDITFLHTAIF
NRTGLVTFHGPMLSSDIGMEDCHPLSKALLKQLFQPQEMMYTEEYSNLDILVEGKAAGQI
TGGNLSLITSSIGTSFEIDTKAKILLIEDINEEPRSIDRMLNQLQQAGKLTDAAGIIIGD
FHQCLPKRDKSLVLDEVIDHYIQKAGKPTMKGFKIGHCSPHISIPLGVNAEINTNEKVLM
IDSGVE
>PK3-045_04793 Dipeptide-binding protein DppE
MKKIAISFLAMIIIFSLAACTANSDAGKEKAAGETKEKVLNLNNGQEPSSFDPPIGFDSV
SWTALNNLMEGLTRLDNNHEPQAAIAEKWDVSEDGKVYTFHLRENANWSNGDPVTAGDFV
FAWKRLLNPDTKSPAAFLGYFIEGGEAYANGEGSAEDVKLKAVDEKTLEVTLTAPQAYFL
NVITNPAFFPINEKVATENPKWFSEADSFVGNGPFKLTKWEHDSYFEMEKNEKYWDADTV
KLDKIHWAMVDDSNTEYQMFQNGELDVSDVPAELSEQLFSEGKVKVEDQAGTYFYRFNVT
KEPFTNKNIRKAFALAVDQQQIVDYVTKNQEKPAYGFVSYGYLDNDGNDFRKTNGDLIKT
DVEAAKKLLEQGMKEEGYTTLPEVTLTYSTSDTHKAIAEALQAMFKDNLGIDVKLANMEA
SVFTQEQTALKLQLSRSSFLADYGDPINFLENFQSGLAMNRTGWSNAEYDQLIKEAKNES
DEAKRFELMYKAEKLLLDEAPIFPIHFYNYVYLQNDSVTGIVRHPVGYLELKWADKK
>PK3-045_04794 Oligopeptide transport ATP-binding protein OppD
MTAILEIRNLHVSFASYGGEVKAVRGVNFSLQKGETLAIVGESGCGKSVTSQTIMRLIPS
PPGRITDGSILYKGMDLTKLKDEDMRKIRGADISMIFQDPMTALNPTLTIGDQIMEGIKQ
HKQISKAEAKDKAIEMLTLVGIPNPEMRLKQYPHQFSGGMRQRIVIAMALICEPEILIAD
EPTTALDVTIQAQILDLFREIQQKREVSIILITHDLGVVAQVADRVAVMYAGKIVEMGNR
RDIFYSPQHPYTKGLLNSVPRLDQEGELVPIDGTPPDLFSPPKGCSFTARCPYAMEVCKR
VYPSKSNLSAQHQVNCWLQDERARRVLHTI
>PK3-045_04795 Dipeptide transport system permease protein DppC
MGLRQETMYEKKDDIALDEWFVPIERQLGEAEAVVRPSLSYWQEAWRNLWKNKLAMGAFF
FLILLIIMSIIGPIISPHSISEQKLINQNQPPSSEYWFGTDSLGRDVFSRTWYGARISLF
VGIAAAVIDFLIGVAYGGLSGYKGGKMDHVMMRIVEVLYGLPYLLIVILMSVVMGPGLGS
IIIALSITGWVGMARIVRGQVLQIKNYEFILASKTFGAKTYRIIRKNLLPNTMGPIIVQM
TLTVPSAIFAEAFLSFLGLGIQAPLTSWGVMADEGLSAILTGHWWRLFFPTLFISLTMFA
FNVLGDGLQDALDPKLRGGK
>PK3-045_04796 Dipeptide transport system permease protein DppB
MKSYYVKRFFSMVVTLWVIITITFFLMHFTPGSPFNDERTTNDAIQKNLEEQYHLDKPLI
VQYGMYLKQIATFDFGISIKKSSQTVNEMIGRGFPVSFELGMVSLIVAVISGITLGVIAS
LKHNGVIDYIAMTIAVIGISIPNFVLATMLIQQFAVHWKILPTATWSSWKHMILPTIALA
TGPTAIIARLTRTSMLEVLTQDYIKTARAKGLSPFKIIVKHALRNALLPVVTLLGALAAS
ILTGTFVIEKIFAIPGMGKYFVDSINNRDYPVIMGTTIFYSTILIIMLFLVDLAYGILDP
RIKLQKKEG
>PK3-045_04797 D-aminopeptidase
MGKIYMSVDMEGITGLIDHTQVDSDKLNYERSRILMTDEANYVVTSLFDQGIEEVVVNDS
HSKMNNLLIERFHPKTKLITGDVKPYSMVQGLDASYDGAIFVGYHARASVPGVMTHSMIF
GVRNMYIDDVVVGELGFNAYVAGYFGVPIILVAGDDQAAQEAEQLIPNVTTAIVKNSISR
SAAMSLTPAQAGELLKEKTREALEKKHLIKPLVPPASPLLRIEFANYGQAEWAHLMPGTE
IEPGTTIVRFQAKNILEAYQAMLVMTELAMRTTFC
>PK3-045_04798 hypothetical protein
MYHANTIYIIGESKTSSNNAIMQQYNGFFIALVVDRVSHTIIDAECSSTINITSSFIKSI
VVGKSMLDLDTVLKEVENRYFGSSQKAVMVAFKNAHIKYKQLLKELV
>PK3-045_04799 hypothetical protein
MDHTVMVFIVLITMSGALHVILAIIAYMNRQAFEGMRTFLWFSCFNAIYAFGYALGLAST
TIEGMKFWTAVQYLGMPFSAPATLILVLQYIGYDRHLNKKMYFFYYLIPALSFLLVATND
YHHLFYQSVYLEYRNATPLMQITMGQWYLLHGAYSFGASAIAFVLLSIYWFKEKSRQTKQ
VAILLTGILVPVGASFSYLIGLTPNGLDPVPIAMLFSSSLYLYAIISTKFLLVPPIEKDY
IFESMGEAVLVLDQTYHLKDFNKAASRLFIDVKRGKHIAAVLGLDDPILGLLKNIDTDSV
ISEVERTNKSATEYYQVKISPIKKGESAIVGTSIMFANITEQKKEQLSLTKLAYTDSLTQ
IYNRAYVTALAEEMLVKHRKIAVILFDIDHFKKINDTYGHFGGDEALKHIASLSKALVPG
NGVFGRYGGEEFILFLFGKEAESAIDLSRKLRRLIAESPFYYKEIVINITASFGVAIKEN
CLALIPLISEADEALYASKREGRNTVCVAENGEYIKLESSPLVGKY
>PK3-045_04800 Protoporphyrinogen oxidase
MKTVLVVGGGITGLSAMYYLQKENRERQLGLRLVLVEANDYLGGKIHTVTKDDLLMETGA
DSIVARNKNVLPFVKELNLEEEIVYNATGTSYIHTQNKLLEIPKDSIFGIPMTLEALFTS
ELLSTRGKLEALKDLFRTKSSFTRESSIGEFLEYYLGKEIVEKQIAPVLAGVYSGNIYSL
TMGSTLPYLLEYKEQYGSIIRGLGKNKESFQSAANKKFISFKDGLSTIIDRLEKVLEDVS
IRKGIAVTRINKEADQYKVQLSNGEEEMADMVVLSTPHNVTQHILRKDELNPVFSKLKNS
SNITLYLSYDISDDELPKDGTGFIVAGDSDIVCNACTWTSRKWKHTSKNNQLLLRLFYKK
TNPAYERLNSLTEEELIQEARKDIERSLGITSKPKSYEVTKWTNAMPVYSLEHKQAVEQL
SQDLALLYPNVHLAGCSYYGVGIAACIANGEETAKKILHSIE
>PK3-045_04801 Putative HTH-type transcriptional regulator YwnA
MANSRLSVAIHILSLIASKPYEQITSDSIAESVNTNPVVIRRMCGLLKRGGMLTSRAGIS
GASLLKSPADITLLDIYLAVQPKSEWFAIHDHPNHRCPIGSKIHPTLNRTFSTIQLTMEK
ELEHITLQDIMDEMEIYSKI
>PK3-045_04802 Putative teichuronic acid biosynthesis glycosyltransferase TuaH
MRTIHVIVATGVWNLDNLTYRRHRFAEFLQKQQETEEVIWLCPGEKQTPEVTRLENGIYQ
WIISDLGNYKVQRFARFIPFFYQKKLRSLSNYLAEKKGDYLVNLWYTYPAFPTLHKIYSW
DQIVYDCSDLWAEQLSGKFSFLSYLKQKIIYQSEQTIVEKASYITCTSSFLAEEIISRTP
AYRDKIFTYENGVEYELFQERKNREPVIEKEGLTIGYIGGIKPKLDFGLIQQIAQMRRDW
TILLVGPDGTNNSPEFMKLLKEPNIQWMGSVSRNQVPAYMHMLDIGIMPYKDTPYNKAIF
PLKLFEFLAAGKPVIGMNLPSTKGYVEEGVYELLLGEPEVNQFIHACEKMAENAGSQVWQ
SRRKQLAMLKDWENIFQEMIQVDKETSI
>PK3-045_04803 Putative teichuronic acid biosynthesis glycosyltransferase TuaG
MAPSVSIIMPSYNCKEYISFSIQSVREQTYTDWELLIVDDHSTDGTVEVLKEWEKVEERI
RVFYRTVNGGAAVARNMALEHARGKYIAFLDSDDRWKQEKLEVQLAYMKENQYAFTFTAY
ECIDQKGEQINKYIRVPEQVDYQTMLKNTIVGCLTVLIDREQVGNFQMPNIRTRQDLATW
LMILKRGFRAFGLNEILAEYRVGNDSISKNKWKAAKNNWHVYRQIEQLNFLQSSWYFSHY
AYNAIRKRL
>PK3-045_04804 Teichuronic acid biosynthesis protein TuaF
MKSVLSIIATRWKKYFIPLLLLSALLGAIGWFAPAGKEKGAVKAEATILLGNYENEYLNN
SEVIASLLRNETTFVHYLPGVDIEKEQLLISADTPKKISFTLTGPSEQEAVDSLSELVTA
FLEMDQQYYQEKEEIISESIDQLQEITVQAESAVDQQRFLYELKTKQVNMQPAMLVKDVA
AVSGDNRVISPRDRALMGVMIGIMLSCLWIIYPVFLKSESD
>PK3-045_04805 Teichuronic acid biosynthesis protein TuaE
MGNNRTVSKTIGFSVLGIGCLTVLYWTTIYQLTWILPIVCIWIAIQVGIYLKSIITLDQL
FQNVMYVLLLSTFLNQSILSVNVGAFTVFLYRILLLLAIILYIGTALYKKRMVHDFNRSG
LPFIWLFFGGWILYGTISILWSISIIASLKYMSLLVMGIAFVYLANVTFKTRQQLQYFLA
GWIGMTILLVGIGFVNYIFSIQLPSSGLYGASSYKLSYPTAVFYNQNDFAVYLGISFFLF
LAVVKNTKRTMLKGSMFILSILVFLLIYLTESRAGLLALAGGGLVYIFLIIPKWWKKLIL
RISLGVGLLGGIIFANRGFSKIQSLIELSGQYELNEVLPSNLARINLLRNTFSYLLDSYG
FGIGAGNIPYYLEYKSYFPTGNVYQVHNWYAEIAGNFGLMILLGYLMILIYAFISFYRAY
EKTESGTDKMLLEACMIGMVSFIISSISPSSVMNLYFHWVFLGFILCTLSVYKNKKLES
>PK3-045_04806 UDP-glucose 4-epimerase
MTKVLVTGGAGFIGSHIVESLLAEGYEVIVIDNFSTGKFENIKDLAIKICPFDITDSRVI
DYIVDLKPDYIIHQAAQVSVAESVHDILHDENVNVKGSLHVIKAAIRASVQKILFASSAA
VYGNPVELPVTTEHPTLPESPYGLTKLTVEKYLKLASKLYGLSYGILRYSNVYGPKQDGK
GEGGVISIFADRVFENKAPVIYGSGEQTRDFIYVKDVASANLHALKQDENLCLNISANNR
ISINQLWENIADISEVSLKPIYKAEREGDILHSILCNEQTIQKLKWKPQTNLEYGLRETL
FSSKQVLQK
>PK3-045_04807 Putative teichuronic acid biosynthesis glycosyltransferase TuaC
MKVLWITSVYPSADNPGSGVFHETQVRALSSLGVEITVINPVPLNASFFRIWKKKYRKKN
YPYLEKRHGVNIYRPVYRATPGQLRWFQPDKRIAACILKTWKKENIEADLIHAHFAMPSG
GAARIVASKYKKPWLLTLHGSDVHIYPSFSRSAERIFQKTVKSADEVIAVGEHLAAAAEM
KTGRKCLPLPLGIDLSKFTLNQAAALKESSRKELALPVNKKIILFVGRLVKEKGIFELAE
ALAYLPEDYVVVYVGAGQGKERLQKEKTYNKRLFLAGQIPNEKVSDYLSACDIFILPSYS
EGLPTVVIEAMALKIPIICTSVGGIPDLFGEYADLLIQPRSVQEIVTRVKEQAADAALFD
KAAEQLYQRVLDNYSAIDNAKKLLRNYQELASKSIESTNQLNHFWEEA
>PK3-045_04808 Teichuronic acid biosynthesis protein TuaB
MDSIKGKINSGAKWTSISTIVITLLQIGQFIVLGNIMSAKEFGMIGMLTTITIFAQIFVE
LGLGAAVIQKHHATDRQLSTLFWINVLLGIFICFLMQAASPMIADYFQTKELEGKVRLLS
IVFLIAPIGQQSQYLMQRDLSFKTLGKIETFSNVFSFSLLIGLLLFIKQNPINAYVWSQV
CLYSLKGILFYICYSPKWRPSFVLDIKDCKEFFSFGVYQLLSRLVNRLGSNMDMLLIGRF
MGMEALGIYNLVYQIITIPVLKLNPIITRVAFPVFAKDKNNNRALESGYLYMTKLLAIVS
FPLLLGLYAVADLVIPLFFGEQWMAAVPILEIMIIVGILRVLMNPNGSIILAKGKADIAF
YWDLGVLVCYGLALLAAVRSNQLEIVAWTYVGVSILNFIGGRILLTRMIGLQLKSYVKAL
LLPLILAVVSSGIALLLKTQMTSIHNNLVWALVWSVLISGIIYLLMLHALKHVAFREEYQ
>PK3-045_04809 hypothetical protein
MQANRSIHILKEISIVQANNLKSSKKVSFYQIFKRMMDLFIASIGIVITLPLILLFAILI
RIDSPGSPFYVQQRVGKNGKCFRLIKLRSMRMDAEKDGEKWAEVNDPRITKIGSFIRKTR
IDELPQLFSVLKGDMSIIGPRPERPSFTEQFSKEIDGFSNRLLVKPGLTGLAQVNGGYDI
TPREKLKYDLQYINNVTFSLEMKILVKTIKVVLTGEGAR
>PK3-045_04810 Energy-coupling factor transporter transmembrane protein EcfT
MNKLILGRYFPGESCLHQLDARAKMISVLLLIAMLFIADNWMAYLLLWMITLFIMHLSQV
PFRTYVRGVKPMIWLILFTVILQVLFTSGSNVYIAWGPITISEYGLINGIFIFSRFVLIV
FLSTVLTLTTKPIDLTDGINKMLSPLRFIKVPVDDISIMLSISLRFIPNLLDETQKVMDA
QKARGTEFGQGSLFQQMKTLVPIFLPLFVNSLNRAEDMANMMDVKGYRAGIKRSAFRRVY
WKKQDTWCLCSVCFIGVITVLLSR
>PK3-045_04811 Energy-coupling factor transporter ATP-binding protein EcfA2
MDMQIELKDVSANYQIGPIRKPNVLNSINLTIESGTFTALIGRTGAGKSSLLKILNGLLL
PTKGSVRIGETMIESPIQKENIRKIRKQVGMVFQFPESQLFAETVEKDICFGPLNFGVSL
EEAQEKAAQVIELVGLEPSILSKSPFALSGGQKRRVAIAGILAMEPSVLVLDEPGAGLDP
QGKKEIMSLLATWHKQASLTTILVTHDMEDVALFADQVILMDQGKIIKSDKTKMIFSDPA
LLESWGLEMPQARYYQMKIEQETGIKLPRVCLTLDELADALVSVGLV
>PK3-045_04812 Energy-coupling factor transporter ATP-binding protein EcfA1
MQTVLEVEELSFRYDKKRDKSHVENISFLLREGEWTALIGHNGSGKSTLAHLLVGLLQPD
EGKIKINGVSQKKGQGAQGIGIVFQNPENQFIGTTVEDDVAFGLENINMSYEEMHERVDQ
ALTDVDMLGFRMVDPSQLSGGQKQRVAIAGMLALEPKVLILDEAFVMLDPRSRKELMAII
RKLTNKGMTILSITHDMEEAAQADRVMVMEQGRITKIESPSQLFYTDSTLEKPFSEKLRE
SLKNRGSKVPDKYMTEEEMVRWICKSN
>PK3-045_04813 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MSIRSFLKLVEIQTKIASIFPFFIGILFVLYRYEALHWKNTLIFFASMLIFDLTTTAINN
YMDYRKANSDEYRKEKNVIGQEGIKESTVIATIFTLFFTATGLGIWLTAETGLLVLLIGF
ICFCIGILYTFGPIPLSRMPLGEVFSGVTMGFGIVFLTVYVNAFDYGIASLVWEQDVILL
QVNIIKIIEIIIVSLPCMFTIANLMLANNICDVEDDIKNHRFTLPFYLGKKYSLWLYNGL
YAGSFMAILISVFFHLLPVIALISLIAILPVYKHIRIFNQIQVKSKTFSLAVKNLIIVNG
CLVLSLAMFFIIS
>PK3-045_04814 FAD:protein FMN transferase
MNKFKFAMILFLSLLLLIGCGKQKESDEMVNSNPYKRTEFLMGTVVTIKIYDKDKEAVLD
KAFDRIELLASQITVNEDGSIVDEINENAGRNPVQVPEDIYRLVKAGKKYSGYSGGDFDI
TIGPLTNLWHIGFPDEKKPTQSEIDAVLPLINYTKIELNEEKQTVFLPEQGMMLDLGGIA
KGFITDEVIKVLNDNKVESAIVDLGGNIYVKGTNPSGKPWEVGVQDPFSDRGEMVGKMEE
TNTSIVTSGIYERYLEVDGVKYHHILSPKNGYSVNNEVAGITIVSDKSFDGDGYSTTIFI
KGIEEGLKAVEKMEGIEAIFVTKDKEVYLTSGLKGKFTLTNEKFKLANE
>PK3-045_04815 Nitric oxide reductase FlRd-NAD(+) reductase
MDKKNIVIIGAGYAGVHAAKKLAKKYKKDDSVSITLIDRHSYHTMMTELHEVAAHRVEPD
AIQFDLRRLFNRTKVNLVTDNVKHVDYQSKVVTTEHGQFAFDYLILGMGGEPNDFGTPGV
QENGFTLWSWEDAVKLREHIEKIVRKAAHVHDEATRKAMLTFTVCGSGFTGIEMVGELIE
WKERLAKDNKLDAEDITLYVVEAAPTILNMLERRDADKAESYMVKKGVKILKSSPIVEVK
EDAIVLKSGEELPTYTLIWTAGVRANSDTKDYGMSAGRAGRLKVNAHMESEDYKDVYVVG
DLAYFEEEPGKPTPQIVEAAEQTAMTAAKNIIAEISGGEKEKYKGKYHGVMVSIGARYGV
ANLSGMHLSGWFANFMKHMVNLYYFFGIRSGYYMYQYVMHEFFHTKDKRNIFRDFLTRYG
NVLWSLPLRVFVAGFWIVEACAKLWGESTWKDSISSWSKVPNLFNGLGDDSWLTATSVKM
PFEWLQTATSGASEAATSTDFATPILNKMPFWFEWIMKIMLPTPEVALFMQKMMIFIELA
IGLAILAGLFTWLANAASAGFLVMFTLTAMLGWDKVWALPASIALMNGSGRTFGLDYWVV
PFLQRKLGDWWYGKERAIYKDYK
>PK3-045_04816 hypothetical protein
MTKNQRLVYIALLASQAVIISLLERAIPFPFAFAPGAKLGLANIITCLALYTLPTKDAFK
VVAIRLCLATLLGGTLSTFMYSASGALLSFIGMWGVKQLGTKRISLIGVSTTGAIFHNIG
QLAIASFVAQTWTVFLYLPILSFIGILSGIAIGILANYLITHVEKLQFYRDLSEINESR
>PK3-045_04817 Heptaprenyl diphosphate synthase component 2
MRVHQMWDTYPELKNDLSKVLQLIESNIRVRDKVVEKTIKDLIYSGGKLLRPAYSLLCSQ
IGPSKDKNRAIAVAAALETLHMATLIHDDVIDESPTRHNIPTIHTHNGNKFAIYAGDYLF
CVCFTILSKYATSLSHLEFNARSMEKILSGELDQLNARYQSTVTVKKYLARVSGKTAQLF
AVSCYSGAVESEASRPLAMNAWNMGHYIGMAFQIMDDILDYKGDSQTLGKPVMADIKQGH
YNLPLIYAIQANPHELIPILDKKEALTNEDLAQLSKLIAKYKGVEKAELLAKKYTEKAIK
QLNKLPDGDYKNRLFEITLSLLNRNV
>PK3-045_04818 hypothetical protein
MEGNSGKRAKGKGKMTDMYTMVKRAKADPEMLHELIKLFEPKVNKLTKRTSPNDMADLSQ
ELKLMLIQSTYQYDLDSIPGFWEFKDKHNRE
>PK3-045_04819 hypothetical protein
MELVDMTQWMTMISNFGFPLTLSLFVLLRLDKKMDQLLKEWKETQENERKEKEK
>PK3-045_04820 RNA polymerase sigma factor SigO
MKECRSSQSEAFTAFLEENKSLLSNPIVKSFLQKKDNVHLLKKALECPTKENKEKVDESF
KKHFFTIRFTSYITSSMEYSTINFNKNLSMYQKRFPLILTEKEEGGEKDINLNDKEAEIE
AIVEKEALWSEMEEYISNKTIYSAVLSLTSSQRKILTYAYLYKFTDTEIARRIRTSQQYV
SKTRKAALKRILSFINNKEEGRWN
>PK3-045_04821 hypothetical protein
MMRVALNFAIMLEQVKAKGFKEEAVSKALETEDFAFFQNCGNGLPDWQTLFSYYKDNKAS
VKAIMQDDYEITFLTKGTLKRLILLKYQLVEGRDYEDCGESIGTITLPKESFQQFTKILA
KNWTIVVLEENQDNVIFDVKLFVID
>PK3-045_04822 4-hydroxy-tetrahydrodipicolinate synthase
MITQNPFVSYSVAMVTPFDQREKLSQTGIYSLIDYYKQNHVPALLISGSTGEQHSMTIEE
RQILYREVKSAGKDAFLLIGGVAAVRTTDTIRLAEAAQKEGLDGIMLGFPPYLRINQKEA
AAYVEQVCAVTNLPILLYNNPSRTGFNLELNTLYRLVEKHPQIKGLKEAGNPDNALILQK
ELGSSFSVLTGTDLYLLDHLRNGYDGITSIIGNIFPQEIQQIVQLIKSQKWELAKKQFSK
LLPTIHTILEIGALRAIKYLLSESNIEAGICRKPLSTLNKQEQKTLMEVWQKGEA
>PK3-045_04823 Molybdate-binding protein ModA
MKKHFQPIMLLITILILASCSNNQGQSAASKQEPISITISAAASMQDALESIKEKFEKEH
PDITLTFNFGSSGALQQQISQGAPVDLFLSAAKDKMALLIKGGFISESDHTNLVKNNLVL
ITNKQSDTTINNFADLETLDKEKIAIGIPKSVPAGNYAKETLQSLHIWEKVQENIVPAKD
VRQVLSYVETNNVAAGIVYGTDAKTSDAVQVAAIADEASHSPIVYPLGIIKDSKHYQAAK
VFYDYLQTPISLEVFKENGFIVN
>PK3-045_04824 Molybdenum transport system permease protein ModB
MDLLLTKEDWSNFWPPFSLSLQVSLIATVCVAVSGIILAALLARKKFKGKVLLETCLLLP
IVLPPTVTGFLLLVVFGRNSIIGKGIEWLFQQPIIFTWWAAVIAAFIVSFPLMYQSAKAG
FIQIDRSIEEAARVDGANEWKVLTSISIPLASHSLISGSILSFARGLGEFGATLMFAGNI
PGKTQTLPTAIYVAIETGNMRMAWIWVITITIISFIMLALCQPKQQ
>PK3-045_04825 hypothetical protein
MKITYHGQSTIEISTEGKSLIIDPFISGNPSAVTKVEEVKVDAVLLTHAHMDHILDAAPI
AKANNAPVVANPELAAYMSWQGVETIGMNIGGTVDLGFAKAKMTHAFHSSGIIDEENKNI
LYGGMPGGYIIEAEGKTIHHAGDTGLFSDMKMIGDRHPLDVVFLPIGDHFTMGPEDALQA
AEWYQAKLIIPIHYNTFPVIEQDAKEFVTKLEELGLKGKVLELGETFEL
>PK3-045_04826 hypothetical protein
MSEYRVLLYYKYVPIENPEELTKEHLAFCKELGLLGRILISHEGINGTVSGTVEQTDKYI
EAMRQDPRFSDTIFKIDEADGHAFKKMHVRHKKELVNLSLEDDVDPLKLTGKHLKPAEFY
EKMQDPETIVIDARNDYEYDLGHFRGAIKPEIETFRELPQWIKENKDKLEGKKILTYCTG
GVRCEKFSGWLMKEGFEDVSQLDGGIVTYGKDPEVQGELWDGQCYVFDQRISVPVNQKEH
VIVGRDFFTGEPCERYVNCANPECNRKMLCSEENEEKYMRSCSHECRTHPRNFYVKQHGL
TQEQVEARVKEIAQWEEESKVI
>PK3-045_04827 PTS system N,N'-diacetylchitobiose-specific EIIC component
MGFMAAFEKFAEKTLVPVAAKLNSQRHIVAIRDAFILSFPITLAGSLIVLLNFAVLAPDG
FIAKILFLHKLFPNLADLQAVFSPVLNGSVNILSMFIVFLVARNMAISLKADELLSGLTG
LSVFFIIYPPYTNVEGTNFLTTQWVGAQGLFVALIVGLLVGELFSRLSRSKKLQINMPDS
VPPAVSRSFKVLFPIIIITVVFAIANALINAVYPEGLHGFIYAVIQTPLKSLGTNIVSLV
ILAIVSNLLWVFGIHGPNTIAAIREAMFAEAGLENLNFVAEHGTAWGAPYPVTWAINDAF
ANYGGSGMTLGLLIAIFIVAKRQDYRDIGKLSLAPGIFNINEPIIFGLPVVLNPILIVPF
ILVPAINIIIGYVAIVSGLIPPIAYSVPWTTPGPLIAFLGTGGNYIALLLGFVCLAVSTL
VYIPFVMAANKANAVSYGGEKK
>PK3-045_04828 PTS system cellobiose-specific EIIB component
MKKLLLVCAAGMSTSLLVNKMKDAAKEKGIELEIFALPVSECQKVAHEVDVVLLGPQVRY
QKPQVEEIIAGRVPVEVIDMRAYGMMNGKAVLERALELMA
>PK3-045_04829 HTH-type transcriptional regulator GlvR
MFTNEMIQSFNDLEMLLYNYVTKNIDKVIYMRIRELSDETHVSTSSILRFCRKLNCDGFS
EFKVKLKLYLDQSKQENLKSTKYYLSEFLERTMKGNFETYIQETADMVSQSDKVIFVGTG
SSGILAEYGARYFSSLGKFSTFIKDPFYPINSKELKKCTAIILSVSGETDYTIHLANRLK
MEGCNIISITNSKDCHLAKISDINIAYYVTEVYTGQSNITSQLPVMYILEESAHKVKKNS
KLNEEREA
>PK3-045_04830 hypothetical protein
MSESNLKLTSSEIASLWTSYLNNCMSKQVLTHMIQHVKDREIADAIRFAYRFAQKQEKRF
VKIFLENKFAIPHGFTEDDVNKKAPALFTDFFCLAYINQMAKAGLVAYGGFLSMSTRKDI
IHFFHEGLLDTSKLYHLSTSILDKKGLLVRAPFTSVPKEADFIENRKYLSGFSLFHKKRS
LNAVEVSHLFMNAQTNNMGLKITLAFAQTTTNKEVQAYMLRGKEISQKHLKIFTDTLLKE
GIQSPNSSDFGITDSTVRTFSDKLMMFHISLLSASGIGNYALAGGASQRSDLLLNYDRLS
IEIGQYAKDGADLMIDYNWVEQPPPIIQTKNDVTGK
>PK3-045_04831 HTH-type transcriptional regulator MurR
MKNSDMLFLDYANDKNLTEAEKDIIQFLIEKKLAGETLSIRSAANNLFVSTATIIRLCKK
LGFSGYSEFIYNLNLKVTKMLDQEVEYVDSIHQPLIEAVSSFKRNYKQTIDSLDETTIEQ
FLSQINENKMIYFYGAGFSTLFSSYFAKKLELFGYYVSNTTTSDSRAIFLNNIQKYKLLI
AFSRSGETAKVLEKVKIAKDKGVKTILFTGNNKSSTAKIADIVFTVLDPTIESQQEFEVT
SYESNMFMLIDLLLIIAIKRGIIKEY
>PK3-045_04832 PTS system glucose-specific EIICBA component
MKKVVNGLQLFGKSLFAPILILPIIGLFIAFGNVFGNGNLAQYIPFLEHPYIQNTGKFIS
SSAVSILQNLALIFAVGIPIGLAKKDKGYAALTGLVTFVIFINAMHQVLSLTGSLVAPEE
MQLAGQAMVLNVQVLEMGVFSGILLGALVGILHNKYCDTEFKGVMAIYSGHRFVAILAIP
SAMILGAIAAEFWPFVQDGITAVASGIKNLGVFGLLIYGFLERILIPTGLHHLVYTPFLY
TELGGVAHIGNEIIYGARNIYFAEMADSSIKVLSSTVNWDARGLSKMFGLMGAALAMYVT
ADKKKKTIAKAILLPAAFTSFLLGVTEPLEFAFLFTAPILFVLHAVLSGVGMMLLSIFHV
HAIGANGFIDFLLYNLPLGTTKSNWPMFILVGLLMAAIYFLLFRFLILKLNLKTPGREED
TDTVTETSETANAEAAASGTTRNGSPSALGATIVNALGGKANIENVDNCYTRLRLILKDP
NAVDEQTLKQTGSKGIIKSGNNVQVVYGLNVKSVRDQVDQQLGGI
>PK3-045_04833 Maltose-6'-phosphate glucosidase
MKTFKLAVAGGGSTYTPGIIRSLMDRLEDLPLSEIRFYDIDGERQAKVVVAAKAVIEEYT
DKIKVIDTTDPQTAFEDVDFVFAQMRVGKYAMRELDEKIPLFHNVVGQETCGPGGLAYGL
RTIAPMIELIDYVEKYAKETAWIVNYSNPASIVAEGVRKLRPNSRVLNICDMPVATMRNI
AAILGVEREELEVDYFGLNHFGWFTSIKVDGVERLPEIREHVYKYGLLTEDISKIDYRHA
DSSWIKTFKNIKLIMDHFPEYLPNPYLQYYLFPDHIVETSNKEYTRANEVMDGREKTLFE
TVKKYEETGILEDSFAVGVHGTFIVDVTVSLAQNLGKRYLVMVENNGTIPNLPADAMIEV
PALITSNGPKPEFVGDIPYFYKAMIDQQLASEKILVEAIVEGSYEKALQAFTLNKTLPSA
KVAKAVLDDLIEANKEYWPTLTKEYKEGVLV
>PK3-045_04834 hypothetical protein
MYASIEVDSAHWKNRGDDTMIDSRKIGAYISKLRKEKDLTQVELADKLNISHQAISKWER
GESLPDITSIPVIAHVFDVSIDLLMNAGVDKMDHSKQLGKIVQHLLEDKPEEVAHLINSG
SAQVNELVDIAPIIKSSQLSKVSKKMNTNVWDVDSIVHLAPFLQTEALDEIVIEAAKKAI
DCKLIQRIAPFVSAHTLNTIADQLLNESTEPMELLDLAPFLEEEYLNDMLLKVSTGKITW
RFITEMAPFVSDTALSALVLQEMKNPLNEEKILPLAPFLEEETIDQLILIAGGRGSWTFI
QKMVPFIGEETLNTLVDKAVDGDIELKELTELAPFLEEEAIERLLARIDPNKLSPEILAK
LAPFMGGSSLGNMVKQLLKTK
>PK3-045_04835 DNA-invertase hin
MKYGYIRPTIADIHCEQQFKILKPICEQVYKEEHDSAKNRTKLLELLSCLSKGDKIVVVQ
LFAIADSSRHLMEILDILEKKGAYLQTIKEEIDTERTKEYSLSEMLSHLIEFQNEIIRER
TKKGMEYAKQHGKTSGRPRKADENVKKAIEMYQSKKYTLKDIKEETGISKSTLYRYLEN
>PK3-045_04836 Bicarbonate transporter BicA
MIEKIKREWFSNIRGDILSGMVVALALIPEAIAFSIIAGVDPMIGLYASFTMAVVISFTG
GRPGMISAATGAMALLMGPLVRDYGLEYLFAATILTGIIQIIFGVLKIAKLMKFIPRAVM
IGFVNALAILIFMAQVPHLVNVTSITYLFVIITLLIVYILPRFIKVIPAPLIAIIILTAV
AIFGNVNVATVGDLGKITQSLPTFFLPNVPFSFETLAIIFPYALALSIVGLLESLLTSSI
VDDATDTESNKNREARGQGIANIVTGFFGGMAGCAMIGQSVINVKSGGRGRLSTFVAGVF
LMFLIMVLGSLVVQIPMPVLVGIMIMVCIGTFDWSSFKYLVNAPKADALVMLVTVIIVVA
TDNLSLGVIAGVLLSAVFFAAKISHVKVHRQERTNEEHYAVEGQLFFASVDSFIKAFDTS
ITNKQISIDFTHSHVWDDSAVGAIDKIALKLKENQNTVIMTGLNSASQKIVDKLTVFQNP
NAKVSDH
>PK3-045_04837 6-deoxy-6-sulfogluconolactonase
MHDEVELVLDAKAELGEGPCWDFRNNLLYWVDIEGKKVHMYNHISGKHKQIQLEREVSAI
IPCSKKDTEFIVTLDNGFHLLNIETGQLEFMTDPEKELTRNRFNDGKCDAKGRLWAGTMS
REDKKEAALYCVGKDGRCKEKMSDLTISNGMAWTSDNKYFYHIDTPTQIITQYEYELETG
ELGRAKQIIDFSEEEGFPDGMTIDSAGMLWVAHYGGGKVSRWNPDNGEKLEEILLPVPNV
TSCTFGGKKLDELYITTARSGLDDEKLNEHPQSGGLFKVKLGIKGVKTYLYQN
>PK3-045_04838 Aspartate--tRNA(Asp/Asn) ligase
MESSKRVLISECEQYVGKEVVLKGWVKKIRQLGKVGFLLLRDRTGTIQCVLEQEQNQLKI
ETESVVRVAGVLVDTEKTANGVELQVRELTILAEAGPLPFEINKNQVKVGLDHVLNHRVL
SLRHEEINAIFTIQSMFVKGFTEFLTTEGFTRIFTPKIVSQGAEGGANVFTFNYFEKHAY
LAQSPQFYKQMMVGAGFERVFEIAPVYRAEEHNSSRHLNEYISLDVEIGFIDNVEEVMEI
ERQVLQYTFQYVKEHCLNQLDLLKVEIPELNNIPKMTLEEAQQLLKDKYQKSSPEGDLNT
EGEKYIGRYIKDKYGSDFVFITNYPRTTRPMYTMPNKENPALTDSFDLLYKGSEITSGGQ
RIHCQTELIESFKEKGLNPSEFTAYIDSFAYGMPPHGGFGIGLERIIMKFLNLGNIREAS
AFPRDCDRLIP
>PK3-045_04839 hypothetical protein
MDDDDDNDMNQKKLLILGGTTIWNLQKGYSSLNANSMLERK
>PK3-045_04841 Sporulenol synthase
MNTIIEIVEKEQHRRIKKLVEHQQRDGSFRFRFQGSLMTDAFYIITIRALNIETEEENIR
LLTKTLRTTQEKEGYWKAYRDEPNGHLSATIIAYTALLYSGHYTKDDKQMKKARSFIIKN
GGLAKAHFMIKWMLSVNGLYPWSHMIYIPMTFLLMPTFQPINFYQFSAYARIHFIPMLIA
SNKKFTLQPKAKLDDLFVRDMALYPSYEYLENERSPLTFLWKEMKRIGKFPAYLHHLGFQ
YGEKYMLDRLEEDGTLYSYASATFFMIYALLALGYKKDSPVINKAVSGLSSLIDKRGELS
HLENSTSTVWDTGLISYTLQQAGMSSESIPIKKATKYLLTKQHTKKGDWQVHNPRAEPGG
WGFSDINTNNPDNDDTSAVLRALTAATAKNPTVHQAWLKGTNYLLSMQNRDGGWGAFEKN
TDWEILKLVPIENAKDAAVDPSTADLTGRVLEYLGNFAHLRYTHPHIKLAVDWLSDNQEK
NGSWYGRWGVCYIYGTWAAITGLTAVGMSLNHPTIKKAVTWLKRIQHSNGGWGESCQSCE
KLTYVPLPFSTESQTAWAVDALIAAGEGASSEVKRGIQYLLEKKGENHAITYPTGIGLPT
QFYIYYHSYNHIFPLLALSHYRNDLLNKPANS
>PK3-045_04842 hypothetical protein
MKKVLNIAFFYAILGLVSGVYYREFTKMRDFTGETQLSVVHTHSFALGMMIMLIVYLFCY
TMKIHTLKNFDVFFYFYNIGVLSTITLMIIRGTLQVLEFDLSSGLDSAISGIAGLGHIAV
TIGLVLFFLLLKKNHHENIRTK
>PK3-045_04844 mupirocin-resistant isoleucine--tRNA ligase MupB
METPKETDRGREERILAFWEEKQIFQKSIEQRENKEPFVFYEGPPTANGLPHVGHALGRT
IKDIIARFQTMNGKQVIRKAGWDTHGLPVELGVERALGISGKQEIEEYGVIPFIEQCKAS
VFSYEQQWRTFTKELGYWVDMDDPYMTMSNDYIESVWNILGSIHEKGWLYKGHRVSPYCP
SCQTSLSSHEVAQGYKDVKDLSATVKFKLASKENEYVLGWTTTPWTLPANVALAVHKDLD
YVKVKMEDDVFIIAKNRLQAVFGTEGEVIEQLKGEDLLGLSYIAPFSYVQVEKGHTIHHG
DFVTSDSGTGIVHIAPAYGEDDYHLVQANDLSFVHVVDERGRYKEAITPLAGTFVKDGKT
DVEIIKMLHQKGLLFHKEKYEHSYPHCWRCDTPLLYYATESWFIKTTAAKEMLIAKNQEV
NWYPEHIKDGRFGNFLEGLVDWNISRNRYWGTPLNVWQCTCCQTEIAPKSIAQLKKYTKI
PFDHLELHKPYVDELILTCPSCSGEMHRTPEVIDVWFDSGSMPFAQYHTPFENSGIFQQQ
FPADVVVEGIDQTRGWFYSLLAVSVLYSGKAPYKNVVATGHVLDEQGQKMSKSKGNALDP
VELIQTYGADALRWALVADSAPWNQKRFSEKNVQEAKSKIIDTFLSLFHFYSIYAEIDHF
DPNLPRANNLPIMDRWILSRLETTSMIVQTEMEQYQLTNAARKIAALMDDISNWYIRRNR
ERFWSRGMSDDKLSAFQTLYSVLIHSSQLLASFIPFTSESIHLALTGKSVHLTNFPSKNS
ERVNKQLEEQMEKVKEVVELGRSLRHRFQIKTKQPLATLLIFSNNSNQNTDFLQFESIIK
EELNVKRINWIDSQEDYVQYSLKLDFKKAGPKLGKSVKFIKDKLQAATEEEINLFRNKGY
LTFQLESKECITLTSEEILLQRKTNLPGYHEASSKNFTVMLDTTISEALKREGNIRELIR
SVQDLRKEKNLPVDKKIDLYIDCSITFQHTIMEYHSLIHKGVILQELLFERITEMKELQI
DGEKVSIGLK
>PK3-045_04845 Oligoribonuclease NrnB
MYKLLSHNDLDGVGCGIIAKLAFGEDVEVRYNSVSFLNQEVEKFLDQKTEDTFLFITDLS
VNEENTIRLDDYYKKGGKVQLIDHHKTALHLNDFEWGFVSVQDEDGTLTSATSLLYEYLV
KHEYMTPSPAISEFVELVRQYDTWDWERNNNLEAQRLNALFYLISFDEFVEKMVTRLKES
DHFYFDELETQILDMEEKKIDRYIRRKRRELVQKEIDGLYAGVVYAEQYHSELGNELGKE
YPHLDYIAIVNIGGKKLGFRTIHDHVDVSKVAGVYGGGGHVKASGCNLTDKAYQNYCLET
FALEPLREDPKKNEYNKKDSPLGTLFENKQDEVFFLYQVSKNQWAINHKKTKLPQTFSTF
LQGEIFLRRNYGVWLARDDKYIRYVMDFVKHK
>PK3-045_04846 hypothetical protein
MNTKLLIVEGLIGFGKSTTANLLYDILTEKNIEVELFLEGNLDHPADYDGVSCFTRKEFD
LILKKSGNLEKIFKDKVMKKGENYLLPYRKIKNEHGQEFSDELLNMVFKNDLYELPFDKN
VELITEKWTDFAKIAKKDNKVYIFECCFIQNPLTIGMVKFGVQKEKVINYVMRLAKIIEA
LNPILIYIEQDNLEFSFKKALKERTSDWSTGIINYYTNQGHGKEHKLSGIEGAMKVLEAR
RNIELEIFEMLKMKKVKMNNTKYEIGSYRSSLKDKLTLQIMN
>PK3-045_04847 hypothetical protein
MTNEYEKEEVLTGGNISDVYRSGNTVRRDIKPGSEKIHKLLKHLENKGFGYAPRFLGIDE
KNREILTYIEGEAGNYPLKKYMWSDNVLKEIANMLRLYHDAVSDFSLLNEWEPMDNTPDS
IEVVCHNDFAVYNIIFKGEKPVGIIDFDVAAPGPRLWDIAYTLYTCVPLSRLWHTEKGEA
VHYNPVKDANRIKQRVKLFFECYDVENLEKDFLEMVILRVEGLCKYMIKRAGEGEVAFQK
MLDEGQLEHYQKELQFIHEHGKEWV
>PK3-045_04848 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKPLNGKVAIVTGASRSTGIGAAICLSLAKAGADIFFTHWSKFDEKEGNGIEVGFPTMLS
EKIKSFGVRSEHISLDLSLDESPTKLLEAVEETLGTACILVNNATYESPSNFRELNTKML
DKHYKVNNSGTLMLSVEFAKKYEKVFRTKKDGRIINLVSGGPDPNNLAYIATKGMIIAIT
EPLSVALAPIGITVNSINPGPTDSGWINEDIKDYLLAQFPTGRLGKPEDVAKVITFIASD
DSYWLTGQTIRCEGGFLGK
>PK3-045_04849 hypothetical protein
MFKRFFMVVLTLIIAVGTVLLVAKHPTGPNTISYDEPIVLWISIGIIIILFLPPLILSLF
SNLVARVISAVYQAFVFISFLVIIPIGFFTSNNIVVSVIAILGALVSIGSVAVTLITKSK
REINI
>PK3-045_04850 hypothetical protein
MDKFSLFGKFMVREGERDTMVNILLEAAESMKNLDDCEIYLVNISESEPNSVYVYEVWSN
ENAHQASLTLEATQTLIRQAKPIITGMDRISTLKTKGGKGISSISY
>PK3-045_04851 hypothetical protein
MSISNSEDKKKIILNAAADIVKEEGVAKLTLEAVAKKAGLSKGGLLYHYSSKEALIIGMV
QDWTYRYFKSIETIVENNTKSGVGNWTSAYIKASFSDLNLDKRLSSALLAAMFTNPSLLE
EYKKEYDILLGKLMNDGVDPINVTIIRLAIDGMWFSEIFGLGSLDTNLKNNFINKLNNMI
KEEE
>PK3-045_04852 Quaternary ammonium compound-resistance protein QacC
MSYLYLMLAIVGELIGTSMLKASEGFSKLYPTIGVIIAFIGSFFFLSMAMKTIPLNTTYA
LWSGIGIVATTLISVIIWKEKINVASVAGITLILIGVVVLNLFGPGHGEASNHEANESSI
VLSNKTE
>PK3-045_04853 sugar efflux transporter
MKTNQIIEDKRISSWIMFLIASACGLIVANLYYAQTLVGPISVSIGLSSAATGLIVTLTQ
IGYVVGLLFIVPLSDIFENRRLVAVSLMVVVCALLAATFARNALSFLIASLFIGLGSVVA
QILVPYAANLASEEQRGRVVGNVMSGLLLGIMFARPLASFITSIWGWQTVFALSAIVIAL
LTVLLSRILPERRPSPTINYGKLIISLGTLLKQTPILRRRGFYQACLFGAFSLFWTVVPL
RLVDDFGMSQQGIALFALVGMGGAIAAPIAGRLADKGWTRFLTGLAMLIATLSFLLSYIF
QGNSTTALILLILAAIMLDAAVSGNLVLGQREIYSLGSEARGRLNGLFMSIFFIGGAIGS
SLGGWSYAHGGWSFTSIIGVVMPLLALLYFLTEKRSICKGR
>PK3-045_04854 HTH-type transcriptional regulator AqdR
MNAKRGRPRNVETQKSILSASYDLLLENGLGTVTVEKIAERAGVSKATIYKWWTNKADVV
MDGFLAAAAARLPVPDTGSVFNDILIHATSLARFLTSREGKIIKELIGEGQMDSGLAEAY
RTRYFHPRRLEAKKLLERGIQRGELRENLDLDLSIDLIYGPIFYRLLVIGENLDDAYVEN
LVKYSFTGINSI
>PK3-045_04855 Phthiocerol synthesis polyketide synthase type I PpsC
MDAKCIRFYEFGNPKDVLTVEYKNIEPPKDNEILVRMLARPINPSDLIPIRGSYSHRISL
PNIPGYEGVGIVEDVGSLVSHNFIGKRVLPLRGEGTWQEFVKTPSELAVSIPDSIDDFTA
SQMYINPITAWVTCNEVLKLKANDVLLVNAGGSSIGHIFAQLSKILGFRLIAVTRNDKYK
EDLLHLGASYVIDTSNVSLYETVMELTNGIGADAAIDSVGGSPGNDLAFCVRPNGNFLTI
GLLSGIQVNWADIVNKAKVNANMFHLRNWNKNVPVNKWQETFSHLIRLIDEQKLRLMMVD
SRYDLLNIKTAIDVVESSKETKGKVFLTSY
>PK3-045_04856 hypothetical protein
MVPQRVSLLTLGALRLPELRRFYQRIGWLEKESSSDQYAIFKTAGVLLTLFPLEELAKDA
GVELQNPMEGYRGVTFAINVNTPEDVDAVMEKVKEAGGKIIREASDAFWGGRTAYFADPE
NNLWEVAWNPDLYLMKEE
>PK3-045_04857 Sensor histidine kinase RcsC
MQYSAQSIEQKKNLSSSVSEPIYILMVDDLQENLMALEAVLNSPRYHLVFAKSGEEALKC
ILKYDFAVILLDVQMPGLNGFETAKLIKERKKSRHIPIIFITAISQDIHHITQGYQAGAI
DYIVKPFNPDALRSKVAQFVQIFESHTTSLHEMNWQTTSELEKMNKELRITKMDLTKNAV
FSSVLQKALQDTIVTFDEEGIIISVNPSVKRMFGYVEGELIGASIEVLLHSAESEISGET
PITFEMMVPKLIGRMIEAKAKRKNHTVFPVDIYIGDAMVEDYQLFVCTIRDISERKEVEL
LRKQQLDRLEHAVEERTLELLSMNHQLHREREEKSKVTDDLMLSEGRFRQIFEASPCMMA
IRTLQNPSFIAVNNNWVTSTGYTIEELKDDSYQWEIAKEINGIEESFQEEEWLTPFKNQR
VNFMLKNGEQKQGLLSTEIITIEKKNCVLIVLNDITERLAFEKEMARLDQLNLVGEMAAG
IAHEIRNPMTTVHGFLQIGKSNPSNLSLEHMELMIDELDRANKIIKEFLTLAKNKTSDKR
LYSLNRIIEIIFPLINAEALLTGKKVNLQLEECPELFLDEKEIRQLLLNLALNGLEAMEP
DGILTIKTFCKGKYLVLEIIDSGNGIDEEILKKLGTPFFTTKDNGTGLGLAVCYRIAERH
MARIKVHTSESGTKFSVCFEIEEGK
>PK3-045_04858 Sensor histidine kinase RcsC
MRFSTKLYVGLGIIFVFITILIIVLMSMLRQQNDKMHVLAHDKTERINAAYTLKNEVTNL
SRQIYELSSQSSKTLNEITMRQMEETRKEINKAYNFLTENDKRDETQDLLIKFSTLYQPF
EEKGQQIVEAKNKKMNTNFWARESDEKNRLLQIASSLYSAQIKEMQEELEDSKKTYDIVV
LMTYAYIIVGVICSITLAIYLIRGLTKNLHKVTTVMSGVSFKRGIKFPRLEINSKDEIGE
IARAFNEMVTTLEKYSRDEIESRAQAEEQSWLDSRLAEITTSFSMVETMESLADYFISQI
TPAVGAQYGVFYLLSEKGNARCLKEIANYAFDNEDRQSIIQLGEGLVGQAAKENKSISLI
DIPNGYIKIKSGSGEAEPKQVLIQPISYEGEVLAIVELASLQYFRPVQQSLLKEVGEYLG
ISIHGIFNRLEVKRLLEDEQRLTEELQSQSEELQAQQQELMAINEELQAQYRVSEEKNAE
LEKIGKKLEEKAQQLIYNSQYKSEFLANMSHELRTPLNSMLILSQMLVEKENENLTTKQI
QYLQTIYYSGNELLRLINEILDLEKIETGMMEIIEEPVKMEGIQNCLKSQFSPIANQKKL
DFCVKIDKEVPAFIETDTHRLNQVLKNLLSNAFKFTEKGSVELIIRMEETAKSRFAIADE
SIVSFTVKDTGIGIPKDKMNIIFEPFKQADGTISRKYGGTGLGLSICKEISRLLGGELVA
TSIEGMGSSFSLYLPVKRQKQKGAVEQSPIEESYRQIAVTNNELIDTTELNKSANLIGKK
VLIIDDDIRNIFSIHAALEEYNIEILYAENAKDGISLLEENVDIDLVLMDIMMPEMSGLE
AISIIRKKDKFKTLPIIALTAKAMKHNREQCMEAGASDYISKPVNLEQLYSLIQVWLYKE
>PK3-045_04859 Precorrin-2 dehydrogenase
MLSLLVDIKDKHCVVVGGGKIAYRKVLMLLDEEASVTVISPEVCTEIEELSEDRKIRLLR
RTGKEEDFAHAFLTITATNDSQENHRIAKQIKSFCLVNDASSFEEGNCQIPASFKKGRLH
LSVSTNGASPKLAKKLKEEWQQKYDDNYIAYIDFLYEVRTLIKQRSLSADVSNAILTEIL
DDAYKASASLRHNYYEKLLNL
>PK3-045_04860 Sirohydrochlorin ferrochelatase
MEAVLYICHGSRVKEASDQAISFIEKCMKINGFKGIQEYSFLELADPSIEEGFRKCVEKG
ASTINIIPVLLLTAAHAKKDIPEVLEKLSLKYPHVQMKYGKPIGVHPQMVKIVADKIRSA
SLYKESNETMLVMLVGRGSSDPDVKRDLGKIAALLEQQVEQIVVQDCYLTAAQPSFEEAL
QMADHSSYRHVLVIPYLLFTGILMKSMEKTINKIKSNHKEYELAPYLGYDPLIAGILKER
IDEMMVGNEYAFITS
>PK3-045_04861 Uroporphyrinogen-III C-methyltransferase
MGRVYLVGAGPGDPDLITVKGLKCIKNADVILYDRLVNRELLEYAKPKAELIYCGKLPHH
HAMKQELINQTLVKHAKKGKIVTRLKGGDPFVFGRGGEEAEELAKNQIPFEIVPGITAGI
AAPSYAGIPVTHRNYGSSFAFVTGHIKNGEEDHIKWEALSQIDTLAIYMGVKNLPYIQSK
LLSFGKKGTIPVALINWGTTFKQKTIITDLNHVIEDAEKGEIENPCMIVIGEVVKMREKI
KWFEESFGETIPKEVV
>PK3-045_04862 putative adenylyl-sulfate kinase
MSQSTNITWHDHAVTKKDRREKNKHHSYVLWFTGLSGSGKSTVANAVAKRLYEDQTNSYV
LDGDNIRFGINKDLGFSDEDRKENIRRIGEVSKLFVDSGQVVLTAFISPFREDRDRVRAL
LEENEFVEIYIKCSIEACEARDPKGLYEKARKGIIKDFTGISSPYEEPLQPELIVDTEKH
SIEECVEQIVQYLKEKEYYIS
>PK3-045_04863 Sulfate adenylyltransferase
MSLSQPHGGKLINLYDPNYDISELKVELEIDTIALSDLELIGNGAYSPLTGFLSQKDYEA
VVENMRLATGEVWSIPITLPISKEQSDTIELQDTVKLVHQSEVYGVLTVEDIYIPDKSKE
AVSVYRTDDLAHPGVKKMFDRGNIYIGGPIKLIKKVEKTDFSNFYLDPAETREIFAEKGW
KTVVGFQTRNPVHRAHEYIQKSALEIVDGLFLNPLVGETKADDIPADVRMESYQVLLKNY
YPKERVFLAVFPAAMRYAGPREAIFHAMVRKNYGCTHFIVGRDHAGVGSYYGTYDAQRIF
DQFTQEELGINLLFFEHSFYCKKCENMASTKTCPHGKEHHEILSGTKVRELLRNGEIPPS
TFSRKEVVEVLIKGLQKQEIHS
>PK3-045_04864 Sulfate permease CysP
MIIILAGIMSLFFAMNIGASGAAASLGVAYGSGAIPKKRVALLICAVAIFLGAVIGGSEV
VKTVGEGLIPSSILDAKIVLIILSSAALSLFIANIMGIPLSTSEITVGSVVGVGVAFKSL
YIANILWIVFFWLLVPIVSFFIALGAGKYVRKLENQNEWIRNPSNEKYLSIFVIIVGCFE
AFSAGMNNVANSIGPLVGADMISMQTGVVVGGFFIAIGAFLLGGRVLQTNGKKIVQFTKL
EGGLISGTGATLVTIASIFGIPVPLTQVTSSAIIGIGVSKNGYEILKKKLVLRIFKVWIV
SPVLSLVISYGLVQLFIEADIYNVLIILSVCIATLGIISLMKTIREDNSTIYEDGGGI
>PK3-045_04865 Phosphoadenosine phosphosulfate reductase
MSQLLTYETIDTYPPVDFSSETETKGALEVLKWAYDTYREDIVYACSFGIEGIVLIDLIS
KIKKDARIVFLDTDVHFDETYELIEKVKQRYPDLQIEMKKPAITLEEQAAQYGEELWLSN
PNKCCEIRKVVPLHEVLSEPIAWISGLRREQSETRKNTQYLNKDNKFKSIKVCPLIHWTW
KDVWRYAHKNSLDYNILHDKGYPSIGCRTCTQPAINMDDLRSGRWTGKGKTECGLHLQ
>PK3-045_04866 hypothetical protein
MGETNQLDKVKIQLEQILNTMKFGSVTLVVQDGKIIQIEKNEKIRLGK
>PK3-045_04868 Pantothenate transporter PanT
MKKKNKTTRLVLLGLLTAIIIIQTFVPILGYIPTPVLSITIIQITVIIAAIVLGPLEGAI
IGGVWGIITFIRAFTYPTSVLAPIIFTNPLISVFPRVMIGVVAGLLFYKVLRDKMNETVA
MSISGVIGSLINTILVLGFVYLFVREPYANAIGVNVEDLLPAILAIVGTNGVPEAILSGI
LTPIIAKPLLKIRKK
>PK3-045_04869 HTH-type transcriptional regulator CysL
MQYEALKTFVTLVEVKNFTKTAEMLLMSQPSVSLHIKNLEKEFQTKLLERSPKYLKVTPT
GQMLYDCAIQMIRLYDQTRQHILEHHHAIKGELKIGASFTIGEYILPALLLDLQREHSEL
QIQATIGNTEEIVQAVRLYEVDIGLIEGQTNDKELQVVPFMEDELFIVASVHHPLATQES
ISISELHDQTWITRELGSGTREYLDHVIRSNGLRAESFLTISSNQGIKETLINGNGLSLL
SKSVIERDVKNGNLSIIPITNARFTRRLSYLFAPIMKEKQNVITFIETLKKTFPYTE
>PK3-045_04870 Sulfite reductase [NADPH] flavoprotein alpha-component
MLQLQVINSPFNQEQTELLNRLLPTLTESQKIWLSGYLSASTAVTASAEPISNTELTEQK
AAEPITKDITILFGSQTGNAQSLAKNHGNRLKELGFNVTVQSMGDFKPNNLKKIQNLLVI
VSTHGEGDPPDTAIAFHEFLHGKRAPKLENFQYSVLALGDSSYEFFCETGKQFDKRLEEL
GGTRLYPRVDCDLDYDEPASEWFEGIVSSLSLQSESTAQSISITPPSLQDSGYSRSNPYY
AEVLEVINLNGRGSNKETLHVELSLEDSGISYEPGDSLGIFPHNDPVLVDLLIQELRFSP
TESVTINKQGEVLAFREALLTYFEITVLTKPLVEKFAKITTNPALEDLLAKGKEDKLKAY
INGRDLLDLIRDYGPIEADVQTFVSLLRKLPTRLYSIASSYKANPDEAHLTIGAVRYHAN
GRDRNGVCSVQIAERIQPGDKLPIYIQNNENFKLPDNPDTPIIMVGPGTGVAPFRSFLQE
REEIGAEGKAWLFFGNQHFVTDFLYQTEWQNWLKDGVLTKMSIAFSRDKAEKVYVQHRML
EHSKELFEWLEEGAVLYVCGDEKHMAHDVHQTLLTIIQKEGQMSLEKAEEYIASMTQTKR
YQRDVY
>PK3-045_04871 Sulfite reductase [NADPH] hemoprotein beta-component
MAKQILKAPDGPPSDVERIKEESNYLRGTLKESMEEELSAGISDDDNRLMKFHGSYLQDD
RDLRNERAKQKLEPAYQFMLRVRTPGGVATPAQWLTMDDLAQKYGNNTLKLTTRQAFQMH
GILKWNMKQTIQDIHQSLLDTIAACGDVNRNVMCNPNPYQSALHSEVYEWSKKLSDYLLP
RTQAYHELWLDKEKVAFTPTVEETEEEPMYGKLYLPRKFKIGIAVPPSNDIDVFSQDLGL
IAITEEEKLIGFNVAIGGGMGMTHGDKATYPQLAKVIGFCTPEQILDVAEKVITIQRDYG
NRSVRKNARFKYTVDRLGLDNVVEELENRLGWKLQEAREFHFNHNGDRYGWEKDIKGKWH
FTLFVEGGRIKDYENYPLMTGLREIAKVHTGDFRLTANQNLIIANVSSRNKKQIADLIEQ
YGIMDGKRFSALRRNSIACVSLPTCGLAMAEAERYLPVLIDKIEEIVDENGLRDEEITIR
MTGCPNGCARHALGEIAFIGKGPGKYNMYLGAAFNGSRLSKLYRENVGEEEILSELRVLL
PRYAKERTANEHFGDFVIRAGIVKEVTDGTNFHD
>PK3-045_04872 hypothetical protein
MSVNPASPAFQLFGDSTQSVNYKRDSYNYITQLFSEQMPAIHTGLFNVHLNQGFIVQPHW
HTNVNELVFVVSGEVMTSVFNPFTQSIMTYHVKPGQASQFPKGWFHWIVALRNNTHFLTI
FDQPQPDIVFGSDFLRFLPKEIANRAYCVNEAAYAHAIAPITQSTILGPPPGCDQIGGAV
NYPYHATQPTPTIHPYLNLSSPPHAY
>PK3-045_04873 General stress protein 39
MTKKQHYGSEVKCEEIEWTFPPQQQTRQPGFEYLMDPLPIFDNPKYIGTGKLKDRTAIIT
GGDSGIGRAVAVAFAKEGANIVISYFDEHTDAETTKRVVEQYGRSCLLIPGDLRRREHCE
FIVQKTLETFGKIDILVNNAAVQFLREDLTSIPDEQWELTFDVNIHAYFHLTKAALPHLK
EGASIVNTTSLVAYIGVSHLIDYTTTKGAIVSYTRALANNLVQKGIRVNAVAPGPFWTPI
QPASQSAENIATLGSDVPMKRAGQPYEIAPVYVLLASDDGSYMTGQTIHVNGGAMVTT
>PK3-045_04874 Beta-galactosidase GanA
MIDKTVADNRLLHGGDYNPDQWLDYPEILKDDLRLMKLAKANTFTLGVFAWSALEPTEGE
FQFDWLDERIEAIYQMGGRVILATPSGARPAWMSKKYPEVLRTTENRMKMLHGGRHNHCF
SSPIYREKVAIINRKLAERYGNHPALLMWHISNEYSGDCHCELCQDNFRNWLKKKYGTLD
KLNHAWWGPFWSHTITDWLEVESPSSIGESMVHGLNLDWKRFVTDQTIDFYKHEIVPLRE
ISPSIPITTNFMADTHDLIPFQSLNYSEFAKHVDIVSWDCYPAWHNDWEETKDLAAKVGF
INDLYRSLKQQPFLIMESTPSGVNWHDVNKTKRPGMHLLSSMQFIAHGSDSVLYFQWRKS
RGSSEKFHGAVVDHDNSETNRVFQEVSAVGGALEKIAEVKGTHKQARVAIVYDWENNWAL
NDAQGFSDSTKQYPQTLQKHYQSFWKKDISVDIVTLNQELASYDLVIAPMLYMMSLDTIS
KLENYVANGGTLVSSYISGLVNETDLAHLSGWPATLKRIFGIDVKETDTLYPKDRNTLIY
NGKQYEIKDYCTIFERKEANILATYMEDFYQGNPAVVENCYGKGKAYFIGARTEQAFLDD
FYEELQKEGNLDSEREILHKEGVSVQRRDSAECYYLFVMNFTEQKQTVTLKESFFDLLTQ
EIKQEQIELLPYEVRVLKREK
>PK3-045_04875 Maltose/maltodextrin transport system permease protein MalG
MAKKTVSIKKQRTIRMTLTYLLLLIVCTLIIYPLVWTIGASFNPGNSLVSTSIIPDNPTV
GHYKDLFQQEGTLYYGKWYMNSMKISILTMVFSILCVSYTAYAFSRFRFKGRKNGLMLFL
LLQMIPQFSALIAIFVLAQMLGLINSHWLLIFIYVGGQIPMNTYLMKGYIDSIPLDLDES
AKIDGASNTRIFWRILMPLSRPMLAVVAMNGFTAPLGDFAISSVILRNPEYYTLPIGLYK
LVSDKIGASYTTFAAGAILISIPVAIVFVALQKHFVSGLTAGGTKG
>PK3-045_04876 hypothetical protein
MSFQAKAVDTDTKTAKRAALLSIIPGLGQFYNKQWGKGAFFLIFSIAFIVVFKDLFNMGL
WGIVTLGEQVPRDNSIFLLAEGIIAVIVIFFGLAFYYLNIKDAYAIGKRREEGFAIPSIK
EQYQVLLAEGYPYIITSPAFLLLIFSVIFPILFCFALAFTNYDLYHSAPANLVDWVGLET
FKKIFTVDIWRATFFDVLGWTLIWTLIASTLQVAIGIFLAVVVHQKELRFKKFFRTILVL
PWAVPGFVTILVFAGMFNDSFGAINTSILAFLGIDSIPWLTSPNWTRLALLLIQGWLGFP
YIFIVTTGVLQSISDDLYEAATIDGASPLQKFKNITLPLILYSMAPIIITQYTFNFNNFN
IIYLFNAGGPAVPGSTAGGTDILVSWIYKLTMQNSQYALAAALTILLSIFVISIALWQFR
RTNSFKEVK
>PK3-045_04877 Cyclodextrin-binding protein
MKKRLTAILLSSSLALALAGCGPSDEASSNTSSKKNNNGYDLLVWEDQSKSEGIADAIKK
FEEENKVKIKVEEKAYADQLEDLRLDGPAGTGADVITIPADQIGTAVTEGILKEITVNDT
QKAMYTEAAMESQMVDGKVYGLPKAVETTILYYNKDLVSEDQLPKTTEEWYEFSKGVTKD
GNYGLLALWDQIYYANGVLSGYGGYVFGQDSSGAYNPEDIGLANEGAIEGAEYISKFYKD
GLFPSGIIGEQGINVLDSLFTEGKAAAVISGPWNLEPYAKAGVNYGVAELPMLANGEHMG
SFIGVKSYNVSTYSKNAELAEKLVEFLANEENSKTRYEITKEVPAVKALAEDPAVKESEN
AKAVANQSQYSQLTPGITAMDAVWQPIDSALQTIATGKAKPKEALSTAVETIKGSIAANS
GN
>PK3-045_04878 HTH-type transcriptional regulator LacR
MVTIKDIAKKAGFSPSTVSRLLNNDSTLSISPETKKRILDTAFELGYERKSIQPLIEKVA
LLYWITDKEELEDVYFKQMRLELEKNAINHNIELHLYKHEDGINSIPHDISGFIAVGAFS
MDEIQKLRKKTKKGVFIDANPVPDLYDAVLPDTVRITKKAIDYFIENGHQKIGFIGGTYH
NPDTNEDEMDIREITFRAHMQNIGLLDERYIFGERHFSVNDGYTVTKKAIDCLKEELPTA
FFIASDPIAVGSLQAFNEYNISIPNRVSIISVNNISVAKYVSPPLTTFHIDIPELCKTGV
SLLLEQILDQRKIPKTVLLQSELIKRKST
>PK3-045_04879 hypothetical protein
MERKILRILLILGIGLLPIIFRKKQAKDWFLVFFLKGYMSSFIDGIVTSKKRLSFPVRLL
PKHFKINVLFDYLLFPITCVVYNQISYHSKLPGIILKALCFSIPMTIVEFLFEKYTKLIS
YKKGWNWYDTLLTETCTFLISRMCIGIIRKLDKEDKKQSIH
>PK3-045_04880 Putative HAD-hydrolase YfnB
MQGLLNNKEETTSKNAGSVKCYQTLLFDVDDTLLDFTAAEDHAFRLLLQEQGVSYRDEWK
QQYQELNKGLWKAFEEGKITRDEVVNTRFTLFFDTLGIKVDGVLLQQSYRDYLGEGNQLL
DGAFDLIQRISNRFDLYIVTNGISKIQEKRLKSSGLYPFFKAVFVSEETGYQKPMKEFFD
YCFERIPQINKETTLIIGDSLSADIQGGCNAGIDTCWFNPLKKKKELEVQPTYEIAKLEE
LLVLLDQEKQSNP
>PK3-045_04881 hypothetical protein
MIYGLLIAFISGSLVGVQNIFNNRVNQKAGLWATTTLVLALGFIASFTLGIISEGTGLFH
LENMHTWYWFSGIIGVGVVVCMTKGIKHLGATYAVSISLSSQLVFALLFDSFGLLGLDQV
PFTFKQLIGVLVIIGGILVFKMGGASEKKQPVKELLK
>PK3-045_04882 Regulatory protein YeiL
MKEMGNLEQIEKYIRKFQLEAIFPKKLKDHLHLYAFNQGEFICTQGQAAEYLYILVDGKV
KIYTTTAEGKTLILSFKTPIEMVGDVEYVRNTDILNTVEAITDGVVIGVHKRYLKQYAND
YAPFLQFLLDIITKKFYIKSSSMRFNLFYPVEVRLASYLVSVSFDKEDPLYNTDGKEINL
KDTANLIGTSYRHLNRVIQQFCQDGLIERKKGFIIVKNRDGLLNLAGKSIYEEGAGE
>PK3-045_04883 hypothetical protein
MRGILFALMGGAFITLQGVANAKISQDIGSWQAATITQFTGFVLAFLILLIVKEEAFSKY
KQVKPLYLAGGSFASVVIFSTITAMHLVGATLTISTALIAQLFITFLIDSNGWFGLEKQQ
MRAPQFIGIGMMIIGVLLLKM
>PK3-045_04884 FMN-dependent NADH-azoreductase 4
MNVLVVKANNRPAAEAVSSKMYETFMESVKGAENLNVNVYDVYAEDTPYFGQELFDAFGK
VQSGEELTDIEQRLLAAKQKAMDALTAADVVVFAFPLWNLTIPAKLQTFIDYVYAAGFAF
KFDAEGNMIQLMTDKKAILLNARGGVYSTPEAASSEMAVNYMRAVFGGVFGMEIIDEVII
EGHNAMPDKAASIIEEGLQKVAAAGKKLAAQTV
>PK3-045_04885 putative N-acetyltransferase YsnE
MKRMMRMHIIIDPVTSKEIIALLEDHLHSMTLHSPPESIHALDVEGLRKPDVTFWSAWED
GELTGCGALKELDNKHGEIKSMKTSPHHLRKGVARKLLLHIIAEAKNRGYSRLSLETGSM
DAFLPAKKLYESLGFEYCGPFSDYTEDPNSVFMTLALEK
>PK3-045_04886 hypothetical protein
MSPINLLEQYIDATNTHDFENVERLLHPQAIYWFSDQTCRSKEEIKNYFENAWNTIKEEK
YSAADIQWLGMGNDTATCVYHYHYEGYYKGEFIKGSGRATNVFVKDTDGNWKIIHEHLSS
F
>PK3-045_04887 Polyisoprenyl-teichoic acid--peptidoglycan teichoic acid transferase TagU
MKKHKKITISILSIIFISICSFVFYLYKTIDNTVDKVYEPIDGETKTESKLRSENVKDKK
PISILLMGVDERKNDVGRTDALIVMTLNPVKEKLQMISIPRDTRAEIVGNGAITRINSAY
ALGGVKMVLDTVEGFTGQKLDYYIKINMEALSGMVDALGGITVDNEIEWLDEGYYKKGYH
YQLGNIDLDGEQALGYARMRKLDPRGDFGRNERQRKVIAAIIDKGTSISSVTKFKDILET
LGENVKTNIPLNEMISIEKGYKNTRNRMEQYEVKGEDAYIDGKYFFVVNEEERNHIKEML
ANNLLD
>PK3-045_04888 hypothetical protein
MKVKLILLVLFFVGVSVWAYRVYNVNKGVALKYDLETYQMGDWIADEKLTFMITELSYGE
IEGDGDYSFVPATVKMEVKNISDENISVSKLIESKLSYGMDYYQTMDGEFDVKQVKELPP
NKTIPITLLYSVAPEYKDKEAKFYIDQNLYIEKVKEQFKQGKRYGIVVDL
>PK3-045_04889 Bacitracin transport ATP-binding protein BcrA
MSEVAYITANHVSKEIKNQPILKDINLRLHKGAIYGFRGKNGSGKTMLFRALCGLIIPTE
GEVIVDGLKLGKNVSFPPSVGVLIEYPGFLAGYTGFKNLKMLASLTNTITDDRIKEAIRQ
VGLDPEDKRKYRKYSLGMKQRLGLAQAIMEKPDLIILDEPTNALDAEGIEEFKKLLLELK
KENKCILIASHDKEDLEYLSDEIFLLENGKIIDHYERKGEK
>PK3-045_04890 hypothetical protein
MKIIYRLFLRDWKFSLSYGKWKYGAWFLFWAFLALMMSIRFSEQGVNSIDIIYMLLKDEG
YFQFLSEYEVPIYWVFTQFFILFFIGDFLSEDFQKNRIYLLLRSQSKSSYILAKIGCLII
QNIGFVIGLFLSIYLVSSFTLRTFSLETSQYFQDFVVPLMDIPVSAGEVVIRIIVGYLIT
SLALSALLFLTMQLLSPALAFFGIIILSGVSTFLDSKWLPGIHSMILKQSIFASDYQLSM
TFSFFYSFLVFLVSSIITYLVFNKKNNL
>PK3-045_04891 hypothetical protein
MKHSNFLFIVKKSFVQHKKTLLYVAVSTIILLWSLLILARKGDWSSRGIFDVMVDIGGIN
GSTNHYMLIVVGIPVLVILLTQIIEDIEKPISLLTYQSRFSIWHTQVVVVVVLSFVLTIF
IIAVSLLLGGVLVGWDNTWLYSSGTIGEYLNNEEQFAAISTNIVTYKIIRTIFLTKFFGF
LMISFSFLFLKQLLKNSAFVLIVMYSITGLDHLGILPFFIYTMNATVSLMDWLEPMKTIH
HMIYLMVVSMVLYVLTGWLYERKDFY
>PK3-045_04892 hypothetical protein
MLRMEINRVTRRPVFWILILIGLIFALLPVIQKWPHGMTIDDYVFYPGSPYVFWMYFTGE
TYYIYTLTFPLLATLVYADAYAEDFNTGLIKSILTKVEKRKYLNTRYFVNFLIGGGVAVF
PLIINFLGVMTAFPLIENNYYFGMPLVIQESYLTHLYYQSPLIYVLLRIFWIFTFGGMLA
SLGLAFSTLIKNRYIVLIFPFLIVLALDVLLSTFGWAGITLLFLGNIKSTWQLPSITVIG
LIGSYLWFRLLGGKNETF
>PK3-045_04893 hypothetical protein
MVQRIRVKISLEFFNKRMYYMVLFYLAIVTIASIASAQRDGGNSLFDYIVGLRFGGTAST
FVLLIGVFPLIAIILPMLVDQMEQEMFILRIQDKKQLLKNYIVFSVVISIFITIWIVASG
VISSFVINGHINNLWQKREGTVYFLLEKKEFFEMYIPYFVSWKVWLYIIASRFLGILFMA
LFILLLKMIIKKNMFIFFLALFLFGVDGFLPKDFSFFLGRIQITLDTWLSVEEQLFNVIY
FLLGITICLYICFKRYEKKEFY
>PK3-045_04894 hypothetical protein
MIKKKFFPVIIITVMALVLIGIKLYPSLKNKWDEEKLVQDDKETASITNKETSIKGNDLH
RNPYKEETFPFVLKEQEELAKKYPDHFQIVEKIYYSWDNVESIYGKFRFKMSEVDNIQDV
EFYADYNRNWSYTHTKESQNGKVVADEIRLYKEGVSTAQKPKEKVYTVWEDKEEGDSVQD
AIKRILDSEDWMFIYDNYSNWKIKEGEKFNLPAYFVEGNIPKSTSELFNGPFSMVIAKDT
GVILDTKIYGKGKEAERSTTVEEIHINEGVPEGAFNIDLNGYQEVSVEDYFKDIVDSFEK
KSGGIDGTKDKSKD
>PK3-045_04895 hypothetical protein
MLKGPFTMIVSKETGIILDAKLYGKSKEPMVNIEVEKIHLNEGNPEDVFQLDLTNNKEIS
AEEYLGEIINHK
>PK3-045_04896 hypothetical protein
MPKKWIAGILLTLLMLGLITIKVYPIAKSNWWNEEEKLEVKEQDLSIKEKNTGTNRFNVS
HRSPYVDEAFPFRTLEEEEYAKQNPEKFHIVNSIYYAWDKVDTVNGEYNYKISELDDTQH
IKFYADYEKFISYTEEETQTESGLFRENRLEDRFGSTKLIRQKLDEKVYNILNNSDSFGM
KLIWIIGSELWMNIYNNYDDW
>PK3-045_04897 hypothetical protein
MDEKLKNLDEKMNGTILKEINFSEEQKQKVLKQINYSTKRTNGIIFVRKYFPIAVSVVLI
VIFFTGIIPFIGSQSKISEGNVREEGSIYNELNNQIGDVASNEDEMQYNRSLAERYPDKF
AIVQKMFRSYPNIHSAYGVFEYRYNDLDEPSTESFYLDINKGLYKSTLKYWDKDGYTLSK
SLWKDGVFTIKRTNAEDYVKPLDNQEFKGMGLPGVIFNNEWYVLLLDNYENWSYKETKKF
NRAVYEIKGNYPFDSEYDTVGGPFSVTIDKETGTVFNLAYYDHRDLDRPARVMVNVKNIS
INEGVPENLFSID
>PK3-045_04898 RNA polymerase sigma-H factor
MLEKKHNMHQREQMSSTDPLEKEERLIWLMDEYGKSVVRLAYTYVRHKQTAEDIAQDVFI
KCYENIDNFRNEASYKTWVYRITVNRCKDVLKSWSYKNILFADFLSFKRDTKEQSVEKQI
LLNEENRFISEQVISLSVPLREVIILYYYEGLSQHEIAELLELNENTVKSRMHRARQKLK
KLLDGGDGNG
>PK3-045_04899 L-amino acid N-acyltransferase MnaT
MSVKVEKISEKYWEAIAAIYRLGIQSRQATFETDVPTWEKWSNNKDLTASLVLLDKETHR
VIGWAAISKVSNRCVYQGVGEHSVYIHPAYHRKGYGKLLLEKLIEHSEQSGYWTLQSGIF
PENKASIYLHKSCGFREVGIREKIGKLDGEWRDIVLVERRSRKF
>PK3-045_04900 hypothetical protein
MNILKKIMKKEQKNDCCTIMIEEVGKKKDGCCVVKEEKEDERKG
>PK3-045_04901 hypothetical protein
MWYEVLKNFAWLVIELTVLFVVVSFIVNLLQGFIRYNKVEMWMKEAPPIVSALIAVVFAF
ITPFCSCSTIPVVVNLLKNKIRFSTVMIFLFTSPVLDPTILTVMAVLMGWKVALTYTAIT
TILSVILGFVLEKWGFEKEVKNVIIKNASQAEKGFSLKNTVSEILTLMKTVYPFLLIGAG
IGAVIGGIVPTEFVATYLGGEKWWLIPIAAIIGIPLYIRLSSMIPISQILIAKGMALGPV
MAMMISSAGASLPELSLLNSIFKRKLVFAFILSVISMSTISGFLFYFI
>PK3-045_04902 hypothetical protein
MENIREILQITMRRFGVLDKNCCSVGKTEISLVQSHILYEIDKRSNPSMQEIAELIGMDI
TTFSRQIQSLVKMELVNKQQSMNDKRVYVLQLTMQGKAIATSIDTQMNQYLEEVLSFMSD
FERETVIRSLKLLNSSMAKSNMCCHPVK
>PK3-045_04903 hypothetical protein
MPISLEFYEEKYKRQLEEYLLSDEQLYYTSTPLDALEKCLTEEDRHPIVILNDGMVAGFF
VLHGWEGVKSYSDNKEAILMRAYSIQHSFQGQGIGGKSMEQLVPFVKKHFPAKKEVILAV
NVKNTRAQYVYQKAGFAETGRRVMGPKGEQIILSRKV
>PK3-045_04904 hypothetical protein
MNITAITETNREKVKLFFQSHWGSPEMVLSTGIYDCSALDGFIAWNKEGEMIGLITYILR
DTECEIISLDSIEEGRGVGTKLLQTVERTAKQAPCDQVKIITTNDNLLALKFYQKRGYCL
AELLKDAVKEARKIKPEIPFFGNDGIPIRDEVVLVKNLSTTK
>PK3-045_04905 hypothetical protein
MKLRFITARANMLEEVNDIYIKCRENLIKHDIFQWDDHYPNRGYFQDCMENKMLFVLLEE
DKIVGHVVLNEWQTEEWQSIPWNGNNPLIIHSLMLNPRYQGKGIGAIMVQHMEEYALAKG
YDSIRLDVFSGNPQALKLYKKHGYIEKGEVFFASKPIGHQKYLCMEKELR
>PK3-045_04906 Cyclopropane-fatty-acyl-phospholipid synthase
MFEKSIYKTILSNSFTIPVKVTYWDGKSAVYGNGDPAIELIFRKPIRIKDIHNNASLALG
EAYMDGKIEIKGSIEDLIASAYENASSFMQNNKFRKFVPKQSHTKARSKEDIQNHYDIGN
DFYKLWLDRSMTYSCAYFKNPEDTLETAQQNKVDHILKKLNLSPGQHLLDIGCGWGNLIF
TAVKDYQVKATGITLSQEQYDYVTQLAKEKGLSENITVYLMDYRDLKDRNFDRITSVGMF
EHVGKENLQAYFHQVHQLLKDDGAALIHGISRQQGGATNAWINKYIFPGGYIPGVAELVS
HMTAENLQLVDLESLRRHYQKTLEIWHANFIANLEEIRKTKDERFIRMWDLYLQACAASF
KASNIDVIQYLLVKKSSNSLPMTRG
>PK3-045_04907 Thioredoxin reductase
MEMNILDCIVIGGGPAGMSAALTLGRARRSVAIFDDGTNRNRVSHESHGFLTRDGISPQM
FKELGMNDLMNYPSIFPYKDTVTEIEKLRGAEVFLVKTKKHKEYLAEKIILATGVQEIIP
IPNARQYYGKSLFSCPYCDGWELRDQALLIIAYTEAQALHMGRLVYNWSKDLVIATNGAA
ISPTTKEIFLKRNVPIVTEPIKSLIGENGYLQQVVFTSGRQIARTGGFVSPSYYRSNQFV
EQLRLDVYENGVLVTDGSGRTSQKNVYVAGETEKEGASSLLFAAADGSKVAIAVNTDLML
ERF
>PK3-045_04908 ECF RNA polymerase sigma factor SigW
MEKQERDKLLTNAMDTYGHYLSRLAYALVKDREKAEDIVQDVFIRYYLQLDQFEGRSSVK
TYLYRITVNECRNYFKSWAFREVEVSKIKNTFLIHKETPEEAYLKQESKNYLADLLNKLP
IKYKEVLWLYYYAELSTQEIIEILNCSSNTVKTRLARGRKKAQLTMSEEEINRAKEH
>PK3-045_04909 hypothetical protein
MPKNIKQLFDEIIPADITLSEENKQRILRNANQQMQNISQRKRIFRPICSVVGIISLLLI
LISPSLVNRLSTHSSFHTPMEKVTIPNVDYSSLIHSFYIKETNELIYADKKSIYSYSLTS
HSQQVLVESGANIDIYVLTANAHWLVWGEKNNKLFIKNRKTLSQKEYKKDIIGDVQLKGN
TLIYDDTSGYKQLNLSTFKETSIHGFTGIARNSKADLDRNLLVIPEQFKSNNRNKTEFFV
YNLTNLKQVGNYSVPYKAAENVTLINNKIYAAFSNEDESPSILGYIDLTNGVFHEIPTPP
FTTYAVYKNYVALSVVEKNTDTVKLYQLETENLKELPIFNNIKERLVMPRFTDDGSLIVN
GEAADFSMYLQDIE
>PK3-045_04910 GTPase HflX
MEGKQKAIVVGVHYDQKEDFANSMEELIQLAEACDIEVVGEITQKLDRVHSAHYIGKGKL
QELTALLAEKDVQAVLFNDELSPSQVRNLEEATDCRIIDRTVLILDIFAQRAKTKEAMLQ
VEIAKLQYMLPRLAGLGESLGRQGGGSGLINRGSGETKLELDRRRIEDRISRLHKELDTL
VVQRKNQRKMRKKKELPSIALVGYTNAGKSTLMNVLLEKYHAATEKMVFEKNMLFATLET
SVRNITLPNNKSFLLTDTVGFISKLPHQLVKAFRSTLEEVAEADLLIHVVDYSNPNYQEQ
INVTNKTLKELNAENIPAIYAFNKIDLAAGETSMAGTDGVYLSAKKQIGINELVEAISKN
VFKQYISCEMTIPYDKGNVLSYLTEKANILSTEYKEEGIFLSIECKEEDYNRYREYVI
>PK3-045_04911 DNA-3-methyladenine glycosylase 1
METRCAWANSSDLMREYHDKEWCIPSHNDRYLFEMLVLEGAQAGLSWSIILKKREAYKKA
FHDFDLEYCANLTETELENIRINTEVVKHPLKIKSVKSNALAMIEIQKEYGSFAEFLWSY
VDGKPIISNWQYDNEIPAQTDLSKKVSKDLKKRGFKFVGPITIYSYLQAVGIVNDHITSC
AFHKE
>PK3-045_04912 hypothetical protein
MKISRLFQIIYILLERKMITANELADKLEVSVRTIYRDIEVLTESGIPIYTMQGKGGGIT
LMDQFVLNKSLLLDKVQDEILFSLQSLSATNYPDTSDILAKLSHLFQKSETKWIEVDFSS
WGSDTKRKEYFSLFRQAILERHVLSFHYINSNGEKSLRRILAEKLLFKDKAWYLEGFCLE
KSANRTFKINRMSNIALTNEIYDNIKKTEELLLNDSLDGDYLEWADLVLKISSRASYRIY
DEFEEKDISKEKDGYHIISTSHIKGEWLYSYLLSYGNYLEVIEPTDIRKEIKRRIQQMMN
QY
>PK3-045_04913 Branched-chain amino acid transport system 2 carrier protein
MQSRISFSTYALIGTMLFGMFFGAGNLIFPIQLGQLAGTNFWLALAGFLVTAIGLPFLGI
LAIGLSGSNGLSELSSRVHPVFGFLFSLFLYLTIGPFFAIPRTATVPFAIGIEPFVANSH
IALFLAIFSFLFFLLVYYFSLNPAKIMDVIGKYLTPAFLLFLFLLIIVSIVRPMGSFQEP
QGAYLNNAFMTGFKEGYNTMDALASLAFGIVVINAIKGKGIMDVKSIAKTTWKSGIFAML
LMMLIYGFITYMGSSSVQAVGTFENGGLIFAAVAKHYFGPFGGILLAVIIVLACLKTSIG
LITSCSEFFHEVFPKIGYKTFVLSLCVVSFLVANLGLNKIILFAVPVLMFLYPLAIVLII
LALFSRLFKGKQSVYLTAMVLTFFVSILDGYQALVKSIPEAKLGFFEEIGHFYENILPFY
EIGLGWILPALIGTVIGYFIRK
>PK3-045_04914 hypothetical protein
MLFRKFTANDFELYYQLVSNERVMAQITERAIPLEEAKIDFEKLLIRNDKNQLFGSYAFF
QPDSEVFIGLGHVTLTEQELAEAELGYMLLPEHWGKGYGGMVADRLMSLVKQTDLKVIKA
IIDPDNIASRKILVSRGFTSAWIGEIEGLPGEILKKVL
>PK3-045_04915 Sulfur carrier protein DsrE2
MEQKLNVLMFSGDYDKAMAGLILANSAREIDVEVTMFFTFWGLLLLRDPEKIDLEGKSFY
EKMFNTFQPKDVEQLPLSKMNYAGLGKIMMKEMLEEEEAPPLIAFLKGARKKHVKFLACK
LSVDILGFKQEEFYPEVEIVDAKVYLKDALKSDIQLFI
>PK3-045_04916 Aminoglycoside 6-adenylyltransferase
MRTEKQMLDLVLKVANQDNRVRAVCMNGSRTNPTVPKDVFQDFDIVYLVDNMESFLNEPN
WIDVFGERIIMQTPEDSTLFPAELGGRFSYLMLFTDGNRIDLTLVPLEEKNKYCQEDGLT
VILLDKDNSLPYMPPSTDKDYWVKKPAAEQFSDCCNEFWWVSTYVVKGLWRQEILYAIDH
MNTIRAMLLKMLEWKVGLETDFSLSIGKNSKYLKWYIDDDTWERLMHTYPSGDYNRVWES
LFSMTALFEKIGLEVGRKMGFLYPLEEAERVKAYLNHVRQLNPNATEVY
>PK3-045_04917 hypothetical protein
MKTWVLQKLYWIIPGVLILLGLFLLFVENFSNVTAQPEPDWSRGLLVGQSEVSKLPAIKE
TEDGHYLFSFFQENKLKTAIMTNDFRIEAEKYYDIPADKWTQIYQGKDELIYFDYKNIFD
QDKTQLVADVAEFFPLEKTILYIKENKLFQLNPETKQTSEIMDIDLEKEKLAVEENADGV
HLLLFTKEKGNVDLALSRVQDGKVNHLYETKIKVDPGKIVNGISFTFEDQKLALLLQEEL
ELTQGKPEFFNYYAEIDITKGQEAAQYELTFQDPARENGKLTEISDVAFTFRDGKPRLLF
KANGYTETKYNEKTGFNIYESEIGENGSTKTERRSNTAAISTIPQWLNEDMIAWMDLHGD
DNKVYVSSNELTKINKQIKHSSEDWLQALGKTFGMISTSFFAFALSFIWLLWPITFVIFM
YLFFSRKVDYNPPWIFYTGIGIYLIAAVIWKDRFFVPNILATAPKYLTFTGSTYFYLLLF
AVISYFLSILTKRINEWTGTPRIIYFVGVHIILLTVYFGPYIIY
>PK3-045_04918 Regulatory protein MsrR
MENNMRVKRKKGIRWKRVFGFAILIFALAVFYSVYQYNKGLKQATQTKGNNKIESSFEDF
EGPEPQYGEINIMLLGSDSRGEEHARTDTLMIVHYNQNTHKMKIASIMRDIYVNIPEIGY
QKMNAAFAYGGPELVRKTLKENFGIDVNYYAIADFEGFSKIVDIVAPKGIEVDIPYEMSY
GIGMTLHPGKQVLHGDQLLGYVRFRHDRLSDFGRVERQQEAIEKLKEQAVSMHSVVNLPK
ILGTVTPYIQTNLDTPTILSITKGLVVNKSDDLDRIRIPVQNSYENDTVNVGAVLKIDMD
ENARVLNEFLDDGLVEGKAGN
>PK3-045_04919 hypothetical protein
MSDTNEIGLLLKNLLKKNAISMRKLSVLTNIDTATISRIINGKRRPTPEHIQKFAKFFDY
PVDKMFTAAGYLPSEASSQSEDIFDSIESIQSELFSSNHYKETFSIKEVQEQLQKYNHYA
LTDEGKGLVADKFAEKVQKVEGVGPFIQQLKEYYQRFSNKKGNITELAVMGAALIYFIIS
VDVIPDYIFPIGYLDDAVAIKISAKLLPAKG
>PK3-045_04920 hypothetical protein
MLTFILLLFICIFAGLLGSILGIGGGIILTPVLTLGFGFDIHHAIGASIISVIATSSGSA
VAYLRDRMLNIRVAMFLEIATTAGAIIGAILVGILSPTLMFILFGSFLLYSAINMVQKLR
SGEKVLKKAQPDYLSDRLKLNNTYYDKSLKTQIDYQVEKVPAGFSVMFGAGLASGLLGIG
SGAFKVMALDTFMKMPLKPSSATSNLMMGVTAAASATVLFFNGSILPEVAAPVAIGVLIG
STIGAKVMQILPAKWIRIIFIPLLCYIGVQMIFEGFGVKF
>PK3-045_04921 hypothetical protein
MEAQKKEQTSEEELVIIEETIGKILRFGVLVSALIILVGIITYLITNNSGYKETFPTNFK
DIFIGVAAFKPFAIIMLGLFCLILTPVLRVGISCYAFYKEKDWLYVGITAIVLIILFISF
LIGYTS
>PK3-045_04922 Ktr system potassium uptake protein B
MRFPKKKDIIALNPPQILIFVFLAFTLLGTMLLKMPLATTGTITWTDALFTSTSAMTVTG
LAVIDTGGSFTLFGEIVILCLIQVGGLGIMTFAVLIFMTLGRKIGFKERLLIQQALGQTS
IGGIIKLAKQLFLFSITLETIAAVLLAIRWVPEMGWQKGVYAAIFHSISSFNNAGFSIWP
DNLSRYVADPVVNIVISLLFIIGGIGFTVIFDLWKKSEFKKLTLHTKIMVVGTIVINVVA
VLLVFGFEYDNPQTLGDLSWSGKIQAAYFQGVVPRTAGFNTVDIGGLNESTLFFMILLMF
IGAGSGSTGGGIKLTTFLAMVFSVLSFLRNKEDIVIFNRSIDDRTVVKSLAITIISLFVI
FVAIFILDITEKDARFLAIVFEVVSAFGTSGLSMGLTSTLTMAGKFVIVLVMFVGKIGPL
TLAFSLAKPNKSKIRFPKEDILTG
>PK3-045_04924 hypothetical protein
MKELHYDFHFNLNEWSILISIFLGFLLVILLPRRFTKKTMSIYLMCGVFFGFIFDHTLSI
LPVRYYIINDSSSFEIMDFFSHVMYAPISYLFFYLYDLFNIKPHFTLLYILGWALVSIAI
ERVCGMIGIFHYQHGYTIYYSFVIYLLVISIWVIFYRLIKEHGEKQY
>PK3-045_04925 hypothetical protein
MSIAIMSLLACIVLIVFAIVPKGLMLTEIVFLYFIIAILTITIFTILDVNLHWVPLTRTV
EGSFAMYICRFIVIPFQILLSICILCSSWKIKWRLLFSGIIVLFLCLEDRIYIWADLLAF
ENWNQLYSALLYVISIVLVWWIARWFIGLDKGELEEK
>PK3-045_04926 putative siderophore transport system ATP-binding protein YusV
MDKIHEFRAEMLTAGYEGKTILQDIELEIPSNKISVIIGANGCGKSTLLKTLSNLIKSSS
GSIALDGKAISKFPPKQLARILGILPQSPIVPEGITVADLVGRGRFPHQKFFSGWSKKDY
EAVAEAMEIMKITEFANRNIDELSGGQRQRVWIAMALAQQTDILFLDEPTTFLDITYQVE
ILDLLTDLNRKYGTTIVMVLHDINLSARYADYIFALEKGKLVGEGKPADIITSKLVKDIF
GLNCTVINDPVSGTPLVVPKGRYHVNA
>PK3-045_04927 Ferric enterobactin transport system permease protein FepG
MNESMNLIMVGRTRRRRRFIIVTCLLAIIAFALCCMMLMLGNTIYPVGDVISVLLGEQVK
GASFAVGTIRFPRMVAGVFAGFAFGISGHVFQTMLRNPLANPNVIGITAGSSAAAVFCII
VLHASSTFVSIASIIGGLATVLVIFLLSKGTSFSIGRLILIGIGIQAMLNAVISYLLLIG
QHHDVPTAMRWLSGSLNGVKMENIYPLMITVLLLAPIIILLGKRLDMLELGEQTAASLGI
NTDRTRVVLVISSVLIIALATATTGPIAFVAFLSGPIAKRLVGIGFSSVIPAGLVGIILV
LASDLIGQFAFVARYPVGVITGILGAPYLIMLLIRMNRKEEL
>PK3-045_04928 putative siderophore transport system permease protein YfiZ
MEQTSVLKNKQLLIPRKFISVLVISIILVGISILASLAFGSRTVGWNEILDGLFHPEVQS
HGANVVRQRIARTVFSLLCGAALGVSGALMQSVTRNPIADPSILGVNTGAALFVVCGISF
FHIGTAGQYIWFALVGAILTAIFVFGIGSMGSGGATPLKLVLAGAATSAALSSLVMAIMI
PRSNVMDQFRFWQVGSVGAGNWDSISIFIPFLLIGILIALFSAPGLNALALGDEAAKGLG
VRTGTLRLVAAFGGVLLCGAATALAGPIGFIGLLATHVIRLIIGPDLRYIIPMSALAGAI
ILTISDVCGRIIGSPGELEVGVVTAFIGAPILILITMKAKMRTL
>PK3-045_04929 hypothetical protein
MFKKRRKPFIPIFLFSIVAILLLAGCSSQSSSKADKEKSADSNTDSSYPITIKHALGETV
IKEKPERVATIAWSNQDVALALGVVPVGFSAANYGVQDDSGMLPWTAKKLEELGEKNPNI
YQDTDGIDFEAISDSNPDVILAAYSGLTQEEYDTLSEIAPVVAYQKNPWVASWREQVTYN
SMGMGMEEEGKQLIADTEKFIADKASEFPELKGKKAAFVSVNGADLSKFYIYSPTDPRGE
FLTELGMEYPESITSQIKDPTSFYLEVSAENADILNDVDIFVSYGNDKTLAALQKDPIYG
KIPAVQRGSVVIIEDNTPLAAAGTPSTLSIEYTLDEYLKLLSEAVSKVK
>PK3-045_04930 putative protein YflH
MNNYNADPNKAEETVKEMNRKTIQEKLENFDEFKSYLSSKIEVGKNLGMDEEQLAKSAEK
VAGYLASNAEPQNREEALLQELWKVGNEEERHKLAHMLVKLAN
>PK3-045_04931 putative transporter YycB
MTNQHIQSNRAVHKLAVWMIVIGIIFIAANLRAPLTSVGPIVGFIRDDLHISNTLAGMIT
TLPLLSFAFFSQLVPKLARKFGVEMMILMSIIFLTLGIILRSLSGVAALYIGTAVLGLAI
SISNVLLPSLIKQEFPTRIGLMTGVYSISMNLLAAIASGISVPIAIGLGIGWKGGLGIWG
ILSFLSILFWLPQVKHLNKETPAVRNKVVDTQVNLWRSPLAWQVTLFMGLQSMVFYILIA
WLPEILQQQGISSDQSGWLLSVMQLALLPFTFIVPIIAGRMKSQRSLVTIMSVLLLAGTL
GLIYGSAKLIVCWIIMIGIGGGCAFSLSMMFFGLRTENGRQAAELSGMAQSVGYLLAAIG
PTLFGYLHDVTNSWTVPLFILAAASLLLFVFGLGAARDRYVSTSK
>PK3-045_04932 HTH-type transcriptional regulator SutR
MNRETDDSKQVVIQVGTVLKKLRKERRLSLENLSEISGVSKLTLGNIERGETNPTIGVLW
KISQSLSIPLMALFSSGNSVNVSRAGSGIRIFGDDGNWAVEPIFQNQKDEMEMCRAYLQP
HSSYYPEKHHPNTTEIATVMSGTITINVNNESYILNEYDSISFDANGNHSYINQTDNVAV
LYILLRYGR
>PK3-045_04933 hypothetical protein
MDKRVERTQKLLLQSLMMFNLKNKNFYEISIRDLCEQAGIARQTFYRNYLVKEDIIIRQI
SNVMSDFKSVLKQQSFNASGFIQLLIQFWKQNQETFVLIEWAGISNEFIRQLANFNKLVM
EQHKAFGKNSEYIANYYAGATYMFLKTFMEKNDFSQEAYAKGAAVYNQLTNQCKGLFEPL
N
>PK3-045_04934 hypothetical protein
METGKVVVITGANNGIGLELTKKILAEGSQVIALIRSSFLKDDIFIQSKITTGQLRIYKA
DLSDFNSLKKALEEINAAEKKIDFLFNNAGGTFPSLLFSKQNRELHYELQTVVPYIIFKE
LSPLFEKGEDKTIVNTSSAVILHMKQFDPDTLENPSSFKRLFGPYATAKLALSLWTKEIA
KKESANGFRFLSVDPGSNNTLRKEKKSGIPFYIKPLMKFFSSPPTKGATLLYDAAMDKTR
AVSGDFIVKGKSTKVNFAEYSSLVLEGVDRIYVREFLNSEE
>PK3-045_04935 putative transporter YycB
MTSLKALKRKEALREGYMVKGKPLKKHSPQVMLVIGVIFIALNLRPALTSIGPIMGVIRD
ELGFSNWNVALLTSLPLLVFAIMSIATSYLSQRFTNEKTLLFGLFILTIGIVLRSTSMMF
FLFFGTLCIGVGIAICNVLLPGIIKDSFPNKLSLMTGLYSTSMAISATMASAISVPFAES
WGLGWRISLLVWAIPAFFALLYWLFIHMYRIKPKASDNKSQKAGISSIAKSPLAWFIALF
MGCQSLLFYITISWFPEILVYFGTNQKTAGFLLSYLQLIGILSSLLVPIISGKLKSQVWM
VIGLNIFLIIGILMLLFYQNILIFIISTTLIGFSLSGNFTLALLFLSMRTNGTKQSTFLS
GMAQSIGYALAAIGPMAIGSIYDITQQWTVPLLILIVLAIFSSLLGLKVGKNELI
>PK3-045_04936 PTS system mannose-specific EIID component
MSNSAQPLKLDSSNRKETEYIKLTKFDLLKSYVLWYIVCEVSNSFERMQSLAFCASISPA
LKKLYKSEEELSEALTRHLVFFNCQGIWGSIIHGITLAMEEQKANKKDVPDNAITGVKTG
LMGPFAGIGDTIDWGTLKPIIFALAASFAALGSPIGAFIPILFAVITFLEGYFLFNLGYS
VGRGSVTSILQSGWIKELITGASILGLFMMGALSAKFVNLEIPIAFHLSGGEEQLSIQEL
LDSIAPGLLPLALTFGIYWYLVKKGFKITHVLILIIVMSLVGSLIGLF
>PK3-045_04937 PTS system sorbose-specific EIIC component
MVFTLALFTGLWYWFNAGAVGYTFHYVLKQPVVMALPIGLIMGDVSTALMVGAAIELVYI
GLVAAGANLPADEALAGVIAIPIALQTNMSPEMAVTFAIPFGVLGVFLDQLRRTINATFV
HMADKYALVNNIKGIWMAALVYPMLIGFLLRFPPVFIANFYGSKVVEQFISAIPEWILHG
LSVAGGALPALGFAITIYVIGRKFLIPFFIIGFFLVAYFDIEIMAAAIFGVCIALLAVFM
KKETNEGAQQ
>PK3-045_04938 PTS system sorbose-specific EIIB component
MANIKLVRIDSRLIHGQVVTKWLKVSNARRIIIIDNELSEDPFMSDIYMLAAPQGIAVDV
YSVETAVTKYKEKQLGKEDILVLFKNVANCYESFKAGFPIDYLQIGGIASAPGRTNVYRA
VSLDSTDVTQLKEIQEQGTEIYIHIIPEESKVRFDKTINKVNL
>PK3-045_04939 PTS system mannose-specific EIIAB component
MIGVLIISHGNFSTELLKSAELIIGKQENVSTLNLNADDDIQILSQKVSEQINEMDQGQG
VLILTDLFGGSPSNVTLANMKNKDNVCGICGVNLPMVIEALVLRHSNPLERLTETCCKSA
MEGIKNLTNIIGPS
>PK3-045_04940 HTH-type transcriptional repressor NagR
MQYISKDAFNFSEYKQLAEPIKKALQKINRESPLPLYHQLYDSLHQVIINQELEPGSFFA
TESLLQEETQMSRATIRKALGELVREKYLIPITGKGTFISITFPENHIVLPQLKSFSQEL
KDRGMKPGTIALQTKIITPTDLIAKKLGIKTSDPVLFTERIRTGNNIPILYLCSYIPVNI
GIMDNQEIPESLFSLIEDQCGKVISSAKHTINAVIINSQISKHLGVDKNSAGLGMERTTY
DVHGLPVLYETGVFRNDLYSYTFSMIKEN
>PK3-045_04941 HTH-type transcriptional repressor NagR
MRRGINHTLFISKEEVVKLGKGSKSMTIDINKNIPLDHCKELPEPVKRAVKTIDRSNPLP
LYQQLFNILCNVIVNKSLEPGSFFATESLLQSETQMSRSTIRKALEELVREKYLIRITGK
GTFVSIVVPKEAIVLPELKSMTQEFTERGLKPGTVILQAKKIIPPKEVAEKLNINTSDQV
LFTERIRTGNEIPILYIQGYIPLNLGITDLKNNPSSLYQLIENCGRKIHSATQLVNASII
PSKIAKLLGVEKSTAGLTMERITFDNQLVPVIYEEGIFRGDLYNYTLTMKNATDA
>PK3-045_04942 putative oxidoreductase/MSMEI_2347
MILKKLKNDVLMPYVGLGVYKMTNSKETVHAVTEAIKVGYRAVDTASYYENEEEVGEAIR
LSGIPRKELFITTKVWNDEQGYDETLRACERSLRQLGVDYIDLYLIHWPVPGEFIDTYRA
IERLYEEKLIRAPGVSNHNKKHLLQLENKVNIMPMVNQVECHPYLQQDDLINFCTEREMA
VTAWAPLGKGMVLQDELIKELAQKYHKTPAQIILRWHLQRETIIIPKSVTPSRILENFDL
FDFTMEKKDMDRISRLERNGRIGIDPDTDEF
>PK3-045_04943 hypothetical protein
MEILFLFFITLVIIQWFFKTKQSKVMHSHYNKFLESGNVLVERSKGLFSGAIVMFQIDQE
ANVKDCLLLSGATFFSSWRNCEELINKNLLLLKQEDLINYKKTEKRVIMKAIQTFENSKA
EKI
>PK3-045_04944 PTS system glucitol/sorbitol-specific EIIA component
MKYEVDIVEIGANVDAMLQSGLLILFNQDAPKDLRPYCVITEGNKLDGQIKLGDKMTIVD
RAYTITAVGEVANENLYSIGHVSLCFDGAEEAELPGHIHLTPNFESDLSFLGKITIA
>PK3-045_04945 PTS system glucitol/sorbitol-specific EIIB component
MEKGKIIKVDKGGSGWGGPLYLECQGKKNKVLSMTGGGIHDLAAYIADAINGEAIDGFKD
VPNDDEIVCVIINCGGTLRCGVYPQKGIYTINLNAIGPSGPLAQHIVKEIYVSGVKKENI
SYVKESDQRENNHVNPITSEPKEQPAKVSKASQEEVKSNPIFNLLSKIGAGVGYVVSMFL
DSGRKTVDLLLKTIIPFMAFVSILVALVQYTGVGEGIANILSPLGSSLWGLLVISIICSF
PFLSPLLGPGAAVAQVVGVLVGTQIAAGAIPPQFALPALFAINAQVGGDFFPVGMSLMQA
KPKTIQYGTPAFLIARQISSPISVVVAYLISIGLYS
>PK3-045_04946 PTS system glucitol/sorbitol-specific EIIC component
MSFVVDFAEKFMGFFEFVGDVFVGMFTGIVPILVGMLTLIQFIVNIVGEKRIERVGQFLA
KSSLLKYSIFPIFAGFFLGNPASITLGRFLPEKSKPGLMEAMFRNGHPLTSLFPHTNPAE
LFVWLGVAQGIEQLGLPVGALAIRYIITGIIVGIISGIITELIFTIIAKRNNYEIDSTVN
FINNEKGTISDKT
>PK3-045_04947 D-arabitol-phosphate dehydrogenase
MTKMRKFAVLTKAKVAEVHEGRIPELGDNQVLIKQETCNICTTDFGQWLGLRDHQPFPMA
GGHEGAGIIAAKGKNVRNEINIGDHVAVAYDYCGECAVCQTGRTSECKEVSNPFKEQNDE
GYYGHLGFATYNVKDANTIIKMNPELPFSEAGFLEPLATVISGLKRLRVTAMDRVVVIGA
GTMGVLNALAAKAFGVEVIITEMMDKKIEAARSMGLNVIDIKKHNPVEKVKELTSGKGAD
AVIIAVGNTKANEQALEMVKEYNGRLLLFAAGYPSPELNVDSNLIHYRKMELIGTYGADI
SDFNISANLLNDGKVNVSKLIEAKVPLEEIQKGYTIASTEGSYRVSVLLQ
>PK3-045_04948 2-amino-4,5-dihydroxy-6-oxo-7-(phosphonooxy)heptanoate synthase
MGKTLRLSRIFRKDTGNALVLPVDHGIGGSMEGLEDPVKTLKELQSPNIDAVLLNDGVAR
QANEVFSGRNAPGRMLNADVFSYEVKNERMHHQITFSPEAAVRRGYDCMKLVLFWDRPAE
ERMRSIKLIASVIEEAEKWEMPVMVEPLTSKPIENLEERIKVLTDANRVAFELGADILKV
AHPGDAETLRNWVKYFDVPIILLGGGKSGTTEDLVKVVDEAIEIGINGVAIGRNVWQRPV
EEAKELLSRFAEIIHKPRK
>PK3-045_04949 Succinate-semialdehyde dehydrogenase [NADP(+)]
MAYINGSWIESKSRLEVLNPATNEIIDTVPVVGKAETIAAIESAREAFKSWKKTTFSERV
DYLVKAASILREQREELAELITKENGKPLRDSRSEVDSGIAYIDWYAEEAKRIYGDVLPA
ADQNKHLLVIREPVGVCAAITPWNFPFSMITRKIAPALATGCTMVLKPASATPLSAIKVF
ECFDKAGVPKGVINLVIGSAQEIGNAMTQSEEVRKITFTGSTAVGKLLLRDSADTVKAVS
MELGGHAPFIIFDDANIDFVIEGVLNTKFTNSGQTCVSTNRIYVQKNIAEEFSKTLASRV
SKLKIGNGLDESVDVGPIIDLKSYEKIMDQIKDAKEKNAKILCGGKPYDNKTDGKFIEPT
IISDANEEMLISSEETFGPVVPIFTFETEDEIIEKVNHRYYGLAGYCYTSDLGRAFRVSG
ELEYGMVGVNDSSPFVVHAPFGGIKESGLGQEGGKYGLEGYLITKYISINTKY
>PK3-045_04950 Zinc-type alcohol dehydrogenase-like protein
MKAVGLYKYLPIEEEESLIDVQVEKPTPTKRDILVKIKAVSVNPVDVKVRAPKDKEESEP
RILGWDASGVVEEVGPDCRMFKPGDEVFYSGDLTRPGTYSEYHLVDERIVGLKPKSLNFA
QSAALPLTSITAWESLFDRLMIDVNNYEENQTKSILIIGGAGGVGSIAIQLAKMAGLQVI
ATASREESKQWVNKLGADYIINHHENFRTQLQDHDIKGVEYILCLNETEQHWQNMADIIF
PQGRICSIVEMANPIDLTALKNKSVTFVWEFMFTRSMYETPDMIKQHELLSKLSKLIDGG
KVTTTLTETLRPINAETLRKAHKIVETGSMIGKIVVENE
>PK3-045_04951 putative HTH-type transcriptional regulator YybR
MRNRKKGYGCPEGCPVEGTLDVIGGKWKGVILFYLLDGKKRFNEFSRLMPGITKRMLSLQ
LRELEEDGIVHREVYPEIPPKVEYSLTEFGRTLEPIISLMNEWGENYKEFLKENKRELK
>PK3-045_04952 hypothetical protein
MLSILQSEWFKLRKSKILLIIFTGPLIGLFTGLTAKPFHLETEMNEWYLPLLSMNLTYAL
LFLPLVTGVLASVICRYEHQAGGWKQLLALPVTRGQVFTGKYILLMLLVLVIQLFYLGAV
YGVGMMKGFTDPFPIEIVWKSIFGGWVATFPLVAFQLWMSILFKSFAAPLAVNVIFTLPS
ILAVNSERFGPYYPWAQPFAMMYMSDTSGDVFSVPWDQLLIVVGGSFILFFLGGYLYFHR
KTV
>PK3-045_04953 hypothetical protein
MIGKLLRADFLKTKRKGFWFLTFLGPFGVVALQMVNYGVRKDYLLKQSEDDWGYYLLNVS
SFTPLALALGIVILTSFMASIENETNSWKQLISLPVSKMNVYLSKFTVLAFFLFLSSVLL
MVFTIAFGVFLDLGEQTPFVEIVKYSFYPYFAALPILALQLWIATVSQNQGIPITIGILG
VIFVYSAMVLPDWMIWKWPSLTNEWNEPMINVLLGIGVGVLLYIAGMIDFTRRDVK
>PK3-045_04954 Bacitracin transport ATP-binding protein BcrA
MEYVVQTENLSKRFGKEEAVAGLNMKIKKGEIYGFLGPNGAGKTTTIRMLLGLMKSTSGR
IHIFQKDLRLERRDILKRVGSLVENPSYYPHLTAYENLEALRKILGVPKTRINEVLEIVR
LQDVANKKVKGFSLGMKQRLGIAASLLNNPELLILDEPTNGLDPSGIIEIRNLIKRLPAE
TGMTILISSHLLSEIDQMATTVGIVTKGKMIFQDSIEALRMYAQQRILLKVSDSKLAWRS
LLGKGINADWQDEIILLTEHSNEGVAKAVQSLVQEGFSIYRVEEEKRSLEEIFLQMTMEE
KAV
>PK3-045_04955 Phosphotransferase RcsD
MRRFFQSLLAKYMMIILIAIFLVQFAFLVVTIFVSGVAENMESGSQSQYRNDFNEIETKW
HAEANNLKNVTPETIEQHFSKWKNQFHDASMFWVDENGKLGKQVNVREQLPSEWSSVFTA
KFIKGRYEGDPFTVIAFVGKEESRGFIVFEIPRTALKSPLEKANDNYGTILLVGVICIIF
LFIIASFLFFRGIRKRLLQLQDAMEIRDVDGLPIQINVKKQDEIGQLEKTFNQMVFELKE
SKQREQKEEQIRRELIANLSHDLRTPLTKIRAQTYSIAKEDLSEEGTKAIKALEASVVNI
DRLMENLMSYTLLMASKYKVDWKDIDVIRYVRECLALWYPVFEKEGFEIEVKLLPFKNSK
WTVDPIWLGRILDNLLQNVLRHAKSGRYICVKTESTDQYDAIVVSDKGKGMKGISNEAGA
GIGLSIVDMMVKGMELYWEIKSSEHGTTIKIIKKRDSSKDRLEKVI
>PK3-045_04956 Alkaline phosphatase synthesis transcriptional regulatory protein SphR
MVHVLYIEDQSDIGSWVTKDLTGRGYEVTWLQSGEGVEEYLLTVDILILDVMLPGLDGFS
IGKRIKKENRDLPILMLSARTSIEDKIEGLYFADDYLTKPFHPDELAARVEVLIRRYQKN
DDILELRHLTIYTKDMRLVNNDTGSEIQLTGKQYHLFQFFIRHLNQILTKEQLYEGVWGE
RYIEGDKTLMVHIRYLREKIEKNPSNPTIIETIRGIGYRVKI
>PK3-045_04957 hypothetical protein
MQRNFGKYDIPASLQKLMELEKELGDCESFYNGLHFYISLSDFRYFNTPSDVIVFGHIGV
DGIHYGFLTDYGSVSDLEEAPIVCICPMEFEKPTRIVAKNLREFLRINCTDSDLFYNYFA
DEDSYLVFKEREVDDELHPQSERQLLKYIDNFLEKNIQMPIIANPYRYIQTLRLQRQKMI
TIQTQDGIGVIAPFLANETHFPLKINKDVEPDLAALKAYLSRAPIPSQYAVFRDIQLHHV
LSDEPLLKKIVLESMYNIGLIDEANRLS
>PK3-045_04958 Riboflavin transporter RibZ
MNTPHSHSNLRHNPILLWLCVLSFFSVLNEMVLNVSLPDIASDFNKEPASINWINTAFLL
TFSIGTAVYGKVSDQLGIKKLLLFGIIINCIGSVIGFVGHSFFLILIAARFIQGAGAAAF
PALVMVVIARYIPKENSGKAFGLIGSIVAMGEGVGPFVGGIIAEYADWSYILLLPVATII
TVPFLAKLLRKEEAIKGSFDTKGMIFMSVGIIFFIMFTTSYRVSFLVVSIICFLIFIKHI
RKVSNPFINPSLGKNVSFIIGIICGGIILGTVAGFISMVPYMMKDVYQLSTAAIGSGIIF
PGAMSVIVFGYFGGVLVDKKGSLFVLTTGVVFLSISFLVAGLFIEITPWLITIILIFVFG
GLSFTKTVISTIVSSSLEQKEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIHLLNRKILPI
NVDTSTHLYSNLLFLFAGITFSSWLVTMKMYKRFKNK
>PK3-045_04959 hypothetical protein
MEVLAAILVGIVAIEHLFIMILEMFFIDSKLAKRAFNLPKHLERDRNVAIMFANQGLYNG
FLAAGLIWGLILGLNSIGYMIQLFFIICVVVAAIFGGFTSNKSIIVKQGLPAILALVTLL
SVM
>PK3-045_04960 Putative NAD(P)H nitroreductase YodC
MKTTLKTNDFMKIMKERRSIRNYDPTVKISKEEMTEILEEATTAPSSVNAQPWRFLIIES
PESKEKLAALAKFNQSQVTTSSAVIAVFADMNNADYLEEIYSKAVDLGYMPQEVKDRQIE
ALKAHFEQLPEQVNRETILVDAGLVSMQLMLTARAHGYETNPIGGYEKENIAEAFGLEKE
RYVPVMLLSIGKAADEGYASYRLPVDRIAQWK
>PK3-045_04961 hypothetical protein
MAQPLQDTSSRLKLKEEGNPEDSRIILARLSEQGRDQVKASSEISA
>PK3-045_04962 Putative monooxygenase YcnE
MIIIHAEMQIDATKQQIFLEEIETLIRASRQESGNISYNLYKDIEKNHTFTMVEVWQDEA
AVASHNTSEHFTSFVAKASNFLVAPLAIKAYDGQPLQS
>PK3-045_04963 Transcriptional regulator SlyA
MTNSCSKEAIILYKLFFINKEINSKFEGCTGVSQSRLELLRHLYQADEMSQKALQKEMNI
DNAAITRHLKQLEANGLILRRKKASDNRITLVTLTDYGRQKISCYQEEKKRFVTSMLKDI
SEEERDLLFDMLNRIQNSIKEI
>PK3-045_04964 hypothetical protein
MTQFEAFSLLREIAKKPVLAQIGGFRPEEARMSWFGGHFYIDKEAGWPHDKDGPMIPVLQ
AYVPEIPGGIDGVGEASLIQLFLNRKQLPIYPVKNGEGWLLIEHQSVEELQLMETPEEAR
GLREFQIRWHKADSDDYPCWEEAWDYVDLTEVNEDEDASDQFFDEFGSYPQTKIGGYASY
IQSPVSLEDCQYIMQIGSEEKPRFMVGDNGTIYLFRSRSTGEWHMHWDCY
>PK3-045_04965 hypothetical protein
MKKTKVLSVSILSAAMLLLAACGNEEKASESPKENDSKAKTEETSNKGKTNEKAEESDTK
SGEVLNPSIAEETEGNVEVVYTNKEPGFLNDINGFKVSVNEYQIVKVTDMNEDSKLRFDG
QNNGYVVTTKVTIENGTDKPMYYNNNHKIQLSNEYDYIPSDWKTLVPEDQQINKIKKNKE
KITLYEAGEKVTGLMSFRLSDAEFEKLKTVKPKYIIEGGLADNDQAKNSNMQQSPAYDFI
YSDEQAKQTAEQPQFYQDRLTTDNMADKKMIFEKSGINDTKEIDKVKITLEGVQYTEVIP
TEANKERFRNFGDNGIVAVTVKLNVDNQTSEPVDISNLKTTLNIDDNRAKVLSQGMVEPR
EQREIAAGQKGEKLHVFLLRKDEFEIYKKFDMRFGPFVGTDGKDQFKGKSATFSLPR
>PK3-045_04966 hypothetical protein
MIFFKMIRSFLYLLAIPVLFILYIALIFSAIISLTAGILRTFGFDQITMTIWKDINLPVI
LSIPFSLILSIILLIVCIYVQRSIAYLKSHLNYN
>PK3-045_04967 hypothetical protein
MTNEQNEKLLSLTLTNGTIDTIEKGYEKLKIRGSVKVLQDVQVKEISTHGHSLFQSQVIS
EILRNTGSCILNGDNKVEKITNSGILKINKGEIKELTSSGSLTIMDIIHVTHMNVIGIVQ
GKEIHSAIFNLKLAGTNKINLLIANDICVERAKMNLTLANKKLICQQIKGDTILLSHTIA
NSVEGNVVTIKKNCEIQKLYYKDHYTISPLATVHQIIRSEES
>PK3-045_04968 hypothetical protein
MSKPSQTQEIEVIMKEMLEIQQKSKAFTNLLTENELLHQNQLVLLLQLKINGVMKVTEIA
EVFSLTPGAITSMVDKLEKLGFIQRVRELEDRRVVNIMLTSDGEVKVQEVFLKFPRDKLT
SIAKVLKEVNTLMSTIF
>PK3-045_04969 hypothetical protein
MTNKNNKTVLVTGGSGFVAGWAIHDLLKQGYNVRTTVRSEKKGVYISNSLLNIGIDTKFL
SFFLADLESDDGWKEAMIGVDYVLHIASPLTTGNNDDLDTFIGPARDGAMRVIREAVNAG
VERVVMTSSLAAATPDISNKDQHINEALWTNLNDKNLNAYRKSKAIAEKAAWDFIKEKNS
KTTLTTILPGAIFGPILYANVPSSIEVIQQLIQGKGLGNPKIGFEIVDVRDLVDLHIRAM
TNPKAAGQRYIASSGFMWMNDMAKFLKEELGEVGKNIPTKTIPDFILRSAAKMNPSLASL
VPMLGRKFRYTSEKARTQLNWSPRLVEETILDSAKKLTKLKLI
>PK3-045_04970 hypothetical protein
MVTENERKEQMINKINDEVVKNGFKTLTMDGIAKVMGISRGKLYQYFPSKDEVIEAVTER
YLQYIKDISVIGAPEEYQEFVDEFISIYFQNVILAGSASEIFVDDLKNIYPHLFEKFSES
MSKRDTVIQNFYEIGMKKGVFNQGMNAQLINLQDKTMLAVLILPKFLFTHRLEPSQAIRD
YLRIRILGIIAPEHQSLVNYEKAEAQIKHLDEKFRRVFIEKI
>PK3-045_04971 hypothetical protein
MKFRVWEAAEFHLTINFTIGLRKIEDTKKDIQFRKSAKEYELKHRPILSNSKLMLHLQIY
I
>PK3-045_04972 hypothetical protein
MGGFHVTRVCNSGGKGKAKSLSEAKTDRSRRVNISGDYRTGINITNEVKLQFEHGINKYY
RKTNNYSLKDVYHFILRDFLKKMVK
>PK3-045_04973 hypothetical protein
MIMINQVLQYVSDSKRLRVIEIEETYVYIVNIDTTSAMPQREIYANLQAEMNQDELFVVN
DPYKKAIPDSELTDVQIRKREEDWRTIEEYILPNIRELLRKKGREKKITEIVKTSGIGQN
KIKKLLSRYGRIPCYQSMQLRR
>PK3-045_04974 hypothetical protein
MINNGQSIFDVAHTIKMKDELLKERILEKFETEREYWHRKEVDWGIVTEEEIHKTMARNI
SYIHNYYEIRDYDVFGEMSAQNIKDLSISLMQRLLGTKESIRKITSEFDKDTYLPFGSDV
TMFYHLLSRKIIIIDMIEPLDLEKPVTIKSIDDSNLKKVKYG
>PK3-045_04975 Transposon Tn7 transposition protein TnsA
MSKRKRTSKIEKWIKEGRGSGIGSEYKPWLKIQDVSSLGRSTRLKGIKTNRQHEFLADLE
RNYFYITEYSDLSLGIREQFPLLPLGKKQLSLQMS
>PK3-045_04976 hypothetical protein
MTCCIIEKLKRIQSNEKQIKVDECFAVTPVFLINQEGEHFIASGISNGELFHTCYFKVIS
VNELRKCVVLELLVPCCMKTLCANKVLYRSGSRILTDISFFCGIGEVEIPVYDYLILKPS
IKDKFEICFLTNENKTGILWNNETNFANTATVTLHHKDTKNCSIKIILHTKENLYSLGVN
KGESCSITVKDLECLKIESSKRKLKGQIEVQLNHIIKTIKYF
>PK3-045_04977 hypothetical protein
MAILGGCSNEQTGFVNDAVCFTIDLGDTGAVATPVWEDGTSFVINGTIMVENNGIVGVGP
TASLTVNGTAVAGFTVAPGESRSVTLNDINSIGIVGAGGTGTANVTVSFSLNYQY
>PK3-045_04978 hypothetical protein
MCAQLNSCGGSRGPTGPTGPTGPTGPTGPTGATGIPGPTGPTGATGATGIPGPTGPTGAT
GATGIPGPTGPTGANPQLFYNEVAGPVSVAVNGTETSIGTLSVPTVTGQLIKLDFAISVD
VTTTANSNFTFQTRVYRNGVFVNTRSVQRNVNAAITSRFPIATTYVETATVTGTTSYEVR
IIFTTASNVSSSSALNLEINAIRFP
>PK3-045_04979 hypothetical protein
MISISLCMIVKNEEAVIGRCLDSVQGIADEINIVDTGSVDKTKDIAARYTDRIFDFEWTD
DFAAARNFSFQQATTDYILWLDADDVFTENDQEILLDLKGTLDPRIDAVSMKYHLAFDEE
NNVTSSLRRYRLVKREKSFKWIGAVHEYLEVYGNLHHSEVAVSHLPLSHDADRNLQIYEK
MASSGKDFSPRDLFYYANELCDHGKMEQAIEYYLRFLQMKQGWVEDNIRACNKLADCYHS
LGLKEKELSWVLHTLVYGPPRAETCCRLGYYFLEKNDFQSAVYWYEKAIENKGAENLAFQ
NHACATWLPHLQLAVCYDKLGQHQLAYQHNESALQYRPHNSRMLANKKYFEDILQQQASS
GGEQHGNQ
>PK3-045_04980 Glutamine--fructose-6-phosphate aminotransferase [isomerizing]
MCGIVGYIGNQDAKEILLKGLEKLEYRGYDSAGIALSNGEGVQVFKEKGRIADLRSIVDE
EVFAPAGIGHTRWATHGVPSRLNAHPHKSASERFTIVHNGVIENYDLLKKEYLADVTLKS
DTDTEVVVQLIEHFVEAGSDVKAAFVQTLKLLKGSYAFALLDEQNKDMIYVAKNKSPLLI
GLGESFNVIASDAMAMLQVTDQYVELVDKEIVIVTKDEVTIETLEGEIISREAYTAELDA
SDIEKGTYPHYMLKEIDEQPVAIRKIIQEYQDKDGKLTIDPAIIEAVKAADRLYIVAAGT
SYHAGLLGKQFIEKLAKIPVEVHVASEFGYNMPLLSEKPLFIFITQSGETADSRAVLVQV
KEMGYPTLTITNVPGSTLSREADHTLLLYAGPEIAVASTKAYTSQMAVLSILAEVTARNK
GYQIDFDLIHELGIIANAMEGVFEDKEELEAIAREYLETSRNAFYIGRGIDYYVGLEGSL
KLKEISYIQAEGFAGGELKHGTIALIEDGTPIIALATQESVNLSIRGNVKEVVARGANPC
IISMKGLEMDGDRYIVPAVHDLLTPLISVVPLQLIAYYAALHRGCDVDKPRNLAKSVTVE
>PK3-045_04982 Phosphoglucosamine mutase
MGKYFGTDGVRGVANSELTPEIAFKLGRYGGFVLTKDHDRPKVLIGRDTRISGHMLEGAL
VAGLLSIGAEVMRLGVISTPGVSYLTKALGAQAGVMISASHNPVADNGIKFFGPDGFKLS
DEQELEIEALIDQAEDTLPRPTGADLGQVDDYFEGGQKYLQFLKQTVDEEFAGIHIALDC
AHGATSSLAMHLFADLDADISTMGASPNGLNINDGVGSTHPEALSKFVLEKEADVGLAFD
GDGDRLIAIDENGDIVDGDQIMYICAKYLKETARLKNNTVVSTVMSNLGFYKALEQHEIT
SIPTAVGDRYVVEEMRNNGYNLGGEQSGHIIFLDYNTTGDGLLTGLQLVNIMKVTKKKLS
ELAGEMKKFPQKLVNVKVTDKFHVTDNEKVKEVIAKVEQDMNGNGRILVRPSGTEPLVRV
MAEAPTEELCEAYVNVISEVVKEEMGLPEE
>PK3-045_04983 CdaA regulatory protein CdaR
MSKLFNNVIGKNWFTKVLSLAFALLLFSYAYDPNESSTDVNVPGDSETVILEDIPVTAYY
DTENVVVTGIPKTVTVTLRGPTVHIQQAKLKKDFEVYVNLANANLGSKTVPLQIKDLSDK
IRASIDPETIKVTVKEKVTQEFNVEAEFSSNALAKGYAAGTPKIEPKTVKVTGAKDEIEK
IAYVKANVNLDGNTNEAVSQQAKVSVLDGSLNKLNVQVEPEIVEVNIPVKRTSKTVPIKI
VEQGKPKDGITIDSITLDTKEATITGPEDVLKDVESTRVEVDLSKIEKDEELTLPVIISN
GVTSVDPELVKVTVKVTAAQQEQEQEQKEDDEQANQDSEEAVTTEKTETRTLSNVPITIK
GLNSDLEATIAKPKSSSTSLRISGEQNRVRELSVSDFNLYIDLTGMDDGEHEVPIKVNGP
DNIDWELATNTASVSITNKEA
>PK3-045_04984 Cyclic di-AMP synthase CdaA
MSFADFPFLKYLANTVDIILVWYVIYKIITIIRGTKAVQLLNGIFVILIIKMLSEYFQLQ
TLSWMMQQVIQWGALALIIIFQGELRRALEQLGRGKFFSRSVVQEHELQAQLVESIVKAV
DYMAKRRIGALITIERETGMSDYIETGIALDSKISAELLINIFIPNTPLHDGAVIIQKTN
IAAAACYLPLSESPFISKELGTRHRAALGISEVTDSLTVVVSEETGAISITKNGDLHREL
KLDAFREMLSSALITPSTKQTTSSKWSWKGKKNE
>PK3-045_04985 Anti-sigma-W factor RsiW
MTCSTKIITYMHQYLDEEIEEENLKELKKHLDQCEECATHFHELKKTIALVQSTSHIQAP
MNFTENILAKLPEEKKQVRVKRWLRHHPMLAAASLFLILMISSLMSSWNEDHQFSVSKQP
NIIVENNTAIVPEGETVKGDVIVRNGDIKIEGQVEGNVTVINGKKYMASANQVTGDIKEV
NEIFDWLWYHIKKTVTDITGVFSDEDNTQKNSLPAI
>PK3-045_04986 ECF RNA polymerase sigma factor SigW
MEALVKKRIQQVLKGDKNAFGDIIELYKDKVFQICYRMLGNRHEAEDIAQEAFIRAYVNV
HRYNMEYKFSTWLYRIATNLCIDRIRKRKPDYYLDAEVPGTDGLNMYSQISSDGKLPEED
VESMELQAMIQREISKLPEKYRAVIVLKYIEELSLNEISEILELPLGTVKTRIHRGREAL
RKQLRYV
>PK3-045_04987 hypothetical protein
MSDRKLLKDIEEHREMMIYLANNTSFSHPKVVDISTKLDLLLNKYEKICSQLSVK
>PK3-045_04988 Arginase
MRKLTIIGMPMDLGQMRRGVDMGPSAIRYAGVFERLSKLFSSIEDWGDISVGRPETIIDV
QSNLRNLHLIAEKNLMLAEMVDKIIQSKSFPLILGGDHSIAIGTLAGVSKHYTNLGVIWY
DAHGDLNTAETSPSGNIHGMPLAVSLGYGHELLTNILGASPKIKPEHVVIIGARSLDEGE
RRLIKELGIKVFTMHEIDRLGMTKVMESTIDYLKEKTDGVHLSLDLDGLDPNDAPGVGTP
VPGGISYRESHLAMEMLAESGLITSAEFVEVNPILDERNKTASLAVALMGSLFGEKLL
>PK3-045_05000 hypothetical protein
MDAAGGLVMIGLLLNKKEIKEIEYLIKRELDEILLDLGDKRIDLAVKKAMIKRYKNLFVL
LKRVASPKECLAYILPESKLLDEKI
>PK3-045_05001 hypothetical protein
MNFFYVLNSKSLKQMALIVVVSFFTAWFLYVENIVQIPVFSSKDGPKAVYKGEKGVALTF
NIGWGDKRAEPILDILKEKKVNATFFLAGSWAERHPELVSRMVKEGHEIGILGYDYVDYS
EVKEEKIRQDISKAKTAFQKLKVENILLARAPTGHFSQSTLTIADQYDYTLVHWSIDSKD
WTNPGSQQIIKKATSAKKGDIVLLHASDSAKQTAKALPEIIGKLQKKNLKFVTVSEMISN
ADSKSKEVH
>PK3-045_05002 Spore germination protein GerD
MLKKGITLLLVISLLSGCSESENSQQMDYDQTKKMVVDILKTDEGKKAIREVMNDEEIKQ
NLVMNEKAVTNTIEKTLVSDKAAEFWQKKFKDPEFAETMAKSMKSENEKLIKDLMKDPGY
RKMMVELLQDPSLESEMKNILKSTEYREHVEQILQETMETPEFKSKFKELLDKAAKEASS
SLLSEENKI
>PK3-045_05003 Iron-sulfur cluster carrier protein
MITKEEIEKIVENMIDPFLHKSLLELSAVKDVKWNEEKGHASLKVAVAKLGSAYQIELQN
QIVSALKERGVESVGLRFTELSSALVEEIIKETESEDKKPIYIAIASGKGGVGKSTVSVN
LAVSLARMGKKVGLLDADIYGFSVPDMMGITNRPEVIKERIIPVERFGVKVISMGFFVED
NTPIIWRGPMLGKMLTSFMDEVEWGELDYLLLDLPPGTGDVALDVHSMLPTSKEIIVTTP
HPTAAFVAARAGAMALRTEHEILGVIENMSYFESRLTGEKEYVFGKGGGTKLAKDLEVPL
LGELPLGQPDWNEEDFAPSVYKETHPIGERYKEIAEQIVEVLEMAADRVEN
>PK3-045_05004 Germination-specific N-acetylmuramoyl-L-alanine amidase
MNKKWKISIYILGLALLFFILQFDFSNDDSWDAWNLPLTGKVIIIDPGHGGPDGGAGDKE
VLEKDIALSVSLKLRDYLQEQGALVIMTREIDKDLASESTKGYRNRKVEDLKERISIINK
SDADLFLSIHLNAIPSSKWSGAQTFYSSKQEGNDRAAKFIQDELIDNLENTTRKAKTLES
VYILKYAERPGVLVEVGFLSNPQEKANLMKEDYQEKIAASIYKGVNRFFTNEEELEIQE
>PK3-045_05005 hypothetical protein
MAVITSFDIRKREKQIKYERAVLREISLKELKEKVAHYFGSSNLTSSILMNNGIEEACYD
VAIEAFLLGANYSKFSEYGEEVQAIKNRCKEEDVHLKETLYHFLLYWGSEESNKNESLYY
LCEQFVDEWWLEGYTKANKRRKLRLH
>PK3-045_05006 hypothetical protein
MEGIRKRQHPIKIVFDIAGFVKSNFFLFIILFVSHFGSEKMYMKIFQVLFLLYAIVQLLS
IVLDWFTHTYSVEEEALHIRSGVFTKSHRVIPFYKIQNIHRHTSVFHKGLHLTSLTLETG
ETGDSSSIPLTVIRKKEADWLESYIHQPENVSAGDGEEAKTVAGSERTVHFQVTRRDLVR
ASFSSLSFLALIPLLISFFSNIDSIFQMEVETSKVLTYLLDHIWMIVGVCIALLIIGVLF
GLGVTFWKYGRFQITSDKDKIYIKKGLVSETSFSIQKEKVQAVKVIQLPMQRLLKIAEVK
LVSAGDIGDEDLEVNSLFPYMPVDQAYEIIEKILPAYRLKKQMKKLPKKALYARLLRPSY
FGIIVAIGLVYWKPEIWYMAILLFILIYLLRVWDYFNSRYIQHEEFIQVKKGSLQSTLIL
TKRAKVMEVNVKRSRLQRNLGLATIEFINRSQPIEQTDLTDVPASDASEFYHWYNKRMSD
IHVEDYVESNEGENGKKALK
>PK3-045_05007 hypothetical protein
MYFSIPEPTKKVSKEAVKVWRISETISNSTILVVLGVCYFLYFYFSWKAWIGPIIVGLGV
LTILAALWGIFIAPPLKQRYWRYDVSEEFIQLKWGVMVENHQLIPMTKVQSVELTQGPLQ
RKYQLYSITVGTMGTSHEIPAIPKEEAYRLRDQIAHFAKIKEVE
>PK3-045_05008 hypothetical protein
MYIGNGHYCYSNSTAMFLSSIGENVSPQLVEVLTGVGLGAMIENEKNLFFSMRDPDDGIN
YALNILGFTAEEHQQASDLDDPFTLLKKQIKQNPVILGPLDMGELTYHPNHKNLHGSDHY
VLGYQMDDENIYVQDPAGFPFVPLSLDQFKKAWMAEGIPYRKGINKYWSTAKKVVTLNNN
EIYERAIDYFKRTYREFEKADIGLIGREAICFYADQLLNAPITADTIGHTTFFLFQLSAR
RANDYAVYFKDRHSRLSELKIEQAKVLGMCHSMSVNKDWKGISEKLMRLADLEEEFRLEL
LKVGN
>PK3-045_05009 hypothetical protein
MKINNLGLLNSLSSIINSGKSANIEYILAEYILKNLYRISSISILEITDECFTSRSAIRR
FCEQLGYANFSELKSSVNKLVFPSNLRFRDIKEYSSYQTHIKNLIDDMILDIDEQLNFEN
INYLCQLIHKDVKVVLLCANNTSGTIIKFQQELLFASKVIHVISTSFTNNKVLNDLNDED
IIITVSASGKFAELSLDFVKSLRGHKFLITGNQDKSIKLAYENIFYISKNSISNDYLSIY
GKYGITYILDLISMQYLFLYA
>PK3-045_05010 hypothetical protein
MKYNSKNVQLREMEAPMPDCSRKPLLIDDETIKTRYENVLQEMRMDGLDALLVYADLEHG
GNFEYLVGFVPRFEEAILVLHSKGDAFLILGNENLNKAQYSRIPAQGIHCPHFSLPNQPM
EPDTPFSSVFLKAGIRESMKIGLVGWKHFTSKVENNRNFFDTPSFIVDTIRDIVGKEGSL
TNRTDIFIAGNRGVRRVNNANEIAHYEFGASLASDCILRTINKLDVGVSEMELGKELNDL
GQRNSVVTIASTGKRFEKGNLYPMSKKVTKGDAISLTVGYKGGLSSRAGYAVMERSELPE
SKKNYVEDLAAPYYTAIVAWLENIRIGMSGGDMYSFINSVLPKEVFHWELCPGHLTADEE
WLASPIYENSDEIIKSGMIFQTDIIPRVAGYDGVSAESTIALADDALKEEIRKNYPELWM
RIQKRKEYINDFLGIKLSKDVLPLCSTVAYLRPYLLNKKLAFCYNHNG
>PK3-045_05011 PTS system glucose-specific EIIA component
MIIMFKNMFMKKVEFSKTIELKAYATGSIMKLEDIPDPVFAEKMMGDGIAIVPAEGNISS
PVNGVIMHVFPTKHAISIKTANDAEILLHIGLETVSMNGEGFTVHVTEGKKVKVGDALVT
VDLDMVKKRAKNTVIPIIIVNTKEMLKIDKPLLSGNVTIAKETILAVTAK
>PK3-045_05012 hypothetical protein
MKIMIAQFIIESNANIPYKSNLEDFNLLFGEDCIQEMKCKDVFIREGIEIIPSIYANANA
GGVLEKPAFDYIERRILEDVKKHLHEIDGIFLHLHGASEVAELDGGSGDHHILKMIRQLV
GPYLPIAVVCDPHGNLSKEYVESTTMIRSYRHSPHTDIQETIEFVCEMLVTFLRNRQNIT
PVYRKLPMILGGEQSVSADEPVKSINKYMDKLEEDPNILSCSWHVGYLRHDTDVAGCGIV
VIPATGDDQEYANEVADKLAKYVWDKRYEFHYTGLTAQPEEAMKMAIEYEDKPVFITDSG
DNVTSGSVGCNTFILRQVLELNHTKSKAKRFLFAGINDSKTLNELIKCEVGETLSISLGM
NLDELSAKVDLDVIVSAKGYLAGYAYTSEGDFGNCITVTVKGKPIDIIVSGNNHPFVELH
QFHAAGIDYKDYDIIIVKQGYIFPELKAAGKLNVMSLTGGATLQDTARLPFKRIMRPMFP
IDNI
>PK3-045_05013 PTS system beta-glucoside-specific EIIBCA component
MKYVNMSKQVLEHIGGVDNLNHVEHCATRLRLHYNSKKLVNEEALKGIENVVGIVSKAGQ
VQVIIGPNVNEAYNDFLEVSGWKEEQHSGSDSAVEEPEDKKAMYYVNKFGSFMATIFMPI
VPALITGGIILALRNLMINYFGVDMESGTAVILNAIFSAAFTFLPVYIGFTMAKRLKMEP
IMGAFLGALLVSSNISGVEGLDFLGISIPVVDYASSVLPIMLGVGLMYFVDKFFQKYIPE
TVKYFLKPLFTMIVVVPITLIALGPIGTVLSDYVGVGVTNMMDTIGGIAMPILAAFYPYM
VMLGLDKAIMPIGFNSVASIGYDPVVMVMGFISNLCIGGTALAVATIIKNDKSKKGMITS
FGVTALCGVTEPAFYGALIMRPKVLIGTAIGAVSAGLVAGIFGLVSYVMGGCPGLLTALF
FMDNDGGFGNLFLAAIVAIVAIVVSFVASKIILSKTEANKNAKFEPELDKVL
>PK3-045_05014 6-phospho-beta-glucosidase GmuD
MNNNNEFLWGSATAAYQCEGAWKEDGKGLNEWDSFNHKSPLNILNVNGDVASDFYHRYKE
DIDLMAEGNQNTYRFSISWARIIPNGVGEVNVKGIEFYNNVIDYCLEKGIIPNVTLFHYD
LPNEMAKIGGWENRKVVDAFNEYAKVCFEHFGDRVKIWSTINEPRYYAYCSYIVGNYPPN
YKADFGRFWTVVYNLMLGSAKAVQTYKKLSLDGNIGVVHDNGNVELDPTTKEKGLVKLRA
DIFYNRIILDTAVLGKLPAELIAVLEDNNVSTTFIHEEDFVEFARGKIDYIGLNLYNRQY
VTDYSEGETEVFHNNKGKGSNSKEGIRIKNMFETSFDPKVKRNLWGREVYPKCMYNALME
IKEKYGDILVYITENGHGQYETPDENGYVEDKERIKLVGEFIDYMLKAREEGVNVQGYYM
WSTMDIYSWINGYEKRYGLVRVDFENNHKRIPKESYYWFKDLIAAKRNI
>PK3-045_05015 hypothetical protein
MTINLCTIGFLQKNLRTFVELLERNHVTKLVDIRLNNTSQLSGYSKTDDWLGLSTFCQWI
GDTI
>PK3-045_05016 hypothetical protein
MIDKKTTVQFTLLTFSIAYFVSGALIVLGPFGYSVHNWVHTFQQFLMNIPFAIYILSPAI
ASYVVLKKNKKIADFKEWLKTVFYIKNNIFVYLFVVAGLALYFLIHIAVSDRTEIVLPFY
TFFLSLPGNLIIGGLEEAGWMYILQPKLNKKYGFVVSSVITGIIWTVWHIPLFFIPGTNH
GEGLINFGMFVVQLMAFRFFHGAIYKISGKGFVFMSVLFHTMFNAASPIFGTMTMTWTGT
IAANTAIILVSILTVVIYEKKSMTIMQVRKL
>PK3-045_05017 hypothetical protein
MLSLELSEQEYELFNVEEKSHLELKNKNFIFGKNGAGKSTLCKMLEKQFTDEFDVRLFTG
FENVVVDTKLNAVVLGEENIDAKKNLQALDRKLNDLISEKKNLVNQIKSLDWNDEYKEEG
LQKHPLYKSKEELSNLYSNKESEINKFYTDKARELREYNSPQITKTTYNRNDFIKDISRK
KILDDKEIEDLKNTLSEIQKSIIIEKAEDKKFDFTTLINNVKRILEHEVAVVTVIEELKD
NPARKQFAQTGLKIHKAGEKCSFCGNEITEDRIKKLKTLVSMPEIQRIQTGINEHIQIID
NIGKEVNKIEELDKERFYITLHKEIDEVNTDIRLYKKKCNQYLVKLKDALNKRLSSIFNT
ILNIDVDIEIPEDFTSIEEKIKNIIKKHNELDENIEHRRIEAQKKLRLHFVDLKLNEKEN
YRKDWRGYEIEFHELERLDNDRLKNQEKIVNSIIKLEGSKDKLEENTVLYLDSEIKKANE
EKEAVLKETKSTYKFVQIINNKLKKAGKYNLELVLNKDEDGIEHYLVKDDNKKVRSIDKL
STGEKNIIAFLYFLESLSDVEKQNDKNKIIVFDDPMNSNDDTMQYLIITEMQKLYTDKYK
DKFKSQKDYFICLTHNAHFYLNIQPHGNFKDKKLINEKLVEISKYDKNNFYRLENGKFKL
ISSQKEDFNTHYELLWIELHSLYESDLLNSMLNSMRRIVETYIKFNKINLENFYKDKEEH
KKLFDVNSHSIDDHSMETIGKDKDTLIAMFKEVFETNNAIDHFGTYWK
>PK3-045_05018 hypothetical protein
MEPEQERLNKIVLEELEKILGDINFLRRLVSKLAPELLMSYKIKNNYTFKEMTTDLQLNG
GGYLESAITKIAKGQRKIREEPGKDEDLQAIIELKGSKELLIDKIITIILDHIRYTEDSD
AYLPSISLEDLNQIFMGKPNSDIGIEKRIQYLKSMSIEVLDIAIEESIQKERNKLISRVE
NLKFNSLYDLQSLSFLRGTFNFYEKYPDADLLFCGFFLKQYDLFSQLLDERIQVDEFSDK
LEELIDTVYTVIDTKNDN
>PK3-045_05019 hypothetical protein
MEIITLLVILLLILLILFFYHKFFDSDDEQVFRQYNFEELNWLKNSIIYPSIEVEIQSVV
LNPSDDKSLCYQKGNRIYCMEIIRTSDIEHLHKELTVNGKYLKGKLQETLHQQHTFGQVP
NLKVLGIAVLNEKFIIVMELIK
>PK3-045_05020 hypothetical protein
MSFFAFYDLQNKEKKLFIDWTKSPHALITGASGSGKTFASKYLIASLVAQMRETELFIVD
YKGDTDFEPFANVQNCYRYNEAKDGILKFLDRFHQRQSGLDTTRTPLFLFIDEFASFLTV
LDKKEAEDFKRKIAELLMLARSFNVHLIMALQRADSSYFINGARDNFPIRIGLGRLSDES
RRMLFPDMQKDDYMPLKRGEGYLQTDSSDIIKFFVPEFDMKLANRFILIGLDQKKNYIK
>PK3-045_05021 hypothetical protein
MPSYSINLESLLTTNTKPREKYKYVNGERTETVEGYSYRLIDVSNGEILNITIPRKKILE
PQTYVEIVNAVGTPFVTNNRATLSIKAEDIHPTEL
>PK3-045_05022 hypothetical protein
MVKAKNMMYVQDLEHLPFTDLTECLEHIKKELNPIKYAGILHNKDISDDGSLKTPHIHVM
LQFENARSIQNIAKVLKDKPQYIQQWKGDSTNGYSYLIHATTDAQEQYQYDVNEVVANFD
YKDLIEKVKKRVKFILTGKDEIIIKGLLDKLYLGEITKEEVEKLLSGSQYAKAKTRIINV
YQKRMEIVADEWREYMRENNLSIEVIWIYGASGVGKTRLAKDYASKYDEDYFVTGSSKDP
FQHYQGQKIIILDELRPSIFQYSDLLKMLDPFNDDVMGASRYFDKPLTANIFIITSPYKP
RDFYMKIIEENKKFDLHTDTFKQLARRINLVLYLDKDSMQIALYDSKLDNFFIEKSSKEL
NPYIEVTKNEDFLQNLKSEKLYKQVLNSTKNNPVKVNNKMPKDNSRTVLF
>PK3-045_05023 hypothetical protein
MQIKESFPFPYLLTREQASRFLGIDPKSFDKYIRSNEQFERFMIGRHERYTIKALINFIE
KQSV
>PK3-045_05024 Tyrosine recombinase XerC
MASIIKRGKSYRAQVSLYKQGKHKKLSKTFPTKKEAELWTLEMELAKGEGKELAHRTTTF
VDFFENWIYLVKVNDVKETTFQNYIRTLGAIKKLFQDIQLKDLNDIVVQKKIDEYAKTHS
RKTTHEVLLKIKTALRDAYARGYIVNDFARLVKTRGENPPKRNRALSITDFKKLRNYVLK
HPEDEFNLLVLLALETGMRRGELLAIRPESLYEYGIKVRHSISPTSDDTSLKTQNAKRDV
SINKEVYELVLNIPVKDNGYIFGFAGFKQSELLAELLTELNIKRTTFHGLRDTHASFLFA
QDIDIAYVSKRLGHINIQTTQNYYLELMPEKKHQQDADALNLLSSL
>PK3-045_05025 30S ribosomal protein S9
MAQVQYIGTGRRKSSVARVRLVPGDGQIIINGREIENYIPFAALREVVKQPLVATETTGS
YNILVNVNGGGYTGQAGAIRHGIARALLQVDPEYRPTLKRAGLLTRDARMKERKKYGLKG
ARRAPQFSKR
>PK3-045_05026 50S ribosomal protein L13
MRTTFMANSNNVDRKWYVIDAEGQTLGRLASEIASILRGKHKPTFTPHVDTGDHVIILNA
SKIELTGKKLTDKIYYRHSMHPGGLKQRTALEMRTNYPEQMLELAIKGMLPKNSLGRQMF
RKLHVYAGSEHPHQAQQPEVYELRG
>PK3-045_05027 tRNA pseudouridine synthase A
MQRYKCTVSYDGSNYSGFQIQPKDRTVQGEIERALRRLHKGVEVKIQASGRTDAGVHAKG
QVIHFDSSLDIPADKWPIALNTLLPHDIVVADAEIVPDSFHARYNVTAKEYRYFIQLGER
RDPFKRNYAYYYPYALNMEAMREALCYFIGEYDFTSFCSAKTDKERKVRTITGVKLTEED
NMLIFSFQGNGFLYNMVRIMVGTLLDVGRGKKLPQDIPVILEKKDRKAAGKTASANGLYL
WKVWY
>PK3-045_05028 Energy-coupling factor transporter transmembrane protein EcfT
MGKMIIGRFIPVDSTLHRMDPRSKLLLVFLFICIVFLANNIWSYLLLIVYVGTLVAISNV
PIKYIYLGLRPIFWLIIFTFILHIFFTKNGELLFEWGWITIYKEGIRMGILISIRFFLLI
IMTSLLTLTTTPIELTDAIETLLGPLKKVKFPVYELALMMSISLRFIPTLMDETEKIMKA
QMARGVEFSSGSIKSRVQAIIPLLIPLFVNSFKRAEELAIAMEARGYQGGEGRTKYRQLI
WNPIDTIMIIILILITAMLFVLRT
>PK3-045_05029 Energy-coupling factor transporter ATP-binding protein EcfA2
MDISLQKVEYRYQENSPFERLAIEDVSFDIPSGSYVAVIGHTGSGKSTILQHLNALLTPS
KGKVVIGDRTLEGGQKHKNLRSIRQRVGIVFQFPEQQLFEETVEKDICFGPLNFGIPESE
AKIRAVKALSEVGLSEDFLMKSPFDLSGGQMRRIAIAGVLAMEPDVLVLDEPTAGLDPRG
RREIMDMFYKLHKERNLTTVLVTHSMEDAAHYADQIVIMNKGKVHRQGTPIEIFKEAEDL
AAIGLNVPEVVRFQKKVEAKFGVKMERVHLNMEDFTDELAVYLQKKVGSS
>PK3-045_05030 Energy-coupling factor transporter ATP-binding protein EcfA1
MDQKILLKVEDVSFKYEEQSEYALNRVSFHVNAGEWVAIVGHNGSGKSTLAKLLNGLQFS
HEGSIVIDGIPITEETVWDIRKKVGMVFQNPDNQFVGTTVKDDVAFGLENNAVPRSEMVT
RVERSLEKVKMLSFLDQEPHHLSGGQKQRVAIAGIIALKPEIIILDEATSMLDPQGREEV
FDIMRELQKENMTIISITHDLDEAAKADRIIVMNKGRVYKEGNPKEIFKLQKELVEIGLD
IPFTIKIRESLINKGISLEEIYLTEEELVTGIWTSHFKK
>PK3-045_05031 50S ribosomal protein L17
MGYRKLGRTSAQRKAMLRDLTTDLIINERIETTEARAKELRSVVEKMITLGKRGDLHARR
QAAAYVRHEVANAETNQDAVQKLFSDVAARYTDRQGGYTRIMKMGPRRGDGAPMVIIELV
>PK3-045_05032 DNA-directed RNA polymerase subunit alpha
MIEIEKPKIETVEINDDAKYGKFVVEPLERGYGTTLGNSLRRILLSSLPGAAVTSIQIDG
VLHEFSTIEGVVEDVTAIILNIKKLALKIYSDDEKTLEIDMQGAGVVTAADITHDSDVEI
LNPDLHIATLGSNGNFRMRLTAKRGRGYTPAEQNKREDQPIGVIPIDSIFTPVSRVSYQV
ENTRVGQLTNYDKLTFDVWTDGSTGPQDAIALGAKILTEHLNIFVGLTDEAQNAEIMVEK
EEDQKEKVLEMTIEELDLSVRSYNCLKRAGINTVQELANKTEEDMMKVRNLGRKSLEEVK
HKLEELGLGLRKDD
>PK3-045_05033 30S ribosomal protein S11
MARKTNTRKRRVKKNIESGVAHIRSTFNNTIVTITDVHGNALSWSSAGALGFRGSRKSTP
FAAQMAAETAAKASMEHGMKTLEVTVKGPGAGREAAIRALQAAGLEVTAIRDVTPVPHNG
CRPPKRRRV
>PK3-045_05034 30S ribosomal protein S13
MARIAGVDIPREKRVVISLTYIYGIGKNTAQKVLAEAGVSEDTRVRDLTEDELNKIRDII
DGLKVEGDLRREISLNIKRLMEIGCYRGLRHRRGLPVRGQNTKNNARTRKGPRKTVANKK
K
>PK3-045_05035 Translation initiation factor IF-1
MAKDDVIEIEGTITETLPNAMFKVELENGHTVLAHVSGKIRMHFIRILPGDKVTVELSPY
DLTRGRITYRFK
>PK3-045_05036 Adenylate kinase
MNLVLMGLPGAGKGTQAEKIVAKYDIPHISTGDMFRAAMKDETELGLKAKSFMDKGELVP
DEVTIGIVRERLSKDDCEKGFLLDGFPRTVPQAEALENILSELNKKLDFCINVQVDQEIL
MERLTGRRICKSCGATYHLVFNPPSKPDTCDRCGGELYQRADDNEATVKNRLEVNIKQSQ
PLLDFYESKGYLRNINGQQDINKVFVDLDELLSTLK
>PK3-045_05037 Protein translocase subunit SecY
MFQTISNFMRVGEIRRKIIFTLLMLIIFRLGTFIPVPYVNAEFLKAQDAFSAFGILNTFG
GGALKNFSILAMGIMPYITASIIVSLLQMDVVPKFTEWSKQGEAGRRKLTQFTRYFTIVL
ALIQGFGMSYGFNNLAGGALITKPGFSSYLVISIVLTAGTAFLMWLGELITSKGVGNGIS
IIIFAGIAAGIPSIANQIYAQQFDNPGDQLFLNIVTLALIVIAVIAIVVGVIFIQQALRK
IPIQYAKRMVNGNSSTGGQSTHLPLKVNSAGVIPVIFAVSFLVTPRTIASFLPQNDVTSW
IQRVFDYTHPIGMIIYTVLILAFTYFYAFIQVNPEQVSENLKKQGGYIPGIRPGKSTQDY
LSRVLSRLTLVGALFLAIIAILPVFFINIAGLPQSAQIGGTSIIIVVGVALETMKQLESQ
LVKRHYKGFIK
>PK3-045_05038 50S ribosomal protein L15
MKLHELKPAEGSRQERKRKGRGIGSGNGKTAGKGHKGQNARSGGGVRPGFEGGQTPLFRR
LPKRGFTNINRKEYAIVNLDTLNRFEEGTEVTPELLIETGVVSNEKAGIKILAKGNVEKK
LTVKAHKFSSAAKEAIEAAGGQTEVI
>PK3-045_05039 50S ribosomal protein L30
MANNLEITLTRSVIGRPQDQRETVKALGLRKVNQTVVQQDNAAIRGMINKVSHLVTVKEN
>PK3-045_05040 30S ribosomal protein S5
MRRIDPNKLELEERVVTVNRVAKVVKGGRRFRFSALVVVGDKNGNVGFGTGKAQEVPDAI
RKAVEDAKKNLIEVPMVGTTIPHEIIGHFGAGEILLKPASAGTGVIAGGPVRAVLELAGV
ADILSKSLGTNTPINMVRATLDGLKQLKRAEDVAKLRGKSVEELLG
>PK3-045_05041 50S ribosomal protein L18
MITKADKNQVRKKRHARVRSKLSGTEARPRLNVFRSNKHIYAQLIDDVNGVTIASASSLD
KELNLESTGNLEAAVKIGELVAKRAVEKGIKSVVFDRGGYLYHGRVKALADAARENGLEF
>PK3-045_05042 50S ribosomal protein L6
MSRVGKKPIEVPAGVTVTIDKSTVTVKGPKGELTRTFNSDIAISLEENVINVTRPSDVKE
HRALHGTTRALLSNMVEGVSKGFERGLELIGVGYRAQKQGSKLVLNVGYSHPVEIEPEAG
IEIEVPSATKVVVKGTSKERVGALAANIRDVRPPEPYKGKGIRYEGEYVRRKEGKTGK
>PK3-045_05043 30S ribosomal protein S8
MVMTDPIADLLTRIRNANMVRHEKLEVPASNIKKEIAEILKREGFVRDVEYIEDNKQGII
RIFLKYGSSNERVITGLKRISKPGLRVYAKATEVPRVLNGLGIALVSTSQGVLTDKEARA
KQVGGEVLAYVW
>PK3-045_05044 30S ribosomal protein S14
MAKKSMIAKQKRTPKYKVQEYTRCERCGRPHSVYRKFKLCRICFRELAYKGQIPGVKKAS
W
>PK3-045_05045 50S ribosomal protein L5
MNRLKEKFVKETTPALMSKFNYKSVMEVPKLEKIVVNMGVGDAVANAKALDVAVEELAQI
TGQKPVITRAKKSIAGFRLREGMPIGAKVTLRGERMYQFLDKLVSVSLPRVRDFRGVSKK
SFDGRGNYTLGVKEQLIFPEIDYDKVNKVRGMDIVIVTTAKTDEEARELLTQFGMPFQK
>PK3-045_05046 50S ribosomal protein L24
MHVKKGDKVMVISGKDKGKTGVVLAAFPKKDRVIVEGINIVKKHSKPSQLNPQGGINDQE
AAIHVSNVMPIDPKTGEPTRVGSKTVDGKKVRVAKKSGEILDK
>PK3-045_05047 50S ribosomal protein L14
MIQQESRLKVADNSGAREVLTIKVLGGSGRKTANIGDIIVVTVKQATPGGVVKKGDVVKA
VVVRTKSGVRRADGTYIRFDENACVIIRDDKSPRGTRIFGPVARELRDNNFMKIVSLAPE
VL
>PK3-045_05048 30S ribosomal protein S17
MSERNQRKVYTGRVVSDKMDKTITVVVETYKKHPLYGKRVKYSKKYKAHDEQNTAKTGDI
VRIMETRPLSATKRFRLVEVVEKAVII
>PK3-045_05049 50S ribosomal protein L29
MKANEIRDLTTAEIEQKVKSLKEELFNLRFQLATGQLENTARIREVRKAIARMKTVIRER
EIGVNNR
>PK3-045_05050 50S ribosomal protein L16
MLLPKRVKYRRVHRGKMRGQAKGGTEVAFGEYGLQSLEASWITNRQIESARIAMTRYMKR
GGKVWIKIFPHKPYTAKPLEVRMGSGKGAPEGWVAVVKPGKIMFEVAGVSEEIAREALRL
AAHKLPVKCKFVKREEIGGETNES
>PK3-045_05051 30S ribosomal protein S3
MGQKVNPVGLRVGIIRDWESKWFAGKDYADLLHEDLKVREYITKRLSDASVSKVEIERAA
NRLNVTIHTAKPGMVIGKGGTEVEALRKALNSLTGKRVHINILEIKRADMDAKLVAENIA
RQLENRVSFRRAQKQAIQRSMRAGAKGIKTMVSGRLGGADIARSESYSEGTVPLHTLRAD
IDYATAEADTTYGKLGVKVWIYRGEILPTKKKTEEGGK
>PK3-045_05052 50S ribosomal protein L22
MQAKAVANTVRIAPRKARLVVDLIRGKQVGEAVAILKLTPKAASPIVEKVLKSAIANAEH
NYEMDINNLVVEQAYVNEGPTLKRFRPRAQGRASQINKRTSHITIVVSEKKEG
>PK3-045_05053 30S ribosomal protein S19
MGRSLKKGPFVDDHLLTKIEKLSDSDKKQVVKTWSRRSTIFPQFIGQTIAVYDGRKHVPV
YVTEDMVGHKLGEFAPTRTYKGHASDDKKTRR
>PK3-045_05054 50S ribosomal protein L2
MAIKKYKPTSNGRRNMTSSDFSEITTSTPEKSLLAPLHRKGGRNNQGKLTVRHQGGGHKR
QYRVIDFKRDKDGIPGRVATIEYDPNRSANIALINYVDGEKRYILAPKNLEVGLEVMSGP
EADIKPGNALPLANIPVGTVIHNIELKPGKGGQLVRSAGTSAQVLGKEGKYVLVRLNSGE
VRLILATCRASIGQVGNEQHELINIGKAGRNRWLGKRPTVRGSVMNPNDHPHGGGEGRAP
IGRKSPMSPWGKPTLGYKTRSKKNKSDKFIVRSRKK
>PK3-045_05055 50S ribosomal protein L23
MDARDTIKRPVITERSTDLMVDKKYTFEVDVRANKTQVKDAVEEIFGVKVEKVNIMNYKG
KFKRMGRFGGYTNKRRKAIVKLTADSKEIEFFEA
>PK3-045_05056 50S ribosomal protein L4
MPKVALFNQDGKQAGDIELNESVFGIEPNKSVLFEAVVMQRASLRQGTHKTKIRSEVAGG
GRKPWRQKGTGRARQGSIRSPQWRGGGTVFGPVPRSYSYKLPKKVRRLAIKSALSTKVLE
ENILVLQSLAFDAPKTKDFKAVLGNLSVEKKALIVTADLDENVALSARNIPGVTVVTASG
ITVLDVLNHDKLIMTKAAVEKVEEVLA
>PK3-045_05057 50S ribosomal protein L3
MTKGILGRKIGMTQVFADNGNLIPVTVVEAAENVVLQKKTVEADGYAAVQIGFENKREKL
ANKPEQGHVAKASTAPKRFVREFRDVSVEEYEVGQEVNVSIFAEGDIVDVTGVSKGKGFQ
GSIKRHGQSRGPMAHGSRYHRRPGSMGPVAPNRVFKGKALPGRMGGEQITVQNLEIVKVD
AERNLLLIKGNVPGARKALLKIKTAVKA
>PK3-045_05058 30S ribosomal protein S10
MAKQKIRIRLKAYDHRILDQSAEKIVETAKRSGAAVSGPIPLPTEKSIYTILRAVHKYKD
SREQFEMRTHKRLIDIVNPTPQTVDSLMRLDLPSGVDIEIKL
>PK3-045_05059 Elongation factor Tu
MAKAKYDRSKPHVNIGTIGHVDHGKTTLTAAITTVLSKVGGGEARGYDQIDAAPEERERG
ITISTAHVEYETATRHYAHVDCPGHADYVKNMITGAAQMDGGILVVSATDGPMPQTREHI
LLSRQVGVPHLVVFLNKCDMVDDEELLELVEMEVRDLLTEYEFPGDDIPVIKGSALKALE
GDAAWEEKITELMAAVDEYIPTPTRDTDKPFMMPVEDVFSITGRGTVATGRVERGQVKVG
DVVDIIGLAEEKKSTTVTGVEMFRKLLDYAEAGDNIGALLRGVAREEIQRGQVLAKPGSI
TPHVKFKAEVYVLSKEEGGRHTPFFTNYRPQFYFRTTDVTGICNLPEGVEMVMPGDNIEM
DVELISSIAIEEGTKFSIREGGRTVGAGVVATIVE
>PK3-045_05060 Elongation factor G
MAREFSLENTRNIGIMAHIDAGKTTTTERVLYYTGRIHKIGETHEGASQMDWMEQEQERG
ITITSAATTAQWKGNRVNIIDTPGHVDFTVEVERSLRVLDGAVAVLDAQSGVEPQTETVW
RQATTYGVPRVVFVNKMDKIGADFLYSLKTLHDRLQANAHAIQLPIGAEDQFEGIIDLVE
MKATFYGNDLGTDIQEREIPEDYRELAEEYHEKLVEAVAELDEELMEKYLGGEEITTDEL
KAAIRKGTVNVEFYPVICGSAFKNKGVQKMLDAVIEYLPSPLDVPAIKGTAPDSDEVIEK
HSSDDEPFAALAFKVMTDPFVGKLTFFRVYSGTLSSGSYVQNSTKGKRERVGRILQMHAN
SRQEITEVYAGDIAAAVGLKDTTTGDTLCDEKDLVILESMEFPEPVIELSIEPKSKADQD
KMTTALQKLQEEDPTFRAHTNQETGQVIIAGMGELHLDILVDRMRREFKVEANVGAPQVA
YRETFRSSAAVEGKFTRQSGGRGQYGHVWIEFSPNEEGKGFEFENAIVGGVVPREYIAPV
QAGLEDALQRGVLAGYPMVDIKAKLFDGSYHDVDSSEMAFKIAASMALKNAASKCNPVIL
EPVMKVEVIIPEEYMGDIMGNITSRRGRVEGMEARGNAQVVRAMVPLSEMFGYATTLRSS
TQGRGVFSMVFDHYEEVPKSISEEIIKKNKG
>PK3-045_05061 30S ribosomal protein S7
MPRKGPVAKRDVLPDPIYNSKLVSRLINKMMIDGKRGKSQAILYSAFEIVAERSGKEAIE
VFDQALKNIMPVLEVRARRVGGSNYQVPVEVRPERRTTLGLRWLVNYARLRGEKTMEERL
ANEILDAANNTGASVKKREDTHKMAEANKAFAHYRW
>PK3-045_05062 30S ribosomal protein S12
MPTINQLVRKPRQSTEEKSKSPALNKGYNSFKKAQTNVSSPQKRGVCTRVGTMTPKKPNS
ALRKYARVRLTNGIEVTAYIPGIGHNLQEHSVVLIRGGRVKDLPGVRYHIVRGALDTAGV
NNRMQGRSKYGTKKPKAAKK
>PK3-045_05063 Ribosome-associated protein L7Ae-like protein
MSYEKVRQASKIVVGTKQTVKALKKGIATEVIVAEDADPMIIRKVSEVAEEVNIPIILVE
SMKKLGESCGIEVGAATVAIII
>PK3-045_05064 DNA-directed RNA polymerase subunit beta'
MLDVNNFEYMKIGLASPDKIRSWSFGEVKKPETINYRTLKPEKDGLFCERIFGPTKDWEC
HCGKYKRVRYKGVVCDRCGVEVTRAKVRRERMGHIELAAPVSHIWYFKGIPSRMGLVLDM
SPRALEEVIYFASYVVTDPGDTALEKKQLLSEKEYRAYRDKYGVKFQASMGAESIKKLLS
DIDLNKEVDALKEELKTAQGQRRTRAIKRLEVLEAFRGSGNEPSWMILDVLPVIPPELRP
MVQLDGGRFATSDLNDLYRRVINRNNRLKRLLDLGAPSIIVQNEKRMLQEAVDALIDNGR
RGRPVTGPGNRPLKSLSHMLKGKQGRFRQNLLGKRVDYSGRSVIVVGPNLKMYQCGLPRE
MAIELFKPFVMKELVEKGIAHNIKSAKRKIERLQPEVWDVLEEVIKEHPVLLNRAPTLHR
LGIQAFEPTLVEGRAIRLHPLVCTAYNADFDGDQMAVHVPLSSEAQAEARLLMLAAQNIL
NPKDGKPVVTPSQDMVLGNYYLTLEREGAVGEGMIFNDTNEALLAYQNGYVHLHTRVAVR
ASSLNNETFTEEQNKQLLLTTVGKLVFNEILPKSFPYINEPTKTNLEEKTPERYFVEPGV
DVPAAIRELPIIEPFKKKILGNIIAEVFKRFKITETSKMLDRMKDLGFKHSTKAGITVGV
ADIVVLGEKQEIIEEAQSKVDNVMKQFRRGLITEEERYDRVISIWSAAKDTIQAKLMKSL
DKRNPIFMMSDSGARGNASNFTQLAGMRGLMANPAGRIIELPIISSFREGLTVLEYFIST
HGARKGLADTALKTADSGYLTRRLVDVAQDVIVREDDCGTDRGLLVSALKEGTEIIESLD
ERLIGRYARRSIKHPETNEVIVPENGLITEDLAVEIVEANIEEVWIRSAFTCNTRHGVCK
KCYGRNLATGQEVEVGEAVGIIAAQSIGEPGTQLTMRTFHTGGVAGDDITQGLPRIQEIF
EARNPKGQAVITEMAGVVVGINEGRDRQHEIVVQGELETRTYTAPYTARLKVKVDDVVEQ
GQELTEGSIDPKELIKVKNVTAVQEYLLREVQKVYRMQGVEIGDKHVEVMVRQMLRKIRV
VDAGETDVLPGTLLDIHQFTDANAKALREGKLPATGRPVLLGITKASLETDSFLSAASFQ
ETTRVLTDAAIKGKRDELLGLKENVIIGKLVPAGTGMPRYRHAEPITAEELTEESVTVE
>PK3-045_05065 DNA-directed RNA polymerase subunit beta
MTGQLVQYGRHRQRRSYARISEVLELPNLIEIQTSSYQWFLDEGLREMFQDISPIEDFTG
NLSLDFIDYSLGDPKYSVEESKERDVTYSAPLRVKVRLVNKETGEVKDQDVFMGDFPLMT
ETGTFVINGAERVIVSQLVRSPSVYYNGKLDKNGKKGFTATVIPNRGAWLEYETDAKDVV
YVRIDRTRKLPVTVLLRALGFGSDQEIIELIGDNEYLRNTLEKDNTEGTDKALLEIYERL
RPGEPPTVENAKSLLVSRFFDPKRYDLANVGRYKINKKLHIKNRLFNQRLAETLVDPETG
EIIAEKGTLLDRRALDRIIPNLENNIGFKKLSPYGGVLEDDVVVQSVKIYSPLDEGDKEI
NVISNAYVEEAVKNISPSDIIASISYFFNLLHGVGLTDDIDHLGNRRLRSVGELLQNQFR
IGLSRMERVVRERMSIQDTNTITPQQLINIRPVIASIKEFFGSSQLSQFMDQTNPLAELT
HKRRLSALGPGGLTRERAGMEVRDVHYSHYGRMCPIETPEGPNIGLINSLSSYAKVNRFG
FIETPYRRVDPETGKVSSRIDYLTADEQDNYVVAQANARLGEDGSFLDEDVVARFRDENV
VVKRDRVDYMDVSPKQVVSAATACIPFLENDDSNRALMGANMQRQAVPLMQPEAPRVGTG
MEYVSGKDSGAAVICKHPGIVEHVEAREVWVRRISEVDGQEVKGNLDKYKMLKFVRSNQG
TCYNQRPIVAVGDKVTKGEVLADGPSMELGELALGRNVLVAFMTWDGYNYEDAIIMSERL
VKDDVYTSIHIEEYESESRDTKLGPEEITRDIPNVGEDALRNLDDRGIIRIGAEVKDGDL
LVGKVTPKGVTELTAEERLLHAIFGEKAREVRDTSLRVPHGGGGIVHDVKVFNREDGDEL
PPGVNQLVRVYIVQKRKIHEGDKMAGRHGNKGVISRILPEEDMPYLPDGTPVDIMLNPLG
VPSRMNIGQVLELHLGMAARSLNIHVASPVFDGAREEDVWETIREAGMAQDAKTVLYDGR
SGEPFDNRVSVGVMYMIKLAHMVDDKLHARSTGPYSLVTQQPLGGKAQFGGQRFGEMEVW
ALEAYGAAYTLQEILTVKSDDVVGRVKTYEAIVKGENVPEPGVPESFRVLMKELQSLGLD
VKILSSTEEEIEMRDTDDDDDIHQAESLTIVSETQEPESEKVGMQE
>PK3-045_05066 Ribosomal RNA small subunit methyltransferase C
MTEHYYSRTQNVNSDPNYWNFTLKGNTIRFKTDNGVFSKKEVDFGSRLLIETYTLPDLDG
DILDVGCGYGPIGISIAKTSPNRMVHMVDVNLRAIELAEENARQNGVENVRIYESDRLLR
VKGQKFASILTNPPIRAGKKVVHDIFEQSYECLVPNGELWVVIQKKQGAPSAIAKLEEFF
KEVNIVEKKKGYFIIQAKKID
>PK3-045_05067 50S ribosomal protein L7/L12
MSKEQILEAVKNMTVLELNDLVKAIEEEFGVTAAAPVAVVAGGGEAAAEKSEFDVVLASA
GDQKIKVIKVVREITGLGLKEAKELVDNTPKAVKEGASKEEAEEIKAKLEEVGANVEVK
>PK3-045_05068 50S ribosomal protein L10
MSSVIEQKKQIVSDIAEKFKASKSTIVVDYRGLTVSEVTELRKQLRDAGIEFKVFKNSLT
RRAAESVELAGLNESLTGPNAIAFSNEDVVAPAKILNDFAKNHEALEIKAGVIEGNLATV
EEVKALAELPSREGLLSMLLSVLQAPIRNLALATKAVADQKEEQGA
>PK3-045_05070 50S ribosomal protein L1
MAKKGKKYLEAIKLVDRTKAYPIQEAIELVKKTSTTKFDASVEVAFRLGVDPKKADQQIR
GAVVLPNGTGKTQRVLVFAKGEKLKEAEAAGADYVGDAEFINKIQQGWFDFDVIVATPDM
MGEVGKLGRVLGPKGLMPNPKTGTVTFDVTKAVNEIKAGKVEYRVDKAGNVHVPIGKVSF
DEAKLVENFQTIFDTMSKAKPAAAKGTYMKNVSVTSTMGPGVKVDPSTV
>PK3-045_05071 50S ribosomal protein L11
MAKKVIKVVKLQIPAAKANPAPPVGPALGQAGVNIMGFCKEFNARTAEQAGLIIPVEITV
FEDRSFTFITKTPPAAVLLKKAAGIESGSGEPNRNKVATVKRDKVREIAETKMPDLNAAS
VESAMRMVEGTARSMGIVIED
>PK3-045_05072 Transcription termination/antitermination protein NusG
MEKNWYVVHTYSGYENKVKANLEKRVETMAMQDKIFRVVVPEEEETDIRNGKTKVVKRKV
FPGYVLVEIVMTDDSWYVVRNTPGVTGFVGSAGSGSKPTPLLPEEVQVILKRMGVEEQRI
EIEFELGETVKVNEGPFANFTGTVEEIDKDKAKVKVLVNMFGRDTPVELDFTQIEKF
>PK3-045_05073 Protein translocase subunit SecE
MQSAVKYFREVGRELKKVSWPKKKELTNYTLTVLVTVVFFAIFFAVVDLGISELIRLILE
>PK3-045_05074 50S ribosomal protein L33 1
MRKKIVLACEKCGSRNYSTVSNNGTERLEVKKFCQNCNAHTVHKETK
>PK3-045_05075 RNA polymerase sigma-H factor
MSTDSWTKSNEYTGNYMELEDEVLVELVHQGESDALDYLIQKYRNFVRAKARSYFLIGAD
KEDIVQEGMIGLYKAIRDFKEDKLSSFKAFAELCITRQIITAIKTATRQKHIPLNSYVSL
DKPIYDEESDRTLMDIISGAKVLDPEELIINQEEYDHIEIKMSELLSDLERKVLSLYLDG
QSYQEISEELNRHVKSIDNALQRVKRKLERYLEIREFSL
>PK3-045_05076 putative protein YacP
MDILIVDGYNIIGAWPELNALKNRDLAAARDALVAKMAEYQGYSGYRVMVVFDAYYVKGT
EKKYKDYKVEVIFTRENETADERIEKLAIELNNRKTQIHVATSDFTEQWAIFGQGALRKS
ARELLLEMAGMEQEIGKKVKKIKEKKPVAKIPLSREVEEIFEKWRRGEK
>PK3-045_05077 Putative TrmH family tRNA/rRNA methyltransferase
MSSDFIVGKNAVIEALKSERDVNKILIAEGSQKGQMQTVIGLAKQANVLVQFVPKKKLDS
LVDANHQGVVAQVAAYQYAEIDDLFALAEKKQETPFFLLLDEIEDPHNLGSIMRTADAVG
AHGIIIPRRRAVGLTATVAKASTGAIEHIPVVRVTNMARTIEELKTRGIWIAGTDAKGSE
DYRKFDGTIPLGLVIGSEGKGMGRLIKEKCDFLIHLPMAGAVTSLNASVAAALLMYEVYR
KRHPLEG
>PK3-045_05078 Mini-ribonuclease 3
MLLYDKKVDEKQLNSLALAYMGDAVLEIYVRRHLLYSGKVKPNQLHREATKYVSAKGQAK
VVHSLLEKGFFSEEEIAVLKRGRNAKSGTIPKNTDVQTYRYSTGFEAVLGYLYLAKREER
LEKIIKAAFSIIESK
>PK3-045_05079 Cysteine--tRNA ligase
MPIQIYNTLTRAKEDFVPLEEGKVKMYVCGPTVYNYIHIGNARPAIVFDTVRRYLEFRGY
DVQFVSNFTDVDDKLIKAANELGETVPVIADRFIDAYFEDVSALGCKKADSHPRVTENMD
IIIDFIAALIDKGFAYESEGDVYYHTRAFDGYGKLSHQSIDELRSGARIAVGEKKQDSLD
FALWKKAKEGEIFWESPWGNGRPGWHIECSAMVRKYLGDTIDIHAGGQDLAFPHHENEIA
QSEALTGKTFANYWMHNGYINIDNEKMSKSLGNFITVNDIIKIHDPQVLRFFMLSVHYRN
PINYSEEVLENTRAGLERIRTSYENLKHRSIASTDLTDTNQEWIAKIADLRKQFVDSMDD
DFNTANGISVLFELSKQANYYLLEKTTSPAVIHAFMNEFEELFTVLGLSLSANEELLDEE
IEALIEKRTQARKDRDFVLADQIRDQLKAMNIILEDTAQGIRWKRG
>PK3-045_05080 Serine acetyltransferase
MFRRMKEDIAVVFEQDPAARSSIEVILTYSGLHAIWFHRIAHFFFRHNRFFLARVISQFS
RFMTGVEIHPGAKIGNRLFIDHGMGVVIGETCEIGDNVTIFQGVTLGGTGKEKGKRHPTV
KNNALIASGAKVLGSIVIGENAKIGAGSVVLKDVPANSTVVGIPGRVKVQDGIKIKKDLN
HCDLPDPIADRLKEMELEISYLREQLKELQEERSYK
>PK3-045_05082 Glutamate--tRNA ligase
MSNEIRVRYAPSPTGHLHIGNARTALFNYLFARSQGGKFIIRIEDTDKKRNIEGGEESQL
KYLKWLGMDWDESTDVGGEYGPYRQSERNDIYKKYYTELLEKGLAYKCYCTEEEIEAERE
DQVSRGETPKYSGKCRHLTKEQQAALEAEGRQPSIRIRVPENVVYEFNDMVKGDVSFESA
TIGDYVIVKKDGTPTYNFAVAIDDHLMDITHVLRGDDHITNTPKQLMIYDALGWDRPIFG
HMTLIVNESRKKLSKRDESIIQFIEQYEELGYLPEALFNFIALLGWSPEGEEELFTIEEF
IRIFDPARLSKSPALFDQNKLAWMNNQYIKKADLETVVRLAVPHLEKAGLVSENRSADEE
AWVNNLVGLYQEQMSCGADIVNLSTLFFSDEVQYDEEAKEVLAGEHVPTVVQAFKEALAE
MPEWSAEQIKAAIKVVQKATGQKGKNLFMPIRVATTGQTHGPDLPKAIELLGKEKIDARL
TALIS
>PK3-045_05083 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase
MFRIGQGFDVHQLVSGRPLIIGGIEIPYEKGLLGHSDADVLLHTIADACLGAIGEGDIGK
HFPDTDEAFKDADSAKLLQHVWQIVKEKGYELVNADCTIMAQQPKMAPHIQAMQARIAEL
LETEQDNINVKATTTEKLGFTGRGEGIASQAVVLLQKRNV
>PK3-045_05084 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase
MTYEVIIPAAGQGKRMGLGKNKLFLALDSLPVFIHTLIVFENDPNCNGIWLVVSSDDKKE
MNELVKKYAITKVIALIEGGTERQHSVYHAVKEISDDTIVLVHDAARPFIQTEQIARLTK
VAVESGAAVLAVPIKDTIKKVDGDLVVETVERSSLWAIQTPQAFRVSILKEAHEKAILDT
YIGTDDASLVERLGQAVQIVEGNYDNIKLTTPEDLYFAEAIVAKRKENIAESK
>PK3-045_05085 putative PIN and TRAM-domain containing protein YacL
MFLLNINSWSLFPEQWKRAFLTLVYDIVIISIKITFSLQIKNSCNIRFQNWEFVYNVKEE
VEVLLKRIVQVCFLIIGGTIGFLFIPDLFSVMSIDHDLINNAYVSAILGAIIFYLITFWA
IDYIVNFIKFLEESIVKAPITDIIFGSLGIGFGLTLAFLVGYALTSVPVLNTVAPILLSL
LFGYLGFQVGFKKRDELLTLFTARKKKVVEEEPTKVEKSNLKILDTSVIIDGRIADICQT
GFLEGTIVIPQFVLGELQHIADSSDALKRNRGRRGLDILNRIQKELAIKVEIYEGDFEDI
TEVDSKLVKLAKLTNGVVVTNDFNLNKVCELQKVAVLNINDLANAVKPVVLPGEEMKIQI
IKDGKEHNQGVAYLDDGTMIVVEEGRNYIGKHIDVLVTSVLQTSAGRMIFAKPKLLEKAL
>PK3-045_05086 DNA repair protein RadA
MAKRKTKFLCQECGYESAKWMGKCPGCGNWNTMVEEVEKSAVQRKGAFAHSAATTVAAKP
IPITSIETVNEPRIYTDLMELNRVLGGGVVRGSLVLIGGDPGIGKSTLLLQVSSQLAHKK
HSVLYVSGEESQKQTKLRADRLGVVSDHLLVYSETNLEEISRTIENTNVEFVVIDSIQTI
YHPEVTSAPGSVSQVRECTAELMRIGKTKGIAIFIVGHVTKEGSIAGPRLLEHMVDTVLY
FEGERHHTYRILRAVKNRFGSTNEMGIFEMKEFGLEEVENPSEIFLEERSQGAAGSTVVA
SMEGTRPVLVEIQALISPTSFGNPRRMATGIDHNRVPLLMAVLEKRVGMLLQNQDAYLKV
AGGVKLDEPAIDLAIAVSIASSFRDKPTRATDCIIGEVGLTGEVRRVSRIEQRVQEAAKL
GFERVIIPANNLSGLKAPKGLEVVGVHTVADALKAALSD
>PK3-045_05087 Negative regulator of genetic competence ClpC/MecB
MMFGRFTERAQKVLALSQEEAIRLGHNNIGTEHILLGLVREGEGIAAKALQALGLGAEKI
QEEVENLIGRGQDTTQTVPHYTPRAKKVIELSMDEARKLGHSYVGTEHILLGLIREGEGV
AARVLNNLGVSLNKARQQVLQLLGSSESGNHPGGSAASANTPTLDSLARDLTAIAREGSL
DPVIGRSKEIQRVIEVLSRRTKNNPVLIGEPGVGKTAIAEGLAQQIVQNEVPEILRDKRV
MTLDMGTVVAGTKYRGEFEDRLKKVMDEIRQAGNIILFIDELHTLIGAGGAEGAIDASNI
LKPSLARGELQCIGATTLDEYRKYIEKDAALERRFQPITVDEPTSDESIQILKGLRDRYE
AHHRVSITDDAIEAAVKLSDRYISDRFLPDKAIDLIDEAGSKVRLRSYTTPPNLKELEVK
LEEVRKEKDASVQSQEFEKAASLRDTEQRLREQLEETKKNWKEKQGQENTEVTVEDIASV
VSSWTGIPVSKLAQTETDKLLNMENILHNRVIGQEEAVIAISKAVRRARAGLKDPKRPIG
SFIFLGPTGVGKTELARALAESMFGDEDAMIRIDMSEYMEKHSTSRLVGSPPGYVGYEEG
GQLTEKVRRKPYSVVLLDEIEKAHPDVFNILLQVLEDGRLTDSKGRTVDFRNTVLIMTSN
VGASALKQNKYVGFNVQDGDQDYKDMKGKVMEELKRAFRPEFLNRIDETIVFHALEKKHL
KEIVTLMADQLVKRLSEQDIQLSITEAAKEKIAEEGYDPEYGARPLRRAIQKHIEDRLSE
ELLKGTVLTGQQIELDVENGEFTVKVNGAEPAVNLQK
>PK3-045_05088 Protein-arginine kinase
MSLEKFISKARTSWMCSDGPDSEIVLTSRIRLARNIEGVKFPLLFSKEEAENVIQQVEGA
IINESNQPFGQLELLAMNNLNTLEKRVLVEKHLISPQLAEQSPNGAAILSEDEEVSIMIN
EEDHIRIQCIKPGLQIEEAIKEANTIDDLLEKKVNYAYHVEMGYLTSCPTNIGTGLRASV
MMHLPGMVLTQQMNRIIPAIQQLGLVVRGIYGEGSEALGNIFQISNQITLGRSEKDIIEE
LKSVVTQLIEQEKEARNALAQTSNIQLEDRVFRSYGILCNSRIMETKEAAKCLSDVRLGI
DMGYIKNISKSILNELMILTQPGFLQLYAGEEMNPNERDIRRAVLIRERLKLETE
>PK3-045_05089 Protein-arginine kinase activator protein
MMCSECNQRPATLHFSKNINGKITEFHLCEHCAKENGDIFMTNGSSGLSLNSLLAGLLNI
EPSFQHITEDTYKRQQPLQCKECNMTFSQFRKLGKLGCPHCYDTFKDQLLPFIKRLHGGN
IEHKGKIPERIGGHFLIKKEIEQLRIELKELINNEEFEKAAIIRDEIKDKEKQLTSFTEG
GE
>PK3-045_05090 Transcriptional regulator CtsR
MRNISDIIENYLKEVLEMSEKSLVEIKRSEIADKFECVPSQINYVINTRFTIEKGYVVES
KRGGGGFIRIMKVQTYDHAHLIDQLLSLIQSRIPQNSAEDLILRLVEEDVISKREAKIML
SVIDRSVLYLELPYRDELRARLLKAMLTSLKYK
>PK3-045_05106 Lysine--tRNA ligase
MSHEELNLNDQLLVRRNKMNELREQGIDPFGKRFDRTHLSEALKKQYESLEKEELEEKNI
SVSIAGRVMTKRGKGKAGFAHIQDLEGQIQLYVRKDNVGEEQYAIFNSVDLGDIVGVEGV
LFKTNVGELSVKVQDFTLLTKALRPLPDKFHGLKDIEQRYRQRYLDLISSEESKNTFILR
SKIIQSMRRYLDSNGYLEVETPMMHSIAGGASARPFITHHNALDMPLYMRIAIELHLKRL
IVGGLEKVYEIGRVFRNEGVSTRHNPEFTMIELYEAYADYRDIMSLTENLVAHIAQEIHG
STTVTYGDYQVDLKPEWTRLHMVDAIKEYTGVDFWPKMTVEEARRLAKENDIEINDNMTY
GHIVNEFFEQRVEEKLIQPTFIYGHPLEISPLAKKNEEDPRFTDRFELFIVGREHANAFT
ELNDPIDQRERFEAQLKEREQGNDEAHLMDEDFVEALEYGMPPTGGLGIGIDRLVMLLTN
SPSIRDVLLFPLMRHR
>PK3-045_05107 tRNA-dihydrouridine synthase B
MFKIGNVEISNRVVLAPMAGISNSAFRLTVKEFGAGLVCAEMISDKGIVLKNKKTMNMLY
IDERENPMSLQIFGGEKETLVEAAQFVDQNTNADIIDINMGCPVPKITKCDAGAKWLLDP
DKIYDMVSAVVDNVRKPVTVKMRMGWDEDHIYAVRNAQAVERAGGAAVALHGRTRVQLYE
GTANWDIIREVKQAINIPLMGNGDVNTPQDAKRMLDETGCDGVMIGRAALGNPWMIYSTV
KYLETGELVSDPSVREKMDVCILHLDRLIHLKGEYVAVREMRKHAAWYLKGIKGNAKTRS
AINECETREQLVTILNALVLEVEAREQSGIEVG
>PK3-045_05108 hypothetical protein
METTEKWGRRIRAFRKLKGYTQEGLAKELLVSVSILGEIERGNRMPSEEMIDSIVGVLKI
TREELDPHQNK
>PK3-045_05109 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase
MNKVYLSLGSNIGDRLEYIREAVQMLHNQEEIKVVNISSVYETDPVGYEEQALFLNIVIQ
VETSLNPLSLLEQCQKIESELGRKRIIRWGPRTIDLDILLYNQENIVSEKLIIPHPRIEE
RAFVLVPLIEIAPDIKLPNKPILLKESLQLLRDREGVRVWKQQKNGEDVFALFES
>PK3-045_05110 Dihydroneopterin aldolase
MDKIILNQMEFYGYHGVFKEETKLGQRFIVDLQVDVDLAKAGATDDLQYSVNYGQLFLDV
KEIVEGEPYKLIEAVAENIAKKLLESYSLIEGLTVRIIKPDPPIPGHYKSVAVEITRKRK
E
>PK3-045_05111 Dihydropteroate synthase
MVNKIVCGPYTLNYEQKTIIMGILNVNPDSFSDGGKYNKMDRAVKRAVQMVEDGAEIIDI
GGESTRPGYTEISVEEELERVIPIIERLANEVNVPLSIDTYKGEVARQSLQAGAHIINDI
WGAKRDPNMAEVAAEFQAPIILMHNRDNLSYTSFLEDVVSDLRESIDMVKRAGVSTEKII
LDPGIGFAKDLKGNLDMMRGLDKLVEMGYPVLLGTSRKSLIGNVLNLPVSERLEGTGATI
CYGIQKGCQLIRVHDVKEMTRMARMMDALMGKGEYSG
>PK3-045_05112 Branched-chain-amino-acid aminotransferase
MYIYLNGQIIRQEEAVISVFDHGFMYGLGLFETLRIYDGHPFLLDDHLKRLNDGLSELNI
EKSFEREDAVSVIKTLLSKNNIENAYIRWNVSAGIGMIGLQTETYTQPNTIVYIKPLPKV
VDMVEKTGQIVTVPRNTPEGFFRLKSHHYLNNILAKREIGPEQTMEGIFLTKEGYLAEGI
TSNIFWVVDGELYTPSLQTGILNGITRQFIVKLAQDHGVAVKEGIFSLNILARAKEVFAT
NSIQEIIPIKRIDKYEYKGKEGPVVTMLYKEYRKHTSQLWSVKELEGIKEW
>PK3-045_05113 Aminodeoxychorismate/anthranilate synthase component 2
MIYMIDNYDSFTYNLVQYLGSLGQELQVKRNDETSIEEIRGEKPMYLMVSPGPCTPNDAG
ISLEAIRTFAGEIPIFGVCLGHQAIGQVFGGEVVKAANLMHGKTSLIYHDNQTIFQGLPN
PFPATRYHSLIVKKESLPKCLEISAWTKEGEVMGLRHKELPVEGVQFHPESIMTKAGMEI
LHNFIQFYQKGTK
>PK3-045_05114 Aminodeoxychorismate synthase component 1
MKNYKVYSKTIPLSYDQFFRRFLTIAEDKSHYVLLESGRGGRYSIGGVSPIVKMIGRSNG
LEVIDGKGTVRIEGNPLQSIKEVMNKYVVETNPDLPDFQGGAIGFISYDYIRYIEKIPNL
TTDDMEIPDVFFLLFEEWFTYDHKENKLWISALYEENQLVMIQDKVETYAQGWMDEEKEE
TVQSHTEKSVGLKVSMADNEFQQSVRKIQNYISEGDVFQVNLSVRQAKPLHVSALEVYRQ
LRVLNPSPYMGYFHTPEFQLVSGSPELLVKKKGKEVSTRPIAGTRSRGRDEAEDVELARE
LIESEKERAEHVMLVDLERNDLGRVCTYGSVQVDEFMVIEKYSHVMHIVSNVKGQLADNK
DEYDLINSMFPGGTITGAPKIRTMEIIEELEPVRRGPYTGSLGWIGFNHDIELNIMIRTM
LVKENQAYVQAGAGIVIDSIPANEYKESMKKARALWNAKELAEEKLGDGN
>PK3-045_05115 Cysteine synthase
MSRIANSVVDLIGGTPIVKLNRLVDDSSADVYLKLEYMNPGSSVKDRIALAMIEAAEKSG
DLKPGSTIIEPTSGNTGIGLAMVAAAKGYRAILVMPETMSMERRRLLKAYGAELVLTPGP
EGMGGAIRKAEELAKENGYFIPQQFKNISNPEVHRLTTGPEIVEAFGEGGLDAFIAGIGT
GGTITGAGEVLKEKYSNIKIYAVEPADSPVLSGGKPGPHKIQGIGAGFVPEILNSEVYDG
IIKVTNEDAFEYARRAGKEEGVLGGISSGAAIYAALQVAKELGKGKKVLAIIPSNGERYL
STPLYQFDEE
>PK3-045_05116 33 kDa chaperonin
MSDYLVKALAFDGEVRAYAVRSTETVGEGQRRHHTWPTASAALGRSLTATAMLGAMLKGD
QKLTVKIDGGGPIGLILVDGNAKGEVRGYVTNPQVHFDLNEHGKLDVRRAVGTEGTLSVV
KDIGMRDYFTGQVPIVSGELGEDFTYYLFNSEQVPSSVGVGVLVNPDNSILAAGGFIIQL
MPGAKDETITKIEQRLSEIPPISKLIEKGLTPEELLEEICGKDNVKVIENMPISFTCTCS
KERFSNAIISLGQAEIEDIINTDGQAEAECHFCNEKYLFTKDELETLLKEAK
>PK3-045_05117 Type III pantothenate kinase
MIFVFDIGNTNIVLGVYDKEELRHHWRIETNRYKTEDEYGMIIKSLFDHVDLTFSDIDGI
IISSVVPPIMFSLERMCQKYFHLKPLVVGPGTKTGLNIKYDNPKEVGADRIVNAVAAIHE
YGSPLIIVDFGTATTFCYINEQKQYMGGAIAPGINIATEALYSKAAKLPRIEIARPEGVI
GKNTVSAMQSGILFGYVGQVEGIVKRMKAESNVQPKVIATGGLANLIAKESNIIDEIDPF
LTLKGLQLIYKKNKDTLK
>PK3-045_05118 ATP-dependent zinc metalloprotease FtsH
MNRIFRNTIFYLLIFLVIIGVVSFFNGNNQPTKQLTYTELINHLDAGDVAEITQQPERGV
LEIRGKLKGYKENETFVSYVTNNETNAQVILKAATEGSKIDVKPAQETSGWITFFTSIIP
FVIIFILFFFLLNQAQGGGGGRVMNFGKSKAKLYNEEKKKVRFNDVAGADEEKQELVEVV
EFLKDPRKFAELGARIPKGVLLNGPPGTGKTLLARAVAGEAGVPFFSISGSDFVEMFVGV
GASRVRDLFENAKKNAPCIIFIDEIDAVGRQRGAGLGGGHDEREQTLNQLLVEMDGFGAN
EGIIIIAATNRPDILDPALLRPGRFDRQITVDRPDVNGREAVLRVHARNKPLDESVNLKS
IAQRTPGFSGADLENLLNEAALVAARADKKKIDMEDMDEATDRVIAGPSKKSRVISKKER
NIVSYHEAGHTIIGVVLDEADMVHKVTIVPRGQAGGYAVMLPKEDRFLMTKQELLDKITG
LLGGRVAEDIVFGEVSTGAHNDFQRATGIARKMVTEYGMSDKLGPLQFGQAQSQVFLGRD
LNNEQNYSDAIAYDIDLEIQRIIKECYERAKQILTENREKLNLIAETLLEIETLDAEQIN
SLYKDGVLPDRTKKADTTLGTEDLKVNINKKDDNE
>PK3-045_05119 Hypoxanthine-guanine phosphoribosyltransferase
MKHDIEKILISEEEIQGKIKDLAFQLTEEYQDKFPLAIGVLKGAMPFMADLLKRVDTYLE
MDFMDVSSYGNSTVSSGEVKILKDLDTSVEGRDILIIEDIIDSGLTLSYLVELFRYRKAK
SIKIVTLLDKPTGRKTDLKADYVGFIVPDAFVVGYGLDYAERYRNLPYIGVLKPEVYTSD
SE
>PK3-045_05120 tRNA(Ile)-lysidine synthase
MFEDQILNYLQGKNMNLEGKKILVGVSGGPDSLALLHFLWTKQEEWKIKVFAGHVDHMFR
GGESLEEAEFVKSFCEERNIPFSWERIDLPAFIQKTGMNSQKAARECRYSFYEKVMEKHN
LDYLALGHHGDDQIETILMRLTRGSLGKSRAGIPFMRPFGTGKIIRPFLCLEREDIEEYC
KVHNLNPRRDPSNEKDTYSRNRYRKQVVPFLKKENIHAAKHFQRFSEELTDDETYLMKQA
EEKLSEVLVEKKAAEVVVDINRFLLIAIPLQRRCIQLILNYLYDEIPISLSALHTEQMMI
LLKSPHSSGNIDLPNGLKVKKSYHFLHFQLNLSPAQSFYYELSKMGELLLPNGYNIKVEY
INGETITNDHCILLDATSISFPLIIRTRRDGDRIHLKGMDGRKKVNRIFIDEKIPIHKRD
HWPIVTDSKGEILWIPGLKKSIYSHSNTNSGSNLLITYKKQ
>PK3-045_05121 putative serine/threonine-protein kinase YabT
MMMNTSKSQFKINSGTVIKGKWHNKQYTVLKELGYGANGTVFLADSKIGRVALKLSNNSV
SITSEVNVLKSFAKVQGYSLGPSLIDVDDWVTNRGTTSFYVMEYISGPDLLTFIHNKEVL
WIDVLMIQLLKDLQNLHENNWVFGDLKPENLIITGPPTKIRCIDVGGTTIKGRAIKEFTE
FFDRGYWGLGTRKAEPGYDLFAVAMIILNLYYPQRFNKKEGGIKQLHMMIRQKQGLMRFE
GILVNALTGKYLSAKEMRLDYLNLTSGESKKTSRSTITAGTNRSKARQANSQPAPSAQTR
SKLVKKKKKAGWAESIVIIILISICYILYIYGQLT
>PK3-045_05122 hypothetical protein
MKTGTLKQVLLITDGCSNKGEDPIAMAALANEQGITVNVIGVMEQDTIDEQGMKEIEGIA
LSGGGVSQVVYAQQLSQTVQMVTKKAMTQTLQGVVNKELQQILGSSKTMEDLPPEKRGEV
MEVVDELGETVELEVLVLLDTSASMKHKLPTVKEALLDLSLSLNARSGENRYSVFVFPGK
KKDVEKLMDWTPRLESLTSIFPKLSTGGITPTGPALKEAIRYFKHKRSLRSLISSDDEYI
EESI
>PK3-045_05123 Stage II sporulation protein E
MEKVERDIIDPIGEVDFGKSRDSFSTLVHKFYTKVENFFLVKGFLLLILGFLLGRALILG
QLTPFALPFFAAVYLSRKDKAPLALIGLIAGAATLGVTEAASNFVLSFLFLISYKIILNW
KNKEQQLVPLFVFGLVFLGSLAKAYLLTNGFTLYGGMLAFVEGSLGYILTLIFLQSLPLL
TVNKRRQALKTEEIVCLIIMLASIMTGTIGWAVYGLSIEHIMSRYLVLLFSFMAGATIGS
TVGVVTGLIFSLASISSFYHMSLLAFSGLLGGLLKEGKKIGVALGLFIATLLIGMYGEGG
GVLSVSLMETTIAVFLFLMTPRSLTSRIAKHIPGTAEYSQEQQQYMRKMRDVTAQRVSQF
SNVFQALSKSFSSPNISEMIEEEDKELDYFLSNVTEKTCQTCFRKEHCWARNFNTTYDYM
KDIMTEMADTGGNISTSLQREWDKHCTRSKKVTDAIHQELTLYQANQKLKKQVQESRKLV
ADQLLGVSEVMGDFAKEIQRERENHYKQEELILEAIQEFGIHIENVEIYSLEQGNVDIDI
TIPYNTGYGECEKLIAPMLSDILGETIIVNKEEVSEYSKDYSHATFRSAKAYTIETGVAH
AAKDGGFISGDSYSTIELGLGKYAMAISDGMGNGKRAHVESEETLQLLQKILQSGIEEQV
AIKSINSILSLRTTDEIFSTLDLAMIDLQNAAVKFLKIGSTPSFIKRGSKVMKIQASNLP
MGILQEFDVDVVSEQLKAGDLLIMMSDGVFEGPKHVENFEIWMKRKIKELKTENPQEVAD
LIMEEVIRSRLGLIEDDMTVLVAKIDHNIPKWASIPVKGFKQIAN
>PK3-045_05125 Polyribonucleotide nucleotidyltransferase
MSIEVGSKLQGKVTGITNFGAFVELPEGATGLVHISEVADNYVKDINDHLKVGDEVEVKV
INVEKDGKIGLSIKKAKDRPERPERPERPQYERGERRESRGGYSGGNSQRSRNAKSNENR
APKENFESKMARFLKDSEDRLASLKRNTESKRGGRGARRG
>PK3-045_05126 Cell division protein DivIC
MSAIRKPDVTTFPTEYNLQHQANSLSGARKKKLLMRRLTTFFVCAAVIGFIMISTLISQS
STLKEKRAEKEQLDGQLVALEKKEADLKDQIAKLNDEEYLAKLARKDLLLSKKGEIIFNI
PEKDAKNTTGK
>PK3-045_05127 Spore protein YabQ
MTLSTQFMTMLAMVSMGLFFGISLDTYQYFLKRPKRKRSIVFIHDILFWVLQALLMFYVL
FLVNKGEVRIYLVLALLLGFAMYKSLFQTLYLQLLKGIISFCVHTYRFFLRVGVNIVYKP
IKSIIFFLFSIIIALGRGLMALVSGIIRTLRFIIGILFKPIEWLLSLLWLIVPKKGKLFV
ERIFNKLAGYYFKIKNYLKQWMAKRKK
>PK3-045_05128 Spore protein YabP
MSQYHESNMTKSNNTVDHDVIMRGRKLLDITGVKQVESFDNEEFILETVMGFLSIRGQNL
QMKNLDVEKGIVSIKGKVFDLVYVDDQSGDKAKGFFSKIFR
>PK3-045_05129 hypothetical protein
MRLDKFLKISRLIKRRTLAKEVADQGRILVNGQQAKASTNVKVGDELQVRFGQKLVTAKV
EMLQESTKKEDAANMYKIIKEETLS
>PK3-045_05130 hypothetical protein
MSQIKIIGLGAGDINQLPLGVYRSLVDENKTIYVRTKDHPVLSMLEQEGITFYSFDSIYE
KHNQFDAVYEEIVEFLLEKAKETDIVYAVPGHPLVAEKTVQILIEKDKEGMASIEIAGGQ
SFLDSIFQALRIDPIEGFQLLDGTALNRASIQLRNHLIIGQVYDTFSASEVKLTLMDILP
HDYPIKVVTAAGSSLEKIKEIELHELDREVDLNNLTSIYVPPVQEEKILYKDFSQLRQII
AELRGPNGCPWDKKQTHESLRKYLLEESYELIEAINEGDIDHIIEELGDVLLQVMLHSQI
GEDEGYFSIDDVVEGISDKMIRRHPHVFGEEQADSVDDVMKHWQNAKKREVKTDRESVLE
GLNSALPNLMQAYELQKRAAKVGFDWPNAEGAWEKVKEEILEFQEELKEINNNVQIESEF
GDILFSLVNIARFYKVDPELAIFRTNKKFIERFSYIEERVKESEKEWSQMSLEELDGFWN
EAKKK
>PK3-045_05131 lipid II flippase MurJ
MKTSQSNVWFKGAFILMIAALITKVLSAVYRIPFQNIVGDKGFYIYQQVYPFYGVIIALS
TYGFPVVLSKLYMEMKVEGNQSGINRLVSSSFFLFVPIGMIAFLALFFNAGRLASWMGDP
YLASLLKVISFAFLFSPLIAILRGIFQGEGNMIPTAVSQVGEQLIRVGIILFVALFFSYQ
NYSLYAIGSGAMFGSVVGGLLSLFVLIYFYRKSALSFSLFRFSLLFEKENRILCKRILYE
GITISISSMLLVLLQLADSLNLYSLLMEDGMAEEKAKVMKGIYDRGQPLIQIGSIISTSM
ALSIVPLITKNRQKTSKKDLMRNIHFSLIVSFFIGLGATVGLIGIIRETNSMLFKNDAGS
EVLTVLFFVIFLNAIIATIMAILQGLGHSFYPAVLIVLGFIGKYVLNIILISSFGIYGAA
YASLIVLSIILILMAVKLKKIVKEPLVSIRHVLIISGASLVMLLVLRGYIPLSSLLLEGI
EHSRIKSAIQAVSGVVIGGIIYVVIVVRGNVFKEKELSLLPLGSKLKWFLPKKGRK
>PK3-045_05132 hypothetical protein
METIIFISMIIITVFFEAAMPFLVRKTVVFGVTIPNKQVNNPQISTYKRRYSLLVIIPSL
IGIIAYYIWQAANNIQADQVAIGGTVLLFAILFWSLSLYFYFHGKMMALKAENKWEAELK
EINITEIGVRQKDEMLPWYVFLIPIIITVGFLIFTATQYHLLPAEIPVHWGLSGKADRFT
KKTPISGVSMLLILLVMQIMFLSINSATKKSGIKISANNKHASKLRQLKYRKYTSWFFLL
TSIAITVLIILLQLTILYDNIFSDHLVFLIPIIITLSILIGAILFTIKLERLNRGAEGEE
QDTKEISSFDGDSYWKGGLIYFNKSDPSIFVEKRFGVGWTLNFANPIGYVIVFVPLLIII
LLSIIE
>PK3-045_05133 HTH-type transcriptional repressor YtrA
MMYIQINPELEMPIYEQLTMQIMIGIIRQELQNGDVLPSVRSLAADLGVNMHTVNKSYHA
LEKKGLIQIIPKSGAIIRTNNGIPTQEEQGRISNSLKPMIVEALVIGMKEKEITGLIQSI
IHKLKEE
>PK3-045_05134 Stage V sporulation protein T
MKATGIVRRIDDLGRVVIPKEIRRTLRIREGDPLEIFVDRDGEVILKKYSPISELSDFAK
EYAEALYDSLGNAVLICDRDSYIAVSGGSKKDYLNKNISSVVEKAMEDRGSILMNQQDQV
SLVDGTTETISAYTIGPIIANGDPIGAVVIFAKEDSLGDVEKKAVETAAGFLARQMES
>PK3-045_05135 Transcription-repair-coupling factor
MLGLKQLFKQQEDIQNVISGLEAGLHEQLVSGLSNSARTLYMTSIYEKTKKPLLIVTHNL
LQAQKLYDDITNIVDEKDVFLYPANELIAAEISIASPELKAQRIEVLNYWAKKKSGIMIA
PVAGLRKLLPPKKLWKEAQLKLEIGQDLDLEAFLLKLVHMGYVRSEMVSSPGEFSVRGGI
LDIYPLTEEDPLRIELFDTEIDSIRAFSLEDQRSKEKKENVSIGPATEILYDENAVGDLL
AMLEKGLAQSLKKIKDEATKTLLTQNISREMEQLRNGQKPEQLYKYLSILYGEHISLIDY
LPNNGFLIVDEISRVQEMNDTLEKEEADWYTSLLGEGEIIHGLTLSQSINHLLHQAKQPI
VYLSLFLRHVPNTNPQNIINVSCKQMQNFHGQMNVLKTEMERWKKNHYTVVLLGNSEERL
EKLEQVLQDYDMEVMIQKNAKKISEGKIQLLEGHLQSGFELPILKLAVITEEELFKTKTK
KISKRRQKLTNAERIKSYSELNVGDYVVHVNHGIGKYLGIETLQINGVHKDYLHLRYQGN
DKLYVPVEQIDLVQKYVGSESKEPKIYKLGGNDWKKVKKKVESSVQDIADDLIKLYAERE
ASVGYAFSPDGEMQREFESAFAYQETEDQLRSIHEIKKDMERERPMDRLLCGDVGYGKTE
VAIRAAFKAIADGKQVAFLVPTTILAQQHYETLRERFQDYPIEIGLLSRFRTRKQQNDTL
KGLKAGTIDIVVGTHRILSKDISYRDLGLLIIDEEQRFGVTHKEKIKQLKTNIDVLTLTA
TPIPRTLHMSMLGVRDLSVIETPPENRFPIQTYVMEYNGGLVREAIERELARNGQIYFLY
NRVEDIERKAEEISMLVPDARVTYAHGKMTENELESVMLGFLEGEYDVLVSTTIIETGVD
IPNVNTLIVQDADRMGLSQLYQLRGRVGRSNRVAYAYFTYKKDKVLTEVAEKRLQAIKEF
TELGSGFKIAMRDLTIRGAGNLLGAQQHGFIDSVGFDLYSQMLKEAIEERKGTISEEQRQ
TIEIDLDIDAYIPDFYINDGQQKIEMYKRFRGVTSLEDMEELREELIDRFGDYPEEVSYL
FKITEMKIYGKQAGVELIKQTKDEVLILLSEHGSDRMDGQKIFEKSSKYGRMIGLGMEGR
KLKMIFHVKGVEKEKWLKACHEMVEALNTFKKEPEQVTK
>PK3-045_05136 Anti-sigma-F factor Fin
MAIHYHCRHCGVHMGTLDAESIAANRLGFDHLSDEDRSEMIQYHQTGDIEVKSICEDCQE
SLSKNPGYYENDYLIH
>PK3-045_05137 Peptidyl-tRNA hydrolase
MKLIVGLGNPGKQYDRTRHNIGFEVIDFLSSHYNIPLDKAKFKGNYGIGVIGGEKVILLK
PLTYMNLSGESIRPIMDYYDLVPEDLVVIYDDLDLPVGRIRLRQKGSSGGHNGIKSTILH
VGTEKFNRIRVGIDRPKNGMKVVDYVLGKFTKEEMDILEGTIKKCADACAQWAEEPFLQV
MNKYNIQ
>PK3-045_05138 General stress protein CTC
MTTTLQAKKRTMDKHSSLTKLRNNGEIPGIVYGSKVENTAISLSEANFLKTIREVGRNGV
ISLDIDGENYNVVLNEYDADPIKRGIIHVDFLAVDLSKAISAPVKVSLVGDAAGVKDGGV
MQQALHEVTVTAKPNDIPSSIDIDVTELQVGDTITIEDVKGYDKIEINHEKEEVIASILA
PRQEEEISTGEQQEEGMPDNVEGRETEPETAEE
>PK3-045_05139 Ribose-phosphate pyrophosphokinase
MPVKNLDPNLKVFSLNSNPALAQEIADSIGVELGKCSVTRFSDGEIQINIEESIRGCDVY
VIQSTSAPVNEHIMELLIMIDALKRASAKTINLVIPYYGYARQDRKARAREPITAKLVAN
LLETAGATRVITLDLHAPQIQGFFDIPIDHLMGVPILGNYFSQREFDGELVIVSPDHGGV
TRARKLAERLKAPIAIIDKRRPKPNVAEVMNIVGNIEGKIAILIDDIIDTAGTITLGANA
LAENGAKEVYACCTHPVLSGPAMERINNSKIKELVVTNSIELGEKKLSANVIQLSVADLL
GEAILRVHQDQSVSFLFD
>PK3-045_05140 Bifunctional protein GlmU
MTTRYAVILAAGQGTRMKSKLYKVLHPVCGKPMVQHVVDQVEKLQMDSIVTVIGHGSEKV
KAQLGNSVKYVNQKEQLGTAHAVIQAKDLLVDKEGVTLVICGDTPLMTSETIEALFLHHE
KVGAKATILTAKASKPDGYGRIIRNSMGVVEKIVEHKDATDEERKITEINTGTYVFDNAL
LFQALDNVSNENVQGEYYLPDVIEILKQQGETVSAFQTTDFNETIGVNDRIALSEAESIM
RKRINEQHMRNGVTIIDPTNTYIGADVMIKEDTVIYPGSMIKGNTVIGSDCIIGPNTEIN
NCSVGNNTAIKQSVAHDSSIGSDVNIGPFAHIRPASMIDDEVKIGNFVEIKKATFGKGSK
ASHLSYIGDANVGSDVNIGCGTITVNYDGKKKFLTTIEDGAFIGCNSNLIAPVTVGKGAY
VAAGSTITDNVPSEALSIARARQVNKENYKRK
>PK3-045_05141 Putative septation protein SpoVG
MEVTDVRLRRVNTDGRMRAIASITLDNEFVVHDIRVIDGNNGLFVAMPSKRTPDGEFRDI
AHPINSGTRGKIQEAVLAEYHRLGELEIEFEEAGAS
>PK3-045_05142 2-iminobutanoate/2-iminopropanoate deaminase
MKVVQTSNAPAAIGPYSQGIIVNNLFFSSGQIPLTAEGTLVEGDVQTQTHQVFKNLAAVL
KEAGASFETVVKATVFIKNMEDFQAINEVYGEYFSTHKPARSCVEVARLPKDVLVEIEVI
ALCK
>PK3-045_05143 Pur operon repressor
MKFRRSERLIDMTNYLLEHPRQLVSLSYFAEKYGAAKSSISEDLAIVKETFEQRGIGTLH
TLPGAAGGVKYQVKVSDEAAKPFVEELCDLIKSPERLLPGGYLYMNDILGNTTIMQKVGR
LFASAFADTDIDVVMTVATKGIPLAYAVGTYLNVPVVMVRRDSKVTEGSTVSINYVSGST
KRIQTMLLSKRSLEDGSKVLIVDDFMKAGGTINGMISLLEEFNASVAGIAVLVEAEEAEE
RLVDDYLSLVKLSGVDVKEKKISVENGNYFDKK
>PK3-045_05144 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase
MKLLVKAPAKINLSLDVLHKRPDGYHEVEMIMTTIDLADRIELALLDNDVIKIVSLNRFV
PDDQRNLAYQAASILKEKFDVKKGVEIKIEKHIPVAAGLAGGSSDAAAVLRGLNKLWDLG
LTLDELAVIGAEIGSDVSFCVYGGTALATGRGEIIKELPAPPVCWVILAKPFIGVSTADI
YKRLDIETIEHPNTEKMIESISAKDYDLMCNSVGNVLENVTLSLYPEVAQIKEQICKFGA
DAVLMSGSGPTVFGLIQHDSRMNRVYNGLRGFCDQVFAVRMIGQRHTLD
>PK3-045_05145 hypothetical protein
MGRRKGIMSEGLKEELAKELGFYDVVQKEGWGGIRARDAGNMVKRAIEIAEQSLLTQNKE
>PK3-045_05146 Protein Veg
MAKTLSDIKKALDSNLGKRLMLKANGGRRKTIERSGVLAETYPSVFVVELDQDENAFERV
SYSYADVLTETVQITFFEDTSGQIALS
>PK3-045_05147 Sporulation-specific protease YabG
MTINIMDIVGRESYQCDLLFRIIDTKEVNGQKIAILYGEDFRLIADAPYEDLVLINQPMQ
RKISQKVQLMEEQSLQLFRQDVNLLRRKQEYQVTEAYSKPSNYFQLPGKVLHIDGDPNYL
KKCLTLYEKIGIPVNGVHCNEKEMPSKIGSLLDYYRPDILVITGHDAYSKALGDKSDINA
YRHSKYFVQTVREARKKLPNLDQLVIFAGACQSHFESLIYAGANFASSPSRVNIHALDPV
YIVAKISFTPFMERVNVWDVLRNTLTGEKGLGGIETKGVLRTGMPYHVDSTEEV
>PK3-045_05148 Ribosomal RNA small subunit methyltransferase A
MYKDIATPARTRAILDKYGFSFKKSLGQNFLIDTNILRNIVDHAQLTEDSGAIEVGPGIG
ALTEQLAKRSKKVVAYEIDQRLLPILKETLEPYPHAKIIHQDILKANVKEMLDTEFKDIK
DIMLVANLPYYVTTPIIMKILEEKLPLRGIVVMLQKEVAERISAKPGTKEYGSLSIAIQY
YTKPEVVMIVPKTVFVPQPNVDSAVIRLTIRETPSVVVKNEAFFFQITRASFAQRRKTIL
NNLSSQLEGGKEKKAEIIEALEQAEIEPSRRGESLSIEEFAKLSDILYETFGK
>PK3-045_05149 Ribonuclease M5
MKIKEIIVVEGRDDTTAIKRAVDADTIETNGSAINQETLDKIKLAQKTRGVIVLTDPDYP
GQKIRHTIEMHVPECKHAFIPKELAIHKHGKGVGVEHASVEVIREALKEAHLMQETIKEE
ITKEDLIDAGLIGGADSKERREQLGKLLKIGYTNGKQLYKRLLMFHITKAEFAQAIKEIR
QEDKHV
>PK3-045_05150 hypothetical protein
MILYIITPREKEAFFIVIKNMKNLFSKSLSKKKVSIFLASFIVFASSIGFIIYETTKSTV
ALTLNGKEQIIETHSSTIQQIFDDLDITVGSKDYVFPSLNTKVTDNLEVVWKKAKQVELQ
KDDEKKTVWTTVDTVKEFLEEQKISLNEHDQINQKENNPIEHKMDVVVHTAFPVTLVDAG
KKKQVWSTSTTVADFLTQQEISLDKLDRVEPALKEKVKEEAIVNITRIEKVTDVVEQPIN
FAVITQKDDDLPHGTEKVLKEGTEGVVSKKYEVTKENGKEISRKLLSETTVKEKQDKIVS
VGTKDEVIQLASRGEERGQEVFVNSTAYTASCNGCSGRTATGIDLKANPNAKVIAVDPSF
IPLGTKVYVEGYGYAVAADTGGSVKGQKIDVFFSTKAEAYRWGNRQVKIKIIN
>PK3-045_05151 putative metal-dependent hydrolase YcfH
MLFDTHTHINANEFQDDIEEVIQRALDVGMEKMVVVGFDRPTITKAMELIEQYDFVYASI
GWHPVDAIDMVDEDLVWIEELAKHPKVIAIGEMGLDYHWDKSPKDIQKEVFRKQIQLAKK
VKLPIIIHNREATADIVEILKEEDAKEVGGIMHCYGGSVETALECINMNFYISLGGTVTF
KNARKPKEVAEAISLDHLLIETDCPYLAPTPFRGKRNEPSYVKLVAEEIAAIKGISYEEV
ASKTTENAKKLFGIN
>PK3-045_05152 Methionine--tRNA ligase
MKDQEKTFYITTPIYYPSGNLHIGHAYTTVAGDAMARYKRMRGYEVRYLTGTDEHGQKIQ
RKAEEAGITPIQYVDEIVAGIKELWDKLDISYDDFIRTTEKRHTDVVEKMFKKLVDQGDI
YLDEYQGWYSVSDETYYTELQLVDPIYDEHGKVIGGKSPDSGHAVELVKEESYFFRMGKY
ADRLLAFYEENPEFIQPESRKNEMINNFIKPGLEDLAVSRTTFDWGIKVPGDPKHVVYVW
IDALSNYITALGYGSDDETLYKKFWPANVHLVGKEIVRFHTIYWPIMLMALDLPLPKKVF
AHGWILMKDGKMSKSKGNVVNPVTLIDRYGLDALRYYLLREVPFGSDGVFTPEAFVERVN
FDLANDLGNLLNRTVAMINKYFNGEIPTYKNSEGTFEKSLVEAHQETVKKYAEHMENMEF
SVVLTTLWQLVSRNNKYIDETQPWVLAKEEKTEELAVVMNHLAESLRRIAIMLKPFLTRT
PDKIFKQLNIQDESLQTWDSLERFGIIPAGTIVEKGDPIFPRLDIQEEVEFIKSEMKGPQ
KEEETKQEVQEVPDVEEITIDDFMKVDLRVAQVLEAEPVKKADKLLKLQLDLGYEKRQVV
SGIAKYYSPEDLVGRKVICVTNLKPVKLRGELSQGMILAGSHDGELSLATIAEALPLGAK
VK
>PK3-045_05153 Transition state regulatory protein AbrB
MKSTGIVRKVDELGRVVIPIELRRTLGIAEKDALEIYVDDEKIILKKYKPNMTCQVTGEV
SDDNLSLAGGKLILSREGAEQLIAEIKSNFELAK
>PK3-045_05154 Ribosomal RNA small subunit methyltransferase I
MKQQKSFKEKRGALYLVPTPIGNLEDMSFRAIRILKEADIIAAEDTRNTKKLCNYFEIAT
PVVSYHEHNKETSGQKLIQALKEDKIIALVSDAGMPTIADPGYELAIDAINQEIPVIPLP
GANAALTALIASGLPTHPFYFYGFLNRQKKEKKKELLFLKSVPGTLLLYESPHRLKETLV
LIREILGNRKITLCRELTKLYEEFIRGTLEEAIAWSQSEEIRGEFCLVIEQGELQTEDNN
WWEDLSIVQHVDHYVEKEGITVKEAIKKTALDREMQKRDIYQEYHIQ
>PK3-045_05155 hypothetical protein
MENKNHYFYVLKCKDGSYYAGYTNDLQKRVKTHNDGKGAKYTRGRLPVSVIYYEEFQTKQ
EAMKAEYAFKQLDRKKKEKFLWKEVGEGNETTKKL
>PK3-045_05156 tRNA1(Val) (adenine(37)-N6)-methyltransferase
MVPLIGDERLDYLLDERLRIIQSPSVFSFSLDAVLLADFVSIPLKRGAIVDLCSGNGVIP
LFLSLRTEGDIVGVEIQERLYDMANRSIQYNHLEQKIKMIHGDIKDAPSLLGYEKYDAVT
CNPPYFKKTNSMAEINGNEHLAIARHEILCTLEDTISISSQLVKQGGKVAFVHRPGRLLD
IITLMRENRLEPKRIRFVYPKEGKEANILLVEAIKDGKPDLKVLPPLFVYKDGNNYTEEM
SRILYGK
>PK3-045_05157 Initiation-control protein YabA
MDKKEVFESVINMESQIGNLYKQLGDLKQHVAELIEENNRLQLENENLRRHLEDIPREKD
SKQDKNKRRNIKQGKTMEEKNIDIGEGYDNLARLYQEGFHICNLHFGSPRKDGDCLFCLS
FLNKK
>PK3-045_05158 hypothetical protein
MYDVVGIRFKKAGKIYYFDPNELIIQKGDFVIVETVRGVEFGRVVIGPKKVDENDVVLPL
KKVLRIADHKDQMIVAENKVAAKEAYDVCCEKVTLHELDMKLVDVEYTFDRNKIIFYFTA
DGRVDFRELVKDLASIFRTRIELRQIGVRDEAKMLGGIGPCGRMLCCSTFLGDFEPVSIK
MAKDQNLSLNPTKISGLCGRLMCCLKYENDDYEAAKELLPDLGDWINTPDGKGKVVGLNI
LERVLQVEISEQERVLEYTLDEILQEDAVSVQSTD
>PK3-045_05159 hypothetical protein
MTRTWEQLEQTQPIVLKMLKNSLKKERLAHAYLFEGMKGTGKREISLVLTKSILCENTID
GYVPCETCSNCKRINNGNHPDVHLLEPDGLSIKKHQIQSLQEEFSKTGVESKQKVYILVH
ADKMTTNAANSLLKFLEEPNAETTAILITEQIQQILPTILSRCQVLSFTPLSPNEMAKEL
VRNGIKPNEAPLLAQITNNFEEALTLSTDEWFVQAQKIVVKLYEALKGAPLEALVALQRD
WFSHFKEKDQFDRGLDLLLLLYKDLLYIQLGKHDQIVYVSEKGRLETYALRTSNRRLTEQ
MTAIFEAKRKLQGNMNPQLLMEQLVLELQEGSSVV
>PK3-045_05160 hypothetical protein
MKNIDDIGNRLGRSQNLKDLTKYKSLVKQFVKEAVELGMKVKKDNSWDQFGQGRDLRVVQ
VIDDKLVELTEEVIATEKKWHKYLR
>PK3-045_05161 Cyclic di-AMP receptor A
MKLILTVIQDKDSNKLLNALVENNFRATKLASTGGFLKSGNTTFMIGTEDIRVEKALQII
KENCQSRDQLVAPVSPMGGNADSYVPYPVEVEVGGATVFVLPVEQFKQF
>PK3-045_05162 Thymidylate kinase
MTKGLFITLEGPEGAGKTTVIDMLLNYYQEKELQIIKTREPGGIPISEKIRNIILDPKHI
EMDARTEALLYAAARRQHLVEKVVPALNGGAIVLCDRFIDSSLAYQGYARGIDMDEIWKI
NQFAIGDIMPELTIYFDLDPRVGLARINNTSDREINRLDLETIEFHERVQEGYSKVIEKF
PERIIKVDASKPLEQVLEDTVDIINRFLK
>PK3-045_05163 Arginine decarboxylase
MQENTPLYSKLLQFQSKNNISFHVPGHKNGELISSEEEWKGPLWNFDVTELNGLDDLHAP
TGVIADAEKLLTDFYGVKKSYFLVNGSTVGNLAMILAALTEGDKVFVQRNSHKSIMNGIK
LAKAEPILLSPDYEEDWKVDTVLSKKTIEQAIARFPEVKKLILTSPNYYGMVGNLQEIID
LAHANGICVLVDEAHGAHFKGNPHFPPSAVELGADIVVQSAHKTLPALTMGAYLHYNTAF
VQQEDVKHYLDILQSSSPSYLIMASLDKARHYIANYSMEDWEYLHTMLTLFREQLHTIPQ
LNVLNYPYDGDPLKITIQSTENRSGFELQKELEKEGIYTELADSNNILFVFPLLKKGISY
PLEKVIYKIKRALLKHTHAYSSQSETVESIKKRQDIVELKLSEKEQAIRSKVEVSLSEAL
HAVCAETIIPYPPGIPILMPGEEITNYHIKQITNLLKDGARFQGSPSIYKNRITIFKK
>PK3-045_05164 hypothetical protein
MGKYQSSRAEACLICEEHKLEGIHLFESFICMDCEREIVNTKTNDPKYLFFVHQMRKART
LQERRQA
>PK3-045_05170 hypothetical protein
MSPVVIISIVIGLVILLLVVGTPIKPLRMIGQGIIKIMIGALFLFFLNTVGNQYGIHVPI
NFATSTVSGILGIPGVAALVAIQLYII
>PK3-045_05171 hypothetical protein
MFFRKKGKLRKEFDEKLLVQFSHLKKEWLNDKSLLDKSFDPSDEVISGAKLSEAKYFFLF
KEAKQRKINLLK
>PK3-045_05172 Recombination protein RecR
MHYPEPISKLIDSFMKLPGIGPKTASRLAFFVLNMKEDTVLDFAKALVNAKRNLTYCSVC
GHITDQDPCYICEDSRRDRSIICVVQDPKDVIAMEKMKEYNGLYHVLHGAISPMDGIGPE
DINVPSLIKRLQDDEAQEVIMATNPNIEGEATAMYISRLLKPSGIKITRIAHGLPVGGDL
EYADEVTLSKALEGRREV
>PK3-045_05173 Nucleoid-associated protein
MRGMGNMQNMMKQMQKMQKKMAEAQEQLGEEKIEGTAGGGMVTVVVSGHKEIIDVIIKEE
VVDPEDVEMLQDLVLAATNDALKKADELTNSTMGQFTKGLNLPGMF
>PK3-045_05174 Holliday junction ATP-dependent DNA helicase RuvB
MNYQALYRVWRPQQFIDVVGQEHVTKTLQNALLQQKISHAYLFSGPRGTGKTSAAKILAK
AVNCERAPISEPCNECDACRGITDGTIPDVIEIDAASNNGVEEIRDIRDKVKFAPSSVPY
KVYIIDEVHMLSIGAFNALLKTLEEPPKHVIFILATTEPHKIPLTIISRCQRFDFRRITS
QAIVNRMRLIMDESAISCEEKALQMIARAADGGMRDALSLLDQAISYSNEVVTVEDALTV
TGAVSQNFLNTLSRAILDGDTVRGLQSLDELLLAGKDSNRFIEDFIFFYRDMLLYKTAPN
LEESLERVLLDDDFKDLAETHTHEQIYELINLLNRTQQDMRWTNHPRIFLEVAIVKLCQL
EAPNISGQSNVNIPEIQSLLSKVSSLEEELANIKQKGVTVVAETQPTQKKTRTNRKGFQA
PLGKITETLKNATKQELQSIKSNWGAMLNTLVQNQMRSQAALLNEAEPVAASTDSIIIKF
KYEIHCQMALDNVKFIETITNSLYQLLGKRYNLLGVPEEQWLNIREEFLNSSQHLEASEE
GDGEERQDNPVVSEAIKLFGEELLEVKD
>PK3-045_05176 tRNA-specific adenosine deaminase
MEINQDQLFMKIAIEEAKKAAEIGEVPIGAVVAYRGEVIARAHNLRETDQSAIAHAELLA
IEKACEVLGTWRLEEATLYVTLEPCAMCSGAILLSRIPRVVYGAADPKGGCAGTFMNLLQ
DDRFNHQSEVITGVLAEECGQLLTSFFREIRNRRKKKKERKTSVLDSYNN
>PK3-045_05177 Vibriobactin-specific isochorismatase
MESSDTALLIIDMINDFRFVHGNILAEKTLIIAEHIQLLKKQCKKEKIPIIYINDHYNLW
QAELNKVIDYCRNEKSEPIIDKIRPDDTDYFLIKPRHSAFYGTALYTLLHQLQVKNLILT
GIAGNICVLFTANDAYMREYPLLIPDNCIASVDNEDNQYAIRMMKNVMNAKIFTFNENTI
ISALSSS
>PK3-045_05178 Cortical fragment-lytic enzyme
MQIHVVRNNQTLTGIAAAYGTTVNDIVEANDLPNPDRLVIGQALVIPIIGSFYWVQSGDT
LWSIAQRFRLNYEQLASINSIAVNQPLQVGLRLYIPERPQRPVESNAYVEPRGTYVAPNL
EESAREAAPYLTYLAPFSFQALRDGGLKEPLLNNFPEIAQRNNNVLMMVITNQENDQFSD
ELGRILLNEKTIQNNFLHNIVTTAKKYGFQDIHFDFEYLRPEDREAYNRFLRRAKNRFSQ
EGWLISTALAPKTSATQKGKWYEAHDYRAHGEIVDFVVIMTYEWGYSGGPAMAVSPIGPV
RDVLEYAITEMPPSKIMMGQNLYGYDWTLPFVEGTVAKALSPQAAIQLAADYNAEILYDQ
KAQAPYFKYTDSEGRLHEVWFEDARSIQAKFNLIKELDLRGISYWKLGLAFPQNWLLLAD
NFHITKRT
>PK3-045_05179 hypothetical protein
MTSRFLKQELFIGKEGQRNIEASHAVILGAGALGSASSEMLVRAGIGRLTIIDRDYVEES
NLQRQQLYTEEDAADKLPKAVAAKRRLKDISSHTLIEAVVEDINCHTIEKFIEGASILID
GTDNFETRLVINDAAIKLKIPFLFGACVGSYGLSYPVAGENAPCLHCLIEQLPSQEITCD
TAGVISPIVQWVAAMQVSQAIQILSGEKLLPVLRSFDIWKMEYAEMNVEKLKKFECPTCG
GRADFPYLSFQNQTKAAVLCGRDAVHIRPATSKRLDLYVLSKQWKALVQNLIANPYLVSF
QYDDYRVILFEDGRAIIHGTSEISVAKSIYARLIG
>PK3-045_05180 Thiazole synthase
MLTIANRTFRSRLLLGTGKYPSFEIQKKAVEVSESEILTFAVRRMNIFEKSQPNFLEQLD
LKRYTLLPNTAGAKTAEEAVRIAKLAKASGLCDMIKVEVIGCDKSLLPDPIETLRASEQL
LEEGFIVLPYTSDDVVLAKRLEQLGVHAIMPGASPIGSGKGIINPLNLQFIIEQSNVPVI
VDAGIGSPKDTAYAMELGADGVLLNTAVSNASDPVKMAQAMKLAIEAGRLGYEAGRIIEK
NYGVASSPIAGMIPS
>PK3-045_05181 Sulfur carrier protein ThiS
MNIQLNGKEQQLPKEVVTVEDLLHFFELNNRIVIVEINRDILQKEQYQTHVLKESDRVEL
IHFVGGG
>PK3-045_05182 Glycine oxidase
MKSVESKKFDVVIVGGGIIGSSIAYYLAKENRKVAILEANTIGGKSTSAAAGMLGAHSEY
KEFKQLYPFARSSQLLYKELYEEIRELTAIDFEKRNGGLLKLAYSEEEKGELEPILALSS
VEWLDAELARKMVPQLSSAIFGAAFLKEDVHITPLIACNGLSKGAQLFGAEVYEYTRVLG
VKKKGIDYVIKTSQGAFFAENVVIASGVWSNYFFQQLGLSHEITPVKGECVSVENEGFPL
QYSVFHNQFYIVPRNNQEFIIGATKKWNEWSEEPSLDGIEEVIQKAKEMIPEVGRMKWKR
AWAGLRPQTYDGYPFIGEHPEMKGLYFATGHQRNGILLAPITGKMIRDLILGMPVKSEWL
DAFKVERRILV
>PK3-045_05183 Thiazole tautomerase
MKIMAVTDNKHSFERLSSILLEIHPYVDYVQIREKAKSPKEIYLLGERLLKEGVPAQKII
INDRLDVAALLSLRHVHLPGNGLPIQPVKNIYPTLSIGVSVHSQQEAIIAENARADYVIY
GHCFPTDSKKGKIPIALPSITDIKRDLTIPIYAIGGITEERVGKLASLGVDGVAIMSAIF
SASQPLKAVQRLRERCEECGIQKI
>PK3-045_05185 Deoxyguanosine kinase
MNSIPFITVEGPIGVGKTSLAKLLSEYFQYELLKEIVEENPFLGKFYENIDEWSFQTEMF
FLCNRFKQLNDTRDHYLNKNIPVVADYHILKNLIFAKRSLQDSDLDKYIRIYDVLTEDLP
MPNIIIYLHASLDTLMARIKKRDRDIEKNISPLYLEQLASDYDVVMNDFKKNNPQIPVLD
FNGDTLDFIQNKQDLVKIIDAIKETLNIGAFNHESTNKI
>PK3-045_05186 Deoxyadenosine/deoxycytidine kinase
MNLRTKYNIPSNSVITIAGTVGVGKSTLTNALADALQFRTSFEKVDTNPYLDKFYHDFSR
WSFHLQVYFLAERFKEQKRIFEYGGGFIQDRSIYEDTGIFARMHYEKGTMSEVDYETYTS
LFEAMVMTPYFPHPDLLIYLEGSLEDILQRIDRRGREMEKQTPIDYWKEMHGRYEKWIDS
FSACPVLRLNINEYDAIAGSQSIEPIIEKIGTILQHKNYSKKA
>PK3-045_05188 Serine--tRNA ligase
MLDIKFVRANFDFVKSQLQHRGEDLSELDNFEALDVRRRELIVETEQLKSKRNEVSQQVA
VLKREKKDAEALISEMREVGEKIKEYDNELRDVEERLQTIMLGIPNLPHESVPVGDTEDD
NVEIRKWGEIRKFDFEPKPHWDVATDLDLLDFERAAKVTGSRFVFYKGLGAKLERALFNF
MLDLHTEEHGYKEIIPPFLVNRASLTGTGQLPKFEEDAFLIEKEDYFLIPTSEVPVTNLH
RDEILDGDQLPIKYAAFSANFRSEAGSAGRDTRGLIRQHQFNKVELVKFVKPEDSYEELE
SLTKNAEKVLQLLGLPYRVLSMCTGDLGFTAAKKYDVEVWIPSYNMYREISSCSNFEAFQ
ARRANIRFRREPKGKPEHVHTLNGSGLAIGRTVAAILENYQQADGSVVIPEVLRPYMRNR
EVIAPE
>PK3-045_05190 Pyridoxal 5'-phosphate synthase subunit PdxT
MSATVNIKIGVLGLQGAVREHVNAIEANNAEAIVVKKVEQLDDIDGLIIPGGESTTMRRL
IDKYEFMEALQAFAKTGKPMFGTCAGLILLANSIKGYDKPHIGVMDVQVERNSFGRQKES
FEANLDIAGVAEDFTAVFIRAPHIVSVGENVEVLAKHNDRIVAAREAQFLGCSFHPELTE
DHRLTGYFIKMAIEAKQHLFA
>PK3-045_05191 Pyridoxal 5'-phosphate synthase subunit PdxS
MKTGTDRVKRGMAEMQKGGVIMDVINAEQAKIAEEAGAVAVMALERVPSDIRAAGGVARM
ADPTIVEEVMNAVTIPVMAKARIGHIVEARVLEAMGVDYIDESEVLTPADEEFHLNKNEY
TVPFVCGCRDLGEAARRIGEGASMLRTKGEPGTGNIVEAVRHIRKVNAQVRKVAYMNEDE
LMTEAKILGAPYELLLEIKRLGRLPVVNFAAGGVATPADAALMMQLGADGVFVGSGIFKS
DNPAKFARAIVEATTHYQDYELIAEISKNLGTAMKGIEISSLAPEARMQERGW
>PK3-045_05192 D-alanyl-D-alanine carboxypeptidase DacA
MKQVKKWTVSFIIAVLFLSTLSTVLPYQANAAEKDELGLNAGAAILVDANTGEILYEKNT
DELLGVASMSKMMTEYIVLESIKNGKISWDQKVKINNYIHRLSGAPELSNVGLTEGEEYT
VKELYEAMAIHSGNAATVALAELIAGTEKNYISVMNKKAEELGLKDFEFVNSSGLNNSDL
LGNIPAGTEKDENKMSAKAVAKLAYRLINDFPEILETSGMPSLKFRDGREYKNFNWLIPS
LIYGYEGVDGLKTGSTDYAKFNVTATAKKGDHRYIVVIMKSETKNSRFAEARKVLDFAFN
NFSTEEVLPANYVDAKNKTIDVIKGKEDKVSIGTKDAVNLVIKNNEKENYVAKVVLDEKK
LNKDGELTAPIKKGDKVGYVTVQTKDGKDVPFLTNDGKEKAQVDLVANETVEKANWFVLA
MRGIGSFFANVWGSVSDTVKGWF
>PK3-045_05193 Inosine-5'-monophosphate dehydrogenase
MWESKFAKEGLTFDDVLLIPAKSEVLPRDVSLKVQLAKNLNLNIPLISAGMDTVTEAEMA
IAIARQGGLGIIHKNMSIEQQAEQVDKVKRSESGVITDPFFLTPEHQVFDAEHLMGKYRI
SGVPIVNNNEEQKLVGILTNRDLRFIEDFSIKISDVMTKENLVTAPVGTTLEEAEKILQR
YKIEKLPLIDEEGVLKGLITIKDIEKVIEFPHSAKDSQGRLLVGAAVGVTNDALKRVELL
VKSNVDVVVIDTAHGHSQGVLEGVRDIRNAYPDLTIIAGNVATAEGTRALIEAGADIVKV
GIGPGSICTTRVVAGVGVPQITAVYDCATEARKHGKSIIADGGIKYSGDIVKALAAGGHA
VMLGSLLAGVSESPGETEIFQGRRFKVYRGMGSVAAMEKGSKDRYFQEDNKKFVPEGIEG
RLPYKGPLSDTIYQLVGGIRSGMGYCGTKDLYELRENAQFVKMTGAGLRESHPHDVQITK
EAPNYSLS
>PK3-045_05194 hypothetical protein
MSKFYKGWSSYSCFFSAEYTQDFLKKCYRNLHISDIDSKSYQNCYPFMYFLEHGKLYYHQ
AANAPMSIQPILLFYGLVHLIKACLLTIDPNYPNSTSVLAHGVSTRKLKKQQYLFFEDEV
KIQKNGLFTYMAEKMFACKNLEGEKIKMGHLLSHIPELSNLFQVLEGKPTFFKVHDQAAN
KIIISNQILDLYYMNINHFKNYLERNHSIQLEEIEENKSELTIRLLEPLKQGSFIKWDSK
EESYAVSADKEKTCLSNELLSHYLILYNLSMIARYEIEWWSELLKTMPNKDYPFIESFLQ
VSSEKGPELIYQFLENLAIS
>PK3-045_05200 hypothetical protein
MIVKVRALKPGSILAEDIFIRTNRPIITAKTVLAEEHIRILKAFLVEEVAIENTQLDGTQ
IIQSSSSFPKGERKDVESGFIDLFLHTVQLYKKEFISWQSGFSVNIANIRNIILPLLEEL
EHVSKEIFSLYHLSNKKEYIHQHSIAVAIISAFIARKMNYSYRDTIQVALAGCLSDAGMA
KIDQRLLYKTEPLTEEEFDEVKKHTRYSFEMIPEHSLLKKETRLAIYQHHERIDGSGYPL
GNIDTKIHAFAKIIGVADTFHAMTSERLYRKKQSPFRVIEQMRQDHFGKFDLTILQALSN
AITQYTIGSKIRLSNGEKAEVLFKEGNASTRPLVKIVESEMILDLEKNRHLFIEEILEE
>PK3-045_05201 DNA gyrase subunit A
MADMPNSQIKDRNISKEMRDSFLDYAMSVIVSRALPDVRDGLKPVHRRILYAMHDLGMHS
DKPFKKSARIVGEVIGKYHPHGDSAVYETMVRMAQDFNYRYMLVDGHGNFGSVDGDSAAA
MRYTEARMSKIAMELLRDINKDTIDYKPNFDGEEKEPVVLPSRFPNLLVNGTSGIAVGMA
TNIPPHQLGEVIDGVLAVSKNADITIPELMEIIPGPDFPTYGMIVGRSGIRKAYETGRGS
IILRARVEIEVKPSGKEVIIVKEIPYQVNKARLVERIAELVRDKKIDGITDLRDESDRNG
MRIVIEVRKDANANVLLNNLYKHTAMQTSFGINLLALVDGQPKVLNLKQCLAHYLDHQKV
IIRRRTEFELRKAEARAHILEGLRIALDHLDEVISLIRSSRTTDIAREGLMTNFNLSEKQ
AQAILDMRLQRLTGLEREKIEDEYQELVKLIAELKAILADEEKILEIIREELLEVKERFN
DTRRTEIIAGGIENIEDEDLIPEENIIITLTHNGYIKRLPASTYRAQRRGGRGIQGMGTN
EDDFVEQLSSTSTHDTILFFTNKGKVYRLKGYEIPEFSRTAKGIPIINLLGVEKDEWVNA
IIPVSEFVDDWYLFFTTKEGISKRSPLSSFANIRNNGLIAVNLREGDELISVRLTDGSKE
IIIGTKNGLLIRFPETDVRSMGRTATGVKGITLSSEDEVVGMEVLEENSEILIVTKKGYG
KRTPIDEYRVQGRGGKGIKTCNITDKNGNLVSMKVVTGEEDVMIITTGGVLIRMAVSDIS
TMGRSTQGVRLIKLNESDNEFVATVAKVEKEDEEVEEVEDVEMTEEGQQASSENDTDSNE
>PK3-045_05202 DNA gyrase subunit B
MSTEQNPVEQQSYDESQIQVLEGLEAVRKRPGMYIGSTSGRGLHHLVWEIVDNSIDEALA
GFCNEINIIIEQDNSITVKDNGRGIPVGIQEKMGRPAVEVIMTVLHAGGKFGGGGYKVSG
GLHGVGASVVNALSTELEVFVHRDGNIYYQKYQKGVPAADLEIIGETDTTGTTTHFKPDG
EIFKETLEYDYETLANRVRELAFLNRDIRITIEDKREGLEKRKEYHYEGGIKSYVEHLNR
NKEVLFEEPIYIEGEKDGITVEISFQYNDGYTGNIHSFANNINTHEGGTHEAGFKTALTR
VINDYARKNNLLKESDTNLSGEDVREGLVAIVSVKHPDPQFEGQTKTKLGNSEVRTITDT
VFSEHLEKFLLENPTVARKIVDKGQMALRARIAAKKARELTRRKSALEVSSLPGKLADCS
SRDPKISELFIVEGDSAGGSAKSGRDRHFQAILPLRGKILNVEKARLDRILSNNEVRSMI
TAIGTGIGDDYDISKARYHKIVIMTDADVDGAHIRTLLLTFFYRYMRKIVEAGYIYIAQP
PLYSIKQGKKLEYAYSDKQLQEVLATLPATPKPNIQRYKGLGEMNAEQLWDTTMDPEHRV
LLQVSLDDAIEADETFEMLMGDKVEPRRNFIEENATYVKNLDV
>PK3-045_05203 hypothetical protein
MYVHIGENILVRTSEILTILDKQTVESSPISKEFLERQKAMTNGKSSTYKSIVITKDTIY
FSPIASNTLKKRIVQLTIQEY
>PK3-045_05204 DNA replication and repair protein RecF
MYIDELLLRNYRNYEELNISFENKVNVILGENAQGKTNVMESIYVLAMAKSHRTSNDKEL
IRWDKEYAKIEGRLVKAHGKIPMQLVVAKKGKKAKFNHIEQRKLSQYIGNMNVVMFAPED
LNLVKGSPQIRRRFIDMEIGQISPVYLHDMSQYQKILHQRNTYLKQLQTNKQTDHTMLEI
LTEQFIDMAVKIVAKRFEFLHLLEKWAVPIHKGISRGLETLEIRYKPSVDVSEDQDLSKM
KSIYEEKFQHLKKREIDRGMTLFGPHRDDMMFYVNNRDVQTFGSQGQQRTTALSIKMAEI
ELIYSEIREYPILLLDDVLSELDDYRQSHLLNTIQGKVQTFVTTTNVDGIDHQTLKEAAT
FQVESGTIKKIQ
>PK3-045_05205 hypothetical protein
MNNQIKIDTDYITLGQFLKVAELIQSGGMAKWFLGEYEVFVNGEQDQRRGRKLRSGDEIN
IPSFGKYTVL
>PK3-045_05206 Beta sliding clamp
MSTSETRPVLTGVNWKIENNDLICIATDSHRLALRKAKIETEEEQSFNIVIPGKSLNELN
RILDDHDEPVEIFVTENQILFKTKHILFFSRLLEGNYPDTNRLIPTESKTDIVVNSKEFL
QSIDRASLLAREGRNNVVKFSTMSDNVIEISSFTPEIGKVMEELVSESVSGEELKISFSA
KFMMDALKVLEGSEVKISFTGAMRPFVIHPTNDDSTLQLILPVRTY
>PK3-045_05207 hypothetical protein
MLNIKAQEKGNKVVSINKVARKEESFLYVCSPVSGKRYRFMYKRFIKSITKYAVIGAVGV
TAAYFMLNAALHAWDAEYEQRMDRLEEYKQNIEANKFEQPEVMSSDAYNIIYGKGGDN
>PK3-045_05208 hypothetical protein
MKKDQIVPVRLSENEKEFLKEDADKMGIGVSTLIRMVLRDYIKERSERSKDK
>PK3-045_05209 hypothetical protein
MNMVNQKSWEEFRSSGMLWWINMILHTFGWALVTEVDEDGNVINAYPSRVKFRGFSEKSN
TEGYQKVSNYLAENADILLEESKD
>PK3-045_05210 hypothetical protein
MFNKKILLRFYLIGLPIIAIWGYYVTNNEPEYIPGETKIWDQAMYEESTSQMFWPIMGAG
VVWIGIAYVIFSVVYKMIKSKK
>PK3-045_05211 hypothetical protein
MGKSRGWTEEEIQYLEDRWGSVSIKGIAKNIDRSINAVKLKANRLGLGDARMHYDGITIN
QLSLALDVSYSTIRSWIKNHDFPVKQKLFALEEKVNVVTYKDFWTWAESHKQIIDFSKVE
KNILGAEPEWVDIKRGADIIGHRKSTPWTNDEDAQLKSMVNAYQYTYPEIAKALRRTEGA
VKNRLKELNIKARPLRLNNNVKYTNEEMDLIVDMYNQGYNVEVIAERIGKSALGVRGKLE
RMGYRFKNGVPVQQNKASNQ
>PK3-045_05212 hypothetical protein
MAEIVVNGSTAIEGKLTVNRALVEVDGQEAIVVEGALRTETYIEEIEDIQSERFSVMGVQ
VVQESFGSEEKEIVYVFRAKKLLVETSPE
>PK3-045_05213 hypothetical protein
MSERDDLDLTEEITDVAADERSQAVMNRENFEAGVKNLWGHSELGIEAKKAAMTMLSTKT
GMYAKIPIICKADSCPFAETCPLLAYDLAPLGEYCPIETAQIELRYQGYSQDFDLEFSSF
TDKAIVSEIINADIMMERCKAMMAKEGVPVTDVVAGIAENGEIYTRPEVSKYWEAYERAQ
KKRNDAYQLMMATRKDKKDDGNDTKSLTEIIAEAVTEGSFIEVEQRPDKFKE
>PK3-045_05214 hypothetical protein
MADYNKIAAGVGSFFQPNDWKMALASKGKATILDSNKAINPFPTGGVHAGGMMSGVPRAI
ANVRHGNMGVVDAIKKAHKTADDKWDYAAIAGSYMGVSAAYRLASGGGVSRDQNGNPNVI
GIPFV
>PK3-045_05215 hypothetical protein
MIPGLKTALAPIADVGKSFSYGFDLPSNIRNEGIRGLTSGLHPHIGGALLGGAIGGYFGT
KLDNVETAPAAIGGAAIGGALLPAIGLAGAGAYGLGRGIINNSDKIVNGVAATGSWLGRA
GVRSITGPQFNFGPSKTGRFFSEAGNRLLNPVARHATTLNKVAENFVSIEPKRQVYDPKR
DRMISKGGVKLKPLGWATIIGGGAIGAVRSVAEAADNSRIGTKDPYITTATPRQSSYANN
AGASGDLVFALNANRRG
>PK3-045_05216 hypothetical protein
MIRTLTQGVRKMAKNSNNVNMLQSIQQGYGNMTWGQKLGAAGTAYAGVSGYADARNQGAS
VPGALAQGVSDAFLMDLIGWKKYVGGAVLMGAGAATIKGIEVMNSSARELGRLGTAAPFS
NSTFVDSEQVYTMRQAGMNMIGQSQQSLRQTILGNEAQAMHR
>PK3-045_05217 hypothetical protein
MAQKDIDTRTAEMEEVEKAINSLNTPTSSEEAGIPKPEDSRTAIHPESPPKSGEIPAVEE
SSKSGGNTSPPDESKKPKKTSDPDGPIAKEQAPNKKTTSVAKAMASKFGKVGKLGLLLNG
GLAVANYSGYRSEGDTTTEAAIKTVGEAAITSVIGPGKYLAGMALTQVPGLISDTFESIN
EQTRELNRLGTMRPFEGNTFVDNPQIFTMRQAAMVTMQQSKYSLEHAMQGNEASFLHR
>PK3-045_05218 hypothetical protein
MAILDKSIKKFYKNAYKRGDLARQTTTATAGVGASAAGEGYRAIDNIVSGLQSNFKNADM
RTIQSHADTIYNSLGDDMINKVAGDKTLFRDMIRQDSKRYGRFEDNIDGYVNSATGNKGW
IGTTPGRGSNFYNLSDEAQAAASQRELRYAQFKSEANRRNDLYYSADTFRKQDFVAGSRT
MQDIRTQSPDISASEVRDALTHQRGTNPDFANQSNFVRKAQTTDSVYDQRAFQNIANRTD
FDQLSDGDIKTLVSQEKRDLREQASQQAAERTKNQAQQQTQQVQNAQQQAVNTAEEIPTA
TEDKAPKPRNAVDKYMQRRYGTMVNDIEGALNSGNKMSSNTIETFAKQTRLNDEVSGQFK
ELIEGGKNAEAISLLKSQQQNYMSSATIMDKALAHKIPQKGAVVVGGAWLVNNMSASRGQ
QSNSQLYGQQTPYM
>PK3-045_05219 hypothetical protein
MALELNKMSPVERKKFQEIVQDPVLWAKVFVKTFDPVQKKIVPWTARWYQVEMLRDKSLK
KVARCGRRTGKCFALCS
>PK3-045_05220 hypothetical protein
MNFKIERQIESGVFSTVIKFISFGNEVMTAEQESKLFSEFGFPEIDLGGVFKGKLKVMDG
KVVLSEDPDTEFISFILNSQKATVDDTFTSEFRIGLGQITSSEIGLILDADTKIAESKCL
LFETEIIKRIDDAVQAIASKACGFSDGYPKELTL
>PK3-045_05221 hypothetical protein
MQLKYNNQIKNKIITIELETTNFTIRENAAIERVGEPVVSIEKEYDGGFPVSFSKKIKTG
FKVRVKFDGTKDLQAATDAANLFFEEVQELVRAEMAAVVERLADLEVEFRPSNGLLDISN
Y
>PK3-045_05222 hypothetical protein
MLKTETMCIDSLHRTFTNPKYRVLFVTPYENQVRLIFMRLRELIDSSPVLKAEVAKMTSN
PFQIVWKNGSAILGFTTGASSGSGGASIRGQKADYIYMDEVDYMADSDFDTVTTIAAERG
DIGIFMSSTPTGKRSKFYEACMNKSMGYTEHYHPSTHNPNWDERMEAEFRAQLSDQGYVH
EILADFGTQDTGVFDKDKLDAACNQEFYHYEKLSPIQLDKVEKLGVRPNLYVYDKGQRAP
MNPFRTMGVDWDKYGASSSILILDFDVIRQKFKVIKRIEVPRADYSYDAAVNMIVELNDQ
YNPSWIYCDRGSGEYQIERLQIIGEKRPSTGLKNKVKGWQFKNVVEVMNPVTKEIDRKPL
KPFMVTQLQIAFERERMILSPFDETLHKQLIDYEVVRQGASGPVFTSENEHFVDALGLAY
LAFVLEFSDLTDTIKKPEFSTKFAHTKARIGEGRAQMALKEIEMPQTTEVKKVLNHDPNE
LRGDRPTWVKVNEGYRSSSGMGRSSWGSRSGGLSRSSW
>PK3-045_05223 hypothetical protein
MADLFYRPDLKPKRDYMSDAEIDDELDQGPDGDSGQDDVPSDLDDIKEKIDDILNVLDIL
PDDIENAMRPSLNRIRQNIYDIAPPWYEDAEDDASPGDGTDISVEEEEAPGESDNSLPSL
LPRNDTIPVVVVPPKPLRVVMDDTFSVDKTEIYKDFINKLRLIIERYMRELLYIAEAGGF
PTYKDLFYRYSVPADQLPDDLKHVGDEIVRSQIRRKQMSKFFQKIYNIDQTIYHLRSNKI
SHELRRRYYEERYSSSKNYLDTNSNDMLRGNRLQYDQKYQQNMYNFYKYLNSSVILVDEV
LQTFVKEAKGKAKLNKEGVDIYKGVREEDELAEKVKKEREERISKNRKEASKKEKERLER
YKTAGRNPNGNSYANSTPSAIVPTGDNAKIVELAQQWVQTRGVGTSNPVIYSMELRGSDM
ELKKYGDCSSFTRRICLDAGKGDIGWTTAQQVVNKKGHFFTDRSQLQPGDMMYFKPSGSH
AISVTLPNGQKAQTAHVAIYVGGTLMIDNSSGVGGISQKDFGSGKYKNYVDQHFLAAVRF
>PK3-045_05224 hypothetical protein
MNLRFWRNKELNEAPRNAPINDKNLRNFVIKAVGLIARQGMHREEFSYPEYDLQEIKVAS
GSDSYIKQALMKYSYLIYKAGYSIKSENEAASEYIKKRFRVMSFATQTPIDITFQEIADD
LVKYSNAFLVKSRVDTIMPGIKAKGVYASKPVGGYFRIDPATVRIKRDDNGKVLKYQQIV
NGKEKDYAPVDIVHFYLDKEPNNAFGTPRIIAALEDVKLLRKIEGNIISLIYRFAIPIYQ
WMIGLPEQGFQATDKEIQDARNEVEKVAMDGMIITNERTQIKAIGAEGHALDASGYLTYF
EKRVFTALGVSESQMGRGGSKQDADSMEAQAHDTVKYIQRTLSIFIENYVINELLLEGGF
NPILNEDDIVTYEFEETSLDTKVKVENHEMLKFQSNVTTLEETRRQLGKKEKVDEKRLYA
NAIDNKNAIAQIREKTKGSLELMKVRDQSSSNSPTNNDTGDGSGVAGNGKEQSSAPNGDV
TNRNRPTNQHGTTSVKIREAAGEAPTMLDNKRKDKENHKKTYSTIYKKYQELRNDIVRNG
EDMDIVMPVSRDSLVKQISEYITLSSQDGIRKAMKDAKVRQDLQGLRKIDLSSLEDESKK
TVTKLLKDIKGRVNKSDDPDAVFESLEYRLRYLLEYIVPKAYWYSYIKACSQVGIDKVYV
DFKGSHDENDHPNVIDTKRFHWEDIPAYHPFCDCEVKLKAGDNK
>PK3-045_05225 hypothetical protein
MSIMIREYFGYDKFDVEYNYTDTKNLQEGLTAEDPVSPNSLMVDIEGIHVGATRNFTRYM
ESALKSSEKSWTRPYEKPLIMHHNEKDGKIIGRIKAVHYTDIKTRSGTGALVFTANVPDK
DGMEQIEDGRLQTTSIGIIGHDVRCSICGHNIAEAGPCEHERGQIYGNEVCYWDIYEMEG
KELSYVIVPSDVYAKNIRIYKPTTQKTQITENLQIHKGVSTVNLTEAEVKQLQDDKQSLE
TQLKEAQDELKTTKDELKTAQEEVQTLKDAKPDESEVELKHQEEKQELEDKLKEAQDSLK
AAQDKLKDIEGELKQEKSLRESLESKSIEQNSATKQALVENYSMLRKLAGKPEMATEKIQ
ERTQDSLIDAIRDLKEELGDSINVATIKPVTNPTITESTEPTVKKDKKASNIDLEEGLES
LFSGIAGKFSNK
>PK3-045_05226 hypothetical protein
MALHPNDFTGQERLQPGARGEIFQADLPGYRGGEDRINRTNNKLNTSAHDVPNIKYQFDY
RLPVLFRYGFAYGFNQIVIPKGRIVAVDPFMDLVDFDMKKQHNTLTIANGGVPVKVRDAA
DKYPVLNGQPTDIVGTEAQGQAVAGVGKEWAPLAGFDQAYNAKAYRPFSRTVTDETSGET
SVVFTGPVAQLGDFKVDPETGKVVTAEGVIADHVRPGNVPIGIMQRNEYTRDDDAYNGMM
PGPVLTDALVELPWFTYKNKAEQNPWGSAYGGLFPGALVKSDENGRFVVSPLSFEEEVAS
MSVAEYEQERQQVLGQVYAVNTSLLPEGAAKWATWALEDRLKFNEFNPAVWSQNGRRGED
AVSNSPYRSNGEYPGYPYDKAYKNSDLHMLASTGRLGNYDQRMNFEHQYENLGIPGLTDG
KNVASRHYDPVTVGHVNKAGEGKEYVDMYFRTIEVDVENLQISFAGATISAEPVTVVQDA
LLLDGALKVKYVDQLQGIVVLAVADKEKMEAAFGTATSIEVKLSFDKRGLAGVPTFLDWD
GVVGSVKVLLTK
>PK3-045_05227 hypothetical protein
MNLYETLEHINGLRKVSIEQQEAFKKGERTDAPKVKPETFDLMESMTRNLYGDYSKGRAS
IQETLTTTDTAKLIPRVIEGQLREAAEPEYLGTRFMNTVHVEGGASTVYVIPVVGELVAS
EVAEGGRYNEDYVDFNTIENSALEVRVKKIGLKVSITEEAISDSSWDILGINVRKMGKAM
ARYKEEWIFNTFSDHGHIIFDNNLREQMPEAGTTGRAEDGTFNDTLSIEDFLDMVLGLMG
NGFVPSDVIMHPLTWVVFARNSMIGNGLTFGAFGGGNVNPWGSVQGTPGFAGLSSTADGQ
KLIMRPEQVQNRLPVPLTINFSPFVHFDKINKRFDMYCIDRNEVGVIVQKEGLGMDNWTD
PERDLRLLKVKERYGVGVLNNGRGITVARNIAVAPTFPQAPVININTNN
>PK3-045_05228 hypothetical protein
MKVLGKIRLAPGEVGFYDELTRIHLTIANPERHVIAGMNTTNIKRAVRSGRLLLASGSLD
LEAAAGKVKASVDADNIKKAEEAKAKAEAKAKAEAEAKAKEEADAKAKAEAEAKAKEEAE
AKAKAEAEAKAKAEEEAKAAAEAEKAEASEKKAPAKKASTKKAPAKKEEASEE
>PK3-045_05229 hypothetical protein
MYQEFNVLSISTSLLEKKVTLEFSLDVNEDTVTLDSLVLVEKATSDIVDFRFNVNRNVVE
LELVDWPIPNTEYLIKVQKGITSIVDDELPDSLQRNVIFPSEITSVAEVTSPADFEEITE
LVISWEEAKTITSENLVRSYYLEIATENAFYNVVRRTEVQDKNSITLAGLPVGQYYVRVR
VQKDGQYGPWSDVVTFIISGENSVPGPIYDEDGEDDGPIYEEELIVISAPANGETPNSFL
IELDEDIDVDSIQEIVVIRRSI
>PK3-045_05230 hypothetical protein
MERVEHTFKVFDNFIEITPKNGVKDNSVYEIRIKKVKALNKNKTIDDLRIKTTTRLTPSY
CSLEAVHSLVDSYDISDEKTLYYIREASLFAEYVTKESYADDNVPFEVFQYVKHKAAYDS
LMKFYVERSAEGGTKGTLGDISFENSSTFPAIKDLLDVLKAEVDKWVEHMRGNGFEGRVA
PASAVRGARSTPGSPYGLRKVGRYVPGHPYGTTFSGMGFSRDVGRS
>PK3-045_05231 hypothetical protein
MREFNNGIKRIIEKFSYDFFIVQQDFSVKCTCIDFTTKQADPLCPKCLGTGRKIKIKKIR
GASSDSSGSFRISGVSESATMTIFYIDAKYPVAEDNIIVDEDNAFMVHRLERKKTANKEM
VYYKAFCNIKKVHSTAFMKNFNRIIKGGS
>PK3-045_05232 hypothetical protein
MIDVMANQSLTEVIKTVDMNQTLLLMGKGATNQAVNKIVYYTTIEAVTAAYGESELTEAF
KIAKGFGVPHIFLINVKNTYDYIEIANVLRHYDFAYVAPASLYLGDAFFDATRNNKKVGY
YHHFLEKLSSYNRSTFVVTDNHASLYEDIDAYLEEMKTIVTQFKNGMNANMNGKNLCFVS
NNLENYQFANVVLASILCVTDLGLYPVIGNLGPVIFDIDAVDIGEHEMVYFKDNYLSGVT
VENLLNFNSKVEPEKIVMIDRIAKYVRRNLDLSRFKGRNMTAYQKLRIEKALIDYFDPMV
NWILRSYQIKNIRFIKDVPGAGVVLCDIDIWPVNSTERFSVVVEG
>PK3-045_05233 hypothetical protein
MNSTDLELLLQASTDNSSGVMSDSEAADLSEERKKAPPPFKANKSANLQDFIKMVSKIVS
MALKKQKVEFIPDEGKRVLVDPNEKIDHPFITYKVISRTPKQELKPRERESLIAEDVVKD
ADGRQGRVYGQKFKCYVQFNIIASEYSEADEVMNTFEDLILSYAHYFKKNGVAELLFEKH
LTDENFDIYRQTMSVRNLQYYVEVERLTVVFDSEIKDVQIND
>PK3-045_05234 hypothetical protein
MSLIDSQTFLPGALTEVESDYSYGYDSSLFGTTDSVLVIGTAFNGPVGVPVEIYSPEHGR
YVFGKAYDAKSKQEATLVSGIEDAYQRGSRTIYGVRISGKQVEKKFNLALDTNLQLHVSG
VYPTNEAKDFFMVYDDTTGDERIRLYKPADRATIVEKMQGLVESENSVLVTEIRLNLDYG
LTKDSMLTDLLRIVNEHAYNNVLRLTIVDENGSDVTNTSIEAMNLPIGAMHPGAYFIGRD
RSLCPTVTDIDFKLITSDADKPFESFSEVVFKRLVLNTDVSQPLPIFAENMEELRDILRT
VEIFTFQDFDFLETQGVADRAFAKDKVDYEEVNISKFDIYQRLGSGFAITARAERRVDAT
TGAELTPKVKETPVSDANRVLALGDGIYSMLENLNTRYRVLTAANADTQITGKLPRPKDF
LVGTPVSVDILNGLVQATPKIDPATNFTPKAFSFKVNAIVDGALEAPVDEIYDDVVFRVV
PNATEEELLNVNVPNGTLAMTFNEDGKGVLKRFNENRYEVLNNSRQIGQLVLVDNVMFQG
VDTPDGTVFEKLEFTAPTDGSPLQFHGKNYVLAENEGRVYALKFLGGADAHVSPIGDIES
MLGENVEQTTVYAQYNHFEANPIVISSALLDGTTVEEFVEYLNNHESLRAQFTFSLTTTG
YEMKDEYVSEAAASAFGVETVLLEDRQASYDYTKYVPYKTNDNFARQLAQHATYTSLKTA
PTHGVIGLSRMSDLSLNSLANRVEEILNLELDLYAKNAQGRNMLDRNNMPYPIGKNISVV
FSQYYLNMSDGYRYVSNGAAGYAGMVSKLPLDQSSTSQPIELDSTMFELTNFQLTRLTQK
GIITIRQSYTRGLVVTDGITQAPAESPFRRLSVTRVIGAVEELIREAVEPFIGKQNHAAN
RNSMQTAVKSNLDKIKDVLIEDYQFNMVIDPRVMKFSYIDIDYKIVPIYEIREVRNRISV
KDEL
>PK3-045_05235 hypothetical protein
MATSASEYTKTYTTFSGCDIVATFGSQVIGSLQAITYSVSREKAPVYTMGSAEPRSFSRG
KRGIAGTMVFTVFDRDALITALKAQNGSVNRIGASNGSQNTATDPMTINEWDQLMTGAVA
GQGIQAANAILQEGEAQYADELPPFDVTISFANEYGQKAVLVIYGVEILNEGTGFSIDSV
TTEKACTFVARKVDYMKQINEDGSVGDKE
>PK3-045_05236 hypothetical protein
MSMASKYTGQNISFSGCDMVVSIDSVFPDGTKFNRVIGSLQTLTYSIHMDKFPVRSVGNA
NAKDYVFGPRTIAGSLIFAVFNKHFAYELMETASKTSGLEKYHFLMDEMPPFNITVSFAN
EYGETARLALYGVRIINEGQTMSVNDIYTENTYQFVATDIEYLNDGTGSSSEGLARTYAD
QVMSGVRTAVPASNPILSEQSAEQGPQVSVQSGNNSMTVNVGRSSATDNSARLTS
>PK3-045_05237 hypothetical protein
MPGMIFEIFNKDGIVLRRGAVEEGSLNIDIQEDDYRYVIRDEIDSSIIYKQGYMQKAVSK
AESNPYSVSIVSMDGKDVELYCNTFKDGHSILCYQKADDPSTKQEVELEGPRMRLEIDPG
KYIFYTRNEVETSTVVQLSIIDETREELLDQVKHNISQYGEKHDLVLSGIQGYLEEDESC
SVYAAAKRVYLEVPKDDKELLIASYDFLFQAERIINERKQLNNEQVISFTKLTTAPQEFV
QVGPEVTRVLVYEVDNDKYLFTHSISTDSNKSHMVSLRIDHPHRLELYAGNNLVSCFDVF
CPGSVIKASMWSSIKEAIDKTEEVSERRFLLFNNRTDLTEDDKERLSVEHYRKPFYEIVS
APEASFVEDSIEIYIQEFEMLRRLDKALYLSVKEDGFVFYPNYSKRFLITDSMMKLNQVK
DGLYPDKSYFIWVEDEEHNQLTSMRLISSDYEEMYNYGVASRLASIRAYQERLTSFVSQQ
FDNAPKLLREEIDQLSTVADISPNNLYRALIAKLSLSKDTKMFNSIANLILQDKYSSFTV
NERFFGSNAILDRKAGILTFPERFFEYIIQVDSFSVGDQEMATSYHNIKDTGMVKLENAD
YFIVSAIDKSNYSRSGFLFLNTFKIDTVLSSWKLGIEVK
>PK3-045_05238 hypothetical protein
MYGIGNRPAYVNYQYGTKGTKADSGTFSIDQPKRYFSSLDAEIYFSDYYVDEIIAIQYTV
AQNNLPLFGYNSFVYDEIAVGNRIVQGQFSINFTSPGYLFNLLDMIKQDVVAATNQQNVN
APAEGTADEVETPAEQVKPSSSPLWSTTFDIDVMFGEENSMGSSKHVVLEGVMIGSCSLQ
VDTTGNPIAETYSFIARDIRTVE
>PK3-045_05239 hypothetical protein
MKEPVENKAAEVKETSTKAAAPKATNKAENATLDDKQIQQWKKQWGKIFKTTVGGEAFIW
RKLKRKEYVEIMSNAEVEEADEEVLGSRIYRRQERITKLVVLFPTDIESRIEENAGLATS
ISDEVIAKSGFDVSATEEL
>PK3-045_05240 hypothetical protein
MKIRNTSEDQYQPEVAPDSSHQDLSVQDATELFISLQDEHRNVFMHQMDNQIFFYRSLGR
SEYKKILTDDRFDDMAKEELICQVCTLWPENFDFEECDAGVPTVLARAILKNSFLDTIDS
RKNILDYYRQEMFDLDNQITCIINEAFPQFDIEEIESWGIEKTTKYLSRAEWKLHNLRGL
QFYDTNAQESYYEAQSNQQTDQVQTEEIGVPQQEQPKPTNMRGGAKEKLTPEKLRELKAK
FPEINWEGDTIMNEGVEGMADAVDVTSPALRPGF
>PK3-045_05241 hypothetical protein
MADELRDNAQQSSLDHMASLGKAALTVGVGAALFYRGGGRKFLSEGARISERVLRDAQNE
IGSRNLKQLTTTDVKQMYNSLVGSPDSALNRARQYAKEGPMLMRKDHSQNLTGGLQENYL
RLLREQEKIARERFETQHVRYPTAQEFVRKFAPDNPTLGRQIERFAFDAGRGIDDANAVE
KTIQDLKLDESLSRNQIDEMLEFIQKRMSDKEGYSKFMQDHQKMNEDALGFALDPTEMER
VYGSLDKPTPKQNFLNKVLGDHQITVNDILNNPDKFRDNKIVDHAIDAEGKGRDVIKDAP
EFYQAMMERVRQRKGDEAADKFGRLFVDSVLRKDGEGNFYSLTEASGITDKALDWLAGTM
PGKILKLRDFTQRAKGPTFNYTPASGSLADPILARLTNKVNENALTPDSDYLRIYDKSYE
ITTDGLRHEKALDDTYLISRYGTQPRLINQLSGNSDYRVQENKILRALDVGQEGTPTILD
DIRSKINKFDDPEWSRNVINDFLNNADTTKRNLAAYRAASELSHEEAQDVHNIINQVKQL
NTFYSKNTYELNSEAVNKLMAQSSGEARQMFRLLSMNDEDMLRELLVSDNGSLRDASHHL
NQDLVSLLFKYNKQPKRTRDMISIKNNRGNFFGGTETAGFFDTLRMEIGKEAFMRHAVDS
APNKEIYNFDAVNDLIESAGLTGATKRETRRLADWAAFQQTGGVHSRLSRKKDTQALIED
ADRVLNAFMEPEDSTQMNATFFKQFRENLENMSKEKSNVFENSYSTFQDQTDIVTAYNQN
EWMTMRKMVSPLEAIKNLNDTEKLKAFGKQFYAGRNNLEDVTSATLVPYFALIRLSDALG
KIGLSFSTRSSGSIGDLTKSMVFKRGLPLVAGLTYFDYMSDMTGVLTGGTTLKGAFAQGI
ANMDLGMRSITDATGLTDYLKTEKEINPFYSYWTGEDYHSREEREDWYQNGYQEMRKGRW
WSFGGIQEFRGSEVSYYQPNFLRRATSEWKDKALYDSVWEKWSRSWLPTPTDPLSPVRYL
MNPYWLEEKHAEDRPYPMTAPMFTEQTPWGAILNPTIGELIKPKKEMHSDRLNSNYVDVR
ALIEARNMEQFEKAKGNNDNHLIRFKEGSIEPVDWTSLNAPTPSQRVLSLNVQDGVMTNA
STGSYQQFSGVMSASSYLDAAASATSGNIRAGIAYDPEGGGEDGDGESGSGSGGGSGSGS
GGGFGGGYVTTDGISFRDELRLRAASGEFLPRIANQIINKADPTYNIEEINRGIVARAQA
IGSRPREKGFATPESIYNTSATFGAQVLENPEARAELKGLSGGDDFVGEMAYASRFLMGI
YGYGAFAMFPGEARAKLEDAGKIDSPVRGFWDMNTGGLGGGYGEIFRRFIPSFNHMVEDF
NPLMNTMPDWMPERFRFGDPYTKVPKGEMRLPGEGFEAINELHPDQYGRYGAFDRFKILA
DISPGSAEYKVWREIALRTVKDPVLRDEMDEIKDRVSEQAKKHDFYPYKFIGRSTERKVA
TVEEVLNNNYFKVVGDDRIYRMAGIEVTGSNGPDFLASYLMPGSEIVMATDKNKYSGTND
DEHYSVNAAVFINGQNINRQLLKEGNAEKRENDRSAAAAQGLYSDAQMVRGHIYEALSHA
PIPFYSQKFFRIRDPLESYKQEQTYGTPFASWSHPIESFLRPGFERALMSDTETAIGVGA
LVMNQVVHNKTSNKGAKFAANAALMLTNRGAFIGGFLGLGIKGGGLATKRMAQAGAVAQM
AGWLYTRSDQPIESTLGFAAVGAFAGHVLKDVGIKKGGLIGAAAGLAIAGSRTNLLSDGL
DKTWIPERTKEKWEMQEYFDRLEYIKYSGLYEKAARKAHLLEGTNIKKLVNNYEKSKLHA
DRMIKELEEYRKIIRDIYPEGDYRGERLISEIDAKLDVLDDKEMMMSVGKWGRTALIYKQ
AMDSTMYGLQENASWSQLLRSLPTNERDYFIEFAAEKDPKKRKEILEYVSPYQQKALQIA
WGEKPKKQESNASFFQRHRLPTPGWAGWRPNVDLKDVEAKTIVNEGMLLSDFGHYESETR
DPNVVNAPNLNPHDNSNTAEVRANLIAALKGFGLTGVNVSVDPTSRDGIEVVANVIQTTT
YNVQQKIKDMFSF
>PK3-045_05242 hypothetical protein
MENINEYIIQLMERISEGDLVQFSMHSGQSVGVVMTAENTYTVLGLKGMVFEFEDEVRAF
MIGLLIGSNDVEVLTKNEAMLKADQGQFKNK
>PK3-045_05243 hypothetical protein
MADMRIHSNPMILNKTLKTQREMYQRQIEGIRSEYAKQDAKDLGLTPEQAKGMMDLLKSD
VLQSFQNTIATLDHQKVNNIITSEALRIFEGGGFQRPSKYPENPDLLMFYDELHSKALSF
LTNKKTTGQDLMWKTTQIADELRYSFNDKANSFSNYADVQEAYRHFKSGQYGLTVFDLET
FGGKNEFGKQQVDKITEFTFDYYDNTNPDATRQRVTGFVGLSQEEAARYANEFSNFRDFG
SLTEKQKVIAKSLSKIGHEDTSIMEDTSKRGRFVVKRYAKEDEATVTKERIMAGIQKSRE
IGETQQKYRYNGMMAWEEDLANAIIKMQGDNSTIAGHNINRADIPWINQFLSQNASSEMR
NYMSSKGFAGQLNLPANRVLDTLSILQMADVNPKAMSELWPESERRRVLKGEGHTPFQQE
ALVKRFFPDMFTSSQVGAHASDFDVDALHKLITKAQIGNKNFFDRMMELAEESQSATRIG
SSLKQNQQQLFYAAKSLGGDFGKESLFGFKSDSLTGSLKTMDGVELAENLKPTKTFPEYL
TKKGVSYTIDSIEEISANQEYVDKMKRINPSLAVNDLMAVKVSPVIDESSLPYADLVQKN
RESSYIVGPRQDIKSFFSNNMVLYGEKDESGEYKLIDGADKILGKNKFVERGGKITLESV
DPGNLINETIKDGTFINMNDAAARNIRDNKMSRYAALSRFSETISQMANEDTSDLPVAEK
KRIAISRMLQSSQEVARATAEGRAHTLTNQQSPVALLQDVLGYEDFRSGKQVVHPRTIDN
AIASLDHFESIKDEINLLLNEVDSRTQGSSKAEKSYLFSQGLEAIQAKSLEKMQQTHADL
VDGFVRGFEKDYFEVDVSSLSEKTKRTPLAKVMDDTNPEGTLKVNLRPGGEHGLIRSLVG
DTRRVNQEPEAVKQLQALVDVLQKDEGLLQDIYGNSKSEFLKNNTSTTFARKIIEGLTEV
RAQDPTAGYLSPNRVHNVQGISEFSGVLSQDEIMETLNERFSGFRQGSVMQINNAQTPEG
ARARRLQAQSIVDDILMAPFDEKSLASYGYNDKQIEKLKMTRDVRRKDYVSYVENLLGGV
SKTNMSLVADSKSGVFGLVDHGEFIDLANIPREGFTDGIFYTQVGRNRVANELHIIPGNA
PSETRLVSGLGQAMKESNWDLERSIDNAIRRGEDPEERVVQWVSNIARTVREGSSITMFD
EQDMKSQFEVNEKNIINALPSMSGLNALDLERKEEFLTAISRKGFAFDNMSDTDKQLWAL
NRTTIVRDVATKSGDKYIAAIAKNINSRAKSSAIDAGRIRFDPVQSELEYYNRSSRGIED
QIRYLAFREDYARDRLREQGLDNRVDLGAPLRTQMGHALSTRTYQGTSQRAYTEFVTDRI
ALTSNEYKEKLVQAKRAATNAEEIKAIDSLLIKGNLTEGGAIGDARLADALFQNYDRQKI
SFKRELFTEHENNMERFKAIDELRQVVPEFQISEDGKIEFTYKKGRYVNRFDKLFDEVGY
GGAVSPVGAKYDGALRFGFFTKGGNLIADESDVIKNVSDLAKEKGLNIQNQDQFLSAAEQ
LYDANFYVERLSAEPYRKVMEDRAEKHMTAFAYYGLGESGDNRILRALSGMGLQGQRGNV
LDRRFFDELLDENNISNSILSDISTKGITTDSYIKAVTDAGFKDIDEFKSELTRERFLPS
TTMDKYLGASMALVNEDYKHQSRQVPITTAINDILDDEANKIMASGVSREDALRQASANV
YDEVKDVFIKDGEAGLKLDGDGKLVLPDMSFYGNDYIDSTKMAQVYNERFKDVEGKTFEG
LLDTGRVSRHSYAVQQDYTGRSGSGVLSRPEVIVGDDGSLRVSPLSEEDKIRQSLSKGAK
ITDREIEMLETTRYDQALIDRMSKSLSPEDFRNAFGHAVDEADGGFVLKDSYEGRTVLGD
FTNEMRRNQFAKSGEALITHSQAPDYLKPTVKAISDVSGGNVGLQTAEEIYSTQMNTMAM
RFNANPGDMSDLKRNGFQVVKLSELDRMTGQDGSYLLNESMNSIYNKNLIIDLQDDIVTS
DIINSTNHGSRYLALGKLPAGKVGENLIQQGPHQLIGSMLSARNKLEDTRMMTDSDVAIQ
RNNLVEAIDGFNNQINTTIFGKSGLLRNTSEIRLEKSSMGKASLMDIQDILNMDGFPGVL
DNVKIDNKSIMQHHQAGTLMDFKILSEDQFREMGVFDDKYLQELGMDEGQLKAQLRSGVM
GFSHRSPTIYEGSIRPTMLILNENMHGNQAIEYAAGALSSHMDADGDAPRTWLSSYTGQD
GQTLDSIQYKVAEKNGKVDSQISEAFNNQKAMMYRNAVVMNPYFSDKLAADVEEISAIDQ
RLASKLTSLNSTSPSGKMYPGLDRKATPAEAAALMDRYSTVQNIAIEQKIADTPSLRALD
GDAARKEATKLFENKLSDQVDYLSRAVRTFDPSEQEEYAKAADYYIANLQDTATDMAKMK
QSAAGEINLPIYQINKVRNLSHDVLDSDQHRFLTHVLESSEEAFLSPKHSEAKMVSNALT
MQEFNRALKSVTGNPLRGDRESPELMEGWFKKNLPGRFSFDRFSDMYDSEDAAYKDAARM
IQKVFSDRDNINRYNTFMSAVGSRKNGIPMDRLEDALIFPEESRSLMSQSYRVLEQLDDS
GYRGESTQRRSIYADAASKADVPDRKLLSEWTPPTDPDMKTASKNILESARTAISKVNLT
GKDLAFGALGIAGAVMVAGFVGGNPSRPATTHAAAQQQQEAPMAIPSLSDGEAMQVAQNP
QGGYIININANTDKGRDYVQDAIQQSMAQSYTSTNINVSMNIKDNTGNITDRNIENIIRG
SFS
>PK3-045_05244 hypothetical protein
MAEKDVYEQFKNSLDESKLTVSDENFKLPDMGEFYNTAVDDPYIKMVDEAIRNVENGDVN
KASFYVEEPYTTQLGSHDIEGVYFIKAKPNISEEAVLTGEFDGDTLYFPKTSIVADNETI
TRITNSLDNALEDLNEKVYVDKDGKSLYKFSDMGVRFLGVNTPETPKYSLEFVNLDKEET
TALPYFEVKDRDESTYFFERGKERKDDDIVHFIKIDNKWKEYNVTSWTPGEEAKEKGIDS
IIQVLHKEGEKDPDKLAAGLEAKRLVKELIEKAGGEVYFMIDRTSLNRSSDRYPGMFGVN
AFSKGAIDKLKYWFQQIVDYNPYKYAGYNLWGQDAYGRYLGTPYVKITDSTGTKWINMAK
YVIANVPEVEVLPDYTGSPLLQDNYAFASKVFKLHTYDYKNRVLADAVGILSDMLDDRRK
IQRDIFGRDFDALKDWTVTIGDVTLFVPPTSIRSVVNTTHERIPTVRSRGSITKGALKEE
RMLEMTIYFNDERGINGFEYEAELPDKKKTTYYMNGLRALISQFKFTPFLPIESHYINEV
LNVDAVTLVNLQISTLPDYPKCIAAVLTLQEFDYMQYMPELPVDTDNTDAYRNVFASTIN
YSVMRWYYQRALQLGQELKDVDVNSKAYLEKTYGAKTALIPMNFNNPNIRFLIANEEHLK
KMLQVKMDSIRRSNAKIILSDVEKEVAKDVSQVYVQLSNMLGSQEYKDALDALLKVGDNQ
AIGVEKTKDTEGEGKLEKTGLGLYNGGNDMYAKDKNGDLTGRANDFLKAISLEMMKANNT
AGKTILTGGKFVYKEKDIEKINYDAYGEFLENESQKYDEDGKYIHDESKWKPEKAKYVKG
SVVLGIEFTVQLDYLTNPDAQINDLIKDAELTTQLTLKDVFKDKKIFIPFEGTFERNEND
DLFSPYVMDKEQYKFKLDTMNEDIQFIAYCYSIATQLGLNDNKTMNEEALDLKQYSDMDS
METLVYEDYDIGDVRIKNLSAGFGNVFTRVSLNGTSGYAPQYMGGQDTIIEVNLETADLY
SVGLLSALPRITTQYARDYRLILPASPLKLDSEITKLLGVNEVVIENLNIDTVPNQPGLY
NISMRLVSMDRTLRNREGLKKINEFAISGNNGMAEQTEMQLQTYFELSKALARAELYPDL
ELPTLEELESHNFVFIRHKFEEGRVYPDPDFYFVYGHVLQSQIFRESVENAAQEGFGEMK
WVDKEGGGVQTNTYKKMGVKIDSANEESKSRDAKFKQLQEINMKMPDESKKKKSGIDVIN
ALRAADITNTWNISDDIKTIFLEPAYLSLLENYDQMSNAPSEKDKLDSSAGVWVHDAMKP
AREAAEKIEEYLSKPPMPPMDYLYVYGAGYATTFSEVAPHEKDDADKKIEQLLSDKSISK
IFELLEIKVDKKFKKALKNIVYAAACAATSEKEYTGKKKEAAWKPNANFIGMRVTNSQDE
AGKSPATSAEEVVKYGIEFGPYRIKMYTKEELKEIANETVPSGIFGDKKNSEDMNTTYFL
LDPYYRRKETTVAEVEYYKESCATNLPFATEAFFRLMLFWLKRMIDDNILPNMSLDVLKG
EMQSELTSAAVEKYVNKEADEELAEMQKYLEFLDKSDRAIDGGKMFATAVMAMTNSDSFY
EPMKNRRYDMLNGMTESSLNGSGDYNPADMDYILLRKFLLALVGLEEIKKETDIGKQADN
PITDFKKELNEKKYIDAAEDPDQYVKHSFFDMIVNDRRGRMCRAFPTFYVVFVDEGREVG
LWKLHDNFYNINAISEIQVAKSRKNPADTCRIVLSNLFHTLTTEDEDSNMTYEADYRDVF
TSIFNPRSYYMKEEAKRMKQQPLNRAKLTAGTRIHVRMGYGSNAATLPVAFNGMIAEVSA
GDLVEIVAQGDGVELLNPILDSTEAHKKKNEDKNPISKFFQNLFNNASTPKTIIDAFLTV
EGGFIEKKIRDWTNGYYFNDHPLGITHFGNPKYNVVFKAGESTQNIFEALNKPAWSGEDS
PLTKEWAMDEVPKFTIDVFGKTFWDILNICGSASPDFIVGVAPFGFRSTIFHGHPRYYYA
YEYYQDTDGTILERRKPYQQFHIYTSFSDIIKNDIKASSQEIKTNAIGMYKLQTIGTKEN
QEKVGPLWVDWDIYPEHQKSMTVDTQLLAKGTPIIGSIVPFLDWIIDKVADDKGVVQSGK
QVAWRMTAHALKQSMHDMYQGELIVVGDPSVKPHDRFYLYDIYENMSGSALVEGVVHNFS
ANNGFTTTVYPDLVAAVDDRHELAVQSIAGNIVSKSMMAYIATLMPSMLFGKSFTPLLTM
AAKQSRSILYGASKLTKAVGAENTTKKIVKAAQTAKKVAKTGKIAAAGATAAGAVAASGG
TALVPLLAVGIEMAVVHTLTSLAESAINRWMASKQVLQVFPLSKNQKVLTAGMNGSKGVV
YGSPTYDMKGMMDTLFTKLNTETNGFGTAVNFVIDLLATDEMKAIAMKYERGENMSEQVG
STVSGIKASDKLLATLAANQSKTQSGYHRLLLTPRIKPQDEDYGEKLTKAFENMAFLDTN
GIEIQPRITNELIYVKLDPKLKELMETGFLQTAWDSNLPENTYESKEFNINGKKTQIRTI
VVEHKDKKLYDIPFLHPDALAVLREIMIKSTFLIPEEEPEKEKTTPENFIMLHSALKVGD
NETFSSLGVSFILEAHGEKKKTVLLDAVKAIENETLELYNEGQLTNKKLFEWSTDKNGSG
EDTMLLVTVYPPEATK
>PK3-045_05245 hypothetical protein
MSLKSFFQNNVVNPTAINRGETLHKFAVITKANESDNVCSIRYIDKDALERNKDNVPVKI
YSPTMQDWFPEKDDVVTIEEKDGNPIITGVPEGNYAVNIKGKNELESDVLSDEMSCDTEG
GYIY
>PK3-045_05246 hypothetical protein
MAEEKKSQDKDRKIVIESDYGLKFKPLLNWIKEKAKYASRGKEKGIVNKKSGSSMVIREN
GNINIVSSANAQYKLSRGGKATETSHTSETVTNRKKITADDIIINNHKLNPKLYELSDMT
KVLNDDKKVVGNLTMMGTVLVKAWEPTLQKYVLIRRQVRMPLFSPVLNTPDIHPDLAIDT
ELKDEFADMADIEKMADMLSDLNEKGAENK
>PK3-045_05247 hypothetical protein
MIDFAISPQGDLIFEEFEEPKSFKIDFRIAESKGLNIKFHVLEPSVNREQGDFKISFATK
QKTGFTHKASLVSETDQKLQQIRIALTTERGELPTRQSIGSRLSLARHQDINDPANLRLI
EQYVIEAISGILTSPEVMAKPEKGAGNFYCQTVGIYIYEKGILIFKFYI
>PK3-045_05248 hypothetical protein
MKSSETIHSDIKGRFEKMTSKSLQEGSVIDFYTVATSEAMEGAYQEIENSKNPHIYSNLT
GQALDDTGFFVNLPRNPGEDDQQYLYRLMNWNISAEASNTTAINDALLNLEFASNAEFIP
LTNGGGTGTVFIIPRNYEQETIESAIREVEIRLSGVVSPSLYIEYIVPEVRAVKIHAYMQ
SGDGDVNQIQANIHESIKNYVNSIPPRDYLLVGQLNRIGINEPSVDYFSVLQVFIDGQEV
KDIEILQNIESKFILDEIIWS
>PK3-045_05249 hypothetical protein
MLDSRAAFEQAVLHFPKWMDIRKRKNKSDGGKYLQSIIQELDDIQAAIEDYKKDFFIINY
IGKEDTVIDYLYVAEVGELVKDNFILLAPLNNVTFDVKEFYFADTPVALYQEGRLLFKIG
EVSESDTVKYSRDGFTYTAKLNKVHIWNVIDEFAMFAGIERHENESNKELLERTLLVFKN
RTNSTELGLKNAIMNVISNYSSLAPGEIKIEKPNEENLHKSDEEFGSIVERLAQLNKDVY
RTKKWDASRWEHPFKKLDHVSPKWDEEPADIIDGVGHNDALKASLLSELENSGTSDVRID
LYEKSDVRINEYIRDQRVEIDLALQLKKYSNVLKPKEVEYKITAAETTDLTDSNVYIETH
RVVEGENEHFVSDLVSNPADVADITIERGKLKPNTKYKLQLIPKAEYDEMEINKININKD
GSNQSLLKEKGAYRFNEEGVLTNSNVRMHATSTRDFKDYSNIRNLKSGFTLADATQDGTV
VLDVTGMANQYVKVEYDSRETSIIRDRELVKADESFVMNESNQLVSTAEEGEIVIELACN
QLYYEMETGNAIVTKTIDGEQFPSEIWFEAKSEHLKFDKTKQVKIVIRKLGNDRQLIMND
ISYARYDVEMRLQNGSFINTPLGSVIPSVAGENALLMTIRTYHGYSPTIYFVHVGSSLKN
AMYETDVFQTGSVTYIDFDSNCIAKLVELDALGKAIATTNNFVCKNLYRNTRSSAAYLQI
DTSGFVTIRRTTPAIDRFSYMGKMSDWIRLEPGQEIDTILIDGNVRSLMDRVFINDLLQD
GPYDRIYASRQLKGFIVQNGSDEKLVKLTREDIGLSADAYTVHNLPYGARGAFIVDSLNN
VESIGTSHSQAFEYFYVFPSNTQEHIAYNKARMLRPEMTDMEIVDMFSPIIPAGKMMVYV
IAPVVKNGLNAKVEFQKNNGLFETWSLGKKKLRVQIEIDQELSDNYDMEQMAVSQKFILS
NNINLEEQIEVNGQSVNLGEYIVIPPEGMRVIHENRSSQPEVFYAEEDGFNKLKYSNIAS
ITSITHNGATIPASDYQLLKEEGIIAWKNDSLIGEEVTIEYRYGVPRYITFIDLEKLYEL
VGYNVEAYRFTSSLYYRNVIEDTLLTDLDAEKIEEADRVITSSSNPNYRVRIDRNAIRVT
KLNEEDYVAVKAGFFYQDGHELYHYANRNENLLERMSNIELINTERLSGQVKFNQQSKNF
LPESSMKPRRNTIVSMIDFINNDRISGLSRMNALTACDNFNHWNTFEMNVGFDKGLNGMG
MKFEKTSEDGYAIMDITEYLTNNTILSMYVEGKPEILIAKERKHQGYSFNKSIFAEPYKS
LEEHEEFRYFIFNKDTFEEDTKYYLVVKSDGLVDDIIIKDYVAAEDIRSIHRKNISALGF
DIQEFATINYIQKLLFDVDGNKMDRLEISEDGTIKTGVNVDWGFTKVQEFKNDWRSCTLK
EVDLMKESYIRSGDRVGSVETEPIYIRNKDSLRSMIVKVNEMLLDTTAGFNIEVYTSERS
GGMYNLIAVEEDSNTLVVPYGRLSNYIKVKVDIPPHKVINNLEVYSEYIETESPLRVGEY
ENGHLLTKIYDTGFTKDYLIKALIADKVVKPEYIDVSIRAFRQDSERLVWTEWKPLMLNE
NLEVTNSVEFEDYRFFQFQISLRSNLASIKLNNIELEVIG
>PK3-045_05250 hypothetical protein
MFRTNSRVERKNGIRFYEQDILCSDYLFTNDLIVEMKLDYLSPGAGIVLLEKNELIEEQA
NDMFVFKVGQNDFTVIRRRYGVQEVVLHVSSTVTPPMMDLPLTFIKSGRSIELKTGDREV
GHYMLPKSLDKYEVGFYSNAGNVLKDASFAAGAPNKWMVNIRNTNGGRVFFFKDGFQIED
CINDAELEQGEVFLAKGKYHLAYDRSDIDGQNDIESFVSLSDDPRFDDKAKTLLDETNTF
ELEEDAYVNVKFKGTSGQITNIAIKDNTMDAYVPTDDLPITSTGSAMIITLDGLEKVTWK
GTVFSVPSYDDLTDVRDYGIISSKVKNYLVSDFDLTFEREYTYVLDVESLRVDVYDGDDL
HKTQVILMSDQDQGKLTVFRNINAIITQIIIKRTNGEEIDVLLQKTSKVYVPATIQGPVV
VTDKYYIPMNLSSSYRISEDEEREDIYLFTNWEREIFNPSEKMVLDKAIIDMPGNIRVYG
ILKDSETNMDNFYRISGEIDTIDLYADKYDVITESLFTIDYYNSQIKLDDEIKDQYKEII
IDYLKEGSYCINYDRDLHSYEVDISTSEETIYVMYDYAYDEQGYGTVSEYQITDIKPGLK
NKFVVLRKN
>PK3-045_05251 hypothetical protein
MKIYPSFHNVRETDKVQPKDIPLSYISNDSVETEIVVSKEPVASQGNKSSSAMPYEVFNS
ADTYLFDESGNRVEVATMMQRLGDEYYFVPQNAIEFSPTRFSFSVLVKKDMTFLNDKEYN
IKVGCVDGVSRLSDRLISIFGDAPRRGLSPLNVSINNQDVSSYSLIDTSFAENDMVFIES
DDGVHIGNTSDRIDFDSILDNHTNIWLSVKDFGGMIEEAETDEFELGSATVYNDTRYKIP
GYNKRFNMDLTNSDFVGYRYIELFRGDCPILLLEKANKGYILVAHESLFTDVPQNVKLIY
ELILGIFLSSYYRSPERNIWITDSTVDYIALKESQYGLNHEKVTLDEMLYNTDYDIGKEY
GLLEIWTSSNDVIFQGLTKEGVILFMKTGMSPDPKKEEDYISTYTTKQTVMLYKKQSVNK
VETDLTVTPIFTETGNYISVQSYRSTSLKIYSVEEQVIRVPEDYTTYTLVCKDSIFKLIP
DGAHDPLVDGLKMATVRVIQNRVTKNYDMRVLGGGLPEDQDPNFNLLDIGHIDGRPYRIG
SSMIITLPKRLEPYREIIEATVNRHVTSGDYPIILFE
>PK3-045_05252 hypothetical protein
MSNQLKRLDFGNGIRANDIQYNFDTIDGQMKRERARIGGYGIVEGFDVEVLSSNQIRVSE
GVIINKQGAEVIIPERIVYIQPPEFAEHKLVTMEEALTVNEAGELTLPYIPYSDKKKGYF
NNNYYQTNWPDVQEELSVSDAENPDLKIRSLRVEKNLLTLDANIWAGKKVFVEYLHTKDR
MDTILVNPSGEFRVEQGIISTSPSHVDLNRYDGFFVIAIVEVLVGDTVTLKAYDDLKTYR
KVYVDEENRLYLNGKLYKESQVVHFVEPVPPYLNALWYDGATNKLMIYKDVDGTLGWVAV
NEEKHIPVKEVKIFSPEEFPEDGQTFLFGPEEINFKFIPGHNQLEIIIDNAPVMSDQFEE
IIDPEIEQYENAGIGFKLKDPLDRATYVEVRVLHTVNAFPLRRTFQRTATFVDDSFTFQD
SLNAEKLFTTEAPYVIGARQLEVYVDGTKLERGLEFEEILEPGVPASSENNGRTSKTYKV
LKELKAGQRVSYRIEKNVYSYDDLDGWVDEIEAKADQALEELDQVRQDMTTMDESFDDKL
QTVNNNITAMAKQLSEQSNFVKKTDKLGKSNMPNEVLNNVMAGSFAVTKPAESITTIEGM
KETDFLLVFYASATQNRALLKDIDYVVQQEGENLLVVLGSELVDESSSIYLTGIKFGI
>PK3-045_05253 hypothetical protein
MEQPKISWFVKEQDGSFMSKEEHHAGTYTKQEQVAVEFQVWNNRWGVEDVLPLADPVLNF
YFDTLEDSSLLHLCKITIDDMGVVPLVIKGEKASARIGRTLSGKQNNGDANSIDNTDNYV
TVKFEFSAEDYRLKENDLKNVYFELVSMS
>PK3-045_05254 hypothetical protein
MSIIRFVDRDIHEPIDYEVAPIDAVLKYVLKKNLPESLPKDTFIYTIDTQELYHGAGYGL
PLKKVYTEEETRKTAVFYFGMLDDANQKVTLYVPLKGVLTRMYVNLGQESAEDLTATVYN
AAEEEIASVIVESGEQFATLDILGTVSYETLKVVVNGELSLPDINVLVDIIPIRND
>PK3-045_05255 hypothetical protein
MAAPIVSWRLGDNSDIMERWSIGRIDAGQEGPQQEILIWNNFAGTEDIAHMQDCKFTTTD
SMLDTLDVVAGKWVYVRCDSMDEVAFTQVGGSEKKTIGARGAEVGVIEGVPNDGAIENET
NFAKVTTYFQSDLHGVQAGPRNFKLRVEYFYV
>PK3-045_05256 hypothetical protein
MFKDCPSVSPVAQDYIWLAEYYKGSLSEFDFETKKENSFYDIDKEKLVRFGLVGRNKKMF
FECSRGSFNLLGKRIDIQYRTDDAVYPLTMQNIYQRDIITYKRAVSESSVGRSSEGTMTS
RILSYSFGYKSEMEIDGVAFNFKPIVTLPDGMDSNFVLTVDLNADQDINGCLELLRGGEV
VSSHEAPLKAGQTGRLHWKIG
>PK3-045_05257 hypothetical protein
MAMVLDVVSSRLSLAEDGLTVTSVNGSWGSARTEQGVSSGKWYWEYEVLDVSGSTKRLML
GVMNSKHTLDNYVGYNTNGRGYYSNTGNKYNSSYTTYGEPYDVGDIVGIALDMDMGTIEF
FKNGISQGIAYSNLLSLGEVYPVLSAVVSGAKAKINLGAEKFQIVESSHDSWKTLVDQGY
KPYDAEIARPWFDKVRNRNVRFTQMYLDHEEAGYILASGEIFSIVDDVEISEEVMYKIES
NDVEVESGIKATPFSFSFAISKESLAIGSNLVQITVEDNDGTQYPMNFEIFKEDRDTFIY
RRQGMYDASIQREGDVVFHGNKGYGFSGFGTGRISFDIPTEGKSNINKITIDGTPEIRNI
VAKTYDMELVQKDGLDPIMSQFKKTVSLTDLTIVLKAELRR
>PK3-045_05258 hypothetical protein
MAGGKFAGGSGSQLDPFLIEDAHDFNAMRLYSSGYYFQLIKDINMNTPPYNIGTGWQPIP
SFNGKIDGQGHKVTGLRIWSTGNDVGLFLASGSSYQLNNIHFDDVYLELITDDTDTRSKK
FTFFGLTHNHNGTFNPLNGVSLIGKFKVQSPGVVARLVSYSLYQPSWASSLRIPLNDCYF
EVENLGDVQINLFGTTSSNNGSSRVQLYRVLVKCKGNFLGFQSGSYGGIEQTDVYLVDDV
DTEYTSFSGFVKQTPEFLSKPENIISFVDASQLGRQLWFFPGNTHVRMVDYSRNKFLLEA
DGVIYSYSVERGLHQVGIAPVLTDMFTLYGMDYIESIPVSVWNQLRQDYGEVDIHCYVEK
IPGKSLVTNREALVFTQALENKVVMKTIIDFSEHNNDINRIRVPAVEPVPVVTEPAPVEP
EPIPTEPTEPETGTTEPENGTTEPDTGTTEPGATDPEATDPETTEPII
>PK3-045_05259 hypothetical protein
MAGGIFGGGTGEIQSPYLIEDADDIFAMRNQPYAFYKLVSSINLMECTQLGPTGWNPAAF
VGTLDGNGFAIENLKNHSGGTDVGLFTVLRGTVRNLQLSNFDIEGGARVGALAGRIEQAK
GLAVENVAVVDSIINGTSYVGSLAGQLITGQIRNSYSKATVQANNNYKGGLFGSISSDVT
VETPVIENCYFDGQILGTGTNGGLVGAKTQEPVVINSFFNSVVGTDNGTGTAKTAEEMLL
AATYVGWDVPMANHLQKVWSIADGSTPELFYNAGSRFLVLAEGKYLRLDSNGEDWIVMGD
MLPTESEFAAYGLSEGDLAGVPGYVWNKLRIHRVIEIVNLRERYRIDQVYEHKLLENQGQ
VTDGFLLKTTINLADYGEALGRVYFKH
>PK3-045_05260 hypothetical protein
MAEEINGGGDELVASPFMTILKNGTHYFTYSNGWVDLGADLSVINGFEQGILISDLNQLW
WWEHFDGEVEVLVYSSTETAEITAYIMQYTDSDIEDVPSEILIDSYKAETVTLQEDRSID
LFGEVLFDNNLGYEVSIDSLLADPVQLDNEHSLLMQGDHNVDLSTEPQEANLDVESNLTE
SMNLEGNHEVLMEGIKTTDASLDGSGFSLDVDSSLTEEMDLDGKYEVLMEGINTTDATQS
GDFVLDVDSNTTNSMELDGDYEVLMEGLNTFDNEASESVIEVDSQRTDSTDVSQDLDLVG
EATSQLRSVISINNGRTWWTFDEDLDNWKQTSLKDINIEGMSISLLNSLDYFDYEKLAPN
RIYTKDLVIATQATSTLEDRETFFRKLDVEFYENQPAFVSNARFSPDSIHNQYTELTFDY
VDLEGDDVFYKVLVQRAGEAEYVQIEPNPSEREWNKRPSEGSVFHAYNYPYFNTGENKVK
VIVQDSRGLKSEHDFSLILTDDVPYIQMTNDQFGMDLVIGDTQMDSVSYKVSLNGEDLLG
FTDFQRSPVNFRYVWKPGQLKRDEINIVRVEVVDSFGNKTIEEFELEGQFTSIMFTDVGG
QYLTDNLGDLLRYLDFGAIVGGTISPHLSVKAVNETGVAVKNLAIKVLSDQLGEGLTVQL
SKEQMPFEETDTIQYSGVMPFQDEKEFYVRIKSGKKVEGIHDFEAVATADTEI
>PK3-045_05261 hypothetical protein
MENRFPYTGESAMVPLFPGKYRVILAQPKSNVAGDILEGTIEIIDFTWGFVNVGAPSGFN
AGRTDFRIRNNIEAELVMATPGDNRYAGYISGYPDHEVNFRGYEFTDIEWSNDINIGEGY
ATIEAVEEYPLATDLFNLKSYYDIGEYLEVVMPNNRTLNKIDLKYNGIWREVYTGRETTF
MLDTSKANRAAKVRYRVEVDGEFITVGESKTFVIGSRSELEATVNLTAGNRFFGTMDVVP
PPYITHNLEPIKDSLVRKKAPIVNYGDSSSLTIGLSEAEREEFETYMGFSLESVPVEEEI
DDARLVLSLKEPYGPLTVKVFEADDDWFERTVRWENRPEIGEQIYQETVIPNKDRQLELD
LTSYVTDWYLGGGEKRSFAIVLETETDEIVYFSSKESSFPPLLKVSYYKIPPNAGVYYMD
ADVVVSLREQSELNAYADIVSQFVVGELPVDLEFPAKPGDLEIDADVLVSVVDISDLLVE
LDFEAKHQSLEMDADIYVRGFSYWDIDAQALMDKKQLAAELDADLVIKIDDQSELDADFE
IEIKYVEDELDVDMLLRAYDFSDINADARFENKYNGHQIDADVEIRSYGDSDMLAEVEFV
AKTGDIEIPADAEFFEKQAFNEIRSDMILSIRWASELDVDLEVEVKRKGTYAFFL
>PK3-045_05262 hypothetical protein
MTKAKEKLLGLLGVRKLIALILTGVFSYLAIVGMIGKDEFLPVFSMVVGYYFGRSTALET
SKNDNQPQG
>PK3-045_05263 hypothetical protein
MISKVTEQELDPKLKLALEKAEGIEETLQIFYEGIMQEVSRINRIADNSRRNADPLGAYP
DGVTIMRINTTGMGFPADFAAVVTNKAGSYGFQIFSNNSADANGFPIWYIRSWMPEVSRW
TEWDHTETAAGAQEKADQKVAKSGDTMSGYLTLHANPVNPKHAATKDYVDSVVEGLDVKS
SVRVATTGQLSISSTTATRLTLSSALTSIDGVVLNVGDRILVKDQSDQKQNGIYQYVSAT
VLDRTEDANSTGKVTPGMYTFVEAGDINSDSGWVLTTNGTIALGTTALHFVQFSGAGQIK
VENGLSKDGNTLSIANTGVTPGTYTKTTVNSRGQVTSGGQLIEEDIPNLGASKINSGIFN
IARIPTGNTSQTVALGNHTHALQDLSNVILTAVATGHIIRYNGSNWVNALLAAADIPNLD
ASKITSGVFDSARIPLLAASKIASGVFDIARIPTGETSTTVALGNHKHSDYEQKNAEQDQ
RLNRIETDRPEVPFGMEGQVPFINKNNANTMEVDYIVTEVSAVDNDTDLAIAKEVFTSNR
EIFDQWGRFSHSGTAQPANASELTAWKYDSVNDLVICTVNSGTYIGFYSDKKYDTYVHQA
TMASADGDDDDIGILIAFAIDANGKEHTLSAIRCANLNQTHTIVNGENYNWAIIYNHKQS
NAKMIANGTSLLTTKVTSQGWSSMPNGTTIRVHRQGDIIEAVTSEFNSTVLNQNTKLTVD
LKSDPVLAVFRGPQSYGYTSHSQNQSTYKDIYFSDAANVIYDIRTGNVWVADSNGNYTID
PSKSLTDLGKGRILSNATTGKMFFVQNDGKVVPIGRTSFRKSVTLAAGAKLTIDAHEEFG
PNVNARNLLVQATVKDTDSTSPTRGMFINSEAVATVGKDDRYIVVVNEYTASLEFDVVVL
R
>PK3-045_05264 hypothetical protein
MALITLSPAPTIFDSATTVQTSQDPQVATVVFSTDGSAPTLAKNLAYDTLSPPNPFISVV
QDGKGNCLFDGGFPKWYNTYFNSAWSTFADLNNTYKYFYNAMDFIAKPGKPKKMLFIGDN
PINADGSFPNYHVKDEGANSGFGRSIKGTCAIAGYEPTIIAPEDYPNQIIDLSYSYLDQF
CGVVLFGSLHTYDKRTISAGTVNNLIAFREAGHGIFIITDHGDVDGSGGFFYNSNFIARE
LGAEFRDNYDRSPVNVGYLIDNYGDHALWKNMSRTDSIHAGGSESRVVITEHPSYTTAPS
FSINRDGWTTVRYLVQLKDGSLHLENFTYGLNVAEFVFFSGNPKTVLNNELINYDVQFPS
GTDASEIRGIVRHNSDVRGEFVRTASGLTKSWLSSNSQRIYPKEGDIIEVAVTEPFTYFK
NIKVGRIQPPADALSLPQLYKDVSIHELASLDQRGFLKDFNSKLGTKSYISAAQKTKSLR
DYFNN
>PK3-045_05265 hypothetical protein
MFLCPFYLHTVHGFTIDAQVISQGRLLDIKLGIGVGRSE
>PK3-045_05266 hypothetical protein
MALRRKMYYALIVALAVGGVVFHKTATAIIKEFPNVFGINSYVFALGIVYLILTISMMEY
FVFYRLKHVDERLREAKVSGYSMTKKVLDAGQDDEIGRIANTINEFMNKFQTKNNQLERS
NEMYSSITEDVPLLVCRFRSDGTITFVNDSYAQSMKQGRDELIGQNFFKLIESVGGQVNR
IKRSLNTLRPEHQTDTYFYDFPIATESYPKWMMWINRAFFDKHGKITEFQSVGLDVYHRT
SNGLNSMMDDILSLVYFVNKDGRLQYASPANEGVLGFKPSDMVGKSIFDFIHDENRGFLE
EQFSKRFGDKEKETSIQELRIKNHKDQYTWVKAAIDSIVASNGSVSDVAINARDITDLKA
ANDHFVDAFSNMQKILDKVDTLEFIIEKSPVITFVWKQGNPLDYISGNISLLGYQKEDFI
DGKLTFEDIVHPEDQDKVMSHISASINEYTELDAISYRLLKMNGDEQFVIDRTIAVKNND
SSVAYYRGVELVSESTSSETVTTSTLYNTRE
>PK3-045_05267 hypothetical protein
MNPADLLTLALEKGLFAALFVFAFWFILSENKKREESQRDLYISLSESLEQAKDAITSIE
GQIERIDNTQSNISQDLLEVKFLVNSMESILKAQLNIRDNNR
>PK3-045_05268 hypothetical protein
MAPIGRGVKKVNESIMQDGRTLIITETDDSQLDWDRIPDGTLKIDPITGQLFIKIQGEGA
WIPAGLTYDGNLTIAKDARIVVEVFKIIRSDNGDGTFTYENEAGEQRTKPLTALGKQTFE
LEKGSFIVKRNKIEAIINDTLHRSATSGGLVEIDETRIALEEKLVAGTKVTLKYFLKVNI
GNPYPRFFINPEEPETADYGDFWLDLNEDQAILKWWDGDSWETLGAEDIEDILGANMVYK
GFNVTPGSGRSVSINHGSDGLGVLFIGGVRYRERQTISNIAVAANSSGSTRTDTLYARTN
SNRLTYSVATGTANAPAGTCKIAEIKVPHGATTISASNITLVRKAMTIRFISDEIYDSTN
QSTAGTLMRRDSAGRAKVAAPSADDDIARKKEVDDAMEVAKAAVKRAGDTMTGQLTIDGF
GVLPKMAAVAANVSGSSYKDGITTFKTGTLAGYPAQNAIAVNFKLDGATATQWIYASGAG
GEIRSWFRHWSSAKSTNNGWSDEFKEVRDLGETADTAYRGDRGKTAYDHSQVRDSNPHET
KHDQLLERGALDPTSTDTTKNKHLSNAQAKKWEDHADANSPHANHLITANYDNQKVFVQS
TKPTSGMKAGDIWIDTSVSYGTK
>PK3-045_05269 hypothetical protein
MAVKSGSFQSNNNSASVNEGWGIRVDWEQLNDSYKIHATVYLELRQSWSDLQLNNDRSGT
LTIDGHSSSLFLNASNYGPAQMDIKIGEATVDVGSAKTFTISAVFNMAWTLRGEYVTEFT
ASRSISTDSIMEAPNAPTGVSLSNPSGTSLSLSWSHSTTSLRPVDDFEVQRSVNGGAYAG
VTTTASKSITGSGSRGSSYQYRVRARNAAGSSAWAYSNTVSIAYLPPNTPSLSSSQSGTT
ADLSWSITTSSDRPIDNFYIDRRVNGGSWAHLTSPASGSRSYANSGLTRGSTYEYRIKAQ
GPGGDSGWSSVVSERIPYLPPTAPSSVSVSRSAYNRFVLTWGAAPTSDRPIDSFDIYRSV
NGGSFSKIANVSGSARSYNDDTVELGKTYQYYVVAINVDATTQSSNSNQLTNPAGIPITN
GTVWNIYPVYVYDGTNWVYRPVYVYNGTVWHWRG
>PK3-045_05270 hypothetical protein
MSENRKFNVGRQSEQLYNEELYKMYESIRTLLMIPEEGKDGPESNLHGALWLNLDKNELN
YYNKELNAWDIIFRDKFRIVDSMLNHFPPDRPVQGQLWINQDVLMYYDGLQWKPIKALMQ
DGSQINLAVFEDFIILSPLHPPGNTVVNDPESDVVVDEANKSQFLVPNIDAGKYFVNREY
RHDYEDINKVTLQYPKEMLNEKVSSWVHVNPGKITNIKKQLFKVDKLNQTIELDPYNTEF
YGFRRDSAFGHFLRPGDGAEDEGDYYAIPEGIQLSYNAAQSFDYVLAVSYEFSWIKSTGR
LNRTSSERITTNYYVGGFGGPINVFVEGYDLENRYYHYDTLTEMLEITDPNMDRDFEISI
FEAISREYGLIRERTLDGRGVIHLRNKYRNPLVFVNGQALHSSLGDIEINDAEGIILVNG
ARRDMSYCVMELDDIENNHNMFVKSGVVNEIVDYQGVIRIDNFASVIPEEDGIILFVDGL
LIKKEDVVRDYSDDSITVNGLERGQEFILLHDKYHALQYDESRLHSALVTGRVDESLVYM
NEFLICNDTAIVTSRTIEEETPEAVNGEIKLFLEPQQDVMEGQFKIWDEYNKTWQDLDAD
TLAAVKLIAFSYENGLNMIQLNIDHDENDFFDVFAYSFANHIEKPVVIESFTCENQQEFN
IRHHFIHGANSLQVYLDGVRQYDNVVTEYVDGSGFKLNAPFTGKVTYVIEHPEGGAQKAC
TREVLDHTNVLAGSPNVYKTNISLYPGRVTVYVSGLRQPQESYVILDNHTILFNDRETML
IGSQDNYPTEHVRKEDGEIVELNRRQQDEILIEVRQKFDRQEQTIQVKDINEYDIGIQKY
DLPPDIIEAADEILIYINGVFTGLRNGIGYVKDRSKGAITVLDGNYVELMNNDPLYTLFM
LDVDKHFLWQQRHDGQPYEPKINNKVTLEWR
>PK3-045_05271 hypothetical protein
MADSSLTKLSISLLPIEDIQELLRYQYDFITKEDNATDTNNVAGIPAERIAVAVSANDRT
TVLNAQRLGGKPASEYLTEEDGGHITRNYNKIREVYSDEIRDLRDELYQLKGELVKRGIV
TNYNPYSGFQDAFHNSDPVYLKDPLVEGLLEDSMTQDEIRIPEYAFKDLDLNDYIVLHQK
DIDRFHVARVTAKMEDGETVKFAPASAFPIKGEMTDLYKSLGMYDNGSFAFMRPAEKIPT
TQEFHSTLNDDTTRTRRNITNPNTGFATTFRVPNSAFSVDGEPKTEGYLVRAEAKITRFG
TPGSLVAYVINEEDIANFKNPQQAEEDGILIAKSQPVLPPAEQMERLIDFDFYDGVSYPI
IKNDETVDKKTRFCLILEATGTVDNMNYYRVQFLQHKDETTGELGDLQLNNITYEYTQRE
NDSDEPALTTNQVVNSADLYYGIVTRGIVTNGIIPYREGVYTAKVNLQEPIEISRARLML
RINREGYYMTGRPGNPIEGSIQDGNNLLFQKDPSLGAIYDMQEIAGIGAKNHDDWVVVGK
QLRKLVSQNQDSIQLEKGVFLEDENMPIYRVGYKVYLKAIRKEYVPEWNTWEERERVKIE
LPLSAVMPDRIKRSETISDRLLFQNEFIDEADPDLAAKYFNEFELQVYWRTEYSGPFDND
RYKEHFLGRIHDLSLSFDKSI
>PK3-045_05272 hypothetical protein
MIDASQNFDEGVAFLLNDLDKDINSKLLLQNNFLDSRRFNETMKNIEDELNLLYEKTRVL
EDMIAYTKEFVQQEIHLNKEKLYDKLKTIEDHRDTMKESAYISYRAPLETKNAEVIRDRD
GTVLDRCDIDNGYLVLSGQDLETIRVVDITKKQELTAYQDNLNESKTTNHYRSFYLLDGP
ASNGVKEELTFLFEDTKTVNSISGVPVNCEILSATLINENGAEEQVVLLENSTIAEKRLK
GVKITIIAKNYETHVYEIESNRLQYDFWSKVAAYEYGQVLGQNSTFDFEAASGVDQYQED
YEVYLTELEEWKAEKSAVEERNRLKLLKYAEDLEAYKEALAAQSEDK
>PK3-045_05273 hypothetical protein
MPTVKTNGSSTQTTSNSSVTTSSESDINLTPPAMPELEEFTVPEPKIKTSLERRYKFGYF
FGLDDMTFKSKNVNLTCGKITKDIEIGKVEMIELETIYSSNNSTAIEFSIVDQDKEIPIM
PIGDQAIENERIFFGLPLRFSIDRSKPYQIKKDGVSIDMTPEMAISKNDGIYTITYTPLN
AQQYIPVSEKVRLKVVMRLYNKSAEAPFIKSALIRAYGGDALWTDHL
>PK3-045_05274 hypothetical protein
MDRSFVTSLREVHAAKYAEEGNTERAREIATAENPYSPIFKPREVHPEEEPSLNELNMFL
SDIGHDLTIVNKGLASSGDKFKSLMEDTKLRLSKVQRDIAIEEERLRDLNMLCGDHSEFD
TVETLTINDFEGGASDIEGVFHAVVVEDAKTRLYVTDVKGNGYEGNQYVYKNKQWLSAIR
DTTDRNHMTDGSLSTAFEYSRINADESEKSVFSLMNFDDIEAECAVTLTAAYPISMVQVL
SDMEDIVLKEVSVSDDGAVYRTVMQEEIAFNKREEIYRNQSQTFGSGIICFPASRYVKLL
FRSDGYTDDKIAFSYYDAKM
>PK3-045_05275 hypothetical protein
MALNFKDIAYKDTETKKAEPKIVEIKSARRHVVRINDIEAHRKQFQSETKMKSRELIRVP
VDSIALFCSEQIPTHFANQKYITYIMTVNGVDYEIEPINSQRAGKKIIKHSELESDQSYA
VYIKESIKSAYLTIVIQSHGETETPYLSNIKILYGRGEENGDV
>PK3-045_05276 hypothetical protein
MATYKDILLKAAYYKEQVTKEMIMKGMFPDDRSIQDRVDRIDKFIALFSHSSVKANMDFD
TESFKKALYLIYQDLSFLYQLLYEETKKEYEYVRSYTDAHLKELENLAERYRLRSKLEID
STSLGETILFQNSGFSIFNRDDAVYVDLGVIEVQEGSTLAVLFDANNVNTEQSLLGLQDS
DGNIHYAAPYNYMQDTFKVPGEPVTTSYSFEIDENQIVNTSFEVSAEGLAPTEKNQYLIF
GGKDQVLFRNDVGRSVITKDENNSFYAREPGTIELFIYKGTYANFNFTRQPEGKNFKGNS
IDDLSDYHSIVIRSEGELAFNLMTDGEVFAVMKKGIVKSDKLYYPEQSDLRSFLVEEVKP
GDTKQYNAFMKIINSNEEPVDINSIAIKELFALEVAQR
>PK3-045_05277 hypothetical protein
MITYNFRYRGPYEYDKFILNIFQFHNEVAILHDLIFQQDTDSTDNILGLKQAFDEHYEQC
IGDNSLSNQIYRQQLLMD
>PK3-045_05278 hypothetical protein
MAIPKLTSKDLNGILAKAQGQIAQMQTNVDAIKTDTSEKLNVLKNEQEYALGELLRMSTV
LGDGQDGSQFVGVKNKAVLTGGDPLLGTYDAFGTTVHRRFLRQPLNVFNLMTIAGPMFRD
NVEVSINGEKREKHKQMLMHVAAKGKGISFGEYDSPNLKLEISVDTDNLLGDTDFNVIEI
DPYLAGSFNIKSLKVYDMYRDPASTTPEYEAKDLKRIGPSRFILDRKHELLKLELEIELL
FKNAVGKYPFGIKHLYFLNADFNPDSVIIAKFEKNNFVETISEDIFIKDQFGKRATTVND
EDIKLYLSETGGILEYELETSTNSVINTISRNTREFFVRIPLQNSAMVSIEFDRIETR
>PK3-045_05279 hypothetical protein
MDYAEFYYSQVVGLYPFDTDDYRMQTDKVMKHLVDSGISESDILRFIEESPPKDCLTPDD
LPEWLWEGSLLKKNTFYYHNTLHLRPPAPTFNPHSREVKASKFYLEMKIKYTMDDLVRYF
YHTLRISTDLADKKKDEGSFNYLLNKYSKLDFCEPIDFVLALIDYNKPDNNPMSPVQGIL
DISQSQAEVYDALKRKAAEASLHKANQILWR
>PK3-045_05280 hypothetical protein
MEGYLIELGGVQKGYFRRNHYTPIDDTFDDEVVEYLEATKNTDVYYSVYTYENEDIDNCH
IYAPLYFDLDLEFENNADFRKIIRDALLVVSYLEDEFGIPEDLIQIYFSGSKGFHILVEP
EVFGIKPSTDLNMQFKKIAQEVNKNTLFHSIDTKIYDRRRLFRFPNSINGKTGLYKVPIT
MSDLRTMDYEKIQEYASEPREVEIAEPRLVETARKKFKQILIVNKLKDAKRRNKNKSKVS
ISTERKDLLPCVKKILNEGAAKGSRNNTCVAIASSMLQSGMTQTEVIDELLAWNEKNDPP
LPEREILTTAKSAYSLVQSGRGYGCTFYQEHDYCVGKTCPLFKK
>PK3-045_05281 hypothetical protein
MTLQQNESEKEELSISENEVLMEDFFETTEDELEEFEQYTWNKGEGYKVPSFPILEQKLE
GLEAGLYLFAGESNSGKSAAMMNLLYDIATHPENNLFGVYYSLDDSKNEIIPRVIAMNEL
IPIGVASKPQRYQKKIDNAEEGSATYQDWLDKRVNGVNRLKELKQQWKVVDGTTIKNAEQ
LYDHIKKVKRYLKAFDPDKNMIIAIDALNDIRFATKKLKPGNELNSEIARTVKEWAVEFD
IPVLGSTHLRKLNQNRRPVLDDLKESGEYVYEASVVWLVHNDVSKNKQAANVYYNAEGVE
EKMPILELDWAKNKKSSFKGRTYQYFTPEMSKLSECQVDVMKRYDALIYES
>PK3-045_05282 hypothetical protein
MGLYDGIKKTNLVTFGNRGDVCELSARELAIQDRIDIGTARNRLKGKLEGKRIVKFRQSG
ADVVISLDYIHKIAAEFPPVKEEEITTNDETKESE
>PK3-045_05283 hypothetical protein
MMKQKNPNDVRGMRISCPSFEQCPLCYGCRNFNSKYDDCRKCESENAKQNICKTDRHRPD
LLEKMIMKEKIVIS
>PK3-045_05284 hypothetical protein
MNLAVRYIQQEHVRRDLSFCGMRFTENQIRYYRALREKIKNDEAHVFHPLELQAPRASGK
TIVLLKLAQQYDIPLIEMNAQFARQLSRSYPGVRVIGASETHRLRGSHFRRFLVDEGVSL
ERLDPSLRIITGINGRNLYYGN
>PK3-045_05285 hypothetical protein
MAIENIRDREQNGLPEELYRTIDFLVIDELREFALNSVERFGTIEKLEEANKVADVVRGL
LTHKRLLDEQTHQSFVDIMLAAALTHNLFYDSEDWLTLFHARKLLAPIANELGINEQALD
ALYHTIEGQLGEQTPVSECIPKPGTPTELFSYAVWFVKNSDLK
>PK3-045_05286 hypothetical protein
MNLVYRYLLSKTKETYRRGAHYLLLKNYDTEPAYLLNSVRIEPGEYFVLEQSKAYEVLNF
ILYEKKVVIIQSIHSGDGPVGEDGTNEDYRTTAI
>PK3-045_05287 hypothetical protein
MKITEQQLFDYIHCPALFEMKYLRQVPLEEPVSSSKLLNKVAKYFYLNLLNGKICTTSEL
KKKWDSVCQGHEGQISGKAIMEGISLIMKLYNWAANEQAVVLDIDTPYTIKVGDTELVGN
LGTILAAPNNKFELLVTDFSSRLPDQTLVDMKLKYTLEAYAFHQVYNKFIDGIRIHSVKH
ARDFYTSRSDGDFKRLEAAIRNVGKSIEDGVYYPREGMCSTCPAKGYCKYWFV
>PK3-045_05288 hypothetical protein
MSISIKEYVGFFDGDKKKQESDKKKSSTQKSKASTTKKKSTK
>PK3-045_05289 hypothetical protein
MAVKNKVKKPKIYTIDGLQFKTKPLYDFYVELKEHKAHGLVNSFTLPTLKEQKAKSKYGA
KKCEVDGYIFDSVMEAKFYVHLKLEKQKGNVVAYELQPKYILQESFKKDGKTVRAIAYIS
DFLVTYKDGSKIVYDVKGRETADFKLKKKMFDFRYRELTLKCVQYRATEKVWMDLDEIKE
LKKKKAKGAKTA
>PK3-045_05290 hypothetical protein
MTTLSANSDTADKTGTDLEEQEKVSREQEWREVEELVMIFKKQFEDGADDIQREISKAAA
EQLLNRFYPLFKKYIILLRSGQIDFNDKEMKLFVASFMDEEALKSALKRQKQKAEYRAKI
YQKFNFVKETYGTVSEEEILVDLQSIFLEMARRYKQMGRSFTGYLYNSFRYEVSRHIKRF
TKNPINIPYRHTQFEEYMRFSEEPSIENNFEDKYYENSVGIPDMTWISGQSCSDLFSVLT
PIERKLIIKYYLEEWNDRQISEEFGIHINTVNQKRRQAISRLAKALNIDESDIKRNRKSG
KKAIMPLRTE
>PK3-045_05291 hypothetical protein
MPINKETHVKAQTILTKLTHEKIVELADKNKRSVSSQIAFMLEESLEREGVVKNEVERP
>PK3-045_05292 hypothetical protein
MKWNVLDADQALVREYMDKLNVNEIMARVFINRGVDYETAHVLLNDPVRAIQDPKLLINV
EQAAAEIIEAIENNAEVWVFADYDVDGITSGFVMTDFLRKTTNNNVYVYYPDRENGYGLN
MDFCKMMVQRKAEEGLEHMLVITVDNGTSCLEEVQFLKDNGIQIVVTDHHKPKAVLPNCT
VVNPHIDSDSVYHHLCGCATAFKTVQVIQDMVGMSKDYVSQYLFAVAFGTVADVMPMTPE
NVALVKIGLEQVNSKNCPKALKYFKDYIGKKSLNANDIGWEVGPRLNACGRMGDIDKGAM
LLFMDNDDTRTDIMDVIIEIEELNQERKSLTKKAEKEMEKIDYSQDYVCIFDASEYPGGI
AGIIAGRMAEKYNKISLVMSGNEVLVGSARAPQGFDLQVILGAELNKGNLLTFGGHEMAA
GFSVHVDKIEDLKASLNETLKVIYDELATVETEEPTLDIDCEIDLDCLNKIVYQSINEMP
YDKNSFPSPVFVLSNLKIVKWKTSKNNENNICFTVQDMNGKQMDIWAWRQGENFKALGEP
EFIDLAGKVEQNFMNKSQYTLNVIDLRSSIAKENKRAV
>PK3-045_05293 hypothetical protein
MELVQLYNQKYSVYHIEKLIERSLVSITTNKLRPGFFSIVLTLNDSMDALRAGKFLVTEL
NELVAKKFVHQLRVQSKSHPYSKRKTTYTLIKPLVSKSSEAGKDTFIYYEPDKSTTIIKL
VATGVHKQSHT
>PK3-045_05294 hypothetical protein
MNLVELYLREPVFPLQKILTWTFEQHIERDMAPIYTYGRAEPVSFSRGPRRARREAQITF
LGLTLKEYEMLYKMKEQRKEVTNLRLRCEQGTLYLTKGIIKSLGTEDPGIIPDDYSRFLM
TVECIDVAINADPPVTGSEAVIQLGDRDAFQARRVALPSFHHTAESPRSFIPEGTFERAF
LGHFHSGYSNLDGVADGGDRDL
>PK3-045_05295 hypothetical protein
MNLVEKHTQVDADNKKKRLEEQQRNSRRSGVFGLGSEVQAFMTGPNGEEIPLGTLQSISM
DSRESAPVFEIGSPDPRSFSGRREFSATLSNVEVNRDALANLLGVSREALDRLSE
>PK3-045_05296 hypothetical protein
MNLVEQYNQLTANKGQVFSIDKITRTRDIVDGTMWFNTENNCLYVSQNSTWVLVSCGLDM
ES
>PK3-045_05297 DNA polymerase III subunit alpha
MEAILNRMNEILEGVKESRNFVHLHLHTSYSFLDGFNDPYESAKRAKELGMTAMAVTDHN
HLGGVLEFQKACKENGIQPLLGVELYWTWDTNVLGMSKDDRDKWAVDRAEADGVEIPKGS
KVKKKDIKDLIAPYEYDTRQYHVLFIASNQTGWKNLVKLQSEAAAKCTFNGRYLIDQEML
RKYNEGIIMTSACIGSPVNRLFIKGEDERAHQILNEWHEIFGERFFIEIQPLDLDKQWIA
NVKLIKWARENNVRIVSTNDVHYTRKEDHDDHDTLLCIGIGRYKDEVDRMTYSNDYWVKN
YDEMLESFARQTQSMIDNDFPGKEYFDPETYIQTAIQGLENTNYVASLCSNIKLGSEKPL
FPKLEIPNGFTPEQWLTLKCYQNLYKYKKSNPEIDVRIYEARLQEELGIINPKGFAPYML
IVEEYIEWANANGCPTGPGRGSAAGSLVLFLLGITKMIDPIKYNLLFFRFLTADRTSPPD
VDTDFDYDNRHRVIEHLEDKYGKANVSHIGTYTYMGVKSSLKDVGRVLRIDFGIMNAVTK
KLDEILDKPSVKFKHFDKLKDSEDMNDRAKWTEFNKLEQENKELFRLARRFEGTPRNIGI
HASGILVTPMPVDEIVPTRKAKDGTTVTLYTGVQLESLNFIKFDILGLKTISVIKNCLKQ
INEELSFEDLYDEVNVDDEGMFEMIRGKNTDGLFQIESNLFKGMIEDIQPDSLNDIIVIN
ALGRPGPLSAGMPQAYARRKNGGEEVTEPLRNTLDIVSNTLGTIAYQEQLMLIAQRVAGF
NGNQADSYLRKGTAKKDKKKMALCRQWFIYGKRNEEAPEGYDPENTDQTMYDPEGKHGTL
IKGGIANGYKKEDLVKFWNDIEGYCDYLFNLSHSACYSYITAITAYLKKYYPVQFMSALL
SAEEKEEKVEKYITVAENMGIKVRVPDINLSGINFTPIQDTILYGLGSIKGVGETSLPDI
IANRPYQSVEDAIARIPKKSFNKRVGLALIKSGAFDFYNQNRYVAMNEFHIARKDKDELY
DTEQYDEVVCGELEKEVLGTAITYKPWWDQLQAEEKVERVFELVDVAEKIDRNGRLMAFI
TVKAQGCTIKGVVFANQYSKFAGLLDLQRNTHAVIKGKKDDKGSLIVNKVTEHRIEKEDK
DTVTDRFHRILA
>PK3-045_05298 hypothetical protein
MTNEERLQTLMQRGWNIQIECKSKWREFAMTYEASGHLIPRPGATQDEITRSFYPIHAYG
NTFEELIAHLEIAAAKAEGGVM
>PK3-045_05299 3'-5' exoribonuclease
MVKAFFDTEFTGLHKDTTLISIGVMYETGHMFYAELTDYDKSQVDQWLQENVINSLTLGE
MEENTYKFGGDMRVKYVRGTKDFVAKELNFWHEYLFHDEQLEMWSDCLSYDWVLYNDLYG
HAFSIPENIYYIPFDICTMFQLKGVDPDISREAFADGFISTEGTGIDPNAVNKHNALWDA
IVIKACYDKLNVMEVAE
>PK3-045_05300 hypothetical protein
MNLLMFCSVFILQFMGHRLGDYFFQTNAQAVQKANNRWARLRHCLVYSVIVASLTLFAVS
WKVALIIFAITIVEHMWIDSRKPIVKYKEFLERKIARTKDFKVEDLPFFVIIDIDQTVHY
LRIFIISLLIAYGVIA
>PK3-045_05301 hypothetical protein
MLKPARMYEGQLKMKMAEIMFDLEYMYSDVRSWRDEVELATDTWNRHEFVSVNENDEVIG
FMGYSINRDSRCCYALQIINFKKDTLSATFGKDLMQLFKDIFMKFHFRKLKFGVTIGNPA
EKFYDKYLDKIGGRVVGIYKEEDILMDGNLYDFKAYEILDKDFLRAILKNSKLFKGAN
>PK3-045_05302 hypothetical protein
MTLQFFLTNVLPMISGIVLAISYIPQIKETRETKNVEGVNKNFWVLISLALFGLTVSTGA
VFYYFGTWGNFILEIFNFGLAFYMLTLVKKYKKK
>PK3-045_05303 hypothetical protein
MDLIIDFDNTIVESDKAIWELYRKDTGDLTTDYKDHSVWWYDDVCPLWSRDQQDNAFQNP
EFFVRLEFMPNAVEYLQKLKQDGHTITVCTVHRGDGVPLKVKWIRENLSFIDNLVIVESS
SVGHKSMICGDIILDDSVSNLSTTRCGVAVCFGEGKWNQQWTGQRAKSWEAFYRYVQEVN
REKQGAEGIRS
>PK3-045_05304 hypothetical protein
MFRKLIGKSKEPKELDPNELLPFCMRCFNVGAMCNEHTSFCHMCGSENTCINVSRENVKY
MQENIDTRIERAVEYGKKQTEVYTMEDCKKDTIEHINQVKEFLIDASVELLERAEEHDKS
KLASPELEIFTEFTPKLKNSTYLSDEYKQNLQQMQKGLQHHYAHNSHHPEHYKKYVCDTC
FKEYKEEPARCEQCQNGQFTVESDISQMDLFDLVEMICDWKAAVMRHADGDIMKSLEGNK
TRFKIDDQLQSILVNTVVRMEAKKQ
>PK3-045_05305 hypothetical protein
MILWAWVFLIVFAVVCIWMAVKGYDQWEIYEEKQQTKMWRENGQIKCCSQLCKQINCPRY
DKCEDAFVSVIRVKNKKRSGGK
>PK3-045_05306 hypothetical protein
MTEEMNQNQQEGIEVNDQEAAAYIQEALKEAGVDMEQDKIILVIEHYYGYLATLGLVQEV
E
>PK3-045_05307 hypothetical protein
MGRLKKEYMQRPEETALAWKYRLIIGKANKQVKLNWGELANLLGLSCSGEYLRKTAYGIL
EFIQWQEEEGLLKMDEDGVFEAIEAIDKLEEKRMEMEREKIRMQDQKRQVKAMLREWARA
EKIKDDIQKAVAEVAKIKPLSIKPKKKLSNYTREGAVLFSDWHRGTKSNHHWNLFTDVEY
EKRVRKLVEKTILYGQEQKIKTLHVFLMGDLINGLIHVTTRIENMEDIVKSTKVVAETIA
EVLTEFADKFDEIKVYSCRGNHDRVTPNKAEAISKESFFDFIPWYLEARVGHIENIEFKE
NEYDDEIIVANICGQNIFAVHGHKDKMNNVVSNLSQMIKIFPDYVFMGHYHHHEENEFHM
CEVIINSSLSGTDEYAKDIRRTSKAAQKFIVFDKDEGRLCTYNIRLDV
>PK3-045_05308 hypothetical protein
MGRVCMSCYESYGSEISMTKVHKDEGGIYFACPKRGCRGEVVEIDDILVPTIILLNEKGY
YTESCCSGHLEEVFTTTYIIFTEVVEHIPGLPPGFQLSAAIPEDGQKRLTLSKHIHGQSS
VQVFQNILTTALQLYAWALSLPYADFEEDEEYTEDVGFFEKLFKQDEPNSIDPSKLKKDV
NATVIPIKEFMDLMNNKNRKDN
>PK3-045_05309 hypothetical protein
MKGYLANGLFSIGDRYVNSLIANKVRRAIPGVDLYVPQENDAINDKEAFADSLLIAKLDY
EALMASDFLVAVIDGVEIDSGVAAEIGAFATTGKPIFALYSDTRQQGRTNQKKINALIED
GTENQFMYRNLFVIGLIKSSKGGVFSTIEDLSHAVGSLVN
>PK3-045_05310 Tyrosine recombinase XerC
MLVQKYIEQKLRAKSESTIKTYKHAIEQFESWLTEAGTNLQEYSRADVQQYLDGLTANGK
SAATVNKVYNAIKSFSRWAGKEEAIEEIRIVKQPDFKNSAPKSLPRLERLRLIRESDRKN
NKRDFAIITTLLNTGVRVSELVSLNRNDVEMSERKGNLTVRQGKGNKERTVPLNPETRRA
IQKSLDERTDDHPALFISNRLKRISIRNVQHILEKYGIHPHLLRHTFITDLVRNNDLVLA
QFLSGHSSTDMLARYSKPTMDDMQEAVDELYIEKHDR
>PK3-045_05311 hypothetical protein
MKCPDCGNIEVKKKEERKDGVSYHCTPCDKDFVYDNSKEDK
>PK3-045_05312 hypothetical protein
MPQGISVDSLIEHSEFSILEYYNSDKVRAYSVGVQVYLPEYQDIEHELLTNKKFHIHLDI
SKRWDSRAIDVVNLTPKVTEAGGFLQWLEHNLGPRFMANYYKEVFRLIEEEHGDGAIGLR
SHANSF
>PK3-045_05313 hypothetical protein
MEDPVVYMERSNSRLLMIKDLESENEYYPCDRNDESGVYIREYDYYFTRRDKDICAFVEE
IATPKYWDHDYISPKLYIASIKKAAAKHNKVVEVLGDSEEPEMMRVVFAIVVCEGYEGKE
TVDTVIEQIDGVIDEIRTEAEIIAKRELLKYINNK
>PK3-045_05314 Tyrosine recombinase XerS
MSQMHLIEERLERLPWYITEFIEYKSRNSSEDTLLSYCRDYEIFFQWLVNEHITPGPVKA
IELETLETLRARNIISFETFCQRQLGNAKDTIARKIASLKSLFHYLSQIAEDDNLYPYLK
RNVMAKIEVVKQVHTEEERAENIAGRILVDDEITLFREFVAHGYGESIKNDTRKWKAYQR
NKVRDLAIVSLILGSGMRVSEIIRLDIDKIDWNNQHLLVKRKGDKLDKIVFSDVACLDLL
EYKQIREAQYKPEANEKAFFLSSPTATGRSTRMSKSAAQRVVDKYADAFGKGALSIHKLR
HTFATNHYKENGDLAALKRQLGHSNINTTMIYTHVFDNTLKDAVNKADK
>PK3-045_05315 hypothetical protein
MVEREMYDFEKDILAKYPYRLSRKFEENLPKFSSHEEARTYFKEQFDNDFFLTGSERING
EKIYFYELVVHRENYDKHQEELRQNGFSSGTDGFMSSHKVEIWENGAVHIVY
>PK3-045_05316 Replication termination protein
MTQGKSTFMLRQRAFIKLYLITMTEQKRLYGFKIWETLEEEFKEFGYKPQRSEIYKSLHE
LLDDGILKSHNVEKEGTKRQEVVVYQFKNHDEAKAYKKLLKAELDRCVGLLQKALKDNYV
>PK3-045_05317 hypothetical protein
MRVFEKDWGREIYFDTIEELLLTIKNDRIKDKVAYKYLSCIPITKPTAFVIRRTHKGFIM
GVYRLHDTIPIFPLYEAPKLNHLKIFQGTSSWPN
>PK3-045_05318 hypothetical protein
MNKVNIQDNYVRKATVCHIVDGDTIDVIFDLGFDITSKQRIRFEIVDTPEKGQEGYQEAK
DYVTEQLLGKEVLIQTTKFKGAGWGRYLGYVYVPNEDGSYTNLGDALLELELAVPYQKG
>PK3-045_05319 hypothetical protein
MLTQLKNGMKIGKATVVVDIVPKGNPEIRPGTKINPTFITYHNTGNSGRGADAESHNKYI
HNLAGKQPKDTSHVSWHLTVDDGHIYQHIPFNENAWHTGDGSGARSGNMTSVGIEICMHK
DQKDYHQAEENAIALGLYIAKELGIPISNHVPHQKWSGKYCPQVILDRDGSFTPFHNRIK
AAASGKSSPAPAPSKPAEKPVSVPAPSGSPIGTAEILVANLNVRADSNFNAKIVDVVQKG
QVFDVYETRNGLHRIKIGWISAGTKYAKFVKKSAAAPVPSGSDSVIGTATVLVGQLNIRA
EANFSSKIVGVAKKGQVFNVYETKNGLHRVPAGWLSAGSSYTKFAKKSTPAKSEKVIGSA
TVLVGQLNIRSDANFNSGVVGVAEKGQTFKVYEAKNGLYRIGSGRWISAGSKYTKFTQVG
STPAKKGDMKTTSIVDYLKSIGVDSSFANRKKLAAQYGISGYEGTPSQNTALLKKMRG
>PK3-045_05320 Dihydrofolate reductase
MLSILVTHDKHRVIGSNNQLPWQLPEGLRFLNKVTTKKTIIMGRKTFEAYGKPLPNRKTM
VLTRDRSYRPYGVEVVRNFNLLKLCKDQPGEYFVIGGEELFRQALSIVDKLYVIYIDESF
DGDAYFPELPANEWELLSEKKGIKDEKNPYDYYFKTYIRRK
>PK3-045_05321 hypothetical protein
MSSSSLWVMDKDYYGSEMQEFSNSWWLSPIAWDILFQKYTPEKVTSQFGTRTTFMTATMF
DNTIHSLLNERINNSEEQIDRIIWELSQQQVFFSKDRKLVADSLRQFLSLNAEYASDAGE
HIHERFNEVADEIEDLVEENHPYFVFKNTSVDDNVEFWFSGYDDEDNYEKRSLKDMDRLV
TEFVNIEDGKITGWKNNLQYFGKTA
>PK3-045_05322 hypothetical protein
MANLEGMRNKFTVVKNDDLDKYLHPEMKSAFLNIAEKVELNKFFEENKKPHTYLIINTDE
PYADEVIEIMKKHGHWG
>PK3-045_05323 hypothetical protein
MRDYLNSSETNQFMVILALTQLLEGTRRMEHNAPKIISMLEEWTSKNNITKDEHRSLKMA
DTYLKKFVQSVYNRLNPREQKTIDKKLNKFDFRLVDDFTLKKIFRETSDRMVNAVVPREQ
FNDWTEQIMQIHCNGCTKDCNACPLYEIFEDNFIPESSWNLPNCKFAYTLEEDNHGQLRR
HAK
>PK3-045_05324 hypothetical protein
MKQVRSSRVQFLEQTLSTLGYQDSLRALDLVIEEMNAEKGFVRHSGAHYYYHLVDVTQKL
LNFGVRDEDTITAALLHDIVEDVDGYTPALIAKLFNSRVAHYVQVLSKKPGVNYKEAENL
VPYLEEISKNCATALIKTADRIHNFGTLLEATPEKKMRQALETEGHFIPYFKMWRNMYPR
YSNFFFEAKTQIEPHLWEIKEHYEEVNSLKREIESLRQRLSTAENYNSSETYRFSGGV
>PK3-045_05325 hypothetical protein
MSFQVTMEGSRTVIEKEPLKQTPAQPIYPDLLEIFIEAPEDVEIIGDIDEEERLKNEKQG
SSMTFTFEELIKKGIDMTKITFNIDDYIKRQKSFDIVKHRHEVKEPNEGKPFNNNDPYPT
DEKIEELEQHVPFMKIHRMEFEGADPAVIELAKQVMDLSDKAEKRIVQLENILATVMRNL
FRVGSRMHINCVYYGGQSNYRKYHTIRCLHHDRIADGQLVTLDQCLACTRYEPIIGQVYD
ILDESGQSLELVLDDNQMSYSTMQDYIKFARAEESNDQSERVLLDTKNLDKRNKKEQDFK
DAWDEGFVMDWNLVPVEEQMFHVNYEDGSKSKTLPSNYKNIEHLYASNGYYTSLEGMGAT
AEMIQRNQDAFDQVYDETLLSYIRDGESYAKNNIDKALKNMASGGYEEILKEICQKKGVD
PLLVMAIITVESGGAITPDGDADSYIGLMQVDRNNLSSGYTSKPELDKARENIEKGVQMY
LGKLKACWDTKNIVLGMVSFNSGEGAILGVSSKGAGPIYEPGLSKSDHNNWTWVDISANL
KRNVTKIYSERSLKEKMTYYPRIHFAYKLLAEKKGYNPLTGDLGLQFPYSPDTIKNTPIY
FTSDFGMRYNTNTKETSMHCGLDFHSGAGTPICAAGAGTVIKVGWQPDGAGRYITIDHGN
NLFTLYMHMQKDSPSKHNISEGTKVKAGQVIGNEGNTGLNMGATGIHLHFEVRNGGNQSK
FAIDPKQKVFPWMAGMKKSSSTPIKFPV
>PK3-045_05326 hypothetical protein
MLHLKRVLHFNDFIRCKISGDIISYGDFYYEDDEDGLIVKATVYKAMQEEKRLNEFNYEK
LEKAESQLEYQQALKEYERQFLTQTLFERKVAHEEVY
>PK3-045_05327 hypothetical protein
MNLVKRYSINLILKTLQSHLCKLNRHNYRTAFSKARSELLSNNLCSSISVHLKDQDTVMV
LTTIDNQRYVLLWDLRKQEIVYQGVKN
>PK3-045_05328 hypothetical protein
MTIEVYLKKRDAGQSLEEIQSEHALSEGTVYTLELGYQCYLKKLPLDKAITIIQNT
>PK3-045_05329 hypothetical protein
MPGVIILATIFIVYEIYKLVFMSRQMDVLGELERMSATKNDTEKRLLSNKAAKSKPHVVT
LLIELCYVIFAVVLFFTQAWFVGLAIIALMFIKSGLDKIRAPRRAVWVIDCLVSIVLLAI
TYPVYLS
>PK3-045_05330 hypothetical protein
MKAVVFIEGGVVQEVLSDEGMEILIVDRDTEGVETNELYKITGDDAYVYSTRGSSVNKEK
IEEIYKELEEQESLRREESK
>PK3-045_05331 RNA-splicing ligase RtcB
MIEVNGKYNSAKIFTDNVEETAMGQIIELCNQEFVKESQIRIMPDTHAGAGCTIGTTMTI
QDKIVPNLVGVDIGCGMEVAIIDKHKDEVNFDQLDEIIRKHVPHGFGVRSRSGRHKFSKL
VDFRNVRAPFNLDRAKDSIGTLGGGNHFVELNELGDKIVLVIHSGSRNLGKQIAEFYQKR
AYEELMEVKDEKEEIIARLKAEGRESEIHEALRGIKKPKIQKELAYLQGQGFDDYMNDMK
IAQHYALLNRKAMADEIVTRMGWEIADNFTTIHNYIDMENMILRKGAISAQAGERVIIPI
NMRDGSIIAYGKGNADWNFSGPHGAGRVLSRSKAKQLLSVDEFKETMSNVWTSSVNESTL
DESPMAYKSLDDIVNNIGESVEISQIIKPVYNFKAN
>PK3-045_05332 hypothetical protein
MPKVQFTYDPLAITRFVLTRYVEEKIQGKFYKAKQFACYDFLDSMTDEELESILRQFIKQ
ENLEEITFKDWEHDARIIWDIISELERYKDLETKFKKSGFGLTGLGVLDKSDNTFYDCAF
VGHWVKVMEIMEHKYPDMYPALQEMYFYADVNESHGYTRSQVDEFIMNQFELIGGSKPLR
EYIGA
>PK3-045_05333 hypothetical protein
MTEITTQDSGLSWLDDRTIILSPTGSHAYGTNTETSDRDYKGVCIPPIEYYLGLESFNEY
NTSGGKNFKNTKDDIDINIIHVNKFVKDAMSGVPNNIEILFVRPEDYLKVTPLGQMLIDN
RHLFLSKLIQKRFGGYAYSQIQKLKNKVSNGTGRQDLINAFGYDTKFFMHSVRLLTSAIE
ILETGDYSTYRTNRQLLLDCRNGRYTFTEAMQMIEEYDAQLKVAVLKSELPATPDYKKIN
KLLMEINRAGLAV
>PK3-045_05334 hypothetical protein
MKSFMRFLKGYLKDVGLMFLITCLIAIPWYIYELIVYGELQTNAFDSVIALVLAGSIYIN
IKLAKRNKEYRSKLIYERMWNILKRHNQSRLEQLEGKELKGTLNVRTVAKHNLTSMEFIE
RIENNKPALSMQEIQSIVYEGREQS
>PK3-045_05335 hypothetical protein
MIHDPLKLMKMTDDEVREALLEDTYNSKSNLRELVRRLLKSAKEFKKAFQYEHSLNNKRD
FWGFIERAAQKQENVDDSWKLVMVDVGSPMYSGRADYKLMNVVTHEKREGYIDSWGMLME
GEQ
>PK3-045_05336 hypothetical protein
MTQRSVDFVQKRDFYRHRFAIPLPAIMRVSRLNDKVINQDKTAIVYVSNISAGGLNFNSE
LDIPIRKGKIYLQFALELGSKTFVVEGLLVRRTEYASRNEISYGVEFEIDSALERELVVS
INQLIIKNRI
>PK3-045_05337 hypothetical protein
MQLRKVNVGNGPYANANIACHDPSTSQIVFLSLISYDGTIKAITKEINRRNSVYVERIGN
FGTSYKSYEIVKTKDQESDYAHAVIYKKDEVTTDRSGNETLNAYLYTKLPDRFNIADAVY
NNGDLPQELLDAVYDKLYAHTPVPLIRDWMNYITRALVNNGSIRELRCFKPEDTNFKVYK
LNIRFSTMFQIVSQGLQNQSINVNGTNQSSPEMADISGLDSYLNSFTGILADQIQRSFTP
KFTPGVDEYNENLQVFDDYAAYRGLKLYEAQKAVIQSASNNLDKNNVSFIIGEMGSGKTI
QGMATVYANAKKEGTTNIILCPGHLVEKWKAELEKYMPLSTAVIVDNFEHFMAIKHEIDN
PKRRRHLFLIMSKETAKFGYEERPSAVWSSSKHCYTCPECGGKLYRIEYEGQGRWKTEKK
VNLTERDFTKQYAYNKVCPNEKVVWDEDNHTWTEVACGAKLWSPLIKEDGTDWIKLGNKQ
GWIQTRHINTVFNELTALDKLDRKDSQFLVALSDALAAAQMGESKPNRAPRKYPIAKFIK
KYYKGKIDYLIADELHLYKGGDSDQGAAFGDLINASKKTIGLTGTLLNGYANGLFYILYR
TFSNIMKKEGFDYNDEAEFARQFGVVRHTSRFAMQNGRQSNRIGSTKEKILPGVSPLVFT
KFLLENASFISLSDISDGLPGYQEIPVPIEMDAELLDAYTRFENDLRSSVGFNGAGGFKA
MGALVQSLSVFPDQAYDQPPVVHPDTGEVIVRPPQLAKGSRRKEERFVELVKEKVEAGEK
VLVYYHWTNRTDLAERLPAILEEEGINAAVLTSSTTSSKNREEWIKKKVEQGIDVLICNP
TLVETGLDLLDFTTIIFYQLGYNIFTMRQASRRSWRLSQTKDIEVYFMFYENTIQEQALS
LMATKLQASQAIEGKFSEEGLHAMSNNEDLLTQIANSVVQGIKHTVDVNVFGTPRKSENE
EDQIMDILYDDDLQETADTEEVVEAKSEVVIEKPKSKYTMFTVYAPTGKKKSKKKPVVTD
THRMMKDLFDKKQHVANLY
>PK3-045_05338 hypothetical protein
MGAYDTPTKECPYCNEKMEADFVDVGVGMVQCGPYHCYACGASEIGPELYDWYNTEPAGP
NQFLNELEPKLKHGHPFSEKELETGFYEPAKQKISPYANTVGGTLVDHKTAKAAYNAGML
DDKNI
>PK3-045_05339 hypothetical protein
MATTEDQFPTKKDIAFRRELLSKHSQLMHMYLRHNSIKPAKEQFEIVKSLFNFLHNLGET
MYFYTLEDFETDSKRFERM
>PK3-045_05340 hypothetical protein
MSLPQIPENDALLLKLLKRRCKELEDGVRKFVDKNYTGGSKSDREDYAQMVSAKDIYDLR
ELIREK
>PK3-045_05341 hypothetical protein
MIDMNIEITKREVLVSISIVLIMVGLGFLIATKVHDYTMSSNEKYFKALKVDNDPELFQY
AIDTEVGNLVSYGTVKAKEPVSDPMIDGKYFDLTKIEEHYVMKTRTVTYTDSNGKTQTKT
ETYWEWEEYDRWYSHTDTFTYLGQTYDFDFIKFSHDSYIDTYEDGMFSDVRYKFYGIPSK
FNGSLYSKATKKTIANNTFHYGQTIKQLMSQKENEASHMTIFFWILWTFVIGLAVFGFVA
LDNKFLNAQN
>PK3-045_05342 hypothetical protein
MSKKAFGILITAIIIISIVVLGALIGVSSQNKAINLEEQIQESSSSIEVQEKRRADLILN
LVDTVENYDEHESGTLTGLAEARSQASQGNVEEARTAIQAVAEAYPDLKSVDNYKTLMNE
LSTTENLIAEYRNNYNVQVKQYNKHVRVFPNTFFLNLMGYEKIDVDYLEYEAPSDAPTDL
FNKE
>PK3-045_05343 hypothetical protein
MHFTVKELREELEAYEDDKIVWISMDNMQAPVRIVTLDEDEEDRLVLK
>PK3-045_05344 hypothetical protein
MSNDFSIREEVRAALQNLEMKMTEEQIDEVVDEIQQYDTFLSVVSLFVLKGTKDVLDSNK
VKYDQEKIEQQIIMAVRGINPDDLA
>PK3-045_05345 hypothetical protein
MHPIIECDEQIRQLENIIRTATMYGDDVSYYENELSKMKNKRIELEEEFRCQMTSRSEKK
>PK3-045_05346 hypothetical protein
MKEKVFVDLNGEKLIVKNRKSAVFFERQADIKKPNSYKGEDHKDYVCITELRRAYKFSEE
SFQAFCNYCSSIALESWSSFTPKEADSWGAEYDDYFDRDFDNNGSLSIGKNVIDIEGPYA
QPKSNGEIVRLIKFNKRKFESFVYDLNRLSSKQ
>PK3-045_05347 hypothetical protein
MKTMSHYESKVIQYENSTEMTDHIIEMEKSGWKCTSPSYSKLRARFRRELENE
>PK3-045_05348 hypothetical protein
MLINIYYIRDSVVRFTSLKKNLERQLSRAEKGETEILPEELKSQKSNFYGIAIDMLNALS
EAVFAFEPNVPYYNTFISSKSMLLEAIKNIKESNTLQTIVDSIDDLLQAYEEFDYNEYST
YSYKTDFRSAYTQRNECTIDEFYLQMIGRTFKTNEDRAIRILDPRPRMGESIAGFKALMP
ESTVTYAAAVPETQGSVTKQKFDKVALGTLKGSVISNDAFDIMFLQPPITLEKQSEKLMI
KKEKDLIRDTIKYIRPGGYLVLVLPHFRFYKDITLILAKNFTDFQIRQFSGGAFERTGAI
FLIAKRKAKSKDRGNEVDPKEYQKLRHLYNLDKVTNIMNENFEEVQLPEGEEPVKFFRGS
ILDTDEIKNIFENSGSMSSFWKAQEVEKLSENPQNPPLPFNTGQLGLVLTSGALDGVVDE
GRGYYHVVKGRVVKKTDSERDTMTNAQGQSEMELVETTSNRVEINVLLPDGTHKVLA
>PK3-045_05349 DNA polymerase III subunit alpha
MLDYVPLHAHTTEGSIGDSILKISEYVKKGKELGLPALAVTDHGSLSAMYAFDAECRKNN
IKPIIGCEVYETKDRLNKDKTDESAKRRWHLVLLAKNNKGMENLLTIVNDAQMNGFYYKP
RTDIEFMKKHGEGIICFSACVGGKIPKAILNNDPEAAIRYIEEYKEAFDEFYLEIQPGTF
EEQRIVNEALIELAEYTNTPLIVTNDVHYLREEDYVPHDAHVKIARKKKFSDPMVYTDKI
YWMMDRKTVIDAFEDTIPRDILEEAVDNTVRVAEQCNVELNDEIHMPEFDTESFGSEALV
LARRCFSALDRIKNTLKDPAEYMTRLLYELETINELGFAGYFLMVEDFISHARSIGIPVG
PGRGSVGGALVAYLLNISLADPIKYNLMFERFLSVHRKSIPDIDIDFDSSRRAEMFDYAA
GKYGVNNCALVSTFQMRKARAAIRDAARILDLDLEIANKASKLIPKVYYGDDGEKETDLS
IEDSLMVSAELAQMAEEYPELFEMAARISDVPSATSIHAAGILVTPVNLSSHIPLVRSNK
EGINATALNLGDAEAAGFVKFDFLSLASLNVYEKTQQDVGFHFDVLSNNFDDEKVWSLIG
SKYTTGLFQISSNTYKSRMPRLKPKSIPELANCLALLRGPCISSGDDKRYMEILEGKQEI
DPIHPLYYKATQDTLGILLYQEQLMEIAVNFGFSLEEGYNLMKVVSKKKIDKIKAFEADF
RLKAEERNVPEDAIDQIWHVILNSGQYCFNRAHAVTYAILSYISGYLKAYYPKEFLVNLL
TNAFNRKKKEEVTEAIEDCRRLGFRFLTVDANKSEWDFTIEDGKIRIGFCAIKGFGQKAA
DEVIEKRPFSSFKDFIDRIEKGKCSKRSMIPGIFSGMFDSFNENRGEVYREFMAERNEEP
LEEIQLQTKEKFSPEEGIDKLEVTLLGGQFISDPSNAMDSVGFRELKVNKVCEFEAFVKN
VKRIKDRNNKQMAFLTLATGDGYIDCTVFSNVLTKNKQAIRKNKFITIKAKKDGDYSCVA
QEVC
>PK3-045_05350 hypothetical protein
MSKLIPETIDSIKSFIETLNNIEKDWDSVYDDIGKCDQEISDLLHEIELTEFDHAEGNKL
SEEIQKVRRRRRELKNYQEIMRHVKEFLERNKSLKMNLFRVLSSVERTRDYQMNRTYTPR
VRTDLKLCSKENQNMMHQQTEFEVETEVFDDTTPVPPVALELPSGEIDMNDSDKEQEVSG
DVRPHPFRSSESFKETETQR
>PK3-045_05351 hypothetical protein
MIYNMFGDFGFLITAEPKEHVVNFLVEEITGRDSSNNEILDKEKYLEGSIKWDSCSHFWF
GDEDKYLHLCGVEDFQRHIQLMEFLYKKAFELMGRRPLESEEWSLEIKSPKEVEQGEQAD
SGDN
>PK3-045_05352 hypothetical protein
MDYNQPQLTMFEISKEEIKLLQFKRIEKLLTQLKKLGKEARSSLFIMFGGYDSVPEEVHE
IPEIRRWAAKFVKRNPEVFYFLNREMQGDQILLTTLCDLTSVHAGEPTKSPEEYHKEGVN
PMELPKKMIELVLPEGLRETITIAVIDHGKQIDDIEGARSSLAIFQIFDR
>PK3-045_05353 hypothetical protein
MGMYTGLRCKVVIKPEYREAMKQLVDNEYEWSESDVDFFKEYGDVSRATFIPRGALAYMP
GEWEGPPFGKLGDGVPTDGFDRKFDPGTGLWTFQCSLKNYEDTIETFMENVLTRITDKVV
HLEYYYEEWDKSIMYDIIDGKVVELKGQGKTYVDEDPEANDYGL
>PK3-045_05354 hypothetical protein
MAFQNERHEKLYNRLKDDAIKRGFTPEEVSTPYLDKLSKQTKSGRIMRMISLAYHLGQMR
GVKMCDELFHTEITLRDGIEEK
>PK3-045_05355 hypothetical protein
MNLVEKHKGVVPVECPQCSGTGLYEGRVECELCAGEKTVPKYVAEEHNRQWAEYQEFYNE
HLSRYTGKAIHMRS
>PK3-045_05356 hypothetical protein
MTQYKVYGTVTMPREVFDNERNGILYRLMQWSPYSQSDMTFSLLNINSKTVGISFDDPEQ
YQENAYHEIRSSLFQSLRALKEKYPEDIKGELMIVSTDGMYYAARIELDGEEYTLFTLQR
SN
>PK3-045_05357 DNA ligase
MSENVKQLKALLDYHDNLYYNQDDPEITDVEYDSIKRRYLELTNQEEYDSVPGEASASLK
KVQHSHPITSLGKVNSLEGLRKEMERLAPFVVQMKVDGLTVVGYPGTTTEAGKFASRGNG
SIGDDITHTAIKMNGINRVGKISEPVRMEAYMKKSVFMALNILRVKEGKEPFKNPRNAVA
GMLRNKDASKVVGVDYFAYNIVGSRMPESKQLSALASNQFETVESIKKADGTIVFEKEDI
DLAIQLIESFDRESLDYEIDGLVIKSNRESALEVFGSTGHHPKNMVAYKFPTEGVWTKLI
EVINQVGRTGKITPVAIIEPTEFMGSTTDRVTLHNYGIINAMKLSKGCEVLFTKANEIIP
AIIDSRNFNPLKAFKKPTHCPECGSELDEVNDQQFCRNPECHAKLLFNICHIAKRDALDI
EGLSEETAKKIIEAGYVEHPFDLFDISQEQIEVLDGYAKKSAAKLYSNIQNARTTSLKQF
IYAAGIPNVGRSVSEDISKTFGSLDAFLFDIEDDCAKFSQIEKVGPTLVDNVKTHGHLLL
KLREKVTPKSEEVKVASAPAKQLTIVITGKFDKPRKYYEGLIKDAGHKASGSVSKKTDYV
FAGEDAGSKLAKAQDLGIQVLETEERLLDVLKEAEA
>PK3-045_05358 hypothetical protein
MFKRKQPIEIDITKDGGILVPRDVIVNMEENVSIMIRRHDAEESAKAVGTVSPELMERYK
KNMDQKKAIRTMLDEIQDRLIENDEERQEIWNAIYEELGIDMNQMYRIDPKTGEVESIDD
FQDVEAWIGKRK
>PK3-045_05359 hypothetical protein
MPELVGLYKALAIHKLTNNAEFTLTDLIKVKGLIDINEFLTKIDLQDGDENQLDYEKGLG
LRDDDDLDRLMEHFDIFEVIEGNDESYRYVRPDNGEDLLFKLKVHHATDRDGYHDTFFDF
NTLEEADEDEFLDQDALDAFFKSATFLVSPGKENEEGSYKFMWDDFDAVNERIRRATDNN
ETLFVYTLQEEGSSGGYIDAGYMRVNRMGYFLADKLIPMPEPIRYW
>PK3-045_05360 hypothetical protein
MIEQVEKIPVYRYWKPCYSTEHYLLLREIAELWDLYSTRGKVKARHILLTTTILQLYSKR
CGYEQVYYETRHGLKAVYPREVYEGAYKWFLEKTDNAQAGTIKLDGKNYAYTIGKPEPVQ
NERYRGNADKTLSS
>PK3-045_05361 hypothetical protein
MSTDLKTRERFTNTLNKLLKANLLKLSDEARIPQSRLLDEAVEDLLLKYQKQGFNMSTTL
SDEEDEKIHG
>PK3-045_05362 Sporulation initiation inhibitor protein Soj
MGNPIVLTCANHKGGSGKSSLAGSLISALAEQGFRVLGVDGDMQRNLSTTYGLREFGKEK
NLYRAIEDLDEKDDFNGADYIVSTDYDNVDFIVSHEDMALLETSLMLKMAERERYVSKLI
DSINETQDYDFIVFDTNPTLGVLNFNIFVASNHIIIPVECSAYGVDGLGAILKFYKNTRR
VNKNLKIGGIVMHKVDIRKSIAKDAIEVVRDMFGDIIFNTMISIDTSVEKSQWDEIPLLY
HTPDSRAAKQYRQLTKEVLAVVGKQSVVQS
>PK3-045_05363 hypothetical protein
MSGSRASSRANRTLNKKEQLQKAIFGNTAVIDDTEEQDTDYASMFTRDIELEKAPSEETS
IDILKLRPAPGDWNFFSTLPDHKMYELVESIESIGLQNRIIVWQEANKENYIILSGHNRF
KAFEMIYNATQDDKYRFIPAKVYRYEDITMTEAKEIIVDTNFVQRSLRPIERARSIVMKI
NLINEKRASTDVPMGRTRDIVAERYGLKGRMVENYRKLIDLNHQFMEMVNSRELSIVSGA
KIAIFSPEMQQWLFDNFYDKLDNDIVGKMRKGMTKDELTELFKAKAEIEKERTRIRIEIP
YGLEKEFSRHFEEWAEKHHLTSKDFKIYIK
>PK3-045_05364 Thymidine kinase
MFSEVDSMPLAIRIGTLDVEWGSMFSGKSDALITAVKRAMIANKRVQVFKPRLDDRYSDD
TIVTHDGREIDCIVAENSYDLMNRINLDTQVVAIDEIQFFDEHIIEVINSLRRYGGMDVV
VAGLDMWANGEPVELTAKLAAIAHRATKHHAVCVETGEDAYVSYCFVEKDGDVLVGGNDK
YIALSEKAYLQRVQK
>PK3-045_05365 hypothetical protein
MTKGLPKIVPLHKNDVVEMLEAMLEMAKAGEIRNFIAAGYMSDGNIMTAVVKADTIEHHT
LNSYLQTNVILRTVEQNINK
>PK3-045_05366 hypothetical protein
MQKSTIDKYIETSLELLKQQLAREGVIIRNTENLTKTVLEIGELYYDLKRKEDLI
>PK3-045_05367 hypothetical protein
MNLVVLYRSTIQPKVEFQALVQTIEEDVRRRLQPFVGRDNTIQLTQEMEEVINQCINGYA
DQLTSFDKEMAAKILTASRQHL
>PK3-045_05368 hypothetical protein
MLPDRALKKKLMEKYQDEQVFVVPFESVTHIQDKFTPSTDDIKALDLYDKLGKYILRYDA
EYNPAFQQLIPYVLITDKSGEKFYVSKRIAGDKRLLENYSLGFGGHINPCDGSVSVILKA
LDRELNEELDMTMIEDSIDFLGNVRDLTSTTPDHLGFVFSVKVKRVKIKEKDKLKGLWMT
KQELIDNYFHFEGWSKYVIDHFFENMKAQS
>PK3-045_05369 DNA-binding protein HU 1
MNKTELINAVAETAELSKKDATAAVDAVFDTITDALKDGDKVQLIGFGNFETRERAARKG
RNPQTGEEIEIAASKVPAFKPGKQLKDAVKA
>PK3-045_05370 hypothetical protein
MTSAILILLILAVILSGATTFLHARDKKQTELVALVKEQAYQLFLYAEKQDWIGPQKMSY
VADQIVKLIPSKSLVQVIGEERIHDWLQSLYDSFKETLAK
>PK3-045_05371 hypothetical protein
MELVKQYNKDNTISVSLIDSNGKEVQAIENVSLEGSRGLLVVTMDEGSTYEEAEMVRRAV
QSALESKESISGLIVPSTIKIDYIKF
>PK3-045_05372 hypothetical protein
MQCFTCNLSPICKIFQTINDSKMVADITINNCKMYQGQYGSVPAVNQQMPQQQTPQQPLR
PQRSPEQLSAMNDIIRQKQQEIKETEEVELSIEVDNEESPAPVVPLKRPCGTCGYETTRL
FPCDGCGQEICDGCAVNSVEDGKKYCESCWDKL
>PK3-045_05373 DNA primase
MSMLSQNFIDEVKAAVDIVKLVQRHTELKKVGEGIWQGQCPHPHHNDGTPSFTVWEKSQS
WACMGCHSGKKNSKHKNYGSDCFAFLQWMEGIGWKQAILKLAKEVGIKPEQDQHAEVYDH
KRRLAVSYHRNMPPQVYQYLQSRGLDRHDLDDWSIGFDGLRITFPLFDRYRKVLGFSKRK
FIETDESAPKYKNSSNSNVFNKSCYLYGTHLVTDDCDEIRITEGAMDVIVPKKYGVQNIV
ATLGTSFTEHHVALIKNMNKIPVFCMDGDSAGLKSIKKSVDMLAEAGVYSKVLLLPDGKD
MADIANEYKELTEDYIQDHSITYAQLMIQEVITQYDSKVNEIKLRLFPTVKQVLQSIKNE
DERKVMQDYVYEKMGLKL
>PK3-045_05374 hypothetical protein
MFQLDRLKQTERSFFSFFEIDPPHELYQIYDKREFYWTAKEEGQHIKIKYARDVGLSDRE
YGTDQIHRFRQTKGGFYERDGVTMFRVTYAVREIEYTYFKVFLNDHFIDDYDNFLELLPS
AQS
>PK3-045_05375 hypothetical protein
MAINEMELQPEQEQKTGNSFLDDLLSFVEEAEVEELDLATVDEGFSIQNMDQANFIAKKL
KEVRAEMDEAAETAQAYLESYQEKISNWLEKTQNPLRSQEAYLLRLLESFARTKLEGSNK
KSLKLIEGTLQFRKQQDKYEYEDNVLLTYAENNLPQFIKTKLSVDKTELKKKATVKNGEL
YIDGVLVPGVTVTAQDEKFDVK
>PK3-045_05376 hypothetical protein
MNHLDWVKDTSQFRDVQERIESDCQSLIDAYFHDGDSYAIEKFLKTYTEGFKYLEKLLLL
QNKIHVDNAFDEPRLDHGEILKRMKQVNATMMNEAKRQFRHALTFMGSIKSHSPALVEER
RNFGLLENAIEKVLDGEAAAKVFACYHEERKIAESE
>PK3-045_05377 hypothetical protein
MKYGDEYRHYKGGHYRFLGIALPVKAGELSPETLSYLTSTGTARYHENTHDVDLSMIDGA
YFIESDVPHVIYQSEKDYQSDQMWAREVDDFFGYILSPEGNFVRRFAKIS
>PK3-045_05378 hypothetical protein
MYYEEKQQNLFKVHDSFHLAHCISRDCKMGAGIAVLFERQFNMRETLLAQKRDNPDCIRV
GRVFNLITKEKYWHKPTLGYVRASLEKMKDIALEQGIKKIAMPCIASGLDRLDWNVVRAT
VIEVFNDTNIHILVCRK
>PK3-045_05379 ATP-dependent RNA helicase DbpA
MIINIEKIDGFYLVSFDGAKHQFNDYINKIMSIEEKQYDFERRCWKFDDKGIEIVRRLFE
VKQKPKKPKADVIQSNARAKKTVSGYQTVGQSMKLQPYDYQKEAIKFGIDNKEILIVYPC
GAGKTPIGIGLYLEARQYGMVDGPGMVVVKASLKTQWVKEVSKFSDLNAKIIRTPKEISS
SIQDKIKRRENRIKKLEAKGNSEKEIAGLRKEIVNLKKEARILFEKQFEGADLFVLNYET
LRDTKIRSQLHKIKLQFIMADEIHYIKNKDSKRSKALYEFGEVPFKVGATATPVGKNPED
LYGIFRFVKPNLFPSWSSFSKSYIKYAGYGKIVGFRNLNKLRDQIAPSIIVKSKEDISDQ
LPSLMVMQRYCDLEPAQQEMHTSIMEQLDELKKQEDAIRSKFKTEIEARNSPDLAKVEAM
ILAHQTFAQQLANSEELLGMSESELSKKFITGSPSNKLELLVDLVEEILGSEEKVCIFSR
FKKMQDIIEKRFAKDFPNAKIAYVHGQLSDKERYKEVYEKFRDDDDYKVLLCTDAGAEGL
NLSKCKYLIEFDLAESYAIQTQRHGRVERADSIHDTVFVYQLIANDSWDEVAAKIIEKKE
GYDAELIRASGDD
>PK3-045_05380 hypothetical protein
MRMKAGCTNCGSETFFCNNCGGIGPFAKALNEHCPNKVKEWRKFGVGLPKKYNPYYIYFI
KEYVSTLDRKSQVAYYHYIADVPRQHTNALLRMTDRQLDKLLDDIYRNAIKFLKDNEESV
FNKNNLIFEGFYDMLLDESIEEEKIAKWFNEDIATIKITRVFALQASKLG
>PK3-045_05381 hypothetical protein
MGQVNNEKKFSKEIESLVGYVKDHMKNEDDWVVIKYRDVPKITGISSYYVRKLFELLKEH
KNIVFEIDKQAKTHKKPLKFRYVNEEEKINTSLTEKNFYYLEQSEIDYVKTRINGKDYRY
VYRILALCNLLASLGAKEKPVIIDIKEISEALVTTKKMTEEALDDLRESEILIDRDGVGK
LILSPDALHSVESELVQSAPVSRTNLHLDTNKLLDKLLEKQGANLQTVGEQEDDLNESNS
LVDNMRNFRNAISAMQDDFRTFIDKEIDRVSKADKKEEELNQGFETLQKLMEENKRLAQK
NKELEEENGKLVKSLEKAQSLRDQFIINAEQRLEVLLAEVIGVVSNYAQIPGWQKDQVAN
AKLQKNILSAVTSAVDDMLQFTKE
>PK3-045_05382 ATP-dependent DNA helicase PcrA
MALTKSQILQELNEDQQQPVINYEGPSFIVAGPGSGKTHTIVSRAAYMIEEGIHPDNMLL
FTFTRKAAGELKERIASKIGKKAEGLTVGTYHSICSRLLRKYATYLGYENNFSIYDEEDK
KNLLKEIVTDNRLKPAVVASYISDWKNKMITPDQAISMAENSFEEISAEYYQKYQKKLKE
RNAFDFDDLIYQTIKLLSNHHTVLEEITDRFHYIMADEFQDSSDRDVELIRLLGGDRENV
CMILDDEQSIYGFRGASVQAVLRMSEYFEGLREFILRQNYRSTKTIVGAARSLIEHNTEQ
IEKTIFTDNEEGEQVVYFETGNPQEEAVKVVKVIMGLIRFENFQKKDIAILYRMSYLSRA
IEEALLKNGISYTVVGGVPFYARKEIKDIMSYVRFVYNPQDVQAFERIVNVPKRGIGKKG
LENIHSVANNLQGDKIDLINACKNTELSGKAKKGLEEFNRTIKTLQELIEEGESPETIIK
SIVKLTNYNKHLLDTEKDAEERIANVVELQTIASQYDSLEEFIYNMALNSDINEDDDEEQ
VNDRVQLLTMHSSKGLEFKAVIIVGANEGIIPHWKADTLSGVEEERRLFYVAMTRAEKML
FIMRPRITHVNGAPMHAKESKFIGEIDEQYLLKTK
>PK3-045_05383 hypothetical protein
MALNQRRIQITIDPKGNYGIEAKEGFAGASCVEQTRELEIAIGGMVVDEGKTSDYYNPDD
NNPVSLNI
>PK3-045_05384 hypothetical protein
MCVACQTHDKAHDGLSKCEDCHYVGNVGYWIGTAECYDGSTVHIEGHVYLDNTGETFDVT
PLLEKYENIKSFDGSAECPICNSSNFY
>PK3-045_05385 hypothetical protein
MSHWRKFEADVLKDINKDLLAKAVKDLGVEMNESIKNIRNTWGNETVSAGLVKDGRPIAL
GFNFKNRNGKIELQLSGDFFGTGLDERTFIDRLAQSYQKHNAIEKLELQGWNIDEMNVND
KGEIVIEAYQWA
>PK3-045_05386 hypothetical protein
MISFVYNPIDAMVKAATNLYPTINADIQFNPAIKAPGVTTFQREGEPALIDINAELPFDS
AIESLAYELAHVATKTTSKSDPLWKEASERILNEFARIVDKRIEKYQKKSKQLR
>PK3-045_05387 hypothetical protein
MIDQDKFKQQAVVKLSDFSKRKAVAAEPDIEEASSSDQKDARAEMQGKIATAKLHANKEM
ESFRKATEEYIGKIRELIVFEGIDSIVEELFLDSLLRSIIAPTIKGQQIPGMPEEDYRTF
RTQLYKALINHYVDGK
>PK3-045_05388 ATP-dependent zinc metalloprotease FtsH
MRESMHQVRDLLKAKIQCIWIDTYEEAEAIKDLKEIVNGLAGLNLFQWSHTEGLKKLPLT
NLEKAEPADPKMMNPQALFNAIREAQEDANAKREGVYVLRDFHLLNDTHAIKRGLRDLKE
YSSKNYNPIIVVSPIVSIPVEHEKLFTIVSYDVPSKPEIERLVSSMASNIGAAIAKGRDF
TAPDAEQQRLLVNACIGLTFNEISDVFAKSLVRYKELSLQAVMEEKIQLVKKAGVIDYVI
PKFNFEDVGGNHAFKEWVLEVEDAMSEEAKAFGCIRPKGYLALGIPGTSKTAAAEAIANR
WGVPLLKLNMSKIMNKLVGESERKIEQAFRVAKACAPCVFLWDEVEKMLGGIKSSNSSDA
GTTSRVFGKALEFLNDNNDVFVVMTSNDVSQLPPEFTRAGRLDAMWYFSLPTKEEREEIF
RIHLGKTGKEVDDSLIQAAADASENFTGAEIAETVKIAMRKAYKRFKDDGVNALLPNDVE
AAAKEIIPLYQSSKEKILALEAWAQGRARNTNHLETSGVEEAHDDELLGDILNLER
>PK3-045_05389 hypothetical protein
MGRRVGNYKDPQTGETHWLDVGTVRQIKLSPQSLVRFKEMGNYRSMVEYKLDNIDMLKVI
TLTAEYECNNKIYRSEAQQIDELEFADRLFDAVNADETIDNADFMNEMKQNALEDLKGKL
LSDGMILDRLELNGAGYVHSKDRKVMTVDGLVINVNNDTTASIELRNCVGPIALSNLVES
DIVFYSLGMEFRINSFHINEEQDGKIKQVTISTDEILIEETDTEEYFKPFNLGDLSNDEI
VDEFVINRNEMLDNLFEDTSNALNDRFADIF
>PK3-045_05390 hypothetical protein
MPHNIKLFTVTWSTDTAGPSPNENMRTEVFFKGCNKAITGNACLGCFNSPLWQDDAQYTY
TPEAIASQIKEHAPSKYVTIGGGEPTDQLEGLIELTRLLKEDGFHIMVYTWKDLYSVLHN
HTGEREGFLQLLQNIDMMVDGIFDPKERLYKMHEGDGLLSSVGSGNQTIWDIRDYRLNGH
ELSGYKMRDLAGLHLKMNDDLVYITTEAKEPIKLTVSQKGAA
>PK3-045_05391 hypothetical protein
MAVFMEDEKYRIKCPECQNRTFYEKPVYAYIKNGNDLHSTLDKTQLVCTRCSVVAHEVKA
GKGTIKR
>PK3-045_05392 hypothetical protein
MAKIEFPKKAKQVIIRPVPDQLIKQRPGGGGKSLSYLSGSTITDLLNEAFGYLWSWEQTE
QWIQKSEPKFNPKYDKEPVPQGPVAHVKGKLTVHIPQEDGQILSIVKTGYGSKAVLGSQG
DQESVFKAAGTDALKKAASLFGIGLELYRDEDEQLFFDELNYEDPWTDEALAQYEKERDY
IKNFMESNELSMEDMEYYFETFSDNAFSSIEYIVPDNIEAFVAFLEEQLAAAAEE
>PK3-045_05393 hypothetical protein
MGQRLNIEIHSGDNVLANAYYHWSGYTRSAIELAKKIVEGFDTVQADNETVRAIKLLELT
GARMTNVEIDYAKSIDLDESFEAANSRNDGLIAISEKGIAETQLWEEARVTIDLADNTVT
FDALWSYSKEEYVDNYSQEEYDKLGEWSHDQDPTEPMSFDKLDAFSQYIDDTIDGGNYTL
KFTIDEEPSVVGFIE
>PK3-045_05394 hypothetical protein
MSFLDKINAAPAAAATATAAAPKKVNPLLKKKIGGGLPKKEDAAPAAEAPKKKILPLKKK
EEATQEEPKQEEAKVEEKQEAAAPAETSAETPAETKEEAKAPEKKAEEKAKPEPEAETKE
EEKAPAEEPAEKEAEEKPAPKKAETKKKSNANSKANNSKKKTAAKKDDEDEVEVEPTDIP
TTSVSYMEAVQSITSPFVDEEWEEFKNEVQDELSAIVISDDMNPGTLKVVISELSILREK
VWFSYQEQKTLYERLSSKEPEGLIERVKRVNLGKGNNDMERKKAGIMACMQYSTDAGDIN
LFEVLDETRTRYNFLKSVIDSIKYKTDVLITLNGALKLENQHL
>PK3-045_05395 hypothetical protein
MSYRPGDAHLENKILQLVKQANPANPLAYVRDIVKEYSREKLDSYILQSSESQLPKSITR
GNVHADVMIIGEAVSEDQLELGKDVVYPMEGTEGLGLLETVLNHFHVNPDEIFYMNAVNC
FPFKEIDGEILPRTPNKNEVLEHKTYLDYAIDIVRPSIIILLGSVALNVYKKEAISKARG
EWIDVRGIPAMPTYHPEYFIQIADKKHPDIIEELKIDFCEDIRKAFLYLQDQYPDNNVLL
SKLEEE
>PK3-045_05396 hypothetical protein
MSCEWGHDNCKNEGIKCELCVVRDFHYDPIVRKTPKPMAKRQQRQDKRMGSSFEYKNHVS
NQNLLTDVSSRMTPNSGAGRVKGDEEIRGIINIMEELKTKVKEQAPGKQSFTIKREWLDK
LHREAMAVNKEFWYLKFAFHEHDNDVYVIVEQDIIMSMVKTMVEDRKKVNEAALKQDIAE
KERRLKEAENIKLLAEIDVLKAKLKQYEPDPEEIH
>PK3-045_05397 Protein RecA
MASLENKPAMALKEKLALLDKVADNVNKKAGKKVLGRIGADPEIMERLKITFIPTPSMNV
NDATGGGFPRRRMTVVAGLPDSGKTSLILETIAKNMKEDPSFVAGWLESENSLQKEYICD
TFGIDPDRFFYVEHERTGAGEKALDLVESVLATGAIDLFAINSLKCLVPSEEFKKSLGDA
VVGVQARMNARMTRKFTALVAEHNTAFVVVTHLSTDIGSMSRDPLVISGGHAIIYAASIT
MDLRKRAIQDSDPISKEEGIKVGVTIKKNHCVPDRNPYVKTDYFAIFGEGIEQYLTTLDI
AIGQGILVQKGAFIRVPDEDGEPKVINGEKMQWQGKDKFRQYCIENQDFFENLKAQIRGE
IVQLSEEEQQELIQEERQIAQTTEKAEKSSGSKKKLPTAKSKAAPKETQE
>PK3-045_05398 hypothetical protein
MVRFKGYSKVATSDTTLRIDKRERIIACILAGATLEKLPPEMSIKSSQDGQPKNTVRLTI
YEHMENEDYFDWKLRMLQEADWLSNFKTWGKDNILYATWQDTRKLRIYYKWIYKNHKKTY
EQVLKYMHSPLFPAILIMDNGAMNKSKELLIDLGVNHGESARLLQQWFKDIFDIYTDVIK
APESHYLSFDQLSTKKILSVIKPIVQNIPSMYEKLYPHTSSKAISKTN
>PK3-045_05399 hypothetical protein
MEVTTERAYKVTTGMTHTELDEFVGAVEKVYSVFAKNHLETEELAPLMRFKDELIMSVHN
AKSQGN
>PK3-045_05400 hypothetical protein
MSYSNDQVQIRQGLVSYIGALIKSSSFEGRAARQNAASILIEEALKLAQDDNELDFYVLK
PLLRGNVFALNHRINELSKLPASPEVKNTIDNYKAIVAHLEQLVNSIK
>PK3-045_05401 DNA gyrase subunit A
MSQIIRQDIGEKLADSFLNYAMYVIVDRALPDIRDGLKPVQRRILYDMYELGLNHNKAFK
KSARTVGDVLGKYHPHGDSSVYEAMVKMAQSFSMRYPLVAGHGNFGSIDGDSAAAMRYTE
AKMSLFGETMQRDIAKNTVDFEPNFDESLTEPTVLPTLFPNLLANGTTGIAVSMATSIPS
HHAGSLYEAIKTLIRNELEGKETTIDDLIAIVQAPDFPTGGEIINLGEVHKGYRTGKGRV
VIRSKYEIEEVKNRQQIVVTEIPYKVNKAKLIEQIDNLRKTALEDIKEVRDESDKDGIRV
VIELRKDANANWIIKKLLKQTQLQDSFSMNMVALVNNRPHTFTLKEALEYFLAHAAEVII
RRTQFDLEKAERRRHLVEGILLCLDQIDEVIATIKASKSNPEIVANLQSTFGLSEEQAKS
ISDMRLRALSQASHEEYVAEQNKLTEDINAWTDIVSDNTVLLNTMLTEFEHISEIFKDDR
KTDISTFDPSSESDRDLVKDEDLVITYTSKGIIKSVSESEFSRKGRGTKGTKATSVKEND
SIQFILMLNSRDDLLFFTNQGRCHVIEAFKIPISTKGQAGKYINNYLNLEPEEVVVSVLA
RNVNSAGSDLLFVTRNGVGKRLELSNLSNTRSTTKVISFRDSDELVSVTLFEKGQEVLLL
TAKGQGVRFNPDAEGGKGMRPMGRSAVGVNAVNLVDGDYVVGTTVISEGEDLFLVTENGT
GKRTAFDQFPTLSRGTKGVRAITVNERTGHLAAVASVKENDDLFIATKGRLVSRISVNGI
RPMGRNASGVKVINLNEGDTVTSISKNEEEDGDEE
>PK3-045_05402 hypothetical protein
MPEKNNSLLSGKVAQIETSHTYLDETFYRFTVEVPRLSDNHDLLPIIVSEKLLYNNEIVV
GDYVSVTGQMRTRNQRTSERNRLLVFSYATEIEKITKEQLDAIEDKNEVEFEGFIVKKPV
FRETKTGRKITELLIASNRQYNKSDYLPSIAWGVDAVYAKKFAVGEKVSVKGRFQSRKYI
TRGADDQPVEKLAYEISISQVSVVKEEE
>PK3-045_05403 DNA gyrase subunit B
MSEQAQIDFLEFPESVRKRRGMYIVDKAHTVFEIVDNSVDEAAAGYCTAIAVAVVGNTIT
VEDNGRGIPITPHKDPKFKGLSQAEVAFTTLHAGGKFGKDGGYTTNTGGMNGVGASCVNA
LSDHMTLSIKTGGSKYEIEFEKGLITKNVEKVEDNVEGTGTTVTYTFDPEIWGEETLDLK
KVKKRMRQLAYLNPGLLIYVYFDTVDANGNEVKSEDQFLFPEGLKSYVEQLTKSKKLISE
IALTDQVIESTDAEGKPLPIDVQIAYAYTEGYNQEIYTFVNNVATENGGDHLTGFTMGVS
KAIERYALENKFIKAASDISSDDTREGIVGIVSVKVRDPHFEGQGKSKIKMNNVRQAVRT
VTEAHLYDHLEQDMEQAKGIINKTLMAAKARLAAKKAREATRNKKELLENTGLPGKLADC
QTKKPEESELYVVEGDSAAGSAKQARDRRTQAILPVFGKILNVEKSRFDSVLKSEKIQDV
LKALKCGIADTFDINKLRYHKIIIMSDADVDGAHIQCLNMTFFFRYLRPIIEAGYLYMAV
PPLYKVTKGKNITYYYSDAELEAANTEGASIQRFKGLGEMNPEQLWETTMDPETRKLVQV
TIDDIESAEEYFSLCMGNDIDSRKAFIIENAEYYAI
>PK3-045_05404 hypothetical protein
MKEEELQRIQDEIMRGLNKEQQMEDMVKELSGEIAAKLTLSPKTHAEIEGMEYMFAFRQI
TIGNKKPGIFMTVANINKYKIVQEKYKPYTVTAEIDNSFTLRENLQAVVEAYLRHILDMV
KVDEV
>PK3-045_05405 Single-stranded DNA-binding protein
MAINQVTLQARIPFDLEIKNADDEKRAFLGFTVSVRRNYKPEGEEYYPEDLIYCKAFGNT
ATFINNYFGKGDNLILQGELRRDEDYEKDGENVKGQMYVHITPGGVHFQNGNGGGEGGGS
KKSSGGSSKGSSKPAGKSSSAGKAPGKKLNPLAKKKSII
>PK3-045_05406 hypothetical protein
MASVNQMFATMMSEGMTAAKAISDPEKKAIACAELAKALAMTGLIVIGDTPTTVVDTPAD
AKEALKEKPKPKQSTKAKEEVVEETQEETASEEPVETTGEATVVEEWNEEMVEMFSDQLA
TVQQLQEEYDEETLDECVKNFSEGVLNGIEDISPLNIDGFIAYMQMLIADAEAE
>PK3-045_05407 ATP-dependent Clp protease ATP-binding subunit ClpX
MADTENKGTTTCSFCKQEPDLDAGRILIQGLDGAFICTECIEECQKVANQYKAKPKKNSA
ISGDVKPSKILEYLNQYVINQDYAKTVLSVAIYNHYKFLDYKQQDNPAVEMDKSNILLVG
PTGSGKTYVIKTIAKMLDVPFAMADATNLTQAGYVGEDPENVVRLLVENANGDIEKAQRG
IIYIDEIDKLSRKGENPSITRDVGGEGVQQALLKIIEGSTVEVAPKGSRKHPLAETIKVD
TSNILFIVGGSFEGIDKIIEKRQKTNKSGMGFGAAVESKTEKSINDFILDVKAEDLKKFG
MLPEFIGRLPVIAPLQELSEEALMQILTEPKNALVKQYQELMRVDGVELEFTPEALTEIA
KLAQKRKTGARSLRSIIEEVLLPHMFSVPDEEIEKLIITKETVVDKKEPIKEFKSKVEEA
>PK3-045_05408 hypothetical protein
MSSLTDVYRSKLKVLHEEKRNLDELYEKAIMDYLVSDKAHEEIRRCYTELFCTTVLFTAT
KGAEPIAFEEQYDYKYTWDQEKVNRYFGTYGPAVNRVLSFVEKSIGNASMSYDDYFTFSL
TPFESLRILMIEEQTEWMESFKYENHYFRTRYGDAAVHNFEKVLEQDAKGILYDALQNDT
EVLTIMILDDEFESYVQEEFDISLQDYEDRAKELPEHLNTKENNLWDIYVAFLSNRQ
>PK3-045_05409 ATP-dependent Clp protease proteolytic subunit
MPLIPMVIESTSKGERSFDIFSRLLRERIIYLNGPVDDHSAGLIIAQLIFLEAEDPDKDI
TFYINSPGGSISAGMGIFDTMNYIKPDVSTVCVGMAASMGAFLLAAGAKGKRYALPNAEV
MIHQPLGGAKGQATEILIAAEHILKLKKKLNTILAEKTGQKVTKVEKDTDRDNWLDAEEA
KAYGLVDDIVTKR
>PK3-045_05410 hypothetical protein
MLSVSNDLVSISEELDWKRKTLLNHLYGLDKLIDGIKEDEESVKEIKAGMKQKLSECLSI
LEDIDSEE
>PK3-045_05411 hypothetical protein
MKISNGLYKLARKIGKAATMSNDIETLMSGDPKKIAKRAARKAIWKTNNRVTRKITDRFK
>PK3-045_05412 hypothetical protein
MKGVANNIVIFGEMGAGKDILADILSDVLGAYVVKLGKRIREDVDHIYGLLPDGPNKRKL
YQDYGEGMRQIFGEDVWNLILHDNIKYGIEKGHSHIIADGRQEHELNYWTKLGFVPIGIT
ADEEIRIQRLKNRDGFDQSTTFNHITEKAVRNIVQKIEKELEPAGEAFLIRNNGTIDELK
SQAIKIAMQLKYYRSAGSF
>PK3-045_05414 hypothetical protein
MTTKRRPRPGSPSPSTPSPIIIDTGGYDSGSSDSGSSCD
>PK3-045_05415 hypothetical protein
MEKMTIHRALTELKTLDARIHSAIDGGTFITANKRSNTKINGKSIEDHKGVIQGSYDKVV
SLIERRNEIKSAIVDSNAKTVVKVAGKEMTVAQAIERKTSIHYDETYLDRLKANYAHAVA
TVNRENEVLPRKLETYLQSVLGNKDSAKTDDVEYHTKSFMDRNEYELIDPVSLKDKIDKL
EEEIYNFKADVDAVLSESNATTFIFDDEEAKEVS
>PK3-045_05416 hypothetical protein
MGTRHLIAVAKDNDYKLAQYGQWDGYPSGQGVSVLSFLKANKLEAFVEKLSNVSFITEEE
LKQRWIEAGAKPEEEWVTLDVSRKMQEMYPENVRDTGAEILDIIMNADRPIKVINSIDFA
ADSMFCEWAYVIDLDKQTLEVFRGINHDPLTESDRFYSMYRPGEFHPIKLLKSYDLSNLP
SEEDFVNELDKLQEEAIA
>PK3-045_05417 hypothetical protein
MSNIKLEIKNSETQVNFQVDGAQEQHITQVIGGMFLELAKGKYGIVHMDEPKAVQPAPVT
PVQPAQPAAPVQSSVPDKTAVSKAPAVNTRQHQPNNTTLAVEPENMDEALKVAVPDNSAI
PSHFKTGYKVKDDGTKLFKTRYRCPKCKNAGNHYVPEGTTSVDCHGCQTTMQVKKATPGT
QGIQPDKFMNWYVAGDQLPVSEFVYGQAKKVN
>PK3-045_05418 hypothetical protein
MTNEKITEKSTKGTIFKAYQEAMEQIEALKSAQLNPTEIAATKKKEEVLKQATNTTKSSV
DSVVANLRKVVDTALTELTAKFEDKTAQFNNLDEAIKLKDAELKEIYDIERQANTLAALI
NSHDVLKKEQSAENEAALKAYQEKLAEIRKLIQDADKEYNAKLNEQRAELAKEQKRAKAE
WDYDFARQKKQAEDELADHIASEKKVVAEEKAKLDAREEAVTAREEAAEELESKVAEIPA
LVEAAAKEAAEKAKKDAEKSFVFEKRAIEANKDAEIKVLQHQVELLTNALETEKENHKKT
SEQLNEAYGRLENVATASVEGQKAQDTITKLLSTVGEKSSK
>PK3-045_05419 hypothetical protein
MKVMDTLRQLFSDSNHEYDLRNRKLVCKQGDRFWQISCKHCKVCKCVPIEQDLTKLPPYL
LNDCKARNHYEASRD
>PK3-045_05420 Intracellular serine protease
MAEDVRLIPFKVQSIETQADKIPGGVQKIQAPEIWDKGEKGKGIVVAVLDTGVQKDHPDL
KDRIIGGRNFTTDDNGNPNTFNDYNGHGTHVAGTIAASANAGGVVGVAPEAQLLVLKVLA
KDGSGSYDWIIKAIDYAASWKGPNGERVRVISMSLGGPQDVPALHKAIQNAVAKDIAVVV
AAGNEGDGKESTQELAYPGAYSEVIEVAASTLDNKLADFSNNNNQVDVIAPGVDILSTWI
GGQYASISGTSMATPHVSGAIALLINLAEKEFGRTLTESEIYAALVKQSVPIGYKKSSEG
HGLVQLDYQSKVRNLLAYIAENF
>PK3-045_05422 Flavodoxin
MKALILYASASATKNTKEIARLLFEEMKASGIETDCFSIREFDDLEAIKNYDSVVVGTYS
WGNGRIPRQMRRLAEHFEENPDKTLVTGVFGSGDTFYPKFCGAVDEFKALLADKTNLAVT
LKVELFPQAKDIAKLSKFVELIKARHQSL
>PK3-045_05423 Ribonucleoside-diphosphate reductase subunit beta
MSTIDIHKPLKPVVLMDPTKPNRSTRIIGGEVSGLLNLNDMAYPQMFELQETLLANFWKP
ADINMQDDIKKWDTLTLPEQIAFLRANTALAGLDSLQTPTMVNVMNVLSDSVFRALTAIV
SQQEAVHTLSYSYVLSSLVELTKQNKAFDDIKKDPIITKRNNFILDVYQEFLDNPTPYNL
FKLLVQSVNLEGIYFYSGFAFFYFLASRQKMMKTATMISYIQKDEMQHAYYVAQVIRILL
DTIPELNTPENIQYMRDSIRQAVELEKEWAADLLKDIDIDLNEFNDYIEYLANKRTRQLG
VANLFPERDNVMPWISVYDDSMISNTKTDQFENTSRNYTMVNSSNGFDEL
>PK3-045_05424 Ribonucleoside-diphosphate reductase subunit alpha 2
MSVDNLSGLADHNGEIIQDVLEIVEDASQIYKLPVEELKAKIQAVGADKANEQGMFYALN
SVDMGAPKWTYVAARFYLNQLYTQASENRAYSRSLKYGSLYKLIAKLTEENVYSSKLLTS
YSEEEINELQRAIDPEKDKLFSYIGLFLLADRYLATDKKKNVYELPQERFMIIAMTLMMN
EDRAKRLELVKESYWALSNLYMTVATPTLSNSGKAFGQLSSCFIDTVDDSLDGIYLNNWD
IARLSKDGGGIGIYFGKVRSLGSAIKDFEGNSSGILPWIRSINQTAVSVDQLGQRSGAVA
VYYDVFGKDIMRFLDLKTNNGDDRNKAHDIFTGVTIPDLFMQTLEETDENGKSIGEWHVF
CPYEVKKFMGWKDEHGNALGLEDFYDEEGEDEKYFTEKYREAVANPMLPRKTYRAMDIMA
RIMISQLEKGVPYMFYRDEVNRQNANKHIAGRGRTSIFCSNLCTEITQNQSPTLIVEEYK
DERGYNHIVRKPGDFVVCNLSSINLPKAVRANVLDRLIAIQVRMLDNVIDLNTIPVAQAQ
DTNQKYRAIGLGTFGWHHLLAIEDIYWESEEAVQRADELYEEIAYHTIKASMELAKEKGA
YPVFEGSEWQTGEYFKRKGYDSPRHVELQEQIREHGLRNGYLMAVAPNSSTAKIGDSTDG
IDPLYNVEYAEEKKNFKFKVTAPELDHVNYEYYKKARHELDQKWSIRQNAKRQRHIDQAI
SFNIYVRHDIKAKELLDIHKTAWKEKLKTTYYVRSTSQEEIEECEMCHS
>PK3-045_05425 hypothetical protein
MTSYLVTVSFGHKVELKFYATKDYLDKFRKKIKKDEKFEMKFSDEVLVTINPDFIQAVLT
VKSEDQPSPELKKTGMEFIEMHTS
>PK3-045_05426 hypothetical protein
MNLLISNKGSKNYTTHNTEKYFMGEEYLKYRIALLDRYIPYLWKILNKQMDMPAIFIYQS
NSCCKACQGSGKVNNVPCTDCKSSGKIPLSTKQQYNNIFKKFVKAKKDKEYFEQALRDRQ
FESYQELEEAKEARPNKKDWVCLKCARNFDGTKGTKVDSCFGCVNYKSGNAQGKEMFVPV
SKTAAKWYKEKGHKLNFNYQDKLH
>PK3-045_05427 hypothetical protein
MSQIVQINDVNLAVKEYNSERIITLKEMDRLHQRKAGSAKKNFMNNREKFIEGEDYYMIS
LREFRELFSSNEDEPHRGNPDLNVVLLTEMGYLMLVKTFSDTLAWQVQRALVNSYFRFKQ
VAHMSDMPAISEFDILHKMVDILEESRSREDQMQKALETMNDKVHNLELQLLDNNALNQE
LITQELMKASDVAHQLKLYSVNGLPHNRIVGAIARKLGFKINVKNYYEDDYIVVMKEGED
ETRLTWQIYYKPDGVDRIIEWFNSNREDIYYEDYYQKNSKNGKAGDLREIGYRVGGVNWA
VRAI
>PK3-045_05428 hypothetical protein
MTLGRNLKRRADKTYTGYDYTYDGAYSPRVKGQDKKRRQRDMRRYLKRITDAEIRGSIE
>PK3-045_05429 hypothetical protein
MLINMPVAFEDFQKGTSALLDFYAKLGWNSEKQFIDPRKIVLNSEDANEAMTNLMSSGNT
AEEQAQLGLFWMNQGPSHSPDMPKGKVKLEAGWVEDETK
>PK3-045_05430 hypothetical protein
MENRYIQRHLKQLWNKKVTPIVISVLFVAMIGSIAYLSTVITSLTADNENLTTELDKTRP
YIQLSEDQAAYIKELEEKVHTLEDSTAELETNLSNLESELSTLESNLNVLGEIKDKTK
>PK3-045_05431 hypothetical protein
MKSIKGALFAGIAVSIVALASNSVLYSVNIAFAKEGPPKVVQDDAPVDKMNQKTEELSKK
VDTLIQESEDKIDQYQKLYDELYDTDLRLSYKHITYSSRLVSKEDNYIKNNPTVNSYREN
PLYLDLRTHSAITAYEIDEYILKDTALEGLGKAFVQAELDYGVNAMFLLSLGVHESSWGR
SAIARDKNNLFGYGAYDGSPYESAIAFSTKGEGIERVAKHLAETFLTADGRYYSGGYTLQ
DVNKKYASDQEWAEKIAGTMDNFNKTIMQKQDTNYHEEKYVIGEDQNGEPIYSKTFKATV
E
>PK3-045_05432 hypothetical protein
MSSNTEVKQQVENSSLEAELTNVLSEFIQNGTVEKLVSQHVEKGINNALDNLFRSYGDVT
KIIETKLKSVMIPFLENYNYDEYIVKLDSVLVEILENTAMDNKMILENFKSMMLPIEGKT
MKLSDLFEKWTEYVAKNVETDGLDIDYDDEPSYEYVEVTMEVEKNEDRSWSAFEHAVINF
ECEHDEKMNFQLRISHYKEGRDETWDISYDRTPDIKSLRHLNDFEILLMKMDQQRITLEM
DTDFEREDVRPEKEPEVTLS
>PK3-045_05433 hypothetical protein
MNTYKVMLHEWKHYNKTTLSKWAGAIKTTILKYPREVNLKELAQALTDGHTVILGHLEYS
RKEKEMIKSQETKIGASSRHWKKQQLFAVDIDNDKYKKDDPKYITIEKAIRMCKDKKCPP
AFIYTTYSHKEEHHKFRVVFASDTEIDTIDKRTKLIESIFEVFAINGECLVDSKCSDPAR
LFYPGKELVYTDYEATINPDDITNRLSPTYKLEVETTTTVVKRSSKRLPSTSNRTINLLR
SGKYDVVQKEVAKRLVEAGKPYHNWVYEHSSKSGIVTILYIIKDYFPDFAQDPLSPVFIR
DPDDYYDLAHQFPLDKLLDCEVNQHIPCVLPGHDDKVGSARIERHHDTGEYIYHCYGCMG
VTQYYDIFTLLEHAVGWSHAKAKEFIDFLLNMESETEWQKEKKKEITEFQDYVMDTQFQK
RFPFLYKELKTSNALEVFTFILGEARRRIYDRLITNSEKPIFFTGIKQLRQRMLSNNIST
GVSDSALQRKLKFITKLNLLEVIPDESLPIEFIKESHRRRQAKNYRYRINYYAIPEFSLK
LLSDAEEIAKETKGKNIRRRYYSRQAELWANGKDEADKQYVQDRNVDKSKKTIVFYEKYK
AVALELLERGYLTEKEILNHRRIRGVKKKKELSATVMPQLLQELNLQVVRYNKYYKELFQ
IKQGTLKYGSSKIIVREKDVYEKE
>PK3-045_05434 hypothetical protein
MKQVNVDLDKLVQLRKKHDLSISHVSASIGYKTPTGYWLIEKGERKVSVQILFHLASLYG
VTMESLLKTED
>PK3-045_05435 hypothetical protein
MNLVEKHRKLSTVKELCDKFAFTVEPFPGKQGSYCIQYMYDKRYDQRRAYLDKEFVSYVM
RKALQTKTDHQDRLVFKVAYETIHYDLNQVIVFNSQEKAKKALFNFMYFVHRRHGSLAFS
IMVQAKNQYAPF
>PK3-045_05436 hypothetical protein
MNCTYCQKELNSFKQSAEIPDQPHWHYIVCNCGNVMKAEIISGSINVIQNTTTAPGPEAI
QEILMAKNLFEKAGIRVSGYSVDNPNRPNNAKEIEEMQKVEEKEVYFAPEPEKEPAAPIE
TPKKEKKSFLAKIRDFCKKLF
>PK3-045_05437 hypothetical protein
MNLTALYQWNQEYETGMHVTVSSPFDIYDERGKLLKHVDRGLNGKVIKLDKKNKTFEAYF
EDDSFHIGLNPTHFTIRRDLDAKKAYSTLQKFFGHYSRTDEQLYQFNIKMHGYQIPEKAY
ELFGYDNVWDKLYEMQEDLLRSFVGDDYDFSPFYYFSWIKLYFAEGKNGGYLMVQDTYPT
KEAYDQVEYFYLEAISEHPDDENYVEDTRNDLLNYQKDLIERVYDLLMIEKLISVYQNGH
YQEVNRLSFWMEQMKYKQA
>PK3-045_05438 hypothetical protein
MITAFVLGLVLGPIAIAYGKHKFRQRYERR
>PK3-045_05439 hypothetical protein
MASEHYKKTATKNSYLRLNRYDSVFYCRHCHEQSDIVIGMMWKDGKPVEHTRDADILCPQ
CLNLSKSEEIIDASGKEITNIYSHLSYFDNGDTVRAYIFSKEISFFSKKLQQKHIKTMVV
FNIKTGQTYFFEPRYENTSKRWKHYGGPRLKNISISSYAGLLMSFKLNEQDPKVQGLMNL
LHAKLQEKFPYPVKSLQSYGQEHNRTKPYGEKRLSLAIMANYVRLPHLNSYDFNQFIEDN
RHLYEDKKFAYIMRKARPDTSNPIGDLVKAFKGPDAKSIRKLVMKNLDYLSRLFMFQDFK
DVNNVRRLLEKTDEWRRGYSLYDVKISPFIKAMLKKAPETVVANKILKDNSIHWLTDAAR
MYFDIKEINEDYDFDISRSLRDLHDIFSMDYDKLQHPNLPLEYSERELKIECDIDGYEFR
LAKETHELITVGAKMDICVGSYGSRAHRKDLAICVAYKDDEPVICFELSRHLDRVLQAKL
YKNQRPKDELYDLCMEFINRNEMKIDTWDLQKPEEYPEAI
>PK3-045_05440 hypothetical protein
MDVKITNGYILPPMSLTELNSFVQEYRETIRVMSKQLVIERLGNMCMGYIDFVSLPEDKR
TYFVEMNRQIFLPKDGLKHSPLFTAYSKMQEMEQRIVTEKIRKPEYDFLCDLILFPSEDH
ILAMLFAEQKAYIDAFEKMPGVRSYSYWDTEEQPEDISKKAWKQRAQHWQEAVGYTGVPS
LEGFNVSCYNQLPFIDPNDIHHYIEERFNLEIRINNYASKIVVLRKYQDLIGQDKLWGTE
EMYKQATLYLKTPEGTAEYQQESELLKTLFKPVITSDDLATSFSVLIESQHE
>PK3-045_05441 hypothetical protein
MYRVIVAGGRDFDRYAILKAALDELLSDLIESGEEVRIVSGKARGADRLGERYAKERGLE
VDPYPADWKRQADGSYDASAGYKRNAEMADNAEACVCFYNGSKGTGHMIDLAKKKGISLV
VLDYNGLEIERWT
>PK3-045_05442 tRNA-specific adenosine deaminase
MRKNWDSYFLDIADKVAERSTCDRLNVGCVIVKDKLIVSTGYNGSIRGQDHCSEAGHLYN
EQGRCIRTIHAEQNAIIFASRDELQGATAYVTHEPCETCSKLLIQAGITRIVFKHPYKNS
NNQNFVKDVTWEHLEQEEAIEEPIFDESQLEYLKKMLDSRVNKVQPLERLFVEGISENLK
KLENK
>PK3-045_05443 Oligoribonuclease NrnB
MKWKLFTHTDLDGISCGIVARIALDDDVDITYCDYHNVNDTVRDFIKSPEIENYTHILIT
DISVQGDVPELLEAIHQAGIQQILLIDHHATNLLLGEMYDWAMIKPVYDDGTLTAGTGLL
LDFFKENYPKLLEDVQLDEYAEIVRRYDTWDWNRMGDPLPKKYNDLFGIIGRERFMKKMI
PSIKIYGAGIFLTEQDEFMLEINQEKIDKYINDVEKKMIRKVIDGHKVGVVFAERNTSEL
GNELCKRNPDIDYALIINMHYETYSLRSVKKDVHCGEISKKLFGGGGHPPAAGAQLNKEQ
MNYIVEYLTN
>PK3-045_05444 hypothetical protein
MEWLPAKENDMGIETIAFEPIDECGELHRTIGYNGILKGDSVLYKEKEYTVVMVSRLGHI
GLSETGQLPYTETAYPNELTKLNKE
>PK3-045_05445 hypothetical protein
MNKYISKKNKYRLLIAVIILAFSLIYIDSTNVRQFYYPYALLLLPMIVVTRIRPSWNVAL
VLACVFNVYRLLDPVLSYGTLYFILNYIEIISSSFVFTVVYLLVAKYQVDYDKKIQEAFV
QIFEDPLTGAKNRRYLTKYLEHFDDYELDFSVIMFDIDRFKLINDNFGHSVGDQVLYDIH
ELVRHKIRDTDSAVRLGGEEFALLLSDTNLSSAFKTAERIRKAVELHPFEYGNRTISVTI
SVGVAQKLPDETKEELMKRADAALYDSKRNGRNRTTVA
>PK3-045_05446 hypothetical protein
MAVKNVEAVSNEELYEDFCLKHNIQPLSFSDLAAALNIPINQLKFSIKGMILYYPERFKQ
LHSEAGVITNN
>PK3-045_05447 hypothetical protein
MGQLILNPIRECKPFADYNFFIVRSAKSVPKGFHHIPELSPPKSLFFQAQRWKKEGSMSD
HFEDYRLAFAKHMQEGELAEYLDHLEDLLKQDVTVQIVCFCPDPTRCHRTIIGDYFFDKG
YDVEFG
>PK3-045_05448 hypothetical protein
MTAAVLLALLSGCSETSKVEVYELKSVNNDAILTIQISSNGEDATFTANCDEDGYCDLDE
EYSVDKVDNGYVFTPKDGEAYNPILNFEDGKIILRDNKNGVLATGEE
>PK3-045_05449 10 kDa chaperonin
MIKPLGDRVVLKVQEISNKTASGIIVPNQEVPNQATVVAVGPGRIMGSGQLTPLEVQVGD
QVIFSKFAGTPISVEDQNYLIVHEADIVAVI
>PK3-045_05450 hypothetical protein
MEIDYEIDNVRETRLDRKLPKLPYQMTKDEILERMNQVNKRMARAVQNYEFYYYEELKSE
MQDLKKELKIREVNTP
>PK3-045_05451 hypothetical protein
MSDSSSSSITKVEPVYRSAAAHNRRKPFDPNKGEELKSQKSFQEALKNAMRKESSC
>PK3-045_05452 hypothetical protein
MGCDIHVMAEKRIYPKHDDDSSGIWVSIDKWIVSQDKILYPEDYQDASDLEIDYKDRFYT
GRNYFLFHVLAGVRGSSAWGPTISLPKGVPDDSCQQIKDEVKRWDSDGHSHSHLTLTELL
AFDWNAKIDDEARFYNKAELDKFLHKLPAEDLIHQSEQPRGKHTLYTVQYRKSYKDFFPD
FMDTMARMNESLESHRGETSDDVRLVFFFDN
>PK3-045_05453 hypothetical protein
MNYVSGNELFQQGFTPCNDGDLNTKVFDLYDTTHIALNDKEGQAHLFVRHGNDYFSHVKP
LSSLEVVS
>PK3-045_05454 hypothetical protein
MGLDMYLFKVKLFDDYSFQEIAKMKEDIEFVERYKDALETSQDFENKYDERDYWNHFDET
KEEKKERIRKALNEFINESQVKYLELKDKYEPALIKKLQEFSYDEVGYWRKANQIHSWFV
ENVQSGVDDCGQYVVSKSQLEKLKGVSQLVLNNIEYADTLLPTRPGFFFGSTDYDDYYKE
DLKETLETLRKVLNETDFEKETILYASSW
>PK3-045_05455 hypothetical protein
MNEEMKQLVEQELRQVRIAARQTSINILSLRIALVDKGVCTQEEMDQYDKTAEQTIDLLM
LQERDKMKAMILEQFGEEAAAEIEQELDKALGK
>PK3-045_05456 hypothetical protein
MQHLGENNMYETLWNGFKEALTIRLLDSLAGETKEDCELLQSFLMEMENSEQKLLGQPEG
NRSSFIYNLLGDIHHE
>PK3-045_05457 Peptide deformylase
MAVKPVFKFHHPVLKTVCDDIETFDQELLLIAQDMRDTLANYKNGVGLAAPQIGITKRII
LIRDQIIVNPVISGAIGEQTVKEGCLSYPGIERQVKRPLSVLVTGRDEHGEEFVSTFKGI
EAAIACHEVDHLNGICKVGERTKRVSKTRNKKKKKGA
>PK3-045_05458 hypothetical protein
MTNKYQVNVDVSNTWDEDDIDVVSIVVEEENAELAYIKAQEDIVRGEHNDKIKDREYYVW
SVNEDDKLTN
>PK3-045_05459 hypothetical protein
MKKGIKILGIIVALIIVIGIIASLGSGSDTEQVEGNVEKQEQSTEQASADKKEAAKEDNN
TDVNKVIADDENVKATLLRVERKKDDVFGDTIDVVFEIQNKTDRNLEFQARSVSVDGKMV
DETILSMSQEISPGKTADARLTMTEFEGYELPALEKDLELELHGFDWDNMDFELNYPVSI
TF
>PK3-045_05460 hypothetical protein
MSTLECSSKGDKRFSAFFAKVDILGKTASIEEHYQHSKLFSIEDHHGNISLESFTDIKHI
KQKQRFGDLPVRFRVGDYDYPAEYLSMYYKLLWLTYLDAKPHLVRYASKFDDFTDMFRGK
NTINCQADVIRQYVKDGRESILDECEPFINILSRDLEE
>PK3-045_05461 hypothetical protein
MIKEVMSMRGEEFDPIYDEALDTDPAFDY
>PK3-045_05462 hypothetical protein
MICPYCNNEAEFMTTKQYYGRDYGTNIYVCRPCDATVGTHGRSKNPKGSLANKKLRDLRI
EVHSHFDKLWKERGMKRTAAYQYLQEIMEIPKEEAHIGMFDEERCLLALDRLSKNNPQSP
MKVGFKNRGHFCNYCRKILENKCGAYSHHTINPAIWYVWKNRETPGLMNEFLENLKATKF
NDSIKEFNSQLRRIAGPFKNQPGYGTK
>PK3-045_05463 hypothetical protein
MKVTTVNKDAVITDGILKGTKGRVVAFDSIEDEVTIRLDEITCVQISSDFINQD
>PK3-045_05464 hypothetical protein
MGEAKMGLQIGDVIIYEDKTYVNLGVIKNFEDIGSCSYDRVYHLFSIEENVEKIVGSEID
VREVHVRETRLPFKRTDWIPYNVFENKSILSRNGSLIAEQYEYTLEQKKPTIVYK
>PK3-045_05465 hypothetical protein
MVAGVKTCSIEGCHGKHIAKGLCWKHYKRLKRNGDISDPDYANKGKICSVDECTDDAKRG
GMCIKHYQRFYKYGDPHKLKDPEEYEEILPYDKGQCIMPGCKERVDSKELCYKHYHNYQY
HLRQENIEDIFDYLRLRDDNPI
>PK3-045_05466 hypothetical protein
MIRMDMPQREYFCAGCGLFHWLEQYQTDESGKISVLPYNGCPNEECVSHDEHDVPVFAVD
TFGYAYFAEANKEFIEEVKWSSPKYAPDNAIAMYRMQGIPIKDVPTAEKVD
>PK3-045_05467 hypothetical protein
MEYTILQMPVSLWHKNQIMFDASSQVNQIDYVPVYKGTAPEPFNKPDLVHEALEELFRIF
NIDHPENYPGRSLSAGDVVMIEDDDERIYFLCGSFGWYRLENFK
>PK3-045_05468 hypothetical protein
MIKFGLDDFQTEMPNWAKHHKEISLRVKRLKPNGEVVLAESKKIQELIEKHEDLLRPKSV
SFFNETSRELEQGTDYFLPLKNLEYQEANLDYYSVGAMNTKQTTYMRMTFLMEYDRVILE
HKFSSEGSFASSFYDMISSFDSVEDIIEEILEKKLPLEEVGISKDNEYEDYKVILVTPEG
DAIDVDVSKRELLSSLVNIEVYKFEHEITD
>PK3-045_05469 hypothetical protein
MTKEQIIERIKDIRQERELLAGFTCLGKIDDVYPDLPKEVLECYRTWIWEWKDKSFRIAT
WDEGNGWCHYICEGTPEELIKHLPE
>PK3-045_05470 hypothetical protein
MKYIGKGVEFYVGDGTKRVGKIKKIEFDHLLGKPVFIIQTPFGNIARLTRNEISKIR
>PK3-045_05471 hypothetical protein
MANQIIGRRCEVTDMFLVNVRKRRMTKKGTVRGFYLNEYWHPYTYRAFHIEFDDGTKDTY
RAKDVNLL
>PK3-045_05472 hypothetical protein
MWTLHYTEEGTLKAKEFSDKQQALDYALENEPIGKIEVHELISPNKTVVMNKEAMTTYYV
ENLERKIL
>PK3-045_05473 hypothetical protein
MKMTLPAQEVKPYISKKLTAINENLSNLEKEALELDLAYQEELEKHQRSFFRRFVLRKPE
PPIGRRFWLIATQTGLQKERIKVSNILSTLDHTSEVELTDKDIEYYGINLFK
>PK3-045_05474 hypothetical protein
MSASFLKALEANYVVGGLQFARRHQEALSTLRHGSYTDQEYLIPGITLSQEVISAVGIPS
HASAEGASNTLKTGEACVSIGHQRSRVVPSVCEDQGSAASVCERAQGNVHVGTYVTTGND
CPLYREGVKTTSMVEANAKTQLEGEGTTSSIEKQATGNDCPHGYVVANGQRLPTPLASTE
RLSEDLNTMRPLHLYTLFASERMRALQSFTKRFVVGTLLMLERAVKQEQECLSLLQNRRL
SLVSS
>PK3-045_05476 hypothetical protein
MENYFALIESAGPEDINLSPELKSAIKNHESDYRYVSCQYIDGVGTQLILRFDNNIGASL
IILDQPEPGFSELELAVIRFEPPEKNDWLMYPENGLTDKSGLARNLTPIEVGELLGKIKG
L
>PK3-045_05477 hypothetical protein
MALDKDKIVMFAGKKFTLGEFLVHYGLDQDTEASVKIVLEHLEKKGRLHYIEQKDKDAKL
FESVAKELELEAKIAEMEAEAERVESYDSAKKKEGKLVYEEVEIDFPNKTIALDFFKFAQ
EDLKVEAALYEEGDKYVLTMKNVSESDLAAIKRKKNIADAGKMIFNTTDKVANVAVGTAA
FATERVLVPTTKATVKTALGLSKSLVKTGTVVGSNLVTSTTNTTRQMVTELANDEDVLRA
RKELIDAKDAVVRLFRRKPRVSADFRIK
>PK3-045_05478 Ribonuclease H
MNVAIFTDGSCLNNGQPDASAGWAVVIKGDINKTLSGKLPGEKQTNNRAELFGLLKALEW
VKNHPEAKAAIYSDSKIAIDGLLGDSQRKANRDIWVDIEQICPDIASQLIIVQHVDREEN
KEADELARKAANALLIFN
>PK3-045_05479 hypothetical protein
MKVSASRKSTHSVMANSGFGDLTIHTAQGVTLSIPQSQITAGGEIKRSVLEHAQELTREN
CEYLENKGIRIFVGKRV
>PK3-045_05480 hypothetical protein
MRIIVSKEEREAASKMKAGIITMLEAEGINASSQNPSDDYKKGISVFRDTQDNTIIDIKT
AFIADIFGTFKKVGVLFIKTAIPFAKACFDIGKLLEGLDERWAETPEKEEEVVRTTTQTT
QVHSRMEQRVSKRPIGFMAQHEEQSKEVK
>PK3-045_05481 hypothetical protein
MKRMTYTLWDVLRGYISEETCDICNQKYLTTLPNDPAHEPPMSICDPCCENGIGEEEAEK
LSA
>PK3-045_05482 hypothetical protein
MLRVYIPARGASVSRVVFNQDSAKFSTLEYDSVVPASVKASTRINALAGVVHTLGQFKEK
GLKGIAVIFTVGLVADAIQKGTFKYWIADGKTSGGEDLNETELELWKEFASLYQELFLNV
VFKNISSASLPRNSRFSITNEMRIDDKYSKLAWDKLPAVGEAEEVEGDAF
>PK3-045_05483 hypothetical protein
MWFCAFSGAIKYMHTFKIQGDVLNMAKVYAVKVGRNTGVFNTWAECEAQVKGFGGAQYKS
FKTIEEANDYLGVASQPASKTEQRVNLSEALKLSQRNSDRLDVFVDGSYHNGRYAWSYVV
YEGNNVVHQDSGVGTNPDAASMHNVAGELAASMRAAKWAMTNEKFITIHHDYQGISSWVD
GTWKAKNGMTKAYRDYMNAYTKIVKFNKVTGHTGIQGNELADKLARQALGI
>PK3-045_05484 hypothetical protein
MSIKNSIEVTVGTATREVTVNTLGPNYSTGYVGKAFFAWKSDEFDMPYVKIKGRTGDDRA
RSLVKLFLMEYKSMLTANKKSPLHFNKSEGSSSSTSKTAHGNDVISGVPHWMREEHKMWT
VCHRKDGSTYMRRTRFKPESKEIVEKYLPFCSGCVFRVNCEQACSDPDLMSQSEVFKTAD
PVEPVEVEEAIAG
>PK3-045_05485 hypothetical protein
MKTNFTIESQTVLEGLSKKVLRNEGGNVVSVSVHKKFAALETMMIPGSGLTELLHVTNDA
VVKAGGNTSKTVKRFFEDVMYVSFVGNGRNSGSHRSNIIFQGAFVKHDGRHTNVLVNHDE
DNYFDLLNHKPVAKAGINIDEYIEMTVIGATPSMLRKKQILMGNKNLPWVQIINKLSYGA
LKMQEGFDGNMAKLNKLFARMFHMWAPHKYMGTADTFAFFNGEFADSKGNAAWDGMMFVD
SRSAAKWMANVLGVAKIEDKAVIGMGMQMRPDTNKAFGSVVSGKFIDQLMNDGKPVYRFT
RDQLTPELEKSIWKDDQYKNAWIIVGEGYPEYVSDRNCLKAEFDLAKGGRMVVLAMAKYS
PAHTSIQMLSKVAANAPKEVFINLVKGLFAKDMEQKLVNLKEKQASVVPVRDAQSGYILG
IVDKIAPKYVAEKDQQLFRSVLETLAQSGMKASNRLKFRVDGASLSLMADIGELVGGERI
LKYGEFYAPYANRYFKQHKDIKAKLGTIIKYPSVGTGEFYQATAVSFSEIRKRVNKLTID
KDVKALIINWYASLSDGLLVMPTVELLKKQLAGLDFDFDGATIVLDEEFNSVMSTINPLI
VDIDPGKTPESNKKYALEFGSFHHVLRAFINSPNKSVGEITVMNDTVIALLNTPFEEAKR
RILEMVEVEEEGSEAFVPLMKDTVELDGVKVDRVSISPESTKEFVANLRNTKITEENIRQ
ILLDIVAIFRYYQEVTIDSVKTGVTVDVAFEMNFVTKSVTQITHKFEDGQMNIQANPVSE
YVDYIDDVINSARVSCAKGVRNRINALLGVMPEYDAADLAMFEAAVQGREDLEEGLVEMK
KLYNDLTGSYITLVDSFEKRRLETDGIRQEHKRRIAAVANMVRRLTADLNAVDRGLITKA
VSMSSKGGTRADGGSRFATIIAPEYVHMISKKWGETGLAGSEIIGKYEDGDVVEFVEGQA
EKAISTNEAINGTFTIKEIDGKLYATKPITDVLEVPEADNSKLVFKLHWSVRGEELENAA
TNLHALTKVKLTANPKDRDTVRDLEGNVIARISCEGRALSSLYNGVVGEVEEVNVAEFYD
TKGRIMKSAIVTLRNIGEATPITEEPLEVEAQEVADGDVF
>PK3-045_05486 hypothetical protein
MKEYIKEWNAMVISIKDIRESVSDETLQDAFIHDIVTDVEDRAPEAV
>PK3-045_05487 hypothetical protein
MSKVVSLKEARRQKIIRQYAEFYHMPVNYTEREERSTYITSNNNQTIKGAVK
>PK3-045_05488 hypothetical protein
MFRREGQLEVYADRDDQLVLLFVVDEEQVA
>PK3-045_05489 hypothetical protein
MNNFQWLWQSGINYVLYSIVIVSGLYISYQIMMDSVKIKYQEVNYKYRIRRIKSGNASPE
SHTYKHPFFKHISLLIRTTSNHRSDNDTGVFLLFTALLGLTSFAFIYYLIKDFVIALLFG
LLLMTVPYLMLRIKLNKLRYVMSTEFLSMVQKLTQAYSVNKYDIYYALSAMQNEIQNKSL
RKVTVRLITDLQLSRNEQELRDSIQVFTYTTGTNWSKRLGSIILKGYKYKENVLHSLLVL
TKQIEDTEEMLEEEQSLTVESIYDGFLTVPLFIGSLLLGYFTSGAQDWFKLQFGEKWTLF
TFCLSVVGTVFSLIISIYLKHPKNDL
>PK3-045_05490 hypothetical protein
MTLNAVKNDTEQSLGLESEFEPSQWLSKTIEEKGLKKDFVTTYERKKTFRLICNQVKEEL
QSIIIAESVENDQSSSLINDDSNSDYVWLNRQHQAVIGDKQAISYFITKINEVLQKENIT
SDEYPSFYDSLPEAIFHEVWGVSILHKWDKEPNSESAVIRGTELWIDKNGYFQKQPEEFE
STAVVNRIKKAFQIRTKEALINEQQPELEIEREDGSRITMMMKPRTKLDIIVFRRFVIKN
NSLEEQARLGTIPQDDIPFYRALSRSMANTIFAGRVRSAKTTFMKSMIRERPPEYTIAVL
EKHFELNLTEDLKDRLIYEVQATEGDLHHAVPRLLRMEHDYITVGEIRSLETEGYLQACE
RGERGAFSTYHLTAVKNIVAQITRHLLDEFPNRKFDNEQERVARNIDLVISLSAERDRRK
KRVIGVTEIIWDEIEKKPKEQDLVRYHPISRQYYYSSNISKELLYLMAEESVEDTKILLN
HLKKKEKLFPMSEYERQKDNILNDLLDGALNE
>PK3-045_05491 hypothetical protein
MEILIFSQNSIYKELIDKMDNLHAHMGNIDYSNKEKIDAVLLDGDSFDINNIGVVREKYP
SIPMYFKPTQIKSEQFTKTITRLCAAYKVTLIHEYSTELQVVEYCINNLTNKDDYLSKRI
IGIFGTHNGAGVSSTTLNLGRALSLKVKEKVLVLSLNSWDPADYFYLYQGQYLNDLKVDL
NVKNLTINRLSEAIYYHDSFYHLAGNRDIKMQRFYKSYEIEHLIQTAQQLFDVILIDAGT
HFDSALAAQAYLSSNMKFLVTNQEEKGYKGYYPYLYQQIIEPSGGKNDDFMLVINKFQPA
NALISEKKLEEELNMNRVVTIPDMKELGSIATFEKKLLYDFSDSSYNKPIDVLANVIIAE
AKLTEKEDTKEHKEKKGFLSIFNR
>PK3-045_05492 hypothetical protein
MNFFKRPSIKIISGLLVGVSAIGLTLFYDQFLRVRIDSTEVVVIKPSSEILKNEPITEDK
ILIERRPKQTLMNDVILPAEVDEIIGLDANQIIQGNSLLTKTMIDYDELLPNEEEGEAIR
PITKEMIYAMPGSLRRKDTVNIYLIYNDGTTNLNKNGPSTTSSEDTKEQIEKISNSMESE
PFLKSIKVVYVKDSSNKEVISSSENNKEDKRLNATSSISDLEIILNEEDFKKLMNEVLGK
GAKLYITYQ
>PK3-045_05493 hypothetical protein
MTKKVLIAVGDKTYTKILIETFSKYPEDFTLSKQEILHRKYLYEIVKEETPSILIVHDTY
LESMQENQKDKDIELLSIIKQLRLDFDDALRIVFLCERSSNDPLLSRLVSMGVLDIFNTQ
RIDIEQFINQLKGKVSFAEVARFINNSLSIDGEVIPSLLEKDSEEESVNEDENGKTHKEK
NTKEKTIVQRIVQKNVIKREYSIHVHNAPSEKVVGVPVRKKTILVGSFYQRNGTTFISHI
LARSIANYQVSTLYVEDPLLNPYTYDRFYGHEFAPNYVNKWSAQQENTSDIQTEWFRDGV
ELICHNPTLSEEPVGISFEDYIKLLYTNSSLVTIIDVGSNLDNEVVTDLLEIADHLFIVL
DSDVTQLQGLGENPLFSSLIESEKTHIIGNRFNEKIKKNPLIQDLFKDKLISIIPSFEDE
DVYEAQYQGIFLNDYKDYKSKVNELLVPILELLLPNKLLKTKASGILNKLFNRKIKIEKT
NPGGNQNE
>PK3-045_05494 hypothetical protein
MAKSNKPIYRVYEEELNELSYQPDGFFDRLLNFSLNKLTNPVKLPYSFFIPVSEYLRGEL
FCEDVSEAMGNYEFTQRDLISILVDDFLFQVKDRNNPYDLYHELKQRNDYFVKIYSYSED
KHQPLTFAKPNKTTKTKQIKCSLRRKVALRLEVMLSDITDVEPENEFVVEDILRLLYSDF
IQQYKKGNLGNIIPNIIRRLNSELS
>PK3-045_05495 hypothetical protein
MDGRKPLNPIFNNNHKKKEDPLLIRNVRKIPITKDEGRKTRIDKKKDVKIPLSDEERKLI
KRLANRRGLQPTPFCSLLVKKALTEYKDAQIFDDSYDPKGKPYPAKLEVYYHDLLFDKTV
EWDCSLKEAAYRLLKFMLIKERDGHLYG
>PK3-045_05496 hypothetical protein
MAKKNTIISPVSKEVLKQFGELGKKSAAVKKVKIKK
>PK3-045_05497 hypothetical protein
MNISEQNNLVMDDFPVFTTRNGEIPFWDHPLLKSSYVKPSKYYPYTGIEGAMTLLNRKII
DEADFTLIKVLGDAVCANEDQIRRYMSSLMSRSETSKRLDRLRTNGVVDRWKVRIRGDEE
TRPPAPFTLGVAGYRLLKHYYSDQFFMAPDRWDNYGVGGLKRYVSMNELRCQFIEKKVVS
KWKWNARLANNARYKFPMSAAEVKTPNGNINFLIDRAQMNQNFIGYFRDKFENWKYVYNK
YGNLPISDFPENPQIVIIYTSTISIAEAIHKELLLDTLPFNILFLVEELINENLESAYYQ
PLKHQKLQRINVHLQGNY
>PK3-045_05498 hypothetical protein
MAETLKTSWVNDNQLNELAKIKRDRTIIKGAVTAVSTRETKVLEDGKYVKKQMEVATFLL
EGTNITAYCPSNEFSDHDFRSLNGFTGSIQEVIVDQIDIEDNIVLVSVRKADDIRKAEFM
KQLVTLEAEDSLKSTIFDGVVRGYNPNTRKVFVRINGADCFMNARHWSWENGNIQHEINR
GETIQVKVLRFDKENNLIQVSRRDTQDDPFKKLIELYNQNSTVAGKVTNLDPIHGIFVKL
DAGLEVKGIRPRHLPEPVVGDIVSCTIRSIDKDKRHAKVTITGYPRGKKKIKDVASFLFE
>PK3-045_05499 hypothetical protein
MKELKVHPKLPGITILVTGLVSVFLSVRSICNYLFLVIGQFYNSVPSFVLFGNSLSPGLI
GFLTCTVFLIISWLVSTKYEKTQKKLWRSLWFWNMFIGITAYYMWLITAPVYNTLIPYLG
NLINSIHVDNIWFNVAVGDINTLFYTLVFTPSIVTSIILIWLGGQYSQYSKQIKEAFEKF
EFKNVYLQKWFRNSKEEVWPDVVLGPDSQTKELIIQPGKDRSLHNGIFGPPGTGKTSALI
LPIINQDLHWLTKFINVFPKVSKLSNYKTEEIRGTYLSSISIIEPSNDLCQKAFQLVKAH
DIPEEAVFYIDPTNPNTPSINPMQGPVDQVAEAFAMVMDGIQEGGTGNFFFQQSQRNHLK
NYIYLLKLHDPSTEAQFDTLLKMYNDPQIVRHMHLKLKETIPKDYHLIKDRDERNHWDIV
KQIDNWFNMNHIPKTSRNGANEQVKEGEYYGETAYFDAQGEYVQGLRNVLNDIGANKLIR
RVLFDKSEFSFDEHLNRGGILLVNTAKDDLGGLSNVLGKFVLLSLQNAVYRRTPLTSTFA
HIIIDEFPDYIYLPFKEFISQARKYKAIITVAAQTVAQLADKYGEMYMHTLLTGFRHKMV
YGDISYFDAQLFSKLLGEEDSYEEGKNEQTVSPLQEEPVMRSGSSYQQKTDVILTPNKLI
FQEPFQAAVKIVVNNKPIPVRQIDANFVPKAEFKEAKVKVIQESASIWLESKSLNTELFH
ETDKALSEIIDIPLQEEEALIGIPLPEKDAVEDIELELVEFDRYPDKYLSKKEAIKEEGY
KTQPISQKGTSLGEKAININDEVVDLDVSSLFSKNIPPSNEVANQSVLDEKEESFYNDLI
KEIDDTTKEGEVEKNEEGKSSPFDFITPFSDKS
>PK3-045_05500 hypothetical protein
MESARVWYGFDNEHEKRKGAWINSTDLELLSLIWTNRYLTNKQLTKYGNQLFGYKGDSIQ
KKLKRWSNYAIVKIEYQSVLNKPPISCYYLGKNGINILKQEGIIKEEEKAININNYIRNS
SHYLGIQDVVIDTLIALKTNRKNIISIHPNKDTYKNEVGEPFIVPDWVFRKGSRTLNIEY
DTGLQTMTKIKEKIRNYIKLSKHKPEEEHYVLISVADNSNIYTVKYYDDRRTRVLNIKDT
IIHKGADKISNLHFYVTTASRSPIIANNILKGIYPFDKSTFKSEQELFELSMEISNSNYQ
LVPLPKKEIFHNDSYNIGELAQYELIHKERTNSKQVLVLNIVEEASVAALNKINFLEEEN
KNNKFKQEVSHLLIVYQSRSELENDIVMKNYETLKFTDTKNWPLLLQGEKQLTLEKKKGG
RVLERTKGSS
>PK3-045_05501 hypothetical protein
MDLELHQKYKNTKFDPETLDLFTDLISNDTVLKKVFLFIAKNEKDSIVTVGEISEKVQVE
RKHRVEKNKRYSFVSKDDYIHRKQAEKIVERLLAMSLIYYKAVPPYKHLFLTIRGKQVIQ
RLYG
>PK3-045_05502 Tubulin-like protein CetZ
MAKTFTKNKPAINITMVGFGQAGTRMADQFAAIKNADGTSVYNCLALNSNDGDLAGLKHI
TPNNRESLELGGLGKNPEEAMQILETNEKVKEQLKSFIKDRVRPTDDLVMFFAGLGGGTG
TSTIVKAIEEFYEYNNKPKIQEEFNKLKEKYGIDEIKKEPKKYLIEATKIARKRFTKIGV
VATIPTRADGPDVLRQVNNFTKKIDDIAKNPNKGVAFVVYPDNQLMYEEFNSLLENERKG
IENYRDYANIKLVEEFHELNTATTGGGTSVTFDSADFRRTILEHQGCLFISKVTKPASEI
KNGLDINKMFSESLDKNSFHDPIELINPETNQMAKIHHIGILAIIDSKLKVGSSFIDDAR
DEIINKLPLNGTVFSGYIEEQNDFSVTVYTFFKAEAFPKRLAKGLVEEYNEFKERQKQIT
YMSQGIEQISETNEEDDFDLSELAAELGVEDLFEESVGEVASSTDDEDIDIDDILQQINE
NELK
>PK3-045_05503 hypothetical protein
MSEISMRELLEDEFKLDPLYNVAIIRELEDYIWTEKILSMSNERTYDTVEASKFIGRADA
TIRYYLRHELSDIYIKPEKQGRYYKLSYYTIFKIHLVSILIDIGGLSTTEILTELGHKTT
TVPSSKNTPLYDDLKKLSQFVEASYKFNNQLLVKMQQQTVLLLSYEKKLSNLRIESVNID
RKIADAKSEVTELKNDSMSNYLLERQDQILVASLKKKPKGFFSRFKNDSKEELINIEVDK
QLKEKQEAAVQSKTELLKEKIDGYYKELNSIKEEIAETEQKYELALREQERILEEGKYSV
QNFLNNPLENNIID
>PK3-045_05504 hypothetical protein
MFLLKTKKSENFILNTIVIVSIFTLVGSILVSI
>PK3-045_05505 hypothetical protein
MKIKKLVLSATAAIAIVGGSAIPTFAASGNTESQLTSASNELSTPYVNLTAYAANSSSVT
ISPPEWKAVSGAVVGKGQYGKIKLYSTGVAGLDVQEKIGNNWVTMGGTGLTLFEEGGEAT
LDYWMEKGKEYRIEIISGTASKTTGTIRNSL
>PK3-045_05506 Tyrosine recombinase XerC
MKYDGFISFLEEKNYSQTTIASYELVLNQFFSFLKQLYKKKIELYEIKSKDIRDYLITQR
ENQKAISTINKELAILKSYFDYLWERNKVPIDPAAKIKRLKVQKHLDISLFYEDLLKVKE
LVIANTNYSAKRKALFILAMEGLKASEFKFKKDDVSIIDDRIKINLSNRVITLDNIDASI
FLEFYYNNLLNESEYLFTYTDSVNNRIIPITFMGIHYHLKNIQKDYDINQNLQLTTIRKA
LCYYLYINKKIAVQRIALIMGIEEQTVSIYLSKLTKS
>PK3-045_05507 hypothetical protein
MERENSFINKVITASLLSEGEKEIQSSSRKLKVPFNKKKILYLSNLLAEYKLENSVSVQF
KKGEFTIHSNALGFFLSNWYIKDHKIFSYRVDPSLIDKEAIIIAAILFGERKQDYISIHS
SIHKDHLKTLCLCINKNINVPVSFHGDRIRIFNVKQFFMNVFRNCSTIHTAELVDFLTEQ
EKKEIKEGSFL
>PK3-045_05508 hypothetical protein
MRYKPFYSSLLISGFIILSGCSNDPFVKEAKKINDTKDTHEETETDSKSQDLESFYKDQV
RPLDEVVAELDGESVKILDKKEVEVKSSYEDPEEFARYAADILYKFQSLQISPEDFYNFI
LDYGSIQTVEELPQKQDAINIFKSIQDSYLQANVKGESYDITVVNLDRFKRQGYFYRKVL
STEGINYFITSIYKENGSWKYITDEPSDPFYEESQGGKEK
>PK3-045_05509 hypothetical protein
MKTLEEIQQKTEEMLMLHYQTNGEFNKDFFLLNQYVRIHLEQFMGAEKIKEYENHLFKVS
KSLLFNGYFIGMEILNNLEEIFKDDEIFEQSNANLKQQTFDMLRQVLGESVEDTLITEPH
RKLTAKLVIEYENILPTLLNYAFYTTVLGVQLAFQDERDRREISLPNQNKEGGILANIED
THFLFPDVFMNISVVNNNVEVWTITQSFWNGFDKIGDIFVIKNSIGDLYLNVTMKNTLPL
VQRNMIFNRIEGMIKEKAKTGKLFKTMTVGEEFFDTSEENFDELLEE
>PK3-045_05510 hypothetical protein
MKKFKRFRQEISSESKPRSTQYNQKEPINWMDLIFSEINRNKEIKAKIRKNLETFSIEEL
REMASSVLLNGLMFFRSTSEINSESMNKDFIDFQLAVNWHLADSLHNVPEAMYAENNLRG
DKPSLIYYLSEYFNFLHVFEQLEDKPNFYYYRKYYTNFQIKEEWKLLYEN
>PK3-045_05511 hypothetical protein
MMDTRNFLTPFFWVVGILSLITMCFYFYEGYKFESTSVKYKVELASKFANKKTVMELDPV
MTAAGVPITTSKEEINLYFKIFVNEKPYDILVTENEFNNYKEGDKIDILIGSGKAKLDNS
KE
>PK3-045_05512 hypothetical protein
MQPISIDLSRSYQSEVYYQILVIGAGGTGGIVIQQLCQMLSMFEISAKLIIAEPDIYEEK
NRNNQLCLAKDVGKNKADVLAKRYRAAYQLDIATYTGGYVEDTKTIDTLFQLNYERIPYN
YRIVPILISCVDNNYSRKIFHEYFNTAQTLLYFDVGNENVILPKDHRNRPIESWTKEELE
EYKDSGFTGQMVCGFKSDWKILSEPIGTLYPDILEDNDEIAPSQLSCQELAASNPQRLIT
NRYSAISVITVLNEIFETKSLSTHRILYHAKRGYMKSEPILG
>PK3-045_05513 hypothetical protein
MTIKQDDIFSLFDIEVETKKVDLNKMNDIKENKPKLKTDTNSSSTKSSTNKKDNFKLTSK
TIIRFGMNEYPVTNYFSKDEIERGLPSKKTSEDGEIEYKPISEEQLRKKLEKDFPILVPK
YTTLVYVEKQDVVIPIMQAKKNGSMDNKEFSFEDSSLKHQKKKIPFQILLDFIHIAKYFS
DNHGTEVFANIYFDHDTEEFFMDIPSQRVSRYLVTITEEAQETALKLIERRYSKVMEIHS
HHILSPTPSKIDDDNQRAPILYAIIGNINGLFPDVLVRTFNKELNEHIIIDSSKVFEFTL
TTKQKVNGYDLTVVEVE
>PK3-045_05514 hypothetical protein
MDIIFRLSDEPQHLNAQVEVLQITSDFNNTLESLDQMIKLNGRMVEGLYNITLPNLFSIL
QESIEDYIIDSQTPILPKNCVKHVWINELAKHQLVYIEVPKQQLDMRYGKTLFKQVGLPR
LIFLYEVMEKKVKLKNIVAVKGSKFLTKDTEVFLFPFSHVSLDGHVCMGGNTFPEIDDIY
QLNSLHLLFLQAPFGEDYGAKTTTNLSVAALFKKYENKQFDDEILLPHSKIQILENL
>PK3-045_05515 hypothetical protein
MTSILMDAESKASYDYSISNLLMLKILHDAKVDVSGYGNYRVEVGFMSNPGYDFLMRGMN
DLGFDTKHATVYTDDPEEISLAKQIESVFNPKAEWYIVLNSFKVEKILLSSQKDEYIAFI
KSTLNHIDLECEAFVEESLGIIIGFIFDGFYHELLSALIEVADETNNIYEKLEEQQNGHY
LSA
>PK3-045_05516 hypothetical protein
MKINMRKLSQEIKNKNTIVKPNSSEAGMAYFMDIVINHSETDSINFNSFTYDEAILAFDE
FYYLPSDEYTDDFSEEDYENIKNNMWSSYLQTQEFFVRWSQESKKIYWYEDDFI
>PK3-045_05517 Beta sliding clamp
MEFIINKESLLEVLSKVEKLVKTKTSNPILQGFYLEVKSDKIIVIGSDLNTTIRYELPVL
FEDESILINKEGKVVVPYQLYEIAKKVKTELSISLDDTQLVIKHGKKKKSEFKLSVFKAE
EYPKLPRFDGIEPTLSIKGTEFISFIKKTGYAASSSDARPVLQGICFETTEEKLRIVCTD
SHRLGVIDVTESHKESKKIVIPAKSILESLKSFDLGEKVTVFCENDRMLILQNNNLTFYC
RLIEGTYPDVSRLIPKEHLAEMKISRKEFLEGFEMISGLTNAADNETKGIVKLHVNGVAT
LSTYQAQTGSGKIEIDYESLEGEDNFDIAFNNNYMIDTLKAMESEYVSFKYQGSMRPFLL
TPCDSSHEEIQLILPVRNK
>PK3-045_05518 hypothetical protein
MTTQSTEEILNKLRQPFSQNDIEWKVQTSNKGNNGAYAFVVAYVNNRAIQNRLDEVFGIG
GWKNSYVEFSGGIICELSCYINGQWITKSDGSEPSNFEAFKGGLSNAMKRAAVQFGIGRY
LYKLEPIYVQVSETKSNNSIYLNDKKNKVVGYYEPPCLPDWALPPDEQKQGKNNETTSTS
DNNNKKREIDKKTGNNTFNRNSYFISITEFINKIKLKPRAAMELFHHINSDTKSDCVEIK
DIKEKATDKELIKYYETLKPVSDLVKMSIHYKIPVENVLNYVRILKPQERIDNLHSCLLR
LNREDIKEINGFIEGDIKNNMFEHQTA
>PK3-045_05519 hypothetical protein
MMRNLNQICIEDDVERLIILRKRLKLNQFQFAKEIGISSSYLRKVESRTIPFPFKFRKKI
DEYLKQEHLIYEKGSNLYK
>PK3-045_05520 hypothetical protein
MKKVLTSISDEQIIGAIQSNDVEIVFYDSNFINHEEENYIFNLLIITSDEINNQFFTTLK
VHDIYILGNSNDNKANGRNMYFFENEDSLRKALFIWPKKVKNSQDKDISTSENTLNMEVQ
VDQGSLHTSITGEAKENKIIDSIETVDCNNAPPVSIKDDFPSTEYPINISHFSTNKIEAM
RKQYVYKGKQYPQNKTIAVWSPLHRIGVSSFILNFAIYLQEQKIQTAVIEAMQPPKLSSV
LSRYEPMPVNFRSFIEVFHLEEYELMELDYHKTNWQYMGVLWLPIGEKDYVYNWTEDFLE
VYFQFFRYHDVILTDLPSGKMTEETEKVLQNIDELWVMVDNSIVDILMWKNYIHQLREKH
GISMKLIYNRSFPFSKINSLVNGLELPLIGTIPDLTEEYIRLQYKKKPLISFDEVREKVK
ENYENLIKAGFQLDSISNSKKIPLKTLIKKLFQSRG
>PK3-045_05521 hypothetical protein
MKLQEVKKVLFSGKGKIIISIHTMQRLEQRGYTKADIVTAILNGEIVERQSISKVAVLGR
DTDDNPVVVVIAKVSNHQFKIVTTMPPIDRSRFKYCI
>PK3-045_05522 hypothetical protein
MNSLYRKTKVKGFYEYYRTPCPICGKTGACMTNEDNSKVVCIRVESDIQFSKNSALISYL
HVLKEDNRNKVNVKEMAEEVNGFPKKDSITLDTIYHALLDNLVLDDFHYNHLTSNERKLS
DEQIAIRNYKSFPDKPWNIVKAISNDLGINDFQGIPGFYFQNGYWSIAGMKGILIPYRNQ
YNQIEGFQYRIDNPPNIVEVKLNGKEFQAKVIKQPNVVEVKYKGNIIFQGEVPLQKDWST
ITDNNEILGWIRVKKGNRYYWLSSANKSNGTGSGNPAPIHVSIPSTKLKKWVPGTLYKAK
TVWLGEGALKGDIAVDLMAYLYDPLEIDHIGDTFISLPGVGAWRLAIPVLKEMGVQTVNI
CFDADAIENVYVKKHLLECAKELKKQKFHANLIVWKESDGKGIDDLMLNGKIPNIKRIY
>PK3-045_05523 hypothetical protein
MNTKKIEEIAVQSVKREILRCDFLSDEIPTNDKTPTWDGEIWVYNNSNQKKDTLHGKVPV
QVKGKKVGKLSRKEIKYKLMKADLENYYNNNGIIFFVVEIVDYDNFKIFYLSLLPIDIKD
ILAKLEDKKSIQLEFKKLPETKGALDTICRNFILHSRKQGHSLLNDIKIDINSFKSLKST
IITTHNSFASDLLEYGTYAYGYNDDLNLDVPLYKMNIESVEEETDIDIGTGGEKFYTATR
IISKNDTFIDFGRSFRINLNQLKLKKLDINFSLKGTIRERIYDLNYLMEIINNKSIEIND
DSINLSSINLSEKILSDLPAQIKELEELEVALNKLNIDLDIDPTKLSHKETFNLKVLKEI
VIDKDFSRVKHEKDRPFIHFEIMGKKIVLVSIVKDKDMVVFNLFNSQDLHKYMKIRAESK
TNPTDQTPHTPYILFDKSDLFNYANFNIENLIQSFTSLVDYSNEYARTITNHFALETLNY
YDQNRNRKDLLKFAEKVFEKLETIDPNSLTYFINKMQTIKRDRDFTFVEEDQILEKKMST
PPTDIESTCGLLLLLDSKNEFRLLFSKLPQEKRNIFIEYPIYNLFKSK
>PK3-045_05524 hypothetical protein
MNNKKDFYVDIQKRAFEIYEQYQYLMKEILKNKTDISKYKLNFYIKETAKIGGKAWYEKN
TDNIQIYKGIIDNFYDYFYSFTKMQSKSFLEKLHFNYEDDNEVSFEFLKFDDNGKSTIFD
SKIIDNKLAGLLTIFVSRFIITHELGHLLNGHCEFINSKDKKNIQYIPMFEKDNNQTTKA
ISPLDFRTLEMDADAFATTDNFRNLILLYERFEEKVDRDLNIKPIDLFYWWSFAIRSNFL
INQRILNDEEYNADKTHLPSVARWILILGSMLNLIDTYKINYRVGDNKEKLLQSLTNGFI
YAEKCYNKCFYTNYNCIEETINSVDYRNYATATQKNWENLRDELDKFSRLPLYESQL
>PK3-045_05525 hypothetical protein
MKTGAIKRVKGLNDIPFYLGALILTYLYLFVPESALAAWKKAGITSQGNVKDSKIYDQLN
NVVYLITGIGAIWALACIIFAGMKLSGSQGNPQNRTQGFIGLAMAGIGVFVIVQAKVIAG
YFAGFGA
>PK3-045_05526 hypothetical protein
MSRRAEVPIDMASEQKTILGFISIRQLIYLGVAGSIVYAYIPMVYKIFSSAGVIVALIAC
VFSVIPTAIFVIVFGFFKKKNLHLNFDQYFLIKMNMKKQNGIWRKGTYPKKWMVNS
>PK3-045_05527 hypothetical protein
MLLFAVGAYVFMKIMLKEPIIPGRGKKATPIKLNKKNNEKGKNNPLQAEEDPRIFEELFS
DVKDISNHLIHYTDYSFSIIAEVDPVNYFLKSQFEQEAIDVTFESWTATLNYPVSVYLQN
RFVDVSEPIEAMNKVMEESKDLNEAALSFGKAMIADIVEWQKSAPRFETKIYMIFTHKIN
VNSISADSEEELEEKIVDKAFAELMRRVNSARNQLRKADIHVSLLPTEGIYELLYYTFNR
RKAVKNRFKDLVNQEKDALYVTADQTDSHIDLVKETIQEYEDNENERERAREKEAS
>PK3-045_05528 hypothetical protein
MKTKEREQEKKKLAKKNTSKKVKGNKNKKSNEVKDIDYQIDTKPTMWEIISPEGLKIESE
DYGVIKTSLGTKTYFRPMYIPRDGYPRKMQTNWLNSLLSSGEVDVFLDIHKVGKSDAIRT
LQRQITMLESNLSFQTKRGNIDQINDLTAKIRDTDLLMSEIQFGENDMFNVGTLAMLYAE
NEKQLNYFSESLEDELSSSFFGLTSTWGRIQKGFKSILPFGKNHIHDSLRNIDRRALSTF
APFISGSGKYMGGVPIGINKITDQLEFINSFGNEDYRPDNYNMFISGFSGSGKSVTLKLL
IARELTGADVYARLIDPEGEFVKITKRLGGINLNINEEEDICINPLALNYSDIPFEDGDE
ELSLIEESDEKEIIEKDGKIYIRFVPIREKINEAIDFFDIICRGKNQESEGLDVFERNYL
EEALQHVIHNKLNINSHPESLFENNVRTIDNHLVQSRVRKPEPTISDVNEYLITKYGEEP
RAFRLIAAIKPFLRTGSKPIFDGQTFLGKGVTQSLENARLVNFNISQMEEGFLRPIAYHV
LLNYTWEHFVKSLDNAKKKKFVYADEAWTLIDSEQTVDFLEKMARRSRKRNAGLRLASQD
FVRFVENKKARGILQNTFSFMFLKQSKLDLKAIRENFDLSEGEIDILFGNPDKGEGILRV
GKSSVWLRTNPSKEELFFIESNEAVYEETMQRQKQKASSFY
>PK3-045_05529 hypothetical protein
MNKIQELISSLFSAMGDWIASPFKSLPTLKNLIFGGDENLAFLTFTENEITKVYTPGMNI
FTALAVTALLISIIMAAMKISSTSINPSNRTYVIEYFKELLLVAVLFANLYSIYAILFLT
NQAIVGLFESDVDLLNLKNAIEMSKYPGGVLGVLGITVVKVGLCIWAFFYYSMRKFTLML
LLITGPLMLVFFLIPQTKSITVAWFKELVGTIFVQSIHASVYFIMAVMVGAANPIEAVIL
MIIFIPVTESLRALIGLGGKMNDGFSKAAAMMGGSALVGMYGAAKGALEGTSVTDAIKRG
YLNAKNKGKGNGKDSDNVSSEDNDPVGDIKKTLAGNTGTDTGTTANAEKMLKPGNILSRS
GKAVFGATGALAGSALGPMGVLTGSTIGFHAGGVAGGLAGRVGGASAQLLANRGSALLKN
GLKGFKDINNADKVADEQLASTIADEKATAWANENEDGFRKDFKERFPDAHEEAVNKAWD
NEKASKKAGFLNEARGMVAGMKSKEGKNANASSLVKNATSNLTNKWAEKNKEPFMKEYDQ
KNPLPVNASKEEISRHQNARENAWQSQLKEKESSIQNLASDVANDIGNGASLNHSYINKE
DFEKRMAERMAGGISQKAISKTSTNLAKDWAKDNKDNFMKNYDEKNPLPLNATAEQKSAH
SNAKAEAWKNEIDNKQKSIANVLGNGNLKLRNGQEKNQLFTNQLAKDIGSIIGVNENSEK
MDQISDQLHNVYSPNPISTATQSLTSSWAKDNKASFMKNYDKSNPLPDNATSEVKANHAQ
QKQNAWDNQVQQKQQKLGNILTSQSNAIMSGKNVPLENVTKSIAQELGISTSDSSKMNAI
SSQVQTGLSSVQGASSKVSNTTEVLASSWAKNNKQNFMNNYDKSNPLPANATSEMITSHN
QQKEKAWNSEVQQKQQSISNIIRDNSNAVLHGTPSQISKVTSAIAKEMGISSNNTAGMNA
ITQQLQTGISSPSLVDKGLKSISSINNVKDSIASVKGTSMYSGKEVNVPYVNNQIASMKI
NEARETFANNSNLPRAQAYQNFDSSGKAQEITSSVQKSMPSNIPLGQRIIQNSAGRITAG
LGNGLVQGVVGASGLKEVSQFVGDTKIGHATKTLGMTAATSFIKNKPNLNSLAQNPTQLV
SAAKESIVDGGKAFVNDYKSYTPSNLVEKQAKFRNAVAYAGGMVAGVGGYQVMAKYAAPS
ISNSKAFGLKGFNPYNNAVNKQIKEISDVAHMAQTVTLDNGQTEIAQGAIQMVTDNKNTV
VQVRDKTGQTHVVSRMASGHSGLKNNQVVYQDLIVRDGQLLSASSSYSLDSGGGKVPAPK
INVNPNQLFTNRNTSKTPRVVQEVQSYNQLVDSGQYYMKDALNEMENIKMVIDHNRSYMT
GTRNGTTYRISPYGPGDARVQNDKTITANCEVRNKKLIPSFSDSDFTTSLKPEDLMAYAV
PNKRNFARKQLEMHRNKAFTSSLR
>PK3-045_05530 hypothetical protein
MSDNKNTQETLNEKLVNGMKGLGRLLSKPFSKKLKQKAAAVAKKAIKVAAKVILKVLKQI
FAWLIGTVGIPGILITLGIIIVTVIISVALSFFWTSDDNLSGDDAKIQAYIKEQSESTVN
MDSDLERPYRVPEGLISSTIMLDFFEQKDYSLSQTKKIIRNMATKLAPEFEYGQYDEWKE
KQVTVCEEGKECNVGKVQHTKNMVTKLNSVEYWNGSTIFTYKPKVTAWKANTVITHKTIK
ENKKVDYWKALEVPMYLVDRSDPYFPFYNSKSKTWKSLLAEETRQKKNKINTSGYVKVYL
LKTKTVKVERIVEVKTTTKTRQQYFESSKQVKQDYANFDAILNSMGLGLDDKMLIEANYS
FLEGDINYIDWLKGNGGVYGFDDISYDGDIIPGAGVPPQYMPIYLAAEKKYGVHWYTLAA
IHSKETAFSTIKPMLSYAGAVGHMQFLPATWAGWKYNIGGGRVSNTTNYTDLNVIKAGGG
YGVDGNNDGKADPFTLEDAIFTAANYLSKNGYSTDKRKSIYQYNHADWYVNDVLARAEKF
KTSASYSGGSDSPELNPGSFIRPTTGKVTSGFGARWGATHYGIDIGLGGRSNVKIYAAAD
GVVHRSYLSSSYGNVVYIQHTIGGKKYETVYAHMQNRAVSAGTKVKQGQFLGYMGSTGNV
TGPHLHFEIHSPAWTANKANAKNPALYIKF
>PK3-045_05531 hypothetical protein
MKATSKLRFSFLILSLVIILSGCSSSSKANIKVTEDNIDYLIEYDESLQTFITEMTSILT
NFNNSLDGLYTHEVSNSQFATIMKETIKKSNELVSNVEALDVNPELFEAHQNLIVLVNRS
HQLLLTAIESANNSSTDESNTMDKDTLRQEYIEIKKEQANTANQWKILREELASAAMEEE
K
>PK3-045_05532 hypothetical protein
MMKKHYIWIISISIITICIAIYINVSSSQKLTPVDLKDMQNNVAKEVSFNKEYQEKTMEW
AEKNAKGDMELDLGFYEPNEHSDVSPQRNVINYFMTGLLQDNIDYFTSAFDIEVLSQDLF
QSKEEDKELVVKEIINRISRNGSIEGLKIKEAKEGIGPNSNRVLLELKYSDGLSKRIEIR
ISPSEYAHSEEHHHSTYSIVTSAWEIVKQIEGTVK
>PK3-045_05533 hypothetical protein
MNKETLIELLIPHKEHLTTVGKWEEYASKHNLPSYYSLRKFFNDWNEIRSALGTEIKGKY
DRNSLIQIGKEHKEHAKTIRMWKDYSANQTLDLPSPGQILTVFKDWSSFKNAIGVENERT
PKYTKQKIKEILEEHNEFFISRSQWDIYASENKLPTYKTIRNHYTYDEILDIVGKKKVFN
LSKEELIKLTLKPEYLYKFLNSTKTKWDEFARENNLPSSYKYIKTFDTWLKAKEEIDKAY
LTMSKGTE
>PK3-045_05534 hypothetical protein
MNTILTFLNGFVQYRRGKQTGLAGLLGLIIFVLAVYRWDITYPILESLKIIDFFDNLGLI
YEGEPGTTLYAIMLFLSRAAIVIMFFLAIALILSLFLMIIGSSKLGQNLLAYVVLTIMIP
LLIVWMLGYYIAYCFGFRTKKEKAEESYENWHQETFGEHSDRYKEEQLKYEESRLSPSDL
LKKYCTTYYIEDTISQLNRLPIFGDTVFMLGETYDGSLYILMPDPLLKYNRKMDIEYRRN
YSTPIKAVPFTVKNVVLEKKDDSNIMKYRPEKMVISLKKNPEYNVNSELIKYEFLVDIEF
LDIKSFYMPDLDLKDIKHYISSFGKRNDYRIYLEDKVEKYFSQKQHLLNFLYRDISSEKF
QEVTNDLRELNATNEDIVKMINDSPKILGVNNE
>PK3-045_05535 Multifunctional non-homologous end joining protein LigD
MLNTPLKPMLLQPSEVISTDSNYIHQLKFDGHRALFHYDHGKITIYTRHGNDVTLKYIEL
LNLNLPVQTCILDGEMIVLDKNGEIPKPNFECLMARFQASQRDKIVSLAKAIPVHFVAFD
ILFLNGVSTIHDPLEKRLDILSSIIDNDHLISAATSFNDGLTLFNKVKELGLEGIVSKKL
SSKYILDSRTFAFQKIKNYQFLIGNIYGYKKNSFGWLIKEGNQSRGIVEFVPKKEREAFY
KISKQLIIGEDKNFVYLDPLLKGEIKYQCLTSKGFMRSASFQKFII
>PK3-045_05536 hypothetical protein
MDFVLDLLKDVAKIFFTTLAAGYANRFASKKKNKRKPAPRRRKQKGGSSK
>PK3-045_05537 hypothetical protein
MTYSFLEEETIYNAMETNSSVSFYVFDHQALGETIITGKTIFIDYNNKHFRLVKDTTEEI
LYLPFSMISKITK
>PK3-045_05538 DNA polymerase IV
MFDYSQFPHKNILAVDMKSFYASVSAVLLGLDPLTCHLAVVGNTEREGSVVLAASPAMKR
DFKIKTGSRKFEIPKDPRIVVVNPSMSLFVRVSTEIVKLFYRYVPPNKVHVYSIDESFLE
LFHSDKWGTPEEIAKQIQYDIYSDFGLPCTVGIGPNMLMAKLCLDLEAKKVDSGIATWTF
NDVQKKLWPISPLSEMWGIGKRTEKTLNSMGIFSIGQLARYDLKLLENKFGILGNQLFHH
AWGIDLSEIGSPIMAGQVSYGKSQILLRDYKERREIETVVLEMCEEVCKRARKNHHAVRT
ISFGLGYSRDEYGGGFNRSRTIENPTNVTMDIYKVCLDIMRENYRGQTVRQISVSLSKFV
DDYEVQLDLFDNNSWKKRKIGYVVDELRNKFGPTSLLRAVSYTPGGTAVHRSKLVGGHRA
>PK3-045_05539 hypothetical protein
MSWPFSKERLFLYLSYVIYSFIVIYAITYIYPNYFNETIVIFLAVMFFSYGAYLISRLTG
VYKKVQEIEGEIYRQEIKKAYAHFFSEKKRDIRNSASSKETKVEKEEWIEFEKAQWSWKG
KTNRALTAAERYFKTENSLRRINTFDRIINLISSHCYGFFILVNPLYAFLTTIPVVIISL
VLFLIYRKLRRKLQELYIEVYPENVRETLESLGIK
>PK3-045_05540 hypothetical protein
MIKNFKCQYCYNDEVEALTFNKDKTGYWCEECDGFTLVNQKDTGRYLLILEDSSGKNESI
ASTIKFRKRLSPLRYPGGKSKMVNYIYNQLDKKKMNHFVSPYTGGGSVEFALLEAGVINH
LHINDKDFGVYALYWVIFNMPFALTERLKTYTPSHEDFYKAQLTIKKDFDKINIVEAAWN
TLIVNRLAYSGIYNANPLGGKKGTPQQLTSRWNPDELIRRIEKLHSFSDQVTITNQDACE
MIEESYWWDQTTIFIDPPYVNKASSLYRCYYKEEDHIKLNCLLDTLYHGFDGADLIITYD
NNEWLESLYLYPTVKAVSRAYTV
>PK3-045_05541 hypothetical protein
MKKTIDNFMTVSEAAERWGVPADTIRNYLKPSNKKKWQKTEKMIELGLLKYHQSKFDTKK
EWILSKDAMEVWFGVEKKEAE
>PK3-045_05542 hypothetical protein
MSFFNKRLGTVRLLVHLPMAFLSIFIYVFLLTSLILVTNLLVGKLLTWALFILLFISYEF
YLRKTNNFYVYPITSNEYEEIKDRHLIHYTNSISDEDYQYFLQTGKIRLKAKISAKTNYV
MKFKNKRKNYIWFHQEEQNMEPNFNSYYFSHMHENSPRKYKVIIRVSDLEKERMLVRPSN
NNVIIMNDLEVPGIIYTKYNSYNTKFYLKKCLMIIKLFKNIVSNPYDYVIRISHIHNKVV
>PK3-045_05543 hypothetical protein
MGKFKNEDLVIIMEGKYKDVIGKVVDNEAPLMWVMLSTTNEVANVHEDHMEKLNLVMKEE
DFKEYEKLIKGLNVDIKTI
>PK3-045_05544 hypothetical protein
MFSKKTKNAEIIFTIGETKIATKINIESATEKADLNGDKNNPNKDINHISLIVKASDKIK
KDLGIVIQDLNPSVEVRYL
>PK3-045_05545 hypothetical protein
MFFEPTLDHTIIHMKIKCFNKSCDNVIDFSYSEDFSPRMVGECPKCGTEYSRKIHGLKDS
EIISRTEQPVYR
>PK3-045_05546 Tyrosine recombinase XerS
MAITKQHEYYERRLEELLKEMPDFINEYVEAKMDNRSPLTLFNYVRDYKEFLSWLMADER
VKWSSLKTFPVSLLGSLPLSDAQDYFKYVSRKKYEKANESHKISSKTVNRHKSSLRSLFN
YLTIEAEVSGTQGEPYFHRNVMKKIPIKKVSETFNERARKISEKIFIGNEDLNFLEYIKN
EYENTLSPSELKFFNRDKERNFAIISLFLGSGIRVNELIELRLKDIDSKNNEISIIRKGG
KKDTIPVTPSSMLDVLDYLSIRNERYKAGNEESQYLFVKQYKGDTLPLTARAVENIVYKY
TKSFDKRMAPHKLRHTYATNLAEQTGGDIPLIMNQLGHTQSDISLLYINTSREKAKLAAE
RLDQRRNK
>PK3-045_05547 hypothetical protein
MSKTNWHEASGKSISADEWFIKFRDDIPICKVCNSSLTFVATARNQRTTHFRHPDNSNCP
TVKFNSKLYENFRPKEKDYQNARKLKEWVIDNPYLLFRQMWKILGGSIRYSEFTDILTAA
NKRQIWYYVGLEVEMLPYTLLVNYGLFPKLKDRTGREREMYMAFESNLSSYEEIWNKPSS
EAKYIFRIYRDTSSTNEYELVRIGDIMLPENLTTPDFMDYYLKKANLI
>PK3-045_05548 hypothetical protein
MGHLLNCTNYESVFKSIKTILGVSHNSLIDFIKLNEYRIKLRRDFGYPIFERFEISEIKD
YFKIDVFNYDEIIVHHAASLLENSTHLEQGIYNLKRLAETHNSFKLFLSNYGITYDTDRV
GTPYFAYNGNKVTSPYLESRFKKDRCINGFLFSYSVLEDTNIKDLKYCPEIVAHLGREIG
IDLRREWIEQSNPCSVSFKVKLREIDNSTLNTSVADNKAKQEYFIKLAIEYLIIDEVMIY
QYPKDNPMVFLKEEIQISPERIVNIVPLSELESF
>PK3-045_05549 hypothetical protein
MSLSPPLKTELMNIFFDESGQDSDKPSTMGGLLIPSSVYKTAEMMELNRRLESRELKLHW
TEYTGHSGLKDNIIEAIITFSKIARFTRMNVINYNRSTLDWRYKLSGDPASGKLEKRERQ
RQLNYATLMVYTKIPERIFYGLLRNFGKDVYIKTDIYIEKEGKYEKYDLEKRLRENLNTQ
SLYRAEQFWVTDCQMVSKGEMIGVELVDLLLGIIRLIINNKPIPPGLSLEEYSTLKIKGL
YMKTKLVIELLKIPSFYNFISGIKYFEWDSHKELAEVTFKDYLDLFMANHYREFL
>PK3-045_05550 hypothetical protein
MSVTKWVYEQYKSNEEGLKHSKNFVLIWGLFENQLNNTISKLDIQNFNLWVQNLEITQGQ
NGMSIKEPNTEKYIDSELIGYINKSFNHFYQKYTNDSVHFINHLFNQTDKQTQQAKTKFY
DFTTSFNKKNIRDKIIFLFHIARRMRNKFFHGIKKIEEIKTEQKEFEKVNGYLIAIITLI
EQYN
>PK3-045_05551 hypothetical protein
MFLENKSLFDATPMGPKFTTRRISGRAIEKMIKNILKHLDNRSIRT
>PK3-045_05552 hypothetical protein
MDSLLESVMKNNNYIDYLKEFEKEVESDNERGIVLVCGSIIDYLLQELLQSFMINEDSIT
KDLFRGNSSLSTFDAKIKTSYYLGLINKELVTNITLIQKVRNKFAHQIVDISFNNDAIKN
ICLNFKIPKNAYQPTKIPFMKEKDTELPKLDLNPIKKDTPSKDRFIYTFRYIFTILLGRI
FEASQERRVKYEKVLTADQQVLLMINTIEDSFKKQEDYLIKLEDSNNELRERVEKLGEKV
EKIPEDMLVTIESMDDSLELAYKELEEVEDRFATLLKINKYTYEVLRNSLK
>PK3-045_05553 hypothetical protein
MVDFISGIDKYRNKRYFAKANTQDMNSILKNELTKIAEDPEKLVLDVVYKNEEILIVYRN
NLDLEDKYGIFLIELKVITSQGVLKDRVRLAAKYTKREVIEILEIQVFGDNQHRGYGSVL
LTALIDIALENSIKEISGWISYTDEDHFDKLDYFYKKHGFSVFWIKNKTHVHKAADIIWT
NDSNKFLNT
>PK3-045_05554 hypothetical protein
MELIVGLCIILFGIFMIFLLSLFSQAFPTEVLVGNEEVIEGFFTINNLIYPIVVILVGLA
HKGSELNNSKFDSLRNAAKKQLSVNTILFKY
>PK3-045_05555 hypothetical protein
MDDKNSKMIDNAKKLANEIVRIENQIQLIIESKQCVFDVLNDGELGWIVQTSYCQIGGCI
VNYIPCKSKITAIEVSARMTFKGMKPAANGICSTCSKDLHEMIT
>PK3-045_05556 hypothetical protein
MISKIKSITFLSAMGLSIGLINGPIHVAANESEKEITTIDSIDEYNKNLKEQIVKMDKAI
NITQNELVLKKRQLNHLKTAIDLNKKQVKKVKDELAAKEHEYRELKKSSVNDLPFLSDNL
AGINEDIIIKKNVKNFNLVEDLNRDFTYLMEKQTLLNEFSDLNEQLQQQQEASSKLTDAL
KEKEDTYKVEKEKLELKSKTLSKDKEMIEAAITNENARVNGERFESDFYQKSITSSKEVP
EEYMPYYLYGEQTYNIPWYYLAAIHAVETSFSTHVTMESSVGAIGPMQFMPSSWVGSKYD
IGGGLVAEDIDITDLETIKRGNGFGIDANNDGKADPWNPADSIASAAYYLASHGFENNKE
KAIWAYNHADWYVDKVIKLAESFKFQKDISTIDLNINNNSGIDVTTVGYKWINNSYYVFG
GGRSKEDISRGYFDCSSFVHWAFEQVGVTLGNRTGVTTDTLKEMGNVVNYEAAKPGDLVF
FDTYKKDGHVGIYLGEGKFIGAQSSTGVAIADMSNGYWNQKFNGRVKRISH
>PK3-045_05557 hypothetical protein
MSLSSELVKNDFIQFPTDYTDMVIRYELSKYEYIEIPFIKKKIESKELAELIIEKSSREE
KKTLVEMIKLIQKRNSSPKGYLGILAVALSTKE
>PK3-045_05558 hypothetical protein
MEREKKLKEGTYCTNVLLRWLTTDLLLTNKRFKGYDRNTVLGLMPIGKNEVTMSLKNIAS
VSTSTKFHLKRFLFGLFFTFILGLPSFVNGDFFIGLVLILIGIVPLFNSYTCSLNVSNNG
GVALPIEISILERGNLQEFANAINDTIAEVE
>PK3-045_05559 hypothetical protein
MKLNDILTEEEKKQVNDLMVELDDCITERQMDKITSAIEEIFNEAKKRYYESIGSNKEQA
ASLQEDRRIFHRRSPKRLRKVSSY
>PK3-045_05560 hypothetical protein
MLNKIILAGCIGFGMGVLTHAKRYGTIKKPRNNKLTFYPGFLLDGCFGAVGAIVTILFSD
PNGTERVILTSILGGYVGENAIIKVEESLQSKKESRIEEINRKINQDL
>PK3-045_05561 hypothetical protein
MIDWREEDVNRFFSYHKTITYYGDEIPKYLVLENPDGDGWIIGMFYPFIGGEYVPLEEAG
DVRLIFSTLKSAKNYVDFNLW
>PK3-045_05562 hypothetical protein
MYKLRDQIERVREEMLKIAFSEGFNSPEAIKKSKELDELILRYQQMNQNESVEVRIC
>PK3-045_05563 Endonuclease YncB
MKKIISTLFILFLLSGCSTDSLVTYQSKENYKTDNQVEKEISFKKYFNDVNRSSEKAADI
KTEKHKAIVKKVIDADTLVLEADKYTALRLIGINGPEITKGKNEPFGQEGKEYLANLIEG
KEITYQLDPNADEKDKYGRILAHVFLDQISIQSYLLKEGYVKLAYLFDEYEFIDVYKDAE
NIAKEKQLNIWSIPGYADTDLNGFVK
>PK3-045_05564 hypothetical protein
MISYTEEEKVVVTKLVMELARIDNKKRRKDLVW
>PK3-045_05565 hypothetical protein
MYYDREIHIRVERERKRIIEFLKEKGITRNKDDEKIDDLTLLSLTLMENELLADINTKKV
SI
>PK3-045_05566 hypothetical protein
METLINTVEQVNFKVETSCFKTYEFSTHNGLYVEEAQSEFSSFRLMIYKNEEAAIFVANE
FDYDISEEVSYLFDIEKIKNICENKKDVPDFSDDYYEEN
>PK3-045_05567 hypothetical protein
MKGKYLGKADSANLVPGMSYYLFENGKDYFYVSRFNNKKAHFGCYEKTPFEINEETREKS
EVTFKVSSSGQISFF
>PK3-045_05568 hypothetical protein
MNEENYYIKKKETIIPFSHGKYKIKKTTYYLQDNEYGLRVEVTRFSLTGTVEVRLVYGGG
LIIEKIYTTKSIVHPTKEQLEKIIKEFCVNSHQYKKLSGK
>PK3-045_05569 hypothetical protein
MNNLVKTIGERVRYFRLYRGFTQEELAEKANIHYTYIGGIERGERNISLETLNKITEALE
ISPTDLFAQNYLKKETDKTLLLKLHQELLSTRSTEEIIIVHQLTQNILQLIDRK
>PK3-045_05570 hypothetical protein
MSDLIERFKHKLDDISLNENHIQNFLEENTELISTPFLLNHHLHFNSIITKFKISDGLIS
DFAFLTKSTDFWHLVLVELEDPKKKIFTNNNEQIKFSAKFNNAMDQITEWKAYIEQNPTQ
ILNRIAPLKKPLEDRPIRFKYVLIYGRNSEKENDIRRTRMFAQKTNDDIRVMTFDSLISE
YTSAWYNYGKMILSHWREGYQVKSIPSNLETSIFAYLTPANLKLEAEQKKILIEQGYEIE
KWEVGNILSHNNKYTEETRQRFKSNKTKL
>PK3-045_05571 hypothetical protein
MDLEKLFKMWVNHPKEGFGRTNLDFTDECWKKVIKDIQIWESSDNKVANEFAKYLKYTGT
LRRVHLNLEKVNFNNHYVSWTAAERLEDIYWFKSSIPHTIITAEATKENPGISVKGFISA
MKLEIPNFELNSSAIREEHEVIFPLQEKTILRIEKIK
>PK3-045_05572 hypothetical protein
MNKYNLVWLLSEYRLELITLYSNEVENFIESKFDEFIQQADEATKGLSEDEKQNYYEYYY
DDLALVRDEYPSILRYSIITATYSSLERALFRIHYQKSKDRHGFKKYKKNNSDLDAILEY
ITIEMEINILHLADELNFIQSLNKVRNNIVHSNGRIFDDNNPKRIEKIINKSSNLEINSG
QLVVKKEYIDEMLFHVNNFLTSIYKELETKHPF
>PK3-045_05573 hypothetical protein
MGQEDKKKQITTKQAAELLGVAENTVLSYSRQGILTAVNEKSWQIDNTKYFYIDDVEEVK
DKLKKPGLSTGEVATQLGVSTVTVFNYIKDGKLTAEKKVYRGRELYFIKQTELERFQKNY
KNVRSRNNKEFYSKPNKQGWFQLFIHERSEEHGRLMVGEDEDYFLLTASGNKIPYTKIEQ
YGFKPVYLIERGSIISKRKFAKFEFPYENNVESNIYSFLDKCYEYITPTNMKMNINKEKI
ELEIKPYCFPYDTLDEDTIKIIKEYMVEGSIISTIKGIFIDSEYDVLSLEIPSHVKDSLK
QIASERNLTLEELVSKILVEYVNENN
>PK3-045_05574 hypothetical protein
MISESLYRALDESTFFVSKYEVQVKTYFLQKSKYGLRVQVSRFVDKRGSLSREKDTVEIK
LLIGGGGVVIDKTFKSITLEKPTRKKVEACITDFLENASEYCKQSKN
>PK3-045_05575 Tyrosine recombinase XerC
MLEKEISFHSNKNSLEFTGSQSSIASFSKTLKDPSLFQNLPDELIIMEDVSNNKEINDLE
MMYLFLHQKKDMDIRKNKMENTIEEYSRDLLIMYKQIIENAFSIGFDLNAQQNPYQVFKL
LNHVHIRKFQEWLAAAPLGKGKKSYAVSTLSRKMVVLKGFLSFLYKTKYIEVPLHEKMLS
SNVRDIDRPDRDLGKNEVVQILDYYKDHPIVHCLLATLITTGLRINELCHSKISDISYVD
GDYWLYVLGKGRHEREVLLHPYIIEEIRKFRRTRRLDFILDGSDNSYIFMTNKGKPYHYK
YLSNYLTKKINEVELPFIKTRKNPITPHTLRHAFAQISSDQGASLDQIKIALGHKSIQTT
SIYLQKKSRRENNAGHAWKNSSIMRSL
>PK3-045_05576 hypothetical protein
MTLTFTYDEINNRYDKFVQNFMSGETNVERTQLLPRFWIVSVPSKGFRVSITCECTGLFH
GIEEWCAIVEESNGEKTQFLLFEKEIDQWAVEIRRQKEMD
>PK3-045_05577 hypothetical protein
MYVIRSKSGMRFETTEIGKTGEQTYETLPEAEKALHSIEKLFITEKFVIESIRN
>PK3-045_05578 hypothetical protein
MNKKGYVVTCNKCESSNIKYDHINSIINVNDNKTSTPVKCLDCGYEATETN
>PK3-045_05579 hypothetical protein
MKKAKQNPLKLGKEIFGTKNIEDAFKEALEPYFKIDTSKCVKSNTLK
>PK3-045_05580 hypothetical protein
MGEKIPDAALLMILSLSEKRMCYRVSIAEIATECDV
>PK3-045_05581 hypothetical protein
MDIGFFESFKMGLDLLWSMLTADPLLTFGIIVFFGGLLLVALIVNLLREQKLRKSGILEI
DKMSGRKFEEYLLALLKAKGYYVQLTPASGDYGADLILSAKGKKIIVQAKRYKKNVGIKA
VQEIASAKSHYKADECWVVTNSFFTEQARKLANSNQVRLIDRKQLMNWMLQENKGDRGFS
RIMG
>PK3-045_05582 hypothetical protein
MKSKYIPKQEKTIINNKIYDVSKSKLVIDIEPEGWYSLYKTENGNYFVTRNYSNNKLLAF
LFRYDSFVDIYKDINPLSKEQTISFLLSNNLYDIAIQEFPDLEDA
>PK3-045_05583 Modification methylase AplI
MITAKSYFSGAGGMDLGMLDAGIEIMESFEIDKVACETLRKNFKHRINQTDITKITVLDQ
QDADVYIGTFPCTKYSRIADIHGTRTGDDLFLHFFRHVALAQPEVYIVENVPGMRKFQVV
MECLTRLPNYYVRVECPVNANMWLPQERKRLIVIGTKKPFHNLSYPEAKPMRMRDIIDIG
AEVYTPDYVQKRLNGAYRDKPIITDLDGKAPTCVAHYSKDRSTRLINDSVSIRPYSVKEY
ARLQGFPDWFKFAGTDNDAYRQIGNAVAVPMGYWIGKELKKYFAA
>PK3-045_05584 hypothetical protein
MHLKNRKIRIFSFANLVLLWSLWIPVWITTIFIKNHLLSIVANWGPAIHAFIIILLSILL
TYKRIHHNKINLVRTEMIDSNCSETQITKVCRKENL
>PK3-045_05585 hypothetical protein
MNLINILIVSLVIINLFLIKNKRFPIIKKVLPWIIVILFSYHWGVGGLIQYPFLANVVGI
IVISFWFIVITQYLRSLYMNKK
>PK3-045_05586 hypothetical protein
MIDKYIINKNYTSCYPDPIILKKNEVVLYGKEDTEFPNWIYCTSLKSSKEGWVPKQILSL
PNPITNESFVQQDYSAHELTVRQGEVVIALYHLNDWSYCKTSTEELGWIPSSHLTKTL
>PK3-045_05587 hypothetical protein
MFKNRKSKEEEMENIEIYHFQPKPNMKLAIFEQMWSKEIDGVKYLSIEHFINNDKYIIHD
VRIFKESKNGHTFRYVWYENK
>PK3-045_05588 hypothetical protein
MSDESILYKEAMERIDELVEDVIQTCLEVADKNDFDRVWVMEKFRSRFNKAKRTNDYNES
NWRMRL
>PK3-045_05589 hypothetical protein
MDITEKKEKLKWTWGDIGALLTVIGIVGLVIYFVTNTIMFFYDLRDEDNYNYQFESSNII
SYDMKIKKSNSFLSKDDYKIYVENEYGQTKILSYINLYVEKGDKNKLVVVQTNTKKNKNV
GTDYVFFLDKDNYASFNREFAKTFNKETNSFYNKDILEKAIIN
>PK3-045_05590 hypothetical protein
MQIILWIEKILLVFLIGSLLFKIHYSRKYLDQLKNHKKVSFINEIDIPYGKSIGKVIEFS
FPINEYDPLNPKWNLIWSMRKENLRVSNRYYEVNKKRFAFKLDNSNYYLFRNEILIPLSK
IKEEYFVIHFNEEIIYSISSLEDLSKKLSEQDLKKEIERVIGFIKEISEYANGIEKQASQ
KVKIYQDEKMKDLLEKHHLAMEQNIKKVQLINKIK
>PK3-045_05591 hypothetical protein
MKQKIAIMSLSIILLFFTAYSTASAKVSLGKTGGSSVKSSSINSGKVSSVKSKTNTKTNV
KTSPSNLKSKNAAATATKGNDKYKGQAYYKGNNFSKTLLTAAGVYLILDSVTNEGDPIYV
SAETGEPVKVEELEDVKPVEDTEPITEEDKEEASKKVNSYYELIRQGNYGTAIKELLLSK
PEIESQLVPEEKRNTSDIQQVIKQISQFYTSKGNSVATFSIEDAKEIDGRSILFTASLTD
SKKYTYQERIVAIKFENQWYLTFDLVDDAVNQVIDEHDLTPREVVTKYYKEVINANYGAA
STLVSKNQSFTKGKTDEEIKTEMIEAFSENENPLSSIDILKEKKENDQMYSFTVNLTHLY
PGFFEDYIEKTTEVEIKALYEGGMWKLNFDDEKKASSKNESPFLSLDDLRILLHIVFIGA
LCISIVIMLSNGLKDRKKLKMAIIKGRR
>PK3-045_05592 hypothetical protein
MIIFLLICVISLMFVIDYLQRNITELKKEQRRDSLEHRKIQQFINGSNGTEIRERSEMKN
GQLKGYSNKSSYETNKNSNEFFNNNFYFENGNVLREMIENTNESSSSSDYTDYNSYDYSS
SDYSNDSSSDSSSSFD
>PK3-045_05593 hypothetical protein
MMSQVERTKMKTYVRKILIFFIVLFIVRSFIFVPLKVDGESMKPTLQNGDLVLINKFNTP
DRFSIIIARLPSGEKIVKRVIGLPGETVQYKNNQLFINNEAIDEVFIPKNKDIYTEDYAL
VGKVPADHLFVLGDNRQFSTDSREIGTIPIESVEGCIGMRYWPLNKVSISIGKDSFK
>PK3-045_05594 hypothetical protein
MKRVGYLTKKTSKGKVYLYIRKSYREGKKVKHQYIYGFGPIEMAKEKLYKIFEEEIEFPN
ELKINGFNLDDVYDWILTLETGVTKSGRLFDIGCFRK
>PK3-045_05595 hypothetical protein
MISAMIRDGRIISINEYNDELHSQQIYCIDKSCKAPLVHVKGNERTTPYFKTTGKNESKH
TSSCGFYRPLSFEESLSKINDYQSDFIDQGLSETVIKLSFNKLDPDYEPRKIQREDKDEE
KKNKETIKIKNETAPPNSISSLKSIVKLFSTYEPDILSSILIQVKGHKIPISNLILSQEV
AHEKLWSDMAVLNLPYLVHGEIEAINRREKVIYLNFKKINNIPFSIVIFEKYFKYFTYTD
EELIGKYILSWGHLHKNTFNDKSFTNLIIKSDEYIEIIKKG
>PK3-045_05596 hypothetical protein
MFFITTDIKGVKGKISVFYKISFSNEKFEKYLLELAYQKVTIHLEIKKQHFHLFRRNKGA
KIIFSDSLLTKDQDCLEDYILNGTTFSFAEMEEALEFAKNIRKATISYLRKQEKKYKWKC
RQVNWSTYVKAKFML
>PK3-045_05597 hypothetical protein
MANTLLVVGGNQDKTFKKMGDRFELKVLHHPGESKKSGNKKEYQTLINKADCVVVLKGAI
NRKSMIMVKEICKEQNKTIVYHQGRGVTGAIQSSLAYFEGLSA
>PK3-045_05598 hypothetical protein
MKEYIFIVENENITFRKGFKDLLEVKFGKDYIVSTKDSLQDTLRGEPKLIILTQEALKEV
KAMDKIKTLYEYGTKFILIKENDNGFPFELNMFNGFLSKRMPTKEMTEAIENVLLHGTIY
VHPDIGAYILSKYNRFVNVLKTKEEVRL
>PK3-045_05599 hypothetical protein
MSLVVDNTKNAKEISYTCRNSCDLYDVLTESCSIKNKVDVDNPLVVSKCSRYLPTSSLEP
DIKINQKELDGLEEEEISYPEIQGQIETLEKSCYPFKPDFPAGRTDANWYVSPCQEYGCW
IVNDYKKPIVLVNPNPGEKVYKSAVPLHNHNASIGLASRIAWYIDENGIGRYVTLLNGHI
LN
>PK3-045_05600 hypothetical protein
MIRSQIKTIMSLIIFTILLIPTKAMANPFSDAPSMDDMITNWGNSINDSAPIVSSLFSSL
FTIMFLVGVVRLGYSIVTKTGQVMKGATGVLIWAPISFFIIRIFLIVLFTINTTNVTLFA
TDVINLLQLSGFYTVVGMTLVGLVMFLFYKLLKHPEFGRWSKRLWASAGFLLIISFIIPY
AFGAS
>PK3-045_05601 hypothetical protein
MVRIGEKSINEIMVTIKEKQLNLSRLEFKTRDKFVLIGPIGTENIKQEDDYYENVKENLI
FANYSWLSPLCDDLNCPFQGHLEVLPTGEMNHHNIDLTISIPLSGSLEKAKIMSTLYEQF
KVLEKYRNFIQFFDVSGFKYMTNLIHVSLKIPGNKITPLLKEAKTKPVNKQIISQWLATV
ENIMDQNANNFSYSHKVYAVDGRMQSTTFESKFTFKVHQRRGIFND
>PK3-045_05602 hypothetical protein
MRSEINTAGLESILSVIEDDNRYIQKLNLDYRIKDNKFYIGCLYGDTFNTSLKKNYLEVL
SQEVINMYERCLLPLSTLKVHDFTVNLEINDRGEFIREEQYIEIIIPVEAVDKLSTLSQL
YSKFKKLIPLYPIINSIEVQGERKQLNQIRIYLNPKEKSYLINENKTDVLGQWIASFDNF
IDNLPETPFYTKIKVQNGMIKPIQFINEKEKWKWFV
>PK3-045_05603 hypothetical protein
MHTITINLDWFVYMYFLIEYFFHAVCMDLKMKQYYLENGLIPTETESKSKDEVIYLEESQ
NLNIQEDDWEEVMRPTNIYHITPTVSELDDRTIEYLSNLTKEINFEELCDEQSGPLEEEL
NLTDLNITTSRECRNKQVNSEIEDQVDDIPTTKIADNLQGKQRWLVSVLGMEEEYIHVSD
GKRAWINIGESVHRINRKDSLSLEIEREGKNIRVLKIEILEHAVSSDYIIPDEKIEYEAA
AI
>PK3-045_05604 hypothetical protein
MKETKTISITEELIETPKMIEVYLDDAWQTAFCYGLAYEKPKQNWQRAKLLLTIIAGNDS
TVQAMKAAIDIGSSGLSFGNGEKGLTDYTYTKELELYTEKGKYEKFPMTIINNRKAIVVV
HDELMGNDDYILSFTGDPAEDLRTVLGGGKFGLHILPEWKDIIFHEFLNIGILQSVDIYF
DSKLFPKGFSLFKLQATEEEVDNLISKMIKEKKLRFRKEGTGTEVEMVSDLTEYMQQNVE
GMINKVSREVSPIHNPLVDHISPKISTYKRELFPVQSHVSTAVAKKLAKSKAVIIQGEMS
TGKSTIMTAVADVLSDMKNKEGYHSVLMCPPSLTKKWPEEIKEIIPHAEVRVIERTSQLI
TYHRDWLMSGRKKPKKPVFFVISFTTMRGDSSIVPAVQFSQKKTSKQQSEDRLPYRYGYY
CPSCGKAHQVIEDIKVIPDTDEPSKEIEVRSTRTMDKDEFGTGRRLQNTQKPANAFCSEC
GESLWTKKVATRYSSIKEWYVYEKKLIHAIKEGNKNLLEHIQSNQKEVPKKQGQPRRVAS
IEYIRRKMKNFFDIAIVDEIHELKASTSAQGNALGSIAAAAKKVVGGTGTLFGGKAEDIY
YTLWRLFPSLMVENGYKYSEVRKWNEEYGVIETTTYNQDSNAEYTNKQSRGGTKRNEKIL
PGISPFVFSKFLVQNTVLVRLVDVWPDPVEFVNVPTILVKPDEDLQQNYLRMVNTFERSI
EELEDGFKLYMPLTQTGISYPDNPFTYPAFYMNGELIWKPEPFEQERILSKEKKLQEIIK
GEISEGRKSIVYVRDTGSSVEGRDVRPRLKHILEMIGAKVCILDTSSTSTNRRSEWLEKK
IKKENYDVCIVSQELVKVGLDLLCTPTLIFYQFSWSLFTINQAARRAWRIKQTEECRLYY
LAYKNMYQEQMATLIAMKNKAAGAINGDVSSDGLNAMLGDTGDLQSMLIQSIKKGNVLQG
STEEWVAEASDRAREILSNIGKSKNFPLKSNKEYFEEWANKYIKTDSSRNVLIRKSKTIA
SNIEKGKIPGFHFNGMLLEVDLYAAFGSNSALDGEIVDYLTRSERESKTNNDSSQISLFD
LVEEKPEKKNKRRVVSGQLAFELF
>PK3-045_05605 hypothetical protein
MGNKIITTHKGENMNIETVQFSYFKYKDRYIEYCGYQYNQYWFLIHNSKRSEVVSISNEL
CPSFDTAMSYLSKMYIDKKMN
>PK3-045_05606 hypothetical protein
MTTKKQSKKRKLKEDTKNSRTIKELVKQIEKKVEQDGYCILKQIHHGNETYHKIWWWMEI
ELMIGEYDLAANKVKETKDIDIENRQNLLDIVVGLEGSVSLVPLVKD
>PK3-045_05607 hypothetical protein
MKILVSKEAIKWFKEEVGLEEGSAIRFYSQIYGTSPIQEGYALAFTIDTLHEDVAVQTVS
EGLTFFIEDADLWFFNGHDLYVEYNDNIDELEYRYVKP
>PK3-045_05608 Riboflavin transporter RibZ
MNKKYLILFTVIIGAFVGNLEAVLPNTAVSVISQSIGTSVEVTTWVLTIYTLLFATFMPL
ASKIGSIIGNRNLYIWSLAMFSLFSLLCGFTNNLGLLIIFRALQGISIAACLPCAMVIIS
QHFDAKERGKAMGILGMVVASSTAIGAPLGGILTDYLGWHSIFYIVVPVTVIGFLLSLYV
LPKEEVTRTRSSFDLKGAIYFSAFIIFLMLLISNTGKYGVVSLVNGIFAILIIVAFIAFI
RTEKQVNSPFIPLDLFQNGAFNSVSISRALQMAMLYGALFLIPLYWSNVYNLTPKETGLA
LFLLPVTIMIISPIVGGLIDRFGSKPFMVIGMIFTSLGSLGLVFMPGTIWSINMTINLIL
LGIGFAMMQSSSMAAVTLVLPKNLLNVGVGIFNMLTFTGGTLGLTIFSSLVNYIHFKGVF
LIMLIAGLLGVLILLKVKASSKVESQKMA
>PK3-045_05609 hypothetical protein
MEHLKTDITLDFFKISNLLSRYGSKMVSEVGLTSIQQWIILRTIIEKGDISIGELKEETL
VTKQNMTGMMNRLQESNIVLLYPDPEDKRRTRVKLTEEGLQIYEQLKSSRNDFNMQTYSI
YTEEEIIVLNDLLSRLVNHLKMN
>PK3-045_05610 Aryl-phospho-beta-D-glucosidase BglH
MNFPKDFLWGAAIAANQAEGAWNIDGKGVSGPDIYAFGGKNNPRRITRVIEENTFYPSHE
AVDFYHHYKEDIALFAEMGLKIFRFSINWTRIFPTGEEPEPNEKGLLFYERVIDECLKHG
IEPLITISHYEVPYALTEKYNGWSSRDMIDIYLNFCKALFTRYKGKVKYWITFNEINSAT
RKTGGFRNQGILNPGTTSNRDIDDIPQLRFQGLHHQFLASAKAVKLAHEIDPNYQVGCMI
LFGTAYPLTCKPKDVLITQSKNQITNWFCGDVMVRGSYPSYMKRFFKENNIIIESQEDDS
NILLEGVVDFYSFSYYMSICHTSDEGLPKTQGNMLGGASNPYLSESEWGWQIDPIGLRYT
LNEVYDRYQIPLMITENGLGATDTVNEDGTIDDDYRISYLKQHIEQMGEAIEDGVDLLGY
TAWSCIDMVSAASGEMEKRYGFIYVDADNLGNGTKKRIKKKSFHWYKEVIETNGESLKKD
F
>PK3-045_05611 PTS system glucose-specific EIIA component
MKTNLISPVLGTVKDIAESSDFMFAEKILGDGIFVSPTDSYVVAPCDGKINSITKSKHAI
TLYTDNQVPVLLHIGIDTVELNGKGFELFVEEGQLVKAGQKLAKVDFDFIKEQGYDNATI
MIIPEKKYKVDKMNLDKNLVSYEQILEVY
>PK3-045_05612 PTS system beta-glucoside-specific EIIBCA component
MNFRESANEILKSIGGSNNVSDVTHCMTRLRVSAADPTKVDIEKIENVDLVKKVIQRGQN
FQIVIGEEVDDVYEEFVKLKEEGEDSMGELVKDSAITNQSDFKKPNPILRVIDTISGCLV
PILPALIASGLISGILSLVTSLGWVDNQTSTYTILSAFSSAPLYFLPFLLAYSSAIRLKV
NPAITLGVAAISLYPQLTQLFTSGDPIDLFGIPVSAVTYSQNLIPILLIVWIQSLIEPKL
SKAIPTYLRTLFLPLIEYTLLGALMLLIVGPIAGLLNDGLYNLFHTLSQGYSWLIVSVLG
GFNAIRIGAGLNHSILPIAVANFSALGYDNIVGPAMHATVFSLAGACFGLMFKSKNPTVR
QTSVSAGFTALMGISEPAVFSVMLTNKRTLLATSIAGFVGGLAMGILHVSVNALGTKGIP
GIALLIGPTFISGIIGCVISFVLAFILAYVLGEDKRLSL
>PK3-045_05613 6-phospho-beta-glucosidase BglA
MAFKKDFLWGGALSANQCEGAWNVDGKGISIVDVLTAGNRNTPRKITPNIDENLYYPNHD
GIKFYFNYKEDIKLFSEMGFKIFRFSINWSRIFPTGEEEEPNEKGLHFYDNLIDECLKYD
IKPLITLSHAEMPFFLTEKYNGWASRELIELYTKFCKVVFERYKNKVEYWLTFNEINSST
KDKSFGSFFSLGILNPGTTNLKNQVDCPETRFQALHHQLVASAIAVKLAHEIDPNYKVGC
MQIFATSYPYTCNPNDLLANQKLNQIRNWFCGDVQVRGEYPGYAKRYLKDRGISIEMDDD
DIKTLSEGCVDFYTLSYYMSSCHSSESDIETEANILGGLKNPYLNESEWGWQIDPKGLRY
SLNEIYDRYQIPIMIVENGLGARDTIDSNGEINDDYRIDYLSKHIAQMREAAADGVNLIG
YTAWGCIDLVSGSTGEMSKRYGMIYVNKQDDGSGDYKRLRKKSFYWYKDVISTNGQSL
>PK3-045_05614 hypothetical protein
MEQIINSPVIGEIKDITDCSDEVFAEKIMGDGIIVIPSDNVITAPCDGIIETVMKSKHAI
TMNSKLNVPILIHVGVDTVELDGNGFKTFVKDGEEVKAGQKLLEVDFKYIESKGYDTSTI
LIVVDKDYSITKENINTKVSDYIEVLKCKKI
>PK3-045_05615 PTS system beta-glucoside-specific EIIBCA component
MNFTNIASQILNLVGGSKNVKEVKHCATRLRIRTNDTSIVNKEEIKKLDGVQTVITRGED
IQVVIGNEVYEVYEEFTKLYDTTAADSKEKKDAQKDVKKEESPNVVTRFVNAISECITPI
LPALIASGIFSAIFALVRSFNWLDAESTTYQILSLFASAPLYFLPFLLAISSAKRFNVNA
YISVAVATLLLHPTLTTLLGSGNPITFFGIGVKEVSYPQSIIPILLIVWCQSYIEPRLTK
IIPSFVRLILLPFLEFAILGILALLLLGPIAGYLTDGIAGVLVPLSTDYAWLVCTILAGL
NVLLVGAGIHHGILPIAVTNFTLLGYDNIIGPAMFATGFAIAGSCIGLAIKTKQGKTKQV
ALSTGFTSLMGINEPAIYSIMFVNRRSLLASMIAGALGGLTMGLLNVRVWALGSKGIPGI
VLLAGPEFLYGCIGIIVSFIAGLTISYFLGLDKNSTSELVEKKVS
>PK3-045_05616 Transcription antiterminator LicT
MKIVSILNNNALLVEEQKGVEFIVIGKGIGFGKKNGDLVDRSKVDKVFESNNKNTNELLE
LLKYVPTEYFESVTIIVRHANKKLKKELNKGIYISLTDHIHSAIERYRDGRALNFALLDE
MCQLYPDEYKVSEWAVDYLNATYDVELPIDEVGFITVHMIASTMENDNLSLVKKVTVIVK
SITDIVNEYYSPSIKKESINYTRFLTHLKFFAIRFLSKEQMNNSLDINFVINNEGLKQTS
LVIQKINDFMREKYGNELTVYEKNYLILHLLRLKKVN
>PK3-045_05617 hypothetical protein
MEEEYYDLKGKKDKLKYFRLKDTGMFTQRSKLINIEDTQEYKTYFYPEQDKLIFEENQVR
NFSLDEHGESIPAIDGELTIFNNYFFDFWGFYLGDATRLYAYLKRHAYGEKDYVYPNFEL
ISEKMDKSRKTLHTYLDILEHYGFVYKFNVINESRNNMEESPIFKVRKQTPLLSKKLIEG
DNNIIIPENAPAHVKKMLKKEREGLPPRLRKEHEVFTRKHLKNKADILPEQLDYEEIYNK
YLQYKDILKNIHKKDKSEEVDSSITYSETEVHLKKNMTQDEKLLLAVVLESAQANISKPS
FDTWFKDILIKVQNNILTIYAPNEFAMDWLEERYKDNIVEWVNKTGSWISDINFSHYEFY
KQV
>PK3-045_05618 hypothetical protein
MENYLLKRIGFTSEDNYVILYSLLKENFTNCNENIRSSVLLSIIQEKPKNRCKKVQEVKL
LISKEQADYLLKINEEKELIREINSIILK
>PK3-045_05619 hypothetical protein
MNSQLSIFDLNIKKVKEIRTEKQIDKNVAYDVGDFITGSRKELDKIKRRFQENHSEEELE
NIEKLNPLLSEELITKRELTKSFSLKLEKENGVEPGVAKLKQLIINRIDKVPAVQTKEGR
RDFMLAIQSFLELINKVKKWDDVSDFIVGFSKTLILERNKESDTNFFILGKSFLKFFLRA
GYKSSINTASKINTWDDIFGKKENGVKGTKKKNSKWERVLPERPDRRGGKPSPVKKPEDL
VELFGFRGVQFGHYMDDEKGMEHLVRASEAILDLADVLEIDVTSLSLDGTLGLAFGARGR
GGNALGTYEALSRVINMTKNKGCLGILAHELFHSIDHYIYIKSNKNISSRGYGTECNTLG
EQIPSQIKSALEYLSESLREGNGTAYFINTNKDDVTYRGVALKRDYERFNGDIALAIKKE
CTIQRESINRRLDFSQYYGASEISLKKEKEKLKRRAKREVKKYALAMAWYHEKITGERVE
RIPYPTDKSQYYLNAIELDNGNESKYWSNIIEMAARAFEAYIADKLSATNRRNDYLVYGT
SDEIAFPQGKEREKINKAFDILFDTLKINDIL
>PK3-045_05620 Modification methylase AplI
MTVIDMIKILELFGGIGAPRKALLNLGVDHKAIDYVEIKENRVRAYNALYDHAHKPQSVV
GWNLKPDILIHGSPCQDFSRSGYRKGGNIKTKTRSSLMFETLKIIENMGKWKPKVVIWEN
VKGVLDRDLIGPFNSYIQQMRKLGYTNSFDVLNAVDFGIPQQRERVFCISIFGKEAFDFN
KLERTPMRHISGFLENKVTGSQYLVNVPSMLSRIEEFNPVKETDKYKRRLSVIEDYCWTI
TERQDRCPNAGIIRLKDKVGYRYLTEREVWRLMGFDDRDFELILEQFPSRKGCRNATLYE
LAGNSIVVPILEAIFKVILKEDFAEDLLTNTKGQLELII
>PK3-045_05621 hypothetical protein
MSHIGNKLKAGFFATPETQGEYIIKLLNVEGSGVWFDPTCGEGEILNQLAAAFNNEETII
NTYGVELDRRRAERASKLLNHCINAPIESMVIQNEAVSFLFLNPPYDFALKGMDDSSAKR
KEWVELERNYRYLKENGILIYIIPSYRFADQKISRFLATNFNEVGIMRFSKEDYEDYKQC
IFIGRKKAGKYKGINEKLYDFLLRMDSEEFILKNVNTIDQIVTREFKWNVPSGYKNLSTF
YTKLANKDDFVESIRESKGFEAFMNRTKPRQLSIGGEPILPLNQGQLSLLLASGAINGEL
GEGENYHLVQGLESVSKIVDEEVKHHDNGSKTVITKTRTKRDVSVKIITPNGMIKKLV
>PK3-045_05622 Single-stranded DNA-binding protein
MKNQCNLIGRLSRDPYLAGTEENPVCFMTLAVNRNYRNQHGEREAEFIPIKAFKEKKLAT
TCHNNLQKGSLIAVTARLQAKFKDNKTEIEIIAEDIVFLDSGKRRLKTEDDGENNHKYSY
EENYHQEDIMPWER
>PK3-045_05623 hypothetical protein
MSRYNDAKEYIKYFGENDTSLPHLLAIIVGETVCDSTIDTLGELGLSGISQLSEEELLKF
EGITTETLFRIKALNGILNMVPKFDWQSEFKISSKFDVIEYVRDIRYKQDSQLDLLFLNK
NNVVIGRQNIVKGTRTLNKDLVHLAFRQAIKRNASKIVVCSNEPAGYAVLKDEDYSLFDY
FLSISNLMNVEVLDHIILGKKMCVSIAEEITNKSKGELA
>PK3-045_05624 hypothetical protein
MMKETISKGPVLQGNVFEESKRKAEKIIASKPILHSRHSIEIILPDGERRIFKAKSVSKE
HAFNEFLVFIECLEQGINSKVMWRYKGDKVYHFSTTIYEKPSTITRLKKAIMGYFFDIE
>PK3-045_05625 hypothetical protein
MKKERIHSIDIIRGFAILGIAFANILPLSGPHLYESSPSSVWMDPIDKLVESILFIFAEG
NFYSLFSILFGFSAIIFMENAEDKGYNPYYLFSKRLWILFAIGFLHAFFIFYGDILMIYA
VIGLFLLPVYKVPGRVMMLLIGIFMIPMLFELIKILLFDYQIAAVDYNLLQNVIINYQTG
GRIALLQNTVDWLTIYSIENLPSLFCSIYPMFLLGMILGKNKALITNIKEIHKLMWVISG
SIGIAIKTLAIIYSDSYFLIRLSEIFGNISMSIFYGLSILLLLKKTGKHFKLIANIGKTS
MSNYLFQTTCCFFMFKVFKLYAQVSPGHLVFLSIALIFIQILLSNWWLKKHKQGPIESVW
RKLTYYKRTPSYNRVDKK
>PK3-045_05626 hypothetical protein
MIETKQVEFKVNDLIIQSNDLIEAYYDNELTTLEHKFIRYVASKIKKNDSQFPDYTITVK
EFAEVMNVKGNNYHSQIKELADDLTRKRIKIRSSNDKMGWFPWFSAIIYDNGTVHVSFNP
IIKDYLISLDSRFTGYSFDDIKKLKSGYTVRVYELLKQYEKIGKRTIELDELKRMIGVGD
KYPIYGNFKQRILNVAKKELEATGELYFSFKEVKQGRKTVAIDFNIHKKSPKQQTPLSKE
SQEFVESVKKSLYIHGIDISDKKILSWKKYGIELILEVLEEIKHRDIENYENYISKVLKS
KYENKEVDPDIGKVENTSKEIIDDINEIDESLLNLARQNIVAKYAPGKELIPDYFLEKEV
IPFFMKFMNVSEKVASELWEKYKTIIMYQIKTKKDEQLQKRYNR
>PK3-045_05627 hypothetical protein
MLLKHVELEDIENNDGWTNKVDIYGYENKVWVMAHGFFKEYPTRDFENTKNKIDSIIAKL
KEVSFKIIYIKQY
>PK3-045_05628 hypothetical protein
MNRIEDLIDILNKRGWDYIIEKKGNIRFILENQEIICSKVDTEGIKKIIIDIINW
>PK3-045_05629 hypothetical protein
MVDFYTSKHFYQIRENILLIDGKIEEKGNISVYHLIKDEPAFIKISQKGNIPKIIKTEDV
LFVDNSSEIYHGQKTIKKHFLVSVLLKFNEQERYITTDILAANEDHAKRIIKVNYSMFHI
LNINVKNVNIVRLFNNIQ
>PK3-045_05630 hypothetical protein
MYKITCFCPLEPTKLESLLKGIGFSSKKDGLEWYFEDIVFRIEPFKGHSNQREKGYRVYF
NGNNTMSFAYMFDLSLGTLNTTITCIEYMLSEEGKNSNDWLSLLDNNPSIITIDTRGFYQ
KNSINIIVTNNTVVFQLRSKKNTSLKLISGLKRIEELVEYIIPTTYDLFSFEEELA
>PK3-045_05631 SOS response-associated protein YedK
MCGRFTLFTDFGTIIDRFNIDSAIEESHYNPNYNVAPSQSVLSVINDGEKNRLGYLRWGL
IPPWSKDMKIGYKMINARSETIAEKPSFRNAYKKKRCLILADSFYEWKRTNERKIPMRIK
LKNNQPFGMAGFWESWKSPEGEMVYSCSVITTQPNKLMTEIHDRMPVILKPEDEQFWLNP
TNTDTNSLSKLLVPFEFEQMEAFEVSNDVNSPKNNSPSLIQQIC
>PK3-045_05632 hypothetical protein
MLIKKSKNNKHSLVYKTSTFYIEKHLVKLTYINKITFNAANGKKTIEVLWSNIKELPLSK
NIS
>PK3-045_05633 hypothetical protein
MEKYCMYLKKTEPVVTFKSGEHIFPAGIGGIQKLPREYVSHTANNAFSAMEGQVMKKSLL
ALPRQFVGPGKRGNITNPKKATQGAVSLMSGVINPDTVEFGYISLGRPYSISQIKINING
SCQFISDKSFGDVGQQTTDFTKNLGNYNGRYTLHEDERFSQDEFLLGVHEGKWYVGLSNK
DLELEVANFVKKLVEQKPFEKQIPDYGTVQQRVHQTLEFDDRYFRVCAKTIFNYLAFVKG
RDFVLQVCFDPIRDWIVNGGENTFATLSGKEMDFSAISFPDQAHKLIIIQKGKILFGHIS
FYGNGFETVVKLSDNFEGLFNLEGFICDWQNRQEYKLLDYLNSRVER
>PK3-045_05634 hypothetical protein
MRNAKIFFLIPILFFLFLLFIQEHHAHASTGDEDIYNVSSTVKNNWNNLMGSKDFTMTSG
RKIVYDVYSDKFVTNGYQVITKNFGKGSQKYIRFSGWSVLFGHREHTSSNQDTYIVARKS
SGDSGIGTVKIYKTVQGSLDATEDLEYNNQGAGIWNQCPSSATNRWNDDCNMKYQDVSFN
AYLPLEELFNRKEKANWDLFIVKKVQNQIVYTPLILPFEFSNKAYEGGKLSLSSGTNTNT
LEMNAEGVLRRKTPRESAPSVIDELGNNRYFTQGKTYTKVDFEESQTAVWYGVRSPHDSN
KTKWANTAYFTFKGDQAKLSFQPNRPPIAKWEWDPSNNVYNDTTVKMINNSSDPDGDPLT
YKWYRKPYGSADSNYVQISTAKTPSSFKIAKGKYTFKLVVSDGKEEAEAGHALYVNNRPP
VAKWEWDPSNTIYNDTPIKMVNSSSDPDGDSLTYRWERKPYGSADSNYVTVSTAKTPSSF
TIGKGDYTFKLTVSDGEDESVVGHALYVINRPPIADFTWNPSTIYNDTSVSFSNKSSDVD
GDSLTYKWETQKPNETTWSTFSTSKDPPYTLNKKGVWKVRLTVSDGEASHNVTKNITVQN
RAPAADFSWSPSTIYNDTSVSFSNKSSDADGDSLTYKWETQKPDDTNWSTISTSKNPSYT
LNKKGIWKVRLTVSDGEASNNVTKNISVKNRAPNADFTWSPSTIYNDTSVSFSNKSSDAD
GDSLTYKWETQKPNETTWSSISTSKEPSYTLNKKGVWKVRLTVSDGEASHNVTKNVTVQN
RTPVADFIWNPSTIYNDTSVSFTNKSTDADKDSLTYKWETQKPNESTWSTISSSKDPSYT
LNKKGVWKVRLTVSDGEASHNVTKNITVQNRIPVADFTWSPSTIYNDTSVSFTNKSTDAD
KDSLTFKWEAQKPNESTWSTISTSKDPSYTLNEKGVWKVRLTVSDGEASHNVIKNITVQN
RIPVADFTWSPSSIYNDTSVSFTNKSTDADKDSLTFKWEAQKPNESTWSTISTSKDPSYT
LNKKGVWKVRLTVSDGEASHNVTKNVTVKNRAPVADFTWNPTTIYNDTTVSFTNKSFDTD
GDPLTNIWEYQEPNKTTWTKFSTEKNPKNIFTKVGDYKIKLTVTDDDGATGTKEKTLKIT
NRPPQVTLTYTPKDVYEGDTVNVCIKVIDLDKQPMTVKLFLKKDYGNKQTVLTKSNINSG
EEVCYVFVPDVGNYDFTTEVDDGHDKTTVDISFYAKPLIIKGHVNHTADWKKKHEKLGNT
LDKFFSGEKFLLEADTSPYETIYVKSTLSAVQMDNKNTTSPVDLNKETNILYNGSLYEEK
HQYYPTMLKVGEAKFEFEVKYKNGVIKKDTVKINIIDDAFNSSKYHRKF
>PK3-045_05635 hypothetical protein
MKRVITLLTLILILGVLKPVHLLADELPLASCSMTINSDKATQANPANASGLCRDIVYGY
YAKAADTFNIFGGVHQSVTKSGQKFIVPVFSDKHTHAELTVYINRVATKPTPKPTPKPEP
KPEPKPTPKPEPKPDPKPAPKPKPESKPVTQPNSDNKATKPSTSTGSKNSSNTNTSKNNS
TNTSKSSSSKSNSTNLSKSSGTSNNTESKKTNSSSSSNSSSKSSQSSSSDRSNNEENKVV
ASVTKINEGSNTSTDKNDNKTKESTMETEQKKESSDKNDPSTENKEDNMDTSITNENNDN
IKEEATRSSILDEDESKSSKLPIIISVVGVLIIGAAVIFIIRKKKLKI
>PK3-045_05636 hypothetical protein
MSTTLRTLLFALLFALIMQLQLNLDTDKTASRQLKNSLELAVHDAGLAISPAALSEGKII
FDKEKSLENLKNSLNNNLKLKSSQGYVYTPTANSFFQKELYLVHLEFIDDSISRTYPFVY
YNDNYQVFENVEGPCVIAIVTTESPRWFKGDLAMIRQAAVYEYKNK
>PK3-045_05637 hypothetical protein
MARTLAEWMVLFITVNLIFTPILASIDSMHREAIEVTLTEGAKKASIEGRLTPEIIKEMK
KTLVEGYNFDESKINITGTSKLTPRNEYIEATIEVPRTFIFILNIFNQGPRTISKSTKIL
SEY
>PK3-045_05638 hypothetical protein
MNTTLAQFLKIGLTVVTISAFLFFIGYNLVGSNTTTYSAKINGAQSNLPTGAGVSSNN
>PK3-045_05639 hypothetical protein
MNKSLLTFMMMAAIVSIMTYLILGTSFNAYKAKNNQHQDMLQNEHQIKIKL
>PK3-045_05640 hypothetical protein
MDYLAPKAGVILLLFVFALPSNPISLFVYIMKRTIDYQTSKLHSEIFMLYDLIINEIEMM
TVHRLNTYSILQNIKPFFYLLQKPLTELLSSWTSDGPSKALEQFSKHLDSKPSEALIGVL
QNLDSMKRETALEQLNGMHGTFAKKQVENYRRKRKITTDLLKIPIKATHFIHILNFVLVV
VMMVIAILDKSQM
>PK3-045_05641 hypothetical protein
MNLYEQIQNDIVKYGLQQKYIAQKIGVSAQSLSYYLQQENQFKFITFYELLMEVYSDKSK
DFIIEKLKQFILVTKKKDNYKECLEWSYKNGERELFEFVLKKEEEANGSEMVKLYEMAMK
RLEKSIDPEDLLFNLGKEVYKQKESIAFAGILELWCLYDTYNYSSILLFTRSIREKIKKM
KKGYLKEAYEIRLEEIELVARMKSGDIENTISKAKKMIEIIDERKFPHNYHYMFSLLAEL
YLFSNPRKSVEYIEKAISIYKTQKLRHYEFRINALLETRDFMKIFSGDFERLTLNSHAER
AHYYARIGKKEKSLEILNEMEKKHKLTPFQLYYKYLATGNERDKEQAEKAFYKAGDYHYS
DLIKKCEKM
>PK3-045_05642 hypothetical protein
MKKIKKVIVAVLVATAIFSFGFQTGNSDVNKNADGTFEINANMDPGGGGGI
>PK3-045_05643 hypothetical protein
MEKYFLVNTVNEIIEHLGLTGQASNYIDGENLNLRKLVDDLPDNIAGEDVEAGIMRIIGK
>PK3-045_05644 hypothetical protein
MNNKNKQNTHTPEFLQEFGNRVRTLRKEKGLSINEAAEKLKVKRPTYSSWELGYRIPQSK
SLQELAKLLDTHESYLMQTSDNPTPTSNNLNKLFEVENVVFDDHVLTEKEIELTTIFLKS
LISNKRK
>PK3-045_05645 hypothetical protein
MICCMVQQKVGVLVEENKVRKRLREERINQGFSQESVANIIGVSRCFYNQIENGNRNPRY
ETIKKIESLFGIGVNSWD
>PK3-045_05646 hypothetical protein
MTTTKNNLYPKRYDELEKLERKEFGRKLLKKRMELDITRKTAAKMMDISVEMVTRIENGY
ISPETPGLLHKVENLRRKEYMRIVI
>PK3-045_05647 hypothetical protein
MKKIWPKWIRVVYYTNSSPEINSLTIGSSNAVTLHNELSRLNITVNTTIELTIDDRQASE
DEIRTFFQWLWSRYLKEEAEFEKRKKAK
>PK3-045_05648 hypothetical protein
MKSGRKPNRKQTNFLLENGYDPKSWLIVKNLDHEIHIVHRSKDESAVIKR
>PK3-045_05649 hypothetical protein
MKEKEGSVHFITNGVKKVLPIPETGFGETRIKFADGKIVACEVRTNIKLSNK
>PK3-045_05650 hypothetical protein
MGNEPSIDITDFRQTDTDIDHLIDEYVQY
>PK3-045_05651 hypothetical protein
MDKVTFADDRTEWMKKEDNFFLCFHRCVHFKECTSRHGIECNRFGGSEIPIMKRREGKKN
GNRKGKNKNRR
>PK3-045_05652 hypothetical protein
MEIEKGKIRTEDNPFIFFESNGFGTIGGYIQQKISVWIDDLSAGVVVKAMEIAVENGVKN
WRYVEAILRNWADKKLHTVEQVNAFELAEREKRSKGKNGYSKSSVRTEKIPDWFGKEQQS
DKMDDQEVNRKKAELQERIKRLGE
>PK3-045_05653 hypothetical protein
MEIKKTIHLNHEELKDAISQFLHEKGYKKVQKIRFEFSEEDGDVSGASAEFSEGEL
>PK3-045_05654 hypothetical protein
MDKQFEMVKDFQSRMGQPVEKKPKEMQQNRRDERYDYMLEELDEFKEADTIVDQADAMID
LIYFGLGTLAELGVRPQKLFEIVHNANMTKLWSDGKPRTNPETGKIIKPPTFVRPEPLLQ
AEIDKQINGKG
>PK3-045_05655 hypothetical protein
MTRVVFADFCLTCNGRGLINAGVLHGQVKERTCPTCKGSGQYRKVEEKKKKEDKGLTGPK
VQAHCPKCLALISKRQYFKATRYATFTCTCGCEWRMLLEDVKVN
>PK3-045_05656 hypothetical protein
MIGKKIKAIKTMKVRDIEDESIPPTIIKPNDIGVITGVNDYPNGKAYEVKINGEDIFIYG
ISNRYWEIID
>PK3-045_05657 hypothetical protein
MNKYIVYSTHIIPSKKKGELPDIAYQYIAVESDIGWHYDVTTFREKAYEFEEFELSYANK
IADLWGMKVEKLN
>PK3-045_05658 hypothetical protein
MKNYKIKILYDNGVEKTYKTGELSEEELNGVLSIIISVFNKGAGGYIQIPNDSGLSTIID
LRKVSNVDFLNQENEKDCWIV
>PK3-045_05659 hypothetical protein
MNKIWNISMLLGKSDVRGYQLEAENATKAAELAKIFYKGTVIRVALAEYDQD
>PK3-045_05660 hypothetical protein
MSKQIKRKYKKARIEFKKELLEKCKNNKALAMLIVETYTAWHHRRHIMKIWAMFRNPDYR
EFQRDYNENLMGKHLSGHDDIWRSLYFTERELHDKYKYQIPEVYAMGDALGIAYSVLKS
>PK3-045_05661 hypothetical protein
MPQNANLEKEKMKYVIKWVVSPYRKDKRTGAINPVPMSPYARYLRDQEIERIRG
>PK3-045_05662 hypothetical protein
MSKKIDEKEVQRLVAGQLKLFKAYRVAVENKTEQESKSLENIFPELDDNYVEKYIVVKQI
ERALEYALDEREREIITRKYLKNSRVKDAEVYLEMGISRDQYYIHKKDAINLIANALGII
>PK3-045_05663 Tyrosine recombinase XerH
MSTVQPIRDKEVIIGIKEYLRIRSMRNYLMFCFGIYSGLRISDLLQLKVWMVRNTTHINT
KETKNKNRKKFIIHPSIRKDLDNFIKDKHDDEYLFASRQMKNKTKIKGQPITRQAAYKVL
KEVANYFELEEIGTHTLRKTWGYLLYEQNPNNITLLMEIYGHKDPANTLSYIGFTQDMMD
DAILKL
>PK3-045_05664 hypothetical protein
MSRHQSPKRSEALKIWLKSGKKKKPKDIAEELGVSPNQIRKWKSIDKWEDNPDSVPKRGA
PYGNQNAVGNKGGPGGPIGNTKAVKHGLFRKWLPDDEEAKEIYDSIREGMSTLDILYEQI
LVAVTNFVRAQKIMYVKDKDDLTKEIKKEKEKDGSFEIEYEIQFAWDKQSKAMTSQAAAM
RSISNMIKQYEDLLRTLPPEEVKEEHRLRMTKIKADIEAAQRKAW
>PK3-045_05665 hypothetical protein
MAKYAILKSFYASEEWQIFRLNLINERGPICQHCGEKIAKARDIIGHHVIELTPENVHDV
MISLNPENVELVCFDCHNKTHKRYGAKFERQVFLVYGPPMSGKTTFVKQNFNRGDIVIDM
DQLYAAVSFLPVYDKPDNLLSNVMGMQNYLLDNIRTRYGKWHNAWIVGGYADKYKRERTA
NDLGAELIFCDVSKEECLRRLSMDEDKKYRQDEWSKYIDKWFASYTE
>PK3-045_05666 hypothetical protein
MPETYLWYRCVKCGKNETISEHETKKDGRTCSNCGGHSMFTGMTGGYDLSKAVETVKCST
YDNIDYALLEIYTRMKHGDSLEKAKQNVIWLEDLTEGDRQLIDDAIHSVKSLGLDDIAAV
ILVKSLYRYTGKIL
>PK3-045_05667 hypothetical protein
MLVDAFNKIFEVLSYPFRKHIDNNNQDAKPIDWKELEARMARPVVMDIPVGTTVNPRAVI
PKPQASKPIDRKRVDSLITYGQYLKELSDSRVASRVNSEELSEQIRDSTLLVINKLNKLL
DLSESSDTDKPIHKAVVVDELAEYLQKTYNNETKLRDR
>PK3-045_05668 hypothetical protein
MSKRAVYEKEKAKMTEIFKDVDESKRKLVEGLIDEAAFIKAENSVLQKLIDESGMVKVHP
DNPTLQKSLETSKQYLKNCNAYSVIIKTLNGVLNKDIIDEDDDDMSEFV
>PK3-045_05669 hypothetical protein
MTDLAVQNVLASPYEYKGTHSYILEYVGRIKKGEIIVGQELMLQLNKLISYFDDPNIKVD
FTEAHKRISFIETKCKHFEAPFAGKPFILDLFQKAFVEAIYCFQIFDDEINRFVRLHQDV
LFLVARKNGKTPLISALCLAEFFCGEMGTRILCSSNDYEQADLMFQAINSMREESSSLEK
VTRSNVKGIFFGNPKRVKKTGKFSYKNKGTIKKISAKTGAKEGKNIKVGAVDEVHELKDN
SSTMPIRQAVSTQDEPLYIELTTEGVINDGYLDERLREARQALNDEIERPRWLIWLYTQD
NEQEIWQDEESWVKSNPGLGVIKKRSFLRKMISEAQTSKSMRVMVLSKDFNIKQNNASAW
LSPEDIKSDETFDMEDFRNAFAIGGVDLAATGDLASARVMLMKPDSQKKYYKQQYFIPES
KLETLSKDDYALYQGWIKEGLMTVSPGNENDFSLVTKWFIQLKKDYGIRAFIVGYDKWSA
VYWVKEMEAYGFDCIKVNQQDWVSMSEAMRLVEADLKKNLINYNRNPIDKWCLENTAIEM
NARMDFRPTKVQGKEDKKIDGAVTIIFTYRVYMDHRTDFLQLVKRAG
>PK3-045_05670 hypothetical protein
MALMDVFKNILPKSRREMTYAKMLDGRSPIFSQFGQNIYVSDVVQMCIGIIATEMSKLQP
RHIRTNANGIQTVVNSSINRLFKYGPNELMTTKEFIEKIIWILYMNNNSFIYPIFEPRQD
NNGNMIKYYTGFYPLNPSGVVFLQDPSGRLFIEFSFANGSKFTLAYSDVIHLRKGFSVND
MMGGGIDGQPDNQALLKVLQINDTLLQGLDKAIKTSLSVRGVLKINTLMDDESMDEKRKE
FEAAMKRGDSSILPMDLKGEYINIGTDVKLVDKDTLEFLQNKVLNYYGVSLPIFTGDFND
EQYQAFYEKTLEPWVILLSQAFTRPLFSTREMDVGNEIVWYQKDMNYLSTNAKMNILKTA
GEQGLLSDNQKLALLGYPPRPDGDRITQSLNYIDINLVNAYQMTNKNNTKGATDSE
>PK3-045_05671 hypothetical protein
MSKQKIPDKNLPVIRNFSLADLRAVDDGNYIEGHPAVYGQVTKIGNWFNEVIERGAFDEC
DFDDVLFSINHDLKKIPLARSRRNNGNSTMQLLTNETGLYIKASLDVENNNEARSLHSAV
KRGDIDGMSFIFYVKDEEWQDMDSEMPTRRIKKIKKVIEVSAVNFPAYSGTDINARDQSV
LDNAKLALDNARSQLDNSKDELEVLRLRSQILINMEAN
>PK3-045_05672 hypothetical protein
MNKKKLKALLQKKEERKQALGQTASTTESVAELRSINQELDALNGEIKELRDVIANLPDD
EDDNPEGRSADPAYEPEQRNAHTPNGAMQVLGSYGLNQNQTPGQQQRSADRFDTPEYRAA
FMDYVTKGTKSDTLEVRADATTGTGDIGVVIPTTVLNKIVEKLKDNGRIWARVTKTSVQG
GVEIPLANAKPTATWVAAGSMSDKQKKQVQGKIVFSYHKLQCRVAVELVASVVAMPVFEQ
TVSDNIYEAMIIALEEGIINGTGTGQPLGITKDTNIPAAQRIEVTAEEFGKYETWTKLFG
KIPRKYRSGAELIMADADWTKYIEGMVDANGQPIARVTYGLDGTIQEKLLGKDVLAIEDY
LPSIDDAEAGEVVAILVKLTDYMVNSNMQMTFKRYFNEETDEWVSKSTLIADGKLADRNG
VVLIVKAAESAA
>PK3-045_05673 hypothetical protein
MADNPMDNDQLLAACKIGLGFEVEDADLDKRIKQKMLQVKMFMIKAGVTEENITSDLGIG
TLVIGINDLWDLSAGDIKFSPAFLTLTTQLA
>PK3-045_05674 hypothetical protein
MRINSVIFLIPLISGSNDIGDPIEIDGNPRKLFAEKVSIRQSEFYQAAATRYKPEISFKI
WSKEYKDEEKLDYKGTKYTIFRTFSKGEYTELICSRVENGVK
>PK3-045_05675 hypothetical protein
MARIPSPIRIRKDGVEYVSNVERTKYTLLELTRAALKDVARFLRRRMLDKARKMPGMKKG
RRIPNAFQYWVRRRETDLIIGIKHDTWYGADQELGTNGQPKRSVLRQTAYENINEIRKIQ
GKYLSAIEDENRALGLIDENEEIGDD
>PK3-045_05676 hypothetical protein
MIDLRKTIQSLIKSVHPRVYFHEAPKSETSYPYIVYDIEIYGLGEGNELVTLEIDGWDDN
KDSLPLETLLENINNTFKELSIITDSFAITFSLDRILPLSDESDKAVNKRRYVYEGRLLR
SDQ
>PK3-045_05677 hypothetical protein
MGKPKLKKEQIENVQIDYGLIIMNYGEPDQERLGPTRGGGEFNATKNIRDIEYDGQPGKT
KSLQTIDEINALLKTTILDTSLSTLAKIMPHADYDEVTKIIKNAQLGAIPLSKYLKNITM
FAKVINGGYKKITLFNAMNETDFVLTAGPKAEGEVAVEFHAHYDPEEDETQTIYTIEDVT
EIVDSSTTSTTNEDTTTEG
>PK3-045_05678 hypothetical protein
MLTVKQGIKLSAIVDKMGLEVKATKVAPDGTTKRLTQEEVGADLIMQGIKNLHKAENELY
AFVASAKKCTVQEAEEVDVVAFIKDMFSDAATIDFLKSAANTVGQE
>PK3-045_05679 hypothetical protein
MAAILDLPISSIESLLDHALEKEINKTAFDVWISVYPLMIEEKIESIDFEDFKGKFFKKQ
TAGSNKSIKEIEKEMDKIITAYEKAVK
>PK3-045_05680 hypothetical protein
MELFKLFGSIFIDNEKANESIDKTEKKGKGLFGTLGNIAGNAGKVGVVLGGALVAGAGAA
AAGIGALFVSGENMNKALVKLQQQTGATDEEMKVLKSSLVDIYRNNYGKSFEDIADSMAL
VKQSTGLAGEELQEATKQALLFRDSMGYEVTESTKTVSVMMKQFGITSKEAYTLLAQGQQ
QGLNYADDMMDSFWEYSVYFKQLGFDAEGMWNVFKAGAEGGAFNTDKLGDSIKELGIRVK
DGSKTTNEAFAGLGLNADDMASKFAKGGDDAQKALSTVFKSLSDIKDPIERNTIGVSLFG
TQFEDLEYKTILALGNVRDQADMTADTLDKIDKVKYNSVGEAIKGMWRIIQGDLLIPIQE
KMMPIINDGVNFFREHLPGAIDYAKSKFESFTQIFAPLENAISGVMALFDGNTAKGKGIL
YSVGLSREEVSTITEVIEKIKLIKPAFEGVMEIFNGDRLAGIGILSRLGLSSDQVMLVLN
AVDLVKGYIANLKEFWTAAFQTAKHVVTDAFNFLQPYIMPILSAIVSFISEKVKMISDFW
SENGEQIMQAVQNAFQFIKSIIEFVMPAVLFIIQMVWENIKGVINGGLNFIMGLIKLFTG
IFTGDFSKMWEGIKQMFSGAIEFIWNFINLLFIGRILGGIKSFVTAGVSTLKSFWTKGVE
IFKNLDTHIWGIVKSFISKILGKFKSLYDQGSRIFGTLKTFGANTFSAMWNAIRTVVSNM
VSGVVTKIKSIYTGARNIFNNLLSTGKSIFGKLKNAIMHPIDSAKEAVKKSISAIKGFFS
GLKLKLPDIKTPHFKIKNWSINPKDWLKARPSIGIDWYAKGTNYADGGLSIVGEHGPELL
NLPRGSQVKNATETRGILNQDSNNDIEVLELLRLIAKNIGGDIYLGSEKVGSVMDKEFSR
RITLEKRRVAIE
>PK3-045_05681 hypothetical protein
MISVGISFNNKHSYQDFGLILQERKIGNPSKIKNTERIPWSNVEYDFSSLYGEQEYEERI
LSYTFALVAHSKEYYTTMKTVVVNWLCSSSGKMILKDDIIPNYYFLAEVVKGPSETDFNS
DGSITVEFTAYPFKISSLKEGHDIWDEFNFLLDYAQETDFTVNESLDVTLYNPGITIVYP
KITCTSAMQLQKGNITYEIPAGYTSSYDFSLSPGENKLKIIGTGSISFEFYKELI
>PK3-045_05682 hypothetical protein
MYRVTINNDGEVMIIHHPHFNDLKLATGQIKQGINVAAGFTFSILPNNPGYNLLRPLKTL
IAVDNLKTGKTEFDGRILMPTESMSDSGAFTKSFVCESELAYLYDSCQRHGEYHNISVRE
FLEVIIANHNKDIEDDEIDKKFVVGNVTVTDTNDSLYRYLGYESTLDTIHDKLINRLGGE
LIVRKENGIRYLDYLVVAGEVKSTEIRLAKNLKSVQKEVDPSDIITKLVPLGQSIESTDG
TSTDASQARLTIESVNGGKDYIIDETARQNFTIQSKSVTFDDITQPANLLTAGKSYLKEN
NRVKVKYSVSALDLSLIDLDTDAFDTGNFYPLINPVMAINETLRVIEKTIDIIKPNKNTL
TIGDLFKTATQYQNEANKVQANVLELKNTVTRQTNKIGSISTELSLTKEELNTTKQMLQQ
TQERLESYENITDGDITAISQSISDLLEAIDDIEQAIAGIPQYQLATTTSDGLMSAADKR
KLDLITILESIDLSDMKQKLDLISIVNPIDLDELVARVTALEGGGQ
>PK3-045_05683 hypothetical protein
MGSITEYLNKIITAVKGVDTRQAMHDAIKQVYDDAAQSGNANMEVTLARGTEPNLNARLN
KMDQVAETNTAKLATKVSRINYDADKSYLDARLNALTSQWGQPFQSFEDLKNALPSNDGK
LHPINDDDSWYFWLDGQGWTAGGKLNTALLANRSVTAKQTDFLNTVSRINYFNKNDILIN
KFYNYETGEITTSITASGSNLIPVKNGDIIRFKSLTAGNYQWVIFDSNKNFLGGGLVSDP
GTDVINTVNISKENAAYFSIAFRNSEIDQFMVVKNISFPAYYHEYYTDDEIDSFSAELKE
SVSLGKSMTQILSSIPSKGITAKMVSFLDSLEVVNLFDKNNIMVNSYYAYNTGEITTGIT
ASGSNLIPVKNGDIIRFKKFTEGNYQYVFLDENKNYIKGGYLTTLTVGQVATVNIDDENA
KYYAMAFRNTEIDQFMIVKNRGFPDEYYEYVSEEDAAGYESKLSEEVSIENHLKEIKENM
KYWFSPWYGKTIVFNGDSITDPNYNATLTFRYPEVVRDTLGFTGFYNYGISGSTLAVNPN
APTERNPFVTRIEEMVVGDVNYFAFGSNDAKYSWTPIGDMDSRDVYTFYGALHLACQKLI
KKCKNKVIVFATPIMRRQDNLSSPTSVNDYGKTIKDYGDSIKEVCGYYGIPVLDMYHESG
LYPFDDEVALEYFLQQGSAGSYYYTHPNGNGQLMMGRRATGFIRQLA
>PK3-045_05684 hypothetical protein
MFSLSIDRIVRYNGMCYQVIESLDSNHLLVVQKEVFDAGIYPMNTCIIPEVNIV
>PK3-045_05685 hypothetical protein
MSQIQITNAQVPTGRPRTLLISGYIDSESFYAEFLSVNLNITSSHTLSVKQVQEFENKLK
KDVFPLPYSGKFDKKEIDEVLEESPIIFTV
>PK3-045_05686 Tyrosine recombinase XerC
MNNVYAGEQMLSEIVVVLFDMFPGLDSHKVKTQLSKIISCYQIEKKVGETLESDIPDKAK
LFISSKKVEGLSEATLKDYAMELRLFSKKVIKMTENITTADIRVYLGELEGLKTSTITKK
LDVLKSFFSFLHGEELISRNPAARIKVPRQEKLIPKALTIEELELLRESCKTVRQRAFLE
CLYATGCRLSEFHALNIKDINEIDMSTVVYGKGKKERGVYFSFKAMFHLKKYLKMRNDDC
EALMVTERKPYRRLSKRAIQDEIRKIANAAGLEKKVTPHVMRHTFATLTLNNGADLVAVQ
ELLGHSNSDTTLRYARITEQRKHEQHKKYLVQ
>PK3-045_05687 hypothetical protein
MIQQLQQINLLEYFPSLILAMLTVYFIFKALDFITGLLKTWKGVVSYQSRVMRDGIIRWI
SELVGIAFVLTLDIVLGLNFYLTGFTLALFIYKEGGSIVENLNTLDVILPSVVKEKLNSF
NKDKKE
>PK3-045_05688 hypothetical protein
MAKGFDCATKLTKTTATTLKKLGYEYVFRYLGPDSSWKSFSATEAKIIKDAGLKLVSICQ
LVNNGPSYFSYNDGAAIAKYAMEHAKRVGQPQGTAIYFAVDFDAQSKHMDKIKEHFKGIK
DTLKGYKVGIYGSYDVMMSMKGKVDYYWQTYAWSNKKVADFIHAHQYLNNVKEGGITIDR
NDVKKNPGDWTSGSGVIDAPKQEVGAEIVTKPNKPTSKRKKNSDGTYTVVSGDTLSEIAA
DFNVSTNDLASWNNIANKNEINVGQKLKFSAPKNAAKPKPATSGTKKITIQKGDTLSVLA
VKYKTTVSNLKALNGYKSDTIYAGKTMKVPSNSSSNTSTKKNYTVKSGDNATKIAKNNGI
TLAKLKELNPSKKNWDLVYPGDKLRIK
>PK3-045_05689 hypothetical protein
MKKFFKFGCLGVIILVVLIIVIALLGNDNDNGVSTNDKSKNTEQAAEKKKEDNKVGTRSN
PVKLNEVATIKTKTMDDDYNDYETTVDLSVEKVIRGEEAQSQLKKMNEFNEDAPEGYEWV
LASAKVKVVDSETEDHPFTIDGIMYFKFVSESGDIYSGDIVGTTEPAFSFEMYKGNEKEG
YIAGLVKKGEKASLEYDPMVSSSVFFSLQ
>PK3-045_05690 hypothetical protein
MNQLIDLLVEFCQLANLKITVNLNNQIDIYSLFMEALNKGVITSKDLDELRSIFYK
>PK3-045_05691 hypothetical protein
MDEKEFDITKIEKITYKGKELTEEQMKKLTALLEEWVKEKN
>PK3-045_05692 hypothetical protein
MTNLKLSQLADETEISLEESNRVYTVAELKREILELGEEHHLDGGWYTVTREKWHPSAEY
MITNYIEQEQAEMYEDWGVQAIGHISDEQINQIQKILDSAFEQAAVTDYWKYDKLVEIDI
FPVK
>PK3-045_05693 hypothetical protein
MRKIQLYADPIKDEIVHNLIDRLEEEGQNTRGYVQNQIKERLKAFELLCKEVGSNDPMEV
VLACMKGVTPKQESHSSQSKNETSASLDSETGNKLIHAAKNGFGIS
>PK3-045_05694 hypothetical protein
MMMKLETPYAIDLGNGYAKRKFNGVVVVEPSILAEDPGYFSSTDSKNLMSYADSANYYIG
DDVRKYQLQAIPALGEDDLNRYNSTEFKKLMYGYIAKDIRNSVEIPLLVTGLPVNHLKAK
QDEVKKMLTGKKIMVFEGKELVIDIKDVHVIPQPMGTYMQLVAEKIVNPETDKTLLIDNG
HGSLDITEVTGYTITKRAGGNLGSKLAHIEIYNFLVDKFGDLASITLPNIADLLEKGLIV
DGLIIDIREMPEVKAILSRHFDSMYSFVRNNNFSLTDYNKVVFTGGTAELHRPHIVAKKK
NNFKIKENAQTANAEGYYEYGKAVLASEKNSTVR
>PK3-045_05695 hypothetical protein
MFNLFSGKPRTKVGKWLDKRGISQEWLANKTKLNRTTISKIASDIDYEPRLSTIKKVMKA
IKEVDPNKNTDDFFDI
>PK3-045_05696 hypothetical protein
MILKINHLTYDEIHNTVVNSESILDVITRKVQNIPAAFNENCNLVRNSVHDELDLVSTIF
DLNVMRTSAKLFEMVSDNILNFIDLSIQYLPDILNFIVMMFI
>PK3-045_05697 hypothetical protein
MSRILLAVKFNELLRMIEKCDCPHRLELLENEFHEVERKLINYARNQQKEKGVQHK
>PK3-045_05698 hypothetical protein
MLGINKKKKVYSISEFLHAPQQAKQLCAHPKPFYGLFGMDITPHSLVSTGFNGPIIFVVS
LGAFCLALALGEYLLRANGLEVIADGLQDTMSIIFPIGFYLYLIIGLITVF
>PK3-045_05699 hypothetical protein
MKFLEQPILKTKLKQCFRKAELCYTSQMGNKTIYSYPKIHTIKSNDDFTEIAFSLLVGLD
PQLMKKKSYVFAQMFGKGIEMDGDLKNFKLTIYKKEFKATYDYVYKEISEHVRNHRLGVI
AGKNRHNQYESFCLTKSPHILVAGETGSGKSTQLRSILTTMILTKKHTDLHLYLADCKKS
EFHIFRKVQHVQCVESSPAKIVKMLQYIKKELDERSDLTELYEVAHIDDLPAEQKRPYLV
VCIDEFVMLRNNETVMEILTEIVAIGRTLGVFAILSMQRPSSKILDTTIRANLTVSMAFK
LRDRIESTITNTPGAEHLDMMGRFIMNRDKLYELQAPYLDIEKAKELLNPFCISKGPVKN
INDKIAAPKQVESDDDLFI
>PK3-045_05700 hypothetical protein
MRQRDRDILDSLSKFKVLSSNQIAALHFSSNSNPIVNCNRVLKRLRKEGYISANTERPFQ
PYLYFLNPAPIKKNSQKIDHFLMIAQTYIDMKSYGDVPIFEVEKKLEHATFIPDCYASWL
DKEWFIECQNSLFSTKQLYDKLNKYVQFYNQGILDPFPNVLIIGKINLNLKNEDYPFLVR
QKQSIHDLKSSIANYRKRKEIVVNSNSSLKIK
>PK3-045_05701 hypothetical protein
MQSTTIDSKMLALNWMSASAFVPVNKLIARKYGLDFAVLLAEAINQYKRWLEQDKLQDDM
FFWTEEDCEMETTLKKGKQAKIFKEMEEQKLLKRHTKKLSGGKTTRYIQIFFDAVVQLMF
EDDQVLKDKIKKQIEERKEKQKIHKKNYVLKRKQSEQEVKKTDENPEVPNSNFPEVSKTN
FWKFQNGTPVINNINKKDNTNNNNNNLNPNLNTVDKYKVLLDSKMPHDLKVKIKVMIADN
IIDLSANEILMIEDAYQHQLKKGYILPNGSKEDATVINDYEFSLTVSKMLNTVKEINNMR
GLIQTWVKKALDYKLLSMDKPDESKFYNWLED
>PK3-045_05702 hypothetical protein
MVKVQKNFRIEKDLIGIVFPLIVEGLQAKTDKFSDELGIPSRLVKETDAIEFMIKETFKK
LLSEGHIDPEDPDLEQVKI
>PK3-045_05703 hypothetical protein
MPKSYTKPNGVSASGKVQYKPDPKKYLYNVDTLWLNADVENYDEIMEDGLLNTLVKGREF
LLDTADHQFIELHITGYENPLSFKIFPGDPPMYQYSIRNDDIAIYFSKKRRDNYMPMRIQ
INQFILWEKGIKQAYFEALCVLSALGFVSWKTQLNRVDFAVHSDQWQWNLKDLQNFDYPR
NIADDNKPNFWRLDPMTGDFQTVYYGDRKRCQLRIYNKSIESKRKKKQYFLDLYEKLGMD
KDNVWNVEIEVRRPFIKECKDFNGQALFDDFELVLNENRLSDLWSYLMCMYKHSSPHWKL
ISVGSPYKSFYKVDGYELTRIKDLDSNFDREVAQIAGRLKLAVIKEEDDISLDNAIEIFK
RKYKEIEVDKKKKDWISEVKNRKQSFHNYEINKSKHLNYLKNKKITAQVNNDLQTQN
>PK3-045_05704 hypothetical protein
MKRKEVDMPRPRKYDYKKDYPVKTAIYVKLPVEVANKLDDMDLKGSELSNLVERFLIDYV
EKNSKKD
>PK3-045_05705 hypothetical protein
MEKVIVMGCQPYDFEQEGQRITGCTIYYLPNAKDPNSRMYGTKAIEIKASLDLAQNFSEG
EGIYELDFAIVPGTRGTPKMVLRTANLVKKLDFNKLIG
>PK3-045_05706 hypothetical protein
MKKILIVSIILLITFNLFNIPKVSANPGIRVVGSLAEKAMISISEKAGAKYATEKASEKA
IKRWNMELYNDLAKQTNYNNINEPIQKAKIIPFPETDSRFGKFGKIMIGGALFLTGADIA
IDVYESIKNAENEKRMLELMENFEMPETEYKSIRGFRVIPKEEPLTSSFDLVNDFEDLTY
KLSGYGSYYFSYPTTMSYKEYNTSVSVYVKAINNNNYTETHTVSVPKTIWNILGDYEAPP
IVEEVPFGWSSPLEVPDFVREYREADSQRKEEIVKEVEHAFPEGVPIVVPIKETAPGEPL
EVDDSPYKETPYEWNDPLPDQLPDPGTNPDPGTDPGTEPNPDPGTEPNPNPDPGTEPTNP
TNPGDGDGGDPTNPGNPSNPGTPKNPIPIALALALLDLLVAIIMYIGRMLEFILTIPLIP
EIPINNSAFQWFKSAKIMGVHVYPIVMSMGTIGLSFLVFKAIRKVMP
>PK3-045_05707 hypothetical protein
MLDMFDSAIETLTALFEKIVLLLNNIIVTISDTADRIDSIKFEETGVFFYLGYAHNAMGD
PLYSLFTTVCLISLGVTMWTYLLKGIGYIKNLLPW
>PK3-045_05708 hypothetical protein
MEPTTPKDMFDSLTSSAITTEATSWAGNFDGLLLVVVGVGIGFACVRFVKGLFF
>PK3-045_05709 hypothetical protein
MNPDELEVDPQVQVDPQTDTSEIVVQEVDQDYIKNNFITDKDVLMLFVAIIFMVSIAWLI
GRLINFIPDFMVSLVRKVRNKSIIYSNEHLNNPDLDPNLDKSDLGLKNLLDRWIK
>PK3-045_05710 hypothetical protein
MIYETILSSDYLLPFLGLTFIAIIIVAVVEFSYRTEQIGEDEE
>PK3-045_05711 hypothetical protein
MNIIVINDEGVEVFKTFREVQRHTSFEKSEFAKIGNDYVLNVTGESYEISKDIKLLERVA
AQKVFGKKPMDSTAIFSFVTMILALLVYMKL
>PK3-045_05712 hypothetical protein
MIDEQKVDDIFSNFIRSGNSSEDIKQIYETLPYLDADQQRVLTLVNTLAVKYNSNVLQEL
SDSVHKYARNNRRTGFRFTRLIESYSLYKHFKGYKMNGSINDEGVK
>PK3-045_05713 hypothetical protein
MPTLGIFGPQGSGKSFFAMLLARSLQLQDKNLMIYTNMNVTGDNIQIINDLGVVPFADNK
NKVLIIDEAYFTLDSRNSSSKNNRIWSKAYALFRKSDFVLTIFITHRPRMIDVNLREQMQ
YYLMCRKNSKHFDYLLLDAMSLLQVPILIPKDNYLFNFANYDTKDFPLPITITSLETHPL
FQIAK
